id	sid	tid	token	lemma	pos
cord-023095-4dannjjm	1	1	key	key	NN
cord-023095-4dannjjm	1	2	:	:	:
cord-023095-4dannjjm	2	1	cord-023095	cord-023095	NNP
cord-023095-4dannjjm	2	2	-	-	HYPH
cord-023095-4dannjjm	2	3	4dannjjm	4dannjjm	CD
cord-023095-4dannjjm	3	1	authors	author	NNS
cord-023095-4dannjjm	3	2	:	:	:
cord-023095-4dannjjm	4	1	nan	nan	NNP
cord-023095-4dannjjm	4	2	title	title	NN
cord-023095-4dannjjm	4	3	:	:	:
cord-023095-4dannjjm	4	4	Research	Research	NNP
cord-023095-4dannjjm	4	5	Abstract	Abstract	NNP
cord-023095-4dannjjm	4	6	Program	Program	NNP
cord-023095-4dannjjm	4	7	of	of	IN
cord-023095-4dannjjm	4	8	the	the	DT
cord-023095-4dannjjm	4	9	2011	2011	CD
cord-023095-4dannjjm	4	10	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	4	11	Forum	Forum	NNP
cord-023095-4dannjjm	4	12	Denver	Denver	NNP
cord-023095-4dannjjm	4	13	,	,	,
cord-023095-4dannjjm	4	14	Colorado	Colorado	NNP
cord-023095-4dannjjm	4	15	,	,	,
cord-023095-4dannjjm	4	16	June	June	NNP
cord-023095-4dannjjm	4	17	15–18	15–18	CD
cord-023095-4dannjjm	4	18	,	,	,
cord-023095-4dannjjm	4	19	2011	2011	CD
cord-023095-4dannjjm	4	20	date	date	NN
cord-023095-4dannjjm	4	21	:	:	:
cord-023095-4dannjjm	4	22	2011	2011	CD
cord-023095-4dannjjm	4	23	-	-	SYM
cord-023095-4dannjjm	4	24	05	05	CD
cord-023095-4dannjjm	4	25	-	-	HYPH
cord-023095-4dannjjm	4	26	03	03	CD
cord-023095-4dannjjm	4	27	journal	journal	NN
cord-023095-4dannjjm	4	28	:	:	:
cord-023095-4dannjjm	4	29	J	J	NNP
cord-023095-4dannjjm	4	30	Vet	Vet	NNP
cord-023095-4dannjjm	4	31	Intern	Intern	NNP
cord-023095-4dannjjm	4	32	Med	Med	NNP
cord-023095-4dannjjm	4	33	DOI	doi	NN
cord-023095-4dannjjm	4	34	:	:	:
cord-023095-4dannjjm	5	1	10.1111	10.1111	CD
cord-023095-4dannjjm	5	2	/	/	SYM
cord-023095-4dannjjm	5	3	j.1939	j.1939	NNP
cord-023095-4dannjjm	5	4	-	-	HYPH
cord-023095-4dannjjm	5	5	1676.2011.0726.x	1676.2011.0726.x	CD
cord-023095-4dannjjm	5	6	sha	sha	NNP
cord-023095-4dannjjm	5	7	:	:	:
cord-023095-4dannjjm	5	8	1707777971b3b3830a3beebff709bafe5942b15f	1707777971b3b3830a3beebff709bafe5942b15f	CD
cord-023095-4dannjjm	6	1	doc_id	doc_id	CD
cord-023095-4dannjjm	6	2	:	:	:
cord-023095-4dannjjm	6	3	23095	23095	CD
cord-023095-4dannjjm	6	4	cord_uid	cord_uid	NNS
cord-023095-4dannjjm	6	5	:	:	:
cord-023095-4dannjjm	7	1	4dannjjm	4dannjjm	CD
cord-023095-4dannjjm	8	1	nan	nan	NNP
cord-023095-4dannjjm	8	2	Clinics	Clinics	NNP
cord-023095-4dannjjm	8	3	ÃÃ	ÃÃ	NNP
cord-023095-4dannjjm	8	4	Also	also	RB
cord-023095-4dannjjm	8	5	see	see	VB
cord-023095-4dannjjm	8	6	Infectious	Infectious	NNP
cord-023095-4dannjjm	8	7	Disease	Disease	NNP
cord-023095-4dannjjm	8	8	abstracts	abstract	NNS
cord-023095-4dannjjm	8	9	ID-1	ID-1	NNP
cord-023095-4dannjjm	8	10	-ID-14	-ID-14	NNP
cord-023095-4dannjjm	9	1	(	(	-LRB-
cord-023095-4dannjjm	9	2	Thursday	Thursday	NNP
cord-023095-4dannjjm	9	3	,	,	,
cord-023095-4dannjjm	9	4	June	June	NNP
cord-023095-4dannjjm	9	5	16	16	CD
cord-023095-4dannjjm	9	6	,	,	,
cord-023095-4dannjjm	9	7	2:15	2:15	CD
cord-023095-4dannjjm	9	8	pm	pm	NN
cord-023095-4dannjjm	10	1	-6:15	-6:15	RB
cord-023095-4dannjjm	11	1	pm	pm	NNP
cord-023095-4dannjjm	11	2	)	)	-RRB-
cord-023095-4dannjjm	12	1	ÃÃ	ÃÃ	NNP
cord-023095-4dannjjm	12	2	Also	also	RB
cord-023095-4dannjjm	12	3	see	see	VB
cord-023095-4dannjjm	12	4	Pharmacology	Pharmacology	NNP
cord-023095-4dannjjm	12	5	abstracts	abstract	NNS
cord-023095-4dannjjm	12	6	P-1	P-1	NNP
cord-023095-4dannjjm	12	7	-P-5	-p-5	NN
cord-023095-4dannjjm	12	8	(	(	-LRB-
cord-023095-4dannjjm	12	9	Thursday	Thursday	NNP
cord-023095-4dannjjm	12	10	,	,	,
cord-023095-4dannjjm	12	11	June	June	NNP
cord-023095-4dannjjm	12	12	16	16	CD
cord-023095-4dannjjm	12	13	,	,	,
cord-023095-4dannjjm	12	14	5:00	5:00	CD
cord-023095-4dannjjm	12	15	pm	pm	NN
cord-023095-4dannjjm	13	1	-6:15	-6:15	RB
cord-023095-4dannjjm	14	1	pm	pm	NNP
cord-023095-4dannjjm	14	2	)	)	-RRB-
cord-023095-4dannjjm	15	1	ÃÃ	ÃÃ	NNP
cord-023095-4dannjjm	15	2	Also	also	RB
cord-023095-4dannjjm	15	3	see	see	VB
cord-023095-4dannjjm	15	4	Gasteroenterology	Gasteroenterology	NNP
cord-023095-4dannjjm	15	5	abstracts	abstract	NNS
cord-023095-4dannjjm	15	6	GI-1	GI-1	NNP
cord-023095-4dannjjm	15	7	-	-	HYPH
cord-023095-4dannjjm	15	8	June	June	NNP
cord-023095-4dannjjm	15	9	17	17	CD
cord-023095-4dannjjm	15	10	,	,	,
cord-023095-4dannjjm	15	11	8	8	CD
cord-023095-4dannjjm	15	12	Hypertrophic	hypertrophic	JJ
cord-023095-4dannjjm	15	13	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	15	14	(	(	-LRB-
cord-023095-4dannjjm	15	15	HCM	HCM	NNP
cord-023095-4dannjjm	15	16	)	)	-RRB-
cord-023095-4dannjjm	16	1	is	be	VBZ
cord-023095-4dannjjm	16	2	the	the	DT
cord-023095-4dannjjm	16	3	most	most	RBS
cord-023095-4dannjjm	16	4	commonly	commonly	RB
cord-023095-4dannjjm	16	5	observed	observe	VBN
cord-023095-4dannjjm	16	6	myocardial	myocardial	JJ
cord-023095-4dannjjm	16	7	disease	disease	NN
cord-023095-4dannjjm	16	8	in	in	IN
cord-023095-4dannjjm	16	9	cats	cat	NNS
cord-023095-4dannjjm	16	10	.	.	.
cord-023095-4dannjjm	17	1	Beta	beta	NN
cord-023095-4dannjjm	17	2	-	-	HYPH
cord-023095-4dannjjm	17	3	blockers	blocker	NNS
cord-023095-4dannjjm	17	4	and	and	CC
cord-023095-4dannjjm	17	5	calcium	calcium	NN
cord-023095-4dannjjm	17	6	channel	channel	NN
cord-023095-4dannjjm	17	7	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	17	8	are	be	VBP
cord-023095-4dannjjm	17	9	frequently	frequently	RB
cord-023095-4dannjjm	17	10	administered	administer	VBN
cord-023095-4dannjjm	17	11	drugs	drug	NNS
cord-023095-4dannjjm	17	12	to	to	IN
cord-023095-4dannjjm	17	13	cats	cat	NNS
cord-023095-4dannjjm	17	14	with	with	IN
cord-023095-4dannjjm	17	15	preclinical	preclinical	JJ
cord-023095-4dannjjm	17	16	HCM	HCM	NNP
cord-023095-4dannjjm	17	17	despite	despite	IN
cord-023095-4dannjjm	17	18	the	the	DT
cord-023095-4dannjjm	17	19	fact	fact	NN
cord-023095-4dannjjm	17	20	that	that	IN
cord-023095-4dannjjm	17	21	neither	neither	DT
cord-023095-4dannjjm	17	22	drug	drug	NN
cord-023095-4dannjjm	17	23	category	category	NN
cord-023095-4dannjjm	17	24	has	have	VBZ
cord-023095-4dannjjm	17	25	been	be	VBN
cord-023095-4dannjjm	17	26	proven	prove	VBN
cord-023095-4dannjjm	17	27	to	to	TO
cord-023095-4dannjjm	17	28	slow	slow	VB
cord-023095-4dannjjm	17	29	disease	disease	NN
cord-023095-4dannjjm	17	30	progression	progression	NN
cord-023095-4dannjjm	17	31	or	or	CC
cord-023095-4dannjjm	17	32	improve	improve	VB
cord-023095-4dannjjm	17	33	survival	survival	NN
cord-023095-4dannjjm	17	34	.	.	.
cord-023095-4dannjjm	18	1	Ivabradine	Ivabradine	NNP
cord-023095-4dannjjm	18	2	(	(	-LRB-
cord-023095-4dannjjm	18	3	Procorolan	Procorolan	NNP
cord-023095-4dannjjm	18	4	s	s	NNP
cord-023095-4dannjjm	18	5	,	,	,
cord-023095-4dannjjm	18	6	Servier	Servier	NNP
cord-023095-4dannjjm	18	7	,	,	,
cord-023095-4dannjjm	18	8	France	France	NNP
cord-023095-4dannjjm	18	9	)	)	-RRB-
cord-023095-4dannjjm	18	10	is	be	VBZ
cord-023095-4dannjjm	18	11	a	a	DT
cord-023095-4dannjjm	18	12	novel	novel	JJ
cord-023095-4dannjjm	18	13	negative	negative	JJ
cord-023095-4dannjjm	18	14	chronotropic	chronotropic	JJ
cord-023095-4dannjjm	18	15	agent	agent	NN
cord-023095-4dannjjm	18	16	used	use	VBN
cord-023095-4dannjjm	18	17	in	in	IN
cord-023095-4dannjjm	18	18	the	the	DT
cord-023095-4dannjjm	18	19	treatment	treatment	NN
cord-023095-4dannjjm	18	20	of	of	IN
cord-023095-4dannjjm	18	21	ischemic	ischemic	JJ
cord-023095-4dannjjm	18	22	heart	heart	NN
cord-023095-4dannjjm	18	23	disease	disease	NN
cord-023095-4dannjjm	18	24	in	in	IN
cord-023095-4dannjjm	18	25	people	people	NNS
cord-023095-4dannjjm	18	26	.	.	.
cord-023095-4dannjjm	19	1	Little	little	JJ
cord-023095-4dannjjm	19	2	is	be	VBZ
cord-023095-4dannjjm	19	3	known	know	VBN
cord-023095-4dannjjm	19	4	about	about	IN
cord-023095-4dannjjm	19	5	its	-PRON-	PRP$
cord-023095-4dannjjm	19	6	efficacy	efficacy	NN
cord-023095-4dannjjm	19	7	and	and	CC
cord-023095-4dannjjm	19	8	safety	safety	NN
cord-023095-4dannjjm	19	9	in	in	IN
cord-023095-4dannjjm	19	10	cats	cat	NNS
cord-023095-4dannjjm	19	11	.	.	.
cord-023095-4dannjjm	20	1	The	the	DT
cord-023095-4dannjjm	20	2	purpose	purpose	NN
cord-023095-4dannjjm	20	3	of	of	IN
cord-023095-4dannjjm	20	4	this	this	DT
cord-023095-4dannjjm	20	5	study	study	NN
cord-023095-4dannjjm	20	6	was	be	VBD
cord-023095-4dannjjm	20	7	to	to	TO
cord-023095-4dannjjm	20	8	determine	determine	VB
cord-023095-4dannjjm	20	9	the	the	DT
cord-023095-4dannjjm	20	10	short	short	JJ
cord-023095-4dannjjm	20	11	-	-	HYPH
cord-023095-4dannjjm	20	12	term	term	NN
cord-023095-4dannjjm	20	13	effects	effect	NNS
cord-023095-4dannjjm	20	14	of	of	IN
cord-023095-4dannjjm	20	15	ivabradine	ivabradine	NN
cord-023095-4dannjjm	20	16	on	on	IN
cord-023095-4dannjjm	20	17	heart	heart	NN
cord-023095-4dannjjm	20	18	rate	rate	NN
cord-023095-4dannjjm	20	19	(	(	-LRB-
cord-023095-4dannjjm	20	20	HR	HR	NNP
cord-023095-4dannjjm	20	21	)	)	-RRB-
cord-023095-4dannjjm	20	22	,	,	,
cord-023095-4dannjjm	20	23	blood	blood	NN
cord-023095-4dannjjm	20	24	pressure	pressure	NN
cord-023095-4dannjjm	20	25	,	,	,
cord-023095-4dannjjm	20	26	left	leave	VBN
cord-023095-4dannjjm	20	27	ventricular	ventricular	JJ
cord-023095-4dannjjm	20	28	(	(	-LRB-
cord-023095-4dannjjm	20	29	LV	LV	NNP
cord-023095-4dannjjm	20	30	)	)	-RRB-
cord-023095-4dannjjm	20	31	systolic	systolic	JJ
cord-023095-4dannjjm	20	32	and	and	CC
cord-023095-4dannjjm	20	33	diastolic	diastolic	JJ
cord-023095-4dannjjm	20	34	function	function	NN
cord-023095-4dannjjm	20	35	,	,	,
cord-023095-4dannjjm	20	36	left	leave	VBN
cord-023095-4dannjjm	20	37	atrial	atrial	JJ
cord-023095-4dannjjm	20	38	(	(	-LRB-
cord-023095-4dannjjm	20	39	LA	LA	NNP
cord-023095-4dannjjm	20	40	)	)	-RRB-
cord-023095-4dannjjm	20	41	performance	performance	NN
cord-023095-4dannjjm	20	42	,	,	,
cord-023095-4dannjjm	20	43	and	and	CC
cord-023095-4dannjjm	20	44	clinical	clinical	JJ
cord-023095-4dannjjm	20	45	tolerance	tolerance	NN
cord-023095-4dannjjm	20	46	in	in	IN
cord-023095-4dannjjm	20	47	healthy	healthy	JJ
cord-023095-4dannjjm	20	48	cats	cat	NNS
cord-023095-4dannjjm	20	49	after	after	IN
cord-023095-4dannjjm	20	50	repeated	repeat	VBN
cord-023095-4dannjjm	20	51	oral	oral	JJ
cord-023095-4dannjjm	20	52	doses	dose	NNS
cord-023095-4dannjjm	20	53	.	.	.
cord-023095-4dannjjm	21	1	Ten	ten	CD
cord-023095-4dannjjm	21	2	healthy	healthy	JJ
cord-023095-4dannjjm	21	3	laboratory	laboratory	NN
cord-023095-4dannjjm	21	4	cats	cat	NNS
cord-023095-4dannjjm	21	5	were	be	VBD
cord-023095-4dannjjm	21	6	involved	involve	VBN
cord-023095-4dannjjm	21	7	in	in	IN
cord-023095-4dannjjm	21	8	the	the	DT
cord-023095-4dannjjm	21	9	present	present	JJ
cord-023095-4dannjjm	21	10	study	study	NN
cord-023095-4dannjjm	21	11	.	.	.
cord-023095-4dannjjm	22	1	Physical	physical	JJ
cord-023095-4dannjjm	22	2	examination	examination	NN
cord-023095-4dannjjm	22	3	,	,	,
cord-023095-4dannjjm	22	4	systolic	systolic	JJ
cord-023095-4dannjjm	22	5	blood	blood	NN
cord-023095-4dannjjm	22	6	pressure	pressure	NN
cord-023095-4dannjjm	22	7	measurement	measurement	NN
cord-023095-4dannjjm	22	8	,	,	,
cord-023095-4dannjjm	22	9	and	and	CC
cord-023095-4dannjjm	22	10	transthoracic	transthoracic	NNP
cord-023095-4dannjjm	22	11	echocardiography	echocardiography	NN
cord-023095-4dannjjm	22	12	were	be	VBD
cord-023095-4dannjjm	22	13	performed	perform	VBN
cord-023095-4dannjjm	22	14	in	in	IN
cord-023095-4dannjjm	22	15	all	all	DT
cord-023095-4dannjjm	22	16	cats	cat	NNS
cord-023095-4dannjjm	22	17	at	at	IN
cord-023095-4dannjjm	22	18	baseline	baseline	NN
cord-023095-4dannjjm	22	19	and	and	CC
cord-023095-4dannjjm	22	20	after	after	IN
cord-023095-4dannjjm	22	21	oral	oral	JJ
cord-023095-4dannjjm	22	22	administration	administration	NN
cord-023095-4dannjjm	22	23	(	(	-LRB-
cord-023095-4dannjjm	22	24	4	4	CD
cord-023095-4dannjjm	22	25	weeks	week	NNS
cord-023095-4dannjjm	22	26	each	each	DT
cord-023095-4dannjjm	22	27	)	)	-RRB-
cord-023095-4dannjjm	22	28	of	of	IN
cord-023095-4dannjjm	22	29	ivabradine	ivabradine	NNP
cord-023095-4dannjjm	22	30	(	(	-LRB-
cord-023095-4dannjjm	22	31	0.3	0.3	CD
cord-023095-4dannjjm	22	32	mg	mg	NNP
cord-023095-4dannjjm	22	33	/	/	SYM
cord-023095-4dannjjm	22	34	kg	kg	NNP
cord-023095-4dannjjm	22	35	,	,	,
cord-023095-4dannjjm	22	36	q12	q12	NN
cord-023095-4dannjjm	22	37	h	h	NNP
cord-023095-4dannjjm	22	38	)	)	-RRB-
cord-023095-4dannjjm	22	39	and	and	CC
cord-023095-4dannjjm	22	40	atenolol	atenolol	NNP
cord-023095-4dannjjm	22	41	(	(	-LRB-
cord-023095-4dannjjm	22	42	6.25	6.25	CD
cord-023095-4dannjjm	22	43	mg	mg	NN
cord-023095-4dannjjm	22	44	/	/	SYM
cord-023095-4dannjjm	22	45	cat	cat	NN
cord-023095-4dannjjm	22	46	,	,	,
cord-023095-4dannjjm	22	47	q12h	q12h	XX
cord-023095-4dannjjm	22	48	;	;	:
cord-023095-4dannjjm	22	49	1.0	1.0	CD
cord-023095-4dannjjm	22	50	-	-	SYM
cord-023095-4dannjjm	22	51	1.7	1.7	CD
cord-023095-4dannjjm	22	52	mg	mg	NNP
cord-023095-4dannjjm	22	53	/	/	SYM
cord-023095-4dannjjm	22	54	kg	kg	NNP
cord-023095-4dannjjm	22	55	)	)	-RRB-
cord-023095-4dannjjm	22	56	in	in	IN
cord-023095-4dannjjm	22	57	a	a	DT
cord-023095-4dannjjm	22	58	prospective	prospective	JJ
cord-023095-4dannjjm	22	59	,	,	,
cord-023095-4dannjjm	22	60	double	double	JJ
cord-023095-4dannjjm	22	61	-	-	HYPH
cord-023095-4dannjjm	22	62	blind	blind	JJ
cord-023095-4dannjjm	22	63	,	,	,
cord-023095-4dannjjm	22	64	randomized	randomized	JJ
cord-023095-4dannjjm	22	65	,	,	,
cord-023095-4dannjjm	22	66	active	active	JJ
cord-023095-4dannjjm	22	67	-	-	HYPH
cord-023095-4dannjjm	22	68	control	control	NN
cord-023095-4dannjjm	22	69	,	,	,
cord-023095-4dannjjm	22	70	fully	fully	RB
cord-023095-4dannjjm	22	71	crossed	cross	VBD
cord-023095-4dannjjm	22	72	study	study	NN
cord-023095-4dannjjm	22	73	.	.	.
cord-023095-4dannjjm	23	1	A	a	LS
cord-023095-4dannjjm	23	2	-	-	HYPH
cord-023095-4dannjjm	23	3	priori	priori	FW
cord-023095-4dannjjm	23	4	non	non	JJ
cord-023095-4dannjjm	23	5	-	-	JJ
cord-023095-4dannjjm	23	6	inferiority	inferiority	JJ
cord-023095-4dannjjm	23	7	margins	margin	NNS
cord-023095-4dannjjm	23	8	for	for	IN
cord-023095-4dannjjm	23	9	the	the	DT
cord-023095-4dannjjm	23	10	effects	effect	NNS
cord-023095-4dannjjm	23	11	of	of	IN
cord-023095-4dannjjm	23	12	ivabradine	ivabradine	NN
cord-023095-4dannjjm	24	1	compared	compare	VBN
cord-023095-4dannjjm	24	2	to	to	IN
cord-023095-4dannjjm	24	3	atenolol	atenolol	NN
cord-023095-4dannjjm	24	4	were	be	VBD
cord-023095-4dannjjm	24	5	set	set	VBN
cord-023095-4dannjjm	24	6	at	at	IN
cord-023095-4dannjjm	24	7	50	50	CD
cord-023095-4dannjjm	24	8	%	%	NN
cord-023095-4dannjjm	24	9	(	(	-LRB-
cord-023095-4dannjjm	24	10	f	f	NNP
cord-023095-4dannjjm	24	11	5	5	CD
cord-023095-4dannjjm	24	12	0.5	0.5	CD
cord-023095-4dannjjm	24	13	)	)	-RRB-
cord-023095-4dannjjm	24	14	based	base	VBN
cord-023095-4dannjjm	24	15	on	on	IN
cord-023095-4dannjjm	24	16	predicted	predict	VBN
cord-023095-4dannjjm	24	17	clinical	clinical	JJ
cord-023095-4dannjjm	24	18	relevance	relevance	NN
cord-023095-4dannjjm	24	19	,	,	,
cord-023095-4dannjjm	24	20	observer	observer	NN
cord-023095-4dannjjm	24	21	measurement	measurement	NN
cord-023095-4dannjjm	24	22	variability	variability	NN
cord-023095-4dannjjm	24	23	,	,	,
cord-023095-4dannjjm	24	24	and	and	CC
cord-023095-4dannjjm	24	25	in	in	IN
cord-023095-4dannjjm	24	26	agreement	agreement	NN
cord-023095-4dannjjm	24	27	with	with	IN
cord-023095-4dannjjm	24	28	FDA	FDA	NNP
cord-023095-4dannjjm	24	29	guidelines	guideline	NNS
cord-023095-4dannjjm	24	30	.	.	.
cord-023095-4dannjjm	25	1	Variables	variable	NNS
cord-023095-4dannjjm	25	2	were	be	VBD
cord-023095-4dannjjm	25	3	compared	compare	VBN
cord-023095-4dannjjm	25	4	by	by	IN
cord-023095-4dannjjm	25	5	use	use	NN
cord-023095-4dannjjm	25	6	of	of	IN
cord-023095-4dannjjm	25	7	2-way	2-way	JJ
cord-023095-4dannjjm	25	8	repeated	repeat	VBN
cord-023095-4dannjjm	25	9	measures	measure	NNS
cord-023095-4dannjjm	25	10	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	25	11	.	.	.
cord-023095-4dannjjm	26	1	Ivabradine	Ivabradine	NNP
cord-023095-4dannjjm	26	2	was	be	VBD
cord-023095-4dannjjm	26	3	clinically	clinically	RB
cord-023095-4dannjjm	26	4	well	well	RB
cord-023095-4dannjjm	26	5	tolerated	tolerate	VBN
cord-023095-4dannjjm	26	6	with	with	IN
cord-023095-4dannjjm	26	7	no	no	DT
cord-023095-4dannjjm	26	8	adverse	adverse	JJ
cord-023095-4dannjjm	26	9	events	event	NNS
cord-023095-4dannjjm	26	10	observed	observe	VBD
cord-023095-4dannjjm	26	11	.	.	.
cord-023095-4dannjjm	27	1	HR	HR	NNP
cord-023095-4dannjjm	27	2	(	(	-LRB-
cord-023095-4dannjjm	27	3	ivabradine	ivabradine	FW
cord-023095-4dannjjm	27	4	,	,	,
cord-023095-4dannjjm	27	5	Po0.001	Po0.001	NNP
cord-023095-4dannjjm	27	6	;	;	:
cord-023095-4dannjjm	27	7	atenolol	atenolol	NN
cord-023095-4dannjjm	27	8	,	,	,
cord-023095-4dannjjm	27	9	Po0.001	Po0.001	NNP
cord-023095-4dannjjm	27	10	;	;	:
cord-023095-4dannjjm	27	11	ivabradine	ivabradine	FW
cord-023095-4dannjjm	27	12	vs.	vs.	FW
cord-023095-4dannjjm	27	13	atenolol	atenolol	NN
cord-023095-4dannjjm	27	14	,	,	,
cord-023095-4dannjjm	27	15	P	p	NN
cord-023095-4dannjjm	27	16	5	5	CD
cord-023095-4dannjjm	27	17	0.721	0.721	CD
cord-023095-4dannjjm	27	18	)	)	-RRB-
cord-023095-4dannjjm	27	19	and	and	CC
cord-023095-4dannjjm	27	20	rate	rate	NN
cord-023095-4dannjjm	27	21	-	-	HYPH
cord-023095-4dannjjm	27	22	pressure	pressure	NN
cord-023095-4dannjjm	27	23	product	product	NN
cord-023095-4dannjjm	27	24	(	(	-LRB-
cord-023095-4dannjjm	27	25	ivabradine	ivabradine	FW
cord-023095-4dannjjm	27	26	,	,	,
cord-023095-4dannjjm	27	27	P	p	NN
cord-023095-4dannjjm	27	28	o	o	NN
cord-023095-4dannjjm	27	29	0.001	0.001	CD
cord-023095-4dannjjm	27	30	;	;	:
cord-023095-4dannjjm	27	31	atenolol	atenolol	NN
cord-023095-4dannjjm	27	32	,	,	,
cord-023095-4dannjjm	27	33	P	p	NN
cord-023095-4dannjjm	27	34	5	5	CD
cord-023095-4dannjjm	27	35	0.001	0.001	CD
cord-023095-4dannjjm	27	36	;	;	:
cord-023095-4dannjjm	27	37	ivabradine	ivabradine	FW
cord-023095-4dannjjm	27	38	vs.	vs.	FW
cord-023095-4dannjjm	27	39	atenolol	atenolol	NN
cord-023095-4dannjjm	27	40	,	,	,
cord-023095-4dannjjm	27	41	P	p	NN
cord-023095-4dannjjm	27	42	5	5	CD
cord-023095-4dannjjm	27	43	0.847	0.847	CD
cord-023095-4dannjjm	27	44	)	)	-RRB-
cord-023095-4dannjjm	27	45	were	be	VBD
cord-023095-4dannjjm	27	46	not	not	RB
cord-023095-4dannjjm	27	47	different	different	JJ
cord-023095-4dannjjm	27	48	between	between	IN
cord-023095-4dannjjm	27	49	treatments	treatment	NNS
cord-023095-4dannjjm	27	50	.	.	.
cord-023095-4dannjjm	28	1	At	at	IN
cord-023095-4dannjjm	28	2	the	the	DT
cord-023095-4dannjjm	28	3	dosages	dosage	NNS
cord-023095-4dannjjm	28	4	used	use	VBN
cord-023095-4dannjjm	28	5	,	,	,
cord-023095-4dannjjm	28	6	ivabradine	ivabradine	NNP
cord-023095-4dannjjm	28	7	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	28	8	more	more	RBR
cord-023095-4dannjjm	28	9	favorable	favorable	JJ
cord-023095-4dannjjm	28	10	effects	effect	NNS
cord-023095-4dannjjm	28	11	than	than	IN
cord-023095-4dannjjm	28	12	atenolol	atenolol	NN
cord-023095-4dannjjm	28	13	on	on	IN
cord-023095-4dannjjm	28	14	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	28	15	indices	index	NNS
cord-023095-4dannjjm	28	16	of	of	IN
cord-023095-4dannjjm	28	17	left	left	JJ
cord-023095-4dannjjm	28	18	ventricular	ventricular	JJ
cord-023095-4dannjjm	28	19	(	(	-LRB-
cord-023095-4dannjjm	28	20	LV	LV	NNP
cord-023095-4dannjjm	28	21	)	)	-RRB-
cord-023095-4dannjjm	28	22	systolic	systolic	JJ
cord-023095-4dannjjm	28	23	and	and	CC
cord-023095-4dannjjm	28	24	diastolic	diastolic	JJ
cord-023095-4dannjjm	28	25	function	function	NN
cord-023095-4dannjjm	28	26	and	and	CC
cord-023095-4dannjjm	28	27	left	leave	VBN
cord-023095-4dannjjm	28	28	atrial	atrial	JJ
cord-023095-4dannjjm	28	29	performance	performance	NN
cord-023095-4dannjjm	28	30	.	.	.
cord-023095-4dannjjm	29	1	Ivabradine	Ivabradine	NNP
cord-023095-4dannjjm	29	2	is	be	VBZ
cord-023095-4dannjjm	29	3	non	non	JJ
cord-023095-4dannjjm	29	4	-	-	JJ
cord-023095-4dannjjm	29	5	inferior	inferior	JJ
cord-023095-4dannjjm	29	6	to	to	IN
cord-023095-4dannjjm	29	7	atenolol	atenolol	NN
cord-023095-4dannjjm	29	8	with	with	IN
cord-023095-4dannjjm	29	9	regard	regard	NN
cord-023095-4dannjjm	29	10	to	to	IN
cord-023095-4dannjjm	29	11	effects	effect	NNS
cord-023095-4dannjjm	29	12	on	on	IN
cord-023095-4dannjjm	29	13	HR	hr	NN
cord-023095-4dannjjm	29	14	,	,	,
cord-023095-4dannjjm	29	15	rate	rate	NN
cord-023095-4dannjjm	29	16	-	-	HYPH
cord-023095-4dannjjm	29	17	pressure	pressure	NN
cord-023095-4dannjjm	29	18	product	product	NN
cord-023095-4dannjjm	29	19	,	,	,
cord-023095-4dannjjm	29	20	LV	LV	NNP
cord-023095-4dannjjm	29	21	function	function	NN
cord-023095-4dannjjm	29	22	,	,	,
cord-023095-4dannjjm	29	23	LA	LA	NNP
cord-023095-4dannjjm	29	24	performance	performance	NN
cord-023095-4dannjjm	29	25	,	,	,
cord-023095-4dannjjm	29	26	and	and	CC
cord-023095-4dannjjm	29	27	clinical	clinical	JJ
cord-023095-4dannjjm	29	28	tolerance	tolerance	NN
cord-023095-4dannjjm	29	29	.	.	.
cord-023095-4dannjjm	30	1	Clinical	clinical	JJ
cord-023095-4dannjjm	30	2	studies	study	NNS
cord-023095-4dannjjm	30	3	in	in	IN
cord-023095-4dannjjm	30	4	cats	cat	NNS
cord-023095-4dannjjm	30	5	with	with	IN
cord-023095-4dannjjm	30	6	HCM	HCM	NNP
cord-023095-4dannjjm	30	7	are	be	VBP
cord-023095-4dannjjm	30	8	needed	need	VBN
cord-023095-4dannjjm	30	9	to	to	TO
cord-023095-4dannjjm	30	10	validate	validate	VB
cord-023095-4dannjjm	30	11	these	these	DT
cord-023095-4dannjjm	30	12	findings	finding	NNS
cord-023095-4dannjjm	30	13	and	and	CC
cord-023095-4dannjjm	30	14	further	further	RB
cord-023095-4dannjjm	30	15	assess	assess	VB
cord-023095-4dannjjm	30	16	safety	safety	NN
cord-023095-4dannjjm	30	17	.	.	.
cord-023095-4dannjjm	31	1	The	the	DT
cord-023095-4dannjjm	31	2	aim	aim	NN
cord-023095-4dannjjm	31	3	of	of	IN
cord-023095-4dannjjm	31	4	this	this	DT
cord-023095-4dannjjm	31	5	study	study	NN
cord-023095-4dannjjm	31	6	was	be	VBD
cord-023095-4dannjjm	31	7	to	to	TO
cord-023095-4dannjjm	31	8	compare	compare	VB
cord-023095-4dannjjm	31	9	outcome	outcome	NN
cord-023095-4dannjjm	31	10	from	from	IN
cord-023095-4dannjjm	31	11	CPA	cpa	NN
cord-023095-4dannjjm	31	12	in	in	IN
cord-023095-4dannjjm	31	13	dogs	dog	NNS
cord-023095-4dannjjm	31	14	following	follow	VBG
cord-023095-4dannjjm	31	15	initial	initial	JJ
cord-023095-4dannjjm	31	16	administration	administration	NN
cord-023095-4dannjjm	31	17	of	of	IN
cord-023095-4dannjjm	31	18	either	either	CC
cord-023095-4dannjjm	31	19	epinephrine	epinephrine	NN
cord-023095-4dannjjm	31	20	or	or	CC
cord-023095-4dannjjm	31	21	vasopressin	vasopressin	NN
cord-023095-4dannjjm	31	22	during	during	IN
cord-023095-4dannjjm	31	23	cardiopulmonary	cardiopulmonary	JJ
cord-023095-4dannjjm	31	24	resuscitation	resuscitation	NN
cord-023095-4dannjjm	31	25	(	(	-LRB-
cord-023095-4dannjjm	31	26	CPR	CPR	NNP
cord-023095-4dannjjm	31	27	)	)	-RRB-
cord-023095-4dannjjm	31	28	.	.	.
cord-023095-4dannjjm	32	1	Dogs	dog	NNS
cord-023095-4dannjjm	32	2	having	have	VBG
cord-023095-4dannjjm	32	3	CPA	cpa	NN
cord-023095-4dannjjm	32	4	in	in	IN
cord-023095-4dannjjm	32	5	the	the	DT
cord-023095-4dannjjm	32	6	ER	ER	NNP
cord-023095-4dannjjm	32	7	or	or	CC
cord-023095-4dannjjm	32	8	ICU	ICU	NNP
cord-023095-4dannjjm	32	9	of	of	IN
cord-023095-4dannjjm	32	10	a	a	DT
cord-023095-4dannjjm	32	11	university	university	NN
cord-023095-4dannjjm	32	12	hospital	hospital	NN
cord-023095-4dannjjm	32	13	were	be	VBD
cord-023095-4dannjjm	32	14	randomized	randomize	VBN
cord-023095-4dannjjm	32	15	to	to	TO
cord-023095-4dannjjm	32	16	receive	receive	VB
cord-023095-4dannjjm	32	17	either	either	CC
cord-023095-4dannjjm	32	18	IV	IV	NNP
cord-023095-4dannjjm	32	19	epinephrine	epinephrine	NN
cord-023095-4dannjjm	32	20	(	(	-LRB-
cord-023095-4dannjjm	32	21	0.01	0.01	CD
cord-023095-4dannjjm	32	22	-	-	SYM
cord-023095-4dannjjm	32	23	0.02	0.02	CD
cord-023095-4dannjjm	32	24	mg	mg	NNP
cord-023095-4dannjjm	32	25	/	/	SYM
cord-023095-4dannjjm	32	26	kg	kg	NNP
cord-023095-4dannjjm	32	27	)	)	-RRB-
cord-023095-4dannjjm	32	28	or	or	CC
cord-023095-4dannjjm	32	29	vasopressin	vasopressin	NN
cord-023095-4dannjjm	32	30	(	(	-LRB-
cord-023095-4dannjjm	32	31	0.5	0.5	CD
cord-023095-4dannjjm	32	32	-	-	SYM
cord-023095-4dannjjm	32	33	1.0	1.0	CD
cord-023095-4dannjjm	32	34	U	U	NNP
cord-023095-4dannjjm	32	35	/	/	SYM
cord-023095-4dannjjm	32	36	kg	kg	NNP
cord-023095-4dannjjm	32	37	)	)	-RRB-
cord-023095-4dannjjm	32	38	in	in	IN
cord-023095-4dannjjm	32	39	a	a	DT
cord-023095-4dannjjm	32	40	blinded	blinded	JJ
cord-023095-4dannjjm	32	41	fashion	fashion	NN
cord-023095-4dannjjm	32	42	immediately	immediately	RB
cord-023095-4dannjjm	32	43	following	follow	VBG
cord-023095-4dannjjm	32	44	establishment	establishment	NN
cord-023095-4dannjjm	32	45	of	of	IN
cord-023095-4dannjjm	32	46	IV	IV	NNP
cord-023095-4dannjjm	32	47	access	access	NN
cord-023095-4dannjjm	32	48	and	and	CC
cord-023095-4dannjjm	32	49	again	again	RB
cord-023095-4dannjjm	32	50	three	three	CD
cord-023095-4dannjjm	32	51	minutes	minute	NNS
cord-023095-4dannjjm	32	52	later	later	RB
cord-023095-4dannjjm	32	53	.	.	.
cord-023095-4dannjjm	33	1	A	a	DT
cord-023095-4dannjjm	33	2	standardized	standardized	JJ
cord-023095-4dannjjm	33	3	CPR	CPR	NNP
cord-023095-4dannjjm	33	4	protocol	protocol	NN
cord-023095-4dannjjm	33	5	was	be	VBD
cord-023095-4dannjjm	33	6	followed	follow	VBN
cord-023095-4dannjjm	33	7	.	.	.
cord-023095-4dannjjm	34	1	Other	other	JJ
cord-023095-4dannjjm	34	2	vasopressors	vasopressor	NNS
cord-023095-4dannjjm	34	3	were	be	VBD
cord-023095-4dannjjm	34	4	not	not	RB
cord-023095-4dannjjm	34	5	permitted	permit	VBN
cord-023095-4dannjjm	34	6	during	during	IN
cord-023095-4dannjjm	34	7	the	the	DT
cord-023095-4dannjjm	34	8	six	six	CD
cord-023095-4dannjjm	34	9	minute	minute	NN
cord-023095-4dannjjm	34	10	study	study	NN
cord-023095-4dannjjm	34	11	period	period	NN
cord-023095-4dannjjm	34	12	,	,	,
cord-023095-4dannjjm	34	13	at	at	IN
cord-023095-4dannjjm	34	14	the	the	DT
cord-023095-4dannjjm	34	15	end	end	NN
cord-023095-4dannjjm	34	16	of	of	IN
cord-023095-4dannjjm	34	17	the	the	DT
cord-023095-4dannjjm	34	18	study	study	NN
cord-023095-4dannjjm	34	19	period	period	NN
cord-023095-4dannjjm	34	20	additional	additional	JJ
cord-023095-4dannjjm	34	21	CPR	CPR	NNP
cord-023095-4dannjjm	34	22	interventions	intervention	NNS
cord-023095-4dannjjm	34	23	were	be	VBD
cord-023095-4dannjjm	34	24	at	at	IN
cord-023095-4dannjjm	34	25	the	the	DT
cord-023095-4dannjjm	34	26	discretion	discretion	NN
cord-023095-4dannjjm	34	27	of	of	IN
cord-023095-4dannjjm	34	28	the	the	DT
cord-023095-4dannjjm	34	29	managing	managing	NN
cord-023095-4dannjjm	34	30	clinician	clinician	NN
cord-023095-4dannjjm	34	31	.	.	.
cord-023095-4dannjjm	35	1	The	the	DT
cord-023095-4dannjjm	35	2	primary	primary	JJ
cord-023095-4dannjjm	35	3	end	end	NN
cord-023095-4dannjjm	35	4	point	point	NN
cord-023095-4dannjjm	35	5	was	be	VBD
cord-023095-4dannjjm	35	6	return	return	NN
cord-023095-4dannjjm	35	7	of	of	IN
cord-023095-4dannjjm	35	8	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	35	9	circulation	circulation	NN
cord-023095-4dannjjm	35	10	(	(	-LRB-
cord-023095-4dannjjm	35	11	ROSC	ROSC	NNP
cord-023095-4dannjjm	35	12	)	)	-RRB-
cord-023095-4dannjjm	35	13	within	within	IN
cord-023095-4dannjjm	35	14	the	the	DT
cord-023095-4dannjjm	35	15	study	study	NN
cord-023095-4dannjjm	35	16	period	period	NN
cord-023095-4dannjjm	35	17	;	;	,
cord-023095-4dannjjm	35	18	secondary	secondary	JJ
cord-023095-4dannjjm	35	19	end	end	NN
cord-023095-4dannjjm	35	20	points	point	NNS
cord-023095-4dannjjm	35	21	included	include	VBN
cord-023095-4dannjjm	35	22	ROSC	ROSC	NNP
cord-023095-4dannjjm	35	23	at	at	IN
cord-023095-4dannjjm	35	24	any	any	DT
cord-023095-4dannjjm	35	25	point	point	NN
cord-023095-4dannjjm	35	26	,	,	,
cord-023095-4dannjjm	35	27	survival	survival	NN
cord-023095-4dannjjm	35	28	to	to	IN
cord-023095-4dannjjm	35	29	20	20	CD
cord-023095-4dannjjm	35	30	minutes	minute	NNS
cord-023095-4dannjjm	35	31	,	,	,
cord-023095-4dannjjm	35	32	and	and	CC
cord-023095-4dannjjm	35	33	survival	survival	NN
cord-023095-4dannjjm	35	34	to	to	IN
cord-023095-4dannjjm	35	35	one	one	CD
cord-023095-4dannjjm	35	36	hour	hour	NN
cord-023095-4dannjjm	35	37	.	.	.
cord-023095-4dannjjm	36	1	Sixty	sixty	JJ
cord-023095-4dannjjm	36	2	dogs	dog	NNS
cord-023095-4dannjjm	36	3	completed	complete	VBD
cord-023095-4dannjjm	36	4	the	the	DT
cord-023095-4dannjjm	36	5	study	study	NN
cord-023095-4dannjjm	36	6	,	,	,
cord-023095-4dannjjm	36	7	31	31	CD
cord-023095-4dannjjm	36	8	received	receive	VBD
cord-023095-4dannjjm	36	9	epinephrine	epinephrine	NN
cord-023095-4dannjjm	36	10	and	and	CC
cord-023095-4dannjjm	36	11	29	29	CD
cord-023095-4dannjjm	36	12	received	receive	VBD
cord-023095-4dannjjm	36	13	vasopressin	vasopressin	NN
cord-023095-4dannjjm	36	14	.	.	.
cord-023095-4dannjjm	37	1	ROSC	rosc	JJ
cord-023095-4dannjjm	37	2	within	within	IN
cord-023095-4dannjjm	37	3	six	six	CD
cord-023095-4dannjjm	37	4	minutes	minute	NNS
cord-023095-4dannjjm	37	5	was	be	VBD
cord-023095-4dannjjm	37	6	53	53	CD
cord-023095-4dannjjm	37	7	%	%	NN
cord-023095-4dannjjm	37	8	(	(	-LRB-
cord-023095-4dannjjm	37	9	13	13	CD
cord-023095-4dannjjm	37	10	vasopressin	vasopressin	NN
cord-023095-4dannjjm	37	11	,	,	,
cord-023095-4dannjjm	37	12	19	19	CD
cord-023095-4dannjjm	37	13	epinephrine	epinephrine	NN
cord-023095-4dannjjm	37	14	p	p	NN
cord-023095-4dannjjm	37	15	5	5	CD
cord-023095-4dannjjm	37	16	0.2	0.2	CD
cord-023095-4dannjjm	37	17	)	)	-RRB-
cord-023095-4dannjjm	37	18	,	,	,
cord-023095-4dannjjm	37	19	ROSC	ROSC	NNP
cord-023095-4dannjjm	37	20	at	at	IN
cord-023095-4dannjjm	37	21	any	any	DT
cord-023095-4dannjjm	37	22	time	time	NN
cord-023095-4dannjjm	37	23	was	be	VBD
cord-023095-4dannjjm	37	24	60	60	CD
cord-023095-4dannjjm	37	25	%	%	NN
cord-023095-4dannjjm	37	26	(	(	-LRB-
cord-023095-4dannjjm	37	27	15	15	CD
cord-023095-4dannjjm	37	28	vasopressin	vasopressin	NN
cord-023095-4dannjjm	37	29	,	,	,
cord-023095-4dannjjm	37	30	21	21	CD
cord-023095-4dannjjm	37	31	epinephrine	epinephrine	NN
cord-023095-4dannjjm	37	32	p	p	NN
cord-023095-4dannjjm	37	33	5	5	CD
cord-023095-4dannjjm	37	34	0.2	0.2	CD
cord-023095-4dannjjm	37	35	)	)	-RRB-
cord-023095-4dannjjm	37	36	.	.	.
cord-023095-4dannjjm	38	1	Survival	survival	NN
cord-023095-4dannjjm	38	2	to	to	IN
cord-023095-4dannjjm	38	3	20	20	CD
cord-023095-4dannjjm	38	4	minutes	minute	NNS
cord-023095-4dannjjm	38	5	was	be	VBD
cord-023095-4dannjjm	38	6	32	32	CD
cord-023095-4dannjjm	38	7	%	%	NN
cord-023095-4dannjjm	38	8	(	(	-LRB-
cord-023095-4dannjjm	38	9	6	6	CD
cord-023095-4dannjjm	38	10	vasopressin	vasopressin	NN
cord-023095-4dannjjm	38	11	,	,	,
cord-023095-4dannjjm	38	12	13	13	CD
cord-023095-4dannjjm	38	13	epinephrine	epinephrine	NN
cord-023095-4dannjjm	38	14	p	p	NN
cord-023095-4dannjjm	38	15	5	5	CD
cord-023095-4dannjjm	38	16	0.077	0.077	CD
cord-023095-4dannjjm	38	17	)	)	-RRB-
cord-023095-4dannjjm	38	18	,	,	,
cord-023095-4dannjjm	38	19	survival	survival	NN
cord-023095-4dannjjm	38	20	to	to	IN
cord-023095-4dannjjm	38	21	one	one	CD
cord-023095-4dannjjm	38	22	hour	hour	NN
cord-023095-4dannjjm	38	23	was	be	VBD
cord-023095-4dannjjm	38	24	18	18	CD
cord-023095-4dannjjm	38	25	%	%	NN
cord-023095-4dannjjm	38	26	(	(	-LRB-
cord-023095-4dannjjm	38	27	2	2	CD
cord-023095-4dannjjm	38	28	vasopressin	vasopressin	NN
cord-023095-4dannjjm	38	29	,	,	,
cord-023095-4dannjjm	38	30	9	9	CD
cord-023095-4dannjjm	38	31	epinephrine	epinephrine	NN
cord-023095-4dannjjm	38	32	p	p	NN
cord-023095-4dannjjm	38	33	5	5	CD
cord-023095-4dannjjm	38	34	0.027	0.027	CD
cord-023095-4dannjjm	38	35	)	)	-RRB-
cord-023095-4dannjjm	38	36	.	.	.
cord-023095-4dannjjm	39	1	Five	five	CD
cord-023095-4dannjjm	39	2	dogs	dog	NNS
cord-023095-4dannjjm	39	3	survived	survive	VBD
cord-023095-4dannjjm	39	4	to	to	IN
cord-023095-4dannjjm	39	5	24	24	CD
cord-023095-4dannjjm	39	6	hours	hour	NNS
cord-023095-4dannjjm	39	7	,	,	,
cord-023095-4dannjjm	39	8	one	one	CD
cord-023095-4dannjjm	39	9	survived	survive	VBD
cord-023095-4dannjjm	39	10	to	to	IN
cord-023095-4dannjjm	39	11	hospital	hospital	NN
cord-023095-4dannjjm	39	12	discharge	discharge	NN
cord-023095-4dannjjm	39	13	.	.	.
cord-023095-4dannjjm	40	1	Of	of	IN
cord-023095-4dannjjm	40	2	animals	animal	NNS
cord-023095-4dannjjm	40	3	dying	die	VBG
cord-023095-4dannjjm	40	4	after	after	IN
cord-023095-4dannjjm	40	5	ROSC	ROSC	NNP
cord-023095-4dannjjm	40	6	,	,	,
cord-023095-4dannjjm	40	7	13/35	13/35	CD
cord-023095-4dannjjm	40	8	were	be	VBD
cord-023095-4dannjjm	40	9	euthanized	euthanize	VBN
cord-023095-4dannjjm	40	10	and	and	CC
cord-023095-4dannjjm	40	11	22/35	22/35	CD
cord-023095-4dannjjm	40	12	rearrested	rearreste	VBD
cord-023095-4dannjjm	40	13	.	.	.
cord-023095-4dannjjm	41	1	No	no	DT
cord-023095-4dannjjm	41	2	advantage	advantage	NN
cord-023095-4dannjjm	41	3	of	of	IN
cord-023095-4dannjjm	41	4	routine	routine	JJ
cord-023095-4dannjjm	41	5	substitution	substitution	NN
cord-023095-4dannjjm	41	6	of	of	IN
cord-023095-4dannjjm	41	7	vasopressin	vasopressin	NN
cord-023095-4dannjjm	41	8	for	for	IN
cord-023095-4dannjjm	41	9	epinephrine	epinephrine	NN
cord-023095-4dannjjm	41	10	was	be	VBD
cord-023095-4dannjjm	41	11	seen	see	VBN
cord-023095-4dannjjm	41	12	for	for	IN
cord-023095-4dannjjm	41	13	ROSC	rosc	NN
cord-023095-4dannjjm	41	14	,	,	,
cord-023095-4dannjjm	41	15	a	a	DT
cord-023095-4dannjjm	41	16	small	small	JJ
cord-023095-4dannjjm	41	17	survival	survival	NN
cord-023095-4dannjjm	41	18	advantage	advantage	NN
cord-023095-4dannjjm	41	19	at	at	IN
cord-023095-4dannjjm	41	20	one	one	CD
cord-023095-4dannjjm	41	21	hour	hour	NN
cord-023095-4dannjjm	41	22	was	be	VBD
cord-023095-4dannjjm	41	23	seen	see	VBN
cord-023095-4dannjjm	41	24	in	in	IN
cord-023095-4dannjjm	41	25	the	the	DT
cord-023095-4dannjjm	41	26	group	group	NN
cord-023095-4dannjjm	41	27	receiving	receive	VBG
cord-023095-4dannjjm	41	28	epinephrine	epinephrine	NN
cord-023095-4dannjjm	41	29	.	.	.
cord-023095-4dannjjm	42	1	The	the	DT
cord-023095-4dannjjm	42	2	study	study	NN
cord-023095-4dannjjm	42	3	also	also	RB
cord-023095-4dannjjm	42	4	demon	demon	NN
cord-023095-4dannjjm	42	5	-	-	,
cord-023095-4dannjjm	42	6	strated	strate	VBD
cord-023095-4dannjjm	42	7	that	that	WDT
cord-023095-4dannjjm	42	8	prospective	prospective	JJ
cord-023095-4dannjjm	42	9	clinical	clinical	JJ
cord-023095-4dannjjm	42	10	CPR	CPR	NNP
cord-023095-4dannjjm	42	11	research	research	NN
cord-023095-4dannjjm	42	12	in	in	IN
cord-023095-4dannjjm	42	13	animals	animal	NNS
cord-023095-4dannjjm	42	14	is	be	VBZ
cord-023095-4dannjjm	42	15	both	both	DT
cord-023095-4dannjjm	42	16	possible	possible	JJ
cord-023095-4dannjjm	42	17	and	and	CC
cord-023095-4dannjjm	42	18	practical	practical	JJ
cord-023095-4dannjjm	42	19	.	.	.
cord-023095-4dannjjm	43	1	Three	three	CD
cord-023095-4dannjjm	43	2	dogs	dog	NNS
cord-023095-4dannjjm	43	3	were	be	VBD
cord-023095-4dannjjm	43	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	43	5	in	in	IN
cord-023095-4dannjjm	43	6	3	3	CD
cord-023095-4dannjjm	43	7	phases	phase	NNS
cord-023095-4dannjjm	43	8	.	.	.
cord-023095-4dannjjm	44	1	Phase-1	phase-1	NN
cord-023095-4dannjjm	44	2	:	:	:
cord-023095-4dannjjm	44	3	single	single	JJ
cord-023095-4dannjjm	44	4	-	-	HYPH
cord-023095-4dannjjm	44	5	dose	dose	NN
cord-023095-4dannjjm	44	6	DiltXR	DiltXR	NNP
cord-023095-4dannjjm	44	7	at	at	IN
cord-023095-4dannjjm	44	8	approximately	approximately	RB
cord-023095-4dannjjm	44	9	6	6	CD
cord-023095-4dannjjm	44	10	mg	mg	NNS
cord-023095-4dannjjm	44	11	/	/	SYM
cord-023095-4dannjjm	44	12	kg	kg	NN
cord-023095-4dannjjm	44	13	PO	po	NN
cord-023095-4dannjjm	44	14	.	.	.
cord-023095-4dannjjm	45	1	Phase-2	phase-2	NN
cord-023095-4dannjjm	45	2	:	:	:
cord-023095-4dannjjm	46	1	same	same	JJ
cord-023095-4dannjjm	46	2	dose	dose	NN
cord-023095-4dannjjm	46	3	q12h	q12h	NFP
cord-023095-4dannjjm	46	4	for	for	IN
cord-023095-4dannjjm	46	5	4.5	4.5	CD
cord-023095-4dannjjm	46	6	days	day	NNS
cord-023095-4dannjjm	46	7	.	.	.
cord-023095-4dannjjm	47	1	Phase-3	Phase-3	NNP
cord-023095-4dannjjm	47	2	:	:	:
cord-023095-4dannjjm	47	3	after	after	IN
cord-023095-4dannjjm	47	4	a	a	DT
cord-023095-4dannjjm	47	5	14	14	CD
cord-023095-4dannjjm	47	6	day	day	NN
cord-023095-4dannjjm	47	7	wash	wash	NN
cord-023095-4dannjjm	47	8	-	-	HYPH
cord-023095-4dannjjm	47	9	out	out	RP
cord-023095-4dannjjm	47	10	the	the	DT
cord-023095-4dannjjm	47	11	single	single	JJ
cord-023095-4dannjjm	47	12	-	-	HYPH
cord-023095-4dannjjm	47	13	dose	dose	NN
cord-023095-4dannjjm	47	14	protocol	protocol	NN
cord-023095-4dannjjm	47	15	was	be	VBD
cord-023095-4dannjjm	47	16	repeated	repeat	VBN
cord-023095-4dannjjm	47	17	using	use	VBG
cord-023095-4dannjjm	47	18	cut	cut	NN
cord-023095-4dannjjm	47	19	tablets	tablet	NNS
cord-023095-4dannjjm	47	20	to	to	TO
cord-023095-4dannjjm	47	21	assess	assess	VB
cord-023095-4dannjjm	47	22	affect	affect	NN
cord-023095-4dannjjm	47	23	on	on	IN
cord-023095-4dannjjm	47	24	extended	extended	JJ
cord-023095-4dannjjm	47	25	release	release	NN
cord-023095-4dannjjm	47	26	properties	property	NNS
cord-023095-4dannjjm	47	27	.	.	.
cord-023095-4dannjjm	48	1	Blood	blood	NN
cord-023095-4dannjjm	48	2	pressure	pressure	NN
cord-023095-4dannjjm	48	3	(	(	-LRB-
cord-023095-4dannjjm	48	4	BP	BP	NNP
cord-023095-4dannjjm	48	5	)	)	-RRB-
cord-023095-4dannjjm	48	6	,	,	,
cord-023095-4dannjjm	48	7	6-lead	6-lead	CD
cord-023095-4dannjjm	48	8	ECG	ECG	NNP
cord-023095-4dannjjm	48	9	,	,	,
cord-023095-4dannjjm	48	10	echocardiogram	echocardiogram	NN
cord-023095-4dannjjm	48	11	,	,	,
cord-023095-4dannjjm	48	12	and	and	CC
cord-023095-4dannjjm	48	13	24h	24h	NNS
cord-023095-4dannjjm	48	14	-	-	HYPH
cord-023095-4dannjjm	48	15	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	48	16	ECG	ECG	NNP
cord-023095-4dannjjm	48	17	were	be	VBD
cord-023095-4dannjjm	48	18	performed	perform	VBN
cord-023095-4dannjjm	48	19	at	at	IN
cord-023095-4dannjjm	48	20	baseline	baseline	NN
cord-023095-4dannjjm	48	21	,	,	,
cord-023095-4dannjjm	48	22	and	and	CC
cord-023095-4dannjjm	48	23	conclusion	conclusion	NN
cord-023095-4dannjjm	48	24	of	of	IN
cord-023095-4dannjjm	48	25	Phase-2	Phase-2	NNP
cord-023095-4dannjjm	48	26	.	.	.
cord-023095-4dannjjm	49	1	Blood	blood	NN
cord-023095-4dannjjm	49	2	samples	sample	NNS
cord-023095-4dannjjm	49	3	and	and	CC
cord-023095-4dannjjm	49	4	BP	BP	NNP
cord-023095-4dannjjm	49	5	was	be	VBD
cord-023095-4dannjjm	49	6	obtained	obtain	VBN
cord-023095-4dannjjm	49	7	0	0	CD
cord-023095-4dannjjm	49	8	,	,	,
cord-023095-4dannjjm	49	9	1	1	CD
cord-023095-4dannjjm	49	10	,	,	,
cord-023095-4dannjjm	49	11	2	2	CD
cord-023095-4dannjjm	49	12	,	,	,
cord-023095-4dannjjm	49	13	4	4	CD
cord-023095-4dannjjm	49	14	,	,	,
cord-023095-4dannjjm	49	15	8	8	CD
cord-023095-4dannjjm	49	16	,	,	,
cord-023095-4dannjjm	49	17	12	12	CD
cord-023095-4dannjjm	49	18	,	,	,
cord-023095-4dannjjm	49	19	and	and	CC
cord-023095-4dannjjm	49	20	24h	24h	NNS
cord-023095-4dannjjm	49	21	after	after	IN
cord-023095-4dannjjm	49	22	final	final	JJ
cord-023095-4dannjjm	49	23	dosing	dosing	NN
cord-023095-4dannjjm	49	24	.	.	.
cord-023095-4dannjjm	50	1	Peak	peak	JJ
cord-023095-4dannjjm	50	2	median	median	JJ
cord-023095-4dannjjm	50	3	plasma	plasma	NN
cord-023095-4dannjjm	50	4	diltiazem	diltiazem	NN
cord-023095-4dannjjm	50	5	concentrations	concentration	NNS
cord-023095-4dannjjm	50	6	(	(	-LRB-
cord-023095-4dannjjm	50	7	mcg	mcg	NNP
cord-023095-4dannjjm	50	8	/	/	SYM
cord-023095-4dannjjm	50	9	ml	ml	NN
cord-023095-4dannjjm	50	10	)	)	-RRB-
cord-023095-4dannjjm	50	11	measured	measure	VBN
cord-023095-4dannjjm	50	12	by	by	IN
cord-023095-4dannjjm	50	13	HPLC	HPLC	NNP
cord-023095-4dannjjm	50	14	for	for	IN
cord-023095-4dannjjm	50	15	each	each	DT
cord-023095-4dannjjm	50	16	phase	phase	NN
cord-023095-4dannjjm	50	17	were	be	VBD
cord-023095-4dannjjm	50	18	0.0979	0.0979	CD
cord-023095-4dannjjm	50	19	,	,	,
cord-023095-4dannjjm	50	20	0.016	0.016	CD
cord-023095-4dannjjm	50	21	,	,	,
cord-023095-4dannjjm	50	22	and	and	CC
cord-023095-4dannjjm	50	23	0.07	0.07	CD
cord-023095-4dannjjm	50	24	respectively	respectively	RB
cord-023095-4dannjjm	50	25	.	.	.
cord-023095-4dannjjm	51	1	Diltiazem	diltiazem	NN
cord-023095-4dannjjm	51	2	concentrations	concentration	NNS
cord-023095-4dannjjm	51	3	were	be	VBD
cord-023095-4dannjjm	51	4	below	below	IN
cord-023095-4dannjjm	51	5	the	the	DT
cord-023095-4dannjjm	51	6	limit	limit	NN
cord-023095-4dannjjm	51	7	of	of	IN
cord-023095-4dannjjm	51	8	detection	detection	NN
cord-023095-4dannjjm	51	9	in	in	IN
cord-023095-4dannjjm	51	10	the	the	DT
cord-023095-4dannjjm	51	11	majority	majority	NN
cord-023095-4dannjjm	51	12	of	of	IN
cord-023095-4dannjjm	51	13	samples	sample	NNS
cord-023095-4dannjjm	51	14	in	in	IN
cord-023095-4dannjjm	51	15	phase-2	phase-2	NNP
cord-023095-4dannjjm	51	16	.	.	.
cord-023095-4dannjjm	52	1	Median	median	JJ
cord-023095-4dannjjm	52	2	diltiazem	diltiazem	NN
cord-023095-4dannjjm	52	3	concentration	concentration	NN
cord-023095-4dannjjm	52	4	reached	reach	VBD
cord-023095-4dannjjm	52	5	purported	purport	VBN
cord-023095-4dannjjm	52	6	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	52	7	concentrations	concentration	NNS
cord-023095-4dannjjm	52	8	(	(	-LRB-
cord-023095-4dannjjm	52	9	0.05	0.05	CD
cord-023095-4dannjjm	52	10	-	-	SYM
cord-023095-4dannjjm	52	11	0.2	0.2	CD
cord-023095-4dannjjm	52	12	mcg	mcg	NN
cord-023095-4dannjjm	52	13	/	/	SYM
cord-023095-4dannjjm	52	14	ml	ml	NNP
cord-023095-4dannjjm	52	15	)	)	-RRB-
cord-023095-4dannjjm	52	16	by	by	IN
cord-023095-4dannjjm	52	17	2	2	CD
cord-023095-4dannjjm	52	18	h	h	NN
cord-023095-4dannjjm	52	19	post	post	JJ
cord-023095-4dannjjm	52	20	-	-	JJ
cord-023095-4dannjjm	52	21	pill	pill	NN
cord-023095-4dannjjm	52	22	in	in	IN
cord-023095-4dannjjm	52	23	phase-1	phase-1	NNP
cord-023095-4dannjjm	52	24	and	and	CC
cord-023095-4dannjjm	52	25	1h	1h	CD
cord-023095-4dannjjm	52	26	post	post	JJ
cord-023095-4dannjjm	52	27	-	-	JJ
cord-023095-4dannjjm	52	28	pill	pill	NN
cord-023095-4dannjjm	52	29	in	in	IN
cord-023095-4dannjjm	52	30	phase-3	phase-3	NNP
cord-023095-4dannjjm	52	31	.	.	.
cord-023095-4dannjjm	53	1	Therapeutic	therapeutic	JJ
cord-023095-4dannjjm	53	2	concentrations	concentration	NNS
cord-023095-4dannjjm	53	3	were	be	VBD
cord-023095-4dannjjm	53	4	maintained	maintain	VBN
cord-023095-4dannjjm	53	5	for	for	IN
cord-023095-4dannjjm	53	6	24	24	CD
cord-023095-4dannjjm	53	7	h	h	NN
cord-023095-4dannjjm	53	8	in	in	IN
cord-023095-4dannjjm	53	9	Phase-1	Phase-1	NNP
cord-023095-4dannjjm	53	10	,	,	,
cord-023095-4dannjjm	53	11	but	but	CC
cord-023095-4dannjjm	53	12	only	only	RB
cord-023095-4dannjjm	53	13	2h	2h	CD
cord-023095-4dannjjm	53	14	in	in	IN
cord-023095-4dannjjm	53	15	phase-3	phase-3	NNP
cord-023095-4dannjjm	53	16	.	.	.
cord-023095-4dannjjm	54	1	Median	median	JJ
cord-023095-4dannjjm	54	2	BP	BP	NNP
cord-023095-4dannjjm	54	3	(	(	-LRB-
cord-023095-4dannjjm	54	4	mmHg	mmHg	NNP
cord-023095-4dannjjm	54	5	)	)	-RRB-
cord-023095-4dannjjm	54	6	was	be	VBD
cord-023095-4dannjjm	54	7	142.7	142.7	CD
cord-023095-4dannjjm	54	8	at	at	IN
cord-023095-4dannjjm	54	9	baseline	baseline	NN
cord-023095-4dannjjm	54	10	and	and	CC
cord-023095-4dannjjm	54	11	126.0	126.0	CD
cord-023095-4dannjjm	54	12	at	at	IN
cord-023095-4dannjjm	54	13	peak	peak	NN
cord-023095-4dannjjm	54	14	concentration	concentration	NN
cord-023095-4dannjjm	54	15	in	in	IN
cord-023095-4dannjjm	54	16	phase-1	phase-1	NNP
cord-023095-4dannjjm	54	17	.	.	.
cord-023095-4dannjjm	55	1	Median	median	JJ
cord-023095-4dannjjm	55	2	heart	heart	NN
cord-023095-4dannjjm	55	3	rate	rate	NN
cord-023095-4dannjjm	55	4	(	(	-LRB-
cord-023095-4dannjjm	55	5	bpm	bpm	NNP
cord-023095-4dannjjm	55	6	)	)	-RRB-
cord-023095-4dannjjm	55	7	was	be	VBD
cord-023095-4dannjjm	55	8	127.1	127.1	CD
cord-023095-4dannjjm	55	9	at	at	IN
cord-023095-4dannjjm	55	10	baseline	baseline	NN
cord-023095-4dannjjm	55	11	.	.	.
cord-023095-4dannjjm	56	1	24h	24h	NNS
cord-023095-4dannjjm	56	2	-	-	HYPH
cord-023095-4dannjjm	56	3	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	56	4	ECG	ECG	NNP
cord-023095-4dannjjm	56	5	analysis	analysis	NN
cord-023095-4dannjjm	56	6	revealed	reveal	VBD
cord-023095-4dannjjm	56	7	the	the	DT
cord-023095-4dannjjm	56	8	median	median	JJ
cord-023095-4dannjjm	56	9	hourly	hourly	JJ
cord-023095-4dannjjm	56	10	heart	heart	NN
cord-023095-4dannjjm	56	11	rate	rate	NN
cord-023095-4dannjjm	56	12	was	be	VBD
cord-023095-4dannjjm	56	13	101.5	101.5	CD
cord-023095-4dannjjm	56	14	at	at	IN
cord-023095-4dannjjm	56	15	baseline	baseline	NN
cord-023095-4dannjjm	56	16	and	and	CC
cord-023095-4dannjjm	56	17	102	102	CD
cord-023095-4dannjjm	56	18	during	during	IN
cord-023095-4dannjjm	56	19	phase-1	phase-1	NNP
cord-023095-4dannjjm	56	20	.	.	.
cord-023095-4dannjjm	57	1	Median	median	JJ
cord-023095-4dannjjm	57	2	heart	heart	NN
cord-023095-4dannjjm	57	3	rate	rate	NN
cord-023095-4dannjjm	57	4	at	at	IN
cord-023095-4dannjjm	57	5	peak	peak	NN
cord-023095-4dannjjm	57	6	concentration	concentration	NN
cord-023095-4dannjjm	57	7	in	in	IN
cord-023095-4dannjjm	57	8	phase-1	phase-1	NNP
cord-023095-4dannjjm	57	9	was	be	VBD
cord-023095-4dannjjm	57	10	127.5	127.5	CD
cord-023095-4dannjjm	57	11	.	.	.
cord-023095-4dannjjm	58	1	Lack	lack	NN
cord-023095-4dannjjm	58	2	of	of	IN
cord-023095-4dannjjm	58	3	detectable	detectable	JJ
cord-023095-4dannjjm	58	4	plasma	plasma	NN
cord-023095-4dannjjm	58	5	diltiazem	diltiazem	NN
cord-023095-4dannjjm	58	6	during	during	IN
cord-023095-4dannjjm	58	7	phase-2	phase-2	NNP
cord-023095-4dannjjm	58	8	may	may	MD
cord-023095-4dannjjm	58	9	be	be	VB
cord-023095-4dannjjm	58	10	due	due	JJ
cord-023095-4dannjjm	58	11	to	to	IN
cord-023095-4dannjjm	58	12	up	up	IN
cord-023095-4dannjjm	58	13	-	-	HYPH
cord-023095-4dannjjm	58	14	regulation	regulation	NN
cord-023095-4dannjjm	58	15	of	of	IN
cord-023095-4dannjjm	58	16	drug	drug	NN
cord-023095-4dannjjm	58	17	metabolism	metabolism	NN
cord-023095-4dannjjm	58	18	via	via	IN
cord-023095-4dannjjm	58	19	P	p	NN
cord-023095-4dannjjm	58	20	-	-	HYPH
cord-023095-4dannjjm	58	21	glycoprotein	glycoprotein	NN
cord-023095-4dannjjm	58	22	(	(	-LRB-
cord-023095-4dannjjm	58	23	ABCB1	ABCB1	NNP
cord-023095-4dannjjm	58	24	-	-	HYPH
cord-023095-4dannjjm	58	25	1	1	CD
cord-023095-4dannjjm	58	26	)	)	-RRB-
cord-023095-4dannjjm	58	27	mutations	mutation	NNS
cord-023095-4dannjjm	58	28	.	.	.
cord-023095-4dannjjm	59	1	Ongoing	ongoing	JJ
cord-023095-4dannjjm	59	2	data	data	NN
cord-023095-4dannjjm	59	3	collection	collection	NN
cord-023095-4dannjjm	59	4	and	and	CC
cord-023095-4dannjjm	59	5	analysis	analysis	NN
cord-023095-4dannjjm	59	6	will	will	MD
cord-023095-4dannjjm	59	7	include	include	VB
cord-023095-4dannjjm	59	8	mutation	mutation	NN
cord-023095-4dannjjm	59	9	testing	testing	NN
cord-023095-4dannjjm	59	10	.	.	.
cord-023095-4dannjjm	60	1	Adiponectin	Adiponectin	NNP
cord-023095-4dannjjm	60	2	(	(	-LRB-
cord-023095-4dannjjm	60	3	ADPN	ADPN	NNP
cord-023095-4dannjjm	60	4	)	)	-RRB-
cord-023095-4dannjjm	60	5	is	be	VBZ
cord-023095-4dannjjm	60	6	a	a	DT
cord-023095-4dannjjm	60	7	cytokine	cytokine	NN
cord-023095-4dannjjm	60	8	produced	produce	VBN
cord-023095-4dannjjm	60	9	by	by	IN
cord-023095-4dannjjm	60	10	fat	fat	JJ
cord-023095-4dannjjm	60	11	cells	cell	NNS
cord-023095-4dannjjm	60	12	which	which	WDT
cord-023095-4dannjjm	60	13	has	have	VBZ
cord-023095-4dannjjm	60	14	been	be	VBN
cord-023095-4dannjjm	60	15	shown	show	VBN
cord-023095-4dannjjm	60	16	to	to	TO
cord-023095-4dannjjm	60	17	be	be	VB
cord-023095-4dannjjm	60	18	correlated	correlate	VBN
cord-023095-4dannjjm	60	19	with	with	IN
cord-023095-4dannjjm	60	20	adverse	adverse	JJ
cord-023095-4dannjjm	60	21	cardiac	cardiac	JJ
cord-023095-4dannjjm	60	22	conditions	condition	NNS
cord-023095-4dannjjm	60	23	in	in	IN
cord-023095-4dannjjm	60	24	humans	human	NNS
cord-023095-4dannjjm	60	25	.	.	.
cord-023095-4dannjjm	61	1	In	in	IN
cord-023095-4dannjjm	61	2	the	the	DT
cord-023095-4dannjjm	61	3	heart	heart	NN
cord-023095-4dannjjm	61	4	,	,	,
cord-023095-4dannjjm	61	5	adiponectin	adiponectin	NN
cord-023095-4dannjjm	61	6	activates	activate	VBZ
cord-023095-4dannjjm	61	7	several	several	JJ
cord-023095-4dannjjm	61	8	pro	pro	JJ
cord-023095-4dannjjm	61	9	-	-	JJ
cord-023095-4dannjjm	61	10	survival	survival	JJ
cord-023095-4dannjjm	61	11	reactions	reaction	NNS
cord-023095-4dannjjm	61	12	,	,	,
cord-023095-4dannjjm	61	13	including	include	VBG
cord-023095-4dannjjm	61	14	the	the	DT
cord-023095-4dannjjm	61	15	AMPK	AMPK	NNP
cord-023095-4dannjjm	61	16	pathway	pathway	NN
cord-023095-4dannjjm	61	17	and	and	CC
cord-023095-4dannjjm	61	18	COX2	cox2	JJ
cord-023095-4dannjjm	61	19	receptors	receptor	NNS
cord-023095-4dannjjm	61	20	,	,	,
cord-023095-4dannjjm	61	21	which	which	WDT
cord-023095-4dannjjm	61	22	protect	protect	VBP
cord-023095-4dannjjm	61	23	the	the	DT
cord-023095-4dannjjm	61	24	heart	heart	NN
cord-023095-4dannjjm	61	25	following	follow	VBG
cord-023095-4dannjjm	61	26	ischemic	ischemic	JJ
cord-023095-4dannjjm	61	27	injury	injury	NN
cord-023095-4dannjjm	61	28	.	.	.
cord-023095-4dannjjm	62	1	Recent	recent	JJ
cord-023095-4dannjjm	62	2	studies	study	NNS
cord-023095-4dannjjm	62	3	have	have	VBP
cord-023095-4dannjjm	62	4	shown	show	VBN
cord-023095-4dannjjm	62	5	that	that	IN
cord-023095-4dannjjm	62	6	higher	high	JJR
cord-023095-4dannjjm	62	7	levels	level	NNS
cord-023095-4dannjjm	62	8	of	of	IN
cord-023095-4dannjjm	62	9	ADPN	ADPN	NNP
cord-023095-4dannjjm	62	10	influence	influence	NN
cord-023095-4dannjjm	62	11	cardiac	cardiac	JJ
cord-023095-4dannjjm	62	12	remodeling	remodeling	NN
cord-023095-4dannjjm	62	13	signaling	signal	VBG
cord-023095-4dannjjm	62	14	,	,	,
cord-023095-4dannjjm	62	15	inhibiting	inhibit	VBG
cord-023095-4dannjjm	62	16	protein	protein	NN
cord-023095-4dannjjm	62	17	synthesis	synthesis	NN
cord-023095-4dannjjm	62	18	and	and	CC
cord-023095-4dannjjm	62	19	suppressing	suppress	VBG
cord-023095-4dannjjm	62	20	pathological	pathological	JJ
cord-023095-4dannjjm	62	21	cardiac	cardiac	JJ
cord-023095-4dannjjm	62	22	growth	growth	NN
cord-023095-4dannjjm	62	23	.	.	.
cord-023095-4dannjjm	63	1	In	in	IN
cord-023095-4dannjjm	63	2	humans	human	NNS
cord-023095-4dannjjm	63	3	,	,	,
cord-023095-4dannjjm	63	4	ADPN	ADPN	NNP
cord-023095-4dannjjm	63	5	plasma	plasma	NN
cord-023095-4dannjjm	63	6	levels	level	NNS
cord-023095-4dannjjm	63	7	rise	rise	VBP
cord-023095-4dannjjm	63	8	with	with	IN
cord-023095-4dannjjm	63	9	decreased	decreased	JJ
cord-023095-4dannjjm	63	10	activity	activity	NN
cord-023095-4dannjjm	63	11	of	of	IN
cord-023095-4dannjjm	63	12	the	the	DT
cord-023095-4dannjjm	63	13	sympathetic	sympathetic	JJ
cord-023095-4dannjjm	63	14	nervous	nervous	JJ
cord-023095-4dannjjm	63	15	system	system	NN
cord-023095-4dannjjm	63	16	and	and	CC
cord-023095-4dannjjm	63	17	b	b	NN
cord-023095-4dannjjm	63	18	-	-	HYPH
cord-023095-4dannjjm	63	19	adrenergic	adrenergic	NN
cord-023095-4dannjjm	63	20	agonists	agonist	NNS
cord-023095-4dannjjm	63	21	inhibit	inhibit	VBP
cord-023095-4dannjjm	63	22	ADPN	ADPN	NNP
cord-023095-4dannjjm	63	23	at	at	IN
cord-023095-4dannjjm	63	24	the	the	DT
cord-023095-4dannjjm	63	25	level	level	NN
cord-023095-4dannjjm	63	26	of	of	IN
cord-023095-4dannjjm	63	27	gene	gene	NN
cord-023095-4dannjjm	63	28	expression	expression	NN
cord-023095-4dannjjm	63	29	.	.	.
cord-023095-4dannjjm	64	1	In	in	IN
cord-023095-4dannjjm	64	2	contrast	contrast	NN
cord-023095-4dannjjm	64	3	C	c	NN
cord-023095-4dannjjm	64	4	-	-	HYPH
cord-023095-4dannjjm	64	5	reactive	reactive	JJ
cord-023095-4dannjjm	64	6	protein	protein	NN
cord-023095-4dannjjm	64	7	(	(	-LRB-
cord-023095-4dannjjm	64	8	CRP	CRP	NNP
cord-023095-4dannjjm	64	9	)	)	-RRB-
cord-023095-4dannjjm	64	10	,	,	,
cord-023095-4dannjjm	64	11	a	a	DT
cord-023095-4dannjjm	64	12	marker	marker	NN
cord-023095-4dannjjm	64	13	of	of	IN
cord-023095-4dannjjm	64	14	systemic	systemic	JJ
cord-023095-4dannjjm	64	15	inflammation	inflammation	NN
cord-023095-4dannjjm	64	16	is	be	VBZ
cord-023095-4dannjjm	64	17	elevated	elevate	VBN
cord-023095-4dannjjm	64	18	in	in	IN
cord-023095-4dannjjm	64	19	humans	human	NNS
cord-023095-4dannjjm	64	20	with	with	IN
cord-023095-4dannjjm	64	21	congestive	congestive	JJ
cord-023095-4dannjjm	64	22	heart	heart	NN
cord-023095-4dannjjm	64	23	failure	failure	NN
cord-023095-4dannjjm	64	24	(	(	-LRB-
cord-023095-4dannjjm	64	25	CHF	CHF	NNP
cord-023095-4dannjjm	64	26	)	)	-RRB-
cord-023095-4dannjjm	64	27	and	and	CC
cord-023095-4dannjjm	64	28	correlates	correlate	VBZ
cord-023095-4dannjjm	64	29	to	to	IN
cord-023095-4dannjjm	64	30	the	the	DT
cord-023095-4dannjjm	64	31	severity	severity	NN
cord-023095-4dannjjm	64	32	of	of	IN
cord-023095-4dannjjm	64	33	disease	disease	NN
cord-023095-4dannjjm	64	34	.	.	.
cord-023095-4dannjjm	65	1	First	first	RB
cord-023095-4dannjjm	65	2	,	,	,
cord-023095-4dannjjm	65	3	we	-PRON-	PRP
cord-023095-4dannjjm	65	4	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	65	5	that	that	IN
cord-023095-4dannjjm	65	6	dogs	dog	NNS
cord-023095-4dannjjm	65	7	with	with	IN
cord-023095-4dannjjm	65	8	CHF	CHF	NNP
cord-023095-4dannjjm	65	9	would	would	MD
cord-023095-4dannjjm	65	10	have	have	VB
cord-023095-4dannjjm	65	11	reduced	reduce	VBN
cord-023095-4dannjjm	65	12	ADPN	ADPN	NNP
cord-023095-4dannjjm	65	13	and	and	CC
cord-023095-4dannjjm	65	14	elevated	elevated	JJ
cord-023095-4dannjjm	65	15	CRP	crp	NN
cord-023095-4dannjjm	65	16	compared	compare	VBN
cord-023095-4dannjjm	65	17	to	to	IN
cord-023095-4dannjjm	65	18	normal	normal	JJ
cord-023095-4dannjjm	65	19	dogs	dog	NNS
cord-023095-4dannjjm	65	20	and	and	CC
cord-023095-4dannjjm	65	21	that	that	IN
cord-023095-4dannjjm	65	22	cytokine	cytokine	NN
cord-023095-4dannjjm	65	23	concentrations	concentration	NNS
cord-023095-4dannjjm	65	24	would	would	MD
cord-023095-4dannjjm	65	25	predict	predict	VB
cord-023095-4dannjjm	65	26	severity	severity	NN
cord-023095-4dannjjm	65	27	of	of	IN
cord-023095-4dannjjm	65	28	CHF	CHF	NNP
cord-023095-4dannjjm	65	29	.	.	.
cord-023095-4dannjjm	66	1	Second	second	RB
cord-023095-4dannjjm	66	2	,	,	,
cord-023095-4dannjjm	66	3	we	-PRON-	PRP
cord-023095-4dannjjm	66	4	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	66	5	that	that	IN
cord-023095-4dannjjm	66	6	ADPN	ADPN	NNP
cord-023095-4dannjjm	66	7	receptor-1	receptor-1	NNP
cord-023095-4dannjjm	66	8	(	(	-LRB-
cord-023095-4dannjjm	66	9	R1	R1	NNP
cord-023095-4dannjjm	66	10	)	)	-RRB-
cord-023095-4dannjjm	66	11	and	and	CC
cord-023095-4dannjjm	66	12	ADPN	ADPN	NNP
cord-023095-4dannjjm	66	13	protein	protein	NN
cord-023095-4dannjjm	66	14	would	would	MD
cord-023095-4dannjjm	66	15	be	be	VB
cord-023095-4dannjjm	66	16	elevated	elevate	VBN
cord-023095-4dannjjm	66	17	in	in	IN
cord-023095-4dannjjm	66	18	the	the	DT
cord-023095-4dannjjm	66	19	myocardium	myocardium	NN
cord-023095-4dannjjm	66	20	of	of	IN
cord-023095-4dannjjm	66	21	CHF	CHF	NNP
cord-023095-4dannjjm	66	22	dogs	dog	NNS
cord-023095-4dannjjm	66	23	reflecting	reflect	VBG
cord-023095-4dannjjm	66	24	a	a	DT
cord-023095-4dannjjm	66	25	compensatory	compensatory	JJ
cord-023095-4dannjjm	66	26	process	process	NN
cord-023095-4dannjjm	66	27	.	.	.
cord-023095-4dannjjm	67	1	We	-PRON-	PRP
cord-023095-4dannjjm	67	2	collected	collect	VBD
cord-023095-4dannjjm	67	3	serum	serum	NN
cord-023095-4dannjjm	67	4	from	from	IN
cord-023095-4dannjjm	67	5	32	32	CD
cord-023095-4dannjjm	67	6	dogs	dog	NNS
cord-023095-4dannjjm	67	7	(	(	-LRB-
cord-023095-4dannjjm	67	8	18	18	CD
cord-023095-4dannjjm	67	9	healthy	healthy	JJ
cord-023095-4dannjjm	67	10	and	and	CC
cord-023095-4dannjjm	67	11	18	18	CD
cord-023095-4dannjjm	67	12	CHF	CHF	NNP
cord-023095-4dannjjm	67	13	)	)	-RRB-
cord-023095-4dannjjm	67	14	.	.	.
cord-023095-4dannjjm	68	1	Circulating	circulate	VBG
cord-023095-4dannjjm	68	2	adiponectin	adiponectin	NN
cord-023095-4dannjjm	68	3	and	and	CC
cord-023095-4dannjjm	68	4	CRP	crp	NN
cord-023095-4dannjjm	68	5	levels	level	NNS
cord-023095-4dannjjm	68	6	were	be	VBD
cord-023095-4dannjjm	68	7	quantified	quantify	VBN
cord-023095-4dannjjm	68	8	using	use	VBG
cord-023095-4dannjjm	68	9	a	a	DT
cord-023095-4dannjjm	68	10	Mouse	Mouse	NNP
cord-023095-4dannjjm	68	11	/	/	SYM
cord-023095-4dannjjm	68	12	Rat	Rat	NNP
cord-023095-4dannjjm	68	13	Adiponectin	Adiponectin	NNP
cord-023095-4dannjjm	68	14	ELISA	ELISA	NNP
cord-023095-4dannjjm	68	15	and	and	CC
cord-023095-4dannjjm	68	16	a	a	DT
cord-023095-4dannjjm	68	17	Canine	Canine	NNP
cord-023095-4dannjjm	68	18	CRP	CRP	NNP
cord-023095-4dannjjm	68	19	ELISA	ELISA	NNP
cord-023095-4dannjjm	68	20	.	.	.
cord-023095-4dannjjm	69	1	We	-PRON-	PRP
cord-023095-4dannjjm	69	2	found	find	VBD
cord-023095-4dannjjm	69	3	lower	low	JJR
cord-023095-4dannjjm	69	4	mean	mean	JJ
cord-023095-4dannjjm	69	5	CRP	CRP	NNP
cord-023095-4dannjjm	69	6	concentrations	concentration	NNS
cord-023095-4dannjjm	69	7	in	in	IN
cord-023095-4dannjjm	69	8	normal	normal	JJ
cord-023095-4dannjjm	69	9	dogs	dog	NNS
cord-023095-4dannjjm	69	10	(	(	-LRB-
cord-023095-4dannjjm	69	11	3.5	3.5	CD
cord-023095-4dannjjm	69	12	AE	AE	NNP
cord-023095-4dannjjm	69	13	2.3	2.3	CD
cord-023095-4dannjjm	69	14	mg/	mg/	NN
cord-023095-4dannjjm	69	15	ml	ml	NNP
cord-023095-4dannjjm	69	16	)	)	-RRB-
cord-023095-4dannjjm	69	17	than	than	IN
cord-023095-4dannjjm	69	18	dogs	dog	NNS
cord-023095-4dannjjm	69	19	with	with	IN
cord-023095-4dannjjm	69	20	CHF	CHF	NNP
cord-023095-4dannjjm	69	21	(	(	-LRB-
cord-023095-4dannjjm	69	22	17.9	17.9	CD
cord-023095-4dannjjm	69	23	AE	AE	NNP
cord-023095-4dannjjm	69	24	17.1	17.1	CD
cord-023095-4dannjjm	69	25	mg	mg	NNP
cord-023095-4dannjjm	69	26	/	/	SYM
cord-023095-4dannjjm	69	27	ml	ml	NNP
cord-023095-4dannjjm	69	28	)	)	-RRB-
cord-023095-4dannjjm	69	29	,	,	,
cord-023095-4dannjjm	69	30	however	however	RB
cord-023095-4dannjjm	69	31	,	,	,
cord-023095-4dannjjm	69	32	the	the	DT
cord-023095-4dannjjm	69	33	results	result	NNS
cord-023095-4dannjjm	69	34	were	be	VBD
cord-023095-4dannjjm	69	35	not	not	RB
cord-023095-4dannjjm	69	36	statistically	statistically	RB
cord-023095-4dannjjm	69	37	significant	significant	JJ
cord-023095-4dannjjm	69	38	due	due	IN
cord-023095-4dannjjm	69	39	to	to	IN
cord-023095-4dannjjm	69	40	the	the	DT
cord-023095-4dannjjm	69	41	large	large	JJ
cord-023095-4dannjjm	69	42	variability	variability	NN
cord-023095-4dannjjm	69	43	seen	see	VBN
cord-023095-4dannjjm	69	44	among	among	IN
cord-023095-4dannjjm	69	45	the	the	DT
cord-023095-4dannjjm	69	46	CHF	CHF	NNP
cord-023095-4dannjjm	69	47	dogs	dog	NNS
cord-023095-4dannjjm	69	48	(	(	-LRB-
cord-023095-4dannjjm	69	49	p	p	NN
cord-023095-4dannjjm	69	50	5	5	CD
cord-023095-4dannjjm	69	51	0.07	0.07	CD
cord-023095-4dannjjm	69	52	)	)	-RRB-
cord-023095-4dannjjm	69	53	.	.	.
cord-023095-4dannjjm	70	1	We	-PRON-	PRP
cord-023095-4dannjjm	70	2	found	find	VBD
cord-023095-4dannjjm	70	3	greater	great	JJR
cord-023095-4dannjjm	70	4	mean	mean	VB
cord-023095-4dannjjm	70	5	ADPN	ADPN	NNP
cord-023095-4dannjjm	70	6	concentrations	concentration	NNS
cord-023095-4dannjjm	70	7	in	in	IN
cord-023095-4dannjjm	70	8	normal	normal	JJ
cord-023095-4dannjjm	70	9	dogs	dog	NNS
cord-023095-4dannjjm	70	10	(	(	-LRB-
cord-023095-4dannjjm	70	11	11.46	11.46	CD
cord-023095-4dannjjm	70	12	AE	AE	NNP
cord-023095-4dannjjm	70	13	3.3	3.3	CD
cord-023095-4dannjjm	70	14	mg	mg	NNP
cord-023095-4dannjjm	70	15	/	/	SYM
cord-023095-4dannjjm	70	16	ml	ml	NNP
cord-023095-4dannjjm	70	17	)	)	-RRB-
cord-023095-4dannjjm	70	18	than	than	IN
cord-023095-4dannjjm	70	19	CHF	CHF	NNP
cord-023095-4dannjjm	70	20	dogs	dog	NNS
cord-023095-4dannjjm	70	21	(	(	-LRB-
cord-023095-4dannjjm	70	22	9.2	9.2	CD
cord-023095-4dannjjm	70	23	AE	AE	NNP
cord-023095-4dannjjm	70	24	3.2	3.2	CD
cord-023095-4dannjjm	70	25	mg	mg	NNP
cord-023095-4dannjjm	70	26	/	/	SYM
cord-023095-4dannjjm	70	27	ml	ml	NN
cord-023095-4dannjjm	70	28	)	)	-RRB-
cord-023095-4dannjjm	71	1	(	(	-LRB-
cord-023095-4dannjjm	71	2	p	p	NN
cord-023095-4dannjjm	71	3	5	5	CD
cord-023095-4dannjjm	71	4	0.05	0.05	CD
cord-023095-4dannjjm	71	5	)	)	-RRB-
cord-023095-4dannjjm	71	6	.	.	.
cord-023095-4dannjjm	72	1	In	in	IN
cord-023095-4dannjjm	72	2	general	general	JJ
cord-023095-4dannjjm	72	3	,	,	,
cord-023095-4dannjjm	72	4	the	the	DT
cord-023095-4dannjjm	72	5	greater	great	JJR
cord-023095-4dannjjm	72	6	the	the	DT
cord-023095-4dannjjm	72	7	severity	severity	NN
cord-023095-4dannjjm	72	8	of	of	IN
cord-023095-4dannjjm	72	9	the	the	DT
cord-023095-4dannjjm	72	10	heart	heart	NN
cord-023095-4dannjjm	72	11	failure	failure	NN
cord-023095-4dannjjm	72	12	,	,	,
cord-023095-4dannjjm	72	13	the	the	DT
cord-023095-4dannjjm	72	14	lower	low	JJR
cord-023095-4dannjjm	72	15	the	the	DT
cord-023095-4dannjjm	72	16	level	level	NN
cord-023095-4dannjjm	72	17	of	of	IN
cord-023095-4dannjjm	72	18	serum	serum	NN
cord-023095-4dannjjm	72	19	ADPN	ADPN	NNP
cord-023095-4dannjjm	72	20	.	.	.
cord-023095-4dannjjm	73	1	When	when	WRB
cord-023095-4dannjjm	73	2	the	the	DT
cord-023095-4dannjjm	73	3	2	2	CD
cord-023095-4dannjjm	73	4	tests	test	NNS
cord-023095-4dannjjm	73	5	The	the	DT
cord-023095-4dannjjm	73	6	purpose	purpose	NN
cord-023095-4dannjjm	73	7	of	of	IN
cord-023095-4dannjjm	73	8	this	this	DT
cord-023095-4dannjjm	73	9	study	study	NN
cord-023095-4dannjjm	73	10	was	be	VBD
cord-023095-4dannjjm	73	11	to	to	TO
cord-023095-4dannjjm	73	12	determine	determine	VB
cord-023095-4dannjjm	73	13	if	if	IN
cord-023095-4dannjjm	73	14	there	there	EX
cord-023095-4dannjjm	73	15	are	be	VBP
cord-023095-4dannjjm	73	16	any	any	DT
cord-023095-4dannjjm	73	17	clinically	clinically	RB
cord-023095-4dannjjm	73	18	important	important	JJ
cord-023095-4dannjjm	73	19	differences	difference	NNS
cord-023095-4dannjjm	73	20	between	between	IN
cord-023095-4dannjjm	73	21	the	the	DT
cord-023095-4dannjjm	73	22	approaches	approach	NNS
cord-023095-4dannjjm	73	23	(	(	-LRB-
cord-023095-4dannjjm	73	24	including	include	VBG
cord-023095-4dannjjm	73	25	devices	device	NNS
cord-023095-4dannjjm	73	26	)	)	-RRB-
cord-023095-4dannjjm	73	27	used	use	VBN
cord-023095-4dannjjm	73	28	in	in	IN
cord-023095-4dannjjm	73	29	non	non	JJ
cord-023095-4dannjjm	73	30	invasive	invasive	JJ
cord-023095-4dannjjm	73	31	transvascular	transvascular	JJ
cord-023095-4dannjjm	73	32	(	(	-LRB-
cord-023095-4dannjjm	73	33	interventional	interventional	JJ
cord-023095-4dannjjm	73	34	)	)	-RRB-
cord-023095-4dannjjm	73	35	closure	closure	NN
cord-023095-4dannjjm	73	36	of	of	IN
cord-023095-4dannjjm	73	37	patent	patent	NN
cord-023095-4dannjjm	73	38	ductus	ductus	NN
cord-023095-4dannjjm	73	39	arteriosus	arteriosus	NN
cord-023095-4dannjjm	73	40	(	(	-LRB-
cord-023095-4dannjjm	73	41	PDA	PDA	NNP
cord-023095-4dannjjm	73	42	)	)	-RRB-
cord-023095-4dannjjm	73	43	in	in	IN
cord-023095-4dannjjm	73	44	dogs	dog	NNS
cord-023095-4dannjjm	73	45	in	in	IN
cord-023095-4dannjjm	73	46	our	-PRON-	PRP$
cord-023095-4dannjjm	73	47	institution	institution	NN
cord-023095-4dannjjm	73	48	.	.	.
cord-023095-4dannjjm	74	1	Initial	initial	JJ
cord-023095-4dannjjm	74	2	and	and	CC
cord-023095-4dannjjm	74	3	follow	follow	VB
cord-023095-4dannjjm	74	4	up	up	RP
cord-023095-4dannjjm	74	5	records	record	NNS
cord-023095-4dannjjm	74	6	from	from	IN
cord-023095-4dannjjm	74	7	all	all	DT
cord-023095-4dannjjm	74	8	dogs	dog	NNS
cord-023095-4dannjjm	74	9	(	(	-LRB-
cord-023095-4dannjjm	74	10	n	n	NN
cord-023095-4dannjjm	74	11	5	5	CD
cord-023095-4dannjjm	74	12	112	112	CD
cord-023095-4dannjjm	74	13	)	)	-RRB-
cord-023095-4dannjjm	74	14	that	that	WDT
cord-023095-4dannjjm	74	15	underwent	undergo	VBD
cord-023095-4dannjjm	74	16	attempted	attempt	VBN
cord-023095-4dannjjm	74	17	transvascular	transvascular	JJ
cord-023095-4dannjjm	74	18	PDA	pda	NN
cord-023095-4dannjjm	74	19	occlusion	occlusion	NN
cord-023095-4dannjjm	74	20	from	from	IN
cord-023095-4dannjjm	74	21	January	January	NNP
cord-023095-4dannjjm	74	22	2006-December	2006-december	CD
cord-023095-4dannjjm	74	23	2009	2009	CD
cord-023095-4dannjjm	74	24	were	be	VBD
cord-023095-4dannjjm	74	25	examined	examine	VBN
cord-023095-4dannjjm	74	26	.	.	.
cord-023095-4dannjjm	75	1	Dogs	dog	NNS
cord-023095-4dannjjm	75	2	were	be	VBD
cord-023095-4dannjjm	75	3	placed	place	VBN
cord-023095-4dannjjm	75	4	into	into	IN
cord-023095-4dannjjm	75	5	4	4	CD
cord-023095-4dannjjm	75	6	groups	group	NNS
cord-023095-4dannjjm	75	7	depending	depend	VBG
cord-023095-4dannjjm	75	8	on	on	IN
cord-023095-4dannjjm	75	9	the	the	DT
cord-023095-4dannjjm	75	10	device	device	NN
cord-023095-4dannjjm	75	11	and	and	CC
cord-023095-4dannjjm	75	12	route	route	NN
cord-023095-4dannjjm	75	13	of	of	IN
cord-023095-4dannjjm	75	14	vascular	vascular	JJ
cord-023095-4dannjjm	75	15	access	access	NN
cord-023095-4dannjjm	75	16	(	(	-LRB-
cord-023095-4dannjjm	75	17	transvenous	transvenous	JJ
cord-023095-4dannjjm	75	18	or	or	CC
cord-023095-4dannjjm	75	19	transarterial	transarterial	NNP
cord-023095-4dannjjm	75	20	)	)	-RRB-
cord-023095-4dannjjm	75	21	.	.	.
cord-023095-4dannjjm	76	1	Group	group	NN
cord-023095-4dannjjm	76	2	1	1	CD
cord-023095-4dannjjm	76	3	:	:	:
cord-023095-4dannjjm	77	1	Amplatz	Amplatz	NNP
cord-023095-4dannjjm	77	2	s	s	POS
cord-023095-4dannjjm	77	3	Canine	Canine	NNP
cord-023095-4dannjjm	77	4	Ductal	Ductal	NNP
cord-023095-4dannjjm	77	5	Occluder	Occluder	NNP
cord-023095-4dannjjm	77	6	(	(	-LRB-
cord-023095-4dannjjm	77	7	ACDO	ACDO	NNP
cord-023095-4dannjjm	77	8	)	)	-RRB-
cord-023095-4dannjjm	78	1	(	(	-LRB-
cord-023095-4dannjjm	78	2	transarterial	transarterial	JJ
cord-023095-4dannjjm	78	3	)	)	-RRB-
cord-023095-4dannjjm	79	1	-36	-36	XX
cord-023095-4dannjjm	80	1	dogs	dog	NNS
cord-023095-4dannjjm	80	2	;	;	:
cord-023095-4dannjjm	80	3	Group	group	NN
cord-023095-4dannjjm	80	4	2	2	CD
cord-023095-4dannjjm	80	5	:	:	:
cord-023095-4dannjjm	80	6	Gianturco	Gianturco	NNP
cord-023095-4dannjjm	80	7	s	s	POS
cord-023095-4dannjjm	80	8	or	or	CC
cord-023095-4dannjjm	80	9	MReye	MReye	NNP
cord-023095-4dannjjm	80	10	Flipper	Flipper	NNP
cord-023095-4dannjjm	80	11	s	s	POS
cord-023095-4dannjjm	80	12	Detachable	detachable	JJ
cord-023095-4dannjjm	80	13	Embolization	Embolization	NNP
cord-023095-4dannjjm	80	14	(	(	-LRB-
cord-023095-4dannjjm	80	15	Flipper	flipper	NN
cord-023095-4dannjjm	80	16	)	)	-RRB-
cord-023095-4dannjjm	80	17	coil	coil	NN
cord-023095-4dannjjm	80	18	(	(	-LRB-
cord-023095-4dannjjm	80	19	transarterial	transarterial	JJ
cord-023095-4dannjjm	80	20	)	)	-RRB-
cord-023095-4dannjjm	80	21	-38	-38	JJ
cord-023095-4dannjjm	80	22	dogs	dog	NNS
cord-023095-4dannjjm	80	23	;	;	:
cord-023095-4dannjjm	80	24	Group	group	NN
cord-023095-4dannjjm	80	25	3	3	CD
cord-023095-4dannjjm	80	26	:	:	:
cord-023095-4dannjjm	81	1	Amplatzer	Amplatzer	NNP
cord-023095-4dannjjm	81	2	s	s	NNP
cord-023095-4dannjjm	82	1	Vascular	vascular	JJ
cord-023095-4dannjjm	82	2	Plug	Plug	NNP
cord-023095-4dannjjm	82	3	(	(	-LRB-
cord-023095-4dannjjm	82	4	AVP	AVP	NNP
cord-023095-4dannjjm	82	5	)	)	-RRB-
cord-023095-4dannjjm	82	6	(	(	-LRB-
cord-023095-4dannjjm	82	7	transarterial	transarterial	JJ
cord-023095-4dannjjm	82	8	)	)	-RRB-
cord-023095-4dannjjm	83	1	-23	-23	.
cord-023095-4dannjjm	84	1	dogs	dog	NNS
cord-023095-4dannjjm	84	2	;	;	:
cord-023095-4dannjjm	84	3	Group	group	NN
cord-023095-4dannjjm	84	4	4	4	CD
cord-023095-4dannjjm	84	5	:	:	:
cord-023095-4dannjjm	84	6	Flipper	flipper	NN
cord-023095-4dannjjm	84	7	coil	coil	NN
cord-023095-4dannjjm	84	8	(	(	-LRB-
cord-023095-4dannjjm	84	9	transvenous	transvenous	NNP
cord-023095-4dannjjm	84	10	)	)	-RRB-
cord-023095-4dannjjm	84	11	-15	-15	CD
cord-023095-4dannjjm	84	12	dogs	dog	NNS
cord-023095-4dannjjm	84	13	.	.	.
cord-023095-4dannjjm	85	1	Statistical	statistical	JJ
cord-023095-4dannjjm	85	2	comparisons	comparison	NNS
cord-023095-4dannjjm	85	3	were	be	VBD
cord-023095-4dannjjm	85	4	made	make	VBN
cord-023095-4dannjjm	85	5	using	use	VBG
cord-023095-4dannjjm	85	6	the	the	DT
cord-023095-4dannjjm	85	7	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	85	8	-	-	HYPH
cord-023095-4dannjjm	85	9	Wallis	Wallis	NNP
cord-023095-4dannjjm	85	10	test	test	NN
cord-023095-4dannjjm	85	11	with	with	IN
cord-023095-4dannjjm	85	12	Mann	Mann	NNP
cord-023095-4dannjjm	85	13	-	-	HYPH
cord-023095-4dannjjm	85	14	Whitney	Whitney	NNP
cord-023095-4dannjjm	85	15	tests	test	VBZ
cord-023095-4dannjjm	85	16	to	to	TO
cord-023095-4dannjjm	85	17	compare	compare	VB
cord-023095-4dannjjm	85	18	pairs	pair	NNS
cord-023095-4dannjjm	85	19	of	of	IN
cord-023095-4dannjjm	85	20	groups	group	NNS
cord-023095-4dannjjm	85	21	when	when	WRB
cord-023095-4dannjjm	85	22	significance	significance	NN
cord-023095-4dannjjm	85	23	was	be	VBD
cord-023095-4dannjjm	85	24	detected	detect	VBN
cord-023095-4dannjjm	85	25	.	.	.
cord-023095-4dannjjm	86	1	P	p	NN
cord-023095-4dannjjm	86	2	o	o	NN
cord-023095-4dannjjm	86	3	0.05	0.05	CD
cord-023095-4dannjjm	86	4	was	be	VBD
cord-023095-4dannjjm	86	5	considered	consider	VBN
cord-023095-4dannjjm	86	6	significant	significant	JJ
cord-023095-4dannjjm	86	7	.	.	.
cord-023095-4dannjjm	87	1	There	there	EX
cord-023095-4dannjjm	87	2	was	be	VBD
cord-023095-4dannjjm	87	3	no	no	DT
cord-023095-4dannjjm	87	4	significant	significant	JJ
cord-023095-4dannjjm	87	5	difference	difference	NN
cord-023095-4dannjjm	87	6	in	in	IN
cord-023095-4dannjjm	87	7	ages	age	NNS
cord-023095-4dannjjm	87	8	between	between	IN
cord-023095-4dannjjm	87	9	the	the	DT
cord-023095-4dannjjm	87	10	4	4	CD
cord-023095-4dannjjm	87	11	groups	group	NNS
cord-023095-4dannjjm	87	12	.	.	.
cord-023095-4dannjjm	88	1	There	there	EX
cord-023095-4dannjjm	88	2	was	be	VBD
cord-023095-4dannjjm	88	3	a	a	DT
cord-023095-4dannjjm	88	4	significant	significant	JJ
cord-023095-4dannjjm	88	5	difference	difference	NN
cord-023095-4dannjjm	88	6	in	in	IN
cord-023095-4dannjjm	88	7	body	body	NN
cord-023095-4dannjjm	88	8	weight	weight	NN
cord-023095-4dannjjm	88	9	between	between	IN
cord-023095-4dannjjm	88	10	groups	group	NNS
cord-023095-4dannjjm	88	11	with	with	IN
cord-023095-4dannjjm	88	12	dogs	dog	NNS
cord-023095-4dannjjm	88	13	receiving	receive	VBG
cord-023095-4dannjjm	88	14	a	a	DT
cord-023095-4dannjjm	88	15	coil	coil	NN
cord-023095-4dannjjm	88	16	either	either	CC
cord-023095-4dannjjm	88	17	transarterially	transarterially	RB
cord-023095-4dannjjm	88	18	or	or	CC
cord-023095-4dannjjm	88	19	transvenously	transvenously	RB
cord-023095-4dannjjm	89	1	(	(	-LRB-
cord-023095-4dannjjm	89	2	groups	group	NNS
cord-023095-4dannjjm	89	3	2	2	CD
cord-023095-4dannjjm	89	4	and	and	CC
cord-023095-4dannjjm	89	5	4	4	LS
cord-023095-4dannjjm	89	6	)	)	-RRB-
cord-023095-4dannjjm	89	7	being	be	VBG
cord-023095-4dannjjm	89	8	significantly	significantly	RB
cord-023095-4dannjjm	89	9	smaller	small	JJR
cord-023095-4dannjjm	89	10	than	than	IN
cord-023095-4dannjjm	89	11	dogs	dog	NNS
cord-023095-4dannjjm	89	12	receiving	receive	VBG
cord-023095-4dannjjm	89	13	an	an	DT
cord-023095-4dannjjm	89	14	ACDO	ACDO	NNP
cord-023095-4dannjjm	89	15	or	or	CC
cord-023095-4dannjjm	89	16	AVP	AVP	NNP
cord-023095-4dannjjm	89	17	.	.	.
cord-023095-4dannjjm	90	1	This	this	DT
cord-023095-4dannjjm	90	2	was	be	VBD
cord-023095-4dannjjm	90	3	by	by	IN
cord-023095-4dannjjm	90	4	design	design	NN
cord-023095-4dannjjm	90	5	since	since	IN
cord-023095-4dannjjm	90	6	the	the	DT
cord-023095-4dannjjm	90	7	ACDO	ACDO	NNP
cord-023095-4dannjjm	90	8	and	and	CC
cord-023095-4dannjjm	90	9	AVP	AVP	NNP
cord-023095-4dannjjm	90	10	can	can	MD
cord-023095-4dannjjm	90	11	not	not	RB
cord-023095-4dannjjm	90	12	be	be	VB
cord-023095-4dannjjm	90	13	used	use	VBN
cord-023095-4dannjjm	90	14	in	in	IN
cord-023095-4dannjjm	90	15	small	small	JJ
cord-023095-4dannjjm	90	16	dogs	dog	NNS
cord-023095-4dannjjm	90	17	.	.	.
cord-023095-4dannjjm	91	1	Overall	overall	RB
cord-023095-4dannjjm	91	2	,	,	,
cord-023095-4dannjjm	91	3	the	the	DT
cord-023095-4dannjjm	91	4	success	success	NN
cord-023095-4dannjjm	91	5	rate	rate	NN
cord-023095-4dannjjm	91	6	of	of	IN
cord-023095-4dannjjm	91	7	the	the	DT
cord-023095-4dannjjm	91	8	total	total	JJ
cord-023095-4dannjjm	91	9	procedure	procedure	NN
cord-023095-4dannjjm	91	10	(	(	-LRB-
cord-023095-4dannjjm	91	11	including	include	VBG
cord-023095-4dannjjm	91	12	vascular	vascular	JJ
cord-023095-4dannjjm	91	13	access	access	NN
cord-023095-4dannjjm	91	14	and	and	CC
cord-023095-4dannjjm	91	15	satisfactory	satisfactory	JJ
cord-023095-4dannjjm	91	16	PDA	pda	NN
cord-023095-4dannjjm	91	17	occlusion	occlusion	NN
cord-023095-4dannjjm	91	18	)	)	-RRB-
cord-023095-4dannjjm	91	19	was	be	VBD
cord-023095-4dannjjm	91	20	high	high	JJ
cord-023095-4dannjjm	91	21	(	(	-LRB-
cord-023095-4dannjjm	91	22	92	92	CD
cord-023095-4dannjjm	91	23	%	%	NN
cord-023095-4dannjjm	91	24	)	)	-RRB-
cord-023095-4dannjjm	91	25	with	with	IN
cord-023095-4dannjjm	91	26	success	success	NN
cord-023095-4dannjjm	91	27	rates	rate	NNS
cord-023095-4dannjjm	91	28	being	be	VBG
cord-023095-4dannjjm	91	29	comparable	comparable	JJ
cord-023095-4dannjjm	91	30	between	between	IN
cord-023095-4dannjjm	91	31	groups	group	NNS
cord-023095-4dannjjm	91	32	(	(	-LRB-
cord-023095-4dannjjm	91	33	87	87	CD
cord-023095-4dannjjm	91	34	-	-	SYM
cord-023095-4dannjjm	91	35	97	97	CD
cord-023095-4dannjjm	91	36	%	%	NN
cord-023095-4dannjjm	91	37	)	)	-RRB-
cord-023095-4dannjjm	91	38	.	.	.
cord-023095-4dannjjm	92	1	There	there	EX
cord-023095-4dannjjm	92	2	was	be	VBD
cord-023095-4dannjjm	92	3	a	a	DT
cord-023095-4dannjjm	92	4	significant	significant	JJ
cord-023095-4dannjjm	92	5	difference	difference	NN
cord-023095-4dannjjm	92	6	in	in	IN
cord-023095-4dannjjm	92	7	complication	complication	NN
cord-023095-4dannjjm	92	8	rate	rate	NN
cord-023095-4dannjjm	92	9	between	between	IN
cord-023095-4dannjjm	92	10	groups	group	NNS
cord-023095-4dannjjm	92	11	(	(	-LRB-
cord-023095-4dannjjm	92	12	p	p	NN
cord-023095-4dannjjm	92	13	o	o	NN
cord-023095-4dannjjm	92	14	0.0001	0.0001	CD
cord-023095-4dannjjm	92	15	)	)	-RRB-
cord-023095-4dannjjm	92	16	with	with	IN
cord-023095-4dannjjm	92	17	the	the	DT
cord-023095-4dannjjm	92	18	ACDO	ACDO	NNP
cord-023095-4dannjjm	92	19	group	group	NN
cord-023095-4dannjjm	92	20	having	have	VBG
cord-023095-4dannjjm	92	21	a	a	DT
cord-023095-4dannjjm	92	22	markedly	markedly	RB
cord-023095-4dannjjm	92	23	lower	low	JJR
cord-023095-4dannjjm	92	24	complication	complication	NN
cord-023095-4dannjjm	92	25	rate	rate	NN
cord-023095-4dannjjm	92	26	than	than	IN
cord-023095-4dannjjm	92	27	the	the	DT
cord-023095-4dannjjm	92	28	remaining	remain	VBG
cord-023095-4dannjjm	92	29	groups	group	NNS
cord-023095-4dannjjm	92	30	(	(	-LRB-
cord-023095-4dannjjm	92	31	3	3	CD
cord-023095-4dannjjm	92	32	%	%	NN
cord-023095-4dannjjm	92	33	for	for	IN
cord-023095-4dannjjm	92	34	ACDO	ACDO	NNP
cord-023095-4dannjjm	92	35	versus	versus	IN
cord-023095-4dannjjm	92	36	24	24	CD
cord-023095-4dannjjm	92	37	-	-	SYM
cord-023095-4dannjjm	92	38	33	33	CD
cord-023095-4dannjjm	92	39	%	%	NN
cord-023095-4dannjjm	92	40	for	for	IN
cord-023095-4dannjjm	92	41	the	the	DT
cord-023095-4dannjjm	92	42	other	other	JJ
cord-023095-4dannjjm	92	43	groups	group	NNS
cord-023095-4dannjjm	92	44	)	)	-RRB-
cord-023095-4dannjjm	92	45	.	.	.
cord-023095-4dannjjm	93	1	Total	total	JJ
cord-023095-4dannjjm	93	2	fluoroscopy	fluoroscopy	JJ
cord-023095-4dannjjm	93	3	time	time	NN
cord-023095-4dannjjm	93	4	ranged	range	VBD
cord-023095-4dannjjm	93	5	from	from	IN
cord-023095-4dannjjm	93	6	3	3	CD
cord-023095-4dannjjm	93	7	-	-	SYM
cord-023095-4dannjjm	93	8	78	78	CD
cord-023095-4dannjjm	93	9	minutes	minute	NNS
cord-023095-4dannjjm	93	10	(	(	-LRB-
cord-023095-4dannjjm	93	11	median	median	JJ
cord-023095-4dannjjm	93	12	8	8	CD
cord-023095-4dannjjm	93	13	minutes	minute	NNS
cord-023095-4dannjjm	93	14	)	)	-RRB-
cord-023095-4dannjjm	93	15	.	.	.
cord-023095-4dannjjm	94	1	Fluoroscopy	fluoroscopy	JJ
cord-023095-4dannjjm	94	2	time	time	NN
cord-023095-4dannjjm	94	3	for	for	IN
cord-023095-4dannjjm	94	4	the	the	DT
cord-023095-4dannjjm	94	5	transvenous	transvenous	JJ
cord-023095-4dannjjm	94	6	method	method	NN
cord-023095-4dannjjm	94	7	was	be	VBD
cord-023095-4dannjjm	94	8	significantly	significantly	RB
cord-023095-4dannjjm	94	9	longer	long	JJR
cord-023095-4dannjjm	94	10	(	(	-LRB-
cord-023095-4dannjjm	94	11	median	median	JJ
cord-023095-4dannjjm	94	12	13	13	CD
cord-023095-4dannjjm	94	13	minutes	minute	NNS
cord-023095-4dannjjm	94	14	;	;	:
cord-023095-4dannjjm	94	15	range	range	VBP
cord-023095-4dannjjm	94	16	10	10	CD
cord-023095-4dannjjm	94	17	-	-	SYM
cord-023095-4dannjjm	94	18	78	78	CD
cord-023095-4dannjjm	94	19	minutes	minute	NNS
cord-023095-4dannjjm	94	20	)	)	-RRB-
cord-023095-4dannjjm	94	21	than	than	IN
cord-023095-4dannjjm	94	22	in	in	IN
cord-023095-4dannjjm	94	23	the	the	DT
cord-023095-4dannjjm	94	24	remaining	remain	VBG
cord-023095-4dannjjm	94	25	groups	group	NNS
cord-023095-4dannjjm	94	26	(	(	-LRB-
cord-023095-4dannjjm	94	27	median	median	JJ
cord-023095-4dannjjm	94	28	6	6	CD
cord-023095-4dannjjm	94	29	minutes	minute	NNS
cord-023095-4dannjjm	94	30	;	;	:
cord-023095-4dannjjm	94	31	range	range	VBP
cord-023095-4dannjjm	94	32	3	3	CD
cord-023095-4dannjjm	94	33	-	-	SYM
cord-023095-4dannjjm	94	34	33	33	CD
cord-023095-4dannjjm	94	35	minutes	minute	NNS
cord-023095-4dannjjm	94	36	)	)	-RRB-
cord-023095-4dannjjm	94	37	(	(	-LRB-
cord-023095-4dannjjm	94	38	p	p	NN
cord-023095-4dannjjm	94	39	o	o	NN
cord-023095-4dannjjm	94	40	0.0001	0.0001	CD
cord-023095-4dannjjm	94	41	)	)	-RRB-
cord-023095-4dannjjm	94	42	.	.	.
cord-023095-4dannjjm	95	1	Number	number	NN
cord-023095-4dannjjm	95	2	of	of	IN
cord-023095-4dannjjm	95	3	dogs	dog	NNS
cord-023095-4dannjjm	95	4	with	with	IN
cord-023095-4dannjjm	95	5	residual	residual	JJ
cord-023095-4dannjjm	95	6	flow	flow	NN
cord-023095-4dannjjm	95	7	immediately	immediately	RB
cord-023095-4dannjjm	95	8	following	follow	VBG
cord-023095-4dannjjm	95	9	the	the	DT
cord-023095-4dannjjm	95	10	procedure	procedure	NN
cord-023095-4dannjjm	95	11	and	and	CC
cord-023095-4dannjjm	95	12	24	24	CD
cord-023095-4dannjjm	95	13	hrs	hrs	NN
cord-023095-4dannjjm	95	14	later	later	RB
cord-023095-4dannjjm	95	15	was	be	VBD
cord-023095-4dannjjm	95	16	significantly	significantly	RB
cord-023095-4dannjjm	95	17	less	less	JJR
cord-023095-4dannjjm	95	18	in	in	IN
cord-023095-4dannjjm	95	19	the	the	DT
cord-023095-4dannjjm	95	20	ACDO	ACDO	NNP
cord-023095-4dannjjm	95	21	group	group	NN
cord-023095-4dannjjm	95	22	than	than	IN
cord-023095-4dannjjm	95	23	in	in	IN
cord-023095-4dannjjm	95	24	the	the	DT
cord-023095-4dannjjm	95	25	remaining	remain	VBG
cord-023095-4dannjjm	95	26	groups	group	NNS
cord-023095-4dannjjm	95	27	(	(	-LRB-
cord-023095-4dannjjm	95	28	2	2	CD
cord-023095-4dannjjm	95	29	dogs	dog	NNS
cord-023095-4dannjjm	95	30	from	from	IN
cord-023095-4dannjjm	95	31	group	group	NN
cord-023095-4dannjjm	95	32	2	2	CD
cord-023095-4dannjjm	95	33	and	and	CC
cord-023095-4dannjjm	95	34	3	3	CD
cord-023095-4dannjjm	95	35	from	from	IN
cord-023095-4dannjjm	95	36	group	group	NN
cord-023095-4dannjjm	95	37	3	3	CD
cord-023095-4dannjjm	95	38	had	have	VBD
cord-023095-4dannjjm	95	39	moderate	moderate	JJ
cord-023095-4dannjjm	95	40	persistent	persistent	JJ
cord-023095-4dannjjm	95	41	flow	flow	NN
cord-023095-4dannjjm	95	42	while	while	IN
cord-023095-4dannjjm	95	43	1	1	CD
cord-023095-4dannjjm	95	44	dog	dog	NN
cord-023095-4dannjjm	95	45	from	from	IN
cord-023095-4dannjjm	95	46	group	group	NN
cord-023095-4dannjjm	95	47	2	2	CD
cord-023095-4dannjjm	95	48	and	and	CC
cord-023095-4dannjjm	95	49	1	1	CD
cord-023095-4dannjjm	95	50	from	from	IN
cord-023095-4dannjjm	95	51	group	group	NN
cord-023095-4dannjjm	95	52	4	4	CD
cord-023095-4dannjjm	95	53	had	have	VBD
cord-023095-4dannjjm	95	54	severe	severe	JJ
cord-023095-4dannjjm	95	55	persistent	persistent	JJ
cord-023095-4dannjjm	95	56	flow	flow	NN
cord-023095-4dannjjm	95	57	24	24	CD
cord-023095-4dannjjm	95	58	hours	hour	NNS
cord-023095-4dannjjm	95	59	after	after	IN
cord-023095-4dannjjm	95	60	the	the	DT
cord-023095-4dannjjm	95	61	procedure	procedure	NN
cord-023095-4dannjjm	95	62	)	)	-RRB-
cord-023095-4dannjjm	95	63	.	.	.
cord-023095-4dannjjm	96	1	The	the	DT
cord-023095-4dannjjm	96	2	ACDO	ACDO	NNP
cord-023095-4dannjjm	96	3	appears	appear	VBZ
cord-023095-4dannjjm	96	4	superior	superior	JJ
cord-023095-4dannjjm	96	5	in	in	IN
cord-023095-4dannjjm	96	6	ease	ease	NN
cord-023095-4dannjjm	96	7	of	of	IN
cord-023095-4dannjjm	96	8	use	use	NN
cord-023095-4dannjjm	96	9	,	,	,
cord-023095-4dannjjm	96	10	complication	complication	NN
cord-023095-4dannjjm	96	11	rate	rate	NN
cord-023095-4dannjjm	96	12	,	,	,
cord-023095-4dannjjm	96	13	completeness	completeness	NN
cord-023095-4dannjjm	96	14	of	of	IN
cord-023095-4dannjjm	96	15	occlusion	occlusion	NN
cord-023095-4dannjjm	96	16	and	and	CC
cord-023095-4dannjjm	96	17	fluoroscopy	fluoroscopy	JJ
cord-023095-4dannjjm	96	18	time	time	NN
cord-023095-4dannjjm	96	19	than	than	IN
cord-023095-4dannjjm	96	20	other	other	JJ
cord-023095-4dannjjm	96	21	devices	device	NNS
cord-023095-4dannjjm	96	22	.	.	.
cord-023095-4dannjjm	97	1	The	the	DT
cord-023095-4dannjjm	97	2	remaining	remain	VBG
cord-023095-4dannjjm	97	3	limiting	limit	VBG
cord-023095-4dannjjm	97	4	factor	factor	NN
cord-023095-4dannjjm	97	5	with	with	IN
cord-023095-4dannjjm	97	6	this	this	DT
cord-023095-4dannjjm	97	7	device	device	NN
cord-023095-4dannjjm	97	8	is	be	VBZ
cord-023095-4dannjjm	97	9	patient	patient	JJ
cord-023095-4dannjjm	97	10	size	size	NN
cord-023095-4dannjjm	97	11	.	.	.
cord-023095-4dannjjm	98	1	Until	until	IN
cord-023095-4dannjjm	98	2	a	a	DT
cord-023095-4dannjjm	98	3	smaller	small	JJR
cord-023095-4dannjjm	98	4	ACDO	ACDO	NNP
cord-023095-4dannjjm	98	5	device	device	NN
cord-023095-4dannjjm	98	6	is	be	VBZ
cord-023095-4dannjjm	98	7	marketed	market	VBN
cord-023095-4dannjjm	98	8	,	,	,
cord-023095-4dannjjm	98	9	coils	coil	NNS
cord-023095-4dannjjm	98	10	remain	remain	VBP
cord-023095-4dannjjm	98	11	the	the	DT
cord-023095-4dannjjm	98	12	only	only	JJ
cord-023095-4dannjjm	98	13	choice	choice	NN
cord-023095-4dannjjm	98	14	for	for	IN
cord-023095-4dannjjm	98	15	interventional	interventional	JJ
cord-023095-4dannjjm	98	16	closure	closure	NN
cord-023095-4dannjjm	98	17	in	in	IN
cord-023095-4dannjjm	98	18	very	very	RB
cord-023095-4dannjjm	98	19	small	small	JJ
cord-023095-4dannjjm	98	20	dogs	dog	NNS
cord-023095-4dannjjm	98	21	(	(	-LRB-
cord-023095-4dannjjm	98	22	o	o	NN
cord-023095-4dannjjm	98	23	2.5	2.5	CD
cord-023095-4dannjjm	98	24	kg	kg	NNS
cord-023095-4dannjjm	98	25	)	)	-RRB-
cord-023095-4dannjjm	98	26	.	.	.
cord-023095-4dannjjm	99	1	Previously	previously	RB
cord-023095-4dannjjm	99	2	presented	present	VBN
cord-023095-4dannjjm	99	3	at	at	IN
cord-023095-4dannjjm	99	4	the	the	DT
cord-023095-4dannjjm	99	5	University	University	NNP
cord-023095-4dannjjm	99	6	of	of	IN
cord-023095-4dannjjm	99	7	California	California	NNP
cord-023095-4dannjjm	99	8	Davis	Davis	NNP
cord-023095-4dannjjm	99	9	,	,	,
cord-023095-4dannjjm	99	10	House	House	NNP
cord-023095-4dannjjm	99	11	Officers	Officers	NNPS
cord-023095-4dannjjm	99	12	Seminar	Seminar	NNP
cord-023095-4dannjjm	99	13	Day	Day	NNP
cord-023095-4dannjjm	99	14	.	.	.
cord-023095-4dannjjm	100	1	Subvalvular	subvalvular	JJ
cord-023095-4dannjjm	100	2	aortic	aortic	JJ
cord-023095-4dannjjm	100	3	stenosis	stenosis	NN
cord-023095-4dannjjm	101	1	(	(	-LRB-
cord-023095-4dannjjm	101	2	SAS	SAS	NNP
cord-023095-4dannjjm	101	3	)	)	-RRB-
cord-023095-4dannjjm	101	4	is	be	VBZ
cord-023095-4dannjjm	101	5	one	one	CD
cord-023095-4dannjjm	101	6	of	of	IN
cord-023095-4dannjjm	101	7	the	the	DT
cord-023095-4dannjjm	101	8	most	most	RBS
cord-023095-4dannjjm	101	9	commonly	commonly	RB
cord-023095-4dannjjm	101	10	reported	report	VBN
cord-023095-4dannjjm	101	11	canine	canine	JJ
cord-023095-4dannjjm	101	12	congenital	congenital	JJ
cord-023095-4dannjjm	101	13	heart	heart	NN
cord-023095-4dannjjm	101	14	defects	defect	NNS
cord-023095-4dannjjm	101	15	and	and	CC
cord-023095-4dannjjm	101	16	is	be	VBZ
cord-023095-4dannjjm	101	17	inherited	inherit	VBN
cord-023095-4dannjjm	101	18	in	in	IN
cord-023095-4dannjjm	101	19	Newfoundland	Newfoundland	NNP
cord-023095-4dannjjm	101	20	dogs	dog	NNS
cord-023095-4dannjjm	101	21	and	and	CC
cord-023095-4dannjjm	101	22	human	human	JJ
cord-023095-4dannjjm	101	23	beings	being	NNS
cord-023095-4dannjjm	101	24	.	.	.
cord-023095-4dannjjm	102	1	The	the	DT
cord-023095-4dannjjm	102	2	golden	golden	JJ
cord-023095-4dannjjm	102	3	retriever	retriever	NN
cord-023095-4dannjjm	102	4	and	and	CC
cord-023095-4dannjjm	102	5	Rottweiler	Rottweiler	NNP
cord-023095-4dannjjm	102	6	are	be	VBP
cord-023095-4dannjjm	102	7	breeds	breed	NNS
cord-023095-4dannjjm	102	8	over	over	RB
cord-023095-4dannjjm	102	9	-	-	HYPH
cord-023095-4dannjjm	102	10	represented	represent	VBN
cord-023095-4dannjjm	102	11	in	in	IN
cord-023095-4dannjjm	102	12	dogs	dog	NNS
cord-023095-4dannjjm	102	13	with	with	IN
cord-023095-4dannjjm	102	14	subvalvular	subvalvular	JJ
cord-023095-4dannjjm	102	15	aortic	aortic	JJ
cord-023095-4dannjjm	102	16	stenosis	stenosis	NN
cord-023095-4dannjjm	102	17	;	;	:
cord-023095-4dannjjm	102	18	however	however	RB
cord-023095-4dannjjm	102	19	,	,	,
cord-023095-4dannjjm	102	20	a	a	DT
cord-023095-4dannjjm	102	21	genetic	genetic	JJ
cord-023095-4dannjjm	102	22	cause	cause	NN
cord-023095-4dannjjm	102	23	of	of	IN
cord-023095-4dannjjm	102	24	this	this	DT
cord-023095-4dannjjm	102	25	disease	disease	NN
cord-023095-4dannjjm	102	26	in	in	IN
cord-023095-4dannjjm	102	27	these	these	DT
cord-023095-4dannjjm	102	28	breeds	breed	NNS
cord-023095-4dannjjm	102	29	has	have	VBZ
cord-023095-4dannjjm	102	30	not	not	RB
cord-023095-4dannjjm	102	31	been	be	VBN
cord-023095-4dannjjm	102	32	described	describe	VBN
cord-023095-4dannjjm	102	33	.	.	.
cord-023095-4dannjjm	103	1	We	-PRON-	PRP
cord-023095-4dannjjm	103	2	performed	perform	VBD
cord-023095-4dannjjm	103	3	genome	genome	NN
cord-023095-4dannjjm	103	4	wide	wide	NNP
cord-023095-4dannjjm	103	5	association	association	NN
cord-023095-4dannjjm	103	6	analysis	analysis	NN
cord-023095-4dannjjm	103	7	in	in	IN
cord-023095-4dannjjm	103	8	both	both	CC
cord-023095-4dannjjm	103	9	normal	normal	JJ
cord-023095-4dannjjm	103	10	and	and	CC
cord-023095-4dannjjm	103	11	SAS	SAS	NNP
cord-023095-4dannjjm	103	12	affected	affect	VBD
cord-023095-4dannjjm	103	13	Rottweilers	Rottweilers	NNPS
cord-023095-4dannjjm	103	14	and	and	CC
cord-023095-4dannjjm	103	15	golden	golden	JJ
cord-023095-4dannjjm	103	16	retrievers	retriever	NNS
cord-023095-4dannjjm	103	17	to	to	TO
cord-023095-4dannjjm	103	18	identify	identify	VB
cord-023095-4dannjjm	103	19	chromosomal	chromosomal	JJ
cord-023095-4dannjjm	103	20	regions	region	NNS
cord-023095-4dannjjm	103	21	of	of	IN
cord-023095-4dannjjm	103	22	interest	interest	NN
cord-023095-4dannjjm	103	23	that	that	WDT
cord-023095-4dannjjm	103	24	could	could	MD
cord-023095-4dannjjm	103	25	implicate	implicate	VB
cord-023095-4dannjjm	103	26	a	a	DT
cord-023095-4dannjjm	103	27	causative	causative	JJ
cord-023095-4dannjjm	103	28	mutation	mutation	NN
cord-023095-4dannjjm	103	29	by	by	IN
cord-023095-4dannjjm	103	30	high	high	JJ
cord-023095-4dannjjm	103	31	density	density	NN
cord-023095-4dannjjm	103	32	single	single	JJ
cord-023095-4dannjjm	103	33	nucleotide	nucleotide	JJ
cord-023095-4dannjjm	103	34	polymorphism	polymorphism	NN
cord-023095-4dannjjm	103	35	(	(	-LRB-
cord-023095-4dannjjm	103	36	SNP	SNP	NNP
cord-023095-4dannjjm	103	37	)	)	-RRB-
cord-023095-4dannjjm	103	38	array	array	NN
cord-023095-4dannjjm	103	39	.	.	.
cord-023095-4dannjjm	104	1	48	48	CD
cord-023095-4dannjjm	105	1	(	(	-LRB-
cord-023095-4dannjjm	105	2	24	24	CD
cord-023095-4dannjjm	105	3	unaffected/24	unaffected/24	NNP
cord-023095-4dannjjm	105	4	affected	affected	JJ
cord-023095-4dannjjm	105	5	)	)	-RRB-
cord-023095-4dannjjm	105	6	adult	adult	NN
cord-023095-4dannjjm	105	7	golden	golden	JJ
cord-023095-4dannjjm	105	8	retrievers	retriever	NNS
cord-023095-4dannjjm	105	9	and	and	CC
cord-023095-4dannjjm	105	10	48	48	CD
cord-023095-4dannjjm	105	11	(	(	-LRB-
cord-023095-4dannjjm	105	12	20	20	CD
cord-023095-4dannjjm	105	13	unaffected/28	unaffected/28	JJ
cord-023095-4dannjjm	105	14	affected	affected	JJ
cord-023095-4dannjjm	105	15	)	)	-RRB-
cord-023095-4dannjjm	105	16	adult	adult	NN
cord-023095-4dannjjm	105	17	Rottweilers	rottweiler	NNS
cord-023095-4dannjjm	105	18	were	be	VBD
cord-023095-4dannjjm	105	19	included	include	VBN
cord-023095-4dannjjm	105	20	in	in	IN
cord-023095-4dannjjm	105	21	this	this	DT
cord-023095-4dannjjm	105	22	study	study	NN
cord-023095-4dannjjm	105	23	.	.	.
cord-023095-4dannjjm	106	1	Criteria	criterion	NNS
cord-023095-4dannjjm	106	2	for	for	IN
cord-023095-4dannjjm	106	3	affected	affect	VBN
cord-023095-4dannjjm	106	4	included	include	VBD
cord-023095-4dannjjm	106	5	a	a	DT
cord-023095-4dannjjm	106	6	subcostal	subcostal	JJ
cord-023095-4dannjjm	106	7	continuous	continuous	JJ
cord-023095-4dannjjm	106	8	-	-	HYPH
cord-023095-4dannjjm	106	9	wave	wave	NN
cord-023095-4dannjjm	106	10	Doppler	Doppler	NNP
cord-023095-4dannjjm	106	11	aortic	aortic	JJ
cord-023095-4dannjjm	106	12	velocity	velocity	NN
cord-023095-4dannjjm	106	13	!	!	.
cord-023095-4dannjjm	107	1	2.5	2.5	CD
cord-023095-4dannjjm	107	2	m	m	NN
cord-023095-4dannjjm	107	3	/	/	SYM
cord-023095-4dannjjm	107	4	s	s	NN
cord-023095-4dannjjm	107	5	and	and	CC
cord-023095-4dannjjm	107	6	presence	presence	NN
cord-023095-4dannjjm	107	7	of	of	IN
cord-023095-4dannjjm	107	8	a	a	DT
cord-023095-4dannjjm	107	9	left	left	JJ
cord-023095-4dannjjm	107	10	basilar	basilar	JJ
cord-023095-4dannjjm	107	11	systolic	systolic	JJ
cord-023095-4dannjjm	107	12	ejection	ejection	NN
cord-023095-4dannjjm	107	13	murmur	murmur	NN
cord-023095-4dannjjm	108	1	;	;	:
cord-023095-4dannjjm	108	2	criteria	criterion	NNS
cord-023095-4dannjjm	108	3	for	for	IN
cord-023095-4dannjjm	108	4	unaffected	unaffected	JJ
cord-023095-4dannjjm	108	5	included	include	VBD
cord-023095-4dannjjm	108	6	a	a	DT
cord-023095-4dannjjm	108	7	Doppler	Doppler	NNP
cord-023095-4dannjjm	108	8	aortic	aortic	JJ
cord-023095-4dannjjm	108	9	velocity	velocity	NN
cord-023095-4dannjjm	108	10	1.8	1.8	CD
cord-023095-4dannjjm	108	11	m	m	NN
cord-023095-4dannjjm	108	12	/	/	SYM
cord-023095-4dannjjm	108	13	s	s	NN
cord-023095-4dannjjm	108	14	.	.	.
cord-023095-4dannjjm	109	1	DNA	dna	NN
cord-023095-4dannjjm	109	2	samples	sample	NNS
cord-023095-4dannjjm	109	3	were	be	VBD
cord-023095-4dannjjm	109	4	obtained	obtain	VBN
cord-023095-4dannjjm	109	5	from	from	IN
cord-023095-4dannjjm	109	6	anticoagulated	anticoagulated	JJ
cord-023095-4dannjjm	109	7	blood	blood	NN
cord-023095-4dannjjm	109	8	.	.	.
cord-023095-4dannjjm	110	1	Genotypes	genotype	NNS
cord-023095-4dannjjm	110	2	were	be	VBD
cord-023095-4dannjjm	110	3	obtained	obtain	VBN
cord-023095-4dannjjm	110	4	using	use	VBG
cord-023095-4dannjjm	110	5	high	high	JJ
cord-023095-4dannjjm	110	6	density	density	NN
cord-023095-4dannjjm	110	7	(	(	-LRB-
cord-023095-4dannjjm	110	8	173,662	173,662	CD
cord-023095-4dannjjm	110	9	)	)	-RRB-
cord-023095-4dannjjm	110	10	SNP	SNP	NNP
cord-023095-4dannjjm	110	11	arrays	array	NNS
cord-023095-4dannjjm	110	12	,	,	,
cord-023095-4dannjjm	110	13	and	and	CC
cord-023095-4dannjjm	110	14	genome	genome	NNP
cord-023095-4dannjjm	110	15	wide	wide	JJ
cord-023095-4dannjjm	110	16	association	association	NN
cord-023095-4dannjjm	110	17	with	with	IN
cord-023095-4dannjjm	110	18	SAS	SAS	NNP
cord-023095-4dannjjm	110	19	was	be	VBD
cord-023095-4dannjjm	110	20	evaluated	evaluate	VBN
cord-023095-4dannjjm	110	21	for	for	IN
cord-023095-4dannjjm	110	22	each	each	DT
cord-023095-4dannjjm	110	23	breed	breed	NN
cord-023095-4dannjjm	110	24	.	.	.
cord-023095-4dannjjm	111	1	Significance	significance	NN
cord-023095-4dannjjm	111	2	cut	cut	NN
cord-023095-4dannjjm	111	3	-	-	HYPH
cord-023095-4dannjjm	111	4	off	off	NN
cord-023095-4dannjjm	111	5	was	be	VBD
cord-023095-4dannjjm	111	6	set	set	VBN
cord-023095-4dannjjm	111	7	at	at	IN
cord-023095-4dannjjm	111	8	p	p	NN
cord-023095-4dannjjm	111	9	5	5	CD
cord-023095-4dannjjm	111	10	5	5	CD
cord-023095-4dannjjm	111	11	Â	â	CD
cord-023095-4dannjjm	111	12	10	10	CD
cord-023095-4dannjjm	111	13	À5	À5	NNP
cord-023095-4dannjjm	111	14	,	,	,
cord-023095-4dannjjm	111	15	and	and	CC
cord-023095-4dannjjm	111	16	all	all	DT
cord-023095-4dannjjm	111	17	SNPs	SNPs	NNPS
cord-023095-4dannjjm	111	18	meeting	meet	VBG
cord-023095-4dannjjm	111	19	this	this	DT
cord-023095-4dannjjm	111	20	criterion	criterion	NN
cord-023095-4dannjjm	111	21	were	be	VBD
cord-023095-4dannjjm	111	22	plotted	plot	VBN
cord-023095-4dannjjm	111	23	within	within	IN
cord-023095-4dannjjm	111	24	each	each	DT
cord-023095-4dannjjm	111	25	breed	breed	NN
cord-023095-4dannjjm	111	26	and	and	CC
cord-023095-4dannjjm	111	27	compared	compare	VBN
cord-023095-4dannjjm	111	28	across	across	IN
cord-023095-4dannjjm	111	29	breeds	breed	NNS
cord-023095-4dannjjm	111	30	using	use	VBG
cord-023095-4dannjjm	111	31	PLINK	PLINK	NNP
cord-023095-4dannjjm	111	32	.	.	.
cord-023095-4dannjjm	112	1	Affected	affected	JJ
cord-023095-4dannjjm	112	2	golden	golden	JJ
cord-023095-4dannjjm	112	3	retriever	retriever	NN
cord-023095-4dannjjm	112	4	data	datum	NNS
cord-023095-4dannjjm	112	5	implicate	implicate	VBP
cord-023095-4dannjjm	112	6	the	the	DT
cord-023095-4dannjjm	112	7	most	most	RBS
cord-023095-4dannjjm	112	8	significant	significant	JJ
cord-023095-4dannjjm	112	9	region	region	NN
cord-023095-4dannjjm	112	10	of	of	IN
cord-023095-4dannjjm	112	11	genetic	genetic	JJ
cord-023095-4dannjjm	112	12	variation	variation	NN
cord-023095-4dannjjm	112	13	on	on	IN
cord-023095-4dannjjm	112	14	chromosome	chromosome	NN
cord-023095-4dannjjm	112	15	21	21	CD
cord-023095-4dannjjm	112	16	at	at	IN
cord-023095-4dannjjm	112	17	location	location	NN
cord-023095-4dannjjm	112	18	27384260	27384260	CD
cord-023095-4dannjjm	113	1	(	(	-LRB-
cord-023095-4dannjjm	113	2	p	p	NN
cord-023095-4dannjjm	113	3	5	5	CD
cord-023095-4dannjjm	113	4	1.15	1.15	CD
cord-023095-4dannjjm	113	5	Â	â	CD
cord-023095-4dannjjm	113	6	10	10	CD
cord-023095-4dannjjm	113	7	À5	À5	NNP
cord-023095-4dannjjm	113	8	;	;	:
cord-023095-4dannjjm	113	9	odds	odd	NNS
cord-023095-4dannjjm	113	10	ratio	ratio	NN
cord-023095-4dannjjm	113	11	7.58	7.58	CD
cord-023095-4dannjjm	113	12	)	)	-RRB-
cord-023095-4dannjjm	113	13	with	with	IN
cord-023095-4dannjjm	113	14	11	11	CD
cord-023095-4dannjjm	113	15	other	other	JJ
cord-023095-4dannjjm	113	16	significant	significant	JJ
cord-023095-4dannjjm	113	17	surrounding	surround	VBG
cord-023095-4dannjjm	113	18	SNPs	snp	NNS
cord-023095-4dannjjm	113	19	.	.	.
cord-023095-4dannjjm	114	1	Affected	affected	JJ
cord-023095-4dannjjm	114	2	Rottweiler	Rottweiler	NNP
cord-023095-4dannjjm	114	3	data	datum	NNS
cord-023095-4dannjjm	114	4	also	also	RB
cord-023095-4dannjjm	114	5	implicate	implicate	VBP
cord-023095-4dannjjm	114	6	the	the	DT
cord-023095-4dannjjm	114	7	most	most	RBS
cord-023095-4dannjjm	114	8	significant	significant	JJ
cord-023095-4dannjjm	114	9	region	region	NN
cord-023095-4dannjjm	114	10	of	of	IN
cord-023095-4dannjjm	114	11	genetic	genetic	JJ
cord-023095-4dannjjm	114	12	variation	variation	NN
cord-023095-4dannjjm	114	13	on	on	IN
cord-023095-4dannjjm	114	14	chromosome	chromosome	NN
cord-023095-4dannjjm	114	15	21	21	CD
cord-023095-4dannjjm	114	16	at	at	IN
cord-023095-4dannjjm	114	17	location	location	NN
cord-023095-4dannjjm	114	18	27895300	27895300	CD
cord-023095-4dannjjm	115	1	(	(	-LRB-
cord-023095-4dannjjm	115	2	p	p	NN
cord-023095-4dannjjm	115	3	5	5	CD
cord-023095-4dannjjm	115	4	8.98	8.98	CD
cord-023095-4dannjjm	115	5	Â	â	CD
cord-023095-4dannjjm	115	6	10	10	CD
cord-023095-4dannjjm	115	7	À6	à6	NN
cord-023095-4dannjjm	115	8	;	;	:
cord-023095-4dannjjm	115	9	odds	odd	NNS
cord-023095-4dannjjm	115	10	ratio	ratio	NN
cord-023095-4dannjjm	115	11	23.39	23.39	CD
cord-023095-4dannjjm	115	12	)	)	-RRB-
cord-023095-4dannjjm	115	13	with	with	IN
cord-023095-4dannjjm	115	14	3	3	CD
cord-023095-4dannjjm	115	15	other	other	JJ
cord-023095-4dannjjm	115	16	significant	significant	JJ
cord-023095-4dannjjm	115	17	surrounding	surround	VBG
cord-023095-4dannjjm	115	18	SNPs	snp	NNS
cord-023095-4dannjjm	115	19	.	.	.
cord-023095-4dannjjm	116	1	Other	other	JJ
cord-023095-4dannjjm	116	2	regions	region	NNS
cord-023095-4dannjjm	116	3	of	of	IN
cord-023095-4dannjjm	116	4	statistical	statistical	JJ
cord-023095-4dannjjm	116	5	significance	significance	NN
cord-023095-4dannjjm	116	6	were	be	VBD
cord-023095-4dannjjm	116	7	on	on	IN
cord-023095-4dannjjm	116	8	chromosomes	chromosome	NNS
cord-023095-4dannjjm	116	9	4	4	CD
cord-023095-4dannjjm	116	10	and	and	CC
cord-023095-4dannjjm	116	11	7	7	CD
cord-023095-4dannjjm	116	12	in	in	IN
cord-023095-4dannjjm	116	13	the	the	DT
cord-023095-4dannjjm	116	14	golden	golden	JJ
cord-023095-4dannjjm	116	15	retriever	retriever	NN
cord-023095-4dannjjm	116	16	and	and	CC
cord-023095-4dannjjm	116	17	11	11	CD
cord-023095-4dannjjm	116	18	and	and	CC
cord-023095-4dannjjm	116	19	38	38	CD
cord-023095-4dannjjm	116	20	in	in	IN
cord-023095-4dannjjm	116	21	the	the	DT
cord-023095-4dannjjm	116	22	Rottweiler	Rottweiler	NNP
cord-023095-4dannjjm	116	23	.	.	.
cord-023095-4dannjjm	117	1	Genome	Genome	NNP
cord-023095-4dannjjm	117	2	wide	wide	JJ
cord-023095-4dannjjm	117	3	association	association	NN
cord-023095-4dannjjm	117	4	with	with	IN
cord-023095-4dannjjm	117	5	subvalvular	subvalvular	JJ
cord-023095-4dannjjm	117	6	aortic	aortic	JJ
cord-023095-4dannjjm	117	7	stenosis	stenosis	NN
cord-023095-4dannjjm	117	8	in	in	IN
cord-023095-4dannjjm	117	9	the	the	DT
cord-023095-4dannjjm	117	10	golden	golden	JJ
cord-023095-4dannjjm	117	11	retriever	retriever	NN
cord-023095-4dannjjm	117	12	and	and	CC
cord-023095-4dannjjm	117	13	Rottweiler	Rottweiler	NNP
cord-023095-4dannjjm	117	14	implicate	implicate	VBP
cord-023095-4dannjjm	117	15	overlapping	overlap	VBG
cord-023095-4dannjjm	117	16	chromosomal	chromosomal	JJ
cord-023095-4dannjjm	117	17	regions	region	NNS
cord-023095-4dannjjm	117	18	of	of	IN
cord-023095-4dannjjm	117	19	interest	interest	NN
cord-023095-4dannjjm	117	20	for	for	IN
cord-023095-4dannjjm	117	21	causative	causative	JJ
cord-023095-4dannjjm	117	22	mutations	mutation	NNS
cord-023095-4dannjjm	117	23	on	on	IN
cord-023095-4dannjjm	117	24	chromosome	chromosome	NN
cord-023095-4dannjjm	117	25	21	21	CD
cord-023095-4dannjjm	117	26	.	.	.
cord-023095-4dannjjm	118	1	The	the	DT
cord-023095-4dannjjm	118	2	different	different	JJ
cord-023095-4dannjjm	118	3	secondary	secondary	JJ
cord-023095-4dannjjm	118	4	chromosomal	chromosomal	JJ
cord-023095-4dannjjm	118	5	regions	region	NNS
cord-023095-4dannjjm	118	6	of	of	IN
cord-023095-4dannjjm	118	7	interest	interest	NN
cord-023095-4dannjjm	118	8	(	(	-LRB-
cord-023095-4dannjjm	118	9	CHR	CHR	NNP
cord-023095-4dannjjm	118	10	4	4	CD
cord-023095-4dannjjm	118	11	,	,	,
cord-023095-4dannjjm	118	12	7	7	CD
cord-023095-4dannjjm	118	13	in	in	IN
cord-023095-4dannjjm	118	14	golden	golden	JJ
cord-023095-4dannjjm	118	15	retrievers	retriever	NNS
cord-023095-4dannjjm	118	16	and	and	CC
cord-023095-4dannjjm	118	17	11	11	CD
cord-023095-4dannjjm	118	18	,	,	,
cord-023095-4dannjjm	118	19	38	38	CD
cord-023095-4dannjjm	118	20	in	in	IN
cord-023095-4dannjjm	118	21	Rottweilers	Rottweilers	NNPS
cord-023095-4dannjjm	118	22	)	)	-RRB-
cord-023095-4dannjjm	118	23	supports	support	VBZ
cord-023095-4dannjjm	118	24	the	the	DT
cord-023095-4dannjjm	118	25	known	know	VBN
cord-023095-4dannjjm	118	26	familial	familial	JJ
cord-023095-4dannjjm	118	27	nature	nature	NN
cord-023095-4dannjjm	118	28	of	of	IN
cord-023095-4dannjjm	118	29	this	this	DT
cord-023095-4dannjjm	118	30	disease	disease	NN
cord-023095-4dannjjm	118	31	within	within	IN
cord-023095-4dannjjm	118	32	different	different	JJ
cord-023095-4dannjjm	118	33	breeds	breed	NNS
cord-023095-4dannjjm	118	34	and	and	CC
cord-023095-4dannjjm	118	35	may	may	MD
cord-023095-4dannjjm	118	36	suggest	suggest	VB
cord-023095-4dannjjm	118	37	the	the	DT
cord-023095-4dannjjm	118	38	presence	presence	NN
cord-023095-4dannjjm	118	39	of	of	IN
cord-023095-4dannjjm	118	40	multiple	multiple	JJ
cord-023095-4dannjjm	118	41	mutations	mutation	NNS
cord-023095-4dannjjm	118	42	or	or	CC
cord-023095-4dannjjm	118	43	breed	breed	VB
cord-023095-4dannjjm	118	44	specific	specific	JJ
cord-023095-4dannjjm	118	45	disease	disease	NN
cord-023095-4dannjjm	118	46	modifiers	modifier	NNS
cord-023095-4dannjjm	118	47	.	.	.
cord-023095-4dannjjm	119	1	These	these	DT
cord-023095-4dannjjm	119	2	data	datum	NNS
cord-023095-4dannjjm	119	3	highlight	highlight	VBP
cord-023095-4dannjjm	119	4	the	the	DT
cord-023095-4dannjjm	119	5	need	need	NN
cord-023095-4dannjjm	119	6	for	for	IN
cord-023095-4dannjjm	119	7	candidate	candidate	NN
cord-023095-4dannjjm	119	8	gene	gene	NN
cord-023095-4dannjjm	119	9	evaluation	evaluation	NN
cord-023095-4dannjjm	119	10	on	on	IN
cord-023095-4dannjjm	119	11	chromosome	chromosome	NN
cord-023095-4dannjjm	119	12	21	21	CD
cord-023095-4dannjjm	119	13	in	in	IN
cord-023095-4dannjjm	119	14	golden	golden	JJ
cord-023095-4dannjjm	119	15	retrievers	retriever	NNS
cord-023095-4dannjjm	119	16	and	and	CC
cord-023095-4dannjjm	119	17	Rottweilers	Rottweilers	NNPS
cord-023095-4dannjjm	119	18	with	with	IN
cord-023095-4dannjjm	119	19	SAS	SAS	NNP
cord-023095-4dannjjm	119	20	.	.	.
cord-023095-4dannjjm	120	1	Heart	heart	NN
cord-023095-4dannjjm	120	2	valves	valve	NNS
cord-023095-4dannjjm	120	3	share	share	VBP
cord-023095-4dannjjm	120	4	developmental	developmental	JJ
cord-023095-4dannjjm	120	5	signaling	signal	VBG
cord-023095-4dannjjm	120	6	pathways	pathway	NNS
cord-023095-4dannjjm	120	7	with	with	IN
cord-023095-4dannjjm	120	8	bone	bone	NN
cord-023095-4dannjjm	120	9	and	and	CC
cord-023095-4dannjjm	120	10	cartilage	cartilage	NN
cord-023095-4dannjjm	120	11	.	.	.
cord-023095-4dannjjm	121	1	Degenerative	degenerative	JJ
cord-023095-4dannjjm	121	2	aortic	aortic	JJ
cord-023095-4dannjjm	121	3	valve	valve	NN
cord-023095-4dannjjm	121	4	disease	disease	NN
cord-023095-4dannjjm	121	5	in	in	IN
cord-023095-4dannjjm	121	6	humans	human	NNS
cord-023095-4dannjjm	121	7	is	be	VBZ
cord-023095-4dannjjm	121	8	characterized	characterize	VBN
cord-023095-4dannjjm	121	9	by	by	IN
cord-023095-4dannjjm	121	10	valve	valve	NN
cord-023095-4dannjjm	121	11	stenosis	stenosis	NN
cord-023095-4dannjjm	121	12	and	and	CC
cord-023095-4dannjjm	121	13	calcification	calcification	NN
cord-023095-4dannjjm	121	14	.	.	.
cord-023095-4dannjjm	122	1	Recent	recent	JJ
cord-023095-4dannjjm	122	2	evidence	evidence	NN
cord-023095-4dannjjm	122	3	suggests	suggest	VBZ
cord-023095-4dannjjm	122	4	that	that	IN
cord-023095-4dannjjm	122	5	degenerative	degenerative	JJ
cord-023095-4dannjjm	122	6	aortic	aortic	JJ
cord-023095-4dannjjm	122	7	valves	valve	NNS
cord-023095-4dannjjm	122	8	are	be	VBP
cord-023095-4dannjjm	122	9	undergoing	undergo	VBG
cord-023095-4dannjjm	122	10	pathologic	pathologic	JJ
cord-023095-4dannjjm	122	11	processes	process	NNS
cord-023095-4dannjjm	122	12	that	that	WDT
cord-023095-4dannjjm	122	13	mimic	mimic	VBP
cord-023095-4dannjjm	122	14	osteogenesis	osteogenesis	NN
cord-023095-4dannjjm	122	15	.	.	.
cord-023095-4dannjjm	123	1	Degenerative	degenerative	JJ
cord-023095-4dannjjm	123	2	mitral	mitral	JJ
cord-023095-4dannjjm	123	3	valves	valve	NNS
cord-023095-4dannjjm	123	4	in	in	IN
cord-023095-4dannjjm	123	5	dogs	dog	NNS
cord-023095-4dannjjm	123	6	and	and	CC
cord-023095-4dannjjm	123	7	humans	human	NNS
cord-023095-4dannjjm	123	8	are	be	VBP
cord-023095-4dannjjm	123	9	characterized	characterize	VBN
cord-023095-4dannjjm	123	10	by	by	IN
cord-023095-4dannjjm	123	11	valve	valve	NN
cord-023095-4dannjjm	123	12	regurgitation	regurgitation	NN
cord-023095-4dannjjm	123	13	,	,	,
cord-023095-4dannjjm	123	14	and	and	CC
cord-023095-4dannjjm	123	15	rarely	rarely	RB
cord-023095-4dannjjm	123	16	undergo	undergo	VB
cord-023095-4dannjjm	123	17	calcification	calcification	NN
cord-023095-4dannjjm	123	18	.	.	.
cord-023095-4dannjjm	124	1	We	-PRON-	PRP
cord-023095-4dannjjm	124	2	tested	test	VBD
cord-023095-4dannjjm	124	3	the	the	DT
cord-023095-4dannjjm	124	4	hypothesis	hypothesis	NN
cord-023095-4dannjjm	124	5	that	that	IN
cord-023095-4dannjjm	124	6	canine	canine	JJ
cord-023095-4dannjjm	124	7	and	and	CC
cord-023095-4dannjjm	124	8	human	human	JJ
cord-023095-4dannjjm	124	9	degenerative	degenerative	JJ
cord-023095-4dannjjm	124	10	mitral	mitral	JJ
cord-023095-4dannjjm	124	11	valves	valve	NNS
cord-023095-4dannjjm	124	12	might	may	MD
cord-023095-4dannjjm	124	13	be	be	VB
cord-023095-4dannjjm	124	14	undergoing	undergo	VBG
cord-023095-4dannjjm	124	15	pathologic	pathologic	JJ
cord-023095-4dannjjm	124	16	processes	process	NNS
cord-023095-4dannjjm	124	17	that	that	WDT
cord-023095-4dannjjm	124	18	mimic	mimic	VBP
cord-023095-4dannjjm	124	19	chondrogenesis	chondrogenesis	NN
cord-023095-4dannjjm	124	20	.	.	.
cord-023095-4dannjjm	125	1	To	to	TO
cord-023095-4dannjjm	125	2	test	test	VB
cord-023095-4dannjjm	125	3	this	this	DT
cord-023095-4dannjjm	125	4	hypothesis	hypothesis	NN
cord-023095-4dannjjm	125	5	,	,	,
cord-023095-4dannjjm	125	6	expression	expression	NN
cord-023095-4dannjjm	125	7	of	of	IN
cord-023095-4dannjjm	125	8	bone	bone	NN
cord-023095-4dannjjm	125	9	morphogenic	morphogenic	JJ
cord-023095-4dannjjm	125	10	protein	protein	NN
cord-023095-4dannjjm	125	11	2	2	CD
cord-023095-4dannjjm	125	12	(	(	-LRB-
cord-023095-4dannjjm	125	13	BMP2	BMP2	NNP
cord-023095-4dannjjm	125	14	)	)	-RRB-
cord-023095-4dannjjm	125	15	,	,	,
cord-023095-4dannjjm	125	16	a	a	DT
cord-023095-4dannjjm	125	17	chondrogenic	chondrogenic	JJ
cord-023095-4dannjjm	125	18	growth	growth	NN
cord-023095-4dannjjm	125	19	factor	factor	NN
cord-023095-4dannjjm	125	20	;	;	:
cord-023095-4dannjjm	125	21	Sox	Sox	NNP
cord-023095-4dannjjm	125	22	9	9	CD
cord-023095-4dannjjm	125	23	,	,	,
cord-023095-4dannjjm	125	24	a	a	DT
cord-023095-4dannjjm	125	25	chondrogenic	chondrogenic	NN
cord-023095-4dannjjm	125	26	transcription	transcription	NN
cord-023095-4dannjjm	125	27	factor	factor	NN
cord-023095-4dannjjm	125	28	;	;	:
cord-023095-4dannjjm	125	29	aggrecan	aggrecan	NNP
cord-023095-4dannjjm	125	30	,	,	,
cord-023095-4dannjjm	125	31	a	a	DT
cord-023095-4dannjjm	125	32	proteoglycan	proteoglycan	NN
cord-023095-4dannjjm	125	33	abundant	abundant	JJ
cord-023095-4dannjjm	125	34	in	in	IN
cord-023095-4dannjjm	125	35	cartilage	cartilage	NN
cord-023095-4dannjjm	125	36	;	;	:
cord-023095-4dannjjm	125	37	and	and	CC
cord-023095-4dannjjm	125	38	type	type	NN
cord-023095-4dannjjm	125	39	II	ii	CD
cord-023095-4dannjjm	125	40	collagen	collagen	NN
cord-023095-4dannjjm	125	41	were	be	VBD
cord-023095-4dannjjm	125	42	evaluated	evaluate	VBN
cord-023095-4dannjjm	125	43	utilizing	utilize	VBG
cord-023095-4dannjjm	125	44	immunohistochemistry	immunohistochemistry	NN
cord-023095-4dannjjm	125	45	.	.	.
cord-023095-4dannjjm	126	1	Normal	normal	JJ
cord-023095-4dannjjm	126	2	canine	canine	JJ
cord-023095-4dannjjm	126	3	mitral	mitral	JJ
cord-023095-4dannjjm	126	4	valves	valve	NNS
cord-023095-4dannjjm	126	5	,	,	,
cord-023095-4dannjjm	126	6	different	different	JJ
cord-023095-4dannjjm	126	7	stages	stage	NNS
cord-023095-4dannjjm	126	8	of	of	IN
cord-023095-4dannjjm	126	9	canine	canine	JJ
cord-023095-4dannjjm	126	10	degenerative	degenerative	JJ
cord-023095-4dannjjm	126	11	mitral	mitral	JJ
cord-023095-4dannjjm	126	12	valves	valve	NNS
cord-023095-4dannjjm	126	13	(	(	-LRB-
cord-023095-4dannjjm	126	14	early	early	JJ
cord-023095-4dannjjm	126	15	,	,	,
cord-023095-4dannjjm	126	16	intermediate	intermediate	JJ
cord-023095-4dannjjm	126	17	,	,	,
cord-023095-4dannjjm	126	18	and	and	CC
cord-023095-4dannjjm	126	19	late	late	RB
cord-023095-4dannjjm	126	20	)	)	-RRB-
cord-023095-4dannjjm	126	21	,	,	,
cord-023095-4dannjjm	126	22	and	and	CC
cord-023095-4dannjjm	126	23	late	late	JJ
cord-023095-4dannjjm	126	24	-	-	HYPH
cord-023095-4dannjjm	126	25	stage	stage	NN
cord-023095-4dannjjm	126	26	human	human	JJ
cord-023095-4dannjjm	126	27	degenerative	degenerative	JJ
cord-023095-4dannjjm	126	28	mitral	mitral	JJ
cord-023095-4dannjjm	126	29	valves	valve	NNS
cord-023095-4dannjjm	126	30	were	be	VBD
cord-023095-4dannjjm	126	31	studied	study	VBN
cord-023095-4dannjjm	126	32	.	.	.
cord-023095-4dannjjm	127	1	Canine	canine	JJ
cord-023095-4dannjjm	127	2	and	and	CC
cord-023095-4dannjjm	127	3	human	human	JJ
cord-023095-4dannjjm	127	4	degenerative	degenerative	JJ
cord-023095-4dannjjm	127	5	mitral	mitral	JJ
cord-023095-4dannjjm	127	6	valves	valve	NNS
cord-023095-4dannjjm	127	7	showed	show	VBD
cord-023095-4dannjjm	127	8	focal	focal	JJ
cord-023095-4dannjjm	127	9	areas	area	NNS
cord-023095-4dannjjm	127	10	that	that	WDT
cord-023095-4dannjjm	127	11	co	co	VBD
cord-023095-4dannjjm	127	12	-	-	VBD
cord-023095-4dannjjm	127	13	expressed	express	VBD
cord-023095-4dannjjm	127	14	all	all	DT
cord-023095-4dannjjm	127	15	four	four	CD
cord-023095-4dannjjm	127	16	markers	marker	NNS
cord-023095-4dannjjm	127	17	of	of	IN
cord-023095-4dannjjm	127	18	chondrogenic	chondrogenic	NN
cord-023095-4dannjjm	127	19	signaling	signaling	NN
cord-023095-4dannjjm	127	20	and	and	CC
cord-023095-4dannjjm	127	21	phenotype	phenotype	NN
cord-023095-4dannjjm	127	22	.	.	.
cord-023095-4dannjjm	128	1	Valve	valve	NN
cord-023095-4dannjjm	128	2	interstitial	interstitial	JJ
cord-023095-4dannjjm	128	3	cells	cell	NNS
cord-023095-4dannjjm	128	4	and	and	CC
cord-023095-4dannjjm	128	5	surrounding	surround	VBG
cord-023095-4dannjjm	128	6	extracellular	extracellular	JJ
cord-023095-4dannjjm	128	7	matrix	matrix	NN
cord-023095-4dannjjm	128	8	in	in	IN
cord-023095-4dannjjm	128	9	these	these	DT
cord-023095-4dannjjm	128	10	focal	focal	JJ
cord-023095-4dannjjm	128	11	areas	area	NNS
cord-023095-4dannjjm	128	12	adopted	adopt	VBD
cord-023095-4dannjjm	128	13	a	a	DT
cord-023095-4dannjjm	128	14	morphologic	morphologic	JJ
cord-023095-4dannjjm	128	15	appearance	appearance	NN
cord-023095-4dannjjm	128	16	reminiscent	reminiscent	JJ
cord-023095-4dannjjm	128	17	of	of	IN
cord-023095-4dannjjm	128	18	cartilage	cartilage	NN
cord-023095-4dannjjm	128	19	.	.	.
cord-023095-4dannjjm	129	1	Focal	focal	JJ
cord-023095-4dannjjm	129	2	chondrogenesis	chondrogenesis	NN
cord-023095-4dannjjm	129	3	was	be	VBD
cord-023095-4dannjjm	129	4	present	present	JJ
cord-023095-4dannjjm	129	5	in	in	IN
cord-023095-4dannjjm	129	6	all	all	DT
cord-023095-4dannjjm	129	7	stages	stage	NNS
cord-023095-4dannjjm	129	8	of	of	IN
cord-023095-4dannjjm	129	9	canine	canine	JJ
cord-023095-4dannjjm	129	10	degenerative	degenerative	JJ
cord-023095-4dannjjm	129	11	mitral	mitral	JJ
cord-023095-4dannjjm	129	12	valves	valve	NNS
cord-023095-4dannjjm	129	13	,	,	,
cord-023095-4dannjjm	129	14	but	but	CC
cord-023095-4dannjjm	129	15	not	not	RB
cord-023095-4dannjjm	129	16	normal	normal	JJ
cord-023095-4dannjjm	129	17	canine	canine	JJ
cord-023095-4dannjjm	129	18	mitral	mitral	JJ
cord-023095-4dannjjm	129	19	valves	valve	NNS
cord-023095-4dannjjm	129	20	.	.	.
cord-023095-4dannjjm	130	1	Focal	focal	JJ
cord-023095-4dannjjm	130	2	areas	area	NNS
cord-023095-4dannjjm	130	3	of	of	IN
cord-023095-4dannjjm	130	4	chondrogenesis	chondrogenesis	NNP
cord-023095-4dannjjm	130	5	did	do	VBD
cord-023095-4dannjjm	130	6	not	not	RB
cord-023095-4dannjjm	130	7	coincide	coincide	VB
cord-023095-4dannjjm	130	8	with	with	IN
cord-023095-4dannjjm	130	9	nodular	nodular	JJ
cord-023095-4dannjjm	130	10	areas	area	NNS
cord-023095-4dannjjm	130	11	of	of	IN
cord-023095-4dannjjm	130	12	glycosaminoglycan	glycosaminoglycan	JJ
cord-023095-4dannjjm	130	13	accumulation	accumulation	NN
cord-023095-4dannjjm	130	14	on	on	IN
cord-023095-4dannjjm	130	15	the	the	DT
cord-023095-4dannjjm	130	16	leaflet	leaflet	NN
cord-023095-4dannjjm	130	17	edge	edge	NN
cord-023095-4dannjjm	130	18	,	,	,
cord-023095-4dannjjm	130	19	but	but	CC
cord-023095-4dannjjm	130	20	rather	rather	RB
cord-023095-4dannjjm	130	21	seemed	seem	VBD
cord-023095-4dannjjm	130	22	to	to	TO
cord-023095-4dannjjm	130	23	occur	occur	VB
cord-023095-4dannjjm	130	24	at	at	IN
cord-023095-4dannjjm	130	25	points	point	NNS
cord-023095-4dannjjm	130	26	of	of	IN
cord-023095-4dannjjm	130	27	chordae	chordae	NNP
cord-023095-4dannjjm	130	28	attachment	attachment	NN
cord-023095-4dannjjm	130	29	to	to	IN
cord-023095-4dannjjm	130	30	leaflets	leaflet	NNS
cord-023095-4dannjjm	130	31	.	.	.
cord-023095-4dannjjm	131	1	In	in	IN
cord-023095-4dannjjm	131	2	conclusion	conclusion	NN
cord-023095-4dannjjm	131	3	,	,	,
cord-023095-4dannjjm	131	4	canine	canine	JJ
cord-023095-4dannjjm	131	5	and	and	CC
cord-023095-4dannjjm	131	6	human	human	JJ
cord-023095-4dannjjm	131	7	degenerative	degenerative	JJ
cord-023095-4dannjjm	131	8	mitral	mitral	JJ
cord-023095-4dannjjm	131	9	valves	valve	NNS
cord-023095-4dannjjm	131	10	undergo	undergo	VBP
cord-023095-4dannjjm	131	11	pathologic	pathologic	JJ
cord-023095-4dannjjm	131	12	processes	process	NNS
cord-023095-4dannjjm	131	13	that	that	WDT
cord-023095-4dannjjm	131	14	mimic	mimic	VBP
cord-023095-4dannjjm	131	15	chondrogenesis	chondrogenesis	NN
cord-023095-4dannjjm	131	16	.	.	.
cord-023095-4dannjjm	132	1	This	this	DT
cord-023095-4dannjjm	132	2	finding	finding	NN
cord-023095-4dannjjm	132	3	suggests	suggest	VBZ
cord-023095-4dannjjm	132	4	that	that	IN
cord-023095-4dannjjm	132	5	mitral	mitral	JJ
cord-023095-4dannjjm	132	6	valve	valve	NN
cord-023095-4dannjjm	132	7	degeneration	degeneration	NN
cord-023095-4dannjjm	132	8	may	may	MD
cord-023095-4dannjjm	132	9	be	be	VB
cord-023095-4dannjjm	132	10	recapitulating	recapitulate	VBG
cord-023095-4dannjjm	132	11	developmental	developmental	JJ
cord-023095-4dannjjm	132	12	signaling	signal	VBG
cord-023095-4dannjjm	132	13	pathways	pathway	NNS
cord-023095-4dannjjm	132	14	shared	share	VBN
cord-023095-4dannjjm	132	15	by	by	IN
cord-023095-4dannjjm	132	16	heart	heart	NN
cord-023095-4dannjjm	132	17	valves	valve	NNS
cord-023095-4dannjjm	132	18	and	and	CC
cord-023095-4dannjjm	132	19	cartilage	cartilage	NN
cord-023095-4dannjjm	132	20	.	.	.
cord-023095-4dannjjm	133	1	The	the	DT
cord-023095-4dannjjm	133	2	triggering	trigger	VBG
cord-023095-4dannjjm	133	3	events	event	NNS
cord-023095-4dannjjm	133	4	for	for	IN
cord-023095-4dannjjm	133	5	chondrogenesis	chondrogenesis	NNP
cord-023095-4dannjjm	133	6	in	in	IN
cord-023095-4dannjjm	133	7	mitral	mitral	JJ
cord-023095-4dannjjm	133	8	valves	valve	NNS
cord-023095-4dannjjm	133	9	remain	remain	VBP
cord-023095-4dannjjm	133	10	unknown	unknown	JJ
cord-023095-4dannjjm	133	11	;	;	:
cord-023095-4dannjjm	133	12	as	as	IN
cord-023095-4dannjjm	133	13	does	do	VBZ
cord-023095-4dannjjm	133	14	the	the	DT
cord-023095-4dannjjm	133	15	reason	reason	NN
cord-023095-4dannjjm	133	16	why	why	WRB
cord-023095-4dannjjm	133	17	aortic	aortic	JJ
cord-023095-4dannjjm	133	18	and	and	CC
cord-023095-4dannjjm	133	19	mitral	mitral	JJ
cord-023095-4dannjjm	133	20	valves	valve	NNS
cord-023095-4dannjjm	133	21	appear	appear	VBP
cord-023095-4dannjjm	133	22	to	to	TO
cord-023095-4dannjjm	133	23	be	be	VB
cord-023095-4dannjjm	133	24	undergoing	undergo	VBG
cord-023095-4dannjjm	133	25	different	different	JJ
cord-023095-4dannjjm	133	26	pathologic	pathologic	JJ
cord-023095-4dannjjm	133	27	processes	process	NNS
cord-023095-4dannjjm	133	28	.	.	.
cord-023095-4dannjjm	134	1	The	the	DT
cord-023095-4dannjjm	134	2	fact	fact	NN
cord-023095-4dannjjm	134	3	that	that	IN
cord-023095-4dannjjm	134	4	humans	human	NNS
cord-023095-4dannjjm	134	5	exhibit	exhibit	VBP
cord-023095-4dannjjm	134	6	degeneration	degeneration	NN
cord-023095-4dannjjm	134	7	of	of	IN
cord-023095-4dannjjm	134	8	both	both	CC
cord-023095-4dannjjm	134	9	the	the	DT
cord-023095-4dannjjm	134	10	aortic	aortic	JJ
cord-023095-4dannjjm	134	11	and	and	CC
cord-023095-4dannjjm	134	12	mitral	mitral	JJ
cord-023095-4dannjjm	134	13	valve	valve	NN
cord-023095-4dannjjm	134	14	,	,	,
cord-023095-4dannjjm	134	15	and	and	CC
cord-023095-4dannjjm	134	16	that	that	IN
cord-023095-4dannjjm	134	17	dogs	dog	NNS
cord-023095-4dannjjm	134	18	commonly	commonly	RB
cord-023095-4dannjjm	134	19	exhibit	exhibit	VBP
cord-023095-4dannjjm	134	20	only	only	RB
cord-023095-4dannjjm	134	21	the	the	DT
cord-023095-4dannjjm	134	22	latter	latter	JJ
cord-023095-4dannjjm	134	23	could	could	MD
cord-023095-4dannjjm	134	24	eventually	eventually	RB
cord-023095-4dannjjm	134	25	provide	provide	VB
cord-023095-4dannjjm	134	26	insight	insight	NN
cord-023095-4dannjjm	134	27	into	into	IN
cord-023095-4dannjjm	134	28	both	both	DT
cord-023095-4dannjjm	134	29	processes	process	NNS
cord-023095-4dannjjm	134	30	.	.	.
cord-023095-4dannjjm	135	1	Arrhythmogenic	Arrhythmogenic	NNP
cord-023095-4dannjjm	135	2	right	right	JJ
cord-023095-4dannjjm	135	3	ventricular	ventricular	JJ
cord-023095-4dannjjm	135	4	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	135	5	(	(	-LRB-
cord-023095-4dannjjm	135	6	ARVC	ARVC	NNP
cord-023095-4dannjjm	135	7	)	)	-RRB-
cord-023095-4dannjjm	135	8	is	be	VBZ
cord-023095-4dannjjm	135	9	a	a	DT
cord-023095-4dannjjm	135	10	familial	familial	JJ
cord-023095-4dannjjm	135	11	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	135	12	characterized	characterize	VBN
cord-023095-4dannjjm	135	13	by	by	IN
cord-023095-4dannjjm	135	14	right	right	JJ
cord-023095-4dannjjm	135	15	ventricular	ventricular	JJ
cord-023095-4dannjjm	135	16	fibrofatty	fibrofatty	JJ
cord-023095-4dannjjm	135	17	infiltration	infiltration	NN
cord-023095-4dannjjm	135	18	and	and	CC
cord-023095-4dannjjm	135	19	ventricular	ventricular	JJ
cord-023095-4dannjjm	135	20	ectopy	ectopy	NN
cord-023095-4dannjjm	135	21	of	of	IN
cord-023095-4dannjjm	135	22	left	left	JJ
cord-023095-4dannjjm	135	23	bundle	bundle	NN
cord-023095-4dannjjm	135	24	branch	branch	NN
cord-023095-4dannjjm	135	25	block	block	NN
cord-023095-4dannjjm	135	26	morphology	morphology	NN
cord-023095-4dannjjm	135	27	(	(	-LRB-
cord-023095-4dannjjm	135	28	VPC	VPC	NNP
cord-023095-4dannjjm	135	29	)	)	-RRB-
cord-023095-4dannjjm	135	30	.	.	.
cord-023095-4dannjjm	136	1	A	a	DT
cord-023095-4dannjjm	136	2	deletion	deletion	NN
cord-023095-4dannjjm	136	3	in	in	IN
cord-023095-4dannjjm	136	4	the	the	DT
cord-023095-4dannjjm	136	5	striatin	striatin	NN
cord-023095-4dannjjm	136	6	gene	gene	NN
cord-023095-4dannjjm	136	7	has	have	VBZ
cord-023095-4dannjjm	136	8	been	be	VBN
cord-023095-4dannjjm	136	9	associated	associate	VBN
cord-023095-4dannjjm	136	10	with	with	IN
cord-023095-4dannjjm	136	11	ARVC	ARVC	NNP
cord-023095-4dannjjm	136	12	in	in	RP
cord-023095-4dannjjm	136	13	at	at	IN
cord-023095-4dannjjm	136	14	least	least	JJS
cord-023095-4dannjjm	136	15	some	some	DT
cord-023095-4dannjjm	136	16	boxer	boxer	NN
cord-023095-4dannjjm	136	17	families	family	NNS
cord-023095-4dannjjm	136	18	.	.	.
cord-023095-4dannjjm	137	1	Syncope	syncope	NN
cord-023095-4dannjjm	137	2	and	and	CC
cord-023095-4dannjjm	137	3	sudden	sudden	JJ
cord-023095-4dannjjm	137	4	death	death	NN
cord-023095-4dannjjm	137	5	(	(	-LRB-
cord-023095-4dannjjm	137	6	SD	sd	NN
cord-023095-4dannjjm	137	7	)	)	-RRB-
cord-023095-4dannjjm	137	8	occur	occur	VBP
cord-023095-4dannjjm	137	9	in	in	IN
cord-023095-4dannjjm	137	10	some	some	DT
cord-023095-4dannjjm	137	11	affected	affect	VBN
cord-023095-4dannjjm	137	12	dogs	dog	NNS
cord-023095-4dannjjm	137	13	,	,	,
cord-023095-4dannjjm	137	14	although	although	IN
cord-023095-4dannjjm	137	15	many	many	JJ
cord-023095-4dannjjm	137	16	affected	affect	VBN
cord-023095-4dannjjm	137	17	dogs	dog	NNS
cord-023095-4dannjjm	137	18	survive	survive	VBP
cord-023095-4dannjjm	137	19	for	for	IN
cord-023095-4dannjjm	137	20	years	year	NNS
cord-023095-4dannjjm	137	21	.	.	.
cord-023095-4dannjjm	138	1	The	the	DT
cord-023095-4dannjjm	138	2	objective	objective	NN
cord-023095-4dannjjm	138	3	of	of	IN
cord-023095-4dannjjm	138	4	this	this	DT
cord-023095-4dannjjm	138	5	study	study	NN
cord-023095-4dannjjm	138	6	was	be	VBD
cord-023095-4dannjjm	138	7	to	to	TO
cord-023095-4dannjjm	138	8	define	define	VB
cord-023095-4dannjjm	138	9	clinical	clinical	JJ
cord-023095-4dannjjm	138	10	characteristics	characteristic	NNS
cord-023095-4dannjjm	138	11	of	of	IN
cord-023095-4dannjjm	138	12	ARVC	ARVC	NNP
cord-023095-4dannjjm	138	13	in	in	IN
cord-023095-4dannjjm	138	14	boxers	boxer	NNS
cord-023095-4dannjjm	138	15	that	that	WDT
cord-023095-4dannjjm	138	16	experienced	experience	VBD
cord-023095-4dannjjm	138	17	SD	sd	NN
cord-023095-4dannjjm	138	18	,	,	,
cord-023095-4dannjjm	138	19	and	and	CC
cord-023095-4dannjjm	138	20	compare	compare	VB
cord-023095-4dannjjm	138	21	them	-PRON-	PRP
cord-023095-4dannjjm	138	22	to	to	IN
cord-023095-4dannjjm	138	23	those	those	DT
cord-023095-4dannjjm	138	24	of	of	IN
cord-023095-4dannjjm	138	25	a	a	DT
cord-023095-4dannjjm	138	26	contemporaneous	contemporaneous	JJ
cord-023095-4dannjjm	138	27	group	group	NN
cord-023095-4dannjjm	138	28	of	of	IN
cord-023095-4dannjjm	138	29	ARVC	ARVC	NNP
cord-023095-4dannjjm	138	30	boxers	boxer	NNS
cord-023095-4dannjjm	138	31	that	that	WDT
cord-023095-4dannjjm	138	32	had	have	VBD
cord-023095-4dannjjm	138	33	not	not	RB
cord-023095-4dannjjm	138	34	died	die	VBN
cord-023095-4dannjjm	138	35	suddenly	suddenly	RB
cord-023095-4dannjjm	138	36	(	(	-LRB-
cord-023095-4dannjjm	138	37	NSD	NSD	NNP
cord-023095-4dannjjm	138	38	)	)	-RRB-
cord-023095-4dannjjm	138	39	.	.	.
cord-023095-4dannjjm	139	1	Data	datum	NNS
cord-023095-4dannjjm	139	2	for	for	IN
cord-023095-4dannjjm	139	3	both	both	DT
cord-023095-4dannjjm	139	4	groups	group	NNS
cord-023095-4dannjjm	139	5	were	be	VBD
cord-023095-4dannjjm	139	6	collected	collect	VBN
cord-023095-4dannjjm	139	7	from	from	IN
cord-023095-4dannjjm	139	8	adult	adult	NN
cord-023095-4dannjjm	139	9	boxers	boxer	NNS
cord-023095-4dannjjm	139	10	enrolled	enrol	VBN
cord-023095-4dannjjm	139	11	in	in	IN
cord-023095-4dannjjm	139	12	a	a	DT
cord-023095-4dannjjm	139	13	long	long	JJ
cord-023095-4dannjjm	139	14	term	term	NN
cord-023095-4dannjjm	139	15	prospective	prospective	JJ
cord-023095-4dannjjm	139	16	study	study	NN
cord-023095-4dannjjm	139	17	of	of	IN
cord-023095-4dannjjm	139	18	ARVC	ARVC	NNP
cord-023095-4dannjjm	139	19	in	in	IN
cord-023095-4dannjjm	139	20	which	which	WDT
cord-023095-4dannjjm	139	21	echocardiograms	echocardiogram	VBZ
cord-023095-4dannjjm	139	22	and	and	CC
cord-023095-4dannjjm	139	23	24	24	CD
cord-023095-4dannjjm	139	24	hour	hour	NN
cord-023095-4dannjjm	139	25	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	139	26	ECG	ECG	NNP
cord-023095-4dannjjm	139	27	(	(	-LRB-
cord-023095-4dannjjm	139	28	AECG	AECG	NNP
cord-023095-4dannjjm	139	29	)	)	-RRB-
cord-023095-4dannjjm	139	30	are	be	VBP
cord-023095-4dannjjm	139	31	evaluated	evaluate	VBN
cord-023095-4dannjjm	139	32	annually	annually	RB
cord-023095-4dannjjm	139	33	.	.	.
cord-023095-4dannjjm	140	1	AECG	AECG	NNP
cord-023095-4dannjjm	140	2	are	be	VBP
cord-023095-4dannjjm	140	3	quantitated	quantitate	VBN
cord-023095-4dannjjm	140	4	for	for	IN
cord-023095-4dannjjm	140	5	VPC	VPC	NNP
cord-023095-4dannjjm	140	6	numbers	number	NNS
cord-023095-4dannjjm	140	7	and	and	CC
cord-023095-4dannjjm	140	8	arrhythmia	arrhythmia	NN
cord-023095-4dannjjm	140	9	grade	grade	NN
cord-023095-4dannjjm	140	10	(	(	-LRB-
cord-023095-4dannjjm	140	11	1	1	CD
cord-023095-4dannjjm	140	12	-	-	SYM
cord-023095-4dannjjm	140	13	4	4	CD
cord-023095-4dannjjm	140	14	)	)	-RRB-
cord-023095-4dannjjm	140	15	.	.	.
cord-023095-4dannjjm	141	1	ARVC	ARVC	NNP
cord-023095-4dannjjm	141	2	diagnosis	diagnosis	NN
cord-023095-4dannjjm	141	3	requires	require	VBZ
cord-023095-4dannjjm	141	4	at	at	IN
cord-023095-4dannjjm	141	5	least	least	JJS
cord-023095-4dannjjm	141	6	100	100	CD
cord-023095-4dannjjm	141	7	VPCs/	VPCs/	NNP
cord-023095-4dannjjm	141	8	24	24	CD
cord-023095-4dannjjm	141	9	hours	hour	NNS
cord-023095-4dannjjm	141	10	in	in	IN
cord-023095-4dannjjm	141	11	the	the	DT
cord-023095-4dannjjm	141	12	absence	absence	NN
cord-023095-4dannjjm	141	13	of	of	IN
cord-023095-4dannjjm	141	14	other	other	JJ
cord-023095-4dannjjm	141	15	disease	disease	NN
cord-023095-4dannjjm	141	16	.	.	.
cord-023095-4dannjjm	142	1	Forty	forty	CD
cord-023095-4dannjjm	142	2	three	three	CD
cord-023095-4dannjjm	142	3	adult	adult	NN
cord-023095-4dannjjm	142	4	boxers	boxer	NNS
cord-023095-4dannjjm	142	5	that	that	WDT
cord-023095-4dannjjm	142	6	entered	enter	VBD
cord-023095-4dannjjm	142	7	the	the	DT
cord-023095-4dannjjm	142	8	study	study	NN
cord-023095-4dannjjm	142	9	had	have	VBD
cord-023095-4dannjjm	142	10	died	die	VBN
cord-023095-4dannjjm	142	11	suddenly	suddenly	RB
cord-023095-4dannjjm	142	12	at	at	IN
cord-023095-4dannjjm	142	13	the	the	DT
cord-023095-4dannjjm	142	14	time	time	NN
cord-023095-4dannjjm	142	15	of	of	IN
cord-023095-4dannjjm	142	16	analysis	analysis	NN
cord-023095-4dannjjm	142	17	(	(	-LRB-
cord-023095-4dannjjm	142	18	SD	SD	NNP
cord-023095-4dannjjm	142	19	defined	define	VBN
cord-023095-4dannjjm	142	20	as	as	IN
cord-023095-4dannjjm	142	21	the	the	DT
cord-023095-4dannjjm	142	22	absence	absence	NN
cord-023095-4dannjjm	142	23	of	of	IN
cord-023095-4dannjjm	142	24	observed	observed	JJ
cord-023095-4dannjjm	142	25	clinical	clinical	JJ
cord-023095-4dannjjm	142	26	signs	sign	NNS
cord-023095-4dannjjm	142	27	within	within	IN
cord-023095-4dannjjm	142	28	24	24	CD
cord-023095-4dannjjm	142	29	hours	hour	NNS
cord-023095-4dannjjm	142	30	prior	prior	RB
cord-023095-4dannjjm	142	31	to	to	IN
cord-023095-4dannjjm	142	32	an	an	DT
cord-023095-4dannjjm	142	33	unexpected	unexpected	JJ
cord-023095-4dannjjm	142	34	and	and	CC
cord-023095-4dannjjm	142	35	unexplained	unexplained	JJ
cord-023095-4dannjjm	142	36	death	death	NN
cord-023095-4dannjjm	142	37	)	)	-RRB-
cord-023095-4dannjjm	142	38	.	.	.
cord-023095-4dannjjm	143	1	Striatin	Striatin	NNP
cord-023095-4dannjjm	143	2	genotype	genotype	NN
cord-023095-4dannjjm	143	3	was	be	VBD
cord-023095-4dannjjm	143	4	available	available	JJ
cord-023095-4dannjjm	143	5	for	for	IN
cord-023095-4dannjjm	143	6	28	28	CD
cord-023095-4dannjjm	143	7	of	of	IN
cord-023095-4dannjjm	143	8	the	the	DT
cord-023095-4dannjjm	143	9	43	43	CD
cord-023095-4dannjjm	143	10	SD	sd	NN
cord-023095-4dannjjm	143	11	dogs	dog	NNS
cord-023095-4dannjjm	143	12	(	(	-LRB-
cord-023095-4dannjjm	143	13	17	17	CD
cord-023095-4dannjjm	143	14	heterozygotes	heterozygote	NNS
cord-023095-4dannjjm	143	15	,	,	,
cord-023095-4dannjjm	143	16	11	11	CD
cord-023095-4dannjjm	143	17	homozygotes	homozygote	NNS
cord-023095-4dannjjm	143	18	)	)	-RRB-
cord-023095-4dannjjm	143	19	;	;	:
cord-023095-4dannjjm	143	20	19	19	CD
cord-023095-4dannjjm	143	21	were	be	VBD
cord-023095-4dannjjm	143	22	female	female	JJ
cord-023095-4dannjjm	143	23	(	(	-LRB-
cord-023095-4dannjjm	143	24	9	9	CD
cord-023095-4dannjjm	143	25	intact	intact	JJ
cord-023095-4dannjjm	143	26	)	)	-RRB-
cord-023095-4dannjjm	143	27	and	and	CC
cord-023095-4dannjjm	143	28	24	24	CD
cord-023095-4dannjjm	143	29	were	be	VBD
cord-023095-4dannjjm	143	30	male	male	JJ
cord-023095-4dannjjm	143	31	(	(	-LRB-
cord-023095-4dannjjm	143	32	14	14	CD
cord-023095-4dannjjm	143	33	intact	intact	JJ
cord-023095-4dannjjm	143	34	)	)	-RRB-
cord-023095-4dannjjm	143	35	.	.	.
cord-023095-4dannjjm	144	1	SD	SD	NNP
cord-023095-4dannjjm	144	2	occurred	occur	VBD
cord-023095-4dannjjm	144	3	at	at	IN
cord-023095-4dannjjm	144	4	a	a	DT
cord-023095-4dannjjm	144	5	mean	mean	JJ
cord-023095-4dannjjm	144	6	age	age	NN
cord-023095-4dannjjm	144	7	of	of	IN
cord-023095-4dannjjm	144	8	8	8	CD
cord-023095-4dannjjm	144	9	years	year	NNS
cord-023095-4dannjjm	145	1	(	(	-LRB-
cord-023095-4dannjjm	145	2	range	range	NN
cord-023095-4dannjjm	145	3	,	,	,
cord-023095-4dannjjm	145	4	1	1	CD
cord-023095-4dannjjm	145	5	-	-	SYM
cord-023095-4dannjjm	145	6	12	12	CD
cord-023095-4dannjjm	145	7	)	)	-RRB-
cord-023095-4dannjjm	145	8	;	;	:
cord-023095-4dannjjm	145	9	27	27	CD
cord-023095-4dannjjm	145	10	SD	sd	NN
cord-023095-4dannjjm	145	11	dogs	dog	NNS
cord-023095-4dannjjm	145	12	(	(	-LRB-
cord-023095-4dannjjm	145	13	63	63	CD
cord-023095-4dannjjm	145	14	%	%	NN
cord-023095-4dannjjm	145	15	)	)	-RRB-
cord-023095-4dannjjm	145	16	had	have	VBD
cord-023095-4dannjjm	145	17	no	no	DT
cord-023095-4dannjjm	145	18	prior	prior	JJ
cord-023095-4dannjjm	145	19	history	history	NN
cord-023095-4dannjjm	145	20	of	of	IN
cord-023095-4dannjjm	145	21	syncope	syncope	NN
cord-023095-4dannjjm	145	22	.	.	.
cord-023095-4dannjjm	146	1	Twelve	twelve	CD
cord-023095-4dannjjm	146	2	SD	sd	NN
cord-023095-4dannjjm	146	3	dogs	dog	NNS
cord-023095-4dannjjm	146	4	(	(	-LRB-
cord-023095-4dannjjm	146	5	28	28	CD
cord-023095-4dannjjm	146	6	%	%	NN
cord-023095-4dannjjm	146	7	)	)	-RRB-
cord-023095-4dannjjm	146	8	were	be	VBD
cord-023095-4dannjjm	146	9	on	on	IN
cord-023095-4dannjjm	146	10	antiarrhythmics	antiarrhythmic	NNS
cord-023095-4dannjjm	146	11	at	at	IN
cord-023095-4dannjjm	146	12	the	the	DT
cord-023095-4dannjjm	146	13	time	time	NN
cord-023095-4dannjjm	146	14	of	of	IN
cord-023095-4dannjjm	146	15	death	death	NN
cord-023095-4dannjjm	146	16	(	(	-LRB-
cord-023095-4dannjjm	146	17	metop	metop	NNP
cord-023095-4dannjjm	146	18	-	-	HYPH
cord-023095-4dannjjm	146	19	p0oooooooooooprolol	p0oooooooooooprolol	NNP
cord-023095-4dannjjm	146	20	(	(	-LRB-
cord-023095-4dannjjm	146	21	1	1	CD
cord-023095-4dannjjm	146	22	)	)	-RRB-
cord-023095-4dannjjm	146	23	,	,	,
cord-023095-4dannjjm	146	24	sotalol	sotalol	NNP
cord-023095-4dannjjm	146	25	(	(	-LRB-
cord-023095-4dannjjm	146	26	4	4	CD
cord-023095-4dannjjm	146	27	)	)	-RRB-
cord-023095-4dannjjm	146	28	,	,	,
cord-023095-4dannjjm	146	29	amiodarone	amiodarone	NN
cord-023095-4dannjjm	146	30	(	(	-LRB-
cord-023095-4dannjjm	146	31	1	1	CD
cord-023095-4dannjjm	146	32	)	)	-RRB-
cord-023095-4dannjjm	146	33	,	,	,
cord-023095-4dannjjm	146	34	procainamide	procainamide	NNP
cord-023095-4dannjjm	146	35	(	(	-LRB-
cord-023095-4dannjjm	146	36	2	2	CD
cord-023095-4dannjjm	146	37	)	)	-RRB-
cord-023095-4dannjjm	146	38	,	,	,
cord-023095-4dannjjm	146	39	mexiletine	mexiletine	NNP
cord-023095-4dannjjm	146	40	&	&	CC
cord-023095-4dannjjm	146	41	atenolol	atenolol	NNP
cord-023095-4dannjjm	146	42	(	(	-LRB-
cord-023095-4dannjjm	146	43	3	3	CD
cord-023095-4dannjjm	146	44	)	)	-RRB-
cord-023095-4dannjjm	146	45	,	,	,
cord-023095-4dannjjm	146	46	atenolol	atenolol	NNP
cord-023095-4dannjjm	146	47	(	(	-LRB-
cord-023095-4dannjjm	146	48	1	1	CD
cord-023095-4dannjjm	146	49	)	)	-RRB-
cord-023095-4dannjjm	146	50	)	)	-RRB-
cord-023095-4dannjjm	146	51	.	.	.
cord-023095-4dannjjm	147	1	Eleven	eleven	CD
cord-023095-4dannjjm	147	2	SD	sd	NN
cord-023095-4dannjjm	147	3	dogs	dog	NNS
cord-023095-4dannjjm	147	4	(	(	-LRB-
cord-023095-4dannjjm	147	5	25	25	CD
cord-023095-4dannjjm	147	6	%	%	NN
cord-023095-4dannjjm	147	7	)	)	-RRB-
cord-023095-4dannjjm	147	8	had	have	VBD
cord-023095-4dannjjm	147	9	decreased	decrease	VBN
cord-023095-4dannjjm	147	10	myocardial	myocardial	JJ
cord-023095-4dannjjm	147	11	systolic	systolic	JJ
cord-023095-4dannjjm	147	12	function	function	NN
cord-023095-4dannjjm	147	13	defined	define	VBN
cord-023095-4dannjjm	147	14	by	by	IN
cord-023095-4dannjjm	147	15	a	a	DT
cord-023095-4dannjjm	147	16	shortening	shorten	VBG
cord-023095-4dannjjm	147	17	fraction	fraction	NN
cord-023095-4dannjjm	147	18	(	(	-LRB-
cord-023095-4dannjjm	147	19	%	%	NN
cord-023095-4dannjjm	147	20	FS	fs	NN
cord-023095-4dannjjm	147	21	)	)	-RRB-
cord-023095-4dannjjm	148	1	o	o	UH
cord-023095-4dannjjm	149	1	25	25	CD
cord-023095-4dannjjm	149	2	%	%	NN
cord-023095-4dannjjm	149	3	(	(	-LRB-
cord-023095-4dannjjm	149	4	range	range	NN
cord-023095-4dannjjm	149	5	11	11	CD
cord-023095-4dannjjm	149	6	-	-	SYM
cord-023095-4dannjjm	149	7	45	45	CD
cord-023095-4dannjjm	149	8	,	,	,
cord-023095-4dannjjm	149	9	mean	mean	VBP
cord-023095-4dannjjm	149	10	5	5	CD
cord-023095-4dannjjm	149	11	27	27	CD
cord-023095-4dannjjm	149	12	)	)	-RRB-
cord-023095-4dannjjm	149	13	on	on	IN
cord-023095-4dannjjm	149	14	the	the	DT
cord-023095-4dannjjm	149	15	most	most	RBS
cord-023095-4dannjjm	149	16	recent	recent	JJ
cord-023095-4dannjjm	149	17	echocardiogram	echocardiogram	NN
cord-023095-4dannjjm	149	18	prior	prior	RB
cord-023095-4dannjjm	149	19	to	to	IN
cord-023095-4dannjjm	149	20	SD	SD	NNP
cord-023095-4dannjjm	149	21	.	.	.
cord-023095-4dannjjm	150	1	Median	median	JJ
cord-023095-4dannjjm	150	2	VPCs/24	vpcs/24	NN
cord-023095-4dannjjm	150	3	hours	hour	NNS
cord-023095-4dannjjm	150	4	on	on	IN
cord-023095-4dannjjm	150	5	annual	annual	JJ
cord-023095-4dannjjm	150	6	AECG	AECG	NNP
cord-023095-4dannjjm	150	7	was	be	VBD
cord-023095-4dannjjm	150	8	7,700	7,700	CD
cord-023095-4dannjjm	151	1	(	(	-LRB-
cord-023095-4dannjjm	151	2	range	range	NNP
cord-023095-4dannjjm	151	3	106	106	CD
cord-023095-4dannjjm	151	4	-	-	SYM
cord-023095-4dannjjm	151	5	91,000	91,000	CD
cord-023095-4dannjjm	151	6	)	)	-RRB-
cord-023095-4dannjjm	151	7	with	with	IN
cord-023095-4dannjjm	151	8	a	a	DT
cord-023095-4dannjjm	151	9	median	median	JJ
cord-023095-4dannjjm	151	10	arrhythmia	arrhythmia	NN
cord-023095-4dannjjm	151	11	grade	grade	NN
cord-023095-4dannjjm	151	12	of	of	IN
cord-023095-4dannjjm	151	13	4	4	CD
cord-023095-4dannjjm	151	14	(	(	-LRB-
cord-023095-4dannjjm	151	15	range	range	NNP
cord-023095-4dannjjm	151	16	2	2	CD
cord-023095-4dannjjm	151	17	-	-	SYM
cord-023095-4dannjjm	151	18	4	4	CD
cord-023095-4dannjjm	151	19	)	)	-RRB-
cord-023095-4dannjjm	151	20	.	.	.
cord-023095-4dannjjm	152	1	Twenty	twenty	CD
cord-023095-4dannjjm	152	2	one	one	NN
cord-023095-4dannjjm	152	3	contemporaneously	contemporaneously	RB
cord-023095-4dannjjm	152	4	entered	enter	VBD
cord-023095-4dannjjm	152	5	ARVC	ARVC	NNP
cord-023095-4dannjjm	152	6	boxers	boxer	NNS
cord-023095-4dannjjm	152	7	that	that	WDT
cord-023095-4dannjjm	152	8	had	have	VBD
cord-023095-4dannjjm	152	9	survived	survive	VBN
cord-023095-4dannjjm	152	10	to	to	IN
cord-023095-4dannjjm	152	11	at	at	IN
cord-023095-4dannjjm	152	12	least	least	JJS
cord-023095-4dannjjm	152	13	the	the	DT
cord-023095-4dannjjm	152	14	median	median	JJ
cord-023095-4dannjjm	152	15	age	age	NN
cord-023095-4dannjjm	152	16	of	of	IN
cord-023095-4dannjjm	152	17	the	the	DT
cord-023095-4dannjjm	152	18	SD	SD	NNP
cord-023095-4dannjjm	152	19	group	group	NN
cord-023095-4dannjjm	152	20	with	with	IN
cord-023095-4dannjjm	152	21	NSD	NSD	NNP
cord-023095-4dannjjm	152	22	were	be	VBD
cord-023095-4dannjjm	152	23	available	available	JJ
cord-023095-4dannjjm	152	24	for	for	IN
cord-023095-4dannjjm	152	25	comparison	comparison	NN
cord-023095-4dannjjm	152	26	;	;	:
cord-023095-4dannjjm	152	27	15/21	15/21	CD
cord-023095-4dannjjm	152	28	were	be	VBD
cord-023095-4dannjjm	152	29	genotyped	genotype	VBN
cord-023095-4dannjjm	152	30	(	(	-LRB-
cord-023095-4dannjjm	152	31	10	10	CD
cord-023095-4dannjjm	152	32	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	152	33	,	,	,
cord-023095-4dannjjm	152	34	1	1	CD
cord-023095-4dannjjm	152	35	homozygous	homozygous	JJ
cord-023095-4dannjjm	152	36	,	,	,
cord-023095-4dannjjm	152	37	4	4	CD
cord-023095-4dannjjm	152	38	negative	negative	JJ
cord-023095-4dannjjm	152	39	)	)	-RRB-
cord-023095-4dannjjm	152	40	,	,	,
cord-023095-4dannjjm	152	41	13	13	CD
cord-023095-4dannjjm	152	42	were	be	VBD
cord-023095-4dannjjm	152	43	female	female	JJ
cord-023095-4dannjjm	152	44	(	(	-LRB-
cord-023095-4dannjjm	152	45	3	3	CD
cord-023095-4dannjjm	152	46	intact	intact	JJ
cord-023095-4dannjjm	152	47	)	)	-RRB-
cord-023095-4dannjjm	152	48	and	and	CC
cord-023095-4dannjjm	152	49	8	8	CD
cord-023095-4dannjjm	152	50	male	male	NN
cord-023095-4dannjjm	152	51	(	(	-LRB-
cord-023095-4dannjjm	152	52	2	2	CD
cord-023095-4dannjjm	152	53	intact	intact	JJ
cord-023095-4dannjjm	152	54	)	)	-RRB-
cord-023095-4dannjjm	152	55	.	.	.
cord-023095-4dannjjm	153	1	Twelve	twelve	CD
cord-023095-4dannjjm	153	2	NSD	NSD	NNP
cord-023095-4dannjjm	153	3	dogs	dog	NNS
cord-023095-4dannjjm	153	4	(	(	-LRB-
cord-023095-4dannjjm	153	5	57	57	CD
cord-023095-4dannjjm	153	6	%	%	NN
cord-023095-4dannjjm	153	7	)	)	-RRB-
cord-023095-4dannjjm	153	8	had	have	VBD
cord-023095-4dannjjm	153	9	no	no	DT
cord-023095-4dannjjm	153	10	prior	prior	JJ
cord-023095-4dannjjm	153	11	history	history	NN
cord-023095-4dannjjm	153	12	of	of	IN
cord-023095-4dannjjm	153	13	syncope	syncope	NN
cord-023095-4dannjjm	153	14	.	.	.
cord-023095-4dannjjm	154	1	Median	median	JJ
cord-023095-4dannjjm	154	2	NSD	NSD	NNP
cord-023095-4dannjjm	154	3	group	group	NN
cord-023095-4dannjjm	154	4	age	age	NN
cord-023095-4dannjjm	154	5	was	be	VBD
cord-023095-4dannjjm	154	6	10	10	CD
cord-023095-4dannjjm	154	7	years	year	NNS
cord-023095-4dannjjm	154	8	(	(	-LRB-
cord-023095-4dannjjm	154	9	range	range	NN
cord-023095-4dannjjm	154	10	,	,	,
cord-023095-4dannjjm	154	11	8	8	CD
cord-023095-4dannjjm	154	12	-	-	SYM
cord-023095-4dannjjm	154	13	13	13	CD
cord-023095-4dannjjm	154	14	)	)	-RRB-
cord-023095-4dannjjm	154	15	;	;	:
cord-023095-4dannjjm	154	16	11/21	11/21	CD
cord-023095-4dannjjm	154	17	(	(	-LRB-
cord-023095-4dannjjm	154	18	52	52	CD
cord-023095-4dannjjm	154	19	%	%	NN
cord-023095-4dannjjm	154	20	)	)	-RRB-
cord-023095-4dannjjm	154	21	were	be	VBD
cord-023095-4dannjjm	154	22	on	on	IN
cord-023095-4dannjjm	154	23	an	an	DT
cord-023095-4dannjjm	154	24	antiarrhythmics	antiarrhythmic	NNS
cord-023095-4dannjjm	154	25	(	(	-LRB-
cord-023095-4dannjjm	154	26	sotalol	sotalol	NNP
cord-023095-4dannjjm	154	27	(	(	-LRB-
cord-023095-4dannjjm	154	28	9	9	CD
cord-023095-4dannjjm	154	29	)	)	-RRB-
cord-023095-4dannjjm	154	30	,	,	,
cord-023095-4dannjjm	154	31	mexiletine	mexiletine	NNP
cord-023095-4dannjjm	154	32	&	&	CC
cord-023095-4dannjjm	154	33	sotalol	sotalol	NNP
cord-023095-4dannjjm	154	34	(	(	-LRB-
cord-023095-4dannjjm	154	35	1	1	CD
cord-023095-4dannjjm	154	36	)	)	-RRB-
cord-023095-4dannjjm	154	37	,	,	,
cord-023095-4dannjjm	154	38	mexiletine	mexiletine	NNP
cord-023095-4dannjjm	154	39	&	&	CC
cord-023095-4dannjjm	154	40	atenolol	atenolol	NNP
cord-023095-4dannjjm	154	41	(	(	-LRB-
cord-023095-4dannjjm	154	42	1	1	CD
cord-023095-4dannjjm	154	43	)	)	-RRB-
cord-023095-4dannjjm	154	44	)	)	-RRB-
cord-023095-4dannjjm	154	45	.	.	.
cord-023095-4dannjjm	155	1	One	one	CD
cord-023095-4dannjjm	155	2	NSD	NSD	NNP
cord-023095-4dannjjm	155	3	dog	dog	NN
cord-023095-4dannjjm	155	4	had	have	VBD
cord-023095-4dannjjm	155	5	decreased	decrease	VBN
cord-023095-4dannjjm	155	6	%	%	NN
cord-023095-4dannjjm	155	7	FS	fs	NN
cord-023095-4dannjjm	155	8	(	(	-LRB-
cord-023095-4dannjjm	155	9	NSD	NSD	NNP
cord-023095-4dannjjm	155	10	group	group	NN
cord-023095-4dannjjm	155	11	%	%	NN
cord-023095-4dannjjm	155	12	FS	fs	NN
cord-023095-4dannjjm	155	13	range	range	NN
cord-023095-4dannjjm	155	14	20	20	CD
cord-023095-4dannjjm	155	15	-	-	SYM
cord-023095-4dannjjm	155	16	42	42	CD
cord-023095-4dannjjm	155	17	,	,	,
cord-023095-4dannjjm	155	18	mean	mean	JJ
cord-023095-4dannjjm	155	19	5	5	CD
cord-023095-4dannjjm	155	20	32	32	CD
cord-023095-4dannjjm	155	21	)	)	-RRB-
cord-023095-4dannjjm	155	22	.	.	.
cord-023095-4dannjjm	156	1	The	the	DT
cord-023095-4dannjjm	156	2	NSD	NSD	NNP
cord-023095-4dannjjm	156	3	median	median	JJ
cord-023095-4dannjjm	156	4	number	number	NN
cord-023095-4dannjjm	156	5	of	of	IN
cord-023095-4dannjjm	156	6	VPCs	vpc	NNS
cord-023095-4dannjjm	156	7	was	be	VBD
cord-023095-4dannjjm	156	8	5,342	5,342	CD
cord-023095-4dannjjm	157	1	(	(	-LRB-
cord-023095-4dannjjm	157	2	range	range	NNP
cord-023095-4dannjjm	157	3	622	622	CD
cord-023095-4dannjjm	157	4	-	-	HYPH
cord-023095-4dannjjm	157	5	62,622	62,622	CD
cord-023095-4dannjjm	157	6	)	)	-RRB-
cord-023095-4dannjjm	157	7	,	,	,
cord-023095-4dannjjm	157	8	median	median	JJ
cord-023095-4dannjjm	157	9	arrhythmia	arrhythmia	NN
cord-023095-4dannjjm	157	10	grade	grade	NN
cord-023095-4dannjjm	157	11	was	be	VBD
cord-023095-4dannjjm	157	12	4	4	CD
cord-023095-4dannjjm	158	1	(	(	-LRB-
cord-023095-4dannjjm	158	2	range	range	NNP
cord-023095-4dannjjm	158	3	2	2	CD
cord-023095-4dannjjm	158	4	-	-	SYM
cord-023095-4dannjjm	158	5	4	4	CD
cord-023095-4dannjjm	158	6	)	)	-RRB-
cord-023095-4dannjjm	158	7	.	.	.
cord-023095-4dannjjm	159	1	Striatin	Striatin	NNP
cord-023095-4dannjjm	159	2	genotype	genotype	NN
cord-023095-4dannjjm	159	3	was	be	VBD
cord-023095-4dannjjm	159	4	significantly	significantly	RB
cord-023095-4dannjjm	159	5	associated	associate	VBN
cord-023095-4dannjjm	159	6	with	with	IN
cord-023095-4dannjjm	159	7	SD	sd	NN
cord-023095-4dannjjm	159	8	.	.	.
cord-023095-4dannjjm	160	1	No	no	DT
cord-023095-4dannjjm	160	2	significant	significant	JJ
cord-023095-4dannjjm	160	3	differences	difference	NNS
cord-023095-4dannjjm	160	4	were	be	VBD
cord-023095-4dannjjm	160	5	found	find	VBN
cord-023095-4dannjjm	160	6	between	between	IN
cord-023095-4dannjjm	160	7	groups	group	NNS
cord-023095-4dannjjm	160	8	with	with	IN
cord-023095-4dannjjm	160	9	respect	respect	NN
cord-023095-4dannjjm	160	10	to	to	IN
cord-023095-4dannjjm	160	11	VPC	VPC	NNP
cord-023095-4dannjjm	160	12	numbers	number	NNS
cord-023095-4dannjjm	160	13	or	or	CC
cord-023095-4dannjjm	160	14	arrhythmia	arrhythmia	NN
cord-023095-4dannjjm	160	15	grade	grade	NN
cord-023095-4dannjjm	160	16	.	.	.
cord-023095-4dannjjm	161	1	Shortening	shorten	VBG
cord-023095-4dannjjm	161	2	fraction	fraction	NN
cord-023095-4dannjjm	161	3	was	be	VBD
cord-023095-4dannjjm	161	4	significantly	significantly	RB
cord-023095-4dannjjm	161	5	lower	low	JJR
cord-023095-4dannjjm	161	6	in	in	IN
cord-023095-4dannjjm	161	7	the	the	DT
cord-023095-4dannjjm	161	8	SD	sd	NN
cord-023095-4dannjjm	161	9	group	group	NN
cord-023095-4dannjjm	161	10	(	(	-LRB-
cord-023095-4dannjjm	161	11	p	p	NN
cord-023095-4dannjjm	161	12	o	o	NN
cord-023095-4dannjjm	161	13	0.01	0.01	CD
cord-023095-4dannjjm	161	14	)	)	-RRB-
cord-023095-4dannjjm	161	15	.	.	.
cord-023095-4dannjjm	162	1	SD	SD	NNP
cord-023095-4dannjjm	162	2	in	in	IN
cord-023095-4dannjjm	162	3	ARVC	ARVC	NNP
cord-023095-4dannjjm	162	4	appears	appear	VBZ
cord-023095-4dannjjm	162	5	to	to	TO
cord-023095-4dannjjm	162	6	be	be	VB
cord-023095-4dannjjm	162	7	associated	associate	VBN
cord-023095-4dannjjm	162	8	with	with	IN
cord-023095-4dannjjm	162	9	the	the	DT
cord-023095-4dannjjm	162	10	presence	presence	NN
cord-023095-4dannjjm	162	11	of	of	IN
cord-023095-4dannjjm	162	12	the	the	DT
cord-023095-4dannjjm	162	13	striatin	striatin	NNP
cord-023095-4dannjjm	162	14	mutation	mutation	NN
cord-023095-4dannjjm	162	15	and	and	CC
cord-023095-4dannjjm	162	16	reduced	reduce	VBN
cord-023095-4dannjjm	162	17	%	%	NN
cord-023095-4dannjjm	162	18	FS	fs	NN
cord-023095-4dannjjm	162	19	,	,	,
cord-023095-4dannjjm	162	20	it	-PRON-	PRP
cord-023095-4dannjjm	162	21	does	do	VBZ
cord-023095-4dannjjm	162	22	not	not	RB
cord-023095-4dannjjm	162	23	appear	appear	VB
cord-023095-4dannjjm	162	24	to	to	TO
cord-023095-4dannjjm	162	25	be	be	VB
cord-023095-4dannjjm	162	26	associated	associate	VBN
cord-023095-4dannjjm	162	27	with	with	IN
cord-023095-4dannjjm	162	28	number	number	NN
cord-023095-4dannjjm	162	29	of	of	IN
cord-023095-4dannjjm	162	30	VPCS	VPCS	NNP
cord-023095-4dannjjm	162	31	or	or	CC
cord-023095-4dannjjm	162	32	arrhythmia	arrhythmia	NN
cord-023095-4dannjjm	162	33	grade	grade	NN
cord-023095-4dannjjm	162	34	.	.	.
cord-023095-4dannjjm	163	1	Coughing	cough	VBG
cord-023095-4dannjjm	163	2	in	in	IN
cord-023095-4dannjjm	163	3	the	the	DT
cord-023095-4dannjjm	163	4	small	small	JJ
cord-023095-4dannjjm	163	5	breed	breed	NN
cord-023095-4dannjjm	163	6	dog	dog	NN
cord-023095-4dannjjm	163	7	may	may	MD
cord-023095-4dannjjm	163	8	be	be	VB
cord-023095-4dannjjm	163	9	related	relate	VBN
cord-023095-4dannjjm	163	10	to	to	IN
cord-023095-4dannjjm	163	11	cardiac	cardiac	JJ
cord-023095-4dannjjm	163	12	causes	cause	NNS
cord-023095-4dannjjm	163	13	associated	associate	VBN
cord-023095-4dannjjm	163	14	with	with	IN
cord-023095-4dannjjm	163	15	myxomatous	myxomatous	JJ
cord-023095-4dannjjm	163	16	mitral	mitral	JJ
cord-023095-4dannjjm	163	17	valve	valve	NN
cord-023095-4dannjjm	163	18	degeneration	degeneration	NN
cord-023095-4dannjjm	163	19	(	(	-LRB-
cord-023095-4dannjjm	163	20	MMVD	MMVD	NNP
cord-023095-4dannjjm	163	21	)	)	-RRB-
cord-023095-4dannjjm	163	22	including	include	VBG
cord-023095-4dannjjm	163	23	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	163	24	edema	edema	NN
cord-023095-4dannjjm	163	25	and	and	CC
cord-023095-4dannjjm	163	26	compression	compression	NN
cord-023095-4dannjjm	163	27	of	of	IN
cord-023095-4dannjjm	163	28	the	the	DT
cord-023095-4dannjjm	163	29	mainstem	mainstem	JJ
cord-023095-4dannjjm	163	30	bronchus	bronchus	NN
cord-023095-4dannjjm	163	31	by	by	IN
cord-023095-4dannjjm	163	32	a	a	DT
cord-023095-4dannjjm	163	33	severely	severely	RB
cord-023095-4dannjjm	163	34	enlarged	enlarge	VBN
cord-023095-4dannjjm	163	35	left	left	JJ
cord-023095-4dannjjm	163	36	atrium	atrium	NN
cord-023095-4dannjjm	163	37	,	,	,
cord-023095-4dannjjm	163	38	or	or	CC
cord-023095-4dannjjm	163	39	due	due	IN
cord-023095-4dannjjm	163	40	to	to	IN
cord-023095-4dannjjm	163	41	respiratory	respiratory	JJ
cord-023095-4dannjjm	163	42	causes	cause	NNS
cord-023095-4dannjjm	163	43	such	such	JJ
cord-023095-4dannjjm	163	44	as	as	IN
cord-023095-4dannjjm	163	45	tracheal	tracheal	NN
cord-023095-4dannjjm	163	46	and/or	and/or	CC
cord-023095-4dannjjm	163	47	bronchial	bronchial	JJ
cord-023095-4dannjjm	163	48	collapse	collapse	NN
cord-023095-4dannjjm	163	49	or	or	CC
cord-023095-4dannjjm	163	50	chronic	chronic	JJ
cord-023095-4dannjjm	163	51	bronchitis	bronchitis	NN
cord-023095-4dannjjm	163	52	.	.	.
cord-023095-4dannjjm	164	1	The	the	DT
cord-023095-4dannjjm	164	2	purpose	purpose	NN
cord-023095-4dannjjm	164	3	of	of	IN
cord-023095-4dannjjm	164	4	this	this	DT
cord-023095-4dannjjm	164	5	study	study	NN
cord-023095-4dannjjm	164	6	was	be	VBD
cord-023095-4dannjjm	164	7	to	to	TO
cord-023095-4dannjjm	164	8	evaluate	evaluate	VB
cord-023095-4dannjjm	164	9	the	the	DT
cord-023095-4dannjjm	164	10	association	association	NN
cord-023095-4dannjjm	164	11	between	between	IN
cord-023095-4dannjjm	164	12	left	left	JJ
cord-023095-4dannjjm	164	13	atrial	atrial	JJ
cord-023095-4dannjjm	164	14	enlargement	enlargement	NN
cord-023095-4dannjjm	164	15	and	and	CC
cord-023095-4dannjjm	164	16	large	large	JJ
cord-023095-4dannjjm	164	17	airway	airway	NN
cord-023095-4dannjjm	164	18	collapse	collapse	NN
cord-023095-4dannjjm	164	19	in	in	IN
cord-023095-4dannjjm	164	20	dogs	dog	NNS
cord-023095-4dannjjm	164	21	with	with	IN
cord-023095-4dannjjm	164	22	MMVD	MMVD	NNP
cord-023095-4dannjjm	164	23	and	and	CC
cord-023095-4dannjjm	164	24	chronic	chronic	JJ
cord-023095-4dannjjm	164	25	cough	cough	NN
cord-023095-4dannjjm	164	26	.	.	.
cord-023095-4dannjjm	165	1	We	-PRON-	PRP
cord-023095-4dannjjm	165	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	165	3	that	that	IN
cord-023095-4dannjjm	165	4	airway	airway	NN
cord-023095-4dannjjm	165	5	collapse	collapse	NN
cord-023095-4dannjjm	165	6	was	be	VBD
cord-023095-4dannjjm	165	7	independent	independent	JJ
cord-023095-4dannjjm	165	8	of	of	IN
cord-023095-4dannjjm	165	9	degree	degree	NN
cord-023095-4dannjjm	165	10	of	of	IN
cord-023095-4dannjjm	165	11	left	left	JJ
cord-023095-4dannjjm	165	12	atrial	atrial	JJ
cord-023095-4dannjjm	165	13	enlargement	enlargement	NN
cord-023095-4dannjjm	165	14	.	.	.
cord-023095-4dannjjm	166	1	Twelve	twelve	CD
cord-023095-4dannjjm	166	2	dogs	dog	NNS
cord-023095-4dannjjm	166	3	with	with	IN
cord-023095-4dannjjm	166	4	MMVD	MMVD	NNP
cord-023095-4dannjjm	166	5	and	and	CC
cord-023095-4dannjjm	166	6	a	a	DT
cord-023095-4dannjjm	166	7	chronic	chronic	JJ
cord-023095-4dannjjm	166	8	cough	cough	NN
cord-023095-4dannjjm	166	9	in	in	IN
cord-023095-4dannjjm	166	10	the	the	DT
cord-023095-4dannjjm	166	11	absence	absence	NN
cord-023095-4dannjjm	166	12	of	of	IN
cord-023095-4dannjjm	166	13	congestive	congestive	JJ
cord-023095-4dannjjm	166	14	heart	heart	NN
cord-023095-4dannjjm	166	15	failure	failure	NN
cord-023095-4dannjjm	166	16	were	be	VBD
cord-023095-4dannjjm	166	17	prospectively	prospectively	RB
cord-023095-4dannjjm	166	18	evaluated	evaluate	VBN
cord-023095-4dannjjm	166	19	with	with	IN
cord-023095-4dannjjm	166	20	thoracic	thoracic	JJ
cord-023095-4dannjjm	166	21	and	and	CC
cord-023095-4dannjjm	166	22	cervical	cervical	JJ
cord-023095-4dannjjm	166	23	radiography	radiography	NN
cord-023095-4dannjjm	166	24	,	,	,
cord-023095-4dannjjm	166	25	echocardiography	echocardiography	NN
cord-023095-4dannjjm	166	26	,	,	,
cord-023095-4dannjjm	166	27	fluoroscopy	fluoroscopy	NN
cord-023095-4dannjjm	166	28	,	,	,
cord-023095-4dannjjm	166	29	bronchoscopy	bronchoscopy	NN
cord-023095-4dannjjm	166	30	and	and	CC
cord-023095-4dannjjm	166	31	bronchoalveolar	bronchoalveolar	NNP
cord-023095-4dannjjm	166	32	lavage	lavage	NNP
cord-023095-4dannjjm	166	33	(	(	-LRB-
cord-023095-4dannjjm	166	34	BAL	BAL	NNP
cord-023095-4dannjjm	166	35	)	)	-RRB-
cord-023095-4dannjjm	166	36	.	.	.
cord-023095-4dannjjm	167	1	Group	group	NN
cord-023095-4dannjjm	167	2	1	1	CD
cord-023095-4dannjjm	167	3	dogs	dog	NNS
cord-023095-4dannjjm	167	4	(	(	-LRB-
cord-023095-4dannjjm	167	5	n	n	NN
cord-023095-4dannjjm	167	6	5	5	CD
cord-023095-4dannjjm	167	7	8)	8)	NNP
cord-023095-4dannjjm	167	8	had	have	VBD
cord-023095-4dannjjm	167	9	moderate	moderate	JJ
cord-023095-4dannjjm	167	10	to	to	TO
cord-023095-4dannjjm	167	11	severe	severe	JJ
cord-023095-4dannjjm	167	12	left	left	JJ
cord-023095-4dannjjm	167	13	atrial	atrial	JJ
cord-023095-4dannjjm	167	14	enlargement	enlargement	NN
cord-023095-4dannjjm	167	15	based	base	VBN
cord-023095-4dannjjm	167	16	on	on	IN
cord-023095-4dannjjm	167	17	an	an	DT
cord-023095-4dannjjm	167	18	echocardiographically	echocardiographically	RB
cord-023095-4dannjjm	167	19	calculated	calculate	VBN
cord-023095-4dannjjm	167	20	left	left	JJ
cord-023095-4dannjjm	167	21	atrial	atrial	NN
cord-023095-4dannjjm	167	22	:	:	:
cord-023095-4dannjjm	167	23	aortic	aortic	JJ
cord-023095-4dannjjm	167	24	surface	surface	NN
cord-023095-4dannjjm	167	25	area	area	NN
cord-023095-4dannjjm	167	26	[	[	-LRB-
cord-023095-4dannjjm	167	27	LA	la	NN
cord-023095-4dannjjm	167	28	:	:	:
cord-023095-4dannjjm	167	29	Ao(a	Ao(a	NNP
cord-023095-4dannjjm	167	30	)	)	-RRB-
cord-023095-4dannjjm	167	31	]	]	-RRB-
cord-023095-4dannjjm	168	1	4	4	CD
cord-023095-4dannjjm	168	2	6	6	CD
cord-023095-4dannjjm	168	3	.	.	.
cord-023095-4dannjjm	169	1	Group	group	NN
cord-023095-4dannjjm	169	2	2	2	CD
cord-023095-4dannjjm	169	3	dogs	dog	NNS
cord-023095-4dannjjm	169	4	(	(	-LRB-
cord-023095-4dannjjm	169	5	n	n	NN
cord-023095-4dannjjm	169	6	5	5	CD
cord-023095-4dannjjm	169	7	4	4	CD
cord-023095-4dannjjm	169	8	)	)	-RRB-
cord-023095-4dannjjm	169	9	had	have	VBD
cord-023095-4dannjjm	169	10	no	no	DT
cord-023095-4dannjjm	169	11	to	to	TO
cord-023095-4dannjjm	169	12	mild	mild	VB
cord-023095-4dannjjm	169	13	left	left	JJ
cord-023095-4dannjjm	169	14	atrial	atrial	JJ
cord-023095-4dannjjm	169	15	enlargement	enlargement	NN
cord-023095-4dannjjm	169	16	[	[	-LRB-
cord-023095-4dannjjm	169	17	LA	la	NN
cord-023095-4dannjjm	169	18	:	:	:
cord-023095-4dannjjm	169	19	Ao(a	Ao(a	NNP
cord-023095-4dannjjm	169	20	)	)	-RRB-
cord-023095-4dannjjm	169	21	6	6	CD
cord-023095-4dannjjm	169	22	]	]	-RRB-
cord-023095-4dannjjm	169	23	.	.	.
cord-023095-4dannjjm	170	1	The	the	DT
cord-023095-4dannjjm	170	2	site	site	NN
cord-023095-4dannjjm	170	3	and	and	CC
cord-023095-4dannjjm	170	4	severity	severity	NN
cord-023095-4dannjjm	170	5	of	of	IN
cord-023095-4dannjjm	170	6	airway	airway	NN
cord-023095-4dannjjm	170	7	collapse	collapse	NN
cord-023095-4dannjjm	170	8	was	be	VBD
cord-023095-4dannjjm	170	9	graded	grade	VBN
cord-023095-4dannjjm	170	10	on	on	IN
cord-023095-4dannjjm	170	11	bronchoscopy	bronchoscopy	NN
cord-023095-4dannjjm	170	12	and	and	CC
cord-023095-4dannjjm	170	13	BAL	bal	NN
cord-023095-4dannjjm	170	14	cytology	cytology	NN
cord-023095-4dannjjm	170	15	was	be	VBD
cord-023095-4dannjjm	170	16	assessed	assess	VBN
cord-023095-4dannjjm	170	17	for	for	IN
cord-023095-4dannjjm	170	18	evidence	evidence	NN
cord-023095-4dannjjm	170	19	of	of	IN
cord-023095-4dannjjm	170	20	inflammation	inflammation	NN
cord-023095-4dannjjm	170	21	or	or	CC
cord-023095-4dannjjm	170	22	infection	infection	NN
cord-023095-4dannjjm	170	23	.	.	.
cord-023095-4dannjjm	171	1	The	the	DT
cord-023095-4dannjjm	171	2	occurrence	occurrence	NN
cord-023095-4dannjjm	171	3	of	of	IN
cord-023095-4dannjjm	171	4	bronchoscopic	bronchoscopic	NNP
cord-023095-4dannjjm	171	5	abnormalities	abnormality	NNS
cord-023095-4dannjjm	171	6	was	be	VBD
cord-023095-4dannjjm	171	7	compared	compare	VBN
cord-023095-4dannjjm	171	8	between	between	IN
cord-023095-4dannjjm	171	9	groups	group	NNS
cord-023095-4dannjjm	171	10	using	use	VBG
cord-023095-4dannjjm	171	11	Fisher	Fisher	NNP
cord-023095-4dannjjm	171	12	's	's	POS
cord-023095-4dannjjm	171	13	Exact	Exact	NNP
cord-023095-4dannjjm	171	14	Test	test	NN
cord-023095-4dannjjm	171	15	.	.	.
cord-023095-4dannjjm	172	1	P	p	NN
cord-023095-4dannjjm	172	2	o	o	NN
cord-023095-4dannjjm	172	3	0.05	0.05	CD
cord-023095-4dannjjm	172	4	was	be	VBD
cord-023095-4dannjjm	172	5	considered	consider	VBN
cord-023095-4dannjjm	172	6	significant	significant	JJ
cord-023095-4dannjjm	172	7	.	.	.
cord-023095-4dannjjm	173	1	Age	age	NN
cord-023095-4dannjjm	173	2	and	and	CC
cord-023095-4dannjjm	173	3	body	body	NN
cord-023095-4dannjjm	173	4	weight	weight	NN
cord-023095-4dannjjm	173	5	did	do	VBD
cord-023095-4dannjjm	173	6	not	not	RB
cord-023095-4dannjjm	173	7	differ	differ	VB
cord-023095-4dannjjm	173	8	between	between	IN
cord-023095-4dannjjm	173	9	groups	group	NNS
cord-023095-4dannjjm	173	10	.	.	.
cord-023095-4dannjjm	174	1	Left	leave	VBN
cord-023095-4dannjjm	174	2	atrial	atrial	JJ
cord-023095-4dannjjm	174	3	size	size	NN
cord-023095-4dannjjm	174	4	was	be	VBD
cord-023095-4dannjjm	174	5	interpreted	interpret	VBN
cord-023095-4dannjjm	174	6	radiographically	radiographically	RB
cord-023095-4dannjjm	174	7	as	as	RB
cord-023095-4dannjjm	174	8	moderately	moderately	RB
cord-023095-4dannjjm	174	9	to	to	TO
cord-023095-4dannjjm	174	10	severely	severely	RB
cord-023095-4dannjjm	174	11	enlarged	enlarge	VBN
cord-023095-4dannjjm	174	12	in	in	IN
cord-023095-4dannjjm	174	13	7	7	CD
cord-023095-4dannjjm	174	14	of	of	IN
cord-023095-4dannjjm	174	15	8	8	CD
cord-023095-4dannjjm	174	16	dogs	dog	NNS
cord-023095-4dannjjm	174	17	in	in	IN
cord-023095-4dannjjm	174	18	group	group	NN
cord-023095-4dannjjm	174	19	1	1	CD
cord-023095-4dannjjm	174	20	and	and	CC
cord-023095-4dannjjm	174	21	as	as	IN
cord-023095-4dannjjm	174	22	moderately	moderately	RB
cord-023095-4dannjjm	174	23	enlarged	enlarged	JJ
cord-023095-4dannjjm	174	24	in	in	IN
cord-023095-4dannjjm	174	25	2	2	CD
cord-023095-4dannjjm	174	26	of	of	IN
cord-023095-4dannjjm	174	27	4	4	CD
cord-023095-4dannjjm	174	28	dogs	dog	NNS
cord-023095-4dannjjm	174	29	in	in	IN
cord-023095-4dannjjm	174	30	group	group	NN
cord-023095-4dannjjm	174	31	2	2	CD
cord-023095-4dannjjm	174	32	.	.	.
cord-023095-4dannjjm	175	1	Fluoroscopy	Fluoroscopy	NNP
cord-023095-4dannjjm	175	2	revealed	reveal	VBD
cord-023095-4dannjjm	175	3	variable	variable	JJ
cord-023095-4dannjjm	175	4	degrees	degree	NNS
cord-023095-4dannjjm	175	5	of	of	IN
cord-023095-4dannjjm	175	6	airway	airway	NN
cord-023095-4dannjjm	175	7	collapse	collapse	NN
cord-023095-4dannjjm	175	8	during	during	IN
cord-023095-4dannjjm	175	9	normal	normal	JJ
cord-023095-4dannjjm	175	10	respiration	respiration	NN
cord-023095-4dannjjm	175	11	and	and	CC
cord-023095-4dannjjm	175	12	induced	induce	VBN
cord-023095-4dannjjm	175	13	cough	cough	NN
cord-023095-4dannjjm	175	14	in	in	IN
cord-023095-4dannjjm	175	15	both	both	DT
cord-023095-4dannjjm	175	16	groups	group	NNS
cord-023095-4dannjjm	175	17	.	.	.
cord-023095-4dannjjm	176	1	Radiography	radiography	NN
cord-023095-4dannjjm	176	2	and	and	CC
cord-023095-4dannjjm	176	3	fluoroscopy	fluoroscopy	NN
cord-023095-4dannjjm	176	4	were	be	VBD
cord-023095-4dannjjm	176	5	not	not	RB
cord-023095-4dannjjm	176	6	accurate	accurate	JJ
cord-023095-4dannjjm	176	7	in	in	IN
cord-023095-4dannjjm	176	8	identifying	identify	VBG
cord-023095-4dannjjm	176	9	site	site	NN
cord-023095-4dannjjm	176	10	and	and	CC
cord-023095-4dannjjm	176	11	degree	degree	NN
cord-023095-4dannjjm	176	12	of	of	IN
cord-023095-4dannjjm	176	13	collapse	collapse	NN
cord-023095-4dannjjm	176	14	in	in	IN
cord-023095-4dannjjm	176	15	either	either	DT
cord-023095-4dannjjm	176	16	group	group	NN
cord-023095-4dannjjm	176	17	when	when	WRB
cord-023095-4dannjjm	176	18	compared	compare	VBN
cord-023095-4dannjjm	176	19	to	to	IN
cord-023095-4dannjjm	176	20	bronchoscopy	bronchoscopy	NN
cord-023095-4dannjjm	176	21	.	.	.
cord-023095-4dannjjm	177	1	Cervical	cervical	JJ
cord-023095-4dannjjm	177	2	tracheal	tracheal	NN
cord-023095-4dannjjm	177	3	collapse	collapse	NN
cord-023095-4dannjjm	177	4	was	be	VBD
cord-023095-4dannjjm	177	5	identified	identify	VBN
cord-023095-4dannjjm	177	6	during	during	IN
cord-023095-4dannjjm	177	7	bronchoscopy	bronchoscopy	NN
cord-023095-4dannjjm	177	8	in	in	IN
cord-023095-4dannjjm	177	9	both	both	DT
cord-023095-4dannjjm	177	10	group	group	NN
cord-023095-4dannjjm	177	11	1	1	CD
cord-023095-4dannjjm	177	12	(	(	-LRB-
cord-023095-4dannjjm	177	13	2	2	CD
cord-023095-4dannjjm	177	14	of	of	IN
cord-023095-4dannjjm	177	15	8)	8)	NN
cord-023095-4dannjjm	177	16	and	and	CC
cord-023095-4dannjjm	177	17	group	group	NN
cord-023095-4dannjjm	177	18	2	2	CD
cord-023095-4dannjjm	177	19	(	(	-LRB-
cord-023095-4dannjjm	177	20	3	3	CD
cord-023095-4dannjjm	177	21	of	of	IN
cord-023095-4dannjjm	177	22	4	4	CD
cord-023095-4dannjjm	177	23	)	)	-RRB-
cord-023095-4dannjjm	177	24	dogs	dog	NNS
cord-023095-4dannjjm	177	25	but	but	CC
cord-023095-4dannjjm	177	26	was	be	VBD
cord-023095-4dannjjm	177	27	subjectively	subjectively	RB
cord-023095-4dannjjm	177	28	less	less	RBR
cord-023095-4dannjjm	177	29	severe	severe	JJ
cord-023095-4dannjjm	177	30	in	in	IN
cord-023095-4dannjjm	177	31	group	group	NN
cord-023095-4dannjjm	177	32	1	1	CD
cord-023095-4dannjjm	177	33	dogs	dog	NNS
cord-023095-4dannjjm	177	34	.	.	.
cord-023095-4dannjjm	178	1	Bronchial	bronchial	JJ
cord-023095-4dannjjm	178	2	collapse	collapse	NN
cord-023095-4dannjjm	179	1	4	4	CD
cord-023095-4dannjjm	179	2	50	50	CD
cord-023095-4dannjjm	179	3	%	%	NN
cord-023095-4dannjjm	179	4	was	be	VBD
cord-023095-4dannjjm	179	5	evident	evident	JJ
cord-023095-4dannjjm	179	6	at	at	IN
cord-023095-4dannjjm	179	7	multiple	multiple	JJ
cord-023095-4dannjjm	179	8	sites	site	NNS
cord-023095-4dannjjm	179	9	in	in	IN
cord-023095-4dannjjm	179	10	both	both	DT
cord-023095-4dannjjm	179	11	groups	group	NNS
cord-023095-4dannjjm	179	12	of	of	IN
cord-023095-4dannjjm	179	13	dogs	dog	NNS
cord-023095-4dannjjm	179	14	with	with	IN
cord-023095-4dannjjm	179	15	no	no	DT
cord-023095-4dannjjm	179	16	difference	difference	NN
cord-023095-4dannjjm	179	17	between	between	IN
cord-023095-4dannjjm	179	18	groups	group	NNS
cord-023095-4dannjjm	179	19	.	.	.
cord-023095-4dannjjm	180	1	All	all	DT
cord-023095-4dannjjm	180	2	dogs	dog	NNS
cord-023095-4dannjjm	180	3	had	have	VBD
cord-023095-4dannjjm	180	4	suppurative	suppurative	JJ
cord-023095-4dannjjm	180	5	and/or	and/or	CC
cord-023095-4dannjjm	180	6	lymphocytic	lymphocytic	JJ
cord-023095-4dannjjm	180	7	inflammation	inflammation	NN
cord-023095-4dannjjm	180	8	on	on	IN
cord-023095-4dannjjm	180	9	airway	airway	NN
cord-023095-4dannjjm	180	10	cytology	cytology	NN
cord-023095-4dannjjm	180	11	.	.	.
cord-023095-4dannjjm	181	1	Infection	infection	NN
cord-023095-4dannjjm	181	2	was	be	VBD
cord-023095-4dannjjm	181	3	not	not	RB
cord-023095-4dannjjm	181	4	present	present	JJ
cord-023095-4dannjjm	181	5	in	in	IN
cord-023095-4dannjjm	181	6	either	either	DT
cord-023095-4dannjjm	181	7	group	group	NN
cord-023095-4dannjjm	181	8	of	of	IN
cord-023095-4dannjjm	181	9	dogs	dog	NNS
cord-023095-4dannjjm	181	10	,	,	,
cord-023095-4dannjjm	181	11	although	although	IN
cord-023095-4dannjjm	181	12	non	non	JJ
cord-023095-4dannjjm	181	13	-	-	JJ
cord-023095-4dannjjm	181	14	specific	specific	JJ
cord-023095-4dannjjm	181	15	light	light	JJ
cord-023095-4dannjjm	181	16	bacterial	bacterial	JJ
cord-023095-4dannjjm	181	17	growth	growth	NN
cord-023095-4dannjjm	181	18	was	be	VBD
cord-023095-4dannjjm	181	19	detected	detect	VBN
cord-023095-4dannjjm	181	20	in	in	IN
cord-023095-4dannjjm	181	21	6	6	CD
cord-023095-4dannjjm	181	22	of	of	IN
cord-023095-4dannjjm	181	23	8	8	CD
cord-023095-4dannjjm	181	24	group	group	NN
cord-023095-4dannjjm	181	25	1	1	CD
cord-023095-4dannjjm	181	26	dogs	dog	NNS
cord-023095-4dannjjm	181	27	and	and	CC
cord-023095-4dannjjm	181	28	1	1	CD
cord-023095-4dannjjm	181	29	of	of	IN
cord-023095-4dannjjm	181	30	4	4	CD
cord-023095-4dannjjm	181	31	group	group	NN
cord-023095-4dannjjm	181	32	2	2	CD
cord-023095-4dannjjm	181	33	dogs	dog	NNS
cord-023095-4dannjjm	181	34	(	(	-LRB-
cord-023095-4dannjjm	181	35	p	p	NN
cord-023095-4dannjjm	181	36	5	5	CD
cord-023095-4dannjjm	181	37	0.22	0.22	CD
cord-023095-4dannjjm	181	38	)	)	-RRB-
cord-023095-4dannjjm	181	39	.	.	.
cord-023095-4dannjjm	182	1	Preliminary	preliminary	JJ
cord-023095-4dannjjm	182	2	results	result	NNS
cord-023095-4dannjjm	182	3	failed	fail	VBD
cord-023095-4dannjjm	182	4	to	to	TO
cord-023095-4dannjjm	182	5	identify	identify	VB
cord-023095-4dannjjm	182	6	an	an	DT
cord-023095-4dannjjm	182	7	association	association	NN
cord-023095-4dannjjm	182	8	between	between	IN
cord-023095-4dannjjm	182	9	left	left	JJ
cord-023095-4dannjjm	182	10	atrial	atrial	JJ
cord-023095-4dannjjm	182	11	enlargement	enlargement	NN
cord-023095-4dannjjm	182	12	and	and	CC
cord-023095-4dannjjm	182	13	airway	airway	NN
cord-023095-4dannjjm	182	14	collapse	collapse	NN
cord-023095-4dannjjm	182	15	in	in	IN
cord-023095-4dannjjm	182	16	dogs	dog	NNS
cord-023095-4dannjjm	182	17	with	with	IN
cord-023095-4dannjjm	182	18	MMVD	MMVD	NNP
cord-023095-4dannjjm	182	19	but	but	CC
cord-023095-4dannjjm	182	20	did	do	VBD
cord-023095-4dannjjm	182	21	suggest	suggest	VB
cord-023095-4dannjjm	182	22	that	that	IN
cord-023095-4dannjjm	182	23	airway	airway	JJ
cord-023095-4dannjjm	182	24	inflammation	inflammation	NN
cord-023095-4dannjjm	182	25	is	be	VBZ
cord-023095-4dannjjm	182	26	common	common	JJ
cord-023095-4dannjjm	182	27	in	in	IN
cord-023095-4dannjjm	182	28	affected	affected	JJ
cord-023095-4dannjjm	182	29	dogs	dog	NNS
cord-023095-4dannjjm	182	30	.	.	.
cord-023095-4dannjjm	183	1	Further	further	JJ
cord-023095-4dannjjm	183	2	studies	study	NNS
cord-023095-4dannjjm	183	3	are	be	VBP
cord-023095-4dannjjm	183	4	needed	need	VBN
cord-023095-4dannjjm	183	5	to	to	TO
cord-023095-4dannjjm	183	6	identify	identify	VB
cord-023095-4dannjjm	183	7	factors	factor	NNS
cord-023095-4dannjjm	183	8	contributing	contribute	VBG
cord-023095-4dannjjm	183	9	to	to	IN
cord-023095-4dannjjm	183	10	airway	airway	NN
cord-023095-4dannjjm	183	11	collapse	collapse	NN
cord-023095-4dannjjm	183	12	in	in	IN
cord-023095-4dannjjm	183	13	dogs	dog	NNS
cord-023095-4dannjjm	183	14	with	with	IN
cord-023095-4dannjjm	183	15	and	and	CC
cord-023095-4dannjjm	183	16	without	without	IN
cord-023095-4dannjjm	183	17	MMVD	MMVD	NNP
cord-023095-4dannjjm	183	18	.	.	.
cord-023095-4dannjjm	184	1	Atenolol	Atenolol	NNP
cord-023095-4dannjjm	184	2	is	be	VBZ
cord-023095-4dannjjm	184	3	often	often	RB
cord-023095-4dannjjm	184	4	used	use	VBN
cord-023095-4dannjjm	184	5	empirically	empirically	RB
cord-023095-4dannjjm	184	6	in	in	IN
cord-023095-4dannjjm	184	7	cats	cat	NNS
cord-023095-4dannjjm	184	8	with	with	IN
cord-023095-4dannjjm	184	9	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	184	10	HCM	HCM	NNP
cord-023095-4dannjjm	184	11	,	,	,
cord-023095-4dannjjm	184	12	even	even	RB
cord-023095-4dannjjm	184	13	though	though	IN
cord-023095-4dannjjm	184	14	clinical	clinical	JJ
cord-023095-4dannjjm	184	15	and	and	CC
cord-023095-4dannjjm	184	16	experimental	experimental	JJ
cord-023095-4dannjjm	184	17	evidence	evidence	NN
cord-023095-4dannjjm	184	18	of	of	IN
cord-023095-4dannjjm	184	19	efficacy	efficacy	NN
cord-023095-4dannjjm	184	20	is	be	VBZ
cord-023095-4dannjjm	184	21	lacking	lack	VBG
cord-023095-4dannjjm	184	22	.	.	.
cord-023095-4dannjjm	185	1	Cardiac	cardiac	JJ
cord-023095-4dannjjm	185	2	biomarkers	biomarker	NNS
cord-023095-4dannjjm	185	3	play	play	VBP
cord-023095-4dannjjm	185	4	a	a	DT
cord-023095-4dannjjm	185	5	critical	critical	JJ
cord-023095-4dannjjm	185	6	role	role	NN
cord-023095-4dannjjm	185	7	in	in	IN
cord-023095-4dannjjm	185	8	the	the	DT
cord-023095-4dannjjm	185	9	early	early	JJ
cord-023095-4dannjjm	185	10	detection	detection	NN
cord-023095-4dannjjm	185	11	of	of	IN
cord-023095-4dannjjm	185	12	subclinical	subclinical	JJ
cord-023095-4dannjjm	185	13	cardiac	cardiac	JJ
cord-023095-4dannjjm	185	14	disease	disease	NN
cord-023095-4dannjjm	185	15	,	,	,
cord-023095-4dannjjm	185	16	in	in	IN
cord-023095-4dannjjm	185	17	the	the	DT
cord-023095-4dannjjm	185	18	prediction	prediction	NN
cord-023095-4dannjjm	185	19	of	of	IN
cord-023095-4dannjjm	185	20	long	long	JJ
cord-023095-4dannjjm	185	21	-	-	HYPH
cord-023095-4dannjjm	185	22	term	term	NN
cord-023095-4dannjjm	185	23	prognosis	prognosis	NN
cord-023095-4dannjjm	185	24	,	,	,
cord-023095-4dannjjm	185	25	and	and	CC
cord-023095-4dannjjm	185	26	in	in	IN
cord-023095-4dannjjm	185	27	monitoring	monitor	VBG
cord-023095-4dannjjm	185	28	the	the	DT
cord-023095-4dannjjm	185	29	response	response	NN
cord-023095-4dannjjm	185	30	to	to	IN
cord-023095-4dannjjm	185	31	therapy	therapy	NN
cord-023095-4dannjjm	185	32	in	in	IN
cord-023095-4dannjjm	185	33	humans	human	NNS
cord-023095-4dannjjm	185	34	.	.	.
cord-023095-4dannjjm	186	1	We	-PRON-	PRP
cord-023095-4dannjjm	186	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	186	3	that	that	IN
cord-023095-4dannjjm	186	4	serum	serum	NN
cord-023095-4dannjjm	186	5	concentrations	concentration	NNS
cord-023095-4dannjjm	186	6	of	of	IN
cord-023095-4dannjjm	186	7	the	the	DT
cord-023095-4dannjjm	186	8	biomarkers	biomarker	NNS
cord-023095-4dannjjm	186	9	,	,	,
cord-023095-4dannjjm	186	10	Nterminal	Nterminal	NNP
cord-023095-4dannjjm	186	11	pro	pro	JJ
cord-023095-4dannjjm	186	12	-	-	JJ
cord-023095-4dannjjm	186	13	brain	brain	JJ
cord-023095-4dannjjm	186	14	natriuretic	natriuretic	JJ
cord-023095-4dannjjm	186	15	peptide	peptide	NN
cord-023095-4dannjjm	186	16	(	(	-LRB-
cord-023095-4dannjjm	186	17	NT	NT	NNP
cord-023095-4dannjjm	186	18	-	-	HYPH
cord-023095-4dannjjm	186	19	proBNP	proBNP	NNP
cord-023095-4dannjjm	186	20	)	)	-RRB-
cord-023095-4dannjjm	186	21	and	and	CC
cord-023095-4dannjjm	186	22	cardiac	cardiac	NN
cord-023095-4dannjjm	186	23	troponin	troponin	NN
cord-023095-4dannjjm	186	24	I	-PRON-	PRP
cord-023095-4dannjjm	186	25	(	(	-LRB-
cord-023095-4dannjjm	186	26	cTnI	cTnI	NNP
cord-023095-4dannjjm	186	27	)	)	-RRB-
cord-023095-4dannjjm	186	28	,	,	,
cord-023095-4dannjjm	186	29	would	would	MD
cord-023095-4dannjjm	186	30	improve	improve	VB
cord-023095-4dannjjm	186	31	following	follow	VBG
cord-023095-4dannjjm	186	32	the	the	DT
cord-023095-4dannjjm	186	33	chronic	chronic	JJ
cord-023095-4dannjjm	186	34	administration	administration	NN
cord-023095-4dannjjm	186	35	of	of	IN
cord-023095-4dannjjm	186	36	atenolol	atenolol	NNP
cord-023095-4dannjjm	186	37	PO	PO	NNP
cord-023095-4dannjjm	186	38	to	to	IN
cord-023095-4dannjjm	186	39	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	186	40	cats	cat	NNS
cord-023095-4dannjjm	186	41	with	with	IN
cord-023095-4dannjjm	186	42	HCM	HCM	NNP
cord-023095-4dannjjm	186	43	.	.	.
cord-023095-4dannjjm	187	1	Six	six	CD
cord-023095-4dannjjm	187	2	Maine	Maine	NNP
cord-023095-4dannjjm	187	3	Coon	Coon	NNP
cord-023095-4dannjjm	187	4	or	or	CC
cord-023095-4dannjjm	187	5	Maine	Maine	NNP
cord-023095-4dannjjm	187	6	Coon	Coon	NNP
cord-023095-4dannjjm	187	7	cross	cross	NN
cord-023095-4dannjjm	187	8	cats	cat	NNS
cord-023095-4dannjjm	187	9	with	with	IN
cord-023095-4dannjjm	187	10	severe	severe	JJ
cord-023095-4dannjjm	187	11	HCM	HCM	NNP
cord-023095-4dannjjm	187	12	from	from	IN
cord-023095-4dannjjm	187	13	the	the	DT
cord-023095-4dannjjm	187	14	research	research	NN
cord-023095-4dannjjm	187	15	colony	colony	NN
cord-023095-4dannjjm	187	16	at	at	IN
cord-023095-4dannjjm	187	17	UCDavis	UCDavis	NNP
cord-023095-4dannjjm	187	18	were	be	VBD
cord-023095-4dannjjm	187	19	administered	administer	VBN
cord-023095-4dannjjm	187	20	atenolol	atenolol	NN
cord-023095-4dannjjm	187	21	(	(	-LRB-
cord-023095-4dannjjm	187	22	12.5	12.5	CD
cord-023095-4dannjjm	187	23	mg	mg	NNP
cord-023095-4dannjjm	187	24	PO	PO	NNP
cord-023095-4dannjjm	187	25	twice	twice	PDT
cord-023095-4dannjjm	187	26	a	a	DT
cord-023095-4dannjjm	187	27	day	day	NN
cord-023095-4dannjjm	187	28	)	)	-RRB-
cord-023095-4dannjjm	187	29	for	for	IN
cord-023095-4dannjjm	187	30	30	30	CD
cord-023095-4dannjjm	187	31	days	day	NNS
cord-023095-4dannjjm	187	32	.	.	.
cord-023095-4dannjjm	188	1	No	no	DT
cord-023095-4dannjjm	188	2	cat	cat	NN
cord-023095-4dannjjm	188	3	had	have	VBD
cord-023095-4dannjjm	188	4	severe	severe	RB
cord-023095-4dannjjm	188	5	left	leave	VBN
cord-023095-4dannjjm	188	6	ventricular	ventricular	JJ
cord-023095-4dannjjm	188	7	dynamic	dynamic	JJ
cord-023095-4dannjjm	188	8	outflow	outflow	NN
cord-023095-4dannjjm	188	9	tract	tract	NN
cord-023095-4dannjjm	188	10	obstruction	obstruction	NN
cord-023095-4dannjjm	188	11	due	due	JJ
cord-023095-4dannjjm	188	12	to	to	IN
cord-023095-4dannjjm	188	13	systolic	systolic	JJ
cord-023095-4dannjjm	188	14	anterior	anterior	JJ
cord-023095-4dannjjm	188	15	motion	motion	NN
cord-023095-4dannjjm	188	16	of	of	IN
cord-023095-4dannjjm	188	17	the	the	DT
cord-023095-4dannjjm	188	18	mitral	mitral	JJ
cord-023095-4dannjjm	188	19	valve	valve	NN
cord-023095-4dannjjm	188	20	.	.	.
cord-023095-4dannjjm	189	1	The	the	DT
cord-023095-4dannjjm	189	2	concentrations	concentration	NNS
cord-023095-4dannjjm	189	3	of	of	IN
cord-023095-4dannjjm	189	4	NT	NT	NNP
cord-023095-4dannjjm	189	5	-	-	HYPH
cord-023095-4dannjjm	189	6	proBNP	probnp	NN
cord-023095-4dannjjm	189	7	and	and	CC
cord-023095-4dannjjm	189	8	cTnI	cTnI	NNP
cord-023095-4dannjjm	189	9	were	be	VBD
cord-023095-4dannjjm	189	10	assayed	assay	VBN
cord-023095-4dannjjm	189	11	prior	prior	RB
cord-023095-4dannjjm	189	12	to	to	IN
cord-023095-4dannjjm	189	13	drug	drug	NN
cord-023095-4dannjjm	189	14	administration	administration	NN
cord-023095-4dannjjm	189	15	and	and	CC
cord-023095-4dannjjm	189	16	on	on	IN
cord-023095-4dannjjm	189	17	the	the	DT
cord-023095-4dannjjm	189	18	last	last	JJ
cord-023095-4dannjjm	189	19	day	day	NN
cord-023095-4dannjjm	189	20	of	of	IN
cord-023095-4dannjjm	189	21	drug	drug	NN
cord-023095-4dannjjm	189	22	administration	administration	NN
cord-023095-4dannjjm	189	23	.	.	.
cord-023095-4dannjjm	190	1	There	there	EX
cord-023095-4dannjjm	190	2	was	be	VBD
cord-023095-4dannjjm	190	3	no	no	DT
cord-023095-4dannjjm	190	4	statistically	statistically	RB
cord-023095-4dannjjm	190	5	significant	significant	JJ
cord-023095-4dannjjm	190	6	difference	difference	NN
cord-023095-4dannjjm	190	7	identified	identify	VBN
cord-023095-4dannjjm	190	8	in	in	IN
cord-023095-4dannjjm	190	9	NT	NT	NNP
cord-023095-4dannjjm	190	10	-	-	HYPH
cord-023095-4dannjjm	190	11	proBNP	probnp	NN
cord-023095-4dannjjm	190	12	[	[	-LRB-
cord-023095-4dannjjm	190	13	median	median	NN
cord-023095-4dannjjm	190	14	before	before	RB
cord-023095-4dannjjm	190	15	:	:	:
cord-023095-4dannjjm	190	16	394	394	CD
cord-023095-4dannjjm	190	17	pmol	pmol	NNP
cord-023095-4dannjjm	190	18	/	/	SYM
cord-023095-4dannjjm	190	19	L	l	NN
cord-023095-4dannjjm	190	20	(	(	-LRB-
cord-023095-4dannjjm	190	21	range	range	NN
cord-023095-4dannjjm	190	22	:	:	:
cord-023095-4dannjjm	190	23	71	71	CD
cord-023095-4dannjjm	190	24	-	-	SYM
cord-023095-4dannjjm	190	25	1500	1500	CD
cord-023095-4dannjjm	190	26	pmol	pmol	NNP
cord-023095-4dannjjm	190	27	/	/	SYM
cord-023095-4dannjjm	190	28	L	L	NNP
cord-023095-4dannjjm	190	29	)	)	-RRB-
cord-023095-4dannjjm	190	30	,	,	.
cord-023095-4dannjjm	191	1	median	median	NN
cord-023095-4dannjjm	191	2	after	after	RB
cord-023095-4dannjjm	191	3	:	:	:
cord-023095-4dannjjm	191	4	439	439	CD
cord-023095-4dannjjm	191	5	pmol	pmol	NNP
cord-023095-4dannjjm	191	6	/	/	SYM
cord-023095-4dannjjm	191	7	L	l	NN
cord-023095-4dannjjm	191	8	(	(	-LRB-
cord-023095-4dannjjm	191	9	range	range	NN
cord-023095-4dannjjm	191	10	:	:	:
cord-023095-4dannjjm	191	11	24	24	CD
cord-023095-4dannjjm	191	12	-	-	SYM
cord-023095-4dannjjm	191	13	1500	1500	CD
cord-023095-4dannjjm	191	14	pmol	pmol	NNP
cord-023095-4dannjjm	191	15	/	/	SYM
cord-023095-4dannjjm	191	16	L	L	NNP
cord-023095-4dannjjm	191	17	)	)	-RRB-
cord-023095-4dannjjm	191	18	;	;	:
cord-023095-4dannjjm	191	19	p	p	NN
cord-023095-4dannjjm	191	20	5	5	CD
cord-023095-4dannjjm	191	21	0.63	0.63	CD
cord-023095-4dannjjm	191	22	]	]	-RRB-
cord-023095-4dannjjm	191	23	or	or	CC
cord-023095-4dannjjm	191	24	cTnI	ctni	XX
cord-023095-4dannjjm	192	1	[	[	-LRB-
cord-023095-4dannjjm	192	2	median	median	NN
cord-023095-4dannjjm	192	3	before	before	RB
cord-023095-4dannjjm	192	4	:	:	:
cord-023095-4dannjjm	192	5	0.24	0.24	CD
cord-023095-4dannjjm	192	6	ng	ng	NNP
cord-023095-4dannjjm	192	7	/	/	SYM
cord-023095-4dannjjm	192	8	ml	ml	NN
cord-023095-4dannjjm	193	1	(	(	-LRB-
cord-023095-4dannjjm	193	2	range:0.10	range:0.10	NN
cord-023095-4dannjjm	193	3	-	-	HYPH
cord-023095-4dannjjm	193	4	0.97	0.97	CD
cord-023095-4dannjjm	193	5	ng	ng	NN
cord-023095-4dannjjm	193	6	/	/	SYM
cord-023095-4dannjjm	193	7	ml	ml	NNP
cord-023095-4dannjjm	193	8	)	)	-RRB-
cord-023095-4dannjjm	193	9	,	,	.
cord-023095-4dannjjm	194	1	median	median	NN
cord-023095-4dannjjm	194	2	after	after	RB
cord-023095-4dannjjm	194	3	:	:	:
cord-023095-4dannjjm	194	4	0.28	0.28	CD
cord-023095-4dannjjm	194	5	ng	ng	NNP
cord-023095-4dannjjm	194	6	/	/	SYM
cord-023095-4dannjjm	194	7	ml	ml	NN
cord-023095-4dannjjm	195	1	(	(	-LRB-
cord-023095-4dannjjm	195	2	range	range	NN
cord-023095-4dannjjm	195	3	:	:	:
cord-023095-4dannjjm	195	4	0.09	0.09	CD
cord-023095-4dannjjm	195	5	-	-	SYM
cord-023095-4dannjjm	195	6	1.0	1.0	CD
cord-023095-4dannjjm	195	7	ng	ng	NN
cord-023095-4dannjjm	195	8	/	/	SYM
cord-023095-4dannjjm	195	9	ml	ml	NN
cord-023095-4dannjjm	195	10	)	)	-RRB-
cord-023095-4dannjjm	195	11	;	;	:
cord-023095-4dannjjm	195	12	p	p	NN
cord-023095-4dannjjm	195	13	5	5	CD
cord-023095-4dannjjm	195	14	0.69	0.69	CD
cord-023095-4dannjjm	195	15	]	]	-RRB-
cord-023095-4dannjjm	195	16	concentrations	concentration	NNS
cord-023095-4dannjjm	195	17	before	before	IN
cord-023095-4dannjjm	195	18	and	and	CC
cord-023095-4dannjjm	195	19	after	after	IN
cord-023095-4dannjjm	195	20	drug	drug	NN
cord-023095-4dannjjm	195	21	administration	administration	NN
cord-023095-4dannjjm	195	22	using	use	VBG
cord-023095-4dannjjm	195	23	the	the	DT
cord-023095-4dannjjm	195	24	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	195	25	matched	match	VBN
cord-023095-4dannjjm	195	26	pairs	pair	NNS
cord-023095-4dannjjm	195	27	test	test	VBP
cord-023095-4dannjjm	195	28	.	.	.
cord-023095-4dannjjm	196	1	The	the	DT
cord-023095-4dannjjm	196	2	cTnI	cTnI	NNP
cord-023095-4dannjjm	196	3	finding	finding	NN
cord-023095-4dannjjm	196	4	suggests	suggest	VBZ
cord-023095-4dannjjm	196	5	that	that	IN
cord-023095-4dannjjm	196	6	atenolol	atenolol	NN
cord-023095-4dannjjm	196	7	does	do	VBZ
cord-023095-4dannjjm	196	8	not	not	RB
cord-023095-4dannjjm	196	9	reduce	reduce	VB
cord-023095-4dannjjm	196	10	chronic	chronic	JJ
cord-023095-4dannjjm	196	11	myocyte	myocyte	NN
cord-023095-4dannjjm	196	12	death	death	NN
cord-023095-4dannjjm	196	13	in	in	IN
cord-023095-4dannjjm	196	14	cats	cat	NNS
cord-023095-4dannjjm	196	15	with	with	IN
cord-023095-4dannjjm	196	16	HCM	HCM	NNP
cord-023095-4dannjjm	196	17	.	.	.
cord-023095-4dannjjm	197	1	The	the	DT
cord-023095-4dannjjm	197	2	lack	lack	NN
cord-023095-4dannjjm	197	3	of	of	IN
cord-023095-4dannjjm	197	4	improvement	improvement	NN
cord-023095-4dannjjm	197	5	in	in	IN
cord-023095-4dannjjm	197	6	NT	NT	NNP
cord-023095-4dannjjm	197	7	-	-	HYPH
cord-023095-4dannjjm	197	8	proBNP	proBNP	NNP
cord-023095-4dannjjm	197	9	suggests	suggest	VBZ
cord-023095-4dannjjm	197	10	that	that	IN
cord-023095-4dannjjm	197	11	atenolol	atenolol	NN
cord-023095-4dannjjm	197	12	does	do	VBZ
cord-023095-4dannjjm	197	13	not	not	RB
cord-023095-4dannjjm	197	14	improve	improve	VB
cord-023095-4dannjjm	197	15	myocardial	myocardial	JJ
cord-023095-4dannjjm	197	16	wall	wall	NN
cord-023095-4dannjjm	197	17	stress	stress	NN
cord-023095-4dannjjm	197	18	in	in	IN
cord-023095-4dannjjm	197	19	cats	cat	NNS
cord-023095-4dannjjm	197	20	with	with	IN
cord-023095-4dannjjm	197	21	HCM	HCM	NNP
cord-023095-4dannjjm	197	22	.	.	.
cord-023095-4dannjjm	198	1	A	a	DT
cord-023095-4dannjjm	198	2	clinical	clinical	JJ
cord-023095-4dannjjm	198	3	trial	trial	NN
cord-023095-4dannjjm	198	4	is	be	VBZ
cord-023095-4dannjjm	198	5	warranted	warrant	VBN
cord-023095-4dannjjm	198	6	to	to	TO
cord-023095-4dannjjm	198	7	confirm	confirm	VB
cord-023095-4dannjjm	198	8	or	or	CC
cord-023095-4dannjjm	198	9	refute	refute	VB
cord-023095-4dannjjm	198	10	the	the	DT
cord-023095-4dannjjm	198	11	findings	finding	NNS
cord-023095-4dannjjm	198	12	from	from	IN
cord-023095-4dannjjm	198	13	this	this	DT
cord-023095-4dannjjm	198	14	study	study	NN
cord-023095-4dannjjm	198	15	.	.	.
cord-023095-4dannjjm	199	1	Therefore	therefore	RB
cord-023095-4dannjjm	199	2	,	,	,
cord-023095-4dannjjm	199	3	leptin	leptin	NN
cord-023095-4dannjjm	199	4	-	-	HYPH
cord-023095-4dannjjm	199	5	gene	gene	NN
cord-023095-4dannjjm	199	6	expression	expression	NN
cord-023095-4dannjjm	199	7	was	be	VBD
cord-023095-4dannjjm	199	8	investigated	investigate	VBN
cord-023095-4dannjjm	199	9	in	in	IN
cord-023095-4dannjjm	199	10	blood	blood	NN
cord-023095-4dannjjm	199	11	samples	sample	NNS
cord-023095-4dannjjm	199	12	of	of	IN
cord-023095-4dannjjm	199	13	dogs	dog	NNS
cord-023095-4dannjjm	199	14	with	with	IN
cord-023095-4dannjjm	199	15	congestive	congestive	JJ
cord-023095-4dannjjm	199	16	heart	heart	NN
cord-023095-4dannjjm	199	17	failure	failure	NN
cord-023095-4dannjjm	199	18	(	(	-LRB-
cord-023095-4dannjjm	199	19	CHF	CHF	NNP
cord-023095-4dannjjm	199	20	;	;	:
cord-023095-4dannjjm	199	21	n	n	NN
cord-023095-4dannjjm	199	22	5	5	CD
cord-023095-4dannjjm	199	23	8)	8)	NN
cord-023095-4dannjjm	199	24	in	in	IN
cord-023095-4dannjjm	199	25	comparison	comparison	NN
cord-023095-4dannjjm	199	26	to	to	IN
cord-023095-4dannjjm	199	27	dogs	dog	NNS
cord-023095-4dannjjm	199	28	presented	present	VBN
cord-023095-4dannjjm	199	29	for	for	IN
cord-023095-4dannjjm	199	30	cardiac	cardiac	JJ
cord-023095-4dannjjm	199	31	screening	screening	NN
cord-023095-4dannjjm	199	32	(	(	-LRB-
cord-023095-4dannjjm	199	33	n	n	NN
cord-023095-4dannjjm	199	34	5	5	CD
cord-023095-4dannjjm	199	35	8)	8)	NN
cord-023095-4dannjjm	199	36	without	without	IN
cord-023095-4dannjjm	199	37	abnormalities	abnormality	NNS
cord-023095-4dannjjm	199	38	.	.	.
cord-023095-4dannjjm	200	1	Additionally	additionally	RB
cord-023095-4dannjjm	200	2	myocardial	myocardial	JJ
cord-023095-4dannjjm	200	3	samples	sample	NNS
cord-023095-4dannjjm	200	4	(	(	-LRB-
cord-023095-4dannjjm	200	5	interventricular	interventricular	NNP
cord-023095-4dannjjm	200	6	septum	septum	NN
cord-023095-4dannjjm	200	7	,	,	,
cord-023095-4dannjjm	200	8	right	right	UH
cord-023095-4dannjjm	200	9	and	and	CC
cord-023095-4dannjjm	200	10	left	left	JJ
cord-023095-4dannjjm	200	11	atrium	atrium	NN
cord-023095-4dannjjm	200	12	and	and	CC
cord-023095-4dannjjm	200	13	ventricle	ventricle	NNP
cord-023095-4dannjjm	200	14	)	)	-RRB-
cord-023095-4dannjjm	200	15	of	of	IN
cord-023095-4dannjjm	200	16	10	10	CD
cord-023095-4dannjjm	200	17	dogs	dog	NNS
cord-023095-4dannjjm	200	18	with	with	IN
cord-023095-4dannjjm	200	19	no	no	DT
cord-023095-4dannjjm	200	20	cardiac	cardiac	JJ
cord-023095-4dannjjm	200	21	abnormalities	abnormality	NNS
cord-023095-4dannjjm	200	22	(	(	-LRB-
cord-023095-4dannjjm	200	23	controls	control	NNS
cord-023095-4dannjjm	200	24	)	)	-RRB-
cord-023095-4dannjjm	200	25	,	,	,
cord-023095-4dannjjm	200	26	seven	seven	CD
cord-023095-4dannjjm	200	27	dogs	dog	NNS
cord-023095-4dannjjm	200	28	with	with	IN
cord-023095-4dannjjm	200	29	acquired	acquire	VBN
cord-023095-4dannjjm	200	30	and	and	CC
cord-023095-4dannjjm	200	31	three	three	CD
cord-023095-4dannjjm	200	32	with	with	IN
cord-023095-4dannjjm	200	33	congenital	congenital	JJ
cord-023095-4dannjjm	200	34	cardiac	cardiac	JJ
cord-023095-4dannjjm	200	35	diseases	disease	NNS
cord-023095-4dannjjm	200	36	were	be	VBD
cord-023095-4dannjjm	200	37	investigated	investigate	VBN
cord-023095-4dannjjm	200	38	using	use	VBG
cord-023095-4dannjjm	200	39	quantitative	quantitative	JJ
cord-023095-4dannjjm	200	40	RT	RT	NNP
cord-023095-4dannjjm	200	41	-	-	HYPH
cord-023095-4dannjjm	200	42	PCR	PCR	NNP
cord-023095-4dannjjm	200	43	.	.	.
cord-023095-4dannjjm	201	1	Leptin	leptin	NN
cord-023095-4dannjjm	201	2	blood	blood	NN
cord-023095-4dannjjm	201	3	levels	level	NNS
cord-023095-4dannjjm	201	4	were	be	VBD
cord-023095-4dannjjm	201	5	significantly	significantly	RB
cord-023095-4dannjjm	201	6	higher	high	JJR
cord-023095-4dannjjm	201	7	in	in	IN
cord-023095-4dannjjm	201	8	dogs	dog	NNS
cord-023095-4dannjjm	201	9	with	with	IN
cord-023095-4dannjjm	201	10	CHF	CHF	NNP
cord-023095-4dannjjm	201	11	in	in	IN
cord-023095-4dannjjm	201	12	comparison	comparison	NN
cord-023095-4dannjjm	201	13	to	to	IN
cord-023095-4dannjjm	201	14	dogs	dog	NNS
cord-023095-4dannjjm	201	15	without	without	IN
cord-023095-4dannjjm	201	16	diseases	disease	NNS
cord-023095-4dannjjm	201	17	(	(	-LRB-
cord-023095-4dannjjm	201	18	p	p	NN
cord-023095-4dannjjm	201	19	5	5	CD
cord-023095-4dannjjm	201	20	0.013	0.013	CD
cord-023095-4dannjjm	201	21	)	)	-RRB-
cord-023095-4dannjjm	201	22	.	.	.
cord-023095-4dannjjm	202	1	There	there	EX
cord-023095-4dannjjm	202	2	was	be	VBD
cord-023095-4dannjjm	202	3	an	an	DT
cord-023095-4dannjjm	202	4	association	association	NN
cord-023095-4dannjjm	202	5	with	with	IN
cord-023095-4dannjjm	202	6	gender	gender	NN
cord-023095-4dannjjm	202	7	with	with	IN
cord-023095-4dannjjm	202	8	higher	high	JJR
cord-023095-4dannjjm	202	9	myocardial	myocardial	JJ
cord-023095-4dannjjm	202	10	leptin	leptin	NN
cord-023095-4dannjjm	202	11	levels	level	NNS
cord-023095-4dannjjm	202	12	in	in	IN
cord-023095-4dannjjm	202	13	female	female	JJ
cord-023095-4dannjjm	202	14	dogs	dog	NNS
cord-023095-4dannjjm	202	15	with	with	IN
cord-023095-4dannjjm	202	16	cardiac	cardiac	JJ
cord-023095-4dannjjm	202	17	diseases	disease	NNS
cord-023095-4dannjjm	202	18	(	(	-LRB-
cord-023095-4dannjjm	202	19	p	p	NN
cord-023095-4dannjjm	202	20	5	5	CD
cord-023095-4dannjjm	202	21	0.001	0.001	CD
cord-023095-4dannjjm	202	22	)	)	-RRB-
cord-023095-4dannjjm	202	23	.	.	.
cord-023095-4dannjjm	203	1	Differences	difference	NNS
cord-023095-4dannjjm	203	2	between	between	IN
cord-023095-4dannjjm	203	3	cardiac	cardiac	JJ
cord-023095-4dannjjm	203	4	regions	region	NNS
cord-023095-4dannjjm	203	5	were	be	VBD
cord-023095-4dannjjm	203	6	present	present	JJ
cord-023095-4dannjjm	203	7	(	(	-LRB-
cord-023095-4dannjjm	203	8	p	p	NN
cord-023095-4dannjjm	203	9	o	o	NN
cord-023095-4dannjjm	203	10	0.05	0.05	CD
cord-023095-4dannjjm	203	11	)	)	-RRB-
cord-023095-4dannjjm	203	12	and	and	CC
cord-023095-4dannjjm	203	13	cardiac	cardiac	JJ
cord-023095-4dannjjm	203	14	diseases	disease	NNS
cord-023095-4dannjjm	203	15	resulted	result	VBD
cord-023095-4dannjjm	203	16	in	in	IN
cord-023095-4dannjjm	203	17	an	an	DT
cord-023095-4dannjjm	203	18	increase	increase	NN
cord-023095-4dannjjm	203	19	in	in	IN
cord-023095-4dannjjm	203	20	atrial	atrial	JJ
cord-023095-4dannjjm	203	21	leptin	leptin	NN
cord-023095-4dannjjm	203	22	levels	level	NNS
cord-023095-4dannjjm	203	23	in	in	IN
cord-023095-4dannjjm	203	24	both	both	DT
cord-023095-4dannjjm	203	25	sexes	sex	NNS
cord-023095-4dannjjm	203	26	(	(	-LRB-
cord-023095-4dannjjm	203	27	p	p	NN
cord-023095-4dannjjm	203	28	5	5	CD
cord-023095-4dannjjm	203	29	0.006	0.006	CD
cord-023095-4dannjjm	203	30	)	)	-RRB-
cord-023095-4dannjjm	203	31	.	.	.
cord-023095-4dannjjm	204	1	Interestingly	interestingly	RB
cord-023095-4dannjjm	204	2	,	,	,
cord-023095-4dannjjm	204	3	a	a	DT
cord-023095-4dannjjm	204	4	significant	significant	JJ
cord-023095-4dannjjm	204	5	reduction	reduction	NN
cord-023095-4dannjjm	204	6	of	of	IN
cord-023095-4dannjjm	204	7	myocardial	myocardial	JJ
cord-023095-4dannjjm	204	8	leptin	leptin	NN
cord-023095-4dannjjm	204	9	was	be	VBD
cord-023095-4dannjjm	204	10	present	present	JJ
cord-023095-4dannjjm	204	11	in	in	IN
cord-023095-4dannjjm	204	12	dogs	dog	NNS
cord-023095-4dannjjm	204	13	with	with	IN
cord-023095-4dannjjm	204	14	congenital	congenital	JJ
cord-023095-4dannjjm	204	15	cardiac	cardiac	JJ
cord-023095-4dannjjm	204	16	diseases	disease	NNS
cord-023095-4dannjjm	204	17	(	(	-LRB-
cord-023095-4dannjjm	204	18	p	p	NN
cord-023095-4dannjjm	204	19	5	5	CD
cord-023095-4dannjjm	204	20	0.016	0.016	CD
cord-023095-4dannjjm	204	21	)	)	-RRB-
cord-023095-4dannjjm	204	22	,	,	,
cord-023095-4dannjjm	204	23	whereas	whereas	IN
cord-023095-4dannjjm	204	24	acquired	acquire	VBN
cord-023095-4dannjjm	204	25	cardiac	cardiac	JJ
cord-023095-4dannjjm	204	26	diseases	disease	NNS
cord-023095-4dannjjm	204	27	resulted	result	VBD
cord-023095-4dannjjm	204	28	in	in	IN
cord-023095-4dannjjm	204	29	an	an	DT
cord-023095-4dannjjm	204	30	increase	increase	NN
cord-023095-4dannjjm	204	31	in	in	IN
cord-023095-4dannjjm	204	32	leptin	leptin	NN
cord-023095-4dannjjm	204	33	(	(	-LRB-
cord-023095-4dannjjm	204	34	p	p	NN
cord-023095-4dannjjm	204	35	5	5	CD
cord-023095-4dannjjm	204	36	0.035	0.035	CD
cord-023095-4dannjjm	204	37	)	)	-RRB-
cord-023095-4dannjjm	204	38	in	in	IN
cord-023095-4dannjjm	204	39	comparison	comparison	NN
cord-023095-4dannjjm	204	40	to	to	IN
cord-023095-4dannjjm	204	41	controls	control	NNS
cord-023095-4dannjjm	204	42	.	.	.
cord-023095-4dannjjm	205	1	These	these	DT
cord-023095-4dannjjm	205	2	results	result	NNS
cord-023095-4dannjjm	205	3	suggest	suggest	VBP
cord-023095-4dannjjm	205	4	that	that	IN
cord-023095-4dannjjm	205	5	the	the	DT
cord-023095-4dannjjm	205	6	heart	heart	NN
cord-023095-4dannjjm	205	7	might	may	MD
cord-023095-4dannjjm	205	8	be	be	VB
cord-023095-4dannjjm	205	9	a	a	DT
cord-023095-4dannjjm	205	10	target	target	NN
cord-023095-4dannjjm	205	11	of	of	IN
cord-023095-4dannjjm	205	12	leptin	leptin	NN
cord-023095-4dannjjm	205	13	action	action	NN
cord-023095-4dannjjm	205	14	in	in	IN
cord-023095-4dannjjm	205	15	the	the	DT
cord-023095-4dannjjm	205	16	dog	dog	NN
cord-023095-4dannjjm	205	17	and	and	CC
cord-023095-4dannjjm	205	18	myocardial	myocardial	JJ
cord-023095-4dannjjm	205	19	leptin	leptin	NN
cord-023095-4dannjjm	205	20	production	production	NN
cord-023095-4dannjjm	205	21	might	may	MD
cord-023095-4dannjjm	205	22	play	play	VB
cord-023095-4dannjjm	205	23	a	a	DT
cord-023095-4dannjjm	205	24	role	role	NN
cord-023095-4dannjjm	205	25	in	in	IN
cord-023095-4dannjjm	205	26	regulating	regulate	VBG
cord-023095-4dannjjm	205	27	cardiac	cardiac	JJ
cord-023095-4dannjjm	205	28	function	function	NN
cord-023095-4dannjjm	205	29	in	in	IN
cord-023095-4dannjjm	205	30	an	an	DT
cord-023095-4dannjjm	205	31	auto	auto	NN
cord-023095-4dannjjm	205	32	-	-	HYPH
cord-023095-4dannjjm	205	33	and	and	CC
cord-023095-4dannjjm	205	34	paracrine	paracrine	JJ
cord-023095-4dannjjm	205	35	manner	manner	NN
cord-023095-4dannjjm	205	36	.	.	.
cord-023095-4dannjjm	206	1	Predicting	predict	VBG
cord-023095-4dannjjm	206	2	risk	risk	NN
cord-023095-4dannjjm	206	3	of	of	IN
cord-023095-4dannjjm	206	4	CHF	CHF	NNP
cord-023095-4dannjjm	206	5	in	in	IN
cord-023095-4dannjjm	206	6	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	206	7	dogs	dog	NNS
cord-023095-4dannjjm	206	8	with	with	IN
cord-023095-4dannjjm	206	9	mitral	mitral	JJ
cord-023095-4dannjjm	206	10	valve	valve	NN
cord-023095-4dannjjm	206	11	disease	disease	NN
cord-023095-4dannjjm	206	12	(	(	-LRB-
cord-023095-4dannjjm	206	13	MVD	MVD	NNP
cord-023095-4dannjjm	206	14	)	)	-RRB-
cord-023095-4dannjjm	206	15	is	be	VBZ
cord-023095-4dannjjm	206	16	challenging	challenging	JJ
cord-023095-4dannjjm	206	17	.	.	.
cord-023095-4dannjjm	207	1	We	-PRON-	PRP
cord-023095-4dannjjm	207	2	examined	examine	VBD
cord-023095-4dannjjm	207	3	ability	ability	NN
cord-023095-4dannjjm	207	4	of	of	IN
cord-023095-4dannjjm	207	5	NT	NT	NNP
cord-023095-4dannjjm	207	6	-	-	HYPH
cord-023095-4dannjjm	207	7	proBNP	probnp	NN
cord-023095-4dannjjm	207	8	to	to	TO
cord-023095-4dannjjm	207	9	identify	identify	VB
cord-023095-4dannjjm	207	10	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	207	11	dogs	dog	NNS
cord-023095-4dannjjm	207	12	at	at	IN
cord-023095-4dannjjm	207	13	high	high	JJ
cord-023095-4dannjjm	207	14	risk	risk	NN
cord-023095-4dannjjm	207	15	for	for	IN
cord-023095-4dannjjm	207	16	CHF	CHF	NNP
cord-023095-4dannjjm	207	17	.	.	.
cord-023095-4dannjjm	208	1	Dogs	dog	NNS
cord-023095-4dannjjm	208	2	with	with	IN
cord-023095-4dannjjm	208	3	ISACHC-1b	ISACHC-1b	NNP
cord-023095-4dannjjm	209	1	(	(	-LRB-
cord-023095-4dannjjm	209	2	LA	LA	NNP
cord-023095-4dannjjm	209	3	:	:	:
cord-023095-4dannjjm	209	4	Ao	Ao	NNP
cord-023095-4dannjjm	209	5	4	4	CD
cord-023095-4dannjjm	209	6	1.6	1.6	CD
cord-023095-4dannjjm	209	7	)	)	-RRB-
cord-023095-4dannjjm	209	8	were	be	VBD
cord-023095-4dannjjm	209	9	prospectively	prospectively	RB
cord-023095-4dannjjm	209	10	recruited	recruit	VBN
cord-023095-4dannjjm	209	11	;	;	:
cord-023095-4dannjjm	209	12	dogs	dog	NNS
cord-023095-4dannjjm	209	13	with	with	IN
cord-023095-4dannjjm	209	14	current	current	JJ
cord-023095-4dannjjm	209	15	or	or	CC
cord-023095-4dannjjm	209	16	previous	previous	JJ
cord-023095-4dannjjm	209	17	CHF	CHF	NNP
cord-023095-4dannjjm	209	18	or	or	CC
cord-023095-4dannjjm	209	19	diuretic	diuretic	JJ
cord-023095-4dannjjm	209	20	therapy	therapy	NN
cord-023095-4dannjjm	209	21	were	be	VBD
cord-023095-4dannjjm	209	22	excluded	exclude	VBN
cord-023095-4dannjjm	209	23	.	.	.
cord-023095-4dannjjm	210	1	Physical	physical	JJ
cord-023095-4dannjjm	210	2	examination	examination	NN
cord-023095-4dannjjm	210	3	,	,	,
cord-023095-4dannjjm	210	4	radiography	radiography	NN
cord-023095-4dannjjm	210	5	,	,	,
cord-023095-4dannjjm	210	6	echocardiography	echocardiography	NN
cord-023095-4dannjjm	210	7	,	,	,
cord-023095-4dannjjm	210	8	and	and	CC
cord-023095-4dannjjm	210	9	NT	NT	NNP
cord-023095-4dannjjm	210	10	-	-	HYPH
cord-023095-4dannjjm	210	11	proBNP	proBNP	NNP
cord-023095-4dannjjm	210	12	were	be	VBD
cord-023095-4dannjjm	210	13	performed	perform	VBN
cord-023095-4dannjjm	210	14	at	at	IN
cord-023095-4dannjjm	210	15	2	2	CD
cord-023095-4dannjjm	210	16	-	-	SYM
cord-023095-4dannjjm	210	17	9	9	CD
cord-023095-4dannjjm	210	18	mo	mo	NN
cord-023095-4dannjjm	210	19	intervals	interval	NNS
cord-023095-4dannjjm	210	20	for	for	IN
cord-023095-4dannjjm	210	21	66	66	CD
cord-023095-4dannjjm	210	22	dogs	dog	NNS
cord-023095-4dannjjm	210	23	(	(	-LRB-
cord-023095-4dannjjm	210	24	median	median	JJ
cord-023095-4dannjjm	210	25	follow	follow	NN
cord-023095-4dannjjm	210	26	-	-	HYPH
cord-023095-4dannjjm	210	27	up	up	NN
cord-023095-4dannjjm	210	28	5	5	CD
cord-023095-4dannjjm	210	29	276	276	CD
cord-023095-4dannjjm	210	30	d	d	NN
cord-023095-4dannjjm	210	31	,	,	,
cord-023095-4dannjjm	210	32	range	range	NN
cord-023095-4dannjjm	210	33	,	,	,
cord-023095-4dannjjm	210	34	17	17	CD
cord-023095-4dannjjm	210	35	-	-	SYM
cord-023095-4dannjjm	210	36	1334	1334	CD
cord-023095-4dannjjm	210	37	d	d	NN
cord-023095-4dannjjm	210	38	)	)	-RRB-
cord-023095-4dannjjm	210	39	.	.	.
cord-023095-4dannjjm	211	1	Thirty	thirty	CD
cord-023095-4dannjjm	211	2	-	-	HYPH
cord-023095-4dannjjm	211	3	one	one	CD
cord-023095-4dannjjm	211	4	patients	patient	NNS
cord-023095-4dannjjm	211	5	reached	reach	VBD
cord-023095-4dannjjm	211	6	a	a	DT
cord-023095-4dannjjm	211	7	study	study	NN
cord-023095-4dannjjm	211	8	endpoint	endpoint	NN
cord-023095-4dannjjm	211	9	of	of	IN
cord-023095-4dannjjm	211	10	radiographic	radiographic	JJ
cord-023095-4dannjjm	211	11	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	211	12	edema	edema	NN
cord-023095-4dannjjm	211	13	;	;	:
cord-023095-4dannjjm	211	14	35	35	CD
cord-023095-4dannjjm	211	15	remained	remain	VBD
cord-023095-4dannjjm	211	16	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	211	17	.	.	.
cord-023095-4dannjjm	212	1	Parameters	parameter	NNS
cord-023095-4dannjjm	212	2	from	from	IN
cord-023095-4dannjjm	212	3	the	the	DT
cord-023095-4dannjjm	212	4	visit	visit	NN
cord-023095-4dannjjm	212	5	immediately	immediately	RB
cord-023095-4dannjjm	212	6	previous	previous	JJ
cord-023095-4dannjjm	212	7	to	to	IN
cord-023095-4dannjjm	212	8	onset	onset	NN
cord-023095-4dannjjm	212	9	of	of	IN
cord-023095-4dannjjm	212	10	CHF	CHF	NNP
cord-023095-4dannjjm	212	11	(	(	-LRB-
cord-023095-4dannjjm	212	12	Future	Future	NNP
cord-023095-4dannjjm	212	13	-	-	HYPH
cord-023095-4dannjjm	212	14	CHF	CHF	NNP
cord-023095-4dannjjm	212	15	)	)	-RRB-
cord-023095-4dannjjm	212	16	or	or	CC
cord-023095-4dannjjm	212	17	prior	prior	RB
cord-023095-4dannjjm	212	18	to	to	IN
cord-023095-4dannjjm	212	19	the	the	DT
cord-023095-4dannjjm	212	20	most	most	RBS
cord-023095-4dannjjm	212	21	recent	recent	JJ
cord-023095-4dannjjm	212	22	visit	visit	NN
cord-023095-4dannjjm	212	23	without	without	IN
cord-023095-4dannjjm	212	24	CHF	CHF	NNP
cord-023095-4dannjjm	212	25	(	(	-LRB-
cord-023095-4dannjjm	212	26	Remain	Remain	NNP
cord-023095-4dannjjm	212	27	-	-	HYPH
cord-023095-4dannjjm	212	28	Asympt	Asympt	NNP
cord-023095-4dannjjm	212	29	)	)	-RRB-
cord-023095-4dannjjm	212	30	were	be	VBD
cord-023095-4dannjjm	212	31	analyzed	analyze	VBN
cord-023095-4dannjjm	212	32	.	.	.
cord-023095-4dannjjm	213	1	Median	median	JJ
cord-023095-4dannjjm	213	2	NT	NT	NNP
cord-023095-4dannjjm	213	3	-	-	HYPH
cord-023095-4dannjjm	213	4	proBNP	probnp	NN
cord-023095-4dannjjm	213	5	of	of	IN
cord-023095-4dannjjm	213	6	Future	Future	NNP
cord-023095-4dannjjm	213	7	-	-	HYPH
cord-023095-4dannjjm	213	8	CHF	CHF	NNP
cord-023095-4dannjjm	214	1	(	(	-LRB-
cord-023095-4dannjjm	214	2	3001pmol	3001pmol	NNP
cord-023095-4dannjjm	214	3	/	/	SYM
cord-023095-4dannjjm	214	4	Lpmol	Lpmol	NNP
cord-023095-4dannjjm	214	5	/	/	SYM
cord-023095-4dannjjm	214	6	L	L	NNP
cord-023095-4dannjjm	214	7	,	,	,
cord-023095-4dannjjm	214	8	IQR	IQR	NNP
cord-023095-4dannjjm	214	9	2255	2255	CD
cord-023095-4dannjjm	214	10	-	-	HYPH
cord-023095-4dannjjm	214	11	3001	3001	CD
cord-023095-4dannjjm	214	12	)	)	-RRB-
cord-023095-4dannjjm	214	13	was	be	VBD
cord-023095-4dannjjm	214	14	significantly	significantly	RB
cord-023095-4dannjjm	214	15	different	different	JJ
cord-023095-4dannjjm	214	16	from	from	IN
cord-023095-4dannjjm	214	17	Remain	Remain	NNP
cord-023095-4dannjjm	214	18	-	-	HYPH
cord-023095-4dannjjm	214	19	Asympt	Asympt	NNP
cord-023095-4dannjjm	214	20	(	(	-LRB-
cord-023095-4dannjjm	214	21	1600	1600	CD
cord-023095-4dannjjm	214	22	pmol	pmol	NNP
cord-023095-4dannjjm	214	23	/	/	SYM
cord-023095-4dannjjm	214	24	L	L	NNP
cord-023095-4dannjjm	214	25	,	,	,
cord-023095-4dannjjm	214	26	984	984	CD
cord-023095-4dannjjm	214	27	-	-	HYPH
cord-023095-4dannjjm	214	28	2863	2863	CD
cord-023095-4dannjjm	214	29	;	;	:
cord-023095-4dannjjm	214	30	P	p	NN
cord-023095-4dannjjm	214	31	5	5	CD
cord-023095-4dannjjm	214	32	0.0004	0.0004	CD
cord-023095-4dannjjm	214	33	)	)	-RRB-
cord-023095-4dannjjm	214	34	.	.	.
cord-023095-4dannjjm	215	1	Median	median	JJ
cord-023095-4dannjjm	215	2	time	time	NN
cord-023095-4dannjjm	215	3	to	to	IN
cord-023095-4dannjjm	215	4	CHF	CHF	NNP
cord-023095-4dannjjm	215	5	of	of	IN
cord-023095-4dannjjm	215	6	Future	Future	NNP
cord-023095-4dannjjm	215	7	-	-	HYPH
cord-023095-4dannjjm	215	8	CHF	CHF	NNP
cord-023095-4dannjjm	215	9	was	be	VBD
cord-023095-4dannjjm	215	10	86d	86d	.
cord-023095-4dannjjm	216	1	(	(	-LRB-
cord-023095-4dannjjm	216	2	IQR	IQR	NNP
cord-023095-4dannjjm	216	3	,	,	,
cord-023095-4dannjjm	216	4	.	.	.
cord-023095-4dannjjm	217	1	Groups	group	NNS
cord-023095-4dannjjm	217	2	also	also	RB
cord-023095-4dannjjm	217	3	differed	differ	VBD
cord-023095-4dannjjm	217	4	in	in	IN
cord-023095-4dannjjm	217	5	median	median	JJ
cord-023095-4dannjjm	217	6	LA	LA	NNP
cord-023095-4dannjjm	217	7	:	:	:
cord-023095-4dannjjm	217	8	Ao	Ao	NNP
cord-023095-4dannjjm	217	9	(	(	-LRB-
cord-023095-4dannjjm	217	10	Future	Future	NNP
cord-023095-4dannjjm	217	11	-	-	HYPH
cord-023095-4dannjjm	217	12	CHF	CHF	NNP
cord-023095-4dannjjm	217	13	2.20	2.20	CD
cord-023095-4dannjjm	217	14	[	[	-LRB-
cord-023095-4dannjjm	217	15	2.00	2.00	CD
cord-023095-4dannjjm	217	16	-	-	SYM
cord-023095-4dannjjm	217	17	2.50	2.50	CD
cord-023095-4dannjjm	217	18	]	]	-RRB-
cord-023095-4dannjjm	217	19	;	;	:
cord-023095-4dannjjm	217	20	Remain	remain	VB
cord-023095-4dannjjm	217	21	-	-	HYPH
cord-023095-4dannjjm	217	22	Asympt	Asympt	NNP
cord-023095-4dannjjm	217	23	1.96	1.96	CD
cord-023095-4dannjjm	217	24	[	[	-LRB-
cord-023095-4dannjjm	217	25	1.85	1.85	CD
cord-023095-4dannjjm	217	26	-	-	SYM
cord-023095-4dannjjm	217	27	2.13	2.13	CD
cord-023095-4dannjjm	217	28	]	]	-RRB-
cord-023095-4dannjjm	217	29	,	,	,
cord-023095-4dannjjm	217	30	P	p	NN
cord-023095-4dannjjm	217	31	5	5	CD
cord-023095-4dannjjm	217	32	0.0014	0.0014	CD
cord-023095-4dannjjm	217	33	)	)	-RRB-
cord-023095-4dannjjm	217	34	;	;	:
cord-023095-4dannjjm	217	35	VHS	VHS	NNP
cord-023095-4dannjjm	217	36	(	(	-LRB-
cord-023095-4dannjjm	217	37	Future-	Future-	NNP
cord-023095-4dannjjm	217	38	]	]	-RRB-
cord-023095-4dannjjm	217	39	;	;	:
cord-023095-4dannjjm	217	40	Remain	remain	VB
cord-023095-4dannjjm	217	41	-	-	HYPH
cord-023095-4dannjjm	217	42	Asympt	Asympt	NNP
cord-023095-4dannjjm	217	43	11.3	11.3	CD
cord-023095-4dannjjm	217	44	[	[	-LRB-
cord-023095-4dannjjm	217	45	10.75	10.75	CD
cord-023095-4dannjjm	217	46	-	-	SYM
cord-023095-4dannjjm	217	47	12.0	12.0	CD
cord-023095-4dannjjm	217	48	]	]	-RRB-
cord-023095-4dannjjm	217	49	,	,	,
cord-023095-4dannjjm	217	50	P	p	NN
cord-023095-4dannjjm	217	51	5	5	CD
cord-023095-4dannjjm	217	52	0.003	0.003	CD
cord-023095-4dannjjm	217	53	)	)	-RRB-
cord-023095-4dannjjm	217	54	;	;	:
cord-023095-4dannjjm	217	55	and	and	CC
cord-023095-4dannjjm	217	56	LVIDd	LVIDd	NNS
cord-023095-4dannjjm	217	57	:	:	:
cord-023095-4dannjjm	217	58	Ao	Ao	NNP
cord-023095-4dannjjm	217	59	]	]	-RRB-
cord-023095-4dannjjm	217	60	;	;	:
cord-023095-4dannjjm	217	61	Remain	remain	VB
cord-023095-4dannjjm	217	62	-	-	HYPH
cord-023095-4dannjjm	217	63	Asympt	Asympt	NNP
cord-023095-4dannjjm	217	64	2.33	2.33	CD
cord-023095-4dannjjm	218	1	[	[	-LRB-
cord-023095-4dannjjm	218	2	2.15	2.15	CD
cord-023095-4dannjjm	218	3	-	-	SYM
cord-023095-4dannjjm	218	4	2.64	2.64	CD
cord-023095-4dannjjm	218	5	]	]	-RRB-
cord-023095-4dannjjm	218	6	,	,	,
cord-023095-4dannjjm	218	7	P	p	NN
cord-023095-4dannjjm	218	8	5	5	CD
cord-023095-4dannjjm	218	9	0.0001	0.0001	CD
cord-023095-4dannjjm	218	10	)	)	-RRB-
cord-023095-4dannjjm	218	11	.	.	.
cord-023095-4dannjjm	219	1	ROC	ROC	NNP
cord-023095-4dannjjm	219	2	analysis	analysis	NN
cord-023095-4dannjjm	219	3	to	to	TO
cord-023095-4dannjjm	219	4	predict	predict	VB
cord-023095-4dannjjm	219	5	if	if	IN
cord-023095-4dannjjm	219	6	CHF	CHF	NNP
cord-023095-4dannjjm	219	7	would	would	MD
cord-023095-4dannjjm	219	8	occur	occur	VB
cord-023095-4dannjjm	219	9	prior	prior	RB
cord-023095-4dannjjm	219	10	to	to	IN
cord-023095-4dannjjm	219	11	the	the	DT
cord-023095-4dannjjm	219	12	next	next	JJ
cord-023095-4dannjjm	219	13	visit	visit	NN
cord-023095-4dannjjm	219	14	yielded	yield	VBD
cord-023095-4dannjjm	219	15	AUC	AUC	NNP
cord-023095-4dannjjm	219	16	5	5	CD
cord-023095-4dannjjm	219	17	0.753	0.753	CD
cord-023095-4dannjjm	219	18	(	(	-LRB-
cord-023095-4dannjjm	219	19	95%CI	95%ci	CD
cord-023095-4dannjjm	219	20	,	,	,
cord-023095-4dannjjm	219	21	0.632	0.632	CD
cord-023095-4dannjjm	219	22	-	-	SYM
cord-023095-4dannjjm	219	23	0.851	0.851	CD
cord-023095-4dannjjm	219	24	)	)	-RRB-
cord-023095-4dannjjm	219	25	.	.	.
cord-023095-4dannjjm	220	1	Sensitivity	sensitivity	NN
cord-023095-4dannjjm	220	2	was	be	VBD
cord-023095-4dannjjm	220	3	90.3	90.3	CD
cord-023095-4dannjjm	220	4	%	%	NN
cord-023095-4dannjjm	220	5	or	or	CC
cord-023095-4dannjjm	220	6	77.4	77.4	CD
cord-023095-4dannjjm	220	7	%	%	NN
cord-023095-4dannjjm	220	8	and	and	CC
cord-023095-4dannjjm	220	9	specificity	specificity	NN
cord-023095-4dannjjm	220	10	48.6	48.6	CD
cord-023095-4dannjjm	220	11	%	%	NN
cord-023095-4dannjjm	220	12	or	or	CC
cord-023095-4dannjjm	220	13	68.6	68.6	CD
cord-023095-4dannjjm	220	14	%	%	NN
cord-023095-4dannjjm	220	15	for	for	IN
cord-023095-4dannjjm	220	16	NT	NT	NNP
cord-023095-4dannjjm	220	17	-	-	HYPH
cord-023095-4dannjjm	220	18	proBNP	proBNP	NNP
cord-023095-4dannjjm	220	19	41490	41490	CD
cord-023095-4dannjjm	220	20	pmol	pmol	NNP
cord-023095-4dannjjm	220	21	/	/	SYM
cord-023095-4dannjjm	220	22	L	l	NN
cord-023095-4dannjjm	220	23	or	or	CC
cord-023095-4dannjjm	220	24	42150	42150	CD
cord-023095-4dannjjm	220	25	pmol	pmol	NNP
cord-023095-4dannjjm	220	26	/	/	SYM
cord-023095-4dannjjm	220	27	L	L	NNP
cord-023095-4dannjjm	220	28	,	,	,
cord-023095-4dannjjm	220	29	respectively	respectively	RB
cord-023095-4dannjjm	220	30	.	.	.
cord-023095-4dannjjm	221	1	Mean	mean	JJ
cord-023095-4dannjjm	221	2	increase	increase	NN
cord-023095-4dannjjm	221	3	in	in	IN
cord-023095-4dannjjm	221	4	NT	NT	NNP
cord-023095-4dannjjm	221	5	-	-	HYPH
cord-023095-4dannjjm	221	6	proBNP	probnp	NN
cord-023095-4dannjjm	221	7	between	between	IN
cord-023095-4dannjjm	221	8	penultimate	penultimate	JJ
cord-023095-4dannjjm	221	9	visit	visit	NN
cord-023095-4dannjjm	221	10	and	and	CC
cord-023095-4dannjjm	221	11	two	two	CD
cord-023095-4dannjjm	221	12	visits	visit	NNS
cord-023095-4dannjjm	221	13	prior	prior	RB
cord-023095-4dannjjm	221	14	to	to	IN
cord-023095-4dannjjm	221	15	endpoint	endpoint	NN
cord-023095-4dannjjm	221	16	:	:	:
cord-023095-4dannjjm	221	17	Future	future	JJ
cord-023095-4dannjjm	221	18	-	-	HYPH
cord-023095-4dannjjm	221	19	CHF	CHF	NNP
cord-023095-4dannjjm	221	20	5	5	CD
cord-023095-4dannjjm	221	21	1440.1	1440.1	CD
cord-023095-4dannjjm	221	22	pmol	pmol	NNP
cord-023095-4dannjjm	221	23	/	/	SYM
cord-023095-4dannjjm	221	24	L	l	NN
cord-023095-4dannjjm	221	25	vs.	vs.	FW
cord-023095-4dannjjm	221	26	Remain	Remain	NNP
cord-023095-4dannjjm	221	27	-	-	HYPH
cord-023095-4dannjjm	221	28	Asympt	Asympt	NNP
cord-023095-4dannjjm	221	29	5	5	CD
cord-023095-4dannjjm	222	1	110.5	110.5	CD
cord-023095-4dannjjm	222	2	pmol	pmol	NNP
cord-023095-4dannjjm	223	1	/L.	/L.	.
cord-023095-4dannjjm	224	1	Within	within	IN
cord-023095-4dannjjm	224	2	6	6	CD
cord-023095-4dannjjm	224	3	mo	mo	NN
cord-023095-4dannjjm	224	4	,	,	,
cord-023095-4dannjjm	224	5	4.5	4.5	CD
cord-023095-4dannjjm	224	6	%	%	NN
cord-023095-4dannjjm	224	7	,	,	,
cord-023095-4dannjjm	224	8	10.7	10.7	CD
cord-023095-4dannjjm	224	9	%	%	NN
cord-023095-4dannjjm	224	10	,	,	,
cord-023095-4dannjjm	224	11	17.4	17.4	CD
cord-023095-4dannjjm	224	12	%	%	NN
cord-023095-4dannjjm	224	13	,	,	,
cord-023095-4dannjjm	224	14	and	and	CC
cord-023095-4dannjjm	224	15	36.7	36.7	CD
cord-023095-4dannjjm	224	16	%	%	NN
cord-023095-4dannjjm	224	17	of	of	IN
cord-023095-4dannjjm	224	18	dogs	dog	NNS
cord-023095-4dannjjm	224	19	with	with	IN
cord-023095-4dannjjm	224	20	NT	NT	NNP
cord-023095-4dannjjm	224	21	-	-	HYPH
cord-023095-4dannjjm	224	22	proBNP	probnp	NN
cord-023095-4dannjjm	224	23	o	o	NN
cord-023095-4dannjjm	224	24	1000	1000	CD
cord-023095-4dannjjm	224	25	,	,	,
cord-023095-4dannjjm	224	26	,	,	,
cord-023095-4dannjjm	224	27	and	and	CC
cord-023095-4dannjjm	224	28	43000	43000	CD
cord-023095-4dannjjm	224	29	pmol	pmol	NNP
cord-023095-4dannjjm	224	30	/	/	SYM
cord-023095-4dannjjm	224	31	L	L	NNP
cord-023095-4dannjjm	224	32	developed	develop	VBD
cord-023095-4dannjjm	224	33	CHF	CHF	NNP
cord-023095-4dannjjm	224	34	.	.	.
cord-023095-4dannjjm	225	1	NT	NT	NNP
cord-023095-4dannjjm	225	2	-	-	HYPH
cord-023095-4dannjjm	225	3	proBNP	probnp	NN
cord-023095-4dannjjm	225	4	and	and	CC
cord-023095-4dannjjm	225	5	heart	heart	NN
cord-023095-4dannjjm	225	6	size	size	NN
cord-023095-4dannjjm	225	7	helped	help	VBD
cord-023095-4dannjjm	225	8	assess	assess	VB
cord-023095-4dannjjm	225	9	risk	risk	NN
cord-023095-4dannjjm	225	10	of	of	IN
cord-023095-4dannjjm	225	11	CHF	CHF	NNP
cord-023095-4dannjjm	225	12	in	in	IN
cord-023095-4dannjjm	225	13	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	225	14	MVD	MVD	NNP
cord-023095-4dannjjm	225	15	.	.	.
cord-023095-4dannjjm	226	1	Increasing	increase	VBG
cord-023095-4dannjjm	226	2	the	the	DT
cord-023095-4dannjjm	226	3	assay	assay	NN
cord-023095-4dannjjm	226	4	's	's	POS
cord-023095-4dannjjm	226	5	upper	upper	JJ
cord-023095-4dannjjm	226	6	limit	limit	NN
cord-023095-4dannjjm	226	7	of	of	IN
cord-023095-4dannjjm	226	8	detection	detection	NN
cord-023095-4dannjjm	226	9	would	would	MD
cord-023095-4dannjjm	226	10	likely	likely	RB
cord-023095-4dannjjm	226	11	improve	improve	VB
cord-023095-4dannjjm	226	12	utility	utility	NN
cord-023095-4dannjjm	226	13	of	of	IN
cord-023095-4dannjjm	226	14	NT	NT	NNP
cord-023095-4dannjjm	226	15	-	-	HYPH
cord-023095-4dannjjm	226	16	proBNP	probnp	NN
cord-023095-4dannjjm	226	17	.	.	.
cord-023095-4dannjjm	227	1	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	227	2	is	be	VBZ
cord-023095-4dannjjm	227	3	a	a	DT
cord-023095-4dannjjm	227	4	serum	serum	NN
cord-023095-4dannjjm	227	5	biomarker	biomarker	NN
cord-023095-4dannjjm	227	6	of	of	IN
cord-023095-4dannjjm	227	7	collagen	collagen	NN
cord-023095-4dannjjm	227	8	biosynthesis	biosynthesis	NN
cord-023095-4dannjjm	227	9	and	and	CC
cord-023095-4dannjjm	227	10	is	be	VBZ
cord-023095-4dannjjm	227	11	described	describe	VBN
cord-023095-4dannjjm	227	12	as	as	IN
cord-023095-4dannjjm	227	13	a	a	DT
cord-023095-4dannjjm	227	14	marker	marker	NN
cord-023095-4dannjjm	227	15	of	of	IN
cord-023095-4dannjjm	227	16	myocardial	myocardial	JJ
cord-023095-4dannjjm	227	17	fibrosis	fibrosis	NN
cord-023095-4dannjjm	227	18	in	in	IN
cord-023095-4dannjjm	227	19	human	human	JJ
cord-023095-4dannjjm	227	20	patients	patient	NNS
cord-023095-4dannjjm	227	21	.	.	.
cord-023095-4dannjjm	228	1	We	-PRON-	PRP
cord-023095-4dannjjm	228	2	hypothesised	hypothesise	VBD
cord-023095-4dannjjm	228	3	that	that	IN
cord-023095-4dannjjm	228	4	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	228	5	concentrations	concentration	NNS
cord-023095-4dannjjm	228	6	would	would	MD
cord-023095-4dannjjm	228	7	vary	vary	VB
cord-023095-4dannjjm	228	8	according	accord	VBG
cord-023095-4dannjjm	228	9	to	to	IN
cord-023095-4dannjjm	228	10	the	the	DT
cord-023095-4dannjjm	228	11	degree	degree	NN
cord-023095-4dannjjm	228	12	of	of	IN
cord-023095-4dannjjm	228	13	remodelling	remodelle	VBG
cord-023095-4dannjjm	228	14	demonstrable	demonstrable	JJ
cord-023095-4dannjjm	228	15	in	in	IN
cord-023095-4dannjjm	228	16	dogs	dog	NNS
cord-023095-4dannjjm	228	17	with	with	IN
cord-023095-4dannjjm	228	18	naturallyoccurring	naturallyoccurre	VBG
cord-023095-4dannjjm	228	19	myxomatous	myxomatous	JJ
cord-023095-4dannjjm	228	20	mitral	mitral	JJ
cord-023095-4dannjjm	228	21	valve	valve	NN
cord-023095-4dannjjm	228	22	disease	disease	NN
cord-023095-4dannjjm	228	23	(	(	-LRB-
cord-023095-4dannjjm	228	24	MMVD	MMVD	NNP
cord-023095-4dannjjm	228	25	)	)	-RRB-
cord-023095-4dannjjm	228	26	.	.	.
cord-023095-4dannjjm	229	1	Serum	serum	NN
cord-023095-4dannjjm	229	2	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	229	3	concentrations	concentration	NNS
cord-023095-4dannjjm	229	4	(	(	-LRB-
cord-023095-4dannjjm	229	5	mg	mg	NNP
cord-023095-4dannjjm	229	6	/	/	SYM
cord-023095-4dannjjm	229	7	ml	ml	NNP
cord-023095-4dannjjm	229	8	)	)	-RRB-
cord-023095-4dannjjm	229	9	were	be	VBD
cord-023095-4dannjjm	229	10	measured	measure	VBN
cord-023095-4dannjjm	229	11	in	in	IN
cord-023095-4dannjjm	229	12	dogs	dog	NNS
cord-023095-4dannjjm	229	13	with	with	IN
cord-023095-4dannjjm	229	14	MMVD	MMVD	NNP
cord-023095-4dannjjm	229	15	and	and	CC
cord-023095-4dannjjm	229	16	healthy	healthy	JJ
cord-023095-4dannjjm	229	17	controls	control	NNS
cord-023095-4dannjjm	229	18	using	use	VBG
cord-023095-4dannjjm	229	19	a	a	DT
cord-023095-4dannjjm	229	20	validated	validate	VBN
cord-023095-4dannjjm	229	21	commerciallyavailable	commerciallyavailable	NN
cord-023095-4dannjjm	229	22	radioimmunoassay	radioimmunoassay	NN
cord-023095-4dannjjm	229	23	.	.	.
cord-023095-4dannjjm	230	1	Results	result	NNS
cord-023095-4dannjjm	230	2	are	be	VBP
cord-023095-4dannjjm	230	3	reported	report	VBN
cord-023095-4dannjjm	230	4	as	as	IN
cord-023095-4dannjjm	230	5	(	(	-LRB-
cord-023095-4dannjjm	230	6	Mean	mean	JJ
cord-023095-4dannjjm	230	7	AE	AE	NNP
cord-023095-4dannjjm	230	8	SD	SD	NNP
cord-023095-4dannjjm	230	9	)	)	-RRB-
cord-023095-4dannjjm	230	10	.	.	.
cord-023095-4dannjjm	231	1	Non	Non	NNS
cord-023095-4dannjjm	231	2	-	-	JJ
cord-023095-4dannjjm	231	3	normally	normally	RB
cord-023095-4dannjjm	231	4	distributed	distribute	VBN
cord-023095-4dannjjm	231	5	variables	variable	NNS
cord-023095-4dannjjm	231	6	were	be	VBD
cord-023095-4dannjjm	231	7	logarithmically	logarithmically	RB
cord-023095-4dannjjm	231	8	transformed	transform	VBN
cord-023095-4dannjjm	231	9	.	.	.
cord-023095-4dannjjm	232	1	Comparisons	comparison	NNS
cord-023095-4dannjjm	232	2	of	of	IN
cord-023095-4dannjjm	232	3	continuous	continuous	JJ
cord-023095-4dannjjm	232	4	variables	variable	NNS
cord-023095-4dannjjm	232	5	were	be	VBD
cord-023095-4dannjjm	232	6	made	make	VBN
cord-023095-4dannjjm	232	7	between	between	IN
cord-023095-4dannjjm	232	8	groups	group	NNS
cord-023095-4dannjjm	232	9	using	use	VBG
cord-023095-4dannjjm	232	10	t	t	NN
cord-023095-4dannjjm	232	11	-	-	HYPH
cord-023095-4dannjjm	232	12	tests	test	NNS
cord-023095-4dannjjm	232	13	and	and	CC
cord-023095-4dannjjm	232	14	one	one	CD
cord-023095-4dannjjm	232	15	-	-	HYPH
cord-023095-4dannjjm	232	16	way	way	NN
cord-023095-4dannjjm	232	17	ANOVAs	anova	NNS
cord-023095-4dannjjm	232	18	with	with	IN
cord-023095-4dannjjm	232	19	Tukey	Tukey	NNP
cord-023095-4dannjjm	232	20	's	's	POS
cord-023095-4dannjjm	232	21	post	post	JJ
cord-023095-4dannjjm	232	22	-	-	JJ
cord-023095-4dannjjm	232	23	hoc	hoc	JJ
cord-023095-4dannjjm	232	24	comparisons	comparison	NNS
cord-023095-4dannjjm	232	25	.	.	.
cord-023095-4dannjjm	233	1	Univariable	univariable	JJ
cord-023095-4dannjjm	233	2	analyses	analysis	NNS
cord-023095-4dannjjm	233	3	were	be	VBD
cord-023095-4dannjjm	233	4	used	use	VBN
cord-023095-4dannjjm	233	5	to	to	TO
cord-023095-4dannjjm	233	6	evaluate	evaluate	VB
cord-023095-4dannjjm	233	7	associations	association	NNS
cord-023095-4dannjjm	233	8	between	between	IN
cord-023095-4dannjjm	233	9	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	233	10	and	and	CC
cord-023095-4dannjjm	233	11	clinical	clinical	JJ
cord-023095-4dannjjm	233	12	characteristics	characteristic	NNS
cord-023095-4dannjjm	233	13	(	(	-LRB-
cord-023095-4dannjjm	233	14	age	age	NN
cord-023095-4dannjjm	233	15	,	,	,
cord-023095-4dannjjm	233	16	breed	breed	VB
cord-023095-4dannjjm	233	17	[	[	-LRB-
cord-023095-4dannjjm	233	18	cavalier	cavalier	JJ
cord-023095-4dannjjm	233	19	King	King	NNP
cord-023095-4dannjjm	233	20	Charles	Charles	NNP
cord-023095-4dannjjm	233	21	spaniel	spaniel	NN
cord-023095-4dannjjm	233	22	(	(	-LRB-
cord-023095-4dannjjm	233	23	CKCS	CKCS	NNP
cord-023095-4dannjjm	233	24	)	)	-RRB-
cord-023095-4dannjjm	233	25	yes/	yes/	NNP
cord-023095-4dannjjm	233	26	no	no	NN
cord-023095-4dannjjm	233	27	]	]	-RRB-
cord-023095-4dannjjm	233	28	,	,	,
cord-023095-4dannjjm	233	29	sex	sex	NN
cord-023095-4dannjjm	233	30	,	,	,
cord-023095-4dannjjm	233	31	weight	weight	NN
cord-023095-4dannjjm	233	32	,	,	,
cord-023095-4dannjjm	233	33	heart	heart	NN
cord-023095-4dannjjm	233	34	rate	rate	NN
cord-023095-4dannjjm	233	35	[	[	-LRB-
cord-023095-4dannjjm	233	36	measured	measure	VBN
cord-023095-4dannjjm	233	37	from	from	IN
cord-023095-4dannjjm	233	38	ECG	ECG	NNP
cord-023095-4dannjjm	233	39	]	]	-RRB-
cord-023095-4dannjjm	233	40	,	,	,
cord-023095-4dannjjm	233	41	treatment	treatment	NN
cord-023095-4dannjjm	233	42	with	with	IN
cord-023095-4dannjjm	233	43	ACEi	ACEi	NNS
cord-023095-4dannjjm	233	44	[	[	-LRB-
cord-023095-4dannjjm	233	45	yes/	yes/	NNP
cord-023095-4dannjjm	233	46	no	no	NN
cord-023095-4dannjjm	233	47	]	]	-RRB-
cord-023095-4dannjjm	233	48	,	,	,
cord-023095-4dannjjm	233	49	treatment	treatment	NN
cord-023095-4dannjjm	233	50	with	with	IN
cord-023095-4dannjjm	233	51	diuretics	diuretic	NNS
cord-023095-4dannjjm	233	52	[	[	-LRB-
cord-023095-4dannjjm	233	53	yes/	yes/	NNP
cord-023095-4dannjjm	233	54	no	no	NN
cord-023095-4dannjjm	233	55	]	]	-RRB-
cord-023095-4dannjjm	233	56	and	and	CC
cord-023095-4dannjjm	233	57	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	233	58	measurements	measurement	NNS
cord-023095-4dannjjm	234	1	[	[	-LRB-
cord-023095-4dannjjm	234	2	LA	LA	NNP
cord-023095-4dannjjm	234	3	/	/	SYM
cord-023095-4dannjjm	234	4	Ao	Ao	NNP
cord-023095-4dannjjm	234	5	,	,	,
cord-023095-4dannjjm	234	6	LVEDD/	LVEDD/	NNP
cord-023095-4dannjjm	234	7	LVFWd	LVFWd	NNS
cord-023095-4dannjjm	234	8	,	,	,
cord-023095-4dannjjm	234	9	LVEDDN	LVEDDN	NNP
cord-023095-4dannjjm	234	10	,	,	,
cord-023095-4dannjjm	234	11	LVESDN	LVESDN	NNP
cord-023095-4dannjjm	234	12	]	]	-RRB-
cord-023095-4dannjjm	234	13	)	)	-RRB-
cord-023095-4dannjjm	234	14	.	.	.
cord-023095-4dannjjm	235	1	Multivariable	multivariable	JJ
cord-023095-4dannjjm	235	2	analysis	analysis	NN
cord-023095-4dannjjm	235	3	was	be	VBD
cord-023095-4dannjjm	235	4	initially	initially	RB
cord-023095-4dannjjm	235	5	performed	perform	VBN
cord-023095-4dannjjm	235	6	with	with	IN
cord-023095-4dannjjm	235	7	all	all	DT
cord-023095-4dannjjm	235	8	dogs	dog	NNS
cord-023095-4dannjjm	235	9	included	include	VBN
cord-023095-4dannjjm	235	10	and	and	CC
cord-023095-4dannjjm	235	11	then	then	RB
cord-023095-4dannjjm	235	12	repeated	repeat	VBD
cord-023095-4dannjjm	235	13	excluding	exclude	VBG
cord-023095-4dannjjm	235	14	all	all	DT
cord-023095-4dannjjm	235	15	dogs	dog	NNS
cord-023095-4dannjjm	235	16	receiving	receive	VBG
cord-023095-4dannjjm	235	17	therapy	therapy	NN
cord-023095-4dannjjm	235	18	.	.	.
cord-023095-4dannjjm	236	1	Dogs	dog	NNS
cord-023095-4dannjjm	236	2	with	with	IN
cord-023095-4dannjjm	236	3	MMVD	MMVD	NNP
cord-023095-4dannjjm	236	4	were	be	VBD
cord-023095-4dannjjm	236	5	divided	divide	VBN
cord-023095-4dannjjm	236	6	into	into	IN
cord-023095-4dannjjm	236	7	those	those	DT
cord-023095-4dannjjm	236	8	with	with	IN
cord-023095-4dannjjm	236	9	no	no	DT
cord-023095-4dannjjm	236	10	cardiomegaly	cardiomegaly	NN
cord-023095-4dannjjm	236	11	(	(	-LRB-
cord-023095-4dannjjm	236	12	NC	NC	NNP
cord-023095-4dannjjm	236	13	)	)	-RRB-
cord-023095-4dannjjm	237	1	(	(	-LRB-
cord-023095-4dannjjm	237	2	LA	LA	NNP
cord-023095-4dannjjm	237	3	/	/	SYM
cord-023095-4dannjjm	237	4	Ao	Ao	NNP
cord-023095-4dannjjm	237	5	o	o	NNP
cord-023095-4dannjjm	237	6	1.5	1.5	CD
cord-023095-4dannjjm	237	7	and	and	CC
cord-023095-4dannjjm	237	8	LVEDDN	LVEDDN	NNP
cord-023095-4dannjjm	237	9	o	o	NNP
cord-023095-4dannjjm	237	10	1.8	1.8	CD
cord-023095-4dannjjm	237	11	)	)	-RRB-
cord-023095-4dannjjm	237	12	,	,	.
cord-023095-4dannjjm	238	1	those	those	DT
cord-023095-4dannjjm	238	2	with	with	IN
cord-023095-4dannjjm	238	3	cardiomegaly	cardiomegaly	NN
cord-023095-4dannjjm	238	4	(	(	-LRB-
cord-023095-4dannjjm	238	5	LA	LA	NNP
cord-023095-4dannjjm	238	6	/	/	SYM
cord-023095-4dannjjm	238	7	Ao	Ao	NNP
cord-023095-4dannjjm	238	8	!	!	.
cord-023095-4dannjjm	239	1	1.5	1.5	CD
cord-023095-4dannjjm	239	2	and/	and/	CD
cord-023095-4dannjjm	239	3	or	or	CC
cord-023095-4dannjjm	239	4	LVEDDN	LVEDDN	NNP
cord-023095-4dannjjm	239	5	!	!	.
cord-023095-4dannjjm	239	6	1.8	1.8	CD
cord-023095-4dannjjm	239	7	)	)	-RRB-
cord-023095-4dannjjm	240	1	but	but	CC
cord-023095-4dannjjm	240	2	no	no	DT
cord-023095-4dannjjm	240	3	clinical	clinical	JJ
cord-023095-4dannjjm	240	4	signs	sign	NNS
cord-023095-4dannjjm	240	5	(	(	-LRB-
cord-023095-4dannjjm	240	6	C	C	NNP
cord-023095-4dannjjm	240	7	)	)	-RRB-
cord-023095-4dannjjm	240	8	and	and	CC
cord-023095-4dannjjm	240	9	those	those	DT
cord-023095-4dannjjm	240	10	dogs	dog	NNS
cord-023095-4dannjjm	240	11	with	with	IN
cord-023095-4dannjjm	240	12	cardiomegaly	cardiomegaly	NN
cord-023095-4dannjjm	240	13	requiring	require	VBG
cord-023095-4dannjjm	240	14	treatment	treatment	NN
cord-023095-4dannjjm	240	15	for	for	IN
cord-023095-4dannjjm	240	16	congestive	congestive	JJ
cord-023095-4dannjjm	240	17	heart	heart	NN
cord-023095-4dannjjm	240	18	failure	failure	NN
cord-023095-4dannjjm	240	19	(	(	-LRB-
cord-023095-4dannjjm	240	20	CHF	CHF	NNP
cord-023095-4dannjjm	240	21	)	)	-RRB-
cord-023095-4dannjjm	240	22	.	.	.
cord-023095-4dannjjm	241	1	One	one	CD
cord-023095-4dannjjm	241	2	hundred	hundred	CD
cord-023095-4dannjjm	241	3	and	and	CC
cord-023095-4dannjjm	241	4	fifty	fifty	CD
cord-023095-4dannjjm	241	5	-	-	HYPH
cord-023095-4dannjjm	241	6	four	four	CD
cord-023095-4dannjjm	241	7	dogs	dog	NNS
cord-023095-4dannjjm	241	8	with	with	IN
cord-023095-4dannjjm	241	9	MMVD	MMVD	NNP
cord-023095-4dannjjm	241	10	and	and	CC
cord-023095-4dannjjm	241	11	23	23	CD
cord-023095-4dannjjm	241	12	control	control	NN
cord-023095-4dannjjm	241	13	dogs	dog	NNS
cord-023095-4dannjjm	241	14	were	be	VBD
cord-023095-4dannjjm	241	15	studied	study	VBN
cord-023095-4dannjjm	241	16	.	.	.
cord-023095-4dannjjm	242	1	There	there	EX
cord-023095-4dannjjm	242	2	was	be	VBD
cord-023095-4dannjjm	242	3	no	no	DT
cord-023095-4dannjjm	242	4	difference	difference	NN
cord-023095-4dannjjm	242	5	in	in	IN
cord-023095-4dannjjm	242	6	age	age	NN
cord-023095-4dannjjm	242	7	(	(	-LRB-
cord-023095-4dannjjm	242	8	P	p	NN
cord-023095-4dannjjm	242	9	5	5	CD
cord-023095-4dannjjm	242	10	0.870	0.870	CD
cord-023095-4dannjjm	242	11	)	)	-RRB-
cord-023095-4dannjjm	242	12	or	or	CC
cord-023095-4dannjjm	242	13	weight	weight	NN
cord-023095-4dannjjm	242	14	(	(	-LRB-
cord-023095-4dannjjm	242	15	P	p	NN
cord-023095-4dannjjm	242	16	5	5	CD
cord-023095-4dannjjm	242	17	0.606	0.606	CD
cord-023095-4dannjjm	242	18	)	)	-RRB-
cord-023095-4dannjjm	242	19	between	between	IN
cord-023095-4dannjjm	242	20	the	the	DT
cord-023095-4dannjjm	242	21	MMVD	MMVD	NNP
cord-023095-4dannjjm	242	22	and	and	CC
cord-023095-4dannjjm	242	23	control	control	NN
cord-023095-4dannjjm	242	24	groups	group	NNS
cord-023095-4dannjjm	242	25	.	.	.
cord-023095-4dannjjm	243	1	There	there	EX
cord-023095-4dannjjm	243	2	was	be	VBD
cord-023095-4dannjjm	243	3	a	a	DT
cord-023095-4dannjjm	243	4	significant	significant	JJ
cord-023095-4dannjjm	243	5	difference	difference	NN
cord-023095-4dannjjm	243	6	in	in	IN
cord-023095-4dannjjm	243	7	serum	serum	NN
cord-023095-4dannjjm	243	8	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	243	9	(	(	-LRB-
cord-023095-4dannjjm	243	10	P	p	NN
cord-023095-4dannjjm	243	11	5	5	CD
cord-023095-4dannjjm	243	12	0.034	0.034	CD
cord-023095-4dannjjm	243	13	)	)	-RRB-
cord-023095-4dannjjm	243	14	between	between	IN
cord-023095-4dannjjm	243	15	normal	normal	JJ
cord-023095-4dannjjm	243	16	(	(	-LRB-
cord-023095-4dannjjm	243	17	11.2	11.2	CD
cord-023095-4dannjjm	243	18	AE	AE	NNP
cord-023095-4dannjjm	243	19	3.66	3.66	CD
cord-023095-4dannjjm	243	20	)	)	-RRB-
cord-023095-4dannjjm	243	21	,	,	,
cord-023095-4dannjjm	243	22	NC	NC	NNP
cord-023095-4dannjjm	243	23	(	(	-LRB-
cord-023095-4dannjjm	243	24	11.6	11.6	CD
cord-023095-4dannjjm	243	25	AE	AE	NNP
cord-023095-4dannjjm	243	26	4.57	4.57	CD
cord-023095-4dannjjm	243	27	)	)	-RRB-
cord-023095-4dannjjm	243	28	,	,	,
cord-023095-4dannjjm	243	29	C	C	NNP
cord-023095-4dannjjm	243	30	(	(	-LRB-
cord-023095-4dannjjm	243	31	10.1	10.1	CD
cord-023095-4dannjjm	243	32	AE	AE	NNP
cord-023095-4dannjjm	243	33	3.44	3.44	CD
cord-023095-4dannjjm	243	34	)	)	-RRB-
cord-023095-4dannjjm	243	35	and	and	CC
cord-023095-4dannjjm	243	36	CHF	CHF	NNP
cord-023095-4dannjjm	243	37	(	(	-LRB-
cord-023095-4dannjjm	243	38	9.4	9.4	CD
cord-023095-4dannjjm	243	39	AE	AE	NNP
cord-023095-4dannjjm	243	40	3.06	3.06	CD
cord-023095-4dannjjm	243	41	)	)	-RRB-
cord-023095-4dannjjm	243	42	groups	group	NNS
cord-023095-4dannjjm	243	43	.	.	.
cord-023095-4dannjjm	244	1	Post	post	JJ
cord-023095-4dannjjm	244	2	-	-	JJ
cord-023095-4dannjjm	244	3	hoc	hoc	JJ
cord-023095-4dannjjm	244	4	comparisons	comparison	NNS
cord-023095-4dannjjm	244	5	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	244	6	a	a	DT
cord-023095-4dannjjm	244	7	difference	difference	NN
cord-023095-4dannjjm	244	8	between	between	IN
cord-023095-4dannjjm	244	9	NC	NC	NNP
cord-023095-4dannjjm	244	10	and	and	CC
cord-023095-4dannjjm	244	11	CHF	CHF	NNP
cord-023095-4dannjjm	244	12	groups	group	NNS
cord-023095-4dannjjm	244	13	(	(	-LRB-
cord-023095-4dannjjm	244	14	P	p	NN
cord-023095-4dannjjm	244	15	5	5	CD
cord-023095-4dannjjm	244	16	0.038	0.038	CD
cord-023095-4dannjjm	244	17	)	)	-RRB-
cord-023095-4dannjjm	244	18	.	.	.
cord-023095-4dannjjm	245	1	There	there	EX
cord-023095-4dannjjm	245	2	was	be	VBD
cord-023095-4dannjjm	245	3	no	no	DT
cord-023095-4dannjjm	245	4	difference	difference	NN
cord-023095-4dannjjm	245	5	in	in	IN
cord-023095-4dannjjm	245	6	serum	serum	NN
cord-023095-4dannjjm	245	7	PIIINP	PIIINP	NNS
cord-023095-4dannjjm	245	8	between	between	IN
cord-023095-4dannjjm	245	9	genders	gender	NNS
cord-023095-4dannjjm	245	10	(	(	-LRB-
cord-023095-4dannjjm	245	11	P	p	NN
cord-023095-4dannjjm	245	12	5	5	CD
cord-023095-4dannjjm	245	13	0.228	0.228	CD
cord-023095-4dannjjm	245	14	)	)	-RRB-
cord-023095-4dannjjm	245	15	.	.	.
cord-023095-4dannjjm	246	1	In	in	IN
cord-023095-4dannjjm	246	2	the	the	DT
cord-023095-4dannjjm	246	3	univariable	univariable	JJ
cord-023095-4dannjjm	246	4	analysis	analysis	NN
cord-023095-4dannjjm	246	5	CKCS	CKCS	NNP
cord-023095-4dannjjm	246	6	(	(	-LRB-
cord-023095-4dannjjm	246	7	yes/	yes/	NNP
cord-023095-4dannjjm	246	8	no	no	NN
cord-023095-4dannjjm	246	9	)	)	-RRB-
cord-023095-4dannjjm	246	10	(	(	-LRB-
cord-023095-4dannjjm	246	11	P	p	NN
cord-023095-4dannjjm	246	12	5	5	CD
cord-023095-4dannjjm	246	13	0.016	0.016	CD
cord-023095-4dannjjm	246	14	)	)	-RRB-
cord-023095-4dannjjm	246	15	was	be	VBD
cord-023095-4dannjjm	246	16	positively	positively	RB
cord-023095-4dannjjm	246	17	associated	associate	VBN
cord-023095-4dannjjm	246	18	with	with	IN
cord-023095-4dannjjm	246	19	serum	serum	NN
cord-023095-4dannjjm	246	20	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	246	21	.	.	.
cord-023095-4dannjjm	247	1	Age	age	NN
cord-023095-4dannjjm	247	2	(	(	-LRB-
cord-023095-4dannjjm	247	3	P	p	NN
cord-023095-4dannjjm	247	4	o	o	NN
cord-023095-4dannjjm	247	5	0.0001	0.0001	CD
cord-023095-4dannjjm	247	6	)	)	-RRB-
cord-023095-4dannjjm	247	7	,	,	,
cord-023095-4dannjjm	247	8	Log	Log	NNP
cord-023095-4dannjjm	247	9	(	(	-LRB-
cord-023095-4dannjjm	247	10	LA	LA	NNP
cord-023095-4dannjjm	247	11	/	/	SYM
cord-023095-4dannjjm	247	12	Ao	Ao	NNP
cord-023095-4dannjjm	247	13	)	)	-RRB-
cord-023095-4dannjjm	248	1	(	(	-LRB-
cord-023095-4dannjjm	248	2	P	p	NN
cord-023095-4dannjjm	248	3	5	5	CD
cord-023095-4dannjjm	248	4	0.002	0.002	CD
cord-023095-4dannjjm	248	5	)	)	-RRB-
cord-023095-4dannjjm	248	6	and	and	CC
cord-023095-4dannjjm	248	7	LVEDDN	LVEDDN	NNP
cord-023095-4dannjjm	248	8	(	(	-LRB-
cord-023095-4dannjjm	248	9	P	p	NN
cord-023095-4dannjjm	248	10	5	5	CD
cord-023095-4dannjjm	248	11	0.002	0.002	CD
cord-023095-4dannjjm	248	12	)	)	-RRB-
cord-023095-4dannjjm	248	13	were	be	VBD
cord-023095-4dannjjm	248	14	negatively	negatively	RB
cord-023095-4dannjjm	248	15	associated	associate	VBN
cord-023095-4dannjjm	248	16	with	with	IN
cord-023095-4dannjjm	248	17	serum	serum	NN
cord-023095-4dannjjm	248	18	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	248	19	.	.	.
cord-023095-4dannjjm	249	1	In	in	IN
cord-023095-4dannjjm	249	2	the	the	DT
cord-023095-4dannjjm	249	3	multivariable	multivariable	JJ
cord-023095-4dannjjm	249	4	model	model	NN
cord-023095-4dannjjm	249	5	including	include	VBG
cord-023095-4dannjjm	249	6	all	all	DT
cord-023095-4dannjjm	249	7	dogs	dog	NNS
cord-023095-4dannjjm	249	8	,	,	,
cord-023095-4dannjjm	249	9	LVEDDN	LVEDDN	NNP
cord-023095-4dannjjm	249	10	(	(	-LRB-
cord-023095-4dannjjm	249	11	P	p	NN
cord-023095-4dannjjm	249	12	o	o	NN
cord-023095-4dannjjm	249	13	0.0001	0.0001	CD
cord-023095-4dannjjm	249	14	,	,	,
cord-023095-4dannjjm	249	15	B	b	NN
cord-023095-4dannjjm	249	16	5	5	CD
cord-023095-4dannjjm	249	17	À4.04	à4.04	NN
cord-023095-4dannjjm	249	18	(	(	-LRB-
cord-023095-4dannjjm	249	19	95%CI	95%ci	CD
cord-023095-4dannjjm	249	20	5	5	CD
cord-023095-4dannjjm	249	21	À6.11	à6.11	DT
cord-023095-4dannjjm	249	22	to	to	IN
cord-023095-4dannjjm	249	23	À1.97	À1.97	NNP
cord-023095-4dannjjm	249	24	)	)	-RRB-
cord-023095-4dannjjm	249	25	)	)	-RRB-
cord-023095-4dannjjm	249	26	,	,	,
cord-023095-4dannjjm	249	27	age	age	NN
cord-023095-4dannjjm	249	28	(	(	-LRB-
cord-023095-4dannjjm	249	29	P	p	NN
cord-023095-4dannjjm	249	30	5	5	CD
cord-023095-4dannjjm	249	31	0.006	0.006	CD
cord-023095-4dannjjm	249	32	,	,	,
cord-023095-4dannjjm	249	33	B	b	NN
cord-023095-4dannjjm	249	34	5	5	CD
cord-023095-4dannjjm	249	35	À0.28	à0.28	NN
cord-023095-4dannjjm	249	36	(	(	-LRB-
cord-023095-4dannjjm	249	37	95%CI	95%ci	CD
cord-023095-4dannjjm	249	38	5	5	CD
cord-023095-4dannjjm	249	39	À0.47	à0.47	NN
cord-023095-4dannjjm	249	40	to	to	IN
cord-023095-4dannjjm	249	41	À0.08	À0.08	NNP
cord-023095-4dannjjm	249	42	)	)	-RRB-
cord-023095-4dannjjm	249	43	)	)	-RRB-
cord-023095-4dannjjm	249	44	and	and	CC
cord-023095-4dannjjm	249	45	CKCS	CKCS	NNP
cord-023095-4dannjjm	249	46	(	(	-LRB-
cord-023095-4dannjjm	249	47	yes/	yes/	NNP
cord-023095-4dannjjm	249	48	no	no	NN
cord-023095-4dannjjm	249	49	)	)	-RRB-
cord-023095-4dannjjm	250	1	(	(	-LRB-
cord-023095-4dannjjm	250	2	P	p	NN
cord-023095-4dannjjm	250	3	5	5	CD
cord-023095-4dannjjm	250	4	0.003	0.003	CD
cord-023095-4dannjjm	250	5	,	,	,
cord-023095-4dannjjm	250	6	B	b	NN
cord-023095-4dannjjm	250	7	5	5	CD
cord-023095-4dannjjm	250	8	2.01	2.01	CD
cord-023095-4dannjjm	250	9	(	(	-LRB-
cord-023095-4dannjjm	250	10	95%CI	95%ci	CD
cord-023095-4dannjjm	250	11	5	5	CD
cord-023095-4dannjjm	250	12	0.67	0.67	CD
cord-023095-4dannjjm	250	13	to	to	IN
cord-023095-4dannjjm	250	14	3.34	3.34	CD
cord-023095-4dannjjm	250	15	)	)	-RRB-
cord-023095-4dannjjm	250	16	)	)	-RRB-
cord-023095-4dannjjm	250	17	were	be	VBD
cord-023095-4dannjjm	250	18	independently	independently	RB
cord-023095-4dannjjm	250	19	associated	associate	VBN
cord-023095-4dannjjm	250	20	with	with	IN
cord-023095-4dannjjm	250	21	serum	serum	NN
cord-023095-4dannjjm	250	22	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	250	23	.	.	.
cord-023095-4dannjjm	251	1	In	in	IN
cord-023095-4dannjjm	251	2	the	the	DT
cord-023095-4dannjjm	251	3	multivariable	multivariable	JJ
cord-023095-4dannjjm	251	4	model	model	NN
cord-023095-4dannjjm	251	5	including	include	VBG
cord-023095-4dannjjm	251	6	only	only	JJ
cord-023095-4dannjjm	251	7	dogs	dog	NNS
cord-023095-4dannjjm	251	8	not	not	RB
cord-023095-4dannjjm	251	9	receiving	receive	VBG
cord-023095-4dannjjm	251	10	therapy	therapy	NN
cord-023095-4dannjjm	251	11	(	(	-LRB-
cord-023095-4dannjjm	251	12	n	n	NN
cord-023095-4dannjjm	251	13	5	5	CD
cord-023095-4dannjjm	251	14	141	141	CD
cord-023095-4dannjjm	251	15	)	)	-RRB-
cord-023095-4dannjjm	251	16	,	,	,
cord-023095-4dannjjm	251	17	LVEDDN	LVEDDN	NNP
cord-023095-4dannjjm	251	18	(	(	-LRB-
cord-023095-4dannjjm	251	19	P	p	NN
cord-023095-4dannjjm	251	20	5	5	CD
cord-023095-4dannjjm	251	21	0.006	0.006	CD
cord-023095-4dannjjm	251	22	,	,	,
cord-023095-4dannjjm	251	23	B	B	NNP
cord-023095-4dannjjm	251	24	5	5	CD
cord-023095-4dannjjm	251	25	À4.30	À4.30	NNP
cord-023095-4dannjjm	251	26	(	(	-LRB-
cord-023095-4dannjjm	251	27	95%CI	95%ci	CD
cord-023095-4dannjjm	251	28	5	5	CD
cord-023095-4dannjjm	251	29	À7.32	à7.32	NN
cord-023095-4dannjjm	251	30	to	to	IN
cord-023095-4dannjjm	251	31	À1.29	À1.29	NNP
cord-023095-4dannjjm	251	32	)	)	-RRB-
cord-023095-4dannjjm	251	33	)	)	-RRB-
cord-023095-4dannjjm	251	34	,	,	,
cord-023095-4dannjjm	251	35	age	age	NN
cord-023095-4dannjjm	251	36	(	(	-LRB-
cord-023095-4dannjjm	251	37	P	p	NN
cord-023095-4dannjjm	251	38	5	5	CD
cord-023095-4dannjjm	251	39	0.011	0.011	CD
cord-023095-4dannjjm	251	40	,	,	,
cord-023095-4dannjjm	251	41	B	b	NN
cord-023095-4dannjjm	251	42	5	5	CD
cord-023095-4dannjjm	251	43	À0.31	À0.31	NNP
cord-023095-4dannjjm	251	44	(	(	-LRB-
cord-023095-4dannjjm	251	45	95%CI	95%ci	CD
cord-023095-4dannjjm	251	46	5	5	CD
cord-023095-4dannjjm	251	47	À0.55	À0.55	NNS
cord-023095-4dannjjm	251	48	to	to	IN
cord-023095-4dannjjm	251	49	À0.07	À0.07	NNS
cord-023095-4dannjjm	251	50	)	)	-RRB-
cord-023095-4dannjjm	251	51	)	)	-RRB-
cord-023095-4dannjjm	251	52	and	and	CC
cord-023095-4dannjjm	251	53	CKCS	CKCS	NNP
cord-023095-4dannjjm	251	54	(	(	-LRB-
cord-023095-4dannjjm	251	55	yes/	yes/	NNP
cord-023095-4dannjjm	251	56	no	no	NN
cord-023095-4dannjjm	251	57	)	)	-RRB-
cord-023095-4dannjjm	251	58	(	(	-LRB-
cord-023095-4dannjjm	251	59	P	p	NN
cord-023095-4dannjjm	251	60	5	5	CD
cord-023095-4dannjjm	251	61	0.034	0.034	CD
cord-023095-4dannjjm	251	62	,	,	,
cord-023095-4dannjjm	251	63	B	b	NN
cord-023095-4dannjjm	251	64	5	5	CD
cord-023095-4dannjjm	251	65	1.75	1.75	CD
cord-023095-4dannjjm	251	66	(	(	-LRB-
cord-023095-4dannjjm	251	67	95%CI	95%ci	CD
cord-023095-4dannjjm	251	68	5	5	CD
cord-023095-4dannjjm	251	69	0.13	0.13	CD
cord-023095-4dannjjm	251	70	to	to	IN
cord-023095-4dannjjm	251	71	3.37	3.37	CD
cord-023095-4dannjjm	251	72	)	)	-RRB-
cord-023095-4dannjjm	251	73	)	)	-RRB-
cord-023095-4dannjjm	251	74	were	be	VBD
cord-023095-4dannjjm	251	75	independently	independently	RB
cord-023095-4dannjjm	251	76	associated	associate	VBN
cord-023095-4dannjjm	251	77	with	with	IN
cord-023095-4dannjjm	251	78	serum	serum	NN
cord-023095-4dannjjm	251	79	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	251	80	.	.	.
cord-023095-4dannjjm	252	1	In	in	IN
cord-023095-4dannjjm	252	2	conclusion	conclusion	NN
cord-023095-4dannjjm	252	3	,	,	,
cord-023095-4dannjjm	252	4	serum	serum	NN
cord-023095-4dannjjm	252	5	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	252	6	decreases	decrease	VBZ
cord-023095-4dannjjm	252	7	with	with	IN
cord-023095-4dannjjm	252	8	age	age	NN
cord-023095-4dannjjm	252	9	and	and	CC
cord-023095-4dannjjm	252	10	with	with	IN
cord-023095-4dannjjm	252	11	increasing	increase	VBG
cord-023095-4dannjjm	252	12	LVEDDN	LVEDDN	NNP
cord-023095-4dannjjm	252	13	.	.	.
cord-023095-4dannjjm	253	1	CKCS	CKCS	NNP
cord-023095-4dannjjm	253	2	have	have	VBP
cord-023095-4dannjjm	253	3	higher	high	JJR
cord-023095-4dannjjm	253	4	serum	serum	NN
cord-023095-4dannjjm	253	5	PIIINP	PIIINP	NNP
cord-023095-4dannjjm	253	6	measurements	measurement	NNS
cord-023095-4dannjjm	253	7	independent	independent	JJ
cord-023095-4dannjjm	253	8	of	of	IN
cord-023095-4dannjjm	253	9	age	age	NN
cord-023095-4dannjjm	253	10	and	and	CC
cord-023095-4dannjjm	253	11	LVEDDN	LVEDDN	NNP
cord-023095-4dannjjm	253	12	,	,	,
cord-023095-4dannjjm	253	13	which	which	WDT
cord-023095-4dannjjm	253	14	may	may	MD
cord-023095-4dannjjm	253	15	reflect	reflect	VB
cord-023095-4dannjjm	253	16	a	a	DT
cord-023095-4dannjjm	253	17	difference	difference	NN
cord-023095-4dannjjm	253	18	in	in	IN
cord-023095-4dannjjm	253	19	collagen	collagen	NN
cord-023095-4dannjjm	253	20	turnover	turnover	NN
cord-023095-4dannjjm	253	21	in	in	IN
cord-023095-4dannjjm	253	22	this	this	DT
cord-023095-4dannjjm	253	23	breed	breed	NN
cord-023095-4dannjjm	253	24	.	.	.
cord-023095-4dannjjm	254	1	Left	leave	VBN
cord-023095-4dannjjm	254	2	atrial	atrial	NN
cord-023095-4dannjjm	254	3	(	(	-LRB-
cord-023095-4dannjjm	254	4	LA	LA	NNP
cord-023095-4dannjjm	254	5	)	)	-RRB-
cord-023095-4dannjjm	254	6	chamber	chamber	NN
cord-023095-4dannjjm	254	7	dilation	dilation	NN
cord-023095-4dannjjm	254	8	and	and	CC
cord-023095-4dannjjm	254	9	congestive	congestive	JJ
cord-023095-4dannjjm	254	10	heart	heart	NN
cord-023095-4dannjjm	254	11	failure	failure	NN
cord-023095-4dannjjm	254	12	(	(	-LRB-
cord-023095-4dannjjm	254	13	CHF	CHF	NNP
cord-023095-4dannjjm	254	14	)	)	-RRB-
cord-023095-4dannjjm	254	15	are	be	VBP
cord-023095-4dannjjm	254	16	common	common	JJ
cord-023095-4dannjjm	254	17	consequences	consequence	NNS
cord-023095-4dannjjm	254	18	of	of	IN
cord-023095-4dannjjm	254	19	cardiac	cardiac	JJ
cord-023095-4dannjjm	254	20	conditions	condition	NNS
cord-023095-4dannjjm	254	21	in	in	IN
cord-023095-4dannjjm	254	22	cats	cat	NNS
cord-023095-4dannjjm	254	23	.	.	.
cord-023095-4dannjjm	255	1	In	in	IN
cord-023095-4dannjjm	255	2	some	some	DT
cord-023095-4dannjjm	255	3	cases	case	NNS
cord-023095-4dannjjm	255	4	CHF	CHF	NNP
cord-023095-4dannjjm	255	5	is	be	VBZ
cord-023095-4dannjjm	255	6	manifest	manifest	JJ
cord-023095-4dannjjm	255	7	as	as	IN
cord-023095-4dannjjm	255	8	right	right	JJ
cord-023095-4dannjjm	255	9	-	-	HYPH
cord-023095-4dannjjm	255	10	sided	sided	JJ
cord-023095-4dannjjm	255	11	CHF	CHF	NNP
cord-023095-4dannjjm	255	12	(	(	-LRB-
cord-023095-4dannjjm	255	13	R	R	NNP
cord-023095-4dannjjm	255	14	-	-	HYPH
cord-023095-4dannjjm	255	15	CHF	CHF	NNP
cord-023095-4dannjjm	255	16	)	)	-RRB-
cord-023095-4dannjjm	255	17	or	or	CC
cord-023095-4dannjjm	255	18	pleural	pleural	JJ
cord-023095-4dannjjm	255	19	effusion	effusion	NN
cord-023095-4dannjjm	255	20	,	,	,
cord-023095-4dannjjm	255	21	in	in	IN
cord-023095-4dannjjm	255	22	other	other	JJ
cord-023095-4dannjjm	255	23	cases	case	NNS
cord-023095-4dannjjm	255	24	CHF	CHF	NNP
cord-023095-4dannjjm	255	25	manifests	manifest	VBZ
cord-023095-4dannjjm	255	26	as	as	IN
cord-023095-4dannjjm	255	27	left	leave	VBN
cord-023095-4dannjjm	255	28	-	-	HYPH
cord-023095-4dannjjm	255	29	sided	sided	JJ
cord-023095-4dannjjm	255	30	CHF	CHF	NNP
cord-023095-4dannjjm	255	31	(	(	-LRB-
cord-023095-4dannjjm	255	32	L	L	NNP
cord-023095-4dannjjm	255	33	-	-	HYPH
cord-023095-4dannjjm	255	34	CHF	CHF	NNP
cord-023095-4dannjjm	255	35	)	)	-RRB-
cord-023095-4dannjjm	255	36	or	or	CC
cord-023095-4dannjjm	255	37	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	255	38	edema	edema	NN
cord-023095-4dannjjm	255	39	.	.	.
cord-023095-4dannjjm	256	1	It	-PRON-	PRP
cord-023095-4dannjjm	256	2	is	be	VBZ
cord-023095-4dannjjm	256	3	not	not	RB
cord-023095-4dannjjm	256	4	always	always	RB
cord-023095-4dannjjm	256	5	readily	readily	RB
cord-023095-4dannjjm	256	6	apparent	apparent	JJ
cord-023095-4dannjjm	256	7	as	as	IN
cord-023095-4dannjjm	256	8	to	to	IN
cord-023095-4dannjjm	256	9	which	which	WDT
cord-023095-4dannjjm	256	10	cats	cat	NNS
cord-023095-4dannjjm	256	11	will	will	MD
cord-023095-4dannjjm	256	12	develop	develop	VB
cord-023095-4dannjjm	256	13	what	what	WDT
cord-023095-4dannjjm	256	14	form	form	NN
cord-023095-4dannjjm	256	15	of	of	IN
cord-023095-4dannjjm	256	16	CHF	CHF	NNP
cord-023095-4dannjjm	256	17	.	.	.
cord-023095-4dannjjm	257	1	A	a	DT
cord-023095-4dannjjm	257	2	general	general	JJ
cord-023095-4dannjjm	257	3	impression	impression	NN
cord-023095-4dannjjm	257	4	has	have	VBZ
cord-023095-4dannjjm	257	5	been	be	VBN
cord-023095-4dannjjm	257	6	that	that	IN
cord-023095-4dannjjm	257	7	LA	LA	NNP
cord-023095-4dannjjm	257	8	enlargement	enlargement	NN
cord-023095-4dannjjm	257	9	is	be	VBZ
cord-023095-4dannjjm	257	10	associated	associate	VBN
cord-023095-4dannjjm	257	11	with	with	IN
cord-023095-4dannjjm	257	12	the	the	DT
cord-023095-4dannjjm	257	13	average	average	JJ
cord-023095-4dannjjm	257	14	burden	burden	NN
cord-023095-4dannjjm	257	15	of	of	IN
cord-023095-4dannjjm	257	16	elevated	elevated	JJ
cord-023095-4dannjjm	257	17	filling	filling	NN
cord-023095-4dannjjm	257	18	pressures	pressure	NNS
cord-023095-4dannjjm	257	19	,	,	,
cord-023095-4dannjjm	257	20	but	but	CC
cord-023095-4dannjjm	257	21	little	little	JJ
cord-023095-4dannjjm	257	22	attention	attention	NN
cord-023095-4dannjjm	257	23	has	have	VBZ
cord-023095-4dannjjm	257	24	been	be	VBN
cord-023095-4dannjjm	257	25	paid	pay	VBN
cord-023095-4dannjjm	257	26	to	to	IN
cord-023095-4dannjjm	257	27	the	the	DT
cord-023095-4dannjjm	257	28	function	function	NN
cord-023095-4dannjjm	257	29	of	of	IN
cord-023095-4dannjjm	257	30	the	the	DT
cord-023095-4dannjjm	257	31	LA	LA	NNP
cord-023095-4dannjjm	257	32	chamber	chamber	NN
cord-023095-4dannjjm	257	33	itself	-PRON-	PRP
cord-023095-4dannjjm	257	34	.	.	.
cord-023095-4dannjjm	258	1	Since	since	IN
cord-023095-4dannjjm	258	2	CHF	CHF	NNP
cord-023095-4dannjjm	258	3	is	be	VBZ
cord-023095-4dannjjm	258	4	classically	classically	RB
cord-023095-4dannjjm	258	5	preceded	precede	VBN
cord-023095-4dannjjm	258	6	by	by	IN
cord-023095-4dannjjm	258	7	abnormal	abnormal	JJ
cord-023095-4dannjjm	258	8	atrial	atrial	JJ
cord-023095-4dannjjm	258	9	chamber	chamber	NN
cord-023095-4dannjjm	258	10	dilation	dilation	NN
cord-023095-4dannjjm	258	11	and	and	CC
cord-023095-4dannjjm	258	12	alterations	alteration	NNS
cord-023095-4dannjjm	258	13	in	in	IN
cord-023095-4dannjjm	258	14	atrial	atrial	JJ
cord-023095-4dannjjm	258	15	chamber	chamber	NN
cord-023095-4dannjjm	258	16	function	function	NN
cord-023095-4dannjjm	258	17	,	,	,
cord-023095-4dannjjm	258	18	we	-PRON-	PRP
cord-023095-4dannjjm	258	19	want	want	VBP
cord-023095-4dannjjm	258	20	to	to	TO
cord-023095-4dannjjm	258	21	understand	understand	VB
cord-023095-4dannjjm	258	22	how	how	WRB
cord-023095-4dannjjm	258	23	these	these	DT
cord-023095-4dannjjm	258	24	changes	change	NNS
cord-023095-4dannjjm	258	25	may	may	MD
cord-023095-4dannjjm	258	26	help	help	VB
cord-023095-4dannjjm	258	27	us	-PRON-	PRP
cord-023095-4dannjjm	258	28	manage	manage	VB
cord-023095-4dannjjm	258	29	or	or	CC
cord-023095-4dannjjm	258	30	predict	predict	VB
cord-023095-4dannjjm	258	31	CHF	CHF	NNP
cord-023095-4dannjjm	258	32	in	in	IN
cord-023095-4dannjjm	258	33	the	the	DT
cord-023095-4dannjjm	258	34	cat	cat	NN
cord-023095-4dannjjm	258	35	.	.	.
cord-023095-4dannjjm	259	1	We	-PRON-	PRP
cord-023095-4dannjjm	259	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	259	3	that	that	IN
cord-023095-4dannjjm	259	4	cats	cat	NNS
cord-023095-4dannjjm	259	5	manifesting	manifest	VBG
cord-023095-4dannjjm	259	6	R	R	NNP
cord-023095-4dannjjm	259	7	-	-	HYPH
cord-023095-4dannjjm	259	8	CHF	CHF	NNP
cord-023095-4dannjjm	259	9	have	have	VB
cord-023095-4dannjjm	259	10	LA	LA	NNP
cord-023095-4dannjjm	259	11	failure	failure	NN
cord-023095-4dannjjm	259	12	with	with	IN
cord-023095-4dannjjm	259	13	the	the	DT
cord-023095-4dannjjm	259	14	LA	LA	NNP
cord-023095-4dannjjm	259	15	acting	act	VBG
cord-023095-4dannjjm	259	16	primarily	primarily	RB
cord-023095-4dannjjm	259	17	as	as	IN
cord-023095-4dannjjm	259	18	a	a	DT
cord-023095-4dannjjm	259	19	conduit	conduit	NN
cord-023095-4dannjjm	259	20	,	,	,
cord-023095-4dannjjm	259	21	resulting	result	VBG
cord-023095-4dannjjm	259	22	in	in	IN
cord-023095-4dannjjm	259	23	greater	great	JJR
cord-023095-4dannjjm	259	24	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	259	25	hypertension	hypertension	NN
cord-023095-4dannjjm	259	26	,	,	,
cord-023095-4dannjjm	259	27	whereas	whereas	IN
cord-023095-4dannjjm	259	28	L	L	NNP
cord-023095-4dannjjm	259	29	-	-	HYPH
cord-023095-4dannjjm	259	30	CHF	CHF	NNP
cord-023095-4dannjjm	259	31	cats	cat	NNS
cord-023095-4dannjjm	259	32	maintain	maintain	VBP
cord-023095-4dannjjm	259	33	some	some	DT
cord-023095-4dannjjm	259	34	booster	booster	NN
cord-023095-4dannjjm	259	35	pump	pump	NN
cord-023095-4dannjjm	259	36	and	and	CC
cord-023095-4dannjjm	259	37	reservoir	reservoir	NN
cord-023095-4dannjjm	259	38	function	function	NN
cord-023095-4dannjjm	259	39	.	.	.
cord-023095-4dannjjm	260	1	We	-PRON-	PRP
cord-023095-4dannjjm	260	2	measured	measure	VBD
cord-023095-4dannjjm	260	3	LA	LA	NNP
cord-023095-4dannjjm	260	4	maximum	maximum	NN
cord-023095-4dannjjm	260	5	and	and	CC
cord-023095-4dannjjm	260	6	minimum	minimum	JJ
cord-023095-4dannjjm	260	7	areas	area	NNS
cord-023095-4dannjjm	260	8	from	from	IN
cord-023095-4dannjjm	260	9	right	right	JJ
cord-023095-4dannjjm	260	10	parasternal	parasternal	JJ
cord-023095-4dannjjm	260	11	long	long	JJ
cord-023095-4dannjjm	260	12	axis	axis	NN
cord-023095-4dannjjm	260	13	four	four	CD
cord-023095-4dannjjm	260	14	-	-	HYPH
cord-023095-4dannjjm	260	15	chamber	chamber	NN
cord-023095-4dannjjm	260	16	views	view	NNS
cord-023095-4dannjjm	260	17	on	on	IN
cord-023095-4dannjjm	260	18	2D	2D	NNP
cord-023095-4dannjjm	260	19	echo	echo	NN
cord-023095-4dannjjm	260	20	,	,	,
cord-023095-4dannjjm	260	21	and	and	CC
cord-023095-4dannjjm	260	22	LA	LA	NNP
cord-023095-4dannjjm	260	23	M	M	NNP
cord-023095-4dannjjm	260	24	-	-	HYPH
cord-023095-4dannjjm	260	25	mode	mode	NN
cord-023095-4dannjjm	260	26	dimensions	dimension	NNS
cord-023095-4dannjjm	260	27	at	at	IN
cord-023095-4dannjjm	260	28	maximum	maximum	JJ
cord-023095-4dannjjm	260	29	,	,	,
cord-023095-4dannjjm	260	30	minimum	minimum	NN
cord-023095-4dannjjm	260	31	,	,	,
cord-023095-4dannjjm	260	32	and	and	CC
cord-023095-4dannjjm	260	33	beginning	beginning	NN
cord-023095-4dannjjm	260	34	of	of	IN
cord-023095-4dannjjm	260	35	atrial	atrial	JJ
cord-023095-4dannjjm	260	36	contraction	contraction	NN
cord-023095-4dannjjm	260	37	.	.	.
cord-023095-4dannjjm	261	1	LA	LA	NNP
cord-023095-4dannjjm	261	2	area	area	NN
cord-023095-4dannjjm	261	3	change	change	NN
cord-023095-4dannjjm	261	4	,	,	,
cord-023095-4dannjjm	261	5	fractional	fractional	JJ
cord-023095-4dannjjm	261	6	shortening	shortening	NN
cord-023095-4dannjjm	261	7	,	,	,
cord-023095-4dannjjm	261	8	active	active	JJ
cord-023095-4dannjjm	261	9	emptying	emptying	NN
cord-023095-4dannjjm	261	10	fraction	fraction	NN
cord-023095-4dannjjm	261	11	,	,	,
cord-023095-4dannjjm	261	12	and	and	CC
cord-023095-4dannjjm	261	13	expansion	expansion	NN
cord-023095-4dannjjm	261	14	index	index	NN
cord-023095-4dannjjm	261	15	were	be	VBD
cord-023095-4dannjjm	261	16	calculated	calculate	VBN
cord-023095-4dannjjm	261	17	from	from	IN
cord-023095-4dannjjm	261	18	these	these	DT
cord-023095-4dannjjm	261	19	measurements	measurement	NNS
cord-023095-4dannjjm	261	20	.	.	.
cord-023095-4dannjjm	262	1	Right	right	JJ
cord-023095-4dannjjm	262	2	ventricular	ventricular	JJ
cord-023095-4dannjjm	262	3	internal	internal	JJ
cord-023095-4dannjjm	262	4	diastolic	diastolic	JJ
cord-023095-4dannjjm	262	5	diameter	diameter	NN
cord-023095-4dannjjm	262	6	was	be	VBD
cord-023095-4dannjjm	262	7	also	also	RB
cord-023095-4dannjjm	262	8	measured	measure	VBN
cord-023095-4dannjjm	262	9	on	on	IN
cord-023095-4dannjjm	262	10	M	M	NNP
cord-023095-4dannjjm	262	11	-	-	HYPH
cord-023095-4dannjjm	262	12	mode	mode	NN
cord-023095-4dannjjm	262	13	views	view	NNS
cord-023095-4dannjjm	262	14	.	.	.
cord-023095-4dannjjm	263	1	Preliminary	preliminary	JJ
cord-023095-4dannjjm	263	2	data	datum	NNS
cord-023095-4dannjjm	263	3	revealed	reveal	VBD
cord-023095-4dannjjm	263	4	that	that	IN
cord-023095-4dannjjm	263	5	maximum	maximum	JJ
cord-023095-4dannjjm	263	6	left	left	JJ
cord-023095-4dannjjm	263	7	atrial	atrial	JJ
cord-023095-4dannjjm	263	8	size	size	NN
cord-023095-4dannjjm	263	9	is	be	VBZ
cord-023095-4dannjjm	263	10	not	not	RB
cord-023095-4dannjjm	263	11	significantly	significantly	RB
cord-023095-4dannjjm	263	12	different	different	JJ
cord-023095-4dannjjm	263	13	between	between	IN
cord-023095-4dannjjm	263	14	R	R	NNP
cord-023095-4dannjjm	263	15	-	-	HYPH
cord-023095-4dannjjm	263	16	CHF	CHF	NNP
cord-023095-4dannjjm	263	17	and	and	CC
cord-023095-4dannjjm	263	18	L	L	NNP
cord-023095-4dannjjm	263	19	-	-	HYPH
cord-023095-4dannjjm	263	20	CHF	CHF	NNP
cord-023095-4dannjjm	263	21	cats	cat	NNS
cord-023095-4dannjjm	263	22	on	on	IN
cord-023095-4dannjjm	263	23	2D	2d	CD
cord-023095-4dannjjm	263	24	or	or	CC
cord-023095-4dannjjm	263	25	M	M	NNP
cord-023095-4dannjjm	263	26	-	-	HYPH
cord-023095-4dannjjm	263	27	mode	mode	NN
cord-023095-4dannjjm	263	28	measurements	measurement	NNS
cord-023095-4dannjjm	263	29	due	due	IN
cord-023095-4dannjjm	263	30	to	to	IN
cord-023095-4dannjjm	263	31	high	high	JJ
cord-023095-4dannjjm	263	32	variability	variability	NN
cord-023095-4dannjjm	263	33	.	.	.
cord-023095-4dannjjm	264	1	However	however	RB
cord-023095-4dannjjm	264	2	,	,	,
cord-023095-4dannjjm	264	3	total	total	JJ
cord-023095-4dannjjm	264	4	left	left	JJ
cord-023095-4dannjjm	264	5	atrial	atrial	JJ
cord-023095-4dannjjm	264	6	fractional	fractional	JJ
cord-023095-4dannjjm	264	7	shortening	shortening	NN
cord-023095-4dannjjm	264	8	is	be	VBZ
cord-023095-4dannjjm	264	9	significantly	significantly	RB
cord-023095-4dannjjm	264	10	reduced	reduce	VBN
cord-023095-4dannjjm	264	11	in	in	IN
cord-023095-4dannjjm	264	12	R	R	NNP
cord-023095-4dannjjm	264	13	-	-	HYPH
cord-023095-4dannjjm	264	14	CHF	CHF	NNP
cord-023095-4dannjjm	264	15	cats	cat	NNS
cord-023095-4dannjjm	264	16	(	(	-LRB-
cord-023095-4dannjjm	264	17	11.32	11.32	CD
cord-023095-4dannjjm	264	18	%	%	NN
cord-023095-4dannjjm	264	19	AE	AE	NNP
cord-023095-4dannjjm	264	20	4.9	4.9	CD
cord-023095-4dannjjm	264	21	)	)	-RRB-
cord-023095-4dannjjm	264	22	compared	compare	VBN
cord-023095-4dannjjm	264	23	to	to	IN
cord-023095-4dannjjm	264	24	L	L	NNP
cord-023095-4dannjjm	264	25	-	-	HYPH
cord-023095-4dannjjm	264	26	CHF	CHF	NNP
cord-023095-4dannjjm	264	27	cats	cat	NNS
cord-023095-4dannjjm	264	28	(	(	-LRB-
cord-023095-4dannjjm	264	29	19.7	19.7	CD
cord-023095-4dannjjm	264	30	%	%	NN
cord-023095-4dannjjm	264	31	AE	AE	NNP
cord-023095-4dannjjm	264	32	5.1)(p	5.1)(p	CD
cord-023095-4dannjjm	264	33	5	5	CD
cord-023095-4dannjjm	264	34	0.001	0.001	CD
cord-023095-4dannjjm	264	35	)	)	-RRB-
cord-023095-4dannjjm	264	36	,	,	,
cord-023095-4dannjjm	264	37	and	and	CC
cord-023095-4dannjjm	264	38	R	R	NNP
cord-023095-4dannjjm	264	39	-	-	HYPH
cord-023095-4dannjjm	264	40	CHF	CHF	NNP
cord-023095-4dannjjm	264	41	cats	cat	NNS
cord-023095-4dannjjm	264	42	have	have	VBP
cord-023095-4dannjjm	264	43	reduced	reduce	VBN
cord-023095-4dannjjm	264	44	left	leave	VBN
cord-023095-4dannjjm	264	45	atrial	atrial	JJ
cord-023095-4dannjjm	264	46	active	active	JJ
cord-023095-4dannjjm	264	47	emptying	empty	VBG
cord-023095-4dannjjm	264	48	fraction	fraction	NN
cord-023095-4dannjjm	264	49	(	(	-LRB-
cord-023095-4dannjjm	264	50	6.12	6.12	CD
cord-023095-4dannjjm	264	51	%	%	NN
cord-023095-4dannjjm	264	52	AE	AE	NNP
cord-023095-4dannjjm	264	53	3.5	3.5	CD
cord-023095-4dannjjm	264	54	)	)	-RRB-
cord-023095-4dannjjm	264	55	as	as	IN
cord-023095-4dannjjm	264	56	compared	compare	VBN
cord-023095-4dannjjm	264	57	to	to	IN
cord-023095-4dannjjm	264	58	L	L	NNP
cord-023095-4dannjjm	264	59	-	-	HYPH
cord-023095-4dannjjm	264	60	CHF	CHF	NNP
cord-023095-4dannjjm	264	61	cats	cat	NNS
cord-023095-4dannjjm	264	62	(	(	-LRB-
cord-023095-4dannjjm	264	63	13.7	13.7	CD
cord-023095-4dannjjm	264	64	%	%	NN
cord-023095-4dannjjm	264	65	AE	AE	NNP
cord-023095-4dannjjm	264	66	3)(p	3)(p	CD
cord-023095-4dannjjm	264	67	o	o	NN
cord-023095-4dannjjm	264	68	0.001	0.001	CD
cord-023095-4dannjjm	264	69	)	)	-RRB-
cord-023095-4dannjjm	264	70	.	.	.
cord-023095-4dannjjm	265	1	Left	leave	VBN
cord-023095-4dannjjm	265	2	atrial	atrial	JJ
cord-023095-4dannjjm	265	3	expansion	expansion	NN
cord-023095-4dannjjm	265	4	ability	ability	NN
cord-023095-4dannjjm	265	5	is	be	VBZ
cord-023095-4dannjjm	265	6	poorer	poor	JJR
cord-023095-4dannjjm	265	7	in	in	IN
cord-023095-4dannjjm	265	8	R	R	NNP
cord-023095-4dannjjm	265	9	-	-	HYPH
cord-023095-4dannjjm	265	10	CHF	CHF	NNP
cord-023095-4dannjjm	265	11	cats	cat	NNS
cord-023095-4dannjjm	265	12	(	(	-LRB-
cord-023095-4dannjjm	265	13	13.11	13.11	CD
cord-023095-4dannjjm	265	14	%	%	NN
cord-023095-4dannjjm	265	15	AE	AE	NNP
cord-023095-4dannjjm	265	16	6.7	6.7	CD
cord-023095-4dannjjm	265	17	)	)	-RRB-
cord-023095-4dannjjm	265	18	than	than	IN
cord-023095-4dannjjm	265	19	in	in	IN
cord-023095-4dannjjm	265	20	L	L	NNP
cord-023095-4dannjjm	265	21	-	-	HYPH
cord-023095-4dannjjm	265	22	CHF	CHF	NNP
cord-023095-4dannjjm	265	23	cats	cat	NNS
cord-023095-4dannjjm	265	24	(	(	-LRB-
cord-023095-4dannjjm	265	25	25.0	25.0	CD
cord-023095-4dannjjm	265	26	%	%	NN
cord-023095-4dannjjm	265	27	AE	AE	NNP
cord-023095-4dannjjm	265	28	8)(p	8)(p	CD
cord-023095-4dannjjm	265	29	5	5	CD
cord-023095-4dannjjm	265	30	0.002	0.002	CD
cord-023095-4dannjjm	265	31	)	)	-RRB-
cord-023095-4dannjjm	265	32	.	.	.
cord-023095-4dannjjm	266	1	These	these	DT
cord-023095-4dannjjm	266	2	findings	finding	NNS
cord-023095-4dannjjm	266	3	may	may	MD
cord-023095-4dannjjm	266	4	suggest	suggest	VB
cord-023095-4dannjjm	266	5	that	that	IN
cord-023095-4dannjjm	266	6	atrial	atrial	JJ
cord-023095-4dannjjm	266	7	stiffness	stiffness	NN
cord-023095-4dannjjm	266	8	and	and	CC
cord-023095-4dannjjm	266	9	poorer	poor	JJR
cord-023095-4dannjjm	266	10	atrial	atrial	JJ
cord-023095-4dannjjm	266	11	function	function	NN
cord-023095-4dannjjm	266	12	is	be	VBZ
cord-023095-4dannjjm	266	13	associated	associate	VBN
cord-023095-4dannjjm	266	14	with	with	IN
cord-023095-4dannjjm	266	15	a	a	DT
cord-023095-4dannjjm	266	16	greater	great	JJR
cord-023095-4dannjjm	266	17	degree	degree	NN
cord-023095-4dannjjm	266	18	of	of	IN
cord-023095-4dannjjm	266	19	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	266	20	venous	venous	NN
cord-023095-4dannjjm	266	21	and	and	CC
cord-023095-4dannjjm	266	22	thus	thus	RB
cord-023095-4dannjjm	266	23	secondary	secondary	JJ
cord-023095-4dannjjm	266	24	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	266	25	arterial	arterial	JJ
cord-023095-4dannjjm	266	26	hypertension	hypertension	NN
cord-023095-4dannjjm	266	27	resulting	result	VBG
cord-023095-4dannjjm	266	28	in	in	IN
cord-023095-4dannjjm	266	29	pleural	pleural	JJ
cord-023095-4dannjjm	266	30	effusion	effusion	NN
cord-023095-4dannjjm	266	31	(	(	-LRB-
cord-023095-4dannjjm	266	32	R	R	NNP
cord-023095-4dannjjm	266	33	-	-	HYPH
cord-023095-4dannjjm	266	34	CHF	CHF	NNP
cord-023095-4dannjjm	266	35	)	)	-RRB-
cord-023095-4dannjjm	266	36	.	.	.
cord-023095-4dannjjm	267	1	Right	right	JJ
cord-023095-4dannjjm	267	2	ventricular	ventricular	JJ
cord-023095-4dannjjm	267	3	diameter	diameter	NN
cord-023095-4dannjjm	267	4	on	on	IN
cord-023095-4dannjjm	267	5	M	M	NNP
cord-023095-4dannjjm	267	6	-	-	HYPH
cord-023095-4dannjjm	267	7	mode	mode	NN
cord-023095-4dannjjm	267	8	was	be	VBD
cord-023095-4dannjjm	267	9	increased	increase	VBN
cord-023095-4dannjjm	267	10	in	in	IN
cord-023095-4dannjjm	267	11	R	R	NNP
cord-023095-4dannjjm	267	12	-	-	HYPH
cord-023095-4dannjjm	267	13	CHF	CHF	NNP
cord-023095-4dannjjm	267	14	cats	cat	NNS
cord-023095-4dannjjm	267	15	(	(	-LRB-
cord-023095-4dannjjm	267	16	4.8	4.8	CD
cord-023095-4dannjjm	267	17	mm	mm	NN
cord-023095-4dannjjm	267	18	AE	AE	NNP
cord-023095-4dannjjm	267	19	2.1	2.1	CD
cord-023095-4dannjjm	267	20	)	)	-RRB-
cord-023095-4dannjjm	267	21	when	when	WRB
cord-023095-4dannjjm	267	22	compared	compare	VBN
cord-023095-4dannjjm	267	23	to	to	IN
cord-023095-4dannjjm	267	24	L	L	NNP
cord-023095-4dannjjm	267	25	-	-	HYPH
cord-023095-4dannjjm	267	26	CHF	CHF	NNP
cord-023095-4dannjjm	267	27	cats	cat	NNS
cord-023095-4dannjjm	267	28	(	(	-LRB-
cord-023095-4dannjjm	267	29	2.89	2.89	CD
cord-023095-4dannjjm	267	30	mm	mm	NN
cord-023095-4dannjjm	267	31	AE	AE	NNP
cord-023095-4dannjjm	267	32	0.8)(p	0.8)(p	CD
cord-023095-4dannjjm	267	33	5	5	CD
cord-023095-4dannjjm	267	34	0.002	0.002	CD
cord-023095-4dannjjm	267	35	)	)	-RRB-
cord-023095-4dannjjm	267	36	and	and	CC
cord-023095-4dannjjm	267	37	normal	normal	JJ
cord-023095-4dannjjm	267	38	cats	cat	NNS
cord-023095-4dannjjm	267	39	(	(	-LRB-
cord-023095-4dannjjm	267	40	2.74	2.74	CD
cord-023095-4dannjjm	267	41	mm	mm	NNS
cord-023095-4dannjjm	267	42	AE	AE	NNP
cord-023095-4dannjjm	267	43	0.8)(p	0.8)(p	CD
cord-023095-4dannjjm	267	44	5	5	CD
cord-023095-4dannjjm	267	45	0.002	0.002	CD
cord-023095-4dannjjm	267	46	)	)	-RRB-
cord-023095-4dannjjm	267	47	,	,	,
cord-023095-4dannjjm	267	48	which	which	WDT
cord-023095-4dannjjm	267	49	may	may	MD
cord-023095-4dannjjm	267	50	also	also	RB
cord-023095-4dannjjm	267	51	be	be	VB
cord-023095-4dannjjm	267	52	evidence	evidence	NN
cord-023095-4dannjjm	267	53	for	for	IN
cord-023095-4dannjjm	267	54	a	a	DT
cord-023095-4dannjjm	267	55	greater	great	JJR
cord-023095-4dannjjm	267	56	degree	degree	NN
cord-023095-4dannjjm	267	57	of	of	IN
cord-023095-4dannjjm	267	58	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	267	59	arterial	arterial	JJ
cord-023095-4dannjjm	267	60	hypertension	hypertension	NN
cord-023095-4dannjjm	267	61	in	in	IN
cord-023095-4dannjjm	267	62	these	these	DT
cord-023095-4dannjjm	267	63	cats	cat	NNS
cord-023095-4dannjjm	267	64	.	.	.
cord-023095-4dannjjm	268	1	Episodic	episodic	JJ
cord-023095-4dannjjm	268	2	weakness	weakness	NN
cord-023095-4dannjjm	268	3	and	and	CC
cord-023095-4dannjjm	268	4	syncope	syncope	NN
cord-023095-4dannjjm	268	5	are	be	VBP
cord-023095-4dannjjm	268	6	common	common	JJ
cord-023095-4dannjjm	268	7	in	in	IN
cord-023095-4dannjjm	268	8	Boxer	Boxer	NNP
cord-023095-4dannjjm	268	9	dogs	dog	NNS
cord-023095-4dannjjm	268	10	.	.	.
cord-023095-4dannjjm	269	1	Reported	report	VBN
cord-023095-4dannjjm	269	2	causes	cause	NNS
cord-023095-4dannjjm	269	3	include	include	VBP
cord-023095-4dannjjm	269	4	rapid	rapid	JJ
cord-023095-4dannjjm	269	5	ventricular	ventricular	JJ
cord-023095-4dannjjm	269	6	tachycardia	tachycardia	NN
cord-023095-4dannjjm	269	7	(	(	-LRB-
cord-023095-4dannjjm	269	8	VT	VT	NNP
cord-023095-4dannjjm	269	9	)	)	-RRB-
cord-023095-4dannjjm	269	10	and	and	CC
cord-023095-4dannjjm	269	11	exertion	exertion	NN
cord-023095-4dannjjm	269	12	-	-	HYPH
cord-023095-4dannjjm	269	13	excitement	excitement	NN
cord-023095-4dannjjm	269	14	triggered	trigger	VBD
cord-023095-4dannjjm	269	15	neurally	neurally	RB
cord-023095-4dannjjm	269	16	-	-	HYPH
cord-023095-4dannjjm	269	17	mediated	mediate	VBN
cord-023095-4dannjjm	269	18	bradycardia	bradycardia	NN
cord-023095-4dannjjm	269	19	(	(	-LRB-
cord-023095-4dannjjm	269	20	NMB	NMB	NNP
cord-023095-4dannjjm	269	21	)	)	-RRB-
cord-023095-4dannjjm	270	1	.The	.The	.
cord-023095-4dannjjm	271	1	purpose	purpose	NN
cord-023095-4dannjjm	271	2	of	of	IN
cord-023095-4dannjjm	271	3	this	this	DT
cord-023095-4dannjjm	271	4	retrospective	retrospective	JJ
cord-023095-4dannjjm	271	5	study	study	NN
cord-023095-4dannjjm	271	6	is	be	VBZ
cord-023095-4dannjjm	271	7	to	to	TO
cord-023095-4dannjjm	271	8	describe	describe	VB
cord-023095-4dannjjm	271	9	the	the	DT
cord-023095-4dannjjm	271	10	features	feature	NNS
cord-023095-4dannjjm	271	11	of	of	IN
cord-023095-4dannjjm	271	12	presumed	presume	VBN
cord-023095-4dannjjm	271	13	NMB	NMB	NNP
cord-023095-4dannjjm	271	14	in	in	IN
cord-023095-4dannjjm	271	15	Boxers	Boxers	NNPS
cord-023095-4dannjjm	271	16	.	.	.
cord-023095-4dannjjm	272	1	To	to	TO
cord-023095-4dannjjm	272	2	be	be	VB
cord-023095-4dannjjm	272	3	included	include	VBN
cord-023095-4dannjjm	272	4	in	in	IN
cord-023095-4dannjjm	272	5	the	the	DT
cord-023095-4dannjjm	272	6	study	study	NN
cord-023095-4dannjjm	272	7	,	,	,
cord-023095-4dannjjm	272	8	each	each	DT
cord-023095-4dannjjm	272	9	dog	dog	NN
cord-023095-4dannjjm	272	10	must	must	MD
cord-023095-4dannjjm	272	11	have	have	VB
cord-023095-4dannjjm	272	12	been	be	VBN
cord-023095-4dannjjm	272	13	overtly	overtly	RB
cord-023095-4dannjjm	272	14	healthy	healthy	JJ
cord-023095-4dannjjm	272	15	with	with	IN
cord-023095-4dannjjm	272	16	a	a	DT
cord-023095-4dannjjm	272	17	history	history	NN
cord-023095-4dannjjm	272	18	of	of	IN
cord-023095-4dannjjm	272	19	exertion	exertion	NN
cord-023095-4dannjjm	272	20	-	-	HYPH
cord-023095-4dannjjm	272	21	excitement	excitement	NN
cord-023095-4dannjjm	272	22	triggered	trigger	VBD
cord-023095-4dannjjm	272	23	syncope	syncope	NN
cord-023095-4dannjjm	272	24	or	or	CC
cord-023095-4dannjjm	272	25	presyncope	presyncope	NN
cord-023095-4dannjjm	272	26	;	;	,
cord-023095-4dannjjm	272	27	had	have	VBD
cord-023095-4dannjjm	272	28	a	a	DT
cord-023095-4dannjjm	272	29	normal	normal	JJ
cord-023095-4dannjjm	272	30	echocardiogram	echocardiogram	NN
cord-023095-4dannjjm	272	31	(	(	-LRB-
cord-023095-4dannjjm	272	32	EC	EC	NNP
cord-023095-4dannjjm	272	33	)	)	-RRB-
cord-023095-4dannjjm	272	34	;	;	,
cord-023095-4dannjjm	272	35	had	have	VBD
cord-023095-4dannjjm	272	36	absence	absence	NN
cord-023095-4dannjjm	272	37	of	of	IN
cord-023095-4dannjjm	272	38	VT	VT	NNP
cord-023095-4dannjjm	272	39	and	and	CC
cord-023095-4dannjjm	272	40	fewer	few	JJR
cord-023095-4dannjjm	272	41	than	than	IN
cord-023095-4dannjjm	272	42	500	500	CD
cord-023095-4dannjjm	272	43	ventricular	ventricular	JJ
cord-023095-4dannjjm	272	44	premature	premature	JJ
cord-023095-4dannjjm	272	45	complexes	complex	NNS
cord-023095-4dannjjm	272	46	(	(	-LRB-
cord-023095-4dannjjm	272	47	VPC	VPC	NNP
cord-023095-4dannjjm	272	48	)	)	-RRB-
cord-023095-4dannjjm	272	49	on	on	IN
cord-023095-4dannjjm	272	50	an	an	DT
cord-023095-4dannjjm	272	51	initial	initial	JJ
cord-023095-4dannjjm	272	52	and	and	CC
cord-023095-4dannjjm	272	53	subsequent	subsequent	JJ
cord-023095-4dannjjm	272	54	24	24	CD
cord-023095-4dannjjm	272	55	hour	hour	NN
cord-023095-4dannjjm	272	56	Holter	Holter	NNP
cord-023095-4dannjjm	272	57	recordings	recording	NNS
cord-023095-4dannjjm	272	58	;	;	:
cord-023095-4dannjjm	272	59	and	and	CC
cord-023095-4dannjjm	272	60	been	be	VBN
cord-023095-4dannjjm	272	61	alive	alive	JJ
cord-023095-4dannjjm	272	62	and	and	CC
cord-023095-4dannjjm	272	63	overtly	overtly	RB
cord-023095-4dannjjm	272	64	healthy	healthy	JJ
cord-023095-4dannjjm	272	65	for	for	IN
cord-023095-4dannjjm	272	66	at	at	RB
cord-023095-4dannjjm	272	67	least	least	JJS
cord-023095-4dannjjm	272	68	six	six	CD
cord-023095-4dannjjm	272	69	months	month	NNS
cord-023095-4dannjjm	272	70	following	follow	VBG
cord-023095-4dannjjm	272	71	the	the	DT
cord-023095-4dannjjm	272	72	initial	initial	JJ
cord-023095-4dannjjm	272	73	evaluation	evaluation	NN
cord-023095-4dannjjm	272	74	.	.	.
cord-023095-4dannjjm	273	1	A	a	DT
cord-023095-4dannjjm	273	2	total	total	NN
cord-023095-4dannjjm	273	3	of	of	IN
cord-023095-4dannjjm	273	4	27	27	CD
cord-023095-4dannjjm	273	5	Boxers	Boxers	NNPS
cord-023095-4dannjjm	273	6	were	be	VBD
cord-023095-4dannjjm	273	7	identified	identify	VBN
cord-023095-4dannjjm	273	8	.	.	.
cord-023095-4dannjjm	274	1	Sixteen	sixteen	CD
cord-023095-4dannjjm	274	2	were	be	VBD
cord-023095-4dannjjm	274	3	male	male	JJ
cord-023095-4dannjjm	274	4	and	and	CC
cord-023095-4dannjjm	274	5	11	11	CD
cord-023095-4dannjjm	274	6	were	be	VBD
cord-023095-4dannjjm	274	7	female	female	JJ
cord-023095-4dannjjm	274	8	.	.	.
cord-023095-4dannjjm	275	1	Most	Most	JJS
cord-023095-4dannjjm	275	2	(	(	-LRB-
cord-023095-4dannjjm	275	3	90	90	CD
cord-023095-4dannjjm	275	4	%	%	NN
cord-023095-4dannjjm	275	5	)	)	-RRB-
cord-023095-4dannjjm	276	1	dogs	dog	NNS
cord-023095-4dannjjm	276	2	were	be	VBD
cord-023095-4dannjjm	276	3	either	either	CC
cord-023095-4dannjjm	276	4	less	less	JJR
cord-023095-4dannjjm	276	5	than	than	IN
cord-023095-4dannjjm	276	6	4	4	CD
cord-023095-4dannjjm	276	7	or	or	CC
cord-023095-4dannjjm	276	8	more	more	JJR
cord-023095-4dannjjm	276	9	than	than	IN
cord-023095-4dannjjm	276	10	7	7	CD
cord-023095-4dannjjm	276	11	years	year	NNS
cord-023095-4dannjjm	276	12	of	of	IN
cord-023095-4dannjjm	276	13	age	age	NN
cord-023095-4dannjjm	276	14	.	.	.
cord-023095-4dannjjm	277	1	Most	Most	JJS
cord-023095-4dannjjm	277	2	dogs	dog	NNS
cord-023095-4dannjjm	277	3	had	have	VBD
cord-023095-4dannjjm	277	4	multiple	multiple	JJ
cord-023095-4dannjjm	277	5	,	,	,
cord-023095-4dannjjm	277	6	but	but	CC
cord-023095-4dannjjm	277	7	infrequent	infrequent	JJ
cord-023095-4dannjjm	277	8	,	,	,
cord-023095-4dannjjm	277	9	episodes	episode	NNS
cord-023095-4dannjjm	277	10	and	and	CC
cord-023095-4dannjjm	277	11	heart	heart	NN
cord-023095-4dannjjm	277	12	rhythm	rhythm	NN
cord-023095-4dannjjm	277	13	was	be	VBD
cord-023095-4dannjjm	277	14	documented	document	VBN
cord-023095-4dannjjm	277	15	at	at	IN
cord-023095-4dannjjm	277	16	the	the	DT
cord-023095-4dannjjm	277	17	time	time	NN
cord-023095-4dannjjm	277	18	of	of	IN
cord-023095-4dannjjm	277	19	an	an	DT
cord-023095-4dannjjm	277	20	episode	episode	NN
cord-023095-4dannjjm	277	21	in	in	IN
cord-023095-4dannjjm	277	22	only	only	RB
cord-023095-4dannjjm	277	23	8	8	CD
cord-023095-4dannjjm	277	24	(	(	-LRB-
cord-023095-4dannjjm	277	25	30	30	CD
cord-023095-4dannjjm	277	26	%	%	NN
cord-023095-4dannjjm	277	27	)	)	-RRB-
cord-023095-4dannjjm	277	28	and	and	CC
cord-023095-4dannjjm	277	29	only	only	RB
cord-023095-4dannjjm	277	30	once	once	RB
cord-023095-4dannjjm	277	31	(	(	-LRB-
cord-023095-4dannjjm	277	32	bradycardia	bradycardia	JJ
cord-023095-4dannjjm	277	33	)	)	-RRB-
cord-023095-4dannjjm	277	34	on	on	IN
cord-023095-4dannjjm	277	35	the	the	DT
cord-023095-4dannjjm	277	36	first	first	JJ
cord-023095-4dannjjm	277	37	Holter	Holter	NNP
cord-023095-4dannjjm	277	38	recording	recording	NN
cord-023095-4dannjjm	277	39	.	.	.
cord-023095-4dannjjm	278	1	Owners	owner	NNS
cord-023095-4dannjjm	278	2	were	be	VBD
cord-023095-4dannjjm	278	3	instructed	instruct	VBN
cord-023095-4dannjjm	278	4	to	to	TO
cord-023095-4dannjjm	278	5	attempt	attempt	VB
cord-023095-4dannjjm	278	6	to	to	TO
cord-023095-4dannjjm	278	7	precipitate	precipitate	VB
cord-023095-4dannjjm	278	8	episodes	episode	NNS
cord-023095-4dannjjm	278	9	.	.	.
cord-023095-4dannjjm	279	1	Bradycardia	bradycardia	JJ
cord-023095-4dannjjm	279	2	related	related	JJ
cord-023095-4dannjjm	279	3	episodes	episode	NNS
cord-023095-4dannjjm	279	4	were	be	VBD
cord-023095-4dannjjm	279	5	subsequently	subsequently	RB
cord-023095-4dannjjm	279	6	recorded	record	VBN
cord-023095-4dannjjm	279	7	in	in	IN
cord-023095-4dannjjm	279	8	5	5	CD
cord-023095-4dannjjm	279	9	:	:	:
cord-023095-4dannjjm	279	10	during	during	IN
cord-023095-4dannjjm	279	11	the	the	DT
cord-023095-4dannjjm	279	12	2nd	2nd	JJ
cord-023095-4dannjjm	279	13	(	(	-LRB-
cord-023095-4dannjjm	279	14	1	1	CD
cord-023095-4dannjjm	279	15	)	)	-RRB-
cord-023095-4dannjjm	279	16	,	,	,
cord-023095-4dannjjm	279	17	3rd	3rd	NN
cord-023095-4dannjjm	279	18	(	(	-LRB-
cord-023095-4dannjjm	279	19	2	2	CD
cord-023095-4dannjjm	279	20	)	)	-RRB-
cord-023095-4dannjjm	279	21	or	or	CC
cord-023095-4dannjjm	279	22	4th	4th	JJ
cord-023095-4dannjjm	279	23	(	(	-LRB-
cord-023095-4dannjjm	279	24	1	1	CD
cord-023095-4dannjjm	279	25	)	)	-RRB-
cord-023095-4dannjjm	279	26	day	day	NN
cord-023095-4dannjjm	279	27	of	of	IN
cord-023095-4dannjjm	279	28	120	120	CD
cord-023095-4dannjjm	279	29	hour	hour	NN
cord-023095-4dannjjm	279	30	Holter	Holter	NNP
cord-023095-4dannjjm	279	31	recordings	recording	NNS
cord-023095-4dannjjm	279	32	and	and	CC
cord-023095-4dannjjm	279	33	during	during	IN
cord-023095-4dannjjm	279	34	the	the	DT
cord-023095-4dannjjm	279	35	5th	5th	JJ
cord-023095-4dannjjm	279	36	day	day	NN
cord-023095-4dannjjm	279	37	of	of	IN
cord-023095-4dannjjm	279	38	an	an	DT
cord-023095-4dannjjm	279	39	event	event	NN
cord-023095-4dannjjm	279	40	recording	record	VBG
cord-023095-4dannjjm	279	41	(	(	-LRB-
cord-023095-4dannjjm	279	42	1	1	CD
cord-023095-4dannjjm	279	43	)	)	-RRB-
cord-023095-4dannjjm	279	44	.	.	.
cord-023095-4dannjjm	280	1	Collapse	collapse	VB
cord-023095-4dannjjm	280	2	and	and	CC
cord-023095-4dannjjm	280	3	bradycardia	bradycardia	NN
cord-023095-4dannjjm	280	4	were	be	VBD
cord-023095-4dannjjm	280	5	documented	document	VBN
cord-023095-4dannjjm	280	6	during	during	IN
cord-023095-4dannjjm	280	7	auscultation	auscultation	NN
cord-023095-4dannjjm	280	8	in	in	IN
cord-023095-4dannjjm	280	9	2	2	CD
cord-023095-4dannjjm	280	10	additional	additional	JJ
cord-023095-4dannjjm	280	11	dogs	dog	NNS
cord-023095-4dannjjm	280	12	.	.	.
cord-023095-4dannjjm	281	1	The	the	DT
cord-023095-4dannjjm	281	2	heart	heart	NN
cord-023095-4dannjjm	281	3	rate	rate	NN
cord-023095-4dannjjm	281	4	during	during	IN
cord-023095-4dannjjm	281	5	syncope	syncope	NN
cord-023095-4dannjjm	281	6	was	be	VBD
cord-023095-4dannjjm	281	7	never	never	RB
cord-023095-4dannjjm	281	8	documented	document	VBN
cord-023095-4dannjjm	281	9	in	in	IN
cord-023095-4dannjjm	281	10	19	19	CD
cord-023095-4dannjjm	281	11	(	(	-LRB-
cord-023095-4dannjjm	281	12	70	70	CD
cord-023095-4dannjjm	281	13	%	%	NN
cord-023095-4dannjjm	281	14	)	)	-RRB-
cord-023095-4dannjjm	281	15	dogs	dog	NNS
cord-023095-4dannjjm	281	16	.	.	.
cord-023095-4dannjjm	282	1	A	a	DT
cord-023095-4dannjjm	282	2	presumptive	presumptive	JJ
cord-023095-4dannjjm	282	3	diagnosis	diagnosis	NN
cord-023095-4dannjjm	282	4	of	of	IN
cord-023095-4dannjjm	282	5	NMB	NMB	NNP
cord-023095-4dannjjm	282	6	was	be	VBD
cord-023095-4dannjjm	282	7	based	base	VBN
cord-023095-4dannjjm	282	8	on	on	IN
cord-023095-4dannjjm	282	9	the	the	DT
cord-023095-4dannjjm	282	10	absence	absence	NN
cord-023095-4dannjjm	282	11	of	of	IN
cord-023095-4dannjjm	282	12	initial	initial	JJ
cord-023095-4dannjjm	282	13	and	and	CC
cord-023095-4dannjjm	282	14	follow	follow	NN
cord-023095-4dannjjm	282	15	-	-	HYPH
cord-023095-4dannjjm	282	16	up	up	NN
cord-023095-4dannjjm	282	17	of	of	IN
cord-023095-4dannjjm	282	18	EC	EC	NNP
cord-023095-4dannjjm	282	19	abnormalities	abnormality	NNS
cord-023095-4dannjjm	282	20	and	and	CC
cord-023095-4dannjjm	282	21	the	the	DT
cord-023095-4dannjjm	282	22	presence	presence	NN
cord-023095-4dannjjm	282	23	of	of	IN
cord-023095-4dannjjm	282	24	no	no	DT
cord-023095-4dannjjm	282	25	or	or	CC
cord-023095-4dannjjm	282	26	few	few	JJ
cord-023095-4dannjjm	282	27	VPC	VPC	NNP
cord-023095-4dannjjm	282	28	during	during	IN
cord-023095-4dannjjm	282	29	extended	extended	JJ
cord-023095-4dannjjm	282	30	ECG	ECG	NNP
cord-023095-4dannjjm	282	31	monitoring	monitoring	NN
cord-023095-4dannjjm	282	32	.	.	.
cord-023095-4dannjjm	283	1	Multiple	multiple	JJ
cord-023095-4dannjjm	283	2	Holter	Holter	NNP
cord-023095-4dannjjm	283	3	recordings	recording	NNS
cord-023095-4dannjjm	283	4	(	(	-LRB-
cord-023095-4dannjjm	283	5	48	48	CD
cord-023095-4dannjjm	283	6	-	-	SYM
cord-023095-4dannjjm	283	7	168	168	CD
cord-023095-4dannjjm	283	8	hours	hour	NNS
cord-023095-4dannjjm	283	9	)	)	-RRB-
cord-023095-4dannjjm	283	10	were	be	VBD
cord-023095-4dannjjm	283	11	performed	perform	VBN
cord-023095-4dannjjm	283	12	in	in	IN
cord-023095-4dannjjm	283	13	8	8	CD
cord-023095-4dannjjm	283	14	of	of	IN
cord-023095-4dannjjm	283	15	19	19	CD
cord-023095-4dannjjm	283	16	(	(	-LRB-
cord-023095-4dannjjm	283	17	42	42	CD
cord-023095-4dannjjm	283	18	%	%	NN
cord-023095-4dannjjm	283	19	)	)	-RRB-
cord-023095-4dannjjm	284	1	dogs	dog	NNS
cord-023095-4dannjjm	284	2	and	and	CC
cord-023095-4dannjjm	284	3	event	event	NN
cord-023095-4dannjjm	284	4	monitoring	monitoring	NN
cord-023095-4dannjjm	284	5	of	of	IN
cord-023095-4dannjjm	284	6	5	5	CD
cord-023095-4dannjjm	284	7	days	day	NNS
cord-023095-4dannjjm	284	8	(	(	-LRB-
cord-023095-4dannjjm	284	9	1	1	CD
cord-023095-4dannjjm	284	10	)	)	-RRB-
cord-023095-4dannjjm	284	11	and	and	CC
cord-023095-4dannjjm	284	12	7	7	CD
cord-023095-4dannjjm	284	13	days	day	NNS
cord-023095-4dannjjm	284	14	(	(	-LRB-
cord-023095-4dannjjm	284	15	1	1	CD
cord-023095-4dannjjm	284	16	)	)	-RRB-
cord-023095-4dannjjm	284	17	was	be	VBD
cord-023095-4dannjjm	284	18	performed	perform	VBN
cord-023095-4dannjjm	284	19	in	in	IN
cord-023095-4dannjjm	284	20	2	2	CD
cord-023095-4dannjjm	284	21	additional	additional	JJ
cord-023095-4dannjjm	284	22	dogs	dog	NNS
cord-023095-4dannjjm	284	23	.	.	.
cord-023095-4dannjjm	285	1	In	in	IN
cord-023095-4dannjjm	285	2	conclusion	conclusion	NN
cord-023095-4dannjjm	285	3	,	,	,
cord-023095-4dannjjm	285	4	documentation	documentation	NN
cord-023095-4dannjjm	285	5	of	of	IN
cord-023095-4dannjjm	285	6	the	the	DT
cord-023095-4dannjjm	285	7	heart	heart	NN
cord-023095-4dannjjm	285	8	rhythm	rhythm	NN
cord-023095-4dannjjm	285	9	during	during	IN
cord-023095-4dannjjm	285	10	episodes	episode	NNS
cord-023095-4dannjjm	285	11	of	of	IN
cord-023095-4dannjjm	285	12	collapse	collapse	NN
cord-023095-4dannjjm	285	13	was	be	VBD
cord-023095-4dannjjm	285	14	difficult	difficult	JJ
cord-023095-4dannjjm	285	15	,	,	,
cord-023095-4dannjjm	285	16	accomplished	accomplish	VBN
cord-023095-4dannjjm	285	17	in	in	IN
cord-023095-4dannjjm	285	18	only	only	RB
cord-023095-4dannjjm	285	19	30	30	CD
cord-023095-4dannjjm	285	20	%	%	NN
cord-023095-4dannjjm	285	21	and	and	CC
cord-023095-4dannjjm	285	22	was	be	VBD
cord-023095-4dannjjm	285	23	unlikely	unlikely	JJ
cord-023095-4dannjjm	285	24	during	during	IN
cord-023095-4dannjjm	285	25	the	the	DT
cord-023095-4dannjjm	285	26	first	first	JJ
cord-023095-4dannjjm	285	27	Holter	Holter	NNP
cord-023095-4dannjjm	285	28	recording	recording	NN
cord-023095-4dannjjm	285	29	.	.	.
cord-023095-4dannjjm	286	1	In	in	IN
cord-023095-4dannjjm	286	2	Boxers	boxer	NNS
cord-023095-4dannjjm	286	3	with	with	IN
cord-023095-4dannjjm	286	4	suspected	suspect	VBN
cord-023095-4dannjjm	286	5	NMB	NMB	NNP
cord-023095-4dannjjm	286	6	,	,	,
cord-023095-4dannjjm	286	7	extended	extended	JJ
cord-023095-4dannjjm	286	8	ECG	ECG	NNP
cord-023095-4dannjjm	286	9	monitoring	monitoring	NN
cord-023095-4dannjjm	286	10	and	and	CC
cord-023095-4dannjjm	286	11	implantable	implantable	JJ
cord-023095-4dannjjm	286	12	loop	loop	NN
cord-023095-4dannjjm	286	13	recorders	recorder	NNS
cord-023095-4dannjjm	286	14	may	may	MD
cord-023095-4dannjjm	286	15	be	be	VB
cord-023095-4dannjjm	286	16	best	good	JJS
cord-023095-4dannjjm	286	17	for	for	IN
cord-023095-4dannjjm	286	18	HR	hr	NN
cord-023095-4dannjjm	286	19	documentation	documentation	NN
cord-023095-4dannjjm	286	20	.	.	.
cord-023095-4dannjjm	287	1	Arrhythmogenic	Arrhythmogenic	NNP
cord-023095-4dannjjm	287	2	right	right	JJ
cord-023095-4dannjjm	287	3	ventricular	ventricular	JJ
cord-023095-4dannjjm	287	4	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	287	5	(	(	-LRB-
cord-023095-4dannjjm	287	6	ARVC	ARVC	NNP
cord-023095-4dannjjm	287	7	)	)	-RRB-
cord-023095-4dannjjm	287	8	is	be	VBZ
cord-023095-4dannjjm	287	9	an	an	DT
cord-023095-4dannjjm	287	10	inherited	inherit	VBN
cord-023095-4dannjjm	287	11	myocardial	myocardial	JJ
cord-023095-4dannjjm	287	12	disease	disease	NN
cord-023095-4dannjjm	287	13	with	with	IN
cord-023095-4dannjjm	287	14	high	high	JJ
cord-023095-4dannjjm	287	15	prevalence	prevalence	NN
cord-023095-4dannjjm	287	16	in	in	IN
cord-023095-4dannjjm	287	17	the	the	DT
cord-023095-4dannjjm	287	18	boxer	boxer	NN
cord-023095-4dannjjm	287	19	dog	dog	NN
cord-023095-4dannjjm	287	20	population	population	NN
cord-023095-4dannjjm	287	21	,	,	,
cord-023095-4dannjjm	287	22	and	and	CC
cord-023095-4dannjjm	287	23	is	be	VBZ
cord-023095-4dannjjm	287	24	associated	associate	VBN
cord-023095-4dannjjm	287	25	with	with	IN
cord-023095-4dannjjm	287	26	sustained	sustained	JJ
cord-023095-4dannjjm	287	27	monomorphic	monomorphic	JJ
cord-023095-4dannjjm	287	28	ventricular	ventricular	JJ
cord-023095-4dannjjm	287	29	tachycardia	tachycardia	NN
cord-023095-4dannjjm	287	30	,	,	,
cord-023095-4dannjjm	287	31	sudden	sudden	JJ
cord-023095-4dannjjm	287	32	cardiac	cardiac	JJ
cord-023095-4dannjjm	287	33	death	death	NN
cord-023095-4dannjjm	287	34	,	,	,
cord-023095-4dannjjm	287	35	and	and	CC
cord-023095-4dannjjm	287	36	replacement	replacement	NN
cord-023095-4dannjjm	287	37	of	of	IN
cord-023095-4dannjjm	287	38	myocardium	myocardium	NN
cord-023095-4dannjjm	287	39	with	with	IN
cord-023095-4dannjjm	287	40	fatty	fatty	JJ
cord-023095-4dannjjm	287	41	or	or	CC
cord-023095-4dannjjm	287	42	fibro	fibro	NN
cord-023095-4dannjjm	287	43	-	-	HYPH
cord-023095-4dannjjm	287	44	fatty	fatty	JJ
cord-023095-4dannjjm	287	45	tissue	tissue	NN
cord-023095-4dannjjm	287	46	.	.	.
cord-023095-4dannjjm	288	1	Though	though	IN
cord-023095-4dannjjm	288	2	several	several	JJ
cord-023095-4dannjjm	288	3	genes	gene	NNS
cord-023095-4dannjjm	288	4	have	have	VBP
cord-023095-4dannjjm	288	5	been	be	VBN
cord-023095-4dannjjm	288	6	linked	link	VBN
cord-023095-4dannjjm	288	7	to	to	IN
cord-023095-4dannjjm	288	8	the	the	DT
cord-023095-4dannjjm	288	9	disease	disease	NN
cord-023095-4dannjjm	288	10	both	both	CC
cord-023095-4dannjjm	288	11	in	in	IN
cord-023095-4dannjjm	288	12	humans	human	NNS
cord-023095-4dannjjm	288	13	and	and	CC
cord-023095-4dannjjm	288	14	in	in	IN
cord-023095-4dannjjm	288	15	boxers	boxer	NNS
cord-023095-4dannjjm	288	16	,	,	,
cord-023095-4dannjjm	288	17	the	the	DT
cord-023095-4dannjjm	288	18	etiology	etiology	NN
cord-023095-4dannjjm	288	19	of	of	IN
cord-023095-4dannjjm	288	20	ARVC	ARVC	NNP
cord-023095-4dannjjm	288	21	is	be	VBZ
cord-023095-4dannjjm	288	22	still	still	RB
cord-023095-4dannjjm	288	23	unclear	unclear	JJ
cord-023095-4dannjjm	288	24	.	.	.
cord-023095-4dannjjm	289	1	Several	several	JJ
cord-023095-4dannjjm	289	2	mechanisms	mechanism	NNS
cord-023095-4dannjjm	289	3	for	for	IN
cord-023095-4dannjjm	289	4	the	the	DT
cord-023095-4dannjjm	289	5	development	development	NN
cord-023095-4dannjjm	289	6	of	of	IN
cord-023095-4dannjjm	289	7	ARVC	ARVC	NNP
cord-023095-4dannjjm	289	8	have	have	VBP
cord-023095-4dannjjm	289	9	been	be	VBN
cord-023095-4dannjjm	289	10	suggested	suggest	VBN
cord-023095-4dannjjm	289	11	,	,	,
cord-023095-4dannjjm	289	12	including	include	VBG
cord-023095-4dannjjm	289	13	dysfunction	dysfunction	NN
cord-023095-4dannjjm	289	14	of	of	IN
cord-023095-4dannjjm	289	15	the	the	DT
cord-023095-4dannjjm	289	16	canonical	canonical	JJ
cord-023095-4dannjjm	289	17	Wnt	Wnt	NNP
cord-023095-4dannjjm	289	18	pathway	pathway	NN
cord-023095-4dannjjm	289	19	,	,	,
cord-023095-4dannjjm	289	20	which	which	WDT
cord-023095-4dannjjm	289	21	results	result	VBZ
cord-023095-4dannjjm	289	22	in	in	IN
cord-023095-4dannjjm	289	23	an	an	DT
cord-023095-4dannjjm	289	24	ARVC	ARVC	NNP
cord-023095-4dannjjm	289	25	phenotype	phenotype	NN
cord-023095-4dannjjm	289	26	in	in	IN
cord-023095-4dannjjm	289	27	the	the	DT
cord-023095-4dannjjm	289	28	mouse	mouse	NN
cord-023095-4dannjjm	289	29	.	.	.
cord-023095-4dannjjm	290	1	The	the	DT
cord-023095-4dannjjm	290	2	canonical	canonical	JJ
cord-023095-4dannjjm	290	3	Wnt	Wnt	NNP
cord-023095-4dannjjm	290	4	pathway	pathway	NN
cord-023095-4dannjjm	290	5	has	have	VBZ
cord-023095-4dannjjm	290	6	been	be	VBN
cord-023095-4dannjjm	290	7	linked	link	VBN
cord-023095-4dannjjm	290	8	to	to	IN
cord-023095-4dannjjm	290	9	many	many	JJ
cord-023095-4dannjjm	290	10	cellular	cellular	JJ
cord-023095-4dannjjm	290	11	functions	function	NNS
cord-023095-4dannjjm	290	12	,	,	,
cord-023095-4dannjjm	290	13	including	include	VBG
cord-023095-4dannjjm	290	14	growth	growth	NN
cord-023095-4dannjjm	290	15	and	and	CC
cord-023095-4dannjjm	290	16	differentiation	differentiation	NN
cord-023095-4dannjjm	290	17	of	of	IN
cord-023095-4dannjjm	290	18	adipocytes	adipocyte	NNS
cord-023095-4dannjjm	290	19	.	.	.
cord-023095-4dannjjm	291	1	With	with	IN
cord-023095-4dannjjm	291	2	the	the	DT
cord-023095-4dannjjm	291	3	recent	recent	JJ
cord-023095-4dannjjm	291	4	discovery	discovery	NN
cord-023095-4dannjjm	291	5	that	that	IN
cord-023095-4dannjjm	291	6	the	the	DT
cord-023095-4dannjjm	291	7	gene	gene	NN
cord-023095-4dannjjm	291	8	encoding	encoding	NN
cord-023095-4dannjjm	291	9	striatin	striatin	NNP
cord-023095-4dannjjm	291	10	,	,	,
cord-023095-4dannjjm	291	11	a	a	DT
cord-023095-4dannjjm	291	12	protein	protein	NN
cord-023095-4dannjjm	291	13	involved	involve	VBN
cord-023095-4dannjjm	291	14	in	in	IN
cord-023095-4dannjjm	291	15	Wnt	Wnt	NNP
cord-023095-4dannjjm	291	16	signaling	signal	VBG
cord-023095-4dannjjm	291	17	,	,	,
cord-023095-4dannjjm	291	18	may	may	MD
cord-023095-4dannjjm	291	19	be	be	VB
cord-023095-4dannjjm	291	20	involved	involve	VBN
cord-023095-4dannjjm	291	21	in	in	IN
cord-023095-4dannjjm	291	22	the	the	DT
cord-023095-4dannjjm	291	23	development	development	NN
cord-023095-4dannjjm	291	24	of	of	IN
cord-023095-4dannjjm	291	25	boxer	boxer	NN
cord-023095-4dannjjm	291	26	ARVC	ARVC	NNP
cord-023095-4dannjjm	291	27	,	,	,
cord-023095-4dannjjm	291	28	we	-PRON-	PRP
cord-023095-4dannjjm	291	29	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	291	30	that	that	IN
cord-023095-4dannjjm	291	31	changes	change	NNS
cord-023095-4dannjjm	291	32	in	in	IN
cord-023095-4dannjjm	291	33	the	the	DT
cord-023095-4dannjjm	291	34	Wnt	Wnt	NNP
cord-023095-4dannjjm	291	35	pathway	pathway	NN
cord-023095-4dannjjm	291	36	may	may	MD
cord-023095-4dannjjm	291	37	also	also	RB
cord-023095-4dannjjm	291	38	play	play	VB
cord-023095-4dannjjm	291	39	a	a	DT
cord-023095-4dannjjm	291	40	role	role	NN
cord-023095-4dannjjm	291	41	in	in	IN
cord-023095-4dannjjm	291	42	the	the	DT
cord-023095-4dannjjm	291	43	etiology	etiology	NN
cord-023095-4dannjjm	291	44	.	.	.
cord-023095-4dannjjm	292	1	Here	here	RB
cord-023095-4dannjjm	292	2	,	,	,
cord-023095-4dannjjm	292	3	we	-PRON-	PRP
cord-023095-4dannjjm	292	4	show	show	VBP
cord-023095-4dannjjm	292	5	changes	change	NNS
cord-023095-4dannjjm	292	6	in	in	IN
cord-023095-4dannjjm	292	7	the	the	DT
cord-023095-4dannjjm	292	8	localization	localization	NN
cord-023095-4dannjjm	292	9	and	and	CC
cord-023095-4dannjjm	292	10	decreased	decrease	VBN
cord-023095-4dannjjm	292	11	amount	amount	NN
cord-023095-4dannjjm	292	12	of	of	IN
cord-023095-4dannjjm	292	13	proteins	protein	NNS
cord-023095-4dannjjm	292	14	affiliated	affiliate	VBN
cord-023095-4dannjjm	292	15	with	with	IN
cord-023095-4dannjjm	292	16	the	the	DT
cord-023095-4dannjjm	292	17	canonical	canonical	JJ
cord-023095-4dannjjm	292	18	Wnt	Wnt	NNP
cord-023095-4dannjjm	292	19	pathway	pathway	NN
cord-023095-4dannjjm	292	20	.	.	.
cord-023095-4dannjjm	293	1	Afflicted	afflicted	JJ
cord-023095-4dannjjm	293	2	boxers	boxer	NNS
cord-023095-4dannjjm	293	3	were	be	VBD
cord-023095-4dannjjm	293	4	identified	identify	VBN
cord-023095-4dannjjm	293	5	by	by	IN
cord-023095-4dannjjm	293	6	24-hour	24-hour	JJ
cord-023095-4dannjjm	293	7	Holter	Holter	NNP
cord-023095-4dannjjm	293	8	monitoring	monitoring	NN
cord-023095-4dannjjm	293	9	and	and	CC
cord-023095-4dannjjm	293	10	histopathological	histopathological	JJ
cord-023095-4dannjjm	293	11	examination	examination	NN
cord-023095-4dannjjm	293	12	of	of	IN
cord-023095-4dannjjm	293	13	the	the	DT
cord-023095-4dannjjm	293	14	heart	heart	NN
cord-023095-4dannjjm	293	15	.	.	.
cord-023095-4dannjjm	294	1	Samples	sample	NNS
cord-023095-4dannjjm	294	2	from	from	IN
cord-023095-4dannjjm	294	3	the	the	DT
cord-023095-4dannjjm	294	4	right	right	JJ
cord-023095-4dannjjm	294	5	ventricle	ventricle	NN
cord-023095-4dannjjm	294	6	RV	RV	NNP
cord-023095-4dannjjm	294	7	)	)	-RRB-
cord-023095-4dannjjm	294	8	of	of	IN
cord-023095-4dannjjm	294	9	15	15	CD
cord-023095-4dannjjm	294	10	ARVC	ARVC	NNP
cord-023095-4dannjjm	294	11	afflicted	afflict	VBN
cord-023095-4dannjjm	294	12	boxers	boxer	NNS
cord-023095-4dannjjm	294	13	,	,	,
cord-023095-4dannjjm	294	14	and	and	CC
cord-023095-4dannjjm	294	15	5	5	CD
cord-023095-4dannjjm	294	16	unafflicted	unafflicted	JJ
cord-023095-4dannjjm	294	17	dogs	dog	NNS
cord-023095-4dannjjm	294	18	(	(	-LRB-
cord-023095-4dannjjm	294	19	1	1	CD
cord-023095-4dannjjm	294	20	beagle	beagle	NN
cord-023095-4dannjjm	294	21	,	,	,
cord-023095-4dannjjm	294	22	2	2	CD
cord-023095-4dannjjm	294	23	mongrels	mongrel	NNS
cord-023095-4dannjjm	294	24	,	,	,
cord-023095-4dannjjm	294	25	and	and	CC
cord-023095-4dannjjm	294	26	2	2	CD
cord-023095-4dannjjm	294	27	German	german	JJ
cord-023095-4dannjjm	294	28	shepherds	shepherd	NNS
cord-023095-4dannjjm	294	29	)	)	-RRB-
cord-023095-4dannjjm	294	30	were	be	VBD
cord-023095-4dannjjm	294	31	collected	collect	VBN
cord-023095-4dannjjm	294	32	,	,	,
cord-023095-4dannjjm	294	33	fixed	fix	VBN
cord-023095-4dannjjm	294	34	in	in	IN
cord-023095-4dannjjm	294	35	10	10	CD
cord-023095-4dannjjm	294	36	%	%	NN
cord-023095-4dannjjm	294	37	formalin	formalin	NN
cord-023095-4dannjjm	294	38	,	,	,
cord-023095-4dannjjm	294	39	processed	process	VBN
cord-023095-4dannjjm	294	40	,	,	,
cord-023095-4dannjjm	294	41	treated	treat	VBN
cord-023095-4dannjjm	294	42	with	with	IN
cord-023095-4dannjjm	294	43	antibodies	antibody	NNS
cord-023095-4dannjjm	294	44	recognizingcatenin	recognizingcatenin	NNS
cord-023095-4dannjjm	294	45	,	,	,
cord-023095-4dannjjm	294	46	striatin	striatin	NN
cord-023095-4dannjjm	294	47	,	,	,
cord-023095-4dannjjm	294	48	and	and	CC
cord-023095-4dannjjm	294	49	calnexin	calnexin	NN
cord-023095-4dannjjm	294	50	,	,	,
cord-023095-4dannjjm	294	51	and	and	CC
cord-023095-4dannjjm	294	52	examined	examine	VBD
cord-023095-4dannjjm	294	53	using	use	VBG
cord-023095-4dannjjm	294	54	confocal	confocal	JJ
cord-023095-4dannjjm	294	55	microscopy	microscopy	NNS
cord-023095-4dannjjm	294	56	.	.	.
cord-023095-4dannjjm	295	1	Western	western	JJ
cord-023095-4dannjjm	295	2	blots	blot	NNS
cord-023095-4dannjjm	295	3	were	be	VBD
cord-023095-4dannjjm	295	4	performed	perform	VBN
cord-023095-4dannjjm	295	5	on	on	IN
cord-023095-4dannjjm	295	6	3	3	CD
cord-023095-4dannjjm	295	7	unafflicted	unafflicted	JJ
cord-023095-4dannjjm	295	8	RV	rv	NN
cord-023095-4dannjjm	295	9	samples	sample	NNS
cord-023095-4dannjjm	295	10	,	,	,
cord-023095-4dannjjm	295	11	and	and	CC
cord-023095-4dannjjm	295	12	2	2	CD
cord-023095-4dannjjm	295	13	ARVC	ARVC	NNP
cord-023095-4dannjjm	295	14	afflicted	afflict	VBN
cord-023095-4dannjjm	295	15	RV	RV	NNP
cord-023095-4dannjjm	295	16	samples	sample	NNS
cord-023095-4dannjjm	295	17	.	.	.
cord-023095-4dannjjm	296	1	Frozen	frozen	JJ
cord-023095-4dannjjm	296	2	tissue	tissue	NN
cord-023095-4dannjjm	296	3	samples	sample	NNS
cord-023095-4dannjjm	296	4	were	be	VBD
cord-023095-4dannjjm	296	5	homogenized	homogenize	VBN
cord-023095-4dannjjm	296	6	in	in	IN
cord-023095-4dannjjm	296	7	Laemmli	Laemmli	NNP
cord-023095-4dannjjm	296	8	buffer	buffer	NN
cord-023095-4dannjjm	296	9	,	,	,
cord-023095-4dannjjm	296	10	and	and	CC
cord-023095-4dannjjm	296	11	10	10	CD
cord-023095-4dannjjm	296	12	mg	mg	NNS
cord-023095-4dannjjm	296	13	of	of	IN
cord-023095-4dannjjm	296	14	protein	protein	NN
cord-023095-4dannjjm	296	15	was	be	VBD
cord-023095-4dannjjm	296	16	loaded	load	VBN
cord-023095-4dannjjm	296	17	into	into	IN
cord-023095-4dannjjm	296	18	each	each	DT
cord-023095-4dannjjm	296	19	well	well	NN
cord-023095-4dannjjm	296	20	of	of	IN
cord-023095-4dannjjm	296	21	a	a	DT
cord-023095-4dannjjm	296	22	8	8	CD
cord-023095-4dannjjm	296	23	-	-	SYM
cord-023095-4dannjjm	296	24	16	16	CD
cord-023095-4dannjjm	296	25	%	%	NN
cord-023095-4dannjjm	296	26	gradient	gradient	NN
cord-023095-4dannjjm	296	27	gel	gel	NN
cord-023095-4dannjjm	296	28	.	.	.
cord-023095-4dannjjm	297	1	-catenin	-catenin	:
cord-023095-4dannjjm	297	2	,	,	,
cord-023095-4dannjjm	297	3	an	an	DT
cord-023095-4dannjjm	297	4	integral	integral	JJ
cord-023095-4dannjjm	297	5	modulator	modulator	NN
cord-023095-4dannjjm	297	6	of	of	IN
cord-023095-4dannjjm	297	7	the	the	DT
cord-023095-4dannjjm	297	8	Wnt	Wnt	NNP
cord-023095-4dannjjm	297	9	pathway	pathway	NN
cord-023095-4dannjjm	297	10	,	,	,
cord-023095-4dannjjm	297	11	and	and	CC
cord-023095-4dannjjm	297	12	striatin	striatin	NNS
cord-023095-4dannjjm	297	13	were	be	VBD
cord-023095-4dannjjm	297	14	colocalized	colocalize	VBN
cord-023095-4dannjjm	297	15	with	with	IN
cord-023095-4dannjjm	297	16	the	the	DT
cord-023095-4dannjjm	297	17	endoplasmic	endoplasmic	NN
cord-023095-4dannjjm	297	18	reticulum	reticulum	NN
cord-023095-4dannjjm	297	19	(	(	-LRB-
cord-023095-4dannjjm	297	20	ER	ER	NNP
cord-023095-4dannjjm	297	21	)	)	-RRB-
cord-023095-4dannjjm	297	22	marker	marker	NN
cord-023095-4dannjjm	297	23	,	,	,
cord-023095-4dannjjm	297	24	calnexin	calnexin	NNP
cord-023095-4dannjjm	297	25	.	.	.
cord-023095-4dannjjm	298	1	In	in	IN
cord-023095-4dannjjm	298	2	the	the	DT
cord-023095-4dannjjm	298	3	unafflicted	unafflicted	JJ
cord-023095-4dannjjm	298	4	animals	animal	NNS
cord-023095-4dannjjm	298	5	,	,	,
cord-023095-4dannjjm	298	6	-catenin	-catenin	:
cord-023095-4dannjjm	298	7	localized	localize	VBN
cord-023095-4dannjjm	298	8	at	at	IN
cord-023095-4dannjjm	298	9	sites	site	NNS
cord-023095-4dannjjm	298	10	of	of	IN
cord-023095-4dannjjm	298	11	cell	cell	NN
cord-023095-4dannjjm	298	12	-	-	HYPH
cord-023095-4dannjjm	298	13	to	to	IN
cord-023095-4dannjjm	298	14	-	-	HYPH
cord-023095-4dannjjm	298	15	cell	cell	NN
cord-023095-4dannjjm	298	16	apposition	apposition	NN
cord-023095-4dannjjm	298	17	,	,	,
cord-023095-4dannjjm	298	18	and	and	CC
cord-023095-4dannjjm	298	19	striatin	striatin	NN
cord-023095-4dannjjm	298	20	localized	localize	VBN
cord-023095-4dannjjm	298	21	in	in	IN
cord-023095-4dannjjm	298	22	a	a	DT
cord-023095-4dannjjm	298	23	diffuse	diffuse	JJ
cord-023095-4dannjjm	298	24	intracellular	intracellular	JJ
cord-023095-4dannjjm	298	25	pattern	pattern	NN
cord-023095-4dannjjm	298	26	,	,	,
cord-023095-4dannjjm	298	27	with	with	IN
cord-023095-4dannjjm	298	28	no	no	DT
cord-023095-4dannjjm	298	29	detectable	detectable	JJ
cord-023095-4dannjjm	298	30	localization	localization	NN
cord-023095-4dannjjm	298	31	in	in	IN
cord-023095-4dannjjm	298	32	the	the	DT
cord-023095-4dannjjm	298	33	ER	er	NN
cord-023095-4dannjjm	298	34	.	.	.
cord-023095-4dannjjm	299	1	In	in	IN
cord-023095-4dannjjm	299	2	contrast	contrast	NN
cord-023095-4dannjjm	299	3	,	,	,
cord-023095-4dannjjm	299	4	in	in	IN
cord-023095-4dannjjm	299	5	the	the	DT
cord-023095-4dannjjm	299	6	15	15	CD
cord-023095-4dannjjm	299	7	ARVC	ARVC	NNP
cord-023095-4dannjjm	299	8	boxers	boxer	NNS
cord-023095-4dannjjm	299	9	,	,	,
cord-023095-4dannjjm	299	10	bothcatenin	bothcatenin	NNP
cord-023095-4dannjjm	299	11	and	and	CC
cord-023095-4dannjjm	299	12	striatin	striatin	NNS
cord-023095-4dannjjm	299	13	were	be	VBD
cord-023095-4dannjjm	299	14	colocalized	colocalize	VBN
cord-023095-4dannjjm	299	15	with	with	IN
cord-023095-4dannjjm	299	16	calnexin	calnexin	NNP
cord-023095-4dannjjm	299	17	in	in	IN
cord-023095-4dannjjm	299	18	an	an	DT
cord-023095-4dannjjm	299	19	ER	ER	NNP
cord-023095-4dannjjm	299	20	pattern	pattern	NN
cord-023095-4dannjjm	299	21	.	.	.
cord-023095-4dannjjm	300	1	In	in	IN
cord-023095-4dannjjm	300	2	the	the	DT
cord-023095-4dannjjm	300	3	afflicted	afflict	VBN
cord-023095-4dannjjm	300	4	samples	sample	NNS
cord-023095-4dannjjm	300	5	,	,	,
cord-023095-4dannjjm	300	6	-catenin	-catenin	:
cord-023095-4dannjjm	300	7	and	and	CC
cord-023095-4dannjjm	300	8	striatin	striatin	NN
cord-023095-4dannjjm	300	9	were	be	VBD
cord-023095-4dannjjm	300	10	not	not	RB
cord-023095-4dannjjm	300	11	visualized	visualize	VBN
cord-023095-4dannjjm	300	12	to	to	IN
cord-023095-4dannjjm	300	13	the	the	DT
cord-023095-4dannjjm	300	14	intercalated	intercalate	VBN
cord-023095-4dannjjm	300	15	disc	disc	NN
cord-023095-4dannjjm	300	16	and	and	CC
cord-023095-4dannjjm	300	17	intracellular	intracellular	JJ
cord-023095-4dannjjm	300	18	space	space	NN
cord-023095-4dannjjm	300	19	,	,	,
cord-023095-4dannjjm	300	20	respectively	respectively	RB
cord-023095-4dannjjm	300	21	.	.	.
cord-023095-4dannjjm	301	1	Western	western	JJ
cord-023095-4dannjjm	301	2	blots	blot	NNS
cord-023095-4dannjjm	301	3	of	of	IN
cord-023095-4dannjjm	301	4	striatin	striatin	NNS
cord-023095-4dannjjm	301	5	and	and	CC
cord-023095-4dannjjm	301	6	-catenin	-catenin	:
cord-023095-4dannjjm	301	7	revealed	reveal	VBD
cord-023095-4dannjjm	301	8	no	no	DT
cord-023095-4dannjjm	301	9	changes	change	NNS
cord-023095-4dannjjm	301	10	in	in	IN
cord-023095-4dannjjm	301	11	the	the	DT
cord-023095-4dannjjm	301	12	amount	amount	NN
cord-023095-4dannjjm	301	13	of	of	IN
cord-023095-4dannjjm	301	14	protein	protein	NN
cord-023095-4dannjjm	301	15	.	.	.
cord-023095-4dannjjm	302	1	Interestingly	interestingly	RB
cord-023095-4dannjjm	302	2	,	,	,
cord-023095-4dannjjm	302	3	a	a	DT
cord-023095-4dannjjm	302	4	Western	western	JJ
cord-023095-4dannjjm	302	5	blot	blot	NN
cord-023095-4dannjjm	302	6	for	for	IN
cord-023095-4dannjjm	302	7	the	the	DT
cord-023095-4dannjjm	302	8	Wnt	Wnt	NNP
cord-023095-4dannjjm	302	9	protein	protein	NN
cord-023095-4dannjjm	302	10	revealed	reveal	VBD
cord-023095-4dannjjm	302	11	a	a	DT
cord-023095-4dannjjm	302	12	decrease	decrease	NN
cord-023095-4dannjjm	302	13	in	in	IN
cord-023095-4dannjjm	302	14	the	the	DT
cord-023095-4dannjjm	302	15	amount	amount	NN
cord-023095-4dannjjm	302	16	of	of	IN
cord-023095-4dannjjm	302	17	protein	protein	NN
cord-023095-4dannjjm	302	18	in	in	IN
cord-023095-4dannjjm	302	19	ARVC	ARVC	NNP
cord-023095-4dannjjm	302	20	samples	sample	NNS
cord-023095-4dannjjm	302	21	,	,	,
cord-023095-4dannjjm	302	22	compared	compare	VBN
cord-023095-4dannjjm	302	23	to	to	IN
cord-023095-4dannjjm	302	24	unafflicted	unafflicted	JJ
cord-023095-4dannjjm	302	25	samples	sample	NNS
cord-023095-4dannjjm	302	26	.	.	.
cord-023095-4dannjjm	303	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	303	2	preliminary	preliminary	JJ
cord-023095-4dannjjm	303	3	data	datum	NNS
cord-023095-4dannjjm	303	4	suggest	suggest	VBP
cord-023095-4dannjjm	303	5	that	that	IN
cord-023095-4dannjjm	303	6	disturbances	disturbance	NNS
cord-023095-4dannjjm	303	7	of	of	IN
cord-023095-4dannjjm	303	8	the	the	DT
cord-023095-4dannjjm	303	9	canonical	canonical	JJ
cord-023095-4dannjjm	303	10	Wnt	Wnt	NNP
cord-023095-4dannjjm	303	11	pathway	pathway	NN
cord-023095-4dannjjm	303	12	may	may	MD
cord-023095-4dannjjm	303	13	play	play	VB
cord-023095-4dannjjm	303	14	an	an	DT
cord-023095-4dannjjm	303	15	etiological	etiological	JJ
cord-023095-4dannjjm	303	16	role	role	NN
cord-023095-4dannjjm	303	17	in	in	IN
cord-023095-4dannjjm	303	18	the	the	DT
cord-023095-4dannjjm	303	19	development	development	NN
cord-023095-4dannjjm	303	20	of	of	IN
cord-023095-4dannjjm	303	21	ARVC	ARVC	NNP
cord-023095-4dannjjm	303	22	in	in	IN
cord-023095-4dannjjm	303	23	the	the	DT
cord-023095-4dannjjm	303	24	boxer	boxer	NN
cord-023095-4dannjjm	303	25	dog	dog	NN
cord-023095-4dannjjm	303	26	.	.	.
cord-023095-4dannjjm	304	1	There	there	EX
cord-023095-4dannjjm	304	2	are	be	VBP
cord-023095-4dannjjm	304	3	numerous	numerous	JJ
cord-023095-4dannjjm	304	4	benefits	benefit	NNS
cord-023095-4dannjjm	304	5	of	of	IN
cord-023095-4dannjjm	304	6	omega-3	omega-3	NN
cord-023095-4dannjjm	304	7	fatty	fatty	JJ
cord-023095-4dannjjm	304	8	acid	acid	NN
cord-023095-4dannjjm	304	9	supplementation	supplementation	NN
cord-023095-4dannjjm	304	10	in	in	IN
cord-023095-4dannjjm	304	11	human	human	JJ
cord-023095-4dannjjm	304	12	heart	heart	NN
cord-023095-4dannjjm	304	13	disease	disease	NN
cord-023095-4dannjjm	304	14	,	,	,
cord-023095-4dannjjm	304	15	including	include	VBG
cord-023095-4dannjjm	304	16	reduction	reduction	NN
cord-023095-4dannjjm	304	17	in	in	IN
cord-023095-4dannjjm	304	18	arrhythmias	arrhythmia	NNS
cord-023095-4dannjjm	304	19	,	,	,
cord-023095-4dannjjm	304	20	decreased	decrease	VBD
cord-023095-4dannjjm	304	21	incidence	incidence	NN
cord-023095-4dannjjm	304	22	of	of	IN
cord-023095-4dannjjm	304	23	sudden	sudden	JJ
cord-023095-4dannjjm	304	24	death	death	NN
cord-023095-4dannjjm	304	25	,	,	,
cord-023095-4dannjjm	304	26	and	and	CC
cord-023095-4dannjjm	304	27	improved	improve	VBN
cord-023095-4dannjjm	304	28	survival	survival	NN
cord-023095-4dannjjm	304	29	in	in	IN
cord-023095-4dannjjm	304	30	heart	heart	NN
cord-023095-4dannjjm	304	31	failure	failure	NN
cord-023095-4dannjjm	304	32	.	.	.
cord-023095-4dannjjm	305	1	Antithrombotic	antithrombotic	JJ
cord-023095-4dannjjm	305	2	effects	effect	NNS
cord-023095-4dannjjm	305	3	of	of	IN
cord-023095-4dannjjm	305	4	omega-3	omega-3	NN
cord-023095-4dannjjm	305	5	fatty	fatty	JJ
cord-023095-4dannjjm	305	6	acids	acid	NNS
cord-023095-4dannjjm	305	7	have	have	VBP
cord-023095-4dannjjm	305	8	been	be	VBN
cord-023095-4dannjjm	305	9	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	305	10	in	in	IN
cord-023095-4dannjjm	305	11	people	people	NNS
cord-023095-4dannjjm	305	12	,	,	,
cord-023095-4dannjjm	305	13	which	which	WDT
cord-023095-4dannjjm	305	14	may	may	MD
cord-023095-4dannjjm	305	15	have	have	VB
cord-023095-4dannjjm	305	16	particular	particular	JJ
cord-023095-4dannjjm	305	17	benefit	benefit	NN
cord-023095-4dannjjm	305	18	in	in	IN
cord-023095-4dannjjm	305	19	cats	cat	NNS
cord-023095-4dannjjm	305	20	given	give	VBN
cord-023095-4dannjjm	305	21	their	-PRON-	PRP$
cord-023095-4dannjjm	305	22	risk	risk	NN
cord-023095-4dannjjm	305	23	of	of	IN
cord-023095-4dannjjm	305	24	thromboembolic	thromboembolic	JJ
cord-023095-4dannjjm	305	25	complications	complication	NNS
cord-023095-4dannjjm	305	26	with	with	IN
cord-023095-4dannjjm	305	27	cardiac	cardiac	JJ
cord-023095-4dannjjm	305	28	disease	disease	NN
cord-023095-4dannjjm	305	29	.	.	.
cord-023095-4dannjjm	306	1	Benefits	benefit	NNS
cord-023095-4dannjjm	306	2	also	also	RB
cord-023095-4dannjjm	306	3	have	have	VBP
cord-023095-4dannjjm	306	4	been	be	VBN
cord-023095-4dannjjm	306	5	found	find	VBN
cord-023095-4dannjjm	306	6	in	in	IN
cord-023095-4dannjjm	306	7	canine	canine	JJ
cord-023095-4dannjjm	306	8	heart	heart	NN
cord-023095-4dannjjm	306	9	disease	disease	NN
cord-023095-4dannjjm	306	10	,	,	,
cord-023095-4dannjjm	306	11	and	and	CC
cord-023095-4dannjjm	306	12	reduced	reduced	JJ
cord-023095-4dannjjm	306	13	serum	serum	NN
cord-023095-4dannjjm	306	14	concentrations	concentration	NNS
cord-023095-4dannjjm	306	15	of	of	IN
cord-023095-4dannjjm	306	16	the	the	DT
cord-023095-4dannjjm	306	17	omega-3	omega-3	NN
cord-023095-4dannjjm	306	18	fatty	fatty	JJ
cord-023095-4dannjjm	306	19	acids	acid	NNS
cord-023095-4dannjjm	306	20	,	,	,
cord-023095-4dannjjm	306	21	eicosapentaenoic	eicosapentaenoic	NN
cord-023095-4dannjjm	306	22	acid	acid	NN
cord-023095-4dannjjm	306	23	(	(	-LRB-
cord-023095-4dannjjm	306	24	EPA	EPA	NNP
cord-023095-4dannjjm	306	25	)	)	-RRB-
cord-023095-4dannjjm	306	26	and	and	CC
cord-023095-4dannjjm	306	27	docosahexaenoic	docosahexaenoic	NNP
cord-023095-4dannjjm	306	28	acid	acid	NNP
cord-023095-4dannjjm	306	29	(	(	-LRB-
cord-023095-4dannjjm	306	30	DHA	DHA	NNP
cord-023095-4dannjjm	306	31	)	)	-RRB-
cord-023095-4dannjjm	306	32	have	have	VBP
cord-023095-4dannjjm	306	33	been	be	VBN
cord-023095-4dannjjm	306	34	found	find	VBN
cord-023095-4dannjjm	306	35	in	in	IN
cord-023095-4dannjjm	306	36	dogs	dog	NNS
cord-023095-4dannjjm	306	37	with	with	IN
cord-023095-4dannjjm	306	38	congestive	congestive	JJ
cord-023095-4dannjjm	306	39	heart	heart	NN
cord-023095-4dannjjm	306	40	failure	failure	NN
cord-023095-4dannjjm	306	41	(	(	-LRB-
cord-023095-4dannjjm	306	42	CHF	CHF	NNP
cord-023095-4dannjjm	306	43	)	)	-RRB-
cord-023095-4dannjjm	306	44	secondary	secondary	JJ
cord-023095-4dannjjm	306	45	to	to	IN
cord-023095-4dannjjm	306	46	DCM	DCM	NNP
cord-023095-4dannjjm	306	47	.	.	.
cord-023095-4dannjjm	307	1	To	to	IN
cord-023095-4dannjjm	307	2	the	the	DT
cord-023095-4dannjjm	307	3	authors	author	NNS
cord-023095-4dannjjm	307	4	'	'	POS
cord-023095-4dannjjm	307	5	knowledge	knowledge	NN
cord-023095-4dannjjm	307	6	,	,	,
cord-023095-4dannjjm	307	7	no	no	DT
cord-023095-4dannjjm	307	8	studies	study	NNS
cord-023095-4dannjjm	307	9	to	to	IN
cord-023095-4dannjjm	307	10	date	date	NN
cord-023095-4dannjjm	307	11	have	have	VBP
cord-023095-4dannjjm	307	12	investigated	investigate	VBN
cord-023095-4dannjjm	307	13	fatty	fatty	JJ
cord-023095-4dannjjm	307	14	acid	acid	NN
cord-023095-4dannjjm	307	15	concentrations	concentration	NNS
cord-023095-4dannjjm	307	16	in	in	IN
cord-023095-4dannjjm	307	17	cats	cat	NNS
cord-023095-4dannjjm	307	18	with	with	IN
cord-023095-4dannjjm	307	19	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	307	20	.	.	.
cord-023095-4dannjjm	308	1	The	the	DT
cord-023095-4dannjjm	308	2	purpose	purpose	NN
cord-023095-4dannjjm	308	3	of	of	IN
cord-023095-4dannjjm	308	4	this	this	DT
cord-023095-4dannjjm	308	5	study	study	NN
cord-023095-4dannjjm	308	6	was	be	VBD
cord-023095-4dannjjm	308	7	to	to	TO
cord-023095-4dannjjm	308	8	measure	measure	VB
cord-023095-4dannjjm	308	9	serum	serum	JJ
cord-023095-4dannjjm	308	10	fatty	fatty	JJ
cord-023095-4dannjjm	308	11	acid	acid	NN
cord-023095-4dannjjm	308	12	concentrations	concentration	NNS
cord-023095-4dannjjm	308	13	in	in	IN
cord-023095-4dannjjm	308	14	normal	normal	JJ
cord-023095-4dannjjm	308	15	cats	cat	NNS
cord-023095-4dannjjm	308	16	and	and	CC
cord-023095-4dannjjm	308	17	cats	cat	NNS
cord-023095-4dannjjm	308	18	with	with	IN
cord-023095-4dannjjm	308	19	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	308	20	.	.	.
cord-023095-4dannjjm	309	1	Serum	serum	NN
cord-023095-4dannjjm	309	2	fatty	fatty	JJ
cord-023095-4dannjjm	309	3	acid	acid	NN
cord-023095-4dannjjm	309	4	concentrations	concentration	NNS
cord-023095-4dannjjm	309	5	were	be	VBD
cord-023095-4dannjjm	309	6	measured	measure	VBN
cord-023095-4dannjjm	309	7	in	in	IN
cord-023095-4dannjjm	309	8	normal	normal	JJ
cord-023095-4dannjjm	309	9	cats	cat	NNS
cord-023095-4dannjjm	309	10	and	and	CC
cord-023095-4dannjjm	309	11	cats	cat	NNS
cord-023095-4dannjjm	309	12	with	with	IN
cord-023095-4dannjjm	309	13	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	309	14	using	use	VBG
cord-023095-4dannjjm	309	15	gas	gas	NN
cord-023095-4dannjjm	309	16	chromatography	chromatography	NN
cord-023095-4dannjjm	309	17	.	.	.
cord-023095-4dannjjm	310	1	Cats	cat	NNS
cord-023095-4dannjjm	310	2	with	with	IN
cord-023095-4dannjjm	310	3	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	310	4	and	and	CC
cord-023095-4dannjjm	310	5	at	at	IN
cord-023095-4dannjjm	310	6	least	least	JJS
cord-023095-4dannjjm	310	7	mild	mild	JJ
cord-023095-4dannjjm	310	8	left	left	JJ
cord-023095-4dannjjm	310	9	atrial	atrial	NN
cord-023095-4dannjjm	310	10	(	(	-LRB-
cord-023095-4dannjjm	310	11	LA	LA	NNP
cord-023095-4dannjjm	310	12	)	)	-RRB-
cord-023095-4dannjjm	310	13	enlargement	enlargement	NN
cord-023095-4dannjjm	310	14	(	(	-LRB-
cord-023095-4dannjjm	310	15	LA	LA	NNP
cord-023095-4dannjjm	310	16	to	to	IN
cord-023095-4dannjjm	310	17	aortic	aortic	JJ
cord-023095-4dannjjm	310	18	ratio	ratio	NN
cord-023095-4dannjjm	310	19	4	4	CD
cord-023095-4dannjjm	310	20	1.5	1.5	CD
cord-023095-4dannjjm	310	21	on	on	IN
cord-023095-4dannjjm	310	22	two	two	CD
cord-023095-4dannjjm	310	23	-	-	HYPH
cord-023095-4dannjjm	310	24	dimensional	dimensional	JJ
cord-023095-4dannjjm	310	25	echocardiography	echocardiography	NN
cord-023095-4dannjjm	310	26	from	from	IN
cord-023095-4dannjjm	310	27	a	a	DT
cord-023095-4dannjjm	310	28	right	right	JJ
cord-023095-4dannjjm	310	29	parasternal	parasternal	JJ
cord-023095-4dannjjm	310	30	short	short	JJ
cord-023095-4dannjjm	310	31	axis	axis	NN
cord-023095-4dannjjm	310	32	view	view	NN
cord-023095-4dannjjm	310	33	)	)	-RRB-
cord-023095-4dannjjm	310	34	were	be	VBD
cord-023095-4dannjjm	310	35	candidates	candidate	NNS
cord-023095-4dannjjm	310	36	for	for	IN
cord-023095-4dannjjm	310	37	study	study	NN
cord-023095-4dannjjm	310	38	.	.	.
cord-023095-4dannjjm	311	1	Normal	normal	JJ
cord-023095-4dannjjm	311	2	cats	cat	NNS
cord-023095-4dannjjm	311	3	had	have	VBD
cord-023095-4dannjjm	311	4	a	a	DT
cord-023095-4dannjjm	311	5	normal	normal	JJ
cord-023095-4dannjjm	311	6	history	history	NN
cord-023095-4dannjjm	311	7	,	,	,
cord-023095-4dannjjm	311	8	physical	physical	JJ
cord-023095-4dannjjm	311	9	examination	examination	NN
cord-023095-4dannjjm	311	10	,	,	,
cord-023095-4dannjjm	311	11	echocardiogram	echocardiogram	NN
cord-023095-4dannjjm	311	12	,	,	,
cord-023095-4dannjjm	311	13	packed	pack	VBN
cord-023095-4dannjjm	311	14	cell	cell	NN
cord-023095-4dannjjm	311	15	volume	volume	NN
cord-023095-4dannjjm	311	16	,	,	,
cord-023095-4dannjjm	311	17	total	total	JJ
cord-023095-4dannjjm	311	18	solids	solid	NNS
cord-023095-4dannjjm	311	19	and	and	CC
cord-023095-4dannjjm	311	20	platelet	platelet	NN
cord-023095-4dannjjm	311	21	count	count	NN
cord-023095-4dannjjm	311	22	.	.	.
cord-023095-4dannjjm	312	1	Cats	cat	NNS
cord-023095-4dannjjm	312	2	with	with	IN
cord-023095-4dannjjm	312	3	evidence	evidence	NN
cord-023095-4dannjjm	312	4	of	of	IN
cord-023095-4dannjjm	312	5	other	other	JJ
cord-023095-4dannjjm	312	6	systemic	systemic	JJ
cord-023095-4dannjjm	312	7	disease	disease	NN
cord-023095-4dannjjm	312	8	or	or	CC
cord-023095-4dannjjm	312	9	those	those	DT
cord-023095-4dannjjm	312	10	receiving	receive	VBG
cord-023095-4dannjjm	312	11	anticoagulants	anticoagulant	NNS
cord-023095-4dannjjm	312	12	were	be	VBD
cord-023095-4dannjjm	312	13	excluded	exclude	VBN
cord-023095-4dannjjm	312	14	from	from	IN
cord-023095-4dannjjm	312	15	the	the	DT
cord-023095-4dannjjm	312	16	study	study	NN
cord-023095-4dannjjm	312	17	.	.	.
cord-023095-4dannjjm	313	1	Normally	normally	RB
cord-023095-4dannjjm	313	2	distributed	distributed	JJ
cord-023095-4dannjjm	313	3	and	and	CC
cord-023095-4dannjjm	313	4	skewed	skewed	JJ
cord-023095-4dannjjm	313	5	data	datum	NNS
cord-023095-4dannjjm	313	6	were	be	VBD
cord-023095-4dannjjm	313	7	compared	compare	VBN
cord-023095-4dannjjm	313	8	between	between	IN
cord-023095-4dannjjm	313	9	the	the	DT
cord-023095-4dannjjm	313	10	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	313	11	and	and	CC
cord-023095-4dannjjm	313	12	control	control	NN
cord-023095-4dannjjm	313	13	groups	group	NNS
cord-023095-4dannjjm	313	14	with	with	IN
cord-023095-4dannjjm	313	15	independent	independent	JJ
cord-023095-4dannjjm	313	16	t	t	NN
cord-023095-4dannjjm	313	17	tests	test	NNS
cord-023095-4dannjjm	313	18	or	or	CC
cord-023095-4dannjjm	313	19	Mann	Mann	NNP
cord-023095-4dannjjm	313	20	Whitney	Whitney	NNP
cord-023095-4dannjjm	313	21	U	U	NNP
cord-023095-4dannjjm	313	22	tests	test	NNS
cord-023095-4dannjjm	313	23	,	,	,
cord-023095-4dannjjm	313	24	respectively	respectively	RB
cord-023095-4dannjjm	313	25	.	.	.
cord-023095-4dannjjm	314	1	Statistical	statistical	JJ
cord-023095-4dannjjm	314	2	significance	significance	NN
cord-023095-4dannjjm	314	3	was	be	VBD
cord-023095-4dannjjm	314	4	set	set	VBN
cord-023095-4dannjjm	314	5	at	at	IN
cord-023095-4dannjjm	314	6	P	p	NN
cord-023095-4dannjjm	314	7	o	o	NN
cord-023095-4dannjjm	314	8	0.01	0.01	CD
cord-023095-4dannjjm	314	9	.	.	.
cord-023095-4dannjjm	315	1	Thirty	thirty	CD
cord-023095-4dannjjm	315	2	cats	cat	NNS
cord-023095-4dannjjm	315	3	with	with	IN
cord-023095-4dannjjm	315	4	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	315	5	(	(	-LRB-
cord-023095-4dannjjm	315	6	23	23	CD
cord-023095-4dannjjm	315	7	neutered	neutered	JJ
cord-023095-4dannjjm	315	8	males	male	NNS
cord-023095-4dannjjm	315	9	and	and	CC
cord-023095-4dannjjm	315	10	7	7	CD
cord-023095-4dannjjm	315	11	neutered	neutered	JJ
cord-023095-4dannjjm	315	12	females	female	NNS
cord-023095-4dannjjm	315	13	)	)	-RRB-
cord-023095-4dannjjm	315	14	and	and	CC
cord-023095-4dannjjm	315	15	27	27	CD
cord-023095-4dannjjm	315	16	healthy	healthy	JJ
cord-023095-4dannjjm	315	17	controls	control	NNS
cord-023095-4dannjjm	315	18	(	(	-LRB-
cord-023095-4dannjjm	315	19	13	13	CD
cord-023095-4dannjjm	315	20	neutered	neutered	JJ
cord-023095-4dannjjm	315	21	males	male	NNS
cord-023095-4dannjjm	315	22	and	and	CC
cord-023095-4dannjjm	315	23	14	14	CD
cord-023095-4dannjjm	315	24	neutered	neutered	JJ
cord-023095-4dannjjm	315	25	females	female	NNS
cord-023095-4dannjjm	315	26	)	)	-RRB-
cord-023095-4dannjjm	315	27	were	be	VBD
cord-023095-4dannjjm	315	28	enrolled	enrol	VBN
cord-023095-4dannjjm	315	29	.	.	.
cord-023095-4dannjjm	316	1	Median	median	JJ
cord-023095-4dannjjm	316	2	age	age	NN
cord-023095-4dannjjm	316	3	was	be	VBD
cord-023095-4dannjjm	316	4	8	8	CD
cord-023095-4dannjjm	316	5	yr	yr	NN
cord-023095-4dannjjm	316	6	(	(	-LRB-
cord-023095-4dannjjm	316	7	range	range	NN
cord-023095-4dannjjm	316	8	,	,	,
cord-023095-4dannjjm	316	9	2	2	CD
cord-023095-4dannjjm	316	10	-	-	SYM
cord-023095-4dannjjm	316	11	16	16	CD
cord-023095-4dannjjm	316	12	yr	yr	NN
cord-023095-4dannjjm	316	13	)	)	-RRB-
cord-023095-4dannjjm	316	14	in	in	IN
cord-023095-4dannjjm	316	15	the	the	DT
cord-023095-4dannjjm	316	16	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	316	17	group	group	NN
cord-023095-4dannjjm	316	18	and	and	CC
cord-023095-4dannjjm	316	19	5	5	CD
cord-023095-4dannjjm	316	20	yr	yr	NN
cord-023095-4dannjjm	316	21	(	(	-LRB-
cord-023095-4dannjjm	316	22	range	range	NN
cord-023095-4dannjjm	316	23	,	,	,
cord-023095-4dannjjm	316	24	1	1	CD
cord-023095-4dannjjm	316	25	-	-	SYM
cord-023095-4dannjjm	316	26	10	10	CD
cord-023095-4dannjjm	316	27	yr	yr	NN
cord-023095-4dannjjm	316	28	)	)	-RRB-
cord-023095-4dannjjm	316	29	in	in	IN
cord-023095-4dannjjm	316	30	the	the	DT
cord-023095-4dannjjm	316	31	control	control	NN
cord-023095-4dannjjm	316	32	group	group	NN
cord-023095-4dannjjm	316	33	(	(	-LRB-
cord-023095-4dannjjm	316	34	P	p	NN
cord-023095-4dannjjm	316	35	5	5	CD
cord-023095-4dannjjm	316	36	.009	.009	CD
cord-023095-4dannjjm	316	37	)	)	-RRB-
cord-023095-4dannjjm	316	38	.	.	.
cord-023095-4dannjjm	317	1	Cats	cat	NNS
cord-023095-4dannjjm	317	2	in	in	IN
cord-023095-4dannjjm	317	3	the	the	DT
cord-023095-4dannjjm	317	4	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	317	5	group	group	NN
cord-023095-4dannjjm	317	6	were	be	VBD
cord-023095-4dannjjm	317	7	classified	classify	VBN
cord-023095-4dannjjm	317	8	in	in	IN
cord-023095-4dannjjm	317	9	the	the	DT
cord-023095-4dannjjm	317	10	International	International	NNP
cord-023095-4dannjjm	317	11	Small	Small	NNP
cord-023095-4dannjjm	317	12	Animal	Animal	NNP
cord-023095-4dannjjm	317	13	Cardiac	Cardiac	NNP
cord-023095-4dannjjm	317	14	Health	Health	NNP
cord-023095-4dannjjm	317	15	Council	Council	NNP
cord-023095-4dannjjm	317	16	stage	stage	NN
cord-023095-4dannjjm	317	17	1b	1b	CD
cord-023095-4dannjjm	317	18	(	(	-LRB-
cord-023095-4dannjjm	317	19	n	n	NN
cord-023095-4dannjjm	317	20	5	5	CD
cord-023095-4dannjjm	317	21	10	10	CD
cord-023095-4dannjjm	317	22	)	)	-RRB-
cord-023095-4dannjjm	317	23	,	,	,
cord-023095-4dannjjm	317	24	2	2	CD
cord-023095-4dannjjm	317	25	(	(	-LRB-
cord-023095-4dannjjm	317	26	n	n	NN
cord-023095-4dannjjm	317	27	5	5	CD
cord-023095-4dannjjm	317	28	8)	8)	NNP
cord-023095-4dannjjm	317	29	,	,	,
cord-023095-4dannjjm	317	30	3a	3a	NNP
cord-023095-4dannjjm	317	31	(	(	-LRB-
cord-023095-4dannjjm	317	32	n	n	NN
cord-023095-4dannjjm	317	33	5	5	CD
cord-023095-4dannjjm	317	34	3	3	CD
cord-023095-4dannjjm	317	35	)	)	-RRB-
cord-023095-4dannjjm	317	36	and	and	CC
cord-023095-4dannjjm	317	37	3b	3b	LS
cord-023095-4dannjjm	317	38	(	(	-LRB-
cord-023095-4dannjjm	317	39	n	n	NN
cord-023095-4dannjjm	317	40	5	5	CD
cord-023095-4dannjjm	317	41	9	9	CD
cord-023095-4dannjjm	317	42	)	)	-RRB-
cord-023095-4dannjjm	317	43	.	.	.
cord-023095-4dannjjm	318	1	Compared	compare	VBN
cord-023095-4dannjjm	318	2	to	to	TO
cord-023095-4dannjjm	318	3	control	control	VB
cord-023095-4dannjjm	318	4	cats	cat	NNS
cord-023095-4dannjjm	318	5	,	,	,
cord-023095-4dannjjm	318	6	cardiomyopathic	cardiomyopathic	NNP
cord-023095-4dannjjm	318	7	cats	cat	NNS
cord-023095-4dannjjm	318	8	had	have	VBD
cord-023095-4dannjjm	318	9	higher	high	JJR
cord-023095-4dannjjm	318	10	concentrations	concentration	NNS
cord-023095-4dannjjm	318	11	of	of	IN
cord-023095-4dannjjm	318	12	palmitic	palmitic	JJ
cord-023095-4dannjjm	318	13	acid	acid	NN
cord-023095-4dannjjm	318	14	(	(	-LRB-
cord-023095-4dannjjm	318	15	P	p	NN
cord-023095-4dannjjm	318	16	5	5	CD
cord-023095-4dannjjm	318	17	.002	.002	NFP
cord-023095-4dannjjm	318	18	)	)	-RRB-
cord-023095-4dannjjm	318	19	and	and	CC
cord-023095-4dannjjm	318	20	DHA	DHA	NNP
cord-023095-4dannjjm	318	21	(	(	-LRB-
cord-023095-4dannjjm	318	22	P	p	NN
cord-023095-4dannjjm	318	23	o	o	NN
cord-023095-4dannjjm	318	24	.001	.001	CD
cord-023095-4dannjjm	318	25	)	)	-RRB-
cord-023095-4dannjjm	318	26	,	,	,
cord-023095-4dannjjm	318	27	and	and	CC
cord-023095-4dannjjm	318	28	lower	low	JJR
cord-023095-4dannjjm	318	29	concentrations	concentration	NNS
cord-023095-4dannjjm	318	30	of	of	IN
cord-023095-4dannjjm	318	31	linoleic	linoleic	JJ
cord-023095-4dannjjm	318	32	acid	acid	NN
cord-023095-4dannjjm	318	33	(	(	-LRB-
cord-023095-4dannjjm	318	34	P	p	NN
cord-023095-4dannjjm	318	35	5	5	CD
cord-023095-4dannjjm	318	36	.005	.005	CD
cord-023095-4dannjjm	318	37	)	)	-RRB-
cord-023095-4dannjjm	318	38	.	.	.
cord-023095-4dannjjm	319	1	Among	among	IN
cord-023095-4dannjjm	319	2	cats	cat	NNS
cord-023095-4dannjjm	319	3	with	with	IN
cord-023095-4dannjjm	319	4	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	319	5	,	,	,
cord-023095-4dannjjm	319	6	there	there	EX
cord-023095-4dannjjm	319	7	was	be	VBD
cord-023095-4dannjjm	319	8	no	no	DT
cord-023095-4dannjjm	319	9	significant	significant	JJ
cord-023095-4dannjjm	319	10	correlation	correlation	NN
cord-023095-4dannjjm	319	11	between	between	IN
cord-023095-4dannjjm	319	12	any	any	DT
cord-023095-4dannjjm	319	13	serum	serum	NN
cord-023095-4dannjjm	319	14	fatty	fatty	JJ
cord-023095-4dannjjm	319	15	acid	acid	NN
cord-023095-4dannjjm	319	16	concentration	concentration	NN
cord-023095-4dannjjm	319	17	and	and	CC
cord-023095-4dannjjm	319	18	left	leave	VBN
cord-023095-4dannjjm	319	19	atrial	atrial	JJ
cord-023095-4dannjjm	319	20	size	size	NN
cord-023095-4dannjjm	319	21	or	or	CC
cord-023095-4dannjjm	319	22	age	age	NN
cord-023095-4dannjjm	319	23	.	.	.
cord-023095-4dannjjm	320	1	These	these	DT
cord-023095-4dannjjm	320	2	findings	finding	NNS
cord-023095-4dannjjm	320	3	warrant	warrant	VBP
cord-023095-4dannjjm	320	4	further	further	JJ
cord-023095-4dannjjm	320	5	investigation	investigation	NN
cord-023095-4dannjjm	320	6	into	into	IN
cord-023095-4dannjjm	320	7	the	the	DT
cord-023095-4dannjjm	320	8	role	role	NN
cord-023095-4dannjjm	320	9	of	of	IN
cord-023095-4dannjjm	320	10	fatty	fatty	JJ
cord-023095-4dannjjm	320	11	acids	acid	NNS
cord-023095-4dannjjm	320	12	in	in	IN
cord-023095-4dannjjm	320	13	cats	cat	NNS
cord-023095-4dannjjm	320	14	with	with	IN
cord-023095-4dannjjm	320	15	cardiac	cardiac	JJ
cord-023095-4dannjjm	320	16	disease	disease	NN
cord-023095-4dannjjm	320	17	.	.	.
cord-023095-4dannjjm	321	1	Platelet	platelet	NN
cord-023095-4dannjjm	321	2	mapping	mapping	NN
cord-023095-4dannjjm	321	3	is	be	VBZ
cord-023095-4dannjjm	321	4	an	an	DT
cord-023095-4dannjjm	321	5	application	application	NN
cord-023095-4dannjjm	321	6	of	of	IN
cord-023095-4dannjjm	321	7	thromboelastography	thromboelastography	NNP
cord-023095-4dannjjm	321	8	that	that	WDT
cord-023095-4dannjjm	321	9	relies	rely	VBZ
cord-023095-4dannjjm	321	10	on	on	IN
cord-023095-4dannjjm	321	11	the	the	DT
cord-023095-4dannjjm	321	12	generation	generation	NN
cord-023095-4dannjjm	321	13	of	of	IN
cord-023095-4dannjjm	321	14	at	at	RB
cord-023095-4dannjjm	321	15	least	least	RBS
cord-023095-4dannjjm	321	16	three	three	CD
cord-023095-4dannjjm	321	17	tracings	tracing	NNS
cord-023095-4dannjjm	321	18	:	:	:
cord-023095-4dannjjm	321	19	MA	MA	NNP
cord-023095-4dannjjm	321	20	THROMBIN	THROMBIN	NNP
cord-023095-4dannjjm	321	21	(	(	-LRB-
cord-023095-4dannjjm	321	22	maximum	maximum	JJ
cord-023095-4dannjjm	321	23	platelet	platelet	NN
cord-023095-4dannjjm	321	24	activity),MA	activity),MA	NNP
cord-023095-4dannjjm	321	25	FIBRIN	fibrin	NN
cord-023095-4dannjjm	321	26	(	(	-LRB-
cord-023095-4dannjjm	321	27	fibrin	fibrin	NN
cord-023095-4dannjjm	321	28	activity	activity	NN
cord-023095-4dannjjm	321	29	only	only	RB
cord-023095-4dannjjm	321	30	)	)	-RRB-
cord-023095-4dannjjm	321	31	,	,	,
cord-023095-4dannjjm	321	32	an	an	DT
cord-023095-4dannjjm	321	33	-	-	HYPH
cord-023095-4dannjjm	321	34	dMA	dma	JJ
cord-023095-4dannjjm	321	35	AA	AA	NNP
cord-023095-4dannjjm	321	36	or	or	CC
cord-023095-4dannjjm	321	37	ADP	ADP	NNP
cord-023095-4dannjjm	321	38	(	(	-LRB-
cord-023095-4dannjjm	321	39	platelet	platelet	NN
cord-023095-4dannjjm	321	40	activity	activity	NN
cord-023095-4dannjjm	321	41	not	not	RB
cord-023095-4dannjjm	321	42	inhibited	inhibit	VBN
cord-023095-4dannjjm	321	43	by	by	IN
cord-023095-4dannjjm	321	44	arachidonic	arachidonic	JJ
cord-023095-4dannjjm	321	45	acid	acid	NN
cord-023095-4dannjjm	321	46	or	or	CC
cord-023095-4dannjjm	321	47	ADP	ADP	NNP
cord-023095-4dannjjm	321	48	receptor	receptor	NN
cord-023095-4dannjjm	321	49	antagonists	antagonist	NNS
cord-023095-4dannjjm	321	50	,	,	,
cord-023095-4dannjjm	321	51	respectively	respectively	RB
cord-023095-4dannjjm	321	52	)	)	-RRB-
cord-023095-4dannjjm	321	53	.	.	.
cord-023095-4dannjjm	322	1	Using	use	VBG
cord-023095-4dannjjm	322	2	these	these	DT
cord-023095-4dannjjm	322	3	three	three	CD
cord-023095-4dannjjm	322	4	tracings	tracing	NNS
cord-023095-4dannjjm	322	5	,	,	,
cord-023095-4dannjjm	322	6	the	the	DT
cord-023095-4dannjjm	322	7	%	%	NN
cord-023095-4dannjjm	322	8	inhibition	inhibition	NN
cord-023095-4dannjjm	322	9	of	of	IN
cord-023095-4dannjjm	322	10	platelets	platelet	NNS
cord-023095-4dannjjm	322	11	can	can	MD
cord-023095-4dannjjm	322	12	be	be	VB
cord-023095-4dannjjm	322	13	calculated	calculate	VBN
cord-023095-4dannjjm	322	14	.	.	.
cord-023095-4dannjjm	323	1	The	the	DT
cord-023095-4dannjjm	323	2	purpose	purpose	NN
cord-023095-4dannjjm	323	3	of	of	IN
cord-023095-4dannjjm	323	4	this	this	DT
cord-023095-4dannjjm	323	5	study	study	NN
cord-023095-4dannjjm	323	6	was	be	VBD
cord-023095-4dannjjm	323	7	to	to	TO
cord-023095-4dannjjm	323	8	evaluate	evaluate	VB
cord-023095-4dannjjm	323	9	the	the	DT
cord-023095-4dannjjm	323	10	Platelet	Platelet	NNP
cord-023095-4dannjjm	323	11	Mapping	Mapping	NNP
cord-023095-4dannjjm	323	12	assay	assay	NN
cord-023095-4dannjjm	323	13	in	in	IN
cord-023095-4dannjjm	323	14	normal	normal	JJ
cord-023095-4dannjjm	323	15	cats	cat	NNS
cord-023095-4dannjjm	323	16	and	and	CC
cord-023095-4dannjjm	323	17	assess	assess	VB
cord-023095-4dannjjm	323	18	platelet	platelet	NN
cord-023095-4dannjjm	323	19	inhibition	inhibition	NN
cord-023095-4dannjjm	323	20	in	in	IN
cord-023095-4dannjjm	323	21	cats	cat	NNS
cord-023095-4dannjjm	323	22	receiving	receive	VBG
cord-023095-4dannjjm	323	23	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	323	24	.	.	.
cord-023095-4dannjjm	324	1	Employee	employee	NN
cord-023095-4dannjjm	324	2	-	-	HYPH
cord-023095-4dannjjm	324	3	owned	own	VBN
cord-023095-4dannjjm	324	4	cats	cat	NNS
cord-023095-4dannjjm	324	5	with	with	IN
cord-023095-4dannjjm	324	6	normal	normal	JJ
cord-023095-4dannjjm	324	7	history	history	NN
cord-023095-4dannjjm	324	8	,	,	,
cord-023095-4dannjjm	324	9	physical	physical	JJ
cord-023095-4dannjjm	324	10	exam	exam	NN
cord-023095-4dannjjm	324	11	,	,	,
cord-023095-4dannjjm	324	12	echocardiogram	echocardiogram	NN
cord-023095-4dannjjm	324	13	,	,	,
cord-023095-4dannjjm	324	14	thromboelastography	thromboelastography	NNP
cord-023095-4dannjjm	324	15	,	,	,
cord-023095-4dannjjm	324	16	packed	pack	VBN
cord-023095-4dannjjm	324	17	cell	cell	NN
cord-023095-4dannjjm	324	18	volume	volume	NN
cord-023095-4dannjjm	324	19	,	,	,
cord-023095-4dannjjm	324	20	total	total	JJ
cord-023095-4dannjjm	324	21	solids	solid	NNS
cord-023095-4dannjjm	324	22	and	and	CC
cord-023095-4dannjjm	324	23	platelet	platelet	NN
cord-023095-4dannjjm	324	24	count	count	NN
cord-023095-4dannjjm	324	25	were	be	VBD
cord-023095-4dannjjm	324	26	eligible	eligible	JJ
cord-023095-4dannjjm	324	27	.	.	.
cord-023095-4dannjjm	325	1	Clopidogrel	Clopidogrel	NNP
cord-023095-4dannjjm	325	2	(	(	-LRB-
cord-023095-4dannjjm	325	3	18.75	18.75	CD
cord-023095-4dannjjm	325	4	mg	mg	NNP
cord-023095-4dannjjm	325	5	PO	PO	NNP
cord-023095-4dannjjm	325	6	Q24h	Q24h	NNP
cord-023095-4dannjjm	325	7	)	)	-RRB-
cord-023095-4dannjjm	325	8	was	be	VBD
cord-023095-4dannjjm	325	9	administered	administer	VBN
cord-023095-4dannjjm	325	10	for	for	IN
cord-023095-4dannjjm	325	11	10	10	CD
cord-023095-4dannjjm	325	12	days	day	NNS
cord-023095-4dannjjm	325	13	with	with	IN
cord-023095-4dannjjm	325	14	Platelet	platelet	NN
cord-023095-4dannjjm	325	15	Mapping	Mapping	NNP
cord-023095-4dannjjm	325	16	performed	perform	VBN
cord-023095-4dannjjm	325	17	on	on	IN
cord-023095-4dannjjm	325	18	days	day	NNS
cord-023095-4dannjjm	325	19	0	0	CD
cord-023095-4dannjjm	325	20	and	and	CC
cord-023095-4dannjjm	325	21	10	10	CD
cord-023095-4dannjjm	325	22	.	.	.
cord-023095-4dannjjm	326	1	Platelet	platelet	NN
cord-023095-4dannjjm	326	2	Mapping	mapping	NN
cord-023095-4dannjjm	326	3	values	value	NNS
cord-023095-4dannjjm	326	4	were	be	VBD
cord-023095-4dannjjm	326	5	compared	compare	VBN
cord-023095-4dannjjm	326	6	using	use	VBG
cord-023095-4dannjjm	326	7	a	a	DT
cord-023095-4dannjjm	326	8	paired	paired	JJ
cord-023095-4dannjjm	326	9	t	t	NN
cord-023095-4dannjjm	326	10	test	test	NN
cord-023095-4dannjjm	326	11	,	,	,
cord-023095-4dannjjm	326	12	with	with	IN
cord-023095-4dannjjm	326	13	significance	significance	NN
cord-023095-4dannjjm	326	14	set	set	VBN
cord-023095-4dannjjm	326	15	at	at	IN
cord-023095-4dannjjm	326	16	P	p	NN
cord-023095-4dannjjm	326	17	o	o	NN
cord-023095-4dannjjm	326	18	0.05	0.05	CD
cord-023095-4dannjjm	326	19	.	.	.
cord-023095-4dannjjm	327	1	Seven	seven	CD
cord-023095-4dannjjm	327	2	cats	cat	NNS
cord-023095-4dannjjm	327	3	(	(	-LRB-
cord-023095-4dannjjm	327	4	4	4	CD
cord-023095-4dannjjm	327	5	FS	fs	NN
cord-023095-4dannjjm	327	6	,	,	,
cord-023095-4dannjjm	327	7	3	3	CD
cord-023095-4dannjjm	327	8	CM	cm	NN
cord-023095-4dannjjm	327	9	,	,	,
cord-023095-4dannjjm	327	10	aged	aged	JJ
cord-023095-4dannjjm	327	11	2	2	CD
cord-023095-4dannjjm	327	12	-	-	SYM
cord-023095-4dannjjm	327	13	10	10	CD
cord-023095-4dannjjm	327	14	years	year	NNS
cord-023095-4dannjjm	327	15	)	)	-RRB-
cord-023095-4dannjjm	327	16	were	be	VBD
cord-023095-4dannjjm	327	17	enrolled	enrol	VBN
cord-023095-4dannjjm	327	18	.	.	.
cord-023095-4dannjjm	328	1	Compared	compare	VBN
cord-023095-4dannjjm	328	2	to	to	IN
cord-023095-4dannjjm	328	3	day	day	NN
cord-023095-4dannjjm	328	4	0	0	CD
cord-023095-4dannjjm	328	5	,	,	,
cord-023095-4dannjjm	328	6	MA	MA	NNP
cord-023095-4dannjjm	328	7	ADP	ADP	NNP
cord-023095-4dannjjm	328	8	(	(	-LRB-
cord-023095-4dannjjm	328	9	P	p	NN
cord-023095-4dannjjm	328	10	o	o	NN
cord-023095-4dannjjm	328	11	.001	.001	CD
cord-023095-4dannjjm	328	12	)	)	-RRB-
cord-023095-4dannjjm	328	13	and	and	CC
cord-023095-4dannjjm	328	14	MA	MA	NNP
cord-023095-4dannjjm	328	15	FIBRIN	FIBRIN	NNP
cord-023095-4dannjjm	329	1	(	(	-LRB-
cord-023095-4dannjjm	329	2	P	p	NN
cord-023095-4dannjjm	329	3	o	o	NN
cord-023095-4dannjjm	329	4	.001	.001	CD
cord-023095-4dannjjm	329	5	)	)	-RRB-
cord-023095-4dannjjm	329	6	were	be	VBD
cord-023095-4dannjjm	329	7	lower	low	JJR
cord-023095-4dannjjm	329	8	on	on	IN
cord-023095-4dannjjm	329	9	day	day	NN
cord-023095-4dannjjm	329	10	10	10	CD
cord-023095-4dannjjm	329	11	.	.	.
cord-023095-4dannjjm	330	1	The	the	DT
cord-023095-4dannjjm	330	2	latter	latter	JJ
cord-023095-4dannjjm	330	3	unexpected	unexpected	JJ
cord-023095-4dannjjm	330	4	result	result	NN
cord-023095-4dannjjm	330	5	prompted	prompt	VBD
cord-023095-4dannjjm	330	6	measurement	measurement	NN
cord-023095-4dannjjm	330	7	of	of	IN
cord-023095-4dannjjm	330	8	fibrinogen	fibrinogen	JJ
cord-023095-4dannjjm	330	9	concentrations	concentration	NNS
cord-023095-4dannjjm	330	10	at	at	IN
cord-023095-4dannjjm	330	11	day	day	NN
cord-023095-4dannjjm	330	12	0	0	CD
cord-023095-4dannjjm	330	13	and	and	CC
cord-023095-4dannjjm	330	14	10	10	CD
cord-023095-4dannjjm	330	15	in	in	IN
cord-023095-4dannjjm	330	16	the	the	DT
cord-023095-4dannjjm	330	17	last	last	JJ
cord-023095-4dannjjm	330	18	5	5	CD
cord-023095-4dannjjm	330	19	of	of	IN
cord-023095-4dannjjm	330	20	these	these	DT
cord-023095-4dannjjm	330	21	7	7	CD
cord-023095-4dannjjm	330	22	cats	cat	NNS
cord-023095-4dannjjm	330	23	.	.	.
cord-023095-4dannjjm	331	1	Fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	331	2	was	be	VBD
cord-023095-4dannjjm	331	3	not	not	RB
cord-023095-4dannjjm	331	4	different	different	JJ
cord-023095-4dannjjm	331	5	from	from	IN
cord-023095-4dannjjm	331	6	day	day	NN
cord-023095-4dannjjm	331	7	0	0	CD
cord-023095-4dannjjm	331	8	to	to	IN
cord-023095-4dannjjm	331	9	10	10	CD
cord-023095-4dannjjm	331	10	in	in	IN
cord-023095-4dannjjm	331	11	these	these	DT
cord-023095-4dannjjm	331	12	5	5	CD
cord-023095-4dannjjm	331	13	cats	cat	NNS
cord-023095-4dannjjm	331	14	.	.	.
cord-023095-4dannjjm	332	1	These	these	DT
cord-023095-4dannjjm	332	2	results	result	NNS
cord-023095-4dannjjm	332	3	suggest	suggest	VBP
cord-023095-4dannjjm	332	4	that	that	IN
cord-023095-4dannjjm	332	5	Platelet	platelet	NN
cord-023095-4dannjjm	332	6	Mapping	mapping	NN
cord-023095-4dannjjm	332	7	may	may	MD
cord-023095-4dannjjm	332	8	be	be	VB
cord-023095-4dannjjm	332	9	a	a	DT
cord-023095-4dannjjm	332	10	simple	simple	JJ
cord-023095-4dannjjm	332	11	,	,	,
cord-023095-4dannjjm	332	12	outpatient	outpatient	JJ
cord-023095-4dannjjm	332	13	clinical	clinical	JJ
cord-023095-4dannjjm	332	14	tool	tool	NN
cord-023095-4dannjjm	332	15	to	to	TO
cord-023095-4dannjjm	332	16	measure	measure	VB
cord-023095-4dannjjm	332	17	antiplatelet	antiplatelet	JJ
cord-023095-4dannjjm	332	18	activity	activity	NN
cord-023095-4dannjjm	332	19	in	in	IN
cord-023095-4dannjjm	332	20	cats	cat	NNS
cord-023095-4dannjjm	332	21	receiving	receive	VBG
cord-023095-4dannjjm	332	22	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	332	23	.	.	.
cord-023095-4dannjjm	333	1	This	this	DT
cord-023095-4dannjjm	333	2	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	333	3	dose	dose	NN
cord-023095-4dannjjm	333	4	resulted	result	VBD
cord-023095-4dannjjm	333	5	in	in	IN
cord-023095-4dannjjm	333	6	significant	significant	JJ
cord-023095-4dannjjm	333	7	platelet	platelet	NN
cord-023095-4dannjjm	333	8	inhibition	inhibition	NN
cord-023095-4dannjjm	333	9	as	as	IN
cord-023095-4dannjjm	333	10	measured	measure	VBN
cord-023095-4dannjjm	333	11	by	by	IN
cord-023095-4dannjjm	333	12	MA	MA	NNP
cord-023095-4dannjjm	333	13	ADP	ADP	NNP
cord-023095-4dannjjm	333	14	in	in	IN
cord-023095-4dannjjm	333	15	all	all	DT
cord-023095-4dannjjm	333	16	cats	cat	NNS
cord-023095-4dannjjm	333	17	.	.	.
cord-023095-4dannjjm	334	1	Further	further	JJ
cord-023095-4dannjjm	334	2	studies	study	NNS
cord-023095-4dannjjm	334	3	correlating	correlate	VBG
cord-023095-4dannjjm	334	4	antiplatelet	antiplatelet	JJ
cord-023095-4dannjjm	334	5	effects	effect	NNS
cord-023095-4dannjjm	334	6	measured	measure	VBN
cord-023095-4dannjjm	334	7	by	by	IN
cord-023095-4dannjjm	334	8	Platelet	platelet	NN
cord-023095-4dannjjm	334	9	Mapping	mapping	NN
cord-023095-4dannjjm	334	10	with	with	IN
cord-023095-4dannjjm	334	11	clinical	clinical	JJ
cord-023095-4dannjjm	334	12	outcomes	outcome	NNS
cord-023095-4dannjjm	334	13	in	in	IN
cord-023095-4dannjjm	334	14	cats	cat	NNS
cord-023095-4dannjjm	334	15	with	with	IN
cord-023095-4dannjjm	334	16	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	334	17	are	be	VBP
cord-023095-4dannjjm	334	18	warranted	warrant	VBN
cord-023095-4dannjjm	334	19	.	.	.
cord-023095-4dannjjm	335	1	This	this	DT
cord-023095-4dannjjm	335	2	study	study	NN
cord-023095-4dannjjm	335	3	investigated	investigate	VBD
cord-023095-4dannjjm	335	4	the	the	DT
cord-023095-4dannjjm	335	5	hemodynamic	hemodynamic	JJ
cord-023095-4dannjjm	335	6	effects	effect	NNS
cord-023095-4dannjjm	335	7	of	of	IN
cord-023095-4dannjjm	335	8	application	application	NN
cord-023095-4dannjjm	335	9	of	of	IN
cord-023095-4dannjjm	335	10	an	an	DT
cord-023095-4dannjjm	335	11	ITD	itd	NN
cord-023095-4dannjjm	335	12	in	in	IN
cord-023095-4dannjjm	335	13	a	a	DT
cord-023095-4dannjjm	335	14	canine	canine	JJ
cord-023095-4dannjjm	335	15	model	model	NN
cord-023095-4dannjjm	335	16	of	of	IN
cord-023095-4dannjjm	335	17	cardiopulmonary	cardiopulmonary	JJ
cord-023095-4dannjjm	335	18	arrest	arrest	NN
cord-023095-4dannjjm	335	19	.	.	.
cord-023095-4dannjjm	336	1	8	8	CD
cord-023095-4dannjjm	336	2	laboratory	laboratory	NN
cord-023095-4dannjjm	336	3	beagles	beagle	NNS
cord-023095-4dannjjm	336	4	which	which	WDT
cord-023095-4dannjjm	336	5	were	be	VBD
cord-023095-4dannjjm	336	6	part	part	NN
cord-023095-4dannjjm	336	7	of	of	IN
cord-023095-4dannjjm	336	8	a	a	DT
cord-023095-4dannjjm	336	9	separate	separate	JJ
cord-023095-4dannjjm	336	10	terminal	terminal	JJ
cord-023095-4dannjjm	336	11	study	study	NN
cord-023095-4dannjjm	336	12	were	be	VBD
cord-023095-4dannjjm	336	13	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	336	14	and	and	CC
cord-023095-4dannjjm	336	15	instrumented	instrument	VBN
cord-023095-4dannjjm	336	16	for	for	IN
cord-023095-4dannjjm	336	17	continuous	continuous	JJ
cord-023095-4dannjjm	336	18	measurement	measurement	NN
cord-023095-4dannjjm	336	19	and	and	CC
cord-023095-4dannjjm	336	20	recording	recording	NN
cord-023095-4dannjjm	336	21	of	of	IN
cord-023095-4dannjjm	336	22	right	right	JJ
cord-023095-4dannjjm	336	23	atrial	atrial	JJ
cord-023095-4dannjjm	336	24	pressure	pressure	NN
cord-023095-4dannjjm	336	25	,	,	,
cord-023095-4dannjjm	336	26	arterial	arterial	JJ
cord-023095-4dannjjm	336	27	pressure	pressure	NN
cord-023095-4dannjjm	336	28	and	and	CC
cord-023095-4dannjjm	336	29	carotid	carotid	JJ
cord-023095-4dannjjm	336	30	blood	blood	NN
cord-023095-4dannjjm	336	31	flow	flow	NN
cord-023095-4dannjjm	336	32	.	.	.
cord-023095-4dannjjm	337	1	Following	follow	VBG
cord-023095-4dannjjm	337	2	euthanasia	euthanasia	NN
cord-023095-4dannjjm	337	3	,	,	,
cord-023095-4dannjjm	337	4	CPR	CPR	NNP
cord-023095-4dannjjm	337	5	was	be	VBD
cord-023095-4dannjjm	337	6	performed	perform	VBN
cord-023095-4dannjjm	337	7	for	for	IN
cord-023095-4dannjjm	337	8	one	one	CD
cord-023095-4dannjjm	337	9	minute	minute	NN
cord-023095-4dannjjm	337	10	,	,	,
cord-023095-4dannjjm	337	11	then	then	RB
cord-023095-4dannjjm	337	12	a	a	DT
cord-023095-4dannjjm	337	13	pause	pause	NN
cord-023095-4dannjjm	337	14	of	of	IN
cord-023095-4dannjjm	337	15	one	one	CD
cord-023095-4dannjjm	337	16	minute	minute	NN
cord-023095-4dannjjm	337	17	followed	follow	VBN
cord-023095-4dannjjm	337	18	by	by	IN
cord-023095-4dannjjm	337	19	a	a	DT
cord-023095-4dannjjm	337	20	second	second	JJ
cord-023095-4dannjjm	337	21	one	one	CD
cord-023095-4dannjjm	337	22	minute	minute	NN
cord-023095-4dannjjm	337	23	period	period	NN
cord-023095-4dannjjm	337	24	at	at	IN
cord-023095-4dannjjm	337	25	a	a	DT
cord-023095-4dannjjm	337	26	compression	compression	NN
cord-023095-4dannjjm	337	27	rate	rate	NN
cord-023095-4dannjjm	337	28	of	of	IN
cord-023095-4dannjjm	337	29	100	100	CD
cord-023095-4dannjjm	337	30	-	-	HYPH
cord-023095-4dannjjm	337	31	120	120	CD
cord-023095-4dannjjm	337	32	/	/	SYM
cord-023095-4dannjjm	337	33	minute	minute	NN
cord-023095-4dannjjm	337	34	,	,	,
cord-023095-4dannjjm	337	35	ventilation	ventilation	NN
cord-023095-4dannjjm	337	36	with	with	IN
cord-023095-4dannjjm	337	37	100	100	CD
cord-023095-4dannjjm	337	38	%	%	NN
cord-023095-4dannjjm	337	39	oxygen	oxygen	NN
cord-023095-4dannjjm	337	40	was	be	VBD
cord-023095-4dannjjm	337	41	delivered	deliver	VBN
cord-023095-4dannjjm	337	42	at	at	IN
cord-023095-4dannjjm	337	43	eight	eight	CD
cord-023095-4dannjjm	337	44	breaths	breath	NNS
cord-023095-4dannjjm	337	45	/	/	SYM
cord-023095-4dannjjm	337	46	min	min	NN
cord-023095-4dannjjm	337	47	and	and	CC
cord-023095-4dannjjm	337	48	15	15	CD
cord-023095-4dannjjm	337	49	ml	ml	NNS
cord-023095-4dannjjm	337	50	/	/	SYM
cord-023095-4dannjjm	337	51	kg	kg	CC
cord-023095-4dannjjm	337	52	tidal	tidal	JJ
cord-023095-4dannjjm	337	53	volume	volume	NN
cord-023095-4dannjjm	337	54	.	.	.
cord-023095-4dannjjm	338	1	CPR	CPR	NNP
cord-023095-4dannjjm	338	2	was	be	VBD
cord-023095-4dannjjm	338	3	performed	perform	VBN
cord-023095-4dannjjm	338	4	with	with	IN
cord-023095-4dannjjm	338	5	the	the	DT
cord-023095-4dannjjm	338	6	ITD	ITD	NNP
cord-023095-4dannjjm	338	7	in	in	IN
cord-023095-4dannjjm	338	8	place	place	NN
cord-023095-4dannjjm	339	1	(	(	-LRB-
cord-023095-4dannjjm	339	2	ITD	ITD	NNP
cord-023095-4dannjjm	339	3	-	-	HYPH
cord-023095-4dannjjm	339	4	CPR	CPR	NNP
cord-023095-4dannjjm	339	5	)	)	-RRB-
cord-023095-4dannjjm	340	1	and	and	CC
cord-023095-4dannjjm	340	2	without	without	IN
cord-023095-4dannjjm	340	3	the	the	DT
cord-023095-4dannjjm	340	4	ITD	ITD	NNP
cord-023095-4dannjjm	340	5	(	(	-LRB-
cord-023095-4dannjjm	340	6	S	S	NNP
cord-023095-4dannjjm	340	7	-	-	HYPH
cord-023095-4dannjjm	340	8	CPR	CPR	NNP
cord-023095-4dannjjm	340	9	)	)	-RRB-
cord-023095-4dannjjm	340	10	for	for	IN
cord-023095-4dannjjm	340	11	one	one	CD
cord-023095-4dannjjm	340	12	period	period	NN
cord-023095-4dannjjm	340	13	each	each	DT
cord-023095-4dannjjm	340	14	in	in	IN
cord-023095-4dannjjm	340	15	a	a	DT
cord-023095-4dannjjm	340	16	randomized	randomized	JJ
cord-023095-4dannjjm	340	17	fashion	fashion	NN
cord-023095-4dannjjm	340	18	with	with	IN
cord-023095-4dannjjm	340	19	the	the	DT
cord-023095-4dannjjm	340	20	rescuer	rescuer	NN
cord-023095-4dannjjm	340	21	blinded	blind	VBN
cord-023095-4dannjjm	340	22	to	to	IN
cord-023095-4dannjjm	340	23	its	-PRON-	PRP$
cord-023095-4dannjjm	340	24	application	application	NN
cord-023095-4dannjjm	340	25	.	.	.
cord-023095-4dannjjm	341	1	Baseline	Baseline	NNP
cord-023095-4dannjjm	341	2	,	,	,
cord-023095-4dannjjm	341	3	S	S	NNP
cord-023095-4dannjjm	341	4	-	-	HYPH
cord-023095-4dannjjm	341	5	CPR	CPR	NNP
cord-023095-4dannjjm	341	6	and	and	CC
cord-023095-4dannjjm	341	7	ITD	ITD	NNP
cord-023095-4dannjjm	341	8	-	-	HYPH
cord-023095-4dannjjm	341	9	CPR	CPR	NNP
cord-023095-4dannjjm	341	10	data	datum	NNS
cord-023095-4dannjjm	341	11	were	be	VBD
cord-023095-4dannjjm	341	12	assessed	assess	VBN
cord-023095-4dannjjm	341	13	for	for	IN
cord-023095-4dannjjm	341	14	normality	normality	NN
cord-023095-4dannjjm	341	15	,	,	,
cord-023095-4dannjjm	341	16	a	a	DT
cord-023095-4dannjjm	341	17	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	341	18	-	-	HYPH
cord-023095-4dannjjm	341	19	Wallis	Wallis	NNP
cord-023095-4dannjjm	341	20	one	one	CD
cord-023095-4dannjjm	341	21	-	-	HYPH
cord-023095-4dannjjm	341	22	way	way	NN
cord-023095-4dannjjm	341	23	ANOVA	anova	NN
cord-023095-4dannjjm	341	24	on	on	IN
cord-023095-4dannjjm	341	25	ranks	rank	NNS
cord-023095-4dannjjm	341	26	was	be	VBD
cord-023095-4dannjjm	341	27	used	use	VBN
cord-023095-4dannjjm	341	28	(	(	-LRB-
cord-023095-4dannjjm	341	29	baseline	baseline	NN
cord-023095-4dannjjm	341	30	v	v	IN
cord-023095-4dannjjm	341	31	CPR	CPR	NNP
cord-023095-4dannjjm	341	32	)	)	-RRB-
cord-023095-4dannjjm	341	33	.	.	.
cord-023095-4dannjjm	342	1	When	when	WRB
cord-023095-4dannjjm	342	2	appropriate	appropriate	VB
cord-023095-4dannjjm	342	3	a	a	DT
cord-023095-4dannjjm	342	4	pairwise	pairwise	JJ
cord-023095-4dannjjm	342	5	multiple	multiple	JJ
cord-023095-4dannjjm	342	6	comparison	comparison	NN
cord-023095-4dannjjm	342	7	procedure	procedure	NN
cord-023095-4dannjjm	342	8	(	(	-LRB-
cord-023095-4dannjjm	342	9	Dunn	Dunn	NNP
cord-023095-4dannjjm	342	10	's	's	POS
cord-023095-4dannjjm	342	11	method	method	NN
cord-023095-4dannjjm	342	12	)	)	-RRB-
cord-023095-4dannjjm	342	13	was	be	VBD
cord-023095-4dannjjm	342	14	used	use	VBN
cord-023095-4dannjjm	342	15	.	.	.
cord-023095-4dannjjm	343	1	Percentage	percentage	NN
cord-023095-4dannjjm	343	2	of	of	IN
cord-023095-4dannjjm	343	3	baseline	baseline	JJ
cord-023095-4dannjjm	343	4	S	S	NNP
cord-023095-4dannjjm	343	5	-	-	HYPH
cord-023095-4dannjjm	343	6	CPR	CPR	NNP
cord-023095-4dannjjm	344	1	v	v	LS
cord-023095-4dannjjm	345	1	ITD	ITD	NNP
cord-023095-4dannjjm	345	2	-	-	HYPH
cord-023095-4dannjjm	345	3	CPR	CPR	NNP
cord-023095-4dannjjm	345	4	was	be	VBD
cord-023095-4dannjjm	345	5	assessed	assess	VBN
cord-023095-4dannjjm	345	6	using	use	VBG
cord-023095-4dannjjm	345	7	the	the	DT
cord-023095-4dannjjm	345	8	Student	Student	NNP
cord-023095-4dannjjm	345	9	t	t	NN
cord-023095-4dannjjm	345	10	-	-	HYPH
cord-023095-4dannjjm	345	11	test	test	NN
cord-023095-4dannjjm	345	12	.	.	.
cord-023095-4dannjjm	346	1	The	the	DT
cord-023095-4dannjjm	346	2	right	right	JJ
cord-023095-4dannjjm	346	3	atrial	atrial	JJ
cord-023095-4dannjjm	346	4	diastolic	diastolic	JJ
cord-023095-4dannjjm	346	5	pressure	pressure	NN
cord-023095-4dannjjm	346	6	was	be	VBD
cord-023095-4dannjjm	346	7	significantly	significantly	RB
cord-023095-4dannjjm	346	8	more	more	RBR
cord-023095-4dannjjm	346	9	negative	negative	JJ
cord-023095-4dannjjm	346	10	with	with	IN
cord-023095-4dannjjm	346	11	the	the	DT
cord-023095-4dannjjm	346	12	ITD	ITD	NNP
cord-023095-4dannjjm	346	13	attached	attach	VBN
cord-023095-4dannjjm	346	14	than	than	IN
cord-023095-4dannjjm	346	15	without	without	IN
cord-023095-4dannjjm	346	16	(	(	-LRB-
cord-023095-4dannjjm	346	17	p	p	NN
cord-023095-4dannjjm	346	18	5	5	CD
cord-023095-4dannjjm	346	19	0.02	0.02	CD
cord-023095-4dannjjm	346	20	)	)	-RRB-
cord-023095-4dannjjm	346	21	,	,	,
cord-023095-4dannjjm	346	22	the	the	DT
cord-023095-4dannjjm	346	23	coronary	coronary	JJ
cord-023095-4dannjjm	346	24	perfusion	perfusion	NN
cord-023095-4dannjjm	346	25	pressure	pressure	NN
cord-023095-4dannjjm	346	26	and	and	CC
cord-023095-4dannjjm	346	27	carotid	carotid	JJ
cord-023095-4dannjjm	346	28	blood	blood	NN
cord-023095-4dannjjm	346	29	flow	flow	NN
cord-023095-4dannjjm	346	30	were	be	VBD
cord-023095-4dannjjm	346	31	significantly	significantly	RB
cord-023095-4dannjjm	346	32	higher	high	JJR
cord-023095-4dannjjm	346	33	during	during	IN
cord-023095-4dannjjm	346	34	CPR	CPR	NNP
cord-023095-4dannjjm	346	35	with	with	IN
cord-023095-4dannjjm	346	36	the	the	DT
cord-023095-4dannjjm	346	37	ITD	ITD	NNP
cord-023095-4dannjjm	346	38	than	than	IN
cord-023095-4dannjjm	346	39	standard	standard	JJ
cord-023095-4dannjjm	346	40	CPR	CPR	NNP
cord-023095-4dannjjm	346	41	(	(	-LRB-
cord-023095-4dannjjm	346	42	p	p	NN
cord-023095-4dannjjm	346	43	5	5	CD
cord-023095-4dannjjm	346	44	0.015	0.015	CD
cord-023095-4dannjjm	346	45	,	,	,
cord-023095-4dannjjm	346	46	p	p	NN
cord-023095-4dannjjm	346	47	5	5	CD
cord-023095-4dannjjm	346	48	0.017	0.017	CD
cord-023095-4dannjjm	346	49	)	)	-RRB-
cord-023095-4dannjjm	346	50	.	.	.
cord-023095-4dannjjm	347	1	No	no	DT
cord-023095-4dannjjm	347	2	significant	significant	JJ
cord-023095-4dannjjm	347	3	differences	difference	NNS
cord-023095-4dannjjm	347	4	in	in	IN
cord-023095-4dannjjm	347	5	diastolic	diastolic	JJ
cord-023095-4dannjjm	347	6	,	,	,
cord-023095-4dannjjm	347	7	mean	mean	JJ
cord-023095-4dannjjm	347	8	or	or	CC
cord-023095-4dannjjm	347	9	systolic	systolic	JJ
cord-023095-4dannjjm	347	10	arterial	arterial	JJ
cord-023095-4dannjjm	347	11	pressure	pressure	NN
cord-023095-4dannjjm	347	12	or	or	CC
cord-023095-4dannjjm	347	13	end	end	VB
cord-023095-4dannjjm	347	14	tidal	tidal	JJ
cord-023095-4dannjjm	347	15	CO	co	NN
cord-023095-4dannjjm	347	16	2	2	CD
cord-023095-4dannjjm	347	17	were	be	VBD
cord-023095-4dannjjm	347	18	seen	see	VBN
cord-023095-4dannjjm	347	19	.	.	.
cord-023095-4dannjjm	348	1	Application	application	NN
cord-023095-4dannjjm	348	2	of	of	IN
cord-023095-4dannjjm	348	3	the	the	DT
cord-023095-4dannjjm	348	4	ITD	ITD	NNP
cord-023095-4dannjjm	348	5	resulted	result	VBD
cord-023095-4dannjjm	348	6	in	in	IN
cord-023095-4dannjjm	348	7	significantly	significantly	RB
cord-023095-4dannjjm	348	8	improved	improve	VBN
cord-023095-4dannjjm	348	9	hemodynamics	hemodynamic	NNS
cord-023095-4dannjjm	348	10	during	during	IN
cord-023095-4dannjjm	348	11	CPR	CPR	NNP
cord-023095-4dannjjm	348	12	in	in	IN
cord-023095-4dannjjm	348	13	dogs	dog	NNS
cord-023095-4dannjjm	348	14	.	.	.
cord-023095-4dannjjm	349	1	Clinical	clinical	JJ
cord-023095-4dannjjm	349	2	evaluation	evaluation	NN
cord-023095-4dannjjm	349	3	of	of	IN
cord-023095-4dannjjm	349	4	the	the	DT
cord-023095-4dannjjm	349	5	device	device	NN
cord-023095-4dannjjm	349	6	is	be	VBZ
cord-023095-4dannjjm	349	7	warranted	warrant	VBN
cord-023095-4dannjjm	349	8	to	to	TO
cord-023095-4dannjjm	349	9	examine	examine	VB
cord-023095-4dannjjm	349	10	whether	whether	IN
cord-023095-4dannjjm	349	11	this	this	DT
cord-023095-4dannjjm	349	12	translates	translate	VBZ
cord-023095-4dannjjm	349	13	into	into	IN
cord-023095-4dannjjm	349	14	improved	improved	JJ
cord-023095-4dannjjm	349	15	success	success	NN
cord-023095-4dannjjm	349	16	in	in	IN
cord-023095-4dannjjm	349	17	resuscitation	resuscitation	NN
cord-023095-4dannjjm	349	18	and	and	CC
cord-023095-4dannjjm	349	19	survival	survival	NN
cord-023095-4dannjjm	349	20	.	.	.
cord-023095-4dannjjm	350	1	Left	leave	VBN
cord-023095-4dannjjm	350	2	ventricular	ventricular	JJ
cord-023095-4dannjjm	350	3	(	(	-LRB-
cord-023095-4dannjjm	350	4	LV	LV	NNP
cord-023095-4dannjjm	350	5	)	)	-RRB-
cord-023095-4dannjjm	350	6	systolic	systolic	JJ
cord-023095-4dannjjm	350	7	dysfunction	dysfunction	NN
cord-023095-4dannjjm	350	8	is	be	VBZ
cord-023095-4dannjjm	350	9	a	a	DT
cord-023095-4dannjjm	350	10	common	common	JJ
cord-023095-4dannjjm	350	11	problem	problem	NN
cord-023095-4dannjjm	350	12	in	in	IN
cord-023095-4dannjjm	350	13	dogs	dog	NNS
cord-023095-4dannjjm	350	14	and	and	CC
cord-023095-4dannjjm	350	15	can	can	MD
cord-023095-4dannjjm	350	16	be	be	VB
cord-023095-4dannjjm	350	17	due	due	JJ
cord-023095-4dannjjm	350	18	to	to	IN
cord-023095-4dannjjm	350	19	a	a	DT
cord-023095-4dannjjm	350	20	variety	variety	NN
cord-023095-4dannjjm	350	21	of	of	IN
cord-023095-4dannjjm	350	22	etiologies	etiology	NNS
cord-023095-4dannjjm	350	23	.	.	.
cord-023095-4dannjjm	351	1	One	one	CD
cord-023095-4dannjjm	351	2	potential	potential	JJ
cord-023095-4dannjjm	351	3	etiology	etiology	NN
cord-023095-4dannjjm	351	4	for	for	IN
cord-023095-4dannjjm	351	5	systolic	systolic	JJ
cord-023095-4dannjjm	351	6	dysfunction	dysfunction	NN
cord-023095-4dannjjm	351	7	is	be	VBZ
cord-023095-4dannjjm	351	8	persistent	persistent	JJ
cord-023095-4dannjjm	351	9	or	or	CC
cord-023095-4dannjjm	351	10	paroxysmal	paroxysmal	JJ
cord-023095-4dannjjm	351	11	tachyarrhythmias	tachyarrhythmia	NNS
cord-023095-4dannjjm	351	12	,	,	,
cord-023095-4dannjjm	351	13	leading	lead	VBG
cord-023095-4dannjjm	351	14	to	to	IN
cord-023095-4dannjjm	351	15	tachycardia	tachycardia	NN
cord-023095-4dannjjm	351	16	-	-	HYPH
cord-023095-4dannjjm	351	17	induced	induce	VBN
cord-023095-4dannjjm	351	18	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	351	19	(	(	-LRB-
cord-023095-4dannjjm	351	20	TICM	TICM	NNP
cord-023095-4dannjjm	351	21	)	)	-RRB-
cord-023095-4dannjjm	351	22	.	.	.
cord-023095-4dannjjm	352	1	In	in	IN
cord-023095-4dannjjm	352	2	humans	human	NNS
cord-023095-4dannjjm	352	3	,	,	,
cord-023095-4dannjjm	352	4	TICM	TICM	NNP
cord-023095-4dannjjm	352	5	carries	carry	VBZ
cord-023095-4dannjjm	352	6	a	a	DT
cord-023095-4dannjjm	352	7	relatively	relatively	RB
cord-023095-4dannjjm	352	8	good	good	JJ
cord-023095-4dannjjm	352	9	prognosis	prognosis	NN
cord-023095-4dannjjm	352	10	in	in	IN
cord-023095-4dannjjm	352	11	that	that	DT
cord-023095-4dannjjm	352	12	remodeling	remodeling	NN
cord-023095-4dannjjm	352	13	may	may	MD
cord-023095-4dannjjm	352	14	be	be	VB
cord-023095-4dannjjm	352	15	reversible	reversible	JJ
cord-023095-4dannjjm	352	16	with	with	IN
cord-023095-4dannjjm	352	17	normalization	normalization	NN
cord-023095-4dannjjm	352	18	of	of	IN
cord-023095-4dannjjm	352	19	heart	heart	NN
cord-023095-4dannjjm	352	20	rate	rate	NN
cord-023095-4dannjjm	352	21	.	.	.
cord-023095-4dannjjm	353	1	Differentiating	differentiate	VBG
cord-023095-4dannjjm	353	2	between	between	IN
cord-023095-4dannjjm	353	3	primary	primary	JJ
cord-023095-4dannjjm	353	4	and	and	CC
cord-023095-4dannjjm	353	5	secondary	secondary	JJ
cord-023095-4dannjjm	353	6	tachyarrhythmias	tachyarrhythmia	NNS
cord-023095-4dannjjm	353	7	in	in	IN
cord-023095-4dannjjm	353	8	dogs	dog	NNS
cord-023095-4dannjjm	353	9	with	with	IN
cord-023095-4dannjjm	353	10	systolic	systolic	JJ
cord-023095-4dannjjm	353	11	dysfunction	dysfunction	NN
cord-023095-4dannjjm	353	12	is	be	VBZ
cord-023095-4dannjjm	353	13	critical	critical	JJ
cord-023095-4dannjjm	353	14	for	for	IN
cord-023095-4dannjjm	353	15	prognostic	prognostic	JJ
cord-023095-4dannjjm	353	16	purposes	purpose	NNS
cord-023095-4dannjjm	353	17	as	as	IN
cord-023095-4dannjjm	353	18	primary	primary	JJ
cord-023095-4dannjjm	353	19	tachyarrhythmias	tachyarrhythmia	NNS
cord-023095-4dannjjm	353	20	may	may	MD
cord-023095-4dannjjm	353	21	be	be	VB
cord-023095-4dannjjm	353	22	associated	associate	VBN
cord-023095-4dannjjm	353	23	with	with	IN
cord-023095-4dannjjm	353	24	a	a	DT
cord-023095-4dannjjm	353	25	better	well	JJR
cord-023095-4dannjjm	353	26	outcome	outcome	NN
cord-023095-4dannjjm	353	27	.	.	.
cord-023095-4dannjjm	354	1	The	the	DT
cord-023095-4dannjjm	354	2	goal	goal	NN
cord-023095-4dannjjm	354	3	of	of	IN
cord-023095-4dannjjm	354	4	our	-PRON-	PRP$
cord-023095-4dannjjm	354	5	study	study	NN
cord-023095-4dannjjm	354	6	was	be	VBD
cord-023095-4dannjjm	354	7	to	to	TO
cord-023095-4dannjjm	354	8	describe	describe	VB
cord-023095-4dannjjm	354	9	a	a	DT
cord-023095-4dannjjm	354	10	population	population	NN
cord-023095-4dannjjm	354	11	of	of	IN
cord-023095-4dannjjm	354	12	dogs	dog	NNS
cord-023095-4dannjjm	354	13	with	with	IN
cord-023095-4dannjjm	354	14	TICM	TICM	NNP
cord-023095-4dannjjm	354	15	and	and	CC
cord-023095-4dannjjm	354	16	to	to	TO
cord-023095-4dannjjm	354	17	determine	determine	VB
cord-023095-4dannjjm	354	18	if	if	IN
cord-023095-4dannjjm	354	19	treatment	treatment	NN
cord-023095-4dannjjm	354	20	of	of	IN
cord-023095-4dannjjm	354	21	arrhythmias	arrhythmia	NNS
cord-023095-4dannjjm	354	22	was	be	VBD
cord-023095-4dannjjm	354	23	associated	associate	VBN
cord-023095-4dannjjm	354	24	with	with	IN
cord-023095-4dannjjm	354	25	reversible	reversible	JJ
cord-023095-4dannjjm	354	26	cardiac	cardiac	JJ
cord-023095-4dannjjm	354	27	remodeling	remodeling	NN
cord-023095-4dannjjm	354	28	as	as	IN
cord-023095-4dannjjm	354	29	indicated	indicate	VBN
cord-023095-4dannjjm	354	30	by	by	IN
cord-023095-4dannjjm	354	31	standard	standard	JJ
cord-023095-4dannjjm	354	32	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	354	33	parameters	parameter	NNS
cord-023095-4dannjjm	354	34	.	.	.
cord-023095-4dannjjm	355	1	Medical	medical	JJ
cord-023095-4dannjjm	355	2	records	record	NNS
cord-023095-4dannjjm	355	3	of	of	IN
cord-023095-4dannjjm	355	4	dogs	dog	NNS
cord-023095-4dannjjm	355	5	referred	refer	VBN
cord-023095-4dannjjm	355	6	to	to	IN
cord-023095-4dannjjm	355	7	the	the	DT
cord-023095-4dannjjm	355	8	cardiology	cardiology	NN
cord-023095-4dannjjm	355	9	service	service	NN
cord-023095-4dannjjm	355	10	of	of	IN
cord-023095-4dannjjm	355	11	KSU	KSU	NNP
cord-023095-4dannjjm	355	12	VMTH	VMTH	NNP
cord-023095-4dannjjm	355	13	from	from	IN
cord-023095-4dannjjm	355	14	2008	2008	CD
cord-023095-4dannjjm	355	15	to	to	IN
cord-023095-4dannjjm	355	16	2010	2010	CD
cord-023095-4dannjjm	355	17	were	be	VBD
cord-023095-4dannjjm	355	18	reviewed	review	VBN
cord-023095-4dannjjm	355	19	.	.	.
cord-023095-4dannjjm	356	1	TICM	TICM	NNP
cord-023095-4dannjjm	356	2	was	be	VBD
cord-023095-4dannjjm	356	3	defined	define	VBN
cord-023095-4dannjjm	356	4	as	as	IN
cord-023095-4dannjjm	356	5	the	the	DT
cord-023095-4dannjjm	356	6	presence	presence	NN
cord-023095-4dannjjm	356	7	of	of	IN
cord-023095-4dannjjm	356	8	severe	severe	JJ
cord-023095-4dannjjm	356	9	tachyarrhythmias	tachyarrhythmia	NNS
cord-023095-4dannjjm	356	10	that	that	WDT
cord-023095-4dannjjm	356	11	were	be	VBD
cord-023095-4dannjjm	356	12	reversible	reversible	JJ
cord-023095-4dannjjm	356	13	with	with	IN
cord-023095-4dannjjm	356	14	treatment	treatment	NN
cord-023095-4dannjjm	356	15	,	,	,
cord-023095-4dannjjm	356	16	systolic	systolic	JJ
cord-023095-4dannjjm	356	17	dysfunction	dysfunction	NN
cord-023095-4dannjjm	356	18	or	or	CC
cord-023095-4dannjjm	356	19	ventricular	ventricular	JJ
cord-023095-4dannjjm	356	20	enlargement	enlargement	NN
cord-023095-4dannjjm	356	21	that	that	WDT
cord-023095-4dannjjm	356	22	improved	improve	VBD
cord-023095-4dannjjm	356	23	with	with	IN
cord-023095-4dannjjm	356	24	treatment	treatment	NN
cord-023095-4dannjjm	356	25	of	of	IN
cord-023095-4dannjjm	356	26	the	the	DT
cord-023095-4dannjjm	356	27	arrhythmia	arrhythmia	NN
cord-023095-4dannjjm	356	28	,	,	,
cord-023095-4dannjjm	356	29	or	or	CC
cord-023095-4dannjjm	356	30	dogs	dog	NNS
cord-023095-4dannjjm	356	31	with	with	IN
cord-023095-4dannjjm	356	32	severe	severe	JJ
cord-023095-4dannjjm	356	33	tachyarrhythmias	tachyarrhythmia	NNS
cord-023095-4dannjjm	356	34	and	and	CC
cord-023095-4dannjjm	356	35	systolic	systolic	JJ
cord-023095-4dannjjm	356	36	dysfunction	dysfunction	NN
cord-023095-4dannjjm	356	37	of	of	IN
cord-023095-4dannjjm	356	38	breeds	breed	NNS
cord-023095-4dannjjm	356	39	with	with	IN
cord-023095-4dannjjm	356	40	that	that	DT
cord-023095-4dannjjm	356	41	are	be	VBP
cord-023095-4dannjjm	356	42	atypical	atypical	JJ
cord-023095-4dannjjm	356	43	for	for	IN
cord-023095-4dannjjm	356	44	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	356	45	dilated	dilated	JJ
cord-023095-4dannjjm	356	46	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	356	47	.	.	.
cord-023095-4dannjjm	357	1	Exclusion	exclusion	NN
cord-023095-4dannjjm	357	2	criteria	criterion	NNS
cord-023095-4dannjjm	357	3	were	be	VBD
cord-023095-4dannjjm	357	4	dogs	dog	NNS
cord-023095-4dannjjm	357	5	with	with	IN
cord-023095-4dannjjm	357	6	congenital	congenital	JJ
cord-023095-4dannjjm	357	7	heart	heart	NN
cord-023095-4dannjjm	357	8	disease	disease	NN
cord-023095-4dannjjm	357	9	,	,	,
cord-023095-4dannjjm	357	10	severe	severe	JJ
cord-023095-4dannjjm	357	11	mitral	mitral	JJ
cord-023095-4dannjjm	357	12	regurgitation	regurgitation	NN
cord-023095-4dannjjm	357	13	,	,	,
cord-023095-4dannjjm	357	14	and	and	CC
cord-023095-4dannjjm	357	15	endocarditis	endocarditis	NN
cord-023095-4dannjjm	357	16	.	.	.
cord-023095-4dannjjm	358	1	Transthoracic	Transthoracic	NNP
cord-023095-4dannjjm	358	2	echocardiography	echocardiography	NN
cord-023095-4dannjjm	358	3	,	,	,
cord-023095-4dannjjm	358	4	thoracic	thoracic	JJ
cord-023095-4dannjjm	358	5	radiographs	radiograph	NNS
cord-023095-4dannjjm	358	6	and	and	CC
cord-023095-4dannjjm	358	7	electrocardiography	electrocardiography	NN
cord-023095-4dannjjm	358	8	(	(	-LRB-
cord-023095-4dannjjm	358	9	ECG	ECG	NNP
cord-023095-4dannjjm	358	10	)	)	-RRB-
cord-023095-4dannjjm	358	11	were	be	VBD
cord-023095-4dannjjm	358	12	performed	perform	VBN
cord-023095-4dannjjm	358	13	in	in	IN
cord-023095-4dannjjm	358	14	all	all	DT
cord-023095-4dannjjm	358	15	dogs	dog	NNS
cord-023095-4dannjjm	358	16	.	.	.
cord-023095-4dannjjm	359	1	Ventricular	ventricular	JJ
cord-023095-4dannjjm	359	2	enlargement	enlargement	NN
cord-023095-4dannjjm	359	3	and	and	CC
cord-023095-4dannjjm	359	4	systolic	systolic	JJ
cord-023095-4dannjjm	359	5	dysfunction	dysfunction	NN
cord-023095-4dannjjm	359	6	were	be	VBD
cord-023095-4dannjjm	359	7	defined	define	VBN
cord-023095-4dannjjm	359	8	according	accord	VBG
cord-023095-4dannjjm	359	9	to	to	IN
cord-023095-4dannjjm	359	10	standard	standard	JJ
cord-023095-4dannjjm	359	11	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	359	12	parameters	parameter	NNS
cord-023095-4dannjjm	359	13	.	.	.
cord-023095-4dannjjm	360	1	Arrhythmias	arrhythmia	NNS
cord-023095-4dannjjm	360	2	were	be	VBD
cord-023095-4dannjjm	360	3	confirmed	confirm	VBN
cord-023095-4dannjjm	360	4	with	with	IN
cord-023095-4dannjjm	360	5	a	a	DT
cord-023095-4dannjjm	360	6	Holter	Holter	NNP
cord-023095-4dannjjm	360	7	monitor	monitor	NN
cord-023095-4dannjjm	360	8	in	in	IN
cord-023095-4dannjjm	360	9	7	7	CD
cord-023095-4dannjjm	360	10	dogs	dog	NNS
cord-023095-4dannjjm	360	11	.	.	.
cord-023095-4dannjjm	361	1	A	a	DT
cord-023095-4dannjjm	361	2	total	total	NN
cord-023095-4dannjjm	361	3	of	of	IN
cord-023095-4dannjjm	361	4	12	12	CD
cord-023095-4dannjjm	361	5	dogs	dog	NNS
cord-023095-4dannjjm	361	6	were	be	VBD
cord-023095-4dannjjm	361	7	included	include	VBN
cord-023095-4dannjjm	361	8	in	in	IN
cord-023095-4dannjjm	361	9	the	the	DT
cord-023095-4dannjjm	361	10	study	study	NN
cord-023095-4dannjjm	361	11	.	.	.
cord-023095-4dannjjm	362	1	Mean	mean	JJ
cord-023095-4dannjjm	362	2	age	age	NN
cord-023095-4dannjjm	362	3	was	be	VBD
cord-023095-4dannjjm	362	4	7	7	CD
cord-023095-4dannjjm	362	5	years	year	NNS
cord-023095-4dannjjm	363	1	(	(	-LRB-
cord-023095-4dannjjm	363	2	range	range	NNP
cord-023095-4dannjjm	363	3	2	2	CD
cord-023095-4dannjjm	363	4	-	-	SYM
cord-023095-4dannjjm	363	5	12	12	CD
cord-023095-4dannjjm	363	6	years	year	NNS
cord-023095-4dannjjm	363	7	)	)	-RRB-
cord-023095-4dannjjm	363	8	with	with	IN
cord-023095-4dannjjm	363	9	8	8	CD
cord-023095-4dannjjm	363	10	males	male	NNS
cord-023095-4dannjjm	363	11	(	(	-LRB-
cord-023095-4dannjjm	363	12	4	4	CD
cord-023095-4dannjjm	363	13	intact	intact	JJ
cord-023095-4dannjjm	363	14	,	,	,
cord-023095-4dannjjm	363	15	4	4	CD
cord-023095-4dannjjm	363	16	castrated	castrate	VBN
cord-023095-4dannjjm	363	17	)	)	-RRB-
cord-023095-4dannjjm	363	18	and	and	CC
cord-023095-4dannjjm	363	19	4	4	CD
cord-023095-4dannjjm	363	20	females	female	NNS
cord-023095-4dannjjm	363	21	(	(	-LRB-
cord-023095-4dannjjm	363	22	3	3	CD
cord-023095-4dannjjm	363	23	spayed	spay	VBN
cord-023095-4dannjjm	363	24	,	,	,
cord-023095-4dannjjm	363	25	1	1	CD
cord-023095-4dannjjm	363	26	intact	intact	JJ
cord-023095-4dannjjm	363	27	)	)	-RRB-
cord-023095-4dannjjm	363	28	.	.	.
cord-023095-4dannjjm	364	1	Four	four	CD
cord-023095-4dannjjm	364	2	dogs	dog	NNS
cord-023095-4dannjjm	364	3	had	have	VBD
cord-023095-4dannjjm	364	4	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	364	5	venous	venous	JJ
cord-023095-4dannjjm	364	6	congestion	congestion	NN
cord-023095-4dannjjm	364	7	or	or	CC
cord-023095-4dannjjm	364	8	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	364	9	edema	edema	NN
cord-023095-4dannjjm	364	10	and	and	CC
cord-023095-4dannjjm	364	11	two	two	CD
cord-023095-4dannjjm	364	12	dogs	dog	NNS
cord-023095-4dannjjm	364	13	had	have	VBD
cord-023095-4dannjjm	364	14	ascites	ascite	NNS
cord-023095-4dannjjm	364	15	.	.	.
cord-023095-4dannjjm	365	1	At	at	IN
cord-023095-4dannjjm	365	2	initial	initial	JJ
cord-023095-4dannjjm	365	3	presentation	presentation	NN
cord-023095-4dannjjm	365	4	,	,	,
cord-023095-4dannjjm	365	5	the	the	DT
cord-023095-4dannjjm	365	6	meanAESD	meanaesd	FW
cord-023095-4dannjjm	365	7	values	value	NNS
cord-023095-4dannjjm	365	8	were	be	VBD
cord-023095-4dannjjm	365	9	as	as	IN
cord-023095-4dannjjm	365	10	follows	follow	VBZ
cord-023095-4dannjjm	365	11	:	:	:
cord-023095-4dannjjm	365	12	heart	heart	NN
cord-023095-4dannjjm	365	13	rate	rate	NN
cord-023095-4dannjjm	365	14	219AE75	219AE75	NNP
cord-023095-4dannjjm	365	15	bpm	bpm	NNP
cord-023095-4dannjjm	365	16	,	,	,
cord-023095-4dannjjm	365	17	M	M	NNP
cord-023095-4dannjjm	365	18	-	-	HYPH
cord-023095-4dannjjm	365	19	mode	mode	NN
cord-023095-4dannjjm	365	20	fractional	fractional	JJ
cord-023095-4dannjjm	365	21	shortening	shortening	NN
cord-023095-4dannjjm	365	22	(	(	-LRB-
cord-023095-4dannjjm	365	23	FS	FS	NNP
cord-023095-4dannjjm	365	24	)	)	-RRB-
cord-023095-4dannjjm	365	25	17.29AE9.05	17.29ae9.05	CD
cord-023095-4dannjjm	365	26	%	%	NN
cord-023095-4dannjjm	365	27	,	,	,
cord-023095-4dannjjm	365	28	ejection	ejection	NN
cord-023095-4dannjjm	365	29	fraction	fraction	NN
cord-023095-4dannjjm	365	30	(	(	-LRB-
cord-023095-4dannjjm	365	31	EF	EF	NNP
cord-023095-4dannjjm	365	32	)	)	-RRB-
cord-023095-4dannjjm	365	33	using	use	VBG
cord-023095-4dannjjm	365	34	the	the	DT
cord-023095-4dannjjm	365	35	area	area	NN
cord-023095-4dannjjm	365	36	-	-	HYPH
cord-023095-4dannjjm	365	37	length	length	NN
cord-023095-4dannjjm	365	38	method	method	NN
cord-023095-4dannjjm	365	39	30.69AE13.45	30.69ae13.45	CD
cord-023095-4dannjjm	365	40	%	%	NN
cord-023095-4dannjjm	365	41	,	,	,
cord-023095-4dannjjm	365	42	and	and	CC
cord-023095-4dannjjm	365	43	left	leave	VBN
cord-023095-4dannjjm	365	44	atrial	atrial	JJ
cord-023095-4dannjjm	365	45	to	to	IN
cord-023095-4dannjjm	365	46	aortic	aortic	JJ
cord-023095-4dannjjm	365	47	root	root	NN
cord-023095-4dannjjm	365	48	ratio	ratio	NN
cord-023095-4dannjjm	365	49	(	(	-LRB-
cord-023095-4dannjjm	365	50	LA	LA	NNP
cord-023095-4dannjjm	365	51	/	/	SYM
cord-023095-4dannjjm	365	52	Ao	Ao	NNP
cord-023095-4dannjjm	365	53	)	)	-RRB-
cord-023095-4dannjjm	365	54	1.92AE0.37	1.92ae0.37	CD
cord-023095-4dannjjm	365	55	.	.	.
cord-023095-4dannjjm	366	1	Initial	initial	JJ
cord-023095-4dannjjm	366	2	meanAESD	meanaesd	NN
cord-023095-4dannjjm	366	3	M	M	NNP
cord-023095-4dannjjm	366	4	-	-	HYPH
cord-023095-4dannjjm	366	5	mode	mode	NN
cord-023095-4dannjjm	366	6	derived	derive	VBN
cord-023095-4dannjjm	366	7	LV	LV	NNP
cord-023095-4dannjjm	366	8	internal	internal	JJ
cord-023095-4dannjjm	366	9	dimensions	dimension	NNS
cord-023095-4dannjjm	366	10	corrected	correct	VBN
cord-023095-4dannjjm	366	11	for	for	IN
cord-023095-4dannjjm	366	12	body	body	NN
cord-023095-4dannjjm	366	13	weight	weight	NN
cord-023095-4dannjjm	366	14	were	be	VBD
cord-023095-4dannjjm	366	15	as	as	IN
cord-023095-4dannjjm	366	16	follows	follow	VBZ
cord-023095-4dannjjm	366	17	:	:	:
cord-023095-4dannjjm	366	18	diastolic	diastolic	JJ
cord-023095-4dannjjm	366	19	1.92AE0.37	1.92ae0.37	CD
cord-023095-4dannjjm	366	20	and	and	CC
cord-023095-4dannjjm	366	21	systolic	systolic	JJ
cord-023095-4dannjjm	366	22	1.49AE0.38	1.49ae0.38	CD
cord-023095-4dannjjm	366	23	.	.	.
cord-023095-4dannjjm	367	1	At	at	RB
cord-023095-4dannjjm	367	2	least	least	RBS
cord-023095-4dannjjm	367	3	one	one	CD
cord-023095-4dannjjm	367	4	of	of	IN
cord-023095-4dannjjm	367	5	the	the	DT
cord-023095-4dannjjm	367	6	following	following	JJ
cord-023095-4dannjjm	367	7	tachyarrhythmias	tachyarrhythmia	NNS
cord-023095-4dannjjm	367	8	were	be	VBD
cord-023095-4dannjjm	367	9	identified	identify	VBN
cord-023095-4dannjjm	367	10	in	in	IN
cord-023095-4dannjjm	367	11	each	each	DT
cord-023095-4dannjjm	367	12	dog	dog	NN
cord-023095-4dannjjm	367	13	:	:	:
cord-023095-4dannjjm	367	14	atrial	atrial	JJ
cord-023095-4dannjjm	367	15	fibrillation	fibrillation	NN
cord-023095-4dannjjm	367	16	(	(	-LRB-
cord-023095-4dannjjm	367	17	4	4	CD
cord-023095-4dannjjm	367	18	)	)	-RRB-
cord-023095-4dannjjm	367	19	,	,	,
cord-023095-4dannjjm	367	20	supraventricular	supraventricular	JJ
cord-023095-4dannjjm	367	21	tachycardia	tachycardia	NN
cord-023095-4dannjjm	367	22	(	(	-LRB-
cord-023095-4dannjjm	367	23	5	5	CD
cord-023095-4dannjjm	367	24	)	)	-RRB-
cord-023095-4dannjjm	367	25	,	,	,
cord-023095-4dannjjm	367	26	junctional	junctional	JJ
cord-023095-4dannjjm	367	27	tachycardia	tachycardia	NN
cord-023095-4dannjjm	367	28	(	(	-LRB-
cord-023095-4dannjjm	367	29	2	2	CD
cord-023095-4dannjjm	367	30	)	)	-RRB-
cord-023095-4dannjjm	367	31	,	,	,
cord-023095-4dannjjm	367	32	and	and	CC
cord-023095-4dannjjm	367	33	ventricular	ventricular	JJ
cord-023095-4dannjjm	367	34	arrhythmias	arrhythmia	NNS
cord-023095-4dannjjm	367	35	(	(	-LRB-
cord-023095-4dannjjm	367	36	3	3	CD
cord-023095-4dannjjm	367	37	)	)	-RRB-
cord-023095-4dannjjm	367	38	.	.	.
cord-023095-4dannjjm	368	1	Ten	ten	CD
cord-023095-4dannjjm	368	2	dogs	dog	NNS
cord-023095-4dannjjm	368	3	were	be	VBD
cord-023095-4dannjjm	368	4	available	available	JJ
cord-023095-4dannjjm	368	5	for	for	IN
cord-023095-4dannjjm	368	6	follow	follow	NN
cord-023095-4dannjjm	368	7	up	up	RP
cord-023095-4dannjjm	368	8	.	.	.
cord-023095-4dannjjm	369	1	Seven	seven	CD
cord-023095-4dannjjm	369	2	dogs	dog	NNS
cord-023095-4dannjjm	369	3	improved	improve	VBD
cord-023095-4dannjjm	369	4	in	in	IN
cord-023095-4dannjjm	369	5	at	at	RB
cord-023095-4dannjjm	369	6	least	least	RBS
cord-023095-4dannjjm	369	7	one	one	CD
cord-023095-4dannjjm	369	8	of	of	IN
cord-023095-4dannjjm	369	9	the	the	DT
cord-023095-4dannjjm	369	10	following	follow	VBG
cord-023095-4dannjjm	369	11	parameters	parameter	NNS
cord-023095-4dannjjm	369	12	:	:	:
cord-023095-4dannjjm	369	13	resolution	resolution	NN
cord-023095-4dannjjm	369	14	of	of	IN
cord-023095-4dannjjm	369	15	tachyarrhythmia	tachyarrhythmia	NN
cord-023095-4dannjjm	369	16	(	(	-LRB-
cord-023095-4dannjjm	369	17	3	3	CD
cord-023095-4dannjjm	369	18	)	)	-RRB-
cord-023095-4dannjjm	369	19	,	,	,
cord-023095-4dannjjm	369	20	improved	improve	VBN
cord-023095-4dannjjm	369	21	systolic	systolic	JJ
cord-023095-4dannjjm	369	22	function	function	NN
cord-023095-4dannjjm	369	23	(	(	-LRB-
cord-023095-4dannjjm	369	24	3	3	CD
cord-023095-4dannjjm	369	25	)	)	-RRB-
cord-023095-4dannjjm	370	1	Antidiuretic	antidiuretic	JJ
cord-023095-4dannjjm	370	2	hormone	hormone	NN
cord-023095-4dannjjm	370	3	(	(	-LRB-
cord-023095-4dannjjm	370	4	ADH	ADH	NNP
cord-023095-4dannjjm	370	5	)	)	-RRB-
cord-023095-4dannjjm	370	6	has	have	VBZ
cord-023095-4dannjjm	370	7	been	be	VBN
cord-023095-4dannjjm	370	8	shown	show	VBN
cord-023095-4dannjjm	370	9	to	to	TO
cord-023095-4dannjjm	370	10	be	be	VB
cord-023095-4dannjjm	370	11	elevated	elevate	VBN
cord-023095-4dannjjm	370	12	in	in	IN
cord-023095-4dannjjm	370	13	humans	human	NNS
cord-023095-4dannjjm	370	14	with	with	IN
cord-023095-4dannjjm	370	15	congestive	congestive	JJ
cord-023095-4dannjjm	370	16	heart	heart	NN
cord-023095-4dannjjm	370	17	failure	failure	NN
cord-023095-4dannjjm	370	18	(	(	-LRB-
cord-023095-4dannjjm	370	19	CHF	CHF	NNP
cord-023095-4dannjjm	370	20	)	)	-RRB-
cord-023095-4dannjjm	370	21	.	.	.
cord-023095-4dannjjm	371	1	Recently	recently	RB
cord-023095-4dannjjm	371	2	,	,	,
cord-023095-4dannjjm	371	3	antidiuretic	antidiuretic	JJ
cord-023095-4dannjjm	371	4	hormone	hormone	NN
cord-023095-4dannjjm	371	5	antagonists	antagonist	NNS
cord-023095-4dannjjm	371	6	were	be	VBD
cord-023095-4dannjjm	371	7	successful	successful	JJ
cord-023095-4dannjjm	371	8	during	during	IN
cord-023095-4dannjjm	371	9	investigational	investigational	JJ
cord-023095-4dannjjm	371	10	treatment	treatment	NN
cord-023095-4dannjjm	371	11	of	of	IN
cord-023095-4dannjjm	371	12	refractory	refractory	JJ
cord-023095-4dannjjm	371	13	congestive	congestive	JJ
cord-023095-4dannjjm	371	14	heart	heart	NN
cord-023095-4dannjjm	371	15	failure	failure	NN
cord-023095-4dannjjm	371	16	in	in	IN
cord-023095-4dannjjm	371	17	humans	human	NNS
cord-023095-4dannjjm	371	18	.	.	.
cord-023095-4dannjjm	372	1	ADH	ADH	NNP
cord-023095-4dannjjm	372	2	levels	level	NNS
cord-023095-4dannjjm	372	3	have	have	VBP
cord-023095-4dannjjm	372	4	been	be	VBN
cord-023095-4dannjjm	372	5	only	only	RB
cord-023095-4dannjjm	372	6	modestly	modestly	RB
cord-023095-4dannjjm	372	7	investigated	investigate	VBN
cord-023095-4dannjjm	372	8	in	in	IN
cord-023095-4dannjjm	372	9	dogs	dog	NNS
cord-023095-4dannjjm	372	10	with	with	IN
cord-023095-4dannjjm	372	11	cardiac	cardiac	JJ
cord-023095-4dannjjm	372	12	disease	disease	NN
cord-023095-4dannjjm	372	13	,	,	,
cord-023095-4dannjjm	372	14	primarily	primarily	RB
cord-023095-4dannjjm	372	15	due	due	IN
cord-023095-4dannjjm	372	16	to	to	IN
cord-023095-4dannjjm	372	17	the	the	DT
cord-023095-4dannjjm	372	18	technical	technical	JJ
cord-023095-4dannjjm	372	19	difficulty	difficulty	NN
cord-023095-4dannjjm	372	20	in	in	IN
cord-023095-4dannjjm	372	21	measuring	measure	VBG
cord-023095-4dannjjm	372	22	ADH	ADH	NNP
cord-023095-4dannjjm	372	23	levels	level	NNS
cord-023095-4dannjjm	372	24	via	via	IN
cord-023095-4dannjjm	372	25	radioimmunoassay	radioimmunoassay	NN
cord-023095-4dannjjm	372	26	.	.	.
cord-023095-4dannjjm	373	1	Based	base	VBN
cord-023095-4dannjjm	373	2	on	on	IN
cord-023095-4dannjjm	373	3	the	the	DT
cord-023095-4dannjjm	373	4	homologous	homologous	JJ
cord-023095-4dannjjm	373	5	structure	structure	NN
cord-023095-4dannjjm	373	6	of	of	IN
cord-023095-4dannjjm	373	7	canine	canine	JJ
cord-023095-4dannjjm	373	8	and	and	CC
cord-023095-4dannjjm	373	9	human	human	JJ
cord-023095-4dannjjm	373	10	ADH	ADH	NNP
cord-023095-4dannjjm	373	11	,	,	,
cord-023095-4dannjjm	373	12	we	-PRON-	PRP
cord-023095-4dannjjm	373	13	aimed	aim	VBD
cord-023095-4dannjjm	373	14	first	first	RB
cord-023095-4dannjjm	373	15	to	to	TO
cord-023095-4dannjjm	373	16	determine	determine	VB
cord-023095-4dannjjm	373	17	the	the	DT
cord-023095-4dannjjm	373	18	feasibility	feasibility	NN
cord-023095-4dannjjm	373	19	of	of	IN
cord-023095-4dannjjm	373	20	measuring	measure	VBG
cord-023095-4dannjjm	373	21	ADH	ADH	NNP
cord-023095-4dannjjm	373	22	in	in	IN
cord-023095-4dannjjm	373	23	dog	dog	NN
cord-023095-4dannjjm	373	24	plasma	plasma	NN
cord-023095-4dannjjm	373	25	using	use	VBG
cord-023095-4dannjjm	373	26	a	a	DT
cord-023095-4dannjjm	373	27	human	human	JJ
cord-023095-4dannjjm	373	28	ELISA	ELISA	NNP
cord-023095-4dannjjm	373	29	kit	kit	NN
cord-023095-4dannjjm	373	30	,	,	,
cord-023095-4dannjjm	373	31	and	and	CC
cord-023095-4dannjjm	373	32	secondly	secondly	RB
cord-023095-4dannjjm	373	33	to	to	TO
cord-023095-4dannjjm	373	34	investigate	investigate	VB
cord-023095-4dannjjm	373	35	the	the	DT
cord-023095-4dannjjm	373	36	level	level	NN
cord-023095-4dannjjm	373	37	of	of	IN
cord-023095-4dannjjm	373	38	ADH	ADH	NNP
cord-023095-4dannjjm	373	39	in	in	IN
cord-023095-4dannjjm	373	40	dogs	dog	NNS
cord-023095-4dannjjm	373	41	with	with	IN
cord-023095-4dannjjm	373	42	congestive	congestive	JJ
cord-023095-4dannjjm	373	43	heart	heart	NN
cord-023095-4dannjjm	373	44	failure	failure	NN
cord-023095-4dannjjm	373	45	due	due	JJ
cord-023095-4dannjjm	373	46	to	to	IN
cord-023095-4dannjjm	373	47	acquired	acquire	VBN
cord-023095-4dannjjm	373	48	cardiac	cardiac	JJ
cord-023095-4dannjjm	373	49	disease	disease	NN
cord-023095-4dannjjm	373	50	.	.	.
cord-023095-4dannjjm	374	1	ELISA	ELISA	NNP
cord-023095-4dannjjm	374	2	assay	assay	NNP
cord-023095-4dannjjm	374	3	kit	kit	NNP
cord-023095-4dannjjm	374	4	validation	validation	NN
cord-023095-4dannjjm	374	5	was	be	VBD
cord-023095-4dannjjm	374	6	performed	perform	VBN
cord-023095-4dannjjm	374	7	using	use	VBG
cord-023095-4dannjjm	374	8	six	six	CD
cord-023095-4dannjjm	374	9	healthy	healthy	JJ
cord-023095-4dannjjm	374	10	dogs	dog	NNS
cord-023095-4dannjjm	374	11	with	with	IN
cord-023095-4dannjjm	374	12	normal	normal	JJ
cord-023095-4dannjjm	374	13	clinical	clinical	JJ
cord-023095-4dannjjm	374	14	and	and	CC
cord-023095-4dannjjm	374	15	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	374	16	examinations	examination	NNS
cord-023095-4dannjjm	374	17	.	.	.
cord-023095-4dannjjm	375	1	Pooled	pool	VBN
cord-023095-4dannjjm	375	2	canine	canine	JJ
cord-023095-4dannjjm	375	3	plasma	plasma	NN
cord-023095-4dannjjm	375	4	was	be	VBD
cord-023095-4dannjjm	375	5	spiked	spike	VBN
cord-023095-4dannjjm	375	6	with	with	IN
cord-023095-4dannjjm	375	7	synthetic	synthetic	JJ
cord-023095-4dannjjm	375	8	ADH	ADH	NNP
cord-023095-4dannjjm	375	9	and	and	CC
cord-023095-4dannjjm	375	10	intra	intra	JJ
cord-023095-4dannjjm	375	11	-	-	JJ
cord-023095-4dannjjm	375	12	assay	assay	JJ
cord-023095-4dannjjm	375	13	precision	precision	NN
cord-023095-4dannjjm	375	14	,	,	,
cord-023095-4dannjjm	375	15	dilutional	dilutional	JJ
cord-023095-4dannjjm	375	16	parallelism	parallelism	NN
cord-023095-4dannjjm	375	17	,	,	,
cord-023095-4dannjjm	375	18	and	and	CC
cord-023095-4dannjjm	375	19	linearity	linearity	NN
cord-023095-4dannjjm	375	20	were	be	VBD
cord-023095-4dannjjm	375	21	assessed	assess	VBN
cord-023095-4dannjjm	375	22	.	.	.
cord-023095-4dannjjm	376	1	To	to	TO
cord-023095-4dannjjm	376	2	address	address	VB
cord-023095-4dannjjm	376	3	the	the	DT
cord-023095-4dannjjm	376	4	second	second	JJ
cord-023095-4dannjjm	376	5	aim	aim	NN
cord-023095-4dannjjm	376	6	of	of	IN
cord-023095-4dannjjm	376	7	the	the	DT
cord-023095-4dannjjm	376	8	study	study	NN
cord-023095-4dannjjm	376	9	,	,	,
cord-023095-4dannjjm	376	10	samples	sample	NNS
cord-023095-4dannjjm	376	11	were	be	VBD
cord-023095-4dannjjm	376	12	collected	collect	VBN
cord-023095-4dannjjm	376	13	from	from	IN
cord-023095-4dannjjm	376	14	normal	normal	JJ
cord-023095-4dannjjm	376	15	dogs	dog	NNS
cord-023095-4dannjjm	376	16	and	and	CC
cord-023095-4dannjjm	376	17	dogs	dog	NNS
cord-023095-4dannjjm	376	18	with	with	IN
cord-023095-4dannjjm	376	19	heart	heart	NN
cord-023095-4dannjjm	376	20	failure	failure	NN
cord-023095-4dannjjm	376	21	due	due	JJ
cord-023095-4dannjjm	376	22	to	to	IN
cord-023095-4dannjjm	376	23	one	one	CD
cord-023095-4dannjjm	376	24	of	of	IN
cord-023095-4dannjjm	376	25	two	two	CD
cord-023095-4dannjjm	376	26	types	type	NNS
cord-023095-4dannjjm	376	27	of	of	IN
cord-023095-4dannjjm	376	28	acquired	acquire	VBN
cord-023095-4dannjjm	376	29	cardiac	cardiac	JJ
cord-023095-4dannjjm	376	30	disease	disease	NN
cord-023095-4dannjjm	376	31	:	:	:
cord-023095-4dannjjm	376	32	chronic	chronic	JJ
cord-023095-4dannjjm	376	33	degenerative	degenerative	JJ
cord-023095-4dannjjm	376	34	valve	valve	NN
cord-023095-4dannjjm	376	35	disease	disease	NN
cord-023095-4dannjjm	376	36	(	(	-LRB-
cord-023095-4dannjjm	376	37	CDVD	CDVD	NNP
cord-023095-4dannjjm	376	38	)	)	-RRB-
cord-023095-4dannjjm	376	39	or	or	CC
cord-023095-4dannjjm	376	40	dilated	dilated	JJ
cord-023095-4dannjjm	376	41	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	376	42	(	(	-LRB-
cord-023095-4dannjjm	376	43	DCM	DCM	NNP
cord-023095-4dannjjm	376	44	)	)	-RRB-
cord-023095-4dannjjm	376	45	.	.	.
cord-023095-4dannjjm	377	1	Patients	patient	NNS
cord-023095-4dannjjm	377	2	underwent	undergo	VBD
cord-023095-4dannjjm	377	3	clinical	clinical	JJ
cord-023095-4dannjjm	377	4	,	,	,
cord-023095-4dannjjm	377	5	radiographic	radiographic	JJ
cord-023095-4dannjjm	377	6	,	,	,
cord-023095-4dannjjm	377	7	and	and	CC
cord-023095-4dannjjm	377	8	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	377	9	examination	examination	NN
cord-023095-4dannjjm	377	10	to	to	TO
cord-023095-4dannjjm	377	11	confirm	confirm	VB
cord-023095-4dannjjm	377	12	diagnosis	diagnosis	NN
cord-023095-4dannjjm	377	13	,	,	,
cord-023095-4dannjjm	377	14	assess	assess	VB
cord-023095-4dannjjm	377	15	severity	severity	NN
cord-023095-4dannjjm	377	16	of	of	IN
cord-023095-4dannjjm	377	17	disease	disease	NN
cord-023095-4dannjjm	377	18	,	,	,
cord-023095-4dannjjm	377	19	and	and	CC
cord-023095-4dannjjm	377	20	determine	determine	VB
cord-023095-4dannjjm	377	21	presence	presence	NN
cord-023095-4dannjjm	377	22	of	of	IN
cord-023095-4dannjjm	377	23	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	377	24	edema	edema	NN
cord-023095-4dannjjm	377	25	.	.	.
cord-023095-4dannjjm	378	1	Whole	whole	JJ
cord-023095-4dannjjm	378	2	blood	blood	NN
cord-023095-4dannjjm	378	3	was	be	VBD
cord-023095-4dannjjm	378	4	collected	collect	VBN
cord-023095-4dannjjm	378	5	into	into	IN
cord-023095-4dannjjm	378	6	EDTA	EDTA	NNP
cord-023095-4dannjjm	378	7	tubes	tube	NNS
cord-023095-4dannjjm	378	8	containing	contain	VBG
cord-023095-4dannjjm	378	9	protease	protease	NN
cord-023095-4dannjjm	378	10	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	378	11	,	,	,
cord-023095-4dannjjm	378	12	cold	cold	JJ
cord-023095-4dannjjm	378	13	centrifuged	centrifuge	VBN
cord-023095-4dannjjm	378	14	,	,	,
cord-023095-4dannjjm	378	15	and	and	CC
cord-023095-4dannjjm	378	16	plasma	plasma	NN
cord-023095-4dannjjm	378	17	was	be	VBD
cord-023095-4dannjjm	378	18	stored	store	VBN
cord-023095-4dannjjm	378	19	at	at	IN
cord-023095-4dannjjm	378	20	À801	À801	NNS
cord-023095-4dannjjm	378	21	until	until	IN
cord-023095-4dannjjm	378	22	analysis	analysis	NN
cord-023095-4dannjjm	378	23	.	.	.
cord-023095-4dannjjm	379	1	Following	follow	VBG
cord-023095-4dannjjm	379	2	ether	ether	NN
cord-023095-4dannjjm	379	3	extraction	extraction	NN
cord-023095-4dannjjm	379	4	,	,	,
cord-023095-4dannjjm	379	5	plasma	plasma	NN
cord-023095-4dannjjm	379	6	ADH	ADH	NNP
cord-023095-4dannjjm	379	7	in	in	IN
cord-023095-4dannjjm	379	8	each	each	DT
cord-023095-4dannjjm	379	9	sample	sample	NN
cord-023095-4dannjjm	379	10	was	be	VBD
cord-023095-4dannjjm	379	11	measured	measure	VBN
cord-023095-4dannjjm	379	12	in	in	IN
cord-023095-4dannjjm	379	13	duplicate	duplicate	NN
cord-023095-4dannjjm	379	14	using	use	VBG
cord-023095-4dannjjm	379	15	a	a	DT
cord-023095-4dannjjm	379	16	human	human	JJ
cord-023095-4dannjjm	379	17	ELISA	ELISA	NNP
cord-023095-4dannjjm	379	18	kit	kit	NN
cord-023095-4dannjjm	379	19	.	.	.
cord-023095-4dannjjm	380	1	Statistical	statistical	JJ
cord-023095-4dannjjm	380	2	analysis	analysis	NN
cord-023095-4dannjjm	380	3	included	include	VBD
cord-023095-4dannjjm	380	4	a	a	DT
cord-023095-4dannjjm	380	5	D	D	NNP
cord-023095-4dannjjm	380	6	-	-	HYPH
cord-023095-4dannjjm	380	7	Agostino	Agostino	NNP
cord-023095-4dannjjm	380	8	and	and	CC
cord-023095-4dannjjm	380	9	Pearson	Pearson	NNP
cord-023095-4dannjjm	380	10	test	test	VBP
cord-023095-4dannjjm	380	11	for	for	IN
cord-023095-4dannjjm	380	12	normality	normality	NN
cord-023095-4dannjjm	380	13	;	;	:
cord-023095-4dannjjm	380	14	group	group	NN
cord-023095-4dannjjm	380	15	results	result	NNS
cord-023095-4dannjjm	380	16	were	be	VBD
cord-023095-4dannjjm	380	17	compared	compare	VBN
cord-023095-4dannjjm	380	18	using	use	VBG
cord-023095-4dannjjm	380	19	a	a	DT
cord-023095-4dannjjm	380	20	nonparametric	nonparametric	JJ
cord-023095-4dannjjm	380	21	Mann	Mann	NNP
cord-023095-4dannjjm	380	22	-	-	HYPH
cord-023095-4dannjjm	380	23	Whitney	Whitney	NNP
cord-023095-4dannjjm	380	24	test	test	NN
cord-023095-4dannjjm	380	25	.	.	.
cord-023095-4dannjjm	381	1	ADH	ADH	NNP
cord-023095-4dannjjm	381	2	was	be	VBD
cord-023095-4dannjjm	381	3	measured	measure	VBN
cord-023095-4dannjjm	381	4	in	in	IN
cord-023095-4dannjjm	381	5	canine	canine	JJ
cord-023095-4dannjjm	381	6	plasma	plasma	NN
cord-023095-4dannjjm	381	7	using	use	VBG
cord-023095-4dannjjm	381	8	the	the	DT
cord-023095-4dannjjm	381	9	human	human	JJ
cord-023095-4dannjjm	381	10	ELISA	ELISA	NNP
cord-023095-4dannjjm	381	11	kit	kit	NN
cord-023095-4dannjjm	381	12	with	with	IN
cord-023095-4dannjjm	381	13	acceptable	acceptable	JJ
cord-023095-4dannjjm	381	14	intra	intra	JJ
cord-023095-4dannjjm	381	15	-	-	JJ
cord-023095-4dannjjm	381	16	assay	assay	JJ
cord-023095-4dannjjm	381	17	precision	precision	NN
cord-023095-4dannjjm	381	18	,	,	,
cord-023095-4dannjjm	381	19	linearity	linearity	NN
cord-023095-4dannjjm	381	20	,	,	,
cord-023095-4dannjjm	381	21	and	and	CC
cord-023095-4dannjjm	381	22	dilutional	dilutional	JJ
cord-023095-4dannjjm	381	23	parallelism	parallelism	NN
cord-023095-4dannjjm	381	24	.	.	.
cord-023095-4dannjjm	382	1	Intra	intra	JJ
cord-023095-4dannjjm	382	2	-	-	JJ
cord-023095-4dannjjm	382	3	assay	assay	JJ
cord-023095-4dannjjm	382	4	coefficient	coefficient	NN
cord-023095-4dannjjm	382	5	of	of	IN
cord-023095-4dannjjm	382	6	variation	variation	NN
cord-023095-4dannjjm	382	7	was	be	VBD
cord-023095-4dannjjm	382	8	11	11	CD
cord-023095-4dannjjm	382	9	%	%	NN
cord-023095-4dannjjm	382	10	.	.	.
cord-023095-4dannjjm	383	1	Twenty	twenty	CD
cord-023095-4dannjjm	383	2	-	-	HYPH
cord-023095-4dannjjm	383	3	four	four	CD
cord-023095-4dannjjm	383	4	dogs	dog	NNS
cord-023095-4dannjjm	383	5	were	be	VBD
cord-023095-4dannjjm	383	6	recruited	recruit	VBN
cord-023095-4dannjjm	383	7	for	for	IN
cord-023095-4dannjjm	383	8	the	the	DT
cord-023095-4dannjjm	383	9	second	second	JJ
cord-023095-4dannjjm	383	10	phase	phase	NN
cord-023095-4dannjjm	383	11	of	of	IN
cord-023095-4dannjjm	383	12	the	the	DT
cord-023095-4dannjjm	383	13	study	study	NN
cord-023095-4dannjjm	383	14	.	.	.
cord-023095-4dannjjm	384	1	Six	six	CD
cord-023095-4dannjjm	384	2	normal	normal	JJ
cord-023095-4dannjjm	384	3	dogs	dog	NNS
cord-023095-4dannjjm	384	4	and	and	CC
cord-023095-4dannjjm	384	5	twelve	twelve	CD
cord-023095-4dannjjm	384	6	dogs	dog	NNS
cord-023095-4dannjjm	384	7	with	with	IN
cord-023095-4dannjjm	384	8	radiographic	radiographic	JJ
cord-023095-4dannjjm	384	9	evidence	evidence	NN
cord-023095-4dannjjm	384	10	of	of	IN
cord-023095-4dannjjm	384	11	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	384	12	edema	edema	NN
cord-023095-4dannjjm	384	13	due	due	IN
cord-023095-4dannjjm	384	14	to	to	IN
cord-023095-4dannjjm	384	15	either	either	CC
cord-023095-4dannjjm	384	16	CDVD	CDVD	NNP
cord-023095-4dannjjm	384	17	or	or	CC
cord-023095-4dannjjm	384	18	DCM	DCM	NNP
cord-023095-4dannjjm	384	19	were	be	VBD
cord-023095-4dannjjm	384	20	selected	select	VBN
cord-023095-4dannjjm	384	21	for	for	IN
cord-023095-4dannjjm	384	22	participation	participation	NN
cord-023095-4dannjjm	384	23	.	.	.
cord-023095-4dannjjm	385	1	The	the	DT
cord-023095-4dannjjm	385	2	remaining	remain	VBG
cord-023095-4dannjjm	385	3	six	six	CD
cord-023095-4dannjjm	385	4	dogs	dog	NNS
cord-023095-4dannjjm	385	5	were	be	VBD
cord-023095-4dannjjm	385	6	excluded	exclude	VBN
cord-023095-4dannjjm	385	7	due	due	IN
cord-023095-4dannjjm	385	8	to	to	IN
cord-023095-4dannjjm	385	9	lack	lack	NN
cord-023095-4dannjjm	385	10	of	of	IN
cord-023095-4dannjjm	385	11	definitive	definitive	JJ
cord-023095-4dannjjm	385	12	radiographic	radiographic	JJ
cord-023095-4dannjjm	385	13	evidence	evidence	NN
cord-023095-4dannjjm	385	14	of	of	IN
cord-023095-4dannjjm	385	15	congestive	congestive	JJ
cord-023095-4dannjjm	385	16	heart	heart	NN
cord-023095-4dannjjm	385	17	failure	failure	NN
cord-023095-4dannjjm	385	18	.	.	.
cord-023095-4dannjjm	386	1	Median	median	JJ
cord-023095-4dannjjm	386	2	ADH	ADH	NNP
cord-023095-4dannjjm	386	3	values	value	NNS
cord-023095-4dannjjm	386	4	were	be	VBD
cord-023095-4dannjjm	386	5	3.67	3.67	CD
cord-023095-4dannjjm	386	6	AE	AE	NNP
cord-023095-4dannjjm	386	7	.38	.38	.
cord-023095-4dannjjm	386	8	pg	pg	NN
cord-023095-4dannjjm	386	9	/	/	SYM
cord-023095-4dannjjm	386	10	mL	ml	NN
cord-023095-4dannjjm	386	11	for	for	IN
cord-023095-4dannjjm	386	12	the	the	DT
cord-023095-4dannjjm	386	13	normal	normal	JJ
cord-023095-4dannjjm	386	14	group	group	NN
cord-023095-4dannjjm	386	15	(	(	-LRB-
cord-023095-4dannjjm	386	16	n	n	NN
cord-023095-4dannjjm	386	17	5	5	CD
cord-023095-4dannjjm	386	18	6	6	CD
cord-023095-4dannjjm	386	19	)	)	-RRB-
cord-023095-4dannjjm	386	20	and	and	CC
cord-023095-4dannjjm	386	21	6.155	6.155	CD
cord-023095-4dannjjm	386	22	AE	AE	NNP
cord-023095-4dannjjm	386	23	.94	.94	.
cord-023095-4dannjjm	386	24	pg	pg	NN
cord-023095-4dannjjm	386	25	/	/	SYM
cord-023095-4dannjjm	386	26	mL	ml	NN
cord-023095-4dannjjm	386	27	for	for	IN
cord-023095-4dannjjm	386	28	the	the	DT
cord-023095-4dannjjm	386	29	heart	heart	NN
cord-023095-4dannjjm	386	30	failure	failure	NN
cord-023095-4dannjjm	386	31	group	group	NNP
cord-023095-4dannjjm	386	32	(	(	-LRB-
cord-023095-4dannjjm	386	33	n	n	NN
cord-023095-4dannjjm	386	34	5	5	CD
cord-023095-4dannjjm	386	35	12	12	CD
cord-023095-4dannjjm	386	36	)	)	-RRB-
cord-023095-4dannjjm	386	37	.	.	.
cord-023095-4dannjjm	387	1	Median	median	JJ
cord-023095-4dannjjm	387	2	ADH	ADH	NNP
cord-023095-4dannjjm	387	3	values	value	NNS
cord-023095-4dannjjm	387	4	for	for	IN
cord-023095-4dannjjm	387	5	the	the	DT
cord-023095-4dannjjm	387	6	two	two	CD
cord-023095-4dannjjm	387	7	groups	group	NNS
cord-023095-4dannjjm	387	8	were	be	VBD
cord-023095-4dannjjm	387	9	statistically	statistically	RB
cord-023095-4dannjjm	387	10	different	different	JJ
cord-023095-4dannjjm	387	11	(	(	-LRB-
cord-023095-4dannjjm	387	12	p	p	NN
cord-023095-4dannjjm	387	13	5	5	CD
cord-023095-4dannjjm	387	14	0.0057	0.0057	CD
cord-023095-4dannjjm	387	15	)	)	-RRB-
cord-023095-4dannjjm	387	16	.	.	.
cord-023095-4dannjjm	388	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	388	2	preliminary	preliminary	JJ
cord-023095-4dannjjm	388	3	results	result	NNS
cord-023095-4dannjjm	388	4	indicate	indicate	VBP
cord-023095-4dannjjm	388	5	that	that	IN
cord-023095-4dannjjm	388	6	measuring	measure	VBG
cord-023095-4dannjjm	388	7	canine	canine	JJ
cord-023095-4dannjjm	388	8	ADH	ADH	NNP
cord-023095-4dannjjm	388	9	using	use	VBG
cord-023095-4dannjjm	388	10	a	a	DT
cord-023095-4dannjjm	388	11	human	human	JJ
cord-023095-4dannjjm	388	12	ELISA	ELISA	NNP
cord-023095-4dannjjm	388	13	kit	kit	NN
cord-023095-4dannjjm	388	14	is	be	VBZ
cord-023095-4dannjjm	388	15	feasible	feasible	JJ
cord-023095-4dannjjm	388	16	and	and	CC
cord-023095-4dannjjm	388	17	provides	provide	VBZ
cord-023095-4dannjjm	388	18	results	result	NNS
cord-023095-4dannjjm	388	19	with	with	IN
cord-023095-4dannjjm	388	20	an	an	DT
cord-023095-4dannjjm	388	21	acceptable	acceptable	JJ
cord-023095-4dannjjm	388	22	coefficient	coefficient	NN
cord-023095-4dannjjm	388	23	of	of	IN
cord-023095-4dannjjm	388	24	variation	variation	NN
cord-023095-4dannjjm	388	25	.	.	.
cord-023095-4dannjjm	389	1	We	-PRON-	PRP
cord-023095-4dannjjm	389	2	also	also	RB
cord-023095-4dannjjm	389	3	showed	show	VBD
cord-023095-4dannjjm	389	4	that	that	IN
cord-023095-4dannjjm	389	5	dogs	dog	NNS
cord-023095-4dannjjm	389	6	with	with	IN
cord-023095-4dannjjm	389	7	congestive	congestive	JJ
cord-023095-4dannjjm	389	8	heart	heart	NN
cord-023095-4dannjjm	389	9	failure	failure	NN
cord-023095-4dannjjm	389	10	due	due	JJ
cord-023095-4dannjjm	389	11	to	to	IN
cord-023095-4dannjjm	389	12	CDVD	CDVD	NNP
cord-023095-4dannjjm	389	13	and	and	CC
cord-023095-4dannjjm	389	14	DCM	DCM	NNP
cord-023095-4dannjjm	389	15	have	have	VBP
cord-023095-4dannjjm	389	16	elevated	elevate	VBN
cord-023095-4dannjjm	389	17	ADH	ADH	NNP
cord-023095-4dannjjm	389	18	levels	level	NNS
cord-023095-4dannjjm	389	19	in	in	IN
cord-023095-4dannjjm	389	20	comparison	comparison	NN
cord-023095-4dannjjm	389	21	to	to	IN
cord-023095-4dannjjm	389	22	normal	normal	JJ
cord-023095-4dannjjm	389	23	dogs	dog	NNS
cord-023095-4dannjjm	389	24	.	.	.
cord-023095-4dannjjm	390	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	390	2	findings	finding	NNS
cord-023095-4dannjjm	390	3	motivate	motivate	VBP
cord-023095-4dannjjm	390	4	further	further	JJ
cord-023095-4dannjjm	390	5	investigation	investigation	NN
cord-023095-4dannjjm	390	6	to	to	TO
cord-023095-4dannjjm	390	7	assess	assess	VB
cord-023095-4dannjjm	390	8	the	the	DT
cord-023095-4dannjjm	390	9	degree	degree	NN
cord-023095-4dannjjm	390	10	of	of	IN
cord-023095-4dannjjm	390	11	plasma	plasma	NN
cord-023095-4dannjjm	390	12	ADH	ADH	NNP
cord-023095-4dannjjm	390	13	level	level	NN
cord-023095-4dannjjm	390	14	elevation	elevation	NN
cord-023095-4dannjjm	390	15	and	and	CC
cord-023095-4dannjjm	390	16	the	the	DT
cord-023095-4dannjjm	390	17	possible	possible	JJ
cord-023095-4dannjjm	390	18	use	use	NN
cord-023095-4dannjjm	390	19	of	of	IN
cord-023095-4dannjjm	390	20	ADH	ADH	NNP
cord-023095-4dannjjm	390	21	antagonists	antagonist	NNS
cord-023095-4dannjjm	390	22	as	as	IN
cord-023095-4dannjjm	390	23	an	an	DT
cord-023095-4dannjjm	390	24	adjunct	adjunct	JJ
cord-023095-4dannjjm	390	25	treatment	treatment	NN
cord-023095-4dannjjm	390	26	for	for	IN
cord-023095-4dannjjm	390	27	refractory	refractory	JJ
cord-023095-4dannjjm	390	28	congestive	congestive	JJ
cord-023095-4dannjjm	390	29	heart	heart	NN
cord-023095-4dannjjm	390	30	failure	failure	NN
cord-023095-4dannjjm	390	31	in	in	IN
cord-023095-4dannjjm	390	32	dogs	dog	NNS
cord-023095-4dannjjm	390	33	.	.	.
cord-023095-4dannjjm	391	1	Aortic	aortic	JJ
cord-023095-4dannjjm	391	2	thromboembolism	thromboembolism	NN
cord-023095-4dannjjm	391	3	(	(	-LRB-
cord-023095-4dannjjm	391	4	ATE	ate	NN
cord-023095-4dannjjm	391	5	)	)	-RRB-
cord-023095-4dannjjm	391	6	occurs	occur	VBZ
cord-023095-4dannjjm	391	7	in	in	IN
cord-023095-4dannjjm	391	8	both	both	DT
cord-023095-4dannjjm	391	9	cats	cat	NNS
cord-023095-4dannjjm	391	10	and	and	CC
cord-023095-4dannjjm	391	11	dogs	dog	NNS
cord-023095-4dannjjm	391	12	.	.	.
cord-023095-4dannjjm	392	1	Whereas	whereas	IN
cord-023095-4dannjjm	392	2	ATE	eat	VBD
cord-023095-4dannjjm	392	3	in	in	IN
cord-023095-4dannjjm	392	4	cats	cat	NNS
cord-023095-4dannjjm	392	5	is	be	VBZ
cord-023095-4dannjjm	392	6	strongly	strongly	RB
cord-023095-4dannjjm	392	7	associated	associate	VBN
cord-023095-4dannjjm	392	8	with	with	IN
cord-023095-4dannjjm	392	9	structural	structural	JJ
cord-023095-4dannjjm	392	10	heart	heart	NN
cord-023095-4dannjjm	392	11	disease	disease	NN
cord-023095-4dannjjm	392	12	and	and	CC
cord-023095-4dannjjm	392	13	typically	typically	RB
cord-023095-4dannjjm	392	14	has	have	VBZ
cord-023095-4dannjjm	392	15	an	an	DT
cord-023095-4dannjjm	392	16	acute	acute	JJ
cord-023095-4dannjjm	392	17	catastrophic	catastrophic	JJ
cord-023095-4dannjjm	392	18	presentation	presentation	NN
cord-023095-4dannjjm	392	19	;	;	:
cord-023095-4dannjjm	392	20	the	the	DT
cord-023095-4dannjjm	392	21	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	392	22	and	and	CC
cord-023095-4dannjjm	392	23	presentation	presentation	NN
cord-023095-4dannjjm	392	24	of	of	IN
cord-023095-4dannjjm	392	25	ATE	eat	VBD
cord-023095-4dannjjm	392	26	in	in	IN
cord-023095-4dannjjm	392	27	dogs	dog	NNS
cord-023095-4dannjjm	392	28	is	be	VBZ
cord-023095-4dannjjm	392	29	less	less	RBR
cord-023095-4dannjjm	392	30	well	well	RB
cord-023095-4dannjjm	392	31	known	known	JJ
cord-023095-4dannjjm	392	32	or	or	CC
cord-023095-4dannjjm	392	33	understood	understand	VBN
cord-023095-4dannjjm	392	34	.	.	.
cord-023095-4dannjjm	393	1	Further	further	RB
cord-023095-4dannjjm	393	2	,	,	,
cord-023095-4dannjjm	393	3	an	an	DT
cord-023095-4dannjjm	393	4	effective	effective	JJ
cord-023095-4dannjjm	393	5	antithrombotic	antithrombotic	JJ
cord-023095-4dannjjm	393	6	strategy	strategy	NN
cord-023095-4dannjjm	393	7	for	for	IN
cord-023095-4dannjjm	393	8	ATE	eat	VBD
cord-023095-4dannjjm	393	9	in	in	IN
cord-023095-4dannjjm	393	10	dogs	dog	NNS
cord-023095-4dannjjm	393	11	has	have	VBZ
cord-023095-4dannjjm	393	12	not	not	RB
cord-023095-4dannjjm	393	13	been	be	VBN
cord-023095-4dannjjm	393	14	reported	report	VBN
cord-023095-4dannjjm	393	15	.	.	.
cord-023095-4dannjjm	394	1	Medical	medical	JJ
cord-023095-4dannjjm	394	2	records	record	NNS
cord-023095-4dannjjm	394	3	of	of	IN
cord-023095-4dannjjm	394	4	dogs	dog	NNS
cord-023095-4dannjjm	394	5	diagnosed	diagnose	VBN
cord-023095-4dannjjm	394	6	with	with	IN
cord-023095-4dannjjm	394	7	ATE	eat	VBD
cord-023095-4dannjjm	394	8	between	between	IN
cord-023095-4dannjjm	394	9	2003	2003	CD
cord-023095-4dannjjm	394	10	and	and	CC
cord-023095-4dannjjm	394	11	2010	2010	CD
cord-023095-4dannjjm	394	12	were	be	VBD
cord-023095-4dannjjm	394	13	examined	examine	VBN
cord-023095-4dannjjm	394	14	retrospectively	retrospectively	RB
cord-023095-4dannjjm	394	15	.	.	.
cord-023095-4dannjjm	395	1	Diagnosis	diagnosis	NN
cord-023095-4dannjjm	395	2	of	of	IN
cord-023095-4dannjjm	395	3	ATE	ATE	NNP
cord-023095-4dannjjm	395	4	was	be	VBD
cord-023095-4dannjjm	395	5	based	base	VBN
cord-023095-4dannjjm	395	6	on	on	IN
cord-023095-4dannjjm	395	7	ultrasonography	ultrasonography	NN
cord-023095-4dannjjm	395	8	,	,	,
cord-023095-4dannjjm	395	9	Doppler	Doppler	NNP
cord-023095-4dannjjm	395	10	flow	flow	NN
cord-023095-4dannjjm	395	11	studies	study	NNS
cord-023095-4dannjjm	395	12	,	,	,
cord-023095-4dannjjm	395	13	and	and	CC
cord-023095-4dannjjm	395	14	diminished	diminish	VBD
cord-023095-4dannjjm	395	15	or	or	CC
cord-023095-4dannjjm	395	16	absent	absent	JJ
cord-023095-4dannjjm	395	17	femoral	femoral	JJ
cord-023095-4dannjjm	395	18	pulses	pulse	NNS
cord-023095-4dannjjm	395	19	.	.	.
cord-023095-4dannjjm	396	1	Dogs	dog	NNS
cord-023095-4dannjjm	396	2	were	be	VBD
cord-023095-4dannjjm	396	3	treated	treat	VBN
cord-023095-4dannjjm	396	4	with	with	IN
cord-023095-4dannjjm	396	5	various	various	JJ
cord-023095-4dannjjm	396	6	acute	acute	JJ
cord-023095-4dannjjm	396	7	and	and	CC
cord-023095-4dannjjm	396	8	chronic	chronic	JJ
cord-023095-4dannjjm	396	9	antithrombotic	antithrombotic	JJ
cord-023095-4dannjjm	396	10	therapies	therapy	NNS
cord-023095-4dannjjm	396	11	.	.	.
cord-023095-4dannjjm	397	1	The	the	DT
cord-023095-4dannjjm	397	2	severity	severity	NN
cord-023095-4dannjjm	397	3	of	of	IN
cord-023095-4dannjjm	397	4	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	397	5	dysfunction	dysfunction	NN
cord-023095-4dannjjm	397	6	was	be	VBD
cord-023095-4dannjjm	397	7	graded	grade	VBN
cord-023095-4dannjjm	397	8	as	as	IN
cord-023095-4dannjjm	397	9	none	none	NN
cord-023095-4dannjjm	397	10	,	,	,
cord-023095-4dannjjm	397	11	mild	mild	JJ
cord-023095-4dannjjm	397	12	,	,	,
cord-023095-4dannjjm	397	13	moderate	moderate	JJ
cord-023095-4dannjjm	397	14	,	,	,
cord-023095-4dannjjm	397	15	severe	severe	JJ
cord-023095-4dannjjm	397	16	,	,	,
cord-023095-4dannjjm	397	17	or	or	CC
cord-023095-4dannjjm	397	18	non	non	JJ
cord-023095-4dannjjm	397	19	-	-	JJ
cord-023095-4dannjjm	397	20	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	397	21	at	at	IN
cord-023095-4dannjjm	397	22	presentation	presentation	NN
cord-023095-4dannjjm	397	23	and	and	CC
cord-023095-4dannjjm	397	24	after	after	IN
cord-023095-4dannjjm	397	25	therapy	therapy	NN
cord-023095-4dannjjm	397	26	.	.	.
cord-023095-4dannjjm	398	1	A	a	DT
cord-023095-4dannjjm	398	2	cohort	cohort	NN
cord-023095-4dannjjm	398	3	of	of	IN
cord-023095-4dannjjm	398	4	dogs	dog	NNS
cord-023095-4dannjjm	398	5	in	in	IN
cord-023095-4dannjjm	398	6	this	this	DT
cord-023095-4dannjjm	398	7	study	study	NN
cord-023095-4dannjjm	398	8	received	receive	VBD
cord-023095-4dannjjm	398	9	a	a	DT
cord-023095-4dannjjm	398	10	standardized	standardized	JJ
cord-023095-4dannjjm	398	11	protocol	protocol	NN
cord-023095-4dannjjm	398	12	of	of	IN
cord-023095-4dannjjm	398	13	chronic	chronic	JJ
cord-023095-4dannjjm	398	14	warfarin	warfarin	NN
cord-023095-4dannjjm	398	15	therapy	therapy	NN
cord-023095-4dannjjm	398	16	with	with	IN
cord-023095-4dannjjm	398	17	or	or	CC
cord-023095-4dannjjm	398	18	without	without	IN
cord-023095-4dannjjm	398	19	antiplatelet	antiplatelet	JJ
cord-023095-4dannjjm	398	20	drugs	drug	NNS
cord-023095-4dannjjm	398	21	.	.	.
cord-023095-4dannjjm	399	1	Target	target	VB
cord-023095-4dannjjm	399	2	international	international	JJ
cord-023095-4dannjjm	399	3	normalized	normalize	VBN
cord-023095-4dannjjm	399	4	ratio	ratio	NN
cord-023095-4dannjjm	399	5	for	for	IN
cord-023095-4dannjjm	399	6	warfarin	warfarin	NN
cord-023095-4dannjjm	399	7	therapy	therapy	NN
cord-023095-4dannjjm	399	8	was	be	VBD
cord-023095-4dannjjm	399	9	2	2	CD
cord-023095-4dannjjm	399	10	to	to	IN
cord-023095-4dannjjm	399	11	3	3	CD
cord-023095-4dannjjm	399	12	.	.	.
cord-023095-4dannjjm	400	1	Twenty	twenty	CD
cord-023095-4dannjjm	400	2	-	-	HYPH
cord-023095-4dannjjm	400	3	six	six	CD
cord-023095-4dannjjm	400	4	dogs	dog	NNS
cord-023095-4dannjjm	400	5	were	be	VBD
cord-023095-4dannjjm	400	6	diagnosed	diagnose	VBN
cord-023095-4dannjjm	400	7	with	with	IN
cord-023095-4dannjjm	400	8	ATE	ATE	NNP
cord-023095-4dannjjm	400	9	.	.	.
cord-023095-4dannjjm	401	1	All	all	DT
cord-023095-4dannjjm	401	2	had	have	VBD
cord-023095-4dannjjm	401	3	an	an	DT
cord-023095-4dannjjm	401	4	apparent	apparent	JJ
cord-023095-4dannjjm	401	5	mural	mural	JJ
cord-023095-4dannjjm	401	6	aortic	aortic	JJ
cord-023095-4dannjjm	401	7	thrombus	thrombus	NN
cord-023095-4dannjjm	401	8	caudal	caudal	RB
cord-023095-4dannjjm	401	9	to	to	IN
cord-023095-4dannjjm	401	10	the	the	DT
cord-023095-4dannjjm	401	11	renal	renal	JJ
cord-023095-4dannjjm	401	12	arteries	artery	NNS
cord-023095-4dannjjm	401	13	with	with	IN
cord-023095-4dannjjm	401	14	most	most	RBS
cord-023095-4dannjjm	401	15	having	have	VBG
cord-023095-4dannjjm	401	16	evidence	evidence	NN
cord-023095-4dannjjm	401	17	of	of	IN
cord-023095-4dannjjm	401	18	embolization	embolization	NN
cord-023095-4dannjjm	401	19	to	to	IN
cord-023095-4dannjjm	401	20	the	the	DT
cord-023095-4dannjjm	401	21	iliac	iliac	JJ
cord-023095-4dannjjm	401	22	and	and	CC
cord-023095-4dannjjm	401	23	femoral	femoral	JJ
cord-023095-4dannjjm	401	24	arteries	artery	NNS
cord-023095-4dannjjm	401	25	.	.	.
cord-023095-4dannjjm	402	1	None	none	NN
cord-023095-4dannjjm	402	2	had	have	VBD
cord-023095-4dannjjm	402	3	structural	structural	JJ
cord-023095-4dannjjm	402	4	heart	heart	NN
cord-023095-4dannjjm	402	5	disease	disease	NN
cord-023095-4dannjjm	402	6	at	at	IN
cord-023095-4dannjjm	402	7	diagnosis	diagnosis	NN
cord-023095-4dannjjm	402	8	.	.	.
cord-023095-4dannjjm	403	1	Twenty	twenty	CD
cord-023095-4dannjjm	403	2	dogs	dog	NNS
cord-023095-4dannjjm	403	3	(	(	-LRB-
cord-023095-4dannjjm	403	4	77	77	CD
cord-023095-4dannjjm	403	5	%	%	NN
cord-023095-4dannjjm	403	6	)	)	-RRB-
cord-023095-4dannjjm	403	7	were	be	VBD
cord-023095-4dannjjm	403	8	still	still	RB
cord-023095-4dannjjm	403	9	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	403	10	at	at	IN
cord-023095-4dannjjm	403	11	diagnosis	diagnosis	NN
cord-023095-4dannjjm	403	12	.	.	.
cord-023095-4dannjjm	404	1	The	the	DT
cord-023095-4dannjjm	404	2	median	median	JJ
cord-023095-4dannjjm	404	3	duration	duration	NN
cord-023095-4dannjjm	404	4	of	of	IN
cord-023095-4dannjjm	404	5	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	404	6	dysfunction	dysfunction	NN
cord-023095-4dannjjm	404	7	prior	prior	RB
cord-023095-4dannjjm	404	8	to	to	IN
cord-023095-4dannjjm	404	9	presentation	presentation	NN
cord-023095-4dannjjm	404	10	was	be	VBD
cord-023095-4dannjjm	404	11	7.8	7.8	CD
cord-023095-4dannjjm	404	12	weeks	week	NNS
cord-023095-4dannjjm	405	1	(	(	-LRB-
cord-023095-4dannjjm	405	2	range	range	NN
cord-023095-4dannjjm	405	3	1	1	CD
cord-023095-4dannjjm	405	4	day	day	NN
cord-023095-4dannjjm	405	5	-52	-52	CD
cord-023095-4dannjjm	405	6	weeks	week	NNS
cord-023095-4dannjjm	405	7	)	)	-RRB-
cord-023095-4dannjjm	405	8	.	.	.
cord-023095-4dannjjm	406	1	A	a	DT
cord-023095-4dannjjm	406	2	majority	majority	NN
cord-023095-4dannjjm	406	3	of	of	IN
cord-023095-4dannjjm	406	4	dogs	dog	NNS
cord-023095-4dannjjm	406	5	(	(	-LRB-
cord-023095-4dannjjm	406	6	58	58	CD
cord-023095-4dannjjm	406	7	%	%	NN
cord-023095-4dannjjm	406	8	)	)	-RRB-
cord-023095-4dannjjm	406	9	had	have	VBD
cord-023095-4dannjjm	406	10	no	no	DT
cord-023095-4dannjjm	406	11	concurrent	concurrent	JJ
cord-023095-4dannjjm	406	12	conditions	condition	NNS
cord-023095-4dannjjm	406	13	at	at	IN
cord-023095-4dannjjm	406	14	diagnosis	diagnosis	NN
cord-023095-4dannjjm	406	15	.	.	.
cord-023095-4dannjjm	407	1	Nine	nine	CD
cord-023095-4dannjjm	407	2	dogs	dog	NNS
cord-023095-4dannjjm	407	3	(	(	-LRB-
cord-023095-4dannjjm	407	4	33	33	CD
cord-023095-4dannjjm	407	5	%	%	NN
cord-023095-4dannjjm	407	6	)	)	-RRB-
cord-023095-4dannjjm	407	7	had	have	VBD
cord-023095-4dannjjm	407	8	protein	protein	NN
cord-023095-4dannjjm	407	9	-	-	HYPH
cord-023095-4dannjjm	407	10	losing	lose	VBG
cord-023095-4dannjjm	407	11	nephropathy	nephropathy	NN
cord-023095-4dannjjm	407	12	.	.	.
cord-023095-4dannjjm	408	1	Four	four	CD
cord-023095-4dannjjm	408	2	dogs	dog	NNS
cord-023095-4dannjjm	408	3	(	(	-LRB-
cord-023095-4dannjjm	408	4	15	15	CD
cord-023095-4dannjjm	408	5	%	%	NN
cord-023095-4dannjjm	408	6	)	)	-RRB-
cord-023095-4dannjjm	408	7	were	be	VBD
cord-023095-4dannjjm	408	8	hypothyroid	hypothyroid	JJ
cord-023095-4dannjjm	408	9	.	.	.
cord-023095-4dannjjm	409	1	Fourteen	fourteen	CD
cord-023095-4dannjjm	409	2	dogs	dog	NNS
cord-023095-4dannjjm	409	3	were	be	VBD
cord-023095-4dannjjm	409	4	treated	treat	VBN
cord-023095-4dannjjm	409	5	with	with	IN
cord-023095-4dannjjm	409	6	a	a	DT
cord-023095-4dannjjm	409	7	standard	standard	JJ
cord-023095-4dannjjm	409	8	warfarin	warfarin	NN
cord-023095-4dannjjm	409	9	protocol	protocol	NN
cord-023095-4dannjjm	409	10	for	for	IN
cord-023095-4dannjjm	409	11	a	a	DT
cord-023095-4dannjjm	409	12	median	median	JJ
cord-023095-4dannjjm	409	13	period	period	NN
cord-023095-4dannjjm	409	14	of	of	IN
cord-023095-4dannjjm	409	15	22.9	22.9	CD
cord-023095-4dannjjm	409	16	months	month	NNS
cord-023095-4dannjjm	409	17	(	(	-LRB-
cord-023095-4dannjjm	409	18	range	range	VBP
cord-023095-4dannjjm	409	19	0.5	0.5	CD
cord-023095-4dannjjm	409	20	-	-	HYPH
cord-023095-4dannjjm	409	21	53	53	CD
cord-023095-4dannjjm	409	22	months	month	NNS
cord-023095-4dannjjm	409	23	)	)	-RRB-
cord-023095-4dannjjm	409	24	.	.	.
cord-023095-4dannjjm	410	1	Eight	eight	CD
cord-023095-4dannjjm	410	2	dogs	dog	NNS
cord-023095-4dannjjm	410	3	were	be	VBD
cord-023095-4dannjjm	410	4	treated	treat	VBN
cord-023095-4dannjjm	410	5	concurrently	concurrently	RB
cord-023095-4dannjjm	410	6	with	with	IN
cord-023095-4dannjjm	410	7	aspirin	aspirin	NN
cord-023095-4dannjjm	410	8	,	,	,
cord-023095-4dannjjm	410	9	2	2	CD
cord-023095-4dannjjm	410	10	dogs	dog	NNS
cord-023095-4dannjjm	410	11	were	be	VBD
cord-023095-4dannjjm	410	12	treated	treat	VBN
cord-023095-4dannjjm	410	13	concurrently	concurrently	RB
cord-023095-4dannjjm	410	14	with	with	IN
cord-023095-4dannjjm	410	15	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	410	16	,	,	,
cord-023095-4dannjjm	410	17	and	and	CC
cord-023095-4dannjjm	410	18	4	4	CD
cord-023095-4dannjjm	410	19	dogs	dog	NNS
cord-023095-4dannjjm	410	20	were	be	VBD
cord-023095-4dannjjm	410	21	treated	treat	VBN
cord-023095-4dannjjm	410	22	with	with	IN
cord-023095-4dannjjm	410	23	warfarin	warfarin	NN
cord-023095-4dannjjm	410	24	only	only	RB
cord-023095-4dannjjm	410	25	.	.	.
cord-023095-4dannjjm	411	1	Ambulatory	ambulatory	JJ
cord-023095-4dannjjm	411	2	function	function	NN
cord-023095-4dannjjm	411	3	improved	improve	VBN
cord-023095-4dannjjm	411	4	between	between	IN
cord-023095-4dannjjm	411	5	1	1	CD
cord-023095-4dannjjm	411	6	and	and	CC
cord-023095-4dannjjm	411	7	3	3	CD
cord-023095-4dannjjm	411	8	grades	grade	NNS
cord-023095-4dannjjm	411	9	in	in	IN
cord-023095-4dannjjm	411	10	dogs	dog	NNS
cord-023095-4dannjjm	411	11	treated	treat	VBN
cord-023095-4dannjjm	411	12	with	with	IN
cord-023095-4dannjjm	411	13	chronic	chronic	JJ
cord-023095-4dannjjm	411	14	warfarin	warfarin	NN
cord-023095-4dannjjm	411	15	.	.	.
cord-023095-4dannjjm	412	1	The	the	DT
cord-023095-4dannjjm	412	2	median	median	JJ
cord-023095-4dannjjm	412	3	period	period	NN
cord-023095-4dannjjm	412	4	until	until	IN
cord-023095-4dannjjm	412	5	clinical	clinical	JJ
cord-023095-4dannjjm	412	6	improvement	improvement	NN
cord-023095-4dannjjm	412	7	was	be	VBD
cord-023095-4dannjjm	412	8	13.9	13.9	CD
cord-023095-4dannjjm	412	9	days	day	NNS
cord-023095-4dannjjm	412	10	(	(	-LRB-
cord-023095-4dannjjm	412	11	range	range	NNP
cord-023095-4dannjjm	412	12	2	2	CD
cord-023095-4dannjjm	412	13	-	-	SYM
cord-023095-4dannjjm	412	14	49	49	CD
cord-023095-4dannjjm	412	15	days	day	NNS
cord-023095-4dannjjm	412	16	)	)	-RRB-
cord-023095-4dannjjm	412	17	.	.	.
cord-023095-4dannjjm	413	1	Two	two	CD
cord-023095-4dannjjm	413	2	dogs	dog	NNS
cord-023095-4dannjjm	413	3	treated	treat	VBN
cord-023095-4dannjjm	413	4	with	with	IN
cord-023095-4dannjjm	413	5	chronic	chronic	JJ
cord-023095-4dannjjm	413	6	warfarin	warfarin	NN
cord-023095-4dannjjm	413	7	therapy	therapy	NN
cord-023095-4dannjjm	413	8	had	have	VBD
cord-023095-4dannjjm	413	9	documented	document	VBN
cord-023095-4dannjjm	413	10	resolution	resolution	NN
cord-023095-4dannjjm	413	11	of	of	IN
cord-023095-4dannjjm	413	12	ATE	ATE	NNP
cord-023095-4dannjjm	413	13	,	,	,
cord-023095-4dannjjm	413	14	and	and	CC
cord-023095-4dannjjm	413	15	5	5	CD
cord-023095-4dannjjm	413	16	dogs	dog	NNS
cord-023095-4dannjjm	413	17	had	have	VBD
cord-023095-4dannjjm	413	18	complete	complete	JJ
cord-023095-4dannjjm	413	19	resolution	resolution	NN
cord-023095-4dannjjm	413	20	of	of	IN
cord-023095-4dannjjm	413	21	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	413	22	dysfunction	dysfunction	NN
cord-023095-4dannjjm	413	23	.	.	.
cord-023095-4dannjjm	414	1	None	none	NN
cord-023095-4dannjjm	414	2	of	of	IN
cord-023095-4dannjjm	414	3	the	the	DT
cord-023095-4dannjjm	414	4	14	14	CD
cord-023095-4dannjjm	414	5	dogs	dog	NNS
cord-023095-4dannjjm	414	6	treated	treat	VBN
cord-023095-4dannjjm	414	7	with	with	IN
cord-023095-4dannjjm	414	8	chronic	chronic	JJ
cord-023095-4dannjjm	414	9	warfarin	warfarin	NN
cord-023095-4dannjjm	414	10	became	become	VBD
cord-023095-4dannjjm	414	11	nonambulatory	nonambulatory	NNP
cord-023095-4dannjjm	414	12	,	,	,
cord-023095-4dannjjm	414	13	died	die	VBD
cord-023095-4dannjjm	414	14	,	,	,
cord-023095-4dannjjm	414	15	or	or	CC
cord-023095-4dannjjm	414	16	underwent	undergo	VBD
cord-023095-4dannjjm	414	17	euthanasia	euthanasia	JJ
cord-023095-4dannjjm	414	18	because	because	IN
cord-023095-4dannjjm	414	19	of	of	IN
cord-023095-4dannjjm	414	20	ATE	ate	NN
cord-023095-4dannjjm	414	21	.	.	.
cord-023095-4dannjjm	415	1	The	the	DT
cord-023095-4dannjjm	415	2	median	median	JJ
cord-023095-4dannjjm	415	3	period	period	NN
cord-023095-4dannjjm	415	4	of	of	IN
cord-023095-4dannjjm	415	5	freedom	freedom	NN
cord-023095-4dannjjm	415	6	from	from	IN
cord-023095-4dannjjm	415	7	an	an	DT
cord-023095-4dannjjm	415	8	adverse	adverse	JJ
cord-023095-4dannjjm	415	9	event	event	NN
cord-023095-4dannjjm	415	10	was	be	VBD
cord-023095-4dannjjm	415	11	24.2	24.2	CD
cord-023095-4dannjjm	415	12	months	month	NNS
cord-023095-4dannjjm	415	13	.	.	.
cord-023095-4dannjjm	416	1	No	no	DT
cord-023095-4dannjjm	416	2	serious	serious	JJ
cord-023095-4dannjjm	416	3	hemorrhagic	hemorrhagic	JJ
cord-023095-4dannjjm	416	4	events	event	NNS
cord-023095-4dannjjm	416	5	were	be	VBD
cord-023095-4dannjjm	416	6	reported	report	VBN
cord-023095-4dannjjm	416	7	.	.	.
cord-023095-4dannjjm	417	1	Four	four	CD
cord-023095-4dannjjm	417	2	dogs	dog	NNS
cord-023095-4dannjjm	417	3	were	be	VBD
cord-023095-4dannjjm	417	4	treated	treat	VBN
cord-023095-4dannjjm	417	5	with	with	IN
cord-023095-4dannjjm	417	6	tPA	tPA	NNP
cord-023095-4dannjjm	417	7	.	.	.
cord-023095-4dannjjm	418	1	Three	three	CD
cord-023095-4dannjjm	418	2	of	of	IN
cord-023095-4dannjjm	418	3	these	these	DT
cord-023095-4dannjjm	418	4	had	have	VBD
cord-023095-4dannjjm	418	5	an	an	DT
cord-023095-4dannjjm	418	6	unfavorable	unfavorable	JJ
cord-023095-4dannjjm	418	7	outcome	outcome	NN
cord-023095-4dannjjm	418	8	.	.	.
cord-023095-4dannjjm	419	1	Two	two	CD
cord-023095-4dannjjm	419	2	dogs	dog	NNS
cord-023095-4dannjjm	419	3	were	be	VBD
cord-023095-4dannjjm	419	4	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	419	5	before	before	IN
cord-023095-4dannjjm	419	6	tPA	tPA	NNP
cord-023095-4dannjjm	419	7	and	and	CC
cord-023095-4dannjjm	419	8	become	become	VB
cord-023095-4dannjjm	419	9	non	non	JJ
cord-023095-4dannjjm	419	10	-	-	JJ
cord-023095-4dannjjm	419	11	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	419	12	after	after	IN
cord-023095-4dannjjm	419	13	treatment	treatment	NN
cord-023095-4dannjjm	419	14	.	.	.
cord-023095-4dannjjm	420	1	Two	two	CD
cord-023095-4dannjjm	420	2	dogs	dog	NNS
cord-023095-4dannjjm	420	3	underwent	undergo	VBD
cord-023095-4dannjjm	420	4	surgical	surgical	JJ
cord-023095-4dannjjm	420	5	thrombectomy	thrombectomy	NN
cord-023095-4dannjjm	420	6	.	.	.
cord-023095-4dannjjm	421	1	One	one	PRP
cord-023095-4dannjjm	421	2	had	have	VBD
cord-023095-4dannjjm	421	3	a	a	DT
cord-023095-4dannjjm	421	4	favorable	favorable	JJ
cord-023095-4dannjjm	421	5	outcome	outcome	NN
cord-023095-4dannjjm	421	6	until	until	IN
cord-023095-4dannjjm	421	7	ATE	eat	VBD
cord-023095-4dannjjm	421	8	recurred	recur	VBN
cord-023095-4dannjjm	421	9	14	14	CD
cord-023095-4dannjjm	421	10	months	month	NNS
cord-023095-4dannjjm	421	11	after	after	IN
cord-023095-4dannjjm	421	12	surgery	surgery	NN
cord-023095-4dannjjm	421	13	.	.	.
cord-023095-4dannjjm	422	1	In	in	IN
cord-023095-4dannjjm	422	2	conclusion	conclusion	NN
cord-023095-4dannjjm	422	3	,	,	,
cord-023095-4dannjjm	422	4	the	the	DT
cord-023095-4dannjjm	422	5	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	422	6	of	of	IN
cord-023095-4dannjjm	422	7	ATE	eat	VBD
cord-023095-4dannjjm	422	8	in	in	IN
cord-023095-4dannjjm	422	9	dogs	dog	NNS
cord-023095-4dannjjm	422	10	is	be	VBZ
cord-023095-4dannjjm	422	11	not	not	RB
cord-023095-4dannjjm	422	12	associated	associate	VBN
cord-023095-4dannjjm	422	13	with	with	IN
cord-023095-4dannjjm	422	14	structural	structural	JJ
cord-023095-4dannjjm	422	15	heart	heart	NN
cord-023095-4dannjjm	422	16	disease	disease	NN
cord-023095-4dannjjm	422	17	or	or	CC
cord-023095-4dannjjm	422	18	left	left	JJ
cord-023095-4dannjjm	422	19	atrial	atrial	JJ
cord-023095-4dannjjm	422	20	thrombus	thrombus	NN
cord-023095-4dannjjm	422	21	formation	formation	NN
cord-023095-4dannjjm	422	22	.	.	.
cord-023095-4dannjjm	423	1	The	the	DT
cord-023095-4dannjjm	423	2	presentation	presentation	NN
cord-023095-4dannjjm	423	3	tends	tend	VBZ
cord-023095-4dannjjm	423	4	to	to	TO
cord-023095-4dannjjm	423	5	be	be	VB
cord-023095-4dannjjm	423	6	for	for	IN
cord-023095-4dannjjm	423	7	chronic	chronic	JJ
cord-023095-4dannjjm	423	8	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	423	9	dysfunction	dysfunction	NN
cord-023095-4dannjjm	423	10	.	.	.
cord-023095-4dannjjm	424	1	Most	Most	JJS
cord-023095-4dannjjm	424	2	dogs	dog	NNS
cord-023095-4dannjjm	424	3	are	be	VBP
cord-023095-4dannjjm	424	4	still	still	RB
cord-023095-4dannjjm	424	5	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	424	6	at	at	IN
cord-023095-4dannjjm	424	7	presentation	presentation	NN
cord-023095-4dannjjm	424	8	.	.	.
cord-023095-4dannjjm	425	1	Warfarin	warfarin	UH
cord-023095-4dannjjm	425	2	,	,	,
cord-023095-4dannjjm	425	3	with	with	IN
cord-023095-4dannjjm	425	4	or	or	CC
cord-023095-4dannjjm	425	5	without	without	IN
cord-023095-4dannjjm	425	6	concurrent	concurrent	JJ
cord-023095-4dannjjm	425	7	antiplatelet	antiplatelet	NN
cord-023095-4dannjjm	425	8	therapy	therapy	NN
cord-023095-4dannjjm	425	9	,	,	,
cord-023095-4dannjjm	425	10	is	be	VBZ
cord-023095-4dannjjm	425	11	an	an	DT
cord-023095-4dannjjm	425	12	effective	effective	JJ
cord-023095-4dannjjm	425	13	antithrombotic	antithrombotic	JJ
cord-023095-4dannjjm	425	14	treatment	treatment	NN
cord-023095-4dannjjm	425	15	strategy	strategy	NN
cord-023095-4dannjjm	425	16	for	for	IN
cord-023095-4dannjjm	425	17	dogs	dog	NNS
cord-023095-4dannjjm	425	18	with	with	IN
cord-023095-4dannjjm	425	19	ATE	ate	NN
cord-023095-4dannjjm	425	20	.	.	.
cord-023095-4dannjjm	426	1	information	information	NN
cord-023095-4dannjjm	426	2	is	be	VBZ
cord-023095-4dannjjm	426	3	known	know	VBN
cord-023095-4dannjjm	426	4	.	.	.
cord-023095-4dannjjm	427	1	Through	through	IN
cord-023095-4dannjjm	427	2	previous	previous	JJ
cord-023095-4dannjjm	427	3	work	work	NN
cord-023095-4dannjjm	427	4	,	,	,
cord-023095-4dannjjm	427	5	investigators	investigator	NNS
cord-023095-4dannjjm	427	6	have	have	VBP
cord-023095-4dannjjm	427	7	encountered	encounter	VBN
cord-023095-4dannjjm	427	8	Norfolk	Norfolk	NNP
cord-023095-4dannjjm	427	9	Terriers	Terriers	NNP
cord-023095-4dannjjm	427	10	(	(	-LRB-
cord-023095-4dannjjm	427	11	NT	NT	NNP
cord-023095-4dannjjm	427	12	)	)	-RRB-
cord-023095-4dannjjm	427	13	with	with	IN
cord-023095-4dannjjm	427	14	echocardiographically	echocardiographically	RB
cord-023095-4dannjjm	427	15	apparent	apparent	JJ
cord-023095-4dannjjm	427	16	DMVD	DMVD	NNS
cord-023095-4dannjjm	427	17	in	in	IN
cord-023095-4dannjjm	427	18	the	the	DT
cord-023095-4dannjjm	427	19	absence	absence	NN
cord-023095-4dannjjm	427	20	of	of	IN
cord-023095-4dannjjm	427	21	a	a	DT
cord-023095-4dannjjm	427	22	heart	heart	NN
cord-023095-4dannjjm	427	23	murmur	murmur	NN
cord-023095-4dannjjm	427	24	.	.	.
cord-023095-4dannjjm	428	1	In	in	IN
cord-023095-4dannjjm	428	2	order	order	NN
cord-023095-4dannjjm	428	3	to	to	TO
cord-023095-4dannjjm	428	4	more	more	RBR
cord-023095-4dannjjm	428	5	fully	fully	RB
cord-023095-4dannjjm	428	6	understand	understand	VB
cord-023095-4dannjjm	428	7	DMVD	DMVD	NNS
cord-023095-4dannjjm	428	8	in	in	IN
cord-023095-4dannjjm	428	9	this	this	DT
cord-023095-4dannjjm	428	10	breed	breed	NN
cord-023095-4dannjjm	428	11	of	of	IN
cord-023095-4dannjjm	428	12	dog	dog	NN
cord-023095-4dannjjm	428	13	,	,	,
cord-023095-4dannjjm	428	14	we	-PRON-	PRP
cord-023095-4dannjjm	428	15	sought	seek	VBD
cord-023095-4dannjjm	428	16	to	to	TO
cord-023095-4dannjjm	428	17	characterize	characterize	VB
cord-023095-4dannjjm	428	18	findings	finding	NNS
cord-023095-4dannjjm	428	19	from	from	IN
cord-023095-4dannjjm	428	20	the	the	DT
cord-023095-4dannjjm	428	21	physical	physical	JJ
cord-023095-4dannjjm	428	22	and	and	CC
cord-023095-4dannjjm	428	23	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	428	24	exam	exam	NN
cord-023095-4dannjjm	428	25	,	,	,
cord-023095-4dannjjm	428	26	biochemical	biochemical	JJ
cord-023095-4dannjjm	428	27	,	,	,
cord-023095-4dannjjm	428	28	biomarker	biomarker	NN
cord-023095-4dannjjm	428	29	,	,	,
cord-023095-4dannjjm	428	30	and	and	CC
cord-023095-4dannjjm	428	31	nutritional	nutritional	JJ
cord-023095-4dannjjm	428	32	profile	profile	NN
cord-023095-4dannjjm	428	33	,	,	,
cord-023095-4dannjjm	428	34	and	and	CC
cord-023095-4dannjjm	428	35	select	select	VB
cord-023095-4dannjjm	428	36	environmental	environmental	JJ
cord-023095-4dannjjm	428	37	variables	variable	NNS
cord-023095-4dannjjm	428	38	from	from	IN
cord-023095-4dannjjm	428	39	a	a	DT
cord-023095-4dannjjm	428	40	cohort	cohort	NN
cord-023095-4dannjjm	428	41	of	of	IN
cord-023095-4dannjjm	428	42	apparently	apparently	RB
cord-023095-4dannjjm	428	43	healthy	healthy	JJ
cord-023095-4dannjjm	428	44	NT	NT	NNP
cord-023095-4dannjjm	428	45	.	.	.
cord-023095-4dannjjm	429	1	Overtly	overtly	RB
cord-023095-4dannjjm	429	2	healthy	healthy	JJ
cord-023095-4dannjjm	429	3	NT	NT	NNP
cord-023095-4dannjjm	429	4	!	!	.
cord-023095-4dannjjm	430	1	6yrs	6yrs	CD
cord-023095-4dannjjm	430	2	old	old	JJ
cord-023095-4dannjjm	430	3	were	be	VBD
cord-023095-4dannjjm	430	4	recruited	recruit	VBN
cord-023095-4dannjjm	430	5	by	by	IN
cord-023095-4dannjjm	430	6	3	3	CD
cord-023095-4dannjjm	430	7	different	different	JJ
cord-023095-4dannjjm	430	8	veterinary	veterinary	JJ
cord-023095-4dannjjm	430	9	hospitals	hospital	NNS
cord-023095-4dannjjm	430	10	and	and	CC
cord-023095-4dannjjm	430	11	underwent	undergo	VBD
cord-023095-4dannjjm	430	12	historical	historical	JJ
cord-023095-4dannjjm	430	13	,	,	,
cord-023095-4dannjjm	430	14	physical	physical	JJ
cord-023095-4dannjjm	430	15	,	,	,
cord-023095-4dannjjm	430	16	ECG	ECG	NNP
cord-023095-4dannjjm	430	17	,	,	,
cord-023095-4dannjjm	430	18	and	and	CC
cord-023095-4dannjjm	430	19	2D	2d	NN
cord-023095-4dannjjm	430	20	/	/	SYM
cord-023095-4dannjjm	430	21	color	color	NN
cord-023095-4dannjjm	430	22	-	-	HYPH
cord-023095-4dannjjm	430	23	flow	flow	NN
cord-023095-4dannjjm	430	24	Doppler	Doppler	NNP
cord-023095-4dannjjm	430	25	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	430	26	exam	exam	NN
cord-023095-4dannjjm	430	27	.	.	.
cord-023095-4dannjjm	431	1	Anterior	anterior	JJ
cord-023095-4dannjjm	431	2	mitral	mitral	JJ
cord-023095-4dannjjm	431	3	valve	valve	NN
cord-023095-4dannjjm	431	4	length	length	NN
cord-023095-4dannjjm	431	5	,	,	,
cord-023095-4dannjjm	431	6	maximal	maximal	JJ
cord-023095-4dannjjm	431	7	thickness	thickness	NN
cord-023095-4dannjjm	431	8	,	,	,
cord-023095-4dannjjm	431	9	area	area	NN
cord-023095-4dannjjm	431	10	,	,	,
cord-023095-4dannjjm	431	11	and	and	CC
cord-023095-4dannjjm	431	12	prolapse	prolapse	NN
cord-023095-4dannjjm	431	13	were	be	VBD
cord-023095-4dannjjm	431	14	measured	measure	VBN
cord-023095-4dannjjm	431	15	from	from	IN
cord-023095-4dannjjm	431	16	2D	2d	NN
cord-023095-4dannjjm	431	17	images	image	NNS
cord-023095-4dannjjm	431	18	.	.	.
cord-023095-4dannjjm	432	1	Presence	presence	NN
cord-023095-4dannjjm	432	2	of	of	IN
cord-023095-4dannjjm	432	3	DMVD	DMVD	NNP
cord-023095-4dannjjm	432	4	was	be	VBD
cord-023095-4dannjjm	432	5	defined	define	VBN
cord-023095-4dannjjm	432	6	as	as	IN
cord-023095-4dannjjm	432	7	thickened	thicken	VBN
cord-023095-4dannjjm	432	8	,	,	,
cord-023095-4dannjjm	432	9	prolapsing	prolapsing	NN
cord-023095-4dannjjm	432	10	,	,	,
cord-023095-4dannjjm	432	11	or	or	CC
cord-023095-4dannjjm	432	12	flail	flail	VB
cord-023095-4dannjjm	432	13	mitral	mitral	JJ
cord-023095-4dannjjm	432	14	valve	valve	NN
cord-023095-4dannjjm	432	15	leaflets	leaflet	NNS
cord-023095-4dannjjm	432	16	in	in	IN
cord-023095-4dannjjm	432	17	the	the	DT
cord-023095-4dannjjm	432	18	presence	presence	NN
cord-023095-4dannjjm	432	19	of	of	IN
cord-023095-4dannjjm	432	20	color	color	NN
cord-023095-4dannjjm	432	21	flow	flow	NN
cord-023095-4dannjjm	432	22	Doppler	Doppler	NNP
cord-023095-4dannjjm	432	23	evidence	evidence	NN
cord-023095-4dannjjm	432	24	of	of	IN
cord-023095-4dannjjm	432	25	mitral	mitral	JJ
cord-023095-4dannjjm	432	26	regurgitation	regurgitation	NN
cord-023095-4dannjjm	432	27	.	.	.
cord-023095-4dannjjm	433	1	Blood	blood	NN
cord-023095-4dannjjm	433	2	samples	sample	NNS
cord-023095-4dannjjm	433	3	were	be	VBD
cord-023095-4dannjjm	433	4	obtained	obtain	VBN
cord-023095-4dannjjm	433	5	for	for	IN
cord-023095-4dannjjm	433	6	serum	serum	NN
cord-023095-4dannjjm	433	7	biochemistry	biochemistry	NN
cord-023095-4dannjjm	433	8	and	and	CC
cord-023095-4dannjjm	433	9	serotonin	serotonin	NN
cord-023095-4dannjjm	433	10	,	,	,
cord-023095-4dannjjm	433	11	plasma	plasma	NN
cord-023095-4dannjjm	433	12	NT	nt	NN
cord-023095-4dannjjm	433	13	-	-	HYPH
cord-023095-4dannjjm	433	14	proBNP	probnp	NN
cord-023095-4dannjjm	433	15	,	,	,
cord-023095-4dannjjm	433	16	amino	amino	NN
cord-023095-4dannjjm	433	17	acid	acid	NN
cord-023095-4dannjjm	433	18	profile	profile	NN
cord-023095-4dannjjm	433	19	,	,	,
cord-023095-4dannjjm	433	20	C	c	NN
cord-023095-4dannjjm	433	21	-	-	HYPH
cord-023095-4dannjjm	433	22	reactive	reactive	JJ
cord-023095-4dannjjm	433	23	protein	protein	NN
cord-023095-4dannjjm	433	24	,	,	,
cord-023095-4dannjjm	433	25	and	and	CC
cord-023095-4dannjjm	433	26	cardiac	cardiac	JJ
cord-023095-4dannjjm	433	27	troponin	troponin	JJ
cord-023095-4dannjjm	433	28	-	-	HYPH
cord-023095-4dannjjm	433	29	I.	I.	NNP
cord-023095-4dannjjm	433	30	Forty	Forty	NNP
cord-023095-4dannjjm	433	31	-	-	HYPH
cord-023095-4dannjjm	433	32	eight	eight	CD
cord-023095-4dannjjm	433	33	dogs	dog	NNS
cord-023095-4dannjjm	433	34	were	be	VBD
cord-023095-4dannjjm	433	35	entered	enter	VBN
cord-023095-4dannjjm	433	36	into	into	IN
cord-023095-4dannjjm	433	37	the	the	DT
cord-023095-4dannjjm	433	38	study	study	NN
cord-023095-4dannjjm	433	39	(	(	-LRB-
cord-023095-4dannjjm	433	40	median	median	JJ
cord-023095-4dannjjm	433	41	age	age	NN
cord-023095-4dannjjm	433	42	,	,	,
cord-023095-4dannjjm	433	43	8yrs	8yrs	NNP
cord-023095-4dannjjm	433	44	IQR	IQR	NNP
cord-023095-4dannjjm	433	45	[	[	-LRB-
cord-023095-4dannjjm	433	46	7	7	CD
cord-023095-4dannjjm	433	47	-	-	SYM
cord-023095-4dannjjm	433	48	10	10	CD
cord-023095-4dannjjm	433	49	]	]	-RRB-
cord-023095-4dannjjm	433	50	;	;	:
cord-023095-4dannjjm	433	51	gender	gender	NN
cord-023095-4dannjjm	433	52	,	,	,
cord-023095-4dannjjm	433	53	29F	29f	CD
cord-023095-4dannjjm	433	54	,	,	,
cord-023095-4dannjjm	433	55	19	19	CD
cord-023095-4dannjjm	433	56	M	M	NNP
cord-023095-4dannjjm	433	57	;	;	:
cord-023095-4dannjjm	433	58	median	median	JJ
cord-023095-4dannjjm	433	59	BCS	BCS	NNP
cord-023095-4dannjjm	433	60	,	,	,
cord-023095-4dannjjm	433	61	)	)	-RRB-
cord-023095-4dannjjm	433	62	.	.	.
cord-023095-4dannjjm	434	1	Of	of	IN
cord-023095-4dannjjm	434	2	the	the	DT
cord-023095-4dannjjm	434	3	48	48	CD
cord-023095-4dannjjm	434	4	dogs	dog	NNS
cord-023095-4dannjjm	434	5	,	,	,
cord-023095-4dannjjm	434	6	23	23	CD
cord-023095-4dannjjm	434	7	(	(	-LRB-
cord-023095-4dannjjm	434	8	48	48	CD
cord-023095-4dannjjm	434	9	%	%	NN
cord-023095-4dannjjm	434	10	)	)	-RRB-
cord-023095-4dannjjm	434	11	had	have	VBD
cord-023095-4dannjjm	434	12	murmurs	murmur	NNS
cord-023095-4dannjjm	434	13	,	,	,
cord-023095-4dannjjm	434	14	2	2	CD
cord-023095-4dannjjm	434	15	(	(	-LRB-
cord-023095-4dannjjm	434	16	4	4	CD
cord-023095-4dannjjm	434	17	%	%	NN
cord-023095-4dannjjm	434	18	)	)	-RRB-
cord-023095-4dannjjm	434	19	had	have	VBD
cord-023095-4dannjjm	434	20	mid	mid	JJ
cord-023095-4dannjjm	434	21	-	-	JJ
cord-023095-4dannjjm	434	22	systolic	systolic	JJ
cord-023095-4dannjjm	434	23	clicks	click	NNS
cord-023095-4dannjjm	434	24	,	,	,
cord-023095-4dannjjm	434	25	11	11	CD
cord-023095-4dannjjm	434	26	(	(	-LRB-
cord-023095-4dannjjm	434	27	23	23	CD
cord-023095-4dannjjm	434	28	%	%	NN
cord-023095-4dannjjm	434	29	)	)	-RRB-
cord-023095-4dannjjm	434	30	had	have	VBD
cord-023095-4dannjjm	434	31	ECG	ECG	NNP
cord-023095-4dannjjm	434	32	p	p	NN
cord-023095-4dannjjm	434	33	-	-	HYPH
cord-023095-4dannjjm	434	34	pulmonale	pulmonale	NN
cord-023095-4dannjjm	434	35	,	,	,
cord-023095-4dannjjm	434	36	and	and	CC
cord-023095-4dannjjm	434	37	41	41	CD
cord-023095-4dannjjm	434	38	(	(	-LRB-
cord-023095-4dannjjm	434	39	85	85	CD
cord-023095-4dannjjm	434	40	%	%	NN
cord-023095-4dannjjm	434	41	)	)	-RRB-
cord-023095-4dannjjm	434	42	were	be	VBD
cord-023095-4dannjjm	434	43	deemed	deem	VBN
cord-023095-4dannjjm	434	44	to	to	TO
cord-023095-4dannjjm	434	45	have	have	VB
cord-023095-4dannjjm	434	46	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	434	47	evidence	evidence	NN
cord-023095-4dannjjm	434	48	of	of	IN
cord-023095-4dannjjm	434	49	DMVD	DMVD	NNP
cord-023095-4dannjjm	434	50	,	,	,
cord-023095-4dannjjm	434	51	including	include	VBG
cord-023095-4dannjjm	434	52	18	18	CD
cord-023095-4dannjjm	434	53	NT	NT	NNP
cord-023095-4dannjjm	434	54	without	without	IN
cord-023095-4dannjjm	434	55	a	a	DT
cord-023095-4dannjjm	434	56	murmur	murmur	NN
cord-023095-4dannjjm	434	57	.	.	.
cord-023095-4dannjjm	435	1	Seven	seven	CD
cord-023095-4dannjjm	435	2	(	(	-LRB-
cord-023095-4dannjjm	435	3	15	15	CD
cord-023095-4dannjjm	435	4	%	%	NN
cord-023095-4dannjjm	435	5	)	)	-RRB-
cord-023095-4dannjjm	435	6	,	,	,
cord-023095-4dannjjm	435	7	28	28	CD
cord-023095-4dannjjm	435	8	(	(	-LRB-
cord-023095-4dannjjm	435	9	58	58	CD
cord-023095-4dannjjm	435	10	%	%	NN
cord-023095-4dannjjm	435	11	)	)	-RRB-
cord-023095-4dannjjm	435	12	,	,	,
cord-023095-4dannjjm	435	13	and	and	CC
cord-023095-4dannjjm	435	14	13	13	CD
cord-023095-4dannjjm	435	15	(	(	-LRB-
cord-023095-4dannjjm	435	16	27	27	CD
cord-023095-4dannjjm	435	17	%	%	NN
cord-023095-4dannjjm	435	18	)	)	-RRB-
cord-023095-4dannjjm	435	19	dogs	dog	NNS
cord-023095-4dannjjm	435	20	were	be	VBD
cord-023095-4dannjjm	435	21	classified	classify	VBN
cord-023095-4dannjjm	435	22	as	as	IN
cord-023095-4dannjjm	435	23	ISACHC	ISACHC	NNP
cord-023095-4dannjjm	435	24	0	0	NFP
cord-023095-4dannjjm	435	25	,	,	,
cord-023095-4dannjjm	435	26	1a	1a	CD
cord-023095-4dannjjm	435	27	,	,	,
cord-023095-4dannjjm	435	28	and	and	CC
cord-023095-4dannjjm	435	29	1b	1b	CD
cord-023095-4dannjjm	435	30	,	,	,
cord-023095-4dannjjm	435	31	respectively	respectively	RB
cord-023095-4dannjjm	435	32	.	.	.
cord-023095-4dannjjm	436	1	Mean	mean	JJ
cord-023095-4dannjjm	436	2	indexed	index	VBN
cord-023095-4dannjjm	436	3	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	436	4	mitral	mitral	JJ
cord-023095-4dannjjm	436	5	leaflet	leaflet	NN
cord-023095-4dannjjm	436	6	length	length	NN
cord-023095-4dannjjm	436	7	(	(	-LRB-
cord-023095-4dannjjm	436	8	P	p	NN
cord-023095-4dannjjm	436	9	o	o	NN
cord-023095-4dannjjm	436	10	0.0001	0.0001	CD
cord-023095-4dannjjm	436	11	)	)	-RRB-
cord-023095-4dannjjm	436	12	,	,	,
cord-023095-4dannjjm	436	13	thickness	thickness	NN
cord-023095-4dannjjm	436	14	(	(	-LRB-
cord-023095-4dannjjm	436	15	P	p	NN
cord-023095-4dannjjm	436	16	5	5	CD
cord-023095-4dannjjm	436	17	0.019	0.019	CD
cord-023095-4dannjjm	436	18	)	)	-RRB-
cord-023095-4dannjjm	436	19	,	,	,
cord-023095-4dannjjm	436	20	prolapse	prolapse	NN
cord-023095-4dannjjm	436	21	(	(	-LRB-
cord-023095-4dannjjm	436	22	P	p	NN
cord-023095-4dannjjm	436	23	5	5	CD
cord-023095-4dannjjm	436	24	0.0005	0.0005	CD
cord-023095-4dannjjm	436	25	)	)	-RRB-
cord-023095-4dannjjm	436	26	,	,	,
cord-023095-4dannjjm	436	27	and	and	CC
cord-023095-4dannjjm	436	28	LA	la	NN
cord-023095-4dannjjm	436	29	:	:	:
cord-023095-4dannjjm	436	30	AoD	AoD	NNP
cord-023095-4dannjjm	436	31	(	(	-LRB-
cord-023095-4dannjjm	436	32	P	p	NN
cord-023095-4dannjjm	436	33	5	5	CD
cord-023095-4dannjjm	436	34	0.01	0.01	CD
cord-023095-4dannjjm	436	35	)	)	-RRB-
cord-023095-4dannjjm	436	36	were	be	VBD
cord-023095-4dannjjm	436	37	significantly	significantly	RB
cord-023095-4dannjjm	436	38	different	different	JJ
cord-023095-4dannjjm	436	39	between	between	IN
cord-023095-4dannjjm	436	40	ISACHC	ISACHC	NNP
cord-023095-4dannjjm	436	41	1a	1a	NNP
cord-023095-4dannjjm	436	42	/	/	SYM
cord-023095-4dannjjm	436	43	b	b	NN
cord-023095-4dannjjm	436	44	vs	vs	IN
cord-023095-4dannjjm	436	45	0	0	CD
cord-023095-4dannjjm	436	46	.	.	.
cord-023095-4dannjjm	437	1	Between	between	IN
cord-023095-4dannjjm	437	2	ISACHC	ISACHC	NNP
cord-023095-4dannjjm	437	3	1a/1b	1a/1b	CD
cord-023095-4dannjjm	437	4	and	and	CC
cord-023095-4dannjjm	437	5	0	0	CD
cord-023095-4dannjjm	437	6	,	,	,
cord-023095-4dannjjm	437	7	there	there	EX
cord-023095-4dannjjm	437	8	were	be	VBD
cord-023095-4dannjjm	437	9	no	no	DT
cord-023095-4dannjjm	437	10	differences	difference	NNS
cord-023095-4dannjjm	437	11	in	in	IN
cord-023095-4dannjjm	437	12	serum	serum	NN
cord-023095-4dannjjm	437	13	amino	amino	NN
cord-023095-4dannjjm	437	14	acids	acid	NNS
cord-023095-4dannjjm	437	15	,	,	,
cord-023095-4dannjjm	437	16	C	c	NN
cord-023095-4dannjjm	437	17	-	-	HYPH
cord-023095-4dannjjm	437	18	reactive	reactive	JJ
cord-023095-4dannjjm	437	19	protein	protein	NN
cord-023095-4dannjjm	437	20	,	,	,
cord-023095-4dannjjm	437	21	troponin	troponin	JJ
cord-023095-4dannjjm	437	22	,	,	,
cord-023095-4dannjjm	437	23	diet	diet	NN
cord-023095-4dannjjm	437	24	,	,	,
cord-023095-4dannjjm	437	25	or	or	CC
cord-023095-4dannjjm	437	26	environmental	environmental	JJ
cord-023095-4dannjjm	437	27	factors	factor	NNS
cord-023095-4dannjjm	437	28	;	;	:
cord-023095-4dannjjm	437	29	however	however	RB
cord-023095-4dannjjm	437	30	6	6	CD
cord-023095-4dannjjm	437	31	different	different	JJ
cord-023095-4dannjjm	437	32	amino	amino	NN
cord-023095-4dannjjm	437	33	acids	acid	NNS
cord-023095-4dannjjm	437	34	(	(	-LRB-
cord-023095-4dannjjm	437	35	Ala	Ala	NNP
cord-023095-4dannjjm	437	36	,	,	,
cord-023095-4dannjjm	437	37	Gly	Gly	NNP
cord-023095-4dannjjm	437	38	,	,	,
cord-023095-4dannjjm	437	39	Phe	Phe	NNP
cord-023095-4dannjjm	437	40	,	,	,
cord-023095-4dannjjm	437	41	Pro	Pro	NNP
cord-023095-4dannjjm	437	42	,	,	,
cord-023095-4dannjjm	437	43	Trp	Trp	NNP
cord-023095-4dannjjm	437	44	,	,	,
cord-023095-4dannjjm	437	45	Tyr	Tyr	NNP
cord-023095-4dannjjm	437	46	)	)	-RRB-
cord-023095-4dannjjm	437	47	were	be	VBD
cord-023095-4dannjjm	437	48	significantly	significantly	RB
cord-023095-4dannjjm	437	49	higher	high	JJR
cord-023095-4dannjjm	437	50	in	in	IN
cord-023095-4dannjjm	437	51	ISACHC	ISACHC	NNP
cord-023095-4dannjjm	437	52	1b	1b	CD
cord-023095-4dannjjm	437	53	vs.	vs.	FW
cord-023095-4dannjjm	437	54	1a	1a	CD
cord-023095-4dannjjm	437	55	.	.	.
cord-023095-4dannjjm	438	1	Median	median	JJ
cord-023095-4dannjjm	438	2	serum	serum	NN
cord-023095-4dannjjm	438	3	serotonin	serotonin	NN
cord-023095-4dannjjm	438	4	was	be	VBD
cord-023095-4dannjjm	438	5	increased	increase	VBN
cord-023095-4dannjjm	438	6	in	in	IN
cord-023095-4dannjjm	438	7	dogs	dog	NNS
cord-023095-4dannjjm	438	8	with	with	IN
cord-023095-4dannjjm	438	9	1a	1a	CD
cord-023095-4dannjjm	438	10	/	/	SYM
cord-023095-4dannjjm	438	11	b	b	NN
cord-023095-4dannjjm	438	12	vs.	vs.	NN
cord-023095-4dannjjm	438	13	0	0	NFP
cord-023095-4dannjjm	439	1	(	(	-LRB-
cord-023095-4dannjjm	439	2	P	p	NN
cord-023095-4dannjjm	439	3	5	5	CD
cord-023095-4dannjjm	439	4	0.025	0.025	CD
cord-023095-4dannjjm	439	5	)	)	-RRB-
cord-023095-4dannjjm	439	6	.	.	.
cord-023095-4dannjjm	440	1	Dogs	dog	NNS
cord-023095-4dannjjm	440	2	whose	whose	WP$
cord-023095-4dannjjm	440	3	diets	diet	NNS
cord-023095-4dannjjm	440	4	contained	contain	VBD
cord-023095-4dannjjm	440	5	some	some	DT
cord-023095-4dannjjm	440	6	canned	can	VBN
cord-023095-4dannjjm	440	7	food	food	NN
cord-023095-4dannjjm	440	8	(	(	-LRB-
cord-023095-4dannjjm	440	9	P	p	NN
cord-023095-4dannjjm	440	10	5	5	CD
cord-023095-4dannjjm	440	11	0.12	0.12	CD
cord-023095-4dannjjm	440	12	)	)	-RRB-
cord-023095-4dannjjm	440	13	and	and	CC
cord-023095-4dannjjm	440	14	dogs	dog	NNS
cord-023095-4dannjjm	440	15	residing	reside	VBG
cord-023095-4dannjjm	440	16	in	in	IN
cord-023095-4dannjjm	440	17	suburban	suburban	JJ
cord-023095-4dannjjm	440	18	environments	environment	NNS
cord-023095-4dannjjm	440	19	(	(	-LRB-
cord-023095-4dannjjm	440	20	P	p	NN
cord-023095-4dannjjm	440	21	5	5	CD
cord-023095-4dannjjm	440	22	0.03	0.03	CD
cord-023095-4dannjjm	440	23	)	)	-RRB-
cord-023095-4dannjjm	440	24	had	have	VBD
cord-023095-4dannjjm	440	25	higher	high	JJR
cord-023095-4dannjjm	440	26	serotonin	serotonin	NN
cord-023095-4dannjjm	440	27	concentrations	concentration	NNS
cord-023095-4dannjjm	440	28	.	.	.
cord-023095-4dannjjm	441	1	NT	NT	NNP
cord-023095-4dannjjm	441	2	-	-	HYPH
cord-023095-4dannjjm	441	3	proBNP	proBNP	NNP
cord-023095-4dannjjm	441	4	tended	tend	VBD
cord-023095-4dannjjm	441	5	(	(	-LRB-
cord-023095-4dannjjm	441	6	P	p	NN
cord-023095-4dannjjm	441	7	5	5	CD
cord-023095-4dannjjm	441	8	0.07	0.07	CD
cord-023095-4dannjjm	441	9	)	)	-RRB-
cord-023095-4dannjjm	441	10	to	to	TO
cord-023095-4dannjjm	441	11	be	be	VB
cord-023095-4dannjjm	441	12	higher	high	JJR
cord-023095-4dannjjm	441	13	in	in	IN
cord-023095-4dannjjm	441	14	ISACHC	ISACHC	NNP
cord-023095-4dannjjm	441	15	1a/1b	1a/1b	CD
cord-023095-4dannjjm	441	16	vs.	vs.	IN
cord-023095-4dannjjm	441	17	0	0	CD
cord-023095-4dannjjm	441	18	.	.	.
cord-023095-4dannjjm	442	1	DMVD	DMVD	NNP
cord-023095-4dannjjm	442	2	appears	appear	VBZ
cord-023095-4dannjjm	442	3	to	to	TO
cord-023095-4dannjjm	442	4	be	be	VB
cord-023095-4dannjjm	442	5	relatively	relatively	RB
cord-023095-4dannjjm	442	6	common	common	JJ
cord-023095-4dannjjm	442	7	in	in	IN
cord-023095-4dannjjm	442	8	NT	NT	NNP
cord-023095-4dannjjm	442	9	and	and	CC
cord-023095-4dannjjm	442	10	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	442	11	changes	change	VBZ
cord-023095-4dannjjm	442	12	consistent	consistent	JJ
cord-023095-4dannjjm	442	13	with	with	IN
cord-023095-4dannjjm	442	14	mild	mild	JJ
cord-023095-4dannjjm	442	15	DMVD	DMVD	NNS
cord-023095-4dannjjm	442	16	can	can	MD
cord-023095-4dannjjm	442	17	be	be	VB
cord-023095-4dannjjm	442	18	seen	see	VBN
cord-023095-4dannjjm	442	19	in	in	IN
cord-023095-4dannjjm	442	20	dogs	dog	NNS
cord-023095-4dannjjm	442	21	without	without	IN
cord-023095-4dannjjm	442	22	a	a	DT
cord-023095-4dannjjm	442	23	heart	heart	NN
cord-023095-4dannjjm	442	24	murmur	murmur	NN
cord-023095-4dannjjm	442	25	.	.	.
cord-023095-4dannjjm	443	1	The	the	DT
cord-023095-4dannjjm	443	2	results	result	NNS
cord-023095-4dannjjm	443	3	of	of	IN
cord-023095-4dannjjm	443	4	this	this	DT
cord-023095-4dannjjm	443	5	study	study	NN
cord-023095-4dannjjm	443	6	establish	establish	VB
cord-023095-4dannjjm	443	7	a	a	DT
cord-023095-4dannjjm	443	8	foundation	foundation	NN
cord-023095-4dannjjm	443	9	of	of	IN
cord-023095-4dannjjm	443	10	useful	useful	JJ
cord-023095-4dannjjm	443	11	information	information	NN
cord-023095-4dannjjm	443	12	upon	upon	IN
cord-023095-4dannjjm	443	13	which	which	WDT
cord-023095-4dannjjm	443	14	additional	additional	JJ
cord-023095-4dannjjm	443	15	prospective	prospective	JJ
cord-023095-4dannjjm	443	16	studies	study	NNS
cord-023095-4dannjjm	443	17	can	can	MD
cord-023095-4dannjjm	443	18	be	be	VB
cord-023095-4dannjjm	443	19	developed	develop	VBN
cord-023095-4dannjjm	443	20	.	.	.
cord-023095-4dannjjm	444	1	Left	left	JJ
cord-023095-4dannjjm	444	2	ventricle	ventricle	NN
cord-023095-4dannjjm	444	3	(	(	-LRB-
cord-023095-4dannjjm	444	4	LV	LV	NNP
cord-023095-4dannjjm	444	5	)	)	-RRB-
cord-023095-4dannjjm	444	6	evaluation	evaluation	NN
cord-023095-4dannjjm	444	7	is	be	VBZ
cord-023095-4dannjjm	444	8	one	one	CD
cord-023095-4dannjjm	444	9	of	of	IN
cord-023095-4dannjjm	444	10	the	the	DT
cord-023095-4dannjjm	444	11	most	most	RBS
cord-023095-4dannjjm	444	12	important	important	JJ
cord-023095-4dannjjm	444	13	contributions	contribution	NNS
cord-023095-4dannjjm	444	14	of	of	IN
cord-023095-4dannjjm	444	15	echocardiography	echocardiography	NN
cord-023095-4dannjjm	444	16	in	in	IN
cord-023095-4dannjjm	444	17	the	the	DT
cord-023095-4dannjjm	444	18	assessment	assessment	NN
cord-023095-4dannjjm	444	19	of	of	IN
cord-023095-4dannjjm	444	20	cardiac	cardiac	JJ
cord-023095-4dannjjm	444	21	function	function	NN
cord-023095-4dannjjm	444	22	.	.	.
cord-023095-4dannjjm	445	1	However	however	RB
cord-023095-4dannjjm	445	2	,	,	,
cord-023095-4dannjjm	445	3	LV	LV	NNP
cord-023095-4dannjjm	445	4	analysis	analysis	NN
cord-023095-4dannjjm	445	5	can	can	MD
cord-023095-4dannjjm	445	6	be	be	VB
cord-023095-4dannjjm	445	7	made	make	VBN
cord-023095-4dannjjm	445	8	from	from	IN
cord-023095-4dannjjm	445	9	images	image	NNS
cord-023095-4dannjjm	445	10	obtained	obtain	VBN
cord-023095-4dannjjm	445	11	by	by	IN
cord-023095-4dannjjm	445	12	different	different	JJ
cord-023095-4dannjjm	445	13	modes	mode	NNS
cord-023095-4dannjjm	445	14	and	and	CC
cord-023095-4dannjjm	445	15	views	view	NNS
cord-023095-4dannjjm	445	16	of	of	IN
cord-023095-4dannjjm	445	17	the	the	DT
cord-023095-4dannjjm	445	18	heart	heart	NN
cord-023095-4dannjjm	445	19	.	.	.
cord-023095-4dannjjm	446	1	The	the	DT
cord-023095-4dannjjm	446	2	aim	aim	NN
cord-023095-4dannjjm	446	3	of	of	IN
cord-023095-4dannjjm	446	4	this	this	DT
cord-023095-4dannjjm	446	5	study	study	NN
cord-023095-4dannjjm	446	6	was	be	VBD
cord-023095-4dannjjm	446	7	to	to	TO
cord-023095-4dannjjm	446	8	compare	compare	VB
cord-023095-4dannjjm	446	9	LV	LV	NNP
cord-023095-4dannjjm	446	10	measurements	measurement	NNS
cord-023095-4dannjjm	446	11	,	,	,
cord-023095-4dannjjm	446	12	shortening	shorten	VBG
cord-023095-4dannjjm	446	13	fraction	fraction	NN
cord-023095-4dannjjm	446	14	(	(	-LRB-
cord-023095-4dannjjm	446	15	SF	SF	NNP
cord-023095-4dannjjm	446	16	)	)	-RRB-
cord-023095-4dannjjm	446	17	and	and	CC
cord-023095-4dannjjm	446	18	ejection	ejection	NN
cord-023095-4dannjjm	446	19	fraction	fraction	NN
cord-023095-4dannjjm	446	20	(	(	-LRB-
cord-023095-4dannjjm	446	21	EF	EF	NNP
cord-023095-4dannjjm	446	22	)	)	-RRB-
cord-023095-4dannjjm	446	23	obtained	obtain	VBD
cord-023095-4dannjjm	446	24	from	from	IN
cord-023095-4dannjjm	446	25	four	four	CD
cord-023095-4dannjjm	446	26	methods	method	NNS
cord-023095-4dannjjm	446	27	:	:	:
cord-023095-4dannjjm	446	28	M	m	NN
cord-023095-4dannjjm	446	29	mode	mode	NN
cord-023095-4dannjjm	446	30	in	in	IN
cord-023095-4dannjjm	446	31	short	short	JJ
cord-023095-4dannjjm	446	32	-	-	HYPH
cord-023095-4dannjjm	446	33	axis	axis	NN
cord-023095-4dannjjm	446	34	and	and	CC
cord-023095-4dannjjm	446	35	in	in	IN
cord-023095-4dannjjm	446	36	long	long	JJ
cord-023095-4dannjjm	446	37	-	-	HYPH
cord-023095-4dannjjm	446	38	axis	axis	NN
cord-023095-4dannjjm	446	39	,	,	,
cord-023095-4dannjjm	446	40	bidimensional	bidimensional	FW
cord-023095-4dannjjm	446	41	mode	mode	NN
cord-023095-4dannjjm	446	42	in	in	IN
cord-023095-4dannjjm	446	43	short	short	JJ
cord-023095-4dannjjm	446	44	-	-	HYPH
cord-023095-4dannjjm	446	45	axis	axis	NN
cord-023095-4dannjjm	446	46	and	and	CC
cord-023095-4dannjjm	446	47	in	in	IN
cord-023095-4dannjjm	446	48	long	long	JJ
cord-023095-4dannjjm	446	49	-	-	HYPH
cord-023095-4dannjjm	446	50	axis	axis	NN
cord-023095-4dannjjm	446	51	views	view	NNS
cord-023095-4dannjjm	446	52	of	of	IN
cord-023095-4dannjjm	446	53	the	the	DT
cord-023095-4dannjjm	446	54	heart	heart	NN
cord-023095-4dannjjm	446	55	.	.	.
cord-023095-4dannjjm	447	1	Forty	forty	CD
cord-023095-4dannjjm	447	2	normal	normal	JJ
cord-023095-4dannjjm	447	3	adult	adult	NN
cord-023095-4dannjjm	447	4	German	german	JJ
cord-023095-4dannjjm	447	5	Shepherds	Shepherds	NNPS
cord-023095-4dannjjm	447	6	were	be	VBD
cord-023095-4dannjjm	447	7	selected	select	VBN
cord-023095-4dannjjm	447	8	.	.	.
cord-023095-4dannjjm	448	1	Echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	448	2	study	study	NN
cord-023095-4dannjjm	448	3	of	of	IN
cord-023095-4dannjjm	448	4	LV	LV	NNP
cord-023095-4dannjjm	448	5	of	of	IN
cord-023095-4dannjjm	448	6	each	each	DT
cord-023095-4dannjjm	448	7	animal	animal	NN
cord-023095-4dannjjm	448	8	was	be	VBD
cord-023095-4dannjjm	448	9	performed	perform	VBN
cord-023095-4dannjjm	448	10	by	by	IN
cord-023095-4dannjjm	448	11	the	the	DT
cord-023095-4dannjjm	448	12	four	four	CD
cord-023095-4dannjjm	448	13	methods	method	NNS
cord-023095-4dannjjm	448	14	described	describe	VBN
cord-023095-4dannjjm	448	15	above	above	RB
cord-023095-4dannjjm	448	16	.	.	.
cord-023095-4dannjjm	449	1	ANCOVA	ANCOVA	NNP
cord-023095-4dannjjm	449	2	test	test	NN
cord-023095-4dannjjm	449	3	was	be	VBD
cord-023095-4dannjjm	449	4	used	use	VBN
cord-023095-4dannjjm	449	5	to	to	TO
cord-023095-4dannjjm	449	6	examine	examine	VB
cord-023095-4dannjjm	449	7	the	the	DT
cord-023095-4dannjjm	449	8	effects	effect	NNS
cord-023095-4dannjjm	449	9	of	of	IN
cord-023095-4dannjjm	449	10	axis	axis	NN
cord-023095-4dannjjm	449	11	,	,	,
cord-023095-4dannjjm	449	12	mode	mode	NN
cord-023095-4dannjjm	449	13	,	,	,
cord-023095-4dannjjm	449	14	weight	weight	NN
cord-023095-4dannjjm	449	15	and	and	CC
cord-023095-4dannjjm	449	16	gender	gender	NN
cord-023095-4dannjjm	449	17	over	over	IN
cord-023095-4dannjjm	449	18	LV	LV	NNP
cord-023095-4dannjjm	449	19	measurements	measurement	NNS
cord-023095-4dannjjm	449	20	.	.	.
cord-023095-4dannjjm	450	1	Isolated	isolated	JJ
cord-023095-4dannjjm	450	2	effect	effect	NN
cord-023095-4dannjjm	450	3	of	of	IN
cord-023095-4dannjjm	450	4	the	the	DT
cord-023095-4dannjjm	450	5	axis	axis	NN
cord-023095-4dannjjm	450	6	was	be	VBD
cord-023095-4dannjjm	450	7	observed	observe	VBN
cord-023095-4dannjjm	450	8	for	for	IN
cord-023095-4dannjjm	450	9	LV	LV	NNP
cord-023095-4dannjjm	450	10	end	end	NN
cord-023095-4dannjjm	450	11	-	-	HYPH
cord-023095-4dannjjm	450	12	diastolic	diastolic	JJ
cord-023095-4dannjjm	450	13	diameter	diameter	NN
cord-023095-4dannjjm	450	14	(	(	-LRB-
cord-023095-4dannjjm	450	15	LVEDD	LVEDD	NNP
cord-023095-4dannjjm	450	16	)	)	-RRB-
cord-023095-4dannjjm	450	17	,	,	,
cord-023095-4dannjjm	450	18	with	with	IN
cord-023095-4dannjjm	450	19	greater	great	JJR
cord-023095-4dannjjm	450	20	values	value	NNS
cord-023095-4dannjjm	450	21	obtained	obtain	VBN
cord-023095-4dannjjm	450	22	from	from	IN
cord-023095-4dannjjm	450	23	short	short	JJ
cord-023095-4dannjjm	450	24	-	-	HYPH
cord-023095-4dannjjm	450	25	axis	axis	NN
cord-023095-4dannjjm	450	26	views	view	NNS
cord-023095-4dannjjm	450	27	.	.	.
cord-023095-4dannjjm	451	1	There	there	EX
cord-023095-4dannjjm	451	2	was	be	VBD
cord-023095-4dannjjm	451	3	isolated	isolate	VBN
cord-023095-4dannjjm	451	4	effect	effect	NN
cord-023095-4dannjjm	451	5	of	of	IN
cord-023095-4dannjjm	451	6	mode	mode	NN
cord-023095-4dannjjm	451	7	over	over	IN
cord-023095-4dannjjm	451	8	EF	EF	NNP
cord-023095-4dannjjm	451	9	and	and	CC
cord-023095-4dannjjm	451	10	SF	SF	NNP
cord-023095-4dannjjm	451	11	,	,	,
cord-023095-4dannjjm	451	12	with	with	IN
cord-023095-4dannjjm	451	13	greater	great	JJR
cord-023095-4dannjjm	451	14	measurements	measurement	NNS
cord-023095-4dannjjm	451	15	derived	derive	VBN
cord-023095-4dannjjm	451	16	from	from	IN
cord-023095-4dannjjm	451	17	bidimensional	bidimensional	JJ
cord-023095-4dannjjm	451	18	mode	mode	NN
cord-023095-4dannjjm	451	19	methods	method	NNS
cord-023095-4dannjjm	451	20	.	.	.
cord-023095-4dannjjm	452	1	Weight	weight	NN
cord-023095-4dannjjm	452	2	correlated	correlate	VBD
cord-023095-4dannjjm	452	3	with	with	IN
cord-023095-4dannjjm	452	4	all	all	DT
cord-023095-4dannjjm	452	5	linear	linear	JJ
cord-023095-4dannjjm	452	6	LV	LV	NNP
cord-023095-4dannjjm	452	7	measures	measure	NNS
cord-023095-4dannjjm	452	8	at	at	IN
cord-023095-4dannjjm	452	9	least	least	JJS
cord-023095-4dannjjm	452	10	in	in	IN
cord-023095-4dannjjm	452	11	one	one	CD
cord-023095-4dannjjm	452	12	method	method	NN
cord-023095-4dannjjm	452	13	,	,	,
cord-023095-4dannjjm	452	14	but	but	CC
cord-023095-4dannjjm	452	15	not	not	RB
cord-023095-4dannjjm	452	16	with	with	IN
cord-023095-4dannjjm	452	17	EF	EF	NNP
cord-023095-4dannjjm	452	18	and	and	CC
cord-023095-4dannjjm	452	19	SF	SF	NNP
cord-023095-4dannjjm	452	20	.	.	.
cord-023095-4dannjjm	453	1	Weight	weight	NN
cord-023095-4dannjjm	453	2	had	have	VBD
cord-023095-4dannjjm	453	3	positive	positive	JJ
cord-023095-4dannjjm	453	4	effect	effect	NN
cord-023095-4dannjjm	453	5	over	over	IN
cord-023095-4dannjjm	453	6	LV	LV	NNP
cord-023095-4dannjjm	453	7	endsystolic	endsystolic	JJ
cord-023095-4dannjjm	453	8	diameter	diameter	NN
cord-023095-4dannjjm	453	9	and	and	CC
cord-023095-4dannjjm	453	10	LV	LV	NNP
cord-023095-4dannjjm	453	11	end	end	NN
cord-023095-4dannjjm	453	12	-	-	HYPH
cord-023095-4dannjjm	453	13	diastole	diastole	NN
cord-023095-4dannjjm	453	14	posterior	posterior	JJ
cord-023095-4dannjjm	453	15	wall	wall	NN
cord-023095-4dannjjm	453	16	thickness	thickness	NN
cord-023095-4dannjjm	453	17	in	in	IN
cord-023095-4dannjjm	453	18	all	all	DT
cord-023095-4dannjjm	453	19	methods	method	NNS
cord-023095-4dannjjm	453	20	,	,	,
cord-023095-4dannjjm	453	21	except	except	IN
cord-023095-4dannjjm	453	22	from	from	IN
cord-023095-4dannjjm	453	23	M	M	NNP
cord-023095-4dannjjm	453	24	mode	mode	NN
cord-023095-4dannjjm	453	25	in	in	IN
cord-023095-4dannjjm	453	26	short	short	JJ
cord-023095-4dannjjm	453	27	axis	axis	NN
cord-023095-4dannjjm	453	28	in	in	IN
cord-023095-4dannjjm	453	29	the	the	DT
cord-023095-4dannjjm	453	30	last	last	JJ
cord-023095-4dannjjm	453	31	one	one	NN
cord-023095-4dannjjm	453	32	.	.	.
cord-023095-4dannjjm	454	1	Gender	gender	NN
cord-023095-4dannjjm	454	2	had	have	VBD
cord-023095-4dannjjm	454	3	isolated	isolate	VBN
cord-023095-4dannjjm	454	4	effect	effect	NN
cord-023095-4dannjjm	454	5	over	over	IN
cord-023095-4dannjjm	454	6	LVEDD	LVEDD	NNP
cord-023095-4dannjjm	454	7	,	,	,
cord-023095-4dannjjm	454	8	males	male	NNS
cord-023095-4dannjjm	454	9	showing	show	VBG
cord-023095-4dannjjm	454	10	greater	great	JJR
cord-023095-4dannjjm	454	11	values	value	NNS
cord-023095-4dannjjm	454	12	than	than	IN
cord-023095-4dannjjm	454	13	females	female	NNS
cord-023095-4dannjjm	454	14	in	in	IN
cord-023095-4dannjjm	454	15	bidimensional	bidimensional	JJ
cord-023095-4dannjjm	454	16	mode	mode	NN
cord-023095-4dannjjm	454	17	in	in	IN
cord-023095-4dannjjm	454	18	short	short	JJ
cord-023095-4dannjjm	454	19	and	and	CC
cord-023095-4dannjjm	454	20	long	long	JJ
cord-023095-4dannjjm	454	21	axis	axis	NN
cord-023095-4dannjjm	454	22	.	.	.
cord-023095-4dannjjm	455	1	The	the	DT
cord-023095-4dannjjm	455	2	combined	combined	JJ
cord-023095-4dannjjm	455	3	effect	effect	NN
cord-023095-4dannjjm	455	4	of	of	IN
cord-023095-4dannjjm	455	5	axis	axis	NN
cord-023095-4dannjjm	455	6	,	,	,
cord-023095-4dannjjm	455	7	gender	gender	NN
cord-023095-4dannjjm	455	8	and	and	CC
cord-023095-4dannjjm	455	9	weight	weight	NN
cord-023095-4dannjjm	455	10	was	be	VBD
cord-023095-4dannjjm	455	11	identified	identify	VBN
cord-023095-4dannjjm	455	12	in	in	IN
cord-023095-4dannjjm	455	13	interventricular	interventricular	JJ
cord-023095-4dannjjm	455	14	septal	septal	JJ
cord-023095-4dannjjm	455	15	end	end	NN
cord-023095-4dannjjm	455	16	-	-	HYPH
cord-023095-4dannjjm	455	17	diastolic	diastolic	JJ
cord-023095-4dannjjm	455	18	thickness	thickness	NN
cord-023095-4dannjjm	455	19	.	.	.
cord-023095-4dannjjm	456	1	We	-PRON-	PRP
cord-023095-4dannjjm	456	2	concluded	conclude	VBD
cord-023095-4dannjjm	456	3	that	that	IN
cord-023095-4dannjjm	456	4	normal	normal	JJ
cord-023095-4dannjjm	456	5	reference	reference	NN
cord-023095-4dannjjm	456	6	values	value	NNS
cord-023095-4dannjjm	456	7	obtained	obtain	VBN
cord-023095-4dannjjm	456	8	by	by	IN
cord-023095-4dannjjm	456	9	different	different	JJ
cord-023095-4dannjjm	456	10	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	456	11	modes	mode	NNS
cord-023095-4dannjjm	456	12	and	and	CC
cord-023095-4dannjjm	456	13	planes	plane	NNS
cord-023095-4dannjjm	456	14	should	should	MD
cord-023095-4dannjjm	456	15	not	not	RB
cord-023095-4dannjjm	456	16	be	be	VB
cord-023095-4dannjjm	456	17	used	use	VBN
cord-023095-4dannjjm	456	18	interchangeably	interchangeably	RB
cord-023095-4dannjjm	456	19	.	.	.
cord-023095-4dannjjm	457	1	ABSTRACT	ABSTRACT	NNP
cord-023095-4dannjjm	457	2	C-29	C-29	NNP
cord-023095-4dannjjm	457	3	 	 	_SP
cord-023095-4dannjjm	457	4	ASSESSMENT	assessment	NN
cord-023095-4dannjjm	457	5	OF	of	IN
cord-023095-4dannjjm	457	6	LEFT	left	JJ
cord-023095-4dannjjm	457	7	VENTRICULAR	ventricular	JJ
cord-023095-4dannjjm	457	8	DIASTOLIC	diastolic	JJ
cord-023095-4dannjjm	457	9	FUNC	func	NN
cord-023095-4dannjjm	457	10	-	-	HYPH
cord-023095-4dannjjm	457	11	TION	tion	NN
cord-023095-4dannjjm	457	12	BY	by	IN
cord-023095-4dannjjm	457	13	COLOR	color	NN
cord-023095-4dannjjm	457	14	TISSUE	tissue	NN
cord-023095-4dannjjm	457	15	DOPPLER	doppler	NN
cord-023095-4dannjjm	457	16	IMAGING	imaging	NN
cord-023095-4dannjjm	457	17	ECHO	echo	NN
cord-023095-4dannjjm	457	18	-	-	HYPH
cord-023095-4dannjjm	457	19	CARDIOGRAPHY	CARDIOGRAPHY	NNP
cord-023095-4dannjjm	457	20	IN	in	IN
cord-023095-4dannjjm	457	21	MAINE	MAINE	NNP
cord-023095-4dannjjm	457	22	COON	COON	NNP
cord-023095-4dannjjm	458	1	CATS	cat	NNS
cord-023095-4dannjjm	458	2	TESTED	test	VBN
cord-023095-4dannjjm	458	3	FOR	for	IN
cord-023095-4dannjjm	458	4	 	 	_SP
cord-023095-4dannjjm	458	5	MYPBC	MYPBC	NNP
cord-023095-4dannjjm	458	6	-	-	HYPH
cord-023095-4dannjjm	458	7	AP31	AP31	NNP
cord-023095-4dannjjm	458	8	MUTATION	mutation	NN
cord-023095-4dannjjm	458	9	Hypertrophic	hypertrophic	JJ
cord-023095-4dannjjm	458	10	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	458	11	(	(	-LRB-
cord-023095-4dannjjm	458	12	HCM	HCM	NNP
cord-023095-4dannjjm	458	13	)	)	-RRB-
cord-023095-4dannjjm	458	14	,	,	,
cord-023095-4dannjjm	458	15	characterized	characterize	VBN
cord-023095-4dannjjm	458	16	by	by	IN
cord-023095-4dannjjm	458	17	increased	increase	VBN
cord-023095-4dannjjm	458	18	cardiac	cardiac	JJ
cord-023095-4dannjjm	458	19	mass	mass	NN
cord-023095-4dannjjm	458	20	and	and	CC
cord-023095-4dannjjm	458	21	diastolic	diastolic	JJ
cord-023095-4dannjjm	458	22	dysfunction	dysfunction	NN
cord-023095-4dannjjm	458	23	,	,	,
cord-023095-4dannjjm	458	24	is	be	VBZ
cord-023095-4dannjjm	458	25	the	the	DT
cord-023095-4dannjjm	458	26	most	most	RBS
cord-023095-4dannjjm	458	27	common	common	JJ
cord-023095-4dannjjm	458	28	feline	feline	JJ
cord-023095-4dannjjm	458	29	heart	heart	NN
cord-023095-4dannjjm	458	30	disease	disease	NN
cord-023095-4dannjjm	458	31	.	.	.
cord-023095-4dannjjm	459	1	Myocardial	myocardial	JJ
cord-023095-4dannjjm	459	2	analysis	analysis	NN
cord-023095-4dannjjm	459	3	by	by	IN
cord-023095-4dannjjm	459	4	color	color	NN
cord-023095-4dannjjm	459	5	tissue	tissue	NN
cord-023095-4dannjjm	459	6	Doppler	doppler	NN
cord-023095-4dannjjm	459	7	imaging	imaging	NN
cord-023095-4dannjjm	459	8	(	(	-LRB-
cord-023095-4dannjjm	459	9	TDI	TDI	NNP
cord-023095-4dannjjm	459	10	)	)	-RRB-
cord-023095-4dannjjm	459	11	is	be	VBZ
cord-023095-4dannjjm	459	12	more	more	RBR
cord-023095-4dannjjm	459	13	sensitive	sensitive	JJ
cord-023095-4dannjjm	459	14	than	than	IN
cord-023095-4dannjjm	459	15	conventional	conventional	JJ
cord-023095-4dannjjm	459	16	echocardiography	echocardiography	NN
cord-023095-4dannjjm	459	17	.	.	.
cord-023095-4dannjjm	460	1	This	this	DT
cord-023095-4dannjjm	460	2	study	study	NN
cord-023095-4dannjjm	460	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	460	4	diastolic	diastolic	JJ
cord-023095-4dannjjm	460	5	dysfunction	dysfunction	NN
cord-023095-4dannjjm	460	6	in	in	IN
cord-023095-4dannjjm	460	7	various	various	JJ
cord-023095-4dannjjm	460	8	stages	stage	NNS
cord-023095-4dannjjm	460	9	of	of	IN
cord-023095-4dannjjm	460	10	feline	feline	JJ
cord-023095-4dannjjm	460	11	HCM	HCM	NNP
cord-023095-4dannjjm	460	12	.	.	.
cord-023095-4dannjjm	461	1	Maine	Maine	NNP
cord-023095-4dannjjm	461	2	Coon	Coon	NNP
cord-023095-4dannjjm	461	3	cats	cat	NNS
cord-023095-4dannjjm	461	4	(	(	-LRB-
cord-023095-4dannjjm	461	5	n	n	NN
cord-023095-4dannjjm	461	6	5	5	CD
cord-023095-4dannjjm	461	7	57	57	CD
cord-023095-4dannjjm	461	8	)	)	-RRB-
cord-023095-4dannjjm	461	9	were	be	VBD
cord-023095-4dannjjm	461	10	screened	screen	VBN
cord-023095-4dannjjm	461	11	for	for	IN
cord-023095-4dannjjm	461	12	the	the	DT
cord-023095-4dannjjm	461	13	MyBPC	MyBPC	NNP
cord-023095-4dannjjm	461	14	-	-	HYPH
cord-023095-4dannjjm	461	15	A31P	A31P	NNP
cord-023095-4dannjjm	461	16	mutation	mutation	NN
cord-023095-4dannjjm	461	17	and	and	CC
cord-023095-4dannjjm	461	18	examined	examine	VBD
cord-023095-4dannjjm	461	19	with	with	IN
cord-023095-4dannjjm	461	20	both	both	DT
cord-023095-4dannjjm	461	21	echocardiography	echocardiography	NN
cord-023095-4dannjjm	461	22	and	and	CC
cord-023095-4dannjjm	461	23	TDI	TDI	NNP
cord-023095-4dannjjm	461	24	.	.	.
cord-023095-4dannjjm	462	1	Then	then	RB
cord-023095-4dannjjm	462	2	,	,	,
cord-023095-4dannjjm	462	3	were	be	VBD
cord-023095-4dannjjm	462	4	phenotypically	phenotypically	RB
cord-023095-4dannjjm	462	5	classified	classify	VBN
cord-023095-4dannjjm	462	6	in	in	IN
cord-023095-4dannjjm	462	7	:	:	:
cord-023095-4dannjjm	462	8	normal	normal	JJ
cord-023095-4dannjjm	462	9	(	(	-LRB-
cord-023095-4dannjjm	462	10	n	n	NN
cord-023095-4dannjjm	462	11	5	5	CD
cord-023095-4dannjjm	462	12	45	45	CD
cord-023095-4dannjjm	462	13	)	)	-RRB-
cord-023095-4dannjjm	462	14	,	,	,
cord-023095-4dannjjm	462	15	suspects	suspect	NNS
cord-023095-4dannjjm	462	16	for	for	IN
cord-023095-4dannjjm	462	17	HCM	HCM	NNP
cord-023095-4dannjjm	462	18	(	(	-LRB-
cord-023095-4dannjjm	462	19	n	n	NN
cord-023095-4dannjjm	462	20	5	5	CD
cord-023095-4dannjjm	462	21	7	7	CD
cord-023095-4dannjjm	462	22	)	)	-RRB-
cord-023095-4dannjjm	462	23	and	and	CC
cord-023095-4dannjjm	462	24	HCM	HCM	NNP
cord-023095-4dannjjm	462	25	group	group	NN
cord-023095-4dannjjm	462	26	(	(	-LRB-
cord-023095-4dannjjm	462	27	n	n	NN
cord-023095-4dannjjm	462	28	5	5	CD
cord-023095-4dannjjm	462	29	5	5	CD
cord-023095-4dannjjm	462	30	)	)	-RRB-
cord-023095-4dannjjm	462	31	;	;	:
cord-023095-4dannjjm	462	32	and	and	CC
cord-023095-4dannjjm	462	33	genotypically	genotypically	RB
cord-023095-4dannjjm	462	34	classified	classify	VBN
cord-023095-4dannjjm	462	35	in	in	IN
cord-023095-4dannjjm	462	36	:	:	:
cord-023095-4dannjjm	462	37	negative	negative	JJ
cord-023095-4dannjjm	462	38	(	(	-LRB-
cord-023095-4dannjjm	462	39	n	n	NN
cord-023095-4dannjjm	462	40	5	5	CD
cord-023095-4dannjjm	462	41	28	28	CD
cord-023095-4dannjjm	462	42	)	)	-RRB-
cord-023095-4dannjjm	462	43	,	,	,
cord-023095-4dannjjm	462	44	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	462	45	(	(	-LRB-
cord-023095-4dannjjm	462	46	n	n	NN
cord-023095-4dannjjm	462	47	5	5	CD
cord-023095-4dannjjm	462	48	26	26	CD
cord-023095-4dannjjm	462	49	)	)	-RRB-
cord-023095-4dannjjm	462	50	and	and	CC
cord-023095-4dannjjm	462	51	homozygous	homozygous	JJ
cord-023095-4dannjjm	462	52	group	group	NN
cord-023095-4dannjjm	462	53	(	(	-LRB-
cord-023095-4dannjjm	462	54	n	n	NN
cord-023095-4dannjjm	462	55	5	5	CD
cord-023095-4dannjjm	462	56	3	3	CD
cord-023095-4dannjjm	462	57	)	)	-RRB-
cord-023095-4dannjjm	462	58	.	.	.
cord-023095-4dannjjm	463	1	Myocardial	myocardial	JJ
cord-023095-4dannjjm	463	2	velocities	velocity	NNS
cord-023095-4dannjjm	463	3	,	,	,
cord-023095-4dannjjm	463	4	measured	measure	VBN
cord-023095-4dannjjm	463	5	in	in	IN
cord-023095-4dannjjm	463	6	the	the	DT
cord-023095-4dannjjm	463	7	basal	basal	NN
cord-023095-4dannjjm	463	8	and	and	CC
cord-023095-4dannjjm	463	9	mild	mild	JJ
cord-023095-4dannjjm	463	10	ventricular	ventricular	JJ
cord-023095-4dannjjm	463	11	segment	segment	NN
cord-023095-4dannjjm	463	12	of	of	IN
cord-023095-4dannjjm	463	13	the	the	DT
cord-023095-4dannjjm	463	14	interventricular	interventricular	JJ
cord-023095-4dannjjm	463	15	septal	septal	JJ
cord-023095-4dannjjm	463	16	wall	wall	NN
cord-023095-4dannjjm	463	17	(	(	-LRB-
cord-023095-4dannjjm	463	18	IVS	IVS	NNP
cord-023095-4dannjjm	463	19	)	)	-RRB-
cord-023095-4dannjjm	463	20	,	,	,
cord-023095-4dannjjm	463	21	left	leave	VBD
cord-023095-4dannjjm	463	22	ventricular	ventricular	JJ
cord-023095-4dannjjm	463	23	free	free	JJ
cord-023095-4dannjjm	463	24	wall	wall	NN
cord-023095-4dannjjm	463	25	(	(	-LRB-
cord-023095-4dannjjm	463	26	LVW	LVW	NNP
cord-023095-4dannjjm	463	27	)	)	-RRB-
cord-023095-4dannjjm	463	28	and	and	CC
cord-023095-4dannjjm	463	29	in	in	IN
cord-023095-4dannjjm	463	30	radial	radial	JJ
cord-023095-4dannjjm	463	31	segment	segment	NN
cord-023095-4dannjjm	463	32	of	of	IN
cord-023095-4dannjjm	463	33	left	left	JJ
cord-023095-4dannjjm	463	34	ventricular	ventricular	JJ
cord-023095-4dannjjm	463	35	wall	wall	NN
cord-023095-4dannjjm	463	36	,	,	,
cord-023095-4dannjjm	463	37	was	be	VBD
cord-023095-4dannjjm	463	38	compared	compare	VBN
cord-023095-4dannjjm	463	39	among	among	IN
cord-023095-4dannjjm	463	40	different	different	JJ
cord-023095-4dannjjm	463	41	groups	group	NNS
cord-023095-4dannjjm	463	42	.	.	.
cord-023095-4dannjjm	464	1	A	a	DT
cord-023095-4dannjjm	464	2	significant	significant	JJ
cord-023095-4dannjjm	464	3	decreased	decrease	VBD
cord-023095-4dannjjm	464	4	(	(	-LRB-
cord-023095-4dannjjm	464	5	P	p	NN
cord-023095-4dannjjm	464	6	5	5	CD
cord-023095-4dannjjm	464	7	0,01	0,01	CD
cord-023095-4dannjjm	464	8	)	)	-RRB-
cord-023095-4dannjjm	465	1	longitudinal	longitudinal	NNP
cord-023095-4dannjjm	465	2	Em	Em	NNP
cord-023095-4dannjjm	465	3	/	/	SYM
cord-023095-4dannjjm	465	4	Am	be	VBP
cord-023095-4dannjjm	465	5	at	at	IN
cord-023095-4dannjjm	465	6	the	the	DT
cord-023095-4dannjjm	465	7	basal	basal	NN
cord-023095-4dannjjm	465	8	segment	segment	NN
cord-023095-4dannjjm	465	9	of	of	IN
cord-023095-4dannjjm	465	10	IVS	IVS	NNP
cord-023095-4dannjjm	465	11	was	be	VBD
cord-023095-4dannjjm	465	12	observed	observe	VBN
cord-023095-4dannjjm	465	13	in	in	IN
cord-023095-4dannjjm	465	14	HCM	HCM	NNP
cord-023095-4dannjjm	465	15	cats	cat	NNS
cord-023095-4dannjjm	465	16	compared	compare	VBN
cord-023095-4dannjjm	465	17	with	with	IN
cord-023095-4dannjjm	465	18	suspects	suspect	NNS
cord-023095-4dannjjm	465	19	and	and	CC
cord-023095-4dannjjm	465	20	normal	normal	JJ
cord-023095-4dannjjm	465	21	cats	cat	NNS
cord-023095-4dannjjm	465	22	.	.	.
cord-023095-4dannjjm	466	1	A	a	DT
cord-023095-4dannjjm	466	2	significant	significant	JJ
cord-023095-4dannjjm	466	3	increased	increase	VBN
cord-023095-4dannjjm	466	4	(	(	-LRB-
cord-023095-4dannjjm	466	5	P	p	NN
cord-023095-4dannjjm	466	6	5	5	CD
cord-023095-4dannjjm	466	7	0,01	0,01	CD
cord-023095-4dannjjm	466	8	)	)	-RRB-
cord-023095-4dannjjm	467	1	longitudinal	longitudinal	NNP
cord-023095-4dannjjm	467	2	E	E	NNP
cord-023095-4dannjjm	467	3	/	/	SYM
cord-023095-4dannjjm	467	4	Em	Em	NNP
cord-023095-4dannjjm	467	5	at	at	IN
cord-023095-4dannjjm	467	6	the	the	DT
cord-023095-4dannjjm	467	7	basal	basal	NN
cord-023095-4dannjjm	467	8	segment	segment	NN
cord-023095-4dannjjm	467	9	of	of	IN
cord-023095-4dannjjm	467	10	IVS	IVS	NNP
cord-023095-4dannjjm	467	11	was	be	VBD
cord-023095-4dannjjm	467	12	observed	observe	VBN
cord-023095-4dannjjm	467	13	in	in	IN
cord-023095-4dannjjm	467	14	HCM	HCM	NNP
cord-023095-4dannjjm	467	15	cats	cat	NNS
cord-023095-4dannjjm	467	16	compared	compare	VBN
cord-023095-4dannjjm	467	17	with	with	IN
cord-023095-4dannjjm	467	18	suspects	suspect	NNS
cord-023095-4dannjjm	467	19	and	and	CC
cord-023095-4dannjjm	467	20	normal	normal	JJ
cord-023095-4dannjjm	467	21	cats	cat	NNS
cord-023095-4dannjjm	467	22	.	.	.
cord-023095-4dannjjm	468	1	And	and	CC
cord-023095-4dannjjm	468	2	a	a	DT
cord-023095-4dannjjm	468	3	significant	significant	JJ
cord-023095-4dannjjm	468	4	decreased	decrease	VBN
cord-023095-4dannjjm	468	5	(	(	-LRB-
cord-023095-4dannjjm	468	6	P	p	NN
cord-023095-4dannjjm	468	7	5	5	CD
cord-023095-4dannjjm	468	8	0,02	0,02	CD
cord-023095-4dannjjm	468	9	)	)	-RRB-
cord-023095-4dannjjm	469	1	longitudinal	longitudinal	NNP
cord-023095-4dannjjm	469	2	Sm	Sm	NNP
cord-023095-4dannjjm	469	3	at	at	IN
cord-023095-4dannjjm	469	4	the	the	DT
cord-023095-4dannjjm	469	5	basal	basal	NN
cord-023095-4dannjjm	469	6	segment	segment	NN
cord-023095-4dannjjm	469	7	of	of	IN
cord-023095-4dannjjm	469	8	the	the	DT
cord-023095-4dannjjm	469	9	LVW	LVW	NNP
cord-023095-4dannjjm	469	10	was	be	VBD
cord-023095-4dannjjm	469	11	observed	observe	VBN
cord-023095-4dannjjm	469	12	in	in	IN
cord-023095-4dannjjm	469	13	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	469	14	cats	cat	NNS
cord-023095-4dannjjm	469	15	compared	compare	VBN
cord-023095-4dannjjm	469	16	with	with	IN
cord-023095-4dannjjm	469	17	negative	negative	JJ
cord-023095-4dannjjm	469	18	cats	cat	NNS
cord-023095-4dannjjm	469	19	,	,	,
cord-023095-4dannjjm	469	20	both	both	CC
cord-023095-4dannjjm	469	21	without	without	IN
cord-023095-4dannjjm	469	22	hypertrophy	hypertrophy	NN
cord-023095-4dannjjm	469	23	.	.	.
cord-023095-4dannjjm	470	1	There	there	EX
cord-023095-4dannjjm	470	2	was	be	VBD
cord-023095-4dannjjm	470	3	a	a	DT
cord-023095-4dannjjm	470	4	significant	significant	JJ
cord-023095-4dannjjm	470	5	positive	positive	JJ
cord-023095-4dannjjm	470	6	correlation	correlation	NN
cord-023095-4dannjjm	470	7	between	between	IN
cord-023095-4dannjjm	470	8	summated	summate	VBN
cord-023095-4dannjjm	470	9	early	early	JJ
cord-023095-4dannjjm	470	10	and	and	CC
cord-023095-4dannjjm	470	11	late	late	JJ
cord-023095-4dannjjm	470	12	diastolic	diastolic	JJ
cord-023095-4dannjjm	470	13	velocities	velocity	NNS
cord-023095-4dannjjm	470	14	(	(	-LRB-
cord-023095-4dannjjm	470	15	EmAm	EmAm	NNP
cord-023095-4dannjjm	470	16	)	)	-RRB-
cord-023095-4dannjjm	470	17	and	and	CC
cord-023095-4dannjjm	470	18	heart	heart	NN
cord-023095-4dannjjm	470	19	rate	rate	NN
cord-023095-4dannjjm	470	20	(	(	-LRB-
cord-023095-4dannjjm	470	21	P	p	NN
cord-023095-4dannjjm	470	22	o	o	NN
cord-023095-4dannjjm	470	23	0,001	0,001	CD
cord-023095-4dannjjm	470	24	)	)	-RRB-
cord-023095-4dannjjm	470	25	;	;	:
cord-023095-4dannjjm	470	26	and	and	CC
cord-023095-4dannjjm	470	27	a	a	DT
cord-023095-4dannjjm	470	28	positive	positive	JJ
cord-023095-4dannjjm	470	29	correlation	correlation	NN
cord-023095-4dannjjm	470	30	between	between	IN
cord-023095-4dannjjm	470	31	Sm	Sm	NNP
cord-023095-4dannjjm	470	32	and	and	CC
cord-023095-4dannjjm	470	33	Em	Em	NNP
cord-023095-4dannjjm	470	34	velocities	velocity	NNS
cord-023095-4dannjjm	470	35	and	and	CC
cord-023095-4dannjjm	470	36	heart	heart	NN
cord-023095-4dannjjm	470	37	rate	rate	NN
cord-023095-4dannjjm	470	38	(	(	-LRB-
cord-023095-4dannjjm	470	39	P	p	NN
cord-023095-4dannjjm	470	40	o	o	NN
cord-023095-4dannjjm	470	41	0,01	0,01	NN
cord-023095-4dannjjm	470	42	)	)	-RRB-
cord-023095-4dannjjm	470	43	.	.	.
cord-023095-4dannjjm	471	1	The	the	DT
cord-023095-4dannjjm	471	2	MYBPC	MYBPC	NNP
cord-023095-4dannjjm	471	3	-	-	HYPH
cord-023095-4dannjjm	471	4	A31P	A31P	NNP
cord-023095-4dannjjm	471	5	mutation	mutation	NN
cord-023095-4dannjjm	471	6	is	be	VBZ
cord-023095-4dannjjm	471	7	not	not	RB
cord-023095-4dannjjm	471	8	consistently	consistently	RB
cord-023095-4dannjjm	471	9	associated	associate	VBN
cord-023095-4dannjjm	471	10	with	with	IN
cord-023095-4dannjjm	471	11	ventricular	ventricular	JJ
cord-023095-4dannjjm	471	12	hypertrophy	hypertrophy	NN
cord-023095-4dannjjm	471	13	and	and	CC
cord-023095-4dannjjm	471	14	negatives	negative	NNS
cord-023095-4dannjjm	471	15	cats	cat	NNS
cord-023095-4dannjjm	471	16	can	can	MD
cord-023095-4dannjjm	471	17	also	also	RB
cord-023095-4dannjjm	471	18	develop	develop	VB
cord-023095-4dannjjm	471	19	HCM	HCM	NNP
cord-023095-4dannjjm	471	20	.	.	.
cord-023095-4dannjjm	472	1	The	the	DT
cord-023095-4dannjjm	472	2	TDI	TDI	NNP
cord-023095-4dannjjm	472	3	alone	alone	RB
cord-023095-4dannjjm	472	4	is	be	VBZ
cord-023095-4dannjjm	472	5	not	not	RB
cord-023095-4dannjjm	472	6	able	able	JJ
cord-023095-4dannjjm	472	7	to	to	TO
cord-023095-4dannjjm	472	8	identify	identify	VB
cord-023095-4dannjjm	472	9	cats	cat	NNS
cord-023095-4dannjjm	472	10	with	with	IN
cord-023095-4dannjjm	472	11	mutation	mutation	NN
cord-023095-4dannjjm	472	12	before	before	IN
cord-023095-4dannjjm	472	13	myocardial	myocardial	JJ
cord-023095-4dannjjm	472	14	hypertrophy	hypertrophy	NN
cord-023095-4dannjjm	472	15	.	.	.
cord-023095-4dannjjm	473	1	Diastolic	diastolic	JJ
cord-023095-4dannjjm	473	2	dysfunction	dysfunction	NN
cord-023095-4dannjjm	473	3	occurs	occur	VBZ
cord-023095-4dannjjm	473	4	in	in	IN
cord-023095-4dannjjm	473	5	many	many	JJ
cord-023095-4dannjjm	473	6	cats	cat	NNS
cord-023095-4dannjjm	473	7	with	with	IN
cord-023095-4dannjjm	473	8	hypertrophic	hypertrophic	JJ
cord-023095-4dannjjm	473	9	cardiomyopathy	cardiomyopathy	NN
cord-023095-4dannjjm	473	10	(	(	-LRB-
cord-023095-4dannjjm	473	11	HCM	HCM	NNP
cord-023095-4dannjjm	473	12	)	)	-RRB-
cord-023095-4dannjjm	473	13	but	but	CC
cord-023095-4dannjjm	473	14	less	less	JJR
cord-023095-4dannjjm	473	15	is	be	VBZ
cord-023095-4dannjjm	473	16	known	know	VBN
cord-023095-4dannjjm	473	17	about	about	IN
cord-023095-4dannjjm	473	18	systolic	systolic	JJ
cord-023095-4dannjjm	473	19	function	function	NN
cord-023095-4dannjjm	473	20	in	in	IN
cord-023095-4dannjjm	473	21	various	various	JJ
cord-023095-4dannjjm	473	22	stages	stage	NNS
cord-023095-4dannjjm	473	23	of	of	IN
cord-023095-4dannjjm	473	24	HCM	HCM	NNP
cord-023095-4dannjjm	473	25	.	.	.
cord-023095-4dannjjm	474	1	Myocardial	myocardial	JJ
cord-023095-4dannjjm	474	2	strain	strain	NN
cord-023095-4dannjjm	474	3	analysis	analysis	NN
cord-023095-4dannjjm	474	4	by	by	IN
cord-023095-4dannjjm	474	5	tissue	tissue	NN
cord-023095-4dannjjm	474	6	Doppler	Doppler	NNP
cord-023095-4dannjjm	474	7	imaging	imaging	NN
cord-023095-4dannjjm	475	1	is	be	VBZ
cord-023095-4dannjjm	475	2	a	a	DT
cord-023095-4dannjjm	475	3	noninvasive	noninvasive	JJ
cord-023095-4dannjjm	475	4	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	475	5	method	method	NN
cord-023095-4dannjjm	475	6	to	to	TO
cord-023095-4dannjjm	475	7	assess	assess	VB
cord-023095-4dannjjm	475	8	systolic	systolic	JJ
cord-023095-4dannjjm	475	9	function	function	NN
cord-023095-4dannjjm	475	10	.	.	.
cord-023095-4dannjjm	476	1	This	this	DT
cord-023095-4dannjjm	476	2	study	study	NN
cord-023095-4dannjjm	476	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	476	4	systolic	systolic	JJ
cord-023095-4dannjjm	476	5	function	function	NN
cord-023095-4dannjjm	476	6	in	in	IN
cord-023095-4dannjjm	476	7	various	various	JJ
cord-023095-4dannjjm	476	8	stages	stage	NNS
cord-023095-4dannjjm	476	9	of	of	IN
cord-023095-4dannjjm	476	10	feline	feline	JJ
cord-023095-4dannjjm	476	11	HCM	HCM	NNP
cord-023095-4dannjjm	476	12	.	.	.
cord-023095-4dannjjm	477	1	Maine	Maine	NNP
cord-023095-4dannjjm	477	2	Coon	Coon	NNP
cord-023095-4dannjjm	477	3	cats	cat	NNS
cord-023095-4dannjjm	477	4	(	(	-LRB-
cord-023095-4dannjjm	477	5	n	n	NN
cord-023095-4dannjjm	477	6	5	5	CD
cord-023095-4dannjjm	477	7	57	57	CD
cord-023095-4dannjjm	477	8	)	)	-RRB-
cord-023095-4dannjjm	477	9	were	be	VBD
cord-023095-4dannjjm	477	10	screened	screen	VBN
cord-023095-4dannjjm	477	11	for	for	IN
cord-023095-4dannjjm	477	12	the	the	DT
cord-023095-4dannjjm	477	13	MyBPC	MyBPC	NNP
cord-023095-4dannjjm	477	14	-	-	HYPH
cord-023095-4dannjjm	477	15	A31P	A31P	NNP
cord-023095-4dannjjm	477	16	mutation	mutation	NN
cord-023095-4dannjjm	477	17	an	an	DT
cord-023095-4dannjjm	477	18	examined	examine	VBN
cord-023095-4dannjjm	477	19	with	with	IN
cord-023095-4dannjjm	477	20	both	both	DT
cord-023095-4dannjjm	477	21	echocardiography	echocardiography	NN
cord-023095-4dannjjm	477	22	and	and	CC
cord-023095-4dannjjm	477	23	strain	strain	NN
cord-023095-4dannjjm	477	24	.	.	.
cord-023095-4dannjjm	478	1	Then	then	RB
cord-023095-4dannjjm	478	2	,	,	,
cord-023095-4dannjjm	478	3	were	be	VBD
cord-023095-4dannjjm	478	4	phenotypically	phenotypically	RB
cord-023095-4dannjjm	478	5	classified	classify	VBN
cord-023095-4dannjjm	478	6	in	in	IN
cord-023095-4dannjjm	478	7	:	:	:
cord-023095-4dannjjm	478	8	normal	normal	JJ
cord-023095-4dannjjm	478	9	(	(	-LRB-
cord-023095-4dannjjm	478	10	n	n	NN
cord-023095-4dannjjm	478	11	5	5	CD
cord-023095-4dannjjm	478	12	45	45	CD
cord-023095-4dannjjm	478	13	)	)	-RRB-
cord-023095-4dannjjm	478	14	,	,	,
cord-023095-4dannjjm	478	15	suspects	suspect	NNS
cord-023095-4dannjjm	478	16	for	for	IN
cord-023095-4dannjjm	478	17	HCM	HCM	NNP
cord-023095-4dannjjm	478	18	(	(	-LRB-
cord-023095-4dannjjm	478	19	n	n	NN
cord-023095-4dannjjm	478	20	5	5	CD
cord-023095-4dannjjm	478	21	7	7	CD
cord-023095-4dannjjm	478	22	)	)	-RRB-
cord-023095-4dannjjm	478	23	and	and	CC
cord-023095-4dannjjm	478	24	HCM	HCM	NNP
cord-023095-4dannjjm	478	25	group	group	NN
cord-023095-4dannjjm	478	26	(	(	-LRB-
cord-023095-4dannjjm	478	27	n	n	NN
cord-023095-4dannjjm	478	28	5	5	CD
cord-023095-4dannjjm	478	29	5	5	CD
cord-023095-4dannjjm	478	30	)	)	-RRB-
cord-023095-4dannjjm	478	31	;	;	:
cord-023095-4dannjjm	478	32	and	and	CC
cord-023095-4dannjjm	478	33	genotypically	genotypically	RB
cord-023095-4dannjjm	478	34	classified	classify	VBN
cord-023095-4dannjjm	478	35	in	in	IN
cord-023095-4dannjjm	478	36	:	:	:
cord-023095-4dannjjm	478	37	negative	negative	JJ
cord-023095-4dannjjm	478	38	(	(	-LRB-
cord-023095-4dannjjm	478	39	n	n	NN
cord-023095-4dannjjm	478	40	5	5	CD
cord-023095-4dannjjm	478	41	28	28	CD
cord-023095-4dannjjm	478	42	)	)	-RRB-
cord-023095-4dannjjm	478	43	,	,	,
cord-023095-4dannjjm	478	44	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	478	45	(	(	-LRB-
cord-023095-4dannjjm	478	46	n	n	NN
cord-023095-4dannjjm	478	47	5	5	CD
cord-023095-4dannjjm	478	48	26	26	CD
cord-023095-4dannjjm	478	49	)	)	-RRB-
cord-023095-4dannjjm	478	50	and	and	CC
cord-023095-4dannjjm	478	51	homozygous	homozygous	JJ
cord-023095-4dannjjm	478	52	group	group	NN
cord-023095-4dannjjm	478	53	(	(	-LRB-
cord-023095-4dannjjm	478	54	n	n	NN
cord-023095-4dannjjm	478	55	5	5	CD
cord-023095-4dannjjm	478	56	3	3	CD
cord-023095-4dannjjm	478	57	)	)	-RRB-
cord-023095-4dannjjm	478	58	.	.	.
cord-023095-4dannjjm	479	1	Peak	peak	JJ
cord-023095-4dannjjm	479	2	myocardial	myocardial	JJ
cord-023095-4dannjjm	479	3	strain	strain	NN
cord-023095-4dannjjm	479	4	,	,	,
cord-023095-4dannjjm	479	5	measured	measure	VBN
cord-023095-4dannjjm	479	6	in	in	IN
cord-023095-4dannjjm	479	7	the	the	DT
cord-023095-4dannjjm	479	8	basal	basal	NN
cord-023095-4dannjjm	479	9	and	and	CC
cord-023095-4dannjjm	479	10	mildventricular	mildventricular	JJ
cord-023095-4dannjjm	479	11	segment	segment	NN
cord-023095-4dannjjm	479	12	of	of	IN
cord-023095-4dannjjm	479	13	the	the	DT
cord-023095-4dannjjm	479	14	interventricular	interventricular	JJ
cord-023095-4dannjjm	479	15	septal	septal	JJ
cord-023095-4dannjjm	479	16	wall	wall	NN
cord-023095-4dannjjm	479	17	(	(	-LRB-
cord-023095-4dannjjm	479	18	IVS	IVS	NNP
cord-023095-4dannjjm	479	19	)	)	-RRB-
cord-023095-4dannjjm	479	20	,	,	,
cord-023095-4dannjjm	479	21	left	leave	VBD
cord-023095-4dannjjm	479	22	ventricular	ventricular	JJ
cord-023095-4dannjjm	479	23	free	free	JJ
cord-023095-4dannjjm	479	24	wall	wall	NN
cord-023095-4dannjjm	479	25	(	(	-LRB-
cord-023095-4dannjjm	479	26	LVW	LVW	NNP
cord-023095-4dannjjm	479	27	)	)	-RRB-
cord-023095-4dannjjm	479	28	,	,	,
cord-023095-4dannjjm	479	29	left	leave	VBD
cord-023095-4dannjjm	479	30	ventricular	ventricular	JJ
cord-023095-4dannjjm	479	31	anterior	anterior	JJ
cord-023095-4dannjjm	479	32	wall	wall	NN
cord-023095-4dannjjm	479	33	(	(	-LRB-
cord-023095-4dannjjm	479	34	LVAW	LVAW	NNP
cord-023095-4dannjjm	479	35	)	)	-RRB-
cord-023095-4dannjjm	479	36	,	,	,
cord-023095-4dannjjm	479	37	left	leave	VBD
cord-023095-4dannjjm	479	38	ventricular	ventricular	JJ
cord-023095-4dannjjm	479	39	posterior	posterior	JJ
cord-023095-4dannjjm	479	40	wall	wall	NN
cord-023095-4dannjjm	479	41	(	(	-LRB-
cord-023095-4dannjjm	479	42	LVPW	LVPW	NNP
cord-023095-4dannjjm	479	43	)	)	-RRB-
cord-023095-4dannjjm	479	44	and	and	CC
cord-023095-4dannjjm	479	45	radial	radial	JJ
cord-023095-4dannjjm	479	46	segment	segment	NN
cord-023095-4dannjjm	479	47	of	of	IN
cord-023095-4dannjjm	479	48	left	left	JJ
cord-023095-4dannjjm	479	49	ventricular	ventricular	JJ
cord-023095-4dannjjm	479	50	wall	wall	NN
cord-023095-4dannjjm	479	51	,	,	,
cord-023095-4dannjjm	479	52	was	be	VBD
cord-023095-4dannjjm	479	53	compared	compare	VBN
cord-023095-4dannjjm	479	54	among	among	IN
cord-023095-4dannjjm	479	55	different	different	JJ
cord-023095-4dannjjm	479	56	groups	group	NNS
cord-023095-4dannjjm	479	57	.	.	.
cord-023095-4dannjjm	480	1	Whereas	whereas	IN
cord-023095-4dannjjm	480	2	conventional	conventional	JJ
cord-023095-4dannjjm	480	3	echocardiography	echocardiography	NN
cord-023095-4dannjjm	480	4	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	480	5	an	an	DT
cord-023095-4dannjjm	480	6	apparently	apparently	RB
cord-023095-4dannjjm	480	7	normal	normal	JJ
cord-023095-4dannjjm	480	8	contractile	contractile	JJ
cord-023095-4dannjjm	480	9	state	state	NN
cord-023095-4dannjjm	480	10	based	base	VBN
cord-023095-4dannjjm	480	11	on	on	IN
cord-023095-4dannjjm	480	12	fractional	fractional	JJ
cord-023095-4dannjjm	480	13	shortening	shortening	NN
cord-023095-4dannjjm	480	14	,	,	,
cord-023095-4dannjjm	480	15	myocardial	myocardial	JJ
cord-023095-4dannjjm	480	16	strain	strain	NN
cord-023095-4dannjjm	480	17	(	(	-LRB-
cord-023095-4dannjjm	480	18	at	at	IN
cord-023095-4dannjjm	480	19	mildventricular	mildventricular	NNP
cord-023095-4dannjjm	480	20	segment	segment	NN
cord-023095-4dannjjm	480	21	of	of	IN
cord-023095-4dannjjm	480	22	IVS	IVS	NNP
cord-023095-4dannjjm	480	23	)	)	-RRB-
cord-023095-4dannjjm	480	24	in	in	IN
cord-023095-4dannjjm	480	25	HCM	HCM	NNP
cord-023095-4dannjjm	480	26	cats	cat	NNS
cord-023095-4dannjjm	480	27	was	be	VBD
cord-023095-4dannjjm	480	28	significantly	significantly	RB
cord-023095-4dannjjm	480	29	decreased	decrease	VBN
cord-023095-4dannjjm	480	30	compared	compare	VBN
cord-023095-4dannjjm	480	31	with	with	IN
cord-023095-4dannjjm	480	32	normal	normal	JJ
cord-023095-4dannjjm	480	33	group	group	NN
cord-023095-4dannjjm	480	34	(	(	-LRB-
cord-023095-4dannjjm	480	35	P	p	NN
cord-023095-4dannjjm	480	36	5	5	CD
cord-023095-4dannjjm	480	37	0,01	0,01	CD
cord-023095-4dannjjm	480	38	)	)	-RRB-
cord-023095-4dannjjm	480	39	.	.	.
cord-023095-4dannjjm	481	1	Myocardial	myocardial	JJ
cord-023095-4dannjjm	481	2	strain	strain	NN
cord-023095-4dannjjm	481	3	(	(	-LRB-
cord-023095-4dannjjm	481	4	at	at	IN
cord-023095-4dannjjm	481	5	basal	basal	NN
cord-023095-4dannjjm	481	6	segment	segment	NN
cord-023095-4dannjjm	481	7	of	of	IN
cord-023095-4dannjjm	481	8	LVAW	LVAW	NNP
cord-023095-4dannjjm	481	9	)	)	-RRB-
cord-023095-4dannjjm	481	10	also	also	RB
cord-023095-4dannjjm	481	11	was	be	VBD
cord-023095-4dannjjm	481	12	significantly	significantly	RB
cord-023095-4dannjjm	481	13	decreased	decrease	VBN
cord-023095-4dannjjm	481	14	in	in	IN
cord-023095-4dannjjm	481	15	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	481	16	cats	cat	NNS
cord-023095-4dannjjm	481	17	compared	compare	VBN
cord-023095-4dannjjm	481	18	with	with	IN
cord-023095-4dannjjm	481	19	negative	negative	JJ
cord-023095-4dannjjm	481	20	group	group	NN
cord-023095-4dannjjm	481	21	(	(	-LRB-
cord-023095-4dannjjm	481	22	P	p	NN
cord-023095-4dannjjm	481	23	5	5	CD
cord-023095-4dannjjm	481	24	0,00	0,00	NN
cord-023095-4dannjjm	481	25	)	)	-RRB-
cord-023095-4dannjjm	481	26	;	;	:
cord-023095-4dannjjm	481	27	and	and	CC
cord-023095-4dannjjm	481	28	was	be	VBD
cord-023095-4dannjjm	481	29	significantly	significantly	RB
cord-023095-4dannjjm	481	30	decreased	decrease	VBN
cord-023095-4dannjjm	481	31	in	in	IN
cord-023095-4dannjjm	481	32	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	481	33	cats	cat	NNS
cord-023095-4dannjjm	481	34	compared	compare	VBN
cord-023095-4dannjjm	481	35	with	with	IN
cord-023095-4dannjjm	481	36	negative	negative	JJ
cord-023095-4dannjjm	481	37	group	group	NN
cord-023095-4dannjjm	481	38	,	,	,
cord-023095-4dannjjm	481	39	both	both	CC
cord-023095-4dannjjm	481	40	without	without	IN
cord-023095-4dannjjm	481	41	ventricular	ventricular	JJ
cord-023095-4dannjjm	481	42	hypertrophy	hypertrophy	NN
cord-023095-4dannjjm	481	43	(	(	-LRB-
cord-023095-4dannjjm	481	44	P	p	NN
cord-023095-4dannjjm	481	45	5	5	CD
cord-023095-4dannjjm	481	46	0,019	0,019	CD
cord-023095-4dannjjm	481	47	)	)	-RRB-
cord-023095-4dannjjm	481	48	.	.	.
cord-023095-4dannjjm	482	1	There	there	EX
cord-023095-4dannjjm	482	2	was	be	VBD
cord-023095-4dannjjm	482	3	a	a	DT
cord-023095-4dannjjm	482	4	significant	significant	JJ
cord-023095-4dannjjm	482	5	negative	negative	JJ
cord-023095-4dannjjm	482	6	correlation	correlation	NN
cord-023095-4dannjjm	482	7	between	between	IN
cord-023095-4dannjjm	482	8	strain	strain	NN
cord-023095-4dannjjm	482	9	values	value	NNS
cord-023095-4dannjjm	482	10	and	and	CC
cord-023095-4dannjjm	482	11	wall	wall	NN
cord-023095-4dannjjm	482	12	thickness	thickness	NN
cord-023095-4dannjjm	482	13	(	(	-LRB-
cord-023095-4dannjjm	482	14	P	p	NN
cord-023095-4dannjjm	482	15	o	o	NN
cord-023095-4dannjjm	482	16	0,05	0,05	NN
cord-023095-4dannjjm	482	17	)	)	-RRB-
cord-023095-4dannjjm	482	18	.	.	.
cord-023095-4dannjjm	483	1	This	this	DT
cord-023095-4dannjjm	483	2	method	method	NN
cord-023095-4dannjjm	483	3	allows	allow	VBZ
cord-023095-4dannjjm	483	4	detection	detection	NN
cord-023095-4dannjjm	483	5	of	of	IN
cord-023095-4dannjjm	483	6	abnormal	abnormal	JJ
cord-023095-4dannjjm	483	7	systolic	systolic	JJ
cord-023095-4dannjjm	483	8	deformation	deformation	NN
cord-023095-4dannjjm	483	9	in	in	IN
cord-023095-4dannjjm	483	10	Maine	Maine	NNP
cord-023095-4dannjjm	483	11	Coons	Coons	NNPS
cord-023095-4dannjjm	483	12	cats	cat	NNS
cord-023095-4dannjjm	483	13	with	with	IN
cord-023095-4dannjjm	483	14	HCM	HCM	NNP
cord-023095-4dannjjm	483	15	mutation	mutation	NN
cord-023095-4dannjjm	483	16	despite	despite	IN
cord-023095-4dannjjm	483	17	apparently	apparently	RB
cord-023095-4dannjjm	483	18	normal	normal	JJ
cord-023095-4dannjjm	483	19	systolic	systolic	JJ
cord-023095-4dannjjm	483	20	function	function	NN
cord-023095-4dannjjm	483	21	.	.	.
cord-023095-4dannjjm	484	1	The	the	DT
cord-023095-4dannjjm	484	2	abnormal	abnormal	JJ
cord-023095-4dannjjm	484	3	systolic	systolic	JJ
cord-023095-4dannjjm	484	4	deformation	deformation	NN
cord-023095-4dannjjm	484	5	already	already	RB
cord-023095-4dannjjm	484	6	can	can	MD
cord-023095-4dannjjm	484	7	be	be	VB
cord-023095-4dannjjm	484	8	present	present	JJ
cord-023095-4dannjjm	484	9	in	in	IN
cord-023095-4dannjjm	484	10	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	484	11	cats	cat	NNS
cord-023095-4dannjjm	484	12	without	without	IN
cord-023095-4dannjjm	484	13	hypertrophy	hypertrophy	NN
cord-023095-4dannjjm	484	14	and	and	CC
cord-023095-4dannjjm	484	15	increased	increase	VBD
cord-023095-4dannjjm	484	16	with	with	IN
cord-023095-4dannjjm	484	17	progressive	progressive	JJ
cord-023095-4dannjjm	484	18	ventricular	ventricular	JJ
cord-023095-4dannjjm	484	19	hypertrophy	hypertrophy	NN
cord-023095-4dannjjm	484	20	.	.	.
cord-023095-4dannjjm	485	1	Recently	recently	RB
cord-023095-4dannjjm	485	2	,	,	,
cord-023095-4dannjjm	485	3	multiple	multiple	JJ
cord-023095-4dannjjm	485	4	advanced	advanced	JJ
cord-023095-4dannjjm	485	5	resting	resting	NN
cord-023095-4dannjjm	485	6	electrocardiographic	electrocardiographic	NNP
cord-023095-4dannjjm	485	7	(	(	-LRB-
cord-023095-4dannjjm	485	8	ECG	ECG	NNP
cord-023095-4dannjjm	485	9	)	)	-RRB-
cord-023095-4dannjjm	485	10	techniques	technique	NNS
cord-023095-4dannjjm	485	11	have	have	VBP
cord-023095-4dannjjm	485	12	been	be	VBN
cord-023095-4dannjjm	485	13	applied	apply	VBN
cord-023095-4dannjjm	485	14	in	in	IN
cord-023095-4dannjjm	485	15	humans	human	NNS
cord-023095-4dannjjm	485	16	for	for	IN
cord-023095-4dannjjm	485	17	detection	detection	NN
cord-023095-4dannjjm	485	18	of	of	IN
cord-023095-4dannjjm	485	19	cardiac	cardiac	JJ
cord-023095-4dannjjm	485	20	autonomic	autonomic	JJ
cord-023095-4dannjjm	485	21	and	and	CC
cord-023095-4dannjjm	485	22	repolarisation	repolarisation	NN
cord-023095-4dannjjm	485	23	function	function	NN
cord-023095-4dannjjm	485	24	.	.	.
cord-023095-4dannjjm	486	1	This	this	DT
cord-023095-4dannjjm	486	2	has	have	VBZ
cord-023095-4dannjjm	486	3	improved	improve	VBN
cord-023095-4dannjjm	486	4	the	the	DT
cord-023095-4dannjjm	486	5	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	486	6	and/or	and/or	CC
cord-023095-4dannjjm	486	7	prognostic	prognostic	JJ
cord-023095-4dannjjm	486	8	value	value	NN
cord-023095-4dannjjm	486	9	of	of	IN
cord-023095-4dannjjm	486	10	short	short	JJ
cord-023095-4dannjjm	486	11	-	-	HYPH
cord-023095-4dannjjm	486	12	time	time	NN
cord-023095-4dannjjm	486	13	ECG	ECG	NNP
cord-023095-4dannjjm	486	14	in	in	IN
cord-023095-4dannjjm	486	15	detection	detection	NN
cord-023095-4dannjjm	486	16	of	of	IN
cord-023095-4dannjjm	486	17	common	common	JJ
cord-023095-4dannjjm	486	18	human	human	JJ
cord-023095-4dannjjm	486	19	cardiac	cardiac	JJ
cord-023095-4dannjjm	486	20	diseases	disease	NNS
cord-023095-4dannjjm	486	21	even	even	RB
cord-023095-4dannjjm	486	22	before	before	IN
cord-023095-4dannjjm	486	23	onset	onset	NN
cord-023095-4dannjjm	486	24	of	of	IN
cord-023095-4dannjjm	486	25	symptoms	symptom	NNS
cord-023095-4dannjjm	486	26	or	or	CC
cord-023095-4dannjjm	486	27	changes	change	NNS
cord-023095-4dannjjm	486	28	in	in	IN
cord-023095-4dannjjm	486	29	the	the	DT
cord-023095-4dannjjm	486	30	standard	standard	JJ
cord-023095-4dannjjm	486	31	ECG	ECG	NNP
cord-023095-4dannjjm	486	32	.	.	.
cord-023095-4dannjjm	487	1	Therefore	therefore	RB
cord-023095-4dannjjm	487	2	,	,	,
cord-023095-4dannjjm	487	3	this	this	DT
cord-023095-4dannjjm	487	4	study	study	NN
cord-023095-4dannjjm	487	5	investigates	investigate	VBZ
cord-023095-4dannjjm	487	6	,	,	,
cord-023095-4dannjjm	487	7	if	if	IN
cord-023095-4dannjjm	487	8	advanced	advanced	JJ
cord-023095-4dannjjm	487	9	ECG	ECG	NNP
cord-023095-4dannjjm	487	10	can	can	MD
cord-023095-4dannjjm	487	11	predict	predict	VB
cord-023095-4dannjjm	487	12	the	the	DT
cord-023095-4dannjjm	487	13	severity	severity	NN
cord-023095-4dannjjm	487	14	of	of	IN
cord-023095-4dannjjm	487	15	mitral	mitral	JJ
cord-023095-4dannjjm	487	16	regurgitation	regurgitation	NN
cord-023095-4dannjjm	487	17	(	(	-LRB-
cord-023095-4dannjjm	487	18	MR	MR	NNP
cord-023095-4dannjjm	487	19	)	)	-RRB-
cord-023095-4dannjjm	487	20	in	in	IN
cord-023095-4dannjjm	487	21	dogs	dog	NNS
cord-023095-4dannjjm	487	22	with	with	IN
cord-023095-4dannjjm	487	23	myxomatous	myxomatous	JJ
cord-023095-4dannjjm	487	24	mitral	mitral	JJ
cord-023095-4dannjjm	487	25	valve	valve	NN
cord-023095-4dannjjm	487	26	disease	disease	NN
cord-023095-4dannjjm	487	27	(	(	-LRB-
cord-023095-4dannjjm	487	28	MMVD	MMVD	NNP
cord-023095-4dannjjm	487	29	)	)	-RRB-
cord-023095-4dannjjm	487	30	and	and	CC
cord-023095-4dannjjm	487	31	thereby	thereby	RB
cord-023095-4dannjjm	487	32	improve	improve	VB
cord-023095-4dannjjm	487	33	the	the	DT
cord-023095-4dannjjm	487	34	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	487	35	value	value	NN
cord-023095-4dannjjm	487	36	of	of	IN
cord-023095-4dannjjm	487	37	ECG	ECG	NNP
cord-023095-4dannjjm	487	38	.	.	.
cord-023095-4dannjjm	488	1	The	the	DT
cord-023095-4dannjjm	488	2	study	study	NN
cord-023095-4dannjjm	488	3	included	include	VBD
cord-023095-4dannjjm	488	4	77	77	CD
cord-023095-4dannjjm	488	5	privately	privately	RB
cord-023095-4dannjjm	488	6	owned	own	VBN
cord-023095-4dannjjm	488	7	Cavalier	Cavalier	NNP
cord-023095-4dannjjm	488	8	King	King	NNP
cord-023095-4dannjjm	488	9	Charles	Charles	NNP
cord-023095-4dannjjm	488	10	Spaniels	Spaniels	NNPS
cord-023095-4dannjjm	488	11	(	(	-LRB-
cord-023095-4dannjjm	488	12	CKCSs	ckcs	NNS
cord-023095-4dannjjm	488	13	)	)	-RRB-
cord-023095-4dannjjm	488	14	(	(	-LRB-
cord-023095-4dannjjm	488	15	age	age	NN
cord-023095-4dannjjm	488	16	6.0	6.0	CD
cord-023095-4dannjjm	488	17	AE	AE	NNP
cord-023095-4dannjjm	488	18	2.7	2.7	CD
cord-023095-4dannjjm	488	19	years	year	NNS
cord-023095-4dannjjm	488	20	;	;	:
cord-023095-4dannjjm	488	21	30	30	CD
cord-023095-4dannjjm	488	22	males	male	NNS
cord-023095-4dannjjm	488	23	and	and	CC
cord-023095-4dannjjm	488	24	47	47	CD
cord-023095-4dannjjm	488	25	females	female	NNS
cord-023095-4dannjjm	488	26	)	)	-RRB-
cord-023095-4dannjjm	488	27	.	.	.
cord-023095-4dannjjm	489	1	All	all	DT
cord-023095-4dannjjm	489	2	dogs	dog	NNS
cord-023095-4dannjjm	489	3	were	be	VBD
cord-023095-4dannjjm	489	4	examined	examine	VBN
cord-023095-4dannjjm	489	5	by	by	IN
cord-023095-4dannjjm	489	6	echocardiography	echocardiography	NN
cord-023095-4dannjjm	489	7	and	and	CC
cord-023095-4dannjjm	489	8	a	a	DT
cord-023095-4dannjjm	489	9	short	short	JJ
cord-023095-4dannjjm	489	10	-	-	HYPH
cord-023095-4dannjjm	489	11	time	time	NN
cord-023095-4dannjjm	489	12	(	(	-LRB-
cord-023095-4dannjjm	489	13	3	3	CD
cord-023095-4dannjjm	489	14	-	-	SYM
cord-023095-4dannjjm	489	15	5	5	CD
cord-023095-4dannjjm	489	16	min	min	NN
cord-023095-4dannjjm	489	17	)	)	-RRB-
cord-023095-4dannjjm	489	18	high	high	JJ
cord-023095-4dannjjm	489	19	-	-	HYPH
cord-023095-4dannjjm	489	20	fidelity	fidelity	NN
cord-023095-4dannjjm	489	21	12-lead	12-lead	JJ
cord-023095-4dannjjm	489	22	ECG	ECG	NNP
cord-023095-4dannjjm	489	23	,	,	,
cord-023095-4dannjjm	489	24	with	with	IN
cord-023095-4dannjjm	489	25	the	the	DT
cord-023095-4dannjjm	489	26	dog	dog	NN
cord-023095-4dannjjm	489	27	in	in	IN
cord-023095-4dannjjm	489	28	a	a	DT
cord-023095-4dannjjm	489	29	resting	rest	VBG
cord-023095-4dannjjm	489	30	position	position	NN
cord-023095-4dannjjm	489	31	and	and	CC
cord-023095-4dannjjm	489	32	in	in	IN
cord-023095-4dannjjm	489	33	sinus	sinus	NN
cord-023095-4dannjjm	489	34	rhythm	rhythm	NN
cord-023095-4dannjjm	489	35	.	.	.
cord-023095-4dannjjm	490	1	Dogs	dog	NNS
cord-023095-4dannjjm	490	2	were	be	VBD
cord-023095-4dannjjm	490	3	divided	divide	VBN
cord-023095-4dannjjm	490	4	into	into	IN
cord-023095-4dannjjm	490	5	5	5	CD
cord-023095-4dannjjm	490	6	groups	group	NNS
cord-023095-4dannjjm	490	7	according	accord	VBG
cord-023095-4dannjjm	490	8	to	to	IN
cord-023095-4dannjjm	490	9	the	the	DT
cord-023095-4dannjjm	490	10	degree	degree	NN
cord-023095-4dannjjm	490	11	of	of	IN
cord-023095-4dannjjm	490	12	MR	MR	NNP
cord-023095-4dannjjm	490	13	estimated	estimate	VBD
cord-023095-4dannjjm	490	14	as	as	IN
cord-023095-4dannjjm	490	15	the	the	DT
cord-023095-4dannjjm	490	16	percentage	percentage	NN
cord-023095-4dannjjm	490	17	of	of	IN
cord-023095-4dannjjm	490	18	the	the	DT
cord-023095-4dannjjm	490	19	left	left	JJ
cord-023095-4dannjjm	490	20	atrium	atrium	NN
cord-023095-4dannjjm	490	21	area	area	NN
cord-023095-4dannjjm	490	22	using	use	VBG
cord-023095-4dannjjm	490	23	color	color	NN
cord-023095-4dannjjm	490	24	Doppler	Doppler	NNP
cord-023095-4dannjjm	490	25	mapping	mapping	NN
cord-023095-4dannjjm	490	26	(	(	-LRB-
cord-023095-4dannjjm	490	27	0	0	CD
cord-023095-4dannjjm	490	28	%	%	NN
cord-023095-4dannjjm	490	29	;	;	:
cord-023095-4dannjjm	490	30	0	0	CD
cord-023095-4dannjjm	490	31	%	%	NN
cord-023095-4dannjjm	490	32	o	o	NN
cord-023095-4dannjjm	490	33	jet	jet	NN
cord-023095-4dannjjm	490	34	15	15	CD
cord-023095-4dannjjm	490	35	%	%	NN
cord-023095-4dannjjm	490	36	;	;	:
cord-023095-4dannjjm	490	37	15	15	CD
cord-023095-4dannjjm	490	38	%	%	NN
cord-023095-4dannjjm	490	39	o	o	UH
cord-023095-4dannjjm	490	40	jet	jet	NN
cord-023095-4dannjjm	490	41	50	50	CD
cord-023095-4dannjjm	490	42	%	%	NN
cord-023095-4dannjjm	490	43	;	;	:
cord-023095-4dannjjm	490	44	jet	jet	NN
cord-023095-4dannjjm	490	45	4	4	CD
cord-023095-4dannjjm	490	46	50	50	CD
cord-023095-4dannjjm	490	47	%	%	NN
cord-023095-4dannjjm	490	48	;	;	:
cord-023095-4dannjjm	490	49	jet	jet	NN
cord-023095-4dannjjm	490	50	5	5	CD
cord-023095-4dannjjm	490	51	100	100	CD
cord-023095-4dannjjm	490	52	%	%	NN
cord-023095-4dannjjm	490	53	and	and	CC
cord-023095-4dannjjm	490	54	with	with	IN
cord-023095-4dannjjm	490	55	clinical	clinical	JJ
cord-023095-4dannjjm	490	56	signs	sign	NNS
cord-023095-4dannjjm	490	57	of	of	IN
cord-023095-4dannjjm	490	58	congestive	congestive	JJ
cord-023095-4dannjjm	490	59	heart	heart	NN
cord-023095-4dannjjm	490	60	failure	failure	NN
cord-023095-4dannjjm	490	61	)	)	-RRB-
cord-023095-4dannjjm	490	62	.	.	.
cord-023095-4dannjjm	491	1	ECG	ECG	NNP
cord-023095-4dannjjm	491	2	recordings	recording	NNS
cord-023095-4dannjjm	491	3	were	be	VBD
cord-023095-4dannjjm	491	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	491	5	via	via	IN
cord-023095-4dannjjm	491	6	custom	custom	NN
cord-023095-4dannjjm	491	7	software	software	NN
cord-023095-4dannjjm	491	8	programs	program	NNS
cord-023095-4dannjjm	491	9	to	to	TO
cord-023095-4dannjjm	491	10	calculate	calculate	VB
cord-023095-4dannjjm	491	11	76	76	CD
cord-023095-4dannjjm	491	12	different	different	JJ
cord-023095-4dannjjm	491	13	parameters	parameter	NNS
cord-023095-4dannjjm	491	14	,	,	,
cord-023095-4dannjjm	491	15	including	include	VBG
cord-023095-4dannjjm	491	16	heart	heart	NN
cord-023095-4dannjjm	491	17	rate	rate	NN
cord-023095-4dannjjm	491	18	variability	variability	NN
cord-023095-4dannjjm	491	19	(	(	-LRB-
cord-023095-4dannjjm	491	20	HRV	HRV	NNP
cord-023095-4dannjjm	491	21	)	)	-RRB-
cord-023095-4dannjjm	491	22	,	,	,
cord-023095-4dannjjm	491	23	QT	qt	NN
cord-023095-4dannjjm	491	24	variability	variability	NN
cord-023095-4dannjjm	491	25	(	(	-LRB-
cord-023095-4dannjjm	491	26	QTV	QTV	NNP
cord-023095-4dannjjm	491	27	)	)	-RRB-
cord-023095-4dannjjm	491	28	,	,	,
cord-023095-4dannjjm	491	29	T	t	NN
cord-023095-4dannjjm	491	30	-	-	HYPH
cord-023095-4dannjjm	491	31	wave	wave	NN
cord-023095-4dannjjm	491	32	complexity	complexity	NN
cord-023095-4dannjjm	491	33	,	,	,
cord-023095-4dannjjm	491	34	wave	wave	NN
cord-023095-4dannjjm	491	35	morphology	morphology	NN
cord-023095-4dannjjm	491	36	and	and	CC
cord-023095-4dannjjm	491	37	3-D	3-d	JJ
cord-023095-4dannjjm	491	38	ECG	ECG	NNP
cord-023095-4dannjjm	491	39	.	.	.
cord-023095-4dannjjm	492	1	One	one	CD
cord-023095-4dannjjm	492	2	-	-	HYPH
cord-023095-4dannjjm	492	3	way	way	NN
cord-023095-4dannjjm	492	4	ANOVA	anova	NN
cord-023095-4dannjjm	492	5	determined	determine	VBD
cord-023095-4dannjjm	492	6	21	21	CD
cord-023095-4dannjjm	492	7	ECG	ECG	NNP
cord-023095-4dannjjm	492	8	parameters	parameter	NNS
cord-023095-4dannjjm	492	9	,	,	,
cord-023095-4dannjjm	492	10	which	which	WDT
cord-023095-4dannjjm	492	11	were	be	VBD
cord-023095-4dannjjm	492	12	significantly	significantly	RB
cord-023095-4dannjjm	492	13	different	different	JJ
cord-023095-4dannjjm	492	14	(	(	-LRB-
cord-023095-4dannjjm	492	15	P	p	NN
cord-023095-4dannjjm	492	16	o	o	NN
cord-023095-4dannjjm	492	17	0.05	0.05	CD
cord-023095-4dannjjm	492	18	)	)	-RRB-
cord-023095-4dannjjm	492	19	between	between	IN
cord-023095-4dannjjm	492	20	the	the	DT
cord-023095-4dannjjm	492	21	5	5	CD
cord-023095-4dannjjm	492	22	dog	dog	NN
cord-023095-4dannjjm	492	23	groups	group	NNS
cord-023095-4dannjjm	492	24	.	.	.
cord-023095-4dannjjm	493	1	Principal	principal	JJ
cord-023095-4dannjjm	493	2	component	component	NN
cord-023095-4dannjjm	493	3	factor	factor	NN
cord-023095-4dannjjm	493	4	analysis	analysis	NN
cord-023095-4dannjjm	493	5	identified	identify	VBD
cord-023095-4dannjjm	493	6	a	a	DT
cord-023095-4dannjjm	493	7	5factor	5factor	CD
cord-023095-4dannjjm	493	8	model	model	NN
cord-023095-4dannjjm	493	9	with	with	IN
cord-023095-4dannjjm	493	10	83.2	83.2	CD
cord-023095-4dannjjm	493	11	%	%	NN
cord-023095-4dannjjm	493	12	explained	explain	VBD
cord-023095-4dannjjm	493	13	variability	variability	NN
cord-023095-4dannjjm	493	14	.	.	.
cord-023095-4dannjjm	494	1	QRS	QRS	NNP
cord-023095-4dannjjm	494	2	dipolar	dipolar	JJ
cord-023095-4dannjjm	494	3	voltage	voltage	NN
cord-023095-4dannjjm	494	4	and	and	CC
cord-023095-4dannjjm	494	5	two	two	CD
cord-023095-4dannjjm	494	6	repolarization	repolarization	NN
cord-023095-4dannjjm	494	7	indices	index	NNS
cord-023095-4dannjjm	494	8	of	of	IN
cord-023095-4dannjjm	494	9	QTV	QTV	NNP
cord-023095-4dannjjm	494	10	increased	increase	VBD
cord-023095-4dannjjm	494	11	significantly	significantly	RB
cord-023095-4dannjjm	494	12	with	with	IN
cord-023095-4dannjjm	494	13	MR	MR	NNP
cord-023095-4dannjjm	494	14	severity	severity	NN
cord-023095-4dannjjm	494	15	,	,	,
cord-023095-4dannjjm	494	16	whereas	whereas	IN
cord-023095-4dannjjm	494	17	total	total	JJ
cord-023095-4dannjjm	494	18	power	power	NN
cord-023095-4dannjjm	494	19	of	of	IN
cord-023095-4dannjjm	494	20	the	the	DT
cord-023095-4dannjjm	494	21	frequency	frequency	NN
cord-023095-4dannjjm	494	22	spectrum	spectrum	NN
cord-023095-4dannjjm	494	23	of	of	IN
cord-023095-4dannjjm	494	24	RR	RR	NNP
cord-023095-4dannjjm	494	25	interval	interval	NN
cord-023095-4dannjjm	494	26	and	and	CC
cord-023095-4dannjjm	494	27	the	the	DT
cord-023095-4dannjjm	494	28	standard	standard	JJ
cord-023095-4dannjjm	494	29	deviation	deviation	NN
cord-023095-4dannjjm	494	30	of	of	IN
cord-023095-4dannjjm	494	31	QTV	QTV	NNP
cord-023095-4dannjjm	494	32	decreased	decrease	VBD
cord-023095-4dannjjm	494	33	significantly	significantly	RB
cord-023095-4dannjjm	494	34	with	with	IN
cord-023095-4dannjjm	494	35	MR	MR	NNP
cord-023095-4dannjjm	494	36	severity	severity	NN
cord-023095-4dannjjm	494	37	.	.	.
cord-023095-4dannjjm	495	1	For	for	IN
cord-023095-4dannjjm	495	2	the	the	DT
cord-023095-4dannjjm	495	3	5	5	CD
cord-023095-4dannjjm	495	4	selected	select	VBN
cord-023095-4dannjjm	495	5	parameters	parameter	NNS
cord-023095-4dannjjm	495	6	the	the	DT
cord-023095-4dannjjm	495	7	prediction	prediction	NN
cord-023095-4dannjjm	495	8	of	of	IN
cord-023095-4dannjjm	495	9	MR	MR	NNP
cord-023095-4dannjjm	495	10	jet	jet	NN
cord-023095-4dannjjm	495	11	value	value	NN
cord-023095-4dannjjm	495	12	was	be	VBD
cord-023095-4dannjjm	495	13	tested	test	VBN
cord-023095-4dannjjm	495	14	by	by	IN
cord-023095-4dannjjm	495	15	multiple	multiple	JJ
cord-023095-4dannjjm	495	16	linear	linear	JJ
cord-023095-4dannjjm	495	17	regression	regression	NN
cord-023095-4dannjjm	495	18	.	.	.
cord-023095-4dannjjm	496	1	A	a	DT
cord-023095-4dannjjm	496	2	correlation	correlation	NN
cord-023095-4dannjjm	496	3	coefficient	coefficient	NN
cord-023095-4dannjjm	496	4	(	(	-LRB-
cord-023095-4dannjjm	496	5	R	r	NN
cord-023095-4dannjjm	496	6	)	)	-RRB-
cord-023095-4dannjjm	496	7	of	of	IN
cord-023095-4dannjjm	496	8	0.65	0.65	CD
cord-023095-4dannjjm	496	9	indicated	indicate	VBD
cord-023095-4dannjjm	496	10	that	that	IN
cord-023095-4dannjjm	496	11	the	the	DT
cord-023095-4dannjjm	496	12	prediction	prediction	NN
cord-023095-4dannjjm	496	13	value	value	NN
cord-023095-4dannjjm	496	14	was	be	VBD
cord-023095-4dannjjm	496	15	significant	significant	JJ
cord-023095-4dannjjm	497	1	(	(	-LRB-
cord-023095-4dannjjm	497	2	P	p	NN
cord-023095-4dannjjm	497	3	o	o	NN
cord-023095-4dannjjm	497	4	0.01	0.01	CD
cord-023095-4dannjjm	497	5	)	)	-RRB-
cord-023095-4dannjjm	497	6	.	.	.
cord-023095-4dannjjm	498	1	If	if	IN
cord-023095-4dannjjm	498	2	age	age	NN
cord-023095-4dannjjm	498	3	was	be	VBD
cord-023095-4dannjjm	498	4	included	include	VBN
cord-023095-4dannjjm	498	5	in	in	IN
cord-023095-4dannjjm	498	6	the	the	DT
cord-023095-4dannjjm	498	7	multiple	multiple	JJ
cord-023095-4dannjjm	498	8	linear	linear	JJ
cord-023095-4dannjjm	498	9	regression	regression	NN
cord-023095-4dannjjm	498	10	the	the	DT
cord-023095-4dannjjm	498	11	prediction	prediction	NN
cord-023095-4dannjjm	498	12	value	value	NN
cord-023095-4dannjjm	498	13	was	be	VBD
cord-023095-4dannjjm	498	14	further	further	RB
cord-023095-4dannjjm	498	15	increased	increase	VBN
cord-023095-4dannjjm	498	16	(	(	-LRB-
cord-023095-4dannjjm	498	17	R	r	NN
cord-023095-4dannjjm	498	18	5	5	CD
cord-023095-4dannjjm	498	19	0.80	0.80	CD
cord-023095-4dannjjm	498	20	)	)	-RRB-
cord-023095-4dannjjm	498	21	.	.	.
cord-023095-4dannjjm	499	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	499	2	results	result	NNS
cord-023095-4dannjjm	499	3	indicate	indicate	VBP
cord-023095-4dannjjm	499	4	that	that	IN
cord-023095-4dannjjm	499	5	for	for	IN
cord-023095-4dannjjm	499	6	a	a	DT
cord-023095-4dannjjm	499	7	cut	cut	VB
cord-023095-4dannjjm	499	8	-	-	HYPH
cord-023095-4dannjjm	499	9	off	off	RP
cord-023095-4dannjjm	499	10	criteria	criterion	NNS
cord-023095-4dannjjm	499	11	of	of	IN
cord-023095-4dannjjm	499	12	MR	MR	NNP
cord-023095-4dannjjm	499	13	!	!	.
cord-023095-4dannjjm	500	1	50	50	CD
cord-023095-4dannjjm	500	2	%	%	NN
cord-023095-4dannjjm	500	3	jet	jet	NN
cord-023095-4dannjjm	501	1	the	the	DT
cord-023095-4dannjjm	501	2	five	five	CD
cord-023095-4dannjjm	501	3	selected	select	VBN
cord-023095-4dannjjm	501	4	ECG	ECG	NNP
cord-023095-4dannjjm	501	5	parameters	parameter	NNS
cord-023095-4dannjjm	501	6	could	could	MD
cord-023095-4dannjjm	501	7	predict	predict	VB
cord-023095-4dannjjm	501	8	the	the	DT
cord-023095-4dannjjm	501	9	severity	severity	NN
cord-023095-4dannjjm	501	10	of	of	IN
cord-023095-4dannjjm	501	11	MR	MR	NNP
cord-023095-4dannjjm	501	12	caused	cause	VBN
cord-023095-4dannjjm	501	13	by	by	IN
cord-023095-4dannjjm	501	14	MMVD	MMVD	NNP
cord-023095-4dannjjm	501	15	in	in	IN
cord-023095-4dannjjm	501	16	CKCSs	ckcs	NNS
cord-023095-4dannjjm	501	17	with	with	IN
cord-023095-4dannjjm	501	18	sinus	sinus	NN
cord-023095-4dannjjm	501	19	rhythm	rhythm	NN
cord-023095-4dannjjm	501	20	with	with	IN
cord-023095-4dannjjm	501	21	sensitivity	sensitivity	NN
cord-023095-4dannjjm	501	22	65	65	CD
cord-023095-4dannjjm	501	23	%	%	NN
cord-023095-4dannjjm	501	24	(	(	-LRB-
cord-023095-4dannjjm	501	25	78	78	CD
cord-023095-4dannjjm	501	26	%	%	NN
cord-023095-4dannjjm	501	27	with	with	IN
cord-023095-4dannjjm	501	28	age	age	NN
cord-023095-4dannjjm	501	29	inclusion	inclusion	NN
cord-023095-4dannjjm	501	30	)	)	-RRB-
cord-023095-4dannjjm	501	31	and	and	CC
cord-023095-4dannjjm	501	32	specificity	specificity	NN
cord-023095-4dannjjm	501	33	98	98	CD
cord-023095-4dannjjm	501	34	%	%	NN
cord-023095-4dannjjm	501	35	(	(	-LRB-
cord-023095-4dannjjm	501	36	92	92	CD
cord-023095-4dannjjm	501	37	%	%	NN
cord-023095-4dannjjm	501	38	with	with	IN
cord-023095-4dannjjm	501	39	age	age	NN
cord-023095-4dannjjm	501	40	inclusion	inclusion	NN
cord-023095-4dannjjm	501	41	)	)	-RRB-
cord-023095-4dannjjm	501	42	(	(	-LRB-
cord-023095-4dannjjm	501	43	P	p	NN
cord-023095-4dannjjm	501	44	o	o	NN
cord-023095-4dannjjm	501	45	0.05	0.05	CD
cord-023095-4dannjjm	501	46	)	)	-RRB-
cord-023095-4dannjjm	501	47	.	.	.
cord-023095-4dannjjm	502	1	NT	NT	NNP
cord-023095-4dannjjm	502	2	-	-	HYPH
cord-023095-4dannjjm	502	3	proBNP	probnp	NN
cord-023095-4dannjjm	502	4	concentration	concentration	NN
cord-023095-4dannjjm	502	5	is	be	VBZ
cord-023095-4dannjjm	502	6	increased	increase	VBN
cord-023095-4dannjjm	502	7	in	in	IN
cord-023095-4dannjjm	502	8	canine	canine	JJ
cord-023095-4dannjjm	502	9	patients	patient	NNS
cord-023095-4dannjjm	502	10	with	with	IN
cord-023095-4dannjjm	502	11	heart	heart	NN
cord-023095-4dannjjm	502	12	disease	disease	NN
cord-023095-4dannjjm	502	13	.	.	.
cord-023095-4dannjjm	503	1	Relatively	relatively	RB
cord-023095-4dannjjm	503	2	little	little	JJ
cord-023095-4dannjjm	503	3	is	be	VBZ
cord-023095-4dannjjm	503	4	known	know	VBN
cord-023095-4dannjjm	503	5	about	about	IN
cord-023095-4dannjjm	503	6	the	the	DT
cord-023095-4dannjjm	503	7	stimuli	stimulus	NNS
cord-023095-4dannjjm	503	8	for	for	IN
cord-023095-4dannjjm	503	9	release	release	NN
cord-023095-4dannjjm	503	10	of	of	IN
cord-023095-4dannjjm	503	11	NT	NT	NNP
cord-023095-4dannjjm	503	12	-	-	HYPH
cord-023095-4dannjjm	503	13	proBNP	probnp	NN
cord-023095-4dannjjm	503	14	in	in	IN
cord-023095-4dannjjm	503	15	dogs	dog	NNS
cord-023095-4dannjjm	503	16	.	.	.
cord-023095-4dannjjm	504	1	Physical	physical	JJ
cord-023095-4dannjjm	504	2	activity	activity	NN
cord-023095-4dannjjm	504	3	independent	independent	JJ
cord-023095-4dannjjm	504	4	of	of	IN
cord-023095-4dannjjm	504	5	cardiac	cardiac	JJ
cord-023095-4dannjjm	504	6	disease	disease	NN
cord-023095-4dannjjm	504	7	and	and	CC
cord-023095-4dannjjm	504	8	the	the	DT
cord-023095-4dannjjm	504	9	stress	stress	NN
cord-023095-4dannjjm	504	10	of	of	IN
cord-023095-4dannjjm	504	11	being	be	VBG
cord-023095-4dannjjm	504	12	in	in	IN
cord-023095-4dannjjm	504	13	the	the	DT
cord-023095-4dannjjm	504	14	hospital	hospital	NN
cord-023095-4dannjjm	504	15	could	could	MD
cord-023095-4dannjjm	504	16	influence	influence	VB
cord-023095-4dannjjm	504	17	NT	NT	NNP
cord-023095-4dannjjm	504	18	-	-	HYPH
cord-023095-4dannjjm	504	19	proBNP	probnp	NN
cord-023095-4dannjjm	504	20	release	release	NN
cord-023095-4dannjjm	504	21	and	and	CC
cord-023095-4dannjjm	504	22	affect	affect	VB
cord-023095-4dannjjm	504	23	diagnosis	diagnosis	NN
cord-023095-4dannjjm	504	24	and	and	CC
cord-023095-4dannjjm	504	25	management	management	NN
cord-023095-4dannjjm	504	26	of	of	IN
cord-023095-4dannjjm	504	27	patients	patient	NNS
cord-023095-4dannjjm	504	28	.	.	.
cord-023095-4dannjjm	505	1	We	-PRON-	PRP
cord-023095-4dannjjm	505	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	505	3	that	that	IN
cord-023095-4dannjjm	505	4	NT	NT	NNP
cord-023095-4dannjjm	505	5	-	-	HYPH
cord-023095-4dannjjm	505	6	proBNP	probnp	NN
cord-023095-4dannjjm	505	7	concentration	concentration	NN
cord-023095-4dannjjm	505	8	in	in	IN
cord-023095-4dannjjm	505	9	healthy	healthy	JJ
cord-023095-4dannjjm	505	10	dogs	dog	NNS
cord-023095-4dannjjm	505	11	would	would	MD
cord-023095-4dannjjm	505	12	not	not	RB
cord-023095-4dannjjm	505	13	exceed	exceed	VB
cord-023095-4dannjjm	505	14	the	the	DT
cord-023095-4dannjjm	505	15	normal	normal	JJ
cord-023095-4dannjjm	505	16	reference	reference	NN
cord-023095-4dannjjm	505	17	value	value	NN
cord-023095-4dannjjm	505	18	(	(	-LRB-
cord-023095-4dannjjm	505	19	900	900	CD
cord-023095-4dannjjm	505	20	pmol	pmol	NN
cord-023095-4dannjjm	505	21	/	/	SYM
cord-023095-4dannjjm	505	22	L	l	NN
cord-023095-4dannjjm	505	23	)	)	-RRB-
cord-023095-4dannjjm	505	24	following	follow	VBG
cord-023095-4dannjjm	505	25	a	a	DT
cord-023095-4dannjjm	505	26	period	period	NN
cord-023095-4dannjjm	505	27	of	of	IN
cord-023095-4dannjjm	505	28	exercise	exercise	NN
cord-023095-4dannjjm	505	29	.	.	.
cord-023095-4dannjjm	506	1	The	the	DT
cord-023095-4dannjjm	506	2	goal	goal	NN
cord-023095-4dannjjm	506	3	of	of	IN
cord-023095-4dannjjm	506	4	this	this	DT
cord-023095-4dannjjm	506	5	study	study	NN
cord-023095-4dannjjm	506	6	was	be	VBD
cord-023095-4dannjjm	506	7	to	to	TO
cord-023095-4dannjjm	506	8	examine	examine	VB
cord-023095-4dannjjm	506	9	whether	whether	IN
cord-023095-4dannjjm	506	10	physical	physical	JJ
cord-023095-4dannjjm	506	11	activity	activity	NN
cord-023095-4dannjjm	506	12	could	could	MD
cord-023095-4dannjjm	506	13	elevate	elevate	VB
cord-023095-4dannjjm	506	14	plasma	plasma	NN
cord-023095-4dannjjm	506	15	NT	nt	NN
cord-023095-4dannjjm	506	16	-	-	HYPH
cord-023095-4dannjjm	506	17	proBNP	probnp	NN
cord-023095-4dannjjm	506	18	and	and	CC
cord-023095-4dannjjm	506	19	cause	cause	VB
cord-023095-4dannjjm	506	20	false	false	JJ
cord-023095-4dannjjm	506	21	positive	positive	JJ
cord-023095-4dannjjm	506	22	results	result	NNS
cord-023095-4dannjjm	506	23	in	in	IN
cord-023095-4dannjjm	506	24	healthy	healthy	JJ
cord-023095-4dannjjm	506	25	dogs	dog	NNS
cord-023095-4dannjjm	506	26	.	.	.
cord-023095-4dannjjm	507	1	The	the	DT
cord-023095-4dannjjm	507	2	study	study	NN
cord-023095-4dannjjm	507	3	population	population	NN
cord-023095-4dannjjm	507	4	included	include	VBD
cord-023095-4dannjjm	507	5	healthy	healthy	JJ
cord-023095-4dannjjm	507	6	dogs	dog	NNS
cord-023095-4dannjjm	507	7	41	41	CD
cord-023095-4dannjjm	507	8	yr	yr	NN
cord-023095-4dannjjm	507	9	of	of	IN
cord-023095-4dannjjm	507	10	age	age	NN
cord-023095-4dannjjm	507	11	without	without	IN
cord-023095-4dannjjm	507	12	heart	heart	NN
cord-023095-4dannjjm	507	13	murmur	murmur	NN
cord-023095-4dannjjm	507	14	or	or	CC
cord-023095-4dannjjm	507	15	known	know	VBN
cord-023095-4dannjjm	507	16	systemic	systemic	JJ
cord-023095-4dannjjm	507	17	disease	disease	NN
cord-023095-4dannjjm	507	18	,	,	,
cord-023095-4dannjjm	507	19	and	and	CC
cord-023095-4dannjjm	507	20	normal	normal	JJ
cord-023095-4dannjjm	507	21	2D	2d	NN
cord-023095-4dannjjm	507	22	/	/	SYM
cord-023095-4dannjjm	507	23	color	color	NN
cord-023095-4dannjjm	507	24	flow	flow	NN
cord-023095-4dannjjm	507	25	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	507	26	exam	exam	NN
cord-023095-4dannjjm	507	27	.	.	.
cord-023095-4dannjjm	508	1	Plasma	plasma	NN
cord-023095-4dannjjm	508	2	samples	sample	NNS
cord-023095-4dannjjm	508	3	for	for	IN
cord-023095-4dannjjm	508	4	NT	NT	NNP
cord-023095-4dannjjm	508	5	-	-	HYPH
cord-023095-4dannjjm	508	6	proBNP	proBNP	NNP
cord-023095-4dannjjm	508	7	were	be	VBD
cord-023095-4dannjjm	508	8	obtained	obtain	VBN
cord-023095-4dannjjm	508	9	before	before	RB
cord-023095-4dannjjm	508	10	,	,	,
cord-023095-4dannjjm	508	11	immediately	immediately	RB
cord-023095-4dannjjm	508	12	after	after	RB
cord-023095-4dannjjm	508	13	,	,	,
cord-023095-4dannjjm	508	14	and	and	CC
cord-023095-4dannjjm	508	15	1	1	CD
cord-023095-4dannjjm	508	16	hour	hour	NN
cord-023095-4dannjjm	508	17	after	after	IN
cord-023095-4dannjjm	508	18	a	a	DT
cord-023095-4dannjjm	508	19	standardized	standardize	VBN
cord-023095-4dannjjm	508	20	5-minute	5-minute	CD
cord-023095-4dannjjm	508	21	submaximal	submaximal	JJ
cord-023095-4dannjjm	508	22	exercise	exercise	NN
cord-023095-4dannjjm	508	23	regimen	regimen	NN
cord-023095-4dannjjm	508	24	.	.	.
cord-023095-4dannjjm	509	1	The	the	DT
cord-023095-4dannjjm	509	2	study	study	NN
cord-023095-4dannjjm	509	3	included	include	VBD
cord-023095-4dannjjm	509	4	14	14	CD
cord-023095-4dannjjm	509	5	dogs	dog	NNS
cord-023095-4dannjjm	509	6	with	with	IN
cord-023095-4dannjjm	509	7	a	a	DT
cord-023095-4dannjjm	509	8	median	median	JJ
cord-023095-4dannjjm	509	9	age	age	NN
cord-023095-4dannjjm	509	10	of	of	IN
cord-023095-4dannjjm	509	11	5.3yrs	5.3yrs	CD
cord-023095-4dannjjm	509	12	and	and	CC
cord-023095-4dannjjm	509	13	included	include	VBD
cord-023095-4dannjjm	509	14	6	6	CD
cord-023095-4dannjjm	509	15	females	female	NNS
cord-023095-4dannjjm	509	16	and	and	CC
cord-023095-4dannjjm	509	17	8	8	CD
cord-023095-4dannjjm	509	18	males	male	NNS
cord-023095-4dannjjm	509	19	.	.	.
cord-023095-4dannjjm	510	1	There	there	EX
cord-023095-4dannjjm	510	2	was	be	VBD
cord-023095-4dannjjm	510	3	no	no	DT
cord-023095-4dannjjm	510	4	statistical	statistical	JJ
cord-023095-4dannjjm	510	5	difference	difference	NN
cord-023095-4dannjjm	510	6	in	in	IN
cord-023095-4dannjjm	510	7	median	median	JJ
cord-023095-4dannjjm	510	8	plasma	plasma	NN
cord-023095-4dannjjm	510	9	NT	nt	NN
cord-023095-4dannjjm	510	10	-	-	HYPH
cord-023095-4dannjjm	510	11	proBNP	probnp	NN
cord-023095-4dannjjm	510	12	concentration	concentration	NN
cord-023095-4dannjjm	510	13	across	across	IN
cord-023095-4dannjjm	510	14	the	the	DT
cord-023095-4dannjjm	510	15	three	three	CD
cord-023095-4dannjjm	510	16	time	time	NN
cord-023095-4dannjjm	510	17	points	point	NNS
cord-023095-4dannjjm	510	18	(	(	-LRB-
cord-023095-4dannjjm	510	19	baseline	baseline	JJ
cord-023095-4dannjjm	510	20	median	median	NN
cord-023095-4dannjjm	510	21	,	,	,
cord-023095-4dannjjm	510	22	617	617	CD
cord-023095-4dannjjm	510	23	[	[	-LRB-
cord-023095-4dannjjm	510	24	IQR	IQR	NNP
cord-023095-4dannjjm	510	25	,	,	,
cord-023095-4dannjjm	510	26	immediately	immediately	RB
cord-023095-4dannjjm	510	27	post	post	VBP
cord-023095-4dannjjm	510	28	,	,	,
cord-023095-4dannjjm	510	29	;	;	:
cord-023095-4dannjjm	510	30	P	p	NN
cord-023095-4dannjjm	510	31	5	5	CD
cord-023095-4dannjjm	510	32	0.11	0.11	CD
cord-023095-4dannjjm	510	33	)	)	-RRB-
cord-023095-4dannjjm	510	34	.	.	.
cord-023095-4dannjjm	511	1	The	the	DT
cord-023095-4dannjjm	511	2	average	average	JJ
cord-023095-4dannjjm	511	3	coefficient	coefficient	NN
cord-023095-4dannjjm	511	4	of	of	IN
cord-023095-4dannjjm	511	5	variation	variation	NN
cord-023095-4dannjjm	511	6	of	of	IN
cord-023095-4dannjjm	511	7	NT	NT	NNP
cord-023095-4dannjjm	511	8	-	-	HYPH
cord-023095-4dannjjm	511	9	proBNP	probnp	NN
cord-023095-4dannjjm	511	10	concentration	concentration	NN
cord-023095-4dannjjm	511	11	across	across	IN
cord-023095-4dannjjm	511	12	the	the	DT
cord-023095-4dannjjm	511	13	exercise	exercise	NN
cord-023095-4dannjjm	511	14	regimen	regimen	NN
cord-023095-4dannjjm	511	15	was	be	VBD
cord-023095-4dannjjm	511	16	23.0	23.0	CD
cord-023095-4dannjjm	511	17	AE	AE	NNP
cord-023095-4dannjjm	511	18	18.9	18.9	CD
cord-023095-4dannjjm	511	19	%	%	NN
cord-023095-4dannjjm	511	20	.	.	.
cord-023095-4dannjjm	512	1	In	in	IN
cord-023095-4dannjjm	512	2	1	1	CD
cord-023095-4dannjjm	512	3	of	of	IN
cord-023095-4dannjjm	512	4	14	14	CD
cord-023095-4dannjjm	512	5	dogs	dog	NNS
cord-023095-4dannjjm	512	6	(	(	-LRB-
cord-023095-4dannjjm	512	7	7.1	7.1	CD
cord-023095-4dannjjm	512	8	%	%	NN
cord-023095-4dannjjm	512	9	)	)	-RRB-
cord-023095-4dannjjm	512	10	,	,	,
cord-023095-4dannjjm	512	11	NT	NT	NNP
cord-023095-4dannjjm	512	12	-	-	HYPH
cord-023095-4dannjjm	512	13	proBNP	proBNP	NNP
cord-023095-4dannjjm	512	14	increased	increase	VBD
cord-023095-4dannjjm	512	15	from	from	IN
cord-023095-4dannjjm	512	16	790	790	CD
cord-023095-4dannjjm	512	17	to	to	IN
cord-023095-4dannjjm	512	18	1054	1054	CD
cord-023095-4dannjjm	512	19	pmol	pmol	NNP
cord-023095-4dannjjm	512	20	/	/	SYM
cord-023095-4dannjjm	512	21	L	L	NNP
cord-023095-4dannjjm	512	22	immediately	immediately	RB
cord-023095-4dannjjm	512	23	after	after	IN
cord-023095-4dannjjm	512	24	exercise	exercise	NN
cord-023095-4dannjjm	512	25	.	.	.
cord-023095-4dannjjm	513	1	The	the	DT
cord-023095-4dannjjm	513	2	results	result	NNS
cord-023095-4dannjjm	513	3	of	of	IN
cord-023095-4dannjjm	513	4	this	this	DT
cord-023095-4dannjjm	513	5	study	study	NN
cord-023095-4dannjjm	513	6	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	513	7	that	that	IN
cord-023095-4dannjjm	513	8	submaximal	submaximal	JJ
cord-023095-4dannjjm	513	9	exercise	exercise	NN
cord-023095-4dannjjm	513	10	does	do	VBZ
cord-023095-4dannjjm	513	11	not	not	RB
cord-023095-4dannjjm	513	12	significantly	significantly	RB
cord-023095-4dannjjm	513	13	change	change	VB
cord-023095-4dannjjm	513	14	median	median	JJ
cord-023095-4dannjjm	513	15	NT	NT	NNP
cord-023095-4dannjjm	513	16	-	-	HYPH
cord-023095-4dannjjm	513	17	proBNP	probnp	NN
cord-023095-4dannjjm	513	18	concentration	concentration	NN
cord-023095-4dannjjm	513	19	and	and	CC
cord-023095-4dannjjm	513	20	the	the	DT
cord-023095-4dannjjm	513	21	incidence	incidence	NN
cord-023095-4dannjjm	513	22	of	of	IN
cord-023095-4dannjjm	513	23	false	false	JJ
cord-023095-4dannjjm	513	24	positive	positive	JJ
cord-023095-4dannjjm	513	25	results	result	NNS
cord-023095-4dannjjm	513	26	is	be	VBZ
cord-023095-4dannjjm	513	27	low	low	JJ
cord-023095-4dannjjm	513	28	.	.	.
cord-023095-4dannjjm	514	1	Further	further	JJ
cord-023095-4dannjjm	514	2	studies	study	NNS
cord-023095-4dannjjm	514	3	should	should	MD
cord-023095-4dannjjm	514	4	investigate	investigate	VB
cord-023095-4dannjjm	514	5	effects	effect	NNS
cord-023095-4dannjjm	514	6	of	of	IN
cord-023095-4dannjjm	514	7	exercise	exercise	NN
cord-023095-4dannjjm	514	8	on	on	IN
cord-023095-4dannjjm	514	9	NT	NT	NNP
cord-023095-4dannjjm	514	10	-	-	HYPH
cord-023095-4dannjjm	514	11	proBNP	probnp	NN
cord-023095-4dannjjm	514	12	concentrations	concentration	NNS
cord-023095-4dannjjm	514	13	in	in	IN
cord-023095-4dannjjm	514	14	dogs	dog	NNS
cord-023095-4dannjjm	514	15	with	with	IN
cord-023095-4dannjjm	514	16	heart	heart	NN
cord-023095-4dannjjm	514	17	disease	disease	NN
cord-023095-4dannjjm	514	18	.	.	.
cord-023095-4dannjjm	515	1	Obesity	obesity	NN
cord-023095-4dannjjm	515	2	is	be	VBZ
cord-023095-4dannjjm	515	3	an	an	DT
cord-023095-4dannjjm	515	4	increasing	increase	VBG
cord-023095-4dannjjm	515	5	problem	problem	NN
cord-023095-4dannjjm	515	6	in	in	IN
cord-023095-4dannjjm	515	7	veterinary	veterinary	JJ
cord-023095-4dannjjm	515	8	medicine	medicine	NN
cord-023095-4dannjjm	515	9	.	.	.
cord-023095-4dannjjm	516	1	Obese	obese	JJ
cord-023095-4dannjjm	516	2	human	human	JJ
cord-023095-4dannjjm	516	3	patients	patient	NNS
cord-023095-4dannjjm	516	4	are	be	VBP
cord-023095-4dannjjm	516	5	shown	show	VBN
cord-023095-4dannjjm	516	6	to	to	TO
cord-023095-4dannjjm	516	7	present	present	VB
cord-023095-4dannjjm	516	8	lower	low	JJR
cord-023095-4dannjjm	516	9	levels	level	NNS
cord-023095-4dannjjm	516	10	of	of	IN
cord-023095-4dannjjm	516	11	natriuretic	natriuretic	JJ
cord-023095-4dannjjm	516	12	peptides	peptide	NNS
cord-023095-4dannjjm	516	13	,	,	,
cord-023095-4dannjjm	516	14	regardless	regardless	RB
cord-023095-4dannjjm	516	15	of	of	IN
cord-023095-4dannjjm	516	16	an	an	DT
cord-023095-4dannjjm	516	17	increased	increase	VBN
cord-023095-4dannjjm	516	18	volume	volume	NN
cord-023095-4dannjjm	516	19	and	and	CC
cord-023095-4dannjjm	516	20	pressure	pressure	NN
cord-023095-4dannjjm	516	21	load	load	NN
cord-023095-4dannjjm	516	22	,	,	,
cord-023095-4dannjjm	516	23	what	what	WP
cord-023095-4dannjjm	516	24	raises	raise	VBZ
cord-023095-4dannjjm	516	25	the	the	DT
cord-023095-4dannjjm	516	26	possibility	possibility	NN
cord-023095-4dannjjm	516	27	that	that	IN
cord-023095-4dannjjm	516	28	the	the	DT
cord-023095-4dannjjm	516	29	natriuretic	natriuretic	JJ
cord-023095-4dannjjm	516	30	response	response	NN
cord-023095-4dannjjm	516	31	is	be	VBZ
cord-023095-4dannjjm	516	32	impaired	impair	VBN
cord-023095-4dannjjm	516	33	in	in	IN
cord-023095-4dannjjm	516	34	these	these	DT
cord-023095-4dannjjm	516	35	individuals	individual	NNS
cord-023095-4dannjjm	516	36	.	.	.
cord-023095-4dannjjm	517	1	Considering	consider	VBG
cord-023095-4dannjjm	517	2	the	the	DT
cord-023095-4dannjjm	517	3	controversial	controversial	JJ
cord-023095-4dannjjm	517	4	findings	finding	NNS
cord-023095-4dannjjm	517	5	in	in	IN
cord-023095-4dannjjm	517	6	obese	obese	JJ
cord-023095-4dannjjm	517	7	humans	human	NNS
cord-023095-4dannjjm	517	8	,	,	,
cord-023095-4dannjjm	517	9	and	and	CC
cord-023095-4dannjjm	517	10	the	the	DT
cord-023095-4dannjjm	517	11	lack	lack	NN
cord-023095-4dannjjm	517	12	of	of	IN
cord-023095-4dannjjm	517	13	studies	study	NNS
cord-023095-4dannjjm	517	14	reported	report	VBN
cord-023095-4dannjjm	517	15	in	in	IN
cord-023095-4dannjjm	517	16	dogs	dog	NNS
cord-023095-4dannjjm	517	17	,	,	,
cord-023095-4dannjjm	517	18	this	this	DT
cord-023095-4dannjjm	517	19	study	study	NN
cord-023095-4dannjjm	517	20	proposed	propose	VBD
cord-023095-4dannjjm	517	21	the	the	DT
cord-023095-4dannjjm	517	22	evaluation	evaluation	NN
cord-023095-4dannjjm	517	23	of	of	IN
cord-023095-4dannjjm	517	24	Nt	Nt	NNP
cord-023095-4dannjjm	517	25	-	-	HYPH
cord-023095-4dannjjm	517	26	proANP	proanp	NN
cord-023095-4dannjjm	517	27	concentration	concentration	NN
cord-023095-4dannjjm	517	28	in	in	IN
cord-023095-4dannjjm	517	29	obese	obese	JJ
cord-023095-4dannjjm	517	30	dogs	dog	NNS
cord-023095-4dannjjm	517	31	.	.	.
cord-023095-4dannjjm	518	1	Nt	Nt	NNP
cord-023095-4dannjjm	518	2	-	-	HYPH
cord-023095-4dannjjm	518	3	proANP	proanp	NN
cord-023095-4dannjjm	518	4	concentration	concentration	NN
cord-023095-4dannjjm	518	5	was	be	VBD
cord-023095-4dannjjm	518	6	determined	determine	VBN
cord-023095-4dannjjm	518	7	prospectively	prospectively	RB
cord-023095-4dannjjm	518	8	in	in	IN
cord-023095-4dannjjm	518	9	39	39	CD
cord-023095-4dannjjm	518	10	obese	obese	JJ
cord-023095-4dannjjm	518	11	dogs	dog	NNS
cord-023095-4dannjjm	518	12	(	(	-LRB-
cord-023095-4dannjjm	518	13	27	27	CD
cord-023095-4dannjjm	518	14	females	female	NNS
cord-023095-4dannjjm	518	15	;	;	:
cord-023095-4dannjjm	518	16	12	12	CD
cord-023095-4dannjjm	518	17	males	male	NNS
cord-023095-4dannjjm	518	18	;	;	:
cord-023095-4dannjjm	518	19	6	6	CD
cord-023095-4dannjjm	518	20	-	-	SYM
cord-023095-4dannjjm	518	21	108	108	CD
cord-023095-4dannjjm	518	22	months	month	NNS
cord-023095-4dannjjm	518	23	)	)	-RRB-
cord-023095-4dannjjm	518	24	and	and	CC
cord-023095-4dannjjm	518	25	in	in	IN
cord-023095-4dannjjm	518	26	23	23	CD
cord-023095-4dannjjm	518	27	non	non	JJ
cord-023095-4dannjjm	518	28	-	-	JJ
cord-023095-4dannjjm	518	29	obese	obese	JJ
cord-023095-4dannjjm	518	30	dogs	dog	NNS
cord-023095-4dannjjm	518	31	(	(	-LRB-
cord-023095-4dannjjm	518	32	controls	control	NNS
cord-023095-4dannjjm	518	33	;	;	:
cord-023095-4dannjjm	518	34	13	13	CD
cord-023095-4dannjjm	518	35	females	female	NNS
cord-023095-4dannjjm	518	36	;	;	:
cord-023095-4dannjjm	518	37	10	10	CD
cord-023095-4dannjjm	518	38	males	male	NNS
cord-023095-4dannjjm	518	39	;	;	:
cord-023095-4dannjjm	518	40	12	12	CD
cord-023095-4dannjjm	518	41	-	-	SYM
cord-023095-4dannjjm	518	42	108	108	CD
cord-023095-4dannjjm	518	43	months	month	NNS
cord-023095-4dannjjm	518	44	)	)	-RRB-
cord-023095-4dannjjm	518	45	from	from	IN
cord-023095-4dannjjm	518	46	a	a	DT
cord-023095-4dannjjm	518	47	veterinary	veterinary	JJ
cord-023095-4dannjjm	518	48	hospital	hospital	NN
cord-023095-4dannjjm	518	49	population	population	NN
cord-023095-4dannjjm	518	50	.	.	.
cord-023095-4dannjjm	519	1	Obesity	obesity	NN
cord-023095-4dannjjm	519	2	was	be	VBD
cord-023095-4dannjjm	519	3	determined	determine	VBN
cord-023095-4dannjjm	519	4	by	by	IN
cord-023095-4dannjjm	519	5	body	body	NN
cord-023095-4dannjjm	519	6	condition	condition	NN
cord-023095-4dannjjm	519	7	score	score	NN
cord-023095-4dannjjm	519	8	[	[	-LRB-
cord-023095-4dannjjm	519	9	2	2	CD
cord-023095-4dannjjm	519	10	(	(	-LRB-
cord-023095-4dannjjm	519	11	4/9	4/9	CD
cord-023095-4dannjjm	519	12	)	)	-RRB-
cord-023095-4dannjjm	519	13	;	;	:
cord-023095-4dannjjm	519	14	21	21	CD
cord-023095-4dannjjm	519	15	(	(	-LRB-
cord-023095-4dannjjm	519	16	5/9	5/9	CD
cord-023095-4dannjjm	519	17	)	)	-RRB-
cord-023095-4dannjjm	519	18	;	;	:
cord-023095-4dannjjm	519	19	1	1	LS
cord-023095-4dannjjm	519	20	(	(	-LRB-
cord-023095-4dannjjm	519	21	6/9	6/9	CD
cord-023095-4dannjjm	519	22	)	)	-RRB-
cord-023095-4dannjjm	519	23	;	;	:
cord-023095-4dannjjm	519	24	3	3	LS
cord-023095-4dannjjm	519	25	(	(	-LRB-
cord-023095-4dannjjm	519	26	7/9	7/9	CD
cord-023095-4dannjjm	519	27	)	)	-RRB-
cord-023095-4dannjjm	519	28	;	;	:
cord-023095-4dannjjm	519	29	19	19	CD
cord-023095-4dannjjm	519	30	(	(	-LRB-
cord-023095-4dannjjm	519	31	8/9	8/9	CD
cord-023095-4dannjjm	519	32	)	)	-RRB-
cord-023095-4dannjjm	519	33	;	;	:
cord-023095-4dannjjm	519	34	18	18	CD
cord-023095-4dannjjm	519	35	(	(	-LRB-
cord-023095-4dannjjm	519	36	9/9	9/9	CD
cord-023095-4dannjjm	519	37	)	)	-RRB-
cord-023095-4dannjjm	519	38	]	]	-RRB-
cord-023095-4dannjjm	519	39	.	.	.
cord-023095-4dannjjm	520	1	Dogs	dog	NNS
cord-023095-4dannjjm	520	2	were	be	VBD
cord-023095-4dannjjm	520	3	excluded	exclude	VBN
cord-023095-4dannjjm	520	4	if	if	IN
cord-023095-4dannjjm	520	5	they	-PRON-	PRP
cord-023095-4dannjjm	520	6	had	have	VBD
cord-023095-4dannjjm	520	7	any	any	DT
cord-023095-4dannjjm	520	8	primary	primary	JJ
cord-023095-4dannjjm	520	9	cardiac	cardiac	JJ
cord-023095-4dannjjm	520	10	disease	disease	NN
cord-023095-4dannjjm	520	11	,	,	,
cord-023095-4dannjjm	520	12	renal	renal	JJ
cord-023095-4dannjjm	520	13	insufficiency	insufficiency	NN
cord-023095-4dannjjm	520	14	,	,	,
cord-023095-4dannjjm	520	15	endocrine	endocrine	JJ
cord-023095-4dannjjm	520	16	disease	disease	NN
cord-023095-4dannjjm	520	17	,	,	,
cord-023095-4dannjjm	520	18	or	or	CC
cord-023095-4dannjjm	520	19	if	if	IN
cord-023095-4dannjjm	520	20	they	-PRON-	PRP
cord-023095-4dannjjm	520	21	were	be	VBD
cord-023095-4dannjjm	520	22	receiving	receive	VBG
cord-023095-4dannjjm	520	23	diuretics	diuretic	NNS
cord-023095-4dannjjm	520	24	,	,	,
cord-023095-4dannjjm	520	25	vasodilators	vasodilator	NNS
cord-023095-4dannjjm	520	26	,	,	,
cord-023095-4dannjjm	520	27	antiepileptic	antiepileptic	JJ
cord-023095-4dannjjm	520	28	drugs	drug	NNS
cord-023095-4dannjjm	520	29	or	or	CC
cord-023095-4dannjjm	520	30	corticosteroids	corticosteroid	NNS
cord-023095-4dannjjm	520	31	.	.	.
cord-023095-4dannjjm	521	1	Commercial	commercial	JJ
cord-023095-4dannjjm	521	2	kits	kit	NNS
cord-023095-4dannjjm	521	3	were	be	VBD
cord-023095-4dannjjm	521	4	used	use	VBN
cord-023095-4dannjjm	522	1	(	(	-LRB-
cord-023095-4dannjjm	522	2	Vetsign	Vetsign	NNP
cord-023095-4dannjjm	522	3	s	s	POS
cord-023095-4dannjjm	522	4	Canine	Canine	NNP
cord-023095-4dannjjm	522	5	Cardio	cardio	NN
cord-023095-4dannjjm	522	6	Screen	screen	NN
cord-023095-4dannjjm	522	7	Nt	nt	NN
cord-023095-4dannjjm	522	8	-	-	HYPH
cord-023095-4dannjjm	522	9	pro	pro	JJ
cord-023095-4dannjjm	522	10	-	-	JJ
cord-023095-4dannjjm	522	11	ANP	ANP	NNP
cord-023095-4dannjjm	522	12	VC3167	VC3167	NNS
cord-023095-4dannjjm	522	13	-Guildhay	-Guildhay	NNP
cord-023095-4dannjjm	522	14	/	/	SYM
cord-023095-4dannjjm	522	15	Biomedica	Biomedica	NNP
cord-023095-4dannjjm	522	16	)	)	-RRB-
cord-023095-4dannjjm	522	17	.	.	.
cord-023095-4dannjjm	523	1	Mann	Mann	NNP
cord-023095-4dannjjm	523	2	Whitney	Whitney	NNP
cord-023095-4dannjjm	523	3	test	test	NN
cord-023095-4dannjjm	523	4	was	be	VBD
cord-023095-4dannjjm	523	5	used	use	VBN
cord-023095-4dannjjm	523	6	for	for	IN
cord-023095-4dannjjm	523	7	group	group	NN
cord-023095-4dannjjm	523	8	comparison	comparison	NN
cord-023095-4dannjjm	523	9	.	.	.
cord-023095-4dannjjm	524	1	Results	result	NNS
cord-023095-4dannjjm	524	2	are	be	VBP
cord-023095-4dannjjm	524	3	presented	present	VBN
cord-023095-4dannjjm	524	4	as	as	IN
cord-023095-4dannjjm	524	5	median	median	NN
cord-023095-4dannjjm	524	6	;	;	:
cord-023095-4dannjjm	524	7	interval	interval	NN
cord-023095-4dannjjm	524	8	;	;	:
cord-023095-4dannjjm	524	9	P25	P25	NNP
cord-023095-4dannjjm	524	10	and	and	CC
cord-023095-4dannjjm	524	11	P75	P75	NNP
cord-023095-4dannjjm	524	12	)	)	-RRB-
cord-023095-4dannjjm	524	13	.	.	.
cord-023095-4dannjjm	525	1	Nt	Nt	NNP
cord-023095-4dannjjm	525	2	-	-	HYPH
cord-023095-4dannjjm	525	3	proANP	proANP	NNP
cord-023095-4dannjjm	525	4	was	be	VBD
cord-023095-4dannjjm	525	5	significantly	significantly	RB
cord-023095-4dannjjm	525	6	lower	low	JJR
cord-023095-4dannjjm	525	7	in	in	IN
cord-023095-4dannjjm	525	8	obese	obese	JJ
cord-023095-4dannjjm	525	9	dogs	dog	NNS
cord-023095-4dannjjm	525	10	[	[	-LRB-
cord-023095-4dannjjm	525	11	413.56fmol	413.56fmol	CD
cord-023095-4dannjjm	525	12	/	/	SYM
cord-023095-4dannjjm	525	13	mL	ml	NN
cord-023095-4dannjjm	525	14	(	(	-LRB-
cord-023095-4dannjjm	525	15	0.0	0.0	CD
cord-023095-4dannjjm	525	16	-	-	SYM
cord-023095-4dannjjm	525	17	1287.14	1287.14	CD
cord-023095-4dannjjm	525	18	)	)	-RRB-
cord-023095-4dannjjm	525	19	;	;	:
cord-023095-4dannjjm	525	20	P25	P25	NNP
cord-023095-4dannjjm	525	21	5	5	CD
cord-023095-4dannjjm	525	22	228.673	228.673	CD
cord-023095-4dannjjm	525	23	;	;	:
cord-023095-4dannjjm	525	24	P75	P75	NNP
cord-023095-4dannjjm	525	25	5	5	CD
cord-023095-4dannjjm	525	26	595.205	595.205	CD
cord-023095-4dannjjm	525	27	]	]	-RRB-
cord-023095-4dannjjm	525	28	than	than	IN
cord-023095-4dannjjm	525	29	in	in	IN
cord-023095-4dannjjm	525	30	controls	control	NNS
cord-023095-4dannjjm	525	31	[	[	-LRB-
cord-023095-4dannjjm	525	32	647.98fmol	647.98fmol	CD
cord-023095-4dannjjm	525	33	/	/	SYM
cord-023095-4dannjjm	525	34	mL	mL	NNP
cord-023095-4dannjjm	525	35	(	(	-LRB-
cord-023095-4dannjjm	525	36	34.99	34.99	CD
cord-023095-4dannjjm	525	37	-	-	SYM
cord-023095-4dannjjm	525	38	1596.82	1596.82	CD
cord-023095-4dannjjm	525	39	)	)	-RRB-
cord-023095-4dannjjm	525	40	;	;	:
cord-023095-4dannjjm	525	41	P25	P25	NNP
cord-023095-4dannjjm	525	42	5	5	CD
cord-023095-4dannjjm	525	43	490.785	490.785	CD
cord-023095-4dannjjm	525	44	;	;	:
cord-023095-4dannjjm	525	45	P75	P75	NNP
cord-023095-4dannjjm	525	46	5	5	CD
cord-023095-4dannjjm	526	1	957.055	957.055	LS
cord-023095-4dannjjm	526	2	]	]	-RRB-
cord-023095-4dannjjm	526	3	;	;	:
cord-023095-4dannjjm	526	4	(	(	-LRB-
cord-023095-4dannjjm	526	5	P	p	NN
cord-023095-4dannjjm	526	6	5	5	CD
cord-023095-4dannjjm	526	7	0.004	0.004	CD
cord-023095-4dannjjm	526	8	)	)	-RRB-
cord-023095-4dannjjm	526	9	.	.	.
cord-023095-4dannjjm	527	1	Results	result	NNS
cord-023095-4dannjjm	527	2	were	be	VBD
cord-023095-4dannjjm	527	3	similar	similar	JJ
cord-023095-4dannjjm	527	4	to	to	IN
cord-023095-4dannjjm	527	5	what	what	WP
cord-023095-4dannjjm	527	6	has	have	VBZ
cord-023095-4dannjjm	527	7	been	be	VBN
cord-023095-4dannjjm	527	8	found	find	VBN
cord-023095-4dannjjm	527	9	in	in	IN
cord-023095-4dannjjm	527	10	obese	obese	JJ
cord-023095-4dannjjm	527	11	humans	human	NNS
cord-023095-4dannjjm	527	12	.	.	.
cord-023095-4dannjjm	528	1	Lower	low	JJR
cord-023095-4dannjjm	528	2	levels	level	NNS
cord-023095-4dannjjm	528	3	of	of	IN
cord-023095-4dannjjm	528	4	natriuretic	natriuretic	JJ
cord-023095-4dannjjm	528	5	peptides	peptide	NNS
cord-023095-4dannjjm	528	6	are	be	VBP
cord-023095-4dannjjm	528	7	also	also	RB
cord-023095-4dannjjm	528	8	seen	see	VBN
cord-023095-4dannjjm	528	9	in	in	IN
cord-023095-4dannjjm	528	10	obese	obese	JJ
cord-023095-4dannjjm	528	11	heart	heart	NN
cord-023095-4dannjjm	528	12	failure	failure	NN
cord-023095-4dannjjm	528	13	patients	patient	NNS
cord-023095-4dannjjm	528	14	.	.	.
cord-023095-4dannjjm	529	1	This	this	DT
cord-023095-4dannjjm	529	2	study	study	NN
cord-023095-4dannjjm	529	3	provides	provide	VBZ
cord-023095-4dannjjm	529	4	important	important	JJ
cord-023095-4dannjjm	529	5	information	information	NN
cord-023095-4dannjjm	529	6	regarding	regard	VBG
cord-023095-4dannjjm	529	7	Nt	Nt	NNP
cord-023095-4dannjjm	529	8	-	-	HYPH
cord-023095-4dannjjm	529	9	proANP	proanp	NN
cord-023095-4dannjjm	529	10	concentration	concentration	NN
cord-023095-4dannjjm	529	11	in	in	IN
cord-023095-4dannjjm	529	12	obese	obese	JJ
cord-023095-4dannjjm	529	13	dogs	dog	NNS
cord-023095-4dannjjm	529	14	,	,	,
cord-023095-4dannjjm	529	15	which	which	WDT
cord-023095-4dannjjm	529	16	should	should	MD
cord-023095-4dannjjm	529	17	be	be	VB
cord-023095-4dannjjm	529	18	better	well	RBR
cord-023095-4dannjjm	529	19	explored	explore	VBN
cord-023095-4dannjjm	529	20	characterizing	characterize	VBG
cord-023095-4dannjjm	529	21	the	the	DT
cord-023095-4dannjjm	529	22	behavior	behavior	NN
cord-023095-4dannjjm	529	23	of	of	IN
cord-023095-4dannjjm	529	24	natriuretic	natriuretic	JJ
cord-023095-4dannjjm	529	25	peptides	peptide	NNS
cord-023095-4dannjjm	529	26	after	after	IN
cord-023095-4dannjjm	529	27	weight	weight	NN
cord-023095-4dannjjm	529	28	loss	loss	NN
cord-023095-4dannjjm	529	29	,	,	,
cord-023095-4dannjjm	529	30	and	and	CC
cord-023095-4dannjjm	529	31	also	also	RB
cord-023095-4dannjjm	529	32	in	in	IN
cord-023095-4dannjjm	529	33	obese	obese	JJ
cord-023095-4dannjjm	529	34	dogs	dog	NNS
cord-023095-4dannjjm	529	35	with	with	IN
cord-023095-4dannjjm	529	36	primary	primary	JJ
cord-023095-4dannjjm	529	37	heart	heart	NN
cord-023095-4dannjjm	529	38	disease	disease	NN
cord-023095-4dannjjm	529	39	.	.	.
cord-023095-4dannjjm	530	1	Left	leave	VBN
cord-023095-4dannjjm	530	2	-	-	HYPH
cord-023095-4dannjjm	530	3	to	to	IN
cord-023095-4dannjjm	530	4	-	-	HYPH
cord-023095-4dannjjm	530	5	right	right	JJ
cord-023095-4dannjjm	530	6	shunting	shunt	VBG
cord-023095-4dannjjm	530	7	patent	patent	NN
cord-023095-4dannjjm	530	8	ductus	ductus	NN
cord-023095-4dannjjm	530	9	arteriosus	arteriosus	NN
cord-023095-4dannjjm	530	10	(	(	-LRB-
cord-023095-4dannjjm	530	11	PDA	PDA	NNP
cord-023095-4dannjjm	530	12	)	)	-RRB-
cord-023095-4dannjjm	530	13	is	be	VBZ
cord-023095-4dannjjm	530	14	one	one	CD
cord-023095-4dannjjm	530	15	of	of	IN
cord-023095-4dannjjm	530	16	the	the	DT
cord-023095-4dannjjm	530	17	most	most	RBS
cord-023095-4dannjjm	530	18	common	common	JJ
cord-023095-4dannjjm	530	19	canine	canine	JJ
cord-023095-4dannjjm	530	20	congenital	congenital	JJ
cord-023095-4dannjjm	530	21	cardiovascular	cardiovascular	JJ
cord-023095-4dannjjm	530	22	defects	defect	NNS
cord-023095-4dannjjm	530	23	.	.	.
cord-023095-4dannjjm	531	1	Human	human	JJ
cord-023095-4dannjjm	531	2	studies	study	NNS
cord-023095-4dannjjm	531	3	have	have	VBP
cord-023095-4dannjjm	531	4	shown	show	VBN
cord-023095-4dannjjm	531	5	that	that	IN
cord-023095-4dannjjm	531	6	BNP	BNP	NNP
cord-023095-4dannjjm	531	7	and	and	CC
cord-023095-4dannjjm	531	8	NT	NT	NNP
cord-023095-4dannjjm	531	9	-	-	HYPH
cord-023095-4dannjjm	531	10	proBNP	probnp	NN
cord-023095-4dannjjm	531	11	concentrations	concentration	NNS
cord-023095-4dannjjm	531	12	are	be	VBP
cord-023095-4dannjjm	531	13	elevated	elevate	VBN
cord-023095-4dannjjm	531	14	in	in	IN
cord-023095-4dannjjm	531	15	patients	patient	NNS
cord-023095-4dannjjm	531	16	with	with	IN
cord-023095-4dannjjm	531	17	PDA	PDA	NNP
cord-023095-4dannjjm	531	18	,	,	,
cord-023095-4dannjjm	531	19	and	and	CC
cord-023095-4dannjjm	531	20	can	can	MD
cord-023095-4dannjjm	531	21	be	be	VB
cord-023095-4dannjjm	531	22	used	use	VBN
cord-023095-4dannjjm	531	23	to	to	TO
cord-023095-4dannjjm	531	24	detect	detect	VB
cord-023095-4dannjjm	531	25	hemodynamically	hemodynamically	RB
cord-023095-4dannjjm	531	26	significant	significant	JJ
cord-023095-4dannjjm	531	27	PDA	pda	NN
cord-023095-4dannjjm	531	28	.	.	.
cord-023095-4dannjjm	532	1	The	the	DT
cord-023095-4dannjjm	532	2	purpose	purpose	NN
cord-023095-4dannjjm	532	3	of	of	IN
cord-023095-4dannjjm	532	4	this	this	DT
cord-023095-4dannjjm	532	5	study	study	NN
cord-023095-4dannjjm	532	6	was	be	VBD
cord-023095-4dannjjm	532	7	to	to	TO
cord-023095-4dannjjm	532	8	measure	measure	VB
cord-023095-4dannjjm	532	9	NT	NT	NNP
cord-023095-4dannjjm	532	10	-	-	HYPH
cord-023095-4dannjjm	532	11	proBNP	probnp	NN
cord-023095-4dannjjm	532	12	concentrations	concentration	NNS
cord-023095-4dannjjm	532	13	in	in	IN
cord-023095-4dannjjm	532	14	dogs	dog	NNS
cord-023095-4dannjjm	532	15	with	with	IN
cord-023095-4dannjjm	532	16	PDA	PDA	NNP
cord-023095-4dannjjm	532	17	,	,	,
cord-023095-4dannjjm	532	18	and	and	CC
cord-023095-4dannjjm	532	19	to	to	TO
cord-023095-4dannjjm	532	20	assess	assess	VB
cord-023095-4dannjjm	532	21	whether	whether	IN
cord-023095-4dannjjm	532	22	additional	additional	JJ
cord-023095-4dannjjm	532	23	indicators	indicator	NNS
cord-023095-4dannjjm	532	24	of	of	IN
cord-023095-4dannjjm	532	25	hemodynamics	hemodynamic	NNS
cord-023095-4dannjjm	532	26	correlate	correlate	VBP
cord-023095-4dannjjm	532	27	with	with	IN
cord-023095-4dannjjm	532	28	NTproBNP	NTproBNP	NNP
cord-023095-4dannjjm	532	29	.	.	.
cord-023095-4dannjjm	533	1	We	-PRON-	PRP
cord-023095-4dannjjm	533	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	533	3	that	that	IN
cord-023095-4dannjjm	533	4	NT	NT	NNP
cord-023095-4dannjjm	533	5	-	-	HYPH
cord-023095-4dannjjm	533	6	proBNP	proBNP	NNP
cord-023095-4dannjjm	533	7	will	will	MD
cord-023095-4dannjjm	533	8	serve	serve	VB
cord-023095-4dannjjm	533	9	as	as	IN
cord-023095-4dannjjm	533	10	a	a	DT
cord-023095-4dannjjm	533	11	simple	simple	JJ
cord-023095-4dannjjm	533	12	non	non	JJ
cord-023095-4dannjjm	533	13	-	-	JJ
cord-023095-4dannjjm	533	14	invasive	invasive	JJ
cord-023095-4dannjjm	533	15	marker	marker	NN
cord-023095-4dannjjm	533	16	of	of	IN
cord-023095-4dannjjm	533	17	hemodynamic	hemodynamic	JJ
cord-023095-4dannjjm	533	18	significance	significance	NN
cord-023095-4dannjjm	533	19	in	in	IN
cord-023095-4dannjjm	533	20	dogs	dog	NNS
cord-023095-4dannjjm	533	21	with	with	IN
cord-023095-4dannjjm	533	22	PDA	PDA	NNP
cord-023095-4dannjjm	533	23	prior	prior	RB
cord-023095-4dannjjm	533	24	to	to	IN
cord-023095-4dannjjm	533	25	and	and	CC
cord-023095-4dannjjm	533	26	following	follow	VBG
cord-023095-4dannjjm	533	27	transcatheter	transcatheter	NNP
cord-023095-4dannjjm	533	28	ductal	ductal	JJ
cord-023095-4dannjjm	533	29	occlusion	occlusion	NN
cord-023095-4dannjjm	533	30	.	.	.
cord-023095-4dannjjm	534	1	NT	NT	NNP
cord-023095-4dannjjm	534	2	-	-	HYPH
cord-023095-4dannjjm	534	3	proBNP	proBNP	NNP
cord-023095-4dannjjm	534	4	was	be	VBD
cord-023095-4dannjjm	534	5	measured	measure	VBN
cord-023095-4dannjjm	534	6	in	in	IN
cord-023095-4dannjjm	534	7	30	30	CD
cord-023095-4dannjjm	534	8	client	client	NN
cord-023095-4dannjjm	534	9	-	-	HYPH
cord-023095-4dannjjm	534	10	owned	own	VBN
cord-023095-4dannjjm	534	11	dogs	dog	NNS
cord-023095-4dannjjm	534	12	with	with	IN
cord-023095-4dannjjm	534	13	echocardiographically	echocardiographically	RB
cord-023095-4dannjjm	534	14	normal	normal	JJ
cord-023095-4dannjjm	534	15	hearts	heart	NNS
cord-023095-4dannjjm	534	16	.	.	.
cord-023095-4dannjjm	535	1	Ten	ten	CD
cord-023095-4dannjjm	535	2	dogs	dog	NNS
cord-023095-4dannjjm	535	3	with	with	IN
cord-023095-4dannjjm	535	4	PDA	PDA	NNP
cord-023095-4dannjjm	535	5	were	be	VBD
cord-023095-4dannjjm	535	6	initially	initially	RB
cord-023095-4dannjjm	535	7	evaluated	evaluate	VBN
cord-023095-4dannjjm	535	8	with	with	IN
cord-023095-4dannjjm	535	9	thoracic	thoracic	JJ
cord-023095-4dannjjm	535	10	radiographs	radiograph	NNS
cord-023095-4dannjjm	535	11	,	,	,
cord-023095-4dannjjm	535	12	transthoracic	transthoracic	NNP
cord-023095-4dannjjm	535	13	and	and	CC
cord-023095-4dannjjm	535	14	transesophageal	transesophageal	NN
cord-023095-4dannjjm	535	15	echocardiography	echocardiography	NN
cord-023095-4dannjjm	535	16	,	,	,
cord-023095-4dannjjm	535	17	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	535	18	capillary	capillary	NN
cord-023095-4dannjjm	535	19	wedge	wedge	NN
cord-023095-4dannjjm	535	20	pressure	pressure	NN
cord-023095-4dannjjm	535	21	(	(	-LRB-
cord-023095-4dannjjm	535	22	PCWP	PCWP	NNP
cord-023095-4dannjjm	535	23	)	)	-RRB-
cord-023095-4dannjjm	535	24	and	and	CC
cord-023095-4dannjjm	535	25	NT	NT	NNP
cord-023095-4dannjjm	535	26	-	-	HYPH
cord-023095-4dannjjm	535	27	proBNP	probnp	NN
cord-023095-4dannjjm	535	28	.	.	.
cord-023095-4dannjjm	536	1	NT	NT	NNP
cord-023095-4dannjjm	536	2	-	-	HYPH
cord-023095-4dannjjm	536	3	proBNP	probnp	NN
cord-023095-4dannjjm	536	4	and	and	CC
cord-023095-4dannjjm	536	5	echocardiography	echocardiography	NN
cord-023095-4dannjjm	536	6	were	be	VBD
cord-023095-4dannjjm	536	7	repeated	repeat	VBN
cord-023095-4dannjjm	536	8	at	at	IN
cord-023095-4dannjjm	536	9	1	1	CD
cord-023095-4dannjjm	536	10	day	day	NN
cord-023095-4dannjjm	536	11	and	and	CC
cord-023095-4dannjjm	536	12	3	3	CD
cord-023095-4dannjjm	536	13	months	month	NNS
cord-023095-4dannjjm	536	14	following	follow	VBG
cord-023095-4dannjjm	536	15	ductal	ductal	JJ
cord-023095-4dannjjm	536	16	occlusion	occlusion	NN
cord-023095-4dannjjm	536	17	.	.	.
cord-023095-4dannjjm	537	1	PCWP	PCWP	NNP
cord-023095-4dannjjm	537	2	was	be	VBD
cord-023095-4dannjjm	537	3	repeated	repeat	VBN
cord-023095-4dannjjm	537	4	at	at	IN
cord-023095-4dannjjm	537	5	3	3	CD
cord-023095-4dannjjm	537	6	months	month	NNS
cord-023095-4dannjjm	537	7	.	.	.
cord-023095-4dannjjm	538	1	Baseline	baseline	JJ
cord-023095-4dannjjm	538	2	NT	NT	NNP
cord-023095-4dannjjm	538	3	-	-	HYPH
cord-023095-4dannjjm	538	4	proBNP	proBNP	NNP
cord-023095-4dannjjm	538	5	was	be	VBD
cord-023095-4dannjjm	538	6	significantly	significantly	RB
cord-023095-4dannjjm	538	7	higher	high	JJR
cord-023095-4dannjjm	538	8	in	in	IN
cord-023095-4dannjjm	538	9	PDA	PDA	NNP
cord-023095-4dannjjm	538	10	dogs	dog	NNS
cord-023095-4dannjjm	538	11	compared	compare	VBN
cord-023095-4dannjjm	538	12	to	to	IN
cord-023095-4dannjjm	538	13	control	control	NN
cord-023095-4dannjjm	538	14	(	(	-LRB-
cord-023095-4dannjjm	538	15	1877	1877	CD
cord-023095-4dannjjm	538	16	AE	AE	NNP
cord-023095-4dannjjm	538	17	2081	2081	CD
cord-023095-4dannjjm	538	18	pmol	pmol	NNP
cord-023095-4dannjjm	538	19	/	/	SYM
cord-023095-4dannjjm	538	20	L	l	NN
cord-023095-4dannjjm	539	1	(	(	-LRB-
cord-023095-4dannjjm	539	2	mean	mean	VB
cord-023095-4dannjjm	539	3	AE	AE	NNP
cord-023095-4dannjjm	539	4	SD	SD	NNP
cord-023095-4dannjjm	539	5	)	)	-RRB-
cord-023095-4dannjjm	539	6	,	,	,
cord-023095-4dannjjm	539	7	651	651	CD
cord-023095-4dannjjm	539	8	AE	AE	NNP
cord-023095-4dannjjm	539	9	301	301	CD
cord-023095-4dannjjm	539	10	;	;	:
cord-023095-4dannjjm	539	11	p	p	NN
cord-023095-4dannjjm	539	12	o	o	CD
cord-023095-4dannjjm	539	13	0.0025	0.0025	CD
cord-023095-4dannjjm	539	14	)	)	-RRB-
cord-023095-4dannjjm	539	15	.	.	.
cord-023095-4dannjjm	540	1	At	at	IN
cord-023095-4dannjjm	540	2	1	1	CD
cord-023095-4dannjjm	540	3	day	day	NN
cord-023095-4dannjjm	540	4	and	and	CC
cord-023095-4dannjjm	540	5	3	3	CD
cord-023095-4dannjjm	540	6	months	month	NNS
cord-023095-4dannjjm	540	7	following	follow	VBG
cord-023095-4dannjjm	540	8	ductal	ductal	JJ
cord-023095-4dannjjm	540	9	occlusion	occlusion	NN
cord-023095-4dannjjm	540	10	,	,	,
cord-023095-4dannjjm	540	11	NT	NT	NNP
cord-023095-4dannjjm	540	12	-	-	HYPH
cord-023095-4dannjjm	540	13	proBNP	proBNP	NNP
cord-023095-4dannjjm	540	14	was	be	VBD
cord-023095-4dannjjm	540	15	1347	1347	CD
cord-023095-4dannjjm	540	16	AE	AE	NNP
cord-023095-4dannjjm	540	17	1256	1256	CD
cord-023095-4dannjjm	540	18	and	and	CC
cord-023095-4dannjjm	540	19	466	466	CD
cord-023095-4dannjjm	540	20	AE	AE	NNP
cord-023095-4dannjjm	540	21	380	380	CD
cord-023095-4dannjjm	540	22	,	,	,
cord-023095-4dannjjm	540	23	respectively	respectively	RB
cord-023095-4dannjjm	540	24	.	.	.
cord-023095-4dannjjm	541	1	The	the	DT
cord-023095-4dannjjm	541	2	following	follow	VBG
cord-023095-4dannjjm	541	3	decreased	decrease	VBD
cord-023095-4dannjjm	541	4	significantly	significantly	RB
cord-023095-4dannjjm	541	5	from	from	IN
cord-023095-4dannjjm	541	6	baseline	baseline	NN
cord-023095-4dannjjm	541	7	:	:	:
cord-023095-4dannjjm	541	8	PCWP	PCWP	NNP
cord-023095-4dannjjm	541	9	(	(	-LRB-
cord-023095-4dannjjm	541	10	11.8	11.8	CD
cord-023095-4dannjjm	541	11	AE	AE	NNP
cord-023095-4dannjjm	541	12	4.7	4.7	CD
cord-023095-4dannjjm	541	13	to	to	IN
cord-023095-4dannjjm	541	14	6.4	6.4	CD
cord-023095-4dannjjm	541	15	AE	AE	NNP
cord-023095-4dannjjm	541	16	3.2	3.2	CD
cord-023095-4dannjjm	541	17	mmHg	mmHg	NNS
cord-023095-4dannjjm	541	18	;	;	:
cord-023095-4dannjjm	541	19	p	p	NN
cord-023095-4dannjjm	541	20	5	5	CD
cord-023095-4dannjjm	541	21	0.018	0.018	CD
cord-023095-4dannjjm	541	22	)	)	-RRB-
cord-023095-4dannjjm	541	23	,	,	,
cord-023095-4dannjjm	541	24	and	and	CC
cord-023095-4dannjjm	541	25	indexed	index	VBN
cord-023095-4dannjjm	541	26	left	leave	VBN
cord-023095-4dannjjm	541	27	ventricular	ventricular	JJ
cord-023095-4dannjjm	541	28	internal	internal	JJ
cord-023095-4dannjjm	541	29	dimensions	dimension	NNS
cord-023095-4dannjjm	541	30	in	in	IN
cord-023095-4dannjjm	541	31	diastole	diastole	NN
cord-023095-4dannjjm	541	32	(	(	-LRB-
cord-023095-4dannjjm	541	33	2.26	2.26	CD
cord-023095-4dannjjm	541	34	AE	AE	NNP
cord-023095-4dannjjm	541	35	0.47	0.47	CD
cord-023095-4dannjjm	541	36	to	to	IN
cord-023095-4dannjjm	541	37	1.67	1.67	CD
cord-023095-4dannjjm	541	38	AE	AE	NNP
cord-023095-4dannjjm	541	39	0.19	0.19	CD
cord-023095-4dannjjm	541	40	;	;	:
cord-023095-4dannjjm	541	41	p	p	NN
cord-023095-4dannjjm	541	42	5	5	CD
cord-023095-4dannjjm	541	43	0.006	0.006	CD
cord-023095-4dannjjm	541	44	)	)	-RRB-
cord-023095-4dannjjm	541	45	but	but	CC
cord-023095-4dannjjm	541	46	not	not	RB
cord-023095-4dannjjm	541	47	significantly	significantly	RB
cord-023095-4dannjjm	541	48	in	in	IN
cord-023095-4dannjjm	541	49	systole	systole	NN
cord-023095-4dannjjm	541	50	(	(	-LRB-
cord-023095-4dannjjm	541	51	1.40	1.40	CD
cord-023095-4dannjjm	541	52	AE	AE	NNP
cord-023095-4dannjjm	541	53	0.31	0.31	CD
cord-023095-4dannjjm	541	54	to	to	IN
cord-023095-4dannjjm	541	55	1.20	1.20	CD
cord-023095-4dannjjm	541	56	AE	AE	NNP
cord-023095-4dannjjm	541	57	0.19	0.19	CD
cord-023095-4dannjjm	541	58	;	;	:
cord-023095-4dannjjm	541	59	p	p	NN
cord-023095-4dannjjm	541	60	5	5	CD
cord-023095-4dannjjm	541	61	0.13	0.13	CD
cord-023095-4dannjjm	541	62	)	)	-RRB-
cord-023095-4dannjjm	541	63	.	.	.
cord-023095-4dannjjm	542	1	NT	NT	NNP
cord-023095-4dannjjm	542	2	-	-	HYPH
cord-023095-4dannjjm	542	3	proBNP	proBNP	NNP
cord-023095-4dannjjm	542	4	is	be	VBZ
cord-023095-4dannjjm	542	5	elevated	elevate	VBN
cord-023095-4dannjjm	542	6	in	in	IN
cord-023095-4dannjjm	542	7	dogs	dog	NNS
cord-023095-4dannjjm	542	8	with	with	IN
cord-023095-4dannjjm	542	9	PDA	PDA	NNP
cord-023095-4dannjjm	542	10	and	and	CC
cord-023095-4dannjjm	542	11	transductal	transductal	JJ
cord-023095-4dannjjm	542	12	closure	closure	NN
cord-023095-4dannjjm	542	13	is	be	VBZ
cord-023095-4dannjjm	542	14	associated	associate	VBN
cord-023095-4dannjjm	542	15	with	with	IN
cord-023095-4dannjjm	542	16	a	a	DT
cord-023095-4dannjjm	542	17	reduction	reduction	NN
cord-023095-4dannjjm	542	18	in	in	IN
cord-023095-4dannjjm	542	19	NT	NT	NNP
cord-023095-4dannjjm	542	20	-	-	HYPH
cord-023095-4dannjjm	542	21	proBNP	probnp	NN
cord-023095-4dannjjm	542	22	,	,	,
cord-023095-4dannjjm	542	23	PCWP	PCWP	NNP
cord-023095-4dannjjm	542	24	and	and	CC
cord-023095-4dannjjm	542	25	left	leave	VBD
cord-023095-4dannjjm	542	26	ventricular	ventricular	JJ
cord-023095-4dannjjm	542	27	size	size	NN
cord-023095-4dannjjm	542	28	.	.	.
cord-023095-4dannjjm	543	1	Cardiac	cardiac	JJ
cord-023095-4dannjjm	543	2	biomarkers	biomarker	NNS
cord-023095-4dannjjm	543	3	,	,	,
cord-023095-4dannjjm	543	4	particularly	particularly	RB
cord-023095-4dannjjm	543	5	NT	NT	NNP
cord-023095-4dannjjm	543	6	-	-	HYPH
cord-023095-4dannjjm	543	7	proBNP	probnp	NN
cord-023095-4dannjjm	543	8	,	,	,
cord-023095-4dannjjm	543	9	are	be	VBP
cord-023095-4dannjjm	543	10	becoming	become	VBG
cord-023095-4dannjjm	543	11	more	more	RBR
cord-023095-4dannjjm	543	12	commonly	commonly	RB
cord-023095-4dannjjm	543	13	used	use	VBN
cord-023095-4dannjjm	543	14	in	in	IN
cord-023095-4dannjjm	543	15	dogs	dog	NNS
cord-023095-4dannjjm	543	16	and	and	CC
cord-023095-4dannjjm	543	17	cats	cat	NNS
cord-023095-4dannjjm	543	18	as	as	IN
cord-023095-4dannjjm	543	19	part	part	NN
cord-023095-4dannjjm	543	20	of	of	IN
cord-023095-4dannjjm	543	21	a	a	DT
cord-023095-4dannjjm	543	22	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	543	23	work	work	NN
cord-023095-4dannjjm	543	24	up	up	RP
cord-023095-4dannjjm	543	25	.	.	.
cord-023095-4dannjjm	544	1	Multiple	multiple	JJ
cord-023095-4dannjjm	544	2	studies	study	NNS
cord-023095-4dannjjm	544	3	already	already	RB
cord-023095-4dannjjm	544	4	have	have	VBP
cord-023095-4dannjjm	544	5	documented	document	VBN
cord-023095-4dannjjm	544	6	the	the	DT
cord-023095-4dannjjm	544	7	correlation	correlation	NN
cord-023095-4dannjjm	544	8	of	of	IN
cord-023095-4dannjjm	544	9	this	this	DT
cord-023095-4dannjjm	544	10	peptide	peptide	NN
cord-023095-4dannjjm	544	11	with	with	IN
cord-023095-4dannjjm	544	12	cardiac	cardiac	JJ
cord-023095-4dannjjm	544	13	disease	disease	NN
cord-023095-4dannjjm	544	14	status	status	NN
cord-023095-4dannjjm	544	15	and	and	CC
cord-023095-4dannjjm	544	16	potential	potential	JJ
cord-023095-4dannjjm	544	17	clinical	clinical	JJ
cord-023095-4dannjjm	544	18	implications	implication	NNS
cord-023095-4dannjjm	544	19	.	.	.
cord-023095-4dannjjm	545	1	In	in	IN
cord-023095-4dannjjm	545	2	a	a	DT
cord-023095-4dannjjm	545	3	portion	portion	NN
cord-023095-4dannjjm	545	4	of	of	IN
cord-023095-4dannjjm	545	5	these	these	DT
cord-023095-4dannjjm	545	6	reports	report	NNS
cord-023095-4dannjjm	545	7	the	the	DT
cord-023095-4dannjjm	545	8	manner	manner	NN
cord-023095-4dannjjm	545	9	in	in	IN
cord-023095-4dannjjm	545	10	which	which	WDT
cord-023095-4dannjjm	545	11	samples	sample	NNS
cord-023095-4dannjjm	545	12	were	be	VBD
cord-023095-4dannjjm	545	13	handled	handle	VBN
cord-023095-4dannjjm	545	14	was	be	VBD
cord-023095-4dannjjm	545	15	placement	placement	NN
cord-023095-4dannjjm	545	16	of	of	IN
cord-023095-4dannjjm	545	17	whole	whole	JJ
cord-023095-4dannjjm	545	18	blood	blood	NN
cord-023095-4dannjjm	545	19	into	into	IN
cord-023095-4dannjjm	545	20	an	an	DT
cord-023095-4dannjjm	545	21	EDTA	edta	NN
cord-023095-4dannjjm	545	22	tube	tube	NN
cord-023095-4dannjjm	545	23	,	,	,
cord-023095-4dannjjm	545	24	followed	follow	VBN
cord-023095-4dannjjm	545	25	by	by	IN
cord-023095-4dannjjm	545	26	centrifugation	centrifugation	NN
cord-023095-4dannjjm	545	27	and	and	CC
cord-023095-4dannjjm	545	28	decanting	decanting	NN
cord-023095-4dannjjm	545	29	of	of	IN
cord-023095-4dannjjm	545	30	the	the	DT
cord-023095-4dannjjm	545	31	supernatant	supernatant	NN
cord-023095-4dannjjm	545	32	that	that	WDT
cord-023095-4dannjjm	545	33	was	be	VBD
cord-023095-4dannjjm	545	34	ultimately	ultimately	RB
cord-023095-4dannjjm	545	35	stored	store	VBN
cord-023095-4dannjjm	545	36	at	at	IN
cord-023095-4dannjjm	545	37	À201C	à201c	CD
cord-023095-4dannjjm	545	38	or	or	CC
cord-023095-4dannjjm	545	39	À801C	À801C	NNPS
cord-023095-4dannjjm	545	40	prior	prior	RB
cord-023095-4dannjjm	545	41	to	to	IN
cord-023095-4dannjjm	545	42	shipment	shipment	NN
cord-023095-4dannjjm	545	43	,	,	,
cord-023095-4dannjjm	545	44	either	either	CC
cord-023095-4dannjjm	545	45	with	with	IN
cord-023095-4dannjjm	545	46	or	or	CC
cord-023095-4dannjjm	545	47	without	without	IN
cord-023095-4dannjjm	545	48	protease	protease	NN
cord-023095-4dannjjm	545	49	inhibition	inhibition	NN
cord-023095-4dannjjm	545	50	.	.	.
cord-023095-4dannjjm	546	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	546	2	objective	objective	NN
cord-023095-4dannjjm	546	3	was	be	VBD
cord-023095-4dannjjm	546	4	to	to	TO
cord-023095-4dannjjm	546	5	compare	compare	VB
cord-023095-4dannjjm	546	6	the	the	DT
cord-023095-4dannjjm	546	7	NT	NT	NNP
cord-023095-4dannjjm	546	8	-	-	HYPH
cord-023095-4dannjjm	546	9	proBNP	probnp	NN
cord-023095-4dannjjm	546	10	concentrations	concentration	NNS
cord-023095-4dannjjm	546	11	in	in	IN
cord-023095-4dannjjm	546	12	feline	feline	JJ
cord-023095-4dannjjm	546	13	plasma	plasma	NN
cord-023095-4dannjjm	546	14	collected	collect	VBN
cord-023095-4dannjjm	546	15	using	use	VBG
cord-023095-4dannjjm	546	16	the	the	DT
cord-023095-4dannjjm	546	17	previously	previously	RB
cord-023095-4dannjjm	546	18	reported	report	VBN
cord-023095-4dannjjm	546	19	methods	method	NNS
cord-023095-4dannjjm	546	20	to	to	IN
cord-023095-4dannjjm	546	21	the	the	DT
cord-023095-4dannjjm	546	22	California	California	NNP
cord-023095-4dannjjm	546	23	Animal	Animal	NNP
cord-023095-4dannjjm	546	24	Hospital	Hospital	NNP
cord-023095-4dannjjm	546	25	(	(	-LRB-
cord-023095-4dannjjm	546	26	CAH	CAH	NNP
cord-023095-4dannjjm	546	27	)	)	-RRB-
cord-023095-4dannjjm	546	28	collection	collection	NN
cord-023095-4dannjjm	546	29	method	method	NN
cord-023095-4dannjjm	546	30	using	use	VBG
cord-023095-4dannjjm	546	31	tubes	tube	NNS
cord-023095-4dannjjm	546	32	containing	contain	VBG
cord-023095-4dannjjm	546	33	a	a	DT
cord-023095-4dannjjm	546	34	protease	protease	NN
cord-023095-4dannjjm	546	35	inhibitor	inhibitor	NN
cord-023095-4dannjjm	546	36	.	.	.
cord-023095-4dannjjm	547	1	This	this	DT
cord-023095-4dannjjm	547	2	study	study	NN
cord-023095-4dannjjm	547	3	compared	compare	VBD
cord-023095-4dannjjm	547	4	NT	NT	NNP
cord-023095-4dannjjm	547	5	-	-	HYPH
cord-023095-4dannjjm	547	6	proBNP	probnp	NN
cord-023095-4dannjjm	547	7	concentrations	concentration	NNS
cord-023095-4dannjjm	547	8	using	use	VBG
cord-023095-4dannjjm	547	9	the	the	DT
cord-023095-4dannjjm	547	10	protease	protease	NN
cord-023095-4dannjjm	547	11	inhibitor	inhibitor	NN
cord-023095-4dannjjm	547	12	tubes	tube	NNS
cord-023095-4dannjjm	547	13	vs.	vs.	IN
cord-023095-4dannjjm	547	14	EDTA	edta	NN
cord-023095-4dannjjm	547	15	tubes	tube	NNS
cord-023095-4dannjjm	547	16	from	from	IN
cord-023095-4dannjjm	547	17	18	18	CD
cord-023095-4dannjjm	547	18	privately	privately	RB
cord-023095-4dannjjm	547	19	owned	own	VBN
cord-023095-4dannjjm	547	20	feline	feline	JJ
cord-023095-4dannjjm	547	21	patients	patient	NNS
cord-023095-4dannjjm	547	22	,	,	,
cord-023095-4dannjjm	547	23	with	with	IN
cord-023095-4dannjjm	547	24	confirmed	confirm	VBN
cord-023095-4dannjjm	547	25	cardiac	cardiac	JJ
cord-023095-4dannjjm	547	26	disease	disease	NN
cord-023095-4dannjjm	547	27	,	,	,
cord-023095-4dannjjm	547	28	and	and	CC
cord-023095-4dannjjm	547	29	6	6	CD
cord-023095-4dannjjm	547	30	control	control	NN
cord-023095-4dannjjm	547	31	feline	feline	JJ
cord-023095-4dannjjm	547	32	patients	patient	NNS
cord-023095-4dannjjm	547	33	.	.	.
cord-023095-4dannjjm	548	1	For	for	IN
cord-023095-4dannjjm	548	2	all	all	DT
cord-023095-4dannjjm	548	3	study	study	NN
cord-023095-4dannjjm	548	4	participants	participant	NNS
cord-023095-4dannjjm	548	5	,	,	,
cord-023095-4dannjjm	548	6	we	-PRON-	PRP
cord-023095-4dannjjm	548	7	performed	perform	VBD
cord-023095-4dannjjm	548	8	a	a	DT
cord-023095-4dannjjm	548	9	full	full	JJ
cord-023095-4dannjjm	548	10	history	history	NN
cord-023095-4dannjjm	548	11	and	and	CC
cord-023095-4dannjjm	548	12	physical	physical	JJ
cord-023095-4dannjjm	548	13	examination	examination	NN
cord-023095-4dannjjm	548	14	,	,	,
cord-023095-4dannjjm	548	15	a	a	DT
cord-023095-4dannjjm	548	16	hematology	hematology	NN
cord-023095-4dannjjm	548	17	and	and	CC
cord-023095-4dannjjm	548	18	chemistry	chemistry	NN
cord-023095-4dannjjm	548	19	panel	panel	NN
cord-023095-4dannjjm	548	20	,	,	,
cord-023095-4dannjjm	548	21	thoracic	thoracic	JJ
cord-023095-4dannjjm	548	22	radiographs	radiograph	NNS
cord-023095-4dannjjm	548	23	,	,	,
cord-023095-4dannjjm	548	24	ECG	ECG	NNP
cord-023095-4dannjjm	548	25	,	,	,
cord-023095-4dannjjm	548	26	and	and	CC
cord-023095-4dannjjm	548	27	echocardiogram	echocardiogram	NN
cord-023095-4dannjjm	548	28	.	.	.
cord-023095-4dannjjm	549	1	In	in	IN
cord-023095-4dannjjm	549	2	each	each	DT
cord-023095-4dannjjm	549	3	study	study	NN
cord-023095-4dannjjm	549	4	participant	participant	NN
cord-023095-4dannjjm	549	5	,	,	,
cord-023095-4dannjjm	549	6	at	at	IN
cord-023095-4dannjjm	549	7	least	least	JJS
cord-023095-4dannjjm	549	8	4	4	CD
cord-023095-4dannjjm	549	9	ml	ml	NN
cord-023095-4dannjjm	549	10	's	's	POS
cord-023095-4dannjjm	549	11	of	of	IN
cord-023095-4dannjjm	549	12	whole	whole	JJ
cord-023095-4dannjjm	549	13	blood	blood	NN
cord-023095-4dannjjm	549	14	was	be	VBD
cord-023095-4dannjjm	549	15	drawn	draw	VBN
cord-023095-4dannjjm	549	16	from	from	IN
cord-023095-4dannjjm	549	17	a	a	DT
cord-023095-4dannjjm	549	18	peripheral	peripheral	JJ
cord-023095-4dannjjm	549	19	vein	vein	NN
cord-023095-4dannjjm	549	20	,	,	,
cord-023095-4dannjjm	549	21	and	and	CC
cord-023095-4dannjjm	549	22	transferred	transfer	VBN
cord-023095-4dannjjm	549	23	to	to	IN
cord-023095-4dannjjm	549	24	a	a	DT
cord-023095-4dannjjm	549	25	plastic	plastic	JJ
cord-023095-4dannjjm	549	26	EDTA	edta	NN
cord-023095-4dannjjm	549	27	tube	tube	NN
cord-023095-4dannjjm	549	28	.	.	.
cord-023095-4dannjjm	550	1	The	the	DT
cord-023095-4dannjjm	550	2	sample	sample	NN
cord-023095-4dannjjm	550	3	was	be	VBD
cord-023095-4dannjjm	550	4	centrifuged	centrifuge	VBN
cord-023095-4dannjjm	550	5	within	within	IN
cord-023095-4dannjjm	550	6	1	1	CD
cord-023095-4dannjjm	550	7	hour	hour	NN
cord-023095-4dannjjm	550	8	after	after	IN
cord-023095-4dannjjm	550	9	collection	collection	NN
cord-023095-4dannjjm	550	10	.	.	.
cord-023095-4dannjjm	551	1	1	1	CD
cord-023095-4dannjjm	551	2	ml	ml	NNS
cord-023095-4dannjjm	551	3	of	of	IN
cord-023095-4dannjjm	551	4	plasma	plasma	NN
cord-023095-4dannjjm	551	5	was	be	VBD
cord-023095-4dannjjm	551	6	then	then	RB
cord-023095-4dannjjm	551	7	transferred	transfer	VBN
cord-023095-4dannjjm	551	8	to	to	IN
cord-023095-4dannjjm	551	9	a	a	DT
cord-023095-4dannjjm	551	10	tube	tube	NN
cord-023095-4dannjjm	551	11	containing	contain	VBG
cord-023095-4dannjjm	551	12	a	a	DT
cord-023095-4dannjjm	551	13	protease	protease	NN
cord-023095-4dannjjm	551	14	inhibitor	inhibitor	NN
cord-023095-4dannjjm	551	15	,	,	,
cord-023095-4dannjjm	551	16	which	which	WDT
cord-023095-4dannjjm	551	17	was	be	VBD
cord-023095-4dannjjm	551	18	stored	store	VBN
cord-023095-4dannjjm	551	19	at	at	IN
cord-023095-4dannjjm	551	20	41C	41c	CD
cord-023095-4dannjjm	551	21	until	until	IN
cord-023095-4dannjjm	551	22	being	be	VBG
cord-023095-4dannjjm	551	23	shipped	ship	VBN
cord-023095-4dannjjm	551	24	within	within	IN
cord-023095-4dannjjm	551	25	24	24	CD
cord-023095-4dannjjm	551	26	hours	hour	NNS
cord-023095-4dannjjm	551	27	of	of	IN
cord-023095-4dannjjm	551	28	collection	collection	NN
cord-023095-4dannjjm	551	29	.	.	.
cord-023095-4dannjjm	552	1	The	the	DT
cord-023095-4dannjjm	552	2	remaining	remain	VBG
cord-023095-4dannjjm	552	3	plasma	plasma	NN
cord-023095-4dannjjm	552	4	was	be	VBD
cord-023095-4dannjjm	552	5	placed	place	VBN
cord-023095-4dannjjm	552	6	into	into	IN
cord-023095-4dannjjm	552	7	2	2	CD
cord-023095-4dannjjm	552	8	separate	separate	JJ
cord-023095-4dannjjm	552	9	microtubes	microtube	NNS
cord-023095-4dannjjm	552	10	,	,	,
cord-023095-4dannjjm	552	11	which	which	WDT
cord-023095-4dannjjm	552	12	did	do	VBD
cord-023095-4dannjjm	552	13	not	not	RB
cord-023095-4dannjjm	552	14	contain	contain	VB
cord-023095-4dannjjm	552	15	a	a	DT
cord-023095-4dannjjm	552	16	protease	protease	NN
cord-023095-4dannjjm	552	17	inhibitor	inhibitor	NN
cord-023095-4dannjjm	552	18	.	.	.
cord-023095-4dannjjm	553	1	One	one	CD
cord-023095-4dannjjm	553	2	microtube	microtube	NN
cord-023095-4dannjjm	553	3	was	be	VBD
cord-023095-4dannjjm	553	4	then	then	RB
cord-023095-4dannjjm	553	5	stored	store	VBN
cord-023095-4dannjjm	553	6	and	and	CC
cord-023095-4dannjjm	553	7	shipped	ship	VBN
cord-023095-4dannjjm	553	8	as	as	IN
cord-023095-4dannjjm	553	9	previous	previous	JJ
cord-023095-4dannjjm	553	10	studies	study	NNS
cord-023095-4dannjjm	553	11	have	have	VBP
cord-023095-4dannjjm	553	12	reported	report	VBN
cord-023095-4dannjjm	553	13	(	(	-LRB-
cord-023095-4dannjjm	553	14	À201C	À201C	NNPS
cord-023095-4dannjjm	553	15	,	,	,
cord-023095-4dannjjm	553	16	Styrofoam	Styrofoam	NNP
cord-023095-4dannjjm	553	17	container	container	NN
cord-023095-4dannjjm	553	18	,	,	,
cord-023095-4dannjjm	553	19	shipment	shipment	NN
cord-023095-4dannjjm	553	20	within	within	IN
cord-023095-4dannjjm	553	21	24	24	CD
cord-023095-4dannjjm	553	22	hours	hour	NNS
cord-023095-4dannjjm	553	23	)	)	-RRB-
cord-023095-4dannjjm	553	24	,	,	,
cord-023095-4dannjjm	553	25	and	and	CC
cord-023095-4dannjjm	553	26	the	the	DT
cord-023095-4dannjjm	553	27	second	second	JJ
cord-023095-4dannjjm	553	28	microtube	microtube	NN
cord-023095-4dannjjm	553	29	was	be	VBD
cord-023095-4dannjjm	553	30	frozen	freeze	VBN
cord-023095-4dannjjm	553	31	at	at	IN
cord-023095-4dannjjm	553	32	À801C.	à801c.	CD
cord-023095-4dannjjm	554	1	All	all	DT
cord-023095-4dannjjm	554	2	samples	sample	NNS
cord-023095-4dannjjm	554	3	were	be	VBD
cord-023095-4dannjjm	554	4	shipped	ship	VBN
cord-023095-4dannjjm	554	5	,	,	,
cord-023095-4dannjjm	554	6	received	receive	VBN
cord-023095-4dannjjm	554	7	and	and	CC
cord-023095-4dannjjm	554	8	analyzed	analyze	VBN
cord-023095-4dannjjm	554	9	within	within	IN
cord-023095-4dannjjm	554	10	24	24	CD
cord-023095-4dannjjm	554	11	hours	hour	NNS
cord-023095-4dannjjm	554	12	of	of	IN
cord-023095-4dannjjm	554	13	collection	collection	NN
cord-023095-4dannjjm	554	14	.	.	.
cord-023095-4dannjjm	555	1	Results	result	NNS
cord-023095-4dannjjm	555	2	of	of	IN
cord-023095-4dannjjm	555	3	this	this	DT
cord-023095-4dannjjm	555	4	study	study	NN
cord-023095-4dannjjm	555	5	showed	show	VBD
cord-023095-4dannjjm	555	6	that	that	IN
cord-023095-4dannjjm	555	7	no	no	DT
cord-023095-4dannjjm	555	8	difference	difference	NN
cord-023095-4dannjjm	555	9	was	be	VBD
cord-023095-4dannjjm	555	10	found	find	VBN
cord-023095-4dannjjm	555	11	between	between	IN
cord-023095-4dannjjm	555	12	the	the	DT
cord-023095-4dannjjm	555	13	2	2	CD
cord-023095-4dannjjm	555	14	frozen	frozen	JJ
cord-023095-4dannjjm	555	15	sample	sample	NN
cord-023095-4dannjjm	555	16	methods	method	NNS
cord-023095-4dannjjm	555	17	(	(	-LRB-
cord-023095-4dannjjm	555	18	663	663	CD
cord-023095-4dannjjm	555	19	pmol	pmol	NN
cord-023095-4dannjjm	555	20	/	/	SYM
cord-023095-4dannjjm	555	21	L	l	NN
cord-023095-4dannjjm	555	22	and	and	CC
cord-023095-4dannjjm	555	23	650	650	CD
cord-023095-4dannjjm	555	24	pmol	pmol	NN
cord-023095-4dannjjm	555	25	/	/	SYM
cord-023095-4dannjjm	555	26	L	l	NN
cord-023095-4dannjjm	555	27	p	p	NN
cord-023095-4dannjjm	555	28	5	5	CD
cord-023095-4dannjjm	555	29	0.40	0.40	CD
cord-023095-4dannjjm	555	30	)	)	-RRB-
cord-023095-4dannjjm	555	31	.	.	.
cord-023095-4dannjjm	556	1	It	-PRON-	PRP
cord-023095-4dannjjm	556	2	was	be	VBD
cord-023095-4dannjjm	556	3	determined	determine	VBN
cord-023095-4dannjjm	556	4	that	that	IN
cord-023095-4dannjjm	556	5	both	both	DT
cord-023095-4dannjjm	556	6	frozen	frozen	JJ
cord-023095-4dannjjm	556	7	methods	method	NNS
cord-023095-4dannjjm	556	8	had	have	VBD
cord-023095-4dannjjm	556	9	lower	low	JJR
cord-023095-4dannjjm	556	10	NT	NT	NNP
cord-023095-4dannjjm	556	11	-	-	HYPH
cord-023095-4dannjjm	556	12	proBNP	probnp	NN
cord-023095-4dannjjm	556	13	levels	level	NNS
cord-023095-4dannjjm	556	14	(	(	-LRB-
cord-023095-4dannjjm	556	15	655	655	CD
cord-023095-4dannjjm	556	16	and	and	CC
cord-023095-4dannjjm	556	17	646	646	CD
cord-023095-4dannjjm	556	18	pmol	pmol	NNP
cord-023095-4dannjjm	556	19	/	/	SYM
cord-023095-4dannjjm	556	20	L	L	NNP
cord-023095-4dannjjm	556	21	)	)	-RRB-
cord-023095-4dannjjm	556	22	when	when	WRB
cord-023095-4dannjjm	556	23	compared	compare	VBN
cord-023095-4dannjjm	556	24	to	to	IN
cord-023095-4dannjjm	556	25	plasma	plasma	NN
cord-023095-4dannjjm	556	26	samples	sample	NNS
cord-023095-4dannjjm	556	27	shipped	ship	VBN
cord-023095-4dannjjm	556	28	in	in	IN
cord-023095-4dannjjm	556	29	protease	protease	JJ
cord-023095-4dannjjm	556	30	inhibitor	inhibitor	NN
cord-023095-4dannjjm	556	31	tubes	tube	NNS
cord-023095-4dannjjm	556	32	(	(	-LRB-
cord-023095-4dannjjm	556	33	756	756	CD
cord-023095-4dannjjm	556	34	and	and	CC
cord-023095-4dannjjm	556	35	794	794	CD
cord-023095-4dannjjm	556	36	pmol	pmol	NNP
cord-023095-4dannjjm	556	37	/	/	SYM
cord-023095-4dannjjm	556	38	L	L	NNP
cord-023095-4dannjjm	556	39	)	)	-RRB-
cord-023095-4dannjjm	556	40	.	.	.
cord-023095-4dannjjm	557	1	The	the	DT
cord-023095-4dannjjm	557	2	findings	finding	NNS
cord-023095-4dannjjm	557	3	of	of	IN
cord-023095-4dannjjm	557	4	this	this	DT
cord-023095-4dannjjm	557	5	trial	trial	NN
cord-023095-4dannjjm	557	6	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	557	7	that	that	IN
cord-023095-4dannjjm	557	8	the	the	DT
cord-023095-4dannjjm	557	9	NT	NT	NNP
cord-023095-4dannjjm	557	10	-	-	HYPH
cord-023095-4dannjjm	557	11	proBNP	probnp	NN
cord-023095-4dannjjm	557	12	levels	level	NNS
cord-023095-4dannjjm	557	13	are	be	VBP
cord-023095-4dannjjm	557	14	significantly	significantly	RB
cord-023095-4dannjjm	557	15	different	different	JJ
cord-023095-4dannjjm	557	16	between	between	IN
cord-023095-4dannjjm	557	17	samples	sample	NNS
cord-023095-4dannjjm	557	18	placed	place	VBN
cord-023095-4dannjjm	557	19	in	in	IN
cord-023095-4dannjjm	557	20	EDTA	EDTA	NNP
cord-023095-4dannjjm	557	21	tubes	tube	NNS
cord-023095-4dannjjm	557	22	vs.	vs.	IN
cord-023095-4dannjjm	557	23	contain	contain	VBP
cord-023095-4dannjjm	557	24	protease	protease	NN
cord-023095-4dannjjm	557	25	inhibitor	inhibitor	NN
cord-023095-4dannjjm	557	26	(	(	-LRB-
cord-023095-4dannjjm	557	27	p	p	NN
cord-023095-4dannjjm	557	28	5	5	CD
cord-023095-4dannjjm	557	29	0.008	0.008	CD
cord-023095-4dannjjm	557	30	and	and	CC
cord-023095-4dannjjm	557	31	p	p	NN
cord-023095-4dannjjm	557	32	5	5	CD
cord-023095-4dannjjm	557	33	0.0006	0.0006	CD
cord-023095-4dannjjm	557	34	)	)	-RRB-
cord-023095-4dannjjm	557	35	.	.	.
cord-023095-4dannjjm	558	1	Utilizing	utilize	VBG
cord-023095-4dannjjm	558	2	protease	protease	NN
cord-023095-4dannjjm	558	3	inhibitor	inhibitor	NN
cord-023095-4dannjjm	558	4	tubes	tube	NNS
cord-023095-4dannjjm	558	5	allows	allow	VBZ
cord-023095-4dannjjm	558	6	more	more	RBR
cord-023095-4dannjjm	558	7	accurate	accurate	JJ
cord-023095-4dannjjm	558	8	measurement	measurement	NN
cord-023095-4dannjjm	558	9	of	of	IN
cord-023095-4dannjjm	558	10	plasma	plasma	NN
cord-023095-4dannjjm	558	11	NT	NT	NNP
cord-023095-4dannjjm	558	12	-	-	HYPH
cord-023095-4dannjjm	558	13	proBNP	probnp	NN
cord-023095-4dannjjm	558	14	.	.	.
cord-023095-4dannjjm	559	1	As	as	IN
cord-023095-4dannjjm	559	2	for	for	IN
cord-023095-4dannjjm	559	3	its	-PRON-	PRP$
cord-023095-4dannjjm	559	4	relevance	relevance	NN
cord-023095-4dannjjm	559	5	for	for	IN
cord-023095-4dannjjm	559	6	future	future	JJ
cord-023095-4dannjjm	559	7	research	research	NN
cord-023095-4dannjjm	559	8	and	and	CC
cord-023095-4dannjjm	559	9	publications	publication	NNS
cord-023095-4dannjjm	559	10	,	,	,
cord-023095-4dannjjm	559	11	authors	author	NNS
cord-023095-4dannjjm	559	12	should	should	MD
cord-023095-4dannjjm	559	13	take	take	VB
cord-023095-4dannjjm	559	14	care	care	NN
cord-023095-4dannjjm	559	15	to	to	TO
cord-023095-4dannjjm	559	16	investigate	investigate	VB
cord-023095-4dannjjm	559	17	the	the	DT
cord-023095-4dannjjm	559	18	manner	manner	NN
cord-023095-4dannjjm	559	19	in	in	IN
cord-023095-4dannjjm	559	20	which	which	WDT
cord-023095-4dannjjm	559	21	blood	blood	NN
cord-023095-4dannjjm	559	22	samples	sample	NNS
cord-023095-4dannjjm	559	23	were	be	VBD
cord-023095-4dannjjm	559	24	handled	handle	VBN
cord-023095-4dannjjm	559	25	and	and	CC
cord-023095-4dannjjm	559	26	the	the	DT
cord-023095-4dannjjm	559	27	conclusion	conclusion	NN
cord-023095-4dannjjm	559	28	/	/	SYM
cord-023095-4dannjjm	559	29	results	result	NNS
cord-023095-4dannjjm	559	30	of	of	IN
cord-023095-4dannjjm	559	31	these	these	DT
cord-023095-4dannjjm	559	32	studies	study	NNS
cord-023095-4dannjjm	559	33	should	should	MD
cord-023095-4dannjjm	559	34	be	be	VB
cord-023095-4dannjjm	559	35	taken	take	VBN
cord-023095-4dannjjm	559	36	in	in	IN
cord-023095-4dannjjm	559	37	light	light	NN
cord-023095-4dannjjm	559	38	of	of	IN
cord-023095-4dannjjm	559	39	the	the	DT
cord-023095-4dannjjm	559	40	methodologies	methodology	NNS
cord-023095-4dannjjm	559	41	used	use	VBN
cord-023095-4dannjjm	559	42	in	in	IN
cord-023095-4dannjjm	559	43	collecting	collect	VBG
cord-023095-4dannjjm	559	44	,	,	,
cord-023095-4dannjjm	559	45	storing	store	VBG
cord-023095-4dannjjm	559	46	,	,	,
cord-023095-4dannjjm	559	47	shipping	ship	VBG
cord-023095-4dannjjm	559	48	and	and	CC
cord-023095-4dannjjm	559	49	analyzing	analyze	VBG
cord-023095-4dannjjm	559	50	the	the	DT
cord-023095-4dannjjm	559	51	samples	sample	NNS
cord-023095-4dannjjm	559	52	.	.	.
cord-023095-4dannjjm	560	1	Degenerative	degenerative	JJ
cord-023095-4dannjjm	560	2	mitral	mitral	JJ
cord-023095-4dannjjm	560	3	valve	valve	NN
cord-023095-4dannjjm	560	4	disease	disease	NN
cord-023095-4dannjjm	560	5	(	(	-LRB-
cord-023095-4dannjjm	560	6	DMVD	DMVD	NNP
cord-023095-4dannjjm	560	7	)	)	-RRB-
cord-023095-4dannjjm	560	8	is	be	VBZ
cord-023095-4dannjjm	560	9	one	one	CD
cord-023095-4dannjjm	560	10	of	of	IN
cord-023095-4dannjjm	560	11	the	the	DT
cord-023095-4dannjjm	560	12	most	most	RBS
cord-023095-4dannjjm	560	13	common	common	JJ
cord-023095-4dannjjm	560	14	heart	heart	NN
cord-023095-4dannjjm	560	15	disease	disease	NN
cord-023095-4dannjjm	560	16	and	and	CC
cord-023095-4dannjjm	560	17	is	be	VBZ
cord-023095-4dannjjm	560	18	present	present	JJ
cord-023095-4dannjjm	560	19	approximately	approximately	RB
cord-023095-4dannjjm	560	20	75	75	CD
cord-023095-4dannjjm	560	21	%	%	NN
cord-023095-4dannjjm	560	22	of	of	IN
cord-023095-4dannjjm	560	23	the	the	DT
cord-023095-4dannjjm	560	24	canine	canine	JJ
cord-023095-4dannjjm	560	25	heart	heart	NN
cord-023095-4dannjjm	560	26	disease	disease	NN
cord-023095-4dannjjm	560	27	.	.	.
cord-023095-4dannjjm	561	1	Although	although	IN
cord-023095-4dannjjm	561	2	the	the	DT
cord-023095-4dannjjm	561	3	high	high	JJ
cord-023095-4dannjjm	561	4	prevalence	prevalence	NN
cord-023095-4dannjjm	561	5	exists	exist	VBZ
cord-023095-4dannjjm	561	6	in	in	IN
cord-023095-4dannjjm	561	7	small	small	JJ
cord-023095-4dannjjm	561	8	dogs	dog	NNS
cord-023095-4dannjjm	561	9	,	,	,
cord-023095-4dannjjm	561	10	the	the	DT
cord-023095-4dannjjm	561	11	underlying	underlying	JJ
cord-023095-4dannjjm	561	12	molecular	molecular	JJ
cord-023095-4dannjjm	561	13	mechanism	mechanism	NN
cord-023095-4dannjjm	561	14	of	of	IN
cord-023095-4dannjjm	561	15	its	-PRON-	PRP$
cord-023095-4dannjjm	561	16	pathophysiology	pathophysiology	NN
cord-023095-4dannjjm	561	17	is	be	VBZ
cord-023095-4dannjjm	561	18	rarely	rarely	RB
cord-023095-4dannjjm	561	19	known	know	VBN
cord-023095-4dannjjm	561	20	.	.	.
cord-023095-4dannjjm	562	1	DMVD	DMVD	NNP
cord-023095-4dannjjm	562	2	is	be	VBZ
cord-023095-4dannjjm	562	3	functionally	functionally	RB
cord-023095-4dannjjm	562	4	and	and	CC
cord-023095-4dannjjm	562	5	pathologically	pathologically	RB
cord-023095-4dannjjm	562	6	similar	similar	JJ
cord-023095-4dannjjm	562	7	in	in	IN
cord-023095-4dannjjm	562	8	humans	human	NNS
cord-023095-4dannjjm	562	9	and	and	CC
cord-023095-4dannjjm	562	10	dogs	dog	NNS
cord-023095-4dannjjm	562	11	,	,	,
cord-023095-4dannjjm	562	12	thus	thus	RB
cord-023095-4dannjjm	562	13	,	,	,
cord-023095-4dannjjm	562	14	there	there	EX
cord-023095-4dannjjm	562	15	will	will	MD
cord-023095-4dannjjm	562	16	be	be	VB
cord-023095-4dannjjm	562	17	a	a	DT
cord-023095-4dannjjm	562	18	common	common	JJ
cord-023095-4dannjjm	562	19	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	562	20	in	in	IN
cord-023095-4dannjjm	562	21	human	human	NN
cord-023095-4dannjjm	562	22	and	and	CC
cord-023095-4dannjjm	562	23	dogs	dog	NNS
cord-023095-4dannjjm	562	24	with	with	IN
cord-023095-4dannjjm	562	25	naturally	naturally	RB
cord-023095-4dannjjm	562	26	occurring	occur	VBG
cord-023095-4dannjjm	562	27	DMVD	DMVD	NNS
cord-023095-4dannjjm	562	28	.	.	.
cord-023095-4dannjjm	563	1	Serotonin	serotonin	NN
cord-023095-4dannjjm	563	2	and	and	CC
cord-023095-4dannjjm	563	3	serotonin	serotonin	NN
cord-023095-4dannjjm	563	4	-	-	HYPH
cord-023095-4dannjjm	563	5	related	relate	VBN
cord-023095-4dannjjm	563	6	mechanisms	mechanism	NNS
cord-023095-4dannjjm	563	7	have	have	VBP
cord-023095-4dannjjm	563	8	been	be	VBN
cord-023095-4dannjjm	563	9	implicated	implicate	VBN
cord-023095-4dannjjm	563	10	as	as	IN
cord-023095-4dannjjm	563	11	a	a	DT
cord-023095-4dannjjm	563	12	cause	cause	NN
cord-023095-4dannjjm	563	13	of	of	IN
cord-023095-4dannjjm	563	14	valvular	valvular	JJ
cord-023095-4dannjjm	563	15	disease	disease	NN
cord-023095-4dannjjm	563	16	in	in	IN
cord-023095-4dannjjm	563	17	human	human	NN
cord-023095-4dannjjm	563	18	and	and	CC
cord-023095-4dannjjm	563	19	animals	animal	NNS
cord-023095-4dannjjm	563	20	,	,	,
cord-023095-4dannjjm	563	21	including	include	VBG
cord-023095-4dannjjm	563	22	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	563	23	DMVD	DMVD	NNS
cord-023095-4dannjjm	563	24	in	in	IN
cord-023095-4dannjjm	563	25	dogs	dog	NNS
cord-023095-4dannjjm	563	26	.	.	.
cord-023095-4dannjjm	564	1	Increased	increase	VBN
cord-023095-4dannjjm	564	2	circulating	circulate	VBG
cord-023095-4dannjjm	564	3	5HT	5ht	NN
cord-023095-4dannjjm	564	4	concentration	concentration	NN
cord-023095-4dannjjm	564	5	as	as	IN
cord-023095-4dannjjm	564	6	a	a	DT
cord-023095-4dannjjm	564	7	potential	potential	JJ
cord-023095-4dannjjm	564	8	source	source	NN
cord-023095-4dannjjm	564	9	of	of	IN
cord-023095-4dannjjm	564	10	heightened	heighten	VBN
cord-023095-4dannjjm	564	11	5HT	5ht	NN
cord-023095-4dannjjm	564	12	signaling	signaling	NN
cord-023095-4dannjjm	564	13	is	be	VBZ
cord-023095-4dannjjm	564	14	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	564	15	in	in	IN
cord-023095-4dannjjm	564	16	small	small	JJ
cord-023095-4dannjjm	564	17	dogs	dog	NNS
cord-023095-4dannjjm	564	18	with	with	IN
cord-023095-4dannjjm	564	19	DMVD	DMVD	NNS
cord-023095-4dannjjm	564	20	.	.	.
cord-023095-4dannjjm	565	1	The	the	DT
cord-023095-4dannjjm	565	2	aim	aim	NN
cord-023095-4dannjjm	565	3	of	of	IN
cord-023095-4dannjjm	565	4	this	this	DT
cord-023095-4dannjjm	565	5	study	study	NN
cord-023095-4dannjjm	565	6	was	be	VBD
cord-023095-4dannjjm	565	7	to	to	TO
cord-023095-4dannjjm	565	8	investigate	investigate	VB
cord-023095-4dannjjm	565	9	whether	whether	IN
cord-023095-4dannjjm	565	10	serum	serum	NN
cord-023095-4dannjjm	565	11	5HT	5ht	NN
cord-023095-4dannjjm	565	12	concentrations	concentration	NNS
cord-023095-4dannjjm	565	13	were	be	VBD
cord-023095-4dannjjm	565	14	associated	associate	VBN
cord-023095-4dannjjm	565	15	with	with	IN
cord-023095-4dannjjm	565	16	severity	severity	NN
cord-023095-4dannjjm	565	17	of	of	IN
cord-023095-4dannjjm	565	18	naturally	naturally	RB
cord-023095-4dannjjm	565	19	occurring	occur	VBG
cord-023095-4dannjjm	565	20	DMVD	DMVD	NNP
cord-023095-4dannjjm	565	21	in	in	IN
cord-023095-4dannjjm	565	22	small	small	JJ
cord-023095-4dannjjm	565	23	dogs	dog	NNS
cord-023095-4dannjjm	565	24	and	and	CC
cord-023095-4dannjjm	565	25	to	to	TO
cord-023095-4dannjjm	565	26	investigate	investigate	VB
cord-023095-4dannjjm	565	27	potential	potential	JJ
cord-023095-4dannjjm	565	28	associations	association	NNS
cord-023095-4dannjjm	565	29	of	of	IN
cord-023095-4dannjjm	565	30	dog	dog	NN
cord-023095-4dannjjm	565	31	characteristics	characteristic	NNS
cord-023095-4dannjjm	565	32	on	on	IN
cord-023095-4dannjjm	565	33	serum	serum	NN
cord-023095-4dannjjm	565	34	5HT	5ht	NN
cord-023095-4dannjjm	565	35	concentrations	concentration	NNS
cord-023095-4dannjjm	565	36	in	in	IN
cord-023095-4dannjjm	565	37	our	-PRON-	PRP$
cord-023095-4dannjjm	565	38	study	study	NN
cord-023095-4dannjjm	565	39	population	population	NN
cord-023095-4dannjjm	565	40	.	.	.
cord-023095-4dannjjm	566	1	Forty	forty	CD
cord-023095-4dannjjm	566	2	-	-	HYPH
cord-023095-4dannjjm	566	3	eight	eight	CD
cord-023095-4dannjjm	566	4	dogs	dog	NNS
cord-023095-4dannjjm	566	5	were	be	VBD
cord-023095-4dannjjm	566	6	included	include	VBN
cord-023095-4dannjjm	566	7	in	in	IN
cord-023095-4dannjjm	566	8	this	this	DT
cord-023095-4dannjjm	566	9	study	study	NN
cord-023095-4dannjjm	566	10	and	and	CC
cord-023095-4dannjjm	566	11	were	be	VBD
cord-023095-4dannjjm	566	12	classified	classify	VBN
cord-023095-4dannjjm	566	13	into	into	IN
cord-023095-4dannjjm	566	14	control	control	NN
cord-023095-4dannjjm	566	15	and	and	CC
cord-023095-4dannjjm	566	16	DMVD	DMVD	NNP
cord-023095-4dannjjm	566	17	groups	group	NNS
cord-023095-4dannjjm	566	18	according	accord	VBG
cord-023095-4dannjjm	566	19	to	to	IN
cord-023095-4dannjjm	566	20	the	the	DT
cord-023095-4dannjjm	566	21	results	result	NNS
cord-023095-4dannjjm	566	22	of	of	IN
cord-023095-4dannjjm	566	23	physical	physical	JJ
cord-023095-4dannjjm	566	24	and	and	CC
cord-023095-4dannjjm	566	25	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	566	26	examinations	examination	NNS
cord-023095-4dannjjm	566	27	.	.	.
cord-023095-4dannjjm	567	1	Based	base	VBN
cord-023095-4dannjjm	567	2	on	on	IN
cord-023095-4dannjjm	567	3	the	the	DT
cord-023095-4dannjjm	567	4	LA	la	NN
cord-023095-4dannjjm	567	5	:	:	:
cord-023095-4dannjjm	567	6	Ao	Ao	NNP
cord-023095-4dannjjm	567	7	ratio	ratio	NN
cord-023095-4dannjjm	567	8	,	,	,
cord-023095-4dannjjm	567	9	dogs	dog	NNS
cord-023095-4dannjjm	567	10	with	with	IN
cord-023095-4dannjjm	567	11	DMVD	DMVD	NNP
cord-023095-4dannjjm	567	12	were	be	VBD
cord-023095-4dannjjm	567	13	classified	classify	VBN
cord-023095-4dannjjm	567	14	as	as	IN
cord-023095-4dannjjm	567	15	follow	follow	NN
cord-023095-4dannjjm	567	16	:	:	:
cord-023095-4dannjjm	568	1	Control	Control	NNP
cord-023095-4dannjjm	568	2	(	(	-LRB-
cord-023095-4dannjjm	568	3	LA	LA	NNP
cord-023095-4dannjjm	568	4	:	:	:
cord-023095-4dannjjm	569	1	Ao	Ao	NNP
cord-023095-4dannjjm	569	2	ratio	ratio	NN
cord-023095-4dannjjm	569	3	1.5	1.5	CD
cord-023095-4dannjjm	569	4	and	and	CC
cord-023095-4dannjjm	569	5	no	no	DT
cord-023095-4dannjjm	569	6	MR	MR	NNP
cord-023095-4dannjjm	569	7	)	)	-RRB-
cord-023095-4dannjjm	569	8	,	,	.
cord-023095-4dannjjm	570	1	mild	mild	JJ
cord-023095-4dannjjm	570	2	(	(	-LRB-
cord-023095-4dannjjm	570	3	LA	LA	NNP
cord-023095-4dannjjm	570	4	:	:	:
cord-023095-4dannjjm	571	1	Ao	Ao	NNP
cord-023095-4dannjjm	571	2	ratio	ratio	NN
cord-023095-4dannjjm	571	3	1.5	1.5	CD
cord-023095-4dannjjm	571	4	and	and	CC
cord-023095-4dannjjm	571	5	MR	MR	NNP
cord-023095-4dannjjm	571	6	)	)	-RRB-
cord-023095-4dannjjm	571	7	,	,	.
cord-023095-4dannjjm	572	1	moderate	moderate	JJ
cord-023095-4dannjjm	572	2	(	(	-LRB-
cord-023095-4dannjjm	572	3	1.5	1.5	CD
cord-023095-4dannjjm	572	4	o	o	NN
cord-023095-4dannjjm	572	5	LA	la	NN
cord-023095-4dannjjm	572	6	:	:	:
cord-023095-4dannjjm	573	1	Ao	ao	NN
cord-023095-4dannjjm	573	2	ratio	ratio	NN
cord-023095-4dannjjm	573	3	1.8	1.8	CD
cord-023095-4dannjjm	573	4	and	and	CC
cord-023095-4dannjjm	573	5	MR	MR	NNP
cord-023095-4dannjjm	573	6	)	)	-RRB-
cord-023095-4dannjjm	573	7	,	,	.
cord-023095-4dannjjm	574	1	Severe	severe	JJ
cord-023095-4dannjjm	574	2	(	(	-LRB-
cord-023095-4dannjjm	574	3	LA	la	NN
cord-023095-4dannjjm	574	4	:	:	:
cord-023095-4dannjjm	575	1	Ao	ao	NN
cord-023095-4dannjjm	575	2	ratio	ratio	NN
cord-023095-4dannjjm	575	3	41.8	41.8	CD
cord-023095-4dannjjm	575	4	and	and	CC
cord-023095-4dannjjm	575	5	MR	MR	NNP
cord-023095-4dannjjm	575	6	)	)	-RRB-
cord-023095-4dannjjm	575	7	.	.	.
cord-023095-4dannjjm	576	1	Serum	serum	NN
cord-023095-4dannjjm	576	2	serotonin	serotonin	NN
cord-023095-4dannjjm	576	3	concentrations	concentration	NNS
cord-023095-4dannjjm	576	4	were	be	VBD
cord-023095-4dannjjm	576	5	measured	measure	VBN
cord-023095-4dannjjm	576	6	by	by	IN
cord-023095-4dannjjm	576	7	ELISA	ELISA	NNP
cord-023095-4dannjjm	576	8	.	.	.
cord-023095-4dannjjm	577	1	An	an	DT
cord-023095-4dannjjm	577	2	overall	overall	JJ
cord-023095-4dannjjm	577	3	significant	significant	JJ
cord-023095-4dannjjm	577	4	difference	difference	NN
cord-023095-4dannjjm	577	5	(	(	-LRB-
cord-023095-4dannjjm	577	6	P	p	NN
cord-023095-4dannjjm	577	7	o	o	NN
cord-023095-4dannjjm	577	8	.05	.05	NFP
cord-023095-4dannjjm	577	9	)	)	-RRB-
cord-023095-4dannjjm	577	10	was	be	VBD
cord-023095-4dannjjm	577	11	found	find	VBN
cord-023095-4dannjjm	577	12	among	among	IN
cord-023095-4dannjjm	577	13	4	4	CD
cord-023095-4dannjjm	577	14	groups	group	NNS
cord-023095-4dannjjm	577	15	and	and	CC
cord-023095-4dannjjm	577	16	5HT	5ht	NN
cord-023095-4dannjjm	577	17	concentrations	concentration	NNS
cord-023095-4dannjjm	577	18	(	(	-LRB-
cord-023095-4dannjjm	577	19	control	control	NN
cord-023095-4dannjjm	577	20	,	,	,
cord-023095-4dannjjm	577	21	72.38	72.38	CD
cord-023095-4dannjjm	577	22	ng	ng	NN
cord-023095-4dannjjm	577	23	/	/	SYM
cord-023095-4dannjjm	577	24	ml	ml	NNP
cord-023095-4dannjjm	577	25	[	[	-LRB-
cord-023095-4dannjjm	577	26	51.34	51.34	CD
cord-023095-4dannjjm	577	27	-	-	HYPH
cord-023095-4dannjjm	577	28	95.11	95.11	CD
cord-023095-4dannjjm	577	29	DMVD	DMVD	NNS
cord-023095-4dannjjm	577	30	,	,	,
cord-023095-4dannjjm	577	31	)	)	-RRB-
cord-023095-4dannjjm	577	32	.	.	.
cord-023095-4dannjjm	578	1	Significantly	significantly	RB
cord-023095-4dannjjm	578	2	higher	high	JJR
cord-023095-4dannjjm	578	3	5HT	5ht	NN
cord-023095-4dannjjm	578	4	concentrations	concentration	NNS
cord-023095-4dannjjm	578	5	were	be	VBD
cord-023095-4dannjjm	578	6	observed	observe	VBN
cord-023095-4dannjjm	578	7	in	in	IN
cord-023095-4dannjjm	578	8	dogs	dog	NNS
cord-023095-4dannjjm	578	9	with	with	IN
cord-023095-4dannjjm	578	10	moderate	moderate	JJ
cord-023095-4dannjjm	578	11	(	(	-LRB-
cord-023095-4dannjjm	578	12	P	p	NN
cord-023095-4dannjjm	578	13	o	o	NN
cord-023095-4dannjjm	578	14	.05	.05	NFP
cord-023095-4dannjjm	578	15	)	)	-RRB-
cord-023095-4dannjjm	578	16	and	and	CC
cord-023095-4dannjjm	578	17	severe	severe	JJ
cord-023095-4dannjjm	578	18	(	(	-LRB-
cord-023095-4dannjjm	578	19	P	p	NN
cord-023095-4dannjjm	578	20	o	o	NN
cord-023095-4dannjjm	578	21	.05	.05	NFP
cord-023095-4dannjjm	578	22	)	)	-RRB-
cord-023095-4dannjjm	578	23	DMVD	DMVD	NNS
cord-023095-4dannjjm	578	24	,	,	,
cord-023095-4dannjjm	578	25	compared	compare	VBN
cord-023095-4dannjjm	578	26	with	with	IN
cord-023095-4dannjjm	578	27	concentration	concentration	NN
cord-023095-4dannjjm	578	28	in	in	IN
cord-023095-4dannjjm	578	29	control	control	NN
cord-023095-4dannjjm	578	30	group	group	NN
cord-023095-4dannjjm	578	31	.	.	.
cord-023095-4dannjjm	579	1	Additionally	additionally	RB
cord-023095-4dannjjm	579	2	,	,	,
cord-023095-4dannjjm	579	3	5HT	5ht	NN
cord-023095-4dannjjm	579	4	concentration	concentration	NN
cord-023095-4dannjjm	579	5	in	in	IN
cord-023095-4dannjjm	579	6	dogs	dog	NNS
cord-023095-4dannjjm	579	7	with	with	IN
cord-023095-4dannjjm	579	8	moderate	moderate	JJ
cord-023095-4dannjjm	579	9	DMVD	DMVD	NNS
cord-023095-4dannjjm	579	10	were	be	VBD
cord-023095-4dannjjm	579	11	significantly	significantly	RB
cord-023095-4dannjjm	579	12	higher	high	JJR
cord-023095-4dannjjm	580	1	(	(	-LRB-
cord-023095-4dannjjm	580	2	P	p	NN
cord-023095-4dannjjm	580	3	o	o	NN
cord-023095-4dannjjm	580	4	.05	.05	NFP
cord-023095-4dannjjm	580	5	)	)	-RRB-
cord-023095-4dannjjm	580	6	than	than	IN
cord-023095-4dannjjm	580	7	concentration	concentration	NN
cord-023095-4dannjjm	580	8	in	in	IN
cord-023095-4dannjjm	580	9	dogs	dog	NNS
cord-023095-4dannjjm	580	10	with	with	IN
cord-023095-4dannjjm	580	11	mild	mild	JJ
cord-023095-4dannjjm	580	12	DMVD	DMVD	NNS
cord-023095-4dannjjm	580	13	.	.	.
cord-023095-4dannjjm	581	1	Also	also	RB
cord-023095-4dannjjm	581	2	,	,	,
cord-023095-4dannjjm	581	3	dogs	dog	NNS
cord-023095-4dannjjm	581	4	with	with	IN
cord-023095-4dannjjm	581	5	severe	severe	JJ
cord-023095-4dannjjm	581	6	DMVD	DMVD	NNS
cord-023095-4dannjjm	581	7	had	have	VBD
cord-023095-4dannjjm	581	8	significantly	significantly	RB
cord-023095-4dannjjm	581	9	higher	high	JJR
cord-023095-4dannjjm	581	10	5HT	5ht	NN
cord-023095-4dannjjm	581	11	concentration	concentration	NN
cord-023095-4dannjjm	581	12	than	than	IN
cord-023095-4dannjjm	581	13	dogs	dog	NNS
cord-023095-4dannjjm	581	14	with	with	IN
cord-023095-4dannjjm	581	15	mild	mild	JJ
cord-023095-4dannjjm	581	16	(	(	-LRB-
cord-023095-4dannjjm	581	17	P	p	NN
cord-023095-4dannjjm	581	18	o	o	NN
cord-023095-4dannjjm	581	19	.05	.05	NFP
cord-023095-4dannjjm	581	20	)	)	-RRB-
cord-023095-4dannjjm	581	21	and	and	CC
cord-023095-4dannjjm	581	22	moderate	moderate	JJ
cord-023095-4dannjjm	581	23	(	(	-LRB-
cord-023095-4dannjjm	581	24	P	p	NN
cord-023095-4dannjjm	581	25	o	o	NN
cord-023095-4dannjjm	581	26	.05	.05	NFP
cord-023095-4dannjjm	581	27	)	)	-RRB-
cord-023095-4dannjjm	581	28	DMVD	DMVD	NNS
cord-023095-4dannjjm	581	29	.	.	.
cord-023095-4dannjjm	582	1	There	there	EX
cord-023095-4dannjjm	582	2	was	be	VBD
cord-023095-4dannjjm	582	3	no	no	DT
cord-023095-4dannjjm	582	4	significant	significant	JJ
cord-023095-4dannjjm	582	5	association	association	NN
cord-023095-4dannjjm	582	6	of	of	IN
cord-023095-4dannjjm	582	7	age	age	NN
cord-023095-4dannjjm	582	8	,	,	,
cord-023095-4dannjjm	582	9	platelet	platelet	NN
cord-023095-4dannjjm	582	10	,	,	,
cord-023095-4dannjjm	582	11	and	and	CC
cord-023095-4dannjjm	582	12	LVIDd	LVIDd	NNP
cord-023095-4dannjjm	582	13	,	,	,
cord-023095-4dannjjm	582	14	on	on	IN
cord-023095-4dannjjm	582	15	serum	serum	NN
cord-023095-4dannjjm	582	16	5HT	5ht	NN
cord-023095-4dannjjm	582	17	concentration	concentration	NN
cord-023095-4dannjjm	582	18	,	,	,
cord-023095-4dannjjm	582	19	however	however	RB
cord-023095-4dannjjm	582	20	,	,	,
cord-023095-4dannjjm	582	21	weak	weak	JJ
cord-023095-4dannjjm	582	22	correlation	correlation	NN
cord-023095-4dannjjm	582	23	between	between	IN
cord-023095-4dannjjm	582	24	serum	serum	NN
cord-023095-4dannjjm	582	25	5HT	5ht	NN
cord-023095-4dannjjm	582	26	increased	increase	VBD
cord-023095-4dannjjm	582	27	significantly	significantly	RB
cord-023095-4dannjjm	582	28	and	and	CC
cord-023095-4dannjjm	582	29	LA	LA	NNP
cord-023095-4dannjjm	582	30	:	:	:
cord-023095-4dannjjm	583	1	Ao	Ao	NNP
cord-023095-4dannjjm	583	2	ratio	ratio	NN
cord-023095-4dannjjm	583	3	(	(	-LRB-
cord-023095-4dannjjm	583	4	R	r	NN
cord-023095-4dannjjm	583	5	2	2	CD
cord-023095-4dannjjm	583	6	5	5	CD
cord-023095-4dannjjm	583	7	.211	.211	CD
cord-023095-4dannjjm	583	8	,	,	,
cord-023095-4dannjjm	584	1	P	p	NN
cord-023095-4dannjjm	584	2	o	o	NN
cord-023095-4dannjjm	584	3	.05	.05	NFP
cord-023095-4dannjjm	584	4	)	)	-RRB-
cord-023095-4dannjjm	584	5	was	be	VBD
cord-023095-4dannjjm	584	6	observed	observe	VBN
cord-023095-4dannjjm	584	7	.	.	.
cord-023095-4dannjjm	585	1	The	the	DT
cord-023095-4dannjjm	585	2	results	result	NNS
cord-023095-4dannjjm	585	3	of	of	IN
cord-023095-4dannjjm	585	4	this	this	DT
cord-023095-4dannjjm	585	5	study	study	NN
cord-023095-4dannjjm	585	6	indicate	indicate	VBP
cord-023095-4dannjjm	585	7	that	that	IN
cord-023095-4dannjjm	585	8	serum	serum	NN
cord-023095-4dannjjm	585	9	5HT	5ht	NN
cord-023095-4dannjjm	585	10	concentrations	concentration	NNS
cord-023095-4dannjjm	585	11	were	be	VBD
cord-023095-4dannjjm	585	12	higher	high	JJR
cord-023095-4dannjjm	585	13	with	with	IN
cord-023095-4dannjjm	585	14	increasing	increase	VBG
cord-023095-4dannjjm	585	15	severity	severity	NN
cord-023095-4dannjjm	585	16	of	of	IN
cord-023095-4dannjjm	585	17	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	585	18	DMVD	DMVD	NNS
cord-023095-4dannjjm	585	19	,	,	,
cord-023095-4dannjjm	585	20	which	which	WDT
cord-023095-4dannjjm	585	21	may	may	MD
cord-023095-4dannjjm	585	22	be	be	VB
cord-023095-4dannjjm	585	23	the	the	DT
cord-023095-4dannjjm	585	24	potential	potential	JJ
cord-023095-4dannjjm	585	25	cause	cause	NN
cord-023095-4dannjjm	585	26	to	to	TO
cord-023095-4dannjjm	585	27	advance	advance	VB
cord-023095-4dannjjm	585	28	the	the	DT
cord-023095-4dannjjm	585	29	progression	progression	NN
cord-023095-4dannjjm	585	30	of	of	IN
cord-023095-4dannjjm	585	31	DMVD	DMVD	NNP
cord-023095-4dannjjm	585	32	.	.	.
cord-023095-4dannjjm	586	1	Further	further	JJ
cord-023095-4dannjjm	586	2	studies	study	NNS
cord-023095-4dannjjm	586	3	should	should	MD
cord-023095-4dannjjm	586	4	be	be	VB
cord-023095-4dannjjm	586	5	performed	perform	VBN
cord-023095-4dannjjm	586	6	to	to	TO
cord-023095-4dannjjm	586	7	reveal	reveal	VB
cord-023095-4dannjjm	586	8	the	the	DT
cord-023095-4dannjjm	586	9	role	role	NN
cord-023095-4dannjjm	586	10	of	of	IN
cord-023095-4dannjjm	586	11	5HT	5ht	NN
cord-023095-4dannjjm	586	12	in	in	IN
cord-023095-4dannjjm	586	13	inducing	induce	VBG
cord-023095-4dannjjm	586	14	and	and	CC
cord-023095-4dannjjm	586	15	accelerating	accelerate	VBG
cord-023095-4dannjjm	586	16	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	586	17	DMVD	DMVD	NNS
cord-023095-4dannjjm	586	18	and	and	CC
cord-023095-4dannjjm	586	19	to	to	TO
cord-023095-4dannjjm	586	20	investigate	investigate	VB
cord-023095-4dannjjm	586	21	if	if	IN
cord-023095-4dannjjm	586	22	lowering	lower	VBG
cord-023095-4dannjjm	586	23	serum	serum	NN
cord-023095-4dannjjm	586	24	5HT	5ht	NN
cord-023095-4dannjjm	586	25	concentration	concentration	NN
cord-023095-4dannjjm	586	26	could	could	MD
cord-023095-4dannjjm	586	27	alter	alter	VB
cord-023095-4dannjjm	586	28	the	the	DT
cord-023095-4dannjjm	586	29	progression	progression	NN
cord-023095-4dannjjm	586	30	of	of	IN
cord-023095-4dannjjm	586	31	DMVD	DMVD	NNS
cord-023095-4dannjjm	586	32	.	.	.
cord-023095-4dannjjm	587	1	The	the	DT
cord-023095-4dannjjm	587	2	objective	objective	NN
cord-023095-4dannjjm	587	3	of	of	IN
cord-023095-4dannjjm	587	4	this	this	DT
cord-023095-4dannjjm	587	5	prospective	prospective	JJ
cord-023095-4dannjjm	587	6	study	study	NN
cord-023095-4dannjjm	587	7	was	be	VBD
cord-023095-4dannjjm	587	8	to	to	TO
cord-023095-4dannjjm	587	9	evaluate	evaluate	VB
cord-023095-4dannjjm	587	10	the	the	DT
cord-023095-4dannjjm	587	11	utility	utility	NN
cord-023095-4dannjjm	587	12	of	of	IN
cord-023095-4dannjjm	587	13	cardiac	cardiac	NN
cord-023095-4dannjjm	587	14	troponin	troponin	NN
cord-023095-4dannjjm	587	15	I	-PRON-	PRP
cord-023095-4dannjjm	587	16	(	(	-LRB-
cord-023095-4dannjjm	587	17	cTnI	cTnI	NNP
cord-023095-4dannjjm	587	18	)	)	-RRB-
cord-023095-4dannjjm	587	19	in	in	IN
cord-023095-4dannjjm	587	20	differentiating	differentiate	VBG
cord-023095-4dannjjm	587	21	between	between	IN
cord-023095-4dannjjm	587	22	underlying	underlying	JJ
cord-023095-4dannjjm	587	23	etiologies	etiology	NNS
cord-023095-4dannjjm	587	24	of	of	IN
cord-023095-4dannjjm	587	25	pericardial	pericardial	JJ
cord-023095-4dannjjm	587	26	effusion	effusion	NN
cord-023095-4dannjjm	587	27	in	in	IN
cord-023095-4dannjjm	587	28	the	the	DT
cord-023095-4dannjjm	587	29	canine	canine	JJ
cord-023095-4dannjjm	587	30	patient	patient	NN
cord-023095-4dannjjm	587	31	.	.	.
cord-023095-4dannjjm	588	1	Patients	patient	NNS
cord-023095-4dannjjm	588	2	were	be	VBD
cord-023095-4dannjjm	588	3	prospectively	prospectively	RB
cord-023095-4dannjjm	588	4	recruited	recruit	VBN
cord-023095-4dannjjm	588	5	at	at	IN
cord-023095-4dannjjm	588	6	time	time	NN
cord-023095-4dannjjm	588	7	of	of	IN
cord-023095-4dannjjm	588	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	588	9	of	of	IN
cord-023095-4dannjjm	588	10	novel	novel	JJ
cord-023095-4dannjjm	588	11	pericardial	pericardial	JJ
cord-023095-4dannjjm	588	12	effusion	effusion	NN
cord-023095-4dannjjm	588	13	.	.	.
cord-023095-4dannjjm	589	1	Serum	serum	NN
cord-023095-4dannjjm	589	2	samples	sample	NNS
cord-023095-4dannjjm	589	3	were	be	VBD
cord-023095-4dannjjm	589	4	collected	collect	VBN
cord-023095-4dannjjm	589	5	prior	prior	RB
cord-023095-4dannjjm	589	6	to	to	IN
cord-023095-4dannjjm	589	7	pericardiocentesis	pericardiocentesis	NN
cord-023095-4dannjjm	589	8	.	.	.
cord-023095-4dannjjm	590	1	Patients	patient	NNS
cord-023095-4dannjjm	590	2	were	be	VBD
cord-023095-4dannjjm	590	3	evaluated	evaluate	VBN
cord-023095-4dannjjm	590	4	by	by	IN
cord-023095-4dannjjm	590	5	echocardiography	echocardiography	NN
cord-023095-4dannjjm	590	6	and	and	CC
cord-023095-4dannjjm	590	7	classified	classify	VBN
cord-023095-4dannjjm	590	8	with	with	IN
cord-023095-4dannjjm	590	9	the	the	DT
cord-023095-4dannjjm	590	10	diagnosis	diagnosis	NN
cord-023095-4dannjjm	590	11	of	of	IN
cord-023095-4dannjjm	590	12	hemangiosarcoma	hemangiosarcoma	NN
cord-023095-4dannjjm	590	13	(	(	-LRB-
cord-023095-4dannjjm	590	14	HSA	HSA	NNP
cord-023095-4dannjjm	590	15	)	)	-RRB-
cord-023095-4dannjjm	590	16	,	,	,
cord-023095-4dannjjm	590	17	heart	heart	NN
cord-023095-4dannjjm	590	18	base	base	NN
cord-023095-4dannjjm	590	19	tumor	tumor	NN
cord-023095-4dannjjm	590	20	(	(	-LRB-
cord-023095-4dannjjm	590	21	HBT	HBT	NNP
cord-023095-4dannjjm	590	22	)	)	-RRB-
cord-023095-4dannjjm	590	23	,	,	,
cord-023095-4dannjjm	590	24	or	or	CC
cord-023095-4dannjjm	590	25	unknown	unknown	JJ
cord-023095-4dannjjm	590	26	etiology	etiology	NN
cord-023095-4dannjjm	590	27	at	at	IN
cord-023095-4dannjjm	590	28	the	the	DT
cord-023095-4dannjjm	590	29	initial	initial	JJ
cord-023095-4dannjjm	590	30	evaluation	evaluation	NN
cord-023095-4dannjjm	590	31	based	base	VBN
cord-023095-4dannjjm	590	32	on	on	IN
cord-023095-4dannjjm	590	33	established	establish	VBN
cord-023095-4dannjjm	590	34	characteristic	characteristic	JJ
cord-023095-4dannjjm	590	35	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	590	36	findings	finding	NNS
cord-023095-4dannjjm	590	37	.	.	.
cord-023095-4dannjjm	591	1	Idiopathic	idiopathic	JJ
cord-023095-4dannjjm	591	2	pericardial	pericardial	JJ
cord-023095-4dannjjm	591	3	effusion	effusion	NN
cord-023095-4dannjjm	591	4	(	(	-LRB-
cord-023095-4dannjjm	591	5	IPE	IPE	NNP
cord-023095-4dannjjm	591	6	)	)	-RRB-
cord-023095-4dannjjm	591	7	was	be	VBD
cord-023095-4dannjjm	591	8	defined	define	VBN
cord-023095-4dannjjm	591	9	by	by	IN
cord-023095-4dannjjm	591	10	histopathology	histopathology	NN
cord-023095-4dannjjm	591	11	,	,	,
cord-023095-4dannjjm	591	12	echonegative	echonegative	NNP
cord-023095-4dannjjm	591	13	for	for	IN
cord-023095-4dannjjm	591	14	a	a	DT
cord-023095-4dannjjm	591	15	mass	mass	JJ
cord-023095-4dannjjm	591	16	lesion	lesion	NN
cord-023095-4dannjjm	591	17	with	with	IN
cord-023095-4dannjjm	591	18	no	no	DT
cord-023095-4dannjjm	591	19	recurrence	recurrence	NN
cord-023095-4dannjjm	591	20	of	of	IN
cord-023095-4dannjjm	591	21	pericardial	pericardial	JJ
cord-023095-4dannjjm	591	22	effusion	effusion	NN
cord-023095-4dannjjm	591	23	46	46	CD
cord-023095-4dannjjm	591	24	months	month	NNS
cord-023095-4dannjjm	591	25	,	,	,
cord-023095-4dannjjm	591	26	or	or	CC
cord-023095-4dannjjm	591	27	symptom	symptom	NN
cord-023095-4dannjjm	591	28	free	free	JJ
cord-023095-4dannjjm	591	29	412	412	CD
cord-023095-4dannjjm	591	30	months	month	NNS
cord-023095-4dannjjm	591	31	from	from	IN
cord-023095-4dannjjm	591	32	time	time	NN
cord-023095-4dannjjm	591	33	of	of	IN
cord-023095-4dannjjm	591	34	enrollment	enrollment	NN
cord-023095-4dannjjm	591	35	.	.	.
cord-023095-4dannjjm	592	1	Patients	patient	NNS
cord-023095-4dannjjm	592	2	were	be	VBD
cord-023095-4dannjjm	592	3	excluded	exclude	VBN
cord-023095-4dannjjm	592	4	from	from	IN
cord-023095-4dannjjm	592	5	analysis	analysis	NN
cord-023095-4dannjjm	592	6	if	if	IN
cord-023095-4dannjjm	592	7	a	a	DT
cord-023095-4dannjjm	592	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	592	9	could	could	MD
cord-023095-4dannjjm	592	10	not	not	RB
cord-023095-4dannjjm	592	11	be	be	VB
cord-023095-4dannjjm	592	12	established	establish	VBN
cord-023095-4dannjjm	592	13	based	base	VBN
cord-023095-4dannjjm	592	14	on	on	IN
cord-023095-4dannjjm	592	15	above	above	JJ
cord-023095-4dannjjm	592	16	criteria	criterion	NNS
cord-023095-4dannjjm	592	17	or	or	CC
cord-023095-4dannjjm	592	18	concurrent	concurrent	JJ
cord-023095-4dannjjm	592	19	moderate	moderate	JJ
cord-023095-4dannjjm	592	20	azotemia	azotemia	NN
cord-023095-4dannjjm	592	21	(	(	-LRB-
cord-023095-4dannjjm	592	22	Creatinine	creatinine	NN
cord-023095-4dannjjm	592	23	43.0	43.0	CD
cord-023095-4dannjjm	592	24	mg	mg	NNP
cord-023095-4dannjjm	592	25	/	/	SYM
cord-023095-4dannjjm	592	26	dL	dL	NNP
cord-023095-4dannjjm	592	27	)	)	-RRB-
cord-023095-4dannjjm	592	28	was	be	VBD
cord-023095-4dannjjm	592	29	present	present	JJ
cord-023095-4dannjjm	592	30	at	at	IN
cord-023095-4dannjjm	592	31	time	time	NN
cord-023095-4dannjjm	592	32	of	of	IN
cord-023095-4dannjjm	592	33	sample	sample	NN
cord-023095-4dannjjm	592	34	collection	collection	NN
cord-023095-4dannjjm	592	35	.	.	.
cord-023095-4dannjjm	593	1	Serum	serum	NN
cord-023095-4dannjjm	593	2	samples	sample	NNS
cord-023095-4dannjjm	593	3	were	be	VBD
cord-023095-4dannjjm	593	4	frozen	freeze	VBN
cord-023095-4dannjjm	593	5	and	and	CC
cord-023095-4dannjjm	593	6	analyzed	analyze	VBN
cord-023095-4dannjjm	593	7	in	in	IN
cord-023095-4dannjjm	593	8	batches	batch	NNS
cord-023095-4dannjjm	593	9	within	within	IN
cord-023095-4dannjjm	593	10	60	60	CD
cord-023095-4dannjjm	593	11	days	day	NNS
cord-023095-4dannjjm	593	12	of	of	IN
cord-023095-4dannjjm	593	13	collection	collection	NN
cord-023095-4dannjjm	593	14	by	by	IN
cord-023095-4dannjjm	593	15	a	a	DT
cord-023095-4dannjjm	593	16	cTnI	ctni	JJ
cord-023095-4dannjjm	593	17	assay	assay	NN
cord-023095-4dannjjm	593	18	with	with	IN
cord-023095-4dannjjm	593	19	a	a	DT
cord-023095-4dannjjm	593	20	0.2ng	0.2ng	CD
cord-023095-4dannjjm	593	21	/	/	SYM
cord-023095-4dannjjm	593	22	mL	ml	NN
cord-023095-4dannjjm	593	23	lower	low	JJR
cord-023095-4dannjjm	593	24	limit	limit	NN
cord-023095-4dannjjm	593	25	sensitivity	sensitivity	NN
cord-023095-4dannjjm	593	26	.	.	.
cord-023095-4dannjjm	594	1	Sixty	sixty	CD
cord-023095-4dannjjm	594	2	-	-	HYPH
cord-023095-4dannjjm	594	3	three	three	CD
cord-023095-4dannjjm	594	4	patients	patient	NNS
cord-023095-4dannjjm	594	5	were	be	VBD
cord-023095-4dannjjm	594	6	recruited	recruit	VBN
cord-023095-4dannjjm	594	7	over	over	IN
cord-023095-4dannjjm	594	8	a	a	DT
cord-023095-4dannjjm	594	9	one	one	CD
cord-023095-4dannjjm	594	10	year	year	NN
cord-023095-4dannjjm	594	11	period	period	NN
cord-023095-4dannjjm	594	12	with	with	IN
cord-023095-4dannjjm	594	13	15	15	CD
cord-023095-4dannjjm	594	14	patients	patient	NNS
cord-023095-4dannjjm	594	15	excluded	exclude	VBN
cord-023095-4dannjjm	594	16	due	due	IN
cord-023095-4dannjjm	594	17	to	to	IN
cord-023095-4dannjjm	594	18	lack	lack	NN
cord-023095-4dannjjm	594	19	of	of	IN
cord-023095-4dannjjm	594	20	diagnosis	diagnosis	NN
cord-023095-4dannjjm	594	21	(	(	-LRB-
cord-023095-4dannjjm	594	22	13	13	CD
cord-023095-4dannjjm	594	23	)	)	-RRB-
cord-023095-4dannjjm	594	24	or	or	CC
cord-023095-4dannjjm	594	25	azotemia	azotemia	NNP
cord-023095-4dannjjm	594	26	(	(	-LRB-
cord-023095-4dannjjm	594	27	2	2	CD
cord-023095-4dannjjm	594	28	)	)	-RRB-
cord-023095-4dannjjm	594	29	.	.	.
cord-023095-4dannjjm	595	1	Median	median	JJ
cord-023095-4dannjjm	595	2	cTnI	ctni	JJ
cord-023095-4dannjjm	595	3	levels	level	NNS
cord-023095-4dannjjm	595	4	of	of	IN
cord-023095-4dannjjm	595	5	dogs	dog	NNS
cord-023095-4dannjjm	595	6	with	with	IN
cord-023095-4dannjjm	595	7	HSA	HSA	NNP
cord-023095-4dannjjm	595	8	(	(	-LRB-
cord-023095-4dannjjm	595	9	n	n	NN
cord-023095-4dannjjm	595	10	5	5	CD
cord-023095-4dannjjm	595	11	24	24	CD
cord-023095-4dannjjm	595	12	)	)	-RRB-
cord-023095-4dannjjm	595	13	,	,	,
cord-023095-4dannjjm	595	14	HBT	HBT	NNP
cord-023095-4dannjjm	595	15	(	(	-LRB-
cord-023095-4dannjjm	595	16	n	n	NN
cord-023095-4dannjjm	595	17	5	5	CD
cord-023095-4dannjjm	595	18	19	19	CD
cord-023095-4dannjjm	595	19	)	)	-RRB-
cord-023095-4dannjjm	595	20	,	,	,
cord-023095-4dannjjm	595	21	and	and	CC
cord-023095-4dannjjm	595	22	IPE	IPE	NNP
cord-023095-4dannjjm	595	23	(	(	-LRB-
cord-023095-4dannjjm	595	24	n	n	NN
cord-023095-4dannjjm	595	25	5	5	CD
cord-023095-4dannjjm	595	26	5	5	CD
cord-023095-4dannjjm	595	27	)	)	-RRB-
cord-023095-4dannjjm	595	28	were	be	VBD
cord-023095-4dannjjm	595	29	14.8	14.8	CD
cord-023095-4dannjjm	595	30	ng	ng	NN
cord-023095-4dannjjm	595	31	/	/	SYM
cord-023095-4dannjjm	595	32	dL	dl	NN
cord-023095-4dannjjm	596	1	(	(	-LRB-
cord-023095-4dannjjm	596	2	interquartile	interquartile	JJ
cord-023095-4dannjjm	596	3	range	range	NN
cord-023095-4dannjjm	596	4	(	(	-LRB-
cord-023095-4dannjjm	596	5	IQR	iqr	NN
cord-023095-4dannjjm	596	6	)	)	-RRB-
cord-023095-4dannjjm	597	1	o	o	LS
cord-023095-4dannjjm	597	2	0.2	0.2	CD
cord-023095-4dannjjm	597	3	-	-	HYPH
cord-023095-4dannjjm	597	4	11.3	11.3	CD
cord-023095-4dannjjm	597	5	)	)	-RRB-
cord-023095-4dannjjm	597	6	,	,	,
cord-023095-4dannjjm	597	7	0.23	0.23	CD
cord-023095-4dannjjm	597	8	ng	ng	NN
cord-023095-4dannjjm	597	9	/	/	SYM
cord-023095-4dannjjm	597	10	dL	dl	NN
cord-023095-4dannjjm	598	1	(	(	-LRB-
cord-023095-4dannjjm	598	2	IQR	IQR	NNP
cord-023095-4dannjjm	598	3	o	o	NNP
cord-023095-4dannjjm	598	4	0.2	0.2	CD
cord-023095-4dannjjm	598	5	-	-	HYPH
cord-023095-4dannjjm	598	6	0.29	0.29	CD
cord-023095-4dannjjm	598	7	)	)	-RRB-
cord-023095-4dannjjm	598	8	,	,	,
cord-023095-4dannjjm	598	9	and	and	CC
cord-023095-4dannjjm	598	10	o	o	NN
cord-023095-4dannjjm	598	11	0.2	0.2	CD
cord-023095-4dannjjm	598	12	ng	ng	NN
cord-023095-4dannjjm	598	13	/	/	SYM
cord-023095-4dannjjm	598	14	dL	dl	NN
cord-023095-4dannjjm	599	1	(	(	-LRB-
cord-023095-4dannjjm	599	2	IQR	IQR	NNP
cord-023095-4dannjjm	599	3	o	o	NNP
cord-023095-4dannjjm	599	4	0.2-o	0.2-o	CD
cord-023095-4dannjjm	599	5	0.2	0.2	CD
cord-023095-4dannjjm	599	6	)	)	-RRB-
cord-023095-4dannjjm	599	7	respectively	respectively	RB
cord-023095-4dannjjm	599	8	.	.	.
cord-023095-4dannjjm	600	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	600	2	of	of	IN
cord-023095-4dannjjm	600	3	cTnI	cTnI	NNP
cord-023095-4dannjjm	600	4	differed	differ	VBD
cord-023095-4dannjjm	600	5	significantly	significantly	RB
cord-023095-4dannjjm	600	6	between	between	IN
cord-023095-4dannjjm	600	7	dogs	dog	NNS
cord-023095-4dannjjm	600	8	with	with	IN
cord-023095-4dannjjm	600	9	HSA	HSA	NNP
cord-023095-4dannjjm	600	10	and	and	CC
cord-023095-4dannjjm	600	11	HBT	HBT	NNP
cord-023095-4dannjjm	600	12	(	(	-LRB-
cord-023095-4dannjjm	600	13	p	p	NN
cord-023095-4dannjjm	600	14	5	5	CD
cord-023095-4dannjjm	600	15	0.001	0.001	CD
cord-023095-4dannjjm	600	16	)	)	-RRB-
cord-023095-4dannjjm	600	17	and	and	CC
cord-023095-4dannjjm	600	18	IPE	IPE	NNP
cord-023095-4dannjjm	600	19	(	(	-LRB-
cord-023095-4dannjjm	600	20	p	p	NN
cord-023095-4dannjjm	600	21	5	5	CD
cord-023095-4dannjjm	600	22	0.0029	0.0029	CD
cord-023095-4dannjjm	600	23	)	)	-RRB-
cord-023095-4dannjjm	600	24	.	.	.
cord-023095-4dannjjm	601	1	There	there	EX
cord-023095-4dannjjm	601	2	was	be	VBD
cord-023095-4dannjjm	601	3	no	no	DT
cord-023095-4dannjjm	601	4	difference	difference	NN
cord-023095-4dannjjm	601	5	between	between	IN
cord-023095-4dannjjm	601	6	cTnI	cTnI	NNP
cord-023095-4dannjjm	601	7	concentrations	concentration	NNS
cord-023095-4dannjjm	601	8	between	between	IN
cord-023095-4dannjjm	601	9	HBT	HBT	NNP
cord-023095-4dannjjm	601	10	and	and	CC
cord-023095-4dannjjm	601	11	IPE	IPE	NNP
cord-023095-4dannjjm	601	12	dogs	dog	NNS
cord-023095-4dannjjm	601	13	(	(	-LRB-
cord-023095-4dannjjm	601	14	p	p	NN
cord-023095-4dannjjm	601	15	5	5	CD
cord-023095-4dannjjm	601	16	0.911	0.911	CD
cord-023095-4dannjjm	601	17	)	)	-RRB-
cord-023095-4dannjjm	601	18	.	.	.
cord-023095-4dannjjm	602	1	Receiver	receiver	NN
cord-023095-4dannjjm	602	2	operating	operating	NN
cord-023095-4dannjjm	602	3	curve	curve	NN
cord-023095-4dannjjm	602	4	analysis	analysis	NN
cord-023095-4dannjjm	602	5	to	to	TO
cord-023095-4dannjjm	602	6	determine	determine	VB
cord-023095-4dannjjm	602	7	the	the	DT
cord-023095-4dannjjm	602	8	optimal	optimal	JJ
cord-023095-4dannjjm	602	9	cutoff	cutoff	NN
cord-023095-4dannjjm	602	10	for	for	IN
cord-023095-4dannjjm	602	11	differentiation	differentiation	NN
cord-023095-4dannjjm	602	12	of	of	IN
cord-023095-4dannjjm	602	13	dogs	dog	NNS
cord-023095-4dannjjm	602	14	affected	affect	VBN
cord-023095-4dannjjm	602	15	with	with	IN
cord-023095-4dannjjm	602	16	HSA	HSA	NNP
cord-023095-4dannjjm	602	17	and	and	CC
cord-023095-4dannjjm	602	18	both	both	DT
cord-023095-4dannjjm	602	19	HBT	HBT	NNP
cord-023095-4dannjjm	602	20	and	and	CC
cord-023095-4dannjjm	602	21	IPE	IPE	NNP
cord-023095-4dannjjm	602	22	revealed	reveal	VBD
cord-023095-4dannjjm	602	23	a	a	DT
cord-023095-4dannjjm	602	24	significant	significant	JJ
cord-023095-4dannjjm	602	25	(	(	-LRB-
cord-023095-4dannjjm	602	26	p	p	NN
cord-023095-4dannjjm	602	27	5	5	CD
cord-023095-4dannjjm	602	28	o	o	NN
cord-023095-4dannjjm	602	29	0.001	0.001	CD
cord-023095-4dannjjm	602	30	)	)	-RRB-
cord-023095-4dannjjm	602	31	area	area	NN
cord-023095-4dannjjm	602	32	under	under	IN
cord-023095-4dannjjm	602	33	the	the	DT
cord-023095-4dannjjm	602	34	curve	curve	NN
cord-023095-4dannjjm	602	35	(	(	-LRB-
cord-023095-4dannjjm	602	36	0.79	0.79	CD
cord-023095-4dannjjm	602	37	)	)	-RRB-
cord-023095-4dannjjm	602	38	.	.	.
cord-023095-4dannjjm	603	1	A	a	DT
cord-023095-4dannjjm	603	2	cut	cut	VB
cord-023095-4dannjjm	603	3	-	-	HYPH
cord-023095-4dannjjm	603	4	off	off	RP
cord-023095-4dannjjm	603	5	point	point	NN
cord-023095-4dannjjm	603	6	of	of	IN
cord-023095-4dannjjm	603	7	cTnI	cTnI	NNP
cord-023095-4dannjjm	603	8	of	of	IN
cord-023095-4dannjjm	603	9	40.78	40.78	CD
cord-023095-4dannjjm	603	10	yielded	yield	VBD
cord-023095-4dannjjm	603	11	a	a	DT
cord-023095-4dannjjm	603	12	sensitivity	sensitivity	NN
cord-023095-4dannjjm	603	13	of	of	IN
cord-023095-4dannjjm	603	14	67	67	CD
cord-023095-4dannjjm	603	15	%	%	NN
cord-023095-4dannjjm	603	16	(	(	-LRB-
cord-023095-4dannjjm	603	17	95	95	CD
cord-023095-4dannjjm	603	18	%	%	NN
cord-023095-4dannjjm	603	19	CI	CI	NNP
cord-023095-4dannjjm	603	20	,	,	,
cord-023095-4dannjjm	603	21	45	45	CD
cord-023095-4dannjjm	603	22	-	-	SYM
cord-023095-4dannjjm	603	23	84	84	CD
cord-023095-4dannjjm	603	24	%	%	NN
cord-023095-4dannjjm	603	25	)	)	-RRB-
cord-023095-4dannjjm	603	26	and	and	CC
cord-023095-4dannjjm	603	27	specificity	specificity	NN
cord-023095-4dannjjm	603	28	of	of	IN
cord-023095-4dannjjm	603	29	95	95	CD
cord-023095-4dannjjm	603	30	%	%	NN
cord-023095-4dannjjm	603	31	(	(	-LRB-
cord-023095-4dannjjm	603	32	95	95	CD
cord-023095-4dannjjm	603	33	%	%	NN
cord-023095-4dannjjm	603	34	CI	CI	NNP
cord-023095-4dannjjm	603	35	,	,	,
cord-023095-4dannjjm	603	36	79	79	CD
cord-023095-4dannjjm	603	37	-	-	SYM
cord-023095-4dannjjm	603	38	99	99	CD
cord-023095-4dannjjm	603	39	%	%	NN
cord-023095-4dannjjm	603	40	)	)	-RRB-
cord-023095-4dannjjm	603	41	.	.	.
cord-023095-4dannjjm	604	1	Utilizing	utilize	VBG
cord-023095-4dannjjm	604	2	a	a	DT
cord-023095-4dannjjm	604	3	higher	high	JJR
cord-023095-4dannjjm	604	4	cut	cut	VBN
cord-023095-4dannjjm	604	5	-	-	HYPH
cord-023095-4dannjjm	604	6	off	off	RP
cord-023095-4dannjjm	604	7	point	point	NN
cord-023095-4dannjjm	604	8	of	of	IN
cord-023095-4dannjjm	604	9	43.0	43.0	CD
cord-023095-4dannjjm	604	10	yielded	yield	VBD
cord-023095-4dannjjm	604	11	a	a	DT
cord-023095-4dannjjm	604	12	lower	low	JJR
cord-023095-4dannjjm	604	13	sensitivity	sensitivity	NN
cord-023095-4dannjjm	604	14	of	of	IN
cord-023095-4dannjjm	604	15	50	50	CD
cord-023095-4dannjjm	604	16	%	%	NN
cord-023095-4dannjjm	604	17	(	(	-LRB-
cord-023095-4dannjjm	604	18	95	95	CD
cord-023095-4dannjjm	604	19	%	%	NN
cord-023095-4dannjjm	604	20	CI	CI	NNP
cord-023095-4dannjjm	604	21	,	,	,
cord-023095-4dannjjm	604	22	29	29	CD
cord-023095-4dannjjm	604	23	-	-	SYM
cord-023095-4dannjjm	604	24	71	71	CD
cord-023095-4dannjjm	604	25	%	%	NN
cord-023095-4dannjjm	604	26	)	)	-RRB-
cord-023095-4dannjjm	604	27	,	,	,
cord-023095-4dannjjm	604	28	but	but	CC
cord-023095-4dannjjm	604	29	a	a	DT
cord-023095-4dannjjm	604	30	higher	high	JJR
cord-023095-4dannjjm	604	31	specificity	specificity	NN
cord-023095-4dannjjm	604	32	of	of	IN
cord-023095-4dannjjm	604	33	100	100	CD
cord-023095-4dannjjm	604	34	%	%	NN
cord-023095-4dannjjm	604	35	(	(	-LRB-
cord-023095-4dannjjm	604	36	95	95	CD
cord-023095-4dannjjm	604	37	%	%	NN
cord-023095-4dannjjm	604	38	CI	CI	NNP
cord-023095-4dannjjm	604	39	,	,	,
cord-023095-4dannjjm	604	40	86	86	CD
cord-023095-4dannjjm	604	41	-	-	SYM
cord-023095-4dannjjm	604	42	100	100	CD
cord-023095-4dannjjm	604	43	%	%	NN
cord-023095-4dannjjm	604	44	)	)	-RRB-
cord-023095-4dannjjm	604	45	which	which	WDT
cord-023095-4dannjjm	604	46	may	may	MD
cord-023095-4dannjjm	604	47	have	have	VB
cord-023095-4dannjjm	604	48	more	more	RBR
cord-023095-4dannjjm	604	49	clinical	clinical	JJ
cord-023095-4dannjjm	604	50	utility	utility	NN
cord-023095-4dannjjm	604	51	given	give	VBN
cord-023095-4dannjjm	604	52	the	the	DT
cord-023095-4dannjjm	604	53	disparity	disparity	NN
cord-023095-4dannjjm	604	54	in	in	IN
cord-023095-4dannjjm	604	55	prognoses	prognosis	NNS
cord-023095-4dannjjm	604	56	of	of	IN
cord-023095-4dannjjm	604	57	the	the	DT
cord-023095-4dannjjm	604	58	etiologies	etiology	NNS
cord-023095-4dannjjm	604	59	compared	compare	VBN
cord-023095-4dannjjm	604	60	.	.	.
cord-023095-4dannjjm	605	1	In	in	IN
cord-023095-4dannjjm	605	2	conclusion	conclusion	NN
cord-023095-4dannjjm	605	3	,	,	,
cord-023095-4dannjjm	605	4	this	this	DT
cord-023095-4dannjjm	605	5	study	study	NN
cord-023095-4dannjjm	605	6	supports	support	VBZ
cord-023095-4dannjjm	605	7	the	the	DT
cord-023095-4dannjjm	605	8	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	605	9	utility	utility	NN
cord-023095-4dannjjm	605	10	of	of	IN
cord-023095-4dannjjm	605	11	cTnI	cTnI	NNP
cord-023095-4dannjjm	605	12	concentrations	concentration	NNS
cord-023095-4dannjjm	605	13	to	to	TO
cord-023095-4dannjjm	605	14	delineate	delineate	VB
cord-023095-4dannjjm	605	15	between	between	IN
cord-023095-4dannjjm	605	16	patients	patient	NNS
cord-023095-4dannjjm	605	17	with	with	IN
cord-023095-4dannjjm	605	18	HSA	HSA	NNP
cord-023095-4dannjjm	605	19	and	and	CC
cord-023095-4dannjjm	605	20	other	other	JJ
cord-023095-4dannjjm	605	21	etiologies	etiology	NNS
cord-023095-4dannjjm	605	22	of	of	IN
cord-023095-4dannjjm	605	23	pericardial	pericardial	JJ
cord-023095-4dannjjm	605	24	effusion	effusion	NN
cord-023095-4dannjjm	605	25	,	,	,
cord-023095-4dannjjm	605	26	but	but	CC
cord-023095-4dannjjm	605	27	does	do	VBZ
cord-023095-4dannjjm	605	28	not	not	RB
cord-023095-4dannjjm	605	29	reliably	reliably	RB
cord-023095-4dannjjm	605	30	differentiate	differentiate	VB
cord-023095-4dannjjm	605	31	between	between	IN
cord-023095-4dannjjm	605	32	dogs	dog	NNS
cord-023095-4dannjjm	605	33	with	with	IN
cord-023095-4dannjjm	605	34	IPE	IPE	NNP
cord-023095-4dannjjm	605	35	and	and	CC
cord-023095-4dannjjm	605	36	other	other	JJ
cord-023095-4dannjjm	605	37	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	605	38	etiologies	etiology	NNS
cord-023095-4dannjjm	605	39	.	.	.
cord-023095-4dannjjm	606	1	The	the	DT
cord-023095-4dannjjm	606	2	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	606	3	of	of	IN
cord-023095-4dannjjm	606	4	degenerative	degenerative	JJ
cord-023095-4dannjjm	606	5	mitral	mitral	JJ
cord-023095-4dannjjm	606	6	valve	valve	NN
cord-023095-4dannjjm	606	7	disease	disease	NN
cord-023095-4dannjjm	606	8	(	(	-LRB-
cord-023095-4dannjjm	606	9	DMVD	DMVD	NNP
cord-023095-4dannjjm	606	10	)	)	-RRB-
cord-023095-4dannjjm	606	11	in	in	IN
cord-023095-4dannjjm	606	12	dogs	dog	NNS
cord-023095-4dannjjm	606	13	remains	remain	VBZ
cord-023095-4dannjjm	606	14	to	to	TO
cord-023095-4dannjjm	606	15	be	be	VB
cord-023095-4dannjjm	606	16	fully	fully	RB
cord-023095-4dannjjm	606	17	elucidated	elucidate	VBN
cord-023095-4dannjjm	606	18	.	.	.
cord-023095-4dannjjm	607	1	The	the	DT
cord-023095-4dannjjm	607	2	high	high	JJ
cord-023095-4dannjjm	607	3	sheer	sheer	JJ
cord-023095-4dannjjm	607	4	stress	stress	NN
cord-023095-4dannjjm	607	5	caused	cause	VBN
cord-023095-4dannjjm	607	6	by	by	IN
cord-023095-4dannjjm	607	7	mitral	mitral	JJ
cord-023095-4dannjjm	607	8	regurgitation	regurgitation	NN
cord-023095-4dannjjm	607	9	damages	damage	VBZ
cord-023095-4dannjjm	607	10	the	the	DT
cord-023095-4dannjjm	607	11	endothelial	endothelial	JJ
cord-023095-4dannjjm	607	12	surface	surface	NN
cord-023095-4dannjjm	607	13	of	of	IN
cord-023095-4dannjjm	607	14	the	the	DT
cord-023095-4dannjjm	607	15	valve	valve	NN
cord-023095-4dannjjm	607	16	,	,	,
cord-023095-4dannjjm	607	17	and	and	CC
cord-023095-4dannjjm	607	18	a	a	DT
cord-023095-4dannjjm	607	19	previous	previous	JJ
cord-023095-4dannjjm	607	20	study	study	NN
cord-023095-4dannjjm	607	21	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	607	22	increased	increased	JJ
cord-023095-4dannjjm	607	23	transcription	transcription	NN
cord-023095-4dannjjm	607	24	of	of	IN
cord-023095-4dannjjm	607	25	intercellular	intercellular	JJ
cord-023095-4dannjjm	607	26	adhesion	adhesion	NN
cord-023095-4dannjjm	607	27	molecule-1	molecule-1	NN
cord-023095-4dannjjm	607	28	(	(	-LRB-
cord-023095-4dannjjm	607	29	ICAM-1	ICAM-1	NNP
cord-023095-4dannjjm	607	30	)	)	-RRB-
cord-023095-4dannjjm	607	31	and	and	CC
cord-023095-4dannjjm	607	32	E	E	NNS
cord-023095-4dannjjm	607	33	-	-	NN
cord-023095-4dannjjm	607	34	selectin	selectin	NNS
cord-023095-4dannjjm	607	35	in	in	IN
cord-023095-4dannjjm	607	36	affected	affect	VBN
cord-023095-4dannjjm	607	37	mitral	mitral	JJ
cord-023095-4dannjjm	607	38	leaflet	leaflet	NN
cord-023095-4dannjjm	607	39	tissue	tissue	NN
cord-023095-4dannjjm	607	40	.	.	.
cord-023095-4dannjjm	608	1	We	-PRON-	PRP
cord-023095-4dannjjm	608	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	608	3	that	that	IN
cord-023095-4dannjjm	608	4	this	this	DT
cord-023095-4dannjjm	608	5	may	may	MD
cord-023095-4dannjjm	608	6	be	be	VB
cord-023095-4dannjjm	608	7	responsible	responsible	JJ
cord-023095-4dannjjm	608	8	for	for	IN
cord-023095-4dannjjm	608	9	platelet	platelet	NN
cord-023095-4dannjjm	608	10	recruitment	recruitment	NN
cord-023095-4dannjjm	608	11	and	and	CC
cord-023095-4dannjjm	608	12	adhesion	adhesion	NN
cord-023095-4dannjjm	608	13	,	,	,
cord-023095-4dannjjm	608	14	and	and	CC
cord-023095-4dannjjm	608	15	initiation	initiation	NN
cord-023095-4dannjjm	608	16	of	of	IN
cord-023095-4dannjjm	608	17	a	a	DT
cord-023095-4dannjjm	608	18	proliferative	proliferative	JJ
cord-023095-4dannjjm	608	19	cascade	cascade	NN
cord-023095-4dannjjm	608	20	,	,	,
cord-023095-4dannjjm	608	21	resulting	result	VBG
cord-023095-4dannjjm	608	22	in	in	IN
cord-023095-4dannjjm	608	23	further	further	JJ
cord-023095-4dannjjm	608	24	myxomatous	myxomatous	JJ
cord-023095-4dannjjm	608	25	changes	change	NNS
cord-023095-4dannjjm	608	26	.	.	.
cord-023095-4dannjjm	609	1	The	the	DT
cord-023095-4dannjjm	609	2	goal	goal	NN
cord-023095-4dannjjm	609	3	of	of	IN
cord-023095-4dannjjm	609	4	this	this	DT
cord-023095-4dannjjm	609	5	study	study	NN
cord-023095-4dannjjm	609	6	was	be	VBD
cord-023095-4dannjjm	609	7	to	to	TO
cord-023095-4dannjjm	609	8	compare	compare	VB
cord-023095-4dannjjm	609	9	plasma	plasma	NN
cord-023095-4dannjjm	609	10	levels	level	NNS
cord-023095-4dannjjm	609	11	of	of	IN
cord-023095-4dannjjm	609	12	ICAM-1	icam-1	NN
cord-023095-4dannjjm	609	13	and	and	CC
cord-023095-4dannjjm	609	14	E	E	NNS
cord-023095-4dannjjm	609	15	-	-	NN
cord-023095-4dannjjm	609	16	selectin	selectin	JJ
cord-023095-4dannjjm	609	17	in	in	IN
cord-023095-4dannjjm	609	18	healthy	healthy	JJ
cord-023095-4dannjjm	609	19	dogs	dog	NNS
cord-023095-4dannjjm	609	20	and	and	CC
cord-023095-4dannjjm	609	21	those	those	DT
cord-023095-4dannjjm	609	22	with	with	IN
cord-023095-4dannjjm	609	23	DMVD	DMVD	NNS
cord-023095-4dannjjm	609	24	.	.	.
cord-023095-4dannjjm	610	1	The	the	DT
cord-023095-4dannjjm	610	2	study	study	NN
cord-023095-4dannjjm	610	3	population	population	NN
cord-023095-4dannjjm	610	4	included	include	VBD
cord-023095-4dannjjm	610	5	dogs	dog	NNS
cord-023095-4dannjjm	610	6	with	with	IN
cord-023095-4dannjjm	610	7	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	610	8	evidence	evidence	NN
cord-023095-4dannjjm	610	9	of	of	IN
cord-023095-4dannjjm	610	10	DMVD	DMVD	NNP
cord-023095-4dannjjm	610	11	and	and	CC
cord-023095-4dannjjm	610	12	healthy	healthy	JJ
cord-023095-4dannjjm	610	13	control	control	NN
cord-023095-4dannjjm	610	14	dogs	dog	NNS
cord-023095-4dannjjm	610	15	41	41	CD
cord-023095-4dannjjm	610	16	year	year	NN
cord-023095-4dannjjm	610	17	old	old	JJ
cord-023095-4dannjjm	610	18	with	with	IN
cord-023095-4dannjjm	610	19	no	no	DT
cord-023095-4dannjjm	610	20	heart	heart	NN
cord-023095-4dannjjm	610	21	murmur	murmur	NN
cord-023095-4dannjjm	610	22	or	or	CC
cord-023095-4dannjjm	610	23	known	know	VBN
cord-023095-4dannjjm	610	24	systemic	systemic	JJ
cord-023095-4dannjjm	610	25	diseases	disease	NNS
cord-023095-4dannjjm	610	26	.	.	.
cord-023095-4dannjjm	611	1	DMVD	DMVD	NNP
cord-023095-4dannjjm	611	2	dogs	dog	NNS
cord-023095-4dannjjm	611	3	underwent	undergo	VBD
cord-023095-4dannjjm	611	4	2D	2d	JJ
cord-023095-4dannjjm	611	5	/	/	SYM
cord-023095-4dannjjm	611	6	color	color	NN
cord-023095-4dannjjm	611	7	-	-	HYPH
cord-023095-4dannjjm	611	8	flow	flow	NN
cord-023095-4dannjjm	611	9	Doppler	Doppler	NNP
cord-023095-4dannjjm	611	10	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	611	11	exam	exam	NN
cord-023095-4dannjjm	611	12	.	.	.
cord-023095-4dannjjm	612	1	Blood	blood	NN
cord-023095-4dannjjm	612	2	samples	sample	NNS
cord-023095-4dannjjm	612	3	were	be	VBD
cord-023095-4dannjjm	612	4	obtained	obtain	VBN
cord-023095-4dannjjm	612	5	for	for	IN
cord-023095-4dannjjm	612	6	plasma	plasma	NN
cord-023095-4dannjjm	612	7	ICAM-1	icam-1	NN
cord-023095-4dannjjm	612	8	and	and	CC
cord-023095-4dannjjm	612	9	E	e	NN
cord-023095-4dannjjm	612	10	-	-	NN
cord-023095-4dannjjm	612	11	selectin	selectin	JJ
cord-023095-4dannjjm	612	12	analysis	analysis	NN
cord-023095-4dannjjm	612	13	using	use	VBG
cord-023095-4dannjjm	612	14	commercially	commercially	RB
cord-023095-4dannjjm	612	15	available	available	JJ
cord-023095-4dannjjm	612	16	ELISA	ELISA	NNP
cord-023095-4dannjjm	612	17	kits	kit	NNS
cord-023095-4dannjjm	612	18	.	.	.
cord-023095-4dannjjm	613	1	The	the	DT
cord-023095-4dannjjm	613	2	study	study	NN
cord-023095-4dannjjm	613	3	included	include	VBD
cord-023095-4dannjjm	613	4	34	34	CD
cord-023095-4dannjjm	613	5	dogs	dog	NNS
cord-023095-4dannjjm	613	6	,	,	,
cord-023095-4dannjjm	613	7	of	of	IN
cord-023095-4dannjjm	613	8	which	which	WDT
cord-023095-4dannjjm	613	9	20	20	CD
cord-023095-4dannjjm	613	10	had	have	VBD
cord-023095-4dannjjm	613	11	DMVD	DMVD	NNS
cord-023095-4dannjjm	613	12	and	and	CC
cord-023095-4dannjjm	613	13	14	14	CD
cord-023095-4dannjjm	613	14	were	be	VBD
cord-023095-4dannjjm	613	15	normal	normal	JJ
cord-023095-4dannjjm	613	16	.	.	.
cord-023095-4dannjjm	614	1	The	the	DT
cord-023095-4dannjjm	614	2	DMVD	DMVD	NNP
cord-023095-4dannjjm	614	3	group	group	NN
cord-023095-4dannjjm	614	4	had	have	VBD
cord-023095-4dannjjm	614	5	a	a	DT
cord-023095-4dannjjm	614	6	median	median	JJ
cord-023095-4dannjjm	614	7	age	age	NN
cord-023095-4dannjjm	614	8	of	of	IN
cord-023095-4dannjjm	614	9	9.5yrs	9.5yrs	CD
cord-023095-4dannjjm	614	10	)	)	-RRB-
cord-023095-4dannjjm	614	11	and	and	CC
cord-023095-4dannjjm	614	12	included	include	VBD
cord-023095-4dannjjm	614	13	6	6	CD
cord-023095-4dannjjm	614	14	females	female	NNS
cord-023095-4dannjjm	614	15	and	and	CC
cord-023095-4dannjjm	614	16	14	14	CD
cord-023095-4dannjjm	614	17	males	male	NNS
cord-023095-4dannjjm	614	18	.	.	.
cord-023095-4dannjjm	615	1	Two	two	CD
cord-023095-4dannjjm	615	2	(	(	-LRB-
cord-023095-4dannjjm	615	3	10	10	CD
cord-023095-4dannjjm	615	4	%	%	NN
cord-023095-4dannjjm	615	5	)	)	-RRB-
cord-023095-4dannjjm	615	6	,	,	,
cord-023095-4dannjjm	615	7	13	13	CD
cord-023095-4dannjjm	615	8	(	(	-LRB-
cord-023095-4dannjjm	615	9	65	65	CD
cord-023095-4dannjjm	615	10	%	%	NN
cord-023095-4dannjjm	615	11	)	)	-RRB-
cord-023095-4dannjjm	615	12	,	,	,
cord-023095-4dannjjm	615	13	2	2	CD
cord-023095-4dannjjm	615	14	(	(	-LRB-
cord-023095-4dannjjm	615	15	10	10	CD
cord-023095-4dannjjm	615	16	%	%	NN
cord-023095-4dannjjm	615	17	)	)	-RRB-
cord-023095-4dannjjm	615	18	and	and	CC
cord-023095-4dannjjm	615	19	3	3	CD
cord-023095-4dannjjm	615	20	(	(	-LRB-
cord-023095-4dannjjm	615	21	15	15	CD
cord-023095-4dannjjm	615	22	%	%	NN
cord-023095-4dannjjm	615	23	)	)	-RRB-
cord-023095-4dannjjm	615	24	dogs	dog	NNS
cord-023095-4dannjjm	615	25	were	be	VBD
cord-023095-4dannjjm	615	26	classified	classify	VBN
cord-023095-4dannjjm	615	27	as	as	IN
cord-023095-4dannjjm	615	28	ISACHC	ISACHC	NNP
cord-023095-4dannjjm	615	29	1a	1a	NN
cord-023095-4dannjjm	615	30	,	,	,
cord-023095-4dannjjm	615	31	1b	1b	CD
cord-023095-4dannjjm	615	32	,	,	,
cord-023095-4dannjjm	615	33	2	2	CD
cord-023095-4dannjjm	615	34	and	and	CC
cord-023095-4dannjjm	615	35	3a	3a	NN
cord-023095-4dannjjm	615	36	,	,	,
cord-023095-4dannjjm	615	37	respectively	respectively	RB
cord-023095-4dannjjm	615	38	.	.	.
cord-023095-4dannjjm	616	1	Of	of	IN
cord-023095-4dannjjm	616	2	the	the	DT
cord-023095-4dannjjm	616	3	control	control	NN
cord-023095-4dannjjm	616	4	dogs	dog	NNS
cord-023095-4dannjjm	616	5	,	,	,
cord-023095-4dannjjm	616	6	median	median	JJ
cord-023095-4dannjjm	616	7	age	age	NN
cord-023095-4dannjjm	616	8	was	be	VBD
cord-023095-4dannjjm	616	9	4.5yrs	4.5yrs	CD
cord-023095-4dannjjm	616	10	[	[	-LRB-
cord-023095-4dannjjm	616	11	2	2	CD
cord-023095-4dannjjm	616	12	-	-	SYM
cord-023095-4dannjjm	616	13	6.5	6.5	CD
cord-023095-4dannjjm	616	14	]	]	-RRB-
cord-023095-4dannjjm	616	15	,	,	,
cord-023095-4dannjjm	616	16	with	with	IN
cord-023095-4dannjjm	616	17	5	5	CD
cord-023095-4dannjjm	616	18	females	female	NNS
cord-023095-4dannjjm	616	19	and	and	CC
cord-023095-4dannjjm	616	20	9	9	CD
cord-023095-4dannjjm	616	21	males	male	NNS
cord-023095-4dannjjm	616	22	.	.	.
cord-023095-4dannjjm	617	1	There	there	EX
cord-023095-4dannjjm	617	2	was	be	VBD
cord-023095-4dannjjm	617	3	no	no	DT
cord-023095-4dannjjm	617	4	statistical	statistical	JJ
cord-023095-4dannjjm	617	5	difference	difference	NN
cord-023095-4dannjjm	617	6	in	in	IN
cord-023095-4dannjjm	617	7	plasma	plasma	NN
cord-023095-4dannjjm	617	8	E	e	NN
cord-023095-4dannjjm	617	9	-	-	NN
cord-023095-4dannjjm	617	10	selectin	selectin	NNS
cord-023095-4dannjjm	617	11	between	between	IN
cord-023095-4dannjjm	617	12	control	control	NN
cord-023095-4dannjjm	617	13	dogs	dog	NNS
cord-023095-4dannjjm	617	14	(	(	-LRB-
cord-023095-4dannjjm	617	15	median	median	JJ
cord-023095-4dannjjm	617	16	2.71	2.71	CD
cord-023095-4dannjjm	617	17	[	[	-LRB-
cord-023095-4dannjjm	617	18	2.05	2.05	CD
cord-023095-4dannjjm	617	19	-	-	SYM
cord-023095-4dannjjm	617	20	7.66	7.66	CD
cord-023095-4dannjjm	617	21	]	]	-RRB-
cord-023095-4dannjjm	617	22	)	)	-RRB-
cord-023095-4dannjjm	617	23	and	and	CC
cord-023095-4dannjjm	617	24	those	those	DT
cord-023095-4dannjjm	617	25	with	with	IN
cord-023095-4dannjjm	617	26	DMVD	DMVD	NNS
cord-023095-4dannjjm	617	27	(	(	-LRB-
cord-023095-4dannjjm	617	28	2.46	2.46	CD
cord-023095-4dannjjm	617	29	[	[	-LRB-
cord-023095-4dannjjm	617	30	1.54	1.54	CD
cord-023095-4dannjjm	617	31	-	-	SYM
cord-023095-4dannjjm	617	32	3.55	3.55	CD
cord-023095-4dannjjm	617	33	]	]	-RRB-
cord-023095-4dannjjm	617	34	)	)	-RRB-
cord-023095-4dannjjm	617	35	;	;	:
cord-023095-4dannjjm	617	36	P	p	NN
cord-023095-4dannjjm	617	37	5	5	CD
cord-023095-4dannjjm	617	38	0.35	0.35	CD
cord-023095-4dannjjm	617	39	.	.	.
cord-023095-4dannjjm	618	1	Plasma	plasma	NN
cord-023095-4dannjjm	618	2	ICAM-1	icam-1	NN
cord-023095-4dannjjm	618	3	concentrations	concentration	NNS
cord-023095-4dannjjm	618	4	were	be	VBD
cord-023095-4dannjjm	618	5	higher	high	JJR
cord-023095-4dannjjm	618	6	in	in	IN
cord-023095-4dannjjm	618	7	DMVD	DMVD	NNP
cord-023095-4dannjjm	618	8	dogs	dog	NNS
cord-023095-4dannjjm	618	9	(	(	-LRB-
cord-023095-4dannjjm	618	10	1.58	1.58	CD
cord-023095-4dannjjm	618	11	[	[	-LRB-
cord-023095-4dannjjm	618	12	1.20	1.20	CD
cord-023095-4dannjjm	618	13	-	-	SYM
cord-023095-4dannjjm	618	14	10.58	10.58	CD
cord-023095-4dannjjm	618	15	]	]	-RRB-
cord-023095-4dannjjm	618	16	)	)	-RRB-
cord-023095-4dannjjm	618	17	than	than	IN
cord-023095-4dannjjm	618	18	controls	control	NNS
cord-023095-4dannjjm	618	19	(	(	-LRB-
cord-023095-4dannjjm	618	20	median	median	NN
cord-023095-4dannjjm	618	21	1.31	1.31	CD
cord-023095-4dannjjm	618	22	[	[	-LRB-
cord-023095-4dannjjm	618	23	1.11	1.11	CD
cord-023095-4dannjjm	618	24	-	-	SYM
cord-023095-4dannjjm	618	25	1.65	1.65	CD
cord-023095-4dannjjm	618	26	]	]	-RRB-
cord-023095-4dannjjm	618	27	,	,	,
cord-023095-4dannjjm	618	28	but	but	CC
cord-023095-4dannjjm	618	29	this	this	DT
cord-023095-4dannjjm	618	30	difference	difference	NN
cord-023095-4dannjjm	618	31	did	do	VBD
cord-023095-4dannjjm	618	32	not	not	RB
cord-023095-4dannjjm	618	33	reach	reach	VB
cord-023095-4dannjjm	618	34	statistical	statistical	JJ
cord-023095-4dannjjm	618	35	significance	significance	NN
cord-023095-4dannjjm	618	36	(	(	-LRB-
cord-023095-4dannjjm	618	37	P	p	NN
cord-023095-4dannjjm	618	38	5	5	CD
cord-023095-4dannjjm	618	39	0.22	0.22	CD
cord-023095-4dannjjm	618	40	)	)	-RRB-
cord-023095-4dannjjm	618	41	.	.	.
cord-023095-4dannjjm	619	1	Linear	linear	JJ
cord-023095-4dannjjm	619	2	regression	regression	NN
cord-023095-4dannjjm	619	3	analysis	analysis	NN
cord-023095-4dannjjm	619	4	showed	show	VBD
cord-023095-4dannjjm	619	5	no	no	DT
cord-023095-4dannjjm	619	6	significant	significant	JJ
cord-023095-4dannjjm	619	7	correlation	correlation	NN
cord-023095-4dannjjm	619	8	between	between	IN
cord-023095-4dannjjm	619	9	ICAM-1	icam-1	NN
cord-023095-4dannjjm	619	10	or	or	CC
cord-023095-4dannjjm	619	11	E	e	NN
cord-023095-4dannjjm	619	12	-	-	NN
cord-023095-4dannjjm	619	13	selectin	selectin	JJ
cord-023095-4dannjjm	619	14	and	and	CC
cord-023095-4dannjjm	619	15	serum	serum	NN
cord-023095-4dannjjm	619	16	serotonin	serotonin	NN
cord-023095-4dannjjm	619	17	level	level	NN
cord-023095-4dannjjm	619	18	,	,	,
cord-023095-4dannjjm	619	19	NT	NT	NNP
cord-023095-4dannjjm	619	20	-	-	HYPH
cord-023095-4dannjjm	619	21	proBNP	probnp	NN
cord-023095-4dannjjm	619	22	or	or	CC
cord-023095-4dannjjm	619	23	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	619	24	measures	measure	NNS
cord-023095-4dannjjm	619	25	of	of	IN
cord-023095-4dannjjm	619	26	DMVD	DMVD	NNP
cord-023095-4dannjjm	619	27	severity	severity	NN
cord-023095-4dannjjm	620	1	(	(	-LRB-
cord-023095-4dannjjm	620	2	LA	LA	NNP
cord-023095-4dannjjm	620	3	:	:	:
cord-023095-4dannjjm	621	1	Ao	Ao	NNP
cord-023095-4dannjjm	621	2	,	,	,
cord-023095-4dannjjm	621	3	LVIDd	LVIDd	NNP
cord-023095-4dannjjm	621	4	:	:	:
cord-023095-4dannjjm	622	1	Ao	Ao	NNP
cord-023095-4dannjjm	622	2	,	,	,
cord-023095-4dannjjm	622	3	LVIDs	lvid	NNS
cord-023095-4dannjjm	622	4	:	:	:
cord-023095-4dannjjm	622	5	Ao	Ao	NNP
cord-023095-4dannjjm	622	6	)	)	-RRB-
cord-023095-4dannjjm	622	7	.	.	.
cord-023095-4dannjjm	623	1	The	the	DT
cord-023095-4dannjjm	623	2	results	result	NNS
cord-023095-4dannjjm	623	3	of	of	IN
cord-023095-4dannjjm	623	4	this	this	DT
cord-023095-4dannjjm	623	5	study	study	NN
cord-023095-4dannjjm	623	6	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	623	7	no	no	DT
cord-023095-4dannjjm	623	8	significant	significant	JJ
cord-023095-4dannjjm	623	9	difference	difference	NN
cord-023095-4dannjjm	623	10	in	in	IN
cord-023095-4dannjjm	623	11	circulating	circulate	VBG
cord-023095-4dannjjm	623	12	adhesion	adhesion	NN
cord-023095-4dannjjm	623	13	molecules	molecule	NNS
cord-023095-4dannjjm	623	14	ICAM-1	icam-1	JJ
cord-023095-4dannjjm	623	15	and	and	CC
cord-023095-4dannjjm	623	16	E	E	NNS
cord-023095-4dannjjm	623	17	-	-	NN
cord-023095-4dannjjm	623	18	selectin	selectin	NNS
cord-023095-4dannjjm	623	19	in	in	IN
cord-023095-4dannjjm	623	20	dogs	dog	NNS
cord-023095-4dannjjm	623	21	with	with	IN
cord-023095-4dannjjm	623	22	DMVD	DMVD	NNS
cord-023095-4dannjjm	623	23	as	as	IN
cord-023095-4dannjjm	623	24	compared	compare	VBN
cord-023095-4dannjjm	623	25	with	with	IN
cord-023095-4dannjjm	623	26	healthy	healthy	JJ
cord-023095-4dannjjm	623	27	controls	control	NNS
cord-023095-4dannjjm	623	28	.	.	.
cord-023095-4dannjjm	624	1	Further	further	JJ
cord-023095-4dannjjm	624	2	studies	study	NNS
cord-023095-4dannjjm	624	3	investigating	investigate	VBG
cord-023095-4dannjjm	624	4	adhesion	adhesion	NN
cord-023095-4dannjjm	624	5	molecules	molecule	NNS
cord-023095-4dannjjm	624	6	within	within	IN
cord-023095-4dannjjm	624	7	the	the	DT
cord-023095-4dannjjm	624	8	mitral	mitral	JJ
cord-023095-4dannjjm	624	9	valve	valve	NN
cord-023095-4dannjjm	624	10	tissue	tissue	NN
cord-023095-4dannjjm	624	11	itself	-PRON-	PRP
cord-023095-4dannjjm	624	12	are	be	VBP
cord-023095-4dannjjm	624	13	likely	likely	RB
cord-023095-4dannjjm	624	14	needed	need	VBN
cord-023095-4dannjjm	624	15	if	if	IN
cord-023095-4dannjjm	624	16	ICAM-1	icam-1	NN
cord-023095-4dannjjm	624	17	and	and	CC
cord-023095-4dannjjm	624	18	E	E	NNS
cord-023095-4dannjjm	624	19	-	-	NN
cord-023095-4dannjjm	624	20	selectin	selectin	NN
cord-023095-4dannjjm	624	21	play	play	VBP
cord-023095-4dannjjm	624	22	a	a	DT
cord-023095-4dannjjm	624	23	role	role	NN
cord-023095-4dannjjm	624	24	in	in	IN
cord-023095-4dannjjm	624	25	the	the	DT
cord-023095-4dannjjm	624	26	pathophysiology	pathophysiology	NN
cord-023095-4dannjjm	624	27	of	of	IN
cord-023095-4dannjjm	624	28	DMVD	DMVD	NNS
cord-023095-4dannjjm	624	29	.	.	.
cord-023095-4dannjjm	625	1	The	the	DT
cord-023095-4dannjjm	625	2	rate	rate	NN
cord-023095-4dannjjm	625	3	of	of	IN
cord-023095-4dannjjm	625	4	glucose	glucose	NN
cord-023095-4dannjjm	625	5	utilization	utilization	NN
cord-023095-4dannjjm	625	6	in	in	IN
cord-023095-4dannjjm	625	7	the	the	DT
cord-023095-4dannjjm	625	8	heart	heart	NN
cord-023095-4dannjjm	625	9	is	be	VBZ
cord-023095-4dannjjm	625	10	greater	great	JJR
cord-023095-4dannjjm	625	11	than	than	IN
cord-023095-4dannjjm	625	12	in	in	IN
cord-023095-4dannjjm	625	13	other	other	JJ
cord-023095-4dannjjm	625	14	tissues	tissue	NNS
cord-023095-4dannjjm	625	15	,	,	,
cord-023095-4dannjjm	625	16	and	and	CC
cord-023095-4dannjjm	625	17	impaired	impair	VBD
cord-023095-4dannjjm	625	18	glucose	glucose	NN
cord-023095-4dannjjm	625	19	uptake	uptake	NN
cord-023095-4dannjjm	625	20	may	may	MD
cord-023095-4dannjjm	625	21	play	play	VB
cord-023095-4dannjjm	625	22	a	a	DT
cord-023095-4dannjjm	625	23	major	major	JJ
cord-023095-4dannjjm	625	24	role	role	NN
cord-023095-4dannjjm	625	25	in	in	IN
cord-023095-4dannjjm	625	26	the	the	DT
cord-023095-4dannjjm	625	27	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	625	28	of	of	IN
cord-023095-4dannjjm	625	29	heart	heart	NN
cord-023095-4dannjjm	625	30	failure	failure	NN
cord-023095-4dannjjm	625	31	(	(	-LRB-
cord-023095-4dannjjm	625	32	HF	HF	NNP
cord-023095-4dannjjm	625	33	)	)	-RRB-
cord-023095-4dannjjm	625	34	.	.	.
cord-023095-4dannjjm	626	1	Glucose	glucose	NN
cord-023095-4dannjjm	626	2	uptake	uptake	NN
cord-023095-4dannjjm	626	3	across	across	IN
cord-023095-4dannjjm	626	4	the	the	DT
cord-023095-4dannjjm	626	5	sarcolemma	sarcolemma	NN
cord-023095-4dannjjm	626	6	is	be	VBZ
cord-023095-4dannjjm	626	7	regulated	regulate	VBN
cord-023095-4dannjjm	626	8	by	by	IN
cord-023095-4dannjjm	626	9	a	a	DT
cord-023095-4dannjjm	626	10	family	family	NN
cord-023095-4dannjjm	626	11	of	of	IN
cord-023095-4dannjjm	626	12	membrane	membrane	NN
cord-023095-4dannjjm	626	13	proteins	protein	NNS
cord-023095-4dannjjm	626	14	called	call	VBD
cord-023095-4dannjjm	626	15	glucose	glucose	NN
cord-023095-4dannjjm	626	16	transporters	transporter	NNS
cord-023095-4dannjjm	626	17	(	(	-LRB-
cord-023095-4dannjjm	626	18	GLUTs	GLUTs	NNP
cord-023095-4dannjjm	626	19	)	)	-RRB-
cord-023095-4dannjjm	626	20	,	,	,
cord-023095-4dannjjm	626	21	which	which	WDT
cord-023095-4dannjjm	626	22	includes	include	VBZ
cord-023095-4dannjjm	626	23	GLUT-4	glut-4	NN
cord-023095-4dannjjm	626	24	,	,	,
cord-023095-4dannjjm	626	25	the	the	DT
cord-023095-4dannjjm	626	26	major	major	JJ
cord-023095-4dannjjm	626	27	cardiac	cardiac	JJ
cord-023095-4dannjjm	626	28	isoform	isoform	NN
cord-023095-4dannjjm	626	29	,	,	,
cord-023095-4dannjjm	626	30	and	and	CC
cord-023095-4dannjjm	626	31	GLUT-12	GLUT-12	NNP
cord-023095-4dannjjm	626	32	,	,	,
cord-023095-4dannjjm	626	33	a	a	DT
cord-023095-4dannjjm	626	34	recently	recently	RB
cord-023095-4dannjjm	626	35	discovered	discover	VBN
cord-023095-4dannjjm	626	36	isoform	isoform	NN
cord-023095-4dannjjm	626	37	,	,	,
cord-023095-4dannjjm	626	38	the	the	DT
cord-023095-4dannjjm	626	39	role	role	NN
cord-023095-4dannjjm	626	40	of	of	IN
cord-023095-4dannjjm	626	41	which	which	WDT
cord-023095-4dannjjm	626	42	is	be	VBZ
cord-023095-4dannjjm	626	43	unknown	unknown	JJ
cord-023095-4dannjjm	626	44	in	in	IN
cord-023095-4dannjjm	626	45	the	the	DT
cord-023095-4dannjjm	626	46	heart	heart	NN
cord-023095-4dannjjm	626	47	.	.	.
cord-023095-4dannjjm	627	1	In	in	IN
cord-023095-4dannjjm	627	2	addition	addition	NN
cord-023095-4dannjjm	627	3	,	,	,
cord-023095-4dannjjm	627	4	despite	despite	IN
cord-023095-4dannjjm	627	5	the	the	DT
cord-023095-4dannjjm	627	6	wellknown	wellknown	JJ
cord-023095-4dannjjm	627	7	regional	regional	JJ
cord-023095-4dannjjm	627	8	differences	difference	NNS
cord-023095-4dannjjm	627	9	in	in	IN
cord-023095-4dannjjm	627	10	myocardial	myocardial	JJ
cord-023095-4dannjjm	627	11	structure	structure	NN
cord-023095-4dannjjm	627	12	and	and	CC
cord-023095-4dannjjm	627	13	function	function	NN
cord-023095-4dannjjm	627	14	,	,	,
cord-023095-4dannjjm	627	15	potential	potential	JJ
cord-023095-4dannjjm	627	16	regional	regional	JJ
cord-023095-4dannjjm	627	17	patterns	pattern	NNS
cord-023095-4dannjjm	627	18	in	in	IN
cord-023095-4dannjjm	627	19	glucose	glucose	NN
cord-023095-4dannjjm	627	20	transport	transport	NN
cord-023095-4dannjjm	627	21	have	have	VBP
cord-023095-4dannjjm	627	22	not	not	RB
cord-023095-4dannjjm	627	23	been	be	VBN
cord-023095-4dannjjm	627	24	investigated	investigate	VBN
cord-023095-4dannjjm	627	25	.	.	.
cord-023095-4dannjjm	628	1	Thus	thus	RB
cord-023095-4dannjjm	628	2	,	,	,
cord-023095-4dannjjm	628	3	we	-PRON-	PRP
cord-023095-4dannjjm	628	4	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	628	5	that	that	IN
cord-023095-4dannjjm	628	6	GLUT-4	glut-4	NN
cord-023095-4dannjjm	628	7	and	and	CC
cord-023095-4dannjjm	628	8	-12	-12	:
cord-023095-4dannjjm	628	9	protein	protein	NN
cord-023095-4dannjjm	628	10	and	and	CC
cord-023095-4dannjjm	628	11	gene	gene	NN
cord-023095-4dannjjm	628	12	expression	expression	NN
cord-023095-4dannjjm	628	13	would	would	MD
cord-023095-4dannjjm	628	14	be	be	VB
cord-023095-4dannjjm	628	15	chamber	chamber	NN
cord-023095-4dannjjm	628	16	specific	specific	JJ
cord-023095-4dannjjm	628	17	in	in	IN
cord-023095-4dannjjm	628	18	healthy	healthy	JJ
cord-023095-4dannjjm	628	19	dogs	dog	NNS
cord-023095-4dannjjm	628	20	and	and	CC
cord-023095-4dannjjm	628	21	during	during	IN
cord-023095-4dannjjm	628	22	chronic	chronic	JJ
cord-023095-4dannjjm	628	23	HF	HF	NNP
cord-023095-4dannjjm	628	24	.	.	.
cord-023095-4dannjjm	629	1	Using	use	VBG
cord-023095-4dannjjm	629	2	a	a	DT
cord-023095-4dannjjm	629	3	canine	canine	JJ
cord-023095-4dannjjm	629	4	model	model	NN
cord-023095-4dannjjm	629	5	of	of	IN
cord-023095-4dannjjm	629	6	tachypacing	tachypace	VBG
cord-023095-4dannjjm	629	7	induced	induce	VBN
cord-023095-4dannjjm	629	8	chronic	chronic	JJ
cord-023095-4dannjjm	629	9	HF	HF	NNP
cord-023095-4dannjjm	629	10	,	,	,
cord-023095-4dannjjm	629	11	GLUT	glut	NN
cord-023095-4dannjjm	629	12	protein	protein	NN
cord-023095-4dannjjm	629	13	and	and	CC
cord-023095-4dannjjm	629	14	messenger	messenger	NN
cord-023095-4dannjjm	629	15	RNA	RNA	NNP
cord-023095-4dannjjm	629	16	in	in	IN
cord-023095-4dannjjm	629	17	both	both	CC
cord-023095-4dannjjm	629	18	ventricles	ventricle	NNS
cord-023095-4dannjjm	629	19	and	and	CC
cord-023095-4dannjjm	629	20	atria	atria	NN
cord-023095-4dannjjm	629	21	were	be	VBD
cord-023095-4dannjjm	629	22	investigated	investigate	VBN
cord-023095-4dannjjm	629	23	by	by	IN
cord-023095-4dannjjm	629	24	immunoblotting	immunoblotte	VBG
cord-023095-4dannjjm	629	25	and	and	CC
cord-023095-4dannjjm	629	26	real	real	JJ
cord-023095-4dannjjm	629	27	time	time	NN
cord-023095-4dannjjm	629	28	PCR	PCR	NNP
cord-023095-4dannjjm	629	29	.	.	.
cord-023095-4dannjjm	630	1	In	in	IN
cord-023095-4dannjjm	630	2	control	control	NN
cord-023095-4dannjjm	630	3	dogs	dog	NNS
cord-023095-4dannjjm	630	4	,	,	,
cord-023095-4dannjjm	630	5	GLUT-4	GLUT-4	VBG
cord-023095-4dannjjm	630	6	,	,	,
cord-023095-4dannjjm	630	7	but	but	CC
cord-023095-4dannjjm	630	8	not	not	RB
cord-023095-4dannjjm	630	9	GLUT-12	glut-12	CD
cord-023095-4dannjjm	630	10	,	,	,
cord-023095-4dannjjm	630	11	protein	protein	NN
cord-023095-4dannjjm	630	12	expression	expression	NN
cord-023095-4dannjjm	630	13	were	be	VBD
cord-023095-4dannjjm	630	14	significantly	significantly	RB
cord-023095-4dannjjm	630	15	higher	high	JJR
cord-023095-4dannjjm	630	16	in	in	IN
cord-023095-4dannjjm	630	17	the	the	DT
cord-023095-4dannjjm	630	18	atria	atria	NN
cord-023095-4dannjjm	630	19	compared	compare	VBN
cord-023095-4dannjjm	630	20	to	to	IN
cord-023095-4dannjjm	630	21	the	the	DT
cord-023095-4dannjjm	630	22	ventricles	ventricle	NNS
cord-023095-4dannjjm	630	23	,	,	,
cord-023095-4dannjjm	630	24	with	with	IN
cord-023095-4dannjjm	630	25	the	the	DT
cord-023095-4dannjjm	630	26	highest	high	JJS
cord-023095-4dannjjm	630	27	content	content	NN
cord-023095-4dannjjm	630	28	in	in	IN
cord-023095-4dannjjm	630	29	the	the	DT
cord-023095-4dannjjm	630	30	right	right	JJ
cord-023095-4dannjjm	630	31	atrium	atrium	NN
cord-023095-4dannjjm	630	32	(	(	-LRB-
cord-023095-4dannjjm	630	33	RA	RA	NNP
cord-023095-4dannjjm	630	34	,	,	,
cord-023095-4dannjjm	630	35	P	p	NN
cord-023095-4dannjjm	630	36	o	o	NN
cord-023095-4dannjjm	630	37	0.001	0.001	CD
cord-023095-4dannjjm	630	38	)	)	-RRB-
cord-023095-4dannjjm	630	39	.	.	.
cord-023095-4dannjjm	631	1	GLUT-4	glut-4	NN
cord-023095-4dannjjm	631	2	and	and	CC
cord-023095-4dannjjm	631	3	-12	-12	.
cord-023095-4dannjjm	632	1	mRNA	mRNA	NNP
cord-023095-4dannjjm	632	2	were	be	VBD
cord-023095-4dannjjm	632	3	homogeneously	homogeneously	RB
cord-023095-4dannjjm	632	4	expressed	express	VBN
cord-023095-4dannjjm	632	5	in	in	IN
cord-023095-4dannjjm	632	6	all	all	PDT
cord-023095-4dannjjm	632	7	the	the	DT
cord-023095-4dannjjm	632	8	cardiac	cardiac	JJ
cord-023095-4dannjjm	632	9	chambers	chamber	NNS
cord-023095-4dannjjm	632	10	.	.	.
cord-023095-4dannjjm	633	1	During	during	IN
cord-023095-4dannjjm	633	2	chronic	chronic	JJ
cord-023095-4dannjjm	633	3	HF	HF	NNP
cord-023095-4dannjjm	633	4	,	,	,
cord-023095-4dannjjm	633	5	GLUT	glut	NN
cord-023095-4dannjjm	633	6	-4	-4	NNS
cord-023095-4dannjjm	633	7	and	and	CC
cord-023095-4dannjjm	633	8	-12	-12	CD
cord-023095-4dannjjm	633	9	expression	expression	NN
cord-023095-4dannjjm	633	10	was	be	VBD
cord-023095-4dannjjm	633	11	highest	high	JJS
cord-023095-4dannjjm	633	12	in	in	IN
cord-023095-4dannjjm	633	13	the	the	DT
cord-023095-4dannjjm	633	14	left	left	JJ
cord-023095-4dannjjm	633	15	ventricle	ventricle	NN
cord-023095-4dannjjm	633	16	(	(	-LRB-
cord-023095-4dannjjm	633	17	LV	LV	NNP
cord-023095-4dannjjm	633	18	,	,	,
cord-023095-4dannjjm	633	19	by	by	IN
cord-023095-4dannjjm	633	20	2.5	2.5	CD
cord-023095-4dannjjm	633	21	and	and	CC
cord-023095-4dannjjm	633	22	4.2	4.2	CD
cord-023095-4dannjjm	633	23	fold	fold	VB
cord-023095-4dannjjm	633	24	,	,	,
cord-023095-4dannjjm	633	25	respectively	respectively	RB
cord-023095-4dannjjm	633	26	,	,	,
cord-023095-4dannjjm	633	27	P	p	NN
cord-023095-4dannjjm	633	28	o	o	NN
cord-023095-4dannjjm	633	29	0.01	0.01	CD
cord-023095-4dannjjm	633	30	)	)	-RRB-
cord-023095-4dannjjm	633	31	,	,	,
cord-023095-4dannjjm	633	32	with	with	IN
cord-023095-4dannjjm	633	33	a	a	DT
cord-023095-4dannjjm	633	34	concomitant	concomitant	JJ
cord-023095-4dannjjm	633	35	increase	increase	NN
cord-023095-4dannjjm	633	36	in	in	IN
cord-023095-4dannjjm	633	37	GLUT-4	GLUT-4	NNP
cord-023095-4dannjjm	633	38	and	and	CC
cord-023095-4dannjjm	633	39	-12	-12	:
cord-023095-4dannjjm	633	40	mRNA	mRNA	NNP
cord-023095-4dannjjm	633	41	(	(	-LRB-
cord-023095-4dannjjm	633	42	P	p	NN
cord-023095-4dannjjm	633	43	o	o	NN
cord-023095-4dannjjm	633	44	0.001	0.001	CD
cord-023095-4dannjjm	633	45	)	)	-RRB-
cord-023095-4dannjjm	633	46	.	.	.
cord-023095-4dannjjm	634	1	GLUT	glut	NN
cord-023095-4dannjjm	634	2	-4	-4	XX
cord-023095-4dannjjm	634	3	,	,	,
cord-023095-4dannjjm	634	4	but	but	CC
cord-023095-4dannjjm	634	5	not	not	RB
cord-023095-4dannjjm	634	6	GLUT-12	glut-12	CD
cord-023095-4dannjjm	634	7	,	,	,
cord-023095-4dannjjm	634	8	was	be	VBD
cord-023095-4dannjjm	634	9	decreased	decrease	VBN
cord-023095-4dannjjm	634	10	in	in	IN
cord-023095-4dannjjm	634	11	RA	RA	NNP
cord-023095-4dannjjm	634	12	during	during	IN
cord-023095-4dannjjm	634	13	chronic	chronic	JJ
cord-023095-4dannjjm	634	14	HF	HF	NNP
cord-023095-4dannjjm	634	15	(	(	-LRB-
cord-023095-4dannjjm	634	16	P	p	NN
cord-023095-4dannjjm	634	17	5	5	CD
cord-023095-4dannjjm	634	18	0.001	0.001	CD
cord-023095-4dannjjm	634	19	)	)	-RRB-
cord-023095-4dannjjm	634	20	.	.	.
cord-023095-4dannjjm	635	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	635	2	data	datum	NNS
cord-023095-4dannjjm	635	3	suggest	suggest	VBP
cord-023095-4dannjjm	635	4	that	that	IN
cord-023095-4dannjjm	635	5	GLUT-4	GLUT-4	NNP
cord-023095-4dannjjm	635	6	protein	protein	NN
cord-023095-4dannjjm	635	7	was	be	VBD
cord-023095-4dannjjm	635	8	differentially	differentially	RB
cord-023095-4dannjjm	635	9	expressed	express	VBN
cord-023095-4dannjjm	635	10	across	across	IN
cord-023095-4dannjjm	635	11	the	the	DT
cord-023095-4dannjjm	635	12	cardiac	cardiac	JJ
cord-023095-4dannjjm	635	13	chambers	chamber	NNS
cord-023095-4dannjjm	635	14	in	in	IN
cord-023095-4dannjjm	635	15	the	the	DT
cord-023095-4dannjjm	635	16	healthy	healthy	JJ
cord-023095-4dannjjm	635	17	heart	heart	NN
cord-023095-4dannjjm	635	18	.	.	.
cord-023095-4dannjjm	636	1	During	during	IN
cord-023095-4dannjjm	636	2	chronic	chronic	JJ
cord-023095-4dannjjm	636	3	HF	HF	NNP
cord-023095-4dannjjm	636	4	,	,	,
cord-023095-4dannjjm	636	5	LV	LV	NNP
cord-023095-4dannjjm	636	6	was	be	VBD
cord-023095-4dannjjm	636	7	the	the	DT
cord-023095-4dannjjm	636	8	primary	primary	JJ
cord-023095-4dannjjm	636	9	site	site	NN
cord-023095-4dannjjm	636	10	dependent	dependent	JJ
cord-023095-4dannjjm	636	11	on	on	IN
cord-023095-4dannjjm	636	12	both	both	DT
cord-023095-4dannjjm	636	13	GLUT4and	GLUT4and	NNP
cord-023095-4dannjjm	636	14	GLUT12-mediated	glut12-mediated	JJ
cord-023095-4dannjjm	636	15	glucose	glucose	NN
cord-023095-4dannjjm	636	16	transport	transport	NN
cord-023095-4dannjjm	636	17	,	,	,
cord-023095-4dannjjm	636	18	which	which	WDT
cord-023095-4dannjjm	636	19	was	be	VBD
cord-023095-4dannjjm	636	20	transcriptionally	transcriptionally	RB
cord-023095-4dannjjm	636	21	regulated	regulate	VBN
cord-023095-4dannjjm	636	22	.	.	.
cord-023095-4dannjjm	637	1	In	in	IN
cord-023095-4dannjjm	637	2	addition	addition	NN
cord-023095-4dannjjm	637	3	,	,	,
cord-023095-4dannjjm	637	4	the	the	DT
cord-023095-4dannjjm	637	5	paradoxical	paradoxical	JJ
cord-023095-4dannjjm	637	6	decrease	decrease	NN
cord-023095-4dannjjm	637	7	in	in	IN
cord-023095-4dannjjm	637	8	GLUT4	GLUT4	NNP
cord-023095-4dannjjm	637	9	content	content	NN
cord-023095-4dannjjm	637	10	in	in	IN
cord-023095-4dannjjm	637	11	RA	RA	NNP
cord-023095-4dannjjm	637	12	may	may	MD
cord-023095-4dannjjm	637	13	induce	induce	VB
cord-023095-4dannjjm	637	14	perturbations	perturbation	NNS
cord-023095-4dannjjm	637	15	in	in	IN
cord-023095-4dannjjm	637	16	atrial	atrial	JJ
cord-023095-4dannjjm	637	17	energy	energy	NN
cord-023095-4dannjjm	637	18	production	production	NN
cord-023095-4dannjjm	637	19	during	during	IN
cord-023095-4dannjjm	637	20	chronic	chronic	JJ
cord-023095-4dannjjm	637	21	HF	HF	NNP
cord-023095-4dannjjm	637	22	.	.	.
cord-023095-4dannjjm	638	1	Some	some	DT
cord-023095-4dannjjm	638	2	obese	obese	JJ
cord-023095-4dannjjm	638	3	dogs	dog	NNS
cord-023095-4dannjjm	638	4	are	be	VBP
cord-023095-4dannjjm	638	5	suspected	suspect	VBN
cord-023095-4dannjjm	638	6	to	to	TO
cord-023095-4dannjjm	638	7	have	have	VB
cord-023095-4dannjjm	638	8	cardiac	cardiac	JJ
cord-023095-4dannjjm	638	9	disease	disease	NN
cord-023095-4dannjjm	638	10	because	because	IN
cord-023095-4dannjjm	638	11	they	-PRON-	PRP
cord-023095-4dannjjm	638	12	have	have	VBP
cord-023095-4dannjjm	638	13	enlargement	enlargement	NN
cord-023095-4dannjjm	638	14	of	of	IN
cord-023095-4dannjjm	638	15	the	the	DT
cord-023095-4dannjjm	638	16	heart	heart	NN
cord-023095-4dannjjm	638	17	on	on	IN
cord-023095-4dannjjm	638	18	thoracic	thoracic	JJ
cord-023095-4dannjjm	638	19	radiograph	radiograph	NN
cord-023095-4dannjjm	638	20	.	.	.
cord-023095-4dannjjm	639	1	It	-PRON-	PRP
cord-023095-4dannjjm	639	2	has	have	VBZ
cord-023095-4dannjjm	639	3	been	be	VBN
cord-023095-4dannjjm	639	4	reported	report	VBN
cord-023095-4dannjjm	639	5	in	in	IN
cord-023095-4dannjjm	639	6	cats	cat	NNS
cord-023095-4dannjjm	639	7	that	that	IN
cord-023095-4dannjjm	639	8	the	the	DT
cord-023095-4dannjjm	639	9	fat	fat	NN
cord-023095-4dannjjm	639	10	increases	increase	VBZ
cord-023095-4dannjjm	639	11	the	the	DT
cord-023095-4dannjjm	639	12	cardiac	cardiac	JJ
cord-023095-4dannjjm	639	13	silhouette	silhouette	NN
cord-023095-4dannjjm	639	14	,	,	,
cord-023095-4dannjjm	639	15	while	while	IN
cord-023095-4dannjjm	639	16	echocardiograms	echocardiograms	NNP
cord-023095-4dannjjm	639	17	revealed	reveal	VBD
cord-023095-4dannjjm	639	18	normal	normal	JJ
cord-023095-4dannjjm	639	19	cardiac	cardiac	JJ
cord-023095-4dannjjm	639	20	dimensions	dimension	NNS
cord-023095-4dannjjm	639	21	.	.	.
cord-023095-4dannjjm	640	1	The	the	DT
cord-023095-4dannjjm	640	2	purpose	purpose	NN
cord-023095-4dannjjm	640	3	of	of	IN
cord-023095-4dannjjm	640	4	this	this	DT
cord-023095-4dannjjm	640	5	study	study	NN
cord-023095-4dannjjm	640	6	was	be	VBD
cord-023095-4dannjjm	640	7	to	to	TO
cord-023095-4dannjjm	640	8	determine	determine	VB
cord-023095-4dannjjm	640	9	whether	whether	IN
cord-023095-4dannjjm	640	10	obesity	obesity	NN
cord-023095-4dannjjm	640	11	overestimates	overestimate	VBZ
cord-023095-4dannjjm	640	12	cardiac	cardiac	JJ
cord-023095-4dannjjm	640	13	dimension	dimension	NN
cord-023095-4dannjjm	640	14	in	in	IN
cord-023095-4dannjjm	640	15	radiographs	radiograph	NNS
cord-023095-4dannjjm	640	16	compared	compare	VBN
cord-023095-4dannjjm	640	17	to	to	IN
cord-023095-4dannjjm	640	18	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	640	19	findings	finding	NNS
cord-023095-4dannjjm	640	20	in	in	IN
cord-023095-4dannjjm	640	21	dogs	dog	NNS
cord-023095-4dannjjm	640	22	.	.	.
cord-023095-4dannjjm	641	1	Twenty	twenty	CD
cord-023095-4dannjjm	641	2	three	three	CD
cord-023095-4dannjjm	641	3	obese	obese	JJ
cord-023095-4dannjjm	641	4	dogs	dog	NNS
cord-023095-4dannjjm	641	5	and	and	CC
cord-023095-4dannjjm	641	6	20	20	CD
cord-023095-4dannjjm	641	7	controls	control	NNS
cord-023095-4dannjjm	641	8	were	be	VBD
cord-023095-4dannjjm	641	9	included	include	VBN
cord-023095-4dannjjm	641	10	based	base	VBN
cord-023095-4dannjjm	641	11	on	on	IN
cord-023095-4dannjjm	641	12	a	a	DT
cord-023095-4dannjjm	641	13	1	1	CD
cord-023095-4dannjjm	641	14	-	-	SYM
cord-023095-4dannjjm	641	15	9	9	CD
cord-023095-4dannjjm	641	16	body	body	NN
cord-023095-4dannjjm	641	17	condition	condition	NN
cord-023095-4dannjjm	641	18	scoring	scoring	NN
cord-023095-4dannjjm	641	19	(	(	-LRB-
cord-023095-4dannjjm	641	20	BCS	BCS	NNP
cord-023095-4dannjjm	641	21	)	)	-RRB-
cord-023095-4dannjjm	641	22	.	.	.
cord-023095-4dannjjm	642	1	Computerized	computerized	JJ
cord-023095-4dannjjm	642	2	radiography	radiography	NN
cord-023095-4dannjjm	642	3	was	be	VBD
cord-023095-4dannjjm	642	4	obtained	obtain	VBN
cord-023095-4dannjjm	642	5	and	and	CC
cord-023095-4dannjjm	642	6	VHS	VHS	NNP
cord-023095-4dannjjm	642	7	measurement	measurement	NN
cord-023095-4dannjjm	642	8	was	be	VBD
cord-023095-4dannjjm	642	9	performed	perform	VBN
cord-023095-4dannjjm	642	10	as	as	IN
cord-023095-4dannjjm	642	11	previously	previously	RB
cord-023095-4dannjjm	642	12	described	describe	VBN
cord-023095-4dannjjm	642	13	.	.	.
cord-023095-4dannjjm	643	1	Echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	643	2	measurements	measurement	NNS
cord-023095-4dannjjm	643	3	were	be	VBD
cord-023095-4dannjjm	643	4	interpreted	interpret	VBN
cord-023095-4dannjjm	643	5	based	base	VBN
cord-023095-4dannjjm	643	6	on	on	IN
cord-023095-4dannjjm	643	7	reference	reference	NN
cord-023095-4dannjjm	643	8	values	value	NNS
cord-023095-4dannjjm	643	9	according	accord	VBG
cord-023095-4dannjjm	643	10	to	to	IN
cord-023095-4dannjjm	643	11	lean	lean	JJ
cord-023095-4dannjjm	643	12	body	body	NN
cord-023095-4dannjjm	643	13	weight	weight	NN
cord-023095-4dannjjm	643	14	regression	regression	NN
cord-023095-4dannjjm	643	15	equations	equation	NNS
cord-023095-4dannjjm	643	16	.	.	.
cord-023095-4dannjjm	644	1	Results	result	NNS
cord-023095-4dannjjm	644	2	for	for	IN
cord-023095-4dannjjm	644	3	echo	echo	NN
cord-023095-4dannjjm	644	4	and	and	CC
cord-023095-4dannjjm	644	5	VHS	vhs	NN
cord-023095-4dannjjm	644	6	measurements	measurement	NNS
cord-023095-4dannjjm	644	7	were	be	VBD
cord-023095-4dannjjm	644	8	classified	classify	VBN
cord-023095-4dannjjm	644	9	in	in	IN
cord-023095-4dannjjm	644	10	scores	score	NNS
cord-023095-4dannjjm	644	11	as	as	IN
cord-023095-4dannjjm	644	12	normal	normal	JJ
cord-023095-4dannjjm	644	13	,	,	,
cord-023095-4dannjjm	644	14	mild	mild	JJ
cord-023095-4dannjjm	644	15	,	,	,
cord-023095-4dannjjm	644	16	moderate	moderate	JJ
cord-023095-4dannjjm	644	17	or	or	CC
cord-023095-4dannjjm	644	18	severe	severe	JJ
cord-023095-4dannjjm	644	19	increase	increase	NN
cord-023095-4dannjjm	644	20	.	.	.
cord-023095-4dannjjm	645	1	Student	student	NN
cord-023095-4dannjjm	645	2	's	's	POS
cord-023095-4dannjjm	645	3	t	t	NN
cord-023095-4dannjjm	645	4	test	test	NN
cord-023095-4dannjjm	645	5	was	be	VBD
cord-023095-4dannjjm	645	6	used	use	VBN
cord-023095-4dannjjm	645	7	for	for	IN
cord-023095-4dannjjm	645	8	comparison	comparison	NN
cord-023095-4dannjjm	645	9	of	of	IN
cord-023095-4dannjjm	645	10	VHS	vhs	NN
cord-023095-4dannjjm	645	11	between	between	IN
cord-023095-4dannjjm	645	12	groups	group	NNS
cord-023095-4dannjjm	645	13	.	.	.
cord-023095-4dannjjm	646	1	Mann	Mann	NNP
cord-023095-4dannjjm	646	2	-	-	HYPH
cord-023095-4dannjjm	646	3	Whitney	Whitney	NNP
cord-023095-4dannjjm	646	4	Rank	Rank	NNP
cord-023095-4dannjjm	646	5	Sum	Sum	NNP
cord-023095-4dannjjm	646	6	test	test	NN
cord-023095-4dannjjm	646	7	was	be	VBD
cord-023095-4dannjjm	646	8	used	use	VBN
cord-023095-4dannjjm	646	9	to	to	TO
cord-023095-4dannjjm	646	10	assess	assess	VB
cord-023095-4dannjjm	646	11	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	646	12	scores	score	NNS
cord-023095-4dannjjm	646	13	between	between	IN
cord-023095-4dannjjm	646	14	groups	group	NNS
cord-023095-4dannjjm	646	15	.	.	.
cord-023095-4dannjjm	647	1	Spearman	Spearman	NNP
cord-023095-4dannjjm	647	2	Rank	Rank	NNP
cord-023095-4dannjjm	647	3	Order	Order	NNP
cord-023095-4dannjjm	647	4	Correlation	Correlation	NNP
cord-023095-4dannjjm	647	5	was	be	VBD
cord-023095-4dannjjm	647	6	used	use	VBN
cord-023095-4dannjjm	647	7	to	to	TO
cord-023095-4dannjjm	647	8	assess	assess	VB
cord-023095-4dannjjm	647	9	relationships	relationship	NNS
cord-023095-4dannjjm	647	10	between	between	IN
cord-023095-4dannjjm	647	11	any	any	DT
cord-023095-4dannjjm	647	12	pairs	pair	NNS
cord-023095-4dannjjm	647	13	of	of	IN
cord-023095-4dannjjm	647	14	variables	variable	NNS
cord-023095-4dannjjm	647	15	between	between	IN
cord-023095-4dannjjm	647	16	echo	echo	NN
cord-023095-4dannjjm	647	17	and	and	CC
cord-023095-4dannjjm	647	18	VHS	VHS	NNP
cord-023095-4dannjjm	647	19	scores	score	NNS
cord-023095-4dannjjm	647	20	,	,	,
cord-023095-4dannjjm	647	21	echo	echo	VBP
cord-023095-4dannjjm	647	22	vs	vs	IN
cord-023095-4dannjjm	647	23	BCS	BCS	NNP
cord-023095-4dannjjm	647	24	and	and	CC
cord-023095-4dannjjm	647	25	VHS	VHS	NNP
cord-023095-4dannjjm	647	26	vs	vs	IN
cord-023095-4dannjjm	647	27	BCS	BCS	NNP
cord-023095-4dannjjm	647	28	.	.	.
cord-023095-4dannjjm	648	1	Groups	group	NNS
cord-023095-4dannjjm	648	2	were	be	VBD
cord-023095-4dannjjm	648	3	similar	similar	JJ
cord-023095-4dannjjm	648	4	regarding	regard	VBG
cord-023095-4dannjjm	648	5	age	age	NN
cord-023095-4dannjjm	648	6	[	[	-LRB-
cord-023095-4dannjjm	648	7	obese	obese	JJ
cord-023095-4dannjjm	648	8	(	(	-LRB-
cord-023095-4dannjjm	648	9	69AE24	69ae24	NN
cord-023095-4dannjjm	648	10	)	)	-RRB-
cord-023095-4dannjjm	648	11	;	;	:
cord-023095-4dannjjm	648	12	control	control	NN
cord-023095-4dannjjm	648	13	(	(	-LRB-
cord-023095-4dannjjm	648	14	62AE27	62ae27	NN
cord-023095-4dannjjm	648	15	)	)	-RRB-
cord-023095-4dannjjm	648	16	;	;	:
cord-023095-4dannjjm	648	17	P	p	NN
cord-023095-4dannjjm	648	18	5	5	CD
cord-023095-4dannjjm	648	19	0.368	0.368	CD
cord-023095-4dannjjm	648	20	]	]	-RRB-
cord-023095-4dannjjm	648	21	,	,	,
cord-023095-4dannjjm	648	22	breeds	breed	NNS
cord-023095-4dannjjm	648	23	and	and	CC
cord-023095-4dannjjm	648	24	gender	gender	NN
cord-023095-4dannjjm	648	25	distribution	distribution	NN
cord-023095-4dannjjm	648	26	.	.	.
cord-023095-4dannjjm	649	1	Obese	obese	JJ
cord-023095-4dannjjm	649	2	dogs	dog	NNS
cord-023095-4dannjjm	649	3	had	have	VBD
cord-023095-4dannjjm	649	4	significantly	significantly	RB
cord-023095-4dannjjm	649	5	higher	high	JJR
cord-023095-4dannjjm	649	6	VHS	vhs	NN
cord-023095-4dannjjm	649	7	and	and	CC
cord-023095-4dannjjm	649	8	echo	echo	NN
cord-023095-4dannjjm	649	9	scores	score	NNS
cord-023095-4dannjjm	649	10	compared	compare	VBN
cord-023095-4dannjjm	649	11	with	with	IN
cord-023095-4dannjjm	649	12	controls	control	NNS
cord-023095-4dannjjm	649	13	[	[	-LRB-
cord-023095-4dannjjm	649	14	VHS	vhs	NN
cord-023095-4dannjjm	649	15	:	:	:
cord-023095-4dannjjm	649	16	(	(	-LRB-
cord-023095-4dannjjm	649	17	10.58AE0.69	10.58ae0.69	CD
cord-023095-4dannjjm	649	18	)	)	-RRB-
cord-023095-4dannjjm	649	19	vs	vs	IN
cord-023095-4dannjjm	649	20	(	(	-LRB-
cord-023095-4dannjjm	649	21	9.77AE0.54	9.77ae0.54	CD
cord-023095-4dannjjm	649	22	)	)	-RRB-
cord-023095-4dannjjm	649	23	;	;	:
cord-023095-4dannjjm	650	1	P	p	NN
cord-023095-4dannjjm	650	2	o	o	NN
cord-023095-4dannjjm	650	3	0.001	0.001	CD
cord-023095-4dannjjm	650	4	;	;	:
cord-023095-4dannjjm	650	5	Echo	Echo	NNP
cord-023095-4dannjjm	650	6	score	score	NN
cord-023095-4dannjjm	650	7	:	:	:
cord-023095-4dannjjm	650	8	range	range	NN
cord-023095-4dannjjm	650	9	(	(	-LRB-
cord-023095-4dannjjm	650	10	1	1	CD
cord-023095-4dannjjm	650	11	-	-	SYM
cord-023095-4dannjjm	650	12	4	4	CD
cord-023095-4dannjjm	650	13	)	)	-RRB-
cord-023095-4dannjjm	651	1	vs	vs	IN
cord-023095-4dannjjm	651	2	(	(	-LRB-
cord-023095-4dannjjm	651	3	1	1	CD
cord-023095-4dannjjm	651	4	-	-	SYM
cord-023095-4dannjjm	651	5	2	2	CD
cord-023095-4dannjjm	651	6	)	)	-RRB-
cord-023095-4dannjjm	651	7	;	;	:
cord-023095-4dannjjm	651	8	P	p	NN
cord-023095-4dannjjm	651	9	4	4	CD
cord-023095-4dannjjm	651	10	0.05	0.05	CD
cord-023095-4dannjjm	651	11	]	]	-RRB-
cord-023095-4dannjjm	651	12	.	.	.
cord-023095-4dannjjm	652	1	There	there	EX
cord-023095-4dannjjm	652	2	were	be	VBD
cord-023095-4dannjjm	652	3	no	no	DT
cord-023095-4dannjjm	652	4	relationships	relationship	NNS
cord-023095-4dannjjm	652	5	between	between	IN
cord-023095-4dannjjm	652	6	any	any	DT
cord-023095-4dannjjm	652	7	pair	pair	NN
cord-023095-4dannjjm	652	8	of	of	IN
cord-023095-4dannjjm	652	9	variables	variable	NNS
cord-023095-4dannjjm	652	10	analyzed	analyze	VBN
cord-023095-4dannjjm	652	11	.	.	.
cord-023095-4dannjjm	653	1	These	these	DT
cord-023095-4dannjjm	653	2	results	result	NNS
cord-023095-4dannjjm	653	3	show	show	VBP
cord-023095-4dannjjm	653	4	that	that	IN
cord-023095-4dannjjm	653	5	there	there	EX
cord-023095-4dannjjm	653	6	are	be	VBP
cord-023095-4dannjjm	653	7	changes	change	NNS
cord-023095-4dannjjm	653	8	both	both	DT
cord-023095-4dannjjm	653	9	in	in	IN
cord-023095-4dannjjm	653	10	echo	echo	NN
cord-023095-4dannjjm	653	11	and	and	CC
cord-023095-4dannjjm	653	12	radiographic	radiographic	JJ
cord-023095-4dannjjm	653	13	appearance	appearance	NN
cord-023095-4dannjjm	653	14	of	of	IN
cord-023095-4dannjjm	653	15	the	the	DT
cord-023095-4dannjjm	653	16	heart	heart	NN
cord-023095-4dannjjm	653	17	in	in	IN
cord-023095-4dannjjm	653	18	obese	obese	JJ
cord-023095-4dannjjm	653	19	dogs	dog	NNS
cord-023095-4dannjjm	653	20	,	,	,
cord-023095-4dannjjm	653	21	but	but	CC
cord-023095-4dannjjm	653	22	VHS	VHS	NNP
cord-023095-4dannjjm	653	23	overestimates	overestimate	VBZ
cord-023095-4dannjjm	653	24	cardiac	cardiac	JJ
cord-023095-4dannjjm	653	25	silhouette	silhouette	NN
cord-023095-4dannjjm	653	26	compared	compare	VBN
cord-023095-4dannjjm	653	27	to	to	TO
cord-023095-4dannjjm	653	28	echo	echo	VB
cord-023095-4dannjjm	653	29	,	,	,
cord-023095-4dannjjm	653	30	probably	probably	RB
cord-023095-4dannjjm	653	31	related	relate	VBD
cord-023095-4dannjjm	653	32	to	to	IN
cord-023095-4dannjjm	653	33	pericardial	pericardial	JJ
cord-023095-4dannjjm	653	34	fat	fat	JJ
cord-023095-4dannjjm	653	35	accumulation	accumulation	NN
cord-023095-4dannjjm	653	36	.	.	.
cord-023095-4dannjjm	654	1	Heart	heart	NN
cord-023095-4dannjjm	654	2	rate	rate	NN
cord-023095-4dannjjm	654	3	variability	variability	NN
cord-023095-4dannjjm	654	4	(	(	-LRB-
cord-023095-4dannjjm	654	5	HRV	HRV	NNP
cord-023095-4dannjjm	654	6	)	)	-RRB-
cord-023095-4dannjjm	654	7	is	be	VBZ
cord-023095-4dannjjm	654	8	an	an	DT
cord-023095-4dannjjm	654	9	indirect	indirect	JJ
cord-023095-4dannjjm	654	10	measurement	measurement	NN
cord-023095-4dannjjm	654	11	of	of	IN
cord-023095-4dannjjm	654	12	the	the	DT
cord-023095-4dannjjm	654	13	autonomic	autonomic	JJ
cord-023095-4dannjjm	654	14	modulation	modulation	NN
cord-023095-4dannjjm	654	15	of	of	IN
cord-023095-4dannjjm	654	16	heart	heart	NN
cord-023095-4dannjjm	654	17	rate	rate	NN
cord-023095-4dannjjm	654	18	(	(	-LRB-
cord-023095-4dannjjm	654	19	HR	HR	NNP
cord-023095-4dannjjm	654	20	)	)	-RRB-
cord-023095-4dannjjm	654	21	.	.	.
cord-023095-4dannjjm	655	1	Reduced	reduce	VBN
cord-023095-4dannjjm	655	2	HRV	HRV	NNP
cord-023095-4dannjjm	655	3	measured	measure	VBN
cord-023095-4dannjjm	655	4	from	from	IN
cord-023095-4dannjjm	655	5	short	short	JJ
cord-023095-4dannjjm	655	6	-	-	HYPH
cord-023095-4dannjjm	655	7	time	time	NN
cord-023095-4dannjjm	655	8	electrocardiography	electrocardiography	NN
cord-023095-4dannjjm	655	9	is	be	VBZ
cord-023095-4dannjjm	655	10	seen	see	VBN
cord-023095-4dannjjm	655	11	in	in	IN
cord-023095-4dannjjm	655	12	dogs	dog	NNS
cord-023095-4dannjjm	655	13	with	with	IN
cord-023095-4dannjjm	655	14	heart	heart	NN
cord-023095-4dannjjm	655	15	failure	failure	NN
cord-023095-4dannjjm	655	16	(	(	-LRB-
cord-023095-4dannjjm	655	17	HF	HF	NNP
cord-023095-4dannjjm	655	18	)	)	-RRB-
cord-023095-4dannjjm	655	19	secondary	secondary	JJ
cord-023095-4dannjjm	655	20	to	to	IN
cord-023095-4dannjjm	655	21	myxomatous	myxomatous	JJ
cord-023095-4dannjjm	655	22	mitral	mitral	JJ
cord-023095-4dannjjm	655	23	valve	valve	NN
cord-023095-4dannjjm	655	24	disease	disease	NN
cord-023095-4dannjjm	655	25	(	(	-LRB-
cord-023095-4dannjjm	655	26	MMVD	MMVD	NNP
cord-023095-4dannjjm	655	27	)	)	-RRB-
cord-023095-4dannjjm	655	28	.	.	.
cord-023095-4dannjjm	656	1	However	however	RB
cord-023095-4dannjjm	656	2	,	,	,
cord-023095-4dannjjm	656	3	HRV	HRV	NNP
cord-023095-4dannjjm	656	4	is	be	VBZ
cord-023095-4dannjjm	656	5	suggested	suggest	VBN
cord-023095-4dannjjm	656	6	to	to	TO
cord-023095-4dannjjm	656	7	increase	increase	VB
cord-023095-4dannjjm	656	8	with	with	IN
cord-023095-4dannjjm	656	9	disease	disease	NN
cord-023095-4dannjjm	656	10	severity	severity	NN
cord-023095-4dannjjm	656	11	at	at	IN
cord-023095-4dannjjm	656	12	early	early	JJ
cord-023095-4dannjjm	656	13	stages	stage	NNS
cord-023095-4dannjjm	656	14	of	of	IN
cord-023095-4dannjjm	656	15	MMVD	MMVD	NNP
cord-023095-4dannjjm	656	16	.	.	.
cord-023095-4dannjjm	657	1	The	the	DT
cord-023095-4dannjjm	657	2	aims	aim	NNS
cord-023095-4dannjjm	657	3	of	of	IN
cord-023095-4dannjjm	657	4	this	this	DT
cord-023095-4dannjjm	657	5	study	study	NN
cord-023095-4dannjjm	657	6	were	be	VBD
cord-023095-4dannjjm	657	7	1	1	CD
cord-023095-4dannjjm	657	8	)	)	-RRB-
cord-023095-4dannjjm	657	9	to	to	TO
cord-023095-4dannjjm	657	10	associate	associate	VB
cord-023095-4dannjjm	657	11	HR	HR	NNP
cord-023095-4dannjjm	657	12	and	and	CC
cord-023095-4dannjjm	657	13	HRV	HRV	NNP
cord-023095-4dannjjm	657	14	with	with	IN
cord-023095-4dannjjm	657	15	severity	severity	NN
cord-023095-4dannjjm	657	16	of	of	IN
cord-023095-4dannjjm	657	17	MMVD	MMVD	NNP
cord-023095-4dannjjm	657	18	in	in	IN
cord-023095-4dannjjm	657	19	Cavalier	Cavalier	NNP
cord-023095-4dannjjm	657	20	King	King	NNP
cord-023095-4dannjjm	657	21	Charles	Charles	NNP
cord-023095-4dannjjm	657	22	Spaniels	Spaniels	NNPS
cord-023095-4dannjjm	658	1	(	(	-LRB-
cord-023095-4dannjjm	658	2	CKCS	CKCS	NNP
cord-023095-4dannjjm	658	3	)	)	-RRB-
cord-023095-4dannjjm	658	4	and	and	CC
cord-023095-4dannjjm	658	5	2	2	LS
cord-023095-4dannjjm	658	6	)	)	-RRB-
cord-023095-4dannjjm	659	1	to	to	TO
cord-023095-4dannjjm	659	2	compare	compare	VB
cord-023095-4dannjjm	659	3	HR	HR	NNP
cord-023095-4dannjjm	659	4	and	and	CC
cord-023095-4dannjjm	659	5	HRV	HRV	NNP
cord-023095-4dannjjm	659	6	between	between	IN
cord-023095-4dannjjm	659	7	CKCS	CKCS	NNP
cord-023095-4dannjjm	659	8	and	and	CC
cord-023095-4dannjjm	659	9	other	other	JJ
cord-023095-4dannjjm	659	10	dog	dog	NN
cord-023095-4dannjjm	659	11	breeds	breed	NNS
cord-023095-4dannjjm	659	12	in	in	IN
cord-023095-4dannjjm	659	13	a	a	DT
cord-023095-4dannjjm	659	14	group	group	NN
cord-023095-4dannjjm	659	15	of	of	IN
cord-023095-4dannjjm	659	16	dogs	dog	NNS
cord-023095-4dannjjm	659	17	in	in	IN
cord-023095-4dannjjm	659	18	HF	HF	NNP
cord-023095-4dannjjm	659	19	secondary	secondary	JJ
cord-023095-4dannjjm	659	20	to	to	IN
cord-023095-4dannjjm	659	21	MMVD	MMVD	NNP
cord-023095-4dannjjm	659	22	.	.	.
cord-023095-4dannjjm	660	1	One	one	CD
cord-023095-4dannjjm	660	2	-	-	HYPH
cord-023095-4dannjjm	660	3	hundred	hundred	CD
cord-023095-4dannjjm	660	4	dogs	dog	NNS
cord-023095-4dannjjm	660	5	were	be	VBD
cord-023095-4dannjjm	660	6	examined	examine	VBN
cord-023095-4dannjjm	660	7	by	by	IN
cord-023095-4dannjjm	660	8	echocardiography	echocardiography	NN
cord-023095-4dannjjm	660	9	and	and	CC
cord-023095-4dannjjm	660	10	24hour	24hour	JJ
cord-023095-4dannjjm	660	11	electrocardiography	electrocardiography	NN
cord-023095-4dannjjm	660	12	.	.	.
cord-023095-4dannjjm	661	1	The	the	DT
cord-023095-4dannjjm	661	2	dogs	dog	NNS
cord-023095-4dannjjm	661	3	were	be	VBD
cord-023095-4dannjjm	661	4	divided	divide	VBN
cord-023095-4dannjjm	661	5	into	into	IN
cord-023095-4dannjjm	661	6	five	five	CD
cord-023095-4dannjjm	661	7	groups	group	NNS
cord-023095-4dannjjm	661	8	:	:	:
cord-023095-4dannjjm	662	1	1	1	LS
cord-023095-4dannjjm	662	2	)	)	-RRB-
cord-023095-4dannjjm	662	3	CKCS	ckcs	NN
cord-023095-4dannjjm	662	4	with	with	IN
cord-023095-4dannjjm	662	5	no	no	DT
cord-023095-4dannjjm	662	6	/	/	SYM
cord-023095-4dannjjm	662	7	minimal	minimal	JJ
cord-023095-4dannjjm	662	8	mitral	mitral	JJ
cord-023095-4dannjjm	662	9	regurgitation	regurgitation	NN
cord-023095-4dannjjm	662	10	(	(	-LRB-
cord-023095-4dannjjm	662	11	MR	MR	NNP
cord-023095-4dannjjm	662	12	)	)	-RRB-
cord-023095-4dannjjm	662	13	(	(	-LRB-
cord-023095-4dannjjm	662	14	MR	MR	NNP
cord-023095-4dannjjm	662	15	jet	jet	NN
cord-023095-4dannjjm	662	16	15	15	CD
cord-023095-4dannjjm	662	17	%	%	NN
cord-023095-4dannjjm	662	18	of	of	IN
cord-023095-4dannjjm	662	19	the	the	DT
cord-023095-4dannjjm	662	20	left	left	JJ
cord-023095-4dannjjm	662	21	atrial	atrial	JJ
cord-023095-4dannjjm	662	22	area	area	NN
cord-023095-4dannjjm	662	23	using	use	VBG
cord-023095-4dannjjm	662	24	color	color	NN
cord-023095-4dannjjm	662	25	Doppler	Doppler	NNP
cord-023095-4dannjjm	662	26	mapping	mapping	NN
cord-023095-4dannjjm	662	27	)	)	-RRB-
cord-023095-4dannjjm	662	28	and	and	CC
cord-023095-4dannjjm	662	29	no	no	DT
cord-023095-4dannjjm	662	30	murmur	murmur	NN
cord-023095-4dannjjm	662	31	,	,	,
cord-023095-4dannjjm	662	32	2	2	CD
cord-023095-4dannjjm	662	33	)	)	-RRB-
cord-023095-4dannjjm	663	1	CKCS	CKCS	NNP
cord-023095-4dannjjm	663	2	with	with	IN
cord-023095-4dannjjm	663	3	mild	mild	JJ
cord-023095-4dannjjm	663	4	MR	MR	NNP
cord-023095-4dannjjm	663	5	(	(	-LRB-
cord-023095-4dannjjm	663	6	20	20	CD
cord-023095-4dannjjm	663	7	%	%	NN
cord-023095-4dannjjm	664	1	o	o	UH
cord-023095-4dannjjm	664	2	jet	jet	NN
cord-023095-4dannjjm	664	3	50	50	CD
cord-023095-4dannjjm	664	4	%	%	NN
cord-023095-4dannjjm	664	5	)	)	-RRB-
cord-023095-4dannjjm	664	6	,	,	.
cord-023095-4dannjjm	665	1	3	3	LS
cord-023095-4dannjjm	665	2	)	)	-RRB-
cord-023095-4dannjjm	665	3	CKCS	CKCS	NNP
cord-023095-4dannjjm	665	4	with	with	IN
cord-023095-4dannjjm	665	5	moderate/	moderate/	CD
cord-023095-4dannjjm	666	1	severe	severe	JJ
cord-023095-4dannjjm	666	2	MR	MR	NNP
cord-023095-4dannjjm	666	3	(	(	-LRB-
cord-023095-4dannjjm	666	4	jet450	jet450	NNP
cord-023095-4dannjjm	666	5	%	%	NN
cord-023095-4dannjjm	666	6	)	)	-RRB-
cord-023095-4dannjjm	666	7	and	and	CC
cord-023095-4dannjjm	666	8	no	no	DT
cord-023095-4dannjjm	666	9	clinical	clinical	JJ
cord-023095-4dannjjm	666	10	signs	sign	NNS
cord-023095-4dannjjm	666	11	of	of	IN
cord-023095-4dannjjm	666	12	HF	HF	NNP
cord-023095-4dannjjm	666	13	,	,	,
cord-023095-4dannjjm	666	14	4	4	CD
cord-023095-4dannjjm	666	15	)	)	-RRB-
cord-023095-4dannjjm	667	1	CKCS	CKCS	NNP
cord-023095-4dannjjm	667	2	in	in	IN
cord-023095-4dannjjm	667	3	HF	HF	NNP
cord-023095-4dannjjm	667	4	(	(	-LRB-
cord-023095-4dannjjm	667	5	HF	HF	NNP
cord-023095-4dannjjm	667	6	defined	define	VBN
cord-023095-4dannjjm	667	7	as	as	IN
cord-023095-4dannjjm	667	8	left	leave	VBN
cord-023095-4dannjjm	667	9	atrium	atrium	NN
cord-023095-4dannjjm	667	10	to	to	IN
cord-023095-4dannjjm	667	11	aortic	aortic	JJ
cord-023095-4dannjjm	667	12	root	root	NN
cord-023095-4dannjjm	667	13	ratio	ratio	NN
cord-023095-4dannjjm	667	14	(	(	-LRB-
cord-023095-4dannjjm	667	15	LA	LA	NNP
cord-023095-4dannjjm	667	16	/	/	SYM
cord-023095-4dannjjm	667	17	Ao	Ao	NNP
cord-023095-4dannjjm	667	18	)	)	-RRB-
cord-023095-4dannjjm	667	19	41.5	41.5	CD
cord-023095-4dannjjm	667	20	,	,	,
cord-023095-4dannjjm	667	21	clinical	clinical	JJ
cord-023095-4dannjjm	667	22	signs	sign	NNS
cord-023095-4dannjjm	667	23	of	of	IN
cord-023095-4dannjjm	667	24	HF	HF	NNP
cord-023095-4dannjjm	667	25	and	and	CC
cord-023095-4dannjjm	667	26	furosemide	furosemide	NN
cord-023095-4dannjjm	667	27	responsiveness	responsiveness	NN
cord-023095-4dannjjm	667	28	)	)	-RRB-
cord-023095-4dannjjm	667	29	and	and	CC
cord-023095-4dannjjm	667	30	5	5	LS
cord-023095-4dannjjm	667	31	)	)	-RRB-
cord-023095-4dannjjm	667	32	non	non	JJ
cord-023095-4dannjjm	667	33	-	-	JJ
cord-023095-4dannjjm	667	34	CKCS	CKCS	NNP
cord-023095-4dannjjm	667	35	in	in	IN
cord-023095-4dannjjm	667	36	HF	HF	NNP
cord-023095-4dannjjm	667	37	.	.	.
cord-023095-4dannjjm	668	1	Dogs	Dogs	NNP
cord-023095-4dannjjm	668	2	in	in	IN
cord-023095-4dannjjm	668	3	HF	HF	NNP
cord-023095-4dannjjm	668	4	were	be	VBD
cord-023095-4dannjjm	668	5	allowed	allow	VBN
cord-023095-4dannjjm	668	6	HF	HF	NNP
cord-023095-4dannjjm	668	7	therapy	therapy	NN
cord-023095-4dannjjm	668	8	.	.	.
cord-023095-4dannjjm	669	1	Both	both	DT
cord-023095-4dannjjm	669	2	HR	HR	NNP
cord-023095-4dannjjm	669	3	and	and	CC
cord-023095-4dannjjm	669	4	HRV	HRV	NNP
cord-023095-4dannjjm	669	5	were	be	VBD
cord-023095-4dannjjm	669	6	analyzed	analyze	VBN
cord-023095-4dannjjm	669	7	over	over	IN
cord-023095-4dannjjm	669	8	a	a	DT
cord-023095-4dannjjm	669	9	24-hour	24-hour	JJ
cord-023095-4dannjjm	669	10	period	period	NN
cord-023095-4dannjjm	669	11	,	,	,
cord-023095-4dannjjm	669	12	while	while	IN
cord-023095-4dannjjm	669	13	HRV	HRV	NNP
cord-023095-4dannjjm	669	14	were	be	VBD
cord-023095-4dannjjm	669	15	also	also	RB
cord-023095-4dannjjm	669	16	analysed	analyse	VBN
cord-023095-4dannjjm	669	17	over	over	IN
cord-023095-4dannjjm	669	18	a	a	DT
cord-023095-4dannjjm	669	19	6-hour	6-hour	CD
cord-023095-4dannjjm	669	20	nightly	nightly	JJ
cord-023095-4dannjjm	669	21	period	period	NN
cord-023095-4dannjjm	669	22	.	.	.
cord-023095-4dannjjm	670	1	Analyses	analysis	NNS
cord-023095-4dannjjm	670	2	of	of	IN
cord-023095-4dannjjm	670	3	variance	variance	NN
cord-023095-4dannjjm	670	4	were	be	VBD
cord-023095-4dannjjm	670	5	performed	perform	VBN
cord-023095-4dannjjm	670	6	with	with	IN
cord-023095-4dannjjm	670	7	HR	HR	NNP
cord-023095-4dannjjm	670	8	or	or	CC
cord-023095-4dannjjm	670	9	HRV	HRV	NNP
cord-023095-4dannjjm	670	10	as	as	IN
cord-023095-4dannjjm	670	11	response	response	NN
cord-023095-4dannjjm	670	12	variables	variable	NNS
cord-023095-4dannjjm	670	13	and	and	CC
cord-023095-4dannjjm	670	14	the	the	DT
cord-023095-4dannjjm	670	15	explanatory	explanatory	JJ
cord-023095-4dannjjm	670	16	variables	variable	NNS
cord-023095-4dannjjm	670	17	dog	dog	NN
cord-023095-4dannjjm	670	18	group	group	NN
cord-023095-4dannjjm	670	19	and	and	CC
cord-023095-4dannjjm	670	20	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	670	21	indices	index	NNS
cord-023095-4dannjjm	670	22	of	of	IN
cord-023095-4dannjjm	670	23	MMVD	MMVD	NNP
cord-023095-4dannjjm	670	24	were	be	VBD
cord-023095-4dannjjm	670	25	included	include	VBN
cord-023095-4dannjjm	670	26	separately	separately	RB
cord-023095-4dannjjm	670	27	.	.	.
cord-023095-4dannjjm	671	1	All	all	DT
cord-023095-4dannjjm	671	2	P	p	NN
cord-023095-4dannjjm	671	3	-	-	HYPH
cord-023095-4dannjjm	671	4	values	value	NNS
cord-023095-4dannjjm	671	5	were	be	VBD
cord-023095-4dannjjm	671	6	Bonferroni	Bonferroni	NNP
cord-023095-4dannjjm	671	7	corrected	correct	VBN
cord-023095-4dannjjm	671	8	.	.	.
cord-023095-4dannjjm	672	1	Minimum	minimum	NN
cord-023095-4dannjjm	672	2	-	-	:
cord-023095-4dannjjm	672	3	and	and	CC
cord-023095-4dannjjm	672	4	mean	mean	VB
cord-023095-4dannjjm	672	5	HR	HR	NNP
cord-023095-4dannjjm	672	6	were	be	VBD
cord-023095-4dannjjm	672	7	significantly	significantly	RB
cord-023095-4dannjjm	672	8	higher	high	JJR
cord-023095-4dannjjm	672	9	in	in	IN
cord-023095-4dannjjm	672	10	CKCS	CKCS	NNP
cord-023095-4dannjjm	672	11	with	with	IN
cord-023095-4dannjjm	672	12	moderate	moderate	JJ
cord-023095-4dannjjm	672	13	/	/	SYM
cord-023095-4dannjjm	672	14	severe	severe	JJ
cord-023095-4dannjjm	672	15	MR	MR	NNP
cord-023095-4dannjjm	672	16	and	and	CC
cord-023095-4dannjjm	672	17	in	in	IN
cord-023095-4dannjjm	672	18	HF	HF	NNP
cord-023095-4dannjjm	672	19	compared	compare	VBN
cord-023095-4dannjjm	672	20	to	to	IN
cord-023095-4dannjjm	672	21	CKCS	CKCS	NNP
cord-023095-4dannjjm	672	22	with	with	IN
cord-023095-4dannjjm	672	23	no/	no/	NNP
cord-023095-4dannjjm	672	24	minimal	minimal	JJ
cord-023095-4dannjjm	672	25	and	and	CC
cord-023095-4dannjjm	672	26	mild	mild	JJ
cord-023095-4dannjjm	672	27	MR	MR	NNP
cord-023095-4dannjjm	672	28	(	(	-LRB-
cord-023095-4dannjjm	672	29	all	all	DT
cord-023095-4dannjjm	672	30	P	p	NN
cord-023095-4dannjjm	672	31	o	o	NN
cord-023095-4dannjjm	672	32	0.001	0.001	CD
cord-023095-4dannjjm	672	33	)	)	-RRB-
cord-023095-4dannjjm	672	34	.	.	.
cord-023095-4dannjjm	673	1	Seven	seven	CD
cord-023095-4dannjjm	673	2	out	out	IN
cord-023095-4dannjjm	673	3	of	of	IN
cord-023095-4dannjjm	673	4	26	26	CD
cord-023095-4dannjjm	673	5	HRV	HRV	NNP
cord-023095-4dannjjm	673	6	variables	variable	NNS
cord-023095-4dannjjm	673	7	were	be	VBD
cord-023095-4dannjjm	673	8	significantly	significantly	RB
cord-023095-4dannjjm	673	9	decreased	decrease	VBN
cord-023095-4dannjjm	673	10	in	in	IN
cord-023095-4dannjjm	673	11	CKCS	CKCS	NNP
cord-023095-4dannjjm	673	12	with	with	IN
cord-023095-4dannjjm	673	13	moderate/	moderate/	CD
cord-023095-4dannjjm	674	1	severe	severe	JJ
cord-023095-4dannjjm	674	2	MR	MR	NNP
cord-023095-4dannjjm	674	3	and	and	CC
cord-023095-4dannjjm	674	4	in	in	IN
cord-023095-4dannjjm	674	5	HF	HF	NNP
cord-023095-4dannjjm	675	1	compared	compare	VBN
cord-023095-4dannjjm	675	2	to	to	IN
cord-023095-4dannjjm	675	3	CKCS	CKCS	NNP
cord-023095-4dannjjm	675	4	with	with	IN
cord-023095-4dannjjm	675	5	no	no	DT
cord-023095-4dannjjm	675	6	/	/	SYM
cord-023095-4dannjjm	675	7	minimal	minimal	JJ
cord-023095-4dannjjm	675	8	and	and	CC
cord-023095-4dannjjm	675	9	mild	mild	JJ
cord-023095-4dannjjm	675	10	MR	MR	NNP
cord-023095-4dannjjm	675	11	(	(	-LRB-
cord-023095-4dannjjm	675	12	all	all	DT
cord-023095-4dannjjm	675	13	P	p	NN
cord-023095-4dannjjm	675	14	o	o	NN
cord-023095-4dannjjm	675	15	0.02	0.02	CD
cord-023095-4dannjjm	675	16	)	)	-RRB-
cord-023095-4dannjjm	675	17	.	.	.
cord-023095-4dannjjm	676	1	Another	another	DT
cord-023095-4dannjjm	676	2	10	10	CD
cord-023095-4dannjjm	676	3	HRV	HRV	NNP
cord-023095-4dannjjm	676	4	variables	variable	NNS
cord-023095-4dannjjm	676	5	showed	show	VBD
cord-023095-4dannjjm	676	6	the	the	DT
cord-023095-4dannjjm	676	7	same	same	JJ
cord-023095-4dannjjm	676	8	groupwise	groupwise	NNP
cord-023095-4dannjjm	676	9	differences	difference	NNS
cord-023095-4dannjjm	676	10	(	(	-LRB-
cord-023095-4dannjjm	676	11	all	all	DT
cord-023095-4dannjjm	676	12	P	p	NN
cord-023095-4dannjjm	676	13	o	o	NN
cord-023095-4dannjjm	676	14	0.02	0.02	CD
cord-023095-4dannjjm	676	15	)	)	-RRB-
cord-023095-4dannjjm	676	16	,	,	,
cord-023095-4dannjjm	676	17	except	except	IN
cord-023095-4dannjjm	676	18	that	that	IN
cord-023095-4dannjjm	676	19	the	the	DT
cord-023095-4dannjjm	676	20	difference	difference	NN
cord-023095-4dannjjm	676	21	between	between	IN
cord-023095-4dannjjm	676	22	CKCS	CKCS	NNP
cord-023095-4dannjjm	676	23	with	with	IN
cord-023095-4dannjjm	676	24	mild	mild	JJ
cord-023095-4dannjjm	676	25	MR	MR	NNP
cord-023095-4dannjjm	676	26	and	and	CC
cord-023095-4dannjjm	676	27	CKCS	CKCS	NNP
cord-023095-4dannjjm	676	28	with	with	IN
cord-023095-4dannjjm	676	29	moderate	moderate	JJ
cord-023095-4dannjjm	676	30	/	/	SYM
cord-023095-4dannjjm	676	31	severe	severe	JJ
cord-023095-4dannjjm	676	32	MR	MR	NNP
cord-023095-4dannjjm	676	33	did	do	VBD
cord-023095-4dannjjm	676	34	not	not	RB
cord-023095-4dannjjm	676	35	reach	reach	VB
cord-023095-4dannjjm	676	36	statistical	statistical	JJ
cord-023095-4dannjjm	676	37	significance	significance	NN
cord-023095-4dannjjm	676	38	.	.	.
cord-023095-4dannjjm	677	1	Mminimum	Mminimum	NNP
cord-023095-4dannjjm	677	2	HR	HR	NNP
cord-023095-4dannjjm	677	3	,	,	,
cord-023095-4dannjjm	677	4	mean	mean	JJ
cord-023095-4dannjjm	677	5	HR	HR	NNP
cord-023095-4dannjjm	677	6	and	and	CC
cord-023095-4dannjjm	677	7	the	the	DT
cord-023095-4dannjjm	677	8	HRV	HRV	NNP
cord-023095-4dannjjm	677	9	variables	variable	NNS
cord-023095-4dannjjm	677	10	(	(	-LRB-
cord-023095-4dannjjm	677	11	7	7	CD
cord-023095-4dannjjm	677	12	and	and	CC
cord-023095-4dannjjm	677	13	10	10	CD
cord-023095-4dannjjm	677	14	)	)	-RRB-
cord-023095-4dannjjm	677	15	differing	differ	VBG
cord-023095-4dannjjm	677	16	between	between	IN
cord-023095-4dannjjm	677	17	dog	dog	NN
cord-023095-4dannjjm	677	18	groups	group	NNS
cord-023095-4dannjjm	677	19	,	,	,
cord-023095-4dannjjm	677	20	also	also	RB
cord-023095-4dannjjm	677	21	consistently	consistently	RB
cord-023095-4dannjjm	677	22	decreased	decrease	VBD
cord-023095-4dannjjm	677	23	with	with	IN
cord-023095-4dannjjm	677	24	increasing	increase	VBG
cord-023095-4dannjjm	677	25	MR	MR	NNP
cord-023095-4dannjjm	677	26	,	,	,
cord-023095-4dannjjm	677	27	LA	LA	NNP
cord-023095-4dannjjm	677	28	/	/	SYM
cord-023095-4dannjjm	677	29	Ao	Ao	NNP
cord-023095-4dannjjm	677	30	and	and	CC
cord-023095-4dannjjm	677	31	the	the	DT
cord-023095-4dannjjm	677	32	proximal	proximal	JJ
cord-023095-4dannjjm	677	33	isovelocity	isovelocity	NN
cord-023095-4dannjjm	677	34	surface	surface	NN
cord-023095-4dannjjm	677	35	area	area	NN
cord-023095-4dannjjm	677	36	in	in	IN
cord-023095-4dannjjm	677	37	CKCS	CKCS	NNP
cord-023095-4dannjjm	677	38	.	.	.
cord-023095-4dannjjm	678	1	Non	non	JJ
cord-023095-4dannjjm	678	2	-	-	NNP
cord-023095-4dannjjm	678	3	CKCS	CKCS	NNP
cord-023095-4dannjjm	678	4	in	in	IN
cord-023095-4dannjjm	678	5	HF	HF	NNP
cord-023095-4dannjjm	678	6	had	have	VBD
cord-023095-4dannjjm	678	7	a	a	DT
cord-023095-4dannjjm	678	8	lower	low	JJR
cord-023095-4dannjjm	678	9	minimum	minimum	NN
cord-023095-4dannjjm	678	10	HR	hr	NN
cord-023095-4dannjjm	678	11	compared	compare	VBN
cord-023095-4dannjjm	678	12	to	to	IN
cord-023095-4dannjjm	678	13	CKCS	CKCS	NNP
cord-023095-4dannjjm	678	14	in	in	IN
cord-023095-4dannjjm	678	15	HF	HF	NNP
cord-023095-4dannjjm	678	16	(	(	-LRB-
cord-023095-4dannjjm	678	17	P	p	NN
cord-023095-4dannjjm	678	18	5	5	CD
cord-023095-4dannjjm	678	19	0.03	0.03	CD
cord-023095-4dannjjm	678	20	)	)	-RRB-
cord-023095-4dannjjm	678	21	and	and	CC
cord-023095-4dannjjm	678	22	a	a	DT
cord-023095-4dannjjm	678	23	higher	high	JJR
cord-023095-4dannjjm	678	24	triangular	triangular	JJ
cord-023095-4dannjjm	678	25	index	index	NN
cord-023095-4dannjjm	678	26	measured	measure	VBN
cord-023095-4dannjjm	678	27	in	in	IN
cord-023095-4dannjjm	678	28	both	both	DT
cord-023095-4dannjjm	678	29	periods	period	NNS
cord-023095-4dannjjm	678	30	(	(	-LRB-
cord-023095-4dannjjm	678	31	all	all	DT
cord-023095-4dannjjm	678	32	P	p	NN
cord-023095-4dannjjm	678	33	o	o	NN
cord-023095-4dannjjm	678	34	0.04	0.04	CD
cord-023095-4dannjjm	678	35	)	)	-RRB-
cord-023095-4dannjjm	678	36	.	.	.
cord-023095-4dannjjm	679	1	In	in	IN
cord-023095-4dannjjm	679	2	conclusion	conclusion	NN
cord-023095-4dannjjm	679	3	,	,	,
cord-023095-4dannjjm	679	4	HR	HR	NNP
cord-023095-4dannjjm	679	5	increased	increase	VBD
cord-023095-4dannjjm	679	6	and	and	CC
cord-023095-4dannjjm	679	7	most	most	JJS
cord-023095-4dannjjm	679	8	HRV	HRV	NNP
cord-023095-4dannjjm	679	9	variables	variable	NNS
cord-023095-4dannjjm	679	10	decreased	decrease	VBD
cord-023095-4dannjjm	679	11	with	with	IN
cord-023095-4dannjjm	679	12	increasing	increase	VBG
cord-023095-4dannjjm	679	13	severity	severity	NN
cord-023095-4dannjjm	679	14	of	of	IN
cord-023095-4dannjjm	679	15	MMVD	MMVD	NNP
cord-023095-4dannjjm	679	16	in	in	IN
cord-023095-4dannjjm	679	17	CKCS	CKCS	NNP
cord-023095-4dannjjm	679	18	,	,	,
cord-023095-4dannjjm	679	19	even	even	RB
cord-023095-4dannjjm	679	20	prior	prior	RB
cord-023095-4dannjjm	679	21	to	to	IN
cord-023095-4dannjjm	679	22	the	the	DT
cord-023095-4dannjjm	679	23	development	development	NN
cord-023095-4dannjjm	679	24	of	of	IN
cord-023095-4dannjjm	679	25	HF	HF	NNP
cord-023095-4dannjjm	679	26	.	.	.
cord-023095-4dannjjm	680	1	Other	other	JJ
cord-023095-4dannjjm	680	2	breeds	breed	NNS
cord-023095-4dannjjm	680	3	in	in	IN
cord-023095-4dannjjm	680	4	HF	HF	NNP
cord-023095-4dannjjm	680	5	secondary	secondary	JJ
cord-023095-4dannjjm	680	6	to	to	IN
cord-023095-4dannjjm	680	7	MMVD	MMVD	NNP
cord-023095-4dannjjm	680	8	had	have	VBD
cord-023095-4dannjjm	680	9	lower	low	JJR
cord-023095-4dannjjm	680	10	minimum	minimum	NN
cord-023095-4dannjjm	680	11	HR	hr	NN
cord-023095-4dannjjm	680	12	,	,	,
cord-023095-4dannjjm	680	13	but	but	CC
cord-023095-4dannjjm	680	14	higher	high	JJR
cord-023095-4dannjjm	680	15	triangular	triangular	JJ
cord-023095-4dannjjm	680	16	index	index	NN
cord-023095-4dannjjm	680	17	compared	compare	VBN
cord-023095-4dannjjm	680	18	to	to	IN
cord-023095-4dannjjm	680	19	CKCS	CKCS	NNP
cord-023095-4dannjjm	680	20	in	in	IN
cord-023095-4dannjjm	680	21	HF	HF	NNP
cord-023095-4dannjjm	680	22	.	.	.
cord-023095-4dannjjm	681	1	Although	although	IN
cord-023095-4dannjjm	681	2	the	the	DT
cord-023095-4dannjjm	681	3	cells	cell	NNS
cord-023095-4dannjjm	681	4	in	in	IN
cord-023095-4dannjjm	681	5	the	the	DT
cord-023095-4dannjjm	681	6	specialized	specialized	JJ
cord-023095-4dannjjm	681	7	conduction	conduction	NN
cord-023095-4dannjjm	681	8	system	system	NN
cord-023095-4dannjjm	681	9	in	in	IN
cord-023095-4dannjjm	681	10	the	the	DT
cord-023095-4dannjjm	681	11	heart	heart	NN
cord-023095-4dannjjm	681	12	are	be	VBP
cord-023095-4dannjjm	681	13	capable	capable	JJ
cord-023095-4dannjjm	681	14	of	of	IN
cord-023095-4dannjjm	681	15	initiating	initiate	VBG
cord-023095-4dannjjm	681	16	their	-PRON-	PRP$
cord-023095-4dannjjm	681	17	own	own	JJ
cord-023095-4dannjjm	681	18	impulse	impulse	NN
cord-023095-4dannjjm	681	19	,	,	,
cord-023095-4dannjjm	681	20	the	the	DT
cord-023095-4dannjjm	681	21	rate	rate	NN
cord-023095-4dannjjm	681	22	in	in	IN
cord-023095-4dannjjm	681	23	which	which	WDT
cord-023095-4dannjjm	681	24	those	those	DT
cord-023095-4dannjjm	681	25	impulses	impulse	NNS
cord-023095-4dannjjm	681	26	are	be	VBP
cord-023095-4dannjjm	681	27	generated	generate	VBN
cord-023095-4dannjjm	681	28	can	can	MD
cord-023095-4dannjjm	681	29	be	be	VB
cord-023095-4dannjjm	681	30	influenced	influence	VBN
cord-023095-4dannjjm	681	31	by	by	IN
cord-023095-4dannjjm	681	32	autonomic	autonomic	JJ
cord-023095-4dannjjm	681	33	nervous	nervous	JJ
cord-023095-4dannjjm	681	34	system	system	NN
cord-023095-4dannjjm	681	35	.	.	.
cord-023095-4dannjjm	682	1	Different	different	JJ
cord-023095-4dannjjm	682	2	types	type	NNS
cord-023095-4dannjjm	682	3	of	of	IN
cord-023095-4dannjjm	682	4	respiratory	respiratory	JJ
cord-023095-4dannjjm	682	5	patterns	pattern	NNS
cord-023095-4dannjjm	682	6	can	can	MD
cord-023095-4dannjjm	682	7	stimulate	stimulate	VB
cord-023095-4dannjjm	682	8	autonomic	autonomic	JJ
cord-023095-4dannjjm	682	9	nervous	nervous	JJ
cord-023095-4dannjjm	682	10	system	system	NN
cord-023095-4dannjjm	682	11	in	in	IN
cord-023095-4dannjjm	682	12	different	different	JJ
cord-023095-4dannjjm	682	13	manners	manner	NNS
cord-023095-4dannjjm	682	14	.	.	.
cord-023095-4dannjjm	683	1	Thus	thus	RB
cord-023095-4dannjjm	683	2	,	,	,
cord-023095-4dannjjm	683	3	non	non	JJ
cord-023095-4dannjjm	683	4	-	-	JJ
cord-023095-4dannjjm	683	5	sedated	sedated	JJ
cord-023095-4dannjjm	683	6	rabbits	rabbit	NNS
cord-023095-4dannjjm	683	7	were	be	VBD
cord-023095-4dannjjm	683	8	studied	study	VBN
cord-023095-4dannjjm	683	9	during	during	IN
cord-023095-4dannjjm	683	10	forced	force	VBN
cord-023095-4dannjjm	683	11	respiration	respiration	NN
cord-023095-4dannjjm	683	12	aiming	aim	VBG
cord-023095-4dannjjm	683	13	to	to	TO
cord-023095-4dannjjm	683	14	evaluate	evaluate	VB
cord-023095-4dannjjm	683	15	the	the	DT
cord-023095-4dannjjm	683	16	influence	influence	NN
cord-023095-4dannjjm	683	17	of	of	IN
cord-023095-4dannjjm	683	18	this	this	DT
cord-023095-4dannjjm	683	19	breathing	breathing	NN
cord-023095-4dannjjm	683	20	pattern	pattern	NN
cord-023095-4dannjjm	683	21	on	on	IN
cord-023095-4dannjjm	683	22	heart	heart	NN
cord-023095-4dannjjm	683	23	rate	rate	NN
cord-023095-4dannjjm	683	24	.	.	.
cord-023095-4dannjjm	684	1	Twenty	twenty	CD
cord-023095-4dannjjm	684	2	male	male	NN
cord-023095-4dannjjm	684	3	,	,	,
cord-023095-4dannjjm	684	4	one	one	CD
cord-023095-4dannjjm	684	5	-	-	HYPH
cord-023095-4dannjjm	684	6	year	year	NN
cord-023095-4dannjjm	684	7	-	-	HYPH
cord-023095-4dannjjm	684	8	old	old	JJ
cord-023095-4dannjjm	684	9	healthy	healthy	JJ
cord-023095-4dannjjm	684	10	New	New	NNP
cord-023095-4dannjjm	684	11	Zealand	Zealand	NNP
cord-023095-4dannjjm	684	12	rabbits	rabbit	NNS
cord-023095-4dannjjm	684	13	were	be	VBD
cord-023095-4dannjjm	684	14	enrolled	enrol	VBN
cord-023095-4dannjjm	684	15	in	in	IN
cord-023095-4dannjjm	684	16	the	the	DT
cord-023095-4dannjjm	684	17	study	study	NN
cord-023095-4dannjjm	684	18	.	.	.
cord-023095-4dannjjm	685	1	Animals	animal	NNS
cord-023095-4dannjjm	685	2	were	be	VBD
cord-023095-4dannjjm	685	3	set	set	VBN
cord-023095-4dannjjm	685	4	in	in	IN
cord-023095-4dannjjm	685	5	right	right	JJ
cord-023095-4dannjjm	685	6	lateral	lateral	JJ
cord-023095-4dannjjm	685	7	recumbency	recumbency	NN
cord-023095-4dannjjm	685	8	and	and	CC
cord-023095-4dannjjm	685	9	maintained	maintain	VBD
cord-023095-4dannjjm	685	10	that	that	DT
cord-023095-4dannjjm	685	11	way	way	NN
cord-023095-4dannjjm	685	12	by	by	IN
cord-023095-4dannjjm	685	13	physical	physical	JJ
cord-023095-4dannjjm	685	14	contention	contention	NN
cord-023095-4dannjjm	685	15	.	.	.
cord-023095-4dannjjm	686	1	Chemical	chemical	JJ
cord-023095-4dannjjm	686	2	sedation	sedation	NN
cord-023095-4dannjjm	686	3	was	be	VBD
cord-023095-4dannjjm	686	4	not	not	RB
cord-023095-4dannjjm	686	5	used	use	VBN
cord-023095-4dannjjm	686	6	.	.	.
cord-023095-4dannjjm	687	1	Partial	partial	JJ
cord-023095-4dannjjm	687	2	nasal	nasal	JJ
cord-023095-4dannjjm	687	3	obstruction	obstruction	NN
cord-023095-4dannjjm	687	4	by	by	IN
cord-023095-4dannjjm	687	5	digital	digital	JJ
cord-023095-4dannjjm	687	6	compression	compression	NN
cord-023095-4dannjjm	687	7	was	be	VBD
cord-023095-4dannjjm	687	8	applied	apply	VBN
cord-023095-4dannjjm	687	9	to	to	IN
cord-023095-4dannjjm	687	10	those	those	DT
cord-023095-4dannjjm	687	11	rabbits	rabbit	NNS
cord-023095-4dannjjm	687	12	for	for	IN
cord-023095-4dannjjm	687	13	five	five	CD
cord-023095-4dannjjm	687	14	seconds	second	NNS
cord-023095-4dannjjm	687	15	,	,	,
cord-023095-4dannjjm	687	16	eliciting	elicit	VBG
cord-023095-4dannjjm	687	17	a	a	DT
cord-023095-4dannjjm	687	18	forced	force	VBN
cord-023095-4dannjjm	687	19	inhaling	inhaling	NN
cord-023095-4dannjjm	687	20	and	and	CC
cord-023095-4dannjjm	687	21	exhaling	exhale	VBG
cord-023095-4dannjjm	687	22	against	against	IN
cord-023095-4dannjjm	687	23	semi	semi	JJ
cord-023095-4dannjjm	687	24	closed	closed	JJ
cord-023095-4dannjjm	687	25	nostrils	nostril	NNS
cord-023095-4dannjjm	687	26	.	.	.
cord-023095-4dannjjm	688	1	Heart	heart	NN
cord-023095-4dannjjm	688	2	rate	rate	NN
cord-023095-4dannjjm	688	3	was	be	VBD
cord-023095-4dannjjm	688	4	obtained	obtain	VBN
cord-023095-4dannjjm	688	5	by	by	IN
cord-023095-4dannjjm	688	6	measurement	measurement	NN
cord-023095-4dannjjm	688	7	of	of	IN
cord-023095-4dannjjm	688	8	two	two	CD
cord-023095-4dannjjm	688	9	consecutives	consecutive	NNS
cord-023095-4dannjjm	688	10	RR	rr	NN
cord-023095-4dannjjm	688	11	intervals	interval	NNS
cord-023095-4dannjjm	688	12	in	in	IN
cord-023095-4dannjjm	688	13	the	the	DT
cord-023095-4dannjjm	688	14	computerized	computerized	JJ
cord-023095-4dannjjm	688	15	electrocardiography	electrocardiography	NN
cord-023095-4dannjjm	688	16	,	,	,
cord-023095-4dannjjm	688	17	recorded	record	VBN
cord-023095-4dannjjm	688	18	continuously	continuously	RB
cord-023095-4dannjjm	688	19	prior	prior	RB
cord-023095-4dannjjm	688	20	and	and	CC
cord-023095-4dannjjm	688	21	during	during	IN
cord-023095-4dannjjm	688	22	the	the	DT
cord-023095-4dannjjm	688	23	maneuver	maneuver	NN
cord-023095-4dannjjm	688	24	.	.	.
cord-023095-4dannjjm	689	1	Heart	heart	NN
cord-023095-4dannjjm	689	2	rate	rate	NN
cord-023095-4dannjjm	689	3	before	before	IN
cord-023095-4dannjjm	689	4	the	the	DT
cord-023095-4dannjjm	689	5	intervention	intervention	NN
cord-023095-4dannjjm	689	6	was	be	VBD
cord-023095-4dannjjm	689	7	251	251	CD
cord-023095-4dannjjm	689	8	AE	AE	NNP
cord-023095-4dannjjm	689	9	34	34	CD
cord-023095-4dannjjm	689	10	bpm	bpm	NN
cord-023095-4dannjjm	689	11	(	(	-LRB-
cord-023095-4dannjjm	689	12	mean	mean	VB
cord-023095-4dannjjm	689	13	AE	AE	NNP
cord-023095-4dannjjm	689	14	standard	standard	JJ
cord-023095-4dannjjm	689	15	deviation	deviation	NN
cord-023095-4dannjjm	689	16	)	)	-RRB-
cord-023095-4dannjjm	689	17	.	.	.
cord-023095-4dannjjm	690	1	All	all	DT
cord-023095-4dannjjm	690	2	rabbits	rabbit	NNS
cord-023095-4dannjjm	690	3	submitted	submit	VBN
cord-023095-4dannjjm	690	4	to	to	IN
cord-023095-4dannjjm	690	5	the	the	DT
cord-023095-4dannjjm	690	6	maneuver	maneuver	NN
cord-023095-4dannjjm	690	7	showed	show	VBD
cord-023095-4dannjjm	690	8	a	a	DT
cord-023095-4dannjjm	690	9	dramatic	dramatic	JJ
cord-023095-4dannjjm	690	10	reduction	reduction	NN
cord-023095-4dannjjm	690	11	in	in	IN
cord-023095-4dannjjm	690	12	this	this	DT
cord-023095-4dannjjm	690	13	parameter	parameter	NN
cord-023095-4dannjjm	690	14	.	.	.
cord-023095-4dannjjm	691	1	After	after	IN
cord-023095-4dannjjm	691	2	nasal	nasal	JJ
cord-023095-4dannjjm	691	3	partial	partial	JJ
cord-023095-4dannjjm	691	4	obstruction	obstruction	NN
cord-023095-4dannjjm	691	5	,	,	,
cord-023095-4dannjjm	691	6	heart	heart	NN
cord-023095-4dannjjm	691	7	rate	rate	NN
cord-023095-4dannjjm	691	8	was	be	VBD
cord-023095-4dannjjm	691	9	142	142	CD
cord-023095-4dannjjm	691	10	AE	AE	NNP
cord-023095-4dannjjm	691	11	32	32	CD
cord-023095-4dannjjm	691	12	bpm	bpm	NN
cord-023095-4dannjjm	691	13	.	.	.
cord-023095-4dannjjm	692	1	Data	datum	NNS
cord-023095-4dannjjm	692	2	was	be	VBD
cord-023095-4dannjjm	692	3	submitted	submit	VBN
cord-023095-4dannjjm	692	4	to	to	IN
cord-023095-4dannjjm	692	5	statistical	statistical	JJ
cord-023095-4dannjjm	692	6	analysis	analysis	NN
cord-023095-4dannjjm	692	7	by	by	IN
cord-023095-4dannjjm	692	8	paired	pair	VBN
cord-023095-4dannjjm	692	9	Student	Student	NNP
cord-023095-4dannjjm	692	10	's	's	POS
cord-023095-4dannjjm	692	11	t	t	NN
cord-023095-4dannjjm	692	12	test	test	NN
cord-023095-4dannjjm	692	13	and	and	CC
cord-023095-4dannjjm	692	14	a	a	DT
cord-023095-4dannjjm	692	15	significant	significant	JJ
cord-023095-4dannjjm	692	16	difference	difference	NN
cord-023095-4dannjjm	692	17	between	between	IN
cord-023095-4dannjjm	692	18	the	the	DT
cord-023095-4dannjjm	692	19	heart	heart	NN
cord-023095-4dannjjm	692	20	rate	rate	NN
cord-023095-4dannjjm	692	21	before	before	RB
cord-023095-4dannjjm	692	22	and	and	CC
cord-023095-4dannjjm	692	23	after	after	IN
cord-023095-4dannjjm	692	24	the	the	DT
cord-023095-4dannjjm	692	25	maneuver	maneuver	NN
cord-023095-4dannjjm	692	26	was	be	VBD
cord-023095-4dannjjm	692	27	observed	observe	VBN
cord-023095-4dannjjm	692	28	(	(	-LRB-
cord-023095-4dannjjm	692	29	p	p	NN
cord-023095-4dannjjm	692	30	o	o	CD
cord-023095-4dannjjm	692	31	0.0001	0.0001	CD
cord-023095-4dannjjm	692	32	)	)	-RRB-
cord-023095-4dannjjm	692	33	.	.	.
cord-023095-4dannjjm	693	1	Although	although	IN
cord-023095-4dannjjm	693	2	the	the	DT
cord-023095-4dannjjm	693	3	exactly	exactly	RB
cord-023095-4dannjjm	693	4	mechanism	mechanism	NN
cord-023095-4dannjjm	693	5	involved	involve	VBN
cord-023095-4dannjjm	693	6	in	in	IN
cord-023095-4dannjjm	693	7	this	this	DT
cord-023095-4dannjjm	693	8	response	response	NN
cord-023095-4dannjjm	693	9	was	be	VBD
cord-023095-4dannjjm	693	10	not	not	RB
cord-023095-4dannjjm	693	11	elucidated	elucidate	VBN
cord-023095-4dannjjm	693	12	,	,	,
cord-023095-4dannjjm	693	13	the	the	DT
cord-023095-4dannjjm	693	14	presented	present	VBN
cord-023095-4dannjjm	693	15	data	datum	NNS
cord-023095-4dannjjm	693	16	support	support	VBP
cord-023095-4dannjjm	693	17	the	the	DT
cord-023095-4dannjjm	693	18	applicability	applicability	NN
cord-023095-4dannjjm	693	19	of	of	IN
cord-023095-4dannjjm	693	20	this	this	DT
cord-023095-4dannjjm	693	21	maneuver	maneuver	NN
cord-023095-4dannjjm	693	22	as	as	IN
cord-023095-4dannjjm	693	23	an	an	DT
cord-023095-4dannjjm	693	24	efficient	efficient	JJ
cord-023095-4dannjjm	693	25	method	method	NN
cord-023095-4dannjjm	693	26	for	for	IN
cord-023095-4dannjjm	693	27	non	non	JJ
cord-023095-4dannjjm	693	28	-	-	JJ
cord-023095-4dannjjm	693	29	pharmacological	pharmacological	JJ
cord-023095-4dannjjm	693	30	heart	heart	NN
cord-023095-4dannjjm	693	31	rate	rate	NN
cord-023095-4dannjjm	693	32	reduction	reduction	NN
cord-023095-4dannjjm	693	33	in	in	IN
cord-023095-4dannjjm	693	34	rabbits	rabbit	NNS
cord-023095-4dannjjm	693	35	.	.	.
cord-023095-4dannjjm	694	1	Obesity	obesity	NN
cord-023095-4dannjjm	694	2	can	can	MD
cord-023095-4dannjjm	694	3	affect	affect	VB
cord-023095-4dannjjm	694	4	cardiac	cardiac	JJ
cord-023095-4dannjjm	694	5	function	function	NN
cord-023095-4dannjjm	694	6	due	due	IN
cord-023095-4dannjjm	694	7	to	to	IN
cord-023095-4dannjjm	694	8	effects	effect	NNS
cord-023095-4dannjjm	694	9	on	on	IN
cord-023095-4dannjjm	694	10	cardiac	cardiac	JJ
cord-023095-4dannjjm	694	11	rhythm	rhythm	NN
cord-023095-4dannjjm	694	12	,	,	,
cord-023095-4dannjjm	694	13	ventricular	ventricular	JJ
cord-023095-4dannjjm	694	14	volume	volume	NN
cord-023095-4dannjjm	694	15	and	and	CC
cord-023095-4dannjjm	694	16	blood	blood	NN
cord-023095-4dannjjm	694	17	pressure	pressure	NN
cord-023095-4dannjjm	694	18	.	.	.
cord-023095-4dannjjm	695	1	The	the	DT
cord-023095-4dannjjm	695	2	purpose	purpose	NN
cord-023095-4dannjjm	695	3	of	of	IN
cord-023095-4dannjjm	695	4	this	this	DT
cord-023095-4dannjjm	695	5	study	study	NN
cord-023095-4dannjjm	695	6	was	be	VBD
cord-023095-4dannjjm	695	7	to	to	TO
cord-023095-4dannjjm	695	8	determine	determine	VB
cord-023095-4dannjjm	695	9	the	the	DT
cord-023095-4dannjjm	695	10	effects	effect	NNS
cord-023095-4dannjjm	695	11	of	of	IN
cord-023095-4dannjjm	695	12	obesity	obesity	NN
cord-023095-4dannjjm	695	13	and	and	CC
cord-023095-4dannjjm	695	14	overweight	overweight	NN
cord-023095-4dannjjm	695	15	on	on	IN
cord-023095-4dannjjm	695	16	noninvasive	noninvasive	JJ
cord-023095-4dannjjm	695	17	systemic	systemic	JJ
cord-023095-4dannjjm	695	18	blood	blood	NN
cord-023095-4dannjjm	695	19	pressure	pressure	NN
cord-023095-4dannjjm	695	20	and	and	CC
cord-023095-4dannjjm	695	21	Doppler	Doppler	NNP
cord-023095-4dannjjm	695	22	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	695	23	parameters	parameter	NNS
cord-023095-4dannjjm	695	24	in	in	IN
cord-023095-4dannjjm	695	25	cats	cat	NNS
cord-023095-4dannjjm	695	26	without	without	IN
cord-023095-4dannjjm	695	27	others	other	NNS
cord-023095-4dannjjm	695	28	causes	cause	VBZ
cord-023095-4dannjjm	695	29	of	of	IN
cord-023095-4dannjjm	695	30	cardiac	cardiac	JJ
cord-023095-4dannjjm	695	31	hypertrophy	hypertrophy	NN
cord-023095-4dannjjm	695	32	.	.	.
cord-023095-4dannjjm	696	1	The	the	DT
cord-023095-4dannjjm	696	2	study	study	NN
cord-023095-4dannjjm	696	3	groups	group	NNS
cord-023095-4dannjjm	696	4	comprised	comprise	VBD
cord-023095-4dannjjm	696	5	fifteen	fifteen	CD
cord-023095-4dannjjm	696	6	obese	obese	JJ
cord-023095-4dannjjm	696	7	cats	cat	NNS
cord-023095-4dannjjm	696	8	with	with	IN
cord-023095-4dannjjm	696	9	mean	mean	JJ
cord-023095-4dannjjm	696	10	body	body	NN
cord-023095-4dannjjm	696	11	score	score	NN
cord-023095-4dannjjm	696	12	index	index	NN
cord-023095-4dannjjm	696	13	(	(	-LRB-
cord-023095-4dannjjm	696	14	BSI	BSI	NNP
cord-023095-4dannjjm	696	15	)	)	-RRB-
cord-023095-4dannjjm	696	16	of	of	IN
cord-023095-4dannjjm	696	17	8,8	8,8	CD
cord-023095-4dannjjm	696	18	,	,	,
cord-023095-4dannjjm	696	19	seven	seven	CD
cord-023095-4dannjjm	696	20	overweight	overweight	JJ
cord-023095-4dannjjm	696	21	cats	cat	NNS
cord-023095-4dannjjm	696	22	(	(	-LRB-
cord-023095-4dannjjm	696	23	BSI	BSI	NNP
cord-023095-4dannjjm	696	24	5	5	CD
cord-023095-4dannjjm	696	25	6,3	6,3	CD
cord-023095-4dannjjm	696	26	)	)	-RRB-
cord-023095-4dannjjm	696	27	and	and	CC
cord-023095-4dannjjm	696	28	seven	seven	CD
cord-023095-4dannjjm	696	29	cats	cat	NNS
cord-023095-4dannjjm	696	30	with	with	IN
cord-023095-4dannjjm	696	31	ideal	ideal	JJ
cord-023095-4dannjjm	696	32	BSI	BSI	NNP
cord-023095-4dannjjm	696	33	(	(	-LRB-
cord-023095-4dannjjm	696	34	4,9	4,9	CD
cord-023095-4dannjjm	696	35	)	)	-RRB-
cord-023095-4dannjjm	696	36	.	.	.
cord-023095-4dannjjm	697	1	The	the	DT
cord-023095-4dannjjm	697	2	blood	blood	NN
cord-023095-4dannjjm	697	3	pressure	pressure	NN
cord-023095-4dannjjm	697	4	was	be	VBD
cord-023095-4dannjjm	697	5	measured	measure	VBN
cord-023095-4dannjjm	697	6	by	by	IN
cord-023095-4dannjjm	697	7	Doppler	Doppler	NNP
cord-023095-4dannjjm	697	8	method	method	NN
cord-023095-4dannjjm	697	9	and	and	CC
cord-023095-4dannjjm	697	10	the	the	DT
cord-023095-4dannjjm	697	11	Doppler	Doppler	NNP
cord-023095-4dannjjm	697	12	echocardiography	echocardiography	NN
cord-023095-4dannjjm	697	13	was	be	VBD
cord-023095-4dannjjm	697	14	performed	perform	VBN
cord-023095-4dannjjm	697	15	in	in	IN
cord-023095-4dannjjm	697	16	conscious	conscious	JJ
cord-023095-4dannjjm	697	17	animals	animal	NNS
cord-023095-4dannjjm	697	18	.	.	.
cord-023095-4dannjjm	698	1	The	the	DT
cord-023095-4dannjjm	698	2	statistical	statistical	JJ
cord-023095-4dannjjm	698	3	analysis	analysis	NN
cord-023095-4dannjjm	698	4	was	be	VBD
cord-023095-4dannjjm	698	5	performed	perform	VBN
cord-023095-4dannjjm	698	6	by	by	IN
cord-023095-4dannjjm	698	7	analysis	analysis	NN
cord-023095-4dannjjm	698	8	of	of	IN
cord-023095-4dannjjm	698	9	variance	variance	NN
cord-023095-4dannjjm	698	10	followed	follow	VBN
cord-023095-4dannjjm	698	11	by	by	IN
cord-023095-4dannjjm	698	12	Tukey	Tukey	NNP
cord-023095-4dannjjm	698	13	's	's	POS
cord-023095-4dannjjm	698	14	test	test	NN
cord-023095-4dannjjm	698	15	and	and	CC
cord-023095-4dannjjm	698	16	Pearson	Pearson	NNP
cord-023095-4dannjjm	698	17	's	's	POS
cord-023095-4dannjjm	698	18	correlation	correlation	NN
cord-023095-4dannjjm	698	19	.	.	.
cord-023095-4dannjjm	699	1	The	the	DT
cord-023095-4dannjjm	699	2	blood	blood	NN
cord-023095-4dannjjm	699	3	pressure	pressure	NN
cord-023095-4dannjjm	699	4	values	value	NNS
cord-023095-4dannjjm	699	5	of	of	IN
cord-023095-4dannjjm	699	6	the	the	DT
cord-023095-4dannjjm	699	7	obese	obese	JJ
cord-023095-4dannjjm	699	8	cats	cat	NNS
cord-023095-4dannjjm	699	9	were	be	VBD
cord-023095-4dannjjm	699	10	superior	superior	JJ
cord-023095-4dannjjm	699	11	(	(	-LRB-
cord-023095-4dannjjm	699	12	159,12	159,12	NNP
cord-023095-4dannjjm	699	13	AE	AE	NNP
cord-023095-4dannjjm	699	14	11,22	11,22	CD
cord-023095-4dannjjm	699	15	mmHg	mmHg	NNS
cord-023095-4dannjjm	699	16	,	,	,
cord-023095-4dannjjm	699	17	p	p	NN
cord-023095-4dannjjm	699	18	o	o	NN
cord-023095-4dannjjm	699	19	0,0001	0,0001	CD
cord-023095-4dannjjm	699	20	)	)	-RRB-
cord-023095-4dannjjm	699	21	than	than	IN
cord-023095-4dannjjm	699	22	in	in	IN
cord-023095-4dannjjm	699	23	overweight	overweight	NN
cord-023095-4dannjjm	699	24	(	(	-LRB-
cord-023095-4dannjjm	699	25	134,45	134,45	CD
cord-023095-4dannjjm	699	26	AE	AE	NNP
cord-023095-4dannjjm	699	27	13,81	13,81	CD
cord-023095-4dannjjm	699	28	mmHg	mmHg	NNS
cord-023095-4dannjjm	699	29	)	)	-RRB-
cord-023095-4dannjjm	699	30	and	and	CC
cord-023095-4dannjjm	699	31	normal	normal	JJ
cord-023095-4dannjjm	699	32	cats	cat	NNS
cord-023095-4dannjjm	700	1	(	(	-LRB-
cord-023095-4dannjjm	700	2	136,90	136,90	CD
cord-023095-4dannjjm	700	3	AE	AE	NNP
cord-023095-4dannjjm	700	4	13,17	13,17	CD
cord-023095-4dannjjm	700	5	mmHg	mmHg	NNS
cord-023095-4dannjjm	700	6	)	)	-RRB-
cord-023095-4dannjjm	700	7	and	and	CC
cord-023095-4dannjjm	701	1	57	57	CD
cord-023095-4dannjjm	701	2	%	%	NN
cord-023095-4dannjjm	701	3	of	of	IN
cord-023095-4dannjjm	701	4	the	the	DT
cord-023095-4dannjjm	701	5	obese	obese	JJ
cord-023095-4dannjjm	701	6	cats	cat	NNS
cord-023095-4dannjjm	701	7	had	have	VBD
cord-023095-4dannjjm	701	8	blood	blood	NN
cord-023095-4dannjjm	701	9	pressure	pressure	NN
cord-023095-4dannjjm	701	10	higher	high	JJR
cord-023095-4dannjjm	701	11	than	than	IN
cord-023095-4dannjjm	701	12	160	160	CD
cord-023095-4dannjjm	701	13	mmHg	mmHg	NNS
cord-023095-4dannjjm	701	14	.	.	.
cord-023095-4dannjjm	702	1	There	there	EX
cord-023095-4dannjjm	702	2	were	be	VBD
cord-023095-4dannjjm	702	3	observed	observe	VBN
cord-023095-4dannjjm	702	4	differences	difference	NNS
cord-023095-4dannjjm	702	5	on	on	IN
cord-023095-4dannjjm	702	6	the	the	DT
cord-023095-4dannjjm	702	7	ratio	ratio	NN
cord-023095-4dannjjm	702	8	of	of	IN
cord-023095-4dannjjm	702	9	early	early	JJ
cord-023095-4dannjjm	702	10	(	(	-LRB-
cord-023095-4dannjjm	702	11	E	e	NN
cord-023095-4dannjjm	702	12	)	)	-RRB-
cord-023095-4dannjjm	702	13	and	and	CC
cord-023095-4dannjjm	702	14	late	late	JJ
cord-023095-4dannjjm	702	15	(	(	-LRB-
cord-023095-4dannjjm	702	16	A	a	NN
cord-023095-4dannjjm	702	17	)	)	-RRB-
cord-023095-4dannjjm	702	18	left	leave	VBN
cord-023095-4dannjjm	702	19	ventricular	ventricular	JJ
cord-023095-4dannjjm	702	20	filling	filling	NN
cord-023095-4dannjjm	702	21	velocity	velocity	NN
cord-023095-4dannjjm	702	22	(	(	-LRB-
cord-023095-4dannjjm	702	23	p	p	NN
cord-023095-4dannjjm	702	24	5	5	CD
cord-023095-4dannjjm	702	25	0,008	0,008	CD
cord-023095-4dannjjm	702	26	)	)	-RRB-
cord-023095-4dannjjm	702	27	of	of	IN
cord-023095-4dannjjm	702	28	obese	obese	JJ
cord-023095-4dannjjm	702	29	animals	animal	NNS
cord-023095-4dannjjm	703	1	(	(	-LRB-
cord-023095-4dannjjm	703	2	E	E	NNP
cord-023095-4dannjjm	703	3	/	/	SYM
cord-023095-4dannjjm	703	4	A	a	NN
cord-023095-4dannjjm	703	5	5	5	CD
cord-023095-4dannjjm	703	6	1,07	1,07	CD
cord-023095-4dannjjm	703	7	AE	AE	NNP
cord-023095-4dannjjm	703	8	0,39	0,39	NNP
cord-023095-4dannjjm	703	9	)	)	-RRB-
cord-023095-4dannjjm	704	1	compared	compare	VBN
cord-023095-4dannjjm	704	2	to	to	IN
cord-023095-4dannjjm	704	3	overweight	overweight	NN
cord-023095-4dannjjm	704	4	(	(	-LRB-
cord-023095-4dannjjm	704	5	1,68	1,68	CD
cord-023095-4dannjjm	704	6	AE	AE	NNP
cord-023095-4dannjjm	704	7	0,37	0,37	NNP
cord-023095-4dannjjm	704	8	)	)	-RRB-
cord-023095-4dannjjm	704	9	and	and	CC
cord-023095-4dannjjm	704	10	normal	normal	JJ
cord-023095-4dannjjm	704	11	cats	cat	NNS
cord-023095-4dannjjm	704	12	(	(	-LRB-
cord-023095-4dannjjm	704	13	1,43	1,43	CD
cord-023095-4dannjjm	704	14	AE	AE	NNP
cord-023095-4dannjjm	704	15	0,24	0,24	NN
cord-023095-4dannjjm	704	16	)	)	-RRB-
cord-023095-4dannjjm	704	17	.	.	.
cord-023095-4dannjjm	705	1	Seven	seven	CD
cord-023095-4dannjjm	705	2	obese	obese	JJ
cord-023095-4dannjjm	705	3	cats	cat	NNS
cord-023095-4dannjjm	705	4	(	(	-LRB-
cord-023095-4dannjjm	705	5	50	50	CD
cord-023095-4dannjjm	705	6	%	%	NN
cord-023095-4dannjjm	705	7	)	)	-RRB-
cord-023095-4dannjjm	705	8	had	have	VBD
cord-023095-4dannjjm	705	9	inversion	inversion	NN
cord-023095-4dannjjm	705	10	of	of	IN
cord-023095-4dannjjm	705	11	E	e	NN
cord-023095-4dannjjm	705	12	/	/	CC
cord-023095-4dannjjm	705	13	A	a	NN
cord-023095-4dannjjm	705	14	compatible	compatible	JJ
cord-023095-4dannjjm	705	15	with	with	IN
cord-023095-4dannjjm	705	16	diastolic	diastolic	JJ
cord-023095-4dannjjm	705	17	dysfunction	dysfunction	NN
cord-023095-4dannjjm	705	18	and	and	CC
cord-023095-4dannjjm	705	19	there	there	EX
cord-023095-4dannjjm	705	20	were	be	VBD
cord-023095-4dannjjm	705	21	negative	negative	JJ
cord-023095-4dannjjm	705	22	correlation	correlation	NN
cord-023095-4dannjjm	705	23	(	(	-LRB-
cord-023095-4dannjjm	706	1	r	r	LS
cord-023095-4dannjjm	706	2	5	5	CD
cord-023095-4dannjjm	706	3	À0,453	à0,453	CD
cord-023095-4dannjjm	706	4	,	,	,
cord-023095-4dannjjm	706	5	p	p	NN
cord-023095-4dannjjm	706	6	5	5	CD
cord-023095-4dannjjm	706	7	0,026	0,026	CD
cord-023095-4dannjjm	706	8	)	)	-RRB-
cord-023095-4dannjjm	706	9	between	between	IN
cord-023095-4dannjjm	706	10	the	the	DT
cord-023095-4dannjjm	706	11	E	e	NN
cord-023095-4dannjjm	706	12	/	/	SYM
cord-023095-4dannjjm	706	13	A	a	DT
cord-023095-4dannjjm	706	14	ratio	ratio	NN
cord-023095-4dannjjm	706	15	and	and	CC
cord-023095-4dannjjm	706	16	blood	blood	NN
cord-023095-4dannjjm	706	17	pressure	pressure	NN
cord-023095-4dannjjm	706	18	values	value	NNS
cord-023095-4dannjjm	706	19	.	.	.
cord-023095-4dannjjm	707	1	Other	other	JJ
cord-023095-4dannjjm	707	2	differences	difference	NNS
cord-023095-4dannjjm	707	3	observed	observe	VBD
cord-023095-4dannjjm	707	4	were	be	VBD
cord-023095-4dannjjm	707	5	increases	increase	NNS
cord-023095-4dannjjm	707	6	in	in	IN
cord-023095-4dannjjm	707	7	left	left	JJ
cord-023095-4dannjjm	707	8	ventricular	ventricular	JJ
cord-023095-4dannjjm	707	9	septum	septum	NN
cord-023095-4dannjjm	707	10	in	in	IN
cord-023095-4dannjjm	707	11	diastole	diastole	NN
cord-023095-4dannjjm	707	12	(	(	-LRB-
cord-023095-4dannjjm	707	13	p	p	NN
cord-023095-4dannjjm	707	14	5	5	CD
cord-023095-4dannjjm	707	15	0,002	0,002	CD
cord-023095-4dannjjm	707	16	)	)	-RRB-
cord-023095-4dannjjm	707	17	and	and	CC
cord-023095-4dannjjm	707	18	in	in	IN
cord-023095-4dannjjm	707	19	free	free	JJ
cord-023095-4dannjjm	707	20	wall	wall	NN
cord-023095-4dannjjm	707	21	in	in	IN
cord-023095-4dannjjm	707	22	diastole	diastole	NN
cord-023095-4dannjjm	707	23	(	(	-LRB-
cord-023095-4dannjjm	707	24	p	p	NN
cord-023095-4dannjjm	707	25	5	5	CD
cord-023095-4dannjjm	707	26	0,023	0,023	CD
cord-023095-4dannjjm	707	27	)	)	-RRB-
cord-023095-4dannjjm	707	28	and	and	CC
cord-023095-4dannjjm	707	29	systole	systole	NN
cord-023095-4dannjjm	707	30	(	(	-LRB-
cord-023095-4dannjjm	707	31	p	p	NN
cord-023095-4dannjjm	707	32	5	5	CD
cord-023095-4dannjjm	707	33	0,042	0,042	CD
cord-023095-4dannjjm	707	34	)	)	-RRB-
cord-023095-4dannjjm	707	35	of	of	IN
cord-023095-4dannjjm	707	36	the	the	DT
cord-023095-4dannjjm	707	37	obese	obese	JJ
cord-023095-4dannjjm	707	38	animals	animal	NNS
cord-023095-4dannjjm	707	39	compared	compare	VBN
cord-023095-4dannjjm	707	40	to	to	IN
cord-023095-4dannjjm	707	41	overweight	overweight	JJ
cord-023095-4dannjjm	707	42	and	and	CC
cord-023095-4dannjjm	707	43	normal	normal	JJ
cord-023095-4dannjjm	707	44	cats	cat	NNS
cord-023095-4dannjjm	707	45	.	.	.
cord-023095-4dannjjm	708	1	These	these	DT
cord-023095-4dannjjm	708	2	results	result	NNS
cord-023095-4dannjjm	708	3	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	708	4	the	the	DT
cord-023095-4dannjjm	708	5	possibility	possibility	NN
cord-023095-4dannjjm	708	6	of	of	IN
cord-023095-4dannjjm	708	7	cardiovascular	cardiovascular	JJ
cord-023095-4dannjjm	708	8	effects	effect	NNS
cord-023095-4dannjjm	708	9	related	relate	VBN
cord-023095-4dannjjm	708	10	to	to	IN
cord-023095-4dannjjm	708	11	obesity	obesity	NN
cord-023095-4dannjjm	708	12	in	in	IN
cord-023095-4dannjjm	708	13	cats	cat	NNS
cord-023095-4dannjjm	708	14	,	,	,
cord-023095-4dannjjm	708	15	such	such	JJ
cord-023095-4dannjjm	708	16	as	as	IN
cord-023095-4dannjjm	708	17	systemic	systemic	JJ
cord-023095-4dannjjm	708	18	arterial	arterial	JJ
cord-023095-4dannjjm	708	19	hypertension	hypertension	NN
cord-023095-4dannjjm	708	20	and	and	CC
cord-023095-4dannjjm	708	21	secondary	secondary	JJ
cord-023095-4dannjjm	708	22	diastolic	diastolic	JJ
cord-023095-4dannjjm	708	23	dysfunction	dysfunction	NN
cord-023095-4dannjjm	708	24	.	.	.
cord-023095-4dannjjm	709	1	Diuretic	diuretic	JJ
cord-023095-4dannjjm	709	2	therapy	therapy	NN
cord-023095-4dannjjm	709	3	reduces	reduce	VBZ
cord-023095-4dannjjm	709	4	preload	preload	NN
cord-023095-4dannjjm	709	5	,	,	,
cord-023095-4dannjjm	709	6	and	and	CC
cord-023095-4dannjjm	709	7	relieves	relieve	VBZ
cord-023095-4dannjjm	709	8	congestion	congestion	NN
cord-023095-4dannjjm	709	9	secondary	secondary	JJ
cord-023095-4dannjjm	709	10	to	to	IN
cord-023095-4dannjjm	709	11	cardiac	cardiac	JJ
cord-023095-4dannjjm	709	12	dysfunction	dysfunction	NN
cord-023095-4dannjjm	709	13	.	.	.
cord-023095-4dannjjm	710	1	Torsemide	Torsemide	NNP
cord-023095-4dannjjm	710	2	(	(	-LRB-
cord-023095-4dannjjm	710	3	torasemide	torasemide	NNP
cord-023095-4dannjjm	710	4	)	)	-RRB-
cord-023095-4dannjjm	710	5	is	be	VBZ
cord-023095-4dannjjm	710	6	a	a	DT
cord-023095-4dannjjm	710	7	loop	loop	NN
cord-023095-4dannjjm	710	8	diuretic	diuretic	NN
cord-023095-4dannjjm	710	9	with	with	IN
cord-023095-4dannjjm	710	10	longer	long	JJR
cord-023095-4dannjjm	710	11	duration	duration	NN
cord-023095-4dannjjm	710	12	of	of	IN
cord-023095-4dannjjm	710	13	action	action	NN
cord-023095-4dannjjm	710	14	,	,	,
cord-023095-4dannjjm	710	15	less	less	RBR
cord-023095-4dannjjm	710	16	diuretic	diuretic	JJ
cord-023095-4dannjjm	710	17	resistance	resistance	NN
cord-023095-4dannjjm	710	18	,	,	,
cord-023095-4dannjjm	710	19	and	and	CC
cord-023095-4dannjjm	710	20	adjunctive	adjunctive	JJ
cord-023095-4dannjjm	710	21	aldosterone	aldosterone	NN
cord-023095-4dannjjm	710	22	antagonism	antagonism	NN
cord-023095-4dannjjm	710	23	as	as	IN
cord-023095-4dannjjm	710	24	compared	compare	VBN
cord-023095-4dannjjm	710	25	to	to	IN
cord-023095-4dannjjm	710	26	furosemide	furosemide	NN
cord-023095-4dannjjm	710	27	.	.	.
cord-023095-4dannjjm	711	1	We	-PRON-	PRP
cord-023095-4dannjjm	711	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	711	3	that	that	IN
cord-023095-4dannjjm	711	4	torsemide	torsemide	NN
cord-023095-4dannjjm	711	5	was	be	VBD
cord-023095-4dannjjm	711	6	no	no	DT
cord-023095-4dannjjm	711	7	less	less	RBR
cord-023095-4dannjjm	711	8	effective	effective	JJ
cord-023095-4dannjjm	711	9	than	than	IN
cord-023095-4dannjjm	711	10	furosemide	furosemide	NN
cord-023095-4dannjjm	711	11	at	at	IN
cord-023095-4dannjjm	711	12	diuresis	diuresis	NN
cord-023095-4dannjjm	711	13	,	,	,
cord-023095-4dannjjm	711	14	control	control	NN
cord-023095-4dannjjm	711	15	of	of	IN
cord-023095-4dannjjm	711	16	clinical	clinical	JJ
cord-023095-4dannjjm	711	17	signs	sign	NNS
cord-023095-4dannjjm	711	18	,	,	,
cord-023095-4dannjjm	711	19	and	and	CC
cord-023095-4dannjjm	711	20	maintenance	maintenance	NN
cord-023095-4dannjjm	711	21	of	of	IN
cord-023095-4dannjjm	711	22	quality	quality	NN
cord-023095-4dannjjm	711	23	of	of	IN
cord-023095-4dannjjm	711	24	life	life	NN
cord-023095-4dannjjm	711	25	in	in	IN
cord-023095-4dannjjm	711	26	dogs	dog	NNS
cord-023095-4dannjjm	711	27	with	with	IN
cord-023095-4dannjjm	711	28	congestive	congestive	JJ
cord-023095-4dannjjm	711	29	heart	heart	NN
cord-023095-4dannjjm	711	30	failure	failure	NN
cord-023095-4dannjjm	711	31	.	.	.
cord-023095-4dannjjm	712	1	A	a	DT
cord-023095-4dannjjm	712	2	double	double	RB
cord-023095-4dannjjm	712	3	-	-	HYPH
cord-023095-4dannjjm	712	4	blinded	blinded	JJ
cord-023095-4dannjjm	712	5	,	,	,
cord-023095-4dannjjm	712	6	randomized	randomized	JJ
cord-023095-4dannjjm	712	7	,	,	,
cord-023095-4dannjjm	712	8	crossover	crossover	JJ
cord-023095-4dannjjm	712	9	clinical	clinical	JJ
cord-023095-4dannjjm	712	10	trial	trial	NN
cord-023095-4dannjjm	712	11	was	be	VBD
cord-023095-4dannjjm	712	12	performed	perform	VBN
cord-023095-4dannjjm	712	13	in	in	IN
cord-023095-4dannjjm	712	14	7	7	CD
cord-023095-4dannjjm	712	15	dogs	dog	NNS
cord-023095-4dannjjm	712	16	with	with	IN
cord-023095-4dannjjm	712	17	stable	stable	JJ
cord-023095-4dannjjm	712	18	heart	heart	NN
cord-023095-4dannjjm	712	19	failure	failure	NN
cord-023095-4dannjjm	712	20	receiving	receive	VBG
cord-023095-4dannjjm	712	21	BID	BID	VBN
cord-023095-4dannjjm	712	22	furosemide	furosemide	NN
cord-023095-4dannjjm	712	23	and	and	CC
cord-023095-4dannjjm	712	24	adjunctive	adjunctive	JJ
cord-023095-4dannjjm	712	25	medications	medication	NNS
cord-023095-4dannjjm	712	26	.	.	.
cord-023095-4dannjjm	713	1	Dogs	dog	NNS
cord-023095-4dannjjm	713	2	were	be	VBD
cord-023095-4dannjjm	713	3	randomized	randomize	VBN
cord-023095-4dannjjm	713	4	to	to	IN
cord-023095-4dannjjm	713	5	their	-PRON-	PRP$
cord-023095-4dannjjm	713	6	current	current	JJ
cord-023095-4dannjjm	713	7	furosemide	furosemide	NN
cord-023095-4dannjjm	713	8	dose	dose	NN
cord-023095-4dannjjm	713	9	or	or	CC
cord-023095-4dannjjm	713	10	torsemide	torsemide	NN
cord-023095-4dannjjm	713	11	(	(	-LRB-
cord-023095-4dannjjm	713	12	calculated	calculate	VBN
cord-023095-4dannjjm	713	13	as	as	IN
cord-023095-4dannjjm	713	14	1/10	1/10	CD
cord-023095-4dannjjm	713	15	of	of	IN
cord-023095-4dannjjm	713	16	the	the	DT
cord-023095-4dannjjm	713	17	daily	daily	JJ
cord-023095-4dannjjm	713	18	furosemide	furosemide	NN
cord-023095-4dannjjm	713	19	dose	dose	NN
cord-023095-4dannjjm	713	20	divided	divide	VBN
cord-023095-4dannjjm	713	21	into	into	IN
cord-023095-4dannjjm	713	22	BID	BID	NNP
cord-023095-4dannjjm	713	23	dosing	dosing	NN
cord-023095-4dannjjm	713	24	)	)	-RRB-
cord-023095-4dannjjm	713	25	.	.	.
cord-023095-4dannjjm	714	1	Crossover	crossover	NN
cord-023095-4dannjjm	714	2	occurred	occur	VBD
cord-023095-4dannjjm	714	3	at	at	IN
cord-023095-4dannjjm	714	4	day	day	NN
cord-023095-4dannjjm	714	5	7	7	CD
cord-023095-4dannjjm	714	6	and	and	CC
cord-023095-4dannjjm	714	7	the	the	DT
cord-023095-4dannjjm	714	8	study	study	NN
cord-023095-4dannjjm	714	9	ended	end	VBD
cord-023095-4dannjjm	714	10	on	on	IN
cord-023095-4dannjjm	714	11	day	day	NN
cord-023095-4dannjjm	714	12	14	14	CD
cord-023095-4dannjjm	714	13	.	.	.
cord-023095-4dannjjm	715	1	Clinical	clinical	JJ
cord-023095-4dannjjm	715	2	,	,	,
cord-023095-4dannjjm	715	3	laboratory	laboratory	NN
cord-023095-4dannjjm	715	4	,	,	,
cord-023095-4dannjjm	715	5	radiographic	radiographic	JJ
cord-023095-4dannjjm	715	6	,	,	,
cord-023095-4dannjjm	715	7	and	and	CC
cord-023095-4dannjjm	715	8	owner	owner	NN
cord-023095-4dannjjm	715	9	-	-	HYPH
cord-023095-4dannjjm	715	10	perceived	perceive	VBN
cord-023095-4dannjjm	715	11	quality	quality	NN
cord-023095-4dannjjm	715	12	of	of	IN
cord-023095-4dannjjm	715	13	life	life	NN
cord-023095-4dannjjm	715	14	variables	variable	NNS
cord-023095-4dannjjm	715	15	were	be	VBD
cord-023095-4dannjjm	715	16	evaluated	evaluate	VBN
cord-023095-4dannjjm	715	17	on	on	IN
cord-023095-4dannjjm	715	18	days	day	NNS
cord-023095-4dannjjm	715	19	0	0	CD
cord-023095-4dannjjm	715	20	,	,	,
cord-023095-4dannjjm	715	21	7	7	CD
cord-023095-4dannjjm	715	22	and	and	CC
cord-023095-4dannjjm	715	23	14	14	CD
cord-023095-4dannjjm	715	24	.	.	.
cord-023095-4dannjjm	716	1	No	no	DT
cord-023095-4dannjjm	716	2	dog	dog	NN
cord-023095-4dannjjm	716	3	developed	develop	VBD
cord-023095-4dannjjm	716	4	recurrent	recurrent	JJ
cord-023095-4dannjjm	716	5	heart	heart	NN
cord-023095-4dannjjm	716	6	failure	failure	NN
cord-023095-4dannjjm	716	7	during	during	IN
cord-023095-4dannjjm	716	8	the	the	DT
cord-023095-4dannjjm	716	9	study	study	NN
cord-023095-4dannjjm	716	10	.	.	.
cord-023095-4dannjjm	717	1	Average	average	JJ
cord-023095-4dannjjm	717	2	furosemide	furosemide	NN
cord-023095-4dannjjm	717	3	dose	dose	NN
cord-023095-4dannjjm	717	4	on	on	IN
cord-023095-4dannjjm	717	5	day	day	NN
cord-023095-4dannjjm	717	6	0	0	CD
cord-023095-4dannjjm	717	7	was	be	VBD
cord-023095-4dannjjm	717	8	5.13	5.13	CD
cord-023095-4dannjjm	717	9	mg	mg	NNP
cord-023095-4dannjjm	717	10	/	/	SYM
cord-023095-4dannjjm	717	11	kg	kg	NNP
cord-023095-4dannjjm	717	12	/	/	SYM
cord-023095-4dannjjm	717	13	day	day	NN
cord-023095-4dannjjm	717	14	(	(	-LRB-
cord-023095-4dannjjm	717	15	range	range	NN
cord-023095-4dannjjm	717	16	,	,	,
cord-023095-4dannjjm	717	17	2.8	2.8	CD
cord-023095-4dannjjm	717	18	-	-	SYM
cord-023095-4dannjjm	717	19	9.6	9.6	CD
cord-023095-4dannjjm	717	20	)	)	-RRB-
cord-023095-4dannjjm	717	21	.	.	.
cord-023095-4dannjjm	718	1	Following	follow	VBG
cord-023095-4dannjjm	718	2	torsemide	torsemide	JJ
cord-023095-4dannjjm	718	3	treatment	treatment	NN
cord-023095-4dannjjm	718	4	,	,	,
cord-023095-4dannjjm	718	5	blood	blood	NN
cord-023095-4dannjjm	718	6	urea	urea	NN
cord-023095-4dannjjm	718	7	nitrogen	nitrogen	NN
cord-023095-4dannjjm	718	8	(	(	-LRB-
cord-023095-4dannjjm	718	9	P	p	NN
cord-023095-4dannjjm	718	10	5	5	CD
cord-023095-4dannjjm	718	11	0.0028	0.0028	CD
cord-023095-4dannjjm	718	12	)	)	-RRB-
cord-023095-4dannjjm	718	13	,	,	,
cord-023095-4dannjjm	718	14	albumin	albumin	NN
cord-023095-4dannjjm	718	15	(	(	-LRB-
cord-023095-4dannjjm	718	16	P	p	NN
cord-023095-4dannjjm	718	17	5	5	CD
cord-023095-4dannjjm	718	18	0.0287	0.0287	CD
cord-023095-4dannjjm	718	19	)	)	-RRB-
cord-023095-4dannjjm	718	20	,	,	,
cord-023095-4dannjjm	718	21	and	and	CC
cord-023095-4dannjjm	718	22	albumin	albumin	NN
cord-023095-4dannjjm	718	23	:	:	:
cord-023095-4dannjjm	718	24	globulin	globulin	NN
cord-023095-4dannjjm	718	25	ratio	ratio	NN
cord-023095-4dannjjm	718	26	(	(	-LRB-
cord-023095-4dannjjm	718	27	P	p	NN
cord-023095-4dannjjm	718	28	5	5	CD
cord-023095-4dannjjm	718	29	0.0012	0.0012	CD
cord-023095-4dannjjm	718	30	)	)	-RRB-
cord-023095-4dannjjm	718	31	were	be	VBD
cord-023095-4dannjjm	718	32	significantly	significantly	RB
cord-023095-4dannjjm	718	33	increased	increase	VBN
cord-023095-4dannjjm	718	34	,	,	,
cord-023095-4dannjjm	718	35	and	and	CC
cord-023095-4dannjjm	718	36	urine	urine	VB
cord-023095-4dannjjm	718	37	specific	specific	JJ
cord-023095-4dannjjm	718	38	gravity	gravity	NN
cord-023095-4dannjjm	718	39	(	(	-LRB-
cord-023095-4dannjjm	718	40	P	p	NN
cord-023095-4dannjjm	718	41	5	5	CD
cord-023095-4dannjjm	718	42	0.0062	0.0062	CD
cord-023095-4dannjjm	718	43	)	)	-RRB-
cord-023095-4dannjjm	718	44	and	and	CC
cord-023095-4dannjjm	718	45	chloride	chloride	NN
cord-023095-4dannjjm	718	46	(	(	-LRB-
cord-023095-4dannjjm	718	47	P	p	NN
cord-023095-4dannjjm	718	48	5	5	CD
cord-023095-4dannjjm	718	49	0.0051	0.0051	CD
cord-023095-4dannjjm	718	50	)	)	-RRB-
cord-023095-4dannjjm	718	51	were	be	VBD
cord-023095-4dannjjm	718	52	significantly	significantly	RB
cord-023095-4dannjjm	718	53	decreased	decrease	VBN
cord-023095-4dannjjm	718	54	as	as	IN
cord-023095-4dannjjm	718	55	compared	compare	VBN
cord-023095-4dannjjm	718	56	to	to	IN
cord-023095-4dannjjm	718	57	baseline	baseline	NN
cord-023095-4dannjjm	718	58	and/or	and/or	CC
cord-023095-4dannjjm	718	59	furosemide	furosemide	NN
cord-023095-4dannjjm	718	60	dosing	dosing	NN
cord-023095-4dannjjm	718	61	(	(	-LRB-
cord-023095-4dannjjm	718	62	one	one	CD
cord-023095-4dannjjm	718	63	-	-	HYPH
cord-023095-4dannjjm	718	64	way	way	NN
cord-023095-4dannjjm	718	65	ANOVA	anova	NN
cord-023095-4dannjjm	718	66	with	with	IN
cord-023095-4dannjjm	718	67	Bonferroni	Bonferroni	NNP
cord-023095-4dannjjm	718	68	correction	correction	NN
cord-023095-4dannjjm	718	69	)	)	-RRB-
cord-023095-4dannjjm	718	70	.	.	.
cord-023095-4dannjjm	719	1	No	no	DT
cord-023095-4dannjjm	719	2	differences	difference	NNS
cord-023095-4dannjjm	719	3	in	in	IN
cord-023095-4dannjjm	719	4	QOL	QOL	NNP
cord-023095-4dannjjm	719	5	were	be	VBD
cord-023095-4dannjjm	719	6	found	find	VBN
cord-023095-4dannjjm	719	7	.	.	.
cord-023095-4dannjjm	720	1	Results	result	NNS
cord-023095-4dannjjm	720	2	indicate	indicate	VBP
cord-023095-4dannjjm	720	3	that	that	IN
cord-023095-4dannjjm	720	4	torsemide	torsemide	NN
cord-023095-4dannjjm	720	5	is	be	VBZ
cord-023095-4dannjjm	720	6	equivalent	equivalent	JJ
cord-023095-4dannjjm	720	7	to	to	TO
cord-023095-4dannjjm	720	8	furosemide	furosemide	VB
cord-023095-4dannjjm	720	9	at	at	IN
cord-023095-4dannjjm	720	10	controlling	control	VBG
cord-023095-4dannjjm	720	11	clinical	clinical	JJ
cord-023095-4dannjjm	720	12	heart	heart	NN
cord-023095-4dannjjm	720	13	failure	failure	NN
cord-023095-4dannjjm	720	14	in	in	IN
cord-023095-4dannjjm	720	15	dogs	dog	NNS
cord-023095-4dannjjm	720	16	,	,	,
cord-023095-4dannjjm	720	17	and	and	CC
cord-023095-4dannjjm	720	18	might	may	MD
cord-023095-4dannjjm	720	19	in	in	IN
cord-023095-4dannjjm	720	20	fact	fact	NN
cord-023095-4dannjjm	720	21	,	,	,
cord-023095-4dannjjm	720	22	achieve	achieve	VB
cord-023095-4dannjjm	720	23	greater	great	JJR
cord-023095-4dannjjm	720	24	diuresis	diuresis	NN
cord-023095-4dannjjm	720	25	vs.	vs.	IN
cord-023095-4dannjjm	720	26	furosemide	furosemide	NN
cord-023095-4dannjjm	720	27	.	.	.
cord-023095-4dannjjm	721	1	Larger	large	JJR
cord-023095-4dannjjm	721	2	clinical	clinical	JJ
cord-023095-4dannjjm	721	3	trials	trial	NNS
cord-023095-4dannjjm	721	4	evaluating	evaluate	VBG
cord-023095-4dannjjm	721	5	furosemide	furosemide	NN
cord-023095-4dannjjm	721	6	resistance	resistance	NN
cord-023095-4dannjjm	722	1	and/or	and/or	CC
cord-023095-4dannjjm	722	2	torsemide	torsemide	RB
cord-023095-4dannjjm	722	3	as	as	IN
cord-023095-4dannjjm	722	4	a	a	DT
cord-023095-4dannjjm	722	5	first	first	JJ
cord-023095-4dannjjm	722	6	-	-	HYPH
cord-023095-4dannjjm	722	7	line	line	NN
cord-023095-4dannjjm	722	8	loop	loop	NN
cord-023095-4dannjjm	722	9	diuretic	diuretic	NN
cord-023095-4dannjjm	722	10	for	for	IN
cord-023095-4dannjjm	722	11	congestive	congestive	JJ
cord-023095-4dannjjm	722	12	heart	heart	NN
cord-023095-4dannjjm	722	13	failure	failure	NN
cord-023095-4dannjjm	722	14	in	in	IN
cord-023095-4dannjjm	722	15	dogs	dog	NNS
cord-023095-4dannjjm	722	16	with	with	IN
cord-023095-4dannjjm	722	17	heart	heart	NN
cord-023095-4dannjjm	722	18	failure	failure	NN
cord-023095-4dannjjm	723	1	are	be	VBP
cord-023095-4dannjjm	723	2	warranted	warrant	VBN
cord-023095-4dannjjm	723	3	.	.	.
cord-023095-4dannjjm	724	1	The	the	DT
cord-023095-4dannjjm	724	2	purpose	purpose	NN
cord-023095-4dannjjm	724	3	of	of	IN
cord-023095-4dannjjm	724	4	this	this	DT
cord-023095-4dannjjm	724	5	study	study	NN
cord-023095-4dannjjm	724	6	was	be	VBD
cord-023095-4dannjjm	724	7	to	to	TO
cord-023095-4dannjjm	724	8	investigate	investigate	VB
cord-023095-4dannjjm	724	9	the	the	DT
cord-023095-4dannjjm	724	10	feasibility	feasibility	NN
cord-023095-4dannjjm	724	11	of	of	IN
cord-023095-4dannjjm	724	12	speckle	speckle	NN
cord-023095-4dannjjm	724	13	tracking	tracking	NN
cord-023095-4dannjjm	724	14	echocardiography	echocardiography	NN
cord-023095-4dannjjm	724	15	(	(	-LRB-
cord-023095-4dannjjm	724	16	STE	STE	NNP
cord-023095-4dannjjm	724	17	)	)	-RRB-
cord-023095-4dannjjm	724	18	in	in	IN
cord-023095-4dannjjm	724	19	healthy	healthy	JJ
cord-023095-4dannjjm	724	20	cats	cat	NNS
cord-023095-4dannjjm	724	21	and	and	CC
cord-023095-4dannjjm	724	22	to	to	TO
cord-023095-4dannjjm	724	23	determine	determine	VB
cord-023095-4dannjjm	724	24	whether	whether	IN
cord-023095-4dannjjm	724	25	or	or	CC
cord-023095-4dannjjm	724	26	not	not	RB
cord-023095-4dannjjm	724	27	it	-PRON-	PRP
cord-023095-4dannjjm	724	28	can	can	MD
cord-023095-4dannjjm	724	29	detect	detect	VB
cord-023095-4dannjjm	724	30	myocardial	myocardial	JJ
cord-023095-4dannjjm	724	31	dysfunction	dysfunction	NN
cord-023095-4dannjjm	724	32	in	in	IN
cord-023095-4dannjjm	724	33	cats	cat	NNS
cord-023095-4dannjjm	724	34	with	with	IN
cord-023095-4dannjjm	724	35	diseased	diseased	JJ
cord-023095-4dannjjm	724	36	heart	heart	NN
cord-023095-4dannjjm	724	37	.	.	.
cord-023095-4dannjjm	725	1	Radial	radial	JJ
cord-023095-4dannjjm	725	2	and	and	CC
cord-023095-4dannjjm	725	3	circumferential	circumferential	JJ
cord-023095-4dannjjm	725	4	strain	strain	NN
cord-023095-4dannjjm	725	5	and	and	CC
cord-023095-4dannjjm	725	6	strain	strain	NN
cord-023095-4dannjjm	725	7	rate	rate	NN
cord-023095-4dannjjm	725	8	were	be	VBD
cord-023095-4dannjjm	725	9	measured	measure	VBN
cord-023095-4dannjjm	725	10	by	by	IN
cord-023095-4dannjjm	725	11	STE	STE	NNP
cord-023095-4dannjjm	725	12	using	use	VBG
cord-023095-4dannjjm	725	13	left	left	JJ
cord-023095-4dannjjm	725	14	ventricle	ventricle	NN
cord-023095-4dannjjm	725	15	short	short	JJ
cord-023095-4dannjjm	725	16	-	-	HYPH
cord-023095-4dannjjm	725	17	axis	axis	NN
cord-023095-4dannjjm	725	18	view	view	NN
cord-023095-4dannjjm	725	19	in	in	IN
cord-023095-4dannjjm	725	20	clinically	clinically	RB
cord-023095-4dannjjm	725	21	healthy	healthy	JJ
cord-023095-4dannjjm	725	22	cats	cat	NNS
cord-023095-4dannjjm	725	23	.	.	.
cord-023095-4dannjjm	726	1	Eighteen	eighteen	CD
cord-023095-4dannjjm	726	2	cats	cat	NNS
cord-023095-4dannjjm	726	3	with	with	IN
cord-023095-4dannjjm	726	4	HCM	HCM	NNP
cord-023095-4dannjjm	726	5	whose	whose	WP$
cord-023095-4dannjjm	726	6	LV	LV	NNP
cord-023095-4dannjjm	726	7	thickness	thickness	NN
cord-023095-4dannjjm	726	8	at	at	IN
cord-023095-4dannjjm	726	9	end	end	NN
cord-023095-4dannjjm	726	10	-	-	HYPH
cord-023095-4dannjjm	726	11	diastole	diastole	NN
cord-023095-4dannjjm	726	12	with	with	IN
cord-023095-4dannjjm	726	13	6	6	CD
cord-023095-4dannjjm	726	14	mm	mm	NNS
cord-023095-4dannjjm	726	15	or	or	CC
cord-023095-4dannjjm	726	16	more	more	JJR
cord-023095-4dannjjm	726	17	were	be	VBD
cord-023095-4dannjjm	726	18	evaluated	evaluate	VBN
cord-023095-4dannjjm	726	19	with	with	IN
cord-023095-4dannjjm	726	20	STE	STE	NNP
cord-023095-4dannjjm	726	21	analysis	analysis	NN
cord-023095-4dannjjm	726	22	,	,	,
cord-023095-4dannjjm	726	23	and	and	CC
cord-023095-4dannjjm	726	24	compared	compare	VBN
cord-023095-4dannjjm	726	25	with	with	IN
cord-023095-4dannjjm	726	26	healthy	healthy	JJ
cord-023095-4dannjjm	726	27	cats	cat	NNS
cord-023095-4dannjjm	726	28	.	.	.
cord-023095-4dannjjm	727	1	Index	index	NN
cord-023095-4dannjjm	727	2	of	of	IN
cord-023095-4dannjjm	727	3	left	left	JJ
cord-023095-4dannjjm	727	4	ventricular	ventricular	JJ
cord-023095-4dannjjm	727	5	synchrony	synchrony	NN
cord-023095-4dannjjm	727	6	(	(	-LRB-
cord-023095-4dannjjm	727	7	Trs	Trs	NNP
cord-023095-4dannjjm	727	8	-	-	HYPH
cord-023095-4dannjjm	727	9	SD	SD	NNP
cord-023095-4dannjjm	727	10	)	)	-RRB-
cord-023095-4dannjjm	727	11	was	be	VBD
cord-023095-4dannjjm	727	12	also	also	RB
cord-023095-4dannjjm	727	13	assessed	assess	VBN
cord-023095-4dannjjm	727	14	in	in	IN
cord-023095-4dannjjm	727	15	cats	cat	NNS
cord-023095-4dannjjm	727	16	with	with	IN
cord-023095-4dannjjm	727	17	HCM	HCM	NNP
cord-023095-4dannjjm	727	18	,	,	,
cord-023095-4dannjjm	727	19	and	and	CC
cord-023095-4dannjjm	727	20	compared	compare	VBN
cord-023095-4dannjjm	727	21	to	to	IN
cord-023095-4dannjjm	727	22	healthy	healthy	JJ
cord-023095-4dannjjm	727	23	subjects	subject	NNS
cord-023095-4dannjjm	727	24	.	.	.
cord-023095-4dannjjm	728	1	STE	STE	NNP
cord-023095-4dannjjm	728	2	resulted	result	VBD
cord-023095-4dannjjm	728	3	in	in	IN
cord-023095-4dannjjm	728	4	technically	technically	RB
cord-023095-4dannjjm	728	5	adequate	adequate	JJ
cord-023095-4dannjjm	728	6	images	image	NNS
cord-023095-4dannjjm	728	7	in	in	IN
cord-023095-4dannjjm	728	8	100	100	CD
cord-023095-4dannjjm	728	9	%	%	NN
cord-023095-4dannjjm	728	10	of	of	IN
cord-023095-4dannjjm	728	11	the	the	DT
cord-023095-4dannjjm	728	12	cats	cat	NNS
cord-023095-4dannjjm	728	13	.	.	.
cord-023095-4dannjjm	729	1	Fusions	fusion	NNS
cord-023095-4dannjjm	729	2	of	of	IN
cord-023095-4dannjjm	729	3	early	early	JJ
cord-023095-4dannjjm	729	4	and	and	CC
cord-023095-4dannjjm	729	5	late	late	JJ
cord-023095-4dannjjm	729	6	diastolic	diastolic	NN
cord-023095-4dannjjm	729	7	(	(	-LRB-
cord-023095-4dannjjm	729	8	E	e	NN
cord-023095-4dannjjm	729	9	and	and	CC
cord-023095-4dannjjm	729	10	A	a	NN
cord-023095-4dannjjm	729	11	)	)	-RRB-
cord-023095-4dannjjm	729	12	wave	wave	NN
cord-023095-4dannjjm	729	13	in	in	IN
cord-023095-4dannjjm	729	14	strain	strain	NN
cord-023095-4dannjjm	729	15	rate	rate	NN
cord-023095-4dannjjm	729	16	were	be	VBD
cord-023095-4dannjjm	729	17	seen	see	VBN
cord-023095-4dannjjm	729	18	in	in	IN
cord-023095-4dannjjm	729	19	3	3	CD
cord-023095-4dannjjm	729	20	of	of	IN
cord-023095-4dannjjm	729	21	16	16	CD
cord-023095-4dannjjm	729	22	cats	cat	NNS
cord-023095-4dannjjm	729	23	.	.	.
cord-023095-4dannjjm	730	1	Percent	percent	NN
cord-023095-4dannjjm	730	2	errors	error	NNS
cord-023095-4dannjjm	730	3	in	in	IN
cord-023095-4dannjjm	730	4	analysis	analysis	NN
cord-023095-4dannjjm	730	5	with	with	IN
cord-023095-4dannjjm	730	6	or	or	CC
cord-023095-4dannjjm	730	7	without	without	IN
cord-023095-4dannjjm	730	8	simultaneous	simultaneous	JJ
cord-023095-4dannjjm	730	9	ECG	ECG	NNP
cord-023095-4dannjjm	730	10	monitoring	monitoring	NN
cord-023095-4dannjjm	730	11	were	be	VBD
cord-023095-4dannjjm	730	12	5.3	5.3	CD
cord-023095-4dannjjm	730	13	-	-	SYM
cord-023095-4dannjjm	730	14	14.7	14.7	CD
cord-023095-4dannjjm	730	15	%	%	NN
cord-023095-4dannjjm	730	16	in	in	IN
cord-023095-4dannjjm	730	17	all	all	DT
cord-023095-4dannjjm	730	18	parameters	parameter	NNS
cord-023095-4dannjjm	730	19	.	.	.
cord-023095-4dannjjm	731	1	Inter	Inter	NNP
cord-023095-4dannjjm	731	2	-	-	:
cord-023095-4dannjjm	731	3	and	and	CC
cord-023095-4dannjjm	731	4	intraobserver	intraobserver	NNP
cord-023095-4dannjjm	731	5	variability	variability	NN
cord-023095-4dannjjm	731	6	of	of	IN
cord-023095-4dannjjm	731	7	STE	STE	NNP
cord-023095-4dannjjm	731	8	parameters	parameter	NNS
cord-023095-4dannjjm	731	9	in	in	IN
cord-023095-4dannjjm	731	10	healthy	healthy	JJ
cord-023095-4dannjjm	731	11	cats	cat	NNS
cord-023095-4dannjjm	731	12	was	be	VBD
cord-023095-4dannjjm	731	13	minimal	minimal	JJ
cord-023095-4dannjjm	731	14	(	(	-LRB-
cord-023095-4dannjjm	731	15	4.1	4.1	CD
cord-023095-4dannjjm	731	16	-	-	SYM
cord-023095-4dannjjm	731	17	15.6	15.6	CD
cord-023095-4dannjjm	731	18	%	%	NN
cord-023095-4dannjjm	731	19	)	)	-RRB-
cord-023095-4dannjjm	731	20	except	except	IN
cord-023095-4dannjjm	731	21	for	for	IN
cord-023095-4dannjjm	731	22	the	the	DT
cord-023095-4dannjjm	731	23	systolic	systolic	JJ
cord-023095-4dannjjm	731	24	circumferential	circumferential	JJ
cord-023095-4dannjjm	731	25	strain	strain	NN
cord-023095-4dannjjm	731	26	rate	rate	NN
cord-023095-4dannjjm	731	27	.	.	.
cord-023095-4dannjjm	732	1	Sedation	sedation	NN
cord-023095-4dannjjm	732	2	using	use	VBG
cord-023095-4dannjjm	732	3	buprenorphine	buprenorphine	NN
cord-023095-4dannjjm	732	4	and	and	CC
cord-023095-4dannjjm	732	5	acepromazine	acepromazine	NN
cord-023095-4dannjjm	732	6	did	do	VBD
cord-023095-4dannjjm	732	7	not	not	RB
cord-023095-4dannjjm	732	8	affect	affect	VB
cord-023095-4dannjjm	732	9	any	any	DT
cord-023095-4dannjjm	732	10	STE	STE	NNP
cord-023095-4dannjjm	732	11	parameter	parameter	NN
cord-023095-4dannjjm	732	12	.	.	.
cord-023095-4dannjjm	733	1	E	e	NN
cord-023095-4dannjjm	733	2	wave	wave	NN
cord-023095-4dannjjm	733	3	in	in	IN
cord-023095-4dannjjm	733	4	radial	radial	JJ
cord-023095-4dannjjm	733	5	and	and	CC
cord-023095-4dannjjm	733	6	circumferential	circumferential	JJ
cord-023095-4dannjjm	733	7	strain	strain	NN
cord-023095-4dannjjm	733	8	rate	rate	NN
cord-023095-4dannjjm	733	9	of	of	IN
cord-023095-4dannjjm	733	10	HCM	HCM	NNP
cord-023095-4dannjjm	733	11	cats	cat	NNS
cord-023095-4dannjjm	733	12	was	be	VBD
cord-023095-4dannjjm	733	13	significantly	significantly	RB
cord-023095-4dannjjm	733	14	decreased	decrease	VBN
cord-023095-4dannjjm	733	15	compared	compare	VBN
cord-023095-4dannjjm	733	16	with	with	IN
cord-023095-4dannjjm	733	17	healthy	healthy	JJ
cord-023095-4dannjjm	733	18	cats	cat	NNS
cord-023095-4dannjjm	733	19	.	.	.
cord-023095-4dannjjm	734	1	No	no	DT
cord-023095-4dannjjm	734	2	significant	significant	JJ
cord-023095-4dannjjm	734	3	difference	difference	NN
cord-023095-4dannjjm	734	4	was	be	VBD
cord-023095-4dannjjm	734	5	seen	see	VBN
cord-023095-4dannjjm	734	6	in	in	IN
cord-023095-4dannjjm	734	7	Trs	Trs	NNP
cord-023095-4dannjjm	734	8	-	-	HYPH
cord-023095-4dannjjm	734	9	SD	SD	NNP
cord-023095-4dannjjm	734	10	.	.	.
cord-023095-4dannjjm	735	1	STE	STE	NNP
cord-023095-4dannjjm	735	2	analysis	analysis	NN
cord-023095-4dannjjm	735	3	was	be	VBD
cord-023095-4dannjjm	735	4	considered	consider	VBN
cord-023095-4dannjjm	735	5	clinically	clinically	RB
cord-023095-4dannjjm	735	6	feasible	feasible	JJ
cord-023095-4dannjjm	735	7	to	to	TO
cord-023095-4dannjjm	735	8	assess	assess	VB
cord-023095-4dannjjm	735	9	cardiac	cardiac	JJ
cord-023095-4dannjjm	735	10	function	function	NN
cord-023095-4dannjjm	735	11	in	in	IN
cord-023095-4dannjjm	735	12	cats	cat	NNS
cord-023095-4dannjjm	735	13	,	,	,
cord-023095-4dannjjm	735	14	and	and	CC
cord-023095-4dannjjm	735	15	could	could	MD
cord-023095-4dannjjm	735	16	detect	detect	VB
cord-023095-4dannjjm	735	17	myocardial	myocardial	JJ
cord-023095-4dannjjm	735	18	dysfunction	dysfunction	NN
cord-023095-4dannjjm	735	19	in	in	IN
cord-023095-4dannjjm	735	20	cats	cat	NNS
cord-023095-4dannjjm	735	21	with	with	IN
cord-023095-4dannjjm	735	22	HCM	HCM	NNP
cord-023095-4dannjjm	735	23	.	.	.
cord-023095-4dannjjm	736	1	Further	further	JJ
cord-023095-4dannjjm	736	2	study	study	NN
cord-023095-4dannjjm	736	3	is	be	VBZ
cord-023095-4dannjjm	736	4	warranted	warrant	VBN
cord-023095-4dannjjm	736	5	to	to	TO
cord-023095-4dannjjm	736	6	investigate	investigate	VB
cord-023095-4dannjjm	736	7	to	to	TO
cord-023095-4dannjjm	736	8	assess	assess	VB
cord-023095-4dannjjm	736	9	whether	whether	IN
cord-023095-4dannjjm	736	10	or	or	CC
cord-023095-4dannjjm	736	11	not	not	RB
cord-023095-4dannjjm	736	12	STE	STE	NNP
cord-023095-4dannjjm	736	13	can	can	MD
cord-023095-4dannjjm	736	14	differentiate	differentiate	VB
cord-023095-4dannjjm	736	15	the	the	DT
cord-023095-4dannjjm	736	16	etiology	etiology	NN
cord-023095-4dannjjm	736	17	of	of	IN
cord-023095-4dannjjm	736	18	left	left	JJ
cord-023095-4dannjjm	736	19	ventricular	ventricular	JJ
cord-023095-4dannjjm	736	20	concentric	concentric	JJ
cord-023095-4dannjjm	736	21	hypertrophy	hypertrophy	NN
cord-023095-4dannjjm	736	22	since	since	IN
cord-023095-4dannjjm	736	23	it	-PRON-	PRP
cord-023095-4dannjjm	736	24	is	be	VBZ
cord-023095-4dannjjm	736	25	clinically	clinically	RB
cord-023095-4dannjjm	736	26	important	important	JJ
cord-023095-4dannjjm	736	27	.	.	.
cord-023095-4dannjjm	737	1	Carvedilol	Carvedilol	NNP
cord-023095-4dannjjm	737	2	,	,	,
cord-023095-4dannjjm	737	3	a	a	DT
cord-023095-4dannjjm	737	4	3rd	3rd	JJ
cord-023095-4dannjjm	737	5	generation	generation	NN
cord-023095-4dannjjm	737	6	non	non	JJ
cord-023095-4dannjjm	737	7	-	-	JJ
cord-023095-4dannjjm	737	8	selective	selective	JJ
cord-023095-4dannjjm	737	9	beta	beta	NN
cord-023095-4dannjjm	737	10	-	-	HYPH
cord-023095-4dannjjm	737	11	blocker	blocker	NN
cord-023095-4dannjjm	737	12	with	with	IN
cord-023095-4dannjjm	737	13	ancillary	ancillary	JJ
cord-023095-4dannjjm	737	14	alpha	alpha	NN
cord-023095-4dannjjm	737	15	1	1	CD
cord-023095-4dannjjm	737	16	-blocking	-blocking	NN
cord-023095-4dannjjm	737	17	and	and	CC
cord-023095-4dannjjm	737	18	antioxidant	antioxidant	NN
cord-023095-4dannjjm	737	19	properties	property	NNS
cord-023095-4dannjjm	737	20	may	may	MD
cord-023095-4dannjjm	737	21	have	have	VB
cord-023095-4dannjjm	737	22	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	737	23	implications	implication	NNS
cord-023095-4dannjjm	737	24	for	for	IN
cord-023095-4dannjjm	737	25	multiple	multiple	JJ
cord-023095-4dannjjm	737	26	diseases	disease	NNS
cord-023095-4dannjjm	737	27	in	in	IN
cord-023095-4dannjjm	737	28	cats	cat	NNS
cord-023095-4dannjjm	737	29	;	;	:
cord-023095-4dannjjm	737	30	however	however	RB
cord-023095-4dannjjm	737	31	,	,	,
cord-023095-4dannjjm	737	32	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	737	33	and	and	CC
cord-023095-4dannjjm	737	34	bioavailability	bioavailability	NN
cord-023095-4dannjjm	737	35	of	of	IN
cord-023095-4dannjjm	737	36	commercially	commercially	RB
cord-023095-4dannjjm	737	37	prepared	prepare	VBN
cord-023095-4dannjjm	737	38	oral	oral	JJ
cord-023095-4dannjjm	737	39	carvedilol	carvedilol	NN
cord-023095-4dannjjm	737	40	has	have	VBZ
cord-023095-4dannjjm	737	41	not	not	RB
cord-023095-4dannjjm	737	42	been	be	VBN
cord-023095-4dannjjm	737	43	determined	determine	VBN
cord-023095-4dannjjm	737	44	.	.	.
cord-023095-4dannjjm	738	1	HPLC	HPLC	NNP
cord-023095-4dannjjm	738	2	for	for	IN
cord-023095-4dannjjm	738	3	carvedilol	carvedilol	NN
cord-023095-4dannjjm	738	4	measurement	measurement	NN
cord-023095-4dannjjm	738	5	in	in	IN
cord-023095-4dannjjm	738	6	feline	feline	JJ
cord-023095-4dannjjm	738	7	plasma	plasma	NN
cord-023095-4dannjjm	738	8	was	be	VBD
cord-023095-4dannjjm	738	9	validated	validate	VBN
cord-023095-4dannjjm	738	10	and	and	CC
cord-023095-4dannjjm	738	11	standardization	standardization	NN
cord-023095-4dannjjm	738	12	curves	curve	NNS
cord-023095-4dannjjm	738	13	created	create	VBN
cord-023095-4dannjjm	738	14	.	.	.
cord-023095-4dannjjm	739	1	The	the	DT
cord-023095-4dannjjm	739	2	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	739	3	(	(	-LRB-
cord-023095-4dannjjm	739	4	PK	PK	NNP
cord-023095-4dannjjm	739	5	)	)	-RRB-
cord-023095-4dannjjm	739	6	of	of	IN
cord-023095-4dannjjm	739	7	carvedilol	carvedilol	NNP
cord-023095-4dannjjm	739	8	was	be	VBD
cord-023095-4dannjjm	739	9	evaluated	evaluate	VBN
cord-023095-4dannjjm	739	10	in	in	IN
cord-023095-4dannjjm	739	11	5	5	CD
cord-023095-4dannjjm	739	12	apparently	apparently	RB
cord-023095-4dannjjm	739	13	healthy	healthy	JJ
cord-023095-4dannjjm	739	14	male	male	JJ
cord-023095-4dannjjm	739	15	neutered	neuter	VBN
cord-023095-4dannjjm	739	16	adult	adult	NN
cord-023095-4dannjjm	739	17	cats	cat	NNS
cord-023095-4dannjjm	739	18	(	(	-LRB-
cord-023095-4dannjjm	739	19	average	average	JJ
cord-023095-4dannjjm	739	20	weight	weight	NN
cord-023095-4dannjjm	739	21	of	of	IN
cord-023095-4dannjjm	739	22	5	5	CD
cord-023095-4dannjjm	739	23	kg	kg	NN
cord-023095-4dannjjm	739	24	)	)	-RRB-
cord-023095-4dannjjm	739	25	following	follow	VBG
cord-023095-4dannjjm	739	26	single	single	JJ
cord-023095-4dannjjm	739	27	dose	dose	NN
cord-023095-4dannjjm	739	28	intravenous	intravenous	NN
cord-023095-4dannjjm	739	29	(	(	-LRB-
cord-023095-4dannjjm	739	30	IV	IV	NNP
cord-023095-4dannjjm	739	31	)	)	-RRB-
cord-023095-4dannjjm	739	32	of	of	IN
cord-023095-4dannjjm	739	33	0.5	0.5	CD
cord-023095-4dannjjm	739	34	mg	mg	NNP
cord-023095-4dannjjm	739	35	/	/	SYM
cord-023095-4dannjjm	739	36	kg	kg	NNS
cord-023095-4dannjjm	739	37	and	and	CC
cord-023095-4dannjjm	739	38	single	single	JJ
cord-023095-4dannjjm	739	39	dose	dose	NN
cord-023095-4dannjjm	739	40	oral	oral	JJ
cord-023095-4dannjjm	739	41	administration	administration	NN
cord-023095-4dannjjm	739	42	of	of	IN
cord-023095-4dannjjm	739	43	1.6	1.6	CD
cord-023095-4dannjjm	739	44	to	to	TO
cord-023095-4dannjjm	739	45	2.0	2.0	CD
cord-023095-4dannjjm	739	46	mg	mg	NNS
cord-023095-4dannjjm	739	47	/	/	SYM
cord-023095-4dannjjm	739	48	kg	kg	NN
cord-023095-4dannjjm	739	49	.	.	.
cord-023095-4dannjjm	740	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	740	2	of	of	IN
cord-023095-4dannjjm	740	3	the	the	DT
cord-023095-4dannjjm	740	4	active	active	JJ
cord-023095-4dannjjm	740	5	parent	parent	NN
cord-023095-4dannjjm	740	6	compound	compound	NN
cord-023095-4dannjjm	740	7	,	,	,
cord-023095-4dannjjm	740	8	carvedilol	carvedilol	NN
cord-023095-4dannjjm	740	9	,	,	,
cord-023095-4dannjjm	740	10	were	be	VBD
cord-023095-4dannjjm	740	11	detected	detect	VBN
cord-023095-4dannjjm	740	12	in	in	IN
cord-023095-4dannjjm	740	13	plasma	plasma	NN
cord-023095-4dannjjm	740	14	using	use	VBG
cord-023095-4dannjjm	740	15	HPLC	HPLC	NNP
cord-023095-4dannjjm	740	16	analysis	analysis	NN
cord-023095-4dannjjm	740	17	.	.	.
cord-023095-4dannjjm	741	1	Lower	low	JJR
cord-023095-4dannjjm	741	2	limit	limit	NN
cord-023095-4dannjjm	741	3	of	of	IN
cord-023095-4dannjjm	741	4	quantification	quantification	NN
cord-023095-4dannjjm	741	5	was	be	VBD
cord-023095-4dannjjm	741	6	5	5	CD
cord-023095-4dannjjm	741	7	ng	ng	NN
cord-023095-4dannjjm	741	8	/	/	SYM
cord-023095-4dannjjm	741	9	ml	ml	NN
cord-023095-4dannjjm	741	10	.	.	.
cord-023095-4dannjjm	742	1	The	the	DT
cord-023095-4dannjjm	742	2	mean	mean	JJ
cord-023095-4dannjjm	742	3	peak	peak	NN
cord-023095-4dannjjm	742	4	concentration	concentration	NN
cord-023095-4dannjjm	742	5	after	after	IN
cord-023095-4dannjjm	742	6	IV	IV	NNP
cord-023095-4dannjjm	742	7	administration	administration	NN
cord-023095-4dannjjm	742	8	of	of	IN
cord-023095-4dannjjm	742	9	carvedilol	carvedilol	NNP
cord-023095-4dannjjm	742	10	was	be	VBD
cord-023095-4dannjjm	742	11	8639	8639	CD
cord-023095-4dannjjm	742	12	ng	ng	NN
cord-023095-4dannjjm	742	13	/	/	SYM
cord-023095-4dannjjm	742	14	mL	ml	NN
cord-023095-4dannjjm	742	15	(	(	-LRB-
cord-023095-4dannjjm	742	16	range	range	NN
cord-023095-4dannjjm	742	17	,	,	,
cord-023095-4dannjjm	742	18	901	901	CD
cord-023095-4dannjjm	742	19	to	to	IN
cord-023095-4dannjjm	742	20	8648	8648	CD
cord-023095-4dannjjm	742	21	)	)	-RRB-
cord-023095-4dannjjm	742	22	,	,	,
cord-023095-4dannjjm	742	23	elimination	elimination	NN
cord-023095-4dannjjm	742	24	half	half	JJ
cord-023095-4dannjjm	742	25	-	-	HYPH
cord-023095-4dannjjm	742	26	life	life	NN
cord-023095-4dannjjm	742	27	was	be	VBD
cord-023095-4dannjjm	742	28	2.9	2.9	CD
cord-023095-4dannjjm	742	29	hours	hour	NNS
cord-023095-4dannjjm	742	30	(	(	-LRB-
cord-023095-4dannjjm	742	31	range	range	NN
cord-023095-4dannjjm	742	32	,	,	,
cord-023095-4dannjjm	742	33	2.0	2.0	CD
cord-023095-4dannjjm	742	34	to	to	IN
cord-023095-4dannjjm	742	35	5.4	5.4	CD
cord-023095-4dannjjm	742	36	)	)	-RRB-
cord-023095-4dannjjm	742	37	,	,	,
cord-023095-4dannjjm	742	38	and	and	CC
cord-023095-4dannjjm	742	39	clearance	clearance	NN
cord-023095-4dannjjm	742	40	was	be	VBD
cord-023095-4dannjjm	742	41	0.35	0.35	CD
cord-023095-4dannjjm	742	42	L	l	NN
cord-023095-4dannjjm	742	43	/	/	SYM
cord-023095-4dannjjm	742	44	hr	hr	NN
cord-023095-4dannjjm	742	45	/	/	SYM
cord-023095-4dannjjm	742	46	kg	kg	NNS
cord-023095-4dannjjm	742	47	.	.	.
cord-023095-4dannjjm	743	1	The	the	DT
cord-023095-4dannjjm	743	2	volume	volume	NN
cord-023095-4dannjjm	743	3	of	of	IN
cord-023095-4dannjjm	743	4	distribution	distribution	NN
cord-023095-4dannjjm	743	5	was	be	VBD
cord-023095-4dannjjm	743	6	1.18	1.18	CD
cord-023095-4dannjjm	743	7	L	l	NN
cord-023095-4dannjjm	743	8	/	/	SYM
cord-023095-4dannjjm	743	9	hr	hr	NN
cord-023095-4dannjjm	743	10	.	.	.
cord-023095-4dannjjm	744	1	After	after	IN
cord-023095-4dannjjm	744	2	a	a	DT
cord-023095-4dannjjm	744	3	single	single	JJ
cord-023095-4dannjjm	744	4	oral	oral	JJ
cord-023095-4dannjjm	744	5	administration	administration	NN
cord-023095-4dannjjm	744	6	of	of	IN
cord-023095-4dannjjm	744	7	carvedilol	carvedilol	NNP
cord-023095-4dannjjm	744	8	,	,	,
cord-023095-4dannjjm	744	9	the	the	DT
cord-023095-4dannjjm	744	10	time	time	NN
cord-023095-4dannjjm	744	11	to	to	TO
cord-023095-4dannjjm	744	12	peak	peak	VB
cord-023095-4dannjjm	744	13	plasma	plasma	NN
cord-023095-4dannjjm	744	14	concentration	concentration	NN
cord-023095-4dannjjm	744	15	was	be	VBD
cord-023095-4dannjjm	744	16	60	60	CD
cord-023095-4dannjjm	744	17	minutes	minute	NNS
cord-023095-4dannjjm	744	18	(	(	-LRB-
cord-023095-4dannjjm	744	19	range	range	NN
cord-023095-4dannjjm	744	20	,	,	,
cord-023095-4dannjjm	744	21	30	30	CD
cord-023095-4dannjjm	744	22	to	to	TO
cord-023095-4dannjjm	744	23	90	90	CD
cord-023095-4dannjjm	744	24	minutes	minute	NNS
cord-023095-4dannjjm	744	25	)	)	-RRB-
cord-023095-4dannjjm	744	26	and	and	CC
cord-023095-4dannjjm	744	27	the	the	DT
cord-023095-4dannjjm	744	28	mean	mean	JJ
cord-023095-4dannjjm	744	29	residual	residual	JJ
cord-023095-4dannjjm	744	30	time	time	NN
cord-023095-4dannjjm	744	31	was	be	VBD
cord-023095-4dannjjm	744	32	4.8	4.8	CD
cord-023095-4dannjjm	744	33	hours	hour	NNS
cord-023095-4dannjjm	744	34	.	.	.
cord-023095-4dannjjm	745	1	The	the	DT
cord-023095-4dannjjm	745	2	half	half	JJ
cord-023095-4dannjjm	745	3	life	life	NN
cord-023095-4dannjjm	745	4	was	be	VBD
cord-023095-4dannjjm	745	5	4.44	4.44	CD
cord-023095-4dannjjm	745	6	hours	hour	NNS
cord-023095-4dannjjm	745	7	.	.	.
cord-023095-4dannjjm	746	1	Maximal	maximal	JJ
cord-023095-4dannjjm	746	2	concentration	concentration	NN
cord-023095-4dannjjm	746	3	294	294	CD
cord-023095-4dannjjm	746	4	ng/	ng/	NN
cord-023095-4dannjjm	746	5	mL	ml	NN
cord-023095-4dannjjm	747	1	and	and	CC
cord-023095-4dannjjm	747	2	the	the	DT
cord-023095-4dannjjm	747	3	mean	mean	JJ
cord-023095-4dannjjm	747	4	bioavailability	bioavailability	NN
cord-023095-4dannjjm	747	5	was	be	VBD
cord-023095-4dannjjm	747	6	15.7	15.7	CD
cord-023095-4dannjjm	747	7	%	%	NN
cord-023095-4dannjjm	747	8	with	with	IN
cord-023095-4dannjjm	747	9	a	a	DT
cord-023095-4dannjjm	747	10	median	median	NN
cord-023095-4dannjjm	747	11	of	of	IN
cord-023095-4dannjjm	747	12	9.97	9.97	CD
cord-023095-4dannjjm	747	13	%	%	NN
cord-023095-4dannjjm	747	14	(	(	-LRB-
cord-023095-4dannjjm	747	15	range	range	NN
cord-023095-4dannjjm	747	16	,	,	,
cord-023095-4dannjjm	747	17	4.7	4.7	CD
cord-023095-4dannjjm	747	18	%	%	NN
cord-023095-4dannjjm	747	19	to	to	IN
cord-023095-4dannjjm	747	20	46	46	CD
cord-023095-4dannjjm	747	21	%	%	NN
cord-023095-4dannjjm	747	22	)	)	-RRB-
cord-023095-4dannjjm	747	23	.	.	.
cord-023095-4dannjjm	748	1	These	these	DT
cord-023095-4dannjjm	748	2	data	datum	NNS
cord-023095-4dannjjm	748	3	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	748	4	a	a	DT
cord-023095-4dannjjm	748	5	low	low	JJ
cord-023095-4dannjjm	748	6	bioavailability	bioavailability	NN
cord-023095-4dannjjm	748	7	of	of	IN
cord-023095-4dannjjm	748	8	oral	oral	JJ
cord-023095-4dannjjm	748	9	carvedilol	carvedilol	NN
cord-023095-4dannjjm	748	10	and	and	CC
cord-023095-4dannjjm	748	11	a	a	DT
cord-023095-4dannjjm	748	12	wide	wide	JJ
cord-023095-4dannjjm	748	13	variation	variation	NN
cord-023095-4dannjjm	748	14	in	in	IN
cord-023095-4dannjjm	748	15	cats	cat	NNS
cord-023095-4dannjjm	748	16	.	.	.
cord-023095-4dannjjm	749	1	All	all	DT
cord-023095-4dannjjm	749	2	cats	cat	NNS
cord-023095-4dannjjm	749	3	tolerated	tolerate	VBD
cord-023095-4dannjjm	749	4	the	the	DT
cord-023095-4dannjjm	749	5	oral	oral	JJ
cord-023095-4dannjjm	749	6	dose	dose	NN
cord-023095-4dannjjm	749	7	of	of	IN
cord-023095-4dannjjm	749	8	carvedilol	carvedilol	NN
cord-023095-4dannjjm	749	9	with	with	IN
cord-023095-4dannjjm	749	10	no	no	DT
cord-023095-4dannjjm	749	11	major	major	JJ
cord-023095-4dannjjm	749	12	adverse	adverse	JJ
cord-023095-4dannjjm	749	13	effects	effect	NNS
cord-023095-4dannjjm	749	14	.	.	.
cord-023095-4dannjjm	750	1	Also	also	RB
cord-023095-4dannjjm	750	2	,	,	,
cord-023095-4dannjjm	750	3	a	a	DT
cord-023095-4dannjjm	750	4	mean	mean	JJ
cord-023095-4dannjjm	750	5	residual	residual	JJ
cord-023095-4dannjjm	750	6	time	time	NN
cord-023095-4dannjjm	750	7	of	of	IN
cord-023095-4dannjjm	750	8	4.8	4.8	CD
cord-023095-4dannjjm	750	9	hours	hour	NNS
cord-023095-4dannjjm	750	10	would	would	MD
cord-023095-4dannjjm	750	11	suggest	suggest	VB
cord-023095-4dannjjm	750	12	that	that	IN
cord-023095-4dannjjm	750	13	a	a	DT
cord-023095-4dannjjm	750	14	more	more	RBR
cord-023095-4dannjjm	750	15	frequent	frequent	JJ
cord-023095-4dannjjm	750	16	dosing	dosing	NN
cord-023095-4dannjjm	750	17	schedule	schedule	NN
cord-023095-4dannjjm	750	18	may	may	MD
cord-023095-4dannjjm	750	19	be	be	VB
cord-023095-4dannjjm	750	20	required	require	VBN
cord-023095-4dannjjm	750	21	to	to	TO
cord-023095-4dannjjm	750	22	maintain	maintain	VB
cord-023095-4dannjjm	750	23	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	750	24	plasma	plasma	NN
cord-023095-4dannjjm	750	25	levels	level	NNS
cord-023095-4dannjjm	750	26	.	.	.
cord-023095-4dannjjm	751	1	Pharmacodynamic	Pharmacodynamic	NNP
cord-023095-4dannjjm	751	2	studies	study	NNS
cord-023095-4dannjjm	751	3	investigating	investigate	VBG
cord-023095-4dannjjm	751	4	beta	beta	JJ
cord-023095-4dannjjm	751	5	-	-	HYPH
cord-023095-4dannjjm	751	6	adrenergic	adrenergic	NN
cord-023095-4dannjjm	751	7	blockade	blockade	NN
cord-023095-4dannjjm	751	8	duration	duration	NN
cord-023095-4dannjjm	751	9	may	may	MD
cord-023095-4dannjjm	751	10	provide	provide	VB
cord-023095-4dannjjm	751	11	a	a	DT
cord-023095-4dannjjm	751	12	more	more	RBR
cord-023095-4dannjjm	751	13	accurate	accurate	JJ
cord-023095-4dannjjm	751	14	dosing	dosing	NN
cord-023095-4dannjjm	751	15	interval	interval	NN
cord-023095-4dannjjm	751	16	of	of	IN
cord-023095-4dannjjm	751	17	carvedilol	carvedilol	NN
cord-023095-4dannjjm	751	18	.	.	.
cord-023095-4dannjjm	752	1	ABSTRACT	abstract	JJ
cord-023095-4dannjjm	752	2	C-49	C-49	NNP
cord-023095-4dannjjm	752	3	EFFECTS	effects	NN
cord-023095-4dannjjm	752	4	OF	of	IN
cord-023095-4dannjjm	752	5	SILDENAFIL	SILDENAFIL	NNP
cord-023095-4dannjjm	752	6	CITRATE	CITRATE	NNP
cord-023095-4dannjjm	752	7	ON	on	IN
cord-023095-4dannjjm	752	8	DOGS	dog	NNS
cord-023095-4dannjjm	752	9	WITH	with	IN
cord-023095-4dannjjm	752	10	EI	EI	NNP
cord-023095-4dannjjm	752	11	-	-	HYPH
cord-023095-4dannjjm	752	12	SENMENGER	SENMENGER	NNP
cord-023095-4dannjjm	752	13	'S	's	POS
cord-023095-4dannjjm	752	14	SYNDROME	syndrome	NN
cord-023095-4dannjjm	752	15	.	.	.
cord-023095-4dannjjm	753	1	K	K	NNP
cord-023095-4dannjjm	753	2	Nakamura	Nakamura	NNP
cord-023095-4dannjjm	753	3	,	,	,
cord-023095-4dannjjm	753	4	M	M	NNP
cord-023095-4dannjjm	753	5	Yamasaki	Yamasaki	NNP
cord-023095-4dannjjm	753	6	,	,	,
cord-023095-4dannjjm	753	7	H	H	NNP
cord-023095-4dannjjm	753	8	Ohta	Ohta	NNP
cord-023095-4dannjjm	753	9	,	,	,
cord-023095-4dannjjm	753	10	M	M	NNP
cord-023095-4dannjjm	753	11	Takiguchi	Takiguchi	NNP
cord-023095-4dannjjm	753	12	.	.	.
cord-023095-4dannjjm	754	1	Department	Department	NNP
cord-023095-4dannjjm	754	2	of	of	IN
cord-023095-4dannjjm	754	3	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	754	4	Clinical	Clinical	NNP
cord-023095-4dannjjm	754	5	Sciences	Sciences	NNPS
cord-023095-4dannjjm	754	6	,	,	,
cord-023095-4dannjjm	754	7	Graduate	Graduate	NNP
cord-023095-4dannjjm	754	8	School	School	NNP
cord-023095-4dannjjm	754	9	of	of	IN
cord-023095-4dannjjm	754	10	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	754	11	Medicine	Medicine	NNP
cord-023095-4dannjjm	754	12	,	,	,
cord-023095-4dannjjm	754	13	Hokkaido	Hokkaido	NNP
cord-023095-4dannjjm	754	14	University	University	NNP
cord-023095-4dannjjm	754	15	,	,	,
cord-023095-4dannjjm	754	16	Sapporo	Sapporo	NNP
cord-023095-4dannjjm	754	17	,	,	,
cord-023095-4dannjjm	754	18	Hokkaido	Hokkaido	NNP
cord-023095-4dannjjm	754	19	,	,	,
cord-023095-4dannjjm	754	20	Japan	Japan	NNP
cord-023095-4dannjjm	754	21	.	.	.
cord-023095-4dannjjm	755	1	Sildenafil	Sildenafil	NNP
cord-023095-4dannjjm	755	2	has	have	VBZ
cord-023095-4dannjjm	755	3	shown	show	VBN
cord-023095-4dannjjm	755	4	to	to	TO
cord-023095-4dannjjm	755	5	be	be	VB
cord-023095-4dannjjm	755	6	effective	effective	JJ
cord-023095-4dannjjm	755	7	for	for	IN
cord-023095-4dannjjm	755	8	dogs	dog	NNS
cord-023095-4dannjjm	755	9	with	with	IN
cord-023095-4dannjjm	755	10	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	755	11	hypertension	hypertension	NN
cord-023095-4dannjjm	755	12	;	;	:
cord-023095-4dannjjm	755	13	however	however	RB
cord-023095-4dannjjm	755	14	,	,	,
cord-023095-4dannjjm	755	15	its	-PRON-	PRP$
cord-023095-4dannjjm	755	16	efficacy	efficacy	NN
cord-023095-4dannjjm	755	17	for	for	IN
cord-023095-4dannjjm	755	18	dogs	dog	NNS
cord-023095-4dannjjm	755	19	with	with	IN
cord-023095-4dannjjm	755	20	Eisenmenger	Eisenmenger	NNP
cord-023095-4dannjjm	755	21	's	's	POS
cord-023095-4dannjjm	755	22	syndrome	syndrome	NN
cord-023095-4dannjjm	755	23	(	(	-LRB-
cord-023095-4dannjjm	755	24	ES	ES	NNP
cord-023095-4dannjjm	755	25	)	)	-RRB-
cord-023095-4dannjjm	755	26	and	and	CC
cord-023095-4dannjjm	755	27	secondary	secondary	JJ
cord-023095-4dannjjm	755	28	erythrocytosis	erythrocytosis	NN
cord-023095-4dannjjm	755	29	has	have	VBZ
cord-023095-4dannjjm	755	30	not	not	RB
cord-023095-4dannjjm	755	31	yet	yet	RB
cord-023095-4dannjjm	755	32	been	be	VBN
cord-023095-4dannjjm	755	33	determined	determine	VBN
cord-023095-4dannjjm	755	34	.	.	.
cord-023095-4dannjjm	756	1	The	the	DT
cord-023095-4dannjjm	756	2	objective	objective	NN
cord-023095-4dannjjm	756	3	of	of	IN
cord-023095-4dannjjm	756	4	this	this	DT
cord-023095-4dannjjm	756	5	study	study	NN
cord-023095-4dannjjm	756	6	is	be	VBZ
cord-023095-4dannjjm	756	7	to	to	TO
cord-023095-4dannjjm	756	8	determine	determine	VB
cord-023095-4dannjjm	756	9	the	the	DT
cord-023095-4dannjjm	756	10	effect	effect	NN
cord-023095-4dannjjm	756	11	of	of	IN
cord-023095-4dannjjm	756	12	Sildenafil	Sildenafil	NNP
cord-023095-4dannjjm	756	13	for	for	IN
cord-023095-4dannjjm	756	14	dogs	dog	NNS
cord-023095-4dannjjm	756	15	with	with	IN
cord-023095-4dannjjm	756	16	Eisenmeger	Eisenmeger	NNP
cord-023095-4dannjjm	756	17	's	's	POS
cord-023095-4dannjjm	756	18	syndrome	syndrome	NN
cord-023095-4dannjjm	756	19	and	and	CC
cord-023095-4dannjjm	756	20	secondary	secondary	JJ
cord-023095-4dannjjm	756	21	erythrocytosis	erythrocytosis	NN
cord-023095-4dannjjm	756	22	.	.	.
cord-023095-4dannjjm	757	1	This	this	DT
cord-023095-4dannjjm	757	2	was	be	VBD
cord-023095-4dannjjm	757	3	a	a	DT
cord-023095-4dannjjm	757	4	prospective	prospective	JJ
cord-023095-4dannjjm	757	5	,	,	,
cord-023095-4dannjjm	757	6	single	single	JJ
cord-023095-4dannjjm	757	7	arm	arm	NN
cord-023095-4dannjjm	757	8	,	,	,
cord-023095-4dannjjm	757	9	open	open	JJ
cord-023095-4dannjjm	757	10	-	-	HYPH
cord-023095-4dannjjm	757	11	label	label	NN
cord-023095-4dannjjm	757	12	study	study	NN
cord-023095-4dannjjm	757	13	.	.	.
cord-023095-4dannjjm	758	1	Five	five	CD
cord-023095-4dannjjm	758	2	clinical	clinical	JJ
cord-023095-4dannjjm	758	3	dogs	dog	NNS
cord-023095-4dannjjm	758	4	with	with	IN
cord-023095-4dannjjm	758	5	ES	es	NN
cord-023095-4dannjjm	758	6	and	and	CC
cord-023095-4dannjjm	758	7	secondary	secondary	JJ
cord-023095-4dannjjm	758	8	erythrocytosis	erythrocytosis	NN
cord-023095-4dannjjm	758	9	were	be	VBD
cord-023095-4dannjjm	758	10	included	include	VBN
cord-023095-4dannjjm	758	11	.	.	.
cord-023095-4dannjjm	759	1	New	New	NNP
cord-023095-4dannjjm	759	2	York	York	NNP
cord-023095-4dannjjm	759	3	Heart	Heart	NNP
cord-023095-4dannjjm	759	4	Association	Association	NNP
cord-023095-4dannjjm	759	5	(	(	-LRB-
cord-023095-4dannjjm	759	6	NYHA	NYHA	NNP
cord-023095-4dannjjm	759	7	)	)	-RRB-
cord-023095-4dannjjm	759	8	functional	functional	JJ
cord-023095-4dannjjm	759	9	class	class	NN
cord-023095-4dannjjm	759	10	,	,	,
cord-023095-4dannjjm	759	11	PCV	pcv	NN
cord-023095-4dannjjm	759	12	,	,	,
cord-023095-4dannjjm	759	13	and	and	CC
cord-023095-4dannjjm	759	14	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	759	15	artery	artery	NN
cord-023095-4dannjjm	759	16	acceleration	acceleration	NN
cord-023095-4dannjjm	759	17	time	time	NN
cord-023095-4dannjjm	759	18	to	to	IN
cord-023095-4dannjjm	759	19	ejection	ejection	NN
cord-023095-4dannjjm	759	20	time	time	NN
cord-023095-4dannjjm	759	21	ratio	ratio	NN
cord-023095-4dannjjm	759	22	(	(	-LRB-
cord-023095-4dannjjm	759	23	PA	PA	NNP
cord-023095-4dannjjm	759	24	AT	AT	NNP
cord-023095-4dannjjm	759	25	:	:	:
cord-023095-4dannjjm	759	26	ET	ET	NNP
cord-023095-4dannjjm	759	27	)	)	-RRB-
cord-023095-4dannjjm	759	28	were	be	VBD
cord-023095-4dannjjm	759	29	evaluated	evaluate	VBN
cord-023095-4dannjjm	759	30	before	before	IN
cord-023095-4dannjjm	759	31	and	and	CC
cord-023095-4dannjjm	759	32	after	after	IN
cord-023095-4dannjjm	759	33	sildenafil	sildenafil	NNP
cord-023095-4dannjjm	759	34	therapy	therapy	NNP
cord-023095-4dannjjm	759	35	(	(	-LRB-
cord-023095-4dannjjm	759	36	0.5	0.5	CD
cord-023095-4dannjjm	759	37	mg	mg	NNP
cord-023095-4dannjjm	759	38	/	/	SYM
cord-023095-4dannjjm	759	39	kg	kg	NNP
cord-023095-4dannjjm	759	40	,	,	,
cord-023095-4dannjjm	759	41	bid	bid	NN
cord-023095-4dannjjm	759	42	)	)	-RRB-
cord-023095-4dannjjm	759	43	.	.	.
cord-023095-4dannjjm	760	1	NYHA	NYHA	NNP
cord-023095-4dannjjm	760	2	functional	functional	JJ
cord-023095-4dannjjm	760	3	class	class	NN
cord-023095-4dannjjm	760	4	was	be	VBD
cord-023095-4dannjjm	760	5	significantly	significantly	RB
cord-023095-4dannjjm	760	6	improved	improve	VBN
cord-023095-4dannjjm	760	7	after	after	IN
cord-023095-4dannjjm	760	8	1	1	CD
cord-023095-4dannjjm	760	9	(	(	-LRB-
cord-023095-4dannjjm	760	10	median	median	JJ
cord-023095-4dannjjm	760	11	2	2	CD
cord-023095-4dannjjm	760	12	;	;	:
cord-023095-4dannjjm	760	13	range	range	VBP
cord-023095-4dannjjm	760	14	1	1	CD
cord-023095-4dannjjm	760	15	-	-	SYM
cord-023095-4dannjjm	760	16	2	2	CD
cord-023095-4dannjjm	760	17	,	,	,
cord-023095-4dannjjm	760	18	P	p	NN
cord-023095-4dannjjm	760	19	5	5	CD
cord-023095-4dannjjm	760	20	0.031	0.031	CD
cord-023095-4dannjjm	760	21	)	)	-RRB-
cord-023095-4dannjjm	760	22	and	and	CC
cord-023095-4dannjjm	760	23	3	3	CD
cord-023095-4dannjjm	760	24	months	month	NNS
cord-023095-4dannjjm	760	25	(	(	-LRB-
cord-023095-4dannjjm	760	26	median	median	JJ
cord-023095-4dannjjm	760	27	2	2	CD
cord-023095-4dannjjm	760	28	;	;	:
cord-023095-4dannjjm	760	29	range	range	VBP
cord-023095-4dannjjm	760	30	1	1	CD
cord-023095-4dannjjm	760	31	-	-	SYM
cord-023095-4dannjjm	760	32	2	2	CD
cord-023095-4dannjjm	760	33	,	,	,
cord-023095-4dannjjm	760	34	P	p	NN
cord-023095-4dannjjm	760	35	5	5	CD
cord-023095-4dannjjm	760	36	0.031	0.031	CD
cord-023095-4dannjjm	760	37	)	)	-RRB-
cord-023095-4dannjjm	760	38	of	of	IN
cord-023095-4dannjjm	760	39	sildenafil	sildenafil	NNP
cord-023095-4dannjjm	760	40	therapy	therapy	NN
cord-023095-4dannjjm	760	41	,	,	,
cord-023095-4dannjjm	760	42	compared	compare	VBN
cord-023095-4dannjjm	760	43	with	with	IN
cord-023095-4dannjjm	760	44	the	the	DT
cord-023095-4dannjjm	760	45	baseline	baseline	NN
cord-023095-4dannjjm	760	46	(	(	-LRB-
cord-023095-4dannjjm	760	47	median	median	NN
cord-023095-4dannjjm	760	48	3	3	CD
cord-023095-4dannjjm	760	49	,	,	,
cord-023095-4dannjjm	760	50	range	range	VBP
cord-023095-4dannjjm	760	51	2	2	CD
cord-023095-4dannjjm	760	52	-	-	SYM
cord-023095-4dannjjm	760	53	3	3	CD
cord-023095-4dannjjm	760	54	)	)	-RRB-
cord-023095-4dannjjm	760	55	.	.	.
cord-023095-4dannjjm	761	1	PCV	PCV	NNP
cord-023095-4dannjjm	761	2	was	be	VBD
cord-023095-4dannjjm	761	3	significantly	significantly	RB
cord-023095-4dannjjm	761	4	decreased	decrease	VBN
cord-023095-4dannjjm	761	5	after	after	IN
cord-023095-4dannjjm	761	6	1	1	CD
cord-023095-4dannjjm	761	7	month	month	NN
cord-023095-4dannjjm	761	8	(	(	-LRB-
cord-023095-4dannjjm	761	9	62.4	62.4	CD
cord-023095-4dannjjm	761	10	AE	AE	NNP
cord-023095-4dannjjm	761	11	4.7	4.7	CD
cord-023095-4dannjjm	761	12	%	%	NN
cord-023095-4dannjjm	761	13	,	,	,
cord-023095-4dannjjm	761	14	P	p	NN
cord-023095-4dannjjm	761	15	5	5	CD
cord-023095-4dannjjm	761	16	0.015	0.015	CD
cord-023095-4dannjjm	761	17	)	)	-RRB-
cord-023095-4dannjjm	761	18	and	and	CC
cord-023095-4dannjjm	761	19	3	3	CD
cord-023095-4dannjjm	761	20	months	month	NNS
cord-023095-4dannjjm	761	21	(	(	-LRB-
cord-023095-4dannjjm	761	22	59.9	59.9	CD
cord-023095-4dannjjm	761	23	AE	AE	NNP
cord-023095-4dannjjm	761	24	3.6	3.6	CD
cord-023095-4dannjjm	761	25	%	%	NN
cord-023095-4dannjjm	761	26	,	,	,
cord-023095-4dannjjm	761	27	P	p	NN
cord-023095-4dannjjm	761	28	5	5	CD
cord-023095-4dannjjm	761	29	0.01	0.01	CD
cord-023095-4dannjjm	761	30	)	)	-RRB-
cord-023095-4dannjjm	761	31	of	of	IN
cord-023095-4dannjjm	761	32	therapy	therapy	NN
cord-023095-4dannjjm	761	33	,	,	,
cord-023095-4dannjjm	761	34	compared	compare	VBN
cord-023095-4dannjjm	761	35	with	with	IN
cord-023095-4dannjjm	761	36	the	the	DT
cord-023095-4dannjjm	761	37	baseline	baseline	NN
cord-023095-4dannjjm	761	38	(	(	-LRB-
cord-023095-4dannjjm	761	39	68.0	68.0	CD
cord-023095-4dannjjm	761	40	AE	AE	NNP
cord-023095-4dannjjm	761	41	5.6	5.6	CD
cord-023095-4dannjjm	761	42	%	%	NN
cord-023095-4dannjjm	761	43	)	)	-RRB-
cord-023095-4dannjjm	761	44	.	.	.
cord-023095-4dannjjm	762	1	AT	at	IN
cord-023095-4dannjjm	762	2	:	:	:
cord-023095-4dannjjm	762	3	ET	ET	NNP
cord-023095-4dannjjm	762	4	was	be	VBD
cord-023095-4dannjjm	762	5	significantly	significantly	RB
cord-023095-4dannjjm	762	6	increased	increase	VBN
cord-023095-4dannjjm	762	7	after	after	IN
cord-023095-4dannjjm	762	8	1	1	CD
cord-023095-4dannjjm	762	9	month	month	NN
cord-023095-4dannjjm	762	10	of	of	IN
cord-023095-4dannjjm	762	11	therapy	therapy	NN
cord-023095-4dannjjm	762	12	(	(	-LRB-
cord-023095-4dannjjm	762	13	0.39	0.39	CD
cord-023095-4dannjjm	762	14	AE	AE	NNP
cord-023095-4dannjjm	762	15	0.06	0.06	CD
cord-023095-4dannjjm	762	16	,	,	,
cord-023095-4dannjjm	762	17	P	p	NN
cord-023095-4dannjjm	762	18	5	5	CD
cord-023095-4dannjjm	762	19	0.013	0.013	CD
cord-023095-4dannjjm	762	20	)	)	-RRB-
cord-023095-4dannjjm	762	21	from	from	IN
cord-023095-4dannjjm	762	22	the	the	DT
cord-023095-4dannjjm	762	23	baseline	baseline	NN
cord-023095-4dannjjm	762	24	(	(	-LRB-
cord-023095-4dannjjm	762	25	0.28	0.28	CD
cord-023095-4dannjjm	762	26	AE	AE	NNP
cord-023095-4dannjjm	762	27	0.04	0.04	CD
cord-023095-4dannjjm	762	28	)	)	-RRB-
cord-023095-4dannjjm	762	29	.	.	.
cord-023095-4dannjjm	763	1	Sildenafil	Sildenafil	NNP
cord-023095-4dannjjm	763	2	resolved	resolve	VBD
cord-023095-4dannjjm	763	3	the	the	DT
cord-023095-4dannjjm	763	4	clinical	clinical	JJ
cord-023095-4dannjjm	763	5	signs	sign	NNS
cord-023095-4dannjjm	763	6	and	and	CC
cord-023095-4dannjjm	763	7	secondary	secondary	JJ
cord-023095-4dannjjm	763	8	erythrocytosis	erythrocytosis	NN
cord-023095-4dannjjm	763	9	in	in	IN
cord-023095-4dannjjm	763	10	dogs	dog	NNS
cord-023095-4dannjjm	763	11	with	with	IN
cord-023095-4dannjjm	763	12	ES	ES	NNP
cord-023095-4dannjjm	763	13	.	.	.
cord-023095-4dannjjm	764	1	Sildenafil	sildenafil	NN
cord-023095-4dannjjm	764	2	therapy	therapy	NN
cord-023095-4dannjjm	764	3	could	could	MD
cord-023095-4dannjjm	764	4	be	be	VB
cord-023095-4dannjjm	764	5	the	the	DT
cord-023095-4dannjjm	764	6	treatment	treatment	NN
cord-023095-4dannjjm	764	7	of	of	IN
cord-023095-4dannjjm	764	8	choice	choice	NN
cord-023095-4dannjjm	764	9	for	for	IN
cord-023095-4dannjjm	764	10	dogs	dog	NNS
cord-023095-4dannjjm	764	11	with	with	IN
cord-023095-4dannjjm	764	12	ES	ES	NNP
cord-023095-4dannjjm	764	13	.	.	.
cord-023095-4dannjjm	765	1	Sepsis	sepsis	NN
cord-023095-4dannjjm	765	2	is	be	VBZ
cord-023095-4dannjjm	765	3	the	the	DT
cord-023095-4dannjjm	765	4	number	number	NN
cord-023095-4dannjjm	765	5	one	one	CD
cord-023095-4dannjjm	765	6	cause	cause	NN
cord-023095-4dannjjm	765	7	of	of	IN
cord-023095-4dannjjm	765	8	mortality	mortality	NN
cord-023095-4dannjjm	765	9	in	in	IN
cord-023095-4dannjjm	765	10	neonatal	neonatal	JJ
cord-023095-4dannjjm	765	11	foals	foal	NNS
cord-023095-4dannjjm	765	12	.	.	.
cord-023095-4dannjjm	766	1	The	the	DT
cord-023095-4dannjjm	766	2	role	role	NN
cord-023095-4dannjjm	766	3	of	of	IN
cord-023095-4dannjjm	766	4	the	the	DT
cord-023095-4dannjjm	766	5	RAAS	raa	NNS
cord-023095-4dannjjm	766	6	and	and	CC
cord-023095-4dannjjm	766	7	HPAA	HPAA	NNP
cord-023095-4dannjjm	766	8	in	in	IN
cord-023095-4dannjjm	766	9	systemic	systemic	JJ
cord-023095-4dannjjm	766	10	inflammation	inflammation	NN
cord-023095-4dannjjm	766	11	and	and	CC
cord-023095-4dannjjm	766	12	response	response	NN
cord-023095-4dannjjm	766	13	to	to	IN
cord-023095-4dannjjm	766	14	stress	stress	NN
cord-023095-4dannjjm	766	15	is	be	VBZ
cord-023095-4dannjjm	766	16	well	well	RB
cord-023095-4dannjjm	766	17	documented	document	VBN
cord-023095-4dannjjm	766	18	in	in	IN
cord-023095-4dannjjm	766	19	critically	critically	RB
cord-023095-4dannjjm	766	20	ill	ill	JJ
cord-023095-4dannjjm	766	21	human	human	JJ
cord-023095-4dannjjm	766	22	neonates	neonate	NNS
cord-023095-4dannjjm	766	23	,	,	,
cord-023095-4dannjjm	766	24	but	but	CC
cord-023095-4dannjjm	766	25	limited	limited	JJ
cord-023095-4dannjjm	766	26	information	information	NN
cord-023095-4dannjjm	766	27	exists	exist	VBZ
cord-023095-4dannjjm	766	28	in	in	IN
cord-023095-4dannjjm	766	29	foals	foal	NNS
cord-023095-4dannjjm	766	30	.	.	.
cord-023095-4dannjjm	767	1	We	-PRON-	PRP
cord-023095-4dannjjm	767	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	767	3	that	that	IN
cord-023095-4dannjjm	767	4	in	in	IN
cord-023095-4dannjjm	767	5	septic	septic	JJ
cord-023095-4dannjjm	767	6	foals	foal	NNS
cord-023095-4dannjjm	767	7	the	the	DT
cord-023095-4dannjjm	767	8	RAAS	raa	NNS
cord-023095-4dannjjm	767	9	and	and	CC
cord-023095-4dannjjm	767	10	HPAA	HPAA	NNP
cord-023095-4dannjjm	767	11	will	will	MD
cord-023095-4dannjjm	767	12	be	be	VB
cord-023095-4dannjjm	767	13	activated	activate	VBN
cord-023095-4dannjjm	767	14	by	by	IN
cord-023095-4dannjjm	767	15	systemic	systemic	JJ
cord-023095-4dannjjm	767	16	inflammation	inflammation	NN
cord-023095-4dannjjm	767	17	and	and	CC
cord-023095-4dannjjm	767	18	hypoperfusion	hypoperfusion	NN
cord-023095-4dannjjm	767	19	and	and	CC
cord-023095-4dannjjm	767	20	the	the	DT
cord-023095-4dannjjm	767	21	degree	degree	NN
cord-023095-4dannjjm	767	22	of	of	IN
cord-023095-4dannjjm	767	23	activation	activation	NN
cord-023095-4dannjjm	767	24	will	will	MD
cord-023095-4dannjjm	767	25	be	be	VB
cord-023095-4dannjjm	767	26	associated	associate	VBN
cord-023095-4dannjjm	767	27	with	with	IN
cord-023095-4dannjjm	767	28	severity	severity	NN
cord-023095-4dannjjm	767	29	of	of	IN
cord-023095-4dannjjm	767	30	sepsis	sepsis	NN
cord-023095-4dannjjm	767	31	and	and	CC
cord-023095-4dannjjm	767	32	mortality	mortality	NN
cord-023095-4dannjjm	767	33	.	.	.
cord-023095-4dannjjm	768	1	Blood	blood	NN
cord-023095-4dannjjm	768	2	samples	sample	NNS
cord-023095-4dannjjm	768	3	were	be	VBD
cord-023095-4dannjjm	768	4	collected	collect	VBN
cord-023095-4dannjjm	768	5	on	on	IN
cord-023095-4dannjjm	768	6	admission	admission	NN
cord-023095-4dannjjm	768	7	from	from	IN
cord-023095-4dannjjm	768	8	60	60	CD
cord-023095-4dannjjm	768	9	septic	septic	NN
cord-023095-4dannjjm	768	10	(	(	-LRB-
cord-023095-4dannjjm	768	11	sepsis	sepsis	NN
cord-023095-4dannjjm	768	12	score	score	NN
cord-023095-4dannjjm	768	13	4	4	CD
cord-023095-4dannjjm	768	14	12	12	CD
cord-023095-4dannjjm	768	15	)	)	-RRB-
cord-023095-4dannjjm	768	16	,	,	,
cord-023095-4dannjjm	768	17	102	102	CD
cord-023095-4dannjjm	768	18	sick	sick	JJ
cord-023095-4dannjjm	768	19	non	non	JJ
cord-023095-4dannjjm	768	20	-	-	JJ
cord-023095-4dannjjm	768	21	septic	septic	JJ
cord-023095-4dannjjm	768	22	(	(	-LRB-
cord-023095-4dannjjm	768	23	SNS	SNS	NNP
cord-023095-4dannjjm	768	24	)	)	-RRB-
cord-023095-4dannjjm	768	25	,	,	,
cord-023095-4dannjjm	768	26	and	and	CC
cord-023095-4dannjjm	768	27	18	18	CD
cord-023095-4dannjjm	768	28	healthy	healthy	JJ
cord-023095-4dannjjm	768	29	foals	foal	NNS
cord-023095-4dannjjm	768	30	of	of	IN
cord-023095-4dannjjm	768	31	o	o	NN
cord-023095-4dannjjm	768	32	7	7	CD
cord-023095-4dannjjm	768	33	days	day	NNS
cord-023095-4dannjjm	768	34	of	of	IN
cord-023095-4dannjjm	768	35	age	age	NN
cord-023095-4dannjjm	768	36	.	.	.
cord-023095-4dannjjm	769	1	Blood	blood	NN
cord-023095-4dannjjm	769	2	concentrations	concentration	NNS
cord-023095-4dannjjm	769	3	of	of	IN
cord-023095-4dannjjm	769	4	corticotropin	corticotropin	NNP
cord-023095-4dannjjm	769	5	-	-	HYPH
cord-023095-4dannjjm	769	6	releasing	release	VBG
cord-023095-4dannjjm	769	7	hormone	hormone	NN
cord-023095-4dannjjm	769	8	(	(	-LRB-
cord-023095-4dannjjm	769	9	CRH	CRH	NNP
cord-023095-4dannjjm	769	10	)	)	-RRB-
cord-023095-4dannjjm	769	11	,	,	,
cord-023095-4dannjjm	769	12	adrenocorticotropin	adrenocorticotropin	NNP
cord-023095-4dannjjm	769	13	(	(	-LRB-
cord-023095-4dannjjm	769	14	ACTH	ACTH	NNP
cord-023095-4dannjjm	769	15	)	)	-RRB-
cord-023095-4dannjjm	770	1	,	,	,
cord-023095-4dannjjm	770	2	cortisol	cortisol	NN
cord-023095-4dannjjm	770	3	,	,	,
cord-023095-4dannjjm	770	4	aldosterone	aldosterone	NN
cord-023095-4dannjjm	770	5	,	,	,
cord-023095-4dannjjm	770	6	angiotensin	angiotensin	NN
cord-023095-4dannjjm	770	7	-	-	HYPH
cord-023095-4dannjjm	770	8	II	II	NNP
cord-023095-4dannjjm	770	9	(	(	-LRB-
cord-023095-4dannjjm	770	10	ANG	ANG	NNP
cord-023095-4dannjjm	770	11	-	-	HYPH
cord-023095-4dannjjm	770	12	II	II	NNP
cord-023095-4dannjjm	770	13	)	)	-RRB-
cord-023095-4dannjjm	770	14	,	,	,
cord-023095-4dannjjm	770	15	arginine	arginine	NN
cord-023095-4dannjjm	770	16	vasopressin	vasopressin	FW
cord-023095-4dannjjm	770	17	(	(	-LRB-
cord-023095-4dannjjm	770	18	AVP	AVP	NNP
cord-023095-4dannjjm	770	19	)	)	-RRB-
cord-023095-4dannjjm	770	20	and	and	CC
cord-023095-4dannjjm	770	21	plasma	plasma	NN
cord-023095-4dannjjm	770	22	renin	renin	NN
cord-023095-4dannjjm	770	23	activity	activity	NN
cord-023095-4dannjjm	770	24	were	be	VBD
cord-023095-4dannjjm	770	25	determined	determine	VBN
cord-023095-4dannjjm	770	26	by	by	IN
cord-023095-4dannjjm	770	27	radioimmunoassays	radioimmunoassay	NNS
cord-023095-4dannjjm	770	28	.	.	.
cord-023095-4dannjjm	771	1	ACTH	ACTH	NNP
cord-023095-4dannjjm	771	2	,	,	,
cord-023095-4dannjjm	771	3	cortisol	cortisol	NN
cord-023095-4dannjjm	771	4	,	,	,
cord-023095-4dannjjm	771	5	aldosterone	aldosterone	NN
cord-023095-4dannjjm	771	6	,	,	,
cord-023095-4dannjjm	771	7	ANG	ANG	NNP
cord-023095-4dannjjm	771	8	-	-	HYPH
cord-023095-4dannjjm	771	9	II	II	NNP
cord-023095-4dannjjm	771	10	and	and	CC
cord-023095-4dannjjm	771	11	AVP	AVP	NNP
cord-023095-4dannjjm	771	12	concentrations	concentration	NNS
cord-023095-4dannjjm	771	13	were	be	VBD
cord-023095-4dannjjm	771	14	higher	high	JJR
cord-023095-4dannjjm	771	15	while	while	IN
cord-023095-4dannjjm	771	16	CRH	CRH	NNP
cord-023095-4dannjjm	771	17	was	be	VBD
cord-023095-4dannjjm	771	18	lower	low	JJR
cord-023095-4dannjjm	771	19	in	in	IN
cord-023095-4dannjjm	771	20	septic	septic	NN
cord-023095-4dannjjm	771	21	and	and	CC
cord-023095-4dannjjm	771	22	SNS	SNS	NNP
cord-023095-4dannjjm	771	23	foals	foal	NNS
cord-023095-4dannjjm	771	24	compared	compare	VBN
cord-023095-4dannjjm	771	25	to	to	IN
cord-023095-4dannjjm	771	26	healthy	healthy	JJ
cord-023095-4dannjjm	771	27	foals	foal	NNS
cord-023095-4dannjjm	771	28	(	(	-LRB-
cord-023095-4dannjjm	771	29	P	p	NN
cord-023095-4dannjjm	771	30	o	o	NN
cord-023095-4dannjjm	771	31	0.05	0.05	CD
cord-023095-4dannjjm	771	32	)	)	-RRB-
cord-023095-4dannjjm	771	33	.	.	.
cord-023095-4dannjjm	772	1	Septic	septic	JJ
cord-023095-4dannjjm	772	2	non	non	JJ
cord-023095-4dannjjm	772	3	-	-	JJ
cord-023095-4dannjjm	772	4	survivor	survivor	JJ
cord-023095-4dannjjm	772	5	foals	foal	NNS
cord-023095-4dannjjm	772	6	had	have	VBD
cord-023095-4dannjjm	772	7	higher	high	JJR
cord-023095-4dannjjm	772	8	concentrations	concentration	NNS
cord-023095-4dannjjm	772	9	of	of	IN
cord-023095-4dannjjm	772	10	aldosterone	aldosterone	NN
cord-023095-4dannjjm	772	11	,	,	,
cord-023095-4dannjjm	772	12	cortisol	cortisol	NN
cord-023095-4dannjjm	772	13	,	,	,
cord-023095-4dannjjm	772	14	ACTH	ACTH	NNP
cord-023095-4dannjjm	772	15	and	and	CC
cord-023095-4dannjjm	772	16	AVP	AVP	NNP
cord-023095-4dannjjm	772	17	and	and	CC
cord-023095-4dannjjm	772	18	lower	low	JJR
cord-023095-4dannjjm	772	19	concentrations	concentration	NNS
cord-023095-4dannjjm	772	20	of	of	IN
cord-023095-4dannjjm	772	21	ANG	ANG	NNP
cord-023095-4dannjjm	772	22	-	-	HYPH
cord-023095-4dannjjm	772	23	II	II	NNP
cord-023095-4dannjjm	772	24	and	and	CC
cord-023095-4dannjjm	772	25	CRH	CRH	NNP
cord-023095-4dannjjm	772	26	than	than	IN
cord-023095-4dannjjm	772	27	survivors	survivor	NNS
cord-023095-4dannjjm	772	28	.	.	.
cord-023095-4dannjjm	773	1	AVP	AVP	NNP
cord-023095-4dannjjm	773	2	was	be	VBD
cord-023095-4dannjjm	773	3	associated	associate	VBN
cord-023095-4dannjjm	773	4	with	with	IN
cord-023095-4dannjjm	773	5	ANG	ANG	NNP
cord-023095-4dannjjm	773	6	-	-	HYPH
cord-023095-4dannjjm	773	7	II	II	NNP
cord-023095-4dannjjm	773	8	in	in	IN
cord-023095-4dannjjm	773	9	septic	septic	NN
cord-023095-4dannjjm	773	10	,	,	,
cord-023095-4dannjjm	773	11	and	and	CC
cord-023095-4dannjjm	773	12	with	with	IN
cord-023095-4dannjjm	773	13	ACTH	ACTH	NNP
cord-023095-4dannjjm	773	14	in	in	IN
cord-023095-4dannjjm	773	15	septic	septic	NN
cord-023095-4dannjjm	773	16	and	and	CC
cord-023095-4dannjjm	773	17	SNS	SNS	NNP
cord-023095-4dannjjm	773	18	foals	foal	NNS
cord-023095-4dannjjm	773	19	(	(	-LRB-
cord-023095-4dannjjm	773	20	P	p	NN
cord-023095-4dannjjm	773	21	o	o	NN
cord-023095-4dannjjm	773	22	0.05	0.05	CD
cord-023095-4dannjjm	773	23	)	)	-RRB-
cord-023095-4dannjjm	773	24	.	.	.
cord-023095-4dannjjm	774	1	There	there	EX
cord-023095-4dannjjm	774	2	was	be	VBD
cord-023095-4dannjjm	774	3	no	no	DT
cord-023095-4dannjjm	774	4	difference	difference	NN
cord-023095-4dannjjm	774	5	in	in	IN
cord-023095-4dannjjm	774	6	renin	renin	NN
cord-023095-4dannjjm	774	7	activity	activity	NN
cord-023095-4dannjjm	774	8	and	and	CC
cord-023095-4dannjjm	774	9	ANG	ANG	NNP
cord-023095-4dannjjm	774	10	-	-	HYPH
cord-023095-4dannjjm	774	11	II	II	NNP
cord-023095-4dannjjm	774	12	concentrations	concentration	NNS
cord-023095-4dannjjm	774	13	among	among	IN
cord-023095-4dannjjm	774	14	foal	foal	NN
cord-023095-4dannjjm	774	15	groups	group	NNS
cord-023095-4dannjjm	774	16	.	.	.
cord-023095-4dannjjm	775	1	Septic	septic	JJ
cord-023095-4dannjjm	775	2	foals	foal	NNS
cord-023095-4dannjjm	775	3	had	have	VBD
cord-023095-4dannjjm	775	4	a	a	DT
cord-023095-4dannjjm	775	5	higher	high	JJR
cord-023095-4dannjjm	775	6	ACTH	ACTH	NNP
cord-023095-4dannjjm	775	7	:	:	:
cord-023095-4dannjjm	775	8	aldosterone	aldosterone	NN
cord-023095-4dannjjm	775	9	ratio	ratio	NN
cord-023095-4dannjjm	775	10	than	than	IN
cord-023095-4dannjjm	775	11	healthy	healthy	JJ
cord-023095-4dannjjm	775	12	foals	foal	NNS
cord-023095-4dannjjm	775	13	(	(	-LRB-
cord-023095-4dannjjm	775	14	P	p	NN
cord-023095-4dannjjm	775	15	o	o	NN
cord-023095-4dannjjm	775	16	0.001	0.001	CD
cord-023095-4dannjjm	775	17	)	)	-RRB-
cord-023095-4dannjjm	775	18	.	.	.
cord-023095-4dannjjm	776	1	This	this	DT
cord-023095-4dannjjm	776	2	study	study	NN
cord-023095-4dannjjm	776	3	shows	show	VBZ
cord-023095-4dannjjm	776	4	that	that	IN
cord-023095-4dannjjm	776	5	in	in	IN
cord-023095-4dannjjm	776	6	response	response	NN
cord-023095-4dannjjm	776	7	to	to	IN
cord-023095-4dannjjm	776	8	sepsis	sepsis	NN
cord-023095-4dannjjm	776	9	there	there	EX
cord-023095-4dannjjm	776	10	is	be	VBZ
cord-023095-4dannjjm	776	11	RAAS	RAAS	NNP
cord-023095-4dannjjm	776	12	and	and	CC
cord-023095-4dannjjm	776	13	HPAA	HPAA	NNP
cord-023095-4dannjjm	776	14	activation	activation	NN
cord-023095-4dannjjm	776	15	in	in	IN
cord-023095-4dannjjm	776	16	critically	critically	RB
cord-023095-4dannjjm	776	17	ill	ill	JJ
cord-023095-4dannjjm	776	18	foals	foal	NNS
cord-023095-4dannjjm	776	19	.	.	.
cord-023095-4dannjjm	777	1	We	-PRON-	PRP
cord-023095-4dannjjm	777	2	propose	propose	VBP
cord-023095-4dannjjm	777	3	that	that	IN
cord-023095-4dannjjm	777	4	in	in	IN
cord-023095-4dannjjm	777	5	sick	sick	JJ
cord-023095-4dannjjm	777	6	foals	foal	NNS
cord-023095-4dannjjm	777	7	AVP	AVP	NNP
cord-023095-4dannjjm	777	8	is	be	VBZ
cord-023095-4dannjjm	777	9	more	more	RBR
cord-023095-4dannjjm	777	10	important	important	JJ
cord-023095-4dannjjm	777	11	than	than	IN
cord-023095-4dannjjm	777	12	CRH	CRH	NNP
cord-023095-4dannjjm	777	13	in	in	IN
cord-023095-4dannjjm	777	14	regulating	regulate	VBG
cord-023095-4dannjjm	777	15	ACTH	ACTH	NNP
cord-023095-4dannjjm	777	16	secretion	secretion	NN
cord-023095-4dannjjm	777	17	.	.	.
cord-023095-4dannjjm	778	1	The	the	DT
cord-023095-4dannjjm	778	2	increased	increase	VBN
cord-023095-4dannjjm	778	3	ACTH	ACTH	NNP
cord-023095-4dannjjm	778	4	:	:	:
cord-023095-4dannjjm	778	5	aldosterone	aldosterone	NN
cord-023095-4dannjjm	778	6	ratio	ratio	NN
cord-023095-4dannjjm	778	7	further	further	RB
cord-023095-4dannjjm	778	8	supports	support	VBZ
cord-023095-4dannjjm	778	9	relative	relative	JJ
cord-023095-4dannjjm	778	10	adrenal	adrenal	JJ
cord-023095-4dannjjm	778	11	insufficiency	insufficiency	NN
cord-023095-4dannjjm	778	12	in	in	IN
cord-023095-4dannjjm	778	13	septic	septic	JJ
cord-023095-4dannjjm	778	14	foals	foal	NNS
cord-023095-4dannjjm	778	15	.	.	.
cord-023095-4dannjjm	779	1	This	this	DT
cord-023095-4dannjjm	779	2	prospective	prospective	NN
cord-023095-4dannjjm	779	3	,	,	,
cord-023095-4dannjjm	779	4	cohort	cohort	NN
cord-023095-4dannjjm	779	5	study	study	NN
cord-023095-4dannjjm	779	6	aimed	aim	VBN
cord-023095-4dannjjm	779	7	to	to	TO
cord-023095-4dannjjm	779	8	characterize	characterize	VB
cord-023095-4dannjjm	779	9	alterations	alteration	NNS
cord-023095-4dannjjm	779	10	in	in	IN
cord-023095-4dannjjm	779	11	coagulation	coagulation	NN
cord-023095-4dannjjm	779	12	and	and	CC
cord-023095-4dannjjm	779	13	blood	blood	NN
cord-023095-4dannjjm	779	14	-	-	HYPH
cord-023095-4dannjjm	779	15	derived	derive	VBN
cord-023095-4dannjjm	779	16	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	779	17	biomarkers	biomarker	NNS
cord-023095-4dannjjm	779	18	in	in	IN
cord-023095-4dannjjm	779	19	adult	adult	NN
cord-023095-4dannjjm	779	20	horses	horse	NNS
cord-023095-4dannjjm	779	21	that	that	WDT
cord-023095-4dannjjm	779	22	developed	develop	VBD
cord-023095-4dannjjm	779	23	diarrhea	diarrhea	NN
cord-023095-4dannjjm	779	24	during	during	IN
cord-023095-4dannjjm	779	25	hospitalization	hospitalization	NN
cord-023095-4dannjjm	779	26	.	.	.
cord-023095-4dannjjm	780	1	Physical	physical	JJ
cord-023095-4dannjjm	780	2	and	and	CC
cord-023095-4dannjjm	780	3	hematological	hematological	JJ
cord-023095-4dannjjm	780	4	parameters	parameter	NNS
cord-023095-4dannjjm	780	5	were	be	VBD
cord-023095-4dannjjm	780	6	evaluated	evaluate	VBN
cord-023095-4dannjjm	780	7	at	at	IN
cord-023095-4dannjjm	780	8	times	time	NNS
cord-023095-4dannjjm	780	9	0	0	NFP
cord-023095-4dannjjm	780	10	(	(	-LRB-
cord-023095-4dannjjm	780	11	onset	onset	NN
cord-023095-4dannjjm	780	12	of	of	IN
cord-023095-4dannjjm	780	13	diarrhea	diarrhea	NN
cord-023095-4dannjjm	780	14	)	)	-RRB-
cord-023095-4dannjjm	780	15	,	,	,
cord-023095-4dannjjm	780	16	6	6	CD
cord-023095-4dannjjm	780	17	,	,	,
cord-023095-4dannjjm	780	18	12	12	CD
cord-023095-4dannjjm	780	19	,	,	,
cord-023095-4dannjjm	780	20	24	24	CD
cord-023095-4dannjjm	780	21	and	and	CC
cord-023095-4dannjjm	780	22	48h	48h	NNS
cord-023095-4dannjjm	780	23	,	,	,
cord-023095-4dannjjm	780	24	then	then	RB
cord-023095-4dannjjm	780	25	every	every	DT
cord-023095-4dannjjm	780	26	48	48	CD
cord-023095-4dannjjm	780	27	h	h	NN
cord-023095-4dannjjm	780	28	until	until	IN
cord-023095-4dannjjm	780	29	resolution	resolution	NN
cord-023095-4dannjjm	780	30	of	of	IN
cord-023095-4dannjjm	780	31	diarrhea	diarrhea	NN
cord-023095-4dannjjm	780	32	or	or	CC
cord-023095-4dannjjm	780	33	death	death	NN
cord-023095-4dannjjm	780	34	.	.	.
cord-023095-4dannjjm	781	1	Each	each	DT
cord-023095-4dannjjm	781	2	hematological	hematological	JJ
cord-023095-4dannjjm	781	3	analysis	analysis	NN
cord-023095-4dannjjm	781	4	included	include	VBD
cord-023095-4dannjjm	781	5	a	a	DT
cord-023095-4dannjjm	781	6	complete	complete	JJ
cord-023095-4dannjjm	781	7	blood	blood	NN
cord-023095-4dannjjm	781	8	count	count	NN
cord-023095-4dannjjm	781	9	(	(	-LRB-
cord-023095-4dannjjm	781	10	CBC	CBC	NNP
cord-023095-4dannjjm	781	11	)	)	-RRB-
cord-023095-4dannjjm	781	12	,	,	,
cord-023095-4dannjjm	781	13	thromboelastography	thromboelastography	NNP
cord-023095-4dannjjm	781	14	(	(	-LRB-
cord-023095-4dannjjm	781	15	TEG	TEG	NNP
cord-023095-4dannjjm	781	16	)	)	-RRB-
cord-023095-4dannjjm	781	17	,	,	,
cord-023095-4dannjjm	781	18	partial	partial	JJ
cord-023095-4dannjjm	781	19	-	-	HYPH
cord-023095-4dannjjm	781	20	thromboplastin	thromboplastin	NN
cord-023095-4dannjjm	781	21	-	-	HYPH
cord-023095-4dannjjm	781	22	time	time	NN
cord-023095-4dannjjm	781	23	(	(	-LRB-
cord-023095-4dannjjm	781	24	PTT	PTT	NNP
cord-023095-4dannjjm	781	25	)	)	-RRB-
cord-023095-4dannjjm	781	26	,	,	,
cord-023095-4dannjjm	781	27	prothrombin	prothrombin	NN
cord-023095-4dannjjm	781	28	-	-	HYPH
cord-023095-4dannjjm	781	29	time	time	NN
cord-023095-4dannjjm	781	30	(	(	-LRB-
cord-023095-4dannjjm	781	31	PT	PT	NNP
cord-023095-4dannjjm	781	32	)	)	-RRB-
cord-023095-4dannjjm	781	33	,	,	,
cord-023095-4dannjjm	781	34	plasma	plasma	NN
cord-023095-4dannjjm	781	35	concentrations	concentration	NNS
cord-023095-4dannjjm	781	36	of	of	IN
cord-023095-4dannjjm	781	37	lactate	lactate	NN
cord-023095-4dannjjm	781	38	,	,	,
cord-023095-4dannjjm	781	39	tumor	tumor	NN
cord-023095-4dannjjm	781	40	necrosis	necrosis	NN
cord-023095-4dannjjm	781	41	factor	factor	NN
cord-023095-4dannjjm	781	42	alpha	alpha	NN
cord-023095-4dannjjm	781	43	(	(	-LRB-
cord-023095-4dannjjm	781	44	TNF	TNF	NNP
cord-023095-4dannjjm	781	45	-	-	HYPH
cord-023095-4dannjjm	781	46	a	a	NNP
cord-023095-4dannjjm	781	47	)	)	-RRB-
cord-023095-4dannjjm	781	48	,	,	,
cord-023095-4dannjjm	781	49	interleukin	interleukin	FW
cord-023095-4dannjjm	781	50	(	(	-LRB-
cord-023095-4dannjjm	781	51	IL)-1	IL)-1	''
cord-023095-4dannjjm	781	52	,	,	,
cord-023095-4dannjjm	781	53	IL-6	IL-6	NNP
cord-023095-4dannjjm	781	54	,	,	,
cord-023095-4dannjjm	781	55	IL-10	IL-10	NNP
cord-023095-4dannjjm	781	56	and	and	CC
cord-023095-4dannjjm	781	57	NT	NT	NNP
cord-023095-4dannjjm	781	58	-	-	HYPH
cord-023095-4dannjjm	781	59	proC	proc	JJ
cord-023095-4dannjjm	781	60	-	-	HYPH
cord-023095-4dannjjm	781	61	type	type	NN
cord-023095-4dannjjm	781	62	-	-	HYPH
cord-023095-4dannjjm	781	63	natriuretic	natriuretic	NN
cord-023095-4dannjjm	781	64	peptide	peptide	NN
cord-023095-4dannjjm	781	65	(	(	-LRB-
cord-023095-4dannjjm	781	66	pCNP	pCNP	NNP
cord-023095-4dannjjm	781	67	)	)	-RRB-
cord-023095-4dannjjm	781	68	.	.	.
cord-023095-4dannjjm	782	1	Horses	horse	NNS
cord-023095-4dannjjm	782	2	were	be	VBD
cord-023095-4dannjjm	782	3	categorized	categorize	VBN
cord-023095-4dannjjm	782	4	into	into	IN
cord-023095-4dannjjm	782	5	three	three	CD
cord-023095-4dannjjm	782	6	groups	group	NNS
cord-023095-4dannjjm	782	7	based	base	VBN
cord-023095-4dannjjm	782	8	on	on	IN
cord-023095-4dannjjm	782	9	the	the	DT
cord-023095-4dannjjm	782	10	duration	duration	NN
cord-023095-4dannjjm	782	11	of	of	IN
cord-023095-4dannjjm	782	12	diarrhea	diarrhea	NN
cord-023095-4dannjjm	782	13	and	and	CC
cord-023095-4dannjjm	782	14	evidence	evidence	NN
cord-023095-4dannjjm	782	15	of	of	IN
cord-023095-4dannjjm	782	16	systemic	systemic	JJ
cord-023095-4dannjjm	782	17	inflammation	inflammation	NN
cord-023095-4dannjjm	782	18	.	.	.
cord-023095-4dannjjm	783	1	Group	group	NN
cord-023095-4dannjjm	783	2	0	0	CD
cord-023095-4dannjjm	783	3	:	:	:
cord-023095-4dannjjm	783	4	Diarrhea	diarrhea	NN
cord-023095-4dannjjm	783	5	o	o	NN
cord-023095-4dannjjm	783	6	6	6	CD
cord-023095-4dannjjm	783	7	h	h	NN
cord-023095-4dannjjm	783	8	without	without	IN
cord-023095-4dannjjm	783	9	systemic	systemic	JJ
cord-023095-4dannjjm	783	10	inflammation	inflammation	NN
cord-023095-4dannjjm	783	11	(	(	-LRB-
cord-023095-4dannjjm	783	12	SI	SI	NNP
cord-023095-4dannjjm	783	13	)	)	-RRB-
cord-023095-4dannjjm	783	14	;	;	:
cord-023095-4dannjjm	783	15	Group	group	NN
cord-023095-4dannjjm	783	16	1	1	CD
cord-023095-4dannjjm	783	17	-Diarrhea	-Diarrhea	NNP
cord-023095-4dannjjm	783	18	!	!	.
cord-023095-4dannjjm	784	1	6	6	CD
cord-023095-4dannjjm	784	2	h	h	NN
cord-023095-4dannjjm	784	3	without	without	IN
cord-023095-4dannjjm	784	4	SI	SI	NNP
cord-023095-4dannjjm	784	5	;	;	:
cord-023095-4dannjjm	784	6	Group	Group	NNP
cord-023095-4dannjjm	784	7	2-Diarrhea	2-Diarrhea	NNP
cord-023095-4dannjjm	784	8	with	with	IN
cord-023095-4dannjjm	784	9	SI	SI	NNP
cord-023095-4dannjjm	784	10	.	.	.
cord-023095-4dannjjm	785	1	Assessment	assessment	NN
cord-023095-4dannjjm	785	2	of	of	IN
cord-023095-4dannjjm	785	3	vital	vital	JJ
cord-023095-4dannjjm	785	4	parameters	parameter	NNS
cord-023095-4dannjjm	785	5	and	and	CC
cord-023095-4dannjjm	785	6	CBC	CBC	NNP
cord-023095-4dannjjm	785	7	established	establish	VBD
cord-023095-4dannjjm	785	8	a	a	DT
cord-023095-4dannjjm	785	9	diagnosis	diagnosis	NN
cord-023095-4dannjjm	785	10	of	of	IN
cord-023095-4dannjjm	785	11	SI	SI	NNP
cord-023095-4dannjjm	785	12	as	as	IN
cord-023095-4dannjjm	785	13	previously	previously	RB
cord-023095-4dannjjm	785	14	described	describe	VBN
cord-023095-4dannjjm	785	15	(	(	-LRB-
cord-023095-4dannjjm	785	16	Levy	Levy	NNP
cord-023095-4dannjjm	785	17	,	,	,
cord-023095-4dannjjm	785	18	2003	2003	CD
cord-023095-4dannjjm	785	19	)	)	-RRB-
cord-023095-4dannjjm	785	20	.	.	.
cord-023095-4dannjjm	786	1	Descriptive	descriptive	JJ
cord-023095-4dannjjm	786	2	and	and	CC
cord-023095-4dannjjm	786	3	univariate	univariate	JJ
cord-023095-4dannjjm	786	4	outcome	outcome	NN
cord-023095-4dannjjm	786	5	analyses	analysis	NNS
cord-023095-4dannjjm	786	6	were	be	VBD
cord-023095-4dannjjm	786	7	based	base	VBN
cord-023095-4dannjjm	786	8	on	on	IN
cord-023095-4dannjjm	786	9	data	datum	NNS
cord-023095-4dannjjm	786	10	normality	normality	NN
cord-023095-4dannjjm	786	11	.	.	.
cord-023095-4dannjjm	787	1	19	19	CD
cord-023095-4dannjjm	787	2	horses	horse	NNS
cord-023095-4dannjjm	787	3	were	be	VBD
cord-023095-4dannjjm	787	4	enrolled	enrol	VBN
cord-023095-4dannjjm	787	5	,	,	,
cord-023095-4dannjjm	787	6	of	of	IN
cord-023095-4dannjjm	787	7	which	which	WDT
cord-023095-4dannjjm	787	8	16	16	CD
cord-023095-4dannjjm	787	9	(	(	-LRB-
cord-023095-4dannjjm	787	10	84.2	84.2	CD
cord-023095-4dannjjm	787	11	%	%	NN
cord-023095-4dannjjm	787	12	)	)	-RRB-
cord-023095-4dannjjm	787	13	survived	survive	VBD
cord-023095-4dannjjm	787	14	to	to	TO
cord-023095-4dannjjm	787	15	discharge	discharge	VB
cord-023095-4dannjjm	787	16	.	.	.
cord-023095-4dannjjm	788	1	The	the	DT
cord-023095-4dannjjm	788	2	mean	mean	JJ
cord-023095-4dannjjm	788	3	age	age	NN
cord-023095-4dannjjm	788	4	was	be	VBD
cord-023095-4dannjjm	788	5	13.61/-5.3	13.61/-5.3	CD
cord-023095-4dannjjm	788	6	years	year	NNS
cord-023095-4dannjjm	788	7	.	.	.
cord-023095-4dannjjm	789	1	Eight	eight	CD
cord-023095-4dannjjm	789	2	horses	horse	NNS
cord-023095-4dannjjm	789	3	(	(	-LRB-
cord-023095-4dannjjm	789	4	42.1	42.1	CD
cord-023095-4dannjjm	789	5	%	%	NN
cord-023095-4dannjjm	789	6	)	)	-RRB-
cord-023095-4dannjjm	789	7	were	be	VBD
cord-023095-4dannjjm	789	8	categorized	categorize	VBN
cord-023095-4dannjjm	789	9	as	as	IN
cord-023095-4dannjjm	789	10	group-0	group-0	NNP
cord-023095-4dannjjm	789	11	,	,	,
cord-023095-4dannjjm	789	12	2	2	CD
cord-023095-4dannjjm	789	13	(	(	-LRB-
cord-023095-4dannjjm	789	14	10.5	10.5	CD
cord-023095-4dannjjm	789	15	%	%	NN
cord-023095-4dannjjm	789	16	)	)	-RRB-
cord-023095-4dannjjm	789	17	as	as	IN
cord-023095-4dannjjm	789	18	group-1	group-1	NN
cord-023095-4dannjjm	789	19	and	and	CC
cord-023095-4dannjjm	789	20	9	9	CD
cord-023095-4dannjjm	789	21	(	(	-LRB-
cord-023095-4dannjjm	789	22	47.4	47.4	CD
cord-023095-4dannjjm	789	23	%	%	NN
cord-023095-4dannjjm	789	24	)	)	-RRB-
cord-023095-4dannjjm	789	25	as	as	IN
cord-023095-4dannjjm	789	26	group-2	group-2	NNP
cord-023095-4dannjjm	789	27	.	.	.
cord-023095-4dannjjm	790	1	Two	two	CD
cord-023095-4dannjjm	790	2	horses	horse	NNS
cord-023095-4dannjjm	790	3	developed	develop	VBD
cord-023095-4dannjjm	790	4	thrombophlebitis	thrombophlebitis	NNP
cord-023095-4dannjjm	790	5	.	.	.
cord-023095-4dannjjm	791	1	Based	base	VBN
cord-023095-4dannjjm	791	2	on	on	IN
cord-023095-4dannjjm	791	3	the	the	DT
cord-023095-4dannjjm	791	4	results	result	NNS
cord-023095-4dannjjm	791	5	of	of	IN
cord-023095-4dannjjm	791	6	TEG	TEG	NNP
cord-023095-4dannjjm	791	7	,	,	,
cord-023095-4dannjjm	791	8	6/19	6/19	CD
cord-023095-4dannjjm	791	9	(	(	-LRB-
cord-023095-4dannjjm	791	10	31.6	31.6	CD
cord-023095-4dannjjm	791	11	%	%	NN
cord-023095-4dannjjm	791	12	)	)	-RRB-
cord-023095-4dannjjm	791	13	were	be	VBD
cord-023095-4dannjjm	791	14	normocoagulable	normocoagulable	JJ
cord-023095-4dannjjm	791	15	,	,	,
cord-023095-4dannjjm	791	16	7/19(36.8	7/19(36.8	CD
cord-023095-4dannjjm	791	17	%	%	NN
cord-023095-4dannjjm	791	18	)	)	-RRB-
cord-023095-4dannjjm	791	19	were	be	VBD
cord-023095-4dannjjm	791	20	hypocoagulable	hypocoagulable	NNP
cord-023095-4dannjjm	791	21	and	and	CC
cord-023095-4dannjjm	791	22	6/19	6/19	CD
cord-023095-4dannjjm	791	23	(	(	-LRB-
cord-023095-4dannjjm	791	24	31.6	31.6	CD
cord-023095-4dannjjm	791	25	%	%	NN
cord-023095-4dannjjm	791	26	)	)	-RRB-
cord-023095-4dannjjm	791	27	were	be	VBD
cord-023095-4dannjjm	791	28	hypercoagulable	hypercoagulable	JJ
cord-023095-4dannjjm	791	29	,	,	,
cord-023095-4dannjjm	791	30	at	at	IN
cord-023095-4dannjjm	791	31	one	one	CD
cord-023095-4dannjjm	791	32	or	or	CC
cord-023095-4dannjjm	791	33	more	more	JJR
cord-023095-4dannjjm	791	34	time	time	NN
cord-023095-4dannjjm	791	35	points	point	NNS
cord-023095-4dannjjm	791	36	.	.	.
cord-023095-4dannjjm	792	1	Of	of	IN
cord-023095-4dannjjm	792	2	these	these	DT
cord-023095-4dannjjm	792	3	,	,	,
cord-023095-4dannjjm	792	4	7/9	7/9	CD
cord-023095-4dannjjm	792	5	(	(	-LRB-
cord-023095-4dannjjm	792	6	77.8	77.8	CD
cord-023095-4dannjjm	792	7	%	%	NN
cord-023095-4dannjjm	792	8	)	)	-RRB-
cord-023095-4dannjjm	793	1	group-2	group-2	NNP
cord-023095-4dannjjm	793	2	horses	horse	NNS
cord-023095-4dannjjm	793	3	were	be	VBD
cord-023095-4dannjjm	793	4	coagulopathic	coagulopathic	JJ
cord-023095-4dannjjm	793	5	.	.	.
cord-023095-4dannjjm	794	1	Additionally	additionally	RB
cord-023095-4dannjjm	794	2	,	,	,
cord-023095-4dannjjm	794	3	group-2	group-2	NNP
cord-023095-4dannjjm	794	4	horses	horse	NNS
cord-023095-4dannjjm	794	5	had	have	VBD
cord-023095-4dannjjm	794	6	a	a	DT
cord-023095-4dannjjm	794	7	significantly	significantly	RB
cord-023095-4dannjjm	794	8	lower	low	JJR
cord-023095-4dannjjm	794	9	MA	MA	NNP
cord-023095-4dannjjm	794	10	than	than	IN
cord-023095-4dannjjm	794	11	group-0	group-0	NNP
cord-023095-4dannjjm	794	12	horses	horse	NNS
cord-023095-4dannjjm	794	13	at	at	IN
cord-023095-4dannjjm	794	14	baseline	baseline	NN
cord-023095-4dannjjm	794	15	(	(	-LRB-
cord-023095-4dannjjm	794	16	43.6	43.6	CD
cord-023095-4dannjjm	794	17	AE	AE	NNP
cord-023095-4dannjjm	794	18	16.7	16.7	CD
cord-023095-4dannjjm	794	19	vs.	vs.	IN
cord-023095-4dannjjm	794	20	61.9	61.9	CD
cord-023095-4dannjjm	794	21	AE	AE	NNP
cord-023095-4dannjjm	794	22	7.2	7.2	CD
cord-023095-4dannjjm	794	23	)	)	-RRB-
cord-023095-4dannjjm	794	24	and	and	CC
cord-023095-4dannjjm	794	25	6h	6h	NN
cord-023095-4dannjjm	794	26	(	(	-LRB-
cord-023095-4dannjjm	794	27	45.9	45.9	CD
cord-023095-4dannjjm	794	28	AE	AE	NNP
cord-023095-4dannjjm	794	29	15.9	15.9	CD
cord-023095-4dannjjm	794	30	vs.	vs.	IN
cord-023095-4dannjjm	794	31	65.5	65.5	CD
cord-023095-4dannjjm	794	32	AE	AE	NNP
cord-023095-4dannjjm	794	33	5.8	5.8	CD
cord-023095-4dannjjm	794	34	)	)	-RRB-
cord-023095-4dannjjm	794	35	.	.	.
cord-023095-4dannjjm	795	1	Biomarker	Biomarker	NNP
cord-023095-4dannjjm	795	2	analyses	analysis	NNS
cord-023095-4dannjjm	795	3	are	be	VBP
cord-023095-4dannjjm	795	4	pending	pende	VBG
cord-023095-4dannjjm	795	5	.	.	.
cord-023095-4dannjjm	796	1	In	in	IN
cord-023095-4dannjjm	796	2	conclusion	conclusion	NN
cord-023095-4dannjjm	796	3	,	,	,
cord-023095-4dannjjm	796	4	SI	SI	NNP
cord-023095-4dannjjm	796	5	was	be	VBD
cord-023095-4dannjjm	796	6	associated	associate	VBN
cord-023095-4dannjjm	796	7	with	with	IN
cord-023095-4dannjjm	796	8	coagulation	coagulation	NN
cord-023095-4dannjjm	796	9	disorders	disorder	NNS
cord-023095-4dannjjm	796	10	in	in	IN
cord-023095-4dannjjm	796	11	horses	horse	NNS
cord-023095-4dannjjm	796	12	with	with	IN
cord-023095-4dannjjm	796	13	hospital	hospital	NN
cord-023095-4dannjjm	796	14	acquired	acquire	VBN
cord-023095-4dannjjm	796	15	diarrhea	diarrhea	NN
cord-023095-4dannjjm	796	16	.	.	.
cord-023095-4dannjjm	797	1	Clostridium	clostridium	NN
cord-023095-4dannjjm	797	2	difficile	difficile	NN
cord-023095-4dannjjm	797	3	and	and	CC
cord-023095-4dannjjm	797	4	Clostridium	clostridium	NN
cord-023095-4dannjjm	797	5	perfringens	perfringen	NNS
cord-023095-4dannjjm	797	6	are	be	VBP
cord-023095-4dannjjm	797	7	commonly	commonly	RB
cord-023095-4dannjjm	797	8	associated	associate	VBN
cord-023095-4dannjjm	797	9	with	with	IN
cord-023095-4dannjjm	797	10	colitis	colitis	NN
cord-023095-4dannjjm	797	11	and	and	CC
cord-023095-4dannjjm	797	12	diarrhea	diarrhea	NN
cord-023095-4dannjjm	797	13	in	in	IN
cord-023095-4dannjjm	797	14	equines	equine	NNS
cord-023095-4dannjjm	797	15	but	but	CC
cord-023095-4dannjjm	797	16	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	797	17	carriers	carrier	NNS
cord-023095-4dannjjm	797	18	exist	exist	VBP
cord-023095-4dannjjm	797	19	.	.	.
cord-023095-4dannjjm	798	1	Reported	report	VBN
cord-023095-4dannjjm	798	2	carrier	carrier	NN
cord-023095-4dannjjm	798	3	rates	rate	NNS
cord-023095-4dannjjm	798	4	of	of	IN
cord-023095-4dannjjm	798	5	toxigenic	toxigenic	JJ
cord-023095-4dannjjm	798	6	C.	C.	NNP
cord-023095-4dannjjm	798	7	difficile	difficile	NNP
cord-023095-4dannjjm	798	8	and	and	CC
cord-023095-4dannjjm	798	9	C.	C.	NNP
cord-023095-4dannjjm	798	10	perfringens	perfringen	VBZ
cord-023095-4dannjjm	798	11	strains	strain	NNS
cord-023095-4dannjjm	798	12	in	in	IN
cord-023095-4dannjjm	798	13	feces	fece	NNS
cord-023095-4dannjjm	798	14	range	range	VBP
cord-023095-4dannjjm	798	15	between	between	IN
cord-023095-4dannjjm	798	16	0	0	CD
cord-023095-4dannjjm	798	17	-	-	SYM
cord-023095-4dannjjm	798	18	25	25	CD
cord-023095-4dannjjm	798	19	%	%	NN
cord-023095-4dannjjm	798	20	and	and	CC
cord-023095-4dannjjm	798	21	0	0	CD
cord-023095-4dannjjm	798	22	-	-	SYM
cord-023095-4dannjjm	798	23	30	30	CD
cord-023095-4dannjjm	798	24	%	%	NN
cord-023095-4dannjjm	798	25	respectively	respectively	RB
cord-023095-4dannjjm	798	26	.	.	.
cord-023095-4dannjjm	799	1	Toxigenic	Toxigenic	NNP
cord-023095-4dannjjm	799	2	C.	C.	NNP
cord-023095-4dannjjm	799	3	difficile	difficile	NN
cord-023095-4dannjjm	799	4	has	have	VBZ
cord-023095-4dannjjm	799	5	also	also	RB
cord-023095-4dannjjm	799	6	been	be	VBN
cord-023095-4dannjjm	799	7	isolated	isolate	VBN
cord-023095-4dannjjm	799	8	from	from	IN
cord-023095-4dannjjm	799	9	the	the	DT
cord-023095-4dannjjm	799	10	small	small	JJ
cord-023095-4dannjjm	799	11	intestine	intestine	NN
cord-023095-4dannjjm	799	12	of	of	IN
cord-023095-4dannjjm	799	13	diseased	diseased	JJ
cord-023095-4dannjjm	799	14	foals	foal	NNS
cord-023095-4dannjjm	799	15	and	and	CC
cord-023095-4dannjjm	799	16	is	be	VBZ
cord-023095-4dannjjm	799	17	implicated	implicate	VBN
cord-023095-4dannjjm	799	18	as	as	IN
cord-023095-4dannjjm	799	19	etiologic	etiologic	JJ
cord-023095-4dannjjm	799	20	agent	agent	NN
cord-023095-4dannjjm	799	21	of	of	IN
cord-023095-4dannjjm	799	22	duodenitis	duodenitis	NNP
cord-023095-4dannjjm	799	23	/	/	SYM
cord-023095-4dannjjm	799	24	proximal	proximal	JJ
cord-023095-4dannjjm	799	25	jejunitis	jejunitis	NN
cord-023095-4dannjjm	799	26	in	in	IN
cord-023095-4dannjjm	799	27	adult	adult	NN
cord-023095-4dannjjm	799	28	horses	horse	NNS
cord-023095-4dannjjm	800	1	however	however	RB
cord-023095-4dannjjm	800	2	scarce	scarce	JJ
cord-023095-4dannjjm	800	3	information	information	NN
cord-023095-4dannjjm	800	4	is	be	VBZ
cord-023095-4dannjjm	800	5	available	available	JJ
cord-023095-4dannjjm	800	6	on	on	IN
cord-023095-4dannjjm	800	7	prevalence	prevalence	NN
cord-023095-4dannjjm	800	8	in	in	IN
cord-023095-4dannjjm	800	9	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	800	10	compartments	compartment	NNS
cord-023095-4dannjjm	800	11	other	other	JJ
cord-023095-4dannjjm	800	12	than	than	IN
cord-023095-4dannjjm	800	13	feces	fece	NNS
cord-023095-4dannjjm	800	14	in	in	IN
cord-023095-4dannjjm	800	15	healthy	healthy	JJ
cord-023095-4dannjjm	800	16	horses	horse	NNS
cord-023095-4dannjjm	800	17	,	,	,
cord-023095-4dannjjm	800	18	and	and	CC
cord-023095-4dannjjm	800	19	it	-PRON-	PRP
cord-023095-4dannjjm	800	20	is	be	VBZ
cord-023095-4dannjjm	800	21	unclear	unclear	JJ
cord-023095-4dannjjm	800	22	whether	whether	IN
cord-023095-4dannjjm	800	23	fecal	fecal	JJ
cord-023095-4dannjjm	800	24	samples	sample	NNS
cord-023095-4dannjjm	800	25	are	be	VBP
cord-023095-4dannjjm	800	26	good	good	JJ
cord-023095-4dannjjm	800	27	predictors	predictor	NNS
cord-023095-4dannjjm	800	28	of	of	IN
cord-023095-4dannjjm	800	29	the	the	DT
cord-023095-4dannjjm	800	30	status	status	NN
cord-023095-4dannjjm	800	31	of	of	IN
cord-023095-4dannjjm	800	32	proximal	proximal	JJ
cord-023095-4dannjjm	800	33	intestinal	intestinal	JJ
cord-023095-4dannjjm	800	34	sites	site	NNS
cord-023095-4dannjjm	800	35	.	.	.
cord-023095-4dannjjm	801	1	The	the	DT
cord-023095-4dannjjm	801	2	objectives	objective	NNS
cord-023095-4dannjjm	801	3	of	of	IN
cord-023095-4dannjjm	801	4	this	this	DT
cord-023095-4dannjjm	801	5	study	study	NN
cord-023095-4dannjjm	801	6	were	be	VBD
cord-023095-4dannjjm	801	7	to	to	TO
cord-023095-4dannjjm	801	8	investigate	investigate	VB
cord-023095-4dannjjm	801	9	the	the	DT
cord-023095-4dannjjm	801	10	presence	presence	NN
cord-023095-4dannjjm	801	11	of	of	IN
cord-023095-4dannjjm	801	12	C.	C.	NNP
cord-023095-4dannjjm	801	13	difficile	difficile	NNP
cord-023095-4dannjjm	801	14	and	and	CC
cord-023095-4dannjjm	801	15	C.	C.	NNP
cord-023095-4dannjjm	801	16	perfringens	perfringen	NNS
cord-023095-4dannjjm	801	17	in	in	IN
cord-023095-4dannjjm	801	18	various	various	JJ
cord-023095-4dannjjm	801	19	intestinal	intestinal	JJ
cord-023095-4dannjjm	801	20	compartments	compartment	NNS
cord-023095-4dannjjm	801	21	of	of	IN
cord-023095-4dannjjm	801	22	healthy	healthy	JJ
cord-023095-4dannjjm	801	23	adult	adult	NN
cord-023095-4dannjjm	801	24	horses	horse	NNS
cord-023095-4dannjjm	801	25	and	and	CC
cord-023095-4dannjjm	801	26	to	to	TO
cord-023095-4dannjjm	801	27	molecularly	molecularly	RB
cord-023095-4dannjjm	801	28	characterize	characterize	VB
cord-023095-4dannjjm	801	29	isolates	isolate	NNS
cord-023095-4dannjjm	801	30	.	.	.
cord-023095-4dannjjm	802	1	Intestinal	intestinal	JJ
cord-023095-4dannjjm	802	2	contents	content	NNS
cord-023095-4dannjjm	802	3	were	be	VBD
cord-023095-4dannjjm	802	4	collected	collect	VBN
cord-023095-4dannjjm	802	5	from	from	IN
cord-023095-4dannjjm	802	6	the	the	DT
cord-023095-4dannjjm	802	7	stomach	stomach	NN
cord-023095-4dannjjm	802	8	,	,	,
cord-023095-4dannjjm	802	9	duodenum	duodenum	NN
cord-023095-4dannjjm	802	10	jejunum	jejunum	NNS
cord-023095-4dannjjm	802	11	,	,	,
cord-023095-4dannjjm	802	12	ileum	ileum	NN
cord-023095-4dannjjm	802	13	,	,	,
cord-023095-4dannjjm	802	14	cecum	cecum	NN
cord-023095-4dannjjm	802	15	,	,	,
cord-023095-4dannjjm	802	16	right	right	JJ
cord-023095-4dannjjm	802	17	dorsal	dorsal	NN
cord-023095-4dannjjm	802	18	and	and	CC
cord-023095-4dannjjm	802	19	left	left	JJ
cord-023095-4dannjjm	802	20	ventral	ventral	JJ
cord-023095-4dannjjm	802	21	colon	colon	NN
cord-023095-4dannjjm	802	22	,	,	,
cord-023095-4dannjjm	802	23	small	small	JJ
cord-023095-4dannjjm	802	24	colon	colon	NN
cord-023095-4dannjjm	802	25	and	and	CC
cord-023095-4dannjjm	802	26	rectum	rectum	NN
cord-023095-4dannjjm	802	27	of	of	IN
cord-023095-4dannjjm	802	28	10	10	CD
cord-023095-4dannjjm	802	29	euthanized	euthanize	VBN
cord-023095-4dannjjm	802	30	horses	horse	NNS
cord-023095-4dannjjm	802	31	free	free	JJ
cord-023095-4dannjjm	802	32	of	of	IN
cord-023095-4dannjjm	802	33	apparent	apparent	JJ
cord-023095-4dannjjm	802	34	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	802	35	disease	disease	NN
cord-023095-4dannjjm	802	36	.	.	.
cord-023095-4dannjjm	803	1	Enrichment	enrichment	NN
cord-023095-4dannjjm	803	2	culture	culture	NN
cord-023095-4dannjjm	803	3	was	be	VBD
cord-023095-4dannjjm	803	4	performed	perform	VBN
cord-023095-4dannjjm	803	5	for	for	IN
cord-023095-4dannjjm	803	6	C.	C.	NNP
cord-023095-4dannjjm	803	7	difficile	difficile	NNP
cord-023095-4dannjjm	803	8	and	and	CC
cord-023095-4dannjjm	803	9	C.	C.	NNP
cord-023095-4dannjjm	803	10	perfringens	perfringen	NNS
cord-023095-4dannjjm	803	11	and	and	CC
cord-023095-4dannjjm	803	12	C.	C.	NNP
cord-023095-4dannjjm	803	13	difficile	difficile	NN
cord-023095-4dannjjm	803	14	isolates	isolate	NNS
cord-023095-4dannjjm	803	15	were	be	VBD
cord-023095-4dannjjm	803	16	further	further	RB
cord-023095-4dannjjm	803	17	characterized	characterize	VBN
cord-023095-4dannjjm	803	18	via	via	IN
cord-023095-4dannjjm	803	19	toxin	toxin	NN
cord-023095-4dannjjm	803	20	gene	gene	NN
cord-023095-4dannjjm	803	21	detection	detection	NN
cord-023095-4dannjjm	803	22	and	and	CC
cord-023095-4dannjjm	803	23	ribotyping	ribotyping	NN
cord-023095-4dannjjm	803	24	.	.	.
cord-023095-4dannjjm	804	1	C.	C.	NNP
cord-023095-4dannjjm	804	2	difficile	difficile	NNP
cord-023095-4dannjjm	804	3	was	be	VBD
cord-023095-4dannjjm	804	4	isolated	isolate	VBN
cord-023095-4dannjjm	804	5	from	from	IN
cord-023095-4dannjjm	804	6	9/90	9/90	CD
cord-023095-4dannjjm	804	7	(	(	-LRB-
cord-023095-4dannjjm	804	8	10	10	CD
cord-023095-4dannjjm	804	9	%	%	NN
cord-023095-4dannjjm	804	10	)	)	-RRB-
cord-023095-4dannjjm	804	11	samples	sample	NNS
cord-023095-4dannjjm	804	12	from	from	IN
cord-023095-4dannjjm	804	13	5/10	5/10	CD
cord-023095-4dannjjm	804	14	(	(	-LRB-
cord-023095-4dannjjm	804	15	50	50	CD
cord-023095-4dannjjm	804	16	%	%	NN
cord-023095-4dannjjm	804	17	)	)	-RRB-
cord-023095-4dannjjm	804	18	horses	horse	NNS
cord-023095-4dannjjm	804	19	.	.	.
cord-023095-4dannjjm	805	1	Between	between	IN
cord-023095-4dannjjm	805	2	zero	zero	CD
cord-023095-4dannjjm	805	3	and	and	CC
cord-023095-4dannjjm	805	4	three	three	CD
cord-023095-4dannjjm	805	5	sites	site	NNS
cord-023095-4dannjjm	805	6	were	be	VBD
cord-023095-4dannjjm	805	7	positive	positive	JJ
cord-023095-4dannjjm	805	8	per	per	IN
cord-023095-4dannjjm	805	9	horse	horse	NN
cord-023095-4dannjjm	805	10	,	,	,
cord-023095-4dannjjm	805	11	and	and	CC
cord-023095-4dannjjm	805	12	multiple	multiple	JJ
cord-023095-4dannjjm	805	13	sites	site	NNS
cord-023095-4dannjjm	805	14	were	be	VBD
cord-023095-4dannjjm	805	15	positive	positive	JJ
cord-023095-4dannjjm	805	16	in	in	IN
cord-023095-4dannjjm	805	17	three	three	CD
cord-023095-4dannjjm	805	18	horses	horse	NNS
cord-023095-4dannjjm	805	19	.	.	.
cord-023095-4dannjjm	806	1	Isolates	isolate	NNS
cord-023095-4dannjjm	806	2	were	be	VBD
cord-023095-4dannjjm	806	3	recovered	recover	VBN
cord-023095-4dannjjm	806	4	from	from	IN
cord-023095-4dannjjm	806	5	duodenum	duodenum	NNP
cord-023095-4dannjjm	806	6	(	(	-LRB-
cord-023095-4dannjjm	806	7	n	n	NN
cord-023095-4dannjjm	806	8	5	5	CD
cord-023095-4dannjjm	806	9	1	1	CD
cord-023095-4dannjjm	806	10	)	)	-RRB-
cord-023095-4dannjjm	806	11	,	,	,
cord-023095-4dannjjm	806	12	right	right	JJ
cord-023095-4dannjjm	806	13	dorsal	dorsal	JJ
cord-023095-4dannjjm	806	14	colon	colon	NN
cord-023095-4dannjjm	806	15	(	(	-LRB-
cord-023095-4dannjjm	806	16	n	n	NN
cord-023095-4dannjjm	806	17	5	5	CD
cord-023095-4dannjjm	806	18	3	3	CD
cord-023095-4dannjjm	806	19	)	)	-RRB-
cord-023095-4dannjjm	806	20	,	,	,
cord-023095-4dannjjm	806	21	small	small	JJ
cord-023095-4dannjjm	806	22	colon	colon	NN
cord-023095-4dannjjm	806	23	(	(	-LRB-
cord-023095-4dannjjm	806	24	n	n	NN
cord-023095-4dannjjm	806	25	5	5	CD
cord-023095-4dannjjm	806	26	1	1	CD
cord-023095-4dannjjm	806	27	)	)	-RRB-
cord-023095-4dannjjm	806	28	and	and	CC
cord-023095-4dannjjm	806	29	rectum	rectum	NN
cord-023095-4dannjjm	806	30	(	(	-LRB-
cord-023095-4dannjjm	806	31	n	n	NN
cord-023095-4dannjjm	806	32	5	5	CD
cord-023095-4dannjjm	806	33	4	4	CD
cord-023095-4dannjjm	806	34	)	)	-RRB-
cord-023095-4dannjjm	806	35	.	.	.
cord-023095-4dannjjm	807	1	In	in	IN
cord-023095-4dannjjm	807	2	one	one	CD
cord-023095-4dannjjm	807	3	horse	horse	NN
cord-023095-4dannjjm	807	4	,	,	,
cord-023095-4dannjjm	807	5	the	the	DT
cord-023095-4dannjjm	807	6	rectal	rectal	JJ
cord-023095-4dannjjm	807	7	sample	sample	NN
cord-023095-4dannjjm	807	8	was	be	VBD
cord-023095-4dannjjm	807	9	negative	negative	JJ
cord-023095-4dannjjm	807	10	but	but	CC
cord-023095-4dannjjm	807	11	C.	C.	NNP
cord-023095-4dannjjm	807	12	difficile	difficile	NNP
cord-023095-4dannjjm	807	13	was	be	VBD
cord-023095-4dannjjm	807	14	isolated	isolate	VBN
cord-023095-4dannjjm	807	15	from	from	IN
cord-023095-4dannjjm	807	16	a	a	DT
cord-023095-4dannjjm	807	17	proximal	proximal	JJ
cord-023095-4dannjjm	807	18	site	site	NN
cord-023095-4dannjjm	807	19	,	,	,
cord-023095-4dannjjm	807	20	all	all	DT
cord-023095-4dannjjm	807	21	other	other	JJ
cord-023095-4dannjjm	807	22	horses	horse	NNS
cord-023095-4dannjjm	807	23	were	be	VBD
cord-023095-4dannjjm	807	24	positive	positive	JJ
cord-023095-4dannjjm	807	25	on	on	IN
cord-023095-4dannjjm	807	26	the	the	DT
cord-023095-4dannjjm	807	27	rectal	rectal	JJ
cord-023095-4dannjjm	807	28	sample	sample	NN
cord-023095-4dannjjm	807	29	if	if	IN
cord-023095-4dannjjm	807	30	a	a	DT
cord-023095-4dannjjm	807	31	more	more	RBR
cord-023095-4dannjjm	807	32	proximal	proximal	JJ
cord-023095-4dannjjm	807	33	compartment	compartment	NN
cord-023095-4dannjjm	807	34	was	be	VBD
cord-023095-4dannjjm	807	35	positive	positive	JJ
cord-023095-4dannjjm	807	36	.	.	.
cord-023095-4dannjjm	808	1	In	in	IN
cord-023095-4dannjjm	808	2	three	three	CD
cord-023095-4dannjjm	808	3	horses	horse	NNS
cord-023095-4dannjjm	808	4	multiple	multiple	JJ
cord-023095-4dannjjm	808	5	compartments	compartment	NNS
cord-023095-4dannjjm	808	6	were	be	VBD
cord-023095-4dannjjm	808	7	positive	positive	JJ
cord-023095-4dannjjm	808	8	however	however	RB
cord-023095-4dannjjm	808	9	different	different	JJ
cord-023095-4dannjjm	808	10	strains	strain	NNS
cord-023095-4dannjjm	808	11	were	be	VBD
cord-023095-4dannjjm	808	12	always	always	RB
cord-023095-4dannjjm	808	13	present	present	JJ
cord-023095-4dannjjm	808	14	within	within	IN
cord-023095-4dannjjm	808	15	the	the	DT
cord-023095-4dannjjm	808	16	same	same	JJ
cord-023095-4dannjjm	808	17	horse	horse	NN
cord-023095-4dannjjm	808	18	(	(	-LRB-
cord-023095-4dannjjm	808	19	n	n	NN
cord-023095-4dannjjm	808	20	5	5	CD
cord-023095-4dannjjm	808	21	2	2	CD
cord-023095-4dannjjm	808	22	)	)	-RRB-
cord-023095-4dannjjm	808	23	.	.	.
cord-023095-4dannjjm	809	1	All	all	DT
cord-023095-4dannjjm	809	2	isolates	isolate	NNS
cord-023095-4dannjjm	809	3	possessed	possess	VBD
cord-023095-4dannjjm	809	4	genes	gene	NNS
cord-023095-4dannjjm	809	5	encoding	encode	VBG
cord-023095-4dannjjm	809	6	toxins	toxin	NNS
cord-023095-4dannjjm	809	7	A	A	NNP
cord-023095-4dannjjm	809	8	and	and	CC
cord-023095-4dannjjm	809	9	B.	B.	NNP
cord-023095-4dannjjm	809	10	Five	five	CD
cord-023095-4dannjjm	809	11	isolates	isolate	NNS
cord-023095-4dannjjm	809	12	were	be	VBD
cord-023095-4dannjjm	809	13	ribotype	ribotype	NNP
cord-023095-4dannjjm	809	14	078	078	CD
cord-023095-4dannjjm	809	15	and	and	CC
cord-023095-4dannjjm	809	16	also	also	RB
cord-023095-4dannjjm	809	17	possessed	possess	VBD
cord-023095-4dannjjm	809	18	genes	gene	NNS
cord-023095-4dannjjm	809	19	encoding	encode	VBG
cord-023095-4dannjjm	809	20	the	the	DT
cord-023095-4dannjjm	809	21	binary	binary	JJ
cord-023095-4dannjjm	809	22	toxin	toxin	NN
cord-023095-4dannjjm	809	23	.	.	.
cord-023095-4dannjjm	810	1	The	the	DT
cord-023095-4dannjjm	810	2	other	other	JJ
cord-023095-4dannjjm	810	3	isolates	isolate	NNS
cord-023095-4dannjjm	810	4	were	be	VBD
cord-023095-4dannjjm	810	5	ribotype	ribotype	NNP
cord-023095-4dannjjm	810	6	001	001	CD
cord-023095-4dannjjm	810	7	and	and	CC
cord-023095-4dannjjm	810	8	were	be	VBD
cord-023095-4dannjjm	810	9	negative	negative	JJ
cord-023095-4dannjjm	810	10	for	for	IN
cord-023095-4dannjjm	810	11	the	the	DT
cord-023095-4dannjjm	810	12	genes	gene	NNS
cord-023095-4dannjjm	810	13	encoding	encode	VBG
cord-023095-4dannjjm	810	14	the	the	DT
cord-023095-4dannjjm	810	15	binary	binary	JJ
cord-023095-4dannjjm	810	16	toxin	toxin	NN
cord-023095-4dannjjm	810	17	.	.	.
cord-023095-4dannjjm	811	1	Despite	despite	IN
cord-023095-4dannjjm	811	2	using	use	VBG
cord-023095-4dannjjm	811	3	a	a	DT
cord-023095-4dannjjm	811	4	method	method	NN
cord-023095-4dannjjm	811	5	with	with	IN
cord-023095-4dannjjm	811	6	a	a	DT
cord-023095-4dannjjm	811	7	detection	detection	NN
cord-023095-4dannjjm	811	8	level	level	NN
cord-023095-4dannjjm	811	9	as	as	RB
cord-023095-4dannjjm	811	10	low	low	JJ
cord-023095-4dannjjm	811	11	as	as	IN
cord-023095-4dannjjm	811	12	9	9	CD
cord-023095-4dannjjm	811	13	cfu	cfu	NN
cord-023095-4dannjjm	811	14	/	/	SYM
cord-023095-4dannjjm	811	15	g	g	NN
cord-023095-4dannjjm	811	16	of	of	IN
cord-023095-4dannjjm	811	17	feces	fece	NNS
cord-023095-4dannjjm	811	18	,	,	,
cord-023095-4dannjjm	811	19	no	no	DT
cord-023095-4dannjjm	811	20	C.	C.	NNP
cord-023095-4dannjjm	811	21	perfringens	perfringen	NNS
cord-023095-4dannjjm	811	22	was	be	VBD
cord-023095-4dannjjm	811	23	recovered	recover	VBN
cord-023095-4dannjjm	811	24	.	.	.
cord-023095-4dannjjm	812	1	Rectal	rectal	JJ
cord-023095-4dannjjm	812	2	samples	sample	NNS
cord-023095-4dannjjm	812	3	were	be	VBD
cord-023095-4dannjjm	812	4	a	a	DT
cord-023095-4dannjjm	812	5	good	good	JJ
cord-023095-4dannjjm	812	6	predictor	predictor	NN
cord-023095-4dannjjm	812	7	of	of	IN
cord-023095-4dannjjm	812	8	overall	overall	JJ
cord-023095-4dannjjm	812	9	C.	C.	NNP
cord-023095-4dannjjm	812	10	difficile	difficile	NN
cord-023095-4dannjjm	812	11	carrier	carrier	NN
cord-023095-4dannjjm	812	12	status	status	NN
cord-023095-4dannjjm	812	13	(	(	-LRB-
cord-023095-4dannjjm	812	14	4/5	4/5	CD
cord-023095-4dannjjm	812	15	horses	horse	NNS
cord-023095-4dannjjm	812	16	)	)	-RRB-
cord-023095-4dannjjm	812	17	,	,	,
cord-023095-4dannjjm	812	18	however	however	RB
cord-023095-4dannjjm	812	19	rectal	rectal	JJ
cord-023095-4dannjjm	812	20	samples	sample	NNS
cord-023095-4dannjjm	812	21	were	be	VBD
cord-023095-4dannjjm	812	22	not	not	RB
cord-023095-4dannjjm	812	23	always	always	RB
cord-023095-4dannjjm	812	24	representative	representative	JJ
cord-023095-4dannjjm	812	25	for	for	IN
cord-023095-4dannjjm	812	26	the	the	DT
cord-023095-4dannjjm	812	27	ribotype	ribotype	NNP
cord-023095-4dannjjm	812	28	carried	carry	VBD
cord-023095-4dannjjm	812	29	in	in	IN
cord-023095-4dannjjm	812	30	more	more	RBR
cord-023095-4dannjjm	812	31	proximal	proximal	JJ
cord-023095-4dannjjm	812	32	compartments	compartment	NNS
cord-023095-4dannjjm	812	33	.	.	.
cord-023095-4dannjjm	813	1	The	the	DT
cord-023095-4dannjjm	813	2	presence	presence	NN
cord-023095-4dannjjm	813	3	of	of	IN
cord-023095-4dannjjm	813	4	variable	variable	JJ
cord-023095-4dannjjm	813	5	strains	strain	NNS
cord-023095-4dannjjm	813	6	within	within	IN
cord-023095-4dannjjm	813	7	the	the	DT
cord-023095-4dannjjm	813	8	same	same	JJ
cord-023095-4dannjjm	813	9	horse	horse	NN
cord-023095-4dannjjm	813	10	suggests	suggest	VBZ
cord-023095-4dannjjm	813	11	transient	transient	JJ
cord-023095-4dannjjm	813	12	passage	passage	NN
cord-023095-4dannjjm	813	13	of	of	IN
cord-023095-4dannjjm	813	14	the	the	DT
cord-023095-4dannjjm	813	15	bacterium	bacterium	NN
cord-023095-4dannjjm	813	16	through	through	IN
cord-023095-4dannjjm	813	17	the	the	DT
cord-023095-4dannjjm	813	18	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	813	19	system	system	NN
cord-023095-4dannjjm	813	20	rather	rather	RB
cord-023095-4dannjjm	813	21	than	than	IN
cord-023095-4dannjjm	813	22	actual	actual	JJ
cord-023095-4dannjjm	813	23	colonization	colonization	NN
cord-023095-4dannjjm	813	24	although	although	IN
cord-023095-4dannjjm	813	25	further	further	JJ
cord-023095-4dannjjm	813	26	study	study	NN
cord-023095-4dannjjm	813	27	testing	test	VBG
cord-023095-4dannjjm	813	28	multiple	multiple	JJ
cord-023095-4dannjjm	813	29	colonies	colony	NNS
cord-023095-4dannjjm	813	30	per	per	IN
cord-023095-4dannjjm	813	31	site	site	NN
cord-023095-4dannjjm	813	32	is	be	VBZ
cord-023095-4dannjjm	813	33	needed	need	VBN
cord-023095-4dannjjm	813	34	.	.	.
cord-023095-4dannjjm	814	1	The	the	DT
cord-023095-4dannjjm	814	2	predominance	predominance	NN
cord-023095-4dannjjm	814	3	of	of	IN
cord-023095-4dannjjm	814	4	ribotype	ribotype	NNP
cord-023095-4dannjjm	814	5	078	078	CD
cord-023095-4dannjjm	814	6	is	be	VBZ
cord-023095-4dannjjm	814	7	consistent	consistent	JJ
cord-023095-4dannjjm	814	8	with	with	IN
cord-023095-4dannjjm	814	9	recent	recent	JJ
cord-023095-4dannjjm	814	10	emergence	emergence	NN
cord-023095-4dannjjm	814	11	of	of	IN
cord-023095-4dannjjm	814	12	this	this	DT
cord-023095-4dannjjm	814	13	strain	strain	NN
cord-023095-4dannjjm	814	14	in	in	IN
cord-023095-4dannjjm	814	15	this	this	DT
cord-023095-4dannjjm	814	16	region	region	NN
cord-023095-4dannjjm	814	17	,	,	,
cord-023095-4dannjjm	814	18	as	as	IN
cord-023095-4dannjjm	814	19	earlier	early	JJR
cord-023095-4dannjjm	814	20	studies	study	NNS
cord-023095-4dannjjm	814	21	found	find	VBD
cord-023095-4dannjjm	814	22	other	other	JJ
cord-023095-4dannjjm	814	23	strains	strain	NNS
cord-023095-4dannjjm	814	24	(	(	-LRB-
cord-023095-4dannjjm	814	25	027	027	CD
cord-023095-4dannjjm	814	26	,	,	,
cord-023095-4dannjjm	814	27	001	001	CD
cord-023095-4dannjjm	814	28	)	)	-RRB-
cord-023095-4dannjjm	814	29	to	to	TO
cord-023095-4dannjjm	814	30	be	be	VB
cord-023095-4dannjjm	814	31	more	more	RBR
cord-023095-4dannjjm	814	32	prevalent	prevalent	JJ
cord-023095-4dannjjm	814	33	and	and	CC
cord-023095-4dannjjm	814	34	a	a	DT
cord-023095-4dannjjm	814	35	variety	variety	NN
cord-023095-4dannjjm	814	36	of	of	IN
cord-023095-4dannjjm	814	37	ribotypes	ribotype	NNS
cord-023095-4dannjjm	814	38	were	be	VBD
cord-023095-4dannjjm	814	39	typically	typically	RB
cord-023095-4dannjjm	814	40	recovered	recover	VBN
cord-023095-4dannjjm	814	41	from	from	IN
cord-023095-4dannjjm	814	42	horses	horse	NNS
cord-023095-4dannjjm	814	43	.	.	.
cord-023095-4dannjjm	815	1	Interestingly	interestingly	RB
cord-023095-4dannjjm	815	2	ribotype	ribotype	NNP
cord-023095-4dannjjm	815	3	078	078	CD
cord-023095-4dannjjm	815	4	has	have	VBZ
cord-023095-4dannjjm	815	5	recently	recently	RB
cord-023095-4dannjjm	815	6	emerged	emerge	VBN
cord-023095-4dannjjm	815	7	as	as	IN
cord-023095-4dannjjm	815	8	a	a	DT
cord-023095-4dannjjm	815	9	hypervirulent	hypervirulent	NN
cord-023095-4dannjjm	815	10	strain	strain	NN
cord-023095-4dannjjm	815	11	in	in	IN
cord-023095-4dannjjm	815	12	humans	human	NNS
cord-023095-4dannjjm	815	13	in	in	IN
cord-023095-4dannjjm	815	14	our	-PRON-	PRP$
cord-023095-4dannjjm	815	15	area	area	NN
cord-023095-4dannjjm	815	16	.	.	.
cord-023095-4dannjjm	816	1	Clostridium	clostridium	NN
cord-023095-4dannjjm	816	2	difficile	difficile	NN
cord-023095-4dannjjm	816	3	,	,	,
cord-023095-4dannjjm	816	4	Clostridium	clostridium	NN
cord-023095-4dannjjm	816	5	perfringens	perfringen	NNS
cord-023095-4dannjjm	816	6	and	and	CC
cord-023095-4dannjjm	816	7	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	816	8	are	be	VBP
cord-023095-4dannjjm	816	9	important	important	JJ
cord-023095-4dannjjm	816	10	enteric	enteric	JJ
cord-023095-4dannjjm	816	11	pathogens	pathogen	NNS
cord-023095-4dannjjm	816	12	in	in	IN
cord-023095-4dannjjm	816	13	horses	horse	NNS
cord-023095-4dannjjm	816	14	,	,	,
cord-023095-4dannjjm	816	15	however	however	RB
cord-023095-4dannjjm	816	16	some	some	DT
cord-023095-4dannjjm	816	17	healthy	healthy	JJ
cord-023095-4dannjjm	816	18	animals	animal	NNS
cord-023095-4dannjjm	816	19	also	also	RB
cord-023095-4dannjjm	816	20	harbour	harbour	VBP
cord-023095-4dannjjm	816	21	these	these	DT
cord-023095-4dannjjm	816	22	pathogens	pathogen	NNS
cord-023095-4dannjjm	816	23	.	.	.
cord-023095-4dannjjm	817	1	Point	point	NN
cord-023095-4dannjjm	817	2	prevalence	prevalence	NN
cord-023095-4dannjjm	817	3	studies	study	NNS
cord-023095-4dannjjm	817	4	have	have	VBP
cord-023095-4dannjjm	817	5	reported	report	VBN
cord-023095-4dannjjm	817	6	these	these	DT
cord-023095-4dannjjm	817	7	carriage	carriage	NN
cord-023095-4dannjjm	817	8	rates	rate	NNS
cord-023095-4dannjjm	817	9	,	,	,
cord-023095-4dannjjm	817	10	but	but	CC
cord-023095-4dannjjm	817	11	there	there	EX
cord-023095-4dannjjm	817	12	are	be	VBP
cord-023095-4dannjjm	817	13	no	no	DT
cord-023095-4dannjjm	817	14	data	datum	NNS
cord-023095-4dannjjm	817	15	regarding	regard	VBG
cord-023095-4dannjjm	817	16	longitudinal	longitudinal	JJ
cord-023095-4dannjjm	817	17	prevalence	prevalence	NN
cord-023095-4dannjjm	817	18	of	of	IN
cord-023095-4dannjjm	817	19	these	these	DT
cord-023095-4dannjjm	817	20	enteric	enteric	JJ
cord-023095-4dannjjm	817	21	bacteria	bacteria	NNS
cord-023095-4dannjjm	817	22	,	,	,
cord-023095-4dannjjm	817	23	information	information	NN
cord-023095-4dannjjm	817	24	that	that	WDT
cord-023095-4dannjjm	817	25	would	would	MD
cord-023095-4dannjjm	817	26	be	be	VB
cord-023095-4dannjjm	817	27	useful	useful	JJ
cord-023095-4dannjjm	817	28	to	to	TO
cord-023095-4dannjjm	817	29	better	better	RB
cord-023095-4dannjjm	817	30	understand	understand	VB
cord-023095-4dannjjm	817	31	the	the	DT
cord-023095-4dannjjm	817	32	epidemiology	epidemiology	NN
cord-023095-4dannjjm	817	33	of	of	IN
cord-023095-4dannjjm	817	34	these	these	DT
cord-023095-4dannjjm	817	35	pathogens	pathogen	NNS
cord-023095-4dannjjm	817	36	.	.	.
cord-023095-4dannjjm	818	1	Additionally	additionally	RB
cord-023095-4dannjjm	818	2	,	,	,
cord-023095-4dannjjm	818	3	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	818	4	resistance	resistance	NN
cord-023095-4dannjjm	818	5	is	be	VBZ
cord-023095-4dannjjm	818	6	a	a	DT
cord-023095-4dannjjm	818	7	pressing	press	VBG
cord-023095-4dannjjm	818	8	concern	concern	NN
cord-023095-4dannjjm	818	9	.	.	.
cord-023095-4dannjjm	819	1	Commensal	Commensal	NNP
cord-023095-4dannjjm	819	2	E.coli	E.coli	NNS
cord-023095-4dannjjm	819	3	is	be	VBZ
cord-023095-4dannjjm	819	4	often	often	RB
cord-023095-4dannjjm	819	5	used	use	VBN
cord-023095-4dannjjm	819	6	as	as	IN
cord-023095-4dannjjm	819	7	an	an	DT
cord-023095-4dannjjm	819	8	indicator	indicator	NN
cord-023095-4dannjjm	819	9	organism	organism	NN
cord-023095-4dannjjm	819	10	to	to	TO
cord-023095-4dannjjm	819	11	evaluate	evaluate	VB
cord-023095-4dannjjm	819	12	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	819	13	resistance	resistance	NN
cord-023095-4dannjjm	819	14	of	of	IN
cord-023095-4dannjjm	819	15	enteric	enteric	JJ
cord-023095-4dannjjm	819	16	bacteria	bacteria	NNS
cord-023095-4dannjjm	819	17	,	,	,
cord-023095-4dannjjm	819	18	yet	yet	CC
cord-023095-4dannjjm	819	19	there	there	EX
cord-023095-4dannjjm	819	20	are	be	VBP
cord-023095-4dannjjm	819	21	limited	limited	JJ
cord-023095-4dannjjm	819	22	data	datum	NNS
cord-023095-4dannjjm	819	23	from	from	IN
cord-023095-4dannjjm	819	24	horses	horse	NNS
cord-023095-4dannjjm	819	25	on	on	IN
cord-023095-4dannjjm	819	26	farms	farm	NNS
cord-023095-4dannjjm	819	27	.	.	.
cord-023095-4dannjjm	820	1	The	the	DT
cord-023095-4dannjjm	820	2	objectives	objective	NNS
cord-023095-4dannjjm	820	3	of	of	IN
cord-023095-4dannjjm	820	4	this	this	DT
cord-023095-4dannjjm	820	5	study	study	NN
cord-023095-4dannjjm	820	6	were	be	VBD
cord-023095-4dannjjm	820	7	to	to	TO
cord-023095-4dannjjm	820	8	longitudinally	longitudinally	RB
cord-023095-4dannjjm	820	9	investigate	investigate	VB
cord-023095-4dannjjm	820	10	the	the	DT
cord-023095-4dannjjm	820	11	above	above	JJ
cord-023095-4dannjjm	820	12	enteric	enteric	JJ
cord-023095-4dannjjm	820	13	pathogens	pathogen	NNS
cord-023095-4dannjjm	820	14	over	over	IN
cord-023095-4dannjjm	820	15	the	the	DT
cord-023095-4dannjjm	820	16	course	course	NN
cord-023095-4dannjjm	820	17	of	of	IN
cord-023095-4dannjjm	820	18	one	one	CD
cord-023095-4dannjjm	820	19	year	year	NN
cord-023095-4dannjjm	820	20	,	,	,
cord-023095-4dannjjm	820	21	molecularly	molecularly	RB
cord-023095-4dannjjm	820	22	characterize	characterize	VB
cord-023095-4dannjjm	820	23	obtained	obtain	VBN
cord-023095-4dannjjm	820	24	isolates	isolate	NNS
cord-023095-4dannjjm	820	25	and	and	CC
cord-023095-4dannjjm	820	26	determine	determine	VB
cord-023095-4dannjjm	820	27	the	the	DT
cord-023095-4dannjjm	820	28	antibiotic	antibiotic	JJ
cord-023095-4dannjjm	820	29	susceptibility	susceptibility	NN
cord-023095-4dannjjm	820	30	profile	profile	NN
cord-023095-4dannjjm	820	31	for	for	IN
cord-023095-4dannjjm	820	32	E.	E.	NNP
cord-023095-4dannjjm	820	33	coli	coli	NNS
cord-023095-4dannjjm	820	34	.	.	.
cord-023095-4dannjjm	821	1	Fecal	fecal	JJ
cord-023095-4dannjjm	821	2	samples	sample	NNS
cord-023095-4dannjjm	821	3	were	be	VBD
cord-023095-4dannjjm	821	4	collected	collect	VBN
cord-023095-4dannjjm	821	5	from	from	IN
cord-023095-4dannjjm	821	6	25	25	CD
cord-023095-4dannjjm	821	7	adult	adult	NN
cord-023095-4dannjjm	821	8	horses	horse	NNS
cord-023095-4dannjjm	821	9	from	from	IN
cord-023095-4dannjjm	821	10	five	five	CD
cord-023095-4dannjjm	821	11	farms	farm	NNS
cord-023095-4dannjjm	821	12	on	on	IN
cord-023095-4dannjjm	821	13	a	a	DT
cord-023095-4dannjjm	821	14	monthly	monthly	JJ
cord-023095-4dannjjm	821	15	basis	basis	NN
cord-023095-4dannjjm	821	16	over	over	IN
cord-023095-4dannjjm	821	17	the	the	DT
cord-023095-4dannjjm	821	18	course	course	NN
cord-023095-4dannjjm	821	19	of	of	IN
cord-023095-4dannjjm	821	20	one	one	CD
cord-023095-4dannjjm	821	21	year	year	NN
cord-023095-4dannjjm	821	22	.	.	.
cord-023095-4dannjjm	822	1	Selective	selective	JJ
cord-023095-4dannjjm	822	2	cultures	culture	NNS
cord-023095-4dannjjm	822	3	were	be	VBD
cord-023095-4dannjjm	822	4	performed	perform	VBN
cord-023095-4dannjjm	822	5	for	for	IN
cord-023095-4dannjjm	822	6	C.	C.	NNP
cord-023095-4dannjjm	822	7	difficile	difficile	NNP
cord-023095-4dannjjm	822	8	,	,	,
cord-023095-4dannjjm	822	9	C.	C.	NNP
cord-023095-4dannjjm	822	10	perfringens	perfringen	NNS
cord-023095-4dannjjm	822	11	,	,	,
cord-023095-4dannjjm	822	12	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	822	13	and	and	CC
cord-023095-4dannjjm	822	14	E.	E.	NNP
cord-023095-4dannjjm	822	15	coli	coli	NNS
cord-023095-4dannjjm	822	16	.	.	.
cord-023095-4dannjjm	823	1	C.	C.	NNP
cord-023095-4dannjjm	823	2	difficile	difficile	NN
cord-023095-4dannjjm	823	3	isolates	isolate	NNS
cord-023095-4dannjjm	823	4	were	be	VBD
cord-023095-4dannjjm	823	5	characterized	characterize	VBN
cord-023095-4dannjjm	823	6	via	via	IN
cord-023095-4dannjjm	823	7	toxin	toxin	NN
cord-023095-4dannjjm	823	8	gene	gene	NN
cord-023095-4dannjjm	823	9	PCR	PCR	NNP
cord-023095-4dannjjm	823	10	and	and	CC
cord-023095-4dannjjm	823	11	ribotyping	ribotype	VBG
cord-023095-4dannjjm	823	12	.	.	.
cord-023095-4dannjjm	824	1	Broth	Broth	NNP
cord-023095-4dannjjm	824	2	microdilution	microdilution	NN
cord-023095-4dannjjm	824	3	was	be	VBD
cord-023095-4dannjjm	824	4	performed	perform	VBN
cord-023095-4dannjjm	824	5	to	to	TO
cord-023095-4dannjjm	824	6	assess	assess	VB
cord-023095-4dannjjm	824	7	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	824	8	susceptibility	susceptibility	NN
cord-023095-4dannjjm	824	9	profiles	profile	NNS
cord-023095-4dannjjm	824	10	of	of	IN
cord-023095-4dannjjm	824	11	E.	E.	NNP
cord-023095-4dannjjm	824	12	coli	coli	NNS
cord-023095-4dannjjm	824	13	.	.	.
cord-023095-4dannjjm	825	1	Clostridium	clostridium	NN
cord-023095-4dannjjm	825	2	difficile	difficile	NN
cord-023095-4dannjjm	825	3	was	be	VBD
cord-023095-4dannjjm	825	4	isolated	isolate	VBN
cord-023095-4dannjjm	825	5	from	from	IN
cord-023095-4dannjjm	825	6	15/275	15/275	CD
cord-023095-4dannjjm	825	7	(	(	-LRB-
cord-023095-4dannjjm	825	8	5.45	5.45	CD
cord-023095-4dannjjm	825	9	%	%	NN
cord-023095-4dannjjm	825	10	)	)	-RRB-
cord-023095-4dannjjm	825	11	samples	sample	NNS
cord-023095-4dannjjm	825	12	from	from	IN
cord-023095-4dannjjm	825	13	11/25	11/25	CD
cord-023095-4dannjjm	825	14	(	(	-LRB-
cord-023095-4dannjjm	825	15	44	44	CD
cord-023095-4dannjjm	825	16	%	%	NN
cord-023095-4dannjjm	825	17	)	)	-RRB-
cord-023095-4dannjjm	825	18	horses	horse	NNS
cord-023095-4dannjjm	825	19	.	.	.
cord-023095-4dannjjm	826	1	Four	four	CD
cord-023095-4dannjjm	826	2	horses	horse	NNS
cord-023095-4dannjjm	826	3	were	be	VBD
cord-023095-4dannjjm	826	4	positive	positive	JJ
cord-023095-4dannjjm	826	5	on	on	IN
cord-023095-4dannjjm	826	6	more	more	JJR
cord-023095-4dannjjm	826	7	than	than	IN
cord-023095-4dannjjm	826	8	one	one	CD
cord-023095-4dannjjm	826	9	occasion	occasion	NN
cord-023095-4dannjjm	826	10	,	,	,
cord-023095-4dannjjm	826	11	three	three	CD
cord-023095-4dannjjm	826	12	were	be	VBD
cord-023095-4dannjjm	826	13	positive	positive	JJ
cord-023095-4dannjjm	826	14	in	in	IN
cord-023095-4dannjjm	826	15	two	two	CD
cord-023095-4dannjjm	826	16	consecutive	consecutive	JJ
cord-023095-4dannjjm	826	17	months	month	NNS
cord-023095-4dannjjm	826	18	.	.	.
cord-023095-4dannjjm	827	1	Different	different	JJ
cord-023095-4dannjjm	827	2	ribotypes	ribotype	NNS
cord-023095-4dannjjm	827	3	were	be	VBD
cord-023095-4dannjjm	827	4	found	find	VBN
cord-023095-4dannjjm	827	5	in	in	IN
cord-023095-4dannjjm	827	6	two	two	CD
cord-023095-4dannjjm	827	7	of	of	IN
cord-023095-4dannjjm	827	8	the	the	DT
cord-023095-4dannjjm	827	9	latter	latter	JJ
cord-023095-4dannjjm	827	10	horses	horse	NNS
cord-023095-4dannjjm	827	11	.	.	.
cord-023095-4dannjjm	828	1	Most	Most	JJS
cord-023095-4dannjjm	828	2	isolates	isolate	NNS
cord-023095-4dannjjm	828	3	were	be	VBD
cord-023095-4dannjjm	828	4	ribotype	ribotype	NNP
cord-023095-4dannjjm	828	5	078	078	CD
cord-023095-4dannjjm	829	1	(	(	-LRB-
cord-023095-4dannjjm	829	2	n	n	NN
cord-023095-4dannjjm	829	3	5	5	CD
cord-023095-4dannjjm	829	4	6	6	CD
cord-023095-4dannjjm	829	5	)	)	-RRB-
cord-023095-4dannjjm	829	6	with	with	IN
cord-023095-4dannjjm	829	7	ribotype	ribotype	NNP
cord-023095-4dannjjm	829	8	001	001	CD
cord-023095-4dannjjm	830	1	(	(	-LRB-
cord-023095-4dannjjm	830	2	n	n	NN
cord-023095-4dannjjm	830	3	5	5	CD
cord-023095-4dannjjm	830	4	5	5	CD
cord-023095-4dannjjm	830	5	)	)	-RRB-
cord-023095-4dannjjm	830	6	and	and	CC
cord-023095-4dannjjm	830	7	ribotype	ribotype	NNP
cord-023095-4dannjjm	830	8	C	C	NNP
cord-023095-4dannjjm	830	9	(	(	-LRB-
cord-023095-4dannjjm	830	10	n	n	NN
cord-023095-4dannjjm	830	11	5	5	CD
cord-023095-4dannjjm	830	12	4	4	CD
cord-023095-4dannjjm	830	13	)	)	-RRB-
cord-023095-4dannjjm	830	14	also	also	RB
cord-023095-4dannjjm	830	15	identified	identify	VBN
cord-023095-4dannjjm	830	16	.	.	.
cord-023095-4dannjjm	831	1	Ribotypes	Ribotypes	NNP
cord-023095-4dannjjm	831	2	078	078	CD
cord-023095-4dannjjm	831	3	and	and	CC
cord-023095-4dannjjm	831	4	C	C	NNP
cord-023095-4dannjjm	831	5	possessed	possess	VBD
cord-023095-4dannjjm	831	6	genes	gene	NNS
cord-023095-4dannjjm	831	7	encoding	encode	VBG
cord-023095-4dannjjm	831	8	toxins	toxin	NNS
cord-023095-4dannjjm	832	1	A	a	LS
cord-023095-4dannjjm	832	2	,	,	,
cord-023095-4dannjjm	832	3	B	b	NN
cord-023095-4dannjjm	832	4	and	and	CC
cord-023095-4dannjjm	832	5	binary	binary	JJ
cord-023095-4dannjjm	832	6	toxin	toxin	NN
cord-023095-4dannjjm	832	7	,	,	,
cord-023095-4dannjjm	832	8	while	while	IN
cord-023095-4dannjjm	832	9	ribotype	ribotype	NNP
cord-023095-4dannjjm	832	10	001	001	CD
cord-023095-4dannjjm	832	11	only	only	RB
cord-023095-4dannjjm	832	12	possessed	possess	VBD
cord-023095-4dannjjm	832	13	toxin	toxin	NN
cord-023095-4dannjjm	832	14	A	a	NN
cord-023095-4dannjjm	832	15	and	and	CC
cord-023095-4dannjjm	832	16	B	b	NN
cord-023095-4dannjjm	832	17	genes	gene	NNS
cord-023095-4dannjjm	832	18	.	.	.
cord-023095-4dannjjm	833	1	Despite	despite	IN
cord-023095-4dannjjm	833	2	a	a	DT
cord-023095-4dannjjm	833	3	detection	detection	NN
cord-023095-4dannjjm	833	4	threshold	threshold	NN
cord-023095-4dannjjm	833	5	of	of	IN
cord-023095-4dannjjm	833	6	9	9	CD
cord-023095-4dannjjm	833	7	cfu	cfu	NN
cord-023095-4dannjjm	833	8	/	/	SYM
cord-023095-4dannjjm	833	9	g	g	NNP
cord-023095-4dannjjm	833	10	feces	fece	NNS
cord-023095-4dannjjm	833	11	,	,	,
cord-023095-4dannjjm	833	12	C.	C.	NNP
cord-023095-4dannjjm	833	13	perfringens	perfringen	NNS
cord-023095-4dannjjm	833	14	was	be	VBD
cord-023095-4dannjjm	833	15	not	not	RB
cord-023095-4dannjjm	833	16	detected	detect	VBN
cord-023095-4dannjjm	833	17	in	in	IN
cord-023095-4dannjjm	833	18	any	any	DT
cord-023095-4dannjjm	833	19	samples	sample	NNS
cord-023095-4dannjjm	833	20	,	,	,
cord-023095-4dannjjm	833	21	nor	nor	CC
cord-023095-4dannjjm	833	22	was	be	VBD
cord-023095-4dannjjm	833	23	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	833	24	.	.	.
cord-023095-4dannjjm	834	1	E	e	NN
cord-023095-4dannjjm	834	2	coli	coli	NNS
cord-023095-4dannjjm	834	3	was	be	VBD
cord-023095-4dannjjm	834	4	isolated	isolate	VBN
cord-023095-4dannjjm	834	5	from	from	IN
cord-023095-4dannjjm	834	6	117/225	117/225	CD
cord-023095-4dannjjm	834	7	(	(	-LRB-
cord-023095-4dannjjm	834	8	52	52	CD
cord-023095-4dannjjm	834	9	%	%	NN
cord-023095-4dannjjm	834	10	)	)	-RRB-
cord-023095-4dannjjm	834	11	samples	sample	NNS
cord-023095-4dannjjm	834	12	.	.	.
cord-023095-4dannjjm	835	1	Resistance	resistance	NN
cord-023095-4dannjjm	835	2	to	to	IN
cord-023095-4dannjjm	835	3	!	!	.
cord-023095-4dannjjm	836	1	1	1	CD
cord-023095-4dannjjm	836	2	antimicrobial	antimicrobial	NN
cord-023095-4dannjjm	836	3	was	be	VBD
cord-023095-4dannjjm	836	4	present	present	JJ
cord-023095-4dannjjm	836	5	in	in	IN
cord-023095-4dannjjm	836	6	only	only	RB
cord-023095-4dannjjm	836	7	19/117	19/117	CD
cord-023095-4dannjjm	836	8	(	(	-LRB-
cord-023095-4dannjjm	836	9	16.9	16.9	CD
cord-023095-4dannjjm	836	10	%	%	NN
cord-023095-4dannjjm	836	11	)	)	-RRB-
cord-023095-4dannjjm	836	12	isolates	isolate	NNS
cord-023095-4dannjjm	836	13	.	.	.
cord-023095-4dannjjm	837	1	Multidrug	multidrug	JJ
cord-023095-4dannjjm	837	2	resistance	resistance	NN
cord-023095-4dannjjm	837	3	(	(	-LRB-
cord-023095-4dannjjm	837	4	!	!	.
cord-023095-4dannjjm	837	5	3	3	CD
cord-023095-4dannjjm	837	6	antibiotics	antibiotic	NNS
cord-023095-4dannjjm	837	7	)	)	-RRB-
cord-023095-4dannjjm	837	8	was	be	VBD
cord-023095-4dannjjm	837	9	present	present	JJ
cord-023095-4dannjjm	837	10	in	in	IN
cord-023095-4dannjjm	837	11	5/117	5/117	CD
cord-023095-4dannjjm	837	12	(	(	-LRB-
cord-023095-4dannjjm	837	13	4	4	CD
cord-023095-4dannjjm	837	14	%	%	NN
cord-023095-4dannjjm	837	15	)	)	-RRB-
cord-023095-4dannjjm	837	16	.	.	.
cord-023095-4dannjjm	838	1	Most	most	RBS
cord-023095-4dannjjm	838	2	commonly	commonly	RB
cord-023095-4dannjjm	838	3	,	,	,
cord-023095-4dannjjm	838	4	isolates	isolate	NNS
cord-023095-4dannjjm	838	5	were	be	VBD
cord-023095-4dannjjm	838	6	resistant	resistant	JJ
cord-023095-4dannjjm	838	7	to	to	IN
cord-023095-4dannjjm	838	8	sulfisoxazole	sulfisoxazole	NNP
cord-023095-4dannjjm	838	9	(	(	-LRB-
cord-023095-4dannjjm	838	10	17/	17/	CD
cord-023095-4dannjjm	838	11	117	117	CD
cord-023095-4dannjjm	838	12	)	)	-RRB-
cord-023095-4dannjjm	838	13	and	and	CC
cord-023095-4dannjjm	838	14	trimethoprim	trimethoprim	NNP
cord-023095-4dannjjm	838	15	sulfamethoxazole	sulfamethoxazole	NNP
cord-023095-4dannjjm	838	16	(	(	-LRB-
cord-023095-4dannjjm	838	17	16/117	16/117	CD
cord-023095-4dannjjm	838	18	)	)	-RRB-
cord-023095-4dannjjm	838	19	.	.	.
cord-023095-4dannjjm	839	1	The	the	DT
cord-023095-4dannjjm	839	2	overall	overall	JJ
cord-023095-4dannjjm	839	3	detection	detection	NN
cord-023095-4dannjjm	839	4	rate	rate	NN
cord-023095-4dannjjm	839	5	for	for	IN
cord-023095-4dannjjm	839	6	toxigenic	toxigenic	NNP
cord-023095-4dannjjm	839	7	C.	C.	NNP
cord-023095-4dannjjm	839	8	difficile	difficile	NN
cord-023095-4dannjjm	839	9	in	in	IN
cord-023095-4dannjjm	839	10	fecal	fecal	JJ
cord-023095-4dannjjm	839	11	samples	sample	NNS
cord-023095-4dannjjm	839	12	of	of	IN
cord-023095-4dannjjm	839	13	healthy	healthy	JJ
cord-023095-4dannjjm	839	14	horses	horse	NNS
cord-023095-4dannjjm	839	15	was	be	VBD
cord-023095-4dannjjm	839	16	5.4	5.4	CD
cord-023095-4dannjjm	839	17	%	%	NN
cord-023095-4dannjjm	839	18	which	which	WDT
cord-023095-4dannjjm	839	19	is	be	VBZ
cord-023095-4dannjjm	839	20	consistent	consistent	JJ
cord-023095-4dannjjm	839	21	with	with	IN
cord-023095-4dannjjm	839	22	previous	previous	JJ
cord-023095-4dannjjm	839	23	studies	study	NNS
cord-023095-4dannjjm	839	24	.	.	.
cord-023095-4dannjjm	840	1	The	the	DT
cord-023095-4dannjjm	840	2	cumulative	cumulative	JJ
cord-023095-4dannjjm	840	3	prevalence	prevalence	NN
cord-023095-4dannjjm	840	4	of	of	IN
cord-023095-4dannjjm	840	5	44	44	CD
cord-023095-4dannjjm	840	6	%	%	NN
cord-023095-4dannjjm	840	7	was	be	VBD
cord-023095-4dannjjm	840	8	striking	striking	JJ
cord-023095-4dannjjm	840	9	but	but	CC
cord-023095-4dannjjm	840	10	only	only	RB
cord-023095-4dannjjm	840	11	one	one	CD
cord-023095-4dannjjm	840	12	horse	horse	NN
cord-023095-4dannjjm	840	13	shed	shed	VBD
cord-023095-4dannjjm	840	14	the	the	DT
cord-023095-4dannjjm	840	15	same	same	JJ
cord-023095-4dannjjm	840	16	strain	strain	NN
cord-023095-4dannjjm	840	17	for	for	IN
cord-023095-4dannjjm	840	18	more	more	JJR
cord-023095-4dannjjm	840	19	than	than	IN
cord-023095-4dannjjm	840	20	one	one	CD
cord-023095-4dannjjm	840	21	month	month	NN
cord-023095-4dannjjm	840	22	,	,	,
cord-023095-4dannjjm	840	23	indicating	indicate	VBG
cord-023095-4dannjjm	840	24	C.	C.	NNP
cord-023095-4dannjjm	840	25	difficile	difficile	NN
cord-023095-4dannjjm	840	26	shedding	shedding	NN
cord-023095-4dannjjm	840	27	is	be	VBZ
cord-023095-4dannjjm	840	28	a	a	DT
cord-023095-4dannjjm	840	29	transient	transient	JJ
cord-023095-4dannjjm	840	30	and	and	CC
cord-023095-4dannjjm	840	31	dynamic	dynamic	JJ
cord-023095-4dannjjm	840	32	state	state	NN
cord-023095-4dannjjm	840	33	.	.	.
cord-023095-4dannjjm	841	1	The	the	DT
cord-023095-4dannjjm	841	2	predominant	predominant	JJ
cord-023095-4dannjjm	841	3	isolation	isolation	NN
cord-023095-4dannjjm	841	4	of	of	IN
cord-023095-4dannjjm	841	5	ribotype	ribotype	NNP
cord-023095-4dannjjm	841	6	078	078	CD
cord-023095-4dannjjm	841	7	is	be	VBZ
cord-023095-4dannjjm	841	8	consistent	consistent	JJ
cord-023095-4dannjjm	841	9	with	with	IN
cord-023095-4dannjjm	841	10	the	the	DT
cord-023095-4dannjjm	841	11	suspicion	suspicion	NN
cord-023095-4dannjjm	841	12	that	that	IN
cord-023095-4dannjjm	841	13	this	this	DT
cord-023095-4dannjjm	841	14	strain	strain	NN
cord-023095-4dannjjm	841	15	has	have	VBZ
cord-023095-4dannjjm	841	16	emerged	emerge	VBN
cord-023095-4dannjjm	841	17	and	and	CC
cord-023095-4dannjjm	841	18	become	become	VBN
cord-023095-4dannjjm	841	19	widely	widely	RB
cord-023095-4dannjjm	841	20	disseminated	disseminate	VBN
cord-023095-4dannjjm	841	21	in	in	IN
cord-023095-4dannjjm	841	22	this	this	DT
cord-023095-4dannjjm	841	23	region	region	NN
cord-023095-4dannjjm	841	24	in	in	IN
cord-023095-4dannjjm	841	25	recent	recent	JJ
cord-023095-4dannjjm	841	26	years	year	NNS
cord-023095-4dannjjm	841	27	.	.	.
cord-023095-4dannjjm	842	1	The	the	DT
cord-023095-4dannjjm	842	2	low	low	JJ
cord-023095-4dannjjm	842	3	prevalence	prevalence	NN
cord-023095-4dannjjm	842	4	of	of	IN
cord-023095-4dannjjm	842	5	C.	C.	NNP
cord-023095-4dannjjm	842	6	perfringens	perfringen	NNS
cord-023095-4dannjjm	842	7	and	and	CC
cord-023095-4dannjjm	842	8	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	842	9	is	be	VBZ
cord-023095-4dannjjm	842	10	in	in	IN
cord-023095-4dannjjm	842	11	agreement	agreement	NN
cord-023095-4dannjjm	842	12	with	with	IN
cord-023095-4dannjjm	842	13	some	some	DT
cord-023095-4dannjjm	842	14	other	other	JJ
cord-023095-4dannjjm	842	15	studies	study	NNS
cord-023095-4dannjjm	842	16	.	.	.
cord-023095-4dannjjm	843	1	The	the	DT
cord-023095-4dannjjm	843	2	low	low	JJ
cord-023095-4dannjjm	843	3	prevalence	prevalence	NN
cord-023095-4dannjjm	843	4	of	of	IN
cord-023095-4dannjjm	843	5	antibiotic	antibiotic	JJ
cord-023095-4dannjjm	843	6	resistance	resistance	NN
cord-023095-4dannjjm	843	7	in	in	IN
cord-023095-4dannjjm	843	8	commensal	commensal	JJ
cord-023095-4dannjjm	843	9	E.	E.	NNP
cord-023095-4dannjjm	843	10	coli	coli	NNS
cord-023095-4dannjjm	843	11	was	be	VBD
cord-023095-4dannjjm	843	12	encouraging	encouraging	JJ
cord-023095-4dannjjm	843	13	and	and	CC
cord-023095-4dannjjm	843	14	suggests	suggest	VBZ
cord-023095-4dannjjm	843	15	that	that	IN
cord-023095-4dannjjm	843	16	healthy	healthy	JJ
cord-023095-4dannjjm	843	17	horses	horse	NNS
cord-023095-4dannjjm	843	18	on	on	IN
cord-023095-4dannjjm	843	19	pleasure	pleasure	NN
cord-023095-4dannjjm	843	20	horse	horse	NN
cord-023095-4dannjjm	843	21	farms	farm	NNS
cord-023095-4dannjjm	843	22	are	be	VBP
cord-023095-4dannjjm	843	23	not	not	RB
cord-023095-4dannjjm	843	24	likely	likely	RB
cord-023095-4dannjjm	843	25	a	a	DT
cord-023095-4dannjjm	843	26	major	major	JJ
cord-023095-4dannjjm	843	27	reservoir	reservoir	NN
cord-023095-4dannjjm	843	28	of	of	IN
cord-023095-4dannjjm	843	29	resistance	resistance	NN
cord-023095-4dannjjm	843	30	in	in	IN
cord-023095-4dannjjm	843	31	enteric	enteric	JJ
cord-023095-4dannjjm	843	32	bacteria	bacteria	NNS
cord-023095-4dannjjm	843	33	.	.	.
cord-023095-4dannjjm	844	1	Type	type	NN
cord-023095-4dannjjm	844	2	1	1	CD
cord-023095-4dannjjm	844	3	Polysaccharide	polysaccharide	NN
cord-023095-4dannjjm	844	4	Storage	Storage	NNP
cord-023095-4dannjjm	844	5	Myopathy	Myopathy	NNP
cord-023095-4dannjjm	844	6	(	(	-LRB-
cord-023095-4dannjjm	844	7	PSSM	PSSM	NNP
cord-023095-4dannjjm	844	8	)	)	-RRB-
cord-023095-4dannjjm	844	9	in	in	IN
cord-023095-4dannjjm	844	10	horses	horse	NNS
cord-023095-4dannjjm	844	11	is	be	VBZ
cord-023095-4dannjjm	844	12	associated	associate	VBN
cord-023095-4dannjjm	844	13	with	with	IN
cord-023095-4dannjjm	844	14	a	a	DT
cord-023095-4dannjjm	844	15	dominant	dominant	JJ
cord-023095-4dannjjm	844	16	missense	missense	NN
cord-023095-4dannjjm	844	17	mutation	mutation	NN
cord-023095-4dannjjm	844	18	(	(	-LRB-
cord-023095-4dannjjm	844	19	R309H	R309H	NNP
cord-023095-4dannjjm	844	20	)	)	-RRB-
cord-023095-4dannjjm	844	21	in	in	IN
cord-023095-4dannjjm	844	22	the	the	DT
cord-023095-4dannjjm	844	23	skeletal	skeletal	JJ
cord-023095-4dannjjm	844	24	muscle	muscle	NN
cord-023095-4dannjjm	844	25	glycogen	glycogen	NN
cord-023095-4dannjjm	844	26	synthase	synthase	NN
cord-023095-4dannjjm	844	27	gene	gene	NN
cord-023095-4dannjjm	844	28	(	(	-LRB-
cord-023095-4dannjjm	844	29	GYS1	GYS1	NNP
cord-023095-4dannjjm	844	30	)	)	-RRB-
cord-023095-4dannjjm	844	31	.	.	.
cord-023095-4dannjjm	845	1	Since	since	IN
cord-023095-4dannjjm	845	2	disease	disease	NN
cord-023095-4dannjjm	845	3	severity	severity	NN
cord-023095-4dannjjm	845	4	varies	vary	VBZ
cord-023095-4dannjjm	845	5	between	between	IN
cord-023095-4dannjjm	845	6	affected	affected	JJ
cord-023095-4dannjjm	845	7	horses	horse	NNS
cord-023095-4dannjjm	845	8	,	,	,
cord-023095-4dannjjm	845	9	we	-PRON-	PRP
cord-023095-4dannjjm	845	10	hypothesised	hypothesise	VBD
cord-023095-4dannjjm	845	11	that	that	IN
cord-023095-4dannjjm	845	12	some	some	DT
cord-023095-4dannjjm	845	13	clinical	clinical	JJ
cord-023095-4dannjjm	845	14	variability	variability	NN
cord-023095-4dannjjm	845	15	could	could	MD
cord-023095-4dannjjm	845	16	be	be	VB
cord-023095-4dannjjm	845	17	accounted	account	VBN
cord-023095-4dannjjm	845	18	for	for	IN
cord-023095-4dannjjm	845	19	by	by	IN
cord-023095-4dannjjm	845	20	the	the	DT
cord-023095-4dannjjm	845	21	underlying	underlie	VBG
cord-023095-4dannjjm	845	22	genotype	genotype	NN
cord-023095-4dannjjm	845	23	.	.	.
cord-023095-4dannjjm	846	1	107	107	CD
cord-023095-4dannjjm	846	2	Belgian	belgian	JJ
cord-023095-4dannjjm	846	3	/	/	SYM
cord-023095-4dannjjm	846	4	Percheron	Percheron	NNP
cord-023095-4dannjjm	846	5	horses	horse	NNS
cord-023095-4dannjjm	846	6	were	be	VBD
cord-023095-4dannjjm	846	7	genotyped	genotype	VBN
cord-023095-4dannjjm	846	8	using	use	VBG
cord-023095-4dannjjm	846	9	a	a	DT
cord-023095-4dannjjm	846	10	validated	validate	VBN
cord-023095-4dannjjm	846	11	restriction	restriction	NN
cord-023095-4dannjjm	846	12	fragment	fragment	NN
cord-023095-4dannjjm	846	13	length	length	NN
cord-023095-4dannjjm	846	14	polymorphism	polymorphism	NN
cord-023095-4dannjjm	846	15	assay	assay	NN
cord-023095-4dannjjm	846	16	enabling	enable	VBG
cord-023095-4dannjjm	846	17	grouping	grouping	NN
cord-023095-4dannjjm	846	18	of	of	IN
cord-023095-4dannjjm	846	19	horses	horse	NNS
cord-023095-4dannjjm	846	20	as	as	IN
cord-023095-4dannjjm	846	21	homozygotes	homozygote	NNS
cord-023095-4dannjjm	846	22	(	(	-LRB-
cord-023095-4dannjjm	846	23	HH	HH	NNP
cord-023095-4dannjjm	846	24	)	)	-RRB-
cord-023095-4dannjjm	846	25	,	,	,
cord-023095-4dannjjm	846	26	heterozygotes(HR	heterozygotes(hr	ADD
cord-023095-4dannjjm	846	27	)	)	-RRB-
cord-023095-4dannjjm	846	28	or	or	CC
cord-023095-4dannjjm	846	29	normal	normal	JJ
cord-023095-4dannjjm	846	30	(	(	-LRB-
cord-023095-4dannjjm	846	31	RR	rr	NN
cord-023095-4dannjjm	846	32	)	)	-RRB-
cord-023095-4dannjjm	846	33	.	.	.
cord-023095-4dannjjm	847	1	Subsequently	subsequently	RB
cord-023095-4dannjjm	847	2	,	,	,
cord-023095-4dannjjm	847	3	semimembranosis	semimembranosis	NN
cord-023095-4dannjjm	847	4	muscle	muscle	NN
cord-023095-4dannjjm	847	5	samples	sample	NNS
cord-023095-4dannjjm	847	6	were	be	VBD
cord-023095-4dannjjm	847	7	biopsied	biopsie	VBN
cord-023095-4dannjjm	847	8	from	from	IN
cord-023095-4dannjjm	847	9	each	each	DT
cord-023095-4dannjjm	847	10	of	of	IN
cord-023095-4dannjjm	847	11	six	six	CD
cord-023095-4dannjjm	847	12	matched	match	VBN
cord-023095-4dannjjm	847	13	sedentary	sedentary	JJ
cord-023095-4dannjjm	847	14	horses	horse	NNS
cord-023095-4dannjjm	847	15	from	from	IN
cord-023095-4dannjjm	847	16	each	each	DT
cord-023095-4dannjjm	847	17	group	group	NN
cord-023095-4dannjjm	847	18	;	;	:
cord-023095-4dannjjm	847	19	one	one	CD
cord-023095-4dannjjm	847	20	sample	sample	NN
cord-023095-4dannjjm	847	21	was	be	VBD
cord-023095-4dannjjm	847	22	formalin	formalin	NN
cord-023095-4dannjjm	847	23	-	-	HYPH
cord-023095-4dannjjm	847	24	fixed	fix	VBN
cord-023095-4dannjjm	847	25	and	and	CC
cord-023095-4dannjjm	847	26	one	one	CD
cord-023095-4dannjjm	847	27	fresh	fresh	JJ
cord-023095-4dannjjm	847	28	frozen	frozen	JJ
cord-023095-4dannjjm	847	29	.	.	.
cord-023095-4dannjjm	848	1	Sections	section	NNS
cord-023095-4dannjjm	848	2	were	be	VBD
cord-023095-4dannjjm	848	3	stained	stain	VBN
cord-023095-4dannjjm	848	4	using	use	VBG
cord-023095-4dannjjm	848	5	haematoxylin	haematoxylin	NNP
cord-023095-4dannjjm	848	6	and	and	CC
cord-023095-4dannjjm	848	7	eosin	eosin	NNP
cord-023095-4dannjjm	848	8	,	,	,
cord-023095-4dannjjm	848	9	periodic	periodic	JJ
cord-023095-4dannjjm	848	10	acid	acid	NN
cord-023095-4dannjjm	848	11	schiff	schiff	NNP
cord-023095-4dannjjm	848	12	1	1	CD
cord-023095-4dannjjm	849	1	/diastase	/diastase	.
cord-023095-4dannjjm	849	2	.	.	.
cord-023095-4dannjjm	850	1	Anti	anti	JJ
cord-023095-4dannjjm	850	2	-	-	JJ
cord-023095-4dannjjm	850	3	dystrophin	dystrophin	JJ
cord-023095-4dannjjm	850	4	,	,	,
cord-023095-4dannjjm	850	5	nNOS	nNOS	NNP
cord-023095-4dannjjm	850	6	and	and	CC
cord-023095-4dannjjm	850	7	myosin	myosin	NN
cord-023095-4dannjjm	850	8	heavy	heavy	JJ
cord-023095-4dannjjm	850	9	chain	chain	NN
cord-023095-4dannjjm	850	10	immunohistochemistry	immunohistochemistry	NN
cord-023095-4dannjjm	850	11	was	be	VBD
cord-023095-4dannjjm	850	12	performed	perform	VBN
cord-023095-4dannjjm	850	13	to	to	TO
cord-023095-4dannjjm	850	14	examine	examine	VB
cord-023095-4dannjjm	850	15	sarcolemmal	sarcolemmal	NNP
cord-023095-4dannjjm	850	16	intregrity	intregrity	NN
cord-023095-4dannjjm	850	17	,	,	,
cord-023095-4dannjjm	850	18	There	there	EX
cord-023095-4dannjjm	850	19	were	be	VBD
cord-023095-4dannjjm	850	20	significant	significant	JJ
cord-023095-4dannjjm	850	21	differences	difference	NNS
cord-023095-4dannjjm	850	22	in	in	IN
cord-023095-4dannjjm	850	23	resting	rest	VBG
cord-023095-4dannjjm	850	24	CK	CK	NNP
cord-023095-4dannjjm	850	25	activity	activity	NN
cord-023095-4dannjjm	850	26	(	(	-LRB-
cord-023095-4dannjjm	850	27	P	p	NN
cord-023095-4dannjjm	850	28	5	5	CD
cord-023095-4dannjjm	850	29	0.023	0.023	CD
cord-023095-4dannjjm	850	30	)	)	-RRB-
cord-023095-4dannjjm	851	1	(	(	-LRB-
cord-023095-4dannjjm	851	2	median	median	JJ
cord-023095-4dannjjm	851	3	HH	HH	NNP
cord-023095-4dannjjm	851	4	5	5	CD
cord-023095-4dannjjm	851	5	364U	364u	CD
cord-023095-4dannjjm	852	1	/l	/l	NFP
cord-023095-4dannjjm	852	2	interquartile	interquartile	JJ
cord-023095-4dannjjm	852	3	range(IR	range(IR	NNS
cord-023095-4dannjjm	852	4	)	)	-RRB-
cord-023095-4dannjjm	853	1	332	332	CD
cord-023095-4dannjjm	853	2	-	-	SYM
cord-023095-4dannjjm	853	3	764	764	CD
cord-023095-4dannjjm	853	4	;	;	.
cord-023095-4dannjjm	854	1	HR	HR	NNP
cord-023095-4dannjjm	854	2	5	5	CD
cord-023095-4dannjjm	854	3	301U/	301u/	CD
cord-023095-4dannjjm	855	1	l	l	NNP
cord-023095-4dannjjm	855	2	IR222	ir222	NN
cord-023095-4dannjjm	855	3	-	-	HYPH
cord-023095-4dannjjm	855	4	377	377	CD
cord-023095-4dannjjm	855	5	;	;	:
cord-023095-4dannjjm	855	6	RR	RR	NNP
cord-023095-4dannjjm	855	7	5	5	CD
cord-023095-4dannjjm	855	8	260U	260u	CD
cord-023095-4dannjjm	855	9	/	/	SYM
cord-023095-4dannjjm	855	10	l	l	NNP
cord-023095-4dannjjm	855	11	IR216	IR216	NNP
cord-023095-4dannjjm	855	12	-	-	HYPH
cord-023095-4dannjjm	855	13	320	320	CD
cord-023095-4dannjjm	855	14	)	)	-RRB-
cord-023095-4dannjjm	855	15	and	and	CC
cord-023095-4dannjjm	855	16	AST	ast	NN
cord-023095-4dannjjm	855	17	activity	activity	NN
cord-023095-4dannjjm	856	1	(	(	-LRB-
cord-023095-4dannjjm	856	2	P	p	NN
cord-023095-4dannjjm	856	3	o	o	NN
cord-023095-4dannjjm	856	4	0.001	0.001	CD
cord-023095-4dannjjm	856	5	)	)	-RRB-
cord-023095-4dannjjm	857	1	(	(	-LRB-
cord-023095-4dannjjm	857	2	AST	AST	NNP
cord-023095-4dannjjm	857	3	mean	mean	VBP
cord-023095-4dannjjm	857	4	HH	HH	NNP
cord-023095-4dannjjm	857	5	5	5	CD
cord-023095-4dannjjm	858	1	502U	502u	CD
cord-023095-4dannjjm	859	1	/l	/l	NNP
cord-023095-4dannjjm	859	2	SD116	SD116	NNP
cord-023095-4dannjjm	860	1	;	;	:
cord-023095-4dannjjm	860	2	HR	HR	NNP
cord-023095-4dannjjm	860	3	5	5	CD
cord-023095-4dannjjm	860	4	357U	357U	NNP
cord-023095-4dannjjm	860	5	/	/	SYM
cord-023095-4dannjjm	860	6	l	l	NNP
cord-023095-4dannjjm	860	7	SD92	SD92	NNP
cord-023095-4dannjjm	860	8	;	;	:
cord-023095-4dannjjm	860	9	RR	RR	NNP
cord-023095-4dannjjm	860	10	5	5	CD
cord-023095-4dannjjm	860	11	311U	311u	CD
cord-023095-4dannjjm	860	12	/	/	SYM
cord-023095-4dannjjm	860	13	l	l	NNP
cord-023095-4dannjjm	860	14	SD64	SD64	NNP
cord-023095-4dannjjm	860	15	)	)	-RRB-
cord-023095-4dannjjm	860	16	and	and	CC
cord-023095-4dannjjm	860	17	muscle	muscle	NN
cord-023095-4dannjjm	860	18	pathology	pathology	NN
cord-023095-4dannjjm	860	19	between	between	IN
cord-023095-4dannjjm	860	20	the	the	DT
cord-023095-4dannjjm	860	21	3	3	CD
cord-023095-4dannjjm	860	22	groups	group	NNS
cord-023095-4dannjjm	860	23	,	,	,
cord-023095-4dannjjm	860	24	with	with	IN
cord-023095-4dannjjm	860	25	severity	severity	NN
cord-023095-4dannjjm	860	26	increasing	increase	VBG
cord-023095-4dannjjm	860	27	RR	rr	NN
cord-023095-4dannjjm	860	28	o	o	NN
cord-023095-4dannjjm	860	29	HR	hr	NN
cord-023095-4dannjjm	860	30	o	o	NN
cord-023095-4dannjjm	860	31	HH	hh	NN
cord-023095-4dannjjm	860	32	.	.	.
cord-023095-4dannjjm	861	1	There	there	EX
cord-023095-4dannjjm	861	2	were	be	VBD
cord-023095-4dannjjm	861	3	significantly	significantly	RB
cord-023095-4dannjjm	861	4	more	more	JJR
cord-023095-4dannjjm	861	5	type	type	NN
cord-023095-4dannjjm	861	6	2a	2a	CD
cord-023095-4dannjjm	861	7	(	(	-LRB-
cord-023095-4dannjjm	861	8	P	p	NN
cord-023095-4dannjjm	861	9	5	5	CD
cord-023095-4dannjjm	861	10	0.04	0.04	CD
cord-023095-4dannjjm	861	11	)	)	-RRB-
cord-023095-4dannjjm	861	12	and	and	CC
cord-023095-4dannjjm	861	13	fewer	few	JJR
cord-023095-4dannjjm	861	14	type	type	NN
cord-023095-4dannjjm	861	15	2x	2x	CD
cord-023095-4dannjjm	861	16	fibres	fibre	NNS
cord-023095-4dannjjm	861	17	(	(	-LRB-
cord-023095-4dannjjm	861	18	P	p	NN
cord-023095-4dannjjm	861	19	5	5	CD
cord-023095-4dannjjm	861	20	0.02	0.02	CD
cord-023095-4dannjjm	861	21	)	)	-RRB-
cord-023095-4dannjjm	861	22	in	in	IN
cord-023095-4dannjjm	861	23	homozygotes	homozygote	NNS
cord-023095-4dannjjm	861	24	(	(	-LRB-
cord-023095-4dannjjm	861	25	2a	2a	CD
cord-023095-4dannjjm	861	26	55	55	CD
cord-023095-4dannjjm	861	27	%	%	NN
cord-023095-4dannjjm	861	28	SD	sd	NN
cord-023095-4dannjjm	861	29	10.2	10.2	CD
cord-023095-4dannjjm	861	30	;	;	:
cord-023095-4dannjjm	861	31	2x	2x	CD
cord-023095-4dannjjm	861	32	32	32	CD
cord-023095-4dannjjm	861	33	%	%	NN
cord-023095-4dannjjm	861	34	SD	SD	NNP
cord-023095-4dannjjm	861	35	18	18	CD
cord-023095-4dannjjm	861	36	)	)	-RRB-
cord-023095-4dannjjm	861	37	compared	compare	VBN
cord-023095-4dannjjm	861	38	with	with	IN
cord-023095-4dannjjm	861	39	the	the	DT
cord-023095-4dannjjm	861	40	other	other	JJ
cord-023095-4dannjjm	861	41	groups	group	NNS
cord-023095-4dannjjm	861	42	(	(	-LRB-
cord-023095-4dannjjm	861	43	HR	HR	NNP
cord-023095-4dannjjm	861	44	2a	2a	CD
cord-023095-4dannjjm	861	45	38	38	CD
cord-023095-4dannjjm	861	46	%	%	NN
cord-023095-4dannjjm	861	47	SD	SD	NNP
cord-023095-4dannjjm	861	48	10.9	10.9	CD
cord-023095-4dannjjm	861	49	,	,	,
cord-023095-4dannjjm	861	50	2x	2x	CD
cord-023095-4dannjjm	861	51	44	44	CD
cord-023095-4dannjjm	861	52	%	%	NN
cord-023095-4dannjjm	861	53	SD	sd	NN
cord-023095-4dannjjm	861	54	10.8	10.8	CD
cord-023095-4dannjjm	861	55	;	;	:
cord-023095-4dannjjm	861	56	RR	rr	NN
cord-023095-4dannjjm	861	57	:	:	:
cord-023095-4dannjjm	862	1	2a	2a	CD
cord-023095-4dannjjm	862	2	36.5	36.5	CD
cord-023095-4dannjjm	862	3	%	%	NN
cord-023095-4dannjjm	862	4	SD	SD	NNP
cord-023095-4dannjjm	862	5	12.4	12.4	CD
cord-023095-4dannjjm	862	6	2x	2x	CD
cord-023095-4dannjjm	862	7	57	57	CD
cord-023095-4dannjjm	862	8	%	%	NN
cord-023095-4dannjjm	862	9	SD	sd	NN
cord-023095-4dannjjm	862	10	11.5	11.5	CD
cord-023095-4dannjjm	862	11	)	)	-RRB-
cord-023095-4dannjjm	862	12	.	.	.
cord-023095-4dannjjm	863	1	More	More	JJR
cord-023095-4dannjjm	863	2	type	type	NN
cord-023095-4dannjjm	863	3	2a	2a	CD
cord-023095-4dannjjm	863	4	fibres	fibre	NNS
cord-023095-4dannjjm	863	5	contained	contain	VBD
cord-023095-4dannjjm	863	6	polysaccharide	polysaccharide	NN
cord-023095-4dannjjm	863	7	inclusions	inclusion	NNS
cord-023095-4dannjjm	863	8	in	in	IN
cord-023095-4dannjjm	863	9	homozygotes	homozygote	NNS
cord-023095-4dannjjm	863	10	(	(	-LRB-
cord-023095-4dannjjm	863	11	30	30	CD
cord-023095-4dannjjm	863	12	%	%	NN
cord-023095-4dannjjm	863	13	SD	sd	NN
cord-023095-4dannjjm	863	14	11.1	11.1	CD
cord-023095-4dannjjm	863	15	)	)	-RRB-
cord-023095-4dannjjm	863	16	than	than	IN
cord-023095-4dannjjm	863	17	in	in	IN
cord-023095-4dannjjm	863	18	heterozygotes	heterozygote	NNS
cord-023095-4dannjjm	863	19	(	(	-LRB-
cord-023095-4dannjjm	863	20	10.6	10.6	CD
cord-023095-4dannjjm	863	21	%	%	NN
cord-023095-4dannjjm	863	22	SD	sd	NN
cord-023095-4dannjjm	863	23	6.9	6.9	CD
cord-023095-4dannjjm	863	24	)	)	-RRB-
cord-023095-4dannjjm	864	1	(	(	-LRB-
cord-023095-4dannjjm	864	2	P	p	NN
cord-023095-4dannjjm	864	3	o	o	NN
cord-023095-4dannjjm	864	4	0.001	0.001	CD
cord-023095-4dannjjm	864	5	)	)	-RRB-
cord-023095-4dannjjm	864	6	.	.	.
cord-023095-4dannjjm	865	1	Both	both	DT
cord-023095-4dannjjm	865	2	dystrophin	dystrophin	NN
cord-023095-4dannjjm	865	3	and	and	CC
cord-023095-4dannjjm	865	4	nNOS	nnos	JJ
cord-023095-4dannjjm	865	5	expression	expression	NN
cord-023095-4dannjjm	865	6	was	be	VBD
cord-023095-4dannjjm	865	7	normally	normally	RB
cord-023095-4dannjjm	865	8	localised	localised	JJ
cord-023095-4dannjjm	865	9	to	to	IN
cord-023095-4dannjjm	865	10	the	the	DT
cord-023095-4dannjjm	865	11	sarcolemma	sarcolemma	NN
cord-023095-4dannjjm	865	12	in	in	IN
cord-023095-4dannjjm	865	13	pathologically	pathologically	RB
cord-023095-4dannjjm	865	14	normal	normal	JJ
cord-023095-4dannjjm	865	15	and	and	CC
cord-023095-4dannjjm	865	16	vacuolated	vacuolated	JJ
cord-023095-4dannjjm	865	17	fibres	fibre	NNS
cord-023095-4dannjjm	865	18	from	from	IN
cord-023095-4dannjjm	865	19	mutant	mutant	JJ
cord-023095-4dannjjm	865	20	horses	horse	NNS
cord-023095-4dannjjm	865	21	.	.	.
cord-023095-4dannjjm	866	1	In	in	IN
cord-023095-4dannjjm	866	2	conclusion	conclusion	NN
cord-023095-4dannjjm	866	3	,	,	,
cord-023095-4dannjjm	866	4	sedentary	sedentary	JJ
cord-023095-4dannjjm	866	5	homozygotes	homozygote	NNS
cord-023095-4dannjjm	866	6	have	have	VBP
cord-023095-4dannjjm	866	7	more	more	RBR
cord-023095-4dannjjm	866	8	severe	severe	JJ
cord-023095-4dannjjm	866	9	skeletal	skeletal	JJ
cord-023095-4dannjjm	866	10	muscle	muscle	NN
cord-023095-4dannjjm	866	11	pathology	pathology	NN
cord-023095-4dannjjm	866	12	and	and	CC
cord-023095-4dannjjm	866	13	higher	high	JJR
cord-023095-4dannjjm	866	14	resting	rest	VBG
cord-023095-4dannjjm	866	15	plasma	plasma	NN
cord-023095-4dannjjm	866	16	CK	CK	NNP
cord-023095-4dannjjm	866	17	and	and	CC
cord-023095-4dannjjm	866	18	AST	AST	NNP
cord-023095-4dannjjm	866	19	activities	activity	NNS
cord-023095-4dannjjm	866	20	than	than	IN
cord-023095-4dannjjm	866	21	heterozygotes	heterozygote	NNS
cord-023095-4dannjjm	866	22	,	,	,
cord-023095-4dannjjm	866	23	and	and	CC
cord-023095-4dannjjm	866	24	PSSM1	pssm1	NN
cord-023095-4dannjjm	866	25	is	be	VBZ
cord-023095-4dannjjm	866	26	associated	associate	VBN
cord-023095-4dannjjm	866	27	with	with	IN
cord-023095-4dannjjm	866	28	a	a	DT
cord-023095-4dannjjm	866	29	fibre	fibre	NN
cord-023095-4dannjjm	866	30	type	type	NN
cord-023095-4dannjjm	866	31	shift	shift	NN
cord-023095-4dannjjm	866	32	towards	towards	IN
cord-023095-4dannjjm	866	33	type	type	NN
cord-023095-4dannjjm	866	34	2a	2a	CD
cord-023095-4dannjjm	866	35	.	.	.
cord-023095-4dannjjm	867	1	Although	although	IN
cord-023095-4dannjjm	867	2	subsarcolemmal	subsarcolemmal	JJ
cord-023095-4dannjjm	867	3	vacuolation	vacuolation	NN
cord-023095-4dannjjm	867	4	likely	likely	RB
cord-023095-4dannjjm	867	5	disrupts	disrupt	VBZ
cord-023095-4dannjjm	867	6	the	the	DT
cord-023095-4dannjjm	867	7	contractile	contractile	JJ
cord-023095-4dannjjm	867	8	apparatus	apparatus	NN
cord-023095-4dannjjm	867	9	's	's	POS
cord-023095-4dannjjm	867	10	attachment	attachment	NN
cord-023095-4dannjjm	867	11	to	to	IN
cord-023095-4dannjjm	867	12	the	the	DT
cord-023095-4dannjjm	867	13	sarcolemma	sarcolemma	NNP
cord-023095-4dannjjm	867	14	,	,	,
cord-023095-4dannjjm	867	15	the	the	DT
cord-023095-4dannjjm	867	16	latter	latter	NN
cord-023095-4dannjjm	867	17	's	's	POS
cord-023095-4dannjjm	867	18	integrity	integrity	NN
cord-023095-4dannjjm	867	19	appeared	appear	VBD
cord-023095-4dannjjm	867	20	intact	intact	JJ
cord-023095-4dannjjm	867	21	.	.	.
cord-023095-4dannjjm	868	1	The	the	DT
cord-023095-4dannjjm	868	2	recumbent	recumbent	JJ
cord-023095-4dannjjm	868	3	horse	horse	NN
cord-023095-4dannjjm	868	4	presents	present	VBZ
cord-023095-4dannjjm	868	5	a	a	DT
cord-023095-4dannjjm	868	6	logistic	logistic	JJ
cord-023095-4dannjjm	868	7	,	,	,
cord-023095-4dannjjm	868	8	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	868	9	,	,	,
cord-023095-4dannjjm	868	10	and	and	CC
cord-023095-4dannjjm	868	11	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	868	12	challenge	challenge	NN
cord-023095-4dannjjm	868	13	to	to	IN
cord-023095-4dannjjm	868	14	the	the	DT
cord-023095-4dannjjm	868	15	equine	equine	JJ
cord-023095-4dannjjm	868	16	practitioner	practitioner	NN
cord-023095-4dannjjm	868	17	.	.	.
cord-023095-4dannjjm	869	1	There	there	EX
cord-023095-4dannjjm	869	2	is	be	VBZ
cord-023095-4dannjjm	869	3	currently	currently	RB
cord-023095-4dannjjm	869	4	very	very	RB
cord-023095-4dannjjm	869	5	little	little	JJ
cord-023095-4dannjjm	869	6	data	datum	NNS
cord-023095-4dannjjm	869	7	available	available	JJ
cord-023095-4dannjjm	869	8	on	on	IN
cord-023095-4dannjjm	869	9	the	the	DT
cord-023095-4dannjjm	869	10	prognosis	prognosis	NN
cord-023095-4dannjjm	869	11	and	and	CC
cord-023095-4dannjjm	869	12	outcome	outcome	NN
cord-023095-4dannjjm	869	13	of	of	IN
cord-023095-4dannjjm	869	14	horses	horse	NNS
cord-023095-4dannjjm	869	15	that	that	WDT
cord-023095-4dannjjm	869	16	are	be	VBP
cord-023095-4dannjjm	869	17	recumbent	recumbent	JJ
cord-023095-4dannjjm	869	18	.	.	.
cord-023095-4dannjjm	870	1	Therefore	therefore	RB
cord-023095-4dannjjm	870	2	,	,	,
cord-023095-4dannjjm	870	3	the	the	DT
cord-023095-4dannjjm	870	4	purpose	purpose	NN
cord-023095-4dannjjm	870	5	of	of	IN
cord-023095-4dannjjm	870	6	this	this	DT
cord-023095-4dannjjm	870	7	study	study	NN
cord-023095-4dannjjm	870	8	was	be	VBD
cord-023095-4dannjjm	870	9	to	to	TO
cord-023095-4dannjjm	870	10	investigate	investigate	VB
cord-023095-4dannjjm	870	11	the	the	DT
cord-023095-4dannjjm	870	12	outcome	outcome	NN
cord-023095-4dannjjm	870	13	of	of	IN
cord-023095-4dannjjm	870	14	hospitalized	hospitalize	VBN
cord-023095-4dannjjm	870	15	horses	horse	NNS
cord-023095-4dannjjm	870	16	that	that	WDT
cord-023095-4dannjjm	870	17	had	have	VBD
cord-023095-4dannjjm	870	18	been	be	VBN
cord-023095-4dannjjm	870	19	recumbent	recumbent	JJ
cord-023095-4dannjjm	870	20	in	in	IN
cord-023095-4dannjjm	870	21	the	the	DT
cord-023095-4dannjjm	870	22	field	field	NN
cord-023095-4dannjjm	870	23	or	or	CC
cord-023095-4dannjjm	870	24	in	in	IN
cord-023095-4dannjjm	870	25	the	the	DT
cord-023095-4dannjjm	870	26	hospital	hospital	NN
cord-023095-4dannjjm	870	27	and	and	CC
cord-023095-4dannjjm	870	28	the	the	DT
cord-023095-4dannjjm	870	29	factors	factor	NNS
cord-023095-4dannjjm	870	30	affecting	affect	VBG
cord-023095-4dannjjm	870	31	their	-PRON-	PRP$
cord-023095-4dannjjm	870	32	survival	survival	NN
cord-023095-4dannjjm	870	33	.	.	.
cord-023095-4dannjjm	871	1	Records	record	NNS
cord-023095-4dannjjm	871	2	of	of	IN
cord-023095-4dannjjm	871	3	horses	horse	NNS
cord-023095-4dannjjm	871	4	admitted	admit	VBN
cord-023095-4dannjjm	871	5	to	to	IN
cord-023095-4dannjjm	871	6	the	the	DT
cord-023095-4dannjjm	871	7	School	School	NNP
cord-023095-4dannjjm	871	8	of	of	IN
cord-023095-4dannjjm	871	9	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	871	10	Medicine	Medicine	NNP
cord-023095-4dannjjm	871	11	,	,	,
cord-023095-4dannjjm	871	12	University	University	NNP
cord-023095-4dannjjm	871	13	of	of	IN
cord-023095-4dannjjm	871	14	California	California	NNP
cord-023095-4dannjjm	871	15	Davis	Davis	NNP
cord-023095-4dannjjm	871	16	from	from	IN
cord-023095-4dannjjm	871	17	January	January	NNP
cord-023095-4dannjjm	871	18	of	of	IN
cord-023095-4dannjjm	871	19	1995	1995	CD
cord-023095-4dannjjm	871	20	to	to	IN
cord-023095-4dannjjm	871	21	December	December	NNP
cord-023095-4dannjjm	871	22	of	of	IN
cord-023095-4dannjjm	871	23	2010	2010	CD
cord-023095-4dannjjm	871	24	with	with	IN
cord-023095-4dannjjm	871	25	a	a	DT
cord-023095-4dannjjm	871	26	history	history	NN
cord-023095-4dannjjm	871	27	of	of	IN
cord-023095-4dannjjm	871	28	recumbency	recumbency	NN
cord-023095-4dannjjm	871	29	or	or	CC
cord-023095-4dannjjm	871	30	horses	horse	NNS
cord-023095-4dannjjm	871	31	that	that	WDT
cord-023095-4dannjjm	871	32	became	become	VBD
cord-023095-4dannjjm	871	33	recumbent	recumbent	JJ
cord-023095-4dannjjm	871	34	while	while	IN
cord-023095-4dannjjm	871	35	hospitalized	hospitalize	VBN
cord-023095-4dannjjm	871	36	were	be	VBD
cord-023095-4dannjjm	871	37	evaluated	evaluate	VBN
cord-023095-4dannjjm	871	38	.	.	.
cord-023095-4dannjjm	872	1	A	a	DT
cord-023095-4dannjjm	872	2	horse	horse	NN
cord-023095-4dannjjm	872	3	was	be	VBD
cord-023095-4dannjjm	872	4	defined	define	VBN
cord-023095-4dannjjm	872	5	as	as	IN
cord-023095-4dannjjm	872	6	recumbent	recumbent	JJ
cord-023095-4dannjjm	872	7	if	if	IN
cord-023095-4dannjjm	872	8	it	-PRON-	PRP
cord-023095-4dannjjm	872	9	was	be	VBD
cord-023095-4dannjjm	872	10	unable	unable	JJ
cord-023095-4dannjjm	872	11	to	to	TO
cord-023095-4dannjjm	872	12	stand	stand	VB
cord-023095-4dannjjm	872	13	on	on	IN
cord-023095-4dannjjm	872	14	its	-PRON-	PRP$
cord-023095-4dannjjm	872	15	own	own	JJ
cord-023095-4dannjjm	872	16	.	.	.
cord-023095-4dannjjm	873	1	The	the	DT
cord-023095-4dannjjm	873	2	medical	medical	JJ
cord-023095-4dannjjm	873	3	record	record	NN
cord-023095-4dannjjm	873	4	was	be	VBD
cord-023095-4dannjjm	873	5	examined	examine	VBN
cord-023095-4dannjjm	873	6	for	for	IN
cord-023095-4dannjjm	873	7	the	the	DT
cord-023095-4dannjjm	873	8	following	follow	VBG
cord-023095-4dannjjm	873	9	criteria	criterion	NNS
cord-023095-4dannjjm	873	10	:	:	:
cord-023095-4dannjjm	873	11	history	history	NN
cord-023095-4dannjjm	873	12	pertaining	pertain	VBG
cord-023095-4dannjjm	873	13	to	to	IN
cord-023095-4dannjjm	873	14	the	the	DT
cord-023095-4dannjjm	873	15	current	current	JJ
cord-023095-4dannjjm	873	16	illness	illness	NN
cord-023095-4dannjjm	873	17	including	include	VBG
cord-023095-4dannjjm	873	18	treatment	treatment	NN
cord-023095-4dannjjm	873	19	by	by	IN
cord-023095-4dannjjm	873	20	the	the	DT
cord-023095-4dannjjm	873	21	rDVM	rdvm	NN
cord-023095-4dannjjm	873	22	,	,	,
cord-023095-4dannjjm	873	23	breed	breed	NN
cord-023095-4dannjjm	873	24	,	,	,
cord-023095-4dannjjm	873	25	age	age	NN
cord-023095-4dannjjm	873	26	,	,	,
cord-023095-4dannjjm	873	27	weight	weight	NN
cord-023095-4dannjjm	873	28	,	,	,
cord-023095-4dannjjm	873	29	date	date	NN
cord-023095-4dannjjm	873	30	of	of	IN
cord-023095-4dannjjm	873	31	presentation	presentation	NN
cord-023095-4dannjjm	873	32	,	,	,
cord-023095-4dannjjm	873	33	physical	physical	JJ
cord-023095-4dannjjm	873	34	and	and	CC
cord-023095-4dannjjm	873	35	neurological	neurological	JJ
cord-023095-4dannjjm	873	36	examination	examination	NN
cord-023095-4dannjjm	873	37	findings	finding	NNS
cord-023095-4dannjjm	873	38	,	,	,
cord-023095-4dannjjm	873	39	CBC	CBC	NNP
cord-023095-4dannjjm	873	40	and	and	CC
cord-023095-4dannjjm	873	41	biochemical	biochemical	JJ
cord-023095-4dannjjm	873	42	profile	profile	NN
cord-023095-4dannjjm	873	43	results	result	NNS
cord-023095-4dannjjm	873	44	,	,	,
cord-023095-4dannjjm	873	45	initial	initial	JJ
cord-023095-4dannjjm	873	46	drugs	drug	NNS
cord-023095-4dannjjm	873	47	administered	administer	VBN
cord-023095-4dannjjm	873	48	on	on	IN
cord-023095-4dannjjm	873	49	arrival	arrival	NN
cord-023095-4dannjjm	873	50	,	,	,
cord-023095-4dannjjm	873	51	time	time	NN
cord-023095-4dannjjm	873	52	spent	spend	VBD
cord-023095-4dannjjm	873	53	recumbent	recumbent	JJ
cord-023095-4dannjjm	873	54	,	,	,
cord-023095-4dannjjm	873	55	time	time	NN
cord-023095-4dannjjm	873	56	spent	spend	VBN
cord-023095-4dannjjm	873	57	in	in	IN
cord-023095-4dannjjm	873	58	a	a	DT
cord-023095-4dannjjm	873	59	sling	sling	NN
cord-023095-4dannjjm	873	60	,	,	,
cord-023095-4dannjjm	873	61	diagnosis	diagnosis	NN
cord-023095-4dannjjm	873	62	,	,	,
cord-023095-4dannjjm	873	63	and	and	CC
cord-023095-4dannjjm	873	64	hospitalization	hospitalization	NN
cord-023095-4dannjjm	873	65	costs	cost	NNS
cord-023095-4dannjjm	873	66	.	.	.
cord-023095-4dannjjm	874	1	Statistical	statistical	JJ
cord-023095-4dannjjm	874	2	analysis	analysis	NN
cord-023095-4dannjjm	874	3	correlating	correlate	VBG
cord-023095-4dannjjm	874	4	factors	factor	NNS
cord-023095-4dannjjm	874	5	associated	associate	VBN
cord-023095-4dannjjm	874	6	with	with	IN
cord-023095-4dannjjm	874	7	survival	survival	NN
cord-023095-4dannjjm	874	8	was	be	VBD
cord-023095-4dannjjm	874	9	performed	perform	VBN
cord-023095-4dannjjm	874	10	using	use	VBG
cord-023095-4dannjjm	874	11	logistic	logistic	JJ
cord-023095-4dannjjm	874	12	regression	regression	NN
cord-023095-4dannjjm	874	13	.	.	.
cord-023095-4dannjjm	875	1	Overall	overall	RB
cord-023095-4dannjjm	875	2	there	there	EX
cord-023095-4dannjjm	875	3	were	be	VBD
cord-023095-4dannjjm	875	4	112	112	CD
cord-023095-4dannjjm	875	5	non	non	JJ
cord-023095-4dannjjm	875	6	survivors	survivor	NNS
cord-023095-4dannjjm	875	7	and	and	CC
cord-023095-4dannjjm	875	8	49	49	CD
cord-023095-4dannjjm	875	9	survivors	survivor	NNS
cord-023095-4dannjjm	875	10	.	.	.
cord-023095-4dannjjm	876	1	Factors	factor	NNS
cord-023095-4dannjjm	876	2	that	that	WDT
cord-023095-4dannjjm	876	3	favored	favor	VBD
cord-023095-4dannjjm	876	4	survival	survival	NN
cord-023095-4dannjjm	876	5	included	include	VBD
cord-023095-4dannjjm	876	6	early	early	JJ
cord-023095-4dannjjm	876	7	initiation	initiation	NN
cord-023095-4dannjjm	876	8	of	of	IN
cord-023095-4dannjjm	876	9	treatment	treatment	NN
cord-023095-4dannjjm	876	10	in	in	IN
cord-023095-4dannjjm	876	11	the	the	DT
cord-023095-4dannjjm	876	12	field	field	NN
cord-023095-4dannjjm	876	13	by	by	IN
cord-023095-4dannjjm	876	14	the	the	DT
cord-023095-4dannjjm	876	15	rDVM	rdvm	NN
cord-023095-4dannjjm	876	16	,	,	,
cord-023095-4dannjjm	876	17	horses	horse	NNS
cord-023095-4dannjjm	876	18	that	that	WDT
cord-023095-4dannjjm	876	19	tolerated	tolerate	VBD
cord-023095-4dannjjm	876	20	a	a	DT
cord-023095-4dannjjm	876	21	sling	sling	NN
cord-023095-4dannjjm	876	22	and	and	CC
cord-023095-4dannjjm	876	23	spent	spend	VBD
cord-023095-4dannjjm	876	24	more	more	JJR
cord-023095-4dannjjm	876	25	time	time	NN
cord-023095-4dannjjm	876	26	in	in	IN
cord-023095-4dannjjm	876	27	a	a	DT
cord-023095-4dannjjm	876	28	sling	sling	NN
cord-023095-4dannjjm	876	29	,	,	,
cord-023095-4dannjjm	876	30	increased	increase	VBN
cord-023095-4dannjjm	876	31	duration	duration	NN
cord-023095-4dannjjm	876	32	and	and	CC
cord-023095-4dannjjm	876	33	costs	cost	NNS
cord-023095-4dannjjm	876	34	of	of	IN
cord-023095-4dannjjm	876	35	hospitalization	hospitalization	NN
cord-023095-4dannjjm	876	36	,	,	,
cord-023095-4dannjjm	876	37	horses	horse	NNS
cord-023095-4dannjjm	876	38	that	that	WDT
cord-023095-4dannjjm	876	39	were	be	VBD
cord-023095-4dannjjm	876	40	recumbent	recumbent	JJ
cord-023095-4dannjjm	876	41	post	post	NN
cord-023095-4dannjjm	876	42	anesthesia	anesthesia	NN
cord-023095-4dannjjm	876	43	,	,	,
cord-023095-4dannjjm	876	44	and	and	CC
cord-023095-4dannjjm	876	45	those	those	DT
cord-023095-4dannjjm	876	46	recumbent	recumbent	JJ
cord-023095-4dannjjm	876	47	due	due	IN
cord-023095-4dannjjm	876	48	to	to	IN
cord-023095-4dannjjm	876	49	disease	disease	NN
cord-023095-4dannjjm	876	50	of	of	IN
cord-023095-4dannjjm	876	51	the	the	DT
cord-023095-4dannjjm	876	52	musculoskeletal	musculoskeletal	JJ
cord-023095-4dannjjm	876	53	system	system	NN
cord-023095-4dannjjm	876	54	.	.	.
cord-023095-4dannjjm	877	1	Factors	factor	NNS
cord-023095-4dannjjm	877	2	that	that	WDT
cord-023095-4dannjjm	877	3	increased	increase	VBD
cord-023095-4dannjjm	877	4	likelihood	likelihood	NN
cord-023095-4dannjjm	877	5	of	of	IN
cord-023095-4dannjjm	877	6	non	non	JJ
cord-023095-4dannjjm	877	7	survival	survival	NN
cord-023095-4dannjjm	877	8	included	include	VBD
cord-023095-4dannjjm	877	9	horses	horse	NNS
cord-023095-4dannjjm	877	10	that	that	WDT
cord-023095-4dannjjm	877	11	were	be	VBD
cord-023095-4dannjjm	877	12	ataxic	ataxic	JJ
cord-023095-4dannjjm	877	13	on	on	IN
cord-023095-4dannjjm	877	14	presentation	presentation	NN
cord-023095-4dannjjm	877	15	,	,	,
cord-023095-4dannjjm	877	16	horses	horse	NNS
cord-023095-4dannjjm	877	17	with	with	IN
cord-023095-4dannjjm	877	18	increased	increase	VBN
cord-023095-4dannjjm	877	19	BUN	bun	NN
cord-023095-4dannjjm	877	20	,	,	,
cord-023095-4dannjjm	877	21	horses	horse	NNS
cord-023095-4dannjjm	877	22	that	that	WDT
cord-023095-4dannjjm	877	23	spent	spend	VBD
cord-023095-4dannjjm	877	24	more	more	JJR
cord-023095-4dannjjm	877	25	time	time	NN
cord-023095-4dannjjm	877	26	recumbent	recumbent	NN
cord-023095-4dannjjm	877	27	,	,	,
cord-023095-4dannjjm	877	28	those	those	DT
cord-023095-4dannjjm	877	29	that	that	WDT
cord-023095-4dannjjm	877	30	did	do	VBD
cord-023095-4dannjjm	877	31	not	not	RB
cord-023095-4dannjjm	877	32	tolerate	tolerate	VB
cord-023095-4dannjjm	877	33	a	a	DT
cord-023095-4dannjjm	877	34	sling	sling	NN
cord-023095-4dannjjm	877	35	,	,	,
cord-023095-4dannjjm	877	36	and	and	CC
cord-023095-4dannjjm	877	37	horses	horse	NNS
cord-023095-4dannjjm	877	38	diagnosed	diagnose	VBN
cord-023095-4dannjjm	877	39	with	with	IN
cord-023095-4dannjjm	877	40	botulism	botulism	NN
cord-023095-4dannjjm	877	41	and	and	CC
cord-023095-4dannjjm	877	42	spinal	spinal	JJ
cord-023095-4dannjjm	877	43	cord	cord	NN
cord-023095-4dannjjm	877	44	disease	disease	NN
cord-023095-4dannjjm	877	45	.	.	.
cord-023095-4dannjjm	878	1	In	in	IN
cord-023095-4dannjjm	878	2	conclusion	conclusion	NN
cord-023095-4dannjjm	878	3	,	,	,
cord-023095-4dannjjm	878	4	this	this	DT
cord-023095-4dannjjm	878	5	retrospective	retrospective	JJ
cord-023095-4dannjjm	878	6	study	study	NN
cord-023095-4dannjjm	878	7	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	878	8	that	that	IN
cord-023095-4dannjjm	878	9	both	both	CC
cord-023095-4dannjjm	878	10	the	the	DT
cord-023095-4dannjjm	878	11	cause	cause	NN
cord-023095-4dannjjm	878	12	of	of	IN
cord-023095-4dannjjm	878	13	recumbency	recumbency	NN
cord-023095-4dannjjm	878	14	and	and	CC
cord-023095-4dannjjm	878	15	the	the	DT
cord-023095-4dannjjm	878	16	ability	ability	NN
cord-023095-4dannjjm	878	17	of	of	IN
cord-023095-4dannjjm	878	18	horses	horse	NNS
cord-023095-4dannjjm	878	19	to	to	TO
cord-023095-4dannjjm	878	20	tolerate	tolerate	VB
cord-023095-4dannjjm	878	21	a	a	DT
cord-023095-4dannjjm	878	22	sling	sling	NN
cord-023095-4dannjjm	878	23	had	have	VBD
cord-023095-4dannjjm	878	24	a	a	DT
cord-023095-4dannjjm	878	25	direct	direct	JJ
cord-023095-4dannjjm	878	26	effect	effect	NN
cord-023095-4dannjjm	878	27	on	on	IN
cord-023095-4dannjjm	878	28	survival	survival	NN
cord-023095-4dannjjm	878	29	.	.	.
cord-023095-4dannjjm	879	1	ABSTRACT	ABSTRACT	NNP
cord-023095-4dannjjm	879	2	E-7	E-7	NNP
cord-023095-4dannjjm	880	1	PLASMA	plasma	NN
cord-023095-4dannjjm	880	2	PEAK	peak	NN
cord-023095-4dannjjm	880	3	AND	and	CC
cord-023095-4dannjjm	880	4	TROUGH	trough	NN
cord-023095-4dannjjm	880	5	GENTAMICIN	GENTAMICIN	NNP
cord-023095-4dannjjm	880	6	CONCENTRA	CONCENTRA	NNP
cord-023095-4dannjjm	880	7	-	-	HYPH
cord-023095-4dannjjm	880	8	TIONS	TIONS	NNP
cord-023095-4dannjjm	881	1	IN	in	IN
cord-023095-4dannjjm	881	2	HOSPITALIZED	hospitalized	JJ
cord-023095-4dannjjm	881	3	HORSES	horse	NNS
cord-023095-4dannjjm	881	4	RECEIVING	receive	VBG
cord-023095-4dannjjm	881	5	ONCE	once	RB
cord-023095-4dannjjm	881	6	DAILY	daily	JJ
cord-023095-4dannjjm	881	7	GENTAMICIN	gentamicin	NN
cord-023095-4dannjjm	881	8	.	.	.
cord-023095-4dannjjm	882	1	JR	JR	NNP
cord-023095-4dannjjm	882	2	Read	Read	NNP
cord-023095-4dannjjm	882	3	1	1	CD
cord-023095-4dannjjm	882	4	,	,	,
cord-023095-4dannjjm	882	5	PA	PA	NNP
cord-023095-4dannjjm	882	6	Wilkins	Wilkins	NNP
cord-023095-4dannjjm	882	7	2	2	CD
cord-023095-4dannjjm	882	8	,	,	,
cord-023095-4dannjjm	882	9	RD	RD	NNP
cord-023095-4dannjjm	882	10	Nolen	Nolen	NNP
cord-023095-4dannjjm	882	11	-	-	HYPH
cord-023095-4dannjjm	882	12	Walston	Walston	NNP
cord-023095-4dannjjm	882	13	1	1	CD
cord-023095-4dannjjm	882	14	.	.	.
cord-023095-4dannjjm	883	1	1	1	CD
cord-023095-4dannjjm	883	2	University	University	NNP
cord-023095-4dannjjm	883	3	of	of	IN
cord-023095-4dannjjm	883	4	Pennsylvania	Pennsylvania	NNP
cord-023095-4dannjjm	883	5	,	,	,
cord-023095-4dannjjm	883	6	New	New	NNP
cord-023095-4dannjjm	883	7	Bolton	Bolton	NNP
cord-023095-4dannjjm	883	8	Center	Center	NNP
cord-023095-4dannjjm	883	9	,	,	,
cord-023095-4dannjjm	883	10	Kennett	Kennett	NNP
cord-023095-4dannjjm	883	11	Square	Square	NNP
cord-023095-4dannjjm	883	12	,	,	,
cord-023095-4dannjjm	883	13	PA	PA	NNP
cord-023095-4dannjjm	883	14	.	.	.
cord-023095-4dannjjm	884	1	2	2	CD
cord-023095-4dannjjm	884	2	University	University	NNP
cord-023095-4dannjjm	884	3	of	of	IN
cord-023095-4dannjjm	884	4	Illinois	Illinois	NNP
cord-023095-4dannjjm	884	5	,	,	,
cord-023095-4dannjjm	884	6	Champaign	Champaign	NNP
cord-023095-4dannjjm	884	7	-	-	HYPH
cord-023095-4dannjjm	884	8	Urbana	Urbana	NNP
cord-023095-4dannjjm	884	9	,	,	,
cord-023095-4dannjjm	884	10	IL	IL	NNP
cord-023095-4dannjjm	884	11	.	.	.
cord-023095-4dannjjm	885	1	Gentamicin	Gentamicin	NNP
cord-023095-4dannjjm	885	2	is	be	VBZ
cord-023095-4dannjjm	885	3	often	often	RB
cord-023095-4dannjjm	885	4	used	use	VBN
cord-023095-4dannjjm	885	5	to	to	TO
cord-023095-4dannjjm	885	6	provide	provide	VB
cord-023095-4dannjjm	885	7	gram	gram	NN
cord-023095-4dannjjm	885	8	negative	negative	JJ
cord-023095-4dannjjm	885	9	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	885	10	coverage	coverage	NN
cord-023095-4dannjjm	885	11	in	in	IN
cord-023095-4dannjjm	885	12	horses	horse	NNS
cord-023095-4dannjjm	885	13	at	at	IN
cord-023095-4dannjjm	885	14	6.6	6.6	CD
cord-023095-4dannjjm	885	15	mg	mg	NNP
cord-023095-4dannjjm	885	16	/	/	SYM
cord-023095-4dannjjm	885	17	kg	kg	NNP
cord-023095-4dannjjm	885	18	IV	IV	NNP
cord-023095-4dannjjm	885	19	every	every	DT
cord-023095-4dannjjm	885	20	24	24	CD
cord-023095-4dannjjm	885	21	hours	hour	NNS
cord-023095-4dannjjm	885	22	.	.	.
cord-023095-4dannjjm	886	1	Therapeutic	therapeutic	JJ
cord-023095-4dannjjm	886	2	drug	drug	NN
cord-023095-4dannjjm	886	3	monitoring	monitoring	NN
cord-023095-4dannjjm	886	4	in	in	IN
cord-023095-4dannjjm	886	5	our	-PRON-	PRP$
cord-023095-4dannjjm	886	6	hospital	hospital	NN
cord-023095-4dannjjm	886	7	suggests	suggest	VBZ
cord-023095-4dannjjm	886	8	larger	large	JJR
cord-023095-4dannjjm	886	9	doses	dose	NNS
cord-023095-4dannjjm	886	10	are	be	VBP
cord-023095-4dannjjm	886	11	required	require	VBN
cord-023095-4dannjjm	886	12	in	in	IN
cord-023095-4dannjjm	886	13	many	many	JJ
cord-023095-4dannjjm	886	14	clinical	clinical	JJ
cord-023095-4dannjjm	886	15	cases	case	NNS
cord-023095-4dannjjm	886	16	to	to	TO
cord-023095-4dannjjm	886	17	achieve	achieve	VB
cord-023095-4dannjjm	886	18	the	the	DT
cord-023095-4dannjjm	886	19	desired	desire	VBN
cord-023095-4dannjjm	886	20	concentration	concentration	NN
cord-023095-4dannjjm	886	21	(	(	-LRB-
cord-023095-4dannjjm	886	22	8	8	CD
cord-023095-4dannjjm	886	23	-	-	SYM
cord-023095-4dannjjm	886	24	10Â	10â	CD
cord-023095-4dannjjm	886	25	minimum	minimum	JJ
cord-023095-4dannjjm	886	26	inhibitory	inhibitory	JJ
cord-023095-4dannjjm	886	27	concentration	concentration	NN
cord-023095-4dannjjm	886	28	)	)	-RRB-
cord-023095-4dannjjm	886	29	for	for	IN
cord-023095-4dannjjm	886	30	common	common	JJ
cord-023095-4dannjjm	886	31	bacterial	bacterial	JJ
cord-023095-4dannjjm	886	32	isolates	isolate	NNS
cord-023095-4dannjjm	886	33	(	(	-LRB-
cord-023095-4dannjjm	886	34	peak	peak	NN
cord-023095-4dannjjm	886	35	target	target	NN
cord-023095-4dannjjm	886	36	range	range	NNP
cord-023095-4dannjjm	886	37	32	32	CD
cord-023095-4dannjjm	886	38	-	-	SYM
cord-023095-4dannjjm	886	39	40	40	CD
cord-023095-4dannjjm	886	40	mg	mg	NNP
cord-023095-4dannjjm	886	41	/	/	SYM
cord-023095-4dannjjm	886	42	ml	ml	NNP
cord-023095-4dannjjm	886	43	)	)	-RRB-
cord-023095-4dannjjm	886	44	.	.	.
cord-023095-4dannjjm	887	1	The	the	DT
cord-023095-4dannjjm	887	2	aim	aim	NN
cord-023095-4dannjjm	887	3	of	of	IN
cord-023095-4dannjjm	887	4	this	this	DT
cord-023095-4dannjjm	887	5	study	study	NN
cord-023095-4dannjjm	887	6	was	be	VBD
cord-023095-4dannjjm	887	7	to	to	TO
cord-023095-4dannjjm	887	8	determine	determine	VB
cord-023095-4dannjjm	887	9	the	the	DT
cord-023095-4dannjjm	887	10	correlation	correlation	NN
cord-023095-4dannjjm	887	11	between	between	IN
cord-023095-4dannjjm	887	12	gentamicin	gentamicin	NN
cord-023095-4dannjjm	887	13	dose	dose	NN
cord-023095-4dannjjm	887	14	and	and	CC
cord-023095-4dannjjm	887	15	plasma	plasma	NN
cord-023095-4dannjjm	887	16	concentration	concentration	NN
cord-023095-4dannjjm	887	17	in	in	IN
cord-023095-4dannjjm	887	18	hospitalized	hospitalize	VBN
cord-023095-4dannjjm	887	19	horses	horse	NNS
cord-023095-4dannjjm	887	20	receiving	receive	VBG
cord-023095-4dannjjm	887	21	gentamicin	gentamicin	NN
cord-023095-4dannjjm	887	22	treatment	treatment	NN
cord-023095-4dannjjm	887	23	in	in	IN
cord-023095-4dannjjm	887	24	order	order	NN
cord-023095-4dannjjm	887	25	to	to	TO
cord-023095-4dannjjm	887	26	identify	identify	VB
cord-023095-4dannjjm	887	27	an	an	DT
cord-023095-4dannjjm	887	28	optimum	optimum	JJ
cord-023095-4dannjjm	887	29	dose	dose	NN
cord-023095-4dannjjm	887	30	range	range	NN
cord-023095-4dannjjm	887	31	for	for	IN
cord-023095-4dannjjm	887	32	this	this	DT
cord-023095-4dannjjm	887	33	population	population	NN
cord-023095-4dannjjm	887	34	.	.	.
cord-023095-4dannjjm	888	1	Review	Review	NNP
cord-023095-4dannjjm	888	2	of	of	IN
cord-023095-4dannjjm	888	3	records	record	NNS
cord-023095-4dannjjm	888	4	(	(	-LRB-
cord-023095-4dannjjm	888	5	2002	2002	CD
cord-023095-4dannjjm	888	6	)	)	-RRB-
cord-023095-4dannjjm	888	7	(	(	-LRB-
cord-023095-4dannjjm	888	8	2003	2003	CD
cord-023095-4dannjjm	888	9	)	)	-RRB-
cord-023095-4dannjjm	888	10	(	(	-LRB-
cord-023095-4dannjjm	888	11	2004	2004	CD
cord-023095-4dannjjm	888	12	)	)	-RRB-
cord-023095-4dannjjm	888	13	(	(	-LRB-
cord-023095-4dannjjm	888	14	2005	2005	CD
cord-023095-4dannjjm	888	15	)	)	-RRB-
cord-023095-4dannjjm	888	16	(	(	-LRB-
cord-023095-4dannjjm	888	17	2006	2006	CD
cord-023095-4dannjjm	888	18	)	)	-RRB-
cord-023095-4dannjjm	888	19	(	(	-LRB-
cord-023095-4dannjjm	888	20	2007	2007	CD
cord-023095-4dannjjm	888	21	)	)	-RRB-
cord-023095-4dannjjm	889	1	(	(	-LRB-
cord-023095-4dannjjm	889	2	2008	2008	CD
cord-023095-4dannjjm	889	3	)	)	-RRB-
cord-023095-4dannjjm	890	1	(	(	-LRB-
cord-023095-4dannjjm	890	2	2009	2009	CD
cord-023095-4dannjjm	890	3	)	)	-RRB-
cord-023095-4dannjjm	891	1	(	(	-LRB-
cord-023095-4dannjjm	891	2	2010	2010	CD
cord-023095-4dannjjm	891	3	)	)	-RRB-
cord-023095-4dannjjm	891	4	identified	identify	VBD
cord-023095-4dannjjm	891	5	71	71	CD
cord-023095-4dannjjm	891	6	horses	horse	NNS
cord-023095-4dannjjm	891	7	!	!	.
cord-023095-4dannjjm	892	1	3	3	CD
cord-023095-4dannjjm	892	2	months	month	NNS
cord-023095-4dannjjm	892	3	old	old	JJ
cord-023095-4dannjjm	892	4	receiving	receive	VBG
cord-023095-4dannjjm	892	5	once	once	RB
cord-023095-4dannjjm	892	6	-	-	HYPH
cord-023095-4dannjjm	892	7	daily	daily	NN
cord-023095-4dannjjm	892	8	gentamicin	gentamicin	NN
cord-023095-4dannjjm	892	9	with	with	IN
cord-023095-4dannjjm	893	1	peak	peak	NNP
cord-023095-4dannjjm	893	2	and	and	CC
cord-023095-4dannjjm	893	3	trough	trough	NN
cord-023095-4dannjjm	893	4	assays	assay	NNS
cord-023095-4dannjjm	893	5	performed	perform	VBD
cord-023095-4dannjjm	893	6	(	(	-LRB-
cord-023095-4dannjjm	893	7	N	n	CD
cord-023095-4dannjjm	893	8	5	5	CD
cord-023095-4dannjjm	893	9	107	107	CD
cord-023095-4dannjjm	893	10	sets	set	NNS
cord-023095-4dannjjm	893	11	)	)	-RRB-
cord-023095-4dannjjm	893	12	.	.	.
cord-023095-4dannjjm	894	1	Spearman	Spearman	NNP
cord-023095-4dannjjm	894	2	Rank	Rank	NNP
cord-023095-4dannjjm	894	3	Correlation	Correlation	NNP
cord-023095-4dannjjm	894	4	coefficient	coefficient	NN
cord-023095-4dannjjm	894	5	analysis	analysis	NN
cord-023095-4dannjjm	894	6	revealed	reveal	VBD
cord-023095-4dannjjm	894	7	a	a	DT
cord-023095-4dannjjm	894	8	weak	weak	JJ
cord-023095-4dannjjm	894	9	(	(	-LRB-
cord-023095-4dannjjm	894	10	R	r	NN
cord-023095-4dannjjm	894	11	5	5	CD
cord-023095-4dannjjm	894	12	0.289	0.289	CD
cord-023095-4dannjjm	894	13	)	)	-RRB-
cord-023095-4dannjjm	894	14	but	but	CC
cord-023095-4dannjjm	894	15	statistically	statistically	RB
cord-023095-4dannjjm	894	16	significant	significant	JJ
cord-023095-4dannjjm	894	17	correlation	correlation	NN
cord-023095-4dannjjm	894	18	(	(	-LRB-
cord-023095-4dannjjm	894	19	P	p	NN
cord-023095-4dannjjm	894	20	5	5	CD
cord-023095-4dannjjm	894	21	0.003	0.003	CD
cord-023095-4dannjjm	894	22	)	)	-RRB-
cord-023095-4dannjjm	894	23	between	between	IN
cord-023095-4dannjjm	894	24	gentamicin	gentamicin	NNS
cord-023095-4dannjjm	894	25	dose	dose	NN
cord-023095-4dannjjm	894	26	and	and	CC
cord-023095-4dannjjm	894	27	peak	peak	NN
cord-023095-4dannjjm	894	28	plasma	plasma	NN
cord-023095-4dannjjm	894	29	concentration	concentration	NN
cord-023095-4dannjjm	894	30	.	.	.
cord-023095-4dannjjm	895	1	Horses	horse	NNS
cord-023095-4dannjjm	895	2	receiving	receive	VBG
cord-023095-4dannjjm	895	3	7.7	7.7	CD
cord-023095-4dannjjm	895	4	-	-	SYM
cord-023095-4dannjjm	895	5	9.7	9.7	CD
cord-023095-4dannjjm	895	6	and	and	CC
cord-023095-4dannjjm	895	7	4	4	CD
cord-023095-4dannjjm	895	8	9.7	9.7	CD
cord-023095-4dannjjm	895	9	mg	mg	NN
cord-023095-4dannjjm	895	10	/	/	SYM
cord-023095-4dannjjm	895	11	kg	kg	NN
cord-023095-4dannjjm	895	12	gentamicin	gentamicin	NNP
cord-023095-4dannjjm	895	13	(	(	-LRB-
cord-023095-4dannjjm	895	14	Groups	group	NNS
cord-023095-4dannjjm	895	15	2	2	CD
cord-023095-4dannjjm	895	16	and	and	CC
cord-023095-4dannjjm	895	17	3	3	LS
cord-023095-4dannjjm	895	18	)	)	-RRB-
cord-023095-4dannjjm	895	19	had	have	VBD
cord-023095-4dannjjm	895	20	higher	high	JJR
cord-023095-4dannjjm	895	21	median	median	JJ
cord-023095-4dannjjm	895	22	peaks	peak	NNS
cord-023095-4dannjjm	895	23	(	(	-LRB-
cord-023095-4dannjjm	895	24	31	31	CD
cord-023095-4dannjjm	895	25	mg	mg	NNP
cord-023095-4dannjjm	895	26	/	/	SYM
cord-023095-4dannjjm	895	27	ml	ml	NNP
cord-023095-4dannjjm	895	28	)	)	-RRB-
cord-023095-4dannjjm	895	29	than	than	IN
cord-023095-4dannjjm	895	30	horses	horse	NNS
cord-023095-4dannjjm	895	31	receiving	receive	VBG
cord-023095-4dannjjm	895	32	5.6	5.6	CD
cord-023095-4dannjjm	895	33	-	-	SYM
cord-023095-4dannjjm	895	34	7.6	7.6	CD
cord-023095-4dannjjm	895	35	mg	mg	NNP
cord-023095-4dannjjm	895	36	/	/	SYM
cord-023095-4dannjjm	895	37	kg	kg	NNP
cord-023095-4dannjjm	895	38	(	(	-LRB-
cord-023095-4dannjjm	895	39	Group	Group	NNP
cord-023095-4dannjjm	895	40	1	1	CD
cord-023095-4dannjjm	895	41	;	;	:
cord-023095-4dannjjm	895	42	25.7	25.7	CD
cord-023095-4dannjjm	895	43	mg	mg	NNP
cord-023095-4dannjjm	895	44	/	/	SYM
cord-023095-4dannjjm	895	45	ml	ml	NNP
cord-023095-4dannjjm	895	46	)	)	-RRB-
cord-023095-4dannjjm	895	47	.	.	.
cord-023095-4dannjjm	896	1	Higher	high	JJR
cord-023095-4dannjjm	896	2	doses	dose	NNS
cord-023095-4dannjjm	896	3	were	be	VBD
cord-023095-4dannjjm	896	4	more	more	RBR
cord-023095-4dannjjm	896	5	likely	likely	JJ
cord-023095-4dannjjm	896	6	to	to	TO
cord-023095-4dannjjm	896	7	result	result	VB
cord-023095-4dannjjm	896	8	in	in	IN
cord-023095-4dannjjm	896	9	peaks	peak	NNS
cord-023095-4dannjjm	896	10	4	4	CD
cord-023095-4dannjjm	896	11	32	32	CD
cord-023095-4dannjjm	896	12	mg	mg	NNP
cord-023095-4dannjjm	896	13	/	/	SYM
cord-023095-4dannjjm	896	14	ml	ml	NN
cord-023095-4dannjjm	896	15	(	(	-LRB-
cord-023095-4dannjjm	896	16	42	42	CD
cord-023095-4dannjjm	896	17	and	and	CC
cord-023095-4dannjjm	896	18	41	41	CD
cord-023095-4dannjjm	896	19	%	%	NN
cord-023095-4dannjjm	896	20	,	,	,
cord-023095-4dannjjm	896	21	Groups	Groups	NNPS
cord-023095-4dannjjm	896	22	2	2	CD
cord-023095-4dannjjm	896	23	and	and	CC
cord-023095-4dannjjm	896	24	3	3	CD
cord-023095-4dannjjm	896	25	respectively	respectively	RB
cord-023095-4dannjjm	896	26	)	)	-RRB-
cord-023095-4dannjjm	896	27	than	than	IN
cord-023095-4dannjjm	896	28	horses	horse	NNS
cord-023095-4dannjjm	896	29	receiving	receive	VBG
cord-023095-4dannjjm	896	30	5.6	5.6	CD
cord-023095-4dannjjm	896	31	-	-	SYM
cord-023095-4dannjjm	896	32	7.6	7.6	CD
cord-023095-4dannjjm	896	33	mg	mg	NNP
cord-023095-4dannjjm	896	34	/	/	SYM
cord-023095-4dannjjm	896	35	kg	kg	NNP
cord-023095-4dannjjm	896	36	(	(	-LRB-
cord-023095-4dannjjm	896	37	Group	Group	NNP
cord-023095-4dannjjm	896	38	1	1	CD
cord-023095-4dannjjm	896	39	;	;	:
cord-023095-4dannjjm	896	40	16	16	CD
cord-023095-4dannjjm	896	41	%	%	NN
cord-023095-4dannjjm	896	42	)	)	-RRB-
cord-023095-4dannjjm	896	43	.	.	.
cord-023095-4dannjjm	897	1	All	all	DT
cord-023095-4dannjjm	897	2	22	22	CD
cord-023095-4dannjjm	897	3	hour	hour	NN
cord-023095-4dannjjm	897	4	post	post	NN
cord-023095-4dannjjm	897	5	-	-	JJ
cord-023095-4dannjjm	897	6	gentamicin	gentamicin	JJ
cord-023095-4dannjjm	897	7	administration	administration	NN
cord-023095-4dannjjm	897	8	trough	trough	NN
cord-023095-4dannjjm	897	9	values	value	NNS
cord-023095-4dannjjm	897	10	were	be	VBD
cord-023095-4dannjjm	897	11	o	o	XX
cord-023095-4dannjjm	898	1	2	2	CD
cord-023095-4dannjjm	898	2	mg	mg	NNP
cord-023095-4dannjjm	898	3	/	/	SYM
cord-023095-4dannjjm	898	4	ml	ml	NN
cord-023095-4dannjjm	898	5	.	.	.
cord-023095-4dannjjm	899	1	No	no	DT
cord-023095-4dannjjm	899	2	correlation	correlation	NN
cord-023095-4dannjjm	899	3	was	be	VBD
cord-023095-4dannjjm	899	4	found	find	VBN
cord-023095-4dannjjm	899	5	between	between	IN
cord-023095-4dannjjm	899	6	dose	dose	NN
cord-023095-4dannjjm	899	7	and	and	CC
cord-023095-4dannjjm	899	8	change	change	NN
cord-023095-4dannjjm	899	9	in	in	IN
cord-023095-4dannjjm	899	10	plasma	plasma	NN
cord-023095-4dannjjm	899	11	creatinine	creatinine	NN
cord-023095-4dannjjm	899	12	during	during	IN
cord-023095-4dannjjm	899	13	treatment	treatment	NN
cord-023095-4dannjjm	899	14	,	,	,
cord-023095-4dannjjm	899	15	nor	nor	CC
cord-023095-4dannjjm	899	16	dose	dose	NN
cord-023095-4dannjjm	899	17	and	and	CC
cord-023095-4dannjjm	899	18	trough	trough	NN
cord-023095-4dannjjm	899	19	level	level	NN
cord-023095-4dannjjm	899	20	.	.	.
cord-023095-4dannjjm	900	1	These	these	DT
cord-023095-4dannjjm	900	2	data	datum	NNS
cord-023095-4dannjjm	900	3	suggest	suggest	VBP
cord-023095-4dannjjm	900	4	that	that	IN
cord-023095-4dannjjm	900	5	gentamicin	gentamicin	NN
cord-023095-4dannjjm	900	6	dosage	dosage	NN
cord-023095-4dannjjm	900	7	in	in	IN
cord-023095-4dannjjm	900	8	horses	horse	NNS
cord-023095-4dannjjm	900	9	should	should	MD
cord-023095-4dannjjm	900	10	be	be	VB
cord-023095-4dannjjm	900	11	individually	individually	RB
cord-023095-4dannjjm	900	12	determined	determine	VBN
cord-023095-4dannjjm	900	13	by	by	IN
cord-023095-4dannjjm	900	14	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	900	15	monitoring	monitoring	NN
cord-023095-4dannjjm	900	16	.	.	.
cord-023095-4dannjjm	901	1	Additionally	additionally	RB
cord-023095-4dannjjm	901	2	,	,	,
cord-023095-4dannjjm	901	3	these	these	DT
cord-023095-4dannjjm	901	4	data	datum	NNS
cord-023095-4dannjjm	901	5	support	support	VBP
cord-023095-4dannjjm	901	6	an	an	DT
cord-023095-4dannjjm	901	7	initial	initial	JJ
cord-023095-4dannjjm	901	8	dose	dose	NN
cord-023095-4dannjjm	901	9	of	of	IN
cord-023095-4dannjjm	901	10	7.7	7.7	CD
cord-023095-4dannjjm	901	11	-	-	SYM
cord-023095-4dannjjm	901	12	9.7	9.7	CD
cord-023095-4dannjjm	901	13	mg	mg	NNP
cord-023095-4dannjjm	901	14	/	/	SYM
cord-023095-4dannjjm	901	15	kg	kg	NNP
cord-023095-4dannjjm	901	16	IV	IV	NNP
cord-023095-4dannjjm	901	17	every	every	DT
cord-023095-4dannjjm	901	18	24	24	CD
cord-023095-4dannjjm	901	19	hours	hour	NNS
cord-023095-4dannjjm	901	20	in	in	IN
cord-023095-4dannjjm	901	21	order	order	NN
cord-023095-4dannjjm	901	22	to	to	TO
cord-023095-4dannjjm	901	23	achieve	achieve	VB
cord-023095-4dannjjm	901	24	desired	desire	VBN
cord-023095-4dannjjm	901	25	peak	peak	NN
cord-023095-4dannjjm	901	26	concentration	concentration	NN
cord-023095-4dannjjm	901	27	and	and	CC
cord-023095-4dannjjm	901	28	an	an	DT
cord-023095-4dannjjm	901	29	appropriately	appropriately	RB
cord-023095-4dannjjm	901	30	low	low	JJ
cord-023095-4dannjjm	901	31	trough	trough	NN
cord-023095-4dannjjm	901	32	concentration	concentration	NN
cord-023095-4dannjjm	901	33	.	.	.
cord-023095-4dannjjm	902	1	Heaves	Heaves	NNP
cord-023095-4dannjjm	902	2	is	be	VBZ
cord-023095-4dannjjm	902	3	a	a	DT
cord-023095-4dannjjm	902	4	common	common	JJ
cord-023095-4dannjjm	902	5	respiratory	respiratory	JJ
cord-023095-4dannjjm	902	6	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	902	7	disease	disease	NN
cord-023095-4dannjjm	902	8	,	,	,
cord-023095-4dannjjm	902	9	characterized	characterize	VBN
cord-023095-4dannjjm	902	10	by	by	IN
cord-023095-4dannjjm	902	11	a	a	DT
cord-023095-4dannjjm	902	12	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	902	13	neutrophilia	neutrophilia	NN
cord-023095-4dannjjm	902	14	.	.	.
cord-023095-4dannjjm	903	1	This	this	DT
cord-023095-4dannjjm	903	2	disease	disease	NN
cord-023095-4dannjjm	903	3	is	be	VBZ
cord-023095-4dannjjm	903	4	also	also	RB
cord-023095-4dannjjm	903	5	characterized	characterize	VBN
cord-023095-4dannjjm	903	6	by	by	IN
cord-023095-4dannjjm	903	7	an	an	DT
cord-023095-4dannjjm	903	8	activation	activation	NN
cord-023095-4dannjjm	903	9	of	of	IN
cord-023095-4dannjjm	903	10	circulating	circulate	VBG
cord-023095-4dannjjm	903	11	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	903	12	after	after	IN
cord-023095-4dannjjm	903	13	antigen	antigen	NN
cord-023095-4dannjjm	903	14	challenge	challenge	NN
cord-023095-4dannjjm	903	15	but	but	CC
cord-023095-4dannjjm	903	16	their	-PRON-	PRP$
cord-023095-4dannjjm	903	17	specific	specific	JJ
cord-023095-4dannjjm	903	18	role	role	NN
cord-023095-4dannjjm	903	19	in	in	IN
cord-023095-4dannjjm	903	20	heaves	heaves	NN
cord-023095-4dannjjm	903	21	is	be	VBZ
cord-023095-4dannjjm	903	22	not	not	RB
cord-023095-4dannjjm	903	23	well	well	RB
cord-023095-4dannjjm	903	24	understood	understand	VBN
cord-023095-4dannjjm	903	25	.	.	.
cord-023095-4dannjjm	904	1	Also	also	RB
cord-023095-4dannjjm	904	2	,	,	,
cord-023095-4dannjjm	904	3	there	there	EX
cord-023095-4dannjjm	904	4	are	be	VBP
cord-023095-4dannjjm	904	5	anecdotal	anecdotal	JJ
cord-023095-4dannjjm	904	6	studies	study	NNS
cord-023095-4dannjjm	904	7	concerning	concern	VBG
cord-023095-4dannjjm	904	8	heaves	heave	NNS
cord-023095-4dannjjm	904	9	-	-	HYPH
cord-023095-4dannjjm	904	10	affected	affect	VBN
cord-023095-4dannjjm	904	11	horse	horse	NN
cord-023095-4dannjjm	904	12	to	to	TO
cord-023095-4dannjjm	904	13	be	be	VB
cord-023095-4dannjjm	904	14	more	more	RBR
cord-023095-4dannjjm	904	15	susceptible	susceptible	JJ
cord-023095-4dannjjm	904	16	to	to	IN
cord-023095-4dannjjm	904	17	infection	infection	NN
cord-023095-4dannjjm	904	18	.	.	.
cord-023095-4dannjjm	905	1	However	however	RB
cord-023095-4dannjjm	905	2	,	,	,
cord-023095-4dannjjm	905	3	to	to	IN
cord-023095-4dannjjm	905	4	our	-PRON-	PRP$
cord-023095-4dannjjm	905	5	knowledge	knowledge	NN
cord-023095-4dannjjm	905	6	,	,	,
cord-023095-4dannjjm	905	7	the	the	DT
cord-023095-4dannjjm	905	8	antibacterial	antibacterial	JJ
cord-023095-4dannjjm	905	9	host	host	NN
cord-023095-4dannjjm	905	10	defense	defense	NN
cord-023095-4dannjjm	905	11	role	role	NN
cord-023095-4dannjjm	905	12	mediated	mediate	VBN
cord-023095-4dannjjm	905	13	by	by	IN
cord-023095-4dannjjm	905	14	circulating	circulate	VBG
cord-023095-4dannjjm	905	15	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	905	16	was	be	VBD
cord-023095-4dannjjm	905	17	not	not	RB
cord-023095-4dannjjm	905	18	investigated	investigate	VBN
cord-023095-4dannjjm	905	19	in	in	IN
cord-023095-4dannjjm	905	20	heaves	heaves	NN
cord-023095-4dannjjm	905	21	-	-	HYPH
cord-023095-4dannjjm	905	22	affected	affect	VBN
cord-023095-4dannjjm	905	23	horses	horse	NNS
cord-023095-4dannjjm	905	24	.	.	.
cord-023095-4dannjjm	906	1	The	the	DT
cord-023095-4dannjjm	906	2	objective	objective	NN
cord-023095-4dannjjm	906	3	of	of	IN
cord-023095-4dannjjm	906	4	this	this	DT
cord-023095-4dannjjm	906	5	study	study	NN
cord-023095-4dannjjm	906	6	was	be	VBD
cord-023095-4dannjjm	906	7	to	to	TO
cord-023095-4dannjjm	906	8	compare	compare	VB
cord-023095-4dannjjm	906	9	phagocytosis	phagocytosis	NN
cord-023095-4dannjjm	906	10	activity	activity	NN
cord-023095-4dannjjm	906	11	and	and	CC
cord-023095-4dannjjm	906	12	bacterial	bacterial	JJ
cord-023095-4dannjjm	906	13	killing	killing	NN
cord-023095-4dannjjm	906	14	by	by	IN
cord-023095-4dannjjm	906	15	circulating	circulate	VBG
cord-023095-4dannjjm	906	16	blood	blood	NN
cord-023095-4dannjjm	906	17	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	906	18	of	of	IN
cord-023095-4dannjjm	906	19	heaves	heave	NNS
cord-023095-4dannjjm	906	20	-	-	HYPH
cord-023095-4dannjjm	906	21	affected	affect	VBN
cord-023095-4dannjjm	906	22	and	and	CC
cord-023095-4dannjjm	906	23	control	control	NN
cord-023095-4dannjjm	906	24	horses	horse	NNS
cord-023095-4dannjjm	906	25	.	.	.
cord-023095-4dannjjm	907	1	Peripheral	peripheral	JJ
cord-023095-4dannjjm	907	2	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	907	3	were	be	VBD
cord-023095-4dannjjm	907	4	isolated	isolate	VBN
cord-023095-4dannjjm	907	5	from	from	IN
cord-023095-4dannjjm	907	6	heaves	heave	NNS
cord-023095-4dannjjm	907	7	-	-	HYPH
cord-023095-4dannjjm	907	8	affected	affect	VBN
cord-023095-4dannjjm	907	9	(	(	-LRB-
cord-023095-4dannjjm	907	10	n	n	NN
cord-023095-4dannjjm	907	11	5	5	CD
cord-023095-4dannjjm	907	12	6	6	CD
cord-023095-4dannjjm	907	13	)	)	-RRB-
cord-023095-4dannjjm	907	14	and	and	CC
cord-023095-4dannjjm	907	15	control	control	NN
cord-023095-4dannjjm	907	16	(	(	-LRB-
cord-023095-4dannjjm	907	17	n	n	NN
cord-023095-4dannjjm	907	18	5	5	CD
cord-023095-4dannjjm	907	19	6	6	CD
cord-023095-4dannjjm	907	20	)	)	-RRB-
cord-023095-4dannjjm	907	21	horses	horse	NNS
cord-023095-4dannjjm	907	22	using	use	VBG
cord-023095-4dannjjm	907	23	a	a	DT
cord-023095-4dannjjm	907	24	density	density	NN
cord-023095-4dannjjm	907	25	gradient	gradient	NN
cord-023095-4dannjjm	907	26	technique	technique	NN
cord-023095-4dannjjm	907	27	.	.	.
cord-023095-4dannjjm	908	1	The	the	DT
cord-023095-4dannjjm	908	2	killing	killing	NN
cord-023095-4dannjjm	908	3	capacity	capacity	NN
cord-023095-4dannjjm	908	4	was	be	VBD
cord-023095-4dannjjm	908	5	assessed	assess	VBN
cord-023095-4dannjjm	908	6	by	by	IN
cord-023095-4dannjjm	908	7	incubating	incubate	VBG
cord-023095-4dannjjm	908	8	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	908	9	with	with	IN
cord-023095-4dannjjm	908	10	Streptococcus	streptococcus	NN
cord-023095-4dannjjm	908	11	equi	equi	NN
cord-023095-4dannjjm	908	12	spp	spp	NN
cord-023095-4dannjjm	908	13	equi	equi	NN
cord-023095-4dannjjm	908	14	and	and	CC
cord-023095-4dannjjm	908	15	spp	spp	NNP
cord-023095-4dannjjm	908	16	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	908	17	.	.	.
cord-023095-4dannjjm	909	1	After	after	IN
cord-023095-4dannjjm	909	2	1	1	CD
cord-023095-4dannjjm	909	3	h	h	NN
cord-023095-4dannjjm	909	4	of	of	IN
cord-023095-4dannjjm	909	5	bacterianeutrophil	bacterianeutrophil	NNP
cord-023095-4dannjjm	909	6	coculture	coculture	NNP
cord-023095-4dannjjm	909	7	,	,	,
cord-023095-4dannjjm	909	8	total	total	JJ
cord-023095-4dannjjm	909	9	viable	viable	JJ
cord-023095-4dannjjm	909	10	bacterial	bacterial	JJ
cord-023095-4dannjjm	909	11	cells	cell	NNS
cord-023095-4dannjjm	909	12	were	be	VBD
cord-023095-4dannjjm	909	13	measured	measure	VBN
cord-023095-4dannjjm	909	14	by	by	IN
cord-023095-4dannjjm	909	15	quantitative	quantitative	JJ
cord-023095-4dannjjm	909	16	plating	plating	NN
cord-023095-4dannjjm	909	17	.	.	.
cord-023095-4dannjjm	910	1	The	the	DT
cord-023095-4dannjjm	910	2	phagocytosis	phagocytosis	NN
cord-023095-4dannjjm	910	3	was	be	VBD
cord-023095-4dannjjm	910	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	910	5	by	by	IN
cord-023095-4dannjjm	910	6	flow	flow	NN
cord-023095-4dannjjm	910	7	cytometry	cytometry	NN
cord-023095-4dannjjm	910	8	using	use	VBG
cord-023095-4dannjjm	910	9	fluorescent	fluorescent	JJ
cord-023095-4dannjjm	910	10	beads	bead	NNS
cord-023095-4dannjjm	910	11	and	and	CC
cord-023095-4dannjjm	910	12	GFP	GFP	NNP
cord-023095-4dannjjm	910	13	-	-	HYPH
cord-023095-4dannjjm	910	14	transformed	transform	VBN
cord-023095-4dannjjm	910	15	Streptococcus	Streptococcus	NNP
cord-023095-4dannjjm	910	16	suis	suis	FW
cord-023095-4dannjjm	910	17	suilysin	suilysin	JJ
cord-023095-4dannjjm	910	18	-	-	HYPH
cord-023095-4dannjjm	910	19	negative	negative	JJ
cord-023095-4dannjjm	910	20	mutant	mutant	JJ
cord-023095-4dannjjm	910	21	strain	strain	NN
cord-023095-4dannjjm	910	22	.	.	.
cord-023095-4dannjjm	911	1	Circulating	circulate	VBG
cord-023095-4dannjjm	911	2	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	911	3	from	from	IN
cord-023095-4dannjjm	911	4	heaves	heave	NNS
cord-023095-4dannjjm	911	5	-	-	HYPH
cord-023095-4dannjjm	911	6	affected	affect	VBN
cord-023095-4dannjjm	911	7	horses	horse	NNS
cord-023095-4dannjjm	911	8	showed	show	VBD
cord-023095-4dannjjm	911	9	a	a	DT
cord-023095-4dannjjm	911	10	significant	significant	JJ
cord-023095-4dannjjm	911	11	decrease	decrease	NN
cord-023095-4dannjjm	911	12	in	in	IN
cord-023095-4dannjjm	911	13	their	-PRON-	PRP$
cord-023095-4dannjjm	911	14	killing	killing	NN
cord-023095-4dannjjm	911	15	capacity	capacity	NN
cord-023095-4dannjjm	911	16	toward	toward	IN
cord-023095-4dannjjm	911	17	S.	S.	NNP
cord-023095-4dannjjm	911	18	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	911	19	(	(	-LRB-
cord-023095-4dannjjm	911	20	p	p	NN
cord-023095-4dannjjm	911	21	5	5	CD
cord-023095-4dannjjm	911	22	0.046	0.046	CD
cord-023095-4dannjjm	911	23	)	)	-RRB-
cord-023095-4dannjjm	911	24	.	.	.
cord-023095-4dannjjm	912	1	A	a	DT
cord-023095-4dannjjm	912	2	reduced	reduce	VBN
cord-023095-4dannjjm	912	3	,	,	,
cord-023095-4dannjjm	912	4	although	although	IN
cord-023095-4dannjjm	912	5	not	not	RB
cord-023095-4dannjjm	912	6	significant	significant	JJ
cord-023095-4dannjjm	912	7	(	(	-LRB-
cord-023095-4dannjjm	912	8	p	p	NN
cord-023095-4dannjjm	912	9	5	5	CD
cord-023095-4dannjjm	912	10	0.1	0.1	CD
cord-023095-4dannjjm	912	11	)	)	-RRB-
cord-023095-4dannjjm	912	12	,	,	,
cord-023095-4dannjjm	912	13	killing	kill	VBG
cord-023095-4dannjjm	912	14	capacity	capacity	NN
cord-023095-4dannjjm	912	15	of	of	IN
cord-023095-4dannjjm	912	16	S.	S.	NNP
cord-023095-4dannjjm	912	17	equi	equi	NN
cord-023095-4dannjjm	912	18	by	by	IN
cord-023095-4dannjjm	912	19	these	these	DT
cord-023095-4dannjjm	912	20	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	912	21	was	be	VBD
cord-023095-4dannjjm	912	22	also	also	RB
cord-023095-4dannjjm	912	23	observed	observe	VBN
cord-023095-4dannjjm	912	24	.	.	.
cord-023095-4dannjjm	913	1	The	the	DT
cord-023095-4dannjjm	913	2	phagocytosis	phagocytosis	NN
cord-023095-4dannjjm	913	3	activity	activity	NN
cord-023095-4dannjjm	913	4	was	be	VBD
cord-023095-4dannjjm	913	5	not	not	RB
cord-023095-4dannjjm	913	6	different	different	JJ
cord-023095-4dannjjm	913	7	between	between	IN
cord-023095-4dannjjm	913	8	groups	group	NNS
cord-023095-4dannjjm	913	9	.	.	.
cord-023095-4dannjjm	914	1	This	this	DT
cord-023095-4dannjjm	914	2	impairment	impairment	NN
cord-023095-4dannjjm	914	3	of	of	IN
cord-023095-4dannjjm	914	4	blood	blood	NN
cord-023095-4dannjjm	914	5	neutrophil	neutrophil	NN
cord-023095-4dannjjm	914	6	bactericidal	bactericidal	JJ
cord-023095-4dannjjm	914	7	activity	activity	NN
cord-023095-4dannjjm	914	8	in	in	IN
cord-023095-4dannjjm	914	9	heaves	heaves	NN
cord-023095-4dannjjm	914	10	-	-	HYPH
cord-023095-4dannjjm	914	11	affected	affect	VBN
cord-023095-4dannjjm	914	12	horses	horse	NNS
cord-023095-4dannjjm	914	13	could	could	MD
cord-023095-4dannjjm	914	14	contribute	contribute	VB
cord-023095-4dannjjm	914	15	to	to	IN
cord-023095-4dannjjm	914	16	an	an	DT
cord-023095-4dannjjm	914	17	increase	increase	NN
cord-023095-4dannjjm	914	18	susceptibility	susceptibility	NN
cord-023095-4dannjjm	914	19	to	to	IN
cord-023095-4dannjjm	914	20	infection	infection	NN
cord-023095-4dannjjm	914	21	.	.	.
cord-023095-4dannjjm	915	1	Obesity	obesity	NN
cord-023095-4dannjjm	915	2	is	be	VBZ
cord-023095-4dannjjm	915	3	a	a	DT
cord-023095-4dannjjm	915	4	common	common	JJ
cord-023095-4dannjjm	915	5	disorder	disorder	NN
cord-023095-4dannjjm	915	6	of	of	IN
cord-023095-4dannjjm	915	7	the	the	DT
cord-023095-4dannjjm	915	8	horse	horse	NN
cord-023095-4dannjjm	915	9	,	,	,
cord-023095-4dannjjm	915	10	with	with	IN
cord-023095-4dannjjm	915	11	current	current	JJ
cord-023095-4dannjjm	915	12	prevalence	prevalence	NN
cord-023095-4dannjjm	915	13	estimated	estimate	VBN
cord-023095-4dannjjm	915	14	at	at	IN
cord-023095-4dannjjm	915	15	30	30	CD
cord-023095-4dannjjm	915	16	%	%	NN
cord-023095-4dannjjm	915	17	.	.	.
cord-023095-4dannjjm	916	1	In	in	IN
cord-023095-4dannjjm	916	2	people	people	NNS
cord-023095-4dannjjm	916	3	,	,	,
cord-023095-4dannjjm	916	4	obesity	obesity	NN
cord-023095-4dannjjm	916	5	is	be	VBZ
cord-023095-4dannjjm	916	6	associated	associate	VBN
cord-023095-4dannjjm	916	7	with	with	IN
cord-023095-4dannjjm	916	8	dyslipidemia	dyslipidemia	NN
cord-023095-4dannjjm	916	9	,	,	,
cord-023095-4dannjjm	916	10	insulin	insulin	NN
cord-023095-4dannjjm	916	11	resistance	resistance	NN
cord-023095-4dannjjm	916	12	,	,	,
cord-023095-4dannjjm	916	13	mitochondrial	mitochondrial	JJ
cord-023095-4dannjjm	916	14	dysfunction	dysfunction	NN
cord-023095-4dannjjm	916	15	and	and	CC
cord-023095-4dannjjm	916	16	downregulation	downregulation	NN
cord-023095-4dannjjm	916	17	of	of	IN
cord-023095-4dannjjm	916	18	lipid	lipid	NN
cord-023095-4dannjjm	916	19	and	and	CC
cord-023095-4dannjjm	916	20	glucose	glucose	NN
cord-023095-4dannjjm	916	21	metabolic	metabolic	JJ
cord-023095-4dannjjm	916	22	pathways	pathway	NNS
cord-023095-4dannjjm	916	23	.	.	.
cord-023095-4dannjjm	917	1	In	in	IN
cord-023095-4dannjjm	917	2	the	the	DT
cord-023095-4dannjjm	917	3	horse	horse	NN
cord-023095-4dannjjm	917	4	,	,	,
cord-023095-4dannjjm	917	5	obesity	obesity	NN
cord-023095-4dannjjm	917	6	is	be	VBZ
cord-023095-4dannjjm	917	7	similarly	similarly	RB
cord-023095-4dannjjm	917	8	associated	associate	VBN
cord-023095-4dannjjm	917	9	with	with	IN
cord-023095-4dannjjm	917	10	insulin	insulin	NN
cord-023095-4dannjjm	917	11	resistance	resistance	NN
cord-023095-4dannjjm	917	12	and	and	CC
cord-023095-4dannjjm	917	13	alterations	alteration	NNS
cord-023095-4dannjjm	917	14	in	in	IN
cord-023095-4dannjjm	917	15	lipid	lipid	NN
cord-023095-4dannjjm	917	16	profiles	profile	NNS
cord-023095-4dannjjm	917	17	;	;	:
cord-023095-4dannjjm	917	18	however	however	RB
cord-023095-4dannjjm	917	19	,	,	,
cord-023095-4dannjjm	917	20	metabolic	metabolic	JJ
cord-023095-4dannjjm	917	21	regulatory	regulatory	JJ
cord-023095-4dannjjm	917	22	gene	gene	NN
cord-023095-4dannjjm	917	23	expression	expression	NN
cord-023095-4dannjjm	917	24	profiles	profile	NNS
cord-023095-4dannjjm	917	25	have	have	VBP
cord-023095-4dannjjm	917	26	not	not	RB
cord-023095-4dannjjm	917	27	been	be	VBN
cord-023095-4dannjjm	917	28	fully	fully	RB
cord-023095-4dannjjm	917	29	characterized	characterize	VBN
cord-023095-4dannjjm	917	30	.	.	.
cord-023095-4dannjjm	918	1	We	-PRON-	PRP
cord-023095-4dannjjm	918	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	918	3	that	that	IN
cord-023095-4dannjjm	918	4	obese	obese	JJ
cord-023095-4dannjjm	918	5	horses	horse	NNS
cord-023095-4dannjjm	918	6	have	have	VBP
cord-023095-4dannjjm	918	7	decreased	decrease	VBN
cord-023095-4dannjjm	918	8	expression	expression	NN
cord-023095-4dannjjm	918	9	of	of	IN
cord-023095-4dannjjm	918	10	metabolic	metabolic	JJ
cord-023095-4dannjjm	918	11	regulatory	regulatory	JJ
cord-023095-4dannjjm	918	12	genes	gene	NNS
cord-023095-4dannjjm	918	13	and	and	CC
cord-023095-4dannjjm	918	14	decreased	decrease	VBD
cord-023095-4dannjjm	918	15	mitochondrial	mitochondrial	JJ
cord-023095-4dannjjm	918	16	content	content	NN
cord-023095-4dannjjm	918	17	in	in	IN
cord-023095-4dannjjm	918	18	skeletal	skeletal	JJ
cord-023095-4dannjjm	918	19	muscle	muscle	NN
cord-023095-4dannjjm	918	20	compared	compare	VBN
cord-023095-4dannjjm	918	21	with	with	IN
cord-023095-4dannjjm	918	22	non	non	JJ
cord-023095-4dannjjm	918	23	-	-	JJ
cord-023095-4dannjjm	918	24	obese	obese	JJ
cord-023095-4dannjjm	918	25	horses	horse	NNS
cord-023095-4dannjjm	918	26	.	.	.
cord-023095-4dannjjm	919	1	Sixteen	sixteen	CD
cord-023095-4dannjjm	919	2	light	light	JJ
cord-023095-4dannjjm	919	3	breed	breed	NN
cord-023095-4dannjjm	919	4	horses	horse	NNS
cord-023095-4dannjjm	919	5	,	,	,
cord-023095-4dannjjm	919	6	2	2	CD
cord-023095-4dannjjm	919	7	-	-	SYM
cord-023095-4dannjjm	919	8	27	27	CD
cord-023095-4dannjjm	919	9	years	year	NNS
cord-023095-4dannjjm	919	10	of	of	IN
cord-023095-4dannjjm	919	11	age	age	NN
cord-023095-4dannjjm	919	12	were	be	VBD
cord-023095-4dannjjm	919	13	included	include	VBN
cord-023095-4dannjjm	919	14	.	.	.
cord-023095-4dannjjm	920	1	Body	body	NN
cord-023095-4dannjjm	920	2	condition	condition	NN
cord-023095-4dannjjm	920	3	score	score	NN
cord-023095-4dannjjm	920	4	(	(	-LRB-
cord-023095-4dannjjm	920	5	n	n	NN
cord-023095-4dannjjm	920	6	5	5	CD
cord-023095-4dannjjm	920	7	16	16	CD
cord-023095-4dannjjm	920	8	)	)	-RRB-
cord-023095-4dannjjm	920	9	and	and	CC
cord-023095-4dannjjm	920	10	neck	neck	NN
cord-023095-4dannjjm	920	11	circumference	circumference	NN
cord-023095-4dannjjm	920	12	(	(	-LRB-
cord-023095-4dannjjm	920	13	n	n	NN
cord-023095-4dannjjm	920	14	5	5	CD
cord-023095-4dannjjm	920	15	9	9	CD
cord-023095-4dannjjm	920	16	)	)	-RRB-
cord-023095-4dannjjm	920	17	were	be	VBD
cord-023095-4dannjjm	920	18	recorded	record	VBN
cord-023095-4dannjjm	920	19	.	.	.
cord-023095-4dannjjm	921	1	Post	post	JJ
cord-023095-4dannjjm	921	2	-	-	JJ
cord-023095-4dannjjm	921	3	mortem	mortem	JJ
cord-023095-4dannjjm	921	4	biopsy	biopsy	NN
cord-023095-4dannjjm	921	5	samples	sample	NNS
cord-023095-4dannjjm	921	6	of	of	IN
cord-023095-4dannjjm	921	7	the	the	DT
cord-023095-4dannjjm	921	8	semi	semi	JJ
cord-023095-4dannjjm	921	9	-	-	JJ
cord-023095-4dannjjm	921	10	membranosus	membranosus	JJ
cord-023095-4dannjjm	921	11	muscle	muscle	NN
cord-023095-4dannjjm	921	12	were	be	VBD
cord-023095-4dannjjm	921	13	obtained	obtain	VBN
cord-023095-4dannjjm	921	14	.	.	.
cord-023095-4dannjjm	922	1	DNA	DNA	NNP
cord-023095-4dannjjm	922	2	and	and	CC
cord-023095-4dannjjm	922	3	RNA	RNA	NNP
cord-023095-4dannjjm	922	4	were	be	VBD
cord-023095-4dannjjm	922	5	isolated	isolate	VBN
cord-023095-4dannjjm	922	6	.	.	.
cord-023095-4dannjjm	923	1	Relative	relative	JJ
cord-023095-4dannjjm	923	2	expression	expression	NN
cord-023095-4dannjjm	923	3	of	of	IN
cord-023095-4dannjjm	923	4	the	the	DT
cord-023095-4dannjjm	923	5	metabolic	metabolic	JJ
cord-023095-4dannjjm	923	6	genes	gene	NNS
cord-023095-4dannjjm	923	7	,	,	,
cord-023095-4dannjjm	923	8	peroxisome	peroxisome	NN
cord-023095-4dannjjm	923	9	proliferator	proliferator	NN
cord-023095-4dannjjm	923	10	activated	activate	VBD
cord-023095-4dannjjm	923	11	receptor	receptor	NN
cord-023095-4dannjjm	923	12	g	g	NN
cord-023095-4dannjjm	923	13	(	(	-LRB-
cord-023095-4dannjjm	923	14	PPARg	PPARg	NNP
cord-023095-4dannjjm	923	15	)	)	-RRB-
cord-023095-4dannjjm	923	16	,	,	,
cord-023095-4dannjjm	923	17	PPARg	PPARg	NNS
cord-023095-4dannjjm	923	18	coactivator-1a	coactivator-1a	NNP
cord-023095-4dannjjm	923	19	(	(	-LRB-
cord-023095-4dannjjm	923	20	PGC-1a	PGC-1a	NNP
cord-023095-4dannjjm	923	21	)	)	-RRB-
cord-023095-4dannjjm	923	22	,	,	,
cord-023095-4dannjjm	923	23	fatty	fatty	JJ
cord-023095-4dannjjm	923	24	acid	acid	NN
cord-023095-4dannjjm	923	25	translocase	translocase	NN
cord-023095-4dannjjm	923	26	(	(	-LRB-
cord-023095-4dannjjm	923	27	FAT	fat	NN
cord-023095-4dannjjm	923	28	)	)	-RRB-
cord-023095-4dannjjm	923	29	and	and	CC
cord-023095-4dannjjm	923	30	estrogen	estrogen	NN
cord-023095-4dannjjm	923	31	related	relate	VBN
cord-023095-4dannjjm	923	32	receptor	receptor	NN
cord-023095-4dannjjm	923	33	a	a	NN
cord-023095-4dannjjm	923	34	(	(	-LRB-
cord-023095-4dannjjm	923	35	ERRa	ERRa	NNS
cord-023095-4dannjjm	923	36	)	)	-RRB-
cord-023095-4dannjjm	923	37	was	be	VBD
cord-023095-4dannjjm	923	38	determined	determine	VBN
cord-023095-4dannjjm	923	39	by	by	IN
cord-023095-4dannjjm	923	40	quantitative	quantitative	JJ
cord-023095-4dannjjm	923	41	polymerase	polymerase	NN
cord-023095-4dannjjm	923	42	chain	chain	NN
cord-023095-4dannjjm	923	43	reaction	reaction	NN
cord-023095-4dannjjm	923	44	(	(	-LRB-
cord-023095-4dannjjm	923	45	qPCR	qPCR	NNP
cord-023095-4dannjjm	923	46	)	)	-RRB-
cord-023095-4dannjjm	923	47	.	.	.
cord-023095-4dannjjm	924	1	Mitochondrial	mitochondrial	JJ
cord-023095-4dannjjm	924	2	content	content	NN
cord-023095-4dannjjm	924	3	was	be	VBD
cord-023095-4dannjjm	924	4	assessed	assess	VBN
cord-023095-4dannjjm	924	5	by	by	IN
cord-023095-4dannjjm	924	6	determining	determine	VBG
cord-023095-4dannjjm	924	7	mitochondrial	mitochondrial	JJ
cord-023095-4dannjjm	924	8	DNA	dna	NN
cord-023095-4dannjjm	924	9	/	/	SYM
cord-023095-4dannjjm	924	10	nuclear	nuclear	JJ
cord-023095-4dannjjm	924	11	DNA	dna	NN
cord-023095-4dannjjm	924	12	ratio	ratio	NN
cord-023095-4dannjjm	924	13	by	by	IN
cord-023095-4dannjjm	924	14	qPCR	qPCR	NNP
cord-023095-4dannjjm	924	15	,	,	,
cord-023095-4dannjjm	924	16	using	use	VBG
cord-023095-4dannjjm	924	17	NADH	NADH	NNP
cord-023095-4dannjjm	924	18	-	-	HYPH
cord-023095-4dannjjm	924	19	dehydrogenase	dehydrogenase	NN
cord-023095-4dannjjm	924	20	subunit	subunit	NN
cord-023095-4dannjjm	924	21	2	2	CD
cord-023095-4dannjjm	924	22	and	and	CC
cord-023095-4dannjjm	924	23	cytochrome	cytochrome	NN
cord-023095-4dannjjm	924	24	oxidase	oxidase	NN
cord-023095-4dannjjm	924	25	subunit	subunit	NN
cord-023095-4dannjjm	924	26	2	2	CD
cord-023095-4dannjjm	924	27	as	as	IN
cord-023095-4dannjjm	924	28	mitochondrial	mitochondrial	JJ
cord-023095-4dannjjm	924	29	genes	gene	NNS
cord-023095-4dannjjm	924	30	and	and	CC
cord-023095-4dannjjm	924	31	beta	beta	NN
cord-023095-4dannjjm	924	32	actin	actin	NN
cord-023095-4dannjjm	924	33	as	as	IN
cord-023095-4dannjjm	924	34	the	the	DT
cord-023095-4dannjjm	924	35	nuclear	nuclear	JJ
cord-023095-4dannjjm	924	36	reference	reference	NN
cord-023095-4dannjjm	924	37	gene	gene	NN
cord-023095-4dannjjm	924	38	.	.	.
cord-023095-4dannjjm	925	1	Non	non	JJ
cord-023095-4dannjjm	925	2	-	-	JJ
cord-023095-4dannjjm	925	3	normal	normal	JJ
cord-023095-4dannjjm	925	4	data	datum	NNS
cord-023095-4dannjjm	925	5	was	be	VBD
cord-023095-4dannjjm	925	6	log	log	NN
cord-023095-4dannjjm	925	7	transformed	transform	VBN
cord-023095-4dannjjm	925	8	for	for	IN
cord-023095-4dannjjm	925	9	analysis	analysis	NN
cord-023095-4dannjjm	925	10	and	and	CC
cord-023095-4dannjjm	925	11	a	a	DT
cord-023095-4dannjjm	925	12	Pearson	Pearson	NNP
cord-023095-4dannjjm	925	13	coefficient	coefficient	NN
cord-023095-4dannjjm	925	14	of	of	IN
cord-023095-4dannjjm	925	15	correlation	correlation	NN
cord-023095-4dannjjm	925	16	was	be	VBD
cord-023095-4dannjjm	925	17	calculated	calculate	VBN
cord-023095-4dannjjm	925	18	for	for	IN
cord-023095-4dannjjm	925	19	relative	relative	JJ
cord-023095-4dannjjm	925	20	gene	gene	NN
cord-023095-4dannjjm	925	21	expression	expression	NN
cord-023095-4dannjjm	925	22	,	,	,
cord-023095-4dannjjm	925	23	body	body	NN
cord-023095-4dannjjm	925	24	condition	condition	NN
cord-023095-4dannjjm	925	25	score	score	NN
cord-023095-4dannjjm	925	26	and	and	CC
cord-023095-4dannjjm	925	27	neck	neck	NN
cord-023095-4dannjjm	925	28	circumference	circumference	NN
cord-023095-4dannjjm	925	29	.	.	.
cord-023095-4dannjjm	926	1	A	a	DT
cord-023095-4dannjjm	926	2	value	value	NN
cord-023095-4dannjjm	926	3	of	of	IN
cord-023095-4dannjjm	926	4	p	p	NN
cord-023095-4dannjjm	926	5	o	o	NN
cord-023095-4dannjjm	926	6	0.05	0.05	CD
cord-023095-4dannjjm	926	7	was	be	VBD
cord-023095-4dannjjm	926	8	considered	consider	VBN
cord-023095-4dannjjm	926	9	significant	significant	JJ
cord-023095-4dannjjm	926	10	.	.	.
cord-023095-4dannjjm	927	1	Body	body	NN
cord-023095-4dannjjm	927	2	condition	condition	NN
cord-023095-4dannjjm	927	3	score	score	NN
cord-023095-4dannjjm	927	4	was	be	VBD
cord-023095-4dannjjm	927	5	strongly	strongly	RB
cord-023095-4dannjjm	927	6	correlated	correlate	VBN
cord-023095-4dannjjm	927	7	with	with	IN
cord-023095-4dannjjm	927	8	neck	neck	NN
cord-023095-4dannjjm	927	9	circumference	circumference	NN
cord-023095-4dannjjm	928	1	(	(	-LRB-
cord-023095-4dannjjm	928	2	n	n	NN
cord-023095-4dannjjm	928	3	5	5	CD
cord-023095-4dannjjm	928	4	9	9	CD
cord-023095-4dannjjm	928	5	,	,	,
cord-023095-4dannjjm	929	1	r	r	LS
cord-023095-4dannjjm	929	2	5	5	CD
cord-023095-4dannjjm	929	3	0.72	0.72	CD
cord-023095-4dannjjm	929	4	,	,	,
cord-023095-4dannjjm	929	5	p	p	NN
cord-023095-4dannjjm	929	6	5	5	CD
cord-023095-4dannjjm	929	7	0.03	0.03	CD
cord-023095-4dannjjm	929	8	)	)	-RRB-
cord-023095-4dannjjm	929	9	.	.	.
cord-023095-4dannjjm	930	1	Relative	relative	JJ
cord-023095-4dannjjm	930	2	expression	expression	NN
cord-023095-4dannjjm	930	3	of	of	IN
cord-023095-4dannjjm	930	4	ERRa	ERRa	NNS
cord-023095-4dannjjm	930	5	and	and	CC
cord-023095-4dannjjm	930	6	GLUT-4	GLUT-4	NNP
cord-023095-4dannjjm	930	7	increased	increase	VBD
cord-023095-4dannjjm	930	8	with	with	IN
cord-023095-4dannjjm	930	9	body	body	NN
cord-023095-4dannjjm	930	10	condition	condition	NN
cord-023095-4dannjjm	930	11	score	score	NN
cord-023095-4dannjjm	930	12	(	(	-LRB-
cord-023095-4dannjjm	930	13	ERRa	ERRa	NNS
cord-023095-4dannjjm	930	14	:	:	:
cord-023095-4dannjjm	930	15	n	n	NN
cord-023095-4dannjjm	930	16	5	5	CD
cord-023095-4dannjjm	930	17	16	16	CD
cord-023095-4dannjjm	930	18	,	,	,
cord-023095-4dannjjm	930	19	r	r	NN
cord-023095-4dannjjm	930	20	5	5	CD
cord-023095-4dannjjm	930	21	0.66	0.66	CD
cord-023095-4dannjjm	930	22	,	,	,
cord-023095-4dannjjm	930	23	p	p	NN
cord-023095-4dannjjm	930	24	5	5	CD
cord-023095-4dannjjm	930	25	0.005	0.005	CD
cord-023095-4dannjjm	930	26	;	;	:
cord-023095-4dannjjm	931	1	GLUT-4	glut-4	NN
cord-023095-4dannjjm	931	2	:	:	:
cord-023095-4dannjjm	932	1	n	n	NN
cord-023095-4dannjjm	932	2	5	5	CD
cord-023095-4dannjjm	932	3	16	16	CD
cord-023095-4dannjjm	932	4	,	,	,
cord-023095-4dannjjm	932	5	r	r	NN
cord-023095-4dannjjm	932	6	5	5	CD
cord-023095-4dannjjm	932	7	0.50	0.50	CD
cord-023095-4dannjjm	932	8	,	,	,
cord-023095-4dannjjm	932	9	p	p	NN
cord-023095-4dannjjm	932	10	5	5	CD
cord-023095-4dannjjm	932	11	0.05	0.05	CD
cord-023095-4dannjjm	932	12	)	)	-RRB-
cord-023095-4dannjjm	932	13	.	.	.
cord-023095-4dannjjm	933	1	Copy	copy	JJ
cord-023095-4dannjjm	933	2	number	number	NN
cord-023095-4dannjjm	933	3	of	of	IN
cord-023095-4dannjjm	933	4	the	the	DT
cord-023095-4dannjjm	933	5	mitochondrial	mitochondrial	JJ
cord-023095-4dannjjm	933	6	genes	gene	NNS
cord-023095-4dannjjm	933	7	(	(	-LRB-
cord-023095-4dannjjm	933	8	NADH	NADH	NNP
cord-023095-4dannjjm	933	9	-	-	HYPH
cord-023095-4dannjjm	933	10	DH	DH	NNP
cord-023095-4dannjjm	933	11	and	and	CC
cord-023095-4dannjjm	933	12	COX-2	COX-2	NNP
cord-023095-4dannjjm	933	13	)	)	-RRB-
cord-023095-4dannjjm	933	14	was	be	VBD
cord-023095-4dannjjm	933	15	not	not	RB
cord-023095-4dannjjm	933	16	related	relate	VBN
cord-023095-4dannjjm	933	17	to	to	IN
cord-023095-4dannjjm	933	18	body	body	NN
cord-023095-4dannjjm	933	19	condition	condition	NN
cord-023095-4dannjjm	933	20	score	score	NN
cord-023095-4dannjjm	933	21	or	or	CC
cord-023095-4dannjjm	933	22	metabolic	metabolic	JJ
cord-023095-4dannjjm	933	23	gene	gene	NN
cord-023095-4dannjjm	933	24	expression	expression	NN
cord-023095-4dannjjm	933	25	.	.	.
cord-023095-4dannjjm	934	1	Expression	expression	NN
cord-023095-4dannjjm	934	2	of	of	IN
cord-023095-4dannjjm	934	3	GLUT-4	GLUT-4	NNP
cord-023095-4dannjjm	934	4	,	,	,
cord-023095-4dannjjm	934	5	ERRa	ERRa	NNS
cord-023095-4dannjjm	934	6	,	,	,
cord-023095-4dannjjm	934	7	PPARg	PPARg	NNS
cord-023095-4dannjjm	934	8	,	,	,
cord-023095-4dannjjm	934	9	and	and	CC
cord-023095-4dannjjm	934	10	FAT	fat	NN
cord-023095-4dannjjm	934	11	were	be	VBD
cord-023095-4dannjjm	934	12	strongly	strongly	RB
cord-023095-4dannjjm	934	13	correlated	correlate	VBN
cord-023095-4dannjjm	934	14	to	to	IN
cord-023095-4dannjjm	934	15	each	each	DT
cord-023095-4dannjjm	934	16	other	other	JJ
cord-023095-4dannjjm	934	17	,	,	,
cord-023095-4dannjjm	934	18	but	but	CC
cord-023095-4dannjjm	934	19	not	not	RB
cord-023095-4dannjjm	934	20	PGC-1a	PGC-1a	NNP
cord-023095-4dannjjm	934	21	.	.	.
cord-023095-4dannjjm	935	1	There	there	EX
cord-023095-4dannjjm	935	2	was	be	VBD
cord-023095-4dannjjm	935	3	a	a	DT
cord-023095-4dannjjm	935	4	strong	strong	JJ
cord-023095-4dannjjm	935	5	trend	trend	NN
cord-023095-4dannjjm	935	6	towards	towards	IN
cord-023095-4dannjjm	935	7	correlation	correlation	NN
cord-023095-4dannjjm	935	8	between	between	IN
cord-023095-4dannjjm	935	9	PPARg	PPARg	NNS
cord-023095-4dannjjm	935	10	and	and	CC
cord-023095-4dannjjm	935	11	PGC-1a	PGC-1a	NNP
cord-023095-4dannjjm	935	12	in	in	IN
cord-023095-4dannjjm	935	13	horses	horse	NNS
cord-023095-4dannjjm	935	14	with	with	IN
cord-023095-4dannjjm	935	15	body	body	NN
cord-023095-4dannjjm	935	16	condition	condition	NN
cord-023095-4dannjjm	935	17	score	score	NN
cord-023095-4dannjjm	935	18	4	4	CD
cord-023095-4dannjjm	935	19	6	6	CD
cord-023095-4dannjjm	935	20	(	(	-LRB-
cord-023095-4dannjjm	935	21	n	n	NN
cord-023095-4dannjjm	935	22	5	5	CD
cord-023095-4dannjjm	935	23	6	6	CD
cord-023095-4dannjjm	935	24	,	,	,
cord-023095-4dannjjm	936	1	r	r	LS
cord-023095-4dannjjm	936	2	5	5	CD
cord-023095-4dannjjm	936	3	0.77	0.77	CD
cord-023095-4dannjjm	936	4	,	,	,
cord-023095-4dannjjm	936	5	p	p	NN
cord-023095-4dannjjm	936	6	5	5	CD
cord-023095-4dannjjm	936	7	0.07	0.07	CD
cord-023095-4dannjjm	936	8	)	)	-RRB-
cord-023095-4dannjjm	936	9	.	.	.
cord-023095-4dannjjm	937	1	In	in	IN
cord-023095-4dannjjm	937	2	this	this	DT
cord-023095-4dannjjm	937	3	study	study	NN
cord-023095-4dannjjm	937	4	,	,	,
cord-023095-4dannjjm	937	5	there	there	EX
cord-023095-4dannjjm	937	6	was	be	VBD
cord-023095-4dannjjm	937	7	no	no	DT
cord-023095-4dannjjm	937	8	change	change	NN
cord-023095-4dannjjm	937	9	in	in	IN
cord-023095-4dannjjm	937	10	mitochondrial	mitochondrial	JJ
cord-023095-4dannjjm	937	11	content	content	NN
cord-023095-4dannjjm	937	12	in	in	IN
cord-023095-4dannjjm	937	13	obese	obese	JJ
cord-023095-4dannjjm	937	14	horses	horse	NNS
cord-023095-4dannjjm	937	15	.	.	.
cord-023095-4dannjjm	938	1	Assessment	assessment	NN
cord-023095-4dannjjm	938	2	of	of	IN
cord-023095-4dannjjm	938	3	mitochondrial	mitochondrial	JJ
cord-023095-4dannjjm	938	4	function	function	NN
cord-023095-4dannjjm	938	5	in	in	IN
cord-023095-4dannjjm	938	6	obese	obese	JJ
cord-023095-4dannjjm	938	7	horses	horse	NNS
cord-023095-4dannjjm	938	8	and	and	CC
cord-023095-4dannjjm	938	9	horses	horse	NNS
cord-023095-4dannjjm	938	10	with	with	IN
cord-023095-4dannjjm	938	11	EMS	EMS	NNP
cord-023095-4dannjjm	938	12	is	be	VBZ
cord-023095-4dannjjm	938	13	under	under	IN
cord-023095-4dannjjm	938	14	way	way	NN
cord-023095-4dannjjm	938	15	.	.	.
cord-023095-4dannjjm	939	1	The	the	DT
cord-023095-4dannjjm	939	2	strong	strong	JJ
cord-023095-4dannjjm	939	3	correlation	correlation	NN
cord-023095-4dannjjm	939	4	between	between	IN
cord-023095-4dannjjm	939	5	PPARg	PPARg	NNS
cord-023095-4dannjjm	939	6	and	and	CC
cord-023095-4dannjjm	939	7	PGC-1a	PGC-1a	NNP
cord-023095-4dannjjm	939	8	observed	observe	VBD
cord-023095-4dannjjm	939	9	only	only	RB
cord-023095-4dannjjm	939	10	in	in	IN
cord-023095-4dannjjm	939	11	horses	horse	NNS
cord-023095-4dannjjm	939	12	with	with	IN
cord-023095-4dannjjm	939	13	high	high	JJ
cord-023095-4dannjjm	939	14	body	body	NN
cord-023095-4dannjjm	939	15	condition	condition	NN
cord-023095-4dannjjm	939	16	scores	score	NNS
cord-023095-4dannjjm	940	1	suggests	suggest	VBZ
cord-023095-4dannjjm	940	2	this	this	DT
cord-023095-4dannjjm	940	3	pathway	pathway	NN
cord-023095-4dannjjm	940	4	is	be	VBZ
cord-023095-4dannjjm	940	5	activated	activate	VBN
cord-023095-4dannjjm	940	6	with	with	IN
cord-023095-4dannjjm	940	7	obesity	obesity	NN
cord-023095-4dannjjm	940	8	.	.	.
cord-023095-4dannjjm	941	1	The	the	DT
cord-023095-4dannjjm	941	2	role	role	NN
cord-023095-4dannjjm	941	3	of	of	IN
cord-023095-4dannjjm	941	4	PPARg	PPARg	NNS
cord-023095-4dannjjm	941	5	and	and	CC
cord-023095-4dannjjm	941	6	PGC-1a	PGC-1a	NNP
cord-023095-4dannjjm	941	7	in	in	IN
cord-023095-4dannjjm	941	8	equine	equine	JJ
cord-023095-4dannjjm	941	9	obesity	obesity	NN
cord-023095-4dannjjm	941	10	should	should	MD
cord-023095-4dannjjm	941	11	be	be	VB
cord-023095-4dannjjm	941	12	further	further	RB
cord-023095-4dannjjm	941	13	investigated	investigate	VBN
cord-023095-4dannjjm	941	14	to	to	TO
cord-023095-4dannjjm	941	15	determine	determine	VB
cord-023095-4dannjjm	941	16	their	-PRON-	PRP$
cord-023095-4dannjjm	941	17	potential	potential	NN
cord-023095-4dannjjm	941	18	as	as	IN
cord-023095-4dannjjm	941	19	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	941	20	targets	target	NNS
cord-023095-4dannjjm	941	21	.	.	.
cord-023095-4dannjjm	942	1	Upregulation	Upregulation	NNP
cord-023095-4dannjjm	942	2	of	of	IN
cord-023095-4dannjjm	942	3	ERRa	ERRa	NNS
cord-023095-4dannjjm	942	4	and	and	CC
cord-023095-4dannjjm	942	5	GLUT-4	glut-4	NN
cord-023095-4dannjjm	942	6	in	in	IN
cord-023095-4dannjjm	942	7	horses	horse	NNS
cord-023095-4dannjjm	942	8	with	with	IN
cord-023095-4dannjjm	942	9	increasing	increase	VBG
cord-023095-4dannjjm	942	10	body	body	NN
cord-023095-4dannjjm	942	11	condition	condition	NN
cord-023095-4dannjjm	942	12	score	score	NN
cord-023095-4dannjjm	942	13	is	be	VBZ
cord-023095-4dannjjm	942	14	unexpected	unexpected	JJ
cord-023095-4dannjjm	942	15	,	,	,
cord-023095-4dannjjm	942	16	and	and	CC
cord-023095-4dannjjm	942	17	may	may	MD
cord-023095-4dannjjm	942	18	indicate	indicate	VB
cord-023095-4dannjjm	942	19	a	a	DT
cord-023095-4dannjjm	942	20	compensatory	compensatory	JJ
cord-023095-4dannjjm	942	21	response	response	NN
cord-023095-4dannjjm	942	22	to	to	IN
cord-023095-4dannjjm	942	23	dysfunction	dysfunction	NN
cord-023095-4dannjjm	942	24	of	of	IN
cord-023095-4dannjjm	942	25	a	a	DT
cord-023095-4dannjjm	942	26	downstream	downstream	JJ
cord-023095-4dannjjm	942	27	pathway	pathway	NN
cord-023095-4dannjjm	942	28	.	.	.
cord-023095-4dannjjm	943	1	Further	further	JJ
cord-023095-4dannjjm	943	2	studies	study	NNS
cord-023095-4dannjjm	943	3	to	to	TO
cord-023095-4dannjjm	943	4	better	better	RB
cord-023095-4dannjjm	943	5	define	define	VB
cord-023095-4dannjjm	943	6	the	the	DT
cord-023095-4dannjjm	943	7	role	role	NN
cord-023095-4dannjjm	943	8	of	of	IN
cord-023095-4dannjjm	943	9	metabolic	metabolic	JJ
cord-023095-4dannjjm	943	10	regulatory	regulatory	JJ
cord-023095-4dannjjm	943	11	gene	gene	NN
cord-023095-4dannjjm	943	12	expression	expression	NN
cord-023095-4dannjjm	943	13	in	in	IN
cord-023095-4dannjjm	943	14	obese	obese	JJ
cord-023095-4dannjjm	943	15	horses	horse	NNS
cord-023095-4dannjjm	943	16	and	and	CC
cord-023095-4dannjjm	943	17	those	those	DT
cord-023095-4dannjjm	943	18	with	with	IN
cord-023095-4dannjjm	943	19	EMS	EMS	NNP
cord-023095-4dannjjm	943	20	are	be	VBP
cord-023095-4dannjjm	943	21	ongoing	ongoing	JJ
cord-023095-4dannjjm	943	22	.	.	.
cord-023095-4dannjjm	944	1	Previously	previously	RB
cord-023095-4dannjjm	944	2	presented	present	VBN
cord-023095-4dannjjm	944	3	at	at	IN
cord-023095-4dannjjm	944	4	the	the	DT
cord-023095-4dannjjm	944	5	7th	7th	JJ
cord-023095-4dannjjm	944	6	Annual	Annual	NNP
cord-023095-4dannjjm	944	7	Harold	Harold	NNP
cord-023095-4dannjjm	944	8	Hamm	Hamm	NNP
cord-023095-4dannjjm	944	9	Diabetes	diabete	VBZ
cord-023095-4dannjjm	944	10	Center	Center	NNP
cord-023095-4dannjjm	944	11	Research	Research	NNP
cord-023095-4dannjjm	944	12	Retreat	Retreat	NNP
cord-023095-4dannjjm	944	13	,	,	,
cord-023095-4dannjjm	944	14	Oklahoma	Oklahoma	NNP
cord-023095-4dannjjm	944	15	City	City	NNP
cord-023095-4dannjjm	944	16	,	,	,
cord-023095-4dannjjm	944	17	OK	ok	UH
cord-023095-4dannjjm	944	18	.	.	.
cord-023095-4dannjjm	945	1	Inflammatory	inflammatory	JJ
cord-023095-4dannjjm	945	2	bowel	bowel	NN
cord-023095-4dannjjm	945	3	disease	disease	NN
cord-023095-4dannjjm	945	4	is	be	VBZ
cord-023095-4dannjjm	945	5	a	a	DT
cord-023095-4dannjjm	945	6	cause	cause	NN
cord-023095-4dannjjm	945	7	of	of	IN
cord-023095-4dannjjm	945	8	weight	weight	NN
cord-023095-4dannjjm	945	9	loss	loss	NN
cord-023095-4dannjjm	945	10	,	,	,
cord-023095-4dannjjm	945	11	decreased	decrease	VBD
cord-023095-4dannjjm	945	12	performance	performance	NN
cord-023095-4dannjjm	945	13	,	,	,
cord-023095-4dannjjm	945	14	and	and	CC
cord-023095-4dannjjm	945	15	colic	colic	NN
cord-023095-4dannjjm	945	16	in	in	IN
cord-023095-4dannjjm	945	17	horses	horse	NNS
cord-023095-4dannjjm	945	18	.	.	.
cord-023095-4dannjjm	946	1	This	this	DT
cord-023095-4dannjjm	946	2	condition	condition	NN
cord-023095-4dannjjm	946	3	is	be	VBZ
cord-023095-4dannjjm	946	4	difficult	difficult	JJ
cord-023095-4dannjjm	946	5	to	to	TO
cord-023095-4dannjjm	946	6	diagnose	diagnose	VB
cord-023095-4dannjjm	946	7	and	and	CC
cord-023095-4dannjjm	946	8	clinicians	clinician	NNS
cord-023095-4dannjjm	946	9	rely	rely	VBP
cord-023095-4dannjjm	946	10	upon	upon	IN
cord-023095-4dannjjm	946	11	absorption	absorption	NN
cord-023095-4dannjjm	946	12	tests	test	NNS
cord-023095-4dannjjm	946	13	to	to	TO
cord-023095-4dannjjm	946	14	document	document	VB
cord-023095-4dannjjm	946	15	malabsorption	malabsorption	NN
cord-023095-4dannjjm	946	16	.	.	.
cord-023095-4dannjjm	947	1	The	the	DT
cord-023095-4dannjjm	947	2	purpose	purpose	NN
cord-023095-4dannjjm	947	3	of	of	IN
cord-023095-4dannjjm	947	4	this	this	DT
cord-023095-4dannjjm	947	5	study	study	NN
cord-023095-4dannjjm	947	6	was	be	VBD
cord-023095-4dannjjm	947	7	to	to	TO
cord-023095-4dannjjm	947	8	compare	compare	VB
cord-023095-4dannjjm	947	9	glucose	glucose	NN
cord-023095-4dannjjm	947	10	and	and	CC
cord-023095-4dannjjm	947	11	xylose	xylose	NN
cord-023095-4dannjjm	947	12	absorption	absorption	NN
cord-023095-4dannjjm	947	13	tests	test	NNS
cord-023095-4dannjjm	947	14	in	in	IN
cord-023095-4dannjjm	947	15	normal	normal	JJ
cord-023095-4dannjjm	947	16	horses	horse	NNS
cord-023095-4dannjjm	947	17	and	and	CC
cord-023095-4dannjjm	947	18	determine	determine	VB
cord-023095-4dannjjm	947	19	the	the	DT
cord-023095-4dannjjm	947	20	repeatability	repeatability	NN
cord-023095-4dannjjm	947	21	of	of	IN
cord-023095-4dannjjm	947	22	these	these	DT
cord-023095-4dannjjm	947	23	procedures	procedure	NNS
cord-023095-4dannjjm	947	24	.	.	.
cord-023095-4dannjjm	948	1	Eight	eight	CD
cord-023095-4dannjjm	948	2	horses	horse	NNS
cord-023095-4dannjjm	948	3	received	receive	VBD
cord-023095-4dannjjm	948	4	500	500	CD
cord-023095-4dannjjm	948	5	mg	mg	NNP
cord-023095-4dannjjm	948	6	/	/	SYM
cord-023095-4dannjjm	948	7	kg	kg	NNS
cord-023095-4dannjjm	948	8	dextrose	dextrose	NN
cord-023095-4dannjjm	948	9	or	or	CC
cord-023095-4dannjjm	948	10	D	d	NN
cord-023095-4dannjjm	948	11	-	-	HYPH
cord-023095-4dannjjm	948	12	xylose	xylose	NN
cord-023095-4dannjjm	948	13	powder	powder	NN
cord-023095-4dannjjm	948	14	mixed	mix	VBN
cord-023095-4dannjjm	948	15	as	as	IN
cord-023095-4dannjjm	948	16	a	a	DT
cord-023095-4dannjjm	948	17	10	10	CD
cord-023095-4dannjjm	948	18	%	%	NN
cord-023095-4dannjjm	948	19	solution	solution	NN
cord-023095-4dannjjm	948	20	in	in	IN
cord-023095-4dannjjm	948	21	water	water	NN
cord-023095-4dannjjm	948	22	or	or	CC
cord-023095-4dannjjm	948	23	water	water	NN
cord-023095-4dannjjm	948	24	alone	alone	RB
cord-023095-4dannjjm	948	25	via	via	IN
cord-023095-4dannjjm	948	26	nasogastric	nasogastric	NN
cord-023095-4dannjjm	948	27	intubation	intubation	NN
cord-023095-4dannjjm	948	28	on	on	IN
cord-023095-4dannjjm	948	29	three	three	CD
cord-023095-4dannjjm	948	30	different	different	JJ
cord-023095-4dannjjm	948	31	occasions	occasion	NNS
cord-023095-4dannjjm	948	32	within	within	IN
cord-023095-4dannjjm	948	33	the	the	DT
cord-023095-4dannjjm	948	34	same	same	JJ
cord-023095-4dannjjm	948	35	week	week	NN
cord-023095-4dannjjm	948	36	for	for	IN
cord-023095-4dannjjm	948	37	three	three	CD
cord-023095-4dannjjm	948	38	consecutive	consecutive	JJ
cord-023095-4dannjjm	948	39	weeks	week	NNS
cord-023095-4dannjjm	948	40	(	(	-LRB-
cord-023095-4dannjjm	948	41	9	9	CD
cord-023095-4dannjjm	948	42	tests	test	NNS
cord-023095-4dannjjm	948	43	/	/	SYM
cord-023095-4dannjjm	948	44	horse	horse	NN
cord-023095-4dannjjm	948	45	)	)	-RRB-
cord-023095-4dannjjm	948	46	.	.	.
cord-023095-4dannjjm	949	1	A	a	DT
cord-023095-4dannjjm	949	2	crossover	crossover	NN
cord-023095-4dannjjm	949	3	design	design	NN
cord-023095-4dannjjm	949	4	was	be	VBD
cord-023095-4dannjjm	949	5	employed	employ	VBN
cord-023095-4dannjjm	949	6	and	and	CC
cord-023095-4dannjjm	949	7	the	the	DT
cord-023095-4dannjjm	949	8	order	order	NN
cord-023095-4dannjjm	949	9	of	of	IN
cord-023095-4dannjjm	949	10	treatments	treatment	NNS
cord-023095-4dannjjm	949	11	was	be	VBD
cord-023095-4dannjjm	949	12	randomized	randomize	VBN
cord-023095-4dannjjm	949	13	.	.	.
cord-023095-4dannjjm	950	1	Blood	blood	NN
cord-023095-4dannjjm	950	2	samples	sample	NNS
cord-023095-4dannjjm	950	3	were	be	VBD
cord-023095-4dannjjm	950	4	collected	collect	VBN
cord-023095-4dannjjm	950	5	at	at	IN
cord-023095-4dannjjm	950	6	time	time	NN
cord-023095-4dannjjm	950	7	5	5	CD
cord-023095-4dannjjm	950	8	0	0	CD
cord-023095-4dannjjm	950	9	,	,	,
cord-023095-4dannjjm	950	10	30	30	CD
cord-023095-4dannjjm	950	11	,	,	,
cord-023095-4dannjjm	950	12	60	60	CD
cord-023095-4dannjjm	950	13	,	,	,
cord-023095-4dannjjm	950	14	90	90	CD
cord-023095-4dannjjm	950	15	,	,	,
cord-023095-4dannjjm	950	16	120	120	CD
cord-023095-4dannjjm	950	17	,	,	,
cord-023095-4dannjjm	950	18	150	150	CD
cord-023095-4dannjjm	950	19	,	,	,
cord-023095-4dannjjm	950	20	and	and	CC
cord-023095-4dannjjm	950	21	180	180	CD
cord-023095-4dannjjm	950	22	min	min	NN
cord-023095-4dannjjm	950	23	.	.	.
cord-023095-4dannjjm	951	1	Data	datum	NNS
cord-023095-4dannjjm	951	2	were	be	VBD
cord-023095-4dannjjm	951	3	analyzed	analyze	VBN
cord-023095-4dannjjm	951	4	by	by	IN
cord-023095-4dannjjm	951	5	repeated	repeat	VBN
cord-023095-4dannjjm	951	6	measures	measure	NNS
cord-023095-4dannjjm	951	7	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	951	8	and	and	CC
cord-023095-4dannjjm	951	9	t	t	NN
cord-023095-4dannjjm	951	10	-	-	HYPH
cord-023095-4dannjjm	951	11	tests	test	NNS
cord-023095-4dannjjm	951	12	.	.	.
cord-023095-4dannjjm	952	1	Results	result	NNS
cord-023095-4dannjjm	952	2	showed	show	VBD
cord-023095-4dannjjm	952	3	that	that	IN
cord-023095-4dannjjm	952	4	the	the	DT
cord-023095-4dannjjm	952	5	xylose	xylose	NN
cord-023095-4dannjjm	952	6	response	response	NN
cord-023095-4dannjjm	952	7	over	over	IN
cord-023095-4dannjjm	952	8	time	time	NN
cord-023095-4dannjjm	952	9	differed	differ	VBD
cord-023095-4dannjjm	952	10	significantly	significantly	RB
cord-023095-4dannjjm	952	11	from	from	IN
cord-023095-4dannjjm	952	12	the	the	DT
cord-023095-4dannjjm	952	13	glucose	glucose	NN
cord-023095-4dannjjm	952	14	response	response	NN
cord-023095-4dannjjm	952	15	over	over	IN
cord-023095-4dannjjm	952	16	time	time	NN
cord-023095-4dannjjm	952	17	(	(	-LRB-
cord-023095-4dannjjm	952	18	test	test	NN
cord-023095-4dannjjm	952	19	Â	â	CD
cord-023095-4dannjjm	952	20	time	time	NN
cord-023095-4dannjjm	952	21	;	;	:
cord-023095-4dannjjm	952	22	P	p	NN
cord-023095-4dannjjm	952	23	o	o	NN
cord-023095-4dannjjm	952	24	0.001	0.001	CD
cord-023095-4dannjjm	952	25	)	)	-RRB-
cord-023095-4dannjjm	952	26	.	.	.
cord-023095-4dannjjm	953	1	Mean	mean	JJ
cord-023095-4dannjjm	953	2	time	time	NN
cord-023095-4dannjjm	953	3	to	to	TO
cord-023095-4dannjjm	953	4	maximum	maximum	VB
cord-023095-4dannjjm	953	5	concentration	concentration	NN
cord-023095-4dannjjm	953	6	differed	differ	VBD
cord-023095-4dannjjm	953	7	(	(	-LRB-
cord-023095-4dannjjm	953	8	P	p	NN
cord-023095-4dannjjm	953	9	o	o	NN
cord-023095-4dannjjm	953	10	0.001	0.001	CD
cord-023095-4dannjjm	953	11	)	)	-RRB-
cord-023095-4dannjjm	953	12	between	between	IN
cord-023095-4dannjjm	953	13	tests	test	NNS
cord-023095-4dannjjm	953	14	(	(	-LRB-
cord-023095-4dannjjm	953	15	glucose	glucose	NN
cord-023095-4dannjjm	953	16	90	90	CD
cord-023095-4dannjjm	953	17	min	min	NN
cord-023095-4dannjjm	953	18	;	;	:
cord-023095-4dannjjm	953	19	xylose	xylose	NNP
cord-023095-4dannjjm	953	20	60	60	CD
cord-023095-4dannjjm	953	21	min	min	NN
cord-023095-4dannjjm	953	22	)	)	-RRB-
cord-023095-4dannjjm	953	23	.	.	.
cord-023095-4dannjjm	954	1	Within	within	IN
cord-023095-4dannjjm	954	2	-	-	HYPH
cord-023095-4dannjjm	954	3	horse	horse	NN
cord-023095-4dannjjm	954	4	area	area	NN
cord-023095-4dannjjm	954	5	under	under	IN
cord-023095-4dannjjm	954	6	the	the	DT
cord-023095-4dannjjm	954	7	curve	curve	NN
cord-023095-4dannjjm	954	8	,	,	,
cord-023095-4dannjjm	954	9	maximum	maximum	JJ
cord-023095-4dannjjm	954	10	concentration	concentration	NN
cord-023095-4dannjjm	954	11	,	,	,
cord-023095-4dannjjm	954	12	and	and	CC
cord-023095-4dannjjm	954	13	time	time	NN
cord-023095-4dannjjm	954	14	to	to	TO
cord-023095-4dannjjm	954	15	maximum	maximum	VB
cord-023095-4dannjjm	954	16	concentration	concentration	NN
cord-023095-4dannjjm	954	17	values	value	NNS
cord-023095-4dannjjm	954	18	for	for	IN
cord-023095-4dannjjm	954	19	dextrose	dextrose	NN
cord-023095-4dannjjm	954	20	and	and	CC
cord-023095-4dannjjm	954	21	xylose	xylose	NNP
cord-023095-4dannjjm	954	22	did	do	VBD
cord-023095-4dannjjm	954	23	not	not	RB
cord-023095-4dannjjm	954	24	differ	differ	VB
cord-023095-4dannjjm	954	25	significantly	significantly	RB
cord-023095-4dannjjm	954	26	when	when	WRB
cord-023095-4dannjjm	954	27	tests	test	NNS
cord-023095-4dannjjm	954	28	were	be	VBD
cord-023095-4dannjjm	954	29	repeated	repeat	VBN
cord-023095-4dannjjm	954	30	.	.	.
cord-023095-4dannjjm	955	1	Results	result	NNS
cord-023095-4dannjjm	955	2	indicate	indicate	VBP
cord-023095-4dannjjm	955	3	that	that	IN
cord-023095-4dannjjm	955	4	glucose	glucose	NN
cord-023095-4dannjjm	955	5	and	and	CC
cord-023095-4dannjjm	955	6	xylose	xylose	NN
cord-023095-4dannjjm	955	7	absorption	absorption	NN
cord-023095-4dannjjm	955	8	tests	test	NNS
cord-023095-4dannjjm	955	9	are	be	VBP
cord-023095-4dannjjm	955	10	repeatable	repeatable	JJ
cord-023095-4dannjjm	955	11	within	within	IN
cord-023095-4dannjjm	955	12	the	the	DT
cord-023095-4dannjjm	955	13	same	same	JJ
cord-023095-4dannjjm	955	14	horse	horse	NN
cord-023095-4dannjjm	955	15	,	,	,
cord-023095-4dannjjm	955	16	but	but	CC
cord-023095-4dannjjm	955	17	plotted	plot	VBN
cord-023095-4dannjjm	955	18	curves	curve	NNS
cord-023095-4dannjjm	955	19	differ	differ	VBP
cord-023095-4dannjjm	955	20	between	between	IN
cord-023095-4dannjjm	955	21	tests	test	NNS
cord-023095-4dannjjm	955	22	,	,	,
cord-023095-4dannjjm	955	23	with	with	IN
cord-023095-4dannjjm	955	24	peak	peak	NN
cord-023095-4dannjjm	955	25	concentrations	concentration	NNS
cord-023095-4dannjjm	955	26	occurring	occur	VBG
cord-023095-4dannjjm	955	27	at	at	IN
cord-023095-4dannjjm	955	28	a	a	DT
cord-023095-4dannjjm	955	29	later	later	JJ
cord-023095-4dannjjm	955	30	time	time	NN
cord-023095-4dannjjm	955	31	point	point	NN
cord-023095-4dannjjm	955	32	for	for	IN
cord-023095-4dannjjm	955	33	the	the	DT
cord-023095-4dannjjm	955	34	glucose	glucose	NN
cord-023095-4dannjjm	955	35	absorption	absorption	NN
cord-023095-4dannjjm	955	36	test	test	NN
cord-023095-4dannjjm	955	37	.	.	.
cord-023095-4dannjjm	956	1	We	-PRON-	PRP
cord-023095-4dannjjm	956	2	conclude	conclude	VBP
cord-023095-4dannjjm	956	3	that	that	IN
cord-023095-4dannjjm	956	4	both	both	DT
cord-023095-4dannjjm	956	5	tests	test	NNS
cord-023095-4dannjjm	956	6	provide	provide	VBP
cord-023095-4dannjjm	956	7	repeatable	repeatable	JJ
cord-023095-4dannjjm	956	8	measures	measure	NNS
cord-023095-4dannjjm	956	9	of	of	IN
cord-023095-4dannjjm	956	10	intestinal	intestinal	JJ
cord-023095-4dannjjm	956	11	absorption	absorption	NN
cord-023095-4dannjjm	956	12	,	,	,
cord-023095-4dannjjm	956	13	but	but	CC
cord-023095-4dannjjm	956	14	glucose	glucose	NN
cord-023095-4dannjjm	956	15	and	and	CC
cord-023095-4dannjjm	956	16	xylose	xylose	NN
cord-023095-4dannjjm	956	17	appear	appear	VBP
cord-023095-4dannjjm	956	18	to	to	TO
cord-023095-4dannjjm	956	19	differ	differ	VB
cord-023095-4dannjjm	956	20	in	in	IN
cord-023095-4dannjjm	956	21	their	-PRON-	PRP$
cord-023095-4dannjjm	956	22	rates	rate	NNS
cord-023095-4dannjjm	956	23	of	of	IN
cord-023095-4dannjjm	956	24	absorption	absorption	NN
cord-023095-4dannjjm	956	25	and	and	CC
cord-023095-4dannjjm	956	26	clearance	clearance	NN
cord-023095-4dannjjm	956	27	.	.	.
cord-023095-4dannjjm	957	1	The	the	DT
cord-023095-4dannjjm	957	2	purpose	purpose	NN
cord-023095-4dannjjm	957	3	of	of	IN
cord-023095-4dannjjm	957	4	this	this	DT
cord-023095-4dannjjm	957	5	study	study	NN
cord-023095-4dannjjm	957	6	was	be	VBD
cord-023095-4dannjjm	957	7	to	to	TO
cord-023095-4dannjjm	957	8	examine	examine	VB
cord-023095-4dannjjm	957	9	the	the	DT
cord-023095-4dannjjm	957	10	records	record	NNS
cord-023095-4dannjjm	957	11	of	of	IN
cord-023095-4dannjjm	957	12	a	a	DT
cord-023095-4dannjjm	957	13	population	population	NN
cord-023095-4dannjjm	957	14	of	of	IN
cord-023095-4dannjjm	957	15	Thoroughbreds	Thoroughbreds	NNPS
cord-023095-4dannjjm	957	16	with	with	IN
cord-023095-4dannjjm	957	17	cervical	cervical	JJ
cord-023095-4dannjjm	957	18	vertebral	vertebral	JJ
cord-023095-4dannjjm	957	19	malformation	malformation	NN
cord-023095-4dannjjm	957	20	(	(	-LRB-
cord-023095-4dannjjm	957	21	CVM	CVM	NNP
cord-023095-4dannjjm	957	22	)	)	-RRB-
cord-023095-4dannjjm	957	23	and	and	CC
cord-023095-4dannjjm	957	24	to	to	TO
cord-023095-4dannjjm	957	25	determine	determine	VB
cord-023095-4dannjjm	957	26	which	which	WDT
cord-023095-4dannjjm	957	27	factors	factor	NNS
cord-023095-4dannjjm	957	28	have	have	VBP
cord-023095-4dannjjm	957	29	an	an	DT
cord-023095-4dannjjm	957	30	effect	effect	NN
cord-023095-4dannjjm	957	31	on	on	IN
cord-023095-4dannjjm	957	32	these	these	DT
cord-023095-4dannjjm	957	33	horses	horse	NNS
cord-023095-4dannjjm	957	34	achieving	achieve	VBG
cord-023095-4dannjjm	957	35	athletic	athletic	JJ
cord-023095-4dannjjm	957	36	function	function	NN
cord-023095-4dannjjm	957	37	.	.	.
cord-023095-4dannjjm	958	1	This	this	DT
cord-023095-4dannjjm	958	2	was	be	VBD
cord-023095-4dannjjm	958	3	a	a	DT
cord-023095-4dannjjm	958	4	retrospective	retrospective	JJ
cord-023095-4dannjjm	958	5	case	case	NN
cord-023095-4dannjjm	958	6	study	study	NN
cord-023095-4dannjjm	958	7	of	of	IN
cord-023095-4dannjjm	958	8	119	119	CD
cord-023095-4dannjjm	958	9	Thoroughbreds	Thoroughbreds	NNPS
cord-023095-4dannjjm	958	10	with	with	IN
cord-023095-4dannjjm	958	11	CVM	CVM	NNP
cord-023095-4dannjjm	958	12	treated	treat	VBD
cord-023095-4dannjjm	958	13	medically	medically	RB
cord-023095-4dannjjm	958	14	from	from	IN
cord-023095-4dannjjm	958	15	2002	2002	CD
cord-023095-4dannjjm	958	16	to	to	IN
cord-023095-4dannjjm	958	17	2010	2010	CD
cord-023095-4dannjjm	958	18	.	.	.
cord-023095-4dannjjm	959	1	Forty	forty	CD
cord-023095-4dannjjm	959	2	-	-	HYPH
cord-023095-4dannjjm	959	3	one	one	CD
cord-023095-4dannjjm	959	4	were	be	VBD
cord-023095-4dannjjm	959	5	euthanized	euthanize	VBN
cord-023095-4dannjjm	959	6	after	after	IN
cord-023095-4dannjjm	959	7	diagnosis	diagnosis	NN
cord-023095-4dannjjm	959	8	,	,	,
cord-023095-4dannjjm	959	9	while	while	IN
cord-023095-4dannjjm	959	10	the	the	DT
cord-023095-4dannjjm	959	11	remaining	remain	VBG
cord-023095-4dannjjm	959	12	78	78	CD
cord-023095-4dannjjm	959	13	were	be	VBD
cord-023095-4dannjjm	959	14	discharged	discharge	VBN
cord-023095-4dannjjm	959	15	for	for	IN
cord-023095-4dannjjm	959	16	treatment	treatment	NN
cord-023095-4dannjjm	959	17	.	.	.
cord-023095-4dannjjm	960	1	Racing	racing	NN
cord-023095-4dannjjm	960	2	records	record	NNS
cord-023095-4dannjjm	960	3	were	be	VBD
cord-023095-4dannjjm	960	4	reviewed	review	VBN
cord-023095-4dannjjm	960	5	to	to	TO
cord-023095-4dannjjm	960	6	determine	determine	VB
cord-023095-4dannjjm	960	7	which	which	WDT
cord-023095-4dannjjm	960	8	horses	horse	NNS
cord-023095-4dannjjm	960	9	raced	race	VBD
cord-023095-4dannjjm	960	10	after	after	IN
cord-023095-4dannjjm	960	11	treatment	treatment	NN
cord-023095-4dannjjm	960	12	.	.	.
cord-023095-4dannjjm	961	1	Horses	horse	NNS
cord-023095-4dannjjm	961	2	were	be	VBD
cord-023095-4dannjjm	961	3	separated	separate	VBN
cord-023095-4dannjjm	961	4	into	into	IN
cord-023095-4dannjjm	961	5	groups	group	NNS
cord-023095-4dannjjm	961	6	based	base	VBN
cord-023095-4dannjjm	961	7	on	on	IN
cord-023095-4dannjjm	961	8	whether	whether	IN
cord-023095-4dannjjm	961	9	or	or	CC
cord-023095-4dannjjm	961	10	not	not	RB
cord-023095-4dannjjm	961	11	they	-PRON-	PRP
cord-023095-4dannjjm	961	12	raced	race	VBD
cord-023095-4dannjjm	961	13	.	.	.
cord-023095-4dannjjm	962	1	Medical	medical	JJ
cord-023095-4dannjjm	962	2	records	record	NNS
cord-023095-4dannjjm	962	3	were	be	VBD
cord-023095-4dannjjm	962	4	reviewed	review	VBN
cord-023095-4dannjjm	962	5	,	,	,
cord-023095-4dannjjm	962	6	and	and	CC
cord-023095-4dannjjm	962	7	results	result	NNS
cord-023095-4dannjjm	962	8	of	of	IN
cord-023095-4dannjjm	962	9	neurologic	neurologic	JJ
cord-023095-4dannjjm	962	10	examination	examination	NN
cord-023095-4dannjjm	962	11	,	,	,
cord-023095-4dannjjm	962	12	radiographic	radiographic	JJ
cord-023095-4dannjjm	962	13	and	and	CC
cord-023095-4dannjjm	962	14	laboratory	laboratory	NN
cord-023095-4dannjjm	962	15	findings	finding	NNS
cord-023095-4dannjjm	962	16	,	,	,
cord-023095-4dannjjm	962	17	treatments	treatment	NNS
cord-023095-4dannjjm	962	18	,	,	,
cord-023095-4dannjjm	962	19	and	and	CC
cord-023095-4dannjjm	962	20	outcome	outcome	NN
cord-023095-4dannjjm	962	21	were	be	VBD
cord-023095-4dannjjm	962	22	assessed	assess	VBN
cord-023095-4dannjjm	962	23	and	and	CC
cord-023095-4dannjjm	962	24	compared	compare	VBN
cord-023095-4dannjjm	962	25	between	between	IN
cord-023095-4dannjjm	962	26	groups	group	NNS
cord-023095-4dannjjm	962	27	.	.	.
cord-023095-4dannjjm	963	1	Twenty	twenty	CD
cord-023095-4dannjjm	963	2	-	-	HYPH
cord-023095-4dannjjm	963	3	one	one	CD
cord-023095-4dannjjm	963	4	of	of	IN
cord-023095-4dannjjm	963	5	78	78	CD
cord-023095-4dannjjm	963	6	horses	horse	NNS
cord-023095-4dannjjm	963	7	treated	treat	VBN
cord-023095-4dannjjm	963	8	medically	medically	RB
cord-023095-4dannjjm	963	9	(	(	-LRB-
cord-023095-4dannjjm	963	10	27	27	CD
cord-023095-4dannjjm	963	11	%	%	NN
cord-023095-4dannjjm	963	12	)	)	-RRB-
cord-023095-4dannjjm	963	13	improved	improve	VBN
cord-023095-4dannjjm	963	14	enough	enough	RB
cord-023095-4dannjjm	963	15	to	to	TO
cord-023095-4dannjjm	963	16	race	race	VB
cord-023095-4dannjjm	963	17	.	.	.
cord-023095-4dannjjm	964	1	Median	median	JJ
cord-023095-4dannjjm	964	2	neurologic	neurologic	JJ
cord-023095-4dannjjm	964	3	grade	grade	NN
cord-023095-4dannjjm	964	4	between	between	IN
cord-023095-4dannjjm	964	5	groups	group	NNS
cord-023095-4dannjjm	964	6	was	be	VBD
cord-023095-4dannjjm	964	7	significantly	significantly	RB
cord-023095-4dannjjm	964	8	different	different	JJ
cord-023095-4dannjjm	964	9	(	(	-LRB-
cord-023095-4dannjjm	964	10	p	p	NN
cord-023095-4dannjjm	964	11	o	o	CD
cord-023095-4dannjjm	964	12	0.0001	0.0001	CD
cord-023095-4dannjjm	964	13	)	)	-RRB-
cord-023095-4dannjjm	964	14	,	,	,
cord-023095-4dannjjm	964	15	with	with	IN
cord-023095-4dannjjm	964	16	a	a	DT
cord-023095-4dannjjm	964	17	hind	hind	NN
cord-023095-4dannjjm	964	18	limb	limb	NN
cord-023095-4dannjjm	964	19	grade	grade	NN
cord-023095-4dannjjm	964	20	of	of	IN
cord-023095-4dannjjm	964	21	2.0	2.0	CD
cord-023095-4dannjjm	964	22	(	(	-LRB-
cord-023095-4dannjjm	964	23	range	range	NNP
cord-023095-4dannjjm	964	24	1	1	CD
cord-023095-4dannjjm	964	25	-	-	SYM
cord-023095-4dannjjm	964	26	3	3	CD
cord-023095-4dannjjm	964	27	)	)	-RRB-
cord-023095-4dannjjm	964	28	for	for	IN
cord-023095-4dannjjm	964	29	the	the	DT
cord-023095-4dannjjm	964	30	raced	race	VBN
cord-023095-4dannjjm	964	31	group	group	NN
cord-023095-4dannjjm	964	32	and	and	CC
cord-023095-4dannjjm	964	33	2.5	2.5	CD
cord-023095-4dannjjm	964	34	(	(	-LRB-
cord-023095-4dannjjm	964	35	range	range	VBP
cord-023095-4dannjjm	964	36	0.5	0.5	CD
cord-023095-4dannjjm	964	37	-	-	SYM
cord-023095-4dannjjm	964	38	4	4	CD
cord-023095-4dannjjm	964	39	)	)	-RRB-
cord-023095-4dannjjm	964	40	for	for	IN
cord-023095-4dannjjm	964	41	the	the	DT
cord-023095-4dannjjm	964	42	unraced	unraced	JJ
cord-023095-4dannjjm	964	43	.	.	.
cord-023095-4dannjjm	965	1	Intravertebral	intravertebral	JJ
cord-023095-4dannjjm	965	2	sagittal	sagittal	JJ
cord-023095-4dannjjm	965	3	ratios	ratio	NNS
cord-023095-4dannjjm	965	4	measured	measure	VBN
cord-023095-4dannjjm	965	5	from	from	IN
cord-023095-4dannjjm	965	6	standing	stand	VBG
cord-023095-4dannjjm	965	7	lateral	lateral	JJ
cord-023095-4dannjjm	965	8	cervical	cervical	JJ
cord-023095-4dannjjm	965	9	radiographs	radiograph	NNS
cord-023095-4dannjjm	965	10	were	be	VBD
cord-023095-4dannjjm	965	11	equivocal	equivocal	JJ
cord-023095-4dannjjm	965	12	between	between	IN
cord-023095-4dannjjm	965	13	groups	group	NNS
cord-023095-4dannjjm	965	14	.	.	.
cord-023095-4dannjjm	966	1	Radiographs	radiograph	NNS
cord-023095-4dannjjm	966	2	of	of	IN
cord-023095-4dannjjm	966	3	all	all	DT
cord-023095-4dannjjm	966	4	horses	horse	NNS
cord-023095-4dannjjm	966	5	were	be	VBD
cord-023095-4dannjjm	966	6	examined	examine	VBN
cord-023095-4dannjjm	966	7	for	for	IN
cord-023095-4dannjjm	966	8	kyphosis	kyphosis	NN
cord-023095-4dannjjm	966	9	,	,	,
cord-023095-4dannjjm	966	10	dorsal	dorsal	JJ
cord-023095-4dannjjm	966	11	over	over	IN
cord-023095-4dannjjm	966	12	-	-	HYPH
cord-023095-4dannjjm	966	13	riding	riding	NN
cord-023095-4dannjjm	966	14	arch	arch	NN
cord-023095-4dannjjm	966	15	,	,	,
cord-023095-4dannjjm	966	16	caudal	caudal	JJ
cord-023095-4dannjjm	966	17	epiphysitis	epiphysitis	NN
cord-023095-4dannjjm	966	18	,	,	,
cord-023095-4dannjjm	966	19	degenerative	degenerative	JJ
cord-023095-4dannjjm	966	20	joint	joint	JJ
cord-023095-4dannjjm	966	21	disease	disease	NN
cord-023095-4dannjjm	966	22	,	,	,
cord-023095-4dannjjm	966	23	cystic	cystic	JJ
cord-023095-4dannjjm	966	24	bone	bone	NN
cord-023095-4dannjjm	966	25	lesions	lesion	NNS
cord-023095-4dannjjm	966	26	,	,	,
cord-023095-4dannjjm	966	27	and	and	CC
cord-023095-4dannjjm	966	28	cranial	cranial	JJ
cord-023095-4dannjjm	966	29	stenosis	stenosis	NN
cord-023095-4dannjjm	966	30	of	of	IN
cord-023095-4dannjjm	966	31	the	the	DT
cord-023095-4dannjjm	966	32	vertebral	vertebral	JJ
cord-023095-4dannjjm	966	33	canal	canal	NN
cord-023095-4dannjjm	966	34	.	.	.
cord-023095-4dannjjm	967	1	Horses	horse	NNS
cord-023095-4dannjjm	967	2	with	with	IN
cord-023095-4dannjjm	967	3	kyphosis	kyphosis	NN
cord-023095-4dannjjm	967	4	(	(	-LRB-
cord-023095-4dannjjm	967	5	p	p	NN
cord-023095-4dannjjm	967	6	5	5	CD
cord-023095-4dannjjm	967	7	0.0178	0.0178	CD
cord-023095-4dannjjm	967	8	)	)	-RRB-
cord-023095-4dannjjm	967	9	,	,	,
cord-023095-4dannjjm	967	10	degenerative	degenerative	JJ
cord-023095-4dannjjm	967	11	joint	joint	JJ
cord-023095-4dannjjm	967	12	disease	disease	NN
cord-023095-4dannjjm	967	13	(	(	-LRB-
cord-023095-4dannjjm	967	14	p	p	NN
cord-023095-4dannjjm	967	15	5	5	CD
cord-023095-4dannjjm	967	16	0.0497	0.0497	CD
cord-023095-4dannjjm	967	17	)	)	-RRB-
cord-023095-4dannjjm	967	18	,	,	,
cord-023095-4dannjjm	967	19	or	or	CC
cord-023095-4dannjjm	967	20	cranial	cranial	JJ
cord-023095-4dannjjm	967	21	stenosis	stenosis	NN
cord-023095-4dannjjm	968	1	(	(	-LRB-
cord-023095-4dannjjm	968	2	p	p	NN
cord-023095-4dannjjm	968	3	5	5	CD
cord-023095-4dannjjm	968	4	0.0357	0.0357	CD
cord-023095-4dannjjm	968	5	)	)	-RRB-
cord-023095-4dannjjm	968	6	at	at	IN
cord-023095-4dannjjm	968	7	any	any	DT
cord-023095-4dannjjm	968	8	site	site	NN
cord-023095-4dannjjm	968	9	were	be	VBD
cord-023095-4dannjjm	968	10	less	less	RBR
cord-023095-4dannjjm	968	11	likely	likely	JJ
cord-023095-4dannjjm	968	12	to	to	TO
cord-023095-4dannjjm	968	13	return	return	VB
cord-023095-4dannjjm	968	14	to	to	IN
cord-023095-4dannjjm	968	15	racing	racing	NN
cord-023095-4dannjjm	968	16	.	.	.
cord-023095-4dannjjm	969	1	Racing	race	VBG
cord-023095-4dannjjm	969	2	prognosis	prognosis	NN
cord-023095-4dannjjm	969	3	for	for	IN
cord-023095-4dannjjm	969	4	horses	horse	NNS
cord-023095-4dannjjm	969	5	with	with	IN
cord-023095-4dannjjm	969	6	CVM	CVM	NNP
cord-023095-4dannjjm	969	7	treated	treat	VBD
cord-023095-4dannjjm	969	8	conservatively	conservatively	RB
cord-023095-4dannjjm	969	9	is	be	VBZ
cord-023095-4dannjjm	969	10	equivalent	equivalent	JJ
cord-023095-4dannjjm	969	11	to	to	IN
cord-023095-4dannjjm	969	12	that	that	DT
cord-023095-4dannjjm	969	13	of	of	IN
cord-023095-4dannjjm	969	14	those	those	DT
cord-023095-4dannjjm	969	15	treated	treat	VBN
cord-023095-4dannjjm	969	16	surgically	surgically	RB
cord-023095-4dannjjm	969	17	as	as	IN
cord-023095-4dannjjm	969	18	reported	report	VBN
cord-023095-4dannjjm	969	19	by	by	IN
cord-023095-4dannjjm	969	20	Rush	Rush	NNP
cord-023095-4dannjjm	969	21	Moore	Moore	NNP
cord-023095-4dannjjm	969	22	et	et	NNP
cord-023095-4dannjjm	969	23	al	al	NNP
cord-023095-4dannjjm	969	24	(	(	-LRB-
cord-023095-4dannjjm	969	25	JAVMA	JAVMA	NNP
cord-023095-4dannjjm	969	26	,	,	,
cord-023095-4dannjjm	969	27	1993	1993	CD
cord-023095-4dannjjm	969	28	)	)	-RRB-
cord-023095-4dannjjm	969	29	.	.	.
cord-023095-4dannjjm	970	1	Radiographic	radiographic	JJ
cord-023095-4dannjjm	970	2	changes	change	NNS
cord-023095-4dannjjm	970	3	and	and	CC
cord-023095-4dannjjm	970	4	neurologic	neurologic	JJ
cord-023095-4dannjjm	970	5	grade	grade	NN
cord-023095-4dannjjm	970	6	may	may	MD
cord-023095-4dannjjm	970	7	help	help	VB
cord-023095-4dannjjm	970	8	serve	serve	VB
cord-023095-4dannjjm	970	9	as	as	IN
cord-023095-4dannjjm	970	10	indicators	indicator	NNS
cord-023095-4dannjjm	970	11	for	for	IN
cord-023095-4dannjjm	970	12	whether	whether	IN
cord-023095-4dannjjm	970	13	a	a	DT
cord-023095-4dannjjm	970	14	horse	horse	NN
cord-023095-4dannjjm	970	15	will	will	MD
cord-023095-4dannjjm	970	16	respond	respond	VB
cord-023095-4dannjjm	970	17	to	to	IN
cord-023095-4dannjjm	970	18	conservative	conservative	JJ
cord-023095-4dannjjm	970	19	therapy	therapy	NN
cord-023095-4dannjjm	970	20	.	.	.
cord-023095-4dannjjm	971	1	Since	since	IN
cord-023095-4dannjjm	971	2	pain	pain	NN
cord-023095-4dannjjm	971	3	assessment	assessment	NN
cord-023095-4dannjjm	971	4	is	be	VBZ
cord-023095-4dannjjm	971	5	vital	vital	JJ
cord-023095-4dannjjm	971	6	for	for	IN
cord-023095-4dannjjm	971	7	management	management	NN
cord-023095-4dannjjm	971	8	of	of	IN
cord-023095-4dannjjm	971	9	colic	colic	NN
cord-023095-4dannjjm	971	10	,	,	,
cord-023095-4dannjjm	971	11	a	a	DT
cord-023095-4dannjjm	971	12	valid	valid	JJ
cord-023095-4dannjjm	971	13	,	,	,
cord-023095-4dannjjm	971	14	reliable	reliable	JJ
cord-023095-4dannjjm	971	15	and	and	CC
cord-023095-4dannjjm	971	16	feasible	feasible	JJ
cord-023095-4dannjjm	971	17	tool	tool	NN
cord-023095-4dannjjm	971	18	for	for	IN
cord-023095-4dannjjm	971	19	assessing	assess	VBG
cord-023095-4dannjjm	971	20	the	the	DT
cord-023095-4dannjjm	971	21	severity	severity	NN
cord-023095-4dannjjm	971	22	of	of	IN
cord-023095-4dannjjm	971	23	acute	acute	JJ
cord-023095-4dannjjm	971	24	abdominal	abdominal	JJ
cord-023095-4dannjjm	971	25	pain	pain	NN
cord-023095-4dannjjm	971	26	in	in	IN
cord-023095-4dannjjm	971	27	horses	horse	NNS
cord-023095-4dannjjm	971	28	is	be	VBZ
cord-023095-4dannjjm	971	29	urgently	urgently	RB
cord-023095-4dannjjm	971	30	needed	need	VBN
cord-023095-4dannjjm	971	31	.	.	.
cord-023095-4dannjjm	972	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	972	2	aim	aim	NN
cord-023095-4dannjjm	972	3	was	be	VBD
cord-023095-4dannjjm	972	4	to	to	TO
cord-023095-4dannjjm	972	5	construct	construct	VB
cord-023095-4dannjjm	972	6	and	and	CC
cord-023095-4dannjjm	972	7	validate	validate	VB
cord-023095-4dannjjm	972	8	a	a	DT
cord-023095-4dannjjm	972	9	behavior	behavior	NN
cord-023095-4dannjjm	972	10	-	-	HYPH
cord-023095-4dannjjm	972	11	based	base	VBN
cord-023095-4dannjjm	972	12	pain	pain	NN
cord-023095-4dannjjm	972	13	scale	scale	NN
cord-023095-4dannjjm	972	14	by	by	IN
cord-023095-4dannjjm	972	15	methodology	methodology	NN
cord-023095-4dannjjm	972	16	utilized	utilize	VBN
cord-023095-4dannjjm	972	17	in	in	IN
cord-023095-4dannjjm	972	18	construction	construction	NN
cord-023095-4dannjjm	972	19	of	of	IN
cord-023095-4dannjjm	972	20	pain	pain	NN
cord-023095-4dannjjm	972	21	scales	scale	NNS
cord-023095-4dannjjm	972	22	in	in	IN
cord-023095-4dannjjm	972	23	non	non	JJ
cord-023095-4dannjjm	972	24	-	-	JJ
cord-023095-4dannjjm	972	25	verbal	verbal	JJ
cord-023095-4dannjjm	972	26	humans	human	NNS
cord-023095-4dannjjm	972	27	.	.	.
cord-023095-4dannjjm	973	1	The	the	DT
cord-023095-4dannjjm	973	2	project	project	NN
cord-023095-4dannjjm	973	3	consisted	consist	VBD
cord-023095-4dannjjm	973	4	of	of	IN
cord-023095-4dannjjm	973	5	four	four	CD
cord-023095-4dannjjm	973	6	stages	stage	NNS
cord-023095-4dannjjm	973	7	.	.	.
cord-023095-4dannjjm	974	1	Firstly	firstly	RB
cord-023095-4dannjjm	974	2	,	,	,
cord-023095-4dannjjm	974	3	behaviors	behavior	NNS
cord-023095-4dannjjm	974	4	to	to	TO
cord-023095-4dannjjm	974	5	include	include	VB
cord-023095-4dannjjm	974	6	in	in	IN
cord-023095-4dannjjm	974	7	a	a	DT
cord-023095-4dannjjm	974	8	scale	scale	NN
cord-023095-4dannjjm	974	9	were	be	VBD
cord-023095-4dannjjm	974	10	empirically	empirically	RB
cord-023095-4dannjjm	974	11	identified	identify	VBN
cord-023095-4dannjjm	974	12	.	.	.
cord-023095-4dannjjm	975	1	Thirty	thirty	CD
cord-023095-4dannjjm	975	2	equine	equine	JJ
cord-023095-4dannjjm	975	3	clinicians	clinician	NNS
cord-023095-4dannjjm	975	4	noted	note	VBD
cord-023095-4dannjjm	975	5	behaviors	behavior	NNS
cord-023095-4dannjjm	975	6	in	in	IN
cord-023095-4dannjjm	975	7	each	each	DT
cord-023095-4dannjjm	975	8	of	of	IN
cord-023095-4dannjjm	975	9	23	23	CD
cord-023095-4dannjjm	975	10	random	random	JJ
cord-023095-4dannjjm	975	11	film	film	NN
cord-023095-4dannjjm	975	12	clips	clip	NNS
cord-023095-4dannjjm	975	13	of	of	IN
cord-023095-4dannjjm	975	14	horses	horse	NNS
cord-023095-4dannjjm	975	15	with	with	IN
cord-023095-4dannjjm	975	16	colic	colic	NN
cord-023095-4dannjjm	975	17	using	use	VBG
cord-023095-4dannjjm	975	18	a	a	DT
cord-023095-4dannjjm	975	19	checklist	checklist	NN
cord-023095-4dannjjm	975	20	.	.	.
cord-023095-4dannjjm	976	1	Nine	nine	CD
cord-023095-4dannjjm	976	2	behaviors	behavior	NNS
cord-023095-4dannjjm	976	3	(	(	-LRB-
cord-023095-4dannjjm	976	4	e.g.	e.g.	RB
cord-023095-4dannjjm	976	5	rolling	roll	VBG
cord-023095-4dannjjm	976	6	,	,	,
cord-023095-4dannjjm	976	7	pawing	paw	VBG
cord-023095-4dannjjm	976	8	,	,	,
cord-023095-4dannjjm	976	9	and	and	CC
cord-023095-4dannjjm	976	10	flank	flank	VB
cord-023095-4dannjjm	976	11	watching	watch	VBG
cord-023095-4dannjjm	976	12	)	)	-RRB-
cord-023095-4dannjjm	976	13	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	976	14	good	good	JJ
cord-023095-4dannjjm	976	15	inter	inter	JJ
cord-023095-4dannjjm	976	16	-	-	JJ
cord-023095-4dannjjm	976	17	observer	observer	JJ
cord-023095-4dannjjm	976	18	agreement	agreement	NN
cord-023095-4dannjjm	976	19	without	without	IN
cord-023095-4dannjjm	976	20	bias	bias	NN
cord-023095-4dannjjm	976	21	(	(	-LRB-
cord-023095-4dannjjm	976	22	multi	multi	JJ
cord-023095-4dannjjm	976	23	-	-	JJ
cord-023095-4dannjjm	976	24	rater	rater	JJ
cord-023095-4dannjjm	976	25	kappas	kappa	NNS
cord-023095-4dannjjm	976	26	:	:	:
cord-023095-4dannjjm	976	27	0.5	0.5	CD
cord-023095-4dannjjm	976	28	-	-	HYPH
cord-023095-4dannjjm	976	29	0.95	0.95	CD
cord-023095-4dannjjm	976	30	)	)	-RRB-
cord-023095-4dannjjm	976	31	.	.	.
cord-023095-4dannjjm	977	1	Secondly	secondly	RB
cord-023095-4dannjjm	977	2	,	,	,
cord-023095-4dannjjm	977	3	the	the	DT
cord-023095-4dannjjm	977	4	clinical	clinical	JJ
cord-023095-4dannjjm	977	5	judgment	judgment	NN
cord-023095-4dannjjm	977	6	of	of	IN
cord-023095-4dannjjm	977	7	experts	expert	NNS
cord-023095-4dannjjm	977	8	was	be	VBD
cord-023095-4dannjjm	977	9	utilized	utilize	VBN
cord-023095-4dannjjm	977	10	to	to	TO
cord-023095-4dannjjm	977	11	identify	identify	VB
cord-023095-4dannjjm	977	12	and	and	CC
cord-023095-4dannjjm	977	13	to	to	TO
cord-023095-4dannjjm	977	14	weight	weight	NN
cord-023095-4dannjjm	977	15	behaviors	behavior	NNS
cord-023095-4dannjjm	977	16	.	.	.
cord-023095-4dannjjm	978	1	Six	six	CD
cord-023095-4dannjjm	978	2	expert	expert	NN
cord-023095-4dannjjm	978	3	clinicians	clinician	NNS
cord-023095-4dannjjm	978	4	independently	independently	RB
cord-023095-4dannjjm	978	5	expressed	express	VBD
cord-023095-4dannjjm	978	6	opinions	opinion	NNS
cord-023095-4dannjjm	978	7	as	as	IN
cord-023095-4dannjjm	978	8	to	to	IN
cord-023095-4dannjjm	978	9	which	which	WDT
cord-023095-4dannjjm	978	10	of	of	IN
cord-023095-4dannjjm	978	11	46	46	CD
cord-023095-4dannjjm	978	12	behaviors	behavior	NNS
cord-023095-4dannjjm	978	13	to	to	TO
cord-023095-4dannjjm	978	14	include	include	VB
cord-023095-4dannjjm	978	15	and	and	CC
cord-023095-4dannjjm	978	16	the	the	DT
cord-023095-4dannjjm	978	17	severity	severity	NN
cord-023095-4dannjjm	978	18	of	of	IN
cord-023095-4dannjjm	978	19	pain	pain	NN
cord-023095-4dannjjm	978	20	they	-PRON-	PRP
cord-023095-4dannjjm	978	21	indicate	indicate	VBP
cord-023095-4dannjjm	978	22	.	.	.
cord-023095-4dannjjm	979	1	Two	two	CD
cord-023095-4dannjjm	979	2	contending	contend	VBG
cord-023095-4dannjjm	979	3	scales	scale	NNS
cord-023095-4dannjjm	979	4	(	(	-LRB-
cord-023095-4dannjjm	979	5	Equine	equine	JJ
cord-023095-4dannjjm	979	6	Acute	acute	JJ
cord-023095-4dannjjm	979	7	Abdominal	abdominal	JJ
cord-023095-4dannjjm	979	8	Pain	pain	NN
cord-023095-4dannjjm	979	9	Scales	scale	NNS
cord-023095-4dannjjm	979	10	(	(	-LRB-
cord-023095-4dannjjm	979	11	EAAPS	EAAPS	NNP
cord-023095-4dannjjm	979	12	)	)	-RRB-
cord-023095-4dannjjm	979	13	1	1	CD
cord-023095-4dannjjm	979	14	&	&	CC
cord-023095-4dannjjm	979	15	2	2	CD
cord-023095-4dannjjm	979	16	)	)	-RRB-
cord-023095-4dannjjm	979	17	were	be	VBD
cord-023095-4dannjjm	979	18	constructed	construct	VBN
cord-023095-4dannjjm	979	19	based	base	VBN
cord-023095-4dannjjm	979	20	on	on	IN
cord-023095-4dannjjm	979	21	both	both	CC
cord-023095-4dannjjm	979	22	the	the	DT
cord-023095-4dannjjm	979	23	empirical	empirical	JJ
cord-023095-4dannjjm	979	24	and	and	CC
cord-023095-4dannjjm	979	25	the	the	DT
cord-023095-4dannjjm	979	26	judgmental	judgmental	JJ
cord-023095-4dannjjm	979	27	approaches	approach	NNS
cord-023095-4dannjjm	979	28	.	.	.
cord-023095-4dannjjm	980	1	Each	each	DT
cord-023095-4dannjjm	980	2	included	include	VBD
cord-023095-4dannjjm	980	3	12	12	CD
cord-023095-4dannjjm	980	4	identical	identical	JJ
cord-023095-4dannjjm	980	5	behaviors	behavior	NNS
cord-023095-4dannjjm	980	6	with	with	IN
cord-023095-4dannjjm	980	7	a	a	DT
cord-023095-4dannjjm	980	8	1	1	CD
cord-023095-4dannjjm	980	9	-	-	SYM
cord-023095-4dannjjm	980	10	5	5	CD
cord-023095-4dannjjm	980	11	point	point	NN
cord-023095-4dannjjm	980	12	score	score	NN
cord-023095-4dannjjm	980	13	range	range	NN
cord-023095-4dannjjm	980	14	;	;	:
cord-023095-4dannjjm	980	15	EAAPS-2	eaaps-2	NN
cord-023095-4dannjjm	980	16	with	with	IN
cord-023095-4dannjjm	980	17	gradations	gradation	NNS
cord-023095-4dannjjm	980	18	to	to	IN
cord-023095-4dannjjm	980	19	some	some	DT
cord-023095-4dannjjm	980	20	of	of	IN
cord-023095-4dannjjm	980	21	the	the	DT
cord-023095-4dannjjm	980	22	behaviors	behavior	NNS
cord-023095-4dannjjm	980	23	and	and	CC
cord-023095-4dannjjm	980	24	EAAPS-1	eaaps-1	NN
cord-023095-4dannjjm	980	25	without	without	IN
cord-023095-4dannjjm	980	26	.	.	.
cord-023095-4dannjjm	981	1	In	in	IN
cord-023095-4dannjjm	981	2	the	the	DT
cord-023095-4dannjjm	981	3	third	third	JJ
cord-023095-4dannjjm	981	4	stage	stage	NN
cord-023095-4dannjjm	981	5	,	,	,
cord-023095-4dannjjm	981	6	blood	blood	NN
cord-023095-4dannjjm	981	7	cortisol	cortisol	NN
cord-023095-4dannjjm	981	8	and	and	CC
cord-023095-4dannjjm	981	9	lactate	lactate	NN
cord-023095-4dannjjm	981	10	levels	level	NNS
cord-023095-4dannjjm	981	11	and	and	CC
cord-023095-4dannjjm	981	12	heart	heart	NN
cord-023095-4dannjjm	981	13	rate	rate	NN
cord-023095-4dannjjm	981	14	were	be	VBD
cord-023095-4dannjjm	981	15	shown	show	VBN
cord-023095-4dannjjm	981	16	to	to	IN
cord-023095-4dannjjm	981	17	only	only	JJ
cord-023095-4dannjjm	981	18	approximate	approximate	JJ
cord-023095-4dannjjm	981	19	pain	pain	NN
cord-023095-4dannjjm	981	20	since	since	IN
cord-023095-4dannjjm	981	21	they	-PRON-	PRP
cord-023095-4dannjjm	981	22	correlate	correlate	VBP
cord-023095-4dannjjm	981	23	poorly	poorly	RB
cord-023095-4dannjjm	981	24	with	with	IN
cord-023095-4dannjjm	981	25	degree	degree	NN
cord-023095-4dannjjm	981	26	of	of	IN
cord-023095-4dannjjm	981	27	pain	pain	NN
cord-023095-4dannjjm	981	28	as	as	IN
cord-023095-4dannjjm	981	29	assessed	assess	VBN
cord-023095-4dannjjm	981	30	by	by	IN
cord-023095-4dannjjm	981	31	visual	visual	JJ
cord-023095-4dannjjm	981	32	analog	analog	NN
cord-023095-4dannjjm	981	33	scale	scale	NN
cord-023095-4dannjjm	981	34	(	(	-LRB-
cord-023095-4dannjjm	981	35	VAS	VAS	NNP
cord-023095-4dannjjm	981	36	)	)	-RRB-
cord-023095-4dannjjm	981	37	in	in	IN
cord-023095-4dannjjm	981	38	32	32	CD
cord-023095-4dannjjm	981	39	horses	horse	NNS
cord-023095-4dannjjm	981	40	with	with	IN
cord-023095-4dannjjm	981	41	colic	colic	NN
cord-023095-4dannjjm	981	42	and	and	CC
cord-023095-4dannjjm	981	43	8	8	CD
cord-023095-4dannjjm	981	44	controls	control	NNS
cord-023095-4dannjjm	981	45	(	(	-LRB-
cord-023095-4dannjjm	981	46	Spearman	Spearman	NNP
cord-023095-4dannjjm	981	47	rho	rho	NN
cord-023095-4dannjjm	981	48	;	;	:
cord-023095-4dannjjm	981	49	lactate	lactate	NNP
cord-023095-4dannjjm	981	50	0.359	0.359	CD
cord-023095-4dannjjm	981	51	;	;	:
cord-023095-4dannjjm	981	52	cortisol	cortisol	NN
cord-023095-4dannjjm	981	53	0.214	0.214	CD
cord-023095-4dannjjm	981	54	;	;	:
cord-023095-4dannjjm	981	55	heart	heart	NN
cord-023095-4dannjjm	981	56	rate	rate	NN
cord-023095-4dannjjm	981	57	0.261	0.261	CD
cord-023095-4dannjjm	981	58	)	)	-RRB-
cord-023095-4dannjjm	981	59	.	.	.
cord-023095-4dannjjm	982	1	Finally	finally	RB
cord-023095-4dannjjm	982	2	,	,	,
cord-023095-4dannjjm	982	3	reliability	reliability	NN
cord-023095-4dannjjm	982	4	and	and	CC
cord-023095-4dannjjm	982	5	validity	validity	NN
cord-023095-4dannjjm	982	6	of	of	IN
cord-023095-4dannjjm	982	7	the	the	DT
cord-023095-4dannjjm	982	8	pain	pain	NN
cord-023095-4dannjjm	982	9	scales	scale	NNS
cord-023095-4dannjjm	982	10	were	be	VBD
cord-023095-4dannjjm	982	11	evaluated	evaluate	VBN
cord-023095-4dannjjm	982	12	including	include	VBG
cord-023095-4dannjjm	982	13	constructs	construct	NNS
cord-023095-4dannjjm	982	14	of	of	IN
cord-023095-4dannjjm	982	15	pain	pain	NN
cord-023095-4dannjjm	982	16	;	;	:
cord-023095-4dannjjm	982	17	face	face	NN
cord-023095-4dannjjm	982	18	validity	validity	NN
cord-023095-4dannjjm	982	19	,	,	,
cord-023095-4dannjjm	982	20	convergent	convergent	JJ
cord-023095-4dannjjm	982	21	and	and	CC
cord-023095-4dannjjm	982	22	discriminate	discriminate	VB
cord-023095-4dannjjm	982	23	validity	validity	NN
cord-023095-4dannjjm	982	24	and	and	CC
cord-023095-4dannjjm	982	25	extreme	extreme	JJ
cord-023095-4dannjjm	982	26	groups	group	NNS
cord-023095-4dannjjm	982	27	.	.	.
cord-023095-4dannjjm	983	1	Thirty	thirty	CD
cord-023095-4dannjjm	983	2	of	of	IN
cord-023095-4dannjjm	983	3	40	40	CD
cord-023095-4dannjjm	983	4	films	film	NNS
cord-023095-4dannjjm	983	5	of	of	IN
cord-023095-4dannjjm	983	6	horses	horse	NNS
cord-023095-4dannjjm	983	7	with	with	IN
cord-023095-4dannjjm	983	8	colic	colic	NN
cord-023095-4dannjjm	983	9	were	be	VBD
cord-023095-4dannjjm	983	10	randomly	randomly	RB
cord-023095-4dannjjm	983	11	presented	present	VBN
cord-023095-4dannjjm	983	12	to	to	IN
cord-023095-4dannjjm	983	13	44	44	CD
cord-023095-4dannjjm	983	14	expert	expert	JJ
cord-023095-4dannjjm	983	15	equine	equine	JJ
cord-023095-4dannjjm	983	16	clinicians	clinician	NNS
cord-023095-4dannjjm	983	17	internationally	internationally	RB
cord-023095-4dannjjm	983	18	who	who	WP
cord-023095-4dannjjm	983	19	were	be	VBD
cord-023095-4dannjjm	983	20	randomly	randomly	RB
cord-023095-4dannjjm	983	21	allocated	allocate	VBN
cord-023095-4dannjjm	983	22	into	into	IN
cord-023095-4dannjjm	983	23	three	three	CD
cord-023095-4dannjjm	983	24	groups	group	NNS
cord-023095-4dannjjm	983	25	to	to	TO
cord-023095-4dannjjm	983	26	score	score	VB
cord-023095-4dannjjm	983	27	pain	pain	NN
cord-023095-4dannjjm	983	28	;	;	:
cord-023095-4dannjjm	983	29	one	one	CD
cord-023095-4dannjjm	983	30	group	group	NN
cord-023095-4dannjjm	983	31	by	by	IN
cord-023095-4dannjjm	983	32	both	both	CC
cord-023095-4dannjjm	983	33	VAS	VAS	NNP
cord-023095-4dannjjm	983	34	and	and	CC
cord-023095-4dannjjm	983	35	numerical	numerical	JJ
cord-023095-4dannjjm	983	36	rating	rating	NN
cord-023095-4dannjjm	983	37	scale	scale	NN
cord-023095-4dannjjm	983	38	(	(	-LRB-
cord-023095-4dannjjm	983	39	NRS	NRS	NNP
cord-023095-4dannjjm	983	40	)	)	-RRB-
cord-023095-4dannjjm	983	41	)	)	-RRB-
cord-023095-4dannjjm	983	42	,	,	,
cord-023095-4dannjjm	983	43	and	and	CC
cord-023095-4dannjjm	983	44	two	two	CD
cord-023095-4dannjjm	983	45	groups	group	NNS
cord-023095-4dannjjm	983	46	,	,	,
cord-023095-4dannjjm	983	47	each	each	DT
cord-023095-4dannjjm	983	48	by	by	IN
cord-023095-4dannjjm	983	49	one	one	CD
cord-023095-4dannjjm	983	50	of	of	IN
cord-023095-4dannjjm	983	51	the	the	DT
cord-023095-4dannjjm	983	52	two	two	CD
cord-023095-4dannjjm	983	53	EAAPS	EAAPS	NNP
cord-023095-4dannjjm	983	54	scales	scale	NNS
cord-023095-4dannjjm	983	55	.	.	.
cord-023095-4dannjjm	984	1	Inter	inter	JJ
cord-023095-4dannjjm	984	2	-	-	JJ
cord-023095-4dannjjm	984	3	observer	observer	JJ
cord-023095-4dannjjm	984	4	reliability	reliability	NN
cord-023095-4dannjjm	984	5	of	of	IN
cord-023095-4dannjjm	984	6	both	both	DT
cord-023095-4dannjjm	984	7	EAAPS	EAAPS	NNP
cord-023095-4dannjjm	984	8	scales	scale	NNS
cord-023095-4dannjjm	984	9	was	be	VBD
cord-023095-4dannjjm	984	10	excellent	excellent	JJ
cord-023095-4dannjjm	985	1	(	(	-LRB-
cord-023095-4dannjjm	985	2	Intraclass	Intraclass	NNP
cord-023095-4dannjjm	985	3	Correlation	Correlation	NNP
cord-023095-4dannjjm	985	4	0.8	0.8	CD
cord-023095-4dannjjm	985	5	)	)	-RRB-
cord-023095-4dannjjm	985	6	.	.	.
cord-023095-4dannjjm	986	1	Intra	intra	JJ
cord-023095-4dannjjm	986	2	-	-	JJ
cord-023095-4dannjjm	986	3	observer	observer	JJ
cord-023095-4dannjjm	986	4	reliability	reliability	NN
cord-023095-4dannjjm	986	5	based	base	VBN
cord-023095-4dannjjm	986	6	on	on	IN
cord-023095-4dannjjm	986	7	scores	score	NNS
cord-023095-4dannjjm	986	8	given	give	VBN
cord-023095-4dannjjm	986	9	for	for	IN
cord-023095-4dannjjm	986	10	identical	identical	JJ
cord-023095-4dannjjm	986	11	films	film	NNS
cord-023095-4dannjjm	986	12	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	986	13	;	;	:
cord-023095-4dannjjm	986	14	87	87	CD
cord-023095-4dannjjm	986	15	%	%	NN
cord-023095-4dannjjm	986	16	and	and	CC
cord-023095-4dannjjm	986	17	56	56	CD
cord-023095-4dannjjm	986	18	%	%	NN
cord-023095-4dannjjm	986	19	agreement	agreement	NN
cord-023095-4dannjjm	986	20	,	,	,
cord-023095-4dannjjm	986	21	kappa	kappa	NNP
cord-023095-4dannjjm	986	22	0.9	0.9	CD
cord-023095-4dannjjm	986	23	and	and	CC
cord-023095-4dannjjm	986	24	0.35	0.35	CD
cord-023095-4dannjjm	986	25	,	,	,
cord-023095-4dannjjm	986	26	and	and	CC
cord-023095-4dannjjm	986	27	Spearman	Spearman	NNP
cord-023095-4dannjjm	986	28	's	's	POS
cord-023095-4dannjjm	986	29	rho	rho	NN
cord-023095-4dannjjm	986	30	5	5	CD
cord-023095-4dannjjm	986	31	0.97	0.97	CD
cord-023095-4dannjjm	986	32	and	and	CC
cord-023095-4dannjjm	986	33	0.58	0.58	CD
cord-023095-4dannjjm	986	34	for	for	IN
cord-023095-4dannjjm	986	35	EAAPS-1	eaaps-1	NN
cord-023095-4dannjjm	986	36	and	and	CC
cord-023095-4dannjjm	986	37	2	2	CD
cord-023095-4dannjjm	986	38	,	,	,
cord-023095-4dannjjm	986	39	respectively	respectively	RB
cord-023095-4dannjjm	986	40	.	.	.
cord-023095-4dannjjm	987	1	Both	both	DT
cord-023095-4dannjjm	987	2	scales	scale	NNS
cord-023095-4dannjjm	987	3	varied	vary	VBN
cord-023095-4dannjjm	987	4	by	by	IN
cord-023095-4dannjjm	987	5	1	1	CD
cord-023095-4dannjjm	987	6	score	score	NN
cord-023095-4dannjjm	987	7	between	between	IN
cord-023095-4dannjjm	987	8	observations	observation	NNS
cord-023095-4dannjjm	987	9	.	.	.
cord-023095-4dannjjm	988	1	Face	face	NN
cord-023095-4dannjjm	988	2	validity	validity	NN
cord-023095-4dannjjm	988	3	;	;	:
cord-023095-4dannjjm	988	4	each	each	DT
cord-023095-4dannjjm	988	5	group	group	NN
cord-023095-4dannjjm	988	6	reported	report	VBD
cord-023095-4dannjjm	988	7	their	-PRON-	PRP$
cord-023095-4dannjjm	988	8	scale	scale	NN
cord-023095-4dannjjm	988	9	to	to	TO
cord-023095-4dannjjm	988	10	be	be	VB
cord-023095-4dannjjm	988	11	valid	valid	JJ
cord-023095-4dannjjm	988	12	(	(	-LRB-
cord-023095-4dannjjm	988	13	67	67	CD
cord-023095-4dannjjm	988	14	%	%	NN
cord-023095-4dannjjm	988	15	&	&	CC
cord-023095-4dannjjm	988	16	81	81	CD
cord-023095-4dannjjm	988	17	%	%	NN
cord-023095-4dannjjm	988	18	)	)	-RRB-
cord-023095-4dannjjm	988	19	.	.	.
cord-023095-4dannjjm	989	1	Convergent	convergent	JJ
cord-023095-4dannjjm	989	2	validity	validity	NN
cord-023095-4dannjjm	989	3	;	;	:
cord-023095-4dannjjm	989	4	the	the	DT
cord-023095-4dannjjm	989	5	scales	scale	NNS
cord-023095-4dannjjm	989	6	compared	compare	VBN
cord-023095-4dannjjm	989	7	favorably	favorably	RB
cord-023095-4dannjjm	989	8	with	with	IN
cord-023095-4dannjjm	989	9	VAS	VAS	NNP
cord-023095-4dannjjm	989	10	/	/	SYM
cord-023095-4dannjjm	989	11	NRS	NRS	NNP
cord-023095-4dannjjm	989	12	scores	score	NNS
cord-023095-4dannjjm	990	1	(	(	-LRB-
cord-023095-4dannjjm	990	2	Spearman	Spearman	NNP
cord-023095-4dannjjm	990	3	's	's	POS
cord-023095-4dannjjm	990	4	rho	rho	NN
cord-023095-4dannjjm	990	5	:	:	:
cord-023095-4dannjjm	990	6	0.84	0.84	CD
cord-023095-4dannjjm	990	7	-	-	HYPH
cord-023095-4dannjjm	990	8	0.89	0.89	CD
cord-023095-4dannjjm	990	9	)	)	-RRB-
cord-023095-4dannjjm	990	10	.	.	.
cord-023095-4dannjjm	991	1	Discriminate	discriminate	VB
cord-023095-4dannjjm	991	2	validity	validity	NN
cord-023095-4dannjjm	991	3	;	;	:
cord-023095-4dannjjm	991	4	correlation	correlation	NN
cord-023095-4dannjjm	991	5	to	to	IN
cord-023095-4dannjjm	991	6	heart	heart	NN
cord-023095-4dannjjm	991	7	rate	rate	NN
cord-023095-4dannjjm	991	8	,	,	,
cord-023095-4dannjjm	991	9	lactate	lactate	NN
cord-023095-4dannjjm	991	10	and	and	CC
cord-023095-4dannjjm	991	11	cortisol	cortisol	NN
cord-023095-4dannjjm	991	12	levels	level	NNS
cord-023095-4dannjjm	991	13	was	be	VBD
cord-023095-4dannjjm	991	14	predictably	predictably	RB
cord-023095-4dannjjm	991	15	low	low	JJ
cord-023095-4dannjjm	992	1	(	(	-LRB-
cord-023095-4dannjjm	992	2	rho	rho	NNP
cord-023095-4dannjjm	992	3	5	5	CD
cord-023095-4dannjjm	992	4	0.2	0.2	CD
cord-023095-4dannjjm	992	5	-	-	HYPH
cord-023095-4dannjjm	992	6	0.5	0.5	CD
cord-023095-4dannjjm	992	7	)	)	-RRB-
cord-023095-4dannjjm	992	8	.	.	.
cord-023095-4dannjjm	993	1	Extreme	extreme	JJ
cord-023095-4dannjjm	993	2	group	group	NN
cord-023095-4dannjjm	993	3	validity	validity	NN
cord-023095-4dannjjm	993	4	;	;	:
cord-023095-4dannjjm	993	5	colic	colic	NN
cord-023095-4dannjjm	993	6	horses	horse	NNS
cord-023095-4dannjjm	993	7	scored	score	VBD
cord-023095-4dannjjm	993	8	significantly	significantly	RB
cord-023095-4dannjjm	993	9	higher	high	JJR
cord-023095-4dannjjm	993	10	than	than	IN
cord-023095-4dannjjm	993	11	control	control	NN
cord-023095-4dannjjm	993	12	horses	horse	NNS
cord-023095-4dannjjm	993	13	;	;	:
cord-023095-4dannjjm	993	14	scores	score	NNS
cord-023095-4dannjjm	993	15	of	of	IN
cord-023095-4dannjjm	993	16	0.6	0.6	CD
cord-023095-4dannjjm	993	17	-	-	SYM
cord-023095-4dannjjm	993	18	0.7	0.7	CD
cord-023095-4dannjjm	993	19	in	in	IN
cord-023095-4dannjjm	993	20	controls	control	NNS
cord-023095-4dannjjm	993	21	versus	versus	IN
cord-023095-4dannjjm	993	22	2.6	2.6	CD
cord-023095-4dannjjm	993	23	-	-	SYM
cord-023095-4dannjjm	993	24	2.7	2.7	CD
cord-023095-4dannjjm	993	25	in	in	IN
cord-023095-4dannjjm	993	26	cases	case	NNS
cord-023095-4dannjjm	993	27	.	.	.
cord-023095-4dannjjm	994	1	In	in	IN
cord-023095-4dannjjm	994	2	conclusion	conclusion	NN
cord-023095-4dannjjm	994	3	,	,	,
cord-023095-4dannjjm	994	4	methodology	methodology	NN
cord-023095-4dannjjm	994	5	established	establish	VBN
cord-023095-4dannjjm	994	6	in	in	IN
cord-023095-4dannjjm	994	7	human	human	JJ
cord-023095-4dannjjm	994	8	medicine	medicine	NN
cord-023095-4dannjjm	994	9	but	but	CC
cord-023095-4dannjjm	994	10	novel	novel	NN
cord-023095-4dannjjm	994	11	in	in	IN
cord-023095-4dannjjm	994	12	veterinary	veterinary	JJ
cord-023095-4dannjjm	994	13	medicine	medicine	NN
cord-023095-4dannjjm	994	14	was	be	VBD
cord-023095-4dannjjm	994	15	used	use	VBN
cord-023095-4dannjjm	994	16	to	to	TO
cord-023095-4dannjjm	994	17	construct	construct	VB
cord-023095-4dannjjm	994	18	and	and	CC
cord-023095-4dannjjm	994	19	validate	validate	VB
cord-023095-4dannjjm	994	20	two	two	CD
cord-023095-4dannjjm	994	21	clinically	clinically	RB
cord-023095-4dannjjm	994	22	feasible	feasible	JJ
cord-023095-4dannjjm	994	23	equine	equine	JJ
cord-023095-4dannjjm	994	24	abdominal	abdominal	JJ
cord-023095-4dannjjm	994	25	pain	pain	NN
cord-023095-4dannjjm	994	26	severity	severity	NN
cord-023095-4dannjjm	994	27	scales	scale	NNS
cord-023095-4dannjjm	994	28	that	that	WDT
cord-023095-4dannjjm	994	29	showed	show	VBD
cord-023095-4dannjjm	994	30	excellent	excellent	JJ
cord-023095-4dannjjm	994	31	reliability	reliability	NN
cord-023095-4dannjjm	994	32	and	and	CC
cord-023095-4dannjjm	994	33	validity	validity	NN
cord-023095-4dannjjm	994	34	.	.	.
cord-023095-4dannjjm	995	1	Further	further	JJ
cord-023095-4dannjjm	995	2	refinement	refinement	NN
cord-023095-4dannjjm	995	3	of	of	IN
cord-023095-4dannjjm	995	4	the	the	DT
cord-023095-4dannjjm	995	5	EAAPS	EAAPS	NNP
cord-023095-4dannjjm	995	6	scale	scale	NN
cord-023095-4dannjjm	995	7	is	be	VBZ
cord-023095-4dannjjm	995	8	advised	advise	VBN
cord-023095-4dannjjm	995	9	prior	prior	RB
cord-023095-4dannjjm	995	10	to	to	IN
cord-023095-4dannjjm	995	11	introduction	introduction	NN
cord-023095-4dannjjm	995	12	into	into	IN
cord-023095-4dannjjm	995	13	clinical	clinical	JJ
cord-023095-4dannjjm	995	14	practice	practice	NN
cord-023095-4dannjjm	995	15	.	.	.
cord-023095-4dannjjm	996	1	Aortic	aortic	JJ
cord-023095-4dannjjm	996	2	valve	valve	NN
cord-023095-4dannjjm	996	3	prolapse	prolapse	NN
cord-023095-4dannjjm	996	4	(	(	-LRB-
cord-023095-4dannjjm	996	5	AVP	AVP	NNP
cord-023095-4dannjjm	996	6	)	)	-RRB-
cord-023095-4dannjjm	996	7	is	be	VBZ
cord-023095-4dannjjm	996	8	a	a	DT
cord-023095-4dannjjm	996	9	common	common	JJ
cord-023095-4dannjjm	996	10	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	996	11	finding	finding	NN
cord-023095-4dannjjm	996	12	in	in	IN
cord-023095-4dannjjm	996	13	horses	horse	NNS
cord-023095-4dannjjm	996	14	,	,	,
cord-023095-4dannjjm	996	15	but	but	CC
cord-023095-4dannjjm	996	16	when	when	WRB
cord-023095-4dannjjm	996	17	compared	compare	VBN
cord-023095-4dannjjm	996	18	with	with	IN
cord-023095-4dannjjm	996	19	mitral	mitral	JJ
cord-023095-4dannjjm	996	20	valve	valve	NN
cord-023095-4dannjjm	996	21	prolapse	prolapse	NN
cord-023095-4dannjjm	996	22	in	in	IN
cord-023095-4dannjjm	996	23	dogs	dog	NNS
cord-023095-4dannjjm	996	24	,	,	,
cord-023095-4dannjjm	996	25	little	little	JJ
cord-023095-4dannjjm	996	26	is	be	VBZ
cord-023095-4dannjjm	996	27	known	know	VBN
cord-023095-4dannjjm	996	28	about	about	IN
cord-023095-4dannjjm	996	29	the	the	DT
cord-023095-4dannjjm	996	30	natural	natural	JJ
cord-023095-4dannjjm	996	31	progression	progression	NN
cord-023095-4dannjjm	996	32	of	of	IN
cord-023095-4dannjjm	996	33	this	this	DT
cord-023095-4dannjjm	996	34	condition	condition	NN
cord-023095-4dannjjm	996	35	.	.	.
cord-023095-4dannjjm	997	1	Previously	previously	RB
cord-023095-4dannjjm	997	2	published	publish	VBN
cord-023095-4dannjjm	997	3	data	datum	NNS
cord-023095-4dannjjm	997	4	has	have	VBZ
cord-023095-4dannjjm	997	5	shown	show	VBN
cord-023095-4dannjjm	997	6	that	that	IN
cord-023095-4dannjjm	997	7	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	997	8	identification	identification	NN
cord-023095-4dannjjm	997	9	of	of	IN
cord-023095-4dannjjm	997	10	AVP	AVP	NNP
cord-023095-4dannjjm	997	11	in	in	IN
cord-023095-4dannjjm	997	12	horses	horse	NNS
cord-023095-4dannjjm	997	13	is	be	VBZ
cord-023095-4dannjjm	997	14	reliable	reliable	JJ
cord-023095-4dannjjm	997	15	,	,	,
cord-023095-4dannjjm	997	16	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	997	17	criteria	criterion	NNS
cord-023095-4dannjjm	997	18	have	have	VBP
cord-023095-4dannjjm	997	19	been	be	VBN
cord-023095-4dannjjm	997	20	established	establish	VBN
cord-023095-4dannjjm	997	21	and	and	CC
cord-023095-4dannjjm	997	22	that	that	IN
cord-023095-4dannjjm	997	23	development	development	NN
cord-023095-4dannjjm	997	24	occurs	occur	VBZ
cord-023095-4dannjjm	997	25	with	with	IN
cord-023095-4dannjjm	997	26	training	training	NN
cord-023095-4dannjjm	997	27	.	.	.
cord-023095-4dannjjm	998	1	The	the	DT
cord-023095-4dannjjm	998	2	aims	aim	NNS
cord-023095-4dannjjm	998	3	of	of	IN
cord-023095-4dannjjm	998	4	this	this	DT
cord-023095-4dannjjm	998	5	study	study	NN
cord-023095-4dannjjm	998	6	were	be	VBD
cord-023095-4dannjjm	998	7	to	to	TO
cord-023095-4dannjjm	998	8	evaluate	evaluate	VB
cord-023095-4dannjjm	998	9	the	the	DT
cord-023095-4dannjjm	998	10	different	different	JJ
cord-023095-4dannjjm	998	11	RNA	RNA	NNP
cord-023095-4dannjjm	998	12	and	and	CC
cord-023095-4dannjjm	998	13	protein	protein	NN
cord-023095-4dannjjm	998	14	expressions	expression	NNS
cord-023095-4dannjjm	998	15	of	of	IN
cord-023095-4dannjjm	998	16	smooth	smooth	JJ
cord-023095-4dannjjm	998	17	muscle	muscle	NN
cord-023095-4dannjjm	998	18	actin	actin	NN
cord-023095-4dannjjm	998	19	(	(	-LRB-
cord-023095-4dannjjm	998	20	SMA	SMA	NNP
cord-023095-4dannjjm	998	21	)	)	-RRB-
cord-023095-4dannjjm	998	22	,	,	,
cord-023095-4dannjjm	998	23	transforming	transform	VBG
cord-023095-4dannjjm	998	24	growth	growth	NN
cord-023095-4dannjjm	998	25	factor	factor	NN
cord-023095-4dannjjm	998	26	-	-	HYPH
cord-023095-4dannjjm	998	27	b	b	NN
cord-023095-4dannjjm	998	28	1	1	CD
cord-023095-4dannjjm	998	29	(	(	-LRB-
cord-023095-4dannjjm	998	30	TGF	TGF	NNP
cord-023095-4dannjjm	998	31	)	)	-RRB-
cord-023095-4dannjjm	998	32	,	,	,
cord-023095-4dannjjm	998	33	nitric	nitric	JJ
cord-023095-4dannjjm	998	34	oxide	oxide	NN
cord-023095-4dannjjm	998	35	synthase	synthase	NN
cord-023095-4dannjjm	998	36	(	(	-LRB-
cord-023095-4dannjjm	998	37	NOS	NOS	NNP
cord-023095-4dannjjm	998	38	)	)	-RRB-
cord-023095-4dannjjm	998	39	and	and	CC
cord-023095-4dannjjm	998	40	the	the	DT
cord-023095-4dannjjm	998	41	concentrations	concentration	NNS
cord-023095-4dannjjm	998	42	of	of	IN
cord-023095-4dannjjm	998	43	elastin	elastin	NN
cord-023095-4dannjjm	998	44	and	and	CC
cord-023095-4dannjjm	998	45	collagen	collagen	NN
cord-023095-4dannjjm	998	46	in	in	IN
cord-023095-4dannjjm	998	47	normal	normal	JJ
cord-023095-4dannjjm	998	48	,	,	,
cord-023095-4dannjjm	998	49	prolapsing	prolapse	VBG
cord-023095-4dannjjm	998	50	and	and	CC
cord-023095-4dannjjm	998	51	diseased	diseased	JJ
cord-023095-4dannjjm	998	52	cusps	cusp	NNS
cord-023095-4dannjjm	998	53	to	to	TO
cord-023095-4dannjjm	998	54	evaluate	evaluate	VB
cord-023095-4dannjjm	998	55	what	what	WP
cord-023095-4dannjjm	998	56	structural	structural	JJ
cord-023095-4dannjjm	998	57	changes	change	NNS
cord-023095-4dannjjm	998	58	may	may	MD
cord-023095-4dannjjm	998	59	predispose	predispose	VB
cord-023095-4dannjjm	998	60	them	-PRON-	PRP
cord-023095-4dannjjm	998	61	to	to	TO
cord-023095-4dannjjm	998	62	prolapse	prolapse	VB
cord-023095-4dannjjm	998	63	.	.	.
cord-023095-4dannjjm	999	1	Valve	valve	NN
cord-023095-4dannjjm	999	2	cusps	cusp	NNS
cord-023095-4dannjjm	999	3	were	be	VBD
cord-023095-4dannjjm	999	4	harvested	harvest	VBN
cord-023095-4dannjjm	999	5	and	and	CC
cord-023095-4dannjjm	999	6	processed	process	VBN
cord-023095-4dannjjm	999	7	from	from	IN
cord-023095-4dannjjm	999	8	a	a	DT
cord-023095-4dannjjm	999	9	group	group	NN
cord-023095-4dannjjm	999	10	of	of	IN
cord-023095-4dannjjm	999	11	176	176	CD
cord-023095-4dannjjm	999	12	horses	horse	NNS
cord-023095-4dannjjm	999	13	at	at	IN
cord-023095-4dannjjm	999	14	a	a	DT
cord-023095-4dannjjm	999	15	commercial	commercial	JJ
cord-023095-4dannjjm	999	16	abattoir	abattoir	NN
cord-023095-4dannjjm	999	17	following	follow	VBG
cord-023095-4dannjjm	999	18	disease	disease	NN
cord-023095-4dannjjm	999	19	classification	classification	NN
cord-023095-4dannjjm	999	20	using	use	VBG
cord-023095-4dannjjm	999	21	echocardiography	echocardiography	NN
cord-023095-4dannjjm	999	22	.	.	.
cord-023095-4dannjjm	1000	1	Horses	horse	NNS
cord-023095-4dannjjm	1000	2	were	be	VBD
cord-023095-4dannjjm	1000	3	aged	aged	JJ
cord-023095-4dannjjm	1000	4	13.7	13.7	CD
cord-023095-4dannjjm	1000	5	AE	AE	NNP
cord-023095-4dannjjm	1000	6	6.7years	6.7year	NNS
cord-023095-4dannjjm	1000	7	,	,	,
cord-023095-4dannjjm	1000	8	weighing	weigh	VBG
cord-023095-4dannjjm	1000	9	518	518	CD
cord-023095-4dannjjm	1000	10	AE	AE	NNP
cord-023095-4dannjjm	1000	11	51	51	CD
cord-023095-4dannjjm	1000	12	Kg	kg	CD
cord-023095-4dannjjm	1000	13	and	and	CC
cord-023095-4dannjjm	1000	14	with	with	IN
cord-023095-4dannjjm	1000	15	a	a	DT
cord-023095-4dannjjm	1000	16	median	median	JJ
cord-023095-4dannjjm	1000	17	body	body	NN
cord-023095-4dannjjm	1000	18	condition	condition	NN
cord-023095-4dannjjm	1000	19	score	score	NN
cord-023095-4dannjjm	1000	20	of	of	IN
cord-023095-4dannjjm	1000	21	4/9	4/9	CD
cord-023095-4dannjjm	1000	22	.	.	.
cord-023095-4dannjjm	1001	1	Cusps	Cusps	NNP
cord-023095-4dannjjm	1001	2	were	be	VBD
cord-023095-4dannjjm	1001	3	collected	collect	VBN
cord-023095-4dannjjm	1001	4	in	in	IN
cord-023095-4dannjjm	1001	5	RNAlater	RNAlater	NNP
cord-023095-4dannjjm	1001	6	s	s	NNP
cord-023095-4dannjjm	1001	7	and	and	CC
cord-023095-4dannjjm	1001	8	stored	store	VBN
cord-023095-4dannjjm	1001	9	at	at	IN
cord-023095-4dannjjm	1001	10	À801C	À801C	NNPS
cord-023095-4dannjjm	1001	11	prior	prior	RB
cord-023095-4dannjjm	1001	12	to	to	IN
cord-023095-4dannjjm	1001	13	processing	processing	NN
cord-023095-4dannjjm	1001	14	.	.	.
cord-023095-4dannjjm	1002	1	cDNA	cDNA	NNP
cord-023095-4dannjjm	1002	2	was	be	VBD
cord-023095-4dannjjm	1002	3	produced	produce	VBN
cord-023095-4dannjjm	1002	4	from	from	IN
cord-023095-4dannjjm	1002	5	half	half	PDT
cord-023095-4dannjjm	1002	6	a	a	DT
cord-023095-4dannjjm	1002	7	valve	valve	NN
cord-023095-4dannjjm	1002	8	using	use	VBG
cord-023095-4dannjjm	1002	9	a	a	DT
cord-023095-4dannjjm	1002	10	standard	standard	JJ
cord-023095-4dannjjm	1002	11	protocoland	protocoland	NN
cord-023095-4dannjjm	1002	12	qRT	qRT	NNP
cord-023095-4dannjjm	1002	13	-	-	HYPH
cord-023095-4dannjjm	1002	14	PCR	PCR	NNP
cord-023095-4dannjjm	1002	15	performed	perform	VBN
cord-023095-4dannjjm	1002	16	to	to	TO
cord-023095-4dannjjm	1002	17	assess	assess	VB
cord-023095-4dannjjm	1002	18	relative	relative	JJ
cord-023095-4dannjjm	1002	19	RNA	RNA	NNP
cord-023095-4dannjjm	1002	20	expression	expression	NN
cord-023095-4dannjjm	1002	21	of	of	IN
cord-023095-4dannjjm	1002	22	SMA	SMA	NNP
cord-023095-4dannjjm	1002	23	,	,	,
cord-023095-4dannjjm	1002	24	TGFb	tgfb	JJ
cord-023095-4dannjjm	1002	25	1	1	CD
cord-023095-4dannjjm	1002	26	,	,	,
cord-023095-4dannjjm	1002	27	endothelial	endothelial	JJ
cord-023095-4dannjjm	1002	28	(	(	-LRB-
cord-023095-4dannjjm	1002	29	eNOS	enos	JJ
cord-023095-4dannjjm	1002	30	)	)	-RRB-
cord-023095-4dannjjm	1002	31	and	and	CC
cord-023095-4dannjjm	1002	32	inducible	inducible	JJ
cord-023095-4dannjjm	1002	33	NOS	NOS	NNP
cord-023095-4dannjjm	1002	34	(	(	-LRB-
cord-023095-4dannjjm	1002	35	iNOS	inos	NN
cord-023095-4dannjjm	1002	36	)	)	-RRB-
cord-023095-4dannjjm	1002	37	and	and	CC
cord-023095-4dannjjm	1002	38	compared	compare	VBN
cord-023095-4dannjjm	1002	39	with	with	IN
cord-023095-4dannjjm	1002	40	the	the	DT
cord-023095-4dannjjm	1002	41	housekeeping	housekeeping	NN
cord-023095-4dannjjm	1002	42	gene	gene	NN
cord-023095-4dannjjm	1002	43	18S.	18s.	CD
cord-023095-4dannjjm	1002	44	A	a	DT
cord-023095-4dannjjm	1002	45	quarter	quarter	NN
cord-023095-4dannjjm	1002	46	of	of	IN
cord-023095-4dannjjm	1002	47	cusp	cusp	NN
cord-023095-4dannjjm	1002	48	was	be	VBD
cord-023095-4dannjjm	1002	49	processed	process	VBN
cord-023095-4dannjjm	1002	50	using	use	VBG
cord-023095-4dannjjm	1002	51	an	an	DT
cord-023095-4dannjjm	1002	52	adapted	adapt	VBN
cord-023095-4dannjjm	1002	53	commercial	commercial	JJ
cord-023095-4dannjjm	1002	54	protocol	protocol	NN
cord-023095-4dannjjm	1002	55	to	to	TO
cord-023095-4dannjjm	1002	56	evaluate	evaluate	VB
cord-023095-4dannjjm	1002	57	protein	protein	NN
cord-023095-4dannjjm	1002	58	expression	expression	NN
cord-023095-4dannjjm	1002	59	of	of	IN
cord-023095-4dannjjm	1002	60	SMA	SMA	NNP
cord-023095-4dannjjm	1002	61	,	,	,
cord-023095-4dannjjm	1002	62	TGF	TGF	NNP
cord-023095-4dannjjm	1002	63	b	b	NNP
cord-023095-4dannjjm	1002	64	1	1	CD
cord-023095-4dannjjm	1002	65	,	,	,
cord-023095-4dannjjm	1002	66	eNOS	enos	JJ
cord-023095-4dannjjm	1002	67	and	and	CC
cord-023095-4dannjjm	1002	68	compared	compare	VBN
cord-023095-4dannjjm	1002	69	to	to	IN
cord-023095-4dannjjm	1002	70	vimentin	vimentin	NNS
cord-023095-4dannjjm	1002	71	.	.	.
cord-023095-4dannjjm	1003	1	Specific	specific	JJ
cord-023095-4dannjjm	1003	2	antibody	antibody	NN
cord-023095-4dannjjm	1003	3	binding	binding	NN
cord-023095-4dannjjm	1003	4	was	be	VBD
cord-023095-4dannjjm	1003	5	assessed	assess	VBN
cord-023095-4dannjjm	1003	6	with	with	IN
cord-023095-4dannjjm	1003	7	western	western	JJ
cord-023095-4dannjjm	1003	8	blotting	blotting	NN
cord-023095-4dannjjm	1003	9	and	and	CC
cord-023095-4dannjjm	1003	10	protein	protein	NN
cord-023095-4dannjjm	1003	11	expression	expression	NN
cord-023095-4dannjjm	1003	12	evaluated	evaluate	VBD
cord-023095-4dannjjm	1003	13	using	use	VBG
cord-023095-4dannjjm	1003	14	dot	dot	NN
cord-023095-4dannjjm	1003	15	blots	blot	NNS
cord-023095-4dannjjm	1003	16	.	.	.
cord-023095-4dannjjm	1004	1	The	the	DT
cord-023095-4dannjjm	1004	2	remaining	remain	VBG
cord-023095-4dannjjm	1004	3	quarter	quarter	NN
cord-023095-4dannjjm	1004	4	cusp	cusp	NN
cord-023095-4dannjjm	1004	5	was	be	VBD
cord-023095-4dannjjm	1004	6	used	use	VBN
cord-023095-4dannjjm	1004	7	to	to	TO
cord-023095-4dannjjm	1004	8	measure	measure	VB
cord-023095-4dannjjm	1004	9	soluble	soluble	JJ
cord-023095-4dannjjm	1004	10	collagen	collagen	NN
cord-023095-4dannjjm	1004	11	and	and	CC
cord-023095-4dannjjm	1004	12	elastin	elastin	NN
cord-023095-4dannjjm	1004	13	concentrations	concentration	NNS
cord-023095-4dannjjm	1004	14	using	use	VBG
cord-023095-4dannjjm	1004	15	commercial	commercial	JJ
cord-023095-4dannjjm	1004	16	assays	assay	NNS
cord-023095-4dannjjm	1004	17	3	3	CD
cord-023095-4dannjjm	1004	18	.	.	.
cord-023095-4dannjjm	1005	1	Statistical	statistical	JJ
cord-023095-4dannjjm	1005	2	analyses	analysis	NNS
cord-023095-4dannjjm	1005	3	included	include	VBD
cord-023095-4dannjjm	1005	4	one	one	CD
cord-023095-4dannjjm	1005	5	way	way	NN
cord-023095-4dannjjm	1005	6	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	1005	7	with	with	IN
cord-023095-4dannjjm	1005	8	post	post	JJ
cord-023095-4dannjjm	1005	9	-	-	JJ
cord-023095-4dannjjm	1005	10	hoc	hoc	JJ
cord-023095-4dannjjm	1005	11	Bonferoni	Bonferoni	NNP
cord-023095-4dannjjm	1005	12	,	,	,
cord-023095-4dannjjm	1005	13	paired	pair	VBN
cord-023095-4dannjjm	1005	14	Student	Student	NNP
cord-023095-4dannjjm	1005	15	's	's	POS
cord-023095-4dannjjm	1005	16	T	t	NN
cord-023095-4dannjjm	1005	17	-	-	HYPH
cord-023095-4dannjjm	1005	18	test	test	NN
cord-023095-4dannjjm	1005	19	,	,	,
cord-023095-4dannjjm	1005	20	linear	linear	JJ
cord-023095-4dannjjm	1005	21	and	and	CC
cord-023095-4dannjjm	1005	22	logistic	logistic	JJ
cord-023095-4dannjjm	1005	23	regression	regression	NN
cord-023095-4dannjjm	1005	24	.	.	.
cord-023095-4dannjjm	1006	1	There	there	EX
cord-023095-4dannjjm	1006	2	was	be	VBD
cord-023095-4dannjjm	1006	3	no	no	DT
cord-023095-4dannjjm	1006	4	effect	effect	NN
cord-023095-4dannjjm	1006	5	of	of	IN
cord-023095-4dannjjm	1006	6	gender	gender	NN
cord-023095-4dannjjm	1006	7	or	or	CC
cord-023095-4dannjjm	1006	8	age	age	NN
cord-023095-4dannjjm	1006	9	on	on	IN
cord-023095-4dannjjm	1006	10	any	any	DT
cord-023095-4dannjjm	1006	11	of	of	IN
cord-023095-4dannjjm	1006	12	the	the	DT
cord-023095-4dannjjm	1006	13	measurements	measurement	NNS
cord-023095-4dannjjm	1006	14	.	.	.
cord-023095-4dannjjm	1007	1	Valves	valve	NNS
cord-023095-4dannjjm	1007	2	from	from	IN
cord-023095-4dannjjm	1007	3	animals	animal	NNS
cord-023095-4dannjjm	1007	4	with	with	IN
cord-023095-4dannjjm	1007	5	AVP	AVP	NNP
cord-023095-4dannjjm	1007	6	had	have	VBD
cord-023095-4dannjjm	1007	7	lower	low	JJR
cord-023095-4dannjjm	1007	8	expression	expression	NN
cord-023095-4dannjjm	1007	9	of	of	IN
cord-023095-4dannjjm	1007	10	SMA	SMA	NNP
cord-023095-4dannjjm	1007	11	and	and	CC
cord-023095-4dannjjm	1007	12	Elastin	Elastin	NNP
cord-023095-4dannjjm	1007	13	compared	compare	VBN
cord-023095-4dannjjm	1007	14	to	to	IN
cord-023095-4dannjjm	1007	15	normal	normal	JJ
cord-023095-4dannjjm	1007	16	and	and	CC
cord-023095-4dannjjm	1007	17	diseased	diseased	JJ
cord-023095-4dannjjm	1007	18	valves	valve	NNS
cord-023095-4dannjjm	1007	19	,	,	,
cord-023095-4dannjjm	1007	20	increased	increase	VBN
cord-023095-4dannjjm	1007	21	expression	expression	NN
cord-023095-4dannjjm	1007	22	of	of	IN
cord-023095-4dannjjm	1007	23	TGFb	tgfb	JJ
cord-023095-4dannjjm	1007	24	1	1	CD
cord-023095-4dannjjm	1007	25	and	and	CC
cord-023095-4dannjjm	1007	26	eNOS	enos	JJ
cord-023095-4dannjjm	1007	27	,	,	,
cord-023095-4dannjjm	1007	28	whereas	whereas	IN
cord-023095-4dannjjm	1007	29	iNOS	inos	JJ
cord-023095-4dannjjm	1007	30	expression	expression	NN
cord-023095-4dannjjm	1007	31	was	be	VBD
cord-023095-4dannjjm	1007	32	greater	great	JJR
cord-023095-4dannjjm	1007	33	than	than	IN
cord-023095-4dannjjm	1007	34	normal	normal	JJ
cord-023095-4dannjjm	1007	35	valves	valve	NNS
cord-023095-4dannjjm	1007	36	(	(	-LRB-
cord-023095-4dannjjm	1007	37	Table	table	NN
cord-023095-4dannjjm	1007	38	1	1	CD
cord-023095-4dannjjm	1007	39	)	)	-RRB-
cord-023095-4dannjjm	1007	40	.	.	.
cord-023095-4dannjjm	1008	1	Collagen	collagen	NN
cord-023095-4dannjjm	1008	2	content	content	NN
cord-023095-4dannjjm	1008	3	of	of	IN
cord-023095-4dannjjm	1008	4	valves	valve	NNS
cord-023095-4dannjjm	1008	5	from	from	IN
cord-023095-4dannjjm	1008	6	horses	horse	NNS
cord-023095-4dannjjm	1008	7	with	with	IN
cord-023095-4dannjjm	1008	8	AVP	AVP	NNP
cord-023095-4dannjjm	1008	9	was	be	VBD
cord-023095-4dannjjm	1008	10	increased	increase	VBN
cord-023095-4dannjjm	1008	11	compared	compare	VBN
cord-023095-4dannjjm	1008	12	to	to	IN
cord-023095-4dannjjm	1008	13	normal	normal	JJ
cord-023095-4dannjjm	1008	14	but	but	CC
cord-023095-4dannjjm	1008	15	lower	low	JJR
cord-023095-4dannjjm	1008	16	than	than	IN
cord-023095-4dannjjm	1008	17	horses	horse	NNS
cord-023095-4dannjjm	1008	18	with	with	IN
cord-023095-4dannjjm	1008	19	valve	valve	NN
cord-023095-4dannjjm	1008	20	disease	disease	NN
cord-023095-4dannjjm	1008	21	.	.	.
cord-023095-4dannjjm	1009	1	Prolapsing	prolapse	VBG
cord-023095-4dannjjm	1009	2	cusps	cusp	NNS
cord-023095-4dannjjm	1009	3	appear	appear	VBP
cord-023095-4dannjjm	1009	4	to	to	TO
cord-023095-4dannjjm	1009	5	be	be	VB
cord-023095-4dannjjm	1009	6	a	a	DT
cord-023095-4dannjjm	1009	7	different	different	JJ
cord-023095-4dannjjm	1009	8	phenotype	phenotype	NN
cord-023095-4dannjjm	1009	9	from	from	IN
cord-023095-4dannjjm	1009	10	diseased	diseased	JJ
cord-023095-4dannjjm	1009	11	cusps	cusp	NNS
cord-023095-4dannjjm	1009	12	.	.	.
cord-023095-4dannjjm	1010	1	Further	further	JJ
cord-023095-4dannjjm	1010	2	studies	study	NNS
cord-023095-4dannjjm	1010	3	will	will	MD
cord-023095-4dannjjm	1010	4	help	help	VB
cord-023095-4dannjjm	1010	5	to	to	TO
cord-023095-4dannjjm	1010	6	elucidate	elucidate	VB
cord-023095-4dannjjm	1010	7	the	the	DT
cord-023095-4dannjjm	1010	8	significance	significance	NN
cord-023095-4dannjjm	1010	9	of	of	IN
cord-023095-4dannjjm	1010	10	these	these	DT
cord-023095-4dannjjm	1010	11	findings	finding	NNS
cord-023095-4dannjjm	1010	12	in	in	IN
cord-023095-4dannjjm	1010	13	vivo	vivo	NN
cord-023095-4dannjjm	1010	14	.	.	.
cord-023095-4dannjjm	1011	1	A	a	DT
cord-023095-4dannjjm	1011	2	clear	clear	JJ
cord-023095-4dannjjm	1011	3	association	association	NN
cord-023095-4dannjjm	1011	4	between	between	IN
cord-023095-4dannjjm	1011	5	heart	heart	NN
cord-023095-4dannjjm	1011	6	rate	rate	NN
cord-023095-4dannjjm	1011	7	(	(	-LRB-
cord-023095-4dannjjm	1011	8	HR	HR	NNP
cord-023095-4dannjjm	1011	9	)	)	-RRB-
cord-023095-4dannjjm	1011	10	and	and	CC
cord-023095-4dannjjm	1011	11	body	body	NN
cord-023095-4dannjjm	1011	12	mass	mass	NN
cord-023095-4dannjjm	1011	13	has	have	VBZ
cord-023095-4dannjjm	1011	14	been	be	VBN
cord-023095-4dannjjm	1011	15	observed	observe	VBN
cord-023095-4dannjjm	1011	16	across	across	IN
cord-023095-4dannjjm	1011	17	a	a	DT
cord-023095-4dannjjm	1011	18	wide	wide	JJ
cord-023095-4dannjjm	1011	19	range	range	NN
cord-023095-4dannjjm	1011	20	of	of	IN
cord-023095-4dannjjm	1011	21	mammalian	mammalian	JJ
cord-023095-4dannjjm	1011	22	species	specie	NNS
cord-023095-4dannjjm	1011	23	.	.	.
cord-023095-4dannjjm	1012	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	1012	2	,	,	,
cord-023095-4dannjjm	1012	3	it	-PRON-	PRP
cord-023095-4dannjjm	1012	4	is	be	VBZ
cord-023095-4dannjjm	1012	5	well	well	RB
cord-023095-4dannjjm	1012	6	known	know	VBN
cord-023095-4dannjjm	1012	7	that	that	IN
cord-023095-4dannjjm	1012	8	electrocardiographic	electrocardiographic	NNP
cord-023095-4dannjjm	1012	9	(	(	-LRB-
cord-023095-4dannjjm	1012	10	ECG	ECG	NNP
cord-023095-4dannjjm	1012	11	)	)	-RRB-
cord-023095-4dannjjm	1012	12	time	time	NN
cord-023095-4dannjjm	1012	13	intervals	interval	NNS
cord-023095-4dannjjm	1012	14	vary	vary	VBP
cord-023095-4dannjjm	1012	15	with	with	IN
cord-023095-4dannjjm	1012	16	heart	heart	NN
cord-023095-4dannjjm	1012	17	rate	rate	NN
cord-023095-4dannjjm	1012	18	and	and	CC
cord-023095-4dannjjm	1012	19	body	body	NN
cord-023095-4dannjjm	1012	20	mass	mass	NN
cord-023095-4dannjjm	1012	21	.	.	.
cord-023095-4dannjjm	1013	1	Within	within	IN
cord-023095-4dannjjm	1013	2	the	the	DT
cord-023095-4dannjjm	1013	3	equine	equine	JJ
cord-023095-4dannjjm	1013	4	species	specie	NNS
cord-023095-4dannjjm	1013	5	,	,	,
cord-023095-4dannjjm	1013	6	small	small	JJ
cord-023095-4dannjjm	1013	7	breeds	breed	NNS
cord-023095-4dannjjm	1013	8	are	be	VBP
cord-023095-4dannjjm	1013	9	generally	generally	RB
cord-023095-4dannjjm	1013	10	thought	think	VBN
cord-023095-4dannjjm	1013	11	to	to	TO
cord-023095-4dannjjm	1013	12	have	have	VB
cord-023095-4dannjjm	1013	13	higher	high	JJR
cord-023095-4dannjjm	1013	14	heart	heart	NN
cord-023095-4dannjjm	1013	15	rates	rate	NNS
cord-023095-4dannjjm	1013	16	than	than	IN
cord-023095-4dannjjm	1013	17	large	large	JJ
cord-023095-4dannjjm	1013	18	breeds	breed	NNS
cord-023095-4dannjjm	1013	19	.	.	.
cord-023095-4dannjjm	1014	1	However	however	RB
cord-023095-4dannjjm	1014	2	,	,	,
cord-023095-4dannjjm	1014	3	despite	despite	IN
cord-023095-4dannjjm	1014	4	the	the	DT
cord-023095-4dannjjm	1014	5	large	large	JJ
cord-023095-4dannjjm	1014	6	differences	difference	NNS
cord-023095-4dannjjm	1014	7	in	in	IN
cord-023095-4dannjjm	1014	8	size	size	NN
cord-023095-4dannjjm	1014	9	among	among	IN
cord-023095-4dannjjm	1014	10	different	different	JJ
cord-023095-4dannjjm	1014	11	equine	equine	NN
cord-023095-4dannjjm	1014	12	breeds	breed	NNS
cord-023095-4dannjjm	1014	13	,	,	,
cord-023095-4dannjjm	1014	14	there	there	EX
cord-023095-4dannjjm	1014	15	is	be	VBZ
cord-023095-4dannjjm	1014	16	little	little	JJ
cord-023095-4dannjjm	1014	17	information	information	NN
cord-023095-4dannjjm	1014	18	about	about	IN
cord-023095-4dannjjm	1014	19	normal	normal	JJ
cord-023095-4dannjjm	1014	20	heart	heart	NN
cord-023095-4dannjjm	1014	21	rates	rate	NNS
cord-023095-4dannjjm	1014	22	and	and	CC
cord-023095-4dannjjm	1014	23	normal	normal	JJ
cord-023095-4dannjjm	1014	24	ECG	ECG	NNP
cord-023095-4dannjjm	1014	25	time	time	NN
cord-023095-4dannjjm	1014	26	intervals	interval	NNS
cord-023095-4dannjjm	1014	27	in	in	IN
cord-023095-4dannjjm	1014	28	horses	horse	NNS
cord-023095-4dannjjm	1014	29	and	and	CC
cord-023095-4dannjjm	1014	30	ponies	pony	NNS
cord-023095-4dannjjm	1014	31	of	of	IN
cord-023095-4dannjjm	1014	32	different	different	JJ
cord-023095-4dannjjm	1014	33	body	body	NN
cord-023095-4dannjjm	1014	34	size	size	NN
cord-023095-4dannjjm	1014	35	.	.	.
cord-023095-4dannjjm	1015	1	Similarly	similarly	RB
cord-023095-4dannjjm	1015	2	,	,	,
cord-023095-4dannjjm	1015	3	the	the	DT
cord-023095-4dannjjm	1015	4	relationship	relationship	NN
cord-023095-4dannjjm	1015	5	between	between	IN
cord-023095-4dannjjm	1015	6	HR	hr	NN
cord-023095-4dannjjm	1015	7	and	and	CC
cord-023095-4dannjjm	1015	8	body	body	NN
cord-023095-4dannjjm	1015	9	mass	mass	NN
cord-023095-4dannjjm	1015	10	in	in	IN
cord-023095-4dannjjm	1015	11	dogs	dog	NNS
cord-023095-4dannjjm	1015	12	of	of	IN
cord-023095-4dannjjm	1015	13	various	various	JJ
cord-023095-4dannjjm	1015	14	breeds	breed	NNS
cord-023095-4dannjjm	1015	15	and	and	CC
cord-023095-4dannjjm	1015	16	sizes	size	NNS
cord-023095-4dannjjm	1015	17	is	be	VBZ
cord-023095-4dannjjm	1015	18	still	still	RB
cord-023095-4dannjjm	1015	19	under	under	IN
cord-023095-4dannjjm	1015	20	debate	debate	NN
cord-023095-4dannjjm	1015	21	.	.	.
cord-023095-4dannjjm	1016	1	The	the	DT
cord-023095-4dannjjm	1016	2	goal	goal	NN
cord-023095-4dannjjm	1016	3	of	of	IN
cord-023095-4dannjjm	1016	4	this	this	DT
cord-023095-4dannjjm	1016	5	study	study	NN
cord-023095-4dannjjm	1016	6	was	be	VBD
cord-023095-4dannjjm	1016	7	to	to	TO
cord-023095-4dannjjm	1016	8	investigate	investigate	VB
cord-023095-4dannjjm	1016	9	the	the	DT
cord-023095-4dannjjm	1016	10	relationship	relationship	NN
cord-023095-4dannjjm	1016	11	between	between	IN
cord-023095-4dannjjm	1016	12	heart	heart	NN
cord-023095-4dannjjm	1016	13	rate	rate	NN
cord-023095-4dannjjm	1016	14	and	and	CC
cord-023095-4dannjjm	1016	15	ECG	ECG	NNP
cord-023095-4dannjjm	1016	16	time	time	NN
cord-023095-4dannjjm	1016	17	intervals	interval	NNS
cord-023095-4dannjjm	1016	18	to	to	IN
cord-023095-4dannjjm	1016	19	body	body	NN
cord-023095-4dannjjm	1016	20	mass	mass	NN
cord-023095-4dannjjm	1016	21	in	in	IN
cord-023095-4dannjjm	1016	22	apparently	apparently	RB
cord-023095-4dannjjm	1016	23	healthy	healthy	JJ
cord-023095-4dannjjm	1016	24	horses	horse	NNS
cord-023095-4dannjjm	1016	25	and	and	CC
cord-023095-4dannjjm	1016	26	ponies	pony	NNS
cord-023095-4dannjjm	1016	27	and	and	CC
cord-023095-4dannjjm	1016	28	to	to	TO
cord-023095-4dannjjm	1016	29	calculate	calculate	VB
cord-023095-4dannjjm	1016	30	normal	normal	JJ
cord-023095-4dannjjm	1016	31	ranges	range	NNS
cord-023095-4dannjjm	1016	32	for	for	IN
cord-023095-4dannjjm	1016	33	different	different	JJ
cord-023095-4dannjjm	1016	34	weight	weight	NN
cord-023095-4dannjjm	1016	35	groups	group	NNS
cord-023095-4dannjjm	1016	36	.	.	.
cord-023095-4dannjjm	1017	1	250	250	CD
cord-023095-4dannjjm	1017	2	adult	adult	NN
cord-023095-4dannjjm	1017	3	horses	horse	NNS
cord-023095-4dannjjm	1017	4	and	and	CC
cord-023095-4dannjjm	1017	5	ponies	pony	NNS
cord-023095-4dannjjm	1017	6	at	at	IN
cord-023095-4dannjjm	1017	7	an	an	DT
cord-023095-4dannjjm	1017	8	age	age	NN
cord-023095-4dannjjm	1017	9	of	of	IN
cord-023095-4dannjjm	1017	10	5.5	5.5	CD
cord-023095-4dannjjm	1017	11	(	(	-LRB-
cord-023095-4dannjjm	1017	12	1	1	CD
cord-023095-4dannjjm	1017	13	-	-	SYM
cord-023095-4dannjjm	1017	14	30	30	CD
cord-023095-4dannjjm	1017	15	)	)	-RRB-
cord-023095-4dannjjm	1017	16	y	y	NN
cord-023095-4dannjjm	1017	17	[	[	-LRB-
cord-023095-4dannjjm	1017	18	median	median	NN
cord-023095-4dannjjm	1017	19	(	(	-LRB-
cord-023095-4dannjjm	1017	20	range	range	NN
cord-023095-4dannjjm	1017	21	)	)	-RRB-
cord-023095-4dannjjm	1017	22	]	]	-RRB-
cord-023095-4dannjjm	1017	23	and	and	CC
cord-023095-4dannjjm	1017	24	a	a	DT
cord-023095-4dannjjm	1017	25	body	body	NN
cord-023095-4dannjjm	1017	26	weight	weight	NN
cord-023095-4dannjjm	1017	27	of	of	IN
cord-023095-4dannjjm	1017	28	479	479	CD
cord-023095-4dannjjm	1017	29	(	(	-LRB-
cord-023095-4dannjjm	1017	30	46	46	CD
cord-023095-4dannjjm	1017	31	-	-	SYM
cord-023095-4dannjjm	1017	32	1120	1120	CD
cord-023095-4dannjjm	1017	33	)	)	-RRB-
cord-023095-4dannjjm	1017	34	kg	kg	NNS
cord-023095-4dannjjm	1017	35	were	be	VBD
cord-023095-4dannjjm	1017	36	included	include	VBN
cord-023095-4dannjjm	1017	37	in	in	IN
cord-023095-4dannjjm	1017	38	the	the	DT
cord-023095-4dannjjm	1017	39	study	study	NN
cord-023095-4dannjjm	1017	40	.	.	.
cord-023095-4dannjjm	1018	1	All	all	DT
cord-023095-4dannjjm	1018	2	animals	animal	NNS
cord-023095-4dannjjm	1018	3	were	be	VBD
cord-023095-4dannjjm	1018	4	considered	consider	VBN
cord-023095-4dannjjm	1018	5	clinically	clinically	RB
cord-023095-4dannjjm	1018	6	healthy	healthy	JJ
cord-023095-4dannjjm	1018	7	based	base	VBN
cord-023095-4dannjjm	1018	8	on	on	IN
cord-023095-4dannjjm	1018	9	history	history	NN
cord-023095-4dannjjm	1018	10	and	and	CC
cord-023095-4dannjjm	1018	11	physical	physical	JJ
cord-023095-4dannjjm	1018	12	examination	examination	NN
cord-023095-4dannjjm	1018	13	.	.	.
cord-023095-4dannjjm	1019	1	A	a	DT
cord-023095-4dannjjm	1019	2	standard	standard	JJ
cord-023095-4dannjjm	1019	3	base	base	NN
cord-023095-4dannjjm	1019	4	-	-	HYPH
cord-023095-4dannjjm	1019	5	apex	apex	NN
cord-023095-4dannjjm	1019	6	ECG	ECG	NNP
cord-023095-4dannjjm	1019	7	was	be	VBD
cord-023095-4dannjjm	1019	8	recorded	record	VBN
cord-023095-4dannjjm	1019	9	at	at	IN
cord-023095-4dannjjm	1019	10	a	a	DT
cord-023095-4dannjjm	1019	11	speed	speed	NN
cord-023095-4dannjjm	1019	12	of	of	IN
cord-023095-4dannjjm	1019	13	25	25	CD
cord-023095-4dannjjm	1019	14	(	(	-LRB-
cord-023095-4dannjjm	1019	15	n	n	NN
cord-023095-4dannjjm	1019	16	5	5	CD
cord-023095-4dannjjm	1019	17	4	4	CD
cord-023095-4dannjjm	1019	18	)	)	-RRB-
cord-023095-4dannjjm	1019	19	or	or	CC
cord-023095-4dannjjm	1019	20	50	50	CD
cord-023095-4dannjjm	1019	21	mm	mm	NNS
cord-023095-4dannjjm	1019	22	/	/	SYM
cord-023095-4dannjjm	1019	23	s	s	NN
cord-023095-4dannjjm	1019	24	(	(	-LRB-
cord-023095-4dannjjm	1019	25	n	n	NN
cord-023095-4dannjjm	1019	26	5	5	CD
cord-023095-4dannjjm	1019	27	246	246	CD
cord-023095-4dannjjm	1019	28	)	)	-RRB-
cord-023095-4dannjjm	1019	29	using	use	VBG
cord-023095-4dannjjm	1019	30	a	a	DT
cord-023095-4dannjjm	1019	31	multiparameter	multiparameter	NN
cord-023095-4dannjjm	1019	32	monitor	monitor	NN
cord-023095-4dannjjm	1019	33	(	(	-LRB-
cord-023095-4dannjjm	1019	34	Datascope	Datascope	NNP
cord-023095-4dannjjm	1019	35	Passport	Passport	NNP
cord-023095-4dannjjm	1019	36	)	)	-RRB-
cord-023095-4dannjjm	1019	37	.	.	.
cord-023095-4dannjjm	1020	1	During	during	IN
cord-023095-4dannjjm	1020	2	the	the	DT
cord-023095-4dannjjm	1020	3	procedure	procedure	NN
cord-023095-4dannjjm	1020	4	,	,	,
cord-023095-4dannjjm	1020	5	the	the	DT
cord-023095-4dannjjm	1020	6	horses	horse	NNS
cord-023095-4dannjjm	1020	7	were	be	VBD
cord-023095-4dannjjm	1020	8	unsedated	unsedate	VBN
cord-023095-4dannjjm	1020	9	,	,	,
cord-023095-4dannjjm	1020	10	standing	stand	VBG
cord-023095-4dannjjm	1020	11	quiet	quiet	JJ
cord-023095-4dannjjm	1020	12	in	in	IN
cord-023095-4dannjjm	1020	13	a	a	DT
cord-023095-4dannjjm	1020	14	box	box	NN
cord-023095-4dannjjm	1020	15	stall	stall	NN
cord-023095-4dannjjm	1020	16	.	.	.
cord-023095-4dannjjm	1021	1	Mean	mean	JJ
cord-023095-4dannjjm	1021	2	HR	hr	NN
cord-023095-4dannjjm	1021	3	over	over	IN
cord-023095-4dannjjm	1021	4	15	15	CD
cord-023095-4dannjjm	1021	5	sec	sec	NNP
cord-023095-4dannjjm	1021	6	was	be	VBD
cord-023095-4dannjjm	1021	7	determined	determine	VBN
cord-023095-4dannjjm	1021	8	for	for	IN
cord-023095-4dannjjm	1021	9	each	each	DT
cord-023095-4dannjjm	1021	10	recording	recording	NN
cord-023095-4dannjjm	1021	11	.	.	.
cord-023095-4dannjjm	1022	1	The	the	DT
cord-023095-4dannjjm	1022	2	following	follow	VBG
cord-023095-4dannjjm	1022	3	ECG	ECG	NNP
cord-023095-4dannjjm	1022	4	time	time	NN
cord-023095-4dannjjm	1022	5	intervals	interval	NNS
cord-023095-4dannjjm	1022	6	were	be	VBD
cord-023095-4dannjjm	1022	7	measured	measure	VBN
cord-023095-4dannjjm	1022	8	in	in	IN
cord-023095-4dannjjm	1022	9	triplicate	triplicate	NN
cord-023095-4dannjjm	1022	10	and	and	CC
cord-023095-4dannjjm	1022	11	averaged	average	VBD
cord-023095-4dannjjm	1022	12	for	for	IN
cord-023095-4dannjjm	1022	13	further	further	JJ
cord-023095-4dannjjm	1022	14	analyses	analysis	NNS
cord-023095-4dannjjm	1022	15	:	:	:
cord-023095-4dannjjm	1022	16	PQ	pq	NN
cord-023095-4dannjjm	1022	17	interval	interval	NN
cord-023095-4dannjjm	1022	18	,	,	,
cord-023095-4dannjjm	1022	19	QRS	qrs	NN
cord-023095-4dannjjm	1022	20	duration	duration	NN
cord-023095-4dannjjm	1022	21	,	,	,
cord-023095-4dannjjm	1022	22	QT	QT	NNP
cord-023095-4dannjjm	1022	23	interval	interval	NN
cord-023095-4dannjjm	1022	24	,	,	,
cord-023095-4dannjjm	1022	25	and	and	CC
cord-023095-4dannjjm	1022	26	difference	difference	NN
cord-023095-4dannjjm	1022	27	between	between	IN
cord-023095-4dannjjm	1022	28	QT	qt	NN
cord-023095-4dannjjm	1022	29	and	and	CC
cord-023095-4dannjjm	1022	30	QRS	qrs	NN
cord-023095-4dannjjm	1022	31	(	(	-LRB-
cord-023095-4dannjjm	1022	32	QT	qt	NN
cord-023095-4dannjjm	1022	33	-	-	HYPH
cord-023095-4dannjjm	1022	34	QRS	qrs	NN
cord-023095-4dannjjm	1022	35	duration	duration	NN
cord-023095-4dannjjm	1022	36	)	)	-RRB-
cord-023095-4dannjjm	1022	37	.	.	.
cord-023095-4dannjjm	1023	1	The	the	DT
cord-023095-4dannjjm	1023	2	relationship	relationship	NN
cord-023095-4dannjjm	1023	3	between	between	IN
cord-023095-4dannjjm	1023	4	HR	hr	NN
cord-023095-4dannjjm	1023	5	,	,	,
cord-023095-4dannjjm	1023	6	ECG	ECG	NNP
cord-023095-4dannjjm	1023	7	time	time	NN
cord-023095-4dannjjm	1023	8	intervals	interval	NNS
cord-023095-4dannjjm	1023	9	,	,	,
cord-023095-4dannjjm	1023	10	and	and	CC
cord-023095-4dannjjm	1023	11	body	body	NN
cord-023095-4dannjjm	1023	12	mass	mass	NN
cord-023095-4dannjjm	1023	13	was	be	VBD
cord-023095-4dannjjm	1023	14	assessed	assess	VBN
cord-023095-4dannjjm	1023	15	using	use	VBG
cord-023095-4dannjjm	1023	16	linear	linear	JJ
cord-023095-4dannjjm	1023	17	regression	regression	NN
cord-023095-4dannjjm	1023	18	analyses	analysis	NNS
cord-023095-4dannjjm	1023	19	.	.	.
cord-023095-4dannjjm	1024	1	Normal	normal	JJ
cord-023095-4dannjjm	1024	2	ranges	range	NNS
cord-023095-4dannjjm	1024	3	(	(	-LRB-
cord-023095-4dannjjm	1024	4	2.5	2.5	CD
cord-023095-4dannjjm	1024	5	%	%	NN
cord-023095-4dannjjm	1024	6	to	to	IN
cord-023095-4dannjjm	1024	7	97.5	97.5	CD
cord-023095-4dannjjm	1024	8	%	%	NN
cord-023095-4dannjjm	1024	9	percentile	percentile	NN
cord-023095-4dannjjm	1024	10	)	)	-RRB-
cord-023095-4dannjjm	1024	11	were	be	VBD
cord-023095-4dannjjm	1024	12	calculated	calculate	VBN
cord-023095-4dannjjm	1024	13	for	for	IN
cord-023095-4dannjjm	1024	14	5	5	CD
cord-023095-4dannjjm	1024	15	different	different	JJ
cord-023095-4dannjjm	1024	16	weight	weight	NN
cord-023095-4dannjjm	1024	17	groups	group	NNS
cord-023095-4dannjjm	1024	18	.	.	.
cord-023095-4dannjjm	1025	1	The	the	DT
cord-023095-4dannjjm	1025	2	level	level	NN
cord-023095-4dannjjm	1025	3	of	of	IN
cord-023095-4dannjjm	1025	4	significance	significance	NN
cord-023095-4dannjjm	1025	5	was	be	VBD
cord-023095-4dannjjm	1025	6	p	p	NN
cord-023095-4dannjjm	1025	7	5	5	CD
cord-023095-4dannjjm	1025	8	0.05	0.05	CD
cord-023095-4dannjjm	1025	9	.	.	.
cord-023095-4dannjjm	1026	1	Heart	heart	NN
cord-023095-4dannjjm	1026	2	rate	rate	NN
cord-023095-4dannjjm	1026	3	was	be	VBD
cord-023095-4dannjjm	1026	4	inversely	inversely	RB
cord-023095-4dannjjm	1026	5	related	relate	VBN
cord-023095-4dannjjm	1026	6	to	to	IN
cord-023095-4dannjjm	1026	7	body	body	NN
cord-023095-4dannjjm	1026	8	mass	mass	NN
cord-023095-4dannjjm	1026	9	(	(	-LRB-
cord-023095-4dannjjm	1026	10	p	p	NN
cord-023095-4dannjjm	1026	11	o	o	NN
cord-023095-4dannjjm	1027	1	0.0001	0.0001	CD
cord-023095-4dannjjm	1027	2	,	,	,
cord-023095-4dannjjm	1027	3	R	r	NN
cord-023095-4dannjjm	1027	4	2	2	CD
cord-023095-4dannjjm	1027	5	5	5	CD
cord-023095-4dannjjm	1027	6	0.122	0.122	CD
cord-023095-4dannjjm	1027	7	)	)	-RRB-
cord-023095-4dannjjm	1027	8	.	.	.
cord-023095-4dannjjm	1028	1	The	the	DT
cord-023095-4dannjjm	1028	2	PQ	PQ	NNP
cord-023095-4dannjjm	1028	3	interval	interval	NN
cord-023095-4dannjjm	1028	4	(	(	-LRB-
cord-023095-4dannjjm	1028	5	p	p	NN
cord-023095-4dannjjm	1028	6	o	o	NN
cord-023095-4dannjjm	1028	7	0.0001	0.0001	CD
cord-023095-4dannjjm	1028	8	,	,	,
cord-023095-4dannjjm	1028	9	R	r	NN
cord-023095-4dannjjm	1028	10	2	2	CD
cord-023095-4dannjjm	1028	11	5	5	CD
cord-023095-4dannjjm	1028	12	0.413	0.413	CD
cord-023095-4dannjjm	1028	13	)	)	-RRB-
cord-023095-4dannjjm	1028	14	,	,	,
cord-023095-4dannjjm	1028	15	QRS	qrs	NN
cord-023095-4dannjjm	1028	16	duration	duration	NN
cord-023095-4dannjjm	1028	17	(	(	-LRB-
cord-023095-4dannjjm	1028	18	p	p	NN
cord-023095-4dannjjm	1028	19	o	o	NN
cord-023095-4dannjjm	1028	20	0.0001	0.0001	CD
cord-023095-4dannjjm	1028	21	,	,	,
cord-023095-4dannjjm	1028	22	R	r	NN
cord-023095-4dannjjm	1028	23	2	2	CD
cord-023095-4dannjjm	1028	24	5	5	CD
cord-023095-4dannjjm	1028	25	0.147	0.147	CD
cord-023095-4dannjjm	1028	26	)	)	-RRB-
cord-023095-4dannjjm	1028	27	,	,	,
cord-023095-4dannjjm	1028	28	QT	QT	NNP
cord-023095-4dannjjm	1028	29	interval	interval	NN
cord-023095-4dannjjm	1028	30	(	(	-LRB-
cord-023095-4dannjjm	1028	31	p	p	NN
cord-023095-4dannjjm	1028	32	o	o	NN
cord-023095-4dannjjm	1028	33	0.0001	0.0001	CD
cord-023095-4dannjjm	1028	34	,	,	,
cord-023095-4dannjjm	1028	35	R	r	NN
cord-023095-4dannjjm	1028	36	2	2	CD
cord-023095-4dannjjm	1028	37	5	5	CD
cord-023095-4dannjjm	1028	38	0.089	0.089	CD
cord-023095-4dannjjm	1028	39	)	)	-RRB-
cord-023095-4dannjjm	1028	40	,	,	,
cord-023095-4dannjjm	1028	41	and	and	CC
cord-023095-4dannjjm	1028	42	QT	qt	NN
cord-023095-4dannjjm	1028	43	-	-	HYPH
cord-023095-4dannjjm	1028	44	QRS	qrs	NN
cord-023095-4dannjjm	1028	45	duration	duration	NN
cord-023095-4dannjjm	1029	1	(	(	-LRB-
cord-023095-4dannjjm	1029	2	p	p	NN
cord-023095-4dannjjm	1029	3	o	o	NN
cord-023095-4dannjjm	1030	1	0.0001	0.0001	CD
cord-023095-4dannjjm	1030	2	,	,	,
cord-023095-4dannjjm	1030	3	R	r	NN
cord-023095-4dannjjm	1030	4	2	2	CD
cord-023095-4dannjjm	1030	5	5	5	CD
cord-023095-4dannjjm	1030	6	0.028	0.028	CD
cord-023095-4dannjjm	1030	7	)	)	-RRB-
cord-023095-4dannjjm	1030	8	were	be	VBD
cord-023095-4dannjjm	1030	9	directly	directly	RB
cord-023095-4dannjjm	1030	10	related	relate	VBN
cord-023095-4dannjjm	1030	11	to	to	IN
cord-023095-4dannjjm	1030	12	body	body	NN
cord-023095-4dannjjm	1030	13	mass	mass	NN
cord-023095-4dannjjm	1030	14	.	.	.
cord-023095-4dannjjm	1031	1	Normal	normal	JJ
cord-023095-4dannjjm	1031	2	ranges	range	NNS
cord-023095-4dannjjm	1031	3	for	for	IN
cord-023095-4dannjjm	1031	4	HR	hr	NN
cord-023095-4dannjjm	1031	5	,	,	,
cord-023095-4dannjjm	1031	6	PQ	PQ	NNP
cord-023095-4dannjjm	1031	7	,	,	,
cord-023095-4dannjjm	1031	8	QRS	QRS	NNP
cord-023095-4dannjjm	1031	9	,	,	,
cord-023095-4dannjjm	1031	10	and	and	CC
cord-023095-4dannjjm	1031	11	QT	qt	NN
cord-023095-4dannjjm	1031	12	within	within	IN
cord-023095-4dannjjm	1031	13	the	the	DT
cord-023095-4dannjjm	1031	14	different	different	JJ
cord-023095-4dannjjm	1031	15	weight	weight	NN
cord-023095-4dannjjm	1031	16	groups	group	NNS
cord-023095-4dannjjm	1031	17	were	be	VBD
cord-023095-4dannjjm	1031	18	36	36	CD
cord-023095-4dannjjm	1031	19	-	-	SYM
cord-023095-4dannjjm	1031	20	64	64	CD
cord-023095-4dannjjm	1031	21	bpm	bpm	NN
cord-023095-4dannjjm	1031	22	,	,	,
cord-023095-4dannjjm	1031	23	107	107	CD
cord-023095-4dannjjm	1031	24	-	-	SYM
cord-023095-4dannjjm	1031	25	230	230	CD
cord-023095-4dannjjm	1031	26	ms	m	NNS
cord-023095-4dannjjm	1031	27	,	,	,
cord-023095-4dannjjm	1031	28	60	60	CD
cord-023095-4dannjjm	1031	29	-	-	SYM
cord-023095-4dannjjm	1031	30	127	127	CD
cord-023095-4dannjjm	1031	31	ms	m	NNS
cord-023095-4dannjjm	1031	32	,	,	,
cord-023095-4dannjjm	1031	33	360	360	CD
cord-023095-4dannjjm	1031	34	-	-	HYPH
cord-023095-4dannjjm	1031	35	510	510	CD
cord-023095-4dannjjm	1031	36	ms	ms	NNP
cord-023095-4dannjjm	1031	37	(	(	-LRB-
cord-023095-4dannjjm	1031	38	o200	o200	NNP
cord-023095-4dannjjm	1031	39	kg	kg	NNP
cord-023095-4dannjjm	1031	40	)	)	-RRB-
cord-023095-4dannjjm	1031	41	;	;	:
cord-023095-4dannjjm	1031	42	28	28	CD
cord-023095-4dannjjm	1031	43	-	-	SYM
cord-023095-4dannjjm	1031	44	68	68	CD
cord-023095-4dannjjm	1031	45	bpm	bpm	NN
cord-023095-4dannjjm	1031	46	,	,	,
cord-023095-4dannjjm	1031	47	162	162	CD
cord-023095-4dannjjm	1031	48	-	-	SYM
cord-023095-4dannjjm	1031	49	319	319	CD
cord-023095-4dannjjm	1031	50	ms	m	NNS
cord-023095-4dannjjm	1031	51	,	,	,
cord-023095-4dannjjm	1031	52	74	74	CD
cord-023095-4dannjjm	1031	53	-	-	SYM
cord-023095-4dannjjm	1031	54	155	155	CD
cord-023095-4dannjjm	1031	55	ms	m	NNS
cord-023095-4dannjjm	1031	56	,	,	,
cord-023095-4dannjjm	1031	57	362	362	CD
cord-023095-4dannjjm	1031	58	-	-	SYM
cord-023095-4dannjjm	1031	59	610	610	CD
cord-023095-4dannjjm	1031	60	ms	ms	NNP
cord-023095-4dannjjm	1031	61	(	(	-LRB-
cord-023095-4dannjjm	1031	62	200	200	CD
cord-023095-4dannjjm	1031	63	-	-	SYM
cord-023095-4dannjjm	1031	64	399	399	CD
cord-023095-4dannjjm	1031	65	kg	kg	NN
cord-023095-4dannjjm	1031	66	)	)	-RRB-
cord-023095-4dannjjm	1031	67	;	;	:
cord-023095-4dannjjm	1031	68	28	28	CD
cord-023095-4dannjjm	1031	69	-	-	SYM
cord-023095-4dannjjm	1031	70	60	60	CD
cord-023095-4dannjjm	1031	71	bpm	bpm	NN
cord-023095-4dannjjm	1031	72	,	,	,
cord-023095-4dannjjm	1031	73	211	211	CD
cord-023095-4dannjjm	1031	74	-	-	SYM
cord-023095-4dannjjm	1031	75	423	423	CD
cord-023095-4dannjjm	1031	76	ms	m	NNS
cord-023095-4dannjjm	1031	77	,	,	,
cord-023095-4dannjjm	1031	78	89	89	CD
cord-023095-4dannjjm	1031	79	-	-	SYM
cord-023095-4dannjjm	1031	80	147	147	CD
cord-023095-4dannjjm	1031	81	ms	ms	NNP
cord-023095-4dannjjm	1031	82	,	,	,
cord-023095-4dannjjm	1031	83	390	390	CD
cord-023095-4dannjjm	1031	84	-	-	SYM
cord-023095-4dannjjm	1031	85	581	581	CD
cord-023095-4dannjjm	1031	86	ms	ms	NN
cord-023095-4dannjjm	1031	87	(	(	-LRB-
cord-023095-4dannjjm	1031	88	400	400	CD
cord-023095-4dannjjm	1031	89	-	-	SYM
cord-023095-4dannjjm	1031	90	599	599	CD
cord-023095-4dannjjm	1031	91	kg	kg	NN
cord-023095-4dannjjm	1031	92	)	)	-RRB-
cord-023095-4dannjjm	1031	93	;	;	:
cord-023095-4dannjjm	1031	94	28	28	CD
cord-023095-4dannjjm	1031	95	-	-	SYM
cord-023095-4dannjjm	1031	96	54	54	CD
cord-023095-4dannjjm	1031	97	bpm	bpm	NNS
cord-023095-4dannjjm	1031	98	,	,	,
cord-023095-4dannjjm	1031	99	220	220	CD
cord-023095-4dannjjm	1031	100	-	-	SYM
cord-023095-4dannjjm	1031	101	380	380	CD
cord-023095-4dannjjm	1031	102	ms	m	NNS
cord-023095-4dannjjm	1031	103	,	,	,
cord-023095-4dannjjm	1031	104	87	87	CD
cord-023095-4dannjjm	1031	105	-	-	SYM
cord-023095-4dannjjm	1031	106	150	150	CD
cord-023095-4dannjjm	1031	107	ms	m	NNS
cord-023095-4dannjjm	1031	108	,	,	,
cord-023095-4dannjjm	1031	109	367	367	CD
cord-023095-4dannjjm	1031	110	-	-	SYM
cord-023095-4dannjjm	1031	111	587	587	CD
cord-023095-4dannjjm	1031	112	ms	m	NNS
cord-023095-4dannjjm	1031	113	(	(	-LRB-
cord-023095-4dannjjm	1031	114	600	600	CD
cord-023095-4dannjjm	1031	115	-	-	SYM
cord-023095-4dannjjm	1031	116	799	799	CD
cord-023095-4dannjjm	1031	117	kg	kg	NN
cord-023095-4dannjjm	1031	118	)	)	-RRB-
cord-023095-4dannjjm	1031	119	;	;	:
cord-023095-4dannjjm	1031	120	and	and	CC
cord-023095-4dannjjm	1031	121	24	24	CD
cord-023095-4dannjjm	1031	122	-	-	SYM
cord-023095-4dannjjm	1031	123	52	52	CD
cord-023095-4dannjjm	1031	124	bpm	bpm	NN
cord-023095-4dannjjm	1031	125	,	,	,
cord-023095-4dannjjm	1032	1	240	240	CD
cord-023095-4dannjjm	1032	2	-	-	SYM
cord-023095-4dannjjm	1032	3	463	463	CD
cord-023095-4dannjjm	1032	4	ms	m	NNS
cord-023095-4dannjjm	1032	5	,	,	,
cord-023095-4dannjjm	1032	6	87	87	CD
cord-023095-4dannjjm	1032	7	-	-	SYM
cord-023095-4dannjjm	1032	8	140	140	CD
cord-023095-4dannjjm	1032	9	ms	m	NNS
cord-023095-4dannjjm	1032	10	,	,	,
cord-023095-4dannjjm	1032	11	437	437	CD
cord-023095-4dannjjm	1032	12	-	-	SYM
cord-023095-4dannjjm	1032	13	533	533	CD
cord-023095-4dannjjm	1032	14	ms	ms	NNP
cord-023095-4dannjjm	1032	15	(	(	-LRB-
cord-023095-4dannjjm	1032	16	4	4	CD
cord-023095-4dannjjm	1032	17	799	799	CD
cord-023095-4dannjjm	1032	18	kg	kg	NN
cord-023095-4dannjjm	1032	19	)	)	-RRB-
cord-023095-4dannjjm	1032	20	.	.	.
cord-023095-4dannjjm	1033	1	We	-PRON-	PRP
cord-023095-4dannjjm	1033	2	conclude	conclude	VBP
cord-023095-4dannjjm	1033	3	that	that	IN
cord-023095-4dannjjm	1033	4	in	in	IN
cord-023095-4dannjjm	1033	5	healthy	healthy	JJ
cord-023095-4dannjjm	1033	6	horses	horse	NNS
cord-023095-4dannjjm	1033	7	there	there	EX
cord-023095-4dannjjm	1033	8	is	be	VBZ
cord-023095-4dannjjm	1033	9	a	a	DT
cord-023095-4dannjjm	1033	10	significant	significant	JJ
cord-023095-4dannjjm	1033	11	but	but	CC
cord-023095-4dannjjm	1033	12	weak	weak	JJ
cord-023095-4dannjjm	1033	13	relationship	relationship	NN
cord-023095-4dannjjm	1033	14	between	between	IN
cord-023095-4dannjjm	1033	15	body	body	NN
cord-023095-4dannjjm	1033	16	mass	mass	NN
cord-023095-4dannjjm	1033	17	and	and	CC
cord-023095-4dannjjm	1033	18	HR	HR	NNP
cord-023095-4dannjjm	1033	19	and	and	CC
cord-023095-4dannjjm	1033	20	between	between	IN
cord-023095-4dannjjm	1033	21	body	body	NN
cord-023095-4dannjjm	1033	22	mass	mass	NN
cord-023095-4dannjjm	1033	23	and	and	CC
cord-023095-4dannjjm	1033	24	ECG	ECG	NNP
cord-023095-4dannjjm	1033	25	time	time	NN
cord-023095-4dannjjm	1033	26	intervals	interval	NNS
cord-023095-4dannjjm	1033	27	,	,	,
cord-023095-4dannjjm	1033	28	respectively	respectively	RB
cord-023095-4dannjjm	1033	29	.	.	.
cord-023095-4dannjjm	1034	1	This	this	DT
cord-023095-4dannjjm	1034	2	study	study	NN
cord-023095-4dannjjm	1034	3	therefore	therefore	RB
cord-023095-4dannjjm	1034	4	supports	support	VBZ
cord-023095-4dannjjm	1034	5	the	the	DT
cord-023095-4dannjjm	1034	6	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1034	7	that	that	IN
cord-023095-4dannjjm	1034	8	within	within	IN
cord-023095-4dannjjm	1034	9	the	the	DT
cord-023095-4dannjjm	1034	10	equine	equine	JJ
cord-023095-4dannjjm	1034	11	species	specie	NNS
cord-023095-4dannjjm	1034	12	,	,	,
cord-023095-4dannjjm	1034	13	small	small	JJ
cord-023095-4dannjjm	1034	14	breeds	breed	NNS
cord-023095-4dannjjm	1034	15	have	have	VBP
cord-023095-4dannjjm	1034	16	faster	fast	JJR
cord-023095-4dannjjm	1034	17	heart	heart	NN
cord-023095-4dannjjm	1034	18	rates	rate	NNS
cord-023095-4dannjjm	1034	19	and	and	CC
cord-023095-4dannjjm	1034	20	shorter	short	JJR
cord-023095-4dannjjm	1034	21	ECG	ECG	NNP
cord-023095-4dannjjm	1034	22	time	time	NN
cord-023095-4dannjjm	1034	23	intervals	interval	NNS
cord-023095-4dannjjm	1034	24	than	than	IN
cord-023095-4dannjjm	1034	25	large	large	JJ
cord-023095-4dannjjm	1034	26	breeds	breed	NNS
cord-023095-4dannjjm	1034	27	.	.	.
cord-023095-4dannjjm	1035	1	Therefore	therefore	RB
cord-023095-4dannjjm	1035	2	,	,	,
cord-023095-4dannjjm	1035	3	body	body	NN
cord-023095-4dannjjm	1035	4	mass	mass	NN
cord-023095-4dannjjm	1035	5	has	have	VBZ
cord-023095-4dannjjm	1035	6	to	to	TO
cord-023095-4dannjjm	1035	7	be	be	VB
cord-023095-4dannjjm	1035	8	considered	consider	VBN
cord-023095-4dannjjm	1035	9	when	when	WRB
cord-023095-4dannjjm	1035	10	comparing	compare	VBG
cord-023095-4dannjjm	1035	11	HR	HR	NNP
cord-023095-4dannjjm	1035	12	and	and	CC
cord-023095-4dannjjm	1035	13	ECG	ECG	NNP
cord-023095-4dannjjm	1035	14	time	time	NN
cord-023095-4dannjjm	1035	15	intervals	interval	NNS
cord-023095-4dannjjm	1035	16	to	to	IN
cord-023095-4dannjjm	1035	17	normal	normal	JJ
cord-023095-4dannjjm	1035	18	ranges	range	NNS
cord-023095-4dannjjm	1035	19	in	in	IN
cord-023095-4dannjjm	1035	20	horses	horse	NNS
cord-023095-4dannjjm	1035	21	.	.	.
cord-023095-4dannjjm	1036	1	Horses	horse	NNS
cord-023095-4dannjjm	1036	2	with	with	IN
cord-023095-4dannjjm	1036	3	pituitary	pituitary	NNP
cord-023095-4dannjjm	1036	4	pars	pars	NNP
cord-023095-4dannjjm	1036	5	intermedia	intermedia	NN
cord-023095-4dannjjm	1036	6	dysfunction	dysfunction	NN
cord-023095-4dannjjm	1036	7	(	(	-LRB-
cord-023095-4dannjjm	1036	8	PPID	PPID	NNP
cord-023095-4dannjjm	1036	9	)	)	-RRB-
cord-023095-4dannjjm	1036	10	often	often	RB
cord-023095-4dannjjm	1036	11	have	have	VBP
cord-023095-4dannjjm	1036	12	elevated	elevate	VBN
cord-023095-4dannjjm	1036	13	plasma	plasma	NN
cord-023095-4dannjjm	1036	14	ACTH	ACTH	NNP
cord-023095-4dannjjm	1036	15	concentrations	concentration	NNS
cord-023095-4dannjjm	1036	16	.	.	.
cord-023095-4dannjjm	1037	1	However	however	RB
cord-023095-4dannjjm	1037	2	,	,	,
cord-023095-4dannjjm	1037	3	PPIDaffected	ppidaffected	JJ
cord-023095-4dannjjm	1037	4	horses	horse	NNS
cord-023095-4dannjjm	1037	5	rarely	rarely	RB
cord-023095-4dannjjm	1037	6	have	have	VBP
cord-023095-4dannjjm	1037	7	resting	rest	VBG
cord-023095-4dannjjm	1037	8	serum	serum	NN
cord-023095-4dannjjm	1037	9	cortisol	cortisol	NN
cord-023095-4dannjjm	1037	10	levels	level	NNS
cord-023095-4dannjjm	1037	11	above	above	IN
cord-023095-4dannjjm	1037	12	the	the	DT
cord-023095-4dannjjm	1037	13	reference	reference	NN
cord-023095-4dannjjm	1037	14	range	range	NN
cord-023095-4dannjjm	1037	15	or	or	CC
cord-023095-4dannjjm	1037	16	adrenal	adrenal	JJ
cord-023095-4dannjjm	1037	17	hyperplasia	hyperplasia	NN
cord-023095-4dannjjm	1037	18	.	.	.
cord-023095-4dannjjm	1038	1	We	-PRON-	PRP
cord-023095-4dannjjm	1038	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1038	3	that	that	IN
cord-023095-4dannjjm	1038	4	this	this	DT
cord-023095-4dannjjm	1038	5	apparent	apparent	JJ
cord-023095-4dannjjm	1038	6	dissociation	dissociation	NN
cord-023095-4dannjjm	1038	7	between	between	IN
cord-023095-4dannjjm	1038	8	plasma	plasma	NN
cord-023095-4dannjjm	1038	9	ACTH	ACTH	NNP
cord-023095-4dannjjm	1038	10	levels	level	NNS
cord-023095-4dannjjm	1038	11	and	and	CC
cord-023095-4dannjjm	1038	12	adrenal	adrenal	JJ
cord-023095-4dannjjm	1038	13	response	response	NN
cord-023095-4dannjjm	1038	14	in	in	IN
cord-023095-4dannjjm	1038	15	horses	horse	NNS
cord-023095-4dannjjm	1038	16	with	with	IN
cord-023095-4dannjjm	1038	17	PPID	PPID	NNP
cord-023095-4dannjjm	1038	18	is	be	VBZ
cord-023095-4dannjjm	1038	19	due	due	JJ
cord-023095-4dannjjm	1038	20	to	to	IN
cord-023095-4dannjjm	1038	21	the	the	DT
cord-023095-4dannjjm	1038	22	secretion	secretion	NN
cord-023095-4dannjjm	1038	23	of	of	IN
cord-023095-4dannjjm	1038	24	ACTH	ACTH	NNP
cord-023095-4dannjjm	1038	25	that	that	WDT
cord-023095-4dannjjm	1038	26	is	be	VBZ
cord-023095-4dannjjm	1038	27	less	less	RBR
cord-023095-4dannjjm	1038	28	biologically	biologically	RB
cord-023095-4dannjjm	1038	29	active	active	JJ
cord-023095-4dannjjm	1038	30	than	than	IN
cord-023095-4dannjjm	1038	31	that	that	DT
cord-023095-4dannjjm	1038	32	from	from	IN
cord-023095-4dannjjm	1038	33	normal	normal	JJ
cord-023095-4dannjjm	1038	34	horses	horse	NNS
cord-023095-4dannjjm	1038	35	.	.	.
cord-023095-4dannjjm	1039	1	To	to	TO
cord-023095-4dannjjm	1039	2	test	test	VB
cord-023095-4dannjjm	1039	3	our	-PRON-	PRP$
cord-023095-4dannjjm	1039	4	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1039	5	,	,	,
cord-023095-4dannjjm	1039	6	a	a	DT
cord-023095-4dannjjm	1039	7	bioassay	bioassay	NN
cord-023095-4dannjjm	1039	8	to	to	TO
cord-023095-4dannjjm	1039	9	evaluate	evaluate	VB
cord-023095-4dannjjm	1039	10	ACTH	ACTH	NNP
cord-023095-4dannjjm	1039	11	activity	activity	NN
cord-023095-4dannjjm	1039	12	was	be	VBD
cord-023095-4dannjjm	1039	13	developed	develop	VBN
cord-023095-4dannjjm	1039	14	.	.	.
cord-023095-4dannjjm	1040	1	Adrenocortical	adrenocortical	JJ
cord-023095-4dannjjm	1040	2	explants	explant	NNS
cord-023095-4dannjjm	1040	3	were	be	VBD
cord-023095-4dannjjm	1040	4	harvested	harvest	VBN
cord-023095-4dannjjm	1040	5	aseptically	aseptically	RB
cord-023095-4dannjjm	1040	6	from	from	IN
cord-023095-4dannjjm	1040	7	normal	normal	JJ
cord-023095-4dannjjm	1040	8	horses	horse	NNS
cord-023095-4dannjjm	1040	9	at	at	IN
cord-023095-4dannjjm	1040	10	euthanasia	euthanasia	NN
cord-023095-4dannjjm	1040	11	and	and	CC
cord-023095-4dannjjm	1040	12	stimulated	stimulate	VBN
cord-023095-4dannjjm	1040	13	with	with	IN
cord-023095-4dannjjm	1040	14	plasma	plasma	NN
cord-023095-4dannjjm	1040	15	from	from	IN
cord-023095-4dannjjm	1040	16	healthy	healthy	JJ
cord-023095-4dannjjm	1040	17	(	(	-LRB-
cord-023095-4dannjjm	1040	18	n	n	NN
cord-023095-4dannjjm	1040	19	5	5	CD
cord-023095-4dannjjm	1040	20	9	9	CD
cord-023095-4dannjjm	1040	21	)	)	-RRB-
cord-023095-4dannjjm	1040	22	and	and	CC
cord-023095-4dannjjm	1040	23	PPID	PPID	NNP
cord-023095-4dannjjm	1040	24	-	-	HYPH
cord-023095-4dannjjm	1040	25	affected	affect	VBN
cord-023095-4dannjjm	1040	26	horses	horse	NNS
cord-023095-4dannjjm	1040	27	(	(	-LRB-
cord-023095-4dannjjm	1040	28	n	n	NN
cord-023095-4dannjjm	1040	29	5	5	CD
cord-023095-4dannjjm	1040	30	11	11	CD
cord-023095-4dannjjm	1040	31	)	)	-RRB-
cord-023095-4dannjjm	1040	32	.	.	.
cord-023095-4dannjjm	1041	1	The	the	DT
cord-023095-4dannjjm	1041	2	assay	assay	NN
cord-023095-4dannjjm	1041	3	was	be	VBD
cord-023095-4dannjjm	1041	4	performed	perform	VBN
cord-023095-4dannjjm	1041	5	three	three	CD
cord-023095-4dannjjm	1041	6	times	time	NNS
cord-023095-4dannjjm	1041	7	with	with	IN
cord-023095-4dannjjm	1041	8	explants	explant	NNS
cord-023095-4dannjjm	1041	9	obtained	obtain	VBN
cord-023095-4dannjjm	1041	10	from	from	IN
cord-023095-4dannjjm	1041	11	different	different	JJ
cord-023095-4dannjjm	1041	12	horses	horse	NNS
cord-023095-4dannjjm	1041	13	.	.	.
cord-023095-4dannjjm	1042	1	Cortisol	cortisol	NN
cord-023095-4dannjjm	1042	2	secreted	secrete	VBN
cord-023095-4dannjjm	1042	3	by	by	IN
cord-023095-4dannjjm	1042	4	the	the	DT
cord-023095-4dannjjm	1042	5	explants	explant	NNS
cord-023095-4dannjjm	1042	6	and	and	CC
cord-023095-4dannjjm	1042	7	plasma	plasma	NN
cord-023095-4dannjjm	1042	8	ACTH	ACTH	NNP
cord-023095-4dannjjm	1042	9	levels	level	NNS
cord-023095-4dannjjm	1042	10	were	be	VBD
cord-023095-4dannjjm	1042	11	measured	measure	VBN
cord-023095-4dannjjm	1042	12	with	with	IN
cord-023095-4dannjjm	1042	13	commercially	commercially	RB
cord-023095-4dannjjm	1042	14	available	available	JJ
cord-023095-4dannjjm	1042	15	radioimmunoassays	radioimmunoassay	NNS
cord-023095-4dannjjm	1042	16	.	.	.
cord-023095-4dannjjm	1043	1	Cortisol	cortisol	NN
cord-023095-4dannjjm	1043	2	secretion	secretion	NN
cord-023095-4dannjjm	1043	3	stimulated	stimulate	VBN
cord-023095-4dannjjm	1043	4	by	by	IN
cord-023095-4dannjjm	1043	5	each	each	DT
cord-023095-4dannjjm	1043	6	sample	sample	NN
cord-023095-4dannjjm	1043	7	was	be	VBD
cord-023095-4dannjjm	1043	8	standardized	standardize	VBN
cord-023095-4dannjjm	1043	9	to	to	IN
cord-023095-4dannjjm	1043	10	the	the	DT
cord-023095-4dannjjm	1043	11	respective	respective	JJ
cord-023095-4dannjjm	1043	12	explant	explant	NN
cord-023095-4dannjjm	1043	13	protein	protein	NN
cord-023095-4dannjjm	1043	14	concentration	concentration	NN
cord-023095-4dannjjm	1043	15	.	.	.
cord-023095-4dannjjm	1044	1	Cortisol	cortisol	NN
cord-023095-4dannjjm	1044	2	data	datum	NNS
cord-023095-4dannjjm	1044	3	was	be	VBD
cord-023095-4dannjjm	1044	4	normalized	normalize	VBN
cord-023095-4dannjjm	1044	5	for	for	IN
cord-023095-4dannjjm	1044	6	ACTH	ACTH	NNP
cord-023095-4dannjjm	1044	7	concentration	concentration	NN
cord-023095-4dannjjm	1044	8	in	in	IN
cord-023095-4dannjjm	1044	9	each	each	DT
cord-023095-4dannjjm	1044	10	plasma	plasma	NN
cord-023095-4dannjjm	1044	11	sample	sample	NN
cord-023095-4dannjjm	1044	12	and	and	CC
cord-023095-4dannjjm	1044	13	expressed	express	VBD
cord-023095-4dannjjm	1044	14	as	as	IN
cord-023095-4dannjjm	1044	15	a	a	DT
cord-023095-4dannjjm	1044	16	cortisol	cortisol	NN
cord-023095-4dannjjm	1044	17	:	:	:
cord-023095-4dannjjm	1044	18	protein	protein	NN
cord-023095-4dannjjm	1044	19	:	:	:
cord-023095-4dannjjm	1044	20	ACTH	ACTH	NNP
cord-023095-4dannjjm	1044	21	ratio	ratio	NN
cord-023095-4dannjjm	1044	22	.	.	.
cord-023095-4dannjjm	1045	1	Ratios	ratio	NNS
cord-023095-4dannjjm	1045	2	from	from	IN
cord-023095-4dannjjm	1045	3	horses	horse	NNS
cord-023095-4dannjjm	1045	4	with	with	IN
cord-023095-4dannjjm	1045	5	PPID	PPID	NNP
cord-023095-4dannjjm	1045	6	and	and	CC
cord-023095-4dannjjm	1045	7	normal	normal	JJ
cord-023095-4dannjjm	1045	8	horses	horse	NNS
cord-023095-4dannjjm	1045	9	were	be	VBD
cord-023095-4dannjjm	1045	10	compared	compare	VBN
cord-023095-4dannjjm	1045	11	by	by	IN
cord-023095-4dannjjm	1045	12	unpaired	unpaired	JJ
cord-023095-4dannjjm	1045	13	t	t	NN
cord-023095-4dannjjm	1045	14	-	-	HYPH
cord-023095-4dannjjm	1045	15	test	test	NN
cord-023095-4dannjjm	1045	16	.	.	.
cord-023095-4dannjjm	1046	1	Horses	horse	NNS
cord-023095-4dannjjm	1046	2	with	with	IN
cord-023095-4dannjjm	1046	3	PPID	PPID	NNP
cord-023095-4dannjjm	1046	4	had	have	VBD
cord-023095-4dannjjm	1046	5	significantly	significantly	RB
cord-023095-4dannjjm	1046	6	lower	low	JJR
cord-023095-4dannjjm	1046	7	cortisol	cortisol	NN
cord-023095-4dannjjm	1046	8	:	:	:
cord-023095-4dannjjm	1046	9	protein	protein	NN
cord-023095-4dannjjm	1046	10	:	:	:
cord-023095-4dannjjm	1046	11	ACTH	ACTH	NNP
cord-023095-4dannjjm	1046	12	ratios	ratio	NNS
cord-023095-4dannjjm	1046	13	compared	compare	VBN
cord-023095-4dannjjm	1046	14	to	to	IN
cord-023095-4dannjjm	1046	15	normal	normal	JJ
cord-023095-4dannjjm	1046	16	horses	horse	NNS
cord-023095-4dannjjm	1046	17	.	.	.
cord-023095-4dannjjm	1047	1	(	(	-LRB-
cord-023095-4dannjjm	1047	2	Assay	assay	NN
cord-023095-4dannjjm	1047	3	1	1	CD
cord-023095-4dannjjm	1047	4	:	:	:
cord-023095-4dannjjm	1047	5	0.06	0.06	CD
cord-023095-4dannjjm	1047	6	AE	AE	NNP
cord-023095-4dannjjm	1047	7	0.04	0.04	CD
cord-023095-4dannjjm	1047	8	vs.	vs.	NN
cord-023095-4dannjjm	1047	9	0.33	0.33	CD
cord-023095-4dannjjm	1047	10	AE	AE	NNP
cord-023095-4dannjjm	1047	11	0.11	0.11	CD
cord-023095-4dannjjm	1047	12	,	,	,
cord-023095-4dannjjm	1047	13	P	p	NN
cord-023095-4dannjjm	1047	14	o	o	NN
cord-023095-4dannjjm	1047	15	0.001	0.001	CD
cord-023095-4dannjjm	1047	16	;	;	:
cord-023095-4dannjjm	1047	17	Assay	assay	NN
cord-023095-4dannjjm	1047	18	2	2	CD
cord-023095-4dannjjm	1047	19	:	:	:
cord-023095-4dannjjm	1047	20	0.06	0.06	CD
cord-023095-4dannjjm	1047	21	AE	AE	NNP
cord-023095-4dannjjm	1047	22	0.04	0.04	CD
cord-023095-4dannjjm	1047	23	vs.	vs.	NN
cord-023095-4dannjjm	1047	24	0.30	0.30	CD
cord-023095-4dannjjm	1047	25	AE	AE	NNP
cord-023095-4dannjjm	1047	26	0.10	0.10	CD
cord-023095-4dannjjm	1047	27	,	,	,
cord-023095-4dannjjm	1047	28	P	p	NN
cord-023095-4dannjjm	1047	29	o	o	NN
cord-023095-4dannjjm	1047	30	0.001	0.001	CD
cord-023095-4dannjjm	1047	31	;	;	:
cord-023095-4dannjjm	1047	32	Assay	assay	NN
cord-023095-4dannjjm	1047	33	3	3	CD
cord-023095-4dannjjm	1047	34	:	:	:
cord-023095-4dannjjm	1047	35	0.07	0.07	CD
cord-023095-4dannjjm	1047	36	AE	AE	NNP
cord-023095-4dannjjm	1047	37	0.06	0.06	CD
cord-023095-4dannjjm	1047	38	vs.	vs.	NN
cord-023095-4dannjjm	1047	39	0.20	0.20	CD
cord-023095-4dannjjm	1047	40	AE	AE	NNP
cord-023095-4dannjjm	1047	41	0.13	0.13	CD
cord-023095-4dannjjm	1047	42	,	,	,
cord-023095-4dannjjm	1047	43	P	p	NN
cord-023095-4dannjjm	1047	44	o	o	NN
cord-023095-4dannjjm	1047	45	0.01	0.01	CD
cord-023095-4dannjjm	1047	46	)	)	-RRB-
cord-023095-4dannjjm	1047	47	.	.	.
cord-023095-4dannjjm	1048	1	These	these	DT
cord-023095-4dannjjm	1048	2	results	result	NNS
cord-023095-4dannjjm	1048	3	suggest	suggest	VBP
cord-023095-4dannjjm	1048	4	that	that	IN
cord-023095-4dannjjm	1048	5	plasma	plasma	NN
cord-023095-4dannjjm	1048	6	ACTH	ACTH	NNP
cord-023095-4dannjjm	1048	7	from	from	IN
cord-023095-4dannjjm	1048	8	PPID	PPID	NNP
cord-023095-4dannjjm	1048	9	horses	horse	NNS
cord-023095-4dannjjm	1048	10	is	be	VBZ
cord-023095-4dannjjm	1048	11	less	less	RBR
cord-023095-4dannjjm	1048	12	biologically	biologically	RB
cord-023095-4dannjjm	1048	13	active	active	JJ
cord-023095-4dannjjm	1048	14	than	than	IN
cord-023095-4dannjjm	1048	15	plasma	plasma	NN
cord-023095-4dannjjm	1048	16	ACTH	ACTH	NNP
cord-023095-4dannjjm	1048	17	from	from	IN
cord-023095-4dannjjm	1048	18	normal	normal	JJ
cord-023095-4dannjjm	1048	19	horses	horse	NNS
cord-023095-4dannjjm	1048	20	.	.	.
cord-023095-4dannjjm	1049	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	1049	2	findings	finding	NNS
cord-023095-4dannjjm	1049	3	give	give	VBP
cord-023095-4dannjjm	1049	4	further	further	JJ
cord-023095-4dannjjm	1049	5	insight	insight	NN
cord-023095-4dannjjm	1049	6	into	into	IN
cord-023095-4dannjjm	1049	7	the	the	DT
cord-023095-4dannjjm	1049	8	pathophysiology	pathophysiology	NN
cord-023095-4dannjjm	1049	9	of	of	IN
cord-023095-4dannjjm	1049	10	PPID	PPID	NNP
cord-023095-4dannjjm	1049	11	and	and	CC
cord-023095-4dannjjm	1049	12	may	may	MD
cord-023095-4dannjjm	1049	13	aid	aid	VB
cord-023095-4dannjjm	1049	14	in	in	IN
cord-023095-4dannjjm	1049	15	the	the	DT
cord-023095-4dannjjm	1049	16	development	development	NN
cord-023095-4dannjjm	1049	17	of	of	IN
cord-023095-4dannjjm	1049	18	novel	novel	JJ
cord-023095-4dannjjm	1049	19	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	1049	20	testing	testing	NN
cord-023095-4dannjjm	1049	21	protocols	protocol	NNS
cord-023095-4dannjjm	1049	22	.	.	.
cord-023095-4dannjjm	1050	1	An	an	DT
cord-023095-4dannjjm	1050	2	online	online	JJ
cord-023095-4dannjjm	1050	3	survey	survey	NN
cord-023095-4dannjjm	1050	4	was	be	VBD
cord-023095-4dannjjm	1050	5	conducted	conduct	VBN
cord-023095-4dannjjm	1050	6	to	to	TO
cord-023095-4dannjjm	1050	7	determine	determine	VB
cord-023095-4dannjjm	1050	8	perceived	perceive	VBN
cord-023095-4dannjjm	1050	9	needs	need	NNS
cord-023095-4dannjjm	1050	10	of	of	IN
cord-023095-4dannjjm	1050	11	potential	potential	JJ
cord-023095-4dannjjm	1050	12	employers	employer	NNS
cord-023095-4dannjjm	1050	13	of	of	IN
cord-023095-4dannjjm	1050	14	new	new	JJ
cord-023095-4dannjjm	1050	15	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	1050	16	-	-	HYPH
cord-023095-4dannjjm	1050	17	LAIM	LAIM	NNP
cord-023095-4dannjjm	1050	18	diplomates	diplomate	NNS
cord-023095-4dannjjm	1050	19	.	.	.
cord-023095-4dannjjm	1051	1	The	the	DT
cord-023095-4dannjjm	1051	2	survey	survey	NN
cord-023095-4dannjjm	1051	3	was	be	VBD
cord-023095-4dannjjm	1051	4	designed	design	VBN
cord-023095-4dannjjm	1051	5	as	as	IN
cord-023095-4dannjjm	1051	6	the	the	DT
cord-023095-4dannjjm	1051	7	first	first	JJ
cord-023095-4dannjjm	1051	8	step	step	NN
cord-023095-4dannjjm	1051	9	in	in	IN
cord-023095-4dannjjm	1051	10	determining	determine	VBG
cord-023095-4dannjjm	1051	11	what	what	WP
cord-023095-4dannjjm	1051	12	is	be	VBZ
cord-023095-4dannjjm	1051	13	needed	need	VBN
cord-023095-4dannjjm	1051	14	for	for	IN
cord-023095-4dannjjm	1051	15	success	success	NN
cord-023095-4dannjjm	1051	16	in	in	IN
cord-023095-4dannjjm	1051	17	the	the	DT
cord-023095-4dannjjm	1051	18	various	various	JJ
cord-023095-4dannjjm	1051	19	sectors	sector	NNS
cord-023095-4dannjjm	1051	20	of	of	IN
cord-023095-4dannjjm	1051	21	practice	practice	NN
cord-023095-4dannjjm	1051	22	employing	employ	VBG
cord-023095-4dannjjm	1051	23	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	1051	24	-	-	HYPH
cord-023095-4dannjjm	1051	25	LAIM	LAIM	NNP
cord-023095-4dannjjm	1051	26	diplomates	diplomate	NNS
cord-023095-4dannjjm	1051	27	.	.	.
cord-023095-4dannjjm	1052	1	Demographic	demographic	JJ
cord-023095-4dannjjm	1052	2	and	and	CC
cord-023095-4dannjjm	1052	3	background	background	NN
cord-023095-4dannjjm	1052	4	data	datum	NNS
cord-023095-4dannjjm	1052	5	were	be	VBD
cord-023095-4dannjjm	1052	6	collected	collect	VBN
cord-023095-4dannjjm	1052	7	using	use	VBG
cord-023095-4dannjjm	1052	8	questions	question	NNS
cord-023095-4dannjjm	1052	9	and	and	CC
cord-023095-4dannjjm	1052	10	drop	drop	VB
cord-023095-4dannjjm	1052	11	-	-	HYPH
cord-023095-4dannjjm	1052	12	down	down	RP
cord-023095-4dannjjm	1052	13	menus	menu	NNS
cord-023095-4dannjjm	1052	14	on	on	IN
cord-023095-4dannjjm	1052	15	the	the	DT
cord-023095-4dannjjm	1052	16	first	first	JJ
cord-023095-4dannjjm	1052	17	page	page	NN
cord-023095-4dannjjm	1052	18	.	.	.
cord-023095-4dannjjm	1053	1	The	the	DT
cord-023095-4dannjjm	1053	2	survey	survey	NN
cord-023095-4dannjjm	1053	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	1053	4	189	189	CD
cord-023095-4dannjjm	1053	5	skills	skill	NNS
cord-023095-4dannjjm	1053	6	or	or	CC
cord-023095-4dannjjm	1053	7	concepts	concept	NNS
cord-023095-4dannjjm	1053	8	in	in	IN
cord-023095-4dannjjm	1053	9	26	26	CD
cord-023095-4dannjjm	1053	10	areas	area	NNS
cord-023095-4dannjjm	1053	11	of	of	IN
cord-023095-4dannjjm	1053	12	veterinary	veterinary	JJ
cord-023095-4dannjjm	1053	13	practice	practice	NN
cord-023095-4dannjjm	1053	14	.	.	.
cord-023095-4dannjjm	1054	1	Participants	participant	NNS
cord-023095-4dannjjm	1054	2	answered	answer	VBD
cord-023095-4dannjjm	1054	3	4	4	CD
cord-023095-4dannjjm	1054	4	questions	question	NNS
cord-023095-4dannjjm	1054	5	about	about	IN
cord-023095-4dannjjm	1054	6	each	each	DT
cord-023095-4dannjjm	1054	7	skill	skill	NN
cord-023095-4dannjjm	1054	8	or	or	CC
cord-023095-4dannjjm	1054	9	concept	concept	NN
cord-023095-4dannjjm	1054	10	using	use	VBG
cord-023095-4dannjjm	1054	11	drop	drop	NN
cord-023095-4dannjjm	1054	12	-	-	HYPH
cord-023095-4dannjjm	1054	13	down	down	RP
cord-023095-4dannjjm	1054	14	ranked	rank	VBN
cord-023095-4dannjjm	1054	15	lists	list	NNS
cord-023095-4dannjjm	1054	16	.	.	.
cord-023095-4dannjjm	1055	1	Those	those	DT
cord-023095-4dannjjm	1055	2	participants	participant	NNS
cord-023095-4dannjjm	1055	3	that	that	WDT
cord-023095-4dannjjm	1055	4	had	have	VBD
cord-023095-4dannjjm	1055	5	completed	complete	VBN
cord-023095-4dannjjm	1055	6	an	an	DT
cord-023095-4dannjjm	1055	7	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	1055	8	-	-	HYPH
cord-023095-4dannjjm	1055	9	LAIM	LAIM	NNP
cord-023095-4dannjjm	1055	10	training	training	NN
cord-023095-4dannjjm	1055	11	program	program	NN
cord-023095-4dannjjm	1055	12	were	be	VBD
cord-023095-4dannjjm	1055	13	asked	ask	VBN
cord-023095-4dannjjm	1055	14	3	3	CD
cord-023095-4dannjjm	1055	15	additional	additional	JJ
cord-023095-4dannjjm	1055	16	questions	question	NNS
cord-023095-4dannjjm	1055	17	about	about	IN
cord-023095-4dannjjm	1055	18	whether	whether	IN
cord-023095-4dannjjm	1055	19	they	-PRON-	PRP
cord-023095-4dannjjm	1055	20	were	be	VBD
cord-023095-4dannjjm	1055	21	taught	teach	VBN
cord-023095-4dannjjm	1055	22	the	the	DT
cord-023095-4dannjjm	1055	23	skill	skill	NN
cord-023095-4dannjjm	1055	24	or	or	CC
cord-023095-4dannjjm	1055	25	concept	concept	NN
cord-023095-4dannjjm	1055	26	during	during	IN
cord-023095-4dannjjm	1055	27	their	-PRON-	PRP$
cord-023095-4dannjjm	1055	28	own	own	JJ
cord-023095-4dannjjm	1055	29	residency	residency	NN
cord-023095-4dannjjm	1055	30	.	.	.
cord-023095-4dannjjm	1056	1	Data	datum	NNS
cord-023095-4dannjjm	1056	2	were	be	VBD
cord-023095-4dannjjm	1056	3	collated	collate	VBN
cord-023095-4dannjjm	1056	4	and	and	CC
cord-023095-4dannjjm	1056	5	descriptive	descriptive	JJ
cord-023095-4dannjjm	1056	6	statistics	statistic	NNS
cord-023095-4dannjjm	1056	7	calculated	calculate	VBN
cord-023095-4dannjjm	1056	8	.	.	.
cord-023095-4dannjjm	1057	1	The	the	DT
cord-023095-4dannjjm	1057	2	mean	mean	JJ
cord-023095-4dannjjm	1057	3	scores	score	NNS
cord-023095-4dannjjm	1057	4	or	or	CC
cord-023095-4dannjjm	1057	5	frequencies	frequency	NNS
cord-023095-4dannjjm	1057	6	of	of	IN
cord-023095-4dannjjm	1057	7	use	use	NN
cord-023095-4dannjjm	1057	8	for	for	IN
cord-023095-4dannjjm	1057	9	each	each	DT
cord-023095-4dannjjm	1057	10	skills	skill	NNS
cord-023095-4dannjjm	1057	11	or	or	CC
cord-023095-4dannjjm	1057	12	concepts	concept	NNS
cord-023095-4dannjjm	1057	13	were	be	VBD
cord-023095-4dannjjm	1057	14	ranked	rank	VBN
cord-023095-4dannjjm	1057	15	to	to	TO
cord-023095-4dannjjm	1057	16	determine	determine	VB
cord-023095-4dannjjm	1057	17	which	which	WDT
cord-023095-4dannjjm	1057	18	of	of	IN
cord-023095-4dannjjm	1057	19	the	the	DT
cord-023095-4dannjjm	1057	20	skills	skill	NNS
cord-023095-4dannjjm	1057	21	or	or	CC
cord-023095-4dannjjm	1057	22	concepts	concept	NNS
cord-023095-4dannjjm	1057	23	were	be	VBD
cord-023095-4dannjjm	1057	24	most	most	RBS
cord-023095-4dannjjm	1057	25	important	important	JJ
cord-023095-4dannjjm	1057	26	for	for	IN
cord-023095-4dannjjm	1057	27	an	an	DT
cord-023095-4dannjjm	1057	28	entry	entry	NN
cord-023095-4dannjjm	1057	29	-	-	HYPH
cord-023095-4dannjjm	1057	30	level	level	NN
cord-023095-4dannjjm	1057	31	diplomate	diplomate	NN
cord-023095-4dannjjm	1057	32	.	.	.
cord-023095-4dannjjm	1058	1	Eighty	eighty	CD
cord-023095-4dannjjm	1058	2	-	-	HYPH
cord-023095-4dannjjm	1058	3	eight	eight	CD
cord-023095-4dannjjm	1058	4	individuals	individual	NNS
cord-023095-4dannjjm	1058	5	participated	participate	VBD
cord-023095-4dannjjm	1058	6	in	in	IN
cord-023095-4dannjjm	1058	7	the	the	DT
cord-023095-4dannjjm	1058	8	survey	survey	NN
cord-023095-4dannjjm	1058	9	with	with	IN
cord-023095-4dannjjm	1058	10	86	86	CD
cord-023095-4dannjjm	1058	11	respondents	respondent	NNS
cord-023095-4dannjjm	1058	12	being	be	VBG
cord-023095-4dannjjm	1058	13	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	1058	14	diplomates	diplomate	NNS
cord-023095-4dannjjm	1058	15	,	,	,
cord-023095-4dannjjm	1058	16	1	1	CD
cord-023095-4dannjjm	1058	17	respondent	respondent	NN
cord-023095-4dannjjm	1058	18	was	be	VBD
cord-023095-4dannjjm	1058	19	not	not	RB
cord-023095-4dannjjm	1058	20	board	board	NN
cord-023095-4dannjjm	1058	21	-	-	HYPH
cord-023095-4dannjjm	1058	22	certified	certify	VBN
cord-023095-4dannjjm	1058	23	and	and	CC
cord-023095-4dannjjm	1058	24	1	1	CD
cord-023095-4dannjjm	1058	25	respondent	respondent	NN
cord-023095-4dannjjm	1058	26	was	be	VBD
cord-023095-4dannjjm	1058	27	an	an	DT
cord-023095-4dannjjm	1058	28	ACT	ACT	NNP
cord-023095-4dannjjm	1058	29	diplomate	diplomate	NN
cord-023095-4dannjjm	1058	30	.	.	.
cord-023095-4dannjjm	1059	1	Nineteen	nineteen	CD
cord-023095-4dannjjm	1059	2	respondents	respondent	NNS
cord-023095-4dannjjm	1059	3	were	be	VBD
cord-023095-4dannjjm	1059	4	diplomates	diplomate	NNS
cord-023095-4dannjjm	1059	5	of	of	IN
cord-023095-4dannjjm	1059	6	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	1059	7	and	and	CC
cord-023095-4dannjjm	1059	8	an	an	DT
cord-023095-4dannjjm	1059	9	additional	additional	JJ
cord-023095-4dannjjm	1059	10	specialty	specialty	NN
cord-023095-4dannjjm	1059	11	.	.	.
cord-023095-4dannjjm	1060	1	Eighty	eighty	CD
cord-023095-4dannjjm	1060	2	-	-	HYPH
cord-023095-4dannjjm	1060	3	three	three	CD
cord-023095-4dannjjm	1060	4	respondents	respondent	NNS
cord-023095-4dannjjm	1060	5	had	have	VBD
cord-023095-4dannjjm	1060	6	completed	complete	VBN
cord-023095-4dannjjm	1060	7	an	an	DT
cord-023095-4dannjjm	1060	8	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	1060	9	residency	residency	NN
cord-023095-4dannjjm	1060	10	.	.	.
cord-023095-4dannjjm	1061	1	The	the	DT
cord-023095-4dannjjm	1061	2	majority	majority	NN
cord-023095-4dannjjm	1061	3	of	of	IN
cord-023095-4dannjjm	1061	4	respondents	respondent	NNS
cord-023095-4dannjjm	1061	5	were	be	VBD
cord-023095-4dannjjm	1061	6	in	in	IN
cord-023095-4dannjjm	1061	7	academia	academia	NN
cord-023095-4dannjjm	1061	8	(	(	-LRB-
cord-023095-4dannjjm	1061	9	65	65	CD
cord-023095-4dannjjm	1061	10	%	%	NN
cord-023095-4dannjjm	1061	11	)	)	-RRB-
cord-023095-4dannjjm	1061	12	with	with	IN
cord-023095-4dannjjm	1061	13	30	30	CD
cord-023095-4dannjjm	1061	14	%	%	NN
cord-023095-4dannjjm	1061	15	being	be	VBG
cord-023095-4dannjjm	1061	16	in	in	IN
cord-023095-4dannjjm	1061	17	private	private	JJ
cord-023095-4dannjjm	1061	18	practice	practice	NN
cord-023095-4dannjjm	1061	19	.	.	.
cord-023095-4dannjjm	1062	1	Equine	equine	NN
cord-023095-4dannjjm	1062	2	specialists	specialist	NNS
cord-023095-4dannjjm	1062	3	prevailed	prevail	VBD
cord-023095-4dannjjm	1062	4	(	(	-LRB-
cord-023095-4dannjjm	1062	5	53	53	CD
cord-023095-4dannjjm	1062	6	%	%	NN
cord-023095-4dannjjm	1062	7	)	)	-RRB-
cord-023095-4dannjjm	1062	8	followed	follow	VBN
cord-023095-4dannjjm	1062	9	by	by	IN
cord-023095-4dannjjm	1062	10	mixed	mixed	JJ
cord-023095-4dannjjm	1062	11	large	large	JJ
cord-023095-4dannjjm	1062	12	animal	animal	NN
cord-023095-4dannjjm	1062	13	(	(	-LRB-
cord-023095-4dannjjm	1062	14	28	28	CD
cord-023095-4dannjjm	1062	15	%	%	NN
cord-023095-4dannjjm	1062	16	)	)	-RRB-
cord-023095-4dannjjm	1062	17	and	and	CC
cord-023095-4dannjjm	1062	18	then	then	RB
cord-023095-4dannjjm	1062	19	food	food	NN
cord-023095-4dannjjm	1062	20	animal	animal	NN
cord-023095-4dannjjm	1062	21	only	only	RB
cord-023095-4dannjjm	1062	22	specialists	specialist	NNS
cord-023095-4dannjjm	1062	23	(	(	-LRB-
cord-023095-4dannjjm	1062	24	13	13	CD
cord-023095-4dannjjm	1062	25	%	%	NN
cord-023095-4dannjjm	1062	26	)	)	-RRB-
cord-023095-4dannjjm	1062	27	.	.	.
cord-023095-4dannjjm	1063	1	The	the	DT
cord-023095-4dannjjm	1063	2	distribution	distribution	NN
cord-023095-4dannjjm	1063	3	of	of	IN
cord-023095-4dannjjm	1063	4	years	year	NNS
cord-023095-4dannjjm	1063	5	post	post	NN
cord-023095-4dannjjm	1063	6	-	-	NN
cord-023095-4dannjjm	1063	7	residency	residency	NN
cord-023095-4dannjjm	1063	8	was	be	VBD
cord-023095-4dannjjm	1063	9	slightly	slightly	RB
cord-023095-4dannjjm	1063	10	skewed	skewed	JJ
cord-023095-4dannjjm	1063	11	toward	toward	IN
cord-023095-4dannjjm	1063	12	younger	young	JJR
cord-023095-4dannjjm	1063	13	diplomates	diplomate	NNS
cord-023095-4dannjjm	1063	14	,	,	,
cord-023095-4dannjjm	1063	15	but	but	CC
cord-023095-4dannjjm	1063	16	overall	overall	JJ
cord-023095-4dannjjm	1063	17	there	there	EX
cord-023095-4dannjjm	1063	18	was	be	VBD
cord-023095-4dannjjm	1063	19	a	a	DT
cord-023095-4dannjjm	1063	20	good	good	JJ
cord-023095-4dannjjm	1063	21	distribution	distribution	NN
cord-023095-4dannjjm	1063	22	of	of	IN
cord-023095-4dannjjm	1063	23	diplomates	diplomate	NNS
cord-023095-4dannjjm	1063	24	across	across	IN
cord-023095-4dannjjm	1063	25	years	year	NNS
cord-023095-4dannjjm	1063	26	of	of	IN
cord-023095-4dannjjm	1063	27	experience	experience	NN
cord-023095-4dannjjm	1063	28	.	.	.
cord-023095-4dannjjm	1064	1	Most	Most	JJS
cord-023095-4dannjjm	1064	2	respondents	respondent	NNS
cord-023095-4dannjjm	1064	3	stated	state	VBD
cord-023095-4dannjjm	1064	4	that	that	IN
cord-023095-4dannjjm	1064	5	they	-PRON-	PRP
cord-023095-4dannjjm	1064	6	did	do	VBD
cord-023095-4dannjjm	1064	7	not	not	RB
cord-023095-4dannjjm	1064	8	make	make	VB
cord-023095-4dannjjm	1064	9	hiring	hire	VBG
cord-023095-4dannjjm	1064	10	decisions	decision	NNS
cord-023095-4dannjjm	1064	11	in	in	IN
cord-023095-4dannjjm	1064	12	their	-PRON-	PRP$
cord-023095-4dannjjm	1064	13	practice	practice	NN
cord-023095-4dannjjm	1064	14	.	.	.
cord-023095-4dannjjm	1065	1	Competency	competency	NN
cord-023095-4dannjjm	1065	2	in	in	IN
cord-023095-4dannjjm	1065	3	disciplines	discipline	NNS
cord-023095-4dannjjm	1065	4	other	other	JJ
cord-023095-4dannjjm	1065	5	than	than	IN
cord-023095-4dannjjm	1065	6	internal	internal	JJ
cord-023095-4dannjjm	1065	7	medicine	medicine	NN
cord-023095-4dannjjm	1065	8	was	be	VBD
cord-023095-4dannjjm	1065	9	expected	expect	VBN
cord-023095-4dannjjm	1065	10	with	with	IN
cord-023095-4dannjjm	1065	11	ultrasonography	ultrasonography	NN
cord-023095-4dannjjm	1065	12	and	and	CC
cord-023095-4dannjjm	1065	13	radiology	radiology	NN
cord-023095-4dannjjm	1065	14	being	be	VBG
cord-023095-4dannjjm	1065	15	the	the	DT
cord-023095-4dannjjm	1065	16	most	most	RBS
cord-023095-4dannjjm	1065	17	desirable	desirable	JJ
cord-023095-4dannjjm	1065	18	followed	follow	VBN
cord-023095-4dannjjm	1065	19	by	by	IN
cord-023095-4dannjjm	1065	20	theriogenology	theriogenology	NN
cord-023095-4dannjjm	1065	21	and	and	CC
cord-023095-4dannjjm	1065	22	lameness	lameness	NN
cord-023095-4dannjjm	1065	23	.	.	.
cord-023095-4dannjjm	1066	1	Surgical	surgical	JJ
cord-023095-4dannjjm	1066	2	skills	skill	NNS
cord-023095-4dannjjm	1066	3	,	,	,
cord-023095-4dannjjm	1066	4	both	both	DT
cord-023095-4dannjjm	1066	5	equine	equine	JJ
cord-023095-4dannjjm	1066	6	abdominal	abdominal	NN
cord-023095-4dannjjm	1066	7	(	(	-LRB-
cord-023095-4dannjjm	1066	8	10	10	CD
cord-023095-4dannjjm	1066	9	%	%	NN
cord-023095-4dannjjm	1066	10	)	)	-RRB-
cord-023095-4dannjjm	1066	11	and	and	CC
cord-023095-4dannjjm	1066	12	food	food	NN
cord-023095-4dannjjm	1066	13	animal	animal	NN
cord-023095-4dannjjm	1066	14	general	general	JJ
cord-023095-4dannjjm	1066	15	surgery	surgery	NN
cord-023095-4dannjjm	1066	16	(	(	-LRB-
cord-023095-4dannjjm	1066	17	11	11	CD
cord-023095-4dannjjm	1066	18	%	%	NN
cord-023095-4dannjjm	1066	19	)	)	-RRB-
cord-023095-4dannjjm	1066	20	were	be	VBD
cord-023095-4dannjjm	1066	21	considered	consider	VBN
cord-023095-4dannjjm	1066	22	important	important	JJ
cord-023095-4dannjjm	1066	23	by	by	IN
cord-023095-4dannjjm	1066	24	some	some	DT
cord-023095-4dannjjm	1066	25	respondents	respondent	NNS
cord-023095-4dannjjm	1066	26	.	.	.
cord-023095-4dannjjm	1067	1	Thirty	thirty	CD
cord-023095-4dannjjm	1067	2	-	-	HYPH
cord-023095-4dannjjm	1067	3	six	six	CD
cord-023095-4dannjjm	1067	4	per	per	IN
cord-023095-4dannjjm	1067	5	cent	cent	NN
cord-023095-4dannjjm	1067	6	of	of	IN
cord-023095-4dannjjm	1067	7	respondents	respondent	NNS
cord-023095-4dannjjm	1067	8	thought	think	VBD
cord-023095-4dannjjm	1067	9	that	that	IN
cord-023095-4dannjjm	1067	10	a	a	DT
cord-023095-4dannjjm	1067	11	new	new	JJ
cord-023095-4dannjjm	1067	12	diplomate	diplomate	NN
cord-023095-4dannjjm	1067	13	should	should	MD
cord-023095-4dannjjm	1067	14	expect	expect	VB
cord-023095-4dannjjm	1067	15	to	to	TO
cord-023095-4dannjjm	1067	16	make	make	VB
cord-023095-4dannjjm	1067	17	o	o	NN
cord-023095-4dannjjm	1067	18	$	$	$
cord-023095-4dannjjm	1067	19	50,000	50,000	CD
cord-023095-4dannjjm	1067	20	per	per	IN
cord-023095-4dannjjm	1067	21	annum	annum	NN
cord-023095-4dannjjm	1067	22	,	,	,
cord-023095-4dannjjm	1067	23	while	while	IN
cord-023095-4dannjjm	1067	24	only	only	RB
cord-023095-4dannjjm	1067	25	13	13	CD
cord-023095-4dannjjm	1067	26	%	%	NN
cord-023095-4dannjjm	1067	27	of	of	IN
cord-023095-4dannjjm	1067	28	respondents	respondent	NNS
cord-023095-4dannjjm	1067	29	thought	think	VBD
cord-023095-4dannjjm	1067	30	that	that	IN
cord-023095-4dannjjm	1067	31	a	a	DT
cord-023095-4dannjjm	1067	32	new	new	JJ
cord-023095-4dannjjm	1067	33	diplomate	diplomate	NN
cord-023095-4dannjjm	1067	34	should	should	MD
cord-023095-4dannjjm	1067	35	expect	expect	VB
cord-023095-4dannjjm	1067	36	to	to	TO
cord-023095-4dannjjm	1067	37	make	make	VB
cord-023095-4dannjjm	1067	38	!	!	.
cord-023095-4dannjjm	1068	1	$	$	$
cord-023095-4dannjjm	1068	2	90,000	90,000	CD
cord-023095-4dannjjm	1068	3	per	per	IN
cord-023095-4dannjjm	1068	4	annum	annum	NN
cord-023095-4dannjjm	1068	5	.	.	.
cord-023095-4dannjjm	1069	1	Not	not	RB
cord-023095-4dannjjm	1069	2	all	all	DT
cord-023095-4dannjjm	1069	3	respondents	respondent	NNS
cord-023095-4dannjjm	1069	4	answered	answer	VBD
cord-023095-4dannjjm	1069	5	questions	question	NNS
cord-023095-4dannjjm	1069	6	on	on	IN
cord-023095-4dannjjm	1069	7	all	all	DT
cord-023095-4dannjjm	1069	8	skills	skill	NNS
cord-023095-4dannjjm	1069	9	or	or	CC
cord-023095-4dannjjm	1069	10	concepts	concept	NNS
cord-023095-4dannjjm	1069	11	.	.	.
cord-023095-4dannjjm	1070	1	The	the	DT
cord-023095-4dannjjm	1070	2	mean	mean	JJ
cord-023095-4dannjjm	1070	3	number	number	NN
cord-023095-4dannjjm	1070	4	of	of	IN
cord-023095-4dannjjm	1070	5	skills	skill	NNS
cord-023095-4dannjjm	1070	6	or	or	CC
cord-023095-4dannjjm	1070	7	concepts	concept	NNS
cord-023095-4dannjjm	1070	8	evaluated	evaluate	VBN
cord-023095-4dannjjm	1070	9	was	be	VBD
cord-023095-4dannjjm	1070	10	86	86	CD
cord-023095-4dannjjm	1071	1	(	(	-LRB-
cord-023095-4dannjjm	1071	2	SD	SD	NNP
cord-023095-4dannjjm	1071	3	5	5	CD
cord-023095-4dannjjm	1071	4	75	75	CD
cord-023095-4dannjjm	1071	5	)	)	-RRB-
cord-023095-4dannjjm	1071	6	with	with	IN
cord-023095-4dannjjm	1071	7	only	only	RB
cord-023095-4dannjjm	1071	8	18	18	CD
cord-023095-4dannjjm	1071	9	respondents	respondent	NNS
cord-023095-4dannjjm	1071	10	answering	answer	VBG
cord-023095-4dannjjm	1071	11	all	all	DT
cord-023095-4dannjjm	1071	12	189	189	CD
cord-023095-4dannjjm	1071	13	.	.	.
cord-023095-4dannjjm	1072	1	All	all	DT
cord-023095-4dannjjm	1072	2	skills	skill	NNS
cord-023095-4dannjjm	1072	3	or	or	CC
cord-023095-4dannjjm	1072	4	concepts	concept	NNS
cord-023095-4dannjjm	1072	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	1072	6	were	be	VBD
cord-023095-4dannjjm	1072	7	found	find	VBN
cord-023095-4dannjjm	1072	8	to	to	TO
cord-023095-4dannjjm	1072	9	be	be	VB
cord-023095-4dannjjm	1072	10	at	at	IN
cord-023095-4dannjjm	1072	11	least	least	JJS
cord-023095-4dannjjm	1072	12	somewhat	somewhat	RB
cord-023095-4dannjjm	1072	13	important	important	JJ
cord-023095-4dannjjm	1072	14	,	,	,
cord-023095-4dannjjm	1072	15	were	be	VBD
cord-023095-4dannjjm	1072	16	estimated	estimate	VBN
cord-023095-4dannjjm	1072	17	to	to	TO
cord-023095-4dannjjm	1072	18	be	be	VB
cord-023095-4dannjjm	1072	19	used	use	VBN
cord-023095-4dannjjm	1072	20	at	at	IN
cord-023095-4dannjjm	1072	21	least	least	JJS
cord-023095-4dannjjm	1072	22	occasionally	occasionally	RB
cord-023095-4dannjjm	1072	23	,	,	,
cord-023095-4dannjjm	1072	24	were	be	VBD
cord-023095-4dannjjm	1072	25	recommended	recommend	VBN
cord-023095-4dannjjm	1072	26	for	for	IN
cord-023095-4dannjjm	1072	27	inclusion	inclusion	NN
cord-023095-4dannjjm	1072	28	in	in	IN
cord-023095-4dannjjm	1072	29	training	training	NN
cord-023095-4dannjjm	1072	30	programs	program	NNS
cord-023095-4dannjjm	1072	31	as	as	IN
cord-023095-4dannjjm	1072	32	core	core	NN
cord-023095-4dannjjm	1072	33	or	or	CC
cord-023095-4dannjjm	1072	34	elective	elective	JJ
cord-023095-4dannjjm	1072	35	,	,	,
cord-023095-4dannjjm	1072	36	and	and	CC
cord-023095-4dannjjm	1072	37	some	some	DT
cord-023095-4dannjjm	1072	38	level	level	NN
cord-023095-4dannjjm	1072	39	of	of	IN
cord-023095-4dannjjm	1072	40	knowledge	knowledge	NN
cord-023095-4dannjjm	1072	41	was	be	VBD
cord-023095-4dannjjm	1072	42	expected	expect	VBN
cord-023095-4dannjjm	1072	43	.	.	.
cord-023095-4dannjjm	1073	1	At	at	IN
cord-023095-4dannjjm	1073	2	least	least	JJS
cord-023095-4dannjjm	1073	3	some	some	DT
cord-023095-4dannjjm	1073	4	of	of	IN
cord-023095-4dannjjm	1073	5	the	the	DT
cord-023095-4dannjjm	1073	6	respondents	respondent	NNS
cord-023095-4dannjjm	1073	7	were	be	VBD
cord-023095-4dannjjm	1073	8	taught	teach	VBN
cord-023095-4dannjjm	1073	9	each	each	DT
cord-023095-4dannjjm	1073	10	of	of	IN
cord-023095-4dannjjm	1073	11	the	the	DT
cord-023095-4dannjjm	1073	12	skills	skill	NNS
cord-023095-4dannjjm	1073	13	or	or	CC
cord-023095-4dannjjm	1073	14	concepts	concept	NNS
cord-023095-4dannjjm	1073	15	during	during	IN
cord-023095-4dannjjm	1073	16	their	-PRON-	PRP$
cord-023095-4dannjjm	1073	17	residency	residency	NN
cord-023095-4dannjjm	1073	18	,	,	,
cord-023095-4dannjjm	1073	19	practiced	practice	VBD
cord-023095-4dannjjm	1073	20	the	the	DT
cord-023095-4dannjjm	1073	21	skill	skill	NN
cord-023095-4dannjjm	1073	22	or	or	CC
cord-023095-4dannjjm	1073	23	concept	concept	NN
cord-023095-4dannjjm	1073	24	at	at	IN
cord-023095-4dannjjm	1073	25	least	least	JJS
cord-023095-4dannjjm	1073	26	occasionally	occasionally	RB
cord-023095-4dannjjm	1073	27	during	during	IN
cord-023095-4dannjjm	1073	28	their	-PRON-	PRP$
cord-023095-4dannjjm	1073	29	residency	residency	NN
cord-023095-4dannjjm	1073	30	,	,	,
cord-023095-4dannjjm	1073	31	and	and	CC
cord-023095-4dannjjm	1073	32	some	some	DT
cord-023095-4dannjjm	1073	33	degree	degree	NN
cord-023095-4dannjjm	1073	34	of	of	IN
cord-023095-4dannjjm	1073	35	competency	competency	NN
cord-023095-4dannjjm	1073	36	was	be	VBD
cord-023095-4dannjjm	1073	37	expected	expect	VBN
cord-023095-4dannjjm	1073	38	at	at	IN
cord-023095-4dannjjm	1073	39	the	the	DT
cord-023095-4dannjjm	1073	40	time	time	NN
cord-023095-4dannjjm	1073	41	of	of	IN
cord-023095-4dannjjm	1073	42	completion	completion	NN
cord-023095-4dannjjm	1073	43	of	of	IN
cord-023095-4dannjjm	1073	44	their	-PRON-	PRP$
cord-023095-4dannjjm	1073	45	residency	residency	NN
cord-023095-4dannjjm	1073	46	.	.	.
cord-023095-4dannjjm	1074	1	These	these	DT
cord-023095-4dannjjm	1074	2	data	datum	NNS
cord-023095-4dannjjm	1074	3	will	will	MD
cord-023095-4dannjjm	1074	4	provide	provide	VB
cord-023095-4dannjjm	1074	5	a	a	DT
cord-023095-4dannjjm	1074	6	framework	framework	NN
cord-023095-4dannjjm	1074	7	for	for	IN
cord-023095-4dannjjm	1074	8	designing	design	VBG
cord-023095-4dannjjm	1074	9	future	future	JJ
cord-023095-4dannjjm	1074	10	LAIM	LAIM	NNP
cord-023095-4dannjjm	1074	11	residency	residency	NN
cord-023095-4dannjjm	1074	12	programs	program	NNS
cord-023095-4dannjjm	1074	13	.	.	.
cord-023095-4dannjjm	1075	1	ABSTRACT	ABSTRACT	NNP
cord-023095-4dannjjm	1076	1	This	this	DT
cord-023095-4dannjjm	1076	2	study	study	NN
cord-023095-4dannjjm	1076	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	1076	4	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	1076	5	and	and	CC
cord-023095-4dannjjm	1076	6	clinical	clinical	JJ
cord-023095-4dannjjm	1076	7	safety	safety	NN
cord-023095-4dannjjm	1076	8	of	of	IN
cord-023095-4dannjjm	1076	9	an	an	DT
cord-023095-4dannjjm	1076	10	oral	oral	JJ
cord-023095-4dannjjm	1076	11	paste	paste	NN
cord-023095-4dannjjm	1076	12	formulation	formulation	NN
cord-023095-4dannjjm	1076	13	of	of	IN
cord-023095-4dannjjm	1076	14	a	a	DT
cord-023095-4dannjjm	1076	15	commercially	commercially	RB
cord-023095-4dannjjm	1076	16	available	available	JJ
cord-023095-4dannjjm	1076	17	COX1-sparing	cox1-spare	VBG
cord-023095-4dannjjm	1076	18	NSAID	NSAID	NNP
cord-023095-4dannjjm	1076	19	in	in	IN
cord-023095-4dannjjm	1076	20	clinically	clinically	RB
cord-023095-4dannjjm	1076	21	healthy	healthy	JJ
cord-023095-4dannjjm	1076	22	pony	pony	NN
cord-023095-4dannjjm	1076	23	foals	foal	NNS
cord-023095-4dannjjm	1076	24	in	in	IN
cord-023095-4dannjjm	1076	25	a	a	DT
cord-023095-4dannjjm	1076	26	randomized	randomized	JJ
cord-023095-4dannjjm	1076	27	controlled	control	VBN
cord-023095-4dannjjm	1076	28	clinical	clinical	JJ
cord-023095-4dannjjm	1076	29	trial	trial	NN
cord-023095-4dannjjm	1076	30	.	.	.
cord-023095-4dannjjm	1077	1	Values	value	NNS
cord-023095-4dannjjm	1077	2	for	for	IN
cord-023095-4dannjjm	1077	3	complete	complete	JJ
cord-023095-4dannjjm	1077	4	blood	blood	NN
cord-023095-4dannjjm	1077	5	count	count	NN
cord-023095-4dannjjm	1077	6	,	,	,
cord-023095-4dannjjm	1077	7	serum	serum	NN
cord-023095-4dannjjm	1077	8	chemistry	chemistry	NN
cord-023095-4dannjjm	1077	9	profile	profile	NN
cord-023095-4dannjjm	1077	10	,	,	,
cord-023095-4dannjjm	1077	11	urinalysis	urinalysis	NN
cord-023095-4dannjjm	1077	12	,	,	,
cord-023095-4dannjjm	1077	13	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	1077	14	assay	assay	NN
cord-023095-4dannjjm	1077	15	,	,	,
cord-023095-4dannjjm	1077	16	and	and	CC
cord-023095-4dannjjm	1077	17	gastric	gastric	JJ
cord-023095-4dannjjm	1077	18	endoscopy	endoscopy	NN
cord-023095-4dannjjm	1077	19	were	be	VBD
cord-023095-4dannjjm	1077	20	evaluated	evaluate	VBN
cord-023095-4dannjjm	1077	21	in	in	IN
cord-023095-4dannjjm	1077	22	eighteen	eighteen	CD
cord-023095-4dannjjm	1077	23	Shetland	Shetland	NNP
cord-023095-4dannjjm	1077	24	pony	pony	NN
cord-023095-4dannjjm	1077	25	foals	foal	NNS
cord-023095-4dannjjm	1077	26	treated	treat	VBN
cord-023095-4dannjjm	1077	27	with	with	IN
cord-023095-4dannjjm	1077	28	firocoxib	firocoxib	NNS
cord-023095-4dannjjm	1077	29	(	(	-LRB-
cord-023095-4dannjjm	1077	30	0.1	0.1	CD
cord-023095-4dannjjm	1077	31	mg	mg	NNP
cord-023095-4dannjjm	1077	32	/	/	SYM
cord-023095-4dannjjm	1077	33	kg	kg	NNP
cord-023095-4dannjjm	1077	34	,	,	,
cord-023095-4dannjjm	1077	35	PO	PO	NNP
cord-023095-4dannjjm	1077	36	,	,	,
cord-023095-4dannjjm	1077	37	q	q	NNP
cord-023095-4dannjjm	1077	38	24	24	CD
cord-023095-4dannjjm	1077	39	h	h	NNP
cord-023095-4dannjjm	1077	40	)	)	-RRB-
cord-023095-4dannjjm	1077	41	or	or	CC
cord-023095-4dannjjm	1077	42	placebo	placebo	NN
cord-023095-4dannjjm	1077	43	for	for	IN
cord-023095-4dannjjm	1077	44	14	14	CD
cord-023095-4dannjjm	1077	45	days	day	NNS
cord-023095-4dannjjm	1077	46	.	.	.
cord-023095-4dannjjm	1078	1	Foals	foal	NNS
cord-023095-4dannjjm	1078	2	were	be	VBD
cord-023095-4dannjjm	1078	3	divided	divide	VBN
cord-023095-4dannjjm	1078	4	into	into	IN
cord-023095-4dannjjm	1078	5	3	3	CD
cord-023095-4dannjjm	1078	6	treatment	treatment	NN
cord-023095-4dannjjm	1078	7	groups	group	NNS
cord-023095-4dannjjm	1078	8	.	.	.
cord-023095-4dannjjm	1079	1	Group	group	NN
cord-023095-4dannjjm	1079	2	1	1	CD
cord-023095-4dannjjm	1079	3	and	and	CC
cord-023095-4dannjjm	1079	4	2	2	CD
cord-023095-4dannjjm	1079	5	foals	foal	NNS
cord-023095-4dannjjm	1079	6	received	receive	VBD
cord-023095-4dannjjm	1079	7	firocoxib	firocoxib	NNS
cord-023095-4dannjjm	1079	8	while	while	IN
cord-023095-4dannjjm	1079	9	a	a	DT
cord-023095-4dannjjm	1079	10	3rd	3rd	JJ
cord-023095-4dannjjm	1079	11	group	group	NN
cord-023095-4dannjjm	1079	12	was	be	VBD
cord-023095-4dannjjm	1079	13	administered	administer	VBN
cord-023095-4dannjjm	1079	14	an	an	DT
cord-023095-4dannjjm	1079	15	oral	oral	JJ
cord-023095-4dannjjm	1079	16	placebo	placebo	NN
cord-023095-4dannjjm	1079	17	.	.	.
cord-023095-4dannjjm	1080	1	Gastric	gastric	JJ
cord-023095-4dannjjm	1080	2	endoscopy	endoscopy	NN
cord-023095-4dannjjm	1080	3	was	be	VBD
cord-023095-4dannjjm	1080	4	performed	perform	VBN
cord-023095-4dannjjm	1080	5	on	on	IN
cord-023095-4dannjjm	1080	6	group	group	NN
cord-023095-4dannjjm	1080	7	1	1	CD
cord-023095-4dannjjm	1080	8	and	and	CC
cord-023095-4dannjjm	1080	9	3	3	CD
cord-023095-4dannjjm	1080	10	foals	foal	NNS
cord-023095-4dannjjm	1080	11	prior	prior	RB
cord-023095-4dannjjm	1080	12	to	to	IN
cord-023095-4dannjjm	1080	13	treatment	treatment	NN
cord-023095-4dannjjm	1080	14	and	and	CC
cord-023095-4dannjjm	1080	15	on	on	IN
cord-023095-4dannjjm	1080	16	days	day	NNS
cord-023095-4dannjjm	1080	17	7	7	CD
cord-023095-4dannjjm	1080	18	and	and	CC
cord-023095-4dannjjm	1080	19	14	14	CD
cord-023095-4dannjjm	1080	20	to	to	TO
cord-023095-4dannjjm	1080	21	monitor	monitor	VB
cord-023095-4dannjjm	1080	22	for	for	IN
cord-023095-4dannjjm	1080	23	the	the	DT
cord-023095-4dannjjm	1080	24	presence	presence	NN
cord-023095-4dannjjm	1080	25	of	of	IN
cord-023095-4dannjjm	1080	26	gastric	gastric	JJ
cord-023095-4dannjjm	1080	27	ulcers	ulcer	NNS
cord-023095-4dannjjm	1080	28	.	.	.
cord-023095-4dannjjm	1081	1	Group	group	NN
cord-023095-4dannjjm	1081	2	2	2	CD
cord-023095-4dannjjm	1081	3	and	and	CC
cord-023095-4dannjjm	1081	4	3	3	CD
cord-023095-4dannjjm	1081	5	foals	foal	NNS
cord-023095-4dannjjm	1081	6	had	have	VBD
cord-023095-4dannjjm	1081	7	blood	blood	NN
cord-023095-4dannjjm	1081	8	and	and	CC
cord-023095-4dannjjm	1081	9	urine	urine	NN
cord-023095-4dannjjm	1081	10	samples	sample	NNS
cord-023095-4dannjjm	1081	11	taken	take	VBN
cord-023095-4dannjjm	1081	12	sequentially	sequentially	RB
cord-023095-4dannjjm	1081	13	for	for	IN
cord-023095-4dannjjm	1081	14	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	1081	15	analysis	analysis	NN
cord-023095-4dannjjm	1081	16	,	,	,
cord-023095-4dannjjm	1081	17	CBC	CBC	NNP
cord-023095-4dannjjm	1081	18	,	,	,
cord-023095-4dannjjm	1081	19	serum	serum	NN
cord-023095-4dannjjm	1081	20	chemistry	chemistry	NN
cord-023095-4dannjjm	1081	21	evaluation	evaluation	NN
cord-023095-4dannjjm	1081	22	,	,	,
cord-023095-4dannjjm	1081	23	and	and	CC
cord-023095-4dannjjm	1081	24	urinalysis	urinalysis	NN
cord-023095-4dannjjm	1081	25	.	.	.
cord-023095-4dannjjm	1082	1	Physical	physical	JJ
cord-023095-4dannjjm	1082	2	examinations	examination	NNS
cord-023095-4dannjjm	1082	3	were	be	VBD
cord-023095-4dannjjm	1082	4	performed	perform	VBN
cord-023095-4dannjjm	1082	5	prior	prior	RB
cord-023095-4dannjjm	1082	6	to	to	IN
cord-023095-4dannjjm	1082	7	treatment	treatment	NN
cord-023095-4dannjjm	1082	8	and	and	CC
cord-023095-4dannjjm	1082	9	daily	daily	NN
cord-023095-4dannjjm	1082	10	for	for	IN
cord-023095-4dannjjm	1082	11	17	17	CD
cord-023095-4dannjjm	1082	12	days	day	NNS
cord-023095-4dannjjm	1082	13	.	.	.
cord-023095-4dannjjm	1083	1	Data	datum	NNS
cord-023095-4dannjjm	1083	2	were	be	VBD
cord-023095-4dannjjm	1083	3	analyzed	analyze	VBN
cord-023095-4dannjjm	1083	4	using	use	VBG
cord-023095-4dannjjm	1083	5	anova	anova	NNP
cord-023095-4dannjjm	1083	6	and	and	CC
cord-023095-4dannjjm	1083	7	paired	pair	VBD
cord-023095-4dannjjm	1083	8	t	t	NN
cord-023095-4dannjjm	1083	9	-	-	HYPH
cord-023095-4dannjjm	1083	10	tests	test	NNS
cord-023095-4dannjjm	1083	11	(	(	-LRB-
cord-023095-4dannjjm	1083	12	P	p	NN
cord-023095-4dannjjm	1083	13	o	o	NN
cord-023095-4dannjjm	1083	14	0.05	0.05	CD
cord-023095-4dannjjm	1083	15	)	)	-RRB-
cord-023095-4dannjjm	1083	16	.	.	.
cord-023095-4dannjjm	1084	1	None	none	NN
cord-023095-4dannjjm	1084	2	of	of	IN
cord-023095-4dannjjm	1084	3	the	the	DT
cord-023095-4dannjjm	1084	4	foals	foal	NNS
cord-023095-4dannjjm	1084	5	presented	present	VBD
cord-023095-4dannjjm	1084	6	adverse	adverse	JJ
cord-023095-4dannjjm	1084	7	clinical	clinical	JJ
cord-023095-4dannjjm	1084	8	effects	effect	NNS
cord-023095-4dannjjm	1084	9	.	.	.
cord-023095-4dannjjm	1085	1	There	there	EX
cord-023095-4dannjjm	1085	2	were	be	VBD
cord-023095-4dannjjm	1085	3	no	no	DT
cord-023095-4dannjjm	1085	4	significant	significant	JJ
cord-023095-4dannjjm	1085	5	changes	change	NNS
cord-023095-4dannjjm	1085	6	in	in	IN
cord-023095-4dannjjm	1085	7	CBC	CBC	NNP
cord-023095-4dannjjm	1085	8	,	,	,
cord-023095-4dannjjm	1085	9	biochemical	biochemical	JJ
cord-023095-4dannjjm	1085	10	profiles	profile	NNS
cord-023095-4dannjjm	1085	11	within	within	IN
cord-023095-4dannjjm	1085	12	groups	group	NNS
cord-023095-4dannjjm	1085	13	,	,	,
cord-023095-4dannjjm	1085	14	or	or	CC
cord-023095-4dannjjm	1085	15	differences	difference	NNS
cord-023095-4dannjjm	1085	16	between	between	IN
cord-023095-4dannjjm	1085	17	groups	group	NNS
cord-023095-4dannjjm	1085	18	.	.	.
cord-023095-4dannjjm	1086	1	Pretreatment	pretreatment	JJ
cord-023095-4dannjjm	1086	2	gastric	gastric	JJ
cord-023095-4dannjjm	1086	3	endoscopy	endoscopy	NN
cord-023095-4dannjjm	1086	4	scores	score	NNS
cord-023095-4dannjjm	1086	5	were	be	VBD
cord-023095-4dannjjm	1086	6	not	not	RB
cord-023095-4dannjjm	1086	7	significantly	significantly	RB
cord-023095-4dannjjm	1086	8	different	different	JJ
cord-023095-4dannjjm	1086	9	from	from	IN
cord-023095-4dannjjm	1086	10	evaluations	evaluation	NNS
cord-023095-4dannjjm	1086	11	at	at	IN
cord-023095-4dannjjm	1086	12	7	7	CD
cord-023095-4dannjjm	1086	13	and	and	CC
cord-023095-4dannjjm	1086	14	14	14	CD
cord-023095-4dannjjm	1086	15	days	day	NNS
cord-023095-4dannjjm	1086	16	.	.	.
cord-023095-4dannjjm	1087	1	Firocoxib	Firocoxib	NNP
cord-023095-4dannjjm	1087	2	was	be	VBD
cord-023095-4dannjjm	1087	3	quickly	quickly	RB
cord-023095-4dannjjm	1087	4	absorbed	absorb	VBN
cord-023095-4dannjjm	1087	5	with	with	IN
cord-023095-4dannjjm	1087	6	an	an	DT
cord-023095-4dannjjm	1087	7	observed	observed	JJ
cord-023095-4dannjjm	1087	8	maximum	maximum	JJ
cord-023095-4dannjjm	1087	9	concentration	concentration	NN
cord-023095-4dannjjm	1087	10	at	at	IN
cord-023095-4dannjjm	1087	11	2	2	CD
cord-023095-4dannjjm	1087	12	hr	hr	NN
cord-023095-4dannjjm	1087	13	,	,	,
cord-023095-4dannjjm	1087	14	the	the	DT
cord-023095-4dannjjm	1087	15	first	first	JJ
cord-023095-4dannjjm	1087	16	sampling	sampling	NN
cord-023095-4dannjjm	1087	17	interval	interval	NN
cord-023095-4dannjjm	1087	18	,	,	,
cord-023095-4dannjjm	1087	19	for	for	IN
cord-023095-4dannjjm	1087	20	the	the	DT
cord-023095-4dannjjm	1087	21	majority	majority	NN
cord-023095-4dannjjm	1087	22	of	of	IN
cord-023095-4dannjjm	1087	23	animals	animal	NNS
cord-023095-4dannjjm	1087	24	.	.	.
cord-023095-4dannjjm	1088	1	Firocoxib	Firocoxib	NNP
cord-023095-4dannjjm	1088	2	plasma	plasma	NN
cord-023095-4dannjjm	1088	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1088	4	decreased	decrease	VBD
cord-023095-4dannjjm	1088	5	in	in	IN
cord-023095-4dannjjm	1088	6	a	a	DT
cord-023095-4dannjjm	1088	7	log	log	NN
cord-023095-4dannjjm	1088	8	-	-	HYPH
cord-023095-4dannjjm	1088	9	linear	linear	JJ
cord-023095-4dannjjm	1088	10	manner	manner	NN
cord-023095-4dannjjm	1088	11	after	after	IN
cord-023095-4dannjjm	1088	12	reaching	reach	VBG
cord-023095-4dannjjm	1088	13	the	the	DT
cord-023095-4dannjjm	1088	14	maximum	maximum	JJ
cord-023095-4dannjjm	1088	15	concentration	concentration	NN
cord-023095-4dannjjm	1088	16	and	and	CC
cord-023095-4dannjjm	1088	17	steady	steady	JJ
cord-023095-4dannjjm	1088	18	state	state	NN
cord-023095-4dannjjm	1088	19	concentrations	concentration	NNS
cord-023095-4dannjjm	1088	20	were	be	VBD
cord-023095-4dannjjm	1088	21	achieved	achieve	VBN
cord-023095-4dannjjm	1088	22	by	by	IN
cord-023095-4dannjjm	1088	23	the	the	DT
cord-023095-4dannjjm	1088	24	7th	7th	JJ
cord-023095-4dannjjm	1088	25	dose	dose	NN
cord-023095-4dannjjm	1088	26	.	.	.
cord-023095-4dannjjm	1089	1	Based	base	VBN
cord-023095-4dannjjm	1089	2	on	on	IN
cord-023095-4dannjjm	1089	3	the	the	DT
cord-023095-4dannjjm	1089	4	sampling	sampling	NN
cord-023095-4dannjjm	1089	5	times	time	NNS
cord-023095-4dannjjm	1089	6	after	after	IN
cord-023095-4dannjjm	1089	7	the	the	DT
cord-023095-4dannjjm	1089	8	final	final	JJ
cord-023095-4dannjjm	1089	9	and	and	CC
cord-023095-4dannjjm	1089	10	14th	14th	JJ
cord-023095-4dannjjm	1089	11	dose	dose	NN
cord-023095-4dannjjm	1089	12	,	,	,
cord-023095-4dannjjm	1089	13	an	an	DT
cord-023095-4dannjjm	1089	14	average	average	JJ
cord-023095-4dannjjm	1089	15	half	half	JJ
cord-023095-4dannjjm	1089	16	life	life	NN
cord-023095-4dannjjm	1089	17	of	of	IN
cord-023095-4dannjjm	1089	18	1.3	1.3	CD
cord-023095-4dannjjm	1089	19	days	day	NNS
cord-023095-4dannjjm	1089	20	was	be	VBD
cord-023095-4dannjjm	1089	21	estimated	estimate	VBN
cord-023095-4dannjjm	1089	22	.	.	.
cord-023095-4dannjjm	1090	1	Administration	Administration	NNP
cord-023095-4dannjjm	1090	2	of	of	IN
cord-023095-4dannjjm	1090	3	firocoxib	firocoxib	NNP
cord-023095-4dannjjm	1090	4	did	do	VBD
cord-023095-4dannjjm	1090	5	not	not	RB
cord-023095-4dannjjm	1090	6	cause	cause	VB
cord-023095-4dannjjm	1090	7	any	any	DT
cord-023095-4dannjjm	1090	8	adverse	adverse	JJ
cord-023095-4dannjjm	1090	9	effects	effect	NNS
cord-023095-4dannjjm	1090	10	on	on	IN
cord-023095-4dannjjm	1090	11	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1090	12	,	,	,
cord-023095-4dannjjm	1090	13	or	or	CC
cord-023095-4dannjjm	1090	14	hematological	hematological	JJ
cord-023095-4dannjjm	1090	15	or	or	CC
cord-023095-4dannjjm	1090	16	serum	serum	JJ
cord-023095-4dannjjm	1090	17	biochemical	biochemical	JJ
cord-023095-4dannjjm	1090	18	variables	variable	NNS
cord-023095-4dannjjm	1090	19	,	,	,
cord-023095-4dannjjm	1090	20	appears	appear	VBZ
cord-023095-4dannjjm	1090	21	to	to	TO
cord-023095-4dannjjm	1090	22	have	have	VB
cord-023095-4dannjjm	1090	23	been	be	VBN
cord-023095-4dannjjm	1090	24	well	well	RB
cord-023095-4dannjjm	1090	25	tolerated	tolerate	VBN
cord-023095-4dannjjm	1090	26	,	,	,
cord-023095-4dannjjm	1090	27	and	and	CC
cord-023095-4dannjjm	1090	28	follows	follow	VBZ
cord-023095-4dannjjm	1090	29	a	a	DT
cord-023095-4dannjjm	1090	30	predictable	predictable	JJ
cord-023095-4dannjjm	1090	31	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	1090	32	pattern	pattern	NN
cord-023095-4dannjjm	1090	33	in	in	IN
cord-023095-4dannjjm	1090	34	4	4	CD
cord-023095-4dannjjm	1090	35	-	-	SYM
cord-023095-4dannjjm	1090	36	6	6	CD
cord-023095-4dannjjm	1090	37	week	week	NN
cord-023095-4dannjjm	1090	38	old	old	JJ
cord-023095-4dannjjm	1090	39	foals	foal	NNS
cord-023095-4dannjjm	1090	40	.	.	.
cord-023095-4dannjjm	1091	1	Equine	equine	JJ
cord-023095-4dannjjm	1091	2	herpesvirus	herpesvirus	NN
cord-023095-4dannjjm	1091	3	1	1	CD
cord-023095-4dannjjm	1091	4	(	(	-LRB-
cord-023095-4dannjjm	1091	5	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1091	6	)	)	-RRB-
cord-023095-4dannjjm	1091	7	is	be	VBZ
cord-023095-4dannjjm	1091	8	highly	highly	RB
cord-023095-4dannjjm	1091	9	prevalent	prevalent	JJ
cord-023095-4dannjjm	1091	10	in	in	IN
cord-023095-4dannjjm	1091	11	most	most	JJS
cord-023095-4dannjjm	1091	12	horse	horse	NN
cord-023095-4dannjjm	1091	13	populations	population	NNS
cord-023095-4dannjjm	1091	14	.	.	.
cord-023095-4dannjjm	1092	1	Horses	horse	NNS
cord-023095-4dannjjm	1092	2	are	be	VBP
cord-023095-4dannjjm	1092	3	routinely	routinely	RB
cord-023095-4dannjjm	1092	4	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	1092	5	against	against	IN
cord-023095-4dannjjm	1092	6	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1092	7	,	,	,
cord-023095-4dannjjm	1092	8	and	and	CC
cord-023095-4dannjjm	1092	9	neutralizing	neutralize	VBG
cord-023095-4dannjjm	1092	10	antibodies	antibody	NNS
cord-023095-4dannjjm	1092	11	have	have	VBP
cord-023095-4dannjjm	1092	12	helped	help	VBN
cord-023095-4dannjjm	1092	13	to	to	TO
cord-023095-4dannjjm	1092	14	prevent	prevent	VB
cord-023095-4dannjjm	1092	15	disease	disease	NN
cord-023095-4dannjjm	1092	16	.	.	.
cord-023095-4dannjjm	1093	1	However	however	RB
cord-023095-4dannjjm	1093	2	,	,	,
cord-023095-4dannjjm	1093	3	the	the	DT
cord-023095-4dannjjm	1093	4	USDA	USDA	NNP
cord-023095-4dannjjm	1093	5	has	have	VBZ
cord-023095-4dannjjm	1093	6	recently	recently	RB
cord-023095-4dannjjm	1093	7	classified	classify	VBN
cord-023095-4dannjjm	1093	8	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1093	9	myeloencephalopathy	myeloencephalopathy	.
cord-023095-4dannjjm	1093	10	(	(	-LRB-
cord-023095-4dannjjm	1093	11	EHM	ehm	UH
cord-023095-4dannjjm	1093	12	)	)	-RRB-
cord-023095-4dannjjm	1093	13	as	as	IN
cord-023095-4dannjjm	1093	14	an	an	DT
cord-023095-4dannjjm	1093	15	emerging	emerge	VBG
cord-023095-4dannjjm	1093	16	disease	disease	NN
cord-023095-4dannjjm	1093	17	,	,	,
cord-023095-4dannjjm	1093	18	in	in	IN
cord-023095-4dannjjm	1093	19	response	response	NN
cord-023095-4dannjjm	1093	20	to	to	IN
cord-023095-4dannjjm	1093	21	the	the	DT
cord-023095-4dannjjm	1093	22	apparent	apparent	JJ
cord-023095-4dannjjm	1093	23	increase	increase	NN
cord-023095-4dannjjm	1093	24	in	in	IN
cord-023095-4dannjjm	1093	25	incidence	incidence	NN
cord-023095-4dannjjm	1093	26	,	,	,
cord-023095-4dannjjm	1093	27	morbidity	morbidity	NN
cord-023095-4dannjjm	1093	28	,	,	,
cord-023095-4dannjjm	1093	29	and	and	CC
cord-023095-4dannjjm	1093	30	mortality	mortality	NN
cord-023095-4dannjjm	1093	31	of	of	IN
cord-023095-4dannjjm	1093	32	EHM	EHM	NNP
cord-023095-4dannjjm	1093	33	that	that	WDT
cord-023095-4dannjjm	1093	34	suggests	suggest	VBZ
cord-023095-4dannjjm	1093	35	a	a	DT
cord-023095-4dannjjm	1093	36	change	change	NN
cord-023095-4dannjjm	1093	37	in	in	IN
cord-023095-4dannjjm	1093	38	virulence	virulence	NN
cord-023095-4dannjjm	1093	39	of	of	IN
cord-023095-4dannjjm	1093	40	the	the	DT
cord-023095-4dannjjm	1093	41	virus	virus	NN
cord-023095-4dannjjm	1093	42	.	.	.
cord-023095-4dannjjm	1094	1	It	-PRON-	PRP
cord-023095-4dannjjm	1094	2	has	have	VBZ
cord-023095-4dannjjm	1094	3	been	be	VBN
cord-023095-4dannjjm	1094	4	reported	report	VBN
cord-023095-4dannjjm	1094	5	that	that	IN
cord-023095-4dannjjm	1094	6	cellular	cellular	JJ
cord-023095-4dannjjm	1094	7	immune	immune	JJ
cord-023095-4dannjjm	1094	8	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1094	9	,	,	,
cord-023095-4dannjjm	1094	10	in	in	IN
cord-023095-4dannjjm	1094	11	particular	particular	JJ
cord-023095-4dannjjm	1094	12	cytotoxic	cytotoxic	JJ
cord-023095-4dannjjm	1094	13	T	t	NN
cord-023095-4dannjjm	1094	14	-	-	HYPH
cord-023095-4dannjjm	1094	15	cells	cell	NNS
cord-023095-4dannjjm	1094	16	(	(	-LRB-
cord-023095-4dannjjm	1094	17	CTLs	CTLs	NNP
cord-023095-4dannjjm	1094	18	)	)	-RRB-
cord-023095-4dannjjm	1094	19	,	,	,
cord-023095-4dannjjm	1094	20	are	be	VBP
cord-023095-4dannjjm	1094	21	important	important	JJ
cord-023095-4dannjjm	1094	22	in	in	IN
cord-023095-4dannjjm	1094	23	controlling	control	VBG
cord-023095-4dannjjm	1094	24	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1094	25	viremia	viremia	NN
cord-023095-4dannjjm	1094	26	.	.	.
cord-023095-4dannjjm	1095	1	Interferon	interferon	NN
cord-023095-4dannjjm	1095	2	-	-	HYPH
cord-023095-4dannjjm	1095	3	alpha	alpha	NN
cord-023095-4dannjjm	1095	4	(	(	-LRB-
cord-023095-4dannjjm	1095	5	IFN	IFN	NNP
cord-023095-4dannjjm	1095	6	-	-	HYPH
cord-023095-4dannjjm	1095	7	a	a	LS
cord-023095-4dannjjm	1095	8	)	)	-RRB-
cord-023095-4dannjjm	1095	9	has	have	VBZ
cord-023095-4dannjjm	1095	10	a	a	DT
cord-023095-4dannjjm	1095	11	key	key	JJ
cord-023095-4dannjjm	1095	12	function	function	NN
cord-023095-4dannjjm	1095	13	in	in	IN
cord-023095-4dannjjm	1095	14	innate	innate	JJ
cord-023095-4dannjjm	1095	15	immune	immune	JJ
cord-023095-4dannjjm	1095	16	regulation	regulation	NN
cord-023095-4dannjjm	1095	17	by	by	IN
cord-023095-4dannjjm	1095	18	inducing	induce	VBG
cord-023095-4dannjjm	1095	19	the	the	DT
cord-023095-4dannjjm	1095	20	differentiation	differentiation	NN
cord-023095-4dannjjm	1095	21	and	and	CC
cord-023095-4dannjjm	1095	22	maturation	maturation	NN
cord-023095-4dannjjm	1095	23	of	of	IN
cord-023095-4dannjjm	1095	24	CTLs	ctl	NNS
cord-023095-4dannjjm	1095	25	.	.	.
cord-023095-4dannjjm	1096	1	Here	here	RB
cord-023095-4dannjjm	1096	2	,	,	,
cord-023095-4dannjjm	1096	3	we	-PRON-	PRP
cord-023095-4dannjjm	1096	4	investigated	investigate	VBD
cord-023095-4dannjjm	1096	5	the	the	DT
cord-023095-4dannjjm	1096	6	influence	influence	NN
cord-023095-4dannjjm	1096	7	of	of	IN
cord-023095-4dannjjm	1096	8	abortogenic	abortogenic	NNP
cord-023095-4dannjjm	1096	9	(	(	-LRB-
cord-023095-4dannjjm	1096	10	RacL11	RacL11	NNP
cord-023095-4dannjjm	1096	11	,	,	,
cord-023095-4dannjjm	1096	12	NY03	NY03	NNP
cord-023095-4dannjjm	1096	13	)	)	-RRB-
cord-023095-4dannjjm	1096	14	and	and	CC
cord-023095-4dannjjm	1096	15	neuropathogenic	neuropathogenic	NNP
cord-023095-4dannjjm	1096	16	(	(	-LRB-
cord-023095-4dannjjm	1096	17	Ab4	ab4	NN
cord-023095-4dannjjm	1096	18	)	)	-RRB-
cord-023095-4dannjjm	1097	1	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1097	2	virus	virus	NN
cord-023095-4dannjjm	1097	3	strains	strain	VBZ
cord-023095-4dannjjm	1097	4	on	on	IN
cord-023095-4dannjjm	1097	5	IFN	IFN	NNP
cord-023095-4dannjjm	1097	6	-	-	HYPH
cord-023095-4dannjjm	1097	7	a	a	NNP
cord-023095-4dannjjm	1097	8	,	,	,
cord-023095-4dannjjm	1097	9	IL-4	IL-4	NNP
cord-023095-4dannjjm	1097	10	and	and	CC
cord-023095-4dannjjm	1097	11	IL-10	IL-10	NNP
cord-023095-4dannjjm	1097	12	secretion	secretion	NN
cord-023095-4dannjjm	1097	13	in	in	IN
cord-023095-4dannjjm	1097	14	equine	equine	JJ
cord-023095-4dannjjm	1097	15	PBMC	PBMC	NNS
cord-023095-4dannjjm	1097	16	.	.	.
cord-023095-4dannjjm	1098	1	Equine	Equine	NNP
cord-023095-4dannjjm	1098	2	PBMC	PBMC	NNP
cord-023095-4dannjjm	1098	3	were	be	VBD
cord-023095-4dannjjm	1098	4	infected	infect	VBN
cord-023095-4dannjjm	1098	5	with	with	IN
cord-023095-4dannjjm	1098	6	RacL11	racl11	NN
cord-023095-4dannjjm	1098	7	,	,	,
cord-023095-4dannjjm	1098	8	NY03	NY03	NNP
cord-023095-4dannjjm	1098	9	or	or	CC
cord-023095-4dannjjm	1098	10	Ab4	Ab4	NNP
cord-023095-4dannjjm	1098	11	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1098	12	strains	strain	NNS
cord-023095-4dannjjm	1098	13	or	or	CC
cord-023095-4dannjjm	1098	14	kept	keep	VBN
cord-023095-4dannjjm	1098	15	in	in	IN
cord-023095-4dannjjm	1098	16	medium	medium	NN
cord-023095-4dannjjm	1098	17	for	for	IN
cord-023095-4dannjjm	1098	18	24	24	CD
cord-023095-4dannjjm	1098	19	hours	hour	NNS
cord-023095-4dannjjm	1098	20	.	.	.
cord-023095-4dannjjm	1099	1	IFN	IFN	NNP
cord-023095-4dannjjm	1099	2	-	-	HYPH
cord-023095-4dannjjm	1099	3	a	a	NNP
cord-023095-4dannjjm	1099	4	,	,	,
cord-023095-4dannjjm	1099	5	IL-10	IL-10	NNP
cord-023095-4dannjjm	1099	6	and	and	CC
cord-023095-4dannjjm	1099	7	IL-4	IL-4	NNP
cord-023095-4dannjjm	1099	8	secretion	secretion	NN
cord-023095-4dannjjm	1099	9	was	be	VBD
cord-023095-4dannjjm	1099	10	detected	detect	VBN
cord-023095-4dannjjm	1099	11	in	in	IN
cord-023095-4dannjjm	1099	12	the	the	DT
cord-023095-4dannjjm	1099	13	supernatants	supernatant	NNS
cord-023095-4dannjjm	1099	14	by	by	IN
cord-023095-4dannjjm	1099	15	a	a	DT
cord-023095-4dannjjm	1099	16	fluorescent	fluorescent	JJ
cord-023095-4dannjjm	1099	17	bead	bead	NN
cord-023095-4dannjjm	1099	18	-	-	HYPH
cord-023095-4dannjjm	1099	19	based	base	VBN
cord-023095-4dannjjm	1099	20	cytokine	cytokine	NN
cord-023095-4dannjjm	1099	21	assay	assay	NN
cord-023095-4dannjjm	1099	22	.	.	.
cord-023095-4dannjjm	1100	1	The	the	DT
cord-023095-4dannjjm	1100	2	production	production	NN
cord-023095-4dannjjm	1100	3	of	of	IN
cord-023095-4dannjjm	1100	4	IFN	IFN	NNP
cord-023095-4dannjjm	1100	5	-	-	:
cord-023095-4dannjjm	1100	6	a	a	DT
cord-023095-4dannjjm	1100	7	increased	increase	VBD
cord-023095-4dannjjm	1100	8	with	with	IN
cord-023095-4dannjjm	1100	9	increasing	increase	VBG
cord-023095-4dannjjm	1100	10	viral	viral	JJ
cord-023095-4dannjjm	1100	11	doses	dose	NNS
cord-023095-4dannjjm	1100	12	and	and	CC
cord-023095-4dannjjm	1100	13	similarly	similarly	RB
cord-023095-4dannjjm	1100	14	for	for	IN
cord-023095-4dannjjm	1100	15	all	all	DT
cord-023095-4dannjjm	1100	16	three	three	CD
cord-023095-4dannjjm	1100	17	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1100	18	strains	strain	NNS
cord-023095-4dannjjm	1100	19	.	.	.
cord-023095-4dannjjm	1101	1	The	the	DT
cord-023095-4dannjjm	1101	2	production	production	NN
cord-023095-4dannjjm	1101	3	of	of	IN
cord-023095-4dannjjm	1101	4	the	the	DT
cord-023095-4dannjjm	1101	5	antiinflammatory	antiinflammatory	JJ
cord-023095-4dannjjm	1101	6	cytokine	cytokine	NN
cord-023095-4dannjjm	1101	7	IL-10	IL-10	NNP
cord-023095-4dannjjm	1101	8	was	be	VBD
cord-023095-4dannjjm	1101	9	significantly	significantly	RB
cord-023095-4dannjjm	1101	10	decreased	decrease	VBN
cord-023095-4dannjjm	1101	11	after	after	IN
cord-023095-4dannjjm	1101	12	Ab4	ab4	NN
cord-023095-4dannjjm	1101	13	infection	infection	NN
cord-023095-4dannjjm	1101	14	compared	compare	VBN
cord-023095-4dannjjm	1101	15	to	to	IN
cord-023095-4dannjjm	1101	16	RacL11	racl11	NN
cord-023095-4dannjjm	1101	17	and	and	CC
cord-023095-4dannjjm	1101	18	NY03	NY03	NNP
cord-023095-4dannjjm	1101	19	strains	strain	NNS
cord-023095-4dannjjm	1101	20	at	at	IN
cord-023095-4dannjjm	1101	21	viral	viral	JJ
cord-023095-4dannjjm	1101	22	infection	infection	NN
cord-023095-4dannjjm	1101	23	doses	dose	NNS
cord-023095-4dannjjm	1101	24	of	of	IN
cord-023095-4dannjjm	1101	25	MOI	MOI	NNP
cord-023095-4dannjjm	1101	26	0.3	0.3	CD
cord-023095-4dannjjm	1101	27	-	-	HYPH
cord-023095-4dannjjm	1101	28	1	1	CD
cord-023095-4dannjjm	1101	29	.	.	.
cord-023095-4dannjjm	1102	1	At	at	IN
cord-023095-4dannjjm	1102	2	high	high	JJ
cord-023095-4dannjjm	1102	3	doses	dose	NNS
cord-023095-4dannjjm	1102	4	(	(	-LRB-
cord-023095-4dannjjm	1102	5	MOI	MOI	NNP
cord-023095-4dannjjm	1102	6	3	3	CD
cord-023095-4dannjjm	1102	7	)	)	-RRB-
cord-023095-4dannjjm	1102	8	,	,	,
cord-023095-4dannjjm	1102	9	IL-10	IL-10	NNP
cord-023095-4dannjjm	1102	10	production	production	NN
cord-023095-4dannjjm	1102	11	was	be	VBD
cord-023095-4dannjjm	1102	12	suppressed	suppress	VBN
cord-023095-4dannjjm	1102	13	by	by	IN
cord-023095-4dannjjm	1102	14	all	all	DT
cord-023095-4dannjjm	1102	15	three	three	CD
cord-023095-4dannjjm	1102	16	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1102	17	strains	strain	NNS
cord-023095-4dannjjm	1102	18	.	.	.
cord-023095-4dannjjm	1103	1	The	the	DT
cord-023095-4dannjjm	1103	2	results	result	NNS
cord-023095-4dannjjm	1103	3	suggested	suggest	VBD
cord-023095-4dannjjm	1103	4	that	that	IN
cord-023095-4dannjjm	1103	5	abortogenic	abortogenic	NNP
cord-023095-4dannjjm	1103	6	and	and	CC
cord-023095-4dannjjm	1103	7	neuropathogenic	neuropathogenic	NNP
cord-023095-4dannjjm	1103	8	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1103	9	strains	strain	NNS
cord-023095-4dannjjm	1103	10	equally	equally	RB
cord-023095-4dannjjm	1103	11	induce	induce	VBP
cord-023095-4dannjjm	1103	12	antiviral	antiviral	JJ
cord-023095-4dannjjm	1103	13	IFN	IFN	NNP
cord-023095-4dannjjm	1103	14	-	-	:
cord-023095-4dannjjm	1103	15	a	a	DT
cord-023095-4dannjjm	1103	16	production	production	NN
cord-023095-4dannjjm	1103	17	in	in	IN
cord-023095-4dannjjm	1103	18	equine	equine	JJ
cord-023095-4dannjjm	1103	19	PBMC	PBMC	NNS
cord-023095-4dannjjm	1103	20	.	.	.
cord-023095-4dannjjm	1104	1	They	-PRON-	PRP
cord-023095-4dannjjm	1104	2	also	also	RB
cord-023095-4dannjjm	1104	3	illustrated	illustrate	VBD
cord-023095-4dannjjm	1104	4	the	the	DT
cord-023095-4dannjjm	1104	5	differences	difference	NNS
cord-023095-4dannjjm	1104	6	in	in	IN
cord-023095-4dannjjm	1104	7	the	the	DT
cord-023095-4dannjjm	1104	8	ability	ability	NN
cord-023095-4dannjjm	1104	9	of	of	IN
cord-023095-4dannjjm	1104	10	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1104	11	strains	strain	NNS
cord-023095-4dannjjm	1104	12	to	to	TO
cord-023095-4dannjjm	1104	13	modulate	modulate	VB
cord-023095-4dannjjm	1104	14	anti	anti	JJ
cord-023095-4dannjjm	1104	15	-	-	JJ
cord-023095-4dannjjm	1104	16	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1104	17	IL-10	IL-10	NNP
cord-023095-4dannjjm	1104	18	.	.	.
cord-023095-4dannjjm	1105	1	Neuropathogenic	Neuropathogenic	NNP
cord-023095-4dannjjm	1105	2	Ab4	ab4	NN
cord-023095-4dannjjm	1105	3	strain	strain	NN
cord-023095-4dannjjm	1105	4	had	have	VBD
cord-023095-4dannjjm	1105	5	an	an	DT
cord-023095-4dannjjm	1105	6	increased	increase	VBN
cord-023095-4dannjjm	1105	7	potential	potential	NN
cord-023095-4dannjjm	1105	8	to	to	IN
cord-023095-4dannjjm	1105	9	down	down	RB
cord-023095-4dannjjm	1105	10	-	-	HYPH
cord-023095-4dannjjm	1105	11	regulate	regulate	VB
cord-023095-4dannjjm	1105	12	IL-10	IL-10	NNP
cord-023095-4dannjjm	1105	13	production	production	NN
cord-023095-4dannjjm	1105	14	suggesting	suggest	VBG
cord-023095-4dannjjm	1105	15	specific	specific	JJ
cord-023095-4dannjjm	1105	16	viral	viral	JJ
cord-023095-4dannjjm	1105	17	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1105	18	that	that	WDT
cord-023095-4dannjjm	1105	19	interfere	interfere	VBP
cord-023095-4dannjjm	1105	20	with	with	IN
cord-023095-4dannjjm	1105	21	the	the	DT
cord-023095-4dannjjm	1105	22	control	control	NN
cord-023095-4dannjjm	1105	23	of	of	IN
cord-023095-4dannjjm	1105	24	inflammation	inflammation	NN
cord-023095-4dannjjm	1105	25	in	in	IN
cord-023095-4dannjjm	1105	26	the	the	DT
cord-023095-4dannjjm	1105	27	host	host	NN
cord-023095-4dannjjm	1105	28	.	.	.
cord-023095-4dannjjm	1106	1	The	the	DT
cord-023095-4dannjjm	1106	2	variations	variation	NNS
cord-023095-4dannjjm	1106	3	in	in	IN
cord-023095-4dannjjm	1106	4	innate	innate	JJ
cord-023095-4dannjjm	1106	5	IL-10	IL-10	NNP
cord-023095-4dannjjm	1106	6	secretion	secretion	NN
cord-023095-4dannjjm	1106	7	might	may	MD
cord-023095-4dannjjm	1106	8	influence	influence	VB
cord-023095-4dannjjm	1106	9	the	the	DT
cord-023095-4dannjjm	1106	10	development	development	NN
cord-023095-4dannjjm	1106	11	of	of	IN
cord-023095-4dannjjm	1106	12	protective	protective	JJ
cord-023095-4dannjjm	1106	13	immunity	immunity	NN
cord-023095-4dannjjm	1106	14	and	and	CC
cord-023095-4dannjjm	1106	15	might	may	MD
cord-023095-4dannjjm	1106	16	offer	offer	VB
cord-023095-4dannjjm	1106	17	an	an	DT
cord-023095-4dannjjm	1106	18	explanation	explanation	NN
cord-023095-4dannjjm	1106	19	why	why	WRB
cord-023095-4dannjjm	1106	20	neuropathogenic	neuropathogenic	NNP
cord-023095-4dannjjm	1106	21	Ab4	Ab4	NNP
cord-023095-4dannjjm	1106	22	induces	induce	VBZ
cord-023095-4dannjjm	1106	23	more	more	RBR
cord-023095-4dannjjm	1106	24	severe	severe	JJ
cord-023095-4dannjjm	1106	25	disease	disease	NN
cord-023095-4dannjjm	1106	26	,	,	,
cord-023095-4dannjjm	1106	27	including	include	VBG
cord-023095-4dannjjm	1106	28	myeloencephalopathy	myeloencephalopathy	NNP
cord-023095-4dannjjm	1106	29	,	,	,
cord-023095-4dannjjm	1106	30	than	than	IN
cord-023095-4dannjjm	1106	31	abortogenic	abortogenic	NNP
cord-023095-4dannjjm	1106	32	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1106	33	strains	strain	NNS
cord-023095-4dannjjm	1106	34	.	.	.
cord-023095-4dannjjm	1107	1	Previously	previously	RB
cord-023095-4dannjjm	1107	2	presented	present	VBN
cord-023095-4dannjjm	1107	3	at	at	IN
cord-023095-4dannjjm	1107	4	a	a	DT
cord-023095-4dannjjm	1107	5	conference	conference	NN
cord-023095-4dannjjm	1107	6	of	of	IN
cord-023095-4dannjjm	1107	7	research	research	NN
cord-023095-4dannjjm	1107	8	workers	worker	NNS
cord-023095-4dannjjm	1107	9	in	in	IN
cord-023095-4dannjjm	1107	10	animal	animal	NN
cord-023095-4dannjjm	1107	11	disease	disease	NN
cord-023095-4dannjjm	1107	12	.	.	.
cord-023095-4dannjjm	1108	1	Rhodoccocus	rhodoccocus	NN
cord-023095-4dannjjm	1108	2	equi	equi	NN
cord-023095-4dannjjm	1108	3	is	be	VBZ
cord-023095-4dannjjm	1108	4	the	the	DT
cord-023095-4dannjjm	1108	5	major	major	JJ
cord-023095-4dannjjm	1108	6	cause	cause	NN
cord-023095-4dannjjm	1108	7	of	of	IN
cord-023095-4dannjjm	1108	8	pneumonia	pneumonia	NN
cord-023095-4dannjjm	1108	9	in	in	IN
cord-023095-4dannjjm	1108	10	foals	foal	NNS
cord-023095-4dannjjm	1108	11	during	during	IN
cord-023095-4dannjjm	1108	12	the	the	DT
cord-023095-4dannjjm	1108	13	first	first	JJ
cord-023095-4dannjjm	1108	14	six	six	CD
cord-023095-4dannjjm	1108	15	months	month	NNS
cord-023095-4dannjjm	1108	16	and	and	CC
cord-023095-4dannjjm	1108	17	control	control	NN
cord-023095-4dannjjm	1108	18	measures	measure	NNS
cord-023095-4dannjjm	1108	19	are	be	VBP
cord-023095-4dannjjm	1108	20	frequently	frequently	RB
cord-023095-4dannjjm	1108	21	ineffective	ineffective	JJ
cord-023095-4dannjjm	1108	22	.	.	.
cord-023095-4dannjjm	1109	1	Treatment	treatment	NN
cord-023095-4dannjjm	1109	2	protocols	protocol	NNS
cord-023095-4dannjjm	1109	3	are	be	VBP
cord-023095-4dannjjm	1109	4	long	long	JJ
cord-023095-4dannjjm	1109	5	,	,	,
cord-023095-4dannjjm	1109	6	expensive	expensive	JJ
cord-023095-4dannjjm	1109	7	and	and	CC
cord-023095-4dannjjm	1109	8	do	do	VBP
cord-023095-4dannjjm	1109	9	not	not	RB
cord-023095-4dannjjm	1109	10	always	always	RB
cord-023095-4dannjjm	1109	11	produce	produce	VB
cord-023095-4dannjjm	1109	12	good	good	JJ
cord-023095-4dannjjm	1109	13	results	result	NNS
cord-023095-4dannjjm	1109	14	.	.	.
cord-023095-4dannjjm	1110	1	Rhodococcosis	rhodococcosis	NN
cord-023095-4dannjjm	1110	2	prevention	prevention	NN
cord-023095-4dannjjm	1110	3	through	through	IN
cord-023095-4dannjjm	1110	4	immunization	immunization	NN
cord-023095-4dannjjm	1110	5	of	of	IN
cord-023095-4dannjjm	1110	6	foals	foal	NNS
cord-023095-4dannjjm	1110	7	using	use	VBG
cord-023095-4dannjjm	1110	8	a	a	DT
cord-023095-4dannjjm	1110	9	safe	safe	JJ
cord-023095-4dannjjm	1110	10	and	and	CC
cord-023095-4dannjjm	1110	11	efficient	efficient	JJ
cord-023095-4dannjjm	1110	12	vaccine	vaccine	NN
cord-023095-4dannjjm	1110	13	is	be	VBZ
cord-023095-4dannjjm	1110	14	still	still	RB
cord-023095-4dannjjm	1110	15	a	a	DT
cord-023095-4dannjjm	1110	16	challenge	challenge	NN
cord-023095-4dannjjm	1110	17	.	.	.
cord-023095-4dannjjm	1111	1	Recent	recent	JJ
cord-023095-4dannjjm	1111	2	studies	study	NNS
cord-023095-4dannjjm	1111	3	are	be	VBP
cord-023095-4dannjjm	1111	4	based	base	VBN
cord-023095-4dannjjm	1111	5	on	on	IN
cord-023095-4dannjjm	1111	6	the	the	DT
cord-023095-4dannjjm	1111	7	use	use	NN
cord-023095-4dannjjm	1111	8	of	of	IN
cord-023095-4dannjjm	1111	9	the	the	DT
cord-023095-4dannjjm	1111	10	virulence	virulence	NN
cord-023095-4dannjjm	1111	11	associated	associate	VBD
cord-023095-4dannjjm	1111	12	protein	protein	NN
cord-023095-4dannjjm	1111	13	A	a	NN
cord-023095-4dannjjm	1111	14	(	(	-LRB-
cord-023095-4dannjjm	1111	15	vapA	vapa	NN
cord-023095-4dannjjm	1111	16	)	)	-RRB-
cord-023095-4dannjjm	1111	17	which	which	WDT
cord-023095-4dannjjm	1111	18	has	have	VBZ
cord-023095-4dannjjm	1111	19	been	be	VBN
cord-023095-4dannjjm	1111	20	described	describe	VBN
cord-023095-4dannjjm	1111	21	as	as	IN
cord-023095-4dannjjm	1111	22	an	an	DT
cord-023095-4dannjjm	1111	23	important	important	JJ
cord-023095-4dannjjm	1111	24	inducer	inducer	NN
cord-023095-4dannjjm	1111	25	of	of	IN
cord-023095-4dannjjm	1111	26	immunity	immunity	NN
cord-023095-4dannjjm	1111	27	against	against	IN
cord-023095-4dannjjm	1111	28	R.	R.	NNP
cord-023095-4dannjjm	1111	29	equi	equi	NN
cord-023095-4dannjjm	1111	30	.	.	.
cord-023095-4dannjjm	1112	1	The	the	DT
cord-023095-4dannjjm	1112	2	present	present	JJ
cord-023095-4dannjjm	1112	3	study	study	NN
cord-023095-4dannjjm	1112	4	evaluated	evaluate	VBD
cord-023095-4dannjjm	1112	5	the	the	DT
cord-023095-4dannjjm	1112	6	clinical	clinical	JJ
cord-023095-4dannjjm	1112	7	and	and	CC
cord-023095-4dannjjm	1112	8	immune	immune	JJ
cord-023095-4dannjjm	1112	9	response	response	NN
cord-023095-4dannjjm	1112	10	of	of	IN
cord-023095-4dannjjm	1112	11	foals	foal	NNS
cord-023095-4dannjjm	1112	12	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	1112	13	with	with	IN
cord-023095-4dannjjm	1112	14	an	an	DT
cord-023095-4dannjjm	1112	15	attenuated	attenuated	JJ
cord-023095-4dannjjm	1112	16	strain	strain	NN
cord-023095-4dannjjm	1112	17	of	of	IN
cord-023095-4dannjjm	1112	18	S.	S.	NNP
cord-023095-4dannjjm	1112	19	enterica	enterica	NNP
cord-023095-4dannjjm	1112	20	typhimurium	typhimurium	NNP
cord-023095-4dannjjm	1112	21	expressing	express	VBG
cord-023095-4dannjjm	1112	22	VapA	VapA	NNP
cord-023095-4dannjjm	1112	23	antigen	antigen	NNP
cord-023095-4dannjjm	1112	24	(	(	-LRB-
cord-023095-4dannjjm	1112	25	test	test	NN
cord-023095-4dannjjm	1112	26	group	group	NN
cord-023095-4dannjjm	1112	27	)	)	-RRB-
cord-023095-4dannjjm	1112	28	or	or	CC
cord-023095-4dannjjm	1112	29	S.	S.	NNP
cord-023095-4dannjjm	1112	30	enterica	enterica	NNP
cord-023095-4dannjjm	1112	31	typhimurium	typhimurium	NN
cord-023095-4dannjjm	1112	32	without	without	IN
cord-023095-4dannjjm	1112	33	the	the	DT
cord-023095-4dannjjm	1112	34	vapA	vapa	CD
cord-023095-4dannjjm	1112	35	gene	gene	NN
cord-023095-4dannjjm	1112	36	(	(	-LRB-
cord-023095-4dannjjm	1112	37	control	control	NNP
cord-023095-4dannjjm	1112	38	group	group	NN
cord-023095-4dannjjm	1112	39	)	)	-RRB-
cord-023095-4dannjjm	1112	40	,	,	,
cord-023095-4dannjjm	1112	41	previous	previous	JJ
cord-023095-4dannjjm	1112	42	to	to	IN
cord-023095-4dannjjm	1112	43	and	and	CC
cord-023095-4dannjjm	1112	44	following	follow	VBG
cord-023095-4dannjjm	1112	45	experimental	experimental	JJ
cord-023095-4dannjjm	1112	46	challenge	challenge	NN
cord-023095-4dannjjm	1112	47	.	.	.
cord-023095-4dannjjm	1113	1	Two	two	CD
cord-023095-4dannjjm	1113	2	experimental	experimental	JJ
cord-023095-4dannjjm	1113	3	phases	phase	NNS
cord-023095-4dannjjm	1113	4	were	be	VBD
cord-023095-4dannjjm	1113	5	established	establish	VBN
cord-023095-4dannjjm	1113	6	according	accord	VBG
cord-023095-4dannjjm	1113	7	to	to	IN
cord-023095-4dannjjm	1113	8	the	the	DT
cord-023095-4dannjjm	1113	9	immunization	immunization	NN
cord-023095-4dannjjm	1113	10	route	route	NN
cord-023095-4dannjjm	1113	11	:	:	:
cord-023095-4dannjjm	1113	12	intranasal	intranasal	NN
cord-023095-4dannjjm	1113	13	or	or	CC
cord-023095-4dannjjm	1113	14	oral	oral	JJ
cord-023095-4dannjjm	1113	15	vaccination	vaccination	NN
cord-023095-4dannjjm	1113	16	up	up	IN
cord-023095-4dannjjm	1113	17	to	to	TO
cord-023095-4dannjjm	1113	18	12	12	CD
cord-023095-4dannjjm	1113	19	hrs	hrs	NN
cord-023095-4dannjjm	1113	20	following	follow	VBG
cord-023095-4dannjjm	1113	21	birth	birth	NN
cord-023095-4dannjjm	1113	22	and	and	CC
cord-023095-4dannjjm	1113	23	at	at	IN
cord-023095-4dannjjm	1113	24	14	14	CD
cord-023095-4dannjjm	1113	25	days	day	NNS
cord-023095-4dannjjm	1113	26	of	of	IN
cord-023095-4dannjjm	1113	27	age	age	NN
cord-023095-4dannjjm	1113	28	.	.	.
cord-023095-4dannjjm	1114	1	The	the	DT
cord-023095-4dannjjm	1114	2	experimental	experimental	JJ
cord-023095-4dannjjm	1114	3	and	and	CC
cord-023095-4dannjjm	1114	4	control	control	NN
cord-023095-4dannjjm	1114	5	groups	group	NNS
cord-023095-4dannjjm	1114	6	were	be	VBD
cord-023095-4dannjjm	1114	7	challenged	challenge	VBN
cord-023095-4dannjjm	1114	8	on	on	IN
cord-023095-4dannjjm	1114	9	day	day	NN
cord-023095-4dannjjm	1114	10	28	28	CD
cord-023095-4dannjjm	1114	11	with	with	IN
cord-023095-4dannjjm	1114	12	a	a	DT
cord-023095-4dannjjm	1114	13	virulent	virulent	JJ
cord-023095-4dannjjm	1114	14	stain	stain	NN
cord-023095-4dannjjm	1114	15	of	of	IN
cord-023095-4dannjjm	1114	16	R.	R.	NNP
cord-023095-4dannjjm	1114	17	equi	equi	NN
cord-023095-4dannjjm	1114	18	.	.	.
cord-023095-4dannjjm	1115	1	Clinical	clinical	JJ
cord-023095-4dannjjm	1115	2	examination	examination	NN
cord-023095-4dannjjm	1115	3	,	,	,
cord-023095-4dannjjm	1115	4	CBC	CBC	NNP
cord-023095-4dannjjm	1115	5	and	and	CC
cord-023095-4dannjjm	1115	6	image	image	NN
cord-023095-4dannjjm	1115	7	complementary	complementary	JJ
cord-023095-4dannjjm	1115	8	exams	exam	NNS
cord-023095-4dannjjm	1115	9	were	be	VBD
cord-023095-4dannjjm	1115	10	used	use	VBN
cord-023095-4dannjjm	1115	11	to	to	TO
cord-023095-4dannjjm	1115	12	evaluate	evaluate	VB
cord-023095-4dannjjm	1115	13	the	the	DT
cord-023095-4dannjjm	1115	14	development	development	NN
cord-023095-4dannjjm	1115	15	of	of	IN
cord-023095-4dannjjm	1115	16	clinical	clinical	JJ
cord-023095-4dannjjm	1115	17	signs	sign	NNS
cord-023095-4dannjjm	1115	18	.	.	.
cord-023095-4dannjjm	1116	1	Immune	immune	JJ
cord-023095-4dannjjm	1116	2	response	response	NN
cord-023095-4dannjjm	1116	3	patterns	pattern	NNS
cord-023095-4dannjjm	1116	4	were	be	VBD
cord-023095-4dannjjm	1116	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	1116	6	though	though	IN
cord-023095-4dannjjm	1116	7	immunoglobulin	immunoglobulin	NN
cord-023095-4dannjjm	1116	8	dosage	dosage	NN
cord-023095-4dannjjm	1116	9	,	,	,
cord-023095-4dannjjm	1116	10	cytokine	cytokine	JJ
cord-023095-4dannjjm	1116	11	expression	expression	NN
cord-023095-4dannjjm	1116	12	,	,	,
cord-023095-4dannjjm	1116	13	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	1116	14	proliferation	proliferation	NN
cord-023095-4dannjjm	1116	15	assays	assay	NNS
cord-023095-4dannjjm	1116	16	,	,	,
cord-023095-4dannjjm	1116	17	isolation	isolation	NN
cord-023095-4dannjjm	1116	18	of	of	IN
cord-023095-4dannjjm	1116	19	R.	R.	NNP
cord-023095-4dannjjm	1116	20	equi	equi	NN
cord-023095-4dannjjm	1116	21	and	and	CC
cord-023095-4dannjjm	1116	22	cytological	cytological	JJ
cord-023095-4dannjjm	1116	23	profiles	profile	NNS
cord-023095-4dannjjm	1116	24	of	of	IN
cord-023095-4dannjjm	1116	25	TBW	TBW	NNP
cord-023095-4dannjjm	1116	26	.	.	.
cord-023095-4dannjjm	1117	1	Clinical	clinical	JJ
cord-023095-4dannjjm	1117	2	manifestation	manifestation	NN
cord-023095-4dannjjm	1117	3	was	be	VBD
cord-023095-4dannjjm	1117	4	less	less	RBR
cord-023095-4dannjjm	1117	5	intense	intense	JJ
cord-023095-4dannjjm	1117	6	in	in	IN
cord-023095-4dannjjm	1117	7	the	the	DT
cord-023095-4dannjjm	1117	8	test	test	NN
cord-023095-4dannjjm	1117	9	group	group	NN
cord-023095-4dannjjm	1117	10	during	during	IN
cord-023095-4dannjjm	1117	11	the	the	DT
cord-023095-4dannjjm	1117	12	second	second	JJ
cord-023095-4dannjjm	1117	13	experimental	experimental	JJ
cord-023095-4dannjjm	1117	14	phase	phase	NN
cord-023095-4dannjjm	1117	15	,	,	,
cord-023095-4dannjjm	1117	16	and	and	CC
cord-023095-4dannjjm	1117	17	death	death	NN
cord-023095-4dannjjm	1117	18	occurred	occur	VBD
cord-023095-4dannjjm	1117	19	only	only	RB
cord-023095-4dannjjm	1117	20	in	in	IN
cord-023095-4dannjjm	1117	21	the	the	DT
cord-023095-4dannjjm	1117	22	control	control	NN
cord-023095-4dannjjm	1117	23	group	group	NN
cord-023095-4dannjjm	1117	24	(	(	-LRB-
cord-023095-4dannjjm	1117	25	2/3	2/3	CD
cord-023095-4dannjjm	1117	26	)	)	-RRB-
cord-023095-4dannjjm	1117	27	and	and	CC
cord-023095-4dannjjm	1117	28	was	be	VBD
cord-023095-4dannjjm	1117	29	due	due	JJ
cord-023095-4dannjjm	1117	30	to	to	IN
cord-023095-4dannjjm	1117	31	R.	R.	NNP
cord-023095-4dannjjm	1117	32	equi	equi	JJ
cord-023095-4dannjjm	1117	33	pneumonia	pneumonia	NN
cord-023095-4dannjjm	1117	34	.	.	.
cord-023095-4dannjjm	1118	1	The	the	DT
cord-023095-4dannjjm	1118	2	test	test	NN
cord-023095-4dannjjm	1118	3	group	group	NN
cord-023095-4dannjjm	1118	4	produced	produce	VBD
cord-023095-4dannjjm	1118	5	a	a	DT
cord-023095-4dannjjm	1118	6	more	more	RBR
cord-023095-4dannjjm	1118	7	intense	intense	JJ
cord-023095-4dannjjm	1118	8	IgGb	IgGb	NNP
cord-023095-4dannjjm	1118	9	response	response	NN
cord-023095-4dannjjm	1118	10	when	when	WRB
cord-023095-4dannjjm	1118	11	compared	compare	VBN
cord-023095-4dannjjm	1118	12	to	to	IN
cord-023095-4dannjjm	1118	13	controls	control	NNS
cord-023095-4dannjjm	1118	14	however	however	RB
cord-023095-4dannjjm	1118	15	no	no	DT
cord-023095-4dannjjm	1118	16	statistical	statistical	JJ
cord-023095-4dannjjm	1118	17	difference	difference	NN
cord-023095-4dannjjm	1118	18	was	be	VBD
cord-023095-4dannjjm	1118	19	observed	observe	VBN
cord-023095-4dannjjm	1118	20	.	.	.
cord-023095-4dannjjm	1119	1	Lymphoproliferation	lymphoproliferation	NN
cord-023095-4dannjjm	1119	2	and	and	CC
cord-023095-4dannjjm	1119	3	Th1	th1	NN
cord-023095-4dannjjm	1119	4	cytokine	cytokine	NN
cord-023095-4dannjjm	1119	5	expression	expression	NN
cord-023095-4dannjjm	1119	6	were	be	VBD
cord-023095-4dannjjm	1119	7	higher	high	JJR
cord-023095-4dannjjm	1119	8	in	in	IN
cord-023095-4dannjjm	1119	9	the	the	DT
cord-023095-4dannjjm	1119	10	test	test	NN
cord-023095-4dannjjm	1119	11	group	group	NN
cord-023095-4dannjjm	1119	12	.	.	.
cord-023095-4dannjjm	1120	1	In	in	IN
cord-023095-4dannjjm	1120	2	contrast	contrast	NN
cord-023095-4dannjjm	1120	3	,	,	,
cord-023095-4dannjjm	1120	4	controls	control	NNS
cord-023095-4dannjjm	1120	5	produced	produce	VBD
cord-023095-4dannjjm	1120	6	an	an	DT
cord-023095-4dannjjm	1120	7	IL-4	IL-4	NNP
cord-023095-4dannjjm	1120	8	response	response	NN
cord-023095-4dannjjm	1120	9	.	.	.
cord-023095-4dannjjm	1121	1	Local	local	JJ
cord-023095-4dannjjm	1121	2	IgA	iga	NN
cord-023095-4dannjjm	1121	3	was	be	VBD
cord-023095-4dannjjm	1121	4	significantly	significantly	RB
cord-023095-4dannjjm	1121	5	higher	high	JJR
cord-023095-4dannjjm	1121	6	in	in	IN
cord-023095-4dannjjm	1121	7	animals	animal	NNS
cord-023095-4dannjjm	1121	8	immunized	immunize	VBN
cord-023095-4dannjjm	1121	9	with	with	IN
cord-023095-4dannjjm	1121	10	Salmonella	salmonella	NN
cord-023095-4dannjjm	1121	11	carrying	carry	VBG
cord-023095-4dannjjm	1121	12	vapA.	vapA.	NNP
cord-023095-4dannjjm	1122	1	Immunization	immunization	NN
cord-023095-4dannjjm	1122	2	protocols	protocol	NNS
cord-023095-4dannjjm	1122	3	produced	produce	VBD
cord-023095-4dannjjm	1122	4	no	no	DT
cord-023095-4dannjjm	1122	5	severe	severe	JJ
cord-023095-4dannjjm	1122	6	toxic	toxic	JJ
cord-023095-4dannjjm	1122	7	effects	effect	NNS
cord-023095-4dannjjm	1122	8	.	.	.
cord-023095-4dannjjm	1123	1	The	the	DT
cord-023095-4dannjjm	1123	2	vaccination	vaccination	NN
cord-023095-4dannjjm	1123	3	of	of	IN
cord-023095-4dannjjm	1123	4	neonatal	neonatal	JJ
cord-023095-4dannjjm	1123	5	foals	foal	NNS
cord-023095-4dannjjm	1123	6	with	with	IN
cord-023095-4dannjjm	1123	7	S.	S.	NNP
cord-023095-4dannjjm	1123	8	enterica	enterica	NNP
cord-023095-4dannjjm	1123	9	typhimurium	typhimurium	NNP
cord-023095-4dannjjm	1123	10	expressing	express	VBG
cord-023095-4dannjjm	1123	11	VapA	VapA	NNP
cord-023095-4dannjjm	1123	12	was	be	VBD
cord-023095-4dannjjm	1123	13	considered	consider	VBN
cord-023095-4dannjjm	1123	14	safe	safe	JJ
cord-023095-4dannjjm	1123	15	,	,	,
cord-023095-4dannjjm	1123	16	produced	produce	VBD
cord-023095-4dannjjm	1123	17	efficient	efficient	JJ
cord-023095-4dannjjm	1123	18	modulation	modulation	NN
cord-023095-4dannjjm	1123	19	of	of	IN
cord-023095-4dannjjm	1123	20	the	the	DT
cord-023095-4dannjjm	1123	21	immune	immune	JJ
cord-023095-4dannjjm	1123	22	response	response	NN
cord-023095-4dannjjm	1123	23	and	and	CC
cord-023095-4dannjjm	1123	24	is	be	VBZ
cord-023095-4dannjjm	1123	25	apparently	apparently	RB
cord-023095-4dannjjm	1123	26	able	able	JJ
cord-023095-4dannjjm	1123	27	to	to	TO
cord-023095-4dannjjm	1123	28	protect	protect	VB
cord-023095-4dannjjm	1123	29	against	against	IN
cord-023095-4dannjjm	1123	30	experimental	experimental	JJ
cord-023095-4dannjjm	1123	31	R.equi	r.equi	JJ
cord-023095-4dannjjm	1123	32	infection	infection	NN
cord-023095-4dannjjm	1123	33	.	.	.
cord-023095-4dannjjm	1124	1	This	this	DT
cord-023095-4dannjjm	1124	2	study	study	NN
cord-023095-4dannjjm	1124	3	was	be	VBD
cord-023095-4dannjjm	1124	4	conducted	conduct	VBN
cord-023095-4dannjjm	1124	5	to	to	TO
cord-023095-4dannjjm	1124	6	test	test	VB
cord-023095-4dannjjm	1124	7	the	the	DT
cord-023095-4dannjjm	1124	8	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1124	9	that	that	IN
cord-023095-4dannjjm	1124	10	the	the	DT
cord-023095-4dannjjm	1124	11	32	32	CD
cord-023095-4dannjjm	1124	12	kD	kD	NNP
cord-023095-4dannjjm	1124	13	protein	protein	NN
cord-023095-4dannjjm	1124	14	,	,	,
cord-023095-4dannjjm	1124	15	Myristolated	Myristolated	NNP
cord-023095-4dannjjm	1124	16	Alanine	Alanine	NNP
cord-023095-4dannjjm	1124	17	-	-	HYPH
cord-023095-4dannjjm	1124	18	Rich	Rich	NNP
cord-023095-4dannjjm	1124	19	C	C	NNP
cord-023095-4dannjjm	1124	20	-	-	HYPH
cord-023095-4dannjjm	1124	21	Kinase	Kinase	NNP
cord-023095-4dannjjm	1124	22	Substrate	Substrate	NNP
cord-023095-4dannjjm	1124	23	(	(	-LRB-
cord-023095-4dannjjm	1124	24	MARCKS	MARCKS	NNP
cord-023095-4dannjjm	1124	25	)	)	-RRB-
cord-023095-4dannjjm	1124	26	,	,	,
cord-023095-4dannjjm	1124	27	is	be	VBZ
cord-023095-4dannjjm	1124	28	involved	involve	VBN
cord-023095-4dannjjm	1124	29	in	in	IN
cord-023095-4dannjjm	1124	30	equine	equine	JJ
cord-023095-4dannjjm	1124	31	neutrophil	neutrophil	NN
cord-023095-4dannjjm	1124	32	migration	migration	NN
cord-023095-4dannjjm	1124	33	and	and	CC
cord-023095-4dannjjm	1124	34	adhesion	adhesion	NN
cord-023095-4dannjjm	1124	35	.	.	.
cord-023095-4dannjjm	1125	1	In	in	IN
cord-023095-4dannjjm	1125	2	other	other	JJ
cord-023095-4dannjjm	1125	3	species	specie	NNS
cord-023095-4dannjjm	1125	4	,	,	,
cord-023095-4dannjjm	1125	5	MARCKS	MARCKS	NNP
cord-023095-4dannjjm	1125	6	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	1125	7	and	and	CC
cord-023095-4dannjjm	1125	8	dephosphorylation	dephosphorylation	NN
cord-023095-4dannjjm	1125	9	causes	cause	VBZ
cord-023095-4dannjjm	1125	10	the	the	DT
cord-023095-4dannjjm	1125	11	protein	protein	NN
cord-023095-4dannjjm	1125	12	to	to	TO
cord-023095-4dannjjm	1125	13	cycle	cycle	VB
cord-023095-4dannjjm	1125	14	between	between	IN
cord-023095-4dannjjm	1125	15	the	the	DT
cord-023095-4dannjjm	1125	16	cell	cell	NN
cord-023095-4dannjjm	1125	17	membrane	membrane	NN
cord-023095-4dannjjm	1125	18	and	and	CC
cord-023095-4dannjjm	1125	19	cytosol	cytosol	NN
cord-023095-4dannjjm	1125	20	,	,	,
cord-023095-4dannjjm	1125	21	respectively	respectively	RB
cord-023095-4dannjjm	1125	22	.	.	.
cord-023095-4dannjjm	1126	1	To	to	TO
cord-023095-4dannjjm	1126	2	investigate	investigate	VB
cord-023095-4dannjjm	1126	3	MARCKS	MARCKS	NNP
cord-023095-4dannjjm	1126	4	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	1126	5	in	in	IN
cord-023095-4dannjjm	1126	6	horses	horse	NNS
cord-023095-4dannjjm	1126	7	,	,	,
cord-023095-4dannjjm	1126	8	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	1126	9	were	be	VBD
cord-023095-4dannjjm	1126	10	isolated	isolate	VBN
cord-023095-4dannjjm	1126	11	from	from	IN
cord-023095-4dannjjm	1126	12	whole	whole	JJ
cord-023095-4dannjjm	1126	13	blood	blood	NN
cord-023095-4dannjjm	1126	14	and	and	CC
cord-023095-4dannjjm	1126	15	stimulated	stimulate	VBD
cord-023095-4dannjjm	1126	16	with	with	IN
cord-023095-4dannjjm	1126	17	platelet	platelet	NN
cord-023095-4dannjjm	1126	18	activating	activate	VBG
cord-023095-4dannjjm	1126	19	factor	factor	NN
cord-023095-4dannjjm	1126	20	(	(	-LRB-
cord-023095-4dannjjm	1126	21	PAF	PAF	NNP
cord-023095-4dannjjm	1126	22	)	)	-RRB-
cord-023095-4dannjjm	1126	23	,	,	,
cord-023095-4dannjjm	1126	24	leukotriene	leukotriene	NN
cord-023095-4dannjjm	1126	25	B	B	NNP
cord-023095-4dannjjm	1126	26	4	4	CD
cord-023095-4dannjjm	1127	1	(	(	-LRB-
cord-023095-4dannjjm	1127	2	LTB	LTB	NNP
cord-023095-4dannjjm	1127	3	4	4	CD
cord-023095-4dannjjm	1127	4	)	)	-RRB-
cord-023095-4dannjjm	1127	5	or	or	CC
cord-023095-4dannjjm	1127	6	phorbol	phorbol	NNP
cord-023095-4dannjjm	1127	7	myristate	myristate	NNP
cord-023095-4dannjjm	1127	8	acetate	acetate	NNP
cord-023095-4dannjjm	1127	9	(	(	-LRB-
cord-023095-4dannjjm	1127	10	PMA	PMA	NNP
cord-023095-4dannjjm	1127	11	)	)	-RRB-
cord-023095-4dannjjm	1127	12	.	.	.
cord-023095-4dannjjm	1128	1	Western	western	JJ
cord-023095-4dannjjm	1128	2	blot	blot	NN
cord-023095-4dannjjm	1128	3	was	be	VBD
cord-023095-4dannjjm	1128	4	performed	perform	VBN
cord-023095-4dannjjm	1128	5	using	use	VBG
cord-023095-4dannjjm	1128	6	specific	specific	JJ
cord-023095-4dannjjm	1128	7	phospho	phospho	NNP
cord-023095-4dannjjm	1128	8	-	-	HYPH
cord-023095-4dannjjm	1128	9	MARCKS	MARCKS	NNP
cord-023095-4dannjjm	1128	10	and	and	CC
cord-023095-4dannjjm	1128	11	total	total	JJ
cord-023095-4dannjjm	1128	12	MARCKS	MARCKS	NNP
cord-023095-4dannjjm	1128	13	primary	primary	JJ
cord-023095-4dannjjm	1128	14	antibodies	antibody	NNS
cord-023095-4dannjjm	1128	15	.	.	.
cord-023095-4dannjjm	1129	1	These	these	DT
cord-023095-4dannjjm	1129	2	results	result	NNS
cord-023095-4dannjjm	1129	3	determined	determine	VBD
cord-023095-4dannjjm	1129	4	MARCKS	MARCKS	NNP
cord-023095-4dannjjm	1129	5	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	1129	6	is	be	VBZ
cord-023095-4dannjjm	1129	7	maximal	maximal	JJ
cord-023095-4dannjjm	1129	8	30	30	CD
cord-023095-4dannjjm	1129	9	seconds	second	NNS
cord-023095-4dannjjm	1129	10	following	follow	VBG
cord-023095-4dannjjm	1129	11	stimulation	stimulation	NN
cord-023095-4dannjjm	1129	12	and	and	CC
cord-023095-4dannjjm	1129	13	that	that	IN
cord-023095-4dannjjm	1129	14	dephosphorylation	dephosphorylation	NN
cord-023095-4dannjjm	1129	15	occurs	occur	VBZ
cord-023095-4dannjjm	1129	16	within	within	IN
cord-023095-4dannjjm	1129	17	3	3	CD
cord-023095-4dannjjm	1129	18	minutes	minute	NNS
cord-023095-4dannjjm	1129	19	.	.	.
cord-023095-4dannjjm	1130	1	To	to	TO
cord-023095-4dannjjm	1130	2	investigate	investigate	VB
cord-023095-4dannjjm	1130	3	the	the	DT
cord-023095-4dannjjm	1130	4	requirement	requirement	NN
cord-023095-4dannjjm	1130	5	for	for	IN
cord-023095-4dannjjm	1130	6	MARCKS	marck	NNS
cord-023095-4dannjjm	1130	7	in	in	IN
cord-023095-4dannjjm	1130	8	equine	equine	JJ
cord-023095-4dannjjm	1130	9	neutrophil	neutrophil	NN
cord-023095-4dannjjm	1130	10	chemotaxis	chemotaxis	NN
cord-023095-4dannjjm	1130	11	,	,	,
cord-023095-4dannjjm	1130	12	isolated	isolated	JJ
cord-023095-4dannjjm	1130	13	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	1130	14	were	be	VBD
cord-023095-4dannjjm	1130	15	pre	pre	VBN
cord-023095-4dannjjm	1130	16	-	-	VBN
cord-023095-4dannjjm	1130	17	treated	treat	VBN
cord-023095-4dannjjm	1130	18	with	with	IN
cord-023095-4dannjjm	1130	19	MANS	MANS	NNP
cord-023095-4dannjjm	1130	20	(	(	-LRB-
cord-023095-4dannjjm	1130	21	a	a	DT
cord-023095-4dannjjm	1130	22	cell	cell	NN
cord-023095-4dannjjm	1130	23	permeant	permeant	JJ
cord-023095-4dannjjm	1130	24	peptide	peptide	NN
cord-023095-4dannjjm	1130	25	identical	identical	JJ
cord-023095-4dannjjm	1130	26	to	to	IN
cord-023095-4dannjjm	1130	27	the	the	DT
cord-023095-4dannjjm	1130	28	N	n	CD
cord-023095-4dannjjm	1130	29	-	-	HYPH
cord-023095-4dannjjm	1130	30	terminal	terminal	JJ
cord-023095-4dannjjm	1130	31	24	24	CD
cord-023095-4dannjjm	1130	32	amino	amino	NN
cord-023095-4dannjjm	1130	33	acids	acid	NNS
cord-023095-4dannjjm	1130	34	of	of	IN
cord-023095-4dannjjm	1130	35	MARCKS	MARCKS	NNP
cord-023095-4dannjjm	1130	36	)	)	-RRB-
cord-023095-4dannjjm	1131	1	,	,	,
cord-023095-4dannjjm	1131	2	RNS	RNS	NNP
cord-023095-4dannjjm	1131	3	(	(	-LRB-
cord-023095-4dannjjm	1131	4	a	a	DT
cord-023095-4dannjjm	1131	5	control	control	NN
cord-023095-4dannjjm	1131	6	peptide	peptide	NN
cord-023095-4dannjjm	1131	7	)	)	-RRB-
cord-023095-4dannjjm	1131	8	or	or	CC
cord-023095-4dannjjm	1131	9	vehicle	vehicle	NN
cord-023095-4dannjjm	1131	10	control	control	NN
cord-023095-4dannjjm	1131	11	(	(	-LRB-
cord-023095-4dannjjm	1131	12	VC	VC	NNP
cord-023095-4dannjjm	1131	13	)	)	-RRB-
cord-023095-4dannjjm	1132	1	prior	prior	RB
cord-023095-4dannjjm	1132	2	to	to	IN
cord-023095-4dannjjm	1132	3	a	a	DT
cord-023095-4dannjjm	1132	4	migration	migration	NN
cord-023095-4dannjjm	1132	5	assay	assay	NN
cord-023095-4dannjjm	1132	6	toward	toward	IN
cord-023095-4dannjjm	1132	7	known	know	VBN
cord-023095-4dannjjm	1132	8	neutrophil	neutrophil	NN
cord-023095-4dannjjm	1132	9	chemoattractants	chemoattractant	NNS
cord-023095-4dannjjm	1132	10	(	(	-LRB-
cord-023095-4dannjjm	1132	11	LTB	LTB	NNP
cord-023095-4dannjjm	1132	12	4	4	CD
cord-023095-4dannjjm	1132	13	or	or	CC
cord-023095-4dannjjm	1132	14	PAF	PAF	NNP
cord-023095-4dannjjm	1132	15	)	)	-RRB-
cord-023095-4dannjjm	1132	16	.	.	.
cord-023095-4dannjjm	1133	1	Pre	pre	JJ
cord-023095-4dannjjm	1133	2	-	-	JJ
cord-023095-4dannjjm	1133	3	treatment	treatment	NN
cord-023095-4dannjjm	1133	4	of	of	IN
cord-023095-4dannjjm	1133	5	equine	equine	JJ
cord-023095-4dannjjm	1133	6	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	1133	7	with	with	IN
cord-023095-4dannjjm	1133	8	MANS	MANS	NNP
cord-023095-4dannjjm	1133	9	significantly	significantly	RB
cord-023095-4dannjjm	1133	10	inhibited	inhibit	VBN
cord-023095-4dannjjm	1133	11	migration	migration	NN
cord-023095-4dannjjm	1133	12	while	while	IN
cord-023095-4dannjjm	1133	13	RNS	RNS	NNP
cord-023095-4dannjjm	1133	14	pre	pre	JJ
cord-023095-4dannjjm	1133	15	-	-	JJ
cord-023095-4dannjjm	1133	16	treatment	treatment	NN
cord-023095-4dannjjm	1133	17	had	have	VBD
cord-023095-4dannjjm	1133	18	no	no	DT
cord-023095-4dannjjm	1133	19	effect	effect	NN
cord-023095-4dannjjm	1133	20	.	.	.
cord-023095-4dannjjm	1134	1	To	to	TO
cord-023095-4dannjjm	1134	2	investigate	investigate	VB
cord-023095-4dannjjm	1134	3	MARCKS	MARCKS	NNP
cord-023095-4dannjjm	1134	4	requirement	requirement	NN
cord-023095-4dannjjm	1134	5	in	in	IN
cord-023095-4dannjjm	1134	6	equine	equine	JJ
cord-023095-4dannjjm	1134	7	neutrophil	neutrophil	NN
cord-023095-4dannjjm	1134	8	adhesion	adhesion	NN
cord-023095-4dannjjm	1134	9	,	,	,
cord-023095-4dannjjm	1134	10	MANS	MANS	NNP
cord-023095-4dannjjm	1134	11	,	,	,
cord-023095-4dannjjm	1134	12	RNS	RNS	NNP
cord-023095-4dannjjm	1134	13	or	or	CC
cord-023095-4dannjjm	1134	14	VC	VC	NNP
cord-023095-4dannjjm	1134	15	treated	treat	VBN
cord-023095-4dannjjm	1134	16	cells	cell	NNS
cord-023095-4dannjjm	1134	17	were	be	VBD
cord-023095-4dannjjm	1134	18	stimulated	stimulate	VBN
cord-023095-4dannjjm	1134	19	to	to	TO
cord-023095-4dannjjm	1134	20	adhere	adhere	VB
cord-023095-4dannjjm	1134	21	to	to	IN
cord-023095-4dannjjm	1134	22	Immulon	Immulon	NNP
cord-023095-4dannjjm	1134	23	2	2	CD
cord-023095-4dannjjm	1134	24	plates	plate	NNS
cord-023095-4dannjjm	1134	25	coated	coat	VBN
cord-023095-4dannjjm	1134	26	with	with	IN
cord-023095-4dannjjm	1134	27	5	5	CD
cord-023095-4dannjjm	1134	28	%	%	NN
cord-023095-4dannjjm	1134	29	FBS	FBS	NNP
cord-023095-4dannjjm	1134	30	.	.	.
cord-023095-4dannjjm	1135	1	Pre	pre	JJ
cord-023095-4dannjjm	1135	2	-	-	JJ
cord-023095-4dannjjm	1135	3	treatment	treatment	NN
cord-023095-4dannjjm	1135	4	of	of	IN
cord-023095-4dannjjm	1135	5	equine	equine	JJ
cord-023095-4dannjjm	1135	6	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	1135	7	with	with	IN
cord-023095-4dannjjm	1135	8	MANS	MANS	NNP
cord-023095-4dannjjm	1135	9	significantly	significantly	RB
cord-023095-4dannjjm	1135	10	inhibited	inhibited	JJ
cord-023095-4dannjjm	1135	11	adhesion	adhesion	NN
cord-023095-4dannjjm	1135	12	while	while	IN
cord-023095-4dannjjm	1135	13	RNS	RNS	NNP
cord-023095-4dannjjm	1135	14	pre	pre	JJ
cord-023095-4dannjjm	1135	15	-	-	JJ
cord-023095-4dannjjm	1135	16	treatment	treatment	NN
cord-023095-4dannjjm	1135	17	had	have	VBD
cord-023095-4dannjjm	1135	18	no	no	DT
cord-023095-4dannjjm	1135	19	effect	effect	NN
cord-023095-4dannjjm	1135	20	.	.	.
cord-023095-4dannjjm	1136	1	Inhibition	inhibition	NN
cord-023095-4dannjjm	1136	2	of	of	IN
cord-023095-4dannjjm	1136	3	MARCKS	MARCKS	NNPS
cord-023095-4dannjjm	1136	4	using	use	VBG
cord-023095-4dannjjm	1136	5	a	a	DT
cord-023095-4dannjjm	1136	6	cell	cell	NN
cord-023095-4dannjjm	1136	7	permeant	permeant	JJ
cord-023095-4dannjjm	1136	8	peptide	peptide	NN
cord-023095-4dannjjm	1136	9	identical	identical	JJ
cord-023095-4dannjjm	1136	10	to	to	IN
cord-023095-4dannjjm	1136	11	the	the	DT
cord-023095-4dannjjm	1136	12	protein	protein	NN
cord-023095-4dannjjm	1136	13	's	's	POS
cord-023095-4dannjjm	1136	14	N	n	CD
cord-023095-4dannjjm	1136	15	-	-	HYPH
cord-023095-4dannjjm	1136	16	terminus	terminus	NN
cord-023095-4dannjjm	1136	17	significantly	significantly	RB
cord-023095-4dannjjm	1136	18	inhibited	inhibit	VBN
cord-023095-4dannjjm	1136	19	equine	equine	JJ
cord-023095-4dannjjm	1136	20	neutrophil	neutrophil	NN
cord-023095-4dannjjm	1136	21	adhesion	adhesion	NN
cord-023095-4dannjjm	1136	22	and	and	CC
cord-023095-4dannjjm	1136	23	migration	migration	NN
cord-023095-4dannjjm	1136	24	.	.	.
cord-023095-4dannjjm	1137	1	These	these	DT
cord-023095-4dannjjm	1137	2	results	result	NNS
cord-023095-4dannjjm	1137	3	indicate	indicate	VBP
cord-023095-4dannjjm	1137	4	that	that	IN
cord-023095-4dannjjm	1137	5	MARCKS	MARCKS	NNP
cord-023095-4dannjjm	1137	6	is	be	VBZ
cord-023095-4dannjjm	1137	7	an	an	DT
cord-023095-4dannjjm	1137	8	important	important	JJ
cord-023095-4dannjjm	1137	9	regulator	regulator	NN
cord-023095-4dannjjm	1137	10	of	of	IN
cord-023095-4dannjjm	1137	11	equine	equine	JJ
cord-023095-4dannjjm	1137	12	neutrophil	neutrophil	NN
cord-023095-4dannjjm	1137	13	chemotaxis	chemotaxis	NN
cord-023095-4dannjjm	1137	14	and	and	CC
cord-023095-4dannjjm	1137	15	represents	represent	VBZ
cord-023095-4dannjjm	1137	16	a	a	DT
cord-023095-4dannjjm	1137	17	potential	potential	JJ
cord-023095-4dannjjm	1137	18	target	target	NN
cord-023095-4dannjjm	1137	19	for	for	IN
cord-023095-4dannjjm	1137	20	anti	anti	JJ
cord-023095-4dannjjm	1137	21	-	-	JJ
cord-023095-4dannjjm	1137	22	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1137	23	therapy	therapy	NN
cord-023095-4dannjjm	1137	24	.	.	.
cord-023095-4dannjjm	1138	1	Amongst	amongst	IN
cord-023095-4dannjjm	1138	2	other	other	JJ
cord-023095-4dannjjm	1138	3	tests	test	NNS
cord-023095-4dannjjm	1138	4	,	,	,
cord-023095-4dannjjm	1138	5	a	a	DT
cord-023095-4dannjjm	1138	6	thorough	thorough	JJ
cord-023095-4dannjjm	1138	7	neurologic	neurologic	JJ
cord-023095-4dannjjm	1138	8	examination	examination	NN
cord-023095-4dannjjm	1138	9	of	of	IN
cord-023095-4dannjjm	1138	10	horses	horse	NNS
cord-023095-4dannjjm	1138	11	may	may	MD
cord-023095-4dannjjm	1138	12	include	include	VB
cord-023095-4dannjjm	1138	13	walking	walk	VBG
cord-023095-4dannjjm	1138	14	with	with	IN
cord-023095-4dannjjm	1138	15	the	the	DT
cord-023095-4dannjjm	1138	16	head	head	NN
cord-023095-4dannjjm	1138	17	elevated	elevate	VBN
cord-023095-4dannjjm	1138	18	and	and	CC
cord-023095-4dannjjm	1138	19	during	during	IN
cord-023095-4dannjjm	1138	20	blindfolding	blindfolding	NN
cord-023095-4dannjjm	1138	21	,	,	,
cord-023095-4dannjjm	1138	22	in	in	IN
cord-023095-4dannjjm	1138	23	order	order	NN
cord-023095-4dannjjm	1138	24	to	to	TO
cord-023095-4dannjjm	1138	25	help	help	VB
cord-023095-4dannjjm	1138	26	differentiate	differentiate	VB
cord-023095-4dannjjm	1138	27	normal	normal	JJ
cord-023095-4dannjjm	1138	28	from	from	IN
cord-023095-4dannjjm	1138	29	abnormal	abnormal	JJ
cord-023095-4dannjjm	1138	30	and	and	CC
cord-023095-4dannjjm	1138	31	to	to	TO
cord-023095-4dannjjm	1138	32	help	help	VB
cord-023095-4dannjjm	1138	33	with	with	IN
cord-023095-4dannjjm	1138	34	neuroanatomically	neuroanatomically	RB
cord-023095-4dannjjm	1138	35	localising	localise	VBG
cord-023095-4dannjjm	1138	36	any	any	DT
cord-023095-4dannjjm	1138	37	lesion(s	lesion(s	NNP
cord-023095-4dannjjm	1138	38	)	)	-RRB-
cord-023095-4dannjjm	1138	39	i.e.	i.e.	FW
cord-023095-4dannjjm	1138	40	in	in	IN
cord-023095-4dannjjm	1138	41	the	the	DT
cord-023095-4dannjjm	1138	42	ataxic	ataxic	JJ
cord-023095-4dannjjm	1138	43	horse	horse	NN
cord-023095-4dannjjm	1138	44	.	.	.
cord-023095-4dannjjm	1139	1	Consensus	consensus	NN
cord-023095-4dannjjm	1139	2	amongst	amongst	IN
cord-023095-4dannjjm	1139	3	equine	equine	JJ
cord-023095-4dannjjm	1139	4	neurologists	neurologist	NNS
cord-023095-4dannjjm	1139	5	suggests	suggest	VBZ
cord-023095-4dannjjm	1139	6	that	that	IN
cord-023095-4dannjjm	1139	7	gait	gait	JJ
cord-023095-4dannjjm	1139	8	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1139	9	associated	associate	VBN
cord-023095-4dannjjm	1139	10	with	with	IN
cord-023095-4dannjjm	1139	11	these	these	DT
cord-023095-4dannjjm	1139	12	specific	specific	JJ
cord-023095-4dannjjm	1139	13	tests	test	NNS
cord-023095-4dannjjm	1139	14	are	be	VBP
cord-023095-4dannjjm	1139	15	often	often	RB
cord-023095-4dannjjm	1139	16	exacerbated	exacerbate	VBN
cord-023095-4dannjjm	1139	17	in	in	IN
cord-023095-4dannjjm	1139	18	horses	horse	NNS
cord-023095-4dannjjm	1139	19	with	with	IN
cord-023095-4dannjjm	1139	20	underlying	underlying	JJ
cord-023095-4dannjjm	1139	21	proprioceptive	proprioceptive	JJ
cord-023095-4dannjjm	1139	22	deficits	deficit	NNS
cord-023095-4dannjjm	1139	23	however	however	RB
cord-023095-4dannjjm	1139	24	the	the	DT
cord-023095-4dannjjm	1139	25	effect	effect	NN
cord-023095-4dannjjm	1139	26	of	of	IN
cord-023095-4dannjjm	1139	27	these	these	DT
cord-023095-4dannjjm	1139	28	tests	test	NNS
cord-023095-4dannjjm	1139	29	on	on	IN
cord-023095-4dannjjm	1139	30	temporal	temporal	JJ
cord-023095-4dannjjm	1139	31	gait	gait	JJ
cord-023095-4dannjjm	1139	32	characteristics	characteristic	NNS
cord-023095-4dannjjm	1139	33	in	in	IN
cord-023095-4dannjjm	1139	34	normal	normal	JJ
cord-023095-4dannjjm	1139	35	horses	horse	NNS
cord-023095-4dannjjm	1139	36	has	have	VBZ
cord-023095-4dannjjm	1139	37	not	not	RB
cord-023095-4dannjjm	1139	38	previously	previously	RB
cord-023095-4dannjjm	1139	39	been	be	VBN
cord-023095-4dannjjm	1139	40	assessed	assess	VBN
cord-023095-4dannjjm	1139	41	quantitatively	quantitatively	RB
cord-023095-4dannjjm	1139	42	.	.	.
cord-023095-4dannjjm	1140	1	We	-PRON-	PRP
cord-023095-4dannjjm	1140	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1140	3	that	that	IN
cord-023095-4dannjjm	1140	4	head	head	NN
cord-023095-4dannjjm	1140	5	elevation	elevation	NN
cord-023095-4dannjjm	1140	6	or	or	CC
cord-023095-4dannjjm	1140	7	blindfolding	blindfolding	NN
cord-023095-4dannjjm	1140	8	,	,	,
cord-023095-4dannjjm	1140	9	in	in	IN
cord-023095-4dannjjm	1140	10	comparison	comparison	NN
cord-023095-4dannjjm	1140	11	with	with	IN
cord-023095-4dannjjm	1140	12	walking	walk	VBG
cord-023095-4dannjjm	1140	13	in	in	IN
cord-023095-4dannjjm	1140	14	a	a	DT
cord-023095-4dannjjm	1140	15	straight	straight	JJ
cord-023095-4dannjjm	1140	16	line	line	NN
cord-023095-4dannjjm	1140	17	would	would	MD
cord-023095-4dannjjm	1140	18	result	result	VB
cord-023095-4dannjjm	1140	19	in	in	IN
cord-023095-4dannjjm	1140	20	a	a	DT
cord-023095-4dannjjm	1140	21	compensatory	compensatory	JJ
cord-023095-4dannjjm	1140	22	decrease	decrease	NN
cord-023095-4dannjjm	1140	23	in	in	IN
cord-023095-4dannjjm	1140	24	lateral	lateral	JJ
cord-023095-4dannjjm	1140	25	(	(	-LRB-
cord-023095-4dannjjm	1140	26	left	left	JJ
cord-023095-4dannjjm	1140	27	front	front	NN
cord-023095-4dannjjm	1140	28	-	-	HYPH
cord-023095-4dannjjm	1140	29	on	on	RP
cord-023095-4dannjjm	1140	30	to	to	IN
cord-023095-4dannjjm	1140	31	left	left	JJ
cord-023095-4dannjjm	1140	32	hind	hind	NN
cord-023095-4dannjjm	1140	33	-	-	HYPH
cord-023095-4dannjjm	1140	34	on	on	JJ
cord-023095-4dannjjm	1140	35	and	and	CC
cord-023095-4dannjjm	1140	36	right	right	JJ
cord-023095-4dannjjm	1140	37	front	front	NN
cord-023095-4dannjjm	1140	38	-	-	HYPH
cord-023095-4dannjjm	1140	39	on	on	NN
cord-023095-4dannjjm	1140	40	to	to	IN
cord-023095-4dannjjm	1140	41	right	right	JJ
cord-023095-4dannjjm	1140	42	hind	hind	NN
cord-023095-4dannjjm	1140	43	-	-	HYPH
cord-023095-4dannjjm	1140	44	on	on	RP
cord-023095-4dannjjm	1140	45	)	)	-RRB-
cord-023095-4dannjjm	1140	46	and	and	CC
cord-023095-4dannjjm	1140	47	diagonal	diagonal	JJ
cord-023095-4dannjjm	1140	48	coupling	coupling	NN
cord-023095-4dannjjm	1140	49	intervals	interval	NNS
cord-023095-4dannjjm	1140	50	(	(	-LRB-
cord-023095-4dannjjm	1140	51	left	leave	VBN
cord-023095-4dannjjm	1140	52	front	front	NN
cord-023095-4dannjjm	1140	53	-	-	HYPH
cord-023095-4dannjjm	1140	54	on	on	NN
cord-023095-4dannjjm	1140	55	to	to	IN
cord-023095-4dannjjm	1140	56	right	right	JJ
cord-023095-4dannjjm	1140	57	hind	hind	NN
cord-023095-4dannjjm	1140	58	-	-	HYPH
cord-023095-4dannjjm	1140	59	on	on	JJ
cord-023095-4dannjjm	1140	60	and	and	CC
cord-023095-4dannjjm	1140	61	right	right	JJ
cord-023095-4dannjjm	1140	62	front	front	NN
cord-023095-4dannjjm	1140	63	-	-	HYPH
cord-023095-4dannjjm	1140	64	on	on	RP
cord-023095-4dannjjm	1140	65	to	to	IN
cord-023095-4dannjjm	1140	66	left	left	JJ
cord-023095-4dannjjm	1140	67	hind	hind	NN
cord-023095-4dannjjm	1140	68	-	-	HYPH
cord-023095-4dannjjm	1140	69	on	on	IN
cord-023095-4dannjjm	1140	70	)	)	-RRB-
cord-023095-4dannjjm	1140	71	in	in	IN
cord-023095-4dannjjm	1140	72	normal	normal	JJ
cord-023095-4dannjjm	1140	73	horses	horse	NNS
cord-023095-4dannjjm	1140	74	.	.	.
cord-023095-4dannjjm	1141	1	Four	four	CD
cord-023095-4dannjjm	1141	2	Thoroughbreds	thoroughbred	NNS
cord-023095-4dannjjm	1141	3	without	without	IN
cord-023095-4dannjjm	1141	4	any	any	DT
cord-023095-4dannjjm	1141	5	history	history	NN
cord-023095-4dannjjm	1141	6	or	or	CC
cord-023095-4dannjjm	1141	7	clinical	clinical	JJ
cord-023095-4dannjjm	1141	8	signs	sign	NNS
cord-023095-4dannjjm	1141	9	suggestive	suggestive	JJ
cord-023095-4dannjjm	1141	10	of	of	IN
cord-023095-4dannjjm	1141	11	neurological	neurological	JJ
cord-023095-4dannjjm	1141	12	disease	disease	NN
cord-023095-4dannjjm	1141	13	(	(	-LRB-
cord-023095-4dannjjm	1141	14	age	age	NN
cord-023095-4dannjjm	1141	15	range	range	NN
cord-023095-4dannjjm	1141	16	3	3	CD
cord-023095-4dannjjm	1141	17	to	to	TO
cord-023095-4dannjjm	1141	18	5	5	CD
cord-023095-4dannjjm	1141	19	years	year	NNS
cord-023095-4dannjjm	1141	20	)	)	-RRB-
cord-023095-4dannjjm	1141	21	were	be	VBD
cord-023095-4dannjjm	1141	22	included	include	VBN
cord-023095-4dannjjm	1141	23	in	in	IN
cord-023095-4dannjjm	1141	24	the	the	DT
cord-023095-4dannjjm	1141	25	study	study	NN
cord-023095-4dannjjm	1141	26	.	.	.
cord-023095-4dannjjm	1142	1	Retroreflective	retroreflective	JJ
cord-023095-4dannjjm	1142	2	markers	marker	NNS
cord-023095-4dannjjm	1142	3	were	be	VBD
cord-023095-4dannjjm	1142	4	applied	apply	VBN
cord-023095-4dannjjm	1142	5	to	to	IN
cord-023095-4dannjjm	1142	6	the	the	DT
cord-023095-4dannjjm	1142	7	withers	withers	NN
cord-023095-4dannjjm	1142	8	,	,	,
cord-023095-4dannjjm	1142	9	to	to	IN
cord-023095-4dannjjm	1142	10	the	the	DT
cord-023095-4dannjjm	1142	11	sacrum	sacrum	NN
cord-023095-4dannjjm	1142	12	and	and	CC
cord-023095-4dannjjm	1142	13	to	to	TO
cord-023095-4dannjjm	1142	14	left	left	VB
cord-023095-4dannjjm	1142	15	and	and	CC
cord-023095-4dannjjm	1142	16	right	right	JJ
cord-023095-4dannjjm	1142	17	tuber	tuber	NN
cord-023095-4dannjjm	1142	18	coxae	coxae	NN
cord-023095-4dannjjm	1142	19	;	;	:
cord-023095-4dannjjm	1142	20	for	for	IN
cord-023095-4dannjjm	1142	21	each	each	DT
cord-023095-4dannjjm	1142	22	limb	limb	NN
cord-023095-4dannjjm	1142	23	,	,	,
cord-023095-4dannjjm	1142	24	lateral	lateral	JJ
cord-023095-4dannjjm	1142	25	fetlock	fetlock	NN
cord-023095-4dannjjm	1142	26	markers	marker	NNS
cord-023095-4dannjjm	1142	27	and	and	CC
cord-023095-4dannjjm	1142	28	dorsal	dorsal	JJ
cord-023095-4dannjjm	1142	29	and	and	CC
cord-023095-4dannjjm	1142	30	lateral	lateral	JJ
cord-023095-4dannjjm	1142	31	hoof	hoof	NN
cord-023095-4dannjjm	1142	32	wall	wall	NN
cord-023095-4dannjjm	1142	33	markers	marker	NNS
cord-023095-4dannjjm	1142	34	were	be	VBD
cord-023095-4dannjjm	1142	35	used	use	VBN
cord-023095-4dannjjm	1142	36	.	.	.
cord-023095-4dannjjm	1143	1	A	a	DT
cord-023095-4dannjjm	1143	2	minimum	minimum	NN
cord-023095-4dannjjm	1143	3	of	of	IN
cord-023095-4dannjjm	1143	4	3	3	CD
cord-023095-4dannjjm	1143	5	trials	trial	NNS
cord-023095-4dannjjm	1143	6	each	each	DT
cord-023095-4dannjjm	1143	7	with	with	IN
cord-023095-4dannjjm	1143	8	2	2	CD
cord-023095-4dannjjm	1143	9	-	-	SYM
cord-023095-4dannjjm	1143	10	4	4	CD
cord-023095-4dannjjm	1143	11	walk	walk	NN
cord-023095-4dannjjm	1143	12	strides	stride	NNS
cord-023095-4dannjjm	1143	13	for	for	IN
cord-023095-4dannjjm	1143	14	each	each	DT
cord-023095-4dannjjm	1143	15	task	task	NN
cord-023095-4dannjjm	1143	16	were	be	VBD
cord-023095-4dannjjm	1143	17	analysed	analyse	VBN
cord-023095-4dannjjm	1143	18	as	as	IN
cord-023095-4dannjjm	1143	19	horses	horse	NNS
cord-023095-4dannjjm	1143	20	walked	walk	VBD
cord-023095-4dannjjm	1143	21	across	across	IN
cord-023095-4dannjjm	1143	22	an	an	DT
cord-023095-4dannjjm	1143	23	8-force	8-force	CD
cord-023095-4dannjjm	1143	24	-	-	HYPH
cord-023095-4dannjjm	1143	25	plate	plate	NN
cord-023095-4dannjjm	1143	26	runway	runway	NN
cord-023095-4dannjjm	1143	27	i	i	PRP
cord-023095-4dannjjm	1143	28	surrounded	surround	VBD
cord-023095-4dannjjm	1143	29	by	by	IN
cord-023095-4dannjjm	1143	30	a	a	DT
cord-023095-4dannjjm	1143	31	12-camera	12-camera	CD
cord-023095-4dannjjm	1143	32	kinematic	kinematic	JJ
cord-023095-4dannjjm	1143	33	system	system	NN
cord-023095-4dannjjm	1143	34	.	.	.
cord-023095-4dannjjm	1144	1	ii	ii	NNP
cord-023095-4dannjjm	1144	2	Force	Force	NNP
cord-023095-4dannjjm	1144	3	-	-	HYPH
cord-023095-4dannjjm	1144	4	plate	plate	NN
cord-023095-4dannjjm	1144	5	data	datum	NNS
cord-023095-4dannjjm	1144	6	were	be	VBD
cord-023095-4dannjjm	1144	7	processed	process	VBN
cord-023095-4dannjjm	1144	8	with	with	IN
cord-023095-4dannjjm	1144	9	semi	semi	JJ
cord-023095-4dannjjm	1144	10	-	-	JJ
cord-023095-4dannjjm	1144	11	automated	automated	JJ
cord-023095-4dannjjm	1144	12	custom	custom	NN
cord-023095-4dannjjm	1144	13	written	write	VBN
cord-023095-4dannjjm	1144	14	Matlab	Matlab	NNP
cord-023095-4dannjjm	1144	15	iii	iii	NNP
cord-023095-4dannjjm	1144	16	scripts	script	NNS
cord-023095-4dannjjm	1144	17	.	.	.
cord-023095-4dannjjm	1145	1	Data	datum	NNS
cord-023095-4dannjjm	1145	2	were	be	VBD
cord-023095-4dannjjm	1145	3	analysed	analyse	VBN
cord-023095-4dannjjm	1145	4	with	with	IN
cord-023095-4dannjjm	1145	5	a	a	DT
cord-023095-4dannjjm	1145	6	mixed	mixed	JJ
cord-023095-4dannjjm	1145	7	model	model	NN
cord-023095-4dannjjm	1145	8	using	use	VBG
cord-023095-4dannjjm	1145	9	the	the	DT
cord-023095-4dannjjm	1145	10	statistical	statistical	JJ
cord-023095-4dannjjm	1145	11	software	software	NN
cord-023095-4dannjjm	1145	12	R.	R.	NNP
cord-023095-4dannjjm	1146	1	There	there	EX
cord-023095-4dannjjm	1146	2	was	be	VBD
cord-023095-4dannjjm	1146	3	a	a	DT
cord-023095-4dannjjm	1146	4	significant	significant	JJ
cord-023095-4dannjjm	1146	5	fixed	fix	VBN
cord-023095-4dannjjm	1146	6	effect	effect	NN
cord-023095-4dannjjm	1146	7	of	of	IN
cord-023095-4dannjjm	1146	8	normal	normal	JJ
cord-023095-4dannjjm	1146	9	walk	walk	NN
cord-023095-4dannjjm	1146	10	on	on	IN
cord-023095-4dannjjm	1146	11	a	a	DT
cord-023095-4dannjjm	1146	12	straight	straight	JJ
cord-023095-4dannjjm	1146	13	line	line	NN
cord-023095-4dannjjm	1146	14	and	and	CC
cord-023095-4dannjjm	1146	15	head	head	NN
cord-023095-4dannjjm	1146	16	elevation	elevation	NN
cord-023095-4dannjjm	1146	17	on	on	IN
cord-023095-4dannjjm	1146	18	left	left	JJ
cord-023095-4dannjjm	1146	19	and	and	CC
cord-023095-4dannjjm	1146	20	right	right	JJ
cord-023095-4dannjjm	1146	21	lateral	lateral	JJ
cord-023095-4dannjjm	1146	22	coupling	coupling	NN
cord-023095-4dannjjm	1146	23	intervals	interval	NNS
cord-023095-4dannjjm	1146	24	(	(	-LRB-
cord-023095-4dannjjm	1146	25	p	p	NN
cord-023095-4dannjjm	1146	26	o	o	NN
cord-023095-4dannjjm	1146	27	0.0001	0.0001	CD
cord-023095-4dannjjm	1146	28	)	)	-RRB-
cord-023095-4dannjjm	1146	29	and	and	CC
cord-023095-4dannjjm	1146	30	of	of	IN
cord-023095-4dannjjm	1146	31	the	the	DT
cord-023095-4dannjjm	1146	32	left	left	JJ
cord-023095-4dannjjm	1146	33	and	and	CC
cord-023095-4dannjjm	1146	34	right	right	JJ
cord-023095-4dannjjm	1146	35	diagonal	diagonal	JJ
cord-023095-4dannjjm	1146	36	coupling	coupling	NN
cord-023095-4dannjjm	1146	37	intervals	interval	NNS
cord-023095-4dannjjm	1146	38	(	(	-LRB-
cord-023095-4dannjjm	1146	39	p	p	NN
cord-023095-4dannjjm	1146	40	o	o	NN
cord-023095-4dannjjm	1146	41	0.0001	0.0001	CD
cord-023095-4dannjjm	1146	42	)	)	-RRB-
cord-023095-4dannjjm	1146	43	.	.	.
cord-023095-4dannjjm	1147	1	There	there	EX
cord-023095-4dannjjm	1147	2	was	be	VBD
cord-023095-4dannjjm	1147	3	no	no	DT
cord-023095-4dannjjm	1147	4	significant	significant	JJ
cord-023095-4dannjjm	1147	5	effect	effect	NN
cord-023095-4dannjjm	1147	6	of	of	IN
cord-023095-4dannjjm	1147	7	blindfolding	blindfold	VBG
cord-023095-4dannjjm	1147	8	on	on	IN
cord-023095-4dannjjm	1147	9	neither	neither	DT
cord-023095-4dannjjm	1147	10	lateral	lateral	JJ
cord-023095-4dannjjm	1147	11	nor	nor	CC
cord-023095-4dannjjm	1147	12	diagonal	diagonal	JJ
cord-023095-4dannjjm	1147	13	coupling	coupling	NN
cord-023095-4dannjjm	1147	14	intervals	interval	NNS
cord-023095-4dannjjm	1147	15	.	.	.
cord-023095-4dannjjm	1148	1	The	the	DT
cord-023095-4dannjjm	1148	2	random	random	JJ
cord-023095-4dannjjm	1148	3	effect	effect	NN
cord-023095-4dannjjm	1148	4	of	of	IN
cord-023095-4dannjjm	1148	5	horse	horse	NN
cord-023095-4dannjjm	1148	6	had	have	VBD
cord-023095-4dannjjm	1148	7	no	no	DT
cord-023095-4dannjjm	1148	8	influence	influence	NN
cord-023095-4dannjjm	1148	9	on	on	IN
cord-023095-4dannjjm	1148	10	the	the	DT
cord-023095-4dannjjm	1148	11	coupling	coupling	NN
cord-023095-4dannjjm	1148	12	intervals	interval	NNS
cord-023095-4dannjjm	1148	13	.	.	.
cord-023095-4dannjjm	1149	1	The	the	DT
cord-023095-4dannjjm	1149	2	decrease	decrease	NN
cord-023095-4dannjjm	1149	3	of	of	IN
cord-023095-4dannjjm	1149	4	the	the	DT
cord-023095-4dannjjm	1149	5	lateral	lateral	JJ
cord-023095-4dannjjm	1149	6	coupling	coupling	NN
cord-023095-4dannjjm	1149	7	intervals	interval	NNS
cord-023095-4dannjjm	1149	8	indicates	indicate	VBZ
cord-023095-4dannjjm	1149	9	a	a	DT
cord-023095-4dannjjm	1149	10	tendency	tendency	NN
cord-023095-4dannjjm	1149	11	towards	towards	IN
cord-023095-4dannjjm	1149	12	a	a	DT
cord-023095-4dannjjm	1149	13	pacing	pace	VBG
cord-023095-4dannjjm	1149	14	gait	gait	NN
cord-023095-4dannjjm	1149	15	during	during	IN
cord-023095-4dannjjm	1149	16	head	head	NN
cord-023095-4dannjjm	1149	17	elevation	elevation	NN
cord-023095-4dannjjm	1149	18	.	.	.
cord-023095-4dannjjm	1150	1	We	-PRON-	PRP
cord-023095-4dannjjm	1150	2	conclude	conclude	VBP
cord-023095-4dannjjm	1150	3	that	that	IN
cord-023095-4dannjjm	1150	4	there	there	EX
cord-023095-4dannjjm	1150	5	is	be	VBZ
cord-023095-4dannjjm	1150	6	a	a	DT
cord-023095-4dannjjm	1150	7	significant	significant	JJ
cord-023095-4dannjjm	1150	8	change	change	NN
cord-023095-4dannjjm	1150	9	in	in	IN
cord-023095-4dannjjm	1150	10	temporal	temporal	JJ
cord-023095-4dannjjm	1150	11	gait	gait	JJ
cord-023095-4dannjjm	1150	12	characteristics	characteristic	NNS
cord-023095-4dannjjm	1150	13	of	of	IN
cord-023095-4dannjjm	1150	14	non	non	JJ
cord-023095-4dannjjm	1150	15	-	-	JJ
cord-023095-4dannjjm	1150	16	neurologic	neurologic	JJ
cord-023095-4dannjjm	1150	17	horses	horse	NNS
cord-023095-4dannjjm	1150	18	when	when	WRB
cord-023095-4dannjjm	1150	19	the	the	DT
cord-023095-4dannjjm	1150	20	head	head	NN
cord-023095-4dannjjm	1150	21	is	be	VBZ
cord-023095-4dannjjm	1150	22	elevated	elevate	VBN
cord-023095-4dannjjm	1150	23	but	but	CC
cord-023095-4dannjjm	1150	24	not	not	RB
cord-023095-4dannjjm	1150	25	during	during	IN
cord-023095-4dannjjm	1150	26	blindfolding	blindfold	VBG
cord-023095-4dannjjm	1150	27	compared	compare	VBN
cord-023095-4dannjjm	1150	28	to	to	IN
cord-023095-4dannjjm	1150	29	normal	normal	JJ
cord-023095-4dannjjm	1150	30	walking	walking	NN
cord-023095-4dannjjm	1150	31	.	.	.
cord-023095-4dannjjm	1151	1	Current	current	JJ
cord-023095-4dannjjm	1151	2	results	result	NNS
cord-023095-4dannjjm	1151	3	suggest	suggest	VBP
cord-023095-4dannjjm	1151	4	that	that	IN
cord-023095-4dannjjm	1151	5	pacing	pace	VBG
cord-023095-4dannjjm	1151	6	and	and	CC
cord-023095-4dannjjm	1151	7	increased	increase	VBN
cord-023095-4dannjjm	1151	8	variation	variation	NN
cord-023095-4dannjjm	1151	9	in	in	IN
cord-023095-4dannjjm	1151	10	foot	foot	NN
cord-023095-4dannjjm	1151	11	-	-	HYPH
cord-023095-4dannjjm	1151	12	placement	placement	NN
cord-023095-4dannjjm	1151	13	during	during	IN
cord-023095-4dannjjm	1151	14	head	head	NN
cord-023095-4dannjjm	1151	15	elevation	elevation	NN
cord-023095-4dannjjm	1151	16	should	should	MD
cord-023095-4dannjjm	1151	17	be	be	VB
cord-023095-4dannjjm	1151	18	interpreted	interpret	VBN
cord-023095-4dannjjm	1151	19	with	with	IN
cord-023095-4dannjjm	1151	20	caution	caution	NN
cord-023095-4dannjjm	1151	21	however	however	RB
cord-023095-4dannjjm	1151	22	further	further	JJ
cord-023095-4dannjjm	1151	23	work	work	NN
cord-023095-4dannjjm	1151	24	is	be	VBZ
cord-023095-4dannjjm	1151	25	required	require	VBN
cord-023095-4dannjjm	1151	26	to	to	TO
cord-023095-4dannjjm	1151	27	determine	determine	VB
cord-023095-4dannjjm	1151	28	whether	whether	IN
cord-023095-4dannjjm	1151	29	the	the	DT
cord-023095-4dannjjm	1151	30	change	change	NN
cord-023095-4dannjjm	1151	31	differs	differ	VBZ
cord-023095-4dannjjm	1151	32	between	between	IN
cord-023095-4dannjjm	1151	33	horses	horse	NNS
cord-023095-4dannjjm	1151	34	with	with	IN
cord-023095-4dannjjm	1151	35	neurological	neurological	JJ
cord-023095-4dannjjm	1151	36	disease	disease	NN
cord-023095-4dannjjm	1151	37	and	and	CC
cord-023095-4dannjjm	1151	38	non	non	JJ
cord-023095-4dannjjm	1151	39	-	-	JJ
cord-023095-4dannjjm	1151	40	neurologic	neurologic	JJ
cord-023095-4dannjjm	1151	41	disease	disease	NN
cord-023095-4dannjjm	1151	42	.	.	.
cord-023095-4dannjjm	1152	1	Hereditary	hereditary	JJ
cord-023095-4dannjjm	1152	2	Equine	Equine	NNP
cord-023095-4dannjjm	1152	3	Regional	Regional	NNP
cord-023095-4dannjjm	1152	4	Dermal	Dermal	NNP
cord-023095-4dannjjm	1152	5	Asthenia	Asthenia	NNP
cord-023095-4dannjjm	1152	6	(	(	-LRB-
cord-023095-4dannjjm	1152	7	HERDA	HERDA	NNP
cord-023095-4dannjjm	1152	8	)	)	-RRB-
cord-023095-4dannjjm	1152	9	is	be	VBZ
cord-023095-4dannjjm	1152	10	an	an	DT
cord-023095-4dannjjm	1152	11	autosomal	autosomal	JJ
cord-023095-4dannjjm	1152	12	recessive	recessive	JJ
cord-023095-4dannjjm	1152	13	connective	connective	JJ
cord-023095-4dannjjm	1152	14	tissue	tissue	NN
cord-023095-4dannjjm	1152	15	disorder	disorder	NN
cord-023095-4dannjjm	1152	16	associated	associate	VBN
cord-023095-4dannjjm	1152	17	with	with	IN
cord-023095-4dannjjm	1152	18	a	a	DT
cord-023095-4dannjjm	1152	19	mutation	mutation	NN
cord-023095-4dannjjm	1152	20	in	in	IN
cord-023095-4dannjjm	1152	21	cyclophillin	cyclophillin	NNP
cord-023095-4dannjjm	1152	22	B	B	NNP
cord-023095-4dannjjm	1152	23	that	that	WDT
cord-023095-4dannjjm	1152	24	leads	lead	VBZ
cord-023095-4dannjjm	1152	25	to	to	IN
cord-023095-4dannjjm	1152	26	impaired	impaired	JJ
cord-023095-4dannjjm	1152	27	collagen	collagen	NN
cord-023095-4dannjjm	1152	28	folding	folding	NN
cord-023095-4dannjjm	1152	29	,	,	,
cord-023095-4dannjjm	1152	30	aberrant	aberrant	JJ
cord-023095-4dannjjm	1152	31	wound	wound	NN
cord-023095-4dannjjm	1152	32	repair	repair	NN
cord-023095-4dannjjm	1152	33	,	,	,
cord-023095-4dannjjm	1152	34	and	and	CC
cord-023095-4dannjjm	1152	35	corneal	corneal	JJ
cord-023095-4dannjjm	1152	36	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1152	37	.	.	.
cord-023095-4dannjjm	1153	1	It	-PRON-	PRP
cord-023095-4dannjjm	1153	2	affects	affect	VBZ
cord-023095-4dannjjm	1153	3	young	young	JJ
cord-023095-4dannjjm	1153	4	Quarter	Quarter	NNP
cord-023095-4dannjjm	1153	5	Horses	Horses	NNPS
cord-023095-4dannjjm	1153	6	,	,	,
cord-023095-4dannjjm	1153	7	Appaloosa	Appaloosa	NNP
cord-023095-4dannjjm	1153	8	,	,	,
cord-023095-4dannjjm	1153	9	and	and	CC
cord-023095-4dannjjm	1153	10	Paints	paint	NNS
cord-023095-4dannjjm	1153	11	.	.	.
cord-023095-4dannjjm	1154	1	HERDA	HERDA	NNP
cord-023095-4dannjjm	1154	2	shows	show	VBZ
cord-023095-4dannjjm	1154	3	similarities	similarity	NNS
cord-023095-4dannjjm	1154	4	to	to	IN
cord-023095-4dannjjm	1154	5	the	the	DT
cord-023095-4dannjjm	1154	6	human	human	JJ
cord-023095-4dannjjm	1154	7	hereditary	hereditary	JJ
cord-023095-4dannjjm	1154	8	connective	connective	JJ
cord-023095-4dannjjm	1154	9	tissue	tissue	NN
cord-023095-4dannjjm	1154	10	syndrome	syndrome	NN
cord-023095-4dannjjm	1154	11	Ehlers	Ehlers	NNP
cord-023095-4dannjjm	1154	12	Danlos	Danlos	NNP
cord-023095-4dannjjm	1154	13	(	(	-LRB-
cord-023095-4dannjjm	1154	14	EDS	EDS	NNP
cord-023095-4dannjjm	1154	15	)	)	-RRB-
cord-023095-4dannjjm	1154	16	.	.	.
cord-023095-4dannjjm	1155	1	Many	many	JJ
cord-023095-4dannjjm	1155	2	EDS	EDS	NNP
cord-023095-4dannjjm	1155	3	patients	patient	NNS
cord-023095-4dannjjm	1155	4	suffer	suffer	VBP
cord-023095-4dannjjm	1155	5	from	from	IN
cord-023095-4dannjjm	1155	6	joint	joint	JJ
cord-023095-4dannjjm	1155	7	pain	pain	NN
cord-023095-4dannjjm	1155	8	and	and	CC
cord-023095-4dannjjm	1155	9	osteoarthritis	osteoarthritis	NN
cord-023095-4dannjjm	1155	10	(	(	-LRB-
cord-023095-4dannjjm	1155	11	OA	OA	NNP
cord-023095-4dannjjm	1155	12	)	)	-RRB-
cord-023095-4dannjjm	1155	13	as	as	IN
cord-023095-4dannjjm	1155	14	adults	adult	NNS
cord-023095-4dannjjm	1155	15	.	.	.
cord-023095-4dannjjm	1156	1	The	the	DT
cord-023095-4dannjjm	1156	2	similarity	similarity	NN
cord-023095-4dannjjm	1156	3	between	between	IN
cord-023095-4dannjjm	1156	4	EDS	EDS	NNP
cord-023095-4dannjjm	1156	5	and	and	CC
cord-023095-4dannjjm	1156	6	HERDA	HERDA	NNP
cord-023095-4dannjjm	1156	7	raises	raise	VBZ
cord-023095-4dannjjm	1156	8	the	the	DT
cord-023095-4dannjjm	1156	9	question	question	NN
cord-023095-4dannjjm	1156	10	whether	whether	IN
cord-023095-4dannjjm	1156	11	horses	horse	NNS
cord-023095-4dannjjm	1156	12	suffering	suffer	VBG
cord-023095-4dannjjm	1156	13	from	from	IN
cord-023095-4dannjjm	1156	14	HERDA	HERDA	NNP
cord-023095-4dannjjm	1156	15	develop	develop	VBP
cord-023095-4dannjjm	1156	16	OA	OA	NNP
cord-023095-4dannjjm	1156	17	.	.	.
cord-023095-4dannjjm	1157	1	In	in	IN
cord-023095-4dannjjm	1157	2	OA	OA	NNP
cord-023095-4dannjjm	1157	3	,	,	,
cord-023095-4dannjjm	1157	4	excess	excess	JJ
cord-023095-4dannjjm	1157	5	production	production	NN
cord-023095-4dannjjm	1157	6	of	of	IN
cord-023095-4dannjjm	1157	7	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1157	8	mediators	mediator	NNS
cord-023095-4dannjjm	1157	9	such	such	JJ
cord-023095-4dannjjm	1157	10	as	as	IN
cord-023095-4dannjjm	1157	11	prostaglandin	prostaglandin	NN
cord-023095-4dannjjm	1157	12	E2	e2	NN
cord-023095-4dannjjm	1157	13	(	(	-LRB-
cord-023095-4dannjjm	1157	14	PGE	PGE	NNP
cord-023095-4dannjjm	1157	15	2	2	CD
cord-023095-4dannjjm	1157	16	)	)	-RRB-
cord-023095-4dannjjm	1157	17	activate	activate	VBP
cord-023095-4dannjjm	1157	18	enzymes	enzyme	NNS
cord-023095-4dannjjm	1157	19	that	that	WDT
cord-023095-4dannjjm	1157	20	degrade	degrade	VBP
cord-023095-4dannjjm	1157	21	cartilage	cartilage	NN
cord-023095-4dannjjm	1157	22	as	as	RB
cord-023095-4dannjjm	1157	23	well	well	RB
cord-023095-4dannjjm	1157	24	as	as	IN
cord-023095-4dannjjm	1157	25	impede	impede	NNS
cord-023095-4dannjjm	1157	26	wound	wind	VBN
cord-023095-4dannjjm	1157	27	healing	healing	NN
cord-023095-4dannjjm	1157	28	.	.	.
cord-023095-4dannjjm	1158	1	The	the	DT
cord-023095-4dannjjm	1158	2	present	present	JJ
cord-023095-4dannjjm	1158	3	study	study	NN
cord-023095-4dannjjm	1158	4	examined	examine	VBD
cord-023095-4dannjjm	1158	5	articular	articular	JJ
cord-023095-4dannjjm	1158	6	cartilage	cartilage	NN
cord-023095-4dannjjm	1158	7	from	from	IN
cord-023095-4dannjjm	1158	8	yearling	yearling	JJ
cord-023095-4dannjjm	1158	9	horses	horse	NNS
cord-023095-4dannjjm	1158	10	afflicted	afflict	VBN
cord-023095-4dannjjm	1158	11	with	with	IN
cord-023095-4dannjjm	1158	12	HERDA	HERDA	NNP
cord-023095-4dannjjm	1158	13	.	.	.
cord-023095-4dannjjm	1159	1	We	-PRON-	PRP
cord-023095-4dannjjm	1159	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1159	3	that	that	IN
cord-023095-4dannjjm	1159	4	chondrocytes	chondrocyte	NNS
cord-023095-4dannjjm	1159	5	from	from	IN
cord-023095-4dannjjm	1159	6	these	these	DT
cord-023095-4dannjjm	1159	7	horses	horse	NNS
cord-023095-4dannjjm	1159	8	are	be	VBP
cord-023095-4dannjjm	1159	9	continually	continually	RB
cord-023095-4dannjjm	1159	10	activated	activate	VBN
cord-023095-4dannjjm	1159	11	to	to	TO
cord-023095-4dannjjm	1159	12	produce	produce	VB
cord-023095-4dannjjm	1159	13	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1159	14	mediators	mediator	NNS
cord-023095-4dannjjm	1159	15	.	.	.
cord-023095-4dannjjm	1160	1	To	to	TO
cord-023095-4dannjjm	1160	2	test	test	VB
cord-023095-4dannjjm	1160	3	this	this	DT
cord-023095-4dannjjm	1160	4	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1160	5	,	,	,
cord-023095-4dannjjm	1160	6	articular	articular	JJ
cord-023095-4dannjjm	1160	7	cartilage	cartilage	NN
cord-023095-4dannjjm	1160	8	from	from	IN
cord-023095-4dannjjm	1160	9	carpal	carpal	NN
cord-023095-4dannjjm	1160	10	and	and	CC
cord-023095-4dannjjm	1160	11	tarsal	tarsal	NN
cord-023095-4dannjjm	1160	12	joints	joint	NNS
cord-023095-4dannjjm	1160	13	of	of	IN
cord-023095-4dannjjm	1160	14	HERDA	HERDA	NNP
cord-023095-4dannjjm	1160	15	horses	horse	NNS
cord-023095-4dannjjm	1160	16	were	be	VBD
cord-023095-4dannjjm	1160	17	evaluated	evaluate	VBN
cord-023095-4dannjjm	1160	18	using	use	VBG
cord-023095-4dannjjm	1160	19	histology	histology	NN
cord-023095-4dannjjm	1160	20	.	.	.
cord-023095-4dannjjm	1161	1	PGE	PGE	NNP
cord-023095-4dannjjm	1161	2	2	2	CD
cord-023095-4dannjjm	1161	3	production	production	NN
cord-023095-4dannjjm	1161	4	by	by	IN
cord-023095-4dannjjm	1161	5	chondrocyte	chondrocyte	NNP
cord-023095-4dannjjm	1161	6	cultures	culture	NNS
cord-023095-4dannjjm	1161	7	was	be	VBD
cord-023095-4dannjjm	1161	8	measured	measure	VBN
cord-023095-4dannjjm	1161	9	by	by	IN
cord-023095-4dannjjm	1161	10	ELISA	ELISA	NNP
cord-023095-4dannjjm	1161	11	and	and	CC
cord-023095-4dannjjm	1161	12	analyzed	analyze	VBN
cord-023095-4dannjjm	1161	13	by	by	IN
cord-023095-4dannjjm	1161	14	one	one	CD
cord-023095-4dannjjm	1161	15	-	-	HYPH
cord-023095-4dannjjm	1161	16	way	way	NN
cord-023095-4dannjjm	1161	17	ANOVA	anova	NN
cord-023095-4dannjjm	1161	18	,	,	,
cord-023095-4dannjjm	1161	19	Tukey	Tukey	NNP
cord-023095-4dannjjm	1161	20	post	post	NN
cord-023095-4dannjjm	1161	21	-	-	JJ
cord-023095-4dannjjm	1161	22	hoc	hoc	JJ
cord-023095-4dannjjm	1161	23	test	test	NN
cord-023095-4dannjjm	1161	24	,	,	,
cord-023095-4dannjjm	1161	25	p	p	NN
cord-023095-4dannjjm	1161	26	o	o	NN
cord-023095-4dannjjm	1161	27	0.05	0.05	CD
cord-023095-4dannjjm	1161	28	significance	significance	NN
cord-023095-4dannjjm	1161	29	.	.	.
cord-023095-4dannjjm	1162	1	We	-PRON-	PRP
cord-023095-4dannjjm	1162	2	also	also	RB
cord-023095-4dannjjm	1162	3	determined	determine	VBD
cord-023095-4dannjjm	1162	4	the	the	DT
cord-023095-4dannjjm	1162	5	antiinflammatory	antiinflammatory	JJ
cord-023095-4dannjjm	1162	6	effects	effect	NNS
cord-023095-4dannjjm	1162	7	of	of	IN
cord-023095-4dannjjm	1162	8	an	an	DT
cord-023095-4dannjjm	1162	9	avocado	avocado	NN
cord-023095-4dannjjm	1162	10	/	/	SYM
cord-023095-4dannjjm	1162	11	soybean	soybean	NN
cord-023095-4dannjjm	1162	12	unsaponifiables	unsaponifiable	NNS
cord-023095-4dannjjm	1162	13	(	(	-LRB-
cord-023095-4dannjjm	1162	14	ASU	ASU	NNP
cord-023095-4dannjjm	1162	15	)	)	-RRB-
cord-023095-4dannjjm	1162	16	,	,	,
cord-023095-4dannjjm	1162	17	glucosamine	glucosamine	FW
cord-023095-4dannjjm	1162	18	(	(	-LRB-
cord-023095-4dannjjm	1162	19	GLU	GLU	NNP
cord-023095-4dannjjm	1162	20	)	)	-RRB-
cord-023095-4dannjjm	1162	21	,	,	,
cord-023095-4dannjjm	1162	22	and	and	CC
cord-023095-4dannjjm	1162	23	chondroitin	chondroitin	NN
cord-023095-4dannjjm	1162	24	sulfate	sulfate	NN
cord-023095-4dannjjm	1162	25	(	(	-LRB-
cord-023095-4dannjjm	1162	26	CS	CS	NNP
cord-023095-4dannjjm	1162	27	)	)	-RRB-
cord-023095-4dannjjm	1162	28	mixture	mixture	NN
cord-023095-4dannjjm	1162	29	(	(	-LRB-
cord-023095-4dannjjm	1162	30	ingredients	ingredient	NNS
cord-023095-4dannjjm	1162	31	found	find	VBN
cord-023095-4dannjjm	1162	32	in	in	IN
cord-023095-4dannjjm	1162	33	Cosequin	Cosequin	NNP
cord-023095-4dannjjm	1162	34	s	s	POS
cord-023095-4dannjjm	1162	35	ASU	ASU	NNP
cord-023095-4dannjjm	1162	36	)	)	-RRB-
cord-023095-4dannjjm	1162	37	and	and	CC
cord-023095-4dannjjm	1162	38	phenylbutazone	phenylbutazone	NNP
cord-023095-4dannjjm	1162	39	(	(	-LRB-
cord-023095-4dannjjm	1162	40	PBZ	PBZ	NNP
cord-023095-4dannjjm	1162	41	)	)	-RRB-
cord-023095-4dannjjm	1162	42	on	on	IN
cord-023095-4dannjjm	1162	43	chondrocytes	chondrocyte	NNS
cord-023095-4dannjjm	1162	44	.	.	.
cord-023095-4dannjjm	1163	1	Cosequin	Cosequin	NNP
cord-023095-4dannjjm	1163	2	s	s	POS
cord-023095-4dannjjm	1163	3	ASU	ASU	NNP
cord-023095-4dannjjm	1163	4	and	and	CC
cord-023095-4dannjjm	1163	5	PBZ	PBZ	NNP
cord-023095-4dannjjm	1163	6	are	be	VBP
cord-023095-4dannjjm	1163	7	used	use	VBN
cord-023095-4dannjjm	1163	8	alone	alone	RB
cord-023095-4dannjjm	1163	9	or	or	CC
cord-023095-4dannjjm	1163	10	in	in	IN
cord-023095-4dannjjm	1163	11	combination	combination	NN
cord-023095-4dannjjm	1163	12	for	for	IN
cord-023095-4dannjjm	1163	13	the	the	DT
cord-023095-4dannjjm	1163	14	management	management	NN
cord-023095-4dannjjm	1163	15	of	of	IN
cord-023095-4dannjjm	1163	16	OA	OA	NNP
cord-023095-4dannjjm	1163	17	.	.	.
cord-023095-4dannjjm	1164	1	Chondrocyte	Chondrocyte	NNP
cord-023095-4dannjjm	1164	2	cultures	culture	NNS
cord-023095-4dannjjm	1164	3	were	be	VBD
cord-023095-4dannjjm	1164	4	incubated	incubate	VBN
cord-023095-4dannjjm	1164	5	for	for	IN
cord-023095-4dannjjm	1164	6	24	24	CD
cord-023095-4dannjjm	1164	7	hrs	hrs	NN
cord-023095-4dannjjm	1164	8	with	with	IN
cord-023095-4dannjjm	1164	9	control	control	NN
cord-023095-4dannjjm	1164	10	media	medium	NNS
cord-023095-4dannjjm	1164	11	alone	alone	RB
cord-023095-4dannjjm	1164	12	,	,	,
cord-023095-4dannjjm	1164	13	a	a	DT
cord-023095-4dannjjm	1164	14	clinically	clinically	RB
cord-023095-4dannjjm	1164	15	relevant	relevant	JJ
cord-023095-4dannjjm	1164	16	concentration	concentration	NN
cord-023095-4dannjjm	1164	17	of	of	IN
cord-023095-4dannjjm	1164	18	PBZ	PBZ	NNP
cord-023095-4dannjjm	1164	19	(	(	-LRB-
cord-023095-4dannjjm	1164	20	4	4	CD
cord-023095-4dannjjm	1164	21	mg	mg	NNP
cord-023095-4dannjjm	1164	22	/	/	SYM
cord-023095-4dannjjm	1164	23	ml	ml	NNP
cord-023095-4dannjjm	1164	24	)	)	-RRB-
cord-023095-4dannjjm	1164	25	,	,	,
cord-023095-4dannjjm	1164	26	or	or	CC
cord-023095-4dannjjm	1164	27	the	the	DT
cord-023095-4dannjjm	1164	28	combination	combination	NN
cord-023095-4dannjjm	1164	29	of	of	IN
cord-023095-4dannjjm	1164	30	ASU	ASU	NNP
cord-023095-4dannjjm	1164	31	(	(	-LRB-
cord-023095-4dannjjm	1164	32	NMX1000	NMX1000	NNP
cord-023095-4dannjjm	1164	33	s	s	NNP
cord-023095-4dannjjm	1164	34	,	,	,
cord-023095-4dannjjm	1164	35	8.3	8.3	CD
cord-023095-4dannjjm	1164	36	mg	mg	NNP
cord-023095-4dannjjm	1164	37	/	/	SYM
cord-023095-4dannjjm	1164	38	ml	ml	NN
cord-023095-4dannjjm	1164	39	)	)	-RRB-
cord-023095-4dannjjm	1164	40	1	1	CD
cord-023095-4dannjjm	1164	41	GLU	GLU	NNP
cord-023095-4dannjjm	1164	42	(	(	-LRB-
cord-023095-4dannjjm	1164	43	FCHG49	FCHG49	NNP
cord-023095-4dannjjm	1164	44	s	s	NNP
cord-023095-4dannjjm	1164	45	,	,	,
cord-023095-4dannjjm	1164	46	11mg	11mg	NN
cord-023095-4dannjjm	1164	47	/	/	SYM
cord-023095-4dannjjm	1164	48	ml	ml	NN
cord-023095-4dannjjm	1164	49	)	)	-RRB-
cord-023095-4dannjjm	1164	50	1	1	CD
cord-023095-4dannjjm	1164	51	CS	CS	NNP
cord-023095-4dannjjm	1164	52	(	(	-LRB-
cord-023095-4dannjjm	1164	53	TRH122	TRH122	NNP
cord-023095-4dannjjm	1164	54	s	s	NNP
cord-023095-4dannjjm	1164	55	,	,	,
cord-023095-4dannjjm	1164	56	20	20	CD
cord-023095-4dannjjm	1164	57	mg	mg	NNP
cord-023095-4dannjjm	1164	58	/	/	SYM
cord-023095-4dannjjm	1164	59	ml	ml	NNP
cord-023095-4dannjjm	1164	60	)	)	-RRB-
cord-023095-4dannjjm	1164	61	.	.	.
cord-023095-4dannjjm	1165	1	Articular	articular	JJ
cord-023095-4dannjjm	1165	2	cartilage	cartilage	NN
cord-023095-4dannjjm	1165	3	from	from	IN
cord-023095-4dannjjm	1165	4	joints	joint	NNS
cord-023095-4dannjjm	1165	5	of	of	IN
cord-023095-4dannjjm	1165	6	five	five	CD
cord-023095-4dannjjm	1165	7	HERDA	HERDA	NNP
cord-023095-4dannjjm	1165	8	-	-	HYPH
cord-023095-4dannjjm	1165	9	afflicted	afflict	VBN
cord-023095-4dannjjm	1165	10	horses	horse	NNS
cord-023095-4dannjjm	1165	11	showed	show	VBD
cord-023095-4dannjjm	1165	12	gross	gross	JJ
cord-023095-4dannjjm	1165	13	and	and	CC
cord-023095-4dannjjm	1165	14	histologic	histologic	JJ
cord-023095-4dannjjm	1165	15	evidence	evidence	NN
cord-023095-4dannjjm	1165	16	of	of	IN
cord-023095-4dannjjm	1165	17	osteoarthritic	osteoarthritic	JJ
cord-023095-4dannjjm	1165	18	lesions	lesion	NNS
cord-023095-4dannjjm	1165	19	.	.	.
cord-023095-4dannjjm	1166	1	Chondrocyte	Chondrocyte	NNP
cord-023095-4dannjjm	1166	2	cultures	culture	NNS
cord-023095-4dannjjm	1166	3	from	from	IN
cord-023095-4dannjjm	1166	4	cartilage	cartilage	NN
cord-023095-4dannjjm	1166	5	of	of	IN
cord-023095-4dannjjm	1166	6	horses	horse	NNS
cord-023095-4dannjjm	1166	7	suffering	suffer	VBG
cord-023095-4dannjjm	1166	8	from	from	IN
cord-023095-4dannjjm	1166	9	HERDA	HERDA	NNP
cord-023095-4dannjjm	1166	10	spontaneously	spontaneously	RB
cord-023095-4dannjjm	1166	11	produced	produce	VBD
cord-023095-4dannjjm	1166	12	greater	great	JJR
cord-023095-4dannjjm	1166	13	PGE	PGE	NNP
cord-023095-4dannjjm	1166	14	2	2	CD
cord-023095-4dannjjm	1166	15	than	than	IN
cord-023095-4dannjjm	1166	16	chondrocytes	chondrocyte	NNS
cord-023095-4dannjjm	1166	17	from	from	IN
cord-023095-4dannjjm	1166	18	normal	normal	JJ
cord-023095-4dannjjm	1166	19	horses	horse	NNS
cord-023095-4dannjjm	1166	20	(	(	-LRB-
cord-023095-4dannjjm	1166	21	41000-fold	41000-fold	CD
cord-023095-4dannjjm	1166	22	)	)	-RRB-
cord-023095-4dannjjm	1166	23	.	.	.
cord-023095-4dannjjm	1167	1	PBZ	pbz	NN
cord-023095-4dannjjm	1167	2	significantly	significantly	RB
cord-023095-4dannjjm	1167	3	decreased	decrease	VBD
cord-023095-4dannjjm	1167	4	PGE	PGE	NNP
cord-023095-4dannjjm	1167	5	2	2	CD
cord-023095-4dannjjm	1167	6	production	production	NN
cord-023095-4dannjjm	1167	7	by	by	IN
cord-023095-4dannjjm	1167	8	$	$	$
cord-023095-4dannjjm	1167	9	90	90	CD
cord-023095-4dannjjm	1167	10	%	%	NN
cord-023095-4dannjjm	1167	11	(	(	-LRB-
cord-023095-4dannjjm	1167	12	p	p	NN
cord-023095-4dannjjm	1167	13	o	o	CD
cord-023095-4dannjjm	1167	14	0.001	0.001	CD
cord-023095-4dannjjm	1167	15	)	)	-RRB-
cord-023095-4dannjjm	1167	16	.	.	.
cord-023095-4dannjjm	1168	1	The	the	DT
cord-023095-4dannjjm	1168	2	combination	combination	NN
cord-023095-4dannjjm	1168	3	of	of	IN
cord-023095-4dannjjm	1168	4	ASU1-GLU1CS	asu1-glu1c	NNS
cord-023095-4dannjjm	1168	5	also	also	RB
cord-023095-4dannjjm	1168	6	significantly	significantly	RB
cord-023095-4dannjjm	1168	7	reduced	reduce	VBD
cord-023095-4dannjjm	1168	8	PGE	PGE	NNP
cord-023095-4dannjjm	1168	9	2	2	CD
cord-023095-4dannjjm	1168	10	production	production	NN
cord-023095-4dannjjm	1168	11	by	by	IN
cord-023095-4dannjjm	1168	12	$	$	$
cord-023095-4dannjjm	1168	13	60	60	CD
cord-023095-4dannjjm	1168	14	%	%	NN
cord-023095-4dannjjm	1168	15	(	(	-LRB-
cord-023095-4dannjjm	1168	16	p	p	NN
cord-023095-4dannjjm	1168	17	o	o	CD
cord-023095-4dannjjm	1168	18	0.001	0.001	CD
cord-023095-4dannjjm	1168	19	)	)	-RRB-
cord-023095-4dannjjm	1168	20	.	.	.
cord-023095-4dannjjm	1169	1	The	the	DT
cord-023095-4dannjjm	1169	2	present	present	JJ
cord-023095-4dannjjm	1169	3	study	study	NN
cord-023095-4dannjjm	1169	4	supports	support	VBZ
cord-023095-4dannjjm	1169	5	anecdotal	anecdotal	JJ
cord-023095-4dannjjm	1169	6	findings	finding	NNS
cord-023095-4dannjjm	1169	7	that	that	WDT
cord-023095-4dannjjm	1169	8	horses	horse	NNS
cord-023095-4dannjjm	1169	9	suffering	suffer	VBG
cord-023095-4dannjjm	1169	10	from	from	IN
cord-023095-4dannjjm	1169	11	HERDA	HERDA	NNP
cord-023095-4dannjjm	1169	12	are	be	VBP
cord-023095-4dannjjm	1169	13	likely	likely	JJ
cord-023095-4dannjjm	1169	14	to	to	TO
cord-023095-4dannjjm	1169	15	develop	develop	VB
cord-023095-4dannjjm	1169	16	OA	OA	NNP
cord-023095-4dannjjm	1169	17	.	.	.
cord-023095-4dannjjm	1170	1	The	the	DT
cord-023095-4dannjjm	1170	2	inhibition	inhibition	NN
cord-023095-4dannjjm	1170	3	of	of	IN
cord-023095-4dannjjm	1170	4	PGE	PGE	NNP
cord-023095-4dannjjm	1170	5	2	2	CD
cord-023095-4dannjjm	1170	6	synthesis	synthesis	NN
cord-023095-4dannjjm	1170	7	by	by	IN
cord-023095-4dannjjm	1170	8	ASU1GLU1CS	asu1glu1cs	CD
cord-023095-4dannjjm	1170	9	suggests	suggest	VBZ
cord-023095-4dannjjm	1170	10	that	that	IN
cord-023095-4dannjjm	1170	11	this	this	DT
cord-023095-4dannjjm	1170	12	combination	combination	NN
cord-023095-4dannjjm	1170	13	may	may	MD
cord-023095-4dannjjm	1170	14	be	be	VB
cord-023095-4dannjjm	1170	15	beneficial	beneficial	JJ
cord-023095-4dannjjm	1170	16	for	for	IN
cord-023095-4dannjjm	1170	17	the	the	DT
cord-023095-4dannjjm	1170	18	management	management	NN
cord-023095-4dannjjm	1170	19	of	of	IN
cord-023095-4dannjjm	1170	20	OA	OA	NNP
cord-023095-4dannjjm	1170	21	in	in	IN
cord-023095-4dannjjm	1170	22	HERDA	HERDA	NNP
cord-023095-4dannjjm	1170	23	.	.	.
cord-023095-4dannjjm	1171	1	Research	research	NN
cord-023095-4dannjjm	1171	2	supported	support	VBN
cord-023095-4dannjjm	1171	3	by	by	IN
cord-023095-4dannjjm	1171	4	Nutramax	Nutramax	NNP
cord-023095-4dannjjm	1171	5	Laboratories	Laboratories	NNP
cord-023095-4dannjjm	1171	6	,	,	,
cord-023095-4dannjjm	1172	1	Inc.	Inc.	NNP
cord-023095-4dannjjm	1172	2	Equine	Equine	NNP
cord-023095-4dannjjm	1172	3	Inflammatory	Inflammatory	NNP
cord-023095-4dannjjm	1172	4	Airway	Airway	NNP
cord-023095-4dannjjm	1172	5	Disease	Disease	NNP
cord-023095-4dannjjm	1172	6	(	(	-LRB-
cord-023095-4dannjjm	1172	7	IAD	IAD	NNP
cord-023095-4dannjjm	1172	8	)	)	-RRB-
cord-023095-4dannjjm	1172	9	is	be	VBZ
cord-023095-4dannjjm	1172	10	a	a	DT
cord-023095-4dannjjm	1172	11	common	common	JJ
cord-023095-4dannjjm	1172	12	condition	condition	NN
cord-023095-4dannjjm	1172	13	often	often	RB
cord-023095-4dannjjm	1172	14	treated	treat	VBN
cord-023095-4dannjjm	1172	15	empirically	empirically	RB
cord-023095-4dannjjm	1172	16	with	with	IN
cord-023095-4dannjjm	1172	17	corticosteroids	corticosteroid	NNS
cord-023095-4dannjjm	1172	18	.	.	.
cord-023095-4dannjjm	1173	1	Gene	gene	NN
cord-023095-4dannjjm	1173	2	expression	expression	NN
cord-023095-4dannjjm	1173	3	analysis	analysis	NN
cord-023095-4dannjjm	1173	4	in	in	IN
cord-023095-4dannjjm	1173	5	the	the	DT
cord-023095-4dannjjm	1173	6	bronchoalveolar	bronchoalveolar	NNP
cord-023095-4dannjjm	1173	7	lavage	lavage	NN
cord-023095-4dannjjm	1173	8	fluid	fluid	NN
cord-023095-4dannjjm	1173	9	(	(	-LRB-
cord-023095-4dannjjm	1173	10	BALF	BALF	NNP
cord-023095-4dannjjm	1173	11	)	)	-RRB-
cord-023095-4dannjjm	1173	12	may	may	MD
cord-023095-4dannjjm	1173	13	help	help	VB
cord-023095-4dannjjm	1173	14	understand	understand	VB
cord-023095-4dannjjm	1173	15	the	the	DT
cord-023095-4dannjjm	1173	16	effects	effect	NNS
cord-023095-4dannjjm	1173	17	of	of	IN
cord-023095-4dannjjm	1173	18	corticosteroids	corticosteroid	NNS
cord-023095-4dannjjm	1173	19	in	in	IN
cord-023095-4dannjjm	1173	20	IAD	IAD	NNP
cord-023095-4dannjjm	1173	21	.	.	.
cord-023095-4dannjjm	1174	1	The	the	DT
cord-023095-4dannjjm	1174	2	first	first	JJ
cord-023095-4dannjjm	1174	3	part	part	NN
cord-023095-4dannjjm	1174	4	of	of	IN
cord-023095-4dannjjm	1174	5	the	the	DT
cord-023095-4dannjjm	1174	6	study	study	NN
cord-023095-4dannjjm	1174	7	aimed	aim	VBN
cord-023095-4dannjjm	1174	8	at	at	IN
cord-023095-4dannjjm	1174	9	identifying	identify	VBG
cord-023095-4dannjjm	1174	10	reference	reference	NN
cord-023095-4dannjjm	1174	11	genes	gene	NNS
cord-023095-4dannjjm	1174	12	in	in	IN
cord-023095-4dannjjm	1174	13	the	the	DT
cord-023095-4dannjjm	1174	14	BALF	BALF	NNP
cord-023095-4dannjjm	1174	15	of	of	IN
cord-023095-4dannjjm	1174	16	IAD	IAD	NNP
cord-023095-4dannjjm	1174	17	horses	horse	NNS
cord-023095-4dannjjm	1174	18	treated	treat	VBN
cord-023095-4dannjjm	1174	19	with	with	IN
cord-023095-4dannjjm	1174	20	corticosteroids	corticosteroid	NNS
cord-023095-4dannjjm	1174	21	.	.	.
cord-023095-4dannjjm	1175	1	The	the	DT
cord-023095-4dannjjm	1175	2	second	second	JJ
cord-023095-4dannjjm	1175	3	part	part	NN
cord-023095-4dannjjm	1175	4	of	of	IN
cord-023095-4dannjjm	1175	5	the	the	DT
cord-023095-4dannjjm	1175	6	study	study	NN
cord-023095-4dannjjm	1175	7	investigated	investigate	VBD
cord-023095-4dannjjm	1175	8	the	the	DT
cord-023095-4dannjjm	1175	9	effects	effect	NNS
cord-023095-4dannjjm	1175	10	of	of	IN
cord-023095-4dannjjm	1175	11	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	1175	12	and	and	CC
cord-023095-4dannjjm	1175	13	fluticasone	fluticasone	NN
cord-023095-4dannjjm	1175	14	propionate	propionate	NN
cord-023095-4dannjjm	1175	15	treatments	treatment	NNS
cord-023095-4dannjjm	1175	16	on	on	IN
cord-023095-4dannjjm	1175	17	the	the	DT
cord-023095-4dannjjm	1175	18	mRNA	mRNA	NNP
cord-023095-4dannjjm	1175	19	expression	expression	NN
cord-023095-4dannjjm	1175	20	of	of	IN
cord-023095-4dannjjm	1175	21	IL-1b	IL-1b	NNS
cord-023095-4dannjjm	1175	22	,	,	,
cord-023095-4dannjjm	1175	23	IL-4	IL-4	NNP
cord-023095-4dannjjm	1175	24	,	,	,
cord-023095-4dannjjm	1175	25	IL-8	IL-8	NNP
cord-023095-4dannjjm	1175	26	and	and	CC
cord-023095-4dannjjm	1175	27	IL-17	IL-17	NNP
cord-023095-4dannjjm	1175	28	.	.	.
cord-023095-4dannjjm	1176	1	The	the	DT
cord-023095-4dannjjm	1176	2	expression	expression	NN
cord-023095-4dannjjm	1176	3	stability	stability	NN
cord-023095-4dannjjm	1176	4	of	of	IN
cord-023095-4dannjjm	1176	5	seven	seven	CD
cord-023095-4dannjjm	1176	6	candidate	candidate	NN
cord-023095-4dannjjm	1176	7	reference	reference	NN
cord-023095-4dannjjm	1176	8	genes	gene	NNS
cord-023095-4dannjjm	1176	9	was	be	VBD
cord-023095-4dannjjm	1176	10	determined	determine	VBN
cord-023095-4dannjjm	1176	11	in	in	IN
cord-023095-4dannjjm	1176	12	BALF	BALF	NNP
cord-023095-4dannjjm	1176	13	taken	take	VBN
cord-023095-4dannjjm	1176	14	pre	pre	AFX
cord-023095-4dannjjm	1176	15	-	-	HYPH
cord-023095-4dannjjm	1176	16	and	and	CC
cord-023095-4dannjjm	1176	17	post	post	JJ
cord-023095-4dannjjm	1176	18	-	-	NN
cord-023095-4dannjjm	1176	19	treatment	treatment	NN
cord-023095-4dannjjm	1176	20	with	with	IN
cord-023095-4dannjjm	1176	21	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	1176	22	and	and	CC
cord-023095-4dannjjm	1176	23	fluticasone	fluticasone	NN
cord-023095-4dannjjm	1176	24	propionate	propionate	NN
cord-023095-4dannjjm	1176	25	in	in	IN
cord-023095-4dannjjm	1176	26	horses	horse	NNS
cord-023095-4dannjjm	1176	27	with	with	IN
cord-023095-4dannjjm	1176	28	IAD	IAD	NNP
cord-023095-4dannjjm	1176	29	.	.	.
cord-023095-4dannjjm	1177	1	Primers	primer	NNS
cord-023095-4dannjjm	1177	2	'	'	POS
cord-023095-4dannjjm	1177	3	efficiencies	efficiency	NNS
cord-023095-4dannjjm	1177	4	were	be	VBD
cord-023095-4dannjjm	1177	5	calculated	calculate	VBN
cord-023095-4dannjjm	1177	6	using	use	VBG
cord-023095-4dannjjm	1177	7	LinRegPCR	LinRegPCR	NNP
cord-023095-4dannjjm	1177	8	.	.	.
cord-023095-4dannjjm	1178	1	NormFinder	NormFinder	NNP
cord-023095-4dannjjm	1178	2	,	,	,
cord-023095-4dannjjm	1178	3	GeNorm	genorm	NN
cord-023095-4dannjjm	1178	4	and	and	CC
cord-023095-4dannjjm	1179	1	qBasePlus	qBasePlus	NNP
cord-023095-4dannjjm	1179	2	softwares	software	NNS
cord-023095-4dannjjm	1179	3	were	be	VBD
cord-023095-4dannjjm	1179	4	used	use	VBN
cord-023095-4dannjjm	1179	5	to	to	TO
cord-023095-4dannjjm	1179	6	rank	rank	VB
cord-023095-4dannjjm	1179	7	the	the	DT
cord-023095-4dannjjm	1179	8	genes	gene	NNS
cord-023095-4dannjjm	1179	9	according	accord	VBG
cord-023095-4dannjjm	1179	10	to	to	IN
cord-023095-4dannjjm	1179	11	their	-PRON-	PRP$
cord-023095-4dannjjm	1179	12	stability	stability	NN
cord-023095-4dannjjm	1179	13	.	.	.
cord-023095-4dannjjm	1180	1	GAPDH	GAPDH	NNP
cord-023095-4dannjjm	1180	2	was	be	VBD
cord-023095-4dannjjm	1180	3	the	the	DT
cord-023095-4dannjjm	1180	4	most	most	RBS
cord-023095-4dannjjm	1180	5	stably	stably	RB
cord-023095-4dannjjm	1180	6	expressed	express	VBN
cord-023095-4dannjjm	1180	7	gene	gene	NN
cord-023095-4dannjjm	1180	8	whereas	whereas	IN
cord-023095-4dannjjm	1180	9	B2	B2	NNP
cord-023095-4dannjjm	1180	10	M	M	NNP
cord-023095-4dannjjm	1180	11	was	be	VBD
cord-023095-4dannjjm	1180	12	the	the	DT
cord-023095-4dannjjm	1180	13	least	least	JJS
cord-023095-4dannjjm	1180	14	stable	stable	JJ
cord-023095-4dannjjm	1180	15	gene	gene	NN
cord-023095-4dannjjm	1180	16	.	.	.
cord-023095-4dannjjm	1181	1	In	in	IN
cord-023095-4dannjjm	1181	2	addition	addition	NN
cord-023095-4dannjjm	1181	3	,	,	,
cord-023095-4dannjjm	1181	4	GeNorm	genorm	NN
cord-023095-4dannjjm	1181	5	analysis	analysis	NN
cord-023095-4dannjjm	1181	6	revealed	reveal	VBD
cord-023095-4dannjjm	1181	7	that	that	IN
cord-023095-4dannjjm	1181	8	the	the	DT
cord-023095-4dannjjm	1181	9	number	number	NN
cord-023095-4dannjjm	1181	10	of	of	IN
cord-023095-4dannjjm	1181	11	genes	gene	NNS
cord-023095-4dannjjm	1181	12	required	require	VBN
cord-023095-4dannjjm	1181	13	for	for	IN
cord-023095-4dannjjm	1181	14	optimal	optimal	JJ
cord-023095-4dannjjm	1181	15	normalization	normalization	NN
cord-023095-4dannjjm	1181	16	was	be	VBD
cord-023095-4dannjjm	1181	17	four	four	CD
cord-023095-4dannjjm	1181	18	(	(	-LRB-
cord-023095-4dannjjm	1181	19	GAPDH	GAPDH	NNP
cord-023095-4dannjjm	1181	20	,	,	,
cord-023095-4dannjjm	1181	21	SDHA	SDHA	NNP
cord-023095-4dannjjm	1181	22	,	,	,
cord-023095-4dannjjm	1181	23	HPRT	HPRT	NNP
cord-023095-4dannjjm	1181	24	,	,	,
cord-023095-4dannjjm	1181	25	RPL32	RPL32	NNP
cord-023095-4dannjjm	1181	26	)	)	-RRB-
cord-023095-4dannjjm	1181	27	.	.	.
cord-023095-4dannjjm	1182	1	In	in	IN
cord-023095-4dannjjm	1182	2	the	the	DT
cord-023095-4dannjjm	1182	3	second	second	JJ
cord-023095-4dannjjm	1182	4	part	part	NN
cord-023095-4dannjjm	1182	5	of	of	IN
cord-023095-4dannjjm	1182	6	the	the	DT
cord-023095-4dannjjm	1182	7	study	study	NN
cord-023095-4dannjjm	1182	8	the	the	DT
cord-023095-4dannjjm	1182	9	mRNA	mRNA	NNP
cord-023095-4dannjjm	1182	10	expression	expression	NN
cord-023095-4dannjjm	1182	11	of	of	IN
cord-023095-4dannjjm	1182	12	IL-1b	IL-1b	NNS
cord-023095-4dannjjm	1182	13	,	,	,
cord-023095-4dannjjm	1182	14	IL-4	IL-4	NNP
cord-023095-4dannjjm	1182	15	,	,	,
cord-023095-4dannjjm	1182	16	IL-8	IL-8	NNP
cord-023095-4dannjjm	1182	17	and	and	CC
cord-023095-4dannjjm	1182	18	IL-17	IL-17	NNP
cord-023095-4dannjjm	1182	19	was	be	VBD
cord-023095-4dannjjm	1182	20	measured	measure	VBN
cord-023095-4dannjjm	1182	21	in	in	IN
cord-023095-4dannjjm	1182	22	BALF	BALF	NNP
cord-023095-4dannjjm	1182	23	samples	sample	NNS
cord-023095-4dannjjm	1182	24	from	from	IN
cord-023095-4dannjjm	1182	25	seven	seven	CD
cord-023095-4dannjjm	1182	26	IAD	IAD	NNP
cord-023095-4dannjjm	1182	27	horses	horse	NNS
cord-023095-4dannjjm	1182	28	treated	treat	VBN
cord-023095-4dannjjm	1182	29	in	in	IN
cord-023095-4dannjjm	1182	30	a	a	DT
cord-023095-4dannjjm	1182	31	randomized	randomized	JJ
cord-023095-4dannjjm	1182	32	cross	cross	NN
cord-023095-4dannjjm	1182	33	-	-	HYPH
cord-023095-4dannjjm	1182	34	over	over	RP
cord-023095-4dannjjm	1182	35	design	design	NN
cord-023095-4dannjjm	1182	36	with	with	IN
cord-023095-4dannjjm	1182	37	dexamethasone	dexamethasone	NNP
cord-023095-4dannjjm	1182	38	(	(	-LRB-
cord-023095-4dannjjm	1182	39	0.05	0.05	CD
cord-023095-4dannjjm	1182	40	mg	mg	NNP
cord-023095-4dannjjm	1182	41	/	/	SYM
cord-023095-4dannjjm	1182	42	kg	kg	NNP
cord-023095-4dannjjm	1182	43	SID	SID	NNP
cord-023095-4dannjjm	1182	44	,	,	,
cord-023095-4dannjjm	1182	45	15	15	CD
cord-023095-4dannjjm	1182	46	days	day	NNS
cord-023095-4dannjjm	1182	47	)	)	-RRB-
cord-023095-4dannjjm	1182	48	or	or	CC
cord-023095-4dannjjm	1182	49	inhaled	inhale	VBN
cord-023095-4dannjjm	1182	50	fluticasone	fluticasone	NN
cord-023095-4dannjjm	1182	51	propionate	propionate	NN
cord-023095-4dannjjm	1182	52	(	(	-LRB-
cord-023095-4dannjjm	1182	53	3000	3000	CD
cord-023095-4dannjjm	1182	54	mcg	mcg	NN
cord-023095-4dannjjm	1182	55	BID	BID	NNP
cord-023095-4dannjjm	1182	56	with	with	IN
cord-023095-4dannjjm	1182	57	Aerohippus	Aerohippus	NNP
cord-023095-4dannjjm	1182	58	,	,	,
cord-023095-4dannjjm	1182	59	15	15	CD
cord-023095-4dannjjm	1182	60	days	day	NNS
cord-023095-4dannjjm	1182	61	)	)	-RRB-
cord-023095-4dannjjm	1182	62	.	.	.
cord-023095-4dannjjm	1183	1	The	the	DT
cord-023095-4dannjjm	1183	2	BALF	BALF	NNP
cord-023095-4dannjjm	1183	3	samples	sample	NNS
cord-023095-4dannjjm	1183	4	were	be	VBD
cord-023095-4dannjjm	1183	5	taken	take	VBN
cord-023095-4dannjjm	1183	6	at	at	IN
cord-023095-4dannjjm	1183	7	baseline	baseline	NN
cord-023095-4dannjjm	1183	8	and	and	CC
cord-023095-4dannjjm	1183	9	after	after	IN
cord-023095-4dannjjm	1183	10	each	each	DT
cord-023095-4dannjjm	1183	11	treatment	treatment	NN
cord-023095-4dannjjm	1183	12	period	period	NN
cord-023095-4dannjjm	1183	13	.	.	.
cord-023095-4dannjjm	1184	1	There	there	EX
cord-023095-4dannjjm	1184	2	was	be	VBD
cord-023095-4dannjjm	1184	3	no	no	DT
cord-023095-4dannjjm	1184	4	significant	significant	JJ
cord-023095-4dannjjm	1184	5	effect	effect	NN
cord-023095-4dannjjm	1184	6	of	of	IN
cord-023095-4dannjjm	1184	7	the	the	DT
cord-023095-4dannjjm	1184	8	corticosteroids	corticosteroid	NNS
cord-023095-4dannjjm	1184	9	treatment	treatment	NN
cord-023095-4dannjjm	1184	10	on	on	IN
cord-023095-4dannjjm	1184	11	the	the	DT
cord-023095-4dannjjm	1184	12	mRNA	mRNA	NNP
cord-023095-4dannjjm	1184	13	expression	expression	NN
cord-023095-4dannjjm	1184	14	of	of	IN
cord-023095-4dannjjm	1184	15	IL-1b	IL-1b	NNS
cord-023095-4dannjjm	1184	16	,	,	,
cord-023095-4dannjjm	1184	17	IL-4	IL-4	NNP
cord-023095-4dannjjm	1184	18	and	and	CC
cord-023095-4dannjjm	1184	19	IL-8	IL-8	NNP
cord-023095-4dannjjm	1184	20	in	in	IN
cord-023095-4dannjjm	1184	21	the	the	DT
cord-023095-4dannjjm	1184	22	BALF	BALF	NNP
cord-023095-4dannjjm	1184	23	.	.	.
cord-023095-4dannjjm	1185	1	The	the	DT
cord-023095-4dannjjm	1185	2	mRNA	mrna	NN
cord-023095-4dannjjm	1185	3	expression	expression	NN
cord-023095-4dannjjm	1185	4	of	of	IN
cord-023095-4dannjjm	1185	5	IL-17	IL-17	NNP
cord-023095-4dannjjm	1185	6	was	be	VBD
cord-023095-4dannjjm	1185	7	suppressed	suppress	VBN
cord-023095-4dannjjm	1185	8	by	by	IN
cord-023095-4dannjjm	1185	9	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	1185	10	and	and	CC
cord-023095-4dannjjm	1185	11	fluticasone	fluticasone	NN
cord-023095-4dannjjm	1185	12	propionate	propionate	NN
cord-023095-4dannjjm	1185	13	treatments	treatment	NNS
cord-023095-4dannjjm	1185	14	.	.	.
cord-023095-4dannjjm	1186	1	Pneumonia	pneumonia	NN
cord-023095-4dannjjm	1186	2	is	be	VBZ
cord-023095-4dannjjm	1186	3	observed	observe	VBN
cord-023095-4dannjjm	1186	4	in	in	IN
cord-023095-4dannjjm	1186	5	horses	horse	NNS
cord-023095-4dannjjm	1186	6	after	after	IN
cord-023095-4dannjjm	1186	7	long	long	JJ
cord-023095-4dannjjm	1186	8	distance	distance	NN
cord-023095-4dannjjm	1186	9	transportation	transportation	NN
cord-023095-4dannjjm	1186	10	in	in	IN
cord-023095-4dannjjm	1186	11	association	association	NN
cord-023095-4dannjjm	1186	12	with	with	IN
cord-023095-4dannjjm	1186	13	confinement	confinement	NN
cord-023095-4dannjjm	1186	14	of	of	IN
cord-023095-4dannjjm	1186	15	horses	horse	NNS
cord-023095-4dannjjm	1186	16	'	'	POS
cord-023095-4dannjjm	1186	17	head	head	NN
cord-023095-4dannjjm	1186	18	position	position	NN
cord-023095-4dannjjm	1186	19	leading	lead	VBG
cord-023095-4dannjjm	1186	20	to	to	IN
cord-023095-4dannjjm	1186	21	a	a	DT
cord-023095-4dannjjm	1186	22	reduction	reduction	NN
cord-023095-4dannjjm	1186	23	in	in	IN
cord-023095-4dannjjm	1186	24	tracheal	tracheal	JJ
cord-023095-4dannjjm	1186	25	mucociliary	mucociliary	JJ
cord-023095-4dannjjm	1186	26	clearance	clearance	NN
cord-023095-4dannjjm	1186	27	time	time	NN
cord-023095-4dannjjm	1186	28	(	(	-LRB-
cord-023095-4dannjjm	1186	29	TMCT	TMCT	NNP
cord-023095-4dannjjm	1186	30	)	)	-RRB-
cord-023095-4dannjjm	1186	31	.	.	.
cord-023095-4dannjjm	1187	1	We	-PRON-	PRP
cord-023095-4dannjjm	1187	2	hypothesize	hypothesize	VBP
cord-023095-4dannjjm	1187	3	that	that	IN
cord-023095-4dannjjm	1187	4	clenbuterol	clenbuterol	NN
cord-023095-4dannjjm	1187	5	,	,	,
cord-023095-4dannjjm	1187	6	a	a	DT
cord-023095-4dannjjm	1187	7	beta-2	beta-2	NN
cord-023095-4dannjjm	1187	8	agonist	agonist	NN
cord-023095-4dannjjm	1187	9	shown	show	VBN
cord-023095-4dannjjm	1187	10	to	to	TO
cord-023095-4dannjjm	1187	11	increase	increase	VB
cord-023095-4dannjjm	1187	12	TMCT	TMCT	NNS
cord-023095-4dannjjm	1187	13	in	in	IN
cord-023095-4dannjjm	1187	14	the	the	DT
cord-023095-4dannjjm	1187	15	horse	horse	NN
cord-023095-4dannjjm	1187	16	,	,	,
cord-023095-4dannjjm	1187	17	will	will	MD
cord-023095-4dannjjm	1187	18	ameliorate	ameliorate	VB
cord-023095-4dannjjm	1187	19	the	the	DT
cord-023095-4dannjjm	1187	20	affect	affect	NN
cord-023095-4dannjjm	1187	21	of	of	IN
cord-023095-4dannjjm	1187	22	a	a	DT
cord-023095-4dannjjm	1187	23	fixed	fixed	JJ
cord-023095-4dannjjm	1187	24	head	head	NN
cord-023095-4dannjjm	1187	25	position	position	NN
cord-023095-4dannjjm	1187	26	on	on	IN
cord-023095-4dannjjm	1187	27	large	large	JJ
cord-023095-4dannjjm	1187	28	airway	airway	NN
cord-023095-4dannjjm	1187	29	contamination	contamination	NN
cord-023095-4dannjjm	1187	30	and	and	CC
cord-023095-4dannjjm	1187	31	inflammation	inflammation	NN
cord-023095-4dannjjm	1187	32	in	in	IN
cord-023095-4dannjjm	1187	33	a	a	DT
cord-023095-4dannjjm	1187	34	long	long	JJ
cord-023095-4dannjjm	1187	35	-	-	HYPH
cord-023095-4dannjjm	1187	36	distance	distance	NN
cord-023095-4dannjjm	1187	37	shipping	shipping	NN
cord-023095-4dannjjm	1187	38	model	model	NN
cord-023095-4dannjjm	1187	39	.	.	.
cord-023095-4dannjjm	1188	1	Six	six	CD
cord-023095-4dannjjm	1188	2	adult	adult	NN
cord-023095-4dannjjm	1188	3	horses	horse	NNS
cord-023095-4dannjjm	1188	4	were	be	VBD
cord-023095-4dannjjm	1188	5	enrolled	enrol	VBN
cord-023095-4dannjjm	1188	6	in	in	IN
cord-023095-4dannjjm	1188	7	a	a	DT
cord-023095-4dannjjm	1188	8	cross	cross	NN
cord-023095-4dannjjm	1188	9	-	-	HYPH
cord-023095-4dannjjm	1188	10	over	over	RP
cord-023095-4dannjjm	1188	11	design	design	NN
cord-023095-4dannjjm	1188	12	prospective	prospective	JJ
cord-023095-4dannjjm	1188	13	study	study	NN
cord-023095-4dannjjm	1188	14	.	.	.
cord-023095-4dannjjm	1189	1	Horses	horse	NNS
cord-023095-4dannjjm	1189	2	were	be	VBD
cord-023095-4dannjjm	1189	3	housed	house	VBN
cord-023095-4dannjjm	1189	4	with	with	IN
cord-023095-4dannjjm	1189	5	their	-PRON-	PRP$
cord-023095-4dannjjm	1189	6	heads	head	NNS
cord-023095-4dannjjm	1189	7	in	in	IN
cord-023095-4dannjjm	1189	8	a	a	DT
cord-023095-4dannjjm	1189	9	fixed	fix	VBN
cord-023095-4dannjjm	1189	10	position	position	NN
cord-023095-4dannjjm	1189	11	for	for	IN
cord-023095-4dannjjm	1189	12	48	48	CD
cord-023095-4dannjjm	1189	13	hours	hour	NNS
cord-023095-4dannjjm	1189	14	to	to	TO
cord-023095-4dannjjm	1189	15	simulate	simulate	VB
cord-023095-4dannjjm	1189	16	long	long	JJ
cord-023095-4dannjjm	1189	17	distance	distance	NN
cord-023095-4dannjjm	1189	18	transport	transport	NN
cord-023095-4dannjjm	1189	19	,	,	,
cord-023095-4dannjjm	1189	20	and	and	CC
cord-023095-4dannjjm	1189	21	treated	treat	VBN
cord-023095-4dannjjm	1189	22	with	with	IN
cord-023095-4dannjjm	1189	23	clenbuterol	clenbuterol	NN
cord-023095-4dannjjm	1189	24	(	(	-LRB-
cord-023095-4dannjjm	1189	25	0.8	0.8	CD
cord-023095-4dannjjm	1189	26	ug	ug	NNP
cord-023095-4dannjjm	1189	27	/	/	SYM
cord-023095-4dannjjm	1189	28	kg	kg	NNP
cord-023095-4dannjjm	1189	29	PO	po	NN
cord-023095-4dannjjm	1189	30	q12	q12	NN
cord-023095-4dannjjm	1189	31	h	h	NNP
cord-023095-4dannjjm	1189	32	)	)	-RRB-
cord-023095-4dannjjm	1189	33	or	or	CC
cord-023095-4dannjjm	1189	34	a	a	DT
cord-023095-4dannjjm	1189	35	placebo	placebo	NN
cord-023095-4dannjjm	1189	36	starting	start	VBG
cord-023095-4dannjjm	1189	37	12	12	CD
cord-023095-4dannjjm	1189	38	hours	hour	NNS
cord-023095-4dannjjm	1189	39	before	before	IN
cord-023095-4dannjjm	1189	40	simulated	simulated	JJ
cord-023095-4dannjjm	1189	41	shipping	shipping	NN
cord-023095-4dannjjm	1189	42	.	.	.
cord-023095-4dannjjm	1190	1	TMCT	TMCT	NNP
cord-023095-4dannjjm	1190	2	was	be	VBD
cord-023095-4dannjjm	1190	3	measured	measure	VBN
cord-023095-4dannjjm	1190	4	using	use	VBG
cord-023095-4dannjjm	1190	5	a	a	DT
cord-023095-4dannjjm	1190	6	charcoal	charcoal	NN
cord-023095-4dannjjm	1190	7	clearance	clearance	NN
cord-023095-4dannjjm	1190	8	technique	technique	NN
cord-023095-4dannjjm	1190	9	.	.	.
cord-023095-4dannjjm	1191	1	Data	datum	NNS
cord-023095-4dannjjm	1191	2	were	be	VBD
cord-023095-4dannjjm	1191	3	collected	collect	VBN
cord-023095-4dannjjm	1191	4	at	at	IN
cord-023095-4dannjjm	1191	5	baseline	baseline	NN
cord-023095-4dannjjm	1191	6	and	and	CC
cord-023095-4dannjjm	1191	7	48	48	CD
cord-023095-4dannjjm	1191	8	hours	hour	NNS
cord-023095-4dannjjm	1191	9	,	,	,
cord-023095-4dannjjm	1191	10	and	and	CC
cord-023095-4dannjjm	1191	11	included	include	VBD
cord-023095-4dannjjm	1191	12	TMCT	TMCT	NNP
cord-023095-4dannjjm	1191	13	,	,	,
cord-023095-4dannjjm	1191	14	tracheal	tracheal	JJ
cord-023095-4dannjjm	1191	15	wash	wash	NN
cord-023095-4dannjjm	1191	16	cytology	cytology	NN
cord-023095-4dannjjm	1191	17	and	and	CC
cord-023095-4dannjjm	1191	18	quantitative	quantitative	JJ
cord-023095-4dannjjm	1191	19	culture	culture	NN
cord-023095-4dannjjm	1191	20	,	,	,
cord-023095-4dannjjm	1191	21	rectal	rectal	JJ
cord-023095-4dannjjm	1191	22	temperature	temperature	NN
cord-023095-4dannjjm	1191	23	,	,	,
cord-023095-4dannjjm	1191	24	CBC	CBC	NNP
cord-023095-4dannjjm	1191	25	,	,	,
cord-023095-4dannjjm	1191	26	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	1191	27	,	,	,
cord-023095-4dannjjm	1191	28	and	and	CC
cord-023095-4dannjjm	1191	29	serum	serum	NN
cord-023095-4dannjjm	1191	30	TNFa	TNFa	NNS
cord-023095-4dannjjm	1191	31	,	,	,
cord-023095-4dannjjm	1191	32	IL-10	IL-10	NNP
cord-023095-4dannjjm	1191	33	and	and	CC
cord-023095-4dannjjm	1191	34	IL-2	IL-2	NNP
cord-023095-4dannjjm	1191	35	levels	level	NNS
cord-023095-4dannjjm	1191	36	.	.	.
cord-023095-4dannjjm	1192	1	There	there	EX
cord-023095-4dannjjm	1192	2	was	be	VBD
cord-023095-4dannjjm	1192	3	a	a	DT
cord-023095-4dannjjm	1192	4	3-week	3-week	CD
cord-023095-4dannjjm	1192	5	washout	washout	NN
cord-023095-4dannjjm	1192	6	between	between	IN
cord-023095-4dannjjm	1192	7	study	study	NN
cord-023095-4dannjjm	1192	8	arms	arm	NNS
cord-023095-4dannjjm	1192	9	,	,	,
cord-023095-4dannjjm	1192	10	and	and	CC
cord-023095-4dannjjm	1192	11	each	each	DT
cord-023095-4dannjjm	1192	12	horse	horse	NN
cord-023095-4dannjjm	1192	13	served	serve	VBD
cord-023095-4dannjjm	1192	14	as	as	IN
cord-023095-4dannjjm	1192	15	its	-PRON-	PRP$
cord-023095-4dannjjm	1192	16	own	own	JJ
cord-023095-4dannjjm	1192	17	control	control	NN
cord-023095-4dannjjm	1192	18	.	.	.
cord-023095-4dannjjm	1193	1	The	the	DT
cord-023095-4dannjjm	1193	2	data	datum	NNS
cord-023095-4dannjjm	1193	3	was	be	VBD
cord-023095-4dannjjm	1193	4	analyzed	analyze	VBN
cord-023095-4dannjjm	1193	5	using	use	VBG
cord-023095-4dannjjm	1193	6	regression	regression	NN
cord-023095-4dannjjm	1193	7	analysis	analysis	NN
cord-023095-4dannjjm	1193	8	and	and	CC
cord-023095-4dannjjm	1193	9	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	1193	10	rank	rank	NN
cord-023095-4dannjjm	1193	11	-	-	HYPH
cord-023095-4dannjjm	1193	12	sum	sum	NN
cord-023095-4dannjjm	1193	13	tests	test	NNS
cord-023095-4dannjjm	1193	14	.	.	.
cord-023095-4dannjjm	1194	1	No	no	DT
cord-023095-4dannjjm	1194	2	statistically	statistically	RB
cord-023095-4dannjjm	1194	3	significant	significant	JJ
cord-023095-4dannjjm	1194	4	difference	difference	NN
cord-023095-4dannjjm	1194	5	was	be	VBD
cord-023095-4dannjjm	1194	6	seen	see	VBN
cord-023095-4dannjjm	1194	7	between	between	IN
cord-023095-4dannjjm	1194	8	treatment	treatment	NN
cord-023095-4dannjjm	1194	9	and	and	CC
cord-023095-4dannjjm	1194	10	placebo	placebo	NN
cord-023095-4dannjjm	1194	11	groups	group	NNS
cord-023095-4dannjjm	1194	12	for	for	IN
cord-023095-4dannjjm	1194	13	any	any	DT
cord-023095-4dannjjm	1194	14	of	of	IN
cord-023095-4dannjjm	1194	15	the	the	DT
cord-023095-4dannjjm	1194	16	variables	variable	NNS
cord-023095-4dannjjm	1194	17	investigated	investigate	VBN
cord-023095-4dannjjm	1194	18	.	.	.
cord-023095-4dannjjm	1195	1	TMCT	TMCT	NNP
cord-023095-4dannjjm	1195	2	did	do	VBD
cord-023095-4dannjjm	1195	3	not	not	RB
cord-023095-4dannjjm	1195	4	differ	differ	VB
cord-023095-4dannjjm	1195	5	after	after	IN
cord-023095-4dannjjm	1195	6	treatment	treatment	NN
cord-023095-4dannjjm	1195	7	(	(	-LRB-
cord-023095-4dannjjm	1195	8	1.71	1.71	CD
cord-023095-4dannjjm	1195	9	AE	AE	NNP
cord-023095-4dannjjm	1195	10	0.64	0.64	CD
cord-023095-4dannjjm	1195	11	cm	cm	NNP
cord-023095-4dannjjm	1195	12	/	/	SYM
cord-023095-4dannjjm	1195	13	min	min	NNP
cord-023095-4dannjjm	1195	14	)	)	-RRB-
cord-023095-4dannjjm	1195	15	versus	versus	IN
cord-023095-4dannjjm	1195	16	placebo	placebo	NN
cord-023095-4dannjjm	1195	17	(	(	-LRB-
cord-023095-4dannjjm	1195	18	1.55	1.55	CD
cord-023095-4dannjjm	1195	19	AE	AE	NNP
cord-023095-4dannjjm	1195	20	0.82	0.82	CD
cord-023095-4dannjjm	1195	21	cm/	cm/	NN
cord-023095-4dannjjm	1195	22	min	min	NN
cord-023095-4dannjjm	1195	23	;	;	:
cord-023095-4dannjjm	1195	24	P	p	NN
cord-023095-4dannjjm	1195	25	4	4	CD
cord-023095-4dannjjm	1195	26	0.10	0.10	CD
cord-023095-4dannjjm	1195	27	)	)	-RRB-
cord-023095-4dannjjm	1195	28	,	,	,
cord-023095-4dannjjm	1195	29	and	and	CC
cord-023095-4dannjjm	1195	30	intratracheal	intratracheal	JJ
cord-023095-4dannjjm	1195	31	bacterial	bacterial	JJ
cord-023095-4dannjjm	1195	32	counts	count	NNS
cord-023095-4dannjjm	1195	33	were	be	VBD
cord-023095-4dannjjm	1195	34	similar	similar	JJ
cord-023095-4dannjjm	1195	35	for	for	IN
cord-023095-4dannjjm	1195	36	treatment	treatment	NN
cord-023095-4dannjjm	1195	37	(	(	-LRB-
cord-023095-4dannjjm	1195	38	105	105	CD
cord-023095-4dannjjm	1195	39	Â	â	CD
cord-023095-4dannjjm	1195	40	10	10	CD
cord-023095-4dannjjm	1195	41	3	3	CD
cord-023095-4dannjjm	1195	42	AE	AE	NNP
cord-023095-4dannjjm	1195	43	42	42	CD
cord-023095-4dannjjm	1195	44	Â	â	NN
cord-023095-4dannjjm	1195	45	103	103	CD
cord-023095-4dannjjm	1195	46	cfu	cfu	NN
cord-023095-4dannjjm	1195	47	;	;	:
cord-023095-4dannjjm	1195	48	P	p	NN
cord-023095-4dannjjm	1195	49	4	4	CD
cord-023095-4dannjjm	1195	50	0.10	0.10	CD
cord-023095-4dannjjm	1195	51	)	)	-RRB-
cord-023095-4dannjjm	1195	52	and	and	CC
cord-023095-4dannjjm	1195	53	placebo	placebo	NN
cord-023095-4dannjjm	1195	54	(	(	-LRB-
cord-023095-4dannjjm	1195	55	98	98	CD
cord-023095-4dannjjm	1195	56	Â	â	CD
cord-023095-4dannjjm	1195	57	10	10	CD
cord-023095-4dannjjm	1195	58	3	3	CD
cord-023095-4dannjjm	1195	59	AE	AE	NNP
cord-023095-4dannjjm	1195	60	41	41	CD
cord-023095-4dannjjm	1195	61	Â	â	CD
cord-023095-4dannjjm	1195	62	103	103	CD
cord-023095-4dannjjm	1195	63	cfu	cfu	NNP
cord-023095-4dannjjm	1195	64	)	)	-RRB-
cord-023095-4dannjjm	1195	65	groups	group	NNS
cord-023095-4dannjjm	1195	66	.	.	.
cord-023095-4dannjjm	1196	1	A	a	DT
cord-023095-4dannjjm	1196	2	reduction	reduction	NN
cord-023095-4dannjjm	1196	3	of	of	IN
cord-023095-4dannjjm	1196	4	tracheal	tracheal	NN
cord-023095-4dannjjm	1196	5	b	b	NN
cord-023095-4dannjjm	1196	6	hemolytic	hemolytic	JJ
cord-023095-4dannjjm	1196	7	Streptococcus	streptococcus	NN
cord-023095-4dannjjm	1196	8	.	.	.
cord-023095-4dannjjm	1196	9	spp	spp	NNS
cord-023095-4dannjjm	1196	10	.	.	.
cord-023095-4dannjjm	1197	1	after	after	IN
cord-023095-4dannjjm	1197	2	clenbuterol	clenbuterol	NNP
cord-023095-4dannjjm	1197	3	versus	versus	IN
cord-023095-4dannjjm	1197	4	placebo	placebo	NN
cord-023095-4dannjjm	1197	5	was	be	VBD
cord-023095-4dannjjm	1197	6	also	also	RB
cord-023095-4dannjjm	1197	7	nonsignificant	nonsignificant	JJ
cord-023095-4dannjjm	1197	8	(	(	-LRB-
cord-023095-4dannjjm	1197	9	0	0	CD
cord-023095-4dannjjm	1197	10	%	%	NN
cord-023095-4dannjjm	1197	11	versus	versus	IN
cord-023095-4dannjjm	1197	12	33	33	CD
cord-023095-4dannjjm	1197	13	%	%	NN
cord-023095-4dannjjm	1197	14	;	;	:
cord-023095-4dannjjm	1197	15	P	p	NN
cord-023095-4dannjjm	1197	16	4	4	CD
cord-023095-4dannjjm	1197	17	0.10	0.10	CD
cord-023095-4dannjjm	1197	18	)	)	-RRB-
cord-023095-4dannjjm	1197	19	.	.	.
cord-023095-4dannjjm	1198	1	In	in	IN
cord-023095-4dannjjm	1198	2	conclusion	conclusion	NN
cord-023095-4dannjjm	1198	3	,	,	,
cord-023095-4dannjjm	1198	4	treatment	treatment	NN
cord-023095-4dannjjm	1198	5	with	with	IN
cord-023095-4dannjjm	1198	6	clenbuterol	clenbuterol	NN
cord-023095-4dannjjm	1198	7	does	do	VBZ
cord-023095-4dannjjm	1198	8	not	not	RB
cord-023095-4dannjjm	1198	9	appear	appear	VB
cord-023095-4dannjjm	1198	10	to	to	TO
cord-023095-4dannjjm	1198	11	combat	combat	VB
cord-023095-4dannjjm	1198	12	the	the	DT
cord-023095-4dannjjm	1198	13	deleterious	deleterious	JJ
cord-023095-4dannjjm	1198	14	effects	effect	NNS
cord-023095-4dannjjm	1198	15	of	of	IN
cord-023095-4dannjjm	1198	16	this	this	DT
cord-023095-4dannjjm	1198	17	long	long	JJ
cord-023095-4dannjjm	1198	18	-	-	HYPH
cord-023095-4dannjjm	1198	19	term	term	NN
cord-023095-4dannjjm	1198	20	shipping	shipping	NN
cord-023095-4dannjjm	1198	21	model	model	NN
cord-023095-4dannjjm	1198	22	.	.	.
cord-023095-4dannjjm	1199	1	Breathing	breathe	VBG
cord-023095-4dannjjm	1199	2	cold	cold	JJ
cord-023095-4dannjjm	1199	3	air	air	NN
cord-023095-4dannjjm	1199	4	during	during	IN
cord-023095-4dannjjm	1199	5	strenuous	strenuous	JJ
cord-023095-4dannjjm	1199	6	exercise	exercise	NN
cord-023095-4dannjjm	1199	7	is	be	VBZ
cord-023095-4dannjjm	1199	8	associated	associate	VBN
cord-023095-4dannjjm	1199	9	with	with	IN
cord-023095-4dannjjm	1199	10	airway	airway	JJ
cord-023095-4dannjjm	1199	11	inflammation	inflammation	NN
cord-023095-4dannjjm	1199	12	.	.	.
cord-023095-4dannjjm	1200	1	Under	under	IN
cord-023095-4dannjjm	1200	2	these	these	DT
cord-023095-4dannjjm	1200	3	conditions	condition	NNS
cord-023095-4dannjjm	1200	4	,	,	,
cord-023095-4dannjjm	1200	5	warming	warming	NN
cord-023095-4dannjjm	1200	6	and	and	CC
cord-023095-4dannjjm	1200	7	humidification	humidification	NN
cord-023095-4dannjjm	1200	8	of	of	IN
cord-023095-4dannjjm	1200	9	inspired	inspire	VBN
cord-023095-4dannjjm	1200	10	air	air	NN
cord-023095-4dannjjm	1200	11	occurs	occur	VBZ
cord-023095-4dannjjm	1200	12	in	in	IN
cord-023095-4dannjjm	1200	13	the	the	DT
cord-023095-4dannjjm	1200	14	lower	low	JJR
cord-023095-4dannjjm	1200	15	respiratory	respiratory	JJ
cord-023095-4dannjjm	1200	16	tract	tract	NN
cord-023095-4dannjjm	1200	17	resulting	result	VBG
cord-023095-4dannjjm	1200	18	in	in	IN
cord-023095-4dannjjm	1200	19	mucosal	mucosal	JJ
cord-023095-4dannjjm	1200	20	cooling	cooling	NN
cord-023095-4dannjjm	1200	21	,	,	,
cord-023095-4dannjjm	1200	22	desiccation	desiccation	NN
cord-023095-4dannjjm	1200	23	,	,	,
cord-023095-4dannjjm	1200	24	and	and	CC
cord-023095-4dannjjm	1200	25	hyperosmolarity	hyperosmolarity	NN
cord-023095-4dannjjm	1200	26	.	.	.
cord-023095-4dannjjm	1201	1	The	the	DT
cord-023095-4dannjjm	1201	2	purpose	purpose	NN
cord-023095-4dannjjm	1201	3	of	of	IN
cord-023095-4dannjjm	1201	4	this	this	DT
cord-023095-4dannjjm	1201	5	research	research	NN
cord-023095-4dannjjm	1201	6	was	be	VBD
cord-023095-4dannjjm	1201	7	to	to	TO
cord-023095-4dannjjm	1201	8	test	test	VB
cord-023095-4dannjjm	1201	9	the	the	DT
cord-023095-4dannjjm	1201	10	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1201	11	that	that	IN
cord-023095-4dannjjm	1201	12	airway	airway	NNP
cord-023095-4dannjjm	1201	13	hypertonicity	hypertonicity	NN
cord-023095-4dannjjm	1201	14	causes	cause	VBZ
cord-023095-4dannjjm	1201	15	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1201	16	cell	cell	NN
cord-023095-4dannjjm	1201	17	migration	migration	NN
cord-023095-4dannjjm	1201	18	and	and	CC
cord-023095-4dannjjm	1201	19	alterations	alteration	NNS
cord-023095-4dannjjm	1201	20	in	in	IN
cord-023095-4dannjjm	1201	21	cytokine	cytokine	JJ
cord-023095-4dannjjm	1201	22	expression	expression	NN
cord-023095-4dannjjm	1201	23	associated	associate	VBN
cord-023095-4dannjjm	1201	24	with	with	IN
cord-023095-4dannjjm	1201	25	exercise	exercise	NN
cord-023095-4dannjjm	1201	26	induced	induce	VBN
cord-023095-4dannjjm	1201	27	airway	airway	NN
cord-023095-4dannjjm	1201	28	inflammation	inflammation	NN
cord-023095-4dannjjm	1201	29	.	.	.
cord-023095-4dannjjm	1202	1	Horses	horse	NNS
cord-023095-4dannjjm	1202	2	(	(	-LRB-
cord-023095-4dannjjm	1202	3	n	n	NN
cord-023095-4dannjjm	1202	4	5	5	CD
cord-023095-4dannjjm	1202	5	9	9	CD
cord-023095-4dannjjm	1202	6	)	)	-RRB-
cord-023095-4dannjjm	1202	7	were	be	VBD
cord-023095-4dannjjm	1202	8	examined	examine	VBN
cord-023095-4dannjjm	1202	9	in	in	IN
cord-023095-4dannjjm	1202	10	a	a	DT
cord-023095-4dannjjm	1202	11	randomized	randomized	JJ
cord-023095-4dannjjm	1202	12	crossover	crossover	NN
cord-023095-4dannjjm	1202	13	design	design	NN
cord-023095-4dannjjm	1202	14	after	after	IN
cord-023095-4dannjjm	1202	15	exposure	exposure	NN
cord-023095-4dannjjm	1202	16	to	to	IN
cord-023095-4dannjjm	1202	17	hypertonic	hypertonic	JJ
cord-023095-4dannjjm	1202	18	aerosols	aerosol	NNS
cord-023095-4dannjjm	1202	19	(	(	-LRB-
cord-023095-4dannjjm	1202	20	5	5	CD
cord-023095-4dannjjm	1202	21	minute	minute	NN
cord-023095-4dannjjm	1202	22	nebulization	nebulization	NN
cord-023095-4dannjjm	1202	23	with	with	IN
cord-023095-4dannjjm	1202	24	solutions	solution	NNS
cord-023095-4dannjjm	1202	25	of	of	IN
cord-023095-4dannjjm	1202	26	either	either	CC
cord-023095-4dannjjm	1202	27	isotonic	isotonic	JJ
cord-023095-4dannjjm	1202	28	or	or	CC
cord-023095-4dannjjm	1202	29	hypertonic	hypertonic	JJ
cord-023095-4dannjjm	1202	30	mannitol	mannitol	NN
cord-023095-4dannjjm	1202	31	)	)	-RRB-
cord-023095-4dannjjm	1202	32	.	.	.
cord-023095-4dannjjm	1203	1	Airway	airway	NN
cord-023095-4dannjjm	1203	2	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1203	3	were	be	VBD
cord-023095-4dannjjm	1203	4	harvested	harvest	VBN
cord-023095-4dannjjm	1203	5	5	5	CD
cord-023095-4dannjjm	1203	6	and	and	CC
cord-023095-4dannjjm	1203	7	24	24	CD
cord-023095-4dannjjm	1203	8	hours	hour	NNS
cord-023095-4dannjjm	1203	9	post	post	NN
cord-023095-4dannjjm	1203	10	aerosol	aerosol	NN
cord-023095-4dannjjm	1203	11	challenge	challenge	NN
cord-023095-4dannjjm	1203	12	via	via	IN
cord-023095-4dannjjm	1203	13	bronchoaveolar	bronchoaveolar	NNP
cord-023095-4dannjjm	1203	14	lavage	lavage	NN
cord-023095-4dannjjm	1203	15	,	,	,
cord-023095-4dannjjm	1203	16	and	and	CC
cord-023095-4dannjjm	1203	17	were	be	VBD
cord-023095-4dannjjm	1203	18	used	use	VBN
cord-023095-4dannjjm	1203	19	to	to	TO
cord-023095-4dannjjm	1203	20	determine	determine	VB
cord-023095-4dannjjm	1203	21	total	total	JJ
cord-023095-4dannjjm	1203	22	and	and	CC
cord-023095-4dannjjm	1203	23	differential	differential	JJ
cord-023095-4dannjjm	1203	24	nucleated	nucleated	JJ
cord-023095-4dannjjm	1203	25	cell	cell	NN
cord-023095-4dannjjm	1203	26	count	count	NN
cord-023095-4dannjjm	1203	27	and	and	CC
cord-023095-4dannjjm	1203	28	expression	expression	NN
cord-023095-4dannjjm	1203	29	of	of	IN
cord-023095-4dannjjm	1203	30	cytokinespecific	cytokinespecific	NNP
cord-023095-4dannjjm	1203	31	mRNA	mRNA	NNP
cord-023095-4dannjjm	1203	32	.	.	.
cord-023095-4dannjjm	1204	1	Hypertonic	Hypertonic	NNP
cord-023095-4dannjjm	1204	2	aerosol	aerosol	NN
cord-023095-4dannjjm	1204	3	challenge	challenge	NN
cord-023095-4dannjjm	1204	4	resulted	result	VBD
cord-023095-4dannjjm	1204	5	in	in	IN
cord-023095-4dannjjm	1204	6	an	an	DT
cord-023095-4dannjjm	1204	7	increase	increase	NN
cord-023095-4dannjjm	1204	8	in	in	IN
cord-023095-4dannjjm	1204	9	total	total	JJ
cord-023095-4dannjjm	1204	10	number	number	NN
cord-023095-4dannjjm	1204	11	of	of	IN
cord-023095-4dannjjm	1204	12	cells	cell	NNS
cord-023095-4dannjjm	1204	13	5	5	CD
cord-023095-4dannjjm	1204	14	hr	hr	NN
cord-023095-4dannjjm	1204	15	after	after	IN
cord-023095-4dannjjm	1204	16	challenge	challenge	NN
cord-023095-4dannjjm	1204	17	,	,	,
cord-023095-4dannjjm	1204	18	characterized	characterize	VBN
cord-023095-4dannjjm	1204	19	by	by	IN
cord-023095-4dannjjm	1204	20	increased	increase	VBN
cord-023095-4dannjjm	1204	21	macrophage	macrophage	NN
cord-023095-4dannjjm	1204	22	(	(	-LRB-
cord-023095-4dannjjm	1204	23	p	p	NN
cord-023095-4dannjjm	1204	24	5	5	CD
cord-023095-4dannjjm	1204	25	0.04	0.04	CD
cord-023095-4dannjjm	1204	26	)	)	-RRB-
cord-023095-4dannjjm	1204	27	and	and	CC
cord-023095-4dannjjm	1204	28	neutrophil	neutrophil	NN
cord-023095-4dannjjm	1204	29	(	(	-LRB-
cord-023095-4dannjjm	1204	30	p	p	NN
cord-023095-4dannjjm	1204	31	5	5	CD
cord-023095-4dannjjm	1204	32	0.03	0.03	CD
cord-023095-4dannjjm	1204	33	)	)	-RRB-
cord-023095-4dannjjm	1204	34	concentrations	concentration	NNS
cord-023095-4dannjjm	1204	35	,	,	,
cord-023095-4dannjjm	1204	36	but	but	CC
cord-023095-4dannjjm	1204	37	there	there	EX
cord-023095-4dannjjm	1204	38	was	be	VBD
cord-023095-4dannjjm	1204	39	no	no	DT
cord-023095-4dannjjm	1204	40	effect	effect	NN
cord-023095-4dannjjm	1204	41	on	on	IN
cord-023095-4dannjjm	1204	42	airway	airway	NN
cord-023095-4dannjjm	1204	43	leukocyte	leukocyte	NN
cord-023095-4dannjjm	1204	44	concentrations	concentration	NNS
cord-023095-4dannjjm	1204	45	24	24	CD
cord-023095-4dannjjm	1204	46	hours	hour	NNS
cord-023095-4dannjjm	1204	47	after	after	IN
cord-023095-4dannjjm	1204	48	nebulization	nebulization	NN
cord-023095-4dannjjm	1204	49	.	.	.
cord-023095-4dannjjm	1205	1	No	no	DT
cord-023095-4dannjjm	1205	2	significant	significant	JJ
cord-023095-4dannjjm	1205	3	changes	change	NNS
cord-023095-4dannjjm	1205	4	in	in	IN
cord-023095-4dannjjm	1205	5	the	the	DT
cord-023095-4dannjjm	1205	6	relative	relative	JJ
cord-023095-4dannjjm	1205	7	quantity	quantity	NN
cord-023095-4dannjjm	1205	8	of	of	IN
cord-023095-4dannjjm	1205	9	mRNA	mrna	NN
cord-023095-4dannjjm	1205	10	for	for	IN
cord-023095-4dannjjm	1205	11	airway	airway	NN
cord-023095-4dannjjm	1205	12	cytokines	cytokine	NNS
cord-023095-4dannjjm	1205	13	were	be	VBD
cord-023095-4dannjjm	1205	14	noted	note	VBN
cord-023095-4dannjjm	1205	15	at	at	IN
cord-023095-4dannjjm	1205	16	either	either	DT
cord-023095-4dannjjm	1205	17	time	time	NN
cord-023095-4dannjjm	1205	18	point	point	NN
cord-023095-4dannjjm	1205	19	.	.	.
cord-023095-4dannjjm	1206	1	These	these	DT
cord-023095-4dannjjm	1206	2	data	datum	NNS
cord-023095-4dannjjm	1206	3	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	1206	4	that	that	IN
cord-023095-4dannjjm	1206	5	transient	transient	JJ
cord-023095-4dannjjm	1206	6	airway	airway	NN
cord-023095-4dannjjm	1206	7	hypertonicity	hypertonicity	NN
cord-023095-4dannjjm	1206	8	can	can	MD
cord-023095-4dannjjm	1206	9	cause	cause	VB
cord-023095-4dannjjm	1206	10	airway	airway	NN
cord-023095-4dannjjm	1206	11	leukocyte	leukocyte	NN
cord-023095-4dannjjm	1206	12	influx	influx	NN
cord-023095-4dannjjm	1206	13	and	and	CC
cord-023095-4dannjjm	1206	14	may	may	MD
cord-023095-4dannjjm	1206	15	be	be	VB
cord-023095-4dannjjm	1206	16	responsible	responsible	JJ
cord-023095-4dannjjm	1206	17	for	for	IN
cord-023095-4dannjjm	1206	18	the	the	DT
cord-023095-4dannjjm	1206	19	airway	airway	NN
cord-023095-4dannjjm	1206	20	inflammation	inflammation	NN
cord-023095-4dannjjm	1206	21	commonly	commonly	RB
cord-023095-4dannjjm	1206	22	found	find	VBN
cord-023095-4dannjjm	1206	23	in	in	IN
cord-023095-4dannjjm	1206	24	athletes	athlete	NNS
cord-023095-4dannjjm	1206	25	that	that	WDT
cord-023095-4dannjjm	1206	26	exercise	exercise	VBP
cord-023095-4dannjjm	1206	27	in	in	IN
cord-023095-4dannjjm	1206	28	cold	cold	JJ
cord-023095-4dannjjm	1206	29	conditions	condition	NNS
cord-023095-4dannjjm	1206	30	.	.	.
cord-023095-4dannjjm	1207	1	However	however	RB
cord-023095-4dannjjm	1207	2	,	,	,
cord-023095-4dannjjm	1207	3	our	-PRON-	PRP$
cord-023095-4dannjjm	1207	4	data	datum	NNS
cord-023095-4dannjjm	1207	5	do	do	VBP
cord-023095-4dannjjm	1207	6	not	not	RB
cord-023095-4dannjjm	1207	7	support	support	VB
cord-023095-4dannjjm	1207	8	the	the	DT
cord-023095-4dannjjm	1207	9	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1207	10	that	that	IN
cord-023095-4dannjjm	1207	11	hypertonicity	hypertonicity	NN
cord-023095-4dannjjm	1207	12	is	be	VBZ
cord-023095-4dannjjm	1207	13	the	the	DT
cord-023095-4dannjjm	1207	14	sole	sole	JJ
cord-023095-4dannjjm	1207	15	initiating	initiate	VBG
cord-023095-4dannjjm	1207	16	cause	cause	NN
cord-023095-4dannjjm	1207	17	of	of	IN
cord-023095-4dannjjm	1207	18	changes	change	NNS
cord-023095-4dannjjm	1207	19	in	in	IN
cord-023095-4dannjjm	1207	20	cytokine	cytokine	JJ
cord-023095-4dannjjm	1207	21	expression	expression	NN
cord-023095-4dannjjm	1207	22	secondary	secondary	JJ
cord-023095-4dannjjm	1207	23	to	to	IN
cord-023095-4dannjjm	1207	24	cold	cold	JJ
cord-023095-4dannjjm	1207	25	weather	weather	NN
cord-023095-4dannjjm	1207	26	exercise	exercise	NN
cord-023095-4dannjjm	1207	27	.	.	.
cord-023095-4dannjjm	1208	1	It	-PRON-	PRP
cord-023095-4dannjjm	1208	2	is	be	VBZ
cord-023095-4dannjjm	1208	3	likely	likely	JJ
cord-023095-4dannjjm	1208	4	that	that	IN
cord-023095-4dannjjm	1208	5	factors	factor	NNS
cord-023095-4dannjjm	1208	6	such	such	JJ
cord-023095-4dannjjm	1208	7	as	as	IN
cord-023095-4dannjjm	1208	8	airway	airway	NN
cord-023095-4dannjjm	1208	9	temperature	temperature	NN
cord-023095-4dannjjm	1208	10	,	,	,
cord-023095-4dannjjm	1208	11	shear	shear	NN
cord-023095-4dannjjm	1208	12	stress	stress	NN
cord-023095-4dannjjm	1208	13	or	or	CC
cord-023095-4dannjjm	1208	14	epithelial	epithelial	JJ
cord-023095-4dannjjm	1208	15	damage	damage	NN
cord-023095-4dannjjm	1208	16	also	also	RB
cord-023095-4dannjjm	1208	17	play	play	VBP
cord-023095-4dannjjm	1208	18	a	a	DT
cord-023095-4dannjjm	1208	19	role	role	NN
cord-023095-4dannjjm	1208	20	in	in	IN
cord-023095-4dannjjm	1208	21	this	this	DT
cord-023095-4dannjjm	1208	22	phenomenon	phenomenon	NN
cord-023095-4dannjjm	1208	23	.	.	.
cord-023095-4dannjjm	1209	1	We	-PRON-	PRP
cord-023095-4dannjjm	1209	2	studied	study	VBD
cord-023095-4dannjjm	1209	3	the	the	DT
cord-023095-4dannjjm	1209	4	importance	importance	NN
cord-023095-4dannjjm	1209	5	of	of	IN
cord-023095-4dannjjm	1209	6	abdominal	abdominal	JJ
cord-023095-4dannjjm	1209	7	sonograms	sonogram	NNS
cord-023095-4dannjjm	1209	8	in	in	IN
cord-023095-4dannjjm	1209	9	neonatal	neonatal	JJ
cord-023095-4dannjjm	1209	10	foals	foal	NNS
cord-023095-4dannjjm	1209	11	suffering	suffer	VBG
cord-023095-4dannjjm	1209	12	from	from	IN
cord-023095-4dannjjm	1209	13	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1209	14	conditions	condition	NNS
cord-023095-4dannjjm	1209	15	.	.	.
cord-023095-4dannjjm	1210	1	We	-PRON-	PRP
cord-023095-4dannjjm	1210	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1210	3	that	that	IN
cord-023095-4dannjjm	1210	4	there	there	EX
cord-023095-4dannjjm	1210	5	would	would	MD
cord-023095-4dannjjm	1210	6	be	be	VB
cord-023095-4dannjjm	1210	7	a	a	DT
cord-023095-4dannjjm	1210	8	subgroup	subgroup	NN
cord-023095-4dannjjm	1210	9	of	of	IN
cord-023095-4dannjjm	1210	10	neonates	neonate	NNS
cord-023095-4dannjjm	1210	11	with	with	IN
cord-023095-4dannjjm	1210	12	sonographically	sonographically	RB
cord-023095-4dannjjm	1210	13	detectable	detectable	JJ
cord-023095-4dannjjm	1210	14	pneumatosis	pneumatosis	NN
cord-023095-4dannjjm	1210	15	intestinalis	intestinalis	FW
cord-023095-4dannjjm	1210	16	(	(	-LRB-
cord-023095-4dannjjm	1210	17	PI	PI	NNP
cord-023095-4dannjjm	1210	18	)	)	-RRB-
cord-023095-4dannjjm	1210	19	as	as	IN
cord-023095-4dannjjm	1210	20	a	a	DT
cord-023095-4dannjjm	1210	21	reflection	reflection	NN
cord-023095-4dannjjm	1210	22	of	of	IN
cord-023095-4dannjjm	1210	23	a	a	DT
cord-023095-4dannjjm	1210	24	necrotizing	necrotize	VBG
cord-023095-4dannjjm	1210	25	component	component	NN
cord-023095-4dannjjm	1210	26	of	of	IN
cord-023095-4dannjjm	1210	27	the	the	DT
cord-023095-4dannjjm	1210	28	disease	disease	NN
cord-023095-4dannjjm	1210	29	.	.	.
cord-023095-4dannjjm	1211	1	Records	record	NNS
cord-023095-4dannjjm	1211	2	of	of	IN
cord-023095-4dannjjm	1211	3	foals	foal	NNS
cord-023095-4dannjjm	1211	4	7	7	CD
cord-023095-4dannjjm	1211	5	days	day	NNS
cord-023095-4dannjjm	1211	6	of	of	IN
cord-023095-4dannjjm	1211	7	age	age	NN
cord-023095-4dannjjm	1211	8	hospitalized	hospitalize	VBN
cord-023095-4dannjjm	1211	9	between	between	IN
cord-023095-4dannjjm	1211	10	2005	2005	CD
cord-023095-4dannjjm	1211	11	and	and	CC
cord-023095-4dannjjm	1211	12	2009	2009	CD
cord-023095-4dannjjm	1211	13	with	with	IN
cord-023095-4dannjjm	1211	14	signs	sign	NNS
cord-023095-4dannjjm	1211	15	of	of	IN
cord-023095-4dannjjm	1211	16	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1211	17	disease	disease	NN
cord-023095-4dannjjm	1211	18	were	be	VBD
cord-023095-4dannjjm	1211	19	evaluated	evaluate	VBN
cord-023095-4dannjjm	1211	20	(	(	-LRB-
cord-023095-4dannjjm	1211	21	N	N	NNP
cord-023095-4dannjjm	1211	22	5	5	CD
cord-023095-4dannjjm	1211	23	89	89	CD
cord-023095-4dannjjm	1211	24	)	)	-RRB-
cord-023095-4dannjjm	1211	25	.	.	.
cord-023095-4dannjjm	1212	1	The	the	DT
cord-023095-4dannjjm	1212	2	association	association	NN
cord-023095-4dannjjm	1212	3	of	of	IN
cord-023095-4dannjjm	1212	4	sonographic	sonographic	NNP
cord-023095-4dannjjm	1212	5	,	,	,
cord-023095-4dannjjm	1212	6	clinical	clinical	JJ
cord-023095-4dannjjm	1212	7	,	,	,
cord-023095-4dannjjm	1212	8	pathological	pathological	JJ
cord-023095-4dannjjm	1212	9	and	and	CC
cord-023095-4dannjjm	1212	10	clinicopathological	clinicopathological	JJ
cord-023095-4dannjjm	1212	11	signs	sign	NNS
cord-023095-4dannjjm	1212	12	with	with	IN
cord-023095-4dannjjm	1212	13	outcome	outcome	NN
cord-023095-4dannjjm	1212	14	and	and	CC
cord-023095-4dannjjm	1212	15	severity	severity	NN
cord-023095-4dannjjm	1212	16	of	of	IN
cord-023095-4dannjjm	1212	17	disease	disease	NN
cord-023095-4dannjjm	1212	18	was	be	VBD
cord-023095-4dannjjm	1212	19	determined	determine	VBN
cord-023095-4dannjjm	1212	20	.	.	.
cord-023095-4dannjjm	1213	1	Pneumatosis	Pneumatosis	NNP
cord-023095-4dannjjm	1213	2	intestinalis	intestinalis	NNP
cord-023095-4dannjjm	1213	3	was	be	VBD
cord-023095-4dannjjm	1213	4	imaged	image	VBN
cord-023095-4dannjjm	1213	5	in	in	IN
cord-023095-4dannjjm	1213	6	19	19	CD
cord-023095-4dannjjm	1213	7	foals	foal	NNS
cord-023095-4dannjjm	1213	8	.	.	.
cord-023095-4dannjjm	1214	1	Twenty	twenty	CD
cord-023095-4dannjjm	1214	2	-	-	HYPH
cord-023095-4dannjjm	1214	3	seven	seven	CD
cord-023095-4dannjjm	1214	4	foals	foal	NNS
cord-023095-4dannjjm	1214	5	were	be	VBD
cord-023095-4dannjjm	1214	6	classified	classify	VBN
cord-023095-4dannjjm	1214	7	as	as	IN
cord-023095-4dannjjm	1214	8	having	have	VBG
cord-023095-4dannjjm	1214	9	necrotizing	necrotize	VBG
cord-023095-4dannjjm	1214	10	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1214	11	disease	disease	NN
cord-023095-4dannjjm	1214	12	based	base	VBN
cord-023095-4dannjjm	1214	13	on	on	IN
cord-023095-4dannjjm	1214	14	the	the	DT
cord-023095-4dannjjm	1214	15	presence	presence	NN
cord-023095-4dannjjm	1214	16	of	of	IN
cord-023095-4dannjjm	1214	17	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1214	18	signs	sign	NNS
cord-023095-4dannjjm	1214	19	(	(	-LRB-
cord-023095-4dannjjm	1214	20	colic	colic	NN
cord-023095-4dannjjm	1214	21	,	,	,
cord-023095-4dannjjm	1214	22	diarrhea	diarrhea	NN
cord-023095-4dannjjm	1214	23	,	,	,
cord-023095-4dannjjm	1214	24	gastric	gastric	JJ
cord-023095-4dannjjm	1214	25	reflux	reflux	NN
cord-023095-4dannjjm	1214	26	or	or	CC
cord-023095-4dannjjm	1214	27	abdominal	abdominal	JJ
cord-023095-4dannjjm	1214	28	distension	distension	NN
cord-023095-4dannjjm	1214	29	)	)	-RRB-
cord-023095-4dannjjm	1214	30	and	and	CC
cord-023095-4dannjjm	1214	31	PI	PI	NNP
cord-023095-4dannjjm	1214	32	detected	detect	VBD
cord-023095-4dannjjm	1214	33	sonographically	sonographically	RB
cord-023095-4dannjjm	1214	34	(	(	-LRB-
cord-023095-4dannjjm	1214	35	19	19	CD
cord-023095-4dannjjm	1214	36	)	)	-RRB-
cord-023095-4dannjjm	1214	37	,	,	,
cord-023095-4dannjjm	1214	38	surgical	surgical	JJ
cord-023095-4dannjjm	1214	39	(	(	-LRB-
cord-023095-4dannjjm	1214	40	2	2	CD
cord-023095-4dannjjm	1214	41	)	)	-RRB-
cord-023095-4dannjjm	1214	42	or	or	CC
cord-023095-4dannjjm	1214	43	pathological	pathological	JJ
cord-023095-4dannjjm	1214	44	(	(	-LRB-
cord-023095-4dannjjm	1214	45	6	6	CD
cord-023095-4dannjjm	1214	46	)	)	-RRB-
cord-023095-4dannjjm	1214	47	evidence	evidence	NN
cord-023095-4dannjjm	1214	48	of	of	IN
cord-023095-4dannjjm	1214	49	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1214	50	necrosis	necrosis	NN
cord-023095-4dannjjm	1214	51	.	.	.
cord-023095-4dannjjm	1215	1	There	there	EX
cord-023095-4dannjjm	1215	2	was	be	VBD
cord-023095-4dannjjm	1215	3	a	a	DT
cord-023095-4dannjjm	1215	4	difference	difference	NN
cord-023095-4dannjjm	1215	5	between	between	IN
cord-023095-4dannjjm	1215	6	overall	overall	JJ
cord-023095-4dannjjm	1215	7	survival	survival	NN
cord-023095-4dannjjm	1215	8	rate	rate	NN
cord-023095-4dannjjm	1215	9	(	(	-LRB-
cord-023095-4dannjjm	1215	10	58	58	CD
cord-023095-4dannjjm	1215	11	%	%	NN
cord-023095-4dannjjm	1215	12	)	)	-RRB-
cord-023095-4dannjjm	1215	13	and	and	CC
cord-023095-4dannjjm	1215	14	survival	survival	NN
cord-023095-4dannjjm	1215	15	rate	rate	NN
cord-023095-4dannjjm	1215	16	in	in	IN
cord-023095-4dannjjm	1215	17	foals	foal	NNS
cord-023095-4dannjjm	1215	18	with	with	IN
cord-023095-4dannjjm	1215	19	necrotizing	necrotize	VBG
cord-023095-4dannjjm	1215	20	disease	disease	NN
cord-023095-4dannjjm	1215	21	(	(	-LRB-
cord-023095-4dannjjm	1215	22	33	33	CD
cord-023095-4dannjjm	1215	23	%	%	NN
cord-023095-4dannjjm	1215	24	,	,	,
cord-023095-4dannjjm	1215	25	P	p	NN
cord-023095-4dannjjm	1215	26	5	5	CD
cord-023095-4dannjjm	1215	27	0.005	0.005	CD
cord-023095-4dannjjm	1215	28	)	)	-RRB-
cord-023095-4dannjjm	1215	29	or	or	CC
cord-023095-4dannjjm	1215	30	foals	foal	NNS
cord-023095-4dannjjm	1215	31	with	with	IN
cord-023095-4dannjjm	1215	32	PI	PI	NNP
cord-023095-4dannjjm	1215	33	detected	detect	VBN
cord-023095-4dannjjm	1215	34	sonographically	sonographically	RB
cord-023095-4dannjjm	1215	35	(	(	-LRB-
cord-023095-4dannjjm	1215	36	37	37	CD
cord-023095-4dannjjm	1215	37	%	%	NN
cord-023095-4dannjjm	1215	38	,	,	,
cord-023095-4dannjjm	1215	39	P	p	NN
cord-023095-4dannjjm	1215	40	5	5	CD
cord-023095-4dannjjm	1215	41	0.02	0.02	CD
cord-023095-4dannjjm	1215	42	)	)	-RRB-
cord-023095-4dannjjm	1215	43	.	.	.
cord-023095-4dannjjm	1216	1	Pneumatosis	Pneumatosis	NNP
cord-023095-4dannjjm	1216	2	intestinalis	intestinalis	NNP
cord-023095-4dannjjm	1216	3	was	be	VBD
cord-023095-4dannjjm	1216	4	the	the	DT
cord-023095-4dannjjm	1216	5	only	only	JJ
cord-023095-4dannjjm	1216	6	sonographic	sonographic	JJ
cord-023095-4dannjjm	1216	7	finding	finding	NN
cord-023095-4dannjjm	1216	8	associated	associate	VBN
cord-023095-4dannjjm	1216	9	with	with	IN
cord-023095-4dannjjm	1216	10	outcome	outcome	NN
cord-023095-4dannjjm	1216	11	.	.	.
cord-023095-4dannjjm	1217	1	Sonographic	sonographic	JJ
cord-023095-4dannjjm	1217	2	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1217	3	in	in	IN
cord-023095-4dannjjm	1217	4	peritoneal	peritoneal	JJ
cord-023095-4dannjjm	1217	5	fluid	fluid	NN
cord-023095-4dannjjm	1217	6	,	,	,
cord-023095-4dannjjm	1217	7	stomach	stomach	NN
cord-023095-4dannjjm	1217	8	,	,	,
cord-023095-4dannjjm	1217	9	duodenum	duodenum	NN
cord-023095-4dannjjm	1217	10	,	,	,
cord-023095-4dannjjm	1217	11	jejunum	jejunum	NN
cord-023095-4dannjjm	1217	12	,	,	,
cord-023095-4dannjjm	1217	13	cecum	cecum	NN
cord-023095-4dannjjm	1217	14	,	,	,
cord-023095-4dannjjm	1217	15	umbilicus	umbilicus	NN
cord-023095-4dannjjm	1217	16	or	or	CC
cord-023095-4dannjjm	1217	17	the	the	DT
cord-023095-4dannjjm	1217	18	presence	presence	NN
cord-023095-4dannjjm	1217	19	of	of	IN
cord-023095-4dannjjm	1217	20	meconium	meconium	NN
cord-023095-4dannjjm	1217	21	were	be	VBD
cord-023095-4dannjjm	1217	22	associated	associate	VBN
cord-023095-4dannjjm	1217	23	(	(	-LRB-
cord-023095-4dannjjm	1217	24	P	p	NN
cord-023095-4dannjjm	1217	25	o	o	NN
cord-023095-4dannjjm	1217	26	0.05	0.05	CD
cord-023095-4dannjjm	1217	27	)	)	-RRB-
cord-023095-4dannjjm	1217	28	with	with	IN
cord-023095-4dannjjm	1217	29	surrogates	surrogate	NNS
cord-023095-4dannjjm	1217	30	of	of	IN
cord-023095-4dannjjm	1217	31	severity	severity	NN
cord-023095-4dannjjm	1217	32	of	of	IN
cord-023095-4dannjjm	1217	33	disease	disease	NN
cord-023095-4dannjjm	1217	34	(	(	-LRB-
cord-023095-4dannjjm	1217	35	hospitalization	hospitalization	NN
cord-023095-4dannjjm	1217	36	cost	cost	NN
cord-023095-4dannjjm	1217	37	or	or	CC
cord-023095-4dannjjm	1217	38	days	day	NNS
cord-023095-4dannjjm	1217	39	of	of	IN
cord-023095-4dannjjm	1217	40	hospitalization	hospitalization	NN
cord-023095-4dannjjm	1217	41	)	)	-RRB-
cord-023095-4dannjjm	1217	42	.	.	.
cord-023095-4dannjjm	1218	1	Hypoproteinemia	Hypoproteinemia	NNP
cord-023095-4dannjjm	1218	2	was	be	VBD
cord-023095-4dannjjm	1218	3	associated	associate	VBN
cord-023095-4dannjjm	1218	4	with	with	IN
cord-023095-4dannjjm	1218	5	PI	pi	NN
cord-023095-4dannjjm	1218	6	(	(	-LRB-
cord-023095-4dannjjm	1218	7	P	p	NN
cord-023095-4dannjjm	1218	8	5	5	CD
cord-023095-4dannjjm	1218	9	0.02	0.02	CD
cord-023095-4dannjjm	1218	10	)	)	-RRB-
cord-023095-4dannjjm	1218	11	.	.	.
cord-023095-4dannjjm	1219	1	The	the	DT
cord-023095-4dannjjm	1219	2	presence	presence	NN
cord-023095-4dannjjm	1219	3	of	of	IN
cord-023095-4dannjjm	1219	4	blood	blood	NN
cord-023095-4dannjjm	1219	5	in	in	IN
cord-023095-4dannjjm	1219	6	the	the	DT
cord-023095-4dannjjm	1219	7	feces	fece	NNS
cord-023095-4dannjjm	1219	8	,	,	,
cord-023095-4dannjjm	1219	9	reflux	reflux	NN
cord-023095-4dannjjm	1219	10	and	and	CC
cord-023095-4dannjjm	1219	11	abdominal	abdominal	JJ
cord-023095-4dannjjm	1219	12	distension	distension	NN
cord-023095-4dannjjm	1219	13	was	be	VBD
cord-023095-4dannjjm	1219	14	associated	associate	VBN
cord-023095-4dannjjm	1219	15	with	with	IN
cord-023095-4dannjjm	1219	16	necrotizing	necrotize	VBG
cord-023095-4dannjjm	1219	17	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1219	18	disease	disease	NN
cord-023095-4dannjjm	1219	19	(	(	-LRB-
cord-023095-4dannjjm	1219	20	P	p	NN
cord-023095-4dannjjm	1219	21	o	o	NN
cord-023095-4dannjjm	1219	22	0.05	0.05	CD
cord-023095-4dannjjm	1219	23	)	)	-RRB-
cord-023095-4dannjjm	1219	24	.	.	.
cord-023095-4dannjjm	1220	1	Abdominal	abdominal	JJ
cord-023095-4dannjjm	1220	2	sonograms	sonogram	NNS
cord-023095-4dannjjm	1220	3	have	have	VBP
cord-023095-4dannjjm	1220	4	prognostic	prognostic	JJ
cord-023095-4dannjjm	1220	5	value	value	NN
cord-023095-4dannjjm	1220	6	in	in	IN
cord-023095-4dannjjm	1220	7	neonatal	neonatal	JJ
cord-023095-4dannjjm	1220	8	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1220	9	disease	disease	NN
cord-023095-4dannjjm	1220	10	.	.	.
cord-023095-4dannjjm	1221	1	Pneumatosis	Pneumatosis	NNP
cord-023095-4dannjjm	1221	2	intestinalis	intestinalis	NNP
cord-023095-4dannjjm	1221	3	was	be	VBD
cord-023095-4dannjjm	1221	4	a	a	DT
cord-023095-4dannjjm	1221	5	common	common	JJ
cord-023095-4dannjjm	1221	6	sonographic	sonographic	JJ
cord-023095-4dannjjm	1221	7	sign	sign	NN
cord-023095-4dannjjm	1221	8	that	that	WDT
cord-023095-4dannjjm	1221	9	worsened	worsen	VBD
cord-023095-4dannjjm	1221	10	the	the	DT
cord-023095-4dannjjm	1221	11	prognosis	prognosis	NN
cord-023095-4dannjjm	1221	12	.	.	.
cord-023095-4dannjjm	1222	1	The	the	DT
cord-023095-4dannjjm	1222	2	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	1222	3	implications	implication	NNS
cord-023095-4dannjjm	1222	4	of	of	IN
cord-023095-4dannjjm	1222	5	detecting	detect	VBG
cord-023095-4dannjjm	1222	6	a	a	DT
cord-023095-4dannjjm	1222	7	necrotizing	necrotize	VBG
cord-023095-4dannjjm	1222	8	component	component	NN
cord-023095-4dannjjm	1222	9	of	of	IN
cord-023095-4dannjjm	1222	10	the	the	DT
cord-023095-4dannjjm	1222	11	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1222	12	disease	disease	NN
cord-023095-4dannjjm	1222	13	deserve	deserve	VBP
cord-023095-4dannjjm	1222	14	further	further	JJ
cord-023095-4dannjjm	1222	15	study	study	NN
cord-023095-4dannjjm	1222	16	.	.	.
cord-023095-4dannjjm	1223	1	The	the	DT
cord-023095-4dannjjm	1223	2	interaction	interaction	NN
cord-023095-4dannjjm	1223	3	of	of	IN
cord-023095-4dannjjm	1223	4	insulin	insulin	NN
cord-023095-4dannjjm	1223	5	and	and	CC
cord-023095-4dannjjm	1223	6	the	the	DT
cord-023095-4dannjjm	1223	7	microvascular	microvascular	JJ
cord-023095-4dannjjm	1223	8	endothelial	endothelial	JJ
cord-023095-4dannjjm	1223	9	insulin	insulin	NN
cord-023095-4dannjjm	1223	10	receptor	receptor	NN
cord-023095-4dannjjm	1223	11	(	(	-LRB-
cord-023095-4dannjjm	1223	12	IRc	IRc	NNP
cord-023095-4dannjjm	1223	13	)	)	-RRB-
cord-023095-4dannjjm	1223	14	plays	play	VBZ
cord-023095-4dannjjm	1223	15	an	an	DT
cord-023095-4dannjjm	1223	16	important	important	JJ
cord-023095-4dannjjm	1223	17	role	role	NN
cord-023095-4dannjjm	1223	18	in	in	IN
cord-023095-4dannjjm	1223	19	the	the	DT
cord-023095-4dannjjm	1223	20	normal	normal	JJ
cord-023095-4dannjjm	1223	21	and	and	CC
cord-023095-4dannjjm	1223	22	insulin	insulin	NN
cord-023095-4dannjjm	1223	23	resistant	resistant	JJ
cord-023095-4dannjjm	1223	24	(	(	-LRB-
cord-023095-4dannjjm	1223	25	IR	IR	NNP
cord-023095-4dannjjm	1223	26	)	)	-RRB-
cord-023095-4dannjjm	1223	27	individual	individual	NN
cord-023095-4dannjjm	1223	28	.	.	.
cord-023095-4dannjjm	1224	1	While	while	IN
cord-023095-4dannjjm	1224	2	endothelial	endothelial	JJ
cord-023095-4dannjjm	1224	3	IRc	irc	NN
cord-023095-4dannjjm	1224	4	signaling	signaling	NN
cord-023095-4dannjjm	1224	5	is	be	VBZ
cord-023095-4dannjjm	1224	6	normally	normally	RB
cord-023095-4dannjjm	1224	7	vasodilatory	vasodilatory	NN
cord-023095-4dannjjm	1224	8	,	,	,
cord-023095-4dannjjm	1224	9	this	this	DT
cord-023095-4dannjjm	1224	10	effect	effect	NN
cord-023095-4dannjjm	1224	11	is	be	VBZ
cord-023095-4dannjjm	1224	12	well	well	RB
cord-023095-4dannjjm	1224	13	-	-	HYPH
cord-023095-4dannjjm	1224	14	documented	document	VBN
cord-023095-4dannjjm	1224	15	to	to	TO
cord-023095-4dannjjm	1224	16	reverse	reverse	VB
cord-023095-4dannjjm	1224	17	in	in	IN
cord-023095-4dannjjm	1224	18	the	the	DT
cord-023095-4dannjjm	1224	19	IR	IR	NNP
cord-023095-4dannjjm	1224	20	individual	individual	NN
cord-023095-4dannjjm	1224	21	,	,	,
cord-023095-4dannjjm	1224	22	resulting	result	VBG
cord-023095-4dannjjm	1224	23	in	in	IN
cord-023095-4dannjjm	1224	24	vasoconstriction	vasoconstriction	NN
cord-023095-4dannjjm	1224	25	.	.	.
cord-023095-4dannjjm	1225	1	Although	although	IN
cord-023095-4dannjjm	1225	2	vascular	vascular	JJ
cord-023095-4dannjjm	1225	3	dysfunction	dysfunction	NN
cord-023095-4dannjjm	1225	4	has	have	VBZ
cord-023095-4dannjjm	1225	5	been	be	VBN
cord-023095-4dannjjm	1225	6	reported	report	VBN
cord-023095-4dannjjm	1225	7	in	in	IN
cord-023095-4dannjjm	1225	8	sepsis	sepsis	NN
cord-023095-4dannjjm	1225	9	-	-	HYPH
cord-023095-4dannjjm	1225	10	associated	associate	VBN
cord-023095-4dannjjm	1225	11	equine	equine	NN
cord-023095-4dannjjm	1225	12	laminitis	laminitis	NN
cord-023095-4dannjjm	1225	13	,	,	,
cord-023095-4dannjjm	1225	14	the	the	DT
cord-023095-4dannjjm	1225	15	role	role	NN
cord-023095-4dannjjm	1225	16	of	of	IN
cord-023095-4dannjjm	1225	17	the	the	DT
cord-023095-4dannjjm	1225	18	laminar	laminar	JJ
cord-023095-4dannjjm	1225	19	microvasculature	microvasculature	NN
cord-023095-4dannjjm	1225	20	in	in	IN
cord-023095-4dannjjm	1225	21	endocrinopathic	endocrinopathic	NNP
cord-023095-4dannjjm	1225	22	laminitis	laminitis	NN
cord-023095-4dannjjm	1225	23	remains	remain	VBZ
cord-023095-4dannjjm	1225	24	poorly	poorly	RB
cord-023095-4dannjjm	1225	25	characterized	characterize	VBN
cord-023095-4dannjjm	1225	26	.	.	.
cord-023095-4dannjjm	1226	1	The	the	DT
cord-023095-4dannjjm	1226	2	purpose	purpose	NN
cord-023095-4dannjjm	1226	3	of	of	IN
cord-023095-4dannjjm	1226	4	this	this	DT
cord-023095-4dannjjm	1226	5	study	study	NN
cord-023095-4dannjjm	1226	6	was	be	VBD
cord-023095-4dannjjm	1226	7	to	to	TO
cord-023095-4dannjjm	1226	8	characterize	characterize	VB
cord-023095-4dannjjm	1226	9	the	the	DT
cord-023095-4dannjjm	1226	10	pattern	pattern	NN
cord-023095-4dannjjm	1226	11	of	of	IN
cord-023095-4dannjjm	1226	12	IRc	irc	JJ
cord-023095-4dannjjm	1226	13	expression	expression	NN
cord-023095-4dannjjm	1226	14	in	in	IN
cord-023095-4dannjjm	1226	15	digital	digital	JJ
cord-023095-4dannjjm	1226	16	laminae	laminae	NNP
cord-023095-4dannjjm	1226	17	in	in	IN
cord-023095-4dannjjm	1226	18	ponies	pony	NNS
cord-023095-4dannjjm	1226	19	subjected	subject	VBN
cord-023095-4dannjjm	1226	20	to	to	IN
cord-023095-4dannjjm	1226	21	a	a	DT
cord-023095-4dannjjm	1226	22	dietary	dietary	JJ
cord-023095-4dannjjm	1226	23	carbohydrate	carbohydrate	NN
cord-023095-4dannjjm	1226	24	challenge	challenge	NN
cord-023095-4dannjjm	1226	25	that	that	WDT
cord-023095-4dannjjm	1226	26	mimicked	mimic	VBD
cord-023095-4dannjjm	1226	27	abrupt	abrupt	JJ
cord-023095-4dannjjm	1226	28	exposure	exposure	NN
cord-023095-4dannjjm	1226	29	to	to	TO
cord-023095-4dannjjm	1226	30	pasture	pasture	VB
cord-023095-4dannjjm	1226	31	rich	rich	JJ
cord-023095-4dannjjm	1226	32	in	in	IN
cord-023095-4dannjjm	1226	33	nonstructural	nonstructural	JJ
cord-023095-4dannjjm	1226	34	carbohydrates	carbohydrate	NNS
cord-023095-4dannjjm	1226	35	(	(	-LRB-
cord-023095-4dannjjm	1226	36	NSC	NSC	NNP
cord-023095-4dannjjm	1226	37	)	)	-RRB-
cord-023095-4dannjjm	1226	38	.	.	.
cord-023095-4dannjjm	1227	1	Mixed	mixed	JJ
cord-023095-4dannjjm	1227	2	-	-	HYPH
cord-023095-4dannjjm	1227	3	breed	breed	NN
cord-023095-4dannjjm	1227	4	ponies	pony	NNS
cord-023095-4dannjjm	1227	5	(	(	-LRB-
cord-023095-4dannjjm	1227	6	body	body	NN
cord-023095-4dannjjm	1227	7	weight	weight	NN
cord-023095-4dannjjm	1227	8	270.9	270.9	CD
cord-023095-4dannjjm	1227	9	1/-74.4	1/-74.4	CD
cord-023095-4dannjjm	1227	10	kg	kg	NNS
cord-023095-4dannjjm	1227	11	)	)	-RRB-
cord-023095-4dannjjm	1227	12	received	receive	VBD
cord-023095-4dannjjm	1227	13	a	a	DT
cord-023095-4dannjjm	1227	14	diet	diet	NN
cord-023095-4dannjjm	1227	15	of	of	IN
cord-023095-4dannjjm	1227	16	hay	hay	NN
cord-023095-4dannjjm	1227	17	chop	chop	NN
cord-023095-4dannjjm	1227	18	(	(	-LRB-
cord-023095-4dannjjm	1227	19	NSC	NSC	NNP
cord-023095-4dannjjm	1227	20	$	$	$
cord-023095-4dannjjm	1227	21	6	6	CD
cord-023095-4dannjjm	1227	22	%	%	NN
cord-023095-4dannjjm	1227	23	on	on	IN
cord-023095-4dannjjm	1227	24	a	a	DT
cord-023095-4dannjjm	1227	25	DM	dm	NN
cord-023095-4dannjjm	1227	26	basis	basis	NN
cord-023095-4dannjjm	1227	27	)	)	-RRB-
cord-023095-4dannjjm	1227	28	for	for	IN
cord-023095-4dannjjm	1227	29	4	4	CD
cord-023095-4dannjjm	1227	30	weeks	week	NNS
cord-023095-4dannjjm	1227	31	prior	prior	RB
cord-023095-4dannjjm	1227	32	to	to	IN
cord-023095-4dannjjm	1227	33	initiation	initiation	NN
cord-023095-4dannjjm	1227	34	of	of	IN
cord-023095-4dannjjm	1227	35	the	the	DT
cord-023095-4dannjjm	1227	36	experimental	experimental	JJ
cord-023095-4dannjjm	1227	37	feeding	feeding	NN
cord-023095-4dannjjm	1227	38	protocol	protocol	NN
cord-023095-4dannjjm	1227	39	.	.	.
cord-023095-4dannjjm	1228	1	Following	follow	VBG
cord-023095-4dannjjm	1228	2	conditioning	conditioning	NN
cord-023095-4dannjjm	1228	3	,	,	,
cord-023095-4dannjjm	1228	4	ponies	pony	NNS
cord-023095-4dannjjm	1228	5	either	either	CC
cord-023095-4dannjjm	1228	6	remained	remain	VBD
cord-023095-4dannjjm	1228	7	on	on	IN
cord-023095-4dannjjm	1228	8	the	the	DT
cord-023095-4dannjjm	1228	9	control	control	NN
cord-023095-4dannjjm	1228	10	diet	diet	NN
cord-023095-4dannjjm	1228	11	(	(	-LRB-
cord-023095-4dannjjm	1228	12	n	n	NN
cord-023095-4dannjjm	1228	13	5	5	CD
cord-023095-4dannjjm	1228	14	11	11	CD
cord-023095-4dannjjm	1228	15	)	)	-RRB-
cord-023095-4dannjjm	1228	16	or	or	CC
cord-023095-4dannjjm	1228	17	received	receive	VBD
cord-023095-4dannjjm	1228	18	the	the	DT
cord-023095-4dannjjm	1228	19	same	same	JJ
cord-023095-4dannjjm	1228	20	diet	diet	NN
cord-023095-4dannjjm	1228	21	supplemented	supplement	VBN
cord-023095-4dannjjm	1228	22	with	with	IN
cord-023095-4dannjjm	1228	23	sweet	sweet	JJ
cord-023095-4dannjjm	1228	24	feed	feed	NN
cord-023095-4dannjjm	1228	25	and	and	CC
cord-023095-4dannjjm	1228	26	oligofructose	oligofructose	JJ
cord-023095-4dannjjm	1228	27	(	(	-LRB-
cord-023095-4dannjjm	1228	28	total	total	JJ
cord-023095-4dannjjm	1228	29	diet	diet	NN
cord-023095-4dannjjm	1228	30	$	$	$
cord-023095-4dannjjm	1228	31	42	42	CD
cord-023095-4dannjjm	1228	32	%	%	NN
cord-023095-4dannjjm	1228	33	NSC	NSC	NNP
cord-023095-4dannjjm	1228	34	;	;	:
cord-023095-4dannjjm	1228	35	n	n	NN
cord-023095-4dannjjm	1228	36	5	5	CD
cord-023095-4dannjjm	1228	37	11	11	CD
cord-023095-4dannjjm	1228	38	)	)	-RRB-
cord-023095-4dannjjm	1228	39	for	for	IN
cord-023095-4dannjjm	1228	40	a	a	DT
cord-023095-4dannjjm	1228	41	period	period	NN
cord-023095-4dannjjm	1228	42	of	of	IN
cord-023095-4dannjjm	1228	43	7	7	CD
cord-023095-4dannjjm	1228	44	days	day	NNS
cord-023095-4dannjjm	1228	45	.	.	.
cord-023095-4dannjjm	1229	1	Serum	serum	NN
cord-023095-4dannjjm	1229	2	insulin	insulin	NN
cord-023095-4dannjjm	1229	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1229	4	were	be	VBD
cord-023095-4dannjjm	1229	5	measured	measure	VBN
cord-023095-4dannjjm	1229	6	prior	prior	RB
cord-023095-4dannjjm	1229	7	to	to	IN
cord-023095-4dannjjm	1229	8	and	and	CC
cord-023095-4dannjjm	1229	9	after	after	IN
cord-023095-4dannjjm	1229	10	completion	completion	NN
cord-023095-4dannjjm	1229	11	of	of	IN
cord-023095-4dannjjm	1229	12	the	the	DT
cord-023095-4dannjjm	1229	13	feeding	feeding	NN
cord-023095-4dannjjm	1229	14	protocol	protocol	NN
cord-023095-4dannjjm	1229	15	.	.	.
cord-023095-4dannjjm	1230	1	At	at	IN
cord-023095-4dannjjm	1230	2	the	the	DT
cord-023095-4dannjjm	1230	3	end	end	NN
cord-023095-4dannjjm	1230	4	of	of	IN
cord-023095-4dannjjm	1230	5	the	the	DT
cord-023095-4dannjjm	1230	6	feeding	feeding	NN
cord-023095-4dannjjm	1230	7	protocol	protocol	NN
cord-023095-4dannjjm	1230	8	,	,	,
cord-023095-4dannjjm	1230	9	sections	section	NNS
cord-023095-4dannjjm	1230	10	of	of	IN
cord-023095-4dannjjm	1230	11	numerous	numerous	JJ
cord-023095-4dannjjm	1230	12	tissues	tissue	NNS
cord-023095-4dannjjm	1230	13	,	,	,
cord-023095-4dannjjm	1230	14	including	include	VBG
cord-023095-4dannjjm	1230	15	dorsal	dorsal	JJ
cord-023095-4dannjjm	1230	16	digital	digital	JJ
cord-023095-4dannjjm	1230	17	laminae	laminae	NN
cord-023095-4dannjjm	1230	18	,	,	,
cord-023095-4dannjjm	1230	19	were	be	VBD
cord-023095-4dannjjm	1230	20	collected	collect	VBN
cord-023095-4dannjjm	1230	21	immediately	immediately	RB
cord-023095-4dannjjm	1230	22	following	follow	VBG
cord-023095-4dannjjm	1230	23	euthanasia	euthanasia	NN
cord-023095-4dannjjm	1230	24	.	.	.
cord-023095-4dannjjm	1231	1	The	the	DT
cord-023095-4dannjjm	1231	2	samples	sample	NNS
cord-023095-4dannjjm	1231	3	were	be	VBD
cord-023095-4dannjjm	1231	4	formalin	formalin	NN
cord-023095-4dannjjm	1231	5	-	-	HYPH
cord-023095-4dannjjm	1231	6	fixed	fix	VBN
cord-023095-4dannjjm	1231	7	for	for	IN
cord-023095-4dannjjm	1231	8	48	48	CD
cord-023095-4dannjjm	1231	9	hours	hour	NNS
cord-023095-4dannjjm	1231	10	,	,	,
cord-023095-4dannjjm	1231	11	transferred	transfer	VBN
cord-023095-4dannjjm	1231	12	to	to	IN
cord-023095-4dannjjm	1231	13	70	70	CD
cord-023095-4dannjjm	1231	14	%	%	NN
cord-023095-4dannjjm	1231	15	ethanol	ethanol	NN
cord-023095-4dannjjm	1231	16	,	,	,
cord-023095-4dannjjm	1231	17	and	and	CC
cord-023095-4dannjjm	1231	18	paraffin	paraffin	NN
cord-023095-4dannjjm	1231	19	-	-	HYPH
cord-023095-4dannjjm	1231	20	embedded	embed	VBN
cord-023095-4dannjjm	1231	21	.	.	.
cord-023095-4dannjjm	1232	1	Laminar	laminar	JJ
cord-023095-4dannjjm	1232	2	sections	section	NNS
cord-023095-4dannjjm	1232	3	were	be	VBD
cord-023095-4dannjjm	1232	4	stained	stain	VBN
cord-023095-4dannjjm	1232	5	immunohistochemically	immunohistochemically	RB
cord-023095-4dannjjm	1232	6	for	for	IN
cord-023095-4dannjjm	1232	7	IRc	irc	NN
cord-023095-4dannjjm	1232	8	using	use	VBG
cord-023095-4dannjjm	1232	9	a	a	DT
cord-023095-4dannjjm	1232	10	commercially	commercially	RB
cord-023095-4dannjjm	1232	11	-	-	HYPH
cord-023095-4dannjjm	1232	12	available	available	JJ
cord-023095-4dannjjm	1232	13	antibody	antibody	NN
cord-023095-4dannjjm	1232	14	(	(	-LRB-
cord-023095-4dannjjm	1232	15	Abcam	Abcam	NNP
cord-023095-4dannjjm	1232	16	)	)	-RRB-
cord-023095-4dannjjm	1232	17	;	;	:
cord-023095-4dannjjm	1232	18	the	the	DT
cord-023095-4dannjjm	1232	19	number	number	NN
cord-023095-4dannjjm	1232	20	of	of	IN
cord-023095-4dannjjm	1232	21	IRc	irc	NN
cord-023095-4dannjjm	1232	22	(	(	-LRB-
cord-023095-4dannjjm	1232	23	1	1	CD
cord-023095-4dannjjm	1232	24	)	)	-RRB-
cord-023095-4dannjjm	1232	25	cells	cell	NNS
cord-023095-4dannjjm	1232	26	was	be	VBD
cord-023095-4dannjjm	1232	27	quantified	quantify	VBN
cord-023095-4dannjjm	1232	28	in	in	IN
cord-023095-4dannjjm	1232	29	40x	40x	CD
cord-023095-4dannjjm	1232	30	light	light	JJ
cord-023095-4dannjjm	1232	31	microscopy	microscopy	NN
cord-023095-4dannjjm	1232	32	fields	field	NNS
cord-023095-4dannjjm	1232	33	(	(	-LRB-
cord-023095-4dannjjm	1232	34	n	n	NN
cord-023095-4dannjjm	1232	35	5	5	CD
cord-023095-4dannjjm	1232	36	10	10	CD
cord-023095-4dannjjm	1232	37	)	)	-RRB-
cord-023095-4dannjjm	1232	38	for	for	IN
cord-023095-4dannjjm	1232	39	each	each	DT
cord-023095-4dannjjm	1232	40	section	section	NN
cord-023095-4dannjjm	1232	41	.	.	.
cord-023095-4dannjjm	1233	1	The	the	DT
cord-023095-4dannjjm	1233	2	total	total	JJ
cord-023095-4dannjjm	1233	3	number	number	NN
cord-023095-4dannjjm	1233	4	of	of	IN
cord-023095-4dannjjm	1233	5	IRc	irc	NN
cord-023095-4dannjjm	1233	6	(	(	-LRB-
cord-023095-4dannjjm	1233	7	1	1	CD
cord-023095-4dannjjm	1233	8	)	)	-RRB-
cord-023095-4dannjjm	1233	9	cells	cell	NNS
cord-023095-4dannjjm	1233	10	was	be	VBD
cord-023095-4dannjjm	1233	11	greater	great	JJR
cord-023095-4dannjjm	1233	12	in	in	IN
cord-023095-4dannjjm	1233	13	the	the	DT
cord-023095-4dannjjm	1233	14	laminae	laminae	NN
cord-023095-4dannjjm	1233	15	of	of	IN
cord-023095-4dannjjm	1233	16	challenged	challenge	VBN
cord-023095-4dannjjm	1233	17	ponies	pony	NNS
cord-023095-4dannjjm	1233	18	than	than	IN
cord-023095-4dannjjm	1233	19	control	control	NN
cord-023095-4dannjjm	1233	20	ponies	pony	NNS
cord-023095-4dannjjm	1233	21	(	(	-LRB-
cord-023095-4dannjjm	1233	22	p	p	NN
cord-023095-4dannjjm	1233	23	5	5	CD
cord-023095-4dannjjm	1233	24	0.0096	0.0096	CD
cord-023095-4dannjjm	1233	25	)	)	-RRB-
cord-023095-4dannjjm	1233	26	,	,	,
cord-023095-4dannjjm	1233	27	and	and	CC
cord-023095-4dannjjm	1233	28	there	there	EX
cord-023095-4dannjjm	1233	29	was	be	VBD
cord-023095-4dannjjm	1233	30	a	a	DT
cord-023095-4dannjjm	1233	31	significant	significant	JJ
cord-023095-4dannjjm	1233	32	correlation	correlation	NN
cord-023095-4dannjjm	1233	33	between	between	IN
cord-023095-4dannjjm	1233	34	the	the	DT
cord-023095-4dannjjm	1233	35	change	change	NN
cord-023095-4dannjjm	1233	36	in	in	IN
cord-023095-4dannjjm	1233	37	serum	serum	NN
cord-023095-4dannjjm	1233	38	basal	basal	NN
cord-023095-4dannjjm	1233	39	insulin	insulin	NN
cord-023095-4dannjjm	1233	40	concentration	concentration	NN
cord-023095-4dannjjm	1233	41	and	and	CC
cord-023095-4dannjjm	1233	42	number	number	NN
cord-023095-4dannjjm	1233	43	of	of	IN
cord-023095-4dannjjm	1233	44	laminar	laminar	JJ
cord-023095-4dannjjm	1233	45	IRc	irc	NN
cord-023095-4dannjjm	1233	46	(	(	-LRB-
cord-023095-4dannjjm	1233	47	1	1	CD
cord-023095-4dannjjm	1233	48	)	)	-RRB-
cord-023095-4dannjjm	1233	49	endothelial	endothelial	JJ
cord-023095-4dannjjm	1233	50	cells	cell	NNS
cord-023095-4dannjjm	1233	51	(	(	-LRB-
cord-023095-4dannjjm	1233	52	r	r	NN
cord-023095-4dannjjm	1233	53	5	5	CD
cord-023095-4dannjjm	1233	54	0.74	0.74	CD
cord-023095-4dannjjm	1233	55	;	;	:
cord-023095-4dannjjm	1233	56	p	p	NN
cord-023095-4dannjjm	1233	57	o	o	NN
cord-023095-4dannjjm	1233	58	0.05	0.05	CD
cord-023095-4dannjjm	1233	59	)	)	-RRB-
cord-023095-4dannjjm	1233	60	.	.	.
cord-023095-4dannjjm	1234	1	While	while	IN
cord-023095-4dannjjm	1234	2	the	the	DT
cord-023095-4dannjjm	1234	3	number	number	NN
cord-023095-4dannjjm	1234	4	of	of	IN
cord-023095-4dannjjm	1234	5	IRc	irc	NN
cord-023095-4dannjjm	1234	6	(	(	-LRB-
cord-023095-4dannjjm	1234	7	1	1	CD
cord-023095-4dannjjm	1234	8	)	)	-RRB-
cord-023095-4dannjjm	1234	9	endothelial	endothelial	JJ
cord-023095-4dannjjm	1234	10	cells	cell	NNS
cord-023095-4dannjjm	1234	11	was	be	VBD
cord-023095-4dannjjm	1234	12	significantly	significantly	RB
cord-023095-4dannjjm	1234	13	greater	great	JJR
cord-023095-4dannjjm	1234	14	in	in	IN
cord-023095-4dannjjm	1234	15	the	the	DT
cord-023095-4dannjjm	1234	16	dermal	dermal	JJ
cord-023095-4dannjjm	1234	17	laminae	laminae	NN
cord-023095-4dannjjm	1234	18	of	of	IN
cord-023095-4dannjjm	1234	19	challenged	challenge	VBN
cord-023095-4dannjjm	1234	20	ponies	pony	NNS
cord-023095-4dannjjm	1234	21	(	(	-LRB-
cord-023095-4dannjjm	1234	22	p	p	NN
cord-023095-4dannjjm	1234	23	5	5	CD
cord-023095-4dannjjm	1234	24	0.0095	0.0095	CD
cord-023095-4dannjjm	1234	25	)	)	-RRB-
cord-023095-4dannjjm	1234	26	,	,	,
cord-023095-4dannjjm	1234	27	there	there	EX
cord-023095-4dannjjm	1234	28	was	be	VBD
cord-023095-4dannjjm	1234	29	no	no	DT
cord-023095-4dannjjm	1234	30	difference	difference	NN
cord-023095-4dannjjm	1234	31	in	in	IN
cord-023095-4dannjjm	1234	32	the	the	DT
cord-023095-4dannjjm	1234	33	number	number	NN
cord-023095-4dannjjm	1234	34	of	of	IN
cord-023095-4dannjjm	1234	35	interstitial	interstitial	JJ
cord-023095-4dannjjm	1234	36	IRc	irc	NN
cord-023095-4dannjjm	1234	37	(	(	-LRB-
cord-023095-4dannjjm	1234	38	1	1	CD
cord-023095-4dannjjm	1234	39	)	)	-RRB-
cord-023095-4dannjjm	1234	40	cells	cell	NNS
cord-023095-4dannjjm	1234	41	(	(	-LRB-
cord-023095-4dannjjm	1234	42	p	p	NN
cord-023095-4dannjjm	1234	43	5	5	CD
cord-023095-4dannjjm	1234	44	0.82	0.82	CD
cord-023095-4dannjjm	1234	45	)	)	-RRB-
cord-023095-4dannjjm	1234	46	.	.	.
cord-023095-4dannjjm	1235	1	No	no	DT
cord-023095-4dannjjm	1235	2	epithelial	epithelial	JJ
cord-023095-4dannjjm	1235	3	IRc	irc	NN
cord-023095-4dannjjm	1235	4	(	(	-LRB-
cord-023095-4dannjjm	1235	5	1	1	CD
cord-023095-4dannjjm	1235	6	)	)	-RRB-
cord-023095-4dannjjm	1235	7	cells	cell	NNS
cord-023095-4dannjjm	1235	8	were	be	VBD
cord-023095-4dannjjm	1235	9	observed	observe	VBN
cord-023095-4dannjjm	1235	10	in	in	IN
cord-023095-4dannjjm	1235	11	any	any	DT
cord-023095-4dannjjm	1235	12	laminar	laminar	JJ
cord-023095-4dannjjm	1235	13	section	section	NN
cord-023095-4dannjjm	1235	14	,	,	,
cord-023095-4dannjjm	1235	15	and	and	CC
cord-023095-4dannjjm	1235	16	IRc	irc	NN
cord-023095-4dannjjm	1235	17	(	(	-LRB-
cord-023095-4dannjjm	1235	18	1	1	CD
cord-023095-4dannjjm	1235	19	)	)	-RRB-
cord-023095-4dannjjm	1235	20	cells	cell	NNS
cord-023095-4dannjjm	1235	21	were	be	VBD
cord-023095-4dannjjm	1235	22	conspicuously	conspicuously	RB
cord-023095-4dannjjm	1235	23	absent	absent	JJ
cord-023095-4dannjjm	1235	24	from	from	IN
cord-023095-4dannjjm	1235	25	the	the	DT
cord-023095-4dannjjm	1235	26	deep	deep	JJ
cord-023095-4dannjjm	1235	27	dermal	dermal	JJ
cord-023095-4dannjjm	1235	28	tissue	tissue	NN
cord-023095-4dannjjm	1235	29	(	(	-LRB-
cord-023095-4dannjjm	1235	30	including	include	VBG
cord-023095-4dannjjm	1235	31	vessels	vessel	NNS
cord-023095-4dannjjm	1235	32	)	)	-RRB-
cord-023095-4dannjjm	1235	33	.	.	.
cord-023095-4dannjjm	1236	1	Up	up	IN
cord-023095-4dannjjm	1236	2	-	-	HYPH
cord-023095-4dannjjm	1236	3	regulation	regulation	NN
cord-023095-4dannjjm	1236	4	of	of	IN
cord-023095-4dannjjm	1236	5	IRc	irc	JJ
cord-023095-4dannjjm	1236	6	expression	expression	NN
cord-023095-4dannjjm	1236	7	in	in	IN
cord-023095-4dannjjm	1236	8	the	the	DT
cord-023095-4dannjjm	1236	9	laminar	laminar	JJ
cord-023095-4dannjjm	1236	10	vasculature	vasculature	NN
cord-023095-4dannjjm	1236	11	occurs	occur	VBZ
cord-023095-4dannjjm	1236	12	acutely	acutely	RB
cord-023095-4dannjjm	1236	13	in	in	IN
cord-023095-4dannjjm	1236	14	response	response	NN
cord-023095-4dannjjm	1236	15	to	to	IN
cord-023095-4dannjjm	1236	16	dietary	dietary	JJ
cord-023095-4dannjjm	1236	17	carbohydrate	carbohydrate	NN
cord-023095-4dannjjm	1236	18	challenge	challenge	NN
cord-023095-4dannjjm	1236	19	and	and	CC
cord-023095-4dannjjm	1236	20	accompanies	accompany	VBZ
cord-023095-4dannjjm	1236	21	hyperinsulinemia	hyperinsulinemia	NN
cord-023095-4dannjjm	1236	22	in	in	IN
cord-023095-4dannjjm	1236	23	ponies	pony	NNS
cord-023095-4dannjjm	1236	24	.	.	.
cord-023095-4dannjjm	1237	1	The	the	DT
cord-023095-4dannjjm	1237	2	dramatic	dramatic	JJ
cord-023095-4dannjjm	1237	3	increase	increase	NN
cord-023095-4dannjjm	1237	4	in	in	IN
cord-023095-4dannjjm	1237	5	endothelial	endothelial	JJ
cord-023095-4dannjjm	1237	6	IRc	irc	JJ
cord-023095-4dannjjm	1237	7	expression	expression	NN
cord-023095-4dannjjm	1237	8	in	in	IN
cord-023095-4dannjjm	1237	9	the	the	DT
cord-023095-4dannjjm	1237	10	laminar	laminar	JJ
cord-023095-4dannjjm	1237	11	microvasculature	microvasculature	NN
cord-023095-4dannjjm	1237	12	in	in	IN
cord-023095-4dannjjm	1237	13	nutritionally	nutritionally	RB
cord-023095-4dannjjm	1237	14	challenged	challenge	VBN
cord-023095-4dannjjm	1237	15	ponies	pony	NNS
cord-023095-4dannjjm	1237	16	,	,	,
cord-023095-4dannjjm	1237	17	with	with	IN
cord-023095-4dannjjm	1237	18	no	no	DT
cord-023095-4dannjjm	1237	19	apparent	apparent	JJ
cord-023095-4dannjjm	1237	20	epithelial	epithelial	JJ
cord-023095-4dannjjm	1237	21	IRc	irc	NN
cord-023095-4dannjjm	1237	22	present	present	NN
cord-023095-4dannjjm	1237	23	,	,	,
cord-023095-4dannjjm	1237	24	suggests	suggest	VBZ
cord-023095-4dannjjm	1237	25	that	that	IN
cord-023095-4dannjjm	1237	26	hyperinsulinemia	hyperinsulinemia	NN
cord-023095-4dannjjm	1237	27	associated	associate	VBN
cord-023095-4dannjjm	1237	28	with	with	IN
cord-023095-4dannjjm	1237	29	exposure	exposure	NN
cord-023095-4dannjjm	1237	30	to	to	IN
cord-023095-4dannjjm	1237	31	increased	increase	VBN
cord-023095-4dannjjm	1237	32	dietary	dietary	JJ
cord-023095-4dannjjm	1237	33	NSC	NSC	NNP
cord-023095-4dannjjm	1237	34	may	may	MD
cord-023095-4dannjjm	1237	35	induce	induce	VB
cord-023095-4dannjjm	1237	36	laminar	laminar	JJ
cord-023095-4dannjjm	1237	37	injury	injury	NN
cord-023095-4dannjjm	1237	38	by	by	IN
cord-023095-4dannjjm	1237	39	causing	cause	VBG
cord-023095-4dannjjm	1237	40	a	a	DT
cord-023095-4dannjjm	1237	41	similar	similar	JJ
cord-023095-4dannjjm	1237	42	vasoconstriction	vasoconstriction	NN
cord-023095-4dannjjm	1237	43	in	in	IN
cord-023095-4dannjjm	1237	44	IR	IR	NNP
cord-023095-4dannjjm	1237	45	equids	equid	NNS
cord-023095-4dannjjm	1237	46	as	as	IN
cord-023095-4dannjjm	1237	47	described	describe	VBN
cord-023095-4dannjjm	1237	48	in	in	IN
cord-023095-4dannjjm	1237	49	the	the	DT
cord-023095-4dannjjm	1237	50	microvasculature	microvasculature	NN
cord-023095-4dannjjm	1237	51	of	of	IN
cord-023095-4dannjjm	1237	52	IR	IR	NNP
cord-023095-4dannjjm	1237	53	humans	human	NNS
cord-023095-4dannjjm	1237	54	.	.	.
cord-023095-4dannjjm	1238	1	Glucose	glucose	NN
cord-023095-4dannjjm	1238	2	transport	transport	NN
cord-023095-4dannjjm	1238	3	from	from	IN
cord-023095-4dannjjm	1238	4	the	the	DT
cord-023095-4dannjjm	1238	5	blood	blood	NN
cord-023095-4dannjjm	1238	6	stream	stream	NN
cord-023095-4dannjjm	1238	7	into	into	IN
cord-023095-4dannjjm	1238	8	cells	cell	NNS
cord-023095-4dannjjm	1238	9	,	,	,
cord-023095-4dannjjm	1238	10	the	the	DT
cord-023095-4dannjjm	1238	11	limiting	limit	VBG
cord-023095-4dannjjm	1238	12	step	step	NN
cord-023095-4dannjjm	1238	13	in	in	IN
cord-023095-4dannjjm	1238	14	whole	whole	JJ
cord-023095-4dannjjm	1238	15	-	-	HYPH
cord-023095-4dannjjm	1238	16	body	body	NN
cord-023095-4dannjjm	1238	17	glucose	glucose	NN
cord-023095-4dannjjm	1238	18	utilization	utilization	NN
cord-023095-4dannjjm	1238	19	,	,	,
cord-023095-4dannjjm	1238	20	is	be	VBZ
cord-023095-4dannjjm	1238	21	regulated	regulate	VBN
cord-023095-4dannjjm	1238	22	by	by	IN
cord-023095-4dannjjm	1238	23	a	a	DT
cord-023095-4dannjjm	1238	24	family	family	NN
cord-023095-4dannjjm	1238	25	of	of	IN
cord-023095-4dannjjm	1238	26	glucose	glucose	NN
cord-023095-4dannjjm	1238	27	transporter	transporter	NN
cord-023095-4dannjjm	1238	28	(	(	-LRB-
cord-023095-4dannjjm	1238	29	GLUT	glut	NN
cord-023095-4dannjjm	1238	30	)	)	-RRB-
cord-023095-4dannjjm	1238	31	proteins	protein	NNS
cord-023095-4dannjjm	1238	32	in	in	IN
cord-023095-4dannjjm	1238	33	insulin	insulin	NN
cord-023095-4dannjjm	1238	34	-	-	HYPH
cord-023095-4dannjjm	1238	35	sensitive	sensitive	JJ
cord-023095-4dannjjm	1238	36	(	(	-LRB-
cord-023095-4dannjjm	1238	37	i.e.	i.e.	FW
cord-023095-4dannjjm	1238	38	,	,	,
cord-023095-4dannjjm	1238	39	muscle	muscle	NN
cord-023095-4dannjjm	1238	40	and	and	CC
cord-023095-4dannjjm	1238	41	adipose	adipose	NN
cord-023095-4dannjjm	1238	42	)	)	-RRB-
cord-023095-4dannjjm	1238	43	tissues	tissue	NNS
cord-023095-4dannjjm	1238	44	.	.	.
cord-023095-4dannjjm	1239	1	We	-PRON-	PRP
cord-023095-4dannjjm	1239	2	previously	previously	RB
cord-023095-4dannjjm	1239	3	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	1239	4	that	that	IN
cord-023095-4dannjjm	1239	5	GLUT4	GLUT4	NNP
cord-023095-4dannjjm	1239	6	,	,	,
cord-023095-4dannjjm	1239	7	the	the	DT
cord-023095-4dannjjm	1239	8	major	major	JJ
cord-023095-4dannjjm	1239	9	isoform	isoform	NN
cord-023095-4dannjjm	1239	10	,	,	,
cord-023095-4dannjjm	1239	11	is	be	VBZ
cord-023095-4dannjjm	1239	12	a	a	DT
cord-023095-4dannjjm	1239	13	key	key	JJ
cord-023095-4dannjjm	1239	14	factor	factor	NN
cord-023095-4dannjjm	1239	15	in	in	IN
cord-023095-4dannjjm	1239	16	the	the	DT
cord-023095-4dannjjm	1239	17	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	1239	18	of	of	IN
cord-023095-4dannjjm	1239	19	equine	equine	JJ
cord-023095-4dannjjm	1239	20	insulin	insulin	NN
cord-023095-4dannjjm	1239	21	resistance	resistance	NN
cord-023095-4dannjjm	1239	22	(	(	-LRB-
cord-023095-4dannjjm	1239	23	IR	IR	NNP
cord-023095-4dannjjm	1239	24	)	)	-RRB-
cord-023095-4dannjjm	1239	25	.	.	.
cord-023095-4dannjjm	1240	1	While	while	IN
cord-023095-4dannjjm	1240	2	it	-PRON-	PRP
cord-023095-4dannjjm	1240	3	has	have	VBZ
cord-023095-4dannjjm	1240	4	been	be	VBN
cord-023095-4dannjjm	1240	5	recently	recently	RB
cord-023095-4dannjjm	1240	6	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	1240	7	that	that	IN
cord-023095-4dannjjm	1240	8	GLUT12	GLUT12	NNP
cord-023095-4dannjjm	1240	9	(	(	-LRB-
cord-023095-4dannjjm	1240	10	a	a	DT
cord-023095-4dannjjm	1240	11	newly	newly	RB
cord-023095-4dannjjm	1240	12	discovered	discover	VBN
cord-023095-4dannjjm	1240	13	isoform	isoform	NN
cord-023095-4dannjjm	1240	14	)	)	-RRB-
cord-023095-4dannjjm	1240	15	increases	increase	VBZ
cord-023095-4dannjjm	1240	16	insulin	insulin	NN
cord-023095-4dannjjm	1240	17	-	-	HYPH
cord-023095-4dannjjm	1240	18	stimulated	stimulate	VBN
cord-023095-4dannjjm	1240	19	glucose	glucose	NN
cord-023095-4dannjjm	1240	20	transport	transport	NN
cord-023095-4dannjjm	1240	21	in	in	IN
cord-023095-4dannjjm	1240	22	human	human	JJ
cord-023095-4dannjjm	1240	23	muscle	muscle	NN
cord-023095-4dannjjm	1240	24	,	,	,
cord-023095-4dannjjm	1240	25	its	-PRON-	PRP$
cord-023095-4dannjjm	1240	26	role	role	NN
cord-023095-4dannjjm	1240	27	in	in	IN
cord-023095-4dannjjm	1240	28	other	other	JJ
cord-023095-4dannjjm	1240	29	tissues	tissue	NNS
cord-023095-4dannjjm	1240	30	,	,	,
cord-023095-4dannjjm	1240	31	particularly	particularly	RB
cord-023095-4dannjjm	1240	32	in	in	IN
cord-023095-4dannjjm	1240	33	the	the	DT
cord-023095-4dannjjm	1240	34	setting	setting	NN
cord-023095-4dannjjm	1240	35	of	of	IN
cord-023095-4dannjjm	1240	36	IR	IR	NNP
cord-023095-4dannjjm	1240	37	,	,	,
cord-023095-4dannjjm	1240	38	is	be	VBZ
cord-023095-4dannjjm	1240	39	not	not	RB
cord-023095-4dannjjm	1240	40	well	well	RB
cord-023095-4dannjjm	1240	41	characterized	characterize	VBN
cord-023095-4dannjjm	1240	42	in	in	IN
cord-023095-4dannjjm	1240	43	any	any	DT
cord-023095-4dannjjm	1240	44	species	specie	NNS
cord-023095-4dannjjm	1240	45	.	.	.
cord-023095-4dannjjm	1241	1	In	in	IN
cord-023095-4dannjjm	1241	2	addition	addition	NN
cord-023095-4dannjjm	1241	3	,	,	,
cord-023095-4dannjjm	1241	4	AS160	AS160	NNP
cord-023095-4dannjjm	1241	5	has	have	VBZ
cord-023095-4dannjjm	1241	6	recently	recently	RB
cord-023095-4dannjjm	1241	7	emerged	emerge	VBN
cord-023095-4dannjjm	1241	8	as	as	IN
cord-023095-4dannjjm	1241	9	a	a	DT
cord-023095-4dannjjm	1241	10	key	key	JJ
cord-023095-4dannjjm	1241	11	downstream	downstream	NN
cord-023095-4dannjjm	1241	12	signaling	signaling	NN
cord-023095-4dannjjm	1241	13	molecule	molecule	NN
cord-023095-4dannjjm	1241	14	regulating	regulate	VBG
cord-023095-4dannjjm	1241	15	translocation	translocation	NN
cord-023095-4dannjjm	1241	16	of	of	IN
cord-023095-4dannjjm	1241	17	GLUT	glut	NN
cord-023095-4dannjjm	1241	18	to	to	IN
cord-023095-4dannjjm	1241	19	the	the	DT
cord-023095-4dannjjm	1241	20	cell	cell	NN
cord-023095-4dannjjm	1241	21	surface	surface	NN
cord-023095-4dannjjm	1241	22	,	,	,
cord-023095-4dannjjm	1241	23	the	the	DT
cord-023095-4dannjjm	1241	24	rate	rate	NN
cord-023095-4dannjjm	1241	25	-	-	HYPH
cord-023095-4dannjjm	1241	26	limiting	limit	VBG
cord-023095-4dannjjm	1241	27	step	step	NN
cord-023095-4dannjjm	1241	28	in	in	IN
cord-023095-4dannjjm	1241	29	glucose	glucose	NN
cord-023095-4dannjjm	1241	30	uptake	uptake	NN
cord-023095-4dannjjm	1241	31	.	.	.
cord-023095-4dannjjm	1242	1	We	-PRON-	PRP
cord-023095-4dannjjm	1242	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1242	3	that	that	IN
cord-023095-4dannjjm	1242	4	GLUT12	GLUT12	NNP
cord-023095-4dannjjm	1242	5	content	content	NN
cord-023095-4dannjjm	1242	6	would	would	MD
cord-023095-4dannjjm	1242	7	be	be	VB
cord-023095-4dannjjm	1242	8	differentially	differentially	RB
cord-023095-4dannjjm	1242	9	expressed	express	VBN
cord-023095-4dannjjm	1242	10	across	across	IN
cord-023095-4dannjjm	1242	11	tissues	tissue	NNS
cord-023095-4dannjjm	1242	12	and	and	CC
cord-023095-4dannjjm	1242	13	that	that	IN
cord-023095-4dannjjm	1242	14	IR	IR	NNP
cord-023095-4dannjjm	1242	15	would	would	MD
cord-023095-4dannjjm	1242	16	induce	induce	VB
cord-023095-4dannjjm	1242	17	alteration	alteration	NN
cord-023095-4dannjjm	1242	18	in	in	IN
cord-023095-4dannjjm	1242	19	glucose	glucose	NN
cord-023095-4dannjjm	1242	20	transport	transport	NN
cord-023095-4dannjjm	1242	21	by	by	IN
cord-023095-4dannjjm	1242	22	affecting	affect	VBG
cord-023095-4dannjjm	1242	23	active	active	JJ
cord-023095-4dannjjm	1242	24	cell	cell	NN
cord-023095-4dannjjm	1242	25	surface	surface	NN
cord-023095-4dannjjm	1243	1	GLUT12	glut12	RB
cord-023095-4dannjjm	1243	2	.	.	.
cord-023095-4dannjjm	1244	1	Biopsies	biopsy	NNS
cord-023095-4dannjjm	1244	2	of	of	IN
cord-023095-4dannjjm	1244	3	skeletal	skeletal	JJ
cord-023095-4dannjjm	1244	4	muscle	muscle	NN
cord-023095-4dannjjm	1244	5	,	,	,
cord-023095-4dannjjm	1244	6	and	and	CC
cord-023095-4dannjjm	1244	7	subcutaneous	subcutaneous	JJ
cord-023095-4dannjjm	1244	8	and	and	CC
cord-023095-4dannjjm	1244	9	visceral	visceral	JJ
cord-023095-4dannjjm	1244	10	adipose	adipose	JJ
cord-023095-4dannjjm	1244	11	tissue	tissue	NN
cord-023095-4dannjjm	1244	12	were	be	VBD
cord-023095-4dannjjm	1244	13	collected	collect	VBN
cord-023095-4dannjjm	1244	14	from	from	IN
cord-023095-4dannjjm	1244	15	light	light	JJ
cord-023095-4dannjjm	1244	16	-	-	HYPH
cord-023095-4dannjjm	1244	17	breed	breed	NN
cord-023095-4dannjjm	1244	18	horses	horse	NNS
cord-023095-4dannjjm	1244	19	,	,	,
cord-023095-4dannjjm	1244	20	characterized	characterize	VBN
cord-023095-4dannjjm	1244	21	as	as	IN
cord-023095-4dannjjm	1244	22	either	either	DT
cord-023095-4dannjjm	1244	23	insulin	insulin	NN
cord-023095-4dannjjm	1244	24	sensitive	sensitive	JJ
cord-023095-4dannjjm	1244	25	or	or	CC
cord-023095-4dannjjm	1244	26	compensated	compensate	VBN
cord-023095-4dannjjm	1244	27	IR	IR	NNP
cord-023095-4dannjjm	1244	28	,	,	,
cord-023095-4dannjjm	1244	29	based	base	VBN
cord-023095-4dannjjm	1244	30	on	on	IN
cord-023095-4dannjjm	1244	31	the	the	DT
cord-023095-4dannjjm	1244	32	results	result	NNS
cord-023095-4dannjjm	1244	33	of	of	IN
cord-023095-4dannjjm	1244	34	an	an	DT
cord-023095-4dannjjm	1244	35	insulin	insulin	NN
cord-023095-4dannjjm	1244	36	-	-	HYPH
cord-023095-4dannjjm	1244	37	modified	modify	VBN
cord-023095-4dannjjm	1244	38	frequently	frequently	RB
cord-023095-4dannjjm	1244	39	-	-	HYPH
cord-023095-4dannjjm	1244	40	sampled	sample	VBN
cord-023095-4dannjjm	1244	41	intravenous	intravenous	JJ
cord-023095-4dannjjm	1244	42	glucose	glucose	NN
cord-023095-4dannjjm	1244	43	tolerance	tolerance	NN
cord-023095-4dannjjm	1244	44	test	test	NN
cord-023095-4dannjjm	1244	45	(	(	-LRB-
cord-023095-4dannjjm	1244	46	n	n	NN
cord-023095-4dannjjm	1244	47	5	5	CD
cord-023095-4dannjjm	1244	48	5	5	CD
cord-023095-4dannjjm	1244	49	/	/	SYM
cord-023095-4dannjjm	1244	50	group	group	NN
cord-023095-4dannjjm	1244	51	)	)	-RRB-
cord-023095-4dannjjm	1244	52	.	.	.
cord-023095-4dannjjm	1245	1	We	-PRON-	PRP
cord-023095-4dannjjm	1245	2	specifically	specifically	RB
cord-023095-4dannjjm	1245	3	quantified	quantify	VBD
cord-023095-4dannjjm	1245	4	active	active	JJ
cord-023095-4dannjjm	1245	5	cell	cell	NN
cord-023095-4dannjjm	1245	6	-	-	HYPH
cord-023095-4dannjjm	1245	7	surface	surface	NN
cord-023095-4dannjjm	1245	8	GLUT12	glut12	RB
cord-023095-4dannjjm	1245	9	in	in	IN
cord-023095-4dannjjm	1245	10	these	these	DT
cord-023095-4dannjjm	1245	11	biopsies	biopsy	NNS
cord-023095-4dannjjm	1245	12	,	,	,
cord-023095-4dannjjm	1245	13	using	use	VBG
cord-023095-4dannjjm	1245	14	an	an	DT
cord-023095-4dannjjm	1245	15	innovative	innovative	JJ
cord-023095-4dannjjm	1245	16	exofacial	exofacial	JJ
cord-023095-4dannjjm	1245	17	bismannose	bismannose	NN
cord-023095-4dannjjm	1245	18	photolabeled	photolabeled	JJ
cord-023095-4dannjjm	1245	19	assay	assay	NN
cord-023095-4dannjjm	1245	20	,	,	,
cord-023095-4dannjjm	1245	21	which	which	WDT
cord-023095-4dannjjm	1245	22	has	have	VBZ
cord-023095-4dannjjm	1245	23	not	not	RB
cord-023095-4dannjjm	1245	24	been	be	VBN
cord-023095-4dannjjm	1245	25	previously	previously	RB
cord-023095-4dannjjm	1245	26	applied	apply	VBN
cord-023095-4dannjjm	1245	27	to	to	IN
cord-023095-4dannjjm	1245	28	GLUT12	GLUT12	NNP
cord-023095-4dannjjm	1245	29	.	.	.
cord-023095-4dannjjm	1246	1	Total	total	JJ
cord-023095-4dannjjm	1247	1	GLUT12	glut12	RB
cord-023095-4dannjjm	1247	2	protein	protein	NN
cord-023095-4dannjjm	1247	3	expression	expression	NN
cord-023095-4dannjjm	1247	4	was	be	VBD
cord-023095-4dannjjm	1247	5	measured	measure	VBN
cord-023095-4dannjjm	1247	6	by	by	IN
cord-023095-4dannjjm	1247	7	Western	western	JJ
cord-023095-4dannjjm	1247	8	blots	blot	NNS
cord-023095-4dannjjm	1247	9	,	,	,
cord-023095-4dannjjm	1247	10	as	as	RB
cord-023095-4dannjjm	1247	11	well	well	RB
cord-023095-4dannjjm	1247	12	as	as	IN
cord-023095-4dannjjm	1247	13	total	total	JJ
cord-023095-4dannjjm	1247	14	and	and	CC
cord-023095-4dannjjm	1247	15	phosphorylated	phosphorylated	JJ
cord-023095-4dannjjm	1247	16	(	(	-LRB-
cord-023095-4dannjjm	1247	17	indicating	indicate	VBG
cord-023095-4dannjjm	1247	18	activation	activation	NN
cord-023095-4dannjjm	1247	19	of	of	IN
cord-023095-4dannjjm	1247	20	)	)	-RRB-
cord-023095-4dannjjm	1248	1	AS160	AS160	NNP
cord-023095-4dannjjm	1248	2	.	.	.
cord-023095-4dannjjm	1249	1	GLUT12	GLUT12	NNP
cord-023095-4dannjjm	1249	2	was	be	VBD
cord-023095-4dannjjm	1249	3	expressed	express	VBN
cord-023095-4dannjjm	1249	4	in	in	IN
cord-023095-4dannjjm	1249	5	all	all	PDT
cord-023095-4dannjjm	1249	6	the	the	DT
cord-023095-4dannjjm	1249	7	depots	depot	NNS
cord-023095-4dannjjm	1249	8	with	with	IN
cord-023095-4dannjjm	1249	9	a	a	DT
cord-023095-4dannjjm	1249	10	significant	significant	JJ
cord-023095-4dannjjm	1249	11	regional	regional	JJ
cord-023095-4dannjjm	1249	12	effect	effect	NN
cord-023095-4dannjjm	1249	13	.	.	.
cord-023095-4dannjjm	1250	1	Total	total	JJ
cord-023095-4dannjjm	1250	2	GLUT12	GLUT12	NNP
cord-023095-4dannjjm	1250	3	protein	protein	NN
cord-023095-4dannjjm	1250	4	content	content	NN
cord-023095-4dannjjm	1250	5	was	be	VBD
cord-023095-4dannjjm	1250	6	increased	increase	VBN
cord-023095-4dannjjm	1250	7	(	(	-LRB-
cord-023095-4dannjjm	1250	8	P	p	NN
cord-023095-4dannjjm	1250	9	o	o	NN
cord-023095-4dannjjm	1250	10	0.05	0.05	CD
cord-023095-4dannjjm	1250	11	)	)	-RRB-
cord-023095-4dannjjm	1250	12	in	in	IN
cord-023095-4dannjjm	1250	13	visceral	visceral	JJ
cord-023095-4dannjjm	1250	14	(	(	-LRB-
cord-023095-4dannjjm	1250	15	omental	omental	JJ
cord-023095-4dannjjm	1250	16	and	and	CC
cord-023095-4dannjjm	1250	17	mesenteric	mesenteric	JJ
cord-023095-4dannjjm	1250	18	)	)	-RRB-
cord-023095-4dannjjm	1250	19	compared	compare	VBN
cord-023095-4dannjjm	1250	20	to	to	IN
cord-023095-4dannjjm	1250	21	subcutaneous	subcutaneous	JJ
cord-023095-4dannjjm	1250	22	(	(	-LRB-
cord-023095-4dannjjm	1250	23	nuchal	nuchal	JJ
cord-023095-4dannjjm	1250	24	ligament	ligament	NN
cord-023095-4dannjjm	1250	25	and	and	CC
cord-023095-4dannjjm	1250	26	tailhead	tailhead	NN
cord-023095-4dannjjm	1250	27	)	)	-RRB-
cord-023095-4dannjjm	1250	28	adipose	adipose	JJ
cord-023095-4dannjjm	1250	29	tissue	tissue	NN
cord-023095-4dannjjm	1250	30	and	and	CC
cord-023095-4dannjjm	1250	31	skeletal	skeletal	JJ
cord-023095-4dannjjm	1250	32	muscle	muscle	NN
cord-023095-4dannjjm	1250	33	of	of	IN
cord-023095-4dannjjm	1250	34	healthy	healthy	JJ
cord-023095-4dannjjm	1250	35	horses	horse	NNS
cord-023095-4dannjjm	1250	36	.	.	.
cord-023095-4dannjjm	1251	1	IR	IR	NNP
cord-023095-4dannjjm	1251	2	did	do	VBD
cord-023095-4dannjjm	1251	3	not	not	RB
cord-023095-4dannjjm	1251	4	induce	induce	VB
cord-023095-4dannjjm	1251	5	alterations	alteration	NNS
cord-023095-4dannjjm	1251	6	in	in	IN
cord-023095-4dannjjm	1251	7	active	active	JJ
cord-023095-4dannjjm	1251	8	cell	cell	NN
cord-023095-4dannjjm	1251	9	-	-	HYPH
cord-023095-4dannjjm	1251	10	surface	surface	NN
cord-023095-4dannjjm	1251	11	and	and	CC
cord-023095-4dannjjm	1251	12	total	total	NN
cord-023095-4dannjjm	1251	13	GLUT12	GLUT12	NNP
cord-023095-4dannjjm	1251	14	content	content	NN
cord-023095-4dannjjm	1251	15	nor	nor	CC
cord-023095-4dannjjm	1251	16	in	in	IN
cord-023095-4dannjjm	1251	17	total	total	JJ
cord-023095-4dannjjm	1251	18	and	and	CC
cord-023095-4dannjjm	1251	19	phosphorylated	phosphorylated	JJ
cord-023095-4dannjjm	1251	20	AS160	as160	NN
cord-023095-4dannjjm	1251	21	in	in	IN
cord-023095-4dannjjm	1251	22	any	any	DT
cord-023095-4dannjjm	1251	23	of	of	IN
cord-023095-4dannjjm	1251	24	the	the	DT
cord-023095-4dannjjm	1251	25	tissues	tissue	NNS
cord-023095-4dannjjm	1251	26	evaluated	evaluate	VBN
cord-023095-4dannjjm	1251	27	.	.	.
cord-023095-4dannjjm	1252	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	1252	2	data	data	NN
cord-023095-4dannjjm	1252	3	suggests	suggest	VBZ
cord-023095-4dannjjm	1252	4	that	that	IN
cord-023095-4dannjjm	1252	5	GLUT12	GLUT12	NNP
cord-023095-4dannjjm	1252	6	is	be	VBZ
cord-023095-4dannjjm	1252	7	abundant	abundant	JJ
cord-023095-4dannjjm	1252	8	in	in	IN
cord-023095-4dannjjm	1252	9	visceral	visceral	JJ
cord-023095-4dannjjm	1252	10	adipose	adipose	JJ
cord-023095-4dannjjm	1252	11	tissue	tissue	NN
cord-023095-4dannjjm	1252	12	and	and	CC
cord-023095-4dannjjm	1252	13	is	be	VBZ
cord-023095-4dannjjm	1252	14	therefore	therefore	RB
cord-023095-4dannjjm	1252	15	likely	likely	JJ
cord-023095-4dannjjm	1252	16	to	to	TO
cord-023095-4dannjjm	1252	17	play	play	VB
cord-023095-4dannjjm	1252	18	a	a	DT
cord-023095-4dannjjm	1252	19	substantial	substantial	JJ
cord-023095-4dannjjm	1252	20	role	role	NN
cord-023095-4dannjjm	1252	21	in	in	IN
cord-023095-4dannjjm	1252	22	the	the	DT
cord-023095-4dannjjm	1252	23	regulation	regulation	NN
cord-023095-4dannjjm	1252	24	of	of	IN
cord-023095-4dannjjm	1252	25	glucose	glucose	NN
cord-023095-4dannjjm	1252	26	transport	transport	NN
cord-023095-4dannjjm	1252	27	.	.	.
cord-023095-4dannjjm	1253	1	However	however	RB
cord-023095-4dannjjm	1253	2	,	,	,
cord-023095-4dannjjm	1253	3	neither	neither	CC
cord-023095-4dannjjm	1253	4	GLUT12	GLUT12	NNP
cord-023095-4dannjjm	1253	5	translocation	translocation	NN
cord-023095-4dannjjm	1253	6	nor	nor	CC
cord-023095-4dannjjm	1253	7	AS160	as160	CD
cord-023095-4dannjjm	1253	8	activation	activation	NN
cord-023095-4dannjjm	1253	9	are	be	VBP
cord-023095-4dannjjm	1253	10	impaired	impair	VBN
cord-023095-4dannjjm	1253	11	in	in	IN
cord-023095-4dannjjm	1253	12	insulin	insulin	NN
cord-023095-4dannjjm	1253	13	-	-	HYPH
cord-023095-4dannjjm	1253	14	sensitive	sensitive	JJ
cord-023095-4dannjjm	1253	15	tissues	tissue	NNS
cord-023095-4dannjjm	1253	16	of	of	IN
cord-023095-4dannjjm	1253	17	IR	IR	NNP
cord-023095-4dannjjm	1253	18	horses	horse	NNS
cord-023095-4dannjjm	1253	19	.	.	.
cord-023095-4dannjjm	1254	1	It	-PRON-	PRP
cord-023095-4dannjjm	1254	2	is	be	VBZ
cord-023095-4dannjjm	1254	3	concluded	conclude	VBN
cord-023095-4dannjjm	1254	4	that	that	IN
cord-023095-4dannjjm	1254	5	,	,	,
cord-023095-4dannjjm	1254	6	in	in	IN
cord-023095-4dannjjm	1254	7	contrast	contrast	NN
cord-023095-4dannjjm	1254	8	with	with	IN
cord-023095-4dannjjm	1254	9	GLUT4	GLUT4	NNP
cord-023095-4dannjjm	1254	10	,	,	,
cord-023095-4dannjjm	1254	11	GLUT12	GLUT12	NNP
cord-023095-4dannjjm	1254	12	does	do	VBZ
cord-023095-4dannjjm	1254	13	not	not	RB
cord-023095-4dannjjm	1254	14	appear	appear	VB
cord-023095-4dannjjm	1254	15	to	to	TO
cord-023095-4dannjjm	1254	16	contribute	contribute	VB
cord-023095-4dannjjm	1254	17	to	to	IN
cord-023095-4dannjjm	1254	18	glucose	glucose	NN
cord-023095-4dannjjm	1254	19	transport	transport	NN
cord-023095-4dannjjm	1254	20	alterations	alteration	NNS
cord-023095-4dannjjm	1254	21	during	during	IN
cord-023095-4dannjjm	1254	22	naturally	naturally	RB
cord-023095-4dannjjm	1254	23	-	-	HYPH
cord-023095-4dannjjm	1254	24	occurring	occur	VBG
cord-023095-4dannjjm	1254	25	equine	equine	NN
cord-023095-4dannjjm	1254	26	IR	IR	NNP
cord-023095-4dannjjm	1254	27	.	.	.
cord-023095-4dannjjm	1255	1	Insulin	insulin	NN
cord-023095-4dannjjm	1255	2	resistance	resistance	NN
cord-023095-4dannjjm	1255	3	(	(	-LRB-
cord-023095-4dannjjm	1255	4	IR	IR	NNP
cord-023095-4dannjjm	1255	5	)	)	-RRB-
cord-023095-4dannjjm	1255	6	,	,	,
cord-023095-4dannjjm	1255	7	characterized	characterize	VBN
cord-023095-4dannjjm	1255	8	by	by	IN
cord-023095-4dannjjm	1255	9	exaggerated	exaggerated	JJ
cord-023095-4dannjjm	1255	10	glycemic	glycemic	NNP
cord-023095-4dannjjm	1255	11	or	or	CC
cord-023095-4dannjjm	1255	12	insulinemic	insulinemic	NNP
cord-023095-4dannjjm	1255	13	responses	response	NNS
cord-023095-4dannjjm	1255	14	to	to	IN
cord-023095-4dannjjm	1255	15	glucose	glucose	NN
cord-023095-4dannjjm	1255	16	challenge	challenge	NN
cord-023095-4dannjjm	1255	17	,	,	,
cord-023095-4dannjjm	1255	18	is	be	VBZ
cord-023095-4dannjjm	1255	19	a	a	DT
cord-023095-4dannjjm	1255	20	key	key	JJ
cord-023095-4dannjjm	1255	21	metabolic	metabolic	JJ
cord-023095-4dannjjm	1255	22	disturbance	disturbance	NN
cord-023095-4dannjjm	1255	23	in	in	IN
cord-023095-4dannjjm	1255	24	horses	horse	NNS
cord-023095-4dannjjm	1255	25	that	that	WDT
cord-023095-4dannjjm	1255	26	develop	develop	VBP
cord-023095-4dannjjm	1255	27	obesity	obesity	NN
cord-023095-4dannjjm	1255	28	-	-	HYPH
cord-023095-4dannjjm	1255	29	associated	associate	VBN
cord-023095-4dannjjm	1255	30	laminitis	laminitis	NN
cord-023095-4dannjjm	1255	31	.	.	.
cord-023095-4dannjjm	1256	1	In	in	IN
cord-023095-4dannjjm	1256	2	addition	addition	NN
cord-023095-4dannjjm	1256	3	to	to	IN
cord-023095-4dannjjm	1256	4	obesity	obesity	NN
cord-023095-4dannjjm	1256	5	,	,	,
cord-023095-4dannjjm	1256	6	diet	diet	NN
cord-023095-4dannjjm	1256	7	and	and	CC
cord-023095-4dannjjm	1256	8	age	age	NN
cord-023095-4dannjjm	1256	9	have	have	VBP
cord-023095-4dannjjm	1256	10	been	be	VBN
cord-023095-4dannjjm	1256	11	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	1256	12	to	to	TO
cord-023095-4dannjjm	1256	13	affect	affect	VB
cord-023095-4dannjjm	1256	14	tissue	tissue	NN
cord-023095-4dannjjm	1256	15	sensitivity	sensitivity	NN
cord-023095-4dannjjm	1256	16	to	to	IN
cord-023095-4dannjjm	1256	17	insulin	insulin	NN
cord-023095-4dannjjm	1256	18	in	in	IN
cord-023095-4dannjjm	1256	19	other	other	JJ
cord-023095-4dannjjm	1256	20	species	specie	NNS
cord-023095-4dannjjm	1256	21	but	but	CC
cord-023095-4dannjjm	1256	22	these	these	DT
cord-023095-4dannjjm	1256	23	factors	factor	NNS
cord-023095-4dannjjm	1256	24	have	have	VBP
cord-023095-4dannjjm	1256	25	received	receive	VBN
cord-023095-4dannjjm	1256	26	limited	limited	JJ
cord-023095-4dannjjm	1256	27	investigation	investigation	NN
cord-023095-4dannjjm	1256	28	in	in	IN
cord-023095-4dannjjm	1256	29	horses	horse	NNS
cord-023095-4dannjjm	1256	30	.	.	.
cord-023095-4dannjjm	1257	1	We	-PRON-	PRP
cord-023095-4dannjjm	1257	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1257	3	that	that	IN
cord-023095-4dannjjm	1257	4	there	there	EX
cord-023095-4dannjjm	1257	5	would	would	MD
cord-023095-4dannjjm	1257	6	be	be	VB
cord-023095-4dannjjm	1257	7	greater	great	JJR
cord-023095-4dannjjm	1257	8	glycemic	glycemic	NNP
cord-023095-4dannjjm	1257	9	and	and	CC
cord-023095-4dannjjm	1257	10	insulinemic	insulinemic	NNP
cord-023095-4dannjjm	1257	11	responses	response	NNS
cord-023095-4dannjjm	1257	12	to	to	IN
cord-023095-4dannjjm	1257	13	a	a	DT
cord-023095-4dannjjm	1257	14	sweet	sweet	JJ
cord-023095-4dannjjm	1257	15	feed	feed	NN
cord-023095-4dannjjm	1257	16	meal	meal	NN
cord-023095-4dannjjm	1257	17	in	in	IN
cord-023095-4dannjjm	1257	18	aged	aged	JJ
cord-023095-4dannjjm	1257	19	horses	horse	NNS
cord-023095-4dannjjm	1257	20	,	,	,
cord-023095-4dannjjm	1257	21	as	as	IN
cord-023095-4dannjjm	1257	22	compared	compare	VBN
cord-023095-4dannjjm	1257	23	to	to	IN
cord-023095-4dannjjm	1257	24	adult	adult	NN
cord-023095-4dannjjm	1257	25	horses	horse	NNS
cord-023095-4dannjjm	1257	26	,	,	,
cord-023095-4dannjjm	1257	27	as	as	RB
cord-023095-4dannjjm	1257	28	well	well	RB
cord-023095-4dannjjm	1257	29	as	as	IN
cord-023095-4dannjjm	1257	30	in	in	IN
cord-023095-4dannjjm	1257	31	horses	horse	NNS
cord-023095-4dannjjm	1257	32	adapted	adapt	VBN
cord-023095-4dannjjm	1257	33	to	to	IN
cord-023095-4dannjjm	1257	34	a	a	DT
cord-023095-4dannjjm	1257	35	forage	forage	NN
cord-023095-4dannjjm	1257	36	-	-	HYPH
cord-023095-4dannjjm	1257	37	only	only	JJ
cord-023095-4dannjjm	1257	38	diet	diet	NN
cord-023095-4dannjjm	1257	39	.	.	.
cord-023095-4dannjjm	1258	1	Three	three	CD
cord-023095-4dannjjm	1258	2	diets	diet	NNS
cord-023095-4dannjjm	1258	3	,	,	,
cord-023095-4dannjjm	1258	4	grass	grass	NN
cord-023095-4dannjjm	1258	5	hay	hay	NN
cord-023095-4dannjjm	1258	6	only	only	RB
cord-023095-4dannjjm	1258	7	,	,	,
cord-023095-4dannjjm	1258	8	grass	grass	NN
cord-023095-4dannjjm	1258	9	hay	hay	NN
cord-023095-4dannjjm	1258	10	plus	plus	CC
cord-023095-4dannjjm	1258	11	sweet	sweet	JJ
cord-023095-4dannjjm	1258	12	feed	feed	NN
cord-023095-4dannjjm	1258	13	(	(	-LRB-
cord-023095-4dannjjm	1258	14	starch	starch	NN
cord-023095-4dannjjm	1258	15	and	and	CC
cord-023095-4dannjjm	1258	16	sugar	sugar	NN
cord-023095-4dannjjm	1258	17	-	-	HYPH
cord-023095-4dannjjm	1258	18	rich	rich	JJ
cord-023095-4dannjjm	1258	19	,	,	,
cord-023095-4dannjjm	1258	20	SS	SS	NNP
cord-023095-4dannjjm	1258	21	)	)	-RRB-
cord-023095-4dannjjm	1258	22	,	,	,
cord-023095-4dannjjm	1258	23	and	and	CC
cord-023095-4dannjjm	1258	24	grass	grass	NN
cord-023095-4dannjjm	1258	25	hay	hay	NN
cord-023095-4dannjjm	1258	26	plus	plus	CC
cord-023095-4dannjjm	1258	27	a	a	DT
cord-023095-4dannjjm	1258	28	fat	fat	NN
cord-023095-4dannjjm	1258	29	and	and	CC
cord-023095-4dannjjm	1258	30	fiber	fiber	NN
cord-023095-4dannjjm	1258	31	(	(	-LRB-
cord-023095-4dannjjm	1258	32	FF	ff	NN
cord-023095-4dannjjm	1258	33	)	)	-RRB-
cord-023095-4dannjjm	1258	34	feed	feed	NN
cord-023095-4dannjjm	1258	35	,	,	,
cord-023095-4dannjjm	1258	36	were	be	VBD
cord-023095-4dannjjm	1258	37	fed	feed	VBN
cord-023095-4dannjjm	1258	38	to	to	IN
cord-023095-4dannjjm	1258	39	17	17	CD
cord-023095-4dannjjm	1258	40	mares	mare	NNS
cord-023095-4dannjjm	1258	41	,	,	,
cord-023095-4dannjjm	1258	42	8	8	CD
cord-023095-4dannjjm	1258	43	adult	adult	NN
cord-023095-4dannjjm	1258	44	(	(	-LRB-
cord-023095-4dannjjm	1258	45	5	5	CD
cord-023095-4dannjjm	1258	46	-	-	SYM
cord-023095-4dannjjm	1258	47	12	12	CD
cord-023095-4dannjjm	1258	48	yr	yr	NN
cord-023095-4dannjjm	1258	49	)	)	-RRB-
cord-023095-4dannjjm	1258	50	and	and	CC
cord-023095-4dannjjm	1258	51	9	9	CD
cord-023095-4dannjjm	1258	52	aged	aged	JJ
cord-023095-4dannjjm	1258	53	(	(	-LRB-
cord-023095-4dannjjm	1258	54	4	4	CD
cord-023095-4dannjjm	1258	55	19	19	CD
cord-023095-4dannjjm	1258	56	yr	yr	NNS
cord-023095-4dannjjm	1258	57	)	)	-RRB-
cord-023095-4dannjjm	1258	58	,	,	,
cord-023095-4dannjjm	1258	59	for	for	IN
cord-023095-4dannjjm	1258	60	a	a	DT
cord-023095-4dannjjm	1258	61	6-week	6-week	JJ
cord-023095-4dannjjm	1258	62	adaptation	adaptation	NN
cord-023095-4dannjjm	1258	63	period	period	NN
cord-023095-4dannjjm	1258	64	in	in	IN
cord-023095-4dannjjm	1258	65	a	a	DT
cord-023095-4dannjjm	1258	66	randomized	randomized	JJ
cord-023095-4dannjjm	1258	67	design	design	NN
cord-023095-4dannjjm	1258	68	.	.	.
cord-023095-4dannjjm	1259	1	Glycemic	Glycemic	NNP
cord-023095-4dannjjm	1259	2	and	and	CC
cord-023095-4dannjjm	1259	3	insulinemic	insulinemic	NN
cord-023095-4dannjjm	1259	4	responses	response	NNS
cord-023095-4dannjjm	1259	5	to	to	IN
cord-023095-4dannjjm	1259	6	a	a	DT
cord-023095-4dannjjm	1259	7	standardized	standardized	JJ
cord-023095-4dannjjm	1259	8	meal	meal	NN
cord-023095-4dannjjm	1259	9	of	of	IN
cord-023095-4dannjjm	1259	10	sweet	sweet	JJ
cord-023095-4dannjjm	1259	11	feed	feed	NN
cord-023095-4dannjjm	1259	12	(	(	-LRB-
cord-023095-4dannjjm	1259	13	4	4	CD
cord-023095-4dannjjm	1259	14	g	g	NN
cord-023095-4dannjjm	1259	15	/	/	SYM
cord-023095-4dannjjm	1259	16	kg	kg	NNP
cord-023095-4dannjjm	1259	17	BW	BW	NNP
cord-023095-4dannjjm	1259	18	offered	offer	VBD
cord-023095-4dannjjm	1259	19	for	for	IN
cord-023095-4dannjjm	1259	20	1	1	CD
cord-023095-4dannjjm	1259	21	hour	hour	NN
cord-023095-4dannjjm	1259	22	)	)	-RRB-
cord-023095-4dannjjm	1259	23	were	be	VBD
cord-023095-4dannjjm	1259	24	determined	determine	VBN
cord-023095-4dannjjm	1259	25	for	for	IN
cord-023095-4dannjjm	1259	26	6	6	CD
cord-023095-4dannjjm	1259	27	hours	hour	NNS
cord-023095-4dannjjm	1259	28	from	from	IN
cord-023095-4dannjjm	1259	29	the	the	DT
cord-023095-4dannjjm	1259	30	onset	onset	NN
cord-023095-4dannjjm	1259	31	of	of	IN
cord-023095-4dannjjm	1259	32	feeding	feeding	NN
cord-023095-4dannjjm	1259	33	.	.	.
cord-023095-4dannjjm	1260	1	Peak	peak	NN
cord-023095-4dannjjm	1260	2	glucose	glucose	NN
cord-023095-4dannjjm	1260	3	and	and	CC
cord-023095-4dannjjm	1260	4	insulin	insulin	NN
cord-023095-4dannjjm	1260	5	concentrations	concentration	NNS
cord-023095-4dannjjm	1260	6	and	and	CC
cord-023095-4dannjjm	1260	7	areas	area	NNS
cord-023095-4dannjjm	1260	8	under	under	IN
cord-023095-4dannjjm	1260	9	the	the	DT
cord-023095-4dannjjm	1260	10	glucose	glucose	NN
cord-023095-4dannjjm	1260	11	or	or	CC
cord-023095-4dannjjm	1260	12	insulin	insulin	NN
cord-023095-4dannjjm	1260	13	vs.	vs.	IN
cord-023095-4dannjjm	1260	14	time	time	NN
cord-023095-4dannjjm	1260	15	curves	curve	NNS
cord-023095-4dannjjm	1260	16	(	(	-LRB-
cord-023095-4dannjjm	1260	17	AUC	AUC	NNP
cord-023095-4dannjjm	1260	18	-	-	HYPH
cord-023095-4dannjjm	1260	19	G	G	NNP
cord-023095-4dannjjm	1260	20	,	,	,
cord-023095-4dannjjm	1260	21	mg/	mg/	NN
cord-023095-4dannjjm	1260	22	dl/360	dl/360	NNP
cord-023095-4dannjjm	1260	23	min	min	NNP
cord-023095-4dannjjm	1260	24	,	,	,
cord-023095-4dannjjm	1260	25	and	and	CC
cord-023095-4dannjjm	1260	26	AUC	AUC	NNP
cord-023095-4dannjjm	1260	27	-	-	HYPH
cord-023095-4dannjjm	1260	28	I	I	NNP
cord-023095-4dannjjm	1260	29	,	,	,
cord-023095-4dannjjm	1260	30	mU	mU	NNP
cord-023095-4dannjjm	1260	31	/	/	SYM
cord-023095-4dannjjm	1260	32	ml/360	ml/360	NNPS
cord-023095-4dannjjm	1260	33	min	min	NNP
cord-023095-4dannjjm	1260	34	)	)	-RRB-
cord-023095-4dannjjm	1260	35	were	be	VBD
cord-023095-4dannjjm	1260	36	determined	determine	VBN
cord-023095-4dannjjm	1260	37	and	and	CC
cord-023095-4dannjjm	1260	38	data	datum	NNS
cord-023095-4dannjjm	1260	39	were	be	VBD
cord-023095-4dannjjm	1260	40	analyzed	analyze	VBN
cord-023095-4dannjjm	1260	41	by	by	IN
cord-023095-4dannjjm	1260	42	one	one	CD
cord-023095-4dannjjm	1260	43	-	-	HYPH
cord-023095-4dannjjm	1260	44	and	and	CC
cord-023095-4dannjjm	1260	45	two	two	CD
cord-023095-4dannjjm	1260	46	-	-	HYPH
cord-023095-4dannjjm	1260	47	factor	factor	NN
cord-023095-4dannjjm	1260	48	repeated	repeat	VBD
cord-023095-4dannjjm	1260	49	measures	measure	NNS
cord-023095-4dannjjm	1260	50	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	1260	51	.	.	.
cord-023095-4dannjjm	1261	1	There	there	EX
cord-023095-4dannjjm	1261	2	were	be	VBD
cord-023095-4dannjjm	1261	3	no	no	DT
cord-023095-4dannjjm	1261	4	differences	difference	NNS
cord-023095-4dannjjm	1261	5	between	between	IN
cord-023095-4dannjjm	1261	6	age	age	NN
cord-023095-4dannjjm	1261	7	groups	group	NNS
cord-023095-4dannjjm	1261	8	in	in	IN
cord-023095-4dannjjm	1261	9	glycemic	glycemic	JJ
cord-023095-4dannjjm	1261	10	responses	response	NNS
cord-023095-4dannjjm	1261	11	to	to	IN
cord-023095-4dannjjm	1261	12	any	any	DT
cord-023095-4dannjjm	1261	13	of	of	IN
cord-023095-4dannjjm	1261	14	the	the	DT
cord-023095-4dannjjm	1261	15	diets	diet	NNS
cord-023095-4dannjjm	1261	16	.	.	.
cord-023095-4dannjjm	1262	1	However	however	RB
cord-023095-4dannjjm	1262	2	,	,	,
cord-023095-4dannjjm	1262	3	in	in	IN
cord-023095-4dannjjm	1262	4	aged	aged	JJ
cord-023095-4dannjjm	1262	5	horses	horse	NNS
cord-023095-4dannjjm	1262	6	peak	peak	VBP
cord-023095-4dannjjm	1262	7	glucose	glucose	NN
cord-023095-4dannjjm	1262	8	concentration	concentration	NN
cord-023095-4dannjjm	1262	9	(	(	-LRB-
cord-023095-4dannjjm	1262	10	p	p	NN
cord-023095-4dannjjm	1262	11	o	o	NN
cord-023095-4dannjjm	1262	12	0.03	0.03	CD
cord-023095-4dannjjm	1262	13	)	)	-RRB-
cord-023095-4dannjjm	1262	14	and	and	CC
cord-023095-4dannjjm	1262	15	AUC	AUC	NNP
cord-023095-4dannjjm	1262	16	-	-	HYPH
cord-023095-4dannjjm	1262	17	G	G	NNP
cord-023095-4dannjjm	1262	18	(	(	-LRB-
cord-023095-4dannjjm	1262	19	p	p	NN
cord-023095-4dannjjm	1262	20	o	o	NN
cord-023095-4dannjjm	1262	21	0.01	0.01	CD
cord-023095-4dannjjm	1262	22	)	)	-RRB-
cord-023095-4dannjjm	1262	23	were	be	VBD
cord-023095-4dannjjm	1262	24	greater	great	JJR
cord-023095-4dannjjm	1262	25	after	after	IN
cord-023095-4dannjjm	1262	26	adaptation	adaptation	NN
cord-023095-4dannjjm	1262	27	to	to	IN
cord-023095-4dannjjm	1262	28	the	the	DT
cord-023095-4dannjjm	1262	29	forage	forage	NN
cord-023095-4dannjjm	1262	30	-	-	HYPH
cord-023095-4dannjjm	1262	31	only	only	RB
cord-023095-4dannjjm	1262	32	diet	diet	NN
cord-023095-4dannjjm	1262	33	,	,	,
cord-023095-4dannjjm	1262	34	as	as	IN
cord-023095-4dannjjm	1262	35	compared	compare	VBN
cord-023095-4dannjjm	1262	36	to	to	IN
cord-023095-4dannjjm	1262	37	the	the	DT
cord-023095-4dannjjm	1262	38	other	other	JJ
cord-023095-4dannjjm	1262	39	two	two	CD
cord-023095-4dannjjm	1262	40	diets	diet	NNS
cord-023095-4dannjjm	1262	41	.	.	.
cord-023095-4dannjjm	1263	1	In	in	IN
cord-023095-4dannjjm	1263	2	contrast	contrast	NN
cord-023095-4dannjjm	1263	3	,	,	,
cord-023095-4dannjjm	1263	4	aged	aged	JJ
cord-023095-4dannjjm	1263	5	horses	horse	NNS
cord-023095-4dannjjm	1263	6	had	have	VBD
cord-023095-4dannjjm	1263	7	a	a	DT
cord-023095-4dannjjm	1263	8	greater	great	JJR
cord-023095-4dannjjm	1263	9	peak	peak	NN
cord-023095-4dannjjm	1263	10	insulin	insulin	NN
cord-023095-4dannjjm	1263	11	concentration	concentration	NN
cord-023095-4dannjjm	1263	12	(	(	-LRB-
cord-023095-4dannjjm	1263	13	p	p	NN
cord-023095-4dannjjm	1263	14	o	o	NN
cord-023095-4dannjjm	1263	15	0.05	0.05	CD
cord-023095-4dannjjm	1263	16	)	)	-RRB-
cord-023095-4dannjjm	1263	17	and	and	CC
cord-023095-4dannjjm	1263	18	AUC	AUC	NNP
cord-023095-4dannjjm	1263	19	-	-	HYPH
cord-023095-4dannjjm	1263	20	I	I	NNP
cord-023095-4dannjjm	1263	21	(	(	-LRB-
cord-023095-4dannjjm	1263	22	p	p	NN
cord-023095-4dannjjm	1263	23	o	o	NN
cord-023095-4dannjjm	1263	24	0.03	0.03	CD
cord-023095-4dannjjm	1263	25	)	)	-RRB-
cord-023095-4dannjjm	1263	26	than	than	IN
cord-023095-4dannjjm	1263	27	adult	adult	NN
cord-023095-4dannjjm	1263	28	horses	horse	NNS
cord-023095-4dannjjm	1263	29	on	on	IN
cord-023095-4dannjjm	1263	30	all	all	DT
cord-023095-4dannjjm	1263	31	diets	diet	NNS
cord-023095-4dannjjm	1263	32	but	but	CC
cord-023095-4dannjjm	1263	33	no	no	DT
cord-023095-4dannjjm	1263	34	differences	difference	NNS
cord-023095-4dannjjm	1263	35	in	in	IN
cord-023095-4dannjjm	1263	36	peak	peak	JJ
cord-023095-4dannjjm	1263	37	insulin	insulin	NN
cord-023095-4dannjjm	1263	38	concentration	concentration	NN
cord-023095-4dannjjm	1263	39	or	or	CC
cord-023095-4dannjjm	1263	40	AUC	AUC	NNP
cord-023095-4dannjjm	1263	41	-	-	:
cord-023095-4dannjjm	1263	42	I	-PRON-	PRP
cord-023095-4dannjjm	1263	43	was	be	VBD
cord-023095-4dannjjm	1263	44	found	find	VBN
cord-023095-4dannjjm	1263	45	between	between	IN
cord-023095-4dannjjm	1263	46	diets	diet	NNS
cord-023095-4dannjjm	1263	47	within	within	IN
cord-023095-4dannjjm	1263	48	age	age	NN
cord-023095-4dannjjm	1263	49	groups	group	NNS
cord-023095-4dannjjm	1263	50	.	.	.
cord-023095-4dannjjm	1264	1	As	as	IN
cord-023095-4dannjjm	1264	2	hypothesized	hypothesize	VBN
cord-023095-4dannjjm	1264	3	,	,	,
cord-023095-4dannjjm	1264	4	the	the	DT
cord-023095-4dannjjm	1264	5	insulin	insulin	NN
cord-023095-4dannjjm	1264	6	response	response	NN
cord-023095-4dannjjm	1264	7	,	,	,
cord-023095-4dannjjm	1264	8	but	but	CC
cord-023095-4dannjjm	1264	9	not	not	RB
cord-023095-4dannjjm	1264	10	the	the	DT
cord-023095-4dannjjm	1264	11	glycemic	glycemic	JJ
cord-023095-4dannjjm	1264	12	response	response	NN
cord-023095-4dannjjm	1264	13	,	,	,
cord-023095-4dannjjm	1264	14	to	to	IN
cord-023095-4dannjjm	1264	15	a	a	DT
cord-023095-4dannjjm	1264	16	sweet	sweet	JJ
cord-023095-4dannjjm	1264	17	feed	feed	NN
cord-023095-4dannjjm	1264	18	meal	meal	NN
cord-023095-4dannjjm	1264	19	was	be	VBD
cord-023095-4dannjjm	1264	20	greater	great	JJR
cord-023095-4dannjjm	1264	21	in	in	IN
cord-023095-4dannjjm	1264	22	aged	aged	JJ
cord-023095-4dannjjm	1264	23	horses	horse	NNS
cord-023095-4dannjjm	1264	24	,	,	,
cord-023095-4dannjjm	1264	25	regardless	regardless	RB
cord-023095-4dannjjm	1264	26	of	of	IN
cord-023095-4dannjjm	1264	27	background	background	NN
cord-023095-4dannjjm	1264	28	diet	diet	NN
cord-023095-4dannjjm	1264	29	.	.	.
cord-023095-4dannjjm	1265	1	Further	further	RB
cord-023095-4dannjjm	1265	2	,	,	,
cord-023095-4dannjjm	1265	3	the	the	DT
cord-023095-4dannjjm	1265	4	glycemic	glycemic	JJ
cord-023095-4dannjjm	1265	5	response	response	NN
cord-023095-4dannjjm	1265	6	was	be	VBD
cord-023095-4dannjjm	1265	7	greatest	great	JJS
cord-023095-4dannjjm	1265	8	after	after	IN
cord-023095-4dannjjm	1265	9	adaptation	adaptation	NN
cord-023095-4dannjjm	1265	10	to	to	IN
cord-023095-4dannjjm	1265	11	a	a	DT
cord-023095-4dannjjm	1265	12	forage	forage	NN
cord-023095-4dannjjm	1265	13	-	-	HYPH
cord-023095-4dannjjm	1265	14	only	only	RB
cord-023095-4dannjjm	1265	15	diet	diet	NN
cord-023095-4dannjjm	1265	16	,	,	,
cord-023095-4dannjjm	1265	17	but	but	CC
cord-023095-4dannjjm	1265	18	this	this	DT
cord-023095-4dannjjm	1265	19	finding	finding	NN
cord-023095-4dannjjm	1265	20	was	be	VBD
cord-023095-4dannjjm	1265	21	only	only	RB
cord-023095-4dannjjm	1265	22	significant	significant	JJ
cord-023095-4dannjjm	1265	23	in	in	IN
cord-023095-4dannjjm	1265	24	aged	aged	JJ
cord-023095-4dannjjm	1265	25	horses	horse	NNS
cord-023095-4dannjjm	1265	26	.	.	.
cord-023095-4dannjjm	1266	1	morbidity	morbidity	NN
cord-023095-4dannjjm	1266	2	,	,	,
cord-023095-4dannjjm	1266	3	mortality	mortality	NN
cord-023095-4dannjjm	1266	4	,	,	,
cord-023095-4dannjjm	1266	5	and	and	CC
cord-023095-4dannjjm	1266	6	economic	economic	JJ
cord-023095-4dannjjm	1266	7	loss	loss	NN
cord-023095-4dannjjm	1266	8	to	to	IN
cord-023095-4dannjjm	1266	9	the	the	DT
cord-023095-4dannjjm	1266	10	equine	equine	NN
cord-023095-4dannjjm	1266	11	industry	industry	NN
cord-023095-4dannjjm	1266	12	.	.	.
cord-023095-4dannjjm	1267	1	In	in	IN
cord-023095-4dannjjm	1267	2	obese	obese	JJ
cord-023095-4dannjjm	1267	3	humans	human	NNS
cord-023095-4dannjjm	1267	4	and	and	CC
cord-023095-4dannjjm	1267	5	rodent	rodent	NN
cord-023095-4dannjjm	1267	6	models	model	NNS
cord-023095-4dannjjm	1267	7	of	of	IN
cord-023095-4dannjjm	1267	8	nutritional	nutritional	JJ
cord-023095-4dannjjm	1267	9	obesity	obesity	NN
cord-023095-4dannjjm	1267	10	,	,	,
cord-023095-4dannjjm	1267	11	systemic	systemic	JJ
cord-023095-4dannjjm	1267	12	insulin	insulin	NN
cord-023095-4dannjjm	1267	13	resistance	resistance	NN
cord-023095-4dannjjm	1267	14	and	and	CC
cord-023095-4dannjjm	1267	15	hyperinsulinemia	hyperinsulinemia	NN
cord-023095-4dannjjm	1267	16	are	be	VBP
cord-023095-4dannjjm	1267	17	followed	follow	VBN
cord-023095-4dannjjm	1267	18	temporally	temporally	RB
cord-023095-4dannjjm	1267	19	in	in	IN
cord-023095-4dannjjm	1267	20	a	a	DT
cord-023095-4dannjjm	1267	21	majority	majority	NN
cord-023095-4dannjjm	1267	22	of	of	IN
cord-023095-4dannjjm	1267	23	individuals	individual	NNS
cord-023095-4dannjjm	1267	24	by	by	IN
cord-023095-4dannjjm	1267	25	decreased	decrease	VBD
cord-023095-4dannjjm	1267	26	glucose	glucose	NN
cord-023095-4dannjjm	1267	27	tolerance	tolerance	NN
cord-023095-4dannjjm	1267	28	,	,	,
cord-023095-4dannjjm	1267	29	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	1267	30	bcell	bcell	NN
cord-023095-4dannjjm	1267	31	failure	failure	NN
cord-023095-4dannjjm	1267	32	,	,	,
cord-023095-4dannjjm	1267	33	and	and	CC
cord-023095-4dannjjm	1267	34	type	type	NN
cord-023095-4dannjjm	1267	35	II	ii	CD
cord-023095-4dannjjm	1267	36	diabetes	diabetes	NN
cord-023095-4dannjjm	1267	37	mellitus	mellitus	NN
cord-023095-4dannjjm	1267	38	.	.	.
cord-023095-4dannjjm	1268	1	In	in	IN
cord-023095-4dannjjm	1268	2	stark	stark	JJ
cord-023095-4dannjjm	1268	3	contrast	contrast	NN
cord-023095-4dannjjm	1268	4	to	to	IN
cord-023095-4dannjjm	1268	5	humans	human	NNS
cord-023095-4dannjjm	1268	6	,	,	,
cord-023095-4dannjjm	1268	7	obese	obese	JJ
cord-023095-4dannjjm	1268	8	horses	horse	NNS
cord-023095-4dannjjm	1268	9	and	and	CC
cord-023095-4dannjjm	1268	10	ponies	pony	NNS
cord-023095-4dannjjm	1268	11	chronically	chronically	RB
cord-023095-4dannjjm	1268	12	remain	remain	VBP
cord-023095-4dannjjm	1268	13	in	in	IN
cord-023095-4dannjjm	1268	14	what	what	WP
cord-023095-4dannjjm	1268	15	is	be	VBZ
cord-023095-4dannjjm	1268	16	termed	term	VBN
cord-023095-4dannjjm	1268	17	a	a	DT
cord-023095-4dannjjm	1268	18	'	'	``
cord-023095-4dannjjm	1268	19	'	'	``
cord-023095-4dannjjm	1268	20	prediabetic	prediabetic	JJ
cord-023095-4dannjjm	1268	21	'	'	''
cord-023095-4dannjjm	1268	22	'	'	''
cord-023095-4dannjjm	1268	23	state	state	NN
cord-023095-4dannjjm	1268	24	in	in	IN
cord-023095-4dannjjm	1268	25	human	human	JJ
cord-023095-4dannjjm	1268	26	IR	IR	NNP
cord-023095-4dannjjm	1268	27	,	,	,
cord-023095-4dannjjm	1268	28	characterized	characterize	VBN
cord-023095-4dannjjm	1268	29	by	by	IN
cord-023095-4dannjjm	1268	30	hyperinsulinemic	hyperinsulinemic	NNP
cord-023095-4dannjjm	1268	31	euglycemia	euglycemia	NNP
cord-023095-4dannjjm	1268	32	.	.	.
cord-023095-4dannjjm	1269	1	Few	few	JJ
cord-023095-4dannjjm	1269	2	data	datum	NNS
cord-023095-4dannjjm	1269	3	exist	exist	VBP
cord-023095-4dannjjm	1269	4	describing	describe	VBG
cord-023095-4dannjjm	1269	5	the	the	DT
cord-023095-4dannjjm	1269	6	biology	biology	NN
cord-023095-4dannjjm	1269	7	of	of	IN
cord-023095-4dannjjm	1269	8	the	the	DT
cord-023095-4dannjjm	1269	9	equine	equine	JJ
cord-023095-4dannjjm	1269	10	endocrine	endocrine	JJ
cord-023095-4dannjjm	1269	11	pancreas	pancrea	NNS
cord-023095-4dannjjm	1269	12	in	in	IN
cord-023095-4dannjjm	1269	13	the	the	DT
cord-023095-4dannjjm	1269	14	chronically	chronically	RB
cord-023095-4dannjjm	1269	15	IR	IR	NNP
cord-023095-4dannjjm	1269	16	animal	animal	NN
cord-023095-4dannjjm	1269	17	that	that	WDT
cord-023095-4dannjjm	1269	18	may	may	MD
cord-023095-4dannjjm	1269	19	both	both	DT
cord-023095-4dannjjm	1269	20	:	:	:
cord-023095-4dannjjm	1269	21	1	1	LS
cord-023095-4dannjjm	1269	22	)	)	-RRB-
cord-023095-4dannjjm	1269	23	explain	explain	VB
cord-023095-4dannjjm	1269	24	this	this	DT
cord-023095-4dannjjm	1269	25	unique	unique	JJ
cord-023095-4dannjjm	1269	26	equine	equine	JJ
cord-023095-4dannjjm	1269	27	endocrine	endocrine	JJ
cord-023095-4dannjjm	1269	28	physiology	physiology	NN
cord-023095-4dannjjm	1269	29	and	and	CC
cord-023095-4dannjjm	1269	30	2	2	LS
cord-023095-4dannjjm	1269	31	)	)	-RRB-
cord-023095-4dannjjm	1269	32	characterize	characterize	VB
cord-023095-4dannjjm	1269	33	the	the	DT
cord-023095-4dannjjm	1269	34	animal	animal	NN
cord-023095-4dannjjm	1269	35	at	at	IN
cord-023095-4dannjjm	1269	36	-	-	HYPH
cord-023095-4dannjjm	1269	37	risk	risk	NN
cord-023095-4dannjjm	1269	38	for	for	IN
cord-023095-4dannjjm	1269	39	hyperinsulinemia	hyperinsulinemia	NN
cord-023095-4dannjjm	1269	40	-	-	HYPH
cord-023095-4dannjjm	1269	41	associated	associate	VBN
cord-023095-4dannjjm	1269	42	laminitis	laminitis	NN
cord-023095-4dannjjm	1269	43	.	.	.
cord-023095-4dannjjm	1270	1	The	the	DT
cord-023095-4dannjjm	1270	2	purpose	purpose	NN
cord-023095-4dannjjm	1270	3	of	of	IN
cord-023095-4dannjjm	1270	4	the	the	DT
cord-023095-4dannjjm	1270	5	study	study	NN
cord-023095-4dannjjm	1270	6	reported	report	VBN
cord-023095-4dannjjm	1270	7	here	here	RB
cord-023095-4dannjjm	1270	8	was	be	VBD
cord-023095-4dannjjm	1270	9	to	to	TO
cord-023095-4dannjjm	1270	10	characterize	characterize	VB
cord-023095-4dannjjm	1270	11	the	the	DT
cord-023095-4dannjjm	1270	12	morphology	morphology	NN
cord-023095-4dannjjm	1270	13	and	and	CC
cord-023095-4dannjjm	1270	14	physiology	physiology	NN
cord-023095-4dannjjm	1270	15	of	of	IN
cord-023095-4dannjjm	1270	16	the	the	DT
cord-023095-4dannjjm	1270	17	equine	equine	JJ
cord-023095-4dannjjm	1270	18	endocrine	endocrine	JJ
cord-023095-4dannjjm	1270	19	pancreas	pancrea	NNS
cord-023095-4dannjjm	1270	20	in	in	IN
cord-023095-4dannjjm	1270	21	response	response	NN
cord-023095-4dannjjm	1270	22	to	to	IN
cord-023095-4dannjjm	1270	23	a	a	DT
cord-023095-4dannjjm	1270	24	dietary	dietary	JJ
cord-023095-4dannjjm	1270	25	carbohydrate	carbohydrate	NN
cord-023095-4dannjjm	1270	26	challenge	challenge	NN
cord-023095-4dannjjm	1270	27	.	.	.
cord-023095-4dannjjm	1271	1	Twenty	twenty	CD
cord-023095-4dannjjm	1271	2	-	-	HYPH
cord-023095-4dannjjm	1271	3	two	two	CD
cord-023095-4dannjjm	1271	4	mixedbreed	mixedbreed	NN
cord-023095-4dannjjm	1271	5	ponies	pony	NNS
cord-023095-4dannjjm	1271	6	(	(	-LRB-
cord-023095-4dannjjm	1271	7	body	body	NN
cord-023095-4dannjjm	1271	8	weight	weight	NN
cord-023095-4dannjjm	1272	1	266.6	266.6	CD
cord-023095-4dannjjm	1272	2	AE	AE	NNP
cord-023095-4dannjjm	1272	3	170.5	170.5	CD
cord-023095-4dannjjm	1272	4	kg	kg	NNP
cord-023095-4dannjjm	1272	5	)	)	-RRB-
cord-023095-4dannjjm	1272	6	were	be	VBD
cord-023095-4dannjjm	1272	7	conditioned	condition	VBN
cord-023095-4dannjjm	1272	8	to	to	IN
cord-023095-4dannjjm	1272	9	a	a	DT
cord-023095-4dannjjm	1272	10	diet	diet	NN
cord-023095-4dannjjm	1272	11	of	of	IN
cord-023095-4dannjjm	1272	12	chopped	chop	VBN
cord-023095-4dannjjm	1272	13	hay	hay	NN
cord-023095-4dannjjm	1272	14	(	(	-LRB-
cord-023095-4dannjjm	1272	15	NSC	NSC	NNP
cord-023095-4dannjjm	1272	16	$	$	$
cord-023095-4dannjjm	1272	17	6	6	CD
cord-023095-4dannjjm	1272	18	%	%	NN
cord-023095-4dannjjm	1272	19	on	on	IN
cord-023095-4dannjjm	1272	20	DM	DM	NNP
cord-023095-4dannjjm	1272	21	basis	basis	NN
cord-023095-4dannjjm	1272	22	)	)	-RRB-
cord-023095-4dannjjm	1272	23	for	for	IN
cord-023095-4dannjjm	1272	24	4	4	CD
cord-023095-4dannjjm	1272	25	weeks	week	NNS
cord-023095-4dannjjm	1272	26	;	;	:
cord-023095-4dannjjm	1272	27	following	follow	VBG
cord-023095-4dannjjm	1272	28	conditioning	conditioning	NN
cord-023095-4dannjjm	1272	29	,	,	,
cord-023095-4dannjjm	1272	30	ponies	pony	NNS
cord-023095-4dannjjm	1272	31	either	either	CC
cord-023095-4dannjjm	1272	32	remained	remain	VBD
cord-023095-4dannjjm	1272	33	on	on	IN
cord-023095-4dannjjm	1272	34	the	the	DT
cord-023095-4dannjjm	1272	35	control	control	NN
cord-023095-4dannjjm	1272	36	diet	diet	NN
cord-023095-4dannjjm	1272	37	(	(	-LRB-
cord-023095-4dannjjm	1272	38	n	n	NN
cord-023095-4dannjjm	1272	39	5	5	CD
cord-023095-4dannjjm	1272	40	11	11	CD
cord-023095-4dannjjm	1272	41	)	)	-RRB-
cord-023095-4dannjjm	1272	42	,	,	,
cord-023095-4dannjjm	1272	43	or	or	CC
cord-023095-4dannjjm	1272	44	received	receive	VBD
cord-023095-4dannjjm	1272	45	the	the	DT
cord-023095-4dannjjm	1272	46	same	same	JJ
cord-023095-4dannjjm	1272	47	hay	hay	NN
cord-023095-4dannjjm	1272	48	supplemented	supplement	VBN
cord-023095-4dannjjm	1272	49	with	with	IN
cord-023095-4dannjjm	1272	50	sweet	sweet	JJ
cord-023095-4dannjjm	1272	51	feed	feed	NN
cord-023095-4dannjjm	1272	52	and	and	CC
cord-023095-4dannjjm	1272	53	oligofructose	oligofructose	JJ
cord-023095-4dannjjm	1272	54	(	(	-LRB-
cord-023095-4dannjjm	1272	55	total	total	JJ
cord-023095-4dannjjm	1272	56	diet	diet	NN
cord-023095-4dannjjm	1272	57	$	$	$
cord-023095-4dannjjm	1272	58	42	42	CD
cord-023095-4dannjjm	1272	59	%	%	NN
cord-023095-4dannjjm	1272	60	NSC	NSC	NNP
cord-023095-4dannjjm	1272	61	;	;	:
cord-023095-4dannjjm	1272	62	n	n	NN
cord-023095-4dannjjm	1272	63	5	5	CD
cord-023095-4dannjjm	1272	64	11	11	CD
cord-023095-4dannjjm	1272	65	)	)	-RRB-
cord-023095-4dannjjm	1272	66	for	for	IN
cord-023095-4dannjjm	1272	67	7	7	CD
cord-023095-4dannjjm	1272	68	days	day	NNS
cord-023095-4dannjjm	1272	69	.	.	.
cord-023095-4dannjjm	1273	1	Serum	serum	NN
cord-023095-4dannjjm	1273	2	insulin	insulin	NN
cord-023095-4dannjjm	1273	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1273	4	were	be	VBD
cord-023095-4dannjjm	1273	5	measured	measure	VBN
cord-023095-4dannjjm	1273	6	prior	prior	RB
cord-023095-4dannjjm	1273	7	to	to	IN
cord-023095-4dannjjm	1273	8	and	and	CC
cord-023095-4dannjjm	1273	9	after	after	IN
cord-023095-4dannjjm	1273	10	completion	completion	NN
cord-023095-4dannjjm	1273	11	of	of	IN
cord-023095-4dannjjm	1273	12	the	the	DT
cord-023095-4dannjjm	1273	13	feeding	feeding	NN
cord-023095-4dannjjm	1273	14	protocol	protocol	NN
cord-023095-4dannjjm	1273	15	.	.	.
cord-023095-4dannjjm	1274	1	At	at	IN
cord-023095-4dannjjm	1274	2	the	the	DT
cord-023095-4dannjjm	1274	3	end	end	NN
cord-023095-4dannjjm	1274	4	of	of	IN
cord-023095-4dannjjm	1274	5	the	the	DT
cord-023095-4dannjjm	1274	6	feeding	feeding	NN
cord-023095-4dannjjm	1274	7	protocol	protocol	NN
cord-023095-4dannjjm	1274	8	,	,	,
cord-023095-4dannjjm	1274	9	sections	section	NNS
cord-023095-4dannjjm	1274	10	of	of	IN
cord-023095-4dannjjm	1274	11	numerous	numerous	JJ
cord-023095-4dannjjm	1274	12	tissues	tissue	NNS
cord-023095-4dannjjm	1274	13	,	,	,
cord-023095-4dannjjm	1274	14	including	include	VBG
cord-023095-4dannjjm	1274	15	pancreas	pancrea	NNS
cord-023095-4dannjjm	1274	16	,	,	,
cord-023095-4dannjjm	1274	17	were	be	VBD
cord-023095-4dannjjm	1274	18	collected	collect	VBN
cord-023095-4dannjjm	1274	19	immediately	immediately	RB
cord-023095-4dannjjm	1274	20	following	follow	VBG
cord-023095-4dannjjm	1274	21	euthanasia	euthanasia	NN
cord-023095-4dannjjm	1274	22	.	.	.
cord-023095-4dannjjm	1275	1	The	the	DT
cord-023095-4dannjjm	1275	2	samples	sample	NNS
cord-023095-4dannjjm	1275	3	were	be	VBD
cord-023095-4dannjjm	1275	4	formalin	formalin	NN
cord-023095-4dannjjm	1275	5	-	-	HYPH
cord-023095-4dannjjm	1275	6	fixed	fix	VBN
cord-023095-4dannjjm	1275	7	for	for	IN
cord-023095-4dannjjm	1275	8	48	48	CD
cord-023095-4dannjjm	1275	9	hours	hour	NNS
cord-023095-4dannjjm	1275	10	,	,	,
cord-023095-4dannjjm	1275	11	transferred	transfer	VBN
cord-023095-4dannjjm	1275	12	to	to	IN
cord-023095-4dannjjm	1275	13	70	70	CD
cord-023095-4dannjjm	1275	14	%	%	NN
cord-023095-4dannjjm	1275	15	ethanol	ethanol	NN
cord-023095-4dannjjm	1275	16	,	,	,
cord-023095-4dannjjm	1275	17	and	and	CC
cord-023095-4dannjjm	1275	18	paraffin	paraffin	NN
cord-023095-4dannjjm	1275	19	-	-	HYPH
cord-023095-4dannjjm	1275	20	embedded	embed	VBN
cord-023095-4dannjjm	1275	21	.	.	.
cord-023095-4dannjjm	1276	1	Immunohistochemistry	Immunohistochemistry	NNP
cord-023095-4dannjjm	1276	2	was	be	VBD
cord-023095-4dannjjm	1276	3	performed	perform	VBN
cord-023095-4dannjjm	1276	4	on	on	IN
cord-023095-4dannjjm	1276	5	pancreas	pancreas	NN
cord-023095-4dannjjm	1276	6	sections	section	NNS
cord-023095-4dannjjm	1276	7	using	use	VBG
cord-023095-4dannjjm	1276	8	a	a	DT
cord-023095-4dannjjm	1276	9	commerciallyavailable	commerciallyavailable	JJ
cord-023095-4dannjjm	1276	10	anti	anti	JJ
cord-023095-4dannjjm	1276	11	-	-	JJ
cord-023095-4dannjjm	1276	12	insulin	insulin	JJ
cord-023095-4dannjjm	1276	13	antibody	antibody	NN
cord-023095-4dannjjm	1276	14	(	(	-LRB-
cord-023095-4dannjjm	1276	15	Abcam	Abcam	NNP
cord-023095-4dannjjm	1276	16	)	)	-RRB-
cord-023095-4dannjjm	1276	17	,	,	,
cord-023095-4dannjjm	1276	18	and	and	CC
cord-023095-4dannjjm	1276	19	measurements	measurement	NNS
cord-023095-4dannjjm	1276	20	of	of	IN
cord-023095-4dannjjm	1276	21	islet	islet	NN
cord-023095-4dannjjm	1276	22	surface	surface	NN
cord-023095-4dannjjm	1276	23	area	area	NN
cord-023095-4dannjjm	1276	24	and	and	CC
cord-023095-4dannjjm	1276	25	b	b	NN
cord-023095-4dannjjm	1276	26	-	-	HYPH
cord-023095-4dannjjm	1276	27	cell	cell	NN
cord-023095-4dannjjm	1276	28	surface	surface	NN
cord-023095-4dannjjm	1276	29	area	area	NN
cord-023095-4dannjjm	1276	30	were	be	VBD
cord-023095-4dannjjm	1276	31	performed	perform	VBN
cord-023095-4dannjjm	1276	32	(	(	-LRB-
cord-023095-4dannjjm	1276	33	n	n	NN
cord-023095-4dannjjm	1276	34	5	5	CD
cord-023095-4dannjjm	1276	35	10	10	CD
cord-023095-4dannjjm	1276	36	islets	islet	NNS
cord-023095-4dannjjm	1276	37	per	per	IN
cord-023095-4dannjjm	1276	38	tissue	tissue	NN
cord-023095-4dannjjm	1276	39	section	section	NN
cord-023095-4dannjjm	1276	40	)	)	-RRB-
cord-023095-4dannjjm	1276	41	using	use	VBG
cord-023095-4dannjjm	1276	42	a	a	DT
cord-023095-4dannjjm	1276	43	commercially	commercially	RB
cord-023095-4dannjjm	1276	44	-	-	HYPH
cord-023095-4dannjjm	1276	45	available	available	JJ
cord-023095-4dannjjm	1276	46	computer	computer	NN
cord-023095-4dannjjm	1276	47	software	software	NN
cord-023095-4dannjjm	1276	48	program	program	NN
cord-023095-4dannjjm	1276	49	(	(	-LRB-
cord-023095-4dannjjm	1276	50	Image	Image	NNP
cord-023095-4dannjjm	1276	51	J	J	NNP
cord-023095-4dannjjm	1276	52	)	)	-RRB-
cord-023095-4dannjjm	1276	53	.	.	.
cord-023095-4dannjjm	1277	1	There	there	EX
cord-023095-4dannjjm	1277	2	was	be	VBD
cord-023095-4dannjjm	1277	3	a	a	DT
cord-023095-4dannjjm	1277	4	trend	trend	NN
cord-023095-4dannjjm	1277	5	for	for	IN
cord-023095-4dannjjm	1277	6	greater	great	JJR
cord-023095-4dannjjm	1277	7	total	total	JJ
cord-023095-4dannjjm	1277	8	islet	islet	NN
cord-023095-4dannjjm	1277	9	surface	surface	NN
cord-023095-4dannjjm	1277	10	area	area	NN
cord-023095-4dannjjm	1277	11	in	in	IN
cord-023095-4dannjjm	1277	12	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	1277	13	tissue	tissue	NN
cord-023095-4dannjjm	1277	14	from	from	IN
cord-023095-4dannjjm	1277	15	ponies	pony	NNS
cord-023095-4dannjjm	1277	16	fed	feed	VBD
cord-023095-4dannjjm	1277	17	the	the	DT
cord-023095-4dannjjm	1277	18	high	high	JJ
cord-023095-4dannjjm	1277	19	NSC	NSC	NNP
cord-023095-4dannjjm	1277	20	diet	diet	NN
cord-023095-4dannjjm	1277	21	when	when	WRB
cord-023095-4dannjjm	1277	22	compared	compare	VBN
cord-023095-4dannjjm	1277	23	to	to	IN
cord-023095-4dannjjm	1277	24	the	the	DT
cord-023095-4dannjjm	1277	25	ponies	pony	NNS
cord-023095-4dannjjm	1277	26	on	on	IN
cord-023095-4dannjjm	1277	27	the	the	DT
cord-023095-4dannjjm	1277	28	hay	hay	NN
cord-023095-4dannjjm	1277	29	diet	diet	NN
cord-023095-4dannjjm	1277	30	(	(	-LRB-
cord-023095-4dannjjm	1277	31	p	p	NN
cord-023095-4dannjjm	1277	32	5	5	CD
cord-023095-4dannjjm	1277	33	0.068	0.068	CD
cord-023095-4dannjjm	1277	34	)	)	-RRB-
cord-023095-4dannjjm	1277	35	;	;	:
cord-023095-4dannjjm	1277	36	however	however	RB
cord-023095-4dannjjm	1277	37	,	,	,
cord-023095-4dannjjm	1277	38	no	no	DT
cord-023095-4dannjjm	1277	39	difference	difference	NN
cord-023095-4dannjjm	1277	40	was	be	VBD
cord-023095-4dannjjm	1277	41	noted	note	VBN
cord-023095-4dannjjm	1277	42	in	in	IN
cord-023095-4dannjjm	1277	43	b	b	NN
cord-023095-4dannjjm	1277	44	-	-	HYPH
cord-023095-4dannjjm	1277	45	cell	cell	NN
cord-023095-4dannjjm	1277	46	surface	surface	NN
cord-023095-4dannjjm	1277	47	area	area	NN
cord-023095-4dannjjm	1277	48	between	between	IN
cord-023095-4dannjjm	1277	49	diet	diet	NN
cord-023095-4dannjjm	1277	50	treatments	treatment	NNS
cord-023095-4dannjjm	1277	51	(	(	-LRB-
cord-023095-4dannjjm	1277	52	p	p	NN
cord-023095-4dannjjm	1277	53	5	5	CD
cord-023095-4dannjjm	1277	54	0.12	0.12	CD
cord-023095-4dannjjm	1277	55	)	)	-RRB-
cord-023095-4dannjjm	1277	56	.	.	.
cord-023095-4dannjjm	1278	1	The	the	DT
cord-023095-4dannjjm	1278	2	change	change	NN
cord-023095-4dannjjm	1278	3	in	in	IN
cord-023095-4dannjjm	1278	4	serum	serum	NN
cord-023095-4dannjjm	1278	5	insulin	insulin	NN
cord-023095-4dannjjm	1278	6	concentration	concentration	NN
cord-023095-4dannjjm	1278	7	was	be	VBD
cord-023095-4dannjjm	1278	8	significantly	significantly	RB
cord-023095-4dannjjm	1278	9	greater	great	JJR
cord-023095-4dannjjm	1278	10	in	in	IN
cord-023095-4dannjjm	1278	11	the	the	DT
cord-023095-4dannjjm	1278	12	high	high	JJ
cord-023095-4dannjjm	1278	13	NSC	NSC	NNP
cord-023095-4dannjjm	1278	14	-	-	HYPH
cord-023095-4dannjjm	1278	15	fed	fed	NNP
cord-023095-4dannjjm	1278	16	ponies	pony	NNS
cord-023095-4dannjjm	1278	17	than	than	IN
cord-023095-4dannjjm	1278	18	in	in	IN
cord-023095-4dannjjm	1278	19	controls	control	NNS
cord-023095-4dannjjm	1278	20	(	(	-LRB-
cord-023095-4dannjjm	1278	21	403.8	403.8	CD
cord-023095-4dannjjm	1278	22	1/-317.1	1/-317.1	CD
cord-023095-4dannjjm	1278	23	mIU	mIU	NNP
cord-023095-4dannjjm	1278	24	/	/	SYM
cord-023095-4dannjjm	1278	25	L	l	NN
cord-023095-4dannjjm	1278	26	vs.	vs.	IN
cord-023095-4dannjjm	1278	27	1.00	1.00	CD
cord-023095-4dannjjm	1278	28	1	1	CD
cord-023095-4dannjjm	1278	29	/	/	SYM
cord-023095-4dannjjm	1278	30	À	à	NN
cord-023095-4dannjjm	1278	31	4.03	4.03	CD
cord-023095-4dannjjm	1278	32	mIU	mIU	NNP
cord-023095-4dannjjm	1278	33	/	/	SYM
cord-023095-4dannjjm	1278	34	L	l	NN
cord-023095-4dannjjm	1278	35	;	;	:
cord-023095-4dannjjm	1278	36	p	p	NN
cord-023095-4dannjjm	1278	37	5	5	CD
cord-023095-4dannjjm	1278	38	0.002	0.002	CD
cord-023095-4dannjjm	1278	39	)	)	-RRB-
cord-023095-4dannjjm	1278	40	;	;	:
cord-023095-4dannjjm	1278	41	however	however	RB
cord-023095-4dannjjm	1278	42	,	,	,
cord-023095-4dannjjm	1278	43	this	this	DT
cord-023095-4dannjjm	1278	44	variable	variable	NN
cord-023095-4dannjjm	1278	45	was	be	VBD
cord-023095-4dannjjm	1278	46	not	not	RB
cord-023095-4dannjjm	1278	47	correlated	correlate	VBN
cord-023095-4dannjjm	1278	48	with	with	IN
cord-023095-4dannjjm	1278	49	total	total	JJ
cord-023095-4dannjjm	1278	50	islet	islet	NN
cord-023095-4dannjjm	1278	51	surface	surface	NN
cord-023095-4dannjjm	1278	52	area	area	NN
cord-023095-4dannjjm	1278	53	(	(	-LRB-
cord-023095-4dannjjm	1278	54	r	r	NN
cord-023095-4dannjjm	1278	55	5	5	CD
cord-023095-4dannjjm	1278	56	0.32	0.32	CD
cord-023095-4dannjjm	1278	57	;	;	:
cord-023095-4dannjjm	1278	58	p	p	NN
cord-023095-4dannjjm	1278	59	5	5	CD
cord-023095-4dannjjm	1278	60	0.17	0.17	CD
cord-023095-4dannjjm	1278	61	)	)	-RRB-
cord-023095-4dannjjm	1278	62	or	or	CC
cord-023095-4dannjjm	1278	63	b	b	NN
cord-023095-4dannjjm	1278	64	-	-	HYPH
cord-023095-4dannjjm	1278	65	cell	cell	NN
cord-023095-4dannjjm	1278	66	surface	surface	NN
cord-023095-4dannjjm	1278	67	area	area	NN
cord-023095-4dannjjm	1278	68	(	(	-LRB-
cord-023095-4dannjjm	1278	69	r	r	NN
cord-023095-4dannjjm	1278	70	5	5	CD
cord-023095-4dannjjm	1278	71	0.25	0.25	CD
cord-023095-4dannjjm	1278	72	;	;	:
cord-023095-4dannjjm	1278	73	p	p	NN
cord-023095-4dannjjm	1278	74	5	5	CD
cord-023095-4dannjjm	1278	75	0.3	0.3	CD
cord-023095-4dannjjm	1278	76	)	)	-RRB-
cord-023095-4dannjjm	1278	77	.	.	.
cord-023095-4dannjjm	1279	1	Due	due	IN
cord-023095-4dannjjm	1279	2	to	to	IN
cord-023095-4dannjjm	1279	3	the	the	DT
cord-023095-4dannjjm	1279	4	relatively	relatively	RB
cord-023095-4dannjjm	1279	5	modest	modest	JJ
cord-023095-4dannjjm	1279	6	changes	change	NNS
cord-023095-4dannjjm	1279	7	in	in	IN
cord-023095-4dannjjm	1279	8	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	1279	9	islet	islet	NN
cord-023095-4dannjjm	1279	10	surface	surface	NN
cord-023095-4dannjjm	1279	11	area	area	NN
cord-023095-4dannjjm	1279	12	that	that	WDT
cord-023095-4dannjjm	1279	13	accompany	accompany	VBP
cord-023095-4dannjjm	1279	14	marked	marked	JJ
cord-023095-4dannjjm	1279	15	increases	increase	NNS
cord-023095-4dannjjm	1279	16	in	in	IN
cord-023095-4dannjjm	1279	17	serum	serum	NN
cord-023095-4dannjjm	1279	18	insulin	insulin	NN
cord-023095-4dannjjm	1279	19	concentrations	concentration	NNS
cord-023095-4dannjjm	1279	20	in	in	IN
cord-023095-4dannjjm	1279	21	ponies	pony	NNS
cord-023095-4dannjjm	1279	22	fed	feed	VBD
cord-023095-4dannjjm	1279	23	a	a	DT
cord-023095-4dannjjm	1279	24	high	high	JJ
cord-023095-4dannjjm	1279	25	NSC	NSC	NNP
cord-023095-4dannjjm	1279	26	diet	diet	NN
cord-023095-4dannjjm	1279	27	,	,	,
cord-023095-4dannjjm	1279	28	it	-PRON-	PRP
cord-023095-4dannjjm	1279	29	is	be	VBZ
cord-023095-4dannjjm	1279	30	important	important	JJ
cord-023095-4dannjjm	1279	31	to	to	TO
cord-023095-4dannjjm	1279	32	assess	assess	VB
cord-023095-4dannjjm	1279	33	both	both	DT
cord-023095-4dannjjm	1279	34	b	b	NN
cord-023095-4dannjjm	1279	35	-	-	HYPH
cord-023095-4dannjjm	1279	36	cell	cell	NN
cord-023095-4dannjjm	1279	37	function	function	NN
cord-023095-4dannjjm	1279	38	and	and	CC
cord-023095-4dannjjm	1279	39	insulin	insulin	NN
cord-023095-4dannjjm	1279	40	clearance	clearance	NN
cord-023095-4dannjjm	1279	41	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1279	42	in	in	IN
cord-023095-4dannjjm	1279	43	future	future	JJ
cord-023095-4dannjjm	1279	44	studies	study	NNS
cord-023095-4dannjjm	1279	45	to	to	TO
cord-023095-4dannjjm	1279	46	delineate	delineate	VB
cord-023095-4dannjjm	1279	47	the	the	DT
cord-023095-4dannjjm	1279	48	mechanism(s	mechanism(s	NNP
cord-023095-4dannjjm	1279	49	)	)	-RRB-
cord-023095-4dannjjm	1279	50	of	of	IN
cord-023095-4dannjjm	1279	51	hyperinsulinemia	hyperinsulinemia	NN
cord-023095-4dannjjm	1279	52	in	in	IN
cord-023095-4dannjjm	1279	53	this	this	DT
cord-023095-4dannjjm	1279	54	model	model	NN
cord-023095-4dannjjm	1279	55	.	.	.
cord-023095-4dannjjm	1280	1	Humans	human	NNS
cord-023095-4dannjjm	1280	2	that	that	WDT
cord-023095-4dannjjm	1280	3	suffer	suffer	VBP
cord-023095-4dannjjm	1280	4	from	from	IN
cord-023095-4dannjjm	1280	5	obesity	obesity	NN
cord-023095-4dannjjm	1280	6	show	show	NN
cord-023095-4dannjjm	1280	7	exaggerated	exaggerate	VBD
cord-023095-4dannjjm	1280	8	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1280	9	responses	response	NNS
cord-023095-4dannjjm	1280	10	and	and	CC
cord-023095-4dannjjm	1280	11	this	this	DT
cord-023095-4dannjjm	1280	12	may	may	MD
cord-023095-4dannjjm	1280	13	be	be	VB
cord-023095-4dannjjm	1280	14	relevant	relevant	JJ
cord-023095-4dannjjm	1280	15	to	to	IN
cord-023095-4dannjjm	1280	16	the	the	DT
cord-023095-4dannjjm	1280	17	association	association	NN
cord-023095-4dannjjm	1280	18	between	between	IN
cord-023095-4dannjjm	1280	19	increased	increase	VBN
cord-023095-4dannjjm	1280	20	adiposity	adiposity	NN
cord-023095-4dannjjm	1280	21	and	and	CC
cord-023095-4dannjjm	1280	22	laminitis	laminitis	NN
cord-023095-4dannjjm	1280	23	in	in	IN
cord-023095-4dannjjm	1280	24	horses	horse	NNS
cord-023095-4dannjjm	1280	25	with	with	IN
cord-023095-4dannjjm	1280	26	Equine	equine	JJ
cord-023095-4dannjjm	1280	27	Metabolic	Metabolic	NNP
cord-023095-4dannjjm	1280	28	Syndrome	Syndrome	NNP
cord-023095-4dannjjm	1280	29	(	(	-LRB-
cord-023095-4dannjjm	1280	30	EMS	EMS	NNP
cord-023095-4dannjjm	1280	31	)	)	-RRB-
cord-023095-4dannjjm	1280	32	.	.	.
cord-023095-4dannjjm	1281	1	This	this	DT
cord-023095-4dannjjm	1281	2	study	study	NN
cord-023095-4dannjjm	1281	3	was	be	VBD
cord-023095-4dannjjm	1281	4	performed	perform	VBN
cord-023095-4dannjjm	1281	5	to	to	TO
cord-023095-4dannjjm	1281	6	test	test	VB
cord-023095-4dannjjm	1281	7	the	the	DT
cord-023095-4dannjjm	1281	8	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1281	9	that	that	IN
cord-023095-4dannjjm	1281	10	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1281	11	responses	response	NNS
cord-023095-4dannjjm	1281	12	to	to	IN
cord-023095-4dannjjm	1281	13	endotoxemia	endotoxemia	NN
cord-023095-4dannjjm	1281	14	differ	differ	VBP
cord-023095-4dannjjm	1281	15	between	between	IN
cord-023095-4dannjjm	1281	16	healthy	healthy	JJ
cord-023095-4dannjjm	1281	17	horses	horse	NNS
cord-023095-4dannjjm	1281	18	and	and	CC
cord-023095-4dannjjm	1281	19	those	those	DT
cord-023095-4dannjjm	1281	20	affected	affect	VBN
cord-023095-4dannjjm	1281	21	by	by	IN
cord-023095-4dannjjm	1281	22	EMS	EMS	NNP
cord-023095-4dannjjm	1281	23	.	.	.
cord-023095-4dannjjm	1282	1	Six	six	CD
cord-023095-4dannjjm	1282	2	healthy	healthy	JJ
cord-023095-4dannjjm	1282	3	adult	adult	NN
cord-023095-4dannjjm	1282	4	mares	mare	NNS
cord-023095-4dannjjm	1282	5	and	and	CC
cord-023095-4dannjjm	1282	6	6	6	CD
cord-023095-4dannjjm	1282	7	horses	horse	NNS
cord-023095-4dannjjm	1282	8	with	with	IN
cord-023095-4dannjjm	1282	9	EMS	EMS	NNP
cord-023095-4dannjjm	1282	10	received	receive	VBD
cord-023095-4dannjjm	1282	11	an	an	DT
cord-023095-4dannjjm	1282	12	intravenous	intravenous	JJ
cord-023095-4dannjjm	1282	13	infusion	infusion	NN
cord-023095-4dannjjm	1282	14	of	of	IN
cord-023095-4dannjjm	1282	15	lipopolysaccharide	lipopolysaccharide	NN
cord-023095-4dannjjm	1282	16	(	(	-LRB-
cord-023095-4dannjjm	1282	17	LPS	LPS	NNP
cord-023095-4dannjjm	1282	18	;	;	:
cord-023095-4dannjjm	1282	19	20	20	CD
cord-023095-4dannjjm	1282	20	ng	ng	NN
cord-023095-4dannjjm	1282	21	/	/	SYM
cord-023095-4dannjjm	1282	22	kg	kg	NNS
cord-023095-4dannjjm	1282	23	in	in	IN
cord-023095-4dannjjm	1282	24	60	60	CD
cord-023095-4dannjjm	1282	25	mL	ml	NN
cord-023095-4dannjjm	1282	26	sterile	sterile	JJ
cord-023095-4dannjjm	1282	27	saline	saline	NN
cord-023095-4dannjjm	1282	28	)	)	-RRB-
cord-023095-4dannjjm	1282	29	or	or	CC
cord-023095-4dannjjm	1282	30	saline	saline	NN
cord-023095-4dannjjm	1282	31	alone	alone	RB
cord-023095-4dannjjm	1282	32	.	.	.
cord-023095-4dannjjm	1283	1	A	a	DT
cord-023095-4dannjjm	1283	2	crossover	crossover	NN
cord-023095-4dannjjm	1283	3	design	design	NN
cord-023095-4dannjjm	1283	4	was	be	VBD
cord-023095-4dannjjm	1283	5	employed	employ	VBN
cord-023095-4dannjjm	1283	6	with	with	IN
cord-023095-4dannjjm	1283	7	a	a	DT
cord-023095-4dannjjm	1283	8	7-day	7-day	JJ
cord-023095-4dannjjm	1283	9	washout	washout	NN
cord-023095-4dannjjm	1283	10	period	period	NN
cord-023095-4dannjjm	1283	11	.	.	.
cord-023095-4dannjjm	1284	1	Physical	physical	JJ
cord-023095-4dannjjm	1284	2	examinations	examination	NNS
cord-023095-4dannjjm	1284	3	were	be	VBD
cord-023095-4dannjjm	1284	4	performed	perform	VBN
cord-023095-4dannjjm	1284	5	hourly	hourly	JJ
cord-023095-4dannjjm	1284	6	for	for	IN
cord-023095-4dannjjm	1284	7	9h	9h	CD
cord-023095-4dannjjm	1284	8	and	and	CC
cord-023095-4dannjjm	1284	9	whole	whole	JJ
cord-023095-4dannjjm	1284	10	blood	blood	NN
cord-023095-4dannjjm	1284	11	was	be	VBD
cord-023095-4dannjjm	1284	12	collected	collect	VBN
cord-023095-4dannjjm	1284	13	at	at	IN
cord-023095-4dannjjm	1284	14	30	30	CD
cord-023095-4dannjjm	1284	15	,	,	,
cord-023095-4dannjjm	1284	16	60	60	CD
cord-023095-4dannjjm	1284	17	,	,	,
cord-023095-4dannjjm	1284	18	90	90	CD
cord-023095-4dannjjm	1284	19	,	,	,
cord-023095-4dannjjm	1284	20	120	120	CD
cord-023095-4dannjjm	1284	21	,	,	,
cord-023095-4dannjjm	1284	22	180	180	CD
cord-023095-4dannjjm	1284	23	,	,	,
cord-023095-4dannjjm	1284	24	and	and	CC
cord-023095-4dannjjm	1284	25	240	240	CD
cord-023095-4dannjjm	1284	26	min	min	NN
cord-023095-4dannjjm	1284	27	for	for	IN
cord-023095-4dannjjm	1284	28	assessment	assessment	NN
cord-023095-4dannjjm	1284	29	of	of	IN
cord-023095-4dannjjm	1284	30	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1284	31	cytokine	cytokine	NN
cord-023095-4dannjjm	1284	32	gene	gene	NN
cord-023095-4dannjjm	1284	33	expression	expression	NN
cord-023095-4dannjjm	1284	34	.	.	.
cord-023095-4dannjjm	1285	1	A	a	DT
cord-023095-4dannjjm	1285	2	liver	liver	NN
cord-023095-4dannjjm	1285	3	biopsy	biopsy	NN
cord-023095-4dannjjm	1285	4	was	be	VBD
cord-023095-4dannjjm	1285	5	performed	perform	VBN
cord-023095-4dannjjm	1285	6	between	between	IN
cord-023095-4dannjjm	1285	7	240	240	CD
cord-023095-4dannjjm	1285	8	and	and	CC
cord-023095-4dannjjm	1285	9	360	360	CD
cord-023095-4dannjjm	1285	10	min	min	NN
cord-023095-4dannjjm	1285	11	postinfusion	postinfusion	NN
cord-023095-4dannjjm	1285	12	.	.	.
cord-023095-4dannjjm	1286	1	Data	datum	NNS
cord-023095-4dannjjm	1286	2	were	be	VBD
cord-023095-4dannjjm	1286	3	analyzed	analyze	VBN
cord-023095-4dannjjm	1286	4	using	use	VBG
cord-023095-4dannjjm	1286	5	mixed	mixed	JJ
cord-023095-4dannjjm	1286	6	model	model	NN
cord-023095-4dannjjm	1286	7	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	1286	8	.	.	.
cord-023095-4dannjjm	1287	1	Mean	mean	JJ
cord-023095-4dannjjm	1287	2	rectal	rectal	JJ
cord-023095-4dannjjm	1287	3	temperature	temperature	NN
cord-023095-4dannjjm	1287	4	,	,	,
cord-023095-4dannjjm	1287	5	heart	heart	NN
cord-023095-4dannjjm	1287	6	rate	rate	NN
cord-023095-4dannjjm	1287	7	,	,	,
cord-023095-4dannjjm	1287	8	and	and	CC
cord-023095-4dannjjm	1287	9	respiratory	respiratory	JJ
cord-023095-4dannjjm	1287	10	rate	rate	NN
cord-023095-4dannjjm	1287	11	increased	increase	VBD
cord-023095-4dannjjm	1287	12	following	follow	VBG
cord-023095-4dannjjm	1287	13	LPS	LPS	NNP
cord-023095-4dannjjm	1287	14	infusion	infusion	NN
cord-023095-4dannjjm	1287	15	(	(	-LRB-
cord-023095-4dannjjm	1287	16	treatment	treatment	NN
cord-023095-4dannjjm	1287	17	Â	â	CD
cord-023095-4dannjjm	1287	18	time	time	NN
cord-023095-4dannjjm	1287	19	;	;	:
cord-023095-4dannjjm	1287	20	P	p	NN
cord-023095-4dannjjm	1287	21	o	o	NN
cord-023095-4dannjjm	1287	22	0.001	0.001	CD
cord-023095-4dannjjm	1287	23	)	)	-RRB-
cord-023095-4dannjjm	1287	24	,	,	,
cord-023095-4dannjjm	1287	25	with	with	IN
cord-023095-4dannjjm	1287	26	higher	high	JJR
cord-023095-4dannjjm	1287	27	heart	heart	NN
cord-023095-4dannjjm	1287	28	(	(	-LRB-
cord-023095-4dannjjm	1287	29	group	group	NN
cord-023095-4dannjjm	1287	30	Â	â	CD
cord-023095-4dannjjm	1287	31	treatment	treatment	NN
cord-023095-4dannjjm	1287	32	;	;	:
cord-023095-4dannjjm	1287	33	P	p	NN
cord-023095-4dannjjm	1287	34	5	5	CD
cord-023095-4dannjjm	1287	35	0.087	0.087	CD
cord-023095-4dannjjm	1287	36	)	)	-RRB-
cord-023095-4dannjjm	1287	37	and	and	CC
cord-023095-4dannjjm	1287	38	respiratory	respiratory	JJ
cord-023095-4dannjjm	1287	39	rates	rate	NNS
cord-023095-4dannjjm	1287	40	(	(	-LRB-
cord-023095-4dannjjm	1287	41	group	group	NN
cord-023095-4dannjjm	1287	42	;	;	:
cord-023095-4dannjjm	1287	43	P	p	NN
cord-023095-4dannjjm	1287	44	5	5	CD
cord-023095-4dannjjm	1287	45	0.017	0.017	CD
cord-023095-4dannjjm	1287	46	)	)	-RRB-
cord-023095-4dannjjm	1287	47	detected	detect	VBN
cord-023095-4dannjjm	1287	48	in	in	IN
cord-023095-4dannjjm	1287	49	EMS	EMS	NNP
cord-023095-4dannjjm	1287	50	horses	horse	NNS
cord-023095-4dannjjm	1287	51	.	.	.
cord-023095-4dannjjm	1288	1	Lipopolysaccharide	Lipopolysaccharide	NNP
cord-023095-4dannjjm	1288	2	infusion	infusion	NN
cord-023095-4dannjjm	1288	3	significantly	significantly	RB
cord-023095-4dannjjm	1288	4	increased	increase	VBD
cord-023095-4dannjjm	1288	5	whole	whole	JJ
cord-023095-4dannjjm	1288	6	blood	blood	NN
cord-023095-4dannjjm	1288	7	gene	gene	NN
cord-023095-4dannjjm	1288	8	expression	expression	NN
cord-023095-4dannjjm	1288	9	of	of	IN
cord-023095-4dannjjm	1288	10	tumor	tumor	NN
cord-023095-4dannjjm	1288	11	necrosis	necrosis	NN
cord-023095-4dannjjm	1288	12	factor	factor	NN
cord-023095-4dannjjm	1288	13	a	a	NN
cord-023095-4dannjjm	1288	14	(	(	-LRB-
cord-023095-4dannjjm	1288	15	TNFa	TNFa	NNP
cord-023095-4dannjjm	1288	16	)	)	-RRB-
cord-023095-4dannjjm	1288	17	,	,	,
cord-023095-4dannjjm	1288	18	interleukin	interleukin	FW
cord-023095-4dannjjm	1288	19	(	(	-LRB-
cord-023095-4dannjjm	1288	20	IL)-1b	IL)-1b	NNP
cord-023095-4dannjjm	1288	21	(	(	-LRB-
cord-023095-4dannjjm	1288	22	P	p	NN
cord-023095-4dannjjm	1288	23	o	o	NN
cord-023095-4dannjjm	1288	24	0.001	0.001	CD
cord-023095-4dannjjm	1288	25	)	)	-RRB-
cord-023095-4dannjjm	1288	26	,	,	,
cord-023095-4dannjjm	1288	27	IL-6	IL-6	NNP
cord-023095-4dannjjm	1288	28	(	(	-LRB-
cord-023095-4dannjjm	1288	29	P	p	NN
cord-023095-4dannjjm	1288	30	o	o	CD
cord-023095-4dannjjm	1288	31	0.001	0.001	CD
cord-023095-4dannjjm	1288	32	)	)	-RRB-
cord-023095-4dannjjm	1288	33	,	,	.
cord-023095-4dannjjm	1289	1	IL-8	IL-8	NNP
cord-023095-4dannjjm	1289	2	(	(	-LRB-
cord-023095-4dannjjm	1289	3	P	p	NN
cord-023095-4dannjjm	1289	4	o	o	NN
cord-023095-4dannjjm	1289	5	0.001	0.001	CD
cord-023095-4dannjjm	1289	6	)	)	-RRB-
cord-023095-4dannjjm	1289	7	,	,	,
cord-023095-4dannjjm	1289	8	and	and	CC
cord-023095-4dannjjm	1289	9	IL-10	IL-10	NNP
cord-023095-4dannjjm	1289	10	(	(	-LRB-
cord-023095-4dannjjm	1289	11	P	p	NN
cord-023095-4dannjjm	1289	12	5	5	CD
cord-023095-4dannjjm	1289	13	0.002	0.002	CD
cord-023095-4dannjjm	1289	14	)	)	-RRB-
cord-023095-4dannjjm	1289	15	,	,	,
cord-023095-4dannjjm	1289	16	and	and	CC
cord-023095-4dannjjm	1289	17	hepatic	hepatic	JJ
cord-023095-4dannjjm	1289	18	gene	gene	NN
cord-023095-4dannjjm	1289	19	expression	expression	NN
cord-023095-4dannjjm	1289	20	of	of	IN
cord-023095-4dannjjm	1289	21	IL-6	IL-6	NNP
cord-023095-4dannjjm	1289	22	(	(	-LRB-
cord-023095-4dannjjm	1289	23	P	p	NN
cord-023095-4dannjjm	1289	24	o	o	CD
cord-023095-4dannjjm	1289	25	0.001	0.001	CD
cord-023095-4dannjjm	1289	26	)	)	-RRB-
cord-023095-4dannjjm	1289	27	,	,	.
cord-023095-4dannjjm	1290	1	IL-8	IL-8	NNP
cord-023095-4dannjjm	1290	2	(	(	-LRB-
cord-023095-4dannjjm	1290	3	P	p	NN
cord-023095-4dannjjm	1290	4	o	o	NN
cord-023095-4dannjjm	1290	5	0.001	0.001	CD
cord-023095-4dannjjm	1290	6	)	)	-RRB-
cord-023095-4dannjjm	1290	7	,	,	,
cord-023095-4dannjjm	1290	8	and	and	CC
cord-023095-4dannjjm	1290	9	IL-10	IL-10	NNP
cord-023095-4dannjjm	1290	10	(	(	-LRB-
cord-023095-4dannjjm	1290	11	P	p	NN
cord-023095-4dannjjm	1290	12	5	5	CD
cord-023095-4dannjjm	1290	13	0.016	0.016	CD
cord-023095-4dannjjm	1290	14	)	)	-RRB-
cord-023095-4dannjjm	1290	15	.	.	.
cord-023095-4dannjjm	1291	1	Inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1291	2	gene	gene	NN
cord-023095-4dannjjm	1291	3	expression	expression	NN
cord-023095-4dannjjm	1291	4	did	do	VBD
cord-023095-4dannjjm	1291	5	not	not	RB
cord-023095-4dannjjm	1291	6	differ	differ	VB
cord-023095-4dannjjm	1291	7	significantly	significantly	RB
cord-023095-4dannjjm	1291	8	between	between	IN
cord-023095-4dannjjm	1291	9	groups	group	NNS
cord-023095-4dannjjm	1291	10	,	,	,
cord-023095-4dannjjm	1291	11	so	so	RB
cord-023095-4dannjjm	1291	12	our	-PRON-	PRP$
cord-023095-4dannjjm	1291	13	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1291	14	was	be	VBD
cord-023095-4dannjjm	1291	15	not	not	RB
cord-023095-4dannjjm	1291	16	supported	support	VBN
cord-023095-4dannjjm	1291	17	.	.	.
cord-023095-4dannjjm	1292	1	Heart	heart	NN
cord-023095-4dannjjm	1292	2	rates	rate	NNS
cord-023095-4dannjjm	1292	3	tended	tend	VBD
cord-023095-4dannjjm	1292	4	to	to	TO
cord-023095-4dannjjm	1292	5	be	be	VB
cord-023095-4dannjjm	1292	6	higher	high	JJR
cord-023095-4dannjjm	1292	7	when	when	WRB
cord-023095-4dannjjm	1292	8	LPS	LPS	NNP
cord-023095-4dannjjm	1292	9	was	be	VBD
cord-023095-4dannjjm	1292	10	administered	administer	VBN
cord-023095-4dannjjm	1292	11	to	to	IN
cord-023095-4dannjjm	1292	12	horses	horse	NNS
cord-023095-4dannjjm	1292	13	with	with	IN
cord-023095-4dannjjm	1292	14	EMS	EMS	NNP
cord-023095-4dannjjm	1292	15	.	.	.
cord-023095-4dannjjm	1293	1	Elevated	elevated	JJ
cord-023095-4dannjjm	1293	2	serum	serum	NN
cord-023095-4dannjjm	1293	3	concentration	concentration	NN
cord-023095-4dannjjm	1293	4	of	of	IN
cord-023095-4dannjjm	1293	5	cardiac	cardiac	NN
cord-023095-4dannjjm	1293	6	troponin	troponin	NN
cord-023095-4dannjjm	1293	7	I	-PRON-	PRP
cord-023095-4dannjjm	1293	8	(	(	-LRB-
cord-023095-4dannjjm	1293	9	cTnI	cTnI	NNP
cord-023095-4dannjjm	1293	10	)	)	-RRB-
cord-023095-4dannjjm	1293	11	is	be	VBZ
cord-023095-4dannjjm	1293	12	a	a	DT
cord-023095-4dannjjm	1293	13	biomarker	biomarker	NN
cord-023095-4dannjjm	1293	14	for	for	IN
cord-023095-4dannjjm	1293	15	myocardial	myocardial	JJ
cord-023095-4dannjjm	1293	16	damage	damage	NN
cord-023095-4dannjjm	1293	17	in	in	IN
cord-023095-4dannjjm	1293	18	horses	horse	NNS
cord-023095-4dannjjm	1293	19	.	.	.
cord-023095-4dannjjm	1294	1	Preferred	preferred	JJ
cord-023095-4dannjjm	1294	2	times	time	NNS
cord-023095-4dannjjm	1294	3	to	to	TO
cord-023095-4dannjjm	1294	4	test	test	VB
cord-023095-4dannjjm	1294	5	blood	blood	NN
cord-023095-4dannjjm	1294	6	for	for	IN
cord-023095-4dannjjm	1294	7	cTnI	cTnI	NNP
cord-023095-4dannjjm	1294	8	levels	level	NNS
cord-023095-4dannjjm	1294	9	following	follow	VBG
cord-023095-4dannjjm	1294	10	athletic	athletic	JJ
cord-023095-4dannjjm	1294	11	performance	performance	NN
cord-023095-4dannjjm	1294	12	or	or	CC
cord-023095-4dannjjm	1294	13	other	other	JJ
cord-023095-4dannjjm	1294	14	events	event	NNS
cord-023095-4dannjjm	1294	15	that	that	WDT
cord-023095-4dannjjm	1294	16	may	may	MD
cord-023095-4dannjjm	1294	17	cause	cause	VB
cord-023095-4dannjjm	1294	18	myocardial	myocardial	JJ
cord-023095-4dannjjm	1294	19	injury	injury	NN
cord-023095-4dannjjm	1294	20	are	be	VBP
cord-023095-4dannjjm	1294	21	not	not	RB
cord-023095-4dannjjm	1294	22	yet	yet	RB
cord-023095-4dannjjm	1294	23	established	establish	VBN
cord-023095-4dannjjm	1294	24	and	and	CC
cord-023095-4dannjjm	1294	25	would	would	MD
cord-023095-4dannjjm	1294	26	be	be	VB
cord-023095-4dannjjm	1294	27	affected	affect	VBN
cord-023095-4dannjjm	1294	28	by	by	IN
cord-023095-4dannjjm	1294	29	time	time	NN
cord-023095-4dannjjm	1294	30	of	of	IN
cord-023095-4dannjjm	1294	31	release	release	NN
cord-023095-4dannjjm	1294	32	from	from	IN
cord-023095-4dannjjm	1294	33	the	the	DT
cord-023095-4dannjjm	1294	34	myocytes	myocyte	NNS
cord-023095-4dannjjm	1294	35	,	,	,
cord-023095-4dannjjm	1294	36	location	location	NN
cord-023095-4dannjjm	1294	37	of	of	IN
cord-023095-4dannjjm	1294	38	release	release	NN
cord-023095-4dannjjm	1294	39	within	within	IN
cord-023095-4dannjjm	1294	40	the	the	DT
cord-023095-4dannjjm	1294	41	myocytes	myocytes	NN
cord-023095-4dannjjm	1294	42	,	,	,
cord-023095-4dannjjm	1294	43	duration	duration	NN
cord-023095-4dannjjm	1294	44	of	of	IN
cord-023095-4dannjjm	1294	45	release	release	NN
cord-023095-4dannjjm	1294	46	and	and	CC
cord-023095-4dannjjm	1294	47	half	half	JJ
cord-023095-4dannjjm	1294	48	-	-	HYPH
cord-023095-4dannjjm	1294	49	life	life	NN
cord-023095-4dannjjm	1294	50	of	of	IN
cord-023095-4dannjjm	1294	51	cTnI	cTnI	NNP
cord-023095-4dannjjm	1294	52	in	in	IN
cord-023095-4dannjjm	1294	53	the	the	DT
cord-023095-4dannjjm	1294	54	horse	horse	NN
cord-023095-4dannjjm	1294	55	.	.	.
cord-023095-4dannjjm	1295	1	This	this	DT
cord-023095-4dannjjm	1295	2	information	information	NN
cord-023095-4dannjjm	1295	3	would	would	MD
cord-023095-4dannjjm	1295	4	be	be	VB
cord-023095-4dannjjm	1295	5	necessary	necessary	JJ
cord-023095-4dannjjm	1295	6	to	to	TO
cord-023095-4dannjjm	1295	7	more	more	RBR
cord-023095-4dannjjm	1295	8	accurately	accurately	RB
cord-023095-4dannjjm	1295	9	and	and	CC
cord-023095-4dannjjm	1295	10	reliably	reliably	RB
cord-023095-4dannjjm	1295	11	test	test	VB
cord-023095-4dannjjm	1295	12	horses	horse	NNS
cord-023095-4dannjjm	1295	13	for	for	IN
cord-023095-4dannjjm	1295	14	myocardial	myocardial	JJ
cord-023095-4dannjjm	1295	15	injury	injury	NN
cord-023095-4dannjjm	1295	16	.	.	.
cord-023095-4dannjjm	1296	1	The	the	DT
cord-023095-4dannjjm	1296	2	aim	aim	NN
cord-023095-4dannjjm	1296	3	of	of	IN
cord-023095-4dannjjm	1296	4	this	this	DT
cord-023095-4dannjjm	1296	5	study	study	NN
cord-023095-4dannjjm	1296	6	was	be	VBD
cord-023095-4dannjjm	1296	7	to	to	TO
cord-023095-4dannjjm	1296	8	determine	determine	VB
cord-023095-4dannjjm	1296	9	the	the	DT
cord-023095-4dannjjm	1296	10	elimination	elimination	NN
cord-023095-4dannjjm	1296	11	half	half	JJ
cord-023095-4dannjjm	1296	12	-	-	HYPH
cord-023095-4dannjjm	1296	13	life	life	NN
cord-023095-4dannjjm	1296	14	(	(	-LRB-
cord-023095-4dannjjm	1296	15	T1/2	T1/2	NNP
cord-023095-4dannjjm	1296	16	)	)	-RRB-
cord-023095-4dannjjm	1296	17	of	of	IN
cord-023095-4dannjjm	1296	18	equine	equine	NN
cord-023095-4dannjjm	1296	19	cTnI.	ctni.	ADD
cord-023095-4dannjjm	1297	1	To	to	TO
cord-023095-4dannjjm	1297	2	establish	establish	VB
cord-023095-4dannjjm	1297	3	the	the	DT
cord-023095-4dannjjm	1297	4	T1/2	t1/2	NN
cord-023095-4dannjjm	1297	5	of	of	IN
cord-023095-4dannjjm	1297	6	equine	equine	NN
cord-023095-4dannjjm	1297	7	cTnI	cTnI	VBN
cord-023095-4dannjjm	1297	8	in	in	IN
cord-023095-4dannjjm	1297	9	horses	horse	NNS
cord-023095-4dannjjm	1297	10	,	,	,
cord-023095-4dannjjm	1297	11	cTnI	cTnI	NNP
cord-023095-4dannjjm	1297	12	was	be	VBD
cord-023095-4dannjjm	1297	13	recombinantly	recombinantly	RB
cord-023095-4dannjjm	1297	14	expressed	express	VBN
cord-023095-4dannjjm	1297	15	in	in	IN
cord-023095-4dannjjm	1297	16	E.coli	E.coli	NNS
cord-023095-4dannjjm	1297	17	.	.	.
cord-023095-4dannjjm	1298	1	Two	two	CD
cord-023095-4dannjjm	1298	2	healthy	healthy	JJ
cord-023095-4dannjjm	1298	3	ponies	pony	NNS
cord-023095-4dannjjm	1298	4	received	receive	VBD
cord-023095-4dannjjm	1298	5	intravenous	intravenous	JJ
cord-023095-4dannjjm	1298	6	injections	injection	NNS
cord-023095-4dannjjm	1298	7	of	of	IN
cord-023095-4dannjjm	1298	8	recombinant	recombinant	JJ
cord-023095-4dannjjm	1298	9	equine	equine	NN
cord-023095-4dannjjm	1298	10	cTnI	cTnI	NNP
cord-023095-4dannjjm	1298	11	and	and	CC
cord-023095-4dannjjm	1298	12	plasma	plasma	NN
cord-023095-4dannjjm	1298	13	cTnI	cTnI	NNP
cord-023095-4dannjjm	1298	14	concentrations	concentration	NNS
cord-023095-4dannjjm	1298	15	were	be	VBD
cord-023095-4dannjjm	1298	16	measured	measure	VBN
cord-023095-4dannjjm	1298	17	with	with	IN
cord-023095-4dannjjm	1298	18	a	a	DT
cord-023095-4dannjjm	1298	19	point	point	NN
cord-023095-4dannjjm	1298	20	-	-	HYPH
cord-023095-4dannjjm	1298	21	of	of	IN
cord-023095-4dannjjm	1298	22	-	-	HYPH
cord-023095-4dannjjm	1298	23	care	care	NN
cord-023095-4dannjjm	1298	24	cTnI	cTnI	NNP
cord-023095-4dannjjm	1298	25	analyzer	analyzer	NN
cord-023095-4dannjjm	1298	26	at	at	IN
cord-023095-4dannjjm	1298	27	multiple	multiple	JJ
cord-023095-4dannjjm	1298	28	time	time	NN
cord-023095-4dannjjm	1298	29	points	point	NNS
cord-023095-4dannjjm	1298	30	after	after	IN
cord-023095-4dannjjm	1298	31	injection	injection	NN
cord-023095-4dannjjm	1298	32	.	.	.
cord-023095-4dannjjm	1299	1	Standard	standard	JJ
cord-023095-4dannjjm	1299	2	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	1299	3	analysis	analysis	NN
cord-023095-4dannjjm	1299	4	was	be	VBD
cord-023095-4dannjjm	1299	5	performed	perform	VBN
cord-023095-4dannjjm	1299	6	to	to	TO
cord-023095-4dannjjm	1299	7	establish	establish	VB
cord-023095-4dannjjm	1299	8	the	the	DT
cord-023095-4dannjjm	1299	9	elimination	elimination	NN
cord-023095-4dannjjm	1299	10	half	half	JJ
cord-023095-4dannjjm	1299	11	-	-	HYPH
cord-023095-4dannjjm	1299	12	life	life	NN
cord-023095-4dannjjm	1299	13	of	of	IN
cord-023095-4dannjjm	1299	14	cTnI.	ctni.	ADD
cord-023095-4dannjjm	1300	1	For	for	IN
cord-023095-4dannjjm	1300	2	comparative	comparative	JJ
cord-023095-4dannjjm	1300	3	purposes	purpose	NNS
cord-023095-4dannjjm	1300	4	,	,	,
cord-023095-4dannjjm	1300	5	data	datum	NNS
cord-023095-4dannjjm	1300	6	were	be	VBD
cord-023095-4dannjjm	1300	7	subjected	subject	VBN
cord-023095-4dannjjm	1300	8	to	to	IN
cord-023095-4dannjjm	1300	9	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	1300	10	models	model	NNS
cord-023095-4dannjjm	1300	11	describing	describe	VBG
cord-023095-4dannjjm	1300	12	a	a	DT
cord-023095-4dannjjm	1300	13	single	single	JJ
cord-023095-4dannjjm	1300	14	versus	versus	IN
cord-023095-4dannjjm	1300	15	biphasic	biphasic	JJ
cord-023095-4dannjjm	1300	16	elimination	elimination	NN
cord-023095-4dannjjm	1300	17	profile	profile	NN
cord-023095-4dannjjm	1300	18	.	.	.
cord-023095-4dannjjm	1301	1	Elimination	elimination	NN
cord-023095-4dannjjm	1301	2	of	of	IN
cord-023095-4dannjjm	1301	3	recombinant	recombinant	JJ
cord-023095-4dannjjm	1301	4	equine	equine	NN
cord-023095-4dannjjm	1301	5	cTnI	cTnI	NNP
cord-023095-4dannjjm	1301	6	following	follow	VBG
cord-023095-4dannjjm	1301	7	intravenous	intravenous	JJ
cord-023095-4dannjjm	1301	8	administration	administration	NN
cord-023095-4dannjjm	1301	9	exhibits	exhibit	VBZ
cord-023095-4dannjjm	1301	10	a	a	DT
cord-023095-4dannjjm	1301	11	short	short	JJ
cord-023095-4dannjjm	1301	12	half	half	JJ
cord-023095-4dannjjm	1301	13	-	-	HYPH
cord-023095-4dannjjm	1301	14	life	life	NN
cord-023095-4dannjjm	1301	15	.	.	.
cord-023095-4dannjjm	1302	1	Establishing	establish	VBG
cord-023095-4dannjjm	1302	2	the	the	DT
cord-023095-4dannjjm	1302	3	T1/2	t1/2	NN
cord-023095-4dannjjm	1302	4	of	of	IN
cord-023095-4dannjjm	1302	5	troponin	troponin	JJ
cord-023095-4dannjjm	1302	6	provides	provide	VBZ
cord-023095-4dannjjm	1302	7	critical	critical	JJ
cord-023095-4dannjjm	1302	8	information	information	NN
cord-023095-4dannjjm	1302	9	in	in	IN
cord-023095-4dannjjm	1302	10	understanding	understand	VBG
cord-023095-4dannjjm	1302	11	the	the	DT
cord-023095-4dannjjm	1302	12	clinical	clinical	JJ
cord-023095-4dannjjm	1302	13	application	application	NN
cord-023095-4dannjjm	1302	14	of	of	IN
cord-023095-4dannjjm	1302	15	this	this	DT
cord-023095-4dannjjm	1302	16	cardiac	cardiac	JJ
cord-023095-4dannjjm	1302	17	biomarker	biomarker	NN
cord-023095-4dannjjm	1302	18	in	in	IN
cord-023095-4dannjjm	1302	19	clinical	clinical	JJ
cord-023095-4dannjjm	1302	20	practice	practice	NN
cord-023095-4dannjjm	1302	21	.	.	.
cord-023095-4dannjjm	1303	1	This	this	DT
cord-023095-4dannjjm	1303	2	study	study	NN
cord-023095-4dannjjm	1303	3	describes	describe	VBZ
cord-023095-4dannjjm	1303	4	a	a	DT
cord-023095-4dannjjm	1303	5	true	true	JJ
cord-023095-4dannjjm	1303	6	biological	biological	JJ
cord-023095-4dannjjm	1303	7	cTnI	cTnI	VBN
cord-023095-4dannjjm	1303	8	T1/2	t1/2	NN
cord-023095-4dannjjm	1303	9	,	,	,
cord-023095-4dannjjm	1303	10	which	which	WDT
cord-023095-4dannjjm	1303	11	has	have	VBZ
cord-023095-4dannjjm	1303	12	not	not	RB
cord-023095-4dannjjm	1303	13	been	be	VBN
cord-023095-4dannjjm	1303	14	documented	document	VBN
cord-023095-4dannjjm	1303	15	in	in	IN
cord-023095-4dannjjm	1303	16	any	any	DT
cord-023095-4dannjjm	1303	17	species	specie	NNS
cord-023095-4dannjjm	1303	18	thus	thus	RB
cord-023095-4dannjjm	1303	19	far	far	RB
cord-023095-4dannjjm	1303	20	.	.	.
cord-023095-4dannjjm	1304	1	Stall	stall	JJ
cord-023095-4dannjjm	1304	2	-	-	HYPH
cord-023095-4dannjjm	1304	3	side	side	NN
cord-023095-4dannjjm	1304	4	assessment	assessment	NN
cord-023095-4dannjjm	1304	5	of	of	IN
cord-023095-4dannjjm	1304	6	this	this	DT
cord-023095-4dannjjm	1304	7	cardiac	cardiac	JJ
cord-023095-4dannjjm	1304	8	biomarker	biomarker	NN
cord-023095-4dannjjm	1304	9	in	in	IN
cord-023095-4dannjjm	1304	10	horses	horse	NNS
cord-023095-4dannjjm	1304	11	should	should	MD
cord-023095-4dannjjm	1304	12	enhance	enhance	VB
cord-023095-4dannjjm	1304	13	the	the	DT
cord-023095-4dannjjm	1304	14	ability	ability	NN
cord-023095-4dannjjm	1304	15	of	of	IN
cord-023095-4dannjjm	1304	16	clinicians	clinician	NNS
cord-023095-4dannjjm	1304	17	to	to	TO
cord-023095-4dannjjm	1304	18	detect	detect	VB
cord-023095-4dannjjm	1304	19	myocardial	myocardial	JJ
cord-023095-4dannjjm	1304	20	damage	damage	NN
cord-023095-4dannjjm	1304	21	and	and	CC
cord-023095-4dannjjm	1304	22	aid	aid	NN
cord-023095-4dannjjm	1304	23	in	in	IN
cord-023095-4dannjjm	1304	24	the	the	DT
cord-023095-4dannjjm	1304	25	management	management	NN
cord-023095-4dannjjm	1304	26	and	and	CC
cord-023095-4dannjjm	1304	27	treatment	treatment	NN
cord-023095-4dannjjm	1304	28	of	of	IN
cord-023095-4dannjjm	1304	29	horses	horse	NNS
cord-023095-4dannjjm	1304	30	with	with	IN
cord-023095-4dannjjm	1304	31	cardiac	cardiac	JJ
cord-023095-4dannjjm	1304	32	disease	disease	NN
cord-023095-4dannjjm	1304	33	.	.	.
cord-023095-4dannjjm	1305	1	The	the	DT
cord-023095-4dannjjm	1305	2	objective	objective	NN
cord-023095-4dannjjm	1305	3	of	of	IN
cord-023095-4dannjjm	1305	4	the	the	DT
cord-023095-4dannjjm	1305	5	study	study	NN
cord-023095-4dannjjm	1305	6	was	be	VBD
cord-023095-4dannjjm	1305	7	to	to	TO
cord-023095-4dannjjm	1305	8	evaluate	evaluate	VB
cord-023095-4dannjjm	1305	9	the	the	DT
cord-023095-4dannjjm	1305	10	between	between	IN
cord-023095-4dannjjm	1305	11	-	-	HYPH
cord-023095-4dannjjm	1305	12	pony	pony	NN
cord-023095-4dannjjm	1305	13	,	,	,
cord-023095-4dannjjm	1305	14	within	within	IN
cord-023095-4dannjjm	1305	15	-	-	HYPH
cord-023095-4dannjjm	1305	16	pony	pony	NN
cord-023095-4dannjjm	1305	17	,	,	,
cord-023095-4dannjjm	1305	18	between	between	IN
cord-023095-4dannjjm	1305	19	-	-	HYPH
cord-023095-4dannjjm	1305	20	analyser	analyser	NN
cord-023095-4dannjjm	1305	21	and	and	CC
cord-023095-4dannjjm	1305	22	within	within	IN
cord-023095-4dannjjm	1305	23	-	-	HYPH
cord-023095-4dannjjm	1305	24	analyser	analyser	NN
cord-023095-4dannjjm	1305	25	variation	variation	NN
cord-023095-4dannjjm	1305	26	of	of	IN
cord-023095-4dannjjm	1305	27	flow	flow	NN
cord-023095-4dannjjm	1305	28	-	-	HYPH
cord-023095-4dannjjm	1305	29	mediated	mediate	VBN
cord-023095-4dannjjm	1305	30	vasodilation	vasodilation	NN
cord-023095-4dannjjm	1305	31	(	(	-LRB-
cord-023095-4dannjjm	1305	32	FMD	FMD	NNP
cord-023095-4dannjjm	1305	33	)	)	-RRB-
cord-023095-4dannjjm	1305	34	measurement	measurement	NN
cord-023095-4dannjjm	1305	35	in	in	IN
cord-023095-4dannjjm	1305	36	healthy	healthy	JJ
cord-023095-4dannjjm	1305	37	ponies	pony	NNS
cord-023095-4dannjjm	1305	38	,	,	,
cord-023095-4dannjjm	1305	39	to	to	TO
cord-023095-4dannjjm	1305	40	investigate	investigate	VB
cord-023095-4dannjjm	1305	41	the	the	DT
cord-023095-4dannjjm	1305	42	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1305	43	that	that	IN
cord-023095-4dannjjm	1305	44	FMD	FMD	NNP
cord-023095-4dannjjm	1305	45	occurs	occur	VBZ
cord-023095-4dannjjm	1305	46	in	in	IN
cord-023095-4dannjjm	1305	47	healthy	healthy	JJ
cord-023095-4dannjjm	1305	48	ponies	pony	NNS
cord-023095-4dannjjm	1305	49	.	.	.
cord-023095-4dannjjm	1306	1	Six	six	CD
cord-023095-4dannjjm	1306	2	healthy	healthy	JJ
cord-023095-4dannjjm	1306	3	,	,	,
cord-023095-4dannjjm	1306	4	native	native	JJ
cord-023095-4dannjjm	1306	5	breed	breed	NN
cord-023095-4dannjjm	1306	6	,	,	,
cord-023095-4dannjjm	1306	7	unrelated	unrelated	JJ
cord-023095-4dannjjm	1306	8	pony	pony	NN
cord-023095-4dannjjm	1306	9	mares	mare	NNS
cord-023095-4dannjjm	1306	10	of	of	IN
cord-023095-4dannjjm	1306	11	varying	vary	VBG
cord-023095-4dannjjm	1306	12	weight	weight	NN
cord-023095-4dannjjm	1306	13	(	(	-LRB-
cord-023095-4dannjjm	1306	14	236	236	CD
cord-023095-4dannjjm	1306	15	-	-	SYM
cord-023095-4dannjjm	1306	16	406	406	CD
cord-023095-4dannjjm	1306	17	kg	kg	NNP
cord-023095-4dannjjm	1306	18	)	)	-RRB-
cord-023095-4dannjjm	1306	19	,	,	,
cord-023095-4dannjjm	1306	20	body	body	NN
cord-023095-4dannjjm	1306	21	condition	condition	NN
cord-023095-4dannjjm	1306	22	score	score	NN
cord-023095-4dannjjm	1306	23	(	(	-LRB-
cord-023095-4dannjjm	1306	24	3/9	3/9	CD
cord-023095-4dannjjm	1306	25	-	-	SYM
cord-023095-4dannjjm	1306	26	7/9	7/9	CD
cord-023095-4dannjjm	1306	27	)	)	-RRB-
cord-023095-4dannjjm	1306	28	and	and	CC
cord-023095-4dannjjm	1306	29	age	age	NN
cord-023095-4dannjjm	1306	30	(	(	-LRB-
cord-023095-4dannjjm	1306	31	14	14	CD
cord-023095-4dannjjm	1306	32	-	-	SYM
cord-023095-4dannjjm	1306	33	25	25	CD
cord-023095-4dannjjm	1306	34	years	year	NNS
cord-023095-4dannjjm	1306	35	)	)	-RRB-
cord-023095-4dannjjm	1306	36	were	be	VBD
cord-023095-4dannjjm	1306	37	used	use	VBN
cord-023095-4dannjjm	1306	38	.	.	.
cord-023095-4dannjjm	1307	1	The	the	DT
cord-023095-4dannjjm	1307	2	median	median	JJ
cord-023095-4dannjjm	1307	3	artery	artery	NN
cord-023095-4dannjjm	1307	4	was	be	VBD
cord-023095-4dannjjm	1307	5	occluded	occlude	VBN
cord-023095-4dannjjm	1307	6	for	for	IN
cord-023095-4dannjjm	1307	7	5	5	CD
cord-023095-4dannjjm	1307	8	minutes	minute	NNS
cord-023095-4dannjjm	1307	9	.	.	.
cord-023095-4dannjjm	1308	1	Twodimensional	Twodimensional	NNP
cord-023095-4dannjjm	1308	2	(	(	-LRB-
cord-023095-4dannjjm	1308	3	2D	2D	NNP
cord-023095-4dannjjm	1308	4	)	)	-RRB-
cord-023095-4dannjjm	1308	5	ultrasonographic	ultrasonographic	JJ
cord-023095-4dannjjm	1308	6	images	image	NNS
cord-023095-4dannjjm	1308	7	of	of	IN
cord-023095-4dannjjm	1308	8	the	the	DT
cord-023095-4dannjjm	1308	9	artery	artery	NN
cord-023095-4dannjjm	1308	10	were	be	VBD
cord-023095-4dannjjm	1308	11	recorded	record	VBN
cord-023095-4dannjjm	1308	12	for	for	IN
cord-023095-4dannjjm	1308	13	30	30	CD
cord-023095-4dannjjm	1308	14	seconds	second	NNS
cord-023095-4dannjjm	1308	15	prior	prior	RB
cord-023095-4dannjjm	1308	16	to	to	IN
cord-023095-4dannjjm	1308	17	and	and	CC
cord-023095-4dannjjm	1308	18	for	for	IN
cord-023095-4dannjjm	1308	19	2	2	CD
cord-023095-4dannjjm	1308	20	minutes	minute	NNS
cord-023095-4dannjjm	1308	21	after	after	IN
cord-023095-4dannjjm	1308	22	occlusion	occlusion	NN
cord-023095-4dannjjm	1308	23	.	.	.
cord-023095-4dannjjm	1309	1	The	the	DT
cord-023095-4dannjjm	1309	2	peak	peak	NN
cord-023095-4dannjjm	1309	3	luminal	luminal	JJ
cord-023095-4dannjjm	1309	4	diameter	diameter	NN
cord-023095-4dannjjm	1309	5	was	be	VBD
cord-023095-4dannjjm	1309	6	compared	compare	VBN
cord-023095-4dannjjm	1309	7	to	to	IN
cord-023095-4dannjjm	1309	8	baseline	baseline	JJ
cord-023095-4dannjjm	1309	9	diameter	diameter	NN
cord-023095-4dannjjm	1309	10	to	to	TO
cord-023095-4dannjjm	1309	11	calculate	calculate	VB
cord-023095-4dannjjm	1309	12	the	the	DT
cord-023095-4dannjjm	1309	13	relative	relative	JJ
cord-023095-4dannjjm	1309	14	percentage	percentage	NN
cord-023095-4dannjjm	1309	15	increase	increase	NN
cord-023095-4dannjjm	1309	16	in	in	IN
cord-023095-4dannjjm	1309	17	luminal	luminal	JJ
cord-023095-4dannjjm	1309	18	size	size	NN
cord-023095-4dannjjm	1309	19	(	(	-LRB-
cord-023095-4dannjjm	1309	20	FMD	FMD	NNP
cord-023095-4dannjjm	1309	21	)	)	-RRB-
cord-023095-4dannjjm	1309	22	.	.	.
cord-023095-4dannjjm	1310	1	Images	image	NNS
cord-023095-4dannjjm	1310	2	were	be	VBD
cord-023095-4dannjjm	1310	3	obtained	obtain	VBN
cord-023095-4dannjjm	1310	4	from	from	IN
cord-023095-4dannjjm	1310	5	six	six	CD
cord-023095-4dannjjm	1310	6	ponies	pony	NNS
cord-023095-4dannjjm	1310	7	on	on	IN
cord-023095-4dannjjm	1310	8	one	one	CD
cord-023095-4dannjjm	1310	9	occasion	occasion	NN
cord-023095-4dannjjm	1310	10	and	and	CC
cord-023095-4dannjjm	1310	11	from	from	IN
cord-023095-4dannjjm	1310	12	one	one	CD
cord-023095-4dannjjm	1310	13	pony	pony	NN
cord-023095-4dannjjm	1310	14	on	on	IN
cord-023095-4dannjjm	1310	15	six	six	CD
cord-023095-4dannjjm	1310	16	occasions	occasion	NNS
cord-023095-4dannjjm	1310	17	.	.	.
cord-023095-4dannjjm	1311	1	Analysis	analysis	NN
cord-023095-4dannjjm	1311	2	of	of	IN
cord-023095-4dannjjm	1311	3	images	image	NNS
cord-023095-4dannjjm	1311	4	was	be	VBD
cord-023095-4dannjjm	1311	5	performed	perform	VBN
cord-023095-4dannjjm	1311	6	by	by	IN
cord-023095-4dannjjm	1311	7	two	two	CD
cord-023095-4dannjjm	1311	8	independent	independent	JJ
cord-023095-4dannjjm	1311	9	analysers	analyser	NNS
cord-023095-4dannjjm	1311	10	and	and	CC
cord-023095-4dannjjm	1311	11	by	by	IN
cord-023095-4dannjjm	1311	12	one	one	CD
cord-023095-4dannjjm	1311	13	analyser	analyser	NN
cord-023095-4dannjjm	1311	14	twice	twice	RB
cord-023095-4dannjjm	1311	15	.	.	.
cord-023095-4dannjjm	1312	1	The	the	DT
cord-023095-4dannjjm	1312	2	mean	mean	JJ
cord-023095-4dannjjm	1312	3	(	(	-LRB-
cord-023095-4dannjjm	1312	4	SD	sd	NN
cord-023095-4dannjjm	1312	5	)	)	-RRB-
cord-023095-4dannjjm	1312	6	FMD	FMD	NNP
cord-023095-4dannjjm	1312	7	in	in	IN
cord-023095-4dannjjm	1312	8	6	6	CD
cord-023095-4dannjjm	1312	9	ponies	pony	NNS
cord-023095-4dannjjm	1312	10	was	be	VBD
cord-023095-4dannjjm	1312	11	12.57	12.57	CD
cord-023095-4dannjjm	1312	12	%	%	NN
cord-023095-4dannjjm	1312	13	(	(	-LRB-
cord-023095-4dannjjm	1312	14	4.28	4.28	CD
cord-023095-4dannjjm	1312	15	%	%	NN
cord-023095-4dannjjm	1312	16	)	)	-RRB-
cord-023095-4dannjjm	1312	17	and	and	CC
cord-023095-4dannjjm	1312	18	in	in	IN
cord-023095-4dannjjm	1312	19	1	1	CD
cord-023095-4dannjjm	1312	20	pony	pony	NN
cord-023095-4dannjjm	1312	21	(	(	-LRB-
cord-023095-4dannjjm	1312	22	6	6	CD
cord-023095-4dannjjm	1312	23	occasions	occasion	NNS
cord-023095-4dannjjm	1312	24	)	)	-RRB-
cord-023095-4dannjjm	1312	25	was	be	VBD
cord-023095-4dannjjm	1312	26	7.30	7.30	CD
cord-023095-4dannjjm	1312	27	%	%	NN
cord-023095-4dannjjm	1312	28	(	(	-LRB-
cord-023095-4dannjjm	1312	29	2.11	2.11	CD
cord-023095-4dannjjm	1312	30	%	%	NN
cord-023095-4dannjjm	1312	31	)	)	-RRB-
cord-023095-4dannjjm	1312	32	.	.	.
cord-023095-4dannjjm	1313	1	Coefficients	coefficient	NNS
cord-023095-4dannjjm	1313	2	of	of	IN
cord-023095-4dannjjm	1313	3	variation	variation	NN
cord-023095-4dannjjm	1313	4	were	be	VBD
cord-023095-4dannjjm	1313	5	34.09	34.09	CD
cord-023095-4dannjjm	1313	6	%	%	NN
cord-023095-4dannjjm	1313	7	and	and	CC
cord-023095-4dannjjm	1313	8	28.84	28.84	CD
cord-023095-4dannjjm	1313	9	%	%	NN
cord-023095-4dannjjm	1313	10	respectively	respectively	RB
cord-023095-4dannjjm	1313	11	.	.	.
cord-023095-4dannjjm	1314	1	Agreement	agreement	NN
cord-023095-4dannjjm	1314	2	between	between	IN
cord-023095-4dannjjm	1314	3	analysers	analyser	NNS
cord-023095-4dannjjm	1314	4	was	be	VBD
cord-023095-4dannjjm	1314	5	fair	fair	JJ
cord-023095-4dannjjm	1314	6	(	(	-LRB-
cord-023095-4dannjjm	1314	7	ICC	ICC	NNP
cord-023095-4dannjjm	1314	8	5	5	CD
cord-023095-4dannjjm	1314	9	0.47	0.47	CD
cord-023095-4dannjjm	1314	10	)	)	-RRB-
cord-023095-4dannjjm	1314	11	and	and	CC
cord-023095-4dannjjm	1314	12	within	within	IN
cord-023095-4dannjjm	1314	13	analyser	analyser	NN
cord-023095-4dannjjm	1314	14	was	be	VBD
cord-023095-4dannjjm	1314	15	poor	poor	JJ
cord-023095-4dannjjm	1314	16	(	(	-LRB-
cord-023095-4dannjjm	1314	17	ICC	ICC	NNP
cord-023095-4dannjjm	1314	18	5	5	CD
cord-023095-4dannjjm	1314	19	0.30	0.30	CD
cord-023095-4dannjjm	1314	20	)	)	-RRB-
cord-023095-4dannjjm	1314	21	.	.	.
cord-023095-4dannjjm	1315	1	FMD	FMD	NNP
cord-023095-4dannjjm	1315	2	is	be	VBZ
cord-023095-4dannjjm	1315	3	used	use	VBN
cord-023095-4dannjjm	1315	4	to	to	TO
cord-023095-4dannjjm	1315	5	assess	assess	VB
cord-023095-4dannjjm	1315	6	endothelial	endothelial	JJ
cord-023095-4dannjjm	1315	7	function	function	NN
cord-023095-4dannjjm	1315	8	in	in	IN
cord-023095-4dannjjm	1315	9	humans	human	NNS
cord-023095-4dannjjm	1315	10	and	and	CC
cord-023095-4dannjjm	1315	11	has	have	VBZ
cord-023095-4dannjjm	1315	12	recently	recently	RB
cord-023095-4dannjjm	1315	13	been	be	VBN
cord-023095-4dannjjm	1315	14	assessed	assess	VBN
cord-023095-4dannjjm	1315	15	for	for	IN
cord-023095-4dannjjm	1315	16	its	-PRON-	PRP$
cord-023095-4dannjjm	1315	17	use	use	NN
cord-023095-4dannjjm	1315	18	in	in	IN
cord-023095-4dannjjm	1315	19	canine	canine	JJ
cord-023095-4dannjjm	1315	20	subjects	subject	NNS
cord-023095-4dannjjm	1315	21	.	.	.
cord-023095-4dannjjm	1316	1	FMD	FMD	NNP
cord-023095-4dannjjm	1316	2	occurs	occur	VBZ
cord-023095-4dannjjm	1316	3	and	and	CC
cord-023095-4dannjjm	1316	4	measurement	measurement	NN
cord-023095-4dannjjm	1316	5	is	be	VBZ
cord-023095-4dannjjm	1316	6	feasible	feasible	JJ
cord-023095-4dannjjm	1316	7	in	in	IN
cord-023095-4dannjjm	1316	8	ponies	pony	NNS
cord-023095-4dannjjm	1316	9	.	.	.
cord-023095-4dannjjm	1317	1	FMD	FMD	NNP
cord-023095-4dannjjm	1317	2	could	could	MD
cord-023095-4dannjjm	1317	3	be	be	VB
cord-023095-4dannjjm	1317	4	used	use	VBN
cord-023095-4dannjjm	1317	5	to	to	TO
cord-023095-4dannjjm	1317	6	assess	assess	VB
cord-023095-4dannjjm	1317	7	endothelial	endothelial	JJ
cord-023095-4dannjjm	1317	8	function	function	NN
cord-023095-4dannjjm	1317	9	,	,	,
cord-023095-4dannjjm	1317	10	in	in	IN
cord-023095-4dannjjm	1317	11	the	the	DT
cord-023095-4dannjjm	1317	12	context	context	NN
cord-023095-4dannjjm	1317	13	of	of	IN
cord-023095-4dannjjm	1317	14	laminitis	laminitis	NN
cord-023095-4dannjjm	1317	15	or	or	CC
cord-023095-4dannjjm	1317	16	other	other	JJ
cord-023095-4dannjjm	1317	17	cardiovascular	cardiovascular	JJ
cord-023095-4dannjjm	1317	18	diseases	disease	NNS
cord-023095-4dannjjm	1317	19	.	.	.
cord-023095-4dannjjm	1318	1	Current	current	JJ
cord-023095-4dannjjm	1318	2	state	state	NN
cord-023095-4dannjjm	1318	3	-	-	HYPH
cord-023095-4dannjjm	1318	4	of	of	IN
cord-023095-4dannjjm	1318	5	-	-	HYPH
cord-023095-4dannjjm	1318	6	the	the	DT
cord-023095-4dannjjm	1318	7	-	-	HYPH
cord-023095-4dannjjm	1318	8	art	art	NN
cord-023095-4dannjjm	1318	9	technique	technique	NN
cord-023095-4dannjjm	1318	10	for	for	IN
cord-023095-4dannjjm	1318	11	measuring	measure	VBG
cord-023095-4dannjjm	1318	12	blood	blood	NN
cord-023095-4dannjjm	1318	13	pressure	pressure	NN
cord-023095-4dannjjm	1318	14	(	(	-LRB-
cord-023095-4dannjjm	1318	15	BP	BP	NNP
cord-023095-4dannjjm	1318	16	)	)	-RRB-
cord-023095-4dannjjm	1318	17	in	in	IN
cord-023095-4dannjjm	1318	18	the	the	DT
cord-023095-4dannjjm	1318	19	horse	horse	NN
cord-023095-4dannjjm	1318	20	is	be	VBZ
cord-023095-4dannjjm	1318	21	invasive	invasive	JJ
cord-023095-4dannjjm	1318	22	and	and	CC
cord-023095-4dannjjm	1318	23	involves	involve	VBZ
cord-023095-4dannjjm	1318	24	cannulation	cannulation	NN
cord-023095-4dannjjm	1318	25	of	of	IN
cord-023095-4dannjjm	1318	26	the	the	DT
cord-023095-4dannjjm	1318	27	facial	facial	JJ
cord-023095-4dannjjm	1318	28	artery	artery	NN
cord-023095-4dannjjm	1318	29	.	.	.
cord-023095-4dannjjm	1319	1	Indirect	indirect	JJ
cord-023095-4dannjjm	1319	2	techniques	technique	NNS
cord-023095-4dannjjm	1319	3	,	,	,
cord-023095-4dannjjm	1319	4	such	such	JJ
cord-023095-4dannjjm	1319	5	as	as	IN
cord-023095-4dannjjm	1319	6	oscillometry	oscillometry	NNP
cord-023095-4dannjjm	1319	7	,	,	,
cord-023095-4dannjjm	1319	8	have	have	VBP
cord-023095-4dannjjm	1319	9	proven	prove	VBN
cord-023095-4dannjjm	1319	10	useful	useful	JJ
cord-023095-4dannjjm	1319	11	in	in	IN
cord-023095-4dannjjm	1319	12	the	the	DT
cord-023095-4dannjjm	1319	13	anaesthetised	anaesthetised	JJ
cord-023095-4dannjjm	1319	14	horse	horse	NN
cord-023095-4dannjjm	1319	15	,	,	,
cord-023095-4dannjjm	1319	16	but	but	CC
cord-023095-4dannjjm	1319	17	have	have	VBP
cord-023095-4dannjjm	1319	18	not	not	RB
cord-023095-4dannjjm	1319	19	become	become	VBN
cord-023095-4dannjjm	1319	20	routine	routine	JJ
cord-023095-4dannjjm	1319	21	in	in	IN
cord-023095-4dannjjm	1319	22	the	the	DT
cord-023095-4dannjjm	1319	23	standing	standing	JJ
cord-023095-4dannjjm	1319	24	horse	horse	NN
cord-023095-4dannjjm	1319	25	.	.	.
cord-023095-4dannjjm	1320	1	Monitoring	Monitoring	NNP
cord-023095-4dannjjm	1320	2	BP	BP	NNP
cord-023095-4dannjjm	1320	3	can	can	MD
cord-023095-4dannjjm	1320	4	be	be	VB
cord-023095-4dannjjm	1320	5	indicated	indicate	VBN
cord-023095-4dannjjm	1320	6	for	for	IN
cord-023095-4dannjjm	1320	7	the	the	DT
cord-023095-4dannjjm	1320	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	1320	9	and	and	CC
cord-023095-4dannjjm	1320	10	treatment	treatment	NN
cord-023095-4dannjjm	1320	11	of	of	IN
cord-023095-4dannjjm	1320	12	the	the	DT
cord-023095-4dannjjm	1320	13	hypotensive	hypotensive	JJ
cord-023095-4dannjjm	1320	14	patient	patient	NN
cord-023095-4dannjjm	1320	15	(	(	-LRB-
cord-023095-4dannjjm	1320	16	ie	ie	FW
cord-023095-4dannjjm	1320	17	.	.	.
cord-023095-4dannjjm	1320	18	caused	cause	VBN
cord-023095-4dannjjm	1320	19	by	by	IN
cord-023095-4dannjjm	1320	20	endotoxemia	endotoxemia	NN
cord-023095-4dannjjm	1320	21	,	,	,
cord-023095-4dannjjm	1320	22	hypovolemia	hypovolemia	NN
cord-023095-4dannjjm	1320	23	,	,	,
cord-023095-4dannjjm	1321	1	Systemic	systemic	JJ
cord-023095-4dannjjm	1321	2	Inflammatory	Inflammatory	NNP
cord-023095-4dannjjm	1321	3	Response	Response	NNP
cord-023095-4dannjjm	1321	4	Syndrome	Syndrome	NNP
cord-023095-4dannjjm	1321	5	and	and	CC
cord-023095-4dannjjm	1321	6	cardiac	cardiac	JJ
cord-023095-4dannjjm	1321	7	failure	failure	NN
cord-023095-4dannjjm	1321	8	)	)	-RRB-
cord-023095-4dannjjm	1321	9	or	or	CC
cord-023095-4dannjjm	1321	10	the	the	DT
cord-023095-4dannjjm	1321	11	hypertensive	hypertensive	JJ
cord-023095-4dannjjm	1321	12	patient	patient	NN
cord-023095-4dannjjm	1321	13	(	(	-LRB-
cord-023095-4dannjjm	1322	1	ie	ie	NNP
cord-023095-4dannjjm	1322	2	.	.	.
cord-023095-4dannjjm	1323	1	due	due	IN
cord-023095-4dannjjm	1323	2	to	to	IN
cord-023095-4dannjjm	1323	3	equine	equine	JJ
cord-023095-4dannjjm	1323	4	metabolic	metabolic	JJ
cord-023095-4dannjjm	1323	5	syndrome	syndrome	NN
cord-023095-4dannjjm	1323	6	or	or	CC
cord-023095-4dannjjm	1323	7	pain	pain	NN
cord-023095-4dannjjm	1323	8	)	)	-RRB-
cord-023095-4dannjjm	1323	9	.	.	.
cord-023095-4dannjjm	1324	1	The	the	DT
cord-023095-4dannjjm	1324	2	objective	objective	NN
cord-023095-4dannjjm	1324	3	of	of	IN
cord-023095-4dannjjm	1324	4	this	this	DT
cord-023095-4dannjjm	1324	5	study	study	NN
cord-023095-4dannjjm	1324	6	was	be	VBD
cord-023095-4dannjjm	1324	7	therefore	therefore	RB
cord-023095-4dannjjm	1324	8	to	to	IN
cord-023095-4dannjjm	1324	9	a	a	DT
cord-023095-4dannjjm	1324	10	)	)	-RRB-
cord-023095-4dannjjm	1324	11	describe	describe	VB
cord-023095-4dannjjm	1324	12	the	the	DT
cord-023095-4dannjjm	1324	13	methodology	methodology	NN
cord-023095-4dannjjm	1324	14	for	for	IN
cord-023095-4dannjjm	1324	15	application	application	NN
cord-023095-4dannjjm	1324	16	of	of	IN
cord-023095-4dannjjm	1324	17	oscillometric	oscillometric	NNP
cord-023095-4dannjjm	1324	18	BP	BP	NNP
cord-023095-4dannjjm	1324	19	using	use	VBG
cord-023095-4dannjjm	1324	20	a	a	DT
cord-023095-4dannjjm	1324	21	cuff	cuff	NN
cord-023095-4dannjjm	1324	22	applied	apply	VBN
cord-023095-4dannjjm	1324	23	to	to	IN
cord-023095-4dannjjm	1324	24	the	the	DT
cord-023095-4dannjjm	1324	25	tail	tail	NN
cord-023095-4dannjjm	1324	26	in	in	IN
cord-023095-4dannjjm	1324	27	the	the	DT
cord-023095-4dannjjm	1324	28	standing	standing	NN
cord-023095-4dannjjm	1324	29	horse	horse	NN
cord-023095-4dannjjm	1324	30	and	and	CC
cord-023095-4dannjjm	1324	31	b	b	LS
cord-023095-4dannjjm	1324	32	)	)	-RRB-
cord-023095-4dannjjm	1324	33	and	and	CC
cord-023095-4dannjjm	1324	34	to	to	TO
cord-023095-4dannjjm	1324	35	determine	determine	VB
cord-023095-4dannjjm	1324	36	accuracy	accuracy	NN
cord-023095-4dannjjm	1324	37	and	and	CC
cord-023095-4dannjjm	1324	38	precision	precision	NN
cord-023095-4dannjjm	1324	39	of	of	IN
cord-023095-4dannjjm	1324	40	this	this	DT
cord-023095-4dannjjm	1324	41	method	method	NN
cord-023095-4dannjjm	1324	42	applied	apply	VBN
cord-023095-4dannjjm	1324	43	to	to	IN
cord-023095-4dannjjm	1324	44	the	the	DT
cord-023095-4dannjjm	1324	45	normotensive	normotensive	JJ
cord-023095-4dannjjm	1324	46	standing	standing	NNP
cord-023095-4dannjjm	1324	47	horse	horse	NN
cord-023095-4dannjjm	1324	48	.	.	.
cord-023095-4dannjjm	1325	1	The	the	DT
cord-023095-4dannjjm	1325	2	oscillometric	oscillometric	JJ
cord-023095-4dannjjm	1325	3	method	method	NN
cord-023095-4dannjjm	1325	4	is	be	VBZ
cord-023095-4dannjjm	1325	5	simple	simple	JJ
cord-023095-4dannjjm	1325	6	to	to	TO
cord-023095-4dannjjm	1325	7	apply	apply	VB
cord-023095-4dannjjm	1325	8	in	in	IN
cord-023095-4dannjjm	1325	9	a	a	DT
cord-023095-4dannjjm	1325	10	clinical	clinical	JJ
cord-023095-4dannjjm	1325	11	setting	setting	NN
cord-023095-4dannjjm	1325	12	.	.	.
cord-023095-4dannjjm	1326	1	A	a	DT
cord-023095-4dannjjm	1326	2	pneumatic	pneumatic	JJ
cord-023095-4dannjjm	1326	3	cuff	cuff	NN
cord-023095-4dannjjm	1326	4	is	be	VBZ
cord-023095-4dannjjm	1326	5	snugly	snugly	RB
cord-023095-4dannjjm	1326	6	applied	apply	VBN
cord-023095-4dannjjm	1326	7	to	to	IN
cord-023095-4dannjjm	1326	8	the	the	DT
cord-023095-4dannjjm	1326	9	unclipped	unclipped	JJ
cord-023095-4dannjjm	1326	10	tail	tail	NN
cord-023095-4dannjjm	1326	11	-	-	HYPH
cord-023095-4dannjjm	1326	12	base	base	NN
cord-023095-4dannjjm	1326	13	with	with	IN
cord-023095-4dannjjm	1326	14	the	the	DT
cord-023095-4dannjjm	1326	15	cuff	cuff	NN
cord-023095-4dannjjm	1326	16	bladder	bladder	NN
cord-023095-4dannjjm	1326	17	centered	center	VBN
cord-023095-4dannjjm	1326	18	over	over	IN
cord-023095-4dannjjm	1326	19	the	the	DT
cord-023095-4dannjjm	1326	20	middle	middle	JJ
cord-023095-4dannjjm	1326	21	coccygeal	coccygeal	NN
cord-023095-4dannjjm	1326	22	artery	artery	NN
cord-023095-4dannjjm	1326	23	.	.	.
cord-023095-4dannjjm	1327	1	The	the	DT
cord-023095-4dannjjm	1327	2	tail	tail	NN
cord-023095-4dannjjm	1327	3	circumference	circumference	NN
cord-023095-4dannjjm	1327	4	must	must	MD
cord-023095-4dannjjm	1327	5	match	match	VB
cord-023095-4dannjjm	1327	6	the	the	DT
cord-023095-4dannjjm	1327	7	manufacturers	manufacturer	NNS
cord-023095-4dannjjm	1327	8	description	description	NN
cord-023095-4dannjjm	1327	9	of	of	IN
cord-023095-4dannjjm	1327	10	the	the	DT
cord-023095-4dannjjm	1327	11	cuffs	cuff	NNS
cord-023095-4dannjjm	1327	12	diameter	diameter	NN
cord-023095-4dannjjm	1327	13	range	range	NN
cord-023095-4dannjjm	1327	14	.	.	.
cord-023095-4dannjjm	1328	1	The	the	DT
cord-023095-4dannjjm	1328	2	oscillometric	oscillometric	NN
cord-023095-4dannjjm	1328	3	apparatus	apparatus	NN
cord-023095-4dannjjm	1328	4	inflates	inflate	VBZ
cord-023095-4dannjjm	1328	5	the	the	DT
cord-023095-4dannjjm	1328	6	cuff	cuff	NN
cord-023095-4dannjjm	1328	7	and	and	CC
cord-023095-4dannjjm	1328	8	obtain	obtain	VB
cord-023095-4dannjjm	1328	9	systolic	systolic	JJ
cord-023095-4dannjjm	1328	10	,	,	,
cord-023095-4dannjjm	1328	11	diastolic	diastolic	JJ
cord-023095-4dannjjm	1328	12	and	and	CC
cord-023095-4dannjjm	1328	13	mean	mean	VBP
cord-023095-4dannjjm	1328	14	arterial	arterial	JJ
cord-023095-4dannjjm	1328	15	BP	BP	NNP
cord-023095-4dannjjm	1328	16	(	(	-LRB-
cord-023095-4dannjjm	1328	17	SAP	SAP	NNP
cord-023095-4dannjjm	1328	18	,	,	,
cord-023095-4dannjjm	1328	19	DAP	DAP	NNP
cord-023095-4dannjjm	1328	20	and	and	CC
cord-023095-4dannjjm	1328	21	MAP	MAP	NNP
cord-023095-4dannjjm	1328	22	)	)	-RRB-
cord-023095-4dannjjm	1328	23	.	.	.
cord-023095-4dannjjm	1329	1	At	at	RB
cord-023095-4dannjjm	1329	2	least	least	JJS
cord-023095-4dannjjm	1329	3	2	2	CD
cord-023095-4dannjjm	1329	4	consecutive	consecutive	JJ
cord-023095-4dannjjm	1329	5	measurements	measurement	NNS
cord-023095-4dannjjm	1329	6	must	must	MD
cord-023095-4dannjjm	1329	7	be	be	VB
cord-023095-4dannjjm	1329	8	obtained	obtain	VBN
cord-023095-4dannjjm	1329	9	.	.	.
cord-023095-4dannjjm	1330	1	A	a	DT
cord-023095-4dannjjm	1330	2	correction	correction	NN
cord-023095-4dannjjm	1330	3	of	of	IN
cord-023095-4dannjjm	1330	4	0.7	0.7	CD
cord-023095-4dannjjm	1330	5	mmHg	mmHg	NNS
cord-023095-4dannjjm	1330	6	/	/	SYM
cord-023095-4dannjjm	1330	7	cm	cm	NN
cord-023095-4dannjjm	1330	8	vertical	vertical	JJ
cord-023095-4dannjjm	1330	9	distance	distance	NN
cord-023095-4dannjjm	1330	10	between	between	IN
cord-023095-4dannjjm	1330	11	cuff	cuff	NN
cord-023095-4dannjjm	1330	12	and	and	CC
cord-023095-4dannjjm	1330	13	heart	heart	NN
cord-023095-4dannjjm	1330	14	level	level	NN
cord-023095-4dannjjm	1330	15	is	be	VBZ
cord-023095-4dannjjm	1330	16	added	add	VBN
cord-023095-4dannjjm	1330	17	to	to	IN
cord-023095-4dannjjm	1330	18	the	the	DT
cord-023095-4dannjjm	1330	19	measurement	measurement	NN
cord-023095-4dannjjm	1330	20	to	to	TO
cord-023095-4dannjjm	1330	21	correct	correct	VB
cord-023095-4dannjjm	1330	22	for	for	IN
cord-023095-4dannjjm	1330	23	hydrostatic	hydrostatic	JJ
cord-023095-4dannjjm	1330	24	pressure	pressure	NN
cord-023095-4dannjjm	1330	25	difference	difference	NN
cord-023095-4dannjjm	1330	26	.	.	.
cord-023095-4dannjjm	1331	1	For	for	IN
cord-023095-4dannjjm	1331	2	determination	determination	NN
cord-023095-4dannjjm	1331	3	of	of	IN
cord-023095-4dannjjm	1331	4	accuracy	accuracy	NN
cord-023095-4dannjjm	1331	5	and	and	CC
cord-023095-4dannjjm	1331	6	precision	precision	NN
cord-023095-4dannjjm	1331	7	of	of	IN
cord-023095-4dannjjm	1331	8	indirect	indirect	JJ
cord-023095-4dannjjm	1331	9	SAP	SAP	NNP
cord-023095-4dannjjm	1331	10	,	,	,
cord-023095-4dannjjm	1331	11	DAP	DAP	NNP
cord-023095-4dannjjm	1331	12	and	and	CC
cord-023095-4dannjjm	1331	13	MAP	MAP	NNP
cord-023095-4dannjjm	1331	14	,	,	,
cord-023095-4dannjjm	1331	15	eight	eight	CD
cord-023095-4dannjjm	1331	16	healthy	healthy	JJ
cord-023095-4dannjjm	1331	17	horses	horse	NNS
cord-023095-4dannjjm	1331	18	(	(	-LRB-
cord-023095-4dannjjm	1331	19	age	age	NN
cord-023095-4dannjjm	1331	20	3	3	CD
cord-023095-4dannjjm	1331	21	to	to	TO
cord-023095-4dannjjm	1331	22	16	16	CD
cord-023095-4dannjjm	1331	23	years	year	NNS
cord-023095-4dannjjm	1331	24	)	)	-RRB-
cord-023095-4dannjjm	1331	25	,	,	,
cord-023095-4dannjjm	1331	26	was	be	VBD
cord-023095-4dannjjm	1331	27	equipped	equip	VBN
cord-023095-4dannjjm	1331	28	with	with	IN
cord-023095-4dannjjm	1331	29	an	an	DT
cord-023095-4dannjjm	1331	30	intra	intra	JJ
cord-023095-4dannjjm	1331	31	-	-	JJ
cord-023095-4dannjjm	1331	32	arterial	arterial	JJ
cord-023095-4dannjjm	1331	33	catheter	catheter	NN
cord-023095-4dannjjm	1331	34	ii	ii	NN
cord-023095-4dannjjm	1331	35	in	in	IN
cord-023095-4dannjjm	1331	36	the	the	DT
cord-023095-4dannjjm	1331	37	facial	facial	JJ
cord-023095-4dannjjm	1331	38	artery	artery	NN
cord-023095-4dannjjm	1331	39	and	and	CC
cord-023095-4dannjjm	1331	40	a	a	DT
cord-023095-4dannjjm	1331	41	commercial	commercial	JJ
cord-023095-4dannjjm	1331	42	tail	tail	NN
cord-023095-4dannjjm	1331	43	-	-	HYPH
cord-023095-4dannjjm	1331	44	cuff	cuff	NN
cord-023095-4dannjjm	1331	45	oscillometric	oscillometric	NN
cord-023095-4dannjjm	1331	46	apparatus	apparatus	NN
cord-023095-4dannjjm	1331	47	.	.	.
cord-023095-4dannjjm	1332	1	i	i	PRP
cord-023095-4dannjjm	1332	2	Measurements	Measurements	NNPS
cord-023095-4dannjjm	1332	3	were	be	VBD
cord-023095-4dannjjm	1332	4	recorded	record	VBN
cord-023095-4dannjjm	1332	5	every	every	DT
cord-023095-4dannjjm	1332	6	2	2	CD
cord-023095-4dannjjm	1332	7	minutes	minute	NNS
cord-023095-4dannjjm	1332	8	for	for	IN
cord-023095-4dannjjm	1332	9	20	20	CD
cord-023095-4dannjjm	1332	10	minutes	minute	NNS
cord-023095-4dannjjm	1332	11	.	.	.
cord-023095-4dannjjm	1333	1	The	the	DT
cord-023095-4dannjjm	1333	2	data	datum	NNS
cord-023095-4dannjjm	1333	3	were	be	VBD
cord-023095-4dannjjm	1333	4	analysed	analyse	VBN
cord-023095-4dannjjm	1333	5	with	with	IN
cord-023095-4dannjjm	1333	6	the	the	DT
cord-023095-4dannjjm	1333	7	statistical	statistical	JJ
cord-023095-4dannjjm	1333	8	software	software	NN
cord-023095-4dannjjm	1333	9	R	r	NN
cord-023095-4dannjjm	1333	10	using	use	VBG
cord-023095-4dannjjm	1333	11	a	a	DT
cord-023095-4dannjjm	1333	12	mixed	mixed	JJ
cord-023095-4dannjjm	1333	13	model	model	NN
cord-023095-4dannjjm	1333	14	with	with	IN
cord-023095-4dannjjm	1333	15	repeated	repeat	VBN
cord-023095-4dannjjm	1333	16	measurements	measurement	NNS
cord-023095-4dannjjm	1333	17	and	and	CC
cord-023095-4dannjjm	1333	18	a	a	DT
cord-023095-4dannjjm	1333	19	Bland	Bland	NNP
cord-023095-4dannjjm	1333	20	-	-	HYPH
cord-023095-4dannjjm	1333	21	Altman	Altman	NNP
cord-023095-4dannjjm	1333	22	analysis	analysis	NN
cord-023095-4dannjjm	1333	23	corrected	correct	VBD
cord-023095-4dannjjm	1333	24	for	for	IN
cord-023095-4dannjjm	1333	25	repeated	repeat	VBN
cord-023095-4dannjjm	1333	26	measurements	measurement	NNS
cord-023095-4dannjjm	1333	27	.	.	.
cord-023095-4dannjjm	1334	1	Oscillometric	Oscillometric	NNP
cord-023095-4dannjjm	1334	2	BP	BP	NNP
cord-023095-4dannjjm	1334	3	was	be	VBD
cord-023095-4dannjjm	1334	4	accurate	accurate	JJ
cord-023095-4dannjjm	1334	5	and	and	CC
cord-023095-4dannjjm	1334	6	precise	precise	JJ
cord-023095-4dannjjm	1334	7	for	for	IN
cord-023095-4dannjjm	1334	8	MAP	MAP	NNP
cord-023095-4dannjjm	1334	9	(	(	-LRB-
cord-023095-4dannjjm	1334	10	mean	mean	VB
cord-023095-4dannjjm	1334	11	bias	bias	NN
cord-023095-4dannjjm	1334	12	,	,	,
cord-023095-4dannjjm	1334	13	lower	lower	VB
cord-023095-4dannjjm	1334	14	confidence	confidence	NN
cord-023095-4dannjjm	1334	15	level	level	NN
cord-023095-4dannjjm	1334	16	,	,	,
cord-023095-4dannjjm	1334	17	upper	upper	JJ
cord-023095-4dannjjm	1334	18	confidence	confidence	NN
cord-023095-4dannjjm	1334	19	level	level	NN
cord-023095-4dannjjm	1334	20	,	,	,
cord-023095-4dannjjm	1334	21	variation	variation	NN
cord-023095-4dannjjm	1334	22	in	in	IN
cord-023095-4dannjjm	1334	23	difference	difference	NN
cord-023095-4dannjjm	1334	24	,	,	,
cord-023095-4dannjjm	1334	25	all	all	DT
cord-023095-4dannjjm	1334	26	mmHg	mmHg	NNS
cord-023095-4dannjjm	1334	27	)	)	-RRB-
cord-023095-4dannjjm	1334	28	(	(	-LRB-
cord-023095-4dannjjm	1334	29	À0.3	À0.3	NNP
cord-023095-4dannjjm	1334	30	,	,	,
cord-023095-4dannjjm	1334	31	À18.5	à18.5	CD
cord-023095-4dannjjm	1334	32	,	,	,
cord-023095-4dannjjm	1334	33	19.1	19.1	CD
cord-023095-4dannjjm	1334	34	,	,	,
cord-023095-4dannjjm	1334	35	33.2	33.2	CD
cord-023095-4dannjjm	1334	36	,	,	,
cord-023095-4dannjjm	1334	37	respectively	respectively	RB
cord-023095-4dannjjm	1334	38	)	)	-RRB-
cord-023095-4dannjjm	1334	39	in	in	IN
cord-023095-4dannjjm	1334	40	the	the	DT
cord-023095-4dannjjm	1334	41	conscious	conscious	JJ
cord-023095-4dannjjm	1334	42	horse	horse	NN
cord-023095-4dannjjm	1334	43	but	but	CC
cord-023095-4dannjjm	1334	44	not	not	RB
cord-023095-4dannjjm	1334	45	for	for	IN
cord-023095-4dannjjm	1334	46	SAP	SAP	NNP
cord-023095-4dannjjm	1334	47	(	(	-LRB-
cord-023095-4dannjjm	1334	48	À1.5	À1.5	NNS
cord-023095-4dannjjm	1334	49	,	,	,
cord-023095-4dannjjm	1334	50	À19.3	à19.3	CD
cord-023095-4dannjjm	1334	51	,	,	,
cord-023095-4dannjjm	1334	52	16.3	16.3	CD
cord-023095-4dannjjm	1334	53	,	,	,
cord-023095-4dannjjm	1334	54	38.2	38.2	CD
cord-023095-4dannjjm	1334	55	,	,	,
cord-023095-4dannjjm	1334	56	respectively	respectively	RB
cord-023095-4dannjjm	1334	57	)	)	-RRB-
cord-023095-4dannjjm	1334	58	and	and	CC
cord-023095-4dannjjm	1334	59	DAP	DAP	NNP
cord-023095-4dannjjm	1334	60	(	(	-LRB-
cord-023095-4dannjjm	1334	61	0.05	0.05	CD
cord-023095-4dannjjm	1334	62	,	,	,
cord-023095-4dannjjm	1334	63	15.9	15.9	CD
cord-023095-4dannjjm	1334	64	,	,	,
cord-023095-4dannjjm	1334	65	16.0	16.0	CD
cord-023095-4dannjjm	1334	66	,	,	,
cord-023095-4dannjjm	1334	67	49	49	CD
cord-023095-4dannjjm	1334	68	,	,	,
cord-023095-4dannjjm	1334	69	respectively	respectively	RB
cord-023095-4dannjjm	1334	70	)	)	-RRB-
cord-023095-4dannjjm	1334	71	.	.	.
cord-023095-4dannjjm	1335	1	There	there	EX
cord-023095-4dannjjm	1335	2	was	be	VBD
cord-023095-4dannjjm	1335	3	no	no	DT
cord-023095-4dannjjm	1335	4	significant	significant	JJ
cord-023095-4dannjjm	1335	5	contribution	contribution	NN
cord-023095-4dannjjm	1335	6	to	to	IN
cord-023095-4dannjjm	1335	7	the	the	DT
cord-023095-4dannjjm	1335	8	statistical	statistical	JJ
cord-023095-4dannjjm	1335	9	model	model	NN
cord-023095-4dannjjm	1335	10	of	of	IN
cord-023095-4dannjjm	1335	11	either	either	DT
cord-023095-4dannjjm	1335	12	horse	horse	NN
cord-023095-4dannjjm	1335	13	or	or	CC
cord-023095-4dannjjm	1335	14	measurement	measurement	NN
cord-023095-4dannjjm	1335	15	number	number	NN
cord-023095-4dannjjm	1335	16	.	.	.
cord-023095-4dannjjm	1336	1	All	all	DT
cord-023095-4dannjjm	1336	2	horses	horse	NNS
cord-023095-4dannjjm	1336	3	tolerated	tolerate	VBD
cord-023095-4dannjjm	1336	4	the	the	DT
cord-023095-4dannjjm	1336	5	tail	tail	NN
cord-023095-4dannjjm	1336	6	-	-	HYPH
cord-023095-4dannjjm	1336	7	cuff	cuff	NN
cord-023095-4dannjjm	1336	8	well	well	NN
cord-023095-4dannjjm	1336	9	and	and	CC
cord-023095-4dannjjm	1336	10	the	the	DT
cord-023095-4dannjjm	1336	11	method	method	NN
cord-023095-4dannjjm	1336	12	was	be	VBD
cord-023095-4dannjjm	1336	13	simple	simple	JJ
cord-023095-4dannjjm	1336	14	to	to	TO
cord-023095-4dannjjm	1336	15	apply	apply	VB
cord-023095-4dannjjm	1336	16	.	.	.
cord-023095-4dannjjm	1337	1	Only	only	RB
cord-023095-4dannjjm	1337	2	MAP	MAP	NNP
cord-023095-4dannjjm	1337	3	could	could	MD
cord-023095-4dannjjm	1337	4	be	be	VB
cord-023095-4dannjjm	1337	5	measured	measure	VBN
cord-023095-4dannjjm	1337	6	with	with	IN
cord-023095-4dannjjm	1337	7	acceptable	acceptable	JJ
cord-023095-4dannjjm	1337	8	accuracy	accuracy	NN
cord-023095-4dannjjm	1337	9	and	and	CC
cord-023095-4dannjjm	1337	10	precision	precision	NN
cord-023095-4dannjjm	1337	11	in	in	IN
cord-023095-4dannjjm	1337	12	the	the	DT
cord-023095-4dannjjm	1337	13	normotensive	normotensive	JJ
cord-023095-4dannjjm	1337	14	standing	standing	NNP
cord-023095-4dannjjm	1337	15	horse	horse	NN
cord-023095-4dannjjm	1337	16	using	use	VBG
cord-023095-4dannjjm	1337	17	the	the	DT
cord-023095-4dannjjm	1337	18	described	describe	VBN
cord-023095-4dannjjm	1337	19	oscillometric	oscillometric	JJ
cord-023095-4dannjjm	1337	20	method	method	NN
cord-023095-4dannjjm	1337	21	.	.	.
cord-023095-4dannjjm	1338	1	Reference	reference	NN
cord-023095-4dannjjm	1338	2	intervals	interval	NNS
cord-023095-4dannjjm	1338	3	for	for	IN
cord-023095-4dannjjm	1338	4	thyroid	thyroid	NN
cord-023095-4dannjjm	1338	5	hormone	hormone	NN
cord-023095-4dannjjm	1338	6	(	(	-LRB-
cord-023095-4dannjjm	1338	7	TH	TH	NNP
cord-023095-4dannjjm	1338	8	)	)	-RRB-
cord-023095-4dannjjm	1338	9	concentrations	concentration	NNS
cord-023095-4dannjjm	1338	10	have	have	VBP
cord-023095-4dannjjm	1338	11	not	not	RB
cord-023095-4dannjjm	1338	12	been	be	VBN
cord-023095-4dannjjm	1338	13	established	establish	VBN
cord-023095-4dannjjm	1338	14	for	for	IN
cord-023095-4dannjjm	1338	15	donkeys	donkey	NNS
cord-023095-4dannjjm	1338	16	.	.	.
cord-023095-4dannjjm	1339	1	Therefore	therefore	RB
cord-023095-4dannjjm	1339	2	,	,	,
cord-023095-4dannjjm	1339	3	clinicians	clinician	NNS
cord-023095-4dannjjm	1339	4	must	must	MD
cord-023095-4dannjjm	1339	5	use	use	VB
cord-023095-4dannjjm	1339	6	reference	reference	NN
cord-023095-4dannjjm	1339	7	ranges	range	NNS
cord-023095-4dannjjm	1339	8	from	from	IN
cord-023095-4dannjjm	1339	9	horses	horse	NNS
cord-023095-4dannjjm	1339	10	,	,	,
cord-023095-4dannjjm	1339	11	potentially	potentially	RB
cord-023095-4dannjjm	1339	12	leading	lead	VBG
cord-023095-4dannjjm	1339	13	to	to	IN
cord-023095-4dannjjm	1339	14	misdiagnosis	misdiagnosis	NN
cord-023095-4dannjjm	1339	15	of	of	IN
cord-023095-4dannjjm	1339	16	thyroid	thyroid	JJ
cord-023095-4dannjjm	1339	17	diseases	disease	NNS
cord-023095-4dannjjm	1339	18	.	.	.
cord-023095-4dannjjm	1340	1	We	-PRON-	PRP
cord-023095-4dannjjm	1340	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1340	3	that	that	IN
cord-023095-4dannjjm	1340	4	TH	TH	NNP
cord-023095-4dannjjm	1340	5	concentrations	concentration	NNS
cord-023095-4dannjjm	1340	6	are	be	VBP
cord-023095-4dannjjm	1340	7	different	different	JJ
cord-023095-4dannjjm	1340	8	between	between	IN
cord-023095-4dannjjm	1340	9	donkeys	donkey	NNS
cord-023095-4dannjjm	1340	10	and	and	CC
cord-023095-4dannjjm	1340	11	horses	horse	NNS
cord-023095-4dannjjm	1340	12	.	.	.
cord-023095-4dannjjm	1341	1	The	the	DT
cord-023095-4dannjjm	1341	2	purposes	purpose	NNS
cord-023095-4dannjjm	1341	3	of	of	IN
cord-023095-4dannjjm	1341	4	this	this	DT
cord-023095-4dannjjm	1341	5	study	study	NN
cord-023095-4dannjjm	1341	6	were	be	VBD
cord-023095-4dannjjm	1341	7	:	:	:
cord-023095-4dannjjm	1341	8	a	a	LS
cord-023095-4dannjjm	1341	9	)	)	-RRB-
cord-023095-4dannjjm	1341	10	to	to	TO
cord-023095-4dannjjm	1341	11	compare	compare	VB
cord-023095-4dannjjm	1341	12	TH	TH	NNP
cord-023095-4dannjjm	1341	13	concentrations	concentration	NNS
cord-023095-4dannjjm	1341	14	between	between	IN
cord-023095-4dannjjm	1341	15	donkeys	donkey	NNS
cord-023095-4dannjjm	1341	16	and	and	CC
cord-023095-4dannjjm	1341	17	horses	horse	NNS
cord-023095-4dannjjm	1341	18	and	and	CC
cord-023095-4dannjjm	1341	19	,	,	,
cord-023095-4dannjjm	1341	20	b	b	LS
cord-023095-4dannjjm	1341	21	)	)	-RRB-
cord-023095-4dannjjm	1341	22	to	to	TO
cord-023095-4dannjjm	1341	23	determine	determine	VB
cord-023095-4dannjjm	1341	24	whether	whether	IN
cord-023095-4dannjjm	1341	25	the	the	DT
cord-023095-4dannjjm	1341	26	age	age	NN
cord-023095-4dannjjm	1341	27	may	may	MD
cord-023095-4dannjjm	1341	28	influence	influence	VB
cord-023095-4dannjjm	1341	29	TH	TH	NNP
cord-023095-4dannjjm	1341	30	concentrations	concentration	NNS
cord-023095-4dannjjm	1341	31	.	.	.
cord-023095-4dannjjm	1342	1	Thirty	thirty	CD
cord-023095-4dannjjm	1342	2	-	-	HYPH
cord-023095-4dannjjm	1342	3	eight	eight	CD
cord-023095-4dannjjm	1342	4	healthy	healthy	JJ
cord-023095-4dannjjm	1342	5	donkeys	donkey	NNS
cord-023095-4dannjjm	1342	6	(	(	-LRB-
cord-023095-4dannjjm	1342	7	8.5	8.5	CD
cord-023095-4dannjjm	1342	8	AE	AE	NNP
cord-023095-4dannjjm	1342	9	0.8	0.8	CD
cord-023095-4dannjjm	1342	10	years	year	NNS
cord-023095-4dannjjm	1342	11	)	)	-RRB-
cord-023095-4dannjjm	1342	12	,	,	.
cord-023095-4dannjjm	1343	1	mixed	mixed	JJ
cord-023095-4dannjjm	1343	2	breeds	breed	NNS
cord-023095-4dannjjm	1343	3	,	,	,
cord-023095-4dannjjm	1343	4	and	and	CC
cord-023095-4dannjjm	1343	5	20	20	CD
cord-023095-4dannjjm	1343	6	healthy	healthy	JJ
cord-023095-4dannjjm	1343	7	Andalusian	andalusian	JJ
cord-023095-4dannjjm	1343	8	horses	horse	NNS
cord-023095-4dannjjm	1343	9	(	(	-LRB-
cord-023095-4dannjjm	1343	10	6.4	6.4	CD
cord-023095-4dannjjm	1343	11	AE	AE	NNP
cord-023095-4dannjjm	1343	12	0.5	0.5	CD
cord-023095-4dannjjm	1343	13	years	year	NNS
cord-023095-4dannjjm	1343	14	)	)	-RRB-
cord-023095-4dannjjm	1343	15	were	be	VBD
cord-023095-4dannjjm	1343	16	used	use	VBN
cord-023095-4dannjjm	1343	17	.	.	.
cord-023095-4dannjjm	1344	1	Donkeys	donkey	NNS
cord-023095-4dannjjm	1344	2	were	be	VBD
cord-023095-4dannjjm	1344	3	divided	divide	VBN
cord-023095-4dannjjm	1344	4	into	into	IN
cord-023095-4dannjjm	1344	5	three	three	CD
cord-023095-4dannjjm	1344	6	groups	group	NNS
cord-023095-4dannjjm	1344	7	:	:	:
cord-023095-4dannjjm	1344	8	o	o	NN
cord-023095-4dannjjm	1344	9	5	5	CD
cord-023095-4dannjjm	1344	10	years	year	NNS
cord-023095-4dannjjm	1344	11	(	(	-LRB-
cord-023095-4dannjjm	1344	12	n	n	NN
cord-023095-4dannjjm	1344	13	5	5	CD
cord-023095-4dannjjm	1344	14	13	13	CD
cord-023095-4dannjjm	1344	15	)	)	-RRB-
cord-023095-4dannjjm	1344	16	,	,	,
cord-023095-4dannjjm	1344	17	5	5	CD
cord-023095-4dannjjm	1344	18	-	-	SYM
cord-023095-4dannjjm	1344	19	10	10	CD
cord-023095-4dannjjm	1344	20	years	year	NNS
cord-023095-4dannjjm	1344	21	(	(	-LRB-
cord-023095-4dannjjm	1344	22	n	n	NN
cord-023095-4dannjjm	1344	23	5	5	CD
cord-023095-4dannjjm	1344	24	12	12	CD
cord-023095-4dannjjm	1344	25	)	)	-RRB-
cord-023095-4dannjjm	1344	26	,	,	,
cord-023095-4dannjjm	1344	27	and	and	CC
cord-023095-4dannjjm	1344	28	411	411	CD
cord-023095-4dannjjm	1344	29	years	year	NNS
cord-023095-4dannjjm	1344	30	(	(	-LRB-
cord-023095-4dannjjm	1344	31	n	n	NN
cord-023095-4dannjjm	1344	32	5	5	CD
cord-023095-4dannjjm	1344	33	13	13	CD
cord-023095-4dannjjm	1344	34	)	)	-RRB-
cord-023095-4dannjjm	1344	35	.	.	.
cord-023095-4dannjjm	1345	1	Serum	serum	NN
cord-023095-4dannjjm	1345	2	concentrations	concentration	NNS
cord-023095-4dannjjm	1345	3	of	of	IN
cord-023095-4dannjjm	1345	4	total	total	JJ
cord-023095-4dannjjm	1345	5	triiodothyronine	triiodothyronine	NN
cord-023095-4dannjjm	1345	6	(	(	-LRB-
cord-023095-4dannjjm	1345	7	tT3	tT3	NNP
cord-023095-4dannjjm	1345	8	)	)	-RRB-
cord-023095-4dannjjm	1345	9	,	,	,
cord-023095-4dannjjm	1345	10	free	free	JJ
cord-023095-4dannjjm	1345	11	triiodothyronine	triiodothyronine	NN
cord-023095-4dannjjm	1345	12	(	(	-LRB-
cord-023095-4dannjjm	1345	13	fT3	ft3	NN
cord-023095-4dannjjm	1345	14	)	)	-RRB-
cord-023095-4dannjjm	1345	15	,	,	,
cord-023095-4dannjjm	1345	16	total	total	JJ
cord-023095-4dannjjm	1345	17	thyroxine	thyroxine	NN
cord-023095-4dannjjm	1345	18	(	(	-LRB-
cord-023095-4dannjjm	1345	19	tT4	tT4	NNP
cord-023095-4dannjjm	1345	20	)	)	-RRB-
cord-023095-4dannjjm	1345	21	,	,	,
cord-023095-4dannjjm	1345	22	free	free	JJ
cord-023095-4dannjjm	1345	23	thyroxine	thyroxine	NN
cord-023095-4dannjjm	1345	24	(	(	-LRB-
cord-023095-4dannjjm	1345	25	fT4	ft4	NN
cord-023095-4dannjjm	1345	26	)	)	-RRB-
cord-023095-4dannjjm	1345	27	,	,	.
cord-023095-4dannjjm	1346	1	reverse	reverse	NNP
cord-023095-4dannjjm	1346	2	triiodothyronine	triiodothyronine	NNP
cord-023095-4dannjjm	1346	3	(	(	-LRB-
cord-023095-4dannjjm	1346	4	rT3	rT3	NNP
cord-023095-4dannjjm	1346	5	)	)	-RRB-
cord-023095-4dannjjm	1346	6	and	and	CC
cord-023095-4dannjjm	1346	7	thyroid	thyroid	NN
cord-023095-4dannjjm	1346	8	-	-	HYPH
cord-023095-4dannjjm	1346	9	stimulating	stimulate	VBG
cord-023095-4dannjjm	1346	10	hormone	hormone	NN
cord-023095-4dannjjm	1346	11	(	(	-LRB-
cord-023095-4dannjjm	1346	12	TSH	TSH	NNP
cord-023095-4dannjjm	1346	13	)	)	-RRB-
cord-023095-4dannjjm	1346	14	were	be	VBD
cord-023095-4dannjjm	1346	15	quantified	quantify	VBN
cord-023095-4dannjjm	1346	16	by	by	IN
cord-023095-4dannjjm	1346	17	radioimmunoassay	radioimmunoassay	JJ
cord-023095-4dannjjm	1346	18	.	.	.
cord-023095-4dannjjm	1347	1	All	all	DT
cord-023095-4dannjjm	1347	2	blood	blood	NN
cord-023095-4dannjjm	1347	3	samples	sample	NNS
cord-023095-4dannjjm	1347	4	were	be	VBD
cord-023095-4dannjjm	1347	5	collected	collect	VBN
cord-023095-4dannjjm	1347	6	the	the	DT
cord-023095-4dannjjm	1347	7	same	same	JJ
cord-023095-4dannjjm	1347	8	day	day	NN
cord-023095-4dannjjm	1347	9	.	.	.
cord-023095-4dannjjm	1348	1	Neither	neither	CC
cord-023095-4dannjjm	1348	2	horses	horse	NNS
cord-023095-4dannjjm	1348	3	nor	nor	CC
cord-023095-4dannjjm	1348	4	donkeys	donkey	NNS
cord-023095-4dannjjm	1348	5	had	have	VBD
cord-023095-4dannjjm	1348	6	received	receive	VBN
cord-023095-4dannjjm	1348	7	any	any	DT
cord-023095-4dannjjm	1348	8	treatment	treatment	NN
cord-023095-4dannjjm	1348	9	for	for	IN
cord-023095-4dannjjm	1348	10	30	30	CD
cord-023095-4dannjjm	1348	11	days	day	NNS
cord-023095-4dannjjm	1348	12	before	before	IN
cord-023095-4dannjjm	1348	13	sampling	sampling	NN
cord-023095-4dannjjm	1348	14	and	and	CC
cord-023095-4dannjjm	1348	15	both	both	DT
cord-023095-4dannjjm	1348	16	farms	farm	NNS
cord-023095-4dannjjm	1348	17	had	have	VBD
cord-023095-4dannjjm	1348	18	similar	similar	JJ
cord-023095-4dannjjm	1348	19	production	production	NN
cord-023095-4dannjjm	1348	20	conditions	condition	NNS
cord-023095-4dannjjm	1348	21	.	.	.
cord-023095-4dannjjm	1349	1	Total	total	JJ
cord-023095-4dannjjm	1349	2	T3	T3	NNP
cord-023095-4dannjjm	1349	3	,	,	,
cord-023095-4dannjjm	1349	4	fT3	ft3	NN
cord-023095-4dannjjm	1349	5	,	,	,
cord-023095-4dannjjm	1349	6	fT4	ft4	VB
cord-023095-4dannjjm	1349	7	and	and	CC
cord-023095-4dannjjm	1349	8	tT4	tT4	NNP
cord-023095-4dannjjm	1349	9	concentrations	concentration	NNS
cord-023095-4dannjjm	1349	10	were	be	VBD
cord-023095-4dannjjm	1349	11	higher	high	JJR
cord-023095-4dannjjm	1349	12	(	(	-LRB-
cord-023095-4dannjjm	1349	13	P	p	NN
cord-023095-4dannjjm	1349	14	o	o	NN
cord-023095-4dannjjm	1349	15	0.01	0.01	CD
cord-023095-4dannjjm	1349	16	)	)	-RRB-
cord-023095-4dannjjm	1349	17	in	in	IN
cord-023095-4dannjjm	1349	18	donkeys	donkey	NNS
cord-023095-4dannjjm	1349	19	than	than	IN
cord-023095-4dannjjm	1349	20	horses	horse	NNS
cord-023095-4dannjjm	1349	21	.	.	.
cord-023095-4dannjjm	1350	1	In	in	IN
cord-023095-4dannjjm	1350	2	contrast	contrast	NN
cord-023095-4dannjjm	1350	3	,	,	,
cord-023095-4dannjjm	1350	4	no	no	DT
cord-023095-4dannjjm	1350	5	statistical	statistical	JJ
cord-023095-4dannjjm	1350	6	differences	difference	NNS
cord-023095-4dannjjm	1350	7	were	be	VBD
cord-023095-4dannjjm	1350	8	found	find	VBN
cord-023095-4dannjjm	1350	9	for	for	IN
cord-023095-4dannjjm	1350	10	rT3	rt3	NN
cord-023095-4dannjjm	1350	11	and	and	CC
cord-023095-4dannjjm	1350	12	TSH	TSH	NNP
cord-023095-4dannjjm	1350	13	concentrations	concentration	NNS
cord-023095-4dannjjm	1350	14	.	.	.
cord-023095-4dannjjm	1351	1	Young	young	JJ
cord-023095-4dannjjm	1351	2	donkeys	donkey	NNS
cord-023095-4dannjjm	1351	3	(	(	-LRB-
cord-023095-4dannjjm	1351	4	o	o	NN
cord-023095-4dannjjm	1351	5	5	5	CD
cord-023095-4dannjjm	1351	6	years	year	NNS
cord-023095-4dannjjm	1351	7	)	)	-RRB-
cord-023095-4dannjjm	1351	8	had	have	VBD
cord-023095-4dannjjm	1351	9	higher	high	JJR
cord-023095-4dannjjm	1351	10	fT4	ft4	NN
cord-023095-4dannjjm	1351	11	,	,	,
cord-023095-4dannjjm	1351	12	tT4	tT4	NNP
cord-023095-4dannjjm	1351	13	and	and	CC
cord-023095-4dannjjm	1351	14	rT3	rt3	JJ
cord-023095-4dannjjm	1351	15	concentrations	concentration	NNS
cord-023095-4dannjjm	1351	16	compared	compare	VBN
cord-023095-4dannjjm	1351	17	to	to	IN
cord-023095-4dannjjm	1351	18	other	other	JJ
cord-023095-4dannjjm	1351	19	donkey	donkey	NN
cord-023095-4dannjjm	1351	20	groups	group	NNS
cord-023095-4dannjjm	1351	21	(	(	-LRB-
cord-023095-4dannjjm	1351	22	P	p	NN
cord-023095-4dannjjm	1351	23	o	o	NN
cord-023095-4dannjjm	1351	24	0.05	0.05	CD
cord-023095-4dannjjm	1351	25	)	)	-RRB-
cord-023095-4dannjjm	1351	26	.	.	.
cord-023095-4dannjjm	1352	1	Old	old	JJ
cord-023095-4dannjjm	1352	2	donkeys	donkey	NNS
cord-023095-4dannjjm	1352	3	(	(	-LRB-
cord-023095-4dannjjm	1352	4	411	411	CD
cord-023095-4dannjjm	1352	5	years	year	NNS
cord-023095-4dannjjm	1352	6	)	)	-RRB-
cord-023095-4dannjjm	1352	7	had	have	VBD
cord-023095-4dannjjm	1352	8	lower	low	JJR
cord-023095-4dannjjm	1352	9	tT3	tt3	NN
cord-023095-4dannjjm	1352	10	and	and	CC
cord-023095-4dannjjm	1352	11	fT3	ft3	NN
cord-023095-4dannjjm	1352	12	concentrations	concentration	NNS
cord-023095-4dannjjm	1352	13	than	than	IN
cord-023095-4dannjjm	1352	14	both	both	DT
cord-023095-4dannjjm	1352	15	younger	young	JJR
cord-023095-4dannjjm	1352	16	donkeys	donkey	NNS
cord-023095-4dannjjm	1352	17	groups	group	NNS
cord-023095-4dannjjm	1352	18	(	(	-LRB-
cord-023095-4dannjjm	1352	19	P	p	NN
cord-023095-4dannjjm	1352	20	o	o	NN
cord-023095-4dannjjm	1352	21	0.05	0.05	CD
cord-023095-4dannjjm	1352	22	)	)	-RRB-
cord-023095-4dannjjm	1352	23	.	.	.
cord-023095-4dannjjm	1353	1	This	this	DT
cord-023095-4dannjjm	1353	2	study	study	NN
cord-023095-4dannjjm	1353	3	shows	show	VBZ
cord-023095-4dannjjm	1353	4	that	that	IN
cord-023095-4dannjjm	1353	5	there	there	EX
cord-023095-4dannjjm	1353	6	are	be	VBP
cord-023095-4dannjjm	1353	7	differences	difference	NNS
cord-023095-4dannjjm	1353	8	in	in	IN
cord-023095-4dannjjm	1353	9	TH	TH	NNP
cord-023095-4dannjjm	1353	10	concentrations	concentration	NNS
cord-023095-4dannjjm	1353	11	between	between	IN
cord-023095-4dannjjm	1353	12	donkeys	donkey	NNS
cord-023095-4dannjjm	1353	13	and	and	CC
cord-023095-4dannjjm	1353	14	horses	horse	NNS
cord-023095-4dannjjm	1353	15	,	,	,
cord-023095-4dannjjm	1353	16	raising	raise	VBG
cord-023095-4dannjjm	1353	17	awareness	awareness	NN
cord-023095-4dannjjm	1353	18	on	on	IN
cord-023095-4dannjjm	1353	19	the	the	DT
cord-023095-4dannjjm	1353	20	possibility	possibility	NN
cord-023095-4dannjjm	1353	21	of	of	IN
cord-023095-4dannjjm	1353	22	misdiagnosis	misdiagnosis	NN
cord-023095-4dannjjm	1353	23	of	of	IN
cord-023095-4dannjjm	1353	24	thyroid	thyroid	JJ
cord-023095-4dannjjm	1353	25	gland	gland	NN
cord-023095-4dannjjm	1353	26	dysfunction	dysfunction	NN
cord-023095-4dannjjm	1353	27	when	when	WRB
cord-023095-4dannjjm	1353	28	using	use	VBG
cord-023095-4dannjjm	1353	29	values	value	NNS
cord-023095-4dannjjm	1353	30	from	from	IN
cord-023095-4dannjjm	1353	31	horses	horse	NNS
cord-023095-4dannjjm	1353	32	,	,	,
cord-023095-4dannjjm	1353	33	being	be	VBG
cord-023095-4dannjjm	1353	34	necessary	necessary	JJ
cord-023095-4dannjjm	1353	35	to	to	TO
cord-023095-4dannjjm	1353	36	determine	determine	VB
cord-023095-4dannjjm	1353	37	exclusive	exclusive	JJ
cord-023095-4dannjjm	1353	38	reference	reference	NN
cord-023095-4dannjjm	1353	39	intervals	interval	NNS
cord-023095-4dannjjm	1353	40	for	for	IN
cord-023095-4dannjjm	1353	41	donkeys	donkey	NNS
cord-023095-4dannjjm	1353	42	.	.	.
cord-023095-4dannjjm	1354	1	Ovariectomy	Ovariectomy	NNP
cord-023095-4dannjjm	1354	2	is	be	VBZ
cord-023095-4dannjjm	1354	3	associated	associate	VBN
cord-023095-4dannjjm	1354	4	with	with	IN
cord-023095-4dannjjm	1354	5	alterations	alteration	NNS
cord-023095-4dannjjm	1354	6	of	of	IN
cord-023095-4dannjjm	1354	7	responses	response	NNS
cord-023095-4dannjjm	1354	8	to	to	IN
cord-023095-4dannjjm	1354	9	many	many	JJ
cord-023095-4dannjjm	1354	10	hormones	hormone	NNS
cord-023095-4dannjjm	1354	11	,	,	,
cord-023095-4dannjjm	1354	12	not	not	RB
cord-023095-4dannjjm	1354	13	just	just	RB
cord-023095-4dannjjm	1354	14	those	those	DT
cord-023095-4dannjjm	1354	15	associated	associate	VBN
cord-023095-4dannjjm	1354	16	with	with	IN
cord-023095-4dannjjm	1354	17	reproductive	reproductive	JJ
cord-023095-4dannjjm	1354	18	function	function	NN
cord-023095-4dannjjm	1354	19	.	.	.
cord-023095-4dannjjm	1355	1	In	in	IN
cord-023095-4dannjjm	1355	2	humans	human	NNS
cord-023095-4dannjjm	1355	3	and	and	CC
cord-023095-4dannjjm	1355	4	rats	rat	NNS
cord-023095-4dannjjm	1355	5	,	,	,
cord-023095-4dannjjm	1355	6	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1355	7	leads	lead	VBZ
cord-023095-4dannjjm	1355	8	to	to	IN
cord-023095-4dannjjm	1355	9	insulin	insulin	NN
cord-023095-4dannjjm	1355	10	resistance	resistance	NN
cord-023095-4dannjjm	1355	11	,	,	,
cord-023095-4dannjjm	1355	12	increased	increase	VBD
cord-023095-4dannjjm	1355	13	adiposity	adiposity	NN
cord-023095-4dannjjm	1355	14	and	and	CC
cord-023095-4dannjjm	1355	15	altered	alter	VBN
cord-023095-4dannjjm	1355	16	fat	fat	JJ
cord-023095-4dannjjm	1355	17	mobilization	mobilization	NN
cord-023095-4dannjjm	1355	18	.	.	.
cord-023095-4dannjjm	1356	1	The	the	DT
cord-023095-4dannjjm	1356	2	effects	effect	NNS
cord-023095-4dannjjm	1356	3	of	of	IN
cord-023095-4dannjjm	1356	4	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1356	5	on	on	IN
cord-023095-4dannjjm	1356	6	energy	energy	NN
cord-023095-4dannjjm	1356	7	metabolism	metabolism	NN
cord-023095-4dannjjm	1356	8	have	have	VBP
cord-023095-4dannjjm	1356	9	not	not	RB
cord-023095-4dannjjm	1356	10	been	be	VBN
cord-023095-4dannjjm	1356	11	reported	report	VBN
cord-023095-4dannjjm	1356	12	in	in	IN
cord-023095-4dannjjm	1356	13	horses	horse	NNS
cord-023095-4dannjjm	1356	14	.	.	.
cord-023095-4dannjjm	1357	1	Ovariectomized	Ovariectomized	NNP
cord-023095-4dannjjm	1357	2	mares	mare	NNS
cord-023095-4dannjjm	1357	3	have	have	VBP
cord-023095-4dannjjm	1357	4	been	be	VBN
cord-023095-4dannjjm	1357	5	shown	show	VBN
cord-023095-4dannjjm	1357	6	to	to	TO
cord-023095-4dannjjm	1357	7	respond	respond	VB
cord-023095-4dannjjm	1357	8	normally	normally	RB
cord-023095-4dannjjm	1357	9	to	to	IN
cord-023095-4dannjjm	1357	10	an	an	DT
cord-023095-4dannjjm	1357	11	ACTH	ACTH	NNP
cord-023095-4dannjjm	1357	12	stimulation	stimulation	NN
cord-023095-4dannjjm	1357	13	test	test	NN
cord-023095-4dannjjm	1357	14	,	,	,
cord-023095-4dannjjm	1357	15	but	but	CC
cord-023095-4dannjjm	1357	16	the	the	DT
cord-023095-4dannjjm	1357	17	response	response	NN
cord-023095-4dannjjm	1357	18	to	to	IN
cord-023095-4dannjjm	1357	19	suppression	suppression	NN
cord-023095-4dannjjm	1357	20	of	of	IN
cord-023095-4dannjjm	1357	21	the	the	DT
cord-023095-4dannjjm	1357	22	hypothalamo	hypothalamo	JJ
cord-023095-4dannjjm	1357	23	-	-	HYPH
cord-023095-4dannjjm	1357	24	pituitary	pituitary	NN
cord-023095-4dannjjm	1357	25	-	-	HYPH
cord-023095-4dannjjm	1357	26	adrenal	adrenal	NN
cord-023095-4dannjjm	1357	27	axis	axis	NN
cord-023095-4dannjjm	1357	28	has	have	VBZ
cord-023095-4dannjjm	1357	29	not	not	RB
cord-023095-4dannjjm	1357	30	been	be	VBN
cord-023095-4dannjjm	1357	31	previously	previously	RB
cord-023095-4dannjjm	1357	32	described	describe	VBN
cord-023095-4dannjjm	1357	33	.	.	.
cord-023095-4dannjjm	1358	1	The	the	DT
cord-023095-4dannjjm	1358	2	aim	aim	NN
cord-023095-4dannjjm	1358	3	of	of	IN
cord-023095-4dannjjm	1358	4	this	this	DT
cord-023095-4dannjjm	1358	5	study	study	NN
cord-023095-4dannjjm	1358	6	was	be	VBD
cord-023095-4dannjjm	1358	7	to	to	TO
cord-023095-4dannjjm	1358	8	evaluate	evaluate	VB
cord-023095-4dannjjm	1358	9	the	the	DT
cord-023095-4dannjjm	1358	10	effect	effect	NN
cord-023095-4dannjjm	1358	11	of	of	IN
cord-023095-4dannjjm	1358	12	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1358	13	on	on	IN
cord-023095-4dannjjm	1358	14	insulin	insulin	NN
cord-023095-4dannjjm	1358	15	response	response	NN
cord-023095-4dannjjm	1358	16	in	in	IN
cord-023095-4dannjjm	1358	17	mares	mare	NNS
cord-023095-4dannjjm	1358	18	and	and	CC
cord-023095-4dannjjm	1358	19	to	to	TO
cord-023095-4dannjjm	1358	20	determine	determine	VB
cord-023095-4dannjjm	1358	21	if	if	IN
cord-023095-4dannjjm	1358	22	mares	mare	NNS
cord-023095-4dannjjm	1358	23	exhibit	exhibit	VBP
cord-023095-4dannjjm	1358	24	alterations	alteration	NNS
cord-023095-4dannjjm	1358	25	in	in	IN
cord-023095-4dannjjm	1358	26	response	response	NN
cord-023095-4dannjjm	1358	27	to	to	IN
cord-023095-4dannjjm	1358	28	dexamethasone	dexamethasone	NNP
cord-023095-4dannjjm	1358	29	administration	administration	NN
cord-023095-4dannjjm	1358	30	after	after	IN
cord-023095-4dannjjm	1358	31	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1358	32	.	.	.
cord-023095-4dannjjm	1359	1	Six	six	CD
cord-023095-4dannjjm	1359	2	healthy	healthy	JJ
cord-023095-4dannjjm	1359	3	mares	mare	NNS
cord-023095-4dannjjm	1359	4	underwent	undergo	VBD
cord-023095-4dannjjm	1359	5	an	an	DT
cord-023095-4dannjjm	1359	6	intravenous	intravenous	JJ
cord-023095-4dannjjm	1359	7	glucose	glucose	NN
cord-023095-4dannjjm	1359	8	tolerance	tolerance	NN
cord-023095-4dannjjm	1359	9	test	test	NN
cord-023095-4dannjjm	1359	10	(	(	-LRB-
cord-023095-4dannjjm	1359	11	IVGTT	IVGTT	NNP
cord-023095-4dannjjm	1359	12	)	)	-RRB-
cord-023095-4dannjjm	1359	13	,	,	,
cord-023095-4dannjjm	1359	14	an	an	DT
cord-023095-4dannjjm	1359	15	insulin	insulin	NN
cord-023095-4dannjjm	1359	16	sensitivity	sensitivity	NN
cord-023095-4dannjjm	1359	17	test	test	NN
cord-023095-4dannjjm	1359	18	(	(	-LRB-
cord-023095-4dannjjm	1359	19	IST	IST	NNP
cord-023095-4dannjjm	1359	20	)	)	-RRB-
cord-023095-4dannjjm	1359	21	and	and	CC
cord-023095-4dannjjm	1359	22	a	a	DT
cord-023095-4dannjjm	1359	23	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	1359	24	suppression	suppression	NN
cord-023095-4dannjjm	1359	25	test	test	NN
cord-023095-4dannjjm	1359	26	(	(	-LRB-
cord-023095-4dannjjm	1359	27	DST	DST	NNP
cord-023095-4dannjjm	1359	28	)	)	-RRB-
cord-023095-4dannjjm	1359	29	before	before	IN
cord-023095-4dannjjm	1359	30	and	and	CC
cord-023095-4dannjjm	1359	31	5	5	CD
cord-023095-4dannjjm	1359	32	weeks	week	NNS
cord-023095-4dannjjm	1359	33	after	after	IN
cord-023095-4dannjjm	1359	34	bilateral	bilateral	JJ
cord-023095-4dannjjm	1359	35	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1359	36	.	.	.
cord-023095-4dannjjm	1360	1	Body	body	NN
cord-023095-4dannjjm	1360	2	weight	weight	NN
cord-023095-4dannjjm	1360	3	,	,	,
cord-023095-4dannjjm	1360	4	cortisol	cortisol	NN
cord-023095-4dannjjm	1360	5	values	value	NNS
cord-023095-4dannjjm	1360	6	at	at	IN
cord-023095-4dannjjm	1360	7	baseline	baseline	NN
cord-023095-4dannjjm	1360	8	,	,	,
cord-023095-4dannjjm	1360	9	15	15	CD
cord-023095-4dannjjm	1360	10	and	and	CC
cord-023095-4dannjjm	1360	11	24	24	CD
cord-023095-4dannjjm	1360	12	hours	hour	NNS
cord-023095-4dannjjm	1360	13	after	after	IN
cord-023095-4dannjjm	1360	14	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	1360	15	injection	injection	NN
cord-023095-4dannjjm	1360	16	and	and	CC
cord-023095-4dannjjm	1360	17	ACTH	ACTH	NNP
cord-023095-4dannjjm	1360	18	values	value	NNS
cord-023095-4dannjjm	1360	19	at	at	IN
cord-023095-4dannjjm	1360	20	baseline	baseline	NN
cord-023095-4dannjjm	1360	21	,	,	,
cord-023095-4dannjjm	1360	22	15	15	CD
cord-023095-4dannjjm	1360	23	and	and	CC
cord-023095-4dannjjm	1360	24	24	24	CD
cord-023095-4dannjjm	1360	25	hours	hour	NNS
cord-023095-4dannjjm	1360	26	after	after	IN
cord-023095-4dannjjm	1360	27	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	1360	28	injection	injection	NN
cord-023095-4dannjjm	1360	29	,	,	,
cord-023095-4dannjjm	1360	30	basal	basal	JJ
cord-023095-4dannjjm	1360	31	insulin	insulin	NN
cord-023095-4dannjjm	1360	32	/	/	SYM
cord-023095-4dannjjm	1360	33	glucose	glucose	NN
cord-023095-4dannjjm	1360	34	ratio	ratio	NN
cord-023095-4dannjjm	1360	35	,	,	,
cord-023095-4dannjjm	1360	36	time	time	NN
cord-023095-4dannjjm	1360	37	to	to	TO
cord-023095-4dannjjm	1360	38	reach	reach	VB
cord-023095-4dannjjm	1360	39	a	a	DT
cord-023095-4dannjjm	1360	40	60	60	CD
cord-023095-4dannjjm	1360	41	%	%	NN
cord-023095-4dannjjm	1360	42	decrease	decrease	NN
cord-023095-4dannjjm	1360	43	in	in	IN
cord-023095-4dannjjm	1360	44	blood	blood	NN
cord-023095-4dannjjm	1360	45	glucose	glucose	NN
cord-023095-4dannjjm	1360	46	in	in	IN
cord-023095-4dannjjm	1360	47	the	the	DT
cord-023095-4dannjjm	1360	48	IST	IST	NNP
cord-023095-4dannjjm	1360	49	,	,	,
cord-023095-4dannjjm	1360	50	time	time	NN
cord-023095-4dannjjm	1360	51	to	to	TO
cord-023095-4dannjjm	1360	52	reach	reach	VB
cord-023095-4dannjjm	1360	53	baseline	baseline	JJ
cord-023095-4dannjjm	1360	54	glucose	glucose	NN
cord-023095-4dannjjm	1360	55	concentration	concentration	NN
cord-023095-4dannjjm	1360	56	in	in	IN
cord-023095-4dannjjm	1360	57	the	the	DT
cord-023095-4dannjjm	1360	58	IVGTT	IVGTT	NNP
cord-023095-4dannjjm	1360	59	and	and	CC
cord-023095-4dannjjm	1360	60	area	area	NN
cord-023095-4dannjjm	1360	61	under	under	IN
cord-023095-4dannjjm	1360	62	the	the	DT
cord-023095-4dannjjm	1360	63	curves	curve	NNS
cord-023095-4dannjjm	1360	64	plotting	plot	VBG
cord-023095-4dannjjm	1360	65	blood	blood	NN
cord-023095-4dannjjm	1360	66	glucose	glucose	NN
cord-023095-4dannjjm	1360	67	and	and	CC
cord-023095-4dannjjm	1360	68	time	time	NN
cord-023095-4dannjjm	1360	69	to	to	IN
cord-023095-4dannjjm	1360	70	injection	injection	NN
cord-023095-4dannjjm	1360	71	of	of	IN
cord-023095-4dannjjm	1360	72	glucose	glucose	NN
cord-023095-4dannjjm	1360	73	or	or	CC
cord-023095-4dannjjm	1360	74	insulin	insulin	NN
cord-023095-4dannjjm	1360	75	were	be	VBD
cord-023095-4dannjjm	1360	76	compared	compare	VBN
cord-023095-4dannjjm	1360	77	before	before	RB
cord-023095-4dannjjm	1360	78	and	and	CC
cord-023095-4dannjjm	1360	79	after	after	IN
cord-023095-4dannjjm	1360	80	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1360	81	using	use	VBG
cord-023095-4dannjjm	1360	82	a	a	DT
cord-023095-4dannjjm	1360	83	paired	paired	JJ
cord-023095-4dannjjm	1360	84	t	t	NN
cord-023095-4dannjjm	1360	85	-	-	HYPH
cord-023095-4dannjjm	1360	86	test	test	NN
cord-023095-4dannjjm	1360	87	or	or	CC
cord-023095-4dannjjm	1360	88	an	an	DT
cord-023095-4dannjjm	1360	89	ANOVA	anova	NN
cord-023095-4dannjjm	1360	90	for	for	IN
cord-023095-4dannjjm	1360	91	repeated	repeat	VBN
cord-023095-4dannjjm	1360	92	measures	measure	NNS
cord-023095-4dannjjm	1360	93	.	.	.
cord-023095-4dannjjm	1361	1	Significance	significance	NN
cord-023095-4dannjjm	1361	2	level	level	NN
cord-023095-4dannjjm	1361	3	was	be	VBD
cord-023095-4dannjjm	1361	4	P	p	NN
cord-023095-4dannjjm	1361	5	o	o	NN
cord-023095-4dannjjm	1361	6	0.05	0.05	CD
cord-023095-4dannjjm	1361	7	.	.	.
cord-023095-4dannjjm	1362	1	Average	average	JJ
cord-023095-4dannjjm	1362	2	body	body	NN
cord-023095-4dannjjm	1362	3	weight	weight	NN
cord-023095-4dannjjm	1362	4	was	be	VBD
cord-023095-4dannjjm	1362	5	decreased	decrease	VBN
cord-023095-4dannjjm	1362	6	after	after	IN
cord-023095-4dannjjm	1362	7	surgery	surgery	NN
cord-023095-4dannjjm	1362	8	(	(	-LRB-
cord-023095-4dannjjm	1362	9	6	6	CD
cord-023095-4dannjjm	1362	10	kg	kg	NN
cord-023095-4dannjjm	1362	11	)	)	-RRB-
cord-023095-4dannjjm	1362	12	.	.	.
cord-023095-4dannjjm	1363	1	The	the	DT
cord-023095-4dannjjm	1363	2	injection	injection	NN
cord-023095-4dannjjm	1363	3	of	of	IN
cord-023095-4dannjjm	1363	4	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	1363	5	resulted	result	VBD
cord-023095-4dannjjm	1363	6	in	in	IN
cord-023095-4dannjjm	1363	7	a	a	DT
cord-023095-4dannjjm	1363	8	serum	serum	NN
cord-023095-4dannjjm	1363	9	cortisol	cortisol	NN
cord-023095-4dannjjm	1363	10	concentration	concentration	NN
cord-023095-4dannjjm	1363	11	of	of	IN
cord-023095-4dannjjm	1363	12	less	less	JJR
cord-023095-4dannjjm	1363	13	than	than	IN
cord-023095-4dannjjm	1363	14	1	1	CD
cord-023095-4dannjjm	1363	15	mg	mg	NNP
cord-023095-4dannjjm	1363	16	/	/	SYM
cord-023095-4dannjjm	1363	17	dL	dl	NN
cord-023095-4dannjjm	1363	18	in	in	IN
cord-023095-4dannjjm	1363	19	all	all	DT
cord-023095-4dannjjm	1363	20	mares	mare	NNS
cord-023095-4dannjjm	1363	21	before	before	IN
cord-023095-4dannjjm	1363	22	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1363	23	,	,	,
cord-023095-4dannjjm	1363	24	whereas	whereas	IN
cord-023095-4dannjjm	1363	25	after	after	IN
cord-023095-4dannjjm	1363	26	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1363	27	,	,	,
cord-023095-4dannjjm	1363	28	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	1363	29	injection	injection	NN
cord-023095-4dannjjm	1363	30	resulted	result	VBD
cord-023095-4dannjjm	1363	31	in	in	IN
cord-023095-4dannjjm	1363	32	a	a	DT
cord-023095-4dannjjm	1363	33	serum	serum	NN
cord-023095-4dannjjm	1363	34	cortisol	cortisol	NN
cord-023095-4dannjjm	1363	35	concentration	concentration	NN
cord-023095-4dannjjm	1363	36	of	of	IN
cord-023095-4dannjjm	1363	37	less	less	JJR
cord-023095-4dannjjm	1363	38	than	than	IN
cord-023095-4dannjjm	1363	39	1	1	CD
cord-023095-4dannjjm	1363	40	mg	mg	NNP
cord-023095-4dannjjm	1363	41	/	/	SYM
cord-023095-4dannjjm	1363	42	dL	dl	NN
cord-023095-4dannjjm	1363	43	in	in	IN
cord-023095-4dannjjm	1363	44	5	5	CD
cord-023095-4dannjjm	1363	45	out	out	IN
cord-023095-4dannjjm	1363	46	of	of	IN
cord-023095-4dannjjm	1363	47	6	6	CD
cord-023095-4dannjjm	1363	48	mares	mare	NNS
cord-023095-4dannjjm	1363	49	.	.	.
cord-023095-4dannjjm	1364	1	In	in	IN
cord-023095-4dannjjm	1364	2	all	all	DT
cord-023095-4dannjjm	1364	3	cases	case	NNS
cord-023095-4dannjjm	1364	4	,	,	,
cord-023095-4dannjjm	1364	5	ACTH	ACTH	NNP
cord-023095-4dannjjm	1364	6	concentration	concentration	NN
cord-023095-4dannjjm	1364	7	was	be	VBD
cord-023095-4dannjjm	1364	8	within	within	IN
cord-023095-4dannjjm	1364	9	the	the	DT
cord-023095-4dannjjm	1364	10	reference	reference	NN
cord-023095-4dannjjm	1364	11	range	range	NN
cord-023095-4dannjjm	1364	12	(	(	-LRB-
cord-023095-4dannjjm	1364	13	9	9	CD
cord-023095-4dannjjm	1364	14	-	-	SYM
cord-023095-4dannjjm	1364	15	35	35	CD
cord-023095-4dannjjm	1364	16	pg	pg	NN
cord-023095-4dannjjm	1364	17	/	/	SYM
cord-023095-4dannjjm	1364	18	mL	mL	NNP
cord-023095-4dannjjm	1364	19	)	)	-RRB-
cord-023095-4dannjjm	1364	20	before	before	IN
cord-023095-4dannjjm	1364	21	and	and	CC
cord-023095-4dannjjm	1364	22	after	after	IN
cord-023095-4dannjjm	1364	23	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1364	24	.	.	.
cord-023095-4dannjjm	1365	1	However	however	RB
cord-023095-4dannjjm	1365	2	,	,	,
cord-023095-4dannjjm	1365	3	ACTH	ACTH	NNP
cord-023095-4dannjjm	1365	4	concentrations	concentration	NNS
cord-023095-4dannjjm	1365	5	at	at	IN
cord-023095-4dannjjm	1365	6	t	t	NN
cord-023095-4dannjjm	1365	7	0	0	CD
cord-023095-4dannjjm	1365	8	and	and	CC
cord-023095-4dannjjm	1365	9	at	at	IN
cord-023095-4dannjjm	1365	10	t	t	NNP
cord-023095-4dannjjm	1365	11	15	15	CD
cord-023095-4dannjjm	1365	12	were	be	VBD
cord-023095-4dannjjm	1365	13	significantly	significantly	RB
cord-023095-4dannjjm	1365	14	higher	high	JJR
cord-023095-4dannjjm	1365	15	after	after	IN
cord-023095-4dannjjm	1365	16	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1365	17	.	.	.
cord-023095-4dannjjm	1366	1	Each	each	DT
cord-023095-4dannjjm	1366	2	mare	mare	NN
cord-023095-4dannjjm	1366	3	had	have	VBD
cord-023095-4dannjjm	1366	4	a	a	DT
cord-023095-4dannjjm	1366	5	normal	normal	JJ
cord-023095-4dannjjm	1366	6	IVGTT	IVGTT	NNP
cord-023095-4dannjjm	1366	7	,	,	,
cord-023095-4dannjjm	1366	8	both	both	CC
cord-023095-4dannjjm	1366	9	before	before	IN
cord-023095-4dannjjm	1366	10	and	and	CC
cord-023095-4dannjjm	1366	11	after	after	IN
cord-023095-4dannjjm	1366	12	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1366	13	.	.	.
cord-023095-4dannjjm	1367	1	Additionally	additionally	RB
cord-023095-4dannjjm	1367	2	,	,	,
cord-023095-4dannjjm	1367	3	no	no	DT
cord-023095-4dannjjm	1367	4	significant	significant	JJ
cord-023095-4dannjjm	1367	5	differences	difference	NNS
cord-023095-4dannjjm	1367	6	were	be	VBD
cord-023095-4dannjjm	1367	7	observed	observe	VBN
cord-023095-4dannjjm	1367	8	in	in	IN
cord-023095-4dannjjm	1367	9	basal	basal	JJ
cord-023095-4dannjjm	1367	10	blood	blood	NN
cord-023095-4dannjjm	1367	11	glucose	glucose	NN
cord-023095-4dannjjm	1367	12	(	(	-LRB-
cord-023095-4dannjjm	1367	13	84	84	CD
cord-023095-4dannjjm	1367	14	AE	AE	NNP
cord-023095-4dannjjm	1367	15	12	12	CD
cord-023095-4dannjjm	1367	16	mg	mg	NNP
cord-023095-4dannjjm	1367	17	/	/	SYM
cord-023095-4dannjjm	1367	18	dL	dl	NN
cord-023095-4dannjjm	1367	19	before	before	RB
cord-023095-4dannjjm	1367	20	and	and	CC
cord-023095-4dannjjm	1367	21	85	85	CD
cord-023095-4dannjjm	1367	22	AE	AE	NNP
cord-023095-4dannjjm	1368	1	3	3	CD
cord-023095-4dannjjm	1368	2	mg	mg	NN
cord-023095-4dannjjm	1368	3	/	/	SYM
cord-023095-4dannjjm	1368	4	dL	dl	NN
cord-023095-4dannjjm	1368	5	after	after	IN
cord-023095-4dannjjm	1368	6	)	)	-RRB-
cord-023095-4dannjjm	1368	7	or	or	CC
cord-023095-4dannjjm	1368	8	in	in	IN
cord-023095-4dannjjm	1368	9	the	the	DT
cord-023095-4dannjjm	1368	10	time	time	NN
cord-023095-4dannjjm	1368	11	to	to	TO
cord-023095-4dannjjm	1368	12	reach	reach	VB
cord-023095-4dannjjm	1368	13	glucose	glucose	NN
cord-023095-4dannjjm	1368	14	baseline	baseline	NN
cord-023095-4dannjjm	1368	15	(	(	-LRB-
cord-023095-4dannjjm	1368	16	108	108	CD
cord-023095-4dannjjm	1368	17	AE	AE	NNP
cord-023095-4dannjjm	1368	18	66	66	CD
cord-023095-4dannjjm	1368	19	min	min	NN
cord-023095-4dannjjm	1368	20	before	before	RB
cord-023095-4dannjjm	1368	21	and	and	CC
cord-023095-4dannjjm	1368	22	99	99	CD
cord-023095-4dannjjm	1368	23	AE	AE	NNP
cord-023095-4dannjjm	1368	24	51	51	CD
cord-023095-4dannjjm	1368	25	min	min	NN
cord-023095-4dannjjm	1368	26	after	after	RB
cord-023095-4dannjjm	1368	27	)	)	-RRB-
cord-023095-4dannjjm	1368	28	.	.	.
cord-023095-4dannjjm	1369	1	Serum	serum	NN
cord-023095-4dannjjm	1369	2	basal	basal	NN
cord-023095-4dannjjm	1369	3	insulin	insulin	NN
cord-023095-4dannjjm	1369	4	concentration	concentration	NN
cord-023095-4dannjjm	1369	5	and	and	CC
cord-023095-4dannjjm	1369	6	insulin	insulin	NN
cord-023095-4dannjjm	1369	7	/	/	SYM
cord-023095-4dannjjm	1369	8	glucose	glucose	NN
cord-023095-4dannjjm	1369	9	ratio	ratio	NN
cord-023095-4dannjjm	1369	10	was	be	VBD
cord-023095-4dannjjm	1369	11	not	not	RB
cord-023095-4dannjjm	1369	12	significantly	significantly	RB
cord-023095-4dannjjm	1369	13	different	different	JJ
cord-023095-4dannjjm	1369	14	before	before	IN
cord-023095-4dannjjm	1369	15	or	or	CC
cord-023095-4dannjjm	1369	16	after	after	IN
cord-023095-4dannjjm	1369	17	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1369	18	(	(	-LRB-
cord-023095-4dannjjm	1369	19	22.0	22.0	CD
cord-023095-4dannjjm	1369	20	AE	AE	NNP
cord-023095-4dannjjm	1369	21	7.9	7.9	CD
cord-023095-4dannjjm	1369	22	mIU	mIU	NNP
cord-023095-4dannjjm	1369	23	/	/	SYM
cord-023095-4dannjjm	1369	24	mL	ml	NN
cord-023095-4dannjjm	1369	25	and	and	CC
cord-023095-4dannjjm	1369	26	17.5	17.5	CD
cord-023095-4dannjjm	1369	27	AE	AE	NNP
cord-023095-4dannjjm	1369	28	8.9	8.9	CD
cord-023095-4dannjjm	1369	29	mIU	mIU	NNP
cord-023095-4dannjjm	1369	30	/	/	SYM
cord-023095-4dannjjm	1369	31	mL	ml	NN
cord-023095-4dannjjm	1369	32	and	and	CC
cord-023095-4dannjjm	1369	33	0.26	0.26	CD
cord-023095-4dannjjm	1369	34	AE	AE	NNP
cord-023095-4dannjjm	1369	35	0.09	0.09	CD
cord-023095-4dannjjm	1369	36	and	and	CC
cord-023095-4dannjjm	1369	37	0.20	0.20	CD
cord-023095-4dannjjm	1369	38	AE	AE	NNP
cord-023095-4dannjjm	1369	39	0.10	0.10	CD
cord-023095-4dannjjm	1369	40	,	,	,
cord-023095-4dannjjm	1369	41	respectively	respectively	RB
cord-023095-4dannjjm	1369	42	)	)	-RRB-
cord-023095-4dannjjm	1369	43	,	,	,
cord-023095-4dannjjm	1369	44	nor	nor	CC
cord-023095-4dannjjm	1369	45	was	be	VBD
cord-023095-4dannjjm	1369	46	the	the	DT
cord-023095-4dannjjm	1369	47	average	average	JJ
cord-023095-4dannjjm	1369	48	time	time	NN
cord-023095-4dannjjm	1369	49	to	to	TO
cord-023095-4dannjjm	1369	50	reach	reach	VB
cord-023095-4dannjjm	1369	51	a	a	DT
cord-023095-4dannjjm	1369	52	60	60	CD
cord-023095-4dannjjm	1369	53	%	%	NN
cord-023095-4dannjjm	1369	54	decrease	decrease	NN
cord-023095-4dannjjm	1369	55	in	in	IN
cord-023095-4dannjjm	1369	56	blood	blood	NN
cord-023095-4dannjjm	1369	57	glucose	glucose	NN
cord-023095-4dannjjm	1369	58	after	after	IN
cord-023095-4dannjjm	1369	59	insulin	insulin	NN
cord-023095-4dannjjm	1369	60	injection	injection	NN
cord-023095-4dannjjm	1369	61	(	(	-LRB-
cord-023095-4dannjjm	1369	62	30	30	CD
cord-023095-4dannjjm	1369	63	AE	AE	NNP
cord-023095-4dannjjm	1369	64	7	7	CD
cord-023095-4dannjjm	1369	65	min	min	NN
cord-023095-4dannjjm	1369	66	and	and	CC
cord-023095-4dannjjm	1369	67	25	25	CD
cord-023095-4dannjjm	1369	68	AE	AE	NNP
cord-023095-4dannjjm	1369	69	9	9	CD
cord-023095-4dannjjm	1369	70	min	min	NN
cord-023095-4dannjjm	1369	71	,	,	,
cord-023095-4dannjjm	1369	72	respectively	respectively	RB
cord-023095-4dannjjm	1369	73	)	)	-RRB-
cord-023095-4dannjjm	1369	74	.	.	.
cord-023095-4dannjjm	1370	1	These	these	DT
cord-023095-4dannjjm	1370	2	findings	finding	NNS
cord-023095-4dannjjm	1370	3	suggest	suggest	VBP
cord-023095-4dannjjm	1370	4	that	that	IN
cord-023095-4dannjjm	1370	5	,	,	,
cord-023095-4dannjjm	1370	6	as	as	IN
cord-023095-4dannjjm	1370	7	reported	report	VBN
cord-023095-4dannjjm	1370	8	in	in	IN
cord-023095-4dannjjm	1370	9	other	other	JJ
cord-023095-4dannjjm	1370	10	species	specie	NNS
cord-023095-4dannjjm	1370	11	,	,	,
cord-023095-4dannjjm	1370	12	the	the	DT
cord-023095-4dannjjm	1370	13	shortterm	shortterm	JJ
cord-023095-4dannjjm	1370	14	effect	effect	NN
cord-023095-4dannjjm	1370	15	of	of	IN
cord-023095-4dannjjm	1370	16	ovariectomy	ovariectomy	NN
cord-023095-4dannjjm	1370	17	may	may	MD
cord-023095-4dannjjm	1370	18	modify	modify	VB
cord-023095-4dannjjm	1370	19	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	1370	20	response	response	NN
cord-023095-4dannjjm	1370	21	in	in	IN
cord-023095-4dannjjm	1370	22	mares	mare	NNS
cord-023095-4dannjjm	1370	23	and	and	CC
cord-023095-4dannjjm	1370	24	that	that	IN
cord-023095-4dannjjm	1370	25	,	,	,
cord-023095-4dannjjm	1370	26	contrary	contrary	JJ
cord-023095-4dannjjm	1370	27	to	to	IN
cord-023095-4dannjjm	1370	28	other	other	JJ
cord-023095-4dannjjm	1370	29	species	specie	NNS
cord-023095-4dannjjm	1370	30	,	,	,
cord-023095-4dannjjm	1370	31	it	-PRON-	PRP
cord-023095-4dannjjm	1370	32	may	may	MD
cord-023095-4dannjjm	1370	33	not	not	RB
cord-023095-4dannjjm	1370	34	modify	modify	VB
cord-023095-4dannjjm	1370	35	insulin	insulin	NN
cord-023095-4dannjjm	1370	36	response	response	NN
cord-023095-4dannjjm	1370	37	.	.	.
cord-023095-4dannjjm	1371	1	Equine	equine	JJ
cord-023095-4dannjjm	1371	2	Gastric	gastric	JJ
cord-023095-4dannjjm	1371	3	Ulcer	ulcer	NN
cord-023095-4dannjjm	1371	4	Syndrome	syndrome	NN
cord-023095-4dannjjm	1371	5	(	(	-LRB-
cord-023095-4dannjjm	1371	6	EGUS	EGUS	NNP
cord-023095-4dannjjm	1371	7	)	)	-RRB-
cord-023095-4dannjjm	1371	8	is	be	VBZ
cord-023095-4dannjjm	1371	9	a	a	DT
cord-023095-4dannjjm	1371	10	common	common	JJ
cord-023095-4dannjjm	1371	11	medical	medical	JJ
cord-023095-4dannjjm	1371	12	problem	problem	NN
cord-023095-4dannjjm	1371	13	in	in	IN
cord-023095-4dannjjm	1371	14	horses	horse	NNS
cord-023095-4dannjjm	1371	15	.	.	.
cord-023095-4dannjjm	1372	1	The	the	DT
cord-023095-4dannjjm	1372	2	high	high	JJ
cord-023095-4dannjjm	1372	3	prevalence	prevalence	NN
cord-023095-4dannjjm	1372	4	of	of	IN
cord-023095-4dannjjm	1372	5	gastric	gastric	JJ
cord-023095-4dannjjm	1372	6	ulcers	ulcer	NNS
cord-023095-4dannjjm	1372	7	,	,	,
cord-023095-4dannjjm	1372	8	vague	vague	JJ
cord-023095-4dannjjm	1372	9	clinical	clinical	JJ
cord-023095-4dannjjm	1372	10	signs	sign	NNS
cord-023095-4dannjjm	1372	11	and	and	CC
cord-023095-4dannjjm	1372	12	negative	negative	JJ
cord-023095-4dannjjm	1372	13	effect	effect	NN
cord-023095-4dannjjm	1372	14	on	on	IN
cord-023095-4dannjjm	1372	15	performance	performance	NN
cord-023095-4dannjjm	1372	16	make	make	VBP
cord-023095-4dannjjm	1372	17	it	-PRON-	PRP
cord-023095-4dannjjm	1372	18	a	a	DT
cord-023095-4dannjjm	1372	19	significant	significant	JJ
cord-023095-4dannjjm	1372	20	clinical	clinical	JJ
cord-023095-4dannjjm	1372	21	and	and	CC
cord-023095-4dannjjm	1372	22	economic	economic	JJ
cord-023095-4dannjjm	1372	23	problem	problem	NN
cord-023095-4dannjjm	1372	24	within	within	IN
cord-023095-4dannjjm	1372	25	the	the	DT
cord-023095-4dannjjm	1372	26	horse	horse	NN
cord-023095-4dannjjm	1372	27	industry	industry	NN
cord-023095-4dannjjm	1372	28	.	.	.
cord-023095-4dannjjm	1373	1	Current	current	JJ
cord-023095-4dannjjm	1373	2	pharmaceutical	pharmaceutical	JJ
cord-023095-4dannjjm	1373	3	treatments	treatment	NNS
cord-023095-4dannjjm	1373	4	are	be	VBP
cord-023095-4dannjjm	1373	5	expensive	expensive	JJ
cord-023095-4dannjjm	1373	6	and	and	CC
cord-023095-4dannjjm	1373	7	alter	alter	VB
cord-023095-4dannjjm	1373	8	the	the	DT
cord-023095-4dannjjm	1373	9	acidic	acidic	JJ
cord-023095-4dannjjm	1373	10	environment	environment	NN
cord-023095-4dannjjm	1373	11	of	of	IN
cord-023095-4dannjjm	1373	12	the	the	DT
cord-023095-4dannjjm	1373	13	stomach	stomach	NN
cord-023095-4dannjjm	1373	14	.	.	.
cord-023095-4dannjjm	1374	1	Berries	berry	NNS
cord-023095-4dannjjm	1374	2	and	and	CC
cord-023095-4dannjjm	1374	3	pulp	pulp	NN
cord-023095-4dannjjm	1374	4	from	from	IN
cord-023095-4dannjjm	1374	5	the	the	DT
cord-023095-4dannjjm	1374	6	seabuckthorn	seabuckthorn	JJ
cord-023095-4dannjjm	1374	7	plant	plant	NN
cord-023095-4dannjjm	1374	8	(	(	-LRB-
cord-023095-4dannjjm	1374	9	Hippophae	Hippophae	NNP
cord-023095-4dannjjm	1374	10	rhamnoides	rhamnoides	NNP
cord-023095-4dannjjm	1374	11	)	)	-RRB-
cord-023095-4dannjjm	1374	12	are	be	VBP
cord-023095-4dannjjm	1374	13	a	a	DT
cord-023095-4dannjjm	1374	14	rich	rich	JJ
cord-023095-4dannjjm	1374	15	source	source	NN
cord-023095-4dannjjm	1374	16	of	of	IN
cord-023095-4dannjjm	1374	17	vitamins	vitamin	NNS
cord-023095-4dannjjm	1374	18	,	,	,
cord-023095-4dannjjm	1374	19	trace	trace	NN
cord-023095-4dannjjm	1374	20	minerals	mineral	NNS
cord-023095-4dannjjm	1374	21	,	,	,
cord-023095-4dannjjm	1374	22	amino	amino	JJ
cord-023095-4dannjjm	1374	23	acids	acid	NNS
cord-023095-4dannjjm	1374	24	,	,	,
cord-023095-4dannjjm	1374	25	antioxidants	antioxidant	NNS
cord-023095-4dannjjm	1374	26	,	,	,
cord-023095-4dannjjm	1374	27	and	and	CC
cord-023095-4dannjjm	1374	28	other	other	JJ
cord-023095-4dannjjm	1374	29	bioactive	bioactive	JJ
cord-023095-4dannjjm	1374	30	substances	substance	NNS
cord-023095-4dannjjm	1374	31	and	and	CC
cord-023095-4dannjjm	1374	32	have	have	VBP
cord-023095-4dannjjm	1374	33	been	be	VBN
cord-023095-4dannjjm	1374	34	used	use	VBN
cord-023095-4dannjjm	1374	35	successfully	successfully	RB
cord-023095-4dannjjm	1374	36	to	to	TO
cord-023095-4dannjjm	1374	37	treat	treat	VB
cord-023095-4dannjjm	1374	38	stomach	stomach	NN
cord-023095-4dannjjm	1374	39	ulcers	ulcer	NNS
cord-023095-4dannjjm	1374	40	in	in	IN
cord-023095-4dannjjm	1374	41	man	man	NN
cord-023095-4dannjjm	1374	42	and	and	CC
cord-023095-4dannjjm	1374	43	rats	rat	NNS
cord-023095-4dannjjm	1374	44	.	.	.
cord-023095-4dannjjm	1375	1	The	the	DT
cord-023095-4dannjjm	1375	2	purpose	purpose	NN
cord-023095-4dannjjm	1375	3	of	of	IN
cord-023095-4dannjjm	1375	4	this	this	DT
cord-023095-4dannjjm	1375	5	study	study	NN
cord-023095-4dannjjm	1375	6	was	be	VBD
cord-023095-4dannjjm	1375	7	to	to	TO
cord-023095-4dannjjm	1375	8	evaluate	evaluate	VB
cord-023095-4dannjjm	1375	9	the	the	DT
cord-023095-4dannjjm	1375	10	efficacy	efficacy	NN
cord-023095-4dannjjm	1375	11	of	of	IN
cord-023095-4dannjjm	1375	12	a	a	DT
cord-023095-4dannjjm	1375	13	commercially	commercially	RB
cord-023095-4dannjjm	1375	14	sold	sell	VBN
cord-023095-4dannjjm	1375	15	,	,	,
cord-023095-4dannjjm	1375	16	liquid	liquid	JJ
cord-023095-4dannjjm	1375	17	extract	extract	NN
cord-023095-4dannjjm	1375	18	of	of	IN
cord-023095-4dannjjm	1375	19	seabuckthorn	seabuckthorn	JJ
cord-023095-4dannjjm	1375	20	berries	berry	NNS
cord-023095-4dannjjm	1376	1	(	(	-LRB-
cord-023095-4dannjjm	1376	2	SeaBuck	SeaBuck	NNP
cord-023095-4dannjjm	1376	3	TM	TM	NNP
cord-023095-4dannjjm	1376	4	SBT	SBT	NNP
cord-023095-4dannjjm	1376	5	Gastro	Gastro	NNP
cord-023095-4dannjjm	1376	6	-	-	HYPH
cord-023095-4dannjjm	1376	7	Plus	Plus	NNP
cord-023095-4dannjjm	1376	8	)	)	-RRB-
cord-023095-4dannjjm	1376	9	for	for	IN
cord-023095-4dannjjm	1376	10	treatment	treatment	NN
cord-023095-4dannjjm	1376	11	and	and	CC
cord-023095-4dannjjm	1376	12	prevention	prevention	NN
cord-023095-4dannjjm	1376	13	of	of	IN
cord-023095-4dannjjm	1376	14	gastric	gastric	JJ
cord-023095-4dannjjm	1376	15	ulcers	ulcer	NNS
cord-023095-4dannjjm	1376	16	in	in	IN
cord-023095-4dannjjm	1376	17	horses	horse	NNS
cord-023095-4dannjjm	1376	18	.	.	.
cord-023095-4dannjjm	1377	1	Eight	eight	CD
cord-023095-4dannjjm	1377	2	Thoroughbred	Thoroughbred	NNP
cord-023095-4dannjjm	1377	3	and	and	CC
cord-023095-4dannjjm	1377	4	Thoroughbred	Thoroughbred	NNP
cord-023095-4dannjjm	1377	5	-	-	HYPH
cord-023095-4dannjjm	1377	6	cross	cross	NN
cord-023095-4dannjjm	1377	7	horses	horse	NNS
cord-023095-4dannjjm	1377	8	(	(	-LRB-
cord-023095-4dannjjm	1377	9	3	3	CD
cord-023095-4dannjjm	1377	10	-	-	SYM
cord-023095-4dannjjm	1377	11	10	10	CD
cord-023095-4dannjjm	1377	12	years	year	NNS
cord-023095-4dannjjm	1377	13	of	of	IN
cord-023095-4dannjjm	1377	14	age	age	NN
cord-023095-4dannjjm	1377	15	,	,	,
cord-023095-4dannjjm	1377	16	5	5	CD
cord-023095-4dannjjm	1377	17	geldings	gelding	NNS
cord-023095-4dannjjm	1377	18	&	&	CC
cord-023095-4dannjjm	1377	19	3	3	CD
cord-023095-4dannjjm	1377	20	mares	mare	NNS
cord-023095-4dannjjm	1377	21	,	,	,
cord-023095-4dannjjm	1377	22	380	380	CD
cord-023095-4dannjjm	1377	23	-	-	SYM
cord-023095-4dannjjm	1377	24	600	600	CD
cord-023095-4dannjjm	1377	25	kg	kg	NNS
cord-023095-4dannjjm	1377	26	)	)	-RRB-
cord-023095-4dannjjm	1377	27	were	be	VBD
cord-023095-4dannjjm	1377	28	used	use	VBN
cord-023095-4dannjjm	1377	29	in	in	IN
cord-023095-4dannjjm	1377	30	a	a	DT
cord-023095-4dannjjm	1377	31	blinded	blinded	JJ
cord-023095-4dannjjm	1377	32	two	two	CD
cord-023095-4dannjjm	1377	33	-	-	HYPH
cord-023095-4dannjjm	1377	34	period	period	NN
cord-023095-4dannjjm	1377	35	cross	cross	NN
cord-023095-4dannjjm	1377	36	-	-	HYPH
cord-023095-4dannjjm	1377	37	over	over	RP
cord-023095-4dannjjm	1377	38	study	study	NN
cord-023095-4dannjjm	1377	39	.	.	.
cord-023095-4dannjjm	1378	1	Treatments	treatment	NNS
cord-023095-4dannjjm	1378	2	consisted	consist	VBN
cord-023095-4dannjjm	1378	3	of	of	IN
cord-023095-4dannjjm	1378	4	control	control	NN
cord-023095-4dannjjm	1378	5	(	(	-LRB-
cord-023095-4dannjjm	1378	6	untreated	untreated	JJ
cord-023095-4dannjjm	1378	7	)	)	-RRB-
cord-023095-4dannjjm	1378	8	and	and	CC
cord-023095-4dannjjm	1378	9	treatment	treatment	NN
cord-023095-4dannjjm	1379	1	(	(	-LRB-
cord-023095-4dannjjm	1379	2	SeaBuck	SeaBuck	NNP
cord-023095-4dannjjm	1379	3	TM	TM	NNP
cord-023095-4dannjjm	1379	4	SBT	SBT	NNP
cord-023095-4dannjjm	1379	5	Gastro	Gastro	NNP
cord-023095-4dannjjm	1379	6	-	-	HYPH
cord-023095-4dannjjm	1379	7	Plus	Plus	NNP
cord-023095-4dannjjm	1379	8	)	)	-RRB-
cord-023095-4dannjjm	1379	9	twice	twice	RB
cord-023095-4dannjjm	1379	10	daily	daily	RB
cord-023095-4dannjjm	1379	11	mixed	mix	VBN
cord-023095-4dannjjm	1379	12	with	with	IN
cord-023095-4dannjjm	1379	13	the	the	DT
cord-023095-4dannjjm	1379	14	grain	grain	NN
cord-023095-4dannjjm	1379	15	meal	meal	NN
cord-023095-4dannjjm	1379	16	.	.	.
cord-023095-4dannjjm	1380	1	Horses	horse	NNS
cord-023095-4dannjjm	1380	2	were	be	VBD
cord-023095-4dannjjm	1380	3	treated	treat	VBN
cord-023095-4dannjjm	1380	4	for	for	IN
cord-023095-4dannjjm	1380	5	5	5	CD
cord-023095-4dannjjm	1380	6	weeks	week	NNS
cord-023095-4dannjjm	1380	7	followed	follow	VBN
cord-023095-4dannjjm	1380	8	by	by	IN
cord-023095-4dannjjm	1380	9	a	a	DT
cord-023095-4dannjjm	1380	10	1	1	CD
cord-023095-4dannjjm	1380	11	week	week	NN
cord-023095-4dannjjm	1380	12	alternating	alternate	VBG
cord-023095-4dannjjm	1380	13	feed	feed	NN
cord-023095-4dannjjm	1380	14	-	-	HYPH
cord-023095-4dannjjm	1380	15	deprivation	deprivation	NN
cord-023095-4dannjjm	1380	16	period	period	NN
cord-023095-4dannjjm	1380	17	to	to	TO
cord-023095-4dannjjm	1380	18	induce	induce	VB
cord-023095-4dannjjm	1380	19	or	or	CC
cord-023095-4dannjjm	1380	20	worsen	worsen	VB
cord-023095-4dannjjm	1380	21	existing	exist	VBG
cord-023095-4dannjjm	1380	22	ulcers	ulcer	NNS
cord-023095-4dannjjm	1380	23	.	.	.
cord-023095-4dannjjm	1381	1	Gastroscopies	gastroscopy	NNS
cord-023095-4dannjjm	1381	2	were	be	VBD
cord-023095-4dannjjm	1381	3	performed	perform	VBN
cord-023095-4dannjjm	1381	4	on	on	IN
cord-023095-4dannjjm	1381	5	all	all	DT
cord-023095-4dannjjm	1381	6	horses	horse	NNS
cord-023095-4dannjjm	1381	7	on	on	IN
cord-023095-4dannjjm	1381	8	day	day	NN
cord-023095-4dannjjm	1381	9	0	0	CD
cord-023095-4dannjjm	1381	10	,	,	,
cord-023095-4dannjjm	1381	11	week	week	NN
cord-023095-4dannjjm	1381	12	5	5	CD
cord-023095-4dannjjm	1381	13	,	,	,
cord-023095-4dannjjm	1381	14	and	and	CC
cord-023095-4dannjjm	1381	15	week	week	NN
cord-023095-4dannjjm	1381	16	6	6	CD
cord-023095-4dannjjm	1381	17	(	(	-LRB-
cord-023095-4dannjjm	1381	18	at	at	IN
cord-023095-4dannjjm	1381	19	the	the	DT
cord-023095-4dannjjm	1381	20	end	end	NN
cord-023095-4dannjjm	1381	21	of	of	IN
cord-023095-4dannjjm	1381	22	the	the	DT
cord-023095-4dannjjm	1381	23	alternating	alternate	VBG
cord-023095-4dannjjm	1381	24	feed	feed	NN
cord-023095-4dannjjm	1381	25	-	-	HYPH
cord-023095-4dannjjm	1381	26	deprivation	deprivation	NN
cord-023095-4dannjjm	1381	27	period	period	NN
cord-023095-4dannjjm	1381	28	)	)	-RRB-
cord-023095-4dannjjm	1381	29	.	.	.
cord-023095-4dannjjm	1382	1	Gastric	gastric	JJ
cord-023095-4dannjjm	1382	2	juice	juice	NN
cord-023095-4dannjjm	1382	3	was	be	VBD
cord-023095-4dannjjm	1382	4	aspirated	aspirate	VBN
cord-023095-4dannjjm	1382	5	and	and	CC
cord-023095-4dannjjm	1382	6	pH	pH	NNP
cord-023095-4dannjjm	1382	7	was	be	VBD
cord-023095-4dannjjm	1382	8	measured	measure	VBN
cord-023095-4dannjjm	1382	9	.	.	.
cord-023095-4dannjjm	1383	1	During	during	IN
cord-023095-4dannjjm	1383	2	gastroscopy	gastroscopy	NN
cord-023095-4dannjjm	1383	3	,	,	,
cord-023095-4dannjjm	1383	4	gastric	gastric	JJ
cord-023095-4dannjjm	1383	5	ulcer	ulcer	NN
cord-023095-4dannjjm	1383	6	scores	score	NNS
cord-023095-4dannjjm	1383	7	were	be	VBD
cord-023095-4dannjjm	1383	8	assigned	assign	VBN
cord-023095-4dannjjm	1383	9	to	to	IN
cord-023095-4dannjjm	1383	10	each	each	DT
cord-023095-4dannjjm	1383	11	stomach	stomach	NN
cord-023095-4dannjjm	1383	12	based	base	VBN
cord-023095-4dannjjm	1383	13	on	on	IN
cord-023095-4dannjjm	1383	14	lesion	lesion	NN
cord-023095-4dannjjm	1383	15	number	number	NN
cord-023095-4dannjjm	1383	16	and	and	CC
cord-023095-4dannjjm	1383	17	severity	severity	NN
cord-023095-4dannjjm	1383	18	.	.	.
cord-023095-4dannjjm	1384	1	Horses	horse	NNS
cord-023095-4dannjjm	1384	2	acted	act	VBD
cord-023095-4dannjjm	1384	3	as	as	IN
cord-023095-4dannjjm	1384	4	their	-PRON-	PRP$
cord-023095-4dannjjm	1384	5	own	own	JJ
cord-023095-4dannjjm	1384	6	controls	control	NNS
cord-023095-4dannjjm	1384	7	,	,	,
cord-023095-4dannjjm	1384	8	and	and	CC
cord-023095-4dannjjm	1384	9	between	between	IN
cord-023095-4dannjjm	1384	10	each	each	DT
cord-023095-4dannjjm	1384	11	treatment	treatment	NN
cord-023095-4dannjjm	1384	12	period	period	NN
cord-023095-4dannjjm	1384	13	the	the	DT
cord-023095-4dannjjm	1384	14	horses	horse	NNS
cord-023095-4dannjjm	1384	15	had	have	VBD
cord-023095-4dannjjm	1384	16	a	a	DT
cord-023095-4dannjjm	1384	17	2-week	2-week	CD
cord-023095-4dannjjm	1384	18	washout	washout	NN
cord-023095-4dannjjm	1384	19	period	period	NN
cord-023095-4dannjjm	1384	20	.	.	.
cord-023095-4dannjjm	1385	1	Data	datum	NNS
cord-023095-4dannjjm	1385	2	was	be	VBD
cord-023095-4dannjjm	1385	3	analyzed	analyze	VBN
cord-023095-4dannjjm	1385	4	by	by	IN
cord-023095-4dannjjm	1385	5	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	1385	6	for	for	IN
cord-023095-4dannjjm	1385	7	repeated	repeat	VBN
cord-023095-4dannjjm	1385	8	measures	measure	NNS
cord-023095-4dannjjm	1385	9	via	via	IN
cord-023095-4dannjjm	1385	10	the	the	DT
cord-023095-4dannjjm	1385	11	GLM	GLM	NNP
cord-023095-4dannjjm	1385	12	procedure	procedure	NN
cord-023095-4dannjjm	1385	13	(	(	-LRB-
cord-023095-4dannjjm	1385	14	SAS	SAS	NNP
cord-023095-4dannjjm	1385	15	Inst	Inst	NNP
cord-023095-4dannjjm	1385	16	.	.	.
cord-023095-4dannjjm	1385	17	Inc.	Inc.	NNP
cord-023095-4dannjjm	1385	18	,	,	,
cord-023095-4dannjjm	1385	19	Cary	Cary	NNP
cord-023095-4dannjjm	1385	20	,	,	,
cord-023095-4dannjjm	1385	21	NC	NC	NNP
cord-023095-4dannjjm	1385	22	)	)	-RRB-
cord-023095-4dannjjm	1385	23	.	.	.
cord-023095-4dannjjm	1386	1	When	when	WRB
cord-023095-4dannjjm	1386	2	significant	significant	JJ
cord-023095-4dannjjm	1386	3	differences	difference	NNS
cord-023095-4dannjjm	1386	4	(	(	-LRB-
cord-023095-4dannjjm	1386	5	P	p	NN
cord-023095-4dannjjm	1386	6	o	o	NN
cord-023095-4dannjjm	1386	7	0.05	0.05	CD
cord-023095-4dannjjm	1386	8	)	)	-RRB-
cord-023095-4dannjjm	1386	9	were	be	VBD
cord-023095-4dannjjm	1386	10	observed	observe	VBN
cord-023095-4dannjjm	1386	11	,	,	,
cord-023095-4dannjjm	1386	12	a	a	DT
cord-023095-4dannjjm	1386	13	post	post	JJ
cord-023095-4dannjjm	1386	14	-	-	JJ
cord-023095-4dannjjm	1386	15	hoc	hoc	FW
cord-023095-4dannjjm	1386	16	Tukey	Tukey	NNP
cord-023095-4dannjjm	1386	17	's	's	POS
cord-023095-4dannjjm	1386	18	test	test	NN
cord-023095-4dannjjm	1386	19	was	be	VBD
cord-023095-4dannjjm	1386	20	used	use	VBN
cord-023095-4dannjjm	1386	21	to	to	TO
cord-023095-4dannjjm	1386	22	determine	determine	VB
cord-023095-4dannjjm	1386	23	differences	difference	NNS
cord-023095-4dannjjm	1386	24	.	.	.
cord-023095-4dannjjm	1387	1	Non	non	JJ
cord-023095-4dannjjm	1387	2	-	-	JJ
cord-023095-4dannjjm	1387	3	glandular	glandular	JJ
cord-023095-4dannjjm	1387	4	gastric	gastric	JJ
cord-023095-4dannjjm	1387	5	ulcer	ulcer	NN
cord-023095-4dannjjm	1387	6	scores	score	NNS
cord-023095-4dannjjm	1387	7	significantly	significantly	RB
cord-023095-4dannjjm	1387	8	increased	increase	VBD
cord-023095-4dannjjm	1387	9	in	in	IN
cord-023095-4dannjjm	1387	10	all	all	DT
cord-023095-4dannjjm	1387	11	control	control	NN
cord-023095-4dannjjm	1387	12	and	and	CC
cord-023095-4dannjjm	1387	13	SBT	SBT	NNP
cord-023095-4dannjjm	1387	14	-	-	HYPH
cord-023095-4dannjjm	1387	15	treated	treat	VBN
cord-023095-4dannjjm	1387	16	horses	horse	NNS
cord-023095-4dannjjm	1387	17	from	from	IN
cord-023095-4dannjjm	1387	18	Week	week	NN
cord-023095-4dannjjm	1387	19	5	5	CD
cord-023095-4dannjjm	1387	20	to	to	IN
cord-023095-4dannjjm	1387	21	Week	week	NN
cord-023095-4dannjjm	1387	22	6	6	CD
cord-023095-4dannjjm	1387	23	,	,	,
cord-023095-4dannjjm	1387	24	after	after	IN
cord-023095-4dannjjm	1387	25	the	the	DT
cord-023095-4dannjjm	1387	26	feed	feed	NN
cord-023095-4dannjjm	1387	27	-	-	HYPH
cord-023095-4dannjjm	1387	28	deprivation	deprivation	NN
cord-023095-4dannjjm	1387	29	phase	phase	NN
cord-023095-4dannjjm	1387	30	of	of	IN
cord-023095-4dannjjm	1387	31	the	the	DT
cord-023095-4dannjjm	1387	32	study	study	NN
cord-023095-4dannjjm	1387	33	.	.	.
cord-023095-4dannjjm	1388	1	There	there	EX
cord-023095-4dannjjm	1388	2	was	be	VBD
cord-023095-4dannjjm	1388	3	no	no	DT
cord-023095-4dannjjm	1388	4	significant	significant	JJ
cord-023095-4dannjjm	1388	5	difference	difference	NN
cord-023095-4dannjjm	1388	6	in	in	IN
cord-023095-4dannjjm	1388	7	the	the	DT
cord-023095-4dannjjm	1388	8	non	non	JJ
cord-023095-4dannjjm	1388	9	-	-	JJ
cord-023095-4dannjjm	1388	10	glandular	glandular	JJ
cord-023095-4dannjjm	1388	11	gastric	gastric	JJ
cord-023095-4dannjjm	1388	12	number	number	NN
cord-023095-4dannjjm	1388	13	(	(	-LRB-
cord-023095-4dannjjm	1388	14	P	p	NN
cord-023095-4dannjjm	1388	15	5	5	CD
cord-023095-4dannjjm	1388	16	0.84	0.84	CD
cord-023095-4dannjjm	1388	17	)	)	-RRB-
cord-023095-4dannjjm	1388	18	and	and	CC
cord-023095-4dannjjm	1388	19	nonglandular	nonglandular	JJ
cord-023095-4dannjjm	1388	20	gastric	gastric	JJ
cord-023095-4dannjjm	1388	21	severity	severity	NN
cord-023095-4dannjjm	1388	22	(	(	-LRB-
cord-023095-4dannjjm	1388	23	P	p	NN
cord-023095-4dannjjm	1388	24	5	5	CD
cord-023095-4dannjjm	1388	25	0.51	0.51	CD
cord-023095-4dannjjm	1388	26	)	)	-RRB-
cord-023095-4dannjjm	1388	27	scores	score	NNS
cord-023095-4dannjjm	1388	28	in	in	IN
cord-023095-4dannjjm	1388	29	SBT	SBT	NNP
cord-023095-4dannjjm	1388	30	-	-	HYPH
cord-023095-4dannjjm	1388	31	treated	treat	VBN
cord-023095-4dannjjm	1388	32	horses	horse	NNS
cord-023095-4dannjjm	1388	33	compared	compare	VBN
cord-023095-4dannjjm	1388	34	to	to	IN
cord-023095-4dannjjm	1388	35	non	non	JJ
cord-023095-4dannjjm	1388	36	-	-	JJ
cord-023095-4dannjjm	1388	37	treated	treat	VBN
cord-023095-4dannjjm	1388	38	controls	control	NNS
cord-023095-4dannjjm	1388	39	.	.	.
cord-023095-4dannjjm	1389	1	Glandular	glandular	JJ
cord-023095-4dannjjm	1389	2	ulcer	ulcer	NN
cord-023095-4dannjjm	1389	3	number	number	NN
cord-023095-4dannjjm	1389	4	(	(	-LRB-
cord-023095-4dannjjm	1389	5	P	p	NN
cord-023095-4dannjjm	1389	6	5	5	CD
cord-023095-4dannjjm	1389	7	0.02	0.02	CD
cord-023095-4dannjjm	1389	8	)	)	-RRB-
cord-023095-4dannjjm	1389	9	and	and	CC
cord-023095-4dannjjm	1389	10	glandular	glandular	JJ
cord-023095-4dannjjm	1389	11	ulcer	ulcer	NN
cord-023095-4dannjjm	1389	12	severity	severity	NN
cord-023095-4dannjjm	1389	13	(	(	-LRB-
cord-023095-4dannjjm	1389	14	P	p	NN
cord-023095-4dannjjm	1389	15	5	5	CD
cord-023095-4dannjjm	1389	16	0.02	0.02	CD
cord-023095-4dannjjm	1389	17	)	)	-RRB-
cord-023095-4dannjjm	1389	18	was	be	VBD
cord-023095-4dannjjm	1389	19	significantly	significantly	RB
cord-023095-4dannjjm	1389	20	lower	low	JJR
cord-023095-4dannjjm	1389	21	in	in	IN
cord-023095-4dannjjm	1389	22	the	the	DT
cord-023095-4dannjjm	1389	23	SBT	SBT	NNP
cord-023095-4dannjjm	1389	24	-	-	HYPH
cord-023095-4dannjjm	1389	25	treated	treat	VBN
cord-023095-4dannjjm	1389	26	horses	horse	NNS
cord-023095-4dannjjm	1389	27	compared	compare	VBN
cord-023095-4dannjjm	1389	28	to	to	IN
cord-023095-4dannjjm	1389	29	the	the	DT
cord-023095-4dannjjm	1389	30	control	control	NN
cord-023095-4dannjjm	1389	31	horses	horse	NNS
cord-023095-4dannjjm	1389	32	.	.	.
cord-023095-4dannjjm	1390	1	There	there	EX
cord-023095-4dannjjm	1390	2	was	be	VBD
cord-023095-4dannjjm	1390	3	no	no	DT
cord-023095-4dannjjm	1390	4	significant	significant	JJ
cord-023095-4dannjjm	1390	5	difference	difference	NN
cord-023095-4dannjjm	1390	6	in	in	IN
cord-023095-4dannjjm	1390	7	the	the	DT
cord-023095-4dannjjm	1390	8	pH	ph	NN
cord-023095-4dannjjm	1391	1	(	(	-LRB-
cord-023095-4dannjjm	1391	2	P	p	NN
cord-023095-4dannjjm	1391	3	5	5	CD
cord-023095-4dannjjm	1391	4	0.06	0.06	CD
cord-023095-4dannjjm	1391	5	)	)	-RRB-
cord-023095-4dannjjm	1391	6	in	in	IN
cord-023095-4dannjjm	1391	7	SBT	SBT	NNP
cord-023095-4dannjjm	1391	8	-	-	HYPH
cord-023095-4dannjjm	1391	9	treated	treat	VBN
cord-023095-4dannjjm	1391	10	horses	horse	NNS
cord-023095-4dannjjm	1391	11	compared	compare	VBN
cord-023095-4dannjjm	1391	12	to	to	IN
cord-023095-4dannjjm	1391	13	non	non	JJ
cord-023095-4dannjjm	1391	14	-	-	JJ
cord-023095-4dannjjm	1391	15	treated	treat	VBN
cord-023095-4dannjjm	1391	16	controls	control	NNS
cord-023095-4dannjjm	1391	17	.	.	.
cord-023095-4dannjjm	1392	1	Thus	thus	RB
cord-023095-4dannjjm	1392	2	,	,	,
cord-023095-4dannjjm	1392	3	SeaBuck	SeaBuck	NNP
cord-023095-4dannjjm	1392	4	TM	TM	NNP
cord-023095-4dannjjm	1392	5	SBT	SBT	NNP
cord-023095-4dannjjm	1392	6	Gastro	Gastro	NNP
cord-023095-4dannjjm	1392	7	-	-	HYPH
cord-023095-4dannjjm	1392	8	Plus	Plus	NNP
cord-023095-4dannjjm	1392	9	,	,	,
cord-023095-4dannjjm	1392	10	mixed	mixed	JJ
cord-023095-4dannjjm	1392	11	in	in	IN
cord-023095-4dannjjm	1392	12	the	the	DT
cord-023095-4dannjjm	1392	13	feed	feed	NN
cord-023095-4dannjjm	1392	14	twice	twice	RB
cord-023095-4dannjjm	1392	15	daily	daily	RB
cord-023095-4dannjjm	1392	16	,	,	,
cord-023095-4dannjjm	1392	17	may	may	MD
cord-023095-4dannjjm	1392	18	be	be	VB
cord-023095-4dannjjm	1392	19	efficacious	efficacious	JJ
cord-023095-4dannjjm	1392	20	in	in	IN
cord-023095-4dannjjm	1392	21	controlling	control	VBG
cord-023095-4dannjjm	1392	22	the	the	DT
cord-023095-4dannjjm	1392	23	severity	severity	NN
cord-023095-4dannjjm	1392	24	of	of	IN
cord-023095-4dannjjm	1392	25	glandular	glandular	JJ
cord-023095-4dannjjm	1392	26	ulcers	ulcer	NNS
cord-023095-4dannjjm	1392	27	in	in	IN
cord-023095-4dannjjm	1392	28	horses	horse	NNS
cord-023095-4dannjjm	1392	29	during	during	IN
cord-023095-4dannjjm	1392	30	stress	stress	NN
cord-023095-4dannjjm	1392	31	,	,	,
cord-023095-4dannjjm	1392	32	without	without	IN
cord-023095-4dannjjm	1392	33	increasing	increase	VBG
cord-023095-4dannjjm	1392	34	stomach	stomach	NN
cord-023095-4dannjjm	1392	35	pH.	ph.	NN
cord-023095-4dannjjm	1393	1	The	the	DT
cord-023095-4dannjjm	1393	2	availability	availability	NN
cord-023095-4dannjjm	1393	3	of	of	IN
cord-023095-4dannjjm	1393	4	rapid	rapid	JJ
cord-023095-4dannjjm	1393	5	and	and	CC
cord-023095-4dannjjm	1393	6	accurate	accurate	JJ
cord-023095-4dannjjm	1393	7	quantitative	quantitative	JJ
cord-023095-4dannjjm	1393	8	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	1393	9	measurements	measurement	NNS
cord-023095-4dannjjm	1393	10	may	may	MD
cord-023095-4dannjjm	1393	11	be	be	VB
cord-023095-4dannjjm	1393	12	useful	useful	JJ
cord-023095-4dannjjm	1393	13	for	for	IN
cord-023095-4dannjjm	1393	14	evaluation	evaluation	NN
cord-023095-4dannjjm	1393	15	of	of	IN
cord-023095-4dannjjm	1393	16	hospitalized	hospitalize	VBN
cord-023095-4dannjjm	1393	17	equine	equine	JJ
cord-023095-4dannjjm	1393	18	patients	patient	NNS
cord-023095-4dannjjm	1393	19	.	.	.
cord-023095-4dannjjm	1394	1	The	the	DT
cord-023095-4dannjjm	1394	2	Abaxis	Abaxis	NNP
cord-023095-4dannjjm	1394	3	VSPro	vspro	NN
cord-023095-4dannjjm	1394	4	analyzer	analyzer	NN
cord-023095-4dannjjm	1394	5	was	be	VBD
cord-023095-4dannjjm	1394	6	evaluated	evaluate	VBN
cord-023095-4dannjjm	1394	7	for	for	IN
cord-023095-4dannjjm	1394	8	precision	precision	NN
cord-023095-4dannjjm	1394	9	using	use	VBG
cord-023095-4dannjjm	1394	10	two	two	CD
cord-023095-4dannjjm	1394	11	levels	level	NNS
cord-023095-4dannjjm	1394	12	of	of	IN
cord-023095-4dannjjm	1394	13	human	human	JJ
cord-023095-4dannjjm	1394	14	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	1394	15	controls	control	NNS
cord-023095-4dannjjm	1394	16	(	(	-LRB-
cord-023095-4dannjjm	1394	17	300	300	CD
cord-023095-4dannjjm	1394	18	mg	mg	NNP
cord-023095-4dannjjm	1394	19	/	/	SYM
cord-023095-4dannjjm	1394	20	dL	dl	NN
cord-023095-4dannjjm	1394	21	and	and	CC
cord-023095-4dannjjm	1394	22	150	150	CD
cord-023095-4dannjjm	1394	23	mg	mg	NNP
cord-023095-4dannjjm	1394	24	/	/	SYM
cord-023095-4dannjjm	1394	25	dL	dl	NN
cord-023095-4dannjjm	1394	26	)	)	-RRB-
cord-023095-4dannjjm	1394	27	,	,	,
cord-023095-4dannjjm	1394	28	four	four	CD
cord-023095-4dannjjm	1394	29	different	different	JJ
cord-023095-4dannjjm	1394	30	VSPro	vspro	NN
cord-023095-4dannjjm	1394	31	machines	machine	NNS
cord-023095-4dannjjm	1394	32	,	,	,
cord-023095-4dannjjm	1394	33	and	and	CC
cord-023095-4dannjjm	1394	34	two	two	CD
cord-023095-4dannjjm	1394	35	different	different	JJ
cord-023095-4dannjjm	1394	36	lots	lot	NNS
cord-023095-4dannjjm	1394	37	of	of	IN
cord-023095-4dannjjm	1394	38	cartridges	cartridge	NNS
cord-023095-4dannjjm	1394	39	,	,	,
cord-023095-4dannjjm	1394	40	assessed	assess	VBN
cord-023095-4dannjjm	1394	41	over	over	IN
cord-023095-4dannjjm	1394	42	5	5	CD
cord-023095-4dannjjm	1394	43	subsequent	subsequent	JJ
cord-023095-4dannjjm	1394	44	days	day	NNS
cord-023095-4dannjjm	1394	45	.	.	.
cord-023095-4dannjjm	1395	1	The	the	DT
cord-023095-4dannjjm	1395	2	coefficients	coefficient	NNS
cord-023095-4dannjjm	1395	3	of	of	IN
cord-023095-4dannjjm	1395	4	variation	variation	NN
cord-023095-4dannjjm	1395	5	of	of	IN
cord-023095-4dannjjm	1395	6	the	the	DT
cord-023095-4dannjjm	1395	7	assay	assay	NN
cord-023095-4dannjjm	1395	8	ranged	range	VBD
cord-023095-4dannjjm	1395	9	from	from	IN
cord-023095-4dannjjm	1395	10	4	4	CD
cord-023095-4dannjjm	1395	11	%	%	NN
cord-023095-4dannjjm	1395	12	(	(	-LRB-
cord-023095-4dannjjm	1395	13	300	300	CD
cord-023095-4dannjjm	1395	14	mg	mg	NNP
cord-023095-4dannjjm	1395	15	/	/	SYM
cord-023095-4dannjjm	1395	16	dL	dl	NN
cord-023095-4dannjjm	1395	17	)	)	-RRB-
cord-023095-4dannjjm	1395	18	to	to	IN
cord-023095-4dannjjm	1395	19	8	8	CD
cord-023095-4dannjjm	1395	20	%	%	NN
cord-023095-4dannjjm	1395	21	(	(	-LRB-
cord-023095-4dannjjm	1395	22	150	150	CD
cord-023095-4dannjjm	1395	23	mg/	mg/	NN
cord-023095-4dannjjm	1395	24	dL	dl	NN
cord-023095-4dannjjm	1395	25	)	)	-RRB-
cord-023095-4dannjjm	1395	26	.	.	.
cord-023095-4dannjjm	1396	1	We	-PRON-	PRP
cord-023095-4dannjjm	1396	2	subsequently	subsequently	RB
cord-023095-4dannjjm	1396	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	1396	4	the	the	DT
cord-023095-4dannjjm	1396	5	Abaxis	Abaxis	NNP
cord-023095-4dannjjm	1396	6	VSPro	VSPro	VBN
cord-023095-4dannjjm	1396	7	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	1396	8	assay	assay	NN
cord-023095-4dannjjm	1396	9	compared	compare	VBN
cord-023095-4dannjjm	1396	10	to	to	IN
cord-023095-4dannjjm	1396	11	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	1396	12	concentration	concentration	NN
cord-023095-4dannjjm	1396	13	measured	measure	VBN
cord-023095-4dannjjm	1396	14	using	use	VBG
cord-023095-4dannjjm	1396	15	the	the	DT
cord-023095-4dannjjm	1396	16	Beckman	Beckman	NNP
cord-023095-4dannjjm	1396	17	Coulter	Coulter	NNP
cord-023095-4dannjjm	1396	18	ACL-1000	ACL-1000	NNP
cord-023095-4dannjjm	1396	19	in	in	IN
cord-023095-4dannjjm	1396	20	50	50	CD
cord-023095-4dannjjm	1396	21	equine	equine	JJ
cord-023095-4dannjjm	1396	22	samples	sample	NNS
cord-023095-4dannjjm	1396	23	of	of	IN
cord-023095-4dannjjm	1396	24	varying	vary	VBG
cord-023095-4dannjjm	1396	25	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	1396	26	concentrations	concentration	NNS
cord-023095-4dannjjm	1396	27	obtained	obtain	VBN
cord-023095-4dannjjm	1396	28	from	from	IN
cord-023095-4dannjjm	1396	29	horses	horse	NNS
cord-023095-4dannjjm	1396	30	with	with	IN
cord-023095-4dannjjm	1396	31	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1396	32	disease	disease	NN
cord-023095-4dannjjm	1396	33	.	.	.
cord-023095-4dannjjm	1397	1	All	all	DT
cord-023095-4dannjjm	1397	2	samples	sample	NNS
cord-023095-4dannjjm	1397	3	were	be	VBD
cord-023095-4dannjjm	1397	4	measured	measure	VBN
cord-023095-4dannjjm	1397	5	in	in	IN
cord-023095-4dannjjm	1397	6	citrated	citrated	JJ
cord-023095-4dannjjm	1397	7	plasma	plasma	NN
cord-023095-4dannjjm	1397	8	.	.	.
cord-023095-4dannjjm	1398	1	Fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	1398	2	samples	sample	NNS
cord-023095-4dannjjm	1398	3	measured	measure	VBN
cord-023095-4dannjjm	1398	4	on	on	IN
cord-023095-4dannjjm	1398	5	the	the	DT
cord-023095-4dannjjm	1398	6	ACL-1000	acl-1000	NN
cord-023095-4dannjjm	1398	7	ranged	range	VBD
cord-023095-4dannjjm	1398	8	from	from	IN
cord-023095-4dannjjm	1398	9	226	226	CD
cord-023095-4dannjjm	1398	10	to	to	TO
cord-023095-4dannjjm	1398	11	959	959	CD
cord-023095-4dannjjm	1398	12	mg	mg	NNP
cord-023095-4dannjjm	1398	13	/	/	SYM
cord-023095-4dannjjm	1398	14	dL	dl	NN
cord-023095-4dannjjm	1398	15	(	(	-LRB-
cord-023095-4dannjjm	1398	16	median	median	JJ
cord-023095-4dannjjm	1398	17	501	501	CD
cord-023095-4dannjjm	1398	18	mg	mg	NNP
cord-023095-4dannjjm	1398	19	/	/	SYM
cord-023095-4dannjjm	1398	20	dL	dl	NN
cord-023095-4dannjjm	1398	21	)	)	-RRB-
cord-023095-4dannjjm	1398	22	.	.	.
cord-023095-4dannjjm	1399	1	VSPro	vspro	JJ
cord-023095-4dannjjm	1399	2	samples	sample	NNS
cord-023095-4dannjjm	1399	3	were	be	VBD
cord-023095-4dannjjm	1399	4	run	run	VBN
cord-023095-4dannjjm	1399	5	in	in	IN
cord-023095-4dannjjm	1399	6	duplicate	duplicate	NN
cord-023095-4dannjjm	1399	7	,	,	,
cord-023095-4dannjjm	1399	8	and	and	CC
cord-023095-4dannjjm	1399	9	the	the	DT
cord-023095-4dannjjm	1399	10	mean	mean	NN
cord-023095-4dannjjm	1399	11	compared	compare	VBN
cord-023095-4dannjjm	1399	12	to	to	IN
cord-023095-4dannjjm	1399	13	the	the	DT
cord-023095-4dannjjm	1399	14	ACL	ACL	NNP
cord-023095-4dannjjm	1399	15	values	value	NNS
cord-023095-4dannjjm	1399	16	.	.	.
cord-023095-4dannjjm	1400	1	Pearson	Pearson	NNP
cord-023095-4dannjjm	1400	2	correlation	correlation	NN
cord-023095-4dannjjm	1400	3	coefficient	coefficient	NN
cord-023095-4dannjjm	1400	4	analysis	analysis	NN
cord-023095-4dannjjm	1400	5	generated	generate	VBD
cord-023095-4dannjjm	1400	6	an	an	DT
cord-023095-4dannjjm	1400	7	r	r	NN
cord-023095-4dannjjm	1400	8	value	value	NN
cord-023095-4dannjjm	1400	9	of	of	IN
cord-023095-4dannjjm	1400	10	0.949	0.949	CD
cord-023095-4dannjjm	1401	1	(	(	-LRB-
cord-023095-4dannjjm	1401	2	P	p	NN
cord-023095-4dannjjm	1401	3	o	o	NN
cord-023095-4dannjjm	1401	4	0.001	0.001	CD
cord-023095-4dannjjm	1401	5	)	)	-RRB-
cord-023095-4dannjjm	1401	6	.	.	.
cord-023095-4dannjjm	1402	1	Duplicate	duplicate	JJ
cord-023095-4dannjjm	1402	2	measurements	measurement	NNS
cord-023095-4dannjjm	1402	3	on	on	IN
cord-023095-4dannjjm	1402	4	the	the	DT
cord-023095-4dannjjm	1402	5	VSPro	vspro	NN
cord-023095-4dannjjm	1402	6	were	be	VBD
cord-023095-4dannjjm	1402	7	strongly	strongly	RB
cord-023095-4dannjjm	1402	8	correlated	correlate	VBN
cord-023095-4dannjjm	1402	9	to	to	IN
cord-023095-4dannjjm	1402	10	each	each	DT
cord-023095-4dannjjm	1402	11	other	other	JJ
cord-023095-4dannjjm	1402	12	with	with	IN
cord-023095-4dannjjm	1402	13	an	an	DT
cord-023095-4dannjjm	1402	14	r	r	NN
cord-023095-4dannjjm	1402	15	value	value	NN
cord-023095-4dannjjm	1402	16	of	of	IN
cord-023095-4dannjjm	1402	17	0.9690	0.9690	CD
cord-023095-4dannjjm	1403	1	(	(	-LRB-
cord-023095-4dannjjm	1403	2	P	p	NN
cord-023095-4dannjjm	1403	3	o	o	NN
cord-023095-4dannjjm	1403	4	0.001	0.001	CD
cord-023095-4dannjjm	1403	5	)	)	-RRB-
cord-023095-4dannjjm	1403	6	.	.	.
cord-023095-4dannjjm	1404	1	Bland	Bland	NNP
cord-023095-4dannjjm	1404	2	-	-	HYPH
cord-023095-4dannjjm	1404	3	Altman	Altman	NNP
cord-023095-4dannjjm	1404	4	analysis	analysis	NN
cord-023095-4dannjjm	1404	5	of	of	IN
cord-023095-4dannjjm	1404	6	these	these	DT
cord-023095-4dannjjm	1404	7	samples	sample	NNS
cord-023095-4dannjjm	1404	8	for	for	IN
cord-023095-4dannjjm	1404	9	the	the	DT
cord-023095-4dannjjm	1404	10	VSPro	vspro	NN
cord-023095-4dannjjm	1405	1	compared	compare	VBN
cord-023095-4dannjjm	1405	2	to	to	IN
cord-023095-4dannjjm	1405	3	the	the	DT
cord-023095-4dannjjm	1405	4	ACL-1000	ACL-1000	NNP
cord-023095-4dannjjm	1405	5	noted	note	VBD
cord-023095-4dannjjm	1405	6	a	a	DT
cord-023095-4dannjjm	1405	7	bias	bias	NN
cord-023095-4dannjjm	1405	8	of	of	IN
cord-023095-4dannjjm	1405	9	À84	À84	NNP
cord-023095-4dannjjm	1405	10	AE	AE	NNP
cord-023095-4dannjjm	1405	11	57	57	CD
cord-023095-4dannjjm	1405	12	mg	mg	NNP
cord-023095-4dannjjm	1405	13	/	/	SYM
cord-023095-4dannjjm	1405	14	dL	dl	NN
cord-023095-4dannjjm	1406	1	The	the	DT
cord-023095-4dannjjm	1406	2	results	result	NNS
cord-023095-4dannjjm	1406	3	of	of	IN
cord-023095-4dannjjm	1406	4	this	this	DT
cord-023095-4dannjjm	1406	5	study	study	NN
cord-023095-4dannjjm	1406	6	indicate	indicate	VBP
cord-023095-4dannjjm	1406	7	that	that	IN
cord-023095-4dannjjm	1406	8	the	the	DT
cord-023095-4dannjjm	1406	9	VSPro	VSPro	VBN
cord-023095-4dannjjm	1406	10	benchtop	benchtop	NN
cord-023095-4dannjjm	1406	11	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	1406	12	analyzer	analyzer	NN
cord-023095-4dannjjm	1406	13	provides	provide	VBZ
cord-023095-4dannjjm	1406	14	accurate	accurate	JJ
cord-023095-4dannjjm	1406	15	and	and	CC
cord-023095-4dannjjm	1406	16	precise	precise	JJ
cord-023095-4dannjjm	1406	17	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	1406	18	data	datum	NNS
cord-023095-4dannjjm	1406	19	compared	compare	VBN
cord-023095-4dannjjm	1406	20	to	to	IN
cord-023095-4dannjjm	1406	21	the	the	DT
cord-023095-4dannjjm	1406	22	ACL-1000	ACL-1000	NNP
cord-023095-4dannjjm	1406	23	reference	reference	NN
cord-023095-4dannjjm	1406	24	analyzer	analyzer	NN
cord-023095-4dannjjm	1406	25	.	.	.
cord-023095-4dannjjm	1407	1	The	the	DT
cord-023095-4dannjjm	1407	2	immune	immune	JJ
cord-023095-4dannjjm	1407	3	response	response	NN
cord-023095-4dannjjm	1407	4	of	of	IN
cord-023095-4dannjjm	1407	5	foals	foal	NNS
cord-023095-4dannjjm	1407	6	to	to	IN
cord-023095-4dannjjm	1407	7	R.	R.	NNP
cord-023095-4dannjjm	1407	8	equi	equi	NN
cord-023095-4dannjjm	1407	9	is	be	VBZ
cord-023095-4dannjjm	1407	10	incompletely	incompletely	RB
cord-023095-4dannjjm	1407	11	understood	understand	VBN
cord-023095-4dannjjm	1407	12	and	and	CC
cord-023095-4dannjjm	1407	13	believed	believe	VBN
cord-023095-4dannjjm	1407	14	to	to	TO
cord-023095-4dannjjm	1407	15	be	be	VB
cord-023095-4dannjjm	1407	16	responsible	responsible	JJ
cord-023095-4dannjjm	1407	17	for	for	IN
cord-023095-4dannjjm	1407	18	clinical	clinical	JJ
cord-023095-4dannjjm	1407	19	disease	disease	NN
cord-023095-4dannjjm	1407	20	caused	cause	VBN
cord-023095-4dannjjm	1407	21	by	by	IN
cord-023095-4dannjjm	1407	22	this	this	DT
cord-023095-4dannjjm	1407	23	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	1407	24	pathogen	pathogen	NN
cord-023095-4dannjjm	1407	25	.	.	.
cord-023095-4dannjjm	1408	1	In	in	IN
cord-023095-4dannjjm	1408	2	a	a	DT
cord-023095-4dannjjm	1408	3	recent	recent	JJ
cord-023095-4dannjjm	1408	4	study	study	NN
cord-023095-4dannjjm	1408	5	foals	foal	NNS
cord-023095-4dannjjm	1408	6	receiving	receive	VBG
cord-023095-4dannjjm	1408	7	a	a	DT
cord-023095-4dannjjm	1408	8	large	large	JJ
cord-023095-4dannjjm	1408	9	inoculum	inoculum	NN
cord-023095-4dannjjm	1408	10	exhibited	exhibit	VBD
cord-023095-4dannjjm	1408	11	Th2	Th2	NNP
cord-023095-4dannjjm	1408	12	skewing	skew	VBG
cord-023095-4dannjjm	1408	13	with	with	IN
cord-023095-4dannjjm	1408	14	pneumonia	pneumonia	NN
cord-023095-4dannjjm	1408	15	and	and	CC
cord-023095-4dannjjm	1408	16	a	a	DT
cord-023095-4dannjjm	1408	17	small	small	JJ
cord-023095-4dannjjm	1408	18	inoculum	inoculum	NN
cord-023095-4dannjjm	1408	19	exhibited	exhibit	VBD
cord-023095-4dannjjm	1408	20	Th1	th1	NN
cord-023095-4dannjjm	1408	21	skewing	skew	VBG
cord-023095-4dannjjm	1408	22	without	without	IN
cord-023095-4dannjjm	1408	23	clinical	clinical	JJ
cord-023095-4dannjjm	1408	24	disease	disease	NN
cord-023095-4dannjjm	1408	25	.	.	.
cord-023095-4dannjjm	1409	1	We	-PRON-	PRP
cord-023095-4dannjjm	1409	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1409	3	that	that	IN
cord-023095-4dannjjm	1409	4	cytokine	cytokine	NN
cord-023095-4dannjjm	1409	5	/	/	SYM
cord-023095-4dannjjm	1409	6	chemokine	chemokine	NN
cord-023095-4dannjjm	1409	7	production	production	NN
cord-023095-4dannjjm	1409	8	by	by	IN
cord-023095-4dannjjm	1409	9	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	1409	10	alveolar	alveolar	NN
cord-023095-4dannjjm	1409	11	macrophages	macrophage	NNS
cord-023095-4dannjjm	1409	12	,	,	,
cord-023095-4dannjjm	1409	13	in	in	IN
cord-023095-4dannjjm	1409	14	vitro	vitro	FW
cord-023095-4dannjjm	1409	15	,	,	,
cord-023095-4dannjjm	1409	16	would	would	MD
cord-023095-4dannjjm	1409	17	increase	increase	VB
cord-023095-4dannjjm	1409	18	with	with	IN
cord-023095-4dannjjm	1409	19	the	the	DT
cord-023095-4dannjjm	1409	20	infective	infective	JJ
cord-023095-4dannjjm	1409	21	dose	dose	NN
cord-023095-4dannjjm	1409	22	and	and	CC
cord-023095-4dannjjm	1409	23	that	that	IN
cord-023095-4dannjjm	1409	24	the	the	DT
cord-023095-4dannjjm	1409	25	magnitude	magnitude	NN
cord-023095-4dannjjm	1409	26	of	of	IN
cord-023095-4dannjjm	1409	27	the	the	DT
cord-023095-4dannjjm	1409	28	response	response	NN
cord-023095-4dannjjm	1409	29	would	would	MD
cord-023095-4dannjjm	1409	30	differ	differ	VB
cord-023095-4dannjjm	1409	31	between	between	IN
cord-023095-4dannjjm	1409	32	foals	foal	NNS
cord-023095-4dannjjm	1409	33	and	and	CC
cord-023095-4dannjjm	1409	34	adults	adult	NNS
cord-023095-4dannjjm	1409	35	.	.	.
cord-023095-4dannjjm	1410	1	Alveolar	alveolar	NN
cord-023095-4dannjjm	1410	2	macrophages	macrophage	NNS
cord-023095-4dannjjm	1410	3	were	be	VBD
cord-023095-4dannjjm	1410	4	obtained	obtain	VBN
cord-023095-4dannjjm	1410	5	by	by	IN
cord-023095-4dannjjm	1410	6	bronchoalevolar	bronchoalevolar	NNP
cord-023095-4dannjjm	1410	7	lavage	lavage	NN
cord-023095-4dannjjm	1410	8	from	from	IN
cord-023095-4dannjjm	1410	9	7	7	CD
cord-023095-4dannjjm	1410	10	healthy	healthy	JJ
cord-023095-4dannjjm	1410	11	mares	mare	NNS
cord-023095-4dannjjm	1410	12	and	and	CC
cord-023095-4dannjjm	1410	13	their	-PRON-	PRP$
cord-023095-4dannjjm	1410	14	5-week	5-week	JJ
cord-023095-4dannjjm	1410	15	-	-	HYPH
cord-023095-4dannjjm	1410	16	old	old	JJ
cord-023095-4dannjjm	1410	17	foals	foal	NNS
cord-023095-4dannjjm	1410	18	.	.	.
cord-023095-4dannjjm	1411	1	Macrophage	macrophage	NN
cord-023095-4dannjjm	1411	2	cultures	culture	NNS
cord-023095-4dannjjm	1411	3	were	be	VBD
cord-023095-4dannjjm	1411	4	infected	infect	VBN
cord-023095-4dannjjm	1411	5	with	with	IN
cord-023095-4dannjjm	1411	6	R.	R.	NNP
cord-023095-4dannjjm	1411	7	equi	equi	NN
cord-023095-4dannjjm	1411	8	(	(	-LRB-
cord-023095-4dannjjm	1411	9	337011	337011	CD
cord-023095-4dannjjm	1411	10	or	or	CC
cord-023095-4dannjjm	1411	11	33701-	33701-	NNP
cord-023095-4dannjjm	1411	12	)	)	-RRB-
cord-023095-4dannjjm	1411	13	at	at	IN
cord-023095-4dannjjm	1411	14	a	a	DT
cord-023095-4dannjjm	1411	15	multiplicity	multiplicity	NN
cord-023095-4dannjjm	1411	16	of	of	IN
cord-023095-4dannjjm	1411	17	infection	infection	NN
cord-023095-4dannjjm	1411	18	(	(	-LRB-
cord-023095-4dannjjm	1411	19	MOI	MOI	NNP
cord-023095-4dannjjm	1411	20	)	)	-RRB-
cord-023095-4dannjjm	1411	21	of	of	IN
cord-023095-4dannjjm	1411	22	1	1	CD
cord-023095-4dannjjm	1411	23	or	or	CC
cord-023095-4dannjjm	1411	24	100	100	CD
cord-023095-4dannjjm	1411	25	.	.	.
cord-023095-4dannjjm	1412	1	Total	Total	NNP
cord-023095-4dannjjm	1412	2	RNA	RNA	NNP
cord-023095-4dannjjm	1412	3	was	be	VBD
cord-023095-4dannjjm	1412	4	harvested	harvest	VBN
cord-023095-4dannjjm	1412	5	4	4	CD
cord-023095-4dannjjm	1412	6	and	and	CC
cord-023095-4dannjjm	1412	7	24	24	CD
cord-023095-4dannjjm	1412	8	hours	hour	NNS
cord-023095-4dannjjm	1412	9	post	post	NN
cord-023095-4dannjjm	1412	10	-	-	NN
cord-023095-4dannjjm	1412	11	infection	infection	JJ
cord-023095-4dannjjm	1412	12	,	,	,
cord-023095-4dannjjm	1412	13	reverse	reverse	VB
cord-023095-4dannjjm	1412	14	transcribed	transcribe	VBN
cord-023095-4dannjjm	1412	15	and	and	CC
cord-023095-4dannjjm	1412	16	used	use	VBN
cord-023095-4dannjjm	1412	17	as	as	IN
cord-023095-4dannjjm	1412	18	template	template	NN
cord-023095-4dannjjm	1412	19	for	for	IN
cord-023095-4dannjjm	1412	20	quantita	quantita	NNP
cord-023095-4dannjjm	1412	21	-	-	HYPH
cord-023095-4dannjjm	1412	22	tive	tive	JJ
cord-023095-4dannjjm	1412	23	PCR	PCR	NNP
cord-023095-4dannjjm	1412	24	.	.	.
cord-023095-4dannjjm	1413	1	The	the	DT
cord-023095-4dannjjm	1413	2	DDCt	DDCt	NNS
cord-023095-4dannjjm	1413	3	method	method	NN
cord-023095-4dannjjm	1413	4	was	be	VBD
cord-023095-4dannjjm	1413	5	used	use	VBN
cord-023095-4dannjjm	1413	6	to	to	TO
cord-023095-4dannjjm	1413	7	calculate	calculate	VB
cord-023095-4dannjjm	1413	8	relative	relative	JJ
cord-023095-4dannjjm	1413	9	gene	gene	NN
cord-023095-4dannjjm	1413	10	transcripts	transcript	NNS
cord-023095-4dannjjm	1413	11	for	for	IN
cord-023095-4dannjjm	1413	12	IL-6	IL-6	NNP
cord-023095-4dannjjm	1413	13	,	,	,
cord-023095-4dannjjm	1413	14	IL-12p40	IL-12p40	NNP
cord-023095-4dannjjm	1413	15	,	,	,
cord-023095-4dannjjm	1413	16	TNFa	TNFa	NNP
cord-023095-4dannjjm	1413	17	and	and	CC
cord-023095-4dannjjm	1413	18	CXCL10	CXCL10	NNP
cord-023095-4dannjjm	1413	19	.	.	.
cord-023095-4dannjjm	1414	1	Cellular	cellular	JJ
cord-023095-4dannjjm	1414	2	infections	infection	NNS
cord-023095-4dannjjm	1414	3	at	at	IN
cord-023095-4dannjjm	1414	4	MOI	MOI	NNP
cord-023095-4dannjjm	1414	5	100	100	CD
cord-023095-4dannjjm	1414	6	resulted	result	VBD
cord-023095-4dannjjm	1414	7	in	in	IN
cord-023095-4dannjjm	1414	8	significantly	significantly	RB
cord-023095-4dannjjm	1414	9	higher	high	JJR
cord-023095-4dannjjm	1414	10	expression	expression	NN
cord-023095-4dannjjm	1414	11	of	of	IN
cord-023095-4dannjjm	1414	12	IL-6	IL-6	NNP
cord-023095-4dannjjm	1414	13	,	,	,
cord-023095-4dannjjm	1414	14	IL-12p40	IL-12p40	NNP
cord-023095-4dannjjm	1414	15	and	and	CC
cord-023095-4dannjjm	1414	16	TNFa	TNFa	NNP
cord-023095-4dannjjm	1414	17	mRNA	mrna	NN
cord-023095-4dannjjm	1414	18	transcripts	transcript	NNS
cord-023095-4dannjjm	1414	19	compared	compare	VBN
cord-023095-4dannjjm	1414	20	to	to	IN
cord-023095-4dannjjm	1414	21	MOI	MOI	NNP
cord-023095-4dannjjm	1414	22	1	1	CD
cord-023095-4dannjjm	1414	23	.	.	.
cord-023095-4dannjjm	1415	1	However	however	RB
cord-023095-4dannjjm	1415	2	,	,	,
cord-023095-4dannjjm	1415	3	the	the	DT
cord-023095-4dannjjm	1415	4	dose	dose	NN
cord-023095-4dannjjm	1415	5	-	-	HYPH
cord-023095-4dannjjm	1415	6	effect	effect	NN
cord-023095-4dannjjm	1415	7	was	be	VBD
cord-023095-4dannjjm	1415	8	reversed	reverse	VBN
cord-023095-4dannjjm	1415	9	for	for	IN
cord-023095-4dannjjm	1415	10	CXCL10	CXCL10	NNP
cord-023095-4dannjjm	1415	11	with	with	IN
cord-023095-4dannjjm	1415	12	significantly	significantly	RB
cord-023095-4dannjjm	1415	13	lower	low	JJR
cord-023095-4dannjjm	1415	14	expression	expression	NN
cord-023095-4dannjjm	1415	15	at	at	IN
cord-023095-4dannjjm	1415	16	the	the	DT
cord-023095-4dannjjm	1415	17	higher	high	JJR
cord-023095-4dannjjm	1415	18	MOI	MOI	NNP
cord-023095-4dannjjm	1415	19	.	.	.
cord-023095-4dannjjm	1416	1	There	there	EX
cord-023095-4dannjjm	1416	2	was	be	VBD
cord-023095-4dannjjm	1416	3	no	no	DT
cord-023095-4dannjjm	1416	4	difference	difference	NN
cord-023095-4dannjjm	1416	5	in	in	IN
cord-023095-4dannjjm	1416	6	magnitude	magnitude	NN
cord-023095-4dannjjm	1416	7	of	of	IN
cord-023095-4dannjjm	1416	8	cytokine	cytokine	NN
cord-023095-4dannjjm	1416	9	/	/	SYM
cord-023095-4dannjjm	1416	10	chemokine	chemokine	NN
cord-023095-4dannjjm	1416	11	responses	response	NNS
cord-023095-4dannjjm	1416	12	by	by	IN
cord-023095-4dannjjm	1416	13	the	the	DT
cord-023095-4dannjjm	1416	14	alveolar	alveolar	JJ
cord-023095-4dannjjm	1416	15	macrophages	macrophage	NNS
cord-023095-4dannjjm	1416	16	between	between	IN
cord-023095-4dannjjm	1416	17	adults	adult	NNS
cord-023095-4dannjjm	1416	18	and	and	CC
cord-023095-4dannjjm	1416	19	foals	foal	NNS
cord-023095-4dannjjm	1416	20	.	.	.
cord-023095-4dannjjm	1417	1	Dose	dose	JJ
cord-023095-4dannjjm	1417	2	-	-	HYPH
cord-023095-4dannjjm	1417	3	dependent	dependent	JJ
cord-023095-4dannjjm	1417	4	responses	response	NNS
cord-023095-4dannjjm	1417	5	of	of	IN
cord-023095-4dannjjm	1417	6	alveolar	alveolar	JJ
cord-023095-4dannjjm	1417	7	macrophages	macrophage	NNS
cord-023095-4dannjjm	1417	8	may	may	MD
cord-023095-4dannjjm	1417	9	represent	represent	VB
cord-023095-4dannjjm	1417	10	a	a	DT
cord-023095-4dannjjm	1417	11	novel	novel	JJ
cord-023095-4dannjjm	1417	12	mechanism	mechanism	NN
cord-023095-4dannjjm	1417	13	by	by	IN
cord-023095-4dannjjm	1417	14	which	which	WDT
cord-023095-4dannjjm	1417	15	R.	R.	NNP
cord-023095-4dannjjm	1417	16	equi	equi	NN
cord-023095-4dannjjm	1417	17	could	could	MD
cord-023095-4dannjjm	1417	18	modulate	modulate	VB
cord-023095-4dannjjm	1417	19	immune	immune	JJ
cord-023095-4dannjjm	1417	20	responses	response	NNS
cord-023095-4dannjjm	1417	21	and	and	CC
cord-023095-4dannjjm	1417	22	therefore	therefore	RB
cord-023095-4dannjjm	1417	23	disease	disease	NN
cord-023095-4dannjjm	1417	24	.	.	.
cord-023095-4dannjjm	1418	1	Significant	significant	JJ
cord-023095-4dannjjm	1418	2	down	down	JJ
cord-023095-4dannjjm	1418	3	-	-	HYPH
cord-023095-4dannjjm	1418	4	regulation	regulation	NN
cord-023095-4dannjjm	1418	5	of	of	IN
cord-023095-4dannjjm	1418	6	CXCL10	CXCL10	NNP
cord-023095-4dannjjm	1418	7	mRNA	mrna	NN
cord-023095-4dannjjm	1418	8	transcripts	transcript	NNS
cord-023095-4dannjjm	1418	9	associated	associate	VBN
cord-023095-4dannjjm	1418	10	with	with	IN
cord-023095-4dannjjm	1418	11	a	a	DT
cord-023095-4dannjjm	1418	12	higher	high	JJR
cord-023095-4dannjjm	1418	13	dose	dose	NN
cord-023095-4dannjjm	1418	14	is	be	VBZ
cord-023095-4dannjjm	1418	15	of	of	IN
cord-023095-4dannjjm	1418	16	particular	particular	JJ
cord-023095-4dannjjm	1418	17	interest	interest	NN
cord-023095-4dannjjm	1418	18	as	as	IN
cord-023095-4dannjjm	1418	19	this	this	DT
cord-023095-4dannjjm	1418	20	chemokine	chemokine	NN
cord-023095-4dannjjm	1418	21	plays	play	VBZ
cord-023095-4dannjjm	1418	22	a	a	DT
cord-023095-4dannjjm	1418	23	role	role	NN
cord-023095-4dannjjm	1418	24	in	in	IN
cord-023095-4dannjjm	1418	25	development	development	NN
cord-023095-4dannjjm	1418	26	of	of	IN
cord-023095-4dannjjm	1418	27	protective	protective	JJ
cord-023095-4dannjjm	1418	28	Th1	th1	CD
cord-023095-4dannjjm	1418	29	responses	response	NNS
cord-023095-4dannjjm	1418	30	.	.	.
cord-023095-4dannjjm	1419	1	The	the	DT
cord-023095-4dannjjm	1419	2	intent	intent	NN
cord-023095-4dannjjm	1419	3	of	of	IN
cord-023095-4dannjjm	1419	4	this	this	DT
cord-023095-4dannjjm	1419	5	study	study	NN
cord-023095-4dannjjm	1419	6	was	be	VBD
cord-023095-4dannjjm	1419	7	to	to	TO
cord-023095-4dannjjm	1419	8	develop	develop	VB
cord-023095-4dannjjm	1419	9	likelihood	likelihood	NN
cord-023095-4dannjjm	1419	10	ratios	ratio	NNS
cord-023095-4dannjjm	1419	11	(	(	-LRB-
cord-023095-4dannjjm	1419	12	LRs	LRs	NNP
cord-023095-4dannjjm	1419	13	)	)	-RRB-
cord-023095-4dannjjm	1419	14	for	for	IN
cord-023095-4dannjjm	1419	15	infection	infection	NN
cord-023095-4dannjjm	1419	16	attributable	attributable	JJ
cord-023095-4dannjjm	1419	17	to	to	IN
cord-023095-4dannjjm	1419	18	Corynebacterium	Corynebacterium	NNP
cord-023095-4dannjjm	1419	19	pseudotuberculosis	pseudotuberculosis	NN
cord-023095-4dannjjm	1419	20	in	in	IN
cord-023095-4dannjjm	1419	21	horses	horse	NNS
cord-023095-4dannjjm	1419	22	based	base	VBN
cord-023095-4dannjjm	1419	23	on	on	IN
cord-023095-4dannjjm	1419	24	synergistic	synergistic	JJ
cord-023095-4dannjjm	1419	25	hemolysis	hemolysis	NN
cord-023095-4dannjjm	1419	26	inhibition	inhibition	NN
cord-023095-4dannjjm	1419	27	(	(	-LRB-
cord-023095-4dannjjm	1419	28	SHI	SHI	NNP
cord-023095-4dannjjm	1419	29	)	)	-RRB-
cord-023095-4dannjjm	1419	30	test	test	NN
cord-023095-4dannjjm	1419	31	titers	titer	NNS
cord-023095-4dannjjm	1419	32	.	.	.
cord-023095-4dannjjm	1420	1	Medical	medical	JJ
cord-023095-4dannjjm	1420	2	records	record	NNS
cord-023095-4dannjjm	1420	3	for	for	IN
cord-023095-4dannjjm	1420	4	horses	horse	NNS
cord-023095-4dannjjm	1420	5	presented	present	VBN
cord-023095-4dannjjm	1420	6	to	to	IN
cord-023095-4dannjjm	1420	7	the	the	DT
cord-023095-4dannjjm	1420	8	UC	UC	NNP
cord-023095-4dannjjm	1420	9	Davis	Davis	NNP
cord-023095-4dannjjm	1420	10	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	1420	11	Teaching	Teaching	NNP
cord-023095-4dannjjm	1420	12	Hospital	Hospital	NNP
cord-023095-4dannjjm	1420	13	with	with	IN
cord-023095-4dannjjm	1420	14	serum	serum	NN
cord-023095-4dannjjm	1420	15	submitted	submit	VBN
cord-023095-4dannjjm	1420	16	for	for	IN
cord-023095-4dannjjm	1420	17	SHI	SHI	NNP
cord-023095-4dannjjm	1420	18	titer	titer	NN
cord-023095-4dannjjm	1420	19	determination	determination	NN
cord-023095-4dannjjm	1420	20	were	be	VBD
cord-023095-4dannjjm	1420	21	evaluated	evaluate	VBN
cord-023095-4dannjjm	1420	22	and	and	CC
cord-023095-4dannjjm	1420	23	171	171	CD
cord-023095-4dannjjm	1420	24	cases	case	NNS
cord-023095-4dannjjm	1420	25	met	meet	VBD
cord-023095-4dannjjm	1420	26	study	study	NN
cord-023095-4dannjjm	1420	27	inclusion	inclusion	NN
cord-023095-4dannjjm	1420	28	criteria	criterion	NNS
cord-023095-4dannjjm	1420	29	.	.	.
cord-023095-4dannjjm	1421	1	These	these	DT
cord-023095-4dannjjm	1421	2	cases	case	NNS
cord-023095-4dannjjm	1421	3	were	be	VBD
cord-023095-4dannjjm	1421	4	grouped	group	VBN
cord-023095-4dannjjm	1421	5	based	base	VBN
cord-023095-4dannjjm	1421	6	on	on	IN
cord-023095-4dannjjm	1421	7	evidence	evidence	NN
cord-023095-4dannjjm	1421	8	of	of	IN
cord-023095-4dannjjm	1421	9	internal	internal	JJ
cord-023095-4dannjjm	1421	10	and/or	and/or	CC
cord-023095-4dannjjm	1421	11	external	external	JJ
cord-023095-4dannjjm	1421	12	infection	infection	NN
cord-023095-4dannjjm	1421	13	attributable	attributable	JJ
cord-023095-4dannjjm	1421	14	to	to	IN
cord-023095-4dannjjm	1421	15	C.	C.	NNP
cord-023095-4dannjjm	1421	16	pseudotuberculosis	pseudotuberculosis	NN
cord-023095-4dannjjm	1421	17	and	and	CC
cord-023095-4dannjjm	1421	18	likelihood	likelihood	NN
cord-023095-4dannjjm	1421	19	ratios	ratio	NNS
cord-023095-4dannjjm	1421	20	with	with	IN
cord-023095-4dannjjm	1421	21	95	95	CD
cord-023095-4dannjjm	1421	22	%	%	NN
cord-023095-4dannjjm	1421	23	confidence	confidence	NN
cord-023095-4dannjjm	1421	24	intervals	interval	NNS
cord-023095-4dannjjm	1421	25	determined	determine	VBN
cord-023095-4dannjjm	1421	26	.	.	.
cord-023095-4dannjjm	1422	1	Results	result	NNS
cord-023095-4dannjjm	1422	2	showed	show	VBD
cord-023095-4dannjjm	1422	3	increasing	increase	VBG
cord-023095-4dannjjm	1422	4	LRs	lr	NNS
cord-023095-4dannjjm	1422	5	indicating	indicate	VBG
cord-023095-4dannjjm	1422	6	increasing	increase	VBG
cord-023095-4dannjjm	1422	7	odds	odd	NNS
cord-023095-4dannjjm	1422	8	for	for	IN
cord-023095-4dannjjm	1422	9	any	any	DT
cord-023095-4dannjjm	1422	10	form	form	NN
cord-023095-4dannjjm	1422	11	of	of	IN
cord-023095-4dannjjm	1422	12	active	active	JJ
cord-023095-4dannjjm	1422	13	disease	disease	NN
cord-023095-4dannjjm	1422	14	as	as	IN
cord-023095-4dannjjm	1422	15	titer	titer	NN
cord-023095-4dannjjm	1422	16	increased	increase	VBD
cord-023095-4dannjjm	1422	17	with	with	IN
cord-023095-4dannjjm	1422	18	all	all	DT
cord-023095-4dannjjm	1422	19	cases	case	NNS
cord-023095-4dannjjm	1422	20	considered	consider	VBN
cord-023095-4dannjjm	1422	21	.	.	.
cord-023095-4dannjjm	1423	1	LRs	LRs	NNP
cord-023095-4dannjjm	1423	2	for	for	IN
cord-023095-4dannjjm	1423	3	internal	internal	JJ
cord-023095-4dannjjm	1423	4	infection	infection	NN
cord-023095-4dannjjm	1423	5	were	be	VBD
cord-023095-4dannjjm	1423	6	4	4	CD
cord-023095-4dannjjm	1423	7	1	1	CD
cord-023095-4dannjjm	1423	8	for	for	IN
cord-023095-4dannjjm	1423	9	titers	titer	NNS
cord-023095-4dannjjm	1423	10	!	!	.
cord-023095-4dannjjm	1424	1	1280	1280	CD
cord-023095-4dannjjm	1424	2	overall	overall	RB
cord-023095-4dannjjm	1424	3	and	and	CC
cord-023095-4dannjjm	1424	4	for	for	IN
cord-023095-4dannjjm	1424	5	titers	titer	NNS
cord-023095-4dannjjm	1424	6	4	4	CD
cord-023095-4dannjjm	1424	7	160	160	CD
cord-023095-4dannjjm	1424	8	with	with	IN
cord-023095-4dannjjm	1424	9	external	external	JJ
cord-023095-4dannjjm	1424	10	abscess	abscess	NN
cord-023095-4dannjjm	1424	11	cases	case	NNS
cord-023095-4dannjjm	1424	12	excluded	exclude	VBN
cord-023095-4dannjjm	1424	13	.	.	.
cord-023095-4dannjjm	1425	1	No	no	DT
cord-023095-4dannjjm	1425	2	difference	difference	NN
cord-023095-4dannjjm	1425	3	from	from	IN
cord-023095-4dannjjm	1425	4	1	1	CD
cord-023095-4dannjjm	1425	5	(	(	-LRB-
cord-023095-4dannjjm	1425	6	and	and	CC
cord-023095-4dannjjm	1425	7	therefore	therefore	RB
cord-023095-4dannjjm	1425	8	no	no	DT
cord-023095-4dannjjm	1425	9	significant	significant	JJ
cord-023095-4dannjjm	1425	10	change	change	NN
cord-023095-4dannjjm	1425	11	in	in	IN
cord-023095-4dannjjm	1425	12	pre	pre	JJ
cord-023095-4dannjjm	1425	13	-	-	JJ
cord-023095-4dannjjm	1425	14	test	test	NN
cord-023095-4dannjjm	1425	15	to	to	TO
cord-023095-4dannjjm	1425	16	post	post	VB
cord-023095-4dannjjm	1425	17	-	-	JJ
cord-023095-4dannjjm	1425	18	test	test	JJ
cord-023095-4dannjjm	1425	19	odds	odd	NNS
cord-023095-4dannjjm	1425	20	)	)	-RRB-
cord-023095-4dannjjm	1425	21	was	be	VBD
cord-023095-4dannjjm	1425	22	seen	see	VBN
cord-023095-4dannjjm	1425	23	in	in	IN
cord-023095-4dannjjm	1425	24	any	any	DT
cord-023095-4dannjjm	1425	25	LRs	LRs	NNP
cord-023095-4dannjjm	1425	26	for	for	IN
cord-023095-4dannjjm	1425	27	internal	internal	JJ
cord-023095-4dannjjm	1425	28	disease	disease	NN
cord-023095-4dannjjm	1425	29	when	when	WRB
cord-023095-4dannjjm	1425	30	only	only	RB
cord-023095-4dannjjm	1425	31	cases	case	NNS
cord-023095-4dannjjm	1425	32	with	with	IN
cord-023095-4dannjjm	1425	33	external	external	JJ
cord-023095-4dannjjm	1425	34	disease	disease	NN
cord-023095-4dannjjm	1425	35	were	be	VBD
cord-023095-4dannjjm	1425	36	examined	examine	VBN
cord-023095-4dannjjm	1425	37	(	(	-LRB-
cord-023095-4dannjjm	1425	38	external	external	JJ
cord-023095-4dannjjm	1425	39	and	and	CC
cord-023095-4dannjjm	1425	40	internal	internal	JJ
cord-023095-4dannjjm	1425	41	disease	disease	NN
cord-023095-4dannjjm	1425	42	vs.	vs.	FW
cord-023095-4dannjjm	1425	43	external	external	JJ
cord-023095-4dannjjm	1425	44	only	only	RB
cord-023095-4dannjjm	1425	45	)	)	-RRB-
cord-023095-4dannjjm	1425	46	.	.	.
cord-023095-4dannjjm	1426	1	Overall	overall	RB
cord-023095-4dannjjm	1426	2	,	,	,
cord-023095-4dannjjm	1426	3	the	the	DT
cord-023095-4dannjjm	1426	4	SHI	SHI	NNP
cord-023095-4dannjjm	1426	5	test	test	NN
cord-023095-4dannjjm	1426	6	results	result	NNS
cord-023095-4dannjjm	1426	7	showed	show	VBD
cord-023095-4dannjjm	1426	8	usefulness	usefulness	NN
cord-023095-4dannjjm	1426	9	in	in	IN
cord-023095-4dannjjm	1426	10	determining	determine	VBG
cord-023095-4dannjjm	1426	11	internal	internal	JJ
cord-023095-4dannjjm	1426	12	C.	C.	NNP
cord-023095-4dannjjm	1426	13	pseudotuberculosis	pseudotuberculosis	NN
cord-023095-4dannjjm	1426	14	infection	infection	NN
cord-023095-4dannjjm	1426	15	in	in	IN
cord-023095-4dannjjm	1426	16	horses	horse	NNS
cord-023095-4dannjjm	1426	17	with	with	IN
cord-023095-4dannjjm	1426	18	no	no	DT
cord-023095-4dannjjm	1426	19	evidence	evidence	NN
cord-023095-4dannjjm	1426	20	of	of	IN
cord-023095-4dannjjm	1426	21	external	external	JJ
cord-023095-4dannjjm	1426	22	abscessation	abscessation	NN
cord-023095-4dannjjm	1426	23	.	.	.
cord-023095-4dannjjm	1427	1	Overall	overall	RB
cord-023095-4dannjjm	1427	2	,	,	,
cord-023095-4dannjjm	1427	3	however	however	RB
cord-023095-4dannjjm	1427	4	,	,	,
cord-023095-4dannjjm	1427	5	higher	high	JJR
cord-023095-4dannjjm	1427	6	titers	titer	NNS
cord-023095-4dannjjm	1427	7	were	be	VBD
cord-023095-4dannjjm	1427	8	more	more	RBR
cord-023095-4dannjjm	1427	9	indicative	indicative	JJ
cord-023095-4dannjjm	1427	10	of	of	IN
cord-023095-4dannjjm	1427	11	active	active	JJ
cord-023095-4dannjjm	1427	12	external	external	JJ
cord-023095-4dannjjm	1427	13	or	or	CC
cord-023095-4dannjjm	1427	14	internal	internal	JJ
cord-023095-4dannjjm	1427	15	disease	disease	NN
cord-023095-4dannjjm	1427	16	than	than	IN
cord-023095-4dannjjm	1427	17	internal	internal	JJ
cord-023095-4dannjjm	1427	18	disease	disease	NN
cord-023095-4dannjjm	1427	19	specifically	specifically	RB
cord-023095-4dannjjm	1427	20	in	in	IN
cord-023095-4dannjjm	1427	21	contrast	contrast	NN
cord-023095-4dannjjm	1427	22	to	to	IN
cord-023095-4dannjjm	1427	23	previous	previous	JJ
cord-023095-4dannjjm	1427	24	reports	report	NNS
cord-023095-4dannjjm	1427	25	.	.	.
cord-023095-4dannjjm	1428	1	The	the	DT
cord-023095-4dannjjm	1428	2	SHI	SHI	NNP
cord-023095-4dannjjm	1428	3	test	test	NN
cord-023095-4dannjjm	1428	4	was	be	VBD
cord-023095-4dannjjm	1428	5	unable	unable	JJ
cord-023095-4dannjjm	1428	6	to	to	TO
cord-023095-4dannjjm	1428	7	distinguish	distinguish	VB
cord-023095-4dannjjm	1428	8	internal	internal	JJ
cord-023095-4dannjjm	1428	9	infection	infection	NN
cord-023095-4dannjjm	1428	10	when	when	WRB
cord-023095-4dannjjm	1428	11	external	external	JJ
cord-023095-4dannjjm	1428	12	abscesses	abscess	NNS
cord-023095-4dannjjm	1428	13	were	be	VBD
cord-023095-4dannjjm	1428	14	present	present	JJ
cord-023095-4dannjjm	1428	15	.	.	.
cord-023095-4dannjjm	1429	1	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1429	2	enterica	enterica	NN
cord-023095-4dannjjm	1429	3	is	be	VBZ
cord-023095-4dannjjm	1429	4	a	a	DT
cord-023095-4dannjjm	1429	5	zoonotic	zoonotic	JJ
cord-023095-4dannjjm	1429	6	pathogen	pathogen	NN
cord-023095-4dannjjm	1429	7	that	that	WDT
cord-023095-4dannjjm	1429	8	has	have	VBZ
cord-023095-4dannjjm	1429	9	tremendous	tremendous	JJ
cord-023095-4dannjjm	1429	10	impact	impact	NN
cord-023095-4dannjjm	1429	11	on	on	IN
cord-023095-4dannjjm	1429	12	many	many	JJ
cord-023095-4dannjjm	1429	13	different	different	JJ
cord-023095-4dannjjm	1429	14	animal	animal	NN
cord-023095-4dannjjm	1429	15	production	production	NN
cord-023095-4dannjjm	1429	16	and	and	CC
cord-023095-4dannjjm	1429	17	management	management	NN
cord-023095-4dannjjm	1429	18	systems	system	NNS
cord-023095-4dannjjm	1429	19	.	.	.
cord-023095-4dannjjm	1430	1	Rapid	rapid	JJ
cord-023095-4dannjjm	1430	2	detection	detection	NN
cord-023095-4dannjjm	1430	3	of	of	IN
cord-023095-4dannjjm	1430	4	S.	S.	NNP
cord-023095-4dannjjm	1430	5	enterica	enterica	NN
cord-023095-4dannjjm	1430	6	in	in	IN
cord-023095-4dannjjm	1430	7	fecal	fecal	JJ
cord-023095-4dannjjm	1430	8	samples	sample	NNS
cord-023095-4dannjjm	1430	9	may	may	MD
cord-023095-4dannjjm	1430	10	facilitate	facilitate	VB
cord-023095-4dannjjm	1430	11	effective	effective	JJ
cord-023095-4dannjjm	1430	12	infection	infection	NN
cord-023095-4dannjjm	1430	13	control	control	NN
cord-023095-4dannjjm	1430	14	practices	practice	NNS
cord-023095-4dannjjm	1430	15	.	.	.
cord-023095-4dannjjm	1431	1	Current	current	JJ
cord-023095-4dannjjm	1431	2	detection	detection	NN
cord-023095-4dannjjm	1431	3	methods	method	NNS
cord-023095-4dannjjm	1431	4	require	require	VBP
cord-023095-4dannjjm	1431	5	24	24	CD
cord-023095-4dannjjm	1431	6	-	-	SYM
cord-023095-4dannjjm	1431	7	48	48	CD
cord-023095-4dannjjm	1431	8	hours	hour	NNS
cord-023095-4dannjjm	1432	1	(	(	-LRB-
cord-023095-4dannjjm	1432	2	Polymerase	Polymerase	NNP
cord-023095-4dannjjm	1432	3	Chain	Chain	NNP
cord-023095-4dannjjm	1432	4	Reaction	Reaction	NNP
cord-023095-4dannjjm	1432	5	or	or	CC
cord-023095-4dannjjm	1432	6	PCR	PCR	NNP
cord-023095-4dannjjm	1432	7	)	)	-RRB-
cord-023095-4dannjjm	1432	8	or	or	CC
cord-023095-4dannjjm	1432	9	48	48	CD
cord-023095-4dannjjm	1432	10	-	-	SYM
cord-023095-4dannjjm	1432	11	72	72	CD
cord-023095-4dannjjm	1432	12	hours	hour	NNS
cord-023095-4dannjjm	1432	13	(	(	-LRB-
cord-023095-4dannjjm	1432	14	enriched	enrich	VBN
cord-023095-4dannjjm	1432	15	aerobic	aerobic	JJ
cord-023095-4dannjjm	1432	16	culture	culture	NN
cord-023095-4dannjjm	1432	17	)	)	-RRB-
cord-023095-4dannjjm	1433	1	to	to	TO
cord-023095-4dannjjm	1433	2	obtain	obtain	VB
cord-023095-4dannjjm	1433	3	results	result	NNS
cord-023095-4dannjjm	1433	4	.	.	.
cord-023095-4dannjjm	1434	1	Alternatives	alternative	NNS
cord-023095-4dannjjm	1434	2	have	have	VBP
cord-023095-4dannjjm	1434	3	been	be	VBN
cord-023095-4dannjjm	1434	4	developed	develop	VBN
cord-023095-4dannjjm	1434	5	,	,	,
cord-023095-4dannjjm	1434	6	lateral	lateral	JJ
cord-023095-4dannjjm	1434	7	flow	flow	NN
cord-023095-4dannjjm	1434	8	antigen	antigen	NN
cord-023095-4dannjjm	1434	9	detection	detection	NN
cord-023095-4dannjjm	1434	10	systems	system	NNS
cord-023095-4dannjjm	1434	11	(	(	-LRB-
cord-023095-4dannjjm	1434	12	LFADS	LFADS	NNP
cord-023095-4dannjjm	1434	13	)	)	-RRB-
cord-023095-4dannjjm	1434	14	,	,	,
cord-023095-4dannjjm	1434	15	which	which	WDT
cord-023095-4dannjjm	1434	16	are	be	VBP
cord-023095-4dannjjm	1434	17	currently	currently	RB
cord-023095-4dannjjm	1434	18	marketed	market	VBN
cord-023095-4dannjjm	1434	19	for	for	IN
cord-023095-4dannjjm	1434	20	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1434	21	detection	detection	NN
cord-023095-4dannjjm	1434	22	related	relate	VBN
cord-023095-4dannjjm	1434	23	to	to	IN
cord-023095-4dannjjm	1434	24	food	food	NN
cord-023095-4dannjjm	1434	25	safety	safety	NN
cord-023095-4dannjjm	1434	26	microbiology	microbiology	NN
cord-023095-4dannjjm	1434	27	.	.	.
cord-023095-4dannjjm	1435	1	The	the	DT
cord-023095-4dannjjm	1435	2	objective	objective	NN
cord-023095-4dannjjm	1435	3	of	of	IN
cord-023095-4dannjjm	1435	4	this	this	DT
cord-023095-4dannjjm	1435	5	study	study	NN
cord-023095-4dannjjm	1435	6	was	be	VBD
cord-023095-4dannjjm	1435	7	to	to	TO
cord-023095-4dannjjm	1435	8	evaluate	evaluate	VB
cord-023095-4dannjjm	1435	9	two	two	CD
cord-023095-4dannjjm	1435	10	commercially	commercially	RB
cord-023095-4dannjjm	1435	11	available	available	JJ
cord-023095-4dannjjm	1435	12	rapid	rapid	JJ
cord-023095-4dannjjm	1435	13	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1435	14	detection	detection	NN
cord-023095-4dannjjm	1435	15	systems	system	NNS
cord-023095-4dannjjm	1435	16	in	in	IN
cord-023095-4dannjjm	1435	17	equine	equine	JJ
cord-023095-4dannjjm	1435	18	feces	fece	NNS
cord-023095-4dannjjm	1435	19	.	.	.
cord-023095-4dannjjm	1436	1	Fecal	fecal	JJ
cord-023095-4dannjjm	1436	2	samples	sample	NNS
cord-023095-4dannjjm	1436	3	collected	collect	VBN
cord-023095-4dannjjm	1436	4	from	from	IN
cord-023095-4dannjjm	1436	5	repeatedly	repeatedly	RB
cord-023095-4dannjjm	1436	6	culture	culture	NN
cord-023095-4dannjjm	1436	7	-	-	HYPH
cord-023095-4dannjjm	1436	8	negative	negative	JJ
cord-023095-4dannjjm	1436	9	horses	horse	NNS
cord-023095-4dannjjm	1436	10	were	be	VBD
cord-023095-4dannjjm	1436	11	inoculated	inoculate	VBN
cord-023095-4dannjjm	1436	12	with	with	IN
cord-023095-4dannjjm	1436	13	known	know	VBN
cord-023095-4dannjjm	1436	14	concentrations	concentration	NNS
cord-023095-4dannjjm	1436	15	of	of	IN
cord-023095-4dannjjm	1436	16	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1436	17	enterica	enterica	NN
cord-023095-4dannjjm	1436	18	serotype	serotype	NN
cord-023095-4dannjjm	1436	19	Typhimurium	Typhimurium	NNP
cord-023095-4dannjjm	1436	20	(	(	-LRB-
cord-023095-4dannjjm	1436	21	five	five	CD
cord-023095-4dannjjm	1436	22	uninoculated	uninoculated	JJ
cord-023095-4dannjjm	1436	23	control	control	NN
cord-023095-4dannjjm	1436	24	samples	sample	NNS
cord-023095-4dannjjm	1436	25	,	,	,
cord-023095-4dannjjm	1436	26	and	and	CC
cord-023095-4dannjjm	1436	27	5	5	CD
cord-023095-4dannjjm	1436	28	samples	sample	NNS
cord-023095-4dannjjm	1436	29	of	of	IN
cord-023095-4dannjjm	1436	30	each	each	DT
cord-023095-4dannjjm	1436	31	10-fold	10-fold	CD
cord-023095-4dannjjm	1436	32	dilution	dilution	NN
cord-023095-4dannjjm	1436	33	[	[	-LRB-
cord-023095-4dannjjm	1436	34	1.9	1.9	CD
cord-023095-4dannjjm	1436	35	Â	â	CD
cord-023095-4dannjjm	1436	36	10	10	CD
cord-023095-4dannjjm	1436	37	0	0	CD
cord-023095-4dannjjm	1436	38	-1.9	-1.9	CD
cord-023095-4dannjjm	1436	39	Â	â	CD
cord-023095-4dannjjm	1436	40	10	10	CD
cord-023095-4dannjjm	1436	41	4	4	CD
cord-023095-4dannjjm	1436	42	cfu	cfu	NN
cord-023095-4dannjjm	1436	43	/	/	SYM
cord-023095-4dannjjm	1436	44	gram	gram	NN
cord-023095-4dannjjm	1436	45	of	of	IN
cord-023095-4dannjjm	1436	46	feces	fece	NNS
cord-023095-4dannjjm	1436	47	]	]	-RRB-
cord-023095-4dannjjm	1436	48	)	)	-RRB-
cord-023095-4dannjjm	1436	49	.	.	.
cord-023095-4dannjjm	1437	1	All	all	DT
cord-023095-4dannjjm	1437	2	samples	sample	NNS
cord-023095-4dannjjm	1437	3	were	be	VBD
cord-023095-4dannjjm	1437	4	aerobically	aerobically	RB
cord-023095-4dannjjm	1437	5	cultured	cultured	JJ
cord-023095-4dannjjm	1437	6	using	use	VBG
cord-023095-4dannjjm	1437	7	a	a	DT
cord-023095-4dannjjm	1437	8	standard	standard	JJ
cord-023095-4dannjjm	1437	9	enrichment	enrichment	NN
cord-023095-4dannjjm	1437	10	technique	technique	NN
cord-023095-4dannjjm	1437	11	.	.	.
cord-023095-4dannjjm	1438	1	In	in	IN
cord-023095-4dannjjm	1438	2	a	a	DT
cord-023095-4dannjjm	1438	3	blinded	blinded	JJ
cord-023095-4dannjjm	1438	4	fashion	fashion	NN
cord-023095-4dannjjm	1438	5	,	,	,
cord-023095-4dannjjm	1438	6	samples	sample	NNS
cord-023095-4dannjjm	1438	7	were	be	VBD
cord-023095-4dannjjm	1438	8	tested	test	VBN
cord-023095-4dannjjm	1438	9	using	use	VBG
cord-023095-4dannjjm	1438	10	two	two	CD
cord-023095-4dannjjm	1438	11	different	different	JJ
cord-023095-4dannjjm	1438	12	LFADS	LFADS	NNP
cord-023095-4dannjjm	1438	13	as	as	RB
cord-023095-4dannjjm	1438	14	well	well	RB
cord-023095-4dannjjm	1438	15	as	as	IN
cord-023095-4dannjjm	1438	16	plated	plate	VBN
cord-023095-4dannjjm	1438	17	on	on	IN
cord-023095-4dannjjm	1438	18	agar	agar	JJ
cord-023095-4dannjjm	1438	19	media	medium	NNS
cord-023095-4dannjjm	1438	20	for	for	IN
cord-023095-4dannjjm	1438	21	confirmatory	confirmatory	JJ
cord-023095-4dannjjm	1438	22	testing	testing	NN
cord-023095-4dannjjm	1438	23	.	.	.
cord-023095-4dannjjm	1439	1	At	at	IN
cord-023095-4dannjjm	1439	2	24	24	CD
cord-023095-4dannjjm	1439	3	hours	hour	NNS
cord-023095-4dannjjm	1439	4	of	of	IN
cord-023095-4dannjjm	1439	5	incubation	incubation	NN
cord-023095-4dannjjm	1439	6	,	,	,
cord-023095-4dannjjm	1439	7	using	use	VBG
cord-023095-4dannjjm	1439	8	bacterial	bacterial	JJ
cord-023095-4dannjjm	1439	9	culture	culture	NN
cord-023095-4dannjjm	1439	10	as	as	IN
cord-023095-4dannjjm	1439	11	the	the	DT
cord-023095-4dannjjm	1439	12	reference	reference	NN
cord-023095-4dannjjm	1439	13	method	method	NN
cord-023095-4dannjjm	1439	14	,	,	,
cord-023095-4dannjjm	1439	15	Test	test	NN
cord-023095-4dannjjm	1439	16	1	1	CD
cord-023095-4dannjjm	1439	17	was	be	VBD
cord-023095-4dannjjm	1439	18	correctly	correctly	RB
cord-023095-4dannjjm	1439	19	identify	identify	VB
cord-023095-4dannjjm	1439	20	70	70	CD
cord-023095-4dannjjm	1439	21	%	%	NN
cord-023095-4dannjjm	1439	22	of	of	IN
cord-023095-4dannjjm	1439	23	samples	sample	NNS
cord-023095-4dannjjm	1439	24	(	(	-LRB-
cord-023095-4dannjjm	1439	25	Bacterial	bacterial	JJ
cord-023095-4dannjjm	1439	26	contamination	contamination	NN
cord-023095-4dannjjm	1439	27	of	of	IN
cord-023095-4dannjjm	1439	28	stalls	stall	NNS
cord-023095-4dannjjm	1439	29	with	with	IN
cord-023095-4dannjjm	1439	30	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1439	31	sp	sp	NNP
cord-023095-4dannjjm	1439	32	.	.	.
cord-023095-4dannjjm	1440	1	is	be	VBZ
cord-023095-4dannjjm	1440	2	a	a	DT
cord-023095-4dannjjm	1440	3	serious	serious	JJ
cord-023095-4dannjjm	1440	4	problem	problem	NN
cord-023095-4dannjjm	1440	5	in	in	IN
cord-023095-4dannjjm	1440	6	equine	equine	JJ
cord-023095-4dannjjm	1440	7	hospitals	hospital	NNS
cord-023095-4dannjjm	1440	8	.	.	.
cord-023095-4dannjjm	1441	1	Salmonella	salmonella	NN
cord-023095-4dannjjm	1441	2	sp	sp	NN
cord-023095-4dannjjm	1441	3	.	.	.
cord-023095-4dannjjm	1442	1	exposure	exposure	NN
cord-023095-4dannjjm	1442	2	to	to	IN
cord-023095-4dannjjm	1442	3	horses	horse	NNS
cord-023095-4dannjjm	1442	4	in	in	IN
cord-023095-4dannjjm	1442	5	the	the	DT
cord-023095-4dannjjm	1442	6	facility	facility	NN
cord-023095-4dannjjm	1442	7	can	can	MD
cord-023095-4dannjjm	1442	8	result	result	VB
cord-023095-4dannjjm	1442	9	in	in	IN
cord-023095-4dannjjm	1442	10	nosocomial	nosocomial	JJ
cord-023095-4dannjjm	1442	11	infections	infection	NNS
cord-023095-4dannjjm	1442	12	which	which	WDT
cord-023095-4dannjjm	1442	13	results	result	VBZ
cord-023095-4dannjjm	1442	14	in	in	IN
cord-023095-4dannjjm	1442	15	temporary	temporary	JJ
cord-023095-4dannjjm	1442	16	facility	facility	NN
cord-023095-4dannjjm	1442	17	closure	closure	NN
cord-023095-4dannjjm	1442	18	,	,	,
cord-023095-4dannjjm	1442	19	until	until	IN
cord-023095-4dannjjm	1442	20	the	the	DT
cord-023095-4dannjjm	1442	21	organism	organism	NN
cord-023095-4dannjjm	1442	22	is	be	VBZ
cord-023095-4dannjjm	1442	23	eradicated	eradicate	VBN
cord-023095-4dannjjm	1442	24	.	.	.
cord-023095-4dannjjm	1443	1	Hospital	hospital	NN
cord-023095-4dannjjm	1443	2	closure	closure	NN
cord-023095-4dannjjm	1443	3	can	can	MD
cord-023095-4dannjjm	1443	4	result	result	VB
cord-023095-4dannjjm	1443	5	in	in	IN
cord-023095-4dannjjm	1443	6	loss	loss	NN
cord-023095-4dannjjm	1443	7	of	of	IN
cord-023095-4dannjjm	1443	8	revenue	revenue	NN
cord-023095-4dannjjm	1443	9	,	,	,
cord-023095-4dannjjm	1443	10	damage	damage	NN
cord-023095-4dannjjm	1443	11	to	to	IN
cord-023095-4dannjjm	1443	12	reputation	reputation	NN
cord-023095-4dannjjm	1443	13	and	and	CC
cord-023095-4dannjjm	1443	14	interference	interference	NN
cord-023095-4dannjjm	1443	15	with	with	IN
cord-023095-4dannjjm	1443	16	patient	patient	JJ
cord-023095-4dannjjm	1443	17	care	care	NN
cord-023095-4dannjjm	1443	18	.	.	.
cord-023095-4dannjjm	1444	1	The	the	DT
cord-023095-4dannjjm	1444	2	purpose	purpose	NN
cord-023095-4dannjjm	1444	3	of	of	IN
cord-023095-4dannjjm	1444	4	this	this	DT
cord-023095-4dannjjm	1444	5	study	study	NN
cord-023095-4dannjjm	1444	6	was	be	VBD
cord-023095-4dannjjm	1444	7	to	to	TO
cord-023095-4dannjjm	1444	8	evaluate	evaluate	VB
cord-023095-4dannjjm	1444	9	three	three	CD
cord-023095-4dannjjm	1444	10	stall	stall	NN
cord-023095-4dannjjm	1444	11	cleaning	cleaning	NN
cord-023095-4dannjjm	1444	12	methods	method	NNS
cord-023095-4dannjjm	1444	13	on	on	IN
cord-023095-4dannjjm	1444	14	eradication	eradication	NN
cord-023095-4dannjjm	1444	15	of	of	IN
cord-023095-4dannjjm	1444	16	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1444	17	sp	sp	NNP
cord-023095-4dannjjm	1444	18	.	.	.
cord-023095-4dannjjm	1445	1	at	at	IN
cord-023095-4dannjjm	1445	2	an	an	DT
cord-023095-4dannjjm	1445	3	equine	equine	JJ
cord-023095-4dannjjm	1445	4	veterinary	veterinary	JJ
cord-023095-4dannjjm	1445	5	teaching	teaching	NN
cord-023095-4dannjjm	1445	6	hospital	hospital	NN
cord-023095-4dannjjm	1445	7	(	(	-LRB-
cord-023095-4dannjjm	1445	8	VTH	VTH	NNP
cord-023095-4dannjjm	1445	9	)	)	-RRB-
cord-023095-4dannjjm	1445	10	.	.	.
cord-023095-4dannjjm	1446	1	Horses	horse	NNS
cord-023095-4dannjjm	1446	2	admitted	admit	VBD
cord-023095-4dannjjm	1446	3	to	to	IN
cord-023095-4dannjjm	1446	4	the	the	DT
cord-023095-4dannjjm	1446	5	VTH	VTH	NNP
cord-023095-4dannjjm	1446	6	were	be	VBD
cord-023095-4dannjjm	1446	7	assigned	assign	VBN
cord-023095-4dannjjm	1446	8	to	to	IN
cord-023095-4dannjjm	1446	9	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1446	10	sp.negative	sp.negative	NNP
cord-023095-4dannjjm	1446	11	stalls	stall	NNS
cord-023095-4dannjjm	1446	12	within	within	IN
cord-023095-4dannjjm	1446	13	areas	area	NNS
cord-023095-4dannjjm	1446	14	of	of	IN
cord-023095-4dannjjm	1446	15	the	the	DT
cord-023095-4dannjjm	1446	16	VTH	VTH	NNP
cord-023095-4dannjjm	1446	17	during	during	IN
cord-023095-4dannjjm	1446	18	the	the	DT
cord-023095-4dannjjm	1446	19	study	study	NN
cord-023095-4dannjjm	1446	20	period	period	NN
cord-023095-4dannjjm	1446	21	(	(	-LRB-
cord-023095-4dannjjm	1446	22	September	September	NNP
cord-023095-4dannjjm	1446	23	2009	2009	CD
cord-023095-4dannjjm	1446	24	-January	-january	SYM
cord-023095-4dannjjm	1446	25	2010	2010	CD
cord-023095-4dannjjm	1446	26	.	.	.
cord-023095-4dannjjm	1447	1	When	when	WRB
cord-023095-4dannjjm	1447	2	the	the	DT
cord-023095-4dannjjm	1447	3	horses	horse	NNS
cord-023095-4dannjjm	1447	4	were	be	VBD
cord-023095-4dannjjm	1447	5	discharged	discharge	VBN
cord-023095-4dannjjm	1447	6	stalls	stall	NNS
cord-023095-4dannjjm	1447	7	were	be	VBD
cord-023095-4dannjjm	1447	8	randomly	randomly	RB
cord-023095-4dannjjm	1447	9	assigned	assign	VBN
cord-023095-4dannjjm	1447	10	to	to	IN
cord-023095-4dannjjm	1447	11	one	one	CD
cord-023095-4dannjjm	1447	12	of	of	IN
cord-023095-4dannjjm	1447	13	three	three	CD
cord-023095-4dannjjm	1447	14	cleaning	cleaning	NN
cord-023095-4dannjjm	1447	15	methods	method	NNS
cord-023095-4dannjjm	1447	16	(	(	-LRB-
cord-023095-4dannjjm	1447	17	pressure	pressure	NN
cord-023095-4dannjjm	1447	18	-	-	HYPH
cord-023095-4dannjjm	1447	19	washing	wash	VBG
cord-023095-4dannjjm	1447	20	only	only	RB
cord-023095-4dannjjm	1447	21	[	[	-LRB-
cord-023095-4dannjjm	1447	22	PW	pw	NN
cord-023095-4dannjjm	1447	23	]	]	-RRB-
cord-023095-4dannjjm	1447	24	,	,	,
cord-023095-4dannjjm	1447	25	pressure	pressure	NN
cord-023095-4dannjjm	1447	26	washing	washing	NN
cord-023095-4dannjjm	1447	27	and	and	CC
cord-023095-4dannjjm	1447	28	hand	hand	NN
cord-023095-4dannjjm	1447	29	scrubbing	scrubbing	NN
cord-023095-4dannjjm	1447	30	[	[	-LRB-
cord-023095-4dannjjm	1447	31	PWS	PWS	NNP
cord-023095-4dannjjm	1447	32	]	]	-RRB-
cord-023095-4dannjjm	1447	33	,	,	,
cord-023095-4dannjjm	1447	34	or	or	CC
cord-023095-4dannjjm	1447	35	hand	hand	NN
cord-023095-4dannjjm	1447	36	scrubbing	scrubbing	NN
cord-023095-4dannjjm	1447	37	only	only	RB
cord-023095-4dannjjm	1447	38	[	[	-LRB-
cord-023095-4dannjjm	1447	39	S	S	NNP
cord-023095-4dannjjm	1447	40	]	]	-RRB-
cord-023095-4dannjjm	1447	41	)	)	-RRB-
cord-023095-4dannjjm	1447	42	in	in	IN
cord-023095-4dannjjm	1447	43	a	a	DT
cord-023095-4dannjjm	1447	44	single	single	JJ
cord-023095-4dannjjm	1447	45	period	period	NN
cord-023095-4dannjjm	1447	46	,	,	,
cord-023095-4dannjjm	1447	47	non	non	JJ
cord-023095-4dannjjm	1447	48	cross	cross	JJ
cord-023095-4dannjjm	1447	49	-	-	HYPH
cord-023095-4dannjjm	1447	50	over	over	RP
cord-023095-4dannjjm	1447	51	design	design	NN
cord-023095-4dannjjm	1447	52	.	.	.
cord-023095-4dannjjm	1448	1	All	all	DT
cord-023095-4dannjjm	1448	2	stalls	stall	NNS
cord-023095-4dannjjm	1448	3	were	be	VBD
cord-023095-4dannjjm	1448	4	stripped	strip	VBN
cord-023095-4dannjjm	1448	5	of	of	IN
cord-023095-4dannjjm	1448	6	bedding	bedding	NN
cord-023095-4dannjjm	1448	7	and	and	CC
cord-023095-4dannjjm	1448	8	surfaces	surface	NNS
cord-023095-4dannjjm	1448	9	sprayed	spray	VBN
cord-023095-4dannjjm	1448	10	with	with	IN
cord-023095-4dannjjm	1448	11	tap	tap	NN
cord-023095-4dannjjm	1448	12	water	water	NN
cord-023095-4dannjjm	1448	13	and	and	CC
cord-023095-4dannjjm	1448	14	cleaned	clean	VBD
cord-023095-4dannjjm	1448	15	with	with	IN
cord-023095-4dannjjm	1448	16	a	a	DT
cord-023095-4dannjjm	1448	17	disinfectant	disinfectant	JJ
cord-023095-4dannjjm	1448	18	quaternary	quaternary	NN
cord-023095-4dannjjm	1448	19	-	-	HYPH
cord-023095-4dannjjm	1448	20	ammonia	ammonia	NN
cord-023095-4dannjjm	1448	21	solution	solution	NN
cord-023095-4dannjjm	1448	22	(	(	-LRB-
cord-023095-4dannjjm	1448	23	Super	Super	NNP
cord-023095-4dannjjm	1448	24	HDQ	HDQ	NNP
cord-023095-4dannjjm	1448	25	Neutral	Neutral	NNP
cord-023095-4dannjjm	1448	26	,	,	,
cord-023095-4dannjjm	1448	27	Spartan	Spartan	NNP
cord-023095-4dannjjm	1448	28	Chemical	Chemical	NNP
cord-023095-4dannjjm	1448	29	Co.	Co.	NNP
cord-023095-4dannjjm	1448	30	,	,	,
cord-023095-4dannjjm	1448	31	Inc	Inc	NNP
cord-023095-4dannjjm	1448	32	,	,	,
cord-023095-4dannjjm	1448	33	Maumee	Maumee	NNP
cord-023095-4dannjjm	1448	34	,	,	,
cord-023095-4dannjjm	1448	35	OH	OH	NNP
cord-023095-4dannjjm	1448	36	)	)	-RRB-
cord-023095-4dannjjm	1448	37	.	.	.
cord-023095-4dannjjm	1449	1	The	the	DT
cord-023095-4dannjjm	1449	2	pressure	pressure	NN
cord-023095-4dannjjm	1449	3	-	-	HYPH
cord-023095-4dannjjm	1449	4	washing	wash	VBG
cord-023095-4dannjjm	1449	5	system	system	NN
cord-023095-4dannjjm	1449	6	(	(	-LRB-
cord-023095-4dannjjm	1449	7	PSC	PSC	NNP
cord-023095-4dannjjm	1449	8	Cleaning	Cleaning	NNP
cord-023095-4dannjjm	1449	9	Systems	Systems	NNPS
cord-023095-4dannjjm	1449	10	,	,	,
cord-023095-4dannjjm	1449	11	Inc.	Inc.	NNP
cord-023095-4dannjjm	1449	12	,	,	,
cord-023095-4dannjjm	1449	13	Toronto	Toronto	NNP
cord-023095-4dannjjm	1449	14	,	,	,
cord-023095-4dannjjm	1449	15	Canada	Canada	NNP
cord-023095-4dannjjm	1449	16	)	)	-RRB-
cord-023095-4dannjjm	1449	17	used	use	VBD
cord-023095-4dannjjm	1449	18	,	,	,
cord-023095-4dannjjm	1449	19	provided	provide	VBD
cord-023095-4dannjjm	1449	20	a	a	DT
cord-023095-4dannjjm	1449	21	pressure	pressure	NN
cord-023095-4dannjjm	1449	22	of	of	IN
cord-023095-4dannjjm	1449	23	3000	3000	CD
cord-023095-4dannjjm	1449	24	psi	psi	NN
cord-023095-4dannjjm	1449	25	and	and	CC
cord-023095-4dannjjm	1449	26	a	a	DT
cord-023095-4dannjjm	1449	27	temperature	temperature	NN
cord-023095-4dannjjm	1449	28	range	range	NN
cord-023095-4dannjjm	1449	29	of	of	IN
cord-023095-4dannjjm	1449	30	1851	1851	CD
cord-023095-4dannjjm	1449	31	-	-	SYM
cord-023095-4dannjjm	1449	32	2151F.	2151f.	CD
cord-023095-4dannjjm	1450	1	Following	follow	VBG
cord-023095-4dannjjm	1450	2	cleaning	clean	VBG
cord-023095-4dannjjm	1450	3	,	,	,
cord-023095-4dannjjm	1450	4	each	each	DT
cord-023095-4dannjjm	1450	5	stall	stall	NN
cord-023095-4dannjjm	1450	6	was	be	VBD
cord-023095-4dannjjm	1450	7	allowed	allow	VBN
cord-023095-4dannjjm	1450	8	to	to	TO
cord-023095-4dannjjm	1450	9	air	air	NN
cord-023095-4dannjjm	1450	10	dry	dry	JJ
cord-023095-4dannjjm	1450	11	and	and	CC
cord-023095-4dannjjm	1450	12	within	within	IN
cord-023095-4dannjjm	1450	13	48	48	CD
cord-023095-4dannjjm	1450	14	hours	hour	NNS
cord-023095-4dannjjm	1450	15	,	,	,
cord-023095-4dannjjm	1450	16	stall	stall	NN
cord-023095-4dannjjm	1450	17	surfaces	surface	NNS
cord-023095-4dannjjm	1450	18	were	be	VBD
cord-023095-4dannjjm	1450	19	sampled	sample	VBN
cord-023095-4dannjjm	1450	20	using	use	VBG
cord-023095-4dannjjm	1450	21	three	three	CD
cord-023095-4dannjjm	1450	22	4	4	CD
cord-023095-4dannjjm	1450	23	00	00	CD
cord-023095-4dannjjm	1450	24	Â	â	CD
cord-023095-4dannjjm	1450	25	4	4	CD
cord-023095-4dannjjm	1450	26	00	00	NFP
cord-023095-4dannjjm	1450	27	sponges	sponge	NNS
cord-023095-4dannjjm	1450	28	moistened	moisten	VBN
cord-023095-4dannjjm	1450	29	with	with	IN
cord-023095-4dannjjm	1450	30	sterile	sterile	JJ
cord-023095-4dannjjm	1450	31	saline	saline	NN
cord-023095-4dannjjm	1450	32	.	.	.
cord-023095-4dannjjm	1451	1	The	the	DT
cord-023095-4dannjjm	1451	2	person	person	NN
cord-023095-4dannjjm	1451	3	collecting	collect	VBG
cord-023095-4dannjjm	1451	4	the	the	DT
cord-023095-4dannjjm	1451	5	samples	sample	NNS
cord-023095-4dannjjm	1451	6	was	be	VBD
cord-023095-4dannjjm	1451	7	masked	mask	VBN
cord-023095-4dannjjm	1451	8	to	to	IN
cord-023095-4dannjjm	1451	9	the	the	DT
cord-023095-4dannjjm	1451	10	method	method	NN
cord-023095-4dannjjm	1451	11	of	of	IN
cord-023095-4dannjjm	1451	12	cleaning	clean	VBG
cord-023095-4dannjjm	1451	13	.	.	.
cord-023095-4dannjjm	1452	1	Sponges	sponge	NNS
cord-023095-4dannjjm	1452	2	were	be	VBD
cord-023095-4dannjjm	1452	3	submitted	submit	VBN
cord-023095-4dannjjm	1452	4	to	to	IN
cord-023095-4dannjjm	1452	5	the	the	DT
cord-023095-4dannjjm	1452	6	Louisiana	Louisiana	NNP
cord-023095-4dannjjm	1452	7	Animal	Animal	NNP
cord-023095-4dannjjm	1452	8	Disease	Disease	NNP
cord-023095-4dannjjm	1452	9	Diagnostic	Diagnostic	NNP
cord-023095-4dannjjm	1452	10	Laboratory	Laboratory	NNP
cord-023095-4dannjjm	1452	11	(	(	-LRB-
cord-023095-4dannjjm	1452	12	LADDL	LADDL	NNP
cord-023095-4dannjjm	1452	13	)	)	-RRB-
cord-023095-4dannjjm	1452	14	for	for	IN
cord-023095-4dannjjm	1452	15	culture	culture	NN
cord-023095-4dannjjm	1452	16	of	of	IN
cord-023095-4dannjjm	1452	17	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1452	18	sp	sp	NNP
cord-023095-4dannjjm	1452	19	.	.	.
cord-023095-4dannjjm	1453	1	A	a	DT
cord-023095-4dannjjm	1453	2	Chi	Chi	NNP
cord-023095-4dannjjm	1453	3	-	-	HYPH
cord-023095-4dannjjm	1453	4	Squared	Squared	NNP
cord-023095-4dannjjm	1453	5	analysis	analysis	NN
cord-023095-4dannjjm	1453	6	was	be	VBD
cord-023095-4dannjjm	1453	7	used	use	VBN
cord-023095-4dannjjm	1453	8	to	to	TO
cord-023095-4dannjjm	1453	9	determine	determine	VB
cord-023095-4dannjjm	1453	10	significant	significant	JJ
cord-023095-4dannjjm	1453	11	differences	difference	NNS
cord-023095-4dannjjm	1453	12	(	(	-LRB-
cord-023095-4dannjjm	1453	13	limit	limit	NN
cord-023095-4dannjjm	1453	14	p	p	NN
cord-023095-4dannjjm	1453	15	o	o	NN
cord-023095-4dannjjm	1453	16	0.05	0.05	CD
cord-023095-4dannjjm	1453	17	)	)	-RRB-
cord-023095-4dannjjm	1453	18	between	between	IN
cord-023095-4dannjjm	1453	19	cleaning	cleaning	NN
cord-023095-4dannjjm	1453	20	methods	method	NNS
cord-023095-4dannjjm	1453	21	and	and	CC
cord-023095-4dannjjm	1453	22	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1453	23	sp	sp	NN
cord-023095-4dannjjm	1453	24	.	.	.
cord-023095-4dannjjm	1453	25	isolation	isolation	NN
cord-023095-4dannjjm	1453	26	.	.	.
cord-023095-4dannjjm	1454	1	During	during	IN
cord-023095-4dannjjm	1454	2	the	the	DT
cord-023095-4dannjjm	1454	3	study	study	NN
cord-023095-4dannjjm	1454	4	period	period	NN
cord-023095-4dannjjm	1454	5	,	,	,
cord-023095-4dannjjm	1454	6	112	112	CD
cord-023095-4dannjjm	1454	7	stalls	stall	NNS
cord-023095-4dannjjm	1454	8	(	(	-LRB-
cord-023095-4dannjjm	1454	9	PW	pw	NN
cord-023095-4dannjjm	1454	10	[	[	-LRB-
cord-023095-4dannjjm	1454	11	n	n	NN
cord-023095-4dannjjm	1454	12	5	5	CD
cord-023095-4dannjjm	1454	13	29	29	CD
cord-023095-4dannjjm	1454	14	]	]	-RRB-
cord-023095-4dannjjm	1454	15	;	;	:
cord-023095-4dannjjm	1454	16	PWS	PWS	NNP
cord-023095-4dannjjm	1454	17	[	[	-LRB-
cord-023095-4dannjjm	1454	18	n	n	NN
cord-023095-4dannjjm	1454	19	5	5	CD
cord-023095-4dannjjm	1454	20	50	50	CD
cord-023095-4dannjjm	1454	21	]	]	-RRB-
cord-023095-4dannjjm	1454	22	;	;	:
cord-023095-4dannjjm	1454	23	S	S	NNP
cord-023095-4dannjjm	1454	24	[	[	-LRB-
cord-023095-4dannjjm	1454	25	n	n	NN
cord-023095-4dannjjm	1454	26	5	5	CD
cord-023095-4dannjjm	1454	27	33	33	CD
cord-023095-4dannjjm	1454	28	]	]	-RRB-
cord-023095-4dannjjm	1454	29	were	be	VBD
cord-023095-4dannjjm	1454	30	included	include	VBN
cord-023095-4dannjjm	1454	31	.	.	.
cord-023095-4dannjjm	1455	1	All	all	DT
cord-023095-4dannjjm	1455	2	stalls	stall	NNS
cord-023095-4dannjjm	1455	3	had	have	VBD
cord-023095-4dannjjm	1455	4	negative	negative	JJ
cord-023095-4dannjjm	1455	5	environmental	environmental	JJ
cord-023095-4dannjjm	1455	6	salmonella	salmonella	NN
cord-023095-4dannjjm	1455	7	sp	sp	NNP
cord-023095-4dannjjm	1455	8	.	.	.
cord-023095-4dannjjm	1456	1	cultures	culture	NNS
cord-023095-4dannjjm	1456	2	prior	prior	RB
cord-023095-4dannjjm	1456	3	to	to	IN
cord-023095-4dannjjm	1456	4	beginning	begin	VBG
cord-023095-4dannjjm	1456	5	the	the	DT
cord-023095-4dannjjm	1456	6	study	study	NN
cord-023095-4dannjjm	1456	7	.	.	.
cord-023095-4dannjjm	1457	1	For	for	IN
cord-023095-4dannjjm	1457	2	PW	pw	NN
cord-023095-4dannjjm	1457	3	cleaned	clean	VBD
cord-023095-4dannjjm	1457	4	stalls	stall	NNS
cord-023095-4dannjjm	1457	5	,	,	,
cord-023095-4dannjjm	1457	6	6/23	6/23	CD
cord-023095-4dannjjm	1457	7	(	(	-LRB-
cord-023095-4dannjjm	1457	8	20.7	20.7	CD
cord-023095-4dannjjm	1457	9	%	%	NN
cord-023095-4dannjjm	1457	10	)	)	-RRB-
cord-023095-4dannjjm	1457	11	were	be	VBD
cord-023095-4dannjjm	1457	12	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1457	13	sp.-positive	sp.-positive	NNP
cord-023095-4dannjjm	1457	14	,	,	,
cord-023095-4dannjjm	1457	15	for	for	IN
cord-023095-4dannjjm	1457	16	PWS	PWS	NNP
cord-023095-4dannjjm	1457	17	cleaned	clean	VBD
cord-023095-4dannjjm	1457	18	stalls	stall	NNS
cord-023095-4dannjjm	1457	19	,	,	,
cord-023095-4dannjjm	1457	20	12/38	12/38	CD
cord-023095-4dannjjm	1457	21	(	(	-LRB-
cord-023095-4dannjjm	1457	22	24	24	CD
cord-023095-4dannjjm	1457	23	%	%	NN
cord-023095-4dannjjm	1457	24	)	)	-RRB-
cord-023095-4dannjjm	1457	25	were	be	VBD
cord-023095-4dannjjm	1457	26	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1457	27	sp.-positive	sp.-positive	NNP
cord-023095-4dannjjm	1457	28	,	,	,
cord-023095-4dannjjm	1457	29	and	and	CC
cord-023095-4dannjjm	1457	30	for	for	IN
cord-023095-4dannjjm	1457	31	S	S	NNP
cord-023095-4dannjjm	1457	32	cleaned	clean	VBD
cord-023095-4dannjjm	1457	33	stalls	stall	NNS
cord-023095-4dannjjm	1457	34	,	,	,
cord-023095-4dannjjm	1457	35	4/29	4/29	CD
cord-023095-4dannjjm	1457	36	(	(	-LRB-
cord-023095-4dannjjm	1457	37	12.1	12.1	CD
cord-023095-4dannjjm	1457	38	%	%	NN
cord-023095-4dannjjm	1457	39	)	)	-RRB-
cord-023095-4dannjjm	1457	40	were	be	VBD
cord-023095-4dannjjm	1457	41	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1457	42	sp.-positive	sp.-positive	NNP
cord-023095-4dannjjm	1457	43	.	.	.
cord-023095-4dannjjm	1458	1	Although	although	IN
cord-023095-4dannjjm	1458	2	,	,	,
cord-023095-4dannjjm	1458	3	there	there	EX
cord-023095-4dannjjm	1458	4	were	be	VBD
cord-023095-4dannjjm	1458	5	fewer	few	JJR
cord-023095-4dannjjm	1458	6	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1458	7	sp.-positive	sp.-positive	JJ
cord-023095-4dannjjm	1458	8	stalls	stall	NNS
cord-023095-4dannjjm	1458	9	(	(	-LRB-
cord-023095-4dannjjm	1458	10	12.1	12.1	CD
cord-023095-4dannjjm	1458	11	%	%	NN
cord-023095-4dannjjm	1458	12	)	)	-RRB-
cord-023095-4dannjjm	1458	13	in	in	IN
cord-023095-4dannjjm	1458	14	the	the	DT
cord-023095-4dannjjm	1458	15	handscrubbed	handscrubbed	NNP
cord-023095-4dannjjm	1458	16	stalls	stall	NNS
cord-023095-4dannjjm	1458	17	,	,	,
cord-023095-4dannjjm	1458	18	cleaning	cleaning	NN
cord-023095-4dannjjm	1458	19	method	method	NN
cord-023095-4dannjjm	1458	20	did	do	VBD
cord-023095-4dannjjm	1458	21	not	not	RB
cord-023095-4dannjjm	1458	22	significantly	significantly	RB
cord-023095-4dannjjm	1458	23	(	(	-LRB-
cord-023095-4dannjjm	1458	24	p	p	NN
cord-023095-4dannjjm	1458	25	5	5	CD
cord-023095-4dannjjm	1458	26	0.4057	0.4057	CD
cord-023095-4dannjjm	1458	27	)	)	-RRB-
cord-023095-4dannjjm	1458	28	affect	affect	VB
cord-023095-4dannjjm	1458	29	the	the	DT
cord-023095-4dannjjm	1458	30	isolation	isolation	NN
cord-023095-4dannjjm	1458	31	of	of	IN
cord-023095-4dannjjm	1458	32	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1458	33	sp	sp	NNP
cord-023095-4dannjjm	1458	34	.	.	.
cord-023095-4dannjjm	1459	1	from	from	IN
cord-023095-4dannjjm	1459	2	the	the	DT
cord-023095-4dannjjm	1459	3	stall	stall	JJ
cord-023095-4dannjjm	1459	4	environment	environment	NN
cord-023095-4dannjjm	1459	5	.	.	.
cord-023095-4dannjjm	1460	1	In	in	IN
cord-023095-4dannjjm	1460	2	conclusion	conclusion	NN
cord-023095-4dannjjm	1460	3	,	,	,
cord-023095-4dannjjm	1460	4	power	power	NN
cord-023095-4dannjjm	1460	5	washing	washing	NN
cord-023095-4dannjjm	1460	6	alone	alone	RB
cord-023095-4dannjjm	1460	7	,	,	,
cord-023095-4dannjjm	1460	8	power	power	NN
cord-023095-4dannjjm	1460	9	washing	washing	NN
cord-023095-4dannjjm	1460	10	and	and	CC
cord-023095-4dannjjm	1460	11	hand	hand	NN
cord-023095-4dannjjm	1460	12	scrubbing	scrubbing	NN
cord-023095-4dannjjm	1460	13	,	,	,
cord-023095-4dannjjm	1460	14	and	and	CC
cord-023095-4dannjjm	1460	15	hand	hand	NN
cord-023095-4dannjjm	1460	16	scrubbing	scrubbing	NN
cord-023095-4dannjjm	1460	17	alone	alone	RB
cord-023095-4dannjjm	1460	18	,	,	,
cord-023095-4dannjjm	1460	19	using	use	VBG
cord-023095-4dannjjm	1460	20	a	a	DT
cord-023095-4dannjjm	1460	21	quaternary	quaternary	JJ
cord-023095-4dannjjm	1460	22	-	-	HYPH
cord-023095-4dannjjm	1460	23	ammonia	ammonia	NN
cord-023095-4dannjjm	1460	24	solution	solution	NN
cord-023095-4dannjjm	1460	25	did	do	VBD
cord-023095-4dannjjm	1460	26	not	not	RB
cord-023095-4dannjjm	1460	27	significantly	significantly	RB
cord-023095-4dannjjm	1460	28	affect	affect	VB
cord-023095-4dannjjm	1460	29	environmental	environmental	JJ
cord-023095-4dannjjm	1460	30	isolation	isolation	NN
cord-023095-4dannjjm	1460	31	of	of	IN
cord-023095-4dannjjm	1460	32	Salmonella	Salmonella	NNP
cord-023095-4dannjjm	1460	33	sp	sp	NNP
cord-023095-4dannjjm	1460	34	.	.	.
cord-023095-4dannjjm	1461	1	from	from	IN
cord-023095-4dannjjm	1461	2	stalls	stall	NNS
cord-023095-4dannjjm	1461	3	surfaces	surface	NNS
cord-023095-4dannjjm	1461	4	in	in	IN
cord-023095-4dannjjm	1461	5	the	the	DT
cord-023095-4dannjjm	1461	6	VTH	VTH	NNP
cord-023095-4dannjjm	1461	7	during	during	IN
cord-023095-4dannjjm	1461	8	this	this	DT
cord-023095-4dannjjm	1461	9	study	study	NN
cord-023095-4dannjjm	1461	10	.	.	.
cord-023095-4dannjjm	1462	1	The	the	DT
cord-023095-4dannjjm	1462	2	objectives	objective	NNS
cord-023095-4dannjjm	1462	3	of	of	IN
cord-023095-4dannjjm	1462	4	this	this	DT
cord-023095-4dannjjm	1462	5	study	study	NN
cord-023095-4dannjjm	1462	6	were	be	VBD
cord-023095-4dannjjm	1462	7	to	to	TO
cord-023095-4dannjjm	1462	8	determine	determine	VB
cord-023095-4dannjjm	1462	9	the	the	DT
cord-023095-4dannjjm	1462	10	plasma	plasma	NN
cord-023095-4dannjjm	1462	11	and	and	CC
cord-023095-4dannjjm	1462	12	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	1462	13	disposition	disposition	NN
cord-023095-4dannjjm	1462	14	of	of	IN
cord-023095-4dannjjm	1462	15	gamithromycin	gamithromycin	NNS
cord-023095-4dannjjm	1462	16	in	in	IN
cord-023095-4dannjjm	1462	17	foals	foal	NNS
cord-023095-4dannjjm	1462	18	and	and	CC
cord-023095-4dannjjm	1462	19	to	to	TO
cord-023095-4dannjjm	1462	20	investigate	investigate	VB
cord-023095-4dannjjm	1462	21	the	the	DT
cord-023095-4dannjjm	1462	22	in	in	FW
cord-023095-4dannjjm	1462	23	vitro	vitro	FW
cord-023095-4dannjjm	1462	24	activity	activity	NN
cord-023095-4dannjjm	1462	25	of	of	IN
cord-023095-4dannjjm	1462	26	the	the	DT
cord-023095-4dannjjm	1462	27	drug	drug	NN
cord-023095-4dannjjm	1462	28	against	against	IN
cord-023095-4dannjjm	1462	29	Streptococcus	streptococcus	NN
cord-023095-4dannjjm	1462	30	equi	equi	NN
cord-023095-4dannjjm	1462	31	subsp	subsp	NN
cord-023095-4dannjjm	1462	32	.	.	.
cord-023095-4dannjjm	1463	1	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	1463	2	(	(	-LRB-
cord-023095-4dannjjm	1463	3	S.	S.	NNP
cord-023095-4dannjjm	1463	4	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	1463	5	)	)	-RRB-
cord-023095-4dannjjm	1463	6	and	and	CC
cord-023095-4dannjjm	1463	7	Rhodococcus	Rhodococcus	NNP
cord-023095-4dannjjm	1463	8	equi	equi	NN
cord-023095-4dannjjm	1463	9	isolates	isolate	NNS
cord-023095-4dannjjm	1463	10	.	.	.
cord-023095-4dannjjm	1464	1	A	a	DT
cord-023095-4dannjjm	1464	2	single	single	JJ
cord-023095-4dannjjm	1464	3	dose	dose	NN
cord-023095-4dannjjm	1464	4	of	of	IN
cord-023095-4dannjjm	1464	5	gamithromycin	gamithromycin	NNS
cord-023095-4dannjjm	1464	6	(	(	-LRB-
cord-023095-4dannjjm	1464	7	6	6	CD
cord-023095-4dannjjm	1464	8	mg	mg	NNP
cord-023095-4dannjjm	1464	9	/	/	SYM
cord-023095-4dannjjm	1464	10	kg	kg	NNS
cord-023095-4dannjjm	1464	11	of	of	IN
cord-023095-4dannjjm	1464	12	body	body	NN
cord-023095-4dannjjm	1464	13	weight	weight	NN
cord-023095-4dannjjm	1464	14	)	)	-RRB-
cord-023095-4dannjjm	1464	15	was	be	VBD
cord-023095-4dannjjm	1464	16	administered	administer	VBN
cord-023095-4dannjjm	1464	17	intramuscularly	intramuscularly	RB
cord-023095-4dannjjm	1464	18	.	.	.
cord-023095-4dannjjm	1465	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	1465	2	of	of	IN
cord-023095-4dannjjm	1465	3	gamithromycin	gamithromycin	NNS
cord-023095-4dannjjm	1465	4	in	in	IN
cord-023095-4dannjjm	1465	5	plasma	plasma	NN
cord-023095-4dannjjm	1465	6	,	,	,
cord-023095-4dannjjm	1465	7	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	1465	8	epithelial	epithelial	JJ
cord-023095-4dannjjm	1465	9	lining	lining	NN
cord-023095-4dannjjm	1465	10	fluid	fluid	NN
cord-023095-4dannjjm	1465	11	(	(	-LRB-
cord-023095-4dannjjm	1465	12	PELF	PELF	NNP
cord-023095-4dannjjm	1465	13	)	)	-RRB-
cord-023095-4dannjjm	1465	14	,	,	,
cord-023095-4dannjjm	1465	15	bronchoalveolar	bronchoalveolar	NNP
cord-023095-4dannjjm	1465	16	lavage	lavage	NNP
cord-023095-4dannjjm	1465	17	(	(	-LRB-
cord-023095-4dannjjm	1465	18	BAL	BAL	NNP
cord-023095-4dannjjm	1465	19	)	)	-RRB-
cord-023095-4dannjjm	1465	20	cells	cell	NNS
cord-023095-4dannjjm	1465	21	,	,	,
cord-023095-4dannjjm	1465	22	and	and	CC
cord-023095-4dannjjm	1465	23	blood	blood	NN
cord-023095-4dannjjm	1465	24	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	1465	25	were	be	VBD
cord-023095-4dannjjm	1465	26	determined	determine	VBN
cord-023095-4dannjjm	1465	27	using	use	VBG
cord-023095-4dannjjm	1465	28	HPLC	HPLC	NNP
cord-023095-4dannjjm	1465	29	with	with	IN
cord-023095-4dannjjm	1465	30	tandem	tandem	JJ
cord-023095-4dannjjm	1465	31	mass	mass	NN
cord-023095-4dannjjm	1465	32	spectrometry	spectrometry	NN
cord-023095-4dannjjm	1465	33	detection	detection	NN
cord-023095-4dannjjm	1465	34	.	.	.
cord-023095-4dannjjm	1466	1	The	the	DT
cord-023095-4dannjjm	1466	2	minimum	minimum	JJ
cord-023095-4dannjjm	1466	3	inhibitory	inhibitory	JJ
cord-023095-4dannjjm	1466	4	concentration	concentration	NN
cord-023095-4dannjjm	1466	5	of	of	IN
cord-023095-4dannjjm	1466	6	gamithromycin	gamithromycin	NNS
cord-023095-4dannjjm	1466	7	required	require	VBN
cord-023095-4dannjjm	1466	8	to	to	TO
cord-023095-4dannjjm	1466	9	inhibit	inhibit	VB
cord-023095-4dannjjm	1466	10	growth	growth	NN
cord-023095-4dannjjm	1466	11	of	of	IN
cord-023095-4dannjjm	1466	12	90	90	CD
cord-023095-4dannjjm	1466	13	%	%	NN
cord-023095-4dannjjm	1466	14	of	of	IN
cord-023095-4dannjjm	1466	15	R.	R.	NNP
cord-023095-4dannjjm	1466	16	equi	equi	NN
cord-023095-4dannjjm	1466	17	and	and	CC
cord-023095-4dannjjm	1466	18	S.	S.	NNP
cord-023095-4dannjjm	1466	19	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	1466	20	isolates	isolate	VBZ
cord-023095-4dannjjm	1466	21	(	(	-LRB-
cord-023095-4dannjjm	1466	22	MIC	MIC	NNP
cord-023095-4dannjjm	1466	23	90	90	CD
cord-023095-4dannjjm	1466	24	)	)	-RRB-
cord-023095-4dannjjm	1466	25	was	be	VBD
cord-023095-4dannjjm	1466	26	determined	determine	VBN
cord-023095-4dannjjm	1466	27	.	.	.
cord-023095-4dannjjm	1467	1	Additionally	additionally	RB
cord-023095-4dannjjm	1467	2	,	,	,
cord-023095-4dannjjm	1467	3	the	the	DT
cord-023095-4dannjjm	1467	4	activity	activity	NN
cord-023095-4dannjjm	1467	5	of	of	IN
cord-023095-4dannjjm	1467	6	gamithromycin	gamithromycin	NNS
cord-023095-4dannjjm	1467	7	against	against	IN
cord-023095-4dannjjm	1467	8	intracellular	intracellular	JJ
cord-023095-4dannjjm	1467	9	R.	R.	NNP
cord-023095-4dannjjm	1467	10	equi	equi	NN
cord-023095-4dannjjm	1467	11	was	be	VBD
cord-023095-4dannjjm	1467	12	measured	measure	VBN
cord-023095-4dannjjm	1467	13	.	.	.
cord-023095-4dannjjm	1468	1	Mean	mean	JJ
cord-023095-4dannjjm	1468	2	peak	peak	NN
cord-023095-4dannjjm	1468	3	gamithromycin	gamithromycin	NNS
cord-023095-4dannjjm	1468	4	concentrations	concentration	NNS
cord-023095-4dannjjm	1468	5	were	be	VBD
cord-023095-4dannjjm	1468	6	significantly	significantly	RB
cord-023095-4dannjjm	1468	7	higher	high	JJR
cord-023095-4dannjjm	1468	8	in	in	IN
cord-023095-4dannjjm	1468	9	blood	blood	NN
cord-023095-4dannjjm	1468	10	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	1468	11	(	(	-LRB-
cord-023095-4dannjjm	1468	12	8.35	8.35	CD
cord-023095-4dannjjm	1468	13	AE	AE	NNP
cord-023095-4dannjjm	1468	14	1.77	1.77	CD
cord-023095-4dannjjm	1468	15	g	g	NN
cord-023095-4dannjjm	1468	16	/	/	SYM
cord-023095-4dannjjm	1468	17	mL	mL	NNP
cord-023095-4dannjjm	1468	18	)	)	-RRB-
cord-023095-4dannjjm	1468	19	and	and	CC
cord-023095-4dannjjm	1468	20	BAL	bal	NN
cord-023095-4dannjjm	1468	21	cells	cell	NNS
cord-023095-4dannjjm	1468	22	(	(	-LRB-
cord-023095-4dannjjm	1468	23	8.91	8.91	CD
cord-023095-4dannjjm	1468	24	AE	AE	NNP
cord-023095-4dannjjm	1468	25	1.65	1.65	CD
cord-023095-4dannjjm	1468	26	g	g	NN
cord-023095-4dannjjm	1468	27	/	/	SYM
cord-023095-4dannjjm	1468	28	mL	ml	NN
cord-023095-4dannjjm	1468	29	)	)	-RRB-
cord-023095-4dannjjm	1468	30	compared	compare	VBN
cord-023095-4dannjjm	1468	31	to	to	IN
cord-023095-4dannjjm	1468	32	PELF	PELF	NNP
cord-023095-4dannjjm	1468	33	(	(	-LRB-
cord-023095-4dannjjm	1468	34	2.15	2.15	CD
cord-023095-4dannjjm	1468	35	AE	AE	NNP
cord-023095-4dannjjm	1468	36	2.78	2.78	CD
cord-023095-4dannjjm	1468	37	g	g	NN
cord-023095-4dannjjm	1468	38	/	/	SYM
cord-023095-4dannjjm	1468	39	mL	mL	NNP
cord-023095-4dannjjm	1468	40	)	)	-RRB-
cord-023095-4dannjjm	1468	41	and	and	CC
cord-023095-4dannjjm	1468	42	plasma	plasma	NN
cord-023095-4dannjjm	1468	43	(	(	-LRB-
cord-023095-4dannjjm	1468	44	0.33	0.33	CD
cord-023095-4dannjjm	1468	45	AE	AE	NNP
cord-023095-4dannjjm	1468	46	0.12	0.12	CD
cord-023095-4dannjjm	1468	47	g	g	NN
cord-023095-4dannjjm	1468	48	/	/	SYM
cord-023095-4dannjjm	1468	49	mL	mL	NNP
cord-023095-4dannjjm	1468	50	)	)	-RRB-
cord-023095-4dannjjm	1468	51	.	.	.
cord-023095-4dannjjm	1469	1	Mean	mean	JJ
cord-023095-4dannjjm	1469	2	terminal	terminal	JJ
cord-023095-4dannjjm	1469	3	half	half	RB
cord-023095-4dannjjm	1469	4	-	-	HYPH
cord-023095-4dannjjm	1469	5	lives	life	NNS
cord-023095-4dannjjm	1469	6	in	in	IN
cord-023095-4dannjjm	1469	7	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	1469	8	(	(	-LRB-
cord-023095-4dannjjm	1469	9	78.6	78.6	CD
cord-023095-4dannjjm	1469	10	h	h	NN
cord-023095-4dannjjm	1469	11	)	)	-RRB-
cord-023095-4dannjjm	1470	1	,	,	,
cord-023095-4dannjjm	1470	2	BAL	BAL	NNP
cord-023095-4dannjjm	1470	3	cells	cell	NNS
cord-023095-4dannjjm	1470	4	(	(	-LRB-
cord-023095-4dannjjm	1470	5	70.3	70.3	CD
cord-023095-4dannjjm	1470	6	h	h	NNP
cord-023095-4dannjjm	1470	7	)	)	-RRB-
cord-023095-4dannjjm	1470	8	,	,	,
cord-023095-4dannjjm	1470	9	and	and	CC
cord-023095-4dannjjm	1470	10	PELF	PELF	NNP
cord-023095-4dannjjm	1470	11	(	(	-LRB-
cord-023095-4dannjjm	1470	12	63.6	63.6	CD
cord-023095-4dannjjm	1470	13	h	h	NN
cord-023095-4dannjjm	1470	14	)	)	-RRB-
cord-023095-4dannjjm	1470	15	were	be	VBD
cord-023095-4dannjjm	1470	16	significantly	significantly	RB
cord-023095-4dannjjm	1470	17	longer	long	JJR
cord-023095-4dannjjm	1470	18	than	than	IN
cord-023095-4dannjjm	1470	19	that	that	DT
cord-023095-4dannjjm	1470	20	of	of	IN
cord-023095-4dannjjm	1470	21	plasma	plasma	NN
cord-023095-4dannjjm	1470	22	(	(	-LRB-
cord-023095-4dannjjm	1470	23	39.1	39.1	CD
cord-023095-4dannjjm	1470	24	h	h	NN
cord-023095-4dannjjm	1470	25	)	)	-RRB-
cord-023095-4dannjjm	1470	26	.	.	.
cord-023095-4dannjjm	1471	1	The	the	DT
cord-023095-4dannjjm	1471	2	MIC	MIC	NNP
cord-023095-4dannjjm	1471	3	90	90	CD
cord-023095-4dannjjm	1471	4	of	of	IN
cord-023095-4dannjjm	1471	5	S.	S.	NNP
cord-023095-4dannjjm	1471	6	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	1471	7	isolates	isolates	NNP
cord-023095-4dannjjm	1471	8	was	be	VBD
cord-023095-4dannjjm	1471	9	0.125	0.125	CD
cord-023095-4dannjjm	1471	10	g	g	NN
cord-023095-4dannjjm	1471	11	/	/	SYM
cord-023095-4dannjjm	1471	12	mL.	mL.	NNP
cord-023095-4dannjjm	1472	1	The	the	DT
cord-023095-4dannjjm	1472	2	MIC	MIC	NNP
cord-023095-4dannjjm	1472	3	90	90	CD
cord-023095-4dannjjm	1472	4	of	of	IN
cord-023095-4dannjjm	1472	5	gamithromycin	gamithromycin	NNS
cord-023095-4dannjjm	1472	6	for	for	IN
cord-023095-4dannjjm	1472	7	macrolide	macrolide	JJ
cord-023095-4dannjjm	1472	8	-	-	HYPH
cord-023095-4dannjjm	1472	9	resistant	resistant	JJ
cord-023095-4dannjjm	1472	10	R.	R.	NNP
cord-023095-4dannjjm	1472	11	equi	equi	NN
cord-023095-4dannjjm	1472	12	isolates	isolate	NNS
cord-023095-4dannjjm	1472	13	(	(	-LRB-
cord-023095-4dannjjm	1472	14	128	128	CD
cord-023095-4dannjjm	1472	15	g	g	NN
cord-023095-4dannjjm	1472	16	/	/	SYM
cord-023095-4dannjjm	1472	17	mL	ml	NN
cord-023095-4dannjjm	1472	18	)	)	-RRB-
cord-023095-4dannjjm	1472	19	was	be	VBD
cord-023095-4dannjjm	1472	20	significantly	significantly	RB
cord-023095-4dannjjm	1472	21	higher	high	JJR
cord-023095-4dannjjm	1472	22	than	than	IN
cord-023095-4dannjjm	1472	23	that	that	DT
cord-023095-4dannjjm	1472	24	of	of	IN
cord-023095-4dannjjm	1472	25	macrolide	macrolide	NN
cord-023095-4dannjjm	1472	26	-	-	HYPH
cord-023095-4dannjjm	1472	27	susceptible	susceptible	JJ
cord-023095-4dannjjm	1472	28	isolates	isolate	NNS
cord-023095-4dannjjm	1472	29	(	(	-LRB-
cord-023095-4dannjjm	1472	30	1.0g/	1.0g/	CD
cord-023095-4dannjjm	1472	31	mL	ml	NN
cord-023095-4dannjjm	1472	32	)	)	-RRB-
cord-023095-4dannjjm	1472	33	.	.	.
cord-023095-4dannjjm	1473	1	The	the	DT
cord-023095-4dannjjm	1473	2	activity	activity	NN
cord-023095-4dannjjm	1473	3	of	of	IN
cord-023095-4dannjjm	1473	4	gamithromycin	gamithromycin	NNS
cord-023095-4dannjjm	1473	5	against	against	IN
cord-023095-4dannjjm	1473	6	intracellular	intracellular	JJ
cord-023095-4dannjjm	1473	7	R.	R.	NNP
cord-023095-4dannjjm	1473	8	equi	equi	NN
cord-023095-4dannjjm	1473	9	was	be	VBD
cord-023095-4dannjjm	1473	10	similar	similar	JJ
cord-023095-4dannjjm	1473	11	to	to	IN
cord-023095-4dannjjm	1473	12	that	that	DT
cord-023095-4dannjjm	1473	13	of	of	IN
cord-023095-4dannjjm	1473	14	azithromycin	azithromycin	NN
cord-023095-4dannjjm	1473	15	and	and	CC
cord-023095-4dannjjm	1473	16	erythromycin	erythromycin	NN
cord-023095-4dannjjm	1473	17	.	.	.
cord-023095-4dannjjm	1474	1	Intramuscular	intramuscular	JJ
cord-023095-4dannjjm	1474	2	administration	administration	NN
cord-023095-4dannjjm	1474	3	of	of	IN
cord-023095-4dannjjm	1474	4	gamithromycin	gamithromycin	NNS
cord-023095-4dannjjm	1474	5	at	at	IN
cord-023095-4dannjjm	1474	6	a	a	DT
cord-023095-4dannjjm	1474	7	dosage	dosage	NN
cord-023095-4dannjjm	1474	8	of	of	IN
cord-023095-4dannjjm	1474	9	6	6	CD
cord-023095-4dannjjm	1474	10	mg	mg	NNP
cord-023095-4dannjjm	1474	11	/	/	SYM
cord-023095-4dannjjm	1474	12	kg	kg	NNS
cord-023095-4dannjjm	1474	13	would	would	MD
cord-023095-4dannjjm	1474	14	maintain	maintain	VB
cord-023095-4dannjjm	1474	15	PELF	PELF	NNP
cord-023095-4dannjjm	1474	16	concentrations	concentration	NNS
cord-023095-4dannjjm	1474	17	above	above	IN
cord-023095-4dannjjm	1474	18	the	the	DT
cord-023095-4dannjjm	1474	19	MIC	MIC	NNP
cord-023095-4dannjjm	1474	20	90	90	CD
cord-023095-4dannjjm	1474	21	for	for	IN
cord-023095-4dannjjm	1474	22	S.	S.	NNP
cord-023095-4dannjjm	1474	23	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	1474	24	and	and	CC
cord-023095-4dannjjm	1474	25	phagocytic	phagocytic	JJ
cord-023095-4dannjjm	1474	26	cell	cell	NN
cord-023095-4dannjjm	1474	27	concentrations	concentration	NNS
cord-023095-4dannjjm	1474	28	above	above	IN
cord-023095-4dannjjm	1474	29	the	the	DT
cord-023095-4dannjjm	1474	30	MIC	MIC	NNP
cord-023095-4dannjjm	1474	31	90	90	CD
cord-023095-4dannjjm	1474	32	for	for	IN
cord-023095-4dannjjm	1474	33	R.	R.	NNP
cord-023095-4dannjjm	1474	34	equi	equi	NN
cord-023095-4dannjjm	1474	35	for	for	IN
cord-023095-4dannjjm	1474	36	approximately	approximately	RB
cord-023095-4dannjjm	1474	37	7	7	CD
cord-023095-4dannjjm	1474	38	days	day	NNS
cord-023095-4dannjjm	1474	39	.	.	.
cord-023095-4dannjjm	1475	1	Eight	eight	CD
cord-023095-4dannjjm	1475	2	Western	western	JJ
cord-023095-4dannjjm	1475	3	stock	stock	NN
cord-023095-4dannjjm	1475	4	yearling	yearling	NN
cord-023095-4dannjjm	1475	5	horses	horse	NNS
cord-023095-4dannjjm	1475	6	were	be	VBD
cord-023095-4dannjjm	1475	7	infected	infect	VBN
cord-023095-4dannjjm	1475	8	with	with	IN
cord-023095-4dannjjm	1475	9	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1475	10	(	(	-LRB-
cord-023095-4dannjjm	1475	11	Ab4	ab4	NN
cord-023095-4dannjjm	1475	12	)	)	-RRB-
cord-023095-4dannjjm	1475	13	by	by	IN
cord-023095-4dannjjm	1475	14	nasopharyngeal	nasopharyngeal	JJ
cord-023095-4dannjjm	1475	15	instillation	instillation	NN
cord-023095-4dannjjm	1475	16	.	.	.
cord-023095-4dannjjm	1476	1	Venous	venous	JJ
cord-023095-4dannjjm	1476	2	blood	blood	NN
cord-023095-4dannjjm	1476	3	samples	sample	NNS
cord-023095-4dannjjm	1476	4	for	for	IN
cord-023095-4dannjjm	1476	5	collection	collection	NN
cord-023095-4dannjjm	1476	6	of	of	IN
cord-023095-4dannjjm	1476	7	plasma	plasma	NN
cord-023095-4dannjjm	1476	8	were	be	VBD
cord-023095-4dannjjm	1476	9	collected	collect	VBN
cord-023095-4dannjjm	1476	10	in	in	IN
cord-023095-4dannjjm	1476	11	Na	Na	NNP
cord-023095-4dannjjm	1476	12	-	-	HYPH
cord-023095-4dannjjm	1476	13	citrate	citrate	NN
cord-023095-4dannjjm	1476	14	tubes	tube	NNS
cord-023095-4dannjjm	1476	15	on	on	IN
cord-023095-4dannjjm	1476	16	the	the	DT
cord-023095-4dannjjm	1476	17	day	day	NN
cord-023095-4dannjjm	1476	18	prior	prior	RB
cord-023095-4dannjjm	1476	19	to	to	IN
cord-023095-4dannjjm	1476	20	infection	infection	NN
cord-023095-4dannjjm	1476	21	(	(	-LRB-
cord-023095-4dannjjm	1476	22	D	D	NNP
cord-023095-4dannjjm	1476	23	-1	-1	NN
cord-023095-4dannjjm	1476	24	)	)	-RRB-
cord-023095-4dannjjm	1476	25	and	and	CC
cord-023095-4dannjjm	1476	26	on	on	IN
cord-023095-4dannjjm	1476	27	D4	d4	NN
cord-023095-4dannjjm	1476	28	through	through	IN
cord-023095-4dannjjm	1476	29	D11	D11	NNP
cord-023095-4dannjjm	1476	30	.	.	.
cord-023095-4dannjjm	1477	1	In	in	IN
cord-023095-4dannjjm	1477	2	addition	addition	NN
cord-023095-4dannjjm	1477	3	,	,	,
cord-023095-4dannjjm	1477	4	clinical	clinical	JJ
cord-023095-4dannjjm	1477	5	data	datum	NNS
cord-023095-4dannjjm	1477	6	,	,	,
cord-023095-4dannjjm	1477	7	nasal	nasal	NN
cord-023095-4dannjjm	1477	8	swabs	swab	NNS
cord-023095-4dannjjm	1477	9	and	and	CC
cord-023095-4dannjjm	1477	10	peripheral	peripheral	JJ
cord-023095-4dannjjm	1477	11	blood	blood	NN
cord-023095-4dannjjm	1477	12	mononuclear	mononuclear	NN
cord-023095-4dannjjm	1477	13	cells	cell	NNS
cord-023095-4dannjjm	1477	14	(	(	-LRB-
cord-023095-4dannjjm	1477	15	PBMC	PBMC	NNP
cord-023095-4dannjjm	1477	16	)	)	-RRB-
cord-023095-4dannjjm	1477	17	for	for	IN
cord-023095-4dannjjm	1477	18	detection	detection	NN
cord-023095-4dannjjm	1477	19	of	of	IN
cord-023095-4dannjjm	1477	20	viremia	viremia	NN
cord-023095-4dannjjm	1477	21	were	be	VBD
cord-023095-4dannjjm	1477	22	collected	collect	VBN
cord-023095-4dannjjm	1477	23	on	on	IN
cord-023095-4dannjjm	1477	24	the	the	DT
cord-023095-4dannjjm	1477	25	day	day	NN
cord-023095-4dannjjm	1477	26	before	before	IN
cord-023095-4dannjjm	1477	27	infection	infection	NN
cord-023095-4dannjjm	1477	28	(	(	-LRB-
cord-023095-4dannjjm	1477	29	D	D	NNP
cord-023095-4dannjjm	1477	30	-1	-1	NN
cord-023095-4dannjjm	1477	31	)	)	-RRB-
cord-023095-4dannjjm	1477	32	and	and	CC
cord-023095-4dannjjm	1477	33	on	on	IN
cord-023095-4dannjjm	1477	34	D1	d1	NN
cord-023095-4dannjjm	1477	35	through	through	IN
cord-023095-4dannjjm	1477	36	D14	D14	NNP
cord-023095-4dannjjm	1477	37	post	post	NN
cord-023095-4dannjjm	1477	38	-	-	NN
cord-023095-4dannjjm	1477	39	infection	infection	NN
cord-023095-4dannjjm	1477	40	.	.	.
cord-023095-4dannjjm	1478	1	D	d	NN
cord-023095-4dannjjm	1478	2	-	-	HYPH
cord-023095-4dannjjm	1478	3	dimer	dimer	NN
cord-023095-4dannjjm	1478	4	concentrations	concentration	NNS
cord-023095-4dannjjm	1478	5	were	be	VBD
cord-023095-4dannjjm	1478	6	determined	determine	VBN
cord-023095-4dannjjm	1478	7	in	in	IN
cord-023095-4dannjjm	1478	8	citrated	citrate	VBN
cord-023095-4dannjjm	1478	9	plasma	plasma	NN
cord-023095-4dannjjm	1478	10	samples	sample	NNS
cord-023095-4dannjjm	1478	11	using	use	VBG
cord-023095-4dannjjm	1478	12	a	a	DT
cord-023095-4dannjjm	1478	13	latex	latex	NN
cord-023095-4dannjjm	1478	14	agglutination	agglutination	NN
cord-023095-4dannjjm	1478	15	test	test	NN
cord-023095-4dannjjm	1478	16	(	(	-LRB-
cord-023095-4dannjjm	1478	17	Minutex	Minutex	NNP
cord-023095-4dannjjm	1478	18	D	D	NNP
cord-023095-4dannjjm	1478	19	-	-	HYPH
cord-023095-4dannjjm	1478	20	dimer	dimer	NN
cord-023095-4dannjjm	1478	21	,	,	,
cord-023095-4dannjjm	1478	22	biopool	biopool	NN
cord-023095-4dannjjm	1478	23	,	,	,
cord-023095-4dannjjm	1478	24	Ireland	Ireland	NNP
cord-023095-4dannjjm	1478	25	)	)	-RRB-
cord-023095-4dannjjm	1478	26	.	.	.
cord-023095-4dannjjm	1479	1	Viral	viral	JJ
cord-023095-4dannjjm	1479	2	load	load	NN
cord-023095-4dannjjm	1479	3	in	in	IN
cord-023095-4dannjjm	1479	4	PBMC	PBMC	NNP
cord-023095-4dannjjm	1479	5	was	be	VBD
cord-023095-4dannjjm	1479	6	determined	determine	VBN
cord-023095-4dannjjm	1479	7	using	use	VBG
cord-023095-4dannjjm	1479	8	quantitative	quantitative	JJ
cord-023095-4dannjjm	1479	9	PCR	PCR	NNP
cord-023095-4dannjjm	1479	10	.	.	.
cord-023095-4dannjjm	1480	1	All	all	DT
cord-023095-4dannjjm	1480	2	horses	horse	NNS
cord-023095-4dannjjm	1480	3	showed	show	VBD
cord-023095-4dannjjm	1480	4	bi	bi	JJ
cord-023095-4dannjjm	1480	5	-	-	JJ
cord-023095-4dannjjm	1480	6	phasic	phasic	JJ
cord-023095-4dannjjm	1480	7	fevers	fever	NNS
cord-023095-4dannjjm	1480	8	typical	typical	JJ
cord-023095-4dannjjm	1480	9	for	for	IN
cord-023095-4dannjjm	1480	10	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1480	11	infections	infection	NNS
cord-023095-4dannjjm	1480	12	.	.	.
cord-023095-4dannjjm	1481	1	One	one	CD
cord-023095-4dannjjm	1481	2	horse	horse	NN
cord-023095-4dannjjm	1481	3	developed	develop	VBD
cord-023095-4dannjjm	1481	4	acute	acute	JJ
cord-023095-4dannjjm	1481	5	EHM	ehm	UH
cord-023095-4dannjjm	1481	6	on	on	IN
cord-023095-4dannjjm	1481	7	D10	D10	NNP
cord-023095-4dannjjm	1481	8	and	and	CC
cord-023095-4dannjjm	1481	9	was	be	VBD
cord-023095-4dannjjm	1481	10	euthanized	euthanize	VBN
cord-023095-4dannjjm	1481	11	after	after	IN
cord-023095-4dannjjm	1481	12	samples	sample	NNS
cord-023095-4dannjjm	1481	13	were	be	VBD
cord-023095-4dannjjm	1481	14	collected	collect	VBN
cord-023095-4dannjjm	1481	15	.	.	.
cord-023095-4dannjjm	1482	1	In	in	IN
cord-023095-4dannjjm	1482	2	all	all	DT
cord-023095-4dannjjm	1482	3	horses	horse	NNS
cord-023095-4dannjjm	1482	4	D	D	NNS
cord-023095-4dannjjm	1482	5	-	-	HYPH
cord-023095-4dannjjm	1482	6	dimers	dimer	NNS
cord-023095-4dannjjm	1482	7	were	be	VBD
cord-023095-4dannjjm	1482	8	undetectable	undetectable	JJ
cord-023095-4dannjjm	1482	9	on	on	IN
cord-023095-4dannjjm	1482	10	D	D	NNP
cord-023095-4dannjjm	1482	11	-1	-1	NN
cord-023095-4dannjjm	1482	12	and	and	CC
cord-023095-4dannjjm	1482	13	on	on	IN
cord-023095-4dannjjm	1482	14	D4	d4	NN
cord-023095-4dannjjm	1482	15	,	,	,
cord-023095-4dannjjm	1482	16	5	5	CD
cord-023095-4dannjjm	1482	17	and	and	CC
cord-023095-4dannjjm	1482	18	11	11	CD
cord-023095-4dannjjm	1482	19	.	.	.
cord-023095-4dannjjm	1483	1	In	in	IN
cord-023095-4dannjjm	1483	2	contrast	contrast	NN
cord-023095-4dannjjm	1483	3	,	,	,
cord-023095-4dannjjm	1483	4	all	all	DT
cord-023095-4dannjjm	1483	5	horses	horse	NNS
cord-023095-4dannjjm	1483	6	had	have	VBD
cord-023095-4dannjjm	1483	7	increased	increase	VBN
cord-023095-4dannjjm	1483	8	Ddimer	Ddimer	NNP
cord-023095-4dannjjm	1483	9	concentrations	concentration	NNS
cord-023095-4dannjjm	1483	10	for	for	IN
cord-023095-4dannjjm	1483	11	3	3	CD
cord-023095-4dannjjm	1483	12	to	to	TO
cord-023095-4dannjjm	1483	13	5	5	CD
cord-023095-4dannjjm	1483	14	consecutive	consecutive	JJ
cord-023095-4dannjjm	1483	15	days	day	NNS
cord-023095-4dannjjm	1483	16	starting	start	VBG
cord-023095-4dannjjm	1483	17	on	on	IN
cord-023095-4dannjjm	1483	18	day	day	NN
cord-023095-4dannjjm	1483	19	6	6	CD
cord-023095-4dannjjm	1483	20	post	post	NN
cord-023095-4dannjjm	1483	21	-	-	NN
cord-023095-4dannjjm	1483	22	infection	infection	NN
cord-023095-4dannjjm	1483	23	.	.	.
cord-023095-4dannjjm	1484	1	D	d	NN
cord-023095-4dannjjm	1484	2	-	-	HYPH
cord-023095-4dannjjm	1484	3	dimer	dimer	JJ
cord-023095-4dannjjm	1484	4	concentrations	concentration	NNS
cord-023095-4dannjjm	1484	5	in	in	IN
cord-023095-4dannjjm	1484	6	2	2	CD
cord-023095-4dannjjm	1484	7	horses	horse	NNS
cord-023095-4dannjjm	1484	8	increased	increase	VBD
cord-023095-4dannjjm	1484	9	to	to	IN
cord-023095-4dannjjm	1484	10	1000	1000	CD
cord-023095-4dannjjm	1484	11	ug	ug	NNP
cord-023095-4dannjjm	1484	12	/	/	SYM
cord-023095-4dannjjm	1484	13	ml	ml	NN
cord-023095-4dannjjm	1484	14	and	and	CC
cord-023095-4dannjjm	1484	15	one	one	CD
cord-023095-4dannjjm	1484	16	of	of	IN
cord-023095-4dannjjm	1484	17	these	these	DT
cord-023095-4dannjjm	1484	18	horses	horse	NNS
cord-023095-4dannjjm	1484	19	was	be	VBD
cord-023095-4dannjjm	1484	20	the	the	DT
cord-023095-4dannjjm	1484	21	horse	horse	NN
cord-023095-4dannjjm	1484	22	with	with	IN
cord-023095-4dannjjm	1484	23	acute	acute	JJ
cord-023095-4dannjjm	1484	24	EHM	EHM	NNP
cord-023095-4dannjjm	1484	25	.	.	.
cord-023095-4dannjjm	1485	1	Interestingly	interestingly	RB
cord-023095-4dannjjm	1485	2	,	,	,
cord-023095-4dannjjm	1485	3	mean	mean	JJ
cord-023095-4dannjjm	1485	4	increased	increase	VBN
cord-023095-4dannjjm	1485	5	D	d	NN
cord-023095-4dannjjm	1485	6	-	-	HYPH
cord-023095-4dannjjm	1485	7	dimer	dimer	NN
cord-023095-4dannjjm	1485	8	concentrations	concentration	NNS
cord-023095-4dannjjm	1485	9	showed	show	VBD
cord-023095-4dannjjm	1485	10	timely	timely	RB
cord-023095-4dannjjm	1485	11	overlap	overlap	VBP
cord-023095-4dannjjm	1485	12	with	with	IN
cord-023095-4dannjjm	1485	13	the	the	DT
cord-023095-4dannjjm	1485	14	mean	mean	JJ
cord-023095-4dannjjm	1485	15	fever	fever	NN
cord-023095-4dannjjm	1485	16	curve	curve	NN
cord-023095-4dannjjm	1485	17	and	and	CC
cord-023095-4dannjjm	1485	18	,	,	,
cord-023095-4dannjjm	1485	19	delayed	delay	VBN
cord-023095-4dannjjm	1485	20	by	by	IN
cord-023095-4dannjjm	1485	21	1	1	CD
cord-023095-4dannjjm	1485	22	day	day	NN
cord-023095-4dannjjm	1485	23	,	,	,
cord-023095-4dannjjm	1485	24	with	with	IN
cord-023095-4dannjjm	1485	25	the	the	DT
cord-023095-4dannjjm	1485	26	mean	mean	JJ
cord-023095-4dannjjm	1485	27	viremia	viremia	NN
cord-023095-4dannjjm	1485	28	curve	curve	NN
cord-023095-4dannjjm	1485	29	.	.	.
cord-023095-4dannjjm	1486	1	Because	because	IN
cord-023095-4dannjjm	1486	2	plasma	plasma	NN
cord-023095-4dannjjm	1486	3	samples	sample	NNS
cord-023095-4dannjjm	1486	4	for	for	IN
cord-023095-4dannjjm	1486	5	D	d	NN
cord-023095-4dannjjm	1486	6	-	-	HYPH
cord-023095-4dannjjm	1486	7	dimer	dimer	NN
cord-023095-4dannjjm	1486	8	measurements	measurement	NNS
cord-023095-4dannjjm	1486	9	were	be	VBD
cord-023095-4dannjjm	1486	10	not	not	RB
cord-023095-4dannjjm	1486	11	collected	collect	VBN
cord-023095-4dannjjm	1486	12	during	during	IN
cord-023095-4dannjjm	1486	13	the	the	DT
cord-023095-4dannjjm	1486	14	first	first	JJ
cord-023095-4dannjjm	1486	15	3	3	CD
cord-023095-4dannjjm	1486	16	days	day	NNS
cord-023095-4dannjjm	1486	17	post	post	NN
cord-023095-4dannjjm	1486	18	-	-	NN
cord-023095-4dannjjm	1486	19	infection	infection	NN
cord-023095-4dannjjm	1486	20	,	,	,
cord-023095-4dannjjm	1486	21	which	which	WDT
cord-023095-4dannjjm	1486	22	are	be	VBP
cord-023095-4dannjjm	1486	23	typically	typically	RB
cord-023095-4dannjjm	1486	24	associated	associate	VBN
cord-023095-4dannjjm	1486	25	with	with	IN
cord-023095-4dannjjm	1486	26	a	a	DT
cord-023095-4dannjjm	1486	27	primary	primary	JJ
cord-023095-4dannjjm	1486	28	fever	fever	NN
cord-023095-4dannjjm	1486	29	,	,	,
cord-023095-4dannjjm	1486	30	conclusion	conclusion	NN
cord-023095-4dannjjm	1486	31	on	on	IN
cord-023095-4dannjjm	1486	32	the	the	DT
cord-023095-4dannjjm	1486	33	association	association	NN
cord-023095-4dannjjm	1486	34	of	of	IN
cord-023095-4dannjjm	1486	35	D	D	NNP
cord-023095-4dannjjm	1486	36	-	-	HYPH
cord-023095-4dannjjm	1486	37	Dimers	Dimers	NNPS
cord-023095-4dannjjm	1486	38	with	with	IN
cord-023095-4dannjjm	1486	39	fever	fever	NN
cord-023095-4dannjjm	1486	40	of	of	IN
cord-023095-4dannjjm	1486	41	viremia	viremia	NN
cord-023095-4dannjjm	1486	42	await	await	VBP
cord-023095-4dannjjm	1486	43	analysis	analysis	NN
cord-023095-4dannjjm	1486	44	of	of	IN
cord-023095-4dannjjm	1486	45	a	a	DT
cord-023095-4dannjjm	1486	46	second	second	JJ
cord-023095-4dannjjm	1486	47	study	study	NN
cord-023095-4dannjjm	1486	48	currently	currently	RB
cord-023095-4dannjjm	1486	49	conducted	conduct	VBN
cord-023095-4dannjjm	1486	50	in	in	IN
cord-023095-4dannjjm	1486	51	our	-PRON-	PRP$
cord-023095-4dannjjm	1486	52	laboratory	laboratory	NN
cord-023095-4dannjjm	1486	53	.	.	.
cord-023095-4dannjjm	1487	1	In	in	IN
cord-023095-4dannjjm	1487	2	conclusion	conclusion	NN
cord-023095-4dannjjm	1487	3	our	-PRON-	PRP$
cord-023095-4dannjjm	1487	4	data	data	NN
cord-023095-4dannjjm	1487	5	indicates	indicate	VBZ
cord-023095-4dannjjm	1487	6	that	that	IN
cord-023095-4dannjjm	1487	7	during	during	IN
cord-023095-4dannjjm	1487	8	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	1487	9	infection	infection	NN
cord-023095-4dannjjm	1487	10	with	with	IN
cord-023095-4dannjjm	1487	11	neuropathogenic	neuropathogenic	NNP
cord-023095-4dannjjm	1487	12	strains	strain	NNS
cord-023095-4dannjjm	1487	13	activation	activation	NN
cord-023095-4dannjjm	1487	14	of	of	IN
cord-023095-4dannjjm	1487	15	the	the	DT
cord-023095-4dannjjm	1487	16	coagulation	coagulation	NN
cord-023095-4dannjjm	1487	17	cascade	cascade	NN
cord-023095-4dannjjm	1487	18	and	and	CC
cord-023095-4dannjjm	1487	19	production	production	NN
cord-023095-4dannjjm	1487	20	of	of	IN
cord-023095-4dannjjm	1487	21	cross	cross	NN
cord-023095-4dannjjm	1487	22	-	-	JJ
cord-023095-4dannjjm	1487	23	linked	link	VBN
cord-023095-4dannjjm	1487	24	fibrin	fibrin	NN
cord-023095-4dannjjm	1487	25	is	be	VBZ
cord-023095-4dannjjm	1487	26	wide	wide	JJ
cord-023095-4dannjjm	1487	27	-	-	HYPH
cord-023095-4dannjjm	1487	28	spread	spread	NN
cord-023095-4dannjjm	1487	29	;	;	:
cord-023095-4dannjjm	1487	30	not	not	RB
cord-023095-4dannjjm	1487	31	limited	limit	VBN
cord-023095-4dannjjm	1487	32	to	to	IN
cord-023095-4dannjjm	1487	33	horses	horse	NNS
cord-023095-4dannjjm	1487	34	with	with	IN
cord-023095-4dannjjm	1487	35	clinical	clinical	JJ
cord-023095-4dannjjm	1487	36	signs	sign	NNS
cord-023095-4dannjjm	1487	37	of	of	IN
cord-023095-4dannjjm	1487	38	EHM	EHM	NNP
cord-023095-4dannjjm	1487	39	,	,	,
cord-023095-4dannjjm	1487	40	and	and	CC
cord-023095-4dannjjm	1487	41	can	can	MD
cord-023095-4dannjjm	1487	42	be	be	VB
cord-023095-4dannjjm	1487	43	expected	expect	VBN
cord-023095-4dannjjm	1487	44	between	between	IN
cord-023095-4dannjjm	1487	45	days	day	NNS
cord-023095-4dannjjm	1487	46	6	6	CD
cord-023095-4dannjjm	1487	47	and	and	CC
cord-023095-4dannjjm	1487	48	10	10	CD
cord-023095-4dannjjm	1487	49	post	post	NN
cord-023095-4dannjjm	1487	50	-	-	NN
cord-023095-4dannjjm	1487	51	infection	infection	NN
cord-023095-4dannjjm	1487	52	.	.	.
cord-023095-4dannjjm	1488	1	Lawsonia	Lawsonia	NNP
cord-023095-4dannjjm	1488	2	intracellularis	intracellularis	NN
cord-023095-4dannjjm	1488	3	is	be	VBZ
cord-023095-4dannjjm	1488	4	an	an	DT
cord-023095-4dannjjm	1488	5	emerging	emerge	VBG
cord-023095-4dannjjm	1488	6	pathogen	pathogen	NN
cord-023095-4dannjjm	1488	7	in	in	IN
cord-023095-4dannjjm	1488	8	horses	horse	NNS
cord-023095-4dannjjm	1488	9	and	and	CC
cord-023095-4dannjjm	1488	10	the	the	DT
cord-023095-4dannjjm	1488	11	causative	causative	JJ
cord-023095-4dannjjm	1488	12	agent	agent	NN
cord-023095-4dannjjm	1488	13	in	in	IN
cord-023095-4dannjjm	1488	14	Equine	Equine	NNP
cord-023095-4dannjjm	1488	15	Proliferative	Proliferative	NNP
cord-023095-4dannjjm	1488	16	Enteropathy	Enteropathy	NNP
cord-023095-4dannjjm	1488	17	(	(	-LRB-
cord-023095-4dannjjm	1488	18	EPE	EPE	NNP
cord-023095-4dannjjm	1488	19	)	)	-RRB-
cord-023095-4dannjjm	1488	20	.	.	.
cord-023095-4dannjjm	1489	1	The	the	DT
cord-023095-4dannjjm	1489	2	goal	goal	NN
cord-023095-4dannjjm	1489	3	of	of	IN
cord-023095-4dannjjm	1489	4	this	this	DT
cord-023095-4dannjjm	1489	5	study	study	NN
cord-023095-4dannjjm	1489	6	was	be	VBD
cord-023095-4dannjjm	1489	7	to	to	TO
cord-023095-4dannjjm	1489	8	evaluate	evaluate	VB
cord-023095-4dannjjm	1489	9	the	the	DT
cord-023095-4dannjjm	1489	10	exposure	exposure	NN
cord-023095-4dannjjm	1489	11	of	of	IN
cord-023095-4dannjjm	1489	12	pre	pre	JJ
cord-023095-4dannjjm	1489	13	-	-	JJ
cord-023095-4dannjjm	1489	14	weanling	weanling	JJ
cord-023095-4dannjjm	1489	15	foals	foal	NNS
cord-023095-4dannjjm	1489	16	and	and	CC
cord-023095-4dannjjm	1489	17	broodmares	broodmare	NNS
cord-023095-4dannjjm	1489	18	to	to	IN
cord-023095-4dannjjm	1489	19	Lawsonia	Lawsonia	NNP
cord-023095-4dannjjm	1489	20	intracelluaris	intracelluaris	RB
cord-023095-4dannjjm	1489	21	on	on	IN
cord-023095-4dannjjm	1489	22	several	several	JJ
cord-023095-4dannjjm	1489	23	farms	farm	NNS
cord-023095-4dannjjm	1489	24	in	in	IN
cord-023095-4dannjjm	1489	25	Louisiana	Louisiana	NNP
cord-023095-4dannjjm	1489	26	with	with	IN
cord-023095-4dannjjm	1489	27	a	a	DT
cord-023095-4dannjjm	1489	28	history	history	NN
cord-023095-4dannjjm	1489	29	of	of	IN
cord-023095-4dannjjm	1489	30	EPE	EPE	NNP
cord-023095-4dannjjm	1489	31	and	and	CC
cord-023095-4dannjjm	1489	32	compare	compare	VB
cord-023095-4dannjjm	1489	33	the	the	DT
cord-023095-4dannjjm	1489	34	results	result	NNS
cord-023095-4dannjjm	1489	35	to	to	IN
cord-023095-4dannjjm	1489	36	several	several	JJ
cord-023095-4dannjjm	1489	37	farms	farm	NNS
cord-023095-4dannjjm	1489	38	with	with	IN
cord-023095-4dannjjm	1489	39	no	no	DT
cord-023095-4dannjjm	1489	40	known	know	VBN
cord-023095-4dannjjm	1489	41	clinical	clinical	JJ
cord-023095-4dannjjm	1489	42	cases	case	NNS
cord-023095-4dannjjm	1489	43	of	of	IN
cord-023095-4dannjjm	1489	44	EPE	EPE	NNP
cord-023095-4dannjjm	1489	45	in	in	IN
cord-023095-4dannjjm	1489	46	foals	foal	NNS
cord-023095-4dannjjm	1489	47	.	.	.
cord-023095-4dannjjm	1490	1	An	an	DT
cord-023095-4dannjjm	1490	2	additional	additional	JJ
cord-023095-4dannjjm	1490	3	goal	goal	NN
cord-023095-4dannjjm	1490	4	of	of	IN
cord-023095-4dannjjm	1490	5	the	the	DT
cord-023095-4dannjjm	1490	6	study	study	NN
cord-023095-4dannjjm	1490	7	was	be	VBD
cord-023095-4dannjjm	1490	8	to	to	TO
cord-023095-4dannjjm	1490	9	identify	identify	VB
cord-023095-4dannjjm	1490	10	whether	whether	IN
cord-023095-4dannjjm	1490	11	a	a	DT
cord-023095-4dannjjm	1490	12	relationship	relationship	NN
cord-023095-4dannjjm	1490	13	exists	exist	VBZ
cord-023095-4dannjjm	1490	14	between	between	IN
cord-023095-4dannjjm	1490	15	Lawsonia	Lawsonia	NNP
cord-023095-4dannjjm	1490	16	intracelluaris	intracelluaris	JJ
cord-023095-4dannjjm	1490	17	and	and	CC
cord-023095-4dannjjm	1490	18	other	other	JJ
cord-023095-4dannjjm	1490	19	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1490	20	pathogens	pathogen	NNS
cord-023095-4dannjjm	1490	21	in	in	IN
cord-023095-4dannjjm	1490	22	foals	foal	NNS
cord-023095-4dannjjm	1490	23	.	.	.
cord-023095-4dannjjm	1491	1	Whole	whole	JJ
cord-023095-4dannjjm	1491	2	blood	blood	NN
cord-023095-4dannjjm	1491	3	and	and	CC
cord-023095-4dannjjm	1491	4	fecal	fecal	JJ
cord-023095-4dannjjm	1491	5	samples	sample	NNS
cord-023095-4dannjjm	1491	6	were	be	VBD
cord-023095-4dannjjm	1491	7	collected	collect	VBN
cord-023095-4dannjjm	1491	8	from	from	IN
cord-023095-4dannjjm	1491	9	66	66	CD
cord-023095-4dannjjm	1491	10	mares	mare	NNS
cord-023095-4dannjjm	1491	11	and	and	CC
cord-023095-4dannjjm	1491	12	68	68	CD
cord-023095-4dannjjm	1491	13	foals	foal	NNS
cord-023095-4dannjjm	1491	14	from	from	IN
cord-023095-4dannjjm	1491	15	four	four	CD
cord-023095-4dannjjm	1491	16	breeding	breed	VBG
cord-023095-4dannjjm	1491	17	farms	farm	NNS
cord-023095-4dannjjm	1491	18	in	in	IN
cord-023095-4dannjjm	1491	19	Louisiana	Louisiana	NNP
cord-023095-4dannjjm	1491	20	.	.	.
cord-023095-4dannjjm	1492	1	Farms	farm	NNS
cord-023095-4dannjjm	1492	2	A	A	NNP
cord-023095-4dannjjm	1492	3	and	and	CC
cord-023095-4dannjjm	1492	4	B	B	NNP
cord-023095-4dannjjm	1492	5	had	have	VBD
cord-023095-4dannjjm	1492	6	no	no	DT
cord-023095-4dannjjm	1492	7	known	know	VBN
cord-023095-4dannjjm	1492	8	clinical	clinical	JJ
cord-023095-4dannjjm	1492	9	cases	case	NNS
cord-023095-4dannjjm	1492	10	of	of	IN
cord-023095-4dannjjm	1492	11	EPE	EPE	NNP
cord-023095-4dannjjm	1492	12	,	,	,
cord-023095-4dannjjm	1492	13	while	while	IN
cord-023095-4dannjjm	1492	14	Farms	farm	NNS
cord-023095-4dannjjm	1492	15	C	C	NNP
cord-023095-4dannjjm	1492	16	and	and	CC
cord-023095-4dannjjm	1492	17	D	D	NNP
cord-023095-4dannjjm	1492	18	had	have	VBD
cord-023095-4dannjjm	1492	19	previous	previous	JJ
cord-023095-4dannjjm	1492	20	know	know	NN
cord-023095-4dannjjm	1492	21	cases	case	NNS
cord-023095-4dannjjm	1492	22	of	of	IN
cord-023095-4dannjjm	1492	23	EPE	EPE	NNP
cord-023095-4dannjjm	1492	24	in	in	IN
cord-023095-4dannjjm	1492	25	2009	2009	CD
cord-023095-4dannjjm	1492	26	.	.	.
cord-023095-4dannjjm	1493	1	Serum	serum	NN
cord-023095-4dannjjm	1493	2	samples	sample	NNS
cord-023095-4dannjjm	1493	3	were	be	VBD
cord-023095-4dannjjm	1493	4	examined	examine	VBN
cord-023095-4dannjjm	1493	5	for	for	IN
cord-023095-4dannjjm	1493	6	the	the	DT
cord-023095-4dannjjm	1493	7	presence	presence	NN
cord-023095-4dannjjm	1493	8	of	of	IN
cord-023095-4dannjjm	1493	9	antibodies	antibody	NNS
cord-023095-4dannjjm	1493	10	against	against	IN
cord-023095-4dannjjm	1493	11	Lawsonia	Lawsonia	NNP
cord-023095-4dannjjm	1493	12	intracellularis	intracellularis	NNP
cord-023095-4dannjjm	1493	13	using	use	VBG
cord-023095-4dannjjm	1493	14	an	an	DT
cord-023095-4dannjjm	1493	15	immunoperoxidase	immunoperoxidase	NN
cord-023095-4dannjjm	1493	16	monolayer	monolayer	NN
cord-023095-4dannjjm	1493	17	assay	assay	NN
cord-023095-4dannjjm	1493	18	(	(	-LRB-
cord-023095-4dannjjm	1493	19	IPMA	IPMA	NNP
cord-023095-4dannjjm	1493	20	)	)	-RRB-
cord-023095-4dannjjm	1493	21	.	.	.
cord-023095-4dannjjm	1494	1	DNA	DNA	NNP
cord-023095-4dannjjm	1494	2	was	be	VBD
cord-023095-4dannjjm	1494	3	extracted	extract	VBN
cord-023095-4dannjjm	1494	4	from	from	IN
cord-023095-4dannjjm	1494	5	fecal	fecal	JJ
cord-023095-4dannjjm	1494	6	samples	sample	NNS
cord-023095-4dannjjm	1494	7	using	use	VBG
cord-023095-4dannjjm	1494	8	a	a	DT
cord-023095-4dannjjm	1494	9	commercial	commercial	JJ
cord-023095-4dannjjm	1494	10	DNA	dna	NN
cord-023095-4dannjjm	1494	11	kit	kit	NN
cord-023095-4dannjjm	1494	12	and	and	CC
cord-023095-4dannjjm	1494	13	molecular	molecular	JJ
cord-023095-4dannjjm	1494	14	detection	detection	NN
cord-023095-4dannjjm	1494	15	of	of	IN
cord-023095-4dannjjm	1494	16	Lawsonia	Lawsonia	NNP
cord-023095-4dannjjm	1494	17	intracelluaris	intracelluaris	NNP
cord-023095-4dannjjm	1494	18	was	be	VBD
cord-023095-4dannjjm	1494	19	assayed	assay	VBN
cord-023095-4dannjjm	1494	20	using	use	VBG
cord-023095-4dannjjm	1494	21	real	real	JJ
cord-023095-4dannjjm	1494	22	-	-	HYPH
cord-023095-4dannjjm	1494	23	time	time	NN
cord-023095-4dannjjm	1494	24	PCR	PCR	NNP
cord-023095-4dannjjm	1494	25	.	.	.
cord-023095-4dannjjm	1495	1	Fecal	fecal	JJ
cord-023095-4dannjjm	1495	2	ova	ova	NN
cord-023095-4dannjjm	1495	3	were	be	VBD
cord-023095-4dannjjm	1495	4	determined	determine	VBN
cord-023095-4dannjjm	1495	5	using	use	VBG
cord-023095-4dannjjm	1495	6	quantitative	quantitative	JJ
cord-023095-4dannjjm	1495	7	sucrose	sucrose	NN
cord-023095-4dannjjm	1495	8	floatation	floatation	NN
cord-023095-4dannjjm	1495	9	.	.	.
cord-023095-4dannjjm	1496	1	The	the	DT
cord-023095-4dannjjm	1496	2	presence	presence	NN
cord-023095-4dannjjm	1496	3	of	of	IN
cord-023095-4dannjjm	1496	4	fecal	fecal	JJ
cord-023095-4dannjjm	1496	5	Clostridium	clostridium	NN
cord-023095-4dannjjm	1496	6	difficile	difficile	NN
cord-023095-4dannjjm	1496	7	toxin	toxin	NN
cord-023095-4dannjjm	1496	8	was	be	VBD
cord-023095-4dannjjm	1496	9	measured	measure	VBN
cord-023095-4dannjjm	1496	10	using	use	VBG
cord-023095-4dannjjm	1496	11	a	a	DT
cord-023095-4dannjjm	1496	12	commercial	commercial	JJ
cord-023095-4dannjjm	1496	13	enzyme	enzyme	NN
cord-023095-4dannjjm	1496	14	linked	link	VBN
cord-023095-4dannjjm	1496	15	immunosorbent	immunosorbent	JJ
cord-023095-4dannjjm	1496	16	assay	assay	NN
cord-023095-4dannjjm	1496	17	(	(	-LRB-
cord-023095-4dannjjm	1496	18	ELISA	ELISA	NNP
cord-023095-4dannjjm	1496	19	)	)	-RRB-
cord-023095-4dannjjm	1496	20	.	.	.
cord-023095-4dannjjm	1497	1	Three	three	CD
cord-023095-4dannjjm	1497	2	of	of	IN
cord-023095-4dannjjm	1497	3	the	the	DT
cord-023095-4dannjjm	1497	4	4	4	CD
cord-023095-4dannjjm	1497	5	farms	farm	NNS
cord-023095-4dannjjm	1497	6	examined	examine	VBN
cord-023095-4dannjjm	1497	7	had	have	VBD
cord-023095-4dannjjm	1497	8	foals	foal	NNS
cord-023095-4dannjjm	1497	9	and	and	CC
cord-023095-4dannjjm	1497	10	mares	mare	NNS
cord-023095-4dannjjm	1497	11	with	with	IN
cord-023095-4dannjjm	1497	12	exposure	exposure	NN
cord-023095-4dannjjm	1497	13	to	to	IN
cord-023095-4dannjjm	1497	14	L.	L.	NNP
cord-023095-4dannjjm	1497	15	intracellularis	intracellularis	NNP
cord-023095-4dannjjm	1497	16	as	as	IN
cord-023095-4dannjjm	1497	17	evidenced	evidence	VBN
cord-023095-4dannjjm	1497	18	by	by	IN
cord-023095-4dannjjm	1497	19	serum	serum	NN
cord-023095-4dannjjm	1497	20	antibodies	antibody	NNS
cord-023095-4dannjjm	1497	21	against	against	IN
cord-023095-4dannjjm	1497	22	the	the	DT
cord-023095-4dannjjm	1497	23	organism	organism	NN
cord-023095-4dannjjm	1497	24	.	.	.
cord-023095-4dannjjm	1498	1	Of	of	IN
cord-023095-4dannjjm	1498	2	the	the	DT
cord-023095-4dannjjm	1498	3	total	total	JJ
cord-023095-4dannjjm	1498	4	population	population	NN
cord-023095-4dannjjm	1498	5	sampled	sample	VBN
cord-023095-4dannjjm	1498	6	,	,	,
cord-023095-4dannjjm	1498	7	6	6	CD
cord-023095-4dannjjm	1498	8	foals	foal	NNS
cord-023095-4dannjjm	1498	9	(	(	-LRB-
cord-023095-4dannjjm	1498	10	8.8	8.8	CD
cord-023095-4dannjjm	1498	11	%	%	NN
cord-023095-4dannjjm	1498	12	)	)	-RRB-
cord-023095-4dannjjm	1498	13	and	and	CC
cord-023095-4dannjjm	1498	14	14	14	CD
cord-023095-4dannjjm	1498	15	mares	mare	NNS
cord-023095-4dannjjm	1498	16	(	(	-LRB-
cord-023095-4dannjjm	1498	17	21.2	21.2	CD
cord-023095-4dannjjm	1498	18	%	%	NN
cord-023095-4dannjjm	1498	19	)	)	-RRB-
cord-023095-4dannjjm	1498	20	had	have	VBD
cord-023095-4dannjjm	1498	21	evidence	evidence	NN
cord-023095-4dannjjm	1498	22	of	of	IN
cord-023095-4dannjjm	1498	23	antibodies	antibody	NNS
cord-023095-4dannjjm	1498	24	to	to	IN
cord-023095-4dannjjm	1498	25	L.	L.	NNP
cord-023095-4dannjjm	1498	26	intracellularis	intracellularis	NNP
cord-023095-4dannjjm	1498	27	based	base	VBN
cord-023095-4dannjjm	1498	28	on	on	IN
cord-023095-4dannjjm	1498	29	serology	serology	NN
cord-023095-4dannjjm	1498	30	.	.	.
cord-023095-4dannjjm	1499	1	Three	three	CD
cord-023095-4dannjjm	1499	2	foals	foal	NNS
cord-023095-4dannjjm	1499	3	(	(	-LRB-
cord-023095-4dannjjm	1499	4	4.4	4.4	CD
cord-023095-4dannjjm	1499	5	%	%	NN
cord-023095-4dannjjm	1499	6	)	)	-RRB-
cord-023095-4dannjjm	1499	7	tested	test	VBD
cord-023095-4dannjjm	1499	8	positive	positive	JJ
cord-023095-4dannjjm	1499	9	for	for	IN
cord-023095-4dannjjm	1499	10	L.	L.	NNP
cord-023095-4dannjjm	1499	11	intracellularis	intracellularis	JJ
cord-023095-4dannjjm	1499	12	organism	organism	NN
cord-023095-4dannjjm	1499	13	by	by	IN
cord-023095-4dannjjm	1499	14	fecal	fecal	JJ
cord-023095-4dannjjm	1499	15	PCR	PCR	NNP
cord-023095-4dannjjm	1499	16	,	,	,
cord-023095-4dannjjm	1499	17	and	and	CC
cord-023095-4dannjjm	1499	18	all	all	DT
cord-023095-4dannjjm	1499	19	of	of	IN
cord-023095-4dannjjm	1499	20	these	these	DT
cord-023095-4dannjjm	1499	21	foals	foal	NNS
cord-023095-4dannjjm	1499	22	were	be	VBD
cord-023095-4dannjjm	1499	23	located	locate	VBN
cord-023095-4dannjjm	1499	24	on	on	IN
cord-023095-4dannjjm	1499	25	farm	farm	NN
cord-023095-4dannjjm	1499	26	C.	C.	NNP
cord-023095-4dannjjm	1499	27	Of	of	IN
cord-023095-4dannjjm	1499	28	these	these	DT
cord-023095-4dannjjm	1499	29	,	,	,
cord-023095-4dannjjm	1499	30	one	one	CD
cord-023095-4dannjjm	1499	31	of	of	IN
cord-023095-4dannjjm	1499	32	the	the	DT
cord-023095-4dannjjm	1499	33	foals	foal	NNS
cord-023095-4dannjjm	1499	34	was	be	VBD
cord-023095-4dannjjm	1499	35	seronegative	seronegative	JJ
cord-023095-4dannjjm	1499	36	,	,	,
cord-023095-4dannjjm	1499	37	while	while	IN
cord-023095-4dannjjm	1499	38	the	the	DT
cord-023095-4dannjjm	1499	39	other	other	JJ
cord-023095-4dannjjm	1499	40	two	two	CD
cord-023095-4dannjjm	1499	41	were	be	VBD
cord-023095-4dannjjm	1499	42	seropositive	seropositive	JJ
cord-023095-4dannjjm	1499	43	.	.	.
cord-023095-4dannjjm	1500	1	Farm	farm	NN
cord-023095-4dannjjm	1500	2	C	C	NNP
cord-023095-4dannjjm	1500	3	also	also	RB
cord-023095-4dannjjm	1500	4	had	have	VBD
cord-023095-4dannjjm	1500	5	the	the	DT
cord-023095-4dannjjm	1500	6	highest	high	JJS
cord-023095-4dannjjm	1500	7	percentage	percentage	NN
cord-023095-4dannjjm	1500	8	of	of	IN
cord-023095-4dannjjm	1500	9	mares	mare	NNS
cord-023095-4dannjjm	1500	10	(	(	-LRB-
cord-023095-4dannjjm	1500	11	28.6	28.6	CD
cord-023095-4dannjjm	1500	12	%	%	NN
cord-023095-4dannjjm	1500	13	)	)	-RRB-
cord-023095-4dannjjm	1500	14	serologically	serologically	RB
cord-023095-4dannjjm	1500	15	positive	positive	JJ
cord-023095-4dannjjm	1500	16	for	for	IN
cord-023095-4dannjjm	1500	17	L.	L.	NNP
cord-023095-4dannjjm	1500	18	intracellularis	intracellularis	NNP
cord-023095-4dannjjm	1500	19	,	,	,
cord-023095-4dannjjm	1500	20	while	while	IN
cord-023095-4dannjjm	1500	21	Farm	Farm	NNP
cord-023095-4dannjjm	1500	22	A	A	NNP
cord-023095-4dannjjm	1500	23	had	have	VBD
cord-023095-4dannjjm	1500	24	the	the	DT
cord-023095-4dannjjm	1500	25	highest	high	JJS
cord-023095-4dannjjm	1500	26	percentage	percentage	NN
cord-023095-4dannjjm	1500	27	of	of	IN
cord-023095-4dannjjm	1500	28	foals	foal	NNS
cord-023095-4dannjjm	1500	29	(	(	-LRB-
cord-023095-4dannjjm	1500	30	14.3	14.3	CD
cord-023095-4dannjjm	1500	31	%	%	NN
cord-023095-4dannjjm	1500	32	)	)	-RRB-
cord-023095-4dannjjm	1500	33	with	with	IN
cord-023095-4dannjjm	1500	34	antibody	antibody	NN
cord-023095-4dannjjm	1500	35	titers	titer	NNS
cord-023095-4dannjjm	1500	36	against	against	IN
cord-023095-4dannjjm	1500	37	L	L	NNP
cord-023095-4dannjjm	1500	38	intracellaris	intracellaris	NNP
cord-023095-4dannjjm	1500	39	.	.	.
cord-023095-4dannjjm	1501	1	Farm	farm	NN
cord-023095-4dannjjm	1501	2	C	C	NNP
cord-023095-4dannjjm	1501	3	also	also	RB
cord-023095-4dannjjm	1501	4	had	have	VBD
cord-023095-4dannjjm	1501	5	the	the	DT
cord-023095-4dannjjm	1501	6	only	only	JJ
cord-023095-4dannjjm	1501	7	pairs	pair	NNS
cord-023095-4dannjjm	1501	8	(	(	-LRB-
cord-023095-4dannjjm	1501	9	n	n	NN
cord-023095-4dannjjm	1501	10	5	5	CD
cord-023095-4dannjjm	1501	11	3	3	CD
cord-023095-4dannjjm	1501	12	)	)	-RRB-
cord-023095-4dannjjm	1501	13	of	of	IN
cord-023095-4dannjjm	1501	14	serologically	serologically	RB
cord-023095-4dannjjm	1501	15	positive	positive	JJ
cord-023095-4dannjjm	1501	16	mares	mare	NNS
cord-023095-4dannjjm	1501	17	with	with	IN
cord-023095-4dannjjm	1501	18	seropositive	seropositive	JJ
cord-023095-4dannjjm	1501	19	foals	foal	NNS
cord-023095-4dannjjm	1501	20	.	.	.
cord-023095-4dannjjm	1502	1	While	while	IN
cord-023095-4dannjjm	1502	2	Farm	Farm	NNP
cord-023095-4dannjjm	1502	3	A	A	NNP
cord-023095-4dannjjm	1502	4	and	and	CC
cord-023095-4dannjjm	1502	5	B	B	NNP
cord-023095-4dannjjm	1502	6	had	have	VBD
cord-023095-4dannjjm	1502	7	seropositive	seropositive	JJ
cord-023095-4dannjjm	1502	8	mares	mare	NNS
cord-023095-4dannjjm	1502	9	and/or	and/or	CC
cord-023095-4dannjjm	1502	10	foals	foal	NNS
cord-023095-4dannjjm	1502	11	,	,	,
cord-023095-4dannjjm	1502	12	none	none	NN
cord-023095-4dannjjm	1502	13	of	of	IN
cord-023095-4dannjjm	1502	14	the	the	DT
cord-023095-4dannjjm	1502	15	foals	foal	NNS
cord-023095-4dannjjm	1502	16	were	be	VBD
cord-023095-4dannjjm	1502	17	positive	positive	JJ
cord-023095-4dannjjm	1502	18	for	for	IN
cord-023095-4dannjjm	1502	19	L.	L.	NNP
cord-023095-4dannjjm	1502	20	intracellularis	intracellularis	JJ
cord-023095-4dannjjm	1502	21	fecal	fecal	JJ
cord-023095-4dannjjm	1502	22	shedding	shed	VBG
cord-023095-4dannjjm	1502	23	by	by	IN
cord-023095-4dannjjm	1502	24	PCR	PCR	NNP
cord-023095-4dannjjm	1502	25	.	.	.
cord-023095-4dannjjm	1503	1	All	all	DT
cord-023095-4dannjjm	1503	2	serum	serum	NN
cord-023095-4dannjjm	1503	3	and	and	CC
cord-023095-4dannjjm	1503	4	fecal	fecal	JJ
cord-023095-4dannjjm	1503	5	samples	sample	NNS
cord-023095-4dannjjm	1503	6	were	be	VBD
cord-023095-4dannjjm	1503	7	negative	negative	JJ
cord-023095-4dannjjm	1503	8	for	for	IN
cord-023095-4dannjjm	1503	9	evidence	evidence	NN
cord-023095-4dannjjm	1503	10	of	of	IN
cord-023095-4dannjjm	1503	11	L.	L.	NNP
cord-023095-4dannjjm	1503	12	intracellaris	intracellaris	NNP
cord-023095-4dannjjm	1503	13	on	on	IN
cord-023095-4dannjjm	1503	14	Farm	Farm	NNP
cord-023095-4dannjjm	1503	15	D.	D.	NNP
cord-023095-4dannjjm	1503	16	Ten	ten	CD
cord-023095-4dannjjm	1503	17	foals	foal	NNS
cord-023095-4dannjjm	1503	18	(	(	-LRB-
cord-023095-4dannjjm	1503	19	14	14	CD
cord-023095-4dannjjm	1503	20	%	%	NN
cord-023095-4dannjjm	1503	21	)	)	-RRB-
cord-023095-4dannjjm	1503	22	had	have	VBD
cord-023095-4dannjjm	1503	23	fecal	fecal	JJ
cord-023095-4dannjjm	1503	24	egg	egg	NN
cord-023095-4dannjjm	1503	25	counts	count	NNS
cord-023095-4dannjjm	1504	1	greater	great	JJR
cord-023095-4dannjjm	1504	2	than	than	IN
cord-023095-4dannjjm	1504	3	200	200	CD
cord-023095-4dannjjm	1504	4	egg	egg	NN
cord-023095-4dannjjm	1504	5	per	per	IN
cord-023095-4dannjjm	1504	6	gram	gram	NN
cord-023095-4dannjjm	1504	7	and	and	CC
cord-023095-4dannjjm	1504	8	2	2	CD
cord-023095-4dannjjm	1504	9	foals	foal	NNS
cord-023095-4dannjjm	1504	10	(	(	-LRB-
cord-023095-4dannjjm	1504	11	3	3	CD
cord-023095-4dannjjm	1504	12	%	%	NN
cord-023095-4dannjjm	1504	13	)	)	-RRB-
cord-023095-4dannjjm	1504	14	were	be	VBD
cord-023095-4dannjjm	1504	15	positive	positive	JJ
cord-023095-4dannjjm	1504	16	for	for	IN
cord-023095-4dannjjm	1504	17	C.	C.	NNP
cord-023095-4dannjjm	1504	18	difficile	difficile	NN
cord-023095-4dannjjm	1504	19	toxin	toxin	NN
cord-023095-4dannjjm	1504	20	.	.	.
cord-023095-4dannjjm	1505	1	This	this	DT
cord-023095-4dannjjm	1505	2	study	study	NN
cord-023095-4dannjjm	1505	3	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	1505	4	evidence	evidence	NN
cord-023095-4dannjjm	1505	5	of	of	IN
cord-023095-4dannjjm	1505	6	natural	natural	JJ
cord-023095-4dannjjm	1505	7	exposure	exposure	NN
cord-023095-4dannjjm	1505	8	to	to	IN
cord-023095-4dannjjm	1505	9	L	L	NNP
cord-023095-4dannjjm	1505	10	intracellularis	intracellularis	NNP
cord-023095-4dannjjm	1505	11	on	on	IN
cord-023095-4dannjjm	1505	12	farms	farm	NNS
cord-023095-4dannjjm	1505	13	both	both	CC
cord-023095-4dannjjm	1505	14	with	with	IN
cord-023095-4dannjjm	1505	15	and	and	CC
cord-023095-4dannjjm	1505	16	without	without	IN
cord-023095-4dannjjm	1505	17	a	a	DT
cord-023095-4dannjjm	1505	18	history	history	NN
cord-023095-4dannjjm	1505	19	of	of	IN
cord-023095-4dannjjm	1505	20	EPE	EPE	NNP
cord-023095-4dannjjm	1505	21	in	in	IN
cord-023095-4dannjjm	1505	22	Louisiana	Louisiana	NNP
cord-023095-4dannjjm	1505	23	.	.	.
cord-023095-4dannjjm	1506	1	Further	further	RB
cord-023095-4dannjjm	1506	2	,	,	,
cord-023095-4dannjjm	1506	3	this	this	DT
cord-023095-4dannjjm	1506	4	study	study	NN
cord-023095-4dannjjm	1506	5	failed	fail	VBD
cord-023095-4dannjjm	1506	6	to	to	TO
cord-023095-4dannjjm	1506	7	establish	establish	VB
cord-023095-4dannjjm	1506	8	a	a	DT
cord-023095-4dannjjm	1506	9	relationship	relationship	NN
cord-023095-4dannjjm	1506	10	between	between	IN
cord-023095-4dannjjm	1506	11	L	L	NNP
cord-023095-4dannjjm	1506	12	intracellularis	intracellularis	NNP
cord-023095-4dannjjm	1506	13	and	and	CC
cord-023095-4dannjjm	1506	14	other	other	JJ
cord-023095-4dannjjm	1506	15	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1506	16	pathogens	pathogen	NNS
cord-023095-4dannjjm	1506	17	.	.	.
cord-023095-4dannjjm	1507	1	The	the	DT
cord-023095-4dannjjm	1507	2	objective	objective	NN
cord-023095-4dannjjm	1507	3	of	of	IN
cord-023095-4dannjjm	1507	4	this	this	DT
cord-023095-4dannjjm	1507	5	study	study	NN
cord-023095-4dannjjm	1507	6	was	be	VBD
cord-023095-4dannjjm	1507	7	to	to	TO
cord-023095-4dannjjm	1507	8	examine	examine	VB
cord-023095-4dannjjm	1507	9	the	the	DT
cord-023095-4dannjjm	1507	10	clinical	clinical	JJ
cord-023095-4dannjjm	1507	11	,	,	,
cord-023095-4dannjjm	1507	12	hematological	hematological	JJ
cord-023095-4dannjjm	1507	13	,	,	,
cord-023095-4dannjjm	1507	14	biochemical	biochemical	JJ
cord-023095-4dannjjm	1507	15	,	,	,
cord-023095-4dannjjm	1507	16	and	and	CC
cord-023095-4dannjjm	1507	17	outcome	outcome	NN
cord-023095-4dannjjm	1507	18	data	datum	NNS
cord-023095-4dannjjm	1507	19	from	from	IN
cord-023095-4dannjjm	1507	20	equids	equid	NNS
cord-023095-4dannjjm	1507	21	infected	infect	VBN
cord-023095-4dannjjm	1507	22	with	with	IN
cord-023095-4dannjjm	1507	23	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	1507	24	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	1507	25	presented	present	VBD
cord-023095-4dannjjm	1507	26	to	to	IN
cord-023095-4dannjjm	1507	27	a	a	DT
cord-023095-4dannjjm	1507	28	primary	primary	JJ
cord-023095-4dannjjm	1507	29	care	care	NN
cord-023095-4dannjjm	1507	30	field	field	NN
cord-023095-4dannjjm	1507	31	setting	set	VBG
cord-023095-4dannjjm	1507	32	in	in	IN
cord-023095-4dannjjm	1507	33	southeastern	southeastern	JJ
cord-023095-4dannjjm	1507	34	Pennsylvania	Pennsylvania	NNP
cord-023095-4dannjjm	1507	35	.	.	.
cord-023095-4dannjjm	1508	1	Computerized	computerized	JJ
cord-023095-4dannjjm	1508	2	medical	medical	JJ
cord-023095-4dannjjm	1508	3	records	record	NNS
cord-023095-4dannjjm	1508	4	from	from	IN
cord-023095-4dannjjm	1508	5	19	19	CD
cord-023095-4dannjjm	1508	6	febrile	febrile	JJ
cord-023095-4dannjjm	1508	7	equids	equid	NNS
cord-023095-4dannjjm	1508	8	with	with	IN
cord-023095-4dannjjm	1508	9	confirmed	confirm	VBN
cord-023095-4dannjjm	1508	10	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	1508	11	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	1508	12	infection	infection	NN
cord-023095-4dannjjm	1508	13	were	be	VBD
cord-023095-4dannjjm	1508	14	reviewed	review	VBN
cord-023095-4dannjjm	1508	15	.	.	.
cord-023095-4dannjjm	1509	1	Confirmation	Confirmation	NNP
cord-023095-4dannjjm	1509	2	of	of	IN
cord-023095-4dannjjm	1509	3	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	1509	4	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	1509	5	was	be	VBD
cord-023095-4dannjjm	1509	6	defined	define	VBN
cord-023095-4dannjjm	1509	7	by	by	IN
cord-023095-4dannjjm	1509	8	the	the	DT
cord-023095-4dannjjm	1509	9	presence	presence	NN
cord-023095-4dannjjm	1509	10	of	of	IN
cord-023095-4dannjjm	1509	11	granular	granular	JJ
cord-023095-4dannjjm	1509	12	inclusion	inclusion	NN
cord-023095-4dannjjm	1509	13	bodies	body	NNS
cord-023095-4dannjjm	1509	14	seen	see	VBN
cord-023095-4dannjjm	1509	15	within	within	IN
cord-023095-4dannjjm	1509	16	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1509	17	or	or	CC
cord-023095-4dannjjm	1509	18	eosinophils	eosinophil	NNS
cord-023095-4dannjjm	1509	19	on	on	IN
cord-023095-4dannjjm	1509	20	microscopic	microscopic	JJ
cord-023095-4dannjjm	1509	21	blood	blood	NN
cord-023095-4dannjjm	1509	22	smear	smear	NN
cord-023095-4dannjjm	1509	23	evaluation	evaluation	NN
cord-023095-4dannjjm	1509	24	and/or	and/or	CC
cord-023095-4dannjjm	1509	25	a	a	DT
cord-023095-4dannjjm	1509	26	positive	positive	JJ
cord-023095-4dannjjm	1509	27	polymerase	polymerase	NN
cord-023095-4dannjjm	1509	28	chain	chain	NN
cord-023095-4dannjjm	1509	29	reaction	reaction	NN
cord-023095-4dannjjm	1509	30	(	(	-LRB-
cord-023095-4dannjjm	1509	31	PCR	PCR	NNP
cord-023095-4dannjjm	1509	32	)	)	-RRB-
cord-023095-4dannjjm	1509	33	for	for	IN
cord-023095-4dannjjm	1509	34	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	1509	35	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	1509	36	.	.	.
cord-023095-4dannjjm	1510	1	18	18	CD
cord-023095-4dannjjm	1510	2	horses	horse	NNS
cord-023095-4dannjjm	1510	3	and	and	CC
cord-023095-4dannjjm	1510	4	1	1	CD
cord-023095-4dannjjm	1510	5	donkey	donkey	NN
cord-023095-4dannjjm	1510	6	presented	present	VBN
cord-023095-4dannjjm	1510	7	with	with	IN
cord-023095-4dannjjm	1510	8	a	a	DT
cord-023095-4dannjjm	1510	9	mean	mean	JJ
cord-023095-4dannjjm	1510	10	fever	fever	NN
cord-023095-4dannjjm	1510	11	of	of	IN
cord-023095-4dannjjm	1510	12	104.41F	104.41f	CD
cord-023095-4dannjjm	1510	13	and	and	CC
cord-023095-4dannjjm	1510	14	mean	mean	VB
cord-023095-4dannjjm	1510	15	fever	fever	NN
cord-023095-4dannjjm	1510	16	duration	duration	NN
cord-023095-4dannjjm	1510	17	of	of	IN
cord-023095-4dannjjm	1510	18	39	39	CD
cord-023095-4dannjjm	1510	19	hours	hour	NNS
cord-023095-4dannjjm	1510	20	.	.	.
cord-023095-4dannjjm	1511	1	The	the	DT
cord-023095-4dannjjm	1511	2	mean	mean	JJ
cord-023095-4dannjjm	1511	3	age	age	NN
cord-023095-4dannjjm	1511	4	at	at	IN
cord-023095-4dannjjm	1511	5	presentation	presentation	NN
cord-023095-4dannjjm	1511	6	was	be	VBD
cord-023095-4dannjjm	1511	7	9.6	9.6	CD
cord-023095-4dannjjm	1511	8	years	year	NNS
cord-023095-4dannjjm	1511	9	and	and	CC
cord-023095-4dannjjm	1511	10	the	the	DT
cord-023095-4dannjjm	1511	11	mean	mean	JJ
cord-023095-4dannjjm	1511	12	pack	pack	NN
cord-023095-4dannjjm	1511	13	cell	cell	NN
cord-023095-4dannjjm	1511	14	volume	volume	NN
cord-023095-4dannjjm	1511	15	was	be	VBD
cord-023095-4dannjjm	1511	16	30.8	30.8	CD
cord-023095-4dannjjm	1511	17	%	%	NN
cord-023095-4dannjjm	1511	18	.	.	.
cord-023095-4dannjjm	1512	1	15/19	15/19	CD
cord-023095-4dannjjm	1512	2	cases	case	NNS
cord-023095-4dannjjm	1512	3	were	be	VBD
cord-023095-4dannjjm	1512	4	diagnosed	diagnose	VBN
cord-023095-4dannjjm	1512	5	in	in	IN
cord-023095-4dannjjm	1512	6	the	the	DT
cord-023095-4dannjjm	1512	7	months	month	NNS
cord-023095-4dannjjm	1512	8	of	of	IN
cord-023095-4dannjjm	1512	9	May	May	NNP
cord-023095-4dannjjm	1512	10	to	to	IN
cord-023095-4dannjjm	1512	11	December	December	NNP
cord-023095-4dannjjm	1512	12	.	.	.
cord-023095-4dannjjm	1513	1	Equids	Equids	NNP
cord-023095-4dannjjm	1513	2	ages	age	NNS
cord-023095-4dannjjm	1513	3	5	5	CD
cord-023095-4dannjjm	1513	4	to	to	TO
cord-023095-4dannjjm	1513	5	15	15	CD
cord-023095-4dannjjm	1513	6	years	year	NNS
cord-023095-4dannjjm	1513	7	had	have	VBD
cord-023095-4dannjjm	1513	8	significantly	significantly	RB
cord-023095-4dannjjm	1513	9	lower	low	JJR
cord-023095-4dannjjm	1513	10	platelet	platelet	NN
cord-023095-4dannjjm	1513	11	counts	count	NNS
cord-023095-4dannjjm	1513	12	.	.	.
cord-023095-4dannjjm	1514	1	16/18	16/18	CD
cord-023095-4dannjjm	1514	2	cases	case	NNS
cord-023095-4dannjjm	1514	3	were	be	VBD
cord-023095-4dannjjm	1514	4	positive	positive	JJ
cord-023095-4dannjjm	1514	5	on	on	IN
cord-023095-4dannjjm	1514	6	blood	blood	NN
cord-023095-4dannjjm	1514	7	smear	smear	NN
cord-023095-4dannjjm	1514	8	for	for	IN
cord-023095-4dannjjm	1514	9	inclusion	inclusion	NN
cord-023095-4dannjjm	1514	10	bodies	body	NNS
cord-023095-4dannjjm	1514	11	and	and	CC
cord-023095-4dannjjm	1514	12	6/6	6/6	CD
cord-023095-4dannjjm	1514	13	cases	case	NNS
cord-023095-4dannjjm	1514	14	were	be	VBD
cord-023095-4dannjjm	1514	15	positive	positive	JJ
cord-023095-4dannjjm	1514	16	for	for	IN
cord-023095-4dannjjm	1514	17	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	1514	18	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	1514	19	on	on	IN
cord-023095-4dannjjm	1514	20	PCR	PCR	NNP
cord-023095-4dannjjm	1514	21	.	.	.
cord-023095-4dannjjm	1515	1	Treatments	treatment	NNS
cord-023095-4dannjjm	1515	2	included	include	VBD
cord-023095-4dannjjm	1515	3	intravenous	intravenous	JJ
cord-023095-4dannjjm	1515	4	oxytetracycline	oxytetracycline	NN
cord-023095-4dannjjm	1515	5	,	,	,
cord-023095-4dannjjm	1515	6	oral	oral	JJ
cord-023095-4dannjjm	1515	7	doxycycline	doxycycline	NN
cord-023095-4dannjjm	1515	8	,	,	,
cord-023095-4dannjjm	1515	9	or	or	CC
cord-023095-4dannjjm	1515	10	both	both	DT
cord-023095-4dannjjm	1515	11	.	.	.
cord-023095-4dannjjm	1516	1	Mean	mean	JJ
cord-023095-4dannjjm	1516	2	treatment	treatment	NN
cord-023095-4dannjjm	1516	3	duration	duration	NN
cord-023095-4dannjjm	1516	4	was	be	VBD
cord-023095-4dannjjm	1516	5	4.8	4.8	CD
cord-023095-4dannjjm	1516	6	days	day	NNS
cord-023095-4dannjjm	1516	7	and	and	CC
cord-023095-4dannjjm	1516	8	mean	mean	VB
cord-023095-4dannjjm	1516	9	treatment	treatment	NN
cord-023095-4dannjjm	1516	10	cost	cost	NN
cord-023095-4dannjjm	1516	11	was	be	VBD
cord-023095-4dannjjm	1516	12	$	$	$
cord-023095-4dannjjm	1516	13	621	621	CD
cord-023095-4dannjjm	1516	14	.	.	.
cord-023095-4dannjjm	1517	1	17/19	17/19	CD
cord-023095-4dannjjm	1517	2	cases	case	NNS
cord-023095-4dannjjm	1517	3	were	be	VBD
cord-023095-4dannjjm	1517	4	normothermic	normothermic	JJ
cord-023095-4dannjjm	1517	5	within	within	IN
cord-023095-4dannjjm	1517	6	48	48	CD
cord-023095-4dannjjm	1517	7	hours	hour	NNS
cord-023095-4dannjjm	1517	8	.	.	.
cord-023095-4dannjjm	1518	1	The	the	DT
cord-023095-4dannjjm	1518	2	treatment	treatment	NN
cord-023095-4dannjjm	1518	3	used	use	VBN
cord-023095-4dannjjm	1518	4	in	in	IN
cord-023095-4dannjjm	1518	5	the	the	DT
cord-023095-4dannjjm	1518	6	two	two	CD
cord-023095-4dannjjm	1518	7	remaining	remain	VBG
cord-023095-4dannjjm	1518	8	cases	case	NNS
cord-023095-4dannjjm	1518	9	was	be	VBD
cord-023095-4dannjjm	1518	10	changed	change	VBN
cord-023095-4dannjjm	1518	11	from	from	IN
cord-023095-4dannjjm	1518	12	oral	oral	JJ
cord-023095-4dannjjm	1518	13	doxycycline	doxycycline	NN
cord-023095-4dannjjm	1518	14	to	to	IN
cord-023095-4dannjjm	1518	15	intravenous	intravenous	JJ
cord-023095-4dannjjm	1518	16	oxtetracycline	oxtetracycline	NN
cord-023095-4dannjjm	1518	17	and	and	CC
cord-023095-4dannjjm	1518	18	was	be	VBD
cord-023095-4dannjjm	1518	19	successful	successful	JJ
cord-023095-4dannjjm	1518	20	.	.	.
cord-023095-4dannjjm	1519	1	This	this	DT
cord-023095-4dannjjm	1519	2	is	be	VBZ
cord-023095-4dannjjm	1519	3	the	the	DT
cord-023095-4dannjjm	1519	4	first	first	JJ
cord-023095-4dannjjm	1519	5	case	case	NN
cord-023095-4dannjjm	1519	6	series	series	NN
cord-023095-4dannjjm	1519	7	of	of	IN
cord-023095-4dannjjm	1519	8	equine	equine	JJ
cord-023095-4dannjjm	1519	9	granulocytic	granulocytic	JJ
cord-023095-4dannjjm	1519	10	anaplasmosis	anaplasmosis	NN
cord-023095-4dannjjm	1519	11	in	in	IN
cord-023095-4dannjjm	1519	12	the	the	DT
cord-023095-4dannjjm	1519	13	mid	mid	JJ
cord-023095-4dannjjm	1519	14	-	-	JJ
cord-023095-4dannjjm	1519	15	Atlantic	atlantic	JJ
cord-023095-4dannjjm	1519	16	states	state	NNS
cord-023095-4dannjjm	1519	17	.	.	.
cord-023095-4dannjjm	1520	1	All	all	DT
cord-023095-4dannjjm	1520	2	cases	case	NNS
cord-023095-4dannjjm	1520	3	were	be	VBD
cord-023095-4dannjjm	1520	4	examined	examine	VBN
cord-023095-4dannjjm	1520	5	and	and	CC
cord-023095-4dannjjm	1520	6	treated	treat	VBN
cord-023095-4dannjjm	1520	7	in	in	IN
cord-023095-4dannjjm	1520	8	the	the	DT
cord-023095-4dannjjm	1520	9	field	field	NN
cord-023095-4dannjjm	1520	10	.	.	.
cord-023095-4dannjjm	1521	1	In	in	IN
cord-023095-4dannjjm	1521	2	order	order	NN
cord-023095-4dannjjm	1521	3	to	to	TO
cord-023095-4dannjjm	1521	4	make	make	VB
cord-023095-4dannjjm	1521	5	a	a	DT
cord-023095-4dannjjm	1521	6	definitive	definitive	JJ
cord-023095-4dannjjm	1521	7	diagnosis	diagnosis	NN
cord-023095-4dannjjm	1521	8	,	,	,
cord-023095-4dannjjm	1521	9	some	some	DT
cord-023095-4dannjjm	1521	10	cases	case	NNS
cord-023095-4dannjjm	1521	11	required	require	VBD
cord-023095-4dannjjm	1521	12	PCR	PCR	NNP
cord-023095-4dannjjm	1521	13	.	.	.
cord-023095-4dannjjm	1522	1	Treatment	treatment	NN
cord-023095-4dannjjm	1522	2	failures	failure	NNS
cord-023095-4dannjjm	1522	3	were	be	VBD
cord-023095-4dannjjm	1522	4	documented	document	VBN
cord-023095-4dannjjm	1522	5	with	with	IN
cord-023095-4dannjjm	1522	6	the	the	DT
cord-023095-4dannjjm	1522	7	use	use	NN
cord-023095-4dannjjm	1522	8	of	of	IN
cord-023095-4dannjjm	1522	9	oral	oral	JJ
cord-023095-4dannjjm	1522	10	doxycycline	doxycycline	NN
cord-023095-4dannjjm	1522	11	alone	alone	JJ
cord-023095-4dannjjm	1522	12	.	.	.
cord-023095-4dannjjm	1523	1	100	100	CD
cord-023095-4dannjjm	1523	2	%	%	NN
cord-023095-4dannjjm	1523	3	of	of	IN
cord-023095-4dannjjm	1523	4	the	the	DT
cord-023095-4dannjjm	1523	5	cases	case	NNS
cord-023095-4dannjjm	1523	6	survived	survive	VBD
cord-023095-4dannjjm	1523	7	.	.	.
cord-023095-4dannjjm	1524	1	A	a	DT
cord-023095-4dannjjm	1524	2	high	high	JJ
cord-023095-4dannjjm	1524	3	incidence	incidence	NN
cord-023095-4dannjjm	1524	4	of	of	IN
cord-023095-4dannjjm	1524	5	clinical	clinical	JJ
cord-023095-4dannjjm	1524	6	and	and	CC
cord-023095-4dannjjm	1524	7	possibly	possibly	RB
cord-023095-4dannjjm	1524	8	genetic	genetic	JJ
cord-023095-4dannjjm	1524	9	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1524	10	has	have	VBZ
cord-023095-4dannjjm	1524	11	been	be	VBN
cord-023095-4dannjjm	1524	12	reported	report	VBN
cord-023095-4dannjjm	1524	13	amongst	amongst	IN
cord-023095-4dannjjm	1524	14	Friesian	friesian	JJ
cord-023095-4dannjjm	1524	15	horses	horse	NNS
cord-023095-4dannjjm	1524	16	including	include	VBG
cord-023095-4dannjjm	1524	17	dwarfism	dwarfism	NN
cord-023095-4dannjjm	1524	18	,	,	,
cord-023095-4dannjjm	1524	19	hydrocephalus	hydrocephalus	NN
cord-023095-4dannjjm	1524	20	,	,	,
cord-023095-4dannjjm	1524	21	dissecting	dissect	VBG
cord-023095-4dannjjm	1524	22	aortic	aortic	JJ
cord-023095-4dannjjm	1524	23	aneurism	aneurism	NN
cord-023095-4dannjjm	1524	24	and	and	CC
cord-023095-4dannjjm	1524	25	esophageal	esophageal	JJ
cord-023095-4dannjjm	1524	26	dysfunction	dysfunction	NN
cord-023095-4dannjjm	1524	27	.	.	.
cord-023095-4dannjjm	1525	1	The	the	DT
cord-023095-4dannjjm	1525	2	purpose	purpose	NN
cord-023095-4dannjjm	1525	3	of	of	IN
cord-023095-4dannjjm	1525	4	the	the	DT
cord-023095-4dannjjm	1525	5	current	current	JJ
cord-023095-4dannjjm	1525	6	study	study	NN
cord-023095-4dannjjm	1525	7	was	be	VBD
cord-023095-4dannjjm	1525	8	to	to	TO
cord-023095-4dannjjm	1525	9	develop	develop	VB
cord-023095-4dannjjm	1525	10	a	a	DT
cord-023095-4dannjjm	1525	11	new	new	JJ
cord-023095-4dannjjm	1525	12	electromyography	electromyography	NN
cord-023095-4dannjjm	1525	13	(	(	-LRB-
cord-023095-4dannjjm	1525	14	EMG	EMG	NNP
cord-023095-4dannjjm	1525	15	)	)	-RRB-
cord-023095-4dannjjm	1525	16	method	method	NN
cord-023095-4dannjjm	1525	17	to	to	TO
cord-023095-4dannjjm	1525	18	assess	assess	VB
cord-023095-4dannjjm	1525	19	neurophysiological	neurophysiological	JJ
cord-023095-4dannjjm	1525	20	function	function	NN
cord-023095-4dannjjm	1525	21	of	of	IN
cord-023095-4dannjjm	1525	22	the	the	DT
cord-023095-4dannjjm	1525	23	esophagus	esophagus	NN
cord-023095-4dannjjm	1525	24	especially	especially	RB
cord-023095-4dannjjm	1525	25	for	for	IN
cord-023095-4dannjjm	1525	26	Friesian	friesian	JJ
cord-023095-4dannjjm	1525	27	horses	horse	NNS
cord-023095-4dannjjm	1525	28	.	.	.
cord-023095-4dannjjm	1526	1	Five	five	CD
cord-023095-4dannjjm	1526	2	Friesian	friesian	JJ
cord-023095-4dannjjm	1526	3	horses	horse	NNS
cord-023095-4dannjjm	1526	4	with	with	IN
cord-023095-4dannjjm	1526	5	esophageal	esophageal	JJ
cord-023095-4dannjjm	1526	6	dysfunction	dysfunction	NN
cord-023095-4dannjjm	1526	7	were	be	VBD
cord-023095-4dannjjm	1526	8	included	include	VBN
cord-023095-4dannjjm	1526	9	(	(	-LRB-
cord-023095-4dannjjm	1526	10	ranging	range	VBG
cord-023095-4dannjjm	1526	11	in	in	IN
cord-023095-4dannjjm	1526	12	age	age	NN
cord-023095-4dannjjm	1526	13	from	from	IN
cord-023095-4dannjjm	1526	14	0.5	0.5	CD
cord-023095-4dannjjm	1526	15	-	-	HYPH
cord-023095-4dannjjm	1526	16	24	24	CD
cord-023095-4dannjjm	1526	17	years	year	NNS
cord-023095-4dannjjm	1526	18	and	and	CC
cord-023095-4dannjjm	1526	19	comprising	comprise	VBG
cord-023095-4dannjjm	1526	20	4	4	CD
cord-023095-4dannjjm	1526	21	mares	mare	NNS
cord-023095-4dannjjm	1526	22	and	and	CC
cord-023095-4dannjjm	1526	23	a	a	DT
cord-023095-4dannjjm	1526	24	stallion	stallion	NN
cord-023095-4dannjjm	1526	25	)	)	-RRB-
cord-023095-4dannjjm	1526	26	and	and	CC
cord-023095-4dannjjm	1526	27	two	two	CD
cord-023095-4dannjjm	1526	28	Friesian	friesian	JJ
cord-023095-4dannjjm	1526	29	control	control	NN
cord-023095-4dannjjm	1526	30	horses	horse	NNS
cord-023095-4dannjjm	1526	31	(	(	-LRB-
cord-023095-4dannjjm	1526	32	a	a	DT
cord-023095-4dannjjm	1526	33	10-and	10-and	CD
cord-023095-4dannjjm	1526	34	12-year	12-year	JJ
cord-023095-4dannjjm	1526	35	-	-	HYPH
cord-023095-4dannjjm	1526	36	old	old	JJ
cord-023095-4dannjjm	1526	37	gelding	gelding	NN
cord-023095-4dannjjm	1526	38	)	)	-RRB-
cord-023095-4dannjjm	1526	39	.	.	.
cord-023095-4dannjjm	1527	1	All	all	DT
cord-023095-4dannjjm	1527	2	five	five	CD
cord-023095-4dannjjm	1527	3	horses	horse	NNS
cord-023095-4dannjjm	1527	4	with	with	IN
cord-023095-4dannjjm	1527	5	esophageal	esophageal	JJ
cord-023095-4dannjjm	1527	6	dysfunction	dysfunction	NN
cord-023095-4dannjjm	1527	7	had	have	VBD
cord-023095-4dannjjm	1527	8	a	a	DT
cord-023095-4dannjjm	1527	9	history	history	NN
cord-023095-4dannjjm	1527	10	of	of	IN
cord-023095-4dannjjm	1527	11	recurrent	recurrent	JJ
cord-023095-4dannjjm	1527	12	esophageal	esophageal	JJ
cord-023095-4dannjjm	1527	13	obstruction	obstruction	NN
cord-023095-4dannjjm	1527	14	and	and	CC
cord-023095-4dannjjm	1527	15	were	be	VBD
cord-023095-4dannjjm	1527	16	examined	examine	VBN
cord-023095-4dannjjm	1527	17	histopathologically	histopathologically	RB
cord-023095-4dannjjm	1527	18	post	post	JJ
cord-023095-4dannjjm	1527	19	-	-	NN
cord-023095-4dannjjm	1527	20	mortem	mortem	JJ
cord-023095-4dannjjm	1527	21	.	.	.
cord-023095-4dannjjm	1528	1	Barium	barium	NN
cord-023095-4dannjjm	1528	2	contrast	contrast	NN
cord-023095-4dannjjm	1528	3	radiography	radiography	NN
cord-023095-4dannjjm	1528	4	was	be	VBD
cord-023095-4dannjjm	1528	5	used	use	VBN
cord-023095-4dannjjm	1528	6	as	as	IN
cord-023095-4dannjjm	1528	7	the	the	DT
cord-023095-4dannjjm	1528	8	gold	gold	NN
cord-023095-4dannjjm	1528	9	standard	standard	NN
cord-023095-4dannjjm	1528	10	to	to	TO
cord-023095-4dannjjm	1528	11	distinguish	distinguish	VB
cord-023095-4dannjjm	1528	12	the	the	DT
cord-023095-4dannjjm	1528	13	diseased	disease	VBN
cord-023095-4dannjjm	1528	14	from	from	IN
cord-023095-4dannjjm	1528	15	the	the	DT
cord-023095-4dannjjm	1528	16	control	control	NN
cord-023095-4dannjjm	1528	17	horses	horse	NNS
cord-023095-4dannjjm	1528	18	.	.	.
cord-023095-4dannjjm	1529	1	An	an	DT
cord-023095-4dannjjm	1529	2	endoscopically	endoscopically	RB
cord-023095-4dannjjm	1529	3	-	-	HYPH
cord-023095-4dannjjm	1529	4	guided	guide	VBN
cord-023095-4dannjjm	1529	5	percutaneous	percutaneous	JJ
cord-023095-4dannjjm	1529	6	needle	needle	NN
cord-023095-4dannjjm	1529	7	EMG	EMG	NNP
cord-023095-4dannjjm	1529	8	procedure	procedure	NN
cord-023095-4dannjjm	1529	9	(	(	-LRB-
cord-023095-4dannjjm	1529	10	Viking	Viking	NNP
cord-023095-4dannjjm	1529	11	Quest	Quest	NNP
cord-023095-4dannjjm	1529	12	r	r	NN
cord-023095-4dannjjm	1529	13	;	;	:
cord-023095-4dannjjm	1529	14	software	software	NN
cord-023095-4dannjjm	1529	15	version	version	NN
cord-023095-4dannjjm	1529	16	11.0	11.0	CD
cord-023095-4dannjjm	1529	17	)	)	-RRB-
cord-023095-4dannjjm	1529	18	was	be	VBD
cord-023095-4dannjjm	1529	19	performed	perform	VBN
cord-023095-4dannjjm	1529	20	just	just	RB
cord-023095-4dannjjm	1529	21	caudal	caudal	JJ
cord-023095-4dannjjm	1529	22	to	to	IN
cord-023095-4dannjjm	1529	23	the	the	DT
cord-023095-4dannjjm	1529	24	larynx	larynx	NN
cord-023095-4dannjjm	1529	25	and	and	CC
cord-023095-4dannjjm	1529	26	just	just	RB
cord-023095-4dannjjm	1529	27	cranial	cranial	JJ
cord-023095-4dannjjm	1529	28	to	to	IN
cord-023095-4dannjjm	1529	29	the	the	DT
cord-023095-4dannjjm	1529	30	thoracic	thoracic	JJ
cord-023095-4dannjjm	1529	31	inlet	inlet	NN
cord-023095-4dannjjm	1529	32	(	(	-LRB-
cord-023095-4dannjjm	1529	33	to	to	TO
cord-023095-4dannjjm	1529	34	monitor	monitor	VB
cord-023095-4dannjjm	1529	35	striated	striated	JJ
cord-023095-4dannjjm	1529	36	and	and	CC
cord-023095-4dannjjm	1529	37	smooth	smooth	JJ
cord-023095-4dannjjm	1529	38	muscle	muscle	NN
cord-023095-4dannjjm	1529	39	,	,	,
cord-023095-4dannjjm	1529	40	respectively	respectively	RB
cord-023095-4dannjjm	1529	41	)	)	-RRB-
cord-023095-4dannjjm	1529	42	to	to	TO
cord-023095-4dannjjm	1529	43	visualize	visualize	VB
cord-023095-4dannjjm	1529	44	esophageal	esophageal	JJ
cord-023095-4dannjjm	1529	45	motility	motility	NN
cord-023095-4dannjjm	1529	46	.	.	.
cord-023095-4dannjjm	1530	1	Esophageal	esophageal	JJ
cord-023095-4dannjjm	1530	2	contractility	contractility	NN
cord-023095-4dannjjm	1530	3	in	in	IN
cord-023095-4dannjjm	1530	4	both	both	DT
cord-023095-4dannjjm	1530	5	control	control	NN
cord-023095-4dannjjm	1530	6	horses	horse	NNS
cord-023095-4dannjjm	1530	7	was	be	VBD
cord-023095-4dannjjm	1530	8	predominantly	predominantly	RB
cord-023095-4dannjjm	1530	9	reflected	reflect	VBN
cord-023095-4dannjjm	1530	10	by	by	IN
cord-023095-4dannjjm	1530	11	interference	interference	NN
cord-023095-4dannjjm	1530	12	patterns	pattern	NNS
cord-023095-4dannjjm	1530	13	associated	associate	VBN
cord-023095-4dannjjm	1530	14	with	with	IN
cord-023095-4dannjjm	1530	15	longer	long	JJR
cord-023095-4dannjjm	1530	16	duration	duration	NN
cord-023095-4dannjjm	1530	17	and	and	CC
cord-023095-4dannjjm	1530	18	lower	low	JJR
cord-023095-4dannjjm	1530	19	amplitude	amplitude	NN
cord-023095-4dannjjm	1530	20	in	in	IN
cord-023095-4dannjjm	1530	21	smooth	smooth	JJ
cord-023095-4dannjjm	1530	22	muscle	muscle	NN
cord-023095-4dannjjm	1530	23	compared	compare	VBN
cord-023095-4dannjjm	1530	24	to	to	IN
cord-023095-4dannjjm	1530	25	striated	striated	JJ
cord-023095-4dannjjm	1530	26	muscle	muscle	NN
cord-023095-4dannjjm	1530	27	.	.	.
cord-023095-4dannjjm	1531	1	Mean	mean	JJ
cord-023095-4dannjjm	1531	2	(	(	-LRB-
cord-023095-4dannjjm	1531	3	AE	AE	NNP
cord-023095-4dannjjm	1531	4	SD	SD	NNP
cord-023095-4dannjjm	1531	5	)	)	-RRB-
cord-023095-4dannjjm	1531	6	values	value	NNS
cord-023095-4dannjjm	1531	7	were	be	VBD
cord-023095-4dannjjm	1531	8	35.1	35.1	CD
cord-023095-4dannjjm	1531	9	AE	AE	NNP
cord-023095-4dannjjm	1531	10	19.4	19.4	CD
cord-023095-4dannjjm	1531	11	ms	ms	NNP
cord-023095-4dannjjm	1531	12	and	and	CC
cord-023095-4dannjjm	1531	13	167.7	167.7	CD
cord-023095-4dannjjm	1531	14	AE	AE	NNP
cord-023095-4dannjjm	1531	15	96.7	96.7	CD
cord-023095-4dannjjm	1531	16	mV	mV	NNP
cord-023095-4dannjjm	1531	17	(	(	-LRB-
cord-023095-4dannjjm	1531	18	n	n	NN
cord-023095-4dannjjm	1531	19	5	5	CD
cord-023095-4dannjjm	1531	20	19	19	CD
cord-023095-4dannjjm	1531	21	readings	reading	NNS
cord-023095-4dannjjm	1531	22	)	)	-RRB-
cord-023095-4dannjjm	1531	23	and	and	CC
cord-023095-4dannjjm	1531	24	10.8	10.8	CD
cord-023095-4dannjjm	1531	25	AE	AE	NNP
cord-023095-4dannjjm	1531	26	14.3	14.3	CD
cord-023095-4dannjjm	1531	27	ms	ms	NNP
cord-023095-4dannjjm	1531	28	and	and	CC
cord-023095-4dannjjm	1531	29	305.8	305.8	CD
cord-023095-4dannjjm	1531	30	AE	AE	NNP
cord-023095-4dannjjm	1532	1	233.7	233.7	NNP
cord-023095-4dannjjm	1532	2	mV	mV	NNP
cord-023095-4dannjjm	1532	3	(	(	-LRB-
cord-023095-4dannjjm	1532	4	n	n	NN
cord-023095-4dannjjm	1532	5	5	5	CD
cord-023095-4dannjjm	1532	6	24	24	CD
cord-023095-4dannjjm	1532	7	readings	reading	NNS
cord-023095-4dannjjm	1532	8	)	)	-RRB-
cord-023095-4dannjjm	1532	9	,	,	,
cord-023095-4dannjjm	1532	10	respectively	respectively	RB
cord-023095-4dannjjm	1532	11	.	.	.
cord-023095-4dannjjm	1533	1	In	in	IN
cord-023095-4dannjjm	1533	2	diseased	diseased	JJ
cord-023095-4dannjjm	1533	3	horses	horse	NNS
cord-023095-4dannjjm	1533	4	,	,	,
cord-023095-4dannjjm	1533	5	aperistalsis	aperistalsis	NN
cord-023095-4dannjjm	1533	6	in	in	IN
cord-023095-4dannjjm	1533	7	smooth	smooth	JJ
cord-023095-4dannjjm	1533	8	muscle	muscle	NN
cord-023095-4dannjjm	1533	9	was	be	VBD
cord-023095-4dannjjm	1533	10	the	the	DT
cord-023095-4dannjjm	1533	11	most	most	RBS
cord-023095-4dannjjm	1533	12	remarkable	remarkable	JJ
cord-023095-4dannjjm	1533	13	finding	finding	NN
cord-023095-4dannjjm	1533	14	suggesting	suggest	VBG
cord-023095-4dannjjm	1533	15	a	a	DT
cord-023095-4dannjjm	1533	16	loss	loss	NN
cord-023095-4dannjjm	1533	17	of	of	IN
cord-023095-4dannjjm	1533	18	inhibitory	inhibitory	JJ
cord-023095-4dannjjm	1533	19	neurogenic	neurogenic	JJ
cord-023095-4dannjjm	1533	20	input	input	NN
cord-023095-4dannjjm	1533	21	resulting	result	VBG
cord-023095-4dannjjm	1533	22	in	in	IN
cord-023095-4dannjjm	1533	23	aperistalsis	aperistalsis	NN
cord-023095-4dannjjm	1533	24	and	and	CC
cord-023095-4dannjjm	1533	25	thus	thus	RB
cord-023095-4dannjjm	1533	26	esophageal	esophageal	JJ
cord-023095-4dannjjm	1533	27	dysfunction	dysfunction	NN
cord-023095-4dannjjm	1533	28	.	.	.
cord-023095-4dannjjm	1534	1	Preliminary	preliminary	JJ
cord-023095-4dannjjm	1534	2	findings	finding	NNS
cord-023095-4dannjjm	1534	3	suggest	suggest	VBP
cord-023095-4dannjjm	1534	4	that	that	IN
cord-023095-4dannjjm	1534	5	endoscopically	endoscopically	RB
cord-023095-4dannjjm	1534	6	-	-	HYPH
cord-023095-4dannjjm	1534	7	guided	guide	VBN
cord-023095-4dannjjm	1534	8	percutaneous	percutaneous	JJ
cord-023095-4dannjjm	1534	9	needle	needle	NN
cord-023095-4dannjjm	1534	10	EMG	EMG	NNP
cord-023095-4dannjjm	1534	11	might	may	MD
cord-023095-4dannjjm	1534	12	become	become	VB
cord-023095-4dannjjm	1534	13	a	a	DT
cord-023095-4dannjjm	1534	14	valuable	valuable	JJ
cord-023095-4dannjjm	1534	15	method	method	NN
cord-023095-4dannjjm	1534	16	in	in	IN
cord-023095-4dannjjm	1534	17	elucidating	elucidate	VBG
cord-023095-4dannjjm	1534	18	the	the	DT
cord-023095-4dannjjm	1534	19	pathophysiology	pathophysiology	NN
cord-023095-4dannjjm	1534	20	of	of	IN
cord-023095-4dannjjm	1534	21	dysfunction	dysfunction	NN
cord-023095-4dannjjm	1534	22	of	of	IN
cord-023095-4dannjjm	1534	23	esophageal	esophageal	JJ
cord-023095-4dannjjm	1534	24	motility	motility	NN
cord-023095-4dannjjm	1534	25	especially	especially	RB
cord-023095-4dannjjm	1534	26	in	in	IN
cord-023095-4dannjjm	1534	27	Friesian	friesian	JJ
cord-023095-4dannjjm	1534	28	horses	horse	NNS
cord-023095-4dannjjm	1534	29	.	.	.
cord-023095-4dannjjm	1535	1	Lymphoma	lymphoma	NN
cord-023095-4dannjjm	1535	2	affects	affect	VBZ
cord-023095-4dannjjm	1535	3	horses	horse	NNS
cord-023095-4dannjjm	1535	4	of	of	IN
cord-023095-4dannjjm	1535	5	all	all	DT
cord-023095-4dannjjm	1535	6	ages	age	NNS
cord-023095-4dannjjm	1535	7	.	.	.
cord-023095-4dannjjm	1536	1	Unlike	unlike	IN
cord-023095-4dannjjm	1536	2	in	in	IN
cord-023095-4dannjjm	1536	3	humans	human	NNS
cord-023095-4dannjjm	1536	4	,	,	,
cord-023095-4dannjjm	1536	5	no	no	DT
cord-023095-4dannjjm	1536	6	etiologic	etiologic	JJ
cord-023095-4dannjjm	1536	7	agent	agent	NN
cord-023095-4dannjjm	1536	8	has	have	VBZ
cord-023095-4dannjjm	1536	9	been	be	VBN
cord-023095-4dannjjm	1536	10	discovered	discover	VBN
cord-023095-4dannjjm	1536	11	.	.	.
cord-023095-4dannjjm	1537	1	A	a	DT
cord-023095-4dannjjm	1537	2	9	9	CD
cord-023095-4dannjjm	1537	3	year	year	NN
cord-023095-4dannjjm	1537	4	old	old	JJ
cord-023095-4dannjjm	1537	5	Thoroughbred	Thoroughbred	NNP
cord-023095-4dannjjm	1537	6	/	/	SYM
cord-023095-4dannjjm	1537	7	Warmblood	Warmblood	NNP
cord-023095-4dannjjm	1537	8	cross	cross	NN
cord-023095-4dannjjm	1537	9	mare	mare	NN
cord-023095-4dannjjm	1537	10	presented	present	VBN
cord-023095-4dannjjm	1537	11	with	with	IN
cord-023095-4dannjjm	1537	12	signs	sign	NNS
cord-023095-4dannjjm	1537	13	of	of	IN
cord-023095-4dannjjm	1537	14	upper	upper	JJ
cord-023095-4dannjjm	1537	15	and	and	CC
cord-023095-4dannjjm	1537	16	lower	low	JJR
cord-023095-4dannjjm	1537	17	respiratory	respiratory	JJ
cord-023095-4dannjjm	1537	18	disease	disease	NN
cord-023095-4dannjjm	1537	19	and	and	CC
cord-023095-4dannjjm	1537	20	was	be	VBD
cord-023095-4dannjjm	1537	21	subsequently	subsequently	RB
cord-023095-4dannjjm	1537	22	diagnosed	diagnose	VBN
cord-023095-4dannjjm	1537	23	with	with	IN
cord-023095-4dannjjm	1537	24	lymphoma	lymphoma	NN
cord-023095-4dannjjm	1537	25	and	and	CC
cord-023095-4dannjjm	1537	26	equine	equine	JJ
cord-023095-4dannjjm	1537	27	multinodular	multinodular	JJ
cord-023095-4dannjjm	1537	28	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	1537	29	fibrosis	fibrosis	NN
cord-023095-4dannjjm	1537	30	(	(	-LRB-
cord-023095-4dannjjm	1537	31	EMPF	EMPF	NNP
cord-023095-4dannjjm	1537	32	)	)	-RRB-
cord-023095-4dannjjm	1537	33	and	and	CC
cord-023095-4dannjjm	1537	34	was	be	VBD
cord-023095-4dannjjm	1537	35	positive	positive	JJ
cord-023095-4dannjjm	1537	36	for	for	IN
cord-023095-4dannjjm	1537	37	equine	equine	JJ
cord-023095-4dannjjm	1537	38	herpes	herpes	NN
cord-023095-4dannjjm	1537	39	virus	virus	NN
cord-023095-4dannjjm	1537	40	5	5	CD
cord-023095-4dannjjm	1537	41	(	(	-LRB-
cord-023095-4dannjjm	1537	42	EHV-5	EHV-5	NNP
cord-023095-4dannjjm	1537	43	)	)	-RRB-
cord-023095-4dannjjm	1537	44	in	in	IN
cord-023095-4dannjjm	1537	45	both	both	CC
cord-023095-4dannjjm	1537	46	the	the	DT
cord-023095-4dannjjm	1537	47	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	1537	48	tissue	tissue	NN
cord-023095-4dannjjm	1537	49	and	and	CC
cord-023095-4dannjjm	1537	50	the	the	DT
cord-023095-4dannjjm	1537	51	lymph	lymph	NN
cord-023095-4dannjjm	1537	52	nodes	node	NNS
cord-023095-4dannjjm	1537	53	.	.	.
cord-023095-4dannjjm	1538	1	Retrospective	retrospective	JJ
cord-023095-4dannjjm	1538	2	polymerase	polymerase	NN
cord-023095-4dannjjm	1538	3	chain	chain	NN
cord-023095-4dannjjm	1538	4	reaction	reaction	NN
cord-023095-4dannjjm	1538	5	(	(	-LRB-
cord-023095-4dannjjm	1538	6	PCR	PCR	NNP
cord-023095-4dannjjm	1538	7	)	)	-RRB-
cord-023095-4dannjjm	1538	8	testing	testing	NN
cord-023095-4dannjjm	1538	9	of	of	IN
cord-023095-4dannjjm	1538	10	six	six	CD
cord-023095-4dannjjm	1538	11	lymphoma	lymphoma	NN
cord-023095-4dannjjm	1538	12	cases	case	NNS
cord-023095-4dannjjm	1538	13	found	find	VBD
cord-023095-4dannjjm	1538	14	that	that	IN
cord-023095-4dannjjm	1538	15	5	5	CD
cord-023095-4dannjjm	1538	16	of	of	IN
cord-023095-4dannjjm	1538	17	6	6	CD
cord-023095-4dannjjm	1538	18	of	of	IN
cord-023095-4dannjjm	1538	19	the	the	DT
cord-023095-4dannjjm	1538	20	cases	case	NNS
cord-023095-4dannjjm	1538	21	were	be	VBD
cord-023095-4dannjjm	1538	22	positive	positive	JJ
cord-023095-4dannjjm	1538	23	on	on	IN
cord-023095-4dannjjm	1538	24	PCR	PCR	NNP
cord-023095-4dannjjm	1538	25	for	for	IN
cord-023095-4dannjjm	1538	26	EHV-5	EHV-5	NNP
cord-023095-4dannjjm	1538	27	(	(	-LRB-
cord-023095-4dannjjm	1538	28	83.3	83.3	CD
cord-023095-4dannjjm	1538	29	%	%	NN
cord-023095-4dannjjm	1538	30	,	,	,
cord-023095-4dannjjm	1538	31	p	p	NN
cord-023095-4dannjjm	1538	32	5	5	CD
cord-023095-4dannjjm	1538	33	0.0045	0.0045	CD
cord-023095-4dannjjm	1538	34	,	,	,
cord-023095-4dannjjm	1538	35	RR	RR	NNP
cord-023095-4dannjjm	1538	36	5.55	5.55	CD
cord-023095-4dannjjm	1538	37	)	)	-RRB-
cord-023095-4dannjjm	1538	38	.	.	.
cord-023095-4dannjjm	1539	1	Electron	electron	NN
cord-023095-4dannjjm	1539	2	microscopy	microscopy	NN
cord-023095-4dannjjm	1539	3	was	be	VBD
cord-023095-4dannjjm	1539	4	performed	perform	VBN
cord-023095-4dannjjm	1539	5	on	on	IN
cord-023095-4dannjjm	1539	6	one	one	CD
cord-023095-4dannjjm	1539	7	sample	sample	NN
cord-023095-4dannjjm	1539	8	and	and	CC
cord-023095-4dannjjm	1539	9	herpes	herpes	NN
cord-023095-4dannjjm	1539	10	virus	virus	NN
cord-023095-4dannjjm	1539	11	particles	particle	NNS
cord-023095-4dannjjm	1539	12	were	be	VBD
cord-023095-4dannjjm	1539	13	identified	identify	VBN
cord-023095-4dannjjm	1539	14	.	.	.
cord-023095-4dannjjm	1540	1	Of	of	IN
cord-023095-4dannjjm	1540	2	the	the	DT
cord-023095-4dannjjm	1540	3	samples	sample	NNS
cord-023095-4dannjjm	1540	4	in	in	IN
cord-023095-4dannjjm	1540	5	which	which	WDT
cord-023095-4dannjjm	1540	6	immunohistochemistry	immunohistochemistry	NN
cord-023095-4dannjjm	1540	7	was	be	VBD
cord-023095-4dannjjm	1540	8	performed	perform	VBN
cord-023095-4dannjjm	1540	9	(	(	-LRB-
cord-023095-4dannjjm	1540	10	3	3	CD
cord-023095-4dannjjm	1540	11	of	of	IN
cord-023095-4dannjjm	1540	12	6	6	CD
cord-023095-4dannjjm	1540	13	)	)	-RRB-
cord-023095-4dannjjm	1540	14	,	,	,
cord-023095-4dannjjm	1540	15	only	only	RB
cord-023095-4dannjjm	1540	16	T	t	NN
cord-023095-4dannjjm	1540	17	-	-	HYPH
cord-023095-4dannjjm	1540	18	cell	cell	NN
cord-023095-4dannjjm	1540	19	rich	rich	JJ
cord-023095-4dannjjm	1540	20	B	b	NN
cord-023095-4dannjjm	1540	21	-	-	HYPH
cord-023095-4dannjjm	1540	22	cell	cell	NN
cord-023095-4dannjjm	1540	23	lymphoma	lymphoma	NN
cord-023095-4dannjjm	1540	24	was	be	VBD
cord-023095-4dannjjm	1540	25	identified	identify	VBN
cord-023095-4dannjjm	1540	26	.	.	.
cord-023095-4dannjjm	1541	1	Samples	sample	NNS
cord-023095-4dannjjm	1541	2	of	of	IN
cord-023095-4dannjjm	1541	3	mesenteric	mesenteric	JJ
cord-023095-4dannjjm	1541	4	or	or	CC
cord-023095-4dannjjm	1541	5	submandibular	submandibular	JJ
cord-023095-4dannjjm	1541	6	lymph	lymph	NN
cord-023095-4dannjjm	1541	7	nodes	node	NNS
cord-023095-4dannjjm	1541	8	from	from	IN
cord-023095-4dannjjm	1541	9	20	20	CD
cord-023095-4dannjjm	1541	10	clinically	clinically	RB
cord-023095-4dannjjm	1541	11	healthy	healthy	JJ
cord-023095-4dannjjm	1541	12	horses	horse	NNS
cord-023095-4dannjjm	1541	13	were	be	VBD
cord-023095-4dannjjm	1541	14	submitted	submit	VBN
cord-023095-4dannjjm	1541	15	for	for	IN
cord-023095-4dannjjm	1541	16	EHV-5	EHV-5	NNP
cord-023095-4dannjjm	1541	17	PCR	PCR	NNP
cord-023095-4dannjjm	1541	18	analysis	analysis	NN
cord-023095-4dannjjm	1541	19	;	;	:
cord-023095-4dannjjm	1541	20	15	15	CD
cord-023095-4dannjjm	1541	21	%	%	NN
cord-023095-4dannjjm	1541	22	were	be	VBD
cord-023095-4dannjjm	1541	23	positive	positive	JJ
cord-023095-4dannjjm	1541	24	.	.	.
cord-023095-4dannjjm	1542	1	Gamma	gamma	NN
cord-023095-4dannjjm	1542	2	herpesviruses	herpesviruse	NNS
cord-023095-4dannjjm	1542	3	in	in	IN
cord-023095-4dannjjm	1542	4	humans	human	NNS
cord-023095-4dannjjm	1542	5	have	have	VBP
cord-023095-4dannjjm	1542	6	been	be	VBN
cord-023095-4dannjjm	1542	7	associated	associate	VBN
cord-023095-4dannjjm	1542	8	with	with	IN
cord-023095-4dannjjm	1542	9	lymphoproliferative	lymphoproliferative	JJ
cord-023095-4dannjjm	1542	10	diseases	disease	NNS
cord-023095-4dannjjm	1542	11	such	such	JJ
cord-023095-4dannjjm	1542	12	as	as	IN
cord-023095-4dannjjm	1542	13	Kaposi	Kaposi	NNP
cord-023095-4dannjjm	1542	14	's	's	POS
cord-023095-4dannjjm	1542	15	sarcoma	sarcoma	NN
cord-023095-4dannjjm	1542	16	and	and	CC
cord-023095-4dannjjm	1542	17	Burkitt	Burkitt	NNP
cord-023095-4dannjjm	1542	18	's	's	POS
cord-023095-4dannjjm	1542	19	lymphoma	lymphoma	NN
cord-023095-4dannjjm	1542	20	.	.	.
cord-023095-4dannjjm	1543	1	Equine	equine	JJ
cord-023095-4dannjjm	1543	2	herpesvirus	herpesvirus	NN
cord-023095-4dannjjm	1543	3	5	5	CD
cord-023095-4dannjjm	1543	4	,	,	,
cord-023095-4dannjjm	1543	5	also	also	RB
cord-023095-4dannjjm	1543	6	a	a	DT
cord-023095-4dannjjm	1543	7	gamma	gamma	NN
cord-023095-4dannjjm	1543	8	herpesvirus	herpesvirus	NN
cord-023095-4dannjjm	1543	9	,	,	,
cord-023095-4dannjjm	1543	10	is	be	VBZ
cord-023095-4dannjjm	1543	11	found	find	VBN
cord-023095-4dannjjm	1543	12	in	in	IN
cord-023095-4dannjjm	1543	13	association	association	NN
cord-023095-4dannjjm	1543	14	with	with	IN
cord-023095-4dannjjm	1543	15	equine	equine	JJ
cord-023095-4dannjjm	1543	16	lymphoma	lymphoma	NN
cord-023095-4dannjjm	1543	17	;	;	:
cord-023095-4dannjjm	1543	18	although	although	IN
cord-023095-4dannjjm	1543	19	the	the	DT
cord-023095-4dannjjm	1543	20	exact	exact	JJ
cord-023095-4dannjjm	1543	21	role	role	NN
cord-023095-4dannjjm	1543	22	this	this	DT
cord-023095-4dannjjm	1543	23	virus	virus	NN
cord-023095-4dannjjm	1543	24	plays	play	VBZ
cord-023095-4dannjjm	1543	25	in	in	IN
cord-023095-4dannjjm	1543	26	the	the	DT
cord-023095-4dannjjm	1543	27	initiation	initiation	NN
cord-023095-4dannjjm	1543	28	or	or	CC
cord-023095-4dannjjm	1543	29	perpetuation	perpetuation	NN
cord-023095-4dannjjm	1543	30	of	of	IN
cord-023095-4dannjjm	1543	31	lymphoproliferative	lymphoproliferative	JJ
cord-023095-4dannjjm	1543	32	neoplasia	neoplasia	NN
cord-023095-4dannjjm	1543	33	remains	remain	VBZ
cord-023095-4dannjjm	1543	34	unknown	unknown	JJ
cord-023095-4dannjjm	1543	35	.	.	.
cord-023095-4dannjjm	1544	1	Pathologic	pathologic	JJ
cord-023095-4dannjjm	1544	2	events	event	NNS
cord-023095-4dannjjm	1544	3	reported	report	VBN
cord-023095-4dannjjm	1544	4	to	to	TO
cord-023095-4dannjjm	1544	5	occur	occur	VB
cord-023095-4dannjjm	1544	6	in	in	IN
cord-023095-4dannjjm	1544	7	the	the	DT
cord-023095-4dannjjm	1544	8	digital	digital	JJ
cord-023095-4dannjjm	1544	9	laminae	laminae	NN
cord-023095-4dannjjm	1544	10	in	in	IN
cord-023095-4dannjjm	1544	11	early	early	JJ
cord-023095-4dannjjm	1544	12	stages	stage	NNS
cord-023095-4dannjjm	1544	13	of	of	IN
cord-023095-4dannjjm	1544	14	sepsis	sepsis	NN
cord-023095-4dannjjm	1544	15	-	-	HYPH
cord-023095-4dannjjm	1544	16	related	relate	VBN
cord-023095-4dannjjm	1544	17	equine	equine	NN
cord-023095-4dannjjm	1544	18	laminitis	laminitis	NN
cord-023095-4dannjjm	1544	19	include	include	VBP
cord-023095-4dannjjm	1544	20	leukocyte	leukocyte	NN
cord-023095-4dannjjm	1544	21	extravasa	extravasa	NNP
cord-023095-4dannjjm	1544	22	-	-	HYPH
cord-023095-4dannjjm	1544	23	tion	tion	NN
cord-023095-4dannjjm	1544	24	into	into	IN
cord-023095-4dannjjm	1544	25	the	the	DT
cord-023095-4dannjjm	1544	26	laminar	laminar	JJ
cord-023095-4dannjjm	1544	27	interstitium	interstitium	NN
cord-023095-4dannjjm	1544	28	,	,	,
cord-023095-4dannjjm	1544	29	pro	pro	JJ
cord-023095-4dannjjm	1544	30	-	-	JJ
cord-023095-4dannjjm	1544	31	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1544	32	cytokine	cytokine	NN
cord-023095-4dannjjm	1544	33	expression	expression	NN
cord-023095-4dannjjm	1544	34	,	,	,
cord-023095-4dannjjm	1544	35	and	and	CC
cord-023095-4dannjjm	1544	36	epithelial	epithelial	JJ
cord-023095-4dannjjm	1544	37	stress	stress	NN
cord-023095-4dannjjm	1544	38	.	.	.
cord-023095-4dannjjm	1545	1	While	while	IN
cord-023095-4dannjjm	1545	2	these	these	DT
cord-023095-4dannjjm	1545	3	events	event	NNS
cord-023095-4dannjjm	1545	4	have	have	VBP
cord-023095-4dannjjm	1545	5	been	be	VBN
cord-023095-4dannjjm	1545	6	documented	document	VBN
cord-023095-4dannjjm	1545	7	early	early	RB
cord-023095-4dannjjm	1545	8	in	in	IN
cord-023095-4dannjjm	1545	9	the	the	DT
cord-023095-4dannjjm	1545	10	disease	disease	NN
cord-023095-4dannjjm	1545	11	process	process	NN
cord-023095-4dannjjm	1545	12	at	at	IN
cord-023095-4dannjjm	1545	13	both	both	CC
cord-023095-4dannjjm	1545	14	a	a	DT
cord-023095-4dannjjm	1545	15	developmental	developmental	JJ
cord-023095-4dannjjm	1545	16	stage	stage	NN
cord-023095-4dannjjm	1545	17	and	and	CC
cord-023095-4dannjjm	1545	18	at	at	IN
cord-023095-4dannjjm	1545	19	the	the	DT
cord-023095-4dannjjm	1545	20	onset	onset	NN
cord-023095-4dannjjm	1545	21	of	of	IN
cord-023095-4dannjjm	1545	22	Obel	Obel	NNP
cord-023095-4dannjjm	1545	23	Grade	Grade	NNP
cord-023095-4dannjjm	1545	24	1	1	CD
cord-023095-4dannjjm	1545	25	(	(	-LRB-
cord-023095-4dannjjm	1545	26	OG1	OG1	NNP
cord-023095-4dannjjm	1545	27	)	)	-RRB-
cord-023095-4dannjjm	1545	28	lameness	lameness	NN
cord-023095-4dannjjm	1545	29	in	in	IN
cord-023095-4dannjjm	1545	30	the	the	DT
cord-023095-4dannjjm	1545	31	carbohydrate	carbohydrate	NN
cord-023095-4dannjjm	1545	32	overload	overload	NN
cord-023095-4dannjjm	1545	33	(	(	-LRB-
cord-023095-4dannjjm	1545	34	CHO	CHO	NNP
cord-023095-4dannjjm	1545	35	)	)	-RRB-
cord-023095-4dannjjm	1545	36	model	model	NN
cord-023095-4dannjjm	1545	37	of	of	IN
cord-023095-4dannjjm	1545	38	laminitis	laminitis	NN
cord-023095-4dannjjm	1545	39	,	,	,
cord-023095-4dannjjm	1545	40	the	the	DT
cord-023095-4dannjjm	1545	41	later	later	JJ
cord-023095-4dannjjm	1545	42	events	event	NNS
cord-023095-4dannjjm	1545	43	occurring	occur	VBG
cord-023095-4dannjjm	1545	44	at	at	IN
cord-023095-4dannjjm	1545	45	the	the	DT
cord-023095-4dannjjm	1545	46	onset	onset	NN
cord-023095-4dannjjm	1545	47	of	of	IN
cord-023095-4dannjjm	1545	48	Obel	Obel	NNP
cord-023095-4dannjjm	1545	49	Grade	Grade	NNP
cord-023095-4dannjjm	1545	50	3	3	CD
cord-023095-4dannjjm	1545	51	lameness(OG3	lameness(og3	NN
cord-023095-4dannjjm	1545	52	,	,	,
cord-023095-4dannjjm	1545	53	time	time	NN
cord-023095-4dannjjm	1545	54	point	point	NN
cord-023095-4dannjjm	1545	55	at	at	IN
cord-023095-4dannjjm	1545	56	which	which	WDT
cord-023095-4dannjjm	1545	57	structural	structural	JJ
cord-023095-4dannjjm	1545	58	failure	failure	NN
cord-023095-4dannjjm	1545	59	of	of	IN
cord-023095-4dannjjm	1545	60	the	the	DT
cord-023095-4dannjjm	1545	61	laminae	laminae	NNP
cord-023095-4dannjjm	1545	62	usually	usually	RB
cord-023095-4dannjjm	1545	63	occurs	occur	VBZ
cord-023095-4dannjjm	1545	64	)	)	-RRB-
cord-023095-4dannjjm	1545	65	have	have	VBP
cord-023095-4dannjjm	1545	66	not	not	RB
cord-023095-4dannjjm	1545	67	been	be	VBN
cord-023095-4dannjjm	1545	68	determined	determine	VBN
cord-023095-4dannjjm	1545	69	.	.	.
cord-023095-4dannjjm	1546	1	We	-PRON-	PRP
cord-023095-4dannjjm	1546	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1546	3	that	that	IN
cord-023095-4dannjjm	1546	4	the	the	DT
cord-023095-4dannjjm	1546	5	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1546	6	events	event	NNS
cord-023095-4dannjjm	1546	7	described	describe	VBN
cord-023095-4dannjjm	1546	8	above	above	RB
cord-023095-4dannjjm	1546	9	are	be	VBP
cord-023095-4dannjjm	1546	10	sustained	sustain	VBN
cord-023095-4dannjjm	1546	11	through	through	IN
cord-023095-4dannjjm	1546	12	OG	OG	NNP
cord-023095-4dannjjm	1546	13	3	3	CD
cord-023095-4dannjjm	1546	14	lameness	lameness	NN
cord-023095-4dannjjm	1546	15	,	,	,
cord-023095-4dannjjm	1546	16	likely	likely	RB
cord-023095-4dannjjm	1546	17	playing	play	VBG
cord-023095-4dannjjm	1546	18	an	an	DT
cord-023095-4dannjjm	1546	19	injurious	injurious	JJ
cord-023095-4dannjjm	1546	20	role	role	NN
cord-023095-4dannjjm	1546	21	culminating	culminate	VBG
cord-023095-4dannjjm	1546	22	in	in	IN
cord-023095-4dannjjm	1546	23	laminar	laminar	JJ
cord-023095-4dannjjm	1546	24	failure	failure	NN
cord-023095-4dannjjm	1546	25	.	.	.
cord-023095-4dannjjm	1547	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	1547	2	objectives	objective	NNS
cord-023095-4dannjjm	1547	3	were	be	VBD
cord-023095-4dannjjm	1547	4	to	to	TO
cord-023095-4dannjjm	1547	5	determine	determine	VB
cord-023095-4dannjjm	1547	6	pro	pro	JJ
cord-023095-4dannjjm	1547	7	-	-	JJ
cord-023095-4dannjjm	1547	8	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1547	9	gene	gene	NN
cord-023095-4dannjjm	1547	10	expression	expression	NN
cord-023095-4dannjjm	1547	11	,	,	,
cord-023095-4dannjjm	1547	12	leukocyte	leukocyte	NN
cord-023095-4dannjjm	1547	13	extravasation	extravasation	NN
cord-023095-4dannjjm	1547	14	,	,	,
cord-023095-4dannjjm	1547	15	and	and	CC
cord-023095-4dannjjm	1547	16	epithelial	epithelial	JJ
cord-023095-4dannjjm	1547	17	stress	stress	NN
cord-023095-4dannjjm	1547	18	at	at	IN
cord-023095-4dannjjm	1547	19	OG	OG	NNP
cord-023095-4dannjjm	1547	20	3	3	CD
cord-023095-4dannjjm	1547	21	induced	induce	VBD
cord-023095-4dannjjm	1547	22	using	use	VBG
cord-023095-4dannjjm	1547	23	the	the	DT
cord-023095-4dannjjm	1547	24	CHO	CHO	NNP
cord-023095-4dannjjm	1547	25	model	model	NN
cord-023095-4dannjjm	1547	26	.	.	.
cord-023095-4dannjjm	1548	1	Archived	archived	JJ
cord-023095-4dannjjm	1548	2	laminar	laminar	JJ
cord-023095-4dannjjm	1548	3	tissue	tissue	NN
cord-023095-4dannjjm	1548	4	samples	sample	NNS
cord-023095-4dannjjm	1548	5	(	(	-LRB-
cord-023095-4dannjjm	1548	6	snap	snap	VB
cord-023095-4dannjjm	1548	7	frozen	frozen	JJ
cord-023095-4dannjjm	1548	8	and	and	CC
cord-023095-4dannjjm	1548	9	paraffin	paraffin	NN
cord-023095-4dannjjm	1548	10	embedded	embed	VBN
cord-023095-4dannjjm	1548	11	sections	section	NNS
cord-023095-4dannjjm	1548	12	)	)	-RRB-
cord-023095-4dannjjm	1548	13	were	be	VBD
cord-023095-4dannjjm	1548	14	used	use	VBN
cord-023095-4dannjjm	1548	15	from	from	IN
cord-023095-4dannjjm	1548	16	a	a	DT
cord-023095-4dannjjm	1548	17	previous	previous	JJ
cord-023095-4dannjjm	1548	18	CHO	CHO	NNP
cord-023095-4dannjjm	1548	19	study	study	NN
cord-023095-4dannjjm	1548	20	at	at	IN
cord-023095-4dannjjm	1548	21	Louisiana	Louisiana	NNP
cord-023095-4dannjjm	1548	22	State	State	NNP
cord-023095-4dannjjm	1548	23	University	University	NNP
cord-023095-4dannjjm	1548	24	(	(	-LRB-
cord-023095-4dannjjm	1548	25	Control	Control	NNP
cord-023095-4dannjjm	1548	26	group	group	NN
cord-023095-4dannjjm	1548	27	[	[	-LRB-
cord-023095-4dannjjm	1548	28	n	n	NN
cord-023095-4dannjjm	1548	29	5	5	CD
cord-023095-4dannjjm	1548	30	6	6	CD
cord-023095-4dannjjm	1548	31	,	,	,
cord-023095-4dannjjm	1548	32	water	water	NN
cord-023095-4dannjjm	1548	33	]	]	-RRB-
cord-023095-4dannjjm	1548	34	,	,	,
cord-023095-4dannjjm	1548	35	CHO	CHO	NNP
cord-023095-4dannjjm	1548	36	group	group	NN
cord-023095-4dannjjm	1548	37	[	[	-LRB-
cord-023095-4dannjjm	1548	38	n	n	NN
cord-023095-4dannjjm	1548	39	5	5	CD
cord-023095-4dannjjm	1548	40	7	7	CD
cord-023095-4dannjjm	1548	41	,	,	,
cord-023095-4dannjjm	1548	42	corn	corn	NN
cord-023095-4dannjjm	1548	43	starch	starch	NN
cord-023095-4dannjjm	1548	44	]	]	-RRB-
cord-023095-4dannjjm	1548	45	.	.	.
cord-023095-4dannjjm	1549	1	Calprotectin	Calprotectin	NNP
cord-023095-4dannjjm	1549	2	(	(	-LRB-
cord-023095-4dannjjm	1549	3	CP	CP	NNP
cord-023095-4dannjjm	1549	4	)	)	-RRB-
cord-023095-4dannjjm	1549	5	immunohistochemistry	immunohistochemistry	NN
cord-023095-4dannjjm	1549	6	(	(	-LRB-
cord-023095-4dannjjm	1549	7	IHC	IHC	NNP
cord-023095-4dannjjm	1549	8	)	)	-RRB-
cord-023095-4dannjjm	1549	9	was	be	VBD
cord-023095-4dannjjm	1549	10	used	use	VBN
cord-023095-4dannjjm	1549	11	to	to	TO
cord-023095-4dannjjm	1549	12	assess	assess	VB
cord-023095-4dannjjm	1549	13	both	both	DT
cord-023095-4dannjjm	1549	14	laminar	laminar	JJ
cord-023095-4dannjjm	1549	15	myeloid	myeloid	JJ
cord-023095-4dannjjm	1549	16	leukocyte	leukocyte	NN
cord-023095-4dannjjm	1549	17	numbers	number	NNS
cord-023095-4dannjjm	1549	18	and	and	CC
cord-023095-4dannjjm	1549	19	epithelial	epithelial	JJ
cord-023095-4dannjjm	1549	20	stress	stress	NN
cord-023095-4dannjjm	1549	21	;	;	:
cord-023095-4dannjjm	1549	22	RT	RT	NNP
cord-023095-4dannjjm	1549	23	-	-	HYPH
cord-023095-4dannjjm	1549	24	qPCR	qPCR	NNP
cord-023095-4dannjjm	1549	25	was	be	VBD
cord-023095-4dannjjm	1549	26	used	use	VBN
cord-023095-4dannjjm	1549	27	to	to	TO
cord-023095-4dannjjm	1549	28	assess	assess	VB
cord-023095-4dannjjm	1549	29	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1549	30	gene	gene	NN
cord-023095-4dannjjm	1549	31	expression	expression	NN
cord-023095-4dannjjm	1549	32	.	.	.
cord-023095-4dannjjm	1550	1	Minimal	minimal	JJ
cord-023095-4dannjjm	1550	2	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1550	3	changes	change	NNS
cord-023095-4dannjjm	1550	4	were	be	VBD
cord-023095-4dannjjm	1550	5	present	present	JJ
cord-023095-4dannjjm	1550	6	at	at	IN
cord-023095-4dannjjm	1550	7	OG3	og3	NN
cord-023095-4dannjjm	1550	8	compared	compare	VBN
cord-023095-4dannjjm	1550	9	to	to	IN
cord-023095-4dannjjm	1550	10	published	publish	VBN
cord-023095-4dannjjm	1550	11	values	value	NNS
cord-023095-4dannjjm	1550	12	at	at	IN
cord-023095-4dannjjm	1550	13	OG1	OG1	NNP
cord-023095-4dannjjm	1550	14	stage	stage	NN
cord-023095-4dannjjm	1550	15	in	in	IN
cord-023095-4dannjjm	1550	16	the	the	DT
cord-023095-4dannjjm	1550	17	CHO	CHO	NNP
cord-023095-4dannjjm	1550	18	lameness	lameness	NN
cord-023095-4dannjjm	1550	19	model	model	NN
cord-023095-4dannjjm	1550	20	including	include	VBG
cord-023095-4dannjjm	1550	21	decreased	decrease	VBD
cord-023095-4dannjjm	1550	22	mRNA	mRNA	NNP
cord-023095-4dannjjm	1550	23	concentrations	concentration	NNS
cord-023095-4dannjjm	1550	24	of	of	IN
cord-023095-4dannjjm	1550	25	cytokines	cytokine	NNS
cord-023095-4dannjjm	1550	26	(	(	-LRB-
cord-023095-4dannjjm	1550	27	i.e.	i.e.	FW
cord-023095-4dannjjm	1550	28	20-fold	20-fold	JJ
cord-023095-4dannjjm	1550	29	increase	increase	NN
cord-023095-4dannjjm	1550	30	in	in	IN
cord-023095-4dannjjm	1550	31	IL-6	IL-6	NNP
cord-023095-4dannjjm	1550	32	at	at	IN
cord-023095-4dannjjm	1550	33	OG3	OG3	NNP
cord-023095-4dannjjm	1550	34	vs.	vs.	IN
cord-023095-4dannjjm	1550	35	4	4	CD
cord-023095-4dannjjm	1550	36	2000-fold	2000-fold	CD
cord-023095-4dannjjm	1550	37	increase	increase	NN
cord-023095-4dannjjm	1550	38	at	at	IN
cord-023095-4dannjjm	1550	39	OG1	OG1	NNP
cord-023095-4dannjjm	1550	40	,	,	,
cord-023095-4dannjjm	1550	41	no	no	DT
cord-023095-4dannjjm	1550	42	increase	increase	NN
cord-023095-4dannjjm	1550	43	in	in	IN
cord-023095-4dannjjm	1550	44	IL-1b	IL-1b	NNS
cord-023095-4dannjjm	1550	45	at	at	IN
cord-023095-4dannjjm	1550	46	OG3	OG3	NNP
cord-023095-4dannjjm	1550	47	vs.	vs.	IN
cord-023095-4dannjjm	1550	48	11-fold	11-fold	CD
cord-023095-4dannjjm	1550	49	increase	increase	NN
cord-023095-4dannjjm	1550	50	at	at	IN
cord-023095-4dannjjm	1550	51	OG1	OG1	NNP
cord-023095-4dannjjm	1550	52	)	)	-RRB-
cord-023095-4dannjjm	1550	53	,	,	,
cord-023095-4dannjjm	1550	54	chemokines	chemokine	NNS
cord-023095-4dannjjm	1550	55	(	(	-LRB-
cord-023095-4dannjjm	1550	56	no	no	DT
cord-023095-4dannjjm	1550	57	change	change	NN
cord-023095-4dannjjm	1550	58	in	in	IN
cord-023095-4dannjjm	1550	59	MCP-1at	MCP-1at	NNP
cord-023095-4dannjjm	1550	60	OG3	OG3	NNP
cord-023095-4dannjjm	1550	61	vs.	vs.	IN
cord-023095-4dannjjm	1550	62	4	4	CD
cord-023095-4dannjjm	1550	63	30	30	CD
cord-023095-4dannjjm	1550	64	fold	fold	NN
cord-023095-4dannjjm	1550	65	increase	increase	NN
cord-023095-4dannjjm	1550	66	at	at	IN
cord-023095-4dannjjm	1550	67	OG1	OG1	NNP
cord-023095-4dannjjm	1550	68	,	,	,
cord-023095-4dannjjm	1551	1	8-fold	8-fold	JJ
cord-023095-4dannjjm	1551	2	increase	increase	NN
cord-023095-4dannjjm	1551	3	in	in	IN
cord-023095-4dannjjm	1551	4	IL-8	IL-8	NNP
cord-023095-4dannjjm	1551	5	at	at	IN
cord-023095-4dannjjm	1551	6	OG3	og3	NN
cord-023095-4dannjjm	1551	7	vs.	vs.	FW
cord-023095-4dannjjm	1551	8	95fold	95fold	CD
cord-023095-4dannjjm	1551	9	increase	increase	NN
cord-023095-4dannjjm	1551	10	at	at	IN
cord-023095-4dannjjm	1551	11	OG1	OG1	NNP
cord-023095-4dannjjm	1551	12	)	)	-RRB-
cord-023095-4dannjjm	1551	13	and	and	CC
cord-023095-4dannjjm	1551	14	adhesion	adhesion	NN
cord-023095-4dannjjm	1551	15	molecules	molecule	NNS
cord-023095-4dannjjm	1551	16	(	(	-LRB-
cord-023095-4dannjjm	1551	17	no	no	DT
cord-023095-4dannjjm	1551	18	change	change	NN
cord-023095-4dannjjm	1551	19	in	in	IN
cord-023095-4dannjjm	1551	20	E	e	NN
cord-023095-4dannjjm	1551	21	-	-	NN
cord-023095-4dannjjm	1551	22	selectin	selectin	NN
cord-023095-4dannjjm	1551	23	at	at	IN
cord-023095-4dannjjm	1551	24	OG3	og3	NN
cord-023095-4dannjjm	1551	25	vs.	vs.	IN
cord-023095-4dannjjm	1551	26	10-fold	10-fold	CD
cord-023095-4dannjjm	1551	27	increase	increase	NN
cord-023095-4dannjjm	1551	28	at	at	IN
cord-023095-4dannjjm	1551	29	OG1	OG1	NNP
cord-023095-4dannjjm	1551	30	)	)	-RRB-
cord-023095-4dannjjm	1551	31	.	.	.
cord-023095-4dannjjm	1552	1	Laminar	laminar	JJ
cord-023095-4dannjjm	1552	2	leukocyte	leukocyte	NN
cord-023095-4dannjjm	1552	3	emigration	emigration	NN
cord-023095-4dannjjm	1552	4	was	be	VBD
cord-023095-4dannjjm	1552	5	also	also	RB
cord-023095-4dannjjm	1552	6	decreased	decrease	VBN
cord-023095-4dannjjm	1552	7	at	at	IN
cord-023095-4dannjjm	1552	8	the	the	DT
cord-023095-4dannjjm	1552	9	onset	onset	NN
cord-023095-4dannjjm	1552	10	of	of	IN
cord-023095-4dannjjm	1552	11	OG	OG	NNP
cord-023095-4dannjjm	1552	12	3	3	CD
cord-023095-4dannjjm	1552	13	lameness	lameness	NN
cord-023095-4dannjjm	1552	14	compared	compare	VBN
cord-023095-4dannjjm	1552	15	to	to	IN
cord-023095-4dannjjm	1552	16	previously	previously	RB
cord-023095-4dannjjm	1552	17	reported	report	VBN
cord-023095-4dannjjm	1552	18	leukocyte	leukocyte	NN
cord-023095-4dannjjm	1552	19	infiltration	infiltration	NN
cord-023095-4dannjjm	1552	20	at	at	IN
cord-023095-4dannjjm	1552	21	OG	OG	NNP
cord-023095-4dannjjm	1552	22	1	1	CD
cord-023095-4dannjjm	1552	23	.	.	.
cord-023095-4dannjjm	1553	1	Interestingly	interestingly	RB
cord-023095-4dannjjm	1553	2	COX-2	COX-2	NNP
cord-023095-4dannjjm	1553	3	,	,	,
cord-023095-4dannjjm	1553	4	underwent	undergo	VBD
cord-023095-4dannjjm	1553	5	a	a	DT
cord-023095-4dannjjm	1553	6	greater	great	JJR
cord-023095-4dannjjm	1553	7	increase	increase	NN
cord-023095-4dannjjm	1553	8	at	at	IN
cord-023095-4dannjjm	1553	9	OG3	og3	NN
cord-023095-4dannjjm	1553	10	(	(	-LRB-
cord-023095-4dannjjm	1553	11	approx	approx	NN
cord-023095-4dannjjm	1553	12	.	.	.
cord-023095-4dannjjm	1553	13	50-fold	50-fold	CD
cord-023095-4dannjjm	1553	14	)	)	-RRB-
cord-023095-4dannjjm	1554	1	compared	compare	VBN
cord-023095-4dannjjm	1554	2	to	to	IN
cord-023095-4dannjjm	1554	3	that	that	DT
cord-023095-4dannjjm	1554	4	reported	report	VBN
cord-023095-4dannjjm	1554	5	at	at	IN
cord-023095-4dannjjm	1554	6	OG1	OG1	NNP
cord-023095-4dannjjm	1554	7	lameness	lameness	NN
cord-023095-4dannjjm	1554	8	(	(	-LRB-
cord-023095-4dannjjm	1554	9	35-fold	35-fold	CD
cord-023095-4dannjjm	1554	10	)	)	-RRB-
cord-023095-4dannjjm	1554	11	.	.	.
cord-023095-4dannjjm	1555	1	Finally	finally	RB
cord-023095-4dannjjm	1555	2	,	,	,
cord-023095-4dannjjm	1555	3	epithelial	epithelial	JJ
cord-023095-4dannjjm	1555	4	stress	stress	NN
cord-023095-4dannjjm	1555	5	at	at	IN
cord-023095-4dannjjm	1555	6	OG3	OG3	NNP
cord-023095-4dannjjm	1555	7	evidenced	evidence	VBN
cord-023095-4dannjjm	1555	8	by	by	IN
cord-023095-4dannjjm	1555	9	CP	CP	NNP
cord-023095-4dannjjm	1555	10	IHC	IHC	NNP
cord-023095-4dannjjm	1555	11	did	do	VBD
cord-023095-4dannjjm	1555	12	not	not	RB
cord-023095-4dannjjm	1555	13	follow	follow	VB
cord-023095-4dannjjm	1555	14	the	the	DT
cord-023095-4dannjjm	1555	15	uniform	uniform	JJ
cord-023095-4dannjjm	1555	16	widespread	widespread	JJ
cord-023095-4dannjjm	1555	17	distribution	distribution	NN
cord-023095-4dannjjm	1555	18	reported	report	VBN
cord-023095-4dannjjm	1555	19	at	at	IN
cord-023095-4dannjjm	1555	20	OG1	OG1	NNP
cord-023095-4dannjjm	1555	21	lameness	lameness	NN
cord-023095-4dannjjm	1555	22	,	,	,
cord-023095-4dannjjm	1555	23	but	but	CC
cord-023095-4dannjjm	1555	24	instead	instead	RB
cord-023095-4dannjjm	1555	25	was	be	VBD
cord-023095-4dannjjm	1555	26	present	present	JJ
cord-023095-4dannjjm	1555	27	in	in	IN
cord-023095-4dannjjm	1555	28	focal	focal	JJ
cord-023095-4dannjjm	1555	29	areas	area	NNS
cord-023095-4dannjjm	1555	30	in	in	IN
cord-023095-4dannjjm	1555	31	which	which	WDT
cord-023095-4dannjjm	1555	32	secondary	secondary	JJ
cord-023095-4dannjjm	1555	33	epidermal	epidermal	JJ
cord-023095-4dannjjm	1555	34	laminae	laminae	RB
cord-023095-4dannjjm	1555	35	on	on	IN
cord-023095-4dannjjm	1555	36	either	either	DT
cord-023095-4dannjjm	1555	37	side	side	NN
cord-023095-4dannjjm	1555	38	of	of	IN
cord-023095-4dannjjm	1555	39	a	a	DT
cord-023095-4dannjjm	1555	40	common	common	JJ
cord-023095-4dannjjm	1555	41	primary	primary	JJ
cord-023095-4dannjjm	1555	42	dermal	dermal	JJ
cord-023095-4dannjjm	1555	43	vascular	vascular	JJ
cord-023095-4dannjjm	1555	44	supply	supply	NN
cord-023095-4dannjjm	1556	1	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	1556	2	increased	increased	JJ
cord-023095-4dannjjm	1556	3	CP	cp	NN
cord-023095-4dannjjm	1556	4	signal	signal	NN
cord-023095-4dannjjm	1556	5	.	.	.
cord-023095-4dannjjm	1557	1	Overall	overall	RB
cord-023095-4dannjjm	1557	2	,	,	,
cord-023095-4dannjjm	1557	3	laminar	laminar	JJ
cord-023095-4dannjjm	1557	4	inflammation	inflammation	NN
cord-023095-4dannjjm	1557	5	appears	appear	VBZ
cord-023095-4dannjjm	1557	6	to	to	TO
cord-023095-4dannjjm	1557	7	be	be	VB
cord-023095-4dannjjm	1557	8	subsiding	subside	VBG
cord-023095-4dannjjm	1557	9	at	at	IN
cord-023095-4dannjjm	1557	10	OG3	og3	JJ
cord-023095-4dannjjm	1557	11	lameness	lameness	NN
cord-023095-4dannjjm	1557	12	,	,	,
cord-023095-4dannjjm	1557	13	with	with	IN
cord-023095-4dannjjm	1557	14	epithelial	epithelial	JJ
cord-023095-4dannjjm	1557	15	stress	stress	NN
cord-023095-4dannjjm	1557	16	possibly	possibly	RB
cord-023095-4dannjjm	1557	17	more	more	RBR
cord-023095-4dannjjm	1557	18	dependent	dependent	JJ
cord-023095-4dannjjm	1557	19	on	on	IN
cord-023095-4dannjjm	1557	20	vascular	vascular	JJ
cord-023095-4dannjjm	1557	21	dysregulation	dysregulation	NN
cord-023095-4dannjjm	1557	22	instead	instead	RB
cord-023095-4dannjjm	1557	23	of	of	IN
cord-023095-4dannjjm	1557	24	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1557	25	events	event	NNS
cord-023095-4dannjjm	1557	26	.	.	.
cord-023095-4dannjjm	1558	1	The	the	DT
cord-023095-4dannjjm	1558	2	sustained	sustained	JJ
cord-023095-4dannjjm	1558	3	increase	increase	NN
cord-023095-4dannjjm	1558	4	in	in	IN
cord-023095-4dannjjm	1558	5	COX-2	COX-2	NNP
cord-023095-4dannjjm	1558	6	,	,	,
cord-023095-4dannjjm	1558	7	central	central	JJ
cord-023095-4dannjjm	1558	8	to	to	IN
cord-023095-4dannjjm	1558	9	the	the	DT
cord-023095-4dannjjm	1558	10	induced	induce	VBN
cord-023095-4dannjjm	1558	11	production	production	NN
cord-023095-4dannjjm	1558	12	of	of	IN
cord-023095-4dannjjm	1558	13	vasoactive	vasoactive	JJ
cord-023095-4dannjjm	1558	14	prostanoids	prostanoid	NNS
cord-023095-4dannjjm	1558	15	in	in	IN
cord-023095-4dannjjm	1558	16	disease	disease	NN
cord-023095-4dannjjm	1558	17	processes	process	NNS
cord-023095-4dannjjm	1558	18	,	,	,
cord-023095-4dannjjm	1558	19	may	may	MD
cord-023095-4dannjjm	1558	20	play	play	VB
cord-023095-4dannjjm	1558	21	a	a	DT
cord-023095-4dannjjm	1558	22	role	role	NN
cord-023095-4dannjjm	1558	23	in	in	IN
cord-023095-4dannjjm	1558	24	vascular	vascular	JJ
cord-023095-4dannjjm	1558	25	dysregulation	dysregulation	NN
cord-023095-4dannjjm	1558	26	.	.	.
cord-023095-4dannjjm	1559	1	This	this	DT
cord-023095-4dannjjm	1559	2	study	study	NN
cord-023095-4dannjjm	1559	3	was	be	VBD
cord-023095-4dannjjm	1559	4	conducted	conduct	VBN
cord-023095-4dannjjm	1559	5	to	to	TO
cord-023095-4dannjjm	1559	6	characterize	characterize	VB
cord-023095-4dannjjm	1559	7	clinical	clinical	JJ
cord-023095-4dannjjm	1559	8	,	,	,
cord-023095-4dannjjm	1559	9	laboratory	laboratory	NN
cord-023095-4dannjjm	1559	10	and	and	CC
cord-023095-4dannjjm	1559	11	postmortem	postmortem	JJ
cord-023095-4dannjjm	1559	12	findings	finding	NNS
cord-023095-4dannjjm	1559	13	associated	associate	VBN
cord-023095-4dannjjm	1559	14	with	with	IN
cord-023095-4dannjjm	1559	15	oleander	oleander	NN
cord-023095-4dannjjm	1559	16	toxicosis	toxicosis	NN
cord-023095-4dannjjm	1559	17	in	in	IN
cord-023095-4dannjjm	1559	18	equids	equid	NNS
cord-023095-4dannjjm	1559	19	and	and	CC
cord-023095-4dannjjm	1559	20	to	to	TO
cord-023095-4dannjjm	1559	21	determine	determine	VB
cord-023095-4dannjjm	1559	22	factors	factor	NNS
cord-023095-4dannjjm	1559	23	predictive	predictive	JJ
cord-023095-4dannjjm	1559	24	of	of	IN
cord-023095-4dannjjm	1559	25	survival	survival	NN
cord-023095-4dannjjm	1559	26	in	in	IN
cord-023095-4dannjjm	1559	27	these	these	DT
cord-023095-4dannjjm	1559	28	cases	case	NNS
cord-023095-4dannjjm	1559	29	.	.	.
cord-023095-4dannjjm	1560	1	Retrospective	retrospective	JJ
cord-023095-4dannjjm	1560	2	analysis	analysis	NN
cord-023095-4dannjjm	1560	3	of	of	IN
cord-023095-4dannjjm	1560	4	medical	medical	JJ
cord-023095-4dannjjm	1560	5	records	record	NNS
cord-023095-4dannjjm	1560	6	from	from	IN
cord-023095-4dannjjm	1560	7	our	-PRON-	PRP$
cord-023095-4dannjjm	1560	8	veterinary	veterinary	JJ
cord-023095-4dannjjm	1560	9	medical	medical	JJ
cord-023095-4dannjjm	1560	10	teaching	teaching	NN
cord-023095-4dannjjm	1560	11	hospital	hospital	NN
cord-023095-4dannjjm	1560	12	from	from	IN
cord-023095-4dannjjm	1560	13	January	January	NNP
cord-023095-4dannjjm	1560	14	1	1	CD
cord-023095-4dannjjm	1560	15	,	,	,
cord-023095-4dannjjm	1560	16	1995	1995	CD
cord-023095-4dannjjm	1560	17	to	to	IN
cord-023095-4dannjjm	1560	18	July	July	NNP
cord-023095-4dannjjm	1560	19	15	15	CD
cord-023095-4dannjjm	1560	20	,	,	,
cord-023095-4dannjjm	1560	21	2010	2010	CD
cord-023095-4dannjjm	1560	22	was	be	VBD
cord-023095-4dannjjm	1560	23	completed	complete	VBN
cord-023095-4dannjjm	1560	24	.	.	.
cord-023095-4dannjjm	1561	1	Records	record	NNS
cord-023095-4dannjjm	1561	2	of	of	IN
cord-023095-4dannjjm	1561	3	equids	equid	NNS
cord-023095-4dannjjm	1561	4	demonstrating	demonstrate	VBG
cord-023095-4dannjjm	1561	5	detectable	detectable	JJ
cord-023095-4dannjjm	1561	6	oleandrin	oleandrin	NN
cord-023095-4dannjjm	1561	7	in	in	IN
cord-023095-4dannjjm	1561	8	serum	serum	NN
cord-023095-4dannjjm	1561	9	,	,	,
cord-023095-4dannjjm	1561	10	plasma	plasma	NN
cord-023095-4dannjjm	1561	11	,	,	,
cord-023095-4dannjjm	1561	12	urine	urine	NN
cord-023095-4dannjjm	1561	13	or	or	CC
cord-023095-4dannjjm	1561	14	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1561	15	fluid	fluid	JJ
cord-023095-4dannjjm	1561	16	samples	sample	NNS
cord-023095-4dannjjm	1561	17	or	or	CC
cord-023095-4dannjjm	1561	18	detectable	detectable	JJ
cord-023095-4dannjjm	1561	19	serum	serum	NN
cord-023095-4dannjjm	1561	20	digoxin	digoxin	NN
cord-023095-4dannjjm	1561	21	in	in	IN
cord-023095-4dannjjm	1561	22	the	the	DT
cord-023095-4dannjjm	1561	23	absence	absence	NN
cord-023095-4dannjjm	1561	24	of	of	IN
cord-023095-4dannjjm	1561	25	pharmaceutical	pharmaceutical	JJ
cord-023095-4dannjjm	1561	26	cardiac	cardiac	JJ
cord-023095-4dannjjm	1561	27	glycoside	glycoside	NN
cord-023095-4dannjjm	1561	28	administration	administration	NNP
cord-023095-4dannjjm	1561	29	were	be	VBD
cord-023095-4dannjjm	1561	30	included	include	VBN
cord-023095-4dannjjm	1561	31	.	.	.
cord-023095-4dannjjm	1562	1	Descriptive	descriptive	JJ
cord-023095-4dannjjm	1562	2	statistics	statistic	NNS
cord-023095-4dannjjm	1562	3	were	be	VBD
cord-023095-4dannjjm	1562	4	used	use	VBN
cord-023095-4dannjjm	1562	5	to	to	TO
cord-023095-4dannjjm	1562	6	evaluate	evaluate	VB
cord-023095-4dannjjm	1562	7	the	the	DT
cord-023095-4dannjjm	1562	8	history	history	NN
cord-023095-4dannjjm	1562	9	,	,	,
cord-023095-4dannjjm	1562	10	physical	physical	JJ
cord-023095-4dannjjm	1562	11	examination	examination	NN
cord-023095-4dannjjm	1562	12	,	,	,
cord-023095-4dannjjm	1562	13	and	and	CC
cord-023095-4dannjjm	1562	14	laboratory	laboratory	NN
cord-023095-4dannjjm	1562	15	and	and	CC
cord-023095-4dannjjm	1562	16	postmortem	postmortem	JJ
cord-023095-4dannjjm	1562	17	data	datum	NNS
cord-023095-4dannjjm	1562	18	of	of	IN
cord-023095-4dannjjm	1562	19	affected	affect	VBN
cord-023095-4dannjjm	1562	20	individuals	individual	NNS
cord-023095-4dannjjm	1562	21	.	.	.
cord-023095-4dannjjm	1563	1	Logistic	logistic	JJ
cord-023095-4dannjjm	1563	2	regression	regression	NN
cord-023095-4dannjjm	1563	3	analysis	analysis	NN
cord-023095-4dannjjm	1563	4	was	be	VBD
cord-023095-4dannjjm	1563	5	used	use	VBN
cord-023095-4dannjjm	1563	6	to	to	TO
cord-023095-4dannjjm	1563	7	detect	detect	VB
cord-023095-4dannjjm	1563	8	physical	physical	JJ
cord-023095-4dannjjm	1563	9	examination	examination	NN
cord-023095-4dannjjm	1563	10	and	and	CC
cord-023095-4dannjjm	1563	11	laboratory	laboratory	NN
cord-023095-4dannjjm	1563	12	factors	factor	NNS
cord-023095-4dannjjm	1563	13	significantly	significantly	RB
cord-023095-4dannjjm	1563	14	associated	associate	VBN
cord-023095-4dannjjm	1563	15	with	with	IN
cord-023095-4dannjjm	1563	16	survival	survival	NN
cord-023095-4dannjjm	1563	17	.	.	.
cord-023095-4dannjjm	1564	1	Thirty	thirty	CD
cord-023095-4dannjjm	1564	2	equids	equid	NNS
cord-023095-4dannjjm	1564	3	met	meet	VBD
cord-023095-4dannjjm	1564	4	inclusion	inclusion	NN
cord-023095-4dannjjm	1564	5	criteria	criterion	NNS
cord-023095-4dannjjm	1564	6	of	of	IN
cord-023095-4dannjjm	1564	7	the	the	DT
cord-023095-4dannjjm	1564	8	study	study	NN
cord-023095-4dannjjm	1564	9	.	.	.
cord-023095-4dannjjm	1565	1	Three	three	CD
cord-023095-4dannjjm	1565	2	of	of	IN
cord-023095-4dannjjm	1565	3	30	30	CD
cord-023095-4dannjjm	1565	4	subjects	subject	NNS
cord-023095-4dannjjm	1565	5	were	be	VBD
cord-023095-4dannjjm	1565	6	dead	dead	JJ
cord-023095-4dannjjm	1565	7	on	on	IN
cord-023095-4dannjjm	1565	8	arrival	arrival	NN
cord-023095-4dannjjm	1565	9	or	or	CC
cord-023095-4dannjjm	1565	10	died	die	VBD
cord-023095-4dannjjm	1565	11	immediately	immediately	RB
cord-023095-4dannjjm	1565	12	upon	upon	IN
cord-023095-4dannjjm	1565	13	arrival	arrival	NN
cord-023095-4dannjjm	1565	14	(	(	-LRB-
cord-023095-4dannjjm	1565	15	10	10	CD
cord-023095-4dannjjm	1565	16	%	%	NN
cord-023095-4dannjjm	1565	17	)	)	-RRB-
cord-023095-4dannjjm	1565	18	.	.	.
cord-023095-4dannjjm	1566	1	Of	of	IN
cord-023095-4dannjjm	1566	2	the	the	DT
cord-023095-4dannjjm	1566	3	remaining	remain	VBG
cord-023095-4dannjjm	1566	4	27	27	CD
cord-023095-4dannjjm	1566	5	equids	equid	NNS
cord-023095-4dannjjm	1566	6	,	,	,
cord-023095-4dannjjm	1566	7	85	85	CD
cord-023095-4dannjjm	1566	8	%	%	NN
cord-023095-4dannjjm	1566	9	presented	present	VBN
cord-023095-4dannjjm	1566	10	with	with	IN
cord-023095-4dannjjm	1566	11	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1566	12	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1566	13	,	,	,
cord-023095-4dannjjm	1566	14	70	70	CD
cord-023095-4dannjjm	1566	15	%	%	NN
cord-023095-4dannjjm	1566	16	were	be	VBD
cord-023095-4dannjjm	1566	17	azotemic	azotemic	JJ
cord-023095-4dannjjm	1566	18	and	and	CC
cord-023095-4dannjjm	1566	19	48	48	CD
cord-023095-4dannjjm	1566	20	%	%	NN
cord-023095-4dannjjm	1566	21	had	have	VBD
cord-023095-4dannjjm	1566	22	cardiac	cardiac	JJ
cord-023095-4dannjjm	1566	23	arrhythmias	arrhythmia	NNS
cord-023095-4dannjjm	1566	24	.	.	.
cord-023095-4dannjjm	1567	1	Mortality	mortality	NN
cord-023095-4dannjjm	1567	2	was	be	VBD
cord-023095-4dannjjm	1567	3	50	50	CD
cord-023095-4dannjjm	1567	4	%	%	NN
cord-023095-4dannjjm	1567	5	for	for	IN
cord-023095-4dannjjm	1567	6	all	all	DT
cord-023095-4dannjjm	1567	7	subjects	subject	NNS
cord-023095-4dannjjm	1567	8	and	and	CC
cord-023095-4dannjjm	1567	9	44	44	CD
cord-023095-4dannjjm	1567	10	%	%	NN
cord-023095-4dannjjm	1567	11	for	for	IN
cord-023095-4dannjjm	1567	12	those	those	DT
cord-023095-4dannjjm	1567	13	treated	treat	VBN
cord-023095-4dannjjm	1567	14	.	.	.
cord-023095-4dannjjm	1568	1	The	the	DT
cord-023095-4dannjjm	1568	2	predominant	predominant	JJ
cord-023095-4dannjjm	1568	3	cause	cause	NN
cord-023095-4dannjjm	1568	4	for	for	IN
cord-023095-4dannjjm	1568	5	non	non	JJ
cord-023095-4dannjjm	1568	6	-	-	JJ
cord-023095-4dannjjm	1568	7	survival	survival	JJ
cord-023095-4dannjjm	1568	8	was	be	VBD
cord-023095-4dannjjm	1568	9	cardiac	cardiac	JJ
cord-023095-4dannjjm	1568	10	dysfunction	dysfunction	NN
cord-023095-4dannjjm	1568	11	.	.	.
cord-023095-4dannjjm	1569	1	Factors	factor	NNS
cord-023095-4dannjjm	1569	2	significantly	significantly	RB
cord-023095-4dannjjm	1569	3	associated	associate	VBD
cord-023095-4dannjjm	1569	4	with	with	IN
cord-023095-4dannjjm	1569	5	survival	survival	NN
cord-023095-4dannjjm	1569	6	included	include	VBD
cord-023095-4dannjjm	1569	7	relatively	relatively	RB
cord-023095-4dannjjm	1569	8	decreased	decrease	VBD
cord-023095-4dannjjm	1569	9	hematocrit	hematocrit	NN
cord-023095-4dannjjm	1569	10	and	and	CC
cord-023095-4dannjjm	1569	11	serum	serum	NN
cord-023095-4dannjjm	1569	12	glucose	glucose	NN
cord-023095-4dannjjm	1569	13	,	,	,
cord-023095-4dannjjm	1569	14	relatively	relatively	RB
cord-023095-4dannjjm	1569	15	increased	increase	VBN
cord-023095-4dannjjm	1569	16	serum	serum	NN
cord-023095-4dannjjm	1569	17	chloride	chloride	NN
cord-023095-4dannjjm	1569	18	,	,	,
cord-023095-4dannjjm	1569	19	absence	absence	NN
cord-023095-4dannjjm	1569	20	of	of	IN
cord-023095-4dannjjm	1569	21	cardiac	cardiac	JJ
cord-023095-4dannjjm	1569	22	arrhythmias	arrhythmia	NNS
cord-023095-4dannjjm	1569	23	,	,	,
cord-023095-4dannjjm	1569	24	and	and	CC
cord-023095-4dannjjm	1569	25	increased	increase	VBN
cord-023095-4dannjjm	1569	26	duration	duration	NN
cord-023095-4dannjjm	1569	27	of	of	IN
cord-023095-4dannjjm	1569	28	hospitalization	hospitalization	NN
cord-023095-4dannjjm	1569	29	.	.	.
cord-023095-4dannjjm	1570	1	Equids	Equids	NNP
cord-023095-4dannjjm	1570	2	with	with	IN
cord-023095-4dannjjm	1570	3	oleander	oleander	NN
cord-023095-4dannjjm	1570	4	toxicosis	toxicosis	NN
cord-023095-4dannjjm	1570	5	frequently	frequently	RB
cord-023095-4dannjjm	1570	6	present	present	VBP
cord-023095-4dannjjm	1570	7	with	with	IN
cord-023095-4dannjjm	1570	8	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1570	9	upset	upset	NN
cord-023095-4dannjjm	1570	10	and	and	CC
cord-023095-4dannjjm	1570	11	may	may	MD
cord-023095-4dannjjm	1570	12	develop	develop	VB
cord-023095-4dannjjm	1570	13	cardiac	cardiac	JJ
cord-023095-4dannjjm	1570	14	and	and	CC
cord-023095-4dannjjm	1570	15	renal	renal	JJ
cord-023095-4dannjjm	1570	16	disturbances	disturbance	NNS
cord-023095-4dannjjm	1570	17	.	.	.
cord-023095-4dannjjm	1571	1	Patients	patient	NNS
cord-023095-4dannjjm	1571	2	with	with	IN
cord-023095-4dannjjm	1571	3	cardiac	cardiac	JJ
cord-023095-4dannjjm	1571	4	arrhythmias	arrhythmia	NNS
cord-023095-4dannjjm	1571	5	and	and	CC
cord-023095-4dannjjm	1571	6	relatively	relatively	RB
cord-023095-4dannjjm	1571	7	increased	increase	VBN
cord-023095-4dannjjm	1571	8	hematocrit	hematocrit	NN
cord-023095-4dannjjm	1571	9	and	and	CC
cord-023095-4dannjjm	1571	10	serum	serum	NN
cord-023095-4dannjjm	1571	11	glucose	glucose	NN
cord-023095-4dannjjm	1571	12	and	and	CC
cord-023095-4dannjjm	1571	13	decreased	decrease	VBD
cord-023095-4dannjjm	1571	14	serum	serum	NN
cord-023095-4dannjjm	1571	15	chloride	chloride	NN
cord-023095-4dannjjm	1571	16	are	be	VBP
cord-023095-4dannjjm	1571	17	significantly	significantly	RB
cord-023095-4dannjjm	1571	18	less	less	RBR
cord-023095-4dannjjm	1571	19	likely	likely	JJ
cord-023095-4dannjjm	1571	20	to	to	TO
cord-023095-4dannjjm	1571	21	survive	survive	VB
cord-023095-4dannjjm	1571	22	.	.	.
cord-023095-4dannjjm	1572	1	Oleander	oleander	NN
cord-023095-4dannjjm	1572	2	intoxication	intoxication	NN
cord-023095-4dannjjm	1572	3	is	be	VBZ
cord-023095-4dannjjm	1572	4	a	a	DT
cord-023095-4dannjjm	1572	5	differential	differential	JJ
cord-023095-4dannjjm	1572	6	diagnosis	diagnosis	NN
cord-023095-4dannjjm	1572	7	for	for	IN
cord-023095-4dannjjm	1572	8	colic	colic	NN
cord-023095-4dannjjm	1572	9	in	in	IN
cord-023095-4dannjjm	1572	10	endemic	endemic	JJ
cord-023095-4dannjjm	1572	11	areas	area	NNS
cord-023095-4dannjjm	1572	12	,	,	,
cord-023095-4dannjjm	1572	13	particularly	particularly	RB
cord-023095-4dannjjm	1572	14	with	with	IN
cord-023095-4dannjjm	1572	15	concurrent	concurrent	JJ
cord-023095-4dannjjm	1572	16	azotemia	azotemia	NN
cord-023095-4dannjjm	1572	17	or	or	CC
cord-023095-4dannjjm	1572	18	cardiac	cardiac	JJ
cord-023095-4dannjjm	1572	19	dysrhythmia	dysrhythmia	NN
cord-023095-4dannjjm	1572	20	.	.	.
cord-023095-4dannjjm	1573	1	The	the	DT
cord-023095-4dannjjm	1573	2	quantitative	quantitative	JJ
cord-023095-4dannjjm	1573	3	physicochemical	physicochemical	JJ
cord-023095-4dannjjm	1573	4	approach	approach	NN
cord-023095-4dannjjm	1573	5	emphasizes	emphasize	VBZ
cord-023095-4dannjjm	1573	6	the	the	DT
cord-023095-4dannjjm	1573	7	importance	importance	NN
cord-023095-4dannjjm	1573	8	of	of	IN
cord-023095-4dannjjm	1573	9	strong	strong	JJ
cord-023095-4dannjjm	1573	10	ions	ion	NNS
cord-023095-4dannjjm	1573	11	(	(	-LRB-
cord-023095-4dannjjm	1573	12	Na	na	UH
cord-023095-4dannjjm	1573	13	,	,	,
cord-023095-4dannjjm	1573	14	K	K	NNP
cord-023095-4dannjjm	1573	15	,	,	,
cord-023095-4dannjjm	1573	16	Cl	Cl	NNP
cord-023095-4dannjjm	1573	17	,	,	,
cord-023095-4dannjjm	1573	18	lactate	lactate	NN
cord-023095-4dannjjm	1573	19	)	)	-RRB-
cord-023095-4dannjjm	1573	20	,	,	,
cord-023095-4dannjjm	1573	21	pCO	pCO	NNP
cord-023095-4dannjjm	1573	22	2	2	CD
cord-023095-4dannjjm	1573	23	,	,	,
cord-023095-4dannjjm	1573	24	and	and	CC
cord-023095-4dannjjm	1573	25	the	the	DT
cord-023095-4dannjjm	1573	26	plasma	plasma	NN
cord-023095-4dannjjm	1573	27	protein	protein	NN
cord-023095-4dannjjm	1573	28	concentrations	concentration	NNS
cord-023095-4dannjjm	1573	29	in	in	IN
cord-023095-4dannjjm	1573	30	determining	determine	VBG
cord-023095-4dannjjm	1573	31	plasma	plasma	NN
cord-023095-4dannjjm	1573	32	pH.	ph.	NN
cord-023095-4dannjjm	1573	33	Serum	Serum	NNP
cord-023095-4dannjjm	1573	34	concentrations	concentration	NNS
cord-023095-4dannjjm	1573	35	of	of	IN
cord-023095-4dannjjm	1573	36	strong	strong	JJ
cord-023095-4dannjjm	1573	37	ions	ion	NNS
cord-023095-4dannjjm	1573	38	,	,	,
cord-023095-4dannjjm	1573	39	proteins	protein	NNS
cord-023095-4dannjjm	1573	40	,	,	,
cord-023095-4dannjjm	1573	41	and	and	CC
cord-023095-4dannjjm	1573	42	total	total	JJ
cord-023095-4dannjjm	1573	43	CO	CO	NNP
cord-023095-4dannjjm	1573	44	2	2	CD
cord-023095-4dannjjm	1573	45	are	be	VBP
cord-023095-4dannjjm	1573	46	reported	report	VBN
cord-023095-4dannjjm	1573	47	on	on	IN
cord-023095-4dannjjm	1573	48	modern	modern	JJ
cord-023095-4dannjjm	1573	49	biochemical	biochemical	JJ
cord-023095-4dannjjm	1573	50	profiles	profile	NNS
cord-023095-4dannjjm	1573	51	.	.	.
cord-023095-4dannjjm	1574	1	We	-PRON-	PRP
cord-023095-4dannjjm	1574	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1574	3	that	that	IN
cord-023095-4dannjjm	1574	4	the	the	DT
cord-023095-4dannjjm	1574	5	results	result	NNS
cord-023095-4dannjjm	1574	6	of	of	IN
cord-023095-4dannjjm	1574	7	serum	serum	NN
cord-023095-4dannjjm	1574	8	biochemical	biochemical	JJ
cord-023095-4dannjjm	1574	9	analysis	analysis	NN
cord-023095-4dannjjm	1574	10	can	can	MD
cord-023095-4dannjjm	1574	11	be	be	VB
cord-023095-4dannjjm	1574	12	used	use	VBN
cord-023095-4dannjjm	1574	13	for	for	IN
cord-023095-4dannjjm	1574	14	acid	acid	NN
cord-023095-4dannjjm	1574	15	-	-	HYPH
cord-023095-4dannjjm	1574	16	base	base	NN
cord-023095-4dannjjm	1574	17	interpretation	interpretation	NN
cord-023095-4dannjjm	1574	18	in	in	IN
cord-023095-4dannjjm	1574	19	horses	horse	NNS
cord-023095-4dannjjm	1574	20	.	.	.
cord-023095-4dannjjm	1575	1	The	the	DT
cord-023095-4dannjjm	1575	2	objective	objective	NN
cord-023095-4dannjjm	1575	3	was	be	VBD
cord-023095-4dannjjm	1575	4	to	to	TO
cord-023095-4dannjjm	1575	5	determine	determine	VB
cord-023095-4dannjjm	1575	6	whether	whether	IN
cord-023095-4dannjjm	1575	7	blood	blood	NN
cord-023095-4dannjjm	1575	8	pH	ph	NN
cord-023095-4dannjjm	1575	9	,	,	,
cord-023095-4dannjjm	1575	10	anion	anion	NN
cord-023095-4dannjjm	1575	11	gap	gap	NN
cord-023095-4dannjjm	1575	12	,	,	,
cord-023095-4dannjjm	1575	13	and	and	CC
cord-023095-4dannjjm	1575	14	strong	strong	JJ
cord-023095-4dannjjm	1575	15	ion	ion	NN
cord-023095-4dannjjm	1575	16	gap	gap	NN
cord-023095-4dannjjm	1575	17	could	could	MD
cord-023095-4dannjjm	1575	18	be	be	VB
cord-023095-4dannjjm	1575	19	quantitatively	quantitatively	RB
cord-023095-4dannjjm	1575	20	estimated	estimate	VBN
cord-023095-4dannjjm	1575	21	and	and	CC
cord-023095-4dannjjm	1575	22	clinically	clinically	RB
cord-023095-4dannjjm	1575	23	used	use	VBN
cord-023095-4dannjjm	1575	24	based	base	VBN
cord-023095-4dannjjm	1575	25	on	on	IN
cord-023095-4dannjjm	1575	26	the	the	DT
cord-023095-4dannjjm	1575	27	results	result	NNS
cord-023095-4dannjjm	1575	28	of	of	IN
cord-023095-4dannjjm	1575	29	serum	serum	NN
cord-023095-4dannjjm	1575	30	or	or	CC
cord-023095-4dannjjm	1575	31	plasma	plasma	NN
cord-023095-4dannjjm	1575	32	biochemical	biochemical	JJ
cord-023095-4dannjjm	1575	33	analysis	analysis	NN
cord-023095-4dannjjm	1575	34	.	.	.
cord-023095-4dannjjm	1576	1	100	100	CD
cord-023095-4dannjjm	1576	2	horses	horse	NNS
cord-023095-4dannjjm	1576	3	(	(	-LRB-
cord-023095-4dannjjm	1576	4	70	70	CD
cord-023095-4dannjjm	1576	5	adults	adult	NNS
cord-023095-4dannjjm	1576	6	and	and	CC
cord-023095-4dannjjm	1576	7	30	30	CD
cord-023095-4dannjjm	1576	8	foals	foal	NNS
cord-023095-4dannjjm	1576	9	)	)	-RRB-
cord-023095-4dannjjm	1576	10	presented	present	VBD
cord-023095-4dannjjm	1576	11	to	to	IN
cord-023095-4dannjjm	1576	12	the	the	DT
cord-023095-4dannjjm	1576	13	isolation	isolation	NN
cord-023095-4dannjjm	1576	14	unit	unit	NN
cord-023095-4dannjjm	1576	15	of	of	IN
cord-023095-4dannjjm	1576	16	our	-PRON-	PRP$
cord-023095-4dannjjm	1576	17	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	1576	18	Teaching	Teaching	NNP
cord-023095-4dannjjm	1576	19	Hospital	Hospital	NNP
cord-023095-4dannjjm	1576	20	for	for	IN
cord-023095-4dannjjm	1576	21	suspected	suspect	VBN
cord-023095-4dannjjm	1576	22	infectious	infectious	JJ
cord-023095-4dannjjm	1576	23	diseases	disease	NNS
cord-023095-4dannjjm	1576	24	were	be	VBD
cord-023095-4dannjjm	1576	25	prospectively	prospectively	RB
cord-023095-4dannjjm	1576	26	enrolled	enrol	VBN
cord-023095-4dannjjm	1576	27	.	.	.
cord-023095-4dannjjm	1577	1	A	a	DT
cord-023095-4dannjjm	1577	2	venous	venous	JJ
cord-023095-4dannjjm	1577	3	serum	serum	NN
cord-023095-4dannjjm	1577	4	sample	sample	NN
cord-023095-4dannjjm	1577	5	was	be	VBD
cord-023095-4dannjjm	1577	6	analyzed	analyze	VBN
cord-023095-4dannjjm	1577	7	using	use	VBG
cord-023095-4dannjjm	1577	8	a	a	DT
cord-023095-4dannjjm	1577	9	Hitachi	Hitachi	NNP
cord-023095-4dannjjm	1577	10	911	911	CD
cord-023095-4dannjjm	1577	11	or	or	CC
cord-023095-4dannjjm	1577	12	Copas	Copas	NNPS
cord-023095-4dannjjm	1577	13	6000	6000	CD
cord-023095-4dannjjm	1577	14	C501	c501	SYM
cord-023095-4dannjjm	1577	15	automated	automate	VBN
cord-023095-4dannjjm	1577	16	machine	machine	NN
cord-023095-4dannjjm	1577	17	.	.	.
cord-023095-4dannjjm	1578	1	Measured	measured	JJ
cord-023095-4dannjjm	1578	2	parameters	parameter	NNS
cord-023095-4dannjjm	1578	3	included	include	VBD
cord-023095-4dannjjm	1578	4	strong	strong	JJ
cord-023095-4dannjjm	1578	5	ion	ion	NN
cord-023095-4dannjjm	1578	6	difference	difference	NN
cord-023095-4dannjjm	1578	7	(	(	-LRB-
cord-023095-4dannjjm	1578	8	SID	SID	NNP
cord-023095-4dannjjm	1578	9	5	5	CD
cord-023095-4dannjjm	1578	10	{	{	-LRB-
cord-023095-4dannjjm	1578	11	Na1K}-{Cl1lac	Na1K}-{Cl1lac	NNP
cord-023095-4dannjjm	1578	12	-	-	HYPH
cord-023095-4dannjjm	1578	13	tate	tate	NNP
cord-023095-4dannjjm	1578	14	}	}	-RRB-
cord-023095-4dannjjm	1578	15	)	)	-RRB-
cord-023095-4dannjjm	1578	16	,	,	,
cord-023095-4dannjjm	1578	17	total	total	JJ
cord-023095-4dannjjm	1578	18	protein	protein	NN
cord-023095-4dannjjm	1578	19	concentration	concentration	NN
cord-023095-4dannjjm	1578	20	(	(	-LRB-
cord-023095-4dannjjm	1578	21	TP	TP	NNP
cord-023095-4dannjjm	1578	22	)	)	-RRB-
cord-023095-4dannjjm	1578	23	,	,	,
cord-023095-4dannjjm	1578	24	and	and	CC
cord-023095-4dannjjm	1578	25	total	total	JJ
cord-023095-4dannjjm	1578	26	CO	co	NN
cord-023095-4dannjjm	1578	27	2	2	CD
cord-023095-4dannjjm	1578	28	(	(	-LRB-
cord-023095-4dannjjm	1578	29	tCO	tCO	NNP
cord-023095-4dannjjm	1578	30	2	2	CD
cord-023095-4dannjjm	1578	31	)	)	-RRB-
cord-023095-4dannjjm	1578	32	,	,	,
cord-023095-4dannjjm	1578	33	with	with	IN
cord-023095-4dannjjm	1578	34	lactate	lactate	NN
cord-023095-4dannjjm	1578	35	being	be	VBG
cord-023095-4dannjjm	1578	36	measured	measure	VBN
cord-023095-4dannjjm	1578	37	by	by	IN
cord-023095-4dannjjm	1578	38	blood	blood	NN
cord-023095-4dannjjm	1578	39	gas	gas	NN
cord-023095-4dannjjm	1578	40	analyzer	analyzer	NN
cord-023095-4dannjjm	1578	41	.	.	.
cord-023095-4dannjjm	1579	1	A	a	DT
cord-023095-4dannjjm	1579	2	second	second	JJ
cord-023095-4dannjjm	1579	3	venous	venous	JJ
cord-023095-4dannjjm	1579	4	blood	blood	NN
cord-023095-4dannjjm	1579	5	sample	sample	NN
cord-023095-4dannjjm	1579	6	was	be	VBD
cord-023095-4dannjjm	1579	7	collected	collect	VBN
cord-023095-4dannjjm	1579	8	into	into	IN
cord-023095-4dannjjm	1579	9	a	a	DT
cord-023095-4dannjjm	1579	10	Na	Na	NNP
cord-023095-4dannjjm	1579	11	-	-	HYPH
cord-023095-4dannjjm	1579	12	heparin	heparin	JJ
cord-023095-4dannjjm	1579	13	blood	blood	NN
cord-023095-4dannjjm	1579	14	gas	gas	NN
cord-023095-4dannjjm	1579	15	syringe	syringe	NN
cord-023095-4dannjjm	1579	16	and	and	CC
cord-023095-4dannjjm	1579	17	analyzed	analyze	VBD
cord-023095-4dannjjm	1579	18	for	for	IN
cord-023095-4dannjjm	1579	19	pH	pH	NNP
cord-023095-4dannjjm	1579	20	(	(	-LRB-
cord-023095-4dannjjm	1579	21	pH	pH	NNP
cord-023095-4dannjjm	1579	22	m	m	NNP
cord-023095-4dannjjm	1579	23	)	)	-RRB-
cord-023095-4dannjjm	1579	24	,	,	,
cord-023095-4dannjjm	1579	25	pCO	pCO	NNP
cord-023095-4dannjjm	1579	26	2	2	CD
cord-023095-4dannjjm	1579	27	and	and	CC
cord-023095-4dannjjm	1579	28	concentrations	concentration	NNS
cord-023095-4dannjjm	1579	29	of	of	IN
cord-023095-4dannjjm	1579	30	Na	Na	NNP
cord-023095-4dannjjm	1579	31	,	,	,
cord-023095-4dannjjm	1579	32	K	K	NNP
cord-023095-4dannjjm	1579	33	,	,	,
cord-023095-4dannjjm	1579	34	Cl	Cl	NNP
cord-023095-4dannjjm	1579	35	,	,	,
cord-023095-4dannjjm	1579	36	and	and	CC
cord-023095-4dannjjm	1579	37	lactate	lactate	NN
cord-023095-4dannjjm	1579	38	using	use	VBG
cord-023095-4dannjjm	1579	39	a	a	DT
cord-023095-4dannjjm	1579	40	Radiometer	Radiometer	NNP
cord-023095-4dannjjm	1579	41	800	800	CD
cord-023095-4dannjjm	1579	42	Flex	flex	JJ
cord-023095-4dannjjm	1579	43	blood	blood	NN
cord-023095-4dannjjm	1579	44	gas	gas	NN
cord-023095-4dannjjm	1579	45	analyzer	analyzer	NN
cord-023095-4dannjjm	1579	46	;	;	:
cord-023095-4dannjjm	1579	47	SID	SID	NNP
cord-023095-4dannjjm	1579	48	was	be	VBD
cord-023095-4dannjjm	1579	49	calculated	calculate	VBN
cord-023095-4dannjjm	1579	50	from	from	IN
cord-023095-4dannjjm	1579	51	the	the	DT
cord-023095-4dannjjm	1579	52	measured	measure	VBN
cord-023095-4dannjjm	1579	53	values	value	NNS
cord-023095-4dannjjm	1579	54	,	,	,
cord-023095-4dannjjm	1579	55	and	and	CC
cord-023095-4dannjjm	1579	56	total	total	JJ
cord-023095-4dannjjm	1579	57	solids	solid	NNS
cord-023095-4dannjjm	1579	58	(	(	-LRB-
cord-023095-4dannjjm	1579	59	TS	TS	NNP
cord-023095-4dannjjm	1579	60	)	)	-RRB-
cord-023095-4dannjjm	1579	61	were	be	VBD
cord-023095-4dannjjm	1579	62	estimated	estimate	VBN
cord-023095-4dannjjm	1579	63	using	use	VBG
cord-023095-4dannjjm	1579	64	refractometry	refractometry	NNP
cord-023095-4dannjjm	1579	65	.	.	.
cord-023095-4dannjjm	1580	1	Serum/	serum/	NN
cord-023095-4dannjjm	1580	2	plasma	plasma	NN
cord-023095-4dannjjm	1580	3	pH	ph	NN
cord-023095-4dannjjm	1581	1	(	(	-LRB-
cord-023095-4dannjjm	1581	2	pH	pH	NNP
cord-023095-4dannjjm	1581	3	calc	calc	NNP
cord-023095-4dannjjm	1581	4	)	)	-RRB-
cord-023095-4dannjjm	1581	5	was	be	VBD
cord-023095-4dannjjm	1581	6	calculated	calculate	VBN
cord-023095-4dannjjm	1581	7	using	use	VBG
cord-023095-4dannjjm	1581	8	Stewart	Stewart	NNP
cord-023095-4dannjjm	1581	9	's	's	POS
cord-023095-4dannjjm	1581	10	8	8	CD
cord-023095-4dannjjm	1581	11	factor	factor	NN
cord-023095-4dannjjm	1581	12	equation	equation	NN
cord-023095-4dannjjm	1581	13	from	from	IN
cord-023095-4dannjjm	1581	14	the	the	DT
cord-023095-4dannjjm	1581	15	results	result	NNS
cord-023095-4dannjjm	1581	16	of	of	IN
cord-023095-4dannjjm	1581	17	serum	serum	NN
cord-023095-4dannjjm	1581	18	or	or	CC
cord-023095-4dannjjm	1581	19	plasma	plasma	NN
cord-023095-4dannjjm	1581	20	biochemical	biochemical	JJ
cord-023095-4dannjjm	1581	21	analysis	analysis	NN
cord-023095-4dannjjm	1581	22	,	,	,
cord-023095-4dannjjm	1581	23	assuming	assume	VBG
cord-023095-4dannjjm	1581	24	pCO	pCO	NNP
cord-023095-4dannjjm	1581	25	2	2	CD
cord-023095-4dannjjm	1581	26	5	5	CD
cord-023095-4dannjjm	1581	27	40	40	CD
cord-023095-4dannjjm	1581	28	mmHg	mmHg	NNS
cord-023095-4dannjjm	1581	29	for	for	IN
cord-023095-4dannjjm	1581	30	serum	serum	NN
cord-023095-4dannjjm	1581	31	and	and	CC
cord-023095-4dannjjm	1581	32	pCO	pco	CD
cord-023095-4dannjjm	1581	33	2	2	CD
cord-023095-4dannjjm	1581	34	accurate	accurate	JJ
cord-023095-4dannjjm	1581	35	for	for	IN
cord-023095-4dannjjm	1581	36	plasma	plasma	NN
cord-023095-4dannjjm	1581	37	.	.	.
cord-023095-4dannjjm	1582	1	Anion	anion	NN
cord-023095-4dannjjm	1582	2	gap	gap	NN
cord-023095-4dannjjm	1582	3	(	(	-LRB-
cord-023095-4dannjjm	1582	4	AG	AG	NNP
cord-023095-4dannjjm	1582	5	)	)	-RRB-
cord-023095-4dannjjm	1582	6	was	be	VBD
cord-023095-4dannjjm	1582	7	calculated	calculate	VBN
cord-023095-4dannjjm	1582	8	as	as	IN
cord-023095-4dannjjm	1582	9	:	:	:
cord-023095-4dannjjm	1582	10	AG	AG	NNP
cord-023095-4dannjjm	1582	11	5	5	CD
cord-023095-4dannjjm	1582	12	(	(	-LRB-
cord-023095-4dannjjm	1582	13	Na1K)-(Cl1tCO	Na1K)-(Cl1tCO	NNP
cord-023095-4dannjjm	1582	14	2	2	CD
cord-023095-4dannjjm	1582	15	)	)	-RRB-
cord-023095-4dannjjm	1582	16	.	.	.
cord-023095-4dannjjm	1583	1	Strong	strong	JJ
cord-023095-4dannjjm	1583	2	ion	ion	NN
cord-023095-4dannjjm	1583	3	gap	gap	NN
cord-023095-4dannjjm	1583	4	(	(	-LRB-
cord-023095-4dannjjm	1583	5	SIG	SIG	NNP
cord-023095-4dannjjm	1583	6	)	)	-RRB-
cord-023095-4dannjjm	1583	7	was	be	VBD
cord-023095-4dannjjm	1583	8	calculated	calculate	VBN
cord-023095-4dannjjm	1583	9	as	as	IN
cord-023095-4dannjjm	1583	10	:	:	:
cord-023095-4dannjjm	1583	11	SIG	SIG	NNP
cord-023095-4dannjjm	1583	12	5	5	CD
cord-023095-4dannjjm	1583	13	0.21x[total	0.21x[total	CD
cord-023095-4dannjjm	1584	1	protein	protein	NN
cord-023095-4dannjjm	1584	2	,	,	,
cord-023095-4dannjjm	1584	3	g	g	NNP
cord-023095-4dannjjm	1584	4	/	/	SYM
cord-023095-4dannjjm	1584	5	L]/	L]/	NNP
cord-023095-4dannjjm	1584	6	(	(	-LRB-
cord-023095-4dannjjm	1584	7	1110	1110	CD
cord-023095-4dannjjm	1584	8	{	{	-LRB-
cord-023095-4dannjjm	1584	9	pKa	pKa	NNP
cord-023095-4dannjjm	1584	10	-	-	HYPH
cord-023095-4dannjjm	1584	11	pH	pH	NNP
cord-023095-4dannjjm	1584	12	}	}	-RRB-
cord-023095-4dannjjm	1584	13	)	)	-RRB-
cord-023095-4dannjjm	1585	1	-AG	-ag	UH
cord-023095-4dannjjm	1585	2	.	.	.
cord-023095-4dannjjm	1586	1	Linear	linear	JJ
cord-023095-4dannjjm	1586	2	regression	regression	NN
cord-023095-4dannjjm	1586	3	analysis	analysis	NN
cord-023095-4dannjjm	1586	4	was	be	VBD
cord-023095-4dannjjm	1586	5	used	use	VBN
cord-023095-4dannjjm	1586	6	to	to	TO
cord-023095-4dannjjm	1586	7	compare	compare	VB
cord-023095-4dannjjm	1586	8	pH	pH	NNP
cord-023095-4dannjjm	1586	9	calc	calc	NNP
cord-023095-4dannjjm	1586	10	to	to	IN
cord-023095-4dannjjm	1586	11	pH	pH	NNP
cord-023095-4dannjjm	1586	12	m	m	NNP
cord-023095-4dannjjm	1586	13	,	,	,
cord-023095-4dannjjm	1586	14	as	as	RB
cord-023095-4dannjjm	1586	15	well	well	RB
cord-023095-4dannjjm	1586	16	as	as	IN
cord-023095-4dannjjm	1586	17	AG	AG	NNP
cord-023095-4dannjjm	1586	18	and	and	CC
cord-023095-4dannjjm	1586	19	SIG	SIG	NNP
cord-023095-4dannjjm	1586	20	to	to	IN
cord-023095-4dannjjm	1586	21	blood	blood	NN
cord-023095-4dannjjm	1586	22	lactate	lactate	NN
cord-023095-4dannjjm	1586	23	concentrations	concentration	NNS
cord-023095-4dannjjm	1586	24	.	.	.
cord-023095-4dannjjm	1587	1	Measured	measure	VBN
cord-023095-4dannjjm	1587	2	pH	pH	NNP
cord-023095-4dannjjm	1587	3	ranged	range	VBD
cord-023095-4dannjjm	1587	4	from	from	IN
cord-023095-4dannjjm	1587	5	7.03	7.03	CD
cord-023095-4dannjjm	1587	6	to	to	IN
cord-023095-4dannjjm	1587	7	7.48	7.48	CD
cord-023095-4dannjjm	1587	8	(	(	-LRB-
cord-023095-4dannjjm	1587	9	7.37	7.37	CD
cord-023095-4dannjjm	1587	10	AE	AE	NNP
cord-023095-4dannjjm	1587	11	0.07	0.07	CD
cord-023095-4dannjjm	1587	12	)	)	-RRB-
cord-023095-4dannjjm	1587	13	.	.	.
cord-023095-4dannjjm	1588	1	Measured	measure	VBN
cord-023095-4dannjjm	1588	2	SID	SID	NNP
cord-023095-4dannjjm	1588	3	from	from	IN
cord-023095-4dannjjm	1588	4	serum	serum	NN
cord-023095-4dannjjm	1588	5	biochemistry	biochemistry	NN
cord-023095-4dannjjm	1588	6	(	(	-LRB-
cord-023095-4dannjjm	1588	7	SID	SID	NNP
cord-023095-4dannjjm	1588	8	SB	SB	NNP
cord-023095-4dannjjm	1588	9	)	)	-RRB-
cord-023095-4dannjjm	1588	10	ranged	range	VBD
cord-023095-4dannjjm	1588	11	from	from	IN
cord-023095-4dannjjm	1588	12	22.3	22.3	CD
cord-023095-4dannjjm	1588	13	to	to	IN
cord-023095-4dannjjm	1588	14	51.4	51.4	CD
cord-023095-4dannjjm	1588	15	mEq	mEq	NNS
cord-023095-4dannjjm	1588	16	/	/	SYM
cord-023095-4dannjjm	1588	17	L	L	NNP
cord-023095-4dannjjm	1588	18	(	(	-LRB-
cord-023095-4dannjjm	1588	19	36.2	36.2	CD
cord-023095-4dannjjm	1588	20	AE	AE	NNP
cord-023095-4dannjjm	1588	21	4.7	4.7	CD
cord-023095-4dannjjm	1588	22	mEq	mEq	NNS
cord-023095-4dannjjm	1588	23	/	/	SYM
cord-023095-4dannjjm	1588	24	L	L	NNP
cord-023095-4dannjjm	1588	25	)	)	-RRB-
cord-023095-4dannjjm	1588	26	and	and	CC
cord-023095-4dannjjm	1588	27	SID	SID	NNP
cord-023095-4dannjjm	1588	28	from	from	IN
cord-023095-4dannjjm	1588	29	blood	blood	NN
cord-023095-4dannjjm	1588	30	gas	gas	NN
cord-023095-4dannjjm	1588	31	analyzer	analyzer	NN
cord-023095-4dannjjm	1588	32	(	(	-LRB-
cord-023095-4dannjjm	1588	33	SID	SID	NNP
cord-023095-4dannjjm	1588	34	BG	BG	NNP
cord-023095-4dannjjm	1588	35	)	)	-RRB-
cord-023095-4dannjjm	1588	36	from	from	IN
cord-023095-4dannjjm	1588	37	14.3	14.3	CD
cord-023095-4dannjjm	1588	38	to	to	IN
cord-023095-4dannjjm	1588	39	46.6	46.6	CD
cord-023095-4dannjjm	1588	40	mEq	mEq	NNS
cord-023095-4dannjjm	1588	41	/	/	SYM
cord-023095-4dannjjm	1588	42	L	L	NNP
cord-023095-4dannjjm	1588	43	(	(	-LRB-
cord-023095-4dannjjm	1588	44	33.3	33.3	CD
cord-023095-4dannjjm	1588	45	AE	AE	NNP
cord-023095-4dannjjm	1588	46	5.4	5.4	CD
cord-023095-4dannjjm	1588	47	mEq	mEq	NNS
cord-023095-4dannjjm	1588	48	/	/	SYM
cord-023095-4dannjjm	1588	49	L	l	NN
cord-023095-4dannjjm	1588	50	;	;	:
cord-023095-4dannjjm	1588	51	R	r	NN
cord-023095-4dannjjm	1588	52	2	2	CD
cord-023095-4dannjjm	1588	53	5	5	CD
cord-023095-4dannjjm	1588	54	0.59	0.59	CD
cord-023095-4dannjjm	1588	55	;	;	:
cord-023095-4dannjjm	1588	56	SID	SID	NNP
cord-023095-4dannjjm	1588	57	BG	BG	NNP
cord-023095-4dannjjm	1588	58	5	5	CD
cord-023095-4dannjjm	1588	59	0.919	0.919	CD
cord-023095-4dannjjm	1589	1	Â	Â	NNP
cord-023095-4dannjjm	1589	2	SID	SID	NNP
cord-023095-4dannjjm	1589	3	SB	SB	NNP
cord-023095-4dannjjm	1589	4	)	)	-RRB-
cord-023095-4dannjjm	1589	5	.	.	.
cord-023095-4dannjjm	1590	1	SID	SID	NNP
cord-023095-4dannjjm	1590	2	SB	SB	NNP
cord-023095-4dannjjm	1590	3	and	and	CC
cord-023095-4dannjjm	1590	4	SID	SID	NNP
cord-023095-4dannjjm	1590	5	BG	BG	NNP
cord-023095-4dannjjm	1590	6	showed	show	VBD
cord-023095-4dannjjm	1590	7	small	small	JJ
cord-023095-4dannjjm	1590	8	variability	variability	NN
cord-023095-4dannjjm	1590	9	in	in	IN
cord-023095-4dannjjm	1590	10	measurements	measurement	NNS
cord-023095-4dannjjm	1590	11	.	.	.
cord-023095-4dannjjm	1591	1	TP	TP	NNP
cord-023095-4dannjjm	1591	2	ranged	range	VBD
cord-023095-4dannjjm	1591	3	from	from	IN
cord-023095-4dannjjm	1591	4	18	18	CD
cord-023095-4dannjjm	1591	5	to	to	TO
cord-023095-4dannjjm	1591	6	88	88	CD
cord-023095-4dannjjm	1591	7	g	g	NN
cord-023095-4dannjjm	1591	8	/	/	SYM
cord-023095-4dannjjm	1591	9	L	l	NN
cord-023095-4dannjjm	1591	10	(	(	-LRB-
cord-023095-4dannjjm	1591	11	51.0	51.0	CD
cord-023095-4dannjjm	1591	12	AE	AE	NNP
cord-023095-4dannjjm	1591	13	13.9	13.9	CD
cord-023095-4dannjjm	1591	14	g	g	NNP
cord-023095-4dannjjm	1591	15	/	/	SYM
cord-023095-4dannjjm	1591	16	L	L	NNP
cord-023095-4dannjjm	1591	17	)	)	-RRB-
cord-023095-4dannjjm	1591	18	and	and	CC
cord-023095-4dannjjm	1591	19	TS	TS	NNP
cord-023095-4dannjjm	1591	20	from	from	IN
cord-023095-4dannjjm	1591	21	20	20	CD
cord-023095-4dannjjm	1591	22	-	-	SYM
cord-023095-4dannjjm	1591	23	84	84	CD
cord-023095-4dannjjm	1591	24	(	(	-LRB-
cord-023095-4dannjjm	1591	25	55.2	55.2	CD
cord-023095-4dannjjm	1591	26	AE	AE	NNP
cord-023095-4dannjjm	1591	27	13.8	13.8	CD
cord-023095-4dannjjm	1591	28	g	g	NN
cord-023095-4dannjjm	1591	29	/	/	SYM
cord-023095-4dannjjm	1591	30	L	l	NN
cord-023095-4dannjjm	1591	31	;	;	:
cord-023095-4dannjjm	1591	32	R	r	NN
cord-023095-4dannjjm	1591	33	2	2	CD
cord-023095-4dannjjm	1591	34	5	5	CD
cord-023095-4dannjjm	1591	35	0.77	0.77	CD
cord-023095-4dannjjm	1591	36	;	;	:
cord-023095-4dannjjm	1591	37	TS	TS	NNP
cord-023095-4dannjjm	1591	38	5	5	CD
cord-023095-4dannjjm	1591	39	1.071	1.071	CD
cord-023095-4dannjjm	1591	40	Â	â	CD
cord-023095-4dannjjm	1591	41	TP	tp	NN
cord-023095-4dannjjm	1591	42	)	)	-RRB-
cord-023095-4dannjjm	1591	43	.	.	.
cord-023095-4dannjjm	1592	1	Using	use	VBG
cord-023095-4dannjjm	1592	2	SID	SID	NNP
cord-023095-4dannjjm	1592	3	SB	SB	NNP
cord-023095-4dannjjm	1592	4	and	and	CC
cord-023095-4dannjjm	1592	5	tCO	tco	NN
cord-023095-4dannjjm	1592	6	2	2	CD
cord-023095-4dannjjm	1592	7	values	value	NNS
cord-023095-4dannjjm	1592	8	with	with	IN
cord-023095-4dannjjm	1592	9	constant	constant	JJ
cord-023095-4dannjjm	1592	10	pCO	pco	CD
cord-023095-4dannjjm	1592	11	2	2	CD
cord-023095-4dannjjm	1592	12	,	,	,
cord-023095-4dannjjm	1592	13	pH	pH	NNP
cord-023095-4dannjjm	1592	14	calc	calc	NNP
cord-023095-4dannjjm	1592	15	was	be	VBD
cord-023095-4dannjjm	1592	16	poorly	poorly	RB
cord-023095-4dannjjm	1592	17	associated	associate	VBN
cord-023095-4dannjjm	1592	18	with	with	IN
cord-023095-4dannjjm	1592	19	pH	pH	NNP
cord-023095-4dannjjm	1592	20	m	m	NNP
cord-023095-4dannjjm	1592	21	(	(	-LRB-
cord-023095-4dannjjm	1592	22	R	r	NN
cord-023095-4dannjjm	1592	23	2	2	CD
cord-023095-4dannjjm	1592	24	5	5	CD
cord-023095-4dannjjm	1592	25	0.27	0.27	CD
cord-023095-4dannjjm	1592	26	;	;	:
cord-023095-4dannjjm	1592	27	pH	pH	NNP
cord-023095-4dannjjm	1592	28	calc	calc	NNP
cord-023095-4dannjjm	1592	29	5	5	CD
cord-023095-4dannjjm	1592	30	0.48	0.48	CD
cord-023095-4dannjjm	1592	31	1	1	CD
cord-023095-4dannjjm	1592	32	3.89	3.89	CD
cord-023095-4dannjjm	1592	33	)	)	-RRB-
cord-023095-4dannjjm	1592	34	.	.	.
cord-023095-4dannjjm	1593	1	In	in	IN
cord-023095-4dannjjm	1593	2	contrast	contrast	NN
cord-023095-4dannjjm	1593	3	,	,	,
cord-023095-4dannjjm	1593	4	using	use	VBG
cord-023095-4dannjjm	1593	5	SID	SID	NNP
cord-023095-4dannjjm	1593	6	BG	BG	NNP
cord-023095-4dannjjm	1593	7	with	with	IN
cord-023095-4dannjjm	1593	8	accurate	accurate	JJ
cord-023095-4dannjjm	1593	9	pCO	pco	CD
cord-023095-4dannjjm	1593	10	2	2	CD
cord-023095-4dannjjm	1593	11	,	,	,
cord-023095-4dannjjm	1593	12	pH	pH	NNP
cord-023095-4dannjjm	1593	13	calc	calc	NNP
cord-023095-4dannjjm	1593	14	was	be	VBD
cord-023095-4dannjjm	1593	15	closely	closely	RB
cord-023095-4dannjjm	1593	16	associated	associate	VBN
cord-023095-4dannjjm	1593	17	with	with	IN
cord-023095-4dannjjm	1593	18	pH	pH	NNP
cord-023095-4dannjjm	1593	19	m	m	NNP
cord-023095-4dannjjm	1593	20	(	(	-LRB-
cord-023095-4dannjjm	1593	21	R	R	NNP
cord-023095-4dannjjm	1593	22	2	2	CD
cord-023095-4dannjjm	1593	23	5	5	CD
cord-023095-4dannjjm	1593	24	0.54	0.54	CD
cord-023095-4dannjjm	1593	25	;	;	.
cord-023095-4dannjjm	1594	1	pHcalc	pHcalc	NNP
cord-023095-4dannjjm	1594	2	5	5	CD
cord-023095-4dannjjm	1594	3	0.98	0.98	CD
cord-023095-4dannjjm	1594	4	1	1	CD
cord-023095-4dannjjm	1594	5	0.15	0.15	CD
cord-023095-4dannjjm	1594	6	)	)	-RRB-
cord-023095-4dannjjm	1594	7	and	and	CC
cord-023095-4dannjjm	1594	8	the	the	DT
cord-023095-4dannjjm	1594	9	equation	equation	NN
cord-023095-4dannjjm	1594	10	was	be	VBD
cord-023095-4dannjjm	1594	11	not	not	RB
cord-023095-4dannjjm	1594	12	different	different	JJ
cord-023095-4dannjjm	1594	13	from	from	IN
cord-023095-4dannjjm	1594	14	the	the	DT
cord-023095-4dannjjm	1594	15	line	line	NN
cord-023095-4dannjjm	1594	16	of	of	IN
cord-023095-4dannjjm	1594	17	identity	identity	NN
cord-023095-4dannjjm	1594	18	.	.	.
cord-023095-4dannjjm	1595	1	Anion	anion	NN
cord-023095-4dannjjm	1595	2	gap	gap	NN
cord-023095-4dannjjm	1595	3	and	and	CC
cord-023095-4dannjjm	1595	4	SIG	SIG	NNP
cord-023095-4dannjjm	1595	5	(	(	-LRB-
cord-023095-4dannjjm	1595	6	mEq	mEq	NNS
cord-023095-4dannjjm	1595	7	/	/	SYM
cord-023095-4dannjjm	1595	8	L	L	NNP
cord-023095-4dannjjm	1595	9	)	)	-RRB-
cord-023095-4dannjjm	1595	10	calculated	calculate	VBN
cord-023095-4dannjjm	1595	11	were	be	VBD
cord-023095-4dannjjm	1595	12	significantly	significantly	RB
cord-023095-4dannjjm	1595	13	linearly	linearly	RB
cord-023095-4dannjjm	1595	14	correlated	correlate	VBN
cord-023095-4dannjjm	1595	15	with	with	IN
cord-023095-4dannjjm	1595	16	lactate	lactate	NN
cord-023095-4dannjjm	1595	17	concentrations	concentration	NNS
cord-023095-4dannjjm	1595	18	(	(	-LRB-
cord-023095-4dannjjm	1595	19	mmol	mmol	NNP
cord-023095-4dannjjm	1595	20	/	/	SYM
cord-023095-4dannjjm	1595	21	L	L	NNP
cord-023095-4dannjjm	1595	22	)	)	-RRB-
cord-023095-4dannjjm	1595	23	;	;	:
cord-023095-4dannjjm	1595	24	AG	AG	NNP
cord-023095-4dannjjm	1595	25	5	5	CD
cord-023095-4dannjjm	1595	26	0.93	0.93	CD
cord-023095-4dannjjm	1595	27	Â	â	NN
cord-023095-4dannjjm	1596	1	[	[	-LRB-
cord-023095-4dannjjm	1596	2	lactate	lactate	NN
cord-023095-4dannjjm	1596	3	]	]	-RRB-
cord-023095-4dannjjm	1596	4	1	1	CD
cord-023095-4dannjjm	1596	5	8.3	8.3	CD
cord-023095-4dannjjm	1597	1	(	(	-LRB-
cord-023095-4dannjjm	1597	2	R	r	NN
cord-023095-4dannjjm	1597	3	2	2	CD
cord-023095-4dannjjm	1597	4	5	5	CD
cord-023095-4dannjjm	1597	5	0.39	0.39	CD
cord-023095-4dannjjm	1597	6	)	)	-RRB-
cord-023095-4dannjjm	1597	7	,	,	,
cord-023095-4dannjjm	1597	8	and	and	CC
cord-023095-4dannjjm	1597	9	SIG	SIG	NNP
cord-023095-4dannjjm	1597	10	5	5	CD
cord-023095-4dannjjm	1598	1	À0.91	À0.91	NNP
cord-023095-4dannjjm	1599	1	Â	â	LS
cord-023095-4dannjjm	1599	2	[	[	-LRB-
cord-023095-4dannjjm	1599	3	lactate	lactate	NN
cord-023095-4dannjjm	1599	4	]	]	-RRB-
cord-023095-4dannjjm	1599	5	1	1	CD
cord-023095-4dannjjm	1599	6	0.5	0.5	CD
cord-023095-4dannjjm	1600	1	(	(	-LRB-
cord-023095-4dannjjm	1600	2	R	r	NN
cord-023095-4dannjjm	1600	3	2	2	CD
cord-023095-4dannjjm	1600	4	5	5	CD
cord-023095-4dannjjm	1600	5	0.41	0.41	CD
cord-023095-4dannjjm	1600	6	)	)	-RRB-
cord-023095-4dannjjm	1600	7	.	.	.
cord-023095-4dannjjm	1601	1	We	-PRON-	PRP
cord-023095-4dannjjm	1601	2	conclude	conclude	VBP
cord-023095-4dannjjm	1601	3	that	that	IN
cord-023095-4dannjjm	1601	4	pH	pH	NNP
cord-023095-4dannjjm	1601	5	calc	calc	NNP
cord-023095-4dannjjm	1601	6	using	use	VBG
cord-023095-4dannjjm	1601	7	SID	SID	NNP
cord-023095-4dannjjm	1601	8	SB	SB	NNP
cord-023095-4dannjjm	1601	9	,	,	,
cord-023095-4dannjjm	1601	10	tCO	tco	NN
cord-023095-4dannjjm	1601	11	2	2	CD
cord-023095-4dannjjm	1601	12	and	and	CC
cord-023095-4dannjjm	1601	13	constant	constant	JJ
cord-023095-4dannjjm	1601	14	pCO	pCO	VBN
cord-023095-4dannjjm	1601	15	2	2	CD
cord-023095-4dannjjm	1601	16	values	value	NNS
cord-023095-4dannjjm	1601	17	is	be	VBZ
cord-023095-4dannjjm	1601	18	not	not	RB
cord-023095-4dannjjm	1601	19	accurate	accurate	JJ
cord-023095-4dannjjm	1601	20	.	.	.
cord-023095-4dannjjm	1602	1	However	however	RB
cord-023095-4dannjjm	1602	2	,	,	,
cord-023095-4dannjjm	1602	3	variability	variability	NN
cord-023095-4dannjjm	1602	4	of	of	IN
cord-023095-4dannjjm	1602	5	measured	measure	VBN
cord-023095-4dannjjm	1602	6	biochemical	biochemical	JJ
cord-023095-4dannjjm	1602	7	parameters	parameter	NNS
cord-023095-4dannjjm	1602	8	between	between	IN
cord-023095-4dannjjm	1602	9	machines	machine	NNS
cord-023095-4dannjjm	1602	10	was	be	VBD
cord-023095-4dannjjm	1602	11	small	small	JJ
cord-023095-4dannjjm	1602	12	,	,	,
cord-023095-4dannjjm	1602	13	permitting	permit	VBG
cord-023095-4dannjjm	1602	14	use	use	NN
cord-023095-4dannjjm	1602	15	of	of	IN
cord-023095-4dannjjm	1602	16	serum	serum	NN
cord-023095-4dannjjm	1602	17	biochemistry	biochemistry	NN
cord-023095-4dannjjm	1602	18	for	for	IN
cord-023095-4dannjjm	1602	19	clinical	clinical	JJ
cord-023095-4dannjjm	1602	20	metabolic	metabolic	JJ
cord-023095-4dannjjm	1602	21	acid	acid	NN
cord-023095-4dannjjm	1602	22	-	-	HYPH
cord-023095-4dannjjm	1602	23	base	base	NN
cord-023095-4dannjjm	1602	24	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1602	25	interpretations	interpretation	NNS
cord-023095-4dannjjm	1602	26	of	of	IN
cord-023095-4dannjjm	1602	27	patients	patient	NNS
cord-023095-4dannjjm	1602	28	.	.	.
cord-023095-4dannjjm	1603	1	These	these	DT
cord-023095-4dannjjm	1603	2	results	result	NNS
cord-023095-4dannjjm	1603	3	reemphasize	reemphasize	VBP
cord-023095-4dannjjm	1603	4	the	the	DT
cord-023095-4dannjjm	1603	5	importance	importance	NN
cord-023095-4dannjjm	1603	6	of	of	IN
cord-023095-4dannjjm	1603	7	strong	strong	JJ
cord-023095-4dannjjm	1603	8	electrolytes	electrolyte	NNS
cord-023095-4dannjjm	1603	9	and	and	CC
cord-023095-4dannjjm	1603	10	proteins	protein	NNS
cord-023095-4dannjjm	1603	11	in	in	IN
cord-023095-4dannjjm	1603	12	acid	acid	NN
cord-023095-4dannjjm	1603	13	-	-	HYPH
cord-023095-4dannjjm	1603	14	base	base	NN
cord-023095-4dannjjm	1603	15	balance	balance	NN
cord-023095-4dannjjm	1603	16	.	.	.
cord-023095-4dannjjm	1604	1	Metalloproteinases	Metalloproteinases	NNP
cord-023095-4dannjjm	1604	2	(	(	-LRB-
cord-023095-4dannjjm	1604	3	MMPs	MMPs	NNP
cord-023095-4dannjjm	1604	4	)	)	-RRB-
cord-023095-4dannjjm	1604	5	are	be	VBP
cord-023095-4dannjjm	1604	6	critically	critically	RB
cord-023095-4dannjjm	1604	7	important	important	JJ
cord-023095-4dannjjm	1604	8	in	in	IN
cord-023095-4dannjjm	1604	9	remodeling	remodel	VBG
cord-023095-4dannjjm	1604	10	processes	process	NNS
cord-023095-4dannjjm	1604	11	and	and	CC
cord-023095-4dannjjm	1604	12	in	in	IN
cord-023095-4dannjjm	1604	13	wound	wound	JJ
cord-023095-4dannjjm	1604	14	healing	healing	NN
cord-023095-4dannjjm	1604	15	.	.	.
cord-023095-4dannjjm	1605	1	However	however	RB
cord-023095-4dannjjm	1605	2	,	,	,
cord-023095-4dannjjm	1605	3	excessive	excessive	JJ
cord-023095-4dannjjm	1605	4	activation	activation	NN
cord-023095-4dannjjm	1605	5	of	of	IN
cord-023095-4dannjjm	1605	6	MMPs	mmp	NNS
cord-023095-4dannjjm	1605	7	by	by	IN
cord-023095-4dannjjm	1605	8	pro	pro	JJ
cord-023095-4dannjjm	1605	9	-	-	JJ
cord-023095-4dannjjm	1605	10	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1605	11	mediators	mediator	NNS
cord-023095-4dannjjm	1605	12	including	include	VBG
cord-023095-4dannjjm	1605	13	cytokines	cytokine	NNS
cord-023095-4dannjjm	1605	14	,	,	,
cord-023095-4dannjjm	1605	15	prostaglandin	prostaglandin	NN
cord-023095-4dannjjm	1605	16	E2	e2	NN
cord-023095-4dannjjm	1605	17	,	,	,
cord-023095-4dannjjm	1605	18	and	and	CC
cord-023095-4dannjjm	1605	19	nitric	nitric	NN
cord-023095-4dannjjm	1605	20	oxide	oxide	NN
cord-023095-4dannjjm	1605	21	lead	lead	NN
cord-023095-4dannjjm	1605	22	to	to	IN
cord-023095-4dannjjm	1605	23	tissue	tissue	NN
cord-023095-4dannjjm	1605	24	breakdown	breakdown	NN
cord-023095-4dannjjm	1605	25	.	.	.
cord-023095-4dannjjm	1606	1	This	this	DT
cord-023095-4dannjjm	1606	2	is	be	VBZ
cord-023095-4dannjjm	1606	3	observed	observe	VBN
cord-023095-4dannjjm	1606	4	in	in	IN
cord-023095-4dannjjm	1606	5	osteoarthritis	osteoarthritis	NN
cord-023095-4dannjjm	1606	6	(	(	-LRB-
cord-023095-4dannjjm	1606	7	OA	OA	NNP
cord-023095-4dannjjm	1606	8	)	)	-RRB-
cord-023095-4dannjjm	1606	9	which	which	WDT
cord-023095-4dannjjm	1606	10	is	be	VBZ
cord-023095-4dannjjm	1606	11	characterized	characterize	VBN
cord-023095-4dannjjm	1606	12	by	by	IN
cord-023095-4dannjjm	1606	13	erosive	erosive	JJ
cord-023095-4dannjjm	1606	14	lesions	lesion	NNS
cord-023095-4dannjjm	1606	15	in	in	IN
cord-023095-4dannjjm	1606	16	articular	articular	JJ
cord-023095-4dannjjm	1606	17	cartilage	cartilage	NN
cord-023095-4dannjjm	1606	18	.	.	.
cord-023095-4dannjjm	1607	1	In	in	IN
cord-023095-4dannjjm	1607	2	Hereditary	Hereditary	NNP
cord-023095-4dannjjm	1607	3	Equine	Equine	NNP
cord-023095-4dannjjm	1607	4	Regional	Regional	NNP
cord-023095-4dannjjm	1607	5	Dermal	Dermal	NNP
cord-023095-4dannjjm	1607	6	Asthenia	Asthenia	NNP
cord-023095-4dannjjm	1607	7	(	(	-LRB-
cord-023095-4dannjjm	1607	8	HERDA	HERDA	NNP
cord-023095-4dannjjm	1607	9	)	)	-RRB-
cord-023095-4dannjjm	1607	10	,	,	,
cord-023095-4dannjjm	1607	11	afflicted	afflict	VBN
cord-023095-4dannjjm	1607	12	horses	horse	NNS
cord-023095-4dannjjm	1607	13	exhibit	exhibit	VBP
cord-023095-4dannjjm	1607	14	collagen	collagen	NN
cord-023095-4dannjjm	1607	15	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1607	16	and	and	CC
cord-023095-4dannjjm	1607	17	can	can	MD
cord-023095-4dannjjm	1607	18	have	have	VB
cord-023095-4dannjjm	1607	19	associated	associate	VBN
cord-023095-4dannjjm	1607	20	chronic	chronic	JJ
cord-023095-4dannjjm	1607	21	inflammation	inflammation	NN
cord-023095-4dannjjm	1607	22	and	and	CC
cord-023095-4dannjjm	1607	23	aberrant	aberrant	JJ
cord-023095-4dannjjm	1607	24	wound	wound	NN
cord-023095-4dannjjm	1607	25	repair	repair	NN
cord-023095-4dannjjm	1607	26	.	.	.
cord-023095-4dannjjm	1608	1	HERDA	HERDA	NNP
cord-023095-4dannjjm	1608	2	affects	affect	VBZ
cord-023095-4dannjjm	1608	3	horses	horse	NNS
cord-023095-4dannjjm	1608	4	with	with	IN
cord-023095-4dannjjm	1608	5	Quarter	Quarter	NNP
cord-023095-4dannjjm	1608	6	Horse	Horse	NNP
cord-023095-4dannjjm	1608	7	bloodlines	bloodline	NNS
cord-023095-4dannjjm	1608	8	and	and	CC
cord-023095-4dannjjm	1608	9	is	be	VBZ
cord-023095-4dannjjm	1608	10	similar	similar	JJ
cord-023095-4dannjjm	1608	11	to	to	IN
cord-023095-4dannjjm	1608	12	the	the	DT
cord-023095-4dannjjm	1608	13	human	human	JJ
cord-023095-4dannjjm	1608	14	hereditary	hereditary	JJ
cord-023095-4dannjjm	1608	15	connective	connective	JJ
cord-023095-4dannjjm	1608	16	tissue	tissue	NN
cord-023095-4dannjjm	1608	17	syndrome	syndrome	NN
cord-023095-4dannjjm	1608	18	Ehlers	Ehlers	NNP
cord-023095-4dannjjm	1608	19	Danlos	Danlos	NNP
cord-023095-4dannjjm	1608	20	(	(	-LRB-
cord-023095-4dannjjm	1608	21	EDS	EDS	NNP
cord-023095-4dannjjm	1608	22	)	)	-RRB-
cord-023095-4dannjjm	1608	23	.	.	.
cord-023095-4dannjjm	1609	1	Many	many	JJ
cord-023095-4dannjjm	1609	2	adult	adult	NN
cord-023095-4dannjjm	1609	3	EDS	EDS	NNP
cord-023095-4dannjjm	1609	4	patients	patient	NNS
cord-023095-4dannjjm	1609	5	suffer	suffer	VBP
cord-023095-4dannjjm	1609	6	from	from	IN
cord-023095-4dannjjm	1609	7	joint	joint	JJ
cord-023095-4dannjjm	1609	8	pain	pain	NN
cord-023095-4dannjjm	1609	9	and	and	CC
cord-023095-4dannjjm	1609	10	OA	OA	NNP
cord-023095-4dannjjm	1609	11	.	.	.
cord-023095-4dannjjm	1610	1	We	-PRON-	PRP
cord-023095-4dannjjm	1610	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1610	3	that	that	IN
cord-023095-4dannjjm	1610	4	chondrocytes	chondrocyte	NNS
cord-023095-4dannjjm	1610	5	from	from	IN
cord-023095-4dannjjm	1610	6	articular	articular	JJ
cord-023095-4dannjjm	1610	7	cartilage	cartilage	NN
cord-023095-4dannjjm	1610	8	of	of	IN
cord-023095-4dannjjm	1610	9	HERDA	HERDA	NNP
cord-023095-4dannjjm	1610	10	horses	horse	NNS
cord-023095-4dannjjm	1610	11	have	have	VBP
cord-023095-4dannjjm	1610	12	increased	increase	VBN
cord-023095-4dannjjm	1610	13	activity	activity	NN
cord-023095-4dannjjm	1610	14	of	of	IN
cord-023095-4dannjjm	1610	15	MMPs	mmp	NNS
cord-023095-4dannjjm	1610	16	.	.	.
cord-023095-4dannjjm	1611	1	To	to	TO
cord-023095-4dannjjm	1611	2	test	test	VB
cord-023095-4dannjjm	1611	3	this	this	DT
cord-023095-4dannjjm	1611	4	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1611	5	,	,	,
cord-023095-4dannjjm	1611	6	chondrocytes	chondrocyte	NNS
cord-023095-4dannjjm	1611	7	were	be	VBD
cord-023095-4dannjjm	1611	8	retrieved	retrieve	VBN
cord-023095-4dannjjm	1611	9	from	from	IN
cord-023095-4dannjjm	1611	10	articular	articular	JJ
cord-023095-4dannjjm	1611	11	cartilage	cartilage	NN
cord-023095-4dannjjm	1611	12	of	of	IN
cord-023095-4dannjjm	1611	13	homozygous	homozygous	JJ
cord-023095-4dannjjm	1611	14	HERDA	HERDA	NNP
cord-023095-4dannjjm	1611	15	carpal	carpal	NN
cord-023095-4dannjjm	1611	16	and	and	CC
cord-023095-4dannjjm	1611	17	hock	hock	NN
cord-023095-4dannjjm	1611	18	joints	joint	NNS
cord-023095-4dannjjm	1611	19	.	.	.
cord-023095-4dannjjm	1612	1	Chondrocytes	chondrocyte	NNS
cord-023095-4dannjjm	1612	2	from	from	IN
cord-023095-4dannjjm	1612	3	normal	normal	JJ
cord-023095-4dannjjm	1612	4	horses	horse	NNS
cord-023095-4dannjjm	1612	5	were	be	VBD
cord-023095-4dannjjm	1612	6	also	also	RB
cord-023095-4dannjjm	1612	7	obtained	obtain	VBN
cord-023095-4dannjjm	1612	8	for	for	IN
cord-023095-4dannjjm	1612	9	comparison	comparison	NN
cord-023095-4dannjjm	1612	10	.	.	.
cord-023095-4dannjjm	1613	1	Chondrocytes	Chondrocytes	NNP
cord-023095-4dannjjm	1613	2	were	be	VBD
cord-023095-4dannjjm	1613	3	seeded	seed	VBN
cord-023095-4dannjjm	1613	4	at	at	IN
cord-023095-4dannjjm	1613	5	5	5	CD
cord-023095-4dannjjm	1613	6	x	x	SYM
cord-023095-4dannjjm	1613	7	10	10	CD
cord-023095-4dannjjm	1613	8	6	6	CD
cord-023095-4dannjjm	1613	9	/ml	/ml	.
cord-023095-4dannjjm	1613	10	into	into	IN
cord-023095-4dannjjm	1613	11	6-well	6-well	CD
cord-023095-4dannjjm	1613	12	plates	plate	NNS
cord-023095-4dannjjm	1613	13	and	and	CC
cord-023095-4dannjjm	1613	14	incubated	incubate	VBN
cord-023095-4dannjjm	1613	15	at	at	IN
cord-023095-4dannjjm	1613	16	371C	371c	CD
cord-023095-4dannjjm	1613	17	,	,	,
cord-023095-4dannjjm	1613	18	5	5	CD
cord-023095-4dannjjm	1613	19	%	%	NN
cord-023095-4dannjjm	1613	20	CO	co	NN
cord-023095-4dannjjm	1613	21	2	2	CD
cord-023095-4dannjjm	1613	22	for	for	IN
cord-023095-4dannjjm	1613	23	up	up	IN
cord-023095-4dannjjm	1613	24	to	to	TO
cord-023095-4dannjjm	1613	25	seven	seven	CD
cord-023095-4dannjjm	1613	26	days	day	NNS
cord-023095-4dannjjm	1613	27	.	.	.
cord-023095-4dannjjm	1614	1	Activity	activity	NN
cord-023095-4dannjjm	1614	2	of	of	IN
cord-023095-4dannjjm	1614	3	secreted	secrete	VBN
cord-023095-4dannjjm	1614	4	MMPs	mmp	NNS
cord-023095-4dannjjm	1614	5	was	be	VBD
cord-023095-4dannjjm	1614	6	determined	determine	VBN
cord-023095-4dannjjm	1614	7	by	by	IN
cord-023095-4dannjjm	1614	8	zymography	zymography	NNP
cord-023095-4dannjjm	1614	9	using	use	VBG
cord-023095-4dannjjm	1614	10	equal	equal	JJ
cord-023095-4dannjjm	1614	11	amounts	amount	NNS
cord-023095-4dannjjm	1614	12	of	of	IN
cord-023095-4dannjjm	1614	13	proteins	protein	NNS
cord-023095-4dannjjm	1614	14	for	for	IN
cord-023095-4dannjjm	1614	15	loading	loading	NN
cord-023095-4dannjjm	1614	16	.	.	.
cord-023095-4dannjjm	1615	1	Secreted	secreted	JJ
cord-023095-4dannjjm	1615	2	MMPs	mmp	NNS
cord-023095-4dannjjm	1615	3	were	be	VBD
cord-023095-4dannjjm	1615	4	analyzed	analyze	VBN
cord-023095-4dannjjm	1615	5	by	by	IN
cord-023095-4dannjjm	1615	6	Western	western	JJ
cord-023095-4dannjjm	1615	7	blot	blot	NN
cord-023095-4dannjjm	1615	8	.	.	.
cord-023095-4dannjjm	1616	1	Zymography	Zymography	NNP
cord-023095-4dannjjm	1616	2	showed	show	VBD
cord-023095-4dannjjm	1616	3	that	that	IN
cord-023095-4dannjjm	1616	4	normal	normal	JJ
cord-023095-4dannjjm	1616	5	chondrocytes	chondrocyte	NNS
cord-023095-4dannjjm	1616	6	secreted	secrete	VBD
cord-023095-4dannjjm	1616	7	two	two	CD
cord-023095-4dannjjm	1616	8	major	major	JJ
cord-023095-4dannjjm	1616	9	bands	band	NNS
cord-023095-4dannjjm	1616	10	with	with	IN
cord-023095-4dannjjm	1616	11	gelatinolytic	gelatinolytic	JJ
cord-023095-4dannjjm	1616	12	activity	activity	NN
cord-023095-4dannjjm	1616	13	observed	observe	VBN
cord-023095-4dannjjm	1616	14	at	at	IN
cord-023095-4dannjjm	1616	15	92	92	CD
cord-023095-4dannjjm	1616	16	and	and	CC
cord-023095-4dannjjm	1616	17	72	72	CD
cord-023095-4dannjjm	1616	18	kDa	kDa	NNS
cord-023095-4dannjjm	1616	19	suggestive	suggestive	JJ
cord-023095-4dannjjm	1616	20	of	of	IN
cord-023095-4dannjjm	1616	21	the	the	DT
cord-023095-4dannjjm	1616	22	latent	latent	JJ
cord-023095-4dannjjm	1616	23	form	form	NN
cord-023095-4dannjjm	1616	24	of	of	IN
cord-023095-4dannjjm	1616	25	MMP-2	MMP-2	NNP
cord-023095-4dannjjm	1616	26	and	and	CC
cord-023095-4dannjjm	1616	27	MMP-9	MMP-9	NNP
cord-023095-4dannjjm	1616	28	,	,	,
cord-023095-4dannjjm	1616	29	respectively	respectively	RB
cord-023095-4dannjjm	1616	30	.	.	.
cord-023095-4dannjjm	1617	1	Less	less	RBR
cord-023095-4dannjjm	1617	2	intense	intense	JJ
cord-023095-4dannjjm	1617	3	bands	band	NNS
cord-023095-4dannjjm	1617	4	of	of	IN
cord-023095-4dannjjm	1617	5	gelatinolytic	gelatinolytic	JJ
cord-023095-4dannjjm	1617	6	activity	activity	NN
cord-023095-4dannjjm	1617	7	were	be	VBD
cord-023095-4dannjjm	1617	8	observed	observe	VBN
cord-023095-4dannjjm	1617	9	at	at	IN
cord-023095-4dannjjm	1617	10	about	about	RB
cord-023095-4dannjjm	1617	11	82	82	CD
cord-023095-4dannjjm	1617	12	and	and	CC
cord-023095-4dannjjm	1617	13	62	62	CD
cord-023095-4dannjjm	1617	14	kDa	kDa	NNS
cord-023095-4dannjjm	1617	15	suggestive	suggestive	JJ
cord-023095-4dannjjm	1617	16	of	of	IN
cord-023095-4dannjjm	1617	17	the	the	DT
cord-023095-4dannjjm	1617	18	active	active	JJ
cord-023095-4dannjjm	1617	19	form	form	NN
cord-023095-4dannjjm	1617	20	of	of	IN
cord-023095-4dannjjm	1617	21	MMP-2	MMP-2	NNP
cord-023095-4dannjjm	1617	22	and	and	CC
cord-023095-4dannjjm	1617	23	MMP-9	MMP-9	NNP
cord-023095-4dannjjm	1617	24	.	.	.
cord-023095-4dannjjm	1618	1	Another	another	DT
cord-023095-4dannjjm	1618	2	band	band	NN
cord-023095-4dannjjm	1618	3	of	of	IN
cord-023095-4dannjjm	1618	4	activity	activity	NN
cord-023095-4dannjjm	1618	5	was	be	VBD
cord-023095-4dannjjm	1618	6	also	also	RB
cord-023095-4dannjjm	1618	7	seen	see	VBN
cord-023095-4dannjjm	1618	8	at	at	IN
cord-023095-4dannjjm	1618	9	240	240	CD
cord-023095-4dannjjm	1618	10	kDa	kDa	NNS
cord-023095-4dannjjm	1618	11	which	which	WDT
cord-023095-4dannjjm	1618	12	is	be	VBZ
cord-023095-4dannjjm	1618	13	suggestive	suggestive	JJ
cord-023095-4dannjjm	1618	14	of	of	IN
cord-023095-4dannjjm	1618	15	a	a	DT
cord-023095-4dannjjm	1618	16	dimer	dimer	NN
cord-023095-4dannjjm	1618	17	of	of	IN
cord-023095-4dannjjm	1618	18	MMP-9	MMP-9	NNP
cord-023095-4dannjjm	1618	19	that	that	WDT
cord-023095-4dannjjm	1618	20	has	have	VBZ
cord-023095-4dannjjm	1618	21	been	be	VBN
cord-023095-4dannjjm	1618	22	reported	report	VBN
cord-023095-4dannjjm	1618	23	when	when	WRB
cord-023095-4dannjjm	1618	24	MMPs	mmp	NNS
cord-023095-4dannjjm	1618	25	are	be	VBP
cord-023095-4dannjjm	1618	26	in	in	IN
cord-023095-4dannjjm	1618	27	excess	excess	NN
cord-023095-4dannjjm	1618	28	of	of	IN
cord-023095-4dannjjm	1618	29	tissue	tissue	NN
cord-023095-4dannjjm	1618	30	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	1618	31	of	of	IN
cord-023095-4dannjjm	1618	32	metalloproteinases	metalloproteinase	NNS
cord-023095-4dannjjm	1618	33	(	(	-LRB-
cord-023095-4dannjjm	1618	34	TIMPs	TIMPs	NNP
cord-023095-4dannjjm	1618	35	)	)	-RRB-
cord-023095-4dannjjm	1618	36	.	.	.
cord-023095-4dannjjm	1619	1	Chondrocyte	Chondrocyte	NNP
cord-023095-4dannjjm	1619	2	cultures	culture	NNS
cord-023095-4dannjjm	1619	3	from	from	IN
cord-023095-4dannjjm	1619	4	homozygous	homozygous	JJ
cord-023095-4dannjjm	1619	5	HERDA	HERDA	NNP
cord-023095-4dannjjm	1619	6	cartilage	cartilage	NN
cord-023095-4dannjjm	1619	7	showed	show	VBD
cord-023095-4dannjjm	1619	8	a	a	DT
cord-023095-4dannjjm	1619	9	similar	similar	JJ
cord-023095-4dannjjm	1619	10	profile	profile	NN
cord-023095-4dannjjm	1619	11	but	but	CC
cord-023095-4dannjjm	1619	12	with	with	IN
cord-023095-4dannjjm	1619	13	decreased	decrease	VBN
cord-023095-4dannjjm	1619	14	activity	activity	NN
cord-023095-4dannjjm	1619	15	by	by	IN
cord-023095-4dannjjm	1619	16	90	90	CD
cord-023095-4dannjjm	1619	17	%	%	NN
cord-023095-4dannjjm	1619	18	at	at	IN
cord-023095-4dannjjm	1619	19	92	92	CD
cord-023095-4dannjjm	1619	20	kDa	kDa	NNS
cord-023095-4dannjjm	1619	21	and	and	CC
cord-023095-4dannjjm	1619	22	10	10	CD
cord-023095-4dannjjm	1619	23	-	-	SYM
cord-023095-4dannjjm	1619	24	50	50	CD
cord-023095-4dannjjm	1619	25	%	%	NN
cord-023095-4dannjjm	1619	26	increased	increase	VBN
cord-023095-4dannjjm	1619	27	activity	activity	NN
cord-023095-4dannjjm	1619	28	at	at	IN
cord-023095-4dannjjm	1619	29	72	72	CD
cord-023095-4dannjjm	1619	30	kDA	kda	XX
cord-023095-4dannjjm	1619	31	compared	compare	VBN
cord-023095-4dannjjm	1619	32	to	to	IN
cord-023095-4dannjjm	1619	33	normal	normal	JJ
cord-023095-4dannjjm	1619	34	chondrocytes	chondrocyte	NNS
cord-023095-4dannjjm	1619	35	.	.	.
cord-023095-4dannjjm	1620	1	Western	western	JJ
cord-023095-4dannjjm	1620	2	blot	blot	NN
cord-023095-4dannjjm	1620	3	analysis	analysis	NN
cord-023095-4dannjjm	1620	4	detected	detect	VBD
cord-023095-4dannjjm	1620	5	MMP-2	MMP-2	NNP
cord-023095-4dannjjm	1620	6	and	and	CC
cord-023095-4dannjjm	1620	7	MMP-9	MMP-9	NNP
cord-023095-4dannjjm	1620	8	immunoreactivity	immunoreactivity	NN
cord-023095-4dannjjm	1620	9	in	in	IN
cord-023095-4dannjjm	1620	10	chondrocyte	chondrocyte	NN
cord-023095-4dannjjm	1620	11	culture	culture	NN
cord-023095-4dannjjm	1620	12	media	medium	NNS
cord-023095-4dannjjm	1620	13	of	of	IN
cord-023095-4dannjjm	1620	14	HERDA	HERDA	NNP
cord-023095-4dannjjm	1620	15	-	-	HYPH
cord-023095-4dannjjm	1620	16	afflicted	afflict	VBN
cord-023095-4dannjjm	1620	17	and	and	CC
cord-023095-4dannjjm	1620	18	normal	normal	JJ
cord-023095-4dannjjm	1620	19	horses	horse	NNS
cord-023095-4dannjjm	1620	20	.	.	.
cord-023095-4dannjjm	1621	1	The	the	DT
cord-023095-4dannjjm	1621	2	present	present	JJ
cord-023095-4dannjjm	1621	3	study	study	NN
cord-023095-4dannjjm	1621	4	demonstrates	demonstrate	VBZ
cord-023095-4dannjjm	1621	5	for	for	IN
cord-023095-4dannjjm	1621	6	the	the	DT
cord-023095-4dannjjm	1621	7	first	first	JJ
cord-023095-4dannjjm	1621	8	time	time	NN
cord-023095-4dannjjm	1621	9	that	that	WDT
cord-023095-4dannjjm	1621	10	horses	horse	NNS
cord-023095-4dannjjm	1621	11	suffering	suffer	VBG
cord-023095-4dannjjm	1621	12	from	from	IN
cord-023095-4dannjjm	1621	13	HERDA	HERDA	NNP
cord-023095-4dannjjm	1621	14	have	have	VBP
cord-023095-4dannjjm	1621	15	increased	increase	VBN
cord-023095-4dannjjm	1621	16	MMP	MMP	NNP
cord-023095-4dannjjm	1621	17	activity	activity	NN
cord-023095-4dannjjm	1621	18	which	which	WDT
cord-023095-4dannjjm	1621	19	may	may	MD
cord-023095-4dannjjm	1621	20	predispose	predispose	VB
cord-023095-4dannjjm	1621	21	them	-PRON-	PRP
cord-023095-4dannjjm	1621	22	to	to	IN
cord-023095-4dannjjm	1621	23	the	the	DT
cord-023095-4dannjjm	1621	24	development	development	NN
cord-023095-4dannjjm	1621	25	of	of	IN
cord-023095-4dannjjm	1621	26	lesions	lesion	NNS
cord-023095-4dannjjm	1621	27	in	in	IN
cord-023095-4dannjjm	1621	28	articular	articular	JJ
cord-023095-4dannjjm	1621	29	cartilage	cartilage	NN
cord-023095-4dannjjm	1621	30	.	.	.
cord-023095-4dannjjm	1622	1	Research	research	NN
cord-023095-4dannjjm	1622	2	supported	support	VBN
cord-023095-4dannjjm	1622	3	by	by	IN
cord-023095-4dannjjm	1622	4	Nutramax	Nutramax	NNP
cord-023095-4dannjjm	1622	5	Laboratories	Laboratories	NNP
cord-023095-4dannjjm	1622	6	,	,	,
cord-023095-4dannjjm	1623	1	Inc.	Inc.	NNP
cord-023095-4dannjjm	1623	2	Equine	Equine	NNP
cord-023095-4dannjjm	1623	3	Polysaccharide	Polysaccharide	NNP
cord-023095-4dannjjm	1623	4	Storage	Storage	NNP
cord-023095-4dannjjm	1623	5	Myopathy	Myopathy	NNP
cord-023095-4dannjjm	1623	6	(	(	-LRB-
cord-023095-4dannjjm	1623	7	PSSM	PSSM	NNP
cord-023095-4dannjjm	1623	8	)	)	-RRB-
cord-023095-4dannjjm	1623	9	type	type	NN
cord-023095-4dannjjm	1623	10	1	1	CD
cord-023095-4dannjjm	1623	11	is	be	VBZ
cord-023095-4dannjjm	1623	12	a	a	DT
cord-023095-4dannjjm	1623	13	dominantly	dominantly	RB
cord-023095-4dannjjm	1623	14	inherited	inherit	VBN
cord-023095-4dannjjm	1623	15	glycogenosis	glycogenosis	NN
cord-023095-4dannjjm	1623	16	caused	cause	VBN
cord-023095-4dannjjm	1623	17	by	by	IN
cord-023095-4dannjjm	1623	18	a	a	DT
cord-023095-4dannjjm	1623	19	mutation	mutation	NN
cord-023095-4dannjjm	1623	20	in	in	IN
cord-023095-4dannjjm	1623	21	the	the	DT
cord-023095-4dannjjm	1623	22	gene	gene	NN
cord-023095-4dannjjm	1623	23	coding	code	VBG
cord-023095-4dannjjm	1623	24	for	for	IN
cord-023095-4dannjjm	1623	25	skeletal	skeletal	JJ
cord-023095-4dannjjm	1623	26	muscle	muscle	NN
cord-023095-4dannjjm	1623	27	glycogen	glycogen	NN
cord-023095-4dannjjm	1623	28	synthase	synthase	NN
cord-023095-4dannjjm	1623	29	type	type	NN
cord-023095-4dannjjm	1623	30	1	1	CD
cord-023095-4dannjjm	1623	31	(	(	-LRB-
cord-023095-4dannjjm	1623	32	GYS-1	GYS-1	NNP
cord-023095-4dannjjm	1623	33	)	)	-RRB-
cord-023095-4dannjjm	1623	34	.	.	.
cord-023095-4dannjjm	1624	1	The	the	DT
cord-023095-4dannjjm	1624	2	disease	disease	NN
cord-023095-4dannjjm	1624	3	has	have	VBZ
cord-023095-4dannjjm	1624	4	been	be	VBN
cord-023095-4dannjjm	1624	5	reported	report	VBN
cord-023095-4dannjjm	1624	6	to	to	TO
cord-023095-4dannjjm	1624	7	affect	affect	VB
cord-023095-4dannjjm	1624	8	the	the	DT
cord-023095-4dannjjm	1624	9	Haflinger	Haflinger	NNP
cord-023095-4dannjjm	1624	10	breed	breed	NN
cord-023095-4dannjjm	1625	1	but	but	CC
cord-023095-4dannjjm	1625	2	so	so	RB
cord-023095-4dannjjm	1625	3	far	far	RB
cord-023095-4dannjjm	1625	4	its	-PRON-	PRP$
cord-023095-4dannjjm	1625	5	prevalence	prevalence	NN
cord-023095-4dannjjm	1625	6	is	be	VBZ
cord-023095-4dannjjm	1625	7	unknown	unknown	JJ
cord-023095-4dannjjm	1625	8	.	.	.
cord-023095-4dannjjm	1626	1	Aim	aim	VB
cord-023095-4dannjjm	1626	2	of	of	IN
cord-023095-4dannjjm	1626	3	this	this	DT
cord-023095-4dannjjm	1626	4	preliminary	preliminary	JJ
cord-023095-4dannjjm	1626	5	study	study	NN
cord-023095-4dannjjm	1626	6	was	be	VBD
cord-023095-4dannjjm	1626	7	to	to	TO
cord-023095-4dannjjm	1626	8	estimate	estimate	VB
cord-023095-4dannjjm	1626	9	the	the	DT
cord-023095-4dannjjm	1626	10	occurrence	occurrence	NN
cord-023095-4dannjjm	1626	11	of	of	IN
cord-023095-4dannjjm	1626	12	the	the	DT
cord-023095-4dannjjm	1626	13	GYS-1	GYS-1	NNP
cord-023095-4dannjjm	1626	14	mutation	mutation	NN
cord-023095-4dannjjm	1626	15	in	in	IN
cord-023095-4dannjjm	1626	16	Austrian	Austrian	NNP
cord-023095-4dannjjm	1626	17	Haflingers	Haflingers	NNP
cord-023095-4dannjjm	1626	18	and	and	CC
cord-023095-4dannjjm	1626	19	establish	establish	VB
cord-023095-4dannjjm	1626	20	which	which	WDT
cord-023095-4dannjjm	1626	21	of	of	IN
cord-023095-4dannjjm	1626	22	the	the	DT
cord-023095-4dannjjm	1626	23	seven	seven	CD
cord-023095-4dannjjm	1626	24	Haflinger	Haflinger	NNP
cord-023095-4dannjjm	1626	25	sire	sire	NN
cord-023095-4dannjjm	1626	26	lines	line	NNS
cord-023095-4dannjjm	1626	27	appear	appear	VBP
cord-023095-4dannjjm	1626	28	mostly	mostly	RB
cord-023095-4dannjjm	1626	29	affected	affect	VBN
cord-023095-4dannjjm	1626	30	.	.	.
cord-023095-4dannjjm	1627	1	GYS-1	GYS-1	NNP
cord-023095-4dannjjm	1627	2	genotyping	genotyping	NN
cord-023095-4dannjjm	1627	3	of	of	IN
cord-023095-4dannjjm	1627	4	50	50	CD
cord-023095-4dannjjm	1627	5	randomly	randomly	RB
cord-023095-4dannjjm	1627	6	chosen	choose	VBN
cord-023095-4dannjjm	1627	7	Haflingers	Haflingers	NNPS
cord-023095-4dannjjm	1627	8	was	be	VBD
cord-023095-4dannjjm	1627	9	performed	perform	VBN
cord-023095-4dannjjm	1627	10	with	with	IN
cord-023095-4dannjjm	1627	11	a	a	DT
cord-023095-4dannjjm	1627	12	validated	validate	VBN
cord-023095-4dannjjm	1627	13	restriction	restriction	NN
cord-023095-4dannjjm	1627	14	fragment	fragment	NN
cord-023095-4dannjjm	1627	15	length	length	NN
cord-023095-4dannjjm	1627	16	polymorphism	polymorphism	NN
cord-023095-4dannjjm	1627	17	assay	assay	NN
cord-023095-4dannjjm	1627	18	.	.	.
cord-023095-4dannjjm	1628	1	Resting	rest	VBG
cord-023095-4dannjjm	1628	2	and	and	CC
cord-023095-4dannjjm	1628	3	post	post	JJ
cord-023095-4dannjjm	1628	4	-	-	JJ
cord-023095-4dannjjm	1628	5	exercise	exercise	JJ
cord-023095-4dannjjm	1628	6	muscle	muscle	NN
cord-023095-4dannjjm	1628	7	enzyme	enzyme	NN
cord-023095-4dannjjm	1628	8	activities	activity	NNS
cord-023095-4dannjjm	1628	9	(	(	-LRB-
cord-023095-4dannjjm	1628	10	creatine	creatine	NN
cord-023095-4dannjjm	1628	11	kinase	kinase	NN
cord-023095-4dannjjm	1628	12	(	(	-LRB-
cord-023095-4dannjjm	1628	13	CK	CK	NNP
cord-023095-4dannjjm	1628	14	)	)	-RRB-
cord-023095-4dannjjm	1628	15	,	,	,
cord-023095-4dannjjm	1628	16	aspartate	aspartate	NN
cord-023095-4dannjjm	1628	17	aminotransferase	aminotransferase	NN
cord-023095-4dannjjm	1628	18	(	(	-LRB-
cord-023095-4dannjjm	1628	19	AST	AST	NNP
cord-023095-4dannjjm	1628	20	)	)	-RRB-
cord-023095-4dannjjm	1628	21	,	,	,
cord-023095-4dannjjm	1628	22	lacate	lacate	NN
cord-023095-4dannjjm	1628	23	dehydrogenase	dehydrogenase	NN
cord-023095-4dannjjm	1628	24	(	(	-LRB-
cord-023095-4dannjjm	1628	25	LDH	LDH	NNP
cord-023095-4dannjjm	1628	26	)	)	-RRB-
cord-023095-4dannjjm	1628	27	)	)	-RRB-
cord-023095-4dannjjm	1628	28	and	and	CC
cord-023095-4dannjjm	1628	29	blood	blood	NN
cord-023095-4dannjjm	1628	30	lactate	lactate	NN
cord-023095-4dannjjm	1628	31	concentrations	concentration	NNS
cord-023095-4dannjjm	1628	32	were	be	VBD
cord-023095-4dannjjm	1628	33	compared	compare	VBN
cord-023095-4dannjjm	1628	34	between	between	IN
cord-023095-4dannjjm	1628	35	horses	horse	NNS
cord-023095-4dannjjm	1628	36	with	with	IN
cord-023095-4dannjjm	1628	37	and	and	CC
cord-023095-4dannjjm	1628	38	without	without	IN
cord-023095-4dannjjm	1628	39	the	the	DT
cord-023095-4dannjjm	1628	40	mutation	mutation	NN
cord-023095-4dannjjm	1628	41	.	.	.
cord-023095-4dannjjm	1629	1	Among	among	IN
cord-023095-4dannjjm	1629	2	the	the	DT
cord-023095-4dannjjm	1629	3	50	50	CD
cord-023095-4dannjjm	1629	4	horses	horse	NNS
cord-023095-4dannjjm	1629	5	9	9	CD
cord-023095-4dannjjm	1629	6	were	be	VBD
cord-023095-4dannjjm	1629	7	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	1629	8	(	(	-LRB-
cord-023095-4dannjjm	1629	9	HR	HR	NNP
cord-023095-4dannjjm	1629	10	)	)	-RRB-
cord-023095-4dannjjm	1629	11	carrier	carrier	NN
cord-023095-4dannjjm	1629	12	of	of	IN
cord-023095-4dannjjm	1629	13	the	the	DT
cord-023095-4dannjjm	1629	14	mutation	mutation	NN
cord-023095-4dannjjm	1629	15	.	.	.
cord-023095-4dannjjm	1630	1	No	no	DT
cord-023095-4dannjjm	1630	2	homozygotes	homozygote	NNS
cord-023095-4dannjjm	1630	3	(	(	-LRB-
cord-023095-4dannjjm	1630	4	HH	HH	NNP
cord-023095-4dannjjm	1630	5	)	)	-RRB-
cord-023095-4dannjjm	1630	6	were	be	VBD
cord-023095-4dannjjm	1630	7	identified	identify	VBN
cord-023095-4dannjjm	1630	8	.	.	.
cord-023095-4dannjjm	1631	1	All	all	DT
cord-023095-4dannjjm	1631	2	horses	horse	NNS
cord-023095-4dannjjm	1631	3	with	with	IN
cord-023095-4dannjjm	1631	4	the	the	DT
cord-023095-4dannjjm	1631	5	GYS-1	GYS-1	NNP
cord-023095-4dannjjm	1631	6	mutation	mutation	NN
cord-023095-4dannjjm	1631	7	were	be	VBD
cord-023095-4dannjjm	1631	8	descendents	descendent	NNS
cord-023095-4dannjjm	1631	9	of	of	IN
cord-023095-4dannjjm	1631	10	the	the	DT
cord-023095-4dannjjm	1631	11	A	A	NNP
cord-023095-4dannjjm	1631	12	-	-	:
cord-023095-4dannjjm	1631	13	or	or	CC
cord-023095-4dannjjm	1631	14	W	w	NN
cord-023095-4dannjjm	1631	15	-	-	HYPH
cord-023095-4dannjjm	1631	16	sire	sire	JJ
cord-023095-4dannjjm	1631	17	lines	line	NNS
cord-023095-4dannjjm	1631	18	.	.	.
cord-023095-4dannjjm	1632	1	The	the	DT
cord-023095-4dannjjm	1632	2	estimated	estimated	JJ
cord-023095-4dannjjm	1632	3	HR	hr	NN
cord-023095-4dannjjm	1632	4	prevalence	prevalence	NN
cord-023095-4dannjjm	1632	5	was	be	VBD
cord-023095-4dannjjm	1632	6	18	18	CD
cord-023095-4dannjjm	1632	7	%	%	NN
cord-023095-4dannjjm	1632	8	(	(	-LRB-
cord-023095-4dannjjm	1632	9	95	95	CD
cord-023095-4dannjjm	1632	10	%	%	NN
cord-023095-4dannjjm	1632	11	CI	ci	NN
cord-023095-4dannjjm	1632	12	:	:	:
cord-023095-4dannjjm	1632	13	8.6	8.6	CD
cord-023095-4dannjjm	1632	14	-	-	HYPH
cord-023095-4dannjjm	1632	15	32.4	32.4	CD
cord-023095-4dannjjm	1632	16	%	%	NN
cord-023095-4dannjjm	1632	17	)	)	-RRB-
cord-023095-4dannjjm	1632	18	.	.	.
cord-023095-4dannjjm	1633	1	CK	CK	NNP
cord-023095-4dannjjm	1633	2	activity	activity	NN
cord-023095-4dannjjm	1633	3	after	after	IN
cord-023095-4dannjjm	1633	4	exercise	exercise	NN
cord-023095-4dannjjm	1633	5	(	(	-LRB-
cord-023095-4dannjjm	1633	6	p	p	NN
cord-023095-4dannjjm	1633	7	5	5	CD
cord-023095-4dannjjm	1633	8	0.022	0.022	CD
cord-023095-4dannjjm	1633	9	)	)	-RRB-
cord-023095-4dannjjm	1633	10	was	be	VBD
cord-023095-4dannjjm	1633	11	significantly	significantly	RB
cord-023095-4dannjjm	1633	12	higher	high	JJR
cord-023095-4dannjjm	1633	13	in	in	IN
cord-023095-4dannjjm	1633	14	HR	hr	NN
cord-023095-4dannjjm	1633	15	horses	horse	NNS
cord-023095-4dannjjm	1633	16	compared	compare	VBN
cord-023095-4dannjjm	1633	17	with	with	IN
cord-023095-4dannjjm	1633	18	horses	horse	NNS
cord-023095-4dannjjm	1633	19	not	not	RB
cord-023095-4dannjjm	1633	20	carrying	carry	VBG
cord-023095-4dannjjm	1633	21	the	the	DT
cord-023095-4dannjjm	1633	22	mutation	mutation	NN
cord-023095-4dannjjm	1633	23	(	(	-LRB-
cord-023095-4dannjjm	1633	24	RR	RR	NNP
cord-023095-4dannjjm	1633	25	)	)	-RRB-
cord-023095-4dannjjm	1633	26	.	.	.
cord-023095-4dannjjm	1634	1	AST	ast	NN
cord-023095-4dannjjm	1634	2	activity	activity	NN
cord-023095-4dannjjm	1634	3	was	be	VBD
cord-023095-4dannjjm	1634	4	significantly	significantly	RB
cord-023095-4dannjjm	1634	5	higher	high	JJR
cord-023095-4dannjjm	1634	6	in	in	IN
cord-023095-4dannjjm	1634	7	the	the	DT
cord-023095-4dannjjm	1634	8	HR	hr	NN
cord-023095-4dannjjm	1634	9	group	group	NN
cord-023095-4dannjjm	1634	10	at	at	IN
cord-023095-4dannjjm	1634	11	rest	rest	NN
cord-023095-4dannjjm	1634	12	and	and	CC
cord-023095-4dannjjm	1634	13	after	after	IN
cord-023095-4dannjjm	1634	14	exercise	exercise	NN
cord-023095-4dannjjm	1634	15	(	(	-LRB-
cord-023095-4dannjjm	1634	16	p	p	NN
cord-023095-4dannjjm	1634	17	o	o	CD
cord-023095-4dannjjm	1634	18	0.001	0.001	CD
cord-023095-4dannjjm	1634	19	)	)	-RRB-
cord-023095-4dannjjm	1634	20	.	.	.
cord-023095-4dannjjm	1635	1	There	there	EX
cord-023095-4dannjjm	1635	2	was	be	VBD
cord-023095-4dannjjm	1635	3	no	no	DT
cord-023095-4dannjjm	1635	4	statistically	statistically	RB
cord-023095-4dannjjm	1635	5	significant	significant	JJ
cord-023095-4dannjjm	1635	6	difference	difference	NN
cord-023095-4dannjjm	1635	7	in	in	IN
cord-023095-4dannjjm	1635	8	resting	rest	VBG
cord-023095-4dannjjm	1635	9	CK	CK	NNP
cord-023095-4dannjjm	1635	10	,	,	,
cord-023095-4dannjjm	1635	11	resting	resting	NN
cord-023095-4dannjjm	1635	12	and	and	CC
cord-023095-4dannjjm	1635	13	post	post	NN
cord-023095-4dannjjm	1635	14	exercise	exercise	NN
cord-023095-4dannjjm	1636	1	LDH	LDH	NNP
cord-023095-4dannjjm	1636	2	activity	activity	NN
cord-023095-4dannjjm	1636	3	or	or	CC
cord-023095-4dannjjm	1636	4	blood	blood	NN
cord-023095-4dannjjm	1636	5	lactate	lactate	NN
cord-023095-4dannjjm	1636	6	between	between	IN
cord-023095-4dannjjm	1636	7	HR	hr	NN
cord-023095-4dannjjm	1636	8	and	and	CC
cord-023095-4dannjjm	1636	9	RR	rr	NN
cord-023095-4dannjjm	1636	10	.	.	.
cord-023095-4dannjjm	1637	1	Results	result	NNS
cord-023095-4dannjjm	1637	2	suggest	suggest	VBP
cord-023095-4dannjjm	1637	3	that	that	IN
cord-023095-4dannjjm	1637	4	the	the	DT
cord-023095-4dannjjm	1637	5	prevalence	prevalence	NN
cord-023095-4dannjjm	1637	6	of	of	IN
cord-023095-4dannjjm	1637	7	HR	hr	NN
cord-023095-4dannjjm	1637	8	in	in	IN
cord-023095-4dannjjm	1637	9	the	the	DT
cord-023095-4dannjjm	1637	10	Austrian	austrian	JJ
cord-023095-4dannjjm	1637	11	Haflinger	Haflinger	NNP
cord-023095-4dannjjm	1637	12	population	population	NN
cord-023095-4dannjjm	1637	13	is	be	VBZ
cord-023095-4dannjjm	1637	14	higher	high	JJR
cord-023095-4dannjjm	1637	15	than	than	IN
cord-023095-4dannjjm	1637	16	in	in	IN
cord-023095-4dannjjm	1637	17	the	the	DT
cord-023095-4dannjjm	1637	18	overall	overall	JJ
cord-023095-4dannjjm	1637	19	Quarter	Quarter	NNP
cord-023095-4dannjjm	1637	20	Horse	Horse	NNP
cord-023095-4dannjjm	1637	21	population	population	NN
cord-023095-4dannjjm	1637	22	and	and	CC
cord-023095-4dannjjm	1637	23	might	may	MD
cord-023095-4dannjjm	1637	24	be	be	VB
cord-023095-4dannjjm	1637	25	as	as	RB
cord-023095-4dannjjm	1637	26	high	high	JJ
cord-023095-4dannjjm	1637	27	as	as	IN
cord-023095-4dannjjm	1637	28	30	30	CD
cord-023095-4dannjjm	1637	29	%	%	NN
cord-023095-4dannjjm	1637	30	,	,	,
cord-023095-4dannjjm	1637	31	similar	similar	JJ
cord-023095-4dannjjm	1637	32	to	to	IN
cord-023095-4dannjjm	1637	33	some	some	DT
cord-023095-4dannjjm	1637	34	Draft	Draft	NNP
cord-023095-4dannjjm	1637	35	horse	horse	NN
cord-023095-4dannjjm	1637	36	breeds	breed	NNS
cord-023095-4dannjjm	1637	37	.	.	.
cord-023095-4dannjjm	1638	1	Further	further	JJ
cord-023095-4dannjjm	1638	2	research	research	NN
cord-023095-4dannjjm	1638	3	is	be	VBZ
cord-023095-4dannjjm	1638	4	needed	need	VBN
cord-023095-4dannjjm	1638	5	to	to	TO
cord-023095-4dannjjm	1638	6	establish	establish	VB
cord-023095-4dannjjm	1638	7	the	the	DT
cord-023095-4dannjjm	1638	8	prevalence	prevalence	NN
cord-023095-4dannjjm	1638	9	within	within	IN
cord-023095-4dannjjm	1638	10	the	the	DT
cord-023095-4dannjjm	1638	11	different	different	JJ
cord-023095-4dannjjm	1638	12	breeding	breeding	NN
cord-023095-4dannjjm	1638	13	lines	line	NNS
cord-023095-4dannjjm	1638	14	.	.	.
cord-023095-4dannjjm	1639	1	Hereditary	hereditary	JJ
cord-023095-4dannjjm	1639	2	equine	equine	JJ
cord-023095-4dannjjm	1639	3	regional	regional	JJ
cord-023095-4dannjjm	1639	4	dermal	dermal	JJ
cord-023095-4dannjjm	1639	5	asthenia	asthenia	NN
cord-023095-4dannjjm	1639	6	(	(	-LRB-
cord-023095-4dannjjm	1639	7	HERDA	HERDA	NNP
cord-023095-4dannjjm	1639	8	)	)	-RRB-
cord-023095-4dannjjm	1639	9	is	be	VBZ
cord-023095-4dannjjm	1639	10	an	an	DT
cord-023095-4dannjjm	1639	11	autosomal	autosomal	JJ
cord-023095-4dannjjm	1639	12	recessive	recessive	JJ
cord-023095-4dannjjm	1639	13	connective	connective	JJ
cord-023095-4dannjjm	1639	14	tissue	tissue	NN
cord-023095-4dannjjm	1639	15	disorder	disorder	NN
cord-023095-4dannjjm	1639	16	affecting	affect	VBG
cord-023095-4dannjjm	1639	17	Quarter	Quarter	NNP
cord-023095-4dannjjm	1639	18	Horse	Horse	NNP
cord-023095-4dannjjm	1639	19	lineages	lineage	NNS
cord-023095-4dannjjm	1639	20	.	.	.
cord-023095-4dannjjm	1640	1	1	1	LS
cord-023095-4dannjjm	1641	1	Although	although	IN
cord-023095-4dannjjm	1641	2	a	a	DT
cord-023095-4dannjjm	1641	3	mutation	mutation	NN
cord-023095-4dannjjm	1641	4	in	in	IN
cord-023095-4dannjjm	1641	5	the	the	DT
cord-023095-4dannjjm	1641	6	gene	gene	NN
cord-023095-4dannjjm	1641	7	encoding	encode	VBG
cord-023095-4dannjjm	1641	8	cyclophilin	cyclophilin	NNP
cord-023095-4dannjjm	1641	9	B	B	NNP
cord-023095-4dannjjm	1641	10	has	have	VBZ
cord-023095-4dannjjm	1641	11	been	be	VBN
cord-023095-4dannjjm	1641	12	genetically	genetically	RB
cord-023095-4dannjjm	1641	13	linked	link	VBN
cord-023095-4dannjjm	1641	14	to	to	IN
cord-023095-4dannjjm	1641	15	HERDA	HERDA	NNP
cord-023095-4dannjjm	1641	16	,	,	,
cord-023095-4dannjjm	1641	17	its	-PRON-	PRP$
cord-023095-4dannjjm	1641	18	causal	causal	JJ
cord-023095-4dannjjm	1641	19	association	association	NN
cord-023095-4dannjjm	1641	20	with	with	IN
cord-023095-4dannjjm	1641	21	the	the	DT
cord-023095-4dannjjm	1641	22	disease	disease	NN
cord-023095-4dannjjm	1641	23	is	be	VBZ
cord-023095-4dannjjm	1641	24	not	not	RB
cord-023095-4dannjjm	1641	25	yet	yet	RB
cord-023095-4dannjjm	1641	26	documented	document	VBN
cord-023095-4dannjjm	1641	27	.	.	.
cord-023095-4dannjjm	1642	1	2	2	LS
cord-023095-4dannjjm	1643	1	Previously	previously	RB
cord-023095-4dannjjm	1643	2	,	,	,
cord-023095-4dannjjm	1643	3	we	-PRON-	PRP
cord-023095-4dannjjm	1643	4	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	1643	5	reductions	reduction	NNS
cord-023095-4dannjjm	1643	6	in	in	IN
cord-023095-4dannjjm	1643	7	ultimate	ultimate	JJ
cord-023095-4dannjjm	1643	8	tensile	tensile	JJ
cord-023095-4dannjjm	1643	9	strength	strength	NN
cord-023095-4dannjjm	1643	10	(	(	-LRB-
cord-023095-4dannjjm	1643	11	UTS	UTS	NNP
cord-023095-4dannjjm	1643	12	)	)	-RRB-
cord-023095-4dannjjm	1643	13	,	,	,
cord-023095-4dannjjm	1643	14	modulus	modulus	NN
cord-023095-4dannjjm	1643	15	of	of	IN
cord-023095-4dannjjm	1643	16	elasticity	elasticity	NN
cord-023095-4dannjjm	1643	17	,	,	,
cord-023095-4dannjjm	1643	18	and	and	CC
cord-023095-4dannjjm	1643	19	energy	energy	NN
cord-023095-4dannjjm	1643	20	to	to	IN
cord-023095-4dannjjm	1643	21	failure	failure	NN
cord-023095-4dannjjm	1643	22	(	(	-LRB-
cord-023095-4dannjjm	1643	23	toughness	toughness	NN
cord-023095-4dannjjm	1643	24	)	)	-RRB-
cord-023095-4dannjjm	1643	25	of	of	IN
cord-023095-4dannjjm	1643	26	skin	skin	NN
cord-023095-4dannjjm	1643	27	from	from	IN
cord-023095-4dannjjm	1643	28	many	many	JJ
cord-023095-4dannjjm	1643	29	corporal	corporal	JJ
cord-023095-4dannjjm	1643	30	regions	region	NNS
cord-023095-4dannjjm	1643	31	of	of	IN
cord-023095-4dannjjm	1643	32	HERDA	HERDA	NNP
cord-023095-4dannjjm	1643	33	animals	animal	NNS
cord-023095-4dannjjm	1643	34	.	.	.
cord-023095-4dannjjm	1644	1	3	3	LS
cord-023095-4dannjjm	1645	1	Given	give	VBN
cord-023095-4dannjjm	1645	2	the	the	DT
cord-023095-4dannjjm	1645	3	presumed	presume	VBN
cord-023095-4dannjjm	1645	4	relationship	relationship	NN
cord-023095-4dannjjm	1645	5	between	between	IN
cord-023095-4dannjjm	1645	6	HER	HER	NNP
cord-023095-4dannjjm	1645	7	-	-	HYPH
cord-023095-4dannjjm	1645	8	DA	DA	NNP
cord-023095-4dannjjm	1645	9	and	and	CC
cord-023095-4dannjjm	1645	10	abnormal	abnormal	JJ
cord-023095-4dannjjm	1645	11	collagen	collagen	NN
cord-023095-4dannjjm	1645	12	structure	structure	NN
cord-023095-4dannjjm	1645	13	,	,	,
cord-023095-4dannjjm	1645	14	and	and	CC
cord-023095-4dannjjm	1645	15	the	the	DT
cord-023095-4dannjjm	1645	16	predominance	predominance	NN
cord-023095-4dannjjm	1645	17	of	of	IN
cord-023095-4dannjjm	1645	18	Type	type	NN
cord-023095-4dannjjm	1645	19	I	-PRON-	PRP
cord-023095-4dannjjm	1645	20	collagen	collagen	NN
cord-023095-4dannjjm	1645	21	in	in	IN
cord-023095-4dannjjm	1645	22	skin	skin	NN
cord-023095-4dannjjm	1645	23	,	,	,
cord-023095-4dannjjm	1645	24	we	-PRON-	PRP
cord-023095-4dannjjm	1645	25	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1645	26	that	that	IN
cord-023095-4dannjjm	1645	27	altered	alter	VBN
cord-023095-4dannjjm	1645	28	biomechanical	biomechanical	JJ
cord-023095-4dannjjm	1645	29	properties	property	NNS
cord-023095-4dannjjm	1645	30	would	would	MD
cord-023095-4dannjjm	1645	31	be	be	VB
cord-023095-4dannjjm	1645	32	detected	detect	VBN
cord-023095-4dannjjm	1645	33	in	in	IN
cord-023095-4dannjjm	1645	34	tendons	tendon	NNS
cord-023095-4dannjjm	1645	35	which	which	WDT
cord-023095-4dannjjm	1645	36	are	be	VBP
cord-023095-4dannjjm	1645	37	rich	rich	JJ
cord-023095-4dannjjm	1645	38	in	in	IN
cord-023095-4dannjjm	1645	39	Type	type	NN
cord-023095-4dannjjm	1645	40	I	-PRON-	PRP
cord-023095-4dannjjm	1645	41	collagen	collagen	NN
cord-023095-4dannjjm	1645	42	.	.	.
cord-023095-4dannjjm	1646	1	To	to	TO
cord-023095-4dannjjm	1646	2	evaluate	evaluate	VB
cord-023095-4dannjjm	1646	3	this	this	DT
cord-023095-4dannjjm	1646	4	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1646	5	we	-PRON-	PRP
cord-023095-4dannjjm	1646	6	compared	compare	VBD
cord-023095-4dannjjm	1646	7	the	the	DT
cord-023095-4dannjjm	1646	8	UTS	UTS	NNP
cord-023095-4dannjjm	1646	9	,	,	,
cord-023095-4dannjjm	1646	10	modulus	modulus	NN
cord-023095-4dannjjm	1646	11	of	of	IN
cord-023095-4dannjjm	1646	12	elasticity	elasticity	NN
cord-023095-4dannjjm	1646	13	,	,	,
cord-023095-4dannjjm	1646	14	and	and	CC
cord-023095-4dannjjm	1646	15	energy	energy	NN
cord-023095-4dannjjm	1646	16	to	to	IN
cord-023095-4dannjjm	1646	17	failure	failure	NN
cord-023095-4dannjjm	1646	18	of	of	IN
cord-023095-4dannjjm	1646	19	forelimb	forelimb	NN
cord-023095-4dannjjm	1646	20	deep	deep	JJ
cord-023095-4dannjjm	1646	21	digital	digital	JJ
cord-023095-4dannjjm	1646	22	flexor	flexor	NN
cord-023095-4dannjjm	1646	23	tendons	tendon	NNS
cord-023095-4dannjjm	1646	24	(	(	-LRB-
cord-023095-4dannjjm	1646	25	DFT	DFT	NNP
cord-023095-4dannjjm	1646	26	)	)	-RRB-
cord-023095-4dannjjm	1646	27	from	from	IN
cord-023095-4dannjjm	1646	28	six	six	CD
cord-023095-4dannjjm	1646	29	HERDA	HERDA	NNP
cord-023095-4dannjjm	1646	30	horses	horse	NNS
cord-023095-4dannjjm	1646	31	to	to	IN
cord-023095-4dannjjm	1646	32	six	six	CD
cord-023095-4dannjjm	1646	33	age	age	NN
cord-023095-4dannjjm	1646	34	-	-	HYPH
cord-023095-4dannjjm	1646	35	matched	match	VBN
cord-023095-4dannjjm	1646	36	controls	control	NNS
cord-023095-4dannjjm	1646	37	.	.	.
cord-023095-4dannjjm	1647	1	Isolated	isolated	JJ
cord-023095-4dannjjm	1647	2	DFT	DFT	NNP
cord-023095-4dannjjm	1647	3	was	be	VBD
cord-023095-4dannjjm	1647	4	secured	secure	VBN
cord-023095-4dannjjm	1647	5	and	and	CC
cord-023095-4dannjjm	1647	6	pulled	pull	VBN
cord-023095-4dannjjm	1647	7	to	to	IN
cord-023095-4dannjjm	1647	8	failure	failure	NN
cord-023095-4dannjjm	1647	9	on	on	IN
cord-023095-4dannjjm	1647	10	an	an	DT
cord-023095-4dannjjm	1647	11	Instron	Instron	NNP
cord-023095-4dannjjm	1647	12	s	s	POS
cord-023095-4dannjjm	1647	13	1011	1011	CD
cord-023095-4dannjjm	1647	14	Universal	Universal	NNP
cord-023095-4dannjjm	1647	15	Testing	Testing	NNP
cord-023095-4dannjjm	1647	16	Instrument	Instrument	NNP
cord-023095-4dannjjm	1647	17	using	use	VBG
cord-023095-4dannjjm	1647	18	purpose	purpose	NN
cord-023095-4dannjjm	1647	19	-	-	HYPH
cord-023095-4dannjjm	1647	20	built	build	VBN
cord-023095-4dannjjm	1647	21	cryogenic	cryogenic	JJ
cord-023095-4dannjjm	1647	22	clamps	clamp	NNS
cord-023095-4dannjjm	1647	23	.	.	.
cord-023095-4dannjjm	1648	1	Analysis	analysis	NN
cord-023095-4dannjjm	1648	2	of	of	IN
cord-023095-4dannjjm	1648	3	Variance	variance	NN
cord-023095-4dannjjm	1648	4	was	be	VBD
cord-023095-4dannjjm	1648	5	executed	execute	VBN
cord-023095-4dannjjm	1648	6	using	use	VBG
cord-023095-4dannjjm	1648	7	SAS	SAS	NNP
cord-023095-4dannjjm	1648	8	9.2	9.2	CD
cord-023095-4dannjjm	1648	9	PROC	proc	NN
cord-023095-4dannjjm	1648	10	GLIMMIX	GLIMMIX	NNP
cord-023095-4dannjjm	1648	11	program	program	NN
cord-023095-4dannjjm	1648	12	(	(	-LRB-
cord-023095-4dannjjm	1648	13	SAS	SAS	NNP
cord-023095-4dannjjm	1648	14	Institute	Institute	NNP
cord-023095-4dannjjm	1648	15	,	,	,
cord-023095-4dannjjm	1648	16	2009	2009	CD
cord-023095-4dannjjm	1648	17	)	)	-RRB-
cord-023095-4dannjjm	1648	18	.	.	.
cord-023095-4dannjjm	1649	1	P	p	NN
cord-023095-4dannjjm	1649	2	-	-	HYPH
cord-023095-4dannjjm	1649	3	values	value	NNS
cord-023095-4dannjjm	1649	4	0.05	0.05	CD
cord-023095-4dannjjm	1649	5	were	be	VBD
cord-023095-4dannjjm	1649	6	identified	identify	VBN
cord-023095-4dannjjm	1649	7	as	as	IN
cord-023095-4dannjjm	1649	8	significant	significant	JJ
cord-023095-4dannjjm	1649	9	.	.	.
cord-023095-4dannjjm	1650	1	UTS	UTS	NNP
cord-023095-4dannjjm	1650	2	and	and	CC
cord-023095-4dannjjm	1650	3	modulus	modulus	NN
cord-023095-4dannjjm	1650	4	of	of	IN
cord-023095-4dannjjm	1650	5	elasticity	elasticity	NN
cord-023095-4dannjjm	1650	6	were	be	VBD
cord-023095-4dannjjm	1650	7	significantly	significantly	RB
cord-023095-4dannjjm	1650	8	lower	low	JJR
cord-023095-4dannjjm	1650	9	in	in	IN
cord-023095-4dannjjm	1650	10	HERDA	HERDA	NNP
cord-023095-4dannjjm	1650	11	DFT	DFT	NNP
cord-023095-4dannjjm	1650	12	when	when	WRB
cord-023095-4dannjjm	1650	13	compared	compare	VBN
cord-023095-4dannjjm	1650	14	with	with	IN
cord-023095-4dannjjm	1650	15	controls	control	NNS
cord-023095-4dannjjm	1650	16	(	(	-LRB-
cord-023095-4dannjjm	1650	17	P	p	NN
cord-023095-4dannjjm	1650	18	o	o	CD
cord-023095-4dannjjm	1650	19	0.0001	0.0001	CD
cord-023095-4dannjjm	1650	20	)	)	-RRB-
cord-023095-4dannjjm	1650	21	;	;	:
cord-023095-4dannjjm	1650	22	energy	energy	NN
cord-023095-4dannjjm	1650	23	to	to	IN
cord-023095-4dannjjm	1650	24	failure	failure	NN
cord-023095-4dannjjm	1650	25	did	do	VBD
cord-023095-4dannjjm	1650	26	not	not	RB
cord-023095-4dannjjm	1650	27	differ	differ	VB
cord-023095-4dannjjm	1650	28	between	between	IN
cord-023095-4dannjjm	1650	29	groups	group	NNS
cord-023095-4dannjjm	1650	30	.	.	.
cord-023095-4dannjjm	1651	1	These	these	DT
cord-023095-4dannjjm	1651	2	findings	finding	NNS
cord-023095-4dannjjm	1651	3	document	document	NN
cord-023095-4dannjjm	1651	4	abnormal	abnormal	JJ
cord-023095-4dannjjm	1651	5	biomechanics	biomechanic	NNS
cord-023095-4dannjjm	1651	6	in	in	IN
cord-023095-4dannjjm	1651	7	HERDA	HERDA	NNP
cord-023095-4dannjjm	1651	8	tendon	tendon	NN
cord-023095-4dannjjm	1651	9	,	,	,
cord-023095-4dannjjm	1651	10	leading	lead	VBG
cord-023095-4dannjjm	1651	11	us	-PRON-	PRP
cord-023095-4dannjjm	1651	12	to	to	TO
cord-023095-4dannjjm	1651	13	postulate	postulate	VB
cord-023095-4dannjjm	1651	14	that	that	IN
cord-023095-4dannjjm	1651	15	lower	low	JJR
cord-023095-4dannjjm	1651	16	UTS	UTS	NNP
cord-023095-4dannjjm	1651	17	and	and	CC
cord-023095-4dannjjm	1651	18	modulus	modulus	NN
cord-023095-4dannjjm	1651	19	of	of	IN
cord-023095-4dannjjm	1651	20	elasticity	elasticity	NN
cord-023095-4dannjjm	1651	21	associated	associate	VBN
cord-023095-4dannjjm	1651	22	with	with	IN
cord-023095-4dannjjm	1651	23	the	the	DT
cord-023095-4dannjjm	1651	24	HERDA	HERDA	NNP
cord-023095-4dannjjm	1651	25	defect	defect	NN
cord-023095-4dannjjm	1651	26	could	could	MD
cord-023095-4dannjjm	1651	27	convey	convey	VB
cord-023095-4dannjjm	1651	28	a	a	DT
cord-023095-4dannjjm	1651	29	competitive	competitive	JJ
cord-023095-4dannjjm	1651	30	advantage	advantage	NN
cord-023095-4dannjjm	1651	31	in	in	IN
cord-023095-4dannjjm	1651	32	the	the	DT
cord-023095-4dannjjm	1651	33	athletic	athletic	JJ
cord-023095-4dannjjm	1651	34	disciplines	discipline	NNS
cord-023095-4dannjjm	1651	35	in	in	IN
cord-023095-4dannjjm	1651	36	which	which	WDT
cord-023095-4dannjjm	1651	37	this	this	DT
cord-023095-4dannjjm	1651	38	defect	defect	NN
cord-023095-4dannjjm	1651	39	has	have	VBZ
cord-023095-4dannjjm	1651	40	segregated	segregate	VBN
cord-023095-4dannjjm	1651	41	.	.	.
cord-023095-4dannjjm	1652	1	(	(	-LRB-
cord-023095-4dannjjm	1652	2	References	reference	NNS
cord-023095-4dannjjm	1652	3	on	on	IN
cord-023095-4dannjjm	1652	4	request	request	NN
cord-023095-4dannjjm	1652	5	)	)	-RRB-
cord-023095-4dannjjm	1652	6	.	.	.
cord-023095-4dannjjm	1653	1	A	a	DT
cord-023095-4dannjjm	1653	2	proprietary	proprietary	JJ
cord-023095-4dannjjm	1653	3	herbal	herbal	JJ
cord-023095-4dannjjm	1653	4	biocontamination	biocontamination	NN
cord-023095-4dannjjm	1653	5	product	product	NN
cord-023095-4dannjjm	1653	6	(	(	-LRB-
cord-023095-4dannjjm	1653	7	BIOS	BIOS	NNP
cord-023095-4dannjjm	1653	8	)	)	-RRB-
cord-023095-4dannjjm	1653	9	approved	approve	VBN
cord-023095-4dannjjm	1653	10	for	for	IN
cord-023095-4dannjjm	1653	11	cosmetic	cosmetic	JJ
cord-023095-4dannjjm	1653	12	use	use	NN
cord-023095-4dannjjm	1653	13	in	in	IN
cord-023095-4dannjjm	1653	14	France	France	NNP
cord-023095-4dannjjm	1653	15	,	,	,
cord-023095-4dannjjm	1653	16	inhibits	inhibit	VBZ
cord-023095-4dannjjm	1653	17	proliferation	proliferation	NN
cord-023095-4dannjjm	1653	18	of	of	IN
cord-023095-4dannjjm	1653	19	medically	medically	RB
cord-023095-4dannjjm	1653	20	relevant	relevant	JJ
cord-023095-4dannjjm	1653	21	bacteria	bacteria	NNS
cord-023095-4dannjjm	1653	22	,	,	,
cord-023095-4dannjjm	1653	23	mold	mold	NN
cord-023095-4dannjjm	1653	24	,	,	,
cord-023095-4dannjjm	1653	25	and	and	CC
cord-023095-4dannjjm	1653	26	viruses	virus	NNS
cord-023095-4dannjjm	1653	27	.	.	.
cord-023095-4dannjjm	1654	1	These	these	DT
cord-023095-4dannjjm	1654	2	properties	property	NNS
cord-023095-4dannjjm	1654	3	make	make	VBP
cord-023095-4dannjjm	1654	4	BIOS	bio	NNS
cord-023095-4dannjjm	1654	5	potentially	potentially	RB
cord-023095-4dannjjm	1654	6	useful	useful	JJ
cord-023095-4dannjjm	1654	7	as	as	IN
cord-023095-4dannjjm	1654	8	a	a	DT
cord-023095-4dannjjm	1654	9	topical	topical	JJ
cord-023095-4dannjjm	1654	10	wound	wound	NN
cord-023095-4dannjjm	1654	11	medication	medication	NN
cord-023095-4dannjjm	1654	12	,	,	,
cord-023095-4dannjjm	1654	13	prompting	prompt	VBG
cord-023095-4dannjjm	1654	14	us	-PRON-	PRP
cord-023095-4dannjjm	1654	15	to	to	TO
cord-023095-4dannjjm	1654	16	compare	compare	VB
cord-023095-4dannjjm	1654	17	BIOS	bio	NNS
cord-023095-4dannjjm	1654	18	to	to	IN
cord-023095-4dannjjm	1654	19	silver	silver	NN
cord-023095-4dannjjm	1654	20	sulfadiazine	sulfadiazine	NNP
cord-023095-4dannjjm	1654	21	(	(	-LRB-
cord-023095-4dannjjm	1654	22	SSD	SSD	NNP
cord-023095-4dannjjm	1654	23	)	)	-RRB-
cord-023095-4dannjjm	1654	24	in	in	IN
cord-023095-4dannjjm	1654	25	a	a	DT
cord-023095-4dannjjm	1654	26	distal	distal	JJ
cord-023095-4dannjjm	1654	27	extremity	extremity	NN
cord-023095-4dannjjm	1654	28	wound	wound	NN
cord-023095-4dannjjm	1654	29	healing	healing	NN
cord-023095-4dannjjm	1654	30	model	model	NN
cord-023095-4dannjjm	1654	31	in	in	IN
cord-023095-4dannjjm	1654	32	horses	horse	NNS
cord-023095-4dannjjm	1654	33	.	.	.
cord-023095-4dannjjm	1655	1	1	1	LS
cord-023095-4dannjjm	1656	1	Using	use	VBG
cord-023095-4dannjjm	1656	2	general	general	JJ
cord-023095-4dannjjm	1656	3	anesthesia	anesthesia	NNP
cord-023095-4dannjjm	1656	4	,	,	,
cord-023095-4dannjjm	1656	5	two	two	CD
cord-023095-4dannjjm	1656	6	6.25	6.25	CD
cord-023095-4dannjjm	1656	7	cm	cm	NNS
cord-023095-4dannjjm	1656	8	2	2	CD
cord-023095-4dannjjm	1656	9	wounds	wound	NNS
cord-023095-4dannjjm	1656	10	were	be	VBD
cord-023095-4dannjjm	1656	11	aseptically	aseptically	RB
cord-023095-4dannjjm	1656	12	created	create	VBN
cord-023095-4dannjjm	1656	13	on	on	IN
cord-023095-4dannjjm	1656	14	the	the	DT
cord-023095-4dannjjm	1656	15	dorsomedial	dorsomedial	JJ
cord-023095-4dannjjm	1656	16	aspect	aspect	NN
cord-023095-4dannjjm	1656	17	of	of	IN
cord-023095-4dannjjm	1656	18	all	all	DT
cord-023095-4dannjjm	1656	19	limbs	limb	NNS
cord-023095-4dannjjm	1656	20	.	.	.
cord-023095-4dannjjm	1657	1	For	for	IN
cord-023095-4dannjjm	1657	2	the	the	DT
cord-023095-4dannjjm	1657	3	duration	duration	NN
cord-023095-4dannjjm	1657	4	of	of	IN
cord-023095-4dannjjm	1657	5	the	the	DT
cord-023095-4dannjjm	1657	6	study	study	NN
cord-023095-4dannjjm	1657	7	,	,	,
cord-023095-4dannjjm	1657	8	two	two	CD
cord-023095-4dannjjm	1657	9	contralateral	contralateral	JJ
cord-023095-4dannjjm	1657	10	limbs	limb	NNS
cord-023095-4dannjjm	1657	11	were	be	VBD
cord-023095-4dannjjm	1657	12	randomly	randomly	RB
cord-023095-4dannjjm	1657	13	chosen	choose	VBN
cord-023095-4dannjjm	1657	14	to	to	TO
cord-023095-4dannjjm	1657	15	be	be	VB
cord-023095-4dannjjm	1657	16	bandaged	bandage	VBN
cord-023095-4dannjjm	1657	17	;	;	:
cord-023095-4dannjjm	1657	18	the	the	DT
cord-023095-4dannjjm	1657	19	other	other	JJ
cord-023095-4dannjjm	1657	20	two	two	CD
cord-023095-4dannjjm	1657	21	limbs	limb	NNS
cord-023095-4dannjjm	1657	22	were	be	VBD
cord-023095-4dannjjm	1657	23	un	un	NNP
cord-023095-4dannjjm	1657	24	-	-	JJ
cord-023095-4dannjjm	1657	25	bandaged	bandage	VBN
cord-023095-4dannjjm	1658	1	-with	-with	:
cord-023095-4dannjjm	1658	2	one	one	CD
cord-023095-4dannjjm	1658	3	limb	limb	NN
cord-023095-4dannjjm	1658	4	of	of	IN
cord-023095-4dannjjm	1658	5	each	each	DT
cord-023095-4dannjjm	1658	6	group	group	NN
cord-023095-4dannjjm	1658	7	being	be	VBG
cord-023095-4dannjjm	1658	8	treated	treat	VBN
cord-023095-4dannjjm	1658	9	with	with	IN
cord-023095-4dannjjm	1658	10	10	10	CD
cord-023095-4dannjjm	1658	11	%	%	NN
cord-023095-4dannjjm	1658	12	BIOS	bio	NNS
cord-023095-4dannjjm	1658	13	and	and	CC
cord-023095-4dannjjm	1658	14	the	the	DT
cord-023095-4dannjjm	1658	15	other	other	JJ
cord-023095-4dannjjm	1658	16	with	with	IN
cord-023095-4dannjjm	1658	17	SSD	SSD	NNP
cord-023095-4dannjjm	1658	18	.	.	.
cord-023095-4dannjjm	1659	1	For	for	IN
cord-023095-4dannjjm	1659	2	each	each	DT
cord-023095-4dannjjm	1659	3	limb	limb	NN
cord-023095-4dannjjm	1659	4	the	the	DT
cord-023095-4dannjjm	1659	5	most	most	RBS
cord-023095-4dannjjm	1659	6	proximal	proximal	JJ
cord-023095-4dannjjm	1659	7	wound	wound	NN
cord-023095-4dannjjm	1659	8	served	serve	VBD
cord-023095-4dannjjm	1659	9	as	as	IN
cord-023095-4dannjjm	1659	10	an	an	DT
cord-023095-4dannjjm	1659	11	untreated	untreated	JJ
cord-023095-4dannjjm	1659	12	control	control	NN
cord-023095-4dannjjm	1659	13	.	.	.
cord-023095-4dannjjm	1660	1	Every	every	DT
cord-023095-4dannjjm	1660	2	48	48	CD
cord-023095-4dannjjm	1660	3	hours	hour	NNS
cord-023095-4dannjjm	1660	4	wounds	wound	NNS
cord-023095-4dannjjm	1660	5	were	be	VBD
cord-023095-4dannjjm	1660	6	evaluated	evaluate	VBN
cord-023095-4dannjjm	1660	7	,	,	,
cord-023095-4dannjjm	1660	8	digitally	digitally	RB
cord-023095-4dannjjm	1660	9	photographed	photograph	VBN
cord-023095-4dannjjm	1660	10	,	,	,
cord-023095-4dannjjm	1660	11	and	and	CC
cord-023095-4dannjjm	1660	12	perimeter	perimeter	NN
cord-023095-4dannjjm	1660	13	and	and	CC
cord-023095-4dannjjm	1660	14	area	area	NN
cord-023095-4dannjjm	1660	15	determined	determine	VBD
cord-023095-4dannjjm	1660	16	using	use	VBG
cord-023095-4dannjjm	1660	17	morphometric	morphometric	JJ
cord-023095-4dannjjm	1660	18	software	software	NN
cord-023095-4dannjjm	1660	19	(	(	-LRB-
cord-023095-4dannjjm	1660	20	ImageJ	imagej	RB
cord-023095-4dannjjm	1660	21	,	,	,
cord-023095-4dannjjm	1660	22	NIH	NIH	NNP
cord-023095-4dannjjm	1660	23	)	)	-RRB-
cord-023095-4dannjjm	1660	24	.	.	.
cord-023095-4dannjjm	1661	1	Analysis	analysis	NN
cord-023095-4dannjjm	1661	2	of	of	IN
cord-023095-4dannjjm	1661	3	variance	variance	NN
cord-023095-4dannjjm	1661	4	did	do	VBD
cord-023095-4dannjjm	1661	5	not	not	RB
cord-023095-4dannjjm	1661	6	identify	identify	VB
cord-023095-4dannjjm	1661	7	significant	significant	JJ
cord-023095-4dannjjm	1661	8	differences	difference	NNS
cord-023095-4dannjjm	1661	9	between	between	IN
cord-023095-4dannjjm	1661	10	SSD	SSD	NNP
cord-023095-4dannjjm	1661	11	or	or	CC
cord-023095-4dannjjm	1661	12	BIOS	bios	NN
cord-023095-4dannjjm	1661	13	treatment	treatment	NN
cord-023095-4dannjjm	1661	14	for	for	IN
cord-023095-4dannjjm	1661	15	wound	wound	NN
cord-023095-4dannjjm	1661	16	perimeter	perimeter	NN
cord-023095-4dannjjm	1661	17	(	(	-LRB-
cord-023095-4dannjjm	1661	18	p	p	NN
cord-023095-4dannjjm	1661	19	5	5	CD
cord-023095-4dannjjm	1661	20	0.76	0.76	CD
cord-023095-4dannjjm	1661	21	)	)	-RRB-
cord-023095-4dannjjm	1661	22	or	or	CC
cord-023095-4dannjjm	1661	23	area	area	NN
cord-023095-4dannjjm	1661	24	(	(	-LRB-
cord-023095-4dannjjm	1661	25	p	p	NN
cord-023095-4dannjjm	1661	26	5	5	CD
cord-023095-4dannjjm	1661	27	0.95	0.95	CD
cord-023095-4dannjjm	1661	28	)	)	-RRB-
cord-023095-4dannjjm	1661	29	.	.	.
cord-023095-4dannjjm	1662	1	At	at	IN
cord-023095-4dannjjm	1662	2	individual	individual	JJ
cord-023095-4dannjjm	1662	3	time	time	NN
cord-023095-4dannjjm	1662	4	points	point	VBZ
cord-023095-4dannjjm	1662	5	the	the	DT
cord-023095-4dannjjm	1662	6	effect	effect	NN
cord-023095-4dannjjm	1662	7	of	of	IN
cord-023095-4dannjjm	1662	8	bandaging	bandaging	NN
cord-023095-4dannjjm	1662	9	was	be	VBD
cord-023095-4dannjjm	1662	10	significant	significant	JJ
cord-023095-4dannjjm	1662	11	when	when	WRB
cord-023095-4dannjjm	1662	12	area	area	NN
cord-023095-4dannjjm	1662	13	was	be	VBD
cord-023095-4dannjjm	1662	14	evaluated	evaluate	VBN
cord-023095-4dannjjm	1662	15	(	(	-LRB-
cord-023095-4dannjjm	1662	16	p	p	NN
cord-023095-4dannjjm	1662	17	5	5	CD
cord-023095-4dannjjm	1662	18	0.019	0.019	CD
cord-023095-4dannjjm	1662	19	)	)	-RRB-
cord-023095-4dannjjm	1662	20	and	and	CC
cord-023095-4dannjjm	1662	21	trended	trend	VBD
cord-023095-4dannjjm	1662	22	toward	toward	IN
cord-023095-4dannjjm	1662	23	significance	significance	NN
cord-023095-4dannjjm	1662	24	for	for	IN
cord-023095-4dannjjm	1662	25	perimeter	perimeter	NN
cord-023095-4dannjjm	1662	26	(	(	-LRB-
cord-023095-4dannjjm	1662	27	p	p	NN
cord-023095-4dannjjm	1662	28	5	5	CD
cord-023095-4dannjjm	1662	29	0.084	0.084	CD
cord-023095-4dannjjm	1662	30	)	)	-RRB-
cord-023095-4dannjjm	1662	31	comparisons	comparison	NNS
cord-023095-4dannjjm	1662	32	,	,	,
cord-023095-4dannjjm	1662	33	substantiating	substantiate	VBG
cord-023095-4dannjjm	1662	34	published	publish	VBN
cord-023095-4dannjjm	1662	35	reports	report	NNS
cord-023095-4dannjjm	1662	36	that	that	IN
cord-023095-4dannjjm	1662	37	bandaging	bandaging	NN
cord-023095-4dannjjm	1662	38	modifies	modify	VBZ
cord-023095-4dannjjm	1662	39	wound	wind	VBN
cord-023095-4dannjjm	1662	40	healing	healing	NN
cord-023095-4dannjjm	1662	41	.	.	.
cord-023095-4dannjjm	1663	1	Difference	difference	NN
cord-023095-4dannjjm	1663	2	in	in	IN
cord-023095-4dannjjm	1663	3	perimeter	perimeter	NN
cord-023095-4dannjjm	1663	4	and	and	CC
cord-023095-4dannjjm	1663	5	area	area	NN
cord-023095-4dannjjm	1663	6	between	between	IN
cord-023095-4dannjjm	1663	7	control	control	NN
cord-023095-4dannjjm	1663	8	and	and	CC
cord-023095-4dannjjm	1663	9	treatment	treatment	NN
cord-023095-4dannjjm	1663	10	were	be	VBD
cord-023095-4dannjjm	1663	11	highly	highly	RB
cord-023095-4dannjjm	1663	12	significant	significant	JJ
cord-023095-4dannjjm	1663	13	(	(	-LRB-
cord-023095-4dannjjm	1663	14	p	p	NN
cord-023095-4dannjjm	1663	15	o	o	NN
cord-023095-4dannjjm	1663	16	0.0001	0.0001	CD
cord-023095-4dannjjm	1663	17	)	)	-RRB-
cord-023095-4dannjjm	1663	18	,	,	,
cord-023095-4dannjjm	1663	19	substantiating	substantiate	VBG
cord-023095-4dannjjm	1663	20	the	the	DT
cord-023095-4dannjjm	1663	21	importance	importance	NN
cord-023095-4dannjjm	1663	22	of	of	IN
cord-023095-4dannjjm	1663	23	topical	topical	JJ
cord-023095-4dannjjm	1663	24	treatment	treatment	NN
cord-023095-4dannjjm	1663	25	.	.	.
cord-023095-4dannjjm	1664	1	Over	over	IN
cord-023095-4dannjjm	1664	2	the	the	DT
cord-023095-4dannjjm	1664	3	study	study	NN
cord-023095-4dannjjm	1664	4	duration	duration	NN
cord-023095-4dannjjm	1664	5	,	,	,
cord-023095-4dannjjm	1664	6	effects	effect	NNS
cord-023095-4dannjjm	1664	7	of	of	IN
cord-023095-4dannjjm	1664	8	bandaging	bandaging	NN
cord-023095-4dannjjm	1664	9	(	(	-LRB-
cord-023095-4dannjjm	1664	10	p	p	NN
cord-023095-4dannjjm	1664	11	o	o	NN
cord-023095-4dannjjm	1664	12	0.0001	0.0001	CD
cord-023095-4dannjjm	1664	13	)	)	-RRB-
cord-023095-4dannjjm	1664	14	and	and	CC
cord-023095-4dannjjm	1664	15	topical	topical	JJ
cord-023095-4dannjjm	1664	16	treatment	treatment	NN
cord-023095-4dannjjm	1664	17	(	(	-LRB-
cord-023095-4dannjjm	1664	18	perimeter	perimeter	NN
cord-023095-4dannjjm	1664	19	p	p	NN
cord-023095-4dannjjm	1664	20	o	o	NN
cord-023095-4dannjjm	1664	21	0.0001	0.0001	CD
cord-023095-4dannjjm	1664	22	;	;	:
cord-023095-4dannjjm	1664	23	area	area	NN
cord-023095-4dannjjm	1664	24	p	p	NN
cord-023095-4dannjjm	1664	25	5	5	CD
cord-023095-4dannjjm	1664	26	0.0016	0.0016	CD
cord-023095-4dannjjm	1664	27	)	)	-RRB-
cord-023095-4dannjjm	1664	28	continued	continue	VBD
cord-023095-4dannjjm	1664	29	to	to	TO
cord-023095-4dannjjm	1664	30	be	be	VB
cord-023095-4dannjjm	1664	31	highly	highly	RB
cord-023095-4dannjjm	1664	32	significant	significant	JJ
cord-023095-4dannjjm	1664	33	.	.	.
cord-023095-4dannjjm	1665	1	BIOS	bios	NN
cord-023095-4dannjjm	1665	2	performance	performance	NN
cord-023095-4dannjjm	1665	3	in	in	IN
cord-023095-4dannjjm	1665	4	the	the	DT
cord-023095-4dannjjm	1665	5	equine	equine	JJ
cord-023095-4dannjjm	1665	6	distal	distal	JJ
cord-023095-4dannjjm	1665	7	extremity	extremity	NN
cord-023095-4dannjjm	1665	8	wound	wound	NN
cord-023095-4dannjjm	1665	9	model	model	NN
cord-023095-4dannjjm	1665	10	was	be	VBD
cord-023095-4dannjjm	1665	11	equivalent	equivalent	JJ
cord-023095-4dannjjm	1665	12	to	to	IN
cord-023095-4dannjjm	1665	13	SSD	SSD	NNP
cord-023095-4dannjjm	1665	14	.	.	.
cord-023095-4dannjjm	1666	1	Both	both	DT
cord-023095-4dannjjm	1666	2	bandaging	bandaging	NN
cord-023095-4dannjjm	1666	3	and	and	CC
cord-023095-4dannjjm	1666	4	topical	topical	JJ
cord-023095-4dannjjm	1666	5	treatment	treatment	NN
cord-023095-4dannjjm	1666	6	significantly	significantly	RB
cord-023095-4dannjjm	1666	7	impacted	impact	VBD
cord-023095-4dannjjm	1666	8	wound	wound	NN
cord-023095-4dannjjm	1666	9	healing	healing	NN
cord-023095-4dannjjm	1666	10	.	.	.
cord-023095-4dannjjm	1667	1	This	this	DT
cord-023095-4dannjjm	1667	2	effect	effect	NN
cord-023095-4dannjjm	1667	3	was	be	VBD
cord-023095-4dannjjm	1667	4	compounded	compound	VBN
cord-023095-4dannjjm	1667	5	when	when	WRB
cord-023095-4dannjjm	1667	6	both	both	DT
cord-023095-4dannjjm	1667	7	variables	variable	NNS
cord-023095-4dannjjm	1667	8	were	be	VBD
cord-023095-4dannjjm	1667	9	evaluated	evaluate	VBN
cord-023095-4dannjjm	1667	10	over	over	IN
cord-023095-4dannjjm	1667	11	time	time	NN
cord-023095-4dannjjm	1667	12	.	.	.
cord-023095-4dannjjm	1668	1	Radiolabeled	Radiolabeled	NNP
cord-023095-4dannjjm	1668	2	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1668	3	are	be	VBP
cord-023095-4dannjjm	1668	4	the	the	DT
cord-023095-4dannjjm	1668	5	only	only	JJ
cord-023095-4dannjjm	1668	6	scintigraphic	scintigraphic	JJ
cord-023095-4dannjjm	1668	7	method	method	NN
cord-023095-4dannjjm	1668	8	currently	currently	RB
cord-023095-4dannjjm	1668	9	available	available	JJ
cord-023095-4dannjjm	1668	10	for	for	IN
cord-023095-4dannjjm	1668	11	identifying	identify	VBG
cord-023095-4dannjjm	1668	12	sites	site	NNS
cord-023095-4dannjjm	1668	13	of	of	IN
cord-023095-4dannjjm	1668	14	infection	infection	NN
cord-023095-4dannjjm	1668	15	and/or	and/or	CC
cord-023095-4dannjjm	1668	16	inflammation	inflammation	NN
cord-023095-4dannjjm	1668	17	in	in	IN
cord-023095-4dannjjm	1668	18	horses	horse	NNS
cord-023095-4dannjjm	1668	19	;	;	:
cord-023095-4dannjjm	1668	20	however	however	RB
cord-023095-4dannjjm	1668	21	the	the	DT
cord-023095-4dannjjm	1668	22	clinical	clinical	JJ
cord-023095-4dannjjm	1668	23	applicability	applicability	NN
cord-023095-4dannjjm	1668	24	of	of	IN
cord-023095-4dannjjm	1668	25	this	this	DT
cord-023095-4dannjjm	1668	26	technique	technique	NN
cord-023095-4dannjjm	1668	27	is	be	VBZ
cord-023095-4dannjjm	1668	28	limited	limit	VBN
cord-023095-4dannjjm	1668	29	by	by	IN
cord-023095-4dannjjm	1668	30	expense	expense	NN
cord-023095-4dannjjm	1668	31	and	and	CC
cord-023095-4dannjjm	1668	32	poor	poor	JJ
cord-023095-4dannjjm	1668	33	efficacy	efficacy	NN
cord-023095-4dannjjm	1668	34	.	.	.
cord-023095-4dannjjm	1669	1	This	this	DT
cord-023095-4dannjjm	1669	2	pilot	pilot	NN
cord-023095-4dannjjm	1669	3	study	study	NN
cord-023095-4dannjjm	1669	4	compares	compare	VBZ
cord-023095-4dannjjm	1669	5	the	the	DT
cord-023095-4dannjjm	1669	6	accumulation	accumulation	NN
cord-023095-4dannjjm	1669	7	of	of	IN
cord-023095-4dannjjm	1669	8	99	99	CD
cord-023095-4dannjjm	1669	9	m	m	NN
cord-023095-4dannjjm	1669	10	Tc	Tc	NNP
cord-023095-4dannjjm	1669	11	-	-	HYPH
cord-023095-4dannjjm	1669	12	labeled	label	VBN
cord-023095-4dannjjm	1669	13	IgG	igg	NN
cord-023095-4dannjjm	1669	14	,	,	,
cord-023095-4dannjjm	1669	15	PEG	peg	NN
cord-023095-4dannjjm	1669	16	-	-	HYPH
cord-023095-4dannjjm	1669	17	liposomes	liposome	NNS
cord-023095-4dannjjm	1669	18	and	and	CC
cord-023095-4dannjjm	1669	19	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1669	20	in	in	IN
cord-023095-4dannjjm	1669	21	an	an	DT
cord-023095-4dannjjm	1669	22	equine	equine	JJ
cord-023095-4dannjjm	1669	23	muscle	muscle	NN
cord-023095-4dannjjm	1669	24	abscess	abscess	NN
cord-023095-4dannjjm	1669	25	model	model	NN
cord-023095-4dannjjm	1669	26	.	.	.
cord-023095-4dannjjm	1670	1	Three	three	CD
cord-023095-4dannjjm	1670	2	mixed	mixed	JJ
cord-023095-4dannjjm	1670	3	breed	breed	NN
cord-023095-4dannjjm	1670	4	adult	adult	NN
cord-023095-4dannjjm	1670	5	horses	horse	NNS
cord-023095-4dannjjm	1670	6	had	have	VBD
cord-023095-4dannjjm	1670	7	2	2	CD
cord-023095-4dannjjm	1670	8	Â	â	CD
cord-023095-4dannjjm	1670	9	10	10	CD
cord-023095-4dannjjm	1670	10	6	6	CD
cord-023095-4dannjjm	1670	11	CFU	CFU	NNP
cord-023095-4dannjjm	1670	12	S.	S.	NNP
cord-023095-4dannjjm	1670	13	equi	equi	NN
cord-023095-4dannjjm	1670	14	zooepidemicus	zooepidemicus	NN
cord-023095-4dannjjm	1670	15	inoculated	inoculate	VBN
cord-023095-4dannjjm	1670	16	into	into	IN
cord-023095-4dannjjm	1670	17	the	the	DT
cord-023095-4dannjjm	1670	18	right	right	JJ
cord-023095-4dannjjm	1670	19	semitendonosis	semitendonosis	NN
cord-023095-4dannjjm	1670	20	to	to	TO
cord-023095-4dannjjm	1670	21	create	create	VB
cord-023095-4dannjjm	1670	22	an	an	DT
cord-023095-4dannjjm	1670	23	abscess	abscess	NN
cord-023095-4dannjjm	1670	24	.	.	.
cord-023095-4dannjjm	1671	1	PEG	peg	NN
cord-023095-4dannjjm	1671	2	-	-	HYPH
cord-023095-4dannjjm	1671	3	liposomes	liposome	NNS
cord-023095-4dannjjm	1671	4	were	be	VBD
cord-023095-4dannjjm	1671	5	prepared	prepare	VBN
cord-023095-4dannjjm	1671	6	via	via	IN
cord-023095-4dannjjm	1671	7	the	the	DT
cord-023095-4dannjjm	1671	8	film	film	NN
cord-023095-4dannjjm	1671	9	hydration	hydration	NN
cord-023095-4dannjjm	1671	10	method	method	NN
cord-023095-4dannjjm	1671	11	and	and	CC
cord-023095-4dannjjm	1671	12	labeled	label	VBD
cord-023095-4dannjjm	1671	13	using	use	VBG
cord-023095-4dannjjm	1671	14	200	200	CD
cord-023095-4dannjjm	1671	15	mCi	mCi	NNS
cord-023095-4dannjjm	1671	16	99	99	CD
cord-023095-4dannjjm	1671	17	m	m	NN
cord-023095-4dannjjm	1671	18	Tc	Tc	NNP
cord-023095-4dannjjm	1671	19	-	-	HYPH
cord-023095-4dannjjm	1671	20	hexamethyl	hexamethyl	JJ
cord-023095-4dannjjm	1671	21	-	-	HYPH
cord-023095-4dannjjm	1671	22	propylene	propylene	NN
cord-023095-4dannjjm	1671	23	-	-	HYPH
cord-023095-4dannjjm	1671	24	amine	amine	NN
cord-023095-4dannjjm	1671	25	-	-	HYPH
cord-023095-4dannjjm	1671	26	oxime	oxime	NN
cord-023095-4dannjjm	1671	27	(	(	-LRB-
cord-023095-4dannjjm	1671	28	99	99	CD
cord-023095-4dannjjm	1671	29	m	m	NN
cord-023095-4dannjjm	1671	30	Tc	Tc	NNP
cord-023095-4dannjjm	1671	31	-	-	HYPH
cord-023095-4dannjjm	1671	32	HMPAO	HMPAO	NNP
cord-023095-4dannjjm	1671	33	)	)	-RRB-
cord-023095-4dannjjm	1671	34	.	.	.
cord-023095-4dannjjm	1672	1	Autologous	autologous	JJ
cord-023095-4dannjjm	1672	2	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1672	3	were	be	VBD
cord-023095-4dannjjm	1672	4	obtained	obtain	VBN
cord-023095-4dannjjm	1672	5	from	from	IN
cord-023095-4dannjjm	1672	6	120	120	CD
cord-023095-4dannjjm	1672	7	ml	ml	NN
cord-023095-4dannjjm	1672	8	whole	whole	JJ
cord-023095-4dannjjm	1672	9	blood	blood	NN
cord-023095-4dannjjm	1672	10	and	and	CC
cord-023095-4dannjjm	1672	11	labelled	label	VBD
cord-023095-4dannjjm	1672	12	using	use	VBG
cord-023095-4dannjjm	1672	13	200	200	CD
cord-023095-4dannjjm	1672	14	mCi	mCi	NNS
cord-023095-4dannjjm	1672	15	99	99	CD
cord-023095-4dannjjm	1672	16	m	m	NNP
cord-023095-4dannjjm	1672	17	Tc	Tc	NNP
cord-023095-4dannjjm	1672	18	-	-	HYPH
cord-023095-4dannjjm	1672	19	HMPAO	HMPAO	NNP
cord-023095-4dannjjm	1672	20	.	.	.
cord-023095-4dannjjm	1673	1	Commercial	commercial	JJ
cord-023095-4dannjjm	1673	2	equine	equine	JJ
cord-023095-4dannjjm	1673	3	polyclonal	polyclonal	JJ
cord-023095-4dannjjm	1673	4	IgG	igg	NN
cord-023095-4dannjjm	1673	5	was	be	VBD
cord-023095-4dannjjm	1673	6	conjugated	conjugate	VBN
cord-023095-4dannjjm	1673	7	with	with	IN
cord-023095-4dannjjm	1673	8	the	the	DT
cord-023095-4dannjjm	1673	9	chelator	chelator	NN
cord-023095-4dannjjm	1673	10	hydrazinonicotinamide	hydrazinonicotinamide	NN
cord-023095-4dannjjm	1673	11	(	(	-LRB-
cord-023095-4dannjjm	1673	12	HYNIC	HYNIC	NNP
cord-023095-4dannjjm	1673	13	)	)	-RRB-
cord-023095-4dannjjm	1673	14	and	and	CC
cord-023095-4dannjjm	1673	15	labelled	label	VBN
cord-023095-4dannjjm	1673	16	with	with	IN
cord-023095-4dannjjm	1673	17	200	200	CD
cord-023095-4dannjjm	1673	18	mCi	mCi	NNS
cord-023095-4dannjjm	1673	19	99	99	CD
cord-023095-4dannjjm	1673	20	m	m	NN
cord-023095-4dannjjm	1673	21	Tc	Tc	NNP
cord-023095-4dannjjm	1673	22	.	.	.
cord-023095-4dannjjm	1673	23	Radiopharmaceutical	Radiopharmaceutical	NNP
cord-023095-4dannjjm	1673	24	administration	administration	NN
cord-023095-4dannjjm	1673	25	was	be	VBD
cord-023095-4dannjjm	1673	26	initiated	initiate	VBN
cord-023095-4dannjjm	1673	27	24	24	CD
cord-023095-4dannjjm	1673	28	hours	hour	NNS
cord-023095-4dannjjm	1673	29	after	after	IN
cord-023095-4dannjjm	1673	30	inoculation	inoculation	NN
cord-023095-4dannjjm	1673	31	.	.	.
cord-023095-4dannjjm	1674	1	Horses	horse	NNS
cord-023095-4dannjjm	1674	2	1	1	CD
cord-023095-4dannjjm	1674	3	and	and	CC
cord-023095-4dannjjm	1674	4	2	2	CD
cord-023095-4dannjjm	1674	5	received	receive	VBD
cord-023095-4dannjjm	1674	6	5	5	CD
cord-023095-4dannjjm	1674	7	mg	mg	CD
cord-023095-4dannjjm	1674	8	99	99	CD
cord-023095-4dannjjm	1674	9	m	m	NNP
cord-023095-4dannjjm	1674	10	Tc	Tc	NNP
cord-023095-4dannjjm	1674	11	-	-	HYPH
cord-023095-4dannjjm	1674	12	IgG	IgG	NNP
cord-023095-4dannjjm	1674	13	,	,	,
cord-023095-4dannjjm	1674	14	2.7	2.7	CD
cord-023095-4dannjjm	1674	15	mmol	mmol	JJ
cord-023095-4dannjjm	1674	16	/	/	SYM
cord-023095-4dannjjm	1674	17	kg	kg	NN
cord-023095-4dannjjm	1674	18	99	99	CD
cord-023095-4dannjjm	1674	19	m	m	NNP
cord-023095-4dannjjm	1674	20	Tc	Tc	NNP
cord-023095-4dannjjm	1674	21	-	-	HYPH
cord-023095-4dannjjm	1674	22	liposomes	liposome	NNS
cord-023095-4dannjjm	1674	23	and	and	CC
cord-023095-4dannjjm	1674	24	99	99	CD
cord-023095-4dannjjm	1674	25	m	m	NN
cord-023095-4dannjjm	1674	26	Tc	Tc	NNP
cord-023095-4dannjjm	1674	27	-	-	HYPH
cord-023095-4dannjjm	1674	28	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1674	29	,	,	,
cord-023095-4dannjjm	1674	30	with	with	IN
cord-023095-4dannjjm	1674	31	a	a	DT
cord-023095-4dannjjm	1674	32	48	48	CD
cord-023095-4dannjjm	1674	33	hour	hour	NN
cord-023095-4dannjjm	1674	34	interval	interval	NN
cord-023095-4dannjjm	1674	35	between	between	IN
cord-023095-4dannjjm	1674	36	each	each	DT
cord-023095-4dannjjm	1674	37	radiopharmaceutical	radiopharmaceutical	NN
cord-023095-4dannjjm	1674	38	.	.	.
cord-023095-4dannjjm	1675	1	Horse	horse	NN
cord-023095-4dannjjm	1675	2	3	3	CD
cord-023095-4dannjjm	1675	3	received	receive	VBD
cord-023095-4dannjjm	1675	4	only	only	RB
cord-023095-4dannjjm	1675	5	99	99	CD
cord-023095-4dannjjm	1675	6	m	m	NN
cord-023095-4dannjjm	1675	7	Tc	Tc	NNP
cord-023095-4dannjjm	1675	8	-	-	HYPH
cord-023095-4dannjjm	1675	9	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1675	10	.	.	.
cord-023095-4dannjjm	1676	1	Scintigraphic	scintigraphic	JJ
cord-023095-4dannjjm	1676	2	examinations	examination	NNS
cord-023095-4dannjjm	1676	3	were	be	VBD
cord-023095-4dannjjm	1676	4	performed	perform	VBN
cord-023095-4dannjjm	1676	5	at	at	IN
cord-023095-4dannjjm	1676	6	8	8	CD
cord-023095-4dannjjm	1676	7	and	and	CC
cord-023095-4dannjjm	1676	8	21	21	CD
cord-023095-4dannjjm	1676	9	hours	hour	NNS
cord-023095-4dannjjm	1676	10	post	post	NN
cord-023095-4dannjjm	1676	11	injection	injection	NN
cord-023095-4dannjjm	1676	12	(	(	-LRB-
cord-023095-4dannjjm	1676	13	p.i	p.i	NNP
cord-023095-4dannjjm	1676	14	.	.	NNP
cord-023095-4dannjjm	1676	15	)	)	-RRB-
cord-023095-4dannjjm	1676	16	with	with	IN
cord-023095-4dannjjm	1676	17	each	each	DT
cord-023095-4dannjjm	1676	18	radiopharmaceutical	radiopharmaceutical	NN
cord-023095-4dannjjm	1676	19	.	.	.
cord-023095-4dannjjm	1677	1	After	after	IN
cord-023095-4dannjjm	1677	2	the	the	DT
cord-023095-4dannjjm	1677	3	final	final	JJ
cord-023095-4dannjjm	1677	4	study	study	NN
cord-023095-4dannjjm	1677	5	,	,	,
cord-023095-4dannjjm	1677	6	horses	horse	NNS
cord-023095-4dannjjm	1677	7	were	be	VBD
cord-023095-4dannjjm	1677	8	euthanized	euthanize	VBN
cord-023095-4dannjjm	1677	9	and	and	CC
cord-023095-4dannjjm	1677	10	tissue	tissue	NN
cord-023095-4dannjjm	1677	11	samples	sample	NNS
cord-023095-4dannjjm	1677	12	collected	collect	VBN
cord-023095-4dannjjm	1677	13	.	.	.
cord-023095-4dannjjm	1678	1	The	the	DT
cord-023095-4dannjjm	1678	2	percentage	percentage	NN
cord-023095-4dannjjm	1678	3	of	of	IN
cord-023095-4dannjjm	1678	4	injected	inject	VBN
cord-023095-4dannjjm	1678	5	dose	dose	NN
cord-023095-4dannjjm	1678	6	per	per	IN
cord-023095-4dannjjm	1678	7	kilogram	kilogram	NN
cord-023095-4dannjjm	1678	8	of	of	IN
cord-023095-4dannjjm	1678	9	tissue	tissue	NN
cord-023095-4dannjjm	1678	10	(	(	-LRB-
cord-023095-4dannjjm	1678	11	%	%	NN
cord-023095-4dannjjm	1678	12	ID	ID	NNP
cord-023095-4dannjjm	1678	13	/	/	SYM
cord-023095-4dannjjm	1678	14	kg	kg	NNP
cord-023095-4dannjjm	1678	15	)	)	-RRB-
cord-023095-4dannjjm	1678	16	was	be	VBD
cord-023095-4dannjjm	1678	17	calculated	calculate	VBN
cord-023095-4dannjjm	1678	18	for	for	IN
cord-023095-4dannjjm	1678	19	the	the	DT
cord-023095-4dannjjm	1678	20	region	region	NN
cord-023095-4dannjjm	1678	21	of	of	IN
cord-023095-4dannjjm	1678	22	the	the	DT
cord-023095-4dannjjm	1678	23	abscess	abscess	NN
cord-023095-4dannjjm	1678	24	,	,	,
cord-023095-4dannjjm	1678	25	normal	normal	JJ
cord-023095-4dannjjm	1678	26	muscle	muscle	NN
cord-023095-4dannjjm	1678	27	and	and	CC
cord-023095-4dannjjm	1678	28	multiple	multiple	JJ
cord-023095-4dannjjm	1678	29	organs	organ	NNS
cord-023095-4dannjjm	1678	30	.	.	.
cord-023095-4dannjjm	1679	1	Scintigraphic	scintigraphic	JJ
cord-023095-4dannjjm	1679	2	examinations	examination	NNS
cord-023095-4dannjjm	1679	3	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	1679	4	increased	increase	VBN
cord-023095-4dannjjm	1679	5	radiopharmaceutical	radiopharmaceutical	NN
cord-023095-4dannjjm	1679	6	in	in	IN
cord-023095-4dannjjm	1679	7	the	the	DT
cord-023095-4dannjjm	1679	8	region	region	NN
cord-023095-4dannjjm	1679	9	of	of	IN
cord-023095-4dannjjm	1679	10	the	the	DT
cord-023095-4dannjjm	1679	11	abscess	abscess	NN
cord-023095-4dannjjm	1679	12	with	with	IN
cord-023095-4dannjjm	1679	13	all	all	DT
cord-023095-4dannjjm	1679	14	three	three	CD
cord-023095-4dannjjm	1679	15	techniques	technique	NNS
cord-023095-4dannjjm	1679	16	at	at	IN
cord-023095-4dannjjm	1679	17	both	both	DT
cord-023095-4dannjjm	1679	18	time	time	NN
cord-023095-4dannjjm	1679	19	-	-	HYPH
cord-023095-4dannjjm	1679	20	points	point	NNS
cord-023095-4dannjjm	1679	21	.	.	.
cord-023095-4dannjjm	1680	1	At	at	IN
cord-023095-4dannjjm	1680	2	8	8	CD
cord-023095-4dannjjm	1680	3	hours	hour	NNS
cord-023095-4dannjjm	1680	4	p.i	p.i	NNP
cord-023095-4dannjjm	1680	5	.	.	NNP
cord-023095-4dannjjm	1680	6	abscess	abscess	NN
cord-023095-4dannjjm	1680	7	-	-	HYPH
cord-023095-4dannjjm	1680	8	to	to	IN
cord-023095-4dannjjm	1680	9	-	-	HYPH
cord-023095-4dannjjm	1680	10	background	background	NN
cord-023095-4dannjjm	1680	11	ratio	ratio	NN
cord-023095-4dannjjm	1680	12	was	be	VBD
cord-023095-4dannjjm	1680	13	highest	highest	RBS
cord-023095-4dannjjm	1680	14	using	use	VBG
cord-023095-4dannjjm	1680	15	99	99	CD
cord-023095-4dannjjm	1680	16	m	m	NNP
cord-023095-4dannjjm	1680	17	Tc	Tc	NNP
cord-023095-4dannjjm	1680	18	-	-	HYPH
cord-023095-4dannjjm	1680	19	IgG	IgG	NNP
cord-023095-4dannjjm	1680	20	(	(	-LRB-
cord-023095-4dannjjm	1680	21	3.7	3.7	CD
cord-023095-4dannjjm	1680	22	AE	AE	NNP
cord-023095-4dannjjm	1680	23	0.2	0.2	CD
cord-023095-4dannjjm	1680	24	)	)	-RRB-
cord-023095-4dannjjm	1680	25	.	.	.
cord-023095-4dannjjm	1681	1	At	at	IN
cord-023095-4dannjjm	1681	2	21	21	CD
cord-023095-4dannjjm	1681	3	hours	hour	NNS
cord-023095-4dannjjm	1681	4	p.i	p.i	NNP
cord-023095-4dannjjm	1681	5	.	.	NNP
cord-023095-4dannjjm	1681	6	abscess	abscess	NN
cord-023095-4dannjjm	1681	7	to	to	IN
cord-023095-4dannjjm	1681	8	background	background	NN
cord-023095-4dannjjm	1681	9	ratio	ratio	NN
cord-023095-4dannjjm	1681	10	was	be	VBD
cord-023095-4dannjjm	1681	11	highest	highest	RBS
cord-023095-4dannjjm	1681	12	using	use	VBG
cord-023095-4dannjjm	1681	13	99	99	CD
cord-023095-4dannjjm	1681	14	m	m	NNP
cord-023095-4dannjjm	1681	15	Tc	Tc	NNP
cord-023095-4dannjjm	1681	16	-	-	HYPH
cord-023095-4dannjjm	1681	17	liposomes	liposomes	NNP
cord-023095-4dannjjm	1681	18	(	(	-LRB-
cord-023095-4dannjjm	1681	19	5.9	5.9	CD
cord-023095-4dannjjm	1681	20	AE	AE	NNP
cord-023095-4dannjjm	1681	21	2	2	CD
cord-023095-4dannjjm	1681	22	)	)	-RRB-
cord-023095-4dannjjm	1681	23	.	.	.
cord-023095-4dannjjm	1682	1	Tissue	tissue	NN
cord-023095-4dannjjm	1682	2	biodistribution	biodistribution	NNP
cord-023095-4dannjjm	1682	3	data	datum	NNS
cord-023095-4dannjjm	1682	4	revealed	reveal	VBD
cord-023095-4dannjjm	1682	5	abscess	abscess	NN
cord-023095-4dannjjm	1682	6	to	to	IN
cord-023095-4dannjjm	1682	7	muscle	muscle	NN
cord-023095-4dannjjm	1682	8	ratios	ratio	NNS
cord-023095-4dannjjm	1682	9	of	of	IN
cord-023095-4dannjjm	1682	10	36	36	CD
cord-023095-4dannjjm	1682	11	(	(	-LRB-
cord-023095-4dannjjm	1682	12	99	99	CD
cord-023095-4dannjjm	1682	13	m	m	NNP
cord-023095-4dannjjm	1682	14	Tc	Tc	NNP
cord-023095-4dannjjm	1682	15	-	-	HYPH
cord-023095-4dannjjm	1682	16	IgG	IgG	NNP
cord-023095-4dannjjm	1682	17	)	)	-RRB-
cord-023095-4dannjjm	1682	18	,	,	,
cord-023095-4dannjjm	1682	19	24	24	CD
cord-023095-4dannjjm	1682	20	(	(	-LRB-
cord-023095-4dannjjm	1682	21	99	99	CD
cord-023095-4dannjjm	1682	22	m	m	NN
cord-023095-4dannjjm	1682	23	Tc	Tc	NNP
cord-023095-4dannjjm	1682	24	-	-	HYPH
cord-023095-4dannjjm	1682	25	liposomes	liposomes	NNP
cord-023095-4dannjjm	1682	26	)	)	-RRB-
cord-023095-4dannjjm	1682	27	,	,	,
cord-023095-4dannjjm	1682	28	and	and	CC
cord-023095-4dannjjm	1682	29	4.1	4.1	CD
cord-023095-4dannjjm	1682	30	(	(	-LRB-
cord-023095-4dannjjm	1682	31	99	99	CD
cord-023095-4dannjjm	1682	32	m	m	NN
cord-023095-4dannjjm	1682	33	Tc	Tc	NNP
cord-023095-4dannjjm	1682	34	-	-	HYPH
cord-023095-4dannjjm	1682	35	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1682	36	)	)	-RRB-
cord-023095-4dannjjm	1682	37	.	.	.
cord-023095-4dannjjm	1683	1	This	this	DT
cord-023095-4dannjjm	1683	2	preliminary	preliminary	JJ
cord-023095-4dannjjm	1683	3	data	data	NN
cord-023095-4dannjjm	1683	4	demonstrates	demonstrate	VBZ
cord-023095-4dannjjm	1683	5	that	that	IN
cord-023095-4dannjjm	1683	6	99	99	CD
cord-023095-4dannjjm	1683	7	m	m	NN
cord-023095-4dannjjm	1683	8	Tc	tc	NN
cord-023095-4dannjjm	1683	9	-	-	HYPH
cord-023095-4dannjjm	1683	10	liposomes	liposome	NNS
cord-023095-4dannjjm	1683	11	,	,	,
cord-023095-4dannjjm	1683	12	99	99	CD
cord-023095-4dannjjm	1683	13	m	m	NNP
cord-023095-4dannjjm	1683	14	Tc	Tc	NNP
cord-023095-4dannjjm	1683	15	-	-	HYPH
cord-023095-4dannjjm	1683	16	IgG	IgG	NNP
cord-023095-4dannjjm	1683	17	and	and	CC
cord-023095-4dannjjm	1683	18	99	99	CD
cord-023095-4dannjjm	1683	19	m	m	NNP
cord-023095-4dannjjm	1683	20	Tc	Tc	NNP
cord-023095-4dannjjm	1683	21	-	-	HYPH
cord-023095-4dannjjm	1683	22	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1683	23	exhibit	exhibit	VBP
cord-023095-4dannjjm	1683	24	long	long	RB
cord-023095-4dannjjm	1683	25	circulating	circulate	VBG
cord-023095-4dannjjm	1683	26	characteristics	characteristic	NNS
cord-023095-4dannjjm	1683	27	and	and	CC
cord-023095-4dannjjm	1683	28	accumulate	accumulate	VBP
cord-023095-4dannjjm	1683	29	at	at	IN
cord-023095-4dannjjm	1683	30	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1683	31	/	/	SYM
cord-023095-4dannjjm	1683	32	infectious	infectious	JJ
cord-023095-4dannjjm	1683	33	foci	foci	NN
cord-023095-4dannjjm	1683	34	after	after	IN
cord-023095-4dannjjm	1683	35	intravenous	intravenous	JJ
cord-023095-4dannjjm	1683	36	injection	injection	NN
cord-023095-4dannjjm	1683	37	in	in	IN
cord-023095-4dannjjm	1683	38	horses	horse	NNS
cord-023095-4dannjjm	1683	39	.	.	.
cord-023095-4dannjjm	1684	1	99	99	CD
cord-023095-4dannjjm	1684	2	m	m	NNP
cord-023095-4dannjjm	1684	3	Tc	Tc	NNP
cord-023095-4dannjjm	1684	4	-	-	HYPH
cord-023095-4dannjjm	1684	5	IgG	IgG	NNP
cord-023095-4dannjjm	1684	6	and	and	CC
cord-023095-4dannjjm	1684	7	99	99	CD
cord-023095-4dannjjm	1684	8	m	m	NNP
cord-023095-4dannjjm	1684	9	Tc	Tc	NNP
cord-023095-4dannjjm	1684	10	-	-	HYPH
cord-023095-4dannjjm	1684	11	liposomes	liposome	NNS
cord-023095-4dannjjm	1684	12	appear	appear	VBP
cord-023095-4dannjjm	1684	13	to	to	TO
cord-023095-4dannjjm	1684	14	be	be	VB
cord-023095-4dannjjm	1684	15	superior	superior	JJ
cord-023095-4dannjjm	1684	16	to	to	IN
cord-023095-4dannjjm	1684	17	99	99	CD
cord-023095-4dannjjm	1684	18	m	m	NN
cord-023095-4dannjjm	1684	19	Tc	Tc	NNP
cord-023095-4dannjjm	1684	20	-	-	HYPH
cord-023095-4dannjjm	1684	21	labelled	label	VBN
cord-023095-4dannjjm	1684	22	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	1684	23	in	in	IN
cord-023095-4dannjjm	1684	24	this	this	DT
cord-023095-4dannjjm	1684	25	model	model	NN
cord-023095-4dannjjm	1684	26	.	.	.
cord-023095-4dannjjm	1685	1	Due	due	IN
cord-023095-4dannjjm	1685	2	to	to	IN
cord-023095-4dannjjm	1685	3	its	-PRON-	PRP$
cord-023095-4dannjjm	1685	4	low	low	JJ
cord-023095-4dannjjm	1685	5	cost	cost	NN
cord-023095-4dannjjm	1685	6	and	and	CC
cord-023095-4dannjjm	1685	7	ease	ease	NN
cord-023095-4dannjjm	1685	8	of	of	IN
cord-023095-4dannjjm	1685	9	preparation	preparation	NN
cord-023095-4dannjjm	1685	10	,	,	,
cord-023095-4dannjjm	1685	11	99	99	CD
cord-023095-4dannjjm	1685	12	m	m	NNP
cord-023095-4dannjjm	1685	13	Tc	Tc	NNP
cord-023095-4dannjjm	1685	14	-	-	HYPH
cord-023095-4dannjjm	1685	15	IgG	IgG	NNP
cord-023095-4dannjjm	1685	16	has	have	VBZ
cord-023095-4dannjjm	1685	17	great	great	JJ
cord-023095-4dannjjm	1685	18	potential	potential	NN
cord-023095-4dannjjm	1685	19	for	for	IN
cord-023095-4dannjjm	1685	20	clinical	clinical	JJ
cord-023095-4dannjjm	1685	21	use	use	NN
cord-023095-4dannjjm	1685	22	where	where	WRB
cord-023095-4dannjjm	1685	23	identification	identification	NN
cord-023095-4dannjjm	1685	24	of	of	IN
cord-023095-4dannjjm	1685	25	infectious	infectious	JJ
cord-023095-4dannjjm	1685	26	or	or	CC
cord-023095-4dannjjm	1685	27	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1685	28	foci	foci	NN
cord-023095-4dannjjm	1685	29	is	be	VBZ
cord-023095-4dannjjm	1685	30	necessary	necessary	JJ
cord-023095-4dannjjm	1685	31	.	.	.
cord-023095-4dannjjm	1686	1	Digital	digital	JJ
cord-023095-4dannjjm	1686	2	hypothermia	hypothermia	NN
cord-023095-4dannjjm	1686	3	is	be	VBZ
cord-023095-4dannjjm	1686	4	used	use	VBN
cord-023095-4dannjjm	1686	5	clinically	clinically	RB
cord-023095-4dannjjm	1686	6	to	to	TO
cord-023095-4dannjjm	1686	7	decrease	decrease	VB
cord-023095-4dannjjm	1686	8	the	the	DT
cord-023095-4dannjjm	1686	9	incidence	incidence	NN
cord-023095-4dannjjm	1686	10	of	of	IN
cord-023095-4dannjjm	1686	11	sepsis	sepsis	NN
cord-023095-4dannjjm	1686	12	-	-	HYPH
cord-023095-4dannjjm	1686	13	related	relate	VBN
cord-023095-4dannjjm	1686	14	equine	equine	NN
cord-023095-4dannjjm	1686	15	laminitis	laminitis	NN
cord-023095-4dannjjm	1686	16	,	,	,
cord-023095-4dannjjm	1686	17	a	a	DT
cord-023095-4dannjjm	1686	18	disease	disease	NN
cord-023095-4dannjjm	1686	19	causing	cause	VBG
cord-023095-4dannjjm	1686	20	structural	structural	JJ
cord-023095-4dannjjm	1686	21	failure	failure	NN
cord-023095-4dannjjm	1686	22	of	of	IN
cord-023095-4dannjjm	1686	23	digital	digital	JJ
cord-023095-4dannjjm	1686	24	laminae	laminae	NNP
cord-023095-4dannjjm	1686	25	resulting	result	VBG
cord-023095-4dannjjm	1686	26	in	in	IN
cord-023095-4dannjjm	1686	27	crippling	crippling	JJ
cord-023095-4dannjjm	1686	28	lameness	lameness	NN
cord-023095-4dannjjm	1686	29	.	.	.
cord-023095-4dannjjm	1687	1	Due	due	IN
cord-023095-4dannjjm	1687	2	to	to	IN
cord-023095-4dannjjm	1687	3	the	the	DT
cord-023095-4dannjjm	1687	4	fact	fact	NN
cord-023095-4dannjjm	1687	5	that	that	IN
cord-023095-4dannjjm	1687	6	hypothermia	hypothermia	NN
cord-023095-4dannjjm	1687	7	was	be	VBD
cord-023095-4dannjjm	1687	8	recently	recently	RB
cord-023095-4dannjjm	1687	9	reported	report	VBN
cord-023095-4dannjjm	1687	10	to	to	TO
cord-023095-4dannjjm	1687	11	effectively	effectively	RB
cord-023095-4dannjjm	1687	12	decrease	decrease	VB
cord-023095-4dannjjm	1687	13	laminar	laminar	JJ
cord-023095-4dannjjm	1687	14	expression	expression	NN
cord-023095-4dannjjm	1687	15	of	of	IN
cord-023095-4dannjjm	1687	16	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1687	17	molecules	molecule	NNS
cord-023095-4dannjjm	1687	18	including	include	VBG
cord-023095-4dannjjm	1687	19	pro	pro	JJ
cord-023095-4dannjjm	1687	20	-	-	JJ
cord-023095-4dannjjm	1687	21	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1687	22	cytokines	cytokine	NNS
cord-023095-4dannjjm	1687	23	,	,	,
cord-023095-4dannjjm	1687	24	chemokines	chemokine	NNS
cord-023095-4dannjjm	1687	25	and	and	CC
cord-023095-4dannjjm	1687	26	COX-2	COX-2	NNP
cord-023095-4dannjjm	1687	27	in	in	IN
cord-023095-4dannjjm	1687	28	equine	equine	JJ
cord-023095-4dannjjm	1687	29	laminitis	laminitis	NN
cord-023095-4dannjjm	1687	30	,	,	,
cord-023095-4dannjjm	1687	31	our	-PRON-	PRP$
cord-023095-4dannjjm	1687	32	laboratory	laboratory	NN
cord-023095-4dannjjm	1687	33	is	be	VBZ
cord-023095-4dannjjm	1687	34	investigating	investigate	VBG
cord-023095-4dannjjm	1687	35	the	the	DT
cord-023095-4dannjjm	1687	36	effect	effect	NN
cord-023095-4dannjjm	1687	37	of	of	IN
cord-023095-4dannjjm	1687	38	hypothermia	hypothermia	NN
cord-023095-4dannjjm	1687	39	on	on	IN
cord-023095-4dannjjm	1687	40	central	central	JJ
cord-023095-4dannjjm	1687	41	upstream	upstream	RB
cord-023095-4dannjjm	1687	42	signaling	signal	VBG
cord-023095-4dannjjm	1687	43	cascades	cascade	NNS
cord-023095-4dannjjm	1687	44	which	which	WDT
cord-023095-4dannjjm	1687	45	may	may	MD
cord-023095-4dannjjm	1687	46	induce	induce	VB
cord-023095-4dannjjm	1687	47	expression	expression	NN
cord-023095-4dannjjm	1687	48	of	of	IN
cord-023095-4dannjjm	1687	49	these	these	DT
cord-023095-4dannjjm	1687	50	diverse	diverse	JJ
cord-023095-4dannjjm	1687	51	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1687	52	molecules	molecule	NNS
cord-023095-4dannjjm	1687	53	.	.	.
cord-023095-4dannjjm	1688	1	The	the	DT
cord-023095-4dannjjm	1688	2	p38	p38	CD
cord-023095-4dannjjm	1688	3	MAPK	MAPK	NNP
cord-023095-4dannjjm	1688	4	pathway	pathway	NN
cord-023095-4dannjjm	1688	5	has	have	VBZ
cord-023095-4dannjjm	1688	6	recently	recently	RB
cord-023095-4dannjjm	1688	7	been	be	VBN
cord-023095-4dannjjm	1688	8	reported	report	VBN
cord-023095-4dannjjm	1688	9	to	to	TO
cord-023095-4dannjjm	1688	10	be	be	VB
cord-023095-4dannjjm	1688	11	a	a	DT
cord-023095-4dannjjm	1688	12	central	central	JJ
cord-023095-4dannjjm	1688	13	component	component	NN
cord-023095-4dannjjm	1688	14	of	of	IN
cord-023095-4dannjjm	1688	15	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1688	16	signaling	signaling	NN
cord-023095-4dannjjm	1688	17	in	in	IN
cord-023095-4dannjjm	1688	18	multiple	multiple	JJ
cord-023095-4dannjjm	1688	19	diseases	disease	NNS
cord-023095-4dannjjm	1688	20	including	include	VBG
cord-023095-4dannjjm	1688	21	human	human	JJ
cord-023095-4dannjjm	1688	22	sepsis	sepsis	NN
cord-023095-4dannjjm	1688	23	,	,	,
cord-023095-4dannjjm	1688	24	and	and	CC
cord-023095-4dannjjm	1688	25	is	be	VBZ
cord-023095-4dannjjm	1688	26	currently	currently	RB
cord-023095-4dannjjm	1688	27	being	be	VBG
cord-023095-4dannjjm	1688	28	assessed	assess	VBN
cord-023095-4dannjjm	1688	29	as	as	IN
cord-023095-4dannjjm	1688	30	a	a	DT
cord-023095-4dannjjm	1688	31	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	1688	32	target	target	NN
cord-023095-4dannjjm	1688	33	.	.	.
cord-023095-4dannjjm	1689	1	We	-PRON-	PRP
cord-023095-4dannjjm	1689	2	thus	thus	RB
cord-023095-4dannjjm	1689	3	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1689	4	that	that	IN
cord-023095-4dannjjm	1689	5	1	1	CD
cord-023095-4dannjjm	1689	6	)	)	-RRB-
cord-023095-4dannjjm	1689	7	p38	p38	CD
cord-023095-4dannjjm	1689	8	MAPK	MAPK	NNP
cord-023095-4dannjjm	1689	9	is	be	VBZ
cord-023095-4dannjjm	1689	10	upregulated	upregulate	VBN
cord-023095-4dannjjm	1689	11	and	and	CC
cord-023095-4dannjjm	1689	12	activated	activate	VBN
cord-023095-4dannjjm	1689	13	in	in	IN
cord-023095-4dannjjm	1689	14	affected	affect	VBN
cord-023095-4dannjjm	1689	15	laminae	laminae	RB
cord-023095-4dannjjm	1689	16	in	in	IN
cord-023095-4dannjjm	1689	17	equine	equine	JJ
cord-023095-4dannjjm	1689	18	laminitis	laminitis	NN
cord-023095-4dannjjm	1689	19	and	and	CC
cord-023095-4dannjjm	1689	20	2	2	CD
cord-023095-4dannjjm	1689	21	)	)	-RRB-
cord-023095-4dannjjm	1690	1	digital	digital	JJ
cord-023095-4dannjjm	1690	2	hypothermia	hypothermia	NN
cord-023095-4dannjjm	1690	3	inhibits	inhibit	VBZ
cord-023095-4dannjjm	1690	4	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1690	5	mediator	mediator	NN
cord-023095-4dannjjm	1690	6	expression	expression	NN
cord-023095-4dannjjm	1690	7	by	by	IN
cord-023095-4dannjjm	1690	8	blocking	block	VBG
cord-023095-4dannjjm	1690	9	p38	p38	CD
cord-023095-4dannjjm	1690	10	MAPK	MAPK	NNP
cord-023095-4dannjjm	1690	11	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	1690	12	(	(	-LRB-
cord-023095-4dannjjm	1690	13	indicator	indicator	NN
cord-023095-4dannjjm	1690	14	of	of	IN
cord-023095-4dannjjm	1690	15	p38	p38	NNP
cord-023095-4dannjjm	1690	16	MAPK	MAPK	NNP
cord-023095-4dannjjm	1690	17	activation	activation	NN
cord-023095-4dannjjm	1690	18	)	)	-RRB-
cord-023095-4dannjjm	1690	19	.	.	.
cord-023095-4dannjjm	1691	1	Western	western	JJ
cord-023095-4dannjjm	1691	2	hybridizations	hybridization	NNS
cord-023095-4dannjjm	1691	3	using	use	VBG
cord-023095-4dannjjm	1691	4	both	both	CC
cord-023095-4dannjjm	1691	5	a	a	DT
cord-023095-4dannjjm	1691	6	total	total	JJ
cord-023095-4dannjjm	1691	7	p38	p38	CD
cord-023095-4dannjjm	1691	8	MAPK	MAPK	NNP
cord-023095-4dannjjm	1691	9	and	and	CC
cord-023095-4dannjjm	1691	10	a	a	DT
cord-023095-4dannjjm	1691	11	phospho	phospho	NN
cord-023095-4dannjjm	1691	12	-	-	HYPH
cord-023095-4dannjjm	1691	13	p38	p38	CD
cord-023095-4dannjjm	1691	14	MAPK	MAPK	NNP
cord-023095-4dannjjm	1691	15	antibody	antibody	NN
cord-023095-4dannjjm	1691	16	were	be	VBD
cord-023095-4dannjjm	1691	17	performed	perform	VBN
cord-023095-4dannjjm	1691	18	on	on	IN
cord-023095-4dannjjm	1691	19	archived	archived	JJ
cord-023095-4dannjjm	1691	20	pooled	pool	VBN
cord-023095-4dannjjm	1691	21	laminar	laminar	JJ
cord-023095-4dannjjm	1691	22	samples	sample	NNS
cord-023095-4dannjjm	1691	23	from	from	IN
cord-023095-4dannjjm	1691	24	black	black	JJ
cord-023095-4dannjjm	1691	25	walnut	walnut	NN
cord-023095-4dannjjm	1691	26	extract	extract	NN
cord-023095-4dannjjm	1691	27	(	(	-LRB-
cord-023095-4dannjjm	1691	28	BWE	BWE	NNP
cord-023095-4dannjjm	1691	29	)	)	-RRB-
cord-023095-4dannjjm	1691	30	model	model	NN
cord-023095-4dannjjm	1691	31	(	(	-LRB-
cord-023095-4dannjjm	1691	32	10	10	CD
cord-023095-4dannjjm	1691	33	control	control	NN
cord-023095-4dannjjm	1691	34	,	,	,
cord-023095-4dannjjm	1691	35	2	2	CD
cord-023095-4dannjjm	1691	36	developmental	developmental	JJ
cord-023095-4dannjjm	1691	37	(	(	-LRB-
cord-023095-4dannjjm	1691	38	DEV	dev	NN
cord-023095-4dannjjm	1691	39	)	)	-RRB-
cord-023095-4dannjjm	1691	40	groups	group	NNS
cord-023095-4dannjjm	1691	41	[	[	-LRB-
cord-023095-4dannjjm	1691	42	1.5H	1.5H	NNP
cord-023095-4dannjjm	1691	43	&	&	CC
cord-023095-4dannjjm	1691	44	3H	3H	NNP
cord-023095-4dannjjm	1691	45	post	post	NNP
cord-023095-4dannjjm	1691	46	BWE	BWE	NNP
cord-023095-4dannjjm	1691	47	administration	administration	NN
cord-023095-4dannjjm	1691	48	]	]	-RRB-
cord-023095-4dannjjm	1691	49	and	and	CC
cord-023095-4dannjjm	1691	50	the	the	DT
cord-023095-4dannjjm	1691	51	onset	onset	NN
cord-023095-4dannjjm	1691	52	of	of	IN
cord-023095-4dannjjm	1691	53	Obel	Obel	NNP
cord-023095-4dannjjm	1691	54	Grade	Grade	NNP
cord-023095-4dannjjm	1691	55	1	1	CD
cord-023095-4dannjjm	1691	56	lameness	lameness	NN
cord-023095-4dannjjm	1691	57	(	(	-LRB-
cord-023095-4dannjjm	1691	58	OG1	OG1	NNP
cord-023095-4dannjjm	1691	59	)	)	-RRB-
cord-023095-4dannjjm	1691	60	[	[	-LRB-
cord-023095-4dannjjm	1691	61	n	n	NN
cord-023095-4dannjjm	1691	62	5	5	CD
cord-023095-4dannjjm	1691	63	5	5	CD
cord-023095-4dannjjm	1691	64	each	each	DT
cord-023095-4dannjjm	1691	65	]	]	-RRB-
cord-023095-4dannjjm	1691	66	)	)	-RRB-
cord-023095-4dannjjm	1691	67	and	and	CC
cord-023095-4dannjjm	1691	68	carbohydrate	carbohydrate	NN
cord-023095-4dannjjm	1691	69	overload	overload	NN
cord-023095-4dannjjm	1691	70	(	(	-LRB-
cord-023095-4dannjjm	1691	71	CHO	CHO	NNP
cord-023095-4dannjjm	1691	72	)	)	-RRB-
cord-023095-4dannjjm	1691	73	models	model	NNS
cord-023095-4dannjjm	1691	74	(	(	-LRB-
cord-023095-4dannjjm	1691	75	CON	con	NN
cord-023095-4dannjjm	1691	76	[	[	-LRB-
cord-023095-4dannjjm	1691	77	n	n	NN
cord-023095-4dannjjm	1691	78	5	5	CD
cord-023095-4dannjjm	1691	79	8	8	CD
cord-023095-4dannjjm	1691	80	]	]	-RRB-
cord-023095-4dannjjm	1691	81	,	,	,
cord-023095-4dannjjm	1691	82	DEV	DEV	NNP
cord-023095-4dannjjm	1691	83	[	[	-LRB-
cord-023095-4dannjjm	1691	84	n	n	NN
cord-023095-4dannjjm	1691	85	5	5	CD
cord-023095-4dannjjm	1691	86	6	6	CD
cord-023095-4dannjjm	1691	87	]	]	-RRB-
cord-023095-4dannjjm	1691	88	,	,	,
cord-023095-4dannjjm	1691	89	OG1[n	OG1[n	NNP
cord-023095-4dannjjm	1691	90	5	5	CD
cord-023095-4dannjjm	1691	91	6	6	CD
cord-023095-4dannjjm	1691	92	]	]	-RRB-
cord-023095-4dannjjm	1691	93	)	)	-RRB-
cord-023095-4dannjjm	1691	94	of	of	IN
cord-023095-4dannjjm	1691	95	laminitis	laminitis	NN
cord-023095-4dannjjm	1691	96	,	,	,
cord-023095-4dannjjm	1691	97	and	and	CC
cord-023095-4dannjjm	1691	98	individual	individual	JJ
cord-023095-4dannjjm	1691	99	laminar	laminar	JJ
cord-023095-4dannjjm	1691	100	samples	sample	NNS
cord-023095-4dannjjm	1691	101	from	from	IN
cord-023095-4dannjjm	1691	102	two	two	CD
cord-023095-4dannjjm	1691	103	groups	group	NNS
cord-023095-4dannjjm	1691	104	of	of	IN
cord-023095-4dannjjm	1691	105	horses	horse	NNS
cord-023095-4dannjjm	1691	106	from	from	IN
cord-023095-4dannjjm	1691	107	a	a	DT
cord-023095-4dannjjm	1691	108	digital	digital	JJ
cord-023095-4dannjjm	1691	109	hypothermia	hypothermia	NN
cord-023095-4dannjjm	1691	110	(	(	-LRB-
cord-023095-4dannjjm	1691	111	DH	DH	NNP
cord-023095-4dannjjm	1691	112	)	)	-RRB-
cord-023095-4dannjjm	1691	113	study	study	NN
cord-023095-4dannjjm	1691	114	.	.	.
cord-023095-4dannjjm	1692	1	In	in	IN
cord-023095-4dannjjm	1692	2	the	the	DT
cord-023095-4dannjjm	1692	3	DH	DH	NNP
cord-023095-4dannjjm	1692	4	study	study	NN
cord-023095-4dannjjm	1692	5	,	,	,
cord-023095-4dannjjm	1692	6	one	one	CD
cord-023095-4dannjjm	1692	7	forelimb	forelimb	NN
cord-023095-4dannjjm	1692	8	of	of	IN
cord-023095-4dannjjm	1692	9	each	each	DT
cord-023095-4dannjjm	1692	10	horse	horse	NN
cord-023095-4dannjjm	1692	11	was	be	VBD
cord-023095-4dannjjm	1692	12	kept	keep	VBN
cord-023095-4dannjjm	1692	13	at	at	IN
cord-023095-4dannjjm	1692	14	approximately	approximately	RB
cord-023095-4dannjjm	1692	15	41C	41c	CD
cord-023095-4dannjjm	1692	16	in	in	IN
cord-023095-4dannjjm	1692	17	ice	ice	NN
cord-023095-4dannjjm	1692	18	water	water	NN
cord-023095-4dannjjm	1692	19	and	and	CC
cord-023095-4dannjjm	1692	20	the	the	DT
cord-023095-4dannjjm	1692	21	other	other	JJ
cord-023095-4dannjjm	1692	22	at	at	IN
cord-023095-4dannjjm	1692	23	ambient	ambient	JJ
cord-023095-4dannjjm	1692	24	temperature	temperature	NN
cord-023095-4dannjjm	1692	25	following	follow	VBG
cord-023095-4dannjjm	1692	26	administration	administration	NN
cord-023095-4dannjjm	1692	27	of	of	IN
cord-023095-4dannjjm	1692	28	10	10	CD
cord-023095-4dannjjm	1692	29	g	g	NN
cord-023095-4dannjjm	1692	30	/	/	SYM
cord-023095-4dannjjm	1692	31	kg	kg	NNP
cord-023095-4dannjjm	1692	32	oligofructose	oligofructose	RB
cord-023095-4dannjjm	1693	1	(	(	-LRB-
cord-023095-4dannjjm	1693	2	OF	of	NN
cord-023095-4dannjjm	1693	3	)	)	-RRB-
cord-023095-4dannjjm	1693	4	.	.	.
cord-023095-4dannjjm	1694	1	Dorsal	dorsal	JJ
cord-023095-4dannjjm	1694	2	laminae	laminae	RB
cord-023095-4dannjjm	1694	3	were	be	VBD
cord-023095-4dannjjm	1694	4	harvested	harvest	VBN
cord-023095-4dannjjm	1694	5	for	for	IN
cord-023095-4dannjjm	1694	6	snap	snap	JJ
cord-023095-4dannjjm	1694	7	freezing	freezing	NN
cord-023095-4dannjjm	1694	8	at	at	IN
cord-023095-4dannjjm	1694	9	either	either	CC
cord-023095-4dannjjm	1694	10	24	24	CD
cord-023095-4dannjjm	1694	11	hours	hour	NNS
cord-023095-4dannjjm	1694	12	after	after	IN
cord-023095-4dannjjm	1694	13	OF	of	IN
cord-023095-4dannjjm	1694	14	administration	administration	NN
cord-023095-4dannjjm	1694	15	(	(	-LRB-
cord-023095-4dannjjm	1694	16	DEV	DEV	NNP
cord-023095-4dannjjm	1694	17	,	,	,
cord-023095-4dannjjm	1694	18	n	n	NN
cord-023095-4dannjjm	1694	19	5	5	CD
cord-023095-4dannjjm	1694	20	7	7	CD
cord-023095-4dannjjm	1694	21	)	)	-RRB-
cord-023095-4dannjjm	1694	22	or	or	CC
cord-023095-4dannjjm	1694	23	at	at	IN
cord-023095-4dannjjm	1694	24	the	the	DT
cord-023095-4dannjjm	1694	25	onset	onset	NN
cord-023095-4dannjjm	1694	26	of	of	IN
cord-023095-4dannjjm	1694	27	lameness	lameness	NN
cord-023095-4dannjjm	1694	28	(	(	-LRB-
cord-023095-4dannjjm	1694	29	OG1	OG1	NNP
cord-023095-4dannjjm	1694	30	,	,	,
cord-023095-4dannjjm	1694	31	n	n	NN
cord-023095-4dannjjm	1694	32	5	5	CD
cord-023095-4dannjjm	1694	33	6	6	CD
cord-023095-4dannjjm	1694	34	)	)	-RRB-
cord-023095-4dannjjm	1694	35	using	use	VBG
cord-023095-4dannjjm	1694	36	protein	protein	NN
cord-023095-4dannjjm	1694	37	extracted	extract	VBN
cord-023095-4dannjjm	1694	38	from	from	IN
cord-023095-4dannjjm	1694	39	treated	treat	VBN
cord-023095-4dannjjm	1694	40	and	and	CC
cord-023095-4dannjjm	1694	41	untreated	untreated	JJ
cord-023095-4dannjjm	1694	42	digital	digital	JJ
cord-023095-4dannjjm	1694	43	laminae	laminae	NN
cord-023095-4dannjjm	1694	44	of	of	IN
cord-023095-4dannjjm	1694	45	each	each	DT
cord-023095-4dannjjm	1694	46	horse	horse	NN
cord-023095-4dannjjm	1694	47	.	.	.
cord-023095-4dannjjm	1695	1	Increased	increase	VBN
cord-023095-4dannjjm	1695	2	laminar	laminar	JJ
cord-023095-4dannjjm	1695	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1695	4	of	of	IN
cord-023095-4dannjjm	1695	5	phospho	phospho	NN
cord-023095-4dannjjm	1695	6	-	-	HYPH
cord-023095-4dannjjm	1695	7	p38	p38	JJ
cord-023095-4dannjjm	1695	8	MAPK	MAPK	NNP
cord-023095-4dannjjm	1695	9	were	be	VBD
cord-023095-4dannjjm	1695	10	present	present	JJ
cord-023095-4dannjjm	1695	11	in	in	IN
cord-023095-4dannjjm	1695	12	the	the	DT
cord-023095-4dannjjm	1695	13	developmental	developmental	JJ
cord-023095-4dannjjm	1695	14	periods	period	NNS
cord-023095-4dannjjm	1695	15	(	(	-LRB-
cord-023095-4dannjjm	1695	16	1.5H	1.5h	NN
cord-023095-4dannjjm	1695	17	and	and	CC
cord-023095-4dannjjm	1695	18	3H	3H	NNP
cord-023095-4dannjjm	1695	19	)	)	-RRB-
cord-023095-4dannjjm	1695	20	in	in	IN
cord-023095-4dannjjm	1695	21	the	the	DT
cord-023095-4dannjjm	1695	22	BWE	BWE	NNP
cord-023095-4dannjjm	1695	23	model	model	NN
cord-023095-4dannjjm	1695	24	,	,	,
cord-023095-4dannjjm	1695	25	and	and	CC
cord-023095-4dannjjm	1695	26	in	in	IN
cord-023095-4dannjjm	1695	27	both	both	CC
cord-023095-4dannjjm	1695	28	the	the	DT
cord-023095-4dannjjm	1695	29	DEV	DEV	NNP
cord-023095-4dannjjm	1695	30	and	and	CC
cord-023095-4dannjjm	1695	31	OG1	OG1	VBN
cord-023095-4dannjjm	1695	32	periods	period	NNS
cord-023095-4dannjjm	1695	33	in	in	IN
cord-023095-4dannjjm	1695	34	the	the	DT
cord-023095-4dannjjm	1695	35	CHO	CHO	NNP
cord-023095-4dannjjm	1695	36	laminitis	laminitis	NN
cord-023095-4dannjjm	1695	37	models	model	NNS
cord-023095-4dannjjm	1695	38	.	.	.
cord-023095-4dannjjm	1696	1	However	however	RB
cord-023095-4dannjjm	1696	2	,	,	,
cord-023095-4dannjjm	1696	3	digital	digital	JJ
cord-023095-4dannjjm	1696	4	hypothermia	hypothermia	NN
cord-023095-4dannjjm	1696	5	had	have	VBD
cord-023095-4dannjjm	1696	6	no	no	DT
cord-023095-4dannjjm	1696	7	effect	effect	NN
cord-023095-4dannjjm	1696	8	on	on	IN
cord-023095-4dannjjm	1696	9	laminar	laminar	JJ
cord-023095-4dannjjm	1696	10	phospho	phospho	JJ
cord-023095-4dannjjm	1696	11	-	-	HYPH
cord-023095-4dannjjm	1696	12	p38	p38	CD
cord-023095-4dannjjm	1696	13	MAPK	MAPK	NNP
cord-023095-4dannjjm	1696	14	concentrations	concentration	NNS
cord-023095-4dannjjm	1696	15	.	.	.
cord-023095-4dannjjm	1697	1	Thus	thus	RB
cord-023095-4dannjjm	1697	2	,	,	,
cord-023095-4dannjjm	1697	3	p38	p38	JJ
cord-023095-4dannjjm	1697	4	MAPK	MAPK	NNP
cord-023095-4dannjjm	1697	5	is	be	VBZ
cord-023095-4dannjjm	1697	6	activated	activate	VBN
cord-023095-4dannjjm	1697	7	in	in	IN
cord-023095-4dannjjm	1697	8	affected	affect	VBN
cord-023095-4dannjjm	1697	9	laminae	laminae	RB
cord-023095-4dannjjm	1697	10	in	in	IN
cord-023095-4dannjjm	1697	11	multiple	multiple	JJ
cord-023095-4dannjjm	1697	12	models	model	NNS
cord-023095-4dannjjm	1697	13	of	of	IN
cord-023095-4dannjjm	1697	14	laminitis	laminitis	NN
cord-023095-4dannjjm	1697	15	,	,	,
cord-023095-4dannjjm	1697	16	but	but	CC
cord-023095-4dannjjm	1697	17	does	do	VBZ
cord-023095-4dannjjm	1697	18	not	not	RB
cord-023095-4dannjjm	1697	19	appear	appear	VB
cord-023095-4dannjjm	1697	20	to	to	TO
cord-023095-4dannjjm	1697	21	be	be	VB
cord-023095-4dannjjm	1697	22	the	the	DT
cord-023095-4dannjjm	1697	23	central	central	JJ
cord-023095-4dannjjm	1697	24	signaling	signal	VBG
cord-023095-4dannjjm	1697	25	cascade	cascade	NN
cord-023095-4dannjjm	1697	26	through	through	IN
cord-023095-4dannjjm	1697	27	which	which	WDT
cord-023095-4dannjjm	1697	28	hypothermia	hypothermia	NN
cord-023095-4dannjjm	1697	29	works	work	VBZ
cord-023095-4dannjjm	1697	30	to	to	TO
cord-023095-4dannjjm	1697	31	block	block	VB
cord-023095-4dannjjm	1697	32	the	the	DT
cord-023095-4dannjjm	1697	33	expression	expression	NN
cord-023095-4dannjjm	1697	34	of	of	IN
cord-023095-4dannjjm	1697	35	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1697	36	molecules	molecule	NNS
cord-023095-4dannjjm	1697	37	.	.	.
cord-023095-4dannjjm	1698	1	Therefore	therefore	RB
cord-023095-4dannjjm	1698	2	,	,	,
cord-023095-4dannjjm	1698	3	p38	p38	JJ
cord-023095-4dannjjm	1698	4	MAPK	MAPK	NNP
cord-023095-4dannjjm	1698	5	is	be	VBZ
cord-023095-4dannjjm	1698	6	not	not	RB
cord-023095-4dannjjm	1698	7	likely	likely	JJ
cord-023095-4dannjjm	1698	8	to	to	TO
cord-023095-4dannjjm	1698	9	be	be	VB
cord-023095-4dannjjm	1698	10	a	a	DT
cord-023095-4dannjjm	1698	11	viable	viable	JJ
cord-023095-4dannjjm	1698	12	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	1698	13	target	target	NN
cord-023095-4dannjjm	1698	14	as	as	IN
cord-023095-4dannjjm	1698	15	a	a	DT
cord-023095-4dannjjm	1698	16	sole	sole	JJ
cord-023095-4dannjjm	1698	17	source	source	NN
cord-023095-4dannjjm	1698	18	for	for	IN
cord-023095-4dannjjm	1698	19	blocking	block	VBG
cord-023095-4dannjjm	1698	20	the	the	DT
cord-023095-4dannjjm	1698	21	multiple	multiple	JJ
cord-023095-4dannjjm	1698	22	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1698	23	signaling	signaling	NN
cord-023095-4dannjjm	1698	24	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1698	25	inhibited	inhibit	VBN
cord-023095-4dannjjm	1698	26	by	by	IN
cord-023095-4dannjjm	1698	27	local	local	JJ
cord-023095-4dannjjm	1698	28	hypothermia	hypothermia	NN
cord-023095-4dannjjm	1698	29	.	.	.
cord-023095-4dannjjm	1699	1	ABSTRACT	ABSTRACT	NNP
cord-023095-4dannjjm	1699	2	E-60	E-60	NNP
cord-023095-4dannjjm	1699	3	DOES	do	VBZ
cord-023095-4dannjjm	1699	4	CEFQUINOME	CEFQUINOME	NNP
cord-023095-4dannjjm	1699	5	PENETRATE	penetrate	VB
cord-023095-4dannjjm	1699	6	THE	the	DT
cord-023095-4dannjjm	1699	7	BLOOD	blood	NN
cord-023095-4dannjjm	1699	8	BRAIN	brain	NN
cord-023095-4dannjjm	1699	9	BARRIER	barrier	NN
cord-023095-4dannjjm	1699	10	IN	in	IN
cord-023095-4dannjjm	1699	11	THE	the	DT
cord-023095-4dannjjm	1699	12	NORMAL	normal	JJ
cord-023095-4dannjjm	1699	13	HORSE	horse	NN
cord-023095-4dannjjm	1699	14	?	?	.
cord-023095-4dannjjm	1700	1	Hollis	Hollis	NNP
cord-023095-4dannjjm	1700	2	AR	AR	NNP
cord-023095-4dannjjm	1700	3	1	1	CD
cord-023095-4dannjjm	1700	4	Duggan	Duggan	NNP
cord-023095-4dannjjm	1700	5	VE	VE	NNP
cord-023095-4dannjjm	1700	6	2	2	CD
cord-023095-4dannjjm	1700	7	and	and	CC
cord-023095-4dannjjm	1700	8	Corley	Corley	NNP
cord-023095-4dannjjm	1700	9	KTT	KTT	NNP
cord-023095-4dannjjm	1700	10	3	3	CD
cord-023095-4dannjjm	1700	11	.	.	.
cord-023095-4dannjjm	1700	12	1	1	CD
cord-023095-4dannjjm	1701	1	Scott	Scott	NNP
cord-023095-4dannjjm	1701	2	Dunn	Dunn	NNP
cord-023095-4dannjjm	1701	3	's	's	POS
cord-023095-4dannjjm	1701	4	Equine	Equine	NNP
cord-023095-4dannjjm	1701	5	Clinic	Clinic	NNP
cord-023095-4dannjjm	1701	6	,	,	,
cord-023095-4dannjjm	1701	7	Berkshire	Berkshire	NNP
cord-023095-4dannjjm	1701	8	,	,	,
cord-023095-4dannjjm	1701	9	UK	UK	NNP
cord-023095-4dannjjm	1701	10	;	;	:
cord-023095-4dannjjm	1701	11	2	2	CD
cord-023095-4dannjjm	1701	12	University	University	NNP
cord-023095-4dannjjm	1701	13	College	College	NNP
cord-023095-4dannjjm	1701	14	Dublin	Dublin	NNP
cord-023095-4dannjjm	1701	15	,	,	,
cord-023095-4dannjjm	1701	16	Dublin	Dublin	NNP
cord-023095-4dannjjm	1701	17	,	,	,
cord-023095-4dannjjm	1701	18	Ireland	Ireland	NNP
cord-023095-4dannjjm	1701	19	;	;	:
cord-023095-4dannjjm	1701	20	3	3	CD
cord-023095-4dannjjm	1701	21	Anglesey	Anglesey	NNP
cord-023095-4dannjjm	1701	22	Lodge	Lodge	NNP
cord-023095-4dannjjm	1701	23	Equine	Equine	NNP
cord-023095-4dannjjm	1701	24	Hospital	Hospital	NNP
cord-023095-4dannjjm	1701	25	,	,	,
cord-023095-4dannjjm	1701	26	The	the	DT
cord-023095-4dannjjm	1701	27	Curragh	Curragh	NNP
cord-023095-4dannjjm	1701	28	,	,	,
cord-023095-4dannjjm	1701	29	Ireland	Ireland	NNP
cord-023095-4dannjjm	1701	30	.	.	.
cord-023095-4dannjjm	1702	1	Meningitis	meningitis	NN
cord-023095-4dannjjm	1702	2	is	be	VBZ
cord-023095-4dannjjm	1702	3	a	a	DT
cord-023095-4dannjjm	1702	4	rare	rare	JJ
cord-023095-4dannjjm	1702	5	but	but	CC
cord-023095-4dannjjm	1702	6	serious	serious	JJ
cord-023095-4dannjjm	1702	7	condition	condition	NN
cord-023095-4dannjjm	1702	8	that	that	WDT
cord-023095-4dannjjm	1702	9	occurs	occur	VBZ
cord-023095-4dannjjm	1702	10	in	in	IN
cord-023095-4dannjjm	1702	11	both	both	DT
cord-023095-4dannjjm	1702	12	foals	foal	NNS
cord-023095-4dannjjm	1702	13	and	and	CC
cord-023095-4dannjjm	1702	14	adult	adult	NN
cord-023095-4dannjjm	1702	15	horses	horse	NNS
cord-023095-4dannjjm	1702	16	.	.	.
cord-023095-4dannjjm	1703	1	There	there	EX
cord-023095-4dannjjm	1703	2	is	be	VBZ
cord-023095-4dannjjm	1703	3	currently	currently	RB
cord-023095-4dannjjm	1703	4	a	a	DT
cord-023095-4dannjjm	1703	5	restricted	restricted	JJ
cord-023095-4dannjjm	1703	6	choice	choice	NN
cord-023095-4dannjjm	1703	7	of	of	IN
cord-023095-4dannjjm	1703	8	antimicrobials	antimicrobial	NNS
cord-023095-4dannjjm	1703	9	that	that	WDT
cord-023095-4dannjjm	1703	10	are	be	VBP
cord-023095-4dannjjm	1703	11	both	both	RB
cord-023095-4dannjjm	1703	12	safe	safe	JJ
cord-023095-4dannjjm	1703	13	to	to	TO
cord-023095-4dannjjm	1703	14	use	use	VB
cord-023095-4dannjjm	1703	15	in	in	IN
cord-023095-4dannjjm	1703	16	horses	horse	NNS
cord-023095-4dannjjm	1703	17	and	and	CC
cord-023095-4dannjjm	1703	18	penetrate	penetrate	VB
cord-023095-4dannjjm	1703	19	the	the	DT
cord-023095-4dannjjm	1703	20	blood	blood	NN
cord-023095-4dannjjm	1703	21	brain	brain	NN
cord-023095-4dannjjm	1703	22	barrier	barrier	NN
cord-023095-4dannjjm	1703	23	.	.	.
cord-023095-4dannjjm	1704	1	Cefquinome	Cefquinome	NNP
cord-023095-4dannjjm	1704	2	is	be	VBZ
cord-023095-4dannjjm	1704	3	a	a	DT
cord-023095-4dannjjm	1704	4	fourth	fourth	JJ
cord-023095-4dannjjm	1704	5	generation	generation	NN
cord-023095-4dannjjm	1704	6	cephalosporin	cephalosporin	NN
cord-023095-4dannjjm	1704	7	that	that	WDT
cord-023095-4dannjjm	1704	8	has	have	VBZ
cord-023095-4dannjjm	1704	9	activity	activity	NN
cord-023095-4dannjjm	1704	10	against	against	IN
cord-023095-4dannjjm	1704	11	Streptococcus	Streptococcus	NNP
cord-023095-4dannjjm	1704	12	,	,	,
cord-023095-4dannjjm	1704	13	the	the	DT
cord-023095-4dannjjm	1704	14	most	most	RBS
cord-023095-4dannjjm	1704	15	commonly	commonly	RB
cord-023095-4dannjjm	1704	16	reported	report	VBN
cord-023095-4dannjjm	1704	17	causative	causative	JJ
cord-023095-4dannjjm	1704	18	organism	organism	NN
cord-023095-4dannjjm	1704	19	in	in	IN
cord-023095-4dannjjm	1704	20	adult	adult	NN
cord-023095-4dannjjm	1704	21	horse	horse	NN
cord-023095-4dannjjm	1704	22	meningitis	meningitis	NN
cord-023095-4dannjjm	1704	23	.	.	.
cord-023095-4dannjjm	1705	1	Therefore	therefore	RB
cord-023095-4dannjjm	1705	2	,	,	,
cord-023095-4dannjjm	1705	3	if	if	IN
cord-023095-4dannjjm	1705	4	cefquinome	cefquinome	NNP
cord-023095-4dannjjm	1705	5	were	be	VBD
cord-023095-4dannjjm	1705	6	to	to	TO
cord-023095-4dannjjm	1705	7	achieve	achieve	VB
cord-023095-4dannjjm	1705	8	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	1705	9	concentrations	concentration	NNS
cord-023095-4dannjjm	1705	10	in	in	IN
cord-023095-4dannjjm	1705	11	cerebrospinal	cerebrospinal	JJ
cord-023095-4dannjjm	1705	12	fluid	fluid	NN
cord-023095-4dannjjm	1705	13	following	follow	VBG
cord-023095-4dannjjm	1705	14	routine	routine	JJ
cord-023095-4dannjjm	1705	15	administration	administration	NN
cord-023095-4dannjjm	1705	16	,	,	,
cord-023095-4dannjjm	1705	17	this	this	DT
cord-023095-4dannjjm	1705	18	would	would	MD
cord-023095-4dannjjm	1705	19	be	be	VB
cord-023095-4dannjjm	1705	20	an	an	DT
cord-023095-4dannjjm	1705	21	exciting	exciting	JJ
cord-023095-4dannjjm	1705	22	advance	advance	NN
cord-023095-4dannjjm	1705	23	for	for	IN
cord-023095-4dannjjm	1705	24	the	the	DT
cord-023095-4dannjjm	1705	25	treatment	treatment	NN
cord-023095-4dannjjm	1705	26	of	of	IN
cord-023095-4dannjjm	1705	27	meningitis	meningitis	NN
cord-023095-4dannjjm	1705	28	in	in	IN
cord-023095-4dannjjm	1705	29	the	the	DT
cord-023095-4dannjjm	1705	30	horse	horse	NN
cord-023095-4dannjjm	1705	31	.	.	.
cord-023095-4dannjjm	1706	1	5	5	CD
cord-023095-4dannjjm	1706	2	mature	mature	JJ
cord-023095-4dannjjm	1706	3	,	,	,
cord-023095-4dannjjm	1706	4	healthy	healthy	JJ
cord-023095-4dannjjm	1706	5	horses	horse	NNS
cord-023095-4dannjjm	1706	6	were	be	VBD
cord-023095-4dannjjm	1706	7	used	use	VBN
cord-023095-4dannjjm	1706	8	on	on	IN
cord-023095-4dannjjm	1706	9	2	2	CD
cord-023095-4dannjjm	1706	10	separate	separate	JJ
cord-023095-4dannjjm	1706	11	occasions	occasion	NNS
cord-023095-4dannjjm	1706	12	,	,	,
cord-023095-4dannjjm	1706	13	seven	seven	CD
cord-023095-4dannjjm	1706	14	days	day	NNS
cord-023095-4dannjjm	1706	15	apart	apart	RB
cord-023095-4dannjjm	1706	16	,	,	,
cord-023095-4dannjjm	1706	17	in	in	IN
cord-023095-4dannjjm	1706	18	a	a	DT
cord-023095-4dannjjm	1706	19	crossover	crossover	NN
cord-023095-4dannjjm	1706	20	design	design	NN
cord-023095-4dannjjm	1706	21	.	.	.
cord-023095-4dannjjm	1707	1	Each	each	DT
cord-023095-4dannjjm	1707	2	horse	horse	NN
cord-023095-4dannjjm	1707	3	was	be	VBD
cord-023095-4dannjjm	1707	4	administered	administer	VBN
cord-023095-4dannjjm	1707	5	either	either	CC
cord-023095-4dannjjm	1707	6	cefquinome	cefquinome	NNP
cord-023095-4dannjjm	1707	7	(	(	-LRB-
cord-023095-4dannjjm	1707	8	1	1	CD
cord-023095-4dannjjm	1707	9	mg	mg	NNP
cord-023095-4dannjjm	1707	10	/	/	SYM
cord-023095-4dannjjm	1707	11	kg	kg	NNP
cord-023095-4dannjjm	1707	12	)	)	-RRB-
cord-023095-4dannjjm	1707	13	or	or	CC
cord-023095-4dannjjm	1707	14	saline	saline	NN
cord-023095-4dannjjm	1707	15	(	(	-LRB-
cord-023095-4dannjjm	1707	16	equivalent	equivalent	JJ
cord-023095-4dannjjm	1707	17	volume	volume	NN
cord-023095-4dannjjm	1707	18	)	)	-RRB-
cord-023095-4dannjjm	1707	19	.	.	.
cord-023095-4dannjjm	1708	1	Cerebrospinal	cerebrospinal	NN
cord-023095-4dannjjm	1708	2	fluid	fluid	NN
cord-023095-4dannjjm	1708	3	was	be	VBD
cord-023095-4dannjjm	1708	4	collected	collect	VBN
cord-023095-4dannjjm	1708	5	via	via	IN
cord-023095-4dannjjm	1708	6	atlanto	atlanto	XX
cord-023095-4dannjjm	1708	7	-	-	HYPH
cord-023095-4dannjjm	1708	8	occipital	occipital	JJ
cord-023095-4dannjjm	1708	9	puncture	puncture	NN
cord-023095-4dannjjm	1708	10	under	under	IN
cord-023095-4dannjjm	1708	11	general	general	JJ
cord-023095-4dannjjm	1708	12	anaesthesia	anaesthesia	NN
cord-023095-4dannjjm	1708	13	1	1	CD
cord-023095-4dannjjm	1708	14	and	and	CC
cord-023095-4dannjjm	1708	15	4	4	CD
cord-023095-4dannjjm	1708	16	hours	hour	NNS
cord-023095-4dannjjm	1708	17	after	after	IN
cord-023095-4dannjjm	1708	18	administration	administration	NN
cord-023095-4dannjjm	1708	19	of	of	IN
cord-023095-4dannjjm	1708	20	cefquinome	cefquinome	NNP
cord-023095-4dannjjm	1708	21	or	or	CC
cord-023095-4dannjjm	1708	22	saline	saline	NN
cord-023095-4dannjjm	1708	23	placebo	placebo	NN
cord-023095-4dannjjm	1708	24	.	.	.
cord-023095-4dannjjm	1709	1	Blood	blood	NN
cord-023095-4dannjjm	1709	2	samples	sample	NNS
cord-023095-4dannjjm	1709	3	were	be	VBD
cord-023095-4dannjjm	1709	4	collected	collect	VBN
cord-023095-4dannjjm	1709	5	prior	prior	RB
cord-023095-4dannjjm	1709	6	to	to	IN
cord-023095-4dannjjm	1709	7	,	,	,
cord-023095-4dannjjm	1709	8	and	and	CC
cord-023095-4dannjjm	1709	9	1	1	CD
cord-023095-4dannjjm	1709	10	and	and	CC
cord-023095-4dannjjm	1709	11	4	4	CD
cord-023095-4dannjjm	1709	12	hours	hour	NNS
cord-023095-4dannjjm	1709	13	after	after	IN
cord-023095-4dannjjm	1709	14	administration	administration	NN
cord-023095-4dannjjm	1709	15	of	of	IN
cord-023095-4dannjjm	1709	16	cefquinome	cefquinome	NNP
cord-023095-4dannjjm	1709	17	or	or	CC
cord-023095-4dannjjm	1709	18	placebo	placebo	NN
cord-023095-4dannjjm	1709	19	.	.	.
cord-023095-4dannjjm	1710	1	All	all	DT
cord-023095-4dannjjm	1710	2	samples	sample	NNS
cord-023095-4dannjjm	1710	3	were	be	VBD
cord-023095-4dannjjm	1710	4	analysed	analyse	VBN
cord-023095-4dannjjm	1710	5	for	for	IN
cord-023095-4dannjjm	1710	6	the	the	DT
cord-023095-4dannjjm	1710	7	presence	presence	NN
cord-023095-4dannjjm	1710	8	of	of	IN
cord-023095-4dannjjm	1710	9	cefquinome	cefquinome	NNP
cord-023095-4dannjjm	1710	10	by	by	IN
cord-023095-4dannjjm	1710	11	a	a	DT
cord-023095-4dannjjm	1710	12	laboratory	laboratory	NN
cord-023095-4dannjjm	1710	13	masked	mask	VBN
cord-023095-4dannjjm	1710	14	to	to	IN
cord-023095-4dannjjm	1710	15	treatments	treatment	NNS
cord-023095-4dannjjm	1710	16	administered	administer	VBN
cord-023095-4dannjjm	1710	17	.	.	.
cord-023095-4dannjjm	1711	1	Cefquinome	Cefquinome	NNP
cord-023095-4dannjjm	1711	2	was	be	VBD
cord-023095-4dannjjm	1711	3	detectable	detectable	JJ
cord-023095-4dannjjm	1711	4	in	in	IN
cord-023095-4dannjjm	1711	5	the	the	DT
cord-023095-4dannjjm	1711	6	cerebrospinal	cerebrospinal	JJ
cord-023095-4dannjjm	1711	7	fluid	fluid	NN
cord-023095-4dannjjm	1711	8	in	in	IN
cord-023095-4dannjjm	1711	9	all	all	DT
cord-023095-4dannjjm	1711	10	horses	horse	NNS
cord-023095-4dannjjm	1711	11	4	4	CD
cord-023095-4dannjjm	1711	12	hours	hour	NNS
cord-023095-4dannjjm	1711	13	after	after	IN
cord-023095-4dannjjm	1711	14	intravenous	intravenous	JJ
cord-023095-4dannjjm	1711	15	administration	administration	NN
cord-023095-4dannjjm	1711	16	,	,	,
cord-023095-4dannjjm	1711	17	and	and	CC
cord-023095-4dannjjm	1711	18	in	in	IN
cord-023095-4dannjjm	1711	19	2	2	CD
cord-023095-4dannjjm	1711	20	horses	horse	NNS
cord-023095-4dannjjm	1711	21	1	1	CD
cord-023095-4dannjjm	1711	22	hour	hour	NN
cord-023095-4dannjjm	1711	23	after	after	IN
cord-023095-4dannjjm	1711	24	administration	administration	NN
cord-023095-4dannjjm	1711	25	.	.	.
cord-023095-4dannjjm	1712	1	Cefquinome	Cefquinome	NNP
cord-023095-4dannjjm	1712	2	penetrates	penetrate	VBZ
cord-023095-4dannjjm	1712	3	the	the	DT
cord-023095-4dannjjm	1712	4	blood	blood	NN
cord-023095-4dannjjm	1712	5	-	-	HYPH
cord-023095-4dannjjm	1712	6	brain	brain	NN
cord-023095-4dannjjm	1712	7	barrier	barrier	NN
cord-023095-4dannjjm	1712	8	and	and	CC
cord-023095-4dannjjm	1712	9	it	-PRON-	PRP
cord-023095-4dannjjm	1712	10	is	be	VBZ
cord-023095-4dannjjm	1712	11	therefore	therefore	RB
cord-023095-4dannjjm	1712	12	a	a	DT
cord-023095-4dannjjm	1712	13	potential	potential	JJ
cord-023095-4dannjjm	1712	14	treatment	treatment	NN
cord-023095-4dannjjm	1712	15	for	for	IN
cord-023095-4dannjjm	1712	16	equine	equine	JJ
cord-023095-4dannjjm	1712	17	meningitis	meningitis	NN
cord-023095-4dannjjm	1712	18	.	.	.
cord-023095-4dannjjm	1713	1	Further	further	JJ
cord-023095-4dannjjm	1713	2	investigation	investigation	NN
cord-023095-4dannjjm	1713	3	of	of	IN
cord-023095-4dannjjm	1713	4	the	the	DT
cord-023095-4dannjjm	1713	5	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	1713	6	and	and	CC
cord-023095-4dannjjm	1713	7	pharmacodynamics	pharmacodynamic	NNS
cord-023095-4dannjjm	1713	8	of	of	IN
cord-023095-4dannjjm	1713	9	cefquinome	cefquinome	NNP
cord-023095-4dannjjm	1713	10	in	in	IN
cord-023095-4dannjjm	1713	11	the	the	DT
cord-023095-4dannjjm	1713	12	cerebrospinal	cerebrospinal	JJ
cord-023095-4dannjjm	1713	13	fluid	fluid	NN
cord-023095-4dannjjm	1713	14	is	be	VBZ
cord-023095-4dannjjm	1713	15	warranted	warrant	VBN
cord-023095-4dannjjm	1713	16	to	to	TO
cord-023095-4dannjjm	1713	17	establish	establish	VB
cord-023095-4dannjjm	1713	18	the	the	DT
cord-023095-4dannjjm	1713	19	optimum	optimum	JJ
cord-023095-4dannjjm	1713	20	intravenous	intravenous	JJ
cord-023095-4dannjjm	1713	21	dose	dose	NN
cord-023095-4dannjjm	1713	22	.	.	.
cord-023095-4dannjjm	1714	1	The	the	DT
cord-023095-4dannjjm	1714	2	purpose	purpose	NN
cord-023095-4dannjjm	1714	3	of	of	IN
cord-023095-4dannjjm	1714	4	this	this	DT
cord-023095-4dannjjm	1714	5	study	study	NN
cord-023095-4dannjjm	1714	6	was	be	VBD
cord-023095-4dannjjm	1714	7	to	to	TO
cord-023095-4dannjjm	1714	8	determine	determine	VB
cord-023095-4dannjjm	1714	9	if	if	IN
cord-023095-4dannjjm	1714	10	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	1714	11	alters	alter	VBZ
cord-023095-4dannjjm	1714	12	the	the	DT
cord-023095-4dannjjm	1714	13	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	1714	14	of	of	IN
cord-023095-4dannjjm	1714	15	firocoxib	firocoxib	NNP
cord-023095-4dannjjm	1714	16	in	in	IN
cord-023095-4dannjjm	1714	17	the	the	DT
cord-023095-4dannjjm	1714	18	horse	horse	NN
cord-023095-4dannjjm	1714	19	.	.	.
cord-023095-4dannjjm	1715	1	Firocoxib	Firocoxib	NNP
cord-023095-4dannjjm	1715	2	is	be	VBZ
cord-023095-4dannjjm	1715	3	a	a	DT
cord-023095-4dannjjm	1715	4	coxibclass	coxibclass	NNP
cord-023095-4dannjjm	1715	5	nonsteroidal	nonsteroidal	JJ
cord-023095-4dannjjm	1715	6	anti	anti	JJ
cord-023095-4dannjjm	1715	7	-	-	JJ
cord-023095-4dannjjm	1715	8	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1715	9	drug	drug	NN
cord-023095-4dannjjm	1715	10	(	(	-LRB-
cord-023095-4dannjjm	1715	11	NSAID	NSAID	NNP
cord-023095-4dannjjm	1715	12	)	)	-RRB-
cord-023095-4dannjjm	1715	13	approved	approve	VBD
cord-023095-4dannjjm	1715	14	for	for	IN
cord-023095-4dannjjm	1715	15	use	use	NN
cord-023095-4dannjjm	1715	16	in	in	IN
cord-023095-4dannjjm	1715	17	horses	horse	NNS
cord-023095-4dannjjm	1715	18	to	to	TO
cord-023095-4dannjjm	1715	19	control	control	VB
cord-023095-4dannjjm	1715	20	pain	pain	NN
cord-023095-4dannjjm	1715	21	and	and	CC
cord-023095-4dannjjm	1715	22	inflammation	inflammation	NN
cord-023095-4dannjjm	1715	23	associated	associate	VBN
cord-023095-4dannjjm	1715	24	with	with	IN
cord-023095-4dannjjm	1715	25	osteoarthritis	osteoarthritis	NN
cord-023095-4dannjjm	1715	26	.	.	.
cord-023095-4dannjjm	1716	1	Dosages	dosage	NNS
cord-023095-4dannjjm	1716	2	of	of	IN
cord-023095-4dannjjm	1716	3	firocoxib	firocoxib	NNS
cord-023095-4dannjjm	1716	4	are	be	VBP
cord-023095-4dannjjm	1716	5	species	specie	NNS
cord-023095-4dannjjm	1716	6	dependent	dependent	JJ
cord-023095-4dannjjm	1716	7	,	,	,
cord-023095-4dannjjm	1716	8	with	with	IN
cord-023095-4dannjjm	1716	9	the	the	DT
cord-023095-4dannjjm	1716	10	recommended	recommend	VBN
cord-023095-4dannjjm	1716	11	dose	dose	NN
cord-023095-4dannjjm	1716	12	for	for	IN
cord-023095-4dannjjm	1716	13	horses	horse	NNS
cord-023095-4dannjjm	1716	14	being	be	VBG
cord-023095-4dannjjm	1716	15	0.1	0.1	CD
cord-023095-4dannjjm	1716	16	mg	mg	NNP
cord-023095-4dannjjm	1716	17	/	/	SYM
cord-023095-4dannjjm	1716	18	kg	kg	NNP
cord-023095-4dannjjm	1716	19	as	as	IN
cord-023095-4dannjjm	1716	20	an	an	DT
cord-023095-4dannjjm	1716	21	oral	oral	JJ
cord-023095-4dannjjm	1716	22	paste	paste	NN
cord-023095-4dannjjm	1716	23	every	every	DT
cord-023095-4dannjjm	1716	24	24	24	CD
cord-023095-4dannjjm	1716	25	h.	h.	NN
cord-023095-4dannjjm	1717	1	The	the	DT
cord-023095-4dannjjm	1717	2	main	main	JJ
cord-023095-4dannjjm	1717	3	elimination	elimination	NN
cord-023095-4dannjjm	1717	4	pathway	pathway	NN
cord-023095-4dannjjm	1717	5	of	of	IN
cord-023095-4dannjjm	1717	6	firocoxib	firocoxib	NNP
cord-023095-4dannjjm	1717	7	is	be	VBZ
cord-023095-4dannjjm	1717	8	hepatic	hepatic	JJ
cord-023095-4dannjjm	1717	9	;	;	:
cord-023095-4dannjjm	1717	10	however	however	RB
cord-023095-4dannjjm	1717	11	the	the	DT
cord-023095-4dannjjm	1717	12	effects	effect	NNS
cord-023095-4dannjjm	1717	13	of	of	IN
cord-023095-4dannjjm	1717	14	concurrent	concurrent	JJ
cord-023095-4dannjjm	1717	15	administration	administration	NN
cord-023095-4dannjjm	1717	16	of	of	IN
cord-023095-4dannjjm	1717	17	drugs	drug	NNS
cord-023095-4dannjjm	1717	18	that	that	WDT
cord-023095-4dannjjm	1717	19	may	may	MD
cord-023095-4dannjjm	1717	20	inhibit	inhibit	VB
cord-023095-4dannjjm	1717	21	its	-PRON-	PRP$
cord-023095-4dannjjm	1717	22	metabolism	metabolism	NN
cord-023095-4dannjjm	1717	23	have	have	VBP
cord-023095-4dannjjm	1717	24	not	not	RB
cord-023095-4dannjjm	1717	25	been	be	VBN
cord-023095-4dannjjm	1717	26	evaluated	evaluate	VBN
cord-023095-4dannjjm	1717	27	.	.	.
cord-023095-4dannjjm	1718	1	Enrofloxacin	Enrofloxacin	NNP
cord-023095-4dannjjm	1718	2	is	be	VBZ
cord-023095-4dannjjm	1718	3	a	a	DT
cord-023095-4dannjjm	1718	4	synthetic	synthetic	JJ
cord-023095-4dannjjm	1718	5	antibacterial	antibacterial	JJ
cord-023095-4dannjjm	1718	6	agent	agent	NN
cord-023095-4dannjjm	1718	7	from	from	IN
cord-023095-4dannjjm	1718	8	the	the	DT
cord-023095-4dannjjm	1718	9	flouroquinolone	flouroquinolone	NNP
cord-023095-4dannjjm	1718	10	group	group	NN
cord-023095-4dannjjm	1718	11	developed	develop	VBN
cord-023095-4dannjjm	1718	12	for	for	IN
cord-023095-4dannjjm	1718	13	veterinary	veterinary	JJ
cord-023095-4dannjjm	1718	14	use	use	NN
cord-023095-4dannjjm	1718	15	.	.	.
cord-023095-4dannjjm	1719	1	It	-PRON-	PRP
cord-023095-4dannjjm	1719	2	is	be	VBZ
cord-023095-4dannjjm	1719	3	primarily	primarily	RB
cord-023095-4dannjjm	1719	4	used	use	VBN
cord-023095-4dannjjm	1719	5	for	for	IN
cord-023095-4dannjjm	1719	6	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	1719	7	,	,	,
cord-023095-4dannjjm	1719	8	urogenital	urogenital	JJ
cord-023095-4dannjjm	1719	9	,	,	,
cord-023095-4dannjjm	1719	10	skin	skin	NN
cord-023095-4dannjjm	1719	11	and	and	CC
cord-023095-4dannjjm	1719	12	respiratory	respiratory	JJ
cord-023095-4dannjjm	1719	13	tract	tract	NN
cord-023095-4dannjjm	1719	14	infections	infection	NNS
cord-023095-4dannjjm	1719	15	in	in	IN
cord-023095-4dannjjm	1719	16	various	various	JJ
cord-023095-4dannjjm	1719	17	animals	animal	NNS
cord-023095-4dannjjm	1719	18	.	.	.
cord-023095-4dannjjm	1720	1	A	a	DT
cord-023095-4dannjjm	1720	2	well	well	RB
cord-023095-4dannjjm	1720	3	acknowledged	acknowledge	VBN
cord-023095-4dannjjm	1720	4	problem	problem	NN
cord-023095-4dannjjm	1720	5	associated	associate	VBN
cord-023095-4dannjjm	1720	6	with	with	IN
cord-023095-4dannjjm	1720	7	flouroquinolone	flouroquinolone	JJ
cord-023095-4dannjjm	1720	8	usage	usage	NN
cord-023095-4dannjjm	1720	9	is	be	VBZ
cord-023095-4dannjjm	1720	10	their	-PRON-	PRP$
cord-023095-4dannjjm	1720	11	effect	effect	NN
cord-023095-4dannjjm	1720	12	on	on	IN
cord-023095-4dannjjm	1720	13	the	the	DT
cord-023095-4dannjjm	1720	14	metabolism	metabolism	NN
cord-023095-4dannjjm	1720	15	of	of	IN
cord-023095-4dannjjm	1720	16	other	other	JJ
cord-023095-4dannjjm	1720	17	drugs	drug	NNS
cord-023095-4dannjjm	1720	18	.	.	.
cord-023095-4dannjjm	1721	1	Co	co	NN
cord-023095-4dannjjm	1721	2	-	-	NN
cord-023095-4dannjjm	1721	3	administration	administration	NN
cord-023095-4dannjjm	1721	4	of	of	IN
cord-023095-4dannjjm	1721	5	multiple	multiple	JJ
cord-023095-4dannjjm	1721	6	drugs	drug	NNS
cord-023095-4dannjjm	1721	7	can	can	MD
cord-023095-4dannjjm	1721	8	result	result	VB
cord-023095-4dannjjm	1721	9	in	in	IN
cord-023095-4dannjjm	1721	10	unpredictable	unpredictable	JJ
cord-023095-4dannjjm	1721	11	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	1721	12	outcomes	outcome	NNS
cord-023095-4dannjjm	1721	13	.	.	.
cord-023095-4dannjjm	1722	1	Often	often	RB
cord-023095-4dannjjm	1722	2	it	-PRON-	PRP
cord-023095-4dannjjm	1722	3	is	be	VBZ
cord-023095-4dannjjm	1722	4	either	either	CC
cord-023095-4dannjjm	1722	5	diminished	diminish	VBN
cord-023095-4dannjjm	1722	6	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	1722	7	efficacy	efficacy	NN
cord-023095-4dannjjm	1722	8	or	or	CC
cord-023095-4dannjjm	1722	9	increased	increase	VBN
cord-023095-4dannjjm	1722	10	toxicity	toxicity	NN
cord-023095-4dannjjm	1722	11	of	of	IN
cord-023095-4dannjjm	1722	12	one	one	CD
cord-023095-4dannjjm	1722	13	or	or	CC
cord-023095-4dannjjm	1722	14	more	more	JJR
cord-023095-4dannjjm	1722	15	of	of	IN
cord-023095-4dannjjm	1722	16	the	the	DT
cord-023095-4dannjjm	1722	17	administered	administer	VBN
cord-023095-4dannjjm	1722	18	drugs	drug	NNS
cord-023095-4dannjjm	1722	19	.	.	.
cord-023095-4dannjjm	1723	1	Various	various	JJ
cord-023095-4dannjjm	1723	2	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	1723	3	interactions	interaction	NNS
cord-023095-4dannjjm	1723	4	between	between	IN
cord-023095-4dannjjm	1723	5	antimicrobials	antimicrobial	NNS
cord-023095-4dannjjm	1723	6	and	and	CC
cord-023095-4dannjjm	1723	7	NSAIDs	nsaid	NNS
cord-023095-4dannjjm	1723	8	have	have	VBP
cord-023095-4dannjjm	1723	9	been	be	VBN
cord-023095-4dannjjm	1723	10	described	describe	VBN
cord-023095-4dannjjm	1723	11	.	.	.
cord-023095-4dannjjm	1724	1	Six	six	CD
cord-023095-4dannjjm	1724	2	healthy	healthy	JJ
cord-023095-4dannjjm	1724	3	,	,	,
cord-023095-4dannjjm	1724	4	adult	adult	NN
cord-023095-4dannjjm	1724	5	mares	mare	NNS
cord-023095-4dannjjm	1724	6	were	be	VBD
cord-023095-4dannjjm	1724	7	administered	administer	VBN
cord-023095-4dannjjm	1724	8	0.1	0.1	CD
cord-023095-4dannjjm	1724	9	mg	mg	NNP
cord-023095-4dannjjm	1724	10	/	/	SYM
cord-023095-4dannjjm	1724	11	kg	kg	NNS
cord-023095-4dannjjm	1724	12	of	of	IN
cord-023095-4dannjjm	1724	13	firocoxib	firocoxib	NN
cord-023095-4dannjjm	1724	14	orally	orally	RB
cord-023095-4dannjjm	1724	15	.	.	.
cord-023095-4dannjjm	1725	1	Samples	sample	NNS
cord-023095-4dannjjm	1725	2	were	be	VBD
cord-023095-4dannjjm	1725	3	collected	collect	VBN
cord-023095-4dannjjm	1725	4	by	by	IN
cord-023095-4dannjjm	1725	5	direct	direct	JJ
cord-023095-4dannjjm	1725	6	venipuncture	venipuncture	NN
cord-023095-4dannjjm	1725	7	of	of	IN
cord-023095-4dannjjm	1725	8	the	the	DT
cord-023095-4dannjjm	1725	9	jugular	jugular	NN
cord-023095-4dannjjm	1725	10	vein	vein	NN
cord-023095-4dannjjm	1725	11	at	at	IN
cord-023095-4dannjjm	1725	12	0	0	NFP
cord-023095-4dannjjm	1725	13	(	(	-LRB-
cord-023095-4dannjjm	1725	14	control	control	NN
cord-023095-4dannjjm	1725	15	)	)	-RRB-
cord-023095-4dannjjm	1725	16	,	,	,
cord-023095-4dannjjm	1725	17	15	15	CD
cord-023095-4dannjjm	1725	18	,	,	,
cord-023095-4dannjjm	1725	19	30	30	CD
cord-023095-4dannjjm	1725	20	,	,	,
cord-023095-4dannjjm	1725	21	and	and	CC
cord-023095-4dannjjm	1725	22	60	60	CD
cord-023095-4dannjjm	1725	23	min	min	NN
cord-023095-4dannjjm	1725	24	,	,	,
cord-023095-4dannjjm	1725	25	2	2	CD
cord-023095-4dannjjm	1725	26	,	,	,
cord-023095-4dannjjm	1725	27	4	4	CD
cord-023095-4dannjjm	1725	28	,	,	,
cord-023095-4dannjjm	1725	29	8	8	CD
cord-023095-4dannjjm	1725	30	,	,	,
cord-023095-4dannjjm	1725	31	12	12	CD
cord-023095-4dannjjm	1725	32	,	,	,
cord-023095-4dannjjm	1725	33	16	16	CD
cord-023095-4dannjjm	1725	34	,	,	,
cord-023095-4dannjjm	1725	35	24	24	CD
cord-023095-4dannjjm	1725	36	,	,	,
cord-023095-4dannjjm	1725	37	48	48	CD
cord-023095-4dannjjm	1725	38	,	,	,
cord-023095-4dannjjm	1725	39	72	72	CD
cord-023095-4dannjjm	1725	40	,	,	,
cord-023095-4dannjjm	1725	41	and	and	CC
cord-023095-4dannjjm	1725	42	96	96	CD
cord-023095-4dannjjm	1725	43	h	h	NN
cord-023095-4dannjjm	1725	44	after	after	IN
cord-023095-4dannjjm	1725	45	administration	administration	NN
cord-023095-4dannjjm	1725	46	.	.	.
cord-023095-4dannjjm	1726	1	After	after	IN
cord-023095-4dannjjm	1726	2	a	a	DT
cord-023095-4dannjjm	1726	3	20	20	CD
cord-023095-4dannjjm	1726	4	day	day	NN
cord-023095-4dannjjm	1726	5	washout	washout	NN
cord-023095-4dannjjm	1726	6	period	period	NN
cord-023095-4dannjjm	1726	7	the	the	DT
cord-023095-4dannjjm	1726	8	six	six	CD
cord-023095-4dannjjm	1726	9	horses	horse	NNS
cord-023095-4dannjjm	1726	10	were	be	VBD
cord-023095-4dannjjm	1726	11	pretreated	pretreate	VBN
cord-023095-4dannjjm	1726	12	3	3	CD
cord-023095-4dannjjm	1726	13	days	day	NNS
cord-023095-4dannjjm	1726	14	with	with	IN
cord-023095-4dannjjm	1726	15	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	1727	1	5	5	CD
cord-023095-4dannjjm	1727	2	mg	mg	NNP
cord-023095-4dannjjm	1727	3	/	/	SYM
cord-023095-4dannjjm	1727	4	kg	kg	XX
cord-023095-4dannjjm	1727	5	intravenously	intravenously	RB
cord-023095-4dannjjm	1727	6	every	every	DT
cord-023095-4dannjjm	1727	7	24	24	CD
cord-023095-4dannjjm	1727	8	h	h	NN
cord-023095-4dannjjm	1727	9	then	then	RB
cord-023095-4dannjjm	1727	10	on	on	IN
cord-023095-4dannjjm	1727	11	the	the	DT
cord-023095-4dannjjm	1727	12	fourth	fourth	JJ
cord-023095-4dannjjm	1727	13	day	day	NN
cord-023095-4dannjjm	1727	14	given	give	VBN
cord-023095-4dannjjm	1727	15	0.1	0.1	CD
cord-023095-4dannjjm	1727	16	mg	mg	NNP
cord-023095-4dannjjm	1727	17	/	/	SYM
cord-023095-4dannjjm	1727	18	kg	kg	NNS
cord-023095-4dannjjm	1727	19	of	of	IN
cord-023095-4dannjjm	1727	20	firocoxib	firocoxib	NN
cord-023095-4dannjjm	1727	21	orally	orally	RB
cord-023095-4dannjjm	1727	22	.	.	.
cord-023095-4dannjjm	1728	1	Samples	sample	NNS
cord-023095-4dannjjm	1728	2	were	be	VBD
cord-023095-4dannjjm	1728	3	collected	collect	VBN
cord-023095-4dannjjm	1728	4	at	at	IN
cord-023095-4dannjjm	1728	5	0	0	CD
cord-023095-4dannjjm	1728	6	(	(	-LRB-
cord-023095-4dannjjm	1728	7	control	control	NN
cord-023095-4dannjjm	1728	8	)	)	-RRB-
cord-023095-4dannjjm	1728	9	,	,	,
cord-023095-4dannjjm	1728	10	15	15	CD
cord-023095-4dannjjm	1728	11	,	,	,
cord-023095-4dannjjm	1728	12	30	30	CD
cord-023095-4dannjjm	1728	13	,	,	,
cord-023095-4dannjjm	1728	14	and	and	CC
cord-023095-4dannjjm	1728	15	60	60	CD
cord-023095-4dannjjm	1728	16	min	min	NN
cord-023095-4dannjjm	1728	17	,	,	,
cord-023095-4dannjjm	1728	18	2	2	CD
cord-023095-4dannjjm	1728	19	,	,	,
cord-023095-4dannjjm	1728	20	4	4	CD
cord-023095-4dannjjm	1728	21	,	,	,
cord-023095-4dannjjm	1728	22	8	8	CD
cord-023095-4dannjjm	1728	23	,	,	,
cord-023095-4dannjjm	1728	24	12	12	CD
cord-023095-4dannjjm	1728	25	,	,	,
cord-023095-4dannjjm	1728	26	16	16	CD
cord-023095-4dannjjm	1728	27	,	,	,
cord-023095-4dannjjm	1728	28	24	24	CD
cord-023095-4dannjjm	1728	29	,	,	,
cord-023095-4dannjjm	1728	30	48	48	CD
cord-023095-4dannjjm	1728	31	,	,	,
cord-023095-4dannjjm	1728	32	72	72	CD
cord-023095-4dannjjm	1728	33	,	,	,
cord-023095-4dannjjm	1728	34	and	and	CC
cord-023095-4dannjjm	1728	35	96	96	CD
cord-023095-4dannjjm	1728	36	h	h	NN
cord-023095-4dannjjm	1728	37	after	after	IN
cord-023095-4dannjjm	1728	38	administration	administration	NN
cord-023095-4dannjjm	1728	39	.	.	.
cord-023095-4dannjjm	1729	1	All	all	DT
cord-023095-4dannjjm	1729	2	samples	sample	NNS
cord-023095-4dannjjm	1729	3	were	be	VBD
cord-023095-4dannjjm	1729	4	stored	store	VBN
cord-023095-4dannjjm	1729	5	at	at	IN
cord-023095-4dannjjm	1729	6	À801C	À801C	NNPS
cord-023095-4dannjjm	1729	7	until	until	IN
cord-023095-4dannjjm	1729	8	analysis	analysis	NN
cord-023095-4dannjjm	1729	9	using	use	VBG
cord-023095-4dannjjm	1729	10	a	a	DT
cord-023095-4dannjjm	1729	11	validated	validate	VBN
cord-023095-4dannjjm	1729	12	HPLC	HPLC	NNP
cord-023095-4dannjjm	1729	13	method	method	NN
cord-023095-4dannjjm	1729	14	.	.	.
cord-023095-4dannjjm	1730	1	The	the	DT
cord-023095-4dannjjm	1730	2	t1/2	t1/2	NN
cord-023095-4dannjjm	1730	3	,	,	,
cord-023095-4dannjjm	1730	4	C	C	NNP
cord-023095-4dannjjm	1730	5	max	max	NN
cord-023095-4dannjjm	1730	6	,	,	,
cord-023095-4dannjjm	1730	7	T	T	NNP
cord-023095-4dannjjm	1730	8	max	max	NN
cord-023095-4dannjjm	1730	9	,	,	,
cord-023095-4dannjjm	1730	10	AUC	AUC	NNP
cord-023095-4dannjjm	1730	11	0	0	CD
cord-023095-4dannjjm	1730	12	-	-	HYPH
cord-023095-4dannjjm	1730	13	24	24	CD
cord-023095-4dannjjm	1730	14	and	and	CC
cord-023095-4dannjjm	1730	15	AUC	AUC	NNP
cord-023095-4dannjjm	1730	16	0-f	0-f	CD
cord-023095-4dannjjm	1730	17	after	after	IN
cord-023095-4dannjjm	1730	18	firocoxib	firocoxib	NNP
cord-023095-4dannjjm	1730	19	administration	administration	NNP
cord-023095-4dannjjm	1730	20	were	be	VBD
cord-023095-4dannjjm	1730	21	30	30	CD
cord-023095-4dannjjm	1730	22	.	.	.
cord-023095-4dannjjm	1731	1	66	66	CD
cord-023095-4dannjjm	1732	1	Angiotensin	angiotensin	NN
cord-023095-4dannjjm	1732	2	converting	convert	VBG
cord-023095-4dannjjm	1732	3	enzyme	enzyme	NN
cord-023095-4dannjjm	1732	4	(	(	-LRB-
cord-023095-4dannjjm	1732	5	ACE	ACE	NNP
cord-023095-4dannjjm	1732	6	)	)	-RRB-
cord-023095-4dannjjm	1732	7	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	1732	8	improve	improve	VBP
cord-023095-4dannjjm	1732	9	survival	survival	NN
cord-023095-4dannjjm	1732	10	and	and	CC
cord-023095-4dannjjm	1732	11	quality	quality	NN
cord-023095-4dannjjm	1732	12	of	of	IN
cord-023095-4dannjjm	1732	13	life	life	NN
cord-023095-4dannjjm	1732	14	in	in	IN
cord-023095-4dannjjm	1732	15	humans	human	NNS
cord-023095-4dannjjm	1732	16	and	and	CC
cord-023095-4dannjjm	1732	17	small	small	JJ
cord-023095-4dannjjm	1732	18	animals	animal	NNS
cord-023095-4dannjjm	1732	19	with	with	IN
cord-023095-4dannjjm	1732	20	cardiovascular	cardiovascular	JJ
cord-023095-4dannjjm	1732	21	and	and	CC
cord-023095-4dannjjm	1732	22	renal	renal	JJ
cord-023095-4dannjjm	1732	23	disease	disease	NN
cord-023095-4dannjjm	1732	24	.	.	.
cord-023095-4dannjjm	1733	1	There	there	EX
cord-023095-4dannjjm	1733	2	is	be	VBZ
cord-023095-4dannjjm	1733	3	limited	limited	JJ
cord-023095-4dannjjm	1733	4	information	information	NN
cord-023095-4dannjjm	1733	5	regarding	regard	VBG
cord-023095-4dannjjm	1733	6	their	-PRON-	PRP$
cord-023095-4dannjjm	1733	7	effects	effect	NNS
cord-023095-4dannjjm	1733	8	in	in	IN
cord-023095-4dannjjm	1733	9	horses	horse	NNS
cord-023095-4dannjjm	1733	10	.	.	.
cord-023095-4dannjjm	1734	1	The	the	DT
cord-023095-4dannjjm	1734	2	purpose	purpose	NN
cord-023095-4dannjjm	1734	3	of	of	IN
cord-023095-4dannjjm	1734	4	this	this	DT
cord-023095-4dannjjm	1734	5	study	study	NN
cord-023095-4dannjjm	1734	6	was	be	VBD
cord-023095-4dannjjm	1734	7	to	to	TO
cord-023095-4dannjjm	1734	8	determine	determine	VB
cord-023095-4dannjjm	1734	9	the	the	DT
cord-023095-4dannjjm	1734	10	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	1734	11	of	of	IN
cord-023095-4dannjjm	1734	12	quinapril	quinapril	NNP
cord-023095-4dannjjm	1734	13	and	and	CC
cord-023095-4dannjjm	1734	14	its	-PRON-	PRP$
cord-023095-4dannjjm	1734	15	effects	effect	NNS
cord-023095-4dannjjm	1734	16	on	on	IN
cord-023095-4dannjjm	1734	17	ACE	ace	NN
cord-023095-4dannjjm	1734	18	inhibition	inhibition	NN
cord-023095-4dannjjm	1734	19	in	in	IN
cord-023095-4dannjjm	1734	20	horses	horse	NNS
cord-023095-4dannjjm	1734	21	.	.	.
cord-023095-4dannjjm	1735	1	Six	six	CD
cord-023095-4dannjjm	1735	2	healthy	healthy	JJ
cord-023095-4dannjjm	1735	3	horses	horse	NNS
cord-023095-4dannjjm	1735	4	were	be	VBD
cord-023095-4dannjjm	1735	5	administered	administer	VBN
cord-023095-4dannjjm	1735	6	quinapril	quinapril	NNP
cord-023095-4dannjjm	1735	7	at	at	IN
cord-023095-4dannjjm	1735	8	120	120	CD
cord-023095-4dannjjm	1735	9	mg	mg	NNP
cord-023095-4dannjjm	1735	10	IV	IV	NNP
cord-023095-4dannjjm	1735	11	,	,	,
cord-023095-4dannjjm	1735	12	120	120	CD
cord-023095-4dannjjm	1735	13	mg	mg	NNP
cord-023095-4dannjjm	1735	14	PO	PO	NNP
cord-023095-4dannjjm	1735	15	or	or	CC
cord-023095-4dannjjm	1735	16	240	240	CD
cord-023095-4dannjjm	1735	17	mg	mg	NNP
cord-023095-4dannjjm	1735	18	PO	PO	NNP
cord-023095-4dannjjm	1735	19	in	in	IN
cord-023095-4dannjjm	1735	20	a	a	DT
cord-023095-4dannjjm	1735	21	3-way	3-way	JJ
cord-023095-4dannjjm	1735	22	crossover	crossover	NN
cord-023095-4dannjjm	1735	23	design	design	NN
cord-023095-4dannjjm	1735	24	.	.	.
cord-023095-4dannjjm	1736	1	Blood	blood	NN
cord-023095-4dannjjm	1736	2	was	be	VBD
cord-023095-4dannjjm	1736	3	collected	collect	VBN
cord-023095-4dannjjm	1736	4	at	at	IN
cord-023095-4dannjjm	1736	5	predetermined	predetermined	JJ
cord-023095-4dannjjm	1736	6	times	time	NNS
cord-023095-4dannjjm	1736	7	for	for	IN
cord-023095-4dannjjm	1736	8	measurement	measurement	NN
cord-023095-4dannjjm	1736	9	of	of	IN
cord-023095-4dannjjm	1736	10	quinapril	quinapril	NNP
cord-023095-4dannjjm	1736	11	and	and	CC
cord-023095-4dannjjm	1736	12	quinaprilat	quinaprilat	NNP
cord-023095-4dannjjm	1736	13	concentrations	concentration	NNS
cord-023095-4dannjjm	1736	14	using	use	VBG
cord-023095-4dannjjm	1736	15	high	high	JJ
cord-023095-4dannjjm	1736	16	pressure	pressure	NN
cord-023095-4dannjjm	1736	17	liquid	liquid	NN
cord-023095-4dannjjm	1736	18	chromatography	chromatography	NN
cord-023095-4dannjjm	1736	19	,	,	,
cord-023095-4dannjjm	1736	20	as	as	RB
cord-023095-4dannjjm	1736	21	well	well	RB
cord-023095-4dannjjm	1736	22	as	as	IN
cord-023095-4dannjjm	1736	23	ACE	ace	NN
cord-023095-4dannjjm	1736	24	concentrations	concentration	NNS
cord-023095-4dannjjm	1736	25	using	use	VBG
cord-023095-4dannjjm	1736	26	a	a	DT
cord-023095-4dannjjm	1736	27	radioenzymatic	radioenzymatic	JJ
cord-023095-4dannjjm	1736	28	assay	assay	NN
cord-023095-4dannjjm	1736	29	.	.	.
cord-023095-4dannjjm	1737	1	Normally	normally	RB
cord-023095-4dannjjm	1737	2	distributed	distribute	VBN
cord-023095-4dannjjm	1737	3	data	datum	NNS
cord-023095-4dannjjm	1737	4	were	be	VBD
cord-023095-4dannjjm	1737	5	analyzed	analyze	VBN
cord-023095-4dannjjm	1737	6	with	with	IN
cord-023095-4dannjjm	1737	7	one	one	CD
cord-023095-4dannjjm	1737	8	way	way	NN
cord-023095-4dannjjm	1737	9	repeated	repeat	VBN
cord-023095-4dannjjm	1737	10	measures	measure	NNS
cord-023095-4dannjjm	1737	11	analysis	analysis	NN
cord-023095-4dannjjm	1737	12	of	of	IN
cord-023095-4dannjjm	1737	13	variance	variance	NN
cord-023095-4dannjjm	1737	14	(	(	-LRB-
cord-023095-4dannjjm	1737	15	RM	rm	NN
cord-023095-4dannjjm	1737	16	-	-	HYPH
cord-023095-4dannjjm	1737	17	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	1737	18	)	)	-RRB-
cord-023095-4dannjjm	1737	19	and	and	CC
cord-023095-4dannjjm	1737	20	non	non	JJ
cord-023095-4dannjjm	1737	21	-	-	JJ
cord-023095-4dannjjm	1737	22	normally	normally	RB
cord-023095-4dannjjm	1737	23	distributed	distribute	VBN
cord-023095-4dannjjm	1737	24	data	datum	NNS
cord-023095-4dannjjm	1737	25	were	be	VBD
cord-023095-4dannjjm	1737	26	analyzed	analyze	VBN
cord-023095-4dannjjm	1737	27	using	use	VBG
cord-023095-4dannjjm	1737	28	Friedman	Friedman	NNP
cord-023095-4dannjjm	1737	29	RM_ANOVA	RM_ANOVA	NNP
cord-023095-4dannjjm	1737	30	on	on	IN
cord-023095-4dannjjm	1737	31	ranks	rank	NNS
cord-023095-4dannjjm	1737	32	.	.	.
cord-023095-4dannjjm	1738	1	Significance	significance	NN
cord-023095-4dannjjm	1738	2	was	be	VBD
cord-023095-4dannjjm	1738	3	set	set	VBN
cord-023095-4dannjjm	1738	4	at	at	IN
cord-023095-4dannjjm	1738	5	P	p	NN
cord-023095-4dannjjm	1738	6	o	o	NN
cord-023095-4dannjjm	1738	7	0.05	0.05	CD
cord-023095-4dannjjm	1738	8	.	.	.
cord-023095-4dannjjm	1739	1	No	no	DT
cord-023095-4dannjjm	1739	2	adverse	adverse	JJ
cord-023095-4dannjjm	1739	3	effects	effect	NNS
cord-023095-4dannjjm	1739	4	were	be	VBD
cord-023095-4dannjjm	1739	5	observed	observe	VBN
cord-023095-4dannjjm	1739	6	during	during	IN
cord-023095-4dannjjm	1739	7	the	the	DT
cord-023095-4dannjjm	1739	8	study	study	NN
cord-023095-4dannjjm	1739	9	period	period	NN
cord-023095-4dannjjm	1739	10	.	.	.
cord-023095-4dannjjm	1740	1	Plasma	plasma	NN
cord-023095-4dannjjm	1740	2	quinapril	quinapril	NN
cord-023095-4dannjjm	1740	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1740	4	were	be	VBD
cord-023095-4dannjjm	1740	5	low	low	JJ
cord-023095-4dannjjm	1740	6	and	and	CC
cord-023095-4dannjjm	1740	7	rapidly	rapidly	RB
cord-023095-4dannjjm	1740	8	declined	decline	VBD
cord-023095-4dannjjm	1740	9	after	after	IN
cord-023095-4dannjjm	1740	10	IV	IV	NNP
cord-023095-4dannjjm	1740	11	administration	administration	NN
cord-023095-4dannjjm	1740	12	.	.	.
cord-023095-4dannjjm	1741	1	Quinaprilat	Quinaprilat	NNP
cord-023095-4dannjjm	1741	2	concentrations	concentration	NNS
cord-023095-4dannjjm	1741	3	were	be	VBD
cord-023095-4dannjjm	1741	4	below	below	IN
cord-023095-4dannjjm	1741	5	the	the	DT
cord-023095-4dannjjm	1741	6	limit	limit	NN
cord-023095-4dannjjm	1741	7	of	of	IN
cord-023095-4dannjjm	1741	8	quantification	quantification	NN
cord-023095-4dannjjm	1741	9	(	(	-LRB-
cord-023095-4dannjjm	1741	10	0.1	0.1	CD
cord-023095-4dannjjm	1741	11	mg	mg	NNP
cord-023095-4dannjjm	1741	12	/	/	SYM
cord-023095-4dannjjm	1741	13	mL	mL	NNP
cord-023095-4dannjjm	1741	14	)	)	-RRB-
cord-023095-4dannjjm	1741	15	.	.	.
cord-023095-4dannjjm	1742	1	ACE	ace	NN
cord-023095-4dannjjm	1742	2	activity	activity	NN
cord-023095-4dannjjm	1742	3	was	be	VBD
cord-023095-4dannjjm	1742	4	significantly	significantly	RB
cord-023095-4dannjjm	1742	5	decreased	decrease	VBN
cord-023095-4dannjjm	1742	6	from	from	IN
cord-023095-4dannjjm	1742	7	baseline	baseline	NN
cord-023095-4dannjjm	1742	8	at	at	IN
cord-023095-4dannjjm	1742	9	0.5	0.5	CD
cord-023095-4dannjjm	1742	10	and	and	CC
cord-023095-4dannjjm	1742	11	1	1	CD
cord-023095-4dannjjm	1742	12	hour	hour	NN
cord-023095-4dannjjm	1742	13	after	after	IN
cord-023095-4dannjjm	1742	14	IV	IV	NNP
cord-023095-4dannjjm	1742	15	dosing	dose	VBG
cord-023095-4dannjjm	1742	16	and	and	CC
cord-023095-4dannjjm	1742	17	at	at	IN
cord-023095-4dannjjm	1742	18	all	all	DT
cord-023095-4dannjjm	1742	19	timepoints	timepoint	NNS
cord-023095-4dannjjm	1742	20	after	after	IN
cord-023095-4dannjjm	1742	21	oral	oral	JJ
cord-023095-4dannjjm	1742	22	dosing	dosing	NN
cord-023095-4dannjjm	1742	23	.	.	.
cord-023095-4dannjjm	1743	1	Maximum	maximum	JJ
cord-023095-4dannjjm	1743	2	%	%	NN
cord-023095-4dannjjm	1743	3	ACE	ace	NN
cord-023095-4dannjjm	1743	4	inhibition	inhibition	NN
cord-023095-4dannjjm	1743	5	was	be	VBD
cord-023095-4dannjjm	1743	6	72	72	CD
cord-023095-4dannjjm	1743	7	,	,	,
cord-023095-4dannjjm	1743	8	53	53	CD
cord-023095-4dannjjm	1743	9	and	and	CC
cord-023095-4dannjjm	1743	10	47	47	CD
cord-023095-4dannjjm	1743	11	%	%	NN
cord-023095-4dannjjm	1743	12	with	with	IN
cord-023095-4dannjjm	1743	13	the	the	DT
cord-023095-4dannjjm	1743	14	IV	IV	NNP
cord-023095-4dannjjm	1743	15	,	,	,
cord-023095-4dannjjm	1743	16	high	high	JJ
cord-023095-4dannjjm	1743	17	and	and	CC
cord-023095-4dannjjm	1743	18	low	low	JJ
cord-023095-4dannjjm	1743	19	oral	oral	JJ
cord-023095-4dannjjm	1743	20	doses	dose	NNS
cord-023095-4dannjjm	1743	21	,	,	,
cord-023095-4dannjjm	1743	22	respectively	respectively	RB
cord-023095-4dannjjm	1743	23	.	.	.
cord-023095-4dannjjm	1744	1	These	these	DT
cord-023095-4dannjjm	1744	2	results	result	NNS
cord-023095-4dannjjm	1744	3	suggest	suggest	VBP
cord-023095-4dannjjm	1744	4	that	that	IN
cord-023095-4dannjjm	1744	5	,	,	,
cord-023095-4dannjjm	1744	6	despite	despite	IN
cord-023095-4dannjjm	1744	7	low	low	JJ
cord-023095-4dannjjm	1744	8	plasma	plasma	NN
cord-023095-4dannjjm	1744	9	concentrations	concentration	NNS
cord-023095-4dannjjm	1744	10	,	,	,
cord-023095-4dannjjm	1744	11	quinapril	quinapril	NNP
cord-023095-4dannjjm	1744	12	has	have	VBZ
cord-023095-4dannjjm	1744	13	sufficient	sufficient	JJ
cord-023095-4dannjjm	1744	14	oral	oral	JJ
cord-023095-4dannjjm	1744	15	absorption	absorption	NN
cord-023095-4dannjjm	1744	16	and	and	CC
cord-023095-4dannjjm	1744	17	results	result	NNS
cord-023095-4dannjjm	1744	18	in	in	IN
cord-023095-4dannjjm	1744	19	inhibition	inhibition	NN
cord-023095-4dannjjm	1744	20	of	of	IN
cord-023095-4dannjjm	1744	21	ACE	ace	NN
cord-023095-4dannjjm	1744	22	in	in	IN
cord-023095-4dannjjm	1744	23	healthy	healthy	JJ
cord-023095-4dannjjm	1744	24	horses	horse	NNS
cord-023095-4dannjjm	1744	25	.	.	.
cord-023095-4dannjjm	1745	1	Controlled	controlled	JJ
cord-023095-4dannjjm	1745	2	studies	study	NNS
cord-023095-4dannjjm	1745	3	in	in	IN
cord-023095-4dannjjm	1745	4	clinically	clinically	RB
cord-023095-4dannjjm	1745	5	affected	affected	JJ
cord-023095-4dannjjm	1745	6	horses	horse	NNS
cord-023095-4dannjjm	1745	7	are	be	VBP
cord-023095-4dannjjm	1745	8	indicated	indicate	VBN
cord-023095-4dannjjm	1745	9	.	.	.
cord-023095-4dannjjm	1746	1	This	this	DT
cord-023095-4dannjjm	1746	2	study	study	NN
cord-023095-4dannjjm	1746	3	determined	determine	VBD
cord-023095-4dannjjm	1746	4	the	the	DT
cord-023095-4dannjjm	1746	5	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	1746	6	profile	profile	NN
cord-023095-4dannjjm	1746	7	of	of	IN
cord-023095-4dannjjm	1746	8	firocoxib	firocoxib	NN
cord-023095-4dannjjm	1746	9	in	in	IN
cord-023095-4dannjjm	1746	10	healthy	healthy	JJ
cord-023095-4dannjjm	1746	11	neonatal	neonatal	JJ
cord-023095-4dannjjm	1746	12	foals	foal	NNS
cord-023095-4dannjjm	1746	13	.	.	.
cord-023095-4dannjjm	1747	1	Foals	foal	NNS
cord-023095-4dannjjm	1747	2	are	be	VBP
cord-023095-4dannjjm	1747	3	more	more	RBR
cord-023095-4dannjjm	1747	4	sensitive	sensitive	JJ
cord-023095-4dannjjm	1747	5	to	to	IN
cord-023095-4dannjjm	1747	6	the	the	DT
cord-023095-4dannjjm	1747	7	side	side	JJ
cord-023095-4dannjjm	1747	8	effects	effect	NNS
cord-023095-4dannjjm	1747	9	of	of	IN
cord-023095-4dannjjm	1747	10	NSAID	NSAID	NNP
cord-023095-4dannjjm	1747	11	,	,	,
cord-023095-4dannjjm	1747	12	primarily	primarily	RB
cord-023095-4dannjjm	1747	13	due	due	JJ
cord-023095-4dannjjm	1747	14	to	to	IN
cord-023095-4dannjjm	1747	15	immature	immature	JJ
cord-023095-4dannjjm	1747	16	renal	renal	JJ
cord-023095-4dannjjm	1747	17	clearance	clearance	NN
cord-023095-4dannjjm	1747	18	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1747	19	and	and	CC
cord-023095-4dannjjm	1747	20	ulcerogenic	ulcerogenic	JJ
cord-023095-4dannjjm	1747	21	effects	effect	NNS
cord-023095-4dannjjm	1747	22	on	on	IN
cord-023095-4dannjjm	1747	23	gastric	gastric	JJ
cord-023095-4dannjjm	1747	24	mucosa	mucosa	NN
cord-023095-4dannjjm	1747	25	.	.	.
cord-023095-4dannjjm	1748	1	Firocoxib	Firocoxib	NNP
cord-023095-4dannjjm	1748	2	,	,	,
cord-023095-4dannjjm	1748	3	a	a	DT
cord-023095-4dannjjm	1748	4	novel	novel	NN
cord-023095-4dannjjm	1748	5	,	,	,
cord-023095-4dannjjm	1748	6	second	second	JJ
cord-023095-4dannjjm	1748	7	generation	generation	NN
cord-023095-4dannjjm	1748	8	NSAID	NSAID	NNP
cord-023095-4dannjjm	1748	9	,	,	,
cord-023095-4dannjjm	1748	10	is	be	VBZ
cord-023095-4dannjjm	1748	11	reported	report	VBN
cord-023095-4dannjjm	1748	12	to	to	TO
cord-023095-4dannjjm	1748	13	have	have	VB
cord-023095-4dannjjm	1748	14	reduced	reduce	VBN
cord-023095-4dannjjm	1748	15	side	side	NN
cord-023095-4dannjjm	1748	16	effects	effect	NNS
cord-023095-4dannjjm	1748	17	due	due	IN
cord-023095-4dannjjm	1748	18	to	to	IN
cord-023095-4dannjjm	1748	19	COX-2	cox-2	JJ
cord-023095-4dannjjm	1748	20	selectivity	selectivity	NN
cord-023095-4dannjjm	1748	21	.	.	.
cord-023095-4dannjjm	1749	1	The	the	DT
cord-023095-4dannjjm	1749	2	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	1749	3	profile	profile	NN
cord-023095-4dannjjm	1749	4	of	of	IN
cord-023095-4dannjjm	1749	5	firocoxib	firocoxib	NN
cord-023095-4dannjjm	1749	6	in	in	IN
cord-023095-4dannjjm	1749	7	neonates	neonate	NNS
cord-023095-4dannjjm	1749	8	has	have	VBZ
cord-023095-4dannjjm	1749	9	not	not	RB
cord-023095-4dannjjm	1749	10	been	be	VBN
cord-023095-4dannjjm	1749	11	established	establish	VBN
cord-023095-4dannjjm	1749	12	.	.	.
cord-023095-4dannjjm	1750	1	We	-PRON-	PRP
cord-023095-4dannjjm	1750	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	1750	3	that	that	IN
cord-023095-4dannjjm	1750	4	firocoxib	firocoxib	NNP
cord-023095-4dannjjm	1750	5	given	give	VBN
cord-023095-4dannjjm	1750	6	PO	po	NN
cord-023095-4dannjjm	1750	7	to	to	IN
cord-023095-4dannjjm	1750	8	neonatal	neonatal	JJ
cord-023095-4dannjjm	1750	9	foals	foal	NNS
cord-023095-4dannjjm	1750	10	would	would	MD
cord-023095-4dannjjm	1750	11	achieve	achieve	VB
cord-023095-4dannjjm	1750	12	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	1750	13	concentrations	concentration	NNS
cord-023095-4dannjjm	1750	14	in	in	IN
cord-023095-4dannjjm	1750	15	plasma	plasma	NN
cord-023095-4dannjjm	1750	16	.	.	.
cord-023095-4dannjjm	1751	1	Seven	seven	CD
cord-023095-4dannjjm	1751	2	healthy	healthy	JJ
cord-023095-4dannjjm	1751	3	foals	foal	NNS
cord-023095-4dannjjm	1751	4	of	of	IN
cord-023095-4dannjjm	1751	5	mixed	mixed	JJ
cord-023095-4dannjjm	1751	6	gender	gender	NN
cord-023095-4dannjjm	1751	7	were	be	VBD
cord-023095-4dannjjm	1751	8	administered	administer	VBN
cord-023095-4dannjjm	1752	1	0.1	0.1	CD
cord-023095-4dannjjm	1752	2	mg	mg	NNP
cord-023095-4dannjjm	1752	3	/	/	SYM
cord-023095-4dannjjm	1752	4	kg	kg	NNP
cord-023095-4dannjjm	1752	5	firocoxib	firocoxib	NN
cord-023095-4dannjjm	1752	6	PO	PO	NNP
cord-023095-4dannjjm	1753	1	q24h	q24h	NNS
cord-023095-4dannjjm	1753	2	for	for	IN
cord-023095-4dannjjm	1753	3	nine	nine	CD
cord-023095-4dannjjm	1753	4	consecutive	consecutive	JJ
cord-023095-4dannjjm	1753	5	days	day	NNS
cord-023095-4dannjjm	1753	6	,	,	,
cord-023095-4dannjjm	1754	1	commencing	commence	VBG
cord-023095-4dannjjm	1754	2	at	at	IN
cord-023095-4dannjjm	1754	3	36h	36h	CD
cord-023095-4dannjjm	1754	4	old	old	JJ
cord-023095-4dannjjm	1754	5	.	.	.
cord-023095-4dannjjm	1755	1	Blood	blood	NN
cord-023095-4dannjjm	1755	2	was	be	VBD
cord-023095-4dannjjm	1755	3	collected	collect	VBN
cord-023095-4dannjjm	1755	4	for	for	IN
cord-023095-4dannjjm	1755	5	firocoxib	firocoxib	NN
cord-023095-4dannjjm	1755	6	analysis	analysis	NN
cord-023095-4dannjjm	1755	7	at	at	IN
cord-023095-4dannjjm	1755	8	0	0	CD
cord-023095-4dannjjm	1755	9	(	(	-LRB-
cord-023095-4dannjjm	1755	10	dose	dose	NN
cord-023095-4dannjjm	1755	11	#	#	$
cord-023095-4dannjjm	1755	12	1	1	CD
cord-023095-4dannjjm	1755	13	only	only	RB
cord-023095-4dannjjm	1755	14	)	)	-RRB-
cord-023095-4dannjjm	1755	15	,	,	,
cord-023095-4dannjjm	1755	16	0.25	0.25	CD
cord-023095-4dannjjm	1755	17	,	,	,
cord-023095-4dannjjm	1755	18	0.5	0.5	CD
cord-023095-4dannjjm	1755	19	,	,	,
cord-023095-4dannjjm	1755	20	1	1	CD
cord-023095-4dannjjm	1755	21	,	,	,
cord-023095-4dannjjm	1755	22	2	2	CD
cord-023095-4dannjjm	1755	23	,	,	,
cord-023095-4dannjjm	1755	24	4	4	CD
cord-023095-4dannjjm	1755	25	,	,	,
cord-023095-4dannjjm	1755	26	8	8	CD
cord-023095-4dannjjm	1755	27	,	,	,
cord-023095-4dannjjm	1755	28	16	16	CD
cord-023095-4dannjjm	1755	29	and	and	CC
cord-023095-4dannjjm	1755	30	24h	24h	NNS
cord-023095-4dannjjm	1755	31	after	after	IN
cord-023095-4dannjjm	1755	32	doses	dose	NNS
cord-023095-4dannjjm	1755	33	#	#	$
cord-023095-4dannjjm	1755	34	1	1	CD
cord-023095-4dannjjm	1755	35	,	,	,
cord-023095-4dannjjm	1755	36	5	5	CD
cord-023095-4dannjjm	1755	37	and	and	CC
cord-023095-4dannjjm	1755	38	9	9	CD
cord-023095-4dannjjm	1755	39	.	.	.
cord-023095-4dannjjm	1756	1	For	for	IN
cord-023095-4dannjjm	1756	2	all	all	DT
cord-023095-4dannjjm	1756	3	other	other	JJ
cord-023095-4dannjjm	1756	4	doses	dose	NNS
cord-023095-4dannjjm	1756	5	(	(	-LRB-
cord-023095-4dannjjm	1756	6	2	2	CD
cord-023095-4dannjjm	1756	7	,	,	,
cord-023095-4dannjjm	1756	8	3	3	CD
cord-023095-4dannjjm	1756	9	,	,	,
cord-023095-4dannjjm	1756	10	4	4	CD
cord-023095-4dannjjm	1756	11	,	,	,
cord-023095-4dannjjm	1756	12	6	6	CD
cord-023095-4dannjjm	1756	13	,	,	,
cord-023095-4dannjjm	1756	14	7	7	CD
cord-023095-4dannjjm	1756	15	and	and	CC
cord-023095-4dannjjm	1756	16	8)	8)	NN
cord-023095-4dannjjm	1756	17	blood	blood	NN
cord-023095-4dannjjm	1756	18	was	be	VBD
cord-023095-4dannjjm	1756	19	collected	collect	VBN
cord-023095-4dannjjm	1756	20	immediately	immediately	RB
cord-023095-4dannjjm	1756	21	prior	prior	RB
cord-023095-4dannjjm	1756	22	to	to	IN
cord-023095-4dannjjm	1756	23	the	the	DT
cord-023095-4dannjjm	1756	24	next	next	JJ
cord-023095-4dannjjm	1756	25	dose	dose	NN
cord-023095-4dannjjm	1756	26	(	(	-LRB-
cord-023095-4dannjjm	1756	27	24h	24h	NNS
cord-023095-4dannjjm	1756	28	trough	trough	NN
cord-023095-4dannjjm	1756	29	)	)	-RRB-
cord-023095-4dannjjm	1756	30	.	.	.
cord-023095-4dannjjm	1757	1	Elimination	elimination	NN
cord-023095-4dannjjm	1757	2	samples	sample	NNS
cord-023095-4dannjjm	1757	3	were	be	VBD
cord-023095-4dannjjm	1757	4	collected	collect	VBN
cord-023095-4dannjjm	1757	5	after	after	IN
cord-023095-4dannjjm	1757	6	dose	dose	NN
cord-023095-4dannjjm	1757	7	#	#	NN
cord-023095-4dannjjm	1757	8	9	9	CD
cord-023095-4dannjjm	1757	9	.	.	.
cord-023095-4dannjjm	1758	1	Plasma	plasma	NN
cord-023095-4dannjjm	1758	2	was	be	VBD
cord-023095-4dannjjm	1758	3	stored	store	VBN
cord-023095-4dannjjm	1758	4	at	at	IN
cord-023095-4dannjjm	1758	5	À801C	À801C	NNPS
cord-023095-4dannjjm	1758	6	until	until	IN
cord-023095-4dannjjm	1758	7	analysis	analysis	NN
cord-023095-4dannjjm	1758	8	.	.	.
cord-023095-4dannjjm	1759	1	Physical	physical	JJ
cord-023095-4dannjjm	1759	2	examinations	examination	NNS
cord-023095-4dannjjm	1759	3	were	be	VBD
cord-023095-4dannjjm	1759	4	performed	perform	VBN
cord-023095-4dannjjm	1759	5	on	on	IN
cord-023095-4dannjjm	1759	6	foals	foal	NNS
cord-023095-4dannjjm	1759	7	daily	daily	JJ
cord-023095-4dannjjm	1759	8	and	and	CC
cord-023095-4dannjjm	1759	9	body	body	NN
cord-023095-4dannjjm	1759	10	weight	weight	NN
cord-023095-4dannjjm	1759	11	obtained	obtain	VBD
cord-023095-4dannjjm	1759	12	every	every	DT
cord-023095-4dannjjm	1759	13	two	two	CD
cord-023095-4dannjjm	1759	14	days	day	NNS
cord-023095-4dannjjm	1759	15	during	during	IN
cord-023095-4dannjjm	1759	16	the	the	DT
cord-023095-4dannjjm	1759	17	sampling	sampling	NN
cord-023095-4dannjjm	1759	18	period	period	NN
cord-023095-4dannjjm	1759	19	.	.	.
cord-023095-4dannjjm	1760	1	Analysis	analysis	NN
cord-023095-4dannjjm	1760	2	of	of	IN
cord-023095-4dannjjm	1760	3	plasma	plasma	NN
cord-023095-4dannjjm	1760	4	samples	sample	NNS
cord-023095-4dannjjm	1760	5	by	by	IN
cord-023095-4dannjjm	1760	6	liquid	liquid	JJ
cord-023095-4dannjjm	1760	7	chromatography	chromatography	NN
cord-023095-4dannjjm	1760	8	-	-	HYPH
cord-023095-4dannjjm	1760	9	mass	mass	NN
cord-023095-4dannjjm	1760	10	spectrometry	spectrometry	NN
cord-023095-4dannjjm	1760	11	revealed	reveal	VBN
cord-023095-4dannjjm	1760	12	firocoxib	firocoxib	NNP
cord-023095-4dannjjm	1760	13	was	be	VBD
cord-023095-4dannjjm	1760	14	rapidly	rapidly	RB
cord-023095-4dannjjm	1760	15	absorbed	absorb	VBN
cord-023095-4dannjjm	1760	16	.	.	.
cord-023095-4dannjjm	1761	1	After	after	IN
cord-023095-4dannjjm	1761	2	the	the	DT
cord-023095-4dannjjm	1761	3	initial	initial	JJ
cord-023095-4dannjjm	1761	4	dose	dose	NN
cord-023095-4dannjjm	1761	5	,	,	,
cord-023095-4dannjjm	1761	6	a	a	DT
cord-023095-4dannjjm	1761	7	maximum	maximum	JJ
cord-023095-4dannjjm	1761	8	plasma	plasma	NN
cord-023095-4dannjjm	1761	9	concentration	concentration	NN
cord-023095-4dannjjm	1761	10	was	be	VBD
cord-023095-4dannjjm	1761	11	reached	reach	VBN
cord-023095-4dannjjm	1761	12	in	in	IN
cord-023095-4dannjjm	1761	13	30	30	CD
cord-023095-4dannjjm	1761	14	min	min	NN
cord-023095-4dannjjm	1761	15	,	,	,
cord-023095-4dannjjm	1761	16	minimal	minimal	JJ
cord-023095-4dannjjm	1761	17	accumulation	accumulation	NN
cord-023095-4dannjjm	1761	18	after	after	IN
cord-023095-4dannjjm	1761	19	repeat	repeat	NN
cord-023095-4dannjjm	1761	20	dosing	dosing	NN
cord-023095-4dannjjm	1761	21	occurred	occur	VBD
cord-023095-4dannjjm	1761	22	and	and	CC
cord-023095-4dannjjm	1761	23	steady	steady	JJ
cord-023095-4dannjjm	1761	24	state	state	NN
cord-023095-4dannjjm	1761	25	was	be	VBD
cord-023095-4dannjjm	1761	26	obtained	obtain	VBN
cord-023095-4dannjjm	1761	27	after	after	IN
cord-023095-4dannjjm	1761	28	approximately	approximately	RB
cord-023095-4dannjjm	1761	29	four	four	CD
cord-023095-4dannjjm	1761	30	doses	dose	NNS
cord-023095-4dannjjm	1761	31	.	.	.
cord-023095-4dannjjm	1762	1	After	after	IN
cord-023095-4dannjjm	1762	2	the	the	DT
cord-023095-4dannjjm	1762	3	final	final	JJ
cord-023095-4dannjjm	1762	4	dose	dose	NN
cord-023095-4dannjjm	1762	5	,	,	,
cord-023095-4dannjjm	1762	6	plasma	plasma	NN
cord-023095-4dannjjm	1762	7	drug	drug	NN
cord-023095-4dannjjm	1762	8	concentration	concentration	NN
cord-023095-4dannjjm	1762	9	decreased	decrease	VBD
cord-023095-4dannjjm	1762	10	in	in	IN
cord-023095-4dannjjm	1762	11	a	a	DT
cord-023095-4dannjjm	1762	12	linear	linear	JJ
cord-023095-4dannjjm	1762	13	manner	manner	NN
cord-023095-4dannjjm	1762	14	with	with	IN
cord-023095-4dannjjm	1762	15	an	an	DT
cord-023095-4dannjjm	1762	16	estimated	estimate	VBN
cord-023095-4dannjjm	1762	17	terminal	terminal	NN
cord-023095-4dannjjm	1762	18	t1/2	t1/2	NN
cord-023095-4dannjjm	1762	19	of	of	IN
cord-023095-4dannjjm	1762	20	11h	11h	NNS
cord-023095-4dannjjm	1762	21	.	.	.
cord-023095-4dannjjm	1763	1	Seventy	seventy	CD
cord-023095-4dannjjm	1763	2	-	-	HYPH
cord-023095-4dannjjm	1763	3	two	two	CD
cord-023095-4dannjjm	1763	4	hours	hour	NNS
cord-023095-4dannjjm	1763	5	after	after	IN
cord-023095-4dannjjm	1763	6	the	the	DT
cord-023095-4dannjjm	1763	7	final	final	JJ
cord-023095-4dannjjm	1763	8	dose	dose	NN
cord-023095-4dannjjm	1763	9	,	,	,
cord-023095-4dannjjm	1763	10	firocoxib	firocoxib	NNP
cord-023095-4dannjjm	1763	11	was	be	VBD
cord-023095-4dannjjm	1763	12	not	not	RB
cord-023095-4dannjjm	1763	13	detectable	detectable	JJ
cord-023095-4dannjjm	1764	1	(	(	-LRB-
cord-023095-4dannjjm	1764	2	o	o	UH
cord-023095-4dannjjm	1764	3	2ng	2ng	NN
cord-023095-4dannjjm	1764	4	/	/	SYM
cord-023095-4dannjjm	1764	5	mL	ml	NN
cord-023095-4dannjjm	1764	6	)	)	-RRB-
cord-023095-4dannjjm	1764	7	.	.	.
cord-023095-4dannjjm	1765	1	Erythrocytosis	Erythrocytosis	NNP
cord-023095-4dannjjm	1765	2	is	be	VBZ
cord-023095-4dannjjm	1765	3	reportedly	reportedly	RB
cord-023095-4dannjjm	1765	4	a	a	DT
cord-023095-4dannjjm	1765	5	rare	rare	JJ
cord-023095-4dannjjm	1765	6	finding	finding	NN
cord-023095-4dannjjm	1765	7	associated	associate	VBN
cord-023095-4dannjjm	1765	8	with	with	IN
cord-023095-4dannjjm	1765	9	hepatocellular	hepatocellular	JJ
cord-023095-4dannjjm	1765	10	carcinoma	carcinoma	NN
cord-023095-4dannjjm	1765	11	in	in	IN
cord-023095-4dannjjm	1765	12	horses	horse	NNS
cord-023095-4dannjjm	1765	13	.	.	.
cord-023095-4dannjjm	1766	1	The	the	DT
cord-023095-4dannjjm	1766	2	purpose	purpose	NN
cord-023095-4dannjjm	1766	3	of	of	IN
cord-023095-4dannjjm	1766	4	this	this	DT
cord-023095-4dannjjm	1766	5	study	study	NN
cord-023095-4dannjjm	1766	6	was	be	VBD
cord-023095-4dannjjm	1766	7	to	to	TO
cord-023095-4dannjjm	1766	8	determine	determine	VB
cord-023095-4dannjjm	1766	9	the	the	DT
cord-023095-4dannjjm	1766	10	relative	relative	JJ
cord-023095-4dannjjm	1766	11	frequency	frequency	NN
cord-023095-4dannjjm	1766	12	of	of	IN
cord-023095-4dannjjm	1766	13	erythrocytosis	erythrocytosis	NN
cord-023095-4dannjjm	1766	14	and	and	CC
cord-023095-4dannjjm	1766	15	the	the	DT
cord-023095-4dannjjm	1766	16	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	1766	17	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1766	18	and	and	CC
cord-023095-4dannjjm	1766	19	hepatic	hepatic	JJ
cord-023095-4dannjjm	1766	20	histopathology	histopathology	NN
cord-023095-4dannjjm	1766	21	associated	associate	VBN
cord-023095-4dannjjm	1766	22	with	with	IN
cord-023095-4dannjjm	1766	23	erythrocytosis	erythrocytosis	NN
cord-023095-4dannjjm	1766	24	in	in	IN
cord-023095-4dannjjm	1766	25	horses	horse	NNS
cord-023095-4dannjjm	1766	26	with	with	IN
cord-023095-4dannjjm	1766	27	liver	liver	NN
cord-023095-4dannjjm	1766	28	disease	disease	NN
cord-023095-4dannjjm	1766	29	.	.	.
cord-023095-4dannjjm	1767	1	Ninety	ninety	CD
cord-023095-4dannjjm	1767	2	-	-	HYPH
cord-023095-4dannjjm	1767	3	seven	seven	CD
cord-023095-4dannjjm	1767	4	horses	horse	NNS
cord-023095-4dannjjm	1767	5	aged	age	VBN
cord-023095-4dannjjm	1767	6	!	!	.
cord-023095-4dannjjm	1768	1	1	1	CD
cord-023095-4dannjjm	1768	2	year	year	NN
cord-023095-4dannjjm	1768	3	with	with	IN
cord-023095-4dannjjm	1768	4	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	1768	5	or	or	CC
cord-023095-4dannjjm	1768	6	clinical	clinical	JJ
cord-023095-4dannjjm	1768	7	signs	sign	NNS
cord-023095-4dannjjm	1768	8	of	of	IN
cord-023095-4dannjjm	1768	9	liver	liver	NN
cord-023095-4dannjjm	1768	10	disease	disease	NN
cord-023095-4dannjjm	1768	11	,	,	,
cord-023095-4dannjjm	1768	12	a	a	DT
cord-023095-4dannjjm	1768	13	complete	complete	JJ
cord-023095-4dannjjm	1768	14	blood	blood	NN
cord-023095-4dannjjm	1768	15	count	count	NN
cord-023095-4dannjjm	1768	16	(	(	-LRB-
cord-023095-4dannjjm	1768	17	CBC	CBC	NNP
cord-023095-4dannjjm	1768	18	)	)	-RRB-
cord-023095-4dannjjm	1768	19	,	,	,
cord-023095-4dannjjm	1768	20	and	and	CC
cord-023095-4dannjjm	1768	21	hepatic	hepatic	JJ
cord-023095-4dannjjm	1768	22	histopathology	histopathology	NN
cord-023095-4dannjjm	1768	23	were	be	VBD
cord-023095-4dannjjm	1768	24	included	include	VBN
cord-023095-4dannjjm	1768	25	.	.	.
cord-023095-4dannjjm	1769	1	Information	information	NN
cord-023095-4dannjjm	1769	2	on	on	IN
cord-023095-4dannjjm	1769	3	CBC	CBC	NNP
cord-023095-4dannjjm	1769	4	,	,	,
cord-023095-4dannjjm	1769	5	biochemical	biochemical	JJ
cord-023095-4dannjjm	1769	6	variables	variable	NNS
cord-023095-4dannjjm	1769	7	,	,	,
cord-023095-4dannjjm	1769	8	and	and	CC
cord-023095-4dannjjm	1769	9	hepatic	hepatic	JJ
cord-023095-4dannjjm	1769	10	histopathology	histopathology	NN
cord-023095-4dannjjm	1769	11	was	be	VBD
cord-023095-4dannjjm	1769	12	collected	collect	VBN
cord-023095-4dannjjm	1769	13	from	from	IN
cord-023095-4dannjjm	1769	14	records	record	NNS
cord-023095-4dannjjm	1769	15	.	.	.
cord-023095-4dannjjm	1770	1	Data	datum	NNS
cord-023095-4dannjjm	1770	2	from	from	IN
cord-023095-4dannjjm	1770	3	horses	horse	NNS
cord-023095-4dannjjm	1770	4	with	with	IN
cord-023095-4dannjjm	1770	5	erythrocytosis	erythrocytosis	NN
cord-023095-4dannjjm	1770	6	(	(	-LRB-
cord-023095-4dannjjm	1770	7	packed	pack	VBN
cord-023095-4dannjjm	1770	8	cell	cell	NN
cord-023095-4dannjjm	1770	9	volume	volume	NN
cord-023095-4dannjjm	1770	10	4	4	CD
cord-023095-4dannjjm	1770	11	45	45	CD
cord-023095-4dannjjm	1770	12	%	%	NN
cord-023095-4dannjjm	1770	13	)	)	-RRB-
cord-023095-4dannjjm	1770	14	were	be	VBD
cord-023095-4dannjjm	1770	15	compared	compare	VBN
cord-023095-4dannjjm	1770	16	to	to	IN
cord-023095-4dannjjm	1770	17	those	those	DT
cord-023095-4dannjjm	1770	18	without	without	IN
cord-023095-4dannjjm	1770	19	using	use	VBG
cord-023095-4dannjjm	1770	20	the	the	DT
cord-023095-4dannjjm	1770	21	Mann	Mann	NNP
cord-023095-4dannjjm	1770	22	-	-	HYPH
cord-023095-4dannjjm	1770	23	Whitney	Whitney	NNP
cord-023095-4dannjjm	1770	24	rank	rank	NN
cord-023095-4dannjjm	1770	25	sum	sum	NN
cord-023095-4dannjjm	1770	26	test	test	NN
cord-023095-4dannjjm	1770	27	with	with	IN
cord-023095-4dannjjm	1770	28	significance	significance	NN
cord-023095-4dannjjm	1770	29	set	set	VBN
cord-023095-4dannjjm	1770	30	at	at	IN
cord-023095-4dannjjm	1770	31	p	p	NN
cord-023095-4dannjjm	1770	32	o	o	NN
cord-023095-4dannjjm	1770	33	0.05	0.05	CD
cord-023095-4dannjjm	1770	34	.	.	.
cord-023095-4dannjjm	1771	1	There	there	EX
cord-023095-4dannjjm	1771	2	were	be	VBD
cord-023095-4dannjjm	1771	3	no	no	DT
cord-023095-4dannjjm	1771	4	differences	difference	NNS
cord-023095-4dannjjm	1771	5	between	between	IN
cord-023095-4dannjjm	1771	6	groups	group	NNS
cord-023095-4dannjjm	1771	7	in	in	IN
cord-023095-4dannjjm	1771	8	white	white	JJ
cord-023095-4dannjjm	1771	9	blood	blood	NN
cord-023095-4dannjjm	1771	10	cell	cell	NN
cord-023095-4dannjjm	1771	11	count	count	NN
cord-023095-4dannjjm	1771	12	,	,	,
cord-023095-4dannjjm	1771	13	gamma	gamma	NN
cord-023095-4dannjjm	1771	14	-	-	HYPH
cord-023095-4dannjjm	1771	15	glutamyl	glutamyl	JJ
cord-023095-4dannjjm	1771	16	transferase	transferase	NN
cord-023095-4dannjjm	1771	17	,	,	,
cord-023095-4dannjjm	1771	18	sorbitol	sorbitol	NN
cord-023095-4dannjjm	1771	19	dehydrogenase	dehydrogenase	NN
cord-023095-4dannjjm	1771	20	,	,	,
cord-023095-4dannjjm	1771	21	aspartate	aspartate	NN
cord-023095-4dannjjm	1771	22	aminotransferase	aminotransferase	NN
cord-023095-4dannjjm	1771	23	,	,	,
cord-023095-4dannjjm	1771	24	and	and	CC
cord-023095-4dannjjm	1771	25	alkaline	alkaline	JJ
cord-023095-4dannjjm	1771	26	phosphatase	phosphatase	NN
cord-023095-4dannjjm	1771	27	activities	activity	NNS
cord-023095-4dannjjm	1771	28	,	,	,
cord-023095-4dannjjm	1771	29	total	total	JJ
cord-023095-4dannjjm	1771	30	protein	protein	NN
cord-023095-4dannjjm	1771	31	,	,	,
cord-023095-4dannjjm	1771	32	albumin	albumin	NN
cord-023095-4dannjjm	1771	33	,	,	,
cord-023095-4dannjjm	1771	34	globulin	globulin	NN
cord-023095-4dannjjm	1771	35	,	,	,
cord-023095-4dannjjm	1771	36	blood	blood	NN
cord-023095-4dannjjm	1771	37	urea	urea	NN
cord-023095-4dannjjm	1771	38	nitrogen	nitrogen	NN
cord-023095-4dannjjm	1771	39	,	,	,
cord-023095-4dannjjm	1771	40	or	or	CC
cord-023095-4dannjjm	1771	41	glucose	glucose	NN
cord-023095-4dannjjm	1771	42	concentrations	concentration	NNS
cord-023095-4dannjjm	1771	43	.	.	.
cord-023095-4dannjjm	1772	1	Fibrosis	fibrosis	NN
cord-023095-4dannjjm	1772	2	(	(	-LRB-
cord-023095-4dannjjm	1772	3	64	64	CD
cord-023095-4dannjjm	1772	4	%	%	NN
cord-023095-4dannjjm	1772	5	)	)	-RRB-
cord-023095-4dannjjm	1772	6	,	,	,
cord-023095-4dannjjm	1772	7	biliary	biliary	JJ
cord-023095-4dannjjm	1772	8	hyperplasia	hyperplasia	NN
cord-023095-4dannjjm	1772	9	(	(	-LRB-
cord-023095-4dannjjm	1772	10	56	56	CD
cord-023095-4dannjjm	1772	11	%	%	NN
cord-023095-4dannjjm	1772	12	)	)	-RRB-
cord-023095-4dannjjm	1772	13	,	,	,
cord-023095-4dannjjm	1772	14	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1772	15	infiltrate	infiltrate	NN
cord-023095-4dannjjm	1772	16	(	(	-LRB-
cord-023095-4dannjjm	1772	17	50	50	CD
cord-023095-4dannjjm	1772	18	%	%	NN
cord-023095-4dannjjm	1772	19	)	)	-RRB-
cord-023095-4dannjjm	1772	20	,	,	.
cord-023095-4dannjjm	1773	1	megalocytosis	megalocytosis	NNP
cord-023095-4dannjjm	1773	2	(	(	-LRB-
cord-023095-4dannjjm	1773	3	25	25	CD
cord-023095-4dannjjm	1773	4	%	%	NN
cord-023095-4dannjjm	1773	5	)	)	-RRB-
cord-023095-4dannjjm	1773	6	,	,	,
cord-023095-4dannjjm	1773	7	degeneration	degeneration	NN
cord-023095-4dannjjm	1773	8	(	(	-LRB-
cord-023095-4dannjjm	1773	9	25	25	CD
cord-023095-4dannjjm	1773	10	%	%	NN
cord-023095-4dannjjm	1773	11	)	)	-RRB-
cord-023095-4dannjjm	1773	12	,	,	,
cord-023095-4dannjjm	1773	13	necrosis	necrosis	NN
cord-023095-4dannjjm	1773	14	(	(	-LRB-
cord-023095-4dannjjm	1773	15	25	25	CD
cord-023095-4dannjjm	1773	16	%	%	NN
cord-023095-4dannjjm	1773	17	)	)	-RRB-
cord-023095-4dannjjm	1774	1	,	,	,
cord-023095-4dannjjm	1774	2	cholestasis	cholestasis	NN
cord-023095-4dannjjm	1774	3	(	(	-LRB-
cord-023095-4dannjjm	1774	4	25	25	CD
cord-023095-4dannjjm	1774	5	%	%	NN
cord-023095-4dannjjm	1774	6	)	)	-RRB-
cord-023095-4dannjjm	1774	7	,	,	,
cord-023095-4dannjjm	1774	8	anisocytosis	anisocytosis	NNP
cord-023095-4dannjjm	1774	9	and	and	CC
cord-023095-4dannjjm	1774	10	anisokaryosis	anisokaryosis	NNP
cord-023095-4dannjjm	1774	11	(	(	-LRB-
cord-023095-4dannjjm	1774	12	11	11	CD
cord-023095-4dannjjm	1774	13	%	%	NN
cord-023095-4dannjjm	1774	14	)	)	-RRB-
cord-023095-4dannjjm	1774	15	,	,	,
cord-023095-4dannjjm	1774	16	and	and	CC
cord-023095-4dannjjm	1774	17	lipidosis	lipidosis	NN
cord-023095-4dannjjm	1774	18	(	(	-LRB-
cord-023095-4dannjjm	1774	19	3	3	CD
cord-023095-4dannjjm	1774	20	%	%	NN
cord-023095-4dannjjm	1774	21	)	)	-RRB-
cord-023095-4dannjjm	1774	22	were	be	VBD
cord-023095-4dannjjm	1774	23	observed	observe	VBN
cord-023095-4dannjjm	1774	24	in	in	IN
cord-023095-4dannjjm	1774	25	livers	liver	NNS
cord-023095-4dannjjm	1774	26	of	of	IN
cord-023095-4dannjjm	1774	27	horses	horse	NNS
cord-023095-4dannjjm	1774	28	with	with	IN
cord-023095-4dannjjm	1774	29	erythrocytosis	erythrocytosis	NN
cord-023095-4dannjjm	1774	30	.	.	.
cord-023095-4dannjjm	1775	1	Neoplasia	neoplasia	NN
cord-023095-4dannjjm	1775	2	(	(	-LRB-
cord-023095-4dannjjm	1775	3	3	3	CD
cord-023095-4dannjjm	1775	4	%	%	NN
cord-023095-4dannjjm	1775	5	)	)	-RRB-
cord-023095-4dannjjm	1775	6	was	be	VBD
cord-023095-4dannjjm	1775	7	observed	observe	VBN
cord-023095-4dannjjm	1775	8	rarely	rarely	RB
cord-023095-4dannjjm	1775	9	.	.	.
cord-023095-4dannjjm	1776	1	This	this	DT
cord-023095-4dannjjm	1776	2	study	study	NN
cord-023095-4dannjjm	1776	3	reports	report	VBZ
cord-023095-4dannjjm	1776	4	a	a	DT
cord-023095-4dannjjm	1776	5	high	high	JJ
cord-023095-4dannjjm	1776	6	frequency	frequency	NN
cord-023095-4dannjjm	1776	7	of	of	IN
cord-023095-4dannjjm	1776	8	erythrocytosis	erythrocytosis	NN
cord-023095-4dannjjm	1776	9	in	in	IN
cord-023095-4dannjjm	1776	10	horses	horse	NNS
cord-023095-4dannjjm	1776	11	with	with	IN
cord-023095-4dannjjm	1776	12	liver	liver	NN
cord-023095-4dannjjm	1776	13	disease	disease	NN
cord-023095-4dannjjm	1776	14	.	.	.
cord-023095-4dannjjm	1777	1	Erythrocytosis	Erythrocytosis	NNP
cord-023095-4dannjjm	1777	2	is	be	VBZ
cord-023095-4dannjjm	1777	3	associated	associate	VBN
cord-023095-4dannjjm	1777	4	with	with	IN
cord-023095-4dannjjm	1777	5	higher	high	JJR
cord-023095-4dannjjm	1777	6	total	total	JJ
cord-023095-4dannjjm	1777	7	bilirubin	bilirubin	NN
cord-023095-4dannjjm	1777	8	and	and	CC
cord-023095-4dannjjm	1777	9	serum	serum	NN
cord-023095-4dannjjm	1777	10	bile	bile	NN
cord-023095-4dannjjm	1777	11	acids	acid	NNS
cord-023095-4dannjjm	1777	12	concentrations	concentration	NNS
cord-023095-4dannjjm	1777	13	.	.	.
cord-023095-4dannjjm	1778	1	Common	common	JJ
cord-023095-4dannjjm	1778	2	histopathologic	histopathologic	JJ
cord-023095-4dannjjm	1778	3	changes	change	NNS
cord-023095-4dannjjm	1778	4	include	include	VBP
cord-023095-4dannjjm	1778	5	fibrosis	fibrosis	NN
cord-023095-4dannjjm	1778	6	,	,	,
cord-023095-4dannjjm	1778	7	biliary	biliary	JJ
cord-023095-4dannjjm	1778	8	hyperplasia	hyperplasia	NN
cord-023095-4dannjjm	1778	9	,	,	,
cord-023095-4dannjjm	1778	10	and	and	CC
cord-023095-4dannjjm	1778	11	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	1778	12	infiltrate	infiltrate	NN
cord-023095-4dannjjm	1778	13	.	.	.
cord-023095-4dannjjm	1779	1	Hepatic	hepatic	JJ
cord-023095-4dannjjm	1779	2	neoplasia	neoplasia	NN
cord-023095-4dannjjm	1779	3	was	be	VBD
cord-023095-4dannjjm	1779	4	rare	rare	JJ
cord-023095-4dannjjm	1779	5	.	.	.
cord-023095-4dannjjm	1780	1	This	this	DT
cord-023095-4dannjjm	1780	2	study	study	NN
cord-023095-4dannjjm	1780	3	was	be	VBD
cord-023095-4dannjjm	1780	4	performed	perform	VBN
cord-023095-4dannjjm	1780	5	to	to	TO
cord-023095-4dannjjm	1780	6	determine	determine	VB
cord-023095-4dannjjm	1780	7	if	if	IN
cord-023095-4dannjjm	1780	8	horses	horse	NNS
cord-023095-4dannjjm	1780	9	diagnosed	diagnose	VBN
cord-023095-4dannjjm	1780	10	with	with	IN
cord-023095-4dannjjm	1780	11	equine	equine	JJ
cord-023095-4dannjjm	1780	12	proliferative	proliferative	FW
cord-023095-4dannjjm	1780	13	enteropathy	enteropathy	NNP
cord-023095-4dannjjm	1780	14	(	(	-LRB-
cord-023095-4dannjjm	1780	15	EPE	EPE	NNP
cord-023095-4dannjjm	1780	16	)	)	-RRB-
cord-023095-4dannjjm	1780	17	from	from	IN
cord-023095-4dannjjm	1780	18	Lawsonia	Lawsonia	NNP
cord-023095-4dannjjm	1780	19	intracellularis	intracellularis	.
cord-023095-4dannjjm	1780	20	(	(	-LRB-
cord-023095-4dannjjm	1780	21	LI	LI	NNP
cord-023095-4dannjjm	1780	22	)	)	-RRB-
cord-023095-4dannjjm	1780	23	infection	infection	NN
cord-023095-4dannjjm	1780	24	had	have	VBD
cord-023095-4dannjjm	1780	25	long	long	JJ
cord-023095-4dannjjm	1780	26	term	term	NN
cord-023095-4dannjjm	1780	27	effects	effect	NNS
cord-023095-4dannjjm	1780	28	from	from	IN
cord-023095-4dannjjm	1780	29	disease	disease	NN
cord-023095-4dannjjm	1780	30	based	base	VBN
cord-023095-4dannjjm	1780	31	on	on	IN
cord-023095-4dannjjm	1780	32	their	-PRON-	PRP$
cord-023095-4dannjjm	1780	33	sale	sale	NN
cord-023095-4dannjjm	1780	34	price	price	NN
cord-023095-4dannjjm	1780	35	as	as	IN
cord-023095-4dannjjm	1780	36	yearlings	yearling	NNS
cord-023095-4dannjjm	1780	37	and	and	CC
cord-023095-4dannjjm	1780	38	race	race	NN
cord-023095-4dannjjm	1780	39	earnings	earning	NNS
cord-023095-4dannjjm	1780	40	.	.	.
cord-023095-4dannjjm	1781	1	A	a	DT
cord-023095-4dannjjm	1781	2	retrospective	retrospective	JJ
cord-023095-4dannjjm	1781	3	review	review	NN
cord-023095-4dannjjm	1781	4	of	of	IN
cord-023095-4dannjjm	1781	5	medical	medical	JJ
cord-023095-4dannjjm	1781	6	records	record	NNS
cord-023095-4dannjjm	1781	7	of	of	IN
cord-023095-4dannjjm	1781	8	Thoroughbred	thoroughbred	JJ
cord-023095-4dannjjm	1781	9	horses	horse	NNS
cord-023095-4dannjjm	1781	10	that	that	WDT
cord-023095-4dannjjm	1781	11	were	be	VBD
cord-023095-4dannjjm	1781	12	treated	treat	VBN
cord-023095-4dannjjm	1781	13	for	for	IN
cord-023095-4dannjjm	1781	14	Lawsonia	Lawsonia	NNP
cord-023095-4dannjjm	1781	15	intracellularis	intracellularis	JJ
cord-023095-4dannjjm	1781	16	infection	infection	NN
cord-023095-4dannjjm	1781	17	between	between	IN
cord-023095-4dannjjm	1781	18	January	January	NNP
cord-023095-4dannjjm	1781	19	1	1	CD
cord-023095-4dannjjm	1781	20	,	,	,
cord-023095-4dannjjm	1781	21	2002	2002	CD
cord-023095-4dannjjm	1781	22	and	and	CC
cord-023095-4dannjjm	1781	23	January	January	NNP
cord-023095-4dannjjm	1781	24	31	31	CD
cord-023095-4dannjjm	1781	25	,	,	,
cord-023095-4dannjjm	1781	26	2008	2008	CD
cord-023095-4dannjjm	1781	27	at	at	IN
cord-023095-4dannjjm	1781	28	Hagyard	Hagyard	NNP
cord-023095-4dannjjm	1781	29	Equine	Equine	NNP
cord-023095-4dannjjm	1781	30	Medical	Medical	NNP
cord-023095-4dannjjm	1781	31	Institute	Institute	NNP
cord-023095-4dannjjm	1781	32	in	in	IN
cord-023095-4dannjjm	1781	33	Lexington	Lexington	NNP
cord-023095-4dannjjm	1781	34	,	,	,
cord-023095-4dannjjm	1781	35	Kentucky	Kentucky	NNP
cord-023095-4dannjjm	1781	36	was	be	VBD
cord-023095-4dannjjm	1781	37	performed	perform	VBN
cord-023095-4dannjjm	1781	38	.	.	.
cord-023095-4dannjjm	1782	1	Three	three	CD
cord-023095-4dannjjm	1782	2	criteria	criterion	NNS
cord-023095-4dannjjm	1782	3	were	be	VBD
cord-023095-4dannjjm	1782	4	used	use	VBN
cord-023095-4dannjjm	1782	5	for	for	IN
cord-023095-4dannjjm	1782	6	inclusion	inclusion	NN
cord-023095-4dannjjm	1782	7	in	in	IN
cord-023095-4dannjjm	1782	8	this	this	DT
cord-023095-4dannjjm	1782	9	study	study	NN
cord-023095-4dannjjm	1782	10	.	.	.
cord-023095-4dannjjm	1783	1	First	first	RB
cord-023095-4dannjjm	1783	2	,	,	,
cord-023095-4dannjjm	1783	3	each	each	DT
cord-023095-4dannjjm	1783	4	horse	horse	NN
cord-023095-4dannjjm	1783	5	had	have	VBD
cord-023095-4dannjjm	1783	6	presumptively	presumptively	RB
cord-023095-4dannjjm	1783	7	been	be	VBN
cord-023095-4dannjjm	1783	8	diagnosed	diagnose	VBN
cord-023095-4dannjjm	1783	9	with	with	IN
cord-023095-4dannjjm	1783	10	LI	LI	NNP
cord-023095-4dannjjm	1783	11	based	base	VBN
cord-023095-4dannjjm	1783	12	on	on	IN
cord-023095-4dannjjm	1783	13	physical	physical	JJ
cord-023095-4dannjjm	1783	14	examination	examination	NN
cord-023095-4dannjjm	1783	15	findings	finding	NNS
cord-023095-4dannjjm	1783	16	such	such	JJ
cord-023095-4dannjjm	1783	17	as	as	IN
cord-023095-4dannjjm	1783	18	ventral	ventral	JJ
cord-023095-4dannjjm	1783	19	edema	edema	NN
cord-023095-4dannjjm	1783	20	,	,	,
cord-023095-4dannjjm	1783	21	diarrhea	diarrhea	NN
cord-023095-4dannjjm	1783	22	,	,	,
cord-023095-4dannjjm	1783	23	lethargy	lethargy	NN
cord-023095-4dannjjm	1783	24	,	,	,
cord-023095-4dannjjm	1783	25	or	or	CC
cord-023095-4dannjjm	1783	26	poor	poor	JJ
cord-023095-4dannjjm	1783	27	body	body	NN
cord-023095-4dannjjm	1783	28	condition	condition	NN
cord-023095-4dannjjm	1783	29	.	.	.
cord-023095-4dannjjm	1784	1	Second	second	RB
cord-023095-4dannjjm	1784	2	,	,	,
cord-023095-4dannjjm	1784	3	horses	horse	NNS
cord-023095-4dannjjm	1784	4	had	have	VBD
cord-023095-4dannjjm	1784	5	hypoalbuminemia	hypoalbuminemia	NN
cord-023095-4dannjjm	1784	6	of	of	IN
cord-023095-4dannjjm	1784	7	less	less	JJR
cord-023095-4dannjjm	1784	8	than	than	IN
cord-023095-4dannjjm	1784	9	2.5	2.5	CD
cord-023095-4dannjjm	1784	10	mg	mg	NNP
cord-023095-4dannjjm	1784	11	/	/	SYM
cord-023095-4dannjjm	1784	12	dL	dl	NN
cord-023095-4dannjjm	1785	1	(	(	-LRB-
cord-023095-4dannjjm	1785	2	normal	normal	JJ
cord-023095-4dannjjm	1785	3	reference	reference	NN
cord-023095-4dannjjm	1785	4	range	range	NN
cord-023095-4dannjjm	1785	5	:	:	:
cord-023095-4dannjjm	1785	6	3.4	3.4	CD
cord-023095-4dannjjm	1785	7	-	-	SYM
cord-023095-4dannjjm	1785	8	4.5	4.5	CD
cord-023095-4dannjjm	1785	9	mg	mg	NNP
cord-023095-4dannjjm	1785	10	/	/	SYM
cord-023095-4dannjjm	1785	11	dL	dl	NN
cord-023095-4dannjjm	1785	12	)	)	-RRB-
cord-023095-4dannjjm	1785	13	.	.	.
cord-023095-4dannjjm	1786	1	Third	third	RB
cord-023095-4dannjjm	1786	2	,	,	,
cord-023095-4dannjjm	1786	3	each	each	DT
cord-023095-4dannjjm	1786	4	horse	horse	NN
cord-023095-4dannjjm	1786	5	had	have	VBD
cord-023095-4dannjjm	1786	6	a	a	DT
cord-023095-4dannjjm	1786	7	positive	positive	JJ
cord-023095-4dannjjm	1786	8	fecal	fecal	JJ
cord-023095-4dannjjm	1786	9	polymerase	polymerase	NN
cord-023095-4dannjjm	1786	10	chain	chain	NN
cord-023095-4dannjjm	1786	11	reaction	reaction	NN
cord-023095-4dannjjm	1786	12	(	(	-LRB-
cord-023095-4dannjjm	1786	13	PCR	PCR	NNP
cord-023095-4dannjjm	1786	14	)	)	-RRB-
cord-023095-4dannjjm	1786	15	for	for	IN
cord-023095-4dannjjm	1786	16	LI	LI	NNP
cord-023095-4dannjjm	1786	17	,	,	,
cord-023095-4dannjjm	1786	18	a	a	DT
cord-023095-4dannjjm	1786	19	positive	positive	JJ
cord-023095-4dannjjm	1786	20	serum	serum	NN
cord-023095-4dannjjm	1786	21	immunoperoxidase	immunoperoxidase	NN
cord-023095-4dannjjm	1786	22	monolayer	monolayer	NN
cord-023095-4dannjjm	1786	23	assay	assay	NN
cord-023095-4dannjjm	1786	24	(	(	-LRB-
cord-023095-4dannjjm	1786	25	IPMA	IPMA	NNP
cord-023095-4dannjjm	1786	26	)	)	-RRB-
cord-023095-4dannjjm	1786	27	,	,	,
cord-023095-4dannjjm	1786	28	or	or	CC
cord-023095-4dannjjm	1786	29	both	both	DT
cord-023095-4dannjjm	1786	30	.	.	.
cord-023095-4dannjjm	1787	1	An	an	DT
cord-023095-4dannjjm	1787	2	IPMA	IPMA	NNP
cord-023095-4dannjjm	1787	3	titer	titer	NN
cord-023095-4dannjjm	1787	4	greater	great	JJR
cord-023095-4dannjjm	1787	5	than	than	IN
cord-023095-4dannjjm	1787	6	or	or	CC
cord-023095-4dannjjm	1787	7	equal	equal	JJ
cord-023095-4dannjjm	1787	8	to	to	IN
cord-023095-4dannjjm	1787	9	60	60	CD
cord-023095-4dannjjm	1787	10	was	be	VBD
cord-023095-4dannjjm	1787	11	considered	consider	VBN
cord-023095-4dannjjm	1787	12	positive	positive	JJ
cord-023095-4dannjjm	1787	13	for	for	IN
cord-023095-4dannjjm	1787	14	disease	disease	NN
cord-023095-4dannjjm	1787	15	.	.	.
cord-023095-4dannjjm	1788	1	116	116	CD
cord-023095-4dannjjm	1788	2	horses	horse	NNS
cord-023095-4dannjjm	1788	3	met	meet	VBD
cord-023095-4dannjjm	1788	4	the	the	DT
cord-023095-4dannjjm	1788	5	initial	initial	JJ
cord-023095-4dannjjm	1788	6	criteria	criterion	NNS
cord-023095-4dannjjm	1788	7	.	.	.
cord-023095-4dannjjm	1789	1	36	36	CD
cord-023095-4dannjjm	1789	2	of	of	IN
cord-023095-4dannjjm	1789	3	the	the	DT
cord-023095-4dannjjm	1789	4	116	116	CD
cord-023095-4dannjjm	1789	5	horses	horse	NNS
cord-023095-4dannjjm	1789	6	sold	sell	VBN
cord-023095-4dannjjm	1789	7	at	at	IN
cord-023095-4dannjjm	1789	8	public	public	JJ
cord-023095-4dannjjm	1789	9	auction	auction	NN
cord-023095-4dannjjm	1789	10	as	as	IN
cord-023095-4dannjjm	1789	11	yearlings	yearling	NNS
cord-023095-4dannjjm	1789	12	.	.	.
cord-023095-4dannjjm	1790	1	The	the	DT
cord-023095-4dannjjm	1790	2	sale	sale	NN
cord-023095-4dannjjm	1790	3	price	price	NN
cord-023095-4dannjjm	1790	4	of	of	IN
cord-023095-4dannjjm	1790	5	these	these	DT
cord-023095-4dannjjm	1790	6	horses	horse	NNS
cord-023095-4dannjjm	1790	7	was	be	VBD
cord-023095-4dannjjm	1790	8	compared	compare	VBN
cord-023095-4dannjjm	1790	9	to	to	IN
cord-023095-4dannjjm	1790	10	the	the	DT
cord-023095-4dannjjm	1790	11	average	average	JJ
cord-023095-4dannjjm	1790	12	sale	sale	NN
cord-023095-4dannjjm	1790	13	price	price	NN
cord-023095-4dannjjm	1790	14	of	of	IN
cord-023095-4dannjjm	1790	15	all	all	DT
cord-023095-4dannjjm	1790	16	yearlings	yearling	NNS
cord-023095-4dannjjm	1790	17	by	by	IN
cord-023095-4dannjjm	1790	18	the	the	DT
cord-023095-4dannjjm	1790	19	same	same	JJ
cord-023095-4dannjjm	1790	20	sire	sire	NN
cord-023095-4dannjjm	1790	21	as	as	IN
cord-023095-4dannjjm	1790	22	the	the	DT
cord-023095-4dannjjm	1790	23	affected	affected	JJ
cord-023095-4dannjjm	1790	24	horse	horse	NN
cord-023095-4dannjjm	1790	25	(	(	-LRB-
cord-023095-4dannjjm	1790	26	control	control	NNP
cord-023095-4dannjjm	1790	27	group	group	NN
cord-023095-4dannjjm	1790	28	)	)	-RRB-
cord-023095-4dannjjm	1790	29	.	.	.
cord-023095-4dannjjm	1791	1	30	30	CD
cord-023095-4dannjjm	1791	2	of	of	IN
cord-023095-4dannjjm	1791	3	the	the	DT
cord-023095-4dannjjm	1791	4	116	116	CD
cord-023095-4dannjjm	1791	5	horses	horse	NNS
cord-023095-4dannjjm	1791	6	raced	race	VBD
cord-023095-4dannjjm	1791	7	in	in	IN
cord-023095-4dannjjm	1791	8	the	the	DT
cord-023095-4dannjjm	1791	9	United	United	NNP
cord-023095-4dannjjm	1791	10	States	States	NNP
cord-023095-4dannjjm	1791	11	.	.	.
cord-023095-4dannjjm	1792	1	Their	-PRON-	PRP$
cord-023095-4dannjjm	1792	2	monetary	monetary	JJ
cord-023095-4dannjjm	1792	3	earnings	earning	NNS
cord-023095-4dannjjm	1792	4	from	from	IN
cord-023095-4dannjjm	1792	5	racing	racing	NN
cord-023095-4dannjjm	1792	6	were	be	VBD
cord-023095-4dannjjm	1792	7	compared	compare	VBN
cord-023095-4dannjjm	1792	8	to	to	IN
cord-023095-4dannjjm	1792	9	the	the	DT
cord-023095-4dannjjm	1792	10	average	average	JJ
cord-023095-4dannjjm	1792	11	monetary	monetary	JJ
cord-023095-4dannjjm	1792	12	earnings	earning	NNS
cord-023095-4dannjjm	1792	13	of	of	IN
cord-023095-4dannjjm	1792	14	all	all	DT
cord-023095-4dannjjm	1792	15	progeny	progeny	NN
cord-023095-4dannjjm	1792	16	by	by	IN
cord-023095-4dannjjm	1792	17	the	the	DT
cord-023095-4dannjjm	1792	18	same	same	JJ
cord-023095-4dannjjm	1792	19	sire	sire	NN
cord-023095-4dannjjm	1792	20	as	as	IN
cord-023095-4dannjjm	1792	21	the	the	DT
cord-023095-4dannjjm	1792	22	affected	affected	JJ
cord-023095-4dannjjm	1792	23	horse	horse	NN
cord-023095-4dannjjm	1792	24	(	(	-LRB-
cord-023095-4dannjjm	1792	25	control	control	NNP
cord-023095-4dannjjm	1792	26	group	group	NN
cord-023095-4dannjjm	1792	27	)	)	-RRB-
cord-023095-4dannjjm	1792	28	.	.	.
cord-023095-4dannjjm	1793	1	Earnings	earning	NNS
cord-023095-4dannjjm	1793	2	of	of	IN
cord-023095-4dannjjm	1793	3	horses	horse	NNS
cord-023095-4dannjjm	1793	4	that	that	WDT
cord-023095-4dannjjm	1793	5	were	be	VBD
cord-023095-4dannjjm	1793	6	between	between	IN
cord-023095-4dannjjm	1793	7	3	3	CD
cord-023095-4dannjjm	1793	8	and	and	CC
cord-023095-4dannjjm	1793	9	7	7	CD
cord-023095-4dannjjm	1793	10	years	year	NNS
cord-023095-4dannjjm	1793	11	of	of	IN
cord-023095-4dannjjm	1793	12	age	age	NN
cord-023095-4dannjjm	1793	13	(	(	-LRB-
cord-023095-4dannjjm	1793	14	23/30	23/30	CD
cord-023095-4dannjjm	1793	15	horses	horse	NNS
cord-023095-4dannjjm	1793	16	)	)	-RRB-
cord-023095-4dannjjm	1793	17	at	at	IN
cord-023095-4dannjjm	1793	18	the	the	DT
cord-023095-4dannjjm	1793	19	conclusion	conclusion	NN
cord-023095-4dannjjm	1793	20	of	of	IN
cord-023095-4dannjjm	1793	21	the	the	DT
cord-023095-4dannjjm	1793	22	study	study	NN
cord-023095-4dannjjm	1793	23	were	be	VBD
cord-023095-4dannjjm	1793	24	compared	compare	VBN
cord-023095-4dannjjm	1793	25	to	to	IN
cord-023095-4dannjjm	1793	26	the	the	DT
cord-023095-4dannjjm	1793	27	lifetime	lifetime	NN
cord-023095-4dannjjm	1793	28	average	average	JJ
cord-023095-4dannjjm	1793	29	earnings	earning	NNS
cord-023095-4dannjjm	1793	30	of	of	IN
cord-023095-4dannjjm	1793	31	the	the	DT
cord-023095-4dannjjm	1793	32	stallion	stallion	NN
cord-023095-4dannjjm	1793	33	's	's	POS
cord-023095-4dannjjm	1793	34	progeny	progeny	NN
cord-023095-4dannjjm	1793	35	.	.	.
cord-023095-4dannjjm	1794	1	Earnings	earning	NNS
cord-023095-4dannjjm	1794	2	from	from	IN
cord-023095-4dannjjm	1794	3	horses	horse	NNS
cord-023095-4dannjjm	1794	4	that	that	WDT
cord-023095-4dannjjm	1794	5	were	be	VBD
cord-023095-4dannjjm	1794	6	two	two	CD
cord-023095-4dannjjm	1794	7	years	year	NNS
cord-023095-4dannjjm	1794	8	of	of	IN
cord-023095-4dannjjm	1794	9	age	age	NN
cord-023095-4dannjjm	1794	10	(	(	-LRB-
cord-023095-4dannjjm	1794	11	7/30	7/30	CD
cord-023095-4dannjjm	1794	12	)	)	-RRB-
cord-023095-4dannjjm	1794	13	at	at	IN
cord-023095-4dannjjm	1794	14	the	the	DT
cord-023095-4dannjjm	1794	15	end	end	NN
cord-023095-4dannjjm	1794	16	of	of	IN
cord-023095-4dannjjm	1794	17	the	the	DT
cord-023095-4dannjjm	1794	18	study	study	NN
cord-023095-4dannjjm	1794	19	were	be	VBD
cord-023095-4dannjjm	1794	20	compared	compare	VBN
cord-023095-4dannjjm	1794	21	to	to	IN
cord-023095-4dannjjm	1794	22	the	the	DT
cord-023095-4dannjjm	1794	23	two	two	CD
cord-023095-4dannjjm	1794	24	year	year	NN
cord-023095-4dannjjm	1794	25	old	old	JJ
cord-023095-4dannjjm	1794	26	average	average	JJ
cord-023095-4dannjjm	1794	27	earnings	earning	NNS
cord-023095-4dannjjm	1794	28	of	of	IN
cord-023095-4dannjjm	1794	29	the	the	DT
cord-023095-4dannjjm	1794	30	stallion	stallion	NN
cord-023095-4dannjjm	1794	31	's	's	POS
cord-023095-4dannjjm	1794	32	progeny	progeny	NN
cord-023095-4dannjjm	1794	33	.	.	.
cord-023095-4dannjjm	1795	1	Monetary	monetary	JJ
cord-023095-4dannjjm	1795	2	earnings	earning	NNS
cord-023095-4dannjjm	1795	3	from	from	IN
cord-023095-4dannjjm	1795	4	all	all	DT
cord-023095-4dannjjm	1795	5	races	race	NNS
cord-023095-4dannjjm	1795	6	prior	prior	RB
cord-023095-4dannjjm	1795	7	to	to	IN
cord-023095-4dannjjm	1795	8	December	December	NNP
cord-023095-4dannjjm	1795	9	31	31	CD
cord-023095-4dannjjm	1795	10	,	,	,
cord-023095-4dannjjm	1795	11	2008	2008	CD
cord-023095-4dannjjm	1795	12	were	be	VBD
cord-023095-4dannjjm	1795	13	included	include	VBN
cord-023095-4dannjjm	1795	14	in	in	IN
cord-023095-4dannjjm	1795	15	the	the	DT
cord-023095-4dannjjm	1795	16	study	study	NN
cord-023095-4dannjjm	1795	17	.	.	.
cord-023095-4dannjjm	1796	1	12	12	CD
cord-023095-4dannjjm	1796	2	horses	horse	NNS
cord-023095-4dannjjm	1796	3	both	both	DT
cord-023095-4dannjjm	1796	4	sold	sell	VBD
cord-023095-4dannjjm	1796	5	at	at	IN
cord-023095-4dannjjm	1796	6	public	public	JJ
cord-023095-4dannjjm	1796	7	auction	auction	NN
cord-023095-4dannjjm	1796	8	and	and	CC
cord-023095-4dannjjm	1796	9	raced	race	VBD
cord-023095-4dannjjm	1796	10	.	.	.
cord-023095-4dannjjm	1797	1	As	as	RB
cord-023095-4dannjjm	1797	2	well	well	RB
cord-023095-4dannjjm	1797	3	as	as	IN
cord-023095-4dannjjm	1797	4	being	be	VBG
cord-023095-4dannjjm	1797	5	included	include	VBN
cord-023095-4dannjjm	1797	6	in	in	IN
cord-023095-4dannjjm	1797	7	the	the	DT
cord-023095-4dannjjm	1797	8	total	total	JJ
cord-023095-4dannjjm	1797	9	number	number	NN
cord-023095-4dannjjm	1797	10	of	of	IN
cord-023095-4dannjjm	1797	11	horses	horse	NNS
cord-023095-4dannjjm	1797	12	that	that	WDT
cord-023095-4dannjjm	1797	13	sold	sell	VBD
cord-023095-4dannjjm	1797	14	and	and	CC
cord-023095-4dannjjm	1797	15	raced	race	VBD
cord-023095-4dannjjm	1797	16	,	,	,
cord-023095-4dannjjm	1797	17	their	-PRON-	PRP$
cord-023095-4dannjjm	1797	18	sale	sale	NN
cord-023095-4dannjjm	1797	19	records	record	NNS
cord-023095-4dannjjm	1797	20	and	and	CC
cord-023095-4dannjjm	1797	21	monetary	monetary	JJ
cord-023095-4dannjjm	1797	22	earnings	earning	NNS
cord-023095-4dannjjm	1797	23	were	be	VBD
cord-023095-4dannjjm	1797	24	compared	compare	VBN
cord-023095-4dannjjm	1797	25	to	to	IN
cord-023095-4dannjjm	1797	26	the	the	DT
cord-023095-4dannjjm	1797	27	averages	average	NNS
cord-023095-4dannjjm	1797	28	from	from	IN
cord-023095-4dannjjm	1797	29	their	-PRON-	PRP$
cord-023095-4dannjjm	1797	30	respective	respective	JJ
cord-023095-4dannjjm	1797	31	sire	sire	NN
cord-023095-4dannjjm	1797	32	as	as	IN
cord-023095-4dannjjm	1797	33	a	a	DT
cord-023095-4dannjjm	1797	34	separate	separate	JJ
cord-023095-4dannjjm	1797	35	group	group	NN
cord-023095-4dannjjm	1797	36	.	.	.
cord-023095-4dannjjm	1798	1	This	this	DT
cord-023095-4dannjjm	1798	2	retrospective	retrospective	JJ
cord-023095-4dannjjm	1798	3	study	study	NN
cord-023095-4dannjjm	1798	4	indicated	indicate	VBD
cord-023095-4dannjjm	1798	5	that	that	IN
cord-023095-4dannjjm	1798	6	yearling	yearling	NN
cord-023095-4dannjjm	1798	7	horses	horse	NNS
cord-023095-4dannjjm	1798	8	previously	previously	RB
cord-023095-4dannjjm	1798	9	infected	infect	VBN
cord-023095-4dannjjm	1798	10	with	with	IN
cord-023095-4dannjjm	1798	11	LI	LI	NNP
cord-023095-4dannjjm	1798	12	do	do	VBP
cord-023095-4dannjjm	1798	13	not	not	RB
cord-023095-4dannjjm	1798	14	sell	sell	VB
cord-023095-4dannjjm	1798	15	for	for	IN
cord-023095-4dannjjm	1798	16	as	as	RB
cord-023095-4dannjjm	1798	17	much	much	JJ
cord-023095-4dannjjm	1798	18	at	at	IN
cord-023095-4dannjjm	1798	19	public	public	JJ
cord-023095-4dannjjm	1798	20	auction	auction	NN
cord-023095-4dannjjm	1798	21	as	as	IN
cord-023095-4dannjjm	1798	22	their	-PRON-	PRP$
cord-023095-4dannjjm	1798	23	herdmates	herdmate	NNS
cord-023095-4dannjjm	1798	24	,	,	,
cord-023095-4dannjjm	1798	25	but	but	CC
cord-023095-4dannjjm	1798	26	their	-PRON-	PRP$
cord-023095-4dannjjm	1798	27	monetary	monetary	JJ
cord-023095-4dannjjm	1798	28	earnings	earning	NNS
cord-023095-4dannjjm	1798	29	from	from	IN
cord-023095-4dannjjm	1798	30	racing	racing	NN
cord-023095-4dannjjm	1798	31	are	be	VBP
cord-023095-4dannjjm	1798	32	not	not	RB
cord-023095-4dannjjm	1798	33	significantly	significantly	RB
cord-023095-4dannjjm	1798	34	different	different	JJ
cord-023095-4dannjjm	1798	35	from	from	IN
cord-023095-4dannjjm	1798	36	other	other	JJ
cord-023095-4dannjjm	1798	37	horses	horse	NNS
cord-023095-4dannjjm	1798	38	.	.	.
cord-023095-4dannjjm	1799	1	These	these	DT
cord-023095-4dannjjm	1799	2	results	result	NNS
cord-023095-4dannjjm	1799	3	should	should	MD
cord-023095-4dannjjm	1799	4	assist	assist	VB
cord-023095-4dannjjm	1799	5	practitioners	practitioner	NNS
cord-023095-4dannjjm	1799	6	in	in	IN
cord-023095-4dannjjm	1799	7	guiding	guide	VBG
cord-023095-4dannjjm	1799	8	owners	owner	NNS
cord-023095-4dannjjm	1799	9	in	in	IN
cord-023095-4dannjjm	1799	10	determing	determe	VBG
cord-023095-4dannjjm	1799	11	if	if	IN
cord-023095-4dannjjm	1799	12	treatment	treatment	NN
cord-023095-4dannjjm	1799	13	of	of	IN
cord-023095-4dannjjm	1799	14	horses	horse	NNS
cord-023095-4dannjjm	1799	15	with	with	IN
cord-023095-4dannjjm	1799	16	EPE	EPE	NNP
cord-023095-4dannjjm	1799	17	is	be	VBZ
cord-023095-4dannjjm	1799	18	appropriate	appropriate	JJ
cord-023095-4dannjjm	1799	19	and	and	CC
cord-023095-4dannjjm	1799	20	it	-PRON-	PRP
cord-023095-4dannjjm	1799	21	may	may	MD
cord-023095-4dannjjm	1799	22	aid	aid	VB
cord-023095-4dannjjm	1799	23	in	in	IN
cord-023095-4dannjjm	1799	24	reassuring	reassuring	JJ
cord-023095-4dannjjm	1799	25	owners	owner	NNS
cord-023095-4dannjjm	1799	26	that	that	IN
cord-023095-4dannjjm	1799	27	despite	despite	IN
cord-023095-4dannjjm	1799	28	the	the	DT
cord-023095-4dannjjm	1799	29	poor	poor	JJ
cord-023095-4dannjjm	1799	30	condition	condition	NN
cord-023095-4dannjjm	1799	31	of	of	IN
cord-023095-4dannjjm	1799	32	the	the	DT
cord-023095-4dannjjm	1799	33	horse	horse	NN
cord-023095-4dannjjm	1799	34	during	during	IN
cord-023095-4dannjjm	1799	35	and	and	CC
cord-023095-4dannjjm	1799	36	shortly	shortly	RB
cord-023095-4dannjjm	1799	37	after	after	IN
cord-023095-4dannjjm	1799	38	the	the	DT
cord-023095-4dannjjm	1799	39	course	course	NN
cord-023095-4dannjjm	1799	40	of	of	IN
cord-023095-4dannjjm	1799	41	disease	disease	NN
cord-023095-4dannjjm	1799	42	,	,	,
cord-023095-4dannjjm	1799	43	horse	horse	NN
cord-023095-4dannjjm	1799	44	may	may	MD
cord-023095-4dannjjm	1799	45	still	still	RB
cord-023095-4dannjjm	1799	46	have	have	VB
cord-023095-4dannjjm	1799	47	future	future	JJ
cord-023095-4dannjjm	1799	48	athletic	athletic	JJ
cord-023095-4dannjjm	1799	49	potential	potential	NN
cord-023095-4dannjjm	1799	50	.	.	.
cord-023095-4dannjjm	1800	1	This	this	DT
cord-023095-4dannjjm	1800	2	abstract	abstract	NN
cord-023095-4dannjjm	1800	3	was	be	VBD
cord-023095-4dannjjm	1800	4	presented	present	VBN
cord-023095-4dannjjm	1800	5	at	at	IN
cord-023095-4dannjjm	1800	6	the	the	DT
cord-023095-4dannjjm	1800	7	AAEP	AAEP	NNP
cord-023095-4dannjjm	1800	8	in	in	IN
cord-023095-4dannjjm	1800	9	December	December	NNP
cord-023095-4dannjjm	1800	10	2009	2009	CD
cord-023095-4dannjjm	1800	11	.	.	.
cord-023095-4dannjjm	1801	1	Bronchopneumonia	bronchopneumonia	NN
cord-023095-4dannjjm	1801	2	caused	cause	VBN
cord-023095-4dannjjm	1801	3	by	by	IN
cord-023095-4dannjjm	1801	4	Streptococccus	streptococccus	JJ
cord-023095-4dannjjm	1801	5	equi	equi	NN
cord-023095-4dannjjm	1801	6	subsp	subsp	NN
cord-023095-4dannjjm	1801	7	.	.	.
cord-023095-4dannjjm	1802	1	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	1802	2	(	(	-LRB-
cord-023095-4dannjjm	1802	3	S.	S.	NNP
cord-023095-4dannjjm	1802	4	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	1802	5	)	)	-RRB-
cord-023095-4dannjjm	1802	6	is	be	VBZ
cord-023095-4dannjjm	1802	7	one	one	CD
cord-023095-4dannjjm	1802	8	of	of	IN
cord-023095-4dannjjm	1802	9	the	the	DT
cord-023095-4dannjjm	1802	10	most	most	RBS
cord-023095-4dannjjm	1802	11	important	important	JJ
cord-023095-4dannjjm	1802	12	causes	cause	NNS
cord-023095-4dannjjm	1802	13	of	of	IN
cord-023095-4dannjjm	1802	14	morbidity	morbidity	NN
cord-023095-4dannjjm	1802	15	in	in	IN
cord-023095-4dannjjm	1802	16	weanling	weanle	VBG
cord-023095-4dannjjm	1802	17	foals	foal	NNS
cord-023095-4dannjjm	1802	18	.	.	.
cord-023095-4dannjjm	1803	1	Ceftiofur	ceftiofur	JJ
cord-023095-4dannjjm	1803	2	crystalline	crystalline	NN
cord-023095-4dannjjm	1803	3	free	free	JJ
cord-023095-4dannjjm	1803	4	acid	acid	NN
cord-023095-4dannjjm	1803	5	(	(	-LRB-
cord-023095-4dannjjm	1803	6	CCFA	CCFA	NNP
cord-023095-4dannjjm	1803	7	)	)	-RRB-
cord-023095-4dannjjm	1803	8	is	be	VBZ
cord-023095-4dannjjm	1803	9	a	a	DT
cord-023095-4dannjjm	1803	10	long	long	JJ
cord-023095-4dannjjm	1803	11	acting	act	VBG
cord-023095-4dannjjm	1803	12	third	third	JJ
cord-023095-4dannjjm	1803	13	-	-	HYPH
cord-023095-4dannjjm	1803	14	generation	generation	NN
cord-023095-4dannjjm	1803	15	cephalosporin	cephalosporin	NN
cord-023095-4dannjjm	1803	16	antimicrobial	antimicrobial	NNP
cord-023095-4dannjjm	1803	17	recently	recently	RB
cord-023095-4dannjjm	1803	18	approved	approve	VBN
cord-023095-4dannjjm	1803	19	for	for	IN
cord-023095-4dannjjm	1803	20	the	the	DT
cord-023095-4dannjjm	1803	21	treatment	treatment	NN
cord-023095-4dannjjm	1803	22	of	of	IN
cord-023095-4dannjjm	1803	23	bronchopneumonia	bronchopneumonia	NN
cord-023095-4dannjjm	1803	24	associated	associate	VBN
cord-023095-4dannjjm	1803	25	with	with	IN
cord-023095-4dannjjm	1803	26	S.	S.	NNP
cord-023095-4dannjjm	1803	27	zooepidemicus	zooepidemicus	NN
cord-023095-4dannjjm	1803	28	in	in	IN
cord-023095-4dannjjm	1803	29	adult	adult	NN
cord-023095-4dannjjm	1803	30	horses	horse	NNS
cord-023095-4dannjjm	1803	31	.	.	.
cord-023095-4dannjjm	1804	1	The	the	DT
cord-023095-4dannjjm	1804	2	objective	objective	NN
cord-023095-4dannjjm	1804	3	of	of	IN
cord-023095-4dannjjm	1804	4	the	the	DT
cord-023095-4dannjjm	1804	5	present	present	JJ
cord-023095-4dannjjm	1804	6	study	study	NN
cord-023095-4dannjjm	1804	7	was	be	VBD
cord-023095-4dannjjm	1804	8	to	to	TO
cord-023095-4dannjjm	1804	9	determine	determine	VB
cord-023095-4dannjjm	1804	10	the	the	DT
cord-023095-4dannjjm	1804	11	disposition	disposition	NN
cord-023095-4dannjjm	1804	12	of	of	IN
cord-023095-4dannjjm	1804	13	CCFA	CCFA	NNP
cord-023095-4dannjjm	1804	14	in	in	IN
cord-023095-4dannjjm	1804	15	plasma	plasma	NN
cord-023095-4dannjjm	1804	16	and	and	CC
cord-023095-4dannjjm	1804	17	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	1804	18	epithelial	epithelial	JJ
cord-023095-4dannjjm	1804	19	lining	lining	NN
cord-023095-4dannjjm	1804	20	fluid	fluid	NN
cord-023095-4dannjjm	1804	21	(	(	-LRB-
cord-023095-4dannjjm	1804	22	PELF	PELF	NNP
cord-023095-4dannjjm	1804	23	)	)	-RRB-
cord-023095-4dannjjm	1804	24	of	of	IN
cord-023095-4dannjjm	1804	25	weanling	weanle	VBG
cord-023095-4dannjjm	1804	26	foals	foal	NNS
cord-023095-4dannjjm	1804	27	.	.	.
cord-023095-4dannjjm	1805	1	Six	six	CD
cord-023095-4dannjjm	1805	2	healthy	healthy	JJ
cord-023095-4dannjjm	1805	3	4-to	4-to	CD
cord-023095-4dannjjm	1805	4	5month	5month	JJ
cord-023095-4dannjjm	1805	5	-	-	JJ
cord-023095-4dannjjm	1805	6	old	old	JJ
cord-023095-4dannjjm	1805	7	weanling	weanle	VBG
cord-023095-4dannjjm	1805	8	foals	foal	NNS
cord-023095-4dannjjm	1805	9	were	be	VBD
cord-023095-4dannjjm	1805	10	administered	administer	VBN
cord-023095-4dannjjm	1805	11	a	a	DT
cord-023095-4dannjjm	1805	12	single	single	JJ
cord-023095-4dannjjm	1805	13	intramuscular	intramuscular	JJ
cord-023095-4dannjjm	1805	14	injection	injection	NN
cord-023095-4dannjjm	1805	15	of	of	IN
cord-023095-4dannjjm	1805	16	CCFA	CCFA	NNP
cord-023095-4dannjjm	1805	17	at	at	IN
cord-023095-4dannjjm	1805	18	a	a	DT
cord-023095-4dannjjm	1805	19	dose	dose	NN
cord-023095-4dannjjm	1805	20	of	of	IN
cord-023095-4dannjjm	1805	21	6.6	6.6	CD
cord-023095-4dannjjm	1805	22	mg	mg	NNP
cord-023095-4dannjjm	1805	23	/	/	SYM
cord-023095-4dannjjm	1805	24	kg	kg	NNS
cord-023095-4dannjjm	1805	25	of	of	IN
cord-023095-4dannjjm	1805	26	body	body	NN
cord-023095-4dannjjm	1805	27	weight	weight	NN
cord-023095-4dannjjm	1805	28	.	.	.
cord-023095-4dannjjm	1806	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	1806	2	of	of	IN
cord-023095-4dannjjm	1806	3	desfuroylceftiofur	desfuroylceftiofur	JJ
cord-023095-4dannjjm	1806	4	acetamide	acetamide	NNP
cord-023095-4dannjjm	1806	5	(	(	-LRB-
cord-023095-4dannjjm	1806	6	DCA	DCA	NNP
cord-023095-4dannjjm	1806	7	)	)	-RRB-
cord-023095-4dannjjm	1806	8	and	and	CC
cord-023095-4dannjjm	1806	9	related	relate	VBN
cord-023095-4dannjjm	1806	10	metabolites	metabolite	NNS
cord-023095-4dannjjm	1806	11	were	be	VBD
cord-023095-4dannjjm	1806	12	measured	measure	VBN
cord-023095-4dannjjm	1806	13	by	by	IN
cord-023095-4dannjjm	1806	14	use	use	NN
cord-023095-4dannjjm	1806	15	of	of	IN
cord-023095-4dannjjm	1806	16	ultra	ultra	JJ
cord-023095-4dannjjm	1806	17	-	-	JJ
cord-023095-4dannjjm	1806	18	high	high	JJ
cord-023095-4dannjjm	1806	19	performance	performance	NN
cord-023095-4dannjjm	1806	20	liquid	liquid	NN
cord-023095-4dannjjm	1806	21	chromatography	chromatography	NN
cord-023095-4dannjjm	1806	22	and	and	CC
cord-023095-4dannjjm	1806	23	tandem	tandem	JJ
cord-023095-4dannjjm	1806	24	mass	mass	NN
cord-023095-4dannjjm	1806	25	spectrometry	spectrometry	NN
cord-023095-4dannjjm	1806	26	.	.	.
cord-023095-4dannjjm	1807	1	Following	follow	VBG
cord-023095-4dannjjm	1807	2	IM	IM	NNP
cord-023095-4dannjjm	1807	3	administration	administration	NN
cord-023095-4dannjjm	1807	4	,	,	,
cord-023095-4dannjjm	1807	5	median	median	JJ
cord-023095-4dannjjm	1807	6	time	time	NN
cord-023095-4dannjjm	1807	7	to	to	TO
cord-023095-4dannjjm	1807	8	maximum	maximum	VB
cord-023095-4dannjjm	1807	9	plasma	plasma	NN
cord-023095-4dannjjm	1807	10	and	and	CC
cord-023095-4dannjjm	1807	11	PELF	PELF	NNP
cord-023095-4dannjjm	1807	12	concentrations	concentration	NNS
cord-023095-4dannjjm	1807	13	was	be	VBD
cord-023095-4dannjjm	1807	14	24	24	CD
cord-023095-4dannjjm	1807	15	h	h	NN
cord-023095-4dannjjm	1807	16	(	(	-LRB-
cord-023095-4dannjjm	1807	17	12	12	CD
cord-023095-4dannjjm	1807	18	-	-	SYM
cord-023095-4dannjjm	1807	19	48	48	CD
cord-023095-4dannjjm	1807	20	h	h	NN
cord-023095-4dannjjm	1807	21	)	)	-RRB-
cord-023095-4dannjjm	1807	22	.	.	.
cord-023095-4dannjjm	1808	1	Mean	mean	JJ
cord-023095-4dannjjm	1808	2	(	(	-LRB-
cord-023095-4dannjjm	1808	3	AE	AE	NNP
cord-023095-4dannjjm	1808	4	SD	SD	NNP
cord-023095-4dannjjm	1808	5	)	)	-RRB-
cord-023095-4dannjjm	1808	6	peak	peak	NN
cord-023095-4dannjjm	1808	7	DCA	DCA	NNP
cord-023095-4dannjjm	1808	8	concentration	concentration	NN
cord-023095-4dannjjm	1808	9	in	in	IN
cord-023095-4dannjjm	1808	10	plasma	plasma	NN
cord-023095-4dannjjm	1808	11	(	(	-LRB-
cord-023095-4dannjjm	1808	12	1.44	1.44	CD
cord-023095-4dannjjm	1808	13	AE	AE	NNP
cord-023095-4dannjjm	1808	14	0.46	0.46	CD
cord-023095-4dannjjm	1808	15	mg	mg	NNP
cord-023095-4dannjjm	1808	16	/	/	SYM
cord-023095-4dannjjm	1808	17	mL	mL	NNP
cord-023095-4dannjjm	1808	18	)	)	-RRB-
cord-023095-4dannjjm	1808	19	was	be	VBD
cord-023095-4dannjjm	1808	20	significantly	significantly	RB
cord-023095-4dannjjm	1808	21	higher	high	JJR
cord-023095-4dannjjm	1808	22	than	than	IN
cord-023095-4dannjjm	1808	23	that	that	DT
cord-023095-4dannjjm	1808	24	in	in	IN
cord-023095-4dannjjm	1808	25	PELF	PELF	NNP
cord-023095-4dannjjm	1808	26	(	(	-LRB-
cord-023095-4dannjjm	1808	27	0.46	0.46	CD
cord-023095-4dannjjm	1808	28	AE	AE	NNP
cord-023095-4dannjjm	1808	29	0.03	0.03	CD
cord-023095-4dannjjm	1808	30	mg	mg	NNP
cord-023095-4dannjjm	1808	31	/	/	SYM
cord-023095-4dannjjm	1808	32	mL	mL	NNP
cord-023095-4dannjjm	1808	33	)	)	-RRB-
cord-023095-4dannjjm	1808	34	.	.	.
cord-023095-4dannjjm	1809	1	Terminal	terminal	JJ
cord-023095-4dannjjm	1809	2	half	half	JJ
cord-023095-4dannjjm	1809	3	-	-	HYPH
cord-023095-4dannjjm	1809	4	life	life	NN
cord-023095-4dannjjm	1809	5	of	of	IN
cord-023095-4dannjjm	1809	6	DCA	DCA	NNP
cord-023095-4dannjjm	1809	7	in	in	IN
cord-023095-4dannjjm	1809	8	plasma	plasma	NN
cord-023095-4dannjjm	1809	9	(	(	-LRB-
cord-023095-4dannjjm	1809	10	74.8	74.8	CD
cord-023095-4dannjjm	1809	11	AE	AE	NNP
cord-023095-4dannjjm	1809	12	20.9	20.9	CD
cord-023095-4dannjjm	1809	13	h	h	NNP
cord-023095-4dannjjm	1809	14	)	)	-RRB-
cord-023095-4dannjjm	1809	15	was	be	VBD
cord-023095-4dannjjm	1809	16	not	not	RB
cord-023095-4dannjjm	1809	17	significantly	significantly	RB
cord-023095-4dannjjm	1809	18	different	different	JJ
cord-023095-4dannjjm	1809	19	from	from	IN
cord-023095-4dannjjm	1809	20	that	that	DT
cord-023095-4dannjjm	1809	21	of	of	IN
cord-023095-4dannjjm	1809	22	PELF	PELF	NNP
cord-023095-4dannjjm	1809	23	(	(	-LRB-
cord-023095-4dannjjm	1809	24	58.5	58.5	CD
cord-023095-4dannjjm	1809	25	AE	AE	NNP
cord-023095-4dannjjm	1809	26	11.4	11.4	CD
cord-023095-4dannjjm	1809	27	h	h	NNP
cord-023095-4dannjjm	1809	28	)	)	-RRB-
cord-023095-4dannjjm	1809	29	.	.	.
cord-023095-4dannjjm	1810	1	Time	time	NN
cord-023095-4dannjjm	1810	2	above	above	IN
cord-023095-4dannjjm	1810	3	the	the	DT
cord-023095-4dannjjm	1810	4	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	1810	5	target	target	NN
cord-023095-4dannjjm	1810	6	of	of	IN
cord-023095-4dannjjm	1810	7	0.2	0.2	CD
cord-023095-4dannjjm	1810	8	mg	mg	NN
cord-023095-4dannjjm	1810	9	/	/	SYM
cord-023095-4dannjjm	1810	10	mL	mL	NNP
cord-023095-4dannjjm	1810	11	was	be	VBD
cord-023095-4dannjjm	1810	12	significantly	significantly	RB
cord-023095-4dannjjm	1810	13	longer	long	JJR
cord-023095-4dannjjm	1810	14	in	in	IN
cord-023095-4dannjjm	1810	15	plasma	plasma	NN
cord-023095-4dannjjm	1810	16	(	(	-LRB-
cord-023095-4dannjjm	1810	17	185	185	CD
cord-023095-4dannjjm	1810	18	AE	AE	NNP
cord-023095-4dannjjm	1810	19	20	20	CD
cord-023095-4dannjjm	1810	20	h	h	NN
cord-023095-4dannjjm	1810	21	)	)	-RRB-
cord-023095-4dannjjm	1810	22	than	than	IN
cord-023095-4dannjjm	1810	23	in	in	IN
cord-023095-4dannjjm	1810	24	PELF	PELF	NNP
cord-023095-4dannjjm	1810	25	(	(	-LRB-
cord-023095-4dannjjm	1810	26	107	107	CD
cord-023095-4dannjjm	1810	27	AE	AE	NNP
cord-023095-4dannjjm	1810	28	31	31	CD
cord-023095-4dannjjm	1810	29	h	h	NN
cord-023095-4dannjjm	1810	30	)	)	-RRB-
cord-023095-4dannjjm	1810	31	.	.	.
cord-023095-4dannjjm	1811	1	Based	base	VBN
cord-023095-4dannjjm	1811	2	on	on	IN
cord-023095-4dannjjm	1811	3	the	the	DT
cord-023095-4dannjjm	1811	4	results	result	NNS
cord-023095-4dannjjm	1811	5	of	of	IN
cord-023095-4dannjjm	1811	6	the	the	DT
cord-023095-4dannjjm	1811	7	present	present	JJ
cord-023095-4dannjjm	1811	8	study	study	NN
cord-023095-4dannjjm	1811	9	,	,	,
cord-023095-4dannjjm	1811	10	intramuscular	intramuscular	JJ
cord-023095-4dannjjm	1811	11	administration	administration	NN
cord-023095-4dannjjm	1811	12	of	of	IN
cord-023095-4dannjjm	1811	13	CCFA	CCFA	NNP
cord-023095-4dannjjm	1811	14	at	at	IN
cord-023095-4dannjjm	1811	15	a	a	DT
cord-023095-4dannjjm	1811	16	dose	dose	NN
cord-023095-4dannjjm	1811	17	of	of	IN
cord-023095-4dannjjm	1811	18	6.6	6.6	CD
cord-023095-4dannjjm	1811	19	mg	mg	NNP
cord-023095-4dannjjm	1811	20	/	/	SYM
cord-023095-4dannjjm	1811	21	kg	kg	NN
cord-023095-4dannjjm	1811	22	would	would	MD
cord-023095-4dannjjm	1811	23	be	be	VB
cord-023095-4dannjjm	1811	24	appropriate	appropriate	JJ
cord-023095-4dannjjm	1811	25	for	for	IN
cord-023095-4dannjjm	1811	26	the	the	DT
cord-023095-4dannjjm	1811	27	treatment	treatment	NN
cord-023095-4dannjjm	1811	28	of	of	IN
cord-023095-4dannjjm	1811	29	bronchopneumonia	bronchopneumonia	NN
cord-023095-4dannjjm	1811	30	caused	cause	VBN
cord-023095-4dannjjm	1811	31	by	by	IN
cord-023095-4dannjjm	1811	32	S.	S.	NNP
cord-023095-4dannjjm	1811	33	zooepidemicus	zooepidemicus	NNP
cord-023095-4dannjjm	1811	34	and	and	CC
cord-023095-4dannjjm	1811	35	other	other	JJ
cord-023095-4dannjjm	1811	36	susceptible	susceptible	JJ
cord-023095-4dannjjm	1811	37	pathogens	pathogen	NNS
cord-023095-4dannjjm	1811	38	in	in	IN
cord-023095-4dannjjm	1811	39	weanling	weanle	VBG
cord-023095-4dannjjm	1811	40	foals	foal	NNS
cord-023095-4dannjjm	1811	41	.	.	.
cord-023095-4dannjjm	1812	1	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	1812	2	is	be	VBZ
cord-023095-4dannjjm	1812	3	secreted	secrete	VBN
cord-023095-4dannjjm	1812	4	by	by	IN
cord-023095-4dannjjm	1812	5	osteocytes	osteocyte	NNS
cord-023095-4dannjjm	1812	6	and	and	CC
cord-023095-4dannjjm	1812	7	osteoblasts	osteoblast	NNS
cord-023095-4dannjjm	1812	8	in	in	IN
cord-023095-4dannjjm	1812	9	response	response	NN
cord-023095-4dannjjm	1812	10	to	to	IN
cord-023095-4dannjjm	1812	11	hyperphosphatemia	hyperphosphatemia	NN
cord-023095-4dannjjm	1812	12	.	.	.
cord-023095-4dannjjm	1813	1	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	1813	2	enhances	enhance	VBZ
cord-023095-4dannjjm	1813	3	phosphaturia	phosphaturia	NNS
cord-023095-4dannjjm	1813	4	and	and	CC
cord-023095-4dannjjm	1813	5	is	be	VBZ
cord-023095-4dannjjm	1813	6	postulated	postulate	VBN
cord-023095-4dannjjm	1813	7	to	to	TO
cord-023095-4dannjjm	1813	8	have	have	VB
cord-023095-4dannjjm	1813	9	a	a	DT
cord-023095-4dannjjm	1813	10	central	central	JJ
cord-023095-4dannjjm	1813	11	role	role	NN
cord-023095-4dannjjm	1813	12	in	in	IN
cord-023095-4dannjjm	1813	13	the	the	DT
cord-023095-4dannjjm	1813	14	development	development	NN
cord-023095-4dannjjm	1813	15	of	of	IN
cord-023095-4dannjjm	1813	16	secondary	secondary	JJ
cord-023095-4dannjjm	1813	17	renal	renal	JJ
cord-023095-4dannjjm	1813	18	hyperparathyroidism	hyperparathyroidism	NN
cord-023095-4dannjjm	1813	19	.	.	.
cord-023095-4dannjjm	1814	1	Hyperthyroid	Hyperthyroid	NNP
cord-023095-4dannjjm	1814	2	cats	cat	NNS
cord-023095-4dannjjm	1814	3	have	have	VBP
cord-023095-4dannjjm	1814	4	elevated	elevate	VBN
cord-023095-4dannjjm	1814	5	plasma	plasma	NN
cord-023095-4dannjjm	1814	6	phosphate	phosphate	NN
cord-023095-4dannjjm	1814	7	and	and	CC
cord-023095-4dannjjm	1814	8	parathyroid	parathyroid	JJ
cord-023095-4dannjjm	1814	9	hormone	hormone	NN
cord-023095-4dannjjm	1814	10	concentrations	concentration	NNS
cord-023095-4dannjjm	1814	11	,	,	,
cord-023095-4dannjjm	1814	12	which	which	WDT
cord-023095-4dannjjm	1814	13	may	may	MD
cord-023095-4dannjjm	1814	14	in	in	IN
cord-023095-4dannjjm	1814	15	part	part	NN
cord-023095-4dannjjm	1814	16	be	be	VB
cord-023095-4dannjjm	1814	17	associated	associate	VBN
cord-023095-4dannjjm	1814	18	with	with	IN
cord-023095-4dannjjm	1814	19	underlying	underlie	VBG
cord-023095-4dannjjm	1814	20	chronic	chronic	JJ
cord-023095-4dannjjm	1814	21	kidney	kidney	NN
cord-023095-4dannjjm	1814	22	disease	disease	NN
cord-023095-4dannjjm	1814	23	(	(	-LRB-
cord-023095-4dannjjm	1814	24	CKD	CKD	NNP
cord-023095-4dannjjm	1814	25	)	)	-RRB-
cord-023095-4dannjjm	1814	26	.	.	.
cord-023095-4dannjjm	1815	1	The	the	DT
cord-023095-4dannjjm	1815	2	aim	aim	NN
cord-023095-4dannjjm	1815	3	of	of	IN
cord-023095-4dannjjm	1815	4	this	this	DT
cord-023095-4dannjjm	1815	5	study	study	NN
cord-023095-4dannjjm	1815	6	was	be	VBD
cord-023095-4dannjjm	1815	7	to	to	TO
cord-023095-4dannjjm	1815	8	determine	determine	VB
cord-023095-4dannjjm	1815	9	if	if	IN
cord-023095-4dannjjm	1815	10	plasma	plasma	NN
cord-023095-4dannjjm	1815	11	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	1815	12	concentrations	concentration	NNS
cord-023095-4dannjjm	1815	13	were	be	VBD
cord-023095-4dannjjm	1815	14	associated	associate	VBN
cord-023095-4dannjjm	1815	15	with	with	IN
cord-023095-4dannjjm	1815	16	the	the	DT
cord-023095-4dannjjm	1815	17	presence	presence	NN
cord-023095-4dannjjm	1815	18	of	of	IN
cord-023095-4dannjjm	1815	19	underlying	underlie	VBG
cord-023095-4dannjjm	1815	20	CKD	CKD	NNP
cord-023095-4dannjjm	1815	21	in	in	IN
cord-023095-4dannjjm	1815	22	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	1815	23	cats	cat	NNS
cord-023095-4dannjjm	1815	24	,	,	,
cord-023095-4dannjjm	1815	25	and	and	CC
cord-023095-4dannjjm	1815	26	to	to	TO
cord-023095-4dannjjm	1815	27	investigate	investigate	VB
cord-023095-4dannjjm	1815	28	the	the	DT
cord-023095-4dannjjm	1815	29	changes	change	NNS
cord-023095-4dannjjm	1815	30	in	in	IN
cord-023095-4dannjjm	1815	31	plasma	plasma	NN
cord-023095-4dannjjm	1815	32	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	1815	33	concentrations	concentration	NNS
cord-023095-4dannjjm	1815	34	that	that	WDT
cord-023095-4dannjjm	1815	35	occur	occur	VBP
cord-023095-4dannjjm	1815	36	following	follow	VBG
cord-023095-4dannjjm	1815	37	treatment	treatment	NN
cord-023095-4dannjjm	1815	38	of	of	IN
cord-023095-4dannjjm	1815	39	HTH	HTH	NNP
cord-023095-4dannjjm	1815	40	.	.	.
cord-023095-4dannjjm	1816	1	Hyperthyroid	Hyperthyroid	NNP
cord-023095-4dannjjm	1816	2	cats	cat	NNS
cord-023095-4dannjjm	1816	3	were	be	VBD
cord-023095-4dannjjm	1816	4	recruited	recruit	VBN
cord-023095-4dannjjm	1816	5	from	from	IN
cord-023095-4dannjjm	1816	6	two	two	CD
cord-023095-4dannjjm	1816	7	London	London	NNP
cord-023095-4dannjjm	1816	8	-	-	HYPH
cord-023095-4dannjjm	1816	9	based	base	VBN
cord-023095-4dannjjm	1816	10	first	first	JJ
cord-023095-4dannjjm	1816	11	opinion	opinion	NN
cord-023095-4dannjjm	1816	12	practices	practice	NNS
cord-023095-4dannjjm	1816	13	between	between	IN
cord-023095-4dannjjm	1816	14	1999	1999	CD
cord-023095-4dannjjm	1816	15	and	and	CC
cord-023095-4dannjjm	1816	16	2009	2009	CD
cord-023095-4dannjjm	1816	17	.	.	.
cord-023095-4dannjjm	1817	1	Cats	cat	NNS
cord-023095-4dannjjm	1817	2	that	that	WDT
cord-023095-4dannjjm	1817	3	were	be	VBD
cord-023095-4dannjjm	1817	4	azotemic	azotemic	JJ
cord-023095-4dannjjm	1817	5	at	at	IN
cord-023095-4dannjjm	1817	6	diagnosis	diagnosis	NN
cord-023095-4dannjjm	1817	7	were	be	VBD
cord-023095-4dannjjm	1817	8	excluded	exclude	VBN
cord-023095-4dannjjm	1817	9	.	.	.
cord-023095-4dannjjm	1818	1	HTH	HTH	NNP
cord-023095-4dannjjm	1818	2	was	be	VBD
cord-023095-4dannjjm	1818	3	treated	treat	VBN
cord-023095-4dannjjm	1818	4	with	with	IN
cord-023095-4dannjjm	1818	5	anti	anti	JJ
cord-023095-4dannjjm	1818	6	-	-	JJ
cord-023095-4dannjjm	1818	7	thyroid	thyroid	JJ
cord-023095-4dannjjm	1818	8	medication	medication	NN
cord-023095-4dannjjm	1818	9	alone	alone	RB
cord-023095-4dannjjm	1818	10	or	or	CC
cord-023095-4dannjjm	1818	11	in	in	IN
cord-023095-4dannjjm	1818	12	combination	combination	NN
cord-023095-4dannjjm	1818	13	with	with	IN
cord-023095-4dannjjm	1818	14	thyroidectomy	thyroidectomy	NN
cord-023095-4dannjjm	1818	15	.	.	.
cord-023095-4dannjjm	1819	1	Cats	cat	NNS
cord-023095-4dannjjm	1819	2	were	be	VBD
cord-023095-4dannjjm	1819	3	included	include	VBN
cord-023095-4dannjjm	1819	4	in	in	IN
cord-023095-4dannjjm	1819	5	the	the	DT
cord-023095-4dannjjm	1819	6	study	study	NN
cord-023095-4dannjjm	1819	7	if	if	IN
cord-023095-4dannjjm	1819	8	they	-PRON-	PRP
cord-023095-4dannjjm	1819	9	had	have	VBD
cord-023095-4dannjjm	1819	10	a	a	DT
cord-023095-4dannjjm	1819	11	plasma	plasma	JJ
cord-023095-4dannjjm	1819	12	total	total	JJ
cord-023095-4dannjjm	1819	13	thyroxine	thyroxine	JJ
cord-023095-4dannjjm	1819	14	concentration	concentration	NN
cord-023095-4dannjjm	1819	15	o	o	NNP
cord-023095-4dannjjm	1819	16	40	40	CD
cord-023095-4dannjjm	1819	17	nmol	nmol	NNP
cord-023095-4dannjjm	1819	18	/	/	SYM
cord-023095-4dannjjm	1819	19	l	l	NNP
cord-023095-4dannjjm	1819	20	documented	document	VBD
cord-023095-4dannjjm	1819	21	for	for	IN
cord-023095-4dannjjm	1819	22	a	a	DT
cord-023095-4dannjjm	1819	23	six	six	CD
cord-023095-4dannjjm	1819	24	month	month	NN
cord-023095-4dannjjm	1819	25	period	period	NN
cord-023095-4dannjjm	1819	26	following	follow	VBG
cord-023095-4dannjjm	1819	27	commencement	commencement	NN
cord-023095-4dannjjm	1819	28	of	of	IN
cord-023095-4dannjjm	1819	29	treatment	treatment	NN
cord-023095-4dannjjm	1819	30	.	.	.
cord-023095-4dannjjm	1820	1	Cats	cat	NNS
cord-023095-4dannjjm	1820	2	were	be	VBD
cord-023095-4dannjjm	1820	3	classified	classify	VBN
cord-023095-4dannjjm	1820	4	as	as	IN
cord-023095-4dannjjm	1820	5	having	have	VBG
cord-023095-4dannjjm	1820	6	azotemic	azotemic	JJ
cord-023095-4dannjjm	1820	7	CKD	CKD	NNP
cord-023095-4dannjjm	1820	8	if	if	IN
cord-023095-4dannjjm	1820	9	they	-PRON-	PRP
cord-023095-4dannjjm	1820	10	developed	develop	VBD
cord-023095-4dannjjm	1820	11	renal	renal	JJ
cord-023095-4dannjjm	1820	12	azotemia	azotemia	NN
cord-023095-4dannjjm	1820	13	within	within	IN
cord-023095-4dannjjm	1820	14	six	six	CD
cord-023095-4dannjjm	1820	15	months	month	NNS
cord-023095-4dannjjm	1820	16	of	of	IN
cord-023095-4dannjjm	1820	17	establishment	establishment	NN
cord-023095-4dannjjm	1820	18	of	of	IN
cord-023095-4dannjjm	1820	19	euthyroidism	euthyroidism	NN
cord-023095-4dannjjm	1820	20	.	.	.
cord-023095-4dannjjm	1821	1	Otherwise	otherwise	RB
cord-023095-4dannjjm	1821	2	cats	cat	NNS
cord-023095-4dannjjm	1821	3	were	be	VBD
cord-023095-4dannjjm	1821	4	deemed	deem	VBN
cord-023095-4dannjjm	1821	5	to	to	TO
cord-023095-4dannjjm	1821	6	have	have	VB
cord-023095-4dannjjm	1821	7	normal	normal	JJ
cord-023095-4dannjjm	1821	8	renal	renal	JJ
cord-023095-4dannjjm	1821	9	function	function	NN
cord-023095-4dannjjm	1821	10	.	.	.
cord-023095-4dannjjm	1822	1	Stored	store	VBN
cord-023095-4dannjjm	1822	2	EDTA	edta	NN
cord-023095-4dannjjm	1822	3	plasma	plasma	NN
cord-023095-4dannjjm	1822	4	samples	sample	NNS
cord-023095-4dannjjm	1822	5	were	be	VBD
cord-023095-4dannjjm	1822	6	assayed	assay	VBN
cord-023095-4dannjjm	1822	7	for	for	IN
cord-023095-4dannjjm	1822	8	FGF-23	FGF-23	NNPS
cord-023095-4dannjjm	1822	9	using	use	VBG
cord-023095-4dannjjm	1822	10	a	a	DT
cord-023095-4dannjjm	1822	11	recently	recently	RB
cord-023095-4dannjjm	1822	12	validated	validate	VBN
cord-023095-4dannjjm	1822	13	ELISA	ELISA	NNP
cord-023095-4dannjjm	1822	14	.	.	.
cord-023095-4dannjjm	1823	1	The	the	DT
cord-023095-4dannjjm	1823	2	Mann	Mann	NNP
cord-023095-4dannjjm	1823	3	-	-	HYPH
cord-023095-4dannjjm	1823	4	Whitney	Whitney	NNP
cord-023095-4dannjjm	1823	5	U	U	NNP
cord-023095-4dannjjm	1823	6	test	test	NN
cord-023095-4dannjjm	1823	7	and	and	CC
cord-023095-4dannjjm	1823	8	the	the	DT
cord-023095-4dannjjm	1823	9	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	1823	10	signed	sign	VBD
cord-023095-4dannjjm	1823	11	rank	rank	NN
cord-023095-4dannjjm	1823	12	test	test	NN
cord-023095-4dannjjm	1823	13	were	be	VBD
cord-023095-4dannjjm	1823	14	used	use	VBN
cord-023095-4dannjjm	1823	15	to	to	TO
cord-023095-4dannjjm	1823	16	compare	compare	VB
cord-023095-4dannjjm	1823	17	between	between	IN
cord-023095-4dannjjm	1823	18	the	the	DT
cord-023095-4dannjjm	1823	19	groups	group	NNS
cord-023095-4dannjjm	1823	20	and	and	CC
cord-023095-4dannjjm	1823	21	assess	assess	VB
cord-023095-4dannjjm	1823	22	the	the	DT
cord-023095-4dannjjm	1823	23	response	response	NN
cord-023095-4dannjjm	1823	24	to	to	IN
cord-023095-4dannjjm	1823	25	treatment	treatment	NN
cord-023095-4dannjjm	1823	26	respectively	respectively	RB
cord-023095-4dannjjm	1823	27	.	.	.
cord-023095-4dannjjm	1824	1	Results	result	NNS
cord-023095-4dannjjm	1824	2	are	be	VBP
cord-023095-4dannjjm	1824	3	reported	report	VBN
cord-023095-4dannjjm	1824	4	as	as	IN
cord-023095-4dannjjm	1824	5	median	median	JJ
cord-023095-4dannjjm	1824	6	[	[	-LRB-
cord-023095-4dannjjm	1824	7	25	25	CD
cord-023095-4dannjjm	1824	8	th	th	XX
cord-023095-4dannjjm	1824	9	,	,	,
cord-023095-4dannjjm	1824	10	75	75	CD
cord-023095-4dannjjm	1824	11	th	th	XX
cord-023095-4dannjjm	1824	12	percentiles	percentile	NNS
cord-023095-4dannjjm	1824	13	]	]	-RRB-
cord-023095-4dannjjm	1824	14	.	.	.
cord-023095-4dannjjm	1825	1	Correlations	correlation	NNS
cord-023095-4dannjjm	1825	2	were	be	VBD
cord-023095-4dannjjm	1825	3	made	make	VBN
cord-023095-4dannjjm	1825	4	using	use	VBG
cord-023095-4dannjjm	1825	5	Spearman	Spearman	NNP
cord-023095-4dannjjm	1825	6	's	's	POS
cord-023095-4dannjjm	1825	7	correlation	correlation	NN
cord-023095-4dannjjm	1825	8	coefficient	coefficient	NN
cord-023095-4dannjjm	1825	9	.	.	.
cord-023095-4dannjjm	1826	1	Thirty	thirty	CD
cord-023095-4dannjjm	1826	2	one	one	CD
cord-023095-4dannjjm	1826	3	cats	cat	NNS
cord-023095-4dannjjm	1826	4	with	with	IN
cord-023095-4dannjjm	1826	5	HTH	HTH	NNP
cord-023095-4dannjjm	1826	6	(	(	-LRB-
cord-023095-4dannjjm	1826	7	14	14	CD
cord-023095-4dannjjm	1826	8	azotemic	azotemic	NNS
cord-023095-4dannjjm	1826	9	and	and	CC
cord-023095-4dannjjm	1826	10	17	17	CD
cord-023095-4dannjjm	1826	11	non	non	JJ
cord-023095-4dannjjm	1826	12	-	-	JJ
cord-023095-4dannjjm	1826	13	azotemic	azotemic	JJ
cord-023095-4dannjjm	1826	14	)	)	-RRB-
cord-023095-4dannjjm	1826	15	were	be	VBD
cord-023095-4dannjjm	1826	16	included	include	VBN
cord-023095-4dannjjm	1826	17	in	in	IN
cord-023095-4dannjjm	1826	18	the	the	DT
cord-023095-4dannjjm	1826	19	study	study	NN
cord-023095-4dannjjm	1826	20	.	.	.
cord-023095-4dannjjm	1827	1	Plasma	plasma	NN
cord-023095-4dannjjm	1827	2	phosphate	phosphate	NN
cord-023095-4dannjjm	1827	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1827	4	decreased	decrease	VBD
cord-023095-4dannjjm	1827	5	following	follow	VBG
cord-023095-4dannjjm	1827	6	treatment	treatment	NN
cord-023095-4dannjjm	1827	7	in	in	IN
cord-023095-4dannjjm	1827	8	cats	cat	NNS
cord-023095-4dannjjm	1827	9	that	that	WDT
cord-023095-4dannjjm	1827	10	did	do	VBD
cord-023095-4dannjjm	1827	11	not	not	RB
cord-023095-4dannjjm	1827	12	develop	develop	VB
cord-023095-4dannjjm	1827	13	azotemia	azotemia	NN
cord-023095-4dannjjm	1827	14	(	(	-LRB-
cord-023095-4dannjjm	1827	15	4.84	4.84	CD
cord-023095-4dannjjm	1827	16	[	[	-LRB-
cord-023095-4dannjjm	1827	17	3.91	3.91	CD
cord-023095-4dannjjm	1827	18	,	,	,
cord-023095-4dannjjm	1827	19	5.64	5.64	CD
cord-023095-4dannjjm	1827	20	]	]	-RRB-
cord-023095-4dannjjm	1827	21	mg	mg	NNP
cord-023095-4dannjjm	1827	22	/	/	SYM
cord-023095-4dannjjm	1827	23	dl	dl	NNP
cord-023095-4dannjjm	1827	24	vs.	vs.	NNP
cord-023095-4dannjjm	1827	25	3.91	3.91	CD
cord-023095-4dannjjm	1827	26	[	[	-LRB-
cord-023095-4dannjjm	1827	27	3.38	3.38	CD
cord-023095-4dannjjm	1827	28	,	,	,
cord-023095-4dannjjm	1827	29	4.37	4.37	CD
cord-023095-4dannjjm	1827	30	]	]	-RRB-
cord-023095-4dannjjm	1827	31	mg	mg	NNP
cord-023095-4dannjjm	1827	32	/	/	SYM
cord-023095-4dannjjm	1827	33	dl	dl	NN
cord-023095-4dannjjm	1827	34	;	;	:
cord-023095-4dannjjm	1827	35	n	n	NNP
cord-023095-4dannjjm	1827	36	5	5	CD
cord-023095-4dannjjm	1827	37	13	13	CD
cord-023095-4dannjjm	1827	38	,	,	,
cord-023095-4dannjjm	1827	39	P	p	NN
cord-023095-4dannjjm	1827	40	5	5	CD
cord-023095-4dannjjm	1827	41	0.01	0.01	CD
cord-023095-4dannjjm	1827	42	)	)	-RRB-
cord-023095-4dannjjm	1828	1	whereas	whereas	IN
cord-023095-4dannjjm	1828	2	plasma	plasma	NN
cord-023095-4dannjjm	1828	3	phosphate	phosphate	NN
cord-023095-4dannjjm	1828	4	concentrations	concentration	NNS
cord-023095-4dannjjm	1828	5	did	do	VBD
cord-023095-4dannjjm	1828	6	not	not	RB
cord-023095-4dannjjm	1828	7	change	change	VB
cord-023095-4dannjjm	1828	8	significantly	significantly	RB
cord-023095-4dannjjm	1828	9	following	follow	VBG
cord-023095-4dannjjm	1828	10	treatment	treatment	NN
cord-023095-4dannjjm	1828	11	in	in	IN
cord-023095-4dannjjm	1828	12	cats	cat	NNS
cord-023095-4dannjjm	1828	13	that	that	WDT
cord-023095-4dannjjm	1828	14	did	do	VBD
cord-023095-4dannjjm	1828	15	develop	develop	VB
cord-023095-4dannjjm	1828	16	azotemia	azotemia	NN
cord-023095-4dannjjm	1828	17	(	(	-LRB-
cord-023095-4dannjjm	1828	18	4.28	4.28	CD
cord-023095-4dannjjm	1828	19	[	[	-LRB-
cord-023095-4dannjjm	1828	20	3.81	3.81	CD
cord-023095-4dannjjm	1828	21	,	,	,
cord-023095-4dannjjm	1828	22	5.64	5.64	CD
cord-023095-4dannjjm	1828	23	]	]	-RRB-
cord-023095-4dannjjm	1829	1	mg/	mg/	NNP
cord-023095-4dannjjm	1829	2	dl	dl	NNP
cord-023095-4dannjjm	1829	3	vs.	vs.	NNP
cord-023095-4dannjjm	1829	4	4.22	4.22	CD
cord-023095-4dannjjm	1829	5	[	[	-LRB-
cord-023095-4dannjjm	1829	6	3.10	3.10	CD
cord-023095-4dannjjm	1829	7	,	,	,
cord-023095-4dannjjm	1829	8	5.33	5.33	CD
cord-023095-4dannjjm	1829	9	]	]	-RRB-
cord-023095-4dannjjm	1829	10	mg	mg	NNP
cord-023095-4dannjjm	1829	11	/	/	SYM
cord-023095-4dannjjm	1829	12	dl	dl	NN
cord-023095-4dannjjm	1829	13	;	;	:
cord-023095-4dannjjm	1830	1	n	n	NN
cord-023095-4dannjjm	1830	2	5	5	CD
cord-023095-4dannjjm	1830	3	14	14	CD
cord-023095-4dannjjm	1830	4	,	,	,
cord-023095-4dannjjm	1830	5	P	p	NN
cord-023095-4dannjjm	1830	6	5	5	CD
cord-023095-4dannjjm	1830	7	0.158	0.158	CD
cord-023095-4dannjjm	1830	8	)	)	-RRB-
cord-023095-4dannjjm	1830	9	.	.	.
cord-023095-4dannjjm	1831	1	Plasma	plasma	NN
cord-023095-4dannjjm	1831	2	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	1831	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1831	4	were	be	VBD
cord-023095-4dannjjm	1831	5	significantly	significantly	RB
cord-023095-4dannjjm	1831	6	higher	high	JJR
cord-023095-4dannjjm	1831	7	in	in	IN
cord-023095-4dannjjm	1831	8	cats	cat	NNS
cord-023095-4dannjjm	1831	9	that	that	WDT
cord-023095-4dannjjm	1831	10	developed	develop	VBD
cord-023095-4dannjjm	1831	11	azotemia	azotemia	NN
cord-023095-4dannjjm	1831	12	than	than	IN
cord-023095-4dannjjm	1831	13	cats	cat	NNS
cord-023095-4dannjjm	1831	14	that	that	WDT
cord-023095-4dannjjm	1831	15	did	do	VBD
cord-023095-4dannjjm	1831	16	not	not	RB
cord-023095-4dannjjm	1831	17	at	at	IN
cord-023095-4dannjjm	1831	18	both	both	DT
cord-023095-4dannjjm	1831	19	pre	pre	JJ
cord-023095-4dannjjm	1831	20	treatment	treatment	NN
cord-023095-4dannjjm	1831	21	(	(	-LRB-
cord-023095-4dannjjm	1831	22	211.7	211.7	CD
cord-023095-4dannjjm	1831	23	[	[	-LRB-
cord-023095-4dannjjm	1831	24	176.4	176.4	CD
cord-023095-4dannjjm	1831	25	,	,	,
cord-023095-4dannjjm	1831	26	356	356	CD
cord-023095-4dannjjm	1831	27	.3	.3	NN
cord-023095-4dannjjm	1831	28	]	]	-RRB-
cord-023095-4dannjjm	1832	1	pg	pg	NNP
cord-023095-4dannjjm	1832	2	/	/	SYM
cord-023095-4dannjjm	1832	3	ml	ml	IN
cord-023095-4dannjjm	1832	4	vs.	vs.	FW
cord-023095-4dannjjm	1832	5	148.3	148.3	CD
cord-023095-4dannjjm	1832	6	[	[	-LRB-
cord-023095-4dannjjm	1832	7	118.8	118.8	CD
cord-023095-4dannjjm	1832	8	,	,	,
cord-023095-4dannjjm	1832	9	274	274	CD
cord-023095-4dannjjm	1832	10	.9	.9	CD
cord-023095-4dannjjm	1832	11	]	]	-RRB-
cord-023095-4dannjjm	1833	1	pg	pg	NNP
cord-023095-4dannjjm	1833	2	/	/	SYM
cord-023095-4dannjjm	1833	3	ml	ml	NN
cord-023095-4dannjjm	1833	4	;	;	:
cord-023095-4dannjjm	1833	5	P	p	NN
cord-023095-4dannjjm	1833	6	5	5	CD
cord-023095-4dannjjm	1833	7	0.039	0.039	CD
cord-023095-4dannjjm	1833	8	)	)	-RRB-
cord-023095-4dannjjm	1833	9	and	and	CC
cord-023095-4dannjjm	1833	10	post	post	JJ
cord-023095-4dannjjm	1833	11	treatment	treatment	NN
cord-023095-4dannjjm	1833	12	(	(	-LRB-
cord-023095-4dannjjm	1833	13	514.0	514.0	CD
cord-023095-4dannjjm	1833	14	[	[	-LRB-
cord-023095-4dannjjm	1833	15	250.2	250.2	CD
cord-023095-4dannjjm	1833	16	,	,	,
cord-023095-4dannjjm	1833	17	800.0	800.0	CD
cord-023095-4dannjjm	1833	18	]	]	-RRB-
cord-023095-4dannjjm	1833	19	pg	pg	NNS
cord-023095-4dannjjm	1833	20	/	/	SYM
cord-023095-4dannjjm	1833	21	ml	ml	NNS
cord-023095-4dannjjm	1833	22	vs.	vs.	IN
cord-023095-4dannjjm	1833	23	195.1	195.1	CD
cord-023095-4dannjjm	1833	24	[	[	-LRB-
cord-023095-4dannjjm	1833	25	160.7	160.7	CD
cord-023095-4dannjjm	1833	26	,	,	,
cord-023095-4dannjjm	1833	27	287	287	CD
cord-023095-4dannjjm	1833	28	.3	.3	CD
cord-023095-4dannjjm	1833	29	]	]	-RRB-
cord-023095-4dannjjm	1834	1	pg	pg	NNP
cord-023095-4dannjjm	1834	2	/	/	SYM
cord-023095-4dannjjm	1834	3	ml	ml	NN
cord-023095-4dannjjm	1834	4	;	;	:
cord-023095-4dannjjm	1834	5	P	p	NN
cord-023095-4dannjjm	1834	6	5	5	CD
cord-023095-4dannjjm	1834	7	0.001	0.001	CD
cord-023095-4dannjjm	1834	8	)	)	-RRB-
cord-023095-4dannjjm	1834	9	timepoints	timepoint	NNS
cord-023095-4dannjjm	1834	10	.	.	.
cord-023095-4dannjjm	1835	1	Plasma	plasma	NN
cord-023095-4dannjjm	1835	2	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	1835	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1835	4	increased	increase	VBD
cord-023095-4dannjjm	1835	5	following	follow	VBG
cord-023095-4dannjjm	1835	6	treatment	treatment	NN
cord-023095-4dannjjm	1835	7	in	in	IN
cord-023095-4dannjjm	1835	8	both	both	DT
cord-023095-4dannjjm	1835	9	azotemic	azotemic	NNS
cord-023095-4dannjjm	1835	10	(	(	-LRB-
cord-023095-4dannjjm	1835	11	P	p	NN
cord-023095-4dannjjm	1835	12	5	5	CD
cord-023095-4dannjjm	1835	13	0.004	0.004	CD
cord-023095-4dannjjm	1835	14	)	)	-RRB-
cord-023095-4dannjjm	1835	15	and	and	CC
cord-023095-4dannjjm	1835	16	non	non	JJ
cord-023095-4dannjjm	1835	17	-	-	JJ
cord-023095-4dannjjm	1835	18	azotemic	azotemic	JJ
cord-023095-4dannjjm	1835	19	groups	group	NNS
cord-023095-4dannjjm	1835	20	(	(	-LRB-
cord-023095-4dannjjm	1835	21	P	p	NN
cord-023095-4dannjjm	1835	22	5	5	CD
cord-023095-4dannjjm	1835	23	0.025	0.025	CD
cord-023095-4dannjjm	1835	24	)	)	-RRB-
cord-023095-4dannjjm	1835	25	.	.	.
cord-023095-4dannjjm	1836	1	Plasma	plasma	NN
cord-023095-4dannjjm	1836	2	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	1836	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1836	4	and	and	CC
cord-023095-4dannjjm	1836	5	plasma	plasma	NN
cord-023095-4dannjjm	1836	6	phosphate	phosphate	NN
cord-023095-4dannjjm	1836	7	concentrations	concentration	NNS
cord-023095-4dannjjm	1836	8	were	be	VBD
cord-023095-4dannjjm	1836	9	not	not	RB
cord-023095-4dannjjm	1836	10	correlated	correlate	VBN
cord-023095-4dannjjm	1836	11	at	at	IN
cord-023095-4dannjjm	1836	12	baseline	baseline	NN
cord-023095-4dannjjm	1836	13	(	(	-LRB-
cord-023095-4dannjjm	1836	14	r	r	NN
cord-023095-4dannjjm	1836	15	s	s	NN
cord-023095-4dannjjm	1836	16	5	5	CD
cord-023095-4dannjjm	1836	17	0.189	0.189	CD
cord-023095-4dannjjm	1836	18	,	,	,
cord-023095-4dannjjm	1836	19	P	p	NN
cord-023095-4dannjjm	1836	20	5	5	CD
cord-023095-4dannjjm	1836	21	0.335	0.335	CD
cord-023095-4dannjjm	1836	22	)	)	-RRB-
cord-023095-4dannjjm	1836	23	or	or	CC
cord-023095-4dannjjm	1836	24	following	follow	VBG
cord-023095-4dannjjm	1836	25	treatment	treatment	NN
cord-023095-4dannjjm	1837	1	(	(	-LRB-
cord-023095-4dannjjm	1837	2	r	r	NNP
cord-023095-4dannjjm	1837	3	s	s	NN
cord-023095-4dannjjm	1837	4	5	5	CD
cord-023095-4dannjjm	1837	5	0.136	0.136	CD
cord-023095-4dannjjm	1837	6	,	,	,
cord-023095-4dannjjm	1837	7	P	p	NN
cord-023095-4dannjjm	1837	8	5	5	CD
cord-023095-4dannjjm	1837	9	0.472	0.472	CD
cord-023095-4dannjjm	1837	10	)	)	-RRB-
cord-023095-4dannjjm	1837	11	.	.	.
cord-023095-4dannjjm	1838	1	Plasma	plasma	NN
cord-023095-4dannjjm	1838	2	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	1838	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1838	4	were	be	VBD
cord-023095-4dannjjm	1838	5	higher	high	JJR
cord-023095-4dannjjm	1838	6	in	in	IN
cord-023095-4dannjjm	1838	7	pre	pre	JJ
cord-023095-4dannjjm	1838	8	-	-	JJ
cord-023095-4dannjjm	1838	9	azotemic	azotemic	JJ
cord-023095-4dannjjm	1838	10	cats	cat	NNS
cord-023095-4dannjjm	1838	11	than	than	IN
cord-023095-4dannjjm	1838	12	non	non	JJ
cord-023095-4dannjjm	1838	13	-	-	JJ
cord-023095-4dannjjm	1838	14	azotemic	azotemic	JJ
cord-023095-4dannjjm	1838	15	cats	cat	NNS
cord-023095-4dannjjm	1838	16	and	and	CC
cord-023095-4dannjjm	1838	17	increased	increase	VBD
cord-023095-4dannjjm	1838	18	following	follow	VBG
cord-023095-4dannjjm	1838	19	treatment	treatment	NN
cord-023095-4dannjjm	1838	20	of	of	IN
cord-023095-4dannjjm	1838	21	HTH	HTH	NNP
cord-023095-4dannjjm	1838	22	.	.	.
cord-023095-4dannjjm	1839	1	The	the	DT
cord-023095-4dannjjm	1839	2	reason	reason	NN
cord-023095-4dannjjm	1839	3	that	that	IN
cord-023095-4dannjjm	1839	4	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	1839	5	concentrations	concentration	NNS
cord-023095-4dannjjm	1839	6	increased	increase	VBD
cord-023095-4dannjjm	1839	7	following	follow	VBG
cord-023095-4dannjjm	1839	8	treatment	treatment	NN
cord-023095-4dannjjm	1839	9	,	,	,
cord-023095-4dannjjm	1839	10	particularly	particularly	RB
cord-023095-4dannjjm	1839	11	in	in	IN
cord-023095-4dannjjm	1839	12	the	the	DT
cord-023095-4dannjjm	1839	13	face	face	NN
cord-023095-4dannjjm	1839	14	of	of	IN
cord-023095-4dannjjm	1839	15	decreasing	decrease	VBG
cord-023095-4dannjjm	1839	16	plasma	plasma	NN
cord-023095-4dannjjm	1839	17	phosphate	phosphate	NN
cord-023095-4dannjjm	1839	18	concentrations	concentration	NNS
cord-023095-4dannjjm	1839	19	in	in	IN
cord-023095-4dannjjm	1839	20	cats	cat	NNS
cord-023095-4dannjjm	1839	21	that	that	WDT
cord-023095-4dannjjm	1839	22	remain	remain	VBP
cord-023095-4dannjjm	1839	23	non	non	JJ
cord-023095-4dannjjm	1839	24	-	-	JJ
cord-023095-4dannjjm	1839	25	azotemic	azotemic	JJ
cord-023095-4dannjjm	1839	26	,	,	,
cord-023095-4dannjjm	1839	27	is	be	VBZ
cord-023095-4dannjjm	1839	28	unclear	unclear	JJ
cord-023095-4dannjjm	1839	29	but	but	CC
cord-023095-4dannjjm	1839	30	may	may	MD
cord-023095-4dannjjm	1839	31	be	be	VB
cord-023095-4dannjjm	1839	32	related	relate	VBN
cord-023095-4dannjjm	1839	33	to	to	IN
cord-023095-4dannjjm	1839	34	the	the	DT
cord-023095-4dannjjm	1839	35	decline	decline	NN
cord-023095-4dannjjm	1839	36	in	in	IN
cord-023095-4dannjjm	1839	37	glomerular	glomerular	JJ
cord-023095-4dannjjm	1839	38	filtration	filtration	NN
cord-023095-4dannjjm	1839	39	rate	rate	NN
cord-023095-4dannjjm	1839	40	.	.	.
cord-023095-4dannjjm	1840	1	Hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	1840	2	is	be	VBZ
cord-023095-4dannjjm	1840	3	a	a	DT
cord-023095-4dannjjm	1840	4	disorder	disorder	NN
cord-023095-4dannjjm	1840	5	resulting	result	VBG
cord-023095-4dannjjm	1840	6	from	from	IN
cord-023095-4dannjjm	1840	7	the	the	DT
cord-023095-4dannjjm	1840	8	excessive	excessive	JJ
cord-023095-4dannjjm	1840	9	production	production	NN
cord-023095-4dannjjm	1840	10	and	and	CC
cord-023095-4dannjjm	1840	11	secretion	secretion	NN
cord-023095-4dannjjm	1840	12	of	of	IN
cord-023095-4dannjjm	1840	13	T4	T4	NNP
cord-023095-4dannjjm	1840	14	and	and	CC
cord-023095-4dannjjm	1840	15	T3	T3	NNP
cord-023095-4dannjjm	1840	16	by	by	IN
cord-023095-4dannjjm	1840	17	the	the	DT
cord-023095-4dannjjm	1840	18	thyroid	thyroid	NN
cord-023095-4dannjjm	1840	19	gland	gland	NN
cord-023095-4dannjjm	1840	20	.	.	.
cord-023095-4dannjjm	1841	1	Although	although	IN
cord-023095-4dannjjm	1841	2	the	the	DT
cord-023095-4dannjjm	1841	3	disorder	disorder	NN
cord-023095-4dannjjm	1841	4	and	and	CC
cord-023095-4dannjjm	1841	5	its	-PRON-	PRP$
cord-023095-4dannjjm	1841	6	pathological	pathological	JJ
cord-023095-4dannjjm	1841	7	lesions	lesion	NNS
cord-023095-4dannjjm	1841	8	have	have	VBP
cord-023095-4dannjjm	1841	9	been	be	VBN
cord-023095-4dannjjm	1841	10	well	well	RB
cord-023095-4dannjjm	1841	11	studied	study	VBN
cord-023095-4dannjjm	1841	12	and	and	CC
cord-023095-4dannjjm	1841	13	described	describe	VBD
cord-023095-4dannjjm	1841	14	the	the	DT
cord-023095-4dannjjm	1841	15	cause	cause	NN
cord-023095-4dannjjm	1841	16	remains	remain	VBZ
cord-023095-4dannjjm	1841	17	illusive	illusive	JJ
cord-023095-4dannjjm	1841	18	.	.	.
cord-023095-4dannjjm	1842	1	Whole	whole	JJ
cord-023095-4dannjjm	1842	2	blood	blood	NN
cord-023095-4dannjjm	1842	3	and	and	CC
cord-023095-4dannjjm	1842	4	solid	solid	JJ
cord-023095-4dannjjm	1842	5	tissue	tissue	NN
cord-023095-4dannjjm	1842	6	samples	sample	NNS
cord-023095-4dannjjm	1842	7	from	from	IN
cord-023095-4dannjjm	1842	8	non	non	JJ
cord-023095-4dannjjm	1842	9	-	-	JJ
cord-023095-4dannjjm	1842	10	diseased	diseased	JJ
cord-023095-4dannjjm	1842	11	,	,	,
cord-023095-4dannjjm	1842	12	severe	severe	JJ
cord-023095-4dannjjm	1842	13	disease	disease	NN
cord-023095-4dannjjm	1842	14	and	and	CC
cord-023095-4dannjjm	1842	15	mild	mild	JJ
cord-023095-4dannjjm	1842	16	disease	disease	NN
cord-023095-4dannjjm	1842	17	cats	cat	NNS
cord-023095-4dannjjm	1842	18	based	base	VBN
cord-023095-4dannjjm	1842	19	on	on	IN
cord-023095-4dannjjm	1842	20	T4	T4	NNP
cord-023095-4dannjjm	1842	21	levels	level	NNS
cord-023095-4dannjjm	1842	22	and	and	CC
cord-023095-4dannjjm	1842	23	thyroid	thyroid	NN
cord-023095-4dannjjm	1842	24	histology	histology	NN
cord-023095-4dannjjm	1842	25	were	be	VBD
cord-023095-4dannjjm	1842	26	used	use	VBN
cord-023095-4dannjjm	1842	27	in	in	IN
cord-023095-4dannjjm	1842	28	this	this	DT
cord-023095-4dannjjm	1842	29	study	study	NN
cord-023095-4dannjjm	1842	30	.	.	.
cord-023095-4dannjjm	1843	1	Whole	whole	JJ
cord-023095-4dannjjm	1843	2	blood	blood	NN
cord-023095-4dannjjm	1843	3	samples	sample	NNS
cord-023095-4dannjjm	1843	4	from	from	IN
cord-023095-4dannjjm	1843	5	29	29	CD
cord-023095-4dannjjm	1843	6	non	non	JJ
cord-023095-4dannjjm	1843	7	-	-	JJ
cord-023095-4dannjjm	1843	8	disease	disease	JJ
cord-023095-4dannjjm	1843	9	cats	cat	NNS
cord-023095-4dannjjm	1843	10	,	,	,
cord-023095-4dannjjm	1843	11	28	28	CD
cord-023095-4dannjjm	1843	12	severe	severe	JJ
cord-023095-4dannjjm	1843	13	disease	disease	NN
cord-023095-4dannjjm	1843	14	cats	cat	NNS
cord-023095-4dannjjm	1843	15	and	and	CC
cord-023095-4dannjjm	1843	16	17	17	CD
cord-023095-4dannjjm	1843	17	mild	mild	JJ
cord-023095-4dannjjm	1843	18	disease	disease	NN
cord-023095-4dannjjm	1843	19	cats	cat	NNS
cord-023095-4dannjjm	1843	20	as	as	RB
cord-023095-4dannjjm	1843	21	well	well	RB
cord-023095-4dannjjm	1843	22	as	as	IN
cord-023095-4dannjjm	1843	23	solid	solid	JJ
cord-023095-4dannjjm	1843	24	thyroid	thyroid	NN
cord-023095-4dannjjm	1843	25	tissue	tissue	NN
cord-023095-4dannjjm	1843	26	samples	sample	NNS
cord-023095-4dannjjm	1843	27	from	from	IN
cord-023095-4dannjjm	1843	28	30	30	CD
cord-023095-4dannjjm	1843	29	non	non	JJ
cord-023095-4dannjjm	1843	30	-	-	JJ
cord-023095-4dannjjm	1843	31	disease	disease	JJ
cord-023095-4dannjjm	1843	32	cats	cat	NNS
cord-023095-4dannjjm	1843	33	,	,	,
cord-023095-4dannjjm	1843	34	31	31	CD
cord-023095-4dannjjm	1843	35	severe	severe	JJ
cord-023095-4dannjjm	1843	36	disease	disease	NN
cord-023095-4dannjjm	1843	37	cats	cat	NNS
cord-023095-4dannjjm	1843	38	and	and	CC
cord-023095-4dannjjm	1843	39	27	27	CD
cord-023095-4dannjjm	1843	40	mild	mild	JJ
cord-023095-4dannjjm	1843	41	disease	disease	NN
cord-023095-4dannjjm	1843	42	cats	cat	NNS
cord-023095-4dannjjm	1843	43	were	be	VBD
cord-023095-4dannjjm	1843	44	collected	collect	VBN
cord-023095-4dannjjm	1843	45	and	and	CC
cord-023095-4dannjjm	1843	46	processed	process	VBN
cord-023095-4dannjjm	1843	47	.	.	.
cord-023095-4dannjjm	1844	1	The	the	DT
cord-023095-4dannjjm	1844	2	resulting	result	VBG
cord-023095-4dannjjm	1844	3	total	total	JJ
cord-023095-4dannjjm	1844	4	RNA	RNA	NNP
cord-023095-4dannjjm	1844	5	samples	sample	NNS
cord-023095-4dannjjm	1844	6	were	be	VBD
cord-023095-4dannjjm	1844	7	used	use	VBN
cord-023095-4dannjjm	1844	8	for	for	IN
cord-023095-4dannjjm	1844	9	GeneChip	GeneChip	NNP
cord-023095-4dannjjm	1844	10	analysis	analysis	NN
cord-023095-4dannjjm	1844	11	using	use	VBG
cord-023095-4dannjjm	1844	12	our	-PRON-	PRP$
cord-023095-4dannjjm	1844	13	custom	custom	NN
cord-023095-4dannjjm	1844	14	feline	feline	JJ
cord-023095-4dannjjm	1844	15	gene	gene	NN
cord-023095-4dannjjm	1844	16	chip	chip	NN
cord-023095-4dannjjm	1844	17	designed	design	VBN
cord-023095-4dannjjm	1844	18	by	by	IN
cord-023095-4dannjjm	1844	19	Affymetrix	Affymetrix	NNP
cord-023095-4dannjjm	1844	20	.	.	.
cord-023095-4dannjjm	1845	1	Data	data	NN
cord-023095-4dannjjm	1845	2	analysis	analysis	NN
cord-023095-4dannjjm	1845	3	was	be	VBD
cord-023095-4dannjjm	1845	4	performed	perform	VBN
cord-023095-4dannjjm	1845	5	using	use	VBG
cord-023095-4dannjjm	1845	6	The	the	DT
cord-023095-4dannjjm	1845	7	Partek	Partek	NNP
cord-023095-4dannjjm	1845	8	s	s	POS
cord-023095-4dannjjm	1845	9	GS	GS	NNP
cord-023095-4dannjjm	1845	10	software	software	NN
cord-023095-4dannjjm	1845	11	for	for	IN
cord-023095-4dannjjm	1845	12	Gene	Gene	NNP
cord-023095-4dannjjm	1845	13	Expression	Expression	NNP
cord-023095-4dannjjm	1845	14	data	datum	NNS
cord-023095-4dannjjm	1845	15	.	.	.
cord-023095-4dannjjm	1846	1	The	the	DT
cord-023095-4dannjjm	1846	2	Robust	Robust	NNP
cord-023095-4dannjjm	1846	3	Multichip	Multichip	NNP
cord-023095-4dannjjm	1846	4	Average	average	JJ
cord-023095-4dannjjm	1846	5	algorithm	algorithm	NN
cord-023095-4dannjjm	1846	6	was	be	VBD
cord-023095-4dannjjm	1846	7	used	use	VBN
cord-023095-4dannjjm	1846	8	for	for	IN
cord-023095-4dannjjm	1846	9	background	background	NN
cord-023095-4dannjjm	1846	10	adjustment	adjustment	NN
cord-023095-4dannjjm	1846	11	,	,	,
cord-023095-4dannjjm	1846	12	normalization	normalization	NN
cord-023095-4dannjjm	1846	13	,	,	,
cord-023095-4dannjjm	1846	14	and	and	CC
cord-023095-4dannjjm	1846	15	probe	probe	NN
cord-023095-4dannjjm	1846	16	-	-	HYPH
cord-023095-4dannjjm	1846	17	level	level	NN
cord-023095-4dannjjm	1846	18	summarization	summarization	NN
cord-023095-4dannjjm	1846	19	of	of	IN
cord-023095-4dannjjm	1846	20	the	the	DT
cord-023095-4dannjjm	1846	21	raw	raw	JJ
cord-023095-4dannjjm	1846	22	data	datum	NNS
cord-023095-4dannjjm	1846	23	.	.	.
cord-023095-4dannjjm	1847	1	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	1847	2	analysis	analysis	NN
cord-023095-4dannjjm	1847	3	was	be	VBD
cord-023095-4dannjjm	1847	4	performed	perform	VBN
cord-023095-4dannjjm	1847	5	to	to	TO
cord-023095-4dannjjm	1847	6	find	find	VB
cord-023095-4dannjjm	1847	7	significant	significant	JJ
cord-023095-4dannjjm	1847	8	differentially	differentially	RB
cord-023095-4dannjjm	1847	9	expressed	express	VBN
cord-023095-4dannjjm	1847	10	genes	gene	NNS
cord-023095-4dannjjm	1847	11	with	with	IN
cord-023095-4dannjjm	1847	12	a	a	DT
cord-023095-4dannjjm	1847	13	minimal	minimal	JJ
cord-023095-4dannjjm	1847	14	False	false	JJ
cord-023095-4dannjjm	1847	15	Discovery	discovery	NN
cord-023095-4dannjjm	1847	16	Rate	rate	NN
cord-023095-4dannjjm	1847	17	control	control	NN
cord-023095-4dannjjm	1847	18	of	of	IN
cord-023095-4dannjjm	1847	19	0.1	0.1	CD
cord-023095-4dannjjm	1847	20	and	and	CC
cord-023095-4dannjjm	1847	21	a	a	DT
cord-023095-4dannjjm	1847	22	fold	fold	JJ
cord-023095-4dannjjm	1847	23	change	change	NN
cord-023095-4dannjjm	1847	24	of	of	IN
cord-023095-4dannjjm	1847	25	1.3	1.3	CD
cord-023095-4dannjjm	1847	26	in	in	IN
cord-023095-4dannjjm	1847	27	each	each	DT
cord-023095-4dannjjm	1847	28	direction	direction	NN
cord-023095-4dannjjm	1847	29	.	.	.
cord-023095-4dannjjm	1848	1	During	during	IN
cord-023095-4dannjjm	1848	2	the	the	DT
cord-023095-4dannjjm	1848	3	mild	mild	JJ
cord-023095-4dannjjm	1848	4	disease	disease	NN
cord-023095-4dannjjm	1848	5	state	state	NN
cord-023095-4dannjjm	1848	6	,	,	,
cord-023095-4dannjjm	1848	7	pathways	pathway	NNS
cord-023095-4dannjjm	1848	8	associated	associate	VBN
cord-023095-4dannjjm	1848	9	with	with	IN
cord-023095-4dannjjm	1848	10	DNA	dna	NN
cord-023095-4dannjjm	1848	11	damage	damage	NN
cord-023095-4dannjjm	1848	12	and	and	CC
cord-023095-4dannjjm	1848	13	apoptosis	apoptosis	NN
cord-023095-4dannjjm	1848	14	are	be	VBP
cord-023095-4dannjjm	1848	15	most	most	RBS
cord-023095-4dannjjm	1848	16	prominent	prominent	JJ
cord-023095-4dannjjm	1848	17	.	.	.
cord-023095-4dannjjm	1849	1	At	at	IN
cord-023095-4dannjjm	1849	2	later	later	JJ
cord-023095-4dannjjm	1849	3	stages	stage	NNS
cord-023095-4dannjjm	1849	4	when	when	WRB
cord-023095-4dannjjm	1849	5	the	the	DT
cord-023095-4dannjjm	1849	6	histopathological	histopathological	JJ
cord-023095-4dannjjm	1849	7	disease	disease	NN
cord-023095-4dannjjm	1849	8	is	be	VBZ
cord-023095-4dannjjm	1849	9	more	more	RBR
cord-023095-4dannjjm	1849	10	severe	severe	JJ
cord-023095-4dannjjm	1849	11	in	in	IN
cord-023095-4dannjjm	1849	12	addition	addition	NN
cord-023095-4dannjjm	1849	13	to	to	IN
cord-023095-4dannjjm	1849	14	the	the	DT
cord-023095-4dannjjm	1849	15	aforementioned	aforementioned	JJ
cord-023095-4dannjjm	1849	16	pathways	pathway	NNS
cord-023095-4dannjjm	1849	17	others	other	NNS
cord-023095-4dannjjm	1849	18	associated	associate	VBN
cord-023095-4dannjjm	1849	19	with	with	IN
cord-023095-4dannjjm	1849	20	TGF	TGF	NNP
cord-023095-4dannjjm	1849	21	-	-	HYPH
cord-023095-4dannjjm	1849	22	beta	beta	NN
cord-023095-4dannjjm	1849	23	signaling	signaling	NN
cord-023095-4dannjjm	1849	24	,	,	,
cord-023095-4dannjjm	1849	25	cell	cell	NN
cord-023095-4dannjjm	1849	26	adhesion	adhesion	NN
cord-023095-4dannjjm	1849	27	and	and	CC
cord-023095-4dannjjm	1849	28	extracellular	extracellular	JJ
cord-023095-4dannjjm	1849	29	matrix	matrix	NN
cord-023095-4dannjjm	1849	30	remodeling	remodeling	NN
cord-023095-4dannjjm	1850	1	take	take	VB
cord-023095-4dannjjm	1850	2	more	more	JJR
cord-023095-4dannjjm	1850	3	prominence	prominence	NN
cord-023095-4dannjjm	1850	4	.	.	.
cord-023095-4dannjjm	1851	1	The	the	DT
cord-023095-4dannjjm	1851	2	analysis	analysis	NN
cord-023095-4dannjjm	1851	3	of	of	IN
cord-023095-4dannjjm	1851	4	this	this	DT
cord-023095-4dannjjm	1851	5	unique	unique	JJ
cord-023095-4dannjjm	1851	6	data	data	NN
cord-023095-4dannjjm	1851	7	set	set	NN
cord-023095-4dannjjm	1851	8	generated	generate	VBN
cord-023095-4dannjjm	1851	9	from	from	IN
cord-023095-4dannjjm	1851	10	the	the	DT
cord-023095-4dannjjm	1851	11	use	use	NN
cord-023095-4dannjjm	1851	12	of	of	IN
cord-023095-4dannjjm	1851	13	our	-PRON-	PRP$
cord-023095-4dannjjm	1851	14	proprietary	proprietary	JJ
cord-023095-4dannjjm	1851	15	GeneChip	GeneChip	NNP
cord-023095-4dannjjm	1851	16	revealed	reveal	VBD
cord-023095-4dannjjm	1851	17	molecular	molecular	JJ
cord-023095-4dannjjm	1851	18	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1851	19	that	that	WDT
cord-023095-4dannjjm	1851	20	are	be	VBP
cord-023095-4dannjjm	1851	21	associated	associate	VBN
cord-023095-4dannjjm	1851	22	with	with	IN
cord-023095-4dannjjm	1851	23	the	the	DT
cord-023095-4dannjjm	1851	24	transition	transition	NN
cord-023095-4dannjjm	1851	25	from	from	IN
cord-023095-4dannjjm	1851	26	non	non	JJ
cord-023095-4dannjjm	1851	27	-	-	JJ
cord-023095-4dannjjm	1851	28	disease	disease	JJ
cord-023095-4dannjjm	1851	29	,	,	,
cord-023095-4dannjjm	1851	30	to	to	IN
cord-023095-4dannjjm	1851	31	mild	mild	JJ
cord-023095-4dannjjm	1851	32	disease	disease	NN
cord-023095-4dannjjm	1851	33	to	to	IN
cord-023095-4dannjjm	1851	34	severe	severe	JJ
cord-023095-4dannjjm	1851	35	disease	disease	NN
cord-023095-4dannjjm	1851	36	,	,	,
cord-023095-4dannjjm	1851	37	in	in	IN
cord-023095-4dannjjm	1851	38	the	the	DT
cord-023095-4dannjjm	1851	39	thyroid	thyroid	NN
cord-023095-4dannjjm	1851	40	tissue	tissue	NN
cord-023095-4dannjjm	1851	41	as	as	RB
cord-023095-4dannjjm	1851	42	well	well	RB
cord-023095-4dannjjm	1851	43	as	as	IN
cord-023095-4dannjjm	1851	44	the	the	DT
cord-023095-4dannjjm	1851	45	blood	blood	NN
cord-023095-4dannjjm	1851	46	.	.	.
cord-023095-4dannjjm	1852	1	These	these	DT
cord-023095-4dannjjm	1852	2	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1852	3	could	could	MD
cord-023095-4dannjjm	1852	4	provide	provide	VB
cord-023095-4dannjjm	1852	5	insights	insight	NNS
cord-023095-4dannjjm	1852	6	into	into	IN
cord-023095-4dannjjm	1852	7	the	the	DT
cord-023095-4dannjjm	1852	8	causes	cause	NNS
cord-023095-4dannjjm	1852	9	of	of	IN
cord-023095-4dannjjm	1852	10	the	the	DT
cord-023095-4dannjjm	1852	11	disease	disease	NN
cord-023095-4dannjjm	1852	12	and	and	CC
cord-023095-4dannjjm	1852	13	identify	identify	VB
cord-023095-4dannjjm	1852	14	potential	potential	JJ
cord-023095-4dannjjm	1852	15	new	new	JJ
cord-023095-4dannjjm	1852	16	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	1852	17	and	and	CC
cord-023095-4dannjjm	1852	18	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	1852	19	targets	target	NNS
cord-023095-4dannjjm	1852	20	.	.	.
cord-023095-4dannjjm	1853	1	Although	although	IN
cord-023095-4dannjjm	1853	2	it	-PRON-	PRP
cord-023095-4dannjjm	1853	3	is	be	VBZ
cord-023095-4dannjjm	1853	4	well	well	RB
cord-023095-4dannjjm	1853	5	established	establish	VBN
cord-023095-4dannjjm	1853	6	that	that	IN
cord-023095-4dannjjm	1853	7	concurrent	concurrent	JJ
cord-023095-4dannjjm	1853	8	chronic	chronic	JJ
cord-023095-4dannjjm	1853	9	kidney	kidney	NN
cord-023095-4dannjjm	1853	10	disease	disease	NN
cord-023095-4dannjjm	1853	11	(	(	-LRB-
cord-023095-4dannjjm	1853	12	CKD	CKD	NNP
cord-023095-4dannjjm	1853	13	)	)	-RRB-
cord-023095-4dannjjm	1853	14	develops	develop	VBZ
cord-023095-4dannjjm	1853	15	in	in	IN
cord-023095-4dannjjm	1853	16	about	about	RB
cord-023095-4dannjjm	1853	17	30	30	CD
cord-023095-4dannjjm	1853	18	%	%	NN
cord-023095-4dannjjm	1853	19	of	of	IN
cord-023095-4dannjjm	1853	20	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	1853	21	cats	cat	NNS
cord-023095-4dannjjm	1853	22	,	,	,
cord-023095-4dannjjm	1853	23	no	no	DT
cord-023095-4dannjjm	1853	24	one	one	NN
cord-023095-4dannjjm	1853	25	has	have	VBZ
cord-023095-4dannjjm	1853	26	reported	report	VBN
cord-023095-4dannjjm	1853	27	the	the	DT
cord-023095-4dannjjm	1853	28	use	use	NN
cord-023095-4dannjjm	1853	29	of	of	IN
cord-023095-4dannjjm	1853	30	the	the	DT
cord-023095-4dannjjm	1853	31	IRIS	IRIS	NNP
cord-023095-4dannjjm	1853	32	staging	staging	NN
cord-023095-4dannjjm	1853	33	system	system	NN
cord-023095-4dannjjm	1853	34	for	for	IN
cord-023095-4dannjjm	1853	35	CKD	CKD	NNP
cord-023095-4dannjjm	1853	36	before	before	RB
cord-023095-4dannjjm	1853	37	and	and	CC
cord-023095-4dannjjm	1853	38	after	after	IN
cord-023095-4dannjjm	1853	39	treatment	treatment	NN
cord-023095-4dannjjm	1853	40	of	of	IN
cord-023095-4dannjjm	1853	41	these	these	DT
cord-023095-4dannjjm	1853	42	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	1853	43	cats	cat	NNS
cord-023095-4dannjjm	1853	44	.	.	.
cord-023095-4dannjjm	1854	1	The	the	DT
cord-023095-4dannjjm	1854	2	purpose	purpose	NN
cord-023095-4dannjjm	1854	3	of	of	IN
cord-023095-4dannjjm	1854	4	this	this	DT
cord-023095-4dannjjm	1854	5	study	study	NN
cord-023095-4dannjjm	1854	6	was	be	VBD
cord-023095-4dannjjm	1854	7	to	to	TO
cord-023095-4dannjjm	1854	8	compare	compare	VB
cord-023095-4dannjjm	1854	9	the	the	DT
cord-023095-4dannjjm	1854	10	effects	effect	NNS
cord-023095-4dannjjm	1854	11	of	of	IN
cord-023095-4dannjjm	1854	12	treatment	treatment	NN
cord-023095-4dannjjm	1854	13	in	in	IN
cord-023095-4dannjjm	1854	14	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	1854	15	cats	cat	NNS
cord-023095-4dannjjm	1854	16	with	with	IN
cord-023095-4dannjjm	1854	17	known	know	VBN
cord-023095-4dannjjm	1854	18	stage	stage	NN
cord-023095-4dannjjm	1854	19	1	1	CD
cord-023095-4dannjjm	1854	20	and	and	CC
cord-023095-4dannjjm	1854	21	2	2	CD
cord-023095-4dannjjm	1854	22	CKD	CKD	NNP
cord-023095-4dannjjm	1854	23	in	in	IN
cord-023095-4dannjjm	1854	24	order	order	NN
cord-023095-4dannjjm	1854	25	to	to	TO
cord-023095-4dannjjm	1854	26	determine	determine	VB
cord-023095-4dannjjm	1854	27	the	the	DT
cord-023095-4dannjjm	1854	28	effects	effect	NNS
cord-023095-4dannjjm	1854	29	of	of	IN
cord-023095-4dannjjm	1854	30	restoring	restore	VBG
cord-023095-4dannjjm	1854	31	euthyroidism	euthyroidism	NN
cord-023095-4dannjjm	1854	32	or	or	CC
cord-023095-4dannjjm	1854	33	inducing	inducing	JJ
cord-023095-4dannjjm	1854	34	hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	1854	35	has	have	VBZ
cord-023095-4dannjjm	1854	36	on	on	IN
cord-023095-4dannjjm	1854	37	the	the	DT
cord-023095-4dannjjm	1854	38	IRIS	IRIS	NNP
cord-023095-4dannjjm	1854	39	stage	stage	NN
cord-023095-4dannjjm	1854	40	in	in	IN
cord-023095-4dannjjm	1854	41	these	these	DT
cord-023095-4dannjjm	1854	42	cats	cat	NNS
cord-023095-4dannjjm	1854	43	.	.	.
cord-023095-4dannjjm	1855	1	We	-PRON-	PRP
cord-023095-4dannjjm	1855	2	evaluated	evaluate	VBD
cord-023095-4dannjjm	1855	3	36	36	CD
cord-023095-4dannjjm	1855	4	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	1855	5	cats	cat	NNS
cord-023095-4dannjjm	1855	6	(	(	-LRB-
cord-023095-4dannjjm	1855	7	median	median	JJ
cord-023095-4dannjjm	1855	8	age	age	NN
cord-023095-4dannjjm	1855	9	,	,	,
cord-023095-4dannjjm	1855	10	14	14	CD
cord-023095-4dannjjm	1855	11	years	year	NNS
cord-023095-4dannjjm	1855	12	)	)	-RRB-
cord-023095-4dannjjm	1855	13	in	in	IN
cord-023095-4dannjjm	1855	14	this	this	DT
cord-023095-4dannjjm	1855	15	study	study	NN
cord-023095-4dannjjm	1855	16	.	.	.
cord-023095-4dannjjm	1856	1	One	one	CD
cord-023095-4dannjjm	1856	2	day	day	NN
cord-023095-4dannjjm	1856	3	prior	prior	RB
cord-023095-4dannjjm	1856	4	to	to	IN
cord-023095-4dannjjm	1856	5	treatment	treatment	NN
cord-023095-4dannjjm	1856	6	,	,	,
cord-023095-4dannjjm	1856	7	serum	serum	NN
cord-023095-4dannjjm	1856	8	T	t	NN
cord-023095-4dannjjm	1856	9	4	4	CD
cord-023095-4dannjjm	1856	10	concentration	concentration	NN
cord-023095-4dannjjm	1856	11	,	,	,
cord-023095-4dannjjm	1856	12	serum	serum	NN
cord-023095-4dannjjm	1856	13	chemistry	chemistry	NN
cord-023095-4dannjjm	1856	14	analysis	analysis	NN
cord-023095-4dannjjm	1856	15	,	,	,
cord-023095-4dannjjm	1856	16	complete	complete	JJ
cord-023095-4dannjjm	1856	17	urinalysis	urinalysis	NN
cord-023095-4dannjjm	1856	18	,	,	,
cord-023095-4dannjjm	1856	19	and	and	CC
cord-023095-4dannjjm	1856	20	urine	urine	NN
cord-023095-4dannjjm	1856	21	protein	protein	NN
cord-023095-4dannjjm	1856	22	-	-	HYPH
cord-023095-4dannjjm	1856	23	to	to	IN
cord-023095-4dannjjm	1856	24	-	-	HYPH
cord-023095-4dannjjm	1856	25	creatinine	creatinine	NN
cord-023095-4dannjjm	1856	26	ratio	ratio	NN
cord-023095-4dannjjm	1856	27	(	(	-LRB-
cord-023095-4dannjjm	1856	28	UPC	UPC	NNP
cord-023095-4dannjjm	1856	29	)	)	-RRB-
cord-023095-4dannjjm	1856	30	were	be	VBD
cord-023095-4dannjjm	1856	31	measured	measure	VBN
cord-023095-4dannjjm	1856	32	.	.	.
cord-023095-4dannjjm	1857	1	All	all	DT
cord-023095-4dannjjm	1857	2	cats	cat	NNS
cord-023095-4dannjjm	1857	3	were	be	VBD
cord-023095-4dannjjm	1857	4	again	again	RB
cord-023095-4dannjjm	1857	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	1857	6	with	with	IN
cord-023095-4dannjjm	1857	7	the	the	DT
cord-023095-4dannjjm	1857	8	same	same	JJ
cord-023095-4dannjjm	1857	9	parameters	parameter	NNS
cord-023095-4dannjjm	1857	10	again	again	RB
cord-023095-4dannjjm	1857	11	3	3	CD
cord-023095-4dannjjm	1857	12	months	month	NNS
cord-023095-4dannjjm	1857	13	after	after	IN
cord-023095-4dannjjm	1857	14	treatment	treatment	NN
cord-023095-4dannjjm	1857	15	with	with	IN
cord-023095-4dannjjm	1857	16	131	131	CD
cord-023095-4dannjjm	1857	17	I.	i.	NN
cord-023095-4dannjjm	1857	18	Prior	Prior	NNP
cord-023095-4dannjjm	1857	19	to	to	IN
cord-023095-4dannjjm	1857	20	treatment	treatment	NN
cord-023095-4dannjjm	1857	21	,	,	,
cord-023095-4dannjjm	1857	22	26	26	CD
cord-023095-4dannjjm	1857	23	(	(	-LRB-
cord-023095-4dannjjm	1857	24	72	72	CD
cord-023095-4dannjjm	1857	25	%	%	NN
cord-023095-4dannjjm	1857	26	)	)	-RRB-
cord-023095-4dannjjm	1857	27	of	of	IN
cord-023095-4dannjjm	1857	28	the	the	DT
cord-023095-4dannjjm	1857	29	36	36	CD
cord-023095-4dannjjm	1857	30	cats	cat	NNS
cord-023095-4dannjjm	1857	31	had	have	VBD
cord-023095-4dannjjm	1857	32	no	no	DT
cord-023095-4dannjjm	1857	33	evidence	evidence	NN
cord-023095-4dannjjm	1857	34	of	of	IN
cord-023095-4dannjjm	1857	35	azotemia	azotemia	NNP
cord-023095-4dannjjm	1857	36	(	(	-LRB-
cord-023095-4dannjjm	1857	37	serum	serum	NN
cord-023095-4dannjjm	1857	38	creatinine	creatinine	NN
cord-023095-4dannjjm	1857	39	o	o	NNP
cord-023095-4dannjjm	1857	40	1.6	1.6	CD
cord-023095-4dannjjm	1857	41	mg	mg	NNP
cord-023095-4dannjjm	1857	42	/	/	SYM
cord-023095-4dannjjm	1857	43	dl	dl	NNP
cord-023095-4dannjjm	1857	44	)	)	-RRB-
cord-023095-4dannjjm	1857	45	,	,	,
cord-023095-4dannjjm	1857	46	whereas	whereas	IN
cord-023095-4dannjjm	1857	47	10	10	CD
cord-023095-4dannjjm	1857	48	cats	cat	NNS
cord-023095-4dannjjm	1857	49	(	(	-LRB-
cord-023095-4dannjjm	1857	50	28	28	CD
cord-023095-4dannjjm	1857	51	%	%	NN
cord-023095-4dannjjm	1857	52	)	)	-RRB-
cord-023095-4dannjjm	1857	53	had	have	VBD
cord-023095-4dannjjm	1857	54	stage	stage	NN
cord-023095-4dannjjm	1857	55	2	2	CD
cord-023095-4dannjjm	1857	56	CKD	CKD	NNP
cord-023095-4dannjjm	1857	57	(	(	-LRB-
cord-023095-4dannjjm	1857	58	serum	serum	NN
cord-023095-4dannjjm	1857	59	creatinine	creatinine	NN
cord-023095-4dannjjm	1857	60	,	,	,
cord-023095-4dannjjm	1857	61	1.6	1.6	CD
cord-023095-4dannjjm	1857	62	-	-	SYM
cord-023095-4dannjjm	1857	63	2.8	2.8	CD
cord-023095-4dannjjm	1857	64	mg	mg	NNP
cord-023095-4dannjjm	1857	65	/	/	SYM
cord-023095-4dannjjm	1857	66	dl	dl	NNP
cord-023095-4dannjjm	1857	67	)	)	-RRB-
cord-023095-4dannjjm	1857	68	.	.	.
cord-023095-4dannjjm	1858	1	In	in	IN
cord-023095-4dannjjm	1858	2	the	the	DT
cord-023095-4dannjjm	1858	3	36	36	CD
cord-023095-4dannjjm	1858	4	cats	cat	NNS
cord-023095-4dannjjm	1858	5	,	,	,
cord-023095-4dannjjm	1858	6	IRIS	IRIS	NNP
cord-023095-4dannjjm	1858	7	staging	stage	VBG
cord-023095-4dannjjm	1858	8	revealed	reveal	VBD
cord-023095-4dannjjm	1858	9	proteinuria	proteinuria	NN
cord-023095-4dannjjm	1858	10	in	in	IN
cord-023095-4dannjjm	1858	11	33	33	CD
cord-023095-4dannjjm	1858	12	cats	cat	NNS
cord-023095-4dannjjm	1858	13	(	(	-LRB-
cord-023095-4dannjjm	1858	14	92	92	CD
cord-023095-4dannjjm	1858	15	%	%	NN
cord-023095-4dannjjm	1858	16	)	)	-RRB-
cord-023095-4dannjjm	1858	17	,	,	,
cord-023095-4dannjjm	1858	18	21	21	CD
cord-023095-4dannjjm	1858	19	with	with	IN
cord-023095-4dannjjm	1858	20	borderline	borderline	JJ
cord-023095-4dannjjm	1858	21	proteinuria	proteinuria	NN
cord-023095-4dannjjm	1858	22	(	(	-LRB-
cord-023095-4dannjjm	1858	23	UPC	UPC	NNP
cord-023095-4dannjjm	1858	24	,	,	,
cord-023095-4dannjjm	1858	25	0.2	0.2	CD
cord-023095-4dannjjm	1858	26	-	-	SYM
cord-023095-4dannjjm	1858	27	0.4	0.4	CD
cord-023095-4dannjjm	1858	28	)	)	-RRB-
cord-023095-4dannjjm	1858	29	and	and	CC
cord-023095-4dannjjm	1858	30	12	12	CD
cord-023095-4dannjjm	1858	31	with	with	IN
cord-023095-4dannjjm	1858	32	overt	overt	JJ
cord-023095-4dannjjm	1858	33	proteinuria	proteinuria	NN
cord-023095-4dannjjm	1858	34	(	(	-LRB-
cord-023095-4dannjjm	1858	35	UPC	UPC	NNP
cord-023095-4dannjjm	1858	36	4	4	CD
cord-023095-4dannjjm	1858	37	0.4	0.4	CD
cord-023095-4dannjjm	1858	38	)	)	-RRB-
cord-023095-4dannjjm	1858	39	.	.	.
cord-023095-4dannjjm	1859	1	Hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	1859	2	was	be	VBD
cord-023095-4dannjjm	1859	3	cured	cure	VBN
cord-023095-4dannjjm	1859	4	in	in	IN
cord-023095-4dannjjm	1859	5	all	all	DT
cord-023095-4dannjjm	1859	6	36	36	CD
cord-023095-4dannjjm	1859	7	cats	cat	NNS
cord-023095-4dannjjm	1859	8	(	(	-LRB-
cord-023095-4dannjjm	1859	9	median	median	JJ
cord-023095-4dannjjm	1859	10	post	post	JJ
cord-023095-4dannjjm	1859	11	-	-	JJ
cord-023095-4dannjjm	1859	12	T4	T4	NNP
cord-023095-4dannjjm	1859	13	,	,	,
cord-023095-4dannjjm	1859	14	1.3	1.3	CD
cord-023095-4dannjjm	1859	15	mg	mg	NNP
cord-023095-4dannjjm	1859	16	/	/	SYM
cord-023095-4dannjjm	1859	17	dl	dl	NNP
cord-023095-4dannjjm	1859	18	)	)	-RRB-
cord-023095-4dannjjm	1859	19	.	.	.
cord-023095-4dannjjm	1860	1	All	all	DT
cord-023095-4dannjjm	1860	2	cats	cat	NNS
cord-023095-4dannjjm	1860	3	had	have	VBD
cord-023095-4dannjjm	1860	4	a	a	DT
cord-023095-4dannjjm	1860	5	good	good	JJ
cord-023095-4dannjjm	1860	6	response	response	NN
cord-023095-4dannjjm	1860	7	to	to	IN
cord-023095-4dannjjm	1860	8	treatment	treatment	NN
cord-023095-4dannjjm	1860	9	;	;	:
cord-023095-4dannjjm	1860	10	there	there	EX
cord-023095-4dannjjm	1860	11	were	be	VBD
cord-023095-4dannjjm	1860	12	no	no	DT
cord-023095-4dannjjm	1860	13	signs	sign	NNS
cord-023095-4dannjjm	1860	14	of	of	IN
cord-023095-4dannjjm	1860	15	CKD	CKD	NNP
cord-023095-4dannjjm	1860	16	except	except	IN
cord-023095-4dannjjm	1860	17	for	for	IN
cord-023095-4dannjjm	1860	18	polyuria	polyuria	NN
cord-023095-4dannjjm	1860	19	and	and	CC
cord-023095-4dannjjm	1860	20	polydipsia	polydipsia	NN
cord-023095-4dannjjm	1860	21	in	in	IN
cord-023095-4dannjjm	1860	22	some	some	DT
cord-023095-4dannjjm	1860	23	cats	cat	NNS
cord-023095-4dannjjm	1860	24	.	.	.
cord-023095-4dannjjm	1861	1	A	a	DT
cord-023095-4dannjjm	1861	2	significant	significant	JJ
cord-023095-4dannjjm	1861	3	(	(	-LRB-
cord-023095-4dannjjm	1861	4	P	p	NN
cord-023095-4dannjjm	1861	5	o	o	NN
cord-023095-4dannjjm	1861	6	0.001	0.001	CD
cord-023095-4dannjjm	1861	7	)	)	-RRB-
cord-023095-4dannjjm	1861	8	increase	increase	NN
cord-023095-4dannjjm	1861	9	in	in	IN
cord-023095-4dannjjm	1861	10	median	median	JJ
cord-023095-4dannjjm	1861	11	values	value	NNS
cord-023095-4dannjjm	1861	12	for	for	IN
cord-023095-4dannjjm	1861	13	both	both	DT
cord-023095-4dannjjm	1861	14	serum	serum	NN
cord-023095-4dannjjm	1861	15	urea	urea	NN
cord-023095-4dannjjm	1861	16	nitrogen	nitrogen	NN
cord-023095-4dannjjm	1861	17	(	(	-LRB-
cord-023095-4dannjjm	1861	18	26	26	CD
cord-023095-4dannjjm	1861	19	mg	mg	NNP
cord-023095-4dannjjm	1861	20	/	/	SYM
cord-023095-4dannjjm	1861	21	dl	dl	NNP
cord-023095-4dannjjm	1861	22	to	to	IN
cord-023095-4dannjjm	1861	23	31	31	CD
cord-023095-4dannjjm	1861	24	mg	mg	NNP
cord-023095-4dannjjm	1861	25	/	/	SYM
cord-023095-4dannjjm	1861	26	dl	dl	NNP
cord-023095-4dannjjm	1861	27	)	)	-RRB-
cord-023095-4dannjjm	1861	28	)	)	-RRB-
cord-023095-4dannjjm	1861	29	and	and	CC
cord-023095-4dannjjm	1861	30	creatinine	creatinine	NN
cord-023095-4dannjjm	1861	31	(	(	-LRB-
cord-023095-4dannjjm	1861	32	1.1	1.1	CD
cord-023095-4dannjjm	1861	33	to	to	TO
cord-023095-4dannjjm	1861	34	1.7	1.7	CD
cord-023095-4dannjjm	1861	35	mg	mg	NNP
cord-023095-4dannjjm	1861	36	/	/	SYM
cord-023095-4dannjjm	1861	37	dl	dl	NNP
cord-023095-4dannjjm	1861	38	)	)	-RRB-
cord-023095-4dannjjm	1861	39	occurred	occur	VBD
cord-023095-4dannjjm	1861	40	after	after	IN
cord-023095-4dannjjm	1861	41	treatment	treatment	NN
cord-023095-4dannjjm	1861	42	.	.	.
cord-023095-4dannjjm	1862	1	Nine	nine	CD
cord-023095-4dannjjm	1862	2	of	of	IN
cord-023095-4dannjjm	1862	3	the	the	DT
cord-023095-4dannjjm	1862	4	26	26	CD
cord-023095-4dannjjm	1862	5	cats	cat	NNS
cord-023095-4dannjjm	1862	6	(	(	-LRB-
cord-023095-4dannjjm	1862	7	34.6	34.6	CD
cord-023095-4dannjjm	1862	8	%	%	NN
cord-023095-4dannjjm	1862	9	)	)	-RRB-
cord-023095-4dannjjm	1862	10	classified	classify	VBN
cord-023095-4dannjjm	1862	11	as	as	IN
cord-023095-4dannjjm	1862	12	nonazotemic	nonazotemic	JJ
cord-023095-4dannjjm	1862	13	or	or	CC
cord-023095-4dannjjm	1862	14	IRIS	IRIS	NNP
cord-023095-4dannjjm	1862	15	stage	stage	NN
cord-023095-4dannjjm	1862	16	1	1	CD
cord-023095-4dannjjm	1862	17	prior	prior	RB
cord-023095-4dannjjm	1862	18	to	to	IN
cord-023095-4dannjjm	1862	19	131	131	CD
cord-023095-4dannjjm	1863	1	I	-PRON-	PRP
cord-023095-4dannjjm	1863	2	progressed	progress	VBD
cord-023095-4dannjjm	1863	3	to	to	TO
cord-023095-4dannjjm	1863	4	stage	stage	VB
cord-023095-4dannjjm	1863	5	2	2	CD
cord-023095-4dannjjm	1863	6	CKD	CKD	NNP
cord-023095-4dannjjm	1863	7	after	after	IN
cord-023095-4dannjjm	1863	8	131	131	CD
cord-023095-4dannjjm	1863	9	I.	i.	NN
cord-023095-4dannjjm	1864	1	All	all	DT
cord-023095-4dannjjm	1864	2	10	10	CD
cord-023095-4dannjjm	1864	3	cats	cat	NNS
cord-023095-4dannjjm	1864	4	with	with	IN
cord-023095-4dannjjm	1864	5	stage	stage	NN
cord-023095-4dannjjm	1864	6	2	2	CD
cord-023095-4dannjjm	1864	7	CKD	CKD	NNP
cord-023095-4dannjjm	1864	8	before	before	IN
cord-023095-4dannjjm	1864	9	treatment	treatment	NN
cord-023095-4dannjjm	1864	10	remained	remain	VBD
cord-023095-4dannjjm	1864	11	azotemic	azotemic	JJ
cord-023095-4dannjjm	1864	12	after	after	IN
cord-023095-4dannjjm	1864	13	131	131	CD
cord-023095-4dannjjm	1864	14	I	I	NNP
cord-023095-4dannjjm	1864	15	,	,	,
cord-023095-4dannjjm	1864	16	with	with	IN
cord-023095-4dannjjm	1864	17	5	5	CD
cord-023095-4dannjjm	1864	18	cats	cat	NNS
cord-023095-4dannjjm	1864	19	remaining	remain	VBG
cord-023095-4dannjjm	1864	20	in	in	IN
cord-023095-4dannjjm	1864	21	stage	stage	NN
cord-023095-4dannjjm	1864	22	2	2	CD
cord-023095-4dannjjm	1864	23	CKD	CKD	NNP
cord-023095-4dannjjm	1864	24	,	,	,
cord-023095-4dannjjm	1864	25	and	and	CC
cord-023095-4dannjjm	1864	26	4	4	CD
cord-023095-4dannjjm	1864	27	cats	cat	NNS
cord-023095-4dannjjm	1864	28	progressing	progress	VBG
cord-023095-4dannjjm	1864	29	to	to	IN
cord-023095-4dannjjm	1864	30	stage	stage	VB
cord-023095-4dannjjm	1864	31	3	3	CD
cord-023095-4dannjjm	1864	32	CKD	CKD	NNP
cord-023095-4dannjjm	1864	33	(	(	-LRB-
cord-023095-4dannjjm	1864	34	serum	serum	NN
cord-023095-4dannjjm	1864	35	creatinine	creatinine	NN
cord-023095-4dannjjm	1864	36	,	,	,
cord-023095-4dannjjm	1864	37	3.1	3.1	CD
cord-023095-4dannjjm	1864	38	-	-	SYM
cord-023095-4dannjjm	1864	39	3.7	3.7	CD
cord-023095-4dannjjm	1864	40	mg	mg	NNP
cord-023095-4dannjjm	1864	41	/	/	SYM
cord-023095-4dannjjm	1864	42	dl	dl	NN
cord-023095-4dannjjm	1864	43	)	)	-RRB-
cord-023095-4dannjjm	1864	44	.	.	.
cord-023095-4dannjjm	1865	1	There	there	EX
cord-023095-4dannjjm	1865	2	was	be	VBD
cord-023095-4dannjjm	1865	3	a	a	DT
cord-023095-4dannjjm	1865	4	significant	significant	JJ
cord-023095-4dannjjm	1865	5	inverse	inverse	NN
cord-023095-4dannjjm	1865	6	relationship	relationship	NN
cord-023095-4dannjjm	1865	7	(	(	-LRB-
cord-023095-4dannjjm	1865	8	P	p	NN
cord-023095-4dannjjm	1865	9	5	5	CD
cord-023095-4dannjjm	1865	10	0.002	0.002	CD
cord-023095-4dannjjm	1865	11	)	)	-RRB-
cord-023095-4dannjjm	1865	12	between	between	IN
cord-023095-4dannjjm	1865	13	pretreatment	pretreatment	NN
cord-023095-4dannjjm	1865	14	urine	urine	NN
cord-023095-4dannjjm	1865	15	specific	specific	JJ
cord-023095-4dannjjm	1865	16	gravity	gravity	NN
cord-023095-4dannjjm	1865	17	(	(	-LRB-
cord-023095-4dannjjm	1865	18	USG	USG	NNP
cord-023095-4dannjjm	1865	19	)	)	-RRB-
cord-023095-4dannjjm	1865	20	and	and	CC
cord-023095-4dannjjm	1865	21	post	post	JJ
cord-023095-4dannjjm	1865	22	-	-	JJ
cord-023095-4dannjjm	1865	23	treatment	treatment	JJ
cord-023095-4dannjjm	1865	24	serum	serum	NN
cord-023095-4dannjjm	1865	25	creatinine	creatinine	NN
cord-023095-4dannjjm	1865	26	in	in	IN
cord-023095-4dannjjm	1865	27	the	the	DT
cord-023095-4dannjjm	1865	28	36	36	CD
cord-023095-4dannjjm	1865	29	cats	cat	NNS
cord-023095-4dannjjm	1865	30	.	.	.
cord-023095-4dannjjm	1866	1	Of	of	IN
cord-023095-4dannjjm	1866	2	the	the	DT
cord-023095-4dannjjm	1866	3	19	19	CD
cord-023095-4dannjjm	1866	4	cats	cat	NNS
cord-023095-4dannjjm	1866	5	with	with	IN
cord-023095-4dannjjm	1866	6	post	post	JJ
cord-023095-4dannjjm	1866	7	-	-	JJ
cord-023095-4dannjjm	1866	8	treatment	treatment	JJ
cord-023095-4dannjjm	1866	9	serum	serum	NN
cord-023095-4dannjjm	1866	10	creatinine	creatinine	NN
cord-023095-4dannjjm	1866	11	values	value	NNS
cord-023095-4dannjjm	1866	12	4	4	CD
cord-023095-4dannjjm	1866	13	1.5	1.5	CD
cord-023095-4dannjjm	1866	14	mg	mg	NNP
cord-023095-4dannjjm	1866	15	/	/	SYM
cord-023095-4dannjjm	1866	16	dl	dl	NNP
cord-023095-4dannjjm	1866	17	(	(	-LRB-
cord-023095-4dannjjm	1866	18	stage	stage	NN
cord-023095-4dannjjm	1866	19	2	2	CD
cord-023095-4dannjjm	1866	20	to	to	IN
cord-023095-4dannjjm	1866	21	3	3	CD
cord-023095-4dannjjm	1866	22	CKD	CKD	NNP
cord-023095-4dannjjm	1866	23	)	)	-RRB-
cord-023095-4dannjjm	1866	24	,	,	,
cord-023095-4dannjjm	1866	25	15	15	CD
cord-023095-4dannjjm	1866	26	(	(	-LRB-
cord-023095-4dannjjm	1866	27	79	79	CD
cord-023095-4dannjjm	1866	28	%	%	NN
cord-023095-4dannjjm	1866	29	)	)	-RRB-
cord-023095-4dannjjm	1866	30	had	have	VBD
cord-023095-4dannjjm	1866	31	pretreatment	pretreatment	NN
cord-023095-4dannjjm	1866	32	USG	USG	NNP
cord-023095-4dannjjm	1866	33	of	of	IN
cord-023095-4dannjjm	1866	34	o	o	CD
cord-023095-4dannjjm	1866	35	1.040	1.040	CD
cord-023095-4dannjjm	1866	36	.	.	.
cord-023095-4dannjjm	1867	1	In	in	IN
cord-023095-4dannjjm	1867	2	contrast	contrast	NN
cord-023095-4dannjjm	1867	3	,	,	,
cord-023095-4dannjjm	1867	4	in	in	IN
cord-023095-4dannjjm	1867	5	the	the	DT
cord-023095-4dannjjm	1867	6	17	17	CD
cord-023095-4dannjjm	1867	7	cats	cat	NNS
cord-023095-4dannjjm	1867	8	with	with	IN
cord-023095-4dannjjm	1867	9	post	post	JJ
cord-023095-4dannjjm	1867	10	-	-	JJ
cord-023095-4dannjjm	1867	11	treatment	treatment	JJ
cord-023095-4dannjjm	1867	12	serum	serum	NN
cord-023095-4dannjjm	1867	13	creatinine	creatinine	NN
cord-023095-4dannjjm	1867	14	values	value	NNS
cord-023095-4dannjjm	1867	15	o	o	CD
cord-023095-4dannjjm	1867	16	1.5	1.5	CD
cord-023095-4dannjjm	1867	17	mg	mg	NNP
cord-023095-4dannjjm	1867	18	/	/	SYM
cord-023095-4dannjjm	1867	19	dl	dl	NNP
cord-023095-4dannjjm	1867	20	,	,	,
cord-023095-4dannjjm	1867	21	only	only	RB
cord-023095-4dannjjm	1867	22	3	3	CD
cord-023095-4dannjjm	1867	23	(	(	-LRB-
cord-023095-4dannjjm	1867	24	18	18	CD
cord-023095-4dannjjm	1867	25	%	%	NN
cord-023095-4dannjjm	1867	26	)	)	-RRB-
cord-023095-4dannjjm	1867	27	had	have	VBD
cord-023095-4dannjjm	1867	28	pretreatment	pretreatment	NN
cord-023095-4dannjjm	1867	29	USG	USG	NNP
cord-023095-4dannjjm	1867	30	of	of	IN
cord-023095-4dannjjm	1867	31	o	o	CD
cord-023095-4dannjjm	1867	32	1.040	1.040	CD
cord-023095-4dannjjm	1867	33	.	.	.
cord-023095-4dannjjm	1868	1	A	a	DT
cord-023095-4dannjjm	1868	2	significant	significant	JJ
cord-023095-4dannjjm	1868	3	(	(	-LRB-
cord-023095-4dannjjm	1868	4	P	p	NN
cord-023095-4dannjjm	1868	5	o	o	NN
cord-023095-4dannjjm	1868	6	0.001	0.001	CD
cord-023095-4dannjjm	1868	7	)	)	-RRB-
cord-023095-4dannjjm	1868	8	decrease	decrease	NN
cord-023095-4dannjjm	1868	9	in	in	IN
cord-023095-4dannjjm	1868	10	median	median	JJ
cord-023095-4dannjjm	1868	11	UPC	UPC	NNP
cord-023095-4dannjjm	1868	12	from	from	IN
cord-023095-4dannjjm	1868	13	0.3	0.3	CD
cord-023095-4dannjjm	1868	14	to	to	IN
cord-023095-4dannjjm	1868	15	0.1	0.1	CD
cord-023095-4dannjjm	1868	16	occurred	occur	VBD
cord-023095-4dannjjm	1868	17	after	after	IN
cord-023095-4dannjjm	1868	18	treatment	treatment	NN
cord-023095-4dannjjm	1868	19	,	,	,
cord-023095-4dannjjm	1868	20	but	but	CC
cord-023095-4dannjjm	1868	21	there	there	EX
cord-023095-4dannjjm	1868	22	was	be	VBD
cord-023095-4dannjjm	1868	23	no	no	DT
cord-023095-4dannjjm	1868	24	relationship	relationship	NN
cord-023095-4dannjjm	1868	25	between	between	IN
cord-023095-4dannjjm	1868	26	degree	degree	NN
cord-023095-4dannjjm	1868	27	of	of	IN
cord-023095-4dannjjm	1868	28	proteinuria	proteinuria	NN
cord-023095-4dannjjm	1868	29	and	and	CC
cord-023095-4dannjjm	1868	30	IRIS	IRIS	NNP
cord-023095-4dannjjm	1868	31	stage	stage	NN
cord-023095-4dannjjm	1868	32	in	in	IN
cord-023095-4dannjjm	1868	33	these	these	DT
cord-023095-4dannjjm	1868	34	cats	cat	NNS
cord-023095-4dannjjm	1868	35	.	.	.
cord-023095-4dannjjm	1869	1	Two	two	CD
cord-023095-4dannjjm	1869	2	cats	cat	NNS
cord-023095-4dannjjm	1869	3	developed	develop	VBD
cord-023095-4dannjjm	1869	4	iatrogenic	iatrogenic	JJ
cord-023095-4dannjjm	1869	5	hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	1869	6	after	after	IN
cord-023095-4dannjjm	1869	7	131	131	CD
cord-023095-4dannjjm	1869	8	I	i	NN
cord-023095-4dannjjm	1869	9	,	,	,
cord-023095-4dannjjm	1869	10	diagnosed	diagnose	VBN
cord-023095-4dannjjm	1869	11	by	by	IN
cord-023095-4dannjjm	1869	12	finding	find	VBG
cord-023095-4dannjjm	1869	13	low	low	JJ
cord-023095-4dannjjm	1869	14	serum	serum	NN
cord-023095-4dannjjm	1869	15	T	T	NNP
cord-023095-4dannjjm	1869	16	4	4	CD
cord-023095-4dannjjm	1869	17	and	and	CC
cord-023095-4dannjjm	1869	18	high	high	JJ
cord-023095-4dannjjm	1869	19	cTSH	cTSH	NNP
cord-023095-4dannjjm	1869	20	concentrations	concentration	NNS
cord-023095-4dannjjm	1869	21	.	.	.
cord-023095-4dannjjm	1870	1	Both	both	DT
cord-023095-4dannjjm	1870	2	hypothyroid	hypothyroid	JJ
cord-023095-4dannjjm	1870	3	cats	cat	NNS
cord-023095-4dannjjm	1870	4	had	have	VBD
cord-023095-4dannjjm	1870	5	progressed	progress	VBN
cord-023095-4dannjjm	1870	6	from	from	IN
cord-023095-4dannjjm	1870	7	stage	stage	NN
cord-023095-4dannjjm	1870	8	1	1	CD
cord-023095-4dannjjm	1870	9	before	before	IN
cord-023095-4dannjjm	1870	10	treatment	treatment	NN
cord-023095-4dannjjm	1870	11	to	to	IN
cord-023095-4dannjjm	1870	12	stage	stage	VB
cord-023095-4dannjjm	1870	13	2	2	CD
cord-023095-4dannjjm	1870	14	and	and	CC
cord-023095-4dannjjm	1870	15	3	3	CD
cord-023095-4dannjjm	1870	16	CKD	CKD	NNP
cord-023095-4dannjjm	1870	17	,	,	,
cord-023095-4dannjjm	1870	18	respectively	respectively	RB
cord-023095-4dannjjm	1870	19	,	,	,
cord-023095-4dannjjm	1870	20	after	after	IN
cord-023095-4dannjjm	1870	21	131	131	CD
cord-023095-4dannjjm	1870	22	I	-PRON-	PRP
cord-023095-4dannjjm	1870	23	;	;	:
cord-023095-4dannjjm	1870	24	after	after	IN
cord-023095-4dannjjm	1870	25	thyroxine	thyroxine	NN
cord-023095-4dannjjm	1870	26	replacement	replacement	NN
cord-023095-4dannjjm	1870	27	,	,	,
cord-023095-4dannjjm	1870	28	serum	serum	NN
cord-023095-4dannjjm	1870	29	creatinine	creatinine	NN
cord-023095-4dannjjm	1870	30	decreased	decrease	VBD
cord-023095-4dannjjm	1870	31	to	to	IN
cord-023095-4dannjjm	1870	32	near	near	JJ
cord-023095-4dannjjm	1870	33	pretreatment	pretreatment	NN
cord-023095-4dannjjm	1870	34	concentrations	concentration	NNS
cord-023095-4dannjjm	1870	35	in	in	IN
cord-023095-4dannjjm	1870	36	both	both	DT
cord-023095-4dannjjm	1870	37	cats	cat	NNS
cord-023095-4dannjjm	1870	38	.	.	.
cord-023095-4dannjjm	1871	1	Conclusions	conclusion	NNS
cord-023095-4dannjjm	1871	2	:	:	:
cord-023095-4dannjjm	1872	1	1	1	LS
cord-023095-4dannjjm	1872	2	)	)	-RRB-
cord-023095-4dannjjm	1872	3	IRIS	IRIS	NNP
cord-023095-4dannjjm	1872	4	stage	stage	NN
cord-023095-4dannjjm	1873	1	2	2	LS
cord-023095-4dannjjm	1873	2	CKD	CKD	NNP
cord-023095-4dannjjm	1873	3	is	be	VBZ
cord-023095-4dannjjm	1873	4	common	common	JJ
cord-023095-4dannjjm	1873	5	in	in	IN
cord-023095-4dannjjm	1873	6	untreated	untreated	JJ
cord-023095-4dannjjm	1873	7	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	1873	8	cats	cat	NNS
cord-023095-4dannjjm	1873	9	.	.	.
cord-023095-4dannjjm	1874	1	2	2	LS
cord-023095-4dannjjm	1874	2	)	)	-RRB-
cord-023095-4dannjjm	1874	3	Progression	progression	NN
cord-023095-4dannjjm	1874	4	to	to	IN
cord-023095-4dannjjm	1874	5	next	next	RB
cord-023095-4dannjjm	1874	6	higher	high	JJR
cord-023095-4dannjjm	1874	7	IRIS	IRIS	NNP
cord-023095-4dannjjm	1874	8	stage	stage	NN
cord-023095-4dannjjm	1874	9	is	be	VBZ
cord-023095-4dannjjm	1874	10	common	common	JJ
cord-023095-4dannjjm	1874	11	after	after	IN
cord-023095-4dannjjm	1874	12	treatment	treatment	NN
cord-023095-4dannjjm	1874	13	,	,	,
cord-023095-4dannjjm	1874	14	but	but	CC
cord-023095-4dannjjm	1874	15	most	most	JJS
cord-023095-4dannjjm	1874	16	cats	cat	NNS
cord-023095-4dannjjm	1874	17	with	with	IN
cord-023095-4dannjjm	1874	18	remain	remain	VBP
cord-023095-4dannjjm	1874	19	relatively	relatively	RB
cord-023095-4dannjjm	1874	20	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	1874	21	for	for	IN
cord-023095-4dannjjm	1874	22	CKD	CKD	NNP
cord-023095-4dannjjm	1874	23	.	.	.
cord-023095-4dannjjm	1875	1	3	3	LS
cord-023095-4dannjjm	1875	2	)	)	-RRB-
cord-023095-4dannjjm	1875	3	USG	USG	NNP
cord-023095-4dannjjm	1875	4	may	may	MD
cord-023095-4dannjjm	1875	5	be	be	VB
cord-023095-4dannjjm	1875	6	helpful	helpful	JJ
cord-023095-4dannjjm	1875	7	in	in	IN
cord-023095-4dannjjm	1875	8	predicting	predict	VBG
cord-023095-4dannjjm	1875	9	which	which	WDT
cord-023095-4dannjjm	1875	10	cat	cat	NN
cord-023095-4dannjjm	1875	11	's	's	POS
cord-023095-4dannjjm	1875	12	IRIS	IRIS	NNP
cord-023095-4dannjjm	1875	13	stage	stage	NN
cord-023095-4dannjjm	1875	14	will	will	MD
cord-023095-4dannjjm	1875	15	progress	progress	VB
cord-023095-4dannjjm	1875	16	after	after	IN
cord-023095-4dannjjm	1875	17	131	131	CD
cord-023095-4dannjjm	1875	18	I.	i.	NN
cord-023095-4dannjjm	1875	19	4	4	CD
cord-023095-4dannjjm	1875	20	)	)	-RRB-
cord-023095-4dannjjm	1876	1	Iatrogenic	iatrogenic	JJ
cord-023095-4dannjjm	1876	2	hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	1876	3	worsens	worsen	VBZ
cord-023095-4dannjjm	1876	4	azotemia	azotemia	NN
cord-023095-4dannjjm	1876	5	,	,	,
cord-023095-4dannjjm	1876	6	an	an	DT
cord-023095-4dannjjm	1876	7	effect	effect	NN
cord-023095-4dannjjm	1876	8	that	that	WDT
cord-023095-4dannjjm	1876	9	appears	appear	VBZ
cord-023095-4dannjjm	1876	10	reversible	reversible	JJ
cord-023095-4dannjjm	1876	11	with	with	IN
cord-023095-4dannjjm	1876	12	replacement	replacement	NN
cord-023095-4dannjjm	1876	13	therapy	therapy	NN
cord-023095-4dannjjm	1876	14	.	.	.
cord-023095-4dannjjm	1877	1	Home	home	NN
cord-023095-4dannjjm	1877	2	blood	blood	NN
cord-023095-4dannjjm	1877	3	glucose	glucose	NN
cord-023095-4dannjjm	1877	4	monitoring	monitoring	NN
cord-023095-4dannjjm	1877	5	(	(	-LRB-
cord-023095-4dannjjm	1877	6	HBGM	HBGM	NNP
cord-023095-4dannjjm	1877	7	)	)	-RRB-
cord-023095-4dannjjm	1877	8	of	of	IN
cord-023095-4dannjjm	1877	9	diabetic	diabetic	JJ
cord-023095-4dannjjm	1877	10	pets	pet	NNS
cord-023095-4dannjjm	1877	11	is	be	VBZ
cord-023095-4dannjjm	1877	12	likely	likely	JJ
cord-023095-4dannjjm	1877	13	to	to	TO
cord-023095-4dannjjm	1877	14	result	result	VB
cord-023095-4dannjjm	1877	15	in	in	IN
cord-023095-4dannjjm	1877	16	superior	superior	JJ
cord-023095-4dannjjm	1877	17	glycaemic	glycaemic	JJ
cord-023095-4dannjjm	1877	18	control	control	NN
cord-023095-4dannjjm	1877	19	,	,	,
cord-023095-4dannjjm	1877	20	minimizing	minimize	VBG
cord-023095-4dannjjm	1877	21	episodes	episode	NNS
cord-023095-4dannjjm	1877	22	and	and	CC
cord-023095-4dannjjm	1877	23	impact	impact	NN
cord-023095-4dannjjm	1877	24	of	of	IN
cord-023095-4dannjjm	1877	25	dangerous	dangerous	JJ
cord-023095-4dannjjm	1877	26	hypoglycaemia	hypoglycaemia	NN
cord-023095-4dannjjm	1877	27	and	and	CC
cord-023095-4dannjjm	1877	28	reducing	reduce	VBG
cord-023095-4dannjjm	1877	29	costs	cost	NNS
cord-023095-4dannjjm	1877	30	.	.	.
cord-023095-4dannjjm	1878	1	Nevertheless	nevertheless	RB
cord-023095-4dannjjm	1878	2	,	,	,
cord-023095-4dannjjm	1878	3	it	-PRON-	PRP
cord-023095-4dannjjm	1878	4	has	have	VBZ
cord-023095-4dannjjm	1878	5	proven	prove	VBN
cord-023095-4dannjjm	1878	6	difficult	difficult	JJ
cord-023095-4dannjjm	1878	7	to	to	TO
cord-023095-4dannjjm	1878	8	objectively	objectively	RB
cord-023095-4dannjjm	1878	9	establish	establish	VB
cord-023095-4dannjjm	1878	10	a	a	DT
cord-023095-4dannjjm	1878	11	clear	clear	JJ
cord-023095-4dannjjm	1878	12	benefit	benefit	NN
cord-023095-4dannjjm	1878	13	of	of	IN
cord-023095-4dannjjm	1878	14	HBGM	HBGM	NNS
cord-023095-4dannjjm	1878	15	using	use	VBG
cord-023095-4dannjjm	1878	16	biological	biological	JJ
cord-023095-4dannjjm	1878	17	parameters	parameter	NNS
cord-023095-4dannjjm	1878	18	(	(	-LRB-
cord-023095-4dannjjm	1878	19	clinical	clinical	JJ
cord-023095-4dannjjm	1878	20	signs	sign	NNS
cord-023095-4dannjjm	1878	21	,	,	,
cord-023095-4dannjjm	1878	22	blood	blood	NN
cord-023095-4dannjjm	1878	23	glucose	glucose	NN
cord-023095-4dannjjm	1878	24	,	,	,
cord-023095-4dannjjm	1878	25	fructosamine	fructosamine	NN
cord-023095-4dannjjm	1878	26	)	)	-RRB-
cord-023095-4dannjjm	1878	27	.	.	.
cord-023095-4dannjjm	1879	1	The	the	DT
cord-023095-4dannjjm	1879	2	current	current	JJ
cord-023095-4dannjjm	1879	3	study	study	NN
cord-023095-4dannjjm	1879	4	aimed	aim	VBN
cord-023095-4dannjjm	1879	5	to	to	TO
cord-023095-4dannjjm	1879	6	assess	assess	VB
cord-023095-4dannjjm	1879	7	the	the	DT
cord-023095-4dannjjm	1879	8	impact	impact	NN
cord-023095-4dannjjm	1879	9	of	of	IN
cord-023095-4dannjjm	1879	10	HBGM	HBGM	NNP
cord-023095-4dannjjm	1879	11	on	on	IN
cord-023095-4dannjjm	1879	12	owner	owner	NN
cord-023095-4dannjjm	1879	13	perceived	perceive	VBN
cord-023095-4dannjjm	1879	14	quality	quality	NN
cord-023095-4dannjjm	1879	15	of	of	IN
cord-023095-4dannjjm	1879	16	life	life	NN
cord-023095-4dannjjm	1879	17	(	(	-LRB-
cord-023095-4dannjjm	1879	18	QoL	QoL	NNP
cord-023095-4dannjjm	1879	19	)	)	-RRB-
cord-023095-4dannjjm	1879	20	aspects	aspect	NNS
cord-023095-4dannjjm	1879	21	of	of	IN
cord-023095-4dannjjm	1879	22	diabetes	diabetes	NN
cord-023095-4dannjjm	1879	23	mellitus	mellitus	NN
cord-023095-4dannjjm	1879	24	(	(	-LRB-
cord-023095-4dannjjm	1879	25	DM	dm	NN
cord-023095-4dannjjm	1879	26	)	)	-RRB-
cord-023095-4dannjjm	1879	27	treatment	treatment	NN
cord-023095-4dannjjm	1879	28	,	,	,
cord-023095-4dannjjm	1879	29	using	use	VBG
cord-023095-4dannjjm	1879	30	the	the	DT
cord-023095-4dannjjm	1879	31	recently	recently	RB
cord-023095-4dannjjm	1879	32	validated	validate	VBN
cord-023095-4dannjjm	1879	33	psychometric	psychometric	JJ
cord-023095-4dannjjm	1879	34	tool	tool	NN
cord-023095-4dannjjm	1879	35	DIAQoL	diaqol	NN
cord-023095-4dannjjm	1879	36	-	-	HYPH
cord-023095-4dannjjm	1879	37	pet	pet	NN
cord-023095-4dannjjm	1879	38	.	.	.
cord-023095-4dannjjm	1880	1	Owners	owner	NNS
cord-023095-4dannjjm	1880	2	of	of	IN
cord-023095-4dannjjm	1880	3	insulin	insulin	NN
cord-023095-4dannjjm	1880	4	treated	treat	VBN
cord-023095-4dannjjm	1880	5	diabetic	diabetic	JJ
cord-023095-4dannjjm	1880	6	cats	cat	NNS
cord-023095-4dannjjm	1880	7	were	be	VBD
cord-023095-4dannjjm	1880	8	recruited	recruit	VBN
cord-023095-4dannjjm	1880	9	to	to	TO
cord-023095-4dannjjm	1880	10	complete	complete	VB
cord-023095-4dannjjm	1880	11	the	the	DT
cord-023095-4dannjjm	1880	12	29-item	29-item	CD
cord-023095-4dannjjm	1880	13	tool	tool	NN
cord-023095-4dannjjm	1880	14	,	,	,
cord-023095-4dannjjm	1880	15	evaluating	evaluate	VBG
cord-023095-4dannjjm	1880	16	areas	area	NNS
cord-023095-4dannjjm	1880	17	affecting	affect	VBG
cord-023095-4dannjjm	1880	18	the	the	DT
cord-023095-4dannjjm	1880	19	cat	cat	NN
cord-023095-4dannjjm	1880	20	's	's	POS
cord-023095-4dannjjm	1880	21	and	and	CC
cord-023095-4dannjjm	1880	22	owner	owner	NN
cord-023095-4dannjjm	1880	23	's	's	POS
cord-023095-4dannjjm	1880	24	QoL	qol	NN
cord-023095-4dannjjm	1880	25	,	,	,
cord-023095-4dannjjm	1880	26	including	include	VBG
cord-023095-4dannjjm	1880	27	:	:	:
cord-023095-4dannjjm	1880	28	worry	worry	VB
cord-023095-4dannjjm	1880	29	about	about	IN
cord-023095-4dannjjm	1880	30	pet	pet	NN
cord-023095-4dannjjm	1880	31	's	's	POS
cord-023095-4dannjjm	1880	32	DM	dm	NN
cord-023095-4dannjjm	1880	33	,	,	,
cord-023095-4dannjjm	1880	34	hypoglycaemia	hypoglycaemia	NN
cord-023095-4dannjjm	1880	35	,	,	,
cord-023095-4dannjjm	1880	36	costs	cost	NNS
cord-023095-4dannjjm	1880	37	,	,	,
cord-023095-4dannjjm	1880	38	owner	owner	NN
cord-023095-4dannjjm	1880	39	's	's	POS
cord-023095-4dannjjm	1880	40	desire	desire	NN
cord-023095-4dannjjm	1880	41	for	for	IN
cord-023095-4dannjjm	1880	42	autonomous	autonomous	JJ
cord-023095-4dannjjm	1880	43	control	control	NN
cord-023095-4dannjjm	1880	44	over	over	IN
cord-023095-4dannjjm	1880	45	the	the	DT
cord-023095-4dannjjm	1880	46	pet	pet	NN
cord-023095-4dannjjm	1880	47	's	's	POS
cord-023095-4dannjjm	1880	48	DM	dm	NN
cord-023095-4dannjjm	1880	49	,	,	,
cord-023095-4dannjjm	1880	50	etc	etc	FW
cord-023095-4dannjjm	1880	51	.	.	.
cord-023095-4dannjjm	1881	1	Item	item	NN
cord-023095-4dannjjm	1881	2	-	-	HYPH
cord-023095-4dannjjm	1881	3	weighted	weight	VBN
cord-023095-4dannjjm	1881	4	-	-	HYPH
cord-023095-4dannjjm	1881	5	impact	impact	NN
cord-023095-4dannjjm	1881	6	-	-	HYPH
cord-023095-4dannjjm	1881	7	scores	score	NNS
cord-023095-4dannjjm	1881	8	(	(	-LRB-
cord-023095-4dannjjm	1881	9	IWIS	IWIS	NNP
cord-023095-4dannjjm	1881	10	)	)	-RRB-
cord-023095-4dannjjm	1881	11	,	,	.
cord-023095-4dannjjm	1882	1	reflecting	reflect	VBG
cord-023095-4dannjjm	1882	2	frequency	frequency	NN
cord-023095-4dannjjm	1882	3	and	and	CC
cord-023095-4dannjjm	1882	4	importance	importance	NN
cord-023095-4dannjjm	1882	5	ratings	rating	NNS
cord-023095-4dannjjm	1882	6	of	of	IN
cord-023095-4dannjjm	1882	7	each	each	DT
cord-023095-4dannjjm	1882	8	item	item	NN
cord-023095-4dannjjm	1882	9	,	,	,
cord-023095-4dannjjm	1882	10	were	be	VBD
cord-023095-4dannjjm	1882	11	calculated	calculate	VBN
cord-023095-4dannjjm	1882	12	,	,	,
cord-023095-4dannjjm	1882	13	as	as	RB
cord-023095-4dannjjm	1882	14	well	well	RB
cord-023095-4dannjjm	1882	15	as	as	IN
cord-023095-4dannjjm	1882	16	averageweighted	averageweighte	VBN
cord-023095-4dannjjm	1882	17	-	-	HYPH
cord-023095-4dannjjm	1882	18	impact	impact	NN
cord-023095-4dannjjm	1882	19	-	-	HYPH
cord-023095-4dannjjm	1882	20	scores	score	NNS
cord-023095-4dannjjm	1882	21	(	(	-LRB-
cord-023095-4dannjjm	1882	22	AWIS	AWIS	NNP
cord-023095-4dannjjm	1882	23	;	;	:
cord-023095-4dannjjm	1882	24	average	average	JJ
cord-023095-4dannjjm	1882	25	IWIS	IWIS	NNP
cord-023095-4dannjjm	1882	26	of	of	IN
cord-023095-4dannjjm	1882	27	all	all	DT
cord-023095-4dannjjm	1882	28	items	item	NNS
cord-023095-4dannjjm	1882	29	)	)	-RRB-
cord-023095-4dannjjm	1882	30	,	,	,
cord-023095-4dannjjm	1882	31	as	as	IN
cord-023095-4dannjjm	1882	32	an	an	DT
cord-023095-4dannjjm	1882	33	overall	overall	JJ
cord-023095-4dannjjm	1882	34	measure	measure	NN
cord-023095-4dannjjm	1882	35	of	of	IN
cord-023095-4dannjjm	1882	36	diabetes	diabetes	NN
cord-023095-4dannjjm	1882	37	dependent	dependent	JJ
cord-023095-4dannjjm	1882	38	QoL.	QoL.	NNP
cord-023095-4dannjjm	1882	39	Frequencies	Frequencies	NNPS
cord-023095-4dannjjm	1882	40	,	,	,
cord-023095-4dannjjm	1882	41	IWIS	IWIS	NNP
cord-023095-4dannjjm	1882	42	and	and	CC
cord-023095-4dannjjm	1882	43	AWIS	AWIS	NNP
cord-023095-4dannjjm	1882	44	were	be	VBD
cord-023095-4dannjjm	1882	45	compared	compare	VBN
cord-023095-4dannjjm	1882	46	between	between	IN
cord-023095-4dannjjm	1882	47	owners	owner	NNS
cord-023095-4dannjjm	1882	48	practising	practise	VBG
cord-023095-4dannjjm	1882	49	HBGM	HBGM	NNS
cord-023095-4dannjjm	1882	50	and	and	CC
cord-023095-4dannjjm	1882	51	those	those	DT
cord-023095-4dannjjm	1882	52	who	who	WP
cord-023095-4dannjjm	1882	53	did	do	VBD
cord-023095-4dannjjm	1882	54	not	not	RB
cord-023095-4dannjjm	1882	55	using	use	VBG
cord-023095-4dannjjm	1882	56	Mann	Mann	NNP
cord-023095-4dannjjm	1882	57	Whitney	Whitney	NNP
cord-023095-4dannjjm	1882	58	U	U	NNP
cord-023095-4dannjjm	1882	59	test	test	NN
cord-023095-4dannjjm	1882	60	(	(	-LRB-
cord-023095-4dannjjm	1882	61	significance	significance	NN
cord-023095-4dannjjm	1882	62	p	p	NN
cord-023095-4dannjjm	1882	63	o	o	NN
cord-023095-4dannjjm	1882	64	0.05	0.05	CD
cord-023095-4dannjjm	1882	65	)	)	-RRB-
cord-023095-4dannjjm	1882	66	.	.	.
cord-023095-4dannjjm	1883	1	Two	two	CD
cord-023095-4dannjjm	1883	2	hundred	hundred	CD
cord-023095-4dannjjm	1883	3	and	and	CC
cord-023095-4dannjjm	1883	4	eleven	eleven	CD
cord-023095-4dannjjm	1883	5	owners	owner	NNS
cord-023095-4dannjjm	1883	6	of	of	IN
cord-023095-4dannjjm	1883	7	insulin	insulin	NN
cord-023095-4dannjjm	1883	8	treated	treat	VBN
cord-023095-4dannjjm	1883	9	diabetic	diabetic	JJ
cord-023095-4dannjjm	1883	10	cats	cat	NNS
cord-023095-4dannjjm	1883	11	completed	complete	VBD
cord-023095-4dannjjm	1883	12	the	the	DT
cord-023095-4dannjjm	1883	13	DIAQoL	diaqol	NN
cord-023095-4dannjjm	1883	14	-	-	HYPH
cord-023095-4dannjjm	1883	15	pet	pet	NN
cord-023095-4dannjjm	1883	16	;	;	:
cord-023095-4dannjjm	1883	17	161	161	CD
cord-023095-4dannjjm	1883	18	owners	owner	NNS
cord-023095-4dannjjm	1883	19	practised	practise	VBD
cord-023095-4dannjjm	1883	20	HBGM	HBGM	NNS
cord-023095-4dannjjm	1883	21	,	,	,
cord-023095-4dannjjm	1883	22	whereas	whereas	IN
cord-023095-4dannjjm	1883	23	the	the	DT
cord-023095-4dannjjm	1883	24	remaining	remain	VBG
cord-023095-4dannjjm	1883	25	50	50	CD
cord-023095-4dannjjm	1883	26	did	do	VBD
cord-023095-4dannjjm	1883	27	not	not	RB
cord-023095-4dannjjm	1883	28	practise	practise	VB
cord-023095-4dannjjm	1883	29	any	any	DT
cord-023095-4dannjjm	1883	30	form	form	NN
cord-023095-4dannjjm	1883	31	of	of	IN
cord-023095-4dannjjm	1883	32	home	home	NN
cord-023095-4dannjjm	1883	33	monitoring	monitoring	NN
cord-023095-4dannjjm	1883	34	(	(	-LRB-
cord-023095-4dannjjm	1883	35	including	include	VBG
cord-023095-4dannjjm	1883	36	urine	urine	NN
cord-023095-4dannjjm	1883	37	glucose	glucose	NN
cord-023095-4dannjjm	1883	38	)	)	-RRB-
cord-023095-4dannjjm	1883	39	.	.	.
cord-023095-4dannjjm	1884	1	IWIS	IWIS	NNP
cord-023095-4dannjjm	1884	2	for	for	IN
cord-023095-4dannjjm	1884	3	'	'	``
cord-023095-4dannjjm	1884	4	excessive	excessive	JJ
cord-023095-4dannjjm	1884	5	drinking	drinking	NN
cord-023095-4dannjjm	1884	6	'	'	''
cord-023095-4dannjjm	1884	7	and	and	CC
cord-023095-4dannjjm	1885	1	'	'	POS
cord-023095-4dannjjm	1885	2	owner	owner	NN
cord-023095-4dannjjm	1885	3	wanting	want	VBG
cord-023095-4dannjjm	1885	4	more	more	JJR
cord-023095-4dannjjm	1885	5	control	control	NN
cord-023095-4dannjjm	1885	6	'	'	''
cord-023095-4dannjjm	1885	7	were	be	VBD
cord-023095-4dannjjm	1885	8	significantly	significantly	RB
cord-023095-4dannjjm	1885	9	different	different	JJ
cord-023095-4dannjjm	1885	10	between	between	IN
cord-023095-4dannjjm	1885	11	the	the	DT
cord-023095-4dannjjm	1885	12	HBGM	HBGM	NNP
cord-023095-4dannjjm	1885	13	-	-	HYPH
cord-023095-4dannjjm	1885	14	group	group	NN
cord-023095-4dannjjm	1885	15	(	(	-LRB-
cord-023095-4dannjjm	1885	16	mean1/-standard	mean1/-standard	NNP
cord-023095-4dannjjm	1885	17	deviation	deviation	NN
cord-023095-4dannjjm	1885	18	:	:	:
cord-023095-4dannjjm	1885	19	À2.011	à2.011	CD
cord-023095-4dannjjm	1885	20	/	/	SYM
cord-023095-4dannjjm	1885	21	À2.4	À2.4	NNP
cord-023095-4dannjjm	1885	22	and	and	CC
cord-023095-4dannjjm	1885	23	À5.071	à5.071	CD
cord-023095-4dannjjm	1885	24	/	/	SYM
cord-023095-4dannjjm	1885	25	À4.8	À4.8	NNP
cord-023095-4dannjjm	1885	26	)	)	-RRB-
cord-023095-4dannjjm	1885	27	and	and	CC
cord-023095-4dannjjm	1885	28	the	the	DT
cord-023095-4dannjjm	1885	29	non	non	JJ
cord-023095-4dannjjm	1885	30	-	-	JJ
cord-023095-4dannjjm	1885	31	HBGM	hbgm	JJ
cord-023095-4dannjjm	1885	32	-	-	HYPH
cord-023095-4dannjjm	1885	33	group	group	NN
cord-023095-4dannjjm	1886	1	(	(	-LRB-
cord-023095-4dannjjm	1886	2	À3.361	À3.361	VBG
cord-023095-4dannjjm	1886	3	/	/	SYM
cord-023095-4dannjjm	1886	4	À3.8	À3.8	NNP
cord-023095-4dannjjm	1886	5	and	and	CC
cord-023095-4dannjjm	1886	6	À1.861	à1.861	CD
cord-023095-4dannjjm	1886	7	/	/	SYM
cord-023095-4dannjjm	1886	8	À3.2	À3.2	NNP
cord-023095-4dannjjm	1886	9	)	)	-RRB-
cord-023095-4dannjjm	1886	10	.	.	.
cord-023095-4dannjjm	1887	1	There	there	EX
cord-023095-4dannjjm	1887	2	was	be	VBD
cord-023095-4dannjjm	1887	3	no	no	DT
cord-023095-4dannjjm	1887	4	significant	significant	JJ
cord-023095-4dannjjm	1887	5	difference	difference	NN
cord-023095-4dannjjm	1887	6	between	between	IN
cord-023095-4dannjjm	1887	7	the	the	DT
cord-023095-4dannjjm	1887	8	groups	group	NNS
cord-023095-4dannjjm	1887	9	with	with	IN
cord-023095-4dannjjm	1887	10	regards	regard	NNS
cord-023095-4dannjjm	1887	11	to	to	IN
cord-023095-4dannjjm	1887	12	the	the	DT
cord-023095-4dannjjm	1887	13	IWIS	IWIS	NNP
cord-023095-4dannjjm	1887	14	for	for	IN
cord-023095-4dannjjm	1887	15	other	other	JJ
cord-023095-4dannjjm	1887	16	items	item	NNS
cord-023095-4dannjjm	1887	17	,	,	,
cord-023095-4dannjjm	1887	18	including	include	VBG
cord-023095-4dannjjm	1887	19	'	'	''
cord-023095-4dannjjm	1887	20	worry	worry	NN
cord-023095-4dannjjm	1887	21	about	about	IN
cord-023095-4dannjjm	1887	22	hypoglycaemia	hypoglycaemia	NN
cord-023095-4dannjjm	1887	23	'	'	''
cord-023095-4dannjjm	1887	24	or	or	CC
cord-023095-4dannjjm	1887	25	'	'	''
cord-023095-4dannjjm	1887	26	worry	worry	NN
cord-023095-4dannjjm	1887	27	about	about	IN
cord-023095-4dannjjm	1887	28	pet	pet	NN
cord-023095-4dannjjm	1887	29	's	's	POS
cord-023095-4dannjjm	1887	30	DM	dm	NN
cord-023095-4dannjjm	1887	31	'	'	''
cord-023095-4dannjjm	1887	32	.	.	.
cord-023095-4dannjjm	1888	1	Polydipsia	Polydipsia	NNP
cord-023095-4dannjjm	1888	2	was	be	VBD
cord-023095-4dannjjm	1888	3	reported	report	VBN
cord-023095-4dannjjm	1888	4	significantly	significantly	RB
cord-023095-4dannjjm	1888	5	more	more	RBR
cord-023095-4dannjjm	1888	6	frequently	frequently	RB
cord-023095-4dannjjm	1888	7	in	in	IN
cord-023095-4dannjjm	1888	8	the	the	DT
cord-023095-4dannjjm	1888	9	non	non	JJ
cord-023095-4dannjjm	1888	10	-	-	JJ
cord-023095-4dannjjm	1888	11	HBGM	hbgm	JJ
cord-023095-4dannjjm	1888	12	-	-	HYPH
cord-023095-4dannjjm	1888	13	group	group	NN
cord-023095-4dannjjm	1888	14	and	and	CC
cord-023095-4dannjjm	1888	15	this	this	DT
cord-023095-4dannjjm	1888	16	was	be	VBD
cord-023095-4dannjjm	1888	17	the	the	DT
cord-023095-4dannjjm	1888	18	reason	reason	NN
cord-023095-4dannjjm	1888	19	for	for	IN
cord-023095-4dannjjm	1888	20	the	the	DT
cord-023095-4dannjjm	1888	21	difference	difference	NN
cord-023095-4dannjjm	1888	22	between	between	IN
cord-023095-4dannjjm	1888	23	groups	group	NNS
cord-023095-4dannjjm	1888	24	in	in	IN
cord-023095-4dannjjm	1888	25	this	this	DT
cord-023095-4dannjjm	1888	26	item	item	NN
cord-023095-4dannjjm	1888	27	's	's	POS
cord-023095-4dannjjm	1888	28	IWIS	IWIS	NNP
cord-023095-4dannjjm	1888	29	as	as	IN
cord-023095-4dannjjm	1888	30	it	-PRON-	PRP
cord-023095-4dannjjm	1888	31	was	be	VBD
cord-023095-4dannjjm	1888	32	considered	consider	VBN
cord-023095-4dannjjm	1888	33	of	of	IN
cord-023095-4dannjjm	1888	34	equal	equal	JJ
cord-023095-4dannjjm	1888	35	importance	importance	NN
cord-023095-4dannjjm	1888	36	.	.	.
cord-023095-4dannjjm	1889	1	Frequency	frequency	NN
cord-023095-4dannjjm	1889	2	and	and	CC
cord-023095-4dannjjm	1889	3	IWIS	IWIS	NNP
cord-023095-4dannjjm	1889	4	of	of	IN
cord-023095-4dannjjm	1889	5	reported	report	VBN
cord-023095-4dannjjm	1889	6	occurrence	occurrence	NN
cord-023095-4dannjjm	1889	7	of	of	IN
cord-023095-4dannjjm	1889	8	hypoglycaemia	hypoglycaemia	NN
cord-023095-4dannjjm	1889	9	signs	sign	NNS
cord-023095-4dannjjm	1889	10	were	be	VBD
cord-023095-4dannjjm	1889	11	not	not	RB
cord-023095-4dannjjm	1889	12	significantly	significantly	RB
cord-023095-4dannjjm	1889	13	different	different	JJ
cord-023095-4dannjjm	1889	14	.	.	.
cord-023095-4dannjjm	1890	1	AWIS	AWIS	NNP
cord-023095-4dannjjm	1890	2	for	for	IN
cord-023095-4dannjjm	1890	3	both	both	DT
cord-023095-4dannjjm	1890	4	groups	group	NNS
cord-023095-4dannjjm	1890	5	was	be	VBD
cord-023095-4dannjjm	1890	6	not	not	RB
cord-023095-4dannjjm	1890	7	significantly	significantly	RB
cord-023095-4dannjjm	1890	8	different	different	JJ
cord-023095-4dannjjm	1891	1	(	(	-LRB-
cord-023095-4dannjjm	1891	2	HBGM	HBGM	NNP
cord-023095-4dannjjm	1891	3	:	:	:
cord-023095-4dannjjm	1892	1	À1.851	À1.851	NNP
cord-023095-4dannjjm	1892	2	/	/	SYM
cord-023095-4dannjjm	1892	3	À1.3	à1.3	XX
cord-023095-4dannjjm	1892	4	;	;	:
cord-023095-4dannjjm	1892	5	non	non	JJ
cord-023095-4dannjjm	1892	6	-	-	JJ
cord-023095-4dannjjm	1892	7	HBGM	hbgm	JJ
cord-023095-4dannjjm	1892	8	:	:	:
cord-023095-4dannjjm	1892	9	À1.871	à1.871	CD
cord-023095-4dannjjm	1892	10	/	/	SYM
cord-023095-4dannjjm	1892	11	À1.1	à1.1	CD
cord-023095-4dannjjm	1892	12	)	)	-RRB-
cord-023095-4dannjjm	1892	13	.	.	.
cord-023095-4dannjjm	1893	1	The	the	DT
cord-023095-4dannjjm	1893	2	current	current	JJ
cord-023095-4dannjjm	1893	3	study	study	NN
cord-023095-4dannjjm	1893	4	suggests	suggest	VBZ
cord-023095-4dannjjm	1893	5	that	that	IN
cord-023095-4dannjjm	1893	6	HBGM	HBGM	NNP
cord-023095-4dannjjm	1893	7	is	be	VBZ
cord-023095-4dannjjm	1893	8	predominantly	predominantly	RB
cord-023095-4dannjjm	1893	9	practised	practise	VBN
cord-023095-4dannjjm	1893	10	by	by	IN
cord-023095-4dannjjm	1893	11	owners	owner	NNS
cord-023095-4dannjjm	1893	12	who	who	WP
cord-023095-4dannjjm	1893	13	desire	desire	VBP
cord-023095-4dannjjm	1893	14	more	more	RBR
cord-023095-4dannjjm	1893	15	autonomous	autonomous	JJ
cord-023095-4dannjjm	1893	16	control	control	NN
cord-023095-4dannjjm	1893	17	over	over	IN
cord-023095-4dannjjm	1893	18	their	-PRON-	PRP$
cord-023095-4dannjjm	1893	19	cat	cat	NN
cord-023095-4dannjjm	1893	20	's	's	POS
cord-023095-4dannjjm	1893	21	DM	dm	NN
cord-023095-4dannjjm	1893	22	.	.	.
cord-023095-4dannjjm	1894	1	The	the	DT
cord-023095-4dannjjm	1894	2	frequency	frequency	NN
cord-023095-4dannjjm	1894	3	of	of	IN
cord-023095-4dannjjm	1894	4	polydipsia	polydipsia	NN
cord-023095-4dannjjm	1894	5	was	be	VBD
cord-023095-4dannjjm	1894	6	lower	low	JJR
cord-023095-4dannjjm	1894	7	in	in	IN
cord-023095-4dannjjm	1894	8	the	the	DT
cord-023095-4dannjjm	1894	9	HBGM	HBGM	NNP
cord-023095-4dannjjm	1894	10	-	-	HYPH
cord-023095-4dannjjm	1894	11	group	group	NN
cord-023095-4dannjjm	1894	12	perhaps	perhaps	RB
cord-023095-4dannjjm	1894	13	suggesting	suggest	VBG
cord-023095-4dannjjm	1894	14	superior	superior	JJ
cord-023095-4dannjjm	1894	15	control	control	NN
cord-023095-4dannjjm	1894	16	.	.	.
cord-023095-4dannjjm	1895	1	However	however	RB
cord-023095-4dannjjm	1895	2	,	,	,
cord-023095-4dannjjm	1895	3	HBGM	HBGM	NNP
cord-023095-4dannjjm	1895	4	did	do	VBD
cord-023095-4dannjjm	1895	5	not	not	RB
cord-023095-4dannjjm	1895	6	detectably	detectably	RB
cord-023095-4dannjjm	1895	7	affect	affect	VB
cord-023095-4dannjjm	1895	8	the	the	DT
cord-023095-4dannjjm	1895	9	impact	impact	NN
cord-023095-4dannjjm	1895	10	of	of	IN
cord-023095-4dannjjm	1895	11	the	the	DT
cord-023095-4dannjjm	1895	12	majority	majority	NN
cord-023095-4dannjjm	1895	13	of	of	IN
cord-023095-4dannjjm	1895	14	QoL	qol	NN
cord-023095-4dannjjm	1895	15	-	-	HYPH
cord-023095-4dannjjm	1895	16	items	item	NNS
cord-023095-4dannjjm	1895	17	,	,	,
cord-023095-4dannjjm	1895	18	nor	nor	CC
cord-023095-4dannjjm	1895	19	the	the	DT
cord-023095-4dannjjm	1895	20	frequency	frequency	NN
cord-023095-4dannjjm	1895	21	of	of	IN
cord-023095-4dannjjm	1895	22	hypoglycaemic	hypoglycaemic	JJ
cord-023095-4dannjjm	1895	23	episodes	episode	NNS
cord-023095-4dannjjm	1895	24	.	.	.
cord-023095-4dannjjm	1896	1	Overall	overall	JJ
cord-023095-4dannjjm	1896	2	diabetes	diabetes	NN
cord-023095-4dannjjm	1896	3	dependent	dependent	JJ
cord-023095-4dannjjm	1896	4	QoL	qol	NN
cord-023095-4dannjjm	1896	5	of	of	IN
cord-023095-4dannjjm	1896	6	diabetic	diabetic	JJ
cord-023095-4dannjjm	1896	7	cat	cat	NN
cord-023095-4dannjjm	1896	8	and	and	CC
cord-023095-4dannjjm	1896	9	owner	owner	NN
cord-023095-4dannjjm	1896	10	,	,	,
cord-023095-4dannjjm	1896	11	as	as	IN
cord-023095-4dannjjm	1896	12	measured	measure	VBN
cord-023095-4dannjjm	1896	13	per	per	IN
cord-023095-4dannjjm	1896	14	DIAQoL	diaqol	NN
cord-023095-4dannjjm	1896	15	-	-	HYPH
cord-023095-4dannjjm	1896	16	pet	pet	NN
cord-023095-4dannjjm	1896	17	,	,	,
cord-023095-4dannjjm	1896	18	was	be	VBD
cord-023095-4dannjjm	1896	19	unaffected	unaffected	JJ
cord-023095-4dannjjm	1896	20	by	by	IN
cord-023095-4dannjjm	1896	21	HBGM	HBGM	NNS
cord-023095-4dannjjm	1896	22	.	.	.
cord-023095-4dannjjm	1897	1	These	these	DT
cord-023095-4dannjjm	1897	2	data	datum	NNS
cord-023095-4dannjjm	1897	3	argue	argue	VBP
cord-023095-4dannjjm	1897	4	for	for	IN
cord-023095-4dannjjm	1897	5	the	the	DT
cord-023095-4dannjjm	1897	6	use	use	NN
cord-023095-4dannjjm	1897	7	of	of	IN
cord-023095-4dannjjm	1897	8	HBGM	HBGM	NNP
cord-023095-4dannjjm	1897	9	in	in	IN
cord-023095-4dannjjm	1897	10	selected	select	VBN
cord-023095-4dannjjm	1897	11	pet	pet	JJ
cord-023095-4dannjjm	1897	12	-	-	HYPH
cord-023095-4dannjjm	1897	13	owner	owner	NN
cord-023095-4dannjjm	1897	14	combinations	combination	NNS
cord-023095-4dannjjm	1897	15	rather	rather	RB
cord-023095-4dannjjm	1897	16	than	than	IN
cord-023095-4dannjjm	1897	17	as	as	IN
cord-023095-4dannjjm	1897	18	part	part	NN
cord-023095-4dannjjm	1897	19	of	of	IN
cord-023095-4dannjjm	1897	20	a	a	DT
cord-023095-4dannjjm	1897	21	practice	practice	NN
cord-023095-4dannjjm	1897	22	's	's	POS
cord-023095-4dannjjm	1897	23	standard	standard	JJ
cord-023095-4dannjjm	1897	24	DM	dm	NN
cord-023095-4dannjjm	1897	25	management	management	NN
cord-023095-4dannjjm	1897	26	protocol	protocol	NN
cord-023095-4dannjjm	1897	27	,	,	,
cord-023095-4dannjjm	1897	28	although	although	IN
cord-023095-4dannjjm	1897	29	further	further	JJ
cord-023095-4dannjjm	1897	30	studies	study	NNS
cord-023095-4dannjjm	1897	31	are	be	VBP
cord-023095-4dannjjm	1897	32	indicated	indicate	VBN
cord-023095-4dannjjm	1897	33	.	.	.
cord-023095-4dannjjm	1898	1	Insulin	insulin	NN
cord-023095-4dannjjm	1898	2	resistance	resistance	NN
cord-023095-4dannjjm	1898	3	is	be	VBZ
cord-023095-4dannjjm	1898	4	associated	associate	VBN
cord-023095-4dannjjm	1898	5	with	with	IN
cord-023095-4dannjjm	1898	6	impaired	impaired	JJ
cord-023095-4dannjjm	1898	7	activation	activation	NN
cord-023095-4dannjjm	1898	8	of	of	IN
cord-023095-4dannjjm	1898	9	the	the	DT
cord-023095-4dannjjm	1898	10	insulin	insulin	NN
cord-023095-4dannjjm	1898	11	signaling	signal	VBG
cord-023095-4dannjjm	1898	12	pathway	pathway	NN
cord-023095-4dannjjm	1898	13	in	in	IN
cord-023095-4dannjjm	1898	14	peripheral	peripheral	JJ
cord-023095-4dannjjm	1898	15	tissues	tissue	NNS
cord-023095-4dannjjm	1898	16	such	such	JJ
cord-023095-4dannjjm	1898	17	as	as	IN
cord-023095-4dannjjm	1898	18	skeletal	skeletal	JJ
cord-023095-4dannjjm	1898	19	muscle	muscle	NN
cord-023095-4dannjjm	1898	20	,	,	,
cord-023095-4dannjjm	1898	21	visceral	visceral	JJ
cord-023095-4dannjjm	1898	22	and	and	CC
cord-023095-4dannjjm	1898	23	subcutaneous	subcutaneous	JJ
cord-023095-4dannjjm	1898	24	(	(	-LRB-
cord-023095-4dannjjm	1898	25	SC	SC	NNP
cord-023095-4dannjjm	1898	26	)	)	-RRB-
cord-023095-4dannjjm	1898	27	adipose	adipose	JJ
cord-023095-4dannjjm	1898	28	tissue	tissue	NN
cord-023095-4dannjjm	1898	29	.	.	.
cord-023095-4dannjjm	1899	1	High	high	JJ
cord-023095-4dannjjm	1899	2	plasma	plasma	NN
cord-023095-4dannjjm	1899	3	glucose	glucose	NN
cord-023095-4dannjjm	1899	4	,	,	,
cord-023095-4dannjjm	1899	5	fatty	fatty	JJ
cord-023095-4dannjjm	1899	6	acid	acid	NN
cord-023095-4dannjjm	1899	7	and	and	CC
cord-023095-4dannjjm	1899	8	endotoxin	endotoxin	NN
cord-023095-4dannjjm	1899	9	levels	level	NNS
cord-023095-4dannjjm	1899	10	are	be	VBP
cord-023095-4dannjjm	1899	11	three	three	CD
cord-023095-4dannjjm	1899	12	major	major	JJ
cord-023095-4dannjjm	1899	13	causes	cause	NNS
cord-023095-4dannjjm	1899	14	of	of	IN
cord-023095-4dannjjm	1899	15	insulin	insulin	NN
cord-023095-4dannjjm	1899	16	resistance	resistance	NN
cord-023095-4dannjjm	1899	17	in	in	IN
cord-023095-4dannjjm	1899	18	feline	feline	JJ
cord-023095-4dannjjm	1899	19	and	and	CC
cord-023095-4dannjjm	1899	20	human	human	JJ
cord-023095-4dannjjm	1899	21	obesity	obesity	NN
cord-023095-4dannjjm	1899	22	and	and	CC
cord-023095-4dannjjm	1899	23	in	in	IN
cord-023095-4dannjjm	1899	24	type	type	NN
cord-023095-4dannjjm	1899	25	2	2	CD
cord-023095-4dannjjm	1899	26	diabetes	diabetes	NN
cord-023095-4dannjjm	1899	27	mellitus	mellitus	NN
cord-023095-4dannjjm	1899	28	.	.	.
cord-023095-4dannjjm	1900	1	However	however	RB
cord-023095-4dannjjm	1900	2	,	,	,
cord-023095-4dannjjm	1900	3	the	the	DT
cord-023095-4dannjjm	1900	4	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1900	5	by	by	IN
cord-023095-4dannjjm	1900	6	which	which	WDT
cord-023095-4dannjjm	1900	7	these	these	DT
cord-023095-4dannjjm	1900	8	factors	factor	NNS
cord-023095-4dannjjm	1900	9	influence	influence	VBP
cord-023095-4dannjjm	1900	10	insulin	insulin	NN
cord-023095-4dannjjm	1900	11	action	action	NN
cord-023095-4dannjjm	1900	12	are	be	VBP
cord-023095-4dannjjm	1900	13	still	still	RB
cord-023095-4dannjjm	1900	14	unclear	unclear	JJ
cord-023095-4dannjjm	1900	15	.	.	.
cord-023095-4dannjjm	1901	1	Therefore	therefore	RB
cord-023095-4dannjjm	1901	2	,	,	,
cord-023095-4dannjjm	1901	3	our	-PRON-	PRP$
cord-023095-4dannjjm	1901	4	aim	aim	NN
cord-023095-4dannjjm	1901	5	was	be	VBD
cord-023095-4dannjjm	1901	6	to	to	TO
cord-023095-4dannjjm	1901	7	investigate	investigate	VB
cord-023095-4dannjjm	1901	8	the	the	DT
cord-023095-4dannjjm	1901	9	tissue	tissue	NN
cord-023095-4dannjjm	1901	10	-	-	HYPH
cord-023095-4dannjjm	1901	11	specific	specific	JJ
cord-023095-4dannjjm	1901	12	expression	expression	NN
cord-023095-4dannjjm	1901	13	of	of	IN
cord-023095-4dannjjm	1901	14	crucial	crucial	JJ
cord-023095-4dannjjm	1901	15	mediators	mediator	NNS
cord-023095-4dannjjm	1901	16	of	of	IN
cord-023095-4dannjjm	1901	17	insulin	insulin	NN
cord-023095-4dannjjm	1901	18	action	action	NN
cord-023095-4dannjjm	1901	19	such	such	JJ
cord-023095-4dannjjm	1901	20	as	as	IN
cord-023095-4dannjjm	1901	21	the	the	DT
cord-023095-4dannjjm	1901	22	insulin	insulin	NN
cord-023095-4dannjjm	1901	23	-	-	HYPH
cord-023095-4dannjjm	1901	24	receptor	receptor	NN
cord-023095-4dannjjm	1901	25	substrate	substrate	NN
cord-023095-4dannjjm	1901	26	1	1	CD
cord-023095-4dannjjm	1901	27	(	(	-LRB-
cord-023095-4dannjjm	1901	28	IRS1	IRS1	NNP
cord-023095-4dannjjm	1901	29	)	)	-RRB-
cord-023095-4dannjjm	1902	1	,	,	,
cord-023095-4dannjjm	1902	2	the	the	DT
cord-023095-4dannjjm	1902	3	serine	serine	NN
cord-023095-4dannjjm	1902	4	/	/	SYM
cord-023095-4dannjjm	1902	5	threonine	threonine	NN
cord-023095-4dannjjm	1902	6	protein	protein	NN
cord-023095-4dannjjm	1902	7	kinase	kinase	NN
cord-023095-4dannjjm	1902	8	B	B	NNP
cord-023095-4dannjjm	1902	9	(	(	-LRB-
cord-023095-4dannjjm	1902	10	PKB	PKB	NNP
cord-023095-4dannjjm	1902	11	/	/	SYM
cord-023095-4dannjjm	1902	12	Akt	Akt	NNP
cord-023095-4dannjjm	1902	13	)	)	-RRB-
cord-023095-4dannjjm	1902	14	and	and	CC
cord-023095-4dannjjm	1903	1	of	of	IN
cord-023095-4dannjjm	1903	2	the	the	DT
cord-023095-4dannjjm	1903	3	principal	principal	JJ
cord-023095-4dannjjm	1903	4	insulin	insulin	NN
cord-023095-4dannjjm	1903	5	-	-	HYPH
cord-023095-4dannjjm	1903	6	dependent	dependent	JJ
cord-023095-4dannjjm	1903	7	glucose	glucose	NN
cord-023095-4dannjjm	1903	8	transporter	transporter	NN
cord-023095-4dannjjm	1903	9	protein	protein	NN
cord-023095-4dannjjm	1903	10	(	(	-LRB-
cord-023095-4dannjjm	1903	11	GLUT4	GLUT4	NNP
cord-023095-4dannjjm	1903	12	)	)	-RRB-
cord-023095-4dannjjm	1903	13	in	in	IN
cord-023095-4dannjjm	1903	14	feline	feline	JJ
cord-023095-4dannjjm	1903	15	models	model	NNS
cord-023095-4dannjjm	1903	16	of	of	IN
cord-023095-4dannjjm	1903	17	hyperglycemia	hyperglycemia	NN
cord-023095-4dannjjm	1903	18	,	,	,
cord-023095-4dannjjm	1903	19	hyperlipidemia	hyperlipidemia	NN
cord-023095-4dannjjm	1903	20	and	and	CC
cord-023095-4dannjjm	1903	21	subacute	subacute	JJ
cord-023095-4dannjjm	1903	22	endotoxemia	endotoxemia	NN
cord-023095-4dannjjm	1903	23	.	.	.
cord-023095-4dannjjm	1904	1	Healthy	healthy	JJ
cord-023095-4dannjjm	1904	2	cats	cat	NNS
cord-023095-4dannjjm	1904	3	were	be	VBD
cord-023095-4dannjjm	1904	4	infused	infuse	VBN
cord-023095-4dannjjm	1904	5	through	through	IN
cord-023095-4dannjjm	1904	6	the	the	DT
cord-023095-4dannjjm	1904	7	jugular	jugular	NN
cord-023095-4dannjjm	1904	8	vein	vein	NN
cord-023095-4dannjjm	1904	9	with	with	IN
cord-023095-4dannjjm	1904	10	glucose	glucose	NN
cord-023095-4dannjjm	1904	11	(	(	-LRB-
cord-023095-4dannjjm	1904	12	n	n	NN
cord-023095-4dannjjm	1904	13	5	5	CD
cord-023095-4dannjjm	1904	14	5	5	CD
cord-023095-4dannjjm	1904	15	)	)	-RRB-
cord-023095-4dannjjm	1904	16	,	,	,
cord-023095-4dannjjm	1904	17	lipids	lipid	NNS
cord-023095-4dannjjm	1904	18	(	(	-LRB-
cord-023095-4dannjjm	1904	19	n	n	NN
cord-023095-4dannjjm	1904	20	5	5	CD
cord-023095-4dannjjm	1904	21	6	6	CD
cord-023095-4dannjjm	1904	22	)	)	-RRB-
cord-023095-4dannjjm	1904	23	or	or	CC
cord-023095-4dannjjm	1904	24	lipopolysaccharide	lipopolysaccharide	NN
cord-023095-4dannjjm	1904	25	(	(	-LRB-
cord-023095-4dannjjm	1904	26	LPS	LPS	NNP
cord-023095-4dannjjm	1904	27	;	;	:
cord-023095-4dannjjm	1904	28	n	n	NN
cord-023095-4dannjjm	1904	29	5	5	CD
cord-023095-4dannjjm	1904	30	5	5	CD
cord-023095-4dannjjm	1904	31	)	)	-RRB-
cord-023095-4dannjjm	1904	32	for	for	IN
cord-023095-4dannjjm	1904	33	10	10	CD
cord-023095-4dannjjm	1904	34	days	day	NNS
cord-023095-4dannjjm	1904	35	to	to	TO
cord-023095-4dannjjm	1904	36	clamp	clamp	VB
cord-023095-4dannjjm	1904	37	their	-PRON-	PRP$
cord-023095-4dannjjm	1904	38	blood	blood	NN
cord-023095-4dannjjm	1904	39	concentrations	concentration	NNS
cord-023095-4dannjjm	1904	40	at	at	IN
cord-023095-4dannjjm	1904	41	the	the	DT
cord-023095-4dannjjm	1904	42	approximate	approximate	JJ
cord-023095-4dannjjm	1904	43	level	level	NN
cord-023095-4dannjjm	1904	44	found	find	VBN
cord-023095-4dannjjm	1904	45	in	in	IN
cord-023095-4dannjjm	1904	46	untreated	untreated	JJ
cord-023095-4dannjjm	1904	47	feline	feline	JJ
cord-023095-4dannjjm	1904	48	diabetes	diabetes	NN
cord-023095-4dannjjm	1904	49	(	(	-LRB-
cord-023095-4dannjjm	1904	50	glucose	glucose	NN
cord-023095-4dannjjm	1904	51	:	:	:
cord-023095-4dannjjm	1904	52	25	25	CD
cord-023095-4dannjjm	1904	53	-	-	SYM
cord-023095-4dannjjm	1904	54	30	30	CD
cord-023095-4dannjjm	1904	55	mmol	mmol	NN
cord-023095-4dannjjm	1904	56	/	/	SYM
cord-023095-4dannjjm	1904	57	l	l	NN
cord-023095-4dannjjm	1904	58	;	;	:
cord-023095-4dannjjm	1904	59	triglycerides	triglyceride	NNS
cord-023095-4dannjjm	1904	60	:	:	:
cord-023095-4dannjjm	1904	61	3	3	CD
cord-023095-4dannjjm	1904	62	-	-	SYM
cord-023095-4dannjjm	1904	63	7	7	CD
cord-023095-4dannjjm	1904	64	mmol	mmol	NN
cord-023095-4dannjjm	1904	65	/	/	SYM
cord-023095-4dannjjm	1904	66	l	l	NN
cord-023095-4dannjjm	1904	67	)	)	-RRB-
cord-023095-4dannjjm	1904	68	or	or	CC
cord-023095-4dannjjm	1904	69	to	to	TO
cord-023095-4dannjjm	1904	70	induce	induce	VB
cord-023095-4dannjjm	1904	71	a	a	DT
cord-023095-4dannjjm	1904	72	systemic	systemic	JJ
cord-023095-4dannjjm	1904	73	low	low	JJ
cord-023095-4dannjjm	1904	74	-	-	HYPH
cord-023095-4dannjjm	1904	75	grade	grade	NN
cord-023095-4dannjjm	1904	76	inflammation	inflammation	NN
cord-023095-4dannjjm	1904	77	(	(	-LRB-
cord-023095-4dannjjm	1904	78	LPS	lp	NNS
cord-023095-4dannjjm	1904	79	;	;	:
cord-023095-4dannjjm	1904	80	rectal	rectal	JJ
cord-023095-4dannjjm	1904	81	temperature	temperature	NN
cord-023095-4dannjjm	1904	82	:	:	:
cord-023095-4dannjjm	1904	83	39.2	39.2	CD
cord-023095-4dannjjm	1904	84	-	-	HYPH
cord-023095-4dannjjm	1904	85	40.51C	40.51c	CD
cord-023095-4dannjjm	1904	86	)	)	-RRB-
cord-023095-4dannjjm	1904	87	,	,	,
cord-023095-4dannjjm	1904	88	respectively	respectively	RB
cord-023095-4dannjjm	1904	89	.	.	.
cord-023095-4dannjjm	1905	1	Healthy	healthy	JJ
cord-023095-4dannjjm	1905	2	control	control	NN
cord-023095-4dannjjm	1905	3	cats	cat	NNS
cord-023095-4dannjjm	1905	4	were	be	VBD
cord-023095-4dannjjm	1905	5	infused	infuse	VBN
cord-023095-4dannjjm	1905	6	with	with	IN
cord-023095-4dannjjm	1905	7	saline	saline	NN
cord-023095-4dannjjm	1905	8	(	(	-LRB-
cord-023095-4dannjjm	1905	9	n	n	NN
cord-023095-4dannjjm	1905	10	5	5	CD
cord-023095-4dannjjm	1905	11	10	10	CD
cord-023095-4dannjjm	1905	12	)	)	-RRB-
cord-023095-4dannjjm	1905	13	.	.	.
cord-023095-4dannjjm	1906	1	On	on	IN
cord-023095-4dannjjm	1906	2	day	day	NN
cord-023095-4dannjjm	1906	3	10	10	CD
cord-023095-4dannjjm	1906	4	,	,	,
cord-023095-4dannjjm	1906	5	specimens	specimen	NNS
cord-023095-4dannjjm	1906	6	were	be	VBD
cord-023095-4dannjjm	1906	7	collected	collect	VBN
cord-023095-4dannjjm	1906	8	from	from	IN
cord-023095-4dannjjm	1906	9	skeletal	skeletal	JJ
cord-023095-4dannjjm	1906	10	muscles	muscle	NNS
cord-023095-4dannjjm	1906	11	,	,	,
cord-023095-4dannjjm	1906	12	visceral	visceral	JJ
cord-023095-4dannjjm	1906	13	and	and	CC
cord-023095-4dannjjm	1906	14	SC	SC	NNP
cord-023095-4dannjjm	1906	15	fat	fat	NN
cord-023095-4dannjjm	1906	16	and	and	CC
cord-023095-4dannjjm	1906	17	processed	process	VBN
cord-023095-4dannjjm	1906	18	for	for	IN
cord-023095-4dannjjm	1907	1	IRS1	IRS1	NNP
cord-023095-4dannjjm	1907	2	mRNA	mRNA	NNP
cord-023095-4dannjjm	1907	3	expression	expression	NN
cord-023095-4dannjjm	1907	4	,	,	,
cord-023095-4dannjjm	1907	5	total	total	JJ
cord-023095-4dannjjm	1907	6	and	and	CC
cord-023095-4dannjjm	1907	7	phosphorylated	phosphorylated	JJ
cord-023095-4dannjjm	1907	8	PKB	PKB	NNP
cord-023095-4dannjjm	1907	9	/	/	SYM
cord-023095-4dannjjm	1907	10	Akt	Akt	NNP
cord-023095-4dannjjm	1907	11	and	and	CC
cord-023095-4dannjjm	1907	12	GLUT4	GLUT4	NNP
cord-023095-4dannjjm	1907	13	protein	protein	NN
cord-023095-4dannjjm	1907	14	expression	expression	NN
cord-023095-4dannjjm	1907	15	.	.	.
cord-023095-4dannjjm	1908	1	Gene	gene	NN
cord-023095-4dannjjm	1908	2	transcripts	transcript	NNS
cord-023095-4dannjjm	1908	3	of	of	IN
cord-023095-4dannjjm	1908	4	IRS1	IRS1	NNP
cord-023095-4dannjjm	1908	5	were	be	VBD
cord-023095-4dannjjm	1908	6	not	not	RB
cord-023095-4dannjjm	1908	7	different	different	JJ
cord-023095-4dannjjm	1908	8	between	between	IN
cord-023095-4dannjjm	1908	9	the	the	DT
cord-023095-4dannjjm	1908	10	groups	group	NNS
cord-023095-4dannjjm	1908	11	.	.	.
cord-023095-4dannjjm	1909	1	Compared	compare	VBN
cord-023095-4dannjjm	1909	2	to	to	IN
cord-023095-4dannjjm	1909	3	controls	control	NNS
cord-023095-4dannjjm	1909	4	,	,	,
cord-023095-4dannjjm	1909	5	skeletal	skeletal	JJ
cord-023095-4dannjjm	1909	6	muscle	muscle	NN
cord-023095-4dannjjm	1909	7	PKB	PKB	NNP
cord-023095-4dannjjm	1909	8	/	/	SYM
cord-023095-4dannjjm	1909	9	Akt	Akt	NNP
cord-023095-4dannjjm	1909	10	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	1909	11	was	be	VBD
cord-023095-4dannjjm	1909	12	91	91	CD
cord-023095-4dannjjm	1909	13	%	%	NN
cord-023095-4dannjjm	1909	14	lower	low	JJR
cord-023095-4dannjjm	1909	15	in	in	IN
cord-023095-4dannjjm	1909	16	cats	cat	NNS
cord-023095-4dannjjm	1909	17	infused	infuse	VBN
cord-023095-4dannjjm	1909	18	with	with	IN
cord-023095-4dannjjm	1909	19	glucose	glucose	NN
cord-023095-4dannjjm	1909	20	(	(	-LRB-
cord-023095-4dannjjm	1909	21	P	p	NN
cord-023095-4dannjjm	1909	22	o	o	NN
cord-023095-4dannjjm	1909	23	0.01	0.01	CD
cord-023095-4dannjjm	1909	24	)	)	-RRB-
cord-023095-4dannjjm	1909	25	;	;	:
cord-023095-4dannjjm	1909	26	lipid	lipid	NN
cord-023095-4dannjjm	1909	27	-	-	HYPH
cord-023095-4dannjjm	1909	28	infused	infuse	VBN
cord-023095-4dannjjm	1909	29	cats	cat	NNS
cord-023095-4dannjjm	1909	30	showed	show	VBD
cord-023095-4dannjjm	1909	31	a	a	DT
cord-023095-4dannjjm	1909	32	trend	trend	NN
cord-023095-4dannjjm	1909	33	for	for	IN
cord-023095-4dannjjm	1909	34	a	a	DT
cord-023095-4dannjjm	1909	35	decrease	decrease	NN
cord-023095-4dannjjm	1909	36	in	in	IN
cord-023095-4dannjjm	1909	37	PKB	PKB	NNP
cord-023095-4dannjjm	1909	38	/	/	SYM
cord-023095-4dannjjm	1909	39	Akt	Akt	NNP
cord-023095-4dannjjm	1909	40	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	1909	41	(	(	-LRB-
cord-023095-4dannjjm	1909	42	31	31	CD
cord-023095-4dannjjm	1909	43	%	%	NN
cord-023095-4dannjjm	1909	44	lower	low	JJR
cord-023095-4dannjjm	1909	45	than	than	IN
cord-023095-4dannjjm	1909	46	saline	saline	NN
cord-023095-4dannjjm	1909	47	)	)	-RRB-
cord-023095-4dannjjm	1909	48	and	and	CC
cord-023095-4dannjjm	1909	49	had	have	VBD
cord-023095-4dannjjm	1909	50	decreased	decrease	VBN
cord-023095-4dannjjm	1909	51	GLUT4	glut4	JJ
cord-023095-4dannjjm	1909	52	expression	expression	NN
cord-023095-4dannjjm	1909	53	(	(	-LRB-
cord-023095-4dannjjm	1909	54	P	p	NN
cord-023095-4dannjjm	1909	55	o	o	NN
cord-023095-4dannjjm	1909	56	0.05	0.05	CD
cord-023095-4dannjjm	1909	57	)	)	-RRB-
cord-023095-4dannjjm	1909	58	in	in	IN
cord-023095-4dannjjm	1909	59	muscle	muscle	NN
cord-023095-4dannjjm	1909	60	.	.	.
cord-023095-4dannjjm	1910	1	Total	total	JJ
cord-023095-4dannjjm	1910	2	(	(	-LRB-
cord-023095-4dannjjm	1910	3	p	p	NN
cord-023095-4dannjjm	1910	4	o	o	NN
cord-023095-4dannjjm	1910	5	0.01	0.01	CD
cord-023095-4dannjjm	1910	6	)	)	-RRB-
cord-023095-4dannjjm	1910	7	and	and	CC
cord-023095-4dannjjm	1910	8	phosphorylated	phosphorylate	VBN
cord-023095-4dannjjm	1910	9	(	(	-LRB-
cord-023095-4dannjjm	1910	10	P	p	NN
cord-023095-4dannjjm	1910	11	o	o	NN
cord-023095-4dannjjm	1910	12	0.05	0.05	CD
cord-023095-4dannjjm	1910	13	)	)	-RRB-
cord-023095-4dannjjm	1911	1	PKB	PKB	NNP
cord-023095-4dannjjm	1911	2	/	/	SYM
cord-023095-4dannjjm	1911	3	Akt	Akt	NNP
cord-023095-4dannjjm	1911	4	protein	protein	NN
cord-023095-4dannjjm	1911	5	expression	expression	NN
cord-023095-4dannjjm	1911	6	were	be	VBD
cord-023095-4dannjjm	1911	7	decreased	decrease	VBN
cord-023095-4dannjjm	1911	8	in	in	IN
cord-023095-4dannjjm	1911	9	the	the	DT
cord-023095-4dannjjm	1911	10	SC	SC	NNP
cord-023095-4dannjjm	1911	11	adipose	adipose	JJ
cord-023095-4dannjjm	1911	12	tissue	tissue	NN
cord-023095-4dannjjm	1911	13	of	of	IN
cord-023095-4dannjjm	1911	14	LPS	LPS	NNP
cord-023095-4dannjjm	1911	15	-	-	HYPH
cord-023095-4dannjjm	1911	16	infused	infuse	VBN
cord-023095-4dannjjm	1911	17	cats	cat	NNS
cord-023095-4dannjjm	1911	18	compared	compare	VBN
cord-023095-4dannjjm	1911	19	to	to	IN
cord-023095-4dannjjm	1911	20	controls	control	NNS
cord-023095-4dannjjm	1911	21	.	.	.
cord-023095-4dannjjm	1912	1	In	in	IN
cord-023095-4dannjjm	1912	2	these	these	DT
cord-023095-4dannjjm	1912	3	cats	cat	NNS
cord-023095-4dannjjm	1912	4	,	,	,
cord-023095-4dannjjm	1912	5	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	1912	6	of	of	IN
cord-023095-4dannjjm	1912	7	PKB	PKB	NNP
cord-023095-4dannjjm	1912	8	/	/	SYM
cord-023095-4dannjjm	1912	9	Akt	Akt	NNP
cord-023095-4dannjjm	1912	10	protein	protein	NN
cord-023095-4dannjjm	1912	11	was	be	VBD
cord-023095-4dannjjm	1912	12	also	also	RB
cord-023095-4dannjjm	1912	13	decreased	decrease	VBN
cord-023095-4dannjjm	1912	14	in	in	IN
cord-023095-4dannjjm	1912	15	visceral	visceral	JJ
cord-023095-4dannjjm	1912	16	fat	fat	NN
cord-023095-4dannjjm	1912	17	(	(	-LRB-
cord-023095-4dannjjm	1912	18	p	p	NN
cord-023095-4dannjjm	1912	19	o	o	NN
cord-023095-4dannjjm	1912	20	0.01	0.01	CD
cord-023095-4dannjjm	1912	21	)	)	-RRB-
cord-023095-4dannjjm	1912	22	.	.	.
cord-023095-4dannjjm	1913	1	Sustained	sustained	JJ
cord-023095-4dannjjm	1913	2	hyperglycemia	hyperglycemia	NN
cord-023095-4dannjjm	1913	3	and	and	CC
cord-023095-4dannjjm	1913	4	,	,	,
cord-023095-4dannjjm	1913	5	to	to	IN
cord-023095-4dannjjm	1913	6	a	a	DT
cord-023095-4dannjjm	1913	7	lesser	less	JJR
cord-023095-4dannjjm	1913	8	extent	extent	NN
cord-023095-4dannjjm	1913	9	,	,	,
cord-023095-4dannjjm	1913	10	hyperlipidemia	hyperlipidemia	NN
cord-023095-4dannjjm	1913	11	impaired	impair	VBD
cord-023095-4dannjjm	1913	12	insulin	insulin	NN
cord-023095-4dannjjm	1913	13	signaling	signaling	NN
cord-023095-4dannjjm	1913	14	and	and	CC
cord-023095-4dannjjm	1913	15	glucose	glucose	NN
cord-023095-4dannjjm	1913	16	transport	transport	NN
cord-023095-4dannjjm	1913	17	pathways	pathway	NNS
cord-023095-4dannjjm	1913	18	primarily	primarily	RB
cord-023095-4dannjjm	1913	19	in	in	IN
cord-023095-4dannjjm	1913	20	skeletal	skeletal	JJ
cord-023095-4dannjjm	1913	21	muscle	muscle	NN
cord-023095-4dannjjm	1913	22	;	;	:
cord-023095-4dannjjm	1913	23	endotoxemia	endotoxemia	NN
cord-023095-4dannjjm	1913	24	reduced	reduce	VBD
cord-023095-4dannjjm	1913	25	insulin	insulin	NN
cord-023095-4dannjjm	1913	26	sensitivity	sensitivity	NN
cord-023095-4dannjjm	1913	27	mainly	mainly	RB
cord-023095-4dannjjm	1913	28	in	in	IN
cord-023095-4dannjjm	1913	29	adipose	adipose	JJ
cord-023095-4dannjjm	1913	30	tissues	tissue	NNS
cord-023095-4dannjjm	1913	31	.	.	.
cord-023095-4dannjjm	1914	1	Thus	thus	RB
cord-023095-4dannjjm	1914	2	,	,	,
cord-023095-4dannjjm	1914	3	the	the	DT
cord-023095-4dannjjm	1914	4	development	development	NN
cord-023095-4dannjjm	1914	5	of	of	IN
cord-023095-4dannjjm	1914	6	insulin	insulin	NN
cord-023095-4dannjjm	1914	7	resistance	resistance	NN
cord-023095-4dannjjm	1914	8	in	in	IN
cord-023095-4dannjjm	1914	9	response	response	NN
cord-023095-4dannjjm	1914	10	to	to	IN
cord-023095-4dannjjm	1914	11	hyperglycemia	hyperglycemia	NN
cord-023095-4dannjjm	1914	12	,	,	,
cord-023095-4dannjjm	1914	13	hyperlipidemia	hyperlipidemia	NN
cord-023095-4dannjjm	1914	14	or	or	CC
cord-023095-4dannjjm	1914	15	endotoxemia	endotoxemia	NN
cord-023095-4dannjjm	1914	16	might	may	MD
cord-023095-4dannjjm	1914	17	be	be	VB
cord-023095-4dannjjm	1914	18	affected	affect	VBN
cord-023095-4dannjjm	1914	19	by	by	IN
cord-023095-4dannjjm	1914	20	tissue	tissue	NN
cord-023095-4dannjjm	1914	21	-	-	HYPH
cord-023095-4dannjjm	1914	22	specific	specific	JJ
cord-023095-4dannjjm	1914	23	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1914	24	in	in	IN
cord-023095-4dannjjm	1914	25	cats	cat	NNS
cord-023095-4dannjjm	1914	26	.	.	.
cord-023095-4dannjjm	1915	1	Separately	separately	RB
cord-023095-4dannjjm	1915	2	used	use	VBN
cord-023095-4dannjjm	1915	3	,	,	,
cord-023095-4dannjjm	1915	4	Single	Single	NNP
cord-023095-4dannjjm	1915	5	Photon	Photon	NNP
cord-023095-4dannjjm	1915	6	Emission	Emission	NNP
cord-023095-4dannjjm	1915	7	Computed	compute	VBN
cord-023095-4dannjjm	1915	8	Tomography	Tomography	NNP
cord-023095-4dannjjm	1915	9	(	(	-LRB-
cord-023095-4dannjjm	1915	10	SPECT	SPECT	NNP
cord-023095-4dannjjm	1915	11	)	)	-RRB-
cord-023095-4dannjjm	1915	12	and	and	CC
cord-023095-4dannjjm	1915	13	Computed	compute	VBN
cord-023095-4dannjjm	1915	14	Tomography	Tomography	NNP
cord-023095-4dannjjm	1915	15	(	(	-LRB-
cord-023095-4dannjjm	1915	16	CT	CT	NNP
cord-023095-4dannjjm	1915	17	)	)	-RRB-
cord-023095-4dannjjm	1915	18	both	both	DT
cord-023095-4dannjjm	1915	19	lack	lack	VBP
cord-023095-4dannjjm	1915	20	sensitivity	sensitivity	NN
cord-023095-4dannjjm	1915	21	and	and	CC
cord-023095-4dannjjm	1915	22	are	be	VBP
cord-023095-4dannjjm	1915	23	additionally	additionally	RB
cord-023095-4dannjjm	1915	24	hampered	hamper	VBN
cord-023095-4dannjjm	1915	25	by	by	IN
cord-023095-4dannjjm	1915	26	a	a	DT
cord-023095-4dannjjm	1915	27	poor	poor	JJ
cord-023095-4dannjjm	1915	28	anatomical	anatomical	JJ
cord-023095-4dannjjm	1915	29	location	location	NN
cord-023095-4dannjjm	1915	30	capacity	capacity	NN
cord-023095-4dannjjm	1915	31	and	and	CC
cord-023095-4dannjjm	1915	32	a	a	DT
cord-023095-4dannjjm	1915	33	lack	lack	NN
cord-023095-4dannjjm	1915	34	of	of	IN
cord-023095-4dannjjm	1915	35	specificity	specificity	NN
cord-023095-4dannjjm	1915	36	,	,	,
cord-023095-4dannjjm	1915	37	respectively	respectively	RB
cord-023095-4dannjjm	1915	38	.	.	.
cord-023095-4dannjjm	1916	1	These	these	DT
cord-023095-4dannjjm	1916	2	drawbacks	drawback	NNS
cord-023095-4dannjjm	1916	3	suggest	suggest	VBP
cord-023095-4dannjjm	1916	4	an	an	DT
cord-023095-4dannjjm	1916	5	interest	interest	NN
cord-023095-4dannjjm	1916	6	in	in	IN
cord-023095-4dannjjm	1916	7	the	the	DT
cord-023095-4dannjjm	1916	8	fusion	fusion	NN
cord-023095-4dannjjm	1916	9	of	of	IN
cord-023095-4dannjjm	1916	10	images	image	NNS
cord-023095-4dannjjm	1916	11	obtained	obtain	VBN
cord-023095-4dannjjm	1916	12	by	by	IN
cord-023095-4dannjjm	1916	13	the	the	DT
cord-023095-4dannjjm	1916	14	2	2	CD
cord-023095-4dannjjm	1916	15	techniques	technique	NNS
cord-023095-4dannjjm	1916	16	.	.	.
cord-023095-4dannjjm	1917	1	The	the	DT
cord-023095-4dannjjm	1917	2	aim	aim	NN
cord-023095-4dannjjm	1917	3	of	of	IN
cord-023095-4dannjjm	1917	4	this	this	DT
cord-023095-4dannjjm	1917	5	study	study	NN
cord-023095-4dannjjm	1917	6	is	be	VBZ
cord-023095-4dannjjm	1917	7	to	to	TO
cord-023095-4dannjjm	1917	8	test	test	VB
cord-023095-4dannjjm	1917	9	SPECT	SPECT	NNP
cord-023095-4dannjjm	1917	10	/	/	SYM
cord-023095-4dannjjm	1917	11	CT	CT	NNP
cord-023095-4dannjjm	1917	12	fusion	fusion	NN
cord-023095-4dannjjm	1917	13	performance	performance	NN
cord-023095-4dannjjm	1917	14	in	in	IN
cord-023095-4dannjjm	1917	15	dogs	dog	NNS
cord-023095-4dannjjm	1917	16	with	with	IN
cord-023095-4dannjjm	1917	17	insulinoma	insulinoma	NN
cord-023095-4dannjjm	1917	18	.	.	.
cord-023095-4dannjjm	1918	1	Inclusion	inclusion	NN
cord-023095-4dannjjm	1918	2	criteria	criterion	NNS
cord-023095-4dannjjm	1918	3	were	be	VBD
cord-023095-4dannjjm	1918	4	:	:	:
cord-023095-4dannjjm	1918	5	1/	1/	CD
cord-023095-4dannjjm	1918	6	a	a	DT
cord-023095-4dannjjm	1918	7	biological	biological	JJ
cord-023095-4dannjjm	1918	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	1918	9	of	of	IN
cord-023095-4dannjjm	1918	10	insulinoma	insulinoma	NN
cord-023095-4dannjjm	1918	11	;	;	:
cord-023095-4dannjjm	1918	12	2/	2/	CD
cord-023095-4dannjjm	1918	13	an	an	DT
cord-023095-4dannjjm	1918	14	examination	examination	NN
cord-023095-4dannjjm	1918	15	by	by	IN
cord-023095-4dannjjm	1918	16	high	high	JJ
cord-023095-4dannjjm	1918	17	resolution	resolution	NN
cord-023095-4dannjjm	1918	18	CT	CT	NNP
cord-023095-4dannjjm	1918	19	scan	scan	NN
cord-023095-4dannjjm	1918	20	and	and	CC
cord-023095-4dannjjm	1919	1	111	111	CD
cord-023095-4dannjjm	1919	2	In	in	IN
cord-023095-4dannjjm	1919	3	-	-	HYPH
cord-023095-4dannjjm	1919	4	pentetreotide	pentetreotide	NN
cord-023095-4dannjjm	1919	5	SPECT	SPECT	NNS
cord-023095-4dannjjm	1919	6	followed	follow	VBN
cord-023095-4dannjjm	1919	7	by	by	IN
cord-023095-4dannjjm	1919	8	SPECT	SPECT	NNP
cord-023095-4dannjjm	1919	9	/	/	SYM
cord-023095-4dannjjm	1919	10	CT	CT	NNP
cord-023095-4dannjjm	1919	11	fusion	fusion	NN
cord-023095-4dannjjm	1919	12	;	;	:
cord-023095-4dannjjm	1919	13	3/	3/	CD
cord-023095-4dannjjm	1919	14	a	a	DT
cord-023095-4dannjjm	1919	15	surgical	surgical	JJ
cord-023095-4dannjjm	1919	16	or	or	CC
cord-023095-4dannjjm	1919	17	post	post	AFX
cord-023095-4dannjjm	1919	18	mortem	mortem	NN
cord-023095-4dannjjm	1919	19	examination	examination	NN
cord-023095-4dannjjm	1919	20	completed	complete	VBN
cord-023095-4dannjjm	1919	21	by	by	IN
cord-023095-4dannjjm	1919	22	histopathological	histopathological	NNP
cord-023095-4dannjjm	1919	23	analysis	analysis	NN
cord-023095-4dannjjm	1919	24	.	.	.
cord-023095-4dannjjm	1920	1	SPECT	SPECT	NNP
cord-023095-4dannjjm	1920	2	examination	examination	NN
cord-023095-4dannjjm	1920	3	showing	show	VBG
cord-023095-4dannjjm	1920	4	abnormal	abnormal	JJ
cord-023095-4dannjjm	1920	5	foci	foci	NN
cord-023095-4dannjjm	1920	6	and	and	CC
cord-023095-4dannjjm	1920	7	CT	CT	NNP
cord-023095-4dannjjm	1920	8	scan	scan	NN
cord-023095-4dannjjm	1920	9	showing	show	VBG
cord-023095-4dannjjm	1920	10	pancreas	pancreas	NN
cord-023095-4dannjjm	1920	11	,	,	,
cord-023095-4dannjjm	1920	12	lymph	lymph	NN
cord-023095-4dannjjm	1920	13	nodes	node	NNS
cord-023095-4dannjjm	1920	14	(	(	-LRB-
cord-023095-4dannjjm	1920	15	LN	LN	NNP
cord-023095-4dannjjm	1920	16	)	)	-RRB-
cord-023095-4dannjjm	1920	17	or	or	CC
cord-023095-4dannjjm	1920	18	liver	liver	NN
cord-023095-4dannjjm	1920	19	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1920	20	were	be	VBD
cord-023095-4dannjjm	1920	21	considered	consider	VBN
cord-023095-4dannjjm	1920	22	positive	positive	JJ
cord-023095-4dannjjm	1920	23	.	.	.
cord-023095-4dannjjm	1921	1	In	in	IN
cord-023095-4dannjjm	1921	2	case	case	NN
cord-023095-4dannjjm	1921	3	of	of	IN
cord-023095-4dannjjm	1921	4	double	double	JJ
cord-023095-4dannjjm	1921	5	positivity	positivity	NN
cord-023095-4dannjjm	1921	6	,	,	,
cord-023095-4dannjjm	1921	7	presence	presence	NN
cord-023095-4dannjjm	1921	8	(	(	-LRB-
cord-023095-4dannjjm	1921	9	IMP1	IMP1	NNP
cord-023095-4dannjjm	1921	10	)	)	-RRB-
cord-023095-4dannjjm	1921	11	or	or	CC
cord-023095-4dannjjm	1921	12	absence	absence	NN
cord-023095-4dannjjm	1921	13	(	(	-LRB-
cord-023095-4dannjjm	1921	14	IMP-	IMP-	NNP
cord-023095-4dannjjm	1921	15	)	)	-RRB-
cord-023095-4dannjjm	1921	16	of	of	IN
cord-023095-4dannjjm	1921	17	superimposition	superimposition	NN
cord-023095-4dannjjm	1921	18	of	of	IN
cord-023095-4dannjjm	1921	19	abnormal	abnormal	JJ
cord-023095-4dannjjm	1921	20	images	image	NNS
cord-023095-4dannjjm	1921	21	was	be	VBD
cord-023095-4dannjjm	1921	22	noted	note	VBN
cord-023095-4dannjjm	1921	23	.	.	.
cord-023095-4dannjjm	1922	1	Ten	ten	CD
cord-023095-4dannjjm	1922	2	dogs	dog	NNS
cord-023095-4dannjjm	1922	3	were	be	VBD
cord-023095-4dannjjm	1922	4	included	include	VBN
cord-023095-4dannjjm	1922	5	.	.	.
cord-023095-4dannjjm	1923	1	In	in	IN
cord-023095-4dannjjm	1923	2	2/10	2/10	CD
cord-023095-4dannjjm	1923	3	dogs	dog	NNS
cord-023095-4dannjjm	1923	4	,	,	,
cord-023095-4dannjjm	1923	5	superimposition	superimposition	NN
cord-023095-4dannjjm	1923	6	of	of	IN
cord-023095-4dannjjm	1923	7	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1923	8	could	could	MD
cord-023095-4dannjjm	1923	9	n't	not	RB
cord-023095-4dannjjm	1923	10	be	be	VB
cord-023095-4dannjjm	1923	11	tested	test	VBN
cord-023095-4dannjjm	1923	12	.	.	.
cord-023095-4dannjjm	1924	1	CT	CT	NNP
cord-023095-4dannjjm	1924	2	scan	scan	NN
cord-023095-4dannjjm	1924	3	detected	detect	VBD
cord-023095-4dannjjm	1924	4	3	3	CD
cord-023095-4dannjjm	1924	5	abnormal	abnormal	JJ
cord-023095-4dannjjm	1924	6	images	image	NNS
cord-023095-4dannjjm	1924	7	[	[	-LRB-
cord-023095-4dannjjm	1924	8	2	2	CD
cord-023095-4dannjjm	1924	9	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	1924	10	nodules	nodule	NNS
cord-023095-4dannjjm	1924	11	(	(	-LRB-
cord-023095-4dannjjm	1924	12	PN	PN	NNP
cord-023095-4dannjjm	1924	13	)	)	-RRB-
cord-023095-4dannjjm	1924	14	,	,	,
cord-023095-4dannjjm	1924	15	1	1	CD
cord-023095-4dannjjm	1924	16	enlarged	enlarge	VBD
cord-023095-4dannjjm	1924	17	LN	LN	NNP
cord-023095-4dannjjm	1924	18	(	(	-LRB-
cord-023095-4dannjjm	1924	19	ELN	ELN	NNP
cord-023095-4dannjjm	1924	20	)	)	-RRB-
cord-023095-4dannjjm	1924	21	]	]	-RRB-
cord-023095-4dannjjm	1924	22	while	while	IN
cord-023095-4dannjjm	1924	23	SPECT	SPECT	NNP
cord-023095-4dannjjm	1924	24	failed	fail	VBD
cord-023095-4dannjjm	1924	25	to	to	TO
cord-023095-4dannjjm	1924	26	show	show	VB
cord-023095-4dannjjm	1924	27	any	any	DT
cord-023095-4dannjjm	1924	28	abnormal	abnormal	JJ
cord-023095-4dannjjm	1924	29	uptake	uptake	NN
cord-023095-4dannjjm	1924	30	.	.	.
cord-023095-4dannjjm	1925	1	Both	both	DT
cord-023095-4dannjjm	1925	2	dogs	dog	NNS
cord-023095-4dannjjm	1925	3	became	become	VBD
cord-023095-4dannjjm	1925	4	euglycemic	euglycemic	JJ
cord-023095-4dannjjm	1925	5	after	after	IN
cord-023095-4dannjjm	1925	6	removal	removal	NN
cord-023095-4dannjjm	1925	7	of	of	IN
cord-023095-4dannjjm	1925	8	PN	PN	NNP
cord-023095-4dannjjm	1925	9	and	and	CC
cord-023095-4dannjjm	1925	10	LN	LN	NNP
cord-023095-4dannjjm	1925	11	designed	design	VBN
cord-023095-4dannjjm	1925	12	by	by	IN
cord-023095-4dannjjm	1925	13	CT	CT	NNP
cord-023095-4dannjjm	1925	14	scan	scan	NN
cord-023095-4dannjjm	1925	15	.	.	.
cord-023095-4dannjjm	1926	1	In	in	IN
cord-023095-4dannjjm	1926	2	6/	6/	CD
cord-023095-4dannjjm	1926	3	10	10	CD
cord-023095-4dannjjm	1926	4	,	,	,
cord-023095-4dannjjm	1926	5	all	all	DT
cord-023095-4dannjjm	1926	6	abnormal	abnormal	JJ
cord-023095-4dannjjm	1926	7	images	image	NNS
cord-023095-4dannjjm	1926	8	were	be	VBD
cord-023095-4dannjjm	1926	9	classified	classify	VBN
cord-023095-4dannjjm	1926	10	as	as	IN
cord-023095-4dannjjm	1926	11	IMP1	IMP1	NNP
cord-023095-4dannjjm	1926	12	[	[	-LRB-
cord-023095-4dannjjm	1926	13	6	6	CD
cord-023095-4dannjjm	1926	14	PN	PN	NNP
cord-023095-4dannjjm	1926	15	,	,	,
cord-023095-4dannjjm	1926	16	1	1	CD
cord-023095-4dannjjm	1926	17	ELN	ELN	NNP
cord-023095-4dannjjm	1926	18	and	and	CC
cord-023095-4dannjjm	1926	19	1	1	CD
cord-023095-4dannjjm	1926	20	diffuse	diffuse	JJ
cord-023095-4dannjjm	1926	21	hepatic	hepatic	JJ
cord-023095-4dannjjm	1926	22	infiltration	infiltration	NN
cord-023095-4dannjjm	1926	23	(	(	-LRB-
cord-023095-4dannjjm	1926	24	DHI	DHI	NNP
cord-023095-4dannjjm	1926	25	)	)	-RRB-
cord-023095-4dannjjm	1926	26	]	]	-RRB-
cord-023095-4dannjjm	1926	27	.	.	.
cord-023095-4dannjjm	1927	1	Surgery	surgery	NN
cord-023095-4dannjjm	1927	2	performed	perform	VBD
cord-023095-4dannjjm	1927	3	on	on	IN
cord-023095-4dannjjm	1927	4	5/6	5/6	CD
cord-023095-4dannjjm	1927	5	resulted	result	VBD
cord-023095-4dannjjm	1927	6	in	in	IN
cord-023095-4dannjjm	1927	7	euglycemia	euglycemia	NN
cord-023095-4dannjjm	1927	8	in	in	IN
cord-023095-4dannjjm	1927	9	4	4	CD
cord-023095-4dannjjm	1927	10	;	;	SYM
cord-023095-4dannjjm	1927	11	1	1	CD
cord-023095-4dannjjm	1927	12	dog	dog	NN
cord-023095-4dannjjm	1927	13	remained	remain	VBD
cord-023095-4dannjjm	1927	14	hypoglycemic	hypoglycemic	JJ
cord-023095-4dannjjm	1927	15	after	after	IN
cord-023095-4dannjjm	1927	16	partial	partial	JJ
cord-023095-4dannjjm	1927	17	removal	removal	NN
cord-023095-4dannjjm	1927	18	of	of	IN
cord-023095-4dannjjm	1927	19	1	1	CD
cord-023095-4dannjjm	1927	20	PN	pn	NN
cord-023095-4dannjjm	1927	21	.	.	.
cord-023095-4dannjjm	1928	1	PN	PN	NNP
cord-023095-4dannjjm	1928	2	localization	localization	NN
cord-023095-4dannjjm	1928	3	and	and	CC
cord-023095-4dannjjm	1928	4	DHI	DHI	NNP
cord-023095-4dannjjm	1928	5	were	be	VBD
cord-023095-4dannjjm	1928	6	confirmed	confirm	VBN
cord-023095-4dannjjm	1928	7	after	after	IN
cord-023095-4dannjjm	1928	8	necropsy	necropsy	JJ
cord-023095-4dannjjm	1928	9	in	in	IN
cord-023095-4dannjjm	1928	10	the	the	DT
cord-023095-4dannjjm	1928	11	6	6	CD
cord-023095-4dannjjm	1928	12	th	th	XX
cord-023095-4dannjjm	1928	13	dog	dog	NN
cord-023095-4dannjjm	1928	14	.	.	.
cord-023095-4dannjjm	1929	1	In	in	IN
cord-023095-4dannjjm	1929	2	2/10	2/10	CD
cord-023095-4dannjjm	1929	3	dogs	dog	NNS
cord-023095-4dannjjm	1929	4	IMP1	IMP1	NNP
cord-023095-4dannjjm	1929	5	and	and	CC
cord-023095-4dannjjm	1929	6	IMP	IMP	NNP
cord-023095-4dannjjm	1929	7	-	-	HYPH
cord-023095-4dannjjm	1929	8	images	image	NNS
cord-023095-4dannjjm	1929	9	were	be	VBD
cord-023095-4dannjjm	1929	10	both	both	DT
cord-023095-4dannjjm	1929	11	recorded	record	VBN
cord-023095-4dannjjm	1929	12	.	.	.
cord-023095-4dannjjm	1930	1	In	in	IN
cord-023095-4dannjjm	1930	2	1	1	CD
cord-023095-4dannjjm	1930	3	dog	dog	NN
cord-023095-4dannjjm	1930	4	,	,	,
cord-023095-4dannjjm	1930	5	a	a	DT
cord-023095-4dannjjm	1930	6	DHI	DHI	NNP
cord-023095-4dannjjm	1930	7	was	be	VBD
cord-023095-4dannjjm	1930	8	classified	classify	VBN
cord-023095-4dannjjm	1930	9	as	as	IN
cord-023095-4dannjjm	1930	10	IMP1	IMP1	NNP
cord-023095-4dannjjm	1930	11	but	but	CC
cord-023095-4dannjjm	1930	12	PN	PN	NNP
cord-023095-4dannjjm	1930	13	localization	localization	NN
cord-023095-4dannjjm	1930	14	was	be	VBD
cord-023095-4dannjjm	1930	15	IMP-	IMP-	NNP
cord-023095-4dannjjm	1930	16	:	:	:
cord-023095-4dannjjm	1930	17	localized	localize	VBN
cord-023095-4dannjjm	1930	18	in	in	IN
cord-023095-4dannjjm	1930	19	the	the	DT
cord-023095-4dannjjm	1930	20	left	left	JJ
cord-023095-4dannjjm	1930	21	lobe	lobe	NN
cord-023095-4dannjjm	1930	22	by	by	IN
cord-023095-4dannjjm	1930	23	CT	CT	NNP
cord-023095-4dannjjm	1930	24	scan	scan	NNP
cord-023095-4dannjjm	1930	25	and	and	CC
cord-023095-4dannjjm	1930	26	in	in	IN
cord-023095-4dannjjm	1930	27	the	the	DT
cord-023095-4dannjjm	1930	28	corpus	corpus	NN
cord-023095-4dannjjm	1930	29	by	by	IN
cord-023095-4dannjjm	1930	30	SPECT	SPECT	NNP
cord-023095-4dannjjm	1930	31	,	,	,
cord-023095-4dannjjm	1930	32	the	the	DT
cord-023095-4dannjjm	1930	33	latest	late	JJS
cord-023095-4dannjjm	1930	34	localization	localization	NN
cord-023095-4dannjjm	1930	35	being	be	VBG
cord-023095-4dannjjm	1930	36	confirmed	confirm	VBN
cord-023095-4dannjjm	1930	37	after	after	IN
cord-023095-4dannjjm	1930	38	necropsy	necropsy	JJ
cord-023095-4dannjjm	1930	39	.	.	.
cord-023095-4dannjjm	1931	1	In	in	IN
cord-023095-4dannjjm	1931	2	the	the	DT
cord-023095-4dannjjm	1931	3	other	other	JJ
cord-023095-4dannjjm	1931	4	dog	dog	NN
cord-023095-4dannjjm	1931	5	PN	pn	NN
cord-023095-4dannjjm	1931	6	localization	localization	NN
cord-023095-4dannjjm	1931	7	was	be	VBD
cord-023095-4dannjjm	1931	8	IMP1	IMP1	NNP
cord-023095-4dannjjm	1931	9	but	but	CC
cord-023095-4dannjjm	1931	10	a	a	DT
cord-023095-4dannjjm	1931	11	diffuse	diffuse	JJ
cord-023095-4dannjjm	1931	12	SPECT	spect	NN
cord-023095-4dannjjm	1931	13	signal	signal	NN
cord-023095-4dannjjm	1931	14	superimposing	superimposing	NN
cord-023095-4dannjjm	1931	15	to	to	IN
cord-023095-4dannjjm	1931	16	the	the	DT
cord-023095-4dannjjm	1931	17	liver	liver	NN
cord-023095-4dannjjm	1931	18	considered	consider	VBN
cord-023095-4dannjjm	1931	19	as	as	RB
cord-023095-4dannjjm	1931	20	normal	normal	JJ
cord-023095-4dannjjm	1931	21	on	on	IN
cord-023095-4dannjjm	1931	22	CT	CT	NNP
cord-023095-4dannjjm	1931	23	scan	scan	NNP
cord-023095-4dannjjm	1931	24	was	be	VBD
cord-023095-4dannjjm	1931	25	noted	note	VBN
cord-023095-4dannjjm	1931	26	.	.	.
cord-023095-4dannjjm	1932	1	Hepatic	hepatic	JJ
cord-023095-4dannjjm	1932	2	biopsy	biopsy	NN
cord-023095-4dannjjm	1932	3	confirmed	confirm	VBD
cord-023095-4dannjjm	1932	4	SPECT	SPECT	NNP
cord-023095-4dannjjm	1932	5	results	result	NNS
cord-023095-4dannjjm	1932	6	.	.	.
cord-023095-4dannjjm	1933	1	This	this	DT
cord-023095-4dannjjm	1933	2	study	study	NN
cord-023095-4dannjjm	1933	3	confirms	confirm	VBZ
cord-023095-4dannjjm	1933	4	an	an	DT
cord-023095-4dannjjm	1933	5	imperfect	imperfect	JJ
cord-023095-4dannjjm	1933	6	sensitivity	sensitivity	NN
cord-023095-4dannjjm	1933	7	of	of	IN
cord-023095-4dannjjm	1933	8	both	both	DT
cord-023095-4dannjjm	1933	9	CT	CT	NNP
cord-023095-4dannjjm	1933	10	scan	scan	NN
cord-023095-4dannjjm	1933	11	and	and	CC
cord-023095-4dannjjm	1933	12	SPECT	SPECT	NNS
cord-023095-4dannjjm	1933	13	.	.	.
cord-023095-4dannjjm	1934	1	It	-PRON-	PRP
cord-023095-4dannjjm	1934	2	confirms	confirm	VBZ
cord-023095-4dannjjm	1934	3	that	that	IN
cord-023095-4dannjjm	1934	4	CT	CT	NNP
cord-023095-4dannjjm	1934	5	scan	scan	NN
cord-023095-4dannjjm	1934	6	can	can	MD
cord-023095-4dannjjm	1934	7	be	be	VB
cord-023095-4dannjjm	1934	8	associated	associate	VBN
cord-023095-4dannjjm	1934	9	with	with	IN
cord-023095-4dannjjm	1934	10	unspecific	unspecific	JJ
cord-023095-4dannjjm	1934	11	abnormal	abnormal	JJ
cord-023095-4dannjjm	1934	12	images	image	NNS
cord-023095-4dannjjm	1934	13	.	.	.
cord-023095-4dannjjm	1935	1	Subject	subject	JJ
cord-023095-4dannjjm	1935	2	to	to	IN
cord-023095-4dannjjm	1935	3	a	a	DT
cord-023095-4dannjjm	1935	4	confirmation	confirmation	NN
cord-023095-4dannjjm	1935	5	on	on	IN
cord-023095-4dannjjm	1935	6	a	a	DT
cord-023095-4dannjjm	1935	7	larger	large	JJR
cord-023095-4dannjjm	1935	8	cohort	cohort	NN
cord-023095-4dannjjm	1935	9	of	of	IN
cord-023095-4dannjjm	1935	10	dogs	dog	NNS
cord-023095-4dannjjm	1935	11	,	,	,
cord-023095-4dannjjm	1935	12	it	-PRON-	PRP
cord-023095-4dannjjm	1935	13	indicates	indicate	VBZ
cord-023095-4dannjjm	1935	14	that	that	IN
cord-023095-4dannjjm	1935	15	IMP1	IMP1	NNP
cord-023095-4dannjjm	1935	16	images	image	NNS
cord-023095-4dannjjm	1935	17	provide	provide	VB
cord-023095-4dannjjm	1935	18	specific	specific	JJ
cord-023095-4dannjjm	1935	19	detection	detection	NN
cord-023095-4dannjjm	1935	20	and	and	CC
cord-023095-4dannjjm	1935	21	accurate	accurate	JJ
cord-023095-4dannjjm	1935	22	localization	localization	NN
cord-023095-4dannjjm	1935	23	of	of	IN
cord-023095-4dannjjm	1935	24	canine	canine	JJ
cord-023095-4dannjjm	1935	25	insulinomas	insulinomas	NNP
cord-023095-4dannjjm	1935	26	'	'	POS
cord-023095-4dannjjm	1935	27	primary	primary	JJ
cord-023095-4dannjjm	1935	28	lesions	lesion	NNS
cord-023095-4dannjjm	1935	29	and	and	CC
cord-023095-4dannjjm	1935	30	metastasis	metastasis	NN
cord-023095-4dannjjm	1935	31	.	.	.
cord-023095-4dannjjm	1936	1	The	the	DT
cord-023095-4dannjjm	1936	2	majority	majority	NN
cord-023095-4dannjjm	1936	3	of	of	IN
cord-023095-4dannjjm	1936	4	dogs	dog	NNS
cord-023095-4dannjjm	1936	5	with	with	IN
cord-023095-4dannjjm	1936	6	primary	primary	JJ
cord-023095-4dannjjm	1936	7	hypoadrenocorticism	hypoadrenocorticism	NN
cord-023095-4dannjjm	1936	8	(	(	-LRB-
cord-023095-4dannjjm	1936	9	PH	PH	NNP
cord-023095-4dannjjm	1936	10	)	)	-RRB-
cord-023095-4dannjjm	1936	11	reveal	reveal	VB
cord-023095-4dannjjm	1936	12	clinical	clinical	JJ
cord-023095-4dannjjm	1936	13	and	and	CC
cord-023095-4dannjjm	1936	14	laboratory	laboratory	NN
cord-023095-4dannjjm	1936	15	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1936	16	of	of	IN
cord-023095-4dannjjm	1936	17	gluco	gluco	NNP
cord-023095-4dannjjm	1936	18	-	-	HYPH
cord-023095-4dannjjm	1936	19	and	and	CC
cord-023095-4dannjjm	1936	20	mineralocorticoid	mineralocorticoid	NN
cord-023095-4dannjjm	1936	21	deficiency	deficiency	NN
cord-023095-4dannjjm	1936	22	.	.	.
cord-023095-4dannjjm	1937	1	In	in	IN
cord-023095-4dannjjm	1937	2	some	some	DT
cord-023095-4dannjjm	1937	3	of	of	IN
cord-023095-4dannjjm	1937	4	them	-PRON-	PRP
cord-023095-4dannjjm	1937	5	sodium	sodium	NN
cord-023095-4dannjjm	1937	6	and	and	CC
cord-023095-4dannjjm	1937	7	potassium	potassium	NN
cord-023095-4dannjjm	1937	8	levels	level	NNS
cord-023095-4dannjjm	1937	9	are	be	VBP
cord-023095-4dannjjm	1937	10	normal	normal	JJ
cord-023095-4dannjjm	1937	11	,	,	,
cord-023095-4dannjjm	1937	12	a	a	DT
cord-023095-4dannjjm	1937	13	phenomenon	phenomenon	NN
cord-023095-4dannjjm	1937	14	currently	currently	RB
cord-023095-4dannjjm	1937	15	called	call	VBN
cord-023095-4dannjjm	1937	16	atypical	atypical	JJ
cord-023095-4dannjjm	1937	17	Addison	Addison	NNP
cord-023095-4dannjjm	1937	18	's	's	POS
cord-023095-4dannjjm	1937	19	.	.	.
cord-023095-4dannjjm	1938	1	It	-PRON-	PRP
cord-023095-4dannjjm	1938	2	has	have	VBZ
cord-023095-4dannjjm	1938	3	been	be	VBN
cord-023095-4dannjjm	1938	4	postulated	postulate	VBN
cord-023095-4dannjjm	1938	5	that	that	IN
cord-023095-4dannjjm	1938	6	in	in	IN
cord-023095-4dannjjm	1938	7	those	those	DT
cord-023095-4dannjjm	1938	8	cases	case	NNS
cord-023095-4dannjjm	1938	9	adrenal	adrenal	JJ
cord-023095-4dannjjm	1938	10	destruction	destruction	NN
cord-023095-4dannjjm	1938	11	is	be	VBZ
cord-023095-4dannjjm	1938	12	confined	confine	VBN
cord-023095-4dannjjm	1938	13	to	to	IN
cord-023095-4dannjjm	1938	14	the	the	DT
cord-023095-4dannjjm	1938	15	zona	zona	NNP
cord-023095-4dannjjm	1938	16	fasciculata	fasciculata	NNP
cord-023095-4dannjjm	1938	17	/	/	SYM
cord-023095-4dannjjm	1938	18	reticularis	reticularis	NNPS
cord-023095-4dannjjm	1938	19	,	,	,
cord-023095-4dannjjm	1938	20	resulting	result	VBG
cord-023095-4dannjjm	1938	21	in	in	IN
cord-023095-4dannjjm	1938	22	isolated	isolate	VBN
cord-023095-4dannjjm	1938	23	glucocorticoid	glucocorticoid	NN
cord-023095-4dannjjm	1938	24	deficiency	deficiency	NN
cord-023095-4dannjjm	1938	25	.	.	.
cord-023095-4dannjjm	1939	1	However	however	RB
cord-023095-4dannjjm	1939	2	,	,	,
cord-023095-4dannjjm	1939	3	there	there	EX
cord-023095-4dannjjm	1939	4	are	be	VBP
cord-023095-4dannjjm	1939	5	no	no	DT
cord-023095-4dannjjm	1939	6	histological	histological	JJ
cord-023095-4dannjjm	1939	7	studies	study	NNS
cord-023095-4dannjjm	1939	8	confirming	confirm	VBG
cord-023095-4dannjjm	1939	9	a	a	DT
cord-023095-4dannjjm	1939	10	normal	normal	JJ
cord-023095-4dannjjm	1939	11	zona	zona	NNP
cord-023095-4dannjjm	1939	12	glomerulosa	glomerulosa	JJ
cord-023095-4dannjjm	1939	13	and	and	CC
cord-023095-4dannjjm	1939	14	in	in	IN
cord-023095-4dannjjm	1939	15	most	most	RBS
cord-023095-4dannjjm	1939	16	reported	report	VBN
cord-023095-4dannjjm	1939	17	cases	case	NNS
cord-023095-4dannjjm	1939	18	diagnosis	diagnosis	NN
cord-023095-4dannjjm	1939	19	was	be	VBD
cord-023095-4dannjjm	1939	20	based	base	VBN
cord-023095-4dannjjm	1939	21	solely	solely	RB
cord-023095-4dannjjm	1939	22	on	on	IN
cord-023095-4dannjjm	1939	23	low	low	JJ
cord-023095-4dannjjm	1939	24	post	post	JJ
cord-023095-4dannjjm	1939	25	-	-	JJ
cord-023095-4dannjjm	1939	26	ACTH	acth	JJ
cord-023095-4dannjjm	1939	27	cortisol	cortisol	NN
cord-023095-4dannjjm	1939	28	levels	level	NNS
cord-023095-4dannjjm	1939	29	.	.	.
cord-023095-4dannjjm	1940	1	The	the	DT
cord-023095-4dannjjm	1940	2	aim	aim	NN
cord-023095-4dannjjm	1940	3	of	of	IN
cord-023095-4dannjjm	1940	4	the	the	DT
cord-023095-4dannjjm	1940	5	study	study	NN
cord-023095-4dannjjm	1940	6	was	be	VBD
cord-023095-4dannjjm	1940	7	to	to	TO
cord-023095-4dannjjm	1940	8	evaluate	evaluate	VB
cord-023095-4dannjjm	1940	9	aldosterone	aldosterone	NN
cord-023095-4dannjjm	1940	10	(	(	-LRB-
cord-023095-4dannjjm	1940	11	ALDO	ALDO	NNP
cord-023095-4dannjjm	1940	12	)	)	-RRB-
cord-023095-4dannjjm	1940	13	levels	level	NNS
cord-023095-4dannjjm	1940	14	in	in	IN
cord-023095-4dannjjm	1940	15	dogs	dog	NNS
cord-023095-4dannjjm	1940	16	with	with	IN
cord-023095-4dannjjm	1940	17	PH	PH	NNP
cord-023095-4dannjjm	1940	18	with	with	IN
cord-023095-4dannjjm	1940	19	and	and	CC
cord-023095-4dannjjm	1940	20	without	without	IN
cord-023095-4dannjjm	1940	21	electrolyte	electrolyte	JJ
cord-023095-4dannjjm	1940	22	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1940	23	.	.	.
cord-023095-4dannjjm	1941	1	Seventy	seventy	CD
cord-023095-4dannjjm	1941	2	dogs	dog	NNS
cord-023095-4dannjjm	1941	3	with	with	IN
cord-023095-4dannjjm	1941	4	newly	newly	RB
cord-023095-4dannjjm	1941	5	diagnosed	diagnose	VBN
cord-023095-4dannjjm	1941	6	PH	PH	NNP
cord-023095-4dannjjm	1941	7	were	be	VBD
cord-023095-4dannjjm	1941	8	included	include	VBN
cord-023095-4dannjjm	1941	9	.	.	.
cord-023095-4dannjjm	1942	1	ALDO	ALDO	NNP
cord-023095-4dannjjm	1942	2	concentrations	concentration	NNS
cord-023095-4dannjjm	1942	3	(	(	-LRB-
cord-023095-4dannjjm	1942	4	RIA	RIA	NNP
cord-023095-4dannjjm	1942	5	,	,	,
cord-023095-4dannjjm	1942	6	Coat	Coat	NNP
cord-023095-4dannjjm	1942	7	-	-	HYPH
cord-023095-4dannjjm	1942	8	A	A	NNP
cord-023095-4dannjjm	1942	9	-	-	HYPH
cord-023095-4dannjjm	1942	10	Count	Count	NNP
cord-023095-4dannjjm	1942	11	s	s	NNP
cord-023095-4dannjjm	1942	12	,	,	,
cord-023095-4dannjjm	1942	13	Siemens	Siemens	NNP
cord-023095-4dannjjm	1942	14	)	)	-RRB-
cord-023095-4dannjjm	1942	15	were	be	VBD
cord-023095-4dannjjm	1942	16	measured	measure	VBN
cord-023095-4dannjjm	1942	17	before	before	RB
cord-023095-4dannjjm	1942	18	and	and	CC
cord-023095-4dannjjm	1942	19	60	60	CD
cord-023095-4dannjjm	1942	20	min	min	NN
cord-023095-4dannjjm	1942	21	after	after	IN
cord-023095-4dannjjm	1942	22	administration	administration	NN
cord-023095-4dannjjm	1942	23	of	of	IN
cord-023095-4dannjjm	1942	24	250	250	CD
cord-023095-4dannjjm	1942	25	mg	mg	CD
cord-023095-4dannjjm	1942	26	synthetic	synthetic	JJ
cord-023095-4dannjjm	1942	27	ACTH	ACTH	NNP
cord-023095-4dannjjm	1943	1	(	(	-LRB-
cord-023095-4dannjjm	1943	2	Synacthen	Synacthen	NNP
cord-023095-4dannjjm	1943	3	s	s	NNP
cord-023095-4dannjjm	1943	4	,	,	,
cord-023095-4dannjjm	1943	5	Novartis	Novartis	NNP
cord-023095-4dannjjm	1943	6	)	)	-RRB-
cord-023095-4dannjjm	1943	7	IV	IV	NNP
cord-023095-4dannjjm	1943	8	.	.	.
cord-023095-4dannjjm	1944	1	Results	result	NNS
cord-023095-4dannjjm	1944	2	were	be	VBD
cord-023095-4dannjjm	1944	3	compared	compare	VBN
cord-023095-4dannjjm	1944	4	to	to	IN
cord-023095-4dannjjm	1944	5	those	those	DT
cord-023095-4dannjjm	1944	6	of	of	IN
cord-023095-4dannjjm	1944	7	19	19	CD
cord-023095-4dannjjm	1944	8	healthy	healthy	JJ
cord-023095-4dannjjm	1944	9	dogs	dog	NNS
cord-023095-4dannjjm	1944	10	and	and	CC
cord-023095-4dannjjm	1944	11	17	17	CD
cord-023095-4dannjjm	1944	12	dogs	dog	NNS
cord-023095-4dannjjm	1944	13	with	with	IN
cord-023095-4dannjjm	1944	14	diseases	disease	NNS
cord-023095-4dannjjm	1944	15	mimicking	mimic	VBG
cord-023095-4dannjjm	1944	16	PH	PH	NNP
cord-023095-4dannjjm	1944	17	.	.	.
cord-023095-4dannjjm	1945	1	To	to	TO
cord-023095-4dannjjm	1945	2	confirm	confirm	VB
cord-023095-4dannjjm	1945	3	that	that	IN
cord-023095-4dannjjm	1945	4	peak	peak	NN
cord-023095-4dannjjm	1945	5	concentrations	concentration	NNS
cord-023095-4dannjjm	1945	6	were	be	VBD
cord-023095-4dannjjm	1945	7	not	not	RB
cord-023095-4dannjjm	1945	8	missed	miss	VBN
cord-023095-4dannjjm	1945	9	ALDO	ALDO	NNP
cord-023095-4dannjjm	1945	10	was	be	VBD
cord-023095-4dannjjm	1945	11	additionally	additionally	RB
cord-023095-4dannjjm	1945	12	measured	measure	VBN
cord-023095-4dannjjm	1945	13	15	15	CD
cord-023095-4dannjjm	1945	14	,	,	,
cord-023095-4dannjjm	1945	15	30	30	CD
cord-023095-4dannjjm	1945	16	and	and	CC
cord-023095-4dannjjm	1945	17	45	45	CD
cord-023095-4dannjjm	1945	18	min	min	NN
cord-023095-4dannjjm	1945	19	after	after	IN
cord-023095-4dannjjm	1945	20	ACTH	ACTH	NNP
cord-023095-4dannjjm	1945	21	in	in	IN
cord-023095-4dannjjm	1945	22	19	19	CD
cord-023095-4dannjjm	1945	23	dogs	dog	NNS
cord-023095-4dannjjm	1945	24	(	(	-LRB-
cord-023095-4dannjjm	1945	25	5	5	CD
cord-023095-4dannjjm	1945	26	with	with	IN
cord-023095-4dannjjm	1945	27	PH	PH	NNP
cord-023095-4dannjjm	1945	28	,	,	,
cord-023095-4dannjjm	1945	29	14	14	CD
cord-023095-4dannjjm	1945	30	with	with	IN
cord-023095-4dannjjm	1945	31	PH	PH	NNP
cord-023095-4dannjjm	1945	32	mimicking	mimic	VBG
cord-023095-4dannjjm	1945	33	diseases	disease	NNS
cord-023095-4dannjjm	1945	34	)	)	-RRB-
cord-023095-4dannjjm	1945	35	.	.	.
cord-023095-4dannjjm	1946	1	Results	result	NNS
cord-023095-4dannjjm	1946	2	were	be	VBD
cord-023095-4dannjjm	1946	3	analysed	analyse	VBN
cord-023095-4dannjjm	1946	4	by	by	IN
cord-023095-4dannjjm	1946	5	means	mean	NNS
cord-023095-4dannjjm	1946	6	of	of	IN
cord-023095-4dannjjm	1946	7	non	non	JJ
cord-023095-4dannjjm	1946	8	-	-	JJ
cord-023095-4dannjjm	1946	9	parametric	parametric	JJ
cord-023095-4dannjjm	1946	10	statistical	statistical	JJ
cord-023095-4dannjjm	1946	11	methods	method	NNS
cord-023095-4dannjjm	1946	12	(	(	-LRB-
cord-023095-4dannjjm	1946	13	p	p	NN
cord-023095-4dannjjm	1946	14	o	o	NN
cord-023095-4dannjjm	1946	15	0.05	0.05	CD
cord-023095-4dannjjm	1946	16	)	)	-RRB-
cord-023095-4dannjjm	1946	17	.	.	.
cord-023095-4dannjjm	1947	1	Post	post	JJ
cord-023095-4dannjjm	1947	2	-	-	JJ
cord-023095-4dannjjm	1947	3	ACTH	ACTH	NNP
cord-023095-4dannjjm	1947	4	ALDO	ALDO	NNP
cord-023095-4dannjjm	1947	5	was	be	VBD
cord-023095-4dannjjm	1947	6	significantly	significantly	RB
cord-023095-4dannjjm	1947	7	lower	low	JJR
cord-023095-4dannjjm	1947	8	in	in	IN
cord-023095-4dannjjm	1947	9	dogs	dog	NNS
cord-023095-4dannjjm	1947	10	with	with	IN
cord-023095-4dannjjm	1947	11	PH	PH	NNP
cord-023095-4dannjjm	1947	12	(	(	-LRB-
cord-023095-4dannjjm	1947	13	0	0	CD
cord-023095-4dannjjm	1947	14	-	-	SYM
cord-023095-4dannjjm	1947	15	253	253	CD
cord-023095-4dannjjm	1947	16	pg	pg	NN
cord-023095-4dannjjm	1947	17	/	/	SYM
cord-023095-4dannjjm	1947	18	ml	ml	NN
cord-023095-4dannjjm	1947	19	,	,	,
cord-023095-4dannjjm	1947	20	median	median	JJ
cord-023095-4dannjjm	1947	21	0	0	CD
cord-023095-4dannjjm	1947	22	pg	pg	NN
cord-023095-4dannjjm	1947	23	/	/	SYM
cord-023095-4dannjjm	1947	24	ml	ml	NNP
cord-023095-4dannjjm	1947	25	)	)	-RRB-
cord-023095-4dannjjm	1947	26	than	than	IN
cord-023095-4dannjjm	1947	27	in	in	IN
cord-023095-4dannjjm	1947	28	healthy	healthy	JJ
cord-023095-4dannjjm	1947	29	dogs	dog	NNS
cord-023095-4dannjjm	1947	30	(	(	-LRB-
cord-023095-4dannjjm	1947	31	46	46	CD
cord-023095-4dannjjm	1947	32	-	-	SYM
cord-023095-4dannjjm	1947	33	602	602	CD
cord-023095-4dannjjm	1947	34	pg	pg	NNP
cord-023095-4dannjjm	1947	35	/	/	SYM
cord-023095-4dannjjm	1947	36	ml	ml	NN
cord-023095-4dannjjm	1947	37	,	,	,
cord-023095-4dannjjm	1947	38	median	median	NN
cord-023095-4dannjjm	1947	39	187	187	CD
cord-023095-4dannjjm	1947	40	pg	pg	NN
cord-023095-4dannjjm	1947	41	/	/	SYM
cord-023095-4dannjjm	1947	42	ml	ml	NNP
cord-023095-4dannjjm	1947	43	)	)	-RRB-
cord-023095-4dannjjm	1947	44	and	and	CC
cord-023095-4dannjjm	1947	45	in	in	IN
cord-023095-4dannjjm	1947	46	dogs	dog	NNS
cord-023095-4dannjjm	1947	47	with	with	IN
cord-023095-4dannjjm	1947	48	PH	PH	NNP
cord-023095-4dannjjm	1947	49	mimicking	mimic	VBG
cord-023095-4dannjjm	1947	50	diseases	disease	NNS
cord-023095-4dannjjm	1947	51	(	(	-LRB-
cord-023095-4dannjjm	1947	52	0	0	CD
cord-023095-4dannjjm	1947	53	-	-	SYM
cord-023095-4dannjjm	1947	54	639	639	CD
cord-023095-4dannjjm	1947	55	pg	pg	NNP
cord-023095-4dannjjm	1947	56	/	/	SYM
cord-023095-4dannjjm	1947	57	ml	ml	NN
cord-023095-4dannjjm	1947	58	,	,	,
cord-023095-4dannjjm	1947	59	median	median	NN
cord-023095-4dannjjm	1947	60	155	155	CD
cord-023095-4dannjjm	1947	61	pg	pg	NN
cord-023095-4dannjjm	1947	62	/	/	SYM
cord-023095-4dannjjm	1947	63	ml	ml	NN
cord-023095-4dannjjm	1947	64	)	)	-RRB-
cord-023095-4dannjjm	1947	65	.	.	.
cord-023095-4dannjjm	1948	1	Low	low	JJ
cord-023095-4dannjjm	1948	2	post	post	JJ
cord-023095-4dannjjm	1948	3	-	-	JJ
cord-023095-4dannjjm	1948	4	ACTH	ACTH	NNP
cord-023095-4dannjjm	1948	5	ALDO	ALDO	NNP
cord-023095-4dannjjm	1948	6	was	be	VBD
cord-023095-4dannjjm	1948	7	found	find	VBN
cord-023095-4dannjjm	1948	8	in	in	IN
cord-023095-4dannjjm	1948	9	67/70	67/70	CD
cord-023095-4dannjjm	1948	10	dogs	dog	NNS
cord-023095-4dannjjm	1948	11	with	with	IN
cord-023095-4dannjjm	1948	12	PH	PH	NNP
cord-023095-4dannjjm	1948	13	,	,	,
cord-023095-4dannjjm	1948	14	in	in	IN
cord-023095-4dannjjm	1948	15	64/67	64/67	CD
cord-023095-4dannjjm	1948	16	of	of	IN
cord-023095-4dannjjm	1948	17	them	-PRON-	PRP
cord-023095-4dannjjm	1948	18	levels	level	NNS
cord-023095-4dannjjm	1948	19	were	be	VBD
cord-023095-4dannjjm	1948	20	below	below	IN
cord-023095-4dannjjm	1948	21	the	the	DT
cord-023095-4dannjjm	1948	22	detection	detection	NN
cord-023095-4dannjjm	1948	23	limit	limit	NN
cord-023095-4dannjjm	1948	24	of	of	IN
cord-023095-4dannjjm	1948	25	the	the	DT
cord-023095-4dannjjm	1948	26	assay	assay	NN
cord-023095-4dannjjm	1948	27	.	.	.
cord-023095-4dannjjm	1949	1	Normal	normal	JJ
cord-023095-4dannjjm	1949	2	sodium	sodium	NN
cord-023095-4dannjjm	1949	3	and	and	CC
cord-023095-4dannjjm	1949	4	potassium	potassium	NN
cord-023095-4dannjjm	1949	5	levels	level	NNS
cord-023095-4dannjjm	1949	6	were	be	VBD
cord-023095-4dannjjm	1949	7	found	find	VBN
cord-023095-4dannjjm	1949	8	in	in	IN
cord-023095-4dannjjm	1949	9	5/67	5/67	CD
cord-023095-4dannjjm	1949	10	dogs	dog	NNS
cord-023095-4dannjjm	1949	11	(	(	-LRB-
cord-023095-4dannjjm	1949	12	7	7	CD
cord-023095-4dannjjm	1949	13	%	%	NN
cord-023095-4dannjjm	1949	14	)	)	-RRB-
cord-023095-4dannjjm	1949	15	,	,	,
cord-023095-4dannjjm	1949	16	6/67	6/67	CD
cord-023095-4dannjjm	1949	17	dogs	dog	NNS
cord-023095-4dannjjm	1949	18	(	(	-LRB-
cord-023095-4dannjjm	1949	19	9	9	CD
cord-023095-4dannjjm	1949	20	%	%	NN
cord-023095-4dannjjm	1949	21	)	)	-RRB-
cord-023095-4dannjjm	1949	22	had	have	VBD
cord-023095-4dannjjm	1949	23	hyponatremia	hyponatremia	NN
cord-023095-4dannjjm	1949	24	and	and	CC
cord-023095-4dannjjm	1949	25	normal	normal	JJ
cord-023095-4dannjjm	1949	26	potassium	potassium	NN
cord-023095-4dannjjm	1949	27	,	,	,
cord-023095-4dannjjm	1949	28	56/67	56/67	CD
cord-023095-4dannjjm	1949	29	dogs	dog	NNS
cord-023095-4dannjjm	1949	30	(	(	-LRB-
cord-023095-4dannjjm	1949	31	84	84	CD
cord-023095-4dannjjm	1949	32	%	%	NN
cord-023095-4dannjjm	1949	33	)	)	-RRB-
cord-023095-4dannjjm	1949	34	had	have	VBD
cord-023095-4dannjjm	1949	35	hyponatremia	hyponatremia	NN
cord-023095-4dannjjm	1949	36	and	and	CC
cord-023095-4dannjjm	1949	37	hyperkalemia	hyperkalemia	NN
cord-023095-4dannjjm	1949	38	.	.	.
cord-023095-4dannjjm	1950	1	Electrolyte	electrolyte	NN
cord-023095-4dannjjm	1950	2	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1950	3	ranged	range	VBD
cord-023095-4dannjjm	1950	4	from	from	IN
cord-023095-4dannjjm	1950	5	mild	mild	JJ
cord-023095-4dannjjm	1950	6	to	to	IN
cord-023095-4dannjjm	1950	7	severe	severe	JJ
cord-023095-4dannjjm	1950	8	.	.	.
cord-023095-4dannjjm	1951	1	There	there	EX
cord-023095-4dannjjm	1951	2	was	be	VBD
cord-023095-4dannjjm	1951	3	no	no	DT
cord-023095-4dannjjm	1951	4	correlation	correlation	NN
cord-023095-4dannjjm	1951	5	between	between	IN
cord-023095-4dannjjm	1951	6	post	post	JJ
cord-023095-4dannjjm	1951	7	-	-	JJ
cord-023095-4dannjjm	1951	8	ACTH	acth	JJ
cord-023095-4dannjjm	1951	9	ALDO	ALDO	NNP
cord-023095-4dannjjm	1951	10	and	and	CC
cord-023095-4dannjjm	1951	11	sodium	sodium	NN
cord-023095-4dannjjm	1951	12	and	and	CC
cord-023095-4dannjjm	1951	13	a	a	DT
cord-023095-4dannjjm	1951	14	weak	weak	JJ
cord-023095-4dannjjm	1951	15	correlation	correlation	NN
cord-023095-4dannjjm	1951	16	between	between	IN
cord-023095-4dannjjm	1951	17	post	post	JJ
cord-023095-4dannjjm	1951	18	-	-	JJ
cord-023095-4dannjjm	1951	19	ACTH	acth	JJ
cord-023095-4dannjjm	1951	20	ALDO	ALDO	NNP
cord-023095-4dannjjm	1951	21	and	and	CC
cord-023095-4dannjjm	1951	22	potassium	potassium	NN
cord-023095-4dannjjm	1951	23	(	(	-LRB-
cord-023095-4dannjjm	1951	24	r	r	NN
cord-023095-4dannjjm	1951	25	5	5	CD
cord-023095-4dannjjm	1951	26	À0.28	à0.28	NN
cord-023095-4dannjjm	1951	27	)	)	-RRB-
cord-023095-4dannjjm	1951	28	.	.	.
cord-023095-4dannjjm	1952	1	ALDO	ALDO	NNP
cord-023095-4dannjjm	1952	2	concentrations	concentration	NNS
cord-023095-4dannjjm	1952	3	were	be	VBD
cord-023095-4dannjjm	1952	4	not	not	RB
cord-023095-4dannjjm	1952	5	different	different	JJ
cord-023095-4dannjjm	1952	6	30	30	CD
cord-023095-4dannjjm	1952	7	,	,	,
cord-023095-4dannjjm	1952	8	45	45	CD
cord-023095-4dannjjm	1952	9	and	and	CC
cord-023095-4dannjjm	1952	10	60	60	CD
cord-023095-4dannjjm	1952	11	min	min	NN
cord-023095-4dannjjm	1952	12	after	after	IN
cord-023095-4dannjjm	1952	13	ACTH	ACTH	NNP
cord-023095-4dannjjm	1952	14	.	.	.
cord-023095-4dannjjm	1953	1	The	the	DT
cord-023095-4dannjjm	1953	2	results	result	NNS
cord-023095-4dannjjm	1953	3	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	1953	4	that	that	IN
cord-023095-4dannjjm	1953	5	ALDO	ALDO	NNP
cord-023095-4dannjjm	1953	6	levels	level	NNS
cord-023095-4dannjjm	1953	7	are	be	VBP
cord-023095-4dannjjm	1953	8	low	low	JJ
cord-023095-4dannjjm	1953	9	in	in	IN
cord-023095-4dannjjm	1953	10	most	most	JJS
cord-023095-4dannjjm	1953	11	dogs	dog	NNS
cord-023095-4dannjjm	1953	12	with	with	IN
cord-023095-4dannjjm	1953	13	PH	PH	NNP
cord-023095-4dannjjm	1953	14	independent	independent	JJ
cord-023095-4dannjjm	1953	15	of	of	IN
cord-023095-4dannjjm	1953	16	the	the	DT
cord-023095-4dannjjm	1953	17	degree	degree	NN
cord-023095-4dannjjm	1953	18	of	of	IN
cord-023095-4dannjjm	1953	19	electrolyte	electrolyte	JJ
cord-023095-4dannjjm	1953	20	abnormalities	abnormality	NNS
cord-023095-4dannjjm	1953	21	.	.	.
cord-023095-4dannjjm	1954	1	This	this	DT
cord-023095-4dannjjm	1954	2	implicates	implicate	VBZ
cord-023095-4dannjjm	1954	3	that	that	IN
cord-023095-4dannjjm	1954	4	all	all	DT
cord-023095-4dannjjm	1954	5	three	three	CD
cord-023095-4dannjjm	1954	6	zones	zone	NNS
cord-023095-4dannjjm	1954	7	of	of	IN
cord-023095-4dannjjm	1954	8	the	the	DT
cord-023095-4dannjjm	1954	9	adrenal	adrenal	JJ
cord-023095-4dannjjm	1954	10	cortex	cortex	NNS
cord-023095-4dannjjm	1954	11	are	be	VBP
cord-023095-4dannjjm	1954	12	compromised	compromise	VBN
cord-023095-4dannjjm	1954	13	and	and	CC
cord-023095-4dannjjm	1954	14	that	that	IN
cord-023095-4dannjjm	1954	15	there	there	EX
cord-023095-4dannjjm	1954	16	are	be	VBP
cord-023095-4dannjjm	1954	17	mechanisms	mechanism	NNS
cord-023095-4dannjjm	1954	18	which	which	WDT
cord-023095-4dannjjm	1954	19	allow	allow	VBP
cord-023095-4dannjjm	1954	20	maintenance	maintenance	NN
cord-023095-4dannjjm	1954	21	of	of	IN
cord-023095-4dannjjm	1954	22	a	a	DT
cord-023095-4dannjjm	1954	23	normal	normal	JJ
cord-023095-4dannjjm	1954	24	electrolyte	electrolyte	JJ
cord-023095-4dannjjm	1954	25	balance	balance	NN
cord-023095-4dannjjm	1954	26	without	without	IN
cord-023095-4dannjjm	1954	27	ALDO	ALDO	NNP
cord-023095-4dannjjm	1954	28	.	.	.
cord-023095-4dannjjm	1955	1	Definitive	definitive	JJ
cord-023095-4dannjjm	1955	2	diagnosis	diagnosis	NN
cord-023095-4dannjjm	1955	3	of	of	IN
cord-023095-4dannjjm	1955	4	canine	canine	JJ
cord-023095-4dannjjm	1955	5	hypoadrenocorticism	hypoadrenocorticism	NN
cord-023095-4dannjjm	1955	6	(	(	-LRB-
cord-023095-4dannjjm	1955	7	HA	HA	NNP
cord-023095-4dannjjm	1955	8	)	)	-RRB-
cord-023095-4dannjjm	1955	9	is	be	VBZ
cord-023095-4dannjjm	1955	10	based	base	VBN
cord-023095-4dannjjm	1955	11	on	on	IN
cord-023095-4dannjjm	1955	12	inadequate	inadequate	JJ
cord-023095-4dannjjm	1955	13	cortisol	cortisol	NN
cord-023095-4dannjjm	1955	14	secretion	secretion	NN
cord-023095-4dannjjm	1955	15	following	follow	VBG
cord-023095-4dannjjm	1955	16	adrenocorticotropic	adrenocorticotropic	JJ
cord-023095-4dannjjm	1955	17	hormone	hormone	NN
cord-023095-4dannjjm	1955	18	(	(	-LRB-
cord-023095-4dannjjm	1955	19	ACTH	ACTH	NNP
cord-023095-4dannjjm	1955	20	)	)	-RRB-
cord-023095-4dannjjm	1955	21	administration	administration	NN
cord-023095-4dannjjm	1955	22	.	.	.
cord-023095-4dannjjm	1956	1	An	an	DT
cord-023095-4dannjjm	1956	2	abnormal	abnormal	JJ
cord-023095-4dannjjm	1956	3	serum	serum	NN
cord-023095-4dannjjm	1956	4	sodium	sodium	NN
cord-023095-4dannjjm	1956	5	to	to	IN
cord-023095-4dannjjm	1956	6	potassium	potassium	NN
cord-023095-4dannjjm	1957	1	(	(	-LRB-
cord-023095-4dannjjm	1957	2	Na	Na	NNP
cord-023095-4dannjjm	1957	3	:	:	:
cord-023095-4dannjjm	1958	1	K	K	NNP
cord-023095-4dannjjm	1958	2	)	)	-RRB-
cord-023095-4dannjjm	1958	3	ratio	ratio	NN
cord-023095-4dannjjm	1958	4	can	can	MD
cord-023095-4dannjjm	1958	5	be	be	VB
cord-023095-4dannjjm	1958	6	used	use	VBN
cord-023095-4dannjjm	1958	7	to	to	TO
cord-023095-4dannjjm	1958	8	determine	determine	VB
cord-023095-4dannjjm	1958	9	whether	whether	IN
cord-023095-4dannjjm	1958	10	an	an	DT
cord-023095-4dannjjm	1958	11	ACTH	ACTH	NNP
cord-023095-4dannjjm	1958	12	stimulation	stimulation	NN
cord-023095-4dannjjm	1958	13	test	test	NN
cord-023095-4dannjjm	1958	14	is	be	VBZ
cord-023095-4dannjjm	1958	15	warranted	warrant	VBN
cord-023095-4dannjjm	1958	16	.	.	.
cord-023095-4dannjjm	1959	1	The	the	DT
cord-023095-4dannjjm	1959	2	aim	aim	NN
cord-023095-4dannjjm	1959	3	of	of	IN
cord-023095-4dannjjm	1959	4	this	this	DT
cord-023095-4dannjjm	1959	5	study	study	NN
cord-023095-4dannjjm	1959	6	was	be	VBD
cord-023095-4dannjjm	1959	7	to	to	TO
cord-023095-4dannjjm	1959	8	examine	examine	VB
cord-023095-4dannjjm	1959	9	the	the	DT
cord-023095-4dannjjm	1959	10	utility	utility	NN
cord-023095-4dannjjm	1959	11	of	of	IN
cord-023095-4dannjjm	1959	12	combining	combine	VBG
cord-023095-4dannjjm	1959	13	the	the	DT
cord-023095-4dannjjm	1959	14	Na	Na	NNP
cord-023095-4dannjjm	1959	15	:	:	:
cord-023095-4dannjjm	1959	16	K	k	NN
cord-023095-4dannjjm	1959	17	ratio	ratio	NN
cord-023095-4dannjjm	1959	18	with	with	IN
cord-023095-4dannjjm	1959	19	white	white	JJ
cord-023095-4dannjjm	1959	20	blood	blood	NN
cord-023095-4dannjjm	1959	21	cell	cell	NN
cord-023095-4dannjjm	1959	22	counts	count	VBZ
cord-023095-4dannjjm	1959	23	to	to	TO
cord-023095-4dannjjm	1959	24	determine	determine	VB
cord-023095-4dannjjm	1959	25	whether	whether	IN
cord-023095-4dannjjm	1959	26	an	an	DT
cord-023095-4dannjjm	1959	27	ACTH	ACTH	NNP
cord-023095-4dannjjm	1959	28	stimulation	stimulation	NN
cord-023095-4dannjjm	1959	29	test	test	NN
cord-023095-4dannjjm	1959	30	is	be	VBZ
cord-023095-4dannjjm	1959	31	warranted	warrant	VBN
cord-023095-4dannjjm	1959	32	.	.	.
cord-023095-4dannjjm	1960	1	A	a	DT
cord-023095-4dannjjm	1960	2	retrospective	retrospective	JJ
cord-023095-4dannjjm	1960	3	review	review	NN
cord-023095-4dannjjm	1960	4	of	of	IN
cord-023095-4dannjjm	1960	5	medical	medical	JJ
cord-023095-4dannjjm	1960	6	records	record	NNS
cord-023095-4dannjjm	1960	7	of	of	IN
cord-023095-4dannjjm	1960	8	dogs	dog	NNS
cord-023095-4dannjjm	1960	9	examined	examine	VBN
cord-023095-4dannjjm	1960	10	between	between	IN
cord-023095-4dannjjm	1960	11	2005	2005	CD
cord-023095-4dannjjm	1960	12	and	and	CC
cord-023095-4dannjjm	1960	13	2009	2009	CD
cord-023095-4dannjjm	1960	14	was	be	VBD
cord-023095-4dannjjm	1960	15	performed	perform	VBN
cord-023095-4dannjjm	1960	16	.	.	.
cord-023095-4dannjjm	1961	1	53	53	CD
cord-023095-4dannjjm	1961	2	dogs	dog	NNS
cord-023095-4dannjjm	1961	3	diagnosed	diagnose	VBN
cord-023095-4dannjjm	1961	4	with	with	IN
cord-023095-4dannjjm	1961	5	HA	HA	NNP
cord-023095-4dannjjm	1961	6	and	and	CC
cord-023095-4dannjjm	1961	7	110	110	CD
cord-023095-4dannjjm	1961	8	control	control	NN
cord-023095-4dannjjm	1961	9	dogs	dog	NNS
cord-023095-4dannjjm	1961	10	,	,	,
cord-023095-4dannjjm	1961	11	in	in	IN
cord-023095-4dannjjm	1961	12	which	which	WDT
cord-023095-4dannjjm	1961	13	a	a	DT
cord-023095-4dannjjm	1961	14	diagnosis	diagnosis	NN
cord-023095-4dannjjm	1961	15	of	of	IN
cord-023095-4dannjjm	1961	16	HA	HA	NNP
cord-023095-4dannjjm	1961	17	was	be	VBD
cord-023095-4dannjjm	1961	18	excluded	exclude	VBN
cord-023095-4dannjjm	1961	19	during	during	IN
cord-023095-4dannjjm	1961	20	the	the	DT
cord-023095-4dannjjm	1961	21	study	study	NN
cord-023095-4dannjjm	1961	22	period	period	NN
cord-023095-4dannjjm	1961	23	,	,	,
cord-023095-4dannjjm	1961	24	were	be	VBD
cord-023095-4dannjjm	1961	25	included	include	VBN
cord-023095-4dannjjm	1961	26	.	.	.
cord-023095-4dannjjm	1962	1	Inclusion	inclusion	NN
cord-023095-4dannjjm	1962	2	criteria	criterion	NNS
cord-023095-4dannjjm	1962	3	for	for	IN
cord-023095-4dannjjm	1962	4	all	all	DT
cord-023095-4dannjjm	1962	5	163	163	CD
cord-023095-4dannjjm	1962	6	dogs	dog	NNS
cord-023095-4dannjjm	1962	7	were	be	VBD
cord-023095-4dannjjm	1962	8	hospitalization	hospitalization	NN
cord-023095-4dannjjm	1962	9	with	with	IN
cord-023095-4dannjjm	1962	10	intravenous	intravenous	JJ
cord-023095-4dannjjm	1962	11	fluid	fluid	NN
cord-023095-4dannjjm	1962	12	therapy	therapy	NN
cord-023095-4dannjjm	1962	13	,	,	,
cord-023095-4dannjjm	1962	14	a	a	DT
cord-023095-4dannjjm	1962	15	complete	complete	JJ
cord-023095-4dannjjm	1962	16	blood	blood	NN
cord-023095-4dannjjm	1962	17	count	count	NN
cord-023095-4dannjjm	1962	18	,	,	,
cord-023095-4dannjjm	1962	19	and	and	CC
cord-023095-4dannjjm	1962	20	serum	serum	NN
cord-023095-4dannjjm	1962	21	Na	Na	NNP
cord-023095-4dannjjm	1962	22	and	and	CC
cord-023095-4dannjjm	1962	23	K	K	NNP
cord-023095-4dannjjm	1962	24	measurements	measurement	NNS
cord-023095-4dannjjm	1962	25	at	at	IN
cord-023095-4dannjjm	1962	26	the	the	DT
cord-023095-4dannjjm	1962	27	time	time	NN
cord-023095-4dannjjm	1962	28	of	of	IN
cord-023095-4dannjjm	1962	29	initial	initial	JJ
cord-023095-4dannjjm	1962	30	examination	examination	NN
cord-023095-4dannjjm	1962	31	.	.	.
cord-023095-4dannjjm	1963	1	Dogs	dog	NNS
cord-023095-4dannjjm	1963	2	were	be	VBD
cord-023095-4dannjjm	1963	3	included	include	VBN
cord-023095-4dannjjm	1963	4	in	in	IN
cord-023095-4dannjjm	1963	5	the	the	DT
cord-023095-4dannjjm	1963	6	HA	HA	NNP
cord-023095-4dannjjm	1963	7	group	group	NN
cord-023095-4dannjjm	1963	8	if	if	IN
cord-023095-4dannjjm	1963	9	they	-PRON-	PRP
cord-023095-4dannjjm	1963	10	also	also	RB
cord-023095-4dannjjm	1963	11	had	have	VBD
cord-023095-4dannjjm	1963	12	pre	pre	VBN
cord-023095-4dannjjm	1963	13	and	and	CC
cord-023095-4dannjjm	1963	14	post	post	VB
cord-023095-4dannjjm	1964	1	ACTH	ACTH	NNP
cord-023095-4dannjjm	1964	2	stimulation	stimulation	NN
cord-023095-4dannjjm	1964	3	serum	serum	NN
cord-023095-4dannjjm	1964	4	cortisol	cortisol	NN
cord-023095-4dannjjm	1964	5	concentrations	concentration	NNS
cord-023095-4dannjjm	1965	1	1.0	1.0	CD
cord-023095-4dannjjm	1965	2	mg	mg	NNP
cord-023095-4dannjjm	1965	3	/	/	SYM
cord-023095-4dannjjm	1965	4	dl	dl	NN
cord-023095-4dannjjm	1965	5	.	.	.
cord-023095-4dannjjm	1966	1	Dogs	dog	NNS
cord-023095-4dannjjm	1966	2	were	be	VBD
cord-023095-4dannjjm	1966	3	included	include	VBN
cord-023095-4dannjjm	1966	4	in	in	IN
cord-023095-4dannjjm	1966	5	the	the	DT
cord-023095-4dannjjm	1966	6	control	control	NN
cord-023095-4dannjjm	1966	7	group	group	NN
cord-023095-4dannjjm	1966	8	if	if	IN
cord-023095-4dannjjm	1966	9	they	-PRON-	PRP
cord-023095-4dannjjm	1966	10	had	have	VBD
cord-023095-4dannjjm	1966	11	resting	rest	VBG
cord-023095-4dannjjm	1966	12	or	or	CC
cord-023095-4dannjjm	1966	13	post	post	VB
cord-023095-4dannjjm	1967	1	ACTH	ACTH	NNP
cord-023095-4dannjjm	1967	2	stimulation	stimulation	NN
cord-023095-4dannjjm	1967	3	serum	serum	NN
cord-023095-4dannjjm	1967	4	cortisol	cortisol	NN
cord-023095-4dannjjm	1967	5	concentration	concentration	NN
cord-023095-4dannjjm	1967	6	4	4	CD
cord-023095-4dannjjm	1968	1	2.0	2.0	CD
cord-023095-4dannjjm	1968	2	mg	mg	NNP
cord-023095-4dannjjm	1968	3	/	/	SYM
cord-023095-4dannjjm	1968	4	dl	dl	NN
cord-023095-4dannjjm	1968	5	.	.	.
cord-023095-4dannjjm	1969	1	Exclusion	exclusion	NN
cord-023095-4dannjjm	1969	2	criteria	criterion	NNS
cord-023095-4dannjjm	1969	3	were	be	VBD
cord-023095-4dannjjm	1969	4	recent	recent	JJ
cord-023095-4dannjjm	1969	5	administration	administration	NN
cord-023095-4dannjjm	1969	6	of	of	IN
cord-023095-4dannjjm	1969	7	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	1969	8	,	,	,
cord-023095-4dannjjm	1969	9	prior	prior	JJ
cord-023095-4dannjjm	1969	10	treatment	treatment	NN
cord-023095-4dannjjm	1969	11	of	of	IN
cord-023095-4dannjjm	1969	12	hyperadrenocorticism	hyperadrenocorticism	NN
cord-023095-4dannjjm	1969	13	,	,	,
cord-023095-4dannjjm	1969	14	or	or	CC
cord-023095-4dannjjm	1969	15	serum	serum	NN
cord-023095-4dannjjm	1969	16	cortisol	cortisol	NN
cord-023095-4dannjjm	1969	17	concentration	concentration	NN
cord-023095-4dannjjm	1969	18	4	4	CD
cord-023095-4dannjjm	1969	19	1.0	1.0	CD
cord-023095-4dannjjm	1969	20	mg	mg	NNP
cord-023095-4dannjjm	1969	21	/	/	SYM
cord-023095-4dannjjm	1969	22	dl	dl	NNP
cord-023095-4dannjjm	1969	23	but	but	CC
cord-023095-4dannjjm	1969	24	2.0	2.0	CD
cord-023095-4dannjjm	1969	25	mg	mg	NNP
cord-023095-4dannjjm	1969	26	/	/	SYM
cord-023095-4dannjjm	1969	27	dl	dl	NN
cord-023095-4dannjjm	1969	28	.	.	.
cord-023095-4dannjjm	1970	1	Continuous	continuous	JJ
cord-023095-4dannjjm	1970	2	variables	variable	NNS
cord-023095-4dannjjm	1970	3	were	be	VBD
cord-023095-4dannjjm	1970	4	compared	compare	VBN
cord-023095-4dannjjm	1970	5	between	between	IN
cord-023095-4dannjjm	1970	6	groups	group	NNS
cord-023095-4dannjjm	1970	7	using	use	VBG
cord-023095-4dannjjm	1970	8	the	the	DT
cord-023095-4dannjjm	1970	9	Mann	Mann	NNP
cord-023095-4dannjjm	1970	10	-	-	HYPH
cord-023095-4dannjjm	1970	11	Whitney	Whitney	NNP
cord-023095-4dannjjm	1970	12	U	U	NNP
cord-023095-4dannjjm	1970	13	test	test	NN
cord-023095-4dannjjm	1970	14	.	.	.
cord-023095-4dannjjm	1971	1	Receiver	receiver	NN
cord-023095-4dannjjm	1971	2	operating	operating	NN
cord-023095-4dannjjm	1971	3	characteristic	characteristic	NN
cord-023095-4dannjjm	1971	4	(	(	-LRB-
cord-023095-4dannjjm	1971	5	ROC	ROC	NNP
cord-023095-4dannjjm	1971	6	)	)	-RRB-
cord-023095-4dannjjm	1971	7	curves	curve	NNS
cord-023095-4dannjjm	1971	8	were	be	VBD
cord-023095-4dannjjm	1971	9	produced	produce	VBN
cord-023095-4dannjjm	1971	10	to	to	TO
cord-023095-4dannjjm	1971	11	assess	assess	VB
cord-023095-4dannjjm	1971	12	the	the	DT
cord-023095-4dannjjm	1971	13	sensitivity	sensitivity	NN
cord-023095-4dannjjm	1971	14	and	and	CC
cord-023095-4dannjjm	1971	15	specificity	specificity	NN
cord-023095-4dannjjm	1971	16	of	of	IN
cord-023095-4dannjjm	1971	17	detecting	detect	VBG
cord-023095-4dannjjm	1971	18	HA	HA	NNP
cord-023095-4dannjjm	1971	19	with	with	IN
cord-023095-4dannjjm	1971	20	various	various	JJ
cord-023095-4dannjjm	1971	21	cutoffs	cutoff	NNS
cord-023095-4dannjjm	1971	22	for	for	IN
cord-023095-4dannjjm	1971	23	each	each	DT
cord-023095-4dannjjm	1971	24	variable	variable	NN
cord-023095-4dannjjm	1971	25	.	.	.
cord-023095-4dannjjm	1972	1	Data	Data	NNP
cord-023095-4dannjjm	1972	2	is	be	VBZ
cord-023095-4dannjjm	1972	3	presented	present	VBN
cord-023095-4dannjjm	1972	4	with	with	IN
cord-023095-4dannjjm	1972	5	95	95	CD
cord-023095-4dannjjm	1972	6	%	%	NN
cord-023095-4dannjjm	1972	7	confidence	confidence	NN
cord-023095-4dannjjm	1972	8	intervals	interval	NNS
cord-023095-4dannjjm	1972	9	(	(	-LRB-
cord-023095-4dannjjm	1972	10	CI	CI	NNP
cord-023095-4dannjjm	1972	11	)	)	-RRB-
cord-023095-4dannjjm	1972	12	and	and	CC
cord-023095-4dannjjm	1972	13	statistical	statistical	JJ
cord-023095-4dannjjm	1972	14	significance	significance	NN
cord-023095-4dannjjm	1972	15	was	be	VBD
cord-023095-4dannjjm	1972	16	defined	define	VBN
cord-023095-4dannjjm	1972	17	as	as	IN
cord-023095-4dannjjm	1972	18	p	p	NN
cord-023095-4dannjjm	1972	19	o	o	NN
cord-023095-4dannjjm	1972	20	0.05	0.05	CD
cord-023095-4dannjjm	1972	21	.	.	.
cord-023095-4dannjjm	1973	1	The	the	DT
cord-023095-4dannjjm	1973	2	Na	Na	NNP
cord-023095-4dannjjm	1973	3	:	:	:
cord-023095-4dannjjm	1974	1	K	K	NNP
cord-023095-4dannjjm	1974	2	ratio	ratio	NN
cord-023095-4dannjjm	1974	3	,	,	,
cord-023095-4dannjjm	1974	4	neutrophil	neutrophil	NN
cord-023095-4dannjjm	1974	5	count	count	NN
cord-023095-4dannjjm	1974	6	and	and	CC
cord-023095-4dannjjm	1974	7	neutrophil	neutrophil	NN
cord-023095-4dannjjm	1974	8	:	:	:
cord-023095-4dannjjm	1974	9	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	1974	10	ratio	ratio	NN
cord-023095-4dannjjm	1974	11	were	be	VBD
cord-023095-4dannjjm	1974	12	significantly	significantly	RB
cord-023095-4dannjjm	1974	13	lower	low	JJR
cord-023095-4dannjjm	1974	14	in	in	IN
cord-023095-4dannjjm	1974	15	dogs	dog	NNS
cord-023095-4dannjjm	1974	16	with	with	IN
cord-023095-4dannjjm	1974	17	HA	HA	NNP
cord-023095-4dannjjm	1974	18	than	than	IN
cord-023095-4dannjjm	1974	19	in	in	IN
cord-023095-4dannjjm	1974	20	dogs	dog	NNS
cord-023095-4dannjjm	1974	21	without	without	IN
cord-023095-4dannjjm	1974	22	HA	HA	NNP
cord-023095-4dannjjm	1974	23	(	(	-LRB-
cord-023095-4dannjjm	1974	24	p	p	NN
cord-023095-4dannjjm	1974	25	o	o	NN
cord-023095-4dannjjm	1974	26	0.01	0.01	CD
cord-023095-4dannjjm	1974	27	for	for	IN
cord-023095-4dannjjm	1974	28	each	each	DT
cord-023095-4dannjjm	1974	29	)	)	-RRB-
cord-023095-4dannjjm	1974	30	.	.	.
cord-023095-4dannjjm	1975	1	Lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	1975	2	and	and	CC
cord-023095-4dannjjm	1975	3	eosinophil	eosinophil	NN
cord-023095-4dannjjm	1975	4	counts	count	NNS
cord-023095-4dannjjm	1975	5	were	be	VBD
cord-023095-4dannjjm	1975	6	significantly	significantly	RB
cord-023095-4dannjjm	1975	7	higher	high	JJR
cord-023095-4dannjjm	1975	8	in	in	IN
cord-023095-4dannjjm	1975	9	dogs	dog	NNS
cord-023095-4dannjjm	1975	10	with	with	IN
cord-023095-4dannjjm	1975	11	HA	HA	NNP
cord-023095-4dannjjm	1975	12	compared	compare	VBN
cord-023095-4dannjjm	1975	13	to	to	IN
cord-023095-4dannjjm	1975	14	dogs	dog	NNS
cord-023095-4dannjjm	1975	15	without	without	IN
cord-023095-4dannjjm	1975	16	HA	HA	NNP
cord-023095-4dannjjm	1975	17	(	(	-LRB-
cord-023095-4dannjjm	1975	18	p	p	NN
cord-023095-4dannjjm	1975	19	o	o	NN
cord-023095-4dannjjm	1975	20	0.001	0.001	CD
cord-023095-4dannjjm	1975	21	for	for	IN
cord-023095-4dannjjm	1975	22	each	each	DT
cord-023095-4dannjjm	1975	23	)	)	-RRB-
cord-023095-4dannjjm	1975	24	.	.	.
cord-023095-4dannjjm	1976	1	The	the	DT
cord-023095-4dannjjm	1976	2	areas	area	NNS
cord-023095-4dannjjm	1976	3	under	under	IN
cord-023095-4dannjjm	1976	4	the	the	DT
cord-023095-4dannjjm	1976	5	curve	curve	NN
cord-023095-4dannjjm	1976	6	by	by	IN
cord-023095-4dannjjm	1976	7	ROC	ROC	NNP
cord-023095-4dannjjm	1976	8	analysis	analysis	NN
cord-023095-4dannjjm	1976	9	were	be	VBD
cord-023095-4dannjjm	1976	10	largest	large	JJS
cord-023095-4dannjjm	1976	11	for	for	IN
cord-023095-4dannjjm	1976	12	Na	Na	NNP
cord-023095-4dannjjm	1976	13	:	:	:
cord-023095-4dannjjm	1976	14	K	k	NN
cord-023095-4dannjjm	1976	15	ratio	ratio	NN
cord-023095-4dannjjm	1976	16	(	(	-LRB-
cord-023095-4dannjjm	1976	17	0.87	0.87	CD
cord-023095-4dannjjm	1976	18	,	,	,
cord-023095-4dannjjm	1976	19	CI:0.81	CI:0.81	NNP
cord-023095-4dannjjm	1976	20	-	-	HYPH
cord-023095-4dannjjm	1976	21	0.92	0.92	CD
cord-023095-4dannjjm	1976	22	)	)	-RRB-
cord-023095-4dannjjm	1976	23	and	and	CC
cord-023095-4dannjjm	1976	24	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	1976	25	count	count	NN
cord-023095-4dannjjm	1976	26	(	(	-LRB-
cord-023095-4dannjjm	1976	27	0.85	0.85	CD
cord-023095-4dannjjm	1976	28	,	,	,
cord-023095-4dannjjm	1976	29	CI:0.78	CI:0.78	NNP
cord-023095-4dannjjm	1976	30	-	-	HYPH
cord-023095-4dannjjm	1976	31	0.90	0.90	CD
cord-023095-4dannjjm	1976	32	)	)	-RRB-
cord-023095-4dannjjm	1976	33	.	.	.
cord-023095-4dannjjm	1977	1	A	a	DT
cord-023095-4dannjjm	1977	2	Na	Na	NNP
cord-023095-4dannjjm	1977	3	:	:	:
cord-023095-4dannjjm	1977	4	K	k	NN
cord-023095-4dannjjm	1977	5	ratio	ratio	NN
cord-023095-4dannjjm	1977	6	39.6	39.6	CD
cord-023095-4dannjjm	1977	7	was	be	VBD
cord-023095-4dannjjm	1977	8	100	100	CD
cord-023095-4dannjjm	1977	9	%	%	NN
cord-023095-4dannjjm	1977	10	sensitive	sensitive	JJ
cord-023095-4dannjjm	1977	11	(	(	-LRB-
cord-023095-4dannjjm	1977	12	CI:93	CI:93	NNP
cord-023095-4dannjjm	1977	13	-	-	SYM
cord-023095-4dannjjm	1977	14	100	100	CD
cord-023095-4dannjjm	1977	15	%	%	NN
cord-023095-4dannjjm	1977	16	)	)	-RRB-
cord-023095-4dannjjm	1977	17	but	but	CC
cord-023095-4dannjjm	1977	18	only	only	RB
cord-023095-4dannjjm	1977	19	15	15	CD
cord-023095-4dannjjm	1977	20	%	%	NN
cord-023095-4dannjjm	1977	21	specific	specific	JJ
cord-023095-4dannjjm	1977	22	(	(	-LRB-
cord-023095-4dannjjm	1977	23	CI:9	ci:9	CD
cord-023095-4dannjjm	1977	24	-	-	:
cord-023095-4dannjjm	1977	25	23	23	CD
cord-023095-4dannjjm	1977	26	%	%	NN
cord-023095-4dannjjm	1977	27	)	)	-RRB-
cord-023095-4dannjjm	1977	28	for	for	IN
cord-023095-4dannjjm	1977	29	detecting	detect	VBG
cord-023095-4dannjjm	1977	30	HA	HA	NNP
cord-023095-4dannjjm	1977	31	.	.	.
cord-023095-4dannjjm	1978	1	A	a	DT
cord-023095-4dannjjm	1978	2	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	1978	3	count	count	NN
cord-023095-4dannjjm	1978	4	!	!	.
cord-023095-4dannjjm	1979	1	0.77	0.77	CD
cord-023095-4dannjjm	1979	2	x10	x10	CD
cord-023095-4dannjjm	1979	3	3	3	CD
cord-023095-4dannjjm	1979	4	cells	cell	NNS
cord-023095-4dannjjm	1979	5	/	/	SYM
cord-023095-4dannjjm	1979	6	mL	ml	NN
cord-023095-4dannjjm	1979	7	was	be	VBD
cord-023095-4dannjjm	1979	8	100	100	CD
cord-023095-4dannjjm	1979	9	%	%	NN
cord-023095-4dannjjm	1979	10	sensitive	sensitive	JJ
cord-023095-4dannjjm	1979	11	(	(	-LRB-
cord-023095-4dannjjm	1979	12	CI:93	CI:93	NNP
cord-023095-4dannjjm	1979	13	-	-	SYM
cord-023095-4dannjjm	1979	14	100	100	CD
cord-023095-4dannjjm	1979	15	%	%	NN
cord-023095-4dannjjm	1979	16	)	)	-RRB-
cord-023095-4dannjjm	1979	17	and	and	CC
cord-023095-4dannjjm	1979	18	35	35	CD
cord-023095-4dannjjm	1979	19	%	%	NN
cord-023095-4dannjjm	1979	20	specific	specific	JJ
cord-023095-4dannjjm	1979	21	(	(	-LRB-
cord-023095-4dannjjm	1979	22	CI:27	CI:27	NNP
cord-023095-4dannjjm	1979	23	-	-	SYM
cord-023095-4dannjjm	1979	24	45	45	CD
cord-023095-4dannjjm	1979	25	%	%	NN
cord-023095-4dannjjm	1979	26	)	)	-RRB-
cord-023095-4dannjjm	1979	27	.	.	.
cord-023095-4dannjjm	1980	1	Conversely	conversely	RB
cord-023095-4dannjjm	1980	2	a	a	DT
cord-023095-4dannjjm	1980	3	Na	Na	NNP
cord-023095-4dannjjm	1980	4	:	:	:
cord-023095-4dannjjm	1980	5	K	k	NN
cord-023095-4dannjjm	1980	6	ratio	ratio	NN
cord-023095-4dannjjm	1980	7	20.1	20.1	CD
cord-023095-4dannjjm	1980	8	was	be	VBD
cord-023095-4dannjjm	1980	9	51	51	CD
cord-023095-4dannjjm	1980	10	%	%	NN
cord-023095-4dannjjm	1980	11	sensitive	sensitive	JJ
cord-023095-4dannjjm	1980	12	(	(	-LRB-
cord-023095-4dannjjm	1980	13	CI:37	CI:37	NNP
cord-023095-4dannjjm	1980	14	-	-	HYPH
cord-023095-4dannjjm	1980	15	65	65	CD
cord-023095-4dannjjm	1980	16	%	%	NN
cord-023095-4dannjjm	1980	17	)	)	-RRB-
cord-023095-4dannjjm	1980	18	but	but	CC
cord-023095-4dannjjm	1980	19	100	100	CD
cord-023095-4dannjjm	1980	20	%	%	NN
cord-023095-4dannjjm	1980	21	specific	specific	JJ
cord-023095-4dannjjm	1980	22	(	(	-LRB-
cord-023095-4dannjjm	1980	23	CI:97	CI:97	NNP
cord-023095-4dannjjm	1980	24	-	-	HYPH
cord-023095-4dannjjm	1980	25	100	100	CD
cord-023095-4dannjjm	1980	26	%	%	NN
cord-023095-4dannjjm	1980	27	)	)	-RRB-
cord-023095-4dannjjm	1980	28	and	and	CC
cord-023095-4dannjjm	1980	29	a	a	DT
cord-023095-4dannjjm	1980	30	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	1980	31	count	count	NN
cord-023095-4dannjjm	1980	32	!	!	.
cord-023095-4dannjjm	1981	1	6.1	6.1	CD
cord-023095-4dannjjm	1981	2	Â	â	CD
cord-023095-4dannjjm	1981	3	10	10	CD
cord-023095-4dannjjm	1981	4	3	3	CD
cord-023095-4dannjjm	1981	5	cells	cell	NNS
cord-023095-4dannjjm	1981	6	/	/	SYM
cord-023095-4dannjjm	1981	7	mL	ml	NN
cord-023095-4dannjjm	1981	8	was	be	VBD
cord-023095-4dannjjm	1981	9	9	9	CD
cord-023095-4dannjjm	1981	10	%	%	NN
cord-023095-4dannjjm	1981	11	sensitive	sensitive	JJ
cord-023095-4dannjjm	1981	12	(	(	-LRB-
cord-023095-4dannjjm	1981	13	CI:3	CI:3	NFP
cord-023095-4dannjjm	1981	14	-	-	:
cord-023095-4dannjjm	1981	15	20	20	CD
cord-023095-4dannjjm	1981	16	%	%	NN
cord-023095-4dannjjm	1981	17	)	)	-RRB-
cord-023095-4dannjjm	1981	18	but	but	CC
cord-023095-4dannjjm	1981	19	100	100	CD
cord-023095-4dannjjm	1981	20	%	%	NN
cord-023095-4dannjjm	1981	21	specific	specific	JJ
cord-023095-4dannjjm	1981	22	(	(	-LRB-
cord-023095-4dannjjm	1981	23	CI:97	CI:97	NNP
cord-023095-4dannjjm	1981	24	-	-	HYPH
cord-023095-4dannjjm	1981	25	100	100	CD
cord-023095-4dannjjm	1981	26	%	%	NN
cord-023095-4dannjjm	1981	27	)	)	-RRB-
cord-023095-4dannjjm	1981	28	.	.	.
cord-023095-4dannjjm	1982	1	A	a	DT
cord-023095-4dannjjm	1982	2	Na	Na	NNP
cord-023095-4dannjjm	1982	3	:	:	:
cord-023095-4dannjjm	1982	4	K	k	NN
cord-023095-4dannjjm	1982	5	ratio	ratio	NN
cord-023095-4dannjjm	1982	6	35.5	35.5	CD
cord-023095-4dannjjm	1982	7	was	be	VBD
cord-023095-4dannjjm	1982	8	96	96	CD
cord-023095-4dannjjm	1982	9	%	%	NN
cord-023095-4dannjjm	1982	10	sensitive	sensitive	JJ
cord-023095-4dannjjm	1982	11	(	(	-LRB-
cord-023095-4dannjjm	1982	12	CI:87	CI:87	NNP
cord-023095-4dannjjm	1982	13	-	-	HYPH
cord-023095-4dannjjm	1982	14	100	100	CD
cord-023095-4dannjjm	1982	15	%	%	NN
cord-023095-4dannjjm	1982	16	)	)	-RRB-
cord-023095-4dannjjm	1982	17	and	and	CC
cord-023095-4dannjjm	1982	18	35	35	CD
cord-023095-4dannjjm	1982	19	%	%	NN
cord-023095-4dannjjm	1982	20	specific	specific	JJ
cord-023095-4dannjjm	1982	21	(	(	-LRB-
cord-023095-4dannjjm	1982	22	CI:26	CI:26	NNP
cord-023095-4dannjjm	1982	23	-	-	HYPH
cord-023095-4dannjjm	1982	24	44	44	CD
cord-023095-4dannjjm	1982	25	%	%	NN
cord-023095-4dannjjm	1982	26	)	)	-RRB-
cord-023095-4dannjjm	1982	27	for	for	IN
cord-023095-4dannjjm	1982	28	detection	detection	NN
cord-023095-4dannjjm	1982	29	of	of	IN
cord-023095-4dannjjm	1982	30	HA	HA	NNP
cord-023095-4dannjjm	1982	31	and	and	CC
cord-023095-4dannjjm	1982	32	a	a	DT
cord-023095-4dannjjm	1982	33	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	1982	34	count	count	NN
cord-023095-4dannjjm	1982	35	!	!	.
cord-023095-4dannjjm	1983	1	0.79	0.79	CD
cord-023095-4dannjjm	1983	2	Â	â	CD
cord-023095-4dannjjm	1983	3	10	10	CD
cord-023095-4dannjjm	1983	4	3	3	CD
cord-023095-4dannjjm	1983	5	cells	cell	NNS
cord-023095-4dannjjm	1983	6	/	/	SYM
cord-023095-4dannjjm	1983	7	mL	ml	NN
cord-023095-4dannjjm	1983	8	was	be	VBD
cord-023095-4dannjjm	1983	9	98	98	CD
cord-023095-4dannjjm	1983	10	%	%	NN
cord-023095-4dannjjm	1983	11	sensitive	sensitive	JJ
cord-023095-4dannjjm	1983	12	(	(	-LRB-
cord-023095-4dannjjm	1983	13	CI:90	CI:90	NNP
cord-023095-4dannjjm	1983	14	-	-	HYPH
cord-023095-4dannjjm	1983	15	100	100	CD
cord-023095-4dannjjm	1983	16	%	%	NN
cord-023095-4dannjjm	1983	17	)	)	-RRB-
cord-023095-4dannjjm	1983	18	and	and	CC
cord-023095-4dannjjm	1983	19	36	36	CD
cord-023095-4dannjjm	1983	20	%	%	NN
cord-023095-4dannjjm	1983	21	specific	specific	JJ
cord-023095-4dannjjm	1983	22	(	(	-LRB-
cord-023095-4dannjjm	1983	23	CI:27	CI:27	NNP
cord-023095-4dannjjm	1983	24	-	-	SYM
cord-023095-4dannjjm	1983	25	46	46	CD
cord-023095-4dannjjm	1983	26	%	%	NN
cord-023095-4dannjjm	1983	27	)	)	-RRB-
cord-023095-4dannjjm	1983	28	for	for	IN
cord-023095-4dannjjm	1983	29	detection	detection	NN
cord-023095-4dannjjm	1983	30	of	of	IN
cord-023095-4dannjjm	1983	31	HA	HA	NNP
cord-023095-4dannjjm	1983	32	.	.	.
cord-023095-4dannjjm	1984	1	A	a	DT
cord-023095-4dannjjm	1984	2	combination	combination	NN
cord-023095-4dannjjm	1984	3	of	of	IN
cord-023095-4dannjjm	1984	4	this	this	DT
cord-023095-4dannjjm	1984	5	Na	Na	NNP
cord-023095-4dannjjm	1984	6	:	:	:
cord-023095-4dannjjm	1984	7	K	k	NN
cord-023095-4dannjjm	1984	8	ratio	ratio	NN
cord-023095-4dannjjm	1984	9	(	(	-LRB-
cord-023095-4dannjjm	1984	10	35.5	35.5	CD
cord-023095-4dannjjm	1984	11	)	)	-RRB-
cord-023095-4dannjjm	1984	12	and	and	CC
cord-023095-4dannjjm	1984	13	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	1984	14	count	count	NN
cord-023095-4dannjjm	1984	15	(	(	-LRB-
cord-023095-4dannjjm	1984	16	!	!	.
cord-023095-4dannjjm	1985	1	0.79	0.79	CD
cord-023095-4dannjjm	1985	2	Â	â	CD
cord-023095-4dannjjm	1985	3	10	10	CD
cord-023095-4dannjjm	1985	4	3	3	CD
cord-023095-4dannjjm	1985	5	cells	cell	NNS
cord-023095-4dannjjm	1985	6	/	/	SYM
cord-023095-4dannjjm	1985	7	mL	ml	NN
cord-023095-4dannjjm	1985	8	)	)	-RRB-
cord-023095-4dannjjm	1985	9	was	be	VBD
cord-023095-4dannjjm	1985	10	96	96	CD
cord-023095-4dannjjm	1985	11	%	%	NN
cord-023095-4dannjjm	1985	12	sensitive	sensitive	JJ
cord-023095-4dannjjm	1985	13	(	(	-LRB-
cord-023095-4dannjjm	1985	14	CI:87	CI:87	NNP
cord-023095-4dannjjm	1985	15	-	-	HYPH
cord-023095-4dannjjm	1985	16	100	100	CD
cord-023095-4dannjjm	1985	17	%	%	NN
cord-023095-4dannjjm	1985	18	)	)	-RRB-
cord-023095-4dannjjm	1985	19	and	and	CC
cord-023095-4dannjjm	1985	20	55	55	CD
cord-023095-4dannjjm	1985	21	%	%	NN
cord-023095-4dannjjm	1985	22	specific	specific	JJ
cord-023095-4dannjjm	1985	23	(	(	-LRB-
cord-023095-4dannjjm	1985	24	CI:47	CI:47	NNP
cord-023095-4dannjjm	1985	25	-	-	:
cord-023095-4dannjjm	1985	26	66	66	CD
cord-023095-4dannjjm	1985	27	%	%	NN
cord-023095-4dannjjm	1985	28	)	)	-RRB-
cord-023095-4dannjjm	1985	29	for	for	IN
cord-023095-4dannjjm	1985	30	detection	detection	NN
cord-023095-4dannjjm	1985	31	of	of	IN
cord-023095-4dannjjm	1985	32	HA	HA	NNP
cord-023095-4dannjjm	1985	33	.	.	.
cord-023095-4dannjjm	1986	1	These	these	DT
cord-023095-4dannjjm	1986	2	results	result	NNS
cord-023095-4dannjjm	1986	3	indicate	indicate	VBP
cord-023095-4dannjjm	1986	4	that	that	IN
cord-023095-4dannjjm	1986	5	the	the	DT
cord-023095-4dannjjm	1986	6	combination	combination	NN
cord-023095-4dannjjm	1986	7	of	of	IN
cord-023095-4dannjjm	1986	8	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	1986	9	count	count	NN
cord-023095-4dannjjm	1986	10	and	and	CC
cord-023095-4dannjjm	1986	11	Na	Na	NNP
cord-023095-4dannjjm	1986	12	:	:	:
cord-023095-4dannjjm	1986	13	K	k	NN
cord-023095-4dannjjm	1986	14	ratio	ratio	NN
cord-023095-4dannjjm	1986	15	results	result	NNS
cord-023095-4dannjjm	1986	16	in	in	IN
cord-023095-4dannjjm	1986	17	a	a	DT
cord-023095-4dannjjm	1986	18	better	well	JJR
cord-023095-4dannjjm	1986	19	screening	screening	NN
cord-023095-4dannjjm	1986	20	test	test	NN
cord-023095-4dannjjm	1986	21	for	for	IN
cord-023095-4dannjjm	1986	22	HA	HA	NNP
cord-023095-4dannjjm	1986	23	than	than	IN
cord-023095-4dannjjm	1986	24	the	the	DT
cord-023095-4dannjjm	1986	25	use	use	NN
cord-023095-4dannjjm	1986	26	of	of	IN
cord-023095-4dannjjm	1986	27	the	the	DT
cord-023095-4dannjjm	1986	28	Na	Na	NNP
cord-023095-4dannjjm	1986	29	:	:	:
cord-023095-4dannjjm	1986	30	K	k	NN
cord-023095-4dannjjm	1986	31	ratio	ratio	NN
cord-023095-4dannjjm	1986	32	alone	alone	RB
cord-023095-4dannjjm	1986	33	.	.	.
cord-023095-4dannjjm	1987	1	Pheochromocytoma	Pheochromocytoma	NNP
cord-023095-4dannjjm	1987	2	is	be	VBZ
cord-023095-4dannjjm	1987	3	a	a	DT
cord-023095-4dannjjm	1987	4	malignant	malignant	JJ
cord-023095-4dannjjm	1987	5	,	,	,
cord-023095-4dannjjm	1987	6	catecholamine	catecholamine	NN
cord-023095-4dannjjm	1987	7	-	-	HYPH
cord-023095-4dannjjm	1987	8	producing	produce	VBG
cord-023095-4dannjjm	1987	9	,	,	,
cord-023095-4dannjjm	1987	10	adrenomedullary	adrenomedullary	NN
cord-023095-4dannjjm	1987	11	tumor	tumor	NN
cord-023095-4dannjjm	1987	12	.	.	.
cord-023095-4dannjjm	1988	1	Clinical	clinical	JJ
cord-023095-4dannjjm	1988	2	signs	sign	NNS
cord-023095-4dannjjm	1988	3	resulting	result	VBG
cord-023095-4dannjjm	1988	4	from	from	IN
cord-023095-4dannjjm	1988	5	excessive	excessive	JJ
cord-023095-4dannjjm	1988	6	catecholamine	catecholamine	NN
cord-023095-4dannjjm	1988	7	secretion	secretion	NN
cord-023095-4dannjjm	1988	8	are	be	VBP
cord-023095-4dannjjm	1988	9	typically	typically	RB
cord-023095-4dannjjm	1988	10	non	non	JJ
cord-023095-4dannjjm	1988	11	-	-	JJ
cord-023095-4dannjjm	1988	12	specific	specific	JJ
cord-023095-4dannjjm	1988	13	,	,	,
cord-023095-4dannjjm	1988	14	making	make	VBG
cord-023095-4dannjjm	1988	15	differentiation	differentiation	NN
cord-023095-4dannjjm	1988	16	from	from	IN
cord-023095-4dannjjm	1988	17	other	other	JJ
cord-023095-4dannjjm	1988	18	adrenal	adrenal	JJ
cord-023095-4dannjjm	1988	19	tumors	tumor	NNS
cord-023095-4dannjjm	1988	20	a	a	DT
cord-023095-4dannjjm	1988	21	challenge	challenge	NN
cord-023095-4dannjjm	1988	22	.	.	.
cord-023095-4dannjjm	1989	1	Elevated	elevated	JJ
cord-023095-4dannjjm	1989	2	plasma	plasma	NN
cord-023095-4dannjjm	1989	3	concentrations	concentration	NNS
cord-023095-4dannjjm	1989	4	of	of	IN
cord-023095-4dannjjm	1989	5	the	the	DT
cord-023095-4dannjjm	1989	6	catecholamine	catecholamine	NN
cord-023095-4dannjjm	1989	7	breakdown	breakdown	NN
cord-023095-4dannjjm	1989	8	products	product	NNS
cord-023095-4dannjjm	1989	9	metanephrine	metanephrine	NNP
cord-023095-4dannjjm	1989	10	(	(	-LRB-
cord-023095-4dannjjm	1989	11	MN	MN	NNP
cord-023095-4dannjjm	1989	12	)	)	-RRB-
cord-023095-4dannjjm	1989	13	and	and	CC
cord-023095-4dannjjm	1989	14	normetanephrine	normetanephrine	NNP
cord-023095-4dannjjm	1989	15	(	(	-LRB-
cord-023095-4dannjjm	1989	16	NMN	NMN	NNP
cord-023095-4dannjjm	1989	17	)	)	-RRB-
cord-023095-4dannjjm	1989	18	are	be	VBP
cord-023095-4dannjjm	1989	19	used	use	VBN
cord-023095-4dannjjm	1989	20	to	to	TO
cord-023095-4dannjjm	1989	21	identify	identify	VB
cord-023095-4dannjjm	1989	22	pheochromocytoma	pheochromocytoma	NN
cord-023095-4dannjjm	1989	23	in	in	IN
cord-023095-4dannjjm	1989	24	humans	human	NNS
cord-023095-4dannjjm	1989	25	.	.	.
cord-023095-4dannjjm	1990	1	This	this	DT
cord-023095-4dannjjm	1990	2	study	study	NN
cord-023095-4dannjjm	1990	3	tested	test	VBD
cord-023095-4dannjjm	1990	4	the	the	DT
cord-023095-4dannjjm	1990	5	hypothesis	hypothesis	NN
cord-023095-4dannjjm	1990	6	that	that	WDT
cord-023095-4dannjjm	1990	7	plasma	plasma	NN
cord-023095-4dannjjm	1990	8	metanephrine	metanephrine	NN
cord-023095-4dannjjm	1990	9	concentrations	concentration	NNS
cord-023095-4dannjjm	1990	10	are	be	VBP
cord-023095-4dannjjm	1990	11	greater	great	JJR
cord-023095-4dannjjm	1990	12	in	in	IN
cord-023095-4dannjjm	1990	13	dogs	dog	NNS
cord-023095-4dannjjm	1990	14	with	with	IN
cord-023095-4dannjjm	1990	15	pheochromocytoma	pheochromocytoma	NN
cord-023095-4dannjjm	1990	16	than	than	IN
cord-023095-4dannjjm	1990	17	in	in	IN
cord-023095-4dannjjm	1990	18	dogs	dog	NNS
cord-023095-4dannjjm	1990	19	with	with	IN
cord-023095-4dannjjm	1990	20	other	other	JJ
cord-023095-4dannjjm	1990	21	adrenal	adrenal	JJ
cord-023095-4dannjjm	1990	22	neoplasms	neoplasm	NNS
cord-023095-4dannjjm	1990	23	,	,	,
cord-023095-4dannjjm	1990	24	healthy	healthy	JJ
cord-023095-4dannjjm	1990	25	dogs	dog	NNS
cord-023095-4dannjjm	1990	26	and	and	CC
cord-023095-4dannjjm	1990	27	dogs	dog	NNS
cord-023095-4dannjjm	1990	28	with	with	IN
cord-023095-4dannjjm	1990	29	non	non	JJ
cord-023095-4dannjjm	1990	30	-	-	JJ
cord-023095-4dannjjm	1990	31	adrenal	adrenal	JJ
cord-023095-4dannjjm	1990	32	illness	illness	NN
cord-023095-4dannjjm	1990	33	.	.	.
cord-023095-4dannjjm	1991	1	EDTA	EDTA	NNP
cord-023095-4dannjjm	1991	2	plasma	plasma	NN
cord-023095-4dannjjm	1991	3	was	be	VBD
cord-023095-4dannjjm	1991	4	collected	collect	VBN
cord-023095-4dannjjm	1991	5	from	from	IN
cord-023095-4dannjjm	1991	6	healthy	healthy	JJ
cord-023095-4dannjjm	1991	7	dogs	dog	NNS
cord-023095-4dannjjm	1991	8	and	and	CC
cord-023095-4dannjjm	1991	9	unwell	unwell	JJ
cord-023095-4dannjjm	1991	10	,	,	,
cord-023095-4dannjjm	1991	11	hospitalized	hospitalize	VBN
cord-023095-4dannjjm	1991	12	dogs	dog	NNS
cord-023095-4dannjjm	1991	13	with	with	IN
cord-023095-4dannjjm	1991	14	non	non	JJ
cord-023095-4dannjjm	1991	15	-	-	JJ
cord-023095-4dannjjm	1991	16	adrenal	adrenal	JJ
cord-023095-4dannjjm	1991	17	illness	illness	NN
cord-023095-4dannjjm	1991	18	,	,	,
cord-023095-4dannjjm	1991	19	pheochromocytoma	pheochromocytoma	NN
cord-023095-4dannjjm	1991	20	and	and	CC
cord-023095-4dannjjm	1991	21	cortical	cortical	JJ
cord-023095-4dannjjm	1991	22	tumors	tumor	NNS
cord-023095-4dannjjm	1991	23	between	between	IN
cord-023095-4dannjjm	1991	24	April	April	NNP
cord-023095-4dannjjm	1991	25	2007	2007	CD
cord-023095-4dannjjm	1991	26	and	and	CC
cord-023095-4dannjjm	1991	27	October	October	NNP
cord-023095-4dannjjm	1991	28	2010	2010	CD
cord-023095-4dannjjm	1991	29	.	.	.
cord-023095-4dannjjm	1992	1	Samples	sample	NNS
cord-023095-4dannjjm	1992	2	were	be	VBD
cord-023095-4dannjjm	1992	3	stored	store	VBN
cord-023095-4dannjjm	1992	4	at	at	IN
cord-023095-4dannjjm	1992	5	À801C	À801C	NNPS
cord-023095-4dannjjm	1992	6	before	before	IN
cord-023095-4dannjjm	1992	7	measurement	measurement	NN
cord-023095-4dannjjm	1992	8	of	of	IN
cord-023095-4dannjjm	1992	9	free	free	JJ
cord-023095-4dannjjm	1992	10	MN	MN	NNP
cord-023095-4dannjjm	1992	11	and	and	CC
cord-023095-4dannjjm	1992	12	NMN	NMN	NNP
cord-023095-4dannjjm	1992	13	concentrations	concentration	NNS
cord-023095-4dannjjm	1992	14	using	use	VBG
cord-023095-4dannjjm	1992	15	high	high	JJ
cord-023095-4dannjjm	1992	16	pressure	pressure	NN
cord-023095-4dannjjm	1992	17	liquid	liquid	NN
cord-023095-4dannjjm	1992	18	chromatography	chromatography	NN
cord-023095-4dannjjm	1992	19	at	at	IN
cord-023095-4dannjjm	1992	20	the	the	DT
cord-023095-4dannjjm	1992	21	Central	Central	NNP
cord-023095-4dannjjm	1992	22	Laboratory	Laboratory	NNP
cord-023095-4dannjjm	1992	23	for	for	IN
cord-023095-4dannjjm	1992	24	Clinical	Clinical	NNP
cord-023095-4dannjjm	1992	25	Chemistry	Chemistry	NNP
cord-023095-4dannjjm	1992	26	at	at	IN
cord-023095-4dannjjm	1992	27	the	the	DT
cord-023095-4dannjjm	1992	28	University	University	NNP
cord-023095-4dannjjm	1992	29	of	of	IN
cord-023095-4dannjjm	1992	30	Groningen	Groningen	NNP
cord-023095-4dannjjm	1992	31	(	(	-LRB-
cord-023095-4dannjjm	1992	32	33	33	CD
cord-023095-4dannjjm	1992	33	samples	sample	NNS
cord-023095-4dannjjm	1992	34	)	)	-RRB-
cord-023095-4dannjjm	1992	35	or	or	CC
cord-023095-4dannjjm	1992	36	the	the	DT
cord-023095-4dannjjm	1992	37	Mayo	Mayo	NNP
cord-023095-4dannjjm	1992	38	Clinic	Clinic	NNP
cord-023095-4dannjjm	1992	39	,	,	,
cord-023095-4dannjjm	1992	40	Rochester	Rochester	NNP
cord-023095-4dannjjm	1992	41	,	,	,
cord-023095-4dannjjm	1992	42	Minnesota	Minnesota	NNP
cord-023095-4dannjjm	1992	43	(	(	-LRB-
cord-023095-4dannjjm	1992	44	7	7	CD
cord-023095-4dannjjm	1992	45	samples	sample	NNS
cord-023095-4dannjjm	1992	46	)	)	-RRB-
cord-023095-4dannjjm	1992	47	.	.	.
cord-023095-4dannjjm	1993	1	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	1993	2	-	-	HYPH
cord-023095-4dannjjm	1993	3	Wallis	Wallis	NNP
cord-023095-4dannjjm	1993	4	tests	test	NNS
cord-023095-4dannjjm	1993	5	followed	follow	VBN
cord-023095-4dannjjm	1993	6	by	by	IN
cord-023095-4dannjjm	1993	7	Dunn	Dunn	NNP
cord-023095-4dannjjm	1993	8	's	's	POS
cord-023095-4dannjjm	1993	9	multiple	multiple	JJ
cord-023095-4dannjjm	1993	10	comparison	comparison	NN
cord-023095-4dannjjm	1993	11	analysis	analysis	NN
cord-023095-4dannjjm	1993	12	were	be	VBD
cord-023095-4dannjjm	1993	13	used	use	VBN
cord-023095-4dannjjm	1993	14	to	to	TO
cord-023095-4dannjjm	1993	15	compare	compare	VB
cord-023095-4dannjjm	1993	16	results	result	NNS
cord-023095-4dannjjm	1993	17	between	between	IN
cord-023095-4dannjjm	1993	18	groups	group	NNS
cord-023095-4dannjjm	1993	19	.	.	.
cord-023095-4dannjjm	1994	1	Significance	significance	NN
cord-023095-4dannjjm	1994	2	was	be	VBD
cord-023095-4dannjjm	1994	3	set	set	VBN
cord-023095-4dannjjm	1994	4	at	at	IN
cord-023095-4dannjjm	1995	1	P	p	NN
cord-023095-4dannjjm	1995	2	o	o	NN
cord-023095-4dannjjm	1995	3	0.05	0.05	CD
cord-023095-4dannjjm	1995	4	.	.	.
cord-023095-4dannjjm	1996	1	Results	result	NNS
cord-023095-4dannjjm	1996	2	are	be	VBP
cord-023095-4dannjjm	1996	3	reported	report	VBN
cord-023095-4dannjjm	1996	4	as	as	IN
cord-023095-4dannjjm	1996	5	median	median	JJ
cord-023095-4dannjjm	1996	6	[	[	-LRB-
cord-023095-4dannjjm	1996	7	range	range	NN
cord-023095-4dannjjm	1996	8	]	]	-RRB-
cord-023095-4dannjjm	1996	9	.	.	.
cord-023095-4dannjjm	1997	1	Eight	eight	CD
cord-023095-4dannjjm	1997	2	dogs	dog	NNS
cord-023095-4dannjjm	1997	3	with	with	IN
cord-023095-4dannjjm	1997	4	pheochromocytoma	pheochromocytoma	NN
cord-023095-4dannjjm	1997	5	,	,	,
cord-023095-4dannjjm	1997	6	5	5	CD
cord-023095-4dannjjm	1997	7	healthy	healthy	JJ
cord-023095-4dannjjm	1997	8	dogs	dog	NNS
cord-023095-4dannjjm	1997	9	,	,	,
cord-023095-4dannjjm	1997	10	15	15	CD
cord-023095-4dannjjm	1997	11	dogs	dog	NNS
cord-023095-4dannjjm	1997	12	with	with	IN
cord-023095-4dannjjm	1997	13	non	non	JJ
cord-023095-4dannjjm	1997	14	-	-	JJ
cord-023095-4dannjjm	1997	15	adrenal	adrenal	JJ
cord-023095-4dannjjm	1997	16	illness	illness	NN
cord-023095-4dannjjm	1997	17	and	and	CC
cord-023095-4dannjjm	1997	18	12	12	CD
cord-023095-4dannjjm	1997	19	dogs	dog	NNS
cord-023095-4dannjjm	1997	20	with	with	IN
cord-023095-4dannjjm	1997	21	cortical	cortical	JJ
cord-023095-4dannjjm	1997	22	tumors	tumor	NNS
cord-023095-4dannjjm	1997	23	were	be	VBD
cord-023095-4dannjjm	1997	24	sampled	sample	VBN
cord-023095-4dannjjm	1997	25	.	.	.
cord-023095-4dannjjm	1998	1	Pheochromocytoma	Pheochromocytoma	NNP
cord-023095-4dannjjm	1998	2	was	be	VBD
cord-023095-4dannjjm	1998	3	diagnosed	diagnose	VBN
cord-023095-4dannjjm	1998	4	histologically	histologically	RB
cord-023095-4dannjjm	1998	5	(	(	-LRB-
cord-023095-4dannjjm	1998	6	7	7	CD
cord-023095-4dannjjm	1998	7	dogs	dog	NNS
cord-023095-4dannjjm	1998	8	)	)	-RRB-
cord-023095-4dannjjm	1998	9	or	or	CC
cord-023095-4dannjjm	1998	10	cytologically	cytologically	NN
cord-023095-4dannjjm	1998	11	(	(	-LRB-
cord-023095-4dannjjm	1998	12	1	1	CD
cord-023095-4dannjjm	1998	13	dog	dog	NN
cord-023095-4dannjjm	1998	14	)	)	-RRB-
cord-023095-4dannjjm	1998	15	.	.	.
cord-023095-4dannjjm	1999	1	Cortical	cortical	JJ
cord-023095-4dannjjm	1999	2	tumors	tumor	NNS
cord-023095-4dannjjm	1999	3	were	be	VBD
cord-023095-4dannjjm	1999	4	diagnosed	diagnose	VBN
cord-023095-4dannjjm	1999	5	histologically	histologically	RB
cord-023095-4dannjjm	1999	6	(	(	-LRB-
cord-023095-4dannjjm	1999	7	9	9	CD
cord-023095-4dannjjm	1999	8	dogs	dog	NNS
cord-023095-4dannjjm	1999	9	)	)	-RRB-
cord-023095-4dannjjm	1999	10	or	or	CC
cord-023095-4dannjjm	1999	11	by	by	IN
cord-023095-4dannjjm	1999	12	response	response	NN
cord-023095-4dannjjm	1999	13	to	to	IN
cord-023095-4dannjjm	1999	14	trilostane	trilostane	NNP
cord-023095-4dannjjm	1999	15	treatment	treatment	NN
cord-023095-4dannjjm	1999	16	after	after	IN
cord-023095-4dannjjm	1999	17	obtaining	obtain	VBG
cord-023095-4dannjjm	1999	18	consistent	consistent	JJ
cord-023095-4dannjjm	1999	19	endocrine	endocrine	JJ
cord-023095-4dannjjm	1999	20	test	test	NN
cord-023095-4dannjjm	1999	21	results	result	NNS
cord-023095-4dannjjm	1999	22	(	(	-LRB-
cord-023095-4dannjjm	1999	23	3	3	CD
cord-023095-4dannjjm	1999	24	dogs	dog	NNS
cord-023095-4dannjjm	1999	25	Occult	occult	JJ
cord-023095-4dannjjm	1999	26	hyperadrenocorticism	hyperadrenocorticism	NN
cord-023095-4dannjjm	1999	27	(	(	-LRB-
cord-023095-4dannjjm	1999	28	HAC	HAC	NNP
cord-023095-4dannjjm	1999	29	)	)	-RRB-
cord-023095-4dannjjm	1999	30	has	have	VBZ
cord-023095-4dannjjm	1999	31	been	be	VBN
cord-023095-4dannjjm	1999	32	theorized	theorize	VBN
cord-023095-4dannjjm	1999	33	to	to	TO
cord-023095-4dannjjm	1999	34	exist	exist	VB
cord-023095-4dannjjm	1999	35	in	in	IN
cord-023095-4dannjjm	1999	36	which	which	WDT
cord-023095-4dannjjm	1999	37	excess	excess	JJ
cord-023095-4dannjjm	1999	38	adrenal	adrenal	JJ
cord-023095-4dannjjm	1999	39	sex	sex	NN
cord-023095-4dannjjm	1999	40	hormone	hormone	NN
cord-023095-4dannjjm	1999	41	secretion	secretion	NN
cord-023095-4dannjjm	1999	42	induces	induce	VBZ
cord-023095-4dannjjm	1999	43	the	the	DT
cord-023095-4dannjjm	1999	44	clinical	clinical	JJ
cord-023095-4dannjjm	1999	45	signs	sign	NNS
cord-023095-4dannjjm	1999	46	and	and	CC
cord-023095-4dannjjm	1999	47	laboratory	laboratory	NN
cord-023095-4dannjjm	1999	48	changes	change	NNS
cord-023095-4dannjjm	1999	49	associated	associate	VBN
cord-023095-4dannjjm	1999	50	with	with	IN
cord-023095-4dannjjm	1999	51	classic	classic	JJ
cord-023095-4dannjjm	1999	52	HAC	HAC	NNP
cord-023095-4dannjjm	1999	53	.	.	.
cord-023095-4dannjjm	2000	1	However	however	RB
cord-023095-4dannjjm	2000	2	,	,	,
cord-023095-4dannjjm	2000	3	the	the	DT
cord-023095-4dannjjm	2000	4	ability	ability	NN
cord-023095-4dannjjm	2000	5	of	of	IN
cord-023095-4dannjjm	2000	6	sex	sex	NN
cord-023095-4dannjjm	2000	7	hormones	hormone	NNS
cord-023095-4dannjjm	2000	8	to	to	TO
cord-023095-4dannjjm	2000	9	cause	cause	VB
cord-023095-4dannjjm	2000	10	such	such	JJ
cord-023095-4dannjjm	2000	11	alterations	alteration	NNS
cord-023095-4dannjjm	2000	12	has	have	VBZ
cord-023095-4dannjjm	2000	13	never	never	RB
cord-023095-4dannjjm	2000	14	been	be	VBN
cord-023095-4dannjjm	2000	15	closely	closely	RB
cord-023095-4dannjjm	2000	16	evaluated	evaluate	VBN
cord-023095-4dannjjm	2000	17	.	.	.
cord-023095-4dannjjm	2001	1	If	if	IN
cord-023095-4dannjjm	2001	2	sex	sex	NN
cord-023095-4dannjjm	2001	3	hormones	hormone	NNS
cord-023095-4dannjjm	2001	4	can	can	MD
cord-023095-4dannjjm	2001	5	cause	cause	VB
cord-023095-4dannjjm	2001	6	a	a	DT
cord-023095-4dannjjm	2001	7	syndrome	syndrome	NN
cord-023095-4dannjjm	2001	8	similar	similar	JJ
cord-023095-4dannjjm	2001	9	to	to	IN
cord-023095-4dannjjm	2001	10	classic	classic	JJ
cord-023095-4dannjjm	2001	11	HAC	HAC	NNP
cord-023095-4dannjjm	2001	12	,	,	,
cord-023095-4dannjjm	2001	13	they	-PRON-	PRP
cord-023095-4dannjjm	2001	14	should	should	MD
cord-023095-4dannjjm	2001	15	be	be	VB
cord-023095-4dannjjm	2001	16	able	able	JJ
cord-023095-4dannjjm	2001	17	to	to	TO
cord-023095-4dannjjm	2001	18	induce	induce	VB
cord-023095-4dannjjm	2001	19	expression	expression	NN
cord-023095-4dannjjm	2001	20	of	of	IN
cord-023095-4dannjjm	2001	21	classic	classic	JJ
cord-023095-4dannjjm	2001	22	glucocorticoid	glucocorticoid	NN
cord-023095-4dannjjm	2001	23	-	-	HYPH
cord-023095-4dannjjm	2001	24	induced	induce	VBN
cord-023095-4dannjjm	2001	25	genes	gene	NNS
cord-023095-4dannjjm	2001	26	.	.	.
cord-023095-4dannjjm	2002	1	The	the	DT
cord-023095-4dannjjm	2002	2	purpose	purpose	NN
cord-023095-4dannjjm	2002	3	of	of	IN
cord-023095-4dannjjm	2002	4	the	the	DT
cord-023095-4dannjjm	2002	5	study	study	NN
cord-023095-4dannjjm	2002	6	was	be	VBD
cord-023095-4dannjjm	2002	7	to	to	TO
cord-023095-4dannjjm	2002	8	determine	determine	VB
cord-023095-4dannjjm	2002	9	if	if	IN
cord-023095-4dannjjm	2002	10	in	in	FW
cord-023095-4dannjjm	2002	11	vitro	vitro	FW
cord-023095-4dannjjm	2002	12	expression	expression	NN
cord-023095-4dannjjm	2002	13	of	of	IN
cord-023095-4dannjjm	2002	14	the	the	DT
cord-023095-4dannjjm	2002	15	gene	gene	NN
cord-023095-4dannjjm	2002	16	for	for	IN
cord-023095-4dannjjm	2002	17	corticosteroid	corticosteroid	NN
cord-023095-4dannjjm	2002	18	-	-	HYPH
cord-023095-4dannjjm	2002	19	induced	induce	VBN
cord-023095-4dannjjm	2002	20	ALP	ALP	NNP
cord-023095-4dannjjm	2002	21	(	(	-LRB-
cord-023095-4dannjjm	2002	22	CIALP	CIALP	NNP
cord-023095-4dannjjm	2002	23	)	)	-RRB-
cord-023095-4dannjjm	2002	24	could	could	MD
cord-023095-4dannjjm	2002	25	be	be	VB
cord-023095-4dannjjm	2002	26	induced	induce	VBN
cord-023095-4dannjjm	2002	27	by	by	IN
cord-023095-4dannjjm	2002	28	clinically	clinically	RB
cord-023095-4dannjjm	2002	29	relevant	relevant	JJ
cord-023095-4dannjjm	2002	30	concentrations	concentration	NNS
cord-023095-4dannjjm	2002	31	of	of	IN
cord-023095-4dannjjm	2002	32	cortisol	cortisol	NN
cord-023095-4dannjjm	2002	33	and	and	CC
cord-023095-4dannjjm	2002	34	sex	sex	NN
cord-023095-4dannjjm	2002	35	hormones	hormone	NNS
cord-023095-4dannjjm	2002	36	believed	believe	VBN
cord-023095-4dannjjm	2002	37	to	to	TO
cord-023095-4dannjjm	2002	38	cause	cause	VB
cord-023095-4dannjjm	2002	39	occult	occult	JJ
cord-023095-4dannjjm	2002	40	HAC	HAC	NNP
cord-023095-4dannjjm	2002	41	.	.	.
cord-023095-4dannjjm	2003	1	Canine	canine	JJ
cord-023095-4dannjjm	2003	2	hepatocytes	hepatocyte	NNS
cord-023095-4dannjjm	2003	3	were	be	VBD
cord-023095-4dannjjm	2003	4	purchased	purchase	VBN
cord-023095-4dannjjm	2003	5	from	from	IN
cord-023095-4dannjjm	2003	6	a	a	DT
cord-023095-4dannjjm	2003	7	commercial	commercial	JJ
cord-023095-4dannjjm	2003	8	source	source	NN
cord-023095-4dannjjm	2003	9	(	(	-LRB-
cord-023095-4dannjjm	2003	10	CellzDirect	CellzDirect	NNP
cord-023095-4dannjjm	2003	11	or	or	CC
cord-023095-4dannjjm	2003	12	InVitro	InVitro	NNP
cord-023095-4dannjjm	2003	13	)	)	-RRB-
cord-023095-4dannjjm	2003	14	in	in	IN
cord-023095-4dannjjm	2003	15	6-well	6-well	CD
cord-023095-4dannjjm	2003	16	plates	plate	NNS
cord-023095-4dannjjm	2003	17	.	.	.
cord-023095-4dannjjm	2004	1	Upon	upon	IN
cord-023095-4dannjjm	2004	2	arrival	arrival	NN
cord-023095-4dannjjm	2004	3	(	(	-LRB-
cord-023095-4dannjjm	2004	4	3	3	CD
cord-023095-4dannjjm	2004	5	-	-	SYM
cord-023095-4dannjjm	2004	6	4	4	CD
cord-023095-4dannjjm	2004	7	plates	plate	NNS
cord-023095-4dannjjm	2004	8	per	per	IN
cord-023095-4dannjjm	2004	9	shipment	shipment	NN
cord-023095-4dannjjm	2004	10	)	)	-RRB-
cord-023095-4dannjjm	2004	11	,	,	,
cord-023095-4dannjjm	2004	12	the	the	DT
cord-023095-4dannjjm	2004	13	cells	cell	NNS
cord-023095-4dannjjm	2004	14	were	be	VBD
cord-023095-4dannjjm	2004	15	allowed	allow	VBN
cord-023095-4dannjjm	2004	16	to	to	TO
cord-023095-4dannjjm	2004	17	recover	recover	VB
cord-023095-4dannjjm	2004	18	in	in	IN
cord-023095-4dannjjm	2004	19	general	general	JJ
cord-023095-4dannjjm	2004	20	media	medium	NNS
cord-023095-4dannjjm	2004	21	per	per	IN
cord-023095-4dannjjm	2004	22	supplier	supplier	NN
cord-023095-4dannjjm	2004	23	recommendations	recommendation	NNS
cord-023095-4dannjjm	2004	24	.	.	.
cord-023095-4dannjjm	2005	1	After	after	IN
cord-023095-4dannjjm	2005	2	4	4	CD
cord-023095-4dannjjm	2005	3	hrs	hrs	NN
cord-023095-4dannjjm	2005	4	,	,	,
cord-023095-4dannjjm	2005	5	media	medium	NNS
cord-023095-4dannjjm	2005	6	was	be	VBD
cord-023095-4dannjjm	2005	7	changed	change	VBN
cord-023095-4dannjjm	2005	8	to	to	IN
cord-023095-4dannjjm	2005	9	William	William	NNP
cord-023095-4dannjjm	2005	10	's	's	POS
cord-023095-4dannjjm	2005	11	E	e	NN
cord-023095-4dannjjm	2005	12	media	medium	NNS
cord-023095-4dannjjm	2005	13	(	(	-LRB-
cord-023095-4dannjjm	2005	14	-L	-L	:
cord-023095-4dannjjm	2005	15	-	-	HYPH
cord-023095-4dannjjm	2005	16	glutamine	glutamine	NN
cord-023095-4dannjjm	2005	17	)	)	-RRB-
cord-023095-4dannjjm	2005	18	containing	contain	VBG
cord-023095-4dannjjm	2005	19	concentrations	concentration	NNS
cord-023095-4dannjjm	2005	20	of	of	IN
cord-023095-4dannjjm	2005	21	cortisol	cortisol	NN
cord-023095-4dannjjm	2005	22	or	or	CC
cord-023095-4dannjjm	2005	23	sex	sex	NN
cord-023095-4dannjjm	2005	24	hormones	hormone	NNS
cord-023095-4dannjjm	2005	25	that	that	WDT
cord-023095-4dannjjm	2005	26	have	have	VBP
cord-023095-4dannjjm	2005	27	been	be	VBN
cord-023095-4dannjjm	2005	28	documented	document	VBN
cord-023095-4dannjjm	2005	29	in	in	IN
cord-023095-4dannjjm	2005	30	the	the	DT
cord-023095-4dannjjm	2005	31	literature	literature	NN
cord-023095-4dannjjm	2005	32	in	in	IN
cord-023095-4dannjjm	2005	33	dogs	dog	NNS
cord-023095-4dannjjm	2005	34	with	with	IN
cord-023095-4dannjjm	2005	35	HAC	HAC	NNP
cord-023095-4dannjjm	2005	36	or	or	CC
cord-023095-4dannjjm	2005	37	with	with	IN
cord-023095-4dannjjm	2005	38	purported	purport	VBN
cord-023095-4dannjjm	2005	39	occult	occult	JJ
cord-023095-4dannjjm	2005	40	HAC	HAC	NNP
cord-023095-4dannjjm	2005	41	.	.	.
cord-023095-4dannjjm	2006	1	Each	each	DT
cord-023095-4dannjjm	2006	2	plate	plate	NN
cord-023095-4dannjjm	2006	3	was	be	VBD
cord-023095-4dannjjm	2006	4	treated	treat	VBN
cord-023095-4dannjjm	2006	5	with	with	IN
cord-023095-4dannjjm	2006	6	a	a	DT
cord-023095-4dannjjm	2006	7	different	different	JJ
cord-023095-4dannjjm	2006	8	hormone	hormone	NN
cord-023095-4dannjjm	2006	9	(	(	-LRB-
cord-023095-4dannjjm	2006	10	cortisol	cortisol	NN
cord-023095-4dannjjm	2006	11	,	,	,
cord-023095-4dannjjm	2006	12	17-hydroxyprogesterone	17-hydroxyprogesterone	CD
cord-023095-4dannjjm	2006	13	[	[	-LRB-
cord-023095-4dannjjm	2006	14	17OHP	17ohp	CD
cord-023095-4dannjjm	2006	15	]	]	-RRB-
cord-023095-4dannjjm	2006	16	,	,	,
cord-023095-4dannjjm	2006	17	progesterone	progesterone	NN
cord-023095-4dannjjm	2006	18	,	,	,
cord-023095-4dannjjm	2006	19	estradiol	estradiol	NN
cord-023095-4dannjjm	2006	20	or	or	CC
cord-023095-4dannjjm	2006	21	androstenedione	androstenedione	NN
cord-023095-4dannjjm	2006	22	)	)	-RRB-
cord-023095-4dannjjm	2006	23	,	,	,
cord-023095-4dannjjm	2006	24	and	and	CC
cord-023095-4dannjjm	2006	25	each	each	DT
cord-023095-4dannjjm	2006	26	well	well	NN
cord-023095-4dannjjm	2006	27	contained	contain	VBD
cord-023095-4dannjjm	2006	28	a	a	DT
cord-023095-4dannjjm	2006	29	different	different	JJ
cord-023095-4dannjjm	2006	30	concentration	concentration	NN
cord-023095-4dannjjm	2006	31	(	(	-LRB-
cord-023095-4dannjjm	2006	32	starting	start	VBG
cord-023095-4dannjjm	2006	33	with	with	IN
cord-023095-4dannjjm	2006	34	no	no	DT
cord-023095-4dannjjm	2006	35	hormone	hormone	NN
cord-023095-4dannjjm	2006	36	added	add	VBN
cord-023095-4dannjjm	2006	37	as	as	IN
cord-023095-4dannjjm	2006	38	a	a	DT
cord-023095-4dannjjm	2006	39	negative	negative	JJ
cord-023095-4dannjjm	2006	40	control	control	NN
cord-023095-4dannjjm	2006	41	)	)	-RRB-
cord-023095-4dannjjm	2006	42	to	to	TO
cord-023095-4dannjjm	2006	43	evaluate	evaluate	VB
cord-023095-4dannjjm	2006	44	a	a	DT
cord-023095-4dannjjm	2006	45	dose	dose	JJ
cord-023095-4dannjjm	2006	46	response	response	NN
cord-023095-4dannjjm	2006	47	.	.	.
cord-023095-4dannjjm	2007	1	Media	Media	NNP
cord-023095-4dannjjm	2007	2	was	be	VBD
cord-023095-4dannjjm	2007	3	changed	change	VBN
cord-023095-4dannjjm	2007	4	daily	daily	RB
cord-023095-4dannjjm	2007	5	.	.	.
cord-023095-4dannjjm	2008	1	After	after	IN
cord-023095-4dannjjm	2008	2	5	5	CD
cord-023095-4dannjjm	2008	3	days	day	NNS
cord-023095-4dannjjm	2008	4	of	of	IN
cord-023095-4dannjjm	2008	5	hormone	hormone	NN
cord-023095-4dannjjm	2008	6	exposure	exposure	NN
cord-023095-4dannjjm	2008	7	,	,	,
cord-023095-4dannjjm	2008	8	RNA	RNA	NNP
cord-023095-4dannjjm	2008	9	was	be	VBD
cord-023095-4dannjjm	2008	10	extracted	extract	VBN
cord-023095-4dannjjm	2008	11	.	.	.
cord-023095-4dannjjm	2009	1	Reverse	reverse	JJ
cord-023095-4dannjjm	2009	2	transcription	transcription	NN
cord-023095-4dannjjm	2009	3	was	be	VBD
cord-023095-4dannjjm	2009	4	performed	perform	VBN
cord-023095-4dannjjm	2009	5	and	and	CC
cord-023095-4dannjjm	2009	6	the	the	DT
cord-023095-4dannjjm	2009	7	product	product	NN
cord-023095-4dannjjm	2009	8	used	use	VBN
cord-023095-4dannjjm	2009	9	for	for	IN
cord-023095-4dannjjm	2009	10	quantitative	quantitative	JJ
cord-023095-4dannjjm	2009	11	PCR	PCR	NNP
cord-023095-4dannjjm	2009	12	for	for	IN
cord-023095-4dannjjm	2009	13	CIALP	CIALP	NNP
cord-023095-4dannjjm	2009	14	and	and	CC
cord-023095-4dannjjm	2009	15	beta	beta	NN
cord-023095-4dannjjm	2009	16	-	-	HYPH
cord-023095-4dannjjm	2009	17	actin	actin	JJ
cord-023095-4dannjjm	2009	18	(	(	-LRB-
cord-023095-4dannjjm	2009	19	Roche	Roche	NNP
cord-023095-4dannjjm	2009	20	Lightcycler	Lightcycler	NNP
cord-023095-4dannjjm	2009	21	)	)	-RRB-
cord-023095-4dannjjm	2009	22	using	use	VBG
cord-023095-4dannjjm	2009	23	a	a	DT
cord-023095-4dannjjm	2009	24	gene	gene	NN
cord-023095-4dannjjm	2009	25	-	-	HYPH
cord-023095-4dannjjm	2009	26	specific	specific	JJ
cord-023095-4dannjjm	2009	27	fluorescent	fluorescent	JJ
cord-023095-4dannjjm	2009	28	probe	probe	NN
cord-023095-4dannjjm	2009	29	for	for	IN
cord-023095-4dannjjm	2009	30	detection	detection	NN
cord-023095-4dannjjm	2009	31	.	.	.
cord-023095-4dannjjm	2010	1	Standard	standard	JJ
cord-023095-4dannjjm	2010	2	curves	curve	NNS
cord-023095-4dannjjm	2010	3	were	be	VBD
cord-023095-4dannjjm	2010	4	created	create	VBN
cord-023095-4dannjjm	2010	5	for	for	IN
cord-023095-4dannjjm	2010	6	each	each	DT
cord-023095-4dannjjm	2010	7	gene	gene	NN
cord-023095-4dannjjm	2010	8	.	.	.
cord-023095-4dannjjm	2011	1	All	all	DT
cord-023095-4dannjjm	2011	2	samples	sample	NNS
cord-023095-4dannjjm	2011	3	and	and	CC
cord-023095-4dannjjm	2011	4	standards	standard	NNS
cord-023095-4dannjjm	2011	5	were	be	VBD
cord-023095-4dannjjm	2011	6	run	run	VBN
cord-023095-4dannjjm	2011	7	in	in	IN
cord-023095-4dannjjm	2011	8	duplicate	duplicate	NN
cord-023095-4dannjjm	2011	9	.	.	.
cord-023095-4dannjjm	2012	1	Using	use	VBG
cord-023095-4dannjjm	2012	2	the	the	DT
cord-023095-4dannjjm	2012	3	Lightcycler	Lightcycler	NNP
cord-023095-4dannjjm	2012	4	software	software	NN
cord-023095-4dannjjm	2012	5	(	(	-LRB-
cord-023095-4dannjjm	2012	6	vers	vers	NNP
cord-023095-4dannjjm	2012	7	4.0	4.0	CD
cord-023095-4dannjjm	2012	8	)	)	-RRB-
cord-023095-4dannjjm	2012	9	,	,	,
cord-023095-4dannjjm	2012	10	CIALP	CIALP	NNP
cord-023095-4dannjjm	2012	11	expression	expression	NN
cord-023095-4dannjjm	2012	12	was	be	VBD
cord-023095-4dannjjm	2012	13	normalized	normalize	VBN
cord-023095-4dannjjm	2012	14	to	to	IN
cord-023095-4dannjjm	2012	15	that	that	DT
cord-023095-4dannjjm	2012	16	of	of	IN
cord-023095-4dannjjm	2012	17	beta	beta	NN
cord-023095-4dannjjm	2012	18	-	-	HYPH
cord-023095-4dannjjm	2012	19	actin	actin	JJ
cord-023095-4dannjjm	2012	20	.	.	.
cord-023095-4dannjjm	2013	1	Fold	fold	VB
cord-023095-4dannjjm	2013	2	change	change	NN
cord-023095-4dannjjm	2013	3	in	in	IN
cord-023095-4dannjjm	2013	4	expression	expression	NN
cord-023095-4dannjjm	2013	5	was	be	VBD
cord-023095-4dannjjm	2013	6	determined	determine	VBN
cord-023095-4dannjjm	2013	7	relative	relative	JJ
cord-023095-4dannjjm	2013	8	to	to	IN
cord-023095-4dannjjm	2013	9	the	the	DT
cord-023095-4dannjjm	2013	10	negative	negative	JJ
cord-023095-4dannjjm	2013	11	control	control	NN
cord-023095-4dannjjm	2013	12	.	.	.
cord-023095-4dannjjm	2014	1	Each	each	DT
cord-023095-4dannjjm	2014	2	sex	sex	NN
cord-023095-4dannjjm	2014	3	hormone	hormone	NN
cord-023095-4dannjjm	2014	4	was	be	VBD
cord-023095-4dannjjm	2014	5	used	use	VBN
cord-023095-4dannjjm	2014	6	to	to	TO
cord-023095-4dannjjm	2014	7	treat	treat	VB
cord-023095-4dannjjm	2014	8	3	3	CD
cord-023095-4dannjjm	2014	9	plates	plate	NNS
cord-023095-4dannjjm	2014	10	;	;	:
cord-023095-4dannjjm	2014	11	one	one	CD
cord-023095-4dannjjm	2014	12	plate	plate	NN
cord-023095-4dannjjm	2014	13	in	in	IN
cord-023095-4dannjjm	2014	14	each	each	DT
cord-023095-4dannjjm	2014	15	shipment	shipment	NN
cord-023095-4dannjjm	2014	16	was	be	VBD
cord-023095-4dannjjm	2014	17	treated	treat	VBN
cord-023095-4dannjjm	2014	18	with	with	IN
cord-023095-4dannjjm	2014	19	cortisol	cortisol	NN
cord-023095-4dannjjm	2014	20	as	as	IN
cord-023095-4dannjjm	2014	21	a	a	DT
cord-023095-4dannjjm	2014	22	positive	positive	JJ
cord-023095-4dannjjm	2014	23	control	control	NN
cord-023095-4dannjjm	2014	24	.	.	.
cord-023095-4dannjjm	2015	1	For	for	IN
cord-023095-4dannjjm	2015	2	cortisol	cortisol	NN
cord-023095-4dannjjm	2015	3	,	,	,
cord-023095-4dannjjm	2015	4	a	a	DT
cord-023095-4dannjjm	2015	5	dose	dose	JJ
cord-023095-4dannjjm	2015	6	response	response	NN
cord-023095-4dannjjm	2015	7	was	be	VBD
cord-023095-4dannjjm	2015	8	seen	see	VBN
cord-023095-4dannjjm	2015	9	in	in	IN
cord-023095-4dannjjm	2015	10	expression	expression	NN
cord-023095-4dannjjm	2015	11	of	of	IN
cord-023095-4dannjjm	2015	12	the	the	DT
cord-023095-4dannjjm	2015	13	CIALP	CIALP	NNP
cord-023095-4dannjjm	2015	14	gene	gene	NN
cord-023095-4dannjjm	2015	15	.	.	.
cord-023095-4dannjjm	2016	1	Compared	compare	VBN
cord-023095-4dannjjm	2016	2	to	to	IN
cord-023095-4dannjjm	2016	3	no	no	DT
cord-023095-4dannjjm	2016	4	cortisol	cortisol	NN
cord-023095-4dannjjm	2016	5	,	,	,
cord-023095-4dannjjm	2016	6	10	10	CD
cord-023095-4dannjjm	2016	7	,	,	,
cord-023095-4dannjjm	2016	8	50	50	CD
cord-023095-4dannjjm	2016	9	,	,	,
cord-023095-4dannjjm	2016	10	100	100	CD
cord-023095-4dannjjm	2016	11	,	,	,
cord-023095-4dannjjm	2016	12	150	150	CD
cord-023095-4dannjjm	2016	13	,	,	,
cord-023095-4dannjjm	2016	14	250	250	CD
cord-023095-4dannjjm	2016	15	and	and	CC
cord-023095-4dannjjm	2016	16	500	500	CD
cord-023095-4dannjjm	2016	17	nmol	nmol	JJ
cord-023095-4dannjjm	2016	18	cortisol	cortisol	NN
cord-023095-4dannjjm	2016	19	increased	increase	VBN
cord-023095-4dannjjm	2016	20	expression	expression	NN
cord-023095-4dannjjm	2016	21	2.8	2.8	CD
cord-023095-4dannjjm	2016	22	,	,	,
cord-023095-4dannjjm	2016	23	4.6	4.6	CD
cord-023095-4dannjjm	2016	24	,	,	,
cord-023095-4dannjjm	2016	25	7.1	7.1	CD
cord-023095-4dannjjm	2016	26	.	.	.
cord-023095-4dannjjm	2016	27	9.3	9.3	CD
cord-023095-4dannjjm	2016	28	,	,	,
cord-023095-4dannjjm	2016	29	9.9	9.9	CD
cord-023095-4dannjjm	2016	30	and	and	CC
cord-023095-4dannjjm	2016	31	9.8	9.8	CD
cord-023095-4dannjjm	2016	32	fold	fold	NN
cord-023095-4dannjjm	2016	33	,	,	,
cord-023095-4dannjjm	2016	34	respectively	respectively	RB
cord-023095-4dannjjm	2016	35	.	.	.
cord-023095-4dannjjm	2017	1	A	a	DT
cord-023095-4dannjjm	2017	2	2-fold	2-fold	CD
cord-023095-4dannjjm	2017	3	increase	increase	NN
cord-023095-4dannjjm	2017	4	is	be	VBZ
cord-023095-4dannjjm	2017	5	considered	consider	VBN
cord-023095-4dannjjm	2017	6	significant	significant	JJ
cord-023095-4dannjjm	2017	7	(	(	-LRB-
cord-023095-4dannjjm	2017	8	J.Vandesompele	J.Vandesompele	NNP
cord-023095-4dannjjm	2017	9	et	et	NNP
cord-023095-4dannjjm	2017	10	al	al	NNP
cord-023095-4dannjjm	2017	11	Genome	Genome	NNP
cord-023095-4dannjjm	2017	12	Biol	Biol	NNP
cord-023095-4dannjjm	2017	13	2002	2002	CD
cord-023095-4dannjjm	2017	14	)	)	-RRB-
cord-023095-4dannjjm	2017	15	.	.	.
cord-023095-4dannjjm	2018	1	Expression	expression	NN
cord-023095-4dannjjm	2018	2	of	of	IN
cord-023095-4dannjjm	2018	3	CIALP	CIALP	NNP
cord-023095-4dannjjm	2018	4	was	be	VBD
cord-023095-4dannjjm	2018	5	not	not	RB
cord-023095-4dannjjm	2018	6	significantly	significantly	RB
cord-023095-4dannjjm	2018	7	induced	induce	VBN
cord-023095-4dannjjm	2018	8	in	in	IN
cord-023095-4dannjjm	2018	9	response	response	NN
cord-023095-4dannjjm	2018	10	to	to	IN
cord-023095-4dannjjm	2018	11	any	any	DT
cord-023095-4dannjjm	2018	12	concentration	concentration	NN
cord-023095-4dannjjm	2018	13	of	of	IN
cord-023095-4dannjjm	2018	14	17OHP	17ohp	CD
cord-023095-4dannjjm	2018	15	(	(	-LRB-
cord-023095-4dannjjm	2018	16	10	10	CD
cord-023095-4dannjjm	2018	17	nM	nm	NN
cord-023095-4dannjjm	2018	18	maximum	maximum	NN
cord-023095-4dannjjm	2018	19	)	)	-RRB-
cord-023095-4dannjjm	2018	20	,	,	,
cord-023095-4dannjjm	2018	21	progesterone	progesterone	NN
cord-023095-4dannjjm	2018	22	(	(	-LRB-
cord-023095-4dannjjm	2018	23	5	5	CD
cord-023095-4dannjjm	2018	24	nM	nm	NN
cord-023095-4dannjjm	2018	25	maximum	maximum	NN
cord-023095-4dannjjm	2018	26	)	)	-RRB-
cord-023095-4dannjjm	2018	27	,	,	,
cord-023095-4dannjjm	2018	28	estradiol	estradiol	FW
cord-023095-4dannjjm	2018	29	(	(	-LRB-
cord-023095-4dannjjm	2018	30	max	max	NNP
cord-023095-4dannjjm	2018	31	400	400	CD
cord-023095-4dannjjm	2018	32	pM	pm	NN
cord-023095-4dannjjm	2018	33	maximum	maximum	NN
cord-023095-4dannjjm	2018	34	)	)	-RRB-
cord-023095-4dannjjm	2018	35	or	or	CC
cord-023095-4dannjjm	2018	36	androstenedione	androstenedione	NN
cord-023095-4dannjjm	2018	37	(	(	-LRB-
cord-023095-4dannjjm	2018	38	100	100	CD
cord-023095-4dannjjm	2018	39	nM	nm	CD
cord-023095-4dannjjm	2018	40	maximum	maximum	NN
cord-023095-4dannjjm	2018	41	)	)	-RRB-
cord-023095-4dannjjm	2018	42	.	.	.
cord-023095-4dannjjm	2019	1	We	-PRON-	PRP
cord-023095-4dannjjm	2019	2	conclude	conclude	VBP
cord-023095-4dannjjm	2019	3	that	that	IN
cord-023095-4dannjjm	2019	4	in	in	IN
cord-023095-4dannjjm	2019	5	vitro	vitro	FW
cord-023095-4dannjjm	2019	6	these	these	DT
cord-023095-4dannjjm	2019	7	sex	sex	NN
cord-023095-4dannjjm	2019	8	hormones	hormone	NNS
cord-023095-4dannjjm	2019	9	do	do	VBP
cord-023095-4dannjjm	2019	10	not	not	RB
cord-023095-4dannjjm	2019	11	induce	induce	VB
cord-023095-4dannjjm	2019	12	expression	expression	NN
cord-023095-4dannjjm	2019	13	of	of	IN
cord-023095-4dannjjm	2019	14	the	the	DT
cord-023095-4dannjjm	2019	15	CIALP	CIALP	NNP
cord-023095-4dannjjm	2019	16	gene	gene	NN
cord-023095-4dannjjm	2019	17	which	which	WDT
cord-023095-4dannjjm	2019	18	is	be	VBZ
cord-023095-4dannjjm	2019	19	classically	classically	RB
cord-023095-4dannjjm	2019	20	induced	induce	VBN
cord-023095-4dannjjm	2019	21	by	by	IN
cord-023095-4dannjjm	2019	22	cortisol	cortisol	NN
cord-023095-4dannjjm	2019	23	in	in	IN
cord-023095-4dannjjm	2019	24	vivo	vivo	NN
cord-023095-4dannjjm	2019	25	;	;	:
cord-023095-4dannjjm	2019	26	indeed	indeed	RB
cord-023095-4dannjjm	2019	27	,	,	,
cord-023095-4dannjjm	2019	28	elevated	elevated	JJ
cord-023095-4dannjjm	2019	29	serum	serum	NN
cord-023095-4dannjjm	2019	30	CIALP	CIALP	NNP
cord-023095-4dannjjm	2019	31	activity	activity	NN
cord-023095-4dannjjm	2019	32	is	be	VBZ
cord-023095-4dannjjm	2019	33	a	a	DT
cord-023095-4dannjjm	2019	34	hallmark	hallmark	NN
cord-023095-4dannjjm	2019	35	of	of	IN
cord-023095-4dannjjm	2019	36	classic	classic	JJ
cord-023095-4dannjjm	2019	37	HAC	HAC	NNP
cord-023095-4dannjjm	2019	38	.	.	.
cord-023095-4dannjjm	2020	1	Thus	thus	RB
cord-023095-4dannjjm	2020	2	,	,	,
cord-023095-4dannjjm	2020	3	the	the	DT
cord-023095-4dannjjm	2020	4	ability	ability	NN
cord-023095-4dannjjm	2020	5	of	of	IN
cord-023095-4dannjjm	2020	6	the	the	DT
cord-023095-4dannjjm	2020	7	sex	sex	NN
cord-023095-4dannjjm	2020	8	hormones	hormone	NNS
cord-023095-4dannjjm	2020	9	to	to	TO
cord-023095-4dannjjm	2020	10	induce	induce	VB
cord-023095-4dannjjm	2020	11	the	the	DT
cord-023095-4dannjjm	2020	12	gene	gene	NN
cord-023095-4dannjjm	2020	13	in	in	IN
cord-023095-4dannjjm	2020	14	vivo	vivo	NN
cord-023095-4dannjjm	2020	15	must	must	MD
cord-023095-4dannjjm	2020	16	be	be	VB
cord-023095-4dannjjm	2020	17	questioned	question	VBN
cord-023095-4dannjjm	2020	18	and	and	CC
cord-023095-4dannjjm	2020	19	evaluated	evaluate	VBN
cord-023095-4dannjjm	2020	20	.	.	.
cord-023095-4dannjjm	2021	1	Measurement	measurement	NN
cord-023095-4dannjjm	2021	2	of	of	IN
cord-023095-4dannjjm	2021	3	sex	sex	NN
cord-023095-4dannjjm	2021	4	hormones	hormone	NNS
cord-023095-4dannjjm	2021	5	has	have	VBZ
cord-023095-4dannjjm	2021	6	been	be	VBN
cord-023095-4dannjjm	2021	7	advocated	advocate	VBN
cord-023095-4dannjjm	2021	8	as	as	IN
cord-023095-4dannjjm	2021	9	an	an	DT
cord-023095-4dannjjm	2021	10	adjunct	adjunct	NN
cord-023095-4dannjjm	2021	11	means	mean	VBZ
cord-023095-4dannjjm	2021	12	for	for	IN
cord-023095-4dannjjm	2021	13	diagnosing	diagnose	VBG
cord-023095-4dannjjm	2021	14	typical	typical	JJ
cord-023095-4dannjjm	2021	15	hyperadrenocorticism	hyperadrenocorticism	NN
cord-023095-4dannjjm	2021	16	(	(	-LRB-
cord-023095-4dannjjm	2021	17	HAC	HAC	NNP
cord-023095-4dannjjm	2021	18	)	)	-RRB-
cord-023095-4dannjjm	2021	19	,	,	,
cord-023095-4dannjjm	2021	20	i.e.	i.e.	FW
cord-023095-4dannjjm	2021	21	disease	disease	NN
cord-023095-4dannjjm	2021	22	due	due	JJ
cord-023095-4dannjjm	2021	23	to	to	IN
cord-023095-4dannjjm	2021	24	excess	excess	JJ
cord-023095-4dannjjm	2021	25	cortisol	cortisol	NN
cord-023095-4dannjjm	2021	26	secretion	secretion	NN
cord-023095-4dannjjm	2021	27	,	,	,
cord-023095-4dannjjm	2021	28	as	as	RB
cord-023095-4dannjjm	2021	29	well	well	RB
cord-023095-4dannjjm	2021	30	as	as	IN
cord-023095-4dannjjm	2021	31	for	for	IN
cord-023095-4dannjjm	2021	32	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2021	33	of	of	IN
cord-023095-4dannjjm	2021	34	atypical	atypical	JJ
cord-023095-4dannjjm	2021	35	HAC	HAC	NNP
cord-023095-4dannjjm	2021	36	,	,	,
cord-023095-4dannjjm	2021	37	i.e.	i.e.	FW
cord-023095-4dannjjm	2021	38	disease	disease	NN
cord-023095-4dannjjm	2021	39	due	due	JJ
cord-023095-4dannjjm	2021	40	to	to	IN
cord-023095-4dannjjm	2021	41	excess	excess	JJ
cord-023095-4dannjjm	2021	42	adrenal	adrenal	JJ
cord-023095-4dannjjm	2021	43	sex	sex	NN
cord-023095-4dannjjm	2021	44	hormone	hormone	NN
cord-023095-4dannjjm	2021	45	secretion	secretion	NN
cord-023095-4dannjjm	2021	46	.	.	.
cord-023095-4dannjjm	2022	1	However	however	RB
cord-023095-4dannjjm	2022	2	,	,	,
cord-023095-4dannjjm	2022	3	measurements	measurement	NNS
cord-023095-4dannjjm	2022	4	in	in	IN
cord-023095-4dannjjm	2022	5	either	either	DT
cord-023095-4dannjjm	2022	6	setting	setting	NN
cord-023095-4dannjjm	2022	7	have	have	VBP
cord-023095-4dannjjm	2022	8	not	not	RB
cord-023095-4dannjjm	2022	9	been	be	VBN
cord-023095-4dannjjm	2022	10	widely	widely	RB
cord-023095-4dannjjm	2022	11	studied	study	VBN
cord-023095-4dannjjm	2022	12	.	.	.
cord-023095-4dannjjm	2023	1	Therefore	therefore	RB
cord-023095-4dannjjm	2023	2	,	,	,
cord-023095-4dannjjm	2023	3	our	-PRON-	PRP$
cord-023095-4dannjjm	2023	4	objectives	objective	NNS
cord-023095-4dannjjm	2023	5	were	be	VBD
cord-023095-4dannjjm	2023	6	:	:	:
cord-023095-4dannjjm	2023	7	1	1	CD
cord-023095-4dannjjm	2023	8	.	.	.
cord-023095-4dannjjm	2024	1	To	to	TO
cord-023095-4dannjjm	2024	2	determine	determine	VB
cord-023095-4dannjjm	2024	3	the	the	DT
cord-023095-4dannjjm	2024	4	sensitivity	sensitivity	NN
cord-023095-4dannjjm	2024	5	of	of	IN
cord-023095-4dannjjm	2024	6	17-hydroxy	17-hydroxy	CD
cord-023095-4dannjjm	2024	7	-	-	HYPH
cord-023095-4dannjjm	2024	8	progesterone	progesterone	NN
cord-023095-4dannjjm	2024	9	(	(	-LRB-
cord-023095-4dannjjm	2024	10	17OHP	17ohp	CD
cord-023095-4dannjjm	2024	11	)	)	-RRB-
cord-023095-4dannjjm	2024	12	and	and	CC
cord-023095-4dannjjm	2024	13	estradiol	estradiol	NN
cord-023095-4dannjjm	2024	14	concentrations	concentration	NNS
cord-023095-4dannjjm	2024	15	pre	pre	VBP
cord-023095-4dannjjm	2024	16	-	-	JJ
cord-023095-4dannjjm	2024	17	and	and	CC
cord-023095-4dannjjm	2024	18	post	post	JJ
cord-023095-4dannjjm	2024	19	-	-	JJ
cord-023095-4dannjjm	2024	20	ACTH	ACTH	NNP
cord-023095-4dannjjm	2024	21	for	for	IN
cord-023095-4dannjjm	2024	22	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2024	23	of	of	IN
cord-023095-4dannjjm	2024	24	typical	typical	JJ
cord-023095-4dannjjm	2024	25	HAC	HAC	NNP
cord-023095-4dannjjm	2024	26	.	.	.
cord-023095-4dannjjm	2025	1	2	2	LS
cord-023095-4dannjjm	2025	2	.	.	.
cord-023095-4dannjjm	2026	1	To	to	TO
cord-023095-4dannjjm	2026	2	determine	determine	VB
cord-023095-4dannjjm	2026	3	the	the	DT
cord-023095-4dannjjm	2026	4	specificity	specificity	NN
cord-023095-4dannjjm	2026	5	of	of	IN
cord-023095-4dannjjm	2026	6	17OHP	17ohp	CD
cord-023095-4dannjjm	2026	7	and	and	CC
cord-023095-4dannjjm	2026	8	estradiol	estradiol	NN
cord-023095-4dannjjm	2026	9	concentrations	concentration	NNS
cord-023095-4dannjjm	2026	10	preand	preand	NNP
cord-023095-4dannjjm	2026	11	post	post	JJ
cord-023095-4dannjjm	2026	12	-	-	JJ
cord-023095-4dannjjm	2026	13	ACTH	ACTH	NNP
cord-023095-4dannjjm	2026	14	for	for	IN
cord-023095-4dannjjm	2026	15	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2026	16	of	of	IN
cord-023095-4dannjjm	2026	17	occult	occult	JJ
cord-023095-4dannjjm	2026	18	HAC	HAC	NNP
cord-023095-4dannjjm	2026	19	.	.	.
cord-023095-4dannjjm	2027	1	Dogs	dog	NNS
cord-023095-4dannjjm	2027	2	that	that	WDT
cord-023095-4dannjjm	2027	3	had	have	VBD
cord-023095-4dannjjm	2027	4	PDH	PDH	NNP
cord-023095-4dannjjm	2027	5	(	(	-LRB-
cord-023095-4dannjjm	2027	6	n	n	NN
cord-023095-4dannjjm	2027	7	5	5	CD
cord-023095-4dannjjm	2027	8	12	12	CD
cord-023095-4dannjjm	2027	9	)	)	-RRB-
cord-023095-4dannjjm	2027	10	,	,	,
cord-023095-4dannjjm	2027	11	dogs	dog	NNS
cord-023095-4dannjjm	2027	12	that	that	WDT
cord-023095-4dannjjm	2027	13	were	be	VBD
cord-023095-4dannjjm	2027	14	suspected	suspect	VBN
cord-023095-4dannjjm	2027	15	to	to	TO
cord-023095-4dannjjm	2027	16	have	have	VB
cord-023095-4dannjjm	2027	17	HAC	HAC	NNP
cord-023095-4dannjjm	2027	18	but	but	CC
cord-023095-4dannjjm	2027	19	proven	prove	VBN
cord-023095-4dannjjm	2027	20	not	not	RB
cord-023095-4dannjjm	2027	21	to	to	IN
cord-023095-4dannjjm	2027	22	(	(	-LRB-
cord-023095-4dannjjm	2027	23	had	have	VBD
cord-023095-4dannjjm	2027	24	non	non	JJ
cord-023095-4dannjjm	2027	25	-	-	JJ
cord-023095-4dannjjm	2027	26	adrenal	adrenal	JJ
cord-023095-4dannjjm	2027	27	illness	illness	NN
cord-023095-4dannjjm	2027	28	[	[	-LRB-
cord-023095-4dannjjm	2027	29	NAI	NAI	NNP
cord-023095-4dannjjm	2027	30	,	,	,
cord-023095-4dannjjm	2027	31	n	n	NN
cord-023095-4dannjjm	2027	32	5	5	CD
cord-023095-4dannjjm	2027	33	89	89	CD
cord-023095-4dannjjm	2027	34	]	]	-RRB-
cord-023095-4dannjjm	2027	35	)	)	-RRB-
cord-023095-4dannjjm	2027	36	or	or	CC
cord-023095-4dannjjm	2027	37	dogs	dog	NNS
cord-023095-4dannjjm	2027	38	that	that	WDT
cord-023095-4dannjjm	2027	39	were	be	VBD
cord-023095-4dannjjm	2027	40	healthy	healthy	JJ
cord-023095-4dannjjm	2027	41	(	(	-LRB-
cord-023095-4dannjjm	2027	42	n	n	NN
cord-023095-4dannjjm	2027	43	5	5	CD
cord-023095-4dannjjm	2027	44	20	20	CD
cord-023095-4dannjjm	2027	45	,	,	,
cord-023095-4dannjjm	2027	46	used	use	VBN
cord-023095-4dannjjm	2027	47	to	to	TO
cord-023095-4dannjjm	2027	48	establish	establish	VB
cord-023095-4dannjjm	2027	49	reference	reference	NN
cord-023095-4dannjjm	2027	50	ranges	range	NNS
cord-023095-4dannjjm	2027	51	[	[	-LRB-
cord-023095-4dannjjm	2027	52	RR	RR	NNP
cord-023095-4dannjjm	2027	53	]	]	-RRB-
cord-023095-4dannjjm	2027	54	)	)	-RRB-
cord-023095-4dannjjm	2027	55	were	be	VBD
cord-023095-4dannjjm	2027	56	enrolled	enrol	VBN
cord-023095-4dannjjm	2027	57	.	.	.
cord-023095-4dannjjm	2028	1	ACTH	ACTH	NNP
cord-023095-4dannjjm	2028	2	stimulation	stimulation	NN
cord-023095-4dannjjm	2028	3	tests	test	NNS
cord-023095-4dannjjm	2028	4	were	be	VBD
cord-023095-4dannjjm	2028	5	performed	perform	VBN
cord-023095-4dannjjm	2028	6	(	(	-LRB-
cord-023095-4dannjjm	2028	7	5	5	CD
cord-023095-4dannjjm	2028	8	mcg	mcg	NNP
cord-023095-4dannjjm	2028	9	/	/	SYM
cord-023095-4dannjjm	2028	10	kg	kg	NNP
cord-023095-4dannjjm	2028	11	cosyntropin	cosyntropin	NNP
cord-023095-4dannjjm	2028	12	IV	IV	NNP
cord-023095-4dannjjm	2028	13	)	)	-RRB-
cord-023095-4dannjjm	2028	14	;	;	:
cord-023095-4dannjjm	2028	15	blood	blood	NN
cord-023095-4dannjjm	2028	16	samples	sample	NNS
cord-023095-4dannjjm	2028	17	were	be	VBD
cord-023095-4dannjjm	2028	18	drawn	draw	VBN
cord-023095-4dannjjm	2028	19	pre	pre	JJ
cord-023095-4dannjjm	2028	20	and	and	CC
cord-023095-4dannjjm	2028	21	60min	60min	JJ
cord-023095-4dannjjm	2028	22	post	post	NN
cord-023095-4dannjjm	2028	23	;	;	:
cord-023095-4dannjjm	2028	24	17OHP	17ohp	CD
cord-023095-4dannjjm	2028	25	and	and	CC
cord-023095-4dannjjm	2028	26	estradiol	estradiol	NN
cord-023095-4dannjjm	2028	27	were	be	VBD
cord-023095-4dannjjm	2028	28	measured	measure	VBN
cord-023095-4dannjjm	2028	29	by	by	IN
cord-023095-4dannjjm	2028	30	previously	previously	RB
cord-023095-4dannjjm	2028	31	validated	validate	VBN
cord-023095-4dannjjm	2028	32	radioimmunoassays	radioimmunoassay	NNS
cord-023095-4dannjjm	2028	33	.	.	.
cord-023095-4dannjjm	2029	1	A	a	DT
cord-023095-4dannjjm	2029	2	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	2029	3	-	-	HYPH
cord-023095-4dannjjm	2029	4	Wallis	Wallis	NNP
cord-023095-4dannjjm	2029	5	Rank	Rank	NNP
cord-023095-4dannjjm	2029	6	Sum	Sum	NNP
cord-023095-4dannjjm	2029	7	test	test	NN
cord-023095-4dannjjm	2029	8	was	be	VBD
cord-023095-4dannjjm	2029	9	used	use	VBN
cord-023095-4dannjjm	2029	10	to	to	TO
cord-023095-4dannjjm	2029	11	compare	compare	VB
cord-023095-4dannjjm	2029	12	values	value	NNS
cord-023095-4dannjjm	2029	13	between	between	IN
cord-023095-4dannjjm	2029	14	the	the	DT
cord-023095-4dannjjm	2029	15	groups	group	NNS
cord-023095-4dannjjm	2029	16	.	.	.
cord-023095-4dannjjm	2030	1	Significance	significance	NN
cord-023095-4dannjjm	2030	2	was	be	VBD
cord-023095-4dannjjm	2030	3	set	set	VBN
cord-023095-4dannjjm	2030	4	at	at	IN
cord-023095-4dannjjm	2030	5	p	p	NN
cord-023095-4dannjjm	2030	6	o	o	NN
cord-023095-4dannjjm	2030	7	0.05	0.05	CD
cord-023095-4dannjjm	2030	8	.	.	.
cord-023095-4dannjjm	2031	1	For	for	IN
cord-023095-4dannjjm	2031	2	basal	basal	NN
cord-023095-4dannjjm	2031	3	and	and	CC
cord-023095-4dannjjm	2031	4	ACTH	ACTH	NNP
cord-023095-4dannjjm	2031	5	-	-	HYPH
cord-023095-4dannjjm	2031	6	stimulated	stimulate	VBN
cord-023095-4dannjjm	2031	7	17OHP	17ohp	CD
cord-023095-4dannjjm	2031	8	concentrations	concentration	NNS
cord-023095-4dannjjm	2031	9	,	,	,
cord-023095-4dannjjm	2031	10	the	the	DT
cord-023095-4dannjjm	2031	11	RR	rr	NN
cord-023095-4dannjjm	2031	12	were	be	VBD
cord-023095-4dannjjm	2031	13	determined	determine	VBN
cord-023095-4dannjjm	2031	14	to	to	TO
cord-023095-4dannjjm	2031	15	be	be	VB
cord-023095-4dannjjm	2031	16	0.03	0.03	CD
cord-023095-4dannjjm	2031	17	-	-	SYM
cord-023095-4dannjjm	2031	18	0.6	0.6	CD
cord-023095-4dannjjm	2031	19	ng	ng	NN
cord-023095-4dannjjm	2031	20	/	/	SYM
cord-023095-4dannjjm	2031	21	mL	ml	NN
cord-023095-4dannjjm	2032	1	(	(	-LRB-
cord-023095-4dannjjm	2032	2	mean	mean	VB
cord-023095-4dannjjm	2032	3	AE	AE	NNP
cord-023095-4dannjjm	2032	4	2	2	CD
cord-023095-4dannjjm	2032	5	s.d	s.d	NNP
cord-023095-4dannjjm	2032	6	.	.	NNP
cord-023095-4dannjjm	2032	7	;	;	:
cord-023095-4dannjjm	2032	8	range	range	VBP
cord-023095-4dannjjm	2032	9	0.03	0.03	CD
cord-023095-4dannjjm	2032	10	-	-	HYPH
cord-023095-4dannjjm	2032	11	0.55	0.55	CD
cord-023095-4dannjjm	2032	12	)	)	-RRB-
cord-023095-4dannjjm	2032	13	and	and	CC
cord-023095-4dannjjm	2032	14	0.3	0.3	CD
cord-023095-4dannjjm	2032	15	-	-	SYM
cord-023095-4dannjjm	2032	16	2.2	2.2	CD
cord-023095-4dannjjm	2032	17	ng	ng	NN
cord-023095-4dannjjm	2032	18	/	/	SYM
cord-023095-4dannjjm	2032	19	mL	ml	NN
cord-023095-4dannjjm	2033	1	(	(	-LRB-
cord-023095-4dannjjm	2033	2	range	range	VBP
cord-023095-4dannjjm	2033	3	0.31	0.31	CD
cord-023095-4dannjjm	2033	4	-	-	SYM
cord-023095-4dannjjm	2033	5	1.95	1.95	CD
cord-023095-4dannjjm	2033	6	)	)	-RRB-
cord-023095-4dannjjm	2033	7	,	,	,
cord-023095-4dannjjm	2033	8	respectively	respectively	RB
cord-023095-4dannjjm	2033	9	.	.	.
cord-023095-4dannjjm	2034	1	In	in	IN
cord-023095-4dannjjm	2034	2	PDH	PDH	NNP
cord-023095-4dannjjm	2034	3	dogs	dog	NNS
cord-023095-4dannjjm	2034	4	,	,	,
cord-023095-4dannjjm	2034	5	3	3	CD
cord-023095-4dannjjm	2034	6	and	and	CC
cord-023095-4dannjjm	2034	7	7	7	CD
cord-023095-4dannjjm	2034	8	had	have	VBD
cord-023095-4dannjjm	2034	9	basal	basal	NN
cord-023095-4dannjjm	2034	10	and	and	CC
cord-023095-4dannjjm	2034	11	post	post	JJ
cord-023095-4dannjjm	2034	12	-	-	JJ
cord-023095-4dannjjm	2034	13	ACTH	acth	JJ
cord-023095-4dannjjm	2034	14	17OHP	17ohp	CD
cord-023095-4dannjjm	2034	15	concentrations	concentration	NNS
cord-023095-4dannjjm	2034	16	above	above	IN
cord-023095-4dannjjm	2034	17	the	the	DT
cord-023095-4dannjjm	2034	18	RR	rr	NN
cord-023095-4dannjjm	2034	19	,	,	,
cord-023095-4dannjjm	2034	20	respectively	respectively	RB
cord-023095-4dannjjm	2034	21	;	;	:
cord-023095-4dannjjm	2034	22	in	in	IN
cord-023095-4dannjjm	2034	23	the	the	DT
cord-023095-4dannjjm	2034	24	NAI	NAI	NNP
cord-023095-4dannjjm	2034	25	group	group	NN
cord-023095-4dannjjm	2034	26	,	,	,
cord-023095-4dannjjm	2034	27	23	23	CD
cord-023095-4dannjjm	2034	28	and	and	CC
cord-023095-4dannjjm	2034	29	25	25	CD
cord-023095-4dannjjm	2034	30	dogs	dog	NNS
cord-023095-4dannjjm	2034	31	had	have	VBD
cord-023095-4dannjjm	2034	32	concentrations	concentration	NNS
cord-023095-4dannjjm	2034	33	above	above	IN
cord-023095-4dannjjm	2034	34	the	the	DT
cord-023095-4dannjjm	2034	35	RR	rr	NN
cord-023095-4dannjjm	2034	36	,	,	,
cord-023095-4dannjjm	2034	37	respectively	respectively	RB
cord-023095-4dannjjm	2034	38	.	.	.
cord-023095-4dannjjm	2035	1	Thus	thus	RB
cord-023095-4dannjjm	2035	2	,	,	,
cord-023095-4dannjjm	2035	3	the	the	DT
cord-023095-4dannjjm	2035	4	sensitivity	sensitivity	NN
cord-023095-4dannjjm	2035	5	of	of	IN
cord-023095-4dannjjm	2035	6	basal	basal	NN
cord-023095-4dannjjm	2035	7	and	and	CC
cord-023095-4dannjjm	2035	8	post	post	JJ
cord-023095-4dannjjm	2035	9	-	-	JJ
cord-023095-4dannjjm	2035	10	ACTH	ACTH	NNP
cord-023095-4dannjjm	2035	11	17OHP	17ohp	CD
cord-023095-4dannjjm	2035	12	measurement	measurement	NN
cord-023095-4dannjjm	2035	13	for	for	IN
cord-023095-4dannjjm	2035	14	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2035	15	of	of	IN
cord-023095-4dannjjm	2035	16	HAC	HAC	NNP
cord-023095-4dannjjm	2035	17	is	be	VBZ
cord-023095-4dannjjm	2035	18	25	25	CD
cord-023095-4dannjjm	2035	19	%	%	NN
cord-023095-4dannjjm	2035	20	and	and	CC
cord-023095-4dannjjm	2035	21	58	58	CD
cord-023095-4dannjjm	2035	22	%	%	NN
cord-023095-4dannjjm	2035	23	,	,	,
cord-023095-4dannjjm	2035	24	respectively	respectively	RB
cord-023095-4dannjjm	2035	25	.	.	.
cord-023095-4dannjjm	2036	1	Specificity	specificity	NN
cord-023095-4dannjjm	2036	2	of	of	IN
cord-023095-4dannjjm	2036	3	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2036	4	is	be	VBZ
cord-023095-4dannjjm	2036	5	72	72	CD
cord-023095-4dannjjm	2036	6	%	%	NN
cord-023095-4dannjjm	2036	7	and	and	CC
cord-023095-4dannjjm	2036	8	74	74	CD
cord-023095-4dannjjm	2036	9	%	%	NN
cord-023095-4dannjjm	2036	10	,	,	,
cord-023095-4dannjjm	2036	11	respectively	respectively	RB
cord-023095-4dannjjm	2036	12	.	.	.
cord-023095-4dannjjm	2037	1	Post	post	JJ
cord-023095-4dannjjm	2037	2	-	-	JJ
cord-023095-4dannjjm	2037	3	ACTH	ACTH	NNP
cord-023095-4dannjjm	2037	4	17OHP	17ohp	CD
cord-023095-4dannjjm	2037	5	concentration	concentration	NN
cord-023095-4dannjjm	2037	6	was	be	VBD
cord-023095-4dannjjm	2037	7	significantly	significantly	RB
cord-023095-4dannjjm	2037	8	different	different	JJ
cord-023095-4dannjjm	2037	9	between	between	IN
cord-023095-4dannjjm	2037	10	groups	group	NNS
cord-023095-4dannjjm	2037	11	.	.	.
cord-023095-4dannjjm	2038	1	For	for	IN
cord-023095-4dannjjm	2038	2	basal	basal	NN
cord-023095-4dannjjm	2038	3	and	and	CC
cord-023095-4dannjjm	2038	4	stimulated	stimulate	VBN
cord-023095-4dannjjm	2038	5	estradiol	estradiol	NN
cord-023095-4dannjjm	2038	6	concentrations	concentration	NNS
cord-023095-4dannjjm	2038	7	,	,	,
cord-023095-4dannjjm	2038	8	the	the	DT
cord-023095-4dannjjm	2038	9	RR	rr	NN
cord-023095-4dannjjm	2038	10	were	be	VBD
cord-023095-4dannjjm	2038	11	determined	determine	VBN
cord-023095-4dannjjm	2038	12	to	to	TO
cord-023095-4dannjjm	2038	13	be	be	VB
cord-023095-4dannjjm	2038	14	81	81	CD
cord-023095-4dannjjm	2038	15	-	-	SYM
cord-023095-4dannjjm	2038	16	180	180	CD
cord-023095-4dannjjm	2038	17	pg	pg	NN
cord-023095-4dannjjm	2038	18	/	/	SYM
cord-023095-4dannjjm	2038	19	mL	ml	NN
cord-023095-4dannjjm	2038	20	(	(	-LRB-
cord-023095-4dannjjm	2038	21	range	range	NNP
cord-023095-4dannjjm	2038	22	89	89	CD
cord-023095-4dannjjm	2038	23	-	-	SYM
cord-023095-4dannjjm	2038	24	195	195	CD
cord-023095-4dannjjm	2038	25	)	)	-RRB-
cord-023095-4dannjjm	2038	26	and	and	CC
cord-023095-4dannjjm	2038	27	71	71	CD
cord-023095-4dannjjm	2038	28	-	-	SYM
cord-023095-4dannjjm	2038	29	170	170	CD
cord-023095-4dannjjm	2038	30	pg	pg	NN
cord-023095-4dannjjm	2038	31	/	/	SYM
cord-023095-4dannjjm	2038	32	mL	ml	NN
cord-023095-4dannjjm	2038	33	(	(	-LRB-
cord-023095-4dannjjm	2038	34	range	range	NNP
cord-023095-4dannjjm	2038	35	74	74	CD
cord-023095-4dannjjm	2038	36	-	-	SYM
cord-023095-4dannjjm	2038	37	151	151	CD
cord-023095-4dannjjm	2038	38	)	)	-RRB-
cord-023095-4dannjjm	2038	39	,	,	,
cord-023095-4dannjjm	2038	40	respectively	respectively	RB
cord-023095-4dannjjm	2038	41	.	.	.
cord-023095-4dannjjm	2039	1	For	for	IN
cord-023095-4dannjjm	2039	2	both	both	DT
cord-023095-4dannjjm	2039	3	basal	basal	NN
cord-023095-4dannjjm	2039	4	and	and	CC
cord-023095-4dannjjm	2039	5	stimulated	stimulate	VBD
cord-023095-4dannjjm	2039	6	estradiol	estradiol	NN
cord-023095-4dannjjm	2039	7	,	,	,
cord-023095-4dannjjm	2039	8	4	4	CD
cord-023095-4dannjjm	2039	9	PDH	PDH	NNP
cord-023095-4dannjjm	2039	10	dogs	dog	NNS
cord-023095-4dannjjm	2039	11	(	(	-LRB-
cord-023095-4dannjjm	2039	12	n	n	NN
cord-023095-4dannjjm	2039	13	5	5	CD
cord-023095-4dannjjm	2039	14	9	9	CD
cord-023095-4dannjjm	2039	15	)	)	-RRB-
cord-023095-4dannjjm	2039	16	had	have	VBD
cord-023095-4dannjjm	2039	17	concentrations	concentration	NNS
cord-023095-4dannjjm	2039	18	above	above	IN
cord-023095-4dannjjm	2039	19	the	the	DT
cord-023095-4dannjjm	2039	20	RR	rr	NN
cord-023095-4dannjjm	2039	21	;	;	:
cord-023095-4dannjjm	2039	22	for	for	IN
cord-023095-4dannjjm	2039	23	those	those	DT
cord-023095-4dannjjm	2039	24	with	with	IN
cord-023095-4dannjjm	2039	25	NAI	NAI	NNP
cord-023095-4dannjjm	2039	26	(	(	-LRB-
cord-023095-4dannjjm	2039	27	n	n	NN
cord-023095-4dannjjm	2039	28	5	5	CD
cord-023095-4dannjjm	2039	29	80	80	CD
cord-023095-4dannjjm	2039	30	)	)	-RRB-
cord-023095-4dannjjm	2039	31	,	,	,
cord-023095-4dannjjm	2039	32	14	14	CD
cord-023095-4dannjjm	2039	33	and	and	CC
cord-023095-4dannjjm	2039	34	15	15	CD
cord-023095-4dannjjm	2039	35	had	have	VBD
cord-023095-4dannjjm	2039	36	concentrations	concentration	NNS
cord-023095-4dannjjm	2039	37	above	above	IN
cord-023095-4dannjjm	2039	38	the	the	DT
cord-023095-4dannjjm	2039	39	RR	rr	NN
cord-023095-4dannjjm	2039	40	,	,	,
cord-023095-4dannjjm	2039	41	respectively	respectively	RB
cord-023095-4dannjjm	2039	42	.	.	.
cord-023095-4dannjjm	2040	1	Thus	thus	RB
cord-023095-4dannjjm	2040	2	,	,	,
cord-023095-4dannjjm	2040	3	the	the	DT
cord-023095-4dannjjm	2040	4	sensitivity	sensitivity	NN
cord-023095-4dannjjm	2040	5	of	of	IN
cord-023095-4dannjjm	2040	6	estradiol	estradiol	NN
cord-023095-4dannjjm	2040	7	measurement	measurement	NN
cord-023095-4dannjjm	2040	8	for	for	IN
cord-023095-4dannjjm	2040	9	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2040	10	of	of	IN
cord-023095-4dannjjm	2040	11	HAC	HAC	NNP
cord-023095-4dannjjm	2040	12	is	be	VBZ
cord-023095-4dannjjm	2040	13	44	44	CD
cord-023095-4dannjjm	2040	14	%	%	NN
cord-023095-4dannjjm	2040	15	for	for	IN
cord-023095-4dannjjm	2040	16	both	both	DT
cord-023095-4dannjjm	2040	17	pre	pre	JJ
cord-023095-4dannjjm	2040	18	-	-	JJ
cord-023095-4dannjjm	2040	19	and	and	CC
cord-023095-4dannjjm	2040	20	post	post	JJ
cord-023095-4dannjjm	2040	21	-	-	JJ
cord-023095-4dannjjm	2040	22	ACTH	ACTH	NNP
cord-023095-4dannjjm	2040	23	.	.	.
cord-023095-4dannjjm	2041	1	Specificity	specificity	NN
cord-023095-4dannjjm	2041	2	of	of	IN
cord-023095-4dannjjm	2041	3	estradiol	estradiol	NN
cord-023095-4dannjjm	2041	4	for	for	IN
cord-023095-4dannjjm	2041	5	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2041	6	for	for	IN
cord-023095-4dannjjm	2041	7	HAC	HAC	NNP
cord-023095-4dannjjm	2041	8	is	be	VBZ
cord-023095-4dannjjm	2041	9	83	83	CD
cord-023095-4dannjjm	2041	10	%	%	NN
cord-023095-4dannjjm	2041	11	and	and	CC
cord-023095-4dannjjm	2041	12	81	81	CD
cord-023095-4dannjjm	2041	13	%	%	NN
cord-023095-4dannjjm	2041	14	for	for	IN
cord-023095-4dannjjm	2041	15	pre	pre	JJ
cord-023095-4dannjjm	2041	16	-	-	JJ
cord-023095-4dannjjm	2041	17	and	and	CC
cord-023095-4dannjjm	2041	18	post	post	JJ
cord-023095-4dannjjm	2041	19	-	-	JJ
cord-023095-4dannjjm	2041	20	ACTH	ACTH	NNP
cord-023095-4dannjjm	2041	21	,	,	,
cord-023095-4dannjjm	2041	22	respectively	respectively	RB
cord-023095-4dannjjm	2041	23	.	.	.
cord-023095-4dannjjm	2042	1	Overall	overall	RB
cord-023095-4dannjjm	2042	2	,	,	,
cord-023095-4dannjjm	2042	3	23	23	CD
cord-023095-4dannjjm	2042	4	dogs	dog	NNS
cord-023095-4dannjjm	2042	5	with	with	IN
cord-023095-4dannjjm	2042	6	NAI	NAI	NNP
cord-023095-4dannjjm	2042	7	had	have	VBD
cord-023095-4dannjjm	2042	8	at	at	RB
cord-023095-4dannjjm	2042	9	least	least	RBS
cord-023095-4dannjjm	2042	10	one	one	CD
cord-023095-4dannjjm	2042	11	elevated	elevate	VBN
cord-023095-4dannjjm	2042	12	estradiol	estradiol	NN
cord-023095-4dannjjm	2042	13	concentration	concentration	NN
cord-023095-4dannjjm	2042	14	(	(	-LRB-
cord-023095-4dannjjm	2042	15	total	total	JJ
cord-023095-4dannjjm	2042	16	specificity	specificity	NN
cord-023095-4dannjjm	2042	17	70	70	CD
cord-023095-4dannjjm	2042	18	%	%	NN
cord-023095-4dannjjm	2042	19	)	)	-RRB-
cord-023095-4dannjjm	2042	20	.	.	.
cord-023095-4dannjjm	2043	1	Post	post	JJ
cord-023095-4dannjjm	2043	2	-	-	JJ
cord-023095-4dannjjm	2043	3	ACTH	ACTH	NNP
cord-023095-4dannjjm	2043	4	estradiol	estradiol	NN
cord-023095-4dannjjm	2043	5	concentration	concentration	NN
cord-023095-4dannjjm	2043	6	was	be	VBD
cord-023095-4dannjjm	2043	7	not	not	RB
cord-023095-4dannjjm	2043	8	significantly	significantly	RB
cord-023095-4dannjjm	2043	9	different	different	JJ
cord-023095-4dannjjm	2043	10	between	between	IN
cord-023095-4dannjjm	2043	11	groups	group	NNS
cord-023095-4dannjjm	2043	12	.	.	.
cord-023095-4dannjjm	2044	1	We	-PRON-	PRP
cord-023095-4dannjjm	2044	2	conclude	conclude	VBP
cord-023095-4dannjjm	2044	3	that	that	IN
cord-023095-4dannjjm	2044	4	use	use	NN
cord-023095-4dannjjm	2044	5	of	of	IN
cord-023095-4dannjjm	2044	6	17OHP	17ohp	CD
cord-023095-4dannjjm	2044	7	and	and	CC
cord-023095-4dannjjm	2044	8	estradiol	estradiol	NN
cord-023095-4dannjjm	2044	9	concentrations	concentration	NNS
cord-023095-4dannjjm	2044	10	for	for	IN
cord-023095-4dannjjm	2044	11	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2044	12	of	of	IN
cord-023095-4dannjjm	2044	13	HAC	HAC	NNP
cord-023095-4dannjjm	2044	14	can	can	MD
cord-023095-4dannjjm	2044	15	be	be	VB
cord-023095-4dannjjm	2044	16	problematic	problematic	JJ
cord-023095-4dannjjm	2044	17	.	.	.
cord-023095-4dannjjm	2045	1	Sensitivity	sensitivity	NN
cord-023095-4dannjjm	2045	2	and	and	CC
cord-023095-4dannjjm	2045	3	specificity	specificity	NN
cord-023095-4dannjjm	2045	4	are	be	VBP
cord-023095-4dannjjm	2045	5	relatively	relatively	RB
cord-023095-4dannjjm	2045	6	low	low	JJ
cord-023095-4dannjjm	2045	7	,	,	,
cord-023095-4dannjjm	2045	8	potentially	potentially	RB
cord-023095-4dannjjm	2045	9	leading	lead	VBG
cord-023095-4dannjjm	2045	10	to	to	IN
cord-023095-4dannjjm	2045	11	misdiagnoses	misdiagnose	NNS
cord-023095-4dannjjm	2045	12	.	.	.
cord-023095-4dannjjm	2046	1	Diabetes	diabetes	NN
cord-023095-4dannjjm	2046	2	mellitus	mellitus	NN
cord-023095-4dannjjm	2046	3	is	be	VBZ
cord-023095-4dannjjm	2046	4	one	one	CD
cord-023095-4dannjjm	2046	5	of	of	IN
cord-023095-4dannjjm	2046	6	the	the	DT
cord-023095-4dannjjm	2046	7	most	most	RBS
cord-023095-4dannjjm	2046	8	common	common	JJ
cord-023095-4dannjjm	2046	9	feline	feline	JJ
cord-023095-4dannjjm	2046	10	endocrinopathies	endocrinopathie	NNS
cord-023095-4dannjjm	2046	11	and	and	CC
cord-023095-4dannjjm	2046	12	is	be	VBZ
cord-023095-4dannjjm	2046	13	considered	consider	VBN
cord-023095-4dannjjm	2046	14	to	to	TO
cord-023095-4dannjjm	2046	15	have	have	VB
cord-023095-4dannjjm	2046	16	a	a	DT
cord-023095-4dannjjm	2046	17	similar	similar	JJ
cord-023095-4dannjjm	2046	18	pathophysiological	pathophysiological	JJ
cord-023095-4dannjjm	2046	19	basis	basis	NN
cord-023095-4dannjjm	2046	20	to	to	IN
cord-023095-4dannjjm	2046	21	human	human	JJ
cord-023095-4dannjjm	2046	22	type	type	NN
cord-023095-4dannjjm	2046	23	2	2	CD
cord-023095-4dannjjm	2046	24	diabetes	diabete	NNS
cord-023095-4dannjjm	2046	25	.	.	.
cord-023095-4dannjjm	2047	1	Several	several	JJ
cord-023095-4dannjjm	2047	2	studies	study	NNS
cord-023095-4dannjjm	2047	3	have	have	VBP
cord-023095-4dannjjm	2047	4	identified	identify	VBN
cord-023095-4dannjjm	2047	5	risk	risk	NN
cord-023095-4dannjjm	2047	6	factors	factor	NNS
cord-023095-4dannjjm	2047	7	for	for	IN
cord-023095-4dannjjm	2047	8	development	development	NN
cord-023095-4dannjjm	2047	9	of	of	IN
cord-023095-4dannjjm	2047	10	diabetes	diabetes	NN
cord-023095-4dannjjm	2047	11	mellitus	mellitus	NN
cord-023095-4dannjjm	2047	12	in	in	IN
cord-023095-4dannjjm	2047	13	cats	cat	NNS
cord-023095-4dannjjm	2047	14	,	,	,
cord-023095-4dannjjm	2047	15	which	which	WDT
cord-023095-4dannjjm	2047	16	include	include	VBP
cord-023095-4dannjjm	2047	17	age	age	NN
cord-023095-4dannjjm	2047	18	,	,	,
cord-023095-4dannjjm	2047	19	obesity	obesity	NN
cord-023095-4dannjjm	2047	20	,	,	,
cord-023095-4dannjjm	2047	21	inappropriate	inappropriate	JJ
cord-023095-4dannjjm	2047	22	diet	diet	NN
cord-023095-4dannjjm	2047	23	and	and	CC
cord-023095-4dannjjm	2047	24	physical	physical	JJ
cord-023095-4dannjjm	2047	25	inactivity	inactivity	NN
cord-023095-4dannjjm	2047	26	.	.	.
cord-023095-4dannjjm	2048	1	However	however	RB
cord-023095-4dannjjm	2048	2	,	,	,
cord-023095-4dannjjm	2048	3	to	to	IN
cord-023095-4dannjjm	2048	4	date	date	NN
cord-023095-4dannjjm	2048	5	,	,	,
cord-023095-4dannjjm	2048	6	no	no	DT
cord-023095-4dannjjm	2048	7	specific	specific	JJ
cord-023095-4dannjjm	2048	8	genetic	genetic	JJ
cord-023095-4dannjjm	2048	9	risk	risk	NN
cord-023095-4dannjjm	2048	10	factors	factor	NNS
cord-023095-4dannjjm	2048	11	have	have	VBP
cord-023095-4dannjjm	2048	12	been	be	VBN
cord-023095-4dannjjm	2048	13	identified	identify	VBN
cord-023095-4dannjjm	2048	14	.	.	.
cord-023095-4dannjjm	2049	1	Genome	genome	NN
cord-023095-4dannjjm	2049	2	-	-	HYPH
cord-023095-4dannjjm	2049	3	wide	wide	JJ
cord-023095-4dannjjm	2049	4	association	association	NN
cord-023095-4dannjjm	2049	5	studies	study	NNS
cord-023095-4dannjjm	2049	6	in	in	IN
cord-023095-4dannjjm	2049	7	humans	human	NNS
cord-023095-4dannjjm	2049	8	have	have	VBP
cord-023095-4dannjjm	2049	9	identified	identify	VBN
cord-023095-4dannjjm	2049	10	several	several	JJ
cord-023095-4dannjjm	2049	11	genes	gene	NNS
cord-023095-4dannjjm	2049	12	that	that	WDT
cord-023095-4dannjjm	2049	13	predispose	predispose	VBP
cord-023095-4dannjjm	2049	14	to	to	IN
cord-023095-4dannjjm	2049	15	obesity	obesity	NN
cord-023095-4dannjjm	2049	16	and/or	and/or	CC
cord-023095-4dannjjm	2049	17	diabetes	diabetes	NN
cord-023095-4dannjjm	2049	18	mellitus	mellitus	NN
cord-023095-4dannjjm	2049	19	,	,	,
cord-023095-4dannjjm	2049	20	one	one	CD
cord-023095-4dannjjm	2049	21	of	of	IN
cord-023095-4dannjjm	2049	22	which	which	WDT
cord-023095-4dannjjm	2049	23	is	be	VBZ
cord-023095-4dannjjm	2049	24	the	the	DT
cord-023095-4dannjjm	2049	25	melanocortin	melanocortin	NNP
cord-023095-4dannjjm	2049	26	receptor	receptor	NN
cord-023095-4dannjjm	2049	27	4	4	CD
cord-023095-4dannjjm	2049	28	(	(	-LRB-
cord-023095-4dannjjm	2049	29	MC4R	MC4R	NNP
cord-023095-4dannjjm	2049	30	)	)	-RRB-
cord-023095-4dannjjm	2049	31	gene	gene	NN
cord-023095-4dannjjm	2049	32	.	.	.
cord-023095-4dannjjm	2050	1	The	the	DT
cord-023095-4dannjjm	2050	2	aim	aim	NN
cord-023095-4dannjjm	2050	3	of	of	IN
cord-023095-4dannjjm	2050	4	the	the	DT
cord-023095-4dannjjm	2050	5	current	current	JJ
cord-023095-4dannjjm	2050	6	study	study	NN
cord-023095-4dannjjm	2050	7	was	be	VBD
cord-023095-4dannjjm	2050	8	to	to	TO
cord-023095-4dannjjm	2050	9	identify	identify	VB
cord-023095-4dannjjm	2050	10	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2050	11	(	(	-LRB-
cord-023095-4dannjjm	2050	12	SNPs	SNPs	NNP
cord-023095-4dannjjm	2050	13	)	)	-RRB-
cord-023095-4dannjjm	2050	14	in	in	IN
cord-023095-4dannjjm	2050	15	the	the	DT
cord-023095-4dannjjm	2050	16	feline	feline	JJ
cord-023095-4dannjjm	2050	17	MC4R	MC4R	NNP
cord-023095-4dannjjm	2050	18	gene	gene	NN
cord-023095-4dannjjm	2050	19	and	and	CC
cord-023095-4dannjjm	2050	20	to	to	TO
cord-023095-4dannjjm	2050	21	use	use	VB
cord-023095-4dannjjm	2050	22	these	these	DT
cord-023095-4dannjjm	2050	23	to	to	TO
cord-023095-4dannjjm	2050	24	perform	perform	VB
cord-023095-4dannjjm	2050	25	a	a	DT
cord-023095-4dannjjm	2050	26	case	case	NN
cord-023095-4dannjjm	2050	27	:	:	:
cord-023095-4dannjjm	2050	28	control	control	NN
cord-023095-4dannjjm	2050	29	study	study	NN
cord-023095-4dannjjm	2050	30	to	to	TO
cord-023095-4dannjjm	2050	31	determine	determine	VB
cord-023095-4dannjjm	2050	32	whether	whether	IN
cord-023095-4dannjjm	2050	33	these	these	DT
cord-023095-4dannjjm	2050	34	candidate	candidate	NN
cord-023095-4dannjjm	2050	35	gene	gene	NN
cord-023095-4dannjjm	2050	36	SNPs	SNPs	NNPS
cord-023095-4dannjjm	2050	37	were	be	VBD
cord-023095-4dannjjm	2050	38	associated	associate	VBN
cord-023095-4dannjjm	2050	39	with	with	IN
cord-023095-4dannjjm	2050	40	diabetes	diabetes	NN
cord-023095-4dannjjm	2050	41	mellitus	mellitus	NN
cord-023095-4dannjjm	2050	42	in	in	IN
cord-023095-4dannjjm	2050	43	cats	cat	NNS
cord-023095-4dannjjm	2050	44	.	.	.
cord-023095-4dannjjm	2051	1	Genomic	genomic	JJ
cord-023095-4dannjjm	2051	2	DNA	dna	NN
cord-023095-4dannjjm	2051	3	from	from	IN
cord-023095-4dannjjm	2051	4	10	10	CD
cord-023095-4dannjjm	2051	5	cats	cat	NNS
cord-023095-4dannjjm	2051	6	(	(	-LRB-
cord-023095-4dannjjm	2051	7	6	6	CD
cord-023095-4dannjjm	2051	8	domestic	domestic	JJ
cord-023095-4dannjjm	2051	9	short	short	JJ
cord-023095-4dannjjm	2051	10	hair	hair	NN
cord-023095-4dannjjm	2051	11	[	[	-LRB-
cord-023095-4dannjjm	2051	12	DSH	DSH	NNP
cord-023095-4dannjjm	2051	13	]	]	-RRB-
cord-023095-4dannjjm	2051	14	,	,	,
cord-023095-4dannjjm	2051	15	4	4	CD
cord-023095-4dannjjm	2051	16	Burmese	Burmese	NNP
cord-023095-4dannjjm	2051	17	)	)	-RRB-
cord-023095-4dannjjm	2051	18	was	be	VBD
cord-023095-4dannjjm	2051	19	initially	initially	RB
cord-023095-4dannjjm	2051	20	analysed	analyse	VBN
cord-023095-4dannjjm	2051	21	by	by	IN
cord-023095-4dannjjm	2051	22	PCR	PCR	NNP
cord-023095-4dannjjm	2051	23	and	and	CC
cord-023095-4dannjjm	2051	24	direct	direct	JJ
cord-023095-4dannjjm	2051	25	sequencing	sequencing	NN
cord-023095-4dannjjm	2051	26	using	use	VBG
cord-023095-4dannjjm	2051	27	felMC4R	felmc4r	NN
cord-023095-4dannjjm	2051	28	-	-	HYPH
cord-023095-4dannjjm	2051	29	specific	specific	JJ
cord-023095-4dannjjm	2051	30	primers	primer	NNS
cord-023095-4dannjjm	2051	31	,	,	,
cord-023095-4dannjjm	2051	32	which	which	WDT
cord-023095-4dannjjm	2051	33	identified	identify	VBD
cord-023095-4dannjjm	2051	34	a	a	DT
cord-023095-4dannjjm	2051	35	missense	missense	NN
cord-023095-4dannjjm	2051	36	mutation	mutation	NN
cord-023095-4dannjjm	2051	37	(	(	-LRB-
cord-023095-4dannjjm	2051	38	MC4R	mc4r	NN
cord-023095-4dannjjm	2051	39	:	:	:
cord-023095-4dannjjm	2051	40	c.92	c.92	NNP
cord-023095-4dannjjm	2051	41	C	C	NNP
cord-023095-4dannjjm	2051	42	4	4	CD
cord-023095-4dannjjm	2051	43	T	T	NNP
cord-023095-4dannjjm	2051	44	)	)	-RRB-
cord-023095-4dannjjm	2051	45	in	in	IN
cord-023095-4dannjjm	2051	46	the	the	DT
cord-023095-4dannjjm	2051	47	region	region	NN
cord-023095-4dannjjm	2051	48	encoding	encode	VBG
cord-023095-4dannjjm	2051	49	the	the	DT
cord-023095-4dannjjm	2051	50	extracellular	extracellular	JJ
cord-023095-4dannjjm	2051	51	domain	domain	NN
cord-023095-4dannjjm	2051	52	of	of	IN
cord-023095-4dannjjm	2051	53	the	the	DT
cord-023095-4dannjjm	2051	54	receptor	receptor	NN
cord-023095-4dannjjm	2051	55	protein	protein	NN
cord-023095-4dannjjm	2051	56	in	in	IN
cord-023095-4dannjjm	2051	57	DSH	DSH	NNP
cord-023095-4dannjjm	2051	58	cats	cat	NNS
cord-023095-4dannjjm	2051	59	only	only	RB
cord-023095-4dannjjm	2051	60	.	.	.
cord-023095-4dannjjm	2052	1	One	one	CD
cord-023095-4dannjjm	2052	2	hundred	hundred	CD
cord-023095-4dannjjm	2052	3	and	and	CC
cord-023095-4dannjjm	2052	4	nineteen	nineteen	CD
cord-023095-4dannjjm	2052	5	DSH	DSH	NNP
cord-023095-4dannjjm	2052	6	cats	cat	NNS
cord-023095-4dannjjm	2052	7	were	be	VBD
cord-023095-4dannjjm	2052	8	subsequently	subsequently	RB
cord-023095-4dannjjm	2052	9	recruited	recruit	VBN
cord-023095-4dannjjm	2052	10	into	into	IN
cord-023095-4dannjjm	2052	11	the	the	DT
cord-023095-4dannjjm	2052	12	case	case	NN
cord-023095-4dannjjm	2052	13	:	:	:
cord-023095-4dannjjm	2052	14	control	control	NN
cord-023095-4dannjjm	2052	15	study	study	NN
cord-023095-4dannjjm	2052	16	.	.	.
cord-023095-4dannjjm	2053	1	Fifty	fifty	CD
cord-023095-4dannjjm	2053	2	nine	nine	CD
cord-023095-4dannjjm	2053	3	cats	cat	NNS
cord-023095-4dannjjm	2053	4	were	be	VBD
cord-023095-4dannjjm	2053	5	obese	obese	JJ
cord-023095-4dannjjm	2053	6	diabetic	diabetic	JJ
cord-023095-4dannjjm	2053	7	(	(	-LRB-
cord-023095-4dannjjm	2053	8	29	29	CD
cord-023095-4dannjjm	2053	9	male	male	NN
cord-023095-4dannjjm	2053	10	,	,	,
cord-023095-4dannjjm	2053	11	30	30	CD
cord-023095-4dannjjm	2053	12	female	female	JJ
cord-023095-4dannjjm	2053	13	)	)	-RRB-
cord-023095-4dannjjm	2053	14	,	,	,
cord-023095-4dannjjm	2053	15	mean	mean	VB
cord-023095-4dannjjm	2053	16	age	age	NN
cord-023095-4dannjjm	2053	17	11.8	11.8	CD
cord-023095-4dannjjm	2053	18	years	year	NNS
cord-023095-4dannjjm	2054	1	(	(	-LRB-
cord-023095-4dannjjm	2054	2	range	range	NNP
cord-023095-4dannjjm	2054	3	6	6	CD
cord-023095-4dannjjm	2054	4	-	-	HYPH
cord-023095-4dannjjm	2054	5	18y	18y	CD
cord-023095-4dannjjm	2054	6	)	)	-RRB-
cord-023095-4dannjjm	2054	7	;	;	:
cord-023095-4dannjjm	2054	8	mean	mean	VB
cord-023095-4dannjjm	2054	9	weight	weight	NN
cord-023095-4dannjjm	2054	10	6.68	6.68	CD
cord-023095-4dannjjm	2054	11	kg	kg	NNS
cord-023095-4dannjjm	2054	12	(	(	-LRB-
cord-023095-4dannjjm	2054	13	range	range	NNP
cord-023095-4dannjjm	2054	14	5.15	5.15	CD
cord-023095-4dannjjm	2054	15	-	-	SYM
cord-023095-4dannjjm	2054	16	10	10	CD
cord-023095-4dannjjm	2054	17	kg	kg	NNP
cord-023095-4dannjjm	2054	18	)	)	-RRB-
cord-023095-4dannjjm	2054	19	.	.	.
cord-023095-4dannjjm	2055	1	Sixty	sixty	CD
cord-023095-4dannjjm	2055	2	lean	lean	JJ
cord-023095-4dannjjm	2055	3	cats	cat	NNS
cord-023095-4dannjjm	2055	4	were	be	VBD
cord-023095-4dannjjm	2055	5	used	use	VBN
cord-023095-4dannjjm	2055	6	as	as	IN
cord-023095-4dannjjm	2055	7	controls	control	NNS
cord-023095-4dannjjm	2055	8	(	(	-LRB-
cord-023095-4dannjjm	2055	9	30	30	CD
cord-023095-4dannjjm	2055	10	male	male	NN
cord-023095-4dannjjm	2055	11	,	,	,
cord-023095-4dannjjm	2055	12	30	30	CD
cord-023095-4dannjjm	2055	13	female	female	JJ
cord-023095-4dannjjm	2055	14	)	)	-RRB-
cord-023095-4dannjjm	2055	15	,	,	,
cord-023095-4dannjjm	2055	16	mean	mean	VB
cord-023095-4dannjjm	2055	17	age	age	NN
cord-023095-4dannjjm	2055	18	13.81	13.81	CD
cord-023095-4dannjjm	2055	19	years	year	NNS
cord-023095-4dannjjm	2056	1	(	(	-LRB-
cord-023095-4dannjjm	2056	2	range	range	NNP
cord-023095-4dannjjm	2056	3	9	9	CD
cord-023095-4dannjjm	2056	4	-	-	SYM
cord-023095-4dannjjm	2056	5	19y	19y	CD
cord-023095-4dannjjm	2056	6	)	)	-RRB-
cord-023095-4dannjjm	2056	7	,	,	,
cord-023095-4dannjjm	2056	8	mean	mean	VBP
cord-023095-4dannjjm	2056	9	weight	weight	NN
cord-023095-4dannjjm	2056	10	3.99	3.99	CD
cord-023095-4dannjjm	2056	11	kg	kg	NNP
cord-023095-4dannjjm	2056	12	(	(	-LRB-
cord-023095-4dannjjm	2056	13	range	range	NNP
cord-023095-4dannjjm	2056	14	2.56	2.56	CD
cord-023095-4dannjjm	2056	15	-	-	SYM
cord-023095-4dannjjm	2056	16	5.68	5.68	CD
cord-023095-4dannjjm	2056	17	kg	kg	NNS
cord-023095-4dannjjm	2056	18	)	)	-RRB-
cord-023095-4dannjjm	2056	19	.	.	.
cord-023095-4dannjjm	2057	1	The	the	DT
cord-023095-4dannjjm	2057	2	T	t	NN
cord-023095-4dannjjm	2057	3	to	to	IN
cord-023095-4dannjjm	2057	4	C	c	NN
cord-023095-4dannjjm	2057	5	base	base	NN
cord-023095-4dannjjm	2057	6	change	change	NN
cord-023095-4dannjjm	2057	7	alters	alter	VBZ
cord-023095-4dannjjm	2057	8	a	a	DT
cord-023095-4dannjjm	2057	9	restriction	restriction	NN
cord-023095-4dannjjm	2057	10	site	site	NN
cord-023095-4dannjjm	2057	11	in	in	IN
cord-023095-4dannjjm	2057	12	the	the	DT
cord-023095-4dannjjm	2057	13	sequence	sequence	NN
cord-023095-4dannjjm	2057	14	recognized	recognize	VBN
cord-023095-4dannjjm	2057	15	by	by	IN
cord-023095-4dannjjm	2057	16	the	the	DT
cord-023095-4dannjjm	2057	17	enzyme	enzyme	NN
cord-023095-4dannjjm	2057	18	BstOI	BstOI	NNS
cord-023095-4dannjjm	2057	19	,	,	,
cord-023095-4dannjjm	2057	20	such	such	JJ
cord-023095-4dannjjm	2057	21	that	that	IN
cord-023095-4dannjjm	2057	22	DNA	dna	NN
cord-023095-4dannjjm	2057	23	from	from	IN
cord-023095-4dannjjm	2057	24	cats	cat	NNS
cord-023095-4dannjjm	2057	25	with	with	IN
cord-023095-4dannjjm	2057	26	the	the	DT
cord-023095-4dannjjm	2057	27	mutant	mutant	NN
cord-023095-4dannjjm	2057	28	(	(	-LRB-
cord-023095-4dannjjm	2057	29	C	C	NNP
cord-023095-4dannjjm	2057	30	)	)	-RRB-
cord-023095-4dannjjm	2057	31	allele	allele	NN
cord-023095-4dannjjm	2057	32	can	can	MD
cord-023095-4dannjjm	2057	33	be	be	VB
cord-023095-4dannjjm	2057	34	cut	cut	VBN
cord-023095-4dannjjm	2057	35	,	,	,
cord-023095-4dannjjm	2057	36	whereas	whereas	IN
cord-023095-4dannjjm	2057	37	that	that	DT
cord-023095-4dannjjm	2057	38	from	from	IN
cord-023095-4dannjjm	2057	39	the	the	DT
cord-023095-4dannjjm	2057	40	wild	wild	JJ
cord-023095-4dannjjm	2057	41	-	-	HYPH
cord-023095-4dannjjm	2057	42	type	type	NN
cord-023095-4dannjjm	2057	43	(	(	-LRB-
cord-023095-4dannjjm	2057	44	T	T	NNP
cord-023095-4dannjjm	2057	45	)	)	-RRB-
cord-023095-4dannjjm	2057	46	allele	allele	NN
cord-023095-4dannjjm	2057	47	can	can	MD
cord-023095-4dannjjm	2057	48	not	not	RB
cord-023095-4dannjjm	2057	49	.	.	.
cord-023095-4dannjjm	2058	1	Primers	primer	NNS
cord-023095-4dannjjm	2058	2	were	be	VBD
cord-023095-4dannjjm	2058	3	designed	design	VBN
cord-023095-4dannjjm	2058	4	that	that	IN
cord-023095-4dannjjm	2058	5	flanked	flank	VBD
cord-023095-4dannjjm	2058	6	the	the	DT
cord-023095-4dannjjm	2058	7	mutation	mutation	NN
cord-023095-4dannjjm	2058	8	to	to	TO
cord-023095-4dannjjm	2058	9	allow	allow	VB
cord-023095-4dannjjm	2058	10	PCR	PCR	NNP
cord-023095-4dannjjm	2058	11	amplification	amplification	NN
cord-023095-4dannjjm	2058	12	of	of	IN
cord-023095-4dannjjm	2058	13	this	this	DT
cord-023095-4dannjjm	2058	14	region	region	NN
cord-023095-4dannjjm	2058	15	of	of	IN
cord-023095-4dannjjm	2058	16	MC4R	MC4R	NNP
cord-023095-4dannjjm	2058	17	from	from	IN
cord-023095-4dannjjm	2058	18	genomic	genomic	JJ
cord-023095-4dannjjm	2058	19	DNA	dna	NN
cord-023095-4dannjjm	2058	20	obtained	obtain	VBN
cord-023095-4dannjjm	2058	21	from	from	IN
cord-023095-4dannjjm	2058	22	EDTA	EDTA	NNP
cord-023095-4dannjjm	2058	23	blood	blood	NN
cord-023095-4dannjjm	2058	24	.	.	.
cord-023095-4dannjjm	2059	1	The	the	DT
cord-023095-4dannjjm	2059	2	PCR	PCR	NNP
cord-023095-4dannjjm	2059	3	products	product	NNS
cord-023095-4dannjjm	2059	4	were	be	VBD
cord-023095-4dannjjm	2059	5	purified	purify	VBN
cord-023095-4dannjjm	2059	6	and	and	CC
cord-023095-4dannjjm	2059	7	subject	subject	JJ
cord-023095-4dannjjm	2059	8	to	to	IN
cord-023095-4dannjjm	2059	9	restriction	restriction	NN
cord-023095-4dannjjm	2059	10	fragment	fragment	NN
cord-023095-4dannjjm	2059	11	length	length	NN
cord-023095-4dannjjm	2059	12	polymorphism	polymorphism	NN
cord-023095-4dannjjm	2059	13	(	(	-LRB-
cord-023095-4dannjjm	2059	14	RFLP	RFLP	NNP
cord-023095-4dannjjm	2059	15	)	)	-RRB-
cord-023095-4dannjjm	2059	16	analysis	analysis	NN
cord-023095-4dannjjm	2059	17	.	.	.
cord-023095-4dannjjm	2060	1	BstOI	BstOI	VBN
cord-023095-4dannjjm	2060	2	digestion	digestion	NN
cord-023095-4dannjjm	2060	3	products	product	NNS
cord-023095-4dannjjm	2060	4	were	be	VBD
cord-023095-4dannjjm	2060	5	then	then	RB
cord-023095-4dannjjm	2060	6	analysed	analyse	VBN
cord-023095-4dannjjm	2060	7	by	by	IN
cord-023095-4dannjjm	2060	8	agarose	agarose	JJ
cord-023095-4dannjjm	2060	9	gel	gel	NN
cord-023095-4dannjjm	2060	10	electrophoresis	electrophoresis	NN
cord-023095-4dannjjm	2060	11	.	.	.
cord-023095-4dannjjm	2061	1	Of	of	IN
cord-023095-4dannjjm	2061	2	the	the	DT
cord-023095-4dannjjm	2061	3	59	59	CD
cord-023095-4dannjjm	2061	4	diabetic	diabetic	JJ
cord-023095-4dannjjm	2061	5	cats	cat	NNS
cord-023095-4dannjjm	2061	6	,	,	,
cord-023095-4dannjjm	2061	7	32	32	CD
cord-023095-4dannjjm	2061	8	(	(	-LRB-
cord-023095-4dannjjm	2061	9	54	54	CD
cord-023095-4dannjjm	2061	10	%	%	NN
cord-023095-4dannjjm	2061	11	)	)	-RRB-
cord-023095-4dannjjm	2061	12	were	be	VBD
cord-023095-4dannjjm	2061	13	homozygous	homozygous	JJ
cord-023095-4dannjjm	2061	14	for	for	IN
cord-023095-4dannjjm	2061	15	the	the	DT
cord-023095-4dannjjm	2061	16	mutation	mutation	NN
cord-023095-4dannjjm	2061	17	(	(	-LRB-
cord-023095-4dannjjm	2061	18	CC	CC	NNP
cord-023095-4dannjjm	2061	19	)	)	-RRB-
cord-023095-4dannjjm	2061	20	,	,	,
cord-023095-4dannjjm	2061	21	compared	compare	VBN
cord-023095-4dannjjm	2061	22	to	to	IN
cord-023095-4dannjjm	2061	23	21	21	CD
cord-023095-4dannjjm	2061	24	(	(	-LRB-
cord-023095-4dannjjm	2061	25	35	35	CD
cord-023095-4dannjjm	2061	26	%	%	NN
cord-023095-4dannjjm	2061	27	)	)	-RRB-
cord-023095-4dannjjm	2061	28	of	of	IN
cord-023095-4dannjjm	2061	29	60	60	CD
cord-023095-4dannjjm	2061	30	control	control	NN
cord-023095-4dannjjm	2061	31	cats	cat	NNS
cord-023095-4dannjjm	2061	32	.	.	.
cord-023095-4dannjjm	2062	1	Statistical	statistical	JJ
cord-023095-4dannjjm	2062	2	analysis	analysis	NN
cord-023095-4dannjjm	2062	3	(	(	-LRB-
cord-023095-4dannjjm	2062	4	two	two	CD
cord-023095-4dannjjm	2062	5	tailed	tailed	JJ
cord-023095-4dannjjm	2062	6	Fisher	Fisher	NNP
cord-023095-4dannjjm	2062	7	's	's	POS
cord-023095-4dannjjm	2062	8	square	square	JJ
cord-023095-4dannjjm	2062	9	test	test	NN
cord-023095-4dannjjm	2062	10	)	)	-RRB-
cord-023095-4dannjjm	2062	11	revealed	reveal	VBD
cord-023095-4dannjjm	2062	12	that	that	IN
cord-023095-4dannjjm	2062	13	this	this	DT
cord-023095-4dannjjm	2062	14	difference	difference	NN
cord-023095-4dannjjm	2062	15	between	between	IN
cord-023095-4dannjjm	2062	16	groups	group	NNS
cord-023095-4dannjjm	2062	17	was	be	VBD
cord-023095-4dannjjm	2062	18	statistically	statistically	RB
cord-023095-4dannjjm	2062	19	significant	significant	JJ
cord-023095-4dannjjm	2062	20	(	(	-LRB-
cord-023095-4dannjjm	2062	21	p	p	NN
cord-023095-4dannjjm	2062	22	5	5	CD
cord-023095-4dannjjm	2062	23	0.0431	0.0431	CD
cord-023095-4dannjjm	2062	24	)	)	-RRB-
cord-023095-4dannjjm	2062	25	.	.	.
cord-023095-4dannjjm	2063	1	In	in	IN
cord-023095-4dannjjm	2063	2	conclusion	conclusion	NN
cord-023095-4dannjjm	2063	3	,	,	,
cord-023095-4dannjjm	2063	4	this	this	DT
cord-023095-4dannjjm	2063	5	pilot	pilot	NN
cord-023095-4dannjjm	2063	6	study	study	NN
cord-023095-4dannjjm	2063	7	has	have	VBZ
cord-023095-4dannjjm	2063	8	identified	identify	VBN
cord-023095-4dannjjm	2063	9	a	a	DT
cord-023095-4dannjjm	2063	10	missense	missense	JJ
cord-023095-4dannjjm	2063	11	mutation	mutation	NN
cord-023095-4dannjjm	2063	12	in	in	IN
cord-023095-4dannjjm	2063	13	the	the	DT
cord-023095-4dannjjm	2063	14	coding	code	VBG
cord-023095-4dannjjm	2063	15	sequence	sequence	NN
cord-023095-4dannjjm	2063	16	of	of	IN
cord-023095-4dannjjm	2063	17	MC4R.	MC4R.	NNP
cord-023095-4dannjjm	2064	1	This	this	DT
cord-023095-4dannjjm	2064	2	could	could	MD
cord-023095-4dannjjm	2064	3	be	be	VB
cord-023095-4dannjjm	2064	4	an	an	DT
cord-023095-4dannjjm	2064	5	important	important	JJ
cord-023095-4dannjjm	2064	6	predisposing	predisposing	NN
cord-023095-4dannjjm	2064	7	factor	factor	NN
cord-023095-4dannjjm	2064	8	for	for	IN
cord-023095-4dannjjm	2064	9	development	development	NN
cord-023095-4dannjjm	2064	10	of	of	IN
cord-023095-4dannjjm	2064	11	diabetes	diabetes	NN
cord-023095-4dannjjm	2064	12	and/or	and/or	CC
cord-023095-4dannjjm	2064	13	obesity	obesity	NN
cord-023095-4dannjjm	2064	14	in	in	IN
cord-023095-4dannjjm	2064	15	DSH	DSH	NNP
cord-023095-4dannjjm	2064	16	cats	cat	NNS
cord-023095-4dannjjm	2064	17	.	.	.
cord-023095-4dannjjm	2065	1	Polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2065	2	in	in	IN
cord-023095-4dannjjm	2065	3	a	a	DT
cord-023095-4dannjjm	2065	4	similar	similar	JJ
cord-023095-4dannjjm	2065	5	region	region	NN
cord-023095-4dannjjm	2065	6	of	of	IN
cord-023095-4dannjjm	2065	7	human	human	JJ
cord-023095-4dannjjm	2065	8	MC4R	MC4R	NNP
cord-023095-4dannjjm	2065	9	predispose	predispose	VB
cord-023095-4dannjjm	2065	10	to	to	IN
cord-023095-4dannjjm	2065	11	obesity	obesity	NN
cord-023095-4dannjjm	2065	12	,	,	,
cord-023095-4dannjjm	2065	13	which	which	WDT
cord-023095-4dannjjm	2065	14	in	in	IN
cord-023095-4dannjjm	2065	15	turn	turn	NN
cord-023095-4dannjjm	2065	16	is	be	VBZ
cord-023095-4dannjjm	2065	17	a	a	DT
cord-023095-4dannjjm	2065	18	major	major	JJ
cord-023095-4dannjjm	2065	19	risk	risk	NN
cord-023095-4dannjjm	2065	20	factor	factor	NN
cord-023095-4dannjjm	2065	21	for	for	IN
cord-023095-4dannjjm	2065	22	Type	type	NN
cord-023095-4dannjjm	2065	23	2	2	CD
cord-023095-4dannjjm	2065	24	diabetes	diabete	NNS
cord-023095-4dannjjm	2065	25	.	.	.
cord-023095-4dannjjm	2066	1	Hyperadrenocorticism	Hyperadrenocorticism	NNP
cord-023095-4dannjjm	2066	2	(	(	-LRB-
cord-023095-4dannjjm	2066	3	HAC	HAC	NNP
cord-023095-4dannjjm	2066	4	)	)	-RRB-
cord-023095-4dannjjm	2066	5	is	be	VBZ
cord-023095-4dannjjm	2066	6	one	one	CD
cord-023095-4dannjjm	2066	7	of	of	IN
cord-023095-4dannjjm	2066	8	the	the	DT
cord-023095-4dannjjm	2066	9	most	most	RBS
cord-023095-4dannjjm	2066	10	common	common	JJ
cord-023095-4dannjjm	2066	11	endocrine	endocrine	JJ
cord-023095-4dannjjm	2066	12	disorders	disorder	NNS
cord-023095-4dannjjm	2066	13	of	of	IN
cord-023095-4dannjjm	2066	14	dogs	dog	NNS
cord-023095-4dannjjm	2066	15	.	.	.
cord-023095-4dannjjm	2067	1	The	the	DT
cord-023095-4dannjjm	2067	2	two	two	CD
cord-023095-4dannjjm	2067	3	most	most	RBS
cord-023095-4dannjjm	2067	4	effective	effective	JJ
cord-023095-4dannjjm	2067	5	medical	medical	JJ
cord-023095-4dannjjm	2067	6	treatments	treatment	NNS
cord-023095-4dannjjm	2067	7	are	be	VBP
cord-023095-4dannjjm	2067	8	trilostane	trilostane	NNP
cord-023095-4dannjjm	2067	9	(	(	-LRB-
cord-023095-4dannjjm	2067	10	Vetoryl	Vetoryl	NNP
cord-023095-4dannjjm	2067	11	s	s	POS
cord-023095-4dannjjm	2067	12	)	)	-RRB-
cord-023095-4dannjjm	2067	13	and	and	CC
cord-023095-4dannjjm	2067	14	mitotane	mitotane	NNP
cord-023095-4dannjjm	2067	15	(	(	-LRB-
cord-023095-4dannjjm	2067	16	Lysodren	Lysodren	NNP
cord-023095-4dannjjm	2067	17	s	s	POS
cord-023095-4dannjjm	2067	18	)	)	-RRB-
cord-023095-4dannjjm	2067	19	.	.	.
cord-023095-4dannjjm	2068	1	Previous	previous	JJ
cord-023095-4dannjjm	2068	2	studies	study	NNS
cord-023095-4dannjjm	2068	3	evaluating	evaluate	VBG
cord-023095-4dannjjm	2068	4	the	the	DT
cord-023095-4dannjjm	2068	5	effect	effect	NN
cord-023095-4dannjjm	2068	6	of	of	IN
cord-023095-4dannjjm	2068	7	treatment	treatment	NN
cord-023095-4dannjjm	2068	8	on	on	IN
cord-023095-4dannjjm	2068	9	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2068	10	secretion	secretion	NN
cord-023095-4dannjjm	2068	11	measured	measure	VBD
cord-023095-4dannjjm	2068	12	the	the	DT
cord-023095-4dannjjm	2068	13	hormone	hormone	NN
cord-023095-4dannjjm	2068	14	at	at	IN
cord-023095-4dannjjm	2068	15	60	60	CD
cord-023095-4dannjjm	2068	16	min	min	NN
cord-023095-4dannjjm	2068	17	post	post	JJ
cord-023095-4dannjjm	2068	18	-	-	JJ
cord-023095-4dannjjm	2068	19	ACTH	ACTH	NNP
cord-023095-4dannjjm	2068	20	administration	administration	NN
cord-023095-4dannjjm	2068	21	.	.	.
cord-023095-4dannjjm	2069	1	However	however	RB
cord-023095-4dannjjm	2069	2	,	,	,
cord-023095-4dannjjm	2069	3	the	the	DT
cord-023095-4dannjjm	2069	4	optimal	optimal	JJ
cord-023095-4dannjjm	2069	5	sampling	sampling	NN
cord-023095-4dannjjm	2069	6	time	time	NN
cord-023095-4dannjjm	2069	7	would	would	MD
cord-023095-4dannjjm	2069	8	be	be	VB
cord-023095-4dannjjm	2069	9	at	at	IN
cord-023095-4dannjjm	2069	10	the	the	DT
cord-023095-4dannjjm	2069	11	time	time	NN
cord-023095-4dannjjm	2069	12	of	of	IN
cord-023095-4dannjjm	2069	13	maximal	maximal	JJ
cord-023095-4dannjjm	2069	14	secretion	secretion	NN
cord-023095-4dannjjm	2069	15	,	,	,
cord-023095-4dannjjm	2069	16	which	which	WDT
cord-023095-4dannjjm	2069	17	occurs	occur	VBZ
cord-023095-4dannjjm	2069	18	30	30	CD
cord-023095-4dannjjm	2069	19	minutes	minute	NNS
cord-023095-4dannjjm	2069	20	after	after	IN
cord-023095-4dannjjm	2069	21	the	the	DT
cord-023095-4dannjjm	2069	22	5	5	CD
cord-023095-4dannjjm	2069	23	mg	mg	NNP
cord-023095-4dannjjm	2069	24	/	/	SYM
cord-023095-4dannjjm	2069	25	kg	kg	NN
cord-023095-4dannjjm	2069	26	dose	dose	NN
cord-023095-4dannjjm	2069	27	commonly	commonly	RB
cord-023095-4dannjjm	2069	28	used	use	VBN
cord-023095-4dannjjm	2069	29	for	for	IN
cord-023095-4dannjjm	2069	30	the	the	DT
cord-023095-4dannjjm	2069	31	test	test	NN
cord-023095-4dannjjm	2069	32	(	(	-LRB-
cord-023095-4dannjjm	2069	33	Carlson	Carlson	NNP
cord-023095-4dannjjm	2069	34	et	et	NNP
cord-023095-4dannjjm	2069	35	al	al	NNP
cord-023095-4dannjjm	2069	36	,	,	,
cord-023095-4dannjjm	2069	37	JVIM	JVIM	NNP
cord-023095-4dannjjm	2069	38	,	,	,
cord-023095-4dannjjm	2069	39	2010	2010	CD
cord-023095-4dannjjm	2069	40	)	)	-RRB-
cord-023095-4dannjjm	2069	41	.	.	.
cord-023095-4dannjjm	2070	1	Thus	thus	RB
cord-023095-4dannjjm	2070	2	,	,	,
cord-023095-4dannjjm	2070	3	the	the	DT
cord-023095-4dannjjm	2070	4	true	true	JJ
cord-023095-4dannjjm	2070	5	effect	effect	NN
cord-023095-4dannjjm	2070	6	of	of	IN
cord-023095-4dannjjm	2070	7	either	either	DT
cord-023095-4dannjjm	2070	8	medication	medication	NN
cord-023095-4dannjjm	2070	9	on	on	IN
cord-023095-4dannjjm	2070	10	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2070	11	secretory	secretory	JJ
cord-023095-4dannjjm	2070	12	capacity	capacity	NN
cord-023095-4dannjjm	2070	13	is	be	VBZ
cord-023095-4dannjjm	2070	14	unknown	unknown	JJ
cord-023095-4dannjjm	2070	15	.	.	.
cord-023095-4dannjjm	2071	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	2071	2	objectives	objective	NNS
cord-023095-4dannjjm	2071	3	were	be	VBD
cord-023095-4dannjjm	2071	4	:	:	:
cord-023095-4dannjjm	2071	5	1	1	LS
cord-023095-4dannjjm	2071	6	)	)	-RRB-
cord-023095-4dannjjm	2071	7	to	to	TO
cord-023095-4dannjjm	2071	8	assess	assess	VB
cord-023095-4dannjjm	2071	9	and	and	CC
cord-023095-4dannjjm	2071	10	compare	compare	VB
cord-023095-4dannjjm	2071	11	the	the	DT
cord-023095-4dannjjm	2071	12	effect	effect	NN
cord-023095-4dannjjm	2071	13	of	of	IN
cord-023095-4dannjjm	2071	14	treatment	treatment	NN
cord-023095-4dannjjm	2071	15	with	with	IN
cord-023095-4dannjjm	2071	16	trilostane	trilostane	NNP
cord-023095-4dannjjm	2071	17	and	and	CC
cord-023095-4dannjjm	2071	18	mitotane	mitotane	NNP
cord-023095-4dannjjm	2071	19	in	in	IN
cord-023095-4dannjjm	2071	20	dogs	dog	NNS
cord-023095-4dannjjm	2071	21	with	with	IN
cord-023095-4dannjjm	2071	22	pituitarydependent	pituitarydependent	NN
cord-023095-4dannjjm	2071	23	HAC	HAC	NNP
cord-023095-4dannjjm	2071	24	(	(	-LRB-
cord-023095-4dannjjm	2071	25	PDH	PDH	NNP
cord-023095-4dannjjm	2071	26	)	)	-RRB-
cord-023095-4dannjjm	2071	27	on	on	IN
cord-023095-4dannjjm	2071	28	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2071	29	secretory	secretory	JJ
cord-023095-4dannjjm	2071	30	reserve	reserve	NN
cord-023095-4dannjjm	2071	31	at	at	IN
cord-023095-4dannjjm	2071	32	30	30	CD
cord-023095-4dannjjm	2071	33	min	min	NN
cord-023095-4dannjjm	2071	34	post	post	JJ
cord-023095-4dannjjm	2071	35	-	-	JJ
cord-023095-4dannjjm	2071	36	ACTH	acth	JJ
cord-023095-4dannjjm	2071	37	stimulation	stimulation	NN
cord-023095-4dannjjm	2071	38	and	and	CC
cord-023095-4dannjjm	2071	39	2	2	CD
cord-023095-4dannjjm	2071	40	)	)	-RRB-
cord-023095-4dannjjm	2071	41	to	to	TO
cord-023095-4dannjjm	2071	42	determine	determine	VB
cord-023095-4dannjjm	2071	43	if	if	IN
cord-023095-4dannjjm	2071	44	changes	change	NNS
cord-023095-4dannjjm	2071	45	in	in	IN
cord-023095-4dannjjm	2071	46	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2071	47	concentration	concentration	NN
cord-023095-4dannjjm	2071	48	at	at	IN
cord-023095-4dannjjm	2071	49	that	that	DT
cord-023095-4dannjjm	2071	50	time	time	NN
cord-023095-4dannjjm	2071	51	correlate	correlate	VBP
cord-023095-4dannjjm	2071	52	with	with	IN
cord-023095-4dannjjm	2071	53	changes	change	NNS
cord-023095-4dannjjm	2071	54	in	in	IN
cord-023095-4dannjjm	2071	55	serum	serum	NN
cord-023095-4dannjjm	2071	56	sodium	sodium	NN
cord-023095-4dannjjm	2071	57	and	and	CC
cord-023095-4dannjjm	2071	58	potassium	potassium	NN
cord-023095-4dannjjm	2071	59	concentrations	concentration	NNS
cord-023095-4dannjjm	2071	60	.	.	.
cord-023095-4dannjjm	2072	1	Forty	forty	CD
cord-023095-4dannjjm	2072	2	-	-	HYPH
cord-023095-4dannjjm	2072	3	six	six	CD
cord-023095-4dannjjm	2072	4	dogs	dog	NNS
cord-023095-4dannjjm	2072	5	being	be	VBG
cord-023095-4dannjjm	2072	6	treated	treat	VBN
cord-023095-4dannjjm	2072	7	for	for	IN
cord-023095-4dannjjm	2072	8	PDH	PDH	NNP
cord-023095-4dannjjm	2072	9	with	with	IN
cord-023095-4dannjjm	2072	10	either	either	DT
cord-023095-4dannjjm	2072	11	mitotane	mitotane	NNP
cord-023095-4dannjjm	2072	12	(	(	-LRB-
cord-023095-4dannjjm	2072	13	n	n	NNP
cord-023095-4dannjjm	2072	14	5	5	CD
cord-023095-4dannjjm	2072	15	30	30	CD
cord-023095-4dannjjm	2072	16	)	)	-RRB-
cord-023095-4dannjjm	2072	17	or	or	CC
cord-023095-4dannjjm	2072	18	trilostane	trilostane	NNP
cord-023095-4dannjjm	2072	19	(	(	-LRB-
cord-023095-4dannjjm	2072	20	n	n	NNP
cord-023095-4dannjjm	2072	21	5	5	CD
cord-023095-4dannjjm	2072	22	16	16	CD
cord-023095-4dannjjm	2072	23	)	)	-RRB-
cord-023095-4dannjjm	2072	24	have	have	VBP
cord-023095-4dannjjm	2072	25	been	be	VBN
cord-023095-4dannjjm	2072	26	enrolled	enrol	VBN
cord-023095-4dannjjm	2072	27	.	.	.
cord-023095-4dannjjm	2073	1	The	the	DT
cord-023095-4dannjjm	2073	2	dogs	dog	NNS
cord-023095-4dannjjm	2073	3	could	could	MD
cord-023095-4dannjjm	2073	4	be	be	VB
cord-023095-4dannjjm	2073	5	treated	treat	VBN
cord-023095-4dannjjm	2073	6	for	for	IN
cord-023095-4dannjjm	2073	7	any	any	DT
cord-023095-4dannjjm	2073	8	length	length	NN
cord-023095-4dannjjm	2073	9	of	of	IN
cord-023095-4dannjjm	2073	10	time	time	NN
cord-023095-4dannjjm	2073	11	.	.	.
cord-023095-4dannjjm	2074	1	All	all	DT
cord-023095-4dannjjm	2074	2	had	have	VBD
cord-023095-4dannjjm	2074	3	ACTH	ACTH	NNP
cord-023095-4dannjjm	2074	4	stimulation	stimulation	NN
cord-023095-4dannjjm	2074	5	tests	test	NNS
cord-023095-4dannjjm	2074	6	performed	perform	VBN
cord-023095-4dannjjm	2074	7	(	(	-LRB-
cord-023095-4dannjjm	2074	8	5	5	CD
cord-023095-4dannjjm	2074	9	mcg	mcg	NNP
cord-023095-4dannjjm	2074	10	/	/	SYM
cord-023095-4dannjjm	2074	11	kg	kg	NNP
cord-023095-4dannjjm	2074	12	cosyntropin	cosyntropin	NNP
cord-023095-4dannjjm	2074	13	IV	IV	NNP
cord-023095-4dannjjm	2074	14	)	)	-RRB-
cord-023095-4dannjjm	2074	15	;	;	:
cord-023095-4dannjjm	2074	16	blood	blood	NN
cord-023095-4dannjjm	2074	17	samples	sample	NNS
cord-023095-4dannjjm	2074	18	were	be	VBD
cord-023095-4dannjjm	2074	19	drawn	draw	VBN
cord-023095-4dannjjm	2074	20	before	before	RB
cord-023095-4dannjjm	2074	21	and	and	CC
cord-023095-4dannjjm	2074	22	at	at	IN
cord-023095-4dannjjm	2074	23	30	30	CD
cord-023095-4dannjjm	2074	24	and	and	CC
cord-023095-4dannjjm	2074	25	60	60	CD
cord-023095-4dannjjm	2074	26	min	min	NN
cord-023095-4dannjjm	2074	27	post	post	NN
cord-023095-4dannjjm	2074	28	-	-	JJ
cord-023095-4dannjjm	2074	29	ACTH	ACTH	NNP
cord-023095-4dannjjm	2074	30	for	for	IN
cord-023095-4dannjjm	2074	31	monitoring	monitoring	NN
cord-023095-4dannjjm	2074	32	of	of	IN
cord-023095-4dannjjm	2074	33	cortisol	cortisol	NN
cord-023095-4dannjjm	2074	34	and	and	CC
cord-023095-4dannjjm	2074	35	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2074	36	concentration	concentration	NN
cord-023095-4dannjjm	2074	37	using	use	VBG
cord-023095-4dannjjm	2074	38	previously	previously	RB
cord-023095-4dannjjm	2074	39	validated	validate	VBN
cord-023095-4dannjjm	2074	40	radioimmunoassays	radioimmunoassay	NNS
cord-023095-4dannjjm	2074	41	.	.	.
cord-023095-4dannjjm	2075	1	Ten	ten	CD
cord-023095-4dannjjm	2075	2	historical	historical	JJ
cord-023095-4dannjjm	2075	3	normal	normal	JJ
cord-023095-4dannjjm	2075	4	controls	control	NNS
cord-023095-4dannjjm	2075	5	were	be	VBD
cord-023095-4dannjjm	2075	6	also	also	RB
cord-023095-4dannjjm	2075	7	included	include	VBN
cord-023095-4dannjjm	2075	8	.	.	.
cord-023095-4dannjjm	2076	1	Serum	serum	NN
cord-023095-4dannjjm	2076	2	sodium	sodium	NN
cord-023095-4dannjjm	2076	3	and	and	CC
cord-023095-4dannjjm	2076	4	potassium	potassium	NN
cord-023095-4dannjjm	2076	5	concentrations	concentration	NNS
cord-023095-4dannjjm	2076	6	were	be	VBD
cord-023095-4dannjjm	2076	7	measured	measure	VBN
cord-023095-4dannjjm	2076	8	in	in	IN
cord-023095-4dannjjm	2076	9	the	the	DT
cord-023095-4dannjjm	2076	10	basal	basal	NN
cord-023095-4dannjjm	2076	11	samples	sample	NNS
cord-023095-4dannjjm	2076	12	.	.	.
cord-023095-4dannjjm	2077	1	A	a	DT
cord-023095-4dannjjm	2077	2	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	2077	3	-	-	HYPH
cord-023095-4dannjjm	2077	4	Wallis	Wallis	NNP
cord-023095-4dannjjm	2077	5	Rank	Rank	NNP
cord-023095-4dannjjm	2077	6	Sum	Sum	NNP
cord-023095-4dannjjm	2077	7	test	test	NN
cord-023095-4dannjjm	2077	8	was	be	VBD
cord-023095-4dannjjm	2077	9	used	use	VBN
cord-023095-4dannjjm	2077	10	to	to	TO
cord-023095-4dannjjm	2077	11	compare	compare	VB
cord-023095-4dannjjm	2077	12	values	value	NNS
cord-023095-4dannjjm	2077	13	between	between	IN
cord-023095-4dannjjm	2077	14	normal	normal	JJ
cord-023095-4dannjjm	2077	15	dogs	dog	NNS
cord-023095-4dannjjm	2077	16	and	and	CC
cord-023095-4dannjjm	2077	17	those	those	DT
cord-023095-4dannjjm	2077	18	treated	treat	VBN
cord-023095-4dannjjm	2077	19	with	with	IN
cord-023095-4dannjjm	2077	20	mitotane	mitotane	NNP
cord-023095-4dannjjm	2077	21	or	or	CC
cord-023095-4dannjjm	2077	22	trilostane	trilostane	NNP
cord-023095-4dannjjm	2077	23	.	.	.
cord-023095-4dannjjm	2078	1	Linear	linear	JJ
cord-023095-4dannjjm	2078	2	regression	regression	NN
cord-023095-4dannjjm	2078	3	analysis	analysis	NN
cord-023095-4dannjjm	2078	4	was	be	VBD
cord-023095-4dannjjm	2078	5	used	use	VBN
cord-023095-4dannjjm	2078	6	to	to	TO
cord-023095-4dannjjm	2078	7	determine	determine	VB
cord-023095-4dannjjm	2078	8	if	if	IN
cord-023095-4dannjjm	2078	9	a	a	DT
cord-023095-4dannjjm	2078	10	correlation	correlation	NN
cord-023095-4dannjjm	2078	11	existed	exist	VBD
cord-023095-4dannjjm	2078	12	between	between	IN
cord-023095-4dannjjm	2078	13	electrolyte	electrolyte	NN
cord-023095-4dannjjm	2078	14	and	and	CC
cord-023095-4dannjjm	2078	15	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2078	16	concentrations	concentration	NNS
cord-023095-4dannjjm	2078	17	or	or	CC
cord-023095-4dannjjm	2078	18	between	between	IN
cord-023095-4dannjjm	2078	19	cortisol	cortisol	NN
cord-023095-4dannjjm	2078	20	and	and	CC
cord-023095-4dannjjm	2078	21	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2078	22	concentrations	concentration	NNS
cord-023095-4dannjjm	2078	23	.	.	.
cord-023095-4dannjjm	2079	1	Significance	significance	NN
cord-023095-4dannjjm	2079	2	was	be	VBD
cord-023095-4dannjjm	2079	3	set	set	VBN
cord-023095-4dannjjm	2079	4	at	at	IN
cord-023095-4dannjjm	2079	5	the	the	DT
cord-023095-4dannjjm	2079	6	p	p	NN
cord-023095-4dannjjm	2079	7	o	o	NN
cord-023095-4dannjjm	2079	8	0.05	0.05	CD
cord-023095-4dannjjm	2079	9	level	level	NN
cord-023095-4dannjjm	2079	10	.	.	.
cord-023095-4dannjjm	2080	1	ACTH	ACTH	NNP
cord-023095-4dannjjm	2080	2	-	-	HYPH
cord-023095-4dannjjm	2080	3	stimulated	stimulate	VBN
cord-023095-4dannjjm	2080	4	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2080	5	concentrations	concentration	NNS
cord-023095-4dannjjm	2080	6	in	in	IN
cord-023095-4dannjjm	2081	1	mitotane	mitotane	NNP
cord-023095-4dannjjm	2081	2	-	-	HYPH
cord-023095-4dannjjm	2081	3	treated	treat	VBN
cord-023095-4dannjjm	2081	4	but	but	CC
cord-023095-4dannjjm	2081	5	not	not	RB
cord-023095-4dannjjm	2081	6	trilostane	trilostane	NN
cord-023095-4dannjjm	2081	7	-	-	HYPH
cord-023095-4dannjjm	2081	8	treated	treat	VBN
cord-023095-4dannjjm	2081	9	dogs	dog	NNS
cord-023095-4dannjjm	2081	10	were	be	VBD
cord-023095-4dannjjm	2081	11	significantly	significantly	RB
cord-023095-4dannjjm	2081	12	lower	low	JJR
cord-023095-4dannjjm	2081	13	than	than	IN
cord-023095-4dannjjm	2081	14	that	that	DT
cord-023095-4dannjjm	2081	15	in	in	IN
cord-023095-4dannjjm	2081	16	normal	normal	JJ
cord-023095-4dannjjm	2081	17	dogs	dog	NNS
cord-023095-4dannjjm	2081	18	at	at	IN
cord-023095-4dannjjm	2081	19	both	both	CC
cord-023095-4dannjjm	2081	20	the	the	DT
cord-023095-4dannjjm	2081	21	30	30	CD
cord-023095-4dannjjm	2081	22	and	and	CC
cord-023095-4dannjjm	2081	23	60	60	CD
cord-023095-4dannjjm	2081	24	min	min	NN
cord-023095-4dannjjm	2081	25	time	time	NN
cord-023095-4dannjjm	2081	26	points	point	NNS
cord-023095-4dannjjm	2081	27	.	.	.
cord-023095-4dannjjm	2082	1	No	no	DT
cord-023095-4dannjjm	2082	2	difference	difference	NN
cord-023095-4dannjjm	2082	3	was	be	VBD
cord-023095-4dannjjm	2082	4	detected	detect	VBN
cord-023095-4dannjjm	2082	5	between	between	IN
cord-023095-4dannjjm	2082	6	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2082	7	concentrations	concentration	NNS
cord-023095-4dannjjm	2082	8	at	at	IN
cord-023095-4dannjjm	2082	9	30	30	CD
cord-023095-4dannjjm	2082	10	and	and	CC
cord-023095-4dannjjm	2082	11	60	60	CD
cord-023095-4dannjjm	2082	12	min	min	NN
cord-023095-4dannjjm	2082	13	after	after	IN
cord-023095-4dannjjm	2082	14	ACTH	ACTH	NNP
cord-023095-4dannjjm	2082	15	injection	injection	NN
cord-023095-4dannjjm	2082	16	in	in	IN
cord-023095-4dannjjm	2082	17	either	either	DT
cord-023095-4dannjjm	2082	18	treatment	treatment	NN
cord-023095-4dannjjm	2082	19	group	group	NN
cord-023095-4dannjjm	2082	20	.	.	.
cord-023095-4dannjjm	2083	1	A	a	DT
cord-023095-4dannjjm	2083	2	positive	positive	JJ
cord-023095-4dannjjm	2083	3	correlation	correlation	NN
cord-023095-4dannjjm	2083	4	existed	exist	VBD
cord-023095-4dannjjm	2083	5	between	between	IN
cord-023095-4dannjjm	2083	6	the	the	DT
cord-023095-4dannjjm	2083	7	60-min	60-min	CD
cord-023095-4dannjjm	2083	8	cortisol	cortisol	NN
cord-023095-4dannjjm	2083	9	and	and	CC
cord-023095-4dannjjm	2083	10	30-min	30-min	CD
cord-023095-4dannjjm	2083	11	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2083	12	concentrations	concentration	NNS
cord-023095-4dannjjm	2083	13	in	in	IN
cord-023095-4dannjjm	2083	14	the	the	DT
cord-023095-4dannjjm	2083	15	trilostane	trilostane	NNP
cord-023095-4dannjjm	2083	16	-	-	HYPH
cord-023095-4dannjjm	2083	17	treated	treat	VBN
cord-023095-4dannjjm	2083	18	group	group	NN
cord-023095-4dannjjm	2083	19	(	(	-LRB-
cord-023095-4dannjjm	2083	20	R	r	NN
cord-023095-4dannjjm	2083	21	5	5	CD
cord-023095-4dannjjm	2083	22	0.813	0.813	CD
cord-023095-4dannjjm	2083	23	)	)	-RRB-
cord-023095-4dannjjm	2083	24	,	,	,
cord-023095-4dannjjm	2083	25	i.e.	i.e.	FW
cord-023095-4dannjjm	2083	26	the	the	DT
cord-023095-4dannjjm	2083	27	peak	peak	JJ
cord-023095-4dannjjm	2083	28	post	post	JJ
cord-023095-4dannjjm	2083	29	-	-	JJ
cord-023095-4dannjjm	2083	30	ACTH	acth	JJ
cord-023095-4dannjjm	2083	31	concentration	concentration	NN
cord-023095-4dannjjm	2083	32	for	for	IN
cord-023095-4dannjjm	2083	33	each	each	DT
cord-023095-4dannjjm	2083	34	hormone	hormone	NN
cord-023095-4dannjjm	2083	35	,	,	,
cord-023095-4dannjjm	2083	36	but	but	CC
cord-023095-4dannjjm	2083	37	not	not	RB
cord-023095-4dannjjm	2083	38	in	in	IN
cord-023095-4dannjjm	2083	39	dogs	dog	NNS
cord-023095-4dannjjm	2083	40	treated	treat	VBN
cord-023095-4dannjjm	2083	41	with	with	IN
cord-023095-4dannjjm	2083	42	mitotane	mitotane	NNP
cord-023095-4dannjjm	2083	43	.	.	.
cord-023095-4dannjjm	2084	1	Basal	basal	NN
cord-023095-4dannjjm	2084	2	serum	serum	NN
cord-023095-4dannjjm	2084	3	sodium	sodium	NN
cord-023095-4dannjjm	2084	4	and	and	CC
cord-023095-4dannjjm	2084	5	potassium	potassium	NN
cord-023095-4dannjjm	2084	6	concentrations	concentration	NNS
cord-023095-4dannjjm	2084	7	were	be	VBD
cord-023095-4dannjjm	2084	8	not	not	RB
cord-023095-4dannjjm	2084	9	correlated	correlate	VBN
cord-023095-4dannjjm	2084	10	with	with	IN
cord-023095-4dannjjm	2084	11	the	the	DT
cord-023095-4dannjjm	2084	12	basal	basal	NN
cord-023095-4dannjjm	2084	13	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2084	14	concentration	concentration	NN
cord-023095-4dannjjm	2084	15	in	in	IN
cord-023095-4dannjjm	2084	16	either	either	DT
cord-023095-4dannjjm	2084	17	treatment	treatment	NN
cord-023095-4dannjjm	2084	18	group	group	NN
cord-023095-4dannjjm	2084	19	.	.	.
cord-023095-4dannjjm	2085	1	In	in	IN
cord-023095-4dannjjm	2085	2	conclusion	conclusion	NN
cord-023095-4dannjjm	2085	3	,	,	,
cord-023095-4dannjjm	2085	4	treatment	treatment	NN
cord-023095-4dannjjm	2085	5	with	with	IN
cord-023095-4dannjjm	2085	6	mitotane	mitotane	NNP
cord-023095-4dannjjm	2085	7	resulted	result	VBD
cord-023095-4dannjjm	2085	8	in	in	IN
cord-023095-4dannjjm	2085	9	decreased	decrease	VBN
cord-023095-4dannjjm	2085	10	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2085	11	secretory	secretory	NN
cord-023095-4dannjjm	2085	12	reserve	reserve	NN
cord-023095-4dannjjm	2085	13	,	,	,
cord-023095-4dannjjm	2085	14	but	but	CC
cord-023095-4dannjjm	2085	15	this	this	DT
cord-023095-4dannjjm	2085	16	did	do	VBD
cord-023095-4dannjjm	2085	17	not	not	RB
cord-023095-4dannjjm	2085	18	correlate	correlate	VB
cord-023095-4dannjjm	2085	19	with	with	IN
cord-023095-4dannjjm	2085	20	hyperkalemia	hyperkalemia	NN
cord-023095-4dannjjm	2085	21	or	or	CC
cord-023095-4dannjjm	2085	22	hyponatremia	hyponatremia	NN
cord-023095-4dannjjm	2085	23	.	.	.
cord-023095-4dannjjm	2086	1	Measurement	measurement	NN
cord-023095-4dannjjm	2086	2	of	of	IN
cord-023095-4dannjjm	2086	3	aldosterone	aldosterone	NN
cord-023095-4dannjjm	2086	4	concentrations	concentration	NNS
cord-023095-4dannjjm	2086	5	is	be	VBZ
cord-023095-4dannjjm	2086	6	not	not	RB
cord-023095-4dannjjm	2086	7	predictive	predictive	JJ
cord-023095-4dannjjm	2086	8	of	of	IN
cord-023095-4dannjjm	2086	9	electrolyte	electrolyte	JJ
cord-023095-4dannjjm	2086	10	concentrations	concentration	NNS
cord-023095-4dannjjm	2086	11	.	.	.
cord-023095-4dannjjm	2087	1	Previously	previously	RB
cord-023095-4dannjjm	2087	2	presented	present	VBN
cord-023095-4dannjjm	2087	3	at	at	IN
cord-023095-4dannjjm	2087	4	the	the	DT
cord-023095-4dannjjm	2087	5	Auburn	Auburn	NNP
cord-023095-4dannjjm	2087	6	University	University	NNP
cord-023095-4dannjjm	2087	7	Phi	Phi	NNP
cord-023095-4dannjjm	2087	8	Zeta	Zeta	NNP
cord-023095-4dannjjm	2087	9	Research	Research	NNP
cord-023095-4dannjjm	2087	10	Emphasis	Emphasis	NNP
cord-023095-4dannjjm	2087	11	Day	Day	NNP
cord-023095-4dannjjm	2087	12	,	,	,
cord-023095-4dannjjm	2087	13	November	November	NNP
cord-023095-4dannjjm	2087	14	10	10	CD
cord-023095-4dannjjm	2087	15	,	,	,
cord-023095-4dannjjm	2087	16	2010	2010	CD
cord-023095-4dannjjm	2087	17	.	.	.
cord-023095-4dannjjm	2088	1	Antioxidant	antioxidant	JJ
cord-023095-4dannjjm	2088	2	depletion	depletion	NN
cord-023095-4dannjjm	2088	3	is	be	VBZ
cord-023095-4dannjjm	2088	4	documented	document	VBN
cord-023095-4dannjjm	2088	5	in	in	IN
cord-023095-4dannjjm	2088	6	humans	human	NNS
cord-023095-4dannjjm	2088	7	with	with	IN
cord-023095-4dannjjm	2088	8	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2088	9	,	,	,
cord-023095-4dannjjm	2088	10	and	and	CC
cord-023095-4dannjjm	2088	11	is	be	VBZ
cord-023095-4dannjjm	2088	12	reversible	reversible	JJ
cord-023095-4dannjjm	2088	13	with	with	IN
cord-023095-4dannjjm	2088	14	treatment	treatment	NN
cord-023095-4dannjjm	2088	15	.	.	.
cord-023095-4dannjjm	2089	1	In	in	IN
cord-023095-4dannjjm	2089	2	addition	addition	NN
cord-023095-4dannjjm	2089	3	,	,	,
cord-023095-4dannjjm	2089	4	antioxidant	antioxidant	JJ
cord-023095-4dannjjm	2089	5	depletion	depletion	NN
cord-023095-4dannjjm	2089	6	has	have	VBZ
cord-023095-4dannjjm	2089	7	been	be	VBN
cord-023095-4dannjjm	2089	8	shown	show	VBN
cord-023095-4dannjjm	2089	9	to	to	TO
cord-023095-4dannjjm	2089	10	increase	increase	VB
cord-023095-4dannjjm	2089	11	the	the	DT
cord-023095-4dannjjm	2089	12	risk	risk	NN
cord-023095-4dannjjm	2089	13	of	of	IN
cord-023095-4dannjjm	2089	14	methimazole	methimazole	NN
cord-023095-4dannjjm	2089	15	toxicity	toxicity	NN
cord-023095-4dannjjm	2089	16	in	in	IN
cord-023095-4dannjjm	2089	17	rats	rat	NNS
cord-023095-4dannjjm	2089	18	.	.	.
cord-023095-4dannjjm	2090	1	The	the	DT
cord-023095-4dannjjm	2090	2	primary	primary	JJ
cord-023095-4dannjjm	2090	3	aim	aim	NN
cord-023095-4dannjjm	2090	4	of	of	IN
cord-023095-4dannjjm	2090	5	this	this	DT
cord-023095-4dannjjm	2090	6	study	study	NN
cord-023095-4dannjjm	2090	7	was	be	VBD
cord-023095-4dannjjm	2090	8	to	to	TO
cord-023095-4dannjjm	2090	9	determine	determine	VB
cord-023095-4dannjjm	2090	10	whether	whether	IN
cord-023095-4dannjjm	2090	11	deficiencies	deficiency	NNS
cord-023095-4dannjjm	2090	12	in	in	IN
cord-023095-4dannjjm	2090	13	glutathione	glutathione	NN
cord-023095-4dannjjm	2090	14	(	(	-LRB-
cord-023095-4dannjjm	2090	15	GSH	GSH	NNP
cord-023095-4dannjjm	2090	16	)	)	-RRB-
cord-023095-4dannjjm	2090	17	,	,	,
cord-023095-4dannjjm	2090	18	ascorbate	ascorbate	NNP
cord-023095-4dannjjm	2090	19	(	(	-LRB-
cord-023095-4dannjjm	2090	20	AA	AA	NNP
cord-023095-4dannjjm	2090	21	)	)	-RRB-
cord-023095-4dannjjm	2090	22	,	,	,
cord-023095-4dannjjm	2090	23	or	or	CC
cord-023095-4dannjjm	2090	24	vitamin	vitamin	NN
cord-023095-4dannjjm	2090	25	E	e	NN
cord-023095-4dannjjm	2090	26	,	,	,
cord-023095-4dannjjm	2090	27	along	along	IN
cord-023095-4dannjjm	2090	28	with	with	IN
cord-023095-4dannjjm	2090	29	increases	increase	NNS
cord-023095-4dannjjm	2090	30	in	in	IN
cord-023095-4dannjjm	2090	31	urinary	urinary	JJ
cord-023095-4dannjjm	2090	32	8-isoprostanes	8-isoprostanes	CD
cord-023095-4dannjjm	2090	33	,	,	,
cord-023095-4dannjjm	2090	34	were	be	VBD
cord-023095-4dannjjm	2090	35	present	present	JJ
cord-023095-4dannjjm	2090	36	in	in	IN
cord-023095-4dannjjm	2090	37	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2090	38	cats	cat	NNS
cord-023095-4dannjjm	2090	39	,	,	,
cord-023095-4dannjjm	2090	40	and	and	CC
cord-023095-4dannjjm	2090	41	were	be	VBD
cord-023095-4dannjjm	2090	42	reversible	reversible	JJ
cord-023095-4dannjjm	2090	43	after	after	IN
cord-023095-4dannjjm	2090	44	radioiodine	radioiodine	NN
cord-023095-4dannjjm	2090	45	treatment	treatment	NN
cord-023095-4dannjjm	2090	46	.	.	.
cord-023095-4dannjjm	2091	1	A	a	DT
cord-023095-4dannjjm	2091	2	secondary	secondary	JJ
cord-023095-4dannjjm	2091	3	aim	aim	NN
cord-023095-4dannjjm	2091	4	was	be	VBD
cord-023095-4dannjjm	2091	5	to	to	TO
cord-023095-4dannjjm	2091	6	determine	determine	VB
cord-023095-4dannjjm	2091	7	whether	whether	IN
cord-023095-4dannjjm	2091	8	antioxidant	antioxidant	JJ
cord-023095-4dannjjm	2091	9	abnormalities	abnormality	NNS
cord-023095-4dannjjm	2091	10	were	be	VBD
cord-023095-4dannjjm	2091	11	associated	associate	VBN
cord-023095-4dannjjm	2091	12	with	with	IN
cord-023095-4dannjjm	2091	13	a	a	DT
cord-023095-4dannjjm	2091	14	prior	prior	JJ
cord-023095-4dannjjm	2091	15	history	history	NN
cord-023095-4dannjjm	2091	16	of	of	IN
cord-023095-4dannjjm	2091	17	methimazole	methimazole	NN
cord-023095-4dannjjm	2091	18	toxicity	toxicity	NN
cord-023095-4dannjjm	2091	19	.	.	.
cord-023095-4dannjjm	2092	1	Ongoing	ongoing	JJ
cord-023095-4dannjjm	2092	2	prospective	prospective	NN
cord-023095-4dannjjm	2092	3	,	,	,
cord-023095-4dannjjm	2092	4	controlled	control	VBN
cord-023095-4dannjjm	2092	5	,	,	,
cord-023095-4dannjjm	2092	6	observational	observational	JJ
cord-023095-4dannjjm	2092	7	study	study	NN
cord-023095-4dannjjm	2092	8	.	.	.
cord-023095-4dannjjm	2093	1	Otherwise	otherwise	RB
cord-023095-4dannjjm	2093	2	healthy	healthy	JJ
cord-023095-4dannjjm	2093	3	client	client	NN
cord-023095-4dannjjm	2093	4	-	-	HYPH
cord-023095-4dannjjm	2093	5	owned	own	VBN
cord-023095-4dannjjm	2093	6	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2093	7	cats	cat	NNS
cord-023095-4dannjjm	2093	8	presenting	present	VBG
cord-023095-4dannjjm	2093	9	for	for	IN
cord-023095-4dannjjm	2093	10	radioiodine	radioiodine	NN
cord-023095-4dannjjm	2093	11	therapy	therapy	NN
cord-023095-4dannjjm	2093	12	(	(	-LRB-
cord-023095-4dannjjm	2093	13	n	n	NN
cord-023095-4dannjjm	2093	14	5	5	CD
cord-023095-4dannjjm	2093	15	26	26	CD
cord-023095-4dannjjm	2093	16	to	to	IN
cord-023095-4dannjjm	2093	17	date	date	NN
cord-023095-4dannjjm	2093	18	)	)	-RRB-
cord-023095-4dannjjm	2093	19	and	and	CC
cord-023095-4dannjjm	2093	20	healthy	healthy	JJ
cord-023095-4dannjjm	2093	21	age	age	NN
cord-023095-4dannjjm	2093	22	-	-	HYPH
cord-023095-4dannjjm	2093	23	matched	match	VBN
cord-023095-4dannjjm	2093	24	controls	control	NNS
cord-023095-4dannjjm	2093	25	(	(	-LRB-
cord-023095-4dannjjm	2093	26	n	n	NN
cord-023095-4dannjjm	2093	27	5	5	CD
cord-023095-4dannjjm	2093	28	32	32	CD
cord-023095-4dannjjm	2093	29	to	to	IN
cord-023095-4dannjjm	2093	30	date	date	NN
cord-023095-4dannjjm	2093	31	)	)	-RRB-
cord-023095-4dannjjm	2093	32	were	be	VBD
cord-023095-4dannjjm	2093	33	recruited	recruit	VBN
cord-023095-4dannjjm	2093	34	.	.	.
cord-023095-4dannjjm	2094	1	All	all	DT
cord-023095-4dannjjm	2094	2	cats	cat	NNS
cord-023095-4dannjjm	2094	3	were	be	VBD
cord-023095-4dannjjm	2094	4	screened	screen	VBN
cord-023095-4dannjjm	2094	5	with	with	IN
cord-023095-4dannjjm	2094	6	CBC	CBC	NNP
cord-023095-4dannjjm	2094	7	,	,	,
cord-023095-4dannjjm	2094	8	biochemical	biochemical	JJ
cord-023095-4dannjjm	2094	9	panel	panel	NN
cord-023095-4dannjjm	2094	10	,	,	,
cord-023095-4dannjjm	2094	11	urinalysis	urinalysis	NN
cord-023095-4dannjjm	2094	12	,	,	,
cord-023095-4dannjjm	2094	13	and	and	CC
cord-023095-4dannjjm	2094	14	T4	T4	NNP
cord-023095-4dannjjm	2094	15	,	,	,
cord-023095-4dannjjm	2094	16	as	as	RB
cord-023095-4dannjjm	2094	17	well	well	RB
cord-023095-4dannjjm	2094	18	as	as	IN
cord-023095-4dannjjm	2094	19	red	red	JJ
cord-023095-4dannjjm	2094	20	blood	blood	NN
cord-023095-4dannjjm	2094	21	cell	cell	NN
cord-023095-4dannjjm	2094	22	(	(	-LRB-
cord-023095-4dannjjm	2094	23	RBC	RBC	NNP
cord-023095-4dannjjm	2094	24	)	)	-RRB-
cord-023095-4dannjjm	2094	25	GSH	GSH	NNP
cord-023095-4dannjjm	2094	26	,	,	,
cord-023095-4dannjjm	2094	27	plasma	plasma	NN
cord-023095-4dannjjm	2094	28	AA	aa	NN
cord-023095-4dannjjm	2094	29	,	,	,
cord-023095-4dannjjm	2094	30	plasma	plasma	NN
cord-023095-4dannjjm	2094	31	vitamin	vitamin	NN
cord-023095-4dannjjm	2094	32	E	e	NN
cord-023095-4dannjjm	2094	33	,	,	,
cord-023095-4dannjjm	2094	34	and	and	CC
cord-023095-4dannjjm	2094	35	urinary	urinary	JJ
cord-023095-4dannjjm	2094	36	8-isoprostanes	8-isoprostanes	CD
cord-023095-4dannjjm	2094	37	.	.	.
cord-023095-4dannjjm	2095	1	Hyperthyroid	Hyperthyroid	NNP
cord-023095-4dannjjm	2095	2	cats	cat	NNS
cord-023095-4dannjjm	2095	3	were	be	VBD
cord-023095-4dannjjm	2095	4	re	re	VBN
cord-023095-4dannjjm	2095	5	-	-	VBN
cord-023095-4dannjjm	2095	6	evaluated	evaluate	VBN
cord-023095-4dannjjm	2095	7	2	2	CD
cord-023095-4dannjjm	2095	8	months	month	NNS
cord-023095-4dannjjm	2095	9	after	after	IN
cord-023095-4dannjjm	2095	10	radioiodine	radioiodine	NN
cord-023095-4dannjjm	2095	11	treatment	treatment	NN
cord-023095-4dannjjm	2095	12	.	.	.
cord-023095-4dannjjm	2096	1	Unlike	unlike	IN
cord-023095-4dannjjm	2096	2	in	in	IN
cord-023095-4dannjjm	2096	3	humans	human	NNS
cord-023095-4dannjjm	2096	4	,	,	,
cord-023095-4dannjjm	2096	5	median	median	JJ
cord-023095-4dannjjm	2096	6	blood	blood	NN
cord-023095-4dannjjm	2096	7	antioxidants	antioxidant	NNS
cord-023095-4dannjjm	2096	8	were	be	VBD
cord-023095-4dannjjm	2096	9	not	not	RB
cord-023095-4dannjjm	2096	10	significantly	significantly	RB
cord-023095-4dannjjm	2096	11	different	different	JJ
cord-023095-4dannjjm	2096	12	in	in	IN
cord-023095-4dannjjm	2096	13	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2096	14	cats	cat	NNS
cord-023095-4dannjjm	2096	15	(	(	-LRB-
cord-023095-4dannjjm	2096	16	GSH	GSH	NNP
cord-023095-4dannjjm	2096	17	1.5	1.5	CD
cord-023095-4dannjjm	2096	18	mM	mm	CD
cord-023095-4dannjjm	2096	19	;	;	:
cord-023095-4dannjjm	2096	20	AA	AA	NNP
cord-023095-4dannjjm	2096	21	11.4	11.4	CD
cord-023095-4dannjjm	2096	22	mM	mM	NNP
cord-023095-4dannjjm	2096	23	,	,	,
cord-023095-4dannjjm	2096	24	and	and	CC
cord-023095-4dannjjm	2096	25	vitamin	vitamin	NN
cord-023095-4dannjjm	2096	26	E	e	NN
cord-023095-4dannjjm	2096	27	,	,	,
cord-023095-4dannjjm	2096	28	19	19	CD
cord-023095-4dannjjm	2096	29	g	g	NN
cord-023095-4dannjjm	2096	30	/	/	SYM
cord-023095-4dannjjm	2096	31	ml	ml	NN
cord-023095-4dannjjm	2096	32	)	)	-RRB-
cord-023095-4dannjjm	2097	1	compared	compare	VBN
cord-023095-4dannjjm	2097	2	to	to	IN
cord-023095-4dannjjm	2097	3	controls	control	NNS
cord-023095-4dannjjm	2097	4	(	(	-LRB-
cord-023095-4dannjjm	2097	5	GSH	GSH	NNP
cord-023095-4dannjjm	2097	6	1.4	1.4	CD
cord-023095-4dannjjm	2097	7	mM	mm	CD
cord-023095-4dannjjm	2097	8	;	;	:
cord-023095-4dannjjm	2097	9	AA	AA	NNP
cord-023095-4dannjjm	2097	10	12.5	12.5	CD
cord-023095-4dannjjm	2097	11	mM	mM	NNP
cord-023095-4dannjjm	2097	12	,	,	,
cord-023095-4dannjjm	2097	13	and	and	CC
cord-023095-4dannjjm	2097	14	vitamin	vitamin	NN
cord-023095-4dannjjm	2097	15	E	e	NN
cord-023095-4dannjjm	2097	16	,	,	,
cord-023095-4dannjjm	2097	17	17	17	CD
cord-023095-4dannjjm	2097	18	g	g	NN
cord-023095-4dannjjm	2097	19	/	/	SYM
cord-023095-4dannjjm	2097	20	ml	ml	NN
cord-023095-4dannjjm	2097	21	)	)	-RRB-
cord-023095-4dannjjm	2097	22	.	.	.
cord-023095-4dannjjm	2098	1	Results	result	NNS
cord-023095-4dannjjm	2098	2	for	for	IN
cord-023095-4dannjjm	2098	3	urinary	urinary	JJ
cord-023095-4dannjjm	2098	4	isoprostanes	isoprostane	NNS
cord-023095-4dannjjm	2098	5	are	be	VBP
cord-023095-4dannjjm	2098	6	pending	pende	VBG
cord-023095-4dannjjm	2098	7	,	,	,
cord-023095-4dannjjm	2098	8	and	and	CC
cord-023095-4dannjjm	2098	9	associations	association	NNS
cord-023095-4dannjjm	2098	10	with	with	IN
cord-023095-4dannjjm	2098	11	methimazole	methimazole	NN
cord-023095-4dannjjm	2098	12	toxicity	toxicity	NN
cord-023095-4dannjjm	2098	13	will	will	MD
cord-023095-4dannjjm	2098	14	be	be	VB
cord-023095-4dannjjm	2098	15	investigated	investigate	VBN
cord-023095-4dannjjm	2098	16	after	after	IN
cord-023095-4dannjjm	2098	17	full	full	JJ
cord-023095-4dannjjm	2098	18	recruitment	recruitment	NN
cord-023095-4dannjjm	2098	19	.	.	.
cord-023095-4dannjjm	2099	1	RBC	RBC	NNP
cord-023095-4dannjjm	2099	2	GSH	GSH	NNP
cord-023095-4dannjjm	2099	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2099	4	did	do	VBD
cord-023095-4dannjjm	2099	5	increase	increase	VB
cord-023095-4dannjjm	2099	6	significantly	significantly	RB
cord-023095-4dannjjm	2099	7	(	(	-LRB-
cord-023095-4dannjjm	2099	8	to	to	IN
cord-023095-4dannjjm	2099	9	1.6	1.6	CD
cord-023095-4dannjjm	2099	10	mM	mm	CD
cord-023095-4dannjjm	2099	11	;	;	:
cord-023095-4dannjjm	2099	12	P	p	NN
cord-023095-4dannjjm	2099	13	5	5	CD
cord-023095-4dannjjm	2099	14	0.019	0.019	CD
cord-023095-4dannjjm	2099	15	)	)	-RRB-
cord-023095-4dannjjm	2099	16	after	after	IN
cord-023095-4dannjjm	2099	17	radioiodine	radioiodine	NN
cord-023095-4dannjjm	2099	18	treatment	treatment	NN
cord-023095-4dannjjm	2099	19	.	.	.
cord-023095-4dannjjm	2100	1	However	however	RB
cord-023095-4dannjjm	2100	2	,	,	,
cord-023095-4dannjjm	2100	3	this	this	DT
cord-023095-4dannjjm	2100	4	modest	modest	JJ
cord-023095-4dannjjm	2100	5	change	change	NN
cord-023095-4dannjjm	2100	6	is	be	VBZ
cord-023095-4dannjjm	2100	7	unlikely	unlikely	JJ
cord-023095-4dannjjm	2100	8	to	to	TO
cord-023095-4dannjjm	2100	9	be	be	VB
cord-023095-4dannjjm	2100	10	clinically	clinically	RB
cord-023095-4dannjjm	2100	11	significant	significant	JJ
cord-023095-4dannjjm	2100	12	.	.	.
cord-023095-4dannjjm	2101	1	Preliminary	preliminary	JJ
cord-023095-4dannjjm	2101	2	data	datum	NNS
cord-023095-4dannjjm	2101	3	do	do	VBP
cord-023095-4dannjjm	2101	4	not	not	RB
cord-023095-4dannjjm	2101	5	indicate	indicate	VB
cord-023095-4dannjjm	2101	6	clinically	clinically	RB
cord-023095-4dannjjm	2101	7	significant	significant	JJ
cord-023095-4dannjjm	2101	8	blood	blood	NN
cord-023095-4dannjjm	2101	9	GSH	GSH	NNP
cord-023095-4dannjjm	2101	10	,	,	,
cord-023095-4dannjjm	2101	11	ascorbate	ascorbate	NN
cord-023095-4dannjjm	2101	12	,	,	,
cord-023095-4dannjjm	2101	13	or	or	CC
cord-023095-4dannjjm	2101	14	vitamin	vitamin	NN
cord-023095-4dannjjm	2101	15	E	e	NN
cord-023095-4dannjjm	2101	16	deficiencies	deficiency	NNS
cord-023095-4dannjjm	2101	17	in	in	IN
cord-023095-4dannjjm	2101	18	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2101	19	cats	cat	NNS
cord-023095-4dannjjm	2101	20	.	.	.
cord-023095-4dannjjm	2102	1	With	with	IN
cord-023095-4dannjjm	2102	2	appropriate	appropriate	JJ
cord-023095-4dannjjm	2102	3	insulin	insulin	NN
cord-023095-4dannjjm	2102	4	therapy	therapy	NN
cord-023095-4dannjjm	2102	5	and	and	CC
cord-023095-4dannjjm	2102	6	a	a	DT
cord-023095-4dannjjm	2102	7	low	low	JJ
cord-023095-4dannjjm	2102	8	carbohydrate	carbohydrate	NN
cord-023095-4dannjjm	2102	9	diet	diet	NN
cord-023095-4dannjjm	2102	10	,	,	,
cord-023095-4dannjjm	2102	11	up	up	IN
cord-023095-4dannjjm	2102	12	to	to	TO
cord-023095-4dannjjm	2102	13	90	90	CD
cord-023095-4dannjjm	2102	14	%	%	NN
cord-023095-4dannjjm	2102	15	of	of	IN
cord-023095-4dannjjm	2102	16	newly	newly	RB
cord-023095-4dannjjm	2102	17	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2102	18	diabetic	diabetic	JJ
cord-023095-4dannjjm	2102	19	cats	cat	NNS
cord-023095-4dannjjm	2102	20	are	be	VBP
cord-023095-4dannjjm	2102	21	eventually	eventually	RB
cord-023095-4dannjjm	2102	22	able	able	JJ
cord-023095-4dannjjm	2102	23	to	to	TO
cord-023095-4dannjjm	2102	24	maintain	maintain	VB
cord-023095-4dannjjm	2102	25	euglycemia	euglycemia	NN
cord-023095-4dannjjm	2102	26	without	without	IN
cord-023095-4dannjjm	2102	27	insulin	insulin	NN
cord-023095-4dannjjm	2102	28	administration	administration	NN
cord-023095-4dannjjm	2102	29	,	,	,
cord-023095-4dannjjm	2102	30	and	and	CC
cord-023095-4dannjjm	2102	31	these	these	DT
cord-023095-4dannjjm	2102	32	cats	cat	NNS
cord-023095-4dannjjm	2102	33	are	be	VBP
cord-023095-4dannjjm	2102	34	considered	consider	VBN
cord-023095-4dannjjm	2102	35	to	to	TO
cord-023095-4dannjjm	2102	36	have	have	VB
cord-023095-4dannjjm	2102	37	achieved	achieve	VBN
cord-023095-4dannjjm	2102	38	remission	remission	NN
cord-023095-4dannjjm	2102	39	.	.	.
cord-023095-4dannjjm	2103	1	There	there	EX
cord-023095-4dannjjm	2103	2	are	be	VBP
cord-023095-4dannjjm	2103	3	currently	currently	RB
cord-023095-4dannjjm	2103	4	no	no	DT
cord-023095-4dannjjm	2103	5	published	publish	VBN
cord-023095-4dannjjm	2103	6	data	datum	NNS
cord-023095-4dannjjm	2103	7	reporting	report	VBG
cord-023095-4dannjjm	2103	8	the	the	DT
cord-023095-4dannjjm	2103	9	glucose	glucose	NN
cord-023095-4dannjjm	2103	10	tolerance	tolerance	NN
cord-023095-4dannjjm	2103	11	status	status	NN
cord-023095-4dannjjm	2103	12	of	of	IN
cord-023095-4dannjjm	2103	13	cats	cat	NNS
cord-023095-4dannjjm	2103	14	classified	classify	VBN
cord-023095-4dannjjm	2103	15	as	as	IN
cord-023095-4dannjjm	2103	16	being	be	VBG
cord-023095-4dannjjm	2103	17	in	in	IN
cord-023095-4dannjjm	2103	18	remission	remission	NN
cord-023095-4dannjjm	2103	19	,	,	,
cord-023095-4dannjjm	2103	20	and	and	CC
cord-023095-4dannjjm	2103	21	it	-PRON-	PRP
cord-023095-4dannjjm	2103	22	is	be	VBZ
cord-023095-4dannjjm	2103	23	unknown	unknown	JJ
cord-023095-4dannjjm	2103	24	whether	whether	IN
cord-023095-4dannjjm	2103	25	these	these	DT
cord-023095-4dannjjm	2103	26	cats	cat	NNS
cord-023095-4dannjjm	2103	27	are	be	VBP
cord-023095-4dannjjm	2103	28	truly	truly	RB
cord-023095-4dannjjm	2103	29	in	in	IN
cord-023095-4dannjjm	2103	30	diabetic	diabetic	JJ
cord-023095-4dannjjm	2103	31	remission	remission	NN
cord-023095-4dannjjm	2103	32	,	,	,
cord-023095-4dannjjm	2103	33	or	or	CC
cord-023095-4dannjjm	2103	34	should	should	MD
cord-023095-4dannjjm	2103	35	be	be	VB
cord-023095-4dannjjm	2103	36	classified	classify	VBN
cord-023095-4dannjjm	2103	37	as	as	IN
cord-023095-4dannjjm	2103	38	non	non	JJ
cord-023095-4dannjjm	2103	39	-	-	JJ
cord-023095-4dannjjm	2103	40	insulin	insulin	JJ
cord-023095-4dannjjm	2103	41	dependent	dependent	JJ
cord-023095-4dannjjm	2103	42	diabetics	diabetic	NNS
cord-023095-4dannjjm	2103	43	,	,	,
cord-023095-4dannjjm	2103	44	or	or	CC
cord-023095-4dannjjm	2103	45	having	have	VBG
cord-023095-4dannjjm	2103	46	impaired	impair	VBN
cord-023095-4dannjjm	2103	47	glucose	glucose	NN
cord-023095-4dannjjm	2103	48	tolerance	tolerance	NN
cord-023095-4dannjjm	2103	49	,	,	,
cord-023095-4dannjjm	2103	50	and/or	and/or	CC
cord-023095-4dannjjm	2103	51	impaired	impaired	JJ
cord-023095-4dannjjm	2103	52	fasting	fast	VBG
cord-023095-4dannjjm	2103	53	blood	blood	NN
cord-023095-4dannjjm	2103	54	glucose	glucose	NN
cord-023095-4dannjjm	2103	55	.	.	.
cord-023095-4dannjjm	2104	1	The	the	DT
cord-023095-4dannjjm	2104	2	aim	aim	NN
cord-023095-4dannjjm	2104	3	of	of	IN
cord-023095-4dannjjm	2104	4	this	this	DT
cord-023095-4dannjjm	2104	5	study	study	NN
cord-023095-4dannjjm	2104	6	was	be	VBD
cord-023095-4dannjjm	2104	7	to	to	TO
cord-023095-4dannjjm	2104	8	determine	determine	VB
cord-023095-4dannjjm	2104	9	fasting	fast	VBG
cord-023095-4dannjjm	2104	10	blood	blood	NN
cord-023095-4dannjjm	2104	11	glucose	glucose	NN
cord-023095-4dannjjm	2104	12	concentrations	concentration	NNS
cord-023095-4dannjjm	2104	13	and	and	CC
cord-023095-4dannjjm	2104	14	glucose	glucose	NN
cord-023095-4dannjjm	2104	15	tolerance	tolerance	NN
cord-023095-4dannjjm	2104	16	status	status	NN
cord-023095-4dannjjm	2104	17	of	of	IN
cord-023095-4dannjjm	2104	18	cats	cat	NNS
cord-023095-4dannjjm	2104	19	in	in	IN
cord-023095-4dannjjm	2104	20	remission	remission	NN
cord-023095-4dannjjm	2104	21	.	.	.
cord-023095-4dannjjm	2105	1	The	the	DT
cord-023095-4dannjjm	2105	2	study	study	NN
cord-023095-4dannjjm	2105	3	was	be	VBD
cord-023095-4dannjjm	2105	4	a	a	DT
cord-023095-4dannjjm	2105	5	prospective	prospective	JJ
cord-023095-4dannjjm	2105	6	study	study	NN
cord-023095-4dannjjm	2105	7	in	in	IN
cord-023095-4dannjjm	2105	8	a	a	DT
cord-023095-4dannjjm	2105	9	feline	feline	JJ
cord-023095-4dannjjm	2105	10	-	-	HYPH
cord-023095-4dannjjm	2105	11	only	only	JJ
cord-023095-4dannjjm	2105	12	clinic	clinic	NN
cord-023095-4dannjjm	2105	13	.	.	.
cord-023095-4dannjjm	2106	1	For	for	IN
cord-023095-4dannjjm	2106	2	inclusion	inclusion	NN
cord-023095-4dannjjm	2106	3	,	,	,
cord-023095-4dannjjm	2106	4	diabetic	diabetic	JJ
cord-023095-4dannjjm	2106	5	cats	cat	NNS
cord-023095-4dannjjm	2106	6	had	have	VBD
cord-023095-4dannjjm	2106	7	to	to	TO
cord-023095-4dannjjm	2106	8	have	have	VB
cord-023095-4dannjjm	2106	9	achieved	achieve	VBN
cord-023095-4dannjjm	2106	10	remission	remission	NN
cord-023095-4dannjjm	2106	11	through	through	IN
cord-023095-4dannjjm	2106	12	insulin	insulin	NN
cord-023095-4dannjjm	2106	13	therapy	therapy	NN
cord-023095-4dannjjm	2106	14	,	,	,
cord-023095-4dannjjm	2106	15	and	and	CC
cord-023095-4dannjjm	2106	16	insulin	insulin	NN
cord-023095-4dannjjm	2106	17	withheld	withhold	VBN
cord-023095-4dannjjm	2106	18	for	for	IN
cord-023095-4dannjjm	2106	19	a	a	DT
cord-023095-4dannjjm	2106	20	minimum	minimum	NN
cord-023095-4dannjjm	2106	21	of	of	IN
cord-023095-4dannjjm	2106	22	two	two	CD
cord-023095-4dannjjm	2106	23	weeks	week	NNS
cord-023095-4dannjjm	2106	24	.	.	.
cord-023095-4dannjjm	2107	1	Five	five	CD
cord-023095-4dannjjm	2107	2	diabetic	diabetic	JJ
cord-023095-4dannjjm	2107	3	cats	cat	NNS
cord-023095-4dannjjm	2107	4	in	in	IN
cord-023095-4dannjjm	2107	5	remission	remission	NN
cord-023095-4dannjjm	2107	6	and	and	CC
cord-023095-4dannjjm	2107	7	five	five	CD
cord-023095-4dannjjm	2107	8	matched	match	VBN
cord-023095-4dannjjm	2107	9	non	non	JJ
cord-023095-4dannjjm	2107	10	-	-	JJ
cord-023095-4dannjjm	2107	11	diabetic	diabetic	JJ
cord-023095-4dannjjm	2107	12	cats	cat	NNS
cord-023095-4dannjjm	2107	13	were	be	VBD
cord-023095-4dannjjm	2107	14	enrolled	enrol	VBN
cord-023095-4dannjjm	2107	15	in	in	IN
cord-023095-4dannjjm	2107	16	the	the	DT
cord-023095-4dannjjm	2107	17	study	study	NN
cord-023095-4dannjjm	2107	18	.	.	.
cord-023095-4dannjjm	2108	1	Blood	blood	NN
cord-023095-4dannjjm	2108	2	samples	sample	NNS
cord-023095-4dannjjm	2108	3	were	be	VBD
cord-023095-4dannjjm	2108	4	obtained	obtain	VBN
cord-023095-4dannjjm	2108	5	via	via	IN
cord-023095-4dannjjm	2108	6	the	the	DT
cord-023095-4dannjjm	2108	7	ear	ear	NN
cord-023095-4dannjjm	2108	8	vein	vein	NN
cord-023095-4dannjjm	2108	9	but	but	CC
cord-023095-4dannjjm	2108	10	where	where	WRB
cord-023095-4dannjjm	2108	11	the	the	DT
cord-023095-4dannjjm	2108	12	cat	cat	NN
cord-023095-4dannjjm	2108	13	's	's	POS
cord-023095-4dannjjm	2108	14	temperament	temperament	NN
cord-023095-4dannjjm	2108	15	precluded	preclude	VBD
cord-023095-4dannjjm	2108	16	this	this	DT
cord-023095-4dannjjm	2108	17	,	,	,
cord-023095-4dannjjm	2108	18	from	from	IN
cord-023095-4dannjjm	2108	19	the	the	DT
cord-023095-4dannjjm	2108	20	jugular	jugular	NN
cord-023095-4dannjjm	2108	21	.	.	.
cord-023095-4dannjjm	2109	1	Glucose	glucose	NN
cord-023095-4dannjjm	2109	2	concentration	concentration	NN
cord-023095-4dannjjm	2109	3	was	be	VBD
cord-023095-4dannjjm	2109	4	measured	measure	VBN
cord-023095-4dannjjm	2109	5	using	use	VBG
cord-023095-4dannjjm	2109	6	a	a	DT
cord-023095-4dannjjm	2109	7	meter	meter	NN
cord-023095-4dannjjm	2109	8	calibrated	calibrate	VBN
cord-023095-4dannjjm	2109	9	for	for	IN
cord-023095-4dannjjm	2109	10	feline	feline	JJ
cord-023095-4dannjjm	2109	11	blood	blood	NN
cord-023095-4dannjjm	2110	1	(	(	-LRB-
cord-023095-4dannjjm	2110	2	Abbott	Abbott	NNP
cord-023095-4dannjjm	2110	3	AlphaTRAK	AlphaTRAK	NNP
cord-023095-4dannjjm	2110	4	)	)	-RRB-
cord-023095-4dannjjm	2110	5	.	.	.
cord-023095-4dannjjm	2111	1	A	a	DT
cord-023095-4dannjjm	2111	2	simplified	simplified	JJ
cord-023095-4dannjjm	2111	3	glucose	glucose	NN
cord-023095-4dannjjm	2111	4	tolerance	tolerance	NN
cord-023095-4dannjjm	2111	5	test	test	NN
cord-023095-4dannjjm	2111	6	was	be	VBD
cord-023095-4dannjjm	2111	7	performed	perform	VBN
cord-023095-4dannjjm	2111	8	after	after	IN
cord-023095-4dannjjm	2111	9	food	food	NN
cord-023095-4dannjjm	2111	10	was	be	VBD
cord-023095-4dannjjm	2111	11	withheld	withhold	VBN
cord-023095-4dannjjm	2111	12	for	for	IN
cord-023095-4dannjjm	2111	13	24	24	CD
cord-023095-4dannjjm	2111	14	hours	hour	NNS
cord-023095-4dannjjm	2111	15	.	.	.
cord-023095-4dannjjm	2112	1	A	a	DT
cord-023095-4dannjjm	2112	2	22	22	CD
cord-023095-4dannjjm	2112	3	G	g	NN
cord-023095-4dannjjm	2112	4	catheter	catheter	NN
cord-023095-4dannjjm	2112	5	was	be	VBD
cord-023095-4dannjjm	2112	6	placed	place	VBN
cord-023095-4dannjjm	2112	7	in	in	IN
cord-023095-4dannjjm	2112	8	a	a	DT
cord-023095-4dannjjm	2112	9	cephalic	cephalic	JJ
cord-023095-4dannjjm	2112	10	vein	vein	NN
cord-023095-4dannjjm	2112	11	three	three	CD
cord-023095-4dannjjm	2112	12	hours	hour	NNS
cord-023095-4dannjjm	2112	13	before	before	IN
cord-023095-4dannjjm	2112	14	the	the	DT
cord-023095-4dannjjm	2112	15	GTT	GTT	NNP
cord-023095-4dannjjm	2112	16	was	be	VBD
cord-023095-4dannjjm	2112	17	commenced	commence	VBN
cord-023095-4dannjjm	2112	18	,	,	,
cord-023095-4dannjjm	2112	19	to	to	TO
cord-023095-4dannjjm	2112	20	minimize	minimize	VB
cord-023095-4dannjjm	2112	21	the	the	DT
cord-023095-4dannjjm	2112	22	effects	effect	NNS
cord-023095-4dannjjm	2112	23	of	of	IN
cord-023095-4dannjjm	2112	24	stress	stress	NN
cord-023095-4dannjjm	2112	25	on	on	IN
cord-023095-4dannjjm	2112	26	blood	blood	NN
cord-023095-4dannjjm	2112	27	glucose	glucose	NN
cord-023095-4dannjjm	2112	28	concentration	concentration	NN
cord-023095-4dannjjm	2112	29	.	.	.
cord-023095-4dannjjm	2113	1	Blood	blood	NN
cord-023095-4dannjjm	2113	2	glucose	glucose	NN
cord-023095-4dannjjm	2113	3	concentration	concentration	NN
cord-023095-4dannjjm	2113	4	was	be	VBD
cord-023095-4dannjjm	2113	5	measured	measure	VBN
cord-023095-4dannjjm	2113	6	at	at	IN
cord-023095-4dannjjm	2113	7	time	time	NN
cord-023095-4dannjjm	2113	8	0	0	NFP
cord-023095-4dannjjm	2113	9	and	and	CC
cord-023095-4dannjjm	2113	10	then	then	RB
cord-023095-4dannjjm	2113	11	a	a	DT
cord-023095-4dannjjm	2113	12	1	1	CD
cord-023095-4dannjjm	2113	13	g	g	NN
cord-023095-4dannjjm	2113	14	/	/	SYM
cord-023095-4dannjjm	2113	15	kg	kg	NN
cord-023095-4dannjjm	2113	16	dose	dose	NN
cord-023095-4dannjjm	2113	17	of	of	IN
cord-023095-4dannjjm	2113	18	glucose	glucose	NN
cord-023095-4dannjjm	2113	19	was	be	VBD
cord-023095-4dannjjm	2113	20	administered	administer	VBN
cord-023095-4dannjjm	2113	21	slowly	slowly	RB
cord-023095-4dannjjm	2113	22	via	via	IN
cord-023095-4dannjjm	2113	23	the	the	DT
cord-023095-4dannjjm	2113	24	intravenous	intravenous	JJ
cord-023095-4dannjjm	2113	25	catheter	catheter	NN
cord-023095-4dannjjm	2113	26	.	.	.
cord-023095-4dannjjm	2114	1	Further	further	JJ
cord-023095-4dannjjm	2114	2	blood	blood	NN
cord-023095-4dannjjm	2114	3	glucose	glucose	NN
cord-023095-4dannjjm	2114	4	measurements	measurement	NNS
cord-023095-4dannjjm	2114	5	were	be	VBD
cord-023095-4dannjjm	2114	6	made	make	VBN
cord-023095-4dannjjm	2114	7	at	at	IN
cord-023095-4dannjjm	2114	8	2	2	CD
cord-023095-4dannjjm	2114	9	hours	hour	NNS
cord-023095-4dannjjm	2114	10	and	and	CC
cord-023095-4dannjjm	2114	11	then	then	RB
cord-023095-4dannjjm	2114	12	hourly	hourly	RB
cord-023095-4dannjjm	2114	13	until	until	IN
cord-023095-4dannjjm	2114	14	glucose	glucose	NN
cord-023095-4dannjjm	2114	15	had	have	VBD
cord-023095-4dannjjm	2114	16	returned	return	VBN
cord-023095-4dannjjm	2114	17	to	to	IN
cord-023095-4dannjjm	2114	18	o	o	CD
cord-023095-4dannjjm	2114	19	117	117	CD
cord-023095-4dannjjm	2114	20	mg	mg	NNP
cord-023095-4dannjjm	2114	21	/	/	SYM
cord-023095-4dannjjm	2114	22	dL	dl	NN
cord-023095-4dannjjm	2115	1	(	(	-LRB-
cord-023095-4dannjjm	2115	2	o	o	UH
cord-023095-4dannjjm	2115	3	6.5	6.5	CD
cord-023095-4dannjjm	2115	4	mmol	mmol	NNP
cord-023095-4dannjjm	2115	5	/	/	SYM
cord-023095-4dannjjm	2115	6	L	L	NNP
cord-023095-4dannjjm	2115	7	)	)	-RRB-
cord-023095-4dannjjm	2115	8	.	.	.
cord-023095-4dannjjm	2116	1	In	in	IN
cord-023095-4dannjjm	2116	2	the	the	DT
cord-023095-4dannjjm	2116	3	control	control	NN
cord-023095-4dannjjm	2116	4	group	group	NN
cord-023095-4dannjjm	2116	5	,	,	,
cord-023095-4dannjjm	2116	6	all	all	DT
cord-023095-4dannjjm	2116	7	cats	cat	NNS
cord-023095-4dannjjm	2116	8	had	have	VBD
cord-023095-4dannjjm	2116	9	a	a	DT
cord-023095-4dannjjm	2116	10	fasting	fast	VBG
cord-023095-4dannjjm	2116	11	blood	blood	NN
cord-023095-4dannjjm	2116	12	glucose	glucose	NN
cord-023095-4dannjjm	2116	13	below	below	IN
cord-023095-4dannjjm	2116	14	117	117	CD
cord-023095-4dannjjm	2116	15	mg	mg	NNP
cord-023095-4dannjjm	2116	16	/	/	SYM
cord-023095-4dannjjm	2116	17	dL	dl	NN
cord-023095-4dannjjm	2116	18	,	,	,
cord-023095-4dannjjm	2116	19	and	and	CC
cord-023095-4dannjjm	2116	20	following	follow	VBG
cord-023095-4dannjjm	2116	21	glucose	glucose	NN
cord-023095-4dannjjm	2116	22	administration	administration	NN
cord-023095-4dannjjm	2116	23	,	,	,
cord-023095-4dannjjm	2116	24	glucose	glucose	NN
cord-023095-4dannjjm	2116	25	had	have	VBD
cord-023095-4dannjjm	2116	26	returned	return	VBN
cord-023095-4dannjjm	2116	27	to	to	IN
cord-023095-4dannjjm	2116	28	o	o	NN
cord-023095-4dannjjm	2117	1	117	117	CD
cord-023095-4dannjjm	2117	2	mg	mg	NNP
cord-023095-4dannjjm	2117	3	/	/	SYM
cord-023095-4dannjjm	2117	4	dL	dl	NN
cord-023095-4dannjjm	2117	5	by	by	IN
cord-023095-4dannjjm	2117	6	3	3	CD
cord-023095-4dannjjm	2117	7	hours	hour	NNS
cord-023095-4dannjjm	2117	8	.	.	.
cord-023095-4dannjjm	2118	1	Fasting	fast	VBG
cord-023095-4dannjjm	2118	2	blood	blood	NN
cord-023095-4dannjjm	2118	3	glucose	glucose	NN
cord-023095-4dannjjm	2118	4	in	in	IN
cord-023095-4dannjjm	2118	5	the	the	DT
cord-023095-4dannjjm	2118	6	remission	remission	NN
cord-023095-4dannjjm	2118	7	group	group	NN
cord-023095-4dannjjm	2118	8	was	be	VBD
cord-023095-4dannjjm	2118	9	o	o	UH
cord-023095-4dannjjm	2119	1	126	126	CD
cord-023095-4dannjjm	2119	2	mg	mg	NNP
cord-023095-4dannjjm	2119	3	/	/	SYM
cord-023095-4dannjjm	2119	4	dL	dl	NN
cord-023095-4dannjjm	2119	5	(	(	-LRB-
cord-023095-4dannjjm	2119	6	7	7	CD
cord-023095-4dannjjm	2119	7	mmol	mmol	NNP
cord-023095-4dannjjm	2119	8	/	/	SYM
cord-023095-4dannjjm	2119	9	L	L	NNP
cord-023095-4dannjjm	2119	10	)	)	-RRB-
cord-023095-4dannjjm	2119	11	in	in	IN
cord-023095-4dannjjm	2119	12	all	all	DT
cord-023095-4dannjjm	2119	13	cats	cat	NNS
cord-023095-4dannjjm	2119	14	except	except	IN
cord-023095-4dannjjm	2119	15	one	one	CD
cord-023095-4dannjjm	2119	16	,	,	,
cord-023095-4dannjjm	2119	17	which	which	WDT
cord-023095-4dannjjm	2119	18	had	have	VBD
cord-023095-4dannjjm	2119	19	fasting	fast	VBG
cord-023095-4dannjjm	2119	20	blood	blood	NN
cord-023095-4dannjjm	2119	21	glucose	glucose	NN
cord-023095-4dannjjm	2119	22	of	of	IN
cord-023095-4dannjjm	2119	23	135	135	CD
cord-023095-4dannjjm	2119	24	mg	mg	NNP
cord-023095-4dannjjm	2119	25	/	/	SYM
cord-023095-4dannjjm	2119	26	dL	dl	NN
cord-023095-4dannjjm	2119	27	(	(	-LRB-
cord-023095-4dannjjm	2119	28	7.5	7.5	CD
cord-023095-4dannjjm	2119	29	mmol	mmol	JJ
cord-023095-4dannjjm	2119	30	/	/	SYM
cord-023095-4dannjjm	2119	31	L	L	NNP
cord-023095-4dannjjm	2119	32	)	)	-RRB-
cord-023095-4dannjjm	2119	33	.	.	.
cord-023095-4dannjjm	2120	1	Following	follow	VBG
cord-023095-4dannjjm	2120	2	glucose	glucose	NN
cord-023095-4dannjjm	2120	3	administration	administration	NN
cord-023095-4dannjjm	2120	4	,	,	,
cord-023095-4dannjjm	2120	5	all	all	DT
cord-023095-4dannjjm	2120	6	five	five	CD
cord-023095-4dannjjm	2120	7	cats	cat	NNS
cord-023095-4dannjjm	2120	8	in	in	IN
cord-023095-4dannjjm	2120	9	remission	remission	NN
cord-023095-4dannjjm	2120	10	had	have	VBD
cord-023095-4dannjjm	2120	11	blood	blood	NN
cord-023095-4dannjjm	2120	12	glucose	glucose	NN
cord-023095-4dannjjm	2120	13	above	above	IN
cord-023095-4dannjjm	2120	14	117	117	CD
cord-023095-4dannjjm	2120	15	mg	mg	NNP
cord-023095-4dannjjm	2120	16	/	/	SYM
cord-023095-4dannjjm	2120	17	dL	dl	NN
cord-023095-4dannjjm	2120	18	(	(	-LRB-
cord-023095-4dannjjm	2120	19	6.5	6.5	CD
cord-023095-4dannjjm	2120	20	mmol	mmol	JJ
cord-023095-4dannjjm	2120	21	/	/	SYM
cord-023095-4dannjjm	2120	22	L	L	NNP
cord-023095-4dannjjm	2120	23	)	)	-RRB-
cord-023095-4dannjjm	2120	24	at	at	IN
cord-023095-4dannjjm	2120	25	three	three	CD
cord-023095-4dannjjm	2120	26	hours	hour	NNS
cord-023095-4dannjjm	2120	27	,	,	,
cord-023095-4dannjjm	2120	28	four	four	CD
cord-023095-4dannjjm	2120	29	were	be	VBD
cord-023095-4dannjjm	2120	30	o	o	NN
cord-023095-4dannjjm	2121	1	117	117	CD
cord-023095-4dannjjm	2121	2	mg	mg	NNP
cord-023095-4dannjjm	2121	3	/	/	SYM
cord-023095-4dannjjm	2121	4	dL	dl	NN
cord-023095-4dannjjm	2121	5	at	at	IN
cord-023095-4dannjjm	2121	6	four	four	CD
cord-023095-4dannjjm	2121	7	hours	hour	NNS
cord-023095-4dannjjm	2121	8	,	,	,
cord-023095-4dannjjm	2121	9	and	and	CC
cord-023095-4dannjjm	2121	10	one	one	CD
cord-023095-4dannjjm	2121	11	returned	return	VBD
cord-023095-4dannjjm	2121	12	to	to	IN
cord-023095-4dannjjm	2121	13	o	o	CD
cord-023095-4dannjjm	2121	14	117	117	CD
cord-023095-4dannjjm	2121	15	mg	mg	NNP
cord-023095-4dannjjm	2121	16	/	/	SYM
cord-023095-4dannjjm	2121	17	dL	dl	NN
cord-023095-4dannjjm	2121	18	at	at	IN
cord-023095-4dannjjm	2121	19	five	five	CD
cord-023095-4dannjjm	2121	20	hours	hour	NNS
cord-023095-4dannjjm	2121	21	.	.	.
cord-023095-4dannjjm	2122	1	The	the	DT
cord-023095-4dannjjm	2122	2	cat	cat	NN
cord-023095-4dannjjm	2122	3	with	with	IN
cord-023095-4dannjjm	2122	4	impaired	impair	VBN
cord-023095-4dannjjm	2122	5	fasting	fast	VBG
cord-023095-4dannjjm	2122	6	glucose	glucose	NN
cord-023095-4dannjjm	2122	7	subsequently	subsequently	RB
cord-023095-4dannjjm	2122	8	became	become	VBD
cord-023095-4dannjjm	2122	9	diabetic	diabetic	JJ
cord-023095-4dannjjm	2122	10	after	after	IN
cord-023095-4dannjjm	2122	11	steroid	steroid	NNP
cord-023095-4dannjjm	2122	12	administration	administration	NN
cord-023095-4dannjjm	2122	13	.	.	.
cord-023095-4dannjjm	2123	1	The	the	DT
cord-023095-4dannjjm	2123	2	results	result	NNS
cord-023095-4dannjjm	2123	3	of	of	IN
cord-023095-4dannjjm	2123	4	this	this	DT
cord-023095-4dannjjm	2123	5	study	study	NN
cord-023095-4dannjjm	2123	6	show	show	VBP
cord-023095-4dannjjm	2123	7	that	that	IN
cord-023095-4dannjjm	2123	8	these	these	DT
cord-023095-4dannjjm	2123	9	cats	cat	NNS
cord-023095-4dannjjm	2123	10	,	,	,
cord-023095-4dannjjm	2123	11	while	while	IN
cord-023095-4dannjjm	2123	12	no	no	DT
cord-023095-4dannjjm	2123	13	longer	long	RBR
cord-023095-4dannjjm	2123	14	diabetic	diabetic	JJ
cord-023095-4dannjjm	2123	15	,	,	,
cord-023095-4dannjjm	2123	16	have	have	VBP
cord-023095-4dannjjm	2123	17	mildly	mildly	RB
cord-023095-4dannjjm	2123	18	impaired	impair	VBN
cord-023095-4dannjjm	2123	19	glucose	glucose	NN
cord-023095-4dannjjm	2123	20	tolerance	tolerance	NN
cord-023095-4dannjjm	2123	21	compared	compare	VBN
cord-023095-4dannjjm	2123	22	to	to	IN
cord-023095-4dannjjm	2123	23	nondiabetic	nondiabetic	JJ
cord-023095-4dannjjm	2123	24	cats	cat	NNS
cord-023095-4dannjjm	2123	25	,	,	,
cord-023095-4dannjjm	2123	26	and	and	CC
cord-023095-4dannjjm	2123	27	a	a	DT
cord-023095-4dannjjm	2123	28	minority	minority	NN
cord-023095-4dannjjm	2123	29	have	have	VBP
cord-023095-4dannjjm	2123	30	impaired	impair	VBN
cord-023095-4dannjjm	2123	31	fasting	fast	VBG
cord-023095-4dannjjm	2123	32	glucose	glucose	NN
cord-023095-4dannjjm	2123	33	.	.	.
cord-023095-4dannjjm	2124	1	The	the	DT
cord-023095-4dannjjm	2124	2	objective	objective	NN
cord-023095-4dannjjm	2124	3	of	of	IN
cord-023095-4dannjjm	2124	4	this	this	DT
cord-023095-4dannjjm	2124	5	study	study	NN
cord-023095-4dannjjm	2124	6	was	be	VBD
cord-023095-4dannjjm	2124	7	to	to	TO
cord-023095-4dannjjm	2124	8	determine	determine	VB
cord-023095-4dannjjm	2124	9	the	the	DT
cord-023095-4dannjjm	2124	10	role	role	NN
cord-023095-4dannjjm	2124	11	of	of	IN
cord-023095-4dannjjm	2124	12	iodine	iodine	NN
cord-023095-4dannjjm	2124	13	restriction	restriction	NN
cord-023095-4dannjjm	2124	14	in	in	IN
cord-023095-4dannjjm	2124	15	the	the	DT
cord-023095-4dannjjm	2124	16	nutritional	nutritional	JJ
cord-023095-4dannjjm	2124	17	management	management	NN
cord-023095-4dannjjm	2124	18	of	of	IN
cord-023095-4dannjjm	2124	19	cats	cat	NNS
cord-023095-4dannjjm	2124	20	with	with	IN
cord-023095-4dannjjm	2124	21	naturally	naturally	RB
cord-023095-4dannjjm	2124	22	occurring	occur	VBG
cord-023095-4dannjjm	2124	23	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2124	24	.	.	.
cord-023095-4dannjjm	2125	1	Five	five	CD
cord-023095-4dannjjm	2125	2	domestic	domestic	JJ
cord-023095-4dannjjm	2125	3	shorthair	shorthair	JJ
cord-023095-4dannjjm	2125	4	cats	cat	NNS
cord-023095-4dannjjm	2125	5	ranging	range	VBG
cord-023095-4dannjjm	2125	6	in	in	IN
cord-023095-4dannjjm	2125	7	age	age	NN
cord-023095-4dannjjm	2125	8	from	from	IN
cord-023095-4dannjjm	2125	9	8	8	CD
cord-023095-4dannjjm	2125	10	-	-	SYM
cord-023095-4dannjjm	2125	11	17	17	CD
cord-023095-4dannjjm	2125	12	years	year	NNS
cord-023095-4dannjjm	2125	13	were	be	VBD
cord-023095-4dannjjm	2125	14	confirmed	confirm	VBN
cord-023095-4dannjjm	2125	15	to	to	TO
cord-023095-4dannjjm	2125	16	have	have	VB
cord-023095-4dannjjm	2125	17	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2125	18	based	base	VBN
cord-023095-4dannjjm	2125	19	on	on	IN
cord-023095-4dannjjm	2125	20	persistently	persistently	RB
cord-023095-4dannjjm	2125	21	increased	increase	VBN
cord-023095-4dannjjm	2125	22	serum	serum	JJ
cord-023095-4dannjjm	2125	23	total	total	JJ
cord-023095-4dannjjm	2125	24	thyroxine	thyroxine	JJ
cord-023095-4dannjjm	2125	25	concentrations	concentration	NNS
cord-023095-4dannjjm	2125	26	(	(	-LRB-
cord-023095-4dannjjm	2125	27	TT4	TT4	NNP
cord-023095-4dannjjm	2125	28	)	)	-RRB-
cord-023095-4dannjjm	2125	29	,	,	,
cord-023095-4dannjjm	2125	30	palpable	palpable	JJ
cord-023095-4dannjjm	2125	31	thyroid	thyroid	NN
cord-023095-4dannjjm	2125	32	nodule	nodule	NN
cord-023095-4dannjjm	2125	33	and	and	CC
cord-023095-4dannjjm	2125	34	weight	weight	NN
cord-023095-4dannjjm	2125	35	loss	loss	NN
cord-023095-4dannjjm	2125	36	.	.	.
cord-023095-4dannjjm	2126	1	Serum	serum	NN
cord-023095-4dannjjm	2126	2	TT4	TT4	NNP
cord-023095-4dannjjm	2126	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2126	4	ranged	range	VBD
cord-023095-4dannjjm	2126	5	from	from	IN
cord-023095-4dannjjm	2126	6	55	55	CD
cord-023095-4dannjjm	2126	7	-	-	SYM
cord-023095-4dannjjm	2126	8	146	146	CD
cord-023095-4dannjjm	2126	9	nmol	nmol	NNP
cord-023095-4dannjjm	2126	10	/	/	SYM
cord-023095-4dannjjm	2126	11	l	l	NN
cord-023095-4dannjjm	2126	12	(	(	-LRB-
cord-023095-4dannjjm	2126	13	reference	reference	NN
cord-023095-4dannjjm	2126	14	range	range	NN
cord-023095-4dannjjm	2126	15	10	10	CD
cord-023095-4dannjjm	2126	16	-	-	SYM
cord-023095-4dannjjm	2126	17	55	55	CD
cord-023095-4dannjjm	2126	18	nmol	nmol	JJ
cord-023095-4dannjjm	2126	19	/	/	SYM
cord-023095-4dannjjm	2126	20	l	l	NN
cord-023095-4dannjjm	2126	21	)	)	-RRB-
cord-023095-4dannjjm	2126	22	.	.	.
cord-023095-4dannjjm	2127	1	The	the	DT
cord-023095-4dannjjm	2127	2	cats	cat	NNS
cord-023095-4dannjjm	2127	3	were	be	VBD
cord-023095-4dannjjm	2127	4	then	then	RB
cord-023095-4dannjjm	2127	5	fed	feed	VBN
cord-023095-4dannjjm	2127	6	a	a	DT
cord-023095-4dannjjm	2127	7	low	low	JJ
cord-023095-4dannjjm	2127	8	iodine	iodine	NN
cord-023095-4dannjjm	2127	9	containing	contain	VBG
cord-023095-4dannjjm	2127	10	food	food	NN
cord-023095-4dannjjm	2127	11	(	(	-LRB-
cord-023095-4dannjjm	2127	12	0.47	0.47	CD
cord-023095-4dannjjm	2127	13	ppm	ppm	NN
cord-023095-4dannjjm	2127	14	iodine	iodine	NN
cord-023095-4dannjjm	2127	15	DMB	DMB	NNP
cord-023095-4dannjjm	2127	16	,	,	,
cord-023095-4dannjjm	2127	17	as	as	IN
cord-023095-4dannjjm	2127	18	measured	measure	VBN
cord-023095-4dannjjm	2127	19	by	by	IN
cord-023095-4dannjjm	2127	20	epiboron	epiboron	NNP
cord-023095-4dannjjm	2127	21	neutron	neutron	NNP
cord-023095-4dannjjm	2127	22	atomic	atomic	NNP
cord-023095-4dannjjm	2127	23	activation	activation	NNP
cord-023095-4dannjjm	2127	24	)	)	-RRB-
cord-023095-4dannjjm	2127	25	.	.	.
cord-023095-4dannjjm	2128	1	Serum	serum	NN
cord-023095-4dannjjm	2128	2	TT4	TT4	NNP
cord-023095-4dannjjm	2128	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2128	4	were	be	VBD
cord-023095-4dannjjm	2128	5	measured	measure	VBN
cord-023095-4dannjjm	2128	6	every	every	DT
cord-023095-4dannjjm	2128	7	3	3	CD
cord-023095-4dannjjm	2128	8	weeks	week	NNS
cord-023095-4dannjjm	2128	9	.	.	.
cord-023095-4dannjjm	2129	1	Biochemistry	biochemistry	NN
cord-023095-4dannjjm	2129	2	parameters	parameter	NNS
cord-023095-4dannjjm	2129	3	were	be	VBD
cord-023095-4dannjjm	2129	4	also	also	RB
cord-023095-4dannjjm	2129	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	2129	6	at	at	IN
cord-023095-4dannjjm	2129	7	weeks	week	NNS
cord-023095-4dannjjm	2129	8	0	0	CD
cord-023095-4dannjjm	2129	9	,	,	,
cord-023095-4dannjjm	2129	10	6	6	CD
cord-023095-4dannjjm	2129	11	and	and	CC
cord-023095-4dannjjm	2129	12	9	9	CD
cord-023095-4dannjjm	2129	13	.	.	.
cord-023095-4dannjjm	2130	1	At	at	IN
cord-023095-4dannjjm	2130	2	9	9	CD
cord-023095-4dannjjm	2130	3	weeks	week	NNS
cord-023095-4dannjjm	2130	4	,	,	,
cord-023095-4dannjjm	2130	5	serum	serum	NN
cord-023095-4dannjjm	2130	6	TT4	TT4	NNP
cord-023095-4dannjjm	2130	7	concentrations	concentration	NNS
cord-023095-4dannjjm	2130	8	had	have	VBD
cord-023095-4dannjjm	2130	9	decreased	decrease	VBN
cord-023095-4dannjjm	2130	10	in	in	IN
cord-023095-4dannjjm	2130	11	all	all	DT
cord-023095-4dannjjm	2130	12	cats	cat	NNS
cord-023095-4dannjjm	2130	13	with	with	IN
cord-023095-4dannjjm	2130	14	4	4	CD
cord-023095-4dannjjm	2130	15	of	of	IN
cord-023095-4dannjjm	2130	16	5	5	CD
cord-023095-4dannjjm	2130	17	cats	cat	NNS
cord-023095-4dannjjm	2130	18	(	(	-LRB-
cord-023095-4dannjjm	2130	19	80	80	CD
cord-023095-4dannjjm	2130	20	%	%	NN
cord-023095-4dannjjm	2130	21	)	)	-RRB-
cord-023095-4dannjjm	2130	22	being	be	VBG
cord-023095-4dannjjm	2130	23	euthyroid	euthyroid	NNP
cord-023095-4dannjjm	2131	1	(	(	-LRB-
cord-023095-4dannjjm	2131	2	mean	mean	VB
cord-023095-4dannjjm	2131	3	48	48	CD
cord-023095-4dannjjm	2131	4	nmol	nmol	JJ
cord-023095-4dannjjm	2131	5	/	/	SYM
cord-023095-4dannjjm	2131	6	l	l	NN
cord-023095-4dannjjm	2131	7	;	;	:
cord-023095-4dannjjm	2131	8	range	range	NNP
cord-023095-4dannjjm	2131	9	41	41	CD
cord-023095-4dannjjm	2131	10	-	-	SYM
cord-023095-4dannjjm	2131	11	54	54	CD
cord-023095-4dannjjm	2131	12	nmol	nmol	JJ
cord-023095-4dannjjm	2131	13	/	/	SYM
cord-023095-4dannjjm	2131	14	l	l	NN
cord-023095-4dannjjm	2131	15	)	)	-RRB-
cord-023095-4dannjjm	2131	16	.	.	.
cord-023095-4dannjjm	2132	1	The	the	DT
cord-023095-4dannjjm	2132	2	remaining	remain	VBG
cord-023095-4dannjjm	2132	3	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2132	4	cat	cat	NN
cord-023095-4dannjjm	2132	5	had	have	VBD
cord-023095-4dannjjm	2132	6	an	an	DT
cord-023095-4dannjjm	2132	7	initial	initial	JJ
cord-023095-4dannjjm	2132	8	serum	serum	NN
cord-023095-4dannjjm	2132	9	TT4	tt4	NN
cord-023095-4dannjjm	2132	10	of	of	IN
cord-023095-4dannjjm	2132	11	146	146	CD
cord-023095-4dannjjm	2132	12	nmol	nmol	NNP
cord-023095-4dannjjm	2132	13	/	/	SYM
cord-023095-4dannjjm	2132	14	l	l	NN
cord-023095-4dannjjm	2132	15	,	,	,
cord-023095-4dannjjm	2132	16	which	which	WDT
cord-023095-4dannjjm	2132	17	decreased	decrease	VBD
cord-023095-4dannjjm	2132	18	to	to	IN
cord-023095-4dannjjm	2132	19	83	83	CD
cord-023095-4dannjjm	2132	20	nmol	nmol	JJ
cord-023095-4dannjjm	2132	21	/	/	SYM
cord-023095-4dannjjm	2132	22	l	l	NN
cord-023095-4dannjjm	2132	23	after	after	IN
cord-023095-4dannjjm	2132	24	being	be	VBG
cord-023095-4dannjjm	2132	25	fed	feed	VBN
cord-023095-4dannjjm	2132	26	the	the	DT
cord-023095-4dannjjm	2132	27	iodine	iodine	NN
cord-023095-4dannjjm	2132	28	-	-	HYPH
cord-023095-4dannjjm	2132	29	restricted	restrict	VBN
cord-023095-4dannjjm	2132	30	food	food	NN
cord-023095-4dannjjm	2132	31	.	.	.
cord-023095-4dannjjm	2133	1	Mean	mean	JJ
cord-023095-4dannjjm	2133	2	decrease	decrease	NN
cord-023095-4dannjjm	2133	3	in	in	IN
cord-023095-4dannjjm	2133	4	TT4	TT4	NNP
cord-023095-4dannjjm	2133	5	for	for	IN
cord-023095-4dannjjm	2133	6	all	all	DT
cord-023095-4dannjjm	2133	7	5	5	CD
cord-023095-4dannjjm	2133	8	cats	cat	NNS
cord-023095-4dannjjm	2133	9	was	be	VBD
cord-023095-4dannjjm	2133	10	26	26	CD
cord-023095-4dannjjm	2133	11	nmol	nmol	JJ
cord-023095-4dannjjm	2133	12	/	/	SYM
cord-023095-4dannjjm	2133	13	l	l	NN
cord-023095-4dannjjm	2133	14	(	(	-LRB-
cord-023095-4dannjjm	2133	15	range	range	NNP
cord-023095-4dannjjm	2133	16	8	8	CD
cord-023095-4dannjjm	2133	17	-	-	SYM
cord-023095-4dannjjm	2133	18	63	63	CD
cord-023095-4dannjjm	2133	19	nmol	nmol	JJ
cord-023095-4dannjjm	2133	20	/	/	SYM
cord-023095-4dannjjm	2133	21	l	l	NN
cord-023095-4dannjjm	2133	22	)	)	-RRB-
cord-023095-4dannjjm	2133	23	.	.	.
cord-023095-4dannjjm	2134	1	Renal	renal	JJ
cord-023095-4dannjjm	2134	2	parameters	parameter	NNS
cord-023095-4dannjjm	2134	3	remained	remain	VBD
cord-023095-4dannjjm	2134	4	stable	stable	JJ
cord-023095-4dannjjm	2134	5	in	in	IN
cord-023095-4dannjjm	2134	6	all	all	DT
cord-023095-4dannjjm	2134	7	5	5	CD
cord-023095-4dannjjm	2134	8	cats	cat	NNS
cord-023095-4dannjjm	2134	9	.	.	.
cord-023095-4dannjjm	2135	1	These	these	DT
cord-023095-4dannjjm	2135	2	5	5	CD
cord-023095-4dannjjm	2135	3	cats	cat	NNS
cord-023095-4dannjjm	2135	4	along	along	IN
cord-023095-4dannjjm	2135	5	with	with	IN
cord-023095-4dannjjm	2135	6	4	4	CD
cord-023095-4dannjjm	2135	7	additional	additional	JJ
cord-023095-4dannjjm	2135	8	newly	newly	RB
cord-023095-4dannjjm	2135	9	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2135	10	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2135	11	cats	cat	NNS
cord-023095-4dannjjm	2135	12	were	be	VBD
cord-023095-4dannjjm	2135	13	transitioned	transition	VBN
cord-023095-4dannjjm	2135	14	to	to	IN
cord-023095-4dannjjm	2135	15	a	a	DT
cord-023095-4dannjjm	2135	16	similar	similar	JJ
cord-023095-4dannjjm	2135	17	food	food	NN
cord-023095-4dannjjm	2135	18	that	that	WDT
cord-023095-4dannjjm	2135	19	contained	contain	VBD
cord-023095-4dannjjm	2135	20	less	less	JJR
cord-023095-4dannjjm	2135	21	iodine	iodine	NN
cord-023095-4dannjjm	2135	22	(	(	-LRB-
cord-023095-4dannjjm	2135	23	0.28	0.28	CD
cord-023095-4dannjjm	2135	24	ppm	ppm	NN
cord-023095-4dannjjm	2135	25	DMB	DMB	NNP
cord-023095-4dannjjm	2135	26	)	)	-RRB-
cord-023095-4dannjjm	2135	27	.	.	.
cord-023095-4dannjjm	2136	1	Baseline	baseline	JJ
cord-023095-4dannjjm	2136	2	serum	serum	NN
cord-023095-4dannjjm	2137	1	TT4	TT4	NNP
cord-023095-4dannjjm	2137	2	concentrations	concentration	NNS
cord-023095-4dannjjm	2137	3	in	in	IN
cord-023095-4dannjjm	2137	4	the	the	DT
cord-023095-4dannjjm	2137	5	4	4	CD
cord-023095-4dannjjm	2137	6	new	new	JJ
cord-023095-4dannjjm	2137	7	cats	cat	NNS
cord-023095-4dannjjm	2137	8	ranged	range	VBD
cord-023095-4dannjjm	2137	9	from	from	IN
cord-023095-4dannjjm	2137	10	55	55	CD
cord-023095-4dannjjm	2137	11	-	-	SYM
cord-023095-4dannjjm	2137	12	73	73	CD
cord-023095-4dannjjm	2137	13	nmol	nmol	JJ
cord-023095-4dannjjm	2137	14	/	/	SYM
cord-023095-4dannjjm	2137	15	l	l	NN
cord-023095-4dannjjm	2137	16	.	.	.
cord-023095-4dannjjm	2138	1	Serum	serum	NN
cord-023095-4dannjjm	2138	2	TT4	TT4	NNP
cord-023095-4dannjjm	2138	3	and	and	CC
cord-023095-4dannjjm	2138	4	other	other	JJ
cord-023095-4dannjjm	2138	5	biochemical	biochemical	JJ
cord-023095-4dannjjm	2138	6	parameters	parameter	NNS
cord-023095-4dannjjm	2138	7	were	be	VBD
cord-023095-4dannjjm	2138	8	monitored	monitor	VBN
cord-023095-4dannjjm	2138	9	every	every	DT
cord-023095-4dannjjm	2138	10	3	3	CD
cord-023095-4dannjjm	2138	11	weeks	week	NNS
cord-023095-4dannjjm	2138	12	for	for	IN
cord-023095-4dannjjm	2138	13	9	9	CD
cord-023095-4dannjjm	2138	14	weeks	week	NNS
cord-023095-4dannjjm	2138	15	,	,	,
cord-023095-4dannjjm	2138	16	and	and	CC
cord-023095-4dannjjm	2138	17	then	then	RB
cord-023095-4dannjjm	2138	18	every	every	DT
cord-023095-4dannjjm	2138	19	4	4	CD
cord-023095-4dannjjm	2138	20	weeks	week	NNS
cord-023095-4dannjjm	2138	21	for	for	IN
cord-023095-4dannjjm	2138	22	an	an	DT
cord-023095-4dannjjm	2138	23	additional	additional	JJ
cord-023095-4dannjjm	2138	24	8	8	CD
cord-023095-4dannjjm	2138	25	weeks	week	NNS
cord-023095-4dannjjm	2138	26	.	.	.
cord-023095-4dannjjm	2139	1	With	with	IN
cord-023095-4dannjjm	2139	2	the	the	DT
cord-023095-4dannjjm	2139	3	0.28	0.28	CD
cord-023095-4dannjjm	2139	4	ppm	ppm	NN
cord-023095-4dannjjm	2139	5	iodine	iodine	NN
cord-023095-4dannjjm	2139	6	food	food	NN
cord-023095-4dannjjm	2139	7	the	the	DT
cord-023095-4dannjjm	2139	8	four	four	CD
cord-023095-4dannjjm	2139	9	new	new	JJ
cord-023095-4dannjjm	2139	10	cats	cat	NNS
cord-023095-4dannjjm	2139	11	became	become	VBD
cord-023095-4dannjjm	2139	12	euthyroid	euthyroid	JJ
cord-023095-4dannjjm	2139	13	with	with	IN
cord-023095-4dannjjm	2139	14	a	a	DT
cord-023095-4dannjjm	2139	15	mean	mean	JJ
cord-023095-4dannjjm	2139	16	TT4	TT4	NNP
cord-023095-4dannjjm	2139	17	concentration	concentration	NN
cord-023095-4dannjjm	2139	18	of	of	IN
cord-023095-4dannjjm	2139	19	41	41	CD
cord-023095-4dannjjm	2139	20	nmol/	nmol/	CD
cord-023095-4dannjjm	2139	21	(	(	-LRB-
cord-023095-4dannjjm	2139	22	range	range	NN
cord-023095-4dannjjm	2139	23	29	29	CD
cord-023095-4dannjjm	2139	24	-	-	HYPH
cord-023095-4dannjjm	2139	25	50nmol	50nmol	CD
cord-023095-4dannjjm	2139	26	/	/	SYM
cord-023095-4dannjjm	2139	27	l	l	NN
cord-023095-4dannjjm	2139	28	)	)	-RRB-
cord-023095-4dannjjm	2139	29	.	.	.
cord-023095-4dannjjm	2140	1	The	the	DT
cord-023095-4dannjjm	2140	2	4	4	CD
cord-023095-4dannjjm	2140	3	euthyroid	euthyroid	JJ
cord-023095-4dannjjm	2140	4	cats	cat	NNS
cord-023095-4dannjjm	2140	5	from	from	IN
cord-023095-4dannjjm	2140	6	the	the	DT
cord-023095-4dannjjm	2140	7	earlier	early	JJR
cord-023095-4dannjjm	2140	8	feeding	feeding	NN
cord-023095-4dannjjm	2140	9	study	study	NN
cord-023095-4dannjjm	2140	10	had	have	VBD
cord-023095-4dannjjm	2140	11	a	a	DT
cord-023095-4dannjjm	2140	12	further	further	JJ
cord-023095-4dannjjm	2140	13	decrease	decrease	NN
cord-023095-4dannjjm	2140	14	in	in	IN
cord-023095-4dannjjm	2140	15	TT4	TT4	NNP
cord-023095-4dannjjm	2140	16	concentration	concentration	NN
cord-023095-4dannjjm	2140	17	(	(	-LRB-
cord-023095-4dannjjm	2140	18	mean	mean	VB
cord-023095-4dannjjm	2141	1	TT4	TT4	NNP
cord-023095-4dannjjm	2141	2	5	5	CD
cord-023095-4dannjjm	2141	3	39	39	CD
cord-023095-4dannjjm	2141	4	nmol	nmol	NNP
cord-023095-4dannjjm	2141	5	/	/	SYM
cord-023095-4dannjjm	2141	6	l	l	NN
cord-023095-4dannjjm	2141	7	,	,	,
cord-023095-4dannjjm	2141	8	range	range	NNP
cord-023095-4dannjjm	2141	9	38	38	CD
cord-023095-4dannjjm	2141	10	-	-	HYPH
cord-023095-4dannjjm	2141	11	54nmol	54nmol	CD
cord-023095-4dannjjm	2141	12	/	/	SYM
cord-023095-4dannjjm	2141	13	l	l	NN
cord-023095-4dannjjm	2141	14	)	)	-RRB-
cord-023095-4dannjjm	2141	15	.	.	.
cord-023095-4dannjjm	2142	1	The	the	DT
cord-023095-4dannjjm	2142	2	single	single	JJ
cord-023095-4dannjjm	2142	3	non	non	JJ
cord-023095-4dannjjm	2142	4	-	-	JJ
cord-023095-4dannjjm	2142	5	euthyroid	euthyroid	JJ
cord-023095-4dannjjm	2142	6	cat	cat	NN
cord-023095-4dannjjm	2142	7	from	from	IN
cord-023095-4dannjjm	2142	8	the	the	DT
cord-023095-4dannjjm	2142	9	first	first	JJ
cord-023095-4dannjjm	2142	10	study	study	NN
cord-023095-4dannjjm	2142	11	had	have	VBD
cord-023095-4dannjjm	2142	12	a	a	DT
cord-023095-4dannjjm	2142	13	serum	serum	NN
cord-023095-4dannjjm	2142	14	TT4	TT4	NNP
cord-023095-4dannjjm	2142	15	concentration	concentration	NN
cord-023095-4dannjjm	2142	16	of	of	IN
cord-023095-4dannjjm	2142	17	61	61	CD
cord-023095-4dannjjm	2142	18	nmol	nmol	JJ
cord-023095-4dannjjm	2142	19	/	/	SYM
cord-023095-4dannjjm	2142	20	l	l	NN
cord-023095-4dannjjm	2142	21	,	,	,
cord-023095-4dannjjm	2142	22	a	a	DT
cord-023095-4dannjjm	2142	23	decrease	decrease	NN
cord-023095-4dannjjm	2142	24	from	from	IN
cord-023095-4dannjjm	2142	25	the	the	DT
cord-023095-4dannjjm	2142	26	baseline	baseline	JJ
cord-023095-4dannjjm	2142	27	concentration	concentration	NN
cord-023095-4dannjjm	2142	28	of	of	IN
cord-023095-4dannjjm	2142	29	83	83	CD
cord-023095-4dannjjm	2142	30	nmol	nmol	JJ
cord-023095-4dannjjm	2142	31	/	/	SYM
cord-023095-4dannjjm	2142	32	l	l	NN
cord-023095-4dannjjm	2142	33	.	.	.
cord-023095-4dannjjm	2143	1	The	the	DT
cord-023095-4dannjjm	2143	2	average	average	JJ
cord-023095-4dannjjm	2143	3	decrease	decrease	NN
cord-023095-4dannjjm	2143	4	in	in	IN
cord-023095-4dannjjm	2143	5	serum	serum	NN
cord-023095-4dannjjm	2143	6	TT4	TT4	NNP
cord-023095-4dannjjm	2143	7	for	for	IN
cord-023095-4dannjjm	2143	8	all	all	DT
cord-023095-4dannjjm	2143	9	9	9	CD
cord-023095-4dannjjm	2143	10	cats	cat	NNS
cord-023095-4dannjjm	2143	11	was	be	VBD
cord-023095-4dannjjm	2143	12	20	20	CD
cord-023095-4dannjjm	2143	13	nmol	nmol	JJ
cord-023095-4dannjjm	2143	14	/	/	SYM
cord-023095-4dannjjm	2143	15	l	l	NN
cord-023095-4dannjjm	2143	16	(	(	-LRB-
cord-023095-4dannjjm	2143	17	range	range	NNP
cord-023095-4dannjjm	2143	18	2	2	CD
cord-023095-4dannjjm	2143	19	-	-	SYM
cord-023095-4dannjjm	2143	20	35	35	CD
cord-023095-4dannjjm	2143	21	nmol	nmol	JJ
cord-023095-4dannjjm	2143	22	/	/	SYM
cord-023095-4dannjjm	2143	23	l	l	NN
cord-023095-4dannjjm	2143	24	)	)	-RRB-
cord-023095-4dannjjm	2143	25	.	.	.
cord-023095-4dannjjm	2144	1	Finally	finally	RB
cord-023095-4dannjjm	2144	2	,	,	,
cord-023095-4dannjjm	2144	3	8	8	CD
cord-023095-4dannjjm	2144	4	of	of	IN
cord-023095-4dannjjm	2144	5	the	the	DT
cord-023095-4dannjjm	2144	6	9	9	CD
cord-023095-4dannjjm	2144	7	cats	cat	NNS
cord-023095-4dannjjm	2144	8	were	be	VBD
cord-023095-4dannjjm	2144	9	fed	feed	VBN
cord-023095-4dannjjm	2144	10	a	a	DT
cord-023095-4dannjjm	2144	11	third	third	JJ
cord-023095-4dannjjm	2144	12	iodine	iodine	NN
cord-023095-4dannjjm	2144	13	-	-	HYPH
cord-023095-4dannjjm	2144	14	restricted	restrict	VBN
cord-023095-4dannjjm	2144	15	food	food	NN
cord-023095-4dannjjm	2144	16	(	(	-LRB-
cord-023095-4dannjjm	2144	17	0.17	0.17	CD
cord-023095-4dannjjm	2144	18	ppm	ppm	NN
cord-023095-4dannjjm	2144	19	DMB	DMB	NNP
cord-023095-4dannjjm	2144	20	)	)	-RRB-
cord-023095-4dannjjm	2144	21	along	along	IN
cord-023095-4dannjjm	2144	22	with	with	IN
cord-023095-4dannjjm	2144	23	one	one	CD
cord-023095-4dannjjm	2144	24	other	other	JJ
cord-023095-4dannjjm	2144	25	newly	newly	RB
cord-023095-4dannjjm	2144	26	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2144	27	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2144	28	cat	cat	NN
cord-023095-4dannjjm	2144	29	(	(	-LRB-
cord-023095-4dannjjm	2144	30	79	79	CD
cord-023095-4dannjjm	2144	31	nmol	nmol	JJ
cord-023095-4dannjjm	2144	32	/	/	SYM
cord-023095-4dannjjm	2144	33	l	l	NN
cord-023095-4dannjjm	2144	34	serum	serum	NN
cord-023095-4dannjjm	2144	35	TT4	TT4	NNP
cord-023095-4dannjjm	2144	36	)	)	-RRB-
cord-023095-4dannjjm	2144	37	and	and	CC
cord-023095-4dannjjm	2144	38	evaluated	evaluate	VBD
cord-023095-4dannjjm	2144	39	every	every	DT
cord-023095-4dannjjm	2144	40	4	4	CD
cord-023095-4dannjjm	2144	41	weeks	week	NNS
cord-023095-4dannjjm	2144	42	.	.	.
cord-023095-4dannjjm	2145	1	All	all	DT
cord-023095-4dannjjm	2145	2	9	9	CD
cord-023095-4dannjjm	2145	3	cats	cat	NNS
cord-023095-4dannjjm	2145	4	in	in	IN
cord-023095-4dannjjm	2145	5	this	this	DT
cord-023095-4dannjjm	2145	6	evaluation	evaluation	NN
cord-023095-4dannjjm	2145	7	were	be	VBD
cord-023095-4dannjjm	2145	8	euthyroid	euthyroid	JJ
cord-023095-4dannjjm	2145	9	(	(	-LRB-
cord-023095-4dannjjm	2145	10	mean	mean	VB
cord-023095-4dannjjm	2146	1	TT4	TT4	NNP
cord-023095-4dannjjm	2146	2	33	33	CD
cord-023095-4dannjjm	2146	3	nmol	nmol	JJ
cord-023095-4dannjjm	2146	4	/	/	SYM
cord-023095-4dannjjm	2146	5	l	l	NN
cord-023095-4dannjjm	2146	6	;	;	:
cord-023095-4dannjjm	2147	1	range	range	VBP
cord-023095-4dannjjm	2147	2	23	23	CD
cord-023095-4dannjjm	2147	3	-	-	SYM
cord-023095-4dannjjm	2147	4	50	50	CD
cord-023095-4dannjjm	2147	5	nmol/	nmol/	NNP
cord-023095-4dannjjm	2147	6	l	l	NN
cord-023095-4dannjjm	2147	7	)	)	-RRB-
cord-023095-4dannjjm	2147	8	.	.	.
cord-023095-4dannjjm	2148	1	This	this	DT
cord-023095-4dannjjm	2148	2	result	result	NN
cord-023095-4dannjjm	2148	3	included	include	VBD
cord-023095-4dannjjm	2148	4	the	the	DT
cord-023095-4dannjjm	2148	5	cat	cat	NN
cord-023095-4dannjjm	2148	6	whose	whose	WP$
cord-023095-4dannjjm	2148	7	serum	serum	NN
cord-023095-4dannjjm	2148	8	TT4	TT4	NNP
cord-023095-4dannjjm	2148	9	remained	remain	VBD
cord-023095-4dannjjm	2148	10	in	in	IN
cord-023095-4dannjjm	2148	11	the	the	DT
cord-023095-4dannjjm	2148	12	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2148	13	range	range	NN
cord-023095-4dannjjm	2148	14	in	in	IN
cord-023095-4dannjjm	2148	15	the	the	DT
cord-023095-4dannjjm	2148	16	first	first	JJ
cord-023095-4dannjjm	2148	17	two	two	CD
cord-023095-4dannjjm	2148	18	evaluations	evaluation	NNS
cord-023095-4dannjjm	2148	19	.	.	.
cord-023095-4dannjjm	2149	1	The	the	DT
cord-023095-4dannjjm	2149	2	average	average	JJ
cord-023095-4dannjjm	2149	3	decrease	decrease	NN
cord-023095-4dannjjm	2149	4	in	in	IN
cord-023095-4dannjjm	2149	5	TT4	TT4	NNP
cord-023095-4dannjjm	2149	6	was	be	VBD
cord-023095-4dannjjm	2149	7	13	13	CD
cord-023095-4dannjjm	2149	8	nmol	nmol	JJ
cord-023095-4dannjjm	2149	9	/	/	SYM
cord-023095-4dannjjm	2149	10	l	l	NN
cord-023095-4dannjjm	2149	11	(	(	-LRB-
cord-023095-4dannjjm	2149	12	range	range	NNP
cord-023095-4dannjjm	2149	13	0	0	CD
cord-023095-4dannjjm	2149	14	-	-	SYM
cord-023095-4dannjjm	2149	15	43	43	CD
cord-023095-4dannjjm	2149	16	nmol	nmol	JJ
cord-023095-4dannjjm	2149	17	/	/	SYM
cord-023095-4dannjjm	2149	18	l	l	NN
cord-023095-4dannjjm	2149	19	)	)	-RRB-
cord-023095-4dannjjm	2149	20	.	.	.
cord-023095-4dannjjm	2150	1	Biochemical	biochemical	JJ
cord-023095-4dannjjm	2150	2	features	feature	NNS
cord-023095-4dannjjm	2150	3	of	of	IN
cord-023095-4dannjjm	2150	4	renal	renal	JJ
cord-023095-4dannjjm	2150	5	function	function	NN
cord-023095-4dannjjm	2150	6	remained	remain	VBD
cord-023095-4dannjjm	2150	7	stable	stable	JJ
cord-023095-4dannjjm	2150	8	and	and	CC
cord-023095-4dannjjm	2150	9	no	no	DT
cord-023095-4dannjjm	2150	10	other	other	JJ
cord-023095-4dannjjm	2150	11	biochemical	biochemical	JJ
cord-023095-4dannjjm	2150	12	abnormalities	abnormality	NNS
cord-023095-4dannjjm	2150	13	were	be	VBD
cord-023095-4dannjjm	2150	14	observed	observe	VBN
cord-023095-4dannjjm	2150	15	.	.	.
cord-023095-4dannjjm	2151	1	In	in	IN
cord-023095-4dannjjm	2151	2	summary	summary	NN
cord-023095-4dannjjm	2151	3	,	,	,
cord-023095-4dannjjm	2151	4	the	the	DT
cord-023095-4dannjjm	2151	5	results	result	NNS
cord-023095-4dannjjm	2151	6	of	of	IN
cord-023095-4dannjjm	2151	7	these	these	DT
cord-023095-4dannjjm	2151	8	three	three	CD
cord-023095-4dannjjm	2151	9	feeding	feeding	NN
cord-023095-4dannjjm	2151	10	studies	study	NNS
cord-023095-4dannjjm	2151	11	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	2151	12	that	that	IN
cord-023095-4dannjjm	2151	13	feline	feline	JJ
cord-023095-4dannjjm	2151	14	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2151	15	can	can	MD
cord-023095-4dannjjm	2151	16	be	be	VB
cord-023095-4dannjjm	2151	17	managed	manage	VBN
cord-023095-4dannjjm	2151	18	effectively	effectively	RB
cord-023095-4dannjjm	2151	19	with	with	IN
cord-023095-4dannjjm	2151	20	dietary	dietary	JJ
cord-023095-4dannjjm	2151	21	iodine	iodine	NN
cord-023095-4dannjjm	2151	22	restriction	restriction	NN
cord-023095-4dannjjm	2151	23	.	.	.
cord-023095-4dannjjm	2152	1	We	-PRON-	PRP
cord-023095-4dannjjm	2152	2	have	have	VBP
cord-023095-4dannjjm	2152	3	shown	show	VBN
cord-023095-4dannjjm	2152	4	previously	previously	RB
cord-023095-4dannjjm	2152	5	that	that	DT
cord-023095-4dannjjm	2152	6	restriction	restriction	NN
cord-023095-4dannjjm	2152	7	of	of	IN
cord-023095-4dannjjm	2152	8	dietary	dietary	JJ
cord-023095-4dannjjm	2152	9	iodine	iodine	NN
cord-023095-4dannjjm	2152	10	(	(	-LRB-
cord-023095-4dannjjm	2152	11	I	i	NN
cord-023095-4dannjjm	2152	12	)	)	-RRB-
cord-023095-4dannjjm	2152	13	is	be	VBZ
cord-023095-4dannjjm	2152	14	a	a	DT
cord-023095-4dannjjm	2152	15	safe	safe	JJ
cord-023095-4dannjjm	2152	16	and	and	CC
cord-023095-4dannjjm	2152	17	effective	effective	JJ
cord-023095-4dannjjm	2152	18	method	method	NN
cord-023095-4dannjjm	2152	19	for	for	IN
cord-023095-4dannjjm	2152	20	decreasing	decrease	VBG
cord-023095-4dannjjm	2152	21	serum	serum	NN
cord-023095-4dannjjm	2152	22	thyroxine	thyroxine	JJ
cord-023095-4dannjjm	2152	23	concentrations	concentration	NNS
cord-023095-4dannjjm	2152	24	(	(	-LRB-
cord-023095-4dannjjm	2152	25	TT4	TT4	NNP
cord-023095-4dannjjm	2152	26	)	)	-RRB-
cord-023095-4dannjjm	2152	27	in	in	IN
cord-023095-4dannjjm	2152	28	cats	cat	NNS
cord-023095-4dannjjm	2152	29	with	with	IN
cord-023095-4dannjjm	2152	30	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2152	31	.	.	.
cord-023095-4dannjjm	2153	1	The	the	DT
cord-023095-4dannjjm	2153	2	objective	objective	NN
cord-023095-4dannjjm	2153	3	of	of	IN
cord-023095-4dannjjm	2153	4	this	this	DT
cord-023095-4dannjjm	2153	5	study	study	NN
cord-023095-4dannjjm	2153	6	was	be	VBD
cord-023095-4dannjjm	2153	7	to	to	TO
cord-023095-4dannjjm	2153	8	determine	determine	VB
cord-023095-4dannjjm	2153	9	the	the	DT
cord-023095-4dannjjm	2153	10	maximum	maximum	JJ
cord-023095-4dannjjm	2153	11	level	level	NN
cord-023095-4dannjjm	2153	12	of	of	IN
cord-023095-4dannjjm	2153	13	iodine	iodine	NN
cord-023095-4dannjjm	2153	14	in	in	IN
cord-023095-4dannjjm	2153	15	a	a	DT
cord-023095-4dannjjm	2153	16	nutritionally	nutritionally	RB
cord-023095-4dannjjm	2153	17	balanced	balanced	JJ
cord-023095-4dannjjm	2153	18	feline	feline	JJ
cord-023095-4dannjjm	2153	19	mature	mature	JJ
cord-023095-4dannjjm	2153	20	adult	adult	NN
cord-023095-4dannjjm	2153	21	food	food	NN
cord-023095-4dannjjm	2153	22	required	require	VBN
cord-023095-4dannjjm	2153	23	to	to	TO
cord-023095-4dannjjm	2153	24	maintain	maintain	VB
cord-023095-4dannjjm	2153	25	normal	normal	JJ
cord-023095-4dannjjm	2153	26	serum	serum	NN
cord-023095-4dannjjm	2153	27	TT4	TT4	NNP
cord-023095-4dannjjm	2153	28	concentrations	concentration	NNS
cord-023095-4dannjjm	2153	29	in	in	IN
cord-023095-4dannjjm	2153	30	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2153	31	cats	cat	NNS
cord-023095-4dannjjm	2153	32	currently	currently	RB
cord-023095-4dannjjm	2153	33	being	be	VBG
cord-023095-4dannjjm	2153	34	controlled	control	VBN
cord-023095-4dannjjm	2153	35	on	on	IN
cord-023095-4dannjjm	2153	36	a	a	DT
cord-023095-4dannjjm	2153	37	food	food	NN
cord-023095-4dannjjm	2153	38	containing	contain	VBG
cord-023095-4dannjjm	2153	39	0.15	0.15	CD
cord-023095-4dannjjm	2153	40	ppm	ppm	NN
cord-023095-4dannjjm	2154	1	I	-PRON-	PRP
cord-023095-4dannjjm	2154	2	(	(	-LRB-
cord-023095-4dannjjm	2154	3	DMB	DMB	NNP
cord-023095-4dannjjm	2154	4	)	)	-RRB-
cord-023095-4dannjjm	2154	5	as	as	IN
cord-023095-4dannjjm	2154	6	measured	measure	VBN
cord-023095-4dannjjm	2154	7	by	by	IN
cord-023095-4dannjjm	2154	8	epiboron	epiboron	NNP
cord-023095-4dannjjm	2154	9	neutron	neutron	NNP
cord-023095-4dannjjm	2154	10	atomic	atomic	NNP
cord-023095-4dannjjm	2154	11	activation	activation	NN
cord-023095-4dannjjm	2154	12	.	.	.
cord-023095-4dannjjm	2155	1	All	all	DT
cord-023095-4dannjjm	2155	2	cats	cat	NNS
cord-023095-4dannjjm	2155	3	were	be	VBD
cord-023095-4dannjjm	2155	4	previously	previously	RB
cord-023095-4dannjjm	2155	5	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2155	6	at	at	IN
cord-023095-4dannjjm	2155	7	least	least	RBS
cord-023095-4dannjjm	2155	8	14	14	CD
cord-023095-4dannjjm	2155	9	months	month	NNS
cord-023095-4dannjjm	2155	10	prior	prior	RB
cord-023095-4dannjjm	2155	11	to	to	IN
cord-023095-4dannjjm	2155	12	the	the	DT
cord-023095-4dannjjm	2155	13	start	start	NN
cord-023095-4dannjjm	2155	14	of	of	IN
cord-023095-4dannjjm	2155	15	the	the	DT
cord-023095-4dannjjm	2155	16	study	study	NN
cord-023095-4dannjjm	2155	17	and	and	CC
cord-023095-4dannjjm	2155	18	their	-PRON-	PRP$
cord-023095-4dannjjm	2155	19	TT4	TT4	NNP
cord-023095-4dannjjm	2155	20	concentrations	concentration	NNS
cord-023095-4dannjjm	2155	21	were	be	VBD
cord-023095-4dannjjm	2155	22	maintained	maintain	VBN
cord-023095-4dannjjm	2155	23	in	in	IN
cord-023095-4dannjjm	2155	24	the	the	DT
cord-023095-4dannjjm	2155	25	normal	normal	JJ
cord-023095-4dannjjm	2155	26	range	range	NN
cord-023095-4dannjjm	2155	27	by	by	IN
cord-023095-4dannjjm	2155	28	dietary	dietary	JJ
cord-023095-4dannjjm	2155	29	iodine	iodine	NN
cord-023095-4dannjjm	2155	30	restriction	restriction	NN
cord-023095-4dannjjm	2155	31	for	for	IN
cord-023095-4dannjjm	2155	32	a	a	DT
cord-023095-4dannjjm	2155	33	minimum	minimum	NN
cord-023095-4dannjjm	2155	34	of	of	IN
cord-023095-4dannjjm	2155	35	10	10	CD
cord-023095-4dannjjm	2155	36	months	month	NNS
cord-023095-4dannjjm	2155	37	(	(	-LRB-
cord-023095-4dannjjm	2155	38	range	range	VBP
cord-023095-4dannjjm	2155	39	10	10	CD
cord-023095-4dannjjm	2155	40	months-3	months-3	JJ
cord-023095-4dannjjm	2155	41	years	year	NNS
cord-023095-4dannjjm	2155	42	)	)	-RRB-
cord-023095-4dannjjm	2155	43	.	.	.
cord-023095-4dannjjm	2156	1	Serum	serum	NN
cord-023095-4dannjjm	2156	2	TT4	TT4	NNP
cord-023095-4dannjjm	2156	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2156	4	ranged	range	VBD
cord-023095-4dannjjm	2156	5	from	from	IN
cord-023095-4dannjjm	2156	6	9	9	CD
cord-023095-4dannjjm	2156	7	-	-	SYM
cord-023095-4dannjjm	2156	8	42	42	CD
cord-023095-4dannjjm	2156	9	nmol	nmol	JJ
cord-023095-4dannjjm	2156	10	/	/	SYM
cord-023095-4dannjjm	2156	11	l	l	NN
cord-023095-4dannjjm	2156	12	(	(	-LRB-
cord-023095-4dannjjm	2156	13	reference	reference	NN
cord-023095-4dannjjm	2156	14	range	range	NN
cord-023095-4dannjjm	2156	15	10	10	CD
cord-023095-4dannjjm	2156	16	-	-	SYM
cord-023095-4dannjjm	2156	17	55	55	CD
cord-023095-4dannjjm	2156	18	nmol	nmol	JJ
cord-023095-4dannjjm	2156	19	/	/	SYM
cord-023095-4dannjjm	2156	20	l	l	NN
cord-023095-4dannjjm	2156	21	)	)	-RRB-
cord-023095-4dannjjm	2156	22	at	at	IN
cord-023095-4dannjjm	2156	23	the	the	DT
cord-023095-4dannjjm	2156	24	beginning	beginning	NN
cord-023095-4dannjjm	2156	25	of	of	IN
cord-023095-4dannjjm	2156	26	the	the	DT
cord-023095-4dannjjm	2156	27	study	study	NN
cord-023095-4dannjjm	2156	28	.	.	.
cord-023095-4dannjjm	2157	1	The	the	DT
cord-023095-4dannjjm	2157	2	cats	cat	NNS
cord-023095-4dannjjm	2157	3	were	be	VBD
cord-023095-4dannjjm	2157	4	divided	divide	VBN
cord-023095-4dannjjm	2157	5	into	into	IN
cord-023095-4dannjjm	2157	6	two	two	CD
cord-023095-4dannjjm	2157	7	groups	group	NNS
cord-023095-4dannjjm	2157	8	each	each	DT
cord-023095-4dannjjm	2157	9	containing	contain	VBG
cord-023095-4dannjjm	2157	10	9	9	CD
cord-023095-4dannjjm	2157	11	cats	cat	NNS
cord-023095-4dannjjm	2157	12	.	.	.
cord-023095-4dannjjm	2158	1	Groups	group	NNS
cord-023095-4dannjjm	2158	2	were	be	VBD
cord-023095-4dannjjm	2158	3	similar	similar	JJ
cord-023095-4dannjjm	2158	4	in	in	IN
cord-023095-4dannjjm	2158	5	age	age	NN
cord-023095-4dannjjm	2158	6	and	and	CC
cord-023095-4dannjjm	2158	7	gender	gender	NN
cord-023095-4dannjjm	2158	8	distribution	distribution	NN
cord-023095-4dannjjm	2159	1	(	(	-LRB-
cord-023095-4dannjjm	2159	2	mean	mean	UH
cord-023095-4dannjjm	2159	3	age	age	NN
cord-023095-4dannjjm	2159	4	5	5	CD
cord-023095-4dannjjm	2159	5	13.8	13.8	CD
cord-023095-4dannjjm	2159	6	years	year	NNS
cord-023095-4dannjjm	2159	7	,	,	,
cord-023095-4dannjjm	2159	8	range	range	VBP
cord-023095-4dannjjm	2159	9	12	12	CD
cord-023095-4dannjjm	2159	10	-	-	SYM
cord-023095-4dannjjm	2159	11	18	18	CD
cord-023095-4dannjjm	2159	12	years	year	NNS
cord-023095-4dannjjm	2159	13	)	)	-RRB-
cord-023095-4dannjjm	2159	14	.	.	.
cord-023095-4dannjjm	2160	1	One	one	CD
cord-023095-4dannjjm	2160	2	group	group	NN
cord-023095-4dannjjm	2160	3	(	(	-LRB-
cord-023095-4dannjjm	2160	4	Group	Group	NNP
cord-023095-4dannjjm	2160	5	A	A	NNP
cord-023095-4dannjjm	2160	6	)	)	-RRB-
cord-023095-4dannjjm	2160	7	was	be	VBD
cord-023095-4dannjjm	2160	8	placed	place	VBN
cord-023095-4dannjjm	2160	9	on	on	IN
cord-023095-4dannjjm	2160	10	a	a	DT
cord-023095-4dannjjm	2160	11	food	food	NN
cord-023095-4dannjjm	2160	12	that	that	WDT
cord-023095-4dannjjm	2160	13	was	be	VBD
cord-023095-4dannjjm	2160	14	formulated	formulate	VBN
cord-023095-4dannjjm	2160	15	for	for	IN
cord-023095-4dannjjm	2160	16	mature	mature	JJ
cord-023095-4dannjjm	2160	17	adult	adult	NN
cord-023095-4dannjjm	2160	18	cats	cat	NNS
cord-023095-4dannjjm	2160	19	containing	contain	VBG
cord-023095-4dannjjm	2160	20	0.39	0.39	CD
cord-023095-4dannjjm	2160	21	ppm	ppm	NN
cord-023095-4dannjjm	2160	22	I	i	NN
cord-023095-4dannjjm	2160	23	(	(	-LRB-
cord-023095-4dannjjm	2160	24	DMB	DMB	NNP
cord-023095-4dannjjm	2160	25	)	)	-RRB-
cord-023095-4dannjjm	2160	26	.	.	.
cord-023095-4dannjjm	2161	1	The	the	DT
cord-023095-4dannjjm	2161	2	other	other	JJ
cord-023095-4dannjjm	2161	3	group	group	NN
cord-023095-4dannjjm	2161	4	(	(	-LRB-
cord-023095-4dannjjm	2161	5	Group	Group	NNP
cord-023095-4dannjjm	2161	6	B	B	NNP
cord-023095-4dannjjm	2161	7	)	)	-RRB-
cord-023095-4dannjjm	2161	8	was	be	VBD
cord-023095-4dannjjm	2161	9	placed	place	VBN
cord-023095-4dannjjm	2161	10	on	on	IN
cord-023095-4dannjjm	2161	11	a	a	DT
cord-023095-4dannjjm	2161	12	similar	similar	JJ
cord-023095-4dannjjm	2161	13	food	food	NN
cord-023095-4dannjjm	2161	14	that	that	WDT
cord-023095-4dannjjm	2161	15	differed	differ	VBD
cord-023095-4dannjjm	2161	16	only	only	RB
cord-023095-4dannjjm	2161	17	in	in	IN
cord-023095-4dannjjm	2161	18	that	that	IN
cord-023095-4dannjjm	2161	19	it	-PRON-	PRP
cord-023095-4dannjjm	2161	20	contained	contain	VBD
cord-023095-4dannjjm	2162	1	0.47	0.47	CD
cord-023095-4dannjjm	2162	2	ppm	ppm	NN
cord-023095-4dannjjm	2163	1	I	-PRON-	PRP
cord-023095-4dannjjm	2163	2	(	(	-LRB-
cord-023095-4dannjjm	2163	3	DMB	DMB	NNP
cord-023095-4dannjjm	2163	4	)	)	-RRB-
cord-023095-4dannjjm	2163	5	.	.	.
cord-023095-4dannjjm	2164	1	Blood	blood	NN
cord-023095-4dannjjm	2164	2	was	be	VBD
cord-023095-4dannjjm	2164	3	collected	collect	VBN
cord-023095-4dannjjm	2164	4	from	from	IN
cord-023095-4dannjjm	2164	5	all	all	DT
cord-023095-4dannjjm	2164	6	cats	cat	NNS
cord-023095-4dannjjm	2164	7	every	every	DT
cord-023095-4dannjjm	2164	8	three	three	CD
cord-023095-4dannjjm	2164	9	weeks	week	NNS
cord-023095-4dannjjm	2164	10	and	and	CC
cord-023095-4dannjjm	2164	11	analyzed	analyze	VBD
cord-023095-4dannjjm	2164	12	for	for	IN
cord-023095-4dannjjm	2164	13	serum	serum	NN
cord-023095-4dannjjm	2164	14	TT4	TT4	NNP
cord-023095-4dannjjm	2164	15	concentration	concentration	NN
cord-023095-4dannjjm	2164	16	.	.	.
cord-023095-4dannjjm	2165	1	Biochemistry	biochemistry	NN
cord-023095-4dannjjm	2165	2	parameters	parameter	NNS
cord-023095-4dannjjm	2165	3	were	be	VBD
cord-023095-4dannjjm	2165	4	also	also	RB
cord-023095-4dannjjm	2165	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	2165	6	at	at	IN
cord-023095-4dannjjm	2165	7	weeks	week	NNS
cord-023095-4dannjjm	2165	8	0	0	CD
cord-023095-4dannjjm	2165	9	,	,	,
cord-023095-4dannjjm	2165	10	6	6	CD
cord-023095-4dannjjm	2165	11	and	and	CC
cord-023095-4dannjjm	2165	12	9	9	CD
cord-023095-4dannjjm	2165	13	.	.	.
cord-023095-4dannjjm	2166	1	All	all	DT
cord-023095-4dannjjm	2166	2	Group	Group	NNP
cord-023095-4dannjjm	2166	3	A	a	DT
cord-023095-4dannjjm	2166	4	cats	cat	NNS
cord-023095-4dannjjm	2166	5	exhibited	exhibit	VBD
cord-023095-4dannjjm	2166	6	increases	increase	NNS
cord-023095-4dannjjm	2166	7	in	in	IN
cord-023095-4dannjjm	2166	8	serum	serum	NN
cord-023095-4dannjjm	2166	9	TT4	TT4	NNP
cord-023095-4dannjjm	2166	10	concentration	concentration	NN
cord-023095-4dannjjm	2166	11	(	(	-LRB-
cord-023095-4dannjjm	2166	12	mean	mean	JJ
cord-023095-4dannjjm	2166	13	increase	increase	NN
cord-023095-4dannjjm	2166	14	of	of	IN
cord-023095-4dannjjm	2166	15	25	25	CD
cord-023095-4dannjjm	2166	16	nmol	nmol	JJ
cord-023095-4dannjjm	2166	17	/	/	SYM
cord-023095-4dannjjm	2166	18	l	l	NN
cord-023095-4dannjjm	2166	19	above	above	IN
cord-023095-4dannjjm	2166	20	baseline	baseline	NN
cord-023095-4dannjjm	2166	21	,	,	,
cord-023095-4dannjjm	2166	22	range	range	VBP
cord-023095-4dannjjm	2166	23	5	5	CD
cord-023095-4dannjjm	2166	24	-	-	SYM
cord-023095-4dannjjm	2166	25	48	48	CD
cord-023095-4dannjjm	2166	26	nmol	nmol	JJ
cord-023095-4dannjjm	2166	27	/	/	SYM
cord-023095-4dannjjm	2166	28	l	l	NN
cord-023095-4dannjjm	2166	29	)	)	-RRB-
cord-023095-4dannjjm	2166	30	.	.	.
cord-023095-4dannjjm	2167	1	Seven	seven	CD
cord-023095-4dannjjm	2167	2	of	of	IN
cord-023095-4dannjjm	2167	3	the	the	DT
cord-023095-4dannjjm	2167	4	cats	cat	NNS
cord-023095-4dannjjm	2167	5	remained	remain	VBD
cord-023095-4dannjjm	2167	6	in	in	IN
cord-023095-4dannjjm	2167	7	the	the	DT
cord-023095-4dannjjm	2167	8	euthyroid	euthyroid	JJ
cord-023095-4dannjjm	2167	9	range	range	NN
cord-023095-4dannjjm	2167	10	(	(	-LRB-
cord-023095-4dannjjm	2167	11	mean	mean	VB
cord-023095-4dannjjm	2167	12	serum	serum	NN
cord-023095-4dannjjm	2167	13	TT4	TT4	NNP
cord-023095-4dannjjm	2167	14	5	5	CD
cord-023095-4dannjjm	2167	15	36	36	CD
cord-023095-4dannjjm	2167	16	nmol	nmol	JJ
cord-023095-4dannjjm	2167	17	/	/	SYM
cord-023095-4dannjjm	2167	18	l	l	NN
cord-023095-4dannjjm	2167	19	,	,	,
cord-023095-4dannjjm	2167	20	range-27	range-27	NNP
cord-023095-4dannjjm	2167	21	-	-	SYM
cord-023095-4dannjjm	2167	22	54	54	CD
cord-023095-4dannjjm	2167	23	nmol	nmol	JJ
cord-023095-4dannjjm	2167	24	/	/	SYM
cord-023095-4dannjjm	2167	25	l	l	NN
cord-023095-4dannjjm	2167	26	)	)	-RRB-
cord-023095-4dannjjm	2167	27	.	.	.
cord-023095-4dannjjm	2168	1	Two	two	CD
cord-023095-4dannjjm	2168	2	cats	cat	NNS
cord-023095-4dannjjm	2168	3	exceeded	exceed	VBD
cord-023095-4dannjjm	2168	4	the	the	DT
cord-023095-4dannjjm	2168	5	upper	upper	JJ
cord-023095-4dannjjm	2168	6	limit	limit	NN
cord-023095-4dannjjm	2168	7	of	of	IN
cord-023095-4dannjjm	2168	8	the	the	DT
cord-023095-4dannjjm	2168	9	reference	reference	NN
cord-023095-4dannjjm	2168	10	range	range	NN
cord-023095-4dannjjm	2168	11	(	(	-LRB-
cord-023095-4dannjjm	2168	12	59	59	CD
cord-023095-4dannjjm	2168	13	and	and	CC
cord-023095-4dannjjm	2168	14	76	76	CD
cord-023095-4dannjjm	2168	15	nmol	nmol	NN
cord-023095-4dannjjm	2168	16	/	/	SYM
cord-023095-4dannjjm	2168	17	l	l	NN
cord-023095-4dannjjm	2168	18	respectively	respectively	RB
cord-023095-4dannjjm	2168	19	)	)	-RRB-
cord-023095-4dannjjm	2168	20	.	.	.
cord-023095-4dannjjm	2169	1	The	the	DT
cord-023095-4dannjjm	2169	2	cats	cat	NNS
cord-023095-4dannjjm	2169	3	in	in	IN
cord-023095-4dannjjm	2169	4	Group	Group	NNP
cord-023095-4dannjjm	2169	5	B	B	NNP
cord-023095-4dannjjm	2169	6	also	also	RB
cord-023095-4dannjjm	2169	7	exhibited	exhibit	VBD
cord-023095-4dannjjm	2169	8	increases	increase	NNS
cord-023095-4dannjjm	2169	9	in	in	IN
cord-023095-4dannjjm	2169	10	serum	serum	NN
cord-023095-4dannjjm	2169	11	TT4	TT4	NNP
cord-023095-4dannjjm	2169	12	concentration	concentration	NN
cord-023095-4dannjjm	2169	13	but	but	CC
cord-023095-4dannjjm	2169	14	to	to	IN
cord-023095-4dannjjm	2169	15	a	a	DT
cord-023095-4dannjjm	2169	16	greater	great	JJR
cord-023095-4dannjjm	2169	17	degree	degree	NN
cord-023095-4dannjjm	2169	18	than	than	IN
cord-023095-4dannjjm	2169	19	the	the	DT
cord-023095-4dannjjm	2169	20	cats	cat	NNS
cord-023095-4dannjjm	2169	21	in	in	IN
cord-023095-4dannjjm	2169	22	Group	Group	NNP
cord-023095-4dannjjm	2169	23	A	A	NNP
cord-023095-4dannjjm	2169	24	(	(	-LRB-
cord-023095-4dannjjm	2169	25	mean	mean	UH
cord-023095-4dannjjm	2169	26	increase	increase	NN
cord-023095-4dannjjm	2169	27	39	39	CD
cord-023095-4dannjjm	2169	28	nmol	nmol	JJ
cord-023095-4dannjjm	2169	29	/	/	SYM
cord-023095-4dannjjm	2169	30	l	l	NN
cord-023095-4dannjjm	2169	31	,	,	,
cord-023095-4dannjjm	2169	32	range	range	NNP
cord-023095-4dannjjm	2169	33	20	20	CD
cord-023095-4dannjjm	2169	34	-	-	SYM
cord-023095-4dannjjm	2169	35	60nmol	60nmol	NN
cord-023095-4dannjjm	2169	36	/	/	SYM
cord-023095-4dannjjm	2169	37	l	l	NN
cord-023095-4dannjjm	2169	38	)	)	-RRB-
cord-023095-4dannjjm	2169	39	.	.	.
cord-023095-4dannjjm	2170	1	Four	four	CD
cord-023095-4dannjjm	2170	2	cats	cat	NNS
cord-023095-4dannjjm	2170	3	remained	remain	VBD
cord-023095-4dannjjm	2170	4	in	in	IN
cord-023095-4dannjjm	2170	5	the	the	DT
cord-023095-4dannjjm	2170	6	euthyroid	euthyroid	JJ
cord-023095-4dannjjm	2170	7	range	range	NN
cord-023095-4dannjjm	2170	8	(	(	-LRB-
cord-023095-4dannjjm	2170	9	mean	mean	VB
cord-023095-4dannjjm	2171	1	serum	serum	NNP
cord-023095-4dannjjm	2171	2	TT4	TT4	NNP
cord-023095-4dannjjm	2171	3	5	5	CD
cord-023095-4dannjjm	2171	4	41	41	CD
cord-023095-4dannjjm	2171	5	,	,	,
cord-023095-4dannjjm	2171	6	range	range	VBP
cord-023095-4dannjjm	2171	7	29	29	CD
cord-023095-4dannjjm	2171	8	-	-	SYM
cord-023095-4dannjjm	2171	9	49	49	CD
cord-023095-4dannjjm	2171	10	nmol	nmol	JJ
cord-023095-4dannjjm	2171	11	/	/	SYM
cord-023095-4dannjjm	2171	12	l	l	NN
cord-023095-4dannjjm	2171	13	)	)	-RRB-
cord-023095-4dannjjm	2171	14	.	.	.
cord-023095-4dannjjm	2172	1	The	the	DT
cord-023095-4dannjjm	2172	2	five	five	CD
cord-023095-4dannjjm	2172	3	remaining	remain	VBG
cord-023095-4dannjjm	2172	4	cats	cat	NNS
cord-023095-4dannjjm	2172	5	all	all	DT
cord-023095-4dannjjm	2172	6	exceeded	exceed	VBD
cord-023095-4dannjjm	2172	7	the	the	DT
cord-023095-4dannjjm	2172	8	upper	upper	JJ
cord-023095-4dannjjm	2172	9	limit	limit	NN
cord-023095-4dannjjm	2172	10	of	of	IN
cord-023095-4dannjjm	2172	11	the	the	DT
cord-023095-4dannjjm	2172	12	reference	reference	NN
cord-023095-4dannjjm	2172	13	range	range	NN
cord-023095-4dannjjm	2172	14	(	(	-LRB-
cord-023095-4dannjjm	2172	15	mean	mean	VB
cord-023095-4dannjjm	2172	16	serum	serum	NN
cord-023095-4dannjjm	2172	17	TT4	TT4	NNP
cord-023095-4dannjjm	2172	18	5	5	CD
cord-023095-4dannjjm	2172	19	76	76	CD
cord-023095-4dannjjm	2172	20	nmol	nmol	NN
cord-023095-4dannjjm	2172	21	/	/	SYM
cord-023095-4dannjjm	2172	22	l	l	NN
cord-023095-4dannjjm	2172	23	,	,	,
cord-023095-4dannjjm	2172	24	range-59	range-59	NNP
cord-023095-4dannjjm	2172	25	-	-	HYPH
cord-023095-4dannjjm	2172	26	99	99	CD
cord-023095-4dannjjm	2172	27	nmol	nmol	JJ
cord-023095-4dannjjm	2172	28	/	/	SYM
cord-023095-4dannjjm	2172	29	l	l	NN
cord-023095-4dannjjm	2172	30	)	)	-RRB-
cord-023095-4dannjjm	2172	31	.	.	.
cord-023095-4dannjjm	2173	1	All	all	DT
cord-023095-4dannjjm	2173	2	cats	cat	NNS
cord-023095-4dannjjm	2173	3	returned	return	VBD
cord-023095-4dannjjm	2173	4	to	to	IN
cord-023095-4dannjjm	2173	5	a	a	DT
cord-023095-4dannjjm	2173	6	euthyroid	euthyroid	JJ
cord-023095-4dannjjm	2173	7	state	state	NN
cord-023095-4dannjjm	2173	8	within	within	IN
cord-023095-4dannjjm	2173	9	1	1	CD
cord-023095-4dannjjm	2173	10	month	month	NN
cord-023095-4dannjjm	2173	11	of	of	IN
cord-023095-4dannjjm	2173	12	being	be	VBG
cord-023095-4dannjjm	2173	13	returned	return	VBN
cord-023095-4dannjjm	2173	14	to	to	IN
cord-023095-4dannjjm	2173	15	a	a	DT
cord-023095-4dannjjm	2173	16	diet	diet	NN
cord-023095-4dannjjm	2173	17	containing	contain	VBG
cord-023095-4dannjjm	2173	18	0.17	0.17	CD
cord-023095-4dannjjm	2173	19	ppm	ppm	NN
cord-023095-4dannjjm	2173	20	I	i	NN
cord-023095-4dannjjm	2173	21	(	(	-LRB-
cord-023095-4dannjjm	2173	22	DMB	DMB	NNP
cord-023095-4dannjjm	2173	23	)	)	-RRB-
cord-023095-4dannjjm	2173	24	.	.	.
cord-023095-4dannjjm	2174	1	It	-PRON-	PRP
cord-023095-4dannjjm	2174	2	was	be	VBD
cord-023095-4dannjjm	2174	3	determined	determine	VBN
cord-023095-4dannjjm	2174	4	that	that	IN
cord-023095-4dannjjm	2174	5	serum	serum	NN
cord-023095-4dannjjm	2174	6	TT4	TT4	NNP
cord-023095-4dannjjm	2174	7	concentrations	concentration	NNS
cord-023095-4dannjjm	2174	8	are	be	VBP
cord-023095-4dannjjm	2174	9	not	not	RB
cord-023095-4dannjjm	2174	10	ideally	ideally	RB
cord-023095-4dannjjm	2174	11	controlled	control	VBN
cord-023095-4dannjjm	2174	12	in	in	IN
cord-023095-4dannjjm	2174	13	the	the	DT
cord-023095-4dannjjm	2174	14	normal	normal	JJ
cord-023095-4dannjjm	2174	15	range	range	NN
cord-023095-4dannjjm	2174	16	in	in	IN
cord-023095-4dannjjm	2174	17	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2174	18	cats	cat	NNS
cord-023095-4dannjjm	2174	19	fed	feed	VBD
cord-023095-4dannjjm	2174	20	a	a	DT
cord-023095-4dannjjm	2174	21	food	food	NN
cord-023095-4dannjjm	2174	22	containing	contain	VBG
cord-023095-4dannjjm	2174	23	!	!	.
cord-023095-4dannjjm	2175	1	0.39	0.39	CD
cord-023095-4dannjjm	2176	1	ppm	ppm	NN
cord-023095-4dannjjm	2176	2	I	I	NNP
cord-023095-4dannjjm	2176	3	(	(	-LRB-
cord-023095-4dannjjm	2176	4	DMB	DMB	NNP
cord-023095-4dannjjm	2176	5	)	)	-RRB-
cord-023095-4dannjjm	2176	6	.	.	.
cord-023095-4dannjjm	2177	1	Hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2177	2	is	be	VBZ
cord-023095-4dannjjm	2177	3	a	a	DT
cord-023095-4dannjjm	2177	4	common	common	JJ
cord-023095-4dannjjm	2177	5	disease	disease	NN
cord-023095-4dannjjm	2177	6	in	in	IN
cord-023095-4dannjjm	2177	7	old	old	JJ
cord-023095-4dannjjm	2177	8	cats	cat	NNS
cord-023095-4dannjjm	2177	9	.	.	.
cord-023095-4dannjjm	2178	1	Excessive	excessive	JJ
cord-023095-4dannjjm	2178	2	production	production	NN
cord-023095-4dannjjm	2178	3	of	of	IN
cord-023095-4dannjjm	2178	4	thyroid	thyroid	JJ
cord-023095-4dannjjm	2178	5	hormones	hormone	NNS
cord-023095-4dannjjm	2178	6	is	be	VBZ
cord-023095-4dannjjm	2178	7	the	the	DT
cord-023095-4dannjjm	2178	8	hallmark	hallmark	NN
cord-023095-4dannjjm	2178	9	of	of	IN
cord-023095-4dannjjm	2178	10	the	the	DT
cord-023095-4dannjjm	2178	11	disease	disease	NN
cord-023095-4dannjjm	2178	12	.	.	.
cord-023095-4dannjjm	2179	1	Three	three	CD
cord-023095-4dannjjm	2179	2	main	main	JJ
cord-023095-4dannjjm	2179	3	treatments	treatment	NNS
cord-023095-4dannjjm	2179	4	for	for	IN
cord-023095-4dannjjm	2179	5	feline	feline	JJ
cord-023095-4dannjjm	2179	6	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2179	7	include	include	VBP
cord-023095-4dannjjm	2179	8	radioactive	radioactive	JJ
cord-023095-4dannjjm	2179	9	iodine	iodine	NN
cord-023095-4dannjjm	2179	10	,	,	,
cord-023095-4dannjjm	2179	11	thyroidectomy	thyroidectomy	NN
cord-023095-4dannjjm	2179	12	,	,	,
cord-023095-4dannjjm	2179	13	and	and	CC
cord-023095-4dannjjm	2179	14	antithyroid	antithyroid	NNP
cord-023095-4dannjjm	2179	15	drugs	drug	NNS
cord-023095-4dannjjm	2179	16	such	such	JJ
cord-023095-4dannjjm	2179	17	as	as	IN
cord-023095-4dannjjm	2179	18	methimazole	methimazole	NN
cord-023095-4dannjjm	2179	19	.	.	.
cord-023095-4dannjjm	2180	1	Previously	previously	RB
cord-023095-4dannjjm	2180	2	we	-PRON-	PRP
cord-023095-4dannjjm	2180	3	have	have	VBP
cord-023095-4dannjjm	2180	4	shown	show	VBN
cord-023095-4dannjjm	2180	5	that	that	IN
cord-023095-4dannjjm	2180	6	limiting	limit	VBG
cord-023095-4dannjjm	2180	7	dietary	dietary	JJ
cord-023095-4dannjjm	2180	8	iodine	iodine	NN
cord-023095-4dannjjm	2180	9	to	to	IN
cord-023095-4dannjjm	2180	10	or	or	CC
cord-023095-4dannjjm	2180	11	below	below	IN
cord-023095-4dannjjm	2180	12	0.27	0.27	CD
cord-023095-4dannjjm	2180	13	ppm	ppm	NN
cord-023095-4dannjjm	2180	14	induces	induce	VBZ
cord-023095-4dannjjm	2180	15	euthyroidism	euthyroidism	NN
cord-023095-4dannjjm	2180	16	in	in	IN
cord-023095-4dannjjm	2180	17	cats	cat	NNS
cord-023095-4dannjjm	2180	18	with	with	IN
cord-023095-4dannjjm	2180	19	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2180	20	compared	compare	VBN
cord-023095-4dannjjm	2180	21	with	with	IN
cord-023095-4dannjjm	2180	22	a	a	DT
cord-023095-4dannjjm	2180	23	similar	similar	JJ
cord-023095-4dannjjm	2180	24	diet	diet	NN
cord-023095-4dannjjm	2180	25	containing	contain	VBG
cord-023095-4dannjjm	2180	26	0.42	0.42	CD
cord-023095-4dannjjm	2180	27	ppm	ppm	NN
cord-023095-4dannjjm	2180	28	iodine	iodine	NN
cord-023095-4dannjjm	2180	29	.	.	.
cord-023095-4dannjjm	2181	1	The	the	DT
cord-023095-4dannjjm	2181	2	objective	objective	NN
cord-023095-4dannjjm	2181	3	of	of	IN
cord-023095-4dannjjm	2181	4	this	this	DT
cord-023095-4dannjjm	2181	5	study	study	NN
cord-023095-4dannjjm	2181	6	was	be	VBD
cord-023095-4dannjjm	2181	7	to	to	TO
cord-023095-4dannjjm	2181	8	test	test	VB
cord-023095-4dannjjm	2181	9	whether	whether	IN
cord-023095-4dannjjm	2181	10	dietary	dietary	JJ
cord-023095-4dannjjm	2181	11	iodine	iodine	NN
cord-023095-4dannjjm	2181	12	at	at	IN
cord-023095-4dannjjm	2181	13	0.32	0.32	CD
cord-023095-4dannjjm	2181	14	ppm	ppm	NN
cord-023095-4dannjjm	2181	15	would	would	MD
cord-023095-4dannjjm	2181	16	induce	induce	VB
cord-023095-4dannjjm	2181	17	euthyroidism	euthyroidism	NN
cord-023095-4dannjjm	2181	18	in	in	IN
cord-023095-4dannjjm	2181	19	cats	cat	NNS
cord-023095-4dannjjm	2181	20	with	with	IN
cord-023095-4dannjjm	2181	21	naturally	naturally	RB
cord-023095-4dannjjm	2181	22	occurring	occur	VBG
cord-023095-4dannjjm	2181	23	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2181	24	.	.	.
cord-023095-4dannjjm	2182	1	Fourteen	fourteen	CD
cord-023095-4dannjjm	2182	2	cats	cat	NNS
cord-023095-4dannjjm	2182	3	with	with	IN
cord-023095-4dannjjm	2182	4	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2182	5	confirmed	confirm	VBN
cord-023095-4dannjjm	2182	6	by	by	IN
cord-023095-4dannjjm	2182	7	serum	serum	NN
cord-023095-4dannjjm	2182	8	TT	TT	NNP
cord-023095-4dannjjm	2182	9	4	4	CD
cord-023095-4dannjjm	2182	10	and	and	CC
cord-023095-4dannjjm	2182	11	FT	FT	NNP
cord-023095-4dannjjm	2182	12	4	4	CD
cord-023095-4dannjjm	2182	13	measurements	measurement	NNS
cord-023095-4dannjjm	2182	14	were	be	VBD
cord-023095-4dannjjm	2182	15	stratified	stratify	VBN
cord-023095-4dannjjm	2182	16	into	into	IN
cord-023095-4dannjjm	2182	17	two	two	CD
cord-023095-4dannjjm	2182	18	groups	group	NNS
cord-023095-4dannjjm	2182	19	based	base	VBN
cord-023095-4dannjjm	2182	20	on	on	IN
cord-023095-4dannjjm	2182	21	gender	gender	NN
cord-023095-4dannjjm	2182	22	and	and	CC
cord-023095-4dannjjm	2182	23	age	age	NN
cord-023095-4dannjjm	2182	24	.	.	.
cord-023095-4dannjjm	2183	1	One	one	CD
cord-023095-4dannjjm	2183	2	group	group	NN
cord-023095-4dannjjm	2183	3	(	(	-LRB-
cord-023095-4dannjjm	2183	4	control	control	NN
cord-023095-4dannjjm	2183	5	:	:	:
cord-023095-4dannjjm	2183	6	4	4	CD
cord-023095-4dannjjm	2183	7	males	male	NNS
cord-023095-4dannjjm	2183	8	and	and	CC
cord-023095-4dannjjm	2183	9	3	3	CD
cord-023095-4dannjjm	2183	10	females	female	NNS
cord-023095-4dannjjm	2183	11	,	,	,
cord-023095-4dannjjm	2183	12	age	age	NN
cord-023095-4dannjjm	2183	13	ranged	range	VBD
cord-023095-4dannjjm	2183	14	from	from	IN
cord-023095-4dannjjm	2183	15	11	11	CD
cord-023095-4dannjjm	2183	16	to	to	TO
cord-023095-4dannjjm	2183	17	15	15	CD
cord-023095-4dannjjm	2183	18	years	year	NNS
cord-023095-4dannjjm	2183	19	)	)	-RRB-
cord-023095-4dannjjm	2183	20	was	be	VBD
cord-023095-4dannjjm	2183	21	given	give	VBN
cord-023095-4dannjjm	2183	22	a	a	DT
cord-023095-4dannjjm	2183	23	positive	positive	JJ
cord-023095-4dannjjm	2183	24	control	control	NN
cord-023095-4dannjjm	2183	25	dry	dry	JJ
cord-023095-4dannjjm	2183	26	cat	cat	NN
cord-023095-4dannjjm	2183	27	food	food	NN
cord-023095-4dannjjm	2183	28	(	(	-LRB-
cord-023095-4dannjjm	2183	29	0.17	0.17	CD
cord-023095-4dannjjm	2183	30	ppm	ppm	NN
cord-023095-4dannjjm	2183	31	iodine	iodine	NN
cord-023095-4dannjjm	2183	32	)	)	-RRB-
cord-023095-4dannjjm	2183	33	while	while	IN
cord-023095-4dannjjm	2183	34	the	the	DT
cord-023095-4dannjjm	2183	35	other	other	JJ
cord-023095-4dannjjm	2183	36	group	group	NN
cord-023095-4dannjjm	2183	37	(	(	-LRB-
cord-023095-4dannjjm	2183	38	test	test	NN
cord-023095-4dannjjm	2183	39	:	:	:
cord-023095-4dannjjm	2183	40	3	3	CD
cord-023095-4dannjjm	2183	41	males	male	NNS
cord-023095-4dannjjm	2183	42	and	and	CC
cord-023095-4dannjjm	2183	43	4	4	CD
cord-023095-4dannjjm	2183	44	females	female	NNS
cord-023095-4dannjjm	2183	45	,	,	,
cord-023095-4dannjjm	2183	46	age	age	NN
cord-023095-4dannjjm	2183	47	ranged	range	VBD
cord-023095-4dannjjm	2183	48	from	from	IN
cord-023095-4dannjjm	2183	49	12	12	CD
cord-023095-4dannjjm	2183	50	to	to	TO
cord-023095-4dannjjm	2183	51	17	17	CD
cord-023095-4dannjjm	2183	52	years	year	NNS
cord-023095-4dannjjm	2183	53	)	)	-RRB-
cord-023095-4dannjjm	2183	54	was	be	VBD
cord-023095-4dannjjm	2183	55	fed	feed	VBN
cord-023095-4dannjjm	2183	56	a	a	DT
cord-023095-4dannjjm	2183	57	commercial	commercial	JJ
cord-023095-4dannjjm	2183	58	dry	dry	JJ
cord-023095-4dannjjm	2183	59	cat	cat	NN
cord-023095-4dannjjm	2183	60	food	food	NN
cord-023095-4dannjjm	2183	61	(	(	-LRB-
cord-023095-4dannjjm	2183	62	1.9	1.9	CD
cord-023095-4dannjjm	2183	63	ppm	ppm	NN
cord-023095-4dannjjm	2183	64	iodine	iodine	NN
cord-023095-4dannjjm	2183	65	)	)	-RRB-
cord-023095-4dannjjm	2183	66	for	for	IN
cord-023095-4dannjjm	2183	67	at	at	RB
cord-023095-4dannjjm	2183	68	least	least	JJS
cord-023095-4dannjjm	2183	69	6	6	CD
cord-023095-4dannjjm	2183	70	weeks	week	NNS
cord-023095-4dannjjm	2183	71	before	before	IN
cord-023095-4dannjjm	2183	72	the	the	DT
cord-023095-4dannjjm	2183	73	study	study	NN
cord-023095-4dannjjm	2183	74	.	.	.
cord-023095-4dannjjm	2184	1	Afterwards	afterwards	RB
cord-023095-4dannjjm	2184	2	(	(	-LRB-
cord-023095-4dannjjm	2184	3	week	week	NN
cord-023095-4dannjjm	2184	4	0	0	CD
cord-023095-4dannjjm	2184	5	)	)	-RRB-
cord-023095-4dannjjm	2184	6	,	,	,
cord-023095-4dannjjm	2184	7	the	the	DT
cord-023095-4dannjjm	2184	8	control	control	NN
cord-023095-4dannjjm	2184	9	cats	cat	NNS
cord-023095-4dannjjm	2184	10	continued	continue	VBD
cord-023095-4dannjjm	2184	11	to	to	TO
cord-023095-4dannjjm	2184	12	receive	receive	VB
cord-023095-4dannjjm	2184	13	the	the	DT
cord-023095-4dannjjm	2184	14	same	same	JJ
cord-023095-4dannjjm	2184	15	food	food	NN
cord-023095-4dannjjm	2184	16	while	while	IN
cord-023095-4dannjjm	2184	17	cats	cat	NNS
cord-023095-4dannjjm	2184	18	in	in	IN
cord-023095-4dannjjm	2184	19	the	the	DT
cord-023095-4dannjjm	2184	20	test	test	NN
cord-023095-4dannjjm	2184	21	group	group	NN
cord-023095-4dannjjm	2184	22	were	be	VBD
cord-023095-4dannjjm	2184	23	given	give	VBN
cord-023095-4dannjjm	2184	24	a	a	DT
cord-023095-4dannjjm	2184	25	test	test	NN
cord-023095-4dannjjm	2184	26	food	food	NN
cord-023095-4dannjjm	2184	27	(	(	-LRB-
cord-023095-4dannjjm	2184	28	0.32	0.32	CD
cord-023095-4dannjjm	2184	29	ppm	ppm	NN
cord-023095-4dannjjm	2184	30	iodine	iodine	NN
cord-023095-4dannjjm	2184	31	)	)	-RRB-
cord-023095-4dannjjm	2184	32	for	for	IN
cord-023095-4dannjjm	2184	33	additional	additional	JJ
cord-023095-4dannjjm	2184	34	12	12	CD
cord-023095-4dannjjm	2184	35	weeks	week	NNS
cord-023095-4dannjjm	2184	36	.	.	.
cord-023095-4dannjjm	2185	1	All	all	DT
cord-023095-4dannjjm	2185	2	cats	cat	NNS
cord-023095-4dannjjm	2185	3	had	have	VBD
cord-023095-4dannjjm	2185	4	free	free	JJ
cord-023095-4dannjjm	2185	5	access	access	NN
cord-023095-4dannjjm	2185	6	to	to	IN
cord-023095-4dannjjm	2185	7	their	-PRON-	PRP$
cord-023095-4dannjjm	2185	8	food	food	NN
cord-023095-4dannjjm	2185	9	and	and	CC
cord-023095-4dannjjm	2185	10	deionized	deionize	VBN
cord-023095-4dannjjm	2185	11	water	water	NN
cord-023095-4dannjjm	2185	12	during	during	IN
cord-023095-4dannjjm	2185	13	the	the	DT
cord-023095-4dannjjm	2185	14	study	study	NN
cord-023095-4dannjjm	2185	15	.	.	.
cord-023095-4dannjjm	2186	1	Blood	blood	NN
cord-023095-4dannjjm	2186	2	samples	sample	NNS
cord-023095-4dannjjm	2186	3	were	be	VBD
cord-023095-4dannjjm	2186	4	collected	collect	VBN
cord-023095-4dannjjm	2186	5	during	during	IN
cord-023095-4dannjjm	2186	6	weeks	week	NNS
cord-023095-4dannjjm	2186	7	0	0	CD
cord-023095-4dannjjm	2186	8	,	,	,
cord-023095-4dannjjm	2186	9	3	3	CD
cord-023095-4dannjjm	2186	10	,	,	,
cord-023095-4dannjjm	2186	11	6	6	CD
cord-023095-4dannjjm	2186	12	,	,	,
cord-023095-4dannjjm	2186	13	and	and	CC
cord-023095-4dannjjm	2186	14	12	12	CD
cord-023095-4dannjjm	2186	15	of	of	IN
cord-023095-4dannjjm	2186	16	the	the	DT
cord-023095-4dannjjm	2186	17	study	study	NN
cord-023095-4dannjjm	2186	18	.	.	.
cord-023095-4dannjjm	2187	1	The	the	DT
cord-023095-4dannjjm	2187	2	control	control	NN
cord-023095-4dannjjm	2187	3	cats	cat	NNS
cord-023095-4dannjjm	2187	4	maintained	maintain	VBD
cord-023095-4dannjjm	2187	5	euthyroidism	euthyroidism	NN
cord-023095-4dannjjm	2187	6	during	during	IN
cord-023095-4dannjjm	2187	7	the	the	DT
cord-023095-4dannjjm	2187	8	study	study	NN
cord-023095-4dannjjm	2187	9	.	.	.
cord-023095-4dannjjm	2188	1	The	the	DT
cord-023095-4dannjjm	2188	2	test	test	NN
cord-023095-4dannjjm	2188	3	food	food	NN
cord-023095-4dannjjm	2188	4	significantly	significantly	RB
cord-023095-4dannjjm	2188	5	reduced	reduce	VBD
cord-023095-4dannjjm	2188	6	serum	serum	NN
cord-023095-4dannjjm	2188	7	TT	TT	NNP
cord-023095-4dannjjm	2188	8	4	4	CD
cord-023095-4dannjjm	2188	9	(	(	-LRB-
cord-023095-4dannjjm	2188	10	72	72	CD
cord-023095-4dannjjm	2188	11	AE	AE	NNP
cord-023095-4dannjjm	2188	12	12	12	CD
cord-023095-4dannjjm	2188	13	,	,	,
cord-023095-4dannjjm	2188	14	43	43	CD
cord-023095-4dannjjm	2188	15	AE	AE	NNP
cord-023095-4dannjjm	2188	16	9	9	CD
cord-023095-4dannjjm	2188	17	Ã	Ã	NNP
cord-023095-4dannjjm	2188	18	,	,	,
cord-023095-4dannjjm	2188	19	42	42	CD
cord-023095-4dannjjm	2188	20	AE	AE	NNP
cord-023095-4dannjjm	2188	21	9	9	CD
cord-023095-4dannjjm	2188	22	Ã	Ã	NNP
cord-023095-4dannjjm	2188	23	,	,	,
cord-023095-4dannjjm	2188	24	40	40	CD
cord-023095-4dannjjm	2188	25	AE	AE	NNP
cord-023095-4dannjjm	2188	26	6	6	CD
cord-023095-4dannjjm	2188	27	Ã	ã	NN
cord-023095-4dannjjm	2188	28	nmol	nmol	NN
cord-023095-4dannjjm	2188	29	/	/	SYM
cord-023095-4dannjjm	2188	30	L	l	NN
cord-023095-4dannjjm	2188	31	in	in	IN
cord-023095-4dannjjm	2188	32	weeks	week	NNS
cord-023095-4dannjjm	2188	33	0	0	CD
cord-023095-4dannjjm	2188	34	,	,	,
cord-023095-4dannjjm	2188	35	3	3	CD
cord-023095-4dannjjm	2188	36	,	,	,
cord-023095-4dannjjm	2188	37	6	6	CD
cord-023095-4dannjjm	2188	38	and	and	CC
cord-023095-4dannjjm	2188	39	12	12	CD
cord-023095-4dannjjm	2188	40	,	,	,
cord-023095-4dannjjm	2188	41	respectively	respectively	RB
cord-023095-4dannjjm	2188	42	;	;	:
cord-023095-4dannjjm	2188	43	Ã	ã	NN
cord-023095-4dannjjm	2188	44	:	:	:
cord-023095-4dannjjm	2188	45	p	p	NN
cord-023095-4dannjjm	2188	46	o	o	NN
cord-023095-4dannjjm	2188	47	0.05	0.05	CD
cord-023095-4dannjjm	2188	48	compared	compare	VBN
cord-023095-4dannjjm	2188	49	with	with	IN
cord-023095-4dannjjm	2188	50	week	week	NN
cord-023095-4dannjjm	2188	51	0	0	CD
cord-023095-4dannjjm	2188	52	,	,	,
cord-023095-4dannjjm	2188	53	Dunnett	Dunnett	NNP
cord-023095-4dannjjm	2188	54	's	's	POS
cord-023095-4dannjjm	2188	55	t	t	NN
cord-023095-4dannjjm	2188	56	test	test	NN
cord-023095-4dannjjm	2188	57	)	)	-RRB-
cord-023095-4dannjjm	2188	58	.	.	.
cord-023095-4dannjjm	2189	1	It	-PRON-	PRP
cord-023095-4dannjjm	2189	2	also	also	RB
cord-023095-4dannjjm	2189	3	significantly	significantly	RB
cord-023095-4dannjjm	2189	4	reduced	reduce	VBD
cord-023095-4dannjjm	2189	5	FT	FT	NNP
cord-023095-4dannjjm	2189	6	4	4	CD
cord-023095-4dannjjm	2189	7	at	at	IN
cord-023095-4dannjjm	2189	8	the	the	DT
cord-023095-4dannjjm	2189	9	end	end	NN
cord-023095-4dannjjm	2189	10	of	of	IN
cord-023095-4dannjjm	2189	11	the	the	DT
cord-023095-4dannjjm	2189	12	study	study	NN
cord-023095-4dannjjm	2189	13	(	(	-LRB-
cord-023095-4dannjjm	2189	14	17	17	CD
cord-023095-4dannjjm	2189	15	AE	AE	NNP
cord-023095-4dannjjm	2189	16	2	2	CD
cord-023095-4dannjjm	2189	17	vs.	vs.	NN
cord-023095-4dannjjm	2189	18	23AE	23ae	CD
cord-023095-4dannjjm	2189	19	2	2	CD
cord-023095-4dannjjm	2189	20	pmol	pmol	NN
cord-023095-4dannjjm	2189	21	,	,	,
cord-023095-4dannjjm	2189	22	week	week	NN
cord-023095-4dannjjm	2189	23	12	12	CD
cord-023095-4dannjjm	2189	24	vs.	vs.	IN
cord-023095-4dannjjm	2189	25	week	week	NN
cord-023095-4dannjjm	2189	26	0	0	CD
cord-023095-4dannjjm	2189	27	;	;	:
cord-023095-4dannjjm	2189	28	Dunnett	Dunnett	NNP
cord-023095-4dannjjm	2189	29	's	's	POS
cord-023095-4dannjjm	2189	30	t	t	NN
cord-023095-4dannjjm	2189	31	test	test	NN
cord-023095-4dannjjm	2189	32	,	,	,
cord-023095-4dannjjm	2189	33	p	p	NN
cord-023095-4dannjjm	2189	34	o	o	NN
cord-023095-4dannjjm	2189	35	0.05	0.05	CD
cord-023095-4dannjjm	2189	36	)	)	-RRB-
cord-023095-4dannjjm	2189	37	.	.	.
cord-023095-4dannjjm	2190	1	Serum	serum	NN
cord-023095-4dannjjm	2190	2	FT	FT	NNP
cord-023095-4dannjjm	2190	3	4	4	CD
cord-023095-4dannjjm	2190	4	was	be	VBD
cord-023095-4dannjjm	2190	5	within	within	IN
cord-023095-4dannjjm	2190	6	the	the	DT
cord-023095-4dannjjm	2190	7	reference	reference	NN
cord-023095-4dannjjm	2190	8	range	range	NN
cord-023095-4dannjjm	2190	9	(	(	-LRB-
cord-023095-4dannjjm	2190	10	10	10	CD
cord-023095-4dannjjm	2190	11	-	-	SYM
cord-023095-4dannjjm	2190	12	55	55	CD
cord-023095-4dannjjm	2190	13	pmol	pmol	NN
cord-023095-4dannjjm	2190	14	/	/	SYM
cord-023095-4dannjjm	2190	15	L	l	NN
cord-023095-4dannjjm	2190	16	)	)	-RRB-
cord-023095-4dannjjm	2190	17	in	in	IN
cord-023095-4dannjjm	2190	18	cats	cat	NNS
cord-023095-4dannjjm	2190	19	in	in	IN
cord-023095-4dannjjm	2190	20	both	both	DT
cord-023095-4dannjjm	2190	21	groups	group	NNS
cord-023095-4dannjjm	2190	22	.	.	.
cord-023095-4dannjjm	2191	1	Serum	serum	NN
cord-023095-4dannjjm	2191	2	TT	TT	NNP
cord-023095-4dannjjm	2191	3	3	3	CD
cord-023095-4dannjjm	2191	4	,	,	,
cord-023095-4dannjjm	2191	5	FT	FT	NNP
cord-023095-4dannjjm	2191	6	3	3	CD
cord-023095-4dannjjm	2191	7	,	,	,
cord-023095-4dannjjm	2191	8	and	and	CC
cord-023095-4dannjjm	2191	9	TSH	TSH	NNP
cord-023095-4dannjjm	2191	10	were	be	VBD
cord-023095-4dannjjm	2191	11	not	not	RB
cord-023095-4dannjjm	2191	12	affected	affect	VBN
cord-023095-4dannjjm	2191	13	by	by	IN
cord-023095-4dannjjm	2191	14	the	the	DT
cord-023095-4dannjjm	2191	15	test	test	NN
cord-023095-4dannjjm	2191	16	food	food	NN
cord-023095-4dannjjm	2191	17	and	and	CC
cord-023095-4dannjjm	2191	18	were	be	VBD
cord-023095-4dannjjm	2191	19	within	within	IN
cord-023095-4dannjjm	2191	20	the	the	DT
cord-023095-4dannjjm	2191	21	reference	reference	NN
cord-023095-4dannjjm	2191	22	ranges	range	VBZ
cord-023095-4dannjjm	2192	1	(	(	-LRB-
cord-023095-4dannjjm	2192	2	TT	TT	NNP
cord-023095-4dannjjm	2192	3	3	3	CD
cord-023095-4dannjjm	2192	4	:	:	:
cord-023095-4dannjjm	2192	5	0.6	0.6	CD
cord-023095-4dannjjm	2192	6	-	-	SYM
cord-023095-4dannjjm	2192	7	1.4	1.4	CD
cord-023095-4dannjjm	2192	8	nmol	nmol	NNP
cord-023095-4dannjjm	2192	9	/	/	SYM
cord-023095-4dannjjm	2192	10	L	L	NNP
cord-023095-4dannjjm	2192	11	,	,	,
cord-023095-4dannjjm	2192	12	FT	FT	NNP
cord-023095-4dannjjm	2192	13	3	3	CD
cord-023095-4dannjjm	2192	14	:	:	:
cord-023095-4dannjjm	2192	15	1.5	1.5	CD
cord-023095-4dannjjm	2192	16	-	-	SYM
cord-023095-4dannjjm	2192	17	6	6	CD
cord-023095-4dannjjm	2192	18	pmol	pmol	NN
cord-023095-4dannjjm	2192	19	/	/	SYM
cord-023095-4dannjjm	2192	20	L	l	NN
cord-023095-4dannjjm	2192	21	,	,	,
cord-023095-4dannjjm	2192	22	and	and	CC
cord-023095-4dannjjm	2192	23	TSH	tsh	NN
cord-023095-4dannjjm	2192	24	:	:	:
cord-023095-4dannjjm	2192	25	0	0	CD
cord-023095-4dannjjm	2192	26	-	-	SYM
cord-023095-4dannjjm	2192	27	21	21	CD
cord-023095-4dannjjm	2192	28	mU	mU	NNS
cord-023095-4dannjjm	2192	29	/	/	SYM
cord-023095-4dannjjm	2192	30	L	l	NN
cord-023095-4dannjjm	2192	31	)	)	-RRB-
cord-023095-4dannjjm	2193	1	in	in	IN
cord-023095-4dannjjm	2193	2	cats	cat	NNS
cord-023095-4dannjjm	2193	3	of	of	IN
cord-023095-4dannjjm	2193	4	both	both	DT
cord-023095-4dannjjm	2193	5	groups	group	NNS
cord-023095-4dannjjm	2193	6	during	during	IN
cord-023095-4dannjjm	2193	7	the	the	DT
cord-023095-4dannjjm	2193	8	study	study	NN
cord-023095-4dannjjm	2193	9	.	.	.
cord-023095-4dannjjm	2194	1	This	this	DT
cord-023095-4dannjjm	2194	2	study	study	NN
cord-023095-4dannjjm	2194	3	demonstrates	demonstrate	VBZ
cord-023095-4dannjjm	2194	4	that	that	IN
cord-023095-4dannjjm	2194	5	dietary	dietary	JJ
cord-023095-4dannjjm	2194	6	iodine	iodine	NN
cord-023095-4dannjjm	2194	7	at	at	IN
cord-023095-4dannjjm	2194	8	or	or	CC
cord-023095-4dannjjm	2194	9	below	below	IN
cord-023095-4dannjjm	2194	10	0.32	0.32	CD
cord-023095-4dannjjm	2194	11	ppm	ppm	NN
cord-023095-4dannjjm	2194	12	provides	provide	VBZ
cord-023095-4dannjjm	2194	13	an	an	DT
cord-023095-4dannjjm	2194	14	effective	effective	JJ
cord-023095-4dannjjm	2194	15	and	and	CC
cord-023095-4dannjjm	2194	16	inexpensive	inexpensive	JJ
cord-023095-4dannjjm	2194	17	therapy	therapy	NN
cord-023095-4dannjjm	2194	18	for	for	IN
cord-023095-4dannjjm	2194	19	cats	cat	NNS
cord-023095-4dannjjm	2194	20	with	with	IN
cord-023095-4dannjjm	2194	21	naturally	naturally	RB
cord-023095-4dannjjm	2194	22	occurring	occur	VBG
cord-023095-4dannjjm	2194	23	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2194	24	.	.	.
cord-023095-4dannjjm	2195	1	Radioactive	radioactive	JJ
cord-023095-4dannjjm	2195	2	iodine	iodine	NN
cord-023095-4dannjjm	2195	3	(	(	-LRB-
cord-023095-4dannjjm	2195	4	131	131	CD
cord-023095-4dannjjm	2195	5	I	i	NN
cord-023095-4dannjjm	2195	6	)	)	-RRB-
cord-023095-4dannjjm	2195	7	is	be	VBZ
cord-023095-4dannjjm	2195	8	a	a	DT
cord-023095-4dannjjm	2195	9	widely	widely	RB
cord-023095-4dannjjm	2195	10	used	use	VBN
cord-023095-4dannjjm	2195	11	treatment	treatment	NN
cord-023095-4dannjjm	2195	12	for	for	IN
cord-023095-4dannjjm	2195	13	feline	feline	JJ
cord-023095-4dannjjm	2195	14	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	2195	15	.	.	.
cord-023095-4dannjjm	2196	1	Prior	prior	RB
cord-023095-4dannjjm	2196	2	to	to	IN
cord-023095-4dannjjm	2196	3	131	131	CD
cord-023095-4dannjjm	2196	4	I	I	NNP
cord-023095-4dannjjm	2196	5	administration	administration	NN
cord-023095-4dannjjm	2196	6	,	,	,
cord-023095-4dannjjm	2196	7	many	many	JJ
cord-023095-4dannjjm	2196	8	cats	cat	NNS
cord-023095-4dannjjm	2196	9	receive	receive	VBP
cord-023095-4dannjjm	2196	10	methimazole	methimazole	NN
cord-023095-4dannjjm	2196	11	therapy	therapy	NN
cord-023095-4dannjjm	2196	12	.	.	.
cord-023095-4dannjjm	2197	1	It	-PRON-	PRP
cord-023095-4dannjjm	2197	2	has	have	VBZ
cord-023095-4dannjjm	2197	3	been	be	VBN
cord-023095-4dannjjm	2197	4	suggested	suggest	VBN
cord-023095-4dannjjm	2197	5	that	that	IN
cord-023095-4dannjjm	2197	6	recent	recent	JJ
cord-023095-4dannjjm	2197	7	withdrawal	withdrawal	NN
cord-023095-4dannjjm	2197	8	of	of	IN
cord-023095-4dannjjm	2197	9	methimazole	methimazole	NN
cord-023095-4dannjjm	2197	10	prior	prior	RB
cord-023095-4dannjjm	2197	11	to	to	IN
cord-023095-4dannjjm	2197	12	131	131	CD
cord-023095-4dannjjm	2197	13	I	-PRON-	PRP
cord-023095-4dannjjm	2197	14	may	may	MD
cord-023095-4dannjjm	2197	15	increase	increase	VB
cord-023095-4dannjjm	2197	16	the	the	DT
cord-023095-4dannjjm	2197	17	risk	risk	NN
cord-023095-4dannjjm	2197	18	of	of	IN
cord-023095-4dannjjm	2197	19	hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	2197	20	,	,	,
cord-023095-4dannjjm	2197	21	inhibit	inhibit	VB
cord-023095-4dannjjm	2197	22	the	the	DT
cord-023095-4dannjjm	2197	23	response	response	NN
cord-023095-4dannjjm	2197	24	to	to	IN
cord-023095-4dannjjm	2197	25	therapy	therapy	NN
cord-023095-4dannjjm	2197	26	,	,	,
cord-023095-4dannjjm	2197	27	or	or	CC
cord-023095-4dannjjm	2197	28	have	have	VBP
cord-023095-4dannjjm	2197	29	no	no	DT
cord-023095-4dannjjm	2197	30	effect	effect	NN
cord-023095-4dannjjm	2197	31	.	.	.
cord-023095-4dannjjm	2198	1	To	to	TO
cord-023095-4dannjjm	2198	2	further	further	RB
cord-023095-4dannjjm	2198	3	address	address	VB
cord-023095-4dannjjm	2198	4	this	this	DT
cord-023095-4dannjjm	2198	5	question	question	NN
cord-023095-4dannjjm	2198	6	,	,	,
cord-023095-4dannjjm	2198	7	a	a	DT
cord-023095-4dannjjm	2198	8	retrospective	retrospective	JJ
cord-023095-4dannjjm	2198	9	medical	medical	JJ
cord-023095-4dannjjm	2198	10	records	record	NNS
cord-023095-4dannjjm	2198	11	search	search	NN
cord-023095-4dannjjm	2198	12	was	be	VBD
cord-023095-4dannjjm	2198	13	performed	perform	VBN
cord-023095-4dannjjm	2198	14	to	to	TO
cord-023095-4dannjjm	2198	15	identify	identify	VB
cord-023095-4dannjjm	2198	16	hyperthyroid	hyperthyroid	JJ
cord-023095-4dannjjm	2198	17	cats	cat	NNS
cord-023095-4dannjjm	2198	18	that	that	WDT
cord-023095-4dannjjm	2198	19	received	receive	VBD
cord-023095-4dannjjm	2198	20	131	131	CD
cord-023095-4dannjjm	2198	21	I	I	NNP
cord-023095-4dannjjm	2198	22	therapy	therapy	NN
cord-023095-4dannjjm	2198	23	after	after	IN
cord-023095-4dannjjm	2198	24	methimazole	methimazole	NN
cord-023095-4dannjjm	2198	25	treatment	treatment	NN
cord-023095-4dannjjm	2198	26	.	.	.
cord-023095-4dannjjm	2199	1	Inclusion	inclusion	NN
cord-023095-4dannjjm	2199	2	criteria	criterion	NNS
cord-023095-4dannjjm	2199	3	included	include	VBD
cord-023095-4dannjjm	2199	4	documentation	documentation	NN
cord-023095-4dannjjm	2199	5	of	of	IN
cord-023095-4dannjjm	2199	6	the	the	DT
cord-023095-4dannjjm	2199	7	time	time	NN
cord-023095-4dannjjm	2199	8	interval	interval	NN
cord-023095-4dannjjm	2199	9	between	between	IN
cord-023095-4dannjjm	2199	10	discontinuation	discontinuation	NN
cord-023095-4dannjjm	2199	11	of	of	IN
cord-023095-4dannjjm	2199	12	methimazole	methimazole	NN
cord-023095-4dannjjm	2199	13	and	and	CC
cord-023095-4dannjjm	2199	14	131	131	CD
cord-023095-4dannjjm	2199	15	I	I	NNP
cord-023095-4dannjjm	2199	16	administration	administration	NN
cord-023095-4dannjjm	2199	17	,	,	,
cord-023095-4dannjjm	2199	18	and	and	CC
cord-023095-4dannjjm	2199	19	measurement	measurement	NN
cord-023095-4dannjjm	2199	20	of	of	IN
cord-023095-4dannjjm	2199	21	thyroxine	thyroxine	NN
cord-023095-4dannjjm	2199	22	(	(	-LRB-
cord-023095-4dannjjm	2199	23	T	T	NNP
cord-023095-4dannjjm	2199	24	4	4	CD
cord-023095-4dannjjm	2199	25	)	)	-RRB-
cord-023095-4dannjjm	2199	26	at	at	IN
cord-023095-4dannjjm	2199	27	7	7	CD
cord-023095-4dannjjm	2199	28	-	-	SYM
cord-023095-4dannjjm	2199	29	14	14	CD
cord-023095-4dannjjm	2199	30	days	day	NNS
cord-023095-4dannjjm	2199	31	after	after	IN
cord-023095-4dannjjm	2199	32	131	131	CD
cord-023095-4dannjjm	2199	33	I.	I.	NNP
cord-023095-4dannjjm	2199	34	Cats	cat	NNS
cord-023095-4dannjjm	2199	35	were	be	VBD
cord-023095-4dannjjm	2199	36	divided	divide	VBN
cord-023095-4dannjjm	2199	37	into	into	IN
cord-023095-4dannjjm	2199	38	2	2	CD
cord-023095-4dannjjm	2199	39	groups	group	NNS
cord-023095-4dannjjm	2199	40	:	:	:
cord-023095-4dannjjm	2199	41	those	those	DT
cord-023095-4dannjjm	2199	42	receiving	receive	VBG
cord-023095-4dannjjm	2199	43	131	131	CD
cord-023095-4dannjjm	2199	44	I	-PRON-	PRP
cord-023095-4dannjjm	2199	45	within	within	IN
cord-023095-4dannjjm	2199	46	1	1	CD
cord-023095-4dannjjm	2199	47	day	day	NN
cord-023095-4dannjjm	2199	48	of	of	IN
cord-023095-4dannjjm	2199	49	stopping	stop	VBG
cord-023095-4dannjjm	2199	50	methimazole	methimazole	NN
cord-023095-4dannjjm	2199	51	,	,	,
cord-023095-4dannjjm	2199	52	and	and	CC
cord-023095-4dannjjm	2199	53	those	those	DT
cord-023095-4dannjjm	2199	54	receiving	receive	VBG
cord-023095-4dannjjm	2199	55	131	131	CD
cord-023095-4dannjjm	2199	56	I	I	NNP
cord-023095-4dannjjm	2199	57	treatment	treatment	NN
cord-023095-4dannjjm	2199	58	5	5	CD
cord-023095-4dannjjm	2199	59	or	or	CC
cord-023095-4dannjjm	2199	60	more	more	JJR
cord-023095-4dannjjm	2199	61	days	day	NNS
cord-023095-4dannjjm	2199	62	after	after	IN
cord-023095-4dannjjm	2199	63	stopping	stop	VBG
cord-023095-4dannjjm	2199	64	methimazole	methimazole	NN
cord-023095-4dannjjm	2199	65	.	.	.
cord-023095-4dannjjm	2200	1	Sixty	sixty	JJ
cord-023095-4dannjjm	2200	2	cats	cat	NNS
cord-023095-4dannjjm	2200	3	met	meet	VBD
cord-023095-4dannjjm	2200	4	the	the	DT
cord-023095-4dannjjm	2200	5	inclusion	inclusion	NN
cord-023095-4dannjjm	2200	6	criteria	criterion	NNS
cord-023095-4dannjjm	2200	7	.	.	.
cord-023095-4dannjjm	2201	1	Forty	forty	CD
cord-023095-4dannjjm	2201	2	received	receive	VBD
cord-023095-4dannjjm	2201	3	131	131	CD
cord-023095-4dannjjm	2201	4	I	-PRON-	PRP
cord-023095-4dannjjm	2201	5	within	within	IN
cord-023095-4dannjjm	2201	6	1	1	CD
cord-023095-4dannjjm	2201	7	day	day	NN
cord-023095-4dannjjm	2201	8	of	of	IN
cord-023095-4dannjjm	2201	9	stopping	stop	VBG
cord-023095-4dannjjm	2201	10	methimazole	methimazole	NN
cord-023095-4dannjjm	2201	11	.	.	.
cord-023095-4dannjjm	2202	1	Of	of	IN
cord-023095-4dannjjm	2202	2	those	those	DT
cord-023095-4dannjjm	2202	3	,	,	,
cord-023095-4dannjjm	2202	4	20	20	CD
cord-023095-4dannjjm	2202	5	(	(	-LRB-
cord-023095-4dannjjm	2202	6	50	50	CD
cord-023095-4dannjjm	2202	7	%	%	NN
cord-023095-4dannjjm	2202	8	)	)	-RRB-
cord-023095-4dannjjm	2202	9	had	have	VBD
cord-023095-4dannjjm	2202	10	a	a	DT
cord-023095-4dannjjm	2202	11	low	low	JJ
cord-023095-4dannjjm	2202	12	T4	T4	NNP
cord-023095-4dannjjm	2202	13	(	(	-LRB-
cord-023095-4dannjjm	2202	14	o	o	NNP
cord-023095-4dannjjm	2202	15	1.2	1.2	CD
cord-023095-4dannjjm	2202	16	mcg	mcg	NNP
cord-023095-4dannjjm	2202	17	/	/	SYM
cord-023095-4dannjjm	2202	18	dl	dl	NNP
cord-023095-4dannjjm	2202	19	)	)	-RRB-
cord-023095-4dannjjm	2202	20	,	,	,
cord-023095-4dannjjm	2202	21	17	17	CD
cord-023095-4dannjjm	2202	22	(	(	-LRB-
cord-023095-4dannjjm	2202	23	42.5	42.5	CD
cord-023095-4dannjjm	2202	24	%	%	NN
cord-023095-4dannjjm	2202	25	)	)	-RRB-
cord-023095-4dannjjm	2202	26	had	have	VBD
cord-023095-4dannjjm	2202	27	a	a	DT
cord-023095-4dannjjm	2202	28	normal	normal	JJ
cord-023095-4dannjjm	2202	29	T4	t4	NN
cord-023095-4dannjjm	2202	30	(	(	-LRB-
cord-023095-4dannjjm	2202	31	1.2	1.2	CD
cord-023095-4dannjjm	2202	32	-	-	SYM
cord-023095-4dannjjm	2202	33	4.8	4.8	CD
cord-023095-4dannjjm	2202	34	mcg	mcg	NNP
cord-023095-4dannjjm	2202	35	/	/	SYM
cord-023095-4dannjjm	2202	36	dl	dl	NNP
cord-023095-4dannjjm	2202	37	)	)	-RRB-
cord-023095-4dannjjm	2202	38	,	,	,
cord-023095-4dannjjm	2202	39	and	and	CC
cord-023095-4dannjjm	2202	40	3	3	CD
cord-023095-4dannjjm	2202	41	(	(	-LRB-
cord-023095-4dannjjm	2202	42	7.5	7.5	CD
cord-023095-4dannjjm	2202	43	%	%	NN
cord-023095-4dannjjm	2202	44	)	)	-RRB-
cord-023095-4dannjjm	2202	45	had	have	VBD
cord-023095-4dannjjm	2202	46	an	an	DT
cord-023095-4dannjjm	2202	47	elevated	elevated	JJ
cord-023095-4dannjjm	2202	48	T4	t4	NN
cord-023095-4dannjjm	2202	49	(	(	-LRB-
cord-023095-4dannjjm	2202	50	4	4	CD
cord-023095-4dannjjm	2202	51	4.8	4.8	CD
cord-023095-4dannjjm	2202	52	mcg	mcg	NNP
cord-023095-4dannjjm	2202	53	/	/	SYM
cord-023095-4dannjjm	2202	54	dl	dl	NN
cord-023095-4dannjjm	2202	55	)	)	-RRB-
cord-023095-4dannjjm	2202	56	at	at	IN
cord-023095-4dannjjm	2202	57	7	7	CD
cord-023095-4dannjjm	2202	58	-	-	SYM
cord-023095-4dannjjm	2202	59	14	14	CD
cord-023095-4dannjjm	2202	60	days	day	NNS
cord-023095-4dannjjm	2202	61	after	after	IN
cord-023095-4dannjjm	2202	62	131	131	CD
cord-023095-4dannjjm	2202	63	I	i	NN
cord-023095-4dannjjm	2202	64	therapy	therapy	NN
cord-023095-4dannjjm	2202	65	.	.	.
cord-023095-4dannjjm	2203	1	Fourteen	fourteen	CD
cord-023095-4dannjjm	2203	2	cats	cat	NNS
cord-023095-4dannjjm	2203	3	received	receive	VBD
cord-023095-4dannjjm	2203	4	131	131	CD
cord-023095-4dannjjm	2203	5	I	-PRON-	PRP
cord-023095-4dannjjm	2203	6	5	5	CD
cord-023095-4dannjjm	2203	7	or	or	CC
cord-023095-4dannjjm	2203	8	more	more	JJR
cord-023095-4dannjjm	2203	9	days	day	NNS
cord-023095-4dannjjm	2203	10	after	after	IN
cord-023095-4dannjjm	2203	11	stopping	stop	VBG
cord-023095-4dannjjm	2203	12	methimazole	methimazole	NN
cord-023095-4dannjjm	2203	13	:	:	:
cord-023095-4dannjjm	2203	14	8	8	CD
cord-023095-4dannjjm	2203	15	(	(	-LRB-
cord-023095-4dannjjm	2203	16	57	57	CD
cord-023095-4dannjjm	2203	17	%	%	NN
cord-023095-4dannjjm	2203	18	)	)	-RRB-
cord-023095-4dannjjm	2203	19	had	have	VBD
cord-023095-4dannjjm	2203	20	a	a	DT
cord-023095-4dannjjm	2203	21	low	low	JJ
cord-023095-4dannjjm	2203	22	T	T	NNP
cord-023095-4dannjjm	2203	23	4	4	CD
cord-023095-4dannjjm	2203	24	,	,	,
cord-023095-4dannjjm	2203	25	5	5	CD
cord-023095-4dannjjm	2203	26	(	(	-LRB-
cord-023095-4dannjjm	2203	27	36	36	CD
cord-023095-4dannjjm	2203	28	%	%	NN
cord-023095-4dannjjm	2203	29	)	)	-RRB-
cord-023095-4dannjjm	2203	30	had	have	VBD
cord-023095-4dannjjm	2203	31	a	a	DT
cord-023095-4dannjjm	2203	32	normal	normal	JJ
cord-023095-4dannjjm	2203	33	T	t	NN
cord-023095-4dannjjm	2203	34	4	4	CD
cord-023095-4dannjjm	2203	35	,	,	,
cord-023095-4dannjjm	2203	36	and	and	CC
cord-023095-4dannjjm	2203	37	1	1	CD
cord-023095-4dannjjm	2203	38	(	(	-LRB-
cord-023095-4dannjjm	2203	39	7	7	CD
cord-023095-4dannjjm	2203	40	%	%	NN
cord-023095-4dannjjm	2203	41	)	)	-RRB-
cord-023095-4dannjjm	2203	42	had	have	VBD
cord-023095-4dannjjm	2203	43	an	an	DT
cord-023095-4dannjjm	2203	44	elevated	elevated	JJ
cord-023095-4dannjjm	2203	45	T	t	NN
cord-023095-4dannjjm	2203	46	4	4	CD
cord-023095-4dannjjm	2203	47	at	at	IN
cord-023095-4dannjjm	2203	48	7	7	CD
cord-023095-4dannjjm	2203	49	-	-	SYM
cord-023095-4dannjjm	2203	50	14	14	CD
cord-023095-4dannjjm	2203	51	days	day	NNS
cord-023095-4dannjjm	2203	52	after	after	IN
cord-023095-4dannjjm	2203	53	131	131	CD
cord-023095-4dannjjm	2204	1	I	-PRON-	PRP
cord-023095-4dannjjm	2204	2	therapy	therapy	NN
cord-023095-4dannjjm	2204	3	.	.	.
cord-023095-4dannjjm	2205	1	The	the	DT
cord-023095-4dannjjm	2205	2	results	result	NNS
cord-023095-4dannjjm	2205	3	were	be	VBD
cord-023095-4dannjjm	2205	4	compared	compare	VBN
cord-023095-4dannjjm	2205	5	with	with	IN
cord-023095-4dannjjm	2205	6	a	a	DT
cord-023095-4dannjjm	2205	7	Fisher	Fisher	NNP
cord-023095-4dannjjm	2205	8	's	's	POS
cord-023095-4dannjjm	2205	9	exact	exact	JJ
cord-023095-4dannjjm	2205	10	test	test	NN
cord-023095-4dannjjm	2205	11	and	and	CC
cord-023095-4dannjjm	2205	12	there	there	EX
cord-023095-4dannjjm	2205	13	was	be	VBD
cord-023095-4dannjjm	2205	14	no	no	DT
cord-023095-4dannjjm	2205	15	difference	difference	NN
cord-023095-4dannjjm	2205	16	between	between	IN
cord-023095-4dannjjm	2205	17	the	the	DT
cord-023095-4dannjjm	2205	18	groups	group	NNS
cord-023095-4dannjjm	2205	19	(	(	-LRB-
cord-023095-4dannjjm	2205	20	p	p	NN
cord-023095-4dannjjm	2205	21	5	5	CD
cord-023095-4dannjjm	2205	22	0.76	0.76	CD
cord-023095-4dannjjm	2205	23	)	)	-RRB-
cord-023095-4dannjjm	2205	24	.	.	.
cord-023095-4dannjjm	2206	1	These	these	DT
cord-023095-4dannjjm	2206	2	findings	finding	NNS
cord-023095-4dannjjm	2206	3	indicate	indicate	VBP
cord-023095-4dannjjm	2206	4	that	that	IN
cord-023095-4dannjjm	2206	5	stopping	stop	VBG
cord-023095-4dannjjm	2206	6	methimazole	methimazole	NN
cord-023095-4dannjjm	2206	7	therapy	therapy	NN
cord-023095-4dannjjm	2206	8	within	within	IN
cord-023095-4dannjjm	2206	9	1	1	CD
cord-023095-4dannjjm	2206	10	day	day	NN
cord-023095-4dannjjm	2206	11	of	of	IN
cord-023095-4dannjjm	2206	12	131	131	CD
cord-023095-4dannjjm	2206	13	I	i	NN
cord-023095-4dannjjm	2206	14	therapy	therapy	NN
cord-023095-4dannjjm	2206	15	does	do	VBZ
cord-023095-4dannjjm	2206	16	not	not	RB
cord-023095-4dannjjm	2206	17	inhibit	inhibit	VB
cord-023095-4dannjjm	2206	18	the	the	DT
cord-023095-4dannjjm	2206	19	response	response	NN
cord-023095-4dannjjm	2206	20	to	to	IN
cord-023095-4dannjjm	2206	21	therapy	therapy	NN
cord-023095-4dannjjm	2206	22	.	.	.
cord-023095-4dannjjm	2207	1	Pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	2207	2	studies	study	NNS
cord-023095-4dannjjm	2207	3	evaluating	evaluate	VBG
cord-023095-4dannjjm	2207	4	synthetic	synthetic	JJ
cord-023095-4dannjjm	2207	5	insulin	insulin	NN
cord-023095-4dannjjm	2207	6	analogs	analog	NNS
cord-023095-4dannjjm	2207	7	such	such	JJ
cord-023095-4dannjjm	2207	8	as	as	IN
cord-023095-4dannjjm	2207	9	glargine	glargine	NNP
cord-023095-4dannjjm	2207	10	necessitate	necessitate	VBP
cord-023095-4dannjjm	2207	11	the	the	DT
cord-023095-4dannjjm	2207	12	ability	ability	NN
cord-023095-4dannjjm	2207	13	to	to	TO
cord-023095-4dannjjm	2207	14	measure	measure	VB
cord-023095-4dannjjm	2207	15	the	the	DT
cord-023095-4dannjjm	2207	16	blood	blood	NN
cord-023095-4dannjjm	2207	17	concentrations	concentration	NNS
cord-023095-4dannjjm	2207	18	of	of	IN
cord-023095-4dannjjm	2207	19	glargine	glargine	NNP
cord-023095-4dannjjm	2207	20	without	without	IN
cord-023095-4dannjjm	2207	21	cross	cross	NN
cord-023095-4dannjjm	2207	22	-	-	NN
cord-023095-4dannjjm	2207	23	reactivity	reactivity	NN
cord-023095-4dannjjm	2207	24	to	to	IN
cord-023095-4dannjjm	2207	25	endogenous	endogenous	JJ
cord-023095-4dannjjm	2207	26	insulin	insulin	NN
cord-023095-4dannjjm	2207	27	.	.	.
cord-023095-4dannjjm	2208	1	Although	although	IN
cord-023095-4dannjjm	2208	2	the	the	DT
cord-023095-4dannjjm	2208	3	cross	cross	NN
cord-023095-4dannjjm	2208	4	-	-	NN
cord-023095-4dannjjm	2208	5	reactivity	reactivity	NN
cord-023095-4dannjjm	2208	6	between	between	IN
cord-023095-4dannjjm	2208	7	endogenous	endogenous	JJ
cord-023095-4dannjjm	2208	8	human	human	JJ
cord-023095-4dannjjm	2208	9	insulin	insulin	NN
cord-023095-4dannjjm	2208	10	assays	assay	NNS
cord-023095-4dannjjm	2208	11	and	and	CC
cord-023095-4dannjjm	2208	12	synthetic	synthetic	JJ
cord-023095-4dannjjm	2208	13	analogs	analog	NNS
cord-023095-4dannjjm	2208	14	is	be	VBZ
cord-023095-4dannjjm	2208	15	often	often	RB
cord-023095-4dannjjm	2208	16	known	know	VBN
cord-023095-4dannjjm	2208	17	for	for	IN
cord-023095-4dannjjm	2208	18	commerciallyavailable	commerciallyavailable	JJ
cord-023095-4dannjjm	2208	19	assays	assay	NNS
cord-023095-4dannjjm	2208	20	,	,	,
cord-023095-4dannjjm	2208	21	the	the	DT
cord-023095-4dannjjm	2208	22	degree	degree	NN
cord-023095-4dannjjm	2208	23	of	of	IN
cord-023095-4dannjjm	2208	24	cross	cross	NN
cord-023095-4dannjjm	2208	25	-	-	NN
cord-023095-4dannjjm	2208	26	reactivity	reactivity	NN
cord-023095-4dannjjm	2208	27	of	of	IN
cord-023095-4dannjjm	2208	28	human	human	JJ
cord-023095-4dannjjm	2208	29	insulin	insulin	NN
cord-023095-4dannjjm	2208	30	assays	assay	NNS
cord-023095-4dannjjm	2208	31	with	with	IN
cord-023095-4dannjjm	2208	32	feline	feline	JJ
cord-023095-4dannjjm	2208	33	insulin	insulin	NN
cord-023095-4dannjjm	2208	34	is	be	VBZ
cord-023095-4dannjjm	2208	35	not	not	RB
cord-023095-4dannjjm	2208	36	.	.	.
cord-023095-4dannjjm	2209	1	The	the	DT
cord-023095-4dannjjm	2209	2	purpose	purpose	NN
cord-023095-4dannjjm	2209	3	of	of	IN
cord-023095-4dannjjm	2209	4	this	this	DT
cord-023095-4dannjjm	2209	5	study	study	NN
cord-023095-4dannjjm	2209	6	was	be	VBD
cord-023095-4dannjjm	2209	7	to	to	TO
cord-023095-4dannjjm	2209	8	evaluate	evaluate	VB
cord-023095-4dannjjm	2209	9	the	the	DT
cord-023095-4dannjjm	2209	10	cross	cross	NN
cord-023095-4dannjjm	2209	11	-	-	NN
cord-023095-4dannjjm	2209	12	reactivity	reactivity	NN
cord-023095-4dannjjm	2209	13	of	of	IN
cord-023095-4dannjjm	2209	14	feline	feline	JJ
cord-023095-4dannjjm	2209	15	insulin	insulin	NN
cord-023095-4dannjjm	2209	16	with	with	IN
cord-023095-4dannjjm	2209	17	a	a	DT
cord-023095-4dannjjm	2209	18	commerciallyavailable	commerciallyavailable	JJ
cord-023095-4dannjjm	2209	19	human	human	JJ
cord-023095-4dannjjm	2209	20	insulin	insulin	NN
cord-023095-4dannjjm	2209	21	ELISA	ELISA	NNP
cord-023095-4dannjjm	2209	22	with	with	IN
cord-023095-4dannjjm	2209	23	known	know	VBN
cord-023095-4dannjjm	2209	24	cross	cross	NN
cord-023095-4dannjjm	2209	25	reactivity	reactivity	NN
cord-023095-4dannjjm	2209	26	to	to	IN
cord-023095-4dannjjm	2209	27	several	several	JJ
cord-023095-4dannjjm	2209	28	synthetic	synthetic	JJ
cord-023095-4dannjjm	2209	29	analogs	analog	NNS
cord-023095-4dannjjm	2209	30	.	.	.
cord-023095-4dannjjm	2210	1	Pre	pre	JJ
cord-023095-4dannjjm	2210	2	-	-	JJ
cord-023095-4dannjjm	2210	3	and	and	CC
cord-023095-4dannjjm	2210	4	post	post	JJ
cord-023095-4dannjjm	2210	5	-	-	JJ
cord-023095-4dannjjm	2210	6	prandial	prandial	JJ
cord-023095-4dannjjm	2210	7	blood	blood	NN
cord-023095-4dannjjm	2210	8	samples	sample	NNS
cord-023095-4dannjjm	2210	9	were	be	VBD
cord-023095-4dannjjm	2210	10	collected	collect	VBN
cord-023095-4dannjjm	2210	11	from	from	IN
cord-023095-4dannjjm	2210	12	four	four	CD
cord-023095-4dannjjm	2210	13	healthy	healthy	JJ
cord-023095-4dannjjm	2210	14	cats	cat	NNS
cord-023095-4dannjjm	2210	15	immediately	immediately	RB
cord-023095-4dannjjm	2210	16	prior	prior	RB
cord-023095-4dannjjm	2210	17	to	to	IN
cord-023095-4dannjjm	2210	18	and	and	CC
cord-023095-4dannjjm	2210	19	approximately	approximately	RB
cord-023095-4dannjjm	2210	20	15	15	CD
cord-023095-4dannjjm	2210	21	minutes	minute	NNS
cord-023095-4dannjjm	2210	22	following	follow	VBG
cord-023095-4dannjjm	2210	23	a	a	DT
cord-023095-4dannjjm	2210	24	meal	meal	NN
cord-023095-4dannjjm	2210	25	,	,	,
cord-023095-4dannjjm	2210	26	for	for	IN
cord-023095-4dannjjm	2210	27	a	a	DT
cord-023095-4dannjjm	2210	28	total	total	NN
cord-023095-4dannjjm	2210	29	of	of	IN
cord-023095-4dannjjm	2210	30	8	8	CD
cord-023095-4dannjjm	2210	31	samples	sample	NNS
cord-023095-4dannjjm	2210	32	.	.	.
cord-023095-4dannjjm	2211	1	Dextrose	dextrose	NN
cord-023095-4dannjjm	2211	2	was	be	VBD
cord-023095-4dannjjm	2211	3	added	add	VBN
cord-023095-4dannjjm	2211	4	to	to	IN
cord-023095-4dannjjm	2211	5	the	the	DT
cord-023095-4dannjjm	2211	6	meals	meal	NNS
cord-023095-4dannjjm	2211	7	given	give	VBN
cord-023095-4dannjjm	2211	8	to	to	IN
cord-023095-4dannjjm	2211	9	two	two	CD
cord-023095-4dannjjm	2211	10	of	of	IN
cord-023095-4dannjjm	2211	11	the	the	DT
cord-023095-4dannjjm	2211	12	cats	cat	NNS
cord-023095-4dannjjm	2211	13	.	.	.
cord-023095-4dannjjm	2212	1	Blood	blood	NN
cord-023095-4dannjjm	2212	2	samples	sample	NNS
cord-023095-4dannjjm	2212	3	were	be	VBD
cord-023095-4dannjjm	2212	4	immediately	immediately	RB
cord-023095-4dannjjm	2212	5	centrifuged	centrifuge	VBN
cord-023095-4dannjjm	2212	6	and	and	CC
cord-023095-4dannjjm	2212	7	the	the	DT
cord-023095-4dannjjm	2212	8	serum	serum	NN
cord-023095-4dannjjm	2212	9	was	be	VBD
cord-023095-4dannjjm	2212	10	collected	collect	VBN
cord-023095-4dannjjm	2212	11	,	,	,
cord-023095-4dannjjm	2212	12	aliquoted	aliquote	VBN
cord-023095-4dannjjm	2212	13	,	,	,
cord-023095-4dannjjm	2212	14	and	and	CC
cord-023095-4dannjjm	2212	15	stored	store	VBN
cord-023095-4dannjjm	2212	16	at	at	IN
cord-023095-4dannjjm	2212	17	À201C	À201C	NNPS
cord-023095-4dannjjm	2212	18	until	until	IN
cord-023095-4dannjjm	2212	19	analysis	analysis	NN
cord-023095-4dannjjm	2212	20	.	.	.
cord-023095-4dannjjm	2213	1	Serum	serum	NN
cord-023095-4dannjjm	2213	2	insulin	insulin	NN
cord-023095-4dannjjm	2213	3	levels	level	NNS
cord-023095-4dannjjm	2213	4	were	be	VBD
cord-023095-4dannjjm	2213	5	determined	determine	VBN
cord-023095-4dannjjm	2213	6	in	in	IN
cord-023095-4dannjjm	2213	7	parallel	parallel	NN
cord-023095-4dannjjm	2213	8	with	with	IN
cord-023095-4dannjjm	2213	9	commercially	commercially	RB
cord-023095-4dannjjm	2213	10	-	-	HYPH
cord-023095-4dannjjm	2213	11	available	available	JJ
cord-023095-4dannjjm	2213	12	feline	feline	JJ
cord-023095-4dannjjm	2213	13	insulin	insulin	NN
cord-023095-4dannjjm	2213	14	and	and	CC
cord-023095-4dannjjm	2213	15	human	human	JJ
cord-023095-4dannjjm	2213	16	insulin	insulin	NN
cord-023095-4dannjjm	2213	17	ELISAs	elisa	NNS
cord-023095-4dannjjm	2213	18	.	.	.
cord-023095-4dannjjm	2214	1	The	the	DT
cord-023095-4dannjjm	2214	2	ELISAs	elisa	NNS
cord-023095-4dannjjm	2214	3	were	be	VBD
cord-023095-4dannjjm	2214	4	run	run	VBN
cord-023095-4dannjjm	2214	5	in	in	IN
cord-023095-4dannjjm	2214	6	duplicate	duplicate	NN
cord-023095-4dannjjm	2214	7	and	and	CC
cord-023095-4dannjjm	2214	8	according	accord	VBG
cord-023095-4dannjjm	2214	9	to	to	IN
cord-023095-4dannjjm	2214	10	the	the	DT
cord-023095-4dannjjm	2214	11	manufacturer	manufacturer	NN
cord-023095-4dannjjm	2214	12	's	's	POS
cord-023095-4dannjjm	2214	13	instructions	instruction	NNS
cord-023095-4dannjjm	2214	14	.	.	.
cord-023095-4dannjjm	2215	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	2215	2	of	of	IN
cord-023095-4dannjjm	2215	3	serum	serum	NN
cord-023095-4dannjjm	2215	4	insulin	insulin	NN
cord-023095-4dannjjm	2215	5	measured	measure	VBN
cord-023095-4dannjjm	2215	6	by	by	IN
cord-023095-4dannjjm	2215	7	the	the	DT
cord-023095-4dannjjm	2215	8	feline	feline	JJ
cord-023095-4dannjjm	2215	9	insulin	insulin	NN
cord-023095-4dannjjm	2215	10	ELISA	ELISA	NNP
cord-023095-4dannjjm	2215	11	ranged	range	VBD
cord-023095-4dannjjm	2215	12	from	from	IN
cord-023095-4dannjjm	2215	13	12.7	12.7	CD
cord-023095-4dannjjm	2215	14	ng	ng	NNP
cord-023095-4dannjjm	2215	15	/	/	SYM
cord-023095-4dannjjm	2215	16	L	L	NNP
cord-023095-4dannjjm	2215	17	to	to	IN
cord-023095-4dannjjm	2215	18	4	4	CD
cord-023095-4dannjjm	2215	19	700	700	CD
cord-023095-4dannjjm	2215	20	ng	ng	NNP
cord-023095-4dannjjm	2215	21	/	/	SYM
cord-023095-4dannjjm	2215	22	L.	L.	NNP
cord-023095-4dannjjm	2216	1	Despite	despite	IN
cord-023095-4dannjjm	2216	2	the	the	DT
cord-023095-4dannjjm	2216	3	wide	wide	JJ
cord-023095-4dannjjm	2216	4	range	range	NN
cord-023095-4dannjjm	2216	5	of	of	IN
cord-023095-4dannjjm	2216	6	concentrations	concentration	NNS
cord-023095-4dannjjm	2216	7	of	of	IN
cord-023095-4dannjjm	2216	8	feline	feline	JJ
cord-023095-4dannjjm	2216	9	insulin	insulin	NN
cord-023095-4dannjjm	2216	10	,	,	,
cord-023095-4dannjjm	2216	11	all	all	DT
cord-023095-4dannjjm	2216	12	8	8	CD
cord-023095-4dannjjm	2216	13	samples	sample	NNS
cord-023095-4dannjjm	2216	14	evaluated	evaluate	VBN
cord-023095-4dannjjm	2216	15	with	with	IN
cord-023095-4dannjjm	2216	16	the	the	DT
cord-023095-4dannjjm	2216	17	human	human	JJ
cord-023095-4dannjjm	2216	18	insulin	insulin	NN
cord-023095-4dannjjm	2216	19	ELISA	ELISA	NNP
cord-023095-4dannjjm	2216	20	yielded	yield	VBD
cord-023095-4dannjjm	2216	21	absorbance	absorbance	NN
cord-023095-4dannjjm	2216	22	readings	reading	NNS
cord-023095-4dannjjm	2216	23	equal	equal	JJ
cord-023095-4dannjjm	2216	24	to	to	IN
cord-023095-4dannjjm	2216	25	or	or	CC
cord-023095-4dannjjm	2216	26	lower	low	JJR
cord-023095-4dannjjm	2216	27	than	than	IN
cord-023095-4dannjjm	2216	28	the	the	DT
cord-023095-4dannjjm	2216	29	absorbance	absorbance	NN
cord-023095-4dannjjm	2216	30	of	of	IN
cord-023095-4dannjjm	2216	31	the	the	DT
cord-023095-4dannjjm	2216	32	negative	negative	JJ
cord-023095-4dannjjm	2216	33	control	control	NN
cord-023095-4dannjjm	2216	34	,	,	,
cord-023095-4dannjjm	2216	35	indicating	indicate	VBG
cord-023095-4dannjjm	2216	36	no	no	DT
cord-023095-4dannjjm	2216	37	crossreactivity	crossreactivity	NN
cord-023095-4dannjjm	2216	38	between	between	IN
cord-023095-4dannjjm	2216	39	the	the	DT
cord-023095-4dannjjm	2216	40	evaluated	evaluate	VBN
cord-023095-4dannjjm	2216	41	human	human	JJ
cord-023095-4dannjjm	2216	42	insulin	insulin	NN
cord-023095-4dannjjm	2216	43	assay	assay	NN
cord-023095-4dannjjm	2216	44	and	and	CC
cord-023095-4dannjjm	2216	45	feline	feline	JJ
cord-023095-4dannjjm	2216	46	insulin	insulin	NN
cord-023095-4dannjjm	2216	47	.	.	.
cord-023095-4dannjjm	2217	1	Since	since	IN
cord-023095-4dannjjm	2217	2	this	this	DT
cord-023095-4dannjjm	2217	3	assay	assay	NN
cord-023095-4dannjjm	2217	4	is	be	VBZ
cord-023095-4dannjjm	2217	5	reported	report	VBN
cord-023095-4dannjjm	2217	6	to	to	TO
cord-023095-4dannjjm	2217	7	cross	cross	VB
cord-023095-4dannjjm	2217	8	-	-	VB
cord-023095-4dannjjm	2217	9	react	react	VB
cord-023095-4dannjjm	2217	10	significantly	significantly	RB
cord-023095-4dannjjm	2217	11	with	with	IN
cord-023095-4dannjjm	2217	12	glargine	glargine	NNP
cord-023095-4dannjjm	2217	13	,	,	,
cord-023095-4dannjjm	2217	14	it	-PRON-	PRP
cord-023095-4dannjjm	2217	15	is	be	VBZ
cord-023095-4dannjjm	2217	16	a	a	DT
cord-023095-4dannjjm	2217	17	great	great	JJ
cord-023095-4dannjjm	2217	18	candidate	candidate	NN
cord-023095-4dannjjm	2217	19	for	for	IN
cord-023095-4dannjjm	2217	20	determination	determination	NN
cord-023095-4dannjjm	2217	21	of	of	IN
cord-023095-4dannjjm	2217	22	serum	serum	NN
cord-023095-4dannjjm	2217	23	glargine	glargine	JJ
cord-023095-4dannjjm	2217	24	concentrations	concentration	NNS
cord-023095-4dannjjm	2217	25	in	in	IN
cord-023095-4dannjjm	2217	26	cats	cat	NNS
cord-023095-4dannjjm	2217	27	.	.	.
cord-023095-4dannjjm	2218	1	The	the	DT
cord-023095-4dannjjm	2218	2	aim	aim	NN
cord-023095-4dannjjm	2218	3	of	of	IN
cord-023095-4dannjjm	2218	4	this	this	DT
cord-023095-4dannjjm	2218	5	prospective	prospective	NN
cord-023095-4dannjjm	2218	6	,	,	,
cord-023095-4dannjjm	2218	7	controlled	controlled	JJ
cord-023095-4dannjjm	2218	8	study	study	NN
cord-023095-4dannjjm	2218	9	was	be	VBD
cord-023095-4dannjjm	2218	10	to	to	TO
cord-023095-4dannjjm	2218	11	compare	compare	VB
cord-023095-4dannjjm	2218	12	the	the	DT
cord-023095-4dannjjm	2218	13	efficacy	efficacy	NN
cord-023095-4dannjjm	2218	14	of	of	IN
cord-023095-4dannjjm	2218	15	two	two	CD
cord-023095-4dannjjm	2218	16	trilostane	trilostane	NNP
cord-023095-4dannjjm	2218	17	protocols	protocol	NNS
cord-023095-4dannjjm	2218	18	for	for	IN
cord-023095-4dannjjm	2218	19	treatment	treatment	NN
cord-023095-4dannjjm	2218	20	of	of	IN
cord-023095-4dannjjm	2218	21	canine	canine	JJ
cord-023095-4dannjjm	2218	22	pituitary	pituitary	NN
cord-023095-4dannjjm	2218	23	-	-	HYPH
cord-023095-4dannjjm	2218	24	dependent	dependent	JJ
cord-023095-4dannjjm	2218	25	hyperadrenocorticism	hyperadrenocorticism	NN
cord-023095-4dannjjm	2218	26	(	(	-LRB-
cord-023095-4dannjjm	2218	27	PDH	PDH	NNP
cord-023095-4dannjjm	2218	28	)	)	-RRB-
cord-023095-4dannjjm	2218	29	.	.	.
cord-023095-4dannjjm	2219	1	Among	among	IN
cord-023095-4dannjjm	2219	2	the	the	DT
cord-023095-4dannjjm	2219	3	28	28	CD
cord-023095-4dannjjm	2219	4	client	client	NN
cord-023095-4dannjjm	2219	5	-	-	HYPH
cord-023095-4dannjjm	2219	6	owned	own	VBN
cord-023095-4dannjjm	2219	7	dogs	dog	NNS
cord-023095-4dannjjm	2219	8	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2219	9	with	with	IN
cord-023095-4dannjjm	2219	10	PDH	PDH	NNP
cord-023095-4dannjjm	2219	11	,	,	,
cord-023095-4dannjjm	2219	12	only	only	RB
cord-023095-4dannjjm	2219	13	the	the	DT
cord-023095-4dannjjm	2219	14	dogs	dog	NNS
cord-023095-4dannjjm	2219	15	weighing	weigh	VBG
cord-023095-4dannjjm	2219	16	o	o	NN
cord-023095-4dannjjm	2219	17	5	5	CD
cord-023095-4dannjjm	2219	18	kg	kg	NNS
cord-023095-4dannjjm	2219	19	were	be	VBD
cord-023095-4dannjjm	2219	20	selected	select	VBN
cord-023095-4dannjjm	2219	21	(	(	-LRB-
cord-023095-4dannjjm	2219	22	n	n	NN
cord-023095-4dannjjm	2219	23	5	5	CD
cord-023095-4dannjjm	2219	24	16	16	CD
cord-023095-4dannjjm	2219	25	)	)	-RRB-
cord-023095-4dannjjm	2219	26	.	.	.
cord-023095-4dannjjm	2220	1	Group	Group	NNP
cord-023095-4dannjjm	2220	2	A	A	NNP
cord-023095-4dannjjm	2220	3	(	(	-LRB-
cord-023095-4dannjjm	2220	4	n	n	NN
cord-023095-4dannjjm	2220	5	5	5	CD
cord-023095-4dannjjm	2220	6	9	9	CD
cord-023095-4dannjjm	2220	7	;	;	:
cord-023095-4dannjjm	2220	8	low	low	JJ
cord-023095-4dannjjm	2220	9	-	-	HYPH
cord-023095-4dannjjm	2220	10	dose	dose	NN
cord-023095-4dannjjm	2220	11	treatment	treatment	NN
cord-023095-4dannjjm	2220	12	group	group	NN
cord-023095-4dannjjm	2220	13	)	)	-RRB-
cord-023095-4dannjjm	2220	14	and	and	CC
cord-023095-4dannjjm	2220	15	group	group	NN
cord-023095-4dannjjm	2220	16	B	B	NNP
cord-023095-4dannjjm	2220	17	(	(	-LRB-
cord-023095-4dannjjm	2220	18	n	n	NN
cord-023095-4dannjjm	2220	19	5	5	CD
cord-023095-4dannjjm	2220	20	7	7	CD
cord-023095-4dannjjm	2220	21	;	;	:
cord-023095-4dannjjm	2220	22	high	high	JJ
cord-023095-4dannjjm	2220	23	-	-	HYPH
cord-023095-4dannjjm	2220	24	dose	dose	NN
cord-023095-4dannjjm	2220	25	treatment	treatment	NN
cord-023095-4dannjjm	2220	26	group	group	NN
cord-023095-4dannjjm	2220	27	)	)	-RRB-
cord-023095-4dannjjm	2220	28	received	receive	VBD
cord-023095-4dannjjm	2220	29	0.8	0.8	CD
cord-023095-4dannjjm	2220	30	AE	AE	NNP
cord-023095-4dannjjm	2220	31	0.3	0.3	CD
cord-023095-4dannjjm	2220	32	mg	mg	NN
cord-023095-4dannjjm	2220	33	of	of	IN
cord-023095-4dannjjm	2220	34	trilostane	trilostane	NNP
cord-023095-4dannjjm	2220	35	/	/	SYM
cord-023095-4dannjjm	2220	36	kg	kg	VBZ
cord-023095-4dannjjm	2220	37	orally	orally	RB
cord-023095-4dannjjm	2220	38	every	every	DT
cord-023095-4dannjjm	2220	39	12	12	CD
cord-023095-4dannjjm	2220	40	hours	hour	NNS
cord-023095-4dannjjm	2220	41	and	and	CC
cord-023095-4dannjjm	2220	42	30	30	CD
cord-023095-4dannjjm	2220	43	mg	mg	NN
cord-023095-4dannjjm	2220	44	of	of	IN
cord-023095-4dannjjm	2220	45	trilostane/	trilostane/	CD
cord-023095-4dannjjm	2220	46	body	body	NN
cord-023095-4dannjjm	2220	47	orally	orally	RB
cord-023095-4dannjjm	2220	48	every	every	DT
cord-023095-4dannjjm	2220	49	24	24	CD
cord-023095-4dannjjm	2220	50	hours	hour	NNS
cord-023095-4dannjjm	2220	51	,	,	,
cord-023095-4dannjjm	2220	52	respectively	respectively	RB
cord-023095-4dannjjm	2220	53	.	.	.
cord-023095-4dannjjm	2221	1	All	all	DT
cord-023095-4dannjjm	2221	2	of	of	IN
cord-023095-4dannjjm	2221	3	the	the	DT
cord-023095-4dannjjm	2221	4	dogs	dog	NNS
cord-023095-4dannjjm	2221	5	were	be	VBD
cord-023095-4dannjjm	2221	6	reassessed	reassess	VBN
cord-023095-4dannjjm	2221	7	at	at	IN
cord-023095-4dannjjm	2221	8	2	2	CD
cord-023095-4dannjjm	2221	9	,	,	,
cord-023095-4dannjjm	2221	10	4	4	CD
cord-023095-4dannjjm	2221	11	,	,	,
cord-023095-4dannjjm	2221	12	12	12	CD
cord-023095-4dannjjm	2221	13	,	,	,
cord-023095-4dannjjm	2221	14	and	and	CC
cord-023095-4dannjjm	2221	15	24	24	CD
cord-023095-4dannjjm	2221	16	weeks	week	NNS
cord-023095-4dannjjm	2221	17	after	after	IN
cord-023095-4dannjjm	2221	18	the	the	DT
cord-023095-4dannjjm	2221	19	initiation	initiation	NN
cord-023095-4dannjjm	2221	20	of	of	IN
cord-023095-4dannjjm	2221	21	treatment	treatment	NN
cord-023095-4dannjjm	2221	22	.	.	.
cord-023095-4dannjjm	2222	1	The	the	DT
cord-023095-4dannjjm	2222	2	improvement	improvement	NN
cord-023095-4dannjjm	2222	3	in	in	IN
cord-023095-4dannjjm	2222	4	post	post	JJ
cord-023095-4dannjjm	2222	5	-	-	JJ
cord-023095-4dannjjm	2222	6	ACTH	acth	JJ
cord-023095-4dannjjm	2222	7	stimulation	stimulation	NN
cord-023095-4dannjjm	2222	8	serum	serum	NN
cord-023095-4dannjjm	2222	9	cortisol	cortisol	NN
cord-023095-4dannjjm	2222	10	concentration	concentration	NN
cord-023095-4dannjjm	2222	11	,	,	,
cord-023095-4dannjjm	2222	12	as	as	RB
cord-023095-4dannjjm	2222	13	well	well	RB
cord-023095-4dannjjm	2222	14	as	as	IN
cord-023095-4dannjjm	2222	15	clinical	clinical	JJ
cord-023095-4dannjjm	2222	16	signs	sign	NNS
cord-023095-4dannjjm	2222	17	in	in	IN
cord-023095-4dannjjm	2222	18	group	group	NN
cord-023095-4dannjjm	2222	19	A	A	NNP
cord-023095-4dannjjm	2222	20	,	,	,
cord-023095-4dannjjm	2222	21	required	require	VBN
cord-023095-4dannjjm	2222	22	more	more	JJR
cord-023095-4dannjjm	2222	23	time	time	NN
cord-023095-4dannjjm	2222	24	than	than	IN
cord-023095-4dannjjm	2222	25	group	group	NN
cord-023095-4dannjjm	2222	26	B	b	NN
cord-023095-4dannjjm	2222	27	;	;	:
cord-023095-4dannjjm	2222	28	however	however	RB
cord-023095-4dannjjm	2222	29	,	,	,
cord-023095-4dannjjm	2222	30	2	2	CD
cord-023095-4dannjjm	2222	31	of	of	IN
cord-023095-4dannjjm	2222	32	7	7	CD
cord-023095-4dannjjm	2222	33	dogs	dog	NNS
cord-023095-4dannjjm	2222	34	in	in	IN
cord-023095-4dannjjm	2222	35	group	group	NN
cord-023095-4dannjjm	2222	36	B	B	NNP
cord-023095-4dannjjm	2222	37	had	have	VBD
cord-023095-4dannjjm	2222	38	clinical	clinical	JJ
cord-023095-4dannjjm	2222	39	signs	sign	NNS
cord-023095-4dannjjm	2222	40	and	and	CC
cord-023095-4dannjjm	2222	41	abnormal	abnormal	JJ
cord-023095-4dannjjm	2222	42	laboratory	laboratory	NN
cord-023095-4dannjjm	2222	43	findings	finding	NNS
cord-023095-4dannjjm	2222	44	consistent	consistent	JJ
cord-023095-4dannjjm	2222	45	with	with	IN
cord-023095-4dannjjm	2222	46	hypoadrenocorticism	hypoadrenocorticism	NN
cord-023095-4dannjjm	2222	47	after	after	IN
cord-023095-4dannjjm	2222	48	treatment	treatment	NN
cord-023095-4dannjjm	2222	49	for	for	IN
cord-023095-4dannjjm	2222	50	20	20	CD
cord-023095-4dannjjm	2222	51	weeks	week	NNS
cord-023095-4dannjjm	2222	52	.	.	.
cord-023095-4dannjjm	2223	1	Twenty	twenty	CD
cord-023095-4dannjjm	2223	2	-	-	HYPH
cord-023095-4dannjjm	2223	3	four	four	CD
cord-023095-4dannjjm	2223	4	weeks	week	NNS
cord-023095-4dannjjm	2223	5	later	later	RB
cord-023095-4dannjjm	2223	6	,	,	,
cord-023095-4dannjjm	2223	7	all	all	DT
cord-023095-4dannjjm	2223	8	of	of	IN
cord-023095-4dannjjm	2223	9	the	the	DT
cord-023095-4dannjjm	2223	10	dogs	dog	NNS
cord-023095-4dannjjm	2223	11	of	of	IN
cord-023095-4dannjjm	2223	12	both	both	DT
cord-023095-4dannjjm	2223	13	groups	group	NNS
cord-023095-4dannjjm	2223	14	improved	improve	VBD
cord-023095-4dannjjm	2223	15	the	the	DT
cord-023095-4dannjjm	2223	16	abnormal	abnormal	JJ
cord-023095-4dannjjm	2223	17	clinical	clinical	JJ
cord-023095-4dannjjm	2223	18	findings	finding	NNS
cord-023095-4dannjjm	2223	19	.	.	.
cord-023095-4dannjjm	2224	1	The	the	DT
cord-023095-4dannjjm	2224	2	present	present	JJ
cord-023095-4dannjjm	2224	3	study	study	NN
cord-023095-4dannjjm	2224	4	suggests	suggest	VBZ
cord-023095-4dannjjm	2224	5	that	that	IN
cord-023095-4dannjjm	2224	6	twice	twice	RB
cord-023095-4dannjjm	2224	7	daily	daily	JJ
cord-023095-4dannjjm	2224	8	,	,	,
cord-023095-4dannjjm	2224	9	low	low	JJ
cord-023095-4dannjjm	2224	10	-	-	HYPH
cord-023095-4dannjjm	2224	11	dose	dose	NN
cord-023095-4dannjjm	2224	12	administration	administration	NN
cord-023095-4dannjjm	2224	13	of	of	IN
cord-023095-4dannjjm	2224	14	trilostane	trilostane	NNP
cord-023095-4dannjjm	2224	15	is	be	VBZ
cord-023095-4dannjjm	2224	16	effective	effective	JJ
cord-023095-4dannjjm	2224	17	in	in	IN
cord-023095-4dannjjm	2224	18	the	the	DT
cord-023095-4dannjjm	2224	19	management	management	NN
cord-023095-4dannjjm	2224	20	of	of	IN
cord-023095-4dannjjm	2224	21	canine	canine	JJ
cord-023095-4dannjjm	2224	22	PDH	PDH	NNP
cord-023095-4dannjjm	2224	23	and	and	CC
cord-023095-4dannjjm	2224	24	may	may	MD
cord-023095-4dannjjm	2224	25	be	be	VB
cord-023095-4dannjjm	2224	26	safe	safe	JJ
cord-023095-4dannjjm	2224	27	without	without	IN
cord-023095-4dannjjm	2224	28	the	the	DT
cord-023095-4dannjjm	2224	29	potential	potential	JJ
cord-023095-4dannjjm	2224	30	adverse	adverse	JJ
cord-023095-4dannjjm	2224	31	effects	effect	NNS
cord-023095-4dannjjm	2224	32	of	of	IN
cord-023095-4dannjjm	2224	33	once	once	RB
cord-023095-4dannjjm	2224	34	daily	daily	JJ
cord-023095-4dannjjm	2224	35	,	,	,
cord-023095-4dannjjm	2224	36	high	high	JJ
cord-023095-4dannjjm	2224	37	-	-	HYPH
cord-023095-4dannjjm	2224	38	dose	dose	NN
cord-023095-4dannjjm	2224	39	treatment	treatment	NN
cord-023095-4dannjjm	2224	40	.	.	.
cord-023095-4dannjjm	2225	1	However	however	RB
cord-023095-4dannjjm	2225	2	,	,	,
cord-023095-4dannjjm	2225	3	because	because	IN
cord-023095-4dannjjm	2225	4	this	this	DT
cord-023095-4dannjjm	2225	5	study	study	NN
cord-023095-4dannjjm	2225	6	involved	involve	VBN
cord-023095-4dannjjm	2225	7	only	only	RB
cord-023095-4dannjjm	2225	8	a	a	DT
cord-023095-4dannjjm	2225	9	small	small	JJ
cord-023095-4dannjjm	2225	10	number	number	NN
cord-023095-4dannjjm	2225	11	of	of	IN
cord-023095-4dannjjm	2225	12	dogs	dog	NNS
cord-023095-4dannjjm	2225	13	,	,	,
cord-023095-4dannjjm	2225	14	a	a	DT
cord-023095-4dannjjm	2225	15	population	population	NN
cord-023095-4dannjjm	2225	16	-	-	HYPH
cord-023095-4dannjjm	2225	17	based	base	VBN
cord-023095-4dannjjm	2225	18	control	control	NN
cord-023095-4dannjjm	2225	19	study	study	NN
cord-023095-4dannjjm	2225	20	will	will	MD
cord-023095-4dannjjm	2225	21	be	be	VB
cord-023095-4dannjjm	2225	22	needed	need	VBN
cord-023095-4dannjjm	2225	23	to	to	TO
cord-023095-4dannjjm	2225	24	clarify	clarify	VB
cord-023095-4dannjjm	2225	25	the	the	DT
cord-023095-4dannjjm	2225	26	efficacy	efficacy	NN
cord-023095-4dannjjm	2225	27	of	of	IN
cord-023095-4dannjjm	2225	28	low	low	RB
cord-023095-4dannjjm	2225	29	-	-	HYPH
cord-023095-4dannjjm	2225	30	compared	compare	VBN
cord-023095-4dannjjm	2225	31	to	to	IN
cord-023095-4dannjjm	2225	32	high	high	JJ
cord-023095-4dannjjm	2225	33	-	-	HYPH
cord-023095-4dannjjm	2225	34	dose	dose	NN
cord-023095-4dannjjm	2225	35	trilostane	trilostane	NNP
cord-023095-4dannjjm	2225	36	treatment	treatment	NN
cord-023095-4dannjjm	2225	37	.	.	.
cord-023095-4dannjjm	2226	1	Cobalamin	Cobalamin	NNP
cord-023095-4dannjjm	2226	2	is	be	VBZ
cord-023095-4dannjjm	2226	3	essential	essential	JJ
cord-023095-4dannjjm	2226	4	for	for	IN
cord-023095-4dannjjm	2226	5	a	a	DT
cord-023095-4dannjjm	2226	6	variety	variety	NN
cord-023095-4dannjjm	2226	7	of	of	IN
cord-023095-4dannjjm	2226	8	metabolic	metabolic	JJ
cord-023095-4dannjjm	2226	9	processes	process	NNS
cord-023095-4dannjjm	2226	10	in	in	IN
cord-023095-4dannjjm	2226	11	many	many	JJ
cord-023095-4dannjjm	2226	12	tissues	tissue	NNS
cord-023095-4dannjjm	2226	13	and	and	CC
cord-023095-4dannjjm	2226	14	organs	organ	NNS
cord-023095-4dannjjm	2226	15	,	,	,
cord-023095-4dannjjm	2226	16	and	and	CC
cord-023095-4dannjjm	2226	17	has	have	VBZ
cord-023095-4dannjjm	2226	18	effects	effect	NNS
cord-023095-4dannjjm	2226	19	on	on	IN
cord-023095-4dannjjm	2226	20	cell	cell	NN
cord-023095-4dannjjm	2226	21	growth	growth	NN
cord-023095-4dannjjm	2226	22	and	and	CC
cord-023095-4dannjjm	2226	23	peripheral	peripheral	JJ
cord-023095-4dannjjm	2226	24	and	and	CC
cord-023095-4dannjjm	2226	25	central	central	JJ
cord-023095-4dannjjm	2226	26	nervous	nervous	JJ
cord-023095-4dannjjm	2226	27	system	system	NN
cord-023095-4dannjjm	2226	28	function	function	NN
cord-023095-4dannjjm	2226	29	.	.	.
cord-023095-4dannjjm	2227	1	Chronic	chronic	JJ
cord-023095-4dannjjm	2227	2	distal	distal	JJ
cord-023095-4dannjjm	2227	3	small	small	JJ
cord-023095-4dannjjm	2227	4	intestinal	intestinal	JJ
cord-023095-4dannjjm	2227	5	disease	disease	NN
cord-023095-4dannjjm	2227	6	in	in	IN
cord-023095-4dannjjm	2227	7	humans	human	NNS
cord-023095-4dannjjm	2227	8	,	,	,
cord-023095-4dannjjm	2227	9	cats	cat	NNS
cord-023095-4dannjjm	2227	10	,	,	,
cord-023095-4dannjjm	2227	11	and	and	CC
cord-023095-4dannjjm	2227	12	dogs	dog	NNS
cord-023095-4dannjjm	2227	13	has	have	VBZ
cord-023095-4dannjjm	2227	14	been	be	VBN
cord-023095-4dannjjm	2227	15	shown	show	VBN
cord-023095-4dannjjm	2227	16	to	to	TO
cord-023095-4dannjjm	2227	17	cause	cause	VB
cord-023095-4dannjjm	2227	18	cobalamin	cobalamin	JJ
cord-023095-4dannjjm	2227	19	deficiency	deficiency	NN
cord-023095-4dannjjm	2227	20	.	.	.
cord-023095-4dannjjm	2228	1	An	an	DT
cord-023095-4dannjjm	2228	2	immunoassay	immunoassay	NN
cord-023095-4dannjjm	2228	3	for	for	IN
cord-023095-4dannjjm	2228	4	the	the	DT
cord-023095-4dannjjm	2228	5	measurement	measurement	NN
cord-023095-4dannjjm	2228	6	of	of	IN
cord-023095-4dannjjm	2228	7	serum	serum	NN
cord-023095-4dannjjm	2228	8	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2228	9	concentration	concentration	NN
cord-023095-4dannjjm	2228	10	in	in	IN
cord-023095-4dannjjm	2228	11	these	these	DT
cord-023095-4dannjjm	2228	12	species	specie	NNS
cord-023095-4dannjjm	2228	13	is	be	VBZ
cord-023095-4dannjjm	2228	14	being	be	VBG
cord-023095-4dannjjm	2228	15	used	use	VBN
cord-023095-4dannjjm	2228	16	in	in	IN
cord-023095-4dannjjm	2228	17	routine	routine	JJ
cord-023095-4dannjjm	2228	18	practice	practice	NN
cord-023095-4dannjjm	2228	19	for	for	IN
cord-023095-4dannjjm	2228	20	the	the	DT
cord-023095-4dannjjm	2228	21	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2228	22	of	of	IN
cord-023095-4dannjjm	2228	23	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2228	24	deficiency	deficiency	NN
cord-023095-4dannjjm	2228	25	.	.	.
cord-023095-4dannjjm	2229	1	In	in	IN
cord-023095-4dannjjm	2229	2	pigs	pig	NNS
cord-023095-4dannjjm	2229	3	,	,	,
cord-023095-4dannjjm	2229	4	the	the	DT
cord-023095-4dannjjm	2229	5	role	role	NN
cord-023095-4dannjjm	2229	6	of	of	IN
cord-023095-4dannjjm	2229	7	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2229	8	has	have	VBZ
cord-023095-4dannjjm	2229	9	not	not	RB
cord-023095-4dannjjm	2229	10	yet	yet	RB
cord-023095-4dannjjm	2229	11	been	be	VBN
cord-023095-4dannjjm	2229	12	extensively	extensively	RB
cord-023095-4dannjjm	2229	13	investigated	investigate	VBN
cord-023095-4dannjjm	2229	14	.	.	.
cord-023095-4dannjjm	2230	1	Thus	thus	RB
cord-023095-4dannjjm	2230	2	,	,	,
cord-023095-4dannjjm	2230	3	the	the	DT
cord-023095-4dannjjm	2230	4	aim	aim	NN
cord-023095-4dannjjm	2230	5	of	of	IN
cord-023095-4dannjjm	2230	6	this	this	DT
cord-023095-4dannjjm	2230	7	study	study	NN
cord-023095-4dannjjm	2230	8	was	be	VBD
cord-023095-4dannjjm	2230	9	to	to	TO
cord-023095-4dannjjm	2230	10	analytically	analytically	RB
cord-023095-4dannjjm	2230	11	validate	validate	VB
cord-023095-4dannjjm	2230	12	an	an	DT
cord-023095-4dannjjm	2230	13	immunoassay	immunoassay	NN
cord-023095-4dannjjm	2230	14	,	,	,
cord-023095-4dannjjm	2230	15	labeled	label	VBN
cord-023095-4dannjjm	2230	16	for	for	IN
cord-023095-4dannjjm	2230	17	use	use	NN
cord-023095-4dannjjm	2230	18	in	in	IN
cord-023095-4dannjjm	2230	19	humans	human	NNS
cord-023095-4dannjjm	2230	20	,	,	,
cord-023095-4dannjjm	2230	21	for	for	IN
cord-023095-4dannjjm	2230	22	the	the	DT
cord-023095-4dannjjm	2230	23	measurement	measurement	NN
cord-023095-4dannjjm	2230	24	of	of	IN
cord-023095-4dannjjm	2230	25	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2230	26	in	in	IN
cord-023095-4dannjjm	2230	27	porcine	porcine	JJ
cord-023095-4dannjjm	2230	28	serum	serum	NN
cord-023095-4dannjjm	2230	29	samples	sample	NNS
cord-023095-4dannjjm	2230	30	and	and	CC
cord-023095-4dannjjm	2230	31	secondly	secondly	RB
cord-023095-4dannjjm	2230	32	to	to	TO
cord-023095-4dannjjm	2230	33	determine	determine	VB
cord-023095-4dannjjm	2230	34	serum	serum	NN
cord-023095-4dannjjm	2230	35	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2230	36	concentrations	concentration	NNS
cord-023095-4dannjjm	2230	37	in	in	IN
cord-023095-4dannjjm	2230	38	weaned	wean	VBN
cord-023095-4dannjjm	2230	39	pigs	pig	NNS
cord-023095-4dannjjm	2230	40	.	.	.
cord-023095-4dannjjm	2231	1	For	for	IN
cord-023095-4dannjjm	2231	2	the	the	DT
cord-023095-4dannjjm	2231	3	analytical	analytical	JJ
cord-023095-4dannjjm	2231	4	validation	validation	NN
cord-023095-4dannjjm	2231	5	of	of	IN
cord-023095-4dannjjm	2231	6	the	the	DT
cord-023095-4dannjjm	2231	7	assay	assay	NN
cord-023095-4dannjjm	2231	8	,	,	,
cord-023095-4dannjjm	2231	9	serum	serum	NN
cord-023095-4dannjjm	2231	10	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2231	11	concentrations	concentration	NNS
cord-023095-4dannjjm	2231	12	were	be	VBD
cord-023095-4dannjjm	2231	13	measured	measure	VBN
cord-023095-4dannjjm	2231	14	using	use	VBG
cord-023095-4dannjjm	2231	15	the	the	DT
cord-023095-4dannjjm	2231	16	commercially	commercially	RB
cord-023095-4dannjjm	2231	17	available	available	JJ
cord-023095-4dannjjm	2231	18	IMMULITE	IMMULITE	NNP
cord-023095-4dannjjm	2231	19	s	s	NN
cord-023095-4dannjjm	2231	20	2000	2000	CD
cord-023095-4dannjjm	2231	21	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2231	22	immunoassay	immunoassay	NN
cord-023095-4dannjjm	2231	23	(	(	-LRB-
cord-023095-4dannjjm	2231	24	Siemens	Siemens	NNP
cord-023095-4dannjjm	2231	25	Healthcare	Healthcare	NNP
cord-023095-4dannjjm	2231	26	Diagnostics	Diagnostics	NNPS
cord-023095-4dannjjm	2231	27	Ltd.	Ltd.	NNP
cord-023095-4dannjjm	2231	28	,	,	,
cord-023095-4dannjjm	2231	29	Deerfield	Deerfield	NNP
cord-023095-4dannjjm	2231	30	,	,	,
cord-023095-4dannjjm	2231	31	IL	IL	NNP
cord-023095-4dannjjm	2231	32	,	,	,
cord-023095-4dannjjm	2231	33	USA	USA	NNP
cord-023095-4dannjjm	2231	34	)	)	-RRB-
cord-023095-4dannjjm	2231	35	in	in	IN
cord-023095-4dannjjm	2231	36	30	30	CD
cord-023095-4dannjjm	2231	37	surplus	surplus	JJ
cord-023095-4dannjjm	2231	38	porcine	porcine	JJ
cord-023095-4dannjjm	2231	39	serum	serum	NN
cord-023095-4dannjjm	2231	40	samples	sample	NNS
cord-023095-4dannjjm	2231	41	from	from	IN
cord-023095-4dannjjm	2231	42	a	a	DT
cord-023095-4dannjjm	2231	43	variety	variety	NN
cord-023095-4dannjjm	2231	44	of	of	IN
cord-023095-4dannjjm	2231	45	studies	study	NNS
cord-023095-4dannjjm	2231	46	.	.	.
cord-023095-4dannjjm	2232	1	Validation	validation	NN
cord-023095-4dannjjm	2232	2	of	of	IN
cord-023095-4dannjjm	2232	3	the	the	DT
cord-023095-4dannjjm	2232	4	assay	assay	NN
cord-023095-4dannjjm	2232	5	consisted	consist	VBD
cord-023095-4dannjjm	2232	6	of	of	IN
cord-023095-4dannjjm	2232	7	determination	determination	NN
cord-023095-4dannjjm	2232	8	of	of	IN
cord-023095-4dannjjm	2232	9	dilutional	dilutional	JJ
cord-023095-4dannjjm	2232	10	parallelism	parallelism	NN
cord-023095-4dannjjm	2232	11	,	,	,
cord-023095-4dannjjm	2232	12	spiking	spike	VBG
cord-023095-4dannjjm	2232	13	recovery	recovery	NN
cord-023095-4dannjjm	2232	14	,	,	,
cord-023095-4dannjjm	2232	15	and	and	CC
cord-023095-4dannjjm	2232	16	intra	intra	JJ
cord-023095-4dannjjm	2232	17	-	-	:
cord-023095-4dannjjm	2232	18	and	and	CC
cord-023095-4dannjjm	2232	19	inter	inter	JJ
cord-023095-4dannjjm	2232	20	-	-	JJ
cord-023095-4dannjjm	2232	21	assay	assay	JJ
cord-023095-4dannjjm	2232	22	variability	variability	NN
cord-023095-4dannjjm	2232	23	.	.	.
cord-023095-4dannjjm	2233	1	Additional	additional	JJ
cord-023095-4dannjjm	2233	2	surplus	surplus	NN
cord-023095-4dannjjm	2233	3	serum	serum	NN
cord-023095-4dannjjm	2233	4	samples	sample	NNS
cord-023095-4dannjjm	2233	5	from	from	IN
cord-023095-4dannjjm	2233	6	27	27	CD
cord-023095-4dannjjm	2233	7	piglets	piglet	NNS
cord-023095-4dannjjm	2233	8	from	from	IN
cord-023095-4dannjjm	2233	9	four	four	CD
cord-023095-4dannjjm	2233	10	litters	litter	NNS
cord-023095-4dannjjm	2233	11	at	at	IN
cord-023095-4dannjjm	2233	12	a	a	DT
cord-023095-4dannjjm	2233	13	Texas	Texas	NNP
cord-023095-4dannjjm	2233	14	A&M	A&M	NNP
cord-023095-4dannjjm	2233	15	University	University	NNP
cord-023095-4dannjjm	2233	16	farm	farm	NN
cord-023095-4dannjjm	2233	17	were	be	VBD
cord-023095-4dannjjm	2233	18	obtained	obtain	VBN
cord-023095-4dannjjm	2233	19	.	.	.
cord-023095-4dannjjm	2234	1	Each	each	DT
cord-023095-4dannjjm	2234	2	piglet	piglet	NN
cord-023095-4dannjjm	2234	3	had	have	VBD
cord-023095-4dannjjm	2234	4	been	be	VBN
cord-023095-4dannjjm	2234	5	bled	bleed	VBN
cord-023095-4dannjjm	2234	6	twice	twice	RB
cord-023095-4dannjjm	2234	7	,	,	,
cord-023095-4dannjjm	2234	8	the	the	DT
cord-023095-4dannjjm	2234	9	first	first	JJ
cord-023095-4dannjjm	2234	10	at	at	IN
cord-023095-4dannjjm	2234	11	weaning	wean	VBG
cord-023095-4dannjjm	2234	12	(	(	-LRB-
cord-023095-4dannjjm	2234	13	21	21	CD
cord-023095-4dannjjm	2234	14	days	day	NNS
cord-023095-4dannjjm	2234	15	of	of	IN
cord-023095-4dannjjm	2234	16	age	age	NN
cord-023095-4dannjjm	2234	17	)	)	-RRB-
cord-023095-4dannjjm	2234	18	and	and	CC
cord-023095-4dannjjm	2234	19	the	the	DT
cord-023095-4dannjjm	2234	20	second	second	JJ
cord-023095-4dannjjm	2234	21	one	one	CD
cord-023095-4dannjjm	2234	22	12	12	CD
cord-023095-4dannjjm	2234	23	days	day	NNS
cord-023095-4dannjjm	2234	24	later	later	RB
cord-023095-4dannjjm	2234	25	.	.	.
cord-023095-4dannjjm	2235	1	To	to	TO
cord-023095-4dannjjm	2235	2	investigate	investigate	VB
cord-023095-4dannjjm	2235	3	results	result	NNS
cord-023095-4dannjjm	2235	4	in	in	IN
cord-023095-4dannjjm	2235	5	comparison	comparison	NN
cord-023095-4dannjjm	2235	6	between	between	IN
cord-023095-4dannjjm	2235	7	age	age	NN
cord-023095-4dannjjm	2235	8	groups	group	NNS
cord-023095-4dannjjm	2235	9	,	,	,
cord-023095-4dannjjm	2235	10	serum	serum	NN
cord-023095-4dannjjm	2235	11	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2235	12	concentrations	concentration	NNS
cord-023095-4dannjjm	2235	13	were	be	VBD
cord-023095-4dannjjm	2235	14	compared	compare	VBN
cord-023095-4dannjjm	2235	15	using	use	VBG
cord-023095-4dannjjm	2235	16	a	a	DT
cord-023095-4dannjjm	2235	17	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	2235	18	matched	match	VBN
cord-023095-4dannjjm	2235	19	pairs	pair	NNS
cord-023095-4dannjjm	2235	20	test	test	VBP
cord-023095-4dannjjm	2235	21	.	.	.
cord-023095-4dannjjm	2236	1	Significance	significance	NN
cord-023095-4dannjjm	2236	2	was	be	VBD
cord-023095-4dannjjm	2236	3	set	set	VBN
cord-023095-4dannjjm	2236	4	at	at	IN
cord-023095-4dannjjm	2236	5	p	p	NN
cord-023095-4dannjjm	2236	6	o	o	NN
cord-023095-4dannjjm	2236	7	0.05	0.05	CD
cord-023095-4dannjjm	2236	8	.	.	.
cord-023095-4dannjjm	2237	1	Observed	observe	VBN
cord-023095-4dannjjm	2237	2	to	to	TO
cord-023095-4dannjjm	2237	3	expected	expect	VBN
cord-023095-4dannjjm	2237	4	ratios	ratio	NNS
cord-023095-4dannjjm	2237	5	(	(	-LRB-
cord-023095-4dannjjm	2237	6	O	o	UH
cord-023095-4dannjjm	2237	7	/	/	SYM
cord-023095-4dannjjm	2237	8	E	e	NN
cord-023095-4dannjjm	2237	9	)	)	-RRB-
cord-023095-4dannjjm	2237	10	for	for	IN
cord-023095-4dannjjm	2237	11	serial	serial	JJ
cord-023095-4dannjjm	2237	12	dilutions	dilution	NNS
cord-023095-4dannjjm	2237	13	ranged	range	VBD
cord-023095-4dannjjm	2237	14	from	from	IN
cord-023095-4dannjjm	2237	15	87.3	87.3	CD
cord-023095-4dannjjm	2237	16	to	to	IN
cord-023095-4dannjjm	2237	17	124.9	124.9	CD
cord-023095-4dannjjm	2237	18	%	%	NN
cord-023095-4dannjjm	2237	19	(	(	-LRB-
cord-023095-4dannjjm	2237	20	mean	mean	VB
cord-023095-4dannjjm	2237	21	AE	AE	NNP
cord-023095-4dannjjm	2237	22	SD	SD	NNP
cord-023095-4dannjjm	2237	23	:	:	:
cord-023095-4dannjjm	2237	24	104.2	104.2	CD
cord-023095-4dannjjm	2237	25	AE	AE	NNP
cord-023095-4dannjjm	2237	26	14.5	14.5	CD
cord-023095-4dannjjm	2237	27	%	%	NN
cord-023095-4dannjjm	2237	28	)	)	-RRB-
cord-023095-4dannjjm	2237	29	for	for	IN
cord-023095-4dannjjm	2237	30	four	four	CD
cord-023095-4dannjjm	2237	31	different	different	JJ
cord-023095-4dannjjm	2237	32	serum	serum	NN
cord-023095-4dannjjm	2237	33	samples	sample	NNS
cord-023095-4dannjjm	2237	34	at	at	IN
cord-023095-4dannjjm	2237	35	dilutions	dilution	NNS
cord-023095-4dannjjm	2237	36	of	of	IN
cord-023095-4dannjjm	2237	37	1:1	1:1	CD
cord-023095-4dannjjm	2237	38	,	,	,
cord-023095-4dannjjm	2237	39	1:2	1:2	CD
cord-023095-4dannjjm	2237	40	,	,	,
cord-023095-4dannjjm	2237	41	and	and	CC
cord-023095-4dannjjm	2237	42	1:4	1:4	CD
cord-023095-4dannjjm	2237	43	,	,	,
cord-023095-4dannjjm	2237	44	and	and	CC
cord-023095-4dannjjm	2237	45	from	from	IN
cord-023095-4dannjjm	2237	46	96.8	96.8	CD
cord-023095-4dannjjm	2237	47	to	to	IN
cord-023095-4dannjjm	2237	48	118.3	118.3	CD
cord-023095-4dannjjm	2237	49	%	%	NN
cord-023095-4dannjjm	2237	50	(	(	-LRB-
cord-023095-4dannjjm	2237	51	mean	mean	VB
cord-023095-4dannjjm	2237	52	AE	AE	NNP
cord-023095-4dannjjm	2237	53	SD	SD	NNP
cord-023095-4dannjjm	2237	54	:	:	:
cord-023095-4dannjjm	2237	55	107.6	107.6	CD
cord-023095-4dannjjm	2237	56	AE	AE	NNP
cord-023095-4dannjjm	2237	57	15.2	15.2	CD
cord-023095-4dannjjm	2237	58	%	%	NN
cord-023095-4dannjjm	2237	59	)	)	-RRB-
cord-023095-4dannjjm	2237	60	for	for	IN
cord-023095-4dannjjm	2237	61	one	one	CD
cord-023095-4dannjjm	2237	62	serum	serum	NN
cord-023095-4dannjjm	2237	63	sample	sample	NN
cord-023095-4dannjjm	2237	64	at	at	IN
cord-023095-4dannjjm	2237	65	dilutions	dilution	NNS
cord-023095-4dannjjm	2237	66	of	of	IN
cord-023095-4dannjjm	2237	67	1:2	1:2	CD
cord-023095-4dannjjm	2237	68	,	,	,
cord-023095-4dannjjm	2237	69	1:4	1:4	CD
cord-023095-4dannjjm	2237	70	,	,	,
cord-023095-4dannjjm	2237	71	and	and	CC
cord-023095-4dannjjm	2237	72	1:8	1:8	CD
cord-023095-4dannjjm	2237	73	.	.	.
cord-023095-4dannjjm	2238	1	O	o	UH
cord-023095-4dannjjm	2238	2	/	/	SYM
cord-023095-4dannjjm	2238	3	E	e	NN
cord-023095-4dannjjm	2238	4	for	for	IN
cord-023095-4dannjjm	2238	5	spiking	spike	VBG
cord-023095-4dannjjm	2238	6	recovery	recovery	NN
cord-023095-4dannjjm	2238	7	ranged	range	VBD
cord-023095-4dannjjm	2238	8	from	from	IN
cord-023095-4dannjjm	2238	9	87.4	87.4	CD
cord-023095-4dannjjm	2238	10	to	to	IN
cord-023095-4dannjjm	2238	11	116.7	116.7	CD
cord-023095-4dannjjm	2238	12	%	%	NN
cord-023095-4dannjjm	2239	1	(	(	-LRB-
cord-023095-4dannjjm	2239	2	mean	mean	VB
cord-023095-4dannjjm	2239	3	AE	AE	NNP
cord-023095-4dannjjm	2239	4	SD	SD	NNP
cord-023095-4dannjjm	2239	5	:	:	:
cord-023095-4dannjjm	2240	1	102.0	102.0	CD
cord-023095-4dannjjm	2240	2	AE	AE	NNP
cord-023095-4dannjjm	2240	3	7.5	7.5	CD
cord-023095-4dannjjm	2240	4	%	%	NN
cord-023095-4dannjjm	2240	5	)	)	-RRB-
cord-023095-4dannjjm	2240	6	for	for	IN
cord-023095-4dannjjm	2240	7	five	five	CD
cord-023095-4dannjjm	2240	8	different	different	JJ
cord-023095-4dannjjm	2240	9	porcine	porcine	JJ
cord-023095-4dannjjm	2240	10	serum	serum	NN
cord-023095-4dannjjm	2240	11	samples	sample	NNS
cord-023095-4dannjjm	2240	12	that	that	WDT
cord-023095-4dannjjm	2240	13	had	have	VBD
cord-023095-4dannjjm	2240	14	been	be	VBN
cord-023095-4dannjjm	2240	15	spiked	spike	VBN
cord-023095-4dannjjm	2240	16	with	with	IN
cord-023095-4dannjjm	2240	17	each	each	DT
cord-023095-4dannjjm	2240	18	other	other	JJ
cord-023095-4dannjjm	2240	19	in	in	IN
cord-023095-4dannjjm	2240	20	a	a	DT
cord-023095-4dannjjm	2240	21	1:1	1:1	CD
cord-023095-4dannjjm	2240	22	dilution	dilution	NN
cord-023095-4dannjjm	2240	23	.	.	.
cord-023095-4dannjjm	2241	1	Intraassay	Intraassay	NNP
cord-023095-4dannjjm	2241	2	coefficients	coefficient	NNS
cord-023095-4dannjjm	2241	3	of	of	IN
cord-023095-4dannjjm	2241	4	variation	variation	NN
cord-023095-4dannjjm	2241	5	(	(	-LRB-
cord-023095-4dannjjm	2241	6	%	%	NN
cord-023095-4dannjjm	2241	7	CV	CV	NNP
cord-023095-4dannjjm	2241	8	)	)	-RRB-
cord-023095-4dannjjm	2241	9	for	for	IN
cord-023095-4dannjjm	2241	10	five	five	CD
cord-023095-4dannjjm	2241	11	different	different	JJ
cord-023095-4dannjjm	2241	12	serum	serum	NN
cord-023095-4dannjjm	2241	13	samples	sample	NNS
cord-023095-4dannjjm	2241	14	were	be	VBD
cord-023095-4dannjjm	2241	15	4.3	4.3	CD
cord-023095-4dannjjm	2241	16	,	,	,
cord-023095-4dannjjm	2241	17	5.7	5.7	CD
cord-023095-4dannjjm	2241	18	,	,	,
cord-023095-4dannjjm	2241	19	4.3	4.3	CD
cord-023095-4dannjjm	2241	20	,	,	,
cord-023095-4dannjjm	2241	21	3.7	3.7	CD
cord-023095-4dannjjm	2241	22	,	,	,
cord-023095-4dannjjm	2241	23	and	and	CC
cord-023095-4dannjjm	2241	24	6.1	6.1	CD
cord-023095-4dannjjm	2241	25	%	%	NN
cord-023095-4dannjjm	2241	26	.	.	.
cord-023095-4dannjjm	2242	1	Inter	inter	JJ
cord-023095-4dannjjm	2242	2	-	-	JJ
cord-023095-4dannjjm	2242	3	assay	assay	NN
cord-023095-4dannjjm	2242	4	%	%	NN
cord-023095-4dannjjm	2242	5	CVs	cv	NNS
cord-023095-4dannjjm	2242	6	for	for	IN
cord-023095-4dannjjm	2242	7	five	five	CD
cord-023095-4dannjjm	2242	8	different	different	JJ
cord-023095-4dannjjm	2242	9	serum	serum	NN
cord-023095-4dannjjm	2242	10	samples	sample	NNS
cord-023095-4dannjjm	2242	11	were	be	VBD
cord-023095-4dannjjm	2242	12	4.9	4.9	CD
cord-023095-4dannjjm	2242	13	,	,	,
cord-023095-4dannjjm	2242	14	7.2	7.2	CD
cord-023095-4dannjjm	2242	15	,	,	,
cord-023095-4dannjjm	2242	16	9.6	9.6	CD
cord-023095-4dannjjm	2242	17	,	,	,
cord-023095-4dannjjm	2242	18	3.5	3.5	CD
cord-023095-4dannjjm	2242	19	,	,	,
cord-023095-4dannjjm	2242	20	and	and	CC
cord-023095-4dannjjm	2242	21	7.6	7.6	CD
cord-023095-4dannjjm	2242	22	%	%	NN
cord-023095-4dannjjm	2242	23	.	.	.
cord-023095-4dannjjm	2243	1	Serum	serum	NN
cord-023095-4dannjjm	2243	2	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2243	3	concentration	concentration	NN
cord-023095-4dannjjm	2243	4	was	be	VBD
cord-023095-4dannjjm	2243	5	significantly	significantly	RB
cord-023095-4dannjjm	2243	6	lower	low	JJR
cord-023095-4dannjjm	2243	7	in	in	IN
cord-023095-4dannjjm	2243	8	piglets	piglet	NNS
cord-023095-4dannjjm	2244	1	post	post	JJ
cord-023095-4dannjjm	2244	2	weaning	weaning	NN
cord-023095-4dannjjm	2244	3	(	(	-LRB-
cord-023095-4dannjjm	2244	4	median	median	NN
cord-023095-4dannjjm	2244	5	:	:	:
cord-023095-4dannjjm	2244	6	242	242	CD
cord-023095-4dannjjm	2244	7	ng	ng	NNP
cord-023095-4dannjjm	2244	8	/	/	SYM
cord-023095-4dannjjm	2244	9	L	L	NNP
cord-023095-4dannjjm	2244	10	)	)	-RRB-
cord-023095-4dannjjm	2244	11	compared	compare	VBN
cord-023095-4dannjjm	2244	12	to	to	IN
cord-023095-4dannjjm	2244	13	those	those	DT
cord-023095-4dannjjm	2244	14	at	at	IN
cord-023095-4dannjjm	2244	15	the	the	DT
cord-023095-4dannjjm	2244	16	time	time	NN
cord-023095-4dannjjm	2244	17	of	of	IN
cord-023095-4dannjjm	2244	18	weaning	weaning	NN
cord-023095-4dannjjm	2244	19	(	(	-LRB-
cord-023095-4dannjjm	2244	20	median	median	NN
cord-023095-4dannjjm	2244	21	:	:	:
cord-023095-4dannjjm	2244	22	324	324	CD
cord-023095-4dannjjm	2244	23	ng	ng	NNP
cord-023095-4dannjjm	2244	24	/	/	SYM
cord-023095-4dannjjm	2244	25	L	l	NN
cord-023095-4dannjjm	2244	26	;	;	:
cord-023095-4dannjjm	2244	27	p	p	NN
cord-023095-4dannjjm	2244	28	5	5	CD
cord-023095-4dannjjm	2244	29	0.009	0.009	CD
cord-023095-4dannjjm	2244	30	)	)	-RRB-
cord-023095-4dannjjm	2244	31	.	.	.
cord-023095-4dannjjm	2245	1	The	the	DT
cord-023095-4dannjjm	2245	2	IMMULITE	IMMULITE	NNP
cord-023095-4dannjjm	2245	3	s	s	NNP
cord-023095-4dannjjm	2245	4	2000	2000	CD
cord-023095-4dannjjm	2245	5	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2245	6	immunoassay	immunoassay	NN
cord-023095-4dannjjm	2245	7	labeled	label	VBN
cord-023095-4dannjjm	2245	8	for	for	IN
cord-023095-4dannjjm	2245	9	use	use	NN
cord-023095-4dannjjm	2245	10	in	in	IN
cord-023095-4dannjjm	2245	11	humans	human	NNS
cord-023095-4dannjjm	2245	12	is	be	VBZ
cord-023095-4dannjjm	2245	13	linear	linear	JJ
cord-023095-4dannjjm	2245	14	,	,	,
cord-023095-4dannjjm	2245	15	accurate	accurate	JJ
cord-023095-4dannjjm	2245	16	,	,	,
cord-023095-4dannjjm	2245	17	precise	precise	JJ
cord-023095-4dannjjm	2245	18	,	,	,
cord-023095-4dannjjm	2245	19	and	and	CC
cord-023095-4dannjjm	2245	20	reproducible	reproducible	JJ
cord-023095-4dannjjm	2245	21	for	for	IN
cord-023095-4dannjjm	2245	22	measurement	measurement	NN
cord-023095-4dannjjm	2245	23	of	of	IN
cord-023095-4dannjjm	2245	24	serum	serum	NN
cord-023095-4dannjjm	2245	25	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2245	26	concentrations	concentration	NNS
cord-023095-4dannjjm	2245	27	in	in	IN
cord-023095-4dannjjm	2245	28	pigs	pig	NNS
cord-023095-4dannjjm	2245	29	.	.	.
cord-023095-4dannjjm	2246	1	This	this	DT
cord-023095-4dannjjm	2246	2	study	study	NN
cord-023095-4dannjjm	2246	3	also	also	RB
cord-023095-4dannjjm	2246	4	showed	show	VBD
cord-023095-4dannjjm	2246	5	that	that	IN
cord-023095-4dannjjm	2246	6	piglets	piglet	NNS
cord-023095-4dannjjm	2246	7	that	that	WDT
cord-023095-4dannjjm	2246	8	differ	differ	VBP
cord-023095-4dannjjm	2246	9	in	in	IN
cord-023095-4dannjjm	2246	10	age	age	NN
cord-023095-4dannjjm	2246	11	by	by	IN
cord-023095-4dannjjm	2246	12	only	only	RB
cord-023095-4dannjjm	2246	13	12	12	CD
cord-023095-4dannjjm	2246	14	days	day	NNS
cord-023095-4dannjjm	2246	15	have	have	VBP
cord-023095-4dannjjm	2246	16	significantly	significantly	RB
cord-023095-4dannjjm	2246	17	different	different	JJ
cord-023095-4dannjjm	2246	18	serum	serum	NN
cord-023095-4dannjjm	2246	19	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2246	20	concentrations	concentration	NNS
cord-023095-4dannjjm	2246	21	.	.	.
cord-023095-4dannjjm	2247	1	Further	further	JJ
cord-023095-4dannjjm	2247	2	investigations	investigation	NNS
cord-023095-4dannjjm	2247	3	of	of	IN
cord-023095-4dannjjm	2247	4	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2247	5	concentrations	concentration	NNS
cord-023095-4dannjjm	2247	6	in	in	IN
cord-023095-4dannjjm	2247	7	both	both	DT
cord-023095-4dannjjm	2247	8	sows	sow	NNS
cord-023095-4dannjjm	2247	9	and	and	CC
cord-023095-4dannjjm	2247	10	piglets	piglet	NNS
cord-023095-4dannjjm	2247	11	at	at	IN
cord-023095-4dannjjm	2247	12	different	different	JJ
cord-023095-4dannjjm	2247	13	stages	stage	NNS
cord-023095-4dannjjm	2247	14	of	of	IN
cord-023095-4dannjjm	2247	15	weaning	weaning	NN
cord-023095-4dannjjm	2247	16	are	be	VBP
cord-023095-4dannjjm	2247	17	warranted	warrant	VBN
cord-023095-4dannjjm	2247	18	.	.	.
cord-023095-4dannjjm	2248	1	Primigravid	Primigravid	NNP
cord-023095-4dannjjm	2248	2	dairy	dairy	NN
cord-023095-4dannjjm	2248	3	heifers	heifer	NNS
cord-023095-4dannjjm	2248	4	can	can	MD
cord-023095-4dannjjm	2248	5	be	be	VB
cord-023095-4dannjjm	2248	6	infected	infect	VBN
cord-023095-4dannjjm	2248	7	with	with	IN
cord-023095-4dannjjm	2248	8	mastitis	mastitis	NN
cord-023095-4dannjjm	2248	9	pathogens	pathogen	NNS
cord-023095-4dannjjm	2248	10	during	during	IN
cord-023095-4dannjjm	2248	11	the	the	DT
cord-023095-4dannjjm	2248	12	periparturient	periparturient	JJ
cord-023095-4dannjjm	2248	13	period	period	NN
cord-023095-4dannjjm	2248	14	.	.	.
cord-023095-4dannjjm	2249	1	The	the	DT
cord-023095-4dannjjm	2249	2	prevalence	prevalence	NN
cord-023095-4dannjjm	2249	3	of	of	IN
cord-023095-4dannjjm	2249	4	intramammary	intramammary	JJ
cord-023095-4dannjjm	2249	5	infection	infection	NN
cord-023095-4dannjjm	2249	6	(	(	-LRB-
cord-023095-4dannjjm	2249	7	IMI	IMI	NNP
cord-023095-4dannjjm	2249	8	)	)	-RRB-
cord-023095-4dannjjm	2249	9	ranges	range	VBZ
cord-023095-4dannjjm	2249	10	from	from	IN
cord-023095-4dannjjm	2249	11	30	30	CD
cord-023095-4dannjjm	2249	12	-	-	SYM
cord-023095-4dannjjm	2249	13	75	75	CD
cord-023095-4dannjjm	2249	14	%	%	NN
cord-023095-4dannjjm	2249	15	of	of	IN
cord-023095-4dannjjm	2249	16	quarters	quarter	NNS
cord-023095-4dannjjm	2249	17	pre	pre	JJ
cord-023095-4dannjjm	2249	18	-	-	JJ
cord-023095-4dannjjm	2249	19	partum	partum	JJ
cord-023095-4dannjjm	2249	20	and	and	CC
cord-023095-4dannjjm	2249	21	12	12	CD
cord-023095-4dannjjm	2249	22	-	-	SYM
cord-023095-4dannjjm	2249	23	45	45	CD
cord-023095-4dannjjm	2249	24	%	%	NN
cord-023095-4dannjjm	2249	25	at	at	IN
cord-023095-4dannjjm	2249	26	parturition	parturition	NN
cord-023095-4dannjjm	2249	27	.	.	.
cord-023095-4dannjjm	2250	1	Some	some	DT
cord-023095-4dannjjm	2250	2	pre	pre	JJ
cord-023095-4dannjjm	2250	3	-	-	JJ
cord-023095-4dannjjm	2250	4	partum	partum	JJ
cord-023095-4dannjjm	2250	5	infections	infection	NNS
cord-023095-4dannjjm	2250	6	self	self	NN
cord-023095-4dannjjm	2250	7	-	-	HYPH
cord-023095-4dannjjm	2250	8	cure	cure	NN
cord-023095-4dannjjm	2250	9	before	before	IN
cord-023095-4dannjjm	2250	10	parturition	parturition	NN
cord-023095-4dannjjm	2250	11	,	,	,
cord-023095-4dannjjm	2250	12	however	however	RB
cord-023095-4dannjjm	2250	13	a	a	DT
cord-023095-4dannjjm	2250	14	number	number	NN
cord-023095-4dannjjm	2250	15	of	of	IN
cord-023095-4dannjjm	2250	16	these	these	DT
cord-023095-4dannjjm	2250	17	IMIs	imi	NNS
cord-023095-4dannjjm	2250	18	persist	persist	VBP
cord-023095-4dannjjm	2250	19	into	into	IN
cord-023095-4dannjjm	2250	20	early	early	JJ
cord-023095-4dannjjm	2250	21	lactation	lactation	NN
cord-023095-4dannjjm	2250	22	.	.	.
cord-023095-4dannjjm	2251	1	These	these	DT
cord-023095-4dannjjm	2251	2	IMIs	imi	NNS
cord-023095-4dannjjm	2251	3	may	may	MD
cord-023095-4dannjjm	2251	4	impact	impact	VB
cord-023095-4dannjjm	2251	5	milk	milk	NN
cord-023095-4dannjjm	2251	6	production	production	NN
cord-023095-4dannjjm	2251	7	and	and	CC
cord-023095-4dannjjm	2251	8	quality	quality	NN
cord-023095-4dannjjm	2251	9	and	and	CC
cord-023095-4dannjjm	2251	10	may	may	MD
cord-023095-4dannjjm	2251	11	serve	serve	VB
cord-023095-4dannjjm	2251	12	as	as	IN
cord-023095-4dannjjm	2251	13	a	a	DT
cord-023095-4dannjjm	2251	14	reservoir	reservoir	NN
cord-023095-4dannjjm	2251	15	for	for	IN
cord-023095-4dannjjm	2251	16	contagious	contagious	JJ
cord-023095-4dannjjm	2251	17	pathogens	pathogen	NNS
cord-023095-4dannjjm	2251	18	.	.	.
cord-023095-4dannjjm	2252	1	No	no	DT
cord-023095-4dannjjm	2252	2	study	study	NN
cord-023095-4dannjjm	2252	3	has	have	VBZ
cord-023095-4dannjjm	2252	4	specifically	specifically	RB
cord-023095-4dannjjm	2252	5	investigated	investigate	VBN
cord-023095-4dannjjm	2252	6	the	the	DT
cord-023095-4dannjjm	2252	7	risk	risk	NN
cord-023095-4dannjjm	2252	8	of	of	IN
cord-023095-4dannjjm	2252	9	an	an	DT
cord-023095-4dannjjm	2252	10	IMI	IMI	NNP
cord-023095-4dannjjm	2252	11	persisting	persist	VBG
cord-023095-4dannjjm	2252	12	from	from	IN
cord-023095-4dannjjm	2252	13	the	the	DT
cord-023095-4dannjjm	2252	14	prepartum	prepartum	NN
cord-023095-4dannjjm	2252	15	period	period	NN
cord-023095-4dannjjm	2252	16	into	into	IN
cord-023095-4dannjjm	2252	17	early	early	JJ
cord-023095-4dannjjm	2252	18	lactation	lactation	NN
cord-023095-4dannjjm	2252	19	.	.	.
cord-023095-4dannjjm	2253	1	The	the	DT
cord-023095-4dannjjm	2253	2	objectives	objective	NNS
cord-023095-4dannjjm	2253	3	of	of	IN
cord-023095-4dannjjm	2253	4	this	this	DT
cord-023095-4dannjjm	2253	5	study	study	NN
cord-023095-4dannjjm	2253	6	were	be	VBD
cord-023095-4dannjjm	2253	7	to	to	TO
cord-023095-4dannjjm	2253	8	describe	describe	VB
cord-023095-4dannjjm	2253	9	the	the	DT
cord-023095-4dannjjm	2253	10	prevalence	prevalence	NN
cord-023095-4dannjjm	2253	11	of	of	IN
cord-023095-4dannjjm	2253	12	mastitis	mastitis	NN
cord-023095-4dannjjm	2253	13	pathogens	pathogen	NNS
cord-023095-4dannjjm	2253	14	in	in	IN
cord-023095-4dannjjm	2253	15	heifers	heifer	NNS
cord-023095-4dannjjm	2253	16	on	on	IN
cord-023095-4dannjjm	2253	17	a	a	DT
cord-023095-4dannjjm	2253	18	grazing	graze	VBG
cord-023095-4dannjjm	2253	19	dairy	dairy	NN
cord-023095-4dannjjm	2253	20	before	before	IN
cord-023095-4dannjjm	2253	21	and	and	CC
cord-023095-4dannjjm	2253	22	after	after	IN
cord-023095-4dannjjm	2253	23	parturition	parturition	NN
cord-023095-4dannjjm	2253	24	and	and	CC
cord-023095-4dannjjm	2253	25	calculate	calculate	VB
cord-023095-4dannjjm	2253	26	the	the	DT
cord-023095-4dannjjm	2253	27	relative	relative	JJ
cord-023095-4dannjjm	2253	28	risk	risk	NN
cord-023095-4dannjjm	2253	29	(	(	-LRB-
cord-023095-4dannjjm	2253	30	RR	rr	NN
cord-023095-4dannjjm	2253	31	)	)	-RRB-
cord-023095-4dannjjm	2253	32	and	and	CC
cord-023095-4dannjjm	2253	33	attributable	attributable	JJ
cord-023095-4dannjjm	2253	34	fraction	fraction	NN
cord-023095-4dannjjm	2253	35	of	of	IN
cord-023095-4dannjjm	2253	36	population	population	NN
cord-023095-4dannjjm	2253	37	(	(	-LRB-
cord-023095-4dannjjm	2253	38	AFP	AFP	NNP
cord-023095-4dannjjm	2253	39	)	)	-RRB-
cord-023095-4dannjjm	2253	40	for	for	IN
cord-023095-4dannjjm	2253	41	the	the	DT
cord-023095-4dannjjm	2253	42	association	association	NN
cord-023095-4dannjjm	2253	43	between	between	IN
cord-023095-4dannjjm	2253	44	a	a	DT
cord-023095-4dannjjm	2253	45	post	post	JJ
cord-023095-4dannjjm	2253	46	-	-	JJ
cord-023095-4dannjjm	2253	47	partum	partum	JJ
cord-023095-4dannjjm	2253	48	and	and	CC
cord-023095-4dannjjm	2253	49	pre	pre	JJ
cord-023095-4dannjjm	2253	50	-	-	JJ
cord-023095-4dannjjm	2253	51	partum	partum	JJ
cord-023095-4dannjjm	2253	52	IMI	IMI	NNP
cord-023095-4dannjjm	2253	53	.	.	.
cord-023095-4dannjjm	2254	1	Two	two	CD
cord-023095-4dannjjm	2254	2	-	-	HYPH
cord-023095-4dannjjm	2254	3	hundred	hundred	CD
cord-023095-4dannjjm	2254	4	-	-	HYPH
cord-023095-4dannjjm	2254	5	ninety	ninety	CD
cord-023095-4dannjjm	2254	6	-	-	HYPH
cord-023095-4dannjjm	2254	7	four	four	CD
cord-023095-4dannjjm	2254	8	heifers	heifer	NNS
cord-023095-4dannjjm	2254	9	were	be	VBD
cord-023095-4dannjjm	2254	10	systematically	systematically	RB
cord-023095-4dannjjm	2254	11	assigned	assign	VBN
cord-023095-4dannjjm	2254	12	to	to	IN
cord-023095-4dannjjm	2254	13	1	1	CD
cord-023095-4dannjjm	2254	14	of	of	IN
cord-023095-4dannjjm	2254	15	3	3	CD
cord-023095-4dannjjm	2254	16	groups	group	NNS
cord-023095-4dannjjm	2254	17	:	:	:
cord-023095-4dannjjm	2254	18	G1	G1	NNP
cord-023095-4dannjjm	2254	19	)	)	-RRB-
cord-023095-4dannjjm	2254	20	pre	pre	JJ
cord-023095-4dannjjm	2254	21	-	-	JJ
cord-023095-4dannjjm	2254	22	partum	partum	JJ
cord-023095-4dannjjm	2254	23	secretions	secretion	NNS
cord-023095-4dannjjm	2254	24	from	from	IN
cord-023095-4dannjjm	2254	25	all	all	DT
cord-023095-4dannjjm	2254	26	mammary	mammary	JJ
cord-023095-4dannjjm	2254	27	quarters	quarter	NNS
cord-023095-4dannjjm	2254	28	(	(	-LRB-
cord-023095-4dannjjm	2254	29	n	n	NN
cord-023095-4dannjjm	2254	30	5	5	CD
cord-023095-4dannjjm	2254	31	98	98	CD
cord-023095-4dannjjm	2254	32	)	)	-RRB-
cord-023095-4dannjjm	2254	33	,	,	,
cord-023095-4dannjjm	2254	34	G2	G2	NNP
cord-023095-4dannjjm	2254	35	)	)	-RRB-
cord-023095-4dannjjm	2255	1	no	no	DT
cord-023095-4dannjjm	2255	2	pre	pre	JJ
cord-023095-4dannjjm	2255	3	-	-	JJ
cord-023095-4dannjjm	2255	4	partum	partum	JJ
cord-023095-4dannjjm	2255	5	secretions	secretion	NNS
cord-023095-4dannjjm	2255	6	collected	collect	VBN
cord-023095-4dannjjm	2255	7	(	(	-LRB-
cord-023095-4dannjjm	2255	8	n	n	NN
cord-023095-4dannjjm	2255	9	5	5	CD
cord-023095-4dannjjm	2255	10	98	98	CD
cord-023095-4dannjjm	2255	11	)	)	-RRB-
cord-023095-4dannjjm	2255	12	and	and	CC
cord-023095-4dannjjm	2255	13	G3	G3	NNP
cord-023095-4dannjjm	2255	14	)	)	-RRB-
cord-023095-4dannjjm	2255	15	pre	pre	JJ
cord-023095-4dannjjm	2255	16	-	-	JJ
cord-023095-4dannjjm	2255	17	partum	partum	JJ
cord-023095-4dannjjm	2255	18	secretions	secretion	NNS
cord-023095-4dannjjm	2255	19	from	from	IN
cord-023095-4dannjjm	2255	20	two	two	CD
cord-023095-4dannjjm	2255	21	diagonal	diagonal	JJ
cord-023095-4dannjjm	2255	22	quarters	quarter	NNS
cord-023095-4dannjjm	2255	23	(	(	-LRB-
cord-023095-4dannjjm	2255	24	n	n	NN
cord-023095-4dannjjm	2255	25	5	5	CD
cord-023095-4dannjjm	2255	26	98	98	CD
cord-023095-4dannjjm	2255	27	)	)	-RRB-
cord-023095-4dannjjm	2255	28	.	.	.
cord-023095-4dannjjm	2256	1	Group	group	NN
cord-023095-4dannjjm	2256	2	assignments	assignment	NNS
cord-023095-4dannjjm	2256	3	were	be	VBD
cord-023095-4dannjjm	2256	4	designed	design	VBN
cord-023095-4dannjjm	2256	5	to	to	TO
cord-023095-4dannjjm	2256	6	assess	assess	VB
cord-023095-4dannjjm	2256	7	whether	whether	IN
cord-023095-4dannjjm	2256	8	pre	pre	JJ
cord-023095-4dannjjm	2256	9	-	-	JJ
cord-023095-4dannjjm	2256	10	partum	partum	JJ
cord-023095-4dannjjm	2256	11	sampling	sampling	NN
cord-023095-4dannjjm	2256	12	increased	increase	VBD
cord-023095-4dannjjm	2256	13	the	the	DT
cord-023095-4dannjjm	2256	14	likelihood	likelihood	NN
cord-023095-4dannjjm	2256	15	of	of	IN
cord-023095-4dannjjm	2256	16	IMI	IMI	NNP
cord-023095-4dannjjm	2256	17	at	at	IN
cord-023095-4dannjjm	2256	18	calving	calving	NN
cord-023095-4dannjjm	2256	19	.	.	.
cord-023095-4dannjjm	2257	1	Mammary	mammary	JJ
cord-023095-4dannjjm	2257	2	quarter	quarter	NN
cord-023095-4dannjjm	2257	3	secretions	secretion	NNS
cord-023095-4dannjjm	2257	4	were	be	VBD
cord-023095-4dannjjm	2257	5	collected	collect	VBN
cord-023095-4dannjjm	2257	6	for	for	IN
cord-023095-4dannjjm	2257	7	bacterial	bacterial	JJ
cord-023095-4dannjjm	2257	8	culture	culture	NN
cord-023095-4dannjjm	2257	9	approximately	approximately	RB
cord-023095-4dannjjm	2257	10	2	2	CD
cord-023095-4dannjjm	2257	11	weeks	week	NNS
cord-023095-4dannjjm	2257	12	prior	prior	RB
cord-023095-4dannjjm	2257	13	to	to	IN
cord-023095-4dannjjm	2257	14	expected	expect	VBN
cord-023095-4dannjjm	2257	15	calving	calving	NN
cord-023095-4dannjjm	2257	16	date	date	NN
cord-023095-4dannjjm	2257	17	.	.	.
cord-023095-4dannjjm	2258	1	Quarter	quarter	NN
cord-023095-4dannjjm	2258	2	milk	milk	NN
cord-023095-4dannjjm	2258	3	samples	sample	NNS
cord-023095-4dannjjm	2258	4	were	be	VBD
cord-023095-4dannjjm	2258	5	collected	collect	VBN
cord-023095-4dannjjm	2258	6	for	for	IN
cord-023095-4dannjjm	2258	7	bacterial	bacterial	JJ
cord-023095-4dannjjm	2258	8	culture	culture	NN
cord-023095-4dannjjm	2258	9	once	once	RB
cord-023095-4dannjjm	2258	10	weekly	weekly	RB
cord-023095-4dannjjm	2258	11	during	during	IN
cord-023095-4dannjjm	2258	12	the	the	DT
cord-023095-4dannjjm	2258	13	1	1	CD
cord-023095-4dannjjm	2258	14	st	st	NNP
cord-023095-4dannjjm	2258	15	3-weeks	3-weeks	CD
cord-023095-4dannjjm	2258	16	of	of	IN
cord-023095-4dannjjm	2258	17	lactation	lactation	NN
cord-023095-4dannjjm	2258	18	.	.	.
cord-023095-4dannjjm	2259	1	Bacterial	bacterial	JJ
cord-023095-4dannjjm	2259	2	isolates	isolate	NNS
cord-023095-4dannjjm	2259	3	were	be	VBD
cord-023095-4dannjjm	2259	4	classified	classify	VBN
cord-023095-4dannjjm	2259	5	as	as	IN
cord-023095-4dannjjm	2259	6	staphylococci	staphylococcus	NNS
cord-023095-4dannjjm	2259	7	,	,	,
cord-023095-4dannjjm	2259	8	non	non	JJ
cord-023095-4dannjjm	2259	9	-	-	JJ
cord-023095-4dannjjm	2259	10	agalactiae	agalactiae	JJ
cord-023095-4dannjjm	2259	11	streptococci	streptococcus	NNS
cord-023095-4dannjjm	2259	12	and	and	CC
cord-023095-4dannjjm	2259	13	Gram	gram	NN
cord-023095-4dannjjm	2259	14	-	-	HYPH
cord-023095-4dannjjm	2259	15	negatives	negative	NNS
cord-023095-4dannjjm	2259	16	.	.	.
cord-023095-4dannjjm	2260	1	Mammary	mammary	JJ
cord-023095-4dannjjm	2260	2	quarter	quarter	NN
cord-023095-4dannjjm	2260	3	samples	sample	NNS
cord-023095-4dannjjm	2260	4	yielding	yield	VBG
cord-023095-4dannjjm	2260	5	2	2	CD
cord-023095-4dannjjm	2260	6	different	different	JJ
cord-023095-4dannjjm	2260	7	bacteria	bacteria	NNS
cord-023095-4dannjjm	2260	8	were	be	VBD
cord-023095-4dannjjm	2260	9	classified	classify	VBN
cord-023095-4dannjjm	2260	10	as	as	IN
cord-023095-4dannjjm	2260	11	mixed	mixed	JJ
cord-023095-4dannjjm	2260	12	infections	infection	NNS
cord-023095-4dannjjm	2260	13	and	and	CC
cord-023095-4dannjjm	2260	14	those	those	DT
cord-023095-4dannjjm	2260	15	yielding	yield	VBG
cord-023095-4dannjjm	2260	16	!	!	.
cord-023095-4dannjjm	2261	1	3	3	CD
cord-023095-4dannjjm	2261	2	bacterial	bacterial	JJ
cord-023095-4dannjjm	2261	3	types	type	NNS
cord-023095-4dannjjm	2261	4	were	be	VBD
cord-023095-4dannjjm	2261	5	classified	classify	VBN
cord-023095-4dannjjm	2261	6	as	as	IN
cord-023095-4dannjjm	2261	7	contaminated	contaminate	VBN
cord-023095-4dannjjm	2261	8	.	.	.
cord-023095-4dannjjm	2262	1	Bacterial	bacterial	JJ
cord-023095-4dannjjm	2262	2	isolates	isolate	NNS
cord-023095-4dannjjm	2262	3	were	be	VBD
cord-023095-4dannjjm	2262	4	speciated	speciate	VBN
cord-023095-4dannjjm	2262	5	using	use	VBG
cord-023095-4dannjjm	2262	6	gene	gene	NN
cord-023095-4dannjjm	2262	7	sequencing	sequencing	NN
cord-023095-4dannjjm	2262	8	methods	method	NNS
cord-023095-4dannjjm	2262	9	and	and	CC
cord-023095-4dannjjm	2262	10	strain	strain	NN
cord-023095-4dannjjm	2262	11	-	-	HYPH
cord-023095-4dannjjm	2262	12	typed	type	VBN
cord-023095-4dannjjm	2262	13	using	use	VBG
cord-023095-4dannjjm	2262	14	pulse	pulse	NN
cord-023095-4dannjjm	2262	15	-	-	HYPH
cord-023095-4dannjjm	2262	16	field	field	NN
cord-023095-4dannjjm	2262	17	-	-	HYPH
cord-023095-4dannjjm	2262	18	gel	gel	NN
cord-023095-4dannjjm	2262	19	-	-	HYPH
cord-023095-4dannjjm	2262	20	electrophorysis	electrophorysis	NN
cord-023095-4dannjjm	2262	21	to	to	TO
cord-023095-4dannjjm	2262	22	evaluate	evaluate	VB
cord-023095-4dannjjm	2262	23	the	the	DT
cord-023095-4dannjjm	2262	24	relatedness	relatedness	NN
cord-023095-4dannjjm	2262	25	of	of	IN
cord-023095-4dannjjm	2262	26	bacteria	bacteria	NNS
cord-023095-4dannjjm	2262	27	isolated	isolate	VBN
cord-023095-4dannjjm	2262	28	from	from	IN
cord-023095-4dannjjm	2262	29	pre	pre	JJ
cord-023095-4dannjjm	2262	30	-	-	JJ
cord-023095-4dannjjm	2262	31	and	and	CC
cord-023095-4dannjjm	2262	32	post	post	JJ
cord-023095-4dannjjm	2262	33	-	-	JJ
cord-023095-4dannjjm	2262	34	partum	partum	JJ
cord-023095-4dannjjm	2262	35	samples	sample	NNS
cord-023095-4dannjjm	2262	36	from	from	IN
cord-023095-4dannjjm	2262	37	the	the	DT
cord-023095-4dannjjm	2262	38	same	same	JJ
cord-023095-4dannjjm	2262	39	mammary	mammary	JJ
cord-023095-4dannjjm	2262	40	quarter	quarter	NN
cord-023095-4dannjjm	2262	41	.	.	.
cord-023095-4dannjjm	2263	1	Relative	relative	JJ
cord-023095-4dannjjm	2263	2	risk	risk	NN
cord-023095-4dannjjm	2263	3	and	and	CC
cord-023095-4dannjjm	2263	4	AFP	AFP	NNP
cord-023095-4dannjjm	2263	5	were	be	VBD
cord-023095-4dannjjm	2263	6	calculated	calculate	VBN
cord-023095-4dannjjm	2263	7	using	use	VBG
cord-023095-4dannjjm	2263	8	2	2	CD
cord-023095-4dannjjm	2263	9	Â	â	CD
cord-023095-4dannjjm	2263	10	2	2	CD
cord-023095-4dannjjm	2263	11	tables	table	NNS
cord-023095-4dannjjm	2263	12	.	.	.
cord-023095-4dannjjm	2264	1	Forty	forty	CD
cord-023095-4dannjjm	2264	2	-	-	HYPH
cord-023095-4dannjjm	2264	3	five	five	CD
cord-023095-4dannjjm	2264	4	percent	percent	NN
cord-023095-4dannjjm	2264	5	of	of	IN
cord-023095-4dannjjm	2264	6	mammary	mammary	JJ
cord-023095-4dannjjm	2264	7	quarters	quarter	NNS
cord-023095-4dannjjm	2264	8	had	have	VBD
cord-023095-4dannjjm	2264	9	a	a	DT
cord-023095-4dannjjm	2264	10	pre	pre	JJ
cord-023095-4dannjjm	2264	11	-	-	JJ
cord-023095-4dannjjm	2264	12	partum	partum	JJ
cord-023095-4dannjjm	2264	13	IMI	IMI	NNP
cord-023095-4dannjjm	2264	14	.	.	.
cord-023095-4dannjjm	2265	1	During	during	IN
cord-023095-4dannjjm	2265	2	the	the	DT
cord-023095-4dannjjm	2265	3	1st	1st	JJ
cord-023095-4dannjjm	2265	4	3	3	CD
cord-023095-4dannjjm	2265	5	weeks	week	NNS
cord-023095-4dannjjm	2265	6	of	of	IN
cord-023095-4dannjjm	2265	7	lactation	lactation	NN
cord-023095-4dannjjm	2265	8	the	the	DT
cord-023095-4dannjjm	2265	9	mean	mean	JJ
cord-023095-4dannjjm	2265	10	prevalence	prevalence	NN
cord-023095-4dannjjm	2265	11	of	of	IN
cord-023095-4dannjjm	2265	12	IMI	IMI	NNP
cord-023095-4dannjjm	2265	13	was	be	VBD
cord-023095-4dannjjm	2265	14	23.3	23.3	CD
cord-023095-4dannjjm	2265	15	%	%	NN
cord-023095-4dannjjm	2265	16	of	of	IN
cord-023095-4dannjjm	2265	17	quarters	quarter	NNS
cord-023095-4dannjjm	2265	18	.	.	.
cord-023095-4dannjjm	2266	1	Staphylococci	staphylococcus	NNS
cord-023095-4dannjjm	2266	2	were	be	VBD
cord-023095-4dannjjm	2266	3	most	most	RBS
cord-023095-4dannjjm	2266	4	frequently	frequently	RB
cord-023095-4dannjjm	2266	5	isolated	isolate	VBN
cord-023095-4dannjjm	2266	6	bacteria	bacteria	NNS
cord-023095-4dannjjm	2266	7	from	from	IN
cord-023095-4dannjjm	2266	8	pre	pre	JJ
cord-023095-4dannjjm	2266	9	-	-	JJ
cord-023095-4dannjjm	2266	10	partum	partum	JJ
cord-023095-4dannjjm	2266	11	secretions	secretion	NNS
cord-023095-4dannjjm	2266	12	and	and	CC
cord-023095-4dannjjm	2266	13	milk	milk	NN
cord-023095-4dannjjm	2266	14	with	with	IN
cord-023095-4dannjjm	2266	15	S.	S.	NNP
cord-023095-4dannjjm	2266	16	chromogenes	chromogene	NNS
cord-023095-4dannjjm	2266	17	and	and	CC
cord-023095-4dannjjm	2266	18	S.	S.	NNP
cord-023095-4dannjjm	2266	19	aureus	aureus	NN
cord-023095-4dannjjm	2266	20	being	be	VBG
cord-023095-4dannjjm	2266	21	the	the	DT
cord-023095-4dannjjm	2266	22	most	most	RBS
cord-023095-4dannjjm	2266	23	common	common	JJ
cord-023095-4dannjjm	2266	24	species	specie	NNS
cord-023095-4dannjjm	2266	25	.	.	.
cord-023095-4dannjjm	2267	1	Using	use	VBG
cord-023095-4dannjjm	2267	2	data	datum	NNS
cord-023095-4dannjjm	2267	3	from	from	IN
cord-023095-4dannjjm	2267	4	228	228	CD
cord-023095-4dannjjm	2267	5	mammary	mammary	JJ
cord-023095-4dannjjm	2267	6	quarters	quarter	NNS
cord-023095-4dannjjm	2267	7	,	,	,
cord-023095-4dannjjm	2267	8	the	the	DT
cord-023095-4dannjjm	2267	9	RR	RR	NNP
cord-023095-4dannjjm	2267	10	and	and	CC
cord-023095-4dannjjm	2267	11	AFP	AFP	NNP
cord-023095-4dannjjm	2267	12	for	for	IN
cord-023095-4dannjjm	2267	13	the	the	DT
cord-023095-4dannjjm	2267	14	association	association	NN
cord-023095-4dannjjm	2267	15	between	between	IN
cord-023095-4dannjjm	2267	16	a	a	DT
cord-023095-4dannjjm	2267	17	post	post	JJ
cord-023095-4dannjjm	2267	18	-	-	JJ
cord-023095-4dannjjm	2267	19	partum	partum	JJ
cord-023095-4dannjjm	2267	20	and	and	CC
cord-023095-4dannjjm	2267	21	pre	pre	JJ
cord-023095-4dannjjm	2267	22	-	-	JJ
cord-023095-4dannjjm	2267	23	partum	partum	JJ
cord-023095-4dannjjm	2267	24	IMI	IMI	NNP
cord-023095-4dannjjm	2267	25	were	be	VBD
cord-023095-4dannjjm	2267	26	11	11	CD
cord-023095-4dannjjm	2267	27	and	and	CC
cord-023095-4dannjjm	2267	28	77	77	CD
cord-023095-4dannjjm	2267	29	%	%	NN
cord-023095-4dannjjm	2267	30	,	,	,
cord-023095-4dannjjm	2267	31	43	43	CD
cord-023095-4dannjjm	2267	32	and	and	CC
cord-023095-4dannjjm	2267	33	86	86	CD
cord-023095-4dannjjm	2267	34	%	%	NN
cord-023095-4dannjjm	2267	35	,	,	,
cord-023095-4dannjjm	2267	36	and	and	CC
cord-023095-4dannjjm	2267	37	12	12	CD
cord-023095-4dannjjm	2267	38	and	and	CC
cord-023095-4dannjjm	2267	39	68	68	CD
cord-023095-4dannjjm	2267	40	%	%	NN
cord-023095-4dannjjm	2267	41	for	for	IN
cord-023095-4dannjjm	2267	42	all	all	DT
cord-023095-4dannjjm	2267	43	staphylococci	staphylococcus	NNS
cord-023095-4dannjjm	2267	44	,	,	,
cord-023095-4dannjjm	2267	45	S.	S.	NNP
cord-023095-4dannjjm	2267	46	aureus	aureus	NN
cord-023095-4dannjjm	2267	47	only	only	RB
cord-023095-4dannjjm	2267	48	and	and	CC
cord-023095-4dannjjm	2267	49	CNS	CNS	NNP
cord-023095-4dannjjm	2267	50	only	only	RB
cord-023095-4dannjjm	2267	51	IMIs	imi	NNS
cord-023095-4dannjjm	2267	52	,	,	,
cord-023095-4dannjjm	2267	53	respectively	respectively	RB
cord-023095-4dannjjm	2267	54	.	.	.
cord-023095-4dannjjm	2268	1	Mammary	mammary	JJ
cord-023095-4dannjjm	2268	2	quarters	quarter	NNS
cord-023095-4dannjjm	2268	3	sampled	sample	VBD
cord-023095-4dannjjm	2268	4	pre	pre	JJ
cord-023095-4dannjjm	2268	5	-	-	NNS
cord-023095-4dannjjm	2268	6	partum	partum	NNP
cord-023095-4dannjjm	2268	7	were	be	VBD
cord-023095-4dannjjm	2268	8	no	no	RB
cord-023095-4dannjjm	2268	9	more	more	RBR
cord-023095-4dannjjm	2268	10	likely	likely	JJ
cord-023095-4dannjjm	2268	11	to	to	TO
cord-023095-4dannjjm	2268	12	have	have	VB
cord-023095-4dannjjm	2268	13	a	a	DT
cord-023095-4dannjjm	2268	14	post	post	JJ
cord-023095-4dannjjm	2268	15	-	-	JJ
cord-023095-4dannjjm	2268	16	partum	partum	JJ
cord-023095-4dannjjm	2268	17	IMI	IMI	NNP
cord-023095-4dannjjm	2268	18	than	than	IN
cord-023095-4dannjjm	2268	19	those	those	DT
cord-023095-4dannjjm	2268	20	not	not	RB
cord-023095-4dannjjm	2268	21	sampled	sample	VBN
cord-023095-4dannjjm	2268	22	(	(	-LRB-
cord-023095-4dannjjm	2268	23	Chisquare	Chisquare	NNP
cord-023095-4dannjjm	2268	24	,	,	,
cord-023095-4dannjjm	2268	25	P	p	NN
cord-023095-4dannjjm	2268	26	!	!	.
cord-023095-4dannjjm	2268	27	0.27	0.27	CD
cord-023095-4dannjjm	2268	28	)	)	-RRB-
cord-023095-4dannjjm	2268	29	.	.	.
cord-023095-4dannjjm	2269	1	These	these	DT
cord-023095-4dannjjm	2269	2	data	datum	NNS
cord-023095-4dannjjm	2269	3	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	2269	4	that	that	IN
cord-023095-4dannjjm	2269	5	pre	pre	JJ
cord-023095-4dannjjm	2269	6	-	-	JJ
cord-023095-4dannjjm	2269	7	partum	partum	JJ
cord-023095-4dannjjm	2269	8	IMIs	imi	NNS
cord-023095-4dannjjm	2269	9	persist	persist	VBP
cord-023095-4dannjjm	2269	10	into	into	IN
cord-023095-4dannjjm	2269	11	early	early	JJ
cord-023095-4dannjjm	2269	12	lactation	lactation	NN
cord-023095-4dannjjm	2269	13	and	and	CC
cord-023095-4dannjjm	2269	14	that	that	IN
cord-023095-4dannjjm	2269	15	pre	pre	JJ
cord-023095-4dannjjm	2269	16	-	-	JJ
cord-023095-4dannjjm	2269	17	partum	partum	JJ
cord-023095-4dannjjm	2269	18	secretion	secretion	NN
cord-023095-4dannjjm	2269	19	cultures	culture	NNS
cord-023095-4dannjjm	2269	20	may	may	MD
cord-023095-4dannjjm	2269	21	be	be	VB
cord-023095-4dannjjm	2269	22	a	a	DT
cord-023095-4dannjjm	2269	23	useful	useful	JJ
cord-023095-4dannjjm	2269	24	,	,	,
cord-023095-4dannjjm	2269	25	not	not	RB
cord-023095-4dannjjm	2269	26	only	only	RB
cord-023095-4dannjjm	2269	27	in	in	IN
cord-023095-4dannjjm	2269	28	predicting	predict	VBG
cord-023095-4dannjjm	2269	29	IMI	IMI	NNP
cord-023095-4dannjjm	2269	30	at	at	IN
cord-023095-4dannjjm	2269	31	calving	calving	NN
cord-023095-4dannjjm	2269	32	,	,	,
cord-023095-4dannjjm	2269	33	but	but	CC
cord-023095-4dannjjm	2269	34	also	also	RB
cord-023095-4dannjjm	2269	35	in	in	IN
cord-023095-4dannjjm	2269	36	assessing	assess	VBG
cord-023095-4dannjjm	2269	37	risk	risk	NN
cord-023095-4dannjjm	2269	38	of	of	IN
cord-023095-4dannjjm	2269	39	introducing	introduce	VBG
cord-023095-4dannjjm	2269	40	new	new	JJ
cord-023095-4dannjjm	2269	41	contagious	contagious	JJ
cord-023095-4dannjjm	2269	42	mastitis	mastitis	NN
cord-023095-4dannjjm	2269	43	pathogens	pathogen	NNS
cord-023095-4dannjjm	2269	44	,	,	,
cord-023095-4dannjjm	2269	45	e.g.	e.g.	RB
cord-023095-4dannjjm	2269	46	,	,	,
cord-023095-4dannjjm	2269	47	S.	S.	NNP
cord-023095-4dannjjm	2269	48	aureus	aureus	NN
cord-023095-4dannjjm	2269	49	,	,	,
cord-023095-4dannjjm	2269	50	into	into	IN
cord-023095-4dannjjm	2269	51	the	the	DT
cord-023095-4dannjjm	2269	52	lactating	lactate	VBG
cord-023095-4dannjjm	2269	53	herd	herd	NN
cord-023095-4dannjjm	2269	54	.	.	.
cord-023095-4dannjjm	2270	1	Despite	despite	IN
cord-023095-4dannjjm	2270	2	concerns	concern	NNS
cord-023095-4dannjjm	2270	3	about	about	IN
cord-023095-4dannjjm	2270	4	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2270	5	resistance	resistance	NN
cord-023095-4dannjjm	2270	6	and	and	CC
cord-023095-4dannjjm	2270	7	Clostridium	clostridium	NN
cord-023095-4dannjjm	2270	8	difficile	difficile	NN
cord-023095-4dannjjm	2270	9	in	in	IN
cord-023095-4dannjjm	2270	10	food	food	NN
cord-023095-4dannjjm	2270	11	animals	animal	NNS
cord-023095-4dannjjm	2270	12	,	,	,
cord-023095-4dannjjm	2270	13	there	there	EX
cord-023095-4dannjjm	2270	14	has	have	VBZ
cord-023095-4dannjjm	2270	15	been	be	VBN
cord-023095-4dannjjm	2270	16	little	little	JJ
cord-023095-4dannjjm	2270	17	study	study	NN
cord-023095-4dannjjm	2270	18	of	of	IN
cord-023095-4dannjjm	2270	19	the	the	DT
cord-023095-4dannjjm	2270	20	prevalence	prevalence	NN
cord-023095-4dannjjm	2270	21	or	or	CC
cord-023095-4dannjjm	2270	22	mechanisms	mechanism	NNS
cord-023095-4dannjjm	2270	23	of	of	IN
cord-023095-4dannjjm	2270	24	resistance	resistance	NN
cord-023095-4dannjjm	2270	25	.	.	.
cord-023095-4dannjjm	2271	1	This	this	DT
cord-023095-4dannjjm	2271	2	study	study	NN
cord-023095-4dannjjm	2271	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	2271	4	the	the	DT
cord-023095-4dannjjm	2271	5	impact	impact	NN
cord-023095-4dannjjm	2271	6	of	of	IN
cord-023095-4dannjjm	2271	7	tetracycline	tetracycline	NNP
cord-023095-4dannjjm	2271	8	treatment	treatment	NN
cord-023095-4dannjjm	2271	9	on	on	IN
cord-023095-4dannjjm	2271	10	C.	C.	NNP
cord-023095-4dannjjm	2271	11	difficile	difficile	NN
cord-023095-4dannjjm	2271	12	shedding	shed	VBG
cord-023095-4dannjjm	2271	13	in	in	IN
cord-023095-4dannjjm	2271	14	veal	veal	NN
cord-023095-4dannjjm	2271	15	calves	calf	NNS
cord-023095-4dannjjm	2271	16	and	and	CC
cord-023095-4dannjjm	2271	17	the	the	DT
cord-023095-4dannjjm	2271	18	impact	impact	NN
cord-023095-4dannjjm	2271	19	on	on	IN
cord-023095-4dannjjm	2271	20	resistance	resistance	NN
cord-023095-4dannjjm	2271	21	.	.	.
cord-023095-4dannjjm	2272	1	Calves	calf	NNS
cord-023095-4dannjjm	2272	2	arriving	arrive	VBG
cord-023095-4dannjjm	2272	3	on	on	IN
cord-023095-4dannjjm	2272	4	1	1	CD
cord-023095-4dannjjm	2272	5	veal	veal	NN
cord-023095-4dannjjm	2272	6	farm	farm	NN
cord-023095-4dannjjm	2272	7	received	receive	VBD
cord-023095-4dannjjm	2272	8	oral	oral	JJ
cord-023095-4dannjjm	2272	9	oxytetracycline	oxytetracycline	NN
cord-023095-4dannjjm	2272	10	for	for	IN
cord-023095-4dannjjm	2272	11	5	5	CD
cord-023095-4dannjjm	2272	12	days	day	NNS
cord-023095-4dannjjm	2272	13	as	as	IN
cord-023095-4dannjjm	2272	14	per	per	IN
cord-023095-4dannjjm	2272	15	farm	farm	NN
cord-023095-4dannjjm	2272	16	protocols	protocol	NNS
cord-023095-4dannjjm	2272	17	.	.	.
cord-023095-4dannjjm	2273	1	Calves	calf	NNS
cord-023095-4dannjjm	2273	2	were	be	VBD
cord-023095-4dannjjm	2273	3	sampled	sample	VBN
cord-023095-4dannjjm	2273	4	at	at	IN
cord-023095-4dannjjm	2273	5	arrival	arrival	NN
cord-023095-4dannjjm	2273	6	and	and	CC
cord-023095-4dannjjm	2273	7	6	6	CD
cord-023095-4dannjjm	2273	8	days	day	NNS
cord-023095-4dannjjm	2273	9	later	later	RB
cord-023095-4dannjjm	2273	10	.	.	.
cord-023095-4dannjjm	2274	1	Selective	selective	JJ
cord-023095-4dannjjm	2274	2	culture	culture	NN
cord-023095-4dannjjm	2274	3	for	for	IN
cord-023095-4dannjjm	2274	4	C.	C.	NNP
cord-023095-4dannjjm	2274	5	difficile	difficile	NNP
cord-023095-4dannjjm	2274	6	was	be	VBD
cord-023095-4dannjjm	2274	7	performed	perform	VBN
cord-023095-4dannjjm	2274	8	.	.	.
cord-023095-4dannjjm	2275	1	Isolates	isolate	NNS
cord-023095-4dannjjm	2275	2	were	be	VBD
cord-023095-4dannjjm	2275	3	ribotyped	ribotype	VBN
cord-023095-4dannjjm	2275	4	,	,	,
cord-023095-4dannjjm	2275	5	and	and	CC
cord-023095-4dannjjm	2275	6	tested	test	VBN
cord-023095-4dannjjm	2275	7	for	for	IN
cord-023095-4dannjjm	2275	8	tetracycline	tetracycline	NNP
cord-023095-4dannjjm	2275	9	susceptibility	susceptibility	NN
cord-023095-4dannjjm	2275	10	and	and	CC
cord-023095-4dannjjm	2275	11	the	the	DT
cord-023095-4dannjjm	2275	12	presence	presence	NN
cord-023095-4dannjjm	2275	13	of	of	IN
cord-023095-4dannjjm	2275	14	tetracycline	tetracycline	NNP
cord-023095-4dannjjm	2275	15	resistance	resistance	NN
cord-023095-4dannjjm	2275	16	genes	gene	NNS
cord-023095-4dannjjm	2275	17	.	.	.
cord-023095-4dannjjm	2276	1	Multivariable	multivariable	JJ
cord-023095-4dannjjm	2276	2	logistic	logistic	JJ
cord-023095-4dannjjm	2276	3	regression	regression	NN
cord-023095-4dannjjm	2276	4	models	model	NNS
cord-023095-4dannjjm	2276	5	were	be	VBD
cord-023095-4dannjjm	2276	6	used	use	VBN
cord-023095-4dannjjm	2276	7	to	to	TO
cord-023095-4dannjjm	2276	8	determine	determine	VB
cord-023095-4dannjjm	2276	9	the	the	DT
cord-023095-4dannjjm	2276	10	relationship	relationship	NN
cord-023095-4dannjjm	2276	11	between	between	IN
cord-023095-4dannjjm	2276	12	tetracycline	tetracycline	NNP
cord-023095-4dannjjm	2276	13	resistance	resistance	NN
cord-023095-4dannjjm	2276	14	and	and	CC
cord-023095-4dannjjm	2276	15	the	the	DT
cord-023095-4dannjjm	2276	16	presence	presence	NN
cord-023095-4dannjjm	2276	17	of	of	IN
cord-023095-4dannjjm	2276	18	tetracycline	tetracycline	NNP
cord-023095-4dannjjm	2276	19	resistance	resistance	NN
cord-023095-4dannjjm	2276	20	genes	gene	NNS
cord-023095-4dannjjm	2276	21	.	.	.
cord-023095-4dannjjm	2277	1	Clostridium	clostridium	NN
cord-023095-4dannjjm	2277	2	difficile	difficile	NN
cord-023095-4dannjjm	2277	3	was	be	VBD
cord-023095-4dannjjm	2277	4	isolated	isolate	VBN
cord-023095-4dannjjm	2277	5	from	from	IN
cord-023095-4dannjjm	2277	6	32	32	CD
cord-023095-4dannjjm	2277	7	%	%	NN
cord-023095-4dannjjm	2277	8	(	(	-LRB-
cord-023095-4dannjjm	2277	9	56/174	56/174	CD
cord-023095-4dannjjm	2277	10	)	)	-RRB-
cord-023095-4dannjjm	2277	11	and	and	CC
cord-023095-4dannjjm	2277	12	51	51	CD
cord-023095-4dannjjm	2277	13	%	%	NN
cord-023095-4dannjjm	2277	14	(	(	-LRB-
cord-023095-4dannjjm	2277	15	88/	88/	CD
cord-023095-4dannjjm	2277	16	172	172	CD
cord-023095-4dannjjm	2277	17	)	)	-RRB-
cord-023095-4dannjjm	2277	18	calves	calf	NNS
cord-023095-4dannjjm	2277	19	,	,	,
cord-023095-4dannjjm	2277	20	at	at	IN
cord-023095-4dannjjm	2277	21	the	the	DT
cord-023095-4dannjjm	2277	22	first	first	JJ
cord-023095-4dannjjm	2277	23	and	and	CC
cord-023095-4dannjjm	2277	24	second	second	JJ
cord-023095-4dannjjm	2277	25	samples	sample	NNS
cord-023095-4dannjjm	2277	26	,	,	,
cord-023095-4dannjjm	2277	27	respectively	respectively	RB
cord-023095-4dannjjm	2277	28	.	.	.
cord-023095-4dannjjm	2278	1	The	the	DT
cord-023095-4dannjjm	2278	2	percentage	percentage	NN
cord-023095-4dannjjm	2278	3	of	of	IN
cord-023095-4dannjjm	2278	4	tetracycline	tetracycline	NN
cord-023095-4dannjjm	2278	5	resistant	resistant	JJ
cord-023095-4dannjjm	2278	6	isolates	isolate	NNS
cord-023095-4dannjjm	2278	7	increased	increase	VBD
cord-023095-4dannjjm	2278	8	from	from	IN
cord-023095-4dannjjm	2278	9	79	79	CD
cord-023095-4dannjjm	2278	10	%	%	NN
cord-023095-4dannjjm	2278	11	to	to	IN
cord-023095-4dannjjm	2278	12	93	93	CD
cord-023095-4dannjjm	2278	13	%	%	NN
cord-023095-4dannjjm	2278	14	.	.	.
cord-023095-4dannjjm	2279	1	Isolates	isolate	NNS
cord-023095-4dannjjm	2279	2	from	from	IN
cord-023095-4dannjjm	2279	3	the	the	DT
cord-023095-4dannjjm	2279	4	second	second	JJ
cord-023095-4dannjjm	2279	5	sample	sample	NN
cord-023095-4dannjjm	2279	6	were	be	VBD
cord-023095-4dannjjm	2279	7	3	3	CD
cord-023095-4dannjjm	2279	8	times	time	NNS
cord-023095-4dannjjm	2279	9	more	more	RBR
cord-023095-4dannjjm	2279	10	likely	likely	JJ
cord-023095-4dannjjm	2279	11	to	to	TO
cord-023095-4dannjjm	2279	12	be	be	VB
cord-023095-4dannjjm	2279	13	tetracycline	tetracycline	NN
cord-023095-4dannjjm	2279	14	resistant	resistant	JJ
cord-023095-4dannjjm	2279	15	(	(	-LRB-
cord-023095-4dannjjm	2279	16	p	p	NN
cord-023095-4dannjjm	2279	17	5	5	CD
cord-023095-4dannjjm	2279	18	0.016	0.016	CD
cord-023095-4dannjjm	2279	19	)	)	-RRB-
cord-023095-4dannjjm	2279	20	and	and	CC
cord-023095-4dannjjm	2279	21	5	5	CD
cord-023095-4dannjjm	2279	22	times	time	NNS
cord-023095-4dannjjm	2279	23	more	more	RBR
cord-023095-4dannjjm	2279	24	likely	likely	JJ
cord-023095-4dannjjm	2279	25	to	to	TO
cord-023095-4dannjjm	2279	26	possess	possess	VB
cord-023095-4dannjjm	2279	27	tet(M	tet(m	ADD
cord-023095-4dannjjm	2279	28	)	)	-RRB-
cord-023095-4dannjjm	2279	29	(	(	-LRB-
cord-023095-4dannjjm	2279	30	p	p	NN
cord-023095-4dannjjm	2279	31	5	5	CD
cord-023095-4dannjjm	2279	32	0.004	0.004	CD
cord-023095-4dannjjm	2279	33	)	)	-RRB-
cord-023095-4dannjjm	2279	34	.	.	.
cord-023095-4dannjjm	2280	1	tet(M	tet(M	NNP
cord-023095-4dannjjm	2280	2	)	)	-RRB-
cord-023095-4dannjjm	2280	3	was	be	VBD
cord-023095-4dannjjm	2280	4	detected	detect	VBN
cord-023095-4dannjjm	2280	5	in	in	IN
cord-023095-4dannjjm	2280	6	13	13	CD
cord-023095-4dannjjm	2280	7	%	%	NN
cord-023095-4dannjjm	2280	8	(	(	-LRB-
cord-023095-4dannjjm	2280	9	7/53	7/53	CD
cord-023095-4dannjjm	2280	10	)	)	-RRB-
cord-023095-4dannjjm	2280	11	and	and	CC
cord-023095-4dannjjm	2280	12	43	43	CD
cord-023095-4dannjjm	2280	13	%	%	NN
cord-023095-4dannjjm	2280	14	(	(	-LRB-
cord-023095-4dannjjm	2280	15	39/	39/	CD
cord-023095-4dannjjm	2280	16	91	91	CD
cord-023095-4dannjjm	2280	17	)	)	-RRB-
cord-023095-4dannjjm	2280	18	,	,	,
cord-023095-4dannjjm	2280	19	tet(O	tet(O	NNP
cord-023095-4dannjjm	2280	20	)	)	-RRB-
cord-023095-4dannjjm	2280	21	in	in	IN
cord-023095-4dannjjm	2280	22	23	23	CD
cord-023095-4dannjjm	2280	23	%	%	NN
cord-023095-4dannjjm	2280	24	(	(	-LRB-
cord-023095-4dannjjm	2280	25	12/53	12/53	CD
cord-023095-4dannjjm	2280	26	)	)	-RRB-
cord-023095-4dannjjm	2280	27	and	and	CC
cord-023095-4dannjjm	2280	28	19	19	CD
cord-023095-4dannjjm	2280	29	%	%	NN
cord-023095-4dannjjm	2280	30	(	(	-LRB-
cord-023095-4dannjjm	2280	31	17/91	17/91	CD
cord-023095-4dannjjm	2280	32	)	)	-RRB-
cord-023095-4dannjjm	2280	33	and	and	CC
cord-023095-4dannjjm	2280	34	tet(W	tet(w	LS
cord-023095-4dannjjm	2280	35	)	)	-RRB-
cord-023095-4dannjjm	2280	36	in	in	IN
cord-023095-4dannjjm	2280	37	2	2	CD
cord-023095-4dannjjm	2280	38	%	%	NN
cord-023095-4dannjjm	2280	39	(	(	-LRB-
cord-023095-4dannjjm	2280	40	1/53	1/53	CD
cord-023095-4dannjjm	2280	41	)	)	-RRB-
cord-023095-4dannjjm	2280	42	and	and	CC
cord-023095-4dannjjm	2280	43	1	1	CD
cord-023095-4dannjjm	2280	44	%	%	NN
cord-023095-4dannjjm	2280	45	(	(	-LRB-
cord-023095-4dannjjm	2280	46	1/91	1/91	CD
cord-023095-4dannjjm	2280	47	)	)	-RRB-
cord-023095-4dannjjm	2280	48	of	of	IN
cord-023095-4dannjjm	2280	49	isolates	isolate	NNS
cord-023095-4dannjjm	2280	50	from	from	IN
cord-023095-4dannjjm	2280	51	first	first	JJ
cord-023095-4dannjjm	2280	52	and	and	CC
cord-023095-4dannjjm	2280	53	second	second	JJ
cord-023095-4dannjjm	2280	54	samples	sample	NNS
cord-023095-4dannjjm	2280	55	,	,	,
cord-023095-4dannjjm	2280	56	respectively	respectively	RB
cord-023095-4dannjjm	2280	57	.	.	.
cord-023095-4dannjjm	2281	1	tet(L	tet(L	NNP
cord-023095-4dannjjm	2281	2	)	)	-RRB-
cord-023095-4dannjjm	2281	3	,	,	,
cord-023095-4dannjjm	2281	4	tet(K	tet(K	NNP
cord-023095-4dannjjm	2281	5	)	)	-RRB-
cord-023095-4dannjjm	2281	6	and	and	CC
cord-023095-4dannjjm	2281	7	tet(S	tet(	NNS
cord-023095-4dannjjm	2281	8	)	)	-RRB-
cord-023095-4dannjjm	2281	9	were	be	VBD
cord-023095-4dannjjm	2281	10	not	not	RB
cord-023095-4dannjjm	2281	11	detected	detect	VBN
cord-023095-4dannjjm	2281	12	.	.	.
cord-023095-4dannjjm	2282	1	54	54	CD
cord-023095-4dannjjm	2282	2	resistant	resistant	JJ
cord-023095-4dannjjm	2282	3	isolates	isolate	NNS
cord-023095-4dannjjm	2282	4	were	be	VBD
cord-023095-4dannjjm	2282	5	not	not	RB
cord-023095-4dannjjm	2282	6	carrying	carry	VBG
cord-023095-4dannjjm	2282	7	any	any	DT
cord-023095-4dannjjm	2282	8	of	of	IN
cord-023095-4dannjjm	2282	9	the	the	DT
cord-023095-4dannjjm	2282	10	genes	gene	NNS
cord-023095-4dannjjm	2282	11	investigated	investigate	VBN
cord-023095-4dannjjm	2282	12	.	.	.
cord-023095-4dannjjm	2283	1	Routine	routine	JJ
cord-023095-4dannjjm	2283	2	tetracycline	tetracycline	NN
cord-023095-4dannjjm	2283	3	use	use	NN
cord-023095-4dannjjm	2283	4	may	may	MD
cord-023095-4dannjjm	2283	5	have	have	VB
cord-023095-4dannjjm	2283	6	had	have	VBN
cord-023095-4dannjjm	2283	7	an	an	DT
cord-023095-4dannjjm	2283	8	impact	impact	NN
cord-023095-4dannjjm	2283	9	on	on	IN
cord-023095-4dannjjm	2283	10	both	both	CC
cord-023095-4dannjjm	2283	11	the	the	DT
cord-023095-4dannjjm	2283	12	prevalence	prevalence	NN
cord-023095-4dannjjm	2283	13	of	of	IN
cord-023095-4dannjjm	2283	14	C.	C.	NNP
cord-023095-4dannjjm	2283	15	difficile	difficile	NNP
cord-023095-4dannjjm	2283	16	,	,	,
cord-023095-4dannjjm	2283	17	as	as	RB
cord-023095-4dannjjm	2283	18	well	well	RB
cord-023095-4dannjjm	2283	19	as	as	IN
cord-023095-4dannjjm	2283	20	the	the	DT
cord-023095-4dannjjm	2283	21	strain	strain	NN
cord-023095-4dannjjm	2283	22	distribution	distribution	NN
cord-023095-4dannjjm	2283	23	and	and	CC
cord-023095-4dannjjm	2283	24	resistance	resistance	NN
cord-023095-4dannjjm	2283	25	patterns	pattern	NNS
cord-023095-4dannjjm	2283	26	.	.	.
cord-023095-4dannjjm	2284	1	This	this	DT
cord-023095-4dannjjm	2284	2	is	be	VBZ
cord-023095-4dannjjm	2284	3	the	the	DT
cord-023095-4dannjjm	2284	4	first	first	JJ
cord-023095-4dannjjm	2284	5	report	report	NN
cord-023095-4dannjjm	2284	6	of	of	IN
cord-023095-4dannjjm	2284	7	presence	presence	NN
cord-023095-4dannjjm	2284	8	of	of	IN
cord-023095-4dannjjm	2284	9	tet	tet	NNP
cord-023095-4dannjjm	2284	10	(	(	-LRB-
cord-023095-4dannjjm	2284	11	The	the	DT
cord-023095-4dannjjm	2284	12	objectives	objective	NNS
cord-023095-4dannjjm	2284	13	of	of	IN
cord-023095-4dannjjm	2284	14	this	this	DT
cord-023095-4dannjjm	2284	15	study	study	NN
cord-023095-4dannjjm	2284	16	were	be	VBD
cord-023095-4dannjjm	2284	17	to	to	IN
cord-023095-4dannjjm	2284	18	1	1	CD
cord-023095-4dannjjm	2284	19	)	)	-RRB-
cord-023095-4dannjjm	2284	20	estimate	estimate	VB
cord-023095-4dannjjm	2284	21	the	the	DT
cord-023095-4dannjjm	2284	22	prevalence	prevalence	NN
cord-023095-4dannjjm	2284	23	of	of	IN
cord-023095-4dannjjm	2284	24	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2284	25	resistance	resistance	NN
cord-023095-4dannjjm	2284	26	in	in	IN
cord-023095-4dannjjm	2284	27	the	the	DT
cord-023095-4dannjjm	2284	28	study	study	NN
cord-023095-4dannjjm	2284	29	population	population	NN
cord-023095-4dannjjm	2284	30	and	and	CC
cord-023095-4dannjjm	2284	31	2	2	CD
cord-023095-4dannjjm	2284	32	)	)	-RRB-
cord-023095-4dannjjm	2284	33	to	to	TO
cord-023095-4dannjjm	2284	34	investigate	investigate	VB
cord-023095-4dannjjm	2284	35	the	the	DT
cord-023095-4dannjjm	2284	36	associations	association	NNS
cord-023095-4dannjjm	2284	37	between	between	IN
cord-023095-4dannjjm	2284	38	exposures	exposure	NNS
cord-023095-4dannjjm	2284	39	to	to	IN
cord-023095-4dannjjm	2284	40	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2284	41	drugs	drug	NNS
cord-023095-4dannjjm	2284	42	and	and	CC
cord-023095-4dannjjm	2284	43	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2284	44	resistance	resistance	NN
cord-023095-4dannjjm	2284	45	in	in	IN
cord-023095-4dannjjm	2284	46	fecal	fecal	JJ
cord-023095-4dannjjm	2284	47	non	non	JJ
cord-023095-4dannjjm	2284	48	-	-	JJ
cord-023095-4dannjjm	2284	49	type	type	JJ
cord-023095-4dannjjm	2284	50	specific	specific	JJ
cord-023095-4dannjjm	2284	51	E.	E.	NNP
cord-023095-4dannjjm	2284	52	coli	coli	NNS
cord-023095-4dannjjm	2284	53	(	(	-LRB-
cord-023095-4dannjjm	2284	54	NTSEC	NTSEC	NNP
cord-023095-4dannjjm	2284	55	)	)	-RRB-
cord-023095-4dannjjm	2284	56	recovered	recover	VBD
cord-023095-4dannjjm	2284	57	from	from	IN
cord-023095-4dannjjm	2284	58	individual	individual	JJ
cord-023095-4dannjjm	2284	59	feedlot	feedlot	NN
cord-023095-4dannjjm	2284	60	cattle	cattle	NNS
cord-023095-4dannjjm	2284	61	.	.	.
cord-023095-4dannjjm	2285	1	Two	two	CD
cord-023095-4dannjjm	2285	2	-	-	HYPH
cord-023095-4dannjjm	2285	3	stage	stage	NN
cord-023095-4dannjjm	2285	4	random	random	JJ
cord-023095-4dannjjm	2285	5	sampling	sampling	NN
cord-023095-4dannjjm	2285	6	was	be	VBD
cord-023095-4dannjjm	2285	7	used	use	VBN
cord-023095-4dannjjm	2285	8	to	to	TO
cord-023095-4dannjjm	2285	9	identify	identify	VB
cord-023095-4dannjjm	2285	10	cattle	cattle	NNS
cord-023095-4dannjjm	2285	11	for	for	IN
cord-023095-4dannjjm	2285	12	enrollment	enrollment	NN
cord-023095-4dannjjm	2285	13	at	at	IN
cord-023095-4dannjjm	2285	14	4	4	CD
cord-023095-4dannjjm	2285	15	western	western	JJ
cord-023095-4dannjjm	2285	16	Canadian	canadian	JJ
cord-023095-4dannjjm	2285	17	feedlots	feedlot	NNS
cord-023095-4dannjjm	2285	18	.	.	.
cord-023095-4dannjjm	2286	1	A	a	DT
cord-023095-4dannjjm	2286	2	fecal	fecal	JJ
cord-023095-4dannjjm	2286	3	sample	sample	NN
cord-023095-4dannjjm	2286	4	was	be	VBD
cord-023095-4dannjjm	2286	5	collected	collect	VBN
cord-023095-4dannjjm	2286	6	per	per	IN
cord-023095-4dannjjm	2286	7	rectum	rectum	NN
cord-023095-4dannjjm	2286	8	from	from	IN
cord-023095-4dannjjm	2286	9	each	each	DT
cord-023095-4dannjjm	2286	10	individual	individual	NN
cord-023095-4dannjjm	2286	11	at	at	IN
cord-023095-4dannjjm	2286	12	arrival	arrival	NN
cord-023095-4dannjjm	2286	13	and	and	CC
cord-023095-4dannjjm	2286	14	in	in	IN
cord-023095-4dannjjm	2286	15	the	the	DT
cord-023095-4dannjjm	2286	16	middle	middle	NN
cord-023095-4dannjjm	2286	17	of	of	IN
cord-023095-4dannjjm	2286	18	the	the	DT
cord-023095-4dannjjm	2286	19	feeding	feeding	NN
cord-023095-4dannjjm	2286	20	period	period	NN
cord-023095-4dannjjm	2286	21	when	when	WRB
cord-023095-4dannjjm	2286	22	cattle	cattle	NNS
cord-023095-4dannjjm	2286	23	were	be	VBD
cord-023095-4dannjjm	2286	24	rehandled	rehandle	VBN
cord-023095-4dannjjm	2286	25	as	as	IN
cord-023095-4dannjjm	2286	26	part	part	NN
cord-023095-4dannjjm	2286	27	of	of	IN
cord-023095-4dannjjm	2286	28	standard	standard	JJ
cord-023095-4dannjjm	2286	29	feedlot	feedlot	NN
cord-023095-4dannjjm	2286	30	protocol	protocol	NN
cord-023095-4dannjjm	2286	31	.	.	.
cord-023095-4dannjjm	2287	1	From	from	IN
cord-023095-4dannjjm	2287	2	samples	sample	NNS
cord-023095-4dannjjm	2287	3	collected	collect	VBN
cord-023095-4dannjjm	2287	4	at	at	IN
cord-023095-4dannjjm	2287	5	this	this	DT
cord-023095-4dannjjm	2287	6	second	second	JJ
cord-023095-4dannjjm	2287	7	time	time	NN
cord-023095-4dannjjm	2287	8	point	point	NN
cord-023095-4dannjjm	2287	9	,	,	,
cord-023095-4dannjjm	2287	10	a	a	DT
cord-023095-4dannjjm	2287	11	total	total	NN
cord-023095-4dannjjm	2287	12	of	of	IN
cord-023095-4dannjjm	2287	13	2,133	2,133	CD
cord-023095-4dannjjm	2287	14	NTSEC	NTSEC	NNP
cord-023095-4dannjjm	2287	15	isolates	isolate	NNS
cord-023095-4dannjjm	2287	16	were	be	VBD
cord-023095-4dannjjm	2287	17	tested	test	VBN
cord-023095-4dannjjm	2287	18	for	for	IN
cord-023095-4dannjjm	2287	19	susceptibility	susceptibility	NN
cord-023095-4dannjjm	2287	20	to	to	IN
cord-023095-4dannjjm	2287	21	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2287	22	drugs	drug	NNS
cord-023095-4dannjjm	2287	23	by	by	IN
cord-023095-4dannjjm	2287	24	disk	disk	NN
cord-023095-4dannjjm	2287	25	diffusion	diffusion	NN
cord-023095-4dannjjm	2287	26	.	.	.
cord-023095-4dannjjm	2288	1	Parenteral	parenteral	JJ
cord-023095-4dannjjm	2288	2	and	and	CC
cord-023095-4dannjjm	2288	3	in	in	IN
cord-023095-4dannjjm	2288	4	-	-	HYPH
cord-023095-4dannjjm	2288	5	feed	feed	NN
cord-023095-4dannjjm	2288	6	exposures	exposure	NNS
cord-023095-4dannjjm	2288	7	to	to	IN
cord-023095-4dannjjm	2288	8	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2288	9	drugs	drug	NNS
cord-023095-4dannjjm	2288	10	were	be	VBD
cord-023095-4dannjjm	2288	11	recorded	record	VBN
cord-023095-4dannjjm	2288	12	for	for	IN
cord-023095-4dannjjm	2288	13	each	each	DT
cord-023095-4dannjjm	2288	14	individual	individual	NN
cord-023095-4dannjjm	2288	15	enrolled	enrol	VBD
cord-023095-4dannjjm	2288	16	in	in	IN
cord-023095-4dannjjm	2288	17	the	the	DT
cord-023095-4dannjjm	2288	18	study	study	NN
cord-023095-4dannjjm	2288	19	.	.	.
cord-023095-4dannjjm	2289	1	The	the	DT
cord-023095-4dannjjm	2289	2	least	least	JJS
cord-023095-4dannjjm	2289	3	square	square	NN
cord-023095-4dannjjm	2289	4	means	mean	NNS
cord-023095-4dannjjm	2289	5	estimates	estimate	NNS
cord-023095-4dannjjm	2289	6	and	and	CC
cord-023095-4dannjjm	2289	7	95	95	CD
cord-023095-4dannjjm	2289	8	%	%	NN
cord-023095-4dannjjm	2289	9	confidence	confidence	NN
cord-023095-4dannjjm	2289	10	intervals	interval	NNS
cord-023095-4dannjjm	2289	11	for	for	IN
cord-023095-4dannjjm	2289	12	the	the	DT
cord-023095-4dannjjm	2289	13	prevalence	prevalence	NN
cord-023095-4dannjjm	2289	14	of	of	IN
cord-023095-4dannjjm	2289	15	resistance	resistance	NN
cord-023095-4dannjjm	2289	16	at	at	IN
cord-023095-4dannjjm	2289	17	each	each	DT
cord-023095-4dannjjm	2289	18	time	time	NN
cord-023095-4dannjjm	2289	19	point	point	NN
cord-023095-4dannjjm	2289	20	were	be	VBD
cord-023095-4dannjjm	2289	21	modeled	model	VBN
cord-023095-4dannjjm	2289	22	using	use	VBG
cord-023095-4dannjjm	2289	23	Poisson	Poisson	NNP
cord-023095-4dannjjm	2289	24	regression	regression	NN
cord-023095-4dannjjm	2289	25	.	.	.
cord-023095-4dannjjm	2290	1	Multivariable	multivariable	JJ
cord-023095-4dannjjm	2290	2	logistic	logistic	JJ
cord-023095-4dannjjm	2290	3	regression	regression	NN
cord-023095-4dannjjm	2290	4	was	be	VBD
cord-023095-4dannjjm	2290	5	used	use	VBN
cord-023095-4dannjjm	2290	6	to	to	TO
cord-023095-4dannjjm	2290	7	investigate	investigate	VB
cord-023095-4dannjjm	2290	8	associations	association	NNS
cord-023095-4dannjjm	2290	9	between	between	IN
cord-023095-4dannjjm	2290	10	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2290	11	resistance	resistance	NN
cord-023095-4dannjjm	2290	12	and	and	CC
cord-023095-4dannjjm	2290	13	exposure	exposure	NN
cord-023095-4dannjjm	2290	14	to	to	IN
cord-023095-4dannjjm	2290	15	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2290	16	drugs	drug	NNS
cord-023095-4dannjjm	2290	17	.	.	.
cord-023095-4dannjjm	2291	1	Regression	regression	NN
cord-023095-4dannjjm	2291	2	models	model	NNS
cord-023095-4dannjjm	2291	3	were	be	VBD
cord-023095-4dannjjm	2291	4	adjusted	adjust	VBN
cord-023095-4dannjjm	2291	5	for	for	IN
cord-023095-4dannjjm	2291	6	clustering	clustering	NN
cord-023095-4dannjjm	2291	7	of	of	IN
cord-023095-4dannjjm	2291	8	observations	observation	NNS
cord-023095-4dannjjm	2291	9	among	among	IN
cord-023095-4dannjjm	2291	10	individuals	individual	NNS
cord-023095-4dannjjm	2291	11	and	and	CC
cord-023095-4dannjjm	2291	12	pens	pen	NNS
cord-023095-4dannjjm	2291	13	.	.	.
cord-023095-4dannjjm	2292	1	The	the	DT
cord-023095-4dannjjm	2292	2	most	most	RBS
cord-023095-4dannjjm	2292	3	common	common	JJ
cord-023095-4dannjjm	2292	4	resistances	resistance	NNS
cord-023095-4dannjjm	2292	5	identified	identify	VBN
cord-023095-4dannjjm	2292	6	in	in	IN
cord-023095-4dannjjm	2292	7	arrival	arrival	NN
cord-023095-4dannjjm	2292	8	samples	sample	NNS
cord-023095-4dannjjm	2292	9	were	be	VBD
cord-023095-4dannjjm	2292	10	sulfisoxazole	sulfisoxazole	NNP
cord-023095-4dannjjm	2292	11	(	(	-LRB-
cord-023095-4dannjjm	2292	12	7.5	7.5	CD
cord-023095-4dannjjm	2292	13	%	%	NN
cord-023095-4dannjjm	2292	14	;	;	:
cord-023095-4dannjjm	2292	15	95%CI	95%ci	CD
cord-023095-4dannjjm	2292	16	:	:	:
cord-023095-4dannjjm	2292	17	6.1	6.1	CD
cord-023095-4dannjjm	2292	18	-	-	SYM
cord-023095-4dannjjm	2292	19	9.2	9.2	CD
cord-023095-4dannjjm	2292	20	)	)	-RRB-
cord-023095-4dannjjm	2292	21	,	,	,
cord-023095-4dannjjm	2292	22	streptomycin	streptomycin	NNS
cord-023095-4dannjjm	2292	23	(	(	-LRB-
cord-023095-4dannjjm	2292	24	7.7	7.7	CD
cord-023095-4dannjjm	2292	25	%	%	NN
cord-023095-4dannjjm	2292	26	;	;	:
cord-023095-4dannjjm	2292	27	95%CI	95%ci	CD
cord-023095-4dannjjm	2292	28	:	:	:
cord-023095-4dannjjm	2292	29	6.3	6.3	CD
cord-023095-4dannjjm	2292	30	-	-	SYM
cord-023095-4dannjjm	2292	31	9.5	9.5	CD
cord-023095-4dannjjm	2292	32	)	)	-RRB-
cord-023095-4dannjjm	2292	33	and	and	CC
cord-023095-4dannjjm	2292	34	tetracycline	tetracycline	NNP
cord-023095-4dannjjm	2292	35	(	(	-LRB-
cord-023095-4dannjjm	2292	36	20.0	20.0	CD
cord-023095-4dannjjm	2292	37	%	%	NN
cord-023095-4dannjjm	2292	38	;	;	:
cord-023095-4dannjjm	2292	39	95%CI	95%ci	CD
cord-023095-4dannjjm	2292	40	:	:	:
cord-023095-4dannjjm	2292	41	17.7	17.7	CD
cord-023095-4dannjjm	2292	42	-	-	HYPH
cord-023095-4dannjjm	2292	43	22.6	22.6	CD
cord-023095-4dannjjm	2292	44	)	)	-RRB-
cord-023095-4dannjjm	2292	45	.	.	.
cord-023095-4dannjjm	2293	1	At	at	IN
cord-023095-4dannjjm	2293	2	the	the	DT
cord-023095-4dannjjm	2293	3	second	second	JJ
cord-023095-4dannjjm	2293	4	sampling	sampling	NN
cord-023095-4dannjjm	2293	5	point	point	NN
cord-023095-4dannjjm	2293	6	,	,	,
cord-023095-4dannjjm	2293	7	resistance	resistance	NN
cord-023095-4dannjjm	2293	8	prevalence	prevalence	NN
cord-023095-4dannjjm	2293	9	was	be	VBD
cord-023095-4dannjjm	2293	10	25.6	25.6	CD
cord-023095-4dannjjm	2293	11	%	%	NN
cord-023095-4dannjjm	2293	12	(	(	-LRB-
cord-023095-4dannjjm	2293	13	95%CI	95%ci	CD
cord-023095-4dannjjm	2293	14	:	:	:
cord-023095-4dannjjm	2293	15	23.5	23.5	CD
cord-023095-4dannjjm	2293	16	-	-	HYPH
cord-023095-4dannjjm	2293	17	28.0	28.0	CD
cord-023095-4dannjjm	2293	18	)	)	-RRB-
cord-023095-4dannjjm	2293	19	for	for	IN
cord-023095-4dannjjm	2293	20	sulfisoxazole	sulfisoxazole	NNP
cord-023095-4dannjjm	2293	21	,	,	,
cord-023095-4dannjjm	2293	22	25.0	25.0	CD
cord-023095-4dannjjm	2293	23	%	%	NN
cord-023095-4dannjjm	2293	24	(	(	-LRB-
cord-023095-4dannjjm	2293	25	95%CI	95%ci	CD
cord-023095-4dannjjm	2293	26	:	:	:
cord-023095-4dannjjm	2293	27	22.8	22.8	CD
cord-023095-4dannjjm	2293	28	-	-	HYPH
cord-023095-4dannjjm	2293	29	27.3	27.3	CD
cord-023095-4dannjjm	2293	30	)	)	-RRB-
cord-023095-4dannjjm	2293	31	for	for	IN
cord-023095-4dannjjm	2293	32	streptomycin	streptomycin	NNS
cord-023095-4dannjjm	2293	33	,	,	,
cord-023095-4dannjjm	2293	34	and	and	CC
cord-023095-4dannjjm	2293	35	72.7	72.7	CD
cord-023095-4dannjjm	2293	36	%	%	NN
cord-023095-4dannjjm	2293	37	(	(	-LRB-
cord-023095-4dannjjm	2293	38	95%CI	95%ci	CD
cord-023095-4dannjjm	2293	39	:	:	:
cord-023095-4dannjjm	2293	40	70.5	70.5	CD
cord-023095-4dannjjm	2293	41	-	-	HYPH
cord-023095-4dannjjm	2293	42	75.1	75.1	CD
cord-023095-4dannjjm	2293	43	)	)	-RRB-
cord-023095-4dannjjm	2293	44	for	for	IN
cord-023095-4dannjjm	2293	45	tetracycline	tetracycline	NNP
cord-023095-4dannjjm	2293	46	.	.	.
cord-023095-4dannjjm	2294	1	Logistic	logistic	JJ
cord-023095-4dannjjm	2294	2	regression	regression	NN
cord-023095-4dannjjm	2294	3	modeling	modeling	NN
cord-023095-4dannjjm	2294	4	identified	identify	VBD
cord-023095-4dannjjm	2294	5	weak	weak	JJ
cord-023095-4dannjjm	2294	6	associations	association	NNS
cord-023095-4dannjjm	2294	7	of	of	IN
cord-023095-4dannjjm	2294	8	exposures	exposure	NNS
cord-023095-4dannjjm	2294	9	to	to	IN
cord-023095-4dannjjm	2294	10	tetracycline	tetracycline	NNP
cord-023095-4dannjjm	2294	11	and	and	CC
cord-023095-4dannjjm	2294	12	macrolide	macrolide	NN
cord-023095-4dannjjm	2294	13	classes	class	NNS
cord-023095-4dannjjm	2294	14	of	of	IN
cord-023095-4dannjjm	2294	15	drugs	drug	NNS
cord-023095-4dannjjm	2294	16	with	with	IN
cord-023095-4dannjjm	2294	17	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2294	18	resistance	resistance	NN
cord-023095-4dannjjm	2294	19	at	at	IN
cord-023095-4dannjjm	2294	20	the	the	DT
cord-023095-4dannjjm	2294	21	second	second	JJ
cord-023095-4dannjjm	2294	22	time	time	NN
cord-023095-4dannjjm	2294	23	point	point	NN
cord-023095-4dannjjm	2294	24	.	.	.
cord-023095-4dannjjm	2295	1	ABSTRACT	ABSTRACT	NNP
cord-023095-4dannjjm	2295	2	FA-5	FA-5	NNP
cord-023095-4dannjjm	2296	1	PREMATURE	premature	JJ
cord-023095-4dannjjm	2296	2	/	/	SYM
cord-023095-4dannjjm	2296	3	DYSMATURE	DYSMATURE	NNP
cord-023095-4dannjjm	2296	4	SYNDROME	syndrome	NN
cord-023095-4dannjjm	2296	5	IN	in	IN
cord-023095-4dannjjm	2296	6	CRIA	cria	NN
cord-023095-4dannjjm	2296	7	:	:	:
cord-023095-4dannjjm	2297	1	A	a	DT
cord-023095-4dannjjm	2297	2	RET	ret	NN
cord-023095-4dannjjm	2297	3	-	-	HYPH
cord-023095-4dannjjm	2297	4	ROSPECTIVE	ROSPECTIVE	NNP
cord-023095-4dannjjm	2297	5	STUDY	study	NN
cord-023095-4dannjjm	2297	6	OF	of	IN
cord-023095-4dannjjm	2297	7	63	63	CD
cord-023095-4dannjjm	2297	8	CASES	case	NNS
cord-023095-4dannjjm	2297	9	(	(	-LRB-
cord-023095-4dannjjm	2297	10	1999	1999	CD
cord-023095-4dannjjm	2297	11	)	)	-RRB-
cord-023095-4dannjjm	2297	12	(	(	-LRB-
cord-023095-4dannjjm	2297	13	2000	2000	CD
cord-023095-4dannjjm	2297	14	)	)	-RRB-
cord-023095-4dannjjm	2297	15	(	(	-LRB-
cord-023095-4dannjjm	2297	16	2001	2001	CD
cord-023095-4dannjjm	2297	17	)	)	-RRB-
cord-023095-4dannjjm	2297	18	(	(	-LRB-
cord-023095-4dannjjm	2297	19	2002	2002	CD
cord-023095-4dannjjm	2297	20	)	)	-RRB-
cord-023095-4dannjjm	2297	21	(	(	-LRB-
cord-023095-4dannjjm	2297	22	2003	2003	CD
cord-023095-4dannjjm	2297	23	)	)	-RRB-
cord-023095-4dannjjm	2297	24	(	(	-LRB-
cord-023095-4dannjjm	2297	25	2004	2004	CD
cord-023095-4dannjjm	2297	26	)	)	-RRB-
cord-023095-4dannjjm	2297	27	(	(	-LRB-
cord-023095-4dannjjm	2297	28	2005	2005	CD
cord-023095-4dannjjm	2297	29	)	)	-RRB-
cord-023095-4dannjjm	2297	30	.	.	.
cord-023095-4dannjjm	2298	1	C.	C.	NNP
cord-023095-4dannjjm	2298	2	Gerspach	Gerspach	NNP
cord-023095-4dannjjm	2298	3	,	,	,
cord-023095-4dannjjm	2298	4	D.	D.	NNP
cord-023095-4dannjjm	2298	5	Anderson	Anderson	NNP
cord-023095-4dannjjm	2298	6	.	.	.
cord-023095-4dannjjm	2299	1	The	the	DT
cord-023095-4dannjjm	2299	2	Ohio	Ohio	NNP
cord-023095-4dannjjm	2299	3	State	State	NNP
cord-023095-4dannjjm	2299	4	University	University	NNP
cord-023095-4dannjjm	2299	5	,	,	,
cord-023095-4dannjjm	2299	6	Columbus	Columbus	NNP
cord-023095-4dannjjm	2299	7	OH	OH	NNP
cord-023095-4dannjjm	2299	8	.	.	.
cord-023095-4dannjjm	2300	1	Prematurity	prematurity	NN
cord-023095-4dannjjm	2300	2	is	be	VBZ
cord-023095-4dannjjm	2300	3	widely	widely	RB
cord-023095-4dannjjm	2300	4	acknowledged	acknowledge	VBN
cord-023095-4dannjjm	2300	5	as	as	IN
cord-023095-4dannjjm	2300	6	risk	risk	NN
cord-023095-4dannjjm	2300	7	factor	factor	NN
cord-023095-4dannjjm	2300	8	for	for	IN
cord-023095-4dannjjm	2300	9	subsequent	subsequent	JJ
cord-023095-4dannjjm	2300	10	morbidity	morbidity	NN
cord-023095-4dannjjm	2300	11	and	and	CC
cord-023095-4dannjjm	2300	12	mortality	mortality	NN
cord-023095-4dannjjm	2300	13	in	in	IN
cord-023095-4dannjjm	2300	14	llama	llama	NN
cord-023095-4dannjjm	2300	15	and	and	CC
cord-023095-4dannjjm	2300	16	alpaca	alpaca	NN
cord-023095-4dannjjm	2300	17	cria	cria	NN
cord-023095-4dannjjm	2300	18	.	.	.
cord-023095-4dannjjm	2301	1	A	a	DT
cord-023095-4dannjjm	2301	2	review	review	NN
cord-023095-4dannjjm	2301	3	of	of	IN
cord-023095-4dannjjm	2301	4	medical	medical	JJ
cord-023095-4dannjjm	2301	5	records	record	NNS
cord-023095-4dannjjm	2301	6	for	for	IN
cord-023095-4dannjjm	2301	7	premature	premature	JJ
cord-023095-4dannjjm	2301	8	cria	cria	NN
cord-023095-4dannjjm	2301	9	alive	alive	JJ
cord-023095-4dannjjm	2301	10	at	at	IN
cord-023095-4dannjjm	2301	11	the	the	DT
cord-023095-4dannjjm	2301	12	time	time	NN
cord-023095-4dannjjm	2301	13	of	of	IN
cord-023095-4dannjjm	2301	14	admission	admission	NN
cord-023095-4dannjjm	2301	15	to	to	IN
cord-023095-4dannjjm	2301	16	the	the	DT
cord-023095-4dannjjm	2301	17	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	2301	18	Teaching	Teaching	NNP
cord-023095-4dannjjm	2301	19	Hospital	Hospital	NNP
cord-023095-4dannjjm	2301	20	between	between	IN
cord-023095-4dannjjm	2301	21	1999	1999	CD
cord-023095-4dannjjm	2301	22	and	and	CC
cord-023095-4dannjjm	2301	23	2005	2005	CD
cord-023095-4dannjjm	2301	24	was	be	VBD
cord-023095-4dannjjm	2301	25	performed	perform	VBN
cord-023095-4dannjjm	2301	26	to	to	TO
cord-023095-4dannjjm	2301	27	determine	determine	VB
cord-023095-4dannjjm	2301	28	risk	risk	NN
cord-023095-4dannjjm	2301	29	factors	factor	NNS
cord-023095-4dannjjm	2301	30	of	of	IN
cord-023095-4dannjjm	2301	31	prematurity	prematurity	NN
cord-023095-4dannjjm	2301	32	and	and	CC
cord-023095-4dannjjm	2301	33	to	to	TO
cord-023095-4dannjjm	2301	34	report	report	VB
cord-023095-4dannjjm	2301	35	the	the	DT
cord-023095-4dannjjm	2301	36	outcome	outcome	NN
cord-023095-4dannjjm	2301	37	and	and	CC
cord-023095-4dannjjm	2301	38	related	related	JJ
cord-023095-4dannjjm	2301	39	conditions	condition	NNS
cord-023095-4dannjjm	2301	40	or	or	CC
cord-023095-4dannjjm	2301	41	diseases	disease	NNS
cord-023095-4dannjjm	2301	42	in	in	IN
cord-023095-4dannjjm	2301	43	affected	affected	JJ
cord-023095-4dannjjm	2301	44	cria	cria	NN
cord-023095-4dannjjm	2301	45	.	.	.
cord-023095-4dannjjm	2302	1	Medical	medical	JJ
cord-023095-4dannjjm	2302	2	records	record	NNS
cord-023095-4dannjjm	2302	3	for	for	IN
cord-023095-4dannjjm	2302	4	63	63	CD
cord-023095-4dannjjm	2303	1	premature	premature	JJ
cord-023095-4dannjjm	2303	2	or	or	CC
cord-023095-4dannjjm	2303	3	dysmature	dysmature	NN
cord-023095-4dannjjm	2303	4	cria	cria	NN
cord-023095-4dannjjm	2303	5	were	be	VBD
cord-023095-4dannjjm	2303	6	included	include	VBN
cord-023095-4dannjjm	2303	7	in	in	IN
cord-023095-4dannjjm	2303	8	this	this	DT
cord-023095-4dannjjm	2303	9	study	study	NN
cord-023095-4dannjjm	2303	10	.	.	.
cord-023095-4dannjjm	2304	1	Of	of	IN
cord-023095-4dannjjm	2304	2	these	these	DT
cord-023095-4dannjjm	2304	3	cria	cria	NN
cord-023095-4dannjjm	2304	4	,	,	,
cord-023095-4dannjjm	2304	5	51	51	CD
cord-023095-4dannjjm	2304	6	were	be	VBD
cord-023095-4dannjjm	2304	7	alpaca	alpaca	NN
cord-023095-4dannjjm	2304	8	and	and	CC
cord-023095-4dannjjm	2304	9	12	12	CD
cord-023095-4dannjjm	2304	10	llama	llama	NN
cord-023095-4dannjjm	2304	11	,	,	,
cord-023095-4dannjjm	2304	12	36	36	CD
cord-023095-4dannjjm	2304	13	were	be	VBD
cord-023095-4dannjjm	2304	14	female	female	JJ
cord-023095-4dannjjm	2304	15	and	and	CC
cord-023095-4dannjjm	2304	16	27	27	CD
cord-023095-4dannjjm	2304	17	were	be	VBD
cord-023095-4dannjjm	2304	18	male	male	JJ
cord-023095-4dannjjm	2304	19	.	.	.
cord-023095-4dannjjm	2305	1	Reasons	reason	NNS
cord-023095-4dannjjm	2305	2	for	for	IN
cord-023095-4dannjjm	2305	3	referral	referral	NN
cord-023095-4dannjjm	2305	4	were	be	VBD
cord-023095-4dannjjm	2305	5	prematurity	prematurity	NN
cord-023095-4dannjjm	2305	6	,	,	,
cord-023095-4dannjjm	2305	7	failure	failure	NN
cord-023095-4dannjjm	2305	8	of	of	IN
cord-023095-4dannjjm	2305	9	passive	passive	JJ
cord-023095-4dannjjm	2305	10	immunity	immunity	NN
cord-023095-4dannjjm	2305	11	,	,	,
cord-023095-4dannjjm	2305	12	dyspnoea	dyspnoea	NNS
cord-023095-4dannjjm	2305	13	,	,	,
cord-023095-4dannjjm	2305	14	weakness	weakness	NN
cord-023095-4dannjjm	2305	15	and	and	CC
cord-023095-4dannjjm	2305	16	failure	failure	NN
cord-023095-4dannjjm	2305	17	to	to	TO
cord-023095-4dannjjm	2305	18	gain	gain	VB
cord-023095-4dannjjm	2305	19	weight	weight	NN
cord-023095-4dannjjm	2305	20	.	.	.
cord-023095-4dannjjm	2306	1	Cria	Cria	NNP
cord-023095-4dannjjm	2306	2	were	be	VBD
cord-023095-4dannjjm	2306	3	presented	present	VBN
cord-023095-4dannjjm	2306	4	at	at	IN
cord-023095-4dannjjm	2306	5	a	a	DT
cord-023095-4dannjjm	2306	6	mean	mean	JJ
cord-023095-4dannjjm	2306	7	age	age	NN
cord-023095-4dannjjm	2306	8	of	of	IN
cord-023095-4dannjjm	2306	9	1.4	1.4	CD
cord-023095-4dannjjm	2306	10	days	day	NNS
cord-023095-4dannjjm	2306	11	and	and	CC
cord-023095-4dannjjm	2306	12	were	be	VBD
cord-023095-4dannjjm	2306	13	premature	premature	JJ
cord-023095-4dannjjm	2306	14	by	by	IN
cord-023095-4dannjjm	2306	15	a	a	DT
cord-023095-4dannjjm	2306	16	mean	mean	JJ
cord-023095-4dannjjm	2306	17	estimated	estimate	VBN
cord-023095-4dannjjm	2306	18	time	time	NN
cord-023095-4dannjjm	2306	19	of	of	IN
cord-023095-4dannjjm	2306	20	19.5	19.5	CD
cord-023095-4dannjjm	2306	21	days	day	NNS
cord-023095-4dannjjm	2306	22	.	.	.
cord-023095-4dannjjm	2307	1	Overall	overall	JJ
cord-023095-4dannjjm	2307	2	survival	survival	NN
cord-023095-4dannjjm	2307	3	rate	rate	NN
cord-023095-4dannjjm	2307	4	was	be	VBD
cord-023095-4dannjjm	2307	5	82.5	82.5	CD
cord-023095-4dannjjm	2307	6	%	%	NN
cord-023095-4dannjjm	2307	7	,	,	,
cord-023095-4dannjjm	2307	8	with	with	IN
cord-023095-4dannjjm	2307	9	all	all	DT
cord-023095-4dannjjm	2307	10	llama	llama	NN
cord-023095-4dannjjm	2307	11	cria	cria	NN
cord-023095-4dannjjm	2307	12	surviving	survive	VBG
cord-023095-4dannjjm	2307	13	.	.	.
cord-023095-4dannjjm	2308	1	A	a	DT
cord-023095-4dannjjm	2308	2	multivariate	multivariate	JJ
cord-023095-4dannjjm	2308	3	logistic	logistic	JJ
cord-023095-4dannjjm	2308	4	regression	regression	NN
cord-023095-4dannjjm	2308	5	model	model	NN
cord-023095-4dannjjm	2308	6	was	be	VBD
cord-023095-4dannjjm	2308	7	used	use	VBN
cord-023095-4dannjjm	2308	8	to	to	TO
cord-023095-4dannjjm	2308	9	identify	identify	VB
cord-023095-4dannjjm	2308	10	risk	risk	NN
cord-023095-4dannjjm	2308	11	factors	factor	NNS
cord-023095-4dannjjm	2308	12	associated	associate	VBN
cord-023095-4dannjjm	2308	13	with	with	IN
cord-023095-4dannjjm	2308	14	not	not	RB
cord-023095-4dannjjm	2308	15	surviving	survive	VBG
cord-023095-4dannjjm	2308	16	.	.	.
cord-023095-4dannjjm	2309	1	Cria	cria	NN
cord-023095-4dannjjm	2309	2	receiving	receive	VBG
cord-023095-4dannjjm	2309	3	camelid	camelid	NNP
cord-023095-4dannjjm	2309	4	colostrum	colostrum	NN
cord-023095-4dannjjm	2309	5	had	have	VBD
cord-023095-4dannjjm	2309	6	a	a	DT
cord-023095-4dannjjm	2309	7	significant	significant	JJ
cord-023095-4dannjjm	2309	8	better	well	JJR
cord-023095-4dannjjm	2309	9	outcome	outcome	NN
cord-023095-4dannjjm	2309	10	than	than	IN
cord-023095-4dannjjm	2309	11	cria	cria	NN
cord-023095-4dannjjm	2309	12	receiving	receive	VBG
cord-023095-4dannjjm	2309	13	no	no	DT
cord-023095-4dannjjm	2309	14	colostrum	colostrum	NN
cord-023095-4dannjjm	2309	15	or	or	CC
cord-023095-4dannjjm	2309	16	colostrum	colostrum	NN
cord-023095-4dannjjm	2309	17	from	from	IN
cord-023095-4dannjjm	2309	18	different	different	JJ
cord-023095-4dannjjm	2309	19	species	specie	NNS
cord-023095-4dannjjm	2309	20	.	.	.
cord-023095-4dannjjm	2310	1	Dyspnea	Dyspnea	NNP
cord-023095-4dannjjm	2310	2	and	and	CC
cord-023095-4dannjjm	2310	3	tachypnea	tachypnea	NNP
cord-023095-4dannjjm	2310	4	was	be	VBD
cord-023095-4dannjjm	2310	5	associated	associate	VBN
cord-023095-4dannjjm	2310	6	with	with	IN
cord-023095-4dannjjm	2310	7	a	a	DT
cord-023095-4dannjjm	2310	8	poor	poor	JJ
cord-023095-4dannjjm	2310	9	outcome	outcome	NN
cord-023095-4dannjjm	2310	10	.	.	.
cord-023095-4dannjjm	2311	1	All	all	DT
cord-023095-4dannjjm	2311	2	cria	cria	NN
cord-023095-4dannjjm	2311	3	that	that	WDT
cord-023095-4dannjjm	2311	4	were	be	VBD
cord-023095-4dannjjm	2311	5	able	able	JJ
cord-023095-4dannjjm	2311	6	to	to	TO
cord-023095-4dannjjm	2311	7	nurse	nurse	VB
cord-023095-4dannjjm	2311	8	,	,	,
cord-023095-4dannjjm	2311	9	without	without	IN
cord-023095-4dannjjm	2311	10	assistance	assistance	NN
cord-023095-4dannjjm	2311	11	prior	prior	RB
cord-023095-4dannjjm	2311	12	to	to	IN
cord-023095-4dannjjm	2311	13	referral	referral	NN
cord-023095-4dannjjm	2311	14	,	,	,
cord-023095-4dannjjm	2311	15	survived	survive	VBD
cord-023095-4dannjjm	2311	16	.	.	.
cord-023095-4dannjjm	2312	1	Clinical	clinical	JJ
cord-023095-4dannjjm	2312	2	pathology	pathology	NN
cord-023095-4dannjjm	2312	3	parameters	parameter	NNS
cord-023095-4dannjjm	2312	4	most	most	RBS
cord-023095-4dannjjm	2312	5	commonly	commonly	RB
cord-023095-4dannjjm	2312	6	associated	associate	VBN
cord-023095-4dannjjm	2312	7	with	with	IN
cord-023095-4dannjjm	2312	8	death	death	NN
cord-023095-4dannjjm	2312	9	were	be	VBD
cord-023095-4dannjjm	2312	10	hyperphosphatemia	hyperphosphatemia	NN
cord-023095-4dannjjm	2312	11	and	and	CC
cord-023095-4dannjjm	2312	12	acidosis	acidosis	NN
cord-023095-4dannjjm	2312	13	.	.	.
cord-023095-4dannjjm	2313	1	Enrofloxacin	Enrofloxacin	NNP
cord-023095-4dannjjm	2313	2	is	be	VBZ
cord-023095-4dannjjm	2313	3	approved	approve	VBN
cord-023095-4dannjjm	2313	4	for	for	IN
cord-023095-4dannjjm	2313	5	the	the	DT
cord-023095-4dannjjm	2313	6	treatment	treatment	NN
cord-023095-4dannjjm	2313	7	of	of	IN
cord-023095-4dannjjm	2313	8	swine	swine	NN
cord-023095-4dannjjm	2313	9	respiratory	respiratory	JJ
cord-023095-4dannjjm	2313	10	disease	disease	NN
cord-023095-4dannjjm	2313	11	,	,	,
cord-023095-4dannjjm	2313	12	however	however	RB
cord-023095-4dannjjm	2313	13	there	there	EX
cord-023095-4dannjjm	2313	14	are	be	VBP
cord-023095-4dannjjm	2313	15	no	no	DT
cord-023095-4dannjjm	2313	16	published	publish	VBN
cord-023095-4dannjjm	2313	17	studies	study	NNS
cord-023095-4dannjjm	2313	18	describing	describe	VBG
cord-023095-4dannjjm	2313	19	the	the	DT
cord-023095-4dannjjm	2313	20	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	2313	21	of	of	IN
cord-023095-4dannjjm	2313	22	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	2313	23	at	at	IN
cord-023095-4dannjjm	2313	24	the	the	DT
cord-023095-4dannjjm	2313	25	approved	approve	VBN
cord-023095-4dannjjm	2313	26	dose	dose	NN
cord-023095-4dannjjm	2313	27	and	and	CC
cord-023095-4dannjjm	2313	28	route	route	NN
cord-023095-4dannjjm	2313	29	in	in	IN
cord-023095-4dannjjm	2313	30	pigs	pig	NNS
cord-023095-4dannjjm	2313	31	(	(	-LRB-
cord-023095-4dannjjm	2313	32	7.5	7.5	CD
cord-023095-4dannjjm	2313	33	mg	mg	NNP
cord-023095-4dannjjm	2313	34	/	/	SYM
cord-023095-4dannjjm	2313	35	kg	kg	NNP
cord-023095-4dannjjm	2313	36	subcutaneously	subcutaneously	RB
cord-023095-4dannjjm	2313	37	)	)	-RRB-
cord-023095-4dannjjm	2313	38	.	.	.
cord-023095-4dannjjm	2314	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	2314	2	no	no	DT
cord-023095-4dannjjm	2314	3	studies	study	NNS
cord-023095-4dannjjm	2314	4	have	have	VBP
cord-023095-4dannjjm	2314	5	assessed	assess	VBN
cord-023095-4dannjjm	2314	6	the	the	DT
cord-023095-4dannjjm	2314	7	unbound	unbound	JJ
cord-023095-4dannjjm	2314	8	concentrations	concentration	NNS
cord-023095-4dannjjm	2314	9	of	of	IN
cord-023095-4dannjjm	2314	10	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	2314	11	at	at	IN
cord-023095-4dannjjm	2314	12	its	-PRON-	PRP$
cord-023095-4dannjjm	2314	13	site	site	NN
cord-023095-4dannjjm	2314	14	of	of	IN
cord-023095-4dannjjm	2314	15	action	action	NN
cord-023095-4dannjjm	2314	16	,	,	,
cord-023095-4dannjjm	2314	17	the	the	DT
cord-023095-4dannjjm	2314	18	extracellular	extracellular	JJ
cord-023095-4dannjjm	2314	19	tissue	tissue	NN
cord-023095-4dannjjm	2314	20	fluid	fluid	NN
cord-023095-4dannjjm	2314	21	.	.	.
cord-023095-4dannjjm	2315	1	Therefore	therefore	RB
cord-023095-4dannjjm	2315	2	the	the	DT
cord-023095-4dannjjm	2315	3	objective	objective	NN
cord-023095-4dannjjm	2315	4	of	of	IN
cord-023095-4dannjjm	2315	5	this	this	DT
cord-023095-4dannjjm	2315	6	study	study	NN
cord-023095-4dannjjm	2315	7	was	be	VBD
cord-023095-4dannjjm	2315	8	to	to	TO
cord-023095-4dannjjm	2315	9	use	use	VB
cord-023095-4dannjjm	2315	10	an	an	DT
cord-023095-4dannjjm	2315	11	in	in	IN
cord-023095-4dannjjm	2315	12	-	-	HYPH
cord-023095-4dannjjm	2315	13	vivo	vivo	NN
cord-023095-4dannjjm	2315	14	ultrafiltration	ultrafiltration	NN
cord-023095-4dannjjm	2315	15	method	method	NN
cord-023095-4dannjjm	2315	16	to	to	TO
cord-023095-4dannjjm	2315	17	measure	measure	VB
cord-023095-4dannjjm	2315	18	the	the	DT
cord-023095-4dannjjm	2315	19	active	active	JJ
cord-023095-4dannjjm	2315	20	fraction	fraction	NN
cord-023095-4dannjjm	2315	21	of	of	IN
cord-023095-4dannjjm	2315	22	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	2315	23	,	,	,
cord-023095-4dannjjm	2315	24	and	and	CC
cord-023095-4dannjjm	2315	25	the	the	DT
cord-023095-4dannjjm	2315	26	metabolite	metabolite	JJ
cord-023095-4dannjjm	2315	27	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	2315	28	,	,	,
cord-023095-4dannjjm	2315	29	at	at	IN
cord-023095-4dannjjm	2315	30	3	3	CD
cord-023095-4dannjjm	2315	31	tissue	tissue	NN
cord-023095-4dannjjm	2315	32	sites	site	NNS
cord-023095-4dannjjm	2315	33	relevant	relevant	JJ
cord-023095-4dannjjm	2315	34	to	to	IN
cord-023095-4dannjjm	2315	35	pigs	pig	NNS
cord-023095-4dannjjm	2315	36	,	,	,
cord-023095-4dannjjm	2315	37	and	and	CC
cord-023095-4dannjjm	2315	38	to	to	TO
cord-023095-4dannjjm	2315	39	compare	compare	VB
cord-023095-4dannjjm	2315	40	these	these	DT
cord-023095-4dannjjm	2315	41	concentrations	concentration	NNS
cord-023095-4dannjjm	2315	42	with	with	IN
cord-023095-4dannjjm	2315	43	plasma	plasma	NN
cord-023095-4dannjjm	2315	44	concentrations	concentration	NNS
cord-023095-4dannjjm	2315	45	collected	collect	VBN
cord-023095-4dannjjm	2315	46	at	at	IN
cord-023095-4dannjjm	2315	47	similar	similar	JJ
cord-023095-4dannjjm	2315	48	time	time	NN
cord-023095-4dannjjm	2315	49	points	point	NNS
cord-023095-4dannjjm	2315	50	.	.	.
cord-023095-4dannjjm	2316	1	Six	six	CD
cord-023095-4dannjjm	2316	2	healthy	healthy	JJ
cord-023095-4dannjjm	2316	3	pigs	pig	NNS
cord-023095-4dannjjm	2316	4	were	be	VBD
cord-023095-4dannjjm	2316	5	used	use	VBN
cord-023095-4dannjjm	2316	6	in	in	IN
cord-023095-4dannjjm	2316	7	this	this	DT
cord-023095-4dannjjm	2316	8	study	study	NN
cord-023095-4dannjjm	2316	9	.	.	.
cord-023095-4dannjjm	2317	1	Pigs	pig	NNS
cord-023095-4dannjjm	2317	2	were	be	VBD
cord-023095-4dannjjm	2317	3	recently	recently	RB
cord-023095-4dannjjm	2317	4	weaned	wean	VBN
cord-023095-4dannjjm	2317	5	and	and	CC
cord-023095-4dannjjm	2317	6	weighed	weigh	VBD
cord-023095-4dannjjm	2317	7	an	an	DT
cord-023095-4dannjjm	2317	8	average	average	JJ
cord-023095-4dannjjm	2317	9	16.3	16.3	CD
cord-023095-4dannjjm	2317	10	kg	kg	NNS
cord-023095-4dannjjm	2317	11	.	.	.
cord-023095-4dannjjm	2318	1	On	on	IN
cord-023095-4dannjjm	2318	2	the	the	DT
cord-023095-4dannjjm	2318	3	day	day	NN
cord-023095-4dannjjm	2318	4	before	before	IN
cord-023095-4dannjjm	2318	5	the	the	DT
cord-023095-4dannjjm	2318	6	experiment	experiment	NN
cord-023095-4dannjjm	2318	7	,	,	,
cord-023095-4dannjjm	2318	8	pigs	pig	NNS
cord-023095-4dannjjm	2318	9	were	be	VBD
cord-023095-4dannjjm	2318	10	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	2318	11	for	for	IN
cord-023095-4dannjjm	2318	12	the	the	DT
cord-023095-4dannjjm	2318	13	placement	placement	NN
cord-023095-4dannjjm	2318	14	of	of	IN
cord-023095-4dannjjm	2318	15	jugular	jugular	NNP
cord-023095-4dannjjm	2318	16	vein	vein	NN
cord-023095-4dannjjm	2318	17	sampling	sampling	NN
cord-023095-4dannjjm	2318	18	catheters	catheter	NNS
cord-023095-4dannjjm	2318	19	and	and	CC
cord-023095-4dannjjm	2318	20	interstitial	interstitial	JJ
cord-023095-4dannjjm	2318	21	fluid	fluid	JJ
cord-023095-4dannjjm	2318	22	collection	collection	NN
cord-023095-4dannjjm	2318	23	probes	probe	NNS
cord-023095-4dannjjm	2318	24	.	.	.
cord-023095-4dannjjm	2319	1	Three	three	CD
cord-023095-4dannjjm	2319	2	ultrafiltration	ultrafiltration	NN
cord-023095-4dannjjm	2319	3	probes	probe	NNS
cord-023095-4dannjjm	2319	4	were	be	VBD
cord-023095-4dannjjm	2319	5	placed	place	VBN
cord-023095-4dannjjm	2319	6	in	in	IN
cord-023095-4dannjjm	2319	7	each	each	DT
cord-023095-4dannjjm	2319	8	pig	pig	NN
cord-023095-4dannjjm	2319	9	in	in	IN
cord-023095-4dannjjm	2319	10	a	a	DT
cord-023095-4dannjjm	2319	11	subcutaneous	subcutaneous	JJ
cord-023095-4dannjjm	2319	12	site	site	NN
cord-023095-4dannjjm	2319	13	near	near	IN
cord-023095-4dannjjm	2319	14	the	the	DT
cord-023095-4dannjjm	2319	15	right	right	JJ
cord-023095-4dannjjm	2319	16	shoulder	shoulder	NN
cord-023095-4dannjjm	2319	17	,	,	,
cord-023095-4dannjjm	2319	18	an	an	DT
cord-023095-4dannjjm	2319	19	intramuscular	intramuscular	JJ
cord-023095-4dannjjm	2319	20	site	site	NN
cord-023095-4dannjjm	2319	21	along	along	IN
cord-023095-4dannjjm	2319	22	the	the	DT
cord-023095-4dannjjm	2319	23	epaxial	epaxial	JJ
cord-023095-4dannjjm	2319	24	muscles	muscle	NNS
cord-023095-4dannjjm	2319	25	,	,	,
cord-023095-4dannjjm	2319	26	and	and	CC
cord-023095-4dannjjm	2319	27	in	in	IN
cord-023095-4dannjjm	2319	28	the	the	DT
cord-023095-4dannjjm	2319	29	pleural	pleural	JJ
cord-023095-4dannjjm	2319	30	space	space	NN
cord-023095-4dannjjm	2319	31	of	of	IN
cord-023095-4dannjjm	2319	32	the	the	DT
cord-023095-4dannjjm	2319	33	chest	chest	NN
cord-023095-4dannjjm	2319	34	cavity	cavity	NN
cord-023095-4dannjjm	2319	35	.	.	.
cord-023095-4dannjjm	2320	1	Each	each	DT
cord-023095-4dannjjm	2320	2	pig	pig	NN
cord-023095-4dannjjm	2320	3	received	receive	VBD
cord-023095-4dannjjm	2320	4	an	an	DT
cord-023095-4dannjjm	2320	5	injection	injection	NN
cord-023095-4dannjjm	2320	6	of	of	IN
cord-023095-4dannjjm	2320	7	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	2320	8	(	(	-LRB-
cord-023095-4dannjjm	2320	9	Baytril	Baytril	NNP
cord-023095-4dannjjm	2320	10	100	100	CD
cord-023095-4dannjjm	2320	11	,	,	,
cord-023095-4dannjjm	2320	12	Bayer	Bayer	NNP
cord-023095-4dannjjm	2320	13	Animal	Animal	NNP
cord-023095-4dannjjm	2320	14	Health	Health	NNP
cord-023095-4dannjjm	2320	15	)	)	-RRB-
cord-023095-4dannjjm	2320	16	at	at	IN
cord-023095-4dannjjm	2320	17	a	a	DT
cord-023095-4dannjjm	2320	18	dose	dose	NN
cord-023095-4dannjjm	2320	19	of	of	IN
cord-023095-4dannjjm	2320	20	7.5	7.5	CD
cord-023095-4dannjjm	2320	21	mg/	mg/	NN
cord-023095-4dannjjm	2320	22	kg	kg	NNP
cord-023095-4dannjjm	2320	23	subcutaneously	subcutaneously	RB
cord-023095-4dannjjm	2320	24	behind	behind	IN
cord-023095-4dannjjm	2320	25	the	the	DT
cord-023095-4dannjjm	2320	26	left	left	JJ
cord-023095-4dannjjm	2320	27	ear	ear	NN
cord-023095-4dannjjm	2320	28	.	.	.
cord-023095-4dannjjm	2321	1	Plasma	plasma	NN
cord-023095-4dannjjm	2321	2	and	and	CC
cord-023095-4dannjjm	2321	3	interstitial	interstitial	JJ
cord-023095-4dannjjm	2321	4	fluid	fluid	NN
cord-023095-4dannjjm	2321	5	samples	sample	NNS
cord-023095-4dannjjm	2321	6	were	be	VBD
cord-023095-4dannjjm	2321	7	collected	collect	VBN
cord-023095-4dannjjm	2321	8	at	at	IN
cord-023095-4dannjjm	2321	9	pre	pre	JJ
cord-023095-4dannjjm	2321	10	-	-	JJ
cord-023095-4dannjjm	2321	11	determined	determined	JJ
cord-023095-4dannjjm	2321	12	time	time	NN
cord-023095-4dannjjm	2321	13	points	point	NNS
cord-023095-4dannjjm	2321	14	,	,	,
cord-023095-4dannjjm	2321	15	and	and	CC
cord-023095-4dannjjm	2321	16	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	2321	17	and	and	CC
cord-023095-4dannjjm	2321	18	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	2321	19	concentrations	concentration	NNS
cord-023095-4dannjjm	2321	20	were	be	VBD
cord-023095-4dannjjm	2321	21	measured	measure	VBN
cord-023095-4dannjjm	2321	22	using	use	VBG
cord-023095-4dannjjm	2321	23	HPLC	HPLC	NNP
cord-023095-4dannjjm	2321	24	with	with	IN
cord-023095-4dannjjm	2321	25	fluorescence	fluorescence	NN
cord-023095-4dannjjm	2321	26	detection	detection	NN
cord-023095-4dannjjm	2321	27	.	.	.
cord-023095-4dannjjm	2322	1	Protein	protein	NN
cord-023095-4dannjjm	2322	2	binding	binding	NN
cord-023095-4dannjjm	2322	3	was	be	VBD
cord-023095-4dannjjm	2322	4	determined	determine	VBN
cord-023095-4dannjjm	2322	5	with	with	IN
cord-023095-4dannjjm	2322	6	a	a	DT
cord-023095-4dannjjm	2322	7	microcentrifugation	microcentrifugation	NN
cord-023095-4dannjjm	2322	8	system	system	NN
cord-023095-4dannjjm	2322	9	.	.	.
cord-023095-4dannjjm	2323	1	Pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	2323	2	data	datum	NNS
cord-023095-4dannjjm	2323	3	was	be	VBD
cord-023095-4dannjjm	2323	4	analyzed	analyze	VBN
cord-023095-4dannjjm	2323	5	using	use	VBG
cord-023095-4dannjjm	2323	6	a	a	DT
cord-023095-4dannjjm	2323	7	one	one	CD
cord-023095-4dannjjm	2323	8	compartment	compartment	NN
cord-023095-4dannjjm	2323	9	model	model	NN
cord-023095-4dannjjm	2323	10	.	.	.
cord-023095-4dannjjm	2324	1	The	the	DT
cord-023095-4dannjjm	2324	2	analysis	analysis	NN
cord-023095-4dannjjm	2324	3	of	of	IN
cord-023095-4dannjjm	2324	4	plasma	plasma	NN
cord-023095-4dannjjm	2324	5	and	and	CC
cord-023095-4dannjjm	2324	6	ISF	ISF	NNP
cord-023095-4dannjjm	2324	7	showed	show	VBD
cord-023095-4dannjjm	2324	8	that	that	IN
cord-023095-4dannjjm	2324	9	only	only	RB
cord-023095-4dannjjm	2324	10	a	a	DT
cord-023095-4dannjjm	2324	11	small	small	JJ
cord-023095-4dannjjm	2324	12	fraction	fraction	NN
cord-023095-4dannjjm	2324	13	of	of	IN
cord-023095-4dannjjm	2324	14	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	2324	15	was	be	VBD
cord-023095-4dannjjm	2324	16	produced	produce	VBN
cord-023095-4dannjjm	2324	17	in	in	IN
cord-023095-4dannjjm	2324	18	these	these	DT
cord-023095-4dannjjm	2324	19	pigs	pig	NNS
cord-023095-4dannjjm	2324	20	,	,	,
cord-023095-4dannjjm	2324	21	therefore	therefore	RB
cord-023095-4dannjjm	2324	22	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	2324	23	concentrations	concentration	NNS
cord-023095-4dannjjm	2324	24	were	be	VBD
cord-023095-4dannjjm	2324	25	not	not	RB
cord-023095-4dannjjm	2324	26	used	use	VBN
cord-023095-4dannjjm	2324	27	in	in	IN
cord-023095-4dannjjm	2324	28	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	2324	29	measurements	measurement	NNS
cord-023095-4dannjjm	2324	30	.	.	.
cord-023095-4dannjjm	2325	1	The	the	DT
cord-023095-4dannjjm	2325	2	plasma	plasma	NN
cord-023095-4dannjjm	2325	3	half	half	JJ
cord-023095-4dannjjm	2325	4	-	-	HYPH
cord-023095-4dannjjm	2325	5	life	life	NN
cord-023095-4dannjjm	2325	6	(	(	-LRB-
cord-023095-4dannjjm	2325	7	t	t	NN
cord-023095-4dannjjm	2325	8	1/2	1/2	CD
cord-023095-4dannjjm	2325	9	)	)	-RRB-
cord-023095-4dannjjm	2325	10	,	,	,
cord-023095-4dannjjm	2325	11	volume	volume	NN
cord-023095-4dannjjm	2325	12	of	of	IN
cord-023095-4dannjjm	2325	13	distribution	distribution	NN
cord-023095-4dannjjm	2325	14	,	,	,
cord-023095-4dannjjm	2325	15	clearance	clearance	NN
cord-023095-4dannjjm	2325	16	,	,	,
cord-023095-4dannjjm	2325	17	and	and	CC
cord-023095-4dannjjm	2325	18	peak	peak	NN
cord-023095-4dannjjm	2325	19	concentration	concentration	NN
cord-023095-4dannjjm	2325	20	(	(	-LRB-
cord-023095-4dannjjm	2325	21	C	C	NNP
cord-023095-4dannjjm	2325	22	max	max	NNP
cord-023095-4dannjjm	2325	23	)	)	-RRB-
cord-023095-4dannjjm	2325	24	for	for	IN
cord-023095-4dannjjm	2325	25	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	2325	26	was	be	VBD
cord-023095-4dannjjm	2325	27	25.9	25.9	CD
cord-023095-4dannjjm	2325	28	hr	hr	NN
cord-023095-4dannjjm	2325	29	(	(	-LRB-
cord-023095-4dannjjm	2325	30	AE	AE	NNP
cord-023095-4dannjjm	2325	31	6.2	6.2	CD
cord-023095-4dannjjm	2325	32	)	)	-RRB-
cord-023095-4dannjjm	2325	33	,	,	,
cord-023095-4dannjjm	2325	34	6.29	6.29	CD
cord-023095-4dannjjm	2325	35	L	l	NN
cord-023095-4dannjjm	2325	36	/	/	SYM
cord-023095-4dannjjm	2325	37	kg	kg	NNP
cord-023095-4dannjjm	2325	38	(	(	-LRB-
cord-023095-4dannjjm	2325	39	AE	AE	NNP
cord-023095-4dannjjm	2325	40	1.23	1.23	CD
cord-023095-4dannjjm	2325	41	)	)	-RRB-
cord-023095-4dannjjm	2325	42	,	,	,
cord-023095-4dannjjm	2325	43	0.168	0.168	CD
cord-023095-4dannjjm	2325	44	L	l	NN
cord-023095-4dannjjm	2325	45	/	/	SYM
cord-023095-4dannjjm	2325	46	kg	kg	NNP
cord-023095-4dannjjm	2325	47	/	/	SYM
cord-023095-4dannjjm	2325	48	hr	hr	NN
cord-023095-4dannjjm	2325	49	(	(	-LRB-
cord-023095-4dannjjm	2325	50	AE	AE	NNP
cord-023095-4dannjjm	2325	51	0.076	0.076	CD
cord-023095-4dannjjm	2325	52	)	)	-RRB-
cord-023095-4dannjjm	2325	53	,	,	,
cord-023095-4dannjjm	2325	54	and	and	CC
cord-023095-4dannjjm	2325	55	1.07	1.07	CD
cord-023095-4dannjjm	2325	56	mg	mg	NNP
cord-023095-4dannjjm	2325	57	/	/	SYM
cord-023095-4dannjjm	2325	58	mL	mL	NNP
cord-023095-4dannjjm	2325	59	(	(	-LRB-
cord-023095-4dannjjm	2325	60	AE	AE	NNP
cord-023095-4dannjjm	2325	61	0.28	0.28	CD
cord-023095-4dannjjm	2325	62	)	)	-RRB-
cord-023095-4dannjjm	2325	63	,	,	,
cord-023095-4dannjjm	2325	64	respectively	respectively	RB
cord-023095-4dannjjm	2325	65	.	.	.
cord-023095-4dannjjm	2326	1	The	the	DT
cord-023095-4dannjjm	2326	2	concentrations	concentration	NNS
cord-023095-4dannjjm	2326	3	from	from	IN
cord-023095-4dannjjm	2326	4	each	each	DT
cord-023095-4dannjjm	2326	5	of	of	IN
cord-023095-4dannjjm	2326	6	three	three	CD
cord-023095-4dannjjm	2326	7	tissues	tissue	NNS
cord-023095-4dannjjm	2326	8	were	be	VBD
cord-023095-4dannjjm	2326	9	not	not	RB
cord-023095-4dannjjm	2326	10	different	different	JJ
cord-023095-4dannjjm	2326	11	in	in	IN
cord-023095-4dannjjm	2326	12	each	each	DT
cord-023095-4dannjjm	2326	13	pig	pig	NN
cord-023095-4dannjjm	2326	14	.	.	.
cord-023095-4dannjjm	2327	1	When	when	WRB
cord-023095-4dannjjm	2327	2	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	2327	3	values	value	NNS
cord-023095-4dannjjm	2327	4	from	from	IN
cord-023095-4dannjjm	2327	5	all	all	DT
cord-023095-4dannjjm	2327	6	tissues	tissue	NNS
cord-023095-4dannjjm	2327	7	were	be	VBD
cord-023095-4dannjjm	2327	8	combined	combine	VBN
cord-023095-4dannjjm	2327	9	for	for	IN
cord-023095-4dannjjm	2327	10	the	the	DT
cord-023095-4dannjjm	2327	11	ISF	ISF	NNP
cord-023095-4dannjjm	2327	12	,	,	,
cord-023095-4dannjjm	2327	13	the	the	DT
cord-023095-4dannjjm	2327	14	t	t	NN
cord-023095-4dannjjm	2327	15	1/2	1/2	CD
cord-023095-4dannjjm	2327	16	was	be	VBD
cord-023095-4dannjjm	2327	17	23.6	23.6	CD
cord-023095-4dannjjm	2327	18	hr	hr	NN
cord-023095-4dannjjm	2327	19	(	(	-LRB-
cord-023095-4dannjjm	2327	20	AE	AE	NNP
cord-023095-4dannjjm	2327	21	4.1	4.1	CD
cord-023095-4dannjjm	2327	22	)	)	-RRB-
cord-023095-4dannjjm	2327	23	and	and	CC
cord-023095-4dannjjm	2327	24	the	the	DT
cord-023095-4dannjjm	2327	25	C	C	NNP
cord-023095-4dannjjm	2327	26	max	max	NN
cord-023095-4dannjjm	2327	27	was	be	VBD
cord-023095-4dannjjm	2327	28	1.26	1.26	CD
cord-023095-4dannjjm	2327	29	mg	mg	NN
cord-023095-4dannjjm	2327	30	/	/	SYM
cord-023095-4dannjjm	2327	31	mL	mL	NNP
cord-023095-4dannjjm	2327	32	(	(	-LRB-
cord-023095-4dannjjm	2327	33	AE	AE	NNP
cord-023095-4dannjjm	2327	34	0.10	0.10	CD
cord-023095-4dannjjm	2327	35	)	)	-RRB-
cord-023095-4dannjjm	2327	36	.	.	.
cord-023095-4dannjjm	2328	1	The	the	DT
cord-023095-4dannjjm	2328	2	enrofloxacin	enrofloxacin	JJ
cord-023095-4dannjjm	2328	3	plasma	plasma	NN
cord-023095-4dannjjm	2328	4	protein	protein	NN
cord-023095-4dannjjm	2328	5	binding	binding	NN
cord-023095-4dannjjm	2328	6	was	be	VBD
cord-023095-4dannjjm	2328	7	31.1	31.1	CD
cord-023095-4dannjjm	2328	8	%	%	NN
cord-023095-4dannjjm	2328	9	(	(	-LRB-
cord-023095-4dannjjm	2328	10	AE	AE	NNP
cord-023095-4dannjjm	2328	11	3.28	3.28	CD
cord-023095-4dannjjm	2328	12	)	)	-RRB-
cord-023095-4dannjjm	2328	13	and	and	CC
cord-023095-4dannjjm	2328	14	37.13	37.13	CD
cord-023095-4dannjjm	2328	15	%	%	NN
cord-023095-4dannjjm	2328	16	(	(	-LRB-
cord-023095-4dannjjm	2328	17	AE	AE	NNP
cord-023095-4dannjjm	2328	18	16.54	16.54	CD
cord-023095-4dannjjm	2328	19	)	)	-RRB-
cord-023095-4dannjjm	2328	20	at	at	IN
cord-023095-4dannjjm	2328	21	a	a	DT
cord-023095-4dannjjm	2328	22	high	high	JJ
cord-023095-4dannjjm	2328	23	and	and	CC
cord-023095-4dannjjm	2328	24	low	low	JJ
cord-023095-4dannjjm	2328	25	concentration	concentration	NN
cord-023095-4dannjjm	2328	26	,	,	,
cord-023095-4dannjjm	2328	27	respectively	respectively	RB
cord-023095-4dannjjm	2328	28	.	.	.
cord-023095-4dannjjm	2329	1	This	this	DT
cord-023095-4dannjjm	2329	2	study	study	NN
cord-023095-4dannjjm	2329	3	has	have	VBZ
cord-023095-4dannjjm	2329	4	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	2329	5	that	that	IN
cord-023095-4dannjjm	2329	6	the	the	DT
cord-023095-4dannjjm	2329	7	concentration	concentration	NN
cord-023095-4dannjjm	2329	8	of	of	IN
cord-023095-4dannjjm	2329	9	biologically	biologically	RB
cord-023095-4dannjjm	2329	10	active	active	JJ
cord-023095-4dannjjm	2329	11	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	2329	12	in	in	IN
cord-023095-4dannjjm	2329	13	tissues	tissue	NNS
cord-023095-4dannjjm	2329	14	exceeds	exceed	VBZ
cord-023095-4dannjjm	2329	15	the	the	DT
cord-023095-4dannjjm	2329	16	concentration	concentration	NN
cord-023095-4dannjjm	2329	17	predicted	predict	VBN
cord-023095-4dannjjm	2329	18	by	by	IN
cord-023095-4dannjjm	2329	19	the	the	DT
cord-023095-4dannjjm	2329	20	unbound	unbound	JJ
cord-023095-4dannjjm	2329	21	fraction	fraction	NN
cord-023095-4dannjjm	2329	22	of	of	IN
cord-023095-4dannjjm	2329	23	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	2329	24	in	in	IN
cord-023095-4dannjjm	2329	25	pig	pig	NN
cord-023095-4dannjjm	2329	26	plasma	plasma	NN
cord-023095-4dannjjm	2329	27	.	.	.
cord-023095-4dannjjm	2330	1	The	the	DT
cord-023095-4dannjjm	2330	2	half	half	JJ
cord-023095-4dannjjm	2330	3	-	-	HYPH
cord-023095-4dannjjm	2330	4	life	life	NN
cord-023095-4dannjjm	2330	5	of	of	IN
cord-023095-4dannjjm	2330	6	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	2330	7	is	be	VBZ
cord-023095-4dannjjm	2330	8	longer	long	JJR
cord-023095-4dannjjm	2330	9	in	in	IN
cord-023095-4dannjjm	2330	10	tissues	tissue	NNS
cord-023095-4dannjjm	2330	11	and	and	CC
cord-023095-4dannjjm	2330	12	plasma	plasma	NN
cord-023095-4dannjjm	2330	13	than	than	IN
cord-023095-4dannjjm	2330	14	has	have	VBZ
cord-023095-4dannjjm	2330	15	been	be	VBN
cord-023095-4dannjjm	2330	16	reported	report	VBN
cord-023095-4dannjjm	2330	17	in	in	IN
cord-023095-4dannjjm	2330	18	previous	previous	JJ
cord-023095-4dannjjm	2330	19	studies	study	NNS
cord-023095-4dannjjm	2330	20	.	.	.
cord-023095-4dannjjm	2331	1	The	the	DT
cord-023095-4dannjjm	2331	2	high	high	JJ
cord-023095-4dannjjm	2331	3	tissue	tissue	NN
cord-023095-4dannjjm	2331	4	concentrations	concentration	NNS
cord-023095-4dannjjm	2331	5	and	and	CC
cord-023095-4dannjjm	2331	6	long	long	JJ
cord-023095-4dannjjm	2331	7	half	half	JJ
cord-023095-4dannjjm	2331	8	-	-	HYPH
cord-023095-4dannjjm	2331	9	life	life	NN
cord-023095-4dannjjm	2331	10	produce	produce	VBP
cord-023095-4dannjjm	2331	11	an	an	DT
cord-023095-4dannjjm	2331	12	AUC	AUC	NNP
cord-023095-4dannjjm	2331	13	/	/	SYM
cord-023095-4dannjjm	2331	14	MIC	mic	NN
cord-023095-4dannjjm	2331	15	ratio	ratio	NN
cord-023095-4dannjjm	2331	16	sufficient	sufficient	JJ
cord-023095-4dannjjm	2331	17	for	for	IN
cord-023095-4dannjjm	2331	18	the	the	DT
cord-023095-4dannjjm	2331	19	pathogens	pathogen	NNS
cord-023095-4dannjjm	2331	20	that	that	WDT
cord-023095-4dannjjm	2331	21	cause	cause	VBP
cord-023095-4dannjjm	2331	22	respiratory	respiratory	JJ
cord-023095-4dannjjm	2331	23	infections	infection	NNS
cord-023095-4dannjjm	2331	24	in	in	IN
cord-023095-4dannjjm	2331	25	pigs	pig	NNS
cord-023095-4dannjjm	2331	26	.	.	.
cord-023095-4dannjjm	2332	1	Ceftiofur	ceftiofur	JJ
cord-023095-4dannjjm	2332	2	crystalline	crystalline	NN
cord-023095-4dannjjm	2332	3	free	free	JJ
cord-023095-4dannjjm	2332	4	acid	acid	NN
cord-023095-4dannjjm	2332	5	(	(	-LRB-
cord-023095-4dannjjm	2332	6	CCFA	CCFA	NNP
cord-023095-4dannjjm	2332	7	)	)	-RRB-
cord-023095-4dannjjm	2332	8	,	,	,
cord-023095-4dannjjm	2332	9	a	a	DT
cord-023095-4dannjjm	2332	10	long	long	RB
cord-023095-4dannjjm	2332	11	-	-	HYPH
cord-023095-4dannjjm	2332	12	acting	act	VBG
cord-023095-4dannjjm	2332	13	ceftiofur	ceftiofur	JJ
cord-023095-4dannjjm	2332	14	formulation	formulation	NN
cord-023095-4dannjjm	2332	15	labeled	label	VBN
cord-023095-4dannjjm	2332	16	for	for	IN
cord-023095-4dannjjm	2332	17	use	use	NN
cord-023095-4dannjjm	2332	18	in	in	IN
cord-023095-4dannjjm	2332	19	cattle	cattle	NNS
cord-023095-4dannjjm	2332	20	,	,	,
cord-023095-4dannjjm	2332	21	pigs	pig	NNS
cord-023095-4dannjjm	2332	22	,	,	,
cord-023095-4dannjjm	2332	23	and	and	CC
cord-023095-4dannjjm	2332	24	horses	horse	NNS
cord-023095-4dannjjm	2332	25	for	for	IN
cord-023095-4dannjjm	2332	26	treatment	treatment	NN
cord-023095-4dannjjm	2332	27	of	of	IN
cord-023095-4dannjjm	2332	28	respiratory	respiratory	JJ
cord-023095-4dannjjm	2332	29	disease	disease	NN
cord-023095-4dannjjm	2332	30	has	have	VBZ
cord-023095-4dannjjm	2332	31	been	be	VBN
cord-023095-4dannjjm	2332	32	used	use	VBN
cord-023095-4dannjjm	2332	33	for	for	IN
cord-023095-4dannjjm	2332	34	treatment	treatment	NN
cord-023095-4dannjjm	2332	35	of	of	IN
cord-023095-4dannjjm	2332	36	ovine	ovine	JJ
cord-023095-4dannjjm	2332	37	respiratory	respiratory	JJ
cord-023095-4dannjjm	2332	38	infections	infection	NNS
cord-023095-4dannjjm	2332	39	in	in	IN
cord-023095-4dannjjm	2332	40	clinical	clinical	JJ
cord-023095-4dannjjm	2332	41	practice	practice	NN
cord-023095-4dannjjm	2332	42	.	.	.
cord-023095-4dannjjm	2333	1	Pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	2333	2	data	datum	NNS
cord-023095-4dannjjm	2333	3	,	,	,
cord-023095-4dannjjm	2333	4	however	however	RB
cord-023095-4dannjjm	2333	5	,	,	,
cord-023095-4dannjjm	2333	6	do	do	VBP
cord-023095-4dannjjm	2333	7	not	not	RB
cord-023095-4dannjjm	2333	8	exist	exist	VB
cord-023095-4dannjjm	2333	9	for	for	IN
cord-023095-4dannjjm	2333	10	CCFA	CCFA	NNP
cord-023095-4dannjjm	2333	11	administered	administer	VBN
cord-023095-4dannjjm	2333	12	subcutaneously	subcutaneously	RB
cord-023095-4dannjjm	2333	13	in	in	IN
cord-023095-4dannjjm	2333	14	sheep	sheep	NNS
cord-023095-4dannjjm	2333	15	.	.	.
cord-023095-4dannjjm	2334	1	The	the	DT
cord-023095-4dannjjm	2334	2	present	present	JJ
cord-023095-4dannjjm	2334	3	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	2334	4	study	study	NN
cord-023095-4dannjjm	2334	5	evaluated	evaluate	VBD
cord-023095-4dannjjm	2334	6	the	the	DT
cord-023095-4dannjjm	2334	7	single	single	JJ
cord-023095-4dannjjm	2334	8	dose	dose	NN
cord-023095-4dannjjm	2334	9	subcutaneous	subcutaneous	JJ
cord-023095-4dannjjm	2334	10	administration	administration	NN
cord-023095-4dannjjm	2334	11	of	of	IN
cord-023095-4dannjjm	2334	12	CCFA	CCFA	NNP
cord-023095-4dannjjm	2334	13	in	in	IN
cord-023095-4dannjjm	2334	14	sheep	sheep	NN
cord-023095-4dannjjm	2334	15	(	(	-LRB-
cord-023095-4dannjjm	2334	16	n	n	NN
cord-023095-4dannjjm	2334	17	5	5	CD
cord-023095-4dannjjm	2334	18	9	9	CD
cord-023095-4dannjjm	2334	19	)	)	-RRB-
cord-023095-4dannjjm	2334	20	at	at	IN
cord-023095-4dannjjm	2334	21	6.6	6.6	CD
cord-023095-4dannjjm	2334	22	mg	mg	NNP
cord-023095-4dannjjm	2334	23	/	/	SYM
cord-023095-4dannjjm	2334	24	kg	kg	NN
cord-023095-4dannjjm	2334	25	body	body	NN
cord-023095-4dannjjm	2334	26	weight	weight	NN
cord-023095-4dannjjm	2334	27	.	.	.
cord-023095-4dannjjm	2335	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	2335	2	of	of	IN
cord-023095-4dannjjm	2335	3	ceftiofur	ceftiofur	JJ
cord-023095-4dannjjm	2335	4	free	free	JJ
cord-023095-4dannjjm	2335	5	acid	acid	NN
cord-023095-4dannjjm	2335	6	equivalents	equivalent	NNS
cord-023095-4dannjjm	2335	7	(	(	-LRB-
cord-023095-4dannjjm	2335	8	CFAE	CFAE	NNP
cord-023095-4dannjjm	2335	9	)	)	-RRB-
cord-023095-4dannjjm	2335	10	in	in	IN
cord-023095-4dannjjm	2335	11	plasma	plasma	NN
cord-023095-4dannjjm	2335	12	were	be	VBD
cord-023095-4dannjjm	2335	13	measured	measure	VBN
cord-023095-4dannjjm	2335	14	by	by	IN
cord-023095-4dannjjm	2335	15	high	high	JJ
cord-023095-4dannjjm	2335	16	performance	performance	NN
cord-023095-4dannjjm	2335	17	liquid	liquid	NN
cord-023095-4dannjjm	2335	18	chromatography	chromatography	NN
cord-023095-4dannjjm	2335	19	for	for	IN
cord-023095-4dannjjm	2335	20	14	14	CD
cord-023095-4dannjjm	2335	21	days	day	NNS
cord-023095-4dannjjm	2335	22	following	follow	VBG
cord-023095-4dannjjm	2335	23	drug	drug	NN
cord-023095-4dannjjm	2335	24	administration	administration	NN
cord-023095-4dannjjm	2335	25	.	.	.
cord-023095-4dannjjm	2336	1	Pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	2336	2	of	of	IN
cord-023095-4dannjjm	2336	3	subcutaneous	subcutaneous	JJ
cord-023095-4dannjjm	2336	4	CCFA	CCFA	NNP
cord-023095-4dannjjm	2336	5	in	in	IN
cord-023095-4dannjjm	2336	6	sheep	sheep	NNS
cord-023095-4dannjjm	2336	7	were	be	VBD
cord-023095-4dannjjm	2336	8	best	best	RB
cord-023095-4dannjjm	2336	9	described	describe	VBN
cord-023095-4dannjjm	2336	10	using	use	VBG
cord-023095-4dannjjm	2336	11	a	a	DT
cord-023095-4dannjjm	2336	12	single	single	JJ
cord-023095-4dannjjm	2336	13	compartment	compartment	NN
cord-023095-4dannjjm	2336	14	model	model	NN
cord-023095-4dannjjm	2336	15	with	with	IN
cord-023095-4dannjjm	2336	16	the	the	DT
cord-023095-4dannjjm	2336	17	following	following	JJ
cord-023095-4dannjjm	2336	18	average	average	NN
cord-023095-4dannjjm	2336	19	(	(	-LRB-
cord-023095-4dannjjm	2336	20	AE	AE	NNP
cord-023095-4dannjjm	2336	21	SD	SD	NNP
cord-023095-4dannjjm	2336	22	)	)	-RRB-
cord-023095-4dannjjm	2336	23	parameters	parameter	NNS
cord-023095-4dannjjm	2336	24	:	:	:
cord-023095-4dannjjm	2336	25	area	area	NN
cord-023095-4dannjjm	2336	26	under	under	IN
cord-023095-4dannjjm	2336	27	the	the	DT
cord-023095-4dannjjm	2336	28	concentration	concentration	NN
cord-023095-4dannjjm	2336	29	time	time	NN
cord-023095-4dannjjm	2336	30	curve	curve	NN
cord-023095-4dannjjm	2336	31	0	0	NFP
cord-023095-4dannjjm	2336	32	!	!	.
cord-023095-4dannjjm	2337	1	1	1	LS
cord-023095-4dannjjm	2338	1	(	(	-LRB-
cord-023095-4dannjjm	2338	2	206.6	206.6	CD
cord-023095-4dannjjm	2338	3	hÃug	hÃug	NNP
cord-023095-4dannjjm	2338	4	/	/	SYM
cord-023095-4dannjjm	2338	5	ml	ml	NN
cord-023095-4dannjjm	2338	6	AE	AE	NNP
cord-023095-4dannjjm	2338	7	24.8	24.8	CD
cord-023095-4dannjjm	2338	8	)	)	-RRB-
cord-023095-4dannjjm	2338	9	,	,	,
cord-023095-4dannjjm	2338	10	observed	observe	VBD
cord-023095-4dannjjm	2338	11	maximum	maximum	JJ
cord-023095-4dannjjm	2338	12	plasma	plasma	NN
cord-023095-4dannjjm	2338	13	concentration	concentration	NN
cord-023095-4dannjjm	2338	14	(	(	-LRB-
cord-023095-4dannjjm	2338	15	2.4	2.4	CD
cord-023095-4dannjjm	2338	16	ug/	ug/	JJ
cord-023095-4dannjjm	2338	17	ml	ml	NN
cord-023095-4dannjjm	2338	18	AE	AE	NNP
cord-023095-4dannjjm	2338	19	0.5	0.5	CD
cord-023095-4dannjjm	2338	20	)	)	-RRB-
cord-023095-4dannjjm	2338	21	,	,	,
cord-023095-4dannjjm	2338	22	and	and	CC
cord-023095-4dannjjm	2338	23	observed	observe	VBD
cord-023095-4dannjjm	2338	24	time	time	NN
cord-023095-4dannjjm	2338	25	of	of	IN
cord-023095-4dannjjm	2338	26	maximum	maximum	JJ
cord-023095-4dannjjm	2338	27	plasma	plasma	NN
cord-023095-4dannjjm	2338	28	concentration	concentration	NN
cord-023095-4dannjjm	2338	29	(	(	-LRB-
cord-023095-4dannjjm	2338	30	23.1	23.1	CD
cord-023095-4dannjjm	2338	31	h	h	NN
cord-023095-4dannjjm	2338	32	AE	AE	NNP
cord-023095-4dannjjm	2338	33	10.1	10.1	CD
cord-023095-4dannjjm	2338	34	)	)	-RRB-
cord-023095-4dannjjm	2338	35	.	.	.
cord-023095-4dannjjm	2339	1	No	no	DT
cord-023095-4dannjjm	2339	2	significant	significant	JJ
cord-023095-4dannjjm	2339	3	adverse	adverse	JJ
cord-023095-4dannjjm	2339	4	drug	drug	NN
cord-023095-4dannjjm	2339	5	reactions	reaction	NNS
cord-023095-4dannjjm	2339	6	were	be	VBD
cord-023095-4dannjjm	2339	7	observed	observe	VBN
cord-023095-4dannjjm	2339	8	.	.	.
cord-023095-4dannjjm	2340	1	Adequate	adequate	JJ
cord-023095-4dannjjm	2340	2	CFAE	CFAE	NNP
cord-023095-4dannjjm	2340	3	plasma	plasma	NN
cord-023095-4dannjjm	2340	4	concentrations	concentration	NNS
cord-023095-4dannjjm	2340	5	were	be	VBD
cord-023095-4dannjjm	2340	6	attained	attain	VBN
cord-023095-4dannjjm	2340	7	to	to	TO
cord-023095-4dannjjm	2340	8	effectively	effectively	RB
cord-023095-4dannjjm	2340	9	treat	treat	VB
cord-023095-4dannjjm	2340	10	respiratory	respiratory	JJ
cord-023095-4dannjjm	2340	11	tract	tract	NN
cord-023095-4dannjjm	2340	12	pathogens	pathogen	NNS
cord-023095-4dannjjm	2340	13	associated	associate	VBN
cord-023095-4dannjjm	2340	14	with	with	IN
cord-023095-4dannjjm	2340	15	pneumonia	pneumonia	NN
cord-023095-4dannjjm	2340	16	in	in	IN
cord-023095-4dannjjm	2340	17	sheep	sheep	NN
cord-023095-4dannjjm	2340	18	.	.	.
cord-023095-4dannjjm	2341	1	The	the	DT
cord-023095-4dannjjm	2341	2	purpose	purpose	NN
cord-023095-4dannjjm	2341	3	of	of	IN
cord-023095-4dannjjm	2341	4	this	this	DT
cord-023095-4dannjjm	2341	5	study	study	NN
cord-023095-4dannjjm	2341	6	was	be	VBD
cord-023095-4dannjjm	2341	7	to	to	TO
cord-023095-4dannjjm	2341	8	assess	assess	VB
cord-023095-4dannjjm	2341	9	,	,	,
cord-023095-4dannjjm	2341	10	using	use	VBG
cord-023095-4dannjjm	2341	11	thoracic	thoracic	JJ
cord-023095-4dannjjm	2341	12	ultrasonography	ultrasonography	NN
cord-023095-4dannjjm	2341	13	,	,	,
cord-023095-4dannjjm	2341	14	the	the	DT
cord-023095-4dannjjm	2341	15	prevalence	prevalence	NN
cord-023095-4dannjjm	2341	16	of	of	IN
cord-023095-4dannjjm	2341	17	lung	lung	NN
cord-023095-4dannjjm	2341	18	lesions	lesion	NNS
cord-023095-4dannjjm	2341	19	in	in	IN
cord-023095-4dannjjm	2341	20	pre	pre	JJ
cord-023095-4dannjjm	2341	21	-	-	JJ
cord-023095-4dannjjm	2341	22	weaned	wean	VBN
cord-023095-4dannjjm	2341	23	dairy	dairy	NN
cord-023095-4dannjjm	2341	24	calves	calf	NNS
cord-023095-4dannjjm	2341	25	.	.	.
cord-023095-4dannjjm	2342	1	Subsequent	subsequent	JJ
cord-023095-4dannjjm	2342	2	aims	aim	NNS
cord-023095-4dannjjm	2342	3	were	be	VBD
cord-023095-4dannjjm	2342	4	to	to	TO
cord-023095-4dannjjm	2342	5	describe	describe	VB
cord-023095-4dannjjm	2342	6	ultrasonographic	ultrasonographic	JJ
cord-023095-4dannjjm	2342	7	changes	change	NNS
cord-023095-4dannjjm	2342	8	within	within	IN
cord-023095-4dannjjm	2342	9	the	the	DT
cord-023095-4dannjjm	2342	10	lung	lung	NN
cord-023095-4dannjjm	2342	11	,	,	,
cord-023095-4dannjjm	2342	12	clinical	clinical	JJ
cord-023095-4dannjjm	2342	13	respiratory	respiratory	JJ
cord-023095-4dannjjm	2342	14	score	score	NN
cord-023095-4dannjjm	2342	15	,	,	,
cord-023095-4dannjjm	2342	16	and	and	CC
cord-023095-4dannjjm	2342	17	treatment	treatment	NN
cord-023095-4dannjjm	2342	18	of	of	IN
cord-023095-4dannjjm	2342	19	respiratory	respiratory	JJ
cord-023095-4dannjjm	2342	20	disease	disease	NN
cord-023095-4dannjjm	2342	21	.	.	.
cord-023095-4dannjjm	2343	1	A	a	DT
cord-023095-4dannjjm	2343	2	longitudinal	longitudinal	JJ
cord-023095-4dannjjm	2343	3	study	study	NN
cord-023095-4dannjjm	2343	4	was	be	VBD
cord-023095-4dannjjm	2343	5	performed	perform	VBN
cord-023095-4dannjjm	2343	6	using	use	VBG
cord-023095-4dannjjm	2343	7	female	female	JJ
cord-023095-4dannjjm	2343	8	dairy	dairy	NN
cord-023095-4dannjjm	2343	9	calves	calf	NNS
cord-023095-4dannjjm	2343	10	from	from	IN
cord-023095-4dannjjm	2343	11	6	6	CD
cord-023095-4dannjjm	2343	12	commercial	commercial	JJ
cord-023095-4dannjjm	2343	13	dairy	dairy	NN
cord-023095-4dannjjm	2343	14	farms	farm	NNS
cord-023095-4dannjjm	2343	15	in	in	IN
cord-023095-4dannjjm	2343	16	New	New	NNP
cord-023095-4dannjjm	2343	17	York	York	NNP
cord-023095-4dannjjm	2343	18	State	State	NNP
cord-023095-4dannjjm	2343	19	.	.	.
cord-023095-4dannjjm	2344	1	Calves	calf	NNS
cord-023095-4dannjjm	2344	2	were	be	VBD
cord-023095-4dannjjm	2344	3	enrolled	enrol	VBN
cord-023095-4dannjjm	2344	4	based	base	VBN
cord-023095-4dannjjm	2344	5	on	on	IN
cord-023095-4dannjjm	2344	6	age	age	NN
cord-023095-4dannjjm	2344	7	.	.	.
cord-023095-4dannjjm	2345	1	Thoracic	thoracic	JJ
cord-023095-4dannjjm	2345	2	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2345	3	and	and	CC
cord-023095-4dannjjm	2345	4	clinical	clinical	JJ
cord-023095-4dannjjm	2345	5	respiratory	respiratory	JJ
cord-023095-4dannjjm	2345	6	scoring	scoring	NN
cord-023095-4dannjjm	2345	7	were	be	VBD
cord-023095-4dannjjm	2345	8	performed	perform	VBN
cord-023095-4dannjjm	2345	9	on	on	IN
cord-023095-4dannjjm	2345	10	each	each	DT
cord-023095-4dannjjm	2345	11	calf	calf	NN
cord-023095-4dannjjm	2345	12	at	at	IN
cord-023095-4dannjjm	2345	13	2	2	CD
cord-023095-4dannjjm	2345	14	time	time	NN
cord-023095-4dannjjm	2345	15	points	point	NNS
cord-023095-4dannjjm	2345	16	.	.	.
cord-023095-4dannjjm	2346	1	A	a	DT
cord-023095-4dannjjm	2346	2	standard	standard	JJ
cord-023095-4dannjjm	2346	3	5	5	CD
cord-023095-4dannjjm	2346	4	mHz	mHz	NNPS
cord-023095-4dannjjm	2346	5	linear	linear	JJ
cord-023095-4dannjjm	2346	6	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2346	7	probe	probe	NN
cord-023095-4dannjjm	2346	8	was	be	VBD
cord-023095-4dannjjm	2346	9	utilized	utilize	VBN
cord-023095-4dannjjm	2346	10	to	to	TO
cord-023095-4dannjjm	2346	11	evaluate	evaluate	VB
cord-023095-4dannjjm	2346	12	intercostal	intercostal	JJ
cord-023095-4dannjjm	2346	13	spaces	space	NNS
cord-023095-4dannjjm	2346	14	1	1	CD
cord-023095-4dannjjm	2346	15	through	through	IN
cord-023095-4dannjjm	2346	16	11	11	CD
cord-023095-4dannjjm	2346	17	of	of	IN
cord-023095-4dannjjm	2346	18	each	each	DT
cord-023095-4dannjjm	2346	19	hemi	hemi	NN
cord-023095-4dannjjm	2346	20	-	-	HYPH
cord-023095-4dannjjm	2346	21	thorax	thorax	NN
cord-023095-4dannjjm	2346	22	with	with	IN
cord-023095-4dannjjm	2346	23	the	the	DT
cord-023095-4dannjjm	2346	24	calf	calf	NN
cord-023095-4dannjjm	2346	25	in	in	IN
cord-023095-4dannjjm	2346	26	lateral	lateral	JJ
cord-023095-4dannjjm	2346	27	recumbency	recumbency	NN
cord-023095-4dannjjm	2346	28	(	(	-LRB-
cord-023095-4dannjjm	2346	29	US1	US1	NNP
cord-023095-4dannjjm	2346	30	)	)	-RRB-
cord-023095-4dannjjm	2346	31	or	or	CC
cord-023095-4dannjjm	2346	32	standing	stand	VBG
cord-023095-4dannjjm	2346	33	(	(	-LRB-
cord-023095-4dannjjm	2346	34	US2	US2	NNP
cord-023095-4dannjjm	2346	35	)	)	-RRB-
cord-023095-4dannjjm	2346	36	.	.	.
cord-023095-4dannjjm	2347	1	Lesion	lesion	NN
cord-023095-4dannjjm	2347	2	appearance	appearance	NN
cord-023095-4dannjjm	2347	3	,	,	,
cord-023095-4dannjjm	2347	4	size	size	NN
cord-023095-4dannjjm	2347	5	,	,	,
cord-023095-4dannjjm	2347	6	and	and	CC
cord-023095-4dannjjm	2347	7	location	location	NN
cord-023095-4dannjjm	2347	8	were	be	VBD
cord-023095-4dannjjm	2347	9	recorded	record	VBN
cord-023095-4dannjjm	2347	10	.	.	.
cord-023095-4dannjjm	2348	1	Respiratory	respiratory	JJ
cord-023095-4dannjjm	2348	2	score	score	NN
cord-023095-4dannjjm	2348	3	(	(	-LRB-
cord-023095-4dannjjm	2348	4	RS	rs	NN
cord-023095-4dannjjm	2348	5	)	)	-RRB-
cord-023095-4dannjjm	2348	6	was	be	VBD
cord-023095-4dannjjm	2348	7	assigned	assign	VBN
cord-023095-4dannjjm	2348	8	based	base	VBN
cord-023095-4dannjjm	2348	9	on	on	IN
cord-023095-4dannjjm	2348	10	a	a	DT
cord-023095-4dannjjm	2348	11	previously	previously	RB
cord-023095-4dannjjm	2348	12	published	publish	VBN
cord-023095-4dannjjm	2348	13	protocol	protocol	NN
cord-023095-4dannjjm	2348	14	incorporating	incorporate	VBG
cord-023095-4dannjjm	2348	15	fever	fever	NN
cord-023095-4dannjjm	2348	16	,	,	,
cord-023095-4dannjjm	2348	17	nasal	nasal	NN
cord-023095-4dannjjm	2348	18	discharge	discharge	NN
cord-023095-4dannjjm	2348	19	,	,	,
cord-023095-4dannjjm	2348	20	cough	cough	NN
cord-023095-4dannjjm	2348	21	,	,	,
cord-023095-4dannjjm	2348	22	ocular	ocular	JJ
cord-023095-4dannjjm	2348	23	discharge	discharge	NN
cord-023095-4dannjjm	2348	24	and	and	CC
cord-023095-4dannjjm	2348	25	ear	ear	NN
cord-023095-4dannjjm	2348	26	droop	droop	VBP
cord-023095-4dannjjm	2348	27	,	,	,
cord-023095-4dannjjm	2348	28	with	with	IN
cord-023095-4dannjjm	2348	29	a	a	DT
cord-023095-4dannjjm	2348	30	higher	high	JJR
cord-023095-4dannjjm	2348	31	numerical	numerical	JJ
cord-023095-4dannjjm	2348	32	score	score	NN
cord-023095-4dannjjm	2348	33	corresponding	correspond	VBG
cord-023095-4dannjjm	2348	34	to	to	IN
cord-023095-4dannjjm	2348	35	more	more	RBR
cord-023095-4dannjjm	2348	36	severe	severe	JJ
cord-023095-4dannjjm	2348	37	disease	disease	NN
cord-023095-4dannjjm	2348	38	.	.	.
cord-023095-4dannjjm	2349	1	Abnormal	abnormal	JJ
cord-023095-4dannjjm	2349	2	lung	lung	NN
cord-023095-4dannjjm	2349	3	on	on	IN
cord-023095-4dannjjm	2349	4	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2349	5	was	be	VBD
cord-023095-4dannjjm	2349	6	defined	define	VBN
cord-023095-4dannjjm	2349	7	as	as	IN
cord-023095-4dannjjm	2349	8	one	one	CD
cord-023095-4dannjjm	2349	9	or	or	CC
cord-023095-4dannjjm	2349	10	more	more	JJR
cord-023095-4dannjjm	2349	11	areas	area	NNS
cord-023095-4dannjjm	2349	12	of	of	IN
cord-023095-4dannjjm	2349	13	!	!	.
cord-023095-4dannjjm	2349	14	1	1	CD
cord-023095-4dannjjm	2349	15	cm	cm	NN
cord-023095-4dannjjm	2349	16	width	width	NN
cord-023095-4dannjjm	2349	17	or	or	CC
cord-023095-4dannjjm	2349	18	depth	depth	NN
cord-023095-4dannjjm	2349	19	of	of	IN
cord-023095-4dannjjm	2349	20	non	non	JJ
cord-023095-4dannjjm	2349	21	-	-	JJ
cord-023095-4dannjjm	2349	22	aerated	aerated	JJ
cord-023095-4dannjjm	2349	23	lung	lung	NN
cord-023095-4dannjjm	2349	24	.	.	.
cord-023095-4dannjjm	2350	1	Farm	farm	NN
cord-023095-4dannjjm	2350	2	records	record	NNS
cord-023095-4dannjjm	2350	3	were	be	VBD
cord-023095-4dannjjm	2350	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	2350	5	to	to	TO
cord-023095-4dannjjm	2350	6	identify	identify	VB
cord-023095-4dannjjm	2350	7	treated	treat	VBN
cord-023095-4dannjjm	2350	8	calves	calf	NNS
cord-023095-4dannjjm	2350	9	.	.	.
cord-023095-4dannjjm	2351	1	Calves	calf	NNS
cord-023095-4dannjjm	2351	2	were	be	VBD
cord-023095-4dannjjm	2351	3	treated	treat	VBN
cord-023095-4dannjjm	2351	4	for	for	IN
cord-023095-4dannjjm	2351	5	respiratory	respiratory	JJ
cord-023095-4dannjjm	2351	6	disease	disease	NN
cord-023095-4dannjjm	2351	7	at	at	IN
cord-023095-4dannjjm	2351	8	the	the	DT
cord-023095-4dannjjm	2351	9	farm	farm	NN
cord-023095-4dannjjm	2351	10	manager	manager	NN
cord-023095-4dannjjm	2351	11	's	's	POS
cord-023095-4dannjjm	2351	12	discretion	discretion	NN
cord-023095-4dannjjm	2351	13	,	,	,
cord-023095-4dannjjm	2351	14	not	not	RB
cord-023095-4dannjjm	2351	15	based	base	VBN
cord-023095-4dannjjm	2351	16	upon	upon	IN
cord-023095-4dannjjm	2351	17	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2351	18	findings	finding	NNS
cord-023095-4dannjjm	2351	19	or	or	CC
cord-023095-4dannjjm	2351	20	RS	rs	NN
cord-023095-4dannjjm	2351	21	.	.	.
cord-023095-4dannjjm	2352	1	Non	non	JJ
cord-023095-4dannjjm	2352	2	-	-	JJ
cord-023095-4dannjjm	2352	3	parametric	parametric	JJ
cord-023095-4dannjjm	2352	4	methods	method	NNS
cord-023095-4dannjjm	2352	5	were	be	VBD
cord-023095-4dannjjm	2352	6	used	use	VBN
cord-023095-4dannjjm	2352	7	to	to	TO
cord-023095-4dannjjm	2352	8	evaluate	evaluate	VB
cord-023095-4dannjjm	2352	9	the	the	DT
cord-023095-4dannjjm	2352	10	data	datum	NNS
cord-023095-4dannjjm	2352	11	.	.	.
cord-023095-4dannjjm	2353	1	Ninety	ninety	CD
cord-023095-4dannjjm	2353	2	-	-	HYPH
cord-023095-4dannjjm	2353	3	one	one	CD
cord-023095-4dannjjm	2353	4	calves	calf	NNS
cord-023095-4dannjjm	2353	5	were	be	VBD
cord-023095-4dannjjm	2353	6	enrolled	enrol	VBN
cord-023095-4dannjjm	2353	7	into	into	IN
cord-023095-4dannjjm	2353	8	the	the	DT
cord-023095-4dannjjm	2353	9	study	study	NN
cord-023095-4dannjjm	2353	10	,	,	,
cord-023095-4dannjjm	2353	11	with	with	IN
cord-023095-4dannjjm	2353	12	6	6	CD
cord-023095-4dannjjm	2353	13	lost	lose	VBN
cord-023095-4dannjjm	2353	14	to	to	TO
cord-023095-4dannjjm	2353	15	follow	follow	VB
cord-023095-4dannjjm	2353	16	-	-	HYPH
cord-023095-4dannjjm	2353	17	up	up	NN
cord-023095-4dannjjm	2353	18	.	.	.
cord-023095-4dannjjm	2354	1	An	an	DT
cord-023095-4dannjjm	2354	2	average	average	NN
cord-023095-4dannjjm	2354	3	of	of	IN
cord-023095-4dannjjm	2354	4	4	4	CD
cord-023095-4dannjjm	2354	5	minutes	minute	NNS
cord-023095-4dannjjm	2354	6	was	be	VBD
cord-023095-4dannjjm	2354	7	spent	spend	VBN
cord-023095-4dannjjm	2354	8	performing	perform	VBG
cord-023095-4dannjjm	2354	9	the	the	DT
cord-023095-4dannjjm	2354	10	RS	rs	NN
cord-023095-4dannjjm	2354	11	and	and	CC
cord-023095-4dannjjm	2354	12	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2354	13	on	on	IN
cord-023095-4dannjjm	2354	14	each	each	DT
cord-023095-4dannjjm	2354	15	calf	calf	NN
cord-023095-4dannjjm	2354	16	.	.	.
cord-023095-4dannjjm	2355	1	The	the	DT
cord-023095-4dannjjm	2355	2	median	median	JJ
cord-023095-4dannjjm	2355	3	ages	age	NNS
cord-023095-4dannjjm	2355	4	at	at	IN
cord-023095-4dannjjm	2355	5	first	first	JJ
cord-023095-4dannjjm	2355	6	(	(	-LRB-
cord-023095-4dannjjm	2355	7	US1	US1	NNP
cord-023095-4dannjjm	2355	8	)	)	-RRB-
cord-023095-4dannjjm	2355	9	and	and	CC
cord-023095-4dannjjm	2356	1	second	second	LS
cord-023095-4dannjjm	2356	2	(	(	-LRB-
cord-023095-4dannjjm	2356	3	US2	US2	NNP
cord-023095-4dannjjm	2356	4	)	)	-RRB-
cord-023095-4dannjjm	2356	5	examination	examination	NN
cord-023095-4dannjjm	2356	6	were	be	VBD
cord-023095-4dannjjm	2356	7	13	13	CD
cord-023095-4dannjjm	2357	1	(	(	-LRB-
cord-023095-4dannjjm	2357	2	interquartile	interquartile	JJ
cord-023095-4dannjjm	2357	3	range	range	VBP
cord-023095-4dannjjm	2357	4	12	12	CD
cord-023095-4dannjjm	2357	5	-	-	SYM
cord-023095-4dannjjm	2357	6	15	15	CD
cord-023095-4dannjjm	2357	7	)	)	-RRB-
cord-023095-4dannjjm	2357	8	and	and	CC
cord-023095-4dannjjm	2357	9	46	46	CD
cord-023095-4dannjjm	2358	1	(	(	-LRB-
cord-023095-4dannjjm	2358	2	interquartile	interquartile	JJ
cord-023095-4dannjjm	2358	3	range	range	VBP
cord-023095-4dannjjm	2358	4	44	44	CD
cord-023095-4dannjjm	2358	5	-	-	SYM
cord-023095-4dannjjm	2358	6	47	47	CD
cord-023095-4dannjjm	2358	7	)	)	-RRB-
cord-023095-4dannjjm	2358	8	days	day	NNS
cord-023095-4dannjjm	2358	9	,	,	,
cord-023095-4dannjjm	2358	10	respectively	respectively	RB
cord-023095-4dannjjm	2358	11	.	.	.
cord-023095-4dannjjm	2359	1	The	the	DT
cord-023095-4dannjjm	2359	2	majority	majority	NN
cord-023095-4dannjjm	2359	3	of	of	IN
cord-023095-4dannjjm	2359	4	calves	calf	NNS
cord-023095-4dannjjm	2359	5	had	have	VBD
cord-023095-4dannjjm	2359	6	a	a	DT
cord-023095-4dannjjm	2359	7	low	low	JJ
cord-023095-4dannjjm	2359	8	RS	rs	NN
cord-023095-4dannjjm	2359	9	(	(	-LRB-
cord-023095-4dannjjm	2359	10	o	o	NN
cord-023095-4dannjjm	2359	11	5	5	CD
cord-023095-4dannjjm	2359	12	)	)	-RRB-
cord-023095-4dannjjm	2359	13	and	and	CC
cord-023095-4dannjjm	2359	14	only	only	RB
cord-023095-4dannjjm	2359	15	3.2	3.2	CD
cord-023095-4dannjjm	2359	16	%	%	NN
cord-023095-4dannjjm	2359	17	of	of	IN
cord-023095-4dannjjm	2359	18	calves	calf	NNS
cord-023095-4dannjjm	2359	19	had	have	VBD
cord-023095-4dannjjm	2359	20	a	a	DT
cord-023095-4dannjjm	2359	21	RS	rs	NN
cord-023095-4dannjjm	2359	22	high	high	JJ
cord-023095-4dannjjm	2359	23	enough	enough	RB
cord-023095-4dannjjm	2359	24	to	to	TO
cord-023095-4dannjjm	2359	25	warrant	warrant	VB
cord-023095-4dannjjm	2359	26	treatment	treatment	NN
cord-023095-4dannjjm	2359	27	based	base	VBN
cord-023095-4dannjjm	2359	28	on	on	IN
cord-023095-4dannjjm	2359	29	previous	previous	JJ
cord-023095-4dannjjm	2359	30	recommendations	recommendation	NNS
cord-023095-4dannjjm	2359	31	(	(	-LRB-
cord-023095-4dannjjm	2359	32	RS!5	RS!5	NNP
cord-023095-4dannjjm	2359	33	)	)	-RRB-
cord-023095-4dannjjm	2359	34	.	.	.
cord-023095-4dannjjm	2360	1	The	the	DT
cord-023095-4dannjjm	2360	2	prevalence	prevalence	NN
cord-023095-4dannjjm	2360	3	of	of	IN
cord-023095-4dannjjm	2360	4	calves	calf	NNS
cord-023095-4dannjjm	2360	5	that	that	WDT
cord-023095-4dannjjm	2360	6	had	have	VBD
cord-023095-4dannjjm	2360	7	abnormal	abnormal	JJ
cord-023095-4dannjjm	2360	8	lungs	lung	NNS
cord-023095-4dannjjm	2360	9	on	on	IN
cord-023095-4dannjjm	2360	10	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2360	11	but	but	CC
cord-023095-4dannjjm	2360	12	a	a	DT
cord-023095-4dannjjm	2360	13	low	low	JJ
cord-023095-4dannjjm	2360	14	RS	rs	NN
cord-023095-4dannjjm	2360	15	(	(	-LRB-
cord-023095-4dannjjm	2360	16	o	o	NN
cord-023095-4dannjjm	2360	17	5	5	CD
cord-023095-4dannjjm	2360	18	)	)	-RRB-
cord-023095-4dannjjm	2360	19	was	be	VBD
cord-023095-4dannjjm	2360	20	5.5	5.5	CD
cord-023095-4dannjjm	2360	21	%	%	NN
cord-023095-4dannjjm	2360	22	(	(	-LRB-
cord-023095-4dannjjm	2360	23	US1	US1	NNP
cord-023095-4dannjjm	2360	24	)	)	-RRB-
cord-023095-4dannjjm	2360	25	and	and	CC
cord-023095-4dannjjm	2360	26	16.5	16.5	CD
cord-023095-4dannjjm	2360	27	%	%	NN
cord-023095-4dannjjm	2360	28	(	(	-LRB-
cord-023095-4dannjjm	2360	29	US2	US2	NNP
cord-023095-4dannjjm	2360	30	)	)	-RRB-
cord-023095-4dannjjm	2360	31	.	.	.
cord-023095-4dannjjm	2361	1	The	the	DT
cord-023095-4dannjjm	2361	2	prevalence	prevalence	NN
cord-023095-4dannjjm	2361	3	of	of	IN
cord-023095-4dannjjm	2361	4	calves	calf	NNS
cord-023095-4dannjjm	2361	5	that	that	WDT
cord-023095-4dannjjm	2361	6	had	have	VBD
cord-023095-4dannjjm	2361	7	abnormal	abnormal	JJ
cord-023095-4dannjjm	2361	8	lungs	lung	NNS
cord-023095-4dannjjm	2361	9	on	on	IN
cord-023095-4dannjjm	2361	10	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2361	11	and	and	CC
cord-023095-4dannjjm	2361	12	a	a	DT
cord-023095-4dannjjm	2361	13	high	high	JJ
cord-023095-4dannjjm	2361	14	RS	rs	NN
cord-023095-4dannjjm	2361	15	(	(	-LRB-
cord-023095-4dannjjm	2361	16	!	!	.
cord-023095-4dannjjm	2361	17	5	5	LS
cord-023095-4dannjjm	2361	18	)	)	-RRB-
cord-023095-4dannjjm	2361	19	was	be	VBD
cord-023095-4dannjjm	2361	20	0	0	CD
cord-023095-4dannjjm	2361	21	%	%	NN
cord-023095-4dannjjm	2361	22	(	(	-LRB-
cord-023095-4dannjjm	2361	23	US1	US1	NNP
cord-023095-4dannjjm	2361	24	)	)	-RRB-
cord-023095-4dannjjm	2361	25	and	and	CC
cord-023095-4dannjjm	2361	26	3.5	3.5	CD
cord-023095-4dannjjm	2361	27	%	%	NN
cord-023095-4dannjjm	2361	28	(	(	-LRB-
cord-023095-4dannjjm	2361	29	US2	US2	NNP
cord-023095-4dannjjm	2361	30	)	)	-RRB-
cord-023095-4dannjjm	2361	31	.	.	.
cord-023095-4dannjjm	2362	1	Of	of	IN
cord-023095-4dannjjm	2362	2	the	the	DT
cord-023095-4dannjjm	2362	3	calves	calf	NNS
cord-023095-4dannjjm	2362	4	that	that	WDT
cord-023095-4dannjjm	2362	5	had	have	VBD
cord-023095-4dannjjm	2362	6	abnormal	abnormal	JJ
cord-023095-4dannjjm	2362	7	lungs	lung	NNS
cord-023095-4dannjjm	2362	8	on	on	IN
cord-023095-4dannjjm	2362	9	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2362	10	but	but	CC
cord-023095-4dannjjm	2362	11	a	a	DT
cord-023095-4dannjjm	2362	12	low	low	JJ
cord-023095-4dannjjm	2362	13	RS	rs	NN
cord-023095-4dannjjm	2362	14	,	,	,
cord-023095-4dannjjm	2362	15	13	13	CD
cord-023095-4dannjjm	2362	16	%	%	NN
cord-023095-4dannjjm	2362	17	were	be	VBD
cord-023095-4dannjjm	2362	18	treated	treat	VBN
cord-023095-4dannjjm	2362	19	with	with	IN
cord-023095-4dannjjm	2362	20	antimicrobials	antimicrobial	NNS
cord-023095-4dannjjm	2362	21	within	within	IN
cord-023095-4dannjjm	2362	22	7	7	CD
cord-023095-4dannjjm	2362	23	days	day	NNS
cord-023095-4dannjjm	2362	24	of	of	IN
cord-023095-4dannjjm	2362	25	examination	examination	NN
cord-023095-4dannjjm	2362	26	.	.	.
cord-023095-4dannjjm	2363	1	None	none	NN
cord-023095-4dannjjm	2363	2	of	of	IN
cord-023095-4dannjjm	2363	3	the	the	DT
cord-023095-4dannjjm	2363	4	calves	calf	NNS
cord-023095-4dannjjm	2363	5	with	with	IN
cord-023095-4dannjjm	2363	6	high	high	JJ
cord-023095-4dannjjm	2363	7	RS	rs	NN
cord-023095-4dannjjm	2363	8	and	and	CC
cord-023095-4dannjjm	2363	9	abnormal	abnormal	JJ
cord-023095-4dannjjm	2363	10	lungs	lung	NNS
cord-023095-4dannjjm	2363	11	on	on	IN
cord-023095-4dannjjm	2363	12	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2363	13	were	be	VBD
cord-023095-4dannjjm	2363	14	treated	treat	VBN
cord-023095-4dannjjm	2363	15	with	with	IN
cord-023095-4dannjjm	2363	16	antibiotics	antibiotic	NNS
cord-023095-4dannjjm	2363	17	within	within	IN
cord-023095-4dannjjm	2363	18	7	7	CD
cord-023095-4dannjjm	2363	19	days	day	NNS
cord-023095-4dannjjm	2363	20	of	of	IN
cord-023095-4dannjjm	2363	21	examination	examination	NN
cord-023095-4dannjjm	2363	22	.	.	.
cord-023095-4dannjjm	2364	1	This	this	DT
cord-023095-4dannjjm	2364	2	study	study	NN
cord-023095-4dannjjm	2364	3	demonstrates	demonstrate	VBZ
cord-023095-4dannjjm	2364	4	a	a	DT
cord-023095-4dannjjm	2364	5	high	high	JJ
cord-023095-4dannjjm	2364	6	prevalence	prevalence	NN
cord-023095-4dannjjm	2364	7	of	of	IN
cord-023095-4dannjjm	2364	8	abnormal	abnormal	JJ
cord-023095-4dannjjm	2364	9	lungs	lung	NNS
cord-023095-4dannjjm	2364	10	,	,	,
cord-023095-4dannjjm	2364	11	as	as	IN
cord-023095-4dannjjm	2364	12	detected	detect	VBN
cord-023095-4dannjjm	2364	13	by	by	IN
cord-023095-4dannjjm	2364	14	thoracic	thoracic	JJ
cord-023095-4dannjjm	2364	15	ultrasonography	ultrasonography	NN
cord-023095-4dannjjm	2364	16	,	,	,
cord-023095-4dannjjm	2364	17	without	without	IN
cord-023095-4dannjjm	2364	18	significant	significant	JJ
cord-023095-4dannjjm	2364	19	clinical	clinical	JJ
cord-023095-4dannjjm	2364	20	signs	sign	NNS
cord-023095-4dannjjm	2364	21	in	in	IN
cord-023095-4dannjjm	2364	22	pre	pre	JJ
cord-023095-4dannjjm	2364	23	-	-	JJ
cord-023095-4dannjjm	2364	24	weaned	wean	VBN
cord-023095-4dannjjm	2364	25	dairy	dairy	NN
cord-023095-4dannjjm	2364	26	calves	calf	NNS
cord-023095-4dannjjm	2364	27	.	.	.
cord-023095-4dannjjm	2365	1	The	the	DT
cord-023095-4dannjjm	2365	2	relatively	relatively	RB
cord-023095-4dannjjm	2365	3	low	low	JJ
cord-023095-4dannjjm	2365	4	treatment	treatment	NN
cord-023095-4dannjjm	2365	5	rate	rate	NN
cord-023095-4dannjjm	2365	6	in	in	IN
cord-023095-4dannjjm	2365	7	these	these	DT
cord-023095-4dannjjm	2365	8	calves	calf	NNS
cord-023095-4dannjjm	2365	9	may	may	MD
cord-023095-4dannjjm	2365	10	suggest	suggest	VB
cord-023095-4dannjjm	2365	11	an	an	DT
cord-023095-4dannjjm	2365	12	area	area	NN
cord-023095-4dannjjm	2365	13	of	of	IN
cord-023095-4dannjjm	2365	14	opportunity	opportunity	NN
cord-023095-4dannjjm	2365	15	for	for	IN
cord-023095-4dannjjm	2365	16	improvement	improvement	NN
cord-023095-4dannjjm	2365	17	in	in	IN
cord-023095-4dannjjm	2365	18	calf	calf	NN
cord-023095-4dannjjm	2365	19	health	health	NN
cord-023095-4dannjjm	2365	20	,	,	,
cord-023095-4dannjjm	2365	21	welfare	welfare	NN
cord-023095-4dannjjm	2365	22	,	,	,
cord-023095-4dannjjm	2365	23	and	and	CC
cord-023095-4dannjjm	2365	24	herd	herd	NN
cord-023095-4dannjjm	2365	25	longevity	longevity	NN
cord-023095-4dannjjm	2365	26	.	.	.
cord-023095-4dannjjm	2366	1	Further	further	JJ
cord-023095-4dannjjm	2366	2	studies	study	NNS
cord-023095-4dannjjm	2366	3	and	and	CC
cord-023095-4dannjjm	2366	4	follow	follow	VB
cord-023095-4dannjjm	2366	5	up	up	RP
cord-023095-4dannjjm	2366	6	are	be	VBP
cord-023095-4dannjjm	2366	7	needed	need	VBN
cord-023095-4dannjjm	2366	8	to	to	TO
cord-023095-4dannjjm	2366	9	elucidate	elucidate	VB
cord-023095-4dannjjm	2366	10	the	the	DT
cord-023095-4dannjjm	2366	11	significance	significance	NN
cord-023095-4dannjjm	2366	12	of	of	IN
cord-023095-4dannjjm	2366	13	these	these	DT
cord-023095-4dannjjm	2366	14	findings	finding	NNS
cord-023095-4dannjjm	2366	15	and	and	CC
cord-023095-4dannjjm	2366	16	whether	whether	IN
cord-023095-4dannjjm	2366	17	or	or	CC
cord-023095-4dannjjm	2366	18	not	not	RB
cord-023095-4dannjjm	2366	19	treatment	treatment	NN
cord-023095-4dannjjm	2366	20	is	be	VBZ
cord-023095-4dannjjm	2366	21	indicated	indicate	VBN
cord-023095-4dannjjm	2366	22	.	.	.
cord-023095-4dannjjm	2367	1	Literature	literature	NN
cord-023095-4dannjjm	2367	2	regarding	regard	VBG
cord-023095-4dannjjm	2367	3	diseases	disease	NNS
cord-023095-4dannjjm	2367	4	causing	cause	VBG
cord-023095-4dannjjm	2367	5	lameness	lameness	NN
cord-023095-4dannjjm	2367	6	in	in	IN
cord-023095-4dannjjm	2367	7	beef	beef	NN
cord-023095-4dannjjm	2367	8	cattle	cattle	NNS
cord-023095-4dannjjm	2367	9	is	be	VBZ
cord-023095-4dannjjm	2367	10	limited	limited	JJ
cord-023095-4dannjjm	2367	11	.	.	.
cord-023095-4dannjjm	2368	1	This	this	DT
cord-023095-4dannjjm	2368	2	retrospective	retrospective	JJ
cord-023095-4dannjjm	2368	3	study	study	NN
cord-023095-4dannjjm	2368	4	was	be	VBD
cord-023095-4dannjjm	2368	5	undertaken	undertake	VBN
cord-023095-4dannjjm	2368	6	to	to	TO
cord-023095-4dannjjm	2368	7	examine	examine	VB
cord-023095-4dannjjm	2368	8	beef	beef	NN
cord-023095-4dannjjm	2368	9	cattle	cattle	NNS
cord-023095-4dannjjm	2368	10	presented	present	VBN
cord-023095-4dannjjm	2368	11	for	for	IN
cord-023095-4dannjjm	2368	12	lameness	lameness	NN
cord-023095-4dannjjm	2368	13	.	.	.
cord-023095-4dannjjm	2369	1	Medical	medical	JJ
cord-023095-4dannjjm	2369	2	records	record	NNS
cord-023095-4dannjjm	2369	3	of	of	IN
cord-023095-4dannjjm	2369	4	beef	beef	NN
cord-023095-4dannjjm	2369	5	cattle	cattle	NNS
cord-023095-4dannjjm	2369	6	having	have	VBG
cord-023095-4dannjjm	2369	7	a	a	DT
cord-023095-4dannjjm	2369	8	lameness	lameness	NN
cord-023095-4dannjjm	2369	9	examination	examination	NN
cord-023095-4dannjjm	2369	10	done	do	VBN
cord-023095-4dannjjm	2369	11	during	during	IN
cord-023095-4dannjjm	2369	12	the	the	DT
cord-023095-4dannjjm	2369	13	period	period	NN
cord-023095-4dannjjm	2369	14	2007	2007	CD
cord-023095-4dannjjm	2369	15	to	to	IN
cord-023095-4dannjjm	2369	16	2010	2010	CD
cord-023095-4dannjjm	2369	17	were	be	VBD
cord-023095-4dannjjm	2369	18	reviewed	review	VBN
cord-023095-4dannjjm	2369	19	and	and	CC
cord-023095-4dannjjm	2369	20	descriptive	descriptive	JJ
cord-023095-4dannjjm	2369	21	statistics	statistic	NNS
cord-023095-4dannjjm	2369	22	generated	generate	VBN
cord-023095-4dannjjm	2369	23	.	.	.
cord-023095-4dannjjm	2370	1	Lameness	lameness	NN
cord-023095-4dannjjm	2370	2	was	be	VBD
cord-023095-4dannjjm	2370	3	classified	classify	VBN
cord-023095-4dannjjm	2370	4	based	base	VBN
cord-023095-4dannjjm	2370	5	on	on	IN
cord-023095-4dannjjm	2370	6	clinical	clinical	JJ
cord-023095-4dannjjm	2370	7	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2370	8	.	.	.
cord-023095-4dannjjm	2371	1	The	the	DT
cord-023095-4dannjjm	2371	2	medical	medical	JJ
cord-023095-4dannjjm	2371	3	records	record	NNS
cord-023095-4dannjjm	2371	4	of	of	IN
cord-023095-4dannjjm	2371	5	270	270	CD
cord-023095-4dannjjm	2371	6	beef	beef	NN
cord-023095-4dannjjm	2371	7	cattle	cattle	NNS
cord-023095-4dannjjm	2371	8	were	be	VBD
cord-023095-4dannjjm	2371	9	reviewed	review	VBN
cord-023095-4dannjjm	2371	10	of	of	IN
cord-023095-4dannjjm	2371	11	which	which	WDT
cord-023095-4dannjjm	2371	12	63.2	63.2	CD
cord-023095-4dannjjm	2371	13	%	%	NN
cord-023095-4dannjjm	2371	14	were	be	VBD
cord-023095-4dannjjm	2371	15	male	male	JJ
cord-023095-4dannjjm	2371	16	and	and	CC
cord-023095-4dannjjm	2371	17	36.8	36.8	CD
cord-023095-4dannjjm	2371	18	%	%	NN
cord-023095-4dannjjm	2371	19	were	be	VBD
cord-023095-4dannjjm	2371	20	female	female	JJ
cord-023095-4dannjjm	2371	21	.	.	.
cord-023095-4dannjjm	2372	1	Beef	beef	NN
cord-023095-4dannjjm	2372	2	cattle	cattle	NNS
cord-023095-4dannjjm	2372	3	presented	present	VBN
cord-023095-4dannjjm	2372	4	for	for	IN
cord-023095-4dannjjm	2372	5	lameness	lameness	NN
cord-023095-4dannjjm	2372	6	most	most	RBS
cord-023095-4dannjjm	2372	7	often	often	RB
cord-023095-4dannjjm	2372	8	during	during	IN
cord-023095-4dannjjm	2372	9	the	the	DT
cord-023095-4dannjjm	2372	10	summer	summer	NN
cord-023095-4dannjjm	2372	11	months	month	NNS
cord-023095-4dannjjm	2372	12	(	(	-LRB-
cord-023095-4dannjjm	2372	13	34	34	CD
cord-023095-4dannjjm	2372	14	%	%	NN
cord-023095-4dannjjm	2372	15	)	)	-RRB-
cord-023095-4dannjjm	2372	16	and	and	CC
cord-023095-4dannjjm	2372	17	least	least	JJS
cord-023095-4dannjjm	2372	18	during	during	IN
cord-023095-4dannjjm	2372	19	autumn	autumn	NN
cord-023095-4dannjjm	2372	20	(	(	-LRB-
cord-023095-4dannjjm	2372	21	18	18	CD
cord-023095-4dannjjm	2372	22	%	%	NN
cord-023095-4dannjjm	2372	23	)	)	-RRB-
cord-023095-4dannjjm	2372	24	.	.	.
cord-023095-4dannjjm	2373	1	Causes	cause	NNS
cord-023095-4dannjjm	2373	2	of	of	IN
cord-023095-4dannjjm	2373	3	lameness	lameness	NN
cord-023095-4dannjjm	2373	4	were	be	VBD
cord-023095-4dannjjm	2373	5	categorized	categorize	VBN
cord-023095-4dannjjm	2373	6	as	as	IN
cord-023095-4dannjjm	2373	7	infectious	infectious	JJ
cord-023095-4dannjjm	2373	8	(	(	-LRB-
cord-023095-4dannjjm	2373	9	44.6	44.6	CD
cord-023095-4dannjjm	2373	10	%	%	NN
cord-023095-4dannjjm	2373	11	)	)	-RRB-
cord-023095-4dannjjm	2373	12	or	or	CC
cord-023095-4dannjjm	2373	13	non	non	JJ
cord-023095-4dannjjm	2373	14	-	-	JJ
cord-023095-4dannjjm	2373	15	infectious	infectious	JJ
cord-023095-4dannjjm	2373	16	(	(	-LRB-
cord-023095-4dannjjm	2373	17	55.4	55.4	CD
cord-023095-4dannjjm	2373	18	%	%	NN
cord-023095-4dannjjm	2373	19	)	)	-RRB-
cord-023095-4dannjjm	2373	20	and	and	CC
cord-023095-4dannjjm	2373	21	infectious	infectious	JJ
cord-023095-4dannjjm	2373	22	lameness	lameness	NN
cord-023095-4dannjjm	2373	23	subcategorized	subcategorize	VBN
cord-023095-4dannjjm	2373	24	as	as	IN
cord-023095-4dannjjm	2373	25	either	either	CC
cord-023095-4dannjjm	2373	26	a	a	DT
cord-023095-4dannjjm	2373	27	primary	primary	JJ
cord-023095-4dannjjm	2373	28	disorder	disorder	NN
cord-023095-4dannjjm	2373	29	or	or	CC
cord-023095-4dannjjm	2373	30	a	a	DT
cord-023095-4dannjjm	2373	31	secondary	secondary	JJ
cord-023095-4dannjjm	2373	32	infection	infection	NN
cord-023095-4dannjjm	2373	33	.	.	.
cord-023095-4dannjjm	2374	1	All	all	DT
cord-023095-4dannjjm	2374	2	cases	case	NNS
cord-023095-4dannjjm	2374	3	of	of	IN
cord-023095-4dannjjm	2374	4	a	a	DT
cord-023095-4dannjjm	2374	5	primary	primary	JJ
cord-023095-4dannjjm	2374	6	infectious	infectious	JJ
cord-023095-4dannjjm	2374	7	disorder	disorder	NN
cord-023095-4dannjjm	2374	8	were	be	VBD
cord-023095-4dannjjm	2374	9	interdigital	interdigital	NNP
cord-023095-4dannjjm	2374	10	phlegmon	phlegmon	NNP
cord-023095-4dannjjm	2374	11	.	.	.
cord-023095-4dannjjm	2375	1	Secondary	secondary	JJ
cord-023095-4dannjjm	2375	2	infections	infection	NNS
cord-023095-4dannjjm	2375	3	diseases	disease	NNS
cord-023095-4dannjjm	2375	4	included	include	VBD
cord-023095-4dannjjm	2375	5	sole	sole	JJ
cord-023095-4dannjjm	2375	6	abscess	abscess	NN
cord-023095-4dannjjm	2375	7	(	(	-LRB-
cord-023095-4dannjjm	2375	8	25.9	25.9	CD
cord-023095-4dannjjm	2375	9	%	%	NN
cord-023095-4dannjjm	2375	10	)	)	-RRB-
cord-023095-4dannjjm	2375	11	,	,	,
cord-023095-4dannjjm	2375	12	septic	septic	JJ
cord-023095-4dannjjm	2375	13	arthritis	arthritis	NN
cord-023095-4dannjjm	2375	14	(	(	-LRB-
cord-023095-4dannjjm	2375	15	11.1	11.1	CD
cord-023095-4dannjjm	2375	16	%	%	NN
cord-023095-4dannjjm	2375	17	)	)	-RRB-
cord-023095-4dannjjm	2375	18	,	,	,
cord-023095-4dannjjm	2375	19	tenosynovitis	tenosynovitis	NNP
cord-023095-4dannjjm	2375	20	(	(	-LRB-
cord-023095-4dannjjm	2375	21	2.8	2.8	CD
cord-023095-4dannjjm	2375	22	%	%	NN
cord-023095-4dannjjm	2375	23	)	)	-RRB-
cord-023095-4dannjjm	2375	24	,	,	,
cord-023095-4dannjjm	2375	25	and	and	CC
cord-023095-4dannjjm	2375	26	pedal	pedal	NN
cord-023095-4dannjjm	2375	27	osteitis	osteitis	NNP
cord-023095-4dannjjm	2375	28	(	(	-LRB-
cord-023095-4dannjjm	2375	29	1.3	1.3	CD
cord-023095-4dannjjm	2375	30	%	%	NN
cord-023095-4dannjjm	2375	31	)	)	-RRB-
cord-023095-4dannjjm	2375	32	.	.	.
cord-023095-4dannjjm	2376	1	Non	non	JJ
cord-023095-4dannjjm	2376	2	-	-	JJ
cord-023095-4dannjjm	2376	3	infectious	infectious	JJ
cord-023095-4dannjjm	2376	4	lameness	lameness	NN
cord-023095-4dannjjm	2376	5	included	include	VBD
cord-023095-4dannjjm	2376	6	proximal	proximal	JJ
cord-023095-4dannjjm	2376	7	limb	limb	NN
cord-023095-4dannjjm	2376	8	lameness	lameness	NN
cord-023095-4dannjjm	2376	9	(	(	-LRB-
cord-023095-4dannjjm	2376	10	19.6	19.6	CD
cord-023095-4dannjjm	2376	11	%	%	NN
cord-023095-4dannjjm	2376	12	)	)	-RRB-
cord-023095-4dannjjm	2376	13	,	,	,
cord-023095-4dannjjm	2376	14	foot	foot	NN
cord-023095-4dannjjm	2376	15	trauma	trauma	NN
cord-023095-4dannjjm	2376	16	(	(	-LRB-
cord-023095-4dannjjm	2376	17	14.6	14.6	CD
cord-023095-4dannjjm	2376	18	%	%	NN
cord-023095-4dannjjm	2376	19	)	)	-RRB-
cord-023095-4dannjjm	2376	20	,	,	,
cord-023095-4dannjjm	2376	21	hoof	hoof	NN
cord-023095-4dannjjm	2376	22	horn	horn	NN
cord-023095-4dannjjm	2376	23	cracks	crack	NNS
cord-023095-4dannjjm	2376	24	(	(	-LRB-
cord-023095-4dannjjm	2376	25	9.5	9.5	CD
cord-023095-4dannjjm	2376	26	%	%	NN
cord-023095-4dannjjm	2376	27	)	)	-RRB-
cord-023095-4dannjjm	2376	28	,	,	,
cord-023095-4dannjjm	2376	29	hoof	hoof	NN
cord-023095-4dannjjm	2376	30	defects	defect	NNS
cord-023095-4dannjjm	2376	31	(	(	-LRB-
cord-023095-4dannjjm	2376	32	2.5	2.5	CD
cord-023095-4dannjjm	2376	33	%	%	NN
cord-023095-4dannjjm	2376	34	)	)	-RRB-
cord-023095-4dannjjm	2376	35	,	,	,
cord-023095-4dannjjm	2376	36	interdigital	interdigital	NNP
cord-023095-4dannjjm	2376	37	fibromas	fibromas	NNP
cord-023095-4dannjjm	2376	38	(	(	-LRB-
cord-023095-4dannjjm	2376	39	1.9	1.9	CD
cord-023095-4dannjjm	2376	40	%	%	NN
cord-023095-4dannjjm	2376	41	)	)	-RRB-
cord-023095-4dannjjm	2376	42	,	,	,
cord-023095-4dannjjm	2376	43	overgrown	overgrown	JJ
cord-023095-4dannjjm	2376	44	hooves	hoof	NNS
cord-023095-4dannjjm	2376	45	(	(	-LRB-
cord-023095-4dannjjm	2376	46	1.9	1.9	CD
cord-023095-4dannjjm	2376	47	%	%	NN
cord-023095-4dannjjm	2376	48	)	)	-RRB-
cord-023095-4dannjjm	2376	49	,	,	,
cord-023095-4dannjjm	2376	50	sole	sole	JJ
cord-023095-4dannjjm	2376	51	bruise	bruise	NN
cord-023095-4dannjjm	2376	52	(	(	-LRB-
cord-023095-4dannjjm	2376	53	1.3	1.3	CD
cord-023095-4dannjjm	2376	54	%	%	NN
cord-023095-4dannjjm	2376	55	)	)	-RRB-
cord-023095-4dannjjm	2376	56	,	,	,
cord-023095-4dannjjm	2376	57	subclinical	subclinical	JJ
cord-023095-4dannjjm	2376	58	laminitis	laminitis	NN
cord-023095-4dannjjm	2376	59	(	(	-LRB-
cord-023095-4dannjjm	2376	60	1.3	1.3	CD
cord-023095-4dannjjm	2376	61	%	%	NN
cord-023095-4dannjjm	2376	62	)	)	-RRB-
cord-023095-4dannjjm	2376	63	,	,	,
cord-023095-4dannjjm	2376	64	white	white	JJ
cord-023095-4dannjjm	2376	65	line	line	NN
cord-023095-4dannjjm	2376	66	disease	disease	NN
cord-023095-4dannjjm	2376	67	(	(	-LRB-
cord-023095-4dannjjm	2376	68	0.9	0.9	CD
cord-023095-4dannjjm	2376	69	%	%	NN
cord-023095-4dannjjm	2376	70	)	)	-RRB-
cord-023095-4dannjjm	2376	71	,	,	,
cord-023095-4dannjjm	2376	72	osteoarthritis	osteoarthritis	NN
cord-023095-4dannjjm	2376	73	(	(	-LRB-
cord-023095-4dannjjm	2376	74	0.9	0.9	CD
cord-023095-4dannjjm	2376	75	%	%	NN
cord-023095-4dannjjm	2376	76	)	)	-RRB-
cord-023095-4dannjjm	2376	77	,	,	,
cord-023095-4dannjjm	2376	78	heel	heel	NN
cord-023095-4dannjjm	2376	79	erosion	erosion	NN
cord-023095-4dannjjm	2376	80	(	(	-LRB-
cord-023095-4dannjjm	2376	81	0.3	0.3	CD
cord-023095-4dannjjm	2376	82	%	%	NN
cord-023095-4dannjjm	2376	83	)	)	-RRB-
cord-023095-4dannjjm	2376	84	,	,	,
cord-023095-4dannjjm	2376	85	sole	sole	JJ
cord-023095-4dannjjm	2376	86	ulcers	ulcer	NNS
cord-023095-4dannjjm	2376	87	(	(	-LRB-
cord-023095-4dannjjm	2376	88	0.3	0.3	CD
cord-023095-4dannjjm	2376	89	%	%	NN
cord-023095-4dannjjm	2376	90	)	)	-RRB-
cord-023095-4dannjjm	2376	91	,	,	,
cord-023095-4dannjjm	2376	92	and	and	CC
cord-023095-4dannjjm	2376	93	sole	sole	JJ
cord-023095-4dannjjm	2376	94	hemorrhage	hemorrhage	NN
cord-023095-4dannjjm	2376	95	(	(	-LRB-
cord-023095-4dannjjm	2376	96	0.3	0.3	CD
cord-023095-4dannjjm	2376	97	%	%	NN
cord-023095-4dannjjm	2376	98	)	)	-RRB-
cord-023095-4dannjjm	2376	99	.	.	.
cord-023095-4dannjjm	2377	1	The	the	DT
cord-023095-4dannjjm	2377	2	most	most	RBS
cord-023095-4dannjjm	2377	3	frequently	frequently	RB
cord-023095-4dannjjm	2377	4	affected	affect	VBN
cord-023095-4dannjjm	2377	5	claw	claw	NN
cord-023095-4dannjjm	2377	6	was	be	VBD
cord-023095-4dannjjm	2377	7	the	the	DT
cord-023095-4dannjjm	2377	8	lateral	lateral	JJ
cord-023095-4dannjjm	2377	9	digit	digit	NN
cord-023095-4dannjjm	2377	10	of	of	IN
cord-023095-4dannjjm	2377	11	the	the	DT
cord-023095-4dannjjm	2377	12	hind	hind	NN
cord-023095-4dannjjm	2377	13	limb	limb	NN
cord-023095-4dannjjm	2377	14	(	(	-LRB-
cord-023095-4dannjjm	2377	15	36.4	36.4	CD
cord-023095-4dannjjm	2377	16	%	%	NN
cord-023095-4dannjjm	2377	17	)	)	-RRB-
cord-023095-4dannjjm	2377	18	,	,	,
cord-023095-4dannjjm	2377	19	followed	follow	VBN
cord-023095-4dannjjm	2377	20	by	by	IN
cord-023095-4dannjjm	2377	21	the	the	DT
cord-023095-4dannjjm	2377	22	medial	medial	JJ
cord-023095-4dannjjm	2377	23	digit	digit	NN
cord-023095-4dannjjm	2377	24	of	of	IN
cord-023095-4dannjjm	2377	25	the	the	DT
cord-023095-4dannjjm	2377	26	front	front	JJ
cord-023095-4dannjjm	2377	27	limb	limb	NN
cord-023095-4dannjjm	2377	28	(	(	-LRB-
cord-023095-4dannjjm	2377	29	27.1	27.1	CD
cord-023095-4dannjjm	2377	30	%	%	NN
cord-023095-4dannjjm	2377	31	)	)	-RRB-
cord-023095-4dannjjm	2377	32	,	,	,
cord-023095-4dannjjm	2377	33	lateral	lateral	JJ
cord-023095-4dannjjm	2377	34	digit	digit	NN
cord-023095-4dannjjm	2377	35	of	of	IN
cord-023095-4dannjjm	2377	36	the	the	DT
cord-023095-4dannjjm	2377	37	front	front	JJ
cord-023095-4dannjjm	2377	38	limb	limb	NN
cord-023095-4dannjjm	2377	39	(	(	-LRB-
cord-023095-4dannjjm	2377	40	23.6	23.6	CD
cord-023095-4dannjjm	2377	41	%	%	NN
cord-023095-4dannjjm	2377	42	)	)	-RRB-
cord-023095-4dannjjm	2377	43	,	,	,
cord-023095-4dannjjm	2377	44	and	and	CC
cord-023095-4dannjjm	2377	45	the	the	DT
cord-023095-4dannjjm	2377	46	medial	medial	JJ
cord-023095-4dannjjm	2377	47	digit	digit	NN
cord-023095-4dannjjm	2377	48	of	of	IN
cord-023095-4dannjjm	2377	49	the	the	DT
cord-023095-4dannjjm	2377	50	hind	hind	NN
cord-023095-4dannjjm	2377	51	limb	limb	NN
cord-023095-4dannjjm	2377	52	(	(	-LRB-
cord-023095-4dannjjm	2377	53	12.9	12.9	CD
cord-023095-4dannjjm	2377	54	%	%	NN
cord-023095-4dannjjm	2377	55	)	)	-RRB-
cord-023095-4dannjjm	2377	56	.	.	.
cord-023095-4dannjjm	2378	1	The	the	DT
cord-023095-4dannjjm	2378	2	findings	finding	NNS
cord-023095-4dannjjm	2378	3	of	of	IN
cord-023095-4dannjjm	2378	4	this	this	DT
cord-023095-4dannjjm	2378	5	study	study	NN
cord-023095-4dannjjm	2378	6	suggest	suggest	VBP
cord-023095-4dannjjm	2378	7	significant	significant	JJ
cord-023095-4dannjjm	2378	8	differences	difference	NNS
cord-023095-4dannjjm	2378	9	in	in	IN
cord-023095-4dannjjm	2378	10	the	the	DT
cord-023095-4dannjjm	2378	11	frequency	frequency	NN
cord-023095-4dannjjm	2378	12	of	of	IN
cord-023095-4dannjjm	2378	13	disease	disease	NN
cord-023095-4dannjjm	2378	14	causing	cause	VBG
cord-023095-4dannjjm	2378	15	lameness	lameness	NN
cord-023095-4dannjjm	2378	16	in	in	IN
cord-023095-4dannjjm	2378	17	beef	beef	NN
cord-023095-4dannjjm	2378	18	cattle	cattle	NNS
cord-023095-4dannjjm	2378	19	compared	compare	VBN
cord-023095-4dannjjm	2378	20	to	to	IN
cord-023095-4dannjjm	2378	21	published	publish	VBN
cord-023095-4dannjjm	2378	22	reports	report	NNS
cord-023095-4dannjjm	2378	23	for	for	IN
cord-023095-4dannjjm	2378	24	dairy	dairy	NN
cord-023095-4dannjjm	2378	25	cattle	cattle	NNS
cord-023095-4dannjjm	2378	26	.	.	.
cord-023095-4dannjjm	2379	1	In	in	IN
cord-023095-4dannjjm	2379	2	people	people	NNS
cord-023095-4dannjjm	2379	3	,	,	,
cord-023095-4dannjjm	2379	4	endoscopic	endoscopic	NNS
cord-023095-4dannjjm	2379	5	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2379	6	(	(	-LRB-
cord-023095-4dannjjm	2379	7	EUS	EUS	NNP
cord-023095-4dannjjm	2379	8	)	)	-RRB-
cord-023095-4dannjjm	2379	9	has	have	VBZ
cord-023095-4dannjjm	2379	10	become	become	VBN
cord-023095-4dannjjm	2379	11	the	the	DT
cord-023095-4dannjjm	2379	12	technique	technique	NN
cord-023095-4dannjjm	2379	13	of	of	IN
cord-023095-4dannjjm	2379	14	choice	choice	NN
cord-023095-4dannjjm	2379	15	for	for	IN
cord-023095-4dannjjm	2379	16	assessing	assess	VBG
cord-023095-4dannjjm	2379	17	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	2379	18	disease	disease	NN
cord-023095-4dannjjm	2379	19	and	and	CC
cord-023095-4dannjjm	2379	20	EUS	eus	NN
cord-023095-4dannjjm	2379	21	-	-	HYPH
cord-023095-4dannjjm	2379	22	guided	guide	VBN
cord-023095-4dannjjm	2379	23	fineneedle	fineneedle	NN
cord-023095-4dannjjm	2379	24	aspiration	aspiration	NN
cord-023095-4dannjjm	2379	25	(	(	-LRB-
cord-023095-4dannjjm	2379	26	EUS	EUS	NNP
cord-023095-4dannjjm	2379	27	FNA	FNA	NNP
cord-023095-4dannjjm	2379	28	)	)	-RRB-
cord-023095-4dannjjm	2379	29	has	have	VBZ
cord-023095-4dannjjm	2379	30	proven	prove	VBN
cord-023095-4dannjjm	2379	31	a	a	DT
cord-023095-4dannjjm	2379	32	useful	useful	JJ
cord-023095-4dannjjm	2379	33	and	and	CC
cord-023095-4dannjjm	2379	34	safe	safe	JJ
cord-023095-4dannjjm	2379	35	modality	modality	NN
cord-023095-4dannjjm	2379	36	for	for	IN
cord-023095-4dannjjm	2379	37	characterizing	characterize	VBG
cord-023095-4dannjjm	2379	38	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	2379	39	lesions	lesion	NNS
cord-023095-4dannjjm	2379	40	.	.	.
cord-023095-4dannjjm	2380	1	Reported	report	VBN
cord-023095-4dannjjm	2380	2	complications	complication	NNS
cord-023095-4dannjjm	2380	3	include	include	VBP
cord-023095-4dannjjm	2380	4	infections	infection	NNS
cord-023095-4dannjjm	2380	5	,	,	,
cord-023095-4dannjjm	2380	6	bleeding	bleed	VBG
cord-023095-4dannjjm	2380	7	and	and	CC
cord-023095-4dannjjm	2380	8	acute	acute	JJ
cord-023095-4dannjjm	2380	9	pancreatitis	pancreatitis	NN
cord-023095-4dannjjm	2380	10	.	.	.
cord-023095-4dannjjm	2381	1	In	in	IN
cord-023095-4dannjjm	2381	2	dogs	dog	NNS
cord-023095-4dannjjm	2381	3	,	,	,
cord-023095-4dannjjm	2381	4	laparoscopic	laparoscopic	JJ
cord-023095-4dannjjm	2381	5	-	-	HYPH
cord-023095-4dannjjm	2381	6	assisted	assist	VBN
cord-023095-4dannjjm	2381	7	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	2381	8	biopsy	biopsy	NN
cord-023095-4dannjjm	2381	9	has	have	VBZ
cord-023095-4dannjjm	2381	10	been	be	VBN
cord-023095-4dannjjm	2381	11	suggested	suggest	VBN
cord-023095-4dannjjm	2381	12	to	to	TO
cord-023095-4dannjjm	2381	13	be	be	VB
cord-023095-4dannjjm	2381	14	a	a	DT
cord-023095-4dannjjm	2381	15	safe	safe	JJ
cord-023095-4dannjjm	2381	16	procedure	procedure	NN
cord-023095-4dannjjm	2381	17	,	,	,
cord-023095-4dannjjm	2381	18	however	however	RB
cord-023095-4dannjjm	2381	19	EUS	eus	NN
cord-023095-4dannjjm	2381	20	and	and	CC
cord-023095-4dannjjm	2381	21	EUS	EUS	NNP
cord-023095-4dannjjm	2381	22	FNA	FNA	NNP
cord-023095-4dannjjm	2381	23	have	have	VBP
cord-023095-4dannjjm	2381	24	not	not	RB
cord-023095-4dannjjm	2381	25	been	be	VBN
cord-023095-4dannjjm	2381	26	evaluated	evaluate	VBN
cord-023095-4dannjjm	2381	27	in	in	IN
cord-023095-4dannjjm	2381	28	dogs	dog	NNS
cord-023095-4dannjjm	2381	29	so	so	RB
cord-023095-4dannjjm	2381	30	far	far	RB
cord-023095-4dannjjm	2381	31	.	.	.
cord-023095-4dannjjm	2382	1	Thus	thus	RB
cord-023095-4dannjjm	2382	2	the	the	DT
cord-023095-4dannjjm	2382	3	aim	aim	NN
cord-023095-4dannjjm	2382	4	of	of	IN
cord-023095-4dannjjm	2382	5	the	the	DT
cord-023095-4dannjjm	2382	6	present	present	JJ
cord-023095-4dannjjm	2382	7	study	study	NN
cord-023095-4dannjjm	2382	8	was	be	VBD
cord-023095-4dannjjm	2382	9	to	to	TO
cord-023095-4dannjjm	2382	10	assess	assess	VB
cord-023095-4dannjjm	2382	11	the	the	DT
cord-023095-4dannjjm	2382	12	practicability	practicability	NN
cord-023095-4dannjjm	2382	13	and	and	CC
cord-023095-4dannjjm	2382	14	safety	safety	NN
cord-023095-4dannjjm	2382	15	of	of	IN
cord-023095-4dannjjm	2382	16	EUS	eus	NN
cord-023095-4dannjjm	2382	17	examination	examination	NN
cord-023095-4dannjjm	2382	18	of	of	IN
cord-023095-4dannjjm	2382	19	the	the	DT
cord-023095-4dannjjm	2382	20	abdominal	abdominal	JJ
cord-023095-4dannjjm	2382	21	cavity	cavity	NN
cord-023095-4dannjjm	2382	22	as	as	RB
cord-023095-4dannjjm	2382	23	well	well	RB
cord-023095-4dannjjm	2382	24	as	as	IN
cord-023095-4dannjjm	2382	25	pancreatic	pancreatic	NN
cord-023095-4dannjjm	2382	26	EUS	eus	NN
cord-023095-4dannjjm	2382	27	FNA	FNA	NNP
cord-023095-4dannjjm	2382	28	in	in	IN
cord-023095-4dannjjm	2382	29	healthy	healthy	JJ
cord-023095-4dannjjm	2382	30	dogs	dog	NNS
cord-023095-4dannjjm	2382	31	.	.	.
cord-023095-4dannjjm	2383	1	This	this	DT
cord-023095-4dannjjm	2383	2	study	study	NN
cord-023095-4dannjjm	2383	3	was	be	VBD
cord-023095-4dannjjm	2383	4	approved	approve	VBN
cord-023095-4dannjjm	2383	5	by	by	IN
cord-023095-4dannjjm	2383	6	the	the	DT
cord-023095-4dannjjm	2383	7	Cantonal	Cantonal	NNP
cord-023095-4dannjjm	2383	8	Committee	Committee	NNP
cord-023095-4dannjjm	2383	9	for	for	IN
cord-023095-4dannjjm	2383	10	the	the	DT
cord-023095-4dannjjm	2383	11	Authorization	Authorization	NNP
cord-023095-4dannjjm	2383	12	of	of	IN
cord-023095-4dannjjm	2383	13	Animal	Animal	NNP
cord-023095-4dannjjm	2383	14	Experimentation	Experimentation	NNP
cord-023095-4dannjjm	2383	15	,	,	,
cord-023095-4dannjjm	2383	16	Zurich	Zurich	NNP
cord-023095-4dannjjm	2383	17	,	,	,
cord-023095-4dannjjm	2383	18	Switzerland	Switzerland	NNP
cord-023095-4dannjjm	2383	19	.	.	.
cord-023095-4dannjjm	2384	1	The	the	DT
cord-023095-4dannjjm	2384	2	study	study	NN
cord-023095-4dannjjm	2384	3	population	population	NN
cord-023095-4dannjjm	2384	4	consisted	consist	VBD
cord-023095-4dannjjm	2384	5	of	of	IN
cord-023095-4dannjjm	2384	6	14	14	CD
cord-023095-4dannjjm	2384	7	healthy	healthy	JJ
cord-023095-4dannjjm	2384	8	beagle	beagle	NN
cord-023095-4dannjjm	2384	9	dogs	dog	NNS
cord-023095-4dannjjm	2384	10	with	with	IN
cord-023095-4dannjjm	2384	11	a	a	DT
cord-023095-4dannjjm	2384	12	median	median	JJ
cord-023095-4dannjjm	2384	13	bodyweight	bodyweight	NN
cord-023095-4dannjjm	2384	14	of	of	IN
cord-023095-4dannjjm	2384	15	13.4	13.4	CD
cord-023095-4dannjjm	2384	16	kg	kg	NNS
cord-023095-4dannjjm	2384	17	(	(	-LRB-
cord-023095-4dannjjm	2384	18	10.9	10.9	CD
cord-023095-4dannjjm	2384	19	-	-	SYM
cord-023095-4dannjjm	2384	20	15.7	15.7	CD
cord-023095-4dannjjm	2384	21	)	)	-RRB-
cord-023095-4dannjjm	2384	22	.	.	.
cord-023095-4dannjjm	2385	1	EUS	EUS	NNP
cord-023095-4dannjjm	2385	2	was	be	VBD
cord-023095-4dannjjm	2385	3	performed	perform	VBN
cord-023095-4dannjjm	2385	4	with	with	IN
cord-023095-4dannjjm	2385	5	an	an	DT
cord-023095-4dannjjm	2385	6	Olympus	Olympus	NNP
cord-023095-4dannjjm	2385	7	GF	GF	NNP
cord-023095-4dannjjm	2385	8	-	-	HYPH
cord-023095-4dannjjm	2385	9	UC140P	uc140p	NN
cord-023095-4dannjjm	2385	10	-	-	HYPH
cord-023095-4dannjjm	2385	11	echoendoscope	echoendoscope	NN
cord-023095-4dannjjm	2385	12	and	and	CC
cord-023095-4dannjjm	2385	13	FNA	FNA	NNP
cord-023095-4dannjjm	2385	14	were	be	VBD
cord-023095-4dannjjm	2385	15	performed	perform	VBN
cord-023095-4dannjjm	2385	16	using	use	VBG
cord-023095-4dannjjm	2385	17	19	19	CD
cord-023095-4dannjjm	2385	18	G	g	NN
cord-023095-4dannjjm	2385	19	needles	needle	NNS
cord-023095-4dannjjm	2385	20	(	(	-LRB-
cord-023095-4dannjjm	2385	21	Cook	Cook	NNP
cord-023095-4dannjjm	2385	22	EchoTipUltra	EchoTipUltra	NNP
cord-023095-4dannjjm	2385	23	)	)	-RRB-
cord-023095-4dannjjm	2385	24	.	.	.
cord-023095-4dannjjm	2386	1	After	after	IN
cord-023095-4dannjjm	2386	2	completion	completion	NN
cord-023095-4dannjjm	2386	3	of	of	IN
cord-023095-4dannjjm	2386	4	the	the	DT
cord-023095-4dannjjm	2386	5	EUS	eus	NN
cord-023095-4dannjjm	2386	6	-	-	HYPH
cord-023095-4dannjjm	2386	7	examination	examination	NN
cord-023095-4dannjjm	2386	8	of	of	IN
cord-023095-4dannjjm	2386	9	the	the	DT
cord-023095-4dannjjm	2386	10	abdominal	abdominal	JJ
cord-023095-4dannjjm	2386	11	cavity	cavity	NN
cord-023095-4dannjjm	2386	12	from	from	IN
cord-023095-4dannjjm	2386	13	the	the	DT
cord-023095-4dannjjm	2386	14	stomach	stomach	NN
cord-023095-4dannjjm	2386	15	(	(	-LRB-
cord-023095-4dannjjm	2386	16	liver	liver	NN
cord-023095-4dannjjm	2386	17	,	,	,
cord-023095-4dannjjm	2386	18	gallbladder	gallbladder	NN
cord-023095-4dannjjm	2386	19	,	,	,
cord-023095-4dannjjm	2386	20	bile	bile	NN
cord-023095-4dannjjm	2386	21	ducts	duct	NNS
cord-023095-4dannjjm	2386	22	,	,	,
cord-023095-4dannjjm	2386	23	kidneys	kidney	NNS
cord-023095-4dannjjm	2386	24	,	,	,
cord-023095-4dannjjm	2386	25	adrenals	adrenal	NNS
cord-023095-4dannjjm	2386	26	,	,	,
cord-023095-4dannjjm	2386	27	pancreas	pancrea	NNS
cord-023095-4dannjjm	2386	28	)	)	-RRB-
cord-023095-4dannjjm	2386	29	,	,	,
cord-023095-4dannjjm	2386	30	the	the	DT
cord-023095-4dannjjm	2386	31	scope	scope	NN
cord-023095-4dannjjm	2386	32	was	be	VBD
cord-023095-4dannjjm	2386	33	advanced	advance	VBN
cord-023095-4dannjjm	2386	34	into	into	IN
cord-023095-4dannjjm	2386	35	the	the	DT
cord-023095-4dannjjm	2386	36	duodenum	duodenum	NN
cord-023095-4dannjjm	2386	37	and	and	CC
cord-023095-4dannjjm	2386	38	EUS	EUS	NNP
cord-023095-4dannjjm	2386	39	FNA	FNA	NNP
cord-023095-4dannjjm	2386	40	of	of	IN
cord-023095-4dannjjm	2386	41	the	the	DT
cord-023095-4dannjjm	2386	42	pancreas	pancreas	NN
cord-023095-4dannjjm	2386	43	was	be	VBD
cord-023095-4dannjjm	2386	44	performed	perform	VBN
cord-023095-4dannjjm	2386	45	.	.	.
cord-023095-4dannjjm	2387	1	FNA	FNA	NNP
cord-023095-4dannjjm	2387	2	tissue	tissue	NN
cord-023095-4dannjjm	2387	3	acquisition	acquisition	NN
cord-023095-4dannjjm	2387	4	was	be	VBD
cord-023095-4dannjjm	2387	5	made	make	VBN
cord-023095-4dannjjm	2387	6	applying	apply	VBG
cord-023095-4dannjjm	2387	7	negative	negative	JJ
cord-023095-4dannjjm	2387	8	pressure	pressure	NN
cord-023095-4dannjjm	2387	9	and	and	CC
cord-023095-4dannjjm	2387	10	6	6	CD
cord-023095-4dannjjm	2387	11	to	to	TO
cord-023095-4dannjjm	2387	12	8	8	CD
cord-023095-4dannjjm	2387	13	needle	needle	NN
cord-023095-4dannjjm	2387	14	passes	pass	NNS
cord-023095-4dannjjm	2387	15	were	be	VBD
cord-023095-4dannjjm	2387	16	made	make	VBN
cord-023095-4dannjjm	2387	17	.	.	.
cord-023095-4dannjjm	2388	1	All	all	DT
cord-023095-4dannjjm	2388	2	dogs	dog	NNS
cord-023095-4dannjjm	2388	3	received	receive	VBD
cord-023095-4dannjjm	2388	4	30	30	CD
cord-023095-4dannjjm	2388	5	mg	mg	NNP
cord-023095-4dannjjm	2388	6	/	/	SYM
cord-023095-4dannjjm	2388	7	kg	kg	NNP
cord-023095-4dannjjm	2388	8	metimazole	metimazole	NN
cord-023095-4dannjjm	2388	9	IM	IM	NNP
cord-023095-4dannjjm	2388	10	after	after	IN
cord-023095-4dannjjm	2388	11	EUS	eus	NN
cord-023095-4dannjjm	2388	12	FNA	FNA	NNP
cord-023095-4dannjjm	2388	13	and	and	CC
cord-023095-4dannjjm	2388	14	were	be	VBD
cord-023095-4dannjjm	2388	15	re	re	VBN
cord-023095-4dannjjm	2388	16	-	-	VBN
cord-023095-4dannjjm	2388	17	checked	check	VBN
cord-023095-4dannjjm	2388	18	ultrasonographically	ultrasonographically	RB
cord-023095-4dannjjm	2388	19	20	20	CD
cord-023095-4dannjjm	2388	20	minutes	minute	NNS
cord-023095-4dannjjm	2388	21	post	post	NN
cord-023095-4dannjjm	2388	22	EUS	eus	NN
cord-023095-4dannjjm	2388	23	FNA	FNA	NNP
cord-023095-4dannjjm	2388	24	.	.	.
cord-023095-4dannjjm	2389	1	Postoperative	postoperative	JJ
cord-023095-4dannjjm	2389	2	activity	activity	NN
cord-023095-4dannjjm	2389	3	was	be	VBD
cord-023095-4dannjjm	2389	4	assessed	assess	VBN
cord-023095-4dannjjm	2389	5	using	use	VBG
cord-023095-4dannjjm	2389	6	a	a	DT
cord-023095-4dannjjm	2389	7	standardized	standardized	JJ
cord-023095-4dannjjm	2389	8	scoring	scoring	NN
cord-023095-4dannjjm	2389	9	system	system	NN
cord-023095-4dannjjm	2389	10	.	.	.
cord-023095-4dannjjm	2390	1	A	a	DT
cord-023095-4dannjjm	2390	2	CBC	CBC	NNP
cord-023095-4dannjjm	2390	3	,	,	,
cord-023095-4dannjjm	2390	4	serum	serum	NN
cord-023095-4dannjjm	2390	5	biochemistry	biochemistry	NN
cord-023095-4dannjjm	2390	6	,	,	,
cord-023095-4dannjjm	2390	7	urinalysis	urinalysis	NN
cord-023095-4dannjjm	2390	8	and	and	CC
cord-023095-4dannjjm	2390	9	spec	spec	NN
cord-023095-4dannjjm	2390	10	cPL	cPL	NNS
cord-023095-4dannjjm	2390	11	s	s	NNPS
cord-023095-4dannjjm	2390	12	were	be	VBD
cord-023095-4dannjjm	2390	13	measured	measure	VBN
cord-023095-4dannjjm	2390	14	before	before	RB
cord-023095-4dannjjm	2390	15	,	,	,
cord-023095-4dannjjm	2390	16	as	as	RB
cord-023095-4dannjjm	2390	17	well	well	RB
cord-023095-4dannjjm	2390	18	as	as	IN
cord-023095-4dannjjm	2390	19	24	24	CD
cord-023095-4dannjjm	2390	20	and	and	CC
cord-023095-4dannjjm	2390	21	48	48	CD
cord-023095-4dannjjm	2390	22	h	h	NN
cord-023095-4dannjjm	2390	23	after	after	IN
cord-023095-4dannjjm	2390	24	EUS	EUS	NNP
cord-023095-4dannjjm	2390	25	FNA	FNA	NNP
cord-023095-4dannjjm	2390	26	.	.	.
cord-023095-4dannjjm	2391	1	The	the	DT
cord-023095-4dannjjm	2391	2	EUS	eus	NN
cord-023095-4dannjjm	2391	3	examination	examination	NN
cord-023095-4dannjjm	2391	4	was	be	VBD
cord-023095-4dannjjm	2391	5	complete	complete	JJ
cord-023095-4dannjjm	2391	6	in	in	IN
cord-023095-4dannjjm	2391	7	13/14	13/14	CD
cord-023095-4dannjjm	2391	8	dogs	dog	NNS
cord-023095-4dannjjm	2391	9	,	,	,
cord-023095-4dannjjm	2391	10	the	the	DT
cord-023095-4dannjjm	2391	11	pancreas	pancreas	NN
cord-023095-4dannjjm	2391	12	could	could	MD
cord-023095-4dannjjm	2391	13	not	not	RB
cord-023095-4dannjjm	2391	14	be	be	VB
cord-023095-4dannjjm	2391	15	visualized	visualize	VBN
cord-023095-4dannjjm	2391	16	in	in	IN
cord-023095-4dannjjm	2391	17	1	1	CD
cord-023095-4dannjjm	2391	18	dog	dog	NN
cord-023095-4dannjjm	2391	19	.	.	.
cord-023095-4dannjjm	2392	1	The	the	DT
cord-023095-4dannjjm	2392	2	pancreas	pancreas	NN
cord-023095-4dannjjm	2392	3	was	be	VBD
cord-023095-4dannjjm	2392	4	hypo-(4/13	hypo-(4/13	NN
cord-023095-4dannjjm	2392	5	)	)	-RRB-
cord-023095-4dannjjm	2392	6	to	to	IN
cord-023095-4dannjjm	2392	7	isoechoic	isoechoic	NNP
cord-023095-4dannjjm	2392	8	(	(	-LRB-
cord-023095-4dannjjm	2392	9	9/13	9/13	CD
cord-023095-4dannjjm	2392	10	)	)	-RRB-
cord-023095-4dannjjm	2392	11	to	to	IN
cord-023095-4dannjjm	2392	12	the	the	DT
cord-023095-4dannjjm	2392	13	surrounding	surround	VBG
cord-023095-4dannjjm	2392	14	mesenterium	mesenterium	NN
cord-023095-4dannjjm	2392	15	in	in	IN
cord-023095-4dannjjm	2392	16	all	all	DT
cord-023095-4dannjjm	2392	17	cases	case	NNS
cord-023095-4dannjjm	2392	18	.	.	.
cord-023095-4dannjjm	2393	1	In	in	IN
cord-023095-4dannjjm	2393	2	3/13	3/13	CD
cord-023095-4dannjjm	2393	3	dogs	dog	NNS
cord-023095-4dannjjm	2393	4	parts	part	NNS
cord-023095-4dannjjm	2393	5	of	of	IN
cord-023095-4dannjjm	2393	6	the	the	DT
cord-023095-4dannjjm	2393	7	pancreas	pancreas	NN
cord-023095-4dannjjm	2393	8	presented	present	VBD
cord-023095-4dannjjm	2393	9	hyperechoic	hyperechoic	NNP
cord-023095-4dannjjm	2393	10	.	.	.
cord-023095-4dannjjm	2394	1	The	the	DT
cord-023095-4dannjjm	2394	2	mean	mean	NN
cord-023095-4dannjjm	2394	3	measured	measure	VBN
cord-023095-4dannjjm	2394	4	thickness	thickness	NN
cord-023095-4dannjjm	2394	5	was	be	VBD
cord-023095-4dannjjm	2394	6	0.88	0.88	CD
cord-023095-4dannjjm	2394	7	cm	cm	NNS
cord-023095-4dannjjm	2394	8	.	.	.
cord-023095-4dannjjm	2395	1	The	the	DT
cord-023095-4dannjjm	2395	2	pancreas	pancreas	NN
cord-023095-4dannjjm	2395	3	was	be	VBD
cord-023095-4dannjjm	2395	4	aspirated	aspirate	VBN
cord-023095-4dannjjm	2395	5	in	in	IN
cord-023095-4dannjjm	2395	6	12	12	CD
cord-023095-4dannjjm	2395	7	dogs	dog	NNS
cord-023095-4dannjjm	2395	8	using	use	VBG
cord-023095-4dannjjm	2395	9	a	a	DT
cord-023095-4dannjjm	2395	10	transgastric	transgastric	JJ
cord-023095-4dannjjm	2395	11	approach	approach	NN
cord-023095-4dannjjm	2395	12	(	(	-LRB-
cord-023095-4dannjjm	2395	13	3	3	CD
cord-023095-4dannjjm	2395	14	)	)	-RRB-
cord-023095-4dannjjm	2395	15	or	or	CC
cord-023095-4dannjjm	2395	16	transduodenal	transduodenal	JJ
cord-023095-4dannjjm	2395	17	approach	approach	NN
cord-023095-4dannjjm	2395	18	(	(	-LRB-
cord-023095-4dannjjm	2395	19	9	9	CD
cord-023095-4dannjjm	2395	20	)	)	-RRB-
cord-023095-4dannjjm	2395	21	.	.	.
cord-023095-4dannjjm	2396	1	Duodenal	Duodenal	NNP
cord-023095-4dannjjm	2396	2	transmural	transmural	NNP
cord-023095-4dannjjm	2396	3	puncture	puncture	NN
cord-023095-4dannjjm	2396	4	was	be	VBD
cord-023095-4dannjjm	2396	5	not	not	RB
cord-023095-4dannjjm	2396	6	accomplished	accomplish	VBN
cord-023095-4dannjjm	2396	7	in	in	IN
cord-023095-4dannjjm	2396	8	1	1	CD
cord-023095-4dannjjm	2396	9	dog	dog	NN
cord-023095-4dannjjm	2396	10	where	where	WRB
cord-023095-4dannjjm	2396	11	a	a	DT
cord-023095-4dannjjm	2396	12	re	re	NN
cord-023095-4dannjjm	2396	13	-	-	JJ
cord-023095-4dannjjm	2396	14	sterilized	sterilized	JJ
cord-023095-4dannjjm	2396	15	needle	needle	NN
cord-023095-4dannjjm	2396	16	was	be	VBD
cord-023095-4dannjjm	2396	17	used	use	VBN
cord-023095-4dannjjm	2396	18	.	.	.
cord-023095-4dannjjm	2397	1	A	a	DT
cord-023095-4dannjjm	2397	2	minimal	minimal	JJ
cord-023095-4dannjjm	2397	3	amount	amount	NN
cord-023095-4dannjjm	2397	4	of	of	IN
cord-023095-4dannjjm	2397	5	peripancreatic	peripancreatic	JJ
cord-023095-4dannjjm	2397	6	fluid	fluid	NN
cord-023095-4dannjjm	2397	7	was	be	VBD
cord-023095-4dannjjm	2397	8	observed	observe	VBN
cord-023095-4dannjjm	2397	9	in	in	IN
cord-023095-4dannjjm	2397	10	1/12	1/12	CD
cord-023095-4dannjjm	2397	11	dogs	dog	NNS
cord-023095-4dannjjm	2397	12	after	after	IN
cord-023095-4dannjjm	2397	13	EUS	EUS	NNP
cord-023095-4dannjjm	2397	14	FNA	FNA	NNP
cord-023095-4dannjjm	2397	15	.	.	.
cord-023095-4dannjjm	2398	1	All	all	DT
cord-023095-4dannjjm	2398	2	dogs	dog	NNS
cord-023095-4dannjjm	2398	3	recovered	recover	VBD
cord-023095-4dannjjm	2398	4	uneventfully	uneventfully	RB
cord-023095-4dannjjm	2398	5	and	and	CC
cord-023095-4dannjjm	2398	6	required	require	VBD
cord-023095-4dannjjm	2398	7	no	no	DT
cord-023095-4dannjjm	2398	8	further	further	JJ
cord-023095-4dannjjm	2398	9	analgesia	analgesia	NN
cord-023095-4dannjjm	2398	10	.	.	.
cord-023095-4dannjjm	2399	1	All	all	DT
cord-023095-4dannjjm	2399	2	laboratory	laboratory	NN
cord-023095-4dannjjm	2399	3	results	result	NNS
cord-023095-4dannjjm	2399	4	including	include	VBG
cord-023095-4dannjjm	2399	5	the	the	DT
cord-023095-4dannjjm	2399	6	spec	spec	NN
cord-023095-4dannjjm	2399	7	cPL	cPL	NNPS
cord-023095-4dannjjm	2399	8	s	s	POS
cord-023095-4dannjjm	2399	9	measurements	measurement	NNS
cord-023095-4dannjjm	2399	10	were	be	VBD
cord-023095-4dannjjm	2399	11	within	within	IN
cord-023095-4dannjjm	2399	12	reference	reference	NN
cord-023095-4dannjjm	2399	13	ranges	range	VBZ
cord-023095-4dannjjm	2399	14	on	on	IN
cord-023095-4dannjjm	2399	15	all	all	DT
cord-023095-4dannjjm	2399	16	three	three	CD
cord-023095-4dannjjm	2399	17	time	time	NN
cord-023095-4dannjjm	2399	18	points	point	NNS
cord-023095-4dannjjm	2399	19	.	.	.
cord-023095-4dannjjm	2400	1	Cytologically	cytologically	RB
cord-023095-4dannjjm	2400	2	,	,	,
cord-023095-4dannjjm	2400	3	conglomerates	conglomerate	NNS
cord-023095-4dannjjm	2400	4	of	of	IN
cord-023095-4dannjjm	2400	5	exocrine	exocrine	JJ
cord-023095-4dannjjm	2400	6	pancreatic	pancreatic	NN
cord-023095-4dannjjm	2400	7	cells	cell	NNS
cord-023095-4dannjjm	2400	8	were	be	VBD
cord-023095-4dannjjm	2400	9	seen	see	VBN
cord-023095-4dannjjm	2400	10	in	in	IN
cord-023095-4dannjjm	2400	11	8/12	8/12	CD
cord-023095-4dannjjm	2400	12	cases	case	NNS
cord-023095-4dannjjm	2400	13	,	,	,
cord-023095-4dannjjm	2400	14	duodenal	duodenal	JJ
cord-023095-4dannjjm	2400	15	villous	villous	NN
cord-023095-4dannjjm	2400	16	epithelial	epithelial	JJ
cord-023095-4dannjjm	2400	17	cells	cell	NNS
cord-023095-4dannjjm	2400	18	were	be	VBD
cord-023095-4dannjjm	2400	19	seen	see	VBN
cord-023095-4dannjjm	2400	20	in	in	IN
cord-023095-4dannjjm	2400	21	11/12	11/12	CD
cord-023095-4dannjjm	2400	22	cases	case	NNS
cord-023095-4dannjjm	2400	23	.	.	.
cord-023095-4dannjjm	2401	1	In	in	IN
cord-023095-4dannjjm	2401	2	1	1	CD
cord-023095-4dannjjm	2401	3	dog	dog	NN
cord-023095-4dannjjm	2401	4	the	the	DT
cord-023095-4dannjjm	2401	5	aspirated	aspirated	JJ
cord-023095-4dannjjm	2401	6	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	2401	7	material	material	NN
cord-023095-4dannjjm	2401	8	was	be	VBD
cord-023095-4dannjjm	2401	9	sufficient	sufficient	JJ
cord-023095-4dannjjm	2401	10	for	for	IN
cord-023095-4dannjjm	2401	11	a	a	DT
cord-023095-4dannjjm	2401	12	histological	histological	JJ
cord-023095-4dannjjm	2401	13	assessment	assessment	NN
cord-023095-4dannjjm	2401	14	.	.	.
cord-023095-4dannjjm	2402	1	The	the	DT
cord-023095-4dannjjm	2402	2	8	8	CD
cord-023095-4dannjjm	2402	3	aspirates	aspirate	NNS
cord-023095-4dannjjm	2402	4	with	with	IN
cord-023095-4dannjjm	2402	5	exocrine	exocrine	JJ
cord-023095-4dannjjm	2402	6	pancreatic	pancreatic	NN
cord-023095-4dannjjm	2402	7	cells	cell	NNS
cord-023095-4dannjjm	2402	8	on	on	IN
cord-023095-4dannjjm	2402	9	cytology	cytology	NN
cord-023095-4dannjjm	2402	10	were	be	VBD
cord-023095-4dannjjm	2402	11	obtained	obtain	VBN
cord-023095-4dannjjm	2402	12	by	by	IN
cord-023095-4dannjjm	2402	13	transgastric	transgastric	NNP
cord-023095-4dannjjm	2402	14	(	(	-LRB-
cord-023095-4dannjjm	2402	15	4	4	CD
cord-023095-4dannjjm	2402	16	)	)	-RRB-
cord-023095-4dannjjm	2402	17	and	and	CC
cord-023095-4dannjjm	2402	18	transduodenal	transduodenal	NNP
cord-023095-4dannjjm	2402	19	(	(	-LRB-
cord-023095-4dannjjm	2402	20	4	4	CD
cord-023095-4dannjjm	2402	21	)	)	-RRB-
cord-023095-4dannjjm	2402	22	aspirations	aspiration	NNS
cord-023095-4dannjjm	2402	23	.	.	.
cord-023095-4dannjjm	2403	1	In	in	IN
cord-023095-4dannjjm	2403	2	conclusion	conclusion	NN
cord-023095-4dannjjm	2403	3	,	,	,
cord-023095-4dannjjm	2403	4	(	(	-LRB-
cord-023095-4dannjjm	2403	5	1	1	LS
cord-023095-4dannjjm	2403	6	)	)	-RRB-
cord-023095-4dannjjm	2403	7	EUS	eus	NN
cord-023095-4dannjjm	2403	8	examination	examination	NN
cord-023095-4dannjjm	2403	9	of	of	IN
cord-023095-4dannjjm	2403	10	the	the	DT
cord-023095-4dannjjm	2403	11	abdomen	abdomen	NN
cord-023095-4dannjjm	2403	12	is	be	VBZ
cord-023095-4dannjjm	2403	13	feasible	feasible	JJ
cord-023095-4dannjjm	2403	14	in	in	IN
cord-023095-4dannjjm	2403	15	medium	medium	JJ
cord-023095-4dannjjm	2403	16	-	-	HYPH
cord-023095-4dannjjm	2403	17	sized	sized	JJ
cord-023095-4dannjjm	2403	18	dogs	dog	NNS
cord-023095-4dannjjm	2403	19	,	,	,
cord-023095-4dannjjm	2403	20	(	(	-LRB-
cord-023095-4dannjjm	2403	21	2	2	LS
cord-023095-4dannjjm	2403	22	)	)	-RRB-
cord-023095-4dannjjm	2403	23	the	the	DT
cord-023095-4dannjjm	2403	24	healthy	healthy	JJ
cord-023095-4dannjjm	2403	25	canine	canine	JJ
cord-023095-4dannjjm	2403	26	pancreas	pancrea	NNS
cord-023095-4dannjjm	2403	27	can	can	MD
cord-023095-4dannjjm	2403	28	be	be	VB
cord-023095-4dannjjm	2403	29	difficult	difficult	JJ
cord-023095-4dannjjm	2403	30	to	to	TO
cord-023095-4dannjjm	2403	31	visualize	visualize	VB
cord-023095-4dannjjm	2403	32	completely	completely	RB
cord-023095-4dannjjm	2403	33	,	,	,
cord-023095-4dannjjm	2403	34	and	and	CC
cord-023095-4dannjjm	2403	35	(	(	-LRB-
cord-023095-4dannjjm	2403	36	3	3	LS
cord-023095-4dannjjm	2403	37	)	)	-RRB-
cord-023095-4dannjjm	2403	38	EUS	eus	NN
cord-023095-4dannjjm	2403	39	-	-	HYPH
cord-023095-4dannjjm	2403	40	guided	guide	VBN
cord-023095-4dannjjm	2403	41	pancreatic	pancreatic	NN
cord-023095-4dannjjm	2403	42	FNA	FNA	NNP
cord-023095-4dannjjm	2403	43	using	use	VBG
cord-023095-4dannjjm	2403	44	a	a	DT
cord-023095-4dannjjm	2403	45	19	19	CD
cord-023095-4dannjjm	2403	46	G	g	NN
cord-023095-4dannjjm	2403	47	needle	needle	NN
cord-023095-4dannjjm	2403	48	is	be	VBZ
cord-023095-4dannjjm	2403	49	a	a	DT
cord-023095-4dannjjm	2403	50	safe	safe	JJ
cord-023095-4dannjjm	2403	51	procedure	procedure	NN
cord-023095-4dannjjm	2403	52	in	in	IN
cord-023095-4dannjjm	2403	53	healthy	healthy	JJ
cord-023095-4dannjjm	2403	54	dogs	dog	NNS
cord-023095-4dannjjm	2403	55	.	.	.
cord-023095-4dannjjm	2404	1	Studies	study	NNS
cord-023095-4dannjjm	2404	2	evaluating	evaluate	VBG
cord-023095-4dannjjm	2404	3	its	-PRON-	PRP$
cord-023095-4dannjjm	2404	4	use	use	NN
cord-023095-4dannjjm	2404	5	in	in	IN
cord-023095-4dannjjm	2404	6	dogs	dog	NNS
cord-023095-4dannjjm	2404	7	with	with	IN
cord-023095-4dannjjm	2404	8	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	2404	9	disease	disease	NN
cord-023095-4dannjjm	2404	10	are	be	VBP
cord-023095-4dannjjm	2404	11	warranted	warrant	VBN
cord-023095-4dannjjm	2404	12	to	to	TO
cord-023095-4dannjjm	2404	13	assess	assess	VB
cord-023095-4dannjjm	2404	14	its	-PRON-	PRP$
cord-023095-4dannjjm	2404	15	clinical	clinical	JJ
cord-023095-4dannjjm	2404	16	utility	utility	NN
cord-023095-4dannjjm	2404	17	.	.	.
cord-023095-4dannjjm	2405	1	Miniature	Miniature	NNP
cord-023095-4dannjjm	2405	2	Schnauzers	Schnauzers	NNPS
cord-023095-4dannjjm	2405	3	have	have	VBP
cord-023095-4dannjjm	2405	4	a	a	DT
cord-023095-4dannjjm	2405	5	high	high	JJ
cord-023095-4dannjjm	2405	6	prevalence	prevalence	NN
cord-023095-4dannjjm	2405	7	of	of	IN
cord-023095-4dannjjm	2405	8	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	2405	9	hyperlipidemia	hyperlipidemia	NN
cord-023095-4dannjjm	2405	10	,	,	,
cord-023095-4dannjjm	2405	11	which	which	WDT
cord-023095-4dannjjm	2405	12	is	be	VBZ
cord-023095-4dannjjm	2405	13	characterized	characterize	VBN
cord-023095-4dannjjm	2405	14	by	by	IN
cord-023095-4dannjjm	2405	15	an	an	DT
cord-023095-4dannjjm	2405	16	increased	increase	VBN
cord-023095-4dannjjm	2405	17	serum	serum	NN
cord-023095-4dannjjm	2405	18	triglyceride	triglyceride	NN
cord-023095-4dannjjm	2405	19	(	(	-LRB-
cord-023095-4dannjjm	2405	20	TG	TG	NNP
cord-023095-4dannjjm	2405	21	)	)	-RRB-
cord-023095-4dannjjm	2405	22	concentration	concentration	NN
cord-023095-4dannjjm	2405	23	,	,	,
cord-023095-4dannjjm	2405	24	with	with	IN
cord-023095-4dannjjm	2405	25	or	or	CC
cord-023095-4dannjjm	2405	26	without	without	IN
cord-023095-4dannjjm	2405	27	an	an	DT
cord-023095-4dannjjm	2405	28	increased	increase	VBN
cord-023095-4dannjjm	2405	29	serum	serum	NN
cord-023095-4dannjjm	2405	30	cholesterol	cholesterol	NN
cord-023095-4dannjjm	2405	31	(	(	-LRB-
cord-023095-4dannjjm	2405	32	CHOL	CHOL	NNP
cord-023095-4dannjjm	2405	33	)	)	-RRB-
cord-023095-4dannjjm	2405	34	concentration	concentration	NN
cord-023095-4dannjjm	2405	35	.	.	.
cord-023095-4dannjjm	2406	1	A	a	DT
cord-023095-4dannjjm	2406	2	common	common	JJ
cord-023095-4dannjjm	2406	3	initial	initial	JJ
cord-023095-4dannjjm	2406	4	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	2406	5	approach	approach	NN
cord-023095-4dannjjm	2406	6	for	for	IN
cord-023095-4dannjjm	2406	7	the	the	DT
cord-023095-4dannjjm	2406	8	management	management	NN
cord-023095-4dannjjm	2406	9	of	of	IN
cord-023095-4dannjjm	2406	10	hyperlipidemia	hyperlipidemia	NN
cord-023095-4dannjjm	2406	11	is	be	VBZ
cord-023095-4dannjjm	2406	12	the	the	DT
cord-023095-4dannjjm	2406	13	use	use	NN
cord-023095-4dannjjm	2406	14	of	of	IN
cord-023095-4dannjjm	2406	15	a	a	DT
cord-023095-4dannjjm	2406	16	low	low	JJ
cord-023095-4dannjjm	2406	17	-	-	HYPH
cord-023095-4dannjjm	2406	18	fat	fat	NN
cord-023095-4dannjjm	2406	19	diet	diet	NN
cord-023095-4dannjjm	2406	20	.	.	.
cord-023095-4dannjjm	2407	1	Also	also	RB
cord-023095-4dannjjm	2407	2	,	,	,
cord-023095-4dannjjm	2407	3	it	-PRON-	PRP
cord-023095-4dannjjm	2407	4	is	be	VBZ
cord-023095-4dannjjm	2407	5	believed	believe	VBN
cord-023095-4dannjjm	2407	6	that	that	IN
cord-023095-4dannjjm	2407	7	low	low	JJ
cord-023095-4dannjjm	2407	8	-	-	HYPH
cord-023095-4dannjjm	2407	9	fat	fat	NN
cord-023095-4dannjjm	2407	10	diets	diet	NNS
cord-023095-4dannjjm	2407	11	may	may	MD
cord-023095-4dannjjm	2407	12	be	be	VB
cord-023095-4dannjjm	2407	13	beneficial	beneficial	JJ
cord-023095-4dannjjm	2407	14	in	in	IN
cord-023095-4dannjjm	2407	15	the	the	DT
cord-023095-4dannjjm	2407	16	treatment	treatment	NN
cord-023095-4dannjjm	2407	17	of	of	IN
cord-023095-4dannjjm	2407	18	pancreatitis	pancreatitis	NN
cord-023095-4dannjjm	2407	19	in	in	IN
cord-023095-4dannjjm	2407	20	dogs	dog	NNS
cord-023095-4dannjjm	2407	21	.	.	.
cord-023095-4dannjjm	2408	1	However	however	RB
cord-023095-4dannjjm	2408	2	,	,	,
cord-023095-4dannjjm	2408	3	the	the	DT
cord-023095-4dannjjm	2408	4	efficacy	efficacy	NN
cord-023095-4dannjjm	2408	5	of	of	IN
cord-023095-4dannjjm	2408	6	this	this	DT
cord-023095-4dannjjm	2408	7	approach	approach	NN
cord-023095-4dannjjm	2408	8	has	have	VBZ
cord-023095-4dannjjm	2408	9	not	not	RB
cord-023095-4dannjjm	2408	10	been	be	VBN
cord-023095-4dannjjm	2408	11	evaluated	evaluate	VBN
cord-023095-4dannjjm	2408	12	for	for	IN
cord-023095-4dannjjm	2408	13	either	either	DT
cord-023095-4dannjjm	2408	14	condition	condition	NN
cord-023095-4dannjjm	2408	15	.	.	.
cord-023095-4dannjjm	2409	1	The	the	DT
cord-023095-4dannjjm	2409	2	aim	aim	NN
cord-023095-4dannjjm	2409	3	of	of	IN
cord-023095-4dannjjm	2409	4	the	the	DT
cord-023095-4dannjjm	2409	5	present	present	JJ
cord-023095-4dannjjm	2409	6	study	study	NN
cord-023095-4dannjjm	2409	7	was	be	VBD
cord-023095-4dannjjm	2409	8	to	to	TO
cord-023095-4dannjjm	2409	9	evaluate	evaluate	VB
cord-023095-4dannjjm	2409	10	the	the	DT
cord-023095-4dannjjm	2409	11	effect	effect	NN
cord-023095-4dannjjm	2409	12	of	of	IN
cord-023095-4dannjjm	2409	13	a	a	DT
cord-023095-4dannjjm	2409	14	commercially	commercially	RB
cord-023095-4dannjjm	2409	15	available	available	JJ
cord-023095-4dannjjm	2409	16	low	low	JJ
cord-023095-4dannjjm	2409	17	-	-	HYPH
cord-023095-4dannjjm	2409	18	fat	fat	NN
cord-023095-4dannjjm	2409	19	diet	diet	NN
cord-023095-4dannjjm	2409	20	on	on	IN
cord-023095-4dannjjm	2409	21	serum	serum	NN
cord-023095-4dannjjm	2409	22	concentrations	concentration	NNS
cord-023095-4dannjjm	2409	23	of	of	IN
cord-023095-4dannjjm	2409	24	TG	TG	NNP
cord-023095-4dannjjm	2409	25	,	,	,
cord-023095-4dannjjm	2409	26	CHOL	CHOL	NNP
cord-023095-4dannjjm	2409	27	,	,	,
cord-023095-4dannjjm	2409	28	and	and	CC
cord-023095-4dannjjm	2409	29	canine	canine	JJ
cord-023095-4dannjjm	2409	30	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	2409	31	lipase	lipase	NN
cord-023095-4dannjjm	2409	32	immunoreactivity	immunoreactivity	NN
cord-023095-4dannjjm	2409	33	(	(	-LRB-
cord-023095-4dannjjm	2409	34	cPLI	cpli	NN
cord-023095-4dannjjm	2409	35	;	;	,
cord-023095-4dannjjm	2409	36	measured	measure	VBN
cord-023095-4dannjjm	2409	37	as	as	IN
cord-023095-4dannjjm	2409	38	Spec	Spec	NNP
cord-023095-4dannjjm	2409	39	cPL	cPL	NNS
cord-023095-4dannjjm	2409	40	s	s	NNP
cord-023095-4dannjjm	2409	41	)	)	-RRB-
cord-023095-4dannjjm	2409	42	in	in	IN
cord-023095-4dannjjm	2409	43	apparently	apparently	RB
cord-023095-4dannjjm	2409	44	healthy	healthy	JJ
cord-023095-4dannjjm	2409	45	Miniature	Miniature	NNP
cord-023095-4dannjjm	2409	46	Schnauzers	Schnauzers	NNPS
cord-023095-4dannjjm	2409	47	with	with	IN
cord-023095-4dannjjm	2409	48	hypertriglyceridemia	hypertriglyceridemia	NN
cord-023095-4dannjjm	2409	49	.	.	.
cord-023095-4dannjjm	2410	1	Blood	blood	NN
cord-023095-4dannjjm	2410	2	samples	sample	NNS
cord-023095-4dannjjm	2410	3	were	be	VBD
cord-023095-4dannjjm	2410	4	collected	collect	VBN
cord-023095-4dannjjm	2410	5	from	from	IN
cord-023095-4dannjjm	2410	6	15	15	CD
cord-023095-4dannjjm	2410	7	apparently	apparently	RB
cord-023095-4dannjjm	2410	8	healthy	healthy	JJ
cord-023095-4dannjjm	2410	9	Miniature	Miniature	NNP
cord-023095-4dannjjm	2410	10	Schnauzers	Schnauzers	NNPS
cord-023095-4dannjjm	2410	11	with	with	IN
cord-023095-4dannjjm	2410	12	hypertriglyceridemia	hypertriglyceridemia	NN
cord-023095-4dannjjm	2410	13	(	(	-LRB-
cord-023095-4dannjjm	2410	14	serum	serum	NN
cord-023095-4dannjjm	2410	15	triglyceride	triglyceride	NN
cord-023095-4dannjjm	2410	16	concentrations	concentration	NNS
cord-023095-4dannjjm	2410	17	4	4	CD
cord-023095-4dannjjm	2410	18	108	108	CD
cord-023095-4dannjjm	2410	19	mg	mg	NN
cord-023095-4dannjjm	2410	20	/	/	SYM
cord-023095-4dannjjm	2410	21	dL	dl	NN
cord-023095-4dannjjm	2410	22	)	)	-RRB-
cord-023095-4dannjjm	2410	23	.	.	.
cord-023095-4dannjjm	2411	1	Common	common	JJ
cord-023095-4dannjjm	2411	2	causes	cause	NNS
cord-023095-4dannjjm	2411	3	of	of	IN
cord-023095-4dannjjm	2411	4	secondary	secondary	JJ
cord-023095-4dannjjm	2411	5	hyperlipidemia	hyperlipidemia	NN
cord-023095-4dannjjm	2411	6	were	be	VBD
cord-023095-4dannjjm	2411	7	excluded	exclude	VBN
cord-023095-4dannjjm	2411	8	based	base	VBN
cord-023095-4dannjjm	2411	9	on	on	IN
cord-023095-4dannjjm	2411	10	historical	historical	JJ
cord-023095-4dannjjm	2411	11	information	information	NN
cord-023095-4dannjjm	2411	12	,	,	,
cord-023095-4dannjjm	2411	13	physical	physical	JJ
cord-023095-4dannjjm	2411	14	examination	examination	NN
cord-023095-4dannjjm	2411	15	findings	finding	NNS
cord-023095-4dannjjm	2411	16	,	,	,
cord-023095-4dannjjm	2411	17	and	and	CC
cord-023095-4dannjjm	2411	18	the	the	DT
cord-023095-4dannjjm	2411	19	measurement	measurement	NN
cord-023095-4dannjjm	2411	20	of	of	IN
cord-023095-4dannjjm	2411	21	serum	serum	NN
cord-023095-4dannjjm	2411	22	glucose	glucose	NN
cord-023095-4dannjjm	2411	23	,	,	,
cord-023095-4dannjjm	2411	24	total	total	JJ
cord-023095-4dannjjm	2411	25	T4	T4	NNP
cord-023095-4dannjjm	2411	26	,	,	,
cord-023095-4dannjjm	2411	27	and	and	CC
cord-023095-4dannjjm	2411	28	free	free	JJ
cord-023095-4dannjjm	2411	29	T4	T4	NNP
cord-023095-4dannjjm	2411	30	(	(	-LRB-
cord-023095-4dannjjm	2411	31	by	by	IN
cord-023095-4dannjjm	2411	32	ED	ED	NNP
cord-023095-4dannjjm	2411	33	)	)	-RRB-
cord-023095-4dannjjm	2411	34	concentrations	concentration	NNS
cord-023095-4dannjjm	2411	35	.	.	.
cord-023095-4dannjjm	2412	1	The	the	DT
cord-023095-4dannjjm	2412	2	owners	owner	NNS
cord-023095-4dannjjm	2412	3	of	of	IN
cord-023095-4dannjjm	2412	4	the	the	DT
cord-023095-4dannjjm	2412	5	dogs	dog	NNS
cord-023095-4dannjjm	2412	6	were	be	VBD
cord-023095-4dannjjm	2412	7	asked	ask	VBN
cord-023095-4dannjjm	2412	8	to	to	TO
cord-023095-4dannjjm	2412	9	switch	switch	VB
cord-023095-4dannjjm	2412	10	their	-PRON-	PRP$
cord-023095-4dannjjm	2412	11	dog	dog	NN
cord-023095-4dannjjm	2412	12	to	to	IN
cord-023095-4dannjjm	2412	13	the	the	DT
cord-023095-4dannjjm	2412	14	study	study	NN
cord-023095-4dannjjm	2412	15	diet	diet	NN
cord-023095-4dannjjm	2412	16	(	(	-LRB-
cord-023095-4dannjjm	2412	17	Royal	Royal	NNP
cord-023095-4dannjjm	2412	18	Canin	Canin	NNP
cord-023095-4dannjjm	2412	19	Gastrointestinal	Gastrointestinal	NNP
cord-023095-4dannjjm	2412	20	Low	Low	NNP
cord-023095-4dannjjm	2412	21	Fat	Fat	NNP
cord-023095-4dannjjm	2412	22	s	s	NNPS
cord-023095-4dannjjm	2412	23	;	;	:
cord-023095-4dannjjm	2412	24	fat	fat	JJ
cord-023095-4dannjjm	2412	25	content	content	NN
cord-023095-4dannjjm	2412	26	:	:	:
cord-023095-4dannjjm	2412	27	18.6	18.6	CD
cord-023095-4dannjjm	2412	28	g/1,000	g/1,000	.
cord-023095-4dannjjm	2412	29	Kcal	Kcal	NNP
cord-023095-4dannjjm	2412	30	)	)	-RRB-
cord-023095-4dannjjm	2412	31	and	and	CC
cord-023095-4dannjjm	2412	32	have	have	VBP
cord-023095-4dannjjm	2412	33	a	a	DT
cord-023095-4dannjjm	2412	34	second	second	JJ
cord-023095-4dannjjm	2412	35	blood	blood	NN
cord-023095-4dannjjm	2412	36	sample	sample	NN
cord-023095-4dannjjm	2412	37	collected	collect	VBD
cord-023095-4dannjjm	2412	38	8	8	CD
cord-023095-4dannjjm	2412	39	weeks	week	NNS
cord-023095-4dannjjm	2412	40	after	after	IN
cord-023095-4dannjjm	2412	41	their	-PRON-	PRP$
cord-023095-4dannjjm	2412	42	dog	dog	NN
cord-023095-4dannjjm	2412	43	had	have	VBD
cord-023095-4dannjjm	2412	44	been	be	VBN
cord-023095-4dannjjm	2412	45	on	on	IN
cord-023095-4dannjjm	2412	46	the	the	DT
cord-023095-4dannjjm	2412	47	new	new	JJ
cord-023095-4dannjjm	2412	48	diet	diet	NN
cord-023095-4dannjjm	2412	49	.	.	.
cord-023095-4dannjjm	2413	1	All	all	DT
cord-023095-4dannjjm	2413	2	blood	blood	NN
cord-023095-4dannjjm	2413	3	samples	sample	NNS
cord-023095-4dannjjm	2413	4	were	be	VBD
cord-023095-4dannjjm	2413	5	collected	collect	VBN
cord-023095-4dannjjm	2413	6	after	after	IN
cord-023095-4dannjjm	2413	7	food	food	NN
cord-023095-4dannjjm	2413	8	had	have	VBD
cord-023095-4dannjjm	2413	9	been	be	VBN
cord-023095-4dannjjm	2413	10	withheld	withhold	VBN
cord-023095-4dannjjm	2413	11	for	for	IN
cord-023095-4dannjjm	2413	12	15	15	CD
cord-023095-4dannjjm	2413	13	hours	hour	NNS
cord-023095-4dannjjm	2413	14	.	.	.
cord-023095-4dannjjm	2414	1	Serum	serum	NN
cord-023095-4dannjjm	2414	2	TG	TG	NNP
cord-023095-4dannjjm	2414	3	,	,	,
cord-023095-4dannjjm	2414	4	CHOL	CHOL	NNP
cord-023095-4dannjjm	2414	5	,	,	,
cord-023095-4dannjjm	2414	6	and	and	CC
cord-023095-4dannjjm	2414	7	Spec	Spec	NNP
cord-023095-4dannjjm	2414	8	cPL	cPL	NNS
cord-023095-4dannjjm	2414	9	concentrations	concentration	NNS
cord-023095-4dannjjm	2414	10	were	be	VBD
cord-023095-4dannjjm	2414	11	measured	measure	VBN
cord-023095-4dannjjm	2414	12	both	both	CC
cord-023095-4dannjjm	2414	13	before	before	IN
cord-023095-4dannjjm	2414	14	and	and	CC
cord-023095-4dannjjm	2414	15	after	after	IN
cord-023095-4dannjjm	2414	16	the	the	DT
cord-023095-4dannjjm	2414	17	diet	diet	NN
cord-023095-4dannjjm	2414	18	change	change	NN
cord-023095-4dannjjm	2414	19	.	.	.
cord-023095-4dannjjm	2415	1	Results	result	NNS
cord-023095-4dannjjm	2415	2	were	be	VBD
cord-023095-4dannjjm	2415	3	compared	compare	VBN
cord-023095-4dannjjm	2415	4	between	between	IN
cord-023095-4dannjjm	2415	5	the	the	DT
cord-023095-4dannjjm	2415	6	two	two	CD
cord-023095-4dannjjm	2415	7	time	time	NN
cord-023095-4dannjjm	2415	8	-	-	HYPH
cord-023095-4dannjjm	2415	9	points	point	NNS
cord-023095-4dannjjm	2415	10	using	use	VBG
cord-023095-4dannjjm	2415	11	the	the	DT
cord-023095-4dannjjm	2415	12	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	2415	13	signed	sign	VBN
cord-023095-4dannjjm	2415	14	rank	rank	NN
cord-023095-4dannjjm	2415	15	and	and	CC
cord-023095-4dannjjm	2415	16	Fisher	Fisher	NNP
cord-023095-4dannjjm	2415	17	's	's	POS
cord-023095-4dannjjm	2415	18	exact	exact	JJ
cord-023095-4dannjjm	2415	19	tests	test	NNS
cord-023095-4dannjjm	2415	20	.	.	.
cord-023095-4dannjjm	2416	1	Serum	serum	NN
cord-023095-4dannjjm	2416	2	TG	TG	NNP
cord-023095-4dannjjm	2416	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2416	4	were	be	VBD
cord-023095-4dannjjm	2416	5	significantly	significantly	RB
cord-023095-4dannjjm	2416	6	higher	high	JJR
cord-023095-4dannjjm	2416	7	before	before	IN
cord-023095-4dannjjm	2416	8	(	(	-LRB-
cord-023095-4dannjjm	2416	9	median	median	NN
cord-023095-4dannjjm	2416	10	:	:	:
cord-023095-4dannjjm	2416	11	432	432	CD
cord-023095-4dannjjm	2416	12	mg	mg	NNP
cord-023095-4dannjjm	2416	13	/	/	SYM
cord-023095-4dannjjm	2416	14	dL	dl	NN
cord-023095-4dannjjm	2416	15	)	)	-RRB-
cord-023095-4dannjjm	2416	16	than	than	IN
cord-023095-4dannjjm	2416	17	after	after	IN
cord-023095-4dannjjm	2416	18	the	the	DT
cord-023095-4dannjjm	2416	19	diet	diet	NN
cord-023095-4dannjjm	2416	20	change	change	NN
cord-023095-4dannjjm	2416	21	(	(	-LRB-
cord-023095-4dannjjm	2416	22	median	median	NN
cord-023095-4dannjjm	2416	23	:	:	:
cord-023095-4dannjjm	2416	24	178	178	CD
cord-023095-4dannjjm	2416	25	mg	mg	NNP
cord-023095-4dannjjm	2416	26	/	/	SYM
cord-023095-4dannjjm	2416	27	dL	dl	NN
cord-023095-4dannjjm	2416	28	;	;	:
cord-023095-4dannjjm	2416	29	p	p	NN
cord-023095-4dannjjm	2416	30	5	5	CD
cord-023095-4dannjjm	2416	31	0.003	0.003	CD
cord-023095-4dannjjm	2416	32	)	)	-RRB-
cord-023095-4dannjjm	2416	33	.	.	.
cord-023095-4dannjjm	2417	1	The	the	DT
cord-023095-4dannjjm	2417	2	proportion	proportion	NN
cord-023095-4dannjjm	2417	3	of	of	IN
cord-023095-4dannjjm	2417	4	dogs	dog	NNS
cord-023095-4dannjjm	2417	5	with	with	IN
cord-023095-4dannjjm	2417	6	hypertriglyceridemia	hypertriglyceridemia	NN
cord-023095-4dannjjm	2417	7	was	be	VBD
cord-023095-4dannjjm	2417	8	significantly	significantly	RB
cord-023095-4dannjjm	2417	9	higher	high	JJR
cord-023095-4dannjjm	2417	10	before	before	IN
cord-023095-4dannjjm	2417	11	(	(	-LRB-
cord-023095-4dannjjm	2417	12	15/15	15/15	CD
cord-023095-4dannjjm	2417	13	)	)	-RRB-
cord-023095-4dannjjm	2417	14	than	than	IN
cord-023095-4dannjjm	2417	15	after	after	IN
cord-023095-4dannjjm	2417	16	the	the	DT
cord-023095-4dannjjm	2417	17	diet	diet	NN
cord-023095-4dannjjm	2417	18	change	change	NN
cord-023095-4dannjjm	2417	19	(	(	-LRB-
cord-023095-4dannjjm	2417	20	10/15	10/15	CD
cord-023095-4dannjjm	2417	21	;	;	:
cord-023095-4dannjjm	2417	22	p	p	NN
cord-023095-4dannjjm	2417	23	5	5	CD
cord-023095-4dannjjm	2417	24	0.042	0.042	CD
cord-023095-4dannjjm	2417	25	)	)	-RRB-
cord-023095-4dannjjm	2417	26	.	.	.
cord-023095-4dannjjm	2418	1	Also	also	RB
cord-023095-4dannjjm	2418	2	,	,	,
cord-023095-4dannjjm	2418	3	the	the	DT
cord-023095-4dannjjm	2418	4	proportion	proportion	NN
cord-023095-4dannjjm	2418	5	of	of	IN
cord-023095-4dannjjm	2418	6	dogs	dog	NNS
cord-023095-4dannjjm	2418	7	with	with	IN
cord-023095-4dannjjm	2418	8	serum	serum	NN
cord-023095-4dannjjm	2418	9	TG	TG	NNP
cord-023095-4dannjjm	2418	10	4	4	CD
cord-023095-4dannjjm	2418	11	500	500	CD
cord-023095-4dannjjm	2419	1	mg	mg	NNP
cord-023095-4dannjjm	2419	2	/	/	SYM
cord-023095-4dannjjm	2419	3	dL	dL	NNP
cord-023095-4dannjjm	2419	4	was	be	VBD
cord-023095-4dannjjm	2419	5	significantly	significantly	RB
cord-023095-4dannjjm	2419	6	higher	high	JJR
cord-023095-4dannjjm	2419	7	before	before	IN
cord-023095-4dannjjm	2419	8	(	(	-LRB-
cord-023095-4dannjjm	2419	9	6/15	6/15	CD
cord-023095-4dannjjm	2419	10	)	)	-RRB-
cord-023095-4dannjjm	2419	11	than	than	IN
cord-023095-4dannjjm	2419	12	after	after	IN
cord-023095-4dannjjm	2419	13	the	the	DT
cord-023095-4dannjjm	2419	14	diet	diet	NN
cord-023095-4dannjjm	2419	15	change	change	NN
cord-023095-4dannjjm	2419	16	(	(	-LRB-
cord-023095-4dannjjm	2419	17	0/15	0/15	CD
cord-023095-4dannjjm	2419	18	;	;	:
cord-023095-4dannjjm	2419	19	p	p	NN
cord-023095-4dannjjm	2419	20	5	5	CD
cord-023095-4dannjjm	2419	21	0.016	0.016	CD
cord-023095-4dannjjm	2419	22	)	)	-RRB-
cord-023095-4dannjjm	2419	23	.	.	.
cord-023095-4dannjjm	2420	1	Serum	serum	NN
cord-023095-4dannjjm	2420	2	CHOL	CHOL	NNP
cord-023095-4dannjjm	2420	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2420	4	were	be	VBD
cord-023095-4dannjjm	2420	5	significantly	significantly	RB
cord-023095-4dannjjm	2420	6	higher	high	JJR
cord-023095-4dannjjm	2420	7	before	before	IN
cord-023095-4dannjjm	2420	8	(	(	-LRB-
cord-023095-4dannjjm	2420	9	median	median	NN
cord-023095-4dannjjm	2420	10	:	:	:
cord-023095-4dannjjm	2420	11	296	296	CD
cord-023095-4dannjjm	2420	12	mg	mg	NNP
cord-023095-4dannjjm	2420	13	/	/	SYM
cord-023095-4dannjjm	2420	14	dL	dl	NN
cord-023095-4dannjjm	2420	15	)	)	-RRB-
cord-023095-4dannjjm	2420	16	than	than	IN
cord-023095-4dannjjm	2420	17	after	after	IN
cord-023095-4dannjjm	2420	18	the	the	DT
cord-023095-4dannjjm	2420	19	diet	diet	NN
cord-023095-4dannjjm	2420	20	change	change	NN
cord-023095-4dannjjm	2420	21	(	(	-LRB-
cord-023095-4dannjjm	2420	22	median	median	NN
cord-023095-4dannjjm	2420	23	:	:	:
cord-023095-4dannjjm	2420	24	258	258	CD
cord-023095-4dannjjm	2420	25	mg	mg	NNP
cord-023095-4dannjjm	2420	26	/	/	SYM
cord-023095-4dannjjm	2420	27	dL	dl	NN
cord-023095-4dannjjm	2420	28	;	;	:
cord-023095-4dannjjm	2420	29	p	p	NN
cord-023095-4dannjjm	2420	30	5	5	CD
cord-023095-4dannjjm	2420	31	0.004	0.004	CD
cord-023095-4dannjjm	2420	32	)	)	-RRB-
cord-023095-4dannjjm	2420	33	.	.	.
cord-023095-4dannjjm	2421	1	The	the	DT
cord-023095-4dannjjm	2421	2	proportion	proportion	NN
cord-023095-4dannjjm	2421	3	of	of	IN
cord-023095-4dannjjm	2421	4	dogs	dog	NNS
cord-023095-4dannjjm	2421	5	with	with	IN
cord-023095-4dannjjm	2421	6	hypercholesterolemia	hypercholesterolemia	NN
cord-023095-4dannjjm	2421	7	was	be	VBD
cord-023095-4dannjjm	2421	8	significantly	significantly	RB
cord-023095-4dannjjm	2421	9	higher	high	JJR
cord-023095-4dannjjm	2421	10	before	before	IN
cord-023095-4dannjjm	2421	11	(	(	-LRB-
cord-023095-4dannjjm	2421	12	8/15	8/15	CD
cord-023095-4dannjjm	2421	13	)	)	-RRB-
cord-023095-4dannjjm	2421	14	than	than	IN
cord-023095-4dannjjm	2421	15	after	after	IN
cord-023095-4dannjjm	2421	16	the	the	DT
cord-023095-4dannjjm	2421	17	diet	diet	NN
cord-023095-4dannjjm	2421	18	change	change	NN
cord-023095-4dannjjm	2421	19	(	(	-LRB-
cord-023095-4dannjjm	2421	20	0/15	0/15	CD
cord-023095-4dannjjm	2421	21	;	;	:
cord-023095-4dannjjm	2421	22	p	p	NN
cord-023095-4dannjjm	2421	23	5	5	CD
cord-023095-4dannjjm	2421	24	0.006	0.006	CD
cord-023095-4dannjjm	2421	25	)	)	-RRB-
cord-023095-4dannjjm	2421	26	.	.	.
cord-023095-4dannjjm	2422	1	Finally	finally	RB
cord-023095-4dannjjm	2422	2	,	,	,
cord-023095-4dannjjm	2422	3	the	the	DT
cord-023095-4dannjjm	2422	4	difference	difference	NN
cord-023095-4dannjjm	2422	5	in	in	IN
cord-023095-4dannjjm	2422	6	serum	serum	NN
cord-023095-4dannjjm	2422	7	Spec	spec	NN
cord-023095-4dannjjm	2422	8	cPL	cPL	NNS
cord-023095-4dannjjm	2422	9	concentrations	concentration	NNS
cord-023095-4dannjjm	2422	10	before	before	IN
cord-023095-4dannjjm	2422	11	(	(	-LRB-
cord-023095-4dannjjm	2422	12	median	median	NN
cord-023095-4dannjjm	2422	13	:	:	:
cord-023095-4dannjjm	2422	14	88	88	CD
cord-023095-4dannjjm	2422	15	mg	mg	NNP
cord-023095-4dannjjm	2422	16	/	/	SYM
cord-023095-4dannjjm	2422	17	L	L	NNP
cord-023095-4dannjjm	2422	18	)	)	-RRB-
cord-023095-4dannjjm	2422	19	and	and	CC
cord-023095-4dannjjm	2422	20	after	after	IN
cord-023095-4dannjjm	2422	21	the	the	DT
cord-023095-4dannjjm	2422	22	diet	diet	NN
cord-023095-4dannjjm	2422	23	change	change	NN
cord-023095-4dannjjm	2422	24	(	(	-LRB-
cord-023095-4dannjjm	2422	25	median	median	NN
cord-023095-4dannjjm	2422	26	:	:	:
cord-023095-4dannjjm	2422	27	56	56	CD
cord-023095-4dannjjm	2422	28	mg	mg	NNP
cord-023095-4dannjjm	2422	29	/	/	SYM
cord-023095-4dannjjm	2422	30	L	L	NNP
cord-023095-4dannjjm	2422	31	)	)	-RRB-
cord-023095-4dannjjm	2422	32	approached	approach	VBD
cord-023095-4dannjjm	2422	33	but	but	CC
cord-023095-4dannjjm	2422	34	did	do	VBD
cord-023095-4dannjjm	2422	35	not	not	RB
cord-023095-4dannjjm	2422	36	reach	reach	VB
cord-023095-4dannjjm	2422	37	significance	significance	NN
cord-023095-4dannjjm	2422	38	(	(	-LRB-
cord-023095-4dannjjm	2422	39	p	p	NN
cord-023095-4dannjjm	2422	40	5	5	CD
cord-023095-4dannjjm	2422	41	0.052	0.052	CD
cord-023095-4dannjjm	2422	42	)	)	-RRB-
cord-023095-4dannjjm	2422	43	.	.	.
cord-023095-4dannjjm	2423	1	Also	also	RB
cord-023095-4dannjjm	2423	2	,	,	,
cord-023095-4dannjjm	2423	3	the	the	DT
cord-023095-4dannjjm	2423	4	proportion	proportion	NN
cord-023095-4dannjjm	2423	5	of	of	IN
cord-023095-4dannjjm	2423	6	dogs	dog	NNS
cord-023095-4dannjjm	2423	7	with	with	IN
cord-023095-4dannjjm	2423	8	high	high	JJ
cord-023095-4dannjjm	2423	9	serum	serum	NN
cord-023095-4dannjjm	2423	10	Spec	spec	NN
cord-023095-4dannjjm	2423	11	cPL	cPL	NNS
cord-023095-4dannjjm	2423	12	concentrations	concentration	NNS
cord-023095-4dannjjm	2423	13	before	before	IN
cord-023095-4dannjjm	2423	14	(	(	-LRB-
cord-023095-4dannjjm	2423	15	4/15	4/15	CD
cord-023095-4dannjjm	2423	16	)	)	-RRB-
cord-023095-4dannjjm	2423	17	and	and	CC
cord-023095-4dannjjm	2423	18	after	after	IN
cord-023095-4dannjjm	2423	19	the	the	DT
cord-023095-4dannjjm	2423	20	diet	diet	NN
cord-023095-4dannjjm	2423	21	change	change	NN
cord-023095-4dannjjm	2423	22	(	(	-LRB-
cord-023095-4dannjjm	2423	23	0/15	0/15	CD
cord-023095-4dannjjm	2423	24	)	)	-RRB-
cord-023095-4dannjjm	2423	25	was	be	VBD
cord-023095-4dannjjm	2423	26	different	different	JJ
cord-023095-4dannjjm	2423	27	,	,	,
cord-023095-4dannjjm	2423	28	but	but	CC
cord-023095-4dannjjm	2423	29	this	this	DT
cord-023095-4dannjjm	2423	30	difference	difference	NN
cord-023095-4dannjjm	2423	31	was	be	VBD
cord-023095-4dannjjm	2423	32	not	not	RB
cord-023095-4dannjjm	2423	33	significant	significant	JJ
cord-023095-4dannjjm	2423	34	(	(	-LRB-
cord-023095-4dannjjm	2423	35	p	p	NN
cord-023095-4dannjjm	2423	36	5	5	CD
cord-023095-4dannjjm	2423	37	0.099	0.099	CD
cord-023095-4dannjjm	2423	38	)	)	-RRB-
cord-023095-4dannjjm	2423	39	.	.	.
cord-023095-4dannjjm	2424	1	In	in	IN
cord-023095-4dannjjm	2424	2	summary	summary	NN
cord-023095-4dannjjm	2424	3	,	,	,
cord-023095-4dannjjm	2424	4	a	a	DT
cord-023095-4dannjjm	2424	5	commercially	commercially	RB
cord-023095-4dannjjm	2424	6	available	available	JJ
cord-023095-4dannjjm	2424	7	low	low	JJ
cord-023095-4dannjjm	2424	8	-	-	HYPH
cord-023095-4dannjjm	2424	9	fat	fat	NN
cord-023095-4dannjjm	2424	10	diet	diet	NN
cord-023095-4dannjjm	2424	11	was	be	VBD
cord-023095-4dannjjm	2424	12	effective	effective	JJ
cord-023095-4dannjjm	2424	13	in	in	IN
cord-023095-4dannjjm	2424	14	reducing	reduce	VBG
cord-023095-4dannjjm	2424	15	serum	serum	NN
cord-023095-4dannjjm	2424	16	TG	TG	NNP
cord-023095-4dannjjm	2424	17	and	and	CC
cord-023095-4dannjjm	2424	18	CHOL	CHOL	NNP
cord-023095-4dannjjm	2424	19	concentrations	concentration	NNS
cord-023095-4dannjjm	2424	20	in	in	IN
cord-023095-4dannjjm	2424	21	Miniature	Miniature	NNP
cord-023095-4dannjjm	2424	22	Schnauzers	Schnauzers	NNPS
cord-023095-4dannjjm	2424	23	with	with	IN
cord-023095-4dannjjm	2424	24	hypertriglyceridemia	hypertriglyceridemia	NN
cord-023095-4dannjjm	2424	25	.	.	.
cord-023095-4dannjjm	2425	1	Toll	toll	NN
cord-023095-4dannjjm	2425	2	-	-	HYPH
cord-023095-4dannjjm	2425	3	like	like	JJ
cord-023095-4dannjjm	2425	4	receptor	receptor	NN
cord-023095-4dannjjm	2425	5	5	5	CD
cord-023095-4dannjjm	2426	1	(	(	-LRB-
cord-023095-4dannjjm	2426	2	TLR5	TLR5	NNP
cord-023095-4dannjjm	2426	3	)	)	-RRB-
cord-023095-4dannjjm	2426	4	is	be	VBZ
cord-023095-4dannjjm	2426	5	an	an	DT
cord-023095-4dannjjm	2426	6	extracellular	extracellular	JJ
cord-023095-4dannjjm	2426	7	pattern	pattern	NN
cord-023095-4dannjjm	2426	8	recognition	recognition	NN
cord-023095-4dannjjm	2426	9	receptor	receptor	NN
cord-023095-4dannjjm	2426	10	which	which	WDT
cord-023095-4dannjjm	2426	11	recognizes	recognize	VBZ
cord-023095-4dannjjm	2426	12	flagellin	flagellin	JJ
cord-023095-4dannjjm	2426	13	present	present	NN
cord-023095-4dannjjm	2426	14	in	in	IN
cord-023095-4dannjjm	2426	15	motile	motile	JJ
cord-023095-4dannjjm	2426	16	bacteria	bacteria	NNS
cord-023095-4dannjjm	2426	17	.	.	.
cord-023095-4dannjjm	2427	1	We	-PRON-	PRP
cord-023095-4dannjjm	2427	2	have	have	VBP
cord-023095-4dannjjm	2427	3	previously	previously	RB
cord-023095-4dannjjm	2427	4	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	2427	5	a	a	DT
cord-023095-4dannjjm	2427	6	significant	significant	JJ
cord-023095-4dannjjm	2427	7	association	association	NN
cord-023095-4dannjjm	2427	8	between	between	IN
cord-023095-4dannjjm	2427	9	three	three	CD
cord-023095-4dannjjm	2427	10	non	non	JJ
cord-023095-4dannjjm	2427	11	-	-	JJ
cord-023095-4dannjjm	2427	12	synonymous	synonymous	JJ
cord-023095-4dannjjm	2427	13	single	single	JJ
cord-023095-4dannjjm	2427	14	nucleotide	nucleotide	JJ
cord-023095-4dannjjm	2427	15	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2427	16	(	(	-LRB-
cord-023095-4dannjjm	2427	17	SNPs	SNPs	NNP
cord-023095-4dannjjm	2427	18	)	)	-RRB-
cord-023095-4dannjjm	2427	19	in	in	IN
cord-023095-4dannjjm	2427	20	the	the	DT
cord-023095-4dannjjm	2427	21	TLR5	TLR5	NNP
cord-023095-4dannjjm	2427	22	gene	gene	NN
cord-023095-4dannjjm	2427	23	(	(	-LRB-
cord-023095-4dannjjm	2427	24	G22A	g22a	NN
cord-023095-4dannjjm	2427	25	,	,	,
cord-023095-4dannjjm	2427	26	C100	C100	NNP
cord-023095-4dannjjm	2427	27	T	T	NNP
cord-023095-4dannjjm	2427	28	and	and	CC
cord-023095-4dannjjm	2427	29	T1844C	T1844C	NNP
cord-023095-4dannjjm	2427	30	)	)	-RRB-
cord-023095-4dannjjm	2427	31	and	and	CC
cord-023095-4dannjjm	2427	32	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2427	33	bowel	bowel	NN
cord-023095-4dannjjm	2427	34	disease	disease	NN
cord-023095-4dannjjm	2427	35	(	(	-LRB-
cord-023095-4dannjjm	2427	36	IBD	IBD	NNP
cord-023095-4dannjjm	2427	37	)	)	-RRB-
cord-023095-4dannjjm	2427	38	in	in	IN
cord-023095-4dannjjm	2427	39	German	german	JJ
cord-023095-4dannjjm	2427	40	shepherd	shepherd	NN
cord-023095-4dannjjm	2427	41	dogs	dog	NNS
cord-023095-4dannjjm	2427	42	(	(	-LRB-
cord-023095-4dannjjm	2427	43	GSDs	GSDs	NNP
cord-023095-4dannjjm	2427	44	)	)	-RRB-
cord-023095-4dannjjm	2427	45	.	.	.
cord-023095-4dannjjm	2428	1	Recently	recently	RB
cord-023095-4dannjjm	2428	2	,	,	,
cord-023095-4dannjjm	2428	3	we	-PRON-	PRP
cord-023095-4dannjjm	2428	4	have	have	VBP
cord-023095-4dannjjm	2428	5	confirmed	confirm	VBN
cord-023095-4dannjjm	2428	6	that	that	IN
cord-023095-4dannjjm	2428	7	two	two	CD
cord-023095-4dannjjm	2428	8	of	of	IN
cord-023095-4dannjjm	2428	9	these	these	DT
cord-023095-4dannjjm	2428	10	TLR5	TLR5	NNP
cord-023095-4dannjjm	2428	11	SNPs	SNPs	NNPS
cord-023095-4dannjjm	2428	12	(	(	-LRB-
cord-023095-4dannjjm	2428	13	C100	C100	NNP
cord-023095-4dannjjm	2428	14	T	T	NNP
cord-023095-4dannjjm	2428	15	and	and	CC
cord-023095-4dannjjm	2428	16	T1844C	T1844C	NNP
cord-023095-4dannjjm	2428	17	)	)	-RRB-
cord-023095-4dannjjm	2428	18	are	be	VBP
cord-023095-4dannjjm	2428	19	significantly	significantly	RB
cord-023095-4dannjjm	2428	20	associated	associate	VBN
cord-023095-4dannjjm	2428	21	with	with	IN
cord-023095-4dannjjm	2428	22	IBD	IBD	NNP
cord-023095-4dannjjm	2428	23	in	in	IN
cord-023095-4dannjjm	2428	24	other	other	JJ
cord-023095-4dannjjm	2428	25	canine	canine	JJ
cord-023095-4dannjjm	2428	26	breeds	breed	NNS
cord-023095-4dannjjm	2428	27	.	.	.
cord-023095-4dannjjm	2429	1	To	to	TO
cord-023095-4dannjjm	2429	2	further	further	RB
cord-023095-4dannjjm	2429	3	substantiate	substantiate	VB
cord-023095-4dannjjm	2429	4	the	the	DT
cord-023095-4dannjjm	2429	5	role	role	NN
cord-023095-4dannjjm	2429	6	of	of	IN
cord-023095-4dannjjm	2429	7	TLR5	TLR5	NNP
cord-023095-4dannjjm	2429	8	in	in	IN
cord-023095-4dannjjm	2429	9	canine	canine	JJ
cord-023095-4dannjjm	2429	10	IBD	IBD	NNP
cord-023095-4dannjjm	2429	11	functional	functional	JJ
cord-023095-4dannjjm	2429	12	analysis	analysis	NN
cord-023095-4dannjjm	2429	13	of	of	IN
cord-023095-4dannjjm	2429	14	these	these	DT
cord-023095-4dannjjm	2429	15	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2429	16	would	would	MD
cord-023095-4dannjjm	2429	17	be	be	VB
cord-023095-4dannjjm	2429	18	needed	need	VBN
cord-023095-4dannjjm	2429	19	.	.	.
cord-023095-4dannjjm	2430	1	Therefore	therefore	RB
cord-023095-4dannjjm	2430	2	the	the	DT
cord-023095-4dannjjm	2430	3	aim	aim	NN
cord-023095-4dannjjm	2430	4	of	of	IN
cord-023095-4dannjjm	2430	5	this	this	DT
cord-023095-4dannjjm	2430	6	study	study	NN
cord-023095-4dannjjm	2430	7	was	be	VBD
cord-023095-4dannjjm	2430	8	to	to	TO
cord-023095-4dannjjm	2430	9	determine	determine	VB
cord-023095-4dannjjm	2430	10	the	the	DT
cord-023095-4dannjjm	2430	11	functional	functional	JJ
cord-023095-4dannjjm	2430	12	significance	significance	NN
cord-023095-4dannjjm	2430	13	of	of	IN
cord-023095-4dannjjm	2430	14	the	the	DT
cord-023095-4dannjjm	2430	15	TLR5	TLR5	NNP
cord-023095-4dannjjm	2430	16	SNPs	snp	NNS
cord-023095-4dannjjm	2430	17	by	by	IN
cord-023095-4dannjjm	2430	18	transfecting	transfecte	VBG
cord-023095-4dannjjm	2430	19	wild	wild	JJ
cord-023095-4dannjjm	2430	20	-	-	HYPH
cord-023095-4dannjjm	2430	21	type	type	NN
cord-023095-4dannjjm	2430	22	and	and	CC
cord-023095-4dannjjm	2430	23	mutant	mutant	JJ
cord-023095-4dannjjm	2430	24	receptors	receptor	NNS
cord-023095-4dannjjm	2430	25	in	in	IN
cord-023095-4dannjjm	2430	26	to	to	IN
cord-023095-4dannjjm	2430	27	human	human	JJ
cord-023095-4dannjjm	2430	28	embryonic	embryonic	JJ
cord-023095-4dannjjm	2430	29	kidney	kidney	NN
cord-023095-4dannjjm	2430	30	cells	cell	NNS
cord-023095-4dannjjm	2430	31	(	(	-LRB-
cord-023095-4dannjjm	2430	32	HEK	HEK	NNP
cord-023095-4dannjjm	2430	33	)	)	-RRB-
cord-023095-4dannjjm	2430	34	and	and	CC
cord-023095-4dannjjm	2430	35	carrying	carry	VBG
cord-023095-4dannjjm	2430	36	out	out	RP
cord-023095-4dannjjm	2430	37	nuclear	nuclear	JJ
cord-023095-4dannjjm	2430	38	factorkappa	factorkappa	NN
cord-023095-4dannjjm	2430	39	B	b	NN
cord-023095-4dannjjm	2430	40	(	(	-LRB-
cord-023095-4dannjjm	2430	41	NF	NF	NNP
cord-023095-4dannjjm	2430	42	-	-	HYPH
cord-023095-4dannjjm	2430	43	kB	kB	NNP
cord-023095-4dannjjm	2430	44	)	)	-RRB-
cord-023095-4dannjjm	2430	45	luciferase	luciferase	NN
cord-023095-4dannjjm	2430	46	assay	assay	NN
cord-023095-4dannjjm	2430	47	and	and	CC
cord-023095-4dannjjm	2430	48	IL-8	IL-8	NNP
cord-023095-4dannjjm	2430	49	ELISA	ELISA	NNP
cord-023095-4dannjjm	2430	50	.	.	.
cord-023095-4dannjjm	2431	1	The	the	DT
cord-023095-4dannjjm	2431	2	TLR5	TLR5	NNP
cord-023095-4dannjjm	2431	3	gene	gene	NN
cord-023095-4dannjjm	2431	4	containing	contain	VBG
cord-023095-4dannjjm	2431	5	the	the	DT
cord-023095-4dannjjm	2431	6	risk	risk	NN
cord-023095-4dannjjm	2431	7	haplotype	haplotype	NN
cord-023095-4dannjjm	2431	8	for	for	IN
cord-023095-4dannjjm	2431	9	IBD	IBD	NNP
cord-023095-4dannjjm	2431	10	(	(	-LRB-
cord-023095-4dannjjm	2431	11	ACC	ACC	NNP
cord-023095-4dannjjm	2431	12	)	)	-RRB-
cord-023095-4dannjjm	2431	13	and	and	CC
cord-023095-4dannjjm	2431	14	wild	wild	JJ
cord-023095-4dannjjm	2431	15	-	-	HYPH
cord-023095-4dannjjm	2431	16	type	type	NN
cord-023095-4dannjjm	2431	17	haplotype	haplotype	NN
cord-023095-4dannjjm	2431	18	(	(	-LRB-
cord-023095-4dannjjm	2431	19	GTT	GTT	NNP
cord-023095-4dannjjm	2431	20	)	)	-RRB-
cord-023095-4dannjjm	2431	21	as	as	IN
cord-023095-4dannjjm	2431	22	determined	determine	VBN
cord-023095-4dannjjm	2431	23	by	by	IN
cord-023095-4dannjjm	2431	24	the	the	DT
cord-023095-4dannjjm	2431	25	case	case	NN
cord-023095-4dannjjm	2431	26	-	-	HYPH
cord-023095-4dannjjm	2431	27	control	control	NN
cord-023095-4dannjjm	2431	28	analysis	analysis	NN
cord-023095-4dannjjm	2431	29	in	in	IN
cord-023095-4dannjjm	2431	30	GSDs	gsds	NN
cord-023095-4dannjjm	2431	31	with	with	IN
cord-023095-4dannjjm	2431	32	IBD	IBD	NNP
cord-023095-4dannjjm	2431	33	were	be	VBD
cord-023095-4dannjjm	2431	34	cloned	clone	VBN
cord-023095-4dannjjm	2431	35	into	into	IN
cord-023095-4dannjjm	2431	36	plasmids	plasmid	NNS
cord-023095-4dannjjm	2431	37	expressing	express	VBG
cord-023095-4dannjjm	2431	38	yellow	yellow	JJ
cord-023095-4dannjjm	2431	39	-	-	HYPH
cord-023095-4dannjjm	2431	40	fluorescent	fluorescent	NN
cord-023095-4dannjjm	2431	41	protein	protein	NN
cord-023095-4dannjjm	2431	42	(	(	-LRB-
cord-023095-4dannjjm	2431	43	YFP	YFP	NNP
cord-023095-4dannjjm	2431	44	)	)	-RRB-
cord-023095-4dannjjm	2431	45	.	.	.
cord-023095-4dannjjm	2432	1	These	these	DT
cord-023095-4dannjjm	2432	2	were	be	VBD
cord-023095-4dannjjm	2432	3	then	then	RB
cord-023095-4dannjjm	2432	4	stably	stably	RB
cord-023095-4dannjjm	2432	5	transfected	transfecte	VBN
cord-023095-4dannjjm	2432	6	into	into	IN
cord-023095-4dannjjm	2432	7	HEK	HEK	NNP
cord-023095-4dannjjm	2432	8	cells	cell	NNS
cord-023095-4dannjjm	2432	9	.	.	.
cord-023095-4dannjjm	2433	1	NF	NF	NNP
cord-023095-4dannjjm	2433	2	-	-	HYPH
cord-023095-4dannjjm	2433	3	kB	kb	CD
cord-023095-4dannjjm	2433	4	activity	activity	NN
cord-023095-4dannjjm	2433	5	was	be	VBD
cord-023095-4dannjjm	2433	6	measured	measure	VBN
cord-023095-4dannjjm	2433	7	by	by	IN
cord-023095-4dannjjm	2433	8	transiently	transiently	RB
cord-023095-4dannjjm	2433	9	transfecting	transfecte	VBG
cord-023095-4dannjjm	2433	10	the	the	DT
cord-023095-4dannjjm	2433	11	cells	cell	NNS
cord-023095-4dannjjm	2433	12	with	with	IN
cord-023095-4dannjjm	2433	13	NF	NF	NNP
cord-023095-4dannjjm	2433	14	-	-	HYPH
cord-023095-4dannjjm	2433	15	kB	kb	CD
cord-023095-4dannjjm	2433	16	firefly	firefly	NN
cord-023095-4dannjjm	2433	17	and	and	CC
cord-023095-4dannjjm	2433	18	HSV	HSV	NNP
cord-023095-4dannjjm	2433	19	-	-	HYPH
cord-023095-4dannjjm	2433	20	thymidine	thymidine	NN
cord-023095-4dannjjm	2433	21	kinase	kinase	NN
cord-023095-4dannjjm	2433	22	promoter	promoter	NN
cord-023095-4dannjjm	2433	23	(	(	-LRB-
cord-023095-4dannjjm	2433	24	pRL	pRL	NNP
cord-023095-4dannjjm	2433	25	-	-	HYPH
cord-023095-4dannjjm	2433	26	TK	TK	NNP
cord-023095-4dannjjm	2433	27	)	)	-RRB-
cord-023095-4dannjjm	2433	28	renilla	renilla	NNP
cord-023095-4dannjjm	2433	29	plasmids	plasmid	NNS
cord-023095-4dannjjm	2433	30	.	.	.
cord-023095-4dannjjm	2434	1	The	the	DT
cord-023095-4dannjjm	2434	2	cells	cell	NNS
cord-023095-4dannjjm	2434	3	were	be	VBD
cord-023095-4dannjjm	2434	4	then	then	RB
cord-023095-4dannjjm	2434	5	stimulated	stimulate	VBN
cord-023095-4dannjjm	2434	6	with	with	IN
cord-023095-4dannjjm	2434	7	various	various	JJ
cord-023095-4dannjjm	2434	8	ligands	ligand	NNS
cord-023095-4dannjjm	2434	9	(	(	-LRB-
cord-023095-4dannjjm	2434	10	0.1	0.1	CD
cord-023095-4dannjjm	2434	11	mg	mg	NNP
cord-023095-4dannjjm	2434	12	/	/	SYM
cord-023095-4dannjjm	2434	13	ml	ml	NNP
cord-023095-4dannjjm	2434	14	flagellin	flagellin	NNP
cord-023095-4dannjjm	2434	15	,	,	,
cord-023095-4dannjjm	2434	16	0.01	0.01	CD
cord-023095-4dannjjm	2434	17	mg	mg	NNP
cord-023095-4dannjjm	2434	18	/	/	SYM
cord-023095-4dannjjm	2434	19	ml	ml	NNP
cord-023095-4dannjjm	2434	20	flagellin	flagellin	NNP
cord-023095-4dannjjm	2434	21	,	,	,
cord-023095-4dannjjm	2434	22	1	1	CD
cord-023095-4dannjjm	2434	23	mg	mg	NNP
cord-023095-4dannjjm	2434	24	/	/	SYM
cord-023095-4dannjjm	2434	25	ml	ml	NNP
cord-023095-4dannjjm	2434	26	LPS	LPS	NNP
cord-023095-4dannjjm	2434	27	,	,	,
cord-023095-4dannjjm	2434	28	1	1	CD
cord-023095-4dannjjm	2434	29	mg	mg	NNP
cord-023095-4dannjjm	2434	30	/	/	SYM
cord-023095-4dannjjm	2434	31	ml	ml	NNP
cord-023095-4dannjjm	2434	32	PAM3CSK	PAM3CSK	NNP
cord-023095-4dannjjm	2434	33	and	and	CC
cord-023095-4dannjjm	2434	34	media	medium	NNS
cord-023095-4dannjjm	2434	35	control	control	NN
cord-023095-4dannjjm	2434	36	)	)	-RRB-
cord-023095-4dannjjm	2434	37	.	.	.
cord-023095-4dannjjm	2435	1	Firefly	Firefly	NNP
cord-023095-4dannjjm	2435	2	and	and	CC
cord-023095-4dannjjm	2435	3	renilla	renilla	NNP
cord-023095-4dannjjm	2435	4	luciferase	luciferase	NN
cord-023095-4dannjjm	2435	5	activities	activity	NNS
cord-023095-4dannjjm	2435	6	were	be	VBD
cord-023095-4dannjjm	2435	7	measured	measure	VBN
cord-023095-4dannjjm	2435	8	using	use	VBG
cord-023095-4dannjjm	2435	9	the	the	DT
cord-023095-4dannjjm	2435	10	Dual	Dual	NNP
cord-023095-4dannjjm	2435	11	-	-	HYPH
cord-023095-4dannjjm	2435	12	Glo	Glo	NNP
cord-023095-4dannjjm	2435	13	Luciferase	Luciferase	NNP
cord-023095-4dannjjm	2435	14	Assay	Assay	NNP
cord-023095-4dannjjm	2435	15	System	System	NNP
cord-023095-4dannjjm	2435	16	(	(	-LRB-
cord-023095-4dannjjm	2435	17	Promega	Promega	NNP
cord-023095-4dannjjm	2435	18	,	,	,
cord-023095-4dannjjm	2435	19	UK	UK	NNP
cord-023095-4dannjjm	2435	20	)	)	-RRB-
cord-023095-4dannjjm	2435	21	according	accord	VBG
cord-023095-4dannjjm	2435	22	to	to	IN
cord-023095-4dannjjm	2435	23	the	the	DT
cord-023095-4dannjjm	2435	24	manufacturer	manufacturer	NN
cord-023095-4dannjjm	2435	25	's	's	POS
cord-023095-4dannjjm	2435	26	recommendations	recommendation	NNS
cord-023095-4dannjjm	2435	27	.	.	.
cord-023095-4dannjjm	2436	1	The	the	DT
cord-023095-4dannjjm	2436	2	supernatants	supernatant	NNS
cord-023095-4dannjjm	2436	3	were	be	VBD
cord-023095-4dannjjm	2436	4	harvested	harvest	VBN
cord-023095-4dannjjm	2436	5	and	and	CC
cord-023095-4dannjjm	2436	6	used	use	VBN
cord-023095-4dannjjm	2436	7	in	in	IN
cord-023095-4dannjjm	2436	8	an	an	DT
cord-023095-4dannjjm	2436	9	IL-8	IL-8	NNP
cord-023095-4dannjjm	2436	10	ELISA	ELISA	NNP
cord-023095-4dannjjm	2436	11	(	(	-LRB-
cord-023095-4dannjjm	2436	12	R&D	R&D	NNP
cord-023095-4dannjjm	2436	13	Systems	Systems	NNP
cord-023095-4dannjjm	2436	14	)	)	-RRB-
cord-023095-4dannjjm	2436	15	.	.	.
cord-023095-4dannjjm	2437	1	Human	Human	NNP
cord-023095-4dannjjm	2437	2	TLR5	TLR5	NNP
cord-023095-4dannjjm	2437	3	transfected	transfecte	VBN
cord-023095-4dannjjm	2437	4	HEK	HEK	NNP
cord-023095-4dannjjm	2437	5	cells	cell	NNS
cord-023095-4dannjjm	2437	6	(	(	-LRB-
cord-023095-4dannjjm	2437	7	Invivogen	Invivogen	NNP
cord-023095-4dannjjm	2437	8	)	)	-RRB-
cord-023095-4dannjjm	2437	9	served	serve	VBD
cord-023095-4dannjjm	2437	10	as	as	IN
cord-023095-4dannjjm	2437	11	positive	positive	JJ
cord-023095-4dannjjm	2437	12	controls	control	NNS
cord-023095-4dannjjm	2437	13	in	in	IN
cord-023095-4dannjjm	2437	14	all	all	DT
cord-023095-4dannjjm	2437	15	experiments	experiment	NNS
cord-023095-4dannjjm	2437	16	.	.	.
cord-023095-4dannjjm	2438	1	Independent	Independent	NNP
cord-023095-4dannjjm	2438	2	T	t	NN
cord-023095-4dannjjm	2438	3	-	-	HYPH
cord-023095-4dannjjm	2438	4	test	test	NN
cord-023095-4dannjjm	2438	5	was	be	VBD
cord-023095-4dannjjm	2438	6	used	use	VBN
cord-023095-4dannjjm	2438	7	to	to	TO
cord-023095-4dannjjm	2438	8	determine	determine	VB
cord-023095-4dannjjm	2438	9	the	the	DT
cord-023095-4dannjjm	2438	10	significance	significance	NN
cord-023095-4dannjjm	2438	11	of	of	IN
cord-023095-4dannjjm	2438	12	relative	relative	JJ
cord-023095-4dannjjm	2438	13	luciferase	luciferase	NN
cord-023095-4dannjjm	2438	14	activity	activity	NN
cord-023095-4dannjjm	2438	15	and	and	CC
cord-023095-4dannjjm	2438	16	IL-8	il-8	NN
cord-023095-4dannjjm	2438	17	concentration	concentration	NN
cord-023095-4dannjjm	2438	18	between	between	IN
cord-023095-4dannjjm	2438	19	wild	wild	JJ
cord-023095-4dannjjm	2438	20	-	-	HYPH
cord-023095-4dannjjm	2438	21	type	type	NN
cord-023095-4dannjjm	2438	22	and	and	CC
cord-023095-4dannjjm	2438	23	mutated	mutate	VBN
cord-023095-4dannjjm	2438	24	TLR5	TLR5	NNP
cord-023095-4dannjjm	2438	25	cells	cell	NNS
cord-023095-4dannjjm	2438	26	.	.	.
cord-023095-4dannjjm	2439	1	Although	although	IN
cord-023095-4dannjjm	2439	2	there	there	EX
cord-023095-4dannjjm	2439	3	was	be	VBD
cord-023095-4dannjjm	2439	4	no	no	DT
cord-023095-4dannjjm	2439	5	significant	significant	JJ
cord-023095-4dannjjm	2439	6	difference	difference	NN
cord-023095-4dannjjm	2439	7	between	between	IN
cord-023095-4dannjjm	2439	8	the	the	DT
cord-023095-4dannjjm	2439	9	wild	wild	JJ
cord-023095-4dannjjm	2439	10	-	-	HYPH
cord-023095-4dannjjm	2439	11	type	type	NN
cord-023095-4dannjjm	2439	12	and	and	CC
cord-023095-4dannjjm	2439	13	mutated	mutate	VBN
cord-023095-4dannjjm	2439	14	receptor	receptor	NN
cord-023095-4dannjjm	2439	15	when	when	WRB
cord-023095-4dannjjm	2439	16	they	-PRON-	PRP
cord-023095-4dannjjm	2439	17	were	be	VBD
cord-023095-4dannjjm	2439	18	stimulated	stimulate	VBN
cord-023095-4dannjjm	2439	19	with	with	IN
cord-023095-4dannjjm	2439	20	0.01	0.01	CD
cord-023095-4dannjjm	2439	21	mg	mg	NNP
cord-023095-4dannjjm	2439	22	/	/	SYM
cord-023095-4dannjjm	2439	23	ml	ml	NNS
cord-023095-4dannjjm	2439	24	of	of	IN
cord-023095-4dannjjm	2439	25	flagellin	flagellin	NNP
cord-023095-4dannjjm	2439	26	(	(	-LRB-
cord-023095-4dannjjm	2439	27	p	p	NN
cord-023095-4dannjjm	2439	28	5	5	CD
cord-023095-4dannjjm	2439	29	0.14	0.14	CD
cord-023095-4dannjjm	2439	30	)	)	-RRB-
cord-023095-4dannjjm	2439	31	,	,	,
cord-023095-4dannjjm	2439	32	there	there	EX
cord-023095-4dannjjm	2439	33	was	be	VBD
cord-023095-4dannjjm	2439	34	a	a	DT
cord-023095-4dannjjm	2439	35	significant	significant	JJ
cord-023095-4dannjjm	2439	36	increase	increase	NN
cord-023095-4dannjjm	2439	37	when	when	WRB
cord-023095-4dannjjm	2439	38	the	the	DT
cord-023095-4dannjjm	2439	39	cells	cell	NNS
cord-023095-4dannjjm	2439	40	with	with	IN
cord-023095-4dannjjm	2439	41	mutated	mutate	VBN
cord-023095-4dannjjm	2439	42	TLR5	TLR5	NNP
cord-023095-4dannjjm	2439	43	were	be	VBD
cord-023095-4dannjjm	2439	44	stimulated	stimulate	VBN
cord-023095-4dannjjm	2439	45	with	with	IN
cord-023095-4dannjjm	2439	46	0.1	0.1	CD
cord-023095-4dannjjm	2439	47	mg	mg	NNP
cord-023095-4dannjjm	2439	48	/	/	SYM
cord-023095-4dannjjm	2439	49	ml	ml	NNS
cord-023095-4dannjjm	2439	50	of	of	IN
cord-023095-4dannjjm	2439	51	flagellin	flagellin	NN
cord-023095-4dannjjm	2439	52	compared	compare	VBN
cord-023095-4dannjjm	2439	53	to	to	IN
cord-023095-4dannjjm	2439	54	the	the	DT
cord-023095-4dannjjm	2439	55	cells	cell	NNS
cord-023095-4dannjjm	2439	56	expressing	express	VBG
cord-023095-4dannjjm	2439	57	wild	wild	JJ
cord-023095-4dannjjm	2439	58	-	-	HYPH
cord-023095-4dannjjm	2439	59	type	type	NN
cord-023095-4dannjjm	2439	60	TLR5	TLR5	NNP
cord-023095-4dannjjm	2439	61	(	(	-LRB-
cord-023095-4dannjjm	2439	62	p	p	NN
cord-023095-4dannjjm	2439	63	5	5	CD
cord-023095-4dannjjm	2439	64	0.027	0.027	CD
cord-023095-4dannjjm	2439	65	)	)	-RRB-
cord-023095-4dannjjm	2439	66	.	.	.
cord-023095-4dannjjm	2440	1	Similarly	similarly	RB
cord-023095-4dannjjm	2440	2	,	,	,
cord-023095-4dannjjm	2440	3	there	there	EX
cord-023095-4dannjjm	2440	4	was	be	VBD
cord-023095-4dannjjm	2440	5	a	a	DT
cord-023095-4dannjjm	2440	6	significant	significant	JJ
cord-023095-4dannjjm	2440	7	increase	increase	NN
cord-023095-4dannjjm	2440	8	in	in	IN
cord-023095-4dannjjm	2440	9	IL-8	IL-8	NNP
cord-023095-4dannjjm	2440	10	concentration	concentration	NN
cord-023095-4dannjjm	2440	11	in	in	IN
cord-023095-4dannjjm	2440	12	the	the	DT
cord-023095-4dannjjm	2440	13	supernatants	supernatant	NNS
cord-023095-4dannjjm	2440	14	in	in	IN
cord-023095-4dannjjm	2440	15	the	the	DT
cord-023095-4dannjjm	2440	16	cells	cell	NNS
cord-023095-4dannjjm	2440	17	with	with	IN
cord-023095-4dannjjm	2440	18	the	the	DT
cord-023095-4dannjjm	2440	19	mutated	mutate	VBN
cord-023095-4dannjjm	2440	20	TLR5	TLR5	NNP
cord-023095-4dannjjm	2440	21	receptor	receptor	NN
cord-023095-4dannjjm	2440	22	when	when	WRB
cord-023095-4dannjjm	2440	23	stimulated	stimulate	VBN
cord-023095-4dannjjm	2440	24	with	with	IN
cord-023095-4dannjjm	2440	25	0.1	0.1	CD
cord-023095-4dannjjm	2440	26	mg	mg	NNP
cord-023095-4dannjjm	2440	27	/	/	SYM
cord-023095-4dannjjm	2440	28	ml	ml	FW
cord-023095-4dannjjm	2440	29	flagellin	flagellin	NN
cord-023095-4dannjjm	2440	30	compared	compare	VBN
cord-023095-4dannjjm	2440	31	to	to	IN
cord-023095-4dannjjm	2440	32	the	the	DT
cord-023095-4dannjjm	2440	33	wild	wild	JJ
cord-023095-4dannjjm	2440	34	-	-	HYPH
cord-023095-4dannjjm	2440	35	type	type	NN
cord-023095-4dannjjm	2440	36	(	(	-LRB-
cord-023095-4dannjjm	2440	37	p	p	NN
cord-023095-4dannjjm	2440	38	5	5	CD
cord-023095-4dannjjm	2440	39	0.025-one	0.025-one	CD
cord-023095-4dannjjm	2440	40	-	-	HYPH
cord-023095-4dannjjm	2440	41	tailed	tailed	JJ
cord-023095-4dannjjm	2440	42	,	,	,
cord-023095-4dannjjm	2440	43	0.05-two	0.05-two	CD
cord-023095-4dannjjm	2440	44	-	-	HYPH
cord-023095-4dannjjm	2440	45	tailed	tailed	JJ
cord-023095-4dannjjm	2440	46	)	)	-RRB-
cord-023095-4dannjjm	2440	47	but	but	CC
cord-023095-4dannjjm	2440	48	not	not	RB
cord-023095-4dannjjm	2440	49	with	with	IN
cord-023095-4dannjjm	2440	50	0.01	0.01	CD
cord-023095-4dannjjm	2440	51	mg	mg	NNP
cord-023095-4dannjjm	2440	52	/	/	SYM
cord-023095-4dannjjm	2440	53	ml	ml	FW
cord-023095-4dannjjm	2440	54	flagellin	flagellin	NNP
cord-023095-4dannjjm	2440	55	(	(	-LRB-
cord-023095-4dannjjm	2440	56	p	p	NN
cord-023095-4dannjjm	2440	57	5	5	CD
cord-023095-4dannjjm	2440	58	0.26	0.26	CD
cord-023095-4dannjjm	2440	59	)	)	-RRB-
cord-023095-4dannjjm	2440	60	.	.	.
cord-023095-4dannjjm	2441	1	We	-PRON-	PRP
cord-023095-4dannjjm	2441	2	show	show	VBP
cord-023095-4dannjjm	2441	3	for	for	IN
cord-023095-4dannjjm	2441	4	the	the	DT
cord-023095-4dannjjm	2441	5	first	first	JJ
cord-023095-4dannjjm	2441	6	time	time	NN
cord-023095-4dannjjm	2441	7	that	that	WDT
cord-023095-4dannjjm	2441	8	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2441	9	associated	associate	VBN
cord-023095-4dannjjm	2441	10	with	with	IN
cord-023095-4dannjjm	2441	11	IBD	IBD	NNP
cord-023095-4dannjjm	2441	12	are	be	VBP
cord-023095-4dannjjm	2441	13	functionally	functionally	RB
cord-023095-4dannjjm	2441	14	hyper	hyper	JJ
cord-023095-4dannjjm	2441	15	-	-	JJ
cord-023095-4dannjjm	2441	16	responsive	responsive	JJ
cord-023095-4dannjjm	2441	17	to	to	TO
cord-023095-4dannjjm	2441	18	flagellin	flagellin	VB
cord-023095-4dannjjm	2441	19	compared	compare	VBN
cord-023095-4dannjjm	2441	20	to	to	IN
cord-023095-4dannjjm	2441	21	the	the	DT
cord-023095-4dannjjm	2441	22	wild	wild	JJ
cord-023095-4dannjjm	2441	23	-	-	HYPH
cord-023095-4dannjjm	2441	24	type	type	NN
cord-023095-4dannjjm	2441	25	receptor	receptor	NN
cord-023095-4dannjjm	2441	26	.	.	.
cord-023095-4dannjjm	2442	1	This	this	DT
cord-023095-4dannjjm	2442	2	suggests	suggest	VBZ
cord-023095-4dannjjm	2442	3	that	that	IN
cord-023095-4dannjjm	2442	4	TLR5	TLR5	NNP
cord-023095-4dannjjm	2442	5	may	may	MD
cord-023095-4dannjjm	2442	6	play	play	VB
cord-023095-4dannjjm	2442	7	a	a	DT
cord-023095-4dannjjm	2442	8	role	role	NN
cord-023095-4dannjjm	2442	9	in	in	IN
cord-023095-4dannjjm	2442	10	canine	canine	JJ
cord-023095-4dannjjm	2442	11	IBD	IBD	NNP
cord-023095-4dannjjm	2442	12	and	and	CC
cord-023095-4dannjjm	2442	13	that	that	IN
cord-023095-4dannjjm	2442	14	blocking	block	VBG
cord-023095-4dannjjm	2442	15	the	the	DT
cord-023095-4dannjjm	2442	16	hyper	hyper	JJ
cord-023095-4dannjjm	2442	17	-	-	JJ
cord-023095-4dannjjm	2442	18	responsive	responsive	JJ
cord-023095-4dannjjm	2442	19	receptor	receptor	NN
cord-023095-4dannjjm	2442	20	found	find	VBN
cord-023095-4dannjjm	2442	21	in	in	IN
cord-023095-4dannjjm	2442	22	susceptible	susceptible	JJ
cord-023095-4dannjjm	2442	23	dogs	dog	NNS
cord-023095-4dannjjm	2442	24	with	with	IN
cord-023095-4dannjjm	2442	25	IBD	IBD	NNP
cord-023095-4dannjjm	2442	26	may	may	MD
cord-023095-4dannjjm	2442	27	alleviate	alleviate	VB
cord-023095-4dannjjm	2442	28	the	the	DT
cord-023095-4dannjjm	2442	29	inappropriate	inappropriate	JJ
cord-023095-4dannjjm	2442	30	inflammation	inflammation	NN
cord-023095-4dannjjm	2442	31	seen	see	VBN
cord-023095-4dannjjm	2442	32	in	in	IN
cord-023095-4dannjjm	2442	33	this	this	DT
cord-023095-4dannjjm	2442	34	disease	disease	NN
cord-023095-4dannjjm	2442	35	.	.	.
cord-023095-4dannjjm	2443	1	However	however	RB
cord-023095-4dannjjm	2443	2	,	,	,
cord-023095-4dannjjm	2443	3	further	far	RBR
cord-023095-4dannjjm	2443	4	in	in	IN
cord-023095-4dannjjm	2443	5	-	-	HYPH
cord-023095-4dannjjm	2443	6	vivo	vivo	NN
cord-023095-4dannjjm	2443	7	functional	functional	JJ
cord-023095-4dannjjm	2443	8	analysis	analysis	NN
cord-023095-4dannjjm	2443	9	of	of	IN
cord-023095-4dannjjm	2443	10	TLR5	TLR5	NNP
cord-023095-4dannjjm	2443	11	,	,	,
cord-023095-4dannjjm	2443	12	especially	especially	RB
cord-023095-4dannjjm	2443	13	at	at	IN
cord-023095-4dannjjm	2443	14	the	the	DT
cord-023095-4dannjjm	2443	15	intestinal	intestinal	JJ
cord-023095-4dannjjm	2443	16	mucosal	mucosal	JJ
cord-023095-4dannjjm	2443	17	level	level	NN
cord-023095-4dannjjm	2443	18	would	would	MD
cord-023095-4dannjjm	2443	19	be	be	VB
cord-023095-4dannjjm	2443	20	needed	need	VBN
cord-023095-4dannjjm	2443	21	to	to	TO
cord-023095-4dannjjm	2443	22	confirm	confirm	VB
cord-023095-4dannjjm	2443	23	these	these	DT
cord-023095-4dannjjm	2443	24	findings	finding	NNS
cord-023095-4dannjjm	2443	25	and	and	CC
cord-023095-4dannjjm	2443	26	predict	predict	VB
cord-023095-4dannjjm	2443	27	the	the	DT
cord-023095-4dannjjm	2443	28	usefulness	usefulness	NN
cord-023095-4dannjjm	2443	29	of	of	IN
cord-023095-4dannjjm	2443	30	any	any	DT
cord-023095-4dannjjm	2443	31	future	future	JJ
cord-023095-4dannjjm	2443	32	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	2443	33	interventions	intervention	NNS
cord-023095-4dannjjm	2443	34	.	.	.
cord-023095-4dannjjm	2444	1	TLR5	TLR5	NNP
cord-023095-4dannjjm	2444	2	has	have	VBZ
cord-023095-4dannjjm	2444	3	been	be	VBN
cord-023095-4dannjjm	2444	4	shown	show	VBN
cord-023095-4dannjjm	2444	5	to	to	TO
cord-023095-4dannjjm	2444	6	play	play	VB
cord-023095-4dannjjm	2444	7	a	a	DT
cord-023095-4dannjjm	2444	8	role	role	NN
cord-023095-4dannjjm	2444	9	in	in	IN
cord-023095-4dannjjm	2444	10	the	the	DT
cord-023095-4dannjjm	2444	11	inappropriate	inappropriate	JJ
cord-023095-4dannjjm	2444	12	inflammation	inflammation	NN
cord-023095-4dannjjm	2444	13	seen	see	VBN
cord-023095-4dannjjm	2444	14	in	in	IN
cord-023095-4dannjjm	2444	15	human	human	JJ
cord-023095-4dannjjm	2444	16	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2444	17	bowel	bowel	NN
cord-023095-4dannjjm	2444	18	disease	disease	NN
cord-023095-4dannjjm	2444	19	(	(	-LRB-
cord-023095-4dannjjm	2444	20	IBD	IBD	NNP
cord-023095-4dannjjm	2444	21	)	)	-RRB-
cord-023095-4dannjjm	2444	22	.	.	.
cord-023095-4dannjjm	2445	1	Similarly	similarly	RB
cord-023095-4dannjjm	2445	2	,	,	,
cord-023095-4dannjjm	2445	3	we	-PRON-	PRP
cord-023095-4dannjjm	2445	4	have	have	VBP
cord-023095-4dannjjm	2445	5	recently	recently	RB
cord-023095-4dannjjm	2445	6	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	2445	7	a	a	DT
cord-023095-4dannjjm	2445	8	significant	significant	JJ
cord-023095-4dannjjm	2445	9	association	association	NN
cord-023095-4dannjjm	2445	10	between	between	IN
cord-023095-4dannjjm	2445	11	three	three	CD
cord-023095-4dannjjm	2445	12	non	non	JJ
cord-023095-4dannjjm	2445	13	-	-	JJ
cord-023095-4dannjjm	2445	14	synonymous	synonymous	JJ
cord-023095-4dannjjm	2445	15	single	single	JJ
cord-023095-4dannjjm	2445	16	nucleotide	nucleotide	JJ
cord-023095-4dannjjm	2445	17	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2445	18	(	(	-LRB-
cord-023095-4dannjjm	2445	19	SNPs	SNPs	NNP
cord-023095-4dannjjm	2445	20	)	)	-RRB-
cord-023095-4dannjjm	2445	21	in	in	IN
cord-023095-4dannjjm	2445	22	the	the	DT
cord-023095-4dannjjm	2445	23	canine	canine	JJ
cord-023095-4dannjjm	2445	24	TLR5	TLR5	NNP
cord-023095-4dannjjm	2445	25	gene	gene	NN
cord-023095-4dannjjm	2445	26	(	(	-LRB-
cord-023095-4dannjjm	2445	27	G22A	g22a	NN
cord-023095-4dannjjm	2445	28	,	,	,
cord-023095-4dannjjm	2445	29	C100	C100	NNP
cord-023095-4dannjjm	2445	30	T	T	NNP
cord-023095-4dannjjm	2445	31	and	and	CC
cord-023095-4dannjjm	2445	32	T1844C	T1844C	NNP
cord-023095-4dannjjm	2445	33	)	)	-RRB-
cord-023095-4dannjjm	2445	34	and	and	CC
cord-023095-4dannjjm	2445	35	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2445	36	bowel	bowel	NN
cord-023095-4dannjjm	2445	37	disease	disease	NN
cord-023095-4dannjjm	2445	38	(	(	-LRB-
cord-023095-4dannjjm	2445	39	IBD	IBD	NNP
cord-023095-4dannjjm	2445	40	)	)	-RRB-
cord-023095-4dannjjm	2445	41	in	in	IN
cord-023095-4dannjjm	2445	42	German	german	JJ
cord-023095-4dannjjm	2445	43	shepherd	shepherd	NN
cord-023095-4dannjjm	2445	44	dogs	dog	NNS
cord-023095-4dannjjm	2445	45	(	(	-LRB-
cord-023095-4dannjjm	2445	46	GSDs	GSDs	NNP
cord-023095-4dannjjm	2445	47	)	)	-RRB-
cord-023095-4dannjjm	2445	48	.	.	.
cord-023095-4dannjjm	2446	1	Therefore	therefore	RB
cord-023095-4dannjjm	2446	2	the	the	DT
cord-023095-4dannjjm	2446	3	aim	aim	NN
cord-023095-4dannjjm	2446	4	of	of	IN
cord-023095-4dannjjm	2446	5	this	this	DT
cord-023095-4dannjjm	2446	6	study	study	NN
cord-023095-4dannjjm	2446	7	was	be	VBD
cord-023095-4dannjjm	2446	8	to	to	TO
cord-023095-4dannjjm	2446	9	determine	determine	VB
cord-023095-4dannjjm	2446	10	the	the	DT
cord-023095-4dannjjm	2446	11	functional	functional	JJ
cord-023095-4dannjjm	2446	12	significance	significance	NN
cord-023095-4dannjjm	2446	13	of	of	IN
cord-023095-4dannjjm	2446	14	the	the	DT
cord-023095-4dannjjm	2446	15	TLR5	TLR5	NNP
cord-023095-4dannjjm	2446	16	SNPs	snp	NNS
cord-023095-4dannjjm	2446	17	in	in	IN
cord-023095-4dannjjm	2446	18	the	the	DT
cord-023095-4dannjjm	2446	19	breed	breed	NN
cord-023095-4dannjjm	2446	20	of	of	IN
cord-023095-4dannjjm	2446	21	GSDs	gsds	NN
cord-023095-4dannjjm	2446	22	.	.	.
cord-023095-4dannjjm	2447	1	The	the	DT
cord-023095-4dannjjm	2447	2	TLR5	TLR5	NNP
cord-023095-4dannjjm	2447	3	gene	gene	NN
cord-023095-4dannjjm	2447	4	containing	contain	VBG
cord-023095-4dannjjm	2447	5	the	the	DT
cord-023095-4dannjjm	2447	6	risk	risk	NN
cord-023095-4dannjjm	2447	7	haplotype	haplotype	NN
cord-023095-4dannjjm	2447	8	for	for	IN
cord-023095-4dannjjm	2447	9	IBD	IBD	NNP
cord-023095-4dannjjm	2447	10	(	(	-LRB-
cord-023095-4dannjjm	2447	11	ACC	ACC	NNP
cord-023095-4dannjjm	2447	12	)	)	-RRB-
cord-023095-4dannjjm	2447	13	and	and	CC
cord-023095-4dannjjm	2447	14	wild	wild	JJ
cord-023095-4dannjjm	2447	15	-	-	HYPH
cord-023095-4dannjjm	2447	16	type	type	NN
cord-023095-4dannjjm	2447	17	haplotype	haplotype	NN
cord-023095-4dannjjm	2447	18	(	(	-LRB-
cord-023095-4dannjjm	2447	19	GTT	GTT	NNP
cord-023095-4dannjjm	2447	20	)	)	-RRB-
cord-023095-4dannjjm	2447	21	were	be	VBD
cord-023095-4dannjjm	2447	22	stably	stably	RB
cord-023095-4dannjjm	2447	23	transfected	transfecte	VBN
cord-023095-4dannjjm	2447	24	into	into	IN
cord-023095-4dannjjm	2447	25	HEK	HEK	NNP
cord-023095-4dannjjm	2447	26	cells	cell	NNS
cord-023095-4dannjjm	2447	27	.	.	.
cord-023095-4dannjjm	2448	1	NF	NF	NNP
cord-023095-4dannjjm	2448	2	-	-	HYPH
cord-023095-4dannjjm	2448	3	kB	kb	CD
cord-023095-4dannjjm	2448	4	activity	activity	NN
cord-023095-4dannjjm	2448	5	was	be	VBD
cord-023095-4dannjjm	2448	6	measured	measure	VBN
cord-023095-4dannjjm	2448	7	by	by	IN
cord-023095-4dannjjm	2448	8	transiently	transiently	RB
cord-023095-4dannjjm	2448	9	transfecting	transfecte	VBG
cord-023095-4dannjjm	2448	10	the	the	DT
cord-023095-4dannjjm	2448	11	cells	cell	NNS
cord-023095-4dannjjm	2448	12	with	with	IN
cord-023095-4dannjjm	2448	13	NF	NF	NNP
cord-023095-4dannjjm	2448	14	-	-	HYPH
cord-023095-4dannjjm	2448	15	kB	kb	CD
cord-023095-4dannjjm	2448	16	firefly	firefly	NN
cord-023095-4dannjjm	2448	17	and	and	CC
cord-023095-4dannjjm	2448	18	HSV	HSV	NNP
cord-023095-4dannjjm	2448	19	-	-	HYPH
cord-023095-4dannjjm	2448	20	thymidine	thymidine	NN
cord-023095-4dannjjm	2448	21	kinase	kinase	NN
cord-023095-4dannjjm	2448	22	promoter	promoter	NN
cord-023095-4dannjjm	2448	23	(	(	-LRB-
cord-023095-4dannjjm	2448	24	pRL	pRL	NNP
cord-023095-4dannjjm	2448	25	-	-	HYPH
cord-023095-4dannjjm	2448	26	TK	TK	NNP
cord-023095-4dannjjm	2448	27	)	)	-RRB-
cord-023095-4dannjjm	2448	28	renilla	renilla	NNP
cord-023095-4dannjjm	2448	29	plasmids	plasmid	NNS
cord-023095-4dannjjm	2448	30	.	.	.
cord-023095-4dannjjm	2449	1	The	the	DT
cord-023095-4dannjjm	2449	2	cells	cell	NNS
cord-023095-4dannjjm	2449	3	were	be	VBD
cord-023095-4dannjjm	2449	4	stimulated	stimulate	VBN
cord-023095-4dannjjm	2449	5	with	with	IN
cord-023095-4dannjjm	2449	6	various	various	JJ
cord-023095-4dannjjm	2449	7	TLR	TLR	NNP
cord-023095-4dannjjm	2449	8	ligands	ligand	NNS
cord-023095-4dannjjm	2449	9	(	(	-LRB-
cord-023095-4dannjjm	2449	10	0.1	0.1	CD
cord-023095-4dannjjm	2449	11	mg/	mg/	NN
cord-023095-4dannjjm	2449	12	ml	ml	NNP
cord-023095-4dannjjm	2449	13	flagellin	flagellin	NNP
cord-023095-4dannjjm	2449	14	,	,	,
cord-023095-4dannjjm	2449	15	0.01	0.01	CD
cord-023095-4dannjjm	2449	16	mg	mg	NNP
cord-023095-4dannjjm	2449	17	/	/	SYM
cord-023095-4dannjjm	2449	18	ml	ml	NNP
cord-023095-4dannjjm	2449	19	flagellin	flagellin	NNP
cord-023095-4dannjjm	2449	20	,	,	,
cord-023095-4dannjjm	2449	21	1	1	CD
cord-023095-4dannjjm	2449	22	mg	mg	NNP
cord-023095-4dannjjm	2449	23	/	/	SYM
cord-023095-4dannjjm	2449	24	ml	ml	NNP
cord-023095-4dannjjm	2449	25	LPS	LPS	NNP
cord-023095-4dannjjm	2449	26	,	,	,
cord-023095-4dannjjm	2449	27	1	1	CD
cord-023095-4dannjjm	2449	28	mg	mg	NNP
cord-023095-4dannjjm	2449	29	/	/	SYM
cord-023095-4dannjjm	2449	30	ml	ml	NNP
cord-023095-4dannjjm	2449	31	PAM3CSK	PAM3CSK	NNP
cord-023095-4dannjjm	2449	32	and	and	CC
cord-023095-4dannjjm	2449	33	media	medium	NNS
cord-023095-4dannjjm	2449	34	control	control	NN
cord-023095-4dannjjm	2449	35	)	)	-RRB-
cord-023095-4dannjjm	2449	36	.	.	.
cord-023095-4dannjjm	2450	1	Firefly	Firefly	NNP
cord-023095-4dannjjm	2450	2	and	and	CC
cord-023095-4dannjjm	2450	3	renilla	renilla	NNP
cord-023095-4dannjjm	2450	4	luciferase	luciferase	NN
cord-023095-4dannjjm	2450	5	activities	activity	NNS
cord-023095-4dannjjm	2450	6	were	be	VBD
cord-023095-4dannjjm	2450	7	measured	measure	VBN
cord-023095-4dannjjm	2450	8	using	use	VBG
cord-023095-4dannjjm	2450	9	the	the	DT
cord-023095-4dannjjm	2450	10	Dual	Dual	NNP
cord-023095-4dannjjm	2450	11	-	-	HYPH
cord-023095-4dannjjm	2450	12	Glo	Glo	NNP
cord-023095-4dannjjm	2450	13	Luciferase	Luciferase	NNP
cord-023095-4dannjjm	2450	14	Assay	Assay	NNP
cord-023095-4dannjjm	2450	15	System	System	NNP
cord-023095-4dannjjm	2450	16	(	(	-LRB-
cord-023095-4dannjjm	2450	17	Promega	Promega	NNP
cord-023095-4dannjjm	2450	18	,	,	,
cord-023095-4dannjjm	2450	19	UK	UK	NNP
cord-023095-4dannjjm	2450	20	)	)	-RRB-
cord-023095-4dannjjm	2450	21	.	.	.
cord-023095-4dannjjm	2451	1	The	the	DT
cord-023095-4dannjjm	2451	2	supernatants	supernatant	NNS
cord-023095-4dannjjm	2451	3	were	be	VBD
cord-023095-4dannjjm	2451	4	harvested	harvest	VBN
cord-023095-4dannjjm	2451	5	and	and	CC
cord-023095-4dannjjm	2451	6	used	use	VBN
cord-023095-4dannjjm	2451	7	in	in	IN
cord-023095-4dannjjm	2451	8	an	an	DT
cord-023095-4dannjjm	2451	9	IL-8	IL-8	NNP
cord-023095-4dannjjm	2451	10	ELISA	ELISA	NNP
cord-023095-4dannjjm	2451	11	(	(	-LRB-
cord-023095-4dannjjm	2451	12	R&D	R&D	NNP
cord-023095-4dannjjm	2451	13	Systems	Systems	NNP
cord-023095-4dannjjm	2451	14	)	)	-RRB-
cord-023095-4dannjjm	2451	15	.	.	.
cord-023095-4dannjjm	2452	1	Peripheral	peripheral	JJ
cord-023095-4dannjjm	2452	2	whole	whole	JJ
cord-023095-4dannjjm	2452	3	blood	blood	NN
cord-023095-4dannjjm	2452	4	from	from	IN
cord-023095-4dannjjm	2452	5	dogs	dog	NNS
cord-023095-4dannjjm	2452	6	carrying	carry	VBG
cord-023095-4dannjjm	2452	7	the	the	DT
cord-023095-4dannjjm	2452	8	wild	wild	JJ
cord-023095-4dannjjm	2452	9	type	type	NN
cord-023095-4dannjjm	2452	10	and	and	CC
cord-023095-4dannjjm	2452	11	mutant	mutant	JJ
cord-023095-4dannjjm	2452	12	TLR5	TLR5	NNP
cord-023095-4dannjjm	2452	13	genes	gene	NNS
cord-023095-4dannjjm	2452	14	was	be	VBD
cord-023095-4dannjjm	2452	15	cultured	cultured	JJ
cord-023095-4dannjjm	2452	16	and	and	CC
cord-023095-4dannjjm	2452	17	stimulated	stimulate	VBN
cord-023095-4dannjjm	2452	18	with	with	IN
cord-023095-4dannjjm	2452	19	TLR	TLR	NNP
cord-023095-4dannjjm	2452	20	ligands	ligand	NNS
cord-023095-4dannjjm	2452	21	as	as	IN
cord-023095-4dannjjm	2452	22	above	above	RB
cord-023095-4dannjjm	2452	23	.	.	.
cord-023095-4dannjjm	2453	1	Canine	Canine	NNP
cord-023095-4dannjjm	2453	2	TNF	TNF	NNP
cord-023095-4dannjjm	2453	3	-	-	HYPH
cord-023095-4dannjjm	2453	4	alpha	alpha	NN
cord-023095-4dannjjm	2453	5	was	be	VBD
cord-023095-4dannjjm	2453	6	measured	measure	VBN
cord-023095-4dannjjm	2453	7	in	in	IN
cord-023095-4dannjjm	2453	8	the	the	DT
cord-023095-4dannjjm	2453	9	supernatant	supernatant	NN
cord-023095-4dannjjm	2453	10	by	by	IN
cord-023095-4dannjjm	2453	11	commercially	commercially	RB
cord-023095-4dannjjm	2453	12	available	available	JJ
cord-023095-4dannjjm	2453	13	ELISA	ELISA	NNP
cord-023095-4dannjjm	2453	14	(	(	-LRB-
cord-023095-4dannjjm	2453	15	R&D	R&D	NNP
cord-023095-4dannjjm	2453	16	Systems	Systems	NNP
cord-023095-4dannjjm	2453	17	)	)	-RRB-
cord-023095-4dannjjm	2453	18	.	.	.
cord-023095-4dannjjm	2454	1	T	t	NN
cord-023095-4dannjjm	2454	2	-	-	HYPH
cord-023095-4dannjjm	2454	3	test	test	NN
cord-023095-4dannjjm	2454	4	was	be	VBD
cord-023095-4dannjjm	2454	5	used	use	VBN
cord-023095-4dannjjm	2454	6	to	to	TO
cord-023095-4dannjjm	2454	7	determine	determine	VB
cord-023095-4dannjjm	2454	8	differences	difference	NNS
cord-023095-4dannjjm	2454	9	of	of	IN
cord-023095-4dannjjm	2454	10	relative	relative	JJ
cord-023095-4dannjjm	2454	11	luciferase	luciferase	NN
cord-023095-4dannjjm	2454	12	activity	activity	NN
cord-023095-4dannjjm	2454	13	,	,	,
cord-023095-4dannjjm	2454	14	IL-8	IL-8	NNP
cord-023095-4dannjjm	2454	15	concentration	concentration	NN
cord-023095-4dannjjm	2454	16	and	and	CC
cord-023095-4dannjjm	2454	17	TNF	tnf	NN
cord-023095-4dannjjm	2454	18	-	-	HYPH
cord-023095-4dannjjm	2454	19	alpha	alpha	NN
cord-023095-4dannjjm	2454	20	concentration	concentration	NN
cord-023095-4dannjjm	2454	21	between	between	IN
cord-023095-4dannjjm	2454	22	wild	wild	JJ
cord-023095-4dannjjm	2454	23	-	-	HYPH
cord-023095-4dannjjm	2454	24	type	type	NN
cord-023095-4dannjjm	2454	25	and	and	CC
cord-023095-4dannjjm	2454	26	mutated	mutate	VBN
cord-023095-4dannjjm	2454	27	TLR5	TLR5	NNP
cord-023095-4dannjjm	2454	28	cells	cell	NNS
cord-023095-4dannjjm	2454	29	.	.	.
cord-023095-4dannjjm	2455	1	There	there	EX
cord-023095-4dannjjm	2455	2	was	be	VBD
cord-023095-4dannjjm	2455	3	a	a	DT
cord-023095-4dannjjm	2455	4	significant	significant	JJ
cord-023095-4dannjjm	2455	5	increase	increase	NN
cord-023095-4dannjjm	2455	6	in	in	IN
cord-023095-4dannjjm	2455	7	NF	NF	NNP
cord-023095-4dannjjm	2455	8	-	-	HYPH
cord-023095-4dannjjm	2455	9	kB	kb	CD
cord-023095-4dannjjm	2455	10	activity	activity	NN
cord-023095-4dannjjm	2455	11	when	when	WRB
cord-023095-4dannjjm	2455	12	the	the	DT
cord-023095-4dannjjm	2455	13	cells	cell	NNS
cord-023095-4dannjjm	2455	14	with	with	IN
cord-023095-4dannjjm	2455	15	mutated	mutate	VBN
cord-023095-4dannjjm	2455	16	TLR5	TLR5	NNP
cord-023095-4dannjjm	2455	17	were	be	VBD
cord-023095-4dannjjm	2455	18	stimulated	stimulate	VBN
cord-023095-4dannjjm	2455	19	with	with	IN
cord-023095-4dannjjm	2455	20	0.1	0.1	CD
cord-023095-4dannjjm	2455	21	mg	mg	NNP
cord-023095-4dannjjm	2455	22	/	/	SYM
cord-023095-4dannjjm	2455	23	ml	ml	NNS
cord-023095-4dannjjm	2455	24	of	of	IN
cord-023095-4dannjjm	2455	25	flagellin	flagellin	NN
cord-023095-4dannjjm	2455	26	compared	compare	VBN
cord-023095-4dannjjm	2455	27	to	to	IN
cord-023095-4dannjjm	2455	28	the	the	DT
cord-023095-4dannjjm	2455	29	cells	cell	NNS
cord-023095-4dannjjm	2455	30	expressing	express	VBG
cord-023095-4dannjjm	2455	31	wild	wild	JJ
cord-023095-4dannjjm	2455	32	-	-	HYPH
cord-023095-4dannjjm	2455	33	type	type	NN
cord-023095-4dannjjm	2455	34	TLR5	TLR5	NNP
cord-023095-4dannjjm	2455	35	(	(	-LRB-
cord-023095-4dannjjm	2455	36	p	p	NN
cord-023095-4dannjjm	2455	37	5	5	CD
cord-023095-4dannjjm	2455	38	0.027	0.027	CD
cord-023095-4dannjjm	2455	39	)	)	-RRB-
cord-023095-4dannjjm	2455	40	,	,	,
cord-023095-4dannjjm	2455	41	which	which	WDT
cord-023095-4dannjjm	2455	42	correlated	correlate	VBD
cord-023095-4dannjjm	2455	43	with	with	IN
cord-023095-4dannjjm	2455	44	IL-8	IL-8	NNP
cord-023095-4dannjjm	2455	45	expression	expression	NN
cord-023095-4dannjjm	2455	46	in	in	IN
cord-023095-4dannjjm	2455	47	the	the	DT
cord-023095-4dannjjm	2455	48	supernatant	supernatant	NN
cord-023095-4dannjjm	2455	49	(	(	-LRB-
cord-023095-4dannjjm	2455	50	p	p	NN
cord-023095-4dannjjm	2455	51	5	5	CD
cord-023095-4dannjjm	2455	52	0.26	0.26	CD
cord-023095-4dannjjm	2455	53	)	)	-RRB-
cord-023095-4dannjjm	2455	54	.	.	.
cord-023095-4dannjjm	2456	1	Similarly	similarly	RB
cord-023095-4dannjjm	2456	2	,	,	,
cord-023095-4dannjjm	2456	3	in	in	IN
cord-023095-4dannjjm	2456	4	the	the	DT
cord-023095-4dannjjm	2456	5	whole	whole	JJ
cord-023095-4dannjjm	2456	6	blood	blood	NN
cord-023095-4dannjjm	2456	7	assay	assay	NN
cord-023095-4dannjjm	2456	8	the	the	DT
cord-023095-4dannjjm	2456	9	TLR5	TLR5	NNP
cord-023095-4dannjjm	2456	10	risk	risk	NN
cord-023095-4dannjjm	2456	11	haplotype	haplotype	NN
cord-023095-4dannjjm	2456	12	for	for	IN
cord-023095-4dannjjm	2456	13	IBD	IBD	NNP
cord-023095-4dannjjm	2456	14	in	in	IN
cord-023095-4dannjjm	2456	15	GSDs	gsds	NN
cord-023095-4dannjjm	2456	16	(	(	-LRB-
cord-023095-4dannjjm	2456	17	ACC	ACC	NNP
cord-023095-4dannjjm	2456	18	)	)	-RRB-
cord-023095-4dannjjm	2456	19	was	be	VBD
cord-023095-4dannjjm	2456	20	significantly	significantly	RB
cord-023095-4dannjjm	2456	21	hyperresponsive	hyperresponsive	NNP
cord-023095-4dannjjm	2456	22	to	to	TO
cord-023095-4dannjjm	2456	23	flagellin	flagellin	VB
cord-023095-4dannjjm	2456	24	at	at	IN
cord-023095-4dannjjm	2456	25	a	a	DT
cord-023095-4dannjjm	2456	26	concentration	concentration	NN
cord-023095-4dannjjm	2456	27	of	of	IN
cord-023095-4dannjjm	2456	28	0.1	0.1	CD
cord-023095-4dannjjm	2456	29	mg	mg	NNP
cord-023095-4dannjjm	2456	30	/	/	SYM
cord-023095-4dannjjm	2456	31	ml	ml	NNS
cord-023095-4dannjjm	2456	32	compared	compare	VBN
cord-023095-4dannjjm	2456	33	to	to	IN
cord-023095-4dannjjm	2456	34	the	the	DT
cord-023095-4dannjjm	2456	35	TLR5	TLR5	NNP
cord-023095-4dannjjm	2456	36	wild	wild	JJ
cord-023095-4dannjjm	2456	37	-	-	HYPH
cord-023095-4dannjjm	2456	38	type	type	NN
cord-023095-4dannjjm	2456	39	haplotype	haplotype	NN
cord-023095-4dannjjm	2456	40	(	(	-LRB-
cord-023095-4dannjjm	2456	41	GTT	GTT	NNP
cord-023095-4dannjjm	2456	42	)	)	-RRB-
cord-023095-4dannjjm	2457	1	(	(	-LRB-
cord-023095-4dannjjm	2457	2	p	p	NN
cord-023095-4dannjjm	2457	3	5	5	CD
cord-023095-4dannjjm	2457	4	0.001	0.001	CD
cord-023095-4dannjjm	2457	5	)	)	-RRB-
cord-023095-4dannjjm	2457	6	.	.	.
cord-023095-4dannjjm	2458	1	We	-PRON-	PRP
cord-023095-4dannjjm	2458	2	show	show	VBP
cord-023095-4dannjjm	2458	3	for	for	IN
cord-023095-4dannjjm	2458	4	the	the	DT
cord-023095-4dannjjm	2458	5	first	first	JJ
cord-023095-4dannjjm	2458	6	time	time	NN
cord-023095-4dannjjm	2458	7	that	that	WDT
cord-023095-4dannjjm	2458	8	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2458	9	associated	associate	VBN
cord-023095-4dannjjm	2458	10	with	with	IN
cord-023095-4dannjjm	2458	11	canine	canine	JJ
cord-023095-4dannjjm	2458	12	IBD	IBD	NNP
cord-023095-4dannjjm	2458	13	in	in	IN
cord-023095-4dannjjm	2458	14	GSDs	gsds	NN
cord-023095-4dannjjm	2458	15	are	be	VBP
cord-023095-4dannjjm	2458	16	functionally	functionally	RB
cord-023095-4dannjjm	2458	17	hyper	hyper	JJ
cord-023095-4dannjjm	2458	18	-	-	JJ
cord-023095-4dannjjm	2458	19	responsive	responsive	JJ
cord-023095-4dannjjm	2458	20	to	to	TO
cord-023095-4dannjjm	2458	21	flagellin	flagellin	VB
cord-023095-4dannjjm	2458	22	compared	compare	VBN
cord-023095-4dannjjm	2458	23	to	to	IN
cord-023095-4dannjjm	2458	24	the	the	DT
cord-023095-4dannjjm	2458	25	wild	wild	JJ
cord-023095-4dannjjm	2458	26	-	-	HYPH
cord-023095-4dannjjm	2458	27	type	type	NN
cord-023095-4dannjjm	2458	28	receptor	receptor	NN
cord-023095-4dannjjm	2458	29	.	.	.
cord-023095-4dannjjm	2459	1	Blocking	block	VBG
cord-023095-4dannjjm	2459	2	the	the	DT
cord-023095-4dannjjm	2459	3	hyper	hyper	JJ
cord-023095-4dannjjm	2459	4	-	-	JJ
cord-023095-4dannjjm	2459	5	responsive	responsive	JJ
cord-023095-4dannjjm	2459	6	receptor	receptor	NN
cord-023095-4dannjjm	2459	7	found	find	VBN
cord-023095-4dannjjm	2459	8	in	in	IN
cord-023095-4dannjjm	2459	9	susceptible	susceptible	JJ
cord-023095-4dannjjm	2459	10	dogs	dog	NNS
cord-023095-4dannjjm	2459	11	with	with	IN
cord-023095-4dannjjm	2459	12	IBD	IBD	NNP
cord-023095-4dannjjm	2459	13	may	may	MD
cord-023095-4dannjjm	2459	14	alleviate	alleviate	VB
cord-023095-4dannjjm	2459	15	the	the	DT
cord-023095-4dannjjm	2459	16	inappropriate	inappropriate	JJ
cord-023095-4dannjjm	2459	17	inflammation	inflammation	NN
cord-023095-4dannjjm	2459	18	seen	see	VBN
cord-023095-4dannjjm	2459	19	in	in	IN
cord-023095-4dannjjm	2459	20	this	this	DT
cord-023095-4dannjjm	2459	21	disease	disease	NN
cord-023095-4dannjjm	2459	22	.	.	.
cord-023095-4dannjjm	2460	1	Proton	proton	NN
cord-023095-4dannjjm	2460	2	pump	pump	NN
cord-023095-4dannjjm	2460	3	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	2460	4	(	(	-LRB-
cord-023095-4dannjjm	2460	5	PPI	PPI	NNP
cord-023095-4dannjjm	2460	6	)	)	-RRB-
cord-023095-4dannjjm	2460	7	are	be	VBP
cord-023095-4dannjjm	2460	8	widely	widely	RB
cord-023095-4dannjjm	2460	9	used	use	VBN
cord-023095-4dannjjm	2460	10	in	in	IN
cord-023095-4dannjjm	2460	11	human	human	JJ
cord-023095-4dannjjm	2460	12	and	and	CC
cord-023095-4dannjjm	2460	13	also	also	RB
cord-023095-4dannjjm	2460	14	veterinary	veterinary	JJ
cord-023095-4dannjjm	2460	15	medicine	medicine	NN
cord-023095-4dannjjm	2460	16	.	.	.
cord-023095-4dannjjm	2461	1	Side	side	NN
cord-023095-4dannjjm	2461	2	-	-	HYPH
cord-023095-4dannjjm	2461	3	effects	effect	NNS
cord-023095-4dannjjm	2461	4	of	of	IN
cord-023095-4dannjjm	2461	5	PPI	PPI	NNP
cord-023095-4dannjjm	2461	6	treatment	treatment	NN
cord-023095-4dannjjm	2461	7	reported	report	VBN
cord-023095-4dannjjm	2461	8	in	in	IN
cord-023095-4dannjjm	2461	9	people	people	NNS
cord-023095-4dannjjm	2461	10	are	be	VBP
cord-023095-4dannjjm	2461	11	atrophic	atrophic	JJ
cord-023095-4dannjjm	2461	12	gastritis	gastritis	NN
cord-023095-4dannjjm	2461	13	,	,	,
cord-023095-4dannjjm	2461	14	gastric	gastric	JJ
cord-023095-4dannjjm	2461	15	and	and	CC
cord-023095-4dannjjm	2461	16	esophageal	esophageal	JJ
cord-023095-4dannjjm	2461	17	cancer	cancer	NN
cord-023095-4dannjjm	2461	18	,	,	,
cord-023095-4dannjjm	2461	19	and	and	CC
cord-023095-4dannjjm	2461	20	rebound	rebound	VB
cord-023095-4dannjjm	2461	21	hyperacidity	hyperacidity	NN
cord-023095-4dannjjm	2461	22	following	follow	VBG
cord-023095-4dannjjm	2461	23	cessation	cessation	NN
cord-023095-4dannjjm	2461	24	of	of	IN
cord-023095-4dannjjm	2461	25	treatment	treatment	NN
cord-023095-4dannjjm	2461	26	,	,	,
cord-023095-4dannjjm	2461	27	which	which	WDT
cord-023095-4dannjjm	2461	28	has	have	VBZ
cord-023095-4dannjjm	2461	29	been	be	VBN
cord-023095-4dannjjm	2461	30	speculated	speculate	VBN
cord-023095-4dannjjm	2461	31	to	to	TO
cord-023095-4dannjjm	2461	32	be	be	VB
cord-023095-4dannjjm	2461	33	due	due	JJ
cord-023095-4dannjjm	2461	34	to	to	IN
cord-023095-4dannjjm	2461	35	a	a	DT
cord-023095-4dannjjm	2461	36	sustained	sustained	JJ
cord-023095-4dannjjm	2461	37	increased	increase	VBN
cord-023095-4dannjjm	2461	38	in	in	IN
cord-023095-4dannjjm	2461	39	circulating	circulate	VBG
cord-023095-4dannjjm	2461	40	gastrin	gastrin	NN
cord-023095-4dannjjm	2461	41	concentration	concentration	NN
cord-023095-4dannjjm	2461	42	.	.	.
cord-023095-4dannjjm	2462	1	Moreover	moreover	RB
cord-023095-4dannjjm	2462	2	,	,	,
cord-023095-4dannjjm	2462	3	long	long	JJ
cord-023095-4dannjjm	2462	4	-	-	HYPH
cord-023095-4dannjjm	2462	5	term	term	NN
cord-023095-4dannjjm	2462	6	PPI	PPI	NNP
cord-023095-4dannjjm	2462	7	treatment	treatment	NN
cord-023095-4dannjjm	2462	8	has	have	VBZ
cord-023095-4dannjjm	2462	9	been	be	VBN
cord-023095-4dannjjm	2462	10	associated	associate	VBN
cord-023095-4dannjjm	2462	11	with	with	IN
cord-023095-4dannjjm	2462	12	an	an	DT
cord-023095-4dannjjm	2462	13	increased	increase	VBN
cord-023095-4dannjjm	2462	14	risk	risk	NN
cord-023095-4dannjjm	2462	15	for	for	IN
cord-023095-4dannjjm	2462	16	osteoporosis	osteoporosis	NN
cord-023095-4dannjjm	2462	17	in	in	IN
cord-023095-4dannjjm	2462	18	people	people	NNS
cord-023095-4dannjjm	2462	19	.	.	.
cord-023095-4dannjjm	2463	1	Little	little	JJ
cord-023095-4dannjjm	2463	2	is	be	VBZ
cord-023095-4dannjjm	2463	3	known	know	VBN
cord-023095-4dannjjm	2463	4	about	about	IN
cord-023095-4dannjjm	2463	5	the	the	DT
cord-023095-4dannjjm	2463	6	effect	effect	NN
cord-023095-4dannjjm	2463	7	of	of	IN
cord-023095-4dannjjm	2463	8	PPI	PPI	NNP
cord-023095-4dannjjm	2463	9	treatment	treatment	NN
cord-023095-4dannjjm	2463	10	on	on	IN
cord-023095-4dannjjm	2463	11	serum	serum	NN
cord-023095-4dannjjm	2463	12	gastrin	gastrin	NN
cord-023095-4dannjjm	2463	13	concentration	concentration	NN
cord-023095-4dannjjm	2463	14	or	or	CC
cord-023095-4dannjjm	2463	15	calcium	calcium	NN
cord-023095-4dannjjm	2463	16	metabolism	metabolism	NN
cord-023095-4dannjjm	2463	17	in	in	IN
cord-023095-4dannjjm	2463	18	dogs	dog	NNS
cord-023095-4dannjjm	2463	19	.	.	.
cord-023095-4dannjjm	2464	1	Eight	eight	CD
cord-023095-4dannjjm	2464	2	healthy	healthy	JJ
cord-023095-4dannjjm	2464	3	adult	adult	NN
cord-023095-4dannjjm	2464	4	research	research	NN
cord-023095-4dannjjm	2464	5	dogs	dog	NNS
cord-023095-4dannjjm	2464	6	(	(	-LRB-
cord-023095-4dannjjm	2464	7	4	4	CD
cord-023095-4dannjjm	2464	8	males	male	NNS
cord-023095-4dannjjm	2464	9	and	and	CC
cord-023095-4dannjjm	2464	10	4	4	CD
cord-023095-4dannjjm	2464	11	females	female	NNS
cord-023095-4dannjjm	2464	12	)	)	-RRB-
cord-023095-4dannjjm	2464	13	were	be	VBD
cord-023095-4dannjjm	2464	14	enrolled	enrol	VBN
cord-023095-4dannjjm	2464	15	into	into	IN
cord-023095-4dannjjm	2464	16	the	the	DT
cord-023095-4dannjjm	2464	17	study	study	NN
cord-023095-4dannjjm	2464	18	.	.	.
cord-023095-4dannjjm	2465	1	The	the	DT
cord-023095-4dannjjm	2465	2	dogs	dog	NNS
cord-023095-4dannjjm	2465	3	received	receive	VBD
cord-023095-4dannjjm	2465	4	an	an	DT
cord-023095-4dannjjm	2465	5	average	average	JJ
cord-023095-4dannjjm	2465	6	dose	dose	NN
cord-023095-4dannjjm	2465	7	of	of	IN
cord-023095-4dannjjm	2465	8	1.1	1.1	CD
cord-023095-4dannjjm	2465	9	mg/	mg/	NN
cord-023095-4dannjjm	2465	10	kg	kg	NNP
cord-023095-4dannjjm	2465	11	of	of	IN
cord-023095-4dannjjm	2465	12	omeprazole	omeprazole	NN
cord-023095-4dannjjm	2465	13	orally	orally	RB
cord-023095-4dannjjm	2465	14	twice	twice	RB
cord-023095-4dannjjm	2465	15	daily	daily	RB
cord-023095-4dannjjm	2465	16	for	for	IN
cord-023095-4dannjjm	2465	17	15	15	CD
cord-023095-4dannjjm	2465	18	days	day	NNS
cord-023095-4dannjjm	2465	19	.	.	.
cord-023095-4dannjjm	2466	1	Blood	blood	NN
cord-023095-4dannjjm	2466	2	samples	sample	NNS
cord-023095-4dannjjm	2466	3	were	be	VBD
cord-023095-4dannjjm	2466	4	collected	collect	VBN
cord-023095-4dannjjm	2466	5	prior	prior	RB
cord-023095-4dannjjm	2466	6	to	to	IN
cord-023095-4dannjjm	2466	7	initiating	initiate	VBG
cord-023095-4dannjjm	2466	8	the	the	DT
cord-023095-4dannjjm	2466	9	treatment	treatment	NN
cord-023095-4dannjjm	2466	10	and	and	CC
cord-023095-4dannjjm	2466	11	every	every	DT
cord-023095-4dannjjm	2466	12	3	3	CD
cord-023095-4dannjjm	2466	13	days	day	NNS
cord-023095-4dannjjm	2466	14	during	during	IN
cord-023095-4dannjjm	2466	15	the	the	DT
cord-023095-4dannjjm	2466	16	15	15	CD
cord-023095-4dannjjm	2466	17	days	day	NNS
cord-023095-4dannjjm	2466	18	of	of	IN
cord-023095-4dannjjm	2466	19	treatment	treatment	NN
cord-023095-4dannjjm	2466	20	and	and	CC
cord-023095-4dannjjm	2466	21	during	during	IN
cord-023095-4dannjjm	2466	22	the	the	DT
cord-023095-4dannjjm	2466	23	15	15	CD
cord-023095-4dannjjm	2466	24	days	day	NNS
cord-023095-4dannjjm	2466	25	after	after	IN
cord-023095-4dannjjm	2466	26	discontinuation	discontinuation	NN
cord-023095-4dannjjm	2466	27	of	of	IN
cord-023095-4dannjjm	2466	28	treatment	treatment	NN
cord-023095-4dannjjm	2466	29	for	for	IN
cord-023095-4dannjjm	2466	30	determination	determination	NN
cord-023095-4dannjjm	2466	31	of	of	IN
cord-023095-4dannjjm	2466	32	serum	serum	NN
cord-023095-4dannjjm	2466	33	gastrin	gastrin	NN
cord-023095-4dannjjm	2466	34	,	,	,
cord-023095-4dannjjm	2466	35	ionized	ionized	JJ
cord-023095-4dannjjm	2466	36	calcium	calcium	NN
cord-023095-4dannjjm	2466	37	,	,	,
cord-023095-4dannjjm	2466	38	PTH	PTH	NNP
cord-023095-4dannjjm	2466	39	,	,	,
cord-023095-4dannjjm	2466	40	and	and	CC
cord-023095-4dannjjm	2466	41	25	25	CD
cord-023095-4dannjjm	2466	42	OH	OH	NNP
cord-023095-4dannjjm	2466	43	vitamin	vitamin	NN
cord-023095-4dannjjm	2466	44	D3	D3	NNP
cord-023095-4dannjjm	2466	45	.	.	.
cord-023095-4dannjjm	2467	1	Gastric	gastric	JJ
cord-023095-4dannjjm	2467	2	fluid	fluid	NN
cord-023095-4dannjjm	2467	3	was	be	VBD
cord-023095-4dannjjm	2467	4	collected	collect	VBN
cord-023095-4dannjjm	2467	5	via	via	IN
cord-023095-4dannjjm	2467	6	gastroscopy	gastroscopy	NN
cord-023095-4dannjjm	2467	7	after	after	IN
cord-023095-4dannjjm	2467	8	an	an	DT
cord-023095-4dannjjm	2467	9	overnight	overnight	JJ
cord-023095-4dannjjm	2467	10	fast	fast	RB
cord-023095-4dannjjm	2467	11	for	for	IN
cord-023095-4dannjjm	2467	12	measurement	measurement	NN
cord-023095-4dannjjm	2467	13	of	of	IN
cord-023095-4dannjjm	2467	14	gastric	gastric	JJ
cord-023095-4dannjjm	2467	15	pH	ph	NN
cord-023095-4dannjjm	2467	16	prior	prior	RB
cord-023095-4dannjjm	2467	17	to	to	IN
cord-023095-4dannjjm	2467	18	,	,	,
cord-023095-4dannjjm	2467	19	during	during	IN
cord-023095-4dannjjm	2467	20	,	,	,
cord-023095-4dannjjm	2467	21	and	and	CC
cord-023095-4dannjjm	2467	22	after	after	IN
cord-023095-4dannjjm	2467	23	the	the	DT
cord-023095-4dannjjm	2467	24	omeprazole	omeprazole	JJ
cord-023095-4dannjjm	2467	25	treatment	treatment	NN
cord-023095-4dannjjm	2467	26	period	period	NN
cord-023095-4dannjjm	2467	27	.	.	.
cord-023095-4dannjjm	2468	1	Normally	normally	RB
cord-023095-4dannjjm	2468	2	distributed	distribute	VBN
cord-023095-4dannjjm	2468	3	data	datum	NNS
cord-023095-4dannjjm	2468	4	were	be	VBD
cord-023095-4dannjjm	2468	5	compared	compare	VBN
cord-023095-4dannjjm	2468	6	with	with	IN
cord-023095-4dannjjm	2468	7	a	a	DT
cord-023095-4dannjjm	2468	8	repeated	repeat	VBN
cord-023095-4dannjjm	2468	9	measures	measure	NNS
cord-023095-4dannjjm	2468	10	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	2468	11	and	and	CC
cord-023095-4dannjjm	2468	12	post	post	VB
cord-023095-4dannjjm	2468	13	hoc	hoc	FW
cord-023095-4dannjjm	2468	14	Dunnett	Dunnett	NNP
cord-023095-4dannjjm	2468	15	's	's	POS
cord-023095-4dannjjm	2468	16	test	test	NN
cord-023095-4dannjjm	2468	17	.	.	.
cord-023095-4dannjjm	2469	1	Data	datum	NNS
cord-023095-4dannjjm	2469	2	that	that	WDT
cord-023095-4dannjjm	2469	3	were	be	VBD
cord-023095-4dannjjm	2469	4	not	not	RB
cord-023095-4dannjjm	2469	5	normally	normally	RB
cord-023095-4dannjjm	2469	6	distributed	distribute	VBN
cord-023095-4dannjjm	2469	7	were	be	VBD
cord-023095-4dannjjm	2469	8	compared	compare	VBN
cord-023095-4dannjjm	2469	9	with	with	IN
cord-023095-4dannjjm	2469	10	a	a	DT
cord-023095-4dannjjm	2469	11	Friedman	Friedman	NNP
cord-023095-4dannjjm	2469	12	's	's	POS
cord-023095-4dannjjm	2469	13	test	test	NN
cord-023095-4dannjjm	2469	14	and	and	CC
cord-023095-4dannjjm	2469	15	a	a	DT
cord-023095-4dannjjm	2469	16	post	post	JJ
cord-023095-4dannjjm	2469	17	-	-	JJ
cord-023095-4dannjjm	2469	18	hoc	hoc	FW
cord-023095-4dannjjm	2469	19	Dunn	Dunn	NNP
cord-023095-4dannjjm	2469	20	's	's	POS
cord-023095-4dannjjm	2469	21	test	test	NN
cord-023095-4dannjjm	2469	22	.	.	.
cord-023095-4dannjjm	2470	1	Gastric	gastric	JJ
cord-023095-4dannjjm	2470	2	fluid	fluid	NN
cord-023095-4dannjjm	2470	3	pH	ph	NN
cord-023095-4dannjjm	2470	4	was	be	VBD
cord-023095-4dannjjm	2470	5	significantly	significantly	RB
cord-023095-4dannjjm	2470	6	higher	high	JJR
cord-023095-4dannjjm	2470	7	(	(	-LRB-
cord-023095-4dannjjm	2470	8	p	p	NN
cord-023095-4dannjjm	2470	9	o	o	NN
cord-023095-4dannjjm	2470	10	0.01	0.01	CD
cord-023095-4dannjjm	2470	11	)	)	-RRB-
cord-023095-4dannjjm	2470	12	at	at	IN
cord-023095-4dannjjm	2470	13	the	the	DT
cord-023095-4dannjjm	2470	14	end	end	NN
cord-023095-4dannjjm	2470	15	of	of	IN
cord-023095-4dannjjm	2470	16	the	the	DT
cord-023095-4dannjjm	2470	17	treatment	treatment	NN
cord-023095-4dannjjm	2470	18	period	period	NN
cord-023095-4dannjjm	2470	19	(	(	-LRB-
cord-023095-4dannjjm	2470	20	median	median	NN
cord-023095-4dannjjm	2470	21	:	:	:
cord-023095-4dannjjm	2470	22	7.4	7.4	CD
cord-023095-4dannjjm	2470	23	;	;	:
cord-023095-4dannjjm	2470	24	range	range	NN
cord-023095-4dannjjm	2470	25	:	:	:
cord-023095-4dannjjm	2470	26	4.2	4.2	CD
cord-023095-4dannjjm	2470	27	-	-	SYM
cord-023095-4dannjjm	2470	28	8.1	8.1	CD
cord-023095-4dannjjm	2470	29	)	)	-RRB-
cord-023095-4dannjjm	2470	30	when	when	WRB
cord-023095-4dannjjm	2470	31	compared	compare	VBN
cord-023095-4dannjjm	2470	32	to	to	IN
cord-023095-4dannjjm	2470	33	pretreatment	pretreatment	NN
cord-023095-4dannjjm	2470	34	values	value	NNS
cord-023095-4dannjjm	2470	35	(	(	-LRB-
cord-023095-4dannjjm	2470	36	median	median	NN
cord-023095-4dannjjm	2470	37	:	:	:
cord-023095-4dannjjm	2470	38	1.7	1.7	CD
cord-023095-4dannjjm	2470	39	;	;	:
cord-023095-4dannjjm	2470	40	range	range	NN
cord-023095-4dannjjm	2470	41	:	:	:
cord-023095-4dannjjm	2470	42	1.0	1.0	CD
cord-023095-4dannjjm	2470	43	-	-	SYM
cord-023095-4dannjjm	2470	44	6.8	6.8	CD
cord-023095-4dannjjm	2470	45	)	)	-RRB-
cord-023095-4dannjjm	2470	46	.	.	.
cord-023095-4dannjjm	2471	1	Serum	serum	NN
cord-023095-4dannjjm	2471	2	gastrin	gastrin	NN
cord-023095-4dannjjm	2471	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2471	4	increased	increase	VBD
cord-023095-4dannjjm	2471	5	significantly	significantly	RB
cord-023095-4dannjjm	2471	6	from	from	IN
cord-023095-4dannjjm	2471	7	a	a	DT
cord-023095-4dannjjm	2471	8	median	median	JJ
cord-023095-4dannjjm	2471	9	baseline	baseline	NN
cord-023095-4dannjjm	2471	10	of	of	IN
cord-023095-4dannjjm	2471	11	10.0	10.0	CD
cord-023095-4dannjjm	2471	12	ng	ng	NNP
cord-023095-4dannjjm	2471	13	/	/	SYM
cord-023095-4dannjjm	2471	14	L	L	NNP
cord-023095-4dannjjm	2471	15	(	(	-LRB-
cord-023095-4dannjjm	2471	16	range	range	NN
cord-023095-4dannjjm	2471	17	:	:	:
cord-023095-4dannjjm	2471	18	10.0	10.0	CD
cord-023095-4dannjjm	2471	19	-	-	HYPH
cord-023095-4dannjjm	2471	20	27.0	27.0	CD
cord-023095-4dannjjm	2471	21	)	)	-RRB-
cord-023095-4dannjjm	2471	22	to	to	IN
cord-023095-4dannjjm	2471	23	a	a	DT
cord-023095-4dannjjm	2471	24	maximum	maximum	JJ
cord-023095-4dannjjm	2471	25	median	median	NN
cord-023095-4dannjjm	2471	26	of	of	IN
cord-023095-4dannjjm	2471	27	379.5	379.5	CD
cord-023095-4dannjjm	2471	28	ng	ng	NNP
cord-023095-4dannjjm	2471	29	/	/	SYM
cord-023095-4dannjjm	2471	30	L	l	NN
cord-023095-4dannjjm	2471	31	(	(	-LRB-
cord-023095-4dannjjm	2471	32	range	range	NN
cord-023095-4dannjjm	2471	33	:	:	:
cord-023095-4dannjjm	2471	34	49.9	49.9	CD
cord-023095-4dannjjm	2471	35	-	-	HYPH
cord-023095-4dannjjm	2471	36	566.0	566.0	CD
cord-023095-4dannjjm	2471	37	)	)	-RRB-
cord-023095-4dannjjm	2471	38	at	at	IN
cord-023095-4dannjjm	2471	39	day	day	NN
cord-023095-4dannjjm	2471	40	9	9	CD
cord-023095-4dannjjm	2471	41	of	of	IN
cord-023095-4dannjjm	2471	42	treatment	treatment	NN
cord-023095-4dannjjm	2471	43	(	(	-LRB-
cord-023095-4dannjjm	2471	44	p	p	NN
cord-023095-4dannjjm	2471	45	o	o	NN
cord-023095-4dannjjm	2471	46	0.01	0.01	CD
cord-023095-4dannjjm	2471	47	)	)	-RRB-
cord-023095-4dannjjm	2471	48	.	.	.
cord-023095-4dannjjm	2472	1	Serum	serum	NN
cord-023095-4dannjjm	2472	2	gastrin	gastrin	NN
cord-023095-4dannjjm	2472	3	remained	remain	VBD
cord-023095-4dannjjm	2472	4	significantly	significantly	RB
cord-023095-4dannjjm	2472	5	increased	increase	VBN
cord-023095-4dannjjm	2472	6	above	above	IN
cord-023095-4dannjjm	2472	7	baseline	baseline	JJ
cord-023095-4dannjjm	2472	8	values	value	NNS
cord-023095-4dannjjm	2472	9	from	from	IN
cord-023095-4dannjjm	2472	10	day	day	NN
cord-023095-4dannjjm	2472	11	6	6	CD
cord-023095-4dannjjm	2472	12	to	to	IN
cord-023095-4dannjjm	2472	13	day	day	NN
cord-023095-4dannjjm	2472	14	15	15	CD
cord-023095-4dannjjm	2472	15	of	of	IN
cord-023095-4dannjjm	2472	16	the	the	DT
cord-023095-4dannjjm	2472	17	treatment	treatment	NN
cord-023095-4dannjjm	2472	18	,	,	,
cord-023095-4dannjjm	2472	19	but	but	CC
cord-023095-4dannjjm	2472	20	was	be	VBD
cord-023095-4dannjjm	2472	21	not	not	RB
cord-023095-4dannjjm	2472	22	different	different	JJ
cord-023095-4dannjjm	2472	23	from	from	IN
cord-023095-4dannjjm	2472	24	pre	pre	JJ
cord-023095-4dannjjm	2472	25	-	-	JJ
cord-023095-4dannjjm	2472	26	treatment	treatment	JJ
cord-023095-4dannjjm	2472	27	values	value	NNS
cord-023095-4dannjjm	2472	28	3	3	CD
cord-023095-4dannjjm	2472	29	days	day	NNS
cord-023095-4dannjjm	2472	30	after	after	IN
cord-023095-4dannjjm	2472	31	the	the	DT
cord-023095-4dannjjm	2472	32	end	end	NN
cord-023095-4dannjjm	2472	33	of	of	IN
cord-023095-4dannjjm	2472	34	the	the	DT
cord-023095-4dannjjm	2472	35	treatment	treatment	NN
cord-023095-4dannjjm	2472	36	.	.	.
cord-023095-4dannjjm	2473	1	Omeprazole	omeprazole	NN
cord-023095-4dannjjm	2473	2	treatment	treatment	NN
cord-023095-4dannjjm	2473	3	had	have	VBD
cord-023095-4dannjjm	2473	4	no	no	DT
cord-023095-4dannjjm	2473	5	effect	effect	NN
cord-023095-4dannjjm	2473	6	on	on	IN
cord-023095-4dannjjm	2473	7	ionized	ionized	JJ
cord-023095-4dannjjm	2473	8	calcium	calcium	NN
cord-023095-4dannjjm	2473	9	or	or	CC
cord-023095-4dannjjm	2473	10	PTH	PTH	NNP
cord-023095-4dannjjm	2473	11	for	for	IN
cord-023095-4dannjjm	2473	12	the	the	DT
cord-023095-4dannjjm	2473	13	duration	duration	NN
cord-023095-4dannjjm	2473	14	of	of	IN
cord-023095-4dannjjm	2473	15	the	the	DT
cord-023095-4dannjjm	2473	16	study	study	NN
cord-023095-4dannjjm	2473	17	.	.	.
cord-023095-4dannjjm	2474	1	Marginal	marginal	JJ
cord-023095-4dannjjm	2474	2	,	,	,
cord-023095-4dannjjm	2474	3	but	but	CC
cord-023095-4dannjjm	2474	4	significant	significant	JJ
cord-023095-4dannjjm	2474	5	changes	change	NNS
cord-023095-4dannjjm	2474	6	of	of	IN
cord-023095-4dannjjm	2474	7	25	25	CD
cord-023095-4dannjjm	2474	8	OH	OH	NNP
cord-023095-4dannjjm	2474	9	vitamin	vitamin	NN
cord-023095-4dannjjm	2474	10	D3	D3	NNP
cord-023095-4dannjjm	2474	11	were	be	VBD
cord-023095-4dannjjm	2474	12	observed	observe	VBN
cord-023095-4dannjjm	2474	13	at	at	IN
cord-023095-4dannjjm	2474	14	day	day	NN
cord-023095-4dannjjm	2474	15	15	15	CD
cord-023095-4dannjjm	2474	16	(	(	-LRB-
cord-023095-4dannjjm	2474	17	end	end	NN
cord-023095-4dannjjm	2474	18	of	of	IN
cord-023095-4dannjjm	2474	19	the	the	DT
cord-023095-4dannjjm	2474	20	treatment	treatment	NN
cord-023095-4dannjjm	2474	21	period	period	NN
cord-023095-4dannjjm	2474	22	-increased	-increase	VBN
cord-023095-4dannjjm	2474	23	by	by	IN
cord-023095-4dannjjm	2474	24	13.8	13.8	CD
cord-023095-4dannjjm	2474	25	%	%	NN
cord-023095-4dannjjm	2474	26	)	)	-RRB-
cord-023095-4dannjjm	2474	27	and	and	CC
cord-023095-4dannjjm	2474	28	day	day	NN
cord-023095-4dannjjm	2474	29	21	21	CD
cord-023095-4dannjjm	2474	30	(	(	-LRB-
cord-023095-4dannjjm	2474	31	6	6	CD
cord-023095-4dannjjm	2474	32	days	day	NNS
cord-023095-4dannjjm	2474	33	after	after	IN
cord-023095-4dannjjm	2474	34	the	the	DT
cord-023095-4dannjjm	2474	35	end	end	NN
cord-023095-4dannjjm	2474	36	of	of	IN
cord-023095-4dannjjm	2474	37	the	the	DT
cord-023095-4dannjjm	2474	38	treatment	treatment	NN
cord-023095-4dannjjm	2474	39	-decreased	-decrease	VBN
cord-023095-4dannjjm	2474	40	by	by	IN
cord-023095-4dannjjm	2474	41	14.7	14.7	CD
cord-023095-4dannjjm	2474	42	%	%	NN
cord-023095-4dannjjm	2474	43	)	)	-RRB-
cord-023095-4dannjjm	2474	44	.	.	.
cord-023095-4dannjjm	2475	1	This	this	DT
cord-023095-4dannjjm	2475	2	study	study	NN
cord-023095-4dannjjm	2475	3	shows	show	VBZ
cord-023095-4dannjjm	2475	4	that	that	DT
cord-023095-4dannjjm	2475	5	treatment	treatment	NN
cord-023095-4dannjjm	2475	6	with	with	IN
cord-023095-4dannjjm	2475	7	omeprazole	omeprazole	NN
cord-023095-4dannjjm	2475	8	for	for	IN
cord-023095-4dannjjm	2475	9	2	2	CD
cord-023095-4dannjjm	2475	10	weeks	week	NNS
cord-023095-4dannjjm	2475	11	results	result	NNS
cord-023095-4dannjjm	2475	12	in	in	IN
cord-023095-4dannjjm	2475	13	a	a	DT
cord-023095-4dannjjm	2475	14	profound	profound	JJ
cord-023095-4dannjjm	2475	15	and	and	CC
cord-023095-4dannjjm	2475	16	sustained	sustained	JJ
cord-023095-4dannjjm	2475	17	increase	increase	NN
cord-023095-4dannjjm	2475	18	in	in	IN
cord-023095-4dannjjm	2475	19	serum	serum	NN
cord-023095-4dannjjm	2475	20	gastrin	gastrin	NN
cord-023095-4dannjjm	2475	21	concentration	concentration	NN
cord-023095-4dannjjm	2475	22	in	in	IN
cord-023095-4dannjjm	2475	23	dogs	dog	NNS
cord-023095-4dannjjm	2475	24	.	.	.
cord-023095-4dannjjm	2476	1	This	this	DT
cord-023095-4dannjjm	2476	2	effect	effect	NN
cord-023095-4dannjjm	2476	3	is	be	VBZ
cord-023095-4dannjjm	2476	4	rapidly	rapidly	RB
cord-023095-4dannjjm	2476	5	reversible	reversible	JJ
cord-023095-4dannjjm	2476	6	after	after	IN
cord-023095-4dannjjm	2476	7	cessation	cessation	NN
cord-023095-4dannjjm	2476	8	of	of	IN
cord-023095-4dannjjm	2476	9	the	the	DT
cord-023095-4dannjjm	2476	10	treatment	treatment	NN
cord-023095-4dannjjm	2476	11	.	.	.
cord-023095-4dannjjm	2477	1	No	no	DT
cord-023095-4dannjjm	2477	2	effect	effect	NN
cord-023095-4dannjjm	2477	3	on	on	IN
cord-023095-4dannjjm	2477	4	calcium	calcium	NN
cord-023095-4dannjjm	2477	5	metabolism	metabolism	NN
cord-023095-4dannjjm	2477	6	was	be	VBD
cord-023095-4dannjjm	2477	7	observed	observe	VBN
cord-023095-4dannjjm	2477	8	.	.	.
cord-023095-4dannjjm	2478	1	However	however	RB
cord-023095-4dannjjm	2478	2	,	,	,
cord-023095-4dannjjm	2478	3	this	this	DT
cord-023095-4dannjjm	2478	4	study	study	NN
cord-023095-4dannjjm	2478	5	documents	document	VBZ
cord-023095-4dannjjm	2478	6	only	only	RB
cord-023095-4dannjjm	2478	7	the	the	DT
cord-023095-4dannjjm	2478	8	effect	effect	NN
cord-023095-4dannjjm	2478	9	of	of	IN
cord-023095-4dannjjm	2478	10	short	short	JJ
cord-023095-4dannjjm	2478	11	-	-	HYPH
cord-023095-4dannjjm	2478	12	term	term	NN
cord-023095-4dannjjm	2478	13	treatment	treatment	NN
cord-023095-4dannjjm	2478	14	and	and	CC
cord-023095-4dannjjm	2478	15	it	-PRON-	PRP
cord-023095-4dannjjm	2478	16	is	be	VBZ
cord-023095-4dannjjm	2478	17	possible	possible	JJ
cord-023095-4dannjjm	2478	18	that	that	IN
cord-023095-4dannjjm	2478	19	the	the	DT
cord-023095-4dannjjm	2478	20	effects	effect	NNS
cord-023095-4dannjjm	2478	21	of	of	IN
cord-023095-4dannjjm	2478	22	long	long	JJ
cord-023095-4dannjjm	2478	23	-	-	HYPH
cord-023095-4dannjjm	2478	24	term	term	NN
cord-023095-4dannjjm	2478	25	administration	administration	NN
cord-023095-4dannjjm	2478	26	are	be	VBP
cord-023095-4dannjjm	2478	27	different	different	JJ
cord-023095-4dannjjm	2478	28	.	.	.
cord-023095-4dannjjm	2479	1	Omeprazole	omeprazole	NN
cord-023095-4dannjjm	2479	2	treatment	treatment	NN
cord-023095-4dannjjm	2479	3	has	have	VBZ
cord-023095-4dannjjm	2479	4	been	be	VBN
cord-023095-4dannjjm	2479	5	associated	associate	VBN
cord-023095-4dannjjm	2479	6	with	with	IN
cord-023095-4dannjjm	2479	7	small	small	JJ
cord-023095-4dannjjm	2479	8	intestinal	intestinal	JJ
cord-023095-4dannjjm	2479	9	bacterial	bacterial	JJ
cord-023095-4dannjjm	2479	10	overgrowth	overgrowth	NN
cord-023095-4dannjjm	2479	11	and	and	CC
cord-023095-4dannjjm	2479	12	a	a	DT
cord-023095-4dannjjm	2479	13	higher	high	JJR
cord-023095-4dannjjm	2479	14	risk	risk	NN
cord-023095-4dannjjm	2479	15	for	for	IN
cord-023095-4dannjjm	2479	16	infectious	infectious	JJ
cord-023095-4dannjjm	2479	17	enteropathies	enteropathy	NNS
cord-023095-4dannjjm	2479	18	in	in	IN
cord-023095-4dannjjm	2479	19	humans	human	NNS
cord-023095-4dannjjm	2479	20	.	.	.
cord-023095-4dannjjm	2480	1	Using	use	VBG
cord-023095-4dannjjm	2480	2	a	a	DT
cord-023095-4dannjjm	2480	3	semi	semi	JJ
cord-023095-4dannjjm	2480	4	-	-	JJ
cord-023095-4dannjjm	2480	5	quantitative	quantitative	JJ
cord-023095-4dannjjm	2480	6	sequencing	sequencing	NN
cord-023095-4dannjjm	2480	7	approach	approach	NN
cord-023095-4dannjjm	2480	8	,	,	,
cord-023095-4dannjjm	2480	9	we	-PRON-	PRP
cord-023095-4dannjjm	2480	10	have	have	VBP
cord-023095-4dannjjm	2480	11	previously	previously	RB
cord-023095-4dannjjm	2480	12	shown	show	VBN
cord-023095-4dannjjm	2480	13	that	that	IN
cord-023095-4dannjjm	2480	14	omeprazole	omeprazole	JJ
cord-023095-4dannjjm	2480	15	treatment	treatment	NN
cord-023095-4dannjjm	2480	16	may	may	MD
cord-023095-4dannjjm	2480	17	lead	lead	VB
cord-023095-4dannjjm	2480	18	to	to	IN
cord-023095-4dannjjm	2480	19	alterations	alteration	NNS
cord-023095-4dannjjm	2480	20	in	in	IN
cord-023095-4dannjjm	2480	21	both	both	DT
cord-023095-4dannjjm	2480	22	duodenal	duodenal	JJ
cord-023095-4dannjjm	2480	23	and	and	CC
cord-023095-4dannjjm	2480	24	gastric	gastric	JJ
cord-023095-4dannjjm	2480	25	bacterial	bacterial	JJ
cord-023095-4dannjjm	2480	26	populations	population	NNS
cord-023095-4dannjjm	2480	27	in	in	IN
cord-023095-4dannjjm	2480	28	healthy	healthy	JJ
cord-023095-4dannjjm	2480	29	dogs	dog	NNS
cord-023095-4dannjjm	2480	30	(	(	-LRB-
cord-023095-4dannjjm	2480	31	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	2480	32	2010	2010	CD
cord-023095-4dannjjm	2480	33	)	)	-RRB-
cord-023095-4dannjjm	2480	34	.	.	.
cord-023095-4dannjjm	2481	1	However	however	RB
cord-023095-4dannjjm	2481	2	,	,	,
cord-023095-4dannjjm	2481	3	a	a	DT
cord-023095-4dannjjm	2481	4	sequencing	sequencing	NN
cord-023095-4dannjjm	2481	5	approach	approach	NN
cord-023095-4dannjjm	2481	6	can	can	MD
cord-023095-4dannjjm	2481	7	only	only	RB
cord-023095-4dannjjm	2481	8	estimate	estimate	VB
cord-023095-4dannjjm	2481	9	relative	relative	JJ
cord-023095-4dannjjm	2481	10	proportions	proportion	NNS
cord-023095-4dannjjm	2481	11	of	of	IN
cord-023095-4dannjjm	2481	12	genomic	genomic	JJ
cord-023095-4dannjjm	2481	13	bacterial	bacterial	JJ
cord-023095-4dannjjm	2481	14	targets	target	NNS
cord-023095-4dannjjm	2481	15	.	.	.
cord-023095-4dannjjm	2482	1	Therefore	therefore	RB
cord-023095-4dannjjm	2482	2	,	,	,
cord-023095-4dannjjm	2482	3	significant	significant	JJ
cord-023095-4dannjjm	2482	4	changes	change	NNS
cord-023095-4dannjjm	2482	5	in	in	IN
cord-023095-4dannjjm	2482	6	the	the	DT
cord-023095-4dannjjm	2482	7	total	total	JJ
cord-023095-4dannjjm	2482	8	number	number	NN
cord-023095-4dannjjm	2482	9	of	of	IN
cord-023095-4dannjjm	2482	10	bacteria	bacteria	NNS
cord-023095-4dannjjm	2482	11	could	could	MD
cord-023095-4dannjjm	2482	12	not	not	RB
cord-023095-4dannjjm	2482	13	be	be	VB
cord-023095-4dannjjm	2482	14	evaluated	evaluate	VBN
cord-023095-4dannjjm	2482	15	.	.	.
cord-023095-4dannjjm	2483	1	The	the	DT
cord-023095-4dannjjm	2483	2	aim	aim	NN
cord-023095-4dannjjm	2483	3	of	of	IN
cord-023095-4dannjjm	2483	4	this	this	DT
cord-023095-4dannjjm	2483	5	study	study	NN
cord-023095-4dannjjm	2483	6	was	be	VBD
cord-023095-4dannjjm	2483	7	to	to	TO
cord-023095-4dannjjm	2483	8	quantify	quantify	VB
cord-023095-4dannjjm	2483	9	gastric	gastric	JJ
cord-023095-4dannjjm	2483	10	and	and	CC
cord-023095-4dannjjm	2483	11	duodenal	duodenal	JJ
cord-023095-4dannjjm	2483	12	bacterial	bacterial	JJ
cord-023095-4dannjjm	2483	13	populations	population	NNS
cord-023095-4dannjjm	2483	14	in	in	IN
cord-023095-4dannjjm	2483	15	dogs	dog	NNS
cord-023095-4dannjjm	2483	16	undergoing	undergo	VBG
cord-023095-4dannjjm	2483	17	omeprazole	omeprazole	NN
cord-023095-4dannjjm	2483	18	treatment	treatment	NN
cord-023095-4dannjjm	2483	19	.	.	.
cord-023095-4dannjjm	2484	1	Eight	eight	CD
cord-023095-4dannjjm	2484	2	9	9	CD
cord-023095-4dannjjm	2484	3	month	month	NN
cord-023095-4dannjjm	2484	4	-	-	HYPH
cord-023095-4dannjjm	2484	5	old	old	JJ
cord-023095-4dannjjm	2484	6	healthy	healthy	JJ
cord-023095-4dannjjm	2484	7	research	research	NN
cord-023095-4dannjjm	2484	8	dogs	dog	NNS
cord-023095-4dannjjm	2484	9	(	(	-LRB-
cord-023095-4dannjjm	2484	10	4	4	CD
cord-023095-4dannjjm	2484	11	males	male	NNS
cord-023095-4dannjjm	2484	12	and	and	CC
cord-023095-4dannjjm	2484	13	4	4	CD
cord-023095-4dannjjm	2484	14	females	female	NNS
cord-023095-4dannjjm	2484	15	)	)	-RRB-
cord-023095-4dannjjm	2484	16	were	be	VBD
cord-023095-4dannjjm	2484	17	enrolled	enrol	VBN
cord-023095-4dannjjm	2484	18	.	.	.
cord-023095-4dannjjm	2485	1	The	the	DT
cord-023095-4dannjjm	2485	2	dogs	dog	NNS
cord-023095-4dannjjm	2485	3	received	receive	VBD
cord-023095-4dannjjm	2485	4	an	an	DT
cord-023095-4dannjjm	2485	5	average	average	JJ
cord-023095-4dannjjm	2485	6	dose	dose	NN
cord-023095-4dannjjm	2485	7	of	of	IN
cord-023095-4dannjjm	2485	8	1.1	1.1	CD
cord-023095-4dannjjm	2485	9	mg	mg	NNP
cord-023095-4dannjjm	2485	10	/	/	SYM
cord-023095-4dannjjm	2485	11	kg	kg	NNP
cord-023095-4dannjjm	2485	12	of	of	IN
cord-023095-4dannjjm	2485	13	omeprazole	omeprazole	NN
cord-023095-4dannjjm	2485	14	orally	orally	RB
cord-023095-4dannjjm	2485	15	twice	twice	PDT
cord-023095-4dannjjm	2485	16	a	a	DT
cord-023095-4dannjjm	2485	17	day	day	NN
cord-023095-4dannjjm	2485	18	for	for	IN
cord-023095-4dannjjm	2485	19	15	15	CD
cord-023095-4dannjjm	2485	20	days	day	NNS
cord-023095-4dannjjm	2485	21	.	.	.
cord-023095-4dannjjm	2486	1	Endoscopic	Endoscopic	NNS
cord-023095-4dannjjm	2486	2	gastric	gastric	JJ
cord-023095-4dannjjm	2486	3	and	and	CC
cord-023095-4dannjjm	2486	4	duodenal	duodenal	JJ
cord-023095-4dannjjm	2486	5	biopsies	biopsy	NNS
cord-023095-4dannjjm	2486	6	were	be	VBD
cord-023095-4dannjjm	2486	7	harvested	harvest	VBN
cord-023095-4dannjjm	2486	8	30	30	CD
cord-023095-4dannjjm	2486	9	and	and	CC
cord-023095-4dannjjm	2486	10	15	15	CD
cord-023095-4dannjjm	2486	11	days	day	NNS
cord-023095-4dannjjm	2486	12	before	before	IN
cord-023095-4dannjjm	2486	13	starting	start	VBG
cord-023095-4dannjjm	2486	14	omeprazole	omeprazole	JJ
cord-023095-4dannjjm	2486	15	treatment	treatment	NN
cord-023095-4dannjjm	2486	16	,	,	,
cord-023095-4dannjjm	2486	17	on	on	IN
cord-023095-4dannjjm	2486	18	the	the	DT
cord-023095-4dannjjm	2486	19	last	last	JJ
cord-023095-4dannjjm	2486	20	day	day	NN
cord-023095-4dannjjm	2486	21	of	of	IN
cord-023095-4dannjjm	2486	22	treatment	treatment	NN
cord-023095-4dannjjm	2486	23	(	(	-LRB-
cord-023095-4dannjjm	2486	24	day	day	NN
cord-023095-4dannjjm	2486	25	15	15	CD
cord-023095-4dannjjm	2486	26	)	)	-RRB-
cord-023095-4dannjjm	2486	27	,	,	,
cord-023095-4dannjjm	2486	28	and	and	CC
cord-023095-4dannjjm	2486	29	15	15	CD
cord-023095-4dannjjm	2486	30	days	day	NNS
cord-023095-4dannjjm	2486	31	after	after	IN
cord-023095-4dannjjm	2486	32	the	the	DT
cord-023095-4dannjjm	2486	33	end	end	NN
cord-023095-4dannjjm	2486	34	of	of	IN
cord-023095-4dannjjm	2486	35	treatment	treatment	NN
cord-023095-4dannjjm	2486	36	(	(	-LRB-
cord-023095-4dannjjm	2486	37	day	day	NN
cord-023095-4dannjjm	2486	38	30	30	CD
cord-023095-4dannjjm	2486	39	)	)	-RRB-
cord-023095-4dannjjm	2486	40	.	.	.
cord-023095-4dannjjm	2487	1	All	all	DT
cord-023095-4dannjjm	2487	2	biopsies	biopsy	NNS
cord-023095-4dannjjm	2487	3	were	be	VBD
cord-023095-4dannjjm	2487	4	fixed	fix	VBN
cord-023095-4dannjjm	2487	5	in	in	IN
cord-023095-4dannjjm	2487	6	10	10	CD
cord-023095-4dannjjm	2487	7	%	%	NN
cord-023095-4dannjjm	2487	8	formalin	formalin	NN
cord-023095-4dannjjm	2487	9	for	for	IN
cord-023095-4dannjjm	2487	10	24	24	CD
cord-023095-4dannjjm	2487	11	hours	hour	NNS
cord-023095-4dannjjm	2487	12	,	,	,
cord-023095-4dannjjm	2487	13	processed	process	VBN
cord-023095-4dannjjm	2487	14	,	,	,
cord-023095-4dannjjm	2487	15	and	and	CC
cord-023095-4dannjjm	2487	16	embedded	embed	VBN
cord-023095-4dannjjm	2487	17	in	in	IN
cord-023095-4dannjjm	2487	18	paraffin	paraffin	NN
cord-023095-4dannjjm	2487	19	blocks	block	NNS
cord-023095-4dannjjm	2487	20	.	.	.
cord-023095-4dannjjm	2488	1	Fluorescent	fluorescent	JJ
cord-023095-4dannjjm	2488	2	in	in	IN
cord-023095-4dannjjm	2488	3	situ	situ	NN
cord-023095-4dannjjm	2488	4	hybridization	hybridization	NN
cord-023095-4dannjjm	2488	5	was	be	VBD
cord-023095-4dannjjm	2488	6	used	use	VBN
cord-023095-4dannjjm	2488	7	to	to	TO
cord-023095-4dannjjm	2488	8	quantify	quantify	VB
cord-023095-4dannjjm	2488	9	mucosa	mucosa	JJ
cord-023095-4dannjjm	2488	10	-	-	HYPH
cord-023095-4dannjjm	2488	11	associated	associate	VBN
cord-023095-4dannjjm	2488	12	bacteria	bacteria	NNS
cord-023095-4dannjjm	2488	13	using	use	VBG
cord-023095-4dannjjm	2488	14	fluorescently	fluorescently	RB
cord-023095-4dannjjm	2488	15	-	-	HYPH
cord-023095-4dannjjm	2488	16	labeled	label	VBN
cord-023095-4dannjjm	2488	17	probes	probe	NNS
cord-023095-4dannjjm	2488	18	targeting	target	VBG
cord-023095-4dannjjm	2488	19	the	the	DT
cord-023095-4dannjjm	2488	20	16S	16S	NNP
cord-023095-4dannjjm	2488	21	ribosomal	ribosomal	NN
cord-023095-4dannjjm	2488	22	RNA	RNA	NNP
cord-023095-4dannjjm	2488	23	.	.	.
cord-023095-4dannjjm	2489	1	Statistical	statistical	JJ
cord-023095-4dannjjm	2489	2	analysis	analysis	NN
cord-023095-4dannjjm	2489	3	aimed	aim	VBN
cord-023095-4dannjjm	2489	4	to	to	TO
cord-023095-4dannjjm	2489	5	compare	compare	VB
cord-023095-4dannjjm	2489	6	changes	change	NNS
cord-023095-4dannjjm	2489	7	in	in	IN
cord-023095-4dannjjm	2489	8	Helicobacter	Helicobacter	NNP
cord-023095-4dannjjm	2489	9	spp	spp	NNS
cord-023095-4dannjjm	2489	10	.	.	.
cord-023095-4dannjjm	2490	1	in	in	IN
cord-023095-4dannjjm	2490	2	gastric	gastric	JJ
cord-023095-4dannjjm	2490	3	biopsies	biopsy	NNS
cord-023095-4dannjjm	2490	4	and	and	CC
cord-023095-4dannjjm	2490	5	total	total	JJ
cord-023095-4dannjjm	2490	6	bacteria	bacteria	NNS
cord-023095-4dannjjm	2490	7	in	in	IN
cord-023095-4dannjjm	2490	8	both	both	CC
cord-023095-4dannjjm	2490	9	gastric	gastric	JJ
cord-023095-4dannjjm	2490	10	and	and	CC
cord-023095-4dannjjm	2490	11	duodenal	duodenal	JJ
cord-023095-4dannjjm	2490	12	biopsies	biopsy	NNS
cord-023095-4dannjjm	2490	13	using	use	VBG
cord-023095-4dannjjm	2490	14	the	the	DT
cord-023095-4dannjjm	2490	15	GLIMMIX	GLIMMIX	NNP
cord-023095-4dannjjm	2490	16	and	and	CC
cord-023095-4dannjjm	2490	17	NPAR1WAY	npar1way	CD
cord-023095-4dannjjm	2490	18	procedures	procedure	NNS
cord-023095-4dannjjm	2490	19	in	in	IN
cord-023095-4dannjjm	2490	20	SAS	SAS	NNP
cord-023095-4dannjjm	2490	21	s	s	POS
cord-023095-4dannjjm	2490	22	9.2	9.2	CD
cord-023095-4dannjjm	2490	23	.	.	.
cord-023095-4dannjjm	2491	1	Bacteria	Bacteria	NNS
cord-023095-4dannjjm	2491	2	were	be	VBD
cord-023095-4dannjjm	2491	3	counted	count	VBN
cord-023095-4dannjjm	2491	4	in	in	IN
cord-023095-4dannjjm	2491	5	1,174	1,174	CD
cord-023095-4dannjjm	2491	6	and	and	CC
cord-023095-4dannjjm	2491	7	989	989	CD
cord-023095-4dannjjm	2491	8	microscopic	microscopic	JJ
cord-023095-4dannjjm	2491	9	fields	field	NNS
cord-023095-4dannjjm	2491	10	(	(	-LRB-
cord-023095-4dannjjm	2491	11	63Â	63Â	NNP
cord-023095-4dannjjm	2491	12	)	)	-RRB-
cord-023095-4dannjjm	2491	13	obtained	obtain	VBN
cord-023095-4dannjjm	2491	14	from	from	IN
cord-023095-4dannjjm	2491	15	155	155	CD
cord-023095-4dannjjm	2491	16	and	and	CC
cord-023095-4dannjjm	2491	17	132	132	CD
cord-023095-4dannjjm	2491	18	gastric	gastric	JJ
cord-023095-4dannjjm	2491	19	and	and	CC
cord-023095-4dannjjm	2491	20	duodenal	duodenal	JJ
cord-023095-4dannjjm	2491	21	biopsies	biopsy	NNS
cord-023095-4dannjjm	2491	22	,	,	,
cord-023095-4dannjjm	2491	23	respectively	respectively	RB
cord-023095-4dannjjm	2491	24	.	.	.
cord-023095-4dannjjm	2492	1	In	in	IN
cord-023095-4dannjjm	2492	2	the	the	DT
cord-023095-4dannjjm	2492	3	stomach	stomach	NN
cord-023095-4dannjjm	2492	4	,	,	,
cord-023095-4dannjjm	2492	5	omeprazole	omeprazole	NN
cord-023095-4dannjjm	2492	6	treatment	treatment	NN
cord-023095-4dannjjm	2492	7	led	lead	VBD
cord-023095-4dannjjm	2492	8	to	to	IN
cord-023095-4dannjjm	2492	9	a	a	DT
cord-023095-4dannjjm	2492	10	decrease	decrease	NN
cord-023095-4dannjjm	2492	11	in	in	IN
cord-023095-4dannjjm	2492	12	Helicobacter	Helicobacter	NNP
cord-023095-4dannjjm	2492	13	spp	spp	NNS
cord-023095-4dannjjm	2492	14	.	.	.
cord-023095-4dannjjm	2493	1	(	(	-LRB-
cord-023095-4dannjjm	2493	2	log	log	NN
cord-023095-4dannjjm	2493	3	of	of	IN
cord-023095-4dannjjm	2493	4	average	average	JJ
cord-023095-4dannjjm	2493	5	counts	count	NNS
cord-023095-4dannjjm	2493	6	AE	AE	NNP
cord-023095-4dannjjm	2493	7	standard	standard	JJ
cord-023095-4dannjjm	2493	8	error	error	NN
cord-023095-4dannjjm	2493	9	:	:	:
cord-023095-4dannjjm	2493	10	1.98	1.98	CD
cord-023095-4dannjjm	2493	11	AE	AE	NNP
cord-023095-4dannjjm	2493	12	0.14	0.14	CD
cord-023095-4dannjjm	2493	13	at	at	IN
cord-023095-4dannjjm	2493	14	day	day	NN
cord-023095-4dannjjm	2493	15	15	15	CD
cord-023095-4dannjjm	2493	16	)	)	-RRB-
cord-023095-4dannjjm	2493	17	when	when	WRB
cord-023095-4dannjjm	2493	18	compared	compare	VBN
cord-023095-4dannjjm	2493	19	to	to	IN
cord-023095-4dannjjm	2493	20	the	the	DT
cord-023095-4dannjjm	2493	21	counts	count	NNS
cord-023095-4dannjjm	2493	22	30	30	CD
cord-023095-4dannjjm	2493	23	(	(	-LRB-
cord-023095-4dannjjm	2493	24	2.43	2.43	CD
cord-023095-4dannjjm	2493	25	AE	AE	NNP
cord-023095-4dannjjm	2493	26	0.13	0.13	CD
cord-023095-4dannjjm	2493	27	,	,	,
cord-023095-4dannjjm	2493	28	p0.0001	p0.0001	CD
cord-023095-4dannjjm	2493	29	)	)	-RRB-
cord-023095-4dannjjm	2493	30	and	and	CC
cord-023095-4dannjjm	2493	31	15	15	CD
cord-023095-4dannjjm	2493	32	(	(	-LRB-
cord-023095-4dannjjm	2493	33	2.40	2.40	CD
cord-023095-4dannjjm	2493	34	AE	AE	NNP
cord-023095-4dannjjm	2493	35	0.13	0.13	CD
cord-023095-4dannjjm	2493	36	,	,	,
cord-023095-4dannjjm	2493	37	p0.0001	p0.0001	CD
cord-023095-4dannjjm	2493	38	)	)	-RRB-
cord-023095-4dannjjm	2493	39	days	day	NNS
cord-023095-4dannjjm	2493	40	before	before	IN
cord-023095-4dannjjm	2493	41	treatment	treatment	NN
cord-023095-4dannjjm	2493	42	.	.	.
cord-023095-4dannjjm	2494	1	After	after	IN
cord-023095-4dannjjm	2494	2	completion	completion	NN
cord-023095-4dannjjm	2494	3	of	of	IN
cord-023095-4dannjjm	2494	4	omeprazole	omeprazole	NN
cord-023095-4dannjjm	2494	5	treatment	treatment	NN
cord-023095-4dannjjm	2494	6	,	,	,
cord-023095-4dannjjm	2494	7	Helicobacter	Helicobacter	NNP
cord-023095-4dannjjm	2494	8	spp	spp	NNS
cord-023095-4dannjjm	2494	9	.	.	.
cord-023095-4dannjjm	2495	1	increased	increase	VBN
cord-023095-4dannjjm	2495	2	and	and	CC
cord-023095-4dannjjm	2495	3	returned	return	VBD
cord-023095-4dannjjm	2495	4	to	to	IN
cord-023095-4dannjjm	2495	5	baseline	baseline	JJ
cord-023095-4dannjjm	2495	6	counts	count	NNS
cord-023095-4dannjjm	2495	7	(	(	-LRB-
cord-023095-4dannjjm	2495	8	2.45	2.45	CD
cord-023095-4dannjjm	2495	9	AE	AE	NNP
cord-023095-4dannjjm	2495	10	0.13	0.13	CD
cord-023095-4dannjjm	2495	11	at	at	IN
cord-023095-4dannjjm	2495	12	day	day	NN
cord-023095-4dannjjm	2495	13	30	30	CD
cord-023095-4dannjjm	2495	14	,	,	,
cord-023095-4dannjjm	2495	15	p0.0001	p0.0001	CD
cord-023095-4dannjjm	2495	16	vs	vs	IN
cord-023095-4dannjjm	2495	17	day	day	NN
cord-023095-4dannjjm	2495	18	15	15	CD
cord-023095-4dannjjm	2495	19	)	)	-RRB-
cord-023095-4dannjjm	2495	20	.	.	.
cord-023095-4dannjjm	2496	1	Also	also	RB
cord-023095-4dannjjm	2496	2	,	,	,
cord-023095-4dannjjm	2496	3	in	in	IN
cord-023095-4dannjjm	2496	4	the	the	DT
cord-023095-4dannjjm	2496	5	stomach	stomach	NN
cord-023095-4dannjjm	2496	6	,	,	,
cord-023095-4dannjjm	2496	7	non	non	JJ
cord-023095-4dannjjm	2496	8	-	-	JJ
cord-023095-4dannjjm	2496	9	Helicobacter	helicobacter	JJ
cord-023095-4dannjjm	2496	10	spp	spp	NNS
cord-023095-4dannjjm	2496	11	.	.	.
cord-023095-4dannjjm	2497	1	bacteria	bacteria	NNS
cord-023095-4dannjjm	2497	2	were	be	VBD
cord-023095-4dannjjm	2497	3	observed	observe	VBN
cord-023095-4dannjjm	2497	4	more	more	RBR
cord-023095-4dannjjm	2497	5	often	often	RB
cord-023095-4dannjjm	2497	6	during	during	IN
cord-023095-4dannjjm	2497	7	omeprazole	omeprazole	JJ
cord-023095-4dannjjm	2497	8	treatment	treatment	NN
cord-023095-4dannjjm	2497	9	(	(	-LRB-
cord-023095-4dannjjm	2497	10	median	median	NN
cord-023095-4dannjjm	2497	11	:	:	:
cord-023095-4dannjjm	2497	12	3	3	CD
cord-023095-4dannjjm	2497	13	,	,	,
cord-023095-4dannjjm	2497	14	range	range	NN
cord-023095-4dannjjm	2497	15	:	:	:
cord-023095-4dannjjm	2497	16	0	0	CD
cord-023095-4dannjjm	2497	17	-	-	SYM
cord-023095-4dannjjm	2497	18	20	20	CD
cord-023095-4dannjjm	2497	19	)	)	-RRB-
cord-023095-4dannjjm	2497	20	than	than	IN
cord-023095-4dannjjm	2497	21	on	on	IN
cord-023095-4dannjjm	2497	22	days	day	NNS
cord-023095-4dannjjm	2497	23	30	30	CD
cord-023095-4dannjjm	2497	24	(	(	-LRB-
cord-023095-4dannjjm	2497	25	median	median	NN
cord-023095-4dannjjm	2497	26	:	:	SYM
cord-023095-4dannjjm	2497	27	0	0	CD
cord-023095-4dannjjm	2497	28	,	,	,
cord-023095-4dannjjm	2497	29	range	range	NN
cord-023095-4dannjjm	2497	30	:	:	:
cord-023095-4dannjjm	2497	31	0	0	CD
cord-023095-4dannjjm	2497	32	-	-	SYM
cord-023095-4dannjjm	2497	33	3	3	CD
cord-023095-4dannjjm	2497	34	)	)	-RRB-
cord-023095-4dannjjm	2497	35	and	and	CC
cord-023095-4dannjjm	2497	36	15	15	CD
cord-023095-4dannjjm	2497	37	(	(	-LRB-
cord-023095-4dannjjm	2497	38	median	median	NN
cord-023095-4dannjjm	2497	39	:	:	SYM
cord-023095-4dannjjm	2497	40	1	1	CD
cord-023095-4dannjjm	2497	41	,	,	,
cord-023095-4dannjjm	2497	42	range	range	NN
cord-023095-4dannjjm	2497	43	:	:	:
cord-023095-4dannjjm	2497	44	0	0	CD
cord-023095-4dannjjm	2497	45	-	-	SYM
cord-023095-4dannjjm	2497	46	6	6	CD
cord-023095-4dannjjm	2497	47	)	)	-RRB-
cord-023095-4dannjjm	2497	48	before	before	IN
cord-023095-4dannjjm	2497	49	and	and	CC
cord-023095-4dannjjm	2497	50	15	15	CD
cord-023095-4dannjjm	2497	51	days	day	NNS
cord-023095-4dannjjm	2497	52	after	after	IN
cord-023095-4dannjjm	2497	53	(	(	-LRB-
cord-023095-4dannjjm	2497	54	median	median	NN
cord-023095-4dannjjm	2497	55	:	:	SYM
cord-023095-4dannjjm	2497	56	0	0	CD
cord-023095-4dannjjm	2497	57	,	,	,
cord-023095-4dannjjm	2497	58	range	range	NN
cord-023095-4dannjjm	2497	59	:	:	:
cord-023095-4dannjjm	2497	60	0	0	CD
cord-023095-4dannjjm	2497	61	-	-	SYM
cord-023095-4dannjjm	2497	62	2	2	CD
cord-023095-4dannjjm	2497	63	)	)	-RRB-
cord-023095-4dannjjm	2498	1	omeprazole	omeprazole	NN
cord-023095-4dannjjm	2498	2	treatment	treatment	NN
cord-023095-4dannjjm	2498	3	;	;	:
cord-023095-4dannjjm	2498	4	however	however	RB
cord-023095-4dannjjm	2498	5	,	,	,
cord-023095-4dannjjm	2498	6	statistical	statistical	JJ
cord-023095-4dannjjm	2498	7	comparison	comparison	NN
cord-023095-4dannjjm	2498	8	across	across	IN
cord-023095-4dannjjm	2498	9	time	time	NN
cord-023095-4dannjjm	2498	10	points	point	NNS
cord-023095-4dannjjm	2498	11	did	do	VBD
cord-023095-4dannjjm	2498	12	not	not	RB
cord-023095-4dannjjm	2498	13	reach	reach	VB
cord-023095-4dannjjm	2498	14	significance	significance	NN
cord-023095-4dannjjm	2498	15	.	.	.
cord-023095-4dannjjm	2499	1	In	in	IN
cord-023095-4dannjjm	2499	2	the	the	DT
cord-023095-4dannjjm	2499	3	duodenum	duodenum	NN
cord-023095-4dannjjm	2499	4	,	,	,
cord-023095-4dannjjm	2499	5	while	while	IN
cord-023095-4dannjjm	2499	6	the	the	DT
cord-023095-4dannjjm	2499	7	median	median	JJ
cord-023095-4dannjjm	2499	8	number	number	NN
cord-023095-4dannjjm	2499	9	of	of	IN
cord-023095-4dannjjm	2499	10	bacteria	bacteria	NNS
cord-023095-4dannjjm	2499	11	for	for	IN
cord-023095-4dannjjm	2499	12	all	all	DT
cord-023095-4dannjjm	2499	13	time	time	NN
cord-023095-4dannjjm	2499	14	points	point	NNS
cord-023095-4dannjjm	2499	15	was	be	VBD
cord-023095-4dannjjm	2499	16	zero	zero	CD
cord-023095-4dannjjm	2499	17	,	,	,
cord-023095-4dannjjm	2499	18	non	non	JJ
cord-023095-4dannjjm	2499	19	-	-	JJ
cord-023095-4dannjjm	2499	20	parametric	parametric	JJ
cord-023095-4dannjjm	2499	21	comparison	comparison	NN
cord-023095-4dannjjm	2499	22	of	of	IN
cord-023095-4dannjjm	2499	23	median	median	JJ
cord-023095-4dannjjm	2499	24	scores	score	NNS
cord-023095-4dannjjm	2499	25	(	(	-LRB-
cord-023095-4dannjjm	2499	26	number	number	NN
cord-023095-4dannjjm	2499	27	of	of	IN
cord-023095-4dannjjm	2499	28	points	point	NNS
cord-023095-4dannjjm	2499	29	above	above	IN
cord-023095-4dannjjm	2499	30	median	median	NN
cord-023095-4dannjjm	2499	31	)	)	-RRB-
cord-023095-4dannjjm	2499	32	revealed	reveal	VBD
cord-023095-4dannjjm	2499	33	significantly	significantly	RB
cord-023095-4dannjjm	2499	34	higher	high	JJR
cord-023095-4dannjjm	2499	35	numbers	number	NNS
cord-023095-4dannjjm	2499	36	of	of	IN
cord-023095-4dannjjm	2499	37	bacteria	bacteria	NNS
cord-023095-4dannjjm	2499	38	during	during	IN
cord-023095-4dannjjm	2499	39	omeprazole	omeprazole	JJ
cord-023095-4dannjjm	2499	40	treatment	treatment	NN
cord-023095-4dannjjm	2499	41	(	(	-LRB-
cord-023095-4dannjjm	2499	42	p	p	NN
cord-023095-4dannjjm	2499	43	5	5	CD
cord-023095-4dannjjm	2499	44	0.0063	0.0063	CD
cord-023095-4dannjjm	2499	45	)	)	-RRB-
cord-023095-4dannjjm	2499	46	.	.	.
cord-023095-4dannjjm	2500	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	2500	2	results	result	NNS
cord-023095-4dannjjm	2500	3	suggest	suggest	VBP
cord-023095-4dannjjm	2500	4	that	that	IN
cord-023095-4dannjjm	2500	5	omeprazole	omeprazole	JJ
cord-023095-4dannjjm	2500	6	treatment	treatment	NN
cord-023095-4dannjjm	2500	7	for	for	IN
cord-023095-4dannjjm	2500	8	2	2	CD
cord-023095-4dannjjm	2500	9	weeks	week	NNS
cord-023095-4dannjjm	2500	10	leads	lead	VBZ
cord-023095-4dannjjm	2500	11	to	to	IN
cord-023095-4dannjjm	2500	12	a	a	DT
cord-023095-4dannjjm	2500	13	lower	low	JJR
cord-023095-4dannjjm	2500	14	abundance	abundance	NN
cord-023095-4dannjjm	2500	15	of	of	IN
cord-023095-4dannjjm	2500	16	Helicobacter	Helicobacter	NNP
cord-023095-4dannjjm	2500	17	spp	spp	NNS
cord-023095-4dannjjm	2500	18	.	.	.
cord-023095-4dannjjm	2501	1	organisms	organism	NNS
cord-023095-4dannjjm	2501	2	in	in	IN
cord-023095-4dannjjm	2501	3	the	the	DT
cord-023095-4dannjjm	2501	4	stomach	stomach	NN
cord-023095-4dannjjm	2501	5	of	of	IN
cord-023095-4dannjjm	2501	6	healthy	healthy	JJ
cord-023095-4dannjjm	2501	7	dogs	dog	NNS
cord-023095-4dannjjm	2501	8	.	.	.
cord-023095-4dannjjm	2502	1	Also	also	RB
cord-023095-4dannjjm	2502	2	,	,	,
cord-023095-4dannjjm	2502	3	this	this	DT
cord-023095-4dannjjm	2502	4	transient	transient	JJ
cord-023095-4dannjjm	2502	5	decrease	decrease	NN
cord-023095-4dannjjm	2502	6	in	in	IN
cord-023095-4dannjjm	2502	7	Helicobacter	Helicobacter	NNP
cord-023095-4dannjjm	2502	8	spp	spp	NNS
cord-023095-4dannjjm	2502	9	.	.	.
cord-023095-4dannjjm	2502	10	was	be	VBD
cord-023095-4dannjjm	2502	11	accompanied	accompany	VBN
cord-023095-4dannjjm	2502	12	by	by	IN
cord-023095-4dannjjm	2502	13	a	a	DT
cord-023095-4dannjjm	2502	14	higher	high	JJR
cord-023095-4dannjjm	2502	15	abundance	abundance	NN
cord-023095-4dannjjm	2502	16	of	of	IN
cord-023095-4dannjjm	2502	17	other	other	JJ
cord-023095-4dannjjm	2502	18	bacteria	bacteria	NNS
cord-023095-4dannjjm	2502	19	in	in	IN
cord-023095-4dannjjm	2502	20	both	both	CC
cord-023095-4dannjjm	2502	21	the	the	DT
cord-023095-4dannjjm	2502	22	stomach	stomach	NN
cord-023095-4dannjjm	2502	23	and	and	CC
cord-023095-4dannjjm	2502	24	the	the	DT
cord-023095-4dannjjm	2502	25	proximal	proximal	JJ
cord-023095-4dannjjm	2502	26	duodenum	duodenum	NN
cord-023095-4dannjjm	2502	27	.	.	.
cord-023095-4dannjjm	2503	1	The	the	DT
cord-023095-4dannjjm	2503	2	SmartPill	SmartPill	NNP
cord-023095-4dannjjm	2503	3	pH.P	pH.P	NNP
cord-023095-4dannjjm	2503	4	s	s	POS
cord-023095-4dannjjm	2503	5	capsule	capsule	NN
cord-023095-4dannjjm	2503	6	(	(	-LRB-
cord-023095-4dannjjm	2503	7	The	the	DT
cord-023095-4dannjjm	2503	8	SmartPill	SmartPill	NNP
cord-023095-4dannjjm	2503	9	Corporation	Corporation	NNP
cord-023095-4dannjjm	2503	10	)	)	-RRB-
cord-023095-4dannjjm	2503	11	is	be	VBZ
cord-023095-4dannjjm	2503	12	a	a	DT
cord-023095-4dannjjm	2503	13	wireless	wireless	JJ
cord-023095-4dannjjm	2503	14	motility	motility	NN
cord-023095-4dannjjm	2503	15	capsule	capsule	NN
cord-023095-4dannjjm	2503	16	that	that	WDT
cord-023095-4dannjjm	2503	17	measures	measure	VBZ
cord-023095-4dannjjm	2503	18	pH	ph	NN
cord-023095-4dannjjm	2503	19	,	,	,
cord-023095-4dannjjm	2503	20	pressure	pressure	NN
cord-023095-4dannjjm	2503	21	,	,	,
cord-023095-4dannjjm	2503	22	and	and	CC
cord-023095-4dannjjm	2503	23	temperature	temperature	NN
cord-023095-4dannjjm	2503	24	as	as	IN
cord-023095-4dannjjm	2503	25	it	-PRON-	PRP
cord-023095-4dannjjm	2503	26	passes	pass	VBZ
cord-023095-4dannjjm	2503	27	through	through	IN
cord-023095-4dannjjm	2503	28	the	the	DT
cord-023095-4dannjjm	2503	29	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2503	30	(	(	-LRB-
cord-023095-4dannjjm	2503	31	GI	GI	NNP
cord-023095-4dannjjm	2503	32	)	)	-RRB-
cord-023095-4dannjjm	2503	33	tract	tract	NN
cord-023095-4dannjjm	2503	34	.	.	.
cord-023095-4dannjjm	2504	1	Analysis	analysis	NN
cord-023095-4dannjjm	2504	2	of	of	IN
cord-023095-4dannjjm	2504	3	this	this	DT
cord-023095-4dannjjm	2504	4	data	data	NN
cord-023095-4dannjjm	2504	5	allows	allow	VBZ
cord-023095-4dannjjm	2504	6	the	the	DT
cord-023095-4dannjjm	2504	7	calculation	calculation	NN
cord-023095-4dannjjm	2504	8	of	of	IN
cord-023095-4dannjjm	2504	9	gastric	gastric	JJ
cord-023095-4dannjjm	2504	10	emptying	emptying	NN
cord-023095-4dannjjm	2504	11	time	time	NN
cord-023095-4dannjjm	2504	12	(	(	-LRB-
cord-023095-4dannjjm	2504	13	GET	get	VB
cord-023095-4dannjjm	2504	14	)	)	-RRB-
cord-023095-4dannjjm	2504	15	,	,	,
cord-023095-4dannjjm	2504	16	small	small	JJ
cord-023095-4dannjjm	2504	17	and	and	CC
cord-023095-4dannjjm	2504	18	large	large	JJ
cord-023095-4dannjjm	2504	19	bowel	bowel	NN
cord-023095-4dannjjm	2504	20	transit	transit	NN
cord-023095-4dannjjm	2504	21	time	time	NN
cord-023095-4dannjjm	2504	22	(	(	-LRB-
cord-023095-4dannjjm	2504	23	SLBTT	SLBTT	NNP
cord-023095-4dannjjm	2504	24	)	)	-RRB-
cord-023095-4dannjjm	2504	25	,	,	,
cord-023095-4dannjjm	2504	26	and	and	CC
cord-023095-4dannjjm	2504	27	total	total	JJ
cord-023095-4dannjjm	2504	28	GI	GI	NNP
cord-023095-4dannjjm	2504	29	transit	transit	NN
cord-023095-4dannjjm	2504	30	time	time	NN
cord-023095-4dannjjm	2504	31	(	(	-LRB-
cord-023095-4dannjjm	2504	32	TGTT	TGTT	NNP
cord-023095-4dannjjm	2504	33	)	)	-RRB-
cord-023095-4dannjjm	2504	34	.	.	.
cord-023095-4dannjjm	2505	1	This	this	DT
cord-023095-4dannjjm	2505	2	study	study	NN
cord-023095-4dannjjm	2505	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	2505	4	the	the	DT
cord-023095-4dannjjm	2505	5	variability	variability	NN
cord-023095-4dannjjm	2505	6	associated	associate	VBN
cord-023095-4dannjjm	2505	7	with	with	IN
cord-023095-4dannjjm	2505	8	repeated	repeat	VBN
cord-023095-4dannjjm	2505	9	measurement	measurement	NN
cord-023095-4dannjjm	2505	10	of	of	IN
cord-023095-4dannjjm	2505	11	GI	GI	NNP
cord-023095-4dannjjm	2505	12	transit	transit	NN
cord-023095-4dannjjm	2505	13	times	time	NNS
cord-023095-4dannjjm	2505	14	and	and	CC
cord-023095-4dannjjm	2505	15	the	the	DT
cord-023095-4dannjjm	2505	16	effect	effect	NN
cord-023095-4dannjjm	2505	17	of	of	IN
cord-023095-4dannjjm	2505	18	oral	oral	JJ
cord-023095-4dannjjm	2505	19	administration	administration	NN
cord-023095-4dannjjm	2505	20	of	of	IN
cord-023095-4dannjjm	2505	21	ranitidine	ranitidine	NNP
cord-023095-4dannjjm	2505	22	(	(	-LRB-
cord-023095-4dannjjm	2505	23	Zantac	Zantac	NNP
cord-023095-4dannjjm	2505	24	s	s	NNP
cord-023095-4dannjjm	2505	25	)	)	-RRB-
cord-023095-4dannjjm	2505	26	on	on	IN
cord-023095-4dannjjm	2505	27	GI	GI	NNP
cord-023095-4dannjjm	2505	28	transit	transit	NN
cord-023095-4dannjjm	2505	29	times	time	NNS
cord-023095-4dannjjm	2505	30	in	in	IN
cord-023095-4dannjjm	2505	31	dogs	dog	NNS
cord-023095-4dannjjm	2505	32	using	use	VBG
cord-023095-4dannjjm	2505	33	this	this	DT
cord-023095-4dannjjm	2505	34	system	system	NN
cord-023095-4dannjjm	2505	35	.	.	.
cord-023095-4dannjjm	2506	1	It	-PRON-	PRP
cord-023095-4dannjjm	2506	2	was	be	VBD
cord-023095-4dannjjm	2506	3	hypothesized	hypothesize	VBN
cord-023095-4dannjjm	2506	4	that	that	IN
cord-023095-4dannjjm	2506	5	ranitidine	ranitidine	NN
cord-023095-4dannjjm	2506	6	would	would	MD
cord-023095-4dannjjm	2506	7	reduce	reduce	VB
cord-023095-4dannjjm	2506	8	GI	GI	NNP
cord-023095-4dannjjm	2506	9	transit	transit	NN
cord-023095-4dannjjm	2506	10	times	time	NNS
cord-023095-4dannjjm	2506	11	.	.	.
cord-023095-4dannjjm	2507	1	Six	six	CD
cord-023095-4dannjjm	2507	2	privately	privately	RB
cord-023095-4dannjjm	2507	3	owned	own	VBN
cord-023095-4dannjjm	2507	4	healthy	healthy	JJ
cord-023095-4dannjjm	2507	5	adult	adult	NN
cord-023095-4dannjjm	2507	6	dogs	dog	NNS
cord-023095-4dannjjm	2507	7	weighing	weigh	VBG
cord-023095-4dannjjm	2507	8	between	between	IN
cord-023095-4dannjjm	2507	9	25.0	25.0	CD
cord-023095-4dannjjm	2507	10	kg	kg	NNS
cord-023095-4dannjjm	2507	11	and	and	CC
cord-023095-4dannjjm	2507	12	41.0	41.0	CD
cord-023095-4dannjjm	2507	13	kg	kg	NNS
cord-023095-4dannjjm	2507	14	were	be	VBD
cord-023095-4dannjjm	2507	15	used	use	VBN
cord-023095-4dannjjm	2507	16	.	.	.
cord-023095-4dannjjm	2508	1	On	on	IN
cord-023095-4dannjjm	2508	2	3	3	CD
cord-023095-4dannjjm	2508	3	occasions	occasion	NNS
cord-023095-4dannjjm	2508	4	each	each	DT
cord-023095-4dannjjm	2508	5	dog	dog	NN
cord-023095-4dannjjm	2508	6	was	be	VBD
cord-023095-4dannjjm	2508	7	fed	feed	VBN
cord-023095-4dannjjm	2508	8	a	a	DT
cord-023095-4dannjjm	2508	9	standard	standard	JJ
cord-023095-4dannjjm	2508	10	meal	meal	NN
cord-023095-4dannjjm	2508	11	followed	follow	VBN
cord-023095-4dannjjm	2508	12	by	by	IN
cord-023095-4dannjjm	2508	13	oral	oral	JJ
cord-023095-4dannjjm	2508	14	administration	administration	NN
cord-023095-4dannjjm	2508	15	of	of	IN
cord-023095-4dannjjm	2508	16	a	a	DT
cord-023095-4dannjjm	2508	17	capsule	capsule	NN
cord-023095-4dannjjm	2508	18	.	.	.
cord-023095-4dannjjm	2509	1	Data	datum	NNS
cord-023095-4dannjjm	2509	2	were	be	VBD
cord-023095-4dannjjm	2509	3	recorded	record	VBN
cord-023095-4dannjjm	2509	4	until	until	IN
cord-023095-4dannjjm	2509	5	the	the	DT
cord-023095-4dannjjm	2509	6	capsule	capsule	NN
cord-023095-4dannjjm	2509	7	had	have	VBD
cord-023095-4dannjjm	2509	8	passed	pass	VBN
cord-023095-4dannjjm	2509	9	in	in	IN
cord-023095-4dannjjm	2509	10	the	the	DT
cord-023095-4dannjjm	2509	11	dog	dog	NN
cord-023095-4dannjjm	2509	12	's	's	POS
cord-023095-4dannjjm	2509	13	feces	fece	NNS
cord-023095-4dannjjm	2509	14	.	.	.
cord-023095-4dannjjm	2510	1	On	on	IN
cord-023095-4dannjjm	2510	2	a	a	DT
cord-023095-4dannjjm	2510	3	4th	4th	JJ
cord-023095-4dannjjm	2510	4	occasion	occasion	NN
cord-023095-4dannjjm	2510	5	each	each	DT
cord-023095-4dannjjm	2510	6	dog	dog	NN
cord-023095-4dannjjm	2510	7	was	be	VBD
cord-023095-4dannjjm	2510	8	given	give	VBN
cord-023095-4dannjjm	2510	9	75	75	CD
cord-023095-4dannjjm	2510	10	mg	mg	NN
cord-023095-4dannjjm	2510	11	of	of	IN
cord-023095-4dannjjm	2510	12	ranitidine	ranitidine	NN
cord-023095-4dannjjm	2510	13	PO	PO	NNP
cord-023095-4dannjjm	2510	14	q12	q12	NN
cord-023095-4dannjjm	2510	15	hrs	hrs	NN
cord-023095-4dannjjm	2510	16	starting	start	VBG
cord-023095-4dannjjm	2510	17	48	48	CD
cord-023095-4dannjjm	2510	18	hrs	hrs	NN
cord-023095-4dannjjm	2510	19	prior	prior	RB
cord-023095-4dannjjm	2510	20	to	to	IN
cord-023095-4dannjjm	2510	21	testing	testing	NN
cord-023095-4dannjjm	2510	22	.	.	.
cord-023095-4dannjjm	2511	1	The	the	DT
cord-023095-4dannjjm	2511	2	dogs	dog	NNS
cord-023095-4dannjjm	2511	3	were	be	VBD
cord-023095-4dannjjm	2511	4	then	then	RB
cord-023095-4dannjjm	2511	5	fed	feed	VBN
cord-023095-4dannjjm	2511	6	the	the	DT
cord-023095-4dannjjm	2511	7	test	test	NN
cord-023095-4dannjjm	2511	8	meal	meal	NN
cord-023095-4dannjjm	2511	9	and	and	CC
cord-023095-4dannjjm	2511	10	the	the	DT
cord-023095-4dannjjm	2511	11	capsule	capsule	NN
cord-023095-4dannjjm	2511	12	was	be	VBD
cord-023095-4dannjjm	2511	13	administered	administer	VBN
cord-023095-4dannjjm	2511	14	as	as	IN
cord-023095-4dannjjm	2511	15	above	above	RB
cord-023095-4dannjjm	2511	16	.	.	.
cord-023095-4dannjjm	2512	1	Ranitidine	Ranitidine	NNP
cord-023095-4dannjjm	2512	2	was	be	VBD
cord-023095-4dannjjm	2512	3	given	give	VBN
cord-023095-4dannjjm	2512	4	until	until	IN
cord-023095-4dannjjm	2512	5	the	the	DT
cord-023095-4dannjjm	2512	6	capsule	capsule	NN
cord-023095-4dannjjm	2512	7	had	have	VBD
cord-023095-4dannjjm	2512	8	passed	pass	VBN
cord-023095-4dannjjm	2512	9	in	in	IN
cord-023095-4dannjjm	2512	10	the	the	DT
cord-023095-4dannjjm	2512	11	dog	dog	NN
cord-023095-4dannjjm	2512	12	's	's	POS
cord-023095-4dannjjm	2512	13	feces	fece	NNS
cord-023095-4dannjjm	2512	14	.	.	.
cord-023095-4dannjjm	2513	1	Proprietary	proprietary	JJ
cord-023095-4dannjjm	2513	2	SmartPill	SmartPill	NNP
cord-023095-4dannjjm	2513	3	software	software	NN
cord-023095-4dannjjm	2513	4	was	be	VBD
cord-023095-4dannjjm	2513	5	used	use	VBN
cord-023095-4dannjjm	2513	6	to	to	TO
cord-023095-4dannjjm	2513	7	calculate	calculate	VB
cord-023095-4dannjjm	2513	8	GET	GET	NNP
cord-023095-4dannjjm	2513	9	,	,	,
cord-023095-4dannjjm	2513	10	SLBTT	SLBTT	NNP
cord-023095-4dannjjm	2513	11	,	,	,
cord-023095-4dannjjm	2513	12	TGTT	TGTT	NNP
cord-023095-4dannjjm	2513	13	,	,	,
cord-023095-4dannjjm	2513	14	and	and	CC
cord-023095-4dannjjm	2513	15	the	the	DT
cord-023095-4dannjjm	2513	16	median	median	JJ
cord-023095-4dannjjm	2513	17	gastric	gastric	JJ
cord-023095-4dannjjm	2513	18	pH	ph	NN
cord-023095-4dannjjm	2513	19	(	(	-LRB-
cord-023095-4dannjjm	2513	20	MGpH	MGpH	NNP
cord-023095-4dannjjm	2513	21	)	)	-RRB-
cord-023095-4dannjjm	2513	22	.	.	.
cord-023095-4dannjjm	2514	1	Mean	mean	JJ
cord-023095-4dannjjm	2514	2	intra	intra	JJ
cord-023095-4dannjjm	2514	3	-	-	JJ
cord-023095-4dannjjm	2514	4	individual	individual	JJ
cord-023095-4dannjjm	2514	5	and	and	CC
cord-023095-4dannjjm	2514	6	inter	inter	JJ
cord-023095-4dannjjm	2514	7	-	-	JJ
cord-023095-4dannjjm	2514	8	individual	individual	JJ
cord-023095-4dannjjm	2514	9	coefficients	coefficient	NNS
cord-023095-4dannjjm	2514	10	of	of	IN
cord-023095-4dannjjm	2514	11	variation	variation	NN
cord-023095-4dannjjm	2514	12	(	(	-LRB-
cord-023095-4dannjjm	2514	13	CV%	CV%	NNP
cord-023095-4dannjjm	2514	14	)	)	-RRB-
cord-023095-4dannjjm	2514	15	were	be	VBD
cord-023095-4dannjjm	2514	16	calculated	calculate	VBN
cord-023095-4dannjjm	2514	17	for	for	IN
cord-023095-4dannjjm	2514	18	GET	get	VB
cord-023095-4dannjjm	2514	19	,	,	,
cord-023095-4dannjjm	2514	20	SLBTT	SLBTT	NNP
cord-023095-4dannjjm	2514	21	,	,	,
cord-023095-4dannjjm	2514	22	and	and	CC
cord-023095-4dannjjm	2514	23	TTT	TTT	NNP
cord-023095-4dannjjm	2514	24	for	for	IN
cord-023095-4dannjjm	2514	25	the	the	DT
cord-023095-4dannjjm	2514	26	first	first	JJ
cord-023095-4dannjjm	2514	27	3	3	CD
cord-023095-4dannjjm	2514	28	time	time	NN
cord-023095-4dannjjm	2514	29	points	point	NNS
cord-023095-4dannjjm	2514	30	.	.	.
cord-023095-4dannjjm	2515	1	Transit	transit	NN
cord-023095-4dannjjm	2515	2	times	time	NNS
cord-023095-4dannjjm	2515	3	and	and	CC
cord-023095-4dannjjm	2515	4	gastric	gastric	JJ
cord-023095-4dannjjm	2515	5	pH	ph	NN
cord-023095-4dannjjm	2515	6	recorded	record	VBN
cord-023095-4dannjjm	2515	7	at	at	IN
cord-023095-4dannjjm	2515	8	all	all	RB
cord-023095-4dannjjm	2515	9	4	4	CD
cord-023095-4dannjjm	2515	10	time	time	NN
cord-023095-4dannjjm	2515	11	points	point	NNS
cord-023095-4dannjjm	2515	12	were	be	VBD
cord-023095-4dannjjm	2515	13	compared	compare	VBN
cord-023095-4dannjjm	2515	14	using	use	VBG
cord-023095-4dannjjm	2515	15	a	a	DT
cord-023095-4dannjjm	2515	16	repeated	repeat	VBN
cord-023095-4dannjjm	2515	17	measures	measure	NNS
cord-023095-4dannjjm	2515	18	ANOVA	anova	NN
cord-023095-4dannjjm	2515	19	.	.	.
cord-023095-4dannjjm	2516	1	Where	where	WRB
cord-023095-4dannjjm	2516	2	significant	significant	JJ
cord-023095-4dannjjm	2516	3	differences	difference	NNS
cord-023095-4dannjjm	2516	4	were	be	VBD
cord-023095-4dannjjm	2516	5	identified	identify	VBN
cord-023095-4dannjjm	2516	6	,	,	,
cord-023095-4dannjjm	2516	7	post	post	VB
cord-023095-4dannjjm	2516	8	-	-	JJ
cord-023095-4dannjjm	2516	9	hoc	hoc	JJ
cord-023095-4dannjjm	2516	10	testing	testing	NN
cord-023095-4dannjjm	2516	11	was	be	VBD
cord-023095-4dannjjm	2516	12	performed	perform	VBN
cord-023095-4dannjjm	2516	13	using	use	VBG
cord-023095-4dannjjm	2516	14	a	a	DT
cord-023095-4dannjjm	2516	15	Bonferroni	Bonferroni	NNP
cord-023095-4dannjjm	2516	16	's	's	POS
cord-023095-4dannjjm	2516	17	multiple	multiple	JJ
cord-023095-4dannjjm	2516	18	comparisons	comparison	NNS
cord-023095-4dannjjm	2516	19	test	test	NN
cord-023095-4dannjjm	2516	20	.	.	.
cord-023095-4dannjjm	2517	1	Significance	significance	NN
cord-023095-4dannjjm	2517	2	was	be	VBD
cord-023095-4dannjjm	2517	3	set	set	VBN
cord-023095-4dannjjm	2517	4	at	at	IN
cord-023095-4dannjjm	2517	5	p	p	NN
cord-023095-4dannjjm	2517	6	o	o	NN
cord-023095-4dannjjm	2517	7	0.05	0.05	CD
cord-023095-4dannjjm	2517	8	.	.	.
cord-023095-4dannjjm	2518	1	A	a	DT
cord-023095-4dannjjm	2518	2	sharp	sharp	JJ
cord-023095-4dannjjm	2518	3	rise	rise	NN
cord-023095-4dannjjm	2518	4	in	in	IN
cord-023095-4dannjjm	2518	5	pH	pH	NNP
cord-023095-4dannjjm	2518	6	indicating	indicate	VBG
cord-023095-4dannjjm	2518	7	exit	exit	NN
cord-023095-4dannjjm	2518	8	of	of	IN
cord-023095-4dannjjm	2518	9	the	the	DT
cord-023095-4dannjjm	2518	10	capsule	capsule	NN
cord-023095-4dannjjm	2518	11	from	from	IN
cord-023095-4dannjjm	2518	12	the	the	DT
cord-023095-4dannjjm	2518	13	stomach	stomach	NN
cord-023095-4dannjjm	2518	14	was	be	VBD
cord-023095-4dannjjm	2518	15	identified	identify	VBN
cord-023095-4dannjjm	2518	16	in	in	IN
cord-023095-4dannjjm	2518	17	each	each	DT
cord-023095-4dannjjm	2518	18	experiment	experiment	NN
cord-023095-4dannjjm	2518	19	.	.	.
cord-023095-4dannjjm	2519	1	Mean	mean	JJ
cord-023095-4dannjjm	2519	2	(	(	-LRB-
cord-023095-4dannjjm	2519	3	AE	AE	NNP
cord-023095-4dannjjm	2519	4	SD	SD	NNP
cord-023095-4dannjjm	2519	5	)	)	-RRB-
cord-023095-4dannjjm	2519	6	GET	get	VBP
cord-023095-4dannjjm	2519	7	,	,	,
cord-023095-4dannjjm	2519	8	SLBTT	SLBTT	NNP
cord-023095-4dannjjm	2519	9	,	,	,
cord-023095-4dannjjm	2519	10	and	and	CC
cord-023095-4dannjjm	2519	11	TGTT	TGTT	NNP
cord-023095-4dannjjm	2519	12	without	without	IN
cord-023095-4dannjjm	2519	13	ranitidine	ranitidine	NN
cord-023095-4dannjjm	2519	14	were	be	VBD
cord-023095-4dannjjm	2519	15	775	775	CD
cord-023095-4dannjjm	2519	16	AE	AE	NNP
cord-023095-4dannjjm	2519	17	144	144	CD
cord-023095-4dannjjm	2519	18	,	,	,
cord-023095-4dannjjm	2519	19	1563	1563	CD
cord-023095-4dannjjm	2519	20	AE	AE	NNP
cord-023095-4dannjjm	2519	21	614	614	CD
cord-023095-4dannjjm	2519	22	,	,	,
cord-023095-4dannjjm	2519	23	and	and	CC
cord-023095-4dannjjm	2519	24	2338	2338	CD
cord-023095-4dannjjm	2519	25	AE	AE	NNP
cord-023095-4dannjjm	2519	26	577	577	CD
cord-023095-4dannjjm	2519	27	min	min	NN
cord-023095-4dannjjm	2519	28	,	,	,
cord-023095-4dannjjm	2519	29	respectively	respectively	RB
cord-023095-4dannjjm	2519	30	.	.	.
cord-023095-4dannjjm	2520	1	Mean	mean	VB
cord-023095-4dannjjm	2520	2	GET	get	VB
cord-023095-4dannjjm	2520	3	,	,	,
cord-023095-4dannjjm	2520	4	SLBTT	SLBTT	NNP
cord-023095-4dannjjm	2520	5	,	,	,
cord-023095-4dannjjm	2520	6	and	and	CC
cord-023095-4dannjjm	2520	7	TGTT	TGTT	NNP
cord-023095-4dannjjm	2520	8	during	during	IN
cord-023095-4dannjjm	2520	9	treatment	treatment	NN
cord-023095-4dannjjm	2520	10	with	with	IN
cord-023095-4dannjjm	2520	11	ranitidine	ranitidine	NN
cord-023095-4dannjjm	2520	12	were	be	VBD
cord-023095-4dannjjm	2520	13	719	719	CD
cord-023095-4dannjjm	2520	14	AE	AE	NNP
cord-023095-4dannjjm	2520	15	11	11	CD
cord-023095-4dannjjm	2520	16	,	,	,
cord-023095-4dannjjm	2520	17	1442	1442	CD
cord-023095-4dannjjm	2520	18	AE	AE	NNP
cord-023095-4dannjjm	2520	19	885	885	CD
cord-023095-4dannjjm	2520	20	,	,	,
cord-023095-4dannjjm	2520	21	and	and	CC
cord-023095-4dannjjm	2520	22	2155	2155	CD
cord-023095-4dannjjm	2520	23	AE	AE	NNP
cord-023095-4dannjjm	2520	24	897	897	CD
cord-023095-4dannjjm	2520	25	min	min	NN
cord-023095-4dannjjm	2520	26	,	,	,
cord-023095-4dannjjm	2520	27	respectively	respectively	RB
cord-023095-4dannjjm	2520	28	.	.	.
cord-023095-4dannjjm	2521	1	Mean	mean	JJ
cord-023095-4dannjjm	2521	2	intra	intra	JJ
cord-023095-4dannjjm	2521	3	-	-	JJ
cord-023095-4dannjjm	2521	4	individual	individual	JJ
cord-023095-4dannjjm	2521	5	CV%	cv%	NN
cord-023095-4dannjjm	2521	6	before	before	IN
cord-023095-4dannjjm	2521	7	ranitidine	ranitidine	NN
cord-023095-4dannjjm	2521	8	for	for	IN
cord-023095-4dannjjm	2521	9	GET	get	VB
cord-023095-4dannjjm	2521	10	,	,	,
cord-023095-4dannjjm	2521	11	SLBTT	SLBTT	NNP
cord-023095-4dannjjm	2521	12	,	,	,
cord-023095-4dannjjm	2521	13	and	and	CC
cord-023095-4dannjjm	2521	14	TGTT	TGTT	NNP
cord-023095-4dannjjm	2521	15	were	be	VBD
cord-023095-4dannjjm	2521	16	12.9	12.9	CD
cord-023095-4dannjjm	2521	17	,	,	,
cord-023095-4dannjjm	2521	18	29.7	29.7	CD
cord-023095-4dannjjm	2521	19	,	,	,
cord-023095-4dannjjm	2521	20	and	and	CC
cord-023095-4dannjjm	2521	21	17.8	17.8	CD
cord-023095-4dannjjm	2521	22	%	%	NN
cord-023095-4dannjjm	2521	23	,	,	,
cord-023095-4dannjjm	2521	24	respectively	respectively	RB
cord-023095-4dannjjm	2521	25	.	.	.
cord-023095-4dannjjm	2522	1	Mean	mean	VB
cord-023095-4dannjjm	2522	2	inter	inter	JJ
cord-023095-4dannjjm	2522	3	-	-	JJ
cord-023095-4dannjjm	2522	4	individual	individual	JJ
cord-023095-4dannjjm	2522	5	CV%	cv%	NN
cord-023095-4dannjjm	2522	6	before	before	IN
cord-023095-4dannjjm	2522	7	treatment	treatment	NN
cord-023095-4dannjjm	2522	8	with	with	IN
cord-023095-4dannjjm	2522	9	ranitidine	ranitidine	NN
cord-023095-4dannjjm	2522	10	for	for	IN
cord-023095-4dannjjm	2522	11	GET	get	VB
cord-023095-4dannjjm	2522	12	,	,	,
cord-023095-4dannjjm	2522	13	SLBTT	SLBTT	NNP
cord-023095-4dannjjm	2522	14	,	,	,
cord-023095-4dannjjm	2522	15	and	and	CC
cord-023095-4dannjjm	2522	16	TTT	TTT	NNP
cord-023095-4dannjjm	2522	17	were	be	VBD
cord-023095-4dannjjm	2522	18	16.1	16.1	CD
cord-023095-4dannjjm	2522	19	,	,	,
cord-023095-4dannjjm	2522	20	40.5	40.5	CD
cord-023095-4dannjjm	2522	21	,	,	,
cord-023095-4dannjjm	2522	22	and	and	CC
cord-023095-4dannjjm	2522	23	24.7	24.7	CD
cord-023095-4dannjjm	2522	24	%	%	NN
cord-023095-4dannjjm	2522	25	,	,	,
cord-023095-4dannjjm	2522	26	respectively	respectively	RB
cord-023095-4dannjjm	2522	27	.	.	.
cord-023095-4dannjjm	2523	1	No	no	DT
cord-023095-4dannjjm	2523	2	significant	significant	JJ
cord-023095-4dannjjm	2523	3	differences	difference	NNS
cord-023095-4dannjjm	2523	4	in	in	IN
cord-023095-4dannjjm	2523	5	GET	get	NN
cord-023095-4dannjjm	2523	6	,	,	,
cord-023095-4dannjjm	2523	7	SLBTT	SLBTT	NNP
cord-023095-4dannjjm	2523	8	,	,	,
cord-023095-4dannjjm	2523	9	or	or	CC
cord-023095-4dannjjm	2523	10	TGTT	TGTT	NNP
cord-023095-4dannjjm	2523	11	were	be	VBD
cord-023095-4dannjjm	2523	12	found	find	VBN
cord-023095-4dannjjm	2523	13	at	at	IN
cord-023095-4dannjjm	2523	14	any	any	DT
cord-023095-4dannjjm	2523	15	of	of	IN
cord-023095-4dannjjm	2523	16	the	the	DT
cord-023095-4dannjjm	2523	17	4	4	CD
cord-023095-4dannjjm	2523	18	time	time	NN
cord-023095-4dannjjm	2523	19	points	point	NNS
cord-023095-4dannjjm	2523	20	.	.	.
cord-023095-4dannjjm	2524	1	The	the	DT
cord-023095-4dannjjm	2524	2	mean	mean	JJ
cord-023095-4dannjjm	2524	3	MGpH	MGpH	NNPS
cord-023095-4dannjjm	2524	4	during	during	IN
cord-023095-4dannjjm	2524	5	treatment	treatment	NN
cord-023095-4dannjjm	2524	6	with	with	IN
cord-023095-4dannjjm	2524	7	ranitidine	ranitidine	NN
cord-023095-4dannjjm	2524	8	(	(	-LRB-
cord-023095-4dannjjm	2524	9	pH	pH	NNP
cord-023095-4dannjjm	2524	10	2.85	2.85	CD
cord-023095-4dannjjm	2524	11	)	)	-RRB-
cord-023095-4dannjjm	2524	12	was	be	VBD
cord-023095-4dannjjm	2524	13	significantly	significantly	RB
cord-023095-4dannjjm	2524	14	higher	high	JJR
cord-023095-4dannjjm	2524	15	than	than	IN
cord-023095-4dannjjm	2524	16	at	at	IN
cord-023095-4dannjjm	2524	17	all	all	DT
cord-023095-4dannjjm	2524	18	other	other	JJ
cord-023095-4dannjjm	2524	19	time	time	NN
cord-023095-4dannjjm	2524	20	points	point	NNS
cord-023095-4dannjjm	2525	1	(	(	-LRB-
cord-023095-4dannjjm	2525	2	overall	overall	JJ
cord-023095-4dannjjm	2525	3	mean	mean	NN
cord-023095-4dannjjm	2525	4	pH	pH	NNP
cord-023095-4dannjjm	2525	5	for	for	IN
cord-023095-4dannjjm	2525	6	the	the	DT
cord-023095-4dannjjm	2525	7	3	3	CD
cord-023095-4dannjjm	2525	8	time	time	NN
cord-023095-4dannjjm	2525	9	points	point	NNS
cord-023095-4dannjjm	2525	10	:	:	:
cord-023095-4dannjjm	2525	11	1.73	1.73	CD
cord-023095-4dannjjm	2525	12	;	;	:
cord-023095-4dannjjm	2525	13	p	p	NN
cord-023095-4dannjjm	2525	14	o	o	NN
cord-023095-4dannjjm	2525	15	0.05	0.05	CD
cord-023095-4dannjjm	2525	16	)	)	-RRB-
cord-023095-4dannjjm	2525	17	.	.	.
cord-023095-4dannjjm	2526	1	The	the	DT
cord-023095-4dannjjm	2526	2	SmartPill	SmartPill	NNP
cord-023095-4dannjjm	2526	3	system	system	NN
cord-023095-4dannjjm	2526	4	is	be	VBZ
cord-023095-4dannjjm	2526	5	an	an	DT
cord-023095-4dannjjm	2526	6	easy	easy	JJ
cord-023095-4dannjjm	2526	7	to	to	TO
cord-023095-4dannjjm	2526	8	use	use	VB
cord-023095-4dannjjm	2526	9	,	,	,
cord-023095-4dannjjm	2526	10	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	2526	11	,	,	,
cord-023095-4dannjjm	2526	12	non	non	JJ
cord-023095-4dannjjm	2526	13	-	-	JJ
cord-023095-4dannjjm	2526	14	invasive	invasive	JJ
cord-023095-4dannjjm	2526	15	,	,	,
cord-023095-4dannjjm	2526	16	non	non	JJ
cord-023095-4dannjjm	2526	17	-	-	JJ
cord-023095-4dannjjm	2526	18	radioactive	radioactive	JJ
cord-023095-4dannjjm	2526	19	method	method	NN
cord-023095-4dannjjm	2526	20	for	for	IN
cord-023095-4dannjjm	2526	21	assessing	assess	VBG
cord-023095-4dannjjm	2526	22	GI	GI	NNP
cord-023095-4dannjjm	2526	23	transit	transit	NN
cord-023095-4dannjjm	2526	24	times	time	NNS
cord-023095-4dannjjm	2526	25	in	in	IN
cord-023095-4dannjjm	2526	26	medium	medium	NN
cord-023095-4dannjjm	2526	27	to	to	IN
cord-023095-4dannjjm	2526	28	large	large	JJ
cord-023095-4dannjjm	2526	29	breed	breed	NN
cord-023095-4dannjjm	2526	30	dogs	dog	NNS
cord-023095-4dannjjm	2526	31	.	.	.
cord-023095-4dannjjm	2527	1	Measurements	measurement	NNS
cord-023095-4dannjjm	2527	2	of	of	IN
cord-023095-4dannjjm	2527	3	GI	GI	NNP
cord-023095-4dannjjm	2527	4	transit	transit	NN
cord-023095-4dannjjm	2527	5	times	time	NNS
cord-023095-4dannjjm	2527	6	,	,	,
cord-023095-4dannjjm	2527	7	especially	especially	RB
cord-023095-4dannjjm	2527	8	SLBTT	SLBTT	NNP
cord-023095-4dannjjm	2527	9	,	,	,
cord-023095-4dannjjm	2527	10	were	be	VBD
cord-023095-4dannjjm	2527	11	subject	subject	JJ
cord-023095-4dannjjm	2527	12	to	to	IN
cord-023095-4dannjjm	2527	13	considerable	considerable	JJ
cord-023095-4dannjjm	2527	14	intra	intra	JJ
cord-023095-4dannjjm	2527	15	-	-	JJ
cord-023095-4dannjjm	2527	16	individual	individual	JJ
cord-023095-4dannjjm	2527	17	and	and	CC
cord-023095-4dannjjm	2527	18	interindividual	interindividual	JJ
cord-023095-4dannjjm	2527	19	variation	variation	NN
cord-023095-4dannjjm	2527	20	.	.	.
cord-023095-4dannjjm	2528	1	No	no	DT
cord-023095-4dannjjm	2528	2	significant	significant	JJ
cord-023095-4dannjjm	2528	3	effect	effect	NN
cord-023095-4dannjjm	2528	4	of	of	IN
cord-023095-4dannjjm	2528	5	oral	oral	JJ
cord-023095-4dannjjm	2528	6	ranitidine	ranitidine	NN
cord-023095-4dannjjm	2528	7	on	on	IN
cord-023095-4dannjjm	2528	8	GI	GI	NNP
cord-023095-4dannjjm	2528	9	motility	motility	NN
cord-023095-4dannjjm	2528	10	was	be	VBD
cord-023095-4dannjjm	2528	11	identified	identify	VBN
cord-023095-4dannjjm	2528	12	in	in	IN
cord-023095-4dannjjm	2528	13	this	this	DT
cord-023095-4dannjjm	2528	14	group	group	NN
cord-023095-4dannjjm	2528	15	of	of	IN
cord-023095-4dannjjm	2528	16	dogs	dog	NNS
cord-023095-4dannjjm	2528	17	.	.	.
cord-023095-4dannjjm	2529	1	However	however	RB
cord-023095-4dannjjm	2529	2	,	,	,
cord-023095-4dannjjm	2529	3	as	as	IN
cord-023095-4dannjjm	2529	4	expected	expect	VBN
cord-023095-4dannjjm	2529	5	,	,	,
cord-023095-4dannjjm	2529	6	oral	oral	JJ
cord-023095-4dannjjm	2529	7	ranitidine	ranitidine	NN
cord-023095-4dannjjm	2529	8	caused	cause	VBD
cord-023095-4dannjjm	2529	9	a	a	DT
cord-023095-4dannjjm	2529	10	significant	significant	JJ
cord-023095-4dannjjm	2529	11	increase	increase	NN
cord-023095-4dannjjm	2529	12	in	in	IN
cord-023095-4dannjjm	2529	13	gastric	gastric	JJ
cord-023095-4dannjjm	2529	14	pH.	ph.	NN
cord-023095-4dannjjm	2529	15	The	the	DT
cord-023095-4dannjjm	2529	16	intestinal	intestinal	JJ
cord-023095-4dannjjm	2529	17	microbiota	microbiota	NN
cord-023095-4dannjjm	2529	18	has	have	VBZ
cord-023095-4dannjjm	2529	19	been	be	VBN
cord-023095-4dannjjm	2529	20	implicated	implicate	VBN
cord-023095-4dannjjm	2529	21	in	in	IN
cord-023095-4dannjjm	2529	22	the	the	DT
cord-023095-4dannjjm	2529	23	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	2529	24	of	of	IN
cord-023095-4dannjjm	2529	25	various	various	JJ
cord-023095-4dannjjm	2529	26	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2529	27	disorders	disorder	NNS
cord-023095-4dannjjm	2529	28	in	in	IN
cord-023095-4dannjjm	2529	29	both	both	DT
cord-023095-4dannjjm	2529	30	humans	human	NNS
cord-023095-4dannjjm	2529	31	and	and	CC
cord-023095-4dannjjm	2529	32	dogs	dog	NNS
cord-023095-4dannjjm	2529	33	.	.	.
cord-023095-4dannjjm	2530	1	Recent	recent	JJ
cord-023095-4dannjjm	2530	2	metagenomic	metagenomic	JJ
cord-023095-4dannjjm	2530	3	data	datum	NNS
cord-023095-4dannjjm	2530	4	suggest	suggest	VBP
cord-023095-4dannjjm	2530	5	that	that	IN
cord-023095-4dannjjm	2530	6	specific	specific	JJ
cord-023095-4dannjjm	2530	7	bacterial	bacterial	JJ
cord-023095-4dannjjm	2530	8	groups	group	NNS
cord-023095-4dannjjm	2530	9	,	,	,
cord-023095-4dannjjm	2530	10	including	include	VBG
cord-023095-4dannjjm	2530	11	bacteria	bacteria	NNS
cord-023095-4dannjjm	2530	12	within	within	IN
cord-023095-4dannjjm	2530	13	the	the	DT
cord-023095-4dannjjm	2530	14	Clostridium	clostridium	NN
cord-023095-4dannjjm	2530	15	clusters	cluster	NNS
cord-023095-4dannjjm	2530	16	IV	IV	NNP
cord-023095-4dannjjm	2530	17	and	and	CC
cord-023095-4dannjjm	2530	18	XIVa	XIVa	NNP
cord-023095-4dannjjm	2530	19	(	(	-LRB-
cord-023095-4dannjjm	2530	20	i.e.	i.e.	FW
cord-023095-4dannjjm	2530	21	,	,	,
cord-023095-4dannjjm	2530	22	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	2530	23	spp	spp	NNS
cord-023095-4dannjjm	2530	24	.	.	.
cord-023095-4dannjjm	2531	1	,	,	,
cord-023095-4dannjjm	2531	2	Ruminococcaceae	Ruminococcaceae	NNP
cord-023095-4dannjjm	2531	3	,	,	,
cord-023095-4dannjjm	2531	4	and	and	CC
cord-023095-4dannjjm	2531	5	Lachnospiraceae	Lachnospiraceae	NNP
cord-023095-4dannjjm	2531	6	)	)	-RRB-
cord-023095-4dannjjm	2531	7	and	and	CC
cord-023095-4dannjjm	2531	8	Bifidobacterium	Bifidobacterium	NNP
cord-023095-4dannjjm	2531	9	spp	spp	NNS
cord-023095-4dannjjm	2531	10	.	.	.
cord-023095-4dannjjm	2532	1	are	be	VBP
cord-023095-4dannjjm	2532	2	decreased	decrease	VBN
cord-023095-4dannjjm	2532	3	,	,	,
cord-023095-4dannjjm	2532	4	while	while	IN
cord-023095-4dannjjm	2532	5	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	2532	6	are	be	VBP
cord-023095-4dannjjm	2532	7	increased	increase	VBN
cord-023095-4dannjjm	2532	8	in	in	IN
cord-023095-4dannjjm	2532	9	dogs	dog	NNS
cord-023095-4dannjjm	2532	10	with	with	IN
cord-023095-4dannjjm	2532	11	clinical	clinical	JJ
cord-023095-4dannjjm	2532	12	signs	sign	NNS
cord-023095-4dannjjm	2532	13	of	of	IN
cord-023095-4dannjjm	2532	14	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2532	15	disease	disease	NN
cord-023095-4dannjjm	2532	16	.	.	.
cord-023095-4dannjjm	2533	1	The	the	DT
cord-023095-4dannjjm	2533	2	objective	objective	NN
cord-023095-4dannjjm	2533	3	of	of	IN
cord-023095-4dannjjm	2533	4	this	this	DT
cord-023095-4dannjjm	2533	5	study	study	NN
cord-023095-4dannjjm	2533	6	was	be	VBD
cord-023095-4dannjjm	2533	7	to	to	TO
cord-023095-4dannjjm	2533	8	establish	establish	VB
cord-023095-4dannjjm	2533	9	quantitative	quantitative	JJ
cord-023095-4dannjjm	2533	10	polymerase	polymerase	NN
cord-023095-4dannjjm	2533	11	chain	chain	NN
cord-023095-4dannjjm	2533	12	reaction	reaction	NN
cord-023095-4dannjjm	2533	13	(	(	-LRB-
cord-023095-4dannjjm	2533	14	qPCR	qPCR	NNP
cord-023095-4dannjjm	2533	15	)	)	-RRB-
cord-023095-4dannjjm	2533	16	assays	assay	NNS
cord-023095-4dannjjm	2533	17	for	for	IN
cord-023095-4dannjjm	2533	18	these	these	DT
cord-023095-4dannjjm	2533	19	specific	specific	JJ
cord-023095-4dannjjm	2533	20	bacterial	bacterial	JJ
cord-023095-4dannjjm	2533	21	groups	group	NNS
cord-023095-4dannjjm	2533	22	and	and	CC
cord-023095-4dannjjm	2533	23	evaluate	evaluate	VB
cord-023095-4dannjjm	2533	24	their	-PRON-	PRP$
cord-023095-4dannjjm	2533	25	abundance	abundance	NN
cord-023095-4dannjjm	2533	26	in	in	IN
cord-023095-4dannjjm	2533	27	healthy	healthy	JJ
cord-023095-4dannjjm	2533	28	dogs	dog	NNS
cord-023095-4dannjjm	2533	29	and	and	CC
cord-023095-4dannjjm	2533	30	dogs	dog	NNS
cord-023095-4dannjjm	2533	31	with	with	IN
cord-023095-4dannjjm	2533	32	clinical	clinical	JJ
cord-023095-4dannjjm	2533	33	signs	sign	NNS
cord-023095-4dannjjm	2533	34	of	of	IN
cord-023095-4dannjjm	2533	35	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2533	36	disease	disease	NN
cord-023095-4dannjjm	2533	37	.	.	.
cord-023095-4dannjjm	2534	1	Fecal	fecal	JJ
cord-023095-4dannjjm	2534	2	samples	sample	NNS
cord-023095-4dannjjm	2534	3	were	be	VBD
cord-023095-4dannjjm	2534	4	collected	collect	VBN
cord-023095-4dannjjm	2534	5	from	from	IN
cord-023095-4dannjjm	2534	6	21	21	CD
cord-023095-4dannjjm	2534	7	healthy	healthy	JJ
cord-023095-4dannjjm	2534	8	dogs	dog	NNS
cord-023095-4dannjjm	2534	9	(	(	-LRB-
cord-023095-4dannjjm	2534	10	14	14	CD
cord-023095-4dannjjm	2534	11	females	female	NNS
cord-023095-4dannjjm	2534	12	and	and	CC
cord-023095-4dannjjm	2534	13	7	7	CD
cord-023095-4dannjjm	2534	14	males	male	NNS
cord-023095-4dannjjm	2534	15	)	)	-RRB-
cord-023095-4dannjjm	2534	16	and	and	CC
cord-023095-4dannjjm	2534	17	20	20	CD
cord-023095-4dannjjm	2534	18	dogs	dog	NNS
cord-023095-4dannjjm	2534	19	with	with	IN
cord-023095-4dannjjm	2534	20	clinical	clinical	JJ
cord-023095-4dannjjm	2534	21	signs	sign	NNS
cord-023095-4dannjjm	2534	22	of	of	IN
cord-023095-4dannjjm	2534	23	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2534	24	disease	disease	NN
cord-023095-4dannjjm	2534	25	(	(	-LRB-
cord-023095-4dannjjm	2534	26	11	11	CD
cord-023095-4dannjjm	2534	27	females	female	NNS
cord-023095-4dannjjm	2534	28	and	and	CC
cord-023095-4dannjjm	2534	29	9	9	CD
cord-023095-4dannjjm	2534	30	males	male	NNS
cord-023095-4dannjjm	2534	31	)	)	-RRB-
cord-023095-4dannjjm	2534	32	.	.	.
cord-023095-4dannjjm	2535	1	Novel	novel	JJ
cord-023095-4dannjjm	2535	2	quantitative	quantitative	JJ
cord-023095-4dannjjm	2535	3	PCR	pcr	NN
cord-023095-4dannjjm	2535	4	assays	assay	NNS
cord-023095-4dannjjm	2535	5	were	be	VBD
cord-023095-4dannjjm	2535	6	established	establish	VBN
cord-023095-4dannjjm	2535	7	for	for	IN
cord-023095-4dannjjm	2535	8	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	2535	9	spp	spp	NNS
cord-023095-4dannjjm	2535	10	.	.	.
cord-023095-4dannjjm	2536	1	,	,	,
cord-023095-4dannjjm	2536	2	Ruminococcaceae	Ruminococcaceae	NNP
cord-023095-4dannjjm	2536	3	,	,	,
cord-023095-4dannjjm	2536	4	and	and	CC
cord-023095-4dannjjm	2536	5	Lachnospiraceae	Lachnospiraceae	NNP
cord-023095-4dannjjm	2536	6	by	by	IN
cord-023095-4dannjjm	2536	7	aligning	align	VBG
cord-023095-4dannjjm	2536	8	respective	respective	JJ
cord-023095-4dannjjm	2536	9	group	group	NN
cord-023095-4dannjjm	2536	10	specific	specific	JJ
cord-023095-4dannjjm	2536	11	sequences	sequence	NNS
cord-023095-4dannjjm	2536	12	against	against	IN
cord-023095-4dannjjm	2536	13	canine	canine	JJ
cord-023095-4dannjjm	2536	14	specific	specific	JJ
cord-023095-4dannjjm	2536	15	sequences	sequence	NNS
cord-023095-4dannjjm	2536	16	obtained	obtain	VBN
cord-023095-4dannjjm	2536	17	from	from	IN
cord-023095-4dannjjm	2536	18	16S	16S	NNP
cord-023095-4dannjjm	2536	19	rRNA	rRNA	NNP
cord-023095-4dannjjm	2536	20	gene	gene	NN
cord-023095-4dannjjm	2536	21	clone	clone	NN
cord-023095-4dannjjm	2536	22	libraries	library	NNS
cord-023095-4dannjjm	2536	23	and	and	CC
cord-023095-4dannjjm	2536	24	sequences	sequence	NNS
cord-023095-4dannjjm	2536	25	available	available	JJ
cord-023095-4dannjjm	2536	26	from	from	IN
cord-023095-4dannjjm	2536	27	the	the	DT
cord-023095-4dannjjm	2536	28	Ribosomal	Ribosomal	NNP
cord-023095-4dannjjm	2536	29	Database	Database	NNP
cord-023095-4dannjjm	2536	30	Project	Project	NNP
cord-023095-4dannjjm	2536	31	.	.	.
cord-023095-4dannjjm	2537	1	Primers	primer	NNS
cord-023095-4dannjjm	2537	2	for	for	IN
cord-023095-4dannjjm	2537	3	Bifidobacterium	bifidobacterium	NN
cord-023095-4dannjjm	2537	4	spp	spp	NNS
cord-023095-4dannjjm	2537	5	.	.	.
cord-023095-4dannjjm	2538	1	and	and	CC
cord-023095-4dannjjm	2538	2	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	2538	3	were	be	VBD
cord-023095-4dannjjm	2538	4	selected	select	VBN
cord-023095-4dannjjm	2538	5	from	from	IN
cord-023095-4dannjjm	2538	6	previously	previously	RB
cord-023095-4dannjjm	2538	7	published	publish	VBN
cord-023095-4dannjjm	2538	8	studies	study	NNS
cord-023095-4dannjjm	2538	9	.	.	.
cord-023095-4dannjjm	2539	1	The	the	DT
cord-023095-4dannjjm	2539	2	specificity	specificity	NN
cord-023095-4dannjjm	2539	3	of	of	IN
cord-023095-4dannjjm	2539	4	the	the	DT
cord-023095-4dannjjm	2539	5	qPCR	qPCR	NNP
cord-023095-4dannjjm	2539	6	assays	assay	NNS
cord-023095-4dannjjm	2539	7	was	be	VBD
cord-023095-4dannjjm	2539	8	confirmed	confirm	VBN
cord-023095-4dannjjm	2539	9	by	by	IN
cord-023095-4dannjjm	2539	10	sequencing	sequence	VBG
cord-023095-4dannjjm	2539	11	of	of	IN
cord-023095-4dannjjm	2539	12	obtained	obtain	VBN
cord-023095-4dannjjm	2539	13	qPCR	qPCR	NNP
cord-023095-4dannjjm	2539	14	amplicons	amplicon	NNS
cord-023095-4dannjjm	2539	15	.	.	.
cord-023095-4dannjjm	2540	1	The	the	DT
cord-023095-4dannjjm	2540	2	bacterial	bacterial	JJ
cord-023095-4dannjjm	2540	3	DNA	dna	NN
cord-023095-4dannjjm	2540	4	abundance	abundance	NN
cord-023095-4dannjjm	2540	5	in	in	IN
cord-023095-4dannjjm	2540	6	fecal	fecal	JJ
cord-023095-4dannjjm	2540	7	samples	sample	NNS
cord-023095-4dannjjm	2540	8	was	be	VBD
cord-023095-4dannjjm	2540	9	compared	compare	VBN
cord-023095-4dannjjm	2540	10	between	between	IN
cord-023095-4dannjjm	2540	11	healthy	healthy	JJ
cord-023095-4dannjjm	2540	12	dogs	dog	NNS
cord-023095-4dannjjm	2540	13	and	and	CC
cord-023095-4dannjjm	2540	14	dogs	dog	NNS
cord-023095-4dannjjm	2540	15	with	with	IN
cord-023095-4dannjjm	2540	16	clinical	clinical	JJ
cord-023095-4dannjjm	2540	17	signs	sign	NNS
cord-023095-4dannjjm	2540	18	of	of	IN
cord-023095-4dannjjm	2540	19	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2540	20	disease	disease	NN
cord-023095-4dannjjm	2540	21	using	use	VBG
cord-023095-4dannjjm	2540	22	a	a	DT
cord-023095-4dannjjm	2540	23	Mann	Mann	NNP
cord-023095-4dannjjm	2540	24	-	-	HYPH
cord-023095-4dannjjm	2540	25	Whitney	Whitney	NNP
cord-023095-4dannjjm	2540	26	U	U	NNP
cord-023095-4dannjjm	2540	27	test	test	NN
cord-023095-4dannjjm	2540	28	.	.	.
cord-023095-4dannjjm	2541	1	Significance	significance	NN
cord-023095-4dannjjm	2541	2	was	be	VBD
cord-023095-4dannjjm	2541	3	set	set	VBN
cord-023095-4dannjjm	2541	4	at	at	IN
cord-023095-4dannjjm	2541	5	p	p	NN
cord-023095-4dannjjm	2541	6	o	o	NN
cord-023095-4dannjjm	2541	7	0.05	0.05	CD
cord-023095-4dannjjm	2541	8	.	.	.
cord-023095-4dannjjm	2542	1	A	a	DT
cord-023095-4dannjjm	2542	2	significantly	significantly	RB
cord-023095-4dannjjm	2542	3	lower	low	JJR
cord-023095-4dannjjm	2542	4	abundance	abundance	NN
cord-023095-4dannjjm	2542	5	of	of	IN
cord-023095-4dannjjm	2542	6	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	2542	7	spp	spp	NNS
cord-023095-4dannjjm	2542	8	.	.	.
cord-023095-4dannjjm	2543	1	(	(	-LRB-
cord-023095-4dannjjm	2543	2	p	p	NN
cord-023095-4dannjjm	2543	3	o	o	NN
cord-023095-4dannjjm	2543	4	0.01	0.01	CD
cord-023095-4dannjjm	2543	5	)	)	-RRB-
cord-023095-4dannjjm	2543	6	and	and	CC
cord-023095-4dannjjm	2543	7	Ruminococcaceae	Ruminococcaceae	NNP
cord-023095-4dannjjm	2543	8	(	(	-LRB-
cord-023095-4dannjjm	2543	9	p	p	NN
cord-023095-4dannjjm	2543	10	5	5	CD
cord-023095-4dannjjm	2543	11	0.02	0.02	CD
cord-023095-4dannjjm	2543	12	)	)	-RRB-
cord-023095-4dannjjm	2543	13	was	be	VBD
cord-023095-4dannjjm	2543	14	observed	observe	VBN
cord-023095-4dannjjm	2543	15	in	in	IN
cord-023095-4dannjjm	2543	16	dogs	dog	NNS
cord-023095-4dannjjm	2543	17	with	with	IN
cord-023095-4dannjjm	2543	18	clinical	clinical	JJ
cord-023095-4dannjjm	2543	19	signs	sign	NNS
cord-023095-4dannjjm	2543	20	of	of	IN
cord-023095-4dannjjm	2543	21	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2543	22	disease	disease	NN
cord-023095-4dannjjm	2543	23	when	when	WRB
cord-023095-4dannjjm	2543	24	compared	compare	VBN
cord-023095-4dannjjm	2543	25	to	to	IN
cord-023095-4dannjjm	2543	26	healthy	healthy	JJ
cord-023095-4dannjjm	2543	27	dogs	dog	NNS
cord-023095-4dannjjm	2543	28	.	.	.
cord-023095-4dannjjm	2544	1	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	2544	2	were	be	VBD
cord-023095-4dannjjm	2544	3	more	more	RBR
cord-023095-4dannjjm	2544	4	abundant	abundant	JJ
cord-023095-4dannjjm	2544	5	in	in	IN
cord-023095-4dannjjm	2544	6	dogs	dog	NNS
cord-023095-4dannjjm	2544	7	with	with	IN
cord-023095-4dannjjm	2544	8	clinical	clinical	JJ
cord-023095-4dannjjm	2544	9	signs	sign	NNS
cord-023095-4dannjjm	2544	10	of	of	IN
cord-023095-4dannjjm	2544	11	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2544	12	disease	disease	NN
cord-023095-4dannjjm	2544	13	,	,	,
cord-023095-4dannjjm	2544	14	but	but	CC
cord-023095-4dannjjm	2544	15	this	this	DT
cord-023095-4dannjjm	2544	16	difference	difference	NN
cord-023095-4dannjjm	2544	17	did	do	VBD
cord-023095-4dannjjm	2544	18	not	not	RB
cord-023095-4dannjjm	2544	19	reach	reach	VB
cord-023095-4dannjjm	2544	20	statistical	statistical	JJ
cord-023095-4dannjjm	2544	21	significance	significance	NN
cord-023095-4dannjjm	2544	22	(	(	-LRB-
cord-023095-4dannjjm	2544	23	p	p	NN
cord-023095-4dannjjm	2544	24	5	5	CD
cord-023095-4dannjjm	2544	25	0.07	0.07	CD
cord-023095-4dannjjm	2544	26	)	)	-RRB-
cord-023095-4dannjjm	2544	27	.	.	.
cord-023095-4dannjjm	2545	1	There	there	EX
cord-023095-4dannjjm	2545	2	was	be	VBD
cord-023095-4dannjjm	2545	3	no	no	DT
cord-023095-4dannjjm	2545	4	significant	significant	JJ
cord-023095-4dannjjm	2545	5	difference	difference	NN
cord-023095-4dannjjm	2545	6	in	in	IN
cord-023095-4dannjjm	2545	7	the	the	DT
cord-023095-4dannjjm	2545	8	abundance	abundance	NN
cord-023095-4dannjjm	2545	9	of	of	IN
cord-023095-4dannjjm	2545	10	Lachnospiraceae	Lachnospiraceae	NNP
cord-023095-4dannjjm	2545	11	(	(	-LRB-
cord-023095-4dannjjm	2545	12	p	p	NN
cord-023095-4dannjjm	2545	13	5	5	CD
cord-023095-4dannjjm	2545	14	0.23	0.23	CD
cord-023095-4dannjjm	2545	15	)	)	-RRB-
cord-023095-4dannjjm	2545	16	and	and	CC
cord-023095-4dannjjm	2545	17	Bifidobacterium	Bifidobacterium	NNP
cord-023095-4dannjjm	2545	18	spp	spp	NNS
cord-023095-4dannjjm	2545	19	.	.	.
cord-023095-4dannjjm	2546	1	(	(	-LRB-
cord-023095-4dannjjm	2546	2	p	p	NN
cord-023095-4dannjjm	2546	3	5	5	CD
cord-023095-4dannjjm	2546	4	0.77	0.77	CD
cord-023095-4dannjjm	2546	5	)	)	-RRB-
cord-023095-4dannjjm	2546	6	between	between	IN
cord-023095-4dannjjm	2546	7	both	both	DT
cord-023095-4dannjjm	2546	8	groups	group	NNS
cord-023095-4dannjjm	2546	9	.	.	.
cord-023095-4dannjjm	2547	1	In	in	IN
cord-023095-4dannjjm	2547	2	conclusion	conclusion	NN
cord-023095-4dannjjm	2547	3	,	,	,
cord-023095-4dannjjm	2547	4	we	-PRON-	PRP
cord-023095-4dannjjm	2547	5	established	establish	VBD
cord-023095-4dannjjm	2547	6	novel	novel	NN
cord-023095-4dannjjm	2547	7	qPCR	qpcr	NN
cord-023095-4dannjjm	2547	8	assays	assay	NNS
cord-023095-4dannjjm	2547	9	for	for	IN
cord-023095-4dannjjm	2547	10	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	2547	11	spp	spp	NNS
cord-023095-4dannjjm	2547	12	.	.	.
cord-023095-4dannjjm	2548	1	,	,	,
cord-023095-4dannjjm	2548	2	Ruminococcaceae	Ruminococcaceae	NNP
cord-023095-4dannjjm	2548	3	,	,	,
cord-023095-4dannjjm	2548	4	and	and	CC
cord-023095-4dannjjm	2548	5	Lachnospiraceae	Lachnospiraceae	NNP
cord-023095-4dannjjm	2548	6	.	.	.
cord-023095-4dannjjm	2549	1	We	-PRON-	PRP
cord-023095-4dannjjm	2549	2	observed	observe	VBD
cord-023095-4dannjjm	2549	3	significant	significant	JJ
cord-023095-4dannjjm	2549	4	decreases	decrease	NNS
cord-023095-4dannjjm	2549	5	in	in	IN
cord-023095-4dannjjm	2549	6	the	the	DT
cord-023095-4dannjjm	2549	7	abundance	abundance	NN
cord-023095-4dannjjm	2549	8	of	of	IN
cord-023095-4dannjjm	2549	9	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	2549	10	spp	spp	NNS
cord-023095-4dannjjm	2549	11	.	.	.
cord-023095-4dannjjm	2550	1	and	and	CC
cord-023095-4dannjjm	2550	2	Ruminococcaceae	Ruminococcaceae	NNP
cord-023095-4dannjjm	2550	3	in	in	IN
cord-023095-4dannjjm	2550	4	dogs	dog	NNS
cord-023095-4dannjjm	2550	5	with	with	IN
cord-023095-4dannjjm	2550	6	clinical	clinical	JJ
cord-023095-4dannjjm	2550	7	signs	sign	NNS
cord-023095-4dannjjm	2550	8	of	of	IN
cord-023095-4dannjjm	2550	9	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2550	10	disease	disease	NN
cord-023095-4dannjjm	2550	11	.	.	.
cord-023095-4dannjjm	2551	1	These	these	DT
cord-023095-4dannjjm	2551	2	bacterial	bacterial	JJ
cord-023095-4dannjjm	2551	3	groups	group	NNS
cord-023095-4dannjjm	2551	4	are	be	VBP
cord-023095-4dannjjm	2551	5	considered	consider	VBN
cord-023095-4dannjjm	2551	6	major	major	JJ
cord-023095-4dannjjm	2551	7	short	short	JJ
cord-023095-4dannjjm	2551	8	-	-	HYPH
cord-023095-4dannjjm	2551	9	chain	chain	NN
cord-023095-4dannjjm	2551	10	fatty	fatty	JJ
cord-023095-4dannjjm	2551	11	acid	acid	NN
cord-023095-4dannjjm	2551	12	producers	producer	NNS
cord-023095-4dannjjm	2551	13	and	and	CC
cord-023095-4dannjjm	2551	14	studies	study	NNS
cord-023095-4dannjjm	2551	15	are	be	VBP
cord-023095-4dannjjm	2551	16	warranted	warrant	VBN
cord-023095-4dannjjm	2551	17	to	to	TO
cord-023095-4dannjjm	2551	18	determine	determine	VB
cord-023095-4dannjjm	2551	19	if	if	IN
cord-023095-4dannjjm	2551	20	a	a	DT
cord-023095-4dannjjm	2551	21	decrease	decrease	NN
cord-023095-4dannjjm	2551	22	in	in	IN
cord-023095-4dannjjm	2551	23	these	these	DT
cord-023095-4dannjjm	2551	24	bacterial	bacterial	JJ
cord-023095-4dannjjm	2551	25	groups	group	NNS
cord-023095-4dannjjm	2551	26	is	be	VBZ
cord-023095-4dannjjm	2551	27	associated	associate	VBN
cord-023095-4dannjjm	2551	28	with	with	IN
cord-023095-4dannjjm	2551	29	decreases	decrease	NNS
cord-023095-4dannjjm	2551	30	in	in	IN
cord-023095-4dannjjm	2551	31	short	short	JJ
cord-023095-4dannjjm	2551	32	chain	chain	NN
cord-023095-4dannjjm	2551	33	fatty	fatty	JJ
cord-023095-4dannjjm	2551	34	acid	acid	NN
cord-023095-4dannjjm	2551	35	production	production	NN
cord-023095-4dannjjm	2551	36	.	.	.
cord-023095-4dannjjm	2552	1	Further	further	JJ
cord-023095-4dannjjm	2552	2	studies	study	NNS
cord-023095-4dannjjm	2552	3	are	be	VBP
cord-023095-4dannjjm	2552	4	also	also	RB
cord-023095-4dannjjm	2552	5	needed	need	VBN
cord-023095-4dannjjm	2552	6	to	to	TO
cord-023095-4dannjjm	2552	7	determine	determine	VB
cord-023095-4dannjjm	2552	8	if	if	IN
cord-023095-4dannjjm	2552	9	these	these	DT
cord-023095-4dannjjm	2552	10	bacterial	bacterial	JJ
cord-023095-4dannjjm	2552	11	shifts	shift	NNS
cord-023095-4dannjjm	2552	12	are	be	VBP
cord-023095-4dannjjm	2552	13	associated	associate	VBN
cord-023095-4dannjjm	2552	14	with	with	IN
cord-023095-4dannjjm	2552	15	specific	specific	JJ
cord-023095-4dannjjm	2552	16	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2552	17	disorders	disorder	NNS
cord-023095-4dannjjm	2552	18	.	.	.
cord-023095-4dannjjm	2553	1	The	the	DT
cord-023095-4dannjjm	2553	2	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	2553	3	of	of	IN
cord-023095-4dannjjm	2553	4	chronic	chronic	JJ
cord-023095-4dannjjm	2553	5	enteropathies	enteropathy	NNS
cord-023095-4dannjjm	2553	6	(	(	-LRB-
cord-023095-4dannjjm	2553	7	CE	CE	NNP
cord-023095-4dannjjm	2553	8	)	)	-RRB-
cord-023095-4dannjjm	2553	9	in	in	IN
cord-023095-4dannjjm	2553	10	dogs	dog	NNS
cord-023095-4dannjjm	2553	11	likely	likely	RB
cord-023095-4dannjjm	2553	12	involves	involve	VBZ
cord-023095-4dannjjm	2553	13	complex	complex	JJ
cord-023095-4dannjjm	2553	14	interaction	interaction	NN
cord-023095-4dannjjm	2553	15	between	between	IN
cord-023095-4dannjjm	2553	16	the	the	DT
cord-023095-4dannjjm	2553	17	mucosal	mucosal	JJ
cord-023095-4dannjjm	2553	18	immune	immune	JJ
cord-023095-4dannjjm	2553	19	system	system	NN
cord-023095-4dannjjm	2553	20	and	and	CC
cord-023095-4dannjjm	2553	21	the	the	DT
cord-023095-4dannjjm	2553	22	intestinal	intestinal	JJ
cord-023095-4dannjjm	2553	23	microbiota	microbiota	NN
cord-023095-4dannjjm	2553	24	.	.	.
cord-023095-4dannjjm	2554	1	While	while	IN
cord-023095-4dannjjm	2554	2	the	the	DT
cord-023095-4dannjjm	2554	3	application	application	NN
cord-023095-4dannjjm	2554	4	of	of	IN
cord-023095-4dannjjm	2554	5	bacterial	bacterial	JJ
cord-023095-4dannjjm	2554	6	16S	16S	NNP
cord-023095-4dannjjm	2554	7	rDNA	rdna	NN
cord-023095-4dannjjm	2554	8	sequence	sequence	NN
cord-023095-4dannjjm	2554	9	-	-	HYPH
cord-023095-4dannjjm	2554	10	based	base	VBN
cord-023095-4dannjjm	2554	11	analysis	analysis	NN
cord-023095-4dannjjm	2554	12	has	have	VBZ
cord-023095-4dannjjm	2554	13	shown	show	VBN
cord-023095-4dannjjm	2554	14	an	an	DT
cord-023095-4dannjjm	2554	15	association	association	NN
cord-023095-4dannjjm	2554	16	between	between	IN
cord-023095-4dannjjm	2554	17	altered	alter	VBN
cord-023095-4dannjjm	2554	18	microbial	microbial	JJ
cord-023095-4dannjjm	2554	19	composition	composition	NN
cord-023095-4dannjjm	2554	20	and	and	CC
cord-023095-4dannjjm	2554	21	duodenal	duodenal	JJ
cord-023095-4dannjjm	2554	22	inflammation	inflammation	NN
cord-023095-4dannjjm	2554	23	in	in	IN
cord-023095-4dannjjm	2554	24	dogs	dog	NNS
cord-023095-4dannjjm	2554	25	,	,	,
cord-023095-4dannjjm	2554	26	relatively	relatively	RB
cord-023095-4dannjjm	2554	27	little	little	JJ
cord-023095-4dannjjm	2554	28	is	be	VBZ
cord-023095-4dannjjm	2554	29	known	know	VBN
cord-023095-4dannjjm	2554	30	about	about	IN
cord-023095-4dannjjm	2554	31	alterations	alteration	NNS
cord-023095-4dannjjm	2554	32	in	in	IN
cord-023095-4dannjjm	2554	33	non	non	JJ
cord-023095-4dannjjm	2554	34	-	-	JJ
cord-023095-4dannjjm	2554	35	invasive	invasive	JJ
cord-023095-4dannjjm	2554	36	mucosal	mucosal	JJ
cord-023095-4dannjjm	2554	37	and	and	CC
cord-023095-4dannjjm	2554	38	luminal	luminal	JJ
cord-023095-4dannjjm	2554	39	bacteria	bacteria	NNS
cord-023095-4dannjjm	2554	40	seen	see	VBN
cord-023095-4dannjjm	2554	41	with	with	IN
cord-023095-4dannjjm	2554	42	diseases	disease	NNS
cord-023095-4dannjjm	2554	43	involving	involve	VBG
cord-023095-4dannjjm	2554	44	the	the	DT
cord-023095-4dannjjm	2554	45	ileum	ileum	NN
cord-023095-4dannjjm	2554	46	and	and	CC
cord-023095-4dannjjm	2554	47	colon	colon	NN
cord-023095-4dannjjm	2554	48	.	.	.
cord-023095-4dannjjm	2555	1	The	the	DT
cord-023095-4dannjjm	2555	2	present	present	JJ
cord-023095-4dannjjm	2555	3	study	study	NN
cord-023095-4dannjjm	2555	4	sought	seek	VBD
cord-023095-4dannjjm	2555	5	to	to	TO
cord-023095-4dannjjm	2555	6	evaluate	evaluate	VB
cord-023095-4dannjjm	2555	7	the	the	DT
cord-023095-4dannjjm	2555	8	relationship	relationship	NN
cord-023095-4dannjjm	2555	9	of	of	IN
cord-023095-4dannjjm	2555	10	enteric	enteric	JJ
cord-023095-4dannjjm	2555	11	bacteria	bacteria	NNS
cord-023095-4dannjjm	2555	12	to	to	TO
cord-023095-4dannjjm	2555	13	type	type	NN
cord-023095-4dannjjm	2555	14	and	and	CC
cord-023095-4dannjjm	2555	15	severity	severity	NN
cord-023095-4dannjjm	2555	16	of	of	IN
cord-023095-4dannjjm	2555	17	mucosal	mucosal	JJ
cord-023095-4dannjjm	2555	18	inflammation	inflammation	NN
cord-023095-4dannjjm	2555	19	affecting	affect	VBG
cord-023095-4dannjjm	2555	20	the	the	DT
cord-023095-4dannjjm	2555	21	ileum	ileum	NN
cord-023095-4dannjjm	2555	22	and	and	CC
cord-023095-4dannjjm	2555	23	colon	colon	NN
cord-023095-4dannjjm	2555	24	of	of	IN
cord-023095-4dannjjm	2555	25	dogs	dog	NNS
cord-023095-4dannjjm	2555	26	with	with	IN
cord-023095-4dannjjm	2555	27	CE	CE	NNP
cord-023095-4dannjjm	2555	28	.	.	.
cord-023095-4dannjjm	2556	1	Eleven	eleven	CD
cord-023095-4dannjjm	2556	2	client	client	NN
cord-023095-4dannjjm	2556	3	-	-	HYPH
cord-023095-4dannjjm	2556	4	owned	own	VBN
cord-023095-4dannjjm	2556	5	dogs	dog	NNS
cord-023095-4dannjjm	2556	6	with	with	IN
cord-023095-4dannjjm	2556	7	CE	CE	NNP
cord-023095-4dannjjm	2556	8	involving	involve	VBG
cord-023095-4dannjjm	2556	9	both	both	CC
cord-023095-4dannjjm	2556	10	the	the	DT
cord-023095-4dannjjm	2556	11	small	small	JJ
cord-023095-4dannjjm	2556	12	and	and	CC
cord-023095-4dannjjm	2556	13	large	large	JJ
cord-023095-4dannjjm	2556	14	intestines	intestine	NNS
cord-023095-4dannjjm	2556	15	were	be	VBD
cord-023095-4dannjjm	2556	16	prospectively	prospectively	RB
cord-023095-4dannjjm	2556	17	enrolled	enrol	VBN
cord-023095-4dannjjm	2556	18	.	.	.
cord-023095-4dannjjm	2557	1	CE	CE	NNP
cord-023095-4dannjjm	2557	2	was	be	VBD
cord-023095-4dannjjm	2557	3	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2557	4	on	on	IN
cord-023095-4dannjjm	2557	5	the	the	DT
cord-023095-4dannjjm	2557	6	basis	basis	NN
cord-023095-4dannjjm	2557	7	of	of	IN
cord-023095-4dannjjm	2557	8	a	a	DT
cord-023095-4dannjjm	2557	9	history	history	NN
cord-023095-4dannjjm	2557	10	of	of	IN
cord-023095-4dannjjm	2557	11	chronic	chronic	JJ
cord-023095-4dannjjm	2557	12	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2557	13	signs	sign	NNS
cord-023095-4dannjjm	2557	14	,	,	,
cord-023095-4dannjjm	2557	15	exclusion	exclusion	NN
cord-023095-4dannjjm	2557	16	of	of	IN
cord-023095-4dannjjm	2557	17	identifiable	identifiable	JJ
cord-023095-4dannjjm	2557	18	underlying	underlying	JJ
cord-023095-4dannjjm	2557	19	disorders	disorder	NNS
cord-023095-4dannjjm	2557	20	,	,	,
cord-023095-4dannjjm	2557	21	and	and	CC
cord-023095-4dannjjm	2557	22	histopathologic	histopathologic	JJ
cord-023095-4dannjjm	2557	23	evidence	evidence	NN
cord-023095-4dannjjm	2557	24	of	of	IN
cord-023095-4dannjjm	2557	25	intestinal	intestinal	JJ
cord-023095-4dannjjm	2557	26	inflammation	inflammation	NN
cord-023095-4dannjjm	2557	27	.	.	.
cord-023095-4dannjjm	2558	1	Mucosal	Mucosal	NNP
cord-023095-4dannjjm	2558	2	bacteria	bacteria	NNS
cord-023095-4dannjjm	2558	3	were	be	VBD
cord-023095-4dannjjm	2558	4	detected	detect	VBN
cord-023095-4dannjjm	2558	5	in	in	IN
cord-023095-4dannjjm	2558	6	formalinfixed	formalinfixed	NNP
cord-023095-4dannjjm	2558	7	ileal	ileal	JJ
cord-023095-4dannjjm	2558	8	and	and	CC
cord-023095-4dannjjm	2558	9	colonic	colonic	JJ
cord-023095-4dannjjm	2558	10	tissue	tissue	NN
cord-023095-4dannjjm	2558	11	sections	section	NNS
cord-023095-4dannjjm	2558	12	with	with	IN
cord-023095-4dannjjm	2558	13	fluorescence	fluorescence	NN
cord-023095-4dannjjm	2558	14	in	in	IN
cord-023095-4dannjjm	2558	15	situ	situ	NN
cord-023095-4dannjjm	2558	16	hybridization	hybridization	NN
cord-023095-4dannjjm	2558	17	(	(	-LRB-
cord-023095-4dannjjm	2558	18	FISH	FISH	NNP
cord-023095-4dannjjm	2558	19	)	)	-RRB-
cord-023095-4dannjjm	2558	20	using	use	VBG
cord-023095-4dannjjm	2558	21	16S	16S	NNP
cord-023095-4dannjjm	2558	22	rDNA	rDNA	NNP
cord-023095-4dannjjm	2558	23	-	-	HYPH
cord-023095-4dannjjm	2558	24	targeted	target	VBN
cord-023095-4dannjjm	2558	25	probes	probe	NNS
cord-023095-4dannjjm	2558	26	directed	direct	VBN
cord-023095-4dannjjm	2558	27	against	against	IN
cord-023095-4dannjjm	2558	28	all	all	DT
cord-023095-4dannjjm	2558	29	bacteria	bacteria	NNS
cord-023095-4dannjjm	2558	30	,	,	,
cord-023095-4dannjjm	2558	31	Enterobacteriaceae	Enterobacteriaceae	NNP
cord-023095-4dannjjm	2558	32	,	,	,
cord-023095-4dannjjm	2558	33	E.	E.	NNP
cord-023095-4dannjjm	2558	34	coli	coli	NNS
cord-023095-4dannjjm	2558	35	,	,	,
cord-023095-4dannjjm	2558	36	Eubacterium	Eubacterium	NNP
cord-023095-4dannjjm	2558	37	rectale	rectale	NN
cord-023095-4dannjjm	2558	38	-	-	HYPH
cord-023095-4dannjjm	2558	39	Clostridium	clostridium	NN
cord-023095-4dannjjm	2558	40	coccoides	coccoide	NNS
cord-023095-4dannjjm	2558	41	group	group	NN
cord-023095-4dannjjm	2558	42	,	,	,
cord-023095-4dannjjm	2558	43	Bacteroides	Bacteroides	NNP
cord-023095-4dannjjm	2558	44	/	/	SYM
cord-023095-4dannjjm	2558	45	Prevotella	Prevotella	NNP
cord-023095-4dannjjm	2558	46	,	,	,
cord-023095-4dannjjm	2558	47	and	and	CC
cord-023095-4dannjjm	2558	48	Helicobacter	Helicobacter	NNP
cord-023095-4dannjjm	2558	49	spp	spp	NNS
cord-023095-4dannjjm	2558	50	.	.	.
cord-023095-4dannjjm	2559	1	Sections	section	NNS
cord-023095-4dannjjm	2559	2	were	be	VBD
cord-023095-4dannjjm	2559	3	examined	examine	VBN
cord-023095-4dannjjm	2559	4	by	by	IN
cord-023095-4dannjjm	2559	5	epifluorescence	epifluorescence	NN
cord-023095-4dannjjm	2559	6	microscopy	microscopy	NNS
cord-023095-4dannjjm	2559	7	and	and	CC
cord-023095-4dannjjm	2559	8	the	the	DT
cord-023095-4dannjjm	2559	9	number	number	NN
cord-023095-4dannjjm	2559	10	of	of	IN
cord-023095-4dannjjm	2559	11	bacteria	bacteria	NNS
cord-023095-4dannjjm	2559	12	and	and	CC
cord-023095-4dannjjm	2559	13	their	-PRON-	PRP$
cord-023095-4dannjjm	2559	14	spatial	spatial	JJ
cord-023095-4dannjjm	2559	15	distribution	distribution	NN
cord-023095-4dannjjm	2559	16	(	(	-LRB-
cord-023095-4dannjjm	2559	17	luminal	luminal	JJ
cord-023095-4dannjjm	2559	18	,	,	,
cord-023095-4dannjjm	2559	19	superficial	superficial	JJ
cord-023095-4dannjjm	2559	20	mucus	mucus	NN
cord-023095-4dannjjm	2559	21	,	,	,
cord-023095-4dannjjm	2559	22	epithelial	epithelial	JJ
cord-023095-4dannjjm	2559	23	adherent	adherent	NN
cord-023095-4dannjjm	2559	24	,	,	,
cord-023095-4dannjjm	2559	25	within	within	IN
cord-023095-4dannjjm	2559	26	mucosa	mucosa	NN
cord-023095-4dannjjm	2559	27	)	)	-RRB-
cord-023095-4dannjjm	2559	28	was	be	VBD
cord-023095-4dannjjm	2559	29	determined	determine	VBN
cord-023095-4dannjjm	2559	30	in	in	IN
cord-023095-4dannjjm	2559	31	ten	ten	CD
cord-023095-4dannjjm	2559	32	60x	60x	NNS
cord-023095-4dannjjm	2559	33	fields	field	NNS
cord-023095-4dannjjm	2559	34	of	of	IN
cord-023095-4dannjjm	2559	35	each	each	DT
cord-023095-4dannjjm	2559	36	section	section	NN
cord-023095-4dannjjm	2559	37	.	.	.
cord-023095-4dannjjm	2560	1	Microbial	microbial	JJ
cord-023095-4dannjjm	2560	2	composition	composition	NN
cord-023095-4dannjjm	2560	3	in	in	IN
cord-023095-4dannjjm	2560	4	CE	CE	NNP
cord-023095-4dannjjm	2560	5	dogs	dog	NNS
cord-023095-4dannjjm	2560	6	was	be	VBD
cord-023095-4dannjjm	2560	7	compared	compare	VBN
cord-023095-4dannjjm	2560	8	to	to	IN
cord-023095-4dannjjm	2560	9	the	the	DT
cord-023095-4dannjjm	2560	10	ileal	ileal	JJ
cord-023095-4dannjjm	2560	11	/	/	SYM
cord-023095-4dannjjm	2560	12	colonic	colonic	JJ
cord-023095-4dannjjm	2560	13	microbiota	microbiota	NN
cord-023095-4dannjjm	2560	14	of	of	IN
cord-023095-4dannjjm	2560	15	7	7	CD
cord-023095-4dannjjm	2560	16	healthy	healthy	JJ
cord-023095-4dannjjm	2560	17	control	control	NN
cord-023095-4dannjjm	2560	18	(	(	-LRB-
cord-023095-4dannjjm	2560	19	HC	HC	NNP
cord-023095-4dannjjm	2560	20	)	)	-RRB-
cord-023095-4dannjjm	2560	21	dogs	dog	NNS
cord-023095-4dannjjm	2560	22	using	use	VBG
cord-023095-4dannjjm	2560	23	a	a	DT
cord-023095-4dannjjm	2560	24	mixed	mixed	JJ
cord-023095-4dannjjm	2560	25	effect	effect	NN
cord-023095-4dannjjm	2560	26	ANOVA	anova	NN
cord-023095-4dannjjm	2560	27	model	model	NN
cord-023095-4dannjjm	2560	28	.	.	.
cord-023095-4dannjjm	2561	1	P	p	NN
cord-023095-4dannjjm	2561	2	values	value	NNS
cord-023095-4dannjjm	2561	3	o	o	CD
cord-023095-4dannjjm	2561	4	0.05	0.05	CD
cord-023095-4dannjjm	2561	5	were	be	VBD
cord-023095-4dannjjm	2561	6	considered	consider	VBN
cord-023095-4dannjjm	2561	7	significant	significant	JJ
cord-023095-4dannjjm	2561	8	.	.	.
cord-023095-4dannjjm	2562	1	The	the	DT
cord-023095-4dannjjm	2562	2	final	final	JJ
cord-023095-4dannjjm	2562	3	diagnoses	diagnosis	NNS
cord-023095-4dannjjm	2562	4	for	for	IN
cord-023095-4dannjjm	2562	5	dogs	dog	NNS
cord-023095-4dannjjm	2562	6	with	with	IN
cord-023095-4dannjjm	2562	7	CE	CE	NNP
cord-023095-4dannjjm	2562	8	included	include	VBD
cord-023095-4dannjjm	2562	9	IBD	IBD	NNP
cord-023095-4dannjjm	2562	10	(	(	-LRB-
cord-023095-4dannjjm	2562	11	n	n	NN
cord-023095-4dannjjm	2562	12	5	5	CD
cord-023095-4dannjjm	2562	13	8)	8)	NNP
cord-023095-4dannjjm	2562	14	and	and	CC
cord-023095-4dannjjm	2562	15	lymphosarcoma	lymphosarcoma	NNP
cord-023095-4dannjjm	2562	16	(	(	-LRB-
cord-023095-4dannjjm	2562	17	n	n	NN
cord-023095-4dannjjm	2562	18	5	5	CD
cord-023095-4dannjjm	2562	19	3	3	CD
cord-023095-4dannjjm	2562	20	)	)	-RRB-
cord-023095-4dannjjm	2562	21	.	.	.
cord-023095-4dannjjm	2563	1	When	when	WRB
cord-023095-4dannjjm	2563	2	compared	compare	VBN
cord-023095-4dannjjm	2563	3	to	to	IN
cord-023095-4dannjjm	2563	4	HC	HC	NNP
cord-023095-4dannjjm	2563	5	dogs	dog	NNS
cord-023095-4dannjjm	2563	6	,	,	,
cord-023095-4dannjjm	2563	7	dogs	dog	NNS
cord-023095-4dannjjm	2563	8	with	with	IN
cord-023095-4dannjjm	2563	9	CE	CE	NNP
cord-023095-4dannjjm	2563	10	showed	show	VBD
cord-023095-4dannjjm	2563	11	regional	regional	JJ
cord-023095-4dannjjm	2563	12	(	(	-LRB-
cord-023095-4dannjjm	2563	13	ileum	ileum	NN
cord-023095-4dannjjm	2563	14	versus	versus	IN
cord-023095-4dannjjm	2563	15	colon	colon	NN
cord-023095-4dannjjm	2563	16	)	)	-RRB-
cord-023095-4dannjjm	2563	17	imbalances	imbalance	NNS
cord-023095-4dannjjm	2563	18	in	in	IN
cord-023095-4dannjjm	2563	19	microbiota	microbiota	NN
cord-023095-4dannjjm	2563	20	composition	composition	NN
cord-023095-4dannjjm	2563	21	characterized	characterize	VBN
cord-023095-4dannjjm	2563	22	by	by	IN
cord-023095-4dannjjm	2563	23	selective	selective	JJ
cord-023095-4dannjjm	2563	24	enrichment	enrichment	NN
cord-023095-4dannjjm	2563	25	of	of	IN
cord-023095-4dannjjm	2563	26	mucosa	mucosa	NN
cord-023095-4dannjjm	2563	27	-	-	HYPH
cord-023095-4dannjjm	2563	28	associated	associate	VBN
cord-023095-4dannjjm	2563	29	populations	population	NNS
cord-023095-4dannjjm	2563	30	.	.	.
cord-023095-4dannjjm	2564	1	Evaluation	evaluation	NN
cord-023095-4dannjjm	2564	2	of	of	IN
cord-023095-4dannjjm	2564	3	colonic	colonic	JJ
cord-023095-4dannjjm	2564	4	biopsies	biopsy	NNS
cord-023095-4dannjjm	2564	5	in	in	IN
cord-023095-4dannjjm	2564	6	dogs	dog	NNS
cord-023095-4dannjjm	2564	7	with	with	IN
cord-023095-4dannjjm	2564	8	CE	CE	NNP
cord-023095-4dannjjm	2564	9	showed	show	VBD
cord-023095-4dannjjm	2564	10	that	that	IN
cord-023095-4dannjjm	2564	11	the	the	DT
cord-023095-4dannjjm	2564	12	total	total	JJ
cord-023095-4dannjjm	2564	13	number	number	NN
cord-023095-4dannjjm	2564	14	of	of	IN
cord-023095-4dannjjm	2564	15	bacteria	bacteria	NNS
cord-023095-4dannjjm	2564	16	(	(	-LRB-
cord-023095-4dannjjm	2564	17	P	p	NN
cord-023095-4dannjjm	2564	18	o	o	NN
cord-023095-4dannjjm	2564	19	0.04	0.04	CD
cord-023095-4dannjjm	2564	20	)	)	-RRB-
cord-023095-4dannjjm	2564	21	,	,	,
cord-023095-4dannjjm	2564	22	Clostridium	clostridium	NN
cord-023095-4dannjjm	2564	23	(	(	-LRB-
cord-023095-4dannjjm	2564	24	P	p	NN
cord-023095-4dannjjm	2564	25	o	o	NN
cord-023095-4dannjjm	2564	26	0.005	0.005	CD
cord-023095-4dannjjm	2564	27	)	)	-RRB-
cord-023095-4dannjjm	2564	28	,	,	,
cord-023095-4dannjjm	2564	29	Enterobacteriaceae	Enterobacteriaceae	NNP
cord-023095-4dannjjm	2564	30	(	(	-LRB-
cord-023095-4dannjjm	2564	31	P	p	NN
cord-023095-4dannjjm	2564	32	o	o	NN
cord-023095-4dannjjm	2564	33	0.04	0.04	CD
cord-023095-4dannjjm	2564	34	)	)	-RRB-
cord-023095-4dannjjm	2564	35	and	and	CC
cord-023095-4dannjjm	2564	36	E.	E.	NNP
cord-023095-4dannjjm	2564	37	coli	coli	NNS
cord-023095-4dannjjm	2564	38	(	(	-LRB-
cord-023095-4dannjjm	2564	39	P	p	NN
cord-023095-4dannjjm	2564	40	o	o	NN
cord-023095-4dannjjm	2564	41	0.03	0.03	CD
cord-023095-4dannjjm	2564	42	)	)	-RRB-
cord-023095-4dannjjm	2564	43	were	be	VBD
cord-023095-4dannjjm	2564	44	increased	increase	VBN
cord-023095-4dannjjm	2564	45	in	in	IN
cord-023095-4dannjjm	2564	46	the	the	DT
cord-023095-4dannjjm	2564	47	adherent	adherent	JJ
cord-023095-4dannjjm	2564	48	mucus	mucus	NN
cord-023095-4dannjjm	2564	49	regions	region	NNS
cord-023095-4dannjjm	2564	50	of	of	IN
cord-023095-4dannjjm	2564	51	dogs	dog	NNS
cord-023095-4dannjjm	2564	52	with	with	IN
cord-023095-4dannjjm	2564	53	IBD	IBD	NNP
cord-023095-4dannjjm	2564	54	as	as	IN
cord-023095-4dannjjm	2564	55	compared	compare	VBN
cord-023095-4dannjjm	2564	56	to	to	IN
cord-023095-4dannjjm	2564	57	HC	HC	NNP
cord-023095-4dannjjm	2564	58	dogs	dog	NNS
cord-023095-4dannjjm	2564	59	.	.	.
cord-023095-4dannjjm	2565	1	Total	total	JJ
cord-023095-4dannjjm	2565	2	bacteria	bacteria	NNS
cord-023095-4dannjjm	2565	3	(	(	-LRB-
cord-023095-4dannjjm	2565	4	P	p	NN
cord-023095-4dannjjm	2565	5	o	o	NN
cord-023095-4dannjjm	2565	6	0.05	0.05	CD
cord-023095-4dannjjm	2565	7	)	)	-RRB-
cord-023095-4dannjjm	2565	8	and	and	CC
cord-023095-4dannjjm	2565	9	E.	E.	NNP
cord-023095-4dannjjm	2565	10	coli	coli	NNS
cord-023095-4dannjjm	2565	11	(	(	-LRB-
cord-023095-4dannjjm	2565	12	P	p	NN
cord-023095-4dannjjm	2565	13	o	o	NN
cord-023095-4dannjjm	2565	14	0.02	0.02	CD
cord-023095-4dannjjm	2565	15	)	)	-RRB-
cord-023095-4dannjjm	2565	16	were	be	VBD
cord-023095-4dannjjm	2565	17	also	also	RB
cord-023095-4dannjjm	2565	18	more	more	RBR
cord-023095-4dannjjm	2565	19	numerous	numerous	JJ
cord-023095-4dannjjm	2565	20	in	in	IN
cord-023095-4dannjjm	2565	21	dogs	dog	NNS
cord-023095-4dannjjm	2565	22	with	with	IN
cord-023095-4dannjjm	2565	23	LSA	LSA	NNP
cord-023095-4dannjjm	2565	24	versus	versus	IN
cord-023095-4dannjjm	2565	25	HC	HC	NNP
cord-023095-4dannjjm	2565	26	and	and	CC
cord-023095-4dannjjm	2565	27	IBD	IBD	NNP
cord-023095-4dannjjm	2565	28	dogs	dog	NNS
cord-023095-4dannjjm	2566	1	(	(	-LRB-
cord-023095-4dannjjm	2566	2	P	p	NN
cord-023095-4dannjjm	2566	3	o	o	NN
cord-023095-4dannjjm	2566	4	0.04	0.04	CD
cord-023095-4dannjjm	2566	5	for	for	IN
cord-023095-4dannjjm	2566	6	E.	E.	NNP
cord-023095-4dannjjm	2566	7	coli	coli	NNS
cord-023095-4dannjjm	2566	8	)	)	-RRB-
cord-023095-4dannjjm	2566	9	.	.	.
cord-023095-4dannjjm	2567	1	Ileal	ileal	NN
cord-023095-4dannjjm	2567	2	biopsies	biopsy	NNS
cord-023095-4dannjjm	2567	3	from	from	IN
cord-023095-4dannjjm	2567	4	CE	CE	NNP
cord-023095-4dannjjm	2567	5	dogs	dog	NNS
cord-023095-4dannjjm	2567	6	similarly	similarly	RB
cord-023095-4dannjjm	2567	7	showed	show	VBD
cord-023095-4dannjjm	2567	8	variable	variable	JJ
cord-023095-4dannjjm	2567	9	dysbiosis	dysbiosis	NN
cord-023095-4dannjjm	2567	10	with	with	IN
cord-023095-4dannjjm	2567	11	increased	increase	VBN
cord-023095-4dannjjm	2567	12	total	total	JJ
cord-023095-4dannjjm	2567	13	bacteria	bacteria	NNS
cord-023095-4dannjjm	2567	14	(	(	-LRB-
cord-023095-4dannjjm	2567	15	P	p	NN
cord-023095-4dannjjm	2567	16	o	o	NN
cord-023095-4dannjjm	2567	17	0.05	0.05	CD
cord-023095-4dannjjm	2567	18	)	)	-RRB-
cord-023095-4dannjjm	2567	19	but	but	CC
cord-023095-4dannjjm	2567	20	decreased	decrease	VBD
cord-023095-4dannjjm	2567	21	Helicobacter	Helicobacter	NNP
cord-023095-4dannjjm	2567	22	spp	spp	NNS
cord-023095-4dannjjm	2567	23	(	(	-LRB-
cord-023095-4dannjjm	2567	24	P	p	NN
cord-023095-4dannjjm	2567	25	o	o	NN
cord-023095-4dannjjm	2567	26	0.001	0.001	CD
cord-023095-4dannjjm	2567	27	)	)	-RRB-
cord-023095-4dannjjm	2567	28	and	and	CC
cord-023095-4dannjjm	2567	29	Bacteroides	Bacteroides	NNP
cord-023095-4dannjjm	2567	30	(	(	-LRB-
cord-023095-4dannjjm	2567	31	P	p	NN
cord-023095-4dannjjm	2567	32	o	o	NN
cord-023095-4dannjjm	2567	33	0.02	0.02	CD
cord-023095-4dannjjm	2567	34	)	)	-RRB-
cord-023095-4dannjjm	2567	35	observed	observe	VBD
cord-023095-4dannjjm	2567	36	within	within	IN
cord-023095-4dannjjm	2567	37	inflamed	inflamed	JJ
cord-023095-4dannjjm	2567	38	intestines	intestine	NNS
cord-023095-4dannjjm	2567	39	as	as	IN
cord-023095-4dannjjm	2567	40	compared	compare	VBN
cord-023095-4dannjjm	2567	41	to	to	IN
cord-023095-4dannjjm	2567	42	HC	HC	NNP
cord-023095-4dannjjm	2567	43	tissues	tissue	NNS
cord-023095-4dannjjm	2567	44	.	.	.
cord-023095-4dannjjm	2568	1	The	the	DT
cord-023095-4dannjjm	2568	2	spatial	spatial	JJ
cord-023095-4dannjjm	2568	3	distribution	distribution	NN
cord-023095-4dannjjm	2568	4	of	of	IN
cord-023095-4dannjjm	2568	5	these	these	DT
cord-023095-4dannjjm	2568	6	bacteria	bacteria	NNS
cord-023095-4dannjjm	2568	7	was	be	VBD
cord-023095-4dannjjm	2568	8	also	also	RB
cord-023095-4dannjjm	2568	9	appreciably	appreciably	RB
cord-023095-4dannjjm	2568	10	different	different	JJ
cord-023095-4dannjjm	2568	11	from	from	IN
cord-023095-4dannjjm	2568	12	HC	HC	NNP
cord-023095-4dannjjm	2568	13	dogs	dog	NNS
cord-023095-4dannjjm	2568	14	,	,	,
cord-023095-4dannjjm	2568	15	with	with	IN
cord-023095-4dannjjm	2568	16	higher	high	JJR
cord-023095-4dannjjm	2568	17	numbers	number	NNS
cord-023095-4dannjjm	2568	18	of	of	IN
cord-023095-4dannjjm	2568	19	bacteria	bacteria	NNS
cord-023095-4dannjjm	2568	20	generally	generally	RB
cord-023095-4dannjjm	2568	21	found	find	VBN
cord-023095-4dannjjm	2568	22	within	within	IN
cord-023095-4dannjjm	2568	23	the	the	DT
cord-023095-4dannjjm	2568	24	adherent	adherent	JJ
cord-023095-4dannjjm	2568	25	mucus	mucus	NN
cord-023095-4dannjjm	2568	26	compartment	compartment	NN
cord-023095-4dannjjm	2568	27	as	as	IN
cord-023095-4dannjjm	2568	28	compared	compare	VBN
cord-023095-4dannjjm	2568	29	to	to	IN
cord-023095-4dannjjm	2568	30	other	other	JJ
cord-023095-4dannjjm	2568	31	ileal	ileal	JJ
cord-023095-4dannjjm	2568	32	regions	region	NNS
cord-023095-4dannjjm	2568	33	.	.	.
cord-023095-4dannjjm	2569	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	2569	2	data	datum	NNS
cord-023095-4dannjjm	2569	3	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	2569	4	that	that	IN
cord-023095-4dannjjm	2569	5	dogs	dog	NNS
cord-023095-4dannjjm	2569	6	with	with	IN
cord-023095-4dannjjm	2569	7	CE	ce	NN
cord-023095-4dannjjm	2569	8	affecting	affect	VBG
cord-023095-4dannjjm	2569	9	the	the	DT
cord-023095-4dannjjm	2569	10	ileum	ileum	NN
cord-023095-4dannjjm	2569	11	and	and	CC
cord-023095-4dannjjm	2569	12	colon	colon	NN
cord-023095-4dannjjm	2569	13	have	have	VBP
cord-023095-4dannjjm	2569	14	altered	alter	VBN
cord-023095-4dannjjm	2569	15	microbiota	microbiota	NN
cord-023095-4dannjjm	2569	16	composition	composition	NN
cord-023095-4dannjjm	2569	17	that	that	WDT
cord-023095-4dannjjm	2569	18	may	may	MD
cord-023095-4dannjjm	2569	19	be	be	VB
cord-023095-4dannjjm	2569	20	a	a	DT
cord-023095-4dannjjm	2569	21	cause	cause	NN
cord-023095-4dannjjm	2569	22	or	or	CC
cord-023095-4dannjjm	2569	23	consequence	consequence	NN
cord-023095-4dannjjm	2569	24	of	of	IN
cord-023095-4dannjjm	2569	25	mucosal	mucosal	JJ
cord-023095-4dannjjm	2569	26	inflammation	inflammation	NN
cord-023095-4dannjjm	2569	27	.	.	.
cord-023095-4dannjjm	2570	1	Recognition	recognition	NN
cord-023095-4dannjjm	2570	2	of	of	IN
cord-023095-4dannjjm	2570	3	these	these	DT
cord-023095-4dannjjm	2570	4	microbiota	microbiota	NN
cord-023095-4dannjjm	2570	5	imbalances	imbalance	NNS
cord-023095-4dannjjm	2570	6	may	may	MD
cord-023095-4dannjjm	2570	7	provide	provide	VB
cord-023095-4dannjjm	2570	8	new	new	JJ
cord-023095-4dannjjm	2570	9	opportunities	opportunity	NNS
cord-023095-4dannjjm	2570	10	for	for	IN
cord-023095-4dannjjm	2570	11	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	2570	12	intervention	intervention	NN
cord-023095-4dannjjm	2570	13	.	.	.
cord-023095-4dannjjm	2571	1	Trichomonads	trichomonad	NNS
cord-023095-4dannjjm	2571	2	have	have	VBP
cord-023095-4dannjjm	2571	3	been	be	VBN
cord-023095-4dannjjm	2571	4	rarely	rarely	RB
cord-023095-4dannjjm	2571	5	reported	report	VBN
cord-023095-4dannjjm	2571	6	in	in	IN
cord-023095-4dannjjm	2571	7	the	the	DT
cord-023095-4dannjjm	2571	8	feces	fece	NNS
cord-023095-4dannjjm	2571	9	of	of	IN
cord-023095-4dannjjm	2571	10	dogs	dog	NNS
cord-023095-4dannjjm	2571	11	and	and	CC
cord-023095-4dannjjm	2571	12	their	-PRON-	PRP$
cord-023095-4dannjjm	2571	13	pathogenicity	pathogenicity	NN
cord-023095-4dannjjm	2571	14	remains	remain	VBZ
cord-023095-4dannjjm	2571	15	uncertain	uncertain	JJ
cord-023095-4dannjjm	2571	16	.	.	.
cord-023095-4dannjjm	2572	1	Although	although	IN
cord-023095-4dannjjm	2572	2	Pentatrichomonas	Pentatrichomonas	NNP
cord-023095-4dannjjm	2572	3	hominis	hominis	NN
cord-023095-4dannjjm	2572	4	(	(	-LRB-
cord-023095-4dannjjm	2572	5	Ph	Ph	NNP
cord-023095-4dannjjm	2572	6	)	)	-RRB-
cord-023095-4dannjjm	2572	7	is	be	VBZ
cord-023095-4dannjjm	2572	8	considered	consider	VBN
cord-023095-4dannjjm	2572	9	to	to	TO
cord-023095-4dannjjm	2572	10	be	be	VB
cord-023095-4dannjjm	2572	11	a	a	DT
cord-023095-4dannjjm	2572	12	commensal	commensal	NN
cord-023095-4dannjjm	2572	13	that	that	WDT
cord-023095-4dannjjm	2572	14	may	may	MD
cord-023095-4dannjjm	2572	15	overgrow	overgrow	VB
cord-023095-4dannjjm	2572	16	in	in	IN
cord-023095-4dannjjm	2572	17	dogs	dog	NNS
cord-023095-4dannjjm	2572	18	with	with	IN
cord-023095-4dannjjm	2572	19	other	other	JJ
cord-023095-4dannjjm	2572	20	causes	cause	NNS
cord-023095-4dannjjm	2572	21	of	of	IN
cord-023095-4dannjjm	2572	22	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2572	23	,	,	,
cord-023095-4dannjjm	2572	24	little	little	JJ
cord-023095-4dannjjm	2572	25	is	be	VBZ
cord-023095-4dannjjm	2572	26	known	know	VBN
cord-023095-4dannjjm	2572	27	regarding	regard	VBG
cord-023095-4dannjjm	2572	28	the	the	DT
cord-023095-4dannjjm	2572	29	history	history	NN
cord-023095-4dannjjm	2572	30	,	,	,
cord-023095-4dannjjm	2572	31	clinical	clinical	JJ
cord-023095-4dannjjm	2572	32	presentation	presentation	NN
cord-023095-4dannjjm	2572	33	or	or	CC
cord-023095-4dannjjm	2572	34	prevalence	prevalence	NN
cord-023095-4dannjjm	2572	35	of	of	IN
cord-023095-4dannjjm	2572	36	concurrent	concurrent	JJ
cord-023095-4dannjjm	2572	37	GI	GI	NNP
cord-023095-4dannjjm	2572	38	infections	infection	NNS
cord-023095-4dannjjm	2572	39	in	in	IN
cord-023095-4dannjjm	2572	40	dogs	dog	NNS
cord-023095-4dannjjm	2572	41	with	with	IN
cord-023095-4dannjjm	2572	42	trichomonosis	trichomonosis	NN
cord-023095-4dannjjm	2572	43	.	.	.
cord-023095-4dannjjm	2573	1	The	the	DT
cord-023095-4dannjjm	2573	2	aim	aim	NN
cord-023095-4dannjjm	2573	3	of	of	IN
cord-023095-4dannjjm	2573	4	this	this	DT
cord-023095-4dannjjm	2573	5	study	study	NN
cord-023095-4dannjjm	2573	6	was	be	VBD
cord-023095-4dannjjm	2573	7	to	to	TO
cord-023095-4dannjjm	2573	8	determine	determine	VB
cord-023095-4dannjjm	2573	9	whether	whether	IN
cord-023095-4dannjjm	2573	10	dogs	dog	NNS
cord-023095-4dannjjm	2573	11	with	with	IN
cord-023095-4dannjjm	2573	12	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2573	13	and	and	CC
cord-023095-4dannjjm	2573	14	trichomonosis	trichomonosis	NN
cord-023095-4dannjjm	2573	15	could	could	MD
cord-023095-4dannjjm	2573	16	be	be	VB
cord-023095-4dannjjm	2573	17	distinguished	distinguish	VBN
cord-023095-4dannjjm	2573	18	from	from	IN
cord-023095-4dannjjm	2573	19	dogs	dog	NNS
cord-023095-4dannjjm	2573	20	having	have	VBG
cord-023095-4dannjjm	2573	21	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2573	22	without	without	IN
cord-023095-4dannjjm	2573	23	trichomonosis	trichomonosis	NN
cord-023095-4dannjjm	2573	24	on	on	IN
cord-023095-4dannjjm	2573	25	the	the	DT
cord-023095-4dannjjm	2573	26	basis	basis	NN
cord-023095-4dannjjm	2573	27	of	of	IN
cord-023095-4dannjjm	2573	28	clinical	clinical	JJ
cord-023095-4dannjjm	2573	29	signs	sign	NNS
cord-023095-4dannjjm	2573	30	or	or	CC
cord-023095-4dannjjm	2573	31	presence	presence	NN
cord-023095-4dannjjm	2573	32	of	of	IN
cord-023095-4dannjjm	2573	33	concurrent	concurrent	JJ
cord-023095-4dannjjm	2573	34	enteric	enteric	JJ
cord-023095-4dannjjm	2573	35	infections	infection	NNS
cord-023095-4dannjjm	2573	36	.	.	.
cord-023095-4dannjjm	2574	1	Fecal	fecal	JJ
cord-023095-4dannjjm	2574	2	samples	sample	NNS
cord-023095-4dannjjm	2574	3	from	from	IN
cord-023095-4dannjjm	2574	4	39	39	CD
cord-023095-4dannjjm	2574	5	dogs	dog	NNS
cord-023095-4dannjjm	2574	6	were	be	VBD
cord-023095-4dannjjm	2574	7	submitted	submit	VBN
cord-023095-4dannjjm	2574	8	to	to	IN
cord-023095-4dannjjm	2574	9	NCSU	NCSU	NNP
cord-023095-4dannjjm	2574	10	from	from	IN
cord-023095-4dannjjm	2574	11	2007	2007	CD
cord-023095-4dannjjm	2574	12	-	-	SYM
cord-023095-4dannjjm	2574	13	2010	2010	CD
cord-023095-4dannjjm	2574	14	for	for	IN
cord-023095-4dannjjm	2574	15	Trichomonas	Trichomonas	NNP
cord-023095-4dannjjm	2574	16	spp	spp	NNP
cord-023095-4dannjjm	2574	17	.	.	.
cord-023095-4dannjjm	2575	1	PCR	PCR	NNP
cord-023095-4dannjjm	2575	2	testing	testing	NN
cord-023095-4dannjjm	2575	3	.	.	.
cord-023095-4dannjjm	2576	1	DNA	DNA	NNP
cord-023095-4dannjjm	2576	2	was	be	VBD
cord-023095-4dannjjm	2576	3	extracted	extract	VBN
cord-023095-4dannjjm	2576	4	using	use	VBG
cord-023095-4dannjjm	2576	5	a	a	DT
cord-023095-4dannjjm	2576	6	ZR	ZR	NNP
cord-023095-4dannjjm	2576	7	Fecal	fecal	JJ
cord-023095-4dannjjm	2576	8	DNA	dna	NN
cord-023095-4dannjjm	2576	9	mini	mini	JJ
cord-023095-4dannjjm	2576	10	-	-	HYPH
cord-023095-4dannjjm	2576	11	prep	prep	JJ
cord-023095-4dannjjm	2576	12	kit	kit	NN
cord-023095-4dannjjm	2576	13	and	and	CC
cord-023095-4dannjjm	2576	14	absence	absence	NN
cord-023095-4dannjjm	2576	15	of	of	IN
cord-023095-4dannjjm	2576	16	PCR	PCR	NNP
cord-023095-4dannjjm	2576	17	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	2576	18	verified	verify	VBN
cord-023095-4dannjjm	2576	19	by	by	IN
cord-023095-4dannjjm	2576	20	amplification	amplification	NN
cord-023095-4dannjjm	2576	21	of	of	IN
cord-023095-4dannjjm	2576	22	bacterial	bacterial	JJ
cord-023095-4dannjjm	2576	23	16S	16S	NNP
cord-023095-4dannjjm	2576	24	rDNA	rDNA	NNP
cord-023095-4dannjjm	2576	25	.	.	.
cord-023095-4dannjjm	2577	1	PCR	PCR	NNP
cord-023095-4dannjjm	2577	2	for	for	IN
cord-023095-4dannjjm	2577	3	Ph	Ph	NNP
cord-023095-4dannjjm	2577	4	and	and	CC
cord-023095-4dannjjm	2577	5	Tritrichomonas	Tritrichomonas	NNP
cord-023095-4dannjjm	2577	6	foetus	foetus	NN
cord-023095-4dannjjm	2577	7	(	(	-LRB-
cord-023095-4dannjjm	2577	8	Tf	Tf	NNP
cord-023095-4dannjjm	2577	9	)	)	-RRB-
cord-023095-4dannjjm	2577	10	was	be	VBD
cord-023095-4dannjjm	2577	11	performed	perform	VBN
cord-023095-4dannjjm	2577	12	as	as	RB
cord-023095-4dannjjm	2577	13	well	well	RB
cord-023095-4dannjjm	2577	14	as	as	IN
cord-023095-4dannjjm	2577	15	real	real	JJ
cord-023095-4dannjjm	2577	16	-	-	HYPH
cord-023095-4dannjjm	2577	17	time	time	NN
cord-023095-4dannjjm	2577	18	PCR	PCR	NNP
cord-023095-4dannjjm	2577	19	assays	assay	NNS
cord-023095-4dannjjm	2577	20	for	for	IN
cord-023095-4dannjjm	2577	21	9	9	CD
cord-023095-4dannjjm	2577	22	possible	possible	JJ
cord-023095-4dannjjm	2577	23	concurrent	concurrent	JJ
cord-023095-4dannjjm	2577	24	enteric	enteric	JJ
cord-023095-4dannjjm	2577	25	infectious	infectious	JJ
cord-023095-4dannjjm	2577	26	agents	agent	NNS
cord-023095-4dannjjm	2577	27	.	.	.
cord-023095-4dannjjm	2578	1	Obtainable	obtainable	JJ
cord-023095-4dannjjm	2578	2	medical	medical	JJ
cord-023095-4dannjjm	2578	3	records	record	NNS
cord-023095-4dannjjm	2578	4	were	be	VBD
cord-023095-4dannjjm	2578	5	reviewed	review	VBN
cord-023095-4dannjjm	2578	6	.	.	.
cord-023095-4dannjjm	2579	1	All	all	DT
cord-023095-4dannjjm	2579	2	submitted	submit	VBD
cord-023095-4dannjjm	2579	3	fecal	fecal	JJ
cord-023095-4dannjjm	2579	4	samples	sample	NNS
cord-023095-4dannjjm	2579	5	were	be	VBD
cord-023095-4dannjjm	2579	6	submitted	submit	VBN
cord-023095-4dannjjm	2579	7	from	from	IN
cord-023095-4dannjjm	2579	8	dogs	dog	NNS
cord-023095-4dannjjm	2579	9	with	with	IN
cord-023095-4dannjjm	2579	10	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2579	11	that	that	WDT
cord-023095-4dannjjm	2579	12	was	be	VBD
cord-023095-4dannjjm	2579	13	variably	variably	RB
cord-023095-4dannjjm	2579	14	described	describe	VBN
cord-023095-4dannjjm	2579	15	as	as	IN
cord-023095-4dannjjm	2579	16	soft	soft	JJ
cord-023095-4dannjjm	2579	17	,	,	,
cord-023095-4dannjjm	2579	18	mucoid	mucoid	JJ
cord-023095-4dannjjm	2579	19	,	,	,
cord-023095-4dannjjm	2579	20	hemorrhagic	hemorrhagic	JJ
cord-023095-4dannjjm	2579	21	,	,	,
cord-023095-4dannjjm	2579	22	or	or	CC
cord-023095-4dannjjm	2579	23	watery	watery	JJ
cord-023095-4dannjjm	2579	24	.	.	.
cord-023095-4dannjjm	2580	1	Mean	mean	JJ
cord-023095-4dannjjm	2580	2	age	age	NN
cord-023095-4dannjjm	2580	3	of	of	IN
cord-023095-4dannjjm	2580	4	the	the	DT
cord-023095-4dannjjm	2580	5	dogs	dog	NNS
cord-023095-4dannjjm	2580	6	was	be	VBD
cord-023095-4dannjjm	2580	7	2.33	2.33	CD
cord-023095-4dannjjm	2580	8	years	year	NNS
cord-023095-4dannjjm	2580	9	(	(	-LRB-
cord-023095-4dannjjm	2580	10	median	median	JJ
cord-023095-4dannjjm	2580	11	1.9	1.9	CD
cord-023095-4dannjjm	2580	12	;	;	:
cord-023095-4dannjjm	2580	13	range	range	NN
cord-023095-4dannjjm	2580	14	:	:	:
cord-023095-4dannjjm	2580	15	2.5	2.5	CD
cord-023095-4dannjjm	2580	16	-	-	SYM
cord-023095-4dannjjm	2580	17	120	120	CD
cord-023095-4dannjjm	2580	18	months	month	NNS
cord-023095-4dannjjm	2580	19	)	)	-RRB-
cord-023095-4dannjjm	2580	20	and	and	CC
cord-023095-4dannjjm	2580	21	represented	represent	VBD
cord-023095-4dannjjm	2580	22	a	a	DT
cord-023095-4dannjjm	2580	23	total	total	NN
cord-023095-4dannjjm	2580	24	of	of	IN
cord-023095-4dannjjm	2580	25	24	24	CD
cord-023095-4dannjjm	2580	26	breeds	breed	NNS
cord-023095-4dannjjm	2580	27	.	.	.
cord-023095-4dannjjm	2581	1	Ph	Ph	NNP
cord-023095-4dannjjm	2581	2	,	,	,
cord-023095-4dannjjm	2581	3	Tf	Tf	NNP
cord-023095-4dannjjm	2581	4	,	,	,
cord-023095-4dannjjm	2581	5	or	or	CC
cord-023095-4dannjjm	2581	6	concurrent	concurrent	JJ
cord-023095-4dannjjm	2581	7	Ph	Ph	NNP
cord-023095-4dannjjm	2581	8	and	and	CC
cord-023095-4dannjjm	2581	9	Tf	Tf	NNP
cord-023095-4dannjjm	2581	10	were	be	VBD
cord-023095-4dannjjm	2581	11	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2581	12	in	in	IN
cord-023095-4dannjjm	2581	13	18	18	CD
cord-023095-4dannjjm	2581	14	,	,	,
cord-023095-4dannjjm	2581	15	1	1	CD
cord-023095-4dannjjm	2581	16	,	,	,
cord-023095-4dannjjm	2581	17	and	and	CC
cord-023095-4dannjjm	2581	18	1	1	CD
cord-023095-4dannjjm	2581	19	dogs	dog	NNS
cord-023095-4dannjjm	2581	20	respectively	respectively	RB
cord-023095-4dannjjm	2581	21	(	(	-LRB-
cord-023095-4dannjjm	2581	22	Group	Group	NNP
cord-023095-4dannjjm	2581	23	A	A	NNP
cord-023095-4dannjjm	2581	24	)	)	-RRB-
cord-023095-4dannjjm	2581	25	.	.	.
cord-023095-4dannjjm	2582	1	The	the	DT
cord-023095-4dannjjm	2582	2	remaining	remain	VBG
cord-023095-4dannjjm	2582	3	19	19	CD
cord-023095-4dannjjm	2582	4	dogs	dog	NNS
cord-023095-4dannjjm	2582	5	were	be	VBD
cord-023095-4dannjjm	2582	6	negative	negative	JJ
cord-023095-4dannjjm	2582	7	for	for	IN
cord-023095-4dannjjm	2582	8	Ph	Ph	NNP
cord-023095-4dannjjm	2582	9	and	and	CC
cord-023095-4dannjjm	2582	10	Tf	Tf	NNP
cord-023095-4dannjjm	2582	11	by	by	IN
cord-023095-4dannjjm	2582	12	PCR	PCR	NNP
cord-023095-4dannjjm	2583	1	No	no	DT
cord-023095-4dannjjm	2583	2	dogs	dog	NNS
cord-023095-4dannjjm	2583	3	were	be	VBD
cord-023095-4dannjjm	2583	4	identified	identify	VBN
cord-023095-4dannjjm	2583	5	as	as	IN
cord-023095-4dannjjm	2583	6	infected	infect	VBN
cord-023095-4dannjjm	2583	7	with	with	IN
cord-023095-4dannjjm	2583	8	canine	canine	JJ
cord-023095-4dannjjm	2583	9	distemper	distemper	NN
cord-023095-4dannjjm	2583	10	virus	virus	NN
cord-023095-4dannjjm	2583	11	or	or	CC
cord-023095-4dannjjm	2583	12	parvovirus	parvovirus	NN
cord-023095-4dannjjm	2583	13	.	.	.
cord-023095-4dannjjm	2584	1	Five	five	CD
cord-023095-4dannjjm	2584	2	samples	sample	NNS
cord-023095-4dannjjm	2584	3	from	from	IN
cord-023095-4dannjjm	2584	4	each	each	DT
cord-023095-4dannjjm	2584	5	group	group	NN
cord-023095-4dannjjm	2584	6	had	have	VBD
cord-023095-4dannjjm	2584	7	insufficient	insufficient	JJ
cord-023095-4dannjjm	2584	8	quantity	quantity	NN
cord-023095-4dannjjm	2584	9	or	or	CC
cord-023095-4dannjjm	2584	10	quality	quality	NN
cord-023095-4dannjjm	2584	11	of	of	IN
cord-023095-4dannjjm	2584	12	DNA	dna	NN
cord-023095-4dannjjm	2584	13	for	for	IN
cord-023095-4dannjjm	2584	14	concurrent	concurrent	JJ
cord-023095-4dannjjm	2584	15	infectious	infectious	JJ
cord-023095-4dannjjm	2584	16	disease	disease	NN
cord-023095-4dannjjm	2584	17	testing	testing	NN
cord-023095-4dannjjm	2584	18	.	.	.
cord-023095-4dannjjm	2585	1	In	in	IN
cord-023095-4dannjjm	2585	2	this	this	DT
cord-023095-4dannjjm	2585	3	large	large	JJ
cord-023095-4dannjjm	2585	4	study	study	NN
cord-023095-4dannjjm	2585	5	of	of	IN
cord-023095-4dannjjm	2585	6	canine	canine	JJ
cord-023095-4dannjjm	2585	7	trichomonosis	trichomonosis	NN
cord-023095-4dannjjm	2585	8	,	,	,
cord-023095-4dannjjm	2585	9	no	no	DT
cord-023095-4dannjjm	2585	10	differences	difference	NNS
cord-023095-4dannjjm	2585	11	in	in	IN
cord-023095-4dannjjm	2585	12	age	age	NN
cord-023095-4dannjjm	2585	13	,	,	,
cord-023095-4dannjjm	2585	14	clinical	clinical	JJ
cord-023095-4dannjjm	2585	15	signs	sign	NNS
cord-023095-4dannjjm	2585	16	,	,	,
cord-023095-4dannjjm	2585	17	or	or	CC
cord-023095-4dannjjm	2585	18	prevalence	prevalence	NN
cord-023095-4dannjjm	2585	19	and	and	CC
cord-023095-4dannjjm	2585	20	identity	identity	NN
cord-023095-4dannjjm	2585	21	of	of	IN
cord-023095-4dannjjm	2585	22	concurrent	concurrent	JJ
cord-023095-4dannjjm	2585	23	enteric	enteric	JJ
cord-023095-4dannjjm	2585	24	infection	infection	NN
cord-023095-4dannjjm	2585	25	between	between	IN
cord-023095-4dannjjm	2585	26	diarrheic	diarrheic	NNS
cord-023095-4dannjjm	2585	27	dogs	dog	NNS
cord-023095-4dannjjm	2585	28	with	with	IN
cord-023095-4dannjjm	2585	29	or	or	CC
cord-023095-4dannjjm	2585	30	without	without	IN
cord-023095-4dannjjm	2585	31	Ph	Ph	NNP
cord-023095-4dannjjm	2585	32	were	be	VBD
cord-023095-4dannjjm	2585	33	identified	identify	VBN
cord-023095-4dannjjm	2585	34	.	.	.
cord-023095-4dannjjm	2586	1	Thus	thus	RB
cord-023095-4dannjjm	2586	2	,	,	,
cord-023095-4dannjjm	2586	3	these	these	DT
cord-023095-4dannjjm	2586	4	findings	finding	NNS
cord-023095-4dannjjm	2586	5	do	do	VBP
cord-023095-4dannjjm	2586	6	not	not	RB
cord-023095-4dannjjm	2586	7	appear	appear	VB
cord-023095-4dannjjm	2586	8	to	to	TO
cord-023095-4dannjjm	2586	9	support	support	VB
cord-023095-4dannjjm	2586	10	a	a	DT
cord-023095-4dannjjm	2586	11	primary	primary	JJ
cord-023095-4dannjjm	2586	12	pathogenic	pathogenic	JJ
cord-023095-4dannjjm	2586	13	role	role	NN
cord-023095-4dannjjm	2586	14	for	for	IN
cord-023095-4dannjjm	2586	15	Ph	Ph	NNP
cord-023095-4dannjjm	2586	16	as	as	IN
cord-023095-4dannjjm	2586	17	a	a	DT
cord-023095-4dannjjm	2586	18	causative	causative	JJ
cord-023095-4dannjjm	2586	19	agent	agent	NN
cord-023095-4dannjjm	2586	20	of	of	IN
cord-023095-4dannjjm	2586	21	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2586	22	in	in	IN
cord-023095-4dannjjm	2586	23	dogs	dog	NNS
cord-023095-4dannjjm	2586	24	.	.	.
cord-023095-4dannjjm	2587	1	Gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2587	2	motility	motility	NN
cord-023095-4dannjjm	2587	3	disorders	disorder	NNS
cord-023095-4dannjjm	2587	4	are	be	VBP
cord-023095-4dannjjm	2587	5	a	a	DT
cord-023095-4dannjjm	2587	6	common	common	JJ
cord-023095-4dannjjm	2587	7	clinical	clinical	JJ
cord-023095-4dannjjm	2587	8	problem	problem	NN
cord-023095-4dannjjm	2587	9	in	in	IN
cord-023095-4dannjjm	2587	10	domestic	domestic	JJ
cord-023095-4dannjjm	2587	11	animals	animal	NNS
cord-023095-4dannjjm	2587	12	.	.	.
cord-023095-4dannjjm	2588	1	Many	many	JJ
cord-023095-4dannjjm	2588	2	of	of	IN
cord-023095-4dannjjm	2588	3	the	the	DT
cord-023095-4dannjjm	2588	4	G.I.	G.I.	NNP
cord-023095-4dannjjm	2588	5	motility	motility	NN
cord-023095-4dannjjm	2588	6	disorders	disorder	NNS
cord-023095-4dannjjm	2588	7	have	have	VBP
cord-023095-4dannjjm	2588	8	been	be	VBN
cord-023095-4dannjjm	2588	9	treated	treat	VBN
cord-023095-4dannjjm	2588	10	previously	previously	RB
cord-023095-4dannjjm	2588	11	with	with	IN
cord-023095-4dannjjm	2588	12	5-HT	5-ht	CD
cord-023095-4dannjjm	2588	13	4	4	CD
cord-023095-4dannjjm	2588	14	agonists	agonist	NNS
cord-023095-4dannjjm	2588	15	although	although	IN
cord-023095-4dannjjm	2588	16	limited	limited	JJ
cord-023095-4dannjjm	2588	17	availability	availability	NN
cord-023095-4dannjjm	2588	18	of	of	IN
cord-023095-4dannjjm	2588	19	drugs	drug	NNS
cord-023095-4dannjjm	2588	20	in	in	IN
cord-023095-4dannjjm	2588	21	this	this	DT
cord-023095-4dannjjm	2588	22	classification	classification	NN
cord-023095-4dannjjm	2588	23	have	have	VBP
cord-023095-4dannjjm	2588	24	stimulated	stimulate	VBN
cord-023095-4dannjjm	2588	25	interest	interest	NN
cord-023095-4dannjjm	2588	26	in	in	IN
cord-023095-4dannjjm	2588	27	the	the	DT
cord-023095-4dannjjm	2588	28	use	use	NN
cord-023095-4dannjjm	2588	29	of	of	IN
cord-023095-4dannjjm	2588	30	new	new	JJ
cord-023095-4dannjjm	2588	31	(	(	-LRB-
cord-023095-4dannjjm	2588	32	and	and	CC
cord-023095-4dannjjm	2588	33	old	old	JJ
cord-023095-4dannjjm	2588	34	)	)	-RRB-
cord-023095-4dannjjm	2588	35	drug	drug	NN
cord-023095-4dannjjm	2588	36	therapies	therapy	NNS
cord-023095-4dannjjm	2588	37	.	.	.
cord-023095-4dannjjm	2589	1	The	the	DT
cord-023095-4dannjjm	2589	2	dopaminergic	dopaminergic	JJ
cord-023095-4dannjjm	2589	3	antagonists	antagonist	NNS
cord-023095-4dannjjm	2589	4	are	be	VBP
cord-023095-4dannjjm	2589	5	a	a	DT
cord-023095-4dannjjm	2589	6	group	group	NN
cord-023095-4dannjjm	2589	7	of	of	IN
cord-023095-4dannjjm	2589	8	drugs	drug	NNS
cord-023095-4dannjjm	2589	9	with	with	IN
cord-023095-4dannjjm	2589	10	well	well	RB
cord-023095-4dannjjm	2589	11	-	-	HYPH
cord-023095-4dannjjm	2589	12	known	know	VBN
cord-023095-4dannjjm	2589	13	anti	anti	JJ
cord-023095-4dannjjm	2589	14	-	-	JJ
cord-023095-4dannjjm	2589	15	emetic	emetic	JJ
cord-023095-4dannjjm	2589	16	effects	effect	NNS
cord-023095-4dannjjm	2589	17	at	at	IN
cord-023095-4dannjjm	2589	18	central	central	JJ
cord-023095-4dannjjm	2589	19	dopamine	dopamine	NN
cord-023095-4dannjjm	2589	20	D	D	NNP
cord-023095-4dannjjm	2589	21	2	2	CD
cord-023095-4dannjjm	2589	22	receptors	receptor	NNS
cord-023095-4dannjjm	2589	23	,	,	,
cord-023095-4dannjjm	2589	24	and	and	CC
cord-023095-4dannjjm	2589	25	putative	putative	JJ
cord-023095-4dannjjm	2589	26	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2589	27	prokinetic	prokinetic	JJ
cord-023095-4dannjjm	2589	28	effects	effect	NNS
cord-023095-4dannjjm	2589	29	at	at	IN
cord-023095-4dannjjm	2589	30	peripheral	peripheral	JJ
cord-023095-4dannjjm	2589	31	D	d	NN
cord-023095-4dannjjm	2589	32	receptors	receptor	NNS
cord-023095-4dannjjm	2589	33	.	.	.
cord-023095-4dannjjm	2590	1	Domperidone	Domperidone	NNP
cord-023095-4dannjjm	2590	2	has	have	VBZ
cord-023095-4dannjjm	2590	3	been	be	VBN
cord-023095-4dannjjm	2590	4	shown	show	VBN
cord-023095-4dannjjm	2590	5	,	,	,
cord-023095-4dannjjm	2590	6	for	for	IN
cord-023095-4dannjjm	2590	7	example	example	NN
cord-023095-4dannjjm	2590	8	,	,	,
cord-023095-4dannjjm	2590	9	to	to	TO
cord-023095-4dannjjm	2590	10	reverse	reverse	VB
cord-023095-4dannjjm	2590	11	gastric	gastric	JJ
cord-023095-4dannjjm	2590	12	relaxation	relaxation	NN
cord-023095-4dannjjm	2590	13	induced	induce	VBN
cord-023095-4dannjjm	2590	14	by	by	IN
cord-023095-4dannjjm	2590	15	dopamine	dopamine	NN
cord-023095-4dannjjm	2590	16	infusion	infusion	NN
cord-023095-4dannjjm	2590	17	in	in	IN
cord-023095-4dannjjm	2590	18	the	the	DT
cord-023095-4dannjjm	2590	19	dog	dog	NN
cord-023095-4dannjjm	2590	20	.	.	.
cord-023095-4dannjjm	2591	1	Similar	similar	JJ
cord-023095-4dannjjm	2591	2	studies	study	NNS
cord-023095-4dannjjm	2591	3	have	have	VBP
cord-023095-4dannjjm	2591	4	not	not	RB
cord-023095-4dannjjm	2591	5	been	be	VBN
cord-023095-4dannjjm	2591	6	reported	report	VBN
cord-023095-4dannjjm	2591	7	in	in	IN
cord-023095-4dannjjm	2591	8	the	the	DT
cord-023095-4dannjjm	2591	9	cat	cat	NN
cord-023095-4dannjjm	2591	10	or	or	CC
cord-023095-4dannjjm	2591	11	rabbit	rabbit	NN
cord-023095-4dannjjm	2591	12	,	,	,
cord-023095-4dannjjm	2591	13	two	two	CD
cord-023095-4dannjjm	2591	14	species	specie	NNS
cord-023095-4dannjjm	2591	15	at	at	IN
cord-023095-4dannjjm	2591	16	risk	risk	NN
cord-023095-4dannjjm	2591	17	for	for	IN
cord-023095-4dannjjm	2591	18	distal	distal	JJ
cord-023095-4dannjjm	2591	19	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2591	20	motility	motility	NN
cord-023095-4dannjjm	2591	21	disorders	disorder	NNS
cord-023095-4dannjjm	2591	22	.	.	.
cord-023095-4dannjjm	2592	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	2592	2	aim	aim	NN
cord-023095-4dannjjm	2592	3	was	be	VBD
cord-023095-4dannjjm	2592	4	to	to	TO
cord-023095-4dannjjm	2592	5	study	study	VB
cord-023095-4dannjjm	2592	6	the	the	DT
cord-023095-4dannjjm	2592	7	effects	effect	NNS
cord-023095-4dannjjm	2592	8	,	,	,
cord-023095-4dannjjm	2592	9	mechanisms	mechanism	NNS
cord-023095-4dannjjm	2592	10	,	,	,
cord-023095-4dannjjm	2592	11	and	and	CC
cord-023095-4dannjjm	2592	12	sites	site	NNS
cord-023095-4dannjjm	2592	13	of	of	IN
cord-023095-4dannjjm	2592	14	action	action	NN
cord-023095-4dannjjm	2592	15	of	of	IN
cord-023095-4dannjjm	2592	16	domperidone	domperidone	NNP
cord-023095-4dannjjm	2592	17	in	in	IN
cord-023095-4dannjjm	2592	18	feline	feline	JJ
cord-023095-4dannjjm	2592	19	colonic	colonic	JJ
cord-023095-4dannjjm	2592	20	and	and	CC
cord-023095-4dannjjm	2592	21	rabbit	rabbit	NN
cord-023095-4dannjjm	2592	22	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2592	23	smooth	smooth	JJ
cord-023095-4dannjjm	2592	24	muscle	muscle	NN
cord-023095-4dannjjm	2592	25	contraction	contraction	NN
cord-023095-4dannjjm	2592	26	.	.	.
cord-023095-4dannjjm	2593	1	Portions	portion	NNS
cord-023095-4dannjjm	2593	2	of	of	IN
cord-023095-4dannjjm	2593	3	stomach	stomach	NN
cord-023095-4dannjjm	2593	4	(	(	-LRB-
cord-023095-4dannjjm	2593	5	fundus	fundus	NN
cord-023095-4dannjjm	2593	6	and	and	CC
cord-023095-4dannjjm	2593	7	antrum	antrum	NN
cord-023095-4dannjjm	2593	8	)	)	-RRB-
cord-023095-4dannjjm	2593	9	,	,	,
cord-023095-4dannjjm	2593	10	intestine	intestine	NN
cord-023095-4dannjjm	2593	11	(	(	-LRB-
cord-023095-4dannjjm	2593	12	duodenum	duodenum	NN
cord-023095-4dannjjm	2593	13	and	and	CC
cord-023095-4dannjjm	2593	14	ileum	ileum	NN
cord-023095-4dannjjm	2593	15	)	)	-RRB-
cord-023095-4dannjjm	2593	16	,	,	,
cord-023095-4dannjjm	2593	17	cecum	cecum	NN
cord-023095-4dannjjm	2593	18	(	(	-LRB-
cord-023095-4dannjjm	2593	19	rabbits	rabbit	NNS
cord-023095-4dannjjm	2593	20	only	only	RB
cord-023095-4dannjjm	2593	21	)	)	-RRB-
cord-023095-4dannjjm	2593	22	,	,	,
cord-023095-4dannjjm	2593	23	and	and	CC
cord-023095-4dannjjm	2593	24	colon	colon	NN
cord-023095-4dannjjm	2593	25	(	(	-LRB-
cord-023095-4dannjjm	2593	26	ascending	ascend	VBG
cord-023095-4dannjjm	2593	27	and	and	CC
cord-023095-4dannjjm	2593	28	descending	descend	VBG
cord-023095-4dannjjm	2593	29	)	)	-RRB-
cord-023095-4dannjjm	2593	30	were	be	VBD
cord-023095-4dannjjm	2593	31	obtained	obtain	VBN
cord-023095-4dannjjm	2593	32	from	from	IN
cord-023095-4dannjjm	2593	33	healthy	healthy	JJ
cord-023095-4dannjjm	2593	34	cats	cat	NNS
cord-023095-4dannjjm	2593	35	and	and	CC
cord-023095-4dannjjm	2593	36	rabbits	rabbit	NNS
cord-023095-4dannjjm	2593	37	from	from	IN
cord-023095-4dannjjm	2593	38	9	9	CD
cord-023095-4dannjjm	2593	39	-	-	SYM
cord-023095-4dannjjm	2593	40	12	12	CD
cord-023095-4dannjjm	2593	41	months	month	NNS
cord-023095-4dannjjm	2593	42	of	of	IN
cord-023095-4dannjjm	2593	43	age	age	NN
cord-023095-4dannjjm	2593	44	.	.	.
cord-023095-4dannjjm	2594	1	Longitudinal	longitudinal	JJ
cord-023095-4dannjjm	2594	2	and	and	CC
cord-023095-4dannjjm	2594	3	circular	circular	JJ
cord-023095-4dannjjm	2594	4	smooth	smooth	JJ
cord-023095-4dannjjm	2594	5	muscle	muscle	NN
cord-023095-4dannjjm	2594	6	strips	strip	NNS
cord-023095-4dannjjm	2594	7	from	from	IN
cord-023095-4dannjjm	2594	8	each	each	DT
cord-023095-4dannjjm	2594	9	site	site	NN
cord-023095-4dannjjm	2594	10	were	be	VBD
cord-023095-4dannjjm	2594	11	suspended	suspend	VBN
cord-023095-4dannjjm	2594	12	in	in	IN
cord-023095-4dannjjm	2594	13	physiologic	physiologic	JJ
cord-023095-4dannjjm	2594	14	(	(	-LRB-
cord-023095-4dannjjm	2594	15	HEPES	hepes	NN
cord-023095-4dannjjm	2594	16	)	)	-RRB-
cord-023095-4dannjjm	2594	17	buffer	buffer	NN
cord-023095-4dannjjm	2594	18	solution	solution	NN
cord-023095-4dannjjm	2594	19	,	,	,
cord-023095-4dannjjm	2594	20	attached	attach	VBN
cord-023095-4dannjjm	2594	21	to	to	IN
cord-023095-4dannjjm	2594	22	isometric	isometric	JJ
cord-023095-4dannjjm	2594	23	force	force	NN
cord-023095-4dannjjm	2594	24	transducers	transducer	NNS
cord-023095-4dannjjm	2594	25	,	,	,
cord-023095-4dannjjm	2594	26	and	and	CC
cord-023095-4dannjjm	2594	27	set	set	VBD
cord-023095-4dannjjm	2594	28	to	to	TO
cord-023095-4dannjjm	2594	29	optimal	optimal	JJ
cord-023095-4dannjjm	2594	30	muscle	muscle	NN
cord-023095-4dannjjm	2594	31	length	length	NN
cord-023095-4dannjjm	2594	32	(	(	-LRB-
cord-023095-4dannjjm	2594	33	L	l	NN
cord-023095-4dannjjm	2594	34	o	o	NN
cord-023095-4dannjjm	2594	35	)	)	-RRB-
cord-023095-4dannjjm	2594	36	using	use	VBG
cord-023095-4dannjjm	2594	37	acetylcholine	acetylcholine	NN
cord-023095-4dannjjm	2594	38	(	(	-LRB-
cord-023095-4dannjjm	2594	39	ACh	ACh	NNP
cord-023095-4dannjjm	2594	40	;	;	:
cord-023095-4dannjjm	2594	41	10	10	CD
cord-023095-4dannjjm	2594	42	À4	À4	NNP
cord-023095-4dannjjm	2594	43	M	M	NNP
cord-023095-4dannjjm	2594	44	)	)	-RRB-
cord-023095-4dannjjm	2594	45	.	.	.
cord-023095-4dannjjm	2595	1	Muscle	muscle	NN
cord-023095-4dannjjm	2595	2	strips	strip	NNS
cord-023095-4dannjjm	2595	3	were	be	VBD
cord-023095-4dannjjm	2595	4	treated	treat	VBN
cord-023095-4dannjjm	2595	5	with	with	IN
cord-023095-4dannjjm	2595	6	domperidone	domperidone	NNP
cord-023095-4dannjjm	2595	7	(	(	-LRB-
cord-023095-4dannjjm	2595	8	D	D	NNP
cord-023095-4dannjjm	2595	9	;	;	:
cord-023095-4dannjjm	2595	10	10	10	CD
cord-023095-4dannjjm	2595	11	À8	à8	CD
cord-023095-4dannjjm	2595	12	to	to	IN
cord-023095-4dannjjm	2595	13	10	10	CD
cord-023095-4dannjjm	2595	14	À4	À4	NNP
cord-023095-4dannjjm	2595	15	M	M	NNP
cord-023095-4dannjjm	2595	16	)	)	-RRB-
cord-023095-4dannjjm	2595	17	in	in	IN
cord-023095-4dannjjm	2595	18	the	the	DT
cord-023095-4dannjjm	2595	19	presence	presence	NN
cord-023095-4dannjjm	2595	20	or	or	CC
cord-023095-4dannjjm	2595	21	absence	absence	NN
cord-023095-4dannjjm	2595	22	of	of	IN
cord-023095-4dannjjm	2595	23	ACh	ACh	NNP
cord-023095-4dannjjm	2595	24	(	(	-LRB-
cord-023095-4dannjjm	2595	25	10	10	CD
cord-023095-4dannjjm	2595	26	À8	à8	CD
cord-023095-4dannjjm	2595	27	to	to	IN
cord-023095-4dannjjm	2595	28	10	10	CD
cord-023095-4dannjjm	2595	29	À4	À4	NNP
cord-023095-4dannjjm	2595	30	M	M	NNP
cord-023095-4dannjjm	2595	31	)	)	-RRB-
cord-023095-4dannjjm	2595	32	,	,	,
cord-023095-4dannjjm	2595	33	and	and	CC
cord-023095-4dannjjm	2595	34	maximal	maximal	JJ
cord-023095-4dannjjm	2595	35	force	force	NN
cord-023095-4dannjjm	2595	36	output	output	NN
cord-023095-4dannjjm	2595	37	(	(	-LRB-
cord-023095-4dannjjm	2595	38	P	p	NN
cord-023095-4dannjjm	2595	39	max	max	NN
cord-023095-4dannjjm	2595	40	)	)	-RRB-
cord-023095-4dannjjm	2595	41	was	be	VBD
cord-023095-4dannjjm	2595	42	normalized	normalize	VBN
cord-023095-4dannjjm	2595	43	for	for	IN
cord-023095-4dannjjm	2595	44	cross	cross	JJ
cord-023095-4dannjjm	2595	45	-	-	JJ
cord-023095-4dannjjm	2595	46	sectional	sectional	JJ
cord-023095-4dannjjm	2595	47	area	area	NN
cord-023095-4dannjjm	2595	48	(	(	-LRB-
cord-023095-4dannjjm	2595	49	N	n	NN
cord-023095-4dannjjm	2595	50	5	5	CD
cord-023095-4dannjjm	2595	51	Â	â	CD
cord-023095-4dannjjm	2595	52	10	10	CD
cord-023095-4dannjjm	2595	53	4	4	CD
cord-023095-4dannjjm	2595	54	Newtons	Newtons	NNPS
cord-023095-4dannjjm	2595	55	/	/	SYM
cord-023095-4dannjjm	2595	56	m	m	NN
cord-023095-4dannjjm	2595	57	2	2	CD
cord-023095-4dannjjm	2595	58	)	)	-RRB-
cord-023095-4dannjjm	2595	59	.	.	.
cord-023095-4dannjjm	2596	1	Domperidone	Domperidone	NNP
cord-023095-4dannjjm	2596	2	(	(	-LRB-
cord-023095-4dannjjm	2596	3	D	D	NNP
cord-023095-4dannjjm	2596	4	)	)	-RRB-
cord-023095-4dannjjm	2596	5	had	have	VBD
cord-023095-4dannjjm	2596	6	a	a	DT
cord-023095-4dannjjm	2596	7	minor	minor	JJ
cord-023095-4dannjjm	2596	8	direct	direct	JJ
cord-023095-4dannjjm	2596	9	effect	effect	NN
cord-023095-4dannjjm	2596	10	of	of	IN
cord-023095-4dannjjm	2596	11	inducing	induce	VBG
cord-023095-4dannjjm	2596	12	feline	feline	JJ
cord-023095-4dannjjm	2596	13	and	and	CC
cord-023095-4dannjjm	2596	14	rabbit	rabbit	NN
cord-023095-4dannjjm	2596	15	gastric	gastric	JJ
cord-023095-4dannjjm	2596	16	,	,	,
cord-023095-4dannjjm	2596	17	cecal	cecal	JJ
cord-023095-4dannjjm	2596	18	,	,	,
cord-023095-4dannjjm	2596	19	and	and	CC
cord-023095-4dannjjm	2596	20	colonic	colonic	JJ
cord-023095-4dannjjm	2596	21	smooth	smooth	JJ
cord-023095-4dannjjm	2596	22	muscle	muscle	NN
cord-023095-4dannjjm	2596	23	contraction	contraction	NN
cord-023095-4dannjjm	2596	24	.	.	.
cord-023095-4dannjjm	2597	1	Direct	direct	JJ
cord-023095-4dannjjm	2597	2	effects	effect	NNS
cord-023095-4dannjjm	2597	3	were	be	VBD
cord-023095-4dannjjm	2597	4	similar	similar	JJ
cord-023095-4dannjjm	2597	5	whether	whether	IN
cord-023095-4dannjjm	2597	6	in	in	IN
cord-023095-4dannjjm	2597	7	the	the	DT
cord-023095-4dannjjm	2597	8	longitudinal	longitudinal	JJ
cord-023095-4dannjjm	2597	9	or	or	CC
cord-023095-4dannjjm	2597	10	circular	circular	JJ
cord-023095-4dannjjm	2597	11	muscle	muscle	NN
cord-023095-4dannjjm	2597	12	orientation	orientation	NN
cord-023095-4dannjjm	2597	13	.	.	.
cord-023095-4dannjjm	2598	1	The	the	DT
cord-023095-4dannjjm	2598	2	direct	direct	JJ
cord-023095-4dannjjm	2598	3	effect	effect	NN
cord-023095-4dannjjm	2598	4	of	of	IN
cord-023095-4dannjjm	2598	5	domperidone	domperidone	NN
cord-023095-4dannjjm	2598	6	was	be	VBD
cord-023095-4dannjjm	2598	7	dose	dose	NN
cord-023095-4dannjjm	2598	8	-	-	HYPH
cord-023095-4dannjjm	2598	9	dependent	dependent	JJ
cord-023095-4dannjjm	2598	10	and	and	CC
cord-023095-4dannjjm	2598	11	maximal	maximal	JJ
cord-023095-4dannjjm	2599	1	(	(	-LRB-
cord-023095-4dannjjm	2599	2	feline	feline	JJ
cord-023095-4dannjjm	2599	3	colon	colon	NN
cord-023095-4dannjjm	2599	4	P	p	NN
cord-023095-4dannjjm	2599	5	max	max	NN
cord-023095-4dannjjm	2599	6	5	5	CD
cord-023095-4dannjjm	2599	7	0.15	0.15	CD
cord-023095-4dannjjm	2599	8	-	-	HYPH
cord-023095-4dannjjm	2599	9	0.22	0.22	CD
cord-023095-4dannjjm	2599	10	N	n	CD
cord-023095-4dannjjm	2599	11	;	;	:
cord-023095-4dannjjm	2599	12	rabbit	rabbit	NN
cord-023095-4dannjjm	2599	13	colon	colon	NN
cord-023095-4dannjjm	2599	14	P	p	NN
cord-023095-4dannjjm	2599	15	max	max	NN
cord-023095-4dannjjm	2599	16	5	5	CD
cord-023095-4dannjjm	2599	17	0.10	0.10	CD
cord-023095-4dannjjm	2599	18	-	-	HYPH
cord-023095-4dannjjm	2599	19	0.19	0.19	CD
cord-023095-4dannjjm	2599	20	N	n	CD
cord-023095-4dannjjm	2599	21	)	)	-RRB-
cord-023095-4dannjjm	2599	22	at	at	IN
cord-023095-4dannjjm	2599	23	a	a	DT
cord-023095-4dannjjm	2599	24	dose	dose	NN
cord-023095-4dannjjm	2599	25	of	of	IN
cord-023095-4dannjjm	2599	26	10	10	CD
cord-023095-4dannjjm	2599	27	À4	À4	NNP
cord-023095-4dannjjm	2599	28	M.	M.	NNP
cord-023095-4dannjjm	2599	29	Domperidone	Domperidone	NNP
cord-023095-4dannjjm	2599	30	had	have	VBD
cord-023095-4dannjjm	2599	31	a	a	DT
cord-023095-4dannjjm	2599	32	much	much	RB
cord-023095-4dannjjm	2599	33	greater	great	JJR
cord-023095-4dannjjm	2599	34	indirect	indirect	JJ
cord-023095-4dannjjm	2599	35	effect	effect	NN
cord-023095-4dannjjm	2599	36	in	in	IN
cord-023095-4dannjjm	2599	37	augmenting	augment	VBG
cord-023095-4dannjjm	2599	38	cholinergic	cholinergic	JJ
cord-023095-4dannjjm	2599	39	(	(	-LRB-
cord-023095-4dannjjm	2599	40	ACh	ACh	NNP
cord-023095-4dannjjm	2599	41	;	;	:
cord-023095-4dannjjm	2599	42	10	10	CD
cord-023095-4dannjjm	2599	43	À4	À4	NNP
cord-023095-4dannjjm	2599	44	M	M	NNP
cord-023095-4dannjjm	2599	45	)	)	-RRB-
cord-023095-4dannjjm	2599	46	contractions	contraction	NNS
cord-023095-4dannjjm	2599	47	in	in	IN
cord-023095-4dannjjm	2599	48	feline	feline	JJ
cord-023095-4dannjjm	2599	49	and	and	CC
cord-023095-4dannjjm	2599	50	rabbit	rabbit	NN
cord-023095-4dannjjm	2599	51	gastric	gastric	JJ
cord-023095-4dannjjm	2599	52	,	,	,
cord-023095-4dannjjm	2599	53	cecal	cecal	JJ
cord-023095-4dannjjm	2599	54	,	,	,
cord-023095-4dannjjm	2599	55	and	and	CC
cord-023095-4dannjjm	2599	56	colonic	colonic	JJ
cord-023095-4dannjjm	2599	57	smooth	smooth	JJ
cord-023095-4dannjjm	2599	58	muscle	muscle	NN
cord-023095-4dannjjm	2599	59	.	.	.
cord-023095-4dannjjm	2600	1	Domperidone	Domperidone	NNP
cord-023095-4dannjjm	2600	2	-	-	HYPH
cord-023095-4dannjjm	2600	3	augmented	augment	VBN
cord-023095-4dannjjm	2600	4	cholinergic	cholinergic	JJ
cord-023095-4dannjjm	2600	5	contractions	contraction	NNS
cord-023095-4dannjjm	2600	6	were	be	VBD
cord-023095-4dannjjm	2600	7	157	157	CD
cord-023095-4dannjjm	2600	8	-	-	SYM
cord-023095-4dannjjm	2600	9	200	200	CD
cord-023095-4dannjjm	2600	10	%	%	NN
cord-023095-4dannjjm	2600	11	(	(	-LRB-
cord-023095-4dannjjm	2600	12	feline	feline	JJ
cord-023095-4dannjjm	2600	13	colon	colon	NN
cord-023095-4dannjjm	2600	14	P	p	NN
cord-023095-4dannjjm	2600	15	max	max	NN
cord-023095-4dannjjm	2600	16	5	5	CD
cord-023095-4dannjjm	2600	17	1.54	1.54	CD
cord-023095-4dannjjm	2600	18	AE	AE	NNP
cord-023095-4dannjjm	2600	19	0.24	0.24	CD
cord-023095-4dannjjm	2600	20	N	N	NNP
cord-023095-4dannjjm	2600	21	ACh	ACh	NNP
cord-023095-4dannjjm	2600	22	only	only	RB
cord-023095-4dannjjm	2600	23	;	;	:
cord-023095-4dannjjm	2600	24	feline	feline	JJ
cord-023095-4dannjjm	2600	25	colon	colon	NN
cord-023095-4dannjjm	2600	26	P	p	NN
cord-023095-4dannjjm	2600	27	max	max	NN
cord-023095-4dannjjm	2600	28	5	5	CD
cord-023095-4dannjjm	2600	29	2.03	2.03	CD
cord-023095-4dannjjm	2600	30	AE	AE	NNP
cord-023095-4dannjjm	2600	31	0.23N	0.23n	CD
cord-023095-4dannjjm	2600	32	ACh	ACh	NNP
cord-023095-4dannjjm	2600	33	1	1	CD
cord-023095-4dannjjm	2600	34	D	D	NNP
cord-023095-4dannjjm	2600	35	)	)	-RRB-
cord-023095-4dannjjm	2600	36	of	of	IN
cord-023095-4dannjjm	2600	37	baseline	baseline	JJ
cord-023095-4dannjjm	2600	38	cholinergic	cholinergic	JJ
cord-023095-4dannjjm	2600	39	contractions	contraction	NNS
cord-023095-4dannjjm	2600	40	.	.	.
cord-023095-4dannjjm	2601	1	Domperidone	Domperidone	NNP
cord-023095-4dannjjm	2601	2	contractions	contraction	NNS
cord-023095-4dannjjm	2601	3	were	be	VBD
cord-023095-4dannjjm	2601	4	of	of	IN
cord-023095-4dannjjm	2601	5	a	a	DT
cord-023095-4dannjjm	2601	6	similar	similar	JJ
cord-023095-4dannjjm	2601	7	magnitude	magnitude	NN
cord-023095-4dannjjm	2601	8	to	to	IN
cord-023095-4dannjjm	2601	9	those	those	DT
cord-023095-4dannjjm	2601	10	induced	induce	VBN
cord-023095-4dannjjm	2601	11	by	by	IN
cord-023095-4dannjjm	2601	12	cisapride	cisapride	NN
cord-023095-4dannjjm	2601	13	.	.	.
cord-023095-4dannjjm	2602	1	Domperidone	Domperidone	NNP
cord-023095-4dannjjm	2602	2	effects	effect	NNS
cord-023095-4dannjjm	2602	3	were	be	VBD
cord-023095-4dannjjm	2602	4	similar	similar	JJ
cord-023095-4dannjjm	2602	5	in	in	IN
cord-023095-4dannjjm	2602	6	mucosaintact	mucosaintact	NN
cord-023095-4dannjjm	2602	7	and	and	CC
cord-023095-4dannjjm	2602	8	mucosa	mucosa	RB
cord-023095-4dannjjm	2602	9	-	-	HYPH
cord-023095-4dannjjm	2602	10	dissected	dissect	VBN
cord-023095-4dannjjm	2602	11	preparations	preparation	NNS
cord-023095-4dannjjm	2602	12	.	.	.
cord-023095-4dannjjm	2603	1	Domperidone	Domperidone	NNP
cord-023095-4dannjjm	2603	2	contractions	contraction	NNS
cord-023095-4dannjjm	2603	3	were	be	VBD
cord-023095-4dannjjm	2603	4	unaffected	unaffected	JJ
cord-023095-4dannjjm	2603	5	by	by	IN
cord-023095-4dannjjm	2603	6	prazosin	prazosin	NN
cord-023095-4dannjjm	2603	7	(	(	-LRB-
cord-023095-4dannjjm	2603	8	a	a	DT
cord-023095-4dannjjm	2603	9	1	1	CD
cord-023095-4dannjjm	2603	10	receptor	receptor	NN
cord-023095-4dannjjm	2603	11	antagonist	antagonist	NN
cord-023095-4dannjjm	2603	12	)	)	-RRB-
cord-023095-4dannjjm	2603	13	,	,	,
cord-023095-4dannjjm	2603	14	yohimbine	yohimbine	NN
cord-023095-4dannjjm	2603	15	(	(	-LRB-
cord-023095-4dannjjm	2603	16	a	a	DT
cord-023095-4dannjjm	2603	17	2	2	CD
cord-023095-4dannjjm	2603	18	receptor	receptor	NN
cord-023095-4dannjjm	2603	19	antagonist	antagonist	NN
cord-023095-4dannjjm	2603	20	)	)	-RRB-
cord-023095-4dannjjm	2603	21	,	,	,
cord-023095-4dannjjm	2603	22	or	or	CC
cord-023095-4dannjjm	2603	23	terbutaline	terbutaline	NN
cord-023095-4dannjjm	2603	24	(	(	-LRB-
cord-023095-4dannjjm	2603	25	b	b	NN
cord-023095-4dannjjm	2603	26	2	2	CD
cord-023095-4dannjjm	2603	27	receptor	receptor	NN
cord-023095-4dannjjm	2603	28	agonist	agonist	NN
cord-023095-4dannjjm	2603	29	)	)	-RRB-
cord-023095-4dannjjm	2603	30	,	,	,
cord-023095-4dannjjm	2603	31	but	but	CC
cord-023095-4dannjjm	2603	32	were	be	VBD
cord-023095-4dannjjm	2603	33	somewhat	somewhat	RB
cord-023095-4dannjjm	2603	34	attenuated	attenuate	VBN
cord-023095-4dannjjm	2603	35	by	by	IN
cord-023095-4dannjjm	2603	36	dopamine	dopamine	NN
cord-023095-4dannjjm	2603	37	(	(	-LRB-
cord-023095-4dannjjm	2603	38	D	D	NNP
cord-023095-4dannjjm	2603	39	2	2	CD
cord-023095-4dannjjm	2603	40	receptor	receptor	NN
cord-023095-4dannjjm	2603	41	agonist	agonist	NN
cord-023095-4dannjjm	2603	42	)	)	-RRB-
cord-023095-4dannjjm	2603	43	and	and	CC
cord-023095-4dannjjm	2603	44	a	a	DT
cord-023095-4dannjjm	2603	45	non	non	JJ
cord-023095-4dannjjm	2603	46	-	-	JJ
cord-023095-4dannjjm	2603	47	specific	specific	JJ
cord-023095-4dannjjm	2603	48	cholinergic	cholinergic	JJ
cord-023095-4dannjjm	2603	49	antagonist	antagonist	NN
cord-023095-4dannjjm	2603	50	(	(	-LRB-
cord-023095-4dannjjm	2603	51	atropine	atropine	NN
cord-023095-4dannjjm	2603	52	)	)	-RRB-
cord-023095-4dannjjm	2603	53	.	.	.
cord-023095-4dannjjm	2604	1	In	in	IN
cord-023095-4dannjjm	2604	2	vitro	vitro	FW
cord-023095-4dannjjm	2604	3	studies	study	NNS
cord-023095-4dannjjm	2604	4	show	show	VBP
cord-023095-4dannjjm	2604	5	for	for	IN
cord-023095-4dannjjm	2604	6	the	the	DT
cord-023095-4dannjjm	2604	7	first	first	JJ
cord-023095-4dannjjm	2604	8	time	time	NN
cord-023095-4dannjjm	2604	9	that	that	IN
cord-023095-4dannjjm	2604	10	domperidone	domperidone	NNP
cord-023095-4dannjjm	2604	11	has	have	VBZ
cord-023095-4dannjjm	2604	12	minor	minor	JJ
cord-023095-4dannjjm	2604	13	direct	direct	JJ
cord-023095-4dannjjm	2604	14	and	and	CC
cord-023095-4dannjjm	2604	15	major	major	JJ
cord-023095-4dannjjm	2604	16	indirect	indirect	JJ
cord-023095-4dannjjm	2604	17	effects	effect	NNS
cord-023095-4dannjjm	2604	18	in	in	IN
cord-023095-4dannjjm	2604	19	augmenting	augment	VBG
cord-023095-4dannjjm	2604	20	cholinergic	cholinergic	JJ
cord-023095-4dannjjm	2604	21	contractions	contraction	NNS
cord-023095-4dannjjm	2604	22	of	of	IN
cord-023095-4dannjjm	2604	23	feline	feline	JJ
cord-023095-4dannjjm	2604	24	and	and	CC
cord-023095-4dannjjm	2604	25	rabbit	rabbit	NN
cord-023095-4dannjjm	2604	26	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2604	27	(	(	-LRB-
cord-023095-4dannjjm	2604	28	stomach	stomach	NN
cord-023095-4dannjjm	2604	29	,	,	,
cord-023095-4dannjjm	2604	30	cecum	cecum	NN
cord-023095-4dannjjm	2604	31	and	and	CC
cord-023095-4dannjjm	2604	32	colon	colon	NN
cord-023095-4dannjjm	2604	33	)	)	-RRB-
cord-023095-4dannjjm	2604	34	smooth	smooth	JJ
cord-023095-4dannjjm	2604	35	muscle	muscle	NN
cord-023095-4dannjjm	2604	36	.	.	.
cord-023095-4dannjjm	2605	1	As	as	IN
cord-023095-4dannjjm	2605	2	recognition	recognition	NN
cord-023095-4dannjjm	2605	3	of	of	IN
cord-023095-4dannjjm	2605	4	acute	acute	JJ
cord-023095-4dannjjm	2605	5	and	and	CC
cord-023095-4dannjjm	2605	6	chronic	chronic	JJ
cord-023095-4dannjjm	2605	7	pain	pain	NN
cord-023095-4dannjjm	2605	8	in	in	IN
cord-023095-4dannjjm	2605	9	dogs	dog	NNS
cord-023095-4dannjjm	2605	10	has	have	VBZ
cord-023095-4dannjjm	2605	11	increased	increase	VBN
cord-023095-4dannjjm	2605	12	,	,	,
cord-023095-4dannjjm	2605	13	so	so	RB
cord-023095-4dannjjm	2605	14	too	too	RB
cord-023095-4dannjjm	2605	15	has	have	VBZ
cord-023095-4dannjjm	2605	16	the	the	DT
cord-023095-4dannjjm	2605	17	use	use	NN
cord-023095-4dannjjm	2605	18	of	of	IN
cord-023095-4dannjjm	2605	19	non	non	JJ
cord-023095-4dannjjm	2605	20	-	-	JJ
cord-023095-4dannjjm	2605	21	steroidal	steroidal	JJ
cord-023095-4dannjjm	2605	22	anti	anti	JJ
cord-023095-4dannjjm	2605	23	-	-	JJ
cord-023095-4dannjjm	2605	24	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2605	25	drugs	drug	NNS
cord-023095-4dannjjm	2605	26	(	(	-LRB-
cord-023095-4dannjjm	2605	27	NSAIDs	nsaid	NNS
cord-023095-4dannjjm	2605	28	)	)	-RRB-
cord-023095-4dannjjm	2605	29	often	often	RB
cord-023095-4dannjjm	2605	30	in	in	IN
cord-023095-4dannjjm	2605	31	conjunction	conjunction	NN
cord-023095-4dannjjm	2605	32	with	with	IN
cord-023095-4dannjjm	2605	33	tramadol	tramadol	NN
cord-023095-4dannjjm	2605	34	.	.	.
cord-023095-4dannjjm	2606	1	In	in	IN
cord-023095-4dannjjm	2606	2	people	people	NNS
cord-023095-4dannjjm	2606	3	and	and	CC
cord-023095-4dannjjm	2606	4	rats	rat	NNS
cord-023095-4dannjjm	2606	5	,	,	,
cord-023095-4dannjjm	2606	6	co	co	NN
cord-023095-4dannjjm	2606	7	-	-	NN
cord-023095-4dannjjm	2606	8	administration	administration	NN
cord-023095-4dannjjm	2606	9	increases	increase	VBZ
cord-023095-4dannjjm	2606	10	the	the	DT
cord-023095-4dannjjm	2606	11	risk	risk	NN
cord-023095-4dannjjm	2606	12	of	of	IN
cord-023095-4dannjjm	2606	13	perforation	perforation	NN
cord-023095-4dannjjm	2606	14	and	and	CC
cord-023095-4dannjjm	2606	15	gastric	gastric	JJ
cord-023095-4dannjjm	2606	16	injury	injury	NN
cord-023095-4dannjjm	2606	17	over	over	IN
cord-023095-4dannjjm	2606	18	NSAIDs	NSAIDs	NNP
cord-023095-4dannjjm	2606	19	alone	alone	RB
cord-023095-4dannjjm	2606	20	.	.	.
cord-023095-4dannjjm	2607	1	Using	use	VBG
cord-023095-4dannjjm	2607	2	an	an	DT
cord-023095-4dannjjm	2607	3	ex	ex	FW
cord-023095-4dannjjm	2607	4	vivo	vivo	NN
cord-023095-4dannjjm	2607	5	model	model	NN
cord-023095-4dannjjm	2607	6	of	of	IN
cord-023095-4dannjjm	2607	7	acid	acid	JJ
cord-023095-4dannjjm	2607	8	injury	injury	NN
cord-023095-4dannjjm	2607	9	in	in	IN
cord-023095-4dannjjm	2607	10	canine	canine	JJ
cord-023095-4dannjjm	2607	11	gastric	gastric	JJ
cord-023095-4dannjjm	2607	12	mucosa	mucosa	NN
cord-023095-4dannjjm	2607	13	,	,	,
cord-023095-4dannjjm	2607	14	we	-PRON-	PRP
cord-023095-4dannjjm	2607	15	examined	examine	VBD
cord-023095-4dannjjm	2607	16	the	the	DT
cord-023095-4dannjjm	2607	17	effects	effect	NNS
cord-023095-4dannjjm	2607	18	of	of	IN
cord-023095-4dannjjm	2607	19	indomethacin	indomethacin	NN
cord-023095-4dannjjm	2607	20	and	and	CC
cord-023095-4dannjjm	2607	21	tramadol	tramadol	NN
cord-023095-4dannjjm	2607	22	on	on	IN
cord-023095-4dannjjm	2607	23	gastric	gastric	JJ
cord-023095-4dannjjm	2607	24	permeability	permeability	NN
cord-023095-4dannjjm	2607	25	and	and	CC
cord-023095-4dannjjm	2607	26	concentrations	concentration	NNS
cord-023095-4dannjjm	2607	27	of	of	IN
cord-023095-4dannjjm	2607	28	gastroprotective	gastroprotective	JJ
cord-023095-4dannjjm	2607	29	prostaglandin	prostaglandin	NN
cord-023095-4dannjjm	2607	30	E	e	NN
cord-023095-4dannjjm	2607	31	2	2	CD
cord-023095-4dannjjm	2608	1	(	(	-LRB-
cord-023095-4dannjjm	2608	2	PGE	PGE	NNP
cord-023095-4dannjjm	2608	3	2	2	CD
cord-023095-4dannjjm	2608	4	)	)	-RRB-
cord-023095-4dannjjm	2608	5	.	.	.
cord-023095-4dannjjm	2609	1	Mucosa	Mucosa	NNP
cord-023095-4dannjjm	2609	2	from	from	IN
cord-023095-4dannjjm	2609	3	the	the	DT
cord-023095-4dannjjm	2609	4	gastric	gastric	JJ
cord-023095-4dannjjm	2609	5	antrum	antrum	NN
cord-023095-4dannjjm	2609	6	was	be	VBD
cord-023095-4dannjjm	2609	7	harvested	harvest	VBN
cord-023095-4dannjjm	2609	8	from	from	IN
cord-023095-4dannjjm	2609	9	5	5	CD
cord-023095-4dannjjm	2609	10	shelter	shelter	NN
cord-023095-4dannjjm	2609	11	dogs	dog	NNS
cord-023095-4dannjjm	2609	12	immediately	immediately	RB
cord-023095-4dannjjm	2609	13	after	after	IN
cord-023095-4dannjjm	2609	14	euthanasia	euthanasia	NN
cord-023095-4dannjjm	2609	15	,	,	,
cord-023095-4dannjjm	2609	16	and	and	CC
cord-023095-4dannjjm	2609	17	mounted	mount	VBD
cord-023095-4dannjjm	2609	18	on	on	IN
cord-023095-4dannjjm	2609	19	Ussing	Ussing	NNP
cord-023095-4dannjjm	2609	20	chambers	chamber	NNS
cord-023095-4dannjjm	2609	21	.	.	.
cord-023095-4dannjjm	2610	1	The	the	DT
cord-023095-4dannjjm	2610	2	tissues	tissue	NNS
cord-023095-4dannjjm	2610	3	were	be	VBD
cord-023095-4dannjjm	2610	4	equilibrated	equilibrate	VBN
cord-023095-4dannjjm	2610	5	for	for	IN
cord-023095-4dannjjm	2610	6	30-minutes	30-minute	NNS
cord-023095-4dannjjm	2610	7	prior	prior	RB
cord-023095-4dannjjm	2610	8	to	to	IN
cord-023095-4dannjjm	2610	9	addition	addition	NN
cord-023095-4dannjjm	2610	10	of	of	IN
cord-023095-4dannjjm	2610	11	acidic	acidic	JJ
cord-023095-4dannjjm	2610	12	Ringer	Ringer	NNP
cord-023095-4dannjjm	2610	13	's	's	POS
cord-023095-4dannjjm	2610	14	solution	solution	NN
cord-023095-4dannjjm	2610	15	(	(	-LRB-
cord-023095-4dannjjm	2610	16	pH	pH	NNP
cord-023095-4dannjjm	2610	17	,	,	,
cord-023095-4dannjjm	2610	18	1.2	1.2	CD
cord-023095-4dannjjm	2610	19	)	)	-RRB-
cord-023095-4dannjjm	2610	20	.	.	.
cord-023095-4dannjjm	2611	1	After	after	IN
cord-023095-4dannjjm	2611	2	45-minutes	45-minutes	CD
cord-023095-4dannjjm	2611	3	of	of	IN
cord-023095-4dannjjm	2611	4	injury	injury	NN
cord-023095-4dannjjm	2611	5	,	,	,
cord-023095-4dannjjm	2611	6	the	the	DT
cord-023095-4dannjjm	2611	7	acid	acid	NN
cord-023095-4dannjjm	2611	8	was	be	VBD
cord-023095-4dannjjm	2611	9	replaced	replace	VBN
cord-023095-4dannjjm	2611	10	with	with	IN
cord-023095-4dannjjm	2611	11	neutral	neutral	JJ
cord-023095-4dannjjm	2611	12	Ringer	Ringer	NNP
cord-023095-4dannjjm	2611	13	's	's	POS
cord-023095-4dannjjm	2611	14	and	and	CC
cord-023095-4dannjjm	2611	15	the	the	DT
cord-023095-4dannjjm	2611	16	tissues	tissue	NNS
cord-023095-4dannjjm	2611	17	were	be	VBD
cord-023095-4dannjjm	2611	18	treated	treat	VBN
cord-023095-4dannjjm	2611	19	with	with	IN
cord-023095-4dannjjm	2611	20	indomethacin	indomethacin	NN
cord-023095-4dannjjm	2611	21	,	,	,
cord-023095-4dannjjm	2611	22	tramadol	tramadol	NN
cord-023095-4dannjjm	2611	23	or	or	CC
cord-023095-4dannjjm	2611	24	both	both	DT
cord-023095-4dannjjm	2611	25	.	.	.
cord-023095-4dannjjm	2612	1	Tissues	tissue	NNS
cord-023095-4dannjjm	2612	2	were	be	VBD
cord-023095-4dannjjm	2612	3	maintained	maintain	VBN
cord-023095-4dannjjm	2612	4	for	for	IN
cord-023095-4dannjjm	2612	5	210minutes	210minute	NNS
cord-023095-4dannjjm	2612	6	total	total	JJ
cord-023095-4dannjjm	2612	7	,	,	,
cord-023095-4dannjjm	2612	8	during	during	IN
cord-023095-4dannjjm	2612	9	which	which	WDT
cord-023095-4dannjjm	2612	10	time	time	NN
cord-023095-4dannjjm	2612	11	permeability	permeability	NN
cord-023095-4dannjjm	2612	12	was	be	VBD
cord-023095-4dannjjm	2612	13	assessed	assess	VBN
cord-023095-4dannjjm	2612	14	electrically	electrically	RB
cord-023095-4dannjjm	2612	15	.	.	.
cord-023095-4dannjjm	2613	1	Prostanoid	Prostanoid	NNP
cord-023095-4dannjjm	2613	2	concentrations	concentration	NNS
cord-023095-4dannjjm	2613	3	were	be	VBD
cord-023095-4dannjjm	2613	4	quantified	quantify	VBN
cord-023095-4dannjjm	2613	5	using	use	VBG
cord-023095-4dannjjm	2613	6	a	a	DT
cord-023095-4dannjjm	2613	7	commercially	commercially	RB
cord-023095-4dannjjm	2613	8	available	available	JJ
cord-023095-4dannjjm	2613	9	ELISA	ELISA	NNP
cord-023095-4dannjjm	2613	10	.	.	.
cord-023095-4dannjjm	2614	1	Western	western	JJ
cord-023095-4dannjjm	2614	2	blots	blot	NNS
cord-023095-4dannjjm	2614	3	were	be	VBD
cord-023095-4dannjjm	2614	4	performed	perform	VBN
cord-023095-4dannjjm	2614	5	for	for	IN
cord-023095-4dannjjm	2614	6	COX-1	COX-1	NNP
cord-023095-4dannjjm	2614	7	and	and	CC
cord-023095-4dannjjm	2614	8	À2	à2	NN
cord-023095-4dannjjm	2614	9	.	.	.
cord-023095-4dannjjm	2615	1	Recovery	recovery	NN
cord-023095-4dannjjm	2615	2	of	of	IN
cord-023095-4dannjjm	2615	3	gastric	gastric	JJ
cord-023095-4dannjjm	2615	4	barrier	barrier	NN
cord-023095-4dannjjm	2615	5	function	function	NN
cord-023095-4dannjjm	2615	6	after	after	IN
cord-023095-4dannjjm	2615	7	acid	acid	NN
cord-023095-4dannjjm	2615	8	injury	injury	NN
cord-023095-4dannjjm	2615	9	was	be	VBD
cord-023095-4dannjjm	2615	10	inhibited	inhibit	VBN
cord-023095-4dannjjm	2615	11	by	by	IN
cord-023095-4dannjjm	2615	12	co	co	NN
cord-023095-4dannjjm	2615	13	-	-	NN
cord-023095-4dannjjm	2615	14	administration	administration	NN
cord-023095-4dannjjm	2615	15	of	of	IN
cord-023095-4dannjjm	2615	16	tramadol	tramadol	NNP
cord-023095-4dannjjm	2615	17	and	and	CC
cord-023095-4dannjjm	2615	18	indomethacin	indomethacin	JJ
cord-023095-4dannjjm	2615	19	(	(	-LRB-
cord-023095-4dannjjm	2615	20	Figure	figure	NN
cord-023095-4dannjjm	2615	21	1	1	CD
cord-023095-4dannjjm	2615	22	)	)	-RRB-
cord-023095-4dannjjm	2615	23	but	but	CC
cord-023095-4dannjjm	2615	24	not	not	RB
cord-023095-4dannjjm	2615	25	by	by	IN
cord-023095-4dannjjm	2615	26	tramadol	tramadol	NN
cord-023095-4dannjjm	2615	27	or	or	CC
cord-023095-4dannjjm	2615	28	indomethacin	indomethacin	NN
cord-023095-4dannjjm	2615	29	alone	alone	RB
cord-023095-4dannjjm	2615	30	(	(	-LRB-
cord-023095-4dannjjm	2615	31	data	datum	NNS
cord-023095-4dannjjm	2615	32	not	not	RB
cord-023095-4dannjjm	2615	33	shown	show	VBN
cord-023095-4dannjjm	2615	34	)	)	-RRB-
cord-023095-4dannjjm	2615	35	.	.	.
cord-023095-4dannjjm	2616	1	Prostaglandin	prostaglandin	NN
cord-023095-4dannjjm	2616	2	E	e	NN
cord-023095-4dannjjm	2616	3	2	2	NN
cord-023095-4dannjjm	2616	4	increased	increase	VBD
cord-023095-4dannjjm	2616	5	with	with	IN
cord-023095-4dannjjm	2616	6	acid	acid	JJ
cord-023095-4dannjjm	2616	7	injury	injury	NN
cord-023095-4dannjjm	2616	8	.	.	.
cord-023095-4dannjjm	2617	1	The	the	DT
cord-023095-4dannjjm	2617	2	increase	increase	NN
cord-023095-4dannjjm	2617	3	in	in	IN
cord-023095-4dannjjm	2617	4	PGE	PGE	NNP
cord-023095-4dannjjm	2617	5	2	2	CD
cord-023095-4dannjjm	2617	6	was	be	VBD
cord-023095-4dannjjm	2617	7	inhibited	inhibit	VBN
cord-023095-4dannjjm	2617	8	by	by	IN
cord-023095-4dannjjm	2617	9	co	co	NN
cord-023095-4dannjjm	2617	10	-	-	NN
cord-023095-4dannjjm	2617	11	administration	administration	NN
cord-023095-4dannjjm	2617	12	of	of	IN
cord-023095-4dannjjm	2617	13	indomethacin	indomethacin	NNP
cord-023095-4dannjjm	2617	14	and	and	CC
cord-023095-4dannjjm	2617	15	tramadol	tramadol	NN
cord-023095-4dannjjm	2617	16	(	(	-LRB-
cord-023095-4dannjjm	2617	17	in	in	IN
cord-023095-4dannjjm	2617	18	pg	pg	NNP
cord-023095-4dannjjm	2617	19	/	/	SYM
cord-023095-4dannjjm	2617	20	ml	ml	NN
cord-023095-4dannjjm	2617	21	:	:	:
cord-023095-4dannjjm	2617	22	acid	acid	JJ
cord-023095-4dannjjm	2617	23	injury	injury	NN
cord-023095-4dannjjm	2617	24	681.25	681.25	CD
cord-023095-4dannjjm	2617	25	AE	AE	NNP
cord-023095-4dannjjm	2617	26	324.88	324.88	CD
cord-023095-4dannjjm	2617	27	,	,	,
cord-023095-4dannjjm	2617	28	indo	indo	NNP
cord-023095-4dannjjm	2617	29	1	1	CD
cord-023095-4dannjjm	2617	30	tramadol	tramadol	NN
cord-023095-4dannjjm	2617	31	149.11	149.11	CD
cord-023095-4dannjjm	2617	32	AE	AE	NNP
cord-023095-4dannjjm	2617	33	35.24	35.24	CD
cord-023095-4dannjjm	2617	34	)	)	-RRB-
cord-023095-4dannjjm	2617	35	.	.	.
cord-023095-4dannjjm	2618	1	There	there	EX
cord-023095-4dannjjm	2618	2	was	be	VBD
cord-023095-4dannjjm	2618	3	no	no	DT
cord-023095-4dannjjm	2618	4	significant	significant	JJ
cord-023095-4dannjjm	2618	5	effect	effect	NN
cord-023095-4dannjjm	2618	6	of	of	IN
cord-023095-4dannjjm	2618	7	treatment	treatment	NN
cord-023095-4dannjjm	2618	8	on	on	IN
cord-023095-4dannjjm	2618	9	COX-1	cox-1	JJ
cord-023095-4dannjjm	2618	10	or	or	CC
cord-023095-4dannjjm	2618	11	À2	à2	JJ
cord-023095-4dannjjm	2618	12	expression	expression	NN
cord-023095-4dannjjm	2618	13	.	.	.
cord-023095-4dannjjm	2619	1	Co	co	NN
cord-023095-4dannjjm	2619	2	-	-	NN
cord-023095-4dannjjm	2619	3	administration	administration	NN
cord-023095-4dannjjm	2619	4	of	of	IN
cord-023095-4dannjjm	2619	5	tramadol	tramadol	NNP
cord-023095-4dannjjm	2619	6	with	with	IN
cord-023095-4dannjjm	2619	7	a	a	DT
cord-023095-4dannjjm	2619	8	non	non	JJ
cord-023095-4dannjjm	2619	9	-	-	JJ
cord-023095-4dannjjm	2619	10	selective	selective	JJ
cord-023095-4dannjjm	2619	11	NSAID	NSAID	NNP
cord-023095-4dannjjm	2619	12	inhibits	inhibit	VBZ
cord-023095-4dannjjm	2619	13	the	the	DT
cord-023095-4dannjjm	2619	14	return	return	NN
cord-023095-4dannjjm	2619	15	of	of	IN
cord-023095-4dannjjm	2619	16	gastric	gastric	JJ
cord-023095-4dannjjm	2619	17	mucosal	mucosal	JJ
cord-023095-4dannjjm	2619	18	barrier	barrier	NN
cord-023095-4dannjjm	2619	19	function	function	NN
cord-023095-4dannjjm	2619	20	after	after	IN
cord-023095-4dannjjm	2619	21	acid	acid	JJ
cord-023095-4dannjjm	2619	22	injury	injury	NN
cord-023095-4dannjjm	2619	23	in	in	IN
cord-023095-4dannjjm	2619	24	canine	canine	JJ
cord-023095-4dannjjm	2619	25	tissue	tissue	NN
cord-023095-4dannjjm	2619	26	,	,	,
cord-023095-4dannjjm	2619	27	suggesting	suggest	VBG
cord-023095-4dannjjm	2619	28	that	that	IN
cord-023095-4dannjjm	2619	29	caution	caution	NN
cord-023095-4dannjjm	2619	30	is	be	VBZ
cord-023095-4dannjjm	2619	31	required	require	VBN
cord-023095-4dannjjm	2619	32	in	in	IN
cord-023095-4dannjjm	2619	33	prescribing	prescribe	VBG
cord-023095-4dannjjm	2619	34	concurrent	concurrent	JJ
cord-023095-4dannjjm	2619	35	use	use	NN
cord-023095-4dannjjm	2619	36	of	of	IN
cord-023095-4dannjjm	2619	37	these	these	DT
cord-023095-4dannjjm	2619	38	drugs	drug	NNS
cord-023095-4dannjjm	2619	39	in	in	IN
cord-023095-4dannjjm	2619	40	dogs	dog	NNS
cord-023095-4dannjjm	2619	41	at	at	IN
cord-023095-4dannjjm	2619	42	risk	risk	NN
cord-023095-4dannjjm	2619	43	for	for	IN
cord-023095-4dannjjm	2619	44	gastric	gastric	JJ
cord-023095-4dannjjm	2619	45	ulcers	ulcer	NNS
cord-023095-4dannjjm	2619	46	.	.	.
cord-023095-4dannjjm	2620	1	These	these	DT
cord-023095-4dannjjm	2620	2	drugs	drug	NNS
cord-023095-4dannjjm	2620	3	may	may	MD
cord-023095-4dannjjm	2620	4	exert	exert	VB
cord-023095-4dannjjm	2620	5	this	this	DT
cord-023095-4dannjjm	2620	6	effect	effect	NN
cord-023095-4dannjjm	2620	7	by	by	IN
cord-023095-4dannjjm	2620	8	decreasing	decrease	VBG
cord-023095-4dannjjm	2620	9	levels	level	NNS
cord-023095-4dannjjm	2620	10	of	of	IN
cord-023095-4dannjjm	2620	11	gastroprotective	gastroprotective	JJ
cord-023095-4dannjjm	2620	12	prostanoids	prostanoid	NNS
cord-023095-4dannjjm	2620	13	.	.	.
cord-023095-4dannjjm	2621	1	Further	further	JJ
cord-023095-4dannjjm	2621	2	study	study	NN
cord-023095-4dannjjm	2621	3	is	be	VBZ
cord-023095-4dannjjm	2621	4	needed	need	VBN
cord-023095-4dannjjm	2621	5	to	to	TO
cord-023095-4dannjjm	2621	6	understand	understand	VB
cord-023095-4dannjjm	2621	7	the	the	DT
cord-023095-4dannjjm	2621	8	mechanism	mechanism	NN
cord-023095-4dannjjm	2621	9	of	of	IN
cord-023095-4dannjjm	2621	10	this	this	DT
cord-023095-4dannjjm	2621	11	drug	drug	NN
cord-023095-4dannjjm	2621	12	interaction	interaction	NN
cord-023095-4dannjjm	2621	13	.	.	.
cord-023095-4dannjjm	2622	1	An	an	DT
cord-023095-4dannjjm	2622	2	increased	increase	VBN
cord-023095-4dannjjm	2622	3	intestinal	intestinal	JJ
cord-023095-4dannjjm	2622	4	permeability	permeability	NN
cord-023095-4dannjjm	2622	5	(	(	-LRB-
cord-023095-4dannjjm	2622	6	IP	IP	NNP
cord-023095-4dannjjm	2622	7	)	)	-RRB-
cord-023095-4dannjjm	2622	8	has	have	VBZ
cord-023095-4dannjjm	2622	9	been	be	VBN
cord-023095-4dannjjm	2622	10	suggested	suggest	VBN
cord-023095-4dannjjm	2622	11	to	to	TO
cord-023095-4dannjjm	2622	12	be	be	VB
cord-023095-4dannjjm	2622	13	both	both	DT
cord-023095-4dannjjm	2622	14	cause	cause	VB
cord-023095-4dannjjm	2622	15	and	and	CC
cord-023095-4dannjjm	2622	16	consequence	consequence	NN
cord-023095-4dannjjm	2622	17	of	of	IN
cord-023095-4dannjjm	2622	18	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2622	19	(	(	-LRB-
cord-023095-4dannjjm	2622	20	GI	GI	NNP
cord-023095-4dannjjm	2622	21	)	)	-RRB-
cord-023095-4dannjjm	2622	22	disease	disease	NN
cord-023095-4dannjjm	2622	23	,	,	,
cord-023095-4dannjjm	2622	24	such	such	JJ
cord-023095-4dannjjm	2622	25	as	as	IN
cord-023095-4dannjjm	2622	26	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2622	27	bowel	bowel	NN
cord-023095-4dannjjm	2622	28	and	and	CC
cord-023095-4dannjjm	2622	29	celiac	celiac	JJ
cord-023095-4dannjjm	2622	30	disease	disease	NN
cord-023095-4dannjjm	2622	31	,	,	,
cord-023095-4dannjjm	2622	32	in	in	IN
cord-023095-4dannjjm	2622	33	people	people	NNS
cord-023095-4dannjjm	2622	34	.	.	.
cord-023095-4dannjjm	2623	1	A	a	DT
cord-023095-4dannjjm	2623	2	novel	novel	JJ
cord-023095-4dannjjm	2623	3	tight	tight	JJ
cord-023095-4dannjjm	2623	4	junction	junction	NN
cord-023095-4dannjjm	2623	5	regulator	regulator	NN
cord-023095-4dannjjm	2623	6	,	,	,
cord-023095-4dannjjm	2623	7	larazotide	larazotide	NN
cord-023095-4dannjjm	2623	8	acetate	acetate	NN
cord-023095-4dannjjm	2623	9	(	(	-LRB-
cord-023095-4dannjjm	2623	10	Alba	Alba	NNP
cord-023095-4dannjjm	2623	11	Therapeutics	Therapeutics	NNP
cord-023095-4dannjjm	2623	12	,	,	,
cord-023095-4dannjjm	2623	13	Baltimore	Baltimore	NNP
cord-023095-4dannjjm	2623	14	,	,	,
cord-023095-4dannjjm	2623	15	MD	MD	NNP
cord-023095-4dannjjm	2623	16	)	)	-RRB-
cord-023095-4dannjjm	2623	17	has	have	VBZ
cord-023095-4dannjjm	2623	18	been	be	VBN
cord-023095-4dannjjm	2623	19	shown	show	VBN
cord-023095-4dannjjm	2623	20	to	to	TO
cord-023095-4dannjjm	2623	21	significantly	significantly	RB
cord-023095-4dannjjm	2623	22	decrease	decrease	VB
cord-023095-4dannjjm	2623	23	IP	ip	NN
cord-023095-4dannjjm	2623	24	in	in	IN
cord-023095-4dannjjm	2623	25	rats	rat	NNS
cord-023095-4dannjjm	2623	26	and	and	CC
cord-023095-4dannjjm	2623	27	in	in	IN
cord-023095-4dannjjm	2623	28	humans	human	NNS
cord-023095-4dannjjm	2623	29	with	with	IN
cord-023095-4dannjjm	2623	30	celiac	celiac	JJ
cord-023095-4dannjjm	2623	31	disease	disease	NN
cord-023095-4dannjjm	2623	32	.	.	.
cord-023095-4dannjjm	2624	1	The	the	DT
cord-023095-4dannjjm	2624	2	purpose	purpose	NN
cord-023095-4dannjjm	2624	3	of	of	IN
cord-023095-4dannjjm	2624	4	this	this	DT
cord-023095-4dannjjm	2624	5	study	study	NN
cord-023095-4dannjjm	2624	6	was	be	VBD
cord-023095-4dannjjm	2624	7	to	to	TO
cord-023095-4dannjjm	2624	8	determine	determine	VB
cord-023095-4dannjjm	2624	9	if	if	IN
cord-023095-4dannjjm	2624	10	larazotide	larazotide	NN
cord-023095-4dannjjm	2624	11	acetate	acetate	NN
cord-023095-4dannjjm	2624	12	reduces	reduce	VBZ
cord-023095-4dannjjm	2624	13	IP	ip	NN
cord-023095-4dannjjm	2624	14	in	in	IN
cord-023095-4dannjjm	2624	15	Soft	Soft	NNP
cord-023095-4dannjjm	2624	16	Coated	Coated	NNP
cord-023095-4dannjjm	2624	17	Wheaten	Wheaten	NNP
cord-023095-4dannjjm	2624	18	Terriers	Terriers	NNPS
cord-023095-4dannjjm	2624	19	(	(	-LRB-
cord-023095-4dannjjm	2624	20	SCWT	SCWT	NNP
cord-023095-4dannjjm	2624	21	)	)	-RRB-
cord-023095-4dannjjm	2624	22	and	and	CC
cord-023095-4dannjjm	2624	23	Norwegian	Norwegian	NNP
cord-023095-4dannjjm	2624	24	Lundehunds	Lundehunds	NNPS
cord-023095-4dannjjm	2624	25	(	(	-LRB-
cord-023095-4dannjjm	2624	26	NL	NL	NNP
cord-023095-4dannjjm	2624	27	)	)	-RRB-
cord-023095-4dannjjm	2624	28	with	with	IN
cord-023095-4dannjjm	2624	29	chronic	chronic	JJ
cord-023095-4dannjjm	2624	30	GI	GI	NNP
cord-023095-4dannjjm	2624	31	disease	disease	NN
cord-023095-4dannjjm	2624	32	and	and	CC
cord-023095-4dannjjm	2624	33	ameliorates	ameliorate	VBZ
cord-023095-4dannjjm	2624	34	clinical	clinical	JJ
cord-023095-4dannjjm	2624	35	signs	sign	NNS
cord-023095-4dannjjm	2624	36	.	.	.
cord-023095-4dannjjm	2625	1	Four	four	CD
cord-023095-4dannjjm	2625	2	NL	NL	NNP
cord-023095-4dannjjm	2625	3	(	(	-LRB-
cord-023095-4dannjjm	2625	4	2	2	CD
cord-023095-4dannjjm	2625	5	females	female	NNS
cord-023095-4dannjjm	2625	6	,	,	,
cord-023095-4dannjjm	2625	7	2	2	CD
cord-023095-4dannjjm	2625	8	males	male	NNS
cord-023095-4dannjjm	2625	9	;	;	:
cord-023095-4dannjjm	2625	10	median	median	JJ
cord-023095-4dannjjm	2625	11	age	age	NN
cord-023095-4dannjjm	2625	12	:	:	:
cord-023095-4dannjjm	2625	13	2.5	2.5	CD
cord-023095-4dannjjm	2625	14	yrs	yr	NNS
cord-023095-4dannjjm	2625	15	,	,	,
cord-023095-4dannjjm	2625	16	range	range	NN
cord-023095-4dannjjm	2625	17	:	:	:
cord-023095-4dannjjm	2625	18	1.5	1.5	CD
cord-023095-4dannjjm	2625	19	-	-	SYM
cord-023095-4dannjjm	2625	20	4.5	4.5	CD
cord-023095-4dannjjm	2625	21	yrs	yr	NNS
cord-023095-4dannjjm	2625	22	)	)	-RRB-
cord-023095-4dannjjm	2625	23	and	and	CC
cord-023095-4dannjjm	2625	24	9	9	CD
cord-023095-4dannjjm	2625	25	SCWT	SCWT	NNP
cord-023095-4dannjjm	2625	26	(	(	-LRB-
cord-023095-4dannjjm	2625	27	7	7	CD
cord-023095-4dannjjm	2625	28	females	female	NNS
cord-023095-4dannjjm	2625	29	,	,	,
cord-023095-4dannjjm	2625	30	2	2	CD
cord-023095-4dannjjm	2625	31	males	male	NNS
cord-023095-4dannjjm	2625	32	;	;	:
cord-023095-4dannjjm	2625	33	median	median	JJ
cord-023095-4dannjjm	2625	34	age	age	NN
cord-023095-4dannjjm	2625	35	:	:	:
cord-023095-4dannjjm	2625	36	5.0	5.0	CD
cord-023095-4dannjjm	2625	37	yrs	yr	NNS
cord-023095-4dannjjm	2625	38	,	,	,
cord-023095-4dannjjm	2625	39	range	range	NN
cord-023095-4dannjjm	2625	40	:	:	:
cord-023095-4dannjjm	2625	41	1.5	1.5	CD
cord-023095-4dannjjm	2625	42	-	-	SYM
cord-023095-4dannjjm	2625	43	9.0	9.0	CD
cord-023095-4dannjjm	2625	44	yrs	yr	NNS
cord-023095-4dannjjm	2625	45	)	)	-RRB-
cord-023095-4dannjjm	2625	46	were	be	VBD
cord-023095-4dannjjm	2625	47	enrolled	enrol	VBN
cord-023095-4dannjjm	2625	48	based	base	VBN
cord-023095-4dannjjm	2625	49	on	on	IN
cord-023095-4dannjjm	2625	50	presence	presence	NN
cord-023095-4dannjjm	2625	51	of	of	IN
cord-023095-4dannjjm	2625	52	clinical	clinical	JJ
cord-023095-4dannjjm	2625	53	signs	sign	NNS
cord-023095-4dannjjm	2625	54	of	of	IN
cord-023095-4dannjjm	2625	55	GI	GI	NNP
cord-023095-4dannjjm	2625	56	disease	disease	NN
cord-023095-4dannjjm	2625	57	and	and	CC
cord-023095-4dannjjm	2625	58	hypoalbuminemia	hypoalbuminemia	NN
cord-023095-4dannjjm	2625	59	,	,	,
cord-023095-4dannjjm	2625	60	increased	increase	VBD
cord-023095-4dannjjm	2625	61	fecal	fecal	JJ
cord-023095-4dannjjm	2625	62	alpha	alpha	NN
cord-023095-4dannjjm	2625	63	1proteinase	1proteinase	CD
cord-023095-4dannjjm	2625	64	inhibitor	inhibitor	NN
cord-023095-4dannjjm	2625	65	(	(	-LRB-
cord-023095-4dannjjm	2625	66	a	a	DT
cord-023095-4dannjjm	2625	67	1	1	CD
cord-023095-4dannjjm	2625	68	-PI	-PI	NNS
cord-023095-4dannjjm	2625	69	)	)	-RRB-
cord-023095-4dannjjm	2625	70	concentrations	concentration	NNS
cord-023095-4dannjjm	2625	71	,	,	,
cord-023095-4dannjjm	2625	72	and/or	and/or	CC
cord-023095-4dannjjm	2625	73	hypocobalaminemia	hypocobalaminemia	NN
cord-023095-4dannjjm	2625	74	.	.	.
cord-023095-4dannjjm	2626	1	SCWT	SCWT	NNP
cord-023095-4dannjjm	2626	2	with	with	IN
cord-023095-4dannjjm	2626	3	protein	protein	NN
cord-023095-4dannjjm	2626	4	-	-	HYPH
cord-023095-4dannjjm	2626	5	losing	lose	VBG
cord-023095-4dannjjm	2626	6	nephropathy	nephropathy	NN
cord-023095-4dannjjm	2626	7	were	be	VBD
cord-023095-4dannjjm	2626	8	excluded	exclude	VBN
cord-023095-4dannjjm	2626	9	.	.	.
cord-023095-4dannjjm	2627	1	Dogs	dog	NNS
cord-023095-4dannjjm	2627	2	were	be	VBD
cord-023095-4dannjjm	2627	3	fed	feed	VBN
cord-023095-4dannjjm	2627	4	q12	q12	NN
cord-023095-4dannjjm	2627	5	hrs	hrs	NN
cord-023095-4dannjjm	2627	6	and	and	CC
cord-023095-4dannjjm	2627	7	received	receive	VBD
cord-023095-4dannjjm	2627	8	0.5	0.5	CD
cord-023095-4dannjjm	2627	9	mg	mg	NN
cord-023095-4dannjjm	2627	10	(	(	-LRB-
cord-023095-4dannjjm	2627	11	4	4	CD
cord-023095-4dannjjm	2627	12	NL	NL	NNP
cord-023095-4dannjjm	2627	13	and	and	CC
cord-023095-4dannjjm	2627	14	2	2	CD
cord-023095-4dannjjm	2627	15	SCWT	SCWT	NNP
cord-023095-4dannjjm	2627	16	)	)	-RRB-
cord-023095-4dannjjm	2627	17	or	or	CC
cord-023095-4dannjjm	2627	18	2.0	2.0	CD
cord-023095-4dannjjm	2627	19	mg	mg	NN
cord-023095-4dannjjm	2627	20	(	(	-LRB-
cord-023095-4dannjjm	2627	21	7	7	CD
cord-023095-4dannjjm	2627	22	SCWT	SCWT	NNP
cord-023095-4dannjjm	2627	23	)	)	-RRB-
cord-023095-4dannjjm	2627	24	of	of	IN
cord-023095-4dannjjm	2627	25	larazotide	larazotide	NN
cord-023095-4dannjjm	2627	26	acetate	acetate	NN
cord-023095-4dannjjm	2627	27	PO	PO	NNP
cord-023095-4dannjjm	2627	28	before	before	IN
cord-023095-4dannjjm	2627	29	each	each	DT
cord-023095-4dannjjm	2627	30	meal	meal	NN
cord-023095-4dannjjm	2627	31	for	for	IN
cord-023095-4dannjjm	2627	32	90	90	CD
cord-023095-4dannjjm	2627	33	days	day	NNS
cord-023095-4dannjjm	2627	34	.	.	.
cord-023095-4dannjjm	2628	1	Prior	prior	RB
cord-023095-4dannjjm	2628	2	to	to	TO
cord-023095-4dannjjm	2628	3	start	start	VB
cord-023095-4dannjjm	2628	4	of	of	IN
cord-023095-4dannjjm	2628	5	treatment	treatment	NN
cord-023095-4dannjjm	2628	6	(	(	-LRB-
cord-023095-4dannjjm	2628	7	day	day	NN
cord-023095-4dannjjm	2628	8	1	1	CD
cord-023095-4dannjjm	2628	9	)	)	-RRB-
cord-023095-4dannjjm	2628	10	and	and	CC
cord-023095-4dannjjm	2628	11	at	at	IN
cord-023095-4dannjjm	2628	12	the	the	DT
cord-023095-4dannjjm	2628	13	end	end	NN
cord-023095-4dannjjm	2628	14	(	(	-LRB-
cord-023095-4dannjjm	2628	15	day	day	NN
cord-023095-4dannjjm	2628	16	90	90	CD
cord-023095-4dannjjm	2628	17	)	)	-RRB-
cord-023095-4dannjjm	2628	18	,	,	,
cord-023095-4dannjjm	2628	19	IP	IP	NNP
cord-023095-4dannjjm	2628	20	was	be	VBD
cord-023095-4dannjjm	2628	21	evaluated	evaluate	VBN
cord-023095-4dannjjm	2628	22	by	by	IN
cord-023095-4dannjjm	2628	23	calculating	calculate	VBG
cord-023095-4dannjjm	2628	24	the	the	DT
cord-023095-4dannjjm	2628	25	lactulose	lactulose	NN
cord-023095-4dannjjm	2628	26	/	/	SYM
cord-023095-4dannjjm	2628	27	rhamnose	rhamnose	NNP
cord-023095-4dannjjm	2628	28	(	(	-LRB-
cord-023095-4dannjjm	2628	29	L	L	NNP
cord-023095-4dannjjm	2628	30	/	/	SYM
cord-023095-4dannjjm	2628	31	R)-ratio	R)-ratio	NNP
cord-023095-4dannjjm	2628	32	in	in	IN
cord-023095-4dannjjm	2628	33	serum	serum	NN
cord-023095-4dannjjm	2628	34	samples	sample	NNS
cord-023095-4dannjjm	2628	35	obtained	obtain	VBN
cord-023095-4dannjjm	2628	36	at	at	IN
cord-023095-4dannjjm	2628	37	30	30	CD
cord-023095-4dannjjm	2628	38	,	,	,
cord-023095-4dannjjm	2628	39	60	60	CD
cord-023095-4dannjjm	2628	40	,	,	,
cord-023095-4dannjjm	2628	41	90	90	CD
cord-023095-4dannjjm	2628	42	,	,	,
cord-023095-4dannjjm	2628	43	and	and	CC
cord-023095-4dannjjm	2628	44	120	120	CD
cord-023095-4dannjjm	2628	45	min	min	NNS
cord-023095-4dannjjm	2628	46	after	after	IN
cord-023095-4dannjjm	2628	47	oral	oral	JJ
cord-023095-4dannjjm	2628	48	dosing	dosing	NN
cord-023095-4dannjjm	2628	49	.	.	.
cord-023095-4dannjjm	2629	1	Also	also	RB
cord-023095-4dannjjm	2629	2	,	,	,
cord-023095-4dannjjm	2629	3	3	3	CD
cord-023095-4dannjjm	2629	4	consecutive	consecutive	JJ
cord-023095-4dannjjm	2629	5	fecal	fecal	JJ
cord-023095-4dannjjm	2629	6	samples	sample	NNS
cord-023095-4dannjjm	2629	7	each	each	DT
cord-023095-4dannjjm	2629	8	were	be	VBD
cord-023095-4dannjjm	2629	9	collected	collect	VBN
cord-023095-4dannjjm	2629	10	prior	prior	RB
cord-023095-4dannjjm	2629	11	to	to	IN
cord-023095-4dannjjm	2629	12	day	day	NN
cord-023095-4dannjjm	2629	13	1	1	CD
cord-023095-4dannjjm	2629	14	and	and	CC
cord-023095-4dannjjm	2629	15	day	day	NN
cord-023095-4dannjjm	2629	16	90	90	CD
cord-023095-4dannjjm	2629	17	for	for	IN
cord-023095-4dannjjm	2629	18	N	n	CD
cord-023095-4dannjjm	2629	19	-	-	HYPH
cord-023095-4dannjjm	2629	20	methylhistamine	methylhistamine	NNP
cord-023095-4dannjjm	2629	21	(	(	-LRB-
cord-023095-4dannjjm	2629	22	NMH	NMH	NNP
cord-023095-4dannjjm	2629	23	)	)	-RRB-
cord-023095-4dannjjm	2629	24	measurement	measurement	NN
cord-023095-4dannjjm	2629	25	.	.	.
cord-023095-4dannjjm	2630	1	Pre	pre	JJ
cord-023095-4dannjjm	2630	2	-	-	JJ
cord-023095-4dannjjm	2630	3	and	and	CC
cord-023095-4dannjjm	2630	4	post	post	JJ
cord-023095-4dannjjm	2630	5	-	-	JJ
cord-023095-4dannjjm	2630	6	treatment	treatment	JJ
cord-023095-4dannjjm	2630	7	data	datum	NNS
cord-023095-4dannjjm	2630	8	were	be	VBD
cord-023095-4dannjjm	2630	9	compared	compare	VBN
cord-023095-4dannjjm	2630	10	using	use	VBG
cord-023095-4dannjjm	2630	11	a	a	DT
cord-023095-4dannjjm	2630	12	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	2630	13	signed	sign	VBN
cord-023095-4dannjjm	2630	14	rank	rank	NN
cord-023095-4dannjjm	2630	15	test	test	NN
cord-023095-4dannjjm	2630	16	.	.	.
cord-023095-4dannjjm	2631	1	The	the	DT
cord-023095-4dannjjm	2631	2	0.5	0.5	CD
cord-023095-4dannjjm	2631	3	mg	mg	NN
cord-023095-4dannjjm	2631	4	vs.	vs.	IN
cord-023095-4dannjjm	2631	5	2.0	2.0	CD
cord-023095-4dannjjm	2631	6	mg	mg	NN
cord-023095-4dannjjm	2631	7	dose	dose	NN
cord-023095-4dannjjm	2631	8	groups	group	NNS
cord-023095-4dannjjm	2631	9	were	be	VBD
cord-023095-4dannjjm	2631	10	compared	compare	VBN
cord-023095-4dannjjm	2631	11	using	use	VBG
cord-023095-4dannjjm	2631	12	a	a	DT
cord-023095-4dannjjm	2631	13	Mann	Mann	NNP
cord-023095-4dannjjm	2631	14	-	-	HYPH
cord-023095-4dannjjm	2631	15	Whitney	Whitney	NNP
cord-023095-4dannjjm	2631	16	U	U	NNP
cord-023095-4dannjjm	2631	17	test	test	NN
cord-023095-4dannjjm	2631	18	.	.	.
cord-023095-4dannjjm	2632	1	Statistical	statistical	JJ
cord-023095-4dannjjm	2632	2	significance	significance	NN
cord-023095-4dannjjm	2632	3	was	be	VBD
cord-023095-4dannjjm	2632	4	set	set	VBN
cord-023095-4dannjjm	2632	5	at	at	IN
cord-023095-4dannjjm	2632	6	p	p	NN
cord-023095-4dannjjm	2632	7	o	o	NN
cord-023095-4dannjjm	2632	8	0.05	0.05	CD
cord-023095-4dannjjm	2632	9	.	.	.
cord-023095-4dannjjm	2633	1	L	L	NNP
cord-023095-4dannjjm	2633	2	/	/	SYM
cord-023095-4dannjjm	2633	3	R	r	NN
cord-023095-4dannjjm	2633	4	-	-	HYPH
cord-023095-4dannjjm	2633	5	ratios	ratio	NNS
cord-023095-4dannjjm	2633	6	(	(	-LRB-
cord-023095-4dannjjm	2633	7	medians	median	NNS
cord-023095-4dannjjm	2633	8	)	)	-RRB-
cord-023095-4dannjjm	2633	9	for	for	IN
cord-023095-4dannjjm	2633	10	the	the	DT
cord-023095-4dannjjm	2633	11	60	60	CD
cord-023095-4dannjjm	2633	12	min	min	NN
cord-023095-4dannjjm	2633	13	sampling	sampling	NN
cord-023095-4dannjjm	2633	14	time	time	NN
cord-023095-4dannjjm	2633	15	point	point	NN
cord-023095-4dannjjm	2633	16	were	be	VBD
cord-023095-4dannjjm	2633	17	significantly	significantly	RB
cord-023095-4dannjjm	2633	18	lower	low	JJR
cord-023095-4dannjjm	2633	19	on	on	IN
cord-023095-4dannjjm	2633	20	day	day	NN
cord-023095-4dannjjm	2633	21	90	90	CD
cord-023095-4dannjjm	2633	22	(	(	-LRB-
cord-023095-4dannjjm	2633	23	0.046	0.046	CD
cord-023095-4dannjjm	2633	24	)	)	-RRB-
cord-023095-4dannjjm	2633	25	than	than	IN
cord-023095-4dannjjm	2633	26	on	on	IN
cord-023095-4dannjjm	2633	27	day	day	NN
cord-023095-4dannjjm	2633	28	1	1	CD
cord-023095-4dannjjm	2633	29	(	(	-LRB-
cord-023095-4dannjjm	2633	30	0.080	0.080	CD
cord-023095-4dannjjm	2633	31	;	;	:
cord-023095-4dannjjm	2633	32	p	p	NN
cord-023095-4dannjjm	2633	33	5	5	CD
cord-023095-4dannjjm	2633	34	0.018	0.018	CD
cord-023095-4dannjjm	2633	35	)	)	-RRB-
cord-023095-4dannjjm	2633	36	.	.	.
cord-023095-4dannjjm	2634	1	Dogs	dog	NNS
cord-023095-4dannjjm	2634	2	treated	treat	VBN
cord-023095-4dannjjm	2634	3	with	with	IN
cord-023095-4dannjjm	2634	4	2.0	2.0	CD
cord-023095-4dannjjm	2634	5	mg	mg	NN
cord-023095-4dannjjm	2635	1	q12	q12	NNP
cord-023095-4dannjjm	2635	2	hrs	hrs	NNP
cord-023095-4dannjjm	2635	3	had	have	VBD
cord-023095-4dannjjm	2635	4	significantly	significantly	RB
cord-023095-4dannjjm	2635	5	lower	low	JJR
cord-023095-4dannjjm	2635	6	60	60	CD
cord-023095-4dannjjm	2635	7	min	min	NN
cord-023095-4dannjjm	2635	8	L	l	NN
cord-023095-4dannjjm	2635	9	/	/	SYM
cord-023095-4dannjjm	2635	10	R	r	NN
cord-023095-4dannjjm	2635	11	ratios	ratio	NNS
cord-023095-4dannjjm	2635	12	on	on	IN
cord-023095-4dannjjm	2635	13	day	day	NN
cord-023095-4dannjjm	2635	14	90	90	CD
cord-023095-4dannjjm	2635	15	than	than	IN
cord-023095-4dannjjm	2635	16	dogs	dog	NNS
cord-023095-4dannjjm	2635	17	treated	treat	VBN
cord-023095-4dannjjm	2635	18	with	with	IN
cord-023095-4dannjjm	2635	19	0.5	0.5	CD
cord-023095-4dannjjm	2635	20	mg	mg	NNP
cord-023095-4dannjjm	2635	21	(	(	-LRB-
cord-023095-4dannjjm	2635	22	0.033	0.033	CD
cord-023095-4dannjjm	2635	23	vs.	vs.	FW
cord-023095-4dannjjm	2635	24	0.094	0.094	CD
cord-023095-4dannjjm	2635	25	;	;	:
cord-023095-4dannjjm	2635	26	p	p	NN
cord-023095-4dannjjm	2635	27	5	5	CD
cord-023095-4dannjjm	2635	28	0.014	0.014	CD
cord-023095-4dannjjm	2635	29	)	)	-RRB-
cord-023095-4dannjjm	2635	30	.	.	.
cord-023095-4dannjjm	2636	1	No	no	DT
cord-023095-4dannjjm	2636	2	difference	difference	NN
cord-023095-4dannjjm	2636	3	was	be	VBD
cord-023095-4dannjjm	2636	4	found	find	VBN
cord-023095-4dannjjm	2636	5	between	between	IN
cord-023095-4dannjjm	2636	6	breeds	breed	NNS
cord-023095-4dannjjm	2636	7	.	.	.
cord-023095-4dannjjm	2637	1	Fecal	fecal	JJ
cord-023095-4dannjjm	2637	2	NMH	NMH	NNP
cord-023095-4dannjjm	2637	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2637	4	were	be	VBD
cord-023095-4dannjjm	2637	5	not	not	RB
cord-023095-4dannjjm	2637	6	different	different	JJ
cord-023095-4dannjjm	2637	7	between	between	IN
cord-023095-4dannjjm	2637	8	time	time	NN
cord-023095-4dannjjm	2637	9	points	point	NNS
cord-023095-4dannjjm	2637	10	,	,	,
cord-023095-4dannjjm	2637	11	treatment	treatment	NN
cord-023095-4dannjjm	2637	12	groups	group	NNS
cord-023095-4dannjjm	2637	13	,	,	,
cord-023095-4dannjjm	2637	14	or	or	CC
cord-023095-4dannjjm	2637	15	breeds	breed	NNS
cord-023095-4dannjjm	2637	16	.	.	.
cord-023095-4dannjjm	2638	1	Fecal	Fecal	NNP
cord-023095-4dannjjm	2638	2	a	a	DT
cord-023095-4dannjjm	2638	3	1	1	CD
cord-023095-4dannjjm	2638	4	-PI	-pi	NN
cord-023095-4dannjjm	2638	5	concentrations	concentration	NNS
cord-023095-4dannjjm	2638	6	were	be	VBD
cord-023095-4dannjjm	2638	7	available	available	JJ
cord-023095-4dannjjm	2638	8	for	for	IN
cord-023095-4dannjjm	2638	9	11	11	CD
cord-023095-4dannjjm	2638	10	of	of	IN
cord-023095-4dannjjm	2638	11	the	the	DT
cord-023095-4dannjjm	2638	12	13	13	CD
cord-023095-4dannjjm	2638	13	dogs	dog	NNS
cord-023095-4dannjjm	2638	14	and	and	CC
cord-023095-4dannjjm	2638	15	were	be	VBD
cord-023095-4dannjjm	2638	16	significantly	significantly	RB
cord-023095-4dannjjm	2638	17	higher	high	JJR
cord-023095-4dannjjm	2638	18	on	on	IN
cord-023095-4dannjjm	2638	19	day	day	NN
cord-023095-4dannjjm	2638	20	90	90	CD
cord-023095-4dannjjm	2638	21	compared	compare	VBN
cord-023095-4dannjjm	2638	22	to	to	IN
cord-023095-4dannjjm	2638	23	day	day	NN
cord-023095-4dannjjm	2638	24	1	1	CD
cord-023095-4dannjjm	2639	1	(	(	-LRB-
cord-023095-4dannjjm	2639	2	p	p	NN
cord-023095-4dannjjm	2639	3	5	5	CD
cord-023095-4dannjjm	2639	4	0.033	0.033	CD
cord-023095-4dannjjm	2639	5	)	)	-RRB-
cord-023095-4dannjjm	2639	6	.	.	.
cord-023095-4dannjjm	2640	1	No	no	DT
cord-023095-4dannjjm	2640	2	differences	difference	NNS
cord-023095-4dannjjm	2640	3	were	be	VBD
cord-023095-4dannjjm	2640	4	found	find	VBN
cord-023095-4dannjjm	2640	5	between	between	IN
cord-023095-4dannjjm	2640	6	pre	pre	JJ
cord-023095-4dannjjm	2640	7	-	-	JJ
cord-023095-4dannjjm	2640	8	and	and	CC
cord-023095-4dannjjm	2640	9	post	post	JJ
cord-023095-4dannjjm	2640	10	-	-	JJ
cord-023095-4dannjjm	2640	11	treatment	treatment	JJ
cord-023095-4dannjjm	2640	12	serum	serum	NN
cord-023095-4dannjjm	2640	13	albumin	albumin	NN
cord-023095-4dannjjm	2640	14	or	or	CC
cord-023095-4dannjjm	2640	15	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2640	16	concentrations	concentration	NNS
cord-023095-4dannjjm	2640	17	.	.	.
cord-023095-4dannjjm	2641	1	Weight	weight	NN
cord-023095-4dannjjm	2641	2	gain	gain	NN
cord-023095-4dannjjm	2641	3	was	be	VBD
cord-023095-4dannjjm	2641	4	seen	see	VBN
cord-023095-4dannjjm	2641	5	in	in	IN
cord-023095-4dannjjm	2641	6	all	all	DT
cord-023095-4dannjjm	2641	7	4	4	CD
cord-023095-4dannjjm	2641	8	NL	NL	NNP
cord-023095-4dannjjm	2641	9	.	.	.
cord-023095-4dannjjm	2642	1	Resolution	resolution	NN
cord-023095-4dannjjm	2642	2	of	of	IN
cord-023095-4dannjjm	2642	3	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2642	4	,	,	,
cord-023095-4dannjjm	2642	5	vomiting	vomit	VBG
cord-023095-4dannjjm	2642	6	,	,	,
cord-023095-4dannjjm	2642	7	hyporexia	hyporexia	NNP
cord-023095-4dannjjm	2642	8	,	,	,
cord-023095-4dannjjm	2642	9	as	as	RB
cord-023095-4dannjjm	2642	10	well	well	RB
cord-023095-4dannjjm	2642	11	as	as	IN
cord-023095-4dannjjm	2642	12	an	an	DT
cord-023095-4dannjjm	2642	13	increased	increase	VBN
cord-023095-4dannjjm	2642	14	activity	activity	NN
cord-023095-4dannjjm	2642	15	was	be	VBD
cord-023095-4dannjjm	2642	16	seen	see	VBN
cord-023095-4dannjjm	2642	17	in	in	IN
cord-023095-4dannjjm	2642	18	1	1	CD
cord-023095-4dannjjm	2642	19	SCWT	SCWT	NNP
cord-023095-4dannjjm	2642	20	.	.	.
cord-023095-4dannjjm	2643	1	Another	another	DT
cord-023095-4dannjjm	2643	2	SCWT	SCWT	NNP
cord-023095-4dannjjm	2643	3	had	have	VBD
cord-023095-4dannjjm	2643	4	resolution	resolution	NN
cord-023095-4dannjjm	2643	5	of	of	IN
cord-023095-4dannjjm	2643	6	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2643	7	and	and	CC
cord-023095-4dannjjm	2643	8	a	a	DT
cord-023095-4dannjjm	2643	9	decrease	decrease	NN
cord-023095-4dannjjm	2643	10	in	in	IN
cord-023095-4dannjjm	2643	11	pruritus	pruritus	NN
cord-023095-4dannjjm	2643	12	.	.	.
cord-023095-4dannjjm	2644	1	No	no	DT
cord-023095-4dannjjm	2644	2	changes	change	NNS
cord-023095-4dannjjm	2644	3	in	in	IN
cord-023095-4dannjjm	2644	4	clinical	clinical	JJ
cord-023095-4dannjjm	2644	5	signs	sign	NNS
cord-023095-4dannjjm	2644	6	were	be	VBD
cord-023095-4dannjjm	2644	7	reported	report	VBN
cord-023095-4dannjjm	2644	8	in	in	IN
cord-023095-4dannjjm	2644	9	the	the	DT
cord-023095-4dannjjm	2644	10	remaining	remain	VBG
cord-023095-4dannjjm	2644	11	7	7	CD
cord-023095-4dannjjm	2644	12	SCWT	SCWT	NNP
cord-023095-4dannjjm	2644	13	.	.	.
cord-023095-4dannjjm	2645	1	This	this	DT
cord-023095-4dannjjm	2645	2	study	study	NN
cord-023095-4dannjjm	2645	3	indicates	indicate	VBZ
cord-023095-4dannjjm	2645	4	that	that	IN
cord-023095-4dannjjm	2645	5	larazotide	larazotide	NN
cord-023095-4dannjjm	2645	6	acetate	acetate	NN
cord-023095-4dannjjm	2645	7	might	may	MD
cord-023095-4dannjjm	2645	8	be	be	VB
cord-023095-4dannjjm	2645	9	able	able	JJ
cord-023095-4dannjjm	2645	10	to	to	TO
cord-023095-4dannjjm	2645	11	reduce	reduce	VB
cord-023095-4dannjjm	2645	12	IP	ip	NN
cord-023095-4dannjjm	2645	13	in	in	IN
cord-023095-4dannjjm	2645	14	dogs	dog	NNS
cord-023095-4dannjjm	2645	15	.	.	.
cord-023095-4dannjjm	2646	1	This	this	DT
cord-023095-4dannjjm	2646	2	effect	effect	NN
cord-023095-4dannjjm	2646	3	may	may	MD
cord-023095-4dannjjm	2646	4	be	be	VB
cord-023095-4dannjjm	2646	5	dose	dose	NN
cord-023095-4dannjjm	2646	6	-	-	HYPH
cord-023095-4dannjjm	2646	7	dependent	dependent	JJ
cord-023095-4dannjjm	2646	8	.	.	.
cord-023095-4dannjjm	2647	1	However	however	RB
cord-023095-4dannjjm	2647	2	,	,	,
cord-023095-4dannjjm	2647	3	not	not	RB
cord-023095-4dannjjm	2647	4	all	all	DT
cord-023095-4dannjjm	2647	5	dogs	dog	NNS
cord-023095-4dannjjm	2647	6	showed	show	VBD
cord-023095-4dannjjm	2647	7	an	an	DT
cord-023095-4dannjjm	2647	8	improvement	improvement	NN
cord-023095-4dannjjm	2647	9	in	in	IN
cord-023095-4dannjjm	2647	10	clinical	clinical	JJ
cord-023095-4dannjjm	2647	11	signs	sign	NNS
cord-023095-4dannjjm	2647	12	,	,	,
cord-023095-4dannjjm	2647	13	suggesting	suggest	VBG
cord-023095-4dannjjm	2647	14	that	that	IN
cord-023095-4dannjjm	2647	15	factors	factor	NNS
cord-023095-4dannjjm	2647	16	other	other	JJ
cord-023095-4dannjjm	2647	17	than	than	IN
cord-023095-4dannjjm	2647	18	increased	increase	VBN
cord-023095-4dannjjm	2647	19	IP	IP	NNP
cord-023095-4dannjjm	2647	20	might	may	MD
cord-023095-4dannjjm	2647	21	have	have	VB
cord-023095-4dannjjm	2647	22	been	be	VBN
cord-023095-4dannjjm	2647	23	responsible	responsible	JJ
cord-023095-4dannjjm	2647	24	for	for	IN
cord-023095-4dannjjm	2647	25	the	the	DT
cord-023095-4dannjjm	2647	26	clinical	clinical	JJ
cord-023095-4dannjjm	2647	27	signs	sign	NNS
cord-023095-4dannjjm	2647	28	in	in	IN
cord-023095-4dannjjm	2647	29	these	these	DT
cord-023095-4dannjjm	2647	30	dogs	dog	NNS
cord-023095-4dannjjm	2647	31	.	.	.
cord-023095-4dannjjm	2648	1	Breed	breed	VB
cord-023095-4dannjjm	2648	2	-	-	HYPH
cord-023095-4dannjjm	2648	3	related	relate	VBN
cord-023095-4dannjjm	2648	4	effects	effect	NNS
cord-023095-4dannjjm	2648	5	can	can	MD
cord-023095-4dannjjm	2648	6	not	not	RB
cord-023095-4dannjjm	2648	7	be	be	VB
cord-023095-4dannjjm	2648	8	ruled	rule	VBN
cord-023095-4dannjjm	2648	9	out	out	RP
cord-023095-4dannjjm	2648	10	,	,	,
cord-023095-4dannjjm	2648	11	and	and	CC
cord-023095-4dannjjm	2648	12	further	further	JJ
cord-023095-4dannjjm	2648	13	studies	study	NNS
cord-023095-4dannjjm	2648	14	are	be	VBP
cord-023095-4dannjjm	2648	15	warranted	warrant	VBN
cord-023095-4dannjjm	2648	16	to	to	TO
cord-023095-4dannjjm	2648	17	determine	determine	VB
cord-023095-4dannjjm	2648	18	the	the	DT
cord-023095-4dannjjm	2648	19	efficacy	efficacy	NN
cord-023095-4dannjjm	2648	20	of	of	IN
cord-023095-4dannjjm	2648	21	larazotide	larazotide	NN
cord-023095-4dannjjm	2648	22	acetate	acetate	NN
cord-023095-4dannjjm	2648	23	in	in	IN
cord-023095-4dannjjm	2648	24	dogs	dog	NNS
cord-023095-4dannjjm	2648	25	of	of	IN
cord-023095-4dannjjm	2648	26	other	other	JJ
cord-023095-4dannjjm	2648	27	breeds	breed	NNS
cord-023095-4dannjjm	2648	28	with	with	IN
cord-023095-4dannjjm	2648	29	GI	GI	NNP
cord-023095-4dannjjm	2648	30	disease	disease	NN
cord-023095-4dannjjm	2648	31	.	.	.
cord-023095-4dannjjm	2649	1	to	to	TO
cord-023095-4dannjjm	2649	2	analyze	analyze	VB
cord-023095-4dannjjm	2649	3	different	different	JJ
cord-023095-4dannjjm	2649	4	biochemical	biochemical	JJ
cord-023095-4dannjjm	2649	5	markers	marker	NNS
cord-023095-4dannjjm	2649	6	,	,	,
cord-023095-4dannjjm	2649	7	calculate	calculate	VB
cord-023095-4dannjjm	2649	8	clinical	clinical	JJ
cord-023095-4dannjjm	2649	9	activity	activity	NN
cord-023095-4dannjjm	2649	10	scores	score	NNS
cord-023095-4dannjjm	2649	11	,	,	,
cord-023095-4dannjjm	2649	12	and	and	CC
cord-023095-4dannjjm	2649	13	assess	assess	VB
cord-023095-4dannjjm	2649	14	survival	survival	NN
cord-023095-4dannjjm	2649	15	in	in	IN
cord-023095-4dannjjm	2649	16	dogs	dog	NNS
cord-023095-4dannjjm	2649	17	with	with	IN
cord-023095-4dannjjm	2649	18	PLE	PLE	NNP
cord-023095-4dannjjm	2649	19	and	and	CC
cord-023095-4dannjjm	2649	20	compare	compare	VB
cord-023095-4dannjjm	2649	21	them	-PRON-	PRP
cord-023095-4dannjjm	2649	22	with	with	IN
cord-023095-4dannjjm	2649	23	those	those	DT
cord-023095-4dannjjm	2649	24	in	in	IN
cord-023095-4dannjjm	2649	25	dogs	dog	NNS
cord-023095-4dannjjm	2649	26	with	with	IN
cord-023095-4dannjjm	2649	27	food	food	NN
cord-023095-4dannjjm	2649	28	-	-	HYPH
cord-023095-4dannjjm	2649	29	responsive	responsive	JJ
cord-023095-4dannjjm	2649	30	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2649	31	(	(	-LRB-
cord-023095-4dannjjm	2649	32	FRD	FRD	NNP
cord-023095-4dannjjm	2649	33	)	)	-RRB-
cord-023095-4dannjjm	2649	34	without	without	IN
cord-023095-4dannjjm	2649	35	protein	protein	NN
cord-023095-4dannjjm	2649	36	loss	loss	NN
cord-023095-4dannjjm	2649	37	.	.	.
cord-023095-4dannjjm	2650	1	29	29	CD
cord-023095-4dannjjm	2650	2	dogs	dog	NNS
cord-023095-4dannjjm	2650	3	with	with	IN
cord-023095-4dannjjm	2650	4	PLE	PLE	NNP
cord-023095-4dannjjm	2650	5	and	and	CC
cord-023095-4dannjjm	2650	6	18	18	CD
cord-023095-4dannjjm	2650	7	dogs	dog	NNS
cord-023095-4dannjjm	2650	8	with	with	IN
cord-023095-4dannjjm	2650	9	FRD	FRD	NNP
cord-023095-4dannjjm	2650	10	,	,	,
cord-023095-4dannjjm	2650	11	referred	refer	VBD
cord-023095-4dannjjm	2650	12	to	to	IN
cord-023095-4dannjjm	2650	13	the	the	DT
cord-023095-4dannjjm	2650	14	University	University	NNP
cord-023095-4dannjjm	2650	15	of	of	IN
cord-023095-4dannjjm	2650	16	Bern	Bern	NNP
cord-023095-4dannjjm	2650	17	,	,	,
cord-023095-4dannjjm	2650	18	CH	CH	NNP
cord-023095-4dannjjm	2650	19	,	,	,
cord-023095-4dannjjm	2650	20	were	be	VBD
cord-023095-4dannjjm	2650	21	enrolled	enrol	VBN
cord-023095-4dannjjm	2650	22	.	.	.
cord-023095-4dannjjm	2651	1	Selection	selection	NN
cord-023095-4dannjjm	2651	2	criteria	criterion	NNS
cord-023095-4dannjjm	2651	3	included	include	VBD
cord-023095-4dannjjm	2651	4	a	a	DT
cord-023095-4dannjjm	2651	5	history	history	NN
cord-023095-4dannjjm	2651	6	of	of	IN
cord-023095-4dannjjm	2651	7	chronic	chronic	JJ
cord-023095-4dannjjm	2651	8	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2651	9	(	(	-LRB-
cord-023095-4dannjjm	2651	10	4	4	CD
cord-023095-4dannjjm	2651	11	3	3	CD
cord-023095-4dannjjm	2651	12	weeks	week	NNS
cord-023095-4dannjjm	2651	13	)	)	-RRB-
cord-023095-4dannjjm	2651	14	,	,	,
cord-023095-4dannjjm	2651	15	exclusion	exclusion	NN
cord-023095-4dannjjm	2651	16	of	of	IN
cord-023095-4dannjjm	2651	17	identifiable	identifiable	JJ
cord-023095-4dannjjm	2651	18	underlying	underlying	JJ
cord-023095-4dannjjm	2651	19	causes	cause	NNS
cord-023095-4dannjjm	2651	20	,	,	,
cord-023095-4dannjjm	2651	21	and	and	CC
cord-023095-4dannjjm	2651	22	histopathologic	histopathologic	JJ
cord-023095-4dannjjm	2651	23	evidence	evidence	NN
cord-023095-4dannjjm	2651	24	of	of	IN
cord-023095-4dannjjm	2651	25	intestinal	intestinal	JJ
cord-023095-4dannjjm	2651	26	inflammation	inflammation	NN
cord-023095-4dannjjm	2651	27	,	,	,
cord-023095-4dannjjm	2651	28	but	but	CC
cord-023095-4dannjjm	2651	29	not	not	RB
cord-023095-4dannjjm	2651	30	neoplasia	neoplasia	NN
cord-023095-4dannjjm	2651	31	.	.	.
cord-023095-4dannjjm	2652	1	Underlying	underlying	JJ
cord-023095-4dannjjm	2652	2	disorders	disorder	NNS
cord-023095-4dannjjm	2652	3	were	be	VBD
cord-023095-4dannjjm	2652	4	excluded	exclude	VBN
cord-023095-4dannjjm	2652	5	based	base	VBN
cord-023095-4dannjjm	2652	6	on	on	IN
cord-023095-4dannjjm	2652	7	CBC	CBC	NNP
cord-023095-4dannjjm	2652	8	,	,	,
cord-023095-4dannjjm	2652	9	chemistry	chemistry	NN
cord-023095-4dannjjm	2652	10	profile	profile	NN
cord-023095-4dannjjm	2652	11	,	,	,
cord-023095-4dannjjm	2652	12	urinalysis	urinalysis	NN
cord-023095-4dannjjm	2652	13	,	,	,
cord-023095-4dannjjm	2652	14	fecal	fecal	JJ
cord-023095-4dannjjm	2652	15	analysis	analysis	NN
cord-023095-4dannjjm	2652	16	,	,	,
cord-023095-4dannjjm	2652	17	trypsinlike	trypsinlike	NNP
cord-023095-4dannjjm	2652	18	immunoreactivity	immunoreactivity	NN
cord-023095-4dannjjm	2652	19	,	,	,
cord-023095-4dannjjm	2652	20	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2652	21	,	,	,
cord-023095-4dannjjm	2652	22	folate	folate	NN
cord-023095-4dannjjm	2652	23	,	,	,
cord-023095-4dannjjm	2652	24	and	and	CC
cord-023095-4dannjjm	2652	25	transabdominal	transabdominal	JJ
cord-023095-4dannjjm	2652	26	ultrasound	ultrasound	NN
cord-023095-4dannjjm	2652	27	.	.	.
cord-023095-4dannjjm	2653	1	Also	also	RB
cord-023095-4dannjjm	2653	2	,	,	,
cord-023095-4dannjjm	2653	3	canine	canine	JJ
cord-023095-4dannjjm	2653	4	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	2653	5	lipase	lipase	NN
cord-023095-4dannjjm	2653	6	immunoreactivity	immunoreactivity	NN
cord-023095-4dannjjm	2653	7	(	(	-LRB-
cord-023095-4dannjjm	2653	8	spec	spec	NN
cord-023095-4dannjjm	2653	9	cPL	cPL	NNPS
cord-023095-4dannjjm	2653	10	s	s	NNP
cord-023095-4dannjjm	2653	11	)	)	-RRB-
cord-023095-4dannjjm	2653	12	,	,	,
cord-023095-4dannjjm	2653	13	C	C	NNP
cord-023095-4dannjjm	2653	14	-	-	HYPH
cord-023095-4dannjjm	2653	15	reactive	reactive	JJ
cord-023095-4dannjjm	2653	16	protein	protein	NN
cord-023095-4dannjjm	2653	17	(	(	-LRB-
cord-023095-4dannjjm	2653	18	CRP	CRP	NNP
cord-023095-4dannjjm	2653	19	)	)	-RRB-
cord-023095-4dannjjm	2653	20	,	,	,
cord-023095-4dannjjm	2653	21	calprotectin	calprotectin	NNP
cord-023095-4dannjjm	2653	22	and	and	CC
cord-023095-4dannjjm	2653	23	alpha	alpha	NN
cord-023095-4dannjjm	2653	24	1	1	CD
cord-023095-4dannjjm	2653	25	-proteinase	-proteinase	NN
cord-023095-4dannjjm	2653	26	inhibitor	inhibitor	NN
cord-023095-4dannjjm	2653	27	(	(	-LRB-
cord-023095-4dannjjm	2653	28	a	a	DT
cord-023095-4dannjjm	2653	29	1	1	CD
cord-023095-4dannjjm	2653	30	-PI	-pi	NN
cord-023095-4dannjjm	2653	31	)	)	-RRB-
cord-023095-4dannjjm	2653	32	were	be	VBD
cord-023095-4dannjjm	2653	33	measured	measure	VBN
cord-023095-4dannjjm	2653	34	in	in	IN
cord-023095-4dannjjm	2653	35	serum	serum	NN
cord-023095-4dannjjm	2653	36	from	from	IN
cord-023095-4dannjjm	2653	37	18	18	CD
cord-023095-4dannjjm	2653	38	dogs	dog	NNS
cord-023095-4dannjjm	2653	39	and	and	CC
cord-023095-4dannjjm	2653	40	compared	compare	VBN
cord-023095-4dannjjm	2653	41	with	with	IN
cord-023095-4dannjjm	2653	42	18	18	CD
cord-023095-4dannjjm	2653	43	dogs	dog	NNS
cord-023095-4dannjjm	2653	44	with	with	IN
cord-023095-4dannjjm	2653	45	FRD	FRD	NNP
cord-023095-4dannjjm	2653	46	without	without	IN
cord-023095-4dannjjm	2653	47	PLE	PLE	NNP
cord-023095-4dannjjm	2653	48	.	.	.
cord-023095-4dannjjm	2654	1	All	all	DT
cord-023095-4dannjjm	2654	2	dogs	dog	NNS
cord-023095-4dannjjm	2654	3	were	be	VBD
cord-023095-4dannjjm	2654	4	scored	score	VBN
cord-023095-4dannjjm	2654	5	using	use	VBG
cord-023095-4dannjjm	2654	6	the	the	DT
cord-023095-4dannjjm	2654	7	canine	canine	JJ
cord-023095-4dannjjm	2654	8	IBD	IBD	NNP
cord-023095-4dannjjm	2654	9	(	(	-LRB-
cord-023095-4dannjjm	2654	10	CIBDAI	CIBDAI	NNP
cord-023095-4dannjjm	2654	11	)	)	-RRB-
cord-023095-4dannjjm	2654	12	and	and	CC
cord-023095-4dannjjm	2654	13	the	the	DT
cord-023095-4dannjjm	2654	14	canine	canine	JJ
cord-023095-4dannjjm	2654	15	chronic	chronic	NN
cord-023095-4dannjjm	2654	16	enteropathy	enteropathy	NNP
cord-023095-4dannjjm	2654	17	(	(	-LRB-
cord-023095-4dannjjm	2654	18	CCE	CCE	NNP
cord-023095-4dannjjm	2654	19	)	)	-RRB-
cord-023095-4dannjjm	2654	20	clinical	clinical	JJ
cord-023095-4dannjjm	2654	21	activity	activity	NN
cord-023095-4dannjjm	2654	22	index	index	NN
cord-023095-4dannjjm	2654	23	(	(	-LRB-
cord-023095-4dannjjm	2654	24	CCECAI	CCECAI	NNP
cord-023095-4dannjjm	2654	25	)	)	-RRB-
cord-023095-4dannjjm	2654	26	.	.	.
cord-023095-4dannjjm	2655	1	Total	total	JJ
cord-023095-4dannjjm	2655	2	protein	protein	NN
cord-023095-4dannjjm	2655	3	,	,	,
cord-023095-4dannjjm	2655	4	albumin	albumin	NN
cord-023095-4dannjjm	2655	5	(	(	-LRB-
cord-023095-4dannjjm	2655	6	5	5	CD
cord-023095-4dannjjm	2655	7	-	-	SYM
cord-023095-4dannjjm	2655	8	28.1	28.1	CD
cord-023095-4dannjjm	2655	9	g	g	NN
cord-023095-4dannjjm	2655	10	/	/	SYM
cord-023095-4dannjjm	2655	11	l	l	NNP
cord-023095-4dannjjm	2655	12	)	)	-RRB-
cord-023095-4dannjjm	2655	13	,	,	,
cord-023095-4dannjjm	2655	14	and	and	CC
cord-023095-4dannjjm	2655	15	total	total	JJ
cord-023095-4dannjjm	2655	16	calcium	calcium	NN
cord-023095-4dannjjm	2655	17	(	(	-LRB-
cord-023095-4dannjjm	2655	18	1.21	1.21	CD
cord-023095-4dannjjm	2655	19	-	-	HYPH
cord-023095-4dannjjm	2655	20	2.32	2.32	CD
cord-023095-4dannjjm	2655	21	mmol	mmol	NNP
cord-023095-4dannjjm	2655	22	/	/	SYM
cord-023095-4dannjjm	2655	23	l	l	NN
cord-023095-4dannjjm	2655	24	)	)	-RRB-
cord-023095-4dannjjm	2655	25	were	be	VBD
cord-023095-4dannjjm	2655	26	decreased	decrease	VBN
cord-023095-4dannjjm	2655	27	in	in	IN
cord-023095-4dannjjm	2655	28	all	all	DT
cord-023095-4dannjjm	2655	29	29	29	CD
cord-023095-4dannjjm	2655	30	dogs	dog	NNS
cord-023095-4dannjjm	2655	31	.	.	.
cord-023095-4dannjjm	2656	1	Cobalamin	Cobalamin	NNP
cord-023095-4dannjjm	2656	2	was	be	VBD
cord-023095-4dannjjm	2656	3	decreased	decrease	VBN
cord-023095-4dannjjm	2656	4	in	in	IN
cord-023095-4dannjjm	2656	5	all	all	DT
cord-023095-4dannjjm	2656	6	but	but	CC
cord-023095-4dannjjm	2656	7	3	3	CD
cord-023095-4dannjjm	2656	8	dogs	dog	NNS
cord-023095-4dannjjm	2656	9	(	(	-LRB-
cord-023095-4dannjjm	2656	10	o	o	UH
cord-023095-4dannjjm	2656	11	100	100	CD
cord-023095-4dannjjm	2656	12	-	-	SYM
cord-023095-4dannjjm	2656	13	490	490	CD
cord-023095-4dannjjm	2656	14	ng	ng	NN
cord-023095-4dannjjm	2656	15	/	/	SYM
cord-023095-4dannjjm	2656	16	l	l	NN
cord-023095-4dannjjm	2656	17	)	)	-RRB-
cord-023095-4dannjjm	2656	18	.	.	.
cord-023095-4dannjjm	2657	1	Spec	spec	NN
cord-023095-4dannjjm	2657	2	cPL	cPL	NNS
cord-023095-4dannjjm	2657	3	was	be	VBD
cord-023095-4dannjjm	2657	4	mildly	mildly	RB
cord-023095-4dannjjm	2657	5	increased	increase	VBN
cord-023095-4dannjjm	2657	6	in	in	IN
cord-023095-4dannjjm	2657	7	3/18	3/18	CD
cord-023095-4dannjjm	2657	8	dogs	dog	NNS
cord-023095-4dannjjm	2657	9	with	with	IN
cord-023095-4dannjjm	2657	10	PLE	PLE	NNP
cord-023095-4dannjjm	2657	11	and	and	CC
cord-023095-4dannjjm	2657	12	normal	normal	JJ
cord-023095-4dannjjm	2657	13	in	in	IN
cord-023095-4dannjjm	2657	14	15/18	15/18	CD
cord-023095-4dannjjm	2657	15	PLE	PLE	NNP
cord-023095-4dannjjm	2657	16	and	and	CC
cord-023095-4dannjjm	2657	17	all	all	DT
cord-023095-4dannjjm	2657	18	FRD	FRD	NNP
cord-023095-4dannjjm	2657	19	dogs	dog	NNS
cord-023095-4dannjjm	2657	20	.	.	.
cord-023095-4dannjjm	2658	1	CRP	CRP	NNP
cord-023095-4dannjjm	2658	2	was	be	VBD
cord-023095-4dannjjm	2658	3	normal	normal	JJ
cord-023095-4dannjjm	2658	4	in	in	IN
cord-023095-4dannjjm	2658	5	5/18	5/18	CD
cord-023095-4dannjjm	2658	6	dogs	dog	NNS
cord-023095-4dannjjm	2658	7	with	with	IN
cord-023095-4dannjjm	2658	8	PLE	PLE	NNP
cord-023095-4dannjjm	2658	9	(	(	-LRB-
cord-023095-4dannjjm	2658	10	16/18	16/18	CD
cord-023095-4dannjjm	2658	11	FRD	FRD	NNP
cord-023095-4dannjjm	2658	12	)	)	-RRB-
cord-023095-4dannjjm	2658	13	,	,	,
cord-023095-4dannjjm	2658	14	mildly	mildly	RB
cord-023095-4dannjjm	2658	15	increased	increase	VBD
cord-023095-4dannjjm	2658	16	in	in	IN
cord-023095-4dannjjm	2658	17	7/18	7/18	CD
cord-023095-4dannjjm	2658	18	(	(	-LRB-
cord-023095-4dannjjm	2658	19	1/18	1/18	CD
cord-023095-4dannjjm	2658	20	FRD	FRD	NNP
cord-023095-4dannjjm	2658	21	)	)	-RRB-
cord-023095-4dannjjm	2658	22	,	,	,
cord-023095-4dannjjm	2658	23	and	and	CC
cord-023095-4dannjjm	2658	24	moderately	moderately	RB
cord-023095-4dannjjm	2658	25	increased	increase	VBD
cord-023095-4dannjjm	2658	26	in	in	IN
cord-023095-4dannjjm	2658	27	6/18	6/18	CD
cord-023095-4dannjjm	2658	28	PLE	PLE	NNP
cord-023095-4dannjjm	2658	29	dogs	dog	NNS
cord-023095-4dannjjm	2658	30	(	(	-LRB-
cord-023095-4dannjjm	2658	31	1/18	1/18	CD
cord-023095-4dannjjm	2658	32	FRD	FRD	NNP
cord-023095-4dannjjm	2658	33	)	)	-RRB-
cord-023095-4dannjjm	2658	34	.	.	.
cord-023095-4dannjjm	2659	1	Calprotectin	Calprotectin	NNP
cord-023095-4dannjjm	2659	2	was	be	VBD
cord-023095-4dannjjm	2659	3	slightly	slightly	RB
cord-023095-4dannjjm	2659	4	higher	high	JJR
cord-023095-4dannjjm	2659	5	in	in	IN
cord-023095-4dannjjm	2659	6	dogs	dog	NNS
cord-023095-4dannjjm	2659	7	with	with	IN
cord-023095-4dannjjm	2659	8	PLE	PLE	NNP
cord-023095-4dannjjm	2659	9	,	,	,
cord-023095-4dannjjm	2659	10	but	but	CC
cord-023095-4dannjjm	2659	11	all	all	DT
cord-023095-4dannjjm	2659	12	PLE	PLE	NNP
cord-023095-4dannjjm	2659	13	and	and	CC
cord-023095-4dannjjm	2659	14	FRD	FRD	NNP
cord-023095-4dannjjm	2659	15	dogs	dog	NNS
cord-023095-4dannjjm	2659	16	yielded	yield	VBD
cord-023095-4dannjjm	2659	17	values	value	NNS
cord-023095-4dannjjm	2659	18	in	in	IN
cord-023095-4dannjjm	2659	19	the	the	DT
cord-023095-4dannjjm	2659	20	normal	normal	JJ
cord-023095-4dannjjm	2659	21	range	range	NN
cord-023095-4dannjjm	2659	22	.	.	.
cord-023095-4dannjjm	2660	1	Serum	serum	NN
cord-023095-4dannjjm	2661	1	a	a	DT
cord-023095-4dannjjm	2661	2	1	1	CD
cord-023095-4dannjjm	2661	3	-PI	-pi	NN
cord-023095-4dannjjm	2661	4	was	be	VBD
cord-023095-4dannjjm	2661	5	significantly	significantly	RB
cord-023095-4dannjjm	2661	6	lower	low	JJR
cord-023095-4dannjjm	2661	7	in	in	IN
cord-023095-4dannjjm	2661	8	dogs	dog	NNS
cord-023095-4dannjjm	2661	9	with	with	IN
cord-023095-4dannjjm	2661	10	PLE	PLE	NNP
cord-023095-4dannjjm	2661	11	than	than	IN
cord-023095-4dannjjm	2661	12	in	in	IN
cord-023095-4dannjjm	2661	13	those	those	DT
cord-023095-4dannjjm	2661	14	with	with	IN
cord-023095-4dannjjm	2661	15	FRD	FRD	NNP
cord-023095-4dannjjm	2661	16	(	(	-LRB-
cord-023095-4dannjjm	2661	17	p	p	NN
cord-023095-4dannjjm	2661	18	o	o	CD
cord-023095-4dannjjm	2661	19	0.001	0.001	CD
cord-023095-4dannjjm	2661	20	)	)	-RRB-
cord-023095-4dannjjm	2661	21	,	,	,
cord-023095-4dannjjm	2661	22	with	with	IN
cord-023095-4dannjjm	2661	23	13/18	13/18	CD
cord-023095-4dannjjm	2661	24	PLE	PLE	NNP
cord-023095-4dannjjm	2661	25	dogs	dog	NNS
cord-023095-4dannjjm	2661	26	below	below	IN
cord-023095-4dannjjm	2661	27	the	the	DT
cord-023095-4dannjjm	2661	28	reference	reference	NN
cord-023095-4dannjjm	2661	29	range	range	NN
cord-023095-4dannjjm	2661	30	(	(	-LRB-
cord-023095-4dannjjm	2661	31	1/18	1/18	CD
cord-023095-4dannjjm	2661	32	FRD	FRD	NNP
cord-023095-4dannjjm	2661	33	)	)	-RRB-
cord-023095-4dannjjm	2661	34	.	.	.
cord-023095-4dannjjm	2662	1	CIBDAI	CIBDAI	NNP
cord-023095-4dannjjm	2662	2	ranged	range	VBD
cord-023095-4dannjjm	2662	3	from	from	IN
cord-023095-4dannjjm	2662	4	4	4	CD
cord-023095-4dannjjm	2662	5	to	to	IN
cord-023095-4dannjjm	2662	6	16	16	CD
cord-023095-4dannjjm	2662	7	and	and	CC
cord-023095-4dannjjm	2662	8	CCECAI	CCECAI	NNP
cord-023095-4dannjjm	2662	9	from	from	IN
cord-023095-4dannjjm	2662	10	6	6	CD
cord-023095-4dannjjm	2662	11	to	to	IN
cord-023095-4dannjjm	2662	12	19	19	CD
cord-023095-4dannjjm	2662	13	.	.	.
cord-023095-4dannjjm	2663	1	At	at	IN
cord-023095-4dannjjm	2663	2	the	the	DT
cord-023095-4dannjjm	2663	3	end	end	NN
cord-023095-4dannjjm	2663	4	of	of	IN
cord-023095-4dannjjm	2663	5	the	the	DT
cord-023095-4dannjjm	2663	6	study	study	NN
cord-023095-4dannjjm	2663	7	,	,	,
cord-023095-4dannjjm	2663	8	12/29	12/29	CD
cord-023095-4dannjjm	2663	9	dogs	dog	NNS
cord-023095-4dannjjm	2663	10	were	be	VBD
cord-023095-4dannjjm	2663	11	still	still	RB
cord-023095-4dannjjm	2663	12	alive	alive	JJ
cord-023095-4dannjjm	2663	13	with	with	IN
cord-023095-4dannjjm	2663	14	survival	survival	NN
cord-023095-4dannjjm	2663	15	times	time	NNS
cord-023095-4dannjjm	2663	16	between	between	IN
cord-023095-4dannjjm	2663	17	26	26	CD
cord-023095-4dannjjm	2663	18	and	and	CC
cord-023095-4dannjjm	2663	19	2544	2544	CD
cord-023095-4dannjjm	2663	20	days	day	NNS
cord-023095-4dannjjm	2663	21	.	.	.
cord-023095-4dannjjm	2664	1	17/29	17/29	CD
cord-023095-4dannjjm	2664	2	dogs	dog	NNS
cord-023095-4dannjjm	2664	3	died	die	VBD
cord-023095-4dannjjm	2664	4	with	with	IN
cord-023095-4dannjjm	2664	5	a	a	DT
cord-023095-4dannjjm	2664	6	median	median	JJ
cord-023095-4dannjjm	2664	7	survival	survival	NN
cord-023095-4dannjjm	2664	8	of	of	IN
cord-023095-4dannjjm	2664	9	96	96	CD
cord-023095-4dannjjm	2664	10	days	day	NNS
cord-023095-4dannjjm	2664	11	(	(	-LRB-
cord-023095-4dannjjm	2664	12	range	range	NNP
cord-023095-4dannjjm	2664	13	2	2	CD
cord-023095-4dannjjm	2664	14	-	-	SYM
cord-023095-4dannjjm	2664	15	874	874	CD
cord-023095-4dannjjm	2664	16	days	day	NNS
cord-023095-4dannjjm	2664	17	)	)	-RRB-
cord-023095-4dannjjm	2664	18	.	.	.
cord-023095-4dannjjm	2665	1	Dogs	dog	NNS
cord-023095-4dannjjm	2665	2	with	with	IN
cord-023095-4dannjjm	2665	3	mildly	mildly	RB
cord-023095-4dannjjm	2665	4	increased	increase	VBN
cord-023095-4dannjjm	2665	5	CRP	CRP	NNP
cord-023095-4dannjjm	2665	6	died	die	VBD
cord-023095-4dannjjm	2665	7	earlier	early	RBR
cord-023095-4dannjjm	2665	8	than	than	IN
cord-023095-4dannjjm	2665	9	dogs	dog	NNS
cord-023095-4dannjjm	2665	10	with	with	IN
cord-023095-4dannjjm	2665	11	a	a	DT
cord-023095-4dannjjm	2665	12	normal	normal	JJ
cord-023095-4dannjjm	2665	13	or	or	CC
cord-023095-4dannjjm	2665	14	moderately	moderately	RB
cord-023095-4dannjjm	2665	15	increased	increase	VBN
cord-023095-4dannjjm	2665	16	CRP	CRP	NNP
cord-023095-4dannjjm	2665	17	(	(	-LRB-
cord-023095-4dannjjm	2665	18	p	p	NN
cord-023095-4dannjjm	2665	19	5	5	CD
cord-023095-4dannjjm	2665	20	0.011	0.011	CD
cord-023095-4dannjjm	2665	21	)	)	-RRB-
cord-023095-4dannjjm	2665	22	,	,	,
cord-023095-4dannjjm	2665	23	whereas	whereas	IN
cord-023095-4dannjjm	2665	24	albumin	albumin	NN
cord-023095-4dannjjm	2665	25	,	,	,
cord-023095-4dannjjm	2665	26	calcium	calcium	NN
cord-023095-4dannjjm	2665	27	,	,	,
cord-023095-4dannjjm	2665	28	Spec	Spec	NNP
cord-023095-4dannjjm	2665	29	cPL	cPL	NNS
cord-023095-4dannjjm	2665	30	,	,	,
cord-023095-4dannjjm	2665	31	calprotectin	calprotectin	NNP
cord-023095-4dannjjm	2665	32	,	,	,
cord-023095-4dannjjm	2665	33	CIBDAI	CIBDAI	NNP
cord-023095-4dannjjm	2665	34	,	,	,
cord-023095-4dannjjm	2665	35	and	and	CC
cord-023095-4dannjjm	2665	36	CCECAI	CCECAI	NNP
cord-023095-4dannjjm	2665	37	had	have	VBD
cord-023095-4dannjjm	2665	38	no	no	DT
cord-023095-4dannjjm	2665	39	significant	significant	JJ
cord-023095-4dannjjm	2665	40	impact	impact	NN
cord-023095-4dannjjm	2665	41	on	on	IN
cord-023095-4dannjjm	2665	42	outcome	outcome	NN
cord-023095-4dannjjm	2665	43	and	and	CC
cord-023095-4dannjjm	2665	44	survival	survival	NN
cord-023095-4dannjjm	2665	45	.	.	.
cord-023095-4dannjjm	2666	1	In	in	IN
cord-023095-4dannjjm	2666	2	conclusion	conclusion	NN
cord-023095-4dannjjm	2666	3	,	,	,
cord-023095-4dannjjm	2666	4	dogs	dog	NNS
cord-023095-4dannjjm	2666	5	with	with	IN
cord-023095-4dannjjm	2666	6	PLE	PLE	NNP
cord-023095-4dannjjm	2666	7	have	have	VBP
cord-023095-4dannjjm	2666	8	a	a	DT
cord-023095-4dannjjm	2666	9	significantly	significantly	RB
cord-023095-4dannjjm	2666	10	lower	low	JJR
cord-023095-4dannjjm	2666	11	a1-PI	a1-pi	JJ
cord-023095-4dannjjm	2666	12	in	in	IN
cord-023095-4dannjjm	2666	13	the	the	DT
cord-023095-4dannjjm	2666	14	serum	serum	NN
cord-023095-4dannjjm	2666	15	than	than	IN
cord-023095-4dannjjm	2666	16	dogs	dog	NNS
cord-023095-4dannjjm	2666	17	with	with	IN
cord-023095-4dannjjm	2666	18	FRD	FRD	NNP
cord-023095-4dannjjm	2666	19	.	.	.
cord-023095-4dannjjm	2667	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	2667	2	,	,	,
cord-023095-4dannjjm	2667	3	most	most	JJS
cord-023095-4dannjjm	2667	4	dogs	dog	NNS
cord-023095-4dannjjm	2667	5	with	with	IN
cord-023095-4dannjjm	2667	6	PLE	PLE	NNP
cord-023095-4dannjjm	2667	7	have	have	VBP
cord-023095-4dannjjm	2667	8	an	an	DT
cord-023095-4dannjjm	2667	9	increased	increase	VBN
cord-023095-4dannjjm	2667	10	CRP	crp	NN
cord-023095-4dannjjm	2667	11	and	and	CC
cord-023095-4dannjjm	2667	12	a	a	DT
cord-023095-4dannjjm	2667	13	decreased	decrease	VBN
cord-023095-4dannjjm	2667	14	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2667	15	.	.	.
cord-023095-4dannjjm	2668	1	A	a	DT
cord-023095-4dannjjm	2668	2	mild	mild	JJ
cord-023095-4dannjjm	2668	3	increase	increase	NN
cord-023095-4dannjjm	2668	4	in	in	IN
cord-023095-4dannjjm	2668	5	CRP	CRP	NNP
cord-023095-4dannjjm	2668	6	appears	appear	VBZ
cord-023095-4dannjjm	2668	7	to	to	TO
cord-023095-4dannjjm	2668	8	be	be	VB
cord-023095-4dannjjm	2668	9	a	a	DT
cord-023095-4dannjjm	2668	10	poor	poor	JJ
cord-023095-4dannjjm	2668	11	prognostic	prognostic	JJ
cord-023095-4dannjjm	2668	12	factor	factor	NN
cord-023095-4dannjjm	2668	13	.	.	.
cord-023095-4dannjjm	2669	1	While	while	IN
cord-023095-4dannjjm	2669	2	hypoalbuminemia	hypoalbuminemia	NNP
cord-023095-4dannjjm	2669	3	is	be	VBZ
cord-023095-4dannjjm	2669	4	a	a	DT
cord-023095-4dannjjm	2669	5	common	common	JJ
cord-023095-4dannjjm	2669	6	finding	finding	NN
cord-023095-4dannjjm	2669	7	associated	associate	VBN
cord-023095-4dannjjm	2669	8	with	with	IN
cord-023095-4dannjjm	2669	9	chronic	chronic	JJ
cord-023095-4dannjjm	2669	10	enteropathies	enteropathy	NNS
cord-023095-4dannjjm	2669	11	,	,	,
cord-023095-4dannjjm	2669	12	its	-PRON-	PRP$
cord-023095-4dannjjm	2669	13	impact	impact	NN
cord-023095-4dannjjm	2669	14	on	on	IN
cord-023095-4dannjjm	2669	15	survival	survival	NN
cord-023095-4dannjjm	2669	16	in	in	IN
cord-023095-4dannjjm	2669	17	this	this	DT
cord-023095-4dannjjm	2669	18	population	population	NN
cord-023095-4dannjjm	2669	19	is	be	VBZ
cord-023095-4dannjjm	2669	20	poorly	poorly	RB
cord-023095-4dannjjm	2669	21	defined	define	VBN
cord-023095-4dannjjm	2669	22	.	.	.
cord-023095-4dannjjm	2670	1	The	the	DT
cord-023095-4dannjjm	2670	2	aim	aim	NN
cord-023095-4dannjjm	2670	3	of	of	IN
cord-023095-4dannjjm	2670	4	this	this	DT
cord-023095-4dannjjm	2670	5	study	study	NN
cord-023095-4dannjjm	2670	6	was	be	VBD
cord-023095-4dannjjm	2670	7	to	to	TO
cord-023095-4dannjjm	2670	8	compare	compare	VB
cord-023095-4dannjjm	2670	9	dogs	dog	NNS
cord-023095-4dannjjm	2670	10	with	with	IN
cord-023095-4dannjjm	2670	11	chronic	chronic	JJ
cord-023095-4dannjjm	2670	12	enteropathies	enteropathy	NNS
cord-023095-4dannjjm	2670	13	on	on	IN
cord-023095-4dannjjm	2670	14	the	the	DT
cord-023095-4dannjjm	2670	15	basis	basis	NN
cord-023095-4dannjjm	2670	16	of	of	IN
cord-023095-4dannjjm	2670	17	their	-PRON-	PRP$
cord-023095-4dannjjm	2670	18	serum	serum	NN
cord-023095-4dannjjm	2670	19	albumin	albumin	NN
cord-023095-4dannjjm	2670	20	concentration	concentration	NN
cord-023095-4dannjjm	2670	21	at	at	IN
cord-023095-4dannjjm	2670	22	the	the	DT
cord-023095-4dannjjm	2670	23	time	time	NN
cord-023095-4dannjjm	2670	24	of	of	IN
cord-023095-4dannjjm	2670	25	presentation	presentation	NN
cord-023095-4dannjjm	2670	26	.	.	.
cord-023095-4dannjjm	2671	1	We	-PRON-	PRP
cord-023095-4dannjjm	2671	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	2671	3	that	that	IN
cord-023095-4dannjjm	2671	4	dogs	dog	NNS
cord-023095-4dannjjm	2671	5	with	with	IN
cord-023095-4dannjjm	2671	6	a	a	DT
cord-023095-4dannjjm	2671	7	protein	protein	NN
cord-023095-4dannjjm	2671	8	losing	lose	VBG
cord-023095-4dannjjm	2671	9	enteropathy	enteropathy	NNS
cord-023095-4dannjjm	2671	10	(	(	-LRB-
cord-023095-4dannjjm	2671	11	PLE	PLE	NNP
cord-023095-4dannjjm	2671	12	)	)	-RRB-
cord-023095-4dannjjm	2671	13	have	have	VBP
cord-023095-4dannjjm	2671	14	a	a	DT
cord-023095-4dannjjm	2671	15	significantly	significantly	RB
cord-023095-4dannjjm	2671	16	shorter	short	JJR
cord-023095-4dannjjm	2671	17	survival	survival	NN
cord-023095-4dannjjm	2671	18	time	time	NN
cord-023095-4dannjjm	2671	19	compared	compare	VBN
cord-023095-4dannjjm	2671	20	to	to	IN
cord-023095-4dannjjm	2671	21	dogs	dog	NNS
cord-023095-4dannjjm	2671	22	with	with	IN
cord-023095-4dannjjm	2671	23	chronic	chronic	JJ
cord-023095-4dannjjm	2671	24	enteropathies	enteropathy	NNS
cord-023095-4dannjjm	2671	25	which	which	WDT
cord-023095-4dannjjm	2671	26	are	be	VBP
cord-023095-4dannjjm	2671	27	not	not	RB
cord-023095-4dannjjm	2671	28	hypoalbuminemic	hypoalbuminemic	JJ
cord-023095-4dannjjm	2671	29	(	(	-LRB-
cord-023095-4dannjjm	2671	30	controls	control	NNS
cord-023095-4dannjjm	2671	31	)	)	-RRB-
cord-023095-4dannjjm	2671	32	.	.	.
cord-023095-4dannjjm	2672	1	Information	information	NN
cord-023095-4dannjjm	2672	2	obtained	obtain	VBN
cord-023095-4dannjjm	2672	3	from	from	IN
cord-023095-4dannjjm	2672	4	the	the	DT
cord-023095-4dannjjm	2672	5	medical	medical	JJ
cord-023095-4dannjjm	2672	6	records	record	NNS
cord-023095-4dannjjm	2672	7	included	include	VBD
cord-023095-4dannjjm	2672	8	signalment	signalment	JJ
cord-023095-4dannjjm	2672	9	,	,	,
cord-023095-4dannjjm	2672	10	duration	duration	NN
cord-023095-4dannjjm	2672	11	and	and	CC
cord-023095-4dannjjm	2672	12	characteristics	characteristic	NNS
cord-023095-4dannjjm	2672	13	of	of	IN
cord-023095-4dannjjm	2672	14	clinical	clinical	JJ
cord-023095-4dannjjm	2672	15	signs	sign	NNS
cord-023095-4dannjjm	2672	16	,	,	,
cord-023095-4dannjjm	2672	17	physical	physical	JJ
cord-023095-4dannjjm	2672	18	examination	examination	NN
cord-023095-4dannjjm	2672	19	findings	finding	NNS
cord-023095-4dannjjm	2672	20	,	,	,
cord-023095-4dannjjm	2672	21	clinicopathologic	clinicopathologic	NNP
cord-023095-4dannjjm	2672	22	data	datum	NNS
cord-023095-4dannjjm	2672	23	and	and	CC
cord-023095-4dannjjm	2672	24	survival	survival	NN
cord-023095-4dannjjm	2672	25	time	time	NN
cord-023095-4dannjjm	2672	26	.	.	.
cord-023095-4dannjjm	2673	1	One	one	CD
cord-023095-4dannjjm	2673	2	hundred	hundred	CD
cord-023095-4dannjjm	2673	3	seventeen	seventeen	CD
cord-023095-4dannjjm	2673	4	cases	case	NNS
cord-023095-4dannjjm	2673	5	fit	fit	VBP
cord-023095-4dannjjm	2673	6	the	the	DT
cord-023095-4dannjjm	2673	7	inclusion	inclusion	NN
cord-023095-4dannjjm	2673	8	criteria	criterion	NNS
cord-023095-4dannjjm	2673	9	;	;	:
cord-023095-4dannjjm	2673	10	68	68	CD
cord-023095-4dannjjm	2673	11	in	in	IN
cord-023095-4dannjjm	2673	12	the	the	DT
cord-023095-4dannjjm	2673	13	PLE	PLE	NNP
cord-023095-4dannjjm	2673	14	group	group	NN
cord-023095-4dannjjm	2673	15	and	and	CC
cord-023095-4dannjjm	2673	16	49	49	CD
cord-023095-4dannjjm	2673	17	controls	control	NNS
cord-023095-4dannjjm	2673	18	.	.	.
cord-023095-4dannjjm	2674	1	There	there	EX
cord-023095-4dannjjm	2674	2	was	be	VBD
cord-023095-4dannjjm	2674	3	no	no	DT
cord-023095-4dannjjm	2674	4	statistical	statistical	JJ
cord-023095-4dannjjm	2674	5	significance	significance	NN
cord-023095-4dannjjm	2674	6	between	between	IN
cord-023095-4dannjjm	2674	7	groups	group	NNS
cord-023095-4dannjjm	2674	8	for	for	IN
cord-023095-4dannjjm	2674	9	age	age	NN
cord-023095-4dannjjm	2674	10	(	(	-LRB-
cord-023095-4dannjjm	2674	11	P	p	NN
cord-023095-4dannjjm	2674	12	5	5	CD
cord-023095-4dannjjm	2674	13	0.12	0.12	CD
cord-023095-4dannjjm	2674	14	)	)	-RRB-
cord-023095-4dannjjm	2674	15	,	,	,
cord-023095-4dannjjm	2674	16	weight	weight	NN
cord-023095-4dannjjm	2674	17	(	(	-LRB-
cord-023095-4dannjjm	2674	18	P	p	NN
cord-023095-4dannjjm	2674	19	5	5	CD
cord-023095-4dannjjm	2674	20	0.17	0.17	CD
cord-023095-4dannjjm	2674	21	)	)	-RRB-
cord-023095-4dannjjm	2674	22	,	,	,
cord-023095-4dannjjm	2674	23	weight	weight	NN
cord-023095-4dannjjm	2674	24	loss	loss	NN
cord-023095-4dannjjm	2674	25	(	(	-LRB-
cord-023095-4dannjjm	2674	26	P	p	NN
cord-023095-4dannjjm	2674	27	5	5	CD
cord-023095-4dannjjm	2674	28	0.59	0.59	CD
cord-023095-4dannjjm	2674	29	)	)	-RRB-
cord-023095-4dannjjm	2674	30	and	and	CC
cord-023095-4dannjjm	2674	31	body	body	NN
cord-023095-4dannjjm	2674	32	condition	condition	NN
cord-023095-4dannjjm	2674	33	score	score	NN
cord-023095-4dannjjm	2674	34	(	(	-LRB-
cord-023095-4dannjjm	2674	35	P	p	NN
cord-023095-4dannjjm	2674	36	5	5	CD
cord-023095-4dannjjm	2674	37	0.072	0.072	CD
cord-023095-4dannjjm	2674	38	)	)	-RRB-
cord-023095-4dannjjm	2674	39	.	.	.
cord-023095-4dannjjm	2675	1	Compared	compare	VBN
cord-023095-4dannjjm	2675	2	to	to	TO
cord-023095-4dannjjm	2675	3	control	control	VB
cord-023095-4dannjjm	2675	4	dogs	dog	NNS
cord-023095-4dannjjm	2675	5	,	,	,
cord-023095-4dannjjm	2675	6	PLE	PLE	NNP
cord-023095-4dannjjm	2675	7	dogs	dog	NNS
cord-023095-4dannjjm	2675	8	had	have	VBD
cord-023095-4dannjjm	2675	9	decreased	decrease	VBN
cord-023095-4dannjjm	2675	10	serum	serum	NN
cord-023095-4dannjjm	2675	11	concentrations	concentration	NNS
cord-023095-4dannjjm	2675	12	of	of	IN
cord-023095-4dannjjm	2675	13	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2675	14	(	(	-LRB-
cord-023095-4dannjjm	2675	15	P	p	NN
cord-023095-4dannjjm	2675	16	5	5	CD
cord-023095-4dannjjm	2675	17	0.002	0.002	CD
cord-023095-4dannjjm	2675	18	)	)	-RRB-
cord-023095-4dannjjm	2675	19	,	,	,
cord-023095-4dannjjm	2675	20	total	total	JJ
cord-023095-4dannjjm	2675	21	calcium	calcium	NN
cord-023095-4dannjjm	2675	22	(	(	-LRB-
cord-023095-4dannjjm	2675	23	P	p	NN
cord-023095-4dannjjm	2675	24	o	o	NN
cord-023095-4dannjjm	2675	25	0.0001	0.0001	CD
cord-023095-4dannjjm	2675	26	)	)	-RRB-
cord-023095-4dannjjm	2675	27	,	,	,
cord-023095-4dannjjm	2675	28	globulin	globulin	NN
cord-023095-4dannjjm	2675	29	(	(	-LRB-
cord-023095-4dannjjm	2675	30	P	p	NN
cord-023095-4dannjjm	2675	31	o	o	NN
cord-023095-4dannjjm	2675	32	0.0001	0.0001	CD
cord-023095-4dannjjm	2675	33	)	)	-RRB-
cord-023095-4dannjjm	2675	34	,	,	,
cord-023095-4dannjjm	2675	35	cholesterol	cholesterol	NN
cord-023095-4dannjjm	2675	36	(	(	-LRB-
cord-023095-4dannjjm	2676	1	P	p	NN
cord-023095-4dannjjm	2676	2	o	o	CD
cord-023095-4dannjjm	2676	3	0.0001	0.0001	CD
cord-023095-4dannjjm	2676	4	)	)	-RRB-
cord-023095-4dannjjm	2676	5	and	and	CC
cord-023095-4dannjjm	2676	6	ionized	ionized	JJ
cord-023095-4dannjjm	2676	7	calcium	calcium	NN
cord-023095-4dannjjm	2677	1	(	(	-LRB-
cord-023095-4dannjjm	2677	2	P	p	NN
cord-023095-4dannjjm	2677	3	o	o	NN
cord-023095-4dannjjm	2677	4	0.001	0.001	CD
cord-023095-4dannjjm	2677	5	)	)	-RRB-
cord-023095-4dannjjm	2677	6	.	.	.
cord-023095-4dannjjm	2678	1	Survival	survival	NN
cord-023095-4dannjjm	2678	2	analysis	analysis	NN
cord-023095-4dannjjm	2678	3	revealed	reveal	VBD
cord-023095-4dannjjm	2678	4	a	a	DT
cord-023095-4dannjjm	2678	5	significantly	significantly	RB
cord-023095-4dannjjm	2678	6	decreased	decrease	VBN
cord-023095-4dannjjm	2678	7	survival	survival	NN
cord-023095-4dannjjm	2678	8	time	time	NN
cord-023095-4dannjjm	2678	9	for	for	IN
cord-023095-4dannjjm	2678	10	PLE	PLE	NNP
cord-023095-4dannjjm	2678	11	dogs	dog	NNS
cord-023095-4dannjjm	2678	12	(	(	-LRB-
cord-023095-4dannjjm	2678	13	P	p	NN
cord-023095-4dannjjm	2678	14	5	5	CD
cord-023095-4dannjjm	2678	15	0.0008	0.0008	CD
cord-023095-4dannjjm	2678	16	)	)	-RRB-
cord-023095-4dannjjm	2678	17	;	;	:
cord-023095-4dannjjm	2678	18	median	median	JJ
cord-023095-4dannjjm	2678	19	survival	survival	NN
cord-023095-4dannjjm	2678	20	was	be	VBD
cord-023095-4dannjjm	2678	21	701	701	CD
cord-023095-4dannjjm	2678	22	days	day	NNS
cord-023095-4dannjjm	2678	23	for	for	IN
cord-023095-4dannjjm	2678	24	PLE	PLE	NNP
cord-023095-4dannjjm	2678	25	dogs	dog	NNS
cord-023095-4dannjjm	2678	26	and	and	CC
cord-023095-4dannjjm	2678	27	4	4	CD
cord-023095-4dannjjm	2678	28	3,500	3,500	CD
cord-023095-4dannjjm	2678	29	days	day	NNS
cord-023095-4dannjjm	2678	30	for	for	IN
cord-023095-4dannjjm	2678	31	controls	control	NNS
cord-023095-4dannjjm	2678	32	.	.	.
cord-023095-4dannjjm	2679	1	While	while	IN
cord-023095-4dannjjm	2679	2	the	the	DT
cord-023095-4dannjjm	2679	3	PLE	PLE	NNP
cord-023095-4dannjjm	2679	4	group	group	NN
cord-023095-4dannjjm	2679	5	did	do	VBD
cord-023095-4dannjjm	2679	6	not	not	RB
cord-023095-4dannjjm	2679	7	survive	survive	VB
cord-023095-4dannjjm	2679	8	as	as	RB
cord-023095-4dannjjm	2679	9	long	long	JJ
cord-023095-4dannjjm	2679	10	,	,	,
cord-023095-4dannjjm	2679	11	survival	survival	NN
cord-023095-4dannjjm	2679	12	was	be	VBD
cord-023095-4dannjjm	2679	13	not	not	RB
cord-023095-4dannjjm	2679	14	directly	directly	RB
cord-023095-4dannjjm	2679	15	associated	associate	VBN
cord-023095-4dannjjm	2679	16	with	with	IN
cord-023095-4dannjjm	2679	17	severity	severity	NN
cord-023095-4dannjjm	2679	18	of	of	IN
cord-023095-4dannjjm	2679	19	hypoalbuminemia	hypoalbuminemia	NN
cord-023095-4dannjjm	2679	20	;	;	:
cord-023095-4dannjjm	2679	21	patients	patient	NNS
cord-023095-4dannjjm	2679	22	with	with	IN
cord-023095-4dannjjm	2679	23	albumin	albumin	NN
cord-023095-4dannjjm	2679	24	concentration	concentration	NN
cord-023095-4dannjjm	2679	25	o	o	NN
cord-023095-4dannjjm	2679	26	1.3	1.3	CD
cord-023095-4dannjjm	2679	27	g	g	NN
cord-023095-4dannjjm	2679	28	/	/	SYM
cord-023095-4dannjjm	2679	29	dL	dl	NN
cord-023095-4dannjjm	2679	30	survived	survive	VBD
cord-023095-4dannjjm	2679	31	longer	long	RBR
cord-023095-4dannjjm	2679	32	than	than	IN
cord-023095-4dannjjm	2679	33	those	those	DT
cord-023095-4dannjjm	2679	34	with	with	IN
cord-023095-4dannjjm	2679	35	mild	mild	JJ
cord-023095-4dannjjm	2679	36	hypoalbuminemia	hypoalbuminemia	NN
cord-023095-4dannjjm	2679	37	(	(	-LRB-
cord-023095-4dannjjm	2679	38	1.6	1.6	CD
cord-023095-4dannjjm	2679	39	-	-	SYM
cord-023095-4dannjjm	2679	40	1.9	1.9	CD
cord-023095-4dannjjm	2679	41	g	g	NN
cord-023095-4dannjjm	2679	42	/	/	SYM
cord-023095-4dannjjm	2679	43	dL	dl	NN
cord-023095-4dannjjm	2679	44	)	)	-RRB-
cord-023095-4dannjjm	2679	45	.	.	.
cord-023095-4dannjjm	2680	1	This	this	DT
cord-023095-4dannjjm	2680	2	study	study	NN
cord-023095-4dannjjm	2680	3	supports	support	VBZ
cord-023095-4dannjjm	2680	4	the	the	DT
cord-023095-4dannjjm	2680	5	observation	observation	NN
cord-023095-4dannjjm	2680	6	that	that	IN
cord-023095-4dannjjm	2680	7	chronic	chronic	JJ
cord-023095-4dannjjm	2680	8	enteropathy	enteropathy	NN
cord-023095-4dannjjm	2680	9	patients	patient	NNS
cord-023095-4dannjjm	2680	10	have	have	VBP
cord-023095-4dannjjm	2680	11	decreased	decrease	VBN
cord-023095-4dannjjm	2680	12	survival	survival	NN
cord-023095-4dannjjm	2680	13	time	time	NN
cord-023095-4dannjjm	2680	14	when	when	WRB
cord-023095-4dannjjm	2680	15	presented	present	VBN
cord-023095-4dannjjm	2680	16	with	with	IN
cord-023095-4dannjjm	2680	17	hypoalbuminemia	hypoalbuminemia	NN
cord-023095-4dannjjm	2680	18	;	;	:
cord-023095-4dannjjm	2680	19	however	however	RB
cord-023095-4dannjjm	2680	20	this	this	DT
cord-023095-4dannjjm	2680	21	study	study	NN
cord-023095-4dannjjm	2680	22	suggests	suggest	VBZ
cord-023095-4dannjjm	2680	23	the	the	DT
cord-023095-4dannjjm	2680	24	severity	severity	NN
cord-023095-4dannjjm	2680	25	of	of	IN
cord-023095-4dannjjm	2680	26	hypoalbuminemia	hypoalbuminemia	NN
cord-023095-4dannjjm	2680	27	is	be	VBZ
cord-023095-4dannjjm	2680	28	not	not	RB
cord-023095-4dannjjm	2680	29	a	a	DT
cord-023095-4dannjjm	2680	30	reliable	reliable	JJ
cord-023095-4dannjjm	2680	31	indicator	indicator	NN
cord-023095-4dannjjm	2680	32	of	of	IN
cord-023095-4dannjjm	2680	33	survival	survival	NN
cord-023095-4dannjjm	2680	34	.	.	.
cord-023095-4dannjjm	2681	1	Cobalamin	Cobalamin	NNP
cord-023095-4dannjjm	2681	2	(	(	-LRB-
cord-023095-4dannjjm	2681	3	vitamin	vitamin	NN
cord-023095-4dannjjm	2681	4	B	b	NN
cord-023095-4dannjjm	2681	5	12	12	CD
cord-023095-4dannjjm	2681	6	)	)	-RRB-
cord-023095-4dannjjm	2681	7	deficiency	deficiency	NN
cord-023095-4dannjjm	2681	8	in	in	IN
cord-023095-4dannjjm	2681	9	the	the	DT
cord-023095-4dannjjm	2681	10	Chinese	chinese	JJ
cord-023095-4dannjjm	2681	11	Shar	Shar	NNP
cord-023095-4dannjjm	2681	12	Pei	Pei	NNP
cord-023095-4dannjjm	2681	13	(	(	-LRB-
cord-023095-4dannjjm	2681	14	Shar	Shar	NNP
cord-023095-4dannjjm	2681	15	Pei	Pei	NNP
cord-023095-4dannjjm	2681	16	)	)	-RRB-
cord-023095-4dannjjm	2681	17	is	be	VBZ
cord-023095-4dannjjm	2681	18	suspected	suspect	VBN
cord-023095-4dannjjm	2681	19	to	to	TO
cord-023095-4dannjjm	2681	20	be	be	VB
cord-023095-4dannjjm	2681	21	hereditary	hereditary	JJ
cord-023095-4dannjjm	2681	22	.	.	.
cord-023095-4dannjjm	2682	1	Inherited	inherit	VBN
cord-023095-4dannjjm	2682	2	causes	cause	NNS
cord-023095-4dannjjm	2682	3	of	of	IN
cord-023095-4dannjjm	2682	4	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2682	5	deficiency	deficiency	NN
cord-023095-4dannjjm	2682	6	have	have	VBP
cord-023095-4dannjjm	2682	7	been	be	VBN
cord-023095-4dannjjm	2682	8	reported	report	VBN
cord-023095-4dannjjm	2682	9	in	in	IN
cord-023095-4dannjjm	2682	10	humans	human	NNS
cord-023095-4dannjjm	2682	11	and	and	CC
cord-023095-4dannjjm	2682	12	may	may	MD
cord-023095-4dannjjm	2682	13	affect	affect	VB
cord-023095-4dannjjm	2682	14	absorption	absorption	NN
cord-023095-4dannjjm	2682	15	,	,	,
cord-023095-4dannjjm	2682	16	transport	transport	NN
cord-023095-4dannjjm	2682	17	,	,	,
cord-023095-4dannjjm	2682	18	or	or	CC
cord-023095-4dannjjm	2682	19	cellular	cellular	JJ
cord-023095-4dannjjm	2682	20	processing	processing	NN
cord-023095-4dannjjm	2682	21	of	of	IN
cord-023095-4dannjjm	2682	22	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2682	23	.	.	.
cord-023095-4dannjjm	2683	1	Based	base	VBN
cord-023095-4dannjjm	2683	2	on	on	IN
cord-023095-4dannjjm	2683	3	human	human	JJ
cord-023095-4dannjjm	2683	4	and	and	CC
cord-023095-4dannjjm	2683	5	veterinary	veterinary	JJ
cord-023095-4dannjjm	2683	6	studies	study	NNS
cord-023095-4dannjjm	2683	7	,	,	,
cord-023095-4dannjjm	2683	8	an	an	DT
cord-023095-4dannjjm	2683	9	increased	increase	VBN
cord-023095-4dannjjm	2683	10	serum	serum	NN
cord-023095-4dannjjm	2683	11	methylmalonic	methylmalonic	NN
cord-023095-4dannjjm	2683	12	acid	acid	NN
cord-023095-4dannjjm	2683	13	(	(	-LRB-
cord-023095-4dannjjm	2683	14	MMA	MMA	NNP
cord-023095-4dannjjm	2683	15	)	)	-RRB-
cord-023095-4dannjjm	2683	16	concentration	concentration	NN
cord-023095-4dannjjm	2683	17	has	have	VBZ
cord-023095-4dannjjm	2683	18	been	be	VBN
cord-023095-4dannjjm	2683	19	suggested	suggest	VBN
cord-023095-4dannjjm	2683	20	to	to	TO
cord-023095-4dannjjm	2683	21	reflect	reflect	VB
cord-023095-4dannjjm	2683	22	cobalamin	cobalamin	JJ
cord-023095-4dannjjm	2683	23	deficiency	deficiency	NN
cord-023095-4dannjjm	2683	24	at	at	IN
cord-023095-4dannjjm	2683	25	the	the	DT
cord-023095-4dannjjm	2683	26	cellular	cellular	JJ
cord-023095-4dannjjm	2683	27	level	level	NN
cord-023095-4dannjjm	2683	28	.	.	.
cord-023095-4dannjjm	2684	1	In	in	IN
cord-023095-4dannjjm	2684	2	this	this	DT
cord-023095-4dannjjm	2684	3	context	context	NN
cord-023095-4dannjjm	2684	4	,	,	,
cord-023095-4dannjjm	2684	5	it	-PRON-	PRP
cord-023095-4dannjjm	2684	6	has	have	VBZ
cord-023095-4dannjjm	2684	7	been	be	VBN
cord-023095-4dannjjm	2684	8	shown	show	VBN
cord-023095-4dannjjm	2684	9	in	in	IN
cord-023095-4dannjjm	2684	10	humans	human	NNS
cord-023095-4dannjjm	2684	11	that	that	WDT
cord-023095-4dannjjm	2684	12	MMA	MMA	NNP
cord-023095-4dannjjm	2684	13	concentrations	concentration	NNS
cord-023095-4dannjjm	2684	14	are	be	VBP
cord-023095-4dannjjm	2684	15	higher	high	JJR
cord-023095-4dannjjm	2684	16	in	in	IN
cord-023095-4dannjjm	2684	17	patients	patient	NNS
cord-023095-4dannjjm	2684	18	with	with	IN
cord-023095-4dannjjm	2684	19	genetic	genetic	JJ
cord-023095-4dannjjm	2684	20	disorders	disorder	NNS
cord-023095-4dannjjm	2684	21	affecting	affect	VBG
cord-023095-4dannjjm	2684	22	intracellular	intracellular	JJ
cord-023095-4dannjjm	2684	23	processing	processing	NN
cord-023095-4dannjjm	2684	24	than	than	IN
cord-023095-4dannjjm	2684	25	in	in	IN
cord-023095-4dannjjm	2684	26	patients	patient	NNS
cord-023095-4dannjjm	2684	27	with	with	IN
cord-023095-4dannjjm	2684	28	genetic	genetic	JJ
cord-023095-4dannjjm	2684	29	defects	defect	NNS
cord-023095-4dannjjm	2684	30	affecting	affect	VBG
cord-023095-4dannjjm	2684	31	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2684	32	processing	processing	NN
cord-023095-4dannjjm	2684	33	and	and	CC
cord-023095-4dannjjm	2684	34	extracellular	extracellular	JJ
cord-023095-4dannjjm	2684	35	transport	transport	NN
cord-023095-4dannjjm	2684	36	of	of	IN
cord-023095-4dannjjm	2684	37	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2684	38	.	.	.
cord-023095-4dannjjm	2685	1	Therefore	therefore	RB
cord-023095-4dannjjm	2685	2	,	,	,
cord-023095-4dannjjm	2685	3	the	the	DT
cord-023095-4dannjjm	2685	4	aim	aim	NN
cord-023095-4dannjjm	2685	5	of	of	IN
cord-023095-4dannjjm	2685	6	this	this	DT
cord-023095-4dannjjm	2685	7	study	study	NN
cord-023095-4dannjjm	2685	8	was	be	VBD
cord-023095-4dannjjm	2685	9	to	to	TO
cord-023095-4dannjjm	2685	10	evaluate	evaluate	VB
cord-023095-4dannjjm	2685	11	serum	serum	NN
cord-023095-4dannjjm	2685	12	MMA	MMA	NNP
cord-023095-4dannjjm	2685	13	concentrations	concentration	NNS
cord-023095-4dannjjm	2685	14	in	in	IN
cord-023095-4dannjjm	2685	15	Shar	Shar	NNP
cord-023095-4dannjjm	2685	16	Peis	Peis	NNP
cord-023095-4dannjjm	2685	17	and	and	CC
cord-023095-4dannjjm	2685	18	dogs	dog	NNS
cord-023095-4dannjjm	2685	19	of	of	IN
cord-023095-4dannjjm	2685	20	six	six	CD
cord-023095-4dannjjm	2685	21	other	other	JJ
cord-023095-4dannjjm	2685	22	breeds	breed	NNS
cord-023095-4dannjjm	2685	23	with	with	IN
cord-023095-4dannjjm	2685	24	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2685	25	deficiency	deficiency	NN
cord-023095-4dannjjm	2685	26	.	.	.
cord-023095-4dannjjm	2686	1	From	from	IN
cord-023095-4dannjjm	2686	2	2008	2008	CD
cord-023095-4dannjjm	2687	1	In	in	IN
cord-023095-4dannjjm	2687	2	conclusion	conclusion	NN
cord-023095-4dannjjm	2687	3	,	,	,
cord-023095-4dannjjm	2687	4	serum	serum	NN
cord-023095-4dannjjm	2687	5	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2687	6	deficient	deficient	JJ
cord-023095-4dannjjm	2687	7	Shar	Shar	NNP
cord-023095-4dannjjm	2687	8	Peis	Peis	NNP
cord-023095-4dannjjm	2687	9	had	have	VBD
cord-023095-4dannjjm	2687	10	a	a	DT
cord-023095-4dannjjm	2687	11	10	10	CD
cord-023095-4dannjjm	2687	12	times	time	NNS
cord-023095-4dannjjm	2687	13	higher	high	JJR
cord-023095-4dannjjm	2687	14	median	median	JJ
cord-023095-4dannjjm	2687	15	serum	serum	NN
cord-023095-4dannjjm	2687	16	MMA	MMA	NNP
cord-023095-4dannjjm	2687	17	concentration	concentration	NN
cord-023095-4dannjjm	2687	18	compared	compare	VBN
cord-023095-4dannjjm	2687	19	to	to	IN
cord-023095-4dannjjm	2687	20	cobalamin	cobalamin	JJ
cord-023095-4dannjjm	2687	21	deficient	deficient	JJ
cord-023095-4dannjjm	2687	22	dogs	dog	NNS
cord-023095-4dannjjm	2687	23	of	of	IN
cord-023095-4dannjjm	2687	24	six	six	CD
cord-023095-4dannjjm	2687	25	other	other	JJ
cord-023095-4dannjjm	2687	26	dog	dog	NN
cord-023095-4dannjjm	2687	27	breeds	breed	NNS
cord-023095-4dannjjm	2687	28	.	.	.
cord-023095-4dannjjm	2688	1	Further	further	JJ
cord-023095-4dannjjm	2688	2	studies	study	NNS
cord-023095-4dannjjm	2688	3	are	be	VBP
cord-023095-4dannjjm	2688	4	needed	need	VBN
cord-023095-4dannjjm	2688	5	to	to	TO
cord-023095-4dannjjm	2688	6	investigate	investigate	VB
cord-023095-4dannjjm	2688	7	the	the	DT
cord-023095-4dannjjm	2688	8	intracellular	intracellular	JJ
cord-023095-4dannjjm	2688	9	processing	processing	NN
cord-023095-4dannjjm	2688	10	of	of	IN
cord-023095-4dannjjm	2688	11	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2688	12	in	in	IN
cord-023095-4dannjjm	2688	13	Shar	Shar	NNP
cord-023095-4dannjjm	2688	14	Peis	Peis	NNP
cord-023095-4dannjjm	2688	15	with	with	IN
cord-023095-4dannjjm	2688	16	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2688	17	deficiency	deficiency	NN
cord-023095-4dannjjm	2688	18	.	.	.
cord-023095-4dannjjm	2689	1	Chinese	chinese	JJ
cord-023095-4dannjjm	2689	2	Shar	Shar	NNP
cord-023095-4dannjjm	2689	3	Peis	Peis	NNP
cord-023095-4dannjjm	2689	4	(	(	-LRB-
cord-023095-4dannjjm	2689	5	Shar	Shar	NNP
cord-023095-4dannjjm	2689	6	Peis	Peis	NNP
cord-023095-4dannjjm	2689	7	)	)	-RRB-
cord-023095-4dannjjm	2689	8	have	have	VBP
cord-023095-4dannjjm	2689	9	a	a	DT
cord-023095-4dannjjm	2689	10	high	high	JJ
cord-023095-4dannjjm	2689	11	prevalence	prevalence	NN
cord-023095-4dannjjm	2689	12	of	of	IN
cord-023095-4dannjjm	2689	13	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2689	14	deficiency	deficiency	NN
cord-023095-4dannjjm	2689	15	.	.	.
cord-023095-4dannjjm	2690	1	Two	two	CD
cord-023095-4dannjjm	2690	2	other	other	JJ
cord-023095-4dannjjm	2690	3	conditions	condition	NNS
cord-023095-4dannjjm	2690	4	reported	report	VBN
cord-023095-4dannjjm	2690	5	frequently	frequently	RB
cord-023095-4dannjjm	2690	6	in	in	IN
cord-023095-4dannjjm	2690	7	this	this	DT
cord-023095-4dannjjm	2690	8	breed	breed	NN
cord-023095-4dannjjm	2690	9	are	be	VBP
cord-023095-4dannjjm	2690	10	Shar	Shar	NNP
cord-023095-4dannjjm	2690	11	Pei	Pei	NNP
cord-023095-4dannjjm	2690	12	fever	fever	NN
cord-023095-4dannjjm	2690	13	and	and	CC
cord-023095-4dannjjm	2690	14	cutaneous	cutaneous	JJ
cord-023095-4dannjjm	2690	15	mucinosis	mucinosis	NN
cord-023095-4dannjjm	2690	16	.	.	.
cord-023095-4dannjjm	2691	1	Shar	Shar	NNP
cord-023095-4dannjjm	2691	2	Pei	Pei	NNP
cord-023095-4dannjjm	2691	3	fever	fever	NN
cord-023095-4dannjjm	2691	4	is	be	VBZ
cord-023095-4dannjjm	2691	5	an	an	DT
cord-023095-4dannjjm	2691	6	autoimmune	autoimmune	JJ
cord-023095-4dannjjm	2691	7	disorder	disorder	NN
cord-023095-4dannjjm	2691	8	causing	cause	VBG
cord-023095-4dannjjm	2691	9	periodic	periodic	JJ
cord-023095-4dannjjm	2691	10	flare	flare	NN
cord-023095-4dannjjm	2691	11	-	-	HYPH
cord-023095-4dannjjm	2691	12	ups	up	NNS
cord-023095-4dannjjm	2691	13	and	and	CC
cord-023095-4dannjjm	2691	14	is	be	VBZ
cord-023095-4dannjjm	2691	15	associated	associate	VBN
cord-023095-4dannjjm	2691	16	with	with	IN
cord-023095-4dannjjm	2691	17	increased	increase	VBN
cord-023095-4dannjjm	2691	18	serum	serum	NN
cord-023095-4dannjjm	2691	19	concentrations	concentration	NNS
cord-023095-4dannjjm	2691	20	of	of	IN
cord-023095-4dannjjm	2691	21	C	c	NN
cord-023095-4dannjjm	2691	22	-	-	HYPH
cord-023095-4dannjjm	2691	23	reactive	reactive	JJ
cord-023095-4dannjjm	2691	24	protein	protein	NN
cord-023095-4dannjjm	2691	25	(	(	-LRB-
cord-023095-4dannjjm	2691	26	CRP	CRP	NNP
cord-023095-4dannjjm	2691	27	)	)	-RRB-
cord-023095-4dannjjm	2691	28	,	,	,
cord-023095-4dannjjm	2691	29	a	a	DT
cord-023095-4dannjjm	2691	30	nonspecific	nonspecific	JJ
cord-023095-4dannjjm	2691	31	marker	marker	NN
cord-023095-4dannjjm	2691	32	of	of	IN
cord-023095-4dannjjm	2691	33	inflammation	inflammation	NN
cord-023095-4dannjjm	2691	34	.	.	.
cord-023095-4dannjjm	2692	1	Cutaneous	cutaneous	JJ
cord-023095-4dannjjm	2692	2	mucinosis	mucinosis	NN
cord-023095-4dannjjm	2692	3	is	be	VBZ
cord-023095-4dannjjm	2692	4	characterized	characterize	VBN
cord-023095-4dannjjm	2692	5	by	by	IN
cord-023095-4dannjjm	2692	6	excessive	excessive	JJ
cord-023095-4dannjjm	2692	7	deposition	deposition	NN
cord-023095-4dannjjm	2692	8	of	of	IN
cord-023095-4dannjjm	2692	9	mucin	mucin	NN
cord-023095-4dannjjm	2692	10	in	in	IN
cord-023095-4dannjjm	2692	11	the	the	DT
cord-023095-4dannjjm	2692	12	dermis	dermis	NN
cord-023095-4dannjjm	2692	13	.	.	.
cord-023095-4dannjjm	2693	1	Also	also	RB
cord-023095-4dannjjm	2693	2	,	,	,
cord-023095-4dannjjm	2693	3	hyaluronic	hyaluronic	NN
cord-023095-4dannjjm	2693	4	acid	acid	NN
cord-023095-4dannjjm	2693	5	(	(	-LRB-
cord-023095-4dannjjm	2693	6	HA	HA	NNP
cord-023095-4dannjjm	2693	7	)	)	-RRB-
cord-023095-4dannjjm	2693	8	,	,	,
cord-023095-4dannjjm	2693	9	the	the	DT
cord-023095-4dannjjm	2693	10	main	main	JJ
cord-023095-4dannjjm	2693	11	component	component	NN
cord-023095-4dannjjm	2693	12	of	of	IN
cord-023095-4dannjjm	2693	13	mucin	mucin	NN
cord-023095-4dannjjm	2693	14	,	,	,
cord-023095-4dannjjm	2693	15	was	be	VBD
cord-023095-4dannjjm	2693	16	shown	show	VBN
cord-023095-4dannjjm	2693	17	to	to	TO
cord-023095-4dannjjm	2693	18	be	be	VB
cord-023095-4dannjjm	2693	19	significantly	significantly	RB
cord-023095-4dannjjm	2693	20	higher	high	JJR
cord-023095-4dannjjm	2693	21	in	in	IN
cord-023095-4dannjjm	2693	22	serum	serum	NN
cord-023095-4dannjjm	2693	23	from	from	IN
cord-023095-4dannjjm	2693	24	Shar	Shar	NNP
cord-023095-4dannjjm	2693	25	Peis	Peis	NNP
cord-023095-4dannjjm	2693	26	with	with	IN
cord-023095-4dannjjm	2693	27	cutaneous	cutaneous	JJ
cord-023095-4dannjjm	2693	28	mucinosis	mucinosis	NN
cord-023095-4dannjjm	2693	29	than	than	IN
cord-023095-4dannjjm	2693	30	in	in	IN
cord-023095-4dannjjm	2693	31	healthy	healthy	JJ
cord-023095-4dannjjm	2693	32	controls	control	NNS
cord-023095-4dannjjm	2693	33	.	.	.
cord-023095-4dannjjm	2694	1	To	to	IN
cord-023095-4dannjjm	2694	2	date	date	NN
cord-023095-4dannjjm	2694	3	,	,	,
cord-023095-4dannjjm	2694	4	a	a	DT
cord-023095-4dannjjm	2694	5	possible	possible	JJ
cord-023095-4dannjjm	2694	6	association	association	NN
cord-023095-4dannjjm	2694	7	between	between	IN
cord-023095-4dannjjm	2694	8	Shar	Shar	NNP
cord-023095-4dannjjm	2694	9	Pei	Pei	NNP
cord-023095-4dannjjm	2694	10	fever	fever	NN
cord-023095-4dannjjm	2694	11	and/or	and/or	CC
cord-023095-4dannjjm	2694	12	cutaneous	cutaneous	JJ
cord-023095-4dannjjm	2694	13	mucinosis	mucinosis	NN
cord-023095-4dannjjm	2694	14	on	on	IN
cord-023095-4dannjjm	2694	15	one	one	CD
cord-023095-4dannjjm	2694	16	side	side	NN
cord-023095-4dannjjm	2694	17	and	and	CC
cord-023095-4dannjjm	2694	18	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2694	19	deficiency	deficiency	NN
cord-023095-4dannjjm	2694	20	on	on	IN
cord-023095-4dannjjm	2694	21	the	the	DT
cord-023095-4dannjjm	2694	22	other	other	JJ
cord-023095-4dannjjm	2694	23	has	have	VBZ
cord-023095-4dannjjm	2694	24	not	not	RB
cord-023095-4dannjjm	2694	25	been	be	VBN
cord-023095-4dannjjm	2694	26	investigated	investigate	VBN
cord-023095-4dannjjm	2694	27	in	in	IN
cord-023095-4dannjjm	2694	28	Shar	Shar	NNP
cord-023095-4dannjjm	2694	29	Peis	Peis	NNP
cord-023095-4dannjjm	2694	30	.	.	.
cord-023095-4dannjjm	2695	1	Thus	thus	RB
cord-023095-4dannjjm	2695	2	,	,	,
cord-023095-4dannjjm	2695	3	the	the	DT
cord-023095-4dannjjm	2695	4	aim	aim	NN
cord-023095-4dannjjm	2695	5	of	of	IN
cord-023095-4dannjjm	2695	6	this	this	DT
cord-023095-4dannjjm	2695	7	study	study	NN
cord-023095-4dannjjm	2695	8	was	be	VBD
cord-023095-4dannjjm	2695	9	to	to	TO
cord-023095-4dannjjm	2695	10	compare	compare	VB
cord-023095-4dannjjm	2695	11	serum	serum	NN
cord-023095-4dannjjm	2695	12	concentrations	concentration	NNS
cord-023095-4dannjjm	2695	13	of	of	IN
cord-023095-4dannjjm	2695	14	HA	HA	NNP
cord-023095-4dannjjm	2695	15	(	(	-LRB-
cord-023095-4dannjjm	2695	16	an	an	DT
cord-023095-4dannjjm	2695	17	indicator	indicator	NN
cord-023095-4dannjjm	2695	18	of	of	IN
cord-023095-4dannjjm	2695	19	cutaneous	cutaneous	JJ
cord-023095-4dannjjm	2695	20	mucinosis	mucinosis	NN
cord-023095-4dannjjm	2695	21	)	)	-RRB-
cord-023095-4dannjjm	2695	22	and	and	CC
cord-023095-4dannjjm	2695	23	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2695	24	markers	marker	NNS
cord-023095-4dannjjm	2695	25	(	(	-LRB-
cord-023095-4dannjjm	2695	26	CRP	CRP	NNP
cord-023095-4dannjjm	2695	27	,	,	,
cord-023095-4dannjjm	2695	28	calprotectin	calprotectin	NNP
cord-023095-4dannjjm	2695	29	,	,	,
cord-023095-4dannjjm	2695	30	and	and	CC
cord-023095-4dannjjm	2695	31	S100A12	s100a12	CD
cord-023095-4dannjjm	2695	32	)	)	-RRB-
cord-023095-4dannjjm	2695	33	,	,	,
cord-023095-4dannjjm	2695	34	assumed	assume	VBN
cord-023095-4dannjjm	2695	35	to	to	TO
cord-023095-4dannjjm	2695	36	be	be	VB
cord-023095-4dannjjm	2695	37	increased	increase	VBN
cord-023095-4dannjjm	2695	38	in	in	IN
cord-023095-4dannjjm	2695	39	episodes	episode	NNS
cord-023095-4dannjjm	2695	40	of	of	IN
cord-023095-4dannjjm	2695	41	Shar	Shar	NNP
cord-023095-4dannjjm	2695	42	Pei	Pei	NNP
cord-023095-4dannjjm	2695	43	fever	fever	NN
cord-023095-4dannjjm	2695	44	,	,	,
cord-023095-4dannjjm	2695	45	in	in	IN
cord-023095-4dannjjm	2695	46	Shar	Shar	NNP
cord-023095-4dannjjm	2695	47	Peis	Peis	NNP
cord-023095-4dannjjm	2695	48	with	with	IN
cord-023095-4dannjjm	2695	49	and	and	CC
cord-023095-4dannjjm	2695	50	without	without	IN
cord-023095-4dannjjm	2695	51	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2695	52	deficiency	deficiency	NN
cord-023095-4dannjjm	2695	53	.	.	.
cord-023095-4dannjjm	2696	1	Serum	serum	NN
cord-023095-4dannjjm	2696	2	samples	sample	NNS
cord-023095-4dannjjm	2696	3	from	from	IN
cord-023095-4dannjjm	2696	4	40	40	CD
cord-023095-4dannjjm	2696	5	Shar	Shar	NNP
cord-023095-4dannjjm	2696	6	Peis	Peis	NNP
cord-023095-4dannjjm	2696	7	,	,	,
cord-023095-4dannjjm	2696	8	collected	collect	VBN
cord-023095-4dannjjm	2696	9	from	from	IN
cord-023095-4dannjjm	2696	10	2008	2008	CD
cord-023095-4dannjjm	2696	11	to	to	IN
cord-023095-4dannjjm	2696	12	2010	2010	CD
cord-023095-4dannjjm	2696	13	,	,	,
cord-023095-4dannjjm	2696	14	were	be	VBD
cord-023095-4dannjjm	2696	15	analyzed	analyze	VBN
cord-023095-4dannjjm	2696	16	.	.	.
cord-023095-4dannjjm	2697	1	Serum	serum	NN
cord-023095-4dannjjm	2697	2	HA	HA	NNP
cord-023095-4dannjjm	2697	3	and	and	CC
cord-023095-4dannjjm	2697	4	CRP	CRP	NNP
cord-023095-4dannjjm	2697	5	(	(	-LRB-
cord-023095-4dannjjm	2697	6	reference	reference	NN
cord-023095-4dannjjm	2697	7	interval	interval	NN
cord-023095-4dannjjm	2697	8	(	(	-LRB-
cord-023095-4dannjjm	2697	9	RI	RI	NNP
cord-023095-4dannjjm	2697	10	)	)	-RRB-
cord-023095-4dannjjm	2697	11	:	:	:
cord-023095-4dannjjm	2697	12	0.0	0.0	CD
cord-023095-4dannjjm	2697	13	-	-	SYM
cord-023095-4dannjjm	2697	14	7.6	7.6	CD
cord-023095-4dannjjm	2697	15	mg	mg	NNP
cord-023095-4dannjjm	2697	16	/	/	SYM
cord-023095-4dannjjm	2697	17	L	L	NNP
cord-023095-4dannjjm	2697	18	)	)	-RRB-
cord-023095-4dannjjm	2697	19	were	be	VBD
cord-023095-4dannjjm	2697	20	quantified	quantify	VBN
cord-023095-4dannjjm	2697	21	by	by	IN
cord-023095-4dannjjm	2697	22	using	use	VBG
cord-023095-4dannjjm	2697	23	commercial	commercial	JJ
cord-023095-4dannjjm	2697	24	ELISA	ELISA	NNP
cord-023095-4dannjjm	2697	25	kits	kit	NNS
cord-023095-4dannjjm	2697	26	(	(	-LRB-
cord-023095-4dannjjm	2697	27	Echelon	Echelon	NNP
cord-023095-4dannjjm	2697	28	Biosciences	Biosciences	NNP
cord-023095-4dannjjm	2697	29	,	,	,
cord-023095-4dannjjm	2697	30	Salt	Salt	NNP
cord-023095-4dannjjm	2697	31	Lake	Lake	NNP
cord-023095-4dannjjm	2697	32	City	City	NNP
cord-023095-4dannjjm	2697	33	,	,	,
cord-023095-4dannjjm	2697	34	UT	UT	NNP
cord-023095-4dannjjm	2697	35	,	,	,
cord-023095-4dannjjm	2697	36	USA	USA	NNP
cord-023095-4dannjjm	2697	37	and	and	CC
cord-023095-4dannjjm	2697	38	Tridelta	Tridelta	NNP
cord-023095-4dannjjm	2697	39	,	,	,
cord-023095-4dannjjm	2697	40	Maynooth	Maynooth	NNP
cord-023095-4dannjjm	2697	41	,	,	,
cord-023095-4dannjjm	2697	42	Ireland	Ireland	NNP
cord-023095-4dannjjm	2697	43	;	;	:
cord-023095-4dannjjm	2697	44	respectively	respectively	RB
cord-023095-4dannjjm	2697	45	)	)	-RRB-
cord-023095-4dannjjm	2697	46	.	.	.
cord-023095-4dannjjm	2698	1	Serum	serum	NN
cord-023095-4dannjjm	2698	2	calgranulin	calgranulin	NN
cord-023095-4dannjjm	2698	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2698	4	were	be	VBD
cord-023095-4dannjjm	2698	5	measured	measure	VBN
cord-023095-4dannjjm	2698	6	using	use	VBG
cord-023095-4dannjjm	2698	7	an	an	DT
cord-023095-4dannjjm	2698	8	in	in	IN
cord-023095-4dannjjm	2698	9	-	-	HYPH
cord-023095-4dannjjm	2698	10	house	house	NN
cord-023095-4dannjjm	2698	11	ELISA	ELISA	NNP
cord-023095-4dannjjm	2698	12	(	(	-LRB-
cord-023095-4dannjjm	2698	13	calprotectin	calprotectin	NNP
cord-023095-4dannjjm	2698	14	;	;	:
cord-023095-4dannjjm	2698	15	RI	RI	NNP
cord-023095-4dannjjm	2698	16	:	:	:
cord-023095-4dannjjm	2698	17	0.9	0.9	CD
cord-023095-4dannjjm	2698	18	-	-	SYM
cord-023095-4dannjjm	2698	19	11.9	11.9	CD
cord-023095-4dannjjm	2698	20	mg	mg	NNP
cord-023095-4dannjjm	2698	21	/	/	SYM
cord-023095-4dannjjm	2698	22	L	L	NNP
cord-023095-4dannjjm	2698	23	)	)	-RRB-
cord-023095-4dannjjm	2698	24	and	and	CC
cord-023095-4dannjjm	2698	25	RIA	RIA	NNP
cord-023095-4dannjjm	2698	26	(	(	-LRB-
cord-023095-4dannjjm	2698	27	S100A12	s100a12	NN
cord-023095-4dannjjm	2698	28	;	;	:
cord-023095-4dannjjm	2698	29	RI	RI	NNP
cord-023095-4dannjjm	2698	30	:	:	:
cord-023095-4dannjjm	2698	31	33.0	33.0	CD
cord-023095-4dannjjm	2698	32	-	-	SYM
cord-023095-4dannjjm	2698	33	233.0	233.0	CD
cord-023095-4dannjjm	2698	34	mg	mg	NNP
cord-023095-4dannjjm	2698	35	/	/	SYM
cord-023095-4dannjjm	2698	36	L	L	NNP
cord-023095-4dannjjm	2698	37	)	)	-RRB-
cord-023095-4dannjjm	2698	38	,	,	,
cord-023095-4dannjjm	2698	39	respectively	respectively	RB
cord-023095-4dannjjm	2698	40	.	.	.
cord-023095-4dannjjm	2699	1	Mann	Mann	NNP
cord-023095-4dannjjm	2699	2	-	-	HYPH
cord-023095-4dannjjm	2699	3	Whitney	Whitney	NNP
cord-023095-4dannjjm	2699	4	U	U	NNP
cord-023095-4dannjjm	2699	5	tests	test	NNS
cord-023095-4dannjjm	2699	6	were	be	VBD
cord-023095-4dannjjm	2699	7	used	use	VBN
cord-023095-4dannjjm	2699	8	to	to	TO
cord-023095-4dannjjm	2699	9	compare	compare	VB
cord-023095-4dannjjm	2699	10	serum	serum	NN
cord-023095-4dannjjm	2699	11	HA	HA	NNP
cord-023095-4dannjjm	2699	12	,	,	,
cord-023095-4dannjjm	2699	13	CRP	CRP	NNP
cord-023095-4dannjjm	2699	14	,	,	,
cord-023095-4dannjjm	2699	15	calprotectin	calprotectin	NNP
cord-023095-4dannjjm	2699	16	,	,	,
cord-023095-4dannjjm	2699	17	and	and	CC
cord-023095-4dannjjm	2699	18	S100A12	s100a12	NN
cord-023095-4dannjjm	2699	19	concentrations	concentration	NNS
cord-023095-4dannjjm	2699	20	between	between	IN
cord-023095-4dannjjm	2699	21	Shar	Shar	NNP
cord-023095-4dannjjm	2699	22	Peis	Peis	NNP
cord-023095-4dannjjm	2699	23	with	with	IN
cord-023095-4dannjjm	2699	24	and	and	CC
cord-023095-4dannjjm	2699	25	without	without	IN
cord-023095-4dannjjm	2699	26	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2699	27	deficiency	deficiency	NN
cord-023095-4dannjjm	2699	28	.	.	.
cord-023095-4dannjjm	2700	1	Significance	significance	NN
cord-023095-4dannjjm	2700	2	was	be	VBD
cord-023095-4dannjjm	2700	3	set	set	VBN
cord-023095-4dannjjm	2700	4	at	at	IN
cord-023095-4dannjjm	2700	5	p	p	NN
cord-023095-4dannjjm	2700	6	o	o	NN
cord-023095-4dannjjm	2700	7	0.05	0.05	CD
cord-023095-4dannjjm	2700	8	.	.	.
cord-023095-4dannjjm	2701	1	Fourteen	fourteen	CD
cord-023095-4dannjjm	2701	2	Shar	Shar	NNP
cord-023095-4dannjjm	2701	3	Peis	Peis	NNP
cord-023095-4dannjjm	2701	4	were	be	VBD
cord-023095-4dannjjm	2701	5	severely	severely	RB
cord-023095-4dannjjm	2701	6	cobalamin	cobalamin	JJ
cord-023095-4dannjjm	2701	7	deficient	deficient	JJ
cord-023095-4dannjjm	2701	8	,	,	,
cord-023095-4dannjjm	2701	9	defined	define	VBN
cord-023095-4dannjjm	2701	10	by	by	IN
cord-023095-4dannjjm	2701	11	an	an	DT
cord-023095-4dannjjm	2701	12	undetectable	undetectable	JJ
cord-023095-4dannjjm	2701	13	serum	serum	NN
cord-023095-4dannjjm	2701	14	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2701	15	concentration	concentration	NN
cord-023095-4dannjjm	2701	16	(	(	-LRB-
cord-023095-4dannjjm	2701	17	o	o	UH
cord-023095-4dannjjm	2701	18	150	150	CD
cord-023095-4dannjjm	2701	19	ng	ng	NN
cord-023095-4dannjjm	2701	20	/	/	SYM
cord-023095-4dannjjm	2701	21	L	L	NNP
cord-023095-4dannjjm	2701	22	)	)	-RRB-
cord-023095-4dannjjm	2701	23	.	.	.
cord-023095-4dannjjm	2702	1	In	in	IN
cord-023095-4dannjjm	2702	2	the	the	DT
cord-023095-4dannjjm	2702	3	remaining	remain	VBG
cord-023095-4dannjjm	2702	4	26	26	CD
cord-023095-4dannjjm	2702	5	dogs	dog	NNS
cord-023095-4dannjjm	2702	6	,	,	,
cord-023095-4dannjjm	2702	7	serum	serum	NN
cord-023095-4dannjjm	2702	8	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2702	9	concentrations	concentration	NNS
cord-023095-4dannjjm	2702	10	were	be	VBD
cord-023095-4dannjjm	2702	11	within	within	IN
cord-023095-4dannjjm	2702	12	the	the	DT
cord-023095-4dannjjm	2702	13	reference	reference	NN
cord-023095-4dannjjm	2702	14	interval	interval	NN
cord-023095-4dannjjm	2702	15	(	(	-LRB-
cord-023095-4dannjjm	2702	16	251	251	CD
cord-023095-4dannjjm	2702	17	-	-	SYM
cord-023095-4dannjjm	2702	18	908	908	CD
cord-023095-4dannjjm	2702	19	ng	ng	NNP
cord-023095-4dannjjm	2702	20	/	/	SYM
cord-023095-4dannjjm	2702	21	L	L	NNP
cord-023095-4dannjjm	2702	22	)	)	-RRB-
cord-023095-4dannjjm	2702	23	.	.	.
cord-023095-4dannjjm	2703	1	Serum	serum	NN
cord-023095-4dannjjm	2703	2	concentrations	concentration	NNS
cord-023095-4dannjjm	2703	3	of	of	IN
cord-023095-4dannjjm	2703	4	HA	HA	NNP
cord-023095-4dannjjm	2703	5	,	,	,
cord-023095-4dannjjm	2703	6	CRP	CRP	NNP
cord-023095-4dannjjm	2703	7	,	,	,
cord-023095-4dannjjm	2703	8	calprotectin	calprotectin	NNP
cord-023095-4dannjjm	2703	9	,	,	,
cord-023095-4dannjjm	2703	10	and	and	CC
cord-023095-4dannjjm	2703	11	S100A12	S100A12	NNS
cord-023095-4dannjjm	2703	12	were	be	VBD
cord-023095-4dannjjm	2703	13	not	not	RB
cord-023095-4dannjjm	2703	14	significantly	significantly	RB
cord-023095-4dannjjm	2703	15	different	different	JJ
cord-023095-4dannjjm	2703	16	between	between	IN
cord-023095-4dannjjm	2703	17	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2703	18	deficient	deficient	JJ
cord-023095-4dannjjm	2703	19	Shar	Shar	NNP
cord-023095-4dannjjm	2703	20	Peis	Peis	NNP
cord-023095-4dannjjm	2703	21	(	(	-LRB-
cord-023095-4dannjjm	2703	22	medians	median	NNS
cord-023095-4dannjjm	2703	23	:	:	:
cord-023095-4dannjjm	2703	24	649.9	649.9	CD
cord-023095-4dannjjm	2703	25	ng	ng	NN
cord-023095-4dannjjm	2703	26	/	/	SYM
cord-023095-4dannjjm	2703	27	ml	ml	NN
cord-023095-4dannjjm	2703	28	,	,	,
cord-023095-4dannjjm	2703	29	4	4	CD
cord-023095-4dannjjm	2703	30	.	.	.
cord-023095-4dannjjm	2703	31	.	.	.
cord-023095-4dannjjm	2704	1	Fifty	fifty	CD
cord-023095-4dannjjm	2704	2	percent	percent	NN
cord-023095-4dannjjm	2704	3	of	of	IN
cord-023095-4dannjjm	2704	4	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2704	5	deficient	deficient	JJ
cord-023095-4dannjjm	2704	6	Shar	Shar	NNP
cord-023095-4dannjjm	2704	7	Peis	Peis	NNP
cord-023095-4dannjjm	2704	8	had	have	VBD
cord-023095-4dannjjm	2704	9	serum	serum	NN
cord-023095-4dannjjm	2704	10	calprotectin	calprotectin	NN
cord-023095-4dannjjm	2704	11	concentrations	concentration	NNS
cord-023095-4dannjjm	2704	12	above	above	IN
cord-023095-4dannjjm	2704	13	the	the	DT
cord-023095-4dannjjm	2704	14	upper	upper	JJ
cord-023095-4dannjjm	2704	15	limit	limit	NN
cord-023095-4dannjjm	2704	16	of	of	IN
cord-023095-4dannjjm	2704	17	the	the	DT
cord-023095-4dannjjm	2704	18	reference	reference	NN
cord-023095-4dannjjm	2704	19	interval	interval	NN
cord-023095-4dannjjm	2704	20	,	,	,
cord-023095-4dannjjm	2704	21	and	and	CC
cord-023095-4dannjjm	2704	22	43	43	CD
cord-023095-4dannjjm	2704	23	%	%	NN
cord-023095-4dannjjm	2704	24	had	have	VBD
cord-023095-4dannjjm	2704	25	serum	serum	NN
cord-023095-4dannjjm	2704	26	S100A12	s100a12	NN
cord-023095-4dannjjm	2704	27	concentrations	concentration	NNS
cord-023095-4dannjjm	2704	28	above	above	IN
cord-023095-4dannjjm	2704	29	the	the	DT
cord-023095-4dannjjm	2704	30	suggested	suggest	VBN
cord-023095-4dannjjm	2704	31	upper	upper	JJ
cord-023095-4dannjjm	2704	32	reference	reference	NN
cord-023095-4dannjjm	2704	33	limit	limit	NN
cord-023095-4dannjjm	2704	34	.	.	.
cord-023095-4dannjjm	2705	1	In	in	IN
cord-023095-4dannjjm	2705	2	this	this	DT
cord-023095-4dannjjm	2705	3	study	study	NN
cord-023095-4dannjjm	2705	4	,	,	,
cord-023095-4dannjjm	2705	5	serum	serum	NN
cord-023095-4dannjjm	2705	6	concentrations	concentration	NNS
cord-023095-4dannjjm	2705	7	of	of	IN
cord-023095-4dannjjm	2705	8	HA	HA	NNP
cord-023095-4dannjjm	2705	9	,	,	,
cord-023095-4dannjjm	2705	10	CRP	CRP	NNP
cord-023095-4dannjjm	2705	11	,	,	,
cord-023095-4dannjjm	2705	12	and	and	CC
cord-023095-4dannjjm	2705	13	the	the	DT
cord-023095-4dannjjm	2705	14	calgranulins	calgranulin	NNS
cord-023095-4dannjjm	2705	15	did	do	VBD
cord-023095-4dannjjm	2705	16	not	not	RB
cord-023095-4dannjjm	2705	17	differ	differ	VB
cord-023095-4dannjjm	2705	18	between	between	IN
cord-023095-4dannjjm	2705	19	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2705	20	deficient	deficient	JJ
cord-023095-4dannjjm	2705	21	Shar	Shar	NNP
cord-023095-4dannjjm	2705	22	Peis	Peis	NNP
cord-023095-4dannjjm	2705	23	and	and	CC
cord-023095-4dannjjm	2705	24	Shar	Shar	NNP
cord-023095-4dannjjm	2705	25	Peis	Peis	NNP
cord-023095-4dannjjm	2705	26	with	with	IN
cord-023095-4dannjjm	2705	27	a	a	DT
cord-023095-4dannjjm	2705	28	normal	normal	JJ
cord-023095-4dannjjm	2705	29	serum	serum	NN
cord-023095-4dannjjm	2705	30	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2705	31	concentration	concentration	NN
cord-023095-4dannjjm	2705	32	.	.	.
cord-023095-4dannjjm	2706	1	This	this	DT
cord-023095-4dannjjm	2706	2	finding	finding	NN
cord-023095-4dannjjm	2706	3	leads	lead	VBZ
cord-023095-4dannjjm	2706	4	us	-PRON-	PRP
cord-023095-4dannjjm	2706	5	to	to	TO
cord-023095-4dannjjm	2706	6	speculate	speculate	VB
cord-023095-4dannjjm	2706	7	that	that	IN
cord-023095-4dannjjm	2706	8	increased	increase	VBD
cord-023095-4dannjjm	2706	9	HA	HA	NNP
cord-023095-4dannjjm	2706	10	and/or	and/or	CC
cord-023095-4dannjjm	2706	11	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2706	12	markers	marker	NNS
cord-023095-4dannjjm	2706	13	are	be	VBP
cord-023095-4dannjjm	2706	14	not	not	RB
cord-023095-4dannjjm	2706	15	associated	associate	VBN
cord-023095-4dannjjm	2706	16	with	with	IN
cord-023095-4dannjjm	2706	17	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2706	18	deficiency	deficiency	NN
cord-023095-4dannjjm	2706	19	in	in	IN
cord-023095-4dannjjm	2706	20	Shar	Shar	NNP
cord-023095-4dannjjm	2706	21	Peis	Peis	NNP
cord-023095-4dannjjm	2706	22	.	.	.
cord-023095-4dannjjm	2707	1	Further	further	JJ
cord-023095-4dannjjm	2707	2	studies	study	NNS
cord-023095-4dannjjm	2707	3	are	be	VBP
cord-023095-4dannjjm	2707	4	needed	need	VBN
cord-023095-4dannjjm	2707	5	to	to	TO
cord-023095-4dannjjm	2707	6	investigate	investigate	VB
cord-023095-4dannjjm	2707	7	serum	serum	NN
cord-023095-4dannjjm	2707	8	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2707	9	concentrations	concentration	NNS
cord-023095-4dannjjm	2707	10	in	in	IN
cord-023095-4dannjjm	2707	11	patients	patient	NNS
cord-023095-4dannjjm	2707	12	with	with	IN
cord-023095-4dannjjm	2707	13	Shar	Shar	NNP
cord-023095-4dannjjm	2707	14	Pei	Pei	NNP
cord-023095-4dannjjm	2707	15	fever	fever	NN
cord-023095-4dannjjm	2707	16	or	or	CC
cord-023095-4dannjjm	2707	17	cutaneous	cutaneous	JJ
cord-023095-4dannjjm	2707	18	mucinosis	mucinosis	NN
cord-023095-4dannjjm	2707	19	.	.	.
cord-023095-4dannjjm	2708	1	Cobalamin	Cobalamin	NNP
cord-023095-4dannjjm	2708	2	deficiency	deficiency	NN
cord-023095-4dannjjm	2708	3	(	(	-LRB-
cord-023095-4dannjjm	2708	4	CD	CD	NNP
cord-023095-4dannjjm	2708	5	)	)	-RRB-
cord-023095-4dannjjm	2708	6	has	have	VBZ
cord-023095-4dannjjm	2708	7	been	be	VBN
cord-023095-4dannjjm	2708	8	associated	associate	VBN
cord-023095-4dannjjm	2708	9	with	with	IN
cord-023095-4dannjjm	2708	10	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2708	11	and	and	CC
cord-023095-4dannjjm	2708	12	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	2708	13	disease	disease	NN
cord-023095-4dannjjm	2708	14	in	in	IN
cord-023095-4dannjjm	2708	15	dogs	dog	NNS
cord-023095-4dannjjm	2708	16	.	.	.
cord-023095-4dannjjm	2709	1	Hereditary	hereditary	JJ
cord-023095-4dannjjm	2709	2	CD	CD	NNP
cord-023095-4dannjjm	2709	3	has	have	VBZ
cord-023095-4dannjjm	2709	4	been	be	VBN
cord-023095-4dannjjm	2709	5	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	2709	6	in	in	IN
cord-023095-4dannjjm	2709	7	Giant	Giant	NNP
cord-023095-4dannjjm	2709	8	Schnauzers	Schnauzers	NNPS
cord-023095-4dannjjm	2709	9	and	and	CC
cord-023095-4dannjjm	2710	1	single	single	JJ
cord-023095-4dannjjm	2710	2	case	case	NN
cord-023095-4dannjjm	2710	3	reports	report	NNS
cord-023095-4dannjjm	2710	4	have	have	VBP
cord-023095-4dannjjm	2710	5	suggested	suggest	VBN
cord-023095-4dannjjm	2710	6	congenital	congenital	JJ
cord-023095-4dannjjm	2710	7	CD	cd	NN
cord-023095-4dannjjm	2710	8	in	in	IN
cord-023095-4dannjjm	2710	9	the	the	DT
cord-023095-4dannjjm	2710	10	Border	Border	NNP
cord-023095-4dannjjm	2710	11	Collie	Collie	NNP
cord-023095-4dannjjm	2710	12	(	(	-LRB-
cord-023095-4dannjjm	2710	13	BC	BC	NNP
cord-023095-4dannjjm	2710	14	)	)	-RRB-
cord-023095-4dannjjm	2710	15	breed	breed	NN
cord-023095-4dannjjm	2710	16	.	.	.
cord-023095-4dannjjm	2711	1	Clinicopathologic	Clinicopathologic	NNP
cord-023095-4dannjjm	2711	2	findings	finding	NNS
cord-023095-4dannjjm	2711	3	of	of	IN
cord-023095-4dannjjm	2711	4	CD	CD	NNP
cord-023095-4dannjjm	2711	5	vary	vary	VBP
cord-023095-4dannjjm	2711	6	and	and	CC
cord-023095-4dannjjm	2711	7	can	can	MD
cord-023095-4dannjjm	2711	8	be	be	VB
cord-023095-4dannjjm	2711	9	unspecific	unspecific	JJ
cord-023095-4dannjjm	2711	10	as	as	IN
cord-023095-4dannjjm	2711	11	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2711	12	acts	act	VBZ
cord-023095-4dannjjm	2711	13	as	as	IN
cord-023095-4dannjjm	2711	14	a	a	DT
cord-023095-4dannjjm	2711	15	Co	co	NN
cord-023095-4dannjjm	2711	16	-	-	NN
cord-023095-4dannjjm	2711	17	Factor	factor	NN
cord-023095-4dannjjm	2711	18	for	for	IN
cord-023095-4dannjjm	2711	19	a	a	DT
cord-023095-4dannjjm	2711	20	multitude	multitude	NN
cord-023095-4dannjjm	2711	21	of	of	IN
cord-023095-4dannjjm	2711	22	enzymatic	enzymatic	JJ
cord-023095-4dannjjm	2711	23	reactions	reaction	NNS
cord-023095-4dannjjm	2711	24	.	.	.
cord-023095-4dannjjm	2712	1	The	the	DT
cord-023095-4dannjjm	2712	2	two	two	CD
cord-023095-4dannjjm	2712	3	most	most	RBS
cord-023095-4dannjjm	2712	4	important	important	JJ
cord-023095-4dannjjm	2712	5	reactions	reaction	NNS
cord-023095-4dannjjm	2712	6	concern	concern	VBP
cord-023095-4dannjjm	2712	7	the	the	DT
cord-023095-4dannjjm	2712	8	conversion	conversion	NN
cord-023095-4dannjjm	2712	9	of	of	IN
cord-023095-4dannjjm	2712	10	methylmalonyl	methylmalonyl	NNP
cord-023095-4dannjjm	2712	11	-	-	HYPH
cord-023095-4dannjjm	2712	12	CoA	CoA	NNP
cord-023095-4dannjjm	2712	13	to	to	IN
cord-023095-4dannjjm	2712	14	succinyl	succinyl	NNP
cord-023095-4dannjjm	2712	15	-	-	HYPH
cord-023095-4dannjjm	2712	16	CoA	CoA	NNP
cord-023095-4dannjjm	2712	17	and	and	CC
cord-023095-4dannjjm	2712	18	the	the	DT
cord-023095-4dannjjm	2712	19	re	re	NN
cord-023095-4dannjjm	2712	20	-	-	NN
cord-023095-4dannjjm	2712	21	methylation	methylation	NN
cord-023095-4dannjjm	2712	22	of	of	IN
cord-023095-4dannjjm	2712	23	homocysteine	homocysteine	NN
cord-023095-4dannjjm	2712	24	(	(	-LRB-
cord-023095-4dannjjm	2712	25	Hcy	Hcy	NNP
cord-023095-4dannjjm	2712	26	)	)	-RRB-
cord-023095-4dannjjm	2712	27	.	.	.
cord-023095-4dannjjm	2713	1	These	these	DT
cord-023095-4dannjjm	2713	2	two	two	CD
cord-023095-4dannjjm	2713	3	metabolites	metabolite	NNS
cord-023095-4dannjjm	2713	4	increase	increase	VBP
cord-023095-4dannjjm	2713	5	when	when	WRB
cord-023095-4dannjjm	2713	6	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2713	7	is	be	VBZ
cord-023095-4dannjjm	2713	8	lacking	lack	VBG
cord-023095-4dannjjm	2713	9	and	and	CC
cord-023095-4dannjjm	2713	10	act	act	VB
cord-023095-4dannjjm	2713	11	as	as	IN
cord-023095-4dannjjm	2713	12	markers	marker	NNS
cord-023095-4dannjjm	2713	13	for	for	IN
cord-023095-4dannjjm	2713	14	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2713	15	availability	availability	NN
cord-023095-4dannjjm	2713	16	on	on	IN
cord-023095-4dannjjm	2713	17	a	a	DT
cord-023095-4dannjjm	2713	18	cellular	cellular	JJ
cord-023095-4dannjjm	2713	19	level	level	NN
cord-023095-4dannjjm	2713	20	.	.	.
cord-023095-4dannjjm	2714	1	Preliminary	preliminary	JJ
cord-023095-4dannjjm	2714	2	data	datum	NNS
cord-023095-4dannjjm	2714	3	from	from	IN
cord-023095-4dannjjm	2714	4	dogs	dog	NNS
cord-023095-4dannjjm	2714	5	suggested	suggest	VBD
cord-023095-4dannjjm	2714	6	that	that	IN
cord-023095-4dannjjm	2714	7	measurement	measurement	NN
cord-023095-4dannjjm	2714	8	of	of	IN
cord-023095-4dannjjm	2714	9	methylmalonic	methylmalonic	NNP
cord-023095-4dannjjm	2714	10	acid	acid	NNP
cord-023095-4dannjjm	2714	11	(	(	-LRB-
cord-023095-4dannjjm	2714	12	MMA	MMA	NNP
cord-023095-4dannjjm	2714	13	)	)	-RRB-
cord-023095-4dannjjm	2714	14	may	may	MD
cord-023095-4dannjjm	2714	15	be	be	VB
cord-023095-4dannjjm	2714	16	a	a	DT
cord-023095-4dannjjm	2714	17	better	well	RBR
cord-023095-4dannjjm	2714	18	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	2714	19	test	test	NN
cord-023095-4dannjjm	2714	20	for	for	IN
cord-023095-4dannjjm	2714	21	CD	CD	NNP
cord-023095-4dannjjm	2714	22	than	than	IN
cord-023095-4dannjjm	2714	23	serum	serum	NN
cord-023095-4dannjjm	2714	24	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2714	25	concentration	concentration	NN
cord-023095-4dannjjm	2714	26	.	.	.
cord-023095-4dannjjm	2715	1	Therefore	therefore	RB
cord-023095-4dannjjm	2715	2	the	the	DT
cord-023095-4dannjjm	2715	3	goals	goal	NNS
cord-023095-4dannjjm	2715	4	of	of	IN
cord-023095-4dannjjm	2715	5	the	the	DT
cord-023095-4dannjjm	2715	6	study	study	NN
cord-023095-4dannjjm	2715	7	were	be	VBD
cord-023095-4dannjjm	2715	8	(	(	-LRB-
cord-023095-4dannjjm	2715	9	1	1	CD
cord-023095-4dannjjm	2715	10	)	)	-RRB-
cord-023095-4dannjjm	2715	11	to	to	TO
cord-023095-4dannjjm	2715	12	establish	establish	VB
cord-023095-4dannjjm	2715	13	reference	reference	NN
cord-023095-4dannjjm	2715	14	values	value	NNS
cord-023095-4dannjjm	2715	15	for	for	IN
cord-023095-4dannjjm	2715	16	serum	serum	NN
cord-023095-4dannjjm	2715	17	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2715	18	,	,	,
cord-023095-4dannjjm	2715	19	urine	urine	NN
cord-023095-4dannjjm	2715	20	MMA	MMA	NNP
cord-023095-4dannjjm	2715	21	and	and	CC
cord-023095-4dannjjm	2715	22	plasma	plasma	NN
cord-023095-4dannjjm	2715	23	Hcy	Hcy	NNP
cord-023095-4dannjjm	2715	24	in	in	IN
cord-023095-4dannjjm	2715	25	healthy	healthy	JJ
cord-023095-4dannjjm	2715	26	pet	pet	JJ
cord-023095-4dannjjm	2715	27	dogs	dog	NNS
cord-023095-4dannjjm	2715	28	,	,	,
cord-023095-4dannjjm	2715	29	(	(	-LRB-
cord-023095-4dannjjm	2715	30	2	2	LS
cord-023095-4dannjjm	2715	31	)	)	-RRB-
cord-023095-4dannjjm	2715	32	to	to	TO
cord-023095-4dannjjm	2715	33	screen	screen	VB
cord-023095-4dannjjm	2715	34	a	a	DT
cord-023095-4dannjjm	2715	35	larger	large	JJR
cord-023095-4dannjjm	2715	36	BC	BC	NNP
cord-023095-4dannjjm	2715	37	population	population	NN
cord-023095-4dannjjm	2715	38	from	from	IN
cord-023095-4dannjjm	2715	39	Switzerland	Switzerland	NNP
cord-023095-4dannjjm	2715	40	for	for	IN
cord-023095-4dannjjm	2715	41	CD	CD	NNP
cord-023095-4dannjjm	2715	42	,	,	,
cord-023095-4dannjjm	2715	43	and	and	CC
cord-023095-4dannjjm	2715	44	(	(	-LRB-
cord-023095-4dannjjm	2715	45	3	3	LS
cord-023095-4dannjjm	2715	46	)	)	-RRB-
cord-023095-4dannjjm	2715	47	to	to	TO
cord-023095-4dannjjm	2715	48	perform	perform	VB
cord-023095-4dannjjm	2715	49	genomic	genomic	JJ
cord-023095-4dannjjm	2715	50	analyses	analysis	NNS
cord-023095-4dannjjm	2715	51	on	on	IN
cord-023095-4dannjjm	2715	52	BC	BC	NNP
cord-023095-4dannjjm	2715	53	with	with	IN
cord-023095-4dannjjm	2715	54	CD	CD	NNP
cord-023095-4dannjjm	2715	55	.	.	.
cord-023095-4dannjjm	2716	1	For	for	IN
cord-023095-4dannjjm	2716	2	determination	determination	NN
cord-023095-4dannjjm	2716	3	of	of	IN
cord-023095-4dannjjm	2716	4	reference	reference	NN
cord-023095-4dannjjm	2716	5	values	value	NNS
cord-023095-4dannjjm	2716	6	35	35	CD
cord-023095-4dannjjm	2716	7	healthy	healthy	JJ
cord-023095-4dannjjm	2716	8	pet	pet	JJ
cord-023095-4dannjjm	2716	9	dogs	dog	NNS
cord-023095-4dannjjm	2716	10	were	be	VBD
cord-023095-4dannjjm	2716	11	used	use	VBN
cord-023095-4dannjjm	2716	12	.	.	.
cord-023095-4dannjjm	2717	1	Serum	serum	NN
cord-023095-4dannjjm	2717	2	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2717	3	was	be	VBD
cord-023095-4dannjjm	2717	4	measured	measure	VBN
cord-023095-4dannjjm	2717	5	using	use	VBG
cord-023095-4dannjjm	2717	6	an	an	DT
cord-023095-4dannjjm	2717	7	automated	automate	VBN
cord-023095-4dannjjm	2717	8	chemiluminescence	chemiluminescence	NN
cord-023095-4dannjjm	2717	9	assay	assay	NN
cord-023095-4dannjjm	2717	10	(	(	-LRB-
cord-023095-4dannjjm	2717	11	Immulite	Immulite	NNP
cord-023095-4dannjjm	2717	12	2000	2000	CD
cord-023095-4dannjjm	2717	13	)	)	-RRB-
cord-023095-4dannjjm	2717	14	,	,	,
cord-023095-4dannjjm	2717	15	urine	urine	NN
cord-023095-4dannjjm	2717	16	MMA	MMA	NNP
cord-023095-4dannjjm	2717	17	was	be	VBD
cord-023095-4dannjjm	2717	18	determined	determine	VBN
cord-023095-4dannjjm	2717	19	using	use	VBG
cord-023095-4dannjjm	2717	20	gas	gas	NN
cord-023095-4dannjjm	2717	21	chromatography	chromatography	NN
cord-023095-4dannjjm	2717	22	and	and	CC
cord-023095-4dannjjm	2717	23	expressed	express	VBD
cord-023095-4dannjjm	2717	24	as	as	IN
cord-023095-4dannjjm	2717	25	a	a	DT
cord-023095-4dannjjm	2717	26	ratio	ratio	NN
cord-023095-4dannjjm	2717	27	to	to	TO
cord-023095-4dannjjm	2717	28	urine	urine	NN
cord-023095-4dannjjm	2717	29	creatinine	creatinine	NN
cord-023095-4dannjjm	2717	30	and	and	CC
cord-023095-4dannjjm	2718	1	plasma	plasma	NNP
cord-023095-4dannjjm	2718	2	Hcy	Hcy	NNP
cord-023095-4dannjjm	2718	3	was	be	VBD
cord-023095-4dannjjm	2718	4	measured	measure	VBN
cord-023095-4dannjjm	2718	5	using	use	VBG
cord-023095-4dannjjm	2718	6	High	High	NNP
cord-023095-4dannjjm	2718	7	Pressure	Pressure	NNP
cord-023095-4dannjjm	2718	8	Liquid	Liquid	NNP
cord-023095-4dannjjm	2718	9	Chromatography	Chromatography	NNP
cord-023095-4dannjjm	2718	10	and	and	CC
cord-023095-4dannjjm	2718	11	fluorimetric	fluorimetric	JJ
cord-023095-4dannjjm	2718	12	detection	detection	NN
cord-023095-4dannjjm	2718	13	.	.	.
cord-023095-4dannjjm	2719	1	To	to	TO
cord-023095-4dannjjm	2719	2	calculate	calculate	VB
cord-023095-4dannjjm	2719	3	reference	reference	NN
cord-023095-4dannjjm	2719	4	ranges	range	VBZ
cord-023095-4dannjjm	2719	5	the	the	DT
cord-023095-4dannjjm	2719	6	10th	10th	JJ
cord-023095-4dannjjm	2719	7	and	and	CC
cord-023095-4dannjjm	2719	8	90th	90th	JJ
cord-023095-4dannjjm	2719	9	percentile	percentile	NN
cord-023095-4dannjjm	2719	10	were	be	VBD
cord-023095-4dannjjm	2719	11	used	use	VBN
cord-023095-4dannjjm	2719	12	.	.	.
cord-023095-4dannjjm	2720	1	Data	datum	NNS
cord-023095-4dannjjm	2720	2	were	be	VBD
cord-023095-4dannjjm	2720	3	analyzed	analyze	VBN
cord-023095-4dannjjm	2720	4	using	use	VBG
cord-023095-4dannjjm	2720	5	non	non	JJ
cord-023095-4dannjjm	2720	6	-	-	JJ
cord-023095-4dannjjm	2720	7	parametric	parametric	JJ
cord-023095-4dannjjm	2720	8	tests	test	NNS
cord-023095-4dannjjm	2720	9	.	.	.
cord-023095-4dannjjm	2721	1	Reference	reference	NN
cord-023095-4dannjjm	2721	2	ranges	range	VBZ
cord-023095-4dannjjm	2721	3	for	for	IN
cord-023095-4dannjjm	2721	4	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2721	5	,	,	,
cord-023095-4dannjjm	2721	6	Hcy	Hcy	NNP
cord-023095-4dannjjm	2721	7	,	,	,
cord-023095-4dannjjm	2721	8	and	and	CC
cord-023095-4dannjjm	2721	9	MMA	MMA	NNP
cord-023095-4dannjjm	2721	10	were	be	VBD
cord-023095-4dannjjm	2721	11	:	:	:
cord-023095-4dannjjm	2721	12	cobalamin	cobalamin	VB
cord-023095-4dannjjm	2721	13	279.2	279.2	CD
cord-023095-4dannjjm	2721	14	-	-	HYPH
cord-023095-4dannjjm	2721	15	972.8	972.8	CD
cord-023095-4dannjjm	2721	16	ng	ng	NN
cord-023095-4dannjjm	2721	17	/	/	SYM
cord-023095-4dannjjm	2721	18	L	l	NN
cord-023095-4dannjjm	2721	19	;	;	:
cord-023095-4dannjjm	2722	1	urine	urine	NNP
cord-023095-4dannjjm	2722	2	MMA	MMA	NNP
cord-023095-4dannjjm	2722	3	2	2	CD
cord-023095-4dannjjm	2722	4	-	-	SYM
cord-023095-4dannjjm	2722	5	4.65	4.65	CD
cord-023095-4dannjjm	2722	6	mmol	mmol	JJ
cord-023095-4dannjjm	2722	7	/	/	SYM
cord-023095-4dannjjm	2722	8	mol	mol	NN
cord-023095-4dannjjm	2722	9	creatinine	creatinine	NN
cord-023095-4dannjjm	2722	10	;	;	:
cord-023095-4dannjjm	2722	11	and	and	CC
cord-023095-4dannjjm	2722	12	plasma	plasma	NN
cord-023095-4dannjjm	2722	13	Hcy	Hcy	NNP
cord-023095-4dannjjm	2722	14	4.73	4.73	CD
cord-023095-4dannjjm	2722	15	-	-	HYPH
cord-023095-4dannjjm	2722	16	18.34	18.34	CD
cord-023095-4dannjjm	2722	17	mmol	mmol	NNP
cord-023095-4dannjjm	2722	18	/	/	SYM
cord-023095-4dannjjm	2722	19	L.	L.	NNP
cord-023095-4dannjjm	2723	1	The	the	DT
cord-023095-4dannjjm	2723	2	screened	screen	VBN
cord-023095-4dannjjm	2723	3	BC	BC	NNP
cord-023095-4dannjjm	2723	4	population	population	NN
cord-023095-4dannjjm	2723	5	comprised	comprise	VBD
cord-023095-4dannjjm	2723	6	113	113	CD
cord-023095-4dannjjm	2723	7	purebred	purebred	JJ
cord-023095-4dannjjm	2723	8	dogs	dog	NNS
cord-023095-4dannjjm	2723	9	and	and	CC
cord-023095-4dannjjm	2723	10	4	4	CD
cord-023095-4dannjjm	2723	11	BC	BC	NNP
cord-023095-4dannjjm	2723	12	(	(	-LRB-
cord-023095-4dannjjm	2723	13	median	median	JJ
cord-023095-4dannjjm	2723	14	11.5	11.5	CD
cord-023095-4dannjjm	2723	15	months	month	NNS
cord-023095-4dannjjm	2723	16	;	;	:
cord-023095-4dannjjm	2724	1	range	range	NNP
cord-023095-4dannjjm	2724	2	8	8	CD
cord-023095-4dannjjm	2724	3	-	-	SYM
cord-023095-4dannjjm	2724	4	41	41	CD
cord-023095-4dannjjm	2724	5	)	)	-RRB-
cord-023095-4dannjjm	2724	6	suffering	suffer	VBG
cord-023095-4dannjjm	2724	7	from	from	IN
cord-023095-4dannjjm	2724	8	congenital	congenital	JJ
cord-023095-4dannjjm	2724	9	CD	cd	NN
cord-023095-4dannjjm	2724	10	could	could	MD
cord-023095-4dannjjm	2724	11	be	be	VB
cord-023095-4dannjjm	2724	12	identified	identify	VBN
cord-023095-4dannjjm	2724	13	.	.	.
cord-023095-4dannjjm	2725	1	Clinical	clinical	JJ
cord-023095-4dannjjm	2725	2	signs	sign	NNS
cord-023095-4dannjjm	2725	3	differed	differ	VBD
cord-023095-4dannjjm	2725	4	and	and	CC
cord-023095-4dannjjm	2725	5	consisted	consist	VBD
cord-023095-4dannjjm	2725	6	of	of	IN
cord-023095-4dannjjm	2725	7	tiredness	tiredness	NN
cord-023095-4dannjjm	2725	8	(	(	-LRB-
cord-023095-4dannjjm	2725	9	4	4	CD
cord-023095-4dannjjm	2725	10	)	)	-RRB-
cord-023095-4dannjjm	2725	11	,	,	,
cord-023095-4dannjjm	2725	12	stunted	stunted	JJ
cord-023095-4dannjjm	2725	13	growth	growth	NN
cord-023095-4dannjjm	2725	14	(	(	-LRB-
cord-023095-4dannjjm	2725	15	4	4	CD
cord-023095-4dannjjm	2725	16	)	)	-RRB-
cord-023095-4dannjjm	2725	17	,	,	,
cord-023095-4dannjjm	2725	18	anemia	anemia	NN
cord-023095-4dannjjm	2725	19	(	(	-LRB-
cord-023095-4dannjjm	2725	20	3	3	CD
cord-023095-4dannjjm	2725	21	)	)	-RRB-
cord-023095-4dannjjm	2725	22	,	,	,
cord-023095-4dannjjm	2725	23	dysphagia	dysphagia	NNP
cord-023095-4dannjjm	2725	24	(	(	-LRB-
cord-023095-4dannjjm	2725	25	2	2	CD
cord-023095-4dannjjm	2725	26	)	)	-RRB-
cord-023095-4dannjjm	2725	27	and	and	CC
cord-023095-4dannjjm	2725	28	persistent	persistent	JJ
cord-023095-4dannjjm	2725	29	fever	fever	NN
cord-023095-4dannjjm	2725	30	(	(	-LRB-
cord-023095-4dannjjm	2725	31	1	1	CD
cord-023095-4dannjjm	2725	32	)	)	-RRB-
cord-023095-4dannjjm	2725	33	.	.	.
cord-023095-4dannjjm	2726	1	Median	median	JJ
cord-023095-4dannjjm	2726	2	(	(	-LRB-
cord-023095-4dannjjm	2726	3	ranges	range	NNS
cord-023095-4dannjjm	2726	4	)	)	-RRB-
cord-023095-4dannjjm	2726	5	results	result	NNS
cord-023095-4dannjjm	2726	6	for	for	IN
cord-023095-4dannjjm	2726	7	healthy	healthy	JJ
cord-023095-4dannjjm	2726	8	BC	BC	NNP
cord-023095-4dannjjm	2726	9	and	and	CC
cord-023095-4dannjjm	2726	10	BC	BC	NNP
cord-023095-4dannjjm	2726	11	with	with	IN
cord-023095-4dannjjm	2726	12	CD	CD	NNP
cord-023095-4dannjjm	2726	13	were	be	VBD
cord-023095-4dannjjm	2726	14	:	:	:
cord-023095-4dannjjm	2726	15	for	for	IN
cord-023095-4dannjjm	2726	16	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2726	17	592	592	CD
cord-023095-4dannjjm	2726	18	(	(	-LRB-
cord-023095-4dannjjm	2726	19	142	142	CD
cord-023095-4dannjjm	2726	20	-	-	SYM
cord-023095-4dannjjm	2726	21	1855	1855	CD
cord-023095-4dannjjm	2726	22	)	)	-RRB-
cord-023095-4dannjjm	2726	23	and	and	CC
cord-023095-4dannjjm	2726	24	72.00	72.00	CD
cord-023095-4dannjjm	2726	25	(	(	-LRB-
cord-023095-4dannjjm	2726	26	30	30	CD
cord-023095-4dannjjm	2726	27	-	-	SYM
cord-023095-4dannjjm	2726	28	139	139	CD
cord-023095-4dannjjm	2726	29	)	)	-RRB-
cord-023095-4dannjjm	2727	1	ng	ng	NNP
cord-023095-4dannjjm	2727	2	/	/	SYM
cord-023095-4dannjjm	2727	3	L	L	NNP
cord-023095-4dannjjm	2727	4	;	;	:
cord-023095-4dannjjm	2727	5	for	for	IN
cord-023095-4dannjjm	2727	6	urine	urine	NN
cord-023095-4dannjjm	2727	7	MMA	MMA	NNP
cord-023095-4dannjjm	2727	8	2	2	CD
cord-023095-4dannjjm	2727	9	(	(	-LRB-
cord-023095-4dannjjm	2727	10	2	2	CD
cord-023095-4dannjjm	2727	11	-	-	SYM
cord-023095-4dannjjm	2727	12	360	360	CD
cord-023095-4dannjjm	2727	13	)	)	-RRB-
cord-023095-4dannjjm	2727	14	and	and	CC
cord-023095-4dannjjm	2727	15	4148	4148	CD
cord-023095-4dannjjm	2727	16	(	(	-LRB-
cord-023095-4dannjjm	2727	17	1800	1800	CD
cord-023095-4dannjjm	2727	18	-	-	SYM
cord-023095-4dannjjm	2727	19	6665	6665	CD
cord-023095-4dannjjm	2727	20	)	)	-RRB-
cord-023095-4dannjjm	2728	1	mmol	mmol	NNP
cord-023095-4dannjjm	2728	2	/	/	SYM
cord-023095-4dannjjm	2728	3	mol	mol	NN
cord-023095-4dannjjm	2728	4	creatinine	creatinine	NN
cord-023095-4dannjjm	2728	5	;	;	:
cord-023095-4dannjjm	2728	6	for	for	IN
cord-023095-4dannjjm	2728	7	Hcy	Hcy	NNP
cord-023095-4dannjjm	2728	8	8.5	8.5	CD
cord-023095-4dannjjm	2728	9	(	(	-LRB-
cord-023095-4dannjjm	2728	10	2.8	2.8	CD
cord-023095-4dannjjm	2728	11	-	-	SYM
cord-023095-4dannjjm	2728	12	22.4	22.4	CD
cord-023095-4dannjjm	2728	13	)	)	-RRB-
cord-023095-4dannjjm	2728	14	and	and	CC
cord-023095-4dannjjm	2728	15	41.00	41.00	CD
cord-023095-4dannjjm	2728	16	(	(	-LRB-
cord-023095-4dannjjm	2728	17	40	40	CD
cord-023095-4dannjjm	2728	18	-	-	SYM
cord-023095-4dannjjm	2728	19	86.6	86.6	CD
cord-023095-4dannjjm	2728	20	)	)	-RRB-
cord-023095-4dannjjm	2728	21	mmol/	mmol/	.
cord-023095-4dannjjm	2729	1	L.	L.	NNP
cord-023095-4dannjjm	2729	2	Strikingly	strikingly	RB
cord-023095-4dannjjm	2729	3	,	,	,
cord-023095-4dannjjm	2729	4	healthy	healthy	JJ
cord-023095-4dannjjm	2729	5	BC	BC	NNP
cord-023095-4dannjjm	2729	6	with	with	IN
cord-023095-4dannjjm	2729	7	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2729	8	concentrations	concentration	NNS
cord-023095-4dannjjm	2729	9	well	well	RB
cord-023095-4dannjjm	2729	10	within	within	IN
cord-023095-4dannjjm	2729	11	the	the	DT
cord-023095-4dannjjm	2729	12	reference	reference	NN
cord-023095-4dannjjm	2729	13	range	range	NN
cord-023095-4dannjjm	2729	14	had	have	VBD
cord-023095-4dannjjm	2729	15	significantly	significantly	RB
cord-023095-4dannjjm	2729	16	higher	high	JJR
cord-023095-4dannjjm	2729	17	urine	urine	NN
cord-023095-4dannjjm	2729	18	MMA	MMA	NNP
cord-023095-4dannjjm	2729	19	concentrations	concentration	NNS
cord-023095-4dannjjm	2729	20	compared	compare	VBN
cord-023095-4dannjjm	2729	21	to	to	TO
cord-023095-4dannjjm	2729	22	control	control	VB
cord-023095-4dannjjm	2729	23	dogs	dog	NNS
cord-023095-4dannjjm	2729	24	.	.	.
cord-023095-4dannjjm	2730	1	Under	under	IN
cord-023095-4dannjjm	2730	2	the	the	DT
cord-023095-4dannjjm	2730	3	assumption	assumption	NN
cord-023095-4dannjjm	2730	4	that	that	IN
cord-023095-4dannjjm	2730	5	the	the	DT
cord-023095-4dannjjm	2730	6	four	four	CD
cord-023095-4dannjjm	2730	7	affected	affect	VBN
cord-023095-4dannjjm	2730	8	BC	BC	NNP
cord-023095-4dannjjm	2730	9	are	be	VBP
cord-023095-4dannjjm	2730	10	inbred	inbred	JJ
cord-023095-4dannjjm	2730	11	to	to	IN
cord-023095-4dannjjm	2730	12	a	a	DT
cord-023095-4dannjjm	2730	13	single	single	JJ
cord-023095-4dannjjm	2730	14	founder	founder	NN
cord-023095-4dannjjm	2730	15	animal	animal	NN
cord-023095-4dannjjm	2730	16	,	,	,
cord-023095-4dannjjm	2730	17	first	first	JJ
cord-023095-4dannjjm	2730	18	results	result	NNS
cord-023095-4dannjjm	2730	19	of	of	IN
cord-023095-4dannjjm	2730	20	genotyping	genotype	VBG
cord-023095-4dannjjm	2730	21	on	on	IN
cord-023095-4dannjjm	2730	22	the	the	DT
cord-023095-4dannjjm	2730	23	170	170	CD
cord-023095-4dannjjm	2730	24	k	k	NNP
cord-023095-4dannjjm	2730	25	illumina	illumina	NNP
cord-023095-4dannjjm	2730	26	canine_HD	canine_hd	FW
cord-023095-4dannjjm	2730	27	SNP	SNP	NNP
cord-023095-4dannjjm	2730	28	chip	chip	NN
cord-023095-4dannjjm	2730	29	suggest	suggest	VBP
cord-023095-4dannjjm	2730	30	that	that	IN
cord-023095-4dannjjm	2730	31	mutations	mutation	NNS
cord-023095-4dannjjm	2730	32	in	in	IN
cord-023095-4dannjjm	2730	33	the	the	DT
cord-023095-4dannjjm	2730	34	CUBN	CUBN	NNP
cord-023095-4dannjjm	2730	35	and	and	CC
cord-023095-4dannjjm	2730	36	AMN	AMN	NNP
cord-023095-4dannjjm	2730	37	gene	gene	NN
cord-023095-4dannjjm	2730	38	can	can	MD
cord-023095-4dannjjm	2730	39	be	be	VB
cord-023095-4dannjjm	2730	40	excluded	exclude	VBN
cord-023095-4dannjjm	2730	41	to	to	TO
cord-023095-4dannjjm	2730	42	cause	cause	VB
cord-023095-4dannjjm	2730	43	the	the	DT
cord-023095-4dannjjm	2730	44	observed	observed	JJ
cord-023095-4dannjjm	2730	45	CD	cd	NN
cord-023095-4dannjjm	2730	46	in	in	IN
cord-023095-4dannjjm	2730	47	these	these	DT
cord-023095-4dannjjm	2730	48	dogs	dog	NNS
cord-023095-4dannjjm	2730	49	.	.	.
cord-023095-4dannjjm	2731	1	We	-PRON-	PRP
cord-023095-4dannjjm	2731	2	conclude	conclude	VBP
cord-023095-4dannjjm	2731	3	that	that	IN
cord-023095-4dannjjm	2731	4	CD	CD	NNP
cord-023095-4dannjjm	2731	5	is	be	VBZ
cord-023095-4dannjjm	2731	6	a	a	DT
cord-023095-4dannjjm	2731	7	rare	rare	JJ
cord-023095-4dannjjm	2731	8	familial	familial	JJ
cord-023095-4dannjjm	2731	9	disease	disease	NN
cord-023095-4dannjjm	2731	10	in	in	IN
cord-023095-4dannjjm	2731	11	BC	BC	NNP
cord-023095-4dannjjm	2731	12	with	with	IN
cord-023095-4dannjjm	2731	13	variable	variable	JJ
cord-023095-4dannjjm	2731	14	clinical	clinical	JJ
cord-023095-4dannjjm	2731	15	signs	sign	NNS
cord-023095-4dannjjm	2731	16	.	.	.
cord-023095-4dannjjm	2732	1	To	to	TO
cord-023095-4dannjjm	2732	2	define	define	VB
cord-023095-4dannjjm	2732	3	the	the	DT
cord-023095-4dannjjm	2732	4	genomic	genomic	JJ
cord-023095-4dannjjm	2732	5	region	region	NN
cord-023095-4dannjjm	2732	6	responsible	responsible	JJ
cord-023095-4dannjjm	2732	7	for	for	IN
cord-023095-4dannjjm	2732	8	CD	CD	NNP
cord-023095-4dannjjm	2732	9	further	further	JJ
cord-023095-4dannjjm	2732	10	genetic	genetic	JJ
cord-023095-4dannjjm	2732	11	analysis	analysis	NN
cord-023095-4dannjjm	2732	12	is	be	VBZ
cord-023095-4dannjjm	2732	13	in	in	IN
cord-023095-4dannjjm	2732	14	progress	progress	NN
cord-023095-4dannjjm	2732	15	.	.	.
cord-023095-4dannjjm	2733	1	It	-PRON-	PRP
cord-023095-4dannjjm	2733	2	remains	remain	VBZ
cord-023095-4dannjjm	2733	3	to	to	TO
cord-023095-4dannjjm	2733	4	be	be	VB
cord-023095-4dannjjm	2733	5	determined	determine	VBN
cord-023095-4dannjjm	2733	6	why	why	WRB
cord-023095-4dannjjm	2733	7	some	some	DT
cord-023095-4dannjjm	2733	8	BC	BC	NNP
cord-023095-4dannjjm	2733	9	have	have	VBP
cord-023095-4dannjjm	2733	10	high	high	JJ
cord-023095-4dannjjm	2733	11	urine	urine	NN
cord-023095-4dannjjm	2733	12	MMA	MMA	NNP
cord-023095-4dannjjm	2733	13	concentrations	concentration	NNS
cord-023095-4dannjjm	2733	14	despite	despite	IN
cord-023095-4dannjjm	2733	15	a	a	DT
cord-023095-4dannjjm	2733	16	serum	serum	NN
cord-023095-4dannjjm	2733	17	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2733	18	concentration	concentration	NN
cord-023095-4dannjjm	2733	19	within	within	IN
cord-023095-4dannjjm	2733	20	the	the	DT
cord-023095-4dannjjm	2733	21	reference	reference	NN
cord-023095-4dannjjm	2733	22	range	range	NN
cord-023095-4dannjjm	2733	23	.	.	.
cord-023095-4dannjjm	2734	1	Calprotectin	Calprotectin	NNP
cord-023095-4dannjjm	2734	2	is	be	VBZ
cord-023095-4dannjjm	2734	3	a	a	DT
cord-023095-4dannjjm	2734	4	protein	protein	NN
cord-023095-4dannjjm	2734	5	complex	complex	NN
cord-023095-4dannjjm	2734	6	that	that	WDT
cord-023095-4dannjjm	2734	7	plays	play	VBZ
cord-023095-4dannjjm	2734	8	an	an	DT
cord-023095-4dannjjm	2734	9	important	important	JJ
cord-023095-4dannjjm	2734	10	role	role	NN
cord-023095-4dannjjm	2734	11	in	in	IN
cord-023095-4dannjjm	2734	12	the	the	DT
cord-023095-4dannjjm	2734	13	innate	innate	JJ
cord-023095-4dannjjm	2734	14	immune	immune	JJ
cord-023095-4dannjjm	2734	15	response	response	NN
cord-023095-4dannjjm	2734	16	.	.	.
cord-023095-4dannjjm	2735	1	Preliminary	preliminary	JJ
cord-023095-4dannjjm	2735	2	data	datum	NNS
cord-023095-4dannjjm	2735	3	suggest	suggest	VBP
cord-023095-4dannjjm	2735	4	that	that	IN
cord-023095-4dannjjm	2735	5	canine	canine	JJ
cord-023095-4dannjjm	2735	6	calprotectin	calprotectin	NNS
cord-023095-4dannjjm	2735	7	(	(	-LRB-
cord-023095-4dannjjm	2735	8	cCP	cCP	NNP
cord-023095-4dannjjm	2735	9	)	)	-RRB-
cord-023095-4dannjjm	2735	10	is	be	VBZ
cord-023095-4dannjjm	2735	11	a	a	DT
cord-023095-4dannjjm	2735	12	useful	useful	JJ
cord-023095-4dannjjm	2735	13	marker	marker	NN
cord-023095-4dannjjm	2735	14	for	for	IN
cord-023095-4dannjjm	2735	15	the	the	DT
cord-023095-4dannjjm	2735	16	detection	detection	NN
cord-023095-4dannjjm	2735	17	of	of	IN
cord-023095-4dannjjm	2735	18	inflammation	inflammation	NN
cord-023095-4dannjjm	2735	19	in	in	IN
cord-023095-4dannjjm	2735	20	dogs	dog	NNS
cord-023095-4dannjjm	2735	21	.	.	.
cord-023095-4dannjjm	2736	1	Recently	recently	RB
cord-023095-4dannjjm	2736	2	,	,	,
cord-023095-4dannjjm	2736	3	a	a	DT
cord-023095-4dannjjm	2736	4	radioimmunoassay	radioimmunoassay	NN
cord-023095-4dannjjm	2736	5	for	for	IN
cord-023095-4dannjjm	2736	6	the	the	DT
cord-023095-4dannjjm	2736	7	measurement	measurement	NN
cord-023095-4dannjjm	2736	8	of	of	IN
cord-023095-4dannjjm	2736	9	cCP	cCP	NNP
cord-023095-4dannjjm	2736	10	has	have	VBZ
cord-023095-4dannjjm	2736	11	been	be	VBN
cord-023095-4dannjjm	2736	12	developed	develop	VBN
cord-023095-4dannjjm	2736	13	and	and	CC
cord-023095-4dannjjm	2736	14	analytically	analytically	RB
cord-023095-4dannjjm	2736	15	validated	validate	VBN
cord-023095-4dannjjm	2736	16	,	,	,
cord-023095-4dannjjm	2736	17	but	but	CC
cord-023095-4dannjjm	2736	18	this	this	DT
cord-023095-4dannjjm	2736	19	test	test	NN
cord-023095-4dannjjm	2736	20	requires	require	VBZ
cord-023095-4dannjjm	2736	21	the	the	DT
cord-023095-4dannjjm	2736	22	use	use	NN
cord-023095-4dannjjm	2736	23	of	of	IN
cord-023095-4dannjjm	2736	24	a	a	DT
cord-023095-4dannjjm	2736	25	radioactive	radioactive	JJ
cord-023095-4dannjjm	2736	26	tracer	tracer	NN
cord-023095-4dannjjm	2736	27	.	.	.
cord-023095-4dannjjm	2737	1	Therefore	therefore	RB
cord-023095-4dannjjm	2737	2	,	,	,
cord-023095-4dannjjm	2737	3	the	the	DT
cord-023095-4dannjjm	2737	4	aim	aim	NN
cord-023095-4dannjjm	2737	5	of	of	IN
cord-023095-4dannjjm	2737	6	this	this	DT
cord-023095-4dannjjm	2737	7	study	study	NN
cord-023095-4dannjjm	2737	8	was	be	VBD
cord-023095-4dannjjm	2737	9	to	to	TO
cord-023095-4dannjjm	2737	10	develop	develop	VB
cord-023095-4dannjjm	2737	11	and	and	CC
cord-023095-4dannjjm	2737	12	analytically	analytically	RB
cord-023095-4dannjjm	2737	13	validate	validate	VB
cord-023095-4dannjjm	2737	14	an	an	DT
cord-023095-4dannjjm	2737	15	enzyme	enzyme	NN
cord-023095-4dannjjm	2737	16	-	-	HYPH
cord-023095-4dannjjm	2737	17	linked	link	VBN
cord-023095-4dannjjm	2737	18	immunosorbent	immunosorbent	JJ
cord-023095-4dannjjm	2737	19	assay	assay	NN
cord-023095-4dannjjm	2737	20	(	(	-LRB-
cord-023095-4dannjjm	2737	21	ELISA	ELISA	NNP
cord-023095-4dannjjm	2737	22	)	)	-RRB-
cord-023095-4dannjjm	2737	23	for	for	IN
cord-023095-4dannjjm	2737	24	the	the	DT
cord-023095-4dannjjm	2737	25	quantification	quantification	NN
cord-023095-4dannjjm	2737	26	of	of	IN
cord-023095-4dannjjm	2737	27	cCP	cCP	NNP
cord-023095-4dannjjm	2737	28	in	in	IN
cord-023095-4dannjjm	2737	29	serum	serum	NN
cord-023095-4dannjjm	2737	30	and	and	CC
cord-023095-4dannjjm	2737	31	fecal	fecal	JJ
cord-023095-4dannjjm	2737	32	specimens	specimen	NNS
cord-023095-4dannjjm	2737	33	from	from	IN
cord-023095-4dannjjm	2737	34	dogs	dog	NNS
cord-023095-4dannjjm	2737	35	.	.	.
cord-023095-4dannjjm	2738	1	Canine	canine	JJ
cord-023095-4dannjjm	2738	2	calprotectin	calprotectin	NNS
cord-023095-4dannjjm	2738	3	(	(	-LRB-
cord-023095-4dannjjm	2738	4	cCP	ccp	RB
cord-023095-4dannjjm	2738	5	)	)	-RRB-
cord-023095-4dannjjm	2738	6	was	be	VBD
cord-023095-4dannjjm	2738	7	purified	purify	VBN
cord-023095-4dannjjm	2738	8	,	,	,
cord-023095-4dannjjm	2738	9	antiserum	antiserum	NN
cord-023095-4dannjjm	2738	10	against	against	IN
cord-023095-4dannjjm	2738	11	purified	purify	VBN
cord-023095-4dannjjm	2738	12	cCP	cCP	NNP
cord-023095-4dannjjm	2738	13	was	be	VBD
cord-023095-4dannjjm	2738	14	raised	raise	VBN
cord-023095-4dannjjm	2738	15	in	in	IN
cord-023095-4dannjjm	2738	16	rabbits	rabbit	NNS
cord-023095-4dannjjm	2738	17	,	,	,
cord-023095-4dannjjm	2738	18	monospecific	monospecific	JJ
cord-023095-4dannjjm	2738	19	antibodies	antibody	NNS
cord-023095-4dannjjm	2738	20	were	be	VBD
cord-023095-4dannjjm	2738	21	purified	purify	VBN
cord-023095-4dannjjm	2738	22	by	by	IN
cord-023095-4dannjjm	2738	23	affinity	affinity	NN
cord-023095-4dannjjm	2738	24	chromatography	chromatography	NN
cord-023095-4dannjjm	2738	25	,	,	,
cord-023095-4dannjjm	2738	26	and	and	CC
cord-023095-4dannjjm	2738	27	a	a	DT
cord-023095-4dannjjm	2738	28	sandwich	sandwich	NN
cord-023095-4dannjjm	2738	29	-	-	:
cord-023095-4dannjjm	2738	30	ELISA	ELISA	NNP
cord-023095-4dannjjm	2738	31	was	be	VBD
cord-023095-4dannjjm	2738	32	developed	develop	VBN
cord-023095-4dannjjm	2738	33	.	.	.
cord-023095-4dannjjm	2739	1	Purified	purify	VBN
cord-023095-4dannjjm	2739	2	antibodies	antibody	NNS
cord-023095-4dannjjm	2739	3	were	be	VBD
cord-023095-4dannjjm	2739	4	used	use	VBN
cord-023095-4dannjjm	2739	5	for	for	IN
cord-023095-4dannjjm	2739	6	capturing	capture	VBG
cord-023095-4dannjjm	2739	7	and	and	CC
cord-023095-4dannjjm	2739	8	,	,	,
cord-023095-4dannjjm	2739	9	after	after	IN
cord-023095-4dannjjm	2739	10	coupling	couple	VBG
cord-023095-4dannjjm	2739	11	with	with	IN
cord-023095-4dannjjm	2739	12	horseradish	horseradish	NN
cord-023095-4dannjjm	2739	13	peroxidase	peroxidase	NN
cord-023095-4dannjjm	2739	14	(	(	-LRB-
cord-023095-4dannjjm	2739	15	HRP	HRP	NNP
cord-023095-4dannjjm	2739	16	)	)	-RRB-
cord-023095-4dannjjm	2739	17	,	,	,
cord-023095-4dannjjm	2739	18	for	for	IN
cord-023095-4dannjjm	2739	19	reporting	report	VBG
cord-023095-4dannjjm	2739	20	.	.	.
cord-023095-4dannjjm	2740	1	A	a	DT
cord-023095-4dannjjm	2740	2	HRP	HRP	NNP
cord-023095-4dannjjm	2740	3	substrate	substrate	NN
cord-023095-4dannjjm	2740	4	was	be	VBD
cord-023095-4dannjjm	2740	5	used	use	VBN
cord-023095-4dannjjm	2740	6	for	for	IN
cord-023095-4dannjjm	2740	7	color	color	NN
cord-023095-4dannjjm	2740	8	development	development	NN
cord-023095-4dannjjm	2740	9	.	.	.
cord-023095-4dannjjm	2741	1	The	the	DT
cord-023095-4dannjjm	2741	2	assay	assay	NN
cord-023095-4dannjjm	2741	3	was	be	VBD
cord-023095-4dannjjm	2741	4	analytically	analytically	RB
cord-023095-4dannjjm	2741	5	validated	validate	VBN
cord-023095-4dannjjm	2741	6	by	by	IN
cord-023095-4dannjjm	2741	7	determination	determination	NN
cord-023095-4dannjjm	2741	8	of	of	IN
cord-023095-4dannjjm	2741	9	analytical	analytical	JJ
cord-023095-4dannjjm	2741	10	sensitivity	sensitivity	NN
cord-023095-4dannjjm	2741	11	and	and	CC
cord-023095-4dannjjm	2741	12	specificity	specificity	NN
cord-023095-4dannjjm	2741	13	,	,	,
cord-023095-4dannjjm	2741	14	dilutional	dilutional	JJ
cord-023095-4dannjjm	2741	15	parallelism	parallelism	NN
cord-023095-4dannjjm	2741	16	,	,	,
cord-023095-4dannjjm	2741	17	spiking	spike	VBG
cord-023095-4dannjjm	2741	18	recovery	recovery	NN
cord-023095-4dannjjm	2741	19	,	,	,
cord-023095-4dannjjm	2741	20	and	and	CC
cord-023095-4dannjjm	2741	21	intra	intra	JJ
cord-023095-4dannjjm	2741	22	-	-	:
cord-023095-4dannjjm	2741	23	and	and	CC
cord-023095-4dannjjm	2741	24	inter	inter	JJ
cord-023095-4dannjjm	2741	25	-	-	JJ
cord-023095-4dannjjm	2741	26	assay	assay	JJ
cord-023095-4dannjjm	2741	27	variability	variability	NN
cord-023095-4dannjjm	2741	28	.	.	.
cord-023095-4dannjjm	2742	1	Control	control	NN
cord-023095-4dannjjm	2742	2	intervals	interval	NNS
cord-023095-4dannjjm	2742	3	for	for	IN
cord-023095-4dannjjm	2742	4	serum	serum	NN
cord-023095-4dannjjm	2742	5	and	and	CC
cord-023095-4dannjjm	2742	6	fecal	fecal	NN
cord-023095-4dannjjm	2742	7	cCP	cCP	NNS
cord-023095-4dannjjm	2742	8	were	be	VBD
cord-023095-4dannjjm	2742	9	established	establish	VBN
cord-023095-4dannjjm	2742	10	from	from	IN
cord-023095-4dannjjm	2742	11	110	110	CD
cord-023095-4dannjjm	2742	12	and	and	CC
cord-023095-4dannjjm	2742	13	52	52	CD
cord-023095-4dannjjm	2742	14	healthy	healthy	JJ
cord-023095-4dannjjm	2742	15	pet	pet	JJ
cord-023095-4dannjjm	2742	16	dogs	dog	NNS
cord-023095-4dannjjm	2742	17	,	,	,
cord-023095-4dannjjm	2742	18	respectively	respectively	RB
cord-023095-4dannjjm	2742	19	,	,	,
cord-023095-4dannjjm	2742	20	using	use	VBG
cord-023095-4dannjjm	2742	21	the	the	DT
cord-023095-4dannjjm	2742	22	central	central	JJ
cord-023095-4dannjjm	2742	23	95	95	CD
cord-023095-4dannjjm	2742	24	th	th	XX
cord-023095-4dannjjm	2742	25	percentile	percentile	NN
cord-023095-4dannjjm	2742	26	.	.	.
cord-023095-4dannjjm	2743	1	Sensitivity	sensitivity	NN
cord-023095-4dannjjm	2743	2	of	of	IN
cord-023095-4dannjjm	2743	3	the	the	DT
cord-023095-4dannjjm	2743	4	assay	assay	NN
cord-023095-4dannjjm	2743	5	for	for	IN
cord-023095-4dannjjm	2743	6	serum	serum	NN
cord-023095-4dannjjm	2743	7	samples	sample	NNS
cord-023095-4dannjjm	2743	8	assayed	assay	VBN
cord-023095-4dannjjm	2743	9	in	in	IN
cord-023095-4dannjjm	2743	10	a	a	DT
cord-023095-4dannjjm	2743	11	1:400	1:400	CD
cord-023095-4dannjjm	2743	12	dilution	dilution	NN
cord-023095-4dannjjm	2743	13	and	and	CC
cord-023095-4dannjjm	2743	14	for	for	IN
cord-023095-4dannjjm	2743	15	fecal	fecal	JJ
cord-023095-4dannjjm	2743	16	extracts	extract	NNS
cord-023095-4dannjjm	2743	17	assayed	assay	VBN
cord-023095-4dannjjm	2743	18	in	in	IN
cord-023095-4dannjjm	2743	19	a	a	DT
cord-023095-4dannjjm	2743	20	1:4,000	1:4,000	CD
cord-023095-4dannjjm	2743	21	dilution	dilution	NN
cord-023095-4dannjjm	2743	22	was	be	VBD
cord-023095-4dannjjm	2743	23	0.3	0.3	CD
cord-023095-4dannjjm	2743	24	mg	mg	NNP
cord-023095-4dannjjm	2743	25	/	/	SYM
cord-023095-4dannjjm	2743	26	L	L	NNP
cord-023095-4dannjjm	2743	27	and	and	CC
cord-023095-4dannjjm	2743	28	3.2	3.2	CD
cord-023095-4dannjjm	2743	29	mg	mg	NNP
cord-023095-4dannjjm	2743	30	/	/	SYM
cord-023095-4dannjjm	2743	31	g	g	NNP
cord-023095-4dannjjm	2743	32	,	,	,
cord-023095-4dannjjm	2743	33	respectively	respectively	RB
cord-023095-4dannjjm	2743	34	.	.	.
cord-023095-4dannjjm	2744	1	Over	over	IN
cord-023095-4dannjjm	2744	2	a	a	DT
cord-023095-4dannjjm	2744	3	wide	wide	JJ
cord-023095-4dannjjm	2744	4	range	range	NN
cord-023095-4dannjjm	2744	5	of	of	IN
cord-023095-4dannjjm	2744	6	the	the	DT
cord-023095-4dannjjm	2744	7	assay	assay	NN
cord-023095-4dannjjm	2744	8	,	,	,
cord-023095-4dannjjm	2744	9	there	there	EX
cord-023095-4dannjjm	2744	10	was	be	VBD
cord-023095-4dannjjm	2744	11	no	no	DT
cord-023095-4dannjjm	2744	12	cross	cross	NN
cord-023095-4dannjjm	2744	13	-	-	NN
cord-023095-4dannjjm	2744	14	reactivity	reactivity	NN
cord-023095-4dannjjm	2744	15	with	with	IN
cord-023095-4dannjjm	2744	16	cS100A12	cs100a12	NN
cord-023095-4dannjjm	2744	17	,	,	,
cord-023095-4dannjjm	2744	18	the	the	DT
cord-023095-4dannjjm	2744	19	closest	close	JJS
cord-023095-4dannjjm	2744	20	structural	structural	JJ
cord-023095-4dannjjm	2744	21	analogue	analogue	NN
cord-023095-4dannjjm	2744	22	of	of	IN
cord-023095-4dannjjm	2744	23	cCP	ccp	RB
cord-023095-4dannjjm	2744	24	available	available	JJ
cord-023095-4dannjjm	2744	25	.	.	.
cord-023095-4dannjjm	2745	1	Observed	observe	VBN
cord-023095-4dannjjm	2745	2	to	to	TO
cord-023095-4dannjjm	2745	3	expected	expect	VBN
cord-023095-4dannjjm	2745	4	ratios	ratio	NNS
cord-023095-4dannjjm	2745	5	(	(	-LRB-
cord-023095-4dannjjm	2745	6	O	o	UH
cord-023095-4dannjjm	2745	7	/	/	SYM
cord-023095-4dannjjm	2745	8	E	e	NN
cord-023095-4dannjjm	2745	9	)	)	-RRB-
cord-023095-4dannjjm	2745	10	for	for	IN
cord-023095-4dannjjm	2745	11	serial	serial	JJ
cord-023095-4dannjjm	2745	12	dilutions	dilution	NNS
cord-023095-4dannjjm	2745	13	ranged	range	VBD
cord-023095-4dannjjm	2745	14	from	from	IN
cord-023095-4dannjjm	2745	15	83.2	83.2	CD
cord-023095-4dannjjm	2745	16	-	-	HYPH
cord-023095-4dannjjm	2745	17	118.5	118.5	CD
cord-023095-4dannjjm	2745	18	%	%	NN
cord-023095-4dannjjm	2745	19	(	(	-LRB-
cord-023095-4dannjjm	2745	20	mean	mean	VB
cord-023095-4dannjjm	2745	21	AE	AE	NNP
cord-023095-4dannjjm	2745	22	standard	standard	JJ
cord-023095-4dannjjm	2745	23	deviation	deviation	NN
cord-023095-4dannjjm	2745	24	[	[	-LRB-
cord-023095-4dannjjm	2745	25	SD	sd	NN
cord-023095-4dannjjm	2745	26	]	]	-RRB-
cord-023095-4dannjjm	2745	27	:	:	:
cord-023095-4dannjjm	2746	1	101.3	101.3	CD
cord-023095-4dannjjm	2746	2	AE	AE	NNP
cord-023095-4dannjjm	2746	3	10.0	10.0	CD
cord-023095-4dannjjm	2746	4	%	%	NN
cord-023095-4dannjjm	2746	5	)	)	-RRB-
cord-023095-4dannjjm	2746	6	for	for	IN
cord-023095-4dannjjm	2746	7	four	four	CD
cord-023095-4dannjjm	2746	8	different	different	JJ
cord-023095-4dannjjm	2746	9	serum	serum	NN
cord-023095-4dannjjm	2746	10	samples	sample	NNS
cord-023095-4dannjjm	2746	11	,	,	,
cord-023095-4dannjjm	2746	12	and	and	CC
cord-023095-4dannjjm	2746	13	from	from	IN
cord-023095-4dannjjm	2746	14	81.7	81.7	CD
cord-023095-4dannjjm	2746	15	-	-	HYPH
cord-023095-4dannjjm	2746	16	129.1	129.1	CD
cord-023095-4dannjjm	2746	17	%	%	NN
cord-023095-4dannjjm	2746	18	(	(	-LRB-
cord-023095-4dannjjm	2746	19	mean	mean	VB
cord-023095-4dannjjm	2746	20	AE	AE	NNP
cord-023095-4dannjjm	2746	21	SD	SD	NNP
cord-023095-4dannjjm	2746	22	:	:	:
cord-023095-4dannjjm	2746	23	101.8	101.8	CD
cord-023095-4dannjjm	2746	24	AE	AE	NNP
cord-023095-4dannjjm	2746	25	14.0	14.0	CD
cord-023095-4dannjjm	2746	26	%	%	NN
cord-023095-4dannjjm	2746	27	)	)	-RRB-
cord-023095-4dannjjm	2746	28	for	for	IN
cord-023095-4dannjjm	2746	29	five	five	CD
cord-023095-4dannjjm	2746	30	different	different	JJ
cord-023095-4dannjjm	2746	31	fecal	fecal	JJ
cord-023095-4dannjjm	2746	32	extracts	extract	NNS
cord-023095-4dannjjm	2746	33	.	.	.
cord-023095-4dannjjm	2747	1	O	o	UH
cord-023095-4dannjjm	2747	2	/	/	SYM
cord-023095-4dannjjm	2747	3	E	e	NN
cord-023095-4dannjjm	2747	4	for	for	IN
cord-023095-4dannjjm	2747	5	spiking	spike	VBG
cord-023095-4dannjjm	2747	6	recovery	recovery	NN
cord-023095-4dannjjm	2747	7	ranged	range	VBD
cord-023095-4dannjjm	2747	8	from	from	IN
cord-023095-4dannjjm	2747	9	87.8	87.8	CD
cord-023095-4dannjjm	2747	10	-	-	HYPH
cord-023095-4dannjjm	2747	11	130.4	130.4	CD
cord-023095-4dannjjm	2747	12	%	%	NN
cord-023095-4dannjjm	2747	13	(	(	-LRB-
cord-023095-4dannjjm	2747	14	mean	mean	VB
cord-023095-4dannjjm	2747	15	AE	AE	NNP
cord-023095-4dannjjm	2747	16	SD	SD	NNP
cord-023095-4dannjjm	2747	17	:	:	:
cord-023095-4dannjjm	2747	18	100.6	100.6	CD
cord-023095-4dannjjm	2747	19	AE	AE	NNP
cord-023095-4dannjjm	2747	20	6.5	6.5	CD
cord-023095-4dannjjm	2747	21	%	%	NN
cord-023095-4dannjjm	2747	22	)	)	-RRB-
cord-023095-4dannjjm	2747	23	for	for	IN
cord-023095-4dannjjm	2747	24	four	four	CD
cord-023095-4dannjjm	2747	25	different	different	JJ
cord-023095-4dannjjm	2747	26	serum	serum	NN
cord-023095-4dannjjm	2747	27	samples	sample	NNS
cord-023095-4dannjjm	2747	28	and	and	CC
cord-023095-4dannjjm	2747	29	6	6	CD
cord-023095-4dannjjm	2747	30	different	different	JJ
cord-023095-4dannjjm	2747	31	spiking	spiking	NN
cord-023095-4dannjjm	2747	32	concentrations	concentration	NNS
cord-023095-4dannjjm	2747	33	,	,	,
cord-023095-4dannjjm	2747	34	and	and	CC
cord-023095-4dannjjm	2747	35	from	from	IN
cord-023095-4dannjjm	2747	36	95.9	95.9	CD
cord-023095-4dannjjm	2747	37	-	-	SYM
cord-023095-4dannjjm	2747	38	152.0	152.0	CD
cord-023095-4dannjjm	2747	39	%	%	NN
cord-023095-4dannjjm	2747	40	(	(	-LRB-
cord-023095-4dannjjm	2747	41	mean	mean	VB
cord-023095-4dannjjm	2747	42	AE	AE	NNP
cord-023095-4dannjjm	2747	43	SD	SD	NNP
cord-023095-4dannjjm	2747	44	:	:	:
cord-023095-4dannjjm	2747	45	104.6	104.6	CD
cord-023095-4dannjjm	2747	46	AE	AE	NNP
cord-023095-4dannjjm	2747	47	11.6	11.6	CD
cord-023095-4dannjjm	2747	48	%	%	NN
cord-023095-4dannjjm	2747	49	)	)	-RRB-
cord-023095-4dannjjm	2747	50	for	for	IN
cord-023095-4dannjjm	2747	51	4	4	CD
cord-023095-4dannjjm	2747	52	different	different	JJ
cord-023095-4dannjjm	2747	53	fecal	fecal	JJ
cord-023095-4dannjjm	2747	54	extracts	extract	NNS
cord-023095-4dannjjm	2747	55	and	and	CC
cord-023095-4dannjjm	2747	56	6	6	CD
cord-023095-4dannjjm	2747	57	different	different	JJ
cord-023095-4dannjjm	2747	58	spiking	spiking	NN
cord-023095-4dannjjm	2747	59	concentrations	concentration	NNS
cord-023095-4dannjjm	2747	60	.	.	.
cord-023095-4dannjjm	2748	1	Intra	intra	JJ
cord-023095-4dannjjm	2748	2	-	-	JJ
cord-023095-4dannjjm	2748	3	assay	assay	NN
cord-023095-4dannjjm	2748	4	coefficients	coefficient	NNS
cord-023095-4dannjjm	2748	5	of	of	IN
cord-023095-4dannjjm	2748	6	variation	variation	NN
cord-023095-4dannjjm	2748	7	(	(	-LRB-
cord-023095-4dannjjm	2748	8	CV	CV	NNP
cord-023095-4dannjjm	2748	9	)	)	-RRB-
cord-023095-4dannjjm	2748	10	for	for	IN
cord-023095-4dannjjm	2748	11	4	4	CD
cord-023095-4dannjjm	2748	12	different	different	JJ
cord-023095-4dannjjm	2748	13	serum	serum	NN
cord-023095-4dannjjm	2748	14	samples	sample	NNS
cord-023095-4dannjjm	2748	15	were	be	VBD
cord-023095-4dannjjm	2748	16	7.8	7.8	CD
cord-023095-4dannjjm	2748	17	,	,	,
cord-023095-4dannjjm	2748	18	5.0	5.0	CD
cord-023095-4dannjjm	2748	19	,	,	,
cord-023095-4dannjjm	2748	20	7.4	7.4	CD
cord-023095-4dannjjm	2748	21	,	,	,
cord-023095-4dannjjm	2748	22	and	and	CC
cord-023095-4dannjjm	2748	23	12.7	12.7	CD
cord-023095-4dannjjm	2748	24	%	%	NN
cord-023095-4dannjjm	2748	25	,	,	,
cord-023095-4dannjjm	2748	26	and	and	CC
cord-023095-4dannjjm	2748	27	10.0	10.0	CD
cord-023095-4dannjjm	2748	28	,	,	,
cord-023095-4dannjjm	2748	29	6.1	6.1	CD
cord-023095-4dannjjm	2748	30	,	,	,
cord-023095-4dannjjm	2748	31	6.2	6.2	CD
cord-023095-4dannjjm	2748	32	,	,	,
cord-023095-4dannjjm	2748	33	and	and	CC
cord-023095-4dannjjm	2748	34	7.0	7.0	CD
cord-023095-4dannjjm	2748	35	%	%	NN
cord-023095-4dannjjm	2748	36	for	for	IN
cord-023095-4dannjjm	2748	37	4	4	CD
cord-023095-4dannjjm	2748	38	different	different	JJ
cord-023095-4dannjjm	2748	39	fecal	fecal	JJ
cord-023095-4dannjjm	2748	40	extracts	extract	NNS
cord-023095-4dannjjm	2748	41	.	.	.
cord-023095-4dannjjm	2749	1	Inter	Inter	NNP
cord-023095-4dannjjm	2749	2	-	-	NN
cord-023095-4dannjjm	2749	3	assay	assay	NN
cord-023095-4dannjjm	2749	4	CV	cv	NN
cord-023095-4dannjjm	2749	5	for	for	IN
cord-023095-4dannjjm	2749	6	4	4	CD
cord-023095-4dannjjm	2749	7	different	different	JJ
cord-023095-4dannjjm	2749	8	serum	serum	NN
cord-023095-4dannjjm	2749	9	samples	sample	NNS
cord-023095-4dannjjm	2749	10	were	be	VBD
cord-023095-4dannjjm	2749	11	17	17	CD
cord-023095-4dannjjm	2749	12	.	.	.
cord-023095-4dannjjm	2750	1	2	2	LS
cord-023095-4dannjjm	2750	2	,	,	,
cord-023095-4dannjjm	2750	3	8.1	8.1	CD
cord-023095-4dannjjm	2750	4	,	,	,
cord-023095-4dannjjm	2750	5	9.9	9.9	CD
cord-023095-4dannjjm	2750	6	,	,	,
cord-023095-4dannjjm	2750	7	and	and	CC
cord-023095-4dannjjm	2750	8	12.6	12.6	CD
cord-023095-4dannjjm	2750	9	%	%	NN
cord-023095-4dannjjm	2750	10	,	,	,
cord-023095-4dannjjm	2750	11	and	and	CC
cord-023095-4dannjjm	2750	12	12.3	12.3	CD
cord-023095-4dannjjm	2750	13	,	,	,
cord-023095-4dannjjm	2750	14	8.3	8.3	CD
cord-023095-4dannjjm	2750	15	,	,	,
cord-023095-4dannjjm	2750	16	7.2	7.2	CD
cord-023095-4dannjjm	2750	17	,	,	,
cord-023095-4dannjjm	2750	18	and	and	CC
cord-023095-4dannjjm	2750	19	9	9	CD
cord-023095-4dannjjm	2750	20	.6	.6	CD
cord-023095-4dannjjm	2750	21	%	%	NN
cord-023095-4dannjjm	2750	22	for	for	IN
cord-023095-4dannjjm	2750	23	4	4	CD
cord-023095-4dannjjm	2750	24	different	different	JJ
cord-023095-4dannjjm	2750	25	fecal	fecal	JJ
cord-023095-4dannjjm	2750	26	extracts	extract	NNS
cord-023095-4dannjjm	2750	27	.	.	.
cord-023095-4dannjjm	2751	1	The	the	DT
cord-023095-4dannjjm	2751	2	control	control	NN
cord-023095-4dannjjm	2751	3	intervals	interval	NNS
cord-023095-4dannjjm	2751	4	for	for	IN
cord-023095-4dannjjm	2751	5	serum	serum	NN
cord-023095-4dannjjm	2751	6	and	and	CC
cord-023095-4dannjjm	2751	7	fecal	fecal	NN
cord-023095-4dannjjm	2751	8	cCP	cCP	NNS
cord-023095-4dannjjm	2751	9	were	be	VBD
cord-023095-4dannjjm	2751	10	established	establish	VBN
cord-023095-4dannjjm	2751	11	as	as	IN
cord-023095-4dannjjm	2751	12	0.9	0.9	CD
cord-023095-4dannjjm	2751	13	-	-	SYM
cord-023095-4dannjjm	2751	14	11.9	11.9	CD
cord-023095-4dannjjm	2751	15	mg	mg	NNP
cord-023095-4dannjjm	2751	16	/	/	SYM
cord-023095-4dannjjm	2751	17	L	L	NNP
cord-023095-4dannjjm	2751	18	and	and	CC
cord-023095-4dannjjm	2751	19	3.2	3.2	CD
cord-023095-4dannjjm	2751	20	-	-	HYPH
cord-023095-4dannjjm	2751	21	65.4	65.4	CD
cord-023095-4dannjjm	2751	22	mg	mg	NNP
cord-023095-4dannjjm	2751	23	/	/	SYM
cord-023095-4dannjjm	2751	24	g	g	NNP
cord-023095-4dannjjm	2751	25	,	,	,
cord-023095-4dannjjm	2751	26	respectively	respectively	RB
cord-023095-4dannjjm	2751	27	.	.	.
cord-023095-4dannjjm	2752	1	We	-PRON-	PRP
cord-023095-4dannjjm	2752	2	conclude	conclude	VBP
cord-023095-4dannjjm	2752	3	that	that	IN
cord-023095-4dannjjm	2752	4	this	this	DT
cord-023095-4dannjjm	2752	5	new	new	JJ
cord-023095-4dannjjm	2752	6	ELISA	ELISA	NNP
cord-023095-4dannjjm	2752	7	for	for	IN
cord-023095-4dannjjm	2752	8	the	the	DT
cord-023095-4dannjjm	2752	9	measurement	measurement	NN
cord-023095-4dannjjm	2752	10	of	of	IN
cord-023095-4dannjjm	2752	11	cCP	cCP	NNP
cord-023095-4dannjjm	2752	12	is	be	VBZ
cord-023095-4dannjjm	2752	13	analytically	analytically	RB
cord-023095-4dannjjm	2752	14	sensitive	sensitive	JJ
cord-023095-4dannjjm	2752	15	,	,	,
cord-023095-4dannjjm	2752	16	linear	linear	JJ
cord-023095-4dannjjm	2752	17	,	,	,
cord-023095-4dannjjm	2752	18	accurate	accurate	JJ
cord-023095-4dannjjm	2752	19	,	,	,
cord-023095-4dannjjm	2752	20	precise	precise	JJ
cord-023095-4dannjjm	2752	21	,	,	,
cord-023095-4dannjjm	2752	22	and	and	CC
cord-023095-4dannjjm	2752	23	reproducible	reproducible	JJ
cord-023095-4dannjjm	2752	24	,	,	,
cord-023095-4dannjjm	2752	25	and	and	CC
cord-023095-4dannjjm	2752	26	does	do	VBZ
cord-023095-4dannjjm	2752	27	not	not	RB
cord-023095-4dannjjm	2752	28	cross	cross	VB
cord-023095-4dannjjm	2752	29	-	-	JJ
cord-023095-4dannjjm	2752	30	react	react	VB
cord-023095-4dannjjm	2752	31	with	with	IN
cord-023095-4dannjjm	2752	32	canine	canine	JJ
cord-023095-4dannjjm	2752	33	S100A12	s100a12	NN
cord-023095-4dannjjm	2752	34	.	.	.
cord-023095-4dannjjm	2753	1	Further	further	JJ
cord-023095-4dannjjm	2753	2	studies	study	NNS
cord-023095-4dannjjm	2753	3	evaluating	evaluate	VBG
cord-023095-4dannjjm	2753	4	the	the	DT
cord-023095-4dannjjm	2753	5	clinical	clinical	JJ
cord-023095-4dannjjm	2753	6	usefulness	usefulness	NN
cord-023095-4dannjjm	2753	7	of	of	IN
cord-023095-4dannjjm	2753	8	measuring	measure	VBG
cord-023095-4dannjjm	2753	9	serum	serum	NN
cord-023095-4dannjjm	2754	1	and/or	and/or	CC
cord-023095-4dannjjm	2754	2	fecal	fecal	JJ
cord-023095-4dannjjm	2755	1	cCP	ccp	RB
cord-023095-4dannjjm	2755	2	are	be	VBP
cord-023095-4dannjjm	2755	3	currently	currently	RB
cord-023095-4dannjjm	2755	4	under	under	IN
cord-023095-4dannjjm	2755	5	way	way	NN
cord-023095-4dannjjm	2755	6	.	.	.
cord-023095-4dannjjm	2756	1	The	the	DT
cord-023095-4dannjjm	2756	2	syndrome	syndrome	NN
cord-023095-4dannjjm	2756	3	of	of	IN
cord-023095-4dannjjm	2756	4	hemorrhagic	hemorrhagic	JJ
cord-023095-4dannjjm	2756	5	gastroenteritis	gastroenteritis	NN
cord-023095-4dannjjm	2756	6	(	(	-LRB-
cord-023095-4dannjjm	2756	7	HGE	HGE	NNP
cord-023095-4dannjjm	2756	8	)	)	-RRB-
cord-023095-4dannjjm	2756	9	is	be	VBZ
cord-023095-4dannjjm	2756	10	characterized	characterize	VBN
cord-023095-4dannjjm	2756	11	by	by	IN
cord-023095-4dannjjm	2756	12	a	a	DT
cord-023095-4dannjjm	2756	13	peracute	peracute	JJ
cord-023095-4dannjjm	2756	14	onset	onset	NN
cord-023095-4dannjjm	2756	15	of	of	IN
cord-023095-4dannjjm	2756	16	hemorrhagic	hemorrhagic	JJ
cord-023095-4dannjjm	2756	17	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2756	18	,	,	,
cord-023095-4dannjjm	2756	19	vomiting	vomiting	NN
cord-023095-4dannjjm	2756	20	,	,	,
cord-023095-4dannjjm	2756	21	depression	depression	NN
cord-023095-4dannjjm	2756	22	,	,	,
cord-023095-4dannjjm	2756	23	and	and	CC
cord-023095-4dannjjm	2756	24	anorexia	anorexia	NN
cord-023095-4dannjjm	2756	25	,	,	,
cord-023095-4dannjjm	2756	26	and	and	CC
cord-023095-4dannjjm	2756	27	can	can	MD
cord-023095-4dannjjm	2756	28	be	be	VB
cord-023095-4dannjjm	2756	29	associated	associate	VBN
cord-023095-4dannjjm	2756	30	with	with	IN
cord-023095-4dannjjm	2756	31	a	a	DT
cord-023095-4dannjjm	2756	32	high	high	JJ
cord-023095-4dannjjm	2756	33	mortality	mortality	NN
cord-023095-4dannjjm	2756	34	if	if	IN
cord-023095-4dannjjm	2756	35	untreated	untreated	JJ
cord-023095-4dannjjm	2756	36	.	.	.
cord-023095-4dannjjm	2757	1	The	the	DT
cord-023095-4dannjjm	2757	2	etiology	etiology	NN
cord-023095-4dannjjm	2757	3	of	of	IN
cord-023095-4dannjjm	2757	4	HGE	HGE	NNP
cord-023095-4dannjjm	2757	5	is	be	VBZ
cord-023095-4dannjjm	2757	6	unknown	unknown	JJ
cord-023095-4dannjjm	2757	7	,	,	,
cord-023095-4dannjjm	2757	8	but	but	CC
cord-023095-4dannjjm	2757	9	it	-PRON-	PRP
cord-023095-4dannjjm	2757	10	is	be	VBZ
cord-023095-4dannjjm	2757	11	speculated	speculate	VBN
cord-023095-4dannjjm	2757	12	that	that	IN
cord-023095-4dannjjm	2757	13	an	an	DT
cord-023095-4dannjjm	2757	14	abnormal	abnormal	JJ
cord-023095-4dannjjm	2757	15	response	response	NN
cord-023095-4dannjjm	2757	16	to	to	IN
cord-023095-4dannjjm	2757	17	bacterial	bacterial	JJ
cord-023095-4dannjjm	2757	18	endotoxins	endotoxin	NNS
cord-023095-4dannjjm	2757	19	,	,	,
cord-023095-4dannjjm	2757	20	bacteria	bacteria	NNS
cord-023095-4dannjjm	2757	21	,	,	,
cord-023095-4dannjjm	2757	22	or	or	CC
cord-023095-4dannjjm	2757	23	dietary	dietary	JJ
cord-023095-4dannjjm	2757	24	components	component	NNS
cord-023095-4dannjjm	2757	25	may	may	MD
cord-023095-4dannjjm	2757	26	play	play	VB
cord-023095-4dannjjm	2757	27	a	a	DT
cord-023095-4dannjjm	2757	28	role	role	NN
cord-023095-4dannjjm	2757	29	.	.	.
cord-023095-4dannjjm	2758	1	HGE	HGE	NNP
cord-023095-4dannjjm	2758	2	is	be	VBZ
cord-023095-4dannjjm	2758	3	characterized	characterize	VBN
cord-023095-4dannjjm	2758	4	by	by	IN
cord-023095-4dannjjm	2758	5	an	an	DT
cord-023095-4dannjjm	2758	6	increased	increase	VBN
cord-023095-4dannjjm	2758	7	vascular	vascular	JJ
cord-023095-4dannjjm	2758	8	/	/	HYPH
cord-023095-4dannjjm	2758	9	mucosal	mucosal	JJ
cord-023095-4dannjjm	2758	10	permeability	permeability	NN
cord-023095-4dannjjm	2758	11	,	,	,
cord-023095-4dannjjm	2758	12	thought	think	VBD
cord-023095-4dannjjm	2758	13	to	to	TO
cord-023095-4dannjjm	2758	14	represent	represent	VB
cord-023095-4dannjjm	2758	15	a	a	DT
cord-023095-4dannjjm	2758	16	type	type	NN
cord-023095-4dannjjm	2758	17	I	i	NN
cord-023095-4dannjjm	2758	18	-	-	HYPH
cord-023095-4dannjjm	2758	19	hypersensitivity	hypersensitivity	NN
cord-023095-4dannjjm	2758	20	reaction	reaction	NN
cord-023095-4dannjjm	2758	21	,	,	,
cord-023095-4dannjjm	2758	22	whereas	whereas	IN
cord-023095-4dannjjm	2758	23	inflammation	inflammation	NN
cord-023095-4dannjjm	2758	24	and	and	CC
cord-023095-4dannjjm	2758	25	necrosis	necrosis	NN
cord-023095-4dannjjm	2758	26	appear	appear	VBP
cord-023095-4dannjjm	2758	27	to	to	TO
cord-023095-4dannjjm	2758	28	be	be	VB
cord-023095-4dannjjm	2758	29	rare	rare	JJ
cord-023095-4dannjjm	2758	30	.	.	.
cord-023095-4dannjjm	2759	1	However	however	RB
cord-023095-4dannjjm	2759	2	,	,	,
cord-023095-4dannjjm	2759	3	markers	marker	NNS
cord-023095-4dannjjm	2759	4	of	of	IN
cord-023095-4dannjjm	2759	5	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2759	6	(	(	-LRB-
cord-023095-4dannjjm	2759	7	GI	gi	NN
cord-023095-4dannjjm	2759	8	)	)	-RRB-
cord-023095-4dannjjm	2759	9	inflammation	inflammation	NN
cord-023095-4dannjjm	2759	10	and	and	CC
cord-023095-4dannjjm	2759	11	changes	change	NNS
cord-023095-4dannjjm	2759	12	in	in	IN
cord-023095-4dannjjm	2759	13	the	the	DT
cord-023095-4dannjjm	2759	14	intestinal	intestinal	JJ
cord-023095-4dannjjm	2759	15	microbiota	microbiota	NN
cord-023095-4dannjjm	2759	16	have	have	VBP
cord-023095-4dannjjm	2759	17	not	not	RB
cord-023095-4dannjjm	2759	18	been	be	VBN
cord-023095-4dannjjm	2759	19	studied	study	VBN
cord-023095-4dannjjm	2759	20	extensively	extensively	RB
cord-023095-4dannjjm	2759	21	in	in	IN
cord-023095-4dannjjm	2759	22	dogs	dog	NNS
cord-023095-4dannjjm	2759	23	with	with	IN
cord-023095-4dannjjm	2759	24	HGE	HGE	NNP
cord-023095-4dannjjm	2759	25	.	.	.
cord-023095-4dannjjm	2760	1	Therefore	therefore	RB
cord-023095-4dannjjm	2760	2	,	,	,
cord-023095-4dannjjm	2760	3	the	the	DT
cord-023095-4dannjjm	2760	4	aim	aim	NN
cord-023095-4dannjjm	2760	5	of	of	IN
cord-023095-4dannjjm	2760	6	this	this	DT
cord-023095-4dannjjm	2760	7	study	study	NN
cord-023095-4dannjjm	2760	8	was	be	VBD
cord-023095-4dannjjm	2760	9	to	to	TO
cord-023095-4dannjjm	2760	10	evaluate	evaluate	VB
cord-023095-4dannjjm	2760	11	fecal	fecal	JJ
cord-023095-4dannjjm	2760	12	canine	canine	JJ
cord-023095-4dannjjm	2760	13	calprotectin	calprotectin	NNS
cord-023095-4dannjjm	2760	14	(	(	-LRB-
cord-023095-4dannjjm	2760	15	CP	CP	NNP
cord-023095-4dannjjm	2760	16	)	)	-RRB-
cord-023095-4dannjjm	2760	17	and	and	CC
cord-023095-4dannjjm	2760	18	S100A12	s100a12	JJ
cord-023095-4dannjjm	2760	19	(	(	-LRB-
cord-023095-4dannjjm	2760	20	A12	A12	NNP
cord-023095-4dannjjm	2760	21	)	)	-RRB-
cord-023095-4dannjjm	2760	22	,	,	,
cord-023095-4dannjjm	2760	23	a	a	DT
cord-023095-4dannjjm	2760	24	1	1	CD
cord-023095-4dannjjm	2760	25	-proteinase	-proteinase	NN
cord-023095-4dannjjm	2760	26	inhibitor	inhibitor	NN
cord-023095-4dannjjm	2760	27	(	(	-LRB-
cord-023095-4dannjjm	2760	28	a	a	DT
cord-023095-4dannjjm	2760	29	1	1	CD
cord-023095-4dannjjm	2760	30	-PI	-pi	NN
cord-023095-4dannjjm	2760	31	,	,	,
cord-023095-4dannjjm	2760	32	a	a	DT
cord-023095-4dannjjm	2760	33	marker	marker	NN
cord-023095-4dannjjm	2760	34	of	of	IN
cord-023095-4dannjjm	2760	35	GI	GI	NNP
cord-023095-4dannjjm	2760	36	protein	protein	NN
cord-023095-4dannjjm	2760	37	loss	loss	NN
cord-023095-4dannjjm	2760	38	)	)	-RRB-
cord-023095-4dannjjm	2760	39	,	,	,
cord-023095-4dannjjm	2760	40	and	and	CC
cord-023095-4dannjjm	2760	41	bacterial	bacterial	JJ
cord-023095-4dannjjm	2760	42	groups	group	NNS
cord-023095-4dannjjm	2760	43	that	that	WDT
cord-023095-4dannjjm	2760	44	have	have	VBP
cord-023095-4dannjjm	2760	45	previously	previously	RB
cord-023095-4dannjjm	2760	46	been	be	VBN
cord-023095-4dannjjm	2760	47	shown	show	VBN
cord-023095-4dannjjm	2760	48	to	to	TO
cord-023095-4dannjjm	2760	49	be	be	VB
cord-023095-4dannjjm	2760	50	decreased	decrease	VBN
cord-023095-4dannjjm	2760	51	(	(	-LRB-
cord-023095-4dannjjm	2760	52	i.e.	i.e.	FW
cord-023095-4dannjjm	2760	53	,	,	,
cord-023095-4dannjjm	2760	54	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	2760	55	spp	spp	NNS
cord-023095-4dannjjm	2760	56	.	.	.
cord-023095-4dannjjm	2761	1	,	,	,
cord-023095-4dannjjm	2761	2	Ruminococcaceae	Ruminococcaceae	NNP
cord-023095-4dannjjm	2761	3	,	,	,
cord-023095-4dannjjm	2761	4	Bifidobacterium	bifidobacterium	NN
cord-023095-4dannjjm	2761	5	spp	spp	NNS
cord-023095-4dannjjm	2761	6	.	.	.
cord-023095-4dannjjm	2761	7	)	)	-RRB-
cord-023095-4dannjjm	2761	8	or	or	CC
cord-023095-4dannjjm	2761	9	increased	increase	VBN
cord-023095-4dannjjm	2761	10	(	(	-LRB-
cord-023095-4dannjjm	2761	11	i.e.	i.e.	FW
cord-023095-4dannjjm	2761	12	,	,	,
cord-023095-4dannjjm	2761	13	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	2761	14	)	)	-RRB-
cord-023095-4dannjjm	2761	15	in	in	IN
cord-023095-4dannjjm	2761	16	fecal	fecal	JJ
cord-023095-4dannjjm	2761	17	samples	sample	NNS
cord-023095-4dannjjm	2761	18	from	from	IN
cord-023095-4dannjjm	2761	19	dogs	dog	NNS
cord-023095-4dannjjm	2761	20	with	with	IN
cord-023095-4dannjjm	2761	21	HGE	HGE	NNP
cord-023095-4dannjjm	2761	22	.	.	.
cord-023095-4dannjjm	2762	1	Fecal	fecal	JJ
cord-023095-4dannjjm	2762	2	samples	sample	NNS
cord-023095-4dannjjm	2762	3	from	from	IN
cord-023095-4dannjjm	2762	4	3	3	CD
cord-023095-4dannjjm	2762	5	consecutive	consecutive	JJ
cord-023095-4dannjjm	2762	6	days	day	NNS
cord-023095-4dannjjm	2762	7	were	be	VBD
cord-023095-4dannjjm	2762	8	collected	collect	VBN
cord-023095-4dannjjm	2762	9	from	from	IN
cord-023095-4dannjjm	2762	10	7	7	CD
cord-023095-4dannjjm	2762	11	dogs	dog	NNS
cord-023095-4dannjjm	2762	12	with	with	IN
cord-023095-4dannjjm	2762	13	HGE	HGE	NNP
cord-023095-4dannjjm	2762	14	.	.	.
cord-023095-4dannjjm	2763	1	Fecal	fecal	JJ
cord-023095-4dannjjm	2763	2	CP	CP	NNP
cord-023095-4dannjjm	2763	3	,	,	,
cord-023095-4dannjjm	2763	4	A12	A12	NNP
cord-023095-4dannjjm	2763	5	,	,	,
cord-023095-4dannjjm	2763	6	and	and	CC
cord-023095-4dannjjm	2763	7	a	a	DT
cord-023095-4dannjjm	2763	8	1	1	CD
cord-023095-4dannjjm	2763	9	-PI	-pi	NN
cord-023095-4dannjjm	2763	10	concentrations	concentration	NNS
cord-023095-4dannjjm	2763	11	were	be	VBD
cord-023095-4dannjjm	2763	12	measured	measure	VBN
cord-023095-4dannjjm	2763	13	by	by	IN
cord-023095-4dannjjm	2763	14	in	in	IN
cord-023095-4dannjjm	2763	15	-	-	HYPH
cord-023095-4dannjjm	2763	16	house	house	NN
cord-023095-4dannjjm	2763	17	immunoassays	immunoassay	NNS
cord-023095-4dannjjm	2763	18	.	.	.
cord-023095-4dannjjm	2764	1	Bacterial	bacterial	JJ
cord-023095-4dannjjm	2764	2	DNA	DNA	NNP
cord-023095-4dannjjm	2764	3	was	be	VBD
cord-023095-4dannjjm	2764	4	extracted	extract	VBN
cord-023095-4dannjjm	2764	5	from	from	IN
cord-023095-4dannjjm	2764	6	each	each	DT
cord-023095-4dannjjm	2764	7	fecal	fecal	JJ
cord-023095-4dannjjm	2764	8	sample	sample	NN
cord-023095-4dannjjm	2764	9	and	and	CC
cord-023095-4dannjjm	2764	10	was	be	VBD
cord-023095-4dannjjm	2764	11	analyzed	analyze	VBN
cord-023095-4dannjjm	2764	12	for	for	IN
cord-023095-4dannjjm	2764	13	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	2764	14	spp	spp	NNS
cord-023095-4dannjjm	2764	15	.	.	.
cord-023095-4dannjjm	2765	1	,	,	,
cord-023095-4dannjjm	2765	2	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	2765	3	,	,	,
cord-023095-4dannjjm	2765	4	Rumino	Rumino	NNP
cord-023095-4dannjjm	2765	5	-	-	HYPH
cord-023095-4dannjjm	2765	6	coccaceae	coccaceae	NNP
cord-023095-4dannjjm	2765	7	,	,	,
cord-023095-4dannjjm	2765	8	and	and	CC
cord-023095-4dannjjm	2765	9	Bifidobacterium	Bifidobacterium	NNP
cord-023095-4dannjjm	2765	10	spp	spp	NNS
cord-023095-4dannjjm	2765	11	.	.	.
cord-023095-4dannjjm	2766	1	using	use	VBG
cord-023095-4dannjjm	2766	2	quantitative	quantitative	JJ
cord-023095-4dannjjm	2766	3	PCR	PCR	NNP
cord-023095-4dannjjm	2766	4	assays	assay	NNS
cord-023095-4dannjjm	2766	5	.	.	.
cord-023095-4dannjjm	2767	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	2767	2	of	of	IN
cord-023095-4dannjjm	2767	3	fecal	fecal	JJ
cord-023095-4dannjjm	2767	4	CP	cp	NN
cord-023095-4dannjjm	2767	5	,	,	,
cord-023095-4dannjjm	2767	6	A12	A12	NNP
cord-023095-4dannjjm	2767	7	,	,	,
cord-023095-4dannjjm	2767	8	and	and	CC
cord-023095-4dannjjm	2767	9	a	a	DT
cord-023095-4dannjjm	2767	10	1	1	CD
cord-023095-4dannjjm	2767	11	-PI	-pi	NN
cord-023095-4dannjjm	2767	12	,	,	,
cord-023095-4dannjjm	2767	13	and	and	CC
cord-023095-4dannjjm	2767	14	the	the	DT
cord-023095-4dannjjm	2767	15	abundance	abundance	NN
cord-023095-4dannjjm	2767	16	of	of	IN
cord-023095-4dannjjm	2767	17	bacterial	bacterial	JJ
cord-023095-4dannjjm	2767	18	DNA	dna	NN
cord-023095-4dannjjm	2767	19	were	be	VBD
cord-023095-4dannjjm	2767	20	compared	compare	VBN
cord-023095-4dannjjm	2767	21	using	use	VBG
cord-023095-4dannjjm	2767	22	a	a	DT
cord-023095-4dannjjm	2767	23	Friedman	Friedman	NNP
cord-023095-4dannjjm	2767	24	test	test	NN
cord-023095-4dannjjm	2767	25	with	with	IN
cord-023095-4dannjjm	2767	26	Dunn	Dunn	NNP
cord-023095-4dannjjm	2767	27	's	's	POS
cord-023095-4dannjjm	2767	28	post	post	JJ
cord-023095-4dannjjm	2767	29	-	-	JJ
cord-023095-4dannjjm	2767	30	hoc	hoc	JJ
cord-023095-4dannjjm	2767	31	tests	test	NNS
cord-023095-4dannjjm	2767	32	.	.	.
cord-023095-4dannjjm	2768	1	Significance	significance	NN
cord-023095-4dannjjm	2768	2	was	be	VBD
cord-023095-4dannjjm	2768	3	set	set	VBN
cord-023095-4dannjjm	2768	4	at	at	IN
cord-023095-4dannjjm	2768	5	p	p	NN
cord-023095-4dannjjm	2768	6	o	o	NN
cord-023095-4dannjjm	2768	7	0.05	0.05	CD
cord-023095-4dannjjm	2768	8	.	.	.
cord-023095-4dannjjm	2769	1	At	at	IN
cord-023095-4dannjjm	2769	2	the	the	DT
cord-023095-4dannjjm	2769	3	time	time	NN
cord-023095-4dannjjm	2769	4	of	of	IN
cord-023095-4dannjjm	2769	5	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2769	6	(	(	-LRB-
cord-023095-4dannjjm	2769	7	day	day	NN
cord-023095-4dannjjm	2769	8	1	1	CD
cord-023095-4dannjjm	2769	9	)	)	-RRB-
cord-023095-4dannjjm	2769	10	,	,	,
cord-023095-4dannjjm	2769	11	fecal	fecal	JJ
cord-023095-4dannjjm	2769	12	CP	cp	NN
cord-023095-4dannjjm	2769	13	,	,	,
cord-023095-4dannjjm	2769	14	A12	A12	NNP
cord-023095-4dannjjm	2769	15	,	,	,
cord-023095-4dannjjm	2769	16	and	and	CC
cord-023095-4dannjjm	2769	17	a	a	DT
cord-023095-4dannjjm	2769	18	1	1	CD
cord-023095-4dannjjm	2769	19	-PI	-pi	NN
cord-023095-4dannjjm	2769	20	were	be	VBD
cord-023095-4dannjjm	2769	21	above	above	IN
cord-023095-4dannjjm	2769	22	the	the	DT
cord-023095-4dannjjm	2769	23	suggested	suggest	VBN
cord-023095-4dannjjm	2769	24	reference	reference	NN
cord-023095-4dannjjm	2769	25	intervals	interval	NNS
cord-023095-4dannjjm	2769	26	in	in	IN
cord-023095-4dannjjm	2769	27	6	6	CD
cord-023095-4dannjjm	2769	28	,	,	,
cord-023095-4dannjjm	2769	29	6	6	CD
cord-023095-4dannjjm	2769	30	,	,	,
cord-023095-4dannjjm	2769	31	and	and	CC
cord-023095-4dannjjm	2769	32	5	5	CD
cord-023095-4dannjjm	2769	33	of	of	IN
cord-023095-4dannjjm	2769	34	the	the	DT
cord-023095-4dannjjm	2769	35	7	7	CD
cord-023095-4dannjjm	2769	36	dogs	dog	NNS
cord-023095-4dannjjm	2769	37	,	,	,
cord-023095-4dannjjm	2769	38	respectively	respectively	RB
cord-023095-4dannjjm	2769	39	.	.	.
cord-023095-4dannjjm	2770	1	Until	until	IN
cord-023095-4dannjjm	2770	2	day	day	NN
cord-023095-4dannjjm	2770	3	3	3	CD
cord-023095-4dannjjm	2770	4	,	,	,
cord-023095-4dannjjm	2770	5	this	this	DT
cord-023095-4dannjjm	2770	6	number	number	NN
cord-023095-4dannjjm	2770	7	decreased	decrease	VBD
cord-023095-4dannjjm	2770	8	to	to	IN
cord-023095-4dannjjm	2770	9	2	2	CD
cord-023095-4dannjjm	2770	10	,	,	,
cord-023095-4dannjjm	2770	11	1	1	CD
cord-023095-4dannjjm	2770	12	,	,	,
cord-023095-4dannjjm	2770	13	and	and	CC
cord-023095-4dannjjm	2770	14	4	4	CD
cord-023095-4dannjjm	2770	15	,	,	,
cord-023095-4dannjjm	2770	16	respectively	respectively	RB
cord-023095-4dannjjm	2770	17	.	.	.
cord-023095-4dannjjm	2771	1	Decreases	decrease	NNS
cord-023095-4dannjjm	2771	2	in	in	IN
cord-023095-4dannjjm	2771	3	concentrations	concentration	NNS
cord-023095-4dannjjm	2771	4	were	be	VBD
cord-023095-4dannjjm	2771	5	significant	significant	JJ
cord-023095-4dannjjm	2771	6	between	between	IN
cord-023095-4dannjjm	2771	7	days	day	NNS
cord-023095-4dannjjm	2771	8	2	2	CD
cord-023095-4dannjjm	2771	9	and	and	CC
cord-023095-4dannjjm	2771	10	3	3	CD
cord-023095-4dannjjm	2771	11	for	for	IN
cord-023095-4dannjjm	2771	12	A12	A12	NNP
cord-023095-4dannjjm	2771	13	(	(	-LRB-
cord-023095-4dannjjm	2771	14	p	p	NN
cord-023095-4dannjjm	2771	15	5	5	CD
cord-023095-4dannjjm	2771	16	0.016	0.016	CD
cord-023095-4dannjjm	2771	17	)	)	-RRB-
cord-023095-4dannjjm	2771	18	,	,	,
cord-023095-4dannjjm	2771	19	and	and	CC
cord-023095-4dannjjm	2771	20	between	between	IN
cord-023095-4dannjjm	2771	21	days	day	NNS
cord-023095-4dannjjm	2771	22	1	1	CD
cord-023095-4dannjjm	2771	23	and	and	CC
cord-023095-4dannjjm	2771	24	3	3	CD
cord-023095-4dannjjm	2771	25	for	for	IN
cord-023095-4dannjjm	2771	26	a	a	DT
cord-023095-4dannjjm	2771	27	1	1	CD
cord-023095-4dannjjm	2771	28	-PI	-pi	NN
cord-023095-4dannjjm	2772	1	(	(	-LRB-
cord-023095-4dannjjm	2772	2	p	p	NN
cord-023095-4dannjjm	2772	3	5	5	CD
cord-023095-4dannjjm	2772	4	0.012	0.012	CD
cord-023095-4dannjjm	2772	5	)	)	-RRB-
cord-023095-4dannjjm	2772	6	,	,	,
cord-023095-4dannjjm	2772	7	but	but	CC
cord-023095-4dannjjm	2772	8	not	not	RB
cord-023095-4dannjjm	2772	9	for	for	IN
cord-023095-4dannjjm	2772	10	CP	CP	NNP
cord-023095-4dannjjm	2772	11	despite	despite	IN
cord-023095-4dannjjm	2772	12	a	a	DT
cord-023095-4dannjjm	2772	13	trend	trend	NN
cord-023095-4dannjjm	2772	14	(	(	-LRB-
cord-023095-4dannjjm	2772	15	p	p	NN
cord-023095-4dannjjm	2772	16	5	5	CD
cord-023095-4dannjjm	2772	17	0.085	0.085	CD
cord-023095-4dannjjm	2772	18	)	)	-RRB-
cord-023095-4dannjjm	2772	19	.	.	.
cord-023095-4dannjjm	2773	1	No	no	DT
cord-023095-4dannjjm	2773	2	differences	difference	NNS
cord-023095-4dannjjm	2773	3	in	in	IN
cord-023095-4dannjjm	2773	4	the	the	DT
cord-023095-4dannjjm	2773	5	abundance	abundance	NN
cord-023095-4dannjjm	2773	6	of	of	IN
cord-023095-4dannjjm	2773	7	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	2773	8	spp	spp	NNS
cord-023095-4dannjjm	2773	9	.	.	.
cord-023095-4dannjjm	2774	1	(	(	-LRB-
cord-023095-4dannjjm	2774	2	p	p	NN
cord-023095-4dannjjm	2774	3	5	5	CD
cord-023095-4dannjjm	2774	4	0.085	0.085	CD
cord-023095-4dannjjm	2774	5	)	)	-RRB-
cord-023095-4dannjjm	2774	6	,	,	,
cord-023095-4dannjjm	2774	7	Bifidobacterium	bifidobacterium	NN
cord-023095-4dannjjm	2774	8	spp	spp	NNS
cord-023095-4dannjjm	2774	9	.	.	.
cord-023095-4dannjjm	2775	1	(	(	-LRB-
cord-023095-4dannjjm	2775	2	p	p	NN
cord-023095-4dannjjm	2775	3	5	5	CD
cord-023095-4dannjjm	2775	4	0.192	0.192	CD
cord-023095-4dannjjm	2775	5	)	)	-RRB-
cord-023095-4dannjjm	2775	6	,	,	,
cord-023095-4dannjjm	2775	7	or	or	CC
cord-023095-4dannjjm	2775	8	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	2775	9	(	(	-LRB-
cord-023095-4dannjjm	2775	10	p	p	NN
cord-023095-4dannjjm	2775	11	5	5	CD
cord-023095-4dannjjm	2775	12	0.305	0.305	CD
cord-023095-4dannjjm	2775	13	)	)	-RRB-
cord-023095-4dannjjm	2775	14	were	be	VBD
cord-023095-4dannjjm	2775	15	observed	observe	VBN
cord-023095-4dannjjm	2775	16	.	.	.
cord-023095-4dannjjm	2776	1	However	however	RB
cord-023095-4dannjjm	2776	2	,	,	,
cord-023095-4dannjjm	2776	3	the	the	DT
cord-023095-4dannjjm	2776	4	abundance	abundance	NN
cord-023095-4dannjjm	2776	5	of	of	IN
cord-023095-4dannjjm	2776	6	Rumino	rumino	NN
cord-023095-4dannjjm	2776	7	-	-	HYPH
cord-023095-4dannjjm	2776	8	coccaceae	coccaceae	NNP
cord-023095-4dannjjm	2776	9	was	be	VBD
cord-023095-4dannjjm	2776	10	significantly	significantly	RB
cord-023095-4dannjjm	2776	11	lower	low	JJR
cord-023095-4dannjjm	2776	12	on	on	IN
cord-023095-4dannjjm	2776	13	day	day	NN
cord-023095-4dannjjm	2776	14	3	3	CD
cord-023095-4dannjjm	2776	15	when	when	WRB
cord-023095-4dannjjm	2776	16	compared	compare	VBN
cord-023095-4dannjjm	2776	17	to	to	IN
cord-023095-4dannjjm	2776	18	day	day	NN
cord-023095-4dannjjm	2776	19	2	2	CD
cord-023095-4dannjjm	2776	20	(	(	-LRB-
cord-023095-4dannjjm	2776	21	p	p	NN
cord-023095-4dannjjm	2776	22	5	5	CD
cord-023095-4dannjjm	2776	23	0.008	0.008	CD
cord-023095-4dannjjm	2776	24	)	)	-RRB-
cord-023095-4dannjjm	2776	25	.	.	.
cord-023095-4dannjjm	2777	1	In	in	IN
cord-023095-4dannjjm	2777	2	this	this	DT
cord-023095-4dannjjm	2777	3	study	study	NN
cord-023095-4dannjjm	2777	4	,	,	,
cord-023095-4dannjjm	2777	5	fecal	fecal	JJ
cord-023095-4dannjjm	2777	6	markers	marker	NNS
cord-023095-4dannjjm	2777	7	of	of	IN
cord-023095-4dannjjm	2777	8	inflammation	inflammation	NN
cord-023095-4dannjjm	2777	9	and	and	CC
cord-023095-4dannjjm	2777	10	GI	GI	NNP
cord-023095-4dannjjm	2777	11	protein	protein	NN
cord-023095-4dannjjm	2777	12	loss	loss	NN
cord-023095-4dannjjm	2777	13	were	be	VBD
cord-023095-4dannjjm	2777	14	increased	increase	VBN
cord-023095-4dannjjm	2777	15	in	in	IN
cord-023095-4dannjjm	2777	16	dogs	dog	NNS
cord-023095-4dannjjm	2777	17	with	with	IN
cord-023095-4dannjjm	2777	18	HGE	HGE	NNP
cord-023095-4dannjjm	2777	19	.	.	.
cord-023095-4dannjjm	2778	1	Although	although	IN
cord-023095-4dannjjm	2778	2	the	the	DT
cord-023095-4dannjjm	2778	3	number	number	NN
cord-023095-4dannjjm	2778	4	of	of	IN
cord-023095-4dannjjm	2778	5	patients	patient	NNS
cord-023095-4dannjjm	2778	6	was	be	VBD
cord-023095-4dannjjm	2778	7	small	small	JJ
cord-023095-4dannjjm	2778	8	,	,	,
cord-023095-4dannjjm	2778	9	following	follow	VBG
cord-023095-4dannjjm	2778	10	initiation	initiation	NN
cord-023095-4dannjjm	2778	11	of	of	IN
cord-023095-4dannjjm	2778	12	treatment	treatment	NN
cord-023095-4dannjjm	2778	13	,	,	,
cord-023095-4dannjjm	2778	14	two	two	CD
cord-023095-4dannjjm	2778	15	of	of	IN
cord-023095-4dannjjm	2778	16	the	the	DT
cord-023095-4dannjjm	2778	17	markers	marker	NNS
cord-023095-4dannjjm	2778	18	decreased	decrease	VBD
cord-023095-4dannjjm	2778	19	significantly	significantly	RB
cord-023095-4dannjjm	2778	20	.	.	.
cord-023095-4dannjjm	2779	1	These	these	DT
cord-023095-4dannjjm	2779	2	results	result	NNS
cord-023095-4dannjjm	2779	3	suggest	suggest	VBP
cord-023095-4dannjjm	2779	4	a	a	DT
cord-023095-4dannjjm	2779	5	loss	loss	NN
cord-023095-4dannjjm	2779	6	of	of	IN
cord-023095-4dannjjm	2779	7	protein	protein	NN
cord-023095-4dannjjm	2779	8	into	into	IN
cord-023095-4dannjjm	2779	9	the	the	DT
cord-023095-4dannjjm	2779	10	GI	GI	NNP
cord-023095-4dannjjm	2779	11	tract	tract	NN
cord-023095-4dannjjm	2779	12	at	at	IN
cord-023095-4dannjjm	2779	13	the	the	DT
cord-023095-4dannjjm	2779	14	onset	onset	NN
cord-023095-4dannjjm	2779	15	of	of	IN
cord-023095-4dannjjm	2779	16	HGE	HGE	NNP
cord-023095-4dannjjm	2779	17	.	.	.
cord-023095-4dannjjm	2780	1	The	the	DT
cord-023095-4dannjjm	2780	2	lack	lack	NN
cord-023095-4dannjjm	2780	3	of	of	IN
cord-023095-4dannjjm	2780	4	significant	significant	JJ
cord-023095-4dannjjm	2780	5	increases	increase	NNS
cord-023095-4dannjjm	2780	6	of	of	IN
cord-023095-4dannjjm	2780	7	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	2780	8	spp	spp	NNS
cord-023095-4dannjjm	2780	9	.	.	.
cord-023095-4dannjjm	2781	1	,	,	,
cord-023095-4dannjjm	2781	2	Bifidobacterium	Bifidobacterium	NNP
cord-023095-4dannjjm	2781	3	spp	spp	NNS
cord-023095-4dannjjm	2781	4	.	.	.
cord-023095-4dannjjm	2782	1	,	,	,
cord-023095-4dannjjm	2783	1	and	and	CC
cord-023095-4dannjjm	2783	2	Ruminococcaceae	Ruminococcaceae	NNP
cord-023095-4dannjjm	2783	3	,	,	,
cord-023095-4dannjjm	2783	4	and	and	CC
cord-023095-4dannjjm	2783	5	decreases	decrease	VBZ
cord-023095-4dannjjm	2783	6	in	in	IN
cord-023095-4dannjjm	2783	7	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	2783	8	may	may	MD
cord-023095-4dannjjm	2783	9	suggest	suggest	VB
cord-023095-4dannjjm	2783	10	GI	GI	NNP
cord-023095-4dannjjm	2783	11	dysbiosis	dysbiosis	NN
cord-023095-4dannjjm	2783	12	.	.	.
cord-023095-4dannjjm	2784	1	Further	further	JJ
cord-023095-4dannjjm	2784	2	longitudinal	longitudinal	JJ
cord-023095-4dannjjm	2784	3	studies	study	NNS
cord-023095-4dannjjm	2784	4	are	be	VBP
cord-023095-4dannjjm	2784	5	needed	need	VBN
cord-023095-4dannjjm	2784	6	and	and	CC
cord-023095-4dannjjm	2784	7	are	be	VBP
cord-023095-4dannjjm	2784	8	currently	currently	RB
cord-023095-4dannjjm	2784	9	under	under	IN
cord-023095-4dannjjm	2784	10	way	way	NN
cord-023095-4dannjjm	2784	11	to	to	TO
cord-023095-4dannjjm	2784	12	evaluate	evaluate	VB
cord-023095-4dannjjm	2784	13	GI	GI	NNP
cord-023095-4dannjjm	2784	14	dysbiosis	dysbiosis	NN
cord-023095-4dannjjm	2784	15	in	in	IN
cord-023095-4dannjjm	2784	16	canine	canine	JJ
cord-023095-4dannjjm	2784	17	HGE	hge	NN
cord-023095-4dannjjm	2784	18	patients	patient	NNS
cord-023095-4dannjjm	2784	19	.	.	.
cord-023095-4dannjjm	2785	1	The	the	DT
cord-023095-4dannjjm	2785	2	most	most	RBS
cord-023095-4dannjjm	2785	3	recent	recent	JJ
cord-023095-4dannjjm	2785	4	antiemetic	antiemetic	NN
cord-023095-4dannjjm	2785	5	approved	approve	VBN
cord-023095-4dannjjm	2785	6	for	for	IN
cord-023095-4dannjjm	2785	7	use	use	NN
cord-023095-4dannjjm	2785	8	in	in	IN
cord-023095-4dannjjm	2785	9	dogs	dog	NNS
cord-023095-4dannjjm	2785	10	is	be	VBZ
cord-023095-4dannjjm	2785	11	maropitant	maropitant	NN
cord-023095-4dannjjm	2785	12	citrate	citrate	NNP
cord-023095-4dannjjm	2785	13	(	(	-LRB-
cord-023095-4dannjjm	2786	1	Cerenia	Cerenia	NNP
cord-023095-4dannjjm	2786	2	s	s	POS
cord-023095-4dannjjm	2786	3	,	,	,
cord-023095-4dannjjm	2786	4	Pfizer	Pfizer	NNP
cord-023095-4dannjjm	2786	5	Animal	Animal	NNP
cord-023095-4dannjjm	2786	6	Health	Health	NNP
cord-023095-4dannjjm	2786	7	)	)	-RRB-
cord-023095-4dannjjm	2786	8	.	.	.
cord-023095-4dannjjm	2787	1	Maropitant	maropitant	NN
cord-023095-4dannjjm	2787	2	is	be	VBZ
cord-023095-4dannjjm	2787	3	a	a	DT
cord-023095-4dannjjm	2787	4	selective	selective	JJ
cord-023095-4dannjjm	2787	5	NK1	nk1	JJ
cord-023095-4dannjjm	2787	6	receptor	receptor	NN
cord-023095-4dannjjm	2787	7	antagonist	antagonist	NN
cord-023095-4dannjjm	2787	8	that	that	WDT
cord-023095-4dannjjm	2787	9	acts	act	VBZ
cord-023095-4dannjjm	2787	10	by	by	IN
cord-023095-4dannjjm	2787	11	blocking	block	VBG
cord-023095-4dannjjm	2787	12	the	the	DT
cord-023095-4dannjjm	2787	13	binding	binding	NN
cord-023095-4dannjjm	2787	14	of	of	IN
cord-023095-4dannjjm	2787	15	substance	substance	NN
cord-023095-4dannjjm	2787	16	-	-	HYPH
cord-023095-4dannjjm	2787	17	P	p	NN
cord-023095-4dannjjm	2787	18	within	within	IN
cord-023095-4dannjjm	2787	19	the	the	DT
cord-023095-4dannjjm	2787	20	emetic	emetic	JJ
cord-023095-4dannjjm	2787	21	center	center	NN
cord-023095-4dannjjm	2787	22	and	and	CC
cord-023095-4dannjjm	2787	23	chemoreceptor	chemoreceptor	NNP
cord-023095-4dannjjm	2787	24	trigger	trigger	NN
cord-023095-4dannjjm	2787	25	zone	zone	NN
cord-023095-4dannjjm	2787	26	.	.	.
cord-023095-4dannjjm	2788	1	Label	Label	NNP
cord-023095-4dannjjm	2788	2	dosage	dosage	NN
cord-023095-4dannjjm	2788	3	recommendations	recommendation	NNS
cord-023095-4dannjjm	2788	4	for	for	IN
cord-023095-4dannjjm	2788	5	maropitant	maropitant	NN
cord-023095-4dannjjm	2788	6	citrate	citrate	NNP
cord-023095-4dannjjm	2788	7	are	be	VBP
cord-023095-4dannjjm	2788	8	1	1	CD
cord-023095-4dannjjm	2788	9	mg/	mg/	NN
cord-023095-4dannjjm	2788	10	kg	kg	NNP
cord-023095-4dannjjm	2788	11	SC	SC	NNP
cord-023095-4dannjjm	2788	12	or	or	CC
cord-023095-4dannjjm	2788	13	2	2	CD
cord-023095-4dannjjm	2788	14	mg	mg	NNP
cord-023095-4dannjjm	2788	15	/	/	SYM
cord-023095-4dannjjm	2788	16	kg	kg	XX
cord-023095-4dannjjm	2788	17	orally	orally	RB
cord-023095-4dannjjm	2788	18	once	once	RB
cord-023095-4dannjjm	2788	19	daily	daily	RB
cord-023095-4dannjjm	2788	20	for	for	IN
cord-023095-4dannjjm	2788	21	up	up	IN
cord-023095-4dannjjm	2788	22	to	to	TO
cord-023095-4dannjjm	2788	23	5	5	CD
cord-023095-4dannjjm	2788	24	consecutive	consecutive	JJ
cord-023095-4dannjjm	2788	25	days	day	NNS
cord-023095-4dannjjm	2788	26	(	(	-LRB-
cord-023095-4dannjjm	2788	27	acute	acute	JJ
cord-023095-4dannjjm	2788	28	emesis	emesis	NN
cord-023095-4dannjjm	2788	29	)	)	-RRB-
cord-023095-4dannjjm	2788	30	and	and	CC
cord-023095-4dannjjm	2788	31	8	8	CD
cord-023095-4dannjjm	2788	32	mg	mg	NN
cord-023095-4dannjjm	2788	33	/	/	SYM
cord-023095-4dannjjm	2788	34	kg	kg	XX
cord-023095-4dannjjm	2788	35	orally	orally	RB
cord-023095-4dannjjm	2788	36	once	once	RB
cord-023095-4dannjjm	2788	37	daily	daily	RB
cord-023095-4dannjjm	2788	38	for	for	IN
cord-023095-4dannjjm	2788	39	up	up	IN
cord-023095-4dannjjm	2788	40	to	to	TO
cord-023095-4dannjjm	2788	41	2	2	CD
cord-023095-4dannjjm	2788	42	consecutive	consecutive	JJ
cord-023095-4dannjjm	2788	43	days	day	NNS
cord-023095-4dannjjm	2788	44	(	(	-LRB-
cord-023095-4dannjjm	2788	45	motion	motion	NN
cord-023095-4dannjjm	2788	46	sickness	sickness	NN
cord-023095-4dannjjm	2788	47	)	)	-RRB-
cord-023095-4dannjjm	2788	48	.	.	.
cord-023095-4dannjjm	2789	1	The	the	DT
cord-023095-4dannjjm	2789	2	study	study	NN
cord-023095-4dannjjm	2789	3	objective	objective	NN
cord-023095-4dannjjm	2789	4	was	be	VBD
cord-023095-4dannjjm	2789	5	to	to	TO
cord-023095-4dannjjm	2789	6	determine	determine	VB
cord-023095-4dannjjm	2789	7	when	when	WRB
cord-023095-4dannjjm	2789	8	steady	steady	JJ
cord-023095-4dannjjm	2789	9	-	-	HYPH
cord-023095-4dannjjm	2789	10	state	state	NN
cord-023095-4dannjjm	2789	11	is	be	VBZ
cord-023095-4dannjjm	2789	12	reached	reach	VBN
cord-023095-4dannjjm	2789	13	and	and	CC
cord-023095-4dannjjm	2789	14	the	the	DT
cord-023095-4dannjjm	2789	15	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	2789	16	of	of	IN
cord-023095-4dannjjm	2789	17	maropitant	maropitant	NNP
cord-023095-4dannjjm	2789	18	administered	administer	VBN
cord-023095-4dannjjm	2789	19	at	at	IN
cord-023095-4dannjjm	2789	20	label	label	NN
cord-023095-4dannjjm	2789	21	oral	oral	JJ
cord-023095-4dannjjm	2789	22	dosages	dosage	NNS
cord-023095-4dannjjm	2789	23	once	once	RB
cord-023095-4dannjjm	2789	24	daily	daily	RB
cord-023095-4dannjjm	2789	25	for	for	IN
cord-023095-4dannjjm	2789	26	14	14	CD
cord-023095-4dannjjm	2789	27	consecutive	consecutive	JJ
cord-023095-4dannjjm	2789	28	days	day	NNS
cord-023095-4dannjjm	2789	29	.	.	.
cord-023095-4dannjjm	2790	1	Two	two	CD
cord-023095-4dannjjm	2790	2	groups	group	NNS
cord-023095-4dannjjm	2790	3	of	of	IN
cord-023095-4dannjjm	2790	4	eight	eight	CD
cord-023095-4dannjjm	2790	5	healthy	healthy	JJ
cord-023095-4dannjjm	2790	6	beagles	beagle	NNS
cord-023095-4dannjjm	2790	7	were	be	VBD
cord-023095-4dannjjm	2790	8	administered	administer	VBN
cord-023095-4dannjjm	2790	9	maropitant	maropitant	NN
cord-023095-4dannjjm	2790	10	citrate	citrate	NN
cord-023095-4dannjjm	2790	11	at	at	IN
cord-023095-4dannjjm	2790	12	2	2	CD
cord-023095-4dannjjm	2790	13	or	or	CC
cord-023095-4dannjjm	2790	14	8	8	CD
cord-023095-4dannjjm	2790	15	mg	mg	NN
cord-023095-4dannjjm	2790	16	/	/	SYM
cord-023095-4dannjjm	2790	17	kg	kg	XX
cord-023095-4dannjjm	2790	18	orally	orally	RB
cord-023095-4dannjjm	2790	19	once	once	RB
cord-023095-4dannjjm	2790	20	daily	daily	RB
cord-023095-4dannjjm	2790	21	for	for	IN
cord-023095-4dannjjm	2790	22	14	14	CD
cord-023095-4dannjjm	2790	23	days	day	NNS
cord-023095-4dannjjm	2790	24	.	.	.
cord-023095-4dannjjm	2791	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	2791	2	of	of	IN
cord-023095-4dannjjm	2791	3	maropitant	maropitant	NN
cord-023095-4dannjjm	2791	4	and	and	CC
cord-023095-4dannjjm	2791	5	its	-PRON-	PRP$
cord-023095-4dannjjm	2791	6	metabolite	metabolite	NN
cord-023095-4dannjjm	2791	7	were	be	VBD
cord-023095-4dannjjm	2791	8	measured	measure	VBN
cord-023095-4dannjjm	2791	9	in	in	IN
cord-023095-4dannjjm	2791	10	plasma	plasma	NN
cord-023095-4dannjjm	2791	11	using	use	VBG
cord-023095-4dannjjm	2791	12	a	a	DT
cord-023095-4dannjjm	2791	13	LC	LC	NNP
cord-023095-4dannjjm	2791	14	-	-	HYPH
cord-023095-4dannjjm	2791	15	MS	MS	NNP
cord-023095-4dannjjm	2791	16	/	/	SYM
cord-023095-4dannjjm	2791	17	MS	MS	NNP
cord-023095-4dannjjm	2791	18	assay	assay	NN
cord-023095-4dannjjm	2791	19	.	.	.
cord-023095-4dannjjm	2792	1	Pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	2792	2	parameters	parameter	NNS
cord-023095-4dannjjm	2792	3	were	be	VBD
cord-023095-4dannjjm	2792	4	estimated	estimate	VBN
cord-023095-4dannjjm	2792	5	using	use	VBG
cord-023095-4dannjjm	2792	6	non	non	JJ
cord-023095-4dannjjm	2792	7	-	-	JJ
cord-023095-4dannjjm	2792	8	compartmental	compartmental	JJ
cord-023095-4dannjjm	2792	9	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	2792	10	techniques	technique	NNS
cord-023095-4dannjjm	2792	11	and	and	CC
cord-023095-4dannjjm	2792	12	a	a	DT
cord-023095-4dannjjm	2792	13	modeling	modeling	NN
cord-023095-4dannjjm	2792	14	approach	approach	NN
cord-023095-4dannjjm	2792	15	was	be	VBD
cord-023095-4dannjjm	2792	16	used	use	VBN
cord-023095-4dannjjm	2792	17	to	to	TO
cord-023095-4dannjjm	2792	18	estimate	estimate	VB
cord-023095-4dannjjm	2792	19	steady	steady	JJ
cord-023095-4dannjjm	2792	20	-	-	HYPH
cord-023095-4dannjjm	2792	21	state	state	NN
cord-023095-4dannjjm	2792	22	.	.	.
cord-023095-4dannjjm	2793	1	The	the	DT
cord-023095-4dannjjm	2793	2	accumulation	accumulation	NN
cord-023095-4dannjjm	2793	3	ratio	ratio	NN
cord-023095-4dannjjm	2793	4	for	for	IN
cord-023095-4dannjjm	2793	5	maropitant	maropitant	NN
cord-023095-4dannjjm	2793	6	was	be	VBD
cord-023095-4dannjjm	2793	7	2.46	2.46	CD
cord-023095-4dannjjm	2793	8	(	(	-LRB-
cord-023095-4dannjjm	2793	9	AUC0	AUC0	NNP
cord-023095-4dannjjm	2793	10	-	-	HYPH
cord-023095-4dannjjm	2793	11	24	24	CD
cord-023095-4dannjjm	2793	12	)	)	-RRB-
cord-023095-4dannjjm	2793	13	and	and	CC
cord-023095-4dannjjm	2793	14	2.03	2.03	CD
cord-023095-4dannjjm	2793	15	(	(	-LRB-
cord-023095-4dannjjm	2793	16	Cmax	Cmax	NNP
cord-023095-4dannjjm	2793	17	)	)	-RRB-
cord-023095-4dannjjm	2793	18	for	for	IN
cord-023095-4dannjjm	2793	19	the	the	DT
cord-023095-4dannjjm	2793	20	2	2	CD
cord-023095-4dannjjm	2793	21	mg	mg	NNP
cord-023095-4dannjjm	2793	22	/	/	SYM
cord-023095-4dannjjm	2793	23	kg	kg	NN
cord-023095-4dannjjm	2793	24	dose	dose	NN
cord-023095-4dannjjm	2793	25	;	;	:
cord-023095-4dannjjm	2793	26	and	and	CC
cord-023095-4dannjjm	2793	27	4.81	4.81	CD
cord-023095-4dannjjm	2793	28	(	(	-LRB-
cord-023095-4dannjjm	2793	29	AUC0	AUC0	NNP
cord-023095-4dannjjm	2793	30	-	-	HYPH
cord-023095-4dannjjm	2793	31	24	24	CD
cord-023095-4dannjjm	2793	32	)	)	-RRB-
cord-023095-4dannjjm	2793	33	and	and	CC
cord-023095-4dannjjm	2793	34	2.77	2.77	CD
cord-023095-4dannjjm	2793	35	(	(	-LRB-
cord-023095-4dannjjm	2793	36	Cmax	Cmax	NNP
cord-023095-4dannjjm	2793	37	)	)	-RRB-
cord-023095-4dannjjm	2793	38	for	for	IN
cord-023095-4dannjjm	2793	39	the	the	DT
cord-023095-4dannjjm	2793	40	8	8	CD
cord-023095-4dannjjm	2793	41	mg	mg	NNP
cord-023095-4dannjjm	2793	42	/	/	SYM
cord-023095-4dannjjm	2793	43	kg	kg	NNS
cord-023095-4dannjjm	2793	44	dose	dose	VBD
cord-023095-4dannjjm	2793	45	after	after	IN
cord-023095-4dannjjm	2793	46	14	14	CD
cord-023095-4dannjjm	2793	47	days	day	NNS
cord-023095-4dannjjm	2793	48	.	.	.
cord-023095-4dannjjm	2794	1	The	the	DT
cord-023095-4dannjjm	2794	2	model	model	NN
cord-023095-4dannjjm	2794	3	estimate	estimate	NN
cord-023095-4dannjjm	2794	4	for	for	IN
cord-023095-4dannjjm	2794	5	the	the	DT
cord-023095-4dannjjm	2794	6	number	number	NN
cord-023095-4dannjjm	2794	7	of	of	IN
cord-023095-4dannjjm	2794	8	doses	dose	NNS
cord-023095-4dannjjm	2794	9	required	require	VBN
cord-023095-4dannjjm	2794	10	to	to	TO
cord-023095-4dannjjm	2794	11	reach	reach	VB
cord-023095-4dannjjm	2794	12	90	90	CD
cord-023095-4dannjjm	2794	13	%	%	NN
cord-023095-4dannjjm	2794	14	of	of	IN
cord-023095-4dannjjm	2794	15	steady	steady	JJ
cord-023095-4dannjjm	2794	16	-	-	HYPH
cord-023095-4dannjjm	2794	17	state	state	NN
cord-023095-4dannjjm	2794	18	was	be	VBD
cord-023095-4dannjjm	2794	19	4.30	4.30	CD
cord-023095-4dannjjm	2794	20	for	for	IN
cord-023095-4dannjjm	2794	21	2	2	CD
cord-023095-4dannjjm	2794	22	mg	mg	NNP
cord-023095-4dannjjm	2794	23	/	/	SYM
cord-023095-4dannjjm	2794	24	kg	kg	NNS
cord-023095-4dannjjm	2794	25	and	and	CC
cord-023095-4dannjjm	2794	26	8.09	8.09	CD
cord-023095-4dannjjm	2794	27	for	for	IN
cord-023095-4dannjjm	2794	28	8	8	CD
cord-023095-4dannjjm	2794	29	mg	mg	NNP
cord-023095-4dannjjm	2794	30	/	/	SYM
cord-023095-4dannjjm	2794	31	kg	kg	NNS
cord-023095-4dannjjm	2794	32	.	.	.
cord-023095-4dannjjm	2795	1	Three	three	CD
cord-023095-4dannjjm	2795	2	dogs	dog	NNS
cord-023095-4dannjjm	2795	3	experienced	experience	VBD
cord-023095-4dannjjm	2795	4	a	a	DT
cord-023095-4dannjjm	2795	5	single	single	JJ
cord-023095-4dannjjm	2795	6	episode	episode	NN
cord-023095-4dannjjm	2795	7	of	of	IN
cord-023095-4dannjjm	2795	8	vomiting	vomiting	NN
cord-023095-4dannjjm	2795	9	.	.	.
cord-023095-4dannjjm	2796	1	Dosing	dosing	NN
cord-023095-4dannjjm	2796	2	maropitant	maropitant	NN
cord-023095-4dannjjm	2796	3	citrate	citrate	NN
cord-023095-4dannjjm	2796	4	beyond	beyond	IN
cord-023095-4dannjjm	2796	5	the	the	DT
cord-023095-4dannjjm	2796	6	label	label	NN
cord-023095-4dannjjm	2796	7	duration	duration	NN
cord-023095-4dannjjm	2796	8	was	be	VBD
cord-023095-4dannjjm	2796	9	well	well	RB
cord-023095-4dannjjm	2796	10	tolerated	tolerate	VBN
cord-023095-4dannjjm	2796	11	by	by	IN
cord-023095-4dannjjm	2796	12	healthy	healthy	JJ
cord-023095-4dannjjm	2796	13	dogs	dog	NNS
cord-023095-4dannjjm	2796	14	.	.	.
cord-023095-4dannjjm	2797	1	Steady	steady	JJ
cord-023095-4dannjjm	2797	2	-	-	HYPH
cord-023095-4dannjjm	2797	3	state	state	NN
cord-023095-4dannjjm	2797	4	was	be	VBD
cord-023095-4dannjjm	2797	5	reached	reach	VBN
cord-023095-4dannjjm	2797	6	after	after	IN
cord-023095-4dannjjm	2797	7	approximately	approximately	RB
cord-023095-4dannjjm	2797	8	4	4	CD
cord-023095-4dannjjm	2797	9	doses	dose	NNS
cord-023095-4dannjjm	2797	10	for	for	IN
cord-023095-4dannjjm	2797	11	daily	daily	JJ
cord-023095-4dannjjm	2797	12	2	2	CD
cord-023095-4dannjjm	2797	13	mg	mg	NNP
cord-023095-4dannjjm	2797	14	/	/	SYM
cord-023095-4dannjjm	2797	15	kg	kg	NNS
cord-023095-4dannjjm	2797	16	and	and	CC
cord-023095-4dannjjm	2797	17	8	8	CD
cord-023095-4dannjjm	2797	18	doses	dose	NNS
cord-023095-4dannjjm	2797	19	for	for	IN
cord-023095-4dannjjm	2797	20	daily	daily	JJ
cord-023095-4dannjjm	2797	21	8	8	CD
cord-023095-4dannjjm	2797	22	mg	mg	NNP
cord-023095-4dannjjm	2797	23	/	/	SYM
cord-023095-4dannjjm	2797	24	kg	kg	CD
cord-023095-4dannjjm	2797	25	oral	oral	JJ
cord-023095-4dannjjm	2797	26	dosing	dosing	NN
cord-023095-4dannjjm	2797	27	.	.	.
cord-023095-4dannjjm	2798	1	Previously	previously	RB
cord-023095-4dannjjm	2798	2	presented	present	VBN
cord-023095-4dannjjm	2798	3	at	at	IN
cord-023095-4dannjjm	2798	4	the	the	DT
cord-023095-4dannjjm	2798	5	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	2798	6	Cancer	Cancer	NNP
cord-023095-4dannjjm	2798	7	Society	Society	NNP
cord-023095-4dannjjm	2798	8	,	,	,
cord-023095-4dannjjm	2798	9	November	November	NNP
cord-023095-4dannjjm	2798	10	2010	2010	CD
cord-023095-4dannjjm	2798	11	.	.	.
cord-023095-4dannjjm	2799	1	Cobalamin	Cobalamin	NNP
cord-023095-4dannjjm	2799	2	(	(	-LRB-
cord-023095-4dannjjm	2799	3	vitamin	vitamin	NN
cord-023095-4dannjjm	2799	4	B	b	NN
cord-023095-4dannjjm	2799	5	12	12	CD
cord-023095-4dannjjm	2799	6	)	)	-RRB-
cord-023095-4dannjjm	2799	7	is	be	VBZ
cord-023095-4dannjjm	2799	8	involved	involve	VBN
cord-023095-4dannjjm	2799	9	in	in	IN
cord-023095-4dannjjm	2799	10	a	a	DT
cord-023095-4dannjjm	2799	11	variety	variety	NN
cord-023095-4dannjjm	2799	12	of	of	IN
cord-023095-4dannjjm	2799	13	metabolic	metabolic	JJ
cord-023095-4dannjjm	2799	14	processes	process	NNS
cord-023095-4dannjjm	2799	15	.	.	.
cord-023095-4dannjjm	2800	1	Altered	altered	JJ
cord-023095-4dannjjm	2800	2	serum	serum	NN
cord-023095-4dannjjm	2800	3	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2800	4	concentrations	concentration	NNS
cord-023095-4dannjjm	2800	5	have	have	VBP
cord-023095-4dannjjm	2800	6	been	be	VBN
cord-023095-4dannjjm	2800	7	observed	observe	VBN
cord-023095-4dannjjm	2800	8	in	in	IN
cord-023095-4dannjjm	2800	9	dogs	dog	NNS
cord-023095-4dannjjm	2800	10	with	with	IN
cord-023095-4dannjjm	2800	11	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2800	12	disorders	disorder	NNS
cord-023095-4dannjjm	2800	13	,	,	,
cord-023095-4dannjjm	2800	14	such	such	JJ
cord-023095-4dannjjm	2800	15	as	as	IN
cord-023095-4dannjjm	2800	16	exocrine	exocrine	JJ
cord-023095-4dannjjm	2800	17	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	2800	18	insufficiency	insufficiency	NN
cord-023095-4dannjjm	2800	19	(	(	-LRB-
cord-023095-4dannjjm	2800	20	EPI	EPI	NNP
cord-023095-4dannjjm	2800	21	)	)	-RRB-
cord-023095-4dannjjm	2800	22	or	or	CC
cord-023095-4dannjjm	2800	23	severe	severe	JJ
cord-023095-4dannjjm	2800	24	and	and	CC
cord-023095-4dannjjm	2800	25	longstanding	longstanding	JJ
cord-023095-4dannjjm	2800	26	ileal	ileal	JJ
cord-023095-4dannjjm	2800	27	disease	disease	NN
cord-023095-4dannjjm	2800	28	.	.	.
cord-023095-4dannjjm	2801	1	This	this	DT
cord-023095-4dannjjm	2801	2	study	study	NN
cord-023095-4dannjjm	2801	3	was	be	VBD
cord-023095-4dannjjm	2801	4	conducted	conduct	VBN
cord-023095-4dannjjm	2801	5	to	to	TO
cord-023095-4dannjjm	2801	6	identify	identify	VB
cord-023095-4dannjjm	2801	7	breeds	breed	NNS
cord-023095-4dannjjm	2801	8	with	with	IN
cord-023095-4dannjjm	2801	9	a	a	DT
cord-023095-4dannjjm	2801	10	higher	high	JJR
cord-023095-4dannjjm	2801	11	proportion	proportion	NN
cord-023095-4dannjjm	2801	12	of	of	IN
cord-023095-4dannjjm	2801	13	a	a	DT
cord-023095-4dannjjm	2801	14	decreased	decrease	VBN
cord-023095-4dannjjm	2801	15	serum	serum	NN
cord-023095-4dannjjm	2801	16	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2801	17	concentration	concentration	NN
cord-023095-4dannjjm	2801	18	that	that	WDT
cord-023095-4dannjjm	2801	19	were	be	VBD
cord-023095-4dannjjm	2801	20	submitted	submit	VBN
cord-023095-4dannjjm	2801	21	to	to	IN
cord-023095-4dannjjm	2801	22	the	the	DT
cord-023095-4dannjjm	2801	23	Gastrointestinal	Gastrointestinal	NNP
cord-023095-4dannjjm	2801	24	Laboratory	Laboratory	NNP
cord-023095-4dannjjm	2801	25	.	.	.
cord-023095-4dannjjm	2802	1	The	the	DT
cord-023095-4dannjjm	2802	2	study	study	NN
cord-023095-4dannjjm	2802	3	was	be	VBD
cord-023095-4dannjjm	2802	4	also	also	RB
cord-023095-4dannjjm	2802	5	aimed	aim	VBN
cord-023095-4dannjjm	2802	6	at	at	IN
cord-023095-4dannjjm	2802	7	investigating	investigate	VBG
cord-023095-4dannjjm	2802	8	serum	serum	NN
cord-023095-4dannjjm	2802	9	trypsin	trypsin	NN
cord-023095-4dannjjm	2802	10	-	-	HYPH
cord-023095-4dannjjm	2802	11	like	like	JJ
cord-023095-4dannjjm	2802	12	immunoreactivity	immunoreactivity	NN
cord-023095-4dannjjm	2802	13	(	(	-LRB-
cord-023095-4dannjjm	2802	14	TLI	TLI	NNP
cord-023095-4dannjjm	2802	15	)	)	-RRB-
cord-023095-4dannjjm	2802	16	concentrations	concentration	NNS
cord-023095-4dannjjm	2802	17	that	that	WDT
cord-023095-4dannjjm	2802	18	were	be	VBD
cord-023095-4dannjjm	2802	19	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	2802	20	for	for	IN
cord-023095-4dannjjm	2802	21	EPI	EPI	NNP
cord-023095-4dannjjm	2802	22	in	in	IN
cord-023095-4dannjjm	2802	23	the	the	DT
cord-023095-4dannjjm	2802	24	dogs	dog	NNS
cord-023095-4dannjjm	2802	25	with	with	IN
cord-023095-4dannjjm	2802	26	a	a	DT
cord-023095-4dannjjm	2802	27	decreased	decrease	VBN
cord-023095-4dannjjm	2802	28	serum	serum	NN
cord-023095-4dannjjm	2802	29	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2802	30	concentration	concentration	NN
cord-023095-4dannjjm	2802	31	.	.	.
cord-023095-4dannjjm	2803	1	Except	except	IN
cord-023095-4dannjjm	2803	2	for	for	IN
cord-023095-4dannjjm	2803	3	CSP	CSP	NNP
cord-023095-4dannjjm	2803	4	,	,	,
cord-023095-4dannjjm	2803	5	breeds	breed	NNS
cord-023095-4dannjjm	2803	6	identified	identify	VBN
cord-023095-4dannjjm	2803	7	here	here	RB
cord-023095-4dannjjm	2803	8	,	,	,
cord-023095-4dannjjm	2803	9	have	have	VBP
cord-023095-4dannjjm	2803	10	not	not	RB
cord-023095-4dannjjm	2803	11	previously	previously	RB
cord-023095-4dannjjm	2803	12	been	be	VBN
cord-023095-4dannjjm	2803	13	identified	identify	VBN
cord-023095-4dannjjm	2803	14	to	to	TO
cord-023095-4dannjjm	2803	15	have	have	VB
cord-023095-4dannjjm	2803	16	a	a	DT
cord-023095-4dannjjm	2803	17	higher	high	JJR
cord-023095-4dannjjm	2803	18	rate	rate	NN
cord-023095-4dannjjm	2803	19	of	of	IN
cord-023095-4dannjjm	2803	20	a	a	DT
cord-023095-4dannjjm	2803	21	decreased	decrease	VBN
cord-023095-4dannjjm	2803	22	serum	serum	NN
cord-023095-4dannjjm	2803	23	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2803	24	concentration	concentration	NN
cord-023095-4dannjjm	2803	25	.	.	.
cord-023095-4dannjjm	2804	1	Also	also	RB
cord-023095-4dannjjm	2804	2	,	,	,
cord-023095-4dannjjm	2804	3	a	a	DT
cord-023095-4dannjjm	2804	4	possible	possible	JJ
cord-023095-4dannjjm	2804	5	association	association	NN
cord-023095-4dannjjm	2804	6	between	between	IN
cord-023095-4dannjjm	2804	7	an	an	DT
cord-023095-4dannjjm	2804	8	undetectable	undetectable	JJ
cord-023095-4dannjjm	2804	9	serum	serum	NN
cord-023095-4dannjjm	2804	10	cobalamin	cobalamin	NN
cord-023095-4dannjjm	2804	11	and	and	CC
cord-023095-4dannjjm	2804	12	a	a	DT
cord-023095-4dannjjm	2804	13	decreased	decrease	VBN
cord-023095-4dannjjm	2804	14	serum	serum	NN
cord-023095-4dannjjm	2804	15	TLI	TLI	NNP
cord-023095-4dannjjm	2804	16	in	in	IN
cord-023095-4dannjjm	2804	17	AI	AI	NNP
cord-023095-4dannjjm	2804	18	needs	need	VBZ
cord-023095-4dannjjm	2804	19	to	to	TO
cord-023095-4dannjjm	2804	20	be	be	VB
cord-023095-4dannjjm	2804	21	further	further	RB
cord-023095-4dannjjm	2804	22	investigated	investigate	VBN
cord-023095-4dannjjm	2804	23	.	.	.
cord-023095-4dannjjm	2805	1	Calprotectin	Calprotectin	NNP
cord-023095-4dannjjm	2805	2	(	(	-LRB-
cord-023095-4dannjjm	2805	3	CP	CP	NNP
cord-023095-4dannjjm	2805	4	)	)	-RRB-
cord-023095-4dannjjm	2805	5	is	be	VBZ
cord-023095-4dannjjm	2805	6	a	a	DT
cord-023095-4dannjjm	2805	7	widely	widely	RB
cord-023095-4dannjjm	2805	8	used	use	VBN
cord-023095-4dannjjm	2805	9	marker	marker	NN
cord-023095-4dannjjm	2805	10	for	for	IN
cord-023095-4dannjjm	2805	11	the	the	DT
cord-023095-4dannjjm	2805	12	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2805	13	and	and	CC
cord-023095-4dannjjm	2805	14	monitoring	monitoring	NN
cord-023095-4dannjjm	2805	15	of	of	IN
cord-023095-4dannjjm	2805	16	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2805	17	(	(	-LRB-
cord-023095-4dannjjm	2805	18	GI	gi	NN
cord-023095-4dannjjm	2805	19	)	)	-RRB-
cord-023095-4dannjjm	2805	20	inflammation	inflammation	NN
cord-023095-4dannjjm	2805	21	in	in	IN
cord-023095-4dannjjm	2805	22	humans	human	NNS
cord-023095-4dannjjm	2805	23	.	.	.
cord-023095-4dannjjm	2806	1	Studies	study	NNS
cord-023095-4dannjjm	2806	2	in	in	IN
cord-023095-4dannjjm	2806	3	humans	human	NNS
cord-023095-4dannjjm	2806	4	usually	usually	RB
cord-023095-4dannjjm	2806	5	report	report	VBP
cord-023095-4dannjjm	2806	6	fecal	fecal	JJ
cord-023095-4dannjjm	2806	7	CP	cp	NN
cord-023095-4dannjjm	2806	8	concentrations	concentration	NNS
cord-023095-4dannjjm	2806	9	based	base	VBN
cord-023095-4dannjjm	2806	10	on	on	IN
cord-023095-4dannjjm	2806	11	a	a	DT
cord-023095-4dannjjm	2806	12	single	single	JJ
cord-023095-4dannjjm	2806	13	stool	stool	NN
cord-023095-4dannjjm	2806	14	sample	sample	NN
cord-023095-4dannjjm	2806	15	although	although	IN
cord-023095-4dannjjm	2806	16	considerable	considerable	JJ
cord-023095-4dannjjm	2806	17	day	day	NN
cord-023095-4dannjjm	2806	18	-	-	HYPH
cord-023095-4dannjjm	2806	19	to	to	IN
cord-023095-4dannjjm	2806	20	-	-	HYPH
cord-023095-4dannjjm	2806	21	day	day	NN
cord-023095-4dannjjm	2806	22	variability	variability	NN
cord-023095-4dannjjm	2806	23	of	of	IN
cord-023095-4dannjjm	2806	24	fecal	fecal	JJ
cord-023095-4dannjjm	2806	25	CP	CP	NNP
cord-023095-4dannjjm	2806	26	was	be	VBD
cord-023095-4dannjjm	2806	27	found	find	VBN
cord-023095-4dannjjm	2806	28	in	in	IN
cord-023095-4dannjjm	2806	29	patients	patient	NNS
cord-023095-4dannjjm	2806	30	with	with	IN
cord-023095-4dannjjm	2806	31	GI	GI	NNP
cord-023095-4dannjjm	2806	32	disease	disease	NN
cord-023095-4dannjjm	2806	33	and	and	CC
cord-023095-4dannjjm	2806	34	in	in	IN
cord-023095-4dannjjm	2806	35	healthy	healthy	JJ
cord-023095-4dannjjm	2806	36	controls	control	NNS
cord-023095-4dannjjm	2806	37	.	.	.
cord-023095-4dannjjm	2807	1	Intra	intra	JJ
cord-023095-4dannjjm	2807	2	-	-	JJ
cord-023095-4dannjjm	2807	3	individual	individual	JJ
cord-023095-4dannjjm	2807	4	variation	variation	NN
cord-023095-4dannjjm	2807	5	of	of	IN
cord-023095-4dannjjm	2807	6	canine	canine	JJ
cord-023095-4dannjjm	2807	7	CP	cp	NN
cord-023095-4dannjjm	2807	8	(	(	-LRB-
cord-023095-4dannjjm	2807	9	cCP	cCP	NNP
cord-023095-4dannjjm	2807	10	)	)	-RRB-
cord-023095-4dannjjm	2807	11	was	be	VBD
cord-023095-4dannjjm	2807	12	also	also	RB
cord-023095-4dannjjm	2807	13	substantial	substantial	JJ
cord-023095-4dannjjm	2807	14	in	in	IN
cord-023095-4dannjjm	2807	15	a	a	DT
cord-023095-4dannjjm	2807	16	small	small	JJ
cord-023095-4dannjjm	2807	17	number	number	NN
cord-023095-4dannjjm	2807	18	of	of	IN
cord-023095-4dannjjm	2807	19	healthy	healthy	JJ
cord-023095-4dannjjm	2807	20	dogs	dog	NNS
cord-023095-4dannjjm	2807	21	but	but	CC
cord-023095-4dannjjm	2807	22	has	have	VBZ
cord-023095-4dannjjm	2807	23	not	not	RB
cord-023095-4dannjjm	2807	24	been	be	VBN
cord-023095-4dannjjm	2807	25	determined	determine	VBN
cord-023095-4dannjjm	2807	26	in	in	IN
cord-023095-4dannjjm	2807	27	dogs	dog	NNS
cord-023095-4dannjjm	2807	28	with	with	IN
cord-023095-4dannjjm	2807	29	chronic	chronic	JJ
cord-023095-4dannjjm	2807	30	GI	GI	NNP
cord-023095-4dannjjm	2807	31	disease	disease	NN
cord-023095-4dannjjm	2807	32	.	.	.
cord-023095-4dannjjm	2808	1	Thus	thus	RB
cord-023095-4dannjjm	2808	2	,	,	,
cord-023095-4dannjjm	2808	3	the	the	DT
cord-023095-4dannjjm	2808	4	aim	aim	NN
cord-023095-4dannjjm	2808	5	of	of	IN
cord-023095-4dannjjm	2808	6	this	this	DT
cord-023095-4dannjjm	2808	7	study	study	NN
cord-023095-4dannjjm	2808	8	was	be	VBD
cord-023095-4dannjjm	2808	9	to	to	TO
cord-023095-4dannjjm	2808	10	compare	compare	VB
cord-023095-4dannjjm	2808	11	the	the	DT
cord-023095-4dannjjm	2808	12	day	day	NN
cord-023095-4dannjjm	2808	13	-	-	HYPH
cord-023095-4dannjjm	2808	14	to	to	IN
cord-023095-4dannjjm	2808	15	-	-	HYPH
cord-023095-4dannjjm	2808	16	day	day	NN
cord-023095-4dannjjm	2808	17	variation	variation	NN
cord-023095-4dannjjm	2808	18	of	of	IN
cord-023095-4dannjjm	2808	19	fecal	fecal	NN
cord-023095-4dannjjm	2808	20	cCP	ccp	RB
cord-023095-4dannjjm	2808	21	in	in	IN
cord-023095-4dannjjm	2808	22	dogs	dog	NNS
cord-023095-4dannjjm	2808	23	with	with	IN
cord-023095-4dannjjm	2808	24	chronic	chronic	JJ
cord-023095-4dannjjm	2808	25	GI	GI	NNP
cord-023095-4dannjjm	2808	26	disease	disease	NN
cord-023095-4dannjjm	2808	27	before	before	IN
cord-023095-4dannjjm	2808	28	and	and	CC
cord-023095-4dannjjm	2808	29	during	during	IN
cord-023095-4dannjjm	2808	30	treatment	treatment	NN
cord-023095-4dannjjm	2808	31	to	to	IN
cord-023095-4dannjjm	2808	32	that	that	DT
cord-023095-4dannjjm	2808	33	in	in	IN
cord-023095-4dannjjm	2808	34	healthy	healthy	JJ
cord-023095-4dannjjm	2808	35	dogs	dog	NNS
cord-023095-4dannjjm	2808	36	.	.	.
cord-023095-4dannjjm	2809	1	We	-PRON-	PRP
cord-023095-4dannjjm	2809	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	2809	3	that	that	IN
cord-023095-4dannjjm	2809	4	fecal	fecal	NN
cord-023095-4dannjjm	2809	5	cCP	ccp	CD
cord-023095-4dannjjm	2809	6	would	would	MD
cord-023095-4dannjjm	2809	7	be	be	VB
cord-023095-4dannjjm	2809	8	less	less	RBR
cord-023095-4dannjjm	2809	9	variable	variable	JJ
cord-023095-4dannjjm	2809	10	in	in	IN
cord-023095-4dannjjm	2809	11	patients	patient	NNS
cord-023095-4dannjjm	2809	12	with	with	IN
cord-023095-4dannjjm	2809	13	chronic	chronic	JJ
cord-023095-4dannjjm	2809	14	GI	GI	NNP
cord-023095-4dannjjm	2809	15	disease	disease	NN
cord-023095-4dannjjm	2809	16	than	than	IN
cord-023095-4dannjjm	2809	17	in	in	IN
cord-023095-4dannjjm	2809	18	healthy	healthy	JJ
cord-023095-4dannjjm	2809	19	controls	control	NNS
cord-023095-4dannjjm	2809	20	,	,	,
cord-023095-4dannjjm	2809	21	and	and	CC
cord-023095-4dannjjm	2809	22	thus	thus	RB
cord-023095-4dannjjm	2809	23	collection	collection	NN
cord-023095-4dannjjm	2809	24	of	of	IN
cord-023095-4dannjjm	2809	25	a	a	DT
cord-023095-4dannjjm	2809	26	single	single	JJ
cord-023095-4dannjjm	2809	27	fecal	fecal	JJ
cord-023095-4dannjjm	2809	28	sample	sample	NN
cord-023095-4dannjjm	2809	29	would	would	MD
cord-023095-4dannjjm	2809	30	be	be	VB
cord-023095-4dannjjm	2809	31	sufficient	sufficient	JJ
cord-023095-4dannjjm	2809	32	.	.	.
cord-023095-4dannjjm	2810	1	Fecal	fecal	JJ
cord-023095-4dannjjm	2810	2	samples	sample	NNS
cord-023095-4dannjjm	2810	3	from	from	IN
cord-023095-4dannjjm	2810	4	3	3	CD
cord-023095-4dannjjm	2810	5	consecutive	consecutive	JJ
cord-023095-4dannjjm	2810	6	days	day	NNS
cord-023095-4dannjjm	2810	7	were	be	VBD
cord-023095-4dannjjm	2810	8	prospectively	prospectively	RB
cord-023095-4dannjjm	2810	9	collected	collect	VBN
cord-023095-4dannjjm	2810	10	from	from	IN
cord-023095-4dannjjm	2810	11	15	15	CD
cord-023095-4dannjjm	2810	12	dogs	dog	NNS
cord-023095-4dannjjm	2810	13	(	(	-LRB-
cord-023095-4dannjjm	2810	14	group	group	NN
cord-023095-4dannjjm	2810	15	A	a	NN
cord-023095-4dannjjm	2810	16	;	;	:
cord-023095-4dannjjm	2810	17	median	median	JJ
cord-023095-4dannjjm	2810	18	age	age	NN
cord-023095-4dannjjm	2810	19	:	:	:
cord-023095-4dannjjm	2810	20	6.1	6.1	CD
cord-023095-4dannjjm	2810	21	years	year	NNS
cord-023095-4dannjjm	2810	22	)	)	-RRB-
cord-023095-4dannjjm	2810	23	referred	refer	VBD
cord-023095-4dannjjm	2810	24	for	for	IN
cord-023095-4dannjjm	2810	25	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	2810	26	work	work	NN
cord-023095-4dannjjm	2810	27	-	-	HYPH
cord-023095-4dannjjm	2810	28	up	up	NN
cord-023095-4dannjjm	2810	29	of	of	IN
cord-023095-4dannjjm	2810	30	chronic	chronic	JJ
cord-023095-4dannjjm	2810	31	signs	sign	NNS
cord-023095-4dannjjm	2810	32	of	of	IN
cord-023095-4dannjjm	2810	33	GI	GI	NNP
cord-023095-4dannjjm	2810	34	disease	disease	NN
cord-023095-4dannjjm	2810	35	,	,	,
cord-023095-4dannjjm	2810	36	from	from	IN
cord-023095-4dannjjm	2810	37	8	8	CD
cord-023095-4dannjjm	2810	38	dogs	dog	NNS
cord-023095-4dannjjm	2810	39	(	(	-LRB-
cord-023095-4dannjjm	2810	40	group	group	NN
cord-023095-4dannjjm	2810	41	B	b	NN
cord-023095-4dannjjm	2810	42	;	;	:
cord-023095-4dannjjm	2810	43	median	median	JJ
cord-023095-4dannjjm	2810	44	age	age	NN
cord-023095-4dannjjm	2810	45	:	:	:
cord-023095-4dannjjm	2810	46	5.6	5.6	CD
cord-023095-4dannjjm	2810	47	years	year	NNS
cord-023095-4dannjjm	2810	48	)	)	-RRB-
cord-023095-4dannjjm	2810	49	with	with	IN
cord-023095-4dannjjm	2810	50	stable	stable	JJ
cord-023095-4dannjjm	2810	51	GI	GI	NNP
cord-023095-4dannjjm	2810	52	disease	disease	NN
cord-023095-4dannjjm	2810	53	while	while	IN
cord-023095-4dannjjm	2810	54	being	be	VBG
cord-023095-4dannjjm	2810	55	treated	treat	VBN
cord-023095-4dannjjm	2810	56	,	,	,
cord-023095-4dannjjm	2810	57	and	and	CC
cord-023095-4dannjjm	2810	58	from	from	IN
cord-023095-4dannjjm	2810	59	44	44	CD
cord-023095-4dannjjm	2810	60	healthy	healthy	JJ
cord-023095-4dannjjm	2810	61	adult	adult	NN
cord-023095-4dannjjm	2810	62	dogs	dog	NNS
cord-023095-4dannjjm	2810	63	(	(	-LRB-
cord-023095-4dannjjm	2810	64	group	group	NN
cord-023095-4dannjjm	2810	65	C	C	NNP
cord-023095-4dannjjm	2810	66	;	;	:
cord-023095-4dannjjm	2810	67	mean	mean	VB
cord-023095-4dannjjm	2810	68	age	age	NN
cord-023095-4dannjjm	2810	69	:	:	:
cord-023095-4dannjjm	2810	70	5.4	5.4	CD
cord-023095-4dannjjm	2810	71	years	year	NNS
cord-023095-4dannjjm	2810	72	)	)	-RRB-
cord-023095-4dannjjm	2810	73	.	.	.
cord-023095-4dannjjm	2811	1	Fecal	fecal	JJ
cord-023095-4dannjjm	2811	2	samples	sample	NNS
cord-023095-4dannjjm	2811	3	were	be	VBD
cord-023095-4dannjjm	2811	4	extracted	extract	VBN
cord-023095-4dannjjm	2811	5	and	and	CC
cord-023095-4dannjjm	2811	6	cCP	cCP	NNP
cord-023095-4dannjjm	2811	7	was	be	VBD
cord-023095-4dannjjm	2811	8	measured	measure	VBN
cord-023095-4dannjjm	2811	9	by	by	IN
cord-023095-4dannjjm	2811	10	an	an	DT
cord-023095-4dannjjm	2811	11	in	in	IN
cord-023095-4dannjjm	2811	12	-	-	HYPH
cord-023095-4dannjjm	2811	13	house	house	NN
cord-023095-4dannjjm	2811	14	immunoassay	immunoassay	NN
cord-023095-4dannjjm	2811	15	.	.	.
cord-023095-4dannjjm	2812	1	Mean	mean	JJ
cord-023095-4dannjjm	2812	2	cCP	ccp	RB
cord-023095-4dannjjm	2812	3	,	,	,
cord-023095-4dannjjm	2812	4	standard	standard	JJ
cord-023095-4dannjjm	2812	5	deviation	deviation	NN
cord-023095-4dannjjm	2812	6	,	,	,
cord-023095-4dannjjm	2812	7	coefficient	coefficient	NN
cord-023095-4dannjjm	2812	8	of	of	IN
cord-023095-4dannjjm	2812	9	variation	variation	NN
cord-023095-4dannjjm	2812	10	(	(	-LRB-
cord-023095-4dannjjm	2812	11	CV	CV	NNP
cord-023095-4dannjjm	2812	12	)	)	-RRB-
cord-023095-4dannjjm	2812	13	,	,	,
cord-023095-4dannjjm	2812	14	and	and	CC
cord-023095-4dannjjm	2812	15	difference	difference	NN
cord-023095-4dannjjm	2812	16	between	between	IN
cord-023095-4dannjjm	2812	17	maximum	maximum	NN
cord-023095-4dannjjm	2812	18	and	and	CC
cord-023095-4dannjjm	2812	19	minimum	minimum	NN
cord-023095-4dannjjm	2812	20	cCP	ccp	RB
cord-023095-4dannjjm	2812	21	for	for	IN
cord-023095-4dannjjm	2812	22	the	the	DT
cord-023095-4dannjjm	2812	23	3-day	3-day	JJ
cord-023095-4dannjjm	2812	24	sample	sample	NN
cord-023095-4dannjjm	2812	25	collection	collection	NN
cord-023095-4dannjjm	2812	26	period	period	NN
cord-023095-4dannjjm	2812	27	were	be	VBD
cord-023095-4dannjjm	2812	28	calculated	calculate	VBN
cord-023095-4dannjjm	2812	29	for	for	IN
cord-023095-4dannjjm	2812	30	each	each	DT
cord-023095-4dannjjm	2812	31	dog	dog	NN
cord-023095-4dannjjm	2812	32	and	and	CC
cord-023095-4dannjjm	2812	33	were	be	VBD
cord-023095-4dannjjm	2812	34	compared	compare	VBN
cord-023095-4dannjjm	2812	35	among	among	IN
cord-023095-4dannjjm	2812	36	groups	group	NNS
cord-023095-4dannjjm	2812	37	using	use	VBG
cord-023095-4dannjjm	2812	38	a	a	DT
cord-023095-4dannjjm	2812	39	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	2812	40	-	-	HYPH
cord-023095-4dannjjm	2812	41	Wallis	Wallis	NNP
cord-023095-4dannjjm	2812	42	test	test	NN
cord-023095-4dannjjm	2812	43	.	.	.
cord-023095-4dannjjm	2813	1	Fecal	fecal	NN
cord-023095-4dannjjm	2813	2	cCP	cCP	NNP
cord-023095-4dannjjm	2813	3	ranged	range	VBD
cord-023095-4dannjjm	2813	4	from	from	IN
cord-023095-4dannjjm	2813	5	2.9	2.9	CD
cord-023095-4dannjjm	2813	6	-	-	SYM
cord-023095-4dannjjm	2813	7	102.7	102.7	CD
cord-023095-4dannjjm	2813	8	mg	mg	NNP
cord-023095-4dannjjm	2813	9	/	/	SYM
cord-023095-4dannjjm	2813	10	g	g	NNP
cord-023095-4dannjjm	2813	11	(	(	-LRB-
cord-023095-4dannjjm	2813	12	median	median	NN
cord-023095-4dannjjm	2813	13	:	:	:
cord-023095-4dannjjm	2813	14	17.6	17.6	CD
cord-023095-4dannjjm	2813	15	mg	mg	NNP
cord-023095-4dannjjm	2813	16	/	/	SYM
cord-023095-4dannjjm	2813	17	g	g	NNP
cord-023095-4dannjjm	2813	18	)	)	-RRB-
cord-023095-4dannjjm	2813	19	in	in	IN
cord-023095-4dannjjm	2813	20	dogs	dog	NNS
cord-023095-4dannjjm	2813	21	with	with	IN
cord-023095-4dannjjm	2813	22	GI	GI	NNP
cord-023095-4dannjjm	2813	23	disease	disease	NN
cord-023095-4dannjjm	2813	24	(	(	-LRB-
cord-023095-4dannjjm	2813	25	group	group	NN
cord-023095-4dannjjm	2813	26	A	A	NNP
cord-023095-4dannjjm	2813	27	)	)	-RRB-
cord-023095-4dannjjm	2813	28	,	,	,
cord-023095-4dannjjm	2813	29	from	from	IN
cord-023095-4dannjjm	2813	30	2.9	2.9	CD
cord-023095-4dannjjm	2813	31	-	-	SYM
cord-023095-4dannjjm	2813	32	265.1	265.1	CD
cord-023095-4dannjjm	2813	33	mg	mg	NNP
cord-023095-4dannjjm	2813	34	/	/	SYM
cord-023095-4dannjjm	2813	35	g	g	NNP
cord-023095-4dannjjm	2813	36	(	(	-LRB-
cord-023095-4dannjjm	2813	37	median	median	NN
cord-023095-4dannjjm	2813	38	:	:	:
cord-023095-4dannjjm	2813	39	18.4	18.4	CD
cord-023095-4dannjjm	2813	40	mg	mg	NNP
cord-023095-4dannjjm	2813	41	/	/	SYM
cord-023095-4dannjjm	2813	42	g	g	NNP
cord-023095-4dannjjm	2813	43	)	)	-RRB-
cord-023095-4dannjjm	2813	44	in	in	IN
cord-023095-4dannjjm	2813	45	dogs	dog	NNS
cord-023095-4dannjjm	2813	46	of	of	IN
cord-023095-4dannjjm	2813	47	group	group	NN
cord-023095-4dannjjm	2813	48	B	B	NNP
cord-023095-4dannjjm	2813	49	,	,	,
cord-023095-4dannjjm	2813	50	and	and	CC
cord-023095-4dannjjm	2813	51	from	from	IN
cord-023095-4dannjjm	2813	52	2.9	2.9	CD
cord-023095-4dannjjm	2813	53	-	-	HYPH
cord-023095-4dannjjm	2813	54	93.1	93.1	CD
cord-023095-4dannjjm	2813	55	mg	mg	NNP
cord-023095-4dannjjm	2813	56	/	/	SYM
cord-023095-4dannjjm	2813	57	g	g	NNP
cord-023095-4dannjjm	2813	58	(	(	-LRB-
cord-023095-4dannjjm	2813	59	median	median	NN
cord-023095-4dannjjm	2813	60	:	:	:
cord-023095-4dannjjm	2813	61	7.9	7.9	CD
cord-023095-4dannjjm	2813	62	mg	mg	NNP
cord-023095-4dannjjm	2813	63	/	/	SYM
cord-023095-4dannjjm	2813	64	g	g	NN
cord-023095-4dannjjm	2813	65	)	)	-RRB-
cord-023095-4dannjjm	2813	66	in	in	IN
cord-023095-4dannjjm	2813	67	healthy	healthy	JJ
cord-023095-4dannjjm	2813	68	controls	control	NNS
cord-023095-4dannjjm	2813	69	(	(	-LRB-
cord-023095-4dannjjm	2813	70	group	group	NN
cord-023095-4dannjjm	2813	71	C	C	NNP
cord-023095-4dannjjm	2813	72	)	)	-RRB-
cord-023095-4dannjjm	2813	73	.	.	.
cord-023095-4dannjjm	2814	1	CVs	cv	NNS
cord-023095-4dannjjm	2814	2	were	be	VBD
cord-023095-4dannjjm	2814	3	0	0	CD
cord-023095-4dannjjm	2814	4	-	-	SYM
cord-023095-4dannjjm	2814	5	121.3	121.3	CD
cord-023095-4dannjjm	2814	6	%	%	NN
cord-023095-4dannjjm	2814	7	in	in	IN
cord-023095-4dannjjm	2814	8	group	group	NN
cord-023095-4dannjjm	2814	9	A	a	NN
cord-023095-4dannjjm	2814	10	(	(	-LRB-
cord-023095-4dannjjm	2814	11	median	median	NN
cord-023095-4dannjjm	2814	12	:	:	:
cord-023095-4dannjjm	2814	13	20.0	20.0	CD
cord-023095-4dannjjm	2814	14	%	%	NN
cord-023095-4dannjjm	2814	15	)	)	-RRB-
cord-023095-4dannjjm	2814	16	,	,	,
cord-023095-4dannjjm	2814	17	2.0	2.0	CD
cord-023095-4dannjjm	2814	18	-	-	HYPH
cord-023095-4dannjjm	2814	19	89.4	89.4	CD
cord-023095-4dannjjm	2814	20	%	%	NN
cord-023095-4dannjjm	2814	21	in	in	IN
cord-023095-4dannjjm	2814	22	group	group	NN
cord-023095-4dannjjm	2814	23	B	b	NN
cord-023095-4dannjjm	2814	24	(	(	-LRB-
cord-023095-4dannjjm	2814	25	median	median	NN
cord-023095-4dannjjm	2814	26	:	:	:
cord-023095-4dannjjm	2814	27	47.4	47.4	CD
cord-023095-4dannjjm	2814	28	%	%	NN
cord-023095-4dannjjm	2814	29	)	)	-RRB-
cord-023095-4dannjjm	2814	30	,	,	,
cord-023095-4dannjjm	2814	31	and	and	CC
cord-023095-4dannjjm	2814	32	0	0	CD
cord-023095-4dannjjm	2814	33	-	-	SYM
cord-023095-4dannjjm	2814	34	145.2	145.2	CD
cord-023095-4dannjjm	2814	35	%	%	NN
cord-023095-4dannjjm	2814	36	in	in	IN
cord-023095-4dannjjm	2814	37	group	group	NN
cord-023095-4dannjjm	2814	38	C	C	NNP
cord-023095-4dannjjm	2814	39	(	(	-LRB-
cord-023095-4dannjjm	2814	40	median	median	NN
cord-023095-4dannjjm	2814	41	:	:	:
cord-023095-4dannjjm	2814	42	40.4	40.4	CD
cord-023095-4dannjjm	2814	43	%	%	NN
cord-023095-4dannjjm	2814	44	)	)	-RRB-
cord-023095-4dannjjm	2814	45	,	,	,
cord-023095-4dannjjm	2814	46	respectively	respectively	RB
cord-023095-4dannjjm	2814	47	.	.	.
cord-023095-4dannjjm	2815	1	Patients	patient	NNS
cord-023095-4dannjjm	2815	2	in	in	IN
cord-023095-4dannjjm	2815	3	group	group	NN
cord-023095-4dannjjm	2815	4	A	A	NNP
cord-023095-4dannjjm	2815	5	appeared	appear	VBD
cord-023095-4dannjjm	2815	6	to	to	TO
cord-023095-4dannjjm	2815	7	have	have	VB
cord-023095-4dannjjm	2815	8	less	less	JJR
cord-023095-4dannjjm	2815	9	variable	variable	JJ
cord-023095-4dannjjm	2815	10	fecal	fecal	NN
cord-023095-4dannjjm	2815	11	cCP	ccp	RB
cord-023095-4dannjjm	2815	12	than	than	IN
cord-023095-4dannjjm	2815	13	dogs	dog	NNS
cord-023095-4dannjjm	2815	14	in	in	IN
cord-023095-4dannjjm	2815	15	group	group	NN
cord-023095-4dannjjm	2815	16	B	B	NNP
cord-023095-4dannjjm	2815	17	and	and	CC
cord-023095-4dannjjm	2815	18	C	C	NNP
cord-023095-4dannjjm	2815	19	,	,	,
cord-023095-4dannjjm	2815	20	but	but	CC
cord-023095-4dannjjm	2815	21	this	this	DT
cord-023095-4dannjjm	2815	22	difference	difference	NN
cord-023095-4dannjjm	2815	23	was	be	VBD
cord-023095-4dannjjm	2815	24	not	not	RB
cord-023095-4dannjjm	2815	25	significant	significant	JJ
cord-023095-4dannjjm	2816	1	(	(	-LRB-
cord-023095-4dannjjm	2816	2	p	p	NN
cord-023095-4dannjjm	2816	3	5	5	CD
cord-023095-4dannjjm	2816	4	0.326	0.326	CD
cord-023095-4dannjjm	2816	5	)	)	-RRB-
cord-023095-4dannjjm	2816	6	.	.	.
cord-023095-4dannjjm	2817	1	The	the	DT
cord-023095-4dannjjm	2817	2	difference	difference	NN
cord-023095-4dannjjm	2817	3	between	between	IN
cord-023095-4dannjjm	2817	4	maximum	maximum	NN
cord-023095-4dannjjm	2817	5	and	and	CC
cord-023095-4dannjjm	2817	6	minimum	minimum	NN
cord-023095-4dannjjm	2817	7	cCP	ccp	RB
cord-023095-4dannjjm	2817	8	for	for	IN
cord-023095-4dannjjm	2817	9	the	the	DT
cord-023095-4dannjjm	2817	10	3-day	3-day	JJ
cord-023095-4dannjjm	2817	11	sample	sample	NN
cord-023095-4dannjjm	2817	12	collection	collection	NN
cord-023095-4dannjjm	2817	13	ranged	range	VBD
cord-023095-4dannjjm	2817	14	from	from	IN
cord-023095-4dannjjm	2817	15	0	0	CD
cord-023095-4dannjjm	2817	16	-	-	SYM
cord-023095-4dannjjm	2817	17	31.1	31.1	CD
cord-023095-4dannjjm	2817	18	mg	mg	NNP
cord-023095-4dannjjm	2817	19	/	/	SYM
cord-023095-4dannjjm	2817	20	g	g	NN
cord-023095-4dannjjm	2817	21	in	in	IN
cord-023095-4dannjjm	2817	22	group	group	NN
cord-023095-4dannjjm	2817	23	A	A	NNP
cord-023095-4dannjjm	2817	24	(	(	-LRB-
cord-023095-4dannjjm	2817	25	median	median	NN
cord-023095-4dannjjm	2817	26	:	:	:
cord-023095-4dannjjm	2817	27	7.2	7.2	CD
cord-023095-4dannjjm	2817	28	mg	mg	NNP
cord-023095-4dannjjm	2817	29	/	/	SYM
cord-023095-4dannjjm	2817	30	g	g	NNP
cord-023095-4dannjjm	2817	31	)	)	-RRB-
cord-023095-4dannjjm	2817	32	,	,	,
cord-023095-4dannjjm	2817	33	from	from	IN
cord-023095-4dannjjm	2817	34	0.1	0.1	CD
cord-023095-4dannjjm	2817	35	-	-	SYM
cord-023095-4dannjjm	2817	36	240.0	240.0	CD
cord-023095-4dannjjm	2817	37	mg	mg	NNP
cord-023095-4dannjjm	2817	38	/	/	SYM
cord-023095-4dannjjm	2817	39	g	g	NN
cord-023095-4dannjjm	2817	40	in	in	IN
cord-023095-4dannjjm	2817	41	group	group	NN
cord-023095-4dannjjm	2817	42	B	b	NN
cord-023095-4dannjjm	2817	43	(	(	-LRB-
cord-023095-4dannjjm	2817	44	median	median	NN
cord-023095-4dannjjm	2817	45	:	:	:
cord-023095-4dannjjm	2817	46	12.5	12.5	CD
cord-023095-4dannjjm	2817	47	mg	mg	NNP
cord-023095-4dannjjm	2817	48	/	/	SYM
cord-023095-4dannjjm	2817	49	g	g	NNP
cord-023095-4dannjjm	2817	50	)	)	-RRB-
cord-023095-4dannjjm	2817	51	,	,	,
cord-023095-4dannjjm	2817	52	and	and	CC
cord-023095-4dannjjm	2817	53	from	from	IN
cord-023095-4dannjjm	2817	54	0	0	CD
cord-023095-4dannjjm	2817	55	-	-	HYPH
cord-023095-4dannjjm	2817	56	57.4	57.4	CD
cord-023095-4dannjjm	2817	57	mg	mg	NNP
cord-023095-4dannjjm	2817	58	/	/	SYM
cord-023095-4dannjjm	2817	59	g	g	NN
cord-023095-4dannjjm	2817	60	in	in	IN
cord-023095-4dannjjm	2817	61	group	group	NN
cord-023095-4dannjjm	2817	62	C	C	NNP
cord-023095-4dannjjm	2817	63	(	(	-LRB-
cord-023095-4dannjjm	2817	64	median	median	NN
cord-023095-4dannjjm	2817	65	:	:	:
cord-023095-4dannjjm	2817	66	14.8	14.8	CD
cord-023095-4dannjjm	2817	67	mg	mg	NNP
cord-023095-4dannjjm	2817	68	/	/	SYM
cord-023095-4dannjjm	2817	69	g	g	NNP
cord-023095-4dannjjm	2817	70	)	)	-RRB-
cord-023095-4dannjjm	2817	71	,	,	,
cord-023095-4dannjjm	2817	72	and	and	CC
cord-023095-4dannjjm	2817	73	were	be	VBD
cord-023095-4dannjjm	2817	74	not	not	RB
cord-023095-4dannjjm	2817	75	significantly	significantly	RB
cord-023095-4dannjjm	2817	76	different	different	JJ
cord-023095-4dannjjm	2817	77	between	between	IN
cord-023095-4dannjjm	2817	78	any	any	DT
cord-023095-4dannjjm	2817	79	of	of	IN
cord-023095-4dannjjm	2817	80	the	the	DT
cord-023095-4dannjjm	2817	81	groups	group	NNS
cord-023095-4dannjjm	2817	82	(	(	-LRB-
cord-023095-4dannjjm	2817	83	p	p	NN
cord-023095-4dannjjm	2817	84	5	5	CD
cord-023095-4dannjjm	2817	85	0.530	0.530	CD
cord-023095-4dannjjm	2817	86	)	)	-RRB-
cord-023095-4dannjjm	2817	87	.	.	.
cord-023095-4dannjjm	2818	1	In	in	IN
cord-023095-4dannjjm	2818	2	this	this	DT
cord-023095-4dannjjm	2818	3	study	study	NN
cord-023095-4dannjjm	2818	4	,	,	,
cord-023095-4dannjjm	2818	5	considerable	considerable	JJ
cord-023095-4dannjjm	2818	6	day	day	NN
cord-023095-4dannjjm	2818	7	-	-	HYPH
cord-023095-4dannjjm	2818	8	to	to	IN
cord-023095-4dannjjm	2818	9	-	-	HYPH
cord-023095-4dannjjm	2818	10	day	day	NN
cord-023095-4dannjjm	2818	11	variation	variation	NN
cord-023095-4dannjjm	2818	12	of	of	IN
cord-023095-4dannjjm	2818	13	fecal	fecal	NN
cord-023095-4dannjjm	2818	14	cCP	cCP	NNP
cord-023095-4dannjjm	2818	15	was	be	VBD
cord-023095-4dannjjm	2818	16	found	find	VBN
cord-023095-4dannjjm	2818	17	in	in	IN
cord-023095-4dannjjm	2818	18	dogs	dog	NNS
cord-023095-4dannjjm	2818	19	with	with	IN
cord-023095-4dannjjm	2818	20	chronic	chronic	JJ
cord-023095-4dannjjm	2818	21	GI	gi	NN
cord-023095-4dannjjm	2818	22	disease	disease	NN
cord-023095-4dannjjm	2818	23	(	(	-LRB-
cord-023095-4dannjjm	2818	24	regardless	regardless	RB
cord-023095-4dannjjm	2818	25	of	of	IN
cord-023095-4dannjjm	2818	26	treatment	treatment	NN
cord-023095-4dannjjm	2818	27	)	)	-RRB-
cord-023095-4dannjjm	2818	28	and	and	CC
cord-023095-4dannjjm	2818	29	was	be	VBD
cord-023095-4dannjjm	2818	30	comparable	comparable	JJ
cord-023095-4dannjjm	2818	31	to	to	IN
cord-023095-4dannjjm	2818	32	that	that	DT
cord-023095-4dannjjm	2818	33	in	in	IN
cord-023095-4dannjjm	2818	34	healthy	healthy	JJ
cord-023095-4dannjjm	2818	35	dogs	dog	NNS
cord-023095-4dannjjm	2818	36	.	.	.
cord-023095-4dannjjm	2819	1	Results	result	NNS
cord-023095-4dannjjm	2819	2	of	of	IN
cord-023095-4dannjjm	2819	3	this	this	DT
cord-023095-4dannjjm	2819	4	study	study	NN
cord-023095-4dannjjm	2819	5	suggest	suggest	VBP
cord-023095-4dannjjm	2819	6	that	that	IN
cord-023095-4dannjjm	2819	7	for	for	IN
cord-023095-4dannjjm	2819	8	evaluating	evaluate	VBG
cord-023095-4dannjjm	2819	9	fecal	fecal	NN
cord-023095-4dannjjm	2819	10	cCP	ccp	RB
cord-023095-4dannjjm	2819	11	in	in	IN
cord-023095-4dannjjm	2819	12	dogs	dog	NNS
cord-023095-4dannjjm	2819	13	with	with	IN
cord-023095-4dannjjm	2819	14	clinical	clinical	JJ
cord-023095-4dannjjm	2819	15	signs	sign	NNS
cord-023095-4dannjjm	2819	16	of	of	IN
cord-023095-4dannjjm	2819	17	GI	GI	NNP
cord-023095-4dannjjm	2819	18	disease	disease	NN
cord-023095-4dannjjm	2819	19	,	,	,
cord-023095-4dannjjm	2819	20	three	three	CD
cord-023095-4dannjjm	2819	21	consecutive	consecutive	JJ
cord-023095-4dannjjm	2819	22	fecal	fecal	JJ
cord-023095-4dannjjm	2819	23	samples	sample	NNS
cord-023095-4dannjjm	2819	24	rather	rather	RB
cord-023095-4dannjjm	2819	25	than	than	IN
cord-023095-4dannjjm	2819	26	a	a	DT
cord-023095-4dannjjm	2819	27	single	single	JJ
cord-023095-4dannjjm	2819	28	fecal	fecal	JJ
cord-023095-4dannjjm	2819	29	sample	sample	NN
cord-023095-4dannjjm	2819	30	should	should	MD
cord-023095-4dannjjm	2819	31	be	be	VB
cord-023095-4dannjjm	2819	32	analyzed	analyze	VBN
cord-023095-4dannjjm	2819	33	.	.	.
cord-023095-4dannjjm	2820	1	Because	because	IN
cord-023095-4dannjjm	2820	2	we	-PRON-	PRP
cord-023095-4dannjjm	2820	3	did	do	VBD
cord-023095-4dannjjm	2820	4	not	not	RB
cord-023095-4dannjjm	2820	5	intend	intend	VB
cord-023095-4dannjjm	2820	6	to	to	TO
cord-023095-4dannjjm	2820	7	evaluate	evaluate	VB
cord-023095-4dannjjm	2820	8	the	the	DT
cord-023095-4dannjjm	2820	9	clinical	clinical	JJ
cord-023095-4dannjjm	2820	10	usefulness	usefulness	NN
cord-023095-4dannjjm	2820	11	of	of	IN
cord-023095-4dannjjm	2820	12	fecal	fecal	NN
cord-023095-4dannjjm	2820	13	cCP	ccp	RB
cord-023095-4dannjjm	2820	14	as	as	IN
cord-023095-4dannjjm	2820	15	a	a	DT
cord-023095-4dannjjm	2820	16	marker	marker	NN
cord-023095-4dannjjm	2820	17	of	of	IN
cord-023095-4dannjjm	2820	18	GI	GI	NNP
cord-023095-4dannjjm	2820	19	disease	disease	NN
cord-023095-4dannjjm	2820	20	in	in	IN
cord-023095-4dannjjm	2820	21	dogs	dog	NNS
cord-023095-4dannjjm	2820	22	,	,	,
cord-023095-4dannjjm	2820	23	disease	disease	NN
cord-023095-4dannjjm	2820	24	severity	severity	NN
cord-023095-4dannjjm	2820	25	,	,	,
cord-023095-4dannjjm	2820	26	quality	quality	NN
cord-023095-4dannjjm	2820	27	,	,	,
cord-023095-4dannjjm	2820	28	and	and	CC
cord-023095-4dannjjm	2820	29	location	location	NN
cord-023095-4dannjjm	2820	30	differed	differ	VBD
cord-023095-4dannjjm	2820	31	among	among	IN
cord-023095-4dannjjm	2820	32	dogs	dog	NNS
cord-023095-4dannjjm	2820	33	in	in	IN
cord-023095-4dannjjm	2820	34	groups	group	NNS
cord-023095-4dannjjm	2821	1	A	A	NNP
cord-023095-4dannjjm	2821	2	and	and	CC
cord-023095-4dannjjm	2821	3	B.	B.	NNP
cord-023095-4dannjjm	2822	1	The	the	DT
cord-023095-4dannjjm	2822	2	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	2822	3	utility	utility	NN
cord-023095-4dannjjm	2822	4	of	of	IN
cord-023095-4dannjjm	2822	5	fecal	fecal	NN
cord-023095-4dannjjm	2822	6	cCP	ccp	RB
cord-023095-4dannjjm	2822	7	in	in	IN
cord-023095-4dannjjm	2822	8	dogs	dog	NNS
cord-023095-4dannjjm	2822	9	with	with	IN
cord-023095-4dannjjm	2822	10	GI	GI	NNP
cord-023095-4dannjjm	2822	11	disease	disease	NN
cord-023095-4dannjjm	2822	12	is	be	VBZ
cord-023095-4dannjjm	2822	13	currently	currently	RB
cord-023095-4dannjjm	2822	14	being	be	VBG
cord-023095-4dannjjm	2822	15	investigated	investigate	VBN
cord-023095-4dannjjm	2822	16	.	.	.
cord-023095-4dannjjm	2823	1	It	-PRON-	PRP
cord-023095-4dannjjm	2823	2	has	have	VBZ
cord-023095-4dannjjm	2823	3	been	be	VBN
cord-023095-4dannjjm	2823	4	suggested	suggest	VBN
cord-023095-4dannjjm	2823	5	that	that	IN
cord-023095-4dannjjm	2823	6	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2823	7	of	of	IN
cord-023095-4dannjjm	2823	8	Clostridium	clostridium	NN
cord-023095-4dannjjm	2823	9	perfringens	perfringen	NNS
cord-023095-4dannjjm	2823	10	related	relate	VBN
cord-023095-4dannjjm	2823	11	enteropathy	enteropathy	NNS
cord-023095-4dannjjm	2823	12	should	should	MD
cord-023095-4dannjjm	2823	13	be	be	VB
cord-023095-4dannjjm	2823	14	based	base	VBN
cord-023095-4dannjjm	2823	15	on	on	IN
cord-023095-4dannjjm	2823	16	the	the	DT
cord-023095-4dannjjm	2823	17	detection	detection	NN
cord-023095-4dannjjm	2823	18	of	of	IN
cord-023095-4dannjjm	2823	19	the	the	DT
cord-023095-4dannjjm	2823	20	C.	C.	NNP
cord-023095-4dannjjm	2823	21	perfringens	perfringens	NN
cord-023095-4dannjjm	2823	22	enterotoxin	enterotoxin	NNP
cord-023095-4dannjjm	2823	23	gene	gene	NNP
cord-023095-4dannjjm	2823	24	(	(	-LRB-
cord-023095-4dannjjm	2823	25	cpe	cpe	NNP
cord-023095-4dannjjm	2823	26	-	-	HYPH
cord-023095-4dannjjm	2823	27	gene	gene	NN
cord-023095-4dannjjm	2823	28	)	)	-RRB-
cord-023095-4dannjjm	2823	29	by	by	IN
cord-023095-4dannjjm	2823	30	PCR	PCR	NNP
cord-023095-4dannjjm	2823	31	and/or	and/or	CC
cord-023095-4dannjjm	2823	32	C.	C.	NNP
cord-023095-4dannjjm	2823	33	perfringens	perfringens	NN
cord-023095-4dannjjm	2823	34	enterotoxin	enterotoxin	NNP
cord-023095-4dannjjm	2823	35	(	(	-LRB-
cord-023095-4dannjjm	2823	36	CPE	CPE	NNP
cord-023095-4dannjjm	2823	37	)	)	-RRB-
cord-023095-4dannjjm	2823	38	by	by	IN
cord-023095-4dannjjm	2823	39	ELISA	ELISA	NNP
cord-023095-4dannjjm	2823	40	in	in	IN
cord-023095-4dannjjm	2823	41	feces	fece	NNS
cord-023095-4dannjjm	2823	42	.	.	.
cord-023095-4dannjjm	2824	1	However	however	RB
cord-023095-4dannjjm	2824	2	,	,	,
cord-023095-4dannjjm	2824	3	the	the	DT
cord-023095-4dannjjm	2824	4	prevalence	prevalence	NN
cord-023095-4dannjjm	2824	5	of	of	IN
cord-023095-4dannjjm	2824	6	the	the	DT
cord-023095-4dannjjm	2824	7	cpe	cpe	NNP
cord-023095-4dannjjm	2824	8	-	-	HYPH
cord-023095-4dannjjm	2824	9	gene	gene	NNP
cord-023095-4dannjjm	2824	10	and	and	CC
cord-023095-4dannjjm	2824	11	CPE	CPE	NNP
cord-023095-4dannjjm	2824	12	in	in	IN
cord-023095-4dannjjm	2824	13	dogs	dog	NNS
cord-023095-4dannjjm	2824	14	and	and	CC
cord-023095-4dannjjm	2824	15	especially	especially	RB
cord-023095-4dannjjm	2824	16	cats	cat	NNS
cord-023095-4dannjjm	2824	17	with	with	IN
cord-023095-4dannjjm	2824	18	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2824	19	disease	disease	NN
cord-023095-4dannjjm	2824	20	has	have	VBZ
cord-023095-4dannjjm	2824	21	not	not	RB
cord-023095-4dannjjm	2824	22	yet	yet	RB
cord-023095-4dannjjm	2824	23	been	be	VBN
cord-023095-4dannjjm	2824	24	reported	report	VBN
cord-023095-4dannjjm	2824	25	.	.	.
cord-023095-4dannjjm	2825	1	Also	also	RB
cord-023095-4dannjjm	2825	2	,	,	,
cord-023095-4dannjjm	2825	3	there	there	EX
cord-023095-4dannjjm	2825	4	is	be	VBZ
cord-023095-4dannjjm	2825	5	limited	limited	JJ
cord-023095-4dannjjm	2825	6	information	information	NN
cord-023095-4dannjjm	2825	7	about	about	IN
cord-023095-4dannjjm	2825	8	the	the	DT
cord-023095-4dannjjm	2825	9	stability	stability	NN
cord-023095-4dannjjm	2825	10	of	of	IN
cord-023095-4dannjjm	2825	11	CPE	CPE	NNP
cord-023095-4dannjjm	2825	12	in	in	IN
cord-023095-4dannjjm	2825	13	fecal	fecal	JJ
cord-023095-4dannjjm	2825	14	samples	sample	NNS
cord-023095-4dannjjm	2825	15	at	at	IN
cord-023095-4dannjjm	2825	16	various	various	JJ
cord-023095-4dannjjm	2825	17	storage	storage	NN
cord-023095-4dannjjm	2825	18	conditions	condition	NNS
cord-023095-4dannjjm	2825	19	.	.	.
cord-023095-4dannjjm	2826	1	The	the	DT
cord-023095-4dannjjm	2826	2	aim	aim	NN
cord-023095-4dannjjm	2826	3	of	of	IN
cord-023095-4dannjjm	2826	4	this	this	DT
cord-023095-4dannjjm	2826	5	study	study	NN
cord-023095-4dannjjm	2826	6	was	be	VBD
cord-023095-4dannjjm	2826	7	to	to	TO
cord-023095-4dannjjm	2826	8	evaluate	evaluate	VB
cord-023095-4dannjjm	2826	9	the	the	DT
cord-023095-4dannjjm	2826	10	prevalence	prevalence	NN
cord-023095-4dannjjm	2826	11	of	of	IN
cord-023095-4dannjjm	2826	12	the	the	DT
cord-023095-4dannjjm	2826	13	cpe	cpe	NNP
cord-023095-4dannjjm	2826	14	-	-	HYPH
cord-023095-4dannjjm	2826	15	gene	gene	NNP
cord-023095-4dannjjm	2826	16	and	and	CC
cord-023095-4dannjjm	2826	17	CPE	CPE	NNP
cord-023095-4dannjjm	2826	18	and	and	CC
cord-023095-4dannjjm	2826	19	the	the	DT
cord-023095-4dannjjm	2826	20	stability	stability	NN
cord-023095-4dannjjm	2826	21	of	of	IN
cord-023095-4dannjjm	2826	22	CPE	CPE	NNP
cord-023095-4dannjjm	2826	23	in	in	IN
cord-023095-4dannjjm	2826	24	fecal	fecal	JJ
cord-023095-4dannjjm	2826	25	samples	sample	NNS
cord-023095-4dannjjm	2826	26	from	from	IN
cord-023095-4dannjjm	2826	27	dogs	dog	NNS
cord-023095-4dannjjm	2826	28	and	and	CC
cord-023095-4dannjjm	2826	29	cats	cat	NNS
cord-023095-4dannjjm	2826	30	.	.	.
cord-023095-4dannjjm	2827	1	To	to	TO
cord-023095-4dannjjm	2827	2	evaluate	evaluate	VB
cord-023095-4dannjjm	2827	3	the	the	DT
cord-023095-4dannjjm	2827	4	prevalence	prevalence	NN
cord-023095-4dannjjm	2827	5	of	of	IN
cord-023095-4dannjjm	2827	6	the	the	DT
cord-023095-4dannjjm	2827	7	cpe	cpe	NNP
cord-023095-4dannjjm	2827	8	-	-	HYPH
cord-023095-4dannjjm	2827	9	gene	gene	NNP
cord-023095-4dannjjm	2827	10	,	,	,
cord-023095-4dannjjm	2827	11	a	a	DT
cord-023095-4dannjjm	2827	12	total	total	NN
cord-023095-4dannjjm	2827	13	of	of	IN
cord-023095-4dannjjm	2827	14	481	481	CD
cord-023095-4dannjjm	2827	15	fecal	fecal	JJ
cord-023095-4dannjjm	2827	16	samples	sample	NNS
cord-023095-4dannjjm	2827	17	from	from	IN
cord-023095-4dannjjm	2827	18	dogs	dog	NNS
cord-023095-4dannjjm	2827	19	and	and	CC
cord-023095-4dannjjm	2827	20	cats	cat	NNS
cord-023095-4dannjjm	2827	21	with	with	IN
cord-023095-4dannjjm	2827	22	clinical	clinical	JJ
cord-023095-4dannjjm	2827	23	signs	sign	NNS
cord-023095-4dannjjm	2827	24	of	of	IN
cord-023095-4dannjjm	2827	25	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2827	26	disease	disease	NN
cord-023095-4dannjjm	2827	27	(	(	-LRB-
cord-023095-4dannjjm	2827	28	273	273	CD
cord-023095-4dannjjm	2827	29	dogs	dog	NNS
cord-023095-4dannjjm	2827	30	and	and	CC
cord-023095-4dannjjm	2827	31	208	208	CD
cord-023095-4dannjjm	2827	32	cats	cat	NNS
cord-023095-4dannjjm	2827	33	)	)	-RRB-
cord-023095-4dannjjm	2827	34	and	and	CC
cord-023095-4dannjjm	2827	35	109	109	CD
cord-023095-4dannjjm	2827	36	fecal	fecal	JJ
cord-023095-4dannjjm	2827	37	samples	sample	NNS
cord-023095-4dannjjm	2827	38	from	from	IN
cord-023095-4dannjjm	2827	39	those	those	DT
cord-023095-4dannjjm	2827	40	without	without	IN
cord-023095-4dannjjm	2827	41	such	such	JJ
cord-023095-4dannjjm	2827	42	signs	sign	NNS
cord-023095-4dannjjm	2827	43	(	(	-LRB-
cord-023095-4dannjjm	2827	44	80	80	CD
cord-023095-4dannjjm	2827	45	dogs	dog	NNS
cord-023095-4dannjjm	2827	46	and	and	CC
cord-023095-4dannjjm	2827	47	29	29	CD
cord-023095-4dannjjm	2827	48	cats	cat	NNS
cord-023095-4dannjjm	2827	49	)	)	-RRB-
cord-023095-4dannjjm	2827	50	were	be	VBD
cord-023095-4dannjjm	2827	51	examined	examine	VBN
cord-023095-4dannjjm	2827	52	using	use	VBG
cord-023095-4dannjjm	2827	53	PCR	PCR	NNP
cord-023095-4dannjjm	2827	54	.	.	.
cord-023095-4dannjjm	2828	1	To	to	TO
cord-023095-4dannjjm	2828	2	evaluate	evaluate	VB
cord-023095-4dannjjm	2828	3	the	the	DT
cord-023095-4dannjjm	2828	4	prevalence	prevalence	NN
cord-023095-4dannjjm	2828	5	of	of	IN
cord-023095-4dannjjm	2828	6	CPE	CPE	NNP
cord-023095-4dannjjm	2828	7	,	,	,
cord-023095-4dannjjm	2828	8	a	a	DT
cord-023095-4dannjjm	2828	9	total	total	NN
cord-023095-4dannjjm	2828	10	of	of	IN
cord-023095-4dannjjm	2828	11	90	90	CD
cord-023095-4dannjjm	2828	12	fecal	fecal	JJ
cord-023095-4dannjjm	2828	13	samples	sample	NNS
cord-023095-4dannjjm	2828	14	from	from	IN
cord-023095-4dannjjm	2828	15	dogs	dog	NNS
cord-023095-4dannjjm	2828	16	and	and	CC
cord-023095-4dannjjm	2828	17	cats	cat	NNS
cord-023095-4dannjjm	2828	18	with	with	IN
cord-023095-4dannjjm	2828	19	clinical	clinical	JJ
cord-023095-4dannjjm	2828	20	signs	sign	NNS
cord-023095-4dannjjm	2828	21	of	of	IN
cord-023095-4dannjjm	2828	22	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2828	23	disease	disease	NN
cord-023095-4dannjjm	2828	24	(	(	-LRB-
cord-023095-4dannjjm	2828	25	31	31	CD
cord-023095-4dannjjm	2828	26	dogs	dog	NNS
cord-023095-4dannjjm	2828	27	and	and	CC
cord-023095-4dannjjm	2828	28	59	59	CD
cord-023095-4dannjjm	2828	29	cats	cat	NNS
cord-023095-4dannjjm	2828	30	)	)	-RRB-
cord-023095-4dannjjm	2828	31	and	and	CC
cord-023095-4dannjjm	2828	32	11	11	CD
cord-023095-4dannjjm	2828	33	dogs	dog	NNS
cord-023095-4dannjjm	2828	34	without	without	IN
cord-023095-4dannjjm	2828	35	such	such	JJ
cord-023095-4dannjjm	2828	36	signs	sign	NNS
cord-023095-4dannjjm	2828	37	were	be	VBD
cord-023095-4dannjjm	2828	38	evaluated	evaluate	VBN
cord-023095-4dannjjm	2828	39	using	use	VBG
cord-023095-4dannjjm	2828	40	a	a	DT
cord-023095-4dannjjm	2828	41	commercially	commercially	RB
cord-023095-4dannjjm	2828	42	available	available	JJ
cord-023095-4dannjjm	2828	43	ELISA	ELISA	NNP
cord-023095-4dannjjm	2828	44	kit	kit	NN
cord-023095-4dannjjm	2828	45	(	(	-LRB-
cord-023095-4dannjjm	2828	46	TechLab	TechLab	NNP
cord-023095-4dannjjm	2828	47	,	,	,
cord-023095-4dannjjm	2828	48	Blacksburg	Blacksburg	NNP
cord-023095-4dannjjm	2828	49	,	,	,
cord-023095-4dannjjm	2828	50	VA	VA	NNP
cord-023095-4dannjjm	2828	51	)	)	-RRB-
cord-023095-4dannjjm	2828	52	.	.	.
cord-023095-4dannjjm	2829	1	The	the	DT
cord-023095-4dannjjm	2829	2	results	result	NNS
cord-023095-4dannjjm	2829	3	were	be	VBD
cord-023095-4dannjjm	2829	4	analyzed	analyze	VBN
cord-023095-4dannjjm	2829	5	using	use	VBG
cord-023095-4dannjjm	2829	6	a	a	DT
cord-023095-4dannjjm	2829	7	Fisher	Fisher	NNP
cord-023095-4dannjjm	2829	8	's	's	POS
cord-023095-4dannjjm	2829	9	exact	exact	JJ
cord-023095-4dannjjm	2829	10	test	test	NN
cord-023095-4dannjjm	2829	11	.	.	.
cord-023095-4dannjjm	2830	1	Significance	significance	NN
cord-023095-4dannjjm	2830	2	was	be	VBD
cord-023095-4dannjjm	2830	3	set	set	VBN
cord-023095-4dannjjm	2830	4	at	at	IN
cord-023095-4dannjjm	2830	5	p	p	NN
cord-023095-4dannjjm	2830	6	o	o	NN
cord-023095-4dannjjm	2830	7	0.05	0.05	CD
cord-023095-4dannjjm	2830	8	.	.	.
cord-023095-4dannjjm	2831	1	To	to	TO
cord-023095-4dannjjm	2831	2	evaluate	evaluate	VB
cord-023095-4dannjjm	2831	3	the	the	DT
cord-023095-4dannjjm	2831	4	stability	stability	NN
cord-023095-4dannjjm	2831	5	of	of	IN
cord-023095-4dannjjm	2831	6	CPE	CPE	NNP
cord-023095-4dannjjm	2831	7	,	,	,
cord-023095-4dannjjm	2831	8	8	8	CD
cord-023095-4dannjjm	2831	9	fecal	fecal	JJ
cord-023095-4dannjjm	2831	10	samples	sample	NNS
cord-023095-4dannjjm	2831	11	from	from	IN
cord-023095-4dannjjm	2831	12	dogs	dog	NNS
cord-023095-4dannjjm	2831	13	and	and	CC
cord-023095-4dannjjm	2831	14	2	2	CD
cord-023095-4dannjjm	2831	15	from	from	IN
cord-023095-4dannjjm	2831	16	cats	cat	NNS
cord-023095-4dannjjm	2831	17	with	with	IN
cord-023095-4dannjjm	2831	18	clinical	clinical	JJ
cord-023095-4dannjjm	2831	19	signs	sign	NNS
cord-023095-4dannjjm	2831	20	of	of	IN
cord-023095-4dannjjm	2831	21	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2831	22	disease	disease	NN
cord-023095-4dannjjm	2831	23	that	that	WDT
cord-023095-4dannjjm	2831	24	were	be	VBD
cord-023095-4dannjjm	2831	25	positive	positive	JJ
cord-023095-4dannjjm	2831	26	for	for	IN
cord-023095-4dannjjm	2831	27	CPE	CPE	NNP
cord-023095-4dannjjm	2831	28	were	be	VBD
cord-023095-4dannjjm	2831	29	examined	examine	VBN
cord-023095-4dannjjm	2831	30	.	.	.
cord-023095-4dannjjm	2832	1	Also	also	RB
cord-023095-4dannjjm	2832	2	,	,	,
cord-023095-4dannjjm	2832	3	5	5	CD
cord-023095-4dannjjm	2832	4	CPE	CPE	NNP
cord-023095-4dannjjm	2832	5	negative	negative	JJ
cord-023095-4dannjjm	2832	6	samples	sample	NNS
cord-023095-4dannjjm	2832	7	from	from	IN
cord-023095-4dannjjm	2832	8	dogs	dog	NNS
cord-023095-4dannjjm	2832	9	were	be	VBD
cord-023095-4dannjjm	2832	10	evaluated	evaluate	VBN
cord-023095-4dannjjm	2832	11	as	as	IN
cord-023095-4dannjjm	2832	12	negative	negative	JJ
cord-023095-4dannjjm	2832	13	controls	control	NNS
cord-023095-4dannjjm	2832	14	.	.	.
cord-023095-4dannjjm	2833	1	Each	each	DT
cord-023095-4dannjjm	2833	2	sample	sample	NN
cord-023095-4dannjjm	2833	3	was	be	VBD
cord-023095-4dannjjm	2833	4	subdivided	subdivide	VBN
cord-023095-4dannjjm	2833	5	into	into	IN
cord-023095-4dannjjm	2833	6	8	8	CD
cord-023095-4dannjjm	2833	7	aliquots	aliquot	NNS
cord-023095-4dannjjm	2833	8	and	and	CC
cord-023095-4dannjjm	2833	9	evaluated	evaluate	VBN
cord-023095-4dannjjm	2833	10	on	on	IN
cord-023095-4dannjjm	2833	11	day	day	NN
cord-023095-4dannjjm	2833	12	0	0	CD
cord-023095-4dannjjm	2833	13	;	;	:
cord-023095-4dannjjm	2833	14	on	on	IN
cord-023095-4dannjjm	2833	15	days	day	NNS
cord-023095-4dannjjm	2833	16	2	2	CD
cord-023095-4dannjjm	2833	17	,	,	,
cord-023095-4dannjjm	2833	18	5	5	CD
cord-023095-4dannjjm	2833	19	,	,	,
cord-023095-4dannjjm	2833	20	and	and	CC
cord-023095-4dannjjm	2833	21	10	10	CD
cord-023095-4dannjjm	2833	22	after	after	IN
cord-023095-4dannjjm	2833	23	being	be	VBG
cord-023095-4dannjjm	2833	24	stored	store	VBN
cord-023095-4dannjjm	2833	25	at	at	IN
cord-023095-4dannjjm	2833	26	room	room	NN
cord-023095-4dannjjm	2833	27	temperature	temperature	NN
cord-023095-4dannjjm	2833	28	(	(	-LRB-
cord-023095-4dannjjm	2833	29	RT	RT	NNP
cord-023095-4dannjjm	2833	30	)	)	-RRB-
cord-023095-4dannjjm	2833	31	or	or	CC
cord-023095-4dannjjm	2833	32	41C	41c	CD
cord-023095-4dannjjm	2833	33	;	;	:
cord-023095-4dannjjm	2833	34	and	and	CC
cord-023095-4dannjjm	2833	35	on	on	IN
cord-023095-4dannjjm	2833	36	day	day	NN
cord-023095-4dannjjm	2833	37	10	10	CD
cord-023095-4dannjjm	2833	38	after	after	IN
cord-023095-4dannjjm	2833	39	being	be	VBG
cord-023095-4dannjjm	2833	40	stored	store	VBN
cord-023095-4dannjjm	2833	41	at	at	IN
cord-023095-4dannjjm	2833	42	À201C.	À201C.	NNS
cord-023095-4dannjjm	2834	1	The	the	DT
cord-023095-4dannjjm	2834	2	prevalence	prevalence	NN
cord-023095-4dannjjm	2834	3	of	of	IN
cord-023095-4dannjjm	2834	4	the	the	DT
cord-023095-4dannjjm	2834	5	cpe	cpe	NNP
cord-023095-4dannjjm	2834	6	-	-	HYPH
cord-023095-4dannjjm	2834	7	gene	gene	NN
cord-023095-4dannjjm	2834	8	was	be	VBD
cord-023095-4dannjjm	2834	9	not	not	RB
cord-023095-4dannjjm	2834	10	significantly	significantly	RB
cord-023095-4dannjjm	2834	11	different	different	JJ
cord-023095-4dannjjm	2834	12	between	between	IN
cord-023095-4dannjjm	2834	13	dogs	dog	NNS
cord-023095-4dannjjm	2834	14	with	with	IN
cord-023095-4dannjjm	2834	15	signs	sign	NNS
cord-023095-4dannjjm	2834	16	of	of	IN
cord-023095-4dannjjm	2834	17	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2834	18	disease	disease	NN
cord-023095-4dannjjm	2834	19	(	(	-LRB-
cord-023095-4dannjjm	2834	20	99/273	99/273	CD
cord-023095-4dannjjm	2834	21	;	;	:
cord-023095-4dannjjm	2834	22	36.3	36.3	CD
cord-023095-4dannjjm	2834	23	%	%	NN
cord-023095-4dannjjm	2834	24	)	)	-RRB-
cord-023095-4dannjjm	2834	25	and	and	CC
cord-023095-4dannjjm	2834	26	dogs	dog	NNS
cord-023095-4dannjjm	2834	27	without	without	IN
cord-023095-4dannjjm	2834	28	(	(	-LRB-
cord-023095-4dannjjm	2834	29	27/80	27/80	CD
cord-023095-4dannjjm	2834	30	;	;	:
cord-023095-4dannjjm	2834	31	33.8	33.8	CD
cord-023095-4dannjjm	2834	32	%	%	NN
cord-023095-4dannjjm	2834	33	;	;	:
cord-023095-4dannjjm	2834	34	p	p	NN
cord-023095-4dannjjm	2834	35	5	5	CD
cord-023095-4dannjjm	2834	36	0.79	0.79	CD
cord-023095-4dannjjm	2834	37	)	)	-RRB-
cord-023095-4dannjjm	2834	38	.	.	.
cord-023095-4dannjjm	2835	1	Also	also	RB
cord-023095-4dannjjm	2835	2	,	,	,
cord-023095-4dannjjm	2835	3	the	the	DT
cord-023095-4dannjjm	2835	4	prevalence	prevalence	NN
cord-023095-4dannjjm	2835	5	of	of	IN
cord-023095-4dannjjm	2835	6	the	the	DT
cord-023095-4dannjjm	2835	7	cpe	cpe	NNP
cord-023095-4dannjjm	2835	8	-	-	HYPH
cord-023095-4dannjjm	2835	9	gene	gene	NN
cord-023095-4dannjjm	2835	10	in	in	IN
cord-023095-4dannjjm	2835	11	cats	cat	NNS
cord-023095-4dannjjm	2835	12	with	with	IN
cord-023095-4dannjjm	2835	13	signs	sign	NNS
cord-023095-4dannjjm	2835	14	of	of	IN
cord-023095-4dannjjm	2835	15	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2835	16	disease	disease	NN
cord-023095-4dannjjm	2835	17	(	(	-LRB-
cord-023095-4dannjjm	2835	18	80/208	80/208	CD
cord-023095-4dannjjm	2835	19	;	;	:
cord-023095-4dannjjm	2835	20	38.5	38.5	CD
cord-023095-4dannjjm	2835	21	%	%	NN
cord-023095-4dannjjm	2835	22	)	)	-RRB-
cord-023095-4dannjjm	2835	23	was	be	VBD
cord-023095-4dannjjm	2835	24	not	not	RB
cord-023095-4dannjjm	2835	25	significantly	significantly	RB
cord-023095-4dannjjm	2835	26	different	different	JJ
cord-023095-4dannjjm	2835	27	compared	compare	VBN
cord-023095-4dannjjm	2835	28	to	to	IN
cord-023095-4dannjjm	2835	29	cats	cat	NNS
cord-023095-4dannjjm	2835	30	without	without	IN
cord-023095-4dannjjm	2835	31	(	(	-LRB-
cord-023095-4dannjjm	2835	32	6/	6/	CD
cord-023095-4dannjjm	2835	33	29	29	CD
cord-023095-4dannjjm	2835	34	;	;	:
cord-023095-4dannjjm	2835	35	20.7	20.7	CD
cord-023095-4dannjjm	2835	36	%	%	NN
cord-023095-4dannjjm	2835	37	;	;	:
cord-023095-4dannjjm	2835	38	p	p	NN
cord-023095-4dannjjm	2835	39	5	5	CD
cord-023095-4dannjjm	2835	40	0.06	0.06	CD
cord-023095-4dannjjm	2835	41	)	)	-RRB-
cord-023095-4dannjjm	2835	42	.	.	.
cord-023095-4dannjjm	2836	1	PCR	PCR	NNP
cord-023095-4dannjjm	2836	2	and	and	CC
cord-023095-4dannjjm	2836	3	ELISA	ELISA	NNP
cord-023095-4dannjjm	2836	4	results	result	NNS
cord-023095-4dannjjm	2836	5	were	be	VBD
cord-023095-4dannjjm	2836	6	available	available	JJ
cord-023095-4dannjjm	2836	7	for	for	IN
cord-023095-4dannjjm	2836	8	90	90	CD
cord-023095-4dannjjm	2836	9	samples	sample	NNS
cord-023095-4dannjjm	2836	10	.	.	.
cord-023095-4dannjjm	2837	1	Of	of	IN
cord-023095-4dannjjm	2837	2	the	the	DT
cord-023095-4dannjjm	2837	3	65	65	CD
cord-023095-4dannjjm	2837	4	PCR	PCR	NNP
cord-023095-4dannjjm	2837	5	positive	positive	JJ
cord-023095-4dannjjm	2837	6	samples	sample	NNS
cord-023095-4dannjjm	2837	7	,	,	,
cord-023095-4dannjjm	2837	8	only	only	RB
cord-023095-4dannjjm	2837	9	6	6	CD
cord-023095-4dannjjm	2837	10	(	(	-LRB-
cord-023095-4dannjjm	2837	11	9.2	9.2	CD
cord-023095-4dannjjm	2837	12	%	%	NN
cord-023095-4dannjjm	2837	13	)	)	-RRB-
cord-023095-4dannjjm	2837	14	were	be	VBD
cord-023095-4dannjjm	2837	15	ELISA	ELISA	NNP
cord-023095-4dannjjm	2837	16	positive	positive	JJ
cord-023095-4dannjjm	2837	17	.	.	.
cord-023095-4dannjjm	2838	1	Of	of	IN
cord-023095-4dannjjm	2838	2	the	the	DT
cord-023095-4dannjjm	2838	3	35	35	CD
cord-023095-4dannjjm	2838	4	PCR	PCR	NNP
cord-023095-4dannjjm	2838	5	negative	negative	JJ
cord-023095-4dannjjm	2838	6	samples	sample	NNS
cord-023095-4dannjjm	2838	7	,	,	,
cord-023095-4dannjjm	2838	8	only	only	RB
cord-023095-4dannjjm	2838	9	1	1	CD
cord-023095-4dannjjm	2838	10	(	(	-LRB-
cord-023095-4dannjjm	2838	11	2.9	2.9	CD
cord-023095-4dannjjm	2838	12	%	%	NN
cord-023095-4dannjjm	2838	13	)	)	-RRB-
cord-023095-4dannjjm	2838	14	was	be	VBD
cord-023095-4dannjjm	2838	15	ELISA	ELISA	NNP
cord-023095-4dannjjm	2838	16	positive	positive	JJ
cord-023095-4dannjjm	2838	17	.	.	.
cord-023095-4dannjjm	2839	1	The	the	DT
cord-023095-4dannjjm	2839	2	prevalence	prevalence	NN
cord-023095-4dannjjm	2839	3	of	of	IN
cord-023095-4dannjjm	2839	4	CPE	CPE	NNP
cord-023095-4dannjjm	2839	5	was	be	VBD
cord-023095-4dannjjm	2839	6	not	not	RB
cord-023095-4dannjjm	2839	7	significantly	significantly	RB
cord-023095-4dannjjm	2839	8	different	different	JJ
cord-023095-4dannjjm	2839	9	between	between	IN
cord-023095-4dannjjm	2839	10	dogs	dog	NNS
cord-023095-4dannjjm	2839	11	with	with	IN
cord-023095-4dannjjm	2839	12	clinical	clinical	JJ
cord-023095-4dannjjm	2839	13	signs	sign	NNS
cord-023095-4dannjjm	2839	14	of	of	IN
cord-023095-4dannjjm	2839	15	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2839	16	disease	disease	NN
cord-023095-4dannjjm	2839	17	(	(	-LRB-
cord-023095-4dannjjm	2839	18	3/31	3/31	CD
cord-023095-4dannjjm	2839	19	;	;	:
cord-023095-4dannjjm	2839	20	9.7	9.7	CD
cord-023095-4dannjjm	2839	21	%	%	NN
cord-023095-4dannjjm	2839	22	)	)	-RRB-
cord-023095-4dannjjm	2839	23	and	and	CC
cord-023095-4dannjjm	2839	24	those	those	DT
cord-023095-4dannjjm	2839	25	without	without	IN
cord-023095-4dannjjm	2839	26	(	(	-LRB-
cord-023095-4dannjjm	2839	27	1/11	1/11	CD
cord-023095-4dannjjm	2839	28	;	;	:
cord-023095-4dannjjm	2839	29	9.0	9.0	CD
cord-023095-4dannjjm	2839	30	%	%	NN
cord-023095-4dannjjm	2839	31	;	;	:
cord-023095-4dannjjm	2839	32	p	p	NN
cord-023095-4dannjjm	2839	33	5	5	CD
cord-023095-4dannjjm	2839	34	1.0	1.0	CD
cord-023095-4dannjjm	2839	35	)	)	-RRB-
cord-023095-4dannjjm	2839	36	.	.	.
cord-023095-4dannjjm	2840	1	The	the	DT
cord-023095-4dannjjm	2840	2	prevalence	prevalence	NN
cord-023095-4dannjjm	2840	3	of	of	IN
cord-023095-4dannjjm	2840	4	CPE	CPE	NNP
cord-023095-4dannjjm	2840	5	in	in	IN
cord-023095-4dannjjm	2840	6	cats	cat	NNS
cord-023095-4dannjjm	2840	7	with	with	IN
cord-023095-4dannjjm	2840	8	signs	sign	NNS
cord-023095-4dannjjm	2840	9	of	of	IN
cord-023095-4dannjjm	2840	10	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2840	11	disease	disease	NN
cord-023095-4dannjjm	2840	12	was	be	VBD
cord-023095-4dannjjm	2840	13	4/59	4/59	CD
cord-023095-4dannjjm	2840	14	(	(	-LRB-
cord-023095-4dannjjm	2840	15	6.8	6.8	CD
cord-023095-4dannjjm	2840	16	%	%	NN
cord-023095-4dannjjm	2840	17	)	)	-RRB-
cord-023095-4dannjjm	2840	18	,	,	,
cord-023095-4dannjjm	2840	19	but	but	CC
cord-023095-4dannjjm	2840	20	no	no	DT
cord-023095-4dannjjm	2840	21	samples	sample	NNS
cord-023095-4dannjjm	2840	22	from	from	IN
cord-023095-4dannjjm	2840	23	cats	cat	NNS
cord-023095-4dannjjm	2840	24	without	without	IN
cord-023095-4dannjjm	2840	25	such	such	JJ
cord-023095-4dannjjm	2840	26	signs	sign	NNS
cord-023095-4dannjjm	2840	27	were	be	VBD
cord-023095-4dannjjm	2840	28	available	available	JJ
cord-023095-4dannjjm	2840	29	.	.	.
cord-023095-4dannjjm	2841	1	When	when	WRB
cord-023095-4dannjjm	2841	2	evaluating	evaluate	VBG
cord-023095-4dannjjm	2841	3	the	the	DT
cord-023095-4dannjjm	2841	4	stability	stability	NN
cord-023095-4dannjjm	2841	5	of	of	IN
cord-023095-4dannjjm	2841	6	CPE	CPE	NNP
cord-023095-4dannjjm	2841	7	,	,	,
cord-023095-4dannjjm	2841	8	results	result	VBZ
cord-023095-4dannjjm	2841	9	for	for	IN
cord-023095-4dannjjm	2841	10	all	all	DT
cord-023095-4dannjjm	2841	11	aliquots	aliquot	NNS
cord-023095-4dannjjm	2841	12	were	be	VBD
cord-023095-4dannjjm	2841	13	consistent	consistent	JJ
cord-023095-4dannjjm	2841	14	with	with	IN
cord-023095-4dannjjm	2841	15	the	the	DT
cord-023095-4dannjjm	2841	16	initial	initial	JJ
cord-023095-4dannjjm	2841	17	result	result	NN
cord-023095-4dannjjm	2841	18	,	,	,
cord-023095-4dannjjm	2841	19	except	except	IN
cord-023095-4dannjjm	2841	20	for	for	IN
cord-023095-4dannjjm	2841	21	one	one	CD
cord-023095-4dannjjm	2841	22	sample	sample	NN
cord-023095-4dannjjm	2841	23	(	(	-LRB-
cord-023095-4dannjjm	2841	24	on	on	IN
cord-023095-4dannjjm	2841	25	day	day	NN
cord-023095-4dannjjm	2841	26	5	5	CD
cord-023095-4dannjjm	2841	27	,	,	,
cord-023095-4dannjjm	2841	28	stored	store	VBN
cord-023095-4dannjjm	2841	29	at	at	IN
cord-023095-4dannjjm	2841	30	RT	RT	NNP
cord-023095-4dannjjm	2841	31	,	,	,
cord-023095-4dannjjm	2841	32	which	which	WDT
cord-023095-4dannjjm	2841	33	was	be	VBD
cord-023095-4dannjjm	2841	34	initially	initially	RB
cord-023095-4dannjjm	2841	35	CPE	CPE	NNP
cord-023095-4dannjjm	2841	36	positive	positive	JJ
cord-023095-4dannjjm	2841	37	)	)	-RRB-
cord-023095-4dannjjm	2841	38	.	.	.
cord-023095-4dannjjm	2842	1	These	these	DT
cord-023095-4dannjjm	2842	2	results	result	NNS
cord-023095-4dannjjm	2842	3	indicate	indicate	VBP
cord-023095-4dannjjm	2842	4	that	that	IN
cord-023095-4dannjjm	2842	5	only	only	RB
cord-023095-4dannjjm	2842	6	a	a	DT
cord-023095-4dannjjm	2842	7	small	small	JJ
cord-023095-4dannjjm	2842	8	proportion	proportion	NN
cord-023095-4dannjjm	2842	9	of	of	IN
cord-023095-4dannjjm	2842	10	samples	sample	NNS
cord-023095-4dannjjm	2842	11	that	that	WDT
cord-023095-4dannjjm	2842	12	are	be	VBP
cord-023095-4dannjjm	2842	13	PCR	PCR	NNP
cord-023095-4dannjjm	2842	14	positive	positive	JJ
cord-023095-4dannjjm	2842	15	for	for	IN
cord-023095-4dannjjm	2842	16	the	the	DT
cord-023095-4dannjjm	2842	17	cpe	cpe	NNP
cord-023095-4dannjjm	2842	18	-	-	HYPH
cord-023095-4dannjjm	2842	19	gene	gene	NN
cord-023095-4dannjjm	2842	20	are	be	VBP
cord-023095-4dannjjm	2842	21	also	also	RB
cord-023095-4dannjjm	2842	22	positive	positive	JJ
cord-023095-4dannjjm	2842	23	for	for	IN
cord-023095-4dannjjm	2842	24	CPE	CPE	NNP
cord-023095-4dannjjm	2842	25	.	.	.
cord-023095-4dannjjm	2843	1	Studies	study	NNS
cord-023095-4dannjjm	2843	2	are	be	VBP
cord-023095-4dannjjm	2843	3	warranted	warrant	VBN
cord-023095-4dannjjm	2843	4	to	to	TO
cord-023095-4dannjjm	2843	5	further	further	RB
cord-023095-4dannjjm	2843	6	compare	compare	VB
cord-023095-4dannjjm	2843	7	the	the	DT
cord-023095-4dannjjm	2843	8	prevalence	prevalence	NN
cord-023095-4dannjjm	2843	9	of	of	IN
cord-023095-4dannjjm	2843	10	CPE	CPE	NNP
cord-023095-4dannjjm	2843	11	among	among	IN
cord-023095-4dannjjm	2843	12	animals	animal	NNS
cord-023095-4dannjjm	2843	13	with	with	IN
cord-023095-4dannjjm	2843	14	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	2843	15	disease	disease	NN
cord-023095-4dannjjm	2843	16	and	and	CC
cord-023095-4dannjjm	2843	17	those	those	DT
cord-023095-4dannjjm	2843	18	without	without	IN
cord-023095-4dannjjm	2843	19	.	.	.
cord-023095-4dannjjm	2844	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	2844	2	,	,	,
cord-023095-4dannjjm	2844	3	the	the	DT
cord-023095-4dannjjm	2844	4	results	result	NNS
cord-023095-4dannjjm	2844	5	indicate	indicate	VBP
cord-023095-4dannjjm	2844	6	that	that	IN
cord-023095-4dannjjm	2844	7	CPE	CPE	NNP
cord-023095-4dannjjm	2844	8	is	be	VBZ
cord-023095-4dannjjm	2844	9	relatively	relatively	RB
cord-023095-4dannjjm	2844	10	stable	stable	JJ
cord-023095-4dannjjm	2844	11	in	in	IN
cord-023095-4dannjjm	2844	12	fecal	fecal	JJ
cord-023095-4dannjjm	2844	13	samples	sample	NNS
cord-023095-4dannjjm	2844	14	at	at	IN
cord-023095-4dannjjm	2844	15	various	various	JJ
cord-023095-4dannjjm	2844	16	storage	storage	NN
cord-023095-4dannjjm	2844	17	temperatures	temperature	NNS
cord-023095-4dannjjm	2844	18	.	.	.
cord-023095-4dannjjm	2845	1	Clostridium	clostridium	NN
cord-023095-4dannjjm	2845	2	perfringens	perfringens	NN
cord-023095-4dannjjm	2845	3	has	have	VBZ
cord-023095-4dannjjm	2845	4	been	be	VBN
cord-023095-4dannjjm	2845	5	implicated	implicate	VBN
cord-023095-4dannjjm	2845	6	as	as	IN
cord-023095-4dannjjm	2845	7	a	a	DT
cord-023095-4dannjjm	2845	8	cause	cause	NN
cord-023095-4dannjjm	2845	9	of	of	IN
cord-023095-4dannjjm	2845	10	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2845	11	in	in	IN
cord-023095-4dannjjm	2845	12	dogs	dog	NNS
cord-023095-4dannjjm	2845	13	.	.	.
cord-023095-4dannjjm	2846	1	The	the	DT
cord-023095-4dannjjm	2846	2	main	main	JJ
cord-023095-4dannjjm	2846	3	study	study	NN
cord-023095-4dannjjm	2846	4	objective	objective	NN
cord-023095-4dannjjm	2846	5	was	be	VBD
cord-023095-4dannjjm	2846	6	to	to	TO
cord-023095-4dannjjm	2846	7	compare	compare	VB
cord-023095-4dannjjm	2846	8	two	two	CD
cord-023095-4dannjjm	2846	9	culture	culture	NN
cord-023095-4dannjjm	2846	10	methods	method	NNS
cord-023095-4dannjjm	2846	11	for	for	IN
cord-023095-4dannjjm	2846	12	the	the	DT
cord-023095-4dannjjm	2846	13	identification	identification	NN
cord-023095-4dannjjm	2846	14	of	of	IN
cord-023095-4dannjjm	2846	15	C.	C.	NNP
cord-023095-4dannjjm	2846	16	perfringens	perfringen	NNS
cord-023095-4dannjjm	2846	17	.	.	.
cord-023095-4dannjjm	2847	1	A	a	DT
cord-023095-4dannjjm	2847	2	secondary	secondary	JJ
cord-023095-4dannjjm	2847	3	objective	objective	NN
cord-023095-4dannjjm	2847	4	was	be	VBD
cord-023095-4dannjjm	2847	5	to	to	TO
cord-023095-4dannjjm	2847	6	evaluate	evaluate	VB
cord-023095-4dannjjm	2847	7	C.	C.	NNP
cord-023095-4dannjjm	2847	8	perfringens	perfringens	NN
cord-023095-4dannjjm	2847	9	toxin	toxin	NN
cord-023095-4dannjjm	2847	10	genes	gene	VBZ
cord-023095-4dannjjm	2847	11	a	a	DT
cord-023095-4dannjjm	2847	12	,	,	,
cord-023095-4dannjjm	2847	13	b	b	NN
cord-023095-4dannjjm	2847	14	,	,	,
cord-023095-4dannjjm	2847	15	b	b	NN
cord-023095-4dannjjm	2847	16	2	2	CD
cord-023095-4dannjjm	2847	17	,	,	,
cord-023095-4dannjjm	2847	18	e	e	NNP
cord-023095-4dannjjm	2847	19	,	,	,
cord-023095-4dannjjm	2847	20	ı	ı	NNP
cord-023095-4dannjjm	2847	21	and	and	CC
cord-023095-4dannjjm	2847	22	cpe	cpe	NNP
cord-023095-4dannjjm	2847	23	from	from	IN
cord-023095-4dannjjm	2847	24	canine	canine	JJ
cord-023095-4dannjjm	2847	25	isolates	isolate	NNS
cord-023095-4dannjjm	2847	26	using	use	VBG
cord-023095-4dannjjm	2847	27	a	a	DT
cord-023095-4dannjjm	2847	28	multiplex	multiplex	NN
cord-023095-4dannjjm	2847	29	PCR	pcr	NN
cord-023095-4dannjjm	2847	30	and	and	CC
cord-023095-4dannjjm	2847	31	determine	determine	VB
cord-023095-4dannjjm	2847	32	their	-PRON-	PRP$
cord-023095-4dannjjm	2847	33	prevalence	prevalence	NN
cord-023095-4dannjjm	2847	34	in	in	IN
cord-023095-4dannjjm	2847	35	a	a	DT
cord-023095-4dannjjm	2847	36	group	group	NN
cord-023095-4dannjjm	2847	37	of	of	IN
cord-023095-4dannjjm	2847	38	normal	normal	JJ
cord-023095-4dannjjm	2847	39	and	and	CC
cord-023095-4dannjjm	2847	40	diarrheic	diarrheic	VBZ
cord-023095-4dannjjm	2847	41	dogs	dog	NNS
cord-023095-4dannjjm	2847	42	.	.	.
cord-023095-4dannjjm	2848	1	Fecal	fecal	JJ
cord-023095-4dannjjm	2848	2	samples	sample	NNS
cord-023095-4dannjjm	2848	3	were	be	VBD
cord-023095-4dannjjm	2848	4	collected	collect	VBN
cord-023095-4dannjjm	2848	5	from	from	IN
cord-023095-4dannjjm	2848	6	clinically	clinically	RB
cord-023095-4dannjjm	2848	7	normal	normal	JJ
cord-023095-4dannjjm	2848	8	(	(	-LRB-
cord-023095-4dannjjm	2848	9	ND	ND	NNP
cord-023095-4dannjjm	2848	10	,	,	,
cord-023095-4dannjjm	2848	11	n	n	NN
cord-023095-4dannjjm	2848	12	5	5	CD
cord-023095-4dannjjm	2848	13	105	105	CD
cord-023095-4dannjjm	2848	14	)	)	-RRB-
cord-023095-4dannjjm	2848	15	and	and	CC
cord-023095-4dannjjm	2848	16	diarrheic	diarrheic	VBZ
cord-023095-4dannjjm	2848	17	dogs	dog	NNS
cord-023095-4dannjjm	2848	18	(	(	-LRB-
cord-023095-4dannjjm	2848	19	DD	DD	NNP
cord-023095-4dannjjm	2848	20	,	,	,
cord-023095-4dannjjm	2848	21	n	n	NN
cord-023095-4dannjjm	2848	22	5	5	CD
cord-023095-4dannjjm	2848	23	54	54	CD
cord-023095-4dannjjm	2848	24	)	)	-RRB-
cord-023095-4dannjjm	2848	25	at	at	IN
cord-023095-4dannjjm	2848	26	a	a	DT
cord-023095-4dannjjm	2848	27	primary	primary	JJ
cord-023095-4dannjjm	2848	28	care	care	NN
cord-023095-4dannjjm	2848	29	veterinary	veterinary	JJ
cord-023095-4dannjjm	2848	30	facility	facility	NN
cord-023095-4dannjjm	2848	31	.	.	.
cord-023095-4dannjjm	2849	1	Isolation	isolation	NN
cord-023095-4dannjjm	2849	2	of	of	IN
cord-023095-4dannjjm	2849	3	C.	C.	NNP
cord-023095-4dannjjm	2849	4	perfringens	perfringen	NNS
cord-023095-4dannjjm	2849	5	was	be	VBD
cord-023095-4dannjjm	2849	6	performed	perform	VBN
cord-023095-4dannjjm	2849	7	using	use	VBG
cord-023095-4dannjjm	2849	8	direct	direct	JJ
cord-023095-4dannjjm	2849	9	inoculation	inoculation	NN
cord-023095-4dannjjm	2849	10	of	of	IN
cord-023095-4dannjjm	2849	11	feces	fece	NNS
cord-023095-4dannjjm	2849	12	onto	onto	IN
cord-023095-4dannjjm	2849	13	5	5	CD
cord-023095-4dannjjm	2849	14	%	%	NN
cord-023095-4dannjjm	2849	15	sheep	sheep	NN
cord-023095-4dannjjm	2849	16	blood	blood	NN
cord-023095-4dannjjm	2849	17	agar	agar	NN
cord-023095-4dannjjm	2849	18	(	(	-LRB-
cord-023095-4dannjjm	2849	19	SBA	SBA	NNP
cord-023095-4dannjjm	2849	20	)	)	-RRB-
cord-023095-4dannjjm	2849	21	as	as	RB
cord-023095-4dannjjm	2849	22	well	well	RB
cord-023095-4dannjjm	2849	23	as	as	IN
cord-023095-4dannjjm	2849	24	enrichment	enrichment	NN
cord-023095-4dannjjm	2849	25	of	of	IN
cord-023095-4dannjjm	2849	26	stool	stool	NN
cord-023095-4dannjjm	2849	27	in	in	IN
cord-023095-4dannjjm	2849	28	BHI	BHI	NNP
cord-023095-4dannjjm	2849	29	broth	broth	NN
cord-023095-4dannjjm	2849	30	followed	follow	VBN
cord-023095-4dannjjm	2849	31	by	by	IN
cord-023095-4dannjjm	2849	32	inoculation	inoculation	NN
cord-023095-4dannjjm	2849	33	onto	onto	IN
cord-023095-4dannjjm	2849	34	SBA	SBA	NNP
cord-023095-4dannjjm	2849	35	.	.	.
cord-023095-4dannjjm	2850	1	Isolates	isolate	NNS
cord-023095-4dannjjm	2850	2	were	be	VBD
cord-023095-4dannjjm	2850	3	tested	test	VBN
cord-023095-4dannjjm	2850	4	by	by	IN
cord-023095-4dannjjm	2850	5	multiplex	multiplex	NN
cord-023095-4dannjjm	2850	6	PCR	pcr	NN
cord-023095-4dannjjm	2850	7	for	for	IN
cord-023095-4dannjjm	2850	8	the	the	DT
cord-023095-4dannjjm	2850	9	presence	presence	NN
cord-023095-4dannjjm	2850	10	of	of	IN
cord-023095-4dannjjm	2850	11	a	a	DT
cord-023095-4dannjjm	2850	12	,	,	,
cord-023095-4dannjjm	2850	13	b	b	NN
cord-023095-4dannjjm	2850	14	,	,	,
cord-023095-4dannjjm	2850	15	b	b	NN
cord-023095-4dannjjm	2850	16	2	2	CD
cord-023095-4dannjjm	2850	17	,	,	,
cord-023095-4dannjjm	2850	18	e	e	NNP
cord-023095-4dannjjm	2850	19	,	,	,
cord-023095-4dannjjm	2850	20	ı	ı	NNP
cord-023095-4dannjjm	2850	21	and	and	CC
cord-023095-4dannjjm	2850	22	cpe	cpe	NNP
cord-023095-4dannjjm	2850	23	genes	gene	NNS
cord-023095-4dannjjm	2850	24	.	.	.
cord-023095-4dannjjm	2851	1	C.	C.	NNP
cord-023095-4dannjjm	2851	2	perfringens	perfringen	NNS
cord-023095-4dannjjm	2851	3	was	be	VBD
cord-023095-4dannjjm	2851	4	isolated	isolate	VBN
cord-023095-4dannjjm	2851	5	from	from	IN
cord-023095-4dannjjm	2851	6	84	84	CD
cord-023095-4dannjjm	2851	7	%	%	NN
cord-023095-4dannjjm	2851	8	(	(	-LRB-
cord-023095-4dannjjm	2851	9	88/105	88/105	CD
cord-023095-4dannjjm	2851	10	)	)	-RRB-
cord-023095-4dannjjm	2851	11	of	of	IN
cord-023095-4dannjjm	2851	12	ND	ND	NNP
cord-023095-4dannjjm	2851	13	fecal	fecal	JJ
cord-023095-4dannjjm	2851	14	samples	sample	NNS
cord-023095-4dannjjm	2851	15	using	use	VBG
cord-023095-4dannjjm	2851	16	direct	direct	JJ
cord-023095-4dannjjm	2851	17	culture	culture	NN
cord-023095-4dannjjm	2851	18	and	and	CC
cord-023095-4dannjjm	2851	19	87.6	87.6	CD
cord-023095-4dannjjm	2851	20	%	%	NN
cord-023095-4dannjjm	2851	21	(	(	-LRB-
cord-023095-4dannjjm	2851	22	92/105	92/105	CD
cord-023095-4dannjjm	2851	23	)	)	-RRB-
cord-023095-4dannjjm	2851	24	with	with	IN
cord-023095-4dannjjm	2851	25	BHI	BHI	NNP
cord-023095-4dannjjm	2851	26	enrichment	enrichment	NN
cord-023095-4dannjjm	2851	27	(	(	-LRB-
cord-023095-4dannjjm	2851	28	p	p	NN
cord-023095-4dannjjm	2851	29	5	5	CD
cord-023095-4dannjjm	2851	30	0.79	0.79	CD
cord-023095-4dannjjm	2851	31	)	)	-RRB-
cord-023095-4dannjjm	2851	32	.	.	.
cord-023095-4dannjjm	2852	1	In	in	IN
cord-023095-4dannjjm	2852	2	the	the	DT
cord-023095-4dannjjm	2852	3	DD	dd	NN
cord-023095-4dannjjm	2852	4	,	,	,
cord-023095-4dannjjm	2852	5	corresponding	correspond	VBG
cord-023095-4dannjjm	2852	6	isolation	isolation	NN
cord-023095-4dannjjm	2852	7	rates	rate	NNS
cord-023095-4dannjjm	2852	8	were	be	VBD
cord-023095-4dannjjm	2852	9	90.7	90.7	CD
cord-023095-4dannjjm	2852	10	%	%	NN
cord-023095-4dannjjm	2852	11	and	and	CC
cord-023095-4dannjjm	2852	12	93.8	93.8	CD
cord-023095-4dannjjm	2852	13	%	%	NN
cord-023095-4dannjjm	2852	14	(	(	-LRB-
cord-023095-4dannjjm	2852	15	p	p	NN
cord-023095-4dannjjm	2852	16	5	5	CD
cord-023095-4dannjjm	2852	17	0.45	0.45	CD
cord-023095-4dannjjm	2852	18	)	)	-RRB-
cord-023095-4dannjjm	2852	19	.	.	.
cord-023095-4dannjjm	2853	1	All	all	DT
cord-023095-4dannjjm	2853	2	isolates	isolate	NNS
cord-023095-4dannjjm	2853	3	possessed	possess	VBD
cord-023095-4dannjjm	2853	4	a	a	DT
cord-023095-4dannjjm	2853	5	toxin	toxin	NN
cord-023095-4dannjjm	2853	6	gene	gene	NN
cord-023095-4dannjjm	2853	7	.	.	.
cord-023095-4dannjjm	2854	1	b	b	LS
cord-023095-4dannjjm	2854	2	,	,	,
cord-023095-4dannjjm	2854	3	b	b	NN
cord-023095-4dannjjm	2854	4	2	2	CD
cord-023095-4dannjjm	2854	5	,	,	,
cord-023095-4dannjjm	2854	6	e	e	NNP
cord-023095-4dannjjm	2854	7	,	,	,
cord-023095-4dannjjm	2854	8	ı	ı	NNP
cord-023095-4dannjjm	2854	9	and	and	CC
cord-023095-4dannjjm	2854	10	cpe	cpe	NNP
cord-023095-4dannjjm	2854	11	toxin	toxin	NN
cord-023095-4dannjjm	2854	12	genes	gene	NNS
cord-023095-4dannjjm	2854	13	were	be	VBD
cord-023095-4dannjjm	2854	14	identified	identify	VBN
cord-023095-4dannjjm	2854	15	in	in	IN
cord-023095-4dannjjm	2854	16	4.4	4.4	CD
cord-023095-4dannjjm	2854	17	%	%	NN
cord-023095-4dannjjm	2854	18	,	,	,
cord-023095-4dannjjm	2854	19	1.1	1.1	CD
cord-023095-4dannjjm	2854	20	%	%	NN
cord-023095-4dannjjm	2854	21	,	,	,
cord-023095-4dannjjm	2854	22	3.3	3.3	CD
cord-023095-4dannjjm	2854	23	%	%	NN
cord-023095-4dannjjm	2854	24	,	,	,
cord-023095-4dannjjm	2854	25	1.1	1.1	CD
cord-023095-4dannjjm	2854	26	%	%	NN
cord-023095-4dannjjm	2854	27	and	and	CC
cord-023095-4dannjjm	2854	28	14.4	14.4	CD
cord-023095-4dannjjm	2854	29	%	%	NN
cord-023095-4dannjjm	2854	30	of	of	IN
cord-023095-4dannjjm	2854	31	ND	ND	NNP
cord-023095-4dannjjm	2854	32	isolates	isolate	NNS
cord-023095-4dannjjm	2854	33	,	,	,
cord-023095-4dannjjm	2854	34	respectively	respectively	RB
cord-023095-4dannjjm	2854	35	.	.	.
cord-023095-4dannjjm	2855	1	In	in	IN
cord-023095-4dannjjm	2855	2	the	the	DT
cord-023095-4dannjjm	2855	3	DD	DD	NNP
cord-023095-4dannjjm	2855	4	group	group	NN
cord-023095-4dannjjm	2855	5	,	,	,
cord-023095-4dannjjm	2855	6	b	b	NN
cord-023095-4dannjjm	2855	7	and	and	CC
cord-023095-4dannjjm	2855	8	b	b	NN
cord-023095-4dannjjm	2855	9	2	2	CD
cord-023095-4dannjjm	2855	10	were	be	VBD
cord-023095-4dannjjm	2855	11	identified	identify	VBN
cord-023095-4dannjjm	2855	12	in	in	IN
cord-023095-4dannjjm	2855	13	5	5	CD
cord-023095-4dannjjm	2855	14	%	%	NN
cord-023095-4dannjjm	2855	15	,	,	,
cord-023095-4dannjjm	2855	16	e	e	LS
cord-023095-4dannjjm	2855	17	and	and	CC
cord-023095-4dannjjm	2855	18	ı	ı	NNP
cord-023095-4dannjjm	2855	19	were	be	VBD
cord-023095-4dannjjm	2855	20	not	not	RB
cord-023095-4dannjjm	2855	21	identified	identify	VBN
cord-023095-4dannjjm	2855	22	and	and	CC
cord-023095-4dannjjm	2855	23	the	the	DT
cord-023095-4dannjjm	2855	24	cpe	cpe	NNP
cord-023095-4dannjjm	2855	25	gene	gene	NN
cord-023095-4dannjjm	2855	26	in	in	IN
cord-023095-4dannjjm	2855	27	16.9	16.9	CD
cord-023095-4dannjjm	2855	28	%	%	NN
cord-023095-4dannjjm	2855	29	of	of	IN
cord-023095-4dannjjm	2855	30	isolates	isolate	NNS
cord-023095-4dannjjm	2855	31	.	.	.
cord-023095-4dannjjm	2856	1	BHI	BHI	NNP
cord-023095-4dannjjm	2856	2	enrichment	enrichment	NN
cord-023095-4dannjjm	2856	3	did	do	VBD
cord-023095-4dannjjm	2856	4	not	not	RB
cord-023095-4dannjjm	2856	5	significantly	significantly	RB
cord-023095-4dannjjm	2856	6	increase	increase	VB
cord-023095-4dannjjm	2856	7	the	the	DT
cord-023095-4dannjjm	2856	8	yield	yield	NN
cord-023095-4dannjjm	2856	9	of	of	IN
cord-023095-4dannjjm	2856	10	C.	C.	NNP
cord-023095-4dannjjm	2856	11	perfringens	perfringen	NNS
cord-023095-4dannjjm	2856	12	compared	compare	VBN
cord-023095-4dannjjm	2856	13	to	to	IN
cord-023095-4dannjjm	2856	14	SBA	SBA	NNP
cord-023095-4dannjjm	2856	15	but	but	CC
cord-023095-4dannjjm	2856	16	increased	increase	VBN
cord-023095-4dannjjm	2856	17	time	time	NN
cord-023095-4dannjjm	2856	18	and	and	CC
cord-023095-4dannjjm	2856	19	cost	cost	NN
cord-023095-4dannjjm	2856	20	involved	involve	VBN
cord-023095-4dannjjm	2856	21	.	.	.
cord-023095-4dannjjm	2857	1	C.	C.	NNP
cord-023095-4dannjjm	2857	2	perfringens	perfringens	NNP
cord-023095-4dannjjm	2857	3	(	(	-LRB-
cord-023095-4dannjjm	2857	4	p	p	NN
cord-023095-4dannjjm	2857	5	5	5	CD
cord-023095-4dannjjm	2857	6	0.64	0.64	CD
cord-023095-4dannjjm	2857	7	)	)	-RRB-
cord-023095-4dannjjm	2857	8	and	and	CC
cord-023095-4dannjjm	2857	9	C.	C.	NNP
cord-023095-4dannjjm	2857	10	perfringens	perfringen	VBZ
cord-023095-4dannjjm	2857	11	toxin	toxin	NN
cord-023095-4dannjjm	2857	12	genes	gene	NNS
cord-023095-4dannjjm	2857	13	were	be	VBD
cord-023095-4dannjjm	2857	14	present	present	JJ
cord-023095-4dannjjm	2857	15	in	in	IN
cord-023095-4dannjjm	2857	16	equal	equal	JJ
cord-023095-4dannjjm	2857	17	proportions	proportion	NNS
cord-023095-4dannjjm	2857	18	in	in	IN
cord-023095-4dannjjm	2857	19	ND	ND	NNP
cord-023095-4dannjjm	2857	20	and	and	CC
cord-023095-4dannjjm	2857	21	DD	DD	NNP
cord-023095-4dannjjm	2857	22	groups	group	NNS
cord-023095-4dannjjm	2857	23	(	(	-LRB-
cord-023095-4dannjjm	2857	24	p	p	NN
cord-023095-4dannjjm	2857	25	!	!	.
cord-023095-4dannjjm	2857	26	0.15	0.15	CD
cord-023095-4dannjjm	2857	27	)	)	-RRB-
cord-023095-4dannjjm	2857	28	.	.	.
cord-023095-4dannjjm	2858	1	Culture	culture	NN
cord-023095-4dannjjm	2858	2	of	of	IN
cord-023095-4dannjjm	2858	3	C.	C.	NNP
cord-023095-4dannjjm	2858	4	perfringens	perfringen	NNS
cord-023095-4dannjjm	2858	5	and	and	CC
cord-023095-4dannjjm	2858	6	PCR	PCR	NNP
cord-023095-4dannjjm	2858	7	for	for	IN
cord-023095-4dannjjm	2858	8	toxin	toxin	NN
cord-023095-4dannjjm	2858	9	genes	gene	NNS
cord-023095-4dannjjm	2858	10	are	be	VBP
cord-023095-4dannjjm	2858	11	of	of	IN
cord-023095-4dannjjm	2858	12	limited	limited	JJ
cord-023095-4dannjjm	2858	13	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	2858	14	utility	utility	NN
cord-023095-4dannjjm	2858	15	due	due	IN
cord-023095-4dannjjm	2858	16	to	to	IN
cord-023095-4dannjjm	2858	17	the	the	DT
cord-023095-4dannjjm	2858	18	high	high	JJ
cord-023095-4dannjjm	2858	19	prevalence	prevalence	NN
cord-023095-4dannjjm	2858	20	of	of	IN
cord-023095-4dannjjm	2858	21	C.perfringens	c.perfringen	NNS
cord-023095-4dannjjm	2858	22	in	in	IN
cord-023095-4dannjjm	2858	23	normal	normal	JJ
cord-023095-4dannjjm	2858	24	dogs	dog	NNS
cord-023095-4dannjjm	2858	25	and	and	CC
cord-023095-4dannjjm	2858	26	the	the	DT
cord-023095-4dannjjm	2858	27	lack	lack	NN
cord-023095-4dannjjm	2858	28	of	of	IN
cord-023095-4dannjjm	2858	29	apparent	apparent	JJ
cord-023095-4dannjjm	2858	30	difference	difference	NN
cord-023095-4dannjjm	2858	31	in	in	IN
cord-023095-4dannjjm	2858	32	toxin	toxin	NN
cord-023095-4dannjjm	2858	33	gene	gene	NN
cord-023095-4dannjjm	2858	34	distribution	distribution	NN
cord-023095-4dannjjm	2858	35	between	between	IN
cord-023095-4dannjjm	2858	36	normal	normal	JJ
cord-023095-4dannjjm	2858	37	and	and	CC
cord-023095-4dannjjm	2858	38	diarrheic	diarrheic	VBZ
cord-023095-4dannjjm	2858	39	dogs	dog	NNS
cord-023095-4dannjjm	2858	40	.	.	.
cord-023095-4dannjjm	2859	1	Endoscopic	endoscopic	JJ
cord-023095-4dannjjm	2859	2	biopsies	biopsy	NNS
cord-023095-4dannjjm	2859	3	are	be	VBP
cord-023095-4dannjjm	2859	4	a	a	DT
cord-023095-4dannjjm	2859	5	relatively	relatively	RB
cord-023095-4dannjjm	2859	6	convenient	convenient	JJ
cord-023095-4dannjjm	2859	7	,	,	,
cord-023095-4dannjjm	2859	8	non	non	JJ
cord-023095-4dannjjm	2859	9	-	-	JJ
cord-023095-4dannjjm	2859	10	invasive	invasive	JJ
cord-023095-4dannjjm	2859	11	test	test	NN
cord-023095-4dannjjm	2859	12	for	for	IN
cord-023095-4dannjjm	2859	13	feline	feline	JJ
cord-023095-4dannjjm	2859	14	infiltrative	infiltrative	JJ
cord-023095-4dannjjm	2859	15	intestinal	intestinal	JJ
cord-023095-4dannjjm	2859	16	disorders	disorder	NNS
cord-023095-4dannjjm	2859	17	.	.	.
cord-023095-4dannjjm	2860	1	Commonly	commonly	RB
cord-023095-4dannjjm	2860	2	,	,	,
cord-023095-4dannjjm	2860	3	only	only	RB
cord-023095-4dannjjm	2860	4	the	the	DT
cord-023095-4dannjjm	2860	5	duodenum	duodenum	NN
cord-023095-4dannjjm	2860	6	is	be	VBZ
cord-023095-4dannjjm	2860	7	examined	examine	VBN
cord-023095-4dannjjm	2860	8	due	due	IN
cord-023095-4dannjjm	2860	9	to	to	IN
cord-023095-4dannjjm	2860	10	cost	cost	NN
cord-023095-4dannjjm	2860	11	,	,	,
cord-023095-4dannjjm	2860	12	risks	risk	NNS
cord-023095-4dannjjm	2860	13	and	and	CC
cord-023095-4dannjjm	2860	14	time	time	NN
cord-023095-4dannjjm	2860	15	required	require	VBN
cord-023095-4dannjjm	2860	16	to	to	TO
cord-023095-4dannjjm	2860	17	prepare	prepare	VB
cord-023095-4dannjjm	2860	18	the	the	DT
cord-023095-4dannjjm	2860	19	colon	colon	NN
cord-023095-4dannjjm	2860	20	using	use	VBG
cord-023095-4dannjjm	2860	21	lavage	lavage	NN
cord-023095-4dannjjm	2860	22	solutions	solution	NNS
cord-023095-4dannjjm	2860	23	,	,	,
cord-023095-4dannjjm	2860	24	cathartics	cathartic	NNS
cord-023095-4dannjjm	2860	25	and/or	and/or	CC
cord-023095-4dannjjm	2860	26	enemas	enema	NNS
cord-023095-4dannjjm	2860	27	.	.	.
cord-023095-4dannjjm	2861	1	The	the	DT
cord-023095-4dannjjm	2861	2	purpose	purpose	NN
cord-023095-4dannjjm	2861	3	of	of	IN
cord-023095-4dannjjm	2861	4	this	this	DT
cord-023095-4dannjjm	2861	5	study	study	NN
cord-023095-4dannjjm	2861	6	was	be	VBD
cord-023095-4dannjjm	2861	7	to	to	TO
cord-023095-4dannjjm	2861	8	evaluate	evaluate	VB
cord-023095-4dannjjm	2861	9	the	the	DT
cord-023095-4dannjjm	2861	10	consistency	consistency	NN
cord-023095-4dannjjm	2861	11	between	between	IN
cord-023095-4dannjjm	2861	12	endoscopic	endoscopic	JJ
cord-023095-4dannjjm	2861	13	biopsies	biopsy	NNS
cord-023095-4dannjjm	2861	14	of	of	IN
cord-023095-4dannjjm	2861	15	the	the	DT
cord-023095-4dannjjm	2861	16	duodenum	duodenum	NN
cord-023095-4dannjjm	2861	17	and	and	CC
cord-023095-4dannjjm	2861	18	ileum	ileum	NN
cord-023095-4dannjjm	2861	19	in	in	IN
cord-023095-4dannjjm	2861	20	cats	cat	NNS
cord-023095-4dannjjm	2861	21	.	.	.
cord-023095-4dannjjm	2862	1	Endoscopic	endoscopic	JJ
cord-023095-4dannjjm	2862	2	biopsies	biopsy	NNS
cord-023095-4dannjjm	2862	3	from	from	IN
cord-023095-4dannjjm	2862	4	70	70	CD
cord-023095-4dannjjm	2862	5	cats	cat	NNS
cord-023095-4dannjjm	2862	6	which	which	WDT
cord-023095-4dannjjm	2862	7	had	have	VBD
cord-023095-4dannjjm	2862	8	duodenal	duodenal	JJ
cord-023095-4dannjjm	2862	9	and	and	CC
cord-023095-4dannjjm	2862	10	ileal	ileal	JJ
cord-023095-4dannjjm	2862	11	tissue	tissue	NN
cord-023095-4dannjjm	2862	12	specimens	specimen	NNS
cord-023095-4dannjjm	2862	13	were	be	VBD
cord-023095-4dannjjm	2862	14	evaluated	evaluate	VBN
cord-023095-4dannjjm	2862	15	retrospectively	retrospectively	RB
cord-023095-4dannjjm	2862	16	.	.	.
cord-023095-4dannjjm	2863	1	All	all	DT
cord-023095-4dannjjm	2863	2	slides	slide	NNS
cord-023095-4dannjjm	2863	3	were	be	VBD
cord-023095-4dannjjm	2863	4	randomized	randomize	VBN
cord-023095-4dannjjm	2863	5	and	and	CC
cord-023095-4dannjjm	2863	6	reviewed	review	VBN
cord-023095-4dannjjm	2863	7	by	by	IN
cord-023095-4dannjjm	2863	8	a	a	DT
cord-023095-4dannjjm	2863	9	single	single	JJ
cord-023095-4dannjjm	2863	10	pathologist	pathologist	NN
cord-023095-4dannjjm	2863	11	(	(	-LRB-
cord-023095-4dannjjm	2863	12	JM	JM	NNP
cord-023095-4dannjjm	2863	13	)	)	-RRB-
cord-023095-4dannjjm	2863	14	for	for	IN
cord-023095-4dannjjm	2863	15	quality	quality	NN
cord-023095-4dannjjm	2863	16	,	,	,
cord-023095-4dannjjm	2863	17	number	number	NN
cord-023095-4dannjjm	2863	18	of	of	IN
cord-023095-4dannjjm	2863	19	biopsies	biopsy	NNS
cord-023095-4dannjjm	2863	20	,	,	,
cord-023095-4dannjjm	2863	21	and	and	CC
cord-023095-4dannjjm	2863	22	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2863	23	according	accord	VBG
cord-023095-4dannjjm	2863	24	to	to	IN
cord-023095-4dannjjm	2863	25	WSAVA	WSAVA	NNP
cord-023095-4dannjjm	2863	26	standards	standard	NNS
cord-023095-4dannjjm	2863	27	.	.	.
cord-023095-4dannjjm	2864	1	No	no	DT
cord-023095-4dannjjm	2864	2	information	information	NN
cord-023095-4dannjjm	2864	3	regarding	regard	VBG
cord-023095-4dannjjm	2864	4	history	history	NN
cord-023095-4dannjjm	2864	5	,	,	,
cord-023095-4dannjjm	2864	6	clinical	clinical	JJ
cord-023095-4dannjjm	2864	7	signs	sign	NNS
cord-023095-4dannjjm	2864	8	,	,	,
cord-023095-4dannjjm	2864	9	endoscopic	endoscopic	JJ
cord-023095-4dannjjm	2864	10	findings	finding	NNS
cord-023095-4dannjjm	2864	11	,	,	,
cord-023095-4dannjjm	2864	12	or	or	CC
cord-023095-4dannjjm	2864	13	previous	previous	JJ
cord-023095-4dannjjm	2864	14	histological	histological	JJ
cord-023095-4dannjjm	2864	15	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2864	16	was	be	VBD
cord-023095-4dannjjm	2864	17	made	make	VBN
cord-023095-4dannjjm	2864	18	available	available	JJ
cord-023095-4dannjjm	2864	19	to	to	IN
cord-023095-4dannjjm	2864	20	the	the	DT
cord-023095-4dannjjm	2864	21	pathologist	pathologist	NN
cord-023095-4dannjjm	2864	22	.	.	.
cord-023095-4dannjjm	2865	1	Statistical	statistical	JJ
cord-023095-4dannjjm	2865	2	comparison	comparison	NN
cord-023095-4dannjjm	2865	3	of	of	IN
cord-023095-4dannjjm	2865	4	the	the	DT
cord-023095-4dannjjm	2865	5	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2865	6	of	of	IN
cord-023095-4dannjjm	2865	7	SC	SC	NNP
cord-023095-4dannjjm	2865	8	-	-	HYPH
cord-023095-4dannjjm	2865	9	LSA	LSA	NNP
cord-023095-4dannjjm	2865	10	and	and	CC
cord-023095-4dannjjm	2865	11	IBD	IBD	NNP
cord-023095-4dannjjm	2865	12	by	by	IN
cord-023095-4dannjjm	2865	13	intestinal	intestinal	JJ
cord-023095-4dannjjm	2865	14	location	location	NN
cord-023095-4dannjjm	2865	15	was	be	VBD
cord-023095-4dannjjm	2865	16	conducted	conduct	VBN
cord-023095-4dannjjm	2865	17	using	use	VBG
cord-023095-4dannjjm	2865	18	Fisher	Fisher	NNP
cord-023095-4dannjjm	2865	19	's	's	POS
cord-023095-4dannjjm	2865	20	exact	exact	JJ
cord-023095-4dannjjm	2865	21	test	test	NN
cord-023095-4dannjjm	2865	22	(	(	-LRB-
cord-023095-4dannjjm	2865	23	p	p	NN
cord-023095-4dannjjm	2865	24	o	o	NN
cord-023095-4dannjjm	2865	25	0.05	0.05	CD
cord-023095-4dannjjm	2865	26	significant	significant	JJ
cord-023095-4dannjjm	2865	27	)	)	-RRB-
cord-023095-4dannjjm	2865	28	.	.	.
cord-023095-4dannjjm	2866	1	18	18	CD
cord-023095-4dannjjm	2866	2	of	of	IN
cord-023095-4dannjjm	2866	3	70	70	CD
cord-023095-4dannjjm	2866	4	cats	cat	NNS
cord-023095-4dannjjm	2866	5	(	(	-LRB-
cord-023095-4dannjjm	2866	6	25.7	25.7	CD
cord-023095-4dannjjm	2866	7	%	%	NN
cord-023095-4dannjjm	2866	8	)	)	-RRB-
cord-023095-4dannjjm	2866	9	were	be	VBD
cord-023095-4dannjjm	2866	10	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2866	11	with	with	IN
cord-023095-4dannjjm	2866	12	SC	SC	NNP
cord-023095-4dannjjm	2866	13	-	-	HYPH
cord-023095-4dannjjm	2866	14	LSA	LSA	NNP
cord-023095-4dannjjm	2866	15	in	in	IN
cord-023095-4dannjjm	2866	16	the	the	DT
cord-023095-4dannjjm	2866	17	duodenum	duodenum	NN
cord-023095-4dannjjm	2866	18	and/or	and/or	CC
cord-023095-4dannjjm	2867	1	ileum	ileum	NNP
cord-023095-4dannjjm	2867	2	.	.	.
cord-023095-4dannjjm	2868	1	Of	of	IN
cord-023095-4dannjjm	2868	2	these	these	DT
cord-023095-4dannjjm	2868	3	18	18	CD
cord-023095-4dannjjm	2868	4	cats	cat	NNS
cord-023095-4dannjjm	2868	5	,	,	,
cord-023095-4dannjjm	2868	6	7	7	CD
cord-023095-4dannjjm	2868	7	(	(	-LRB-
cord-023095-4dannjjm	2868	8	38.9	38.9	CD
cord-023095-4dannjjm	2868	9	%	%	NN
cord-023095-4dannjjm	2868	10	)	)	-RRB-
cord-023095-4dannjjm	2868	11	were	be	VBD
cord-023095-4dannjjm	2868	12	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2868	13	with	with	IN
cord-023095-4dannjjm	2868	14	only	only	JJ
cord-023095-4dannjjm	2868	15	duodenal	duodenal	JJ
cord-023095-4dannjjm	2868	16	SC	SC	NNP
cord-023095-4dannjjm	2868	17	-	-	HYPH
cord-023095-4dannjjm	2868	18	LSA	LSA	NNP
cord-023095-4dannjjm	2868	19	,	,	,
cord-023095-4dannjjm	2868	20	8	8	CD
cord-023095-4dannjjm	2868	21	(	(	-LRB-
cord-023095-4dannjjm	2868	22	44.4	44.4	CD
cord-023095-4dannjjm	2868	23	%	%	NN
cord-023095-4dannjjm	2868	24	)	)	-RRB-
cord-023095-4dannjjm	2868	25	were	be	VBD
cord-023095-4dannjjm	2868	26	diagnosed	diagnose	VBN
cord-023095-4dannjjm	2868	27	with	with	IN
cord-023095-4dannjjm	2868	28	only	only	JJ
cord-023095-4dannjjm	2868	29	ileal	ileal	JJ
cord-023095-4dannjjm	2868	30	SC	SC	NNP
cord-023095-4dannjjm	2868	31	-	-	HYPH
cord-023095-4dannjjm	2868	32	LSA	LSA	NNP
cord-023095-4dannjjm	2868	33	,	,	,
cord-023095-4dannjjm	2868	34	and	and	CC
cord-023095-4dannjjm	2868	35	3	3	CD
cord-023095-4dannjjm	2868	36	(	(	-LRB-
cord-023095-4dannjjm	2868	37	16.7	16.7	CD
cord-023095-4dannjjm	2868	38	%	%	NN
cord-023095-4dannjjm	2868	39	)	)	-RRB-
cord-023095-4dannjjm	2868	40	had	have	VBD
cord-023095-4dannjjm	2868	41	SC	SC	NNP
cord-023095-4dannjjm	2868	42	-	-	HYPH
cord-023095-4dannjjm	2868	43	LSA	LSA	NNP
cord-023095-4dannjjm	2868	44	in	in	IN
cord-023095-4dannjjm	2868	45	both	both	CC
cord-023095-4dannjjm	2868	46	duodenum	duodenum	NN
cord-023095-4dannjjm	2868	47	and	and	CC
cord-023095-4dannjjm	2868	48	ileum	ileum	NN
cord-023095-4dannjjm	2868	49	.	.	.
cord-023095-4dannjjm	2869	1	In	in	IN
cord-023095-4dannjjm	2869	2	8	8	CD
cord-023095-4dannjjm	2869	3	cats	cat	NNS
cord-023095-4dannjjm	2869	4	with	with	IN
cord-023095-4dannjjm	2869	5	only	only	JJ
cord-023095-4dannjjm	2869	6	ileal	ileal	JJ
cord-023095-4dannjjm	2869	7	SC	SC	NNP
cord-023095-4dannjjm	2869	8	-	-	HYPH
cord-023095-4dannjjm	2869	9	LSA	LSA	NNP
cord-023095-4dannjjm	2869	10	,	,	,
cord-023095-4dannjjm	2869	11	3	3	CD
cord-023095-4dannjjm	2869	12	had	have	VBD
cord-023095-4dannjjm	2869	13	severe	severe	JJ
cord-023095-4dannjjm	2869	14	IBD	IBD	NNP
cord-023095-4dannjjm	2869	15	in	in	IN
cord-023095-4dannjjm	2869	16	duodenal	duodenal	JJ
cord-023095-4dannjjm	2869	17	biopsies	biopsy	NNS
cord-023095-4dannjjm	2869	18	,	,	,
cord-023095-4dannjjm	2869	19	possibly	possibly	RB
cord-023095-4dannjjm	2869	20	consistent	consistent	JJ
cord-023095-4dannjjm	2869	21	with	with	IN
cord-023095-4dannjjm	2869	22	early	early	JJ
cord-023095-4dannjjm	2869	23	SC	SC	NNP
cord-023095-4dannjjm	2869	24	-	-	HYPH
cord-023095-4dannjjm	2869	25	LSA	LSA	NNP
cord-023095-4dannjjm	2869	26	.	.	.
cord-023095-4dannjjm	2870	1	5	5	CD
cord-023095-4dannjjm	2870	2	of	of	IN
cord-023095-4dannjjm	2870	3	these	these	DT
cord-023095-4dannjjm	2870	4	8	8	CD
cord-023095-4dannjjm	2870	5	had	have	VBD
cord-023095-4dannjjm	2870	6	duodenal	duodenal	JJ
cord-023095-4dannjjm	2870	7	biopsies	biopsy	NNS
cord-023095-4dannjjm	2870	8	without	without	IN
cord-023095-4dannjjm	2870	9	evidence	evidence	NN
cord-023095-4dannjjm	2870	10	of	of	IN
cord-023095-4dannjjm	2870	11	SC	SC	NNP
cord-023095-4dannjjm	2870	12	-	-	HYPH
cord-023095-4dannjjm	2870	13	LSA	LSA	NNP
cord-023095-4dannjjm	2870	14	.	.	.
cord-023095-4dannjjm	2871	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	2871	2	results	result	NNS
cord-023095-4dannjjm	2871	3	suggest	suggest	VBP
cord-023095-4dannjjm	2871	4	there	there	EX
cord-023095-4dannjjm	2871	5	is	be	VBZ
cord-023095-4dannjjm	2871	6	a	a	DT
cord-023095-4dannjjm	2871	7	population	population	NN
cord-023095-4dannjjm	2871	8	of	of	IN
cord-023095-4dannjjm	2871	9	cats	cat	NNS
cord-023095-4dannjjm	2871	10	in	in	IN
cord-023095-4dannjjm	2871	11	which	which	WDT
cord-023095-4dannjjm	2871	12	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2871	13	of	of	IN
cord-023095-4dannjjm	2871	14	SC	SC	NNP
cord-023095-4dannjjm	2871	15	-	-	HYPH
cord-023095-4dannjjm	2871	16	LSA	LSA	NNP
cord-023095-4dannjjm	2871	17	may	may	MD
cord-023095-4dannjjm	2871	18	only	only	RB
cord-023095-4dannjjm	2871	19	be	be	VB
cord-023095-4dannjjm	2871	20	found	find	VBN
cord-023095-4dannjjm	2871	21	by	by	IN
cord-023095-4dannjjm	2871	22	evaluating	evaluate	VBG
cord-023095-4dannjjm	2871	23	ileal	ileal	JJ
cord-023095-4dannjjm	2871	24	biopsies	biopsy	NNS
cord-023095-4dannjjm	2871	25	.	.	.
cord-023095-4dannjjm	2872	1	Clinicians	clinician	NNS
cord-023095-4dannjjm	2872	2	should	should	MD
cord-023095-4dannjjm	2872	3	consider	consider	VB
cord-023095-4dannjjm	2872	4	performing	perform	VBG
cord-023095-4dannjjm	2872	5	both	both	DT
cord-023095-4dannjjm	2872	6	upper	upper	JJ
cord-023095-4dannjjm	2872	7	and	and	CC
cord-023095-4dannjjm	2872	8	lower	low	JJR
cord-023095-4dannjjm	2872	9	GI	GI	NNP
cord-023095-4dannjjm	2872	10	endoscopic	endoscopic	NN
cord-023095-4dannjjm	2872	11	biopsies	biopsy	NNS
cord-023095-4dannjjm	2872	12	in	in	IN
cord-023095-4dannjjm	2872	13	cats	cat	NNS
cord-023095-4dannjjm	2872	14	with	with	IN
cord-023095-4dannjjm	2872	15	suspected	suspect	VBN
cord-023095-4dannjjm	2872	16	infiltrative	infiltrative	JJ
cord-023095-4dannjjm	2872	17	small	small	JJ
cord-023095-4dannjjm	2872	18	bowel	bowel	NN
cord-023095-4dannjjm	2872	19	disease	disease	NN
cord-023095-4dannjjm	2872	20	.	.	.
cord-023095-4dannjjm	2873	1	Periodontitis	Periodontitis	NNP
cord-023095-4dannjjm	2873	2	is	be	VBZ
cord-023095-4dannjjm	2873	3	one	one	CD
cord-023095-4dannjjm	2873	4	of	of	IN
cord-023095-4dannjjm	2873	5	the	the	DT
cord-023095-4dannjjm	2873	6	most	most	RBS
cord-023095-4dannjjm	2873	7	common	common	JJ
cord-023095-4dannjjm	2873	8	diseases	disease	NNS
cord-023095-4dannjjm	2873	9	in	in	IN
cord-023095-4dannjjm	2873	10	cats	cat	NNS
cord-023095-4dannjjm	2873	11	and	and	CC
cord-023095-4dannjjm	2873	12	is	be	VBZ
cord-023095-4dannjjm	2873	13	mainly	mainly	RB
cord-023095-4dannjjm	2873	14	due	due	JJ
cord-023095-4dannjjm	2873	15	to	to	IN
cord-023095-4dannjjm	2873	16	the	the	DT
cord-023095-4dannjjm	2873	17	presence	presence	NN
cord-023095-4dannjjm	2873	18	of	of	IN
cord-023095-4dannjjm	2873	19	plaque	plaque	NN
cord-023095-4dannjjm	2873	20	and	and	CC
cord-023095-4dannjjm	2873	21	calculus	calculus	NN
cord-023095-4dannjjm	2873	22	.	.	.
cord-023095-4dannjjm	2874	1	In	in	IN
cord-023095-4dannjjm	2874	2	this	this	DT
cord-023095-4dannjjm	2874	3	study	study	NN
cord-023095-4dannjjm	2874	4	,	,	,
cord-023095-4dannjjm	2874	5	we	-PRON-	PRP
cord-023095-4dannjjm	2874	6	investigated	investigate	VBD
cord-023095-4dannjjm	2874	7	putative	putative	JJ
cord-023095-4dannjjm	2874	8	correlations	correlation	NNS
cord-023095-4dannjjm	2874	9	between	between	IN
cord-023095-4dannjjm	2874	10	dental	dental	JJ
cord-023095-4dannjjm	2874	11	tartar	tartar	NN
cord-023095-4dannjjm	2874	12	and	and	CC
cord-023095-4dannjjm	2874	13	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2874	14	and	and	CC
cord-023095-4dannjjm	2874	15	also	also	RB
cord-023095-4dannjjm	2874	16	between	between	IN
cord-023095-4dannjjm	2874	17	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2874	18	and	and	CC
cord-023095-4dannjjm	2874	19	subgingival	subgingival	NN
cord-023095-4dannjjm	2874	20	bacteria	bacteria	NNS
cord-023095-4dannjjm	2874	21	in	in	IN
cord-023095-4dannjjm	2874	22	cats	cat	NNS
cord-023095-4dannjjm	2874	23	.	.	.
cord-023095-4dannjjm	2875	1	Twelve	twelve	CD
cord-023095-4dannjjm	2875	2	cats	cat	NNS
cord-023095-4dannjjm	2875	3	(	(	-LRB-
cord-023095-4dannjjm	2875	4	median	median	JJ
cord-023095-4dannjjm	2875	5	age	age	NN
cord-023095-4dannjjm	2875	6	:	:	:
cord-023095-4dannjjm	2875	7	5	5	CD
cord-023095-4dannjjm	2875	8	years	year	NNS
cord-023095-4dannjjm	2875	9	;	;	:
cord-023095-4dannjjm	2875	10	range	range	NN
cord-023095-4dannjjm	2875	11	:	:	:
cord-023095-4dannjjm	2875	12	1	1	CD
cord-023095-4dannjjm	2875	13	-	-	SYM
cord-023095-4dannjjm	2875	14	10	10	CD
cord-023095-4dannjjm	2875	15	years	year	NNS
cord-023095-4dannjjm	2875	16	;	;	:
cord-023095-4dannjjm	2875	17	6	6	CD
cord-023095-4dannjjm	2875	18	DSH	DSH	NNP
cord-023095-4dannjjm	2875	19	and	and	CC
cord-023095-4dannjjm	2875	20	6	6	CD
cord-023095-4dannjjm	2875	21	Persians	Persians	NNPS
cord-023095-4dannjjm	2875	22	;	;	:
cord-023095-4dannjjm	2875	23	8	8	CD
cord-023095-4dannjjm	2875	24	females	female	NNS
cord-023095-4dannjjm	2875	25	and	and	CC
cord-023095-4dannjjm	2875	26	4	4	CD
cord-023095-4dannjjm	2875	27	males	male	NNS
cord-023095-4dannjjm	2875	28	)	)	-RRB-
cord-023095-4dannjjm	2875	29	were	be	VBD
cord-023095-4dannjjm	2875	30	enrolled	enrol	VBN
cord-023095-4dannjjm	2875	31	.	.	.
cord-023095-4dannjjm	2876	1	Dental	dental	JJ
cord-023095-4dannjjm	2876	2	tartar	tartar	NN
cord-023095-4dannjjm	2876	3	was	be	VBD
cord-023095-4dannjjm	2876	4	obtained	obtain	VBN
cord-023095-4dannjjm	2876	5	during	during	IN
cord-023095-4dannjjm	2876	6	scaling	scale	VBG
cord-023095-4dannjjm	2876	7	for	for	IN
cord-023095-4dannjjm	2876	8	a	a	DT
cord-023095-4dannjjm	2876	9	dental	dental	JJ
cord-023095-4dannjjm	2876	10	prophylactic	prophylactic	JJ
cord-023095-4dannjjm	2876	11	procedure	procedure	NN
cord-023095-4dannjjm	2876	12	.	.	.
cord-023095-4dannjjm	2877	1	All	all	DT
cord-023095-4dannjjm	2877	2	cats	cat	NNS
cord-023095-4dannjjm	2877	3	were	be	VBD
cord-023095-4dannjjm	2877	4	negative	negative	JJ
cord-023095-4dannjjm	2877	5	for	for	IN
cord-023095-4dannjjm	2877	6	FeLV	FeLV	NNP
cord-023095-4dannjjm	2877	7	and	and	CC
cord-023095-4dannjjm	2877	8	FIV	FIV	NNP
cord-023095-4dannjjm	2877	9	infection	infection	NN
cord-023095-4dannjjm	2877	10	as	as	IN
cord-023095-4dannjjm	2877	11	assessed	assess	VBN
cord-023095-4dannjjm	2877	12	by	by	IN
cord-023095-4dannjjm	2877	13	a	a	DT
cord-023095-4dannjjm	2877	14	commercial	commercial	JJ
cord-023095-4dannjjm	2877	15	ELISA	ELISA	NNP
cord-023095-4dannjjm	2877	16	test	test	NN
cord-023095-4dannjjm	2877	17	(	(	-LRB-
cord-023095-4dannjjm	2877	18	SNAP	snap	VB
cord-023095-4dannjjm	2877	19	s	s	PRP
cord-023095-4dannjjm	2877	20	FIV	FIV	NNP
cord-023095-4dannjjm	2877	21	/	/	SYM
cord-023095-4dannjjm	2877	22	FeLV	FeLV	NNP
cord-023095-4dannjjm	2877	23	Combo	Combo	NNP
cord-023095-4dannjjm	2877	24	Test	Test	NNP
cord-023095-4dannjjm	2877	25	)	)	-RRB-
cord-023095-4dannjjm	2877	26	.	.	.
cord-023095-4dannjjm	2878	1	Severity	severity	NN
cord-023095-4dannjjm	2878	2	of	of	IN
cord-023095-4dannjjm	2878	3	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2878	4	(	(	-LRB-
cord-023095-4dannjjm	2878	5	scores	score	NNS
cord-023095-4dannjjm	2878	6	:	:	:
cord-023095-4dannjjm	2878	7	0	0	CD
cord-023095-4dannjjm	2878	8	-	-	SYM
cord-023095-4dannjjm	2878	9	3	3	CD
cord-023095-4dannjjm	2878	10	;	;	:
cord-023095-4dannjjm	2878	11	0	0	CD
cord-023095-4dannjjm	2878	12	5	5	CD
cord-023095-4dannjjm	2878	13	normal	normal	JJ
cord-023095-4dannjjm	2878	14	,	,	,
cord-023095-4dannjjm	2878	15	1	1	CD
cord-023095-4dannjjm	2878	16	5	5	CD
cord-023095-4dannjjm	2878	17	mild	mild	JJ
cord-023095-4dannjjm	2878	18	,	,	,
cord-023095-4dannjjm	2878	19	2	2	CD
cord-023095-4dannjjm	2878	20	5	5	CD
cord-023095-4dannjjm	2878	21	moderate	moderate	JJ
cord-023095-4dannjjm	2878	22	,	,	,
cord-023095-4dannjjm	2878	23	and	and	CC
cord-023095-4dannjjm	2878	24	3	3	CD
cord-023095-4dannjjm	2878	25	5	5	CD
cord-023095-4dannjjm	2878	26	severe	severe	JJ
cord-023095-4dannjjm	2878	27	)	)	-RRB-
cord-023095-4dannjjm	2878	28	and	and	CC
cord-023095-4dannjjm	2878	29	dental	dental	JJ
cord-023095-4dannjjm	2878	30	tartar	tartar	NN
cord-023095-4dannjjm	2878	31	(	(	-LRB-
cord-023095-4dannjjm	2878	32	scores	score	NNS
cord-023095-4dannjjm	2878	33	:	:	:
cord-023095-4dannjjm	2878	34	0	0	CD
cord-023095-4dannjjm	2878	35	-	-	SYM
cord-023095-4dannjjm	2878	36	3	3	CD
cord-023095-4dannjjm	2878	37	)	)	-RRB-
cord-023095-4dannjjm	2878	38	were	be	VBD
cord-023095-4dannjjm	2878	39	scored	score	VBN
cord-023095-4dannjjm	2878	40	in	in	IN
cord-023095-4dannjjm	2878	41	each	each	DT
cord-023095-4dannjjm	2878	42	cat	cat	NN
cord-023095-4dannjjm	2878	43	.	.	.
cord-023095-4dannjjm	2879	1	Endodontic	endodontic	JJ
cord-023095-4dannjjm	2879	2	paper	paper	NN
cord-023095-4dannjjm	2879	3	points	point	NNS
cord-023095-4dannjjm	2879	4	were	be	VBD
cord-023095-4dannjjm	2879	5	applied	apply	VBN
cord-023095-4dannjjm	2879	6	for	for	IN
cord-023095-4dannjjm	2879	7	collecting	collect	VBG
cord-023095-4dannjjm	2879	8	a	a	DT
cord-023095-4dannjjm	2879	9	bacterial	bacterial	JJ
cord-023095-4dannjjm	2879	10	sample	sample	NN
cord-023095-4dannjjm	2879	11	from	from	IN
cord-023095-4dannjjm	2879	12	the	the	DT
cord-023095-4dannjjm	2879	13	subgingival	subgingival	NNP
cord-023095-4dannjjm	2879	14	area	area	NN
cord-023095-4dannjjm	2879	15	and	and	CC
cord-023095-4dannjjm	2879	16	transferred	transfer	VBN
cord-023095-4dannjjm	2879	17	to	to	IN
cord-023095-4dannjjm	2879	18	thioglycollate	thioglycollate	JJ
cord-023095-4dannjjm	2879	19	transporting	transport	VBG
cord-023095-4dannjjm	2879	20	media	medium	NNS
cord-023095-4dannjjm	2879	21	for	for	IN
cord-023095-4dannjjm	2879	22	bacterial	bacterial	JJ
cord-023095-4dannjjm	2879	23	culture	culture	NN
cord-023095-4dannjjm	2879	24	.	.	.
cord-023095-4dannjjm	2880	1	The	the	DT
cord-023095-4dannjjm	2880	2	relationship	relationship	NN
cord-023095-4dannjjm	2880	3	between	between	IN
cord-023095-4dannjjm	2880	4	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2880	5	and	and	CC
cord-023095-4dannjjm	2880	6	tartar	tartar	NN
cord-023095-4dannjjm	2880	7	thickness	thickness	NN
cord-023095-4dannjjm	2880	8	scores	score	NNS
cord-023095-4dannjjm	2880	9	was	be	VBD
cord-023095-4dannjjm	2880	10	analyzed	analyze	VBN
cord-023095-4dannjjm	2880	11	by	by	IN
cord-023095-4dannjjm	2880	12	spearman	spearman	NNP
cord-023095-4dannjjm	2880	13	correlation	correlation	NN
cord-023095-4dannjjm	2880	14	.	.	.
cord-023095-4dannjjm	2881	1	A	a	DT
cord-023095-4dannjjm	2881	2	student	student	NN
cord-023095-4dannjjm	2881	3	's	's	POS
cord-023095-4dannjjm	2881	4	t	t	NN
cord-023095-4dannjjm	2881	5	-	-	HYPH
cord-023095-4dannjjm	2881	6	test	test	NN
cord-023095-4dannjjm	2881	7	was	be	VBD
cord-023095-4dannjjm	2881	8	used	use	VBN
cord-023095-4dannjjm	2881	9	to	to	TO
cord-023095-4dannjjm	2881	10	compare	compare	VB
cord-023095-4dannjjm	2881	11	the	the	DT
cord-023095-4dannjjm	2881	12	mean	mean	JJ
cord-023095-4dannjjm	2881	13	differences	difference	NNS
cord-023095-4dannjjm	2881	14	(	(	-LRB-
cord-023095-4dannjjm	2881	15	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2881	16	and	and	CC
cord-023095-4dannjjm	2881	17	tartar	tartar	NN
cord-023095-4dannjjm	2881	18	thickness	thickness	NN
cord-023095-4dannjjm	2881	19	scores	score	NNS
cord-023095-4dannjjm	2881	20	)	)	-RRB-
cord-023095-4dannjjm	2881	21	between	between	IN
cord-023095-4dannjjm	2881	22	upper	upper	JJ
cord-023095-4dannjjm	2881	23	and	and	CC
cord-023095-4dannjjm	2881	24	lower	low	JJR
cord-023095-4dannjjm	2881	25	teeth	tooth	NNS
cord-023095-4dannjjm	2881	26	.	.	.
cord-023095-4dannjjm	2882	1	The	the	DT
cord-023095-4dannjjm	2882	2	association	association	NN
cord-023095-4dannjjm	2882	3	between	between	IN
cord-023095-4dannjjm	2882	4	severity	severity	NN
cord-023095-4dannjjm	2882	5	of	of	IN
cord-023095-4dannjjm	2882	6	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2882	7	and	and	CC
cord-023095-4dannjjm	2882	8	bacterial	bacterial	JJ
cord-023095-4dannjjm	2882	9	type	type	NN
cord-023095-4dannjjm	2882	10	was	be	VBD
cord-023095-4dannjjm	2882	11	tested	test	VBN
cord-023095-4dannjjm	2882	12	by	by	IN
cord-023095-4dannjjm	2882	13	chi	chi	NNP
cord-023095-4dannjjm	2882	14	square	square	NNP
cord-023095-4dannjjm	2882	15	test	test	NN
cord-023095-4dannjjm	2882	16	.	.	.
cord-023095-4dannjjm	2883	1	The	the	DT
cord-023095-4dannjjm	2883	2	spearman	spearman	NN
cord-023095-4dannjjm	2883	3	correlation	correlation	NN
cord-023095-4dannjjm	2883	4	coefficient	coefficient	NN
cord-023095-4dannjjm	2883	5	for	for	IN
cord-023095-4dannjjm	2883	6	the	the	DT
cord-023095-4dannjjm	2883	7	average	average	JJ
cord-023095-4dannjjm	2883	8	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2883	9	score	score	NN
cord-023095-4dannjjm	2883	10	and	and	CC
cord-023095-4dannjjm	2883	11	the	the	DT
cord-023095-4dannjjm	2883	12	average	average	JJ
cord-023095-4dannjjm	2883	13	tartar	tartar	NN
cord-023095-4dannjjm	2883	14	thickness	thickness	NN
cord-023095-4dannjjm	2883	15	score	score	NN
cord-023095-4dannjjm	2883	16	was	be	VBD
cord-023095-4dannjjm	2883	17	0.91	0.91	CD
cord-023095-4dannjjm	2883	18	(	(	-LRB-
cord-023095-4dannjjm	2883	19	p	p	NN
cord-023095-4dannjjm	2883	20	o	o	NN
cord-023095-4dannjjm	2883	21	0.05	0.05	CD
cord-023095-4dannjjm	2883	22	)	)	-RRB-
cord-023095-4dannjjm	2883	23	.	.	.
cord-023095-4dannjjm	2884	1	Interestingly	interestingly	RB
cord-023095-4dannjjm	2884	2	,	,	,
cord-023095-4dannjjm	2884	3	the	the	DT
cord-023095-4dannjjm	2884	4	average	average	JJ
cord-023095-4dannjjm	2884	5	tartar	tartar	NN
cord-023095-4dannjjm	2884	6	thickness	thickness	NN
cord-023095-4dannjjm	2884	7	scores	score	NNS
cord-023095-4dannjjm	2884	8	from	from	IN
cord-023095-4dannjjm	2884	9	the	the	DT
cord-023095-4dannjjm	2884	10	upper	upper	JJ
cord-023095-4dannjjm	2884	11	jaw	jaw	NN
cord-023095-4dannjjm	2884	12	were	be	VBD
cord-023095-4dannjjm	2884	13	significantly	significantly	RB
cord-023095-4dannjjm	2884	14	higher	high	JJR
cord-023095-4dannjjm	2884	15	than	than	IN
cord-023095-4dannjjm	2884	16	those	those	DT
cord-023095-4dannjjm	2884	17	from	from	IN
cord-023095-4dannjjm	2884	18	the	the	DT
cord-023095-4dannjjm	2884	19	lower	low	JJR
cord-023095-4dannjjm	2884	20	jaw	jaw	NN
cord-023095-4dannjjm	2884	21	(	(	-LRB-
cord-023095-4dannjjm	2884	22	p	p	NN
cord-023095-4dannjjm	2884	23	o	o	NN
cord-023095-4dannjjm	2884	24	0.05	0.05	CD
cord-023095-4dannjjm	2884	25	)	)	-RRB-
cord-023095-4dannjjm	2884	26	.	.	.
cord-023095-4dannjjm	2885	1	The	the	DT
cord-023095-4dannjjm	2885	2	highest	high	JJS
cord-023095-4dannjjm	2885	3	scores	score	NNS
cord-023095-4dannjjm	2885	4	were	be	VBD
cord-023095-4dannjjm	2885	5	found	find	VBN
cord-023095-4dannjjm	2885	6	for	for	IN
cord-023095-4dannjjm	2885	7	the	the	DT
cord-023095-4dannjjm	2885	8	molar	molar	JJ
cord-023095-4dannjjm	2885	9	teeth	tooth	NNS
cord-023095-4dannjjm	2885	10	in	in	IN
cord-023095-4dannjjm	2885	11	all	all	DT
cord-023095-4dannjjm	2885	12	cats	cat	NNS
cord-023095-4dannjjm	2885	13	.	.	.
cord-023095-4dannjjm	2886	1	Bacterial	bacterial	JJ
cord-023095-4dannjjm	2886	2	culture	culture	NN
cord-023095-4dannjjm	2886	3	revealed	reveal	VBD
cord-023095-4dannjjm	2886	4	28.9	28.9	CD
cord-023095-4dannjjm	2886	5	%	%	NN
cord-023095-4dannjjm	2886	6	anaerobic	anaerobic	JJ
cord-023095-4dannjjm	2886	7	bacteria	bacteria	NNS
cord-023095-4dannjjm	2886	8	species	specie	NNS
cord-023095-4dannjjm	2886	9	(	(	-LRB-
cord-023095-4dannjjm	2886	10	i.e.	i.e.	FW
cord-023095-4dannjjm	2886	11	,	,	,
cord-023095-4dannjjm	2886	12	Bacteroides	Bacteroides	NNP
cord-023095-4dannjjm	2886	13	spp	spp	NNS
cord-023095-4dannjjm	2886	14	.	.	.
cord-023095-4dannjjm	2887	1	,	,	,
cord-023095-4dannjjm	2887	2	Peptostreptococcus	Peptostreptococcus	NNP
cord-023095-4dannjjm	2887	3	anaerobius	anaerobius	NN
cord-023095-4dannjjm	2887	4	,	,	,
cord-023095-4dannjjm	2887	5	and	and	CC
cord-023095-4dannjjm	2887	6	Eubacterium	Eubacterium	NNP
cord-023095-4dannjjm	2887	7	aerofaciens	aerofaciens	NNP
cord-023095-4dannjjm	2887	8	)	)	-RRB-
cord-023095-4dannjjm	2887	9	and	and	CC
cord-023095-4dannjjm	2887	10	71.1	71.1	CD
cord-023095-4dannjjm	2887	11	%	%	NN
cord-023095-4dannjjm	2887	12	aerobic	aerobic	JJ
cord-023095-4dannjjm	2887	13	bacteria	bacteria	NNS
cord-023095-4dannjjm	2887	14	species	specie	NNS
cord-023095-4dannjjm	2887	15	(	(	-LRB-
cord-023095-4dannjjm	2887	16	i.e.	i.e.	FW
cord-023095-4dannjjm	2887	17	,	,	,
cord-023095-4dannjjm	2887	18	Pasteurella	Pasteurella	NNP
cord-023095-4dannjjm	2887	19	multocida	multocida	NN
cord-023095-4dannjjm	2887	20	,	,	,
cord-023095-4dannjjm	2887	21	Streptococcus	Streptococcus	NNP
cord-023095-4dannjjm	2887	22	spp	spp	NNS
cord-023095-4dannjjm	2887	23	.	.	.
cord-023095-4dannjjm	2887	24	,	,	,
cord-023095-4dannjjm	2888	1	Enterococcus	Enterococcus	NNP
cord-023095-4dannjjm	2888	2	spp	spp	NNP
cord-023095-4dannjjm	2888	3	.	.	.
cord-023095-4dannjjm	2889	1	,	,	,
cord-023095-4dannjjm	2889	2	Staphylococcus	Staphylococcus	NNP
cord-023095-4dannjjm	2889	3	spp	spp	NNS
cord-023095-4dannjjm	2889	4	.	.	.
cord-023095-4dannjjm	2889	5	,	,	,
cord-023095-4dannjjm	2889	6	Bacillus	bacillus	NN
cord-023095-4dannjjm	2889	7	cereus	cereus	NN
cord-023095-4dannjjm	2889	8	,	,	,
cord-023095-4dannjjm	2889	9	Escherichia	escherichia	NN
cord-023095-4dannjjm	2889	10	coli	coli	NNS
cord-023095-4dannjjm	2889	11	,	,	,
cord-023095-4dannjjm	2889	12	and	and	CC
cord-023095-4dannjjm	2889	13	Pseudomonas	Pseudomonas	NNP
cord-023095-4dannjjm	2889	14	aeruginosa	aeruginosa	NN
cord-023095-4dannjjm	2889	15	)	)	-RRB-
cord-023095-4dannjjm	2889	16	.	.	.
cord-023095-4dannjjm	2890	1	Anaerobic	anaerobic	JJ
cord-023095-4dannjjm	2890	2	bacteria	bacteria	NNS
cord-023095-4dannjjm	2890	3	were	be	VBD
cord-023095-4dannjjm	2890	4	found	find	VBN
cord-023095-4dannjjm	2890	5	mostly	mostly	RB
cord-023095-4dannjjm	2890	6	in	in	IN
cord-023095-4dannjjm	2890	7	cats	cat	NNS
cord-023095-4dannjjm	2890	8	with	with	IN
cord-023095-4dannjjm	2890	9	higher	high	JJR
cord-023095-4dannjjm	2890	10	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2890	11	scores	score	NNS
cord-023095-4dannjjm	2890	12	(	(	-LRB-
cord-023095-4dannjjm	2890	13	2	2	CD
cord-023095-4dannjjm	2890	14	-	-	SYM
cord-023095-4dannjjm	2890	15	3	3	CD
cord-023095-4dannjjm	2890	16	;	;	:
cord-023095-4dannjjm	2890	17	chi	chi	NNP
cord-023095-4dannjjm	2890	18	square	square	NNP
cord-023095-4dannjjm	2890	19	:	:	:
cord-023095-4dannjjm	2891	1	p	p	NN
cord-023095-4dannjjm	2891	2	o	o	NN
cord-023095-4dannjjm	2891	3	0.05	0.05	CD
cord-023095-4dannjjm	2891	4	)	)	-RRB-
cord-023095-4dannjjm	2891	5	,	,	,
cord-023095-4dannjjm	2891	6	while	while	IN
cord-023095-4dannjjm	2891	7	Pasteurella	Pasteurella	NNP
cord-023095-4dannjjm	2891	8	multocida	multocida	NNP
cord-023095-4dannjjm	2891	9	was	be	VBD
cord-023095-4dannjjm	2891	10	found	find	VBN
cord-023095-4dannjjm	2891	11	mostly	mostly	RB
cord-023095-4dannjjm	2891	12	in	in	IN
cord-023095-4dannjjm	2891	13	cats	cat	NNS
cord-023095-4dannjjm	2891	14	with	with	IN
cord-023095-4dannjjm	2891	15	lower	low	JJR
cord-023095-4dannjjm	2891	16	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2891	17	scores	score	NNS
cord-023095-4dannjjm	2891	18	(	(	-LRB-
cord-023095-4dannjjm	2891	19	0	0	CD
cord-023095-4dannjjm	2891	20	-	-	SYM
cord-023095-4dannjjm	2891	21	1	1	CD
cord-023095-4dannjjm	2891	22	;	;	:
cord-023095-4dannjjm	2891	23	chi	chi	NNP
cord-023095-4dannjjm	2891	24	square	square	NNP
cord-023095-4dannjjm	2891	25	:	:	:
cord-023095-4dannjjm	2892	1	p	p	NN
cord-023095-4dannjjm	2892	2	o	o	NN
cord-023095-4dannjjm	2892	3	0.05	0.05	CD
cord-023095-4dannjjm	2892	4	)	)	-RRB-
cord-023095-4dannjjm	2892	5	.	.	.
cord-023095-4dannjjm	2893	1	Antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	2893	2	sensitivity	sensitivity	NN
cord-023095-4dannjjm	2893	3	testing	testing	NN
cord-023095-4dannjjm	2893	4	indicated	indicate	VBD
cord-023095-4dannjjm	2893	5	that	that	IN
cord-023095-4dannjjm	2893	6	all	all	DT
cord-023095-4dannjjm	2893	7	of	of	IN
cord-023095-4dannjjm	2893	8	the	the	DT
cord-023095-4dannjjm	2893	9	anaerobic	anaerobic	JJ
cord-023095-4dannjjm	2893	10	bacteria	bacteria	NNS
cord-023095-4dannjjm	2893	11	were	be	VBD
cord-023095-4dannjjm	2893	12	sensitive	sensitive	JJ
cord-023095-4dannjjm	2893	13	to	to	IN
cord-023095-4dannjjm	2893	14	clindamycin	clindamycin	NN
cord-023095-4dannjjm	2893	15	,	,	,
cord-023095-4dannjjm	2893	16	chloramphenicol	chloramphenicol	NNP
cord-023095-4dannjjm	2893	17	,	,	,
cord-023095-4dannjjm	2893	18	metronidazole	metronidazole	NNP
cord-023095-4dannjjm	2893	19	,	,	,
cord-023095-4dannjjm	2893	20	cefoxitin	cefoxitin	NNS
cord-023095-4dannjjm	2893	21	,	,	,
cord-023095-4dannjjm	2893	22	or	or	CC
cord-023095-4dannjjm	2893	23	tetracycline	tetracycline	NN
cord-023095-4dannjjm	2893	24	,	,	,
cord-023095-4dannjjm	2893	25	90	90	CD
cord-023095-4dannjjm	2893	26	%	%	NN
cord-023095-4dannjjm	2893	27	were	be	VBD
cord-023095-4dannjjm	2893	28	sensitive	sensitive	JJ
cord-023095-4dannjjm	2893	29	to	to	IN
cord-023095-4dannjjm	2893	30	erythromycin	erythromycin	NN
cord-023095-4dannjjm	2893	31	,	,	,
cord-023095-4dannjjm	2893	32	and	and	CC
cord-023095-4dannjjm	2893	33	80	80	CD
cord-023095-4dannjjm	2893	34	%	%	NN
cord-023095-4dannjjm	2893	35	were	be	VBD
cord-023095-4dannjjm	2893	36	sensitive	sensitive	JJ
cord-023095-4dannjjm	2893	37	to	to	IN
cord-023095-4dannjjm	2893	38	penicillin	penicillin	NN
cord-023095-4dannjjm	2893	39	.	.	.
cord-023095-4dannjjm	2894	1	The	the	DT
cord-023095-4dannjjm	2894	2	most	most	RBS
cord-023095-4dannjjm	2894	3	abundant	abundant	JJ
cord-023095-4dannjjm	2894	4	aerobic	aerobic	JJ
cord-023095-4dannjjm	2894	5	bacterial	bacterial	JJ
cord-023095-4dannjjm	2894	6	species	specie	NNS
cord-023095-4dannjjm	2894	7	,	,	,
cord-023095-4dannjjm	2894	8	Pasteurella	Pasteurella	NNP
cord-023095-4dannjjm	2894	9	multocida	multocida	NNP
cord-023095-4dannjjm	2894	10	,	,	,
cord-023095-4dannjjm	2894	11	was	be	VBD
cord-023095-4dannjjm	2894	12	sensitive	sensitive	JJ
cord-023095-4dannjjm	2894	13	to	to	IN
cord-023095-4dannjjm	2894	14	cefoxitin	cefoxitin	NNS
cord-023095-4dannjjm	2894	15	in	in	IN
cord-023095-4dannjjm	2894	16	all	all	DT
cord-023095-4dannjjm	2894	17	cases	case	NNS
cord-023095-4dannjjm	2894	18	in	in	IN
cord-023095-4dannjjm	2894	19	which	which	WDT
cord-023095-4dannjjm	2894	20	it	-PRON-	PRP
cord-023095-4dannjjm	2894	21	had	have	VBD
cord-023095-4dannjjm	2894	22	been	be	VBN
cord-023095-4dannjjm	2894	23	cultured	culture	VBN
cord-023095-4dannjjm	2894	24	.	.	.
cord-023095-4dannjjm	2895	1	These	these	DT
cord-023095-4dannjjm	2895	2	results	result	NNS
cord-023095-4dannjjm	2895	3	suggest	suggest	VBP
cord-023095-4dannjjm	2895	4	that	that	IN
cord-023095-4dannjjm	2895	5	anaerobic	anaerobic	JJ
cord-023095-4dannjjm	2895	6	bacteria	bacteria	NNS
cord-023095-4dannjjm	2895	7	may	may	MD
cord-023095-4dannjjm	2895	8	be	be	VB
cord-023095-4dannjjm	2895	9	associated	associate	VBN
cord-023095-4dannjjm	2895	10	in	in	IN
cord-023095-4dannjjm	2895	11	the	the	DT
cord-023095-4dannjjm	2895	12	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	2895	13	of	of	IN
cord-023095-4dannjjm	2895	14	severe	severe	JJ
cord-023095-4dannjjm	2895	15	gingivitis	gingivitis	NN
cord-023095-4dannjjm	2895	16	.	.	.
cord-023095-4dannjjm	2896	1	These	these	DT
cord-023095-4dannjjm	2896	2	data	datum	NNS
cord-023095-4dannjjm	2896	3	warrant	warrant	VBP
cord-023095-4dannjjm	2896	4	further	further	JJ
cord-023095-4dannjjm	2896	5	studies	study	NNS
cord-023095-4dannjjm	2896	6	of	of	IN
cord-023095-4dannjjm	2896	7	the	the	DT
cord-023095-4dannjjm	2896	8	prophylactic	prophylactic	JJ
cord-023095-4dannjjm	2896	9	use	use	NN
cord-023095-4dannjjm	2896	10	of	of	IN
cord-023095-4dannjjm	2896	11	antibiotics	antibiotic	NNS
cord-023095-4dannjjm	2896	12	in	in	IN
cord-023095-4dannjjm	2896	13	cats	cat	NNS
cord-023095-4dannjjm	2896	14	undergoing	undergo	VBG
cord-023095-4dannjjm	2896	15	dental	dental	JJ
cord-023095-4dannjjm	2896	16	prophylactic	prophylactic	JJ
cord-023095-4dannjjm	2896	17	procedures	procedure	NNS
cord-023095-4dannjjm	2896	18	.	.	.
cord-023095-4dannjjm	2897	1	Inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2897	2	bowel	bowel	NN
cord-023095-4dannjjm	2897	3	disease	disease	NN
cord-023095-4dannjjm	2897	4	is	be	VBZ
cord-023095-4dannjjm	2897	5	the	the	DT
cord-023095-4dannjjm	2897	6	most	most	RBS
cord-023095-4dannjjm	2897	7	common	common	JJ
cord-023095-4dannjjm	2897	8	cause	cause	NN
cord-023095-4dannjjm	2897	9	of	of	IN
cord-023095-4dannjjm	2897	10	vomiting	vomiting	NN
cord-023095-4dannjjm	2897	11	and	and	CC
cord-023095-4dannjjm	2897	12	diarrhea	diarrhea	NN
cord-023095-4dannjjm	2897	13	in	in	IN
cord-023095-4dannjjm	2897	14	dogs	dog	NNS
cord-023095-4dannjjm	2897	15	.	.	.
cord-023095-4dannjjm	2898	1	Although	although	IN
cord-023095-4dannjjm	2898	2	it	-PRON-	PRP
cord-023095-4dannjjm	2898	3	can	can	MD
cord-023095-4dannjjm	2898	4	occur	occur	VB
cord-023095-4dannjjm	2898	5	in	in	IN
cord-023095-4dannjjm	2898	6	any	any	DT
cord-023095-4dannjjm	2898	7	canine	canine	JJ
cord-023095-4dannjjm	2898	8	breed	breed	NN
cord-023095-4dannjjm	2898	9	,	,	,
cord-023095-4dannjjm	2898	10	certain	certain	JJ
cord-023095-4dannjjm	2898	11	breeds	breed	NNS
cord-023095-4dannjjm	2898	12	are	be	VBP
cord-023095-4dannjjm	2898	13	more	more	RBR
cord-023095-4dannjjm	2898	14	susceptible	susceptible	JJ
cord-023095-4dannjjm	2898	15	.	.	.
cord-023095-4dannjjm	2899	1	We	-PRON-	PRP
cord-023095-4dannjjm	2899	2	have	have	VBP
cord-023095-4dannjjm	2899	3	previously	previously	RB
cord-023095-4dannjjm	2899	4	shown	show	VBN
cord-023095-4dannjjm	2899	5	that	that	IN
cord-023095-4dannjjm	2899	6	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2899	7	in	in	IN
cord-023095-4dannjjm	2899	8	the	the	DT
cord-023095-4dannjjm	2899	9	TLR4	TLR4	NNP
cord-023095-4dannjjm	2899	10	and	and	CC
cord-023095-4dannjjm	2899	11	TLR5	TLR5	NNP
cord-023095-4dannjjm	2899	12	gene	gene	NN
cord-023095-4dannjjm	2899	13	are	be	VBP
cord-023095-4dannjjm	2899	14	significantly	significantly	RB
cord-023095-4dannjjm	2899	15	associated	associate	VBN
cord-023095-4dannjjm	2899	16	with	with	IN
cord-023095-4dannjjm	2899	17	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2899	18	bowel	bowel	NN
cord-023095-4dannjjm	2899	19	disease	disease	NN
cord-023095-4dannjjm	2899	20	(	(	-LRB-
cord-023095-4dannjjm	2899	21	IBD	IBD	NNP
cord-023095-4dannjjm	2899	22	)	)	-RRB-
cord-023095-4dannjjm	2899	23	in	in	IN
cord-023095-4dannjjm	2899	24	the	the	DT
cord-023095-4dannjjm	2899	25	German	german	JJ
cord-023095-4dannjjm	2899	26	shepherd	shepherd	NN
cord-023095-4dannjjm	2899	27	dog	dog	NN
cord-023095-4dannjjm	2899	28	(	(	-LRB-
cord-023095-4dannjjm	2899	29	GSD	GSD	NNP
cord-023095-4dannjjm	2899	30	)	)	-RRB-
cord-023095-4dannjjm	2899	31	,	,	,
cord-023095-4dannjjm	2899	32	a	a	DT
cord-023095-4dannjjm	2899	33	breed	breed	NN
cord-023095-4dannjjm	2899	34	at	at	IN
cord-023095-4dannjjm	2899	35	risk	risk	NN
cord-023095-4dannjjm	2899	36	of	of	IN
cord-023095-4dannjjm	2899	37	developing	develop	VBG
cord-023095-4dannjjm	2899	38	this	this	DT
cord-023095-4dannjjm	2899	39	disease	disease	NN
cord-023095-4dannjjm	2899	40	.	.	.
cord-023095-4dannjjm	2900	1	It	-PRON-	PRP
cord-023095-4dannjjm	2900	2	would	would	MD
cord-023095-4dannjjm	2900	3	be	be	VB
cord-023095-4dannjjm	2900	4	useful	useful	JJ
cord-023095-4dannjjm	2900	5	to	to	TO
cord-023095-4dannjjm	2900	6	determine	determine	VB
cord-023095-4dannjjm	2900	7	if	if	IN
cord-023095-4dannjjm	2900	8	these	these	DT
cord-023095-4dannjjm	2900	9	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2900	10	are	be	VBP
cord-023095-4dannjjm	2900	11	significant	significant	JJ
cord-023095-4dannjjm	2900	12	in	in	IN
cord-023095-4dannjjm	2900	13	other	other	JJ
cord-023095-4dannjjm	2900	14	canine	canine	JJ
cord-023095-4dannjjm	2900	15	breeds	breed	NNS
cord-023095-4dannjjm	2900	16	as	as	IN
cord-023095-4dannjjm	2900	17	this	this	DT
cord-023095-4dannjjm	2900	18	may	may	MD
cord-023095-4dannjjm	2900	19	allow	allow	VB
cord-023095-4dannjjm	2900	20	the	the	DT
cord-023095-4dannjjm	2900	21	development	development	NN
cord-023095-4dannjjm	2900	22	of	of	IN
cord-023095-4dannjjm	2900	23	novel	novel	JJ
cord-023095-4dannjjm	2900	24	diagnostics	diagnostic	NNS
cord-023095-4dannjjm	2900	25	and	and	CC
cord-023095-4dannjjm	2900	26	therapeutics	therapeutic	NNS
cord-023095-4dannjjm	2900	27	to	to	TO
cord-023095-4dannjjm	2900	28	be	be	VB
cord-023095-4dannjjm	2900	29	applied	apply	VBN
cord-023095-4dannjjm	2900	30	to	to	IN
cord-023095-4dannjjm	2900	31	all	all	DT
cord-023095-4dannjjm	2900	32	canine	canine	JJ
cord-023095-4dannjjm	2900	33	breeds	breed	NNS
cord-023095-4dannjjm	2900	34	with	with	IN
cord-023095-4dannjjm	2900	35	IBD	IBD	NNP
cord-023095-4dannjjm	2900	36	.	.	.
cord-023095-4dannjjm	2901	1	Therefore	therefore	RB
cord-023095-4dannjjm	2901	2	the	the	DT
cord-023095-4dannjjm	2901	3	aim	aim	NN
cord-023095-4dannjjm	2901	4	of	of	IN
cord-023095-4dannjjm	2901	5	this	this	DT
cord-023095-4dannjjm	2901	6	study	study	NN
cord-023095-4dannjjm	2901	7	was	be	VBD
cord-023095-4dannjjm	2901	8	to	to	TO
cord-023095-4dannjjm	2901	9	investigate	investigate	VB
cord-023095-4dannjjm	2901	10	whether	whether	IN
cord-023095-4dannjjm	2901	11	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2901	12	in	in	IN
cord-023095-4dannjjm	2901	13	canine	canine	JJ
cord-023095-4dannjjm	2901	14	TLR	TLR	NNP
cord-023095-4dannjjm	2901	15	4	4	CD
cord-023095-4dannjjm	2901	16	and	and	CC
cord-023095-4dannjjm	2901	17	TLR	TLR	NNP
cord-023095-4dannjjm	2901	18	5	5	CD
cord-023095-4dannjjm	2901	19	genes	gene	NNS
cord-023095-4dannjjm	2901	20	are	be	VBP
cord-023095-4dannjjm	2901	21	associated	associate	VBN
cord-023095-4dannjjm	2901	22	with	with	IN
cord-023095-4dannjjm	2901	23	IBD	IBD	NNP
cord-023095-4dannjjm	2901	24	in	in	IN
cord-023095-4dannjjm	2901	25	other	other	JJ
cord-023095-4dannjjm	2901	26	non	non	JJ
cord-023095-4dannjjm	2901	27	-	-	JJ
cord-023095-4dannjjm	2901	28	GSD	gsd	JJ
cord-023095-4dannjjm	2901	29	canine	canine	JJ
cord-023095-4dannjjm	2901	30	breeds	breed	NNS
cord-023095-4dannjjm	2901	31	.	.	.
cord-023095-4dannjjm	2902	1	Four	four	CD
cord-023095-4dannjjm	2902	2	non	non	JJ
cord-023095-4dannjjm	2902	3	-	-	JJ
cord-023095-4dannjjm	2902	4	synonymous	synonymous	JJ
cord-023095-4dannjjm	2902	5	SNPs	snp	NNS
cord-023095-4dannjjm	2902	6	in	in	IN
cord-023095-4dannjjm	2902	7	the	the	DT
cord-023095-4dannjjm	2902	8	TLR4	TLR4	NNP
cord-023095-4dannjjm	2902	9	gene	gene	NN
cord-023095-4dannjjm	2902	10	;	;	:
cord-023095-4dannjjm	2902	11	T23C	T23C	NNP
cord-023095-4dannjjm	2902	12	,	,	,
cord-023095-4dannjjm	2902	13	G1039A	G1039A	NNP
cord-023095-4dannjjm	2902	14	,	,	,
cord-023095-4dannjjm	2902	15	A1572	A1572	NNP
cord-023095-4dannjjm	2902	16	T	T	NNP
cord-023095-4dannjjm	2902	17	and	and	CC
cord-023095-4dannjjm	2902	18	G1807A	G1807A	NNP
cord-023095-4dannjjm	2902	19	and	and	CC
cord-023095-4dannjjm	2902	20	three	three	CD
cord-023095-4dannjjm	2902	21	non	non	JJ
cord-023095-4dannjjm	2902	22	-	-	JJ
cord-023095-4dannjjm	2902	23	synonymous	synonymous	JJ
cord-023095-4dannjjm	2902	24	SNPs	snp	NNS
cord-023095-4dannjjm	2902	25	in	in	IN
cord-023095-4dannjjm	2902	26	the	the	DT
cord-023095-4dannjjm	2902	27	TLR5	TLR5	NNP
cord-023095-4dannjjm	2902	28	gene	gene	NN
cord-023095-4dannjjm	2902	29	;	;	:
cord-023095-4dannjjm	2902	30	G22A	g22a	NN
cord-023095-4dannjjm	2902	31	,	,	,
cord-023095-4dannjjm	2902	32	C100	C100	NNP
cord-023095-4dannjjm	2902	33	T	T	NNP
cord-023095-4dannjjm	2902	34	and	and	CC
cord-023095-4dannjjm	2902	35	T1844C	T1844C	NNP
cord-023095-4dannjjm	2902	36	previously	previously	RB
cord-023095-4dannjjm	2902	37	identified	identify	VBN
cord-023095-4dannjjm	2902	38	in	in	IN
cord-023095-4dannjjm	2902	39	a	a	DT
cord-023095-4dannjjm	2902	40	mutational	mutational	JJ
cord-023095-4dannjjm	2902	41	analysis	analysis	NN
cord-023095-4dannjjm	2902	42	in	in	IN
cord-023095-4dannjjm	2902	43	GSDs	gsds	NN
cord-023095-4dannjjm	2902	44	with	with	IN
cord-023095-4dannjjm	2902	45	IBD	IBD	NNP
cord-023095-4dannjjm	2902	46	were	be	VBD
cord-023095-4dannjjm	2902	47	evaluated	evaluate	VBN
cord-023095-4dannjjm	2902	48	in	in	IN
cord-023095-4dannjjm	2902	49	a	a	DT
cord-023095-4dannjjm	2902	50	case	case	NN
cord-023095-4dannjjm	2902	51	-	-	HYPH
cord-023095-4dannjjm	2902	52	control	control	NN
cord-023095-4dannjjm	2902	53	study	study	NN
cord-023095-4dannjjm	2902	54	using	use	VBG
cord-023095-4dannjjm	2902	55	a	a	DT
cord-023095-4dannjjm	2902	56	SNaPSHOT	SNaPSHOT	NNP
cord-023095-4dannjjm	2902	57	multiplex	multiplex	NN
cord-023095-4dannjjm	2902	58	reaction	reaction	NN
cord-023095-4dannjjm	2902	59	.	.	.
cord-023095-4dannjjm	2903	1	Sequencing	sequence	VBG
cord-023095-4dannjjm	2903	2	information	information	NN
cord-023095-4dannjjm	2903	3	from	from	IN
cord-023095-4dannjjm	2903	4	85	85	CD
cord-023095-4dannjjm	2903	5	unrelated	unrelated	JJ
cord-023095-4dannjjm	2903	6	dogs	dog	NNS
cord-023095-4dannjjm	2903	7	with	with	IN
cord-023095-4dannjjm	2903	8	IBD	IBD	NNP
cord-023095-4dannjjm	2903	9	consisting	consist	VBG
cord-023095-4dannjjm	2903	10	of	of	IN
cord-023095-4dannjjm	2903	11	38	38	CD
cord-023095-4dannjjm	2903	12	different	different	JJ
cord-023095-4dannjjm	2903	13	non	non	JJ
cord-023095-4dannjjm	2903	14	-	-	JJ
cord-023095-4dannjjm	2903	15	GSD	gsd	JJ
cord-023095-4dannjjm	2903	16	breeds	breed	NNS
cord-023095-4dannjjm	2903	17	from	from	IN
cord-023095-4dannjjm	2903	18	the	the	DT
cord-023095-4dannjjm	2903	19	UK	UK	NNP
cord-023095-4dannjjm	2903	20	were	be	VBD
cord-023095-4dannjjm	2903	21	compared	compare	VBN
cord-023095-4dannjjm	2903	22	to	to	IN
cord-023095-4dannjjm	2903	23	a	a	DT
cord-023095-4dannjjm	2903	24	breed	breed	NN
cord-023095-4dannjjm	2903	25	-	-	HYPH
cord-023095-4dannjjm	2903	26	matched	match	VBN
cord-023095-4dannjjm	2903	27	control	control	NN
cord-023095-4dannjjm	2903	28	group	group	NN
cord-023095-4dannjjm	2903	29	consisting	consist	VBG
cord-023095-4dannjjm	2903	30	of	of	IN
cord-023095-4dannjjm	2903	31	162	162	CD
cord-023095-4dannjjm	2903	32	unrelated	unrelated	JJ
cord-023095-4dannjjm	2903	33	dogs	dog	NNS
cord-023095-4dannjjm	2903	34	from	from	IN
cord-023095-4dannjjm	2903	35	patients	patient	NNS
cord-023095-4dannjjm	2903	36	treated	treat	VBN
cord-023095-4dannjjm	2903	37	for	for	IN
cord-023095-4dannjjm	2903	38	noninflammatory	noninflammatory	JJ
cord-023095-4dannjjm	2903	39	disease	disease	NN
cord-023095-4dannjjm	2903	40	at	at	IN
cord-023095-4dannjjm	2903	41	the	the	DT
cord-023095-4dannjjm	2903	42	Royal	Royal	NNP
cord-023095-4dannjjm	2903	43	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	2903	44	College	College	NNP
cord-023095-4dannjjm	2903	45	,	,	,
cord-023095-4dannjjm	2903	46	London	London	NNP
cord-023095-4dannjjm	2903	47	,	,	,
cord-023095-4dannjjm	2903	48	UK	UK	NNP
cord-023095-4dannjjm	2903	49	.	.	.
cord-023095-4dannjjm	2904	1	As	as	IN
cord-023095-4dannjjm	2904	2	in	in	IN
cord-023095-4dannjjm	2904	3	the	the	DT
cord-023095-4dannjjm	2904	4	GSD	GSD	NNP
cord-023095-4dannjjm	2904	5	IBD	IBD	NNP
cord-023095-4dannjjm	2904	6	population	population	NN
cord-023095-4dannjjm	2904	7	the	the	DT
cord-023095-4dannjjm	2904	8	two	two	CD
cord-023095-4dannjjm	2904	9	TLR5	TLR5	NNP
cord-023095-4dannjjm	2904	10	SNPs	SNPs	NNPS
cord-023095-4dannjjm	2904	11	;	;	:
cord-023095-4dannjjm	2904	12	C100	C100	NNP
cord-023095-4dannjjm	2904	13	T	T	NNP
cord-023095-4dannjjm	2904	14	and	and	CC
cord-023095-4dannjjm	2904	15	T1844C	T1844C	NNP
cord-023095-4dannjjm	2904	16	were	be	VBD
cord-023095-4dannjjm	2904	17	found	find	VBN
cord-023095-4dannjjm	2904	18	to	to	TO
cord-023095-4dannjjm	2904	19	be	be	VB
cord-023095-4dannjjm	2904	20	significantly	significantly	RB
cord-023095-4dannjjm	2904	21	protective	protective	JJ
cord-023095-4dannjjm	2904	22	for	for	IN
cord-023095-4dannjjm	2904	23	IBD	IBD	NNP
cord-023095-4dannjjm	2904	24	in	in	IN
cord-023095-4dannjjm	2904	25	other	other	JJ
cord-023095-4dannjjm	2904	26	breeds	breed	NNS
cord-023095-4dannjjm	2904	27	included	include	VBN
cord-023095-4dannjjm	2904	28	in	in	IN
cord-023095-4dannjjm	2904	29	this	this	DT
cord-023095-4dannjjm	2904	30	study	study	NN
cord-023095-4dannjjm	2904	31	(	(	-LRB-
cord-023095-4dannjjm	2904	32	p	p	NN
cord-023095-4dannjjm	2904	33	5	5	CD
cord-023095-4dannjjm	2904	34	0.023	0.023	CD
cord-023095-4dannjjm	2904	35	and	and	CC
cord-023095-4dannjjm	2904	36	p	p	NN
cord-023095-4dannjjm	2904	37	5	5	CD
cord-023095-4dannjjm	2904	38	0.0195	0.0195	CD
cord-023095-4dannjjm	2904	39	respectively	respectively	RB
cord-023095-4dannjjm	2904	40	)	)	-RRB-
cord-023095-4dannjjm	2904	41	.	.	.
cord-023095-4dannjjm	2905	1	This	this	DT
cord-023095-4dannjjm	2905	2	study	study	NN
cord-023095-4dannjjm	2905	3	confirms	confirm	VBZ
cord-023095-4dannjjm	2905	4	the	the	DT
cord-023095-4dannjjm	2905	5	protective	protective	JJ
cord-023095-4dannjjm	2905	6	effects	effect	NNS
cord-023095-4dannjjm	2905	7	of	of	IN
cord-023095-4dannjjm	2905	8	the	the	DT
cord-023095-4dannjjm	2905	9	two	two	CD
cord-023095-4dannjjm	2905	10	TLR5	TLR5	NNP
cord-023095-4dannjjm	2905	11	SNPs	SNPs	NNPS
cord-023095-4dannjjm	2905	12	(	(	-LRB-
cord-023095-4dannjjm	2905	13	C100	C100	NNP
cord-023095-4dannjjm	2905	14	T	T	NNP
cord-023095-4dannjjm	2905	15	and	and	CC
cord-023095-4dannjjm	2905	16	T1884C	T1884C	NNP
cord-023095-4dannjjm	2905	17	)	)	-RRB-
cord-023095-4dannjjm	2905	18	in	in	IN
cord-023095-4dannjjm	2905	19	other	other	JJ
cord-023095-4dannjjm	2905	20	canine	canine	JJ
cord-023095-4dannjjm	2905	21	breeds	breed	NNS
cord-023095-4dannjjm	2905	22	with	with	IN
cord-023095-4dannjjm	2905	23	IBD	IBD	NNP
cord-023095-4dannjjm	2905	24	.	.	.
cord-023095-4dannjjm	2906	1	This	this	DT
cord-023095-4dannjjm	2906	2	highlights	highlight	VBZ
cord-023095-4dannjjm	2906	3	the	the	DT
cord-023095-4dannjjm	2906	4	importance	importance	NN
cord-023095-4dannjjm	2906	5	of	of	IN
cord-023095-4dannjjm	2906	6	TLR5	TLR5	NNP
cord-023095-4dannjjm	2906	7	in	in	IN
cord-023095-4dannjjm	2906	8	the	the	DT
cord-023095-4dannjjm	2906	9	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	2906	10	of	of	IN
cord-023095-4dannjjm	2906	11	canine	canine	JJ
cord-023095-4dannjjm	2906	12	IBD	IBD	NNP
cord-023095-4dannjjm	2906	13	and	and	CC
cord-023095-4dannjjm	2906	14	may	may	MD
cord-023095-4dannjjm	2906	15	represent	represent	VB
cord-023095-4dannjjm	2906	16	common	common	JJ
cord-023095-4dannjjm	2906	17	pathological	pathological	JJ
cord-023095-4dannjjm	2906	18	pathways	pathway	NNS
cord-023095-4dannjjm	2906	19	of	of	IN
cord-023095-4dannjjm	2906	20	IBD	IBD	NNP
cord-023095-4dannjjm	2906	21	in	in	IN
cord-023095-4dannjjm	2906	22	different	different	JJ
cord-023095-4dannjjm	2906	23	canine	canine	JJ
cord-023095-4dannjjm	2906	24	breeds	breed	NNS
cord-023095-4dannjjm	2906	25	due	due	JJ
cord-023095-4dannjjm	2906	26	to	to	IN
cord-023095-4dannjjm	2906	27	the	the	DT
cord-023095-4dannjjm	2906	28	high	high	JJ
cord-023095-4dannjjm	2906	29	degree	degree	NN
cord-023095-4dannjjm	2906	30	of	of	IN
cord-023095-4dannjjm	2906	31	haplotype	haplotype	NN
cord-023095-4dannjjm	2906	32	sharing	sharing	NN
cord-023095-4dannjjm	2906	33	seen	see	VBN
cord-023095-4dannjjm	2906	34	among	among	IN
cord-023095-4dannjjm	2906	35	breeds	breed	NNS
cord-023095-4dannjjm	2906	36	.	.	.
cord-023095-4dannjjm	2907	1	This	this	DT
cord-023095-4dannjjm	2907	2	may	may	MD
cord-023095-4dannjjm	2907	3	allow	allow	VB
cord-023095-4dannjjm	2907	4	for	for	IN
cord-023095-4dannjjm	2907	5	the	the	DT
cord-023095-4dannjjm	2907	6	future	future	JJ
cord-023095-4dannjjm	2907	7	expansion	expansion	NN
cord-023095-4dannjjm	2907	8	of	of	IN
cord-023095-4dannjjm	2907	9	novel	novel	JJ
cord-023095-4dannjjm	2907	10	diagnostics	diagnostic	NNS
cord-023095-4dannjjm	2907	11	and	and	CC
cord-023095-4dannjjm	2907	12	therapeutics	therapeutic	NNS
cord-023095-4dannjjm	2907	13	to	to	TO
cord-023095-4dannjjm	2907	14	be	be	VB
cord-023095-4dannjjm	2907	15	applied	apply	VBN
cord-023095-4dannjjm	2907	16	to	to	IN
cord-023095-4dannjjm	2907	17	all	all	DT
cord-023095-4dannjjm	2907	18	canine	canine	JJ
cord-023095-4dannjjm	2907	19	breeds	breed	NNS
cord-023095-4dannjjm	2907	20	with	with	IN
cord-023095-4dannjjm	2907	21	IBD	IBD	NNP
cord-023095-4dannjjm	2907	22	.	.	.
cord-023095-4dannjjm	2908	1	Further	further	JJ
cord-023095-4dannjjm	2908	2	functional	functional	JJ
cord-023095-4dannjjm	2908	3	studies	study	NNS
cord-023095-4dannjjm	2908	4	looking	look	VBG
cord-023095-4dannjjm	2908	5	at	at	IN
cord-023095-4dannjjm	2908	6	the	the	DT
cord-023095-4dannjjm	2908	7	role	role	NN
cord-023095-4dannjjm	2908	8	of	of	IN
cord-023095-4dannjjm	2908	9	TLR5	TLR5	NNP
cord-023095-4dannjjm	2908	10	in	in	IN
cord-023095-4dannjjm	2908	11	the	the	DT
cord-023095-4dannjjm	2908	12	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	2908	13	of	of	IN
cord-023095-4dannjjm	2908	14	canine	canine	JJ
cord-023095-4dannjjm	2908	15	IBD	IBD	NNP
cord-023095-4dannjjm	2908	16	are	be	VBP
cord-023095-4dannjjm	2908	17	needed	need	VBN
cord-023095-4dannjjm	2908	18	to	to	TO
cord-023095-4dannjjm	2908	19	confirm	confirm	VB
cord-023095-4dannjjm	2908	20	these	these	DT
cord-023095-4dannjjm	2908	21	findings	finding	NNS
cord-023095-4dannjjm	2908	22	.	.	.
cord-023095-4dannjjm	2909	1	Toll	toll	NN
cord-023095-4dannjjm	2909	2	-	-	HYPH
cord-023095-4dannjjm	2909	3	like	like	JJ
cord-023095-4dannjjm	2909	4	receptor	receptor	NN
cord-023095-4dannjjm	2909	5	5	5	CD
cord-023095-4dannjjm	2910	1	(	(	-LRB-
cord-023095-4dannjjm	2910	2	TLR5	TLR5	NNP
cord-023095-4dannjjm	2910	3	)	)	-RRB-
cord-023095-4dannjjm	2910	4	is	be	VBZ
cord-023095-4dannjjm	2910	5	an	an	DT
cord-023095-4dannjjm	2910	6	extracellular	extracellular	JJ
cord-023095-4dannjjm	2910	7	pattern	pattern	NN
cord-023095-4dannjjm	2910	8	recognition	recognition	NN
cord-023095-4dannjjm	2910	9	receptor	receptor	NN
cord-023095-4dannjjm	2910	10	belonging	belong	VBG
cord-023095-4dannjjm	2910	11	to	to	IN
cord-023095-4dannjjm	2910	12	the	the	DT
cord-023095-4dannjjm	2910	13	innate	innate	JJ
cord-023095-4dannjjm	2910	14	immune	immune	JJ
cord-023095-4dannjjm	2910	15	system	system	NN
cord-023095-4dannjjm	2910	16	.	.	.
cord-023095-4dannjjm	2911	1	We	-PRON-	PRP
cord-023095-4dannjjm	2911	2	have	have	VBP
cord-023095-4dannjjm	2911	3	recently	recently	RB
cord-023095-4dannjjm	2911	4	shown	show	VBN
cord-023095-4dannjjm	2911	5	that	that	IN
cord-023095-4dannjjm	2911	6	three	three	CD
cord-023095-4dannjjm	2911	7	non	non	JJ
cord-023095-4dannjjm	2911	8	-	-	JJ
cord-023095-4dannjjm	2911	9	synonymous	synonymous	JJ
cord-023095-4dannjjm	2911	10	single	single	JJ
cord-023095-4dannjjm	2911	11	nucleotide	nucleotide	JJ
cord-023095-4dannjjm	2911	12	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2911	13	(	(	-LRB-
cord-023095-4dannjjm	2911	14	SNPs	SNPs	NNP
cord-023095-4dannjjm	2911	15	)	)	-RRB-
cord-023095-4dannjjm	2911	16	in	in	IN
cord-023095-4dannjjm	2911	17	the	the	DT
cord-023095-4dannjjm	2911	18	TLR5	TLR5	NNP
cord-023095-4dannjjm	2911	19	gene	gene	NN
cord-023095-4dannjjm	2911	20	(	(	-LRB-
cord-023095-4dannjjm	2911	21	G22A	g22a	NN
cord-023095-4dannjjm	2911	22	,	,	,
cord-023095-4dannjjm	2911	23	C100	C100	NNP
cord-023095-4dannjjm	2911	24	T	T	NNP
cord-023095-4dannjjm	2911	25	and	and	CC
cord-023095-4dannjjm	2911	26	T1844C	T1844C	NNP
cord-023095-4dannjjm	2911	27	)	)	-RRB-
cord-023095-4dannjjm	2911	28	are	be	VBP
cord-023095-4dannjjm	2911	29	significantly	significantly	RB
cord-023095-4dannjjm	2911	30	associated	associate	VBN
cord-023095-4dannjjm	2911	31	with	with	IN
cord-023095-4dannjjm	2911	32	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	2911	33	bowel	bowel	NN
cord-023095-4dannjjm	2911	34	disease	disease	NN
cord-023095-4dannjjm	2911	35	(	(	-LRB-
cord-023095-4dannjjm	2911	36	IBD	IBD	NNP
cord-023095-4dannjjm	2911	37	)	)	-RRB-
cord-023095-4dannjjm	2911	38	in	in	IN
cord-023095-4dannjjm	2911	39	German	german	JJ
cord-023095-4dannjjm	2911	40	shepherd	shepherd	NN
cord-023095-4dannjjm	2911	41	dogs	dog	NNS
cord-023095-4dannjjm	2911	42	.	.	.
cord-023095-4dannjjm	2912	1	In	in	IN
cord-023095-4dannjjm	2912	2	addition	addition	NN
cord-023095-4dannjjm	2912	3	,	,	,
cord-023095-4dannjjm	2912	4	we	-PRON-	PRP
cord-023095-4dannjjm	2912	5	confirmed	confirm	VBD
cord-023095-4dannjjm	2912	6	that	that	IN
cord-023095-4dannjjm	2912	7	two	two	CD
cord-023095-4dannjjm	2912	8	of	of	IN
cord-023095-4dannjjm	2912	9	these	these	DT
cord-023095-4dannjjm	2912	10	TLR5	TLR5	NNP
cord-023095-4dannjjm	2912	11	SNPs	SNPs	NNPS
cord-023095-4dannjjm	2912	12	(	(	-LRB-
cord-023095-4dannjjm	2912	13	C100	C100	NNP
cord-023095-4dannjjm	2912	14	T	T	NNP
cord-023095-4dannjjm	2912	15	and	and	CC
cord-023095-4dannjjm	2912	16	T1844C	T1844C	NNP
cord-023095-4dannjjm	2912	17	)	)	-RRB-
cord-023095-4dannjjm	2912	18	were	be	VBD
cord-023095-4dannjjm	2912	19	significantly	significantly	RB
cord-023095-4dannjjm	2912	20	associated	associate	VBN
cord-023095-4dannjjm	2912	21	with	with	IN
cord-023095-4dannjjm	2912	22	IBD	IBD	NNP
cord-023095-4dannjjm	2912	23	in	in	IN
cord-023095-4dannjjm	2912	24	a	a	DT
cord-023095-4dannjjm	2912	25	population	population	NN
cord-023095-4dannjjm	2912	26	consisting	consist	VBG
cord-023095-4dannjjm	2912	27	of	of	IN
cord-023095-4dannjjm	2912	28	38	38	CD
cord-023095-4dannjjm	2912	29	different	different	JJ
cord-023095-4dannjjm	2912	30	dog	dog	NN
cord-023095-4dannjjm	2912	31	breeds	breed	NNS
cord-023095-4dannjjm	2912	32	.	.	.
cord-023095-4dannjjm	2913	1	In	in	IN
cord-023095-4dannjjm	2913	2	order	order	NN
cord-023095-4dannjjm	2913	3	to	to	TO
cord-023095-4dannjjm	2913	4	determine	determine	VB
cord-023095-4dannjjm	2913	5	if	if	IN
cord-023095-4dannjjm	2913	6	other	other	JJ
cord-023095-4dannjjm	2913	7	novel	novel	NN
cord-023095-4dannjjm	2913	8	SNPs	snp	NNS
cord-023095-4dannjjm	2913	9	exist	exist	VBP
cord-023095-4dannjjm	2913	10	in	in	IN
cord-023095-4dannjjm	2913	11	the	the	DT
cord-023095-4dannjjm	2913	12	TLR5	TLR5	NNP
cord-023095-4dannjjm	2913	13	gene	gene	NN
cord-023095-4dannjjm	2913	14	in	in	IN
cord-023095-4dannjjm	2913	15	addition	addition	NN
cord-023095-4dannjjm	2913	16	to	to	IN
cord-023095-4dannjjm	2913	17	the	the	DT
cord-023095-4dannjjm	2913	18	ones	one	NNS
cord-023095-4dannjjm	2913	19	identified	identify	VBN
cord-023095-4dannjjm	2913	20	in	in	IN
cord-023095-4dannjjm	2913	21	the	the	DT
cord-023095-4dannjjm	2913	22	GSD	GSD	NNP
cord-023095-4dannjjm	2913	23	population	population	NN
cord-023095-4dannjjm	2913	24	,	,	,
cord-023095-4dannjjm	2913	25	mutational	mutational	JJ
cord-023095-4dannjjm	2913	26	analysis	analysis	NN
cord-023095-4dannjjm	2913	27	was	be	VBD
cord-023095-4dannjjm	2913	28	carried	carry	VBN
cord-023095-4dannjjm	2913	29	out	out	RP
cord-023095-4dannjjm	2913	30	in	in	IN
cord-023095-4dannjjm	2913	31	seven	seven	CD
cord-023095-4dannjjm	2913	32	Boxer	Boxer	NNP
cord-023095-4dannjjm	2913	33	dogs	dog	NNS
cord-023095-4dannjjm	2913	34	with	with	IN
cord-023095-4dannjjm	2913	35	IBD	IBD	NNP
cord-023095-4dannjjm	2913	36	.	.	.
cord-023095-4dannjjm	2914	1	Polymerase	polymerase	NN
cord-023095-4dannjjm	2914	2	chain	chain	NN
cord-023095-4dannjjm	2914	3	reaction	reaction	NN
cord-023095-4dannjjm	2914	4	was	be	VBD
cord-023095-4dannjjm	2914	5	carried	carry	VBN
cord-023095-4dannjjm	2914	6	out	out	RP
cord-023095-4dannjjm	2914	7	to	to	TO
cord-023095-4dannjjm	2914	8	amplify	amplify	VB
cord-023095-4dannjjm	2914	9	the	the	DT
cord-023095-4dannjjm	2914	10	TLR5	TLR5	NNP
cord-023095-4dannjjm	2914	11	coding	code	VBG
cord-023095-4dannjjm	2914	12	region	region	NN
cord-023095-4dannjjm	2914	13	in	in	IN
cord-023095-4dannjjm	2914	14	the	the	DT
cord-023095-4dannjjm	2914	15	seven	seven	CD
cord-023095-4dannjjm	2914	16	dogs	dog	NNS
cord-023095-4dannjjm	2914	17	with	with	IN
cord-023095-4dannjjm	2914	18	IBD	IBD	NNP
cord-023095-4dannjjm	2914	19	.	.	.
cord-023095-4dannjjm	2915	1	Sequencing	sequencing	NN
cord-023095-4dannjjm	2915	2	was	be	VBD
cord-023095-4dannjjm	2915	3	carried	carry	VBN
cord-023095-4dannjjm	2915	4	out	out	RP
cord-023095-4dannjjm	2915	5	using	use	VBG
cord-023095-4dannjjm	2915	6	sequence	sequence	NN
cord-023095-4dannjjm	2915	7	based	base	VBN
cord-023095-4dannjjm	2915	8	typing	typing	NN
cord-023095-4dannjjm	2915	9	with	with	IN
cord-023095-4dannjjm	2915	10	the	the	DT
cord-023095-4dannjjm	2915	11	ABI	ABI	NNP
cord-023095-4dannjjm	2915	12	Prism	Prism	NNP
cord-023095-4dannjjm	2915	13	Sequencing	Sequencing	NNP
cord-023095-4dannjjm	2915	14	Kit	kit	NN
cord-023095-4dannjjm	2915	15	(	(	-LRB-
cord-023095-4dannjjm	2915	16	Applied	Applied	NNP
cord-023095-4dannjjm	2915	17	Biosystems	Biosystems	NNP
cord-023095-4dannjjm	2915	18	,	,	,
cord-023095-4dannjjm	2915	19	UK	UK	NNP
cord-023095-4dannjjm	2915	20	)	)	-RRB-
cord-023095-4dannjjm	2915	21	and	and	CC
cord-023095-4dannjjm	2915	22	analyzed	analyze	VBD
cord-023095-4dannjjm	2915	23	using	use	VBG
cord-023095-4dannjjm	2915	24	an	an	DT
cord-023095-4dannjjm	2915	25	ABI3100	ABI3100	NNP
cord-023095-4dannjjm	2915	26	automated	automate	VBN
cord-023095-4dannjjm	2915	27	sequencer	sequencer	NN
cord-023095-4dannjjm	2915	28	(	(	-LRB-
cord-023095-4dannjjm	2915	29	PE	PE	NNP
cord-023095-4dannjjm	2915	30	Applied	Applied	NNP
cord-023095-4dannjjm	2915	31	Biosystems	Biosystems	NNP
cord-023095-4dannjjm	2915	32	)	)	-RRB-
cord-023095-4dannjjm	2915	33	.	.	.
cord-023095-4dannjjm	2916	1	Sequencing	sequence	VBG
cord-023095-4dannjjm	2916	2	information	information	NN
cord-023095-4dannjjm	2916	3	from	from	IN
cord-023095-4dannjjm	2916	4	seven	seven	CD
cord-023095-4dannjjm	2916	5	Boxer	Boxer	NNP
cord-023095-4dannjjm	2916	6	dogs	dog	NNS
cord-023095-4dannjjm	2916	7	with	with	IN
cord-023095-4dannjjm	2916	8	IBD	IBD	NNP
cord-023095-4dannjjm	2916	9	from	from	IN
cord-023095-4dannjjm	2916	10	the	the	DT
cord-023095-4dannjjm	2916	11	UK	UK	NNP
cord-023095-4dannjjm	2916	12	were	be	VBD
cord-023095-4dannjjm	2916	13	compared	compare	VBN
cord-023095-4dannjjm	2916	14	to	to	IN
cord-023095-4dannjjm	2916	15	the	the	DT
cord-023095-4dannjjm	2916	16	reference	reference	NN
cord-023095-4dannjjm	2916	17	sequence	sequence	NN
cord-023095-4dannjjm	2916	18	published	publish	VBN
cord-023095-4dannjjm	2916	19	on	on	IN
cord-023095-4dannjjm	2916	20	the	the	DT
cord-023095-4dannjjm	2916	21	Ensemble	Ensemble	NNP
cord-023095-4dannjjm	2916	22	webserver	webserver	NN
cord-023095-4dannjjm	2916	23	(	(	-LRB-
cord-023095-4dannjjm	2916	24	www	www	NN
cord-023095-4dannjjm	2916	25	.	.	.
cord-023095-4dannjjm	2916	26	ensembl.org/Canis_familiaris	ensembl.org/Canis_familiaris	NNP
cord-023095-4dannjjm	2916	27	)	)	-RRB-
cord-023095-4dannjjm	2916	28	.	.	.
cord-023095-4dannjjm	2917	1	In	in	IN
cord-023095-4dannjjm	2917	2	addition	addition	NN
cord-023095-4dannjjm	2917	3	to	to	IN
cord-023095-4dannjjm	2917	4	the	the	DT
cord-023095-4dannjjm	2917	5	three	three	CD
cord-023095-4dannjjm	2917	6	SNPs	SNPs	NNPS
cord-023095-4dannjjm	2917	7	identified	identify	VBN
cord-023095-4dannjjm	2917	8	previously	previously	RB
cord-023095-4dannjjm	2917	9	in	in	IN
cord-023095-4dannjjm	2917	10	the	the	DT
cord-023095-4dannjjm	2917	11	TLR5	TLR5	NNP
cord-023095-4dannjjm	2917	12	gene	gene	NN
cord-023095-4dannjjm	2917	13	,	,	,
cord-023095-4dannjjm	2917	14	a	a	DT
cord-023095-4dannjjm	2917	15	novel	novel	JJ
cord-023095-4dannjjm	2917	16	non	non	JJ
cord-023095-4dannjjm	2917	17	-	-	JJ
cord-023095-4dannjjm	2917	18	synonymous	synonymous	JJ
cord-023095-4dannjjm	2917	19	SNP	SNP	NNP
cord-023095-4dannjjm	2917	20	;	;	:
cord-023095-4dannjjm	2917	21	T443C	T443C	NNP
cord-023095-4dannjjm	2917	22	was	be	VBD
cord-023095-4dannjjm	2917	23	identified	identify	VBN
cord-023095-4dannjjm	2917	24	in	in	IN
cord-023095-4dannjjm	2917	25	the	the	DT
cord-023095-4dannjjm	2917	26	Boxer	Boxer	NNP
cord-023095-4dannjjm	2917	27	dog	dog	NN
cord-023095-4dannjjm	2917	28	population	population	NN
cord-023095-4dannjjm	2917	29	with	with	IN
cord-023095-4dannjjm	2917	30	IBD	IBD	NNP
cord-023095-4dannjjm	2917	31	.	.	.
cord-023095-4dannjjm	2918	1	This	this	DT
cord-023095-4dannjjm	2918	2	SNP	SNP	NNP
cord-023095-4dannjjm	2918	3	has	have	VBZ
cord-023095-4dannjjm	2918	4	never	never	RB
cord-023095-4dannjjm	2918	5	been	be	VBN
cord-023095-4dannjjm	2918	6	reported	report	VBN
cord-023095-4dannjjm	2918	7	before	before	RB
cord-023095-4dannjjm	2918	8	and	and	CC
cord-023095-4dannjjm	2918	9	was	be	VBD
cord-023095-4dannjjm	2918	10	present	present	JJ
cord-023095-4dannjjm	2918	11	as	as	IN
cord-023095-4dannjjm	2918	12	the	the	DT
cord-023095-4dannjjm	2918	13	homozygote	homozygote	NNP
cord-023095-4dannjjm	2918	14	genotype	genotype	NNP
cord-023095-4dannjjm	2918	15	in	in	IN
cord-023095-4dannjjm	2918	16	three	three	CD
cord-023095-4dannjjm	2918	17	dogs	dog	NNS
cord-023095-4dannjjm	2918	18	with	with	IN
cord-023095-4dannjjm	2918	19	IBD	IBD	NNP
cord-023095-4dannjjm	2918	20	and	and	CC
cord-023095-4dannjjm	2918	21	in	in	IN
cord-023095-4dannjjm	2918	22	one	one	CD
cord-023095-4dannjjm	2918	23	dog	dog	NN
cord-023095-4dannjjm	2918	24	as	as	IN
cord-023095-4dannjjm	2918	25	the	the	DT
cord-023095-4dannjjm	2918	26	heterozygote	heterozygote	NN
cord-023095-4dannjjm	2918	27	genotype	genotype	NN
cord-023095-4dannjjm	2918	28	.	.	.
cord-023095-4dannjjm	2919	1	Using	use	VBG
cord-023095-4dannjjm	2919	2	the	the	DT
cord-023095-4dannjjm	2919	3	Simple	Simple	NNP
cord-023095-4dannjjm	2919	4	modular	modular	JJ
cord-023095-4dannjjm	2919	5	architecture	architecture	NN
cord-023095-4dannjjm	2919	6	research	research	NN
cord-023095-4dannjjm	2919	7	tool	tool	NN
cord-023095-4dannjjm	2919	8	(	(	-LRB-
cord-023095-4dannjjm	2919	9	SMART	SMART	NNP
cord-023095-4dannjjm	2919	10	)	)	-RRB-
cord-023095-4dannjjm	2919	11	web	web	NN
cord-023095-4dannjjm	2919	12	server	server	NN
cord-023095-4dannjjm	2919	13	(	(	-LRB-
cord-023095-4dannjjm	2919	14	http://	http://	NNP
cord-023095-4dannjjm	2919	15	smart.embl.de/	smart.embl.de/	NNP
cord-023095-4dannjjm	2919	16	)	)	-RRB-
cord-023095-4dannjjm	2920	1	we	-PRON-	PRP
cord-023095-4dannjjm	2920	2	were	be	VBD
cord-023095-4dannjjm	2920	3	able	able	JJ
cord-023095-4dannjjm	2920	4	to	to	TO
cord-023095-4dannjjm	2920	5	map	map	VB
cord-023095-4dannjjm	2920	6	the	the	DT
cord-023095-4dannjjm	2920	7	T443C	T443C	VBN
cord-023095-4dannjjm	2920	8	SNP	SNP	NNP
cord-023095-4dannjjm	2920	9	to	to	IN
cord-023095-4dannjjm	2920	10	the	the	DT
cord-023095-4dannjjm	2920	11	leucine	leucine	NN
cord-023095-4dannjjm	2920	12	rich	rich	JJ
cord-023095-4dannjjm	2920	13	repeat	repeat	NN
cord-023095-4dannjjm	2920	14	domain	domain	NN
cord-023095-4dannjjm	2920	15	of	of	IN
cord-023095-4dannjjm	2920	16	the	the	DT
cord-023095-4dannjjm	2920	17	TLR5	TLR5	NNP
cord-023095-4dannjjm	2920	18	protein	protein	NN
cord-023095-4dannjjm	2920	19	.	.	.
cord-023095-4dannjjm	2921	1	The	the	DT
cord-023095-4dannjjm	2921	2	leucine	leucine	NN
cord-023095-4dannjjm	2921	3	rich	rich	JJ
cord-023095-4dannjjm	2921	4	repeat	repeat	NN
cord-023095-4dannjjm	2921	5	domain	domain	NN
cord-023095-4dannjjm	2921	6	is	be	VBZ
cord-023095-4dannjjm	2921	7	involved	involve	VBN
cord-023095-4dannjjm	2921	8	with	with	IN
cord-023095-4dannjjm	2921	9	ligand	ligand	NN
cord-023095-4dannjjm	2921	10	binding	binding	NN
cord-023095-4dannjjm	2921	11	and	and	CC
cord-023095-4dannjjm	2921	12	therefore	therefore	RB
cord-023095-4dannjjm	2921	13	a	a	DT
cord-023095-4dannjjm	2921	14	change	change	NN
cord-023095-4dannjjm	2921	15	in	in	IN
cord-023095-4dannjjm	2921	16	the	the	DT
cord-023095-4dannjjm	2921	17	amino	amino	NN
cord-023095-4dannjjm	2921	18	acid	acid	NN
cord-023095-4dannjjm	2921	19	in	in	IN
cord-023095-4dannjjm	2921	20	this	this	DT
cord-023095-4dannjjm	2921	21	region	region	NN
cord-023095-4dannjjm	2921	22	may	may	MD
cord-023095-4dannjjm	2921	23	affect	affect	VB
cord-023095-4dannjjm	2921	24	function	function	NN
cord-023095-4dannjjm	2921	25	,	,	,
cord-023095-4dannjjm	2921	26	especially	especially	RB
cord-023095-4dannjjm	2921	27	as	as	IN
cord-023095-4dannjjm	2921	28	the	the	DT
cord-023095-4dannjjm	2921	29	T443C	T443C	NNP
cord-023095-4dannjjm	2921	30	SNP	SNP	NNP
cord-023095-4dannjjm	2921	31	results	result	VBZ
cord-023095-4dannjjm	2921	32	in	in	IN
cord-023095-4dannjjm	2921	33	a	a	DT
cord-023095-4dannjjm	2921	34	change	change	NN
cord-023095-4dannjjm	2921	35	in	in	IN
cord-023095-4dannjjm	2921	36	the	the	DT
cord-023095-4dannjjm	2921	37	amino	amino	NN
cord-023095-4dannjjm	2921	38	acid	acid	NN
cord-023095-4dannjjm	2921	39	from	from	IN
cord-023095-4dannjjm	2921	40	non	non	JJ
cord-023095-4dannjjm	2921	41	-	-	JJ
cord-023095-4dannjjm	2921	42	polar	polar	JJ
cord-023095-4dannjjm	2921	43	to	to	TO
cord-023095-4dannjjm	2921	44	polar	polar	JJ
cord-023095-4dannjjm	2921	45	.	.	.
cord-023095-4dannjjm	2922	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	2922	2	study	study	NN
cord-023095-4dannjjm	2922	3	further	further	RB
cord-023095-4dannjjm	2922	4	confirms	confirm	VBZ
cord-023095-4dannjjm	2922	5	the	the	DT
cord-023095-4dannjjm	2922	6	role	role	NN
cord-023095-4dannjjm	2922	7	of	of	IN
cord-023095-4dannjjm	2922	8	TLR5	TLR5	NNP
cord-023095-4dannjjm	2922	9	in	in	IN
cord-023095-4dannjjm	2922	10	the	the	DT
cord-023095-4dannjjm	2922	11	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	2922	12	of	of	IN
cord-023095-4dannjjm	2922	13	canine	canine	JJ
cord-023095-4dannjjm	2922	14	IBD	IBD	NNP
cord-023095-4dannjjm	2922	15	.	.	.
cord-023095-4dannjjm	2923	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	2923	2	results	result	NNS
cord-023095-4dannjjm	2923	3	suggest	suggest	VBP
cord-023095-4dannjjm	2923	4	that	that	IN
cord-023095-4dannjjm	2923	5	in	in	IN
cord-023095-4dannjjm	2923	6	addition	addition	NN
cord-023095-4dannjjm	2923	7	to	to	IN
cord-023095-4dannjjm	2923	8	shared	share	VBN
cord-023095-4dannjjm	2923	9	risk	risk	NN
cord-023095-4dannjjm	2923	10	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	2923	11	amongst	amongst	IN
cord-023095-4dannjjm	2923	12	breeds	breed	NNS
cord-023095-4dannjjm	2923	13	,	,	,
cord-023095-4dannjjm	2923	14	individual	individual	JJ
cord-023095-4dannjjm	2923	15	breeds	breed	NNS
cord-023095-4dannjjm	2923	16	may	may	MD
cord-023095-4dannjjm	2923	17	harbor	harbor	VB
cord-023095-4dannjjm	2923	18	unique	unique	JJ
cord-023095-4dannjjm	2923	19	SNPs	snp	NNS
cord-023095-4dannjjm	2923	20	arising	arise	VBG
cord-023095-4dannjjm	2923	21	after	after	IN
cord-023095-4dannjjm	2923	22	breed	breed	NN
cord-023095-4dannjjm	2923	23	formation	formation	NN
cord-023095-4dannjjm	2923	24	which	which	WDT
cord-023095-4dannjjm	2923	25	may	may	MD
cord-023095-4dannjjm	2923	26	further	further	RB
cord-023095-4dannjjm	2923	27	affect	affect	VB
cord-023095-4dannjjm	2923	28	their	-PRON-	PRP$
cord-023095-4dannjjm	2923	29	susceptibility	susceptibility	NN
cord-023095-4dannjjm	2923	30	to	to	IN
cord-023095-4dannjjm	2923	31	this	this	DT
cord-023095-4dannjjm	2923	32	disease	disease	NN
cord-023095-4dannjjm	2923	33	.	.	.
cord-023095-4dannjjm	2924	1	However	however	RB
cord-023095-4dannjjm	2924	2	,	,	,
cord-023095-4dannjjm	2924	3	a	a	DT
cord-023095-4dannjjm	2924	4	case	case	NN
cord-023095-4dannjjm	2924	5	-	-	HYPH
cord-023095-4dannjjm	2924	6	control	control	NN
cord-023095-4dannjjm	2924	7	study	study	NN
cord-023095-4dannjjm	2924	8	would	would	MD
cord-023095-4dannjjm	2924	9	be	be	VB
cord-023095-4dannjjm	2924	10	needed	need	VBN
cord-023095-4dannjjm	2924	11	in	in	IN
cord-023095-4dannjjm	2924	12	the	the	DT
cord-023095-4dannjjm	2924	13	Boxer	Boxer	NNP
cord-023095-4dannjjm	2924	14	dog	dog	NN
cord-023095-4dannjjm	2924	15	to	to	TO
cord-023095-4dannjjm	2924	16	confirm	confirm	VB
cord-023095-4dannjjm	2924	17	the	the	DT
cord-023095-4dannjjm	2924	18	significance	significance	NN
cord-023095-4dannjjm	2924	19	of	of	IN
cord-023095-4dannjjm	2924	20	the	the	DT
cord-023095-4dannjjm	2924	21	TLR5	TLR5	NNP
cord-023095-4dannjjm	2924	22	T443C	T443C	VBN
cord-023095-4dannjjm	2924	23	SNP	SNP	NNP
cord-023095-4dannjjm	2924	24	and	and	CC
cord-023095-4dannjjm	2924	25	further	further	JJ
cord-023095-4dannjjm	2924	26	functional	functional	JJ
cord-023095-4dannjjm	2924	27	data	datum	NNS
cord-023095-4dannjjm	2924	28	would	would	MD
cord-023095-4dannjjm	2924	29	be	be	VB
cord-023095-4dannjjm	2924	30	needed	need	VBN
cord-023095-4dannjjm	2924	31	to	to	TO
cord-023095-4dannjjm	2924	32	elucidate	elucidate	VB
cord-023095-4dannjjm	2924	33	the	the	DT
cord-023095-4dannjjm	2924	34	exact	exact	JJ
cord-023095-4dannjjm	2924	35	role	role	NN
cord-023095-4dannjjm	2924	36	of	of	IN
cord-023095-4dannjjm	2924	37	this	this	DT
cord-023095-4dannjjm	2924	38	polymorphism	polymorphism	NN
cord-023095-4dannjjm	2924	39	in	in	IN
cord-023095-4dannjjm	2924	40	canine	canine	JJ
cord-023095-4dannjjm	2924	41	IBD	IBD	NNP
cord-023095-4dannjjm	2924	42	.	.	.
cord-023095-4dannjjm	2925	1	An	an	DT
cord-023095-4dannjjm	2925	2	automated	automate	VBN
cord-023095-4dannjjm	2925	3	power	power	NN
cord-023095-4dannjjm	2925	4	driver	driver	NN
cord-023095-4dannjjm	2925	5	device	device	NN
cord-023095-4dannjjm	2925	6	(	(	-LRB-
cord-023095-4dannjjm	2925	7	OnControl	OnControl	NNP
cord-023095-4dannjjm	2925	8	,	,	,
cord-023095-4dannjjm	2925	9	Vidacare	Vidacare	NNP
cord-023095-4dannjjm	2925	10	)	)	-RRB-
cord-023095-4dannjjm	2925	11	has	have	VBZ
cord-023095-4dannjjm	2925	12	recently	recently	RB
cord-023095-4dannjjm	2925	13	become	become	VBN
cord-023095-4dannjjm	2925	14	available	available	JJ
cord-023095-4dannjjm	2925	15	for	for	IN
cord-023095-4dannjjm	2925	16	bone	bone	NN
cord-023095-4dannjjm	2925	17	marrow	marrow	NN
cord-023095-4dannjjm	2925	18	aspiration	aspiration	NN
cord-023095-4dannjjm	2925	19	(	(	-LRB-
cord-023095-4dannjjm	2925	20	BMA	BMA	NNP
cord-023095-4dannjjm	2925	21	)	)	-RRB-
cord-023095-4dannjjm	2925	22	and	and	CC
cord-023095-4dannjjm	2925	23	bone	bone	NN
cord-023095-4dannjjm	2925	24	marrow	marrow	NN
cord-023095-4dannjjm	2925	25	biopsy	biopsy	NN
cord-023095-4dannjjm	2925	26	(	(	-LRB-
cord-023095-4dannjjm	2925	27	BMB	BMB	NNP
cord-023095-4dannjjm	2925	28	)	)	-RRB-
cord-023095-4dannjjm	2925	29	in	in	IN
cord-023095-4dannjjm	2925	30	humans	human	NNS
cord-023095-4dannjjm	2925	31	.	.	.
cord-023095-4dannjjm	2926	1	The	the	DT
cord-023095-4dannjjm	2926	2	purpose	purpose	NN
cord-023095-4dannjjm	2926	3	of	of	IN
cord-023095-4dannjjm	2926	4	our	-PRON-	PRP$
cord-023095-4dannjjm	2926	5	study	study	NN
cord-023095-4dannjjm	2926	6	was	be	VBD
cord-023095-4dannjjm	2926	7	to	to	TO
cord-023095-4dannjjm	2926	8	compare	compare	VB
cord-023095-4dannjjm	2926	9	this	this	DT
cord-023095-4dannjjm	2926	10	automated	automated	JJ
cord-023095-4dannjjm	2926	11	technique	technique	NN
cord-023095-4dannjjm	2926	12	to	to	IN
cord-023095-4dannjjm	2926	13	the	the	DT
cord-023095-4dannjjm	2926	14	traditional	traditional	JJ
cord-023095-4dannjjm	2926	15	manual	manual	JJ
cord-023095-4dannjjm	2926	16	technique	technique	NN
cord-023095-4dannjjm	2926	17	for	for	IN
cord-023095-4dannjjm	2926	18	bone	bone	NN
cord-023095-4dannjjm	2926	19	marrow	marrow	NN
cord-023095-4dannjjm	2926	20	sampling	sampling	NN
cord-023095-4dannjjm	2926	21	in	in	IN
cord-023095-4dannjjm	2926	22	cats	cat	NNS
cord-023095-4dannjjm	2926	23	.	.	.
cord-023095-4dannjjm	2927	1	Twelve	twelve	CD
cord-023095-4dannjjm	2927	2	healthy	healthy	JJ
cord-023095-4dannjjm	2927	3	research	research	NN
cord-023095-4dannjjm	2927	4	cats	cat	NNS
cord-023095-4dannjjm	2927	5	were	be	VBD
cord-023095-4dannjjm	2927	6	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	2927	7	using	use	VBG
cord-023095-4dannjjm	2927	8	a	a	DT
cord-023095-4dannjjm	2927	9	standardized	standardized	JJ
cord-023095-4dannjjm	2927	10	protocol	protocol	NN
cord-023095-4dannjjm	2927	11	on	on	IN
cord-023095-4dannjjm	2927	12	2	2	CD
cord-023095-4dannjjm	2927	13	different	different	JJ
cord-023095-4dannjjm	2927	14	occasions	occasion	NNS
cord-023095-4dannjjm	2927	15	,	,	,
cord-023095-4dannjjm	2927	16	2	2	CD
cord-023095-4dannjjm	2927	17	days	day	NNS
cord-023095-4dannjjm	2927	18	apart	apart	RB
cord-023095-4dannjjm	2927	19	,	,	,
cord-023095-4dannjjm	2927	20	to	to	TO
cord-023095-4dannjjm	2927	21	have	have	VB
cord-023095-4dannjjm	2927	22	BMAs	bma	NNS
cord-023095-4dannjjm	2927	23	and	and	CC
cord-023095-4dannjjm	2927	24	BMBs	BMBs	NNP
cord-023095-4dannjjm	2927	25	performed	perform	VBN
cord-023095-4dannjjm	2927	26	by	by	IN
cord-023095-4dannjjm	2927	27	the	the	DT
cord-023095-4dannjjm	2927	28	same	same	JJ
cord-023095-4dannjjm	2927	29	operator	operator	NN
cord-023095-4dannjjm	2927	30	.	.	.
cord-023095-4dannjjm	2928	1	On	on	IN
cord-023095-4dannjjm	2928	2	day	day	NN
cord-023095-4dannjjm	2928	3	1	1	CD
cord-023095-4dannjjm	2928	4	,	,	,
cord-023095-4dannjjm	2928	5	half	half	NN
cord-023095-4dannjjm	2928	6	of	of	IN
cord-023095-4dannjjm	2928	7	the	the	DT
cord-023095-4dannjjm	2928	8	cats	cat	NNS
cord-023095-4dannjjm	2928	9	were	be	VBD
cord-023095-4dannjjm	2928	10	randomized	randomize	VBN
cord-023095-4dannjjm	2928	11	to	to	TO
cord-023095-4dannjjm	2928	12	have	have	VB
cord-023095-4dannjjm	2928	13	a	a	DT
cord-023095-4dannjjm	2928	14	BMA	BMA	NNP
cord-023095-4dannjjm	2928	15	performed	perform	VBN
cord-023095-4dannjjm	2928	16	at	at	IN
cord-023095-4dannjjm	2928	17	both	both	CC
cord-023095-4dannjjm	2928	18	the	the	DT
cord-023095-4dannjjm	2928	19	proximal	proximal	JJ
cord-023095-4dannjjm	2928	20	humerus	humerus	NN
cord-023095-4dannjjm	2928	21	and	and	CC
cord-023095-4dannjjm	2928	22	the	the	DT
cord-023095-4dannjjm	2928	23	iliac	iliac	NNP
cord-023095-4dannjjm	2928	24	crest	crest	NN
cord-023095-4dannjjm	2928	25	,	,	,
cord-023095-4dannjjm	2928	26	and	and	CC
cord-023095-4dannjjm	2928	27	a	a	DT
cord-023095-4dannjjm	2928	28	BMB	BMB	NNP
cord-023095-4dannjjm	2928	29	performed	perform	VBN
cord-023095-4dannjjm	2928	30	at	at	IN
cord-023095-4dannjjm	2928	31	the	the	DT
cord-023095-4dannjjm	2928	32	iliac	iliac	NNP
cord-023095-4dannjjm	2928	33	wing	wing	NN
cord-023095-4dannjjm	2928	34	,	,	,
cord-023095-4dannjjm	2928	35	using	use	VBG
cord-023095-4dannjjm	2928	36	the	the	DT
cord-023095-4dannjjm	2928	37	OnControl	OnControl	NNP
cord-023095-4dannjjm	2928	38	device	device	NN
cord-023095-4dannjjm	2928	39	(	(	-LRB-
cord-023095-4dannjjm	2928	40	15-gauge	15-gauge	CD
cord-023095-4dannjjm	2928	41	needle	needle	NN
cord-023095-4dannjjm	2928	42	for	for	IN
cord-023095-4dannjjm	2928	43	BMA	BMA	NNP
cord-023095-4dannjjm	2928	44	;	;	:
cord-023095-4dannjjm	2928	45	11-gauge	11-gauge	CD
cord-023095-4dannjjm	2928	46	needle	needle	NN
cord-023095-4dannjjm	2928	47	for	for	IN
cord-023095-4dannjjm	2928	48	BMB	BMB	NNP
cord-023095-4dannjjm	2928	49	)	)	-RRB-
cord-023095-4dannjjm	2928	50	.	.	.
cord-023095-4dannjjm	2929	1	The	the	DT
cord-023095-4dannjjm	2929	2	other	other	JJ
cord-023095-4dannjjm	2929	3	half	half	NN
cord-023095-4dannjjm	2929	4	of	of	IN
cord-023095-4dannjjm	2929	5	the	the	DT
cord-023095-4dannjjm	2929	6	cats	cat	NNS
cord-023095-4dannjjm	2929	7	had	have	VBD
cord-023095-4dannjjm	2929	8	the	the	DT
cord-023095-4dannjjm	2929	9	same	same	JJ
cord-023095-4dannjjm	2929	10	procedures	procedure	NNS
cord-023095-4dannjjm	2929	11	performed	perform	VBN
cord-023095-4dannjjm	2929	12	using	use	VBG
cord-023095-4dannjjm	2929	13	a	a	DT
cord-023095-4dannjjm	2929	14	manual	manual	JJ
cord-023095-4dannjjm	2929	15	technique	technique	NN
cord-023095-4dannjjm	2929	16	(	(	-LRB-
cord-023095-4dannjjm	2929	17	15-gauge	15-gauge	CD
cord-023095-4dannjjm	2929	18	Illinois	Illinois	NNP
cord-023095-4dannjjm	2929	19	needle	needle	NN
cord-023095-4dannjjm	2929	20	for	for	IN
cord-023095-4dannjjm	2929	21	BMA	BMA	NNP
cord-023095-4dannjjm	2929	22	;	;	:
cord-023095-4dannjjm	2929	23	11-gauge	11-gauge	CD
cord-023095-4dannjjm	2929	24	Jamshidi	Jamshidi	NNP
cord-023095-4dannjjm	2929	25	needle	needle	NN
cord-023095-4dannjjm	2929	26	for	for	IN
cord-023095-4dannjjm	2929	27	BMB	BMB	NNP
cord-023095-4dannjjm	2929	28	)	)	-RRB-
cord-023095-4dannjjm	2929	29	.	.	.
cord-023095-4dannjjm	2930	1	On	on	IN
cord-023095-4dannjjm	2930	2	day	day	NN
cord-023095-4dannjjm	2930	3	3	3	CD
cord-023095-4dannjjm	2930	4	,	,	,
cord-023095-4dannjjm	2930	5	each	each	DT
cord-023095-4dannjjm	2930	6	cat	cat	NN
cord-023095-4dannjjm	2930	7	had	have	VBD
cord-023095-4dannjjm	2930	8	BMA	BMA	NNP
cord-023095-4dannjjm	2930	9	performed	perform	VBN
cord-023095-4dannjjm	2930	10	at	at	IN
cord-023095-4dannjjm	2930	11	the	the	DT
cord-023095-4dannjjm	2930	12	opposite	opposite	JJ
cord-023095-4dannjjm	2930	13	humerus	humerus	NN
cord-023095-4dannjjm	2930	14	and	and	CC
cord-023095-4dannjjm	2930	15	iliac	iliac	NNP
cord-023095-4dannjjm	2930	16	crest	crest	NNP
cord-023095-4dannjjm	2930	17	,	,	,
cord-023095-4dannjjm	2930	18	and	and	CC
cord-023095-4dannjjm	2930	19	a	a	DT
cord-023095-4dannjjm	2930	20	BMB	BMB	NNP
cord-023095-4dannjjm	2930	21	performed	perform	VBN
cord-023095-4dannjjm	2930	22	at	at	IN
cord-023095-4dannjjm	2930	23	the	the	DT
cord-023095-4dannjjm	2930	24	proximal	proximal	JJ
cord-023095-4dannjjm	2930	25	humerus	humerus	NN
cord-023095-4dannjjm	2930	26	using	use	VBG
cord-023095-4dannjjm	2930	27	the	the	DT
cord-023095-4dannjjm	2930	28	opposite	opposite	JJ
cord-023095-4dannjjm	2930	29	technique	technique	NN
cord-023095-4dannjjm	2930	30	from	from	IN
cord-023095-4dannjjm	2930	31	day	day	NN
cord-023095-4dannjjm	2930	32	1	1	CD
cord-023095-4dannjjm	2930	33	.	.	.
cord-023095-4dannjjm	2931	1	For	for	IN
cord-023095-4dannjjm	2931	2	each	each	DT
cord-023095-4dannjjm	2931	3	procedure	procedure	NN
cord-023095-4dannjjm	2931	4	,	,	,
cord-023095-4dannjjm	2931	5	the	the	DT
cord-023095-4dannjjm	2931	6	operator	operator	NN
cord-023095-4dannjjm	2931	7	was	be	VBD
cord-023095-4dannjjm	2931	8	given	give	VBN
cord-023095-4dannjjm	2931	9	a	a	DT
cord-023095-4dannjjm	2931	10	maximum	maximum	NN
cord-023095-4dannjjm	2931	11	of	of	IN
cord-023095-4dannjjm	2931	12	3	3	CD
cord-023095-4dannjjm	2931	13	attempts	attempt	NNS
cord-023095-4dannjjm	2931	14	to	to	TO
cord-023095-4dannjjm	2931	15	successfully	successfully	RB
cord-023095-4dannjjm	2931	16	collect	collect	VB
cord-023095-4dannjjm	2931	17	a	a	DT
cord-023095-4dannjjm	2931	18	sample	sample	NN
cord-023095-4dannjjm	2931	19	.	.	.
cord-023095-4dannjjm	2932	1	The	the	DT
cord-023095-4dannjjm	2932	2	rate	rate	NN
cord-023095-4dannjjm	2932	3	of	of	IN
cord-023095-4dannjjm	2932	4	success	success	NN
cord-023095-4dannjjm	2932	5	,	,	,
cord-023095-4dannjjm	2932	6	as	as	RB
cord-023095-4dannjjm	2932	7	well	well	RB
cord-023095-4dannjjm	2932	8	as	as	IN
cord-023095-4dannjjm	2932	9	the	the	DT
cord-023095-4dannjjm	2932	10	number	number	NN
cord-023095-4dannjjm	2932	11	of	of	IN
cord-023095-4dannjjm	2932	12	attempts	attempt	NNS
cord-023095-4dannjjm	2932	13	were	be	VBD
cord-023095-4dannjjm	2932	14	recorded	record	VBN
cord-023095-4dannjjm	2932	15	.	.	.
cord-023095-4dannjjm	2933	1	The	the	DT
cord-023095-4dannjjm	2933	2	'	'	``
cord-023095-4dannjjm	2933	3	'	'	``
cord-023095-4dannjjm	2933	4	ease	ease	NN
cord-023095-4dannjjm	2933	5	of	of	IN
cord-023095-4dannjjm	2933	6	use	use	NN
cord-023095-4dannjjm	2933	7	'	'	''
cord-023095-4dannjjm	2933	8	'	'	''
cord-023095-4dannjjm	2933	9	of	of	IN
cord-023095-4dannjjm	2933	10	the	the	DT
cord-023095-4dannjjm	2933	11	device	device	NN
cord-023095-4dannjjm	2933	12	was	be	VBD
cord-023095-4dannjjm	2933	13	rated	rate	VBN
cord-023095-4dannjjm	2933	14	by	by	IN
cord-023095-4dannjjm	2933	15	the	the	DT
cord-023095-4dannjjm	2933	16	operator	operator	NN
cord-023095-4dannjjm	2933	17	on	on	IN
cord-023095-4dannjjm	2933	18	a	a	DT
cord-023095-4dannjjm	2933	19	5-point	5-point	CD
cord-023095-4dannjjm	2933	20	scale	scale	NN
cord-023095-4dannjjm	2933	21	after	after	IN
cord-023095-4dannjjm	2933	22	each	each	DT
cord-023095-4dannjjm	2933	23	procedure	procedure	NN
cord-023095-4dannjjm	2933	24	.	.	.
cord-023095-4dannjjm	2934	1	Using	use	VBG
cord-023095-4dannjjm	2934	2	previously	previously	RB
cord-023095-4dannjjm	2934	3	determined	determine	VBN
cord-023095-4dannjjm	2934	4	criteria	criterion	NNS
cord-023095-4dannjjm	2934	5	,	,	,
cord-023095-4dannjjm	2934	6	the	the	DT
cord-023095-4dannjjm	2934	7	macroscopic	macroscopic	JJ
cord-023095-4dannjjm	2934	8	and	and	CC
cord-023095-4dannjjm	2934	9	microscopic	microscopic	JJ
cord-023095-4dannjjm	2934	10	qualities	quality	NNS
cord-023095-4dannjjm	2934	11	of	of	IN
cord-023095-4dannjjm	2934	12	the	the	DT
cord-023095-4dannjjm	2934	13	BMA	BMA	NNP
cord-023095-4dannjjm	2934	14	and	and	CC
cord-023095-4dannjjm	2934	15	BMB	BMB	NNP
cord-023095-4dannjjm	2934	16	samples	sample	NNS
cord-023095-4dannjjm	2934	17	were	be	VBD
cord-023095-4dannjjm	2934	18	assessed	assess	VBN
cord-023095-4dannjjm	2934	19	by	by	IN
cord-023095-4dannjjm	2934	20	a	a	DT
cord-023095-4dannjjm	2934	21	board	board	NN
cord-023095-4dannjjm	2934	22	-	-	HYPH
cord-023095-4dannjjm	2934	23	certified	certify	VBN
cord-023095-4dannjjm	2934	24	pathologist	pathologist	NN
cord-023095-4dannjjm	2934	25	,	,	,
cord-023095-4dannjjm	2934	26	blinded	blind	VBN
cord-023095-4dannjjm	2934	27	to	to	IN
cord-023095-4dannjjm	2934	28	the	the	DT
cord-023095-4dannjjm	2934	29	technique	technique	NN
cord-023095-4dannjjm	2934	30	used	use	VBN
cord-023095-4dannjjm	2934	31	.	.	.
cord-023095-4dannjjm	2935	1	The	the	DT
cord-023095-4dannjjm	2935	2	level	level	NN
cord-023095-4dannjjm	2935	3	of	of	IN
cord-023095-4dannjjm	2935	4	pain	pain	NN
cord-023095-4dannjjm	2935	5	experienced	experience	VBN
cord-023095-4dannjjm	2935	6	by	by	IN
cord-023095-4dannjjm	2935	7	each	each	DT
cord-023095-4dannjjm	2935	8	cat	cat	NN
cord-023095-4dannjjm	2935	9	was	be	VBD
cord-023095-4dannjjm	2935	10	evaluated	evaluate	VBN
cord-023095-4dannjjm	2935	11	6	6	CD
cord-023095-4dannjjm	2935	12	,	,	,
cord-023095-4dannjjm	2935	13	12	12	CD
cord-023095-4dannjjm	2935	14	,	,	,
cord-023095-4dannjjm	2935	15	18	18	CD
cord-023095-4dannjjm	2935	16	,	,	,
cord-023095-4dannjjm	2935	17	24	24	CD
cord-023095-4dannjjm	2935	18	,	,	,
cord-023095-4dannjjm	2935	19	36	36	CD
cord-023095-4dannjjm	2935	20	and	and	CC
cord-023095-4dannjjm	2935	21	48	48	CD
cord-023095-4dannjjm	2935	22	hours	hour	NNS
cord-023095-4dannjjm	2935	23	following	follow	VBG
cord-023095-4dannjjm	2935	24	each	each	DT
cord-023095-4dannjjm	2935	25	set	set	NN
cord-023095-4dannjjm	2935	26	of	of	IN
cord-023095-4dannjjm	2935	27	procedures	procedure	NNS
cord-023095-4dannjjm	2935	28	,	,	,
cord-023095-4dannjjm	2935	29	using	use	VBG
cord-023095-4dannjjm	2935	30	a	a	DT
cord-023095-4dannjjm	2935	31	previously	previously	RB
cord-023095-4dannjjm	2935	32	validated	validate	VBN
cord-023095-4dannjjm	2935	33	pain	pain	NN
cord-023095-4dannjjm	2935	34	scoring	scoring	NN
cord-023095-4dannjjm	2935	35	system	system	NN
cord-023095-4dannjjm	2935	36	.	.	.
cord-023095-4dannjjm	2936	1	Two	two	CD
cord-023095-4dannjjm	2936	2	sample	sample	NN
cord-023095-4dannjjm	2936	3	t	t	NN
cord-023095-4dannjjm	2936	4	-	-	HYPH
cord-023095-4dannjjm	2936	5	tests	test	NNS
cord-023095-4dannjjm	2936	6	were	be	VBD
cord-023095-4dannjjm	2936	7	used	use	VBN
cord-023095-4dannjjm	2936	8	to	to	TO
cord-023095-4dannjjm	2936	9	compare	compare	VB
cord-023095-4dannjjm	2936	10	the	the	DT
cord-023095-4dannjjm	2936	11	automated	automated	JJ
cord-023095-4dannjjm	2936	12	technique	technique	NN
cord-023095-4dannjjm	2936	13	to	to	IN
cord-023095-4dannjjm	2936	14	the	the	DT
cord-023095-4dannjjm	2936	15	manual	manual	JJ
cord-023095-4dannjjm	2936	16	technique	technique	NN
cord-023095-4dannjjm	2936	17	and	and	CC
cord-023095-4dannjjm	2936	18	to	to	TO
cord-023095-4dannjjm	2936	19	compare	compare	VB
cord-023095-4dannjjm	2936	20	the	the	DT
cord-023095-4dannjjm	2936	21	humerus	humerus	NN
cord-023095-4dannjjm	2936	22	to	to	IN
cord-023095-4dannjjm	2936	23	the	the	DT
cord-023095-4dannjjm	2936	24	iliac	iliac	NNP
cord-023095-4dannjjm	2936	25	crest	crest	NNP
cord-023095-4dannjjm	2936	26	site	site	NN
cord-023095-4dannjjm	2936	27	for	for	IN
cord-023095-4dannjjm	2936	28	BMAs	bma	NNS
cord-023095-4dannjjm	2936	29	and	and	CC
cord-023095-4dannjjm	2936	30	the	the	DT
cord-023095-4dannjjm	2936	31	humerus	humerus	NN
cord-023095-4dannjjm	2936	32	to	to	IN
cord-023095-4dannjjm	2936	33	the	the	DT
cord-023095-4dannjjm	2936	34	iliac	iliac	JJ
cord-023095-4dannjjm	2936	35	wing	wing	NN
cord-023095-4dannjjm	2936	36	site	site	NN
cord-023095-4dannjjm	2936	37	for	for	IN
cord-023095-4dannjjm	2936	38	BMBs	BMBs	NNP
cord-023095-4dannjjm	2936	39	.	.	.
cord-023095-4dannjjm	2937	1	For	for	IN
cord-023095-4dannjjm	2937	2	all	all	DT
cord-023095-4dannjjm	2937	3	procedures	procedure	NNS
cord-023095-4dannjjm	2937	4	,	,	,
cord-023095-4dannjjm	2937	5	at	at	IN
cord-023095-4dannjjm	2937	6	all	all	DT
cord-023095-4dannjjm	2937	7	sites	site	NNS
cord-023095-4dannjjm	2937	8	,	,	,
cord-023095-4dannjjm	2937	9	the	the	DT
cord-023095-4dannjjm	2937	10	'	'	''
cord-023095-4dannjjm	2937	11	'	'	''
cord-023095-4dannjjm	2937	12	ease	ease	NN
cord-023095-4dannjjm	2937	13	of	of	IN
cord-023095-4dannjjm	2937	14	use	use	NN
cord-023095-4dannjjm	2937	15	'	'	''
cord-023095-4dannjjm	2937	16	'	'	''
cord-023095-4dannjjm	2937	17	was	be	VBD
cord-023095-4dannjjm	2937	18	better	well	JJR
cord-023095-4dannjjm	2937	19	for	for	IN
cord-023095-4dannjjm	2937	20	the	the	DT
cord-023095-4dannjjm	2937	21	automated	automate	VBN
cord-023095-4dannjjm	2937	22	technique	technique	NN
cord-023095-4dannjjm	2937	23	than	than	IN
cord-023095-4dannjjm	2937	24	for	for	IN
cord-023095-4dannjjm	2937	25	the	the	DT
cord-023095-4dannjjm	2937	26	manual	manual	JJ
cord-023095-4dannjjm	2937	27	technique	technique	NN
cord-023095-4dannjjm	2937	28	(	(	-LRB-
cord-023095-4dannjjm	2937	29	P	p	NN
cord-023095-4dannjjm	2937	30	o	o	NN
cord-023095-4dannjjm	2937	31	0.05	0.05	CD
cord-023095-4dannjjm	2937	32	)	)	-RRB-
cord-023095-4dannjjm	2937	33	.	.	.
cord-023095-4dannjjm	2938	1	The	the	DT
cord-023095-4dannjjm	2938	2	duration	duration	NN
cord-023095-4dannjjm	2938	3	of	of	IN
cord-023095-4dannjjm	2938	4	the	the	DT
cord-023095-4dannjjm	2938	5	procedure	procedure	NN
cord-023095-4dannjjm	2938	6	and	and	CC
cord-023095-4dannjjm	2938	7	the	the	DT
cord-023095-4dannjjm	2938	8	number	number	NN
cord-023095-4dannjjm	2938	9	of	of	IN
cord-023095-4dannjjm	2938	10	attempts	attempt	NNS
cord-023095-4dannjjm	2938	11	to	to	TO
cord-023095-4dannjjm	2938	12	collect	collect	VB
cord-023095-4dannjjm	2938	13	a	a	DT
cord-023095-4dannjjm	2938	14	sample	sample	NN
cord-023095-4dannjjm	2938	15	were	be	VBD
cord-023095-4dannjjm	2938	16	significantly	significantly	RB
cord-023095-4dannjjm	2938	17	lower	low	JJR
cord-023095-4dannjjm	2938	18	with	with	IN
cord-023095-4dannjjm	2938	19	the	the	DT
cord-023095-4dannjjm	2938	20	automated	automate	VBN
cord-023095-4dannjjm	2938	21	technique	technique	NN
cord-023095-4dannjjm	2938	22	for	for	IN
cord-023095-4dannjjm	2938	23	BMA	BMA	NNP
cord-023095-4dannjjm	2938	24	at	at	IN
cord-023095-4dannjjm	2938	25	the	the	DT
cord-023095-4dannjjm	2938	26	proximal	proximal	JJ
cord-023095-4dannjjm	2938	27	humerus	humerus	NN
cord-023095-4dannjjm	2938	28	(	(	-LRB-
cord-023095-4dannjjm	2938	29	P	p	NN
cord-023095-4dannjjm	2938	30	o	o	NN
cord-023095-4dannjjm	2938	31	0.05	0.05	CD
cord-023095-4dannjjm	2938	32	)	)	-RRB-
cord-023095-4dannjjm	2938	33	.	.	.
cord-023095-4dannjjm	2939	1	There	there	EX
cord-023095-4dannjjm	2939	2	was	be	VBD
cord-023095-4dannjjm	2939	3	no	no	DT
cord-023095-4dannjjm	2939	4	significant	significant	JJ
cord-023095-4dannjjm	2939	5	difference	difference	NN
cord-023095-4dannjjm	2939	6	in	in	IN
cord-023095-4dannjjm	2939	7	the	the	DT
cord-023095-4dannjjm	2939	8	level	level	NN
cord-023095-4dannjjm	2939	9	of	of	IN
cord-023095-4dannjjm	2939	10	pain	pain	NN
cord-023095-4dannjjm	2939	11	at	at	IN
cord-023095-4dannjjm	2939	12	any	any	DT
cord-023095-4dannjjm	2939	13	time	time	NN
cord-023095-4dannjjm	2939	14	point	point	NN
cord-023095-4dannjjm	2939	15	following	follow	VBG
cord-023095-4dannjjm	2939	16	each	each	DT
cord-023095-4dannjjm	2939	17	set	set	NN
cord-023095-4dannjjm	2939	18	of	of	IN
cord-023095-4dannjjm	2939	19	procedures	procedure	NNS
cord-023095-4dannjjm	2939	20	with	with	IN
cord-023095-4dannjjm	2939	21	either	either	DT
cord-023095-4dannjjm	2939	22	technique	technique	NN
cord-023095-4dannjjm	2939	23	.	.	.
cord-023095-4dannjjm	2940	1	Performing	perform	VBG
cord-023095-4dannjjm	2940	2	BMA	BMA	NNP
cord-023095-4dannjjm	2940	3	at	at	IN
cord-023095-4dannjjm	2940	4	the	the	DT
cord-023095-4dannjjm	2940	5	proximal	proximal	JJ
cord-023095-4dannjjm	2940	6	humerus	humerus	NN
cord-023095-4dannjjm	2940	7	was	be	VBD
cord-023095-4dannjjm	2940	8	associated	associate	VBN
cord-023095-4dannjjm	2940	9	with	with	IN
cord-023095-4dannjjm	2940	10	a	a	DT
cord-023095-4dannjjm	2940	11	higher	high	JJR
cord-023095-4dannjjm	2940	12	rate	rate	NN
cord-023095-4dannjjm	2940	13	of	of	IN
cord-023095-4dannjjm	2940	14	success	success	NN
cord-023095-4dannjjm	2940	15	(	(	-LRB-
cord-023095-4dannjjm	2940	16	P	p	NN
cord-023095-4dannjjm	2940	17	o	o	NN
cord-023095-4dannjjm	2940	18	0.05	0.05	CD
cord-023095-4dannjjm	2940	19	)	)	-RRB-
cord-023095-4dannjjm	2940	20	,	,	,
cord-023095-4dannjjm	2940	21	a	a	DT
cord-023095-4dannjjm	2940	22	lower	low	JJR
cord-023095-4dannjjm	2940	23	number	number	NN
cord-023095-4dannjjm	2940	24	of	of	IN
cord-023095-4dannjjm	2940	25	attempts	attempt	NNS
cord-023095-4dannjjm	2940	26	(	(	-LRB-
cord-023095-4dannjjm	2940	27	P	p	NN
cord-023095-4dannjjm	2940	28	o	o	NN
cord-023095-4dannjjm	2940	29	0.05	0.05	CD
cord-023095-4dannjjm	2940	30	)	)	-RRB-
cord-023095-4dannjjm	2940	31	,	,	,
cord-023095-4dannjjm	2940	32	a	a	DT
cord-023095-4dannjjm	2940	33	shorter	short	JJR
cord-023095-4dannjjm	2940	34	duration	duration	NN
cord-023095-4dannjjm	2940	35	of	of	IN
cord-023095-4dannjjm	2940	36	the	the	DT
cord-023095-4dannjjm	2940	37	procedure	procedure	NN
cord-023095-4dannjjm	2940	38	(	(	-LRB-
cord-023095-4dannjjm	2940	39	P	p	NN
cord-023095-4dannjjm	2940	40	o	o	NN
cord-023095-4dannjjm	2940	41	0.05	0.05	CD
cord-023095-4dannjjm	2940	42	)	)	-RRB-
cord-023095-4dannjjm	2940	43	,	,	,
cord-023095-4dannjjm	2940	44	a	a	DT
cord-023095-4dannjjm	2940	45	higher	higher	RBR
cord-023095-4dannjjm	2940	46	-	-	HYPH
cord-023095-4dannjjm	2940	47	rated	rate	VBN
cord-023095-4dannjjm	2940	48	'	'	''
cord-023095-4dannjjm	2940	49	'	'	''
cord-023095-4dannjjm	2940	50	ease	ease	NN
cord-023095-4dannjjm	2940	51	of	of	IN
cord-023095-4dannjjm	2940	52	use	use	NN
cord-023095-4dannjjm	2940	53	'	'	''
cord-023095-4dannjjm	2940	54	'	'	''
cord-023095-4dannjjm	2940	55	of	of	IN
cord-023095-4dannjjm	2940	56	the	the	DT
cord-023095-4dannjjm	2940	57	technique	technique	NN
cord-023095-4dannjjm	2940	58	(	(	-LRB-
cord-023095-4dannjjm	2940	59	P	p	NN
cord-023095-4dannjjm	2940	60	o	o	NN
cord-023095-4dannjjm	2940	61	0.05	0.05	CD
cord-023095-4dannjjm	2940	62	)	)	-RRB-
cord-023095-4dannjjm	2940	63	,	,	,
cord-023095-4dannjjm	2940	64	and	and	CC
cord-023095-4dannjjm	2940	65	a	a	DT
cord-023095-4dannjjm	2940	66	better	well	JJR
cord-023095-4dannjjm	2940	67	quality	quality	NN
cord-023095-4dannjjm	2940	68	sample	sample	NN
cord-023095-4dannjjm	2940	69	(	(	-LRB-
cord-023095-4dannjjm	2940	70	P	p	NN
cord-023095-4dannjjm	2940	71	o	o	NN
cord-023095-4dannjjm	2940	72	0.05	0.05	CD
cord-023095-4dannjjm	2940	73	)	)	-RRB-
cord-023095-4dannjjm	2940	74	when	when	WRB
cord-023095-4dannjjm	2940	75	compared	compare	VBN
cord-023095-4dannjjm	2940	76	to	to	IN
cord-023095-4dannjjm	2940	77	sampling	sampling	NN
cord-023095-4dannjjm	2940	78	from	from	IN
cord-023095-4dannjjm	2940	79	the	the	DT
cord-023095-4dannjjm	2940	80	iliac	iliac	NNP
cord-023095-4dannjjm	2940	81	crest	crest	NN
cord-023095-4dannjjm	2940	82	,	,	,
cord-023095-4dannjjm	2941	1	In	in	IN
cord-023095-4dannjjm	2941	2	conclusion	conclusion	NN
cord-023095-4dannjjm	2941	3	,	,	,
cord-023095-4dannjjm	2941	4	we	-PRON-	PRP
cord-023095-4dannjjm	2941	5	found	find	VBD
cord-023095-4dannjjm	2941	6	the	the	DT
cord-023095-4dannjjm	2941	7	automated	automate	VBN
cord-023095-4dannjjm	2941	8	bone	bone	NN
cord-023095-4dannjjm	2941	9	marrow	marrow	NN
cord-023095-4dannjjm	2941	10	sampling	sampling	NN
cord-023095-4dannjjm	2941	11	technique	technique	NN
cord-023095-4dannjjm	2941	12	suitable	suitable	JJ
cord-023095-4dannjjm	2941	13	for	for	IN
cord-023095-4dannjjm	2941	14	use	use	NN
cord-023095-4dannjjm	2941	15	in	in	IN
cord-023095-4dannjjm	2941	16	adult	adult	NN
cord-023095-4dannjjm	2941	17	cats	cat	NNS
cord-023095-4dannjjm	2941	18	.	.	.
cord-023095-4dannjjm	2942	1	This	this	DT
cord-023095-4dannjjm	2942	2	technique	technique	NN
cord-023095-4dannjjm	2942	3	was	be	VBD
cord-023095-4dannjjm	2942	4	easier	easy	JJR
cord-023095-4dannjjm	2942	5	to	to	TO
cord-023095-4dannjjm	2942	6	use	use	VB
cord-023095-4dannjjm	2942	7	than	than	IN
cord-023095-4dannjjm	2942	8	the	the	DT
cord-023095-4dannjjm	2942	9	manual	manual	JJ
cord-023095-4dannjjm	2942	10	technique	technique	NN
cord-023095-4dannjjm	2942	11	for	for	IN
cord-023095-4dannjjm	2942	12	both	both	CC
cord-023095-4dannjjm	2942	13	BMA	BMA	NNP
cord-023095-4dannjjm	2942	14	and	and	CC
cord-023095-4dannjjm	2942	15	BMB	BMB	NNP
cord-023095-4dannjjm	2942	16	,	,	,
cord-023095-4dannjjm	2942	17	and	and	CC
cord-023095-4dannjjm	2942	18	reduced	reduce	VBD
cord-023095-4dannjjm	2942	19	the	the	DT
cord-023095-4dannjjm	2942	20	duration	duration	NN
cord-023095-4dannjjm	2942	21	of	of	IN
cord-023095-4dannjjm	2942	22	the	the	DT
cord-023095-4dannjjm	2942	23	procedure	procedure	NN
cord-023095-4dannjjm	2942	24	and	and	CC
cord-023095-4dannjjm	2942	25	the	the	DT
cord-023095-4dannjjm	2942	26	number	number	NN
cord-023095-4dannjjm	2942	27	of	of	IN
cord-023095-4dannjjm	2942	28	attempts	attempt	NNS
cord-023095-4dannjjm	2942	29	for	for	IN
cord-023095-4dannjjm	2942	30	successful	successful	JJ
cord-023095-4dannjjm	2942	31	BMA	BMA	NNP
cord-023095-4dannjjm	2942	32	at	at	IN
cord-023095-4dannjjm	2942	33	the	the	DT
cord-023095-4dannjjm	2942	34	proximal	proximal	JJ
cord-023095-4dannjjm	2942	35	humerus	humerus	NN
cord-023095-4dannjjm	2942	36	.	.	.
cord-023095-4dannjjm	2943	1	Performing	perform	VBG
cord-023095-4dannjjm	2943	2	BMA	BMA	NNP
cord-023095-4dannjjm	2943	3	at	at	IN
cord-023095-4dannjjm	2943	4	the	the	DT
cord-023095-4dannjjm	2943	5	proximal	proximal	JJ
cord-023095-4dannjjm	2943	6	humerus	humerus	NN
cord-023095-4dannjjm	2943	7	was	be	VBD
cord-023095-4dannjjm	2943	8	faster	fast	JJR
cord-023095-4dannjjm	2943	9	,	,	,
cord-023095-4dannjjm	2943	10	easier	easy	JJR
cord-023095-4dannjjm	2943	11	and	and	CC
cord-023095-4dannjjm	2943	12	allowed	allow	VBN
cord-023095-4dannjjm	2943	13	collection	collection	NN
cord-023095-4dannjjm	2943	14	of	of	IN
cord-023095-4dannjjm	2943	15	better	well	JJR
cord-023095-4dannjjm	2943	16	quality	quality	NN
cord-023095-4dannjjm	2943	17	samples	sample	NNS
cord-023095-4dannjjm	2943	18	than	than	IN
cord-023095-4dannjjm	2943	19	at	at	IN
cord-023095-4dannjjm	2943	20	the	the	DT
cord-023095-4dannjjm	2943	21	iliac	iliac	NNP
cord-023095-4dannjjm	2943	22	crest	crest	NN
cord-023095-4dannjjm	2943	23	,	,	,
cord-023095-4dannjjm	2943	24	independently	independently	RB
cord-023095-4dannjjm	2943	25	of	of	IN
cord-023095-4dannjjm	2943	26	the	the	DT
cord-023095-4dannjjm	2943	27	technique	technique	NN
cord-023095-4dannjjm	2943	28	used	use	VBN
cord-023095-4dannjjm	2943	29	.	.	.
cord-023095-4dannjjm	2944	1	The	the	DT
cord-023095-4dannjjm	2944	2	fractious	fractious	JJ
cord-023095-4dannjjm	2944	3	nature	nature	NN
cord-023095-4dannjjm	2944	4	of	of	IN
cord-023095-4dannjjm	2944	5	some	some	DT
cord-023095-4dannjjm	2944	6	feline	feline	JJ
cord-023095-4dannjjm	2944	7	patients	patient	NNS
cord-023095-4dannjjm	2944	8	sometimes	sometimes	RB
cord-023095-4dannjjm	2944	9	makes	make	VBZ
cord-023095-4dannjjm	2944	10	sedation	sedation	NN
cord-023095-4dannjjm	2944	11	or	or	CC
cord-023095-4dannjjm	2944	12	general	general	JJ
cord-023095-4dannjjm	2944	13	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2944	14	necessary	necessary	JJ
cord-023095-4dannjjm	2944	15	for	for	IN
cord-023095-4dannjjm	2944	16	routine	routine	JJ
cord-023095-4dannjjm	2944	17	procedures	procedure	NNS
cord-023095-4dannjjm	2944	18	such	such	JJ
cord-023095-4dannjjm	2944	19	as	as	IN
cord-023095-4dannjjm	2944	20	blood	blood	NN
cord-023095-4dannjjm	2944	21	collection	collection	NN
cord-023095-4dannjjm	2944	22	for	for	IN
cord-023095-4dannjjm	2944	23	hematologic	hematologic	JJ
cord-023095-4dannjjm	2944	24	analyses	analysis	NNS
cord-023095-4dannjjm	2944	25	.	.	.
cord-023095-4dannjjm	2945	1	It	-PRON-	PRP
cord-023095-4dannjjm	2945	2	has	have	VBZ
cord-023095-4dannjjm	2945	3	been	be	VBN
cord-023095-4dannjjm	2945	4	anecdotally	anecdotally	RB
cord-023095-4dannjjm	2945	5	reported	report	VBN
cord-023095-4dannjjm	2945	6	that	that	IN
cord-023095-4dannjjm	2945	7	sedation	sedation	NN
cord-023095-4dannjjm	2945	8	or	or	CC
cord-023095-4dannjjm	2945	9	general	general	JJ
cord-023095-4dannjjm	2945	10	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2945	11	could	could	MD
cord-023095-4dannjjm	2945	12	induce	induce	VB
cord-023095-4dannjjm	2945	13	variations	variation	NNS
cord-023095-4dannjjm	2945	14	in	in	IN
cord-023095-4dannjjm	2945	15	hematologic	hematologic	JJ
cord-023095-4dannjjm	2945	16	parameters	parameter	NNS
cord-023095-4dannjjm	2945	17	in	in	IN
cord-023095-4dannjjm	2945	18	cats	cat	NNS
cord-023095-4dannjjm	2945	19	,	,	,
cord-023095-4dannjjm	2945	20	making	make	VBG
cord-023095-4dannjjm	2945	21	it	-PRON-	PRP
cord-023095-4dannjjm	2945	22	important	important	JJ
cord-023095-4dannjjm	2945	23	for	for	IN
cord-023095-4dannjjm	2945	24	the	the	DT
cord-023095-4dannjjm	2945	25	clinician	clinician	NN
cord-023095-4dannjjm	2945	26	to	to	TO
cord-023095-4dannjjm	2945	27	be	be	VB
cord-023095-4dannjjm	2945	28	able	able	JJ
cord-023095-4dannjjm	2945	29	to	to	TO
cord-023095-4dannjjm	2945	30	anticipate	anticipate	VB
cord-023095-4dannjjm	2945	31	potential	potential	JJ
cord-023095-4dannjjm	2945	32	changes	change	NNS
cord-023095-4dannjjm	2945	33	on	on	IN
cord-023095-4dannjjm	2945	34	hematologic	hematologic	JJ
cord-023095-4dannjjm	2945	35	parameters	parameter	NNS
cord-023095-4dannjjm	2945	36	that	that	WDT
cord-023095-4dannjjm	2945	37	could	could	MD
cord-023095-4dannjjm	2945	38	result	result	VB
cord-023095-4dannjjm	2945	39	from	from	IN
cord-023095-4dannjjm	2945	40	chemical	chemical	JJ
cord-023095-4dannjjm	2945	41	restraint	restraint	NN
cord-023095-4dannjjm	2945	42	.	.	.
cord-023095-4dannjjm	2946	1	This	this	DT
cord-023095-4dannjjm	2946	2	study	study	NN
cord-023095-4dannjjm	2946	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	2946	4	the	the	DT
cord-023095-4dannjjm	2946	5	effects	effect	NNS
cord-023095-4dannjjm	2946	6	of	of	IN
cord-023095-4dannjjm	2946	7	a	a	DT
cord-023095-4dannjjm	2946	8	standardizecd	standardizecd	JJ
cord-023095-4dannjjm	2946	9	anesthetic	anesthetic	NN
cord-023095-4dannjjm	2946	10	protocol	protocol	NN
cord-023095-4dannjjm	2946	11	using	use	VBG
cord-023095-4dannjjm	2946	12	ketamine	ketamine	NNP
cord-023095-4dannjjm	2946	13	(	(	-LRB-
cord-023095-4dannjjm	2946	14	10	10	CD
cord-023095-4dannjjm	2946	15	mg	mg	NNP
cord-023095-4dannjjm	2946	16	/	/	SYM
cord-023095-4dannjjm	2946	17	kg	kg	NNP
cord-023095-4dannjjm	2946	18	,	,	,
cord-023095-4dannjjm	2946	19	IV	IV	NNP
cord-023095-4dannjjm	2946	20	)	)	-RRB-
cord-023095-4dannjjm	2946	21	,	,	,
cord-023095-4dannjjm	2946	22	midazolam	midazolam	NNP
cord-023095-4dannjjm	2946	23	(	(	-LRB-
cord-023095-4dannjjm	2946	24	0.5	0.5	CD
cord-023095-4dannjjm	2946	25	mg	mg	NNP
cord-023095-4dannjjm	2946	26	/	/	SYM
cord-023095-4dannjjm	2946	27	kg	kg	NNP
cord-023095-4dannjjm	2946	28	,	,	,
cord-023095-4dannjjm	2946	29	IV	IV	NNP
cord-023095-4dannjjm	2946	30	)	)	-RRB-
cord-023095-4dannjjm	2946	31	and	and	CC
cord-023095-4dannjjm	2946	32	buprenorphine	buprenorphine	NN
cord-023095-4dannjjm	2946	33	(	(	-LRB-
cord-023095-4dannjjm	2946	34	10	10	CD
cord-023095-4dannjjm	2946	35	mg	mg	NNP
cord-023095-4dannjjm	2946	36	/	/	SYM
cord-023095-4dannjjm	2946	37	kg	kg	NNP
cord-023095-4dannjjm	2946	38	,	,	,
cord-023095-4dannjjm	2946	39	IM	IM	NNP
cord-023095-4dannjjm	2946	40	)	)	-RRB-
cord-023095-4dannjjm	2946	41	on	on	IN
cord-023095-4dannjjm	2946	42	the	the	DT
cord-023095-4dannjjm	2946	43	hematologic	hematologic	JJ
cord-023095-4dannjjm	2946	44	parameters	parameter	NNS
cord-023095-4dannjjm	2946	45	of	of	IN
cord-023095-4dannjjm	2946	46	12	12	CD
cord-023095-4dannjjm	2946	47	healthy	healthy	JJ
cord-023095-4dannjjm	2946	48	adult	adult	NN
cord-023095-4dannjjm	2946	49	research	research	NN
cord-023095-4dannjjm	2946	50	cats	cat	NNS
cord-023095-4dannjjm	2946	51	.	.	.
cord-023095-4dannjjm	2947	1	Each	each	DT
cord-023095-4dannjjm	2947	2	cat	cat	NN
cord-023095-4dannjjm	2947	3	had	have	VBD
cord-023095-4dannjjm	2947	4	blood	blood	NN
cord-023095-4dannjjm	2947	5	samples	sample	NNS
cord-023095-4dannjjm	2947	6	collected	collect	VBN
cord-023095-4dannjjm	2947	7	before	before	RB
cord-023095-4dannjjm	2947	8	and	and	CC
cord-023095-4dannjjm	2947	9	after	after	IN
cord-023095-4dannjjm	2947	10	induction	induction	NN
cord-023095-4dannjjm	2947	11	of	of	IN
cord-023095-4dannjjm	2947	12	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2947	13	on	on	IN
cord-023095-4dannjjm	2947	14	2	2	CD
cord-023095-4dannjjm	2947	15	different	different	JJ
cord-023095-4dannjjm	2947	16	occasions	occasion	NNS
cord-023095-4dannjjm	2947	17	,	,	,
cord-023095-4dannjjm	2947	18	2	2	CD
cord-023095-4dannjjm	2947	19	days	day	NNS
cord-023095-4dannjjm	2947	20	apart	apart	RB
cord-023095-4dannjjm	2947	21	.	.	.
cord-023095-4dannjjm	2948	1	In	in	IN
cord-023095-4dannjjm	2948	2	total	total	JJ
cord-023095-4dannjjm	2948	3	,	,	,
cord-023095-4dannjjm	2948	4	24	24	CD
cord-023095-4dannjjm	2948	5	pairs	pair	NNS
cord-023095-4dannjjm	2948	6	of	of	IN
cord-023095-4dannjjm	2948	7	complete	complete	JJ
cord-023095-4dannjjm	2948	8	blood	blood	NN
cord-023095-4dannjjm	2948	9	counts	count	NNS
cord-023095-4dannjjm	2948	10	were	be	VBD
cord-023095-4dannjjm	2948	11	obtained	obtain	VBN
cord-023095-4dannjjm	2948	12	.	.	.
cord-023095-4dannjjm	2949	1	Analyses	analysis	NNS
cord-023095-4dannjjm	2949	2	were	be	VBD
cord-023095-4dannjjm	2949	3	performed	perform	VBN
cord-023095-4dannjjm	2949	4	at	at	IN
cord-023095-4dannjjm	2949	5	a	a	DT
cord-023095-4dannjjm	2949	6	certified	certify	VBN
cord-023095-4dannjjm	2949	7	veterinary	veterinary	JJ
cord-023095-4dannjjm	2949	8	laboratory	laboratory	NN
cord-023095-4dannjjm	2949	9	.	.	.
cord-023095-4dannjjm	2950	1	Paired	pair	VBN
cord-023095-4dannjjm	2950	2	sample	sample	NN
cord-023095-4dannjjm	2950	3	t	t	NN
cord-023095-4dannjjm	2950	4	-	-	HYPH
cord-023095-4dannjjm	2950	5	tests	test	NNS
cord-023095-4dannjjm	2950	6	were	be	VBD
cord-023095-4dannjjm	2950	7	used	use	VBN
cord-023095-4dannjjm	2950	8	to	to	TO
cord-023095-4dannjjm	2950	9	determine	determine	VB
cord-023095-4dannjjm	2950	10	whether	whether	IN
cord-023095-4dannjjm	2950	11	there	there	EX
cord-023095-4dannjjm	2950	12	were	be	VBD
cord-023095-4dannjjm	2950	13	any	any	DT
cord-023095-4dannjjm	2950	14	statistical	statistical	JJ
cord-023095-4dannjjm	2950	15	differences	difference	NNS
cord-023095-4dannjjm	2950	16	between	between	IN
cord-023095-4dannjjm	2950	17	hematologic	hematologic	JJ
cord-023095-4dannjjm	2950	18	parameters	parameter	NNS
cord-023095-4dannjjm	2950	19	before	before	IN
cord-023095-4dannjjm	2950	20	and	and	CC
cord-023095-4dannjjm	2950	21	after	after	IN
cord-023095-4dannjjm	2950	22	induction	induction	NN
cord-023095-4dannjjm	2950	23	of	of	IN
cord-023095-4dannjjm	2950	24	general	general	JJ
cord-023095-4dannjjm	2950	25	anesthesia	anesthesia	NNP
cord-023095-4dannjjm	2950	26	,	,	,
cord-023095-4dannjjm	2950	27	for	for	IN
cord-023095-4dannjjm	2950	28	each	each	DT
cord-023095-4dannjjm	2950	29	cat	cat	NN
cord-023095-4dannjjm	2950	30	,	,	,
cord-023095-4dannjjm	2950	31	on	on	IN
cord-023095-4dannjjm	2950	32	2	2	CD
cord-023095-4dannjjm	2950	33	different	different	JJ
cord-023095-4dannjjm	2950	34	occasions	occasion	NNS
cord-023095-4dannjjm	2950	35	.	.	.
cord-023095-4dannjjm	2951	1	Compared	compare	VBN
cord-023095-4dannjjm	2951	2	to	to	IN
cord-023095-4dannjjm	2951	3	preanesthetic	preanesthetic	JJ
cord-023095-4dannjjm	2951	4	values	value	NNS
cord-023095-4dannjjm	2951	5	there	there	EX
cord-023095-4dannjjm	2951	6	was	be	VBD
cord-023095-4dannjjm	2951	7	a	a	DT
cord-023095-4dannjjm	2951	8	significant	significant	JJ
cord-023095-4dannjjm	2951	9	decrease	decrease	NN
cord-023095-4dannjjm	2951	10	in	in	IN
cord-023095-4dannjjm	2951	11	red	red	JJ
cord-023095-4dannjjm	2951	12	blood	blood	NN
cord-023095-4dannjjm	2951	13	cell	cell	NN
cord-023095-4dannjjm	2951	14	count	count	NN
cord-023095-4dannjjm	2951	15	,	,	,
cord-023095-4dannjjm	2951	16	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	2951	17	concentration	concentration	NN
cord-023095-4dannjjm	2951	18	,	,	,
cord-023095-4dannjjm	2951	19	hematocrit	hematocrit	NN
cord-023095-4dannjjm	2951	20	,	,	,
cord-023095-4dannjjm	2951	21	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	2951	22	count	count	NN
cord-023095-4dannjjm	2951	23	and	and	CC
cord-023095-4dannjjm	2951	24	plasma	plasma	VBD
cord-023095-4dannjjm	2951	25	total	total	JJ
cord-023095-4dannjjm	2951	26	protein	protein	NN
cord-023095-4dannjjm	2951	27	concentration	concentration	NN
cord-023095-4dannjjm	2951	28	after	after	IN
cord-023095-4dannjjm	2951	29	induction	induction	NN
cord-023095-4dannjjm	2951	30	of	of	IN
cord-023095-4dannjjm	2951	31	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2951	32	.	.	.
cord-023095-4dannjjm	2952	1	There	there	EX
cord-023095-4dannjjm	2952	2	was	be	VBD
cord-023095-4dannjjm	2952	3	no	no	DT
cord-023095-4dannjjm	2952	4	significant	significant	JJ
cord-023095-4dannjjm	2952	5	difference	difference	NN
cord-023095-4dannjjm	2952	6	in	in	IN
cord-023095-4dannjjm	2952	7	the	the	DT
cord-023095-4dannjjm	2952	8	segmented	segmented	JJ
cord-023095-4dannjjm	2952	9	or	or	CC
cord-023095-4dannjjm	2952	10	band	band	NN
cord-023095-4dannjjm	2952	11	neutrophil	neutrophil	NN
cord-023095-4dannjjm	2952	12	,	,	,
cord-023095-4dannjjm	2952	13	eosinophil	eosinophil	NN
cord-023095-4dannjjm	2952	14	,	,	,
cord-023095-4dannjjm	2952	15	basophil	basophil	NNP
cord-023095-4dannjjm	2952	16	,	,	,
cord-023095-4dannjjm	2952	17	monocyte	monocyte	NNP
cord-023095-4dannjjm	2952	18	and	and	CC
cord-023095-4dannjjm	2952	19	platelet	platelet	NN
cord-023095-4dannjjm	2952	20	counts	count	VBZ
cord-023095-4dannjjm	2952	21	between	between	IN
cord-023095-4dannjjm	2952	22	the	the	DT
cord-023095-4dannjjm	2952	23	samples	sample	NNS
cord-023095-4dannjjm	2952	24	taken	take	VBN
cord-023095-4dannjjm	2952	25	before	before	RB
cord-023095-4dannjjm	2952	26	and	and	CC
cord-023095-4dannjjm	2952	27	after	after	IN
cord-023095-4dannjjm	2952	28	induction	induction	NN
cord-023095-4dannjjm	2952	29	of	of	IN
cord-023095-4dannjjm	2952	30	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2952	31	.	.	.
cord-023095-4dannjjm	2953	1	On	on	IN
cord-023095-4dannjjm	2953	2	average	average	JJ
cord-023095-4dannjjm	2953	3	,	,	,
cord-023095-4dannjjm	2953	4	there	there	EX
cord-023095-4dannjjm	2953	5	was	be	VBD
cord-023095-4dannjjm	2953	6	a	a	DT
cord-023095-4dannjjm	2953	7	23.7	23.7	CD
cord-023095-4dannjjm	2953	8	%	%	NN
cord-023095-4dannjjm	2953	9	decrease	decrease	NN
cord-023095-4dannjjm	2953	10	in	in	IN
cord-023095-4dannjjm	2953	11	the	the	DT
cord-023095-4dannjjm	2953	12	red	red	JJ
cord-023095-4dannjjm	2953	13	blood	blood	NN
cord-023095-4dannjjm	2953	14	cell	cell	NN
cord-023095-4dannjjm	2953	15	count	count	NN
cord-023095-4dannjjm	2953	16	(	(	-LRB-
cord-023095-4dannjjm	2953	17	9.06	9.06	CD
cord-023095-4dannjjm	2953	18	Â	â	CD
cord-023095-4dannjjm	2954	1	10	10	CD
cord-023095-4dannjjm	2954	2	12	12	CD
cord-023095-4dannjjm	2954	3	/L	/l	CD
cord-023095-4dannjjm	2954	4	to	to	IN
cord-023095-4dannjjm	2954	5	6.91	6.91	CD
cord-023095-4dannjjm	2954	6	Â	â	CD
cord-023095-4dannjjm	2954	7	10	10	CD
cord-023095-4dannjjm	2954	8	12	12	CD
cord-023095-4dannjjm	2954	9	/L	/L	.
cord-023095-4dannjjm	2954	10	)	)	-RRB-
cord-023095-4dannjjm	2955	1	(	(	-LRB-
cord-023095-4dannjjm	2955	2	P	p	NN
cord-023095-4dannjjm	2955	3	o	o	CD
cord-023095-4dannjjm	2955	4	0.0001	0.0001	CD
cord-023095-4dannjjm	2955	5	)	)	-RRB-
cord-023095-4dannjjm	2955	6	,	,	,
cord-023095-4dannjjm	2955	7	a	a	DT
cord-023095-4dannjjm	2955	8	23	23	CD
cord-023095-4dannjjm	2955	9	%	%	NN
cord-023095-4dannjjm	2955	10	decrease	decrease	NN
cord-023095-4dannjjm	2955	11	in	in	IN
cord-023095-4dannjjm	2955	12	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	2955	13	concentration	concentration	NN
cord-023095-4dannjjm	2955	14	(	(	-LRB-
cord-023095-4dannjjm	2955	15	133.88	133.88	CD
cord-023095-4dannjjm	2955	16	g	g	NN
cord-023095-4dannjjm	2955	17	/	/	SYM
cord-023095-4dannjjm	2955	18	L	l	NN
cord-023095-4dannjjm	2955	19	to	to	IN
cord-023095-4dannjjm	2955	20	103.08	103.08	CD
cord-023095-4dannjjm	2955	21	g/	g/	JJ
cord-023095-4dannjjm	2955	22	L	l	NN
cord-023095-4dannjjm	2955	23	)	)	-RRB-
cord-023095-4dannjjm	2956	1	(	(	-LRB-
cord-023095-4dannjjm	2956	2	P	p	NN
cord-023095-4dannjjm	2956	3	o	o	CD
cord-023095-4dannjjm	2956	4	0.0001	0.0001	CD
cord-023095-4dannjjm	2956	5	)	)	-RRB-
cord-023095-4dannjjm	2956	6	,	,	,
cord-023095-4dannjjm	2956	7	a	a	DT
cord-023095-4dannjjm	2956	8	24.4	24.4	CD
cord-023095-4dannjjm	2956	9	%	%	NN
cord-023095-4dannjjm	2956	10	decrease	decrease	NN
cord-023095-4dannjjm	2956	11	in	in	IN
cord-023095-4dannjjm	2956	12	the	the	DT
cord-023095-4dannjjm	2956	13	hematocrit	hematocrit	NN
cord-023095-4dannjjm	2956	14	(	(	-LRB-
cord-023095-4dannjjm	2956	15	0.41	0.41	CD
cord-023095-4dannjjm	2956	16	L	l	NN
cord-023095-4dannjjm	2956	17	/	/	SYM
cord-023095-4dannjjm	2956	18	L	l	NN
cord-023095-4dannjjm	2956	19	to	to	IN
cord-023095-4dannjjm	2956	20	0.31	0.31	CD
cord-023095-4dannjjm	2956	21	L	l	NN
cord-023095-4dannjjm	2956	22	/	/	SYM
cord-023095-4dannjjm	2956	23	L	l	NN
cord-023095-4dannjjm	2956	24	)	)	-RRB-
cord-023095-4dannjjm	2957	1	(	(	-LRB-
cord-023095-4dannjjm	2957	2	P	p	NN
cord-023095-4dannjjm	2957	3	o	o	CD
cord-023095-4dannjjm	2957	4	0.0001	0.0001	CD
cord-023095-4dannjjm	2957	5	)	)	-RRB-
cord-023095-4dannjjm	2957	6	,	,	,
cord-023095-4dannjjm	2957	7	a	a	DT
cord-023095-4dannjjm	2957	8	25.3	25.3	CD
cord-023095-4dannjjm	2957	9	%	%	NN
cord-023095-4dannjjm	2957	10	decrease	decrease	NN
cord-023095-4dannjjm	2957	11	in	in	IN
cord-023095-4dannjjm	2957	12	the	the	DT
cord-023095-4dannjjm	2957	13	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	2957	14	count	count	NN
cord-023095-4dannjjm	2957	15	(	(	-LRB-
cord-023095-4dannjjm	2957	16	3.68	3.68	CD
cord-023095-4dannjjm	2957	17	Â	â	CD
cord-023095-4dannjjm	2957	18	10	10	CD
cord-023095-4dannjjm	2957	19	9	9	CD
cord-023095-4dannjjm	2957	20	/L	/l	CD
cord-023095-4dannjjm	2957	21	to	to	IN
cord-023095-4dannjjm	2957	22	2.77	2.77	CD
cord-023095-4dannjjm	2957	23	Â	â	CD
cord-023095-4dannjjm	2957	24	10	10	CD
cord-023095-4dannjjm	2957	25	9	9	CD
cord-023095-4dannjjm	2957	26	/L	/L	.
cord-023095-4dannjjm	2957	27	)	)	-RRB-
cord-023095-4dannjjm	2958	1	(	(	-LRB-
cord-023095-4dannjjm	2958	2	P	p	NN
cord-023095-4dannjjm	2958	3	5	5	CD
cord-023095-4dannjjm	2958	4	0.0023	0.0023	CD
cord-023095-4dannjjm	2958	5	)	)	-RRB-
cord-023095-4dannjjm	2958	6	,	,	,
cord-023095-4dannjjm	2958	7	and	and	CC
cord-023095-4dannjjm	2958	8	a	a	DT
cord-023095-4dannjjm	2958	9	12.1	12.1	CD
cord-023095-4dannjjm	2958	10	%	%	NN
cord-023095-4dannjjm	2958	11	decrease	decrease	NN
cord-023095-4dannjjm	2958	12	in	in	IN
cord-023095-4dannjjm	2958	13	the	the	DT
cord-023095-4dannjjm	2958	14	plasma	plasma	NN
cord-023095-4dannjjm	2958	15	total	total	JJ
cord-023095-4dannjjm	2958	16	protein	protein	NN
cord-023095-4dannjjm	2958	17	concentration	concentration	NN
cord-023095-4dannjjm	2958	18	(	(	-LRB-
cord-023095-4dannjjm	2958	19	84.79	84.79	CD
cord-023095-4dannjjm	2958	20	g	g	NN
cord-023095-4dannjjm	2958	21	/	/	SYM
cord-023095-4dannjjm	2958	22	L	l	NN
cord-023095-4dannjjm	2958	23	to	to	IN
cord-023095-4dannjjm	2958	24	74.54	74.54	CD
cord-023095-4dannjjm	2958	25	g	g	NN
cord-023095-4dannjjm	2958	26	/	/	SYM
cord-023095-4dannjjm	2958	27	L	l	NN
cord-023095-4dannjjm	2958	28	)	)	-RRB-
cord-023095-4dannjjm	2959	1	(	(	-LRB-
cord-023095-4dannjjm	2959	2	P	p	NN
cord-023095-4dannjjm	2959	3	o	o	NN
cord-023095-4dannjjm	2960	1	0.0001	0.0001	LS
cord-023095-4dannjjm	2960	2	)	)	-RRB-
cord-023095-4dannjjm	2960	3	when	when	WRB
cord-023095-4dannjjm	2960	4	samples	sample	NNS
cord-023095-4dannjjm	2960	5	taken	take	VBN
cord-023095-4dannjjm	2960	6	before	before	RB
cord-023095-4dannjjm	2960	7	and	and	CC
cord-023095-4dannjjm	2960	8	after	after	IN
cord-023095-4dannjjm	2960	9	induction	induction	NN
cord-023095-4dannjjm	2960	10	of	of	IN
cord-023095-4dannjjm	2960	11	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2960	12	were	be	VBD
cord-023095-4dannjjm	2960	13	compared	compare	VBN
cord-023095-4dannjjm	2960	14	.	.	.
cord-023095-4dannjjm	2961	1	If	if	IN
cord-023095-4dannjjm	2961	2	only	only	RB
cord-023095-4dannjjm	2961	3	the	the	DT
cord-023095-4dannjjm	2961	4	hematocrit	hematocrit	NN
cord-023095-4dannjjm	2961	5	was	be	VBD
cord-023095-4dannjjm	2961	6	considered	consider	VBN
cord-023095-4dannjjm	2961	7	as	as	IN
cord-023095-4dannjjm	2961	8	a	a	DT
cord-023095-4dannjjm	2961	9	marker	marker	NN
cord-023095-4dannjjm	2961	10	of	of	IN
cord-023095-4dannjjm	2961	11	anemia	anemia	NN
cord-023095-4dannjjm	2961	12	,	,	,
cord-023095-4dannjjm	2961	13	29	29	CD
cord-023095-4dannjjm	2961	14	%	%	NN
cord-023095-4dannjjm	2961	15	of	of	IN
cord-023095-4dannjjm	2961	16	the	the	DT
cord-023095-4dannjjm	2961	17	samples	sample	NNS
cord-023095-4dannjjm	2961	18	from	from	IN
cord-023095-4dannjjm	2961	19	these	these	DT
cord-023095-4dannjjm	2961	20	12	12	CD
cord-023095-4dannjjm	2961	21	healthy	healthy	JJ
cord-023095-4dannjjm	2961	22	cats	cat	NNS
cord-023095-4dannjjm	2961	23	,	,	,
cord-023095-4dannjjm	2961	24	taken	take	VBN
cord-023095-4dannjjm	2961	25	while	while	IN
cord-023095-4dannjjm	2961	26	they	-PRON-	PRP
cord-023095-4dannjjm	2961	27	were	be	VBD
cord-023095-4dannjjm	2961	28	under	under	IN
cord-023095-4dannjjm	2961	29	general	general	JJ
cord-023095-4dannjjm	2961	30	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2961	31	,	,	,
cord-023095-4dannjjm	2961	32	would	would	MD
cord-023095-4dannjjm	2961	33	have	have	VB
cord-023095-4dannjjm	2961	34	been	be	VBN
cord-023095-4dannjjm	2961	35	misinterpreted	misinterpret	VBN
cord-023095-4dannjjm	2961	36	as	as	IN
cord-023095-4dannjjm	2961	37	belonging	belong	VBG
cord-023095-4dannjjm	2961	38	to	to	IN
cord-023095-4dannjjm	2961	39	anemic	anemic	JJ
cord-023095-4dannjjm	2961	40	patients	patient	NNS
cord-023095-4dannjjm	2961	41	(	(	-LRB-
cord-023095-4dannjjm	2961	42	hematocrit	hematocrit	NN
cord-023095-4dannjjm	2961	43	o	o	NN
cord-023095-4dannjjm	2961	44	0.285	0.285	CD
cord-023095-4dannjjm	2961	45	L	L	NNP
cord-023095-4dannjjm	2961	46	/	/	SYM
cord-023095-4dannjjm	2961	47	L	L	NNP
cord-023095-4dannjjm	2961	48	)	)	-RRB-
cord-023095-4dannjjm	2961	49	,	,	,
cord-023095-4dannjjm	2961	50	using	use	VBG
cord-023095-4dannjjm	2961	51	the	the	DT
cord-023095-4dannjjm	2961	52	reference	reference	NN
cord-023095-4dannjjm	2961	53	interval	interval	NN
cord-023095-4dannjjm	2961	54	established	establish	VBN
cord-023095-4dannjjm	2961	55	in	in	IN
cord-023095-4dannjjm	2961	56	our	-PRON-	PRP$
cord-023095-4dannjjm	2961	57	laboratory	laboratory	NN
cord-023095-4dannjjm	2961	58	.	.	.
cord-023095-4dannjjm	2962	1	None	none	NN
cord-023095-4dannjjm	2962	2	of	of	IN
cord-023095-4dannjjm	2962	3	the	the	DT
cord-023095-4dannjjm	2962	4	cats	cat	NNS
cord-023095-4dannjjm	2962	5	would	would	MD
cord-023095-4dannjjm	2962	6	have	have	VB
cord-023095-4dannjjm	2962	7	been	be	VBN
cord-023095-4dannjjm	2962	8	considered	consider	VBN
cord-023095-4dannjjm	2962	9	anemic	anemic	JJ
cord-023095-4dannjjm	2962	10	before	before	IN
cord-023095-4dannjjm	2962	11	induction	induction	NN
cord-023095-4dannjjm	2962	12	of	of	IN
cord-023095-4dannjjm	2962	13	general	general	JJ
cord-023095-4dannjjm	2962	14	anesthesia	anesthesia	NNP
cord-023095-4dannjjm	2962	15	.	.	.
cord-023095-4dannjjm	2963	1	In	in	IN
cord-023095-4dannjjm	2963	2	practice	practice	NN
cord-023095-4dannjjm	2963	3	,	,	,
cord-023095-4dannjjm	2963	4	the	the	DT
cord-023095-4dannjjm	2963	5	decrease	decrease	NN
cord-023095-4dannjjm	2963	6	in	in	IN
cord-023095-4dannjjm	2963	7	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	2963	8	count	count	NN
cord-023095-4dannjjm	2963	9	following	follow	VBG
cord-023095-4dannjjm	2963	10	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2963	11	is	be	VBZ
cord-023095-4dannjjm	2963	12	unlikely	unlikely	JJ
cord-023095-4dannjjm	2963	13	to	to	TO
cord-023095-4dannjjm	2963	14	be	be	VB
cord-023095-4dannjjm	2963	15	of	of	IN
cord-023095-4dannjjm	2963	16	clinical	clinical	JJ
cord-023095-4dannjjm	2963	17	relevance	relevance	NN
cord-023095-4dannjjm	2963	18	,	,	,
cord-023095-4dannjjm	2963	19	as	as	IN
cord-023095-4dannjjm	2963	20	all	all	PDT
cord-023095-4dannjjm	2963	21	the	the	DT
cord-023095-4dannjjm	2963	22	samples	sample	NNS
cord-023095-4dannjjm	2963	23	except	except	IN
cord-023095-4dannjjm	2963	24	2	2	CD
cord-023095-4dannjjm	2963	25	had	have	VBD
cord-023095-4dannjjm	2963	26	a	a	DT
cord-023095-4dannjjm	2963	27	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	2963	28	count	count	NN
cord-023095-4dannjjm	2963	29	that	that	WDT
cord-023095-4dannjjm	2963	30	was	be	VBD
cord-023095-4dannjjm	2963	31	within	within	IN
cord-023095-4dannjjm	2963	32	the	the	DT
cord-023095-4dannjjm	2963	33	reference	reference	NN
cord-023095-4dannjjm	2963	34	interval	interval	NN
cord-023095-4dannjjm	2963	35	for	for	IN
cord-023095-4dannjjm	2963	36	cats	cat	NNS
cord-023095-4dannjjm	2963	37	established	establish	VBN
cord-023095-4dannjjm	2963	38	by	by	IN
cord-023095-4dannjjm	2963	39	our	-PRON-	PRP$
cord-023095-4dannjjm	2963	40	laboratory	laboratory	NN
cord-023095-4dannjjm	2963	41	.	.	.
cord-023095-4dannjjm	2964	1	This	this	DT
cord-023095-4dannjjm	2964	2	study	study	NN
cord-023095-4dannjjm	2964	3	suggests	suggest	VBZ
cord-023095-4dannjjm	2964	4	that	that	IN
cord-023095-4dannjjm	2964	5	complete	complete	JJ
cord-023095-4dannjjm	2964	6	blood	blood	NN
cord-023095-4dannjjm	2964	7	counts	count	NNS
cord-023095-4dannjjm	2964	8	performed	perform	VBN
cord-023095-4dannjjm	2964	9	on	on	IN
cord-023095-4dannjjm	2964	10	blood	blood	NN
cord-023095-4dannjjm	2964	11	taken	take	VBN
cord-023095-4dannjjm	2964	12	under	under	IN
cord-023095-4dannjjm	2964	13	general	general	JJ
cord-023095-4dannjjm	2964	14	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2964	15	with	with	IN
cord-023095-4dannjjm	2964	16	this	this	DT
cord-023095-4dannjjm	2964	17	combination	combination	NN
cord-023095-4dannjjm	2964	18	of	of	IN
cord-023095-4dannjjm	2964	19	anesthetic	anesthetic	JJ
cord-023095-4dannjjm	2964	20	drugs	drug	NNS
cord-023095-4dannjjm	2964	21	in	in	IN
cord-023095-4dannjjm	2964	22	cats	cat	NNS
cord-023095-4dannjjm	2964	23	should	should	MD
cord-023095-4dannjjm	2964	24	be	be	VB
cord-023095-4dannjjm	2964	25	interpreted	interpret	VBN
cord-023095-4dannjjm	2964	26	cautiously	cautiously	RB
cord-023095-4dannjjm	2964	27	in	in	IN
cord-023095-4dannjjm	2964	28	order	order	NN
cord-023095-4dannjjm	2964	29	not	not	RB
cord-023095-4dannjjm	2964	30	to	to	TO
cord-023095-4dannjjm	2964	31	make	make	VB
cord-023095-4dannjjm	2964	32	a	a	DT
cord-023095-4dannjjm	2964	33	false	false	JJ
cord-023095-4dannjjm	2964	34	diagnosis	diagnosis	NN
cord-023095-4dannjjm	2964	35	of	of	IN
cord-023095-4dannjjm	2964	36	anemia	anemia	NN
cord-023095-4dannjjm	2964	37	.	.	.
cord-023095-4dannjjm	2965	1	The	the	DT
cord-023095-4dannjjm	2965	2	mechanism	mechanism	NN
cord-023095-4dannjjm	2965	3	responsible	responsible	JJ
cord-023095-4dannjjm	2965	4	for	for	IN
cord-023095-4dannjjm	2965	5	the	the	DT
cord-023095-4dannjjm	2965	6	decrease	decrease	NN
cord-023095-4dannjjm	2965	7	in	in	IN
cord-023095-4dannjjm	2965	8	circulating	circulate	VBG
cord-023095-4dannjjm	2965	9	red	red	JJ
cord-023095-4dannjjm	2965	10	blood	blood	NN
cord-023095-4dannjjm	2965	11	cell	cell	NN
cord-023095-4dannjjm	2965	12	mass	mass	NN
cord-023095-4dannjjm	2965	13	following	follow	VBG
cord-023095-4dannjjm	2965	14	anesthesia	anesthesia	NN
cord-023095-4dannjjm	2965	15	induction	induction	NN
cord-023095-4dannjjm	2965	16	in	in	IN
cord-023095-4dannjjm	2965	17	cats	cat	NNS
cord-023095-4dannjjm	2965	18	is	be	VBZ
cord-023095-4dannjjm	2965	19	unknown	unknown	JJ
cord-023095-4dannjjm	2965	20	and	and	CC
cord-023095-4dannjjm	2965	21	requires	require	VBZ
cord-023095-4dannjjm	2965	22	further	further	JJ
cord-023095-4dannjjm	2965	23	investigation	investigation	NN
cord-023095-4dannjjm	2965	24	.	.	.
cord-023095-4dannjjm	2966	1	Rivaroxaban	Rivaroxaban	NNP
cord-023095-4dannjjm	2966	2	is	be	VBZ
cord-023095-4dannjjm	2966	3	an	an	DT
cord-023095-4dannjjm	2966	4	oral	oral	JJ
cord-023095-4dannjjm	2966	5	inhibitor	inhibitor	NN
cord-023095-4dannjjm	2966	6	of	of	IN
cord-023095-4dannjjm	2966	7	activated	activate	VBN
cord-023095-4dannjjm	2966	8	coagulation	coagulation	NN
cord-023095-4dannjjm	2966	9	factor	factor	NN
cord-023095-4dannjjm	2966	10	X	X	NNP
cord-023095-4dannjjm	2966	11	(	(	-LRB-
cord-023095-4dannjjm	2966	12	Xa	Xa	NNP
cord-023095-4dannjjm	2966	13	)	)	-RRB-
cord-023095-4dannjjm	2966	14	.	.	.
cord-023095-4dannjjm	2967	1	It	-PRON-	PRP
cord-023095-4dannjjm	2967	2	is	be	VBZ
cord-023095-4dannjjm	2967	3	expected	expect	VBN
cord-023095-4dannjjm	2967	4	to	to	TO
cord-023095-4dannjjm	2967	5	have	have	VB
cord-023095-4dannjjm	2967	6	similar	similar	JJ
cord-023095-4dannjjm	2967	7	coagulation	coagulation	NN
cord-023095-4dannjjm	2967	8	effects	effect	NNS
cord-023095-4dannjjm	2967	9	as	as	IN
cord-023095-4dannjjm	2967	10	low	low	JJ
cord-023095-4dannjjm	2967	11	molecular	molecular	JJ
cord-023095-4dannjjm	2967	12	weight	weight	NN
cord-023095-4dannjjm	2967	13	heparin	heparin	NN
cord-023095-4dannjjm	2967	14	,	,	,
cord-023095-4dannjjm	2967	15	without	without	IN
cord-023095-4dannjjm	2967	16	the	the	DT
cord-023095-4dannjjm	2967	17	need	need	NN
cord-023095-4dannjjm	2967	18	for	for	IN
cord-023095-4dannjjm	2967	19	injection	injection	NN
cord-023095-4dannjjm	2967	20	,	,	,
cord-023095-4dannjjm	2967	21	making	make	VBG
cord-023095-4dannjjm	2967	22	it	-PRON-	PRP
cord-023095-4dannjjm	2967	23	an	an	DT
cord-023095-4dannjjm	2967	24	attractive	attractive	JJ
cord-023095-4dannjjm	2967	25	alternative	alternative	NN
cord-023095-4dannjjm	2967	26	for	for	IN
cord-023095-4dannjjm	2967	27	long	long	JJ
cord-023095-4dannjjm	2967	28	-	-	HYPH
cord-023095-4dannjjm	2967	29	term	term	NN
cord-023095-4dannjjm	2967	30	anticoagulant	anticoagulant	JJ
cord-023095-4dannjjm	2967	31	therapy	therapy	NN
cord-023095-4dannjjm	2967	32	in	in	IN
cord-023095-4dannjjm	2967	33	cats	cat	NNS
cord-023095-4dannjjm	2967	34	.	.	.
cord-023095-4dannjjm	2968	1	Citrated	citrate	VBN
cord-023095-4dannjjm	2968	2	blood	blood	NN
cord-023095-4dannjjm	2968	3	obtained	obtain	VBD
cord-023095-4dannjjm	2968	4	from	from	IN
cord-023095-4dannjjm	2968	5	five	five	CD
cord-023095-4dannjjm	2968	6	healthy	healthy	JJ
cord-023095-4dannjjm	2968	7	adult	adult	NN
cord-023095-4dannjjm	2968	8	cats	cat	NNS
cord-023095-4dannjjm	2968	9	was	be	VBD
cord-023095-4dannjjm	2968	10	exposed	expose	VBN
cord-023095-4dannjjm	2968	11	in	in	IN
cord-023095-4dannjjm	2968	12	vitro	vitro	FW
cord-023095-4dannjjm	2968	13	to	to	IN
cord-023095-4dannjjm	2968	14	varying	vary	VBG
cord-023095-4dannjjm	2968	15	concentrations	concentration	NNS
cord-023095-4dannjjm	2968	16	of	of	IN
cord-023095-4dannjjm	2968	17	rivaroxaban	rivaroxaban	NNP
cord-023095-4dannjjm	2968	18	,	,	,
cord-023095-4dannjjm	2968	19	followed	follow	VBN
cord-023095-4dannjjm	2968	20	by	by	IN
cord-023095-4dannjjm	2968	21	coagulation	coagulation	NN
cord-023095-4dannjjm	2968	22	testing	testing	NN
cord-023095-4dannjjm	2968	23	.	.	.
cord-023095-4dannjjm	2969	1	The	the	DT
cord-023095-4dannjjm	2969	2	rivaroxaban	rivaroxaban	NN
cord-023095-4dannjjm	2969	3	was	be	VBD
cord-023095-4dannjjm	2969	4	extracted	extract	VBN
cord-023095-4dannjjm	2969	5	from	from	IN
cord-023095-4dannjjm	2969	6	commercially	commercially	RB
cord-023095-4dannjjm	2969	7	available	available	JJ
cord-023095-4dannjjm	2969	8	tablets	tablet	NNS
cord-023095-4dannjjm	2969	9	(	(	-LRB-
cord-023095-4dannjjm	2969	10	Xarelto	Xarelto	NNP
cord-023095-4dannjjm	2969	11	s	s	NNP
cord-023095-4dannjjm	2969	12	)	)	-RRB-
cord-023095-4dannjjm	2969	13	and	and	CC
cord-023095-4dannjjm	2969	14	dissolved	dissolve	VBD
cord-023095-4dannjjm	2969	15	in	in	IN
cord-023095-4dannjjm	2969	16	DMSO	DMSO	NNP
cord-023095-4dannjjm	2969	17	prior	prior	RB
cord-023095-4dannjjm	2969	18	to	to	IN
cord-023095-4dannjjm	2969	19	addition	addition	NN
cord-023095-4dannjjm	2969	20	to	to	IN
cord-023095-4dannjjm	2969	21	the	the	DT
cord-023095-4dannjjm	2969	22	blood	blood	NN
cord-023095-4dannjjm	2969	23	.	.	.
cord-023095-4dannjjm	2970	1	Tests	test	NNS
cord-023095-4dannjjm	2970	2	performed	perform	VBD
cord-023095-4dannjjm	2970	3	included	include	VBD
cord-023095-4dannjjm	2970	4	kaolin	kaolin	NN
cord-023095-4dannjjm	2970	5	-	-	HYPH
cord-023095-4dannjjm	2970	6	activated	activate	VBN
cord-023095-4dannjjm	2970	7	thrombelastography	thrombelastography	NN
cord-023095-4dannjjm	2970	8	(	(	-LRB-
cord-023095-4dannjjm	2970	9	TEG	TEG	NNP
cord-023095-4dannjjm	2970	10	)	)	-RRB-
cord-023095-4dannjjm	2970	11	,	,	,
cord-023095-4dannjjm	2970	12	prothrombin	prothrombin	JJ
cord-023095-4dannjjm	2970	13	time	time	NN
cord-023095-4dannjjm	2970	14	(	(	-LRB-
cord-023095-4dannjjm	2970	15	PT	PT	NNP
cord-023095-4dannjjm	2970	16	)	)	-RRB-
cord-023095-4dannjjm	2970	17	,	,	,
cord-023095-4dannjjm	2970	18	dilute	dilute	VB
cord-023095-4dannjjm	2970	19	PT	PT	NNP
cord-023095-4dannjjm	2970	20	(	(	-LRB-
cord-023095-4dannjjm	2970	21	dPT	dPT	NNP
cord-023095-4dannjjm	2970	22	)	)	-RRB-
cord-023095-4dannjjm	2970	23	,	,	,
cord-023095-4dannjjm	2970	24	activated	activate	VBD
cord-023095-4dannjjm	2970	25	partial	partial	JJ
cord-023095-4dannjjm	2970	26	thromboplastin	thromboplastin	NNP
cord-023095-4dannjjm	2970	27	time	time	NN
cord-023095-4dannjjm	2970	28	(	(	-LRB-
cord-023095-4dannjjm	2970	29	aPTT	aPTT	NNP
cord-023095-4dannjjm	2970	30	)	)	-RRB-
cord-023095-4dannjjm	2970	31	,	,	,
cord-023095-4dannjjm	2970	32	and	and	CC
cord-023095-4dannjjm	2970	33	anti	anti	JJ
cord-023095-4dannjjm	2970	34	-	-	NN
cord-023095-4dannjjm	2970	35	factor	factor	NN
cord-023095-4dannjjm	2970	36	Xa	Xa	NNP
cord-023095-4dannjjm	2970	37	(	(	-LRB-
cord-023095-4dannjjm	2970	38	aXa	aXa	NNP
cord-023095-4dannjjm	2970	39	)	)	-RRB-
cord-023095-4dannjjm	2970	40	activity	activity	NN
cord-023095-4dannjjm	2970	41	.	.	.
cord-023095-4dannjjm	2971	1	Dose	dose	JJ
cord-023095-4dannjjm	2971	2	-	-	HYPH
cord-023095-4dannjjm	2971	3	dependent	dependent	JJ
cord-023095-4dannjjm	2971	4	prolongations	prolongation	NNS
cord-023095-4dannjjm	2971	5	were	be	VBD
cord-023095-4dannjjm	2971	6	seen	see	VBN
cord-023095-4dannjjm	2971	7	in	in	IN
cord-023095-4dannjjm	2971	8	all	all	DT
cord-023095-4dannjjm	2971	9	coagulation	coagulation	NN
cord-023095-4dannjjm	2971	10	parameters	parameter	NNS
cord-023095-4dannjjm	2971	11	.	.	.
cord-023095-4dannjjm	2972	1	Similar	similar	JJ
cord-023095-4dannjjm	2972	2	to	to	IN
cord-023095-4dannjjm	2972	3	human	human	JJ
cord-023095-4dannjjm	2972	4	data	datum	NNS
cord-023095-4dannjjm	2972	5	,	,	,
cord-023095-4dannjjm	2972	6	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	2972	7	aXa	aXa	NNP
cord-023095-4dannjjm	2972	8	levels	level	NNS
cord-023095-4dannjjm	2972	9	(	(	-LRB-
cord-023095-4dannjjm	2972	10	between	between	IN
cord-023095-4dannjjm	2972	11	0.5	0.5	CD
cord-023095-4dannjjm	2972	12	-	-	SYM
cord-023095-4dannjjm	2972	13	1.0	1.0	CD
cord-023095-4dannjjm	2972	14	aXa	aXa	NNP
cord-023095-4dannjjm	2972	15	units	unit	NNS
cord-023095-4dannjjm	2972	16	)	)	-RRB-
cord-023095-4dannjjm	2972	17	were	be	VBD
cord-023095-4dannjjm	2972	18	achieved	achieve	VBN
cord-023095-4dannjjm	2972	19	at	at	IN
cord-023095-4dannjjm	2972	20	in	in	FW
cord-023095-4dannjjm	2972	21	vitro	vitro	FW
cord-023095-4dannjjm	2972	22	concentrations	concentration	NNS
cord-023095-4dannjjm	2972	23	between	between	IN
cord-023095-4dannjjm	2972	24	160	160	CD
cord-023095-4dannjjm	2972	25	and	and	CC
cord-023095-4dannjjm	2972	26	220	220	CD
cord-023095-4dannjjm	2972	27	mg	mg	NNP
cord-023095-4dannjjm	2972	28	/	/	SYM
cord-023095-4dannjjm	2972	29	L.	L.	NNP
cord-023095-4dannjjm	2973	1	At	at	IN
cord-023095-4dannjjm	2973	2	220	220	CD
cord-023095-4dannjjm	2973	3	mg	mg	NNP
cord-023095-4dannjjm	2973	4	/	/	SYM
cord-023095-4dannjjm	2973	5	L	L	NNP
cord-023095-4dannjjm	2973	6	,	,	,
cord-023095-4dannjjm	2973	7	dPT	dpt	JJ
cord-023095-4dannjjm	2973	8	measurements	measurement	NNS
cord-023095-4dannjjm	2973	9	were	be	VBD
cord-023095-4dannjjm	2973	10	clinically	clinically	RB
cord-023095-4dannjjm	2973	11	prolonged	prolong	VBN
cord-023095-4dannjjm	2973	12	in	in	IN
cord-023095-4dannjjm	2973	13	all	all	DT
cord-023095-4dannjjm	2973	14	cats	cat	NNS
cord-023095-4dannjjm	2973	15	(	(	-LRB-
cord-023095-4dannjjm	2973	16	29.2	29.2	CD
cord-023095-4dannjjm	2973	17	AE	AE	NNP
cord-023095-4dannjjm	2973	18	4	4	CD
cord-023095-4dannjjm	2973	19	sec	sec	NNP
cord-023095-4dannjjm	2973	20	vs.	vs.	NNP
cord-023095-4dannjjm	2973	21	18.5	18.5	CD
cord-023095-4dannjjm	2973	22	AE	AE	NNP
cord-023095-4dannjjm	2973	23	0.8	0.8	CD
cord-023095-4dannjjm	2973	24	sec	sec	NNP
cord-023095-4dannjjm	2973	25	,	,	,
cord-023095-4dannjjm	2973	26	P	p	NN
cord-023095-4dannjjm	2973	27	5	5	CD
cord-023095-4dannjjm	2973	28	0.148	0.148	CD
cord-023095-4dannjjm	2973	29	)	)	-RRB-
cord-023095-4dannjjm	2973	30	,	,	,
cord-023095-4dannjjm	2973	31	while	while	IN
cord-023095-4dannjjm	2973	32	aPTT	aptt	JJ
cord-023095-4dannjjm	2973	33	values	value	NNS
cord-023095-4dannjjm	2973	34	were	be	VBD
cord-023095-4dannjjm	2973	35	only	only	RB
cord-023095-4dannjjm	2973	36	mildly	mildly	RB
cord-023095-4dannjjm	2973	37	prolonged	prolong	VBN
cord-023095-4dannjjm	2973	38	from	from	IN
cord-023095-4dannjjm	2973	39	baseline	baseline	JJ
cord-023095-4dannjjm	2973	40	(	(	-LRB-
cord-023095-4dannjjm	2973	41	21.9	21.9	CD
cord-023095-4dannjjm	2973	42	AE	AE	NNP
cord-023095-4dannjjm	2973	43	5	5	CD
cord-023095-4dannjjm	2973	44	sec	sec	NNP
cord-023095-4dannjjm	2973	45	vs.	vs.	NNP
cord-023095-4dannjjm	2973	46	15.6	15.6	CD
cord-023095-4dannjjm	2973	47	AE	AE	NNP
cord-023095-4dannjjm	2973	48	2	2	CD
cord-023095-4dannjjm	2973	49	sec	sec	NNP
cord-023095-4dannjjm	2973	50	,	,	,
cord-023095-4dannjjm	2973	51	P	p	NN
cord-023095-4dannjjm	2973	52	5	5	CD
cord-023095-4dannjjm	2973	53	0.07	0.07	CD
cord-023095-4dannjjm	2973	54	)	)	-RRB-
cord-023095-4dannjjm	2973	55	.	.	.
cord-023095-4dannjjm	2974	1	Significant	significant	JJ
cord-023095-4dannjjm	2974	2	prolongations	prolongation	NNS
cord-023095-4dannjjm	2974	3	were	be	VBD
cord-023095-4dannjjm	2974	4	seen	see	VBN
cord-023095-4dannjjm	2974	5	in	in	IN
cord-023095-4dannjjm	2974	6	dPT	dPT	NNP
cord-023095-4dannjjm	2974	7	at	at	IN
cord-023095-4dannjjm	2974	8	500	500	CD
cord-023095-4dannjjm	2974	9	(	(	-LRB-
cord-023095-4dannjjm	2974	10	60.4	60.4	CD
cord-023095-4dannjjm	2974	11	AE	AE	NNP
cord-023095-4dannjjm	2974	12	42	42	CD
cord-023095-4dannjjm	2974	13	ec	ec	NNP
cord-023095-4dannjjm	2974	14	,	,	,
cord-023095-4dannjjm	2974	15	P	p	NN
cord-023095-4dannjjm	2974	16	5	5	CD
cord-023095-4dannjjm	2974	17	0.005	0.005	CD
cord-023095-4dannjjm	2974	18	)	)	-RRB-
cord-023095-4dannjjm	2974	19	.	.	.
cord-023095-4dannjjm	2975	1	TEG	TEG	NNP
cord-023095-4dannjjm	2975	2	R	R	NNP
cord-023095-4dannjjm	2975	3	time	time	NN
cord-023095-4dannjjm	2975	4	did	do	VBD
cord-023095-4dannjjm	2975	5	not	not	RB
cord-023095-4dannjjm	2975	6	prolong	prolong	VB
cord-023095-4dannjjm	2975	7	from	from	IN
cord-023095-4dannjjm	2975	8	baseline	baseline	JJ
cord-023095-4dannjjm	2975	9	values	value	NNS
cord-023095-4dannjjm	2975	10	until	until	IN
cord-023095-4dannjjm	2975	11	concentrations	concentration	NNS
cord-023095-4dannjjm	2975	12	of	of	IN
cord-023095-4dannjjm	2975	13	2000	2000	CD
cord-023095-4dannjjm	2975	14	mg	mg	NNP
cord-023095-4dannjjm	2975	15	/	/	SYM
cord-023095-4dannjjm	2975	16	L	L	NNP
cord-023095-4dannjjm	2975	17	were	be	VBD
cord-023095-4dannjjm	2975	18	reached	reach	VBN
cord-023095-4dannjjm	2975	19	(	(	-LRB-
cord-023095-4dannjjm	2975	20	16.0	16.0	CD
cord-023095-4dannjjm	2975	21	AE	AE	NNP
cord-023095-4dannjjm	2975	22	9	9	CD
cord-023095-4dannjjm	2975	23	min	min	NN
cord-023095-4dannjjm	2975	24	compared	compare	VBN
cord-023095-4dannjjm	2975	25	to	to	IN
cord-023095-4dannjjm	2975	26	3.1	3.1	CD
cord-023095-4dannjjm	2975	27	AE	AE	NNP
cord-023095-4dannjjm	2975	28	0.7	0.7	CD
cord-023095-4dannjjm	2975	29	min	min	NN
cord-023095-4dannjjm	2975	30	,	,	,
cord-023095-4dannjjm	2975	31	P	p	NN
cord-023095-4dannjjm	2975	32	5	5	CD
cord-023095-4dannjjm	2975	33	0.006	0.006	CD
cord-023095-4dannjjm	2975	34	)	)	-RRB-
cord-023095-4dannjjm	2975	35	.	.	.
cord-023095-4dannjjm	2976	1	Rivaroxaban	Rivaroxaban	NNP
cord-023095-4dannjjm	2976	2	has	have	VBZ
cord-023095-4dannjjm	2976	3	similar	similar	JJ
cord-023095-4dannjjm	2976	4	coagulation	coagulation	NN
cord-023095-4dannjjm	2976	5	effects	effect	NNS
cord-023095-4dannjjm	2976	6	in	in	IN
cord-023095-4dannjjm	2976	7	the	the	DT
cord-023095-4dannjjm	2976	8	cat	cat	NN
cord-023095-4dannjjm	2976	9	as	as	IN
cord-023095-4dannjjm	2976	10	in	in	IN
cord-023095-4dannjjm	2976	11	other	other	JJ
cord-023095-4dannjjm	2976	12	species	specie	NNS
cord-023095-4dannjjm	2976	13	and	and	CC
cord-023095-4dannjjm	2976	14	may	may	MD
cord-023095-4dannjjm	2976	15	play	play	VB
cord-023095-4dannjjm	2976	16	a	a	DT
cord-023095-4dannjjm	2976	17	role	role	NN
cord-023095-4dannjjm	2976	18	in	in	IN
cord-023095-4dannjjm	2976	19	feline	feline	JJ
cord-023095-4dannjjm	2976	20	thromboprophylaxis	thromboprophylaxis	NN
cord-023095-4dannjjm	2976	21	.	.	.
cord-023095-4dannjjm	2977	1	Kaolinactivated	Kaolinactivated	NNP
cord-023095-4dannjjm	2977	2	TEG	TEG	NNP
cord-023095-4dannjjm	2977	3	does	do	VBZ
cord-023095-4dannjjm	2977	4	not	not	RB
cord-023095-4dannjjm	2977	5	appear	appear	VB
cord-023095-4dannjjm	2977	6	to	to	TO
cord-023095-4dannjjm	2977	7	be	be	VB
cord-023095-4dannjjm	2977	8	sensitive	sensitive	JJ
cord-023095-4dannjjm	2977	9	to	to	IN
cord-023095-4dannjjm	2977	10	low	low	JJ
cord-023095-4dannjjm	2977	11	concentrations	concentration	NNS
cord-023095-4dannjjm	2977	12	of	of	IN
cord-023095-4dannjjm	2977	13	rivaroxaban	rivaroxaban	NNP
cord-023095-4dannjjm	2977	14	in	in	IN
cord-023095-4dannjjm	2977	15	the	the	DT
cord-023095-4dannjjm	2977	16	cat	cat	NN
cord-023095-4dannjjm	2977	17	.	.	.
cord-023095-4dannjjm	2978	1	Anticoagulated	anticoagulated	JJ
cord-023095-4dannjjm	2978	2	blood	blood	NN
cord-023095-4dannjjm	2978	3	is	be	VBZ
cord-023095-4dannjjm	2978	4	required	require	VBN
cord-023095-4dannjjm	2978	5	for	for	IN
cord-023095-4dannjjm	2978	6	platelet	platelet	NN
cord-023095-4dannjjm	2978	7	function	function	NN
cord-023095-4dannjjm	2978	8	studies	study	NNS
cord-023095-4dannjjm	2978	9	.	.	.
cord-023095-4dannjjm	2979	1	Sodium	sodium	NN
cord-023095-4dannjjm	2979	2	citrate	citrate	NN
cord-023095-4dannjjm	2979	3	,	,	,
cord-023095-4dannjjm	2979	4	a	a	DT
cord-023095-4dannjjm	2979	5	calcium	calcium	NN
cord-023095-4dannjjm	2979	6	chelater	chelater	NN
cord-023095-4dannjjm	2979	7	,	,	,
cord-023095-4dannjjm	2979	8	is	be	VBZ
cord-023095-4dannjjm	2979	9	the	the	DT
cord-023095-4dannjjm	2979	10	most	most	RBS
cord-023095-4dannjjm	2979	11	commonly	commonly	RB
cord-023095-4dannjjm	2979	12	used	use	VBN
cord-023095-4dannjjm	2979	13	anticoagulant	anticoagulant	NN
cord-023095-4dannjjm	2979	14	to	to	TO
cord-023095-4dannjjm	2979	15	measure	measure	VB
cord-023095-4dannjjm	2979	16	coagulation	coagulation	NN
cord-023095-4dannjjm	2979	17	parameters	parameter	NNS
cord-023095-4dannjjm	2979	18	including	include	VBG
cord-023095-4dannjjm	2979	19	platelet	platelet	NN
cord-023095-4dannjjm	2979	20	aggregation	aggregation	NN
cord-023095-4dannjjm	2979	21	but	but	CC
cord-023095-4dannjjm	2979	22	it	-PRON-	PRP
cord-023095-4dannjjm	2979	23	may	may	MD
cord-023095-4dannjjm	2979	24	have	have	VB
cord-023095-4dannjjm	2979	25	a	a	DT
cord-023095-4dannjjm	2979	26	negative	negative	JJ
cord-023095-4dannjjm	2979	27	effect	effect	NN
cord-023095-4dannjjm	2979	28	on	on	IN
cord-023095-4dannjjm	2979	29	platelet	platelet	NN
cord-023095-4dannjjm	2979	30	responsiveness	responsiveness	NN
cord-023095-4dannjjm	2979	31	.	.	.
cord-023095-4dannjjm	2980	1	Dogs	dog	NNS
cord-023095-4dannjjm	2980	2	are	be	VBP
cord-023095-4dannjjm	2980	3	generally	generally	RB
cord-023095-4dannjjm	2980	4	considered	consider	VBN
cord-023095-4dannjjm	2980	5	moderate	moderate	JJ
cord-023095-4dannjjm	2980	6	responders	responder	NNS
cord-023095-4dannjjm	2980	7	to	to	IN
cord-023095-4dannjjm	2980	8	collagen	collagen	NN
cord-023095-4dannjjm	2980	9	on	on	IN
cord-023095-4dannjjm	2980	10	platelet	platelet	NN
cord-023095-4dannjjm	2980	11	aggregation	aggregation	NN
cord-023095-4dannjjm	2980	12	and	and	CC
cord-023095-4dannjjm	2980	13	are	be	VBP
cord-023095-4dannjjm	2980	14	notorious	notorious	JJ
cord-023095-4dannjjm	2980	15	for	for	IN
cord-023095-4dannjjm	2980	16	being	be	VBG
cord-023095-4dannjjm	2980	17	poor	poor	JJ
cord-023095-4dannjjm	2980	18	or	or	CC
cord-023095-4dannjjm	2980	19	inconsistent	inconsistent	JJ
cord-023095-4dannjjm	2980	20	responders	responder	NNS
cord-023095-4dannjjm	2980	21	to	to	IN
cord-023095-4dannjjm	2980	22	ADP	ADP	NNP
cord-023095-4dannjjm	2980	23	-	-	HYPH
cord-023095-4dannjjm	2980	24	induced	induce	VBN
cord-023095-4dannjjm	2980	25	platelet	platelet	NN
cord-023095-4dannjjm	2980	26	aggregation	aggregation	NN
cord-023095-4dannjjm	2980	27	using	use	VBG
cord-023095-4dannjjm	2980	28	citrated	citrate	VBN
cord-023095-4dannjjm	2980	29	whole	whole	JJ
cord-023095-4dannjjm	2980	30	blood	blood	NN
cord-023095-4dannjjm	2980	31	.	.	.
cord-023095-4dannjjm	2981	1	Hirudin	Hirudin	NNP
cord-023095-4dannjjm	2981	2	,	,	,
cord-023095-4dannjjm	2981	3	a	a	DT
cord-023095-4dannjjm	2981	4	selective	selective	JJ
cord-023095-4dannjjm	2981	5	thrombin	thrombin	JJ
cord-023095-4dannjjm	2981	6	inhibitor	inhibitor	NN
cord-023095-4dannjjm	2981	7	,	,	,
cord-023095-4dannjjm	2981	8	can	can	MD
cord-023095-4dannjjm	2981	9	also	also	RB
cord-023095-4dannjjm	2981	10	be	be	VB
cord-023095-4dannjjm	2981	11	used	use	VBN
cord-023095-4dannjjm	2981	12	as	as	IN
cord-023095-4dannjjm	2981	13	an	an	DT
cord-023095-4dannjjm	2981	14	anticoagulant	anticoagulant	NN
cord-023095-4dannjjm	2981	15	for	for	IN
cord-023095-4dannjjm	2981	16	coagulation	coagulation	NN
cord-023095-4dannjjm	2981	17	assays	assay	NNS
cord-023095-4dannjjm	2981	18	and	and	CC
cord-023095-4dannjjm	2981	19	is	be	VBZ
cord-023095-4dannjjm	2981	20	the	the	DT
cord-023095-4dannjjm	2981	21	anticoagulant	anticoagulant	NN
cord-023095-4dannjjm	2981	22	of	of	IN
cord-023095-4dannjjm	2981	23	choice	choice	NN
cord-023095-4dannjjm	2981	24	for	for	IN
cord-023095-4dannjjm	2981	25	certain	certain	JJ
cord-023095-4dannjjm	2981	26	assays	assay	NNS
cord-023095-4dannjjm	2981	27	including	include	VBG
cord-023095-4dannjjm	2981	28	the	the	DT
cord-023095-4dannjjm	2981	29	Multiplate	Multiplate	NNP
cord-023095-4dannjjm	2981	30	s	s	POS
cord-023095-4dannjjm	2981	31	platelet	platelet	NN
cord-023095-4dannjjm	2981	32	function	function	NN
cord-023095-4dannjjm	2981	33	analyzer	analyzer	NN
cord-023095-4dannjjm	2981	34	.	.	.
cord-023095-4dannjjm	2982	1	Ten	ten	CD
cord-023095-4dannjjm	2982	2	adult	adult	NN
cord-023095-4dannjjm	2982	3	healthy	healthy	JJ
cord-023095-4dannjjm	2982	4	dogs	dog	NNS
cord-023095-4dannjjm	2982	5	were	be	VBD
cord-023095-4dannjjm	2982	6	used	use	VBN
cord-023095-4dannjjm	2982	7	to	to	TO
cord-023095-4dannjjm	2982	8	compare	compare	VB
cord-023095-4dannjjm	2982	9	whole	whole	JJ
cord-023095-4dannjjm	2982	10	blood	blood	NN
cord-023095-4dannjjm	2982	11	platelet	platelet	NN
cord-023095-4dannjjm	2982	12	aggregation	aggregation	NN
cord-023095-4dannjjm	2982	13	between	between	IN
cord-023095-4dannjjm	2982	14	citrated	citrated	JJ
cord-023095-4dannjjm	2982	15	and	and	CC
cord-023095-4dannjjm	2982	16	hirudinated	hirudinated	JJ
cord-023095-4dannjjm	2982	17	blood	blood	NN
cord-023095-4dannjjm	2982	18	samples	sample	NNS
cord-023095-4dannjjm	2982	19	.	.	.
cord-023095-4dannjjm	2983	1	Venous	venous	JJ
cord-023095-4dannjjm	2983	2	blood	blood	NN
cord-023095-4dannjjm	2983	3	was	be	VBD
cord-023095-4dannjjm	2983	4	collected	collect	VBN
cord-023095-4dannjjm	2983	5	atraumatically	atraumatically	RB
cord-023095-4dannjjm	2983	6	from	from	IN
cord-023095-4dannjjm	2983	7	the	the	DT
cord-023095-4dannjjm	2983	8	external	external	JJ
cord-023095-4dannjjm	2983	9	jugular	jugular	NN
cord-023095-4dannjjm	2983	10	vein	vein	NN
cord-023095-4dannjjm	2983	11	directly	directly	RB
cord-023095-4dannjjm	2983	12	into	into	IN
cord-023095-4dannjjm	2983	13	tubes	tube	NNS
cord-023095-4dannjjm	2983	14	containing	contain	VBG
cord-023095-4dannjjm	2983	15	3.2	3.2	CD
cord-023095-4dannjjm	2983	16	%	%	NN
cord-023095-4dannjjm	2983	17	trisodium	trisodium	NN
cord-023095-4dannjjm	2983	18	citrate	citrate	NN
cord-023095-4dannjjm	2983	19	or	or	CC
cord-023095-4dannjjm	2983	20	hirudin	hirudin	NN
cord-023095-4dannjjm	2983	21	.	.	.
cord-023095-4dannjjm	2984	1	Whole	whole	JJ
cord-023095-4dannjjm	2984	2	blood	blood	NN
cord-023095-4dannjjm	2984	3	platelet	platelet	NN
cord-023095-4dannjjm	2984	4	aggregation	aggregation	NN
cord-023095-4dannjjm	2984	5	was	be	VBD
cord-023095-4dannjjm	2984	6	performed	perform	VBN
cord-023095-4dannjjm	2985	1	(	(	-LRB-
cord-023095-4dannjjm	2985	2	Whole	whole	JJ
cord-023095-4dannjjm	2985	3	-	-	HYPH
cord-023095-4dannjjm	2985	4	Blood	blood	NN
cord-023095-4dannjjm	2985	5	Lumi	Lumi	NNP
cord-023095-4dannjjm	2985	6	-	-	HYPH
cord-023095-4dannjjm	2985	7	aggregometer	aggregometer	NN
cord-023095-4dannjjm	2985	8	,	,	,
cord-023095-4dannjjm	2985	9	Chrono	chrono	NN
cord-023095-4dannjjm	2985	10	-	-	HYPH
cord-023095-4dannjjm	2985	11	log	log	NNP
cord-023095-4dannjjm	2985	12	Corporation	Corporation	NNP
cord-023095-4dannjjm	2985	13	,	,	,
cord-023095-4dannjjm	2985	14	Havertown	Havertown	NNP
cord-023095-4dannjjm	2985	15	,	,	,
cord-023095-4dannjjm	2985	16	PA	PA	NNP
cord-023095-4dannjjm	2985	17	,	,	,
cord-023095-4dannjjm	2985	18	USA	USA	NNP
cord-023095-4dannjjm	2985	19	)	)	-RRB-
cord-023095-4dannjjm	2985	20	with	with	IN
cord-023095-4dannjjm	2985	21	collagen	collagen	NN
cord-023095-4dannjjm	2985	22	(	(	-LRB-
cord-023095-4dannjjm	2985	23	5	5	CD
cord-023095-4dannjjm	2985	24	mg	mg	NNP
cord-023095-4dannjjm	2985	25	/	/	SYM
cord-023095-4dannjjm	2985	26	ml	ml	NNP
cord-023095-4dannjjm	2985	27	)	)	-RRB-
cord-023095-4dannjjm	2985	28	and	and	CC
cord-023095-4dannjjm	2985	29	ADP	ADP	NNP
cord-023095-4dannjjm	2985	30	(	(	-LRB-
cord-023095-4dannjjm	2985	31	10	10	CD
cord-023095-4dannjjm	2985	32	mM	mm	CD
cord-023095-4dannjjm	2985	33	)	)	-RRB-
cord-023095-4dannjjm	2985	34	as	as	IN
cord-023095-4dannjjm	2985	35	agonists	agonist	NNS
cord-023095-4dannjjm	2985	36	.	.	.
cord-023095-4dannjjm	2986	1	Maximal	maximal	JJ
cord-023095-4dannjjm	2986	2	platelet	platelet	NN
cord-023095-4dannjjm	2986	3	aggregation	aggregation	NN
cord-023095-4dannjjm	2986	4	(	(	-LRB-
cord-023095-4dannjjm	2986	5	Ohms	Ohms	NNP
cord-023095-4dannjjm	2986	6	)	)	-RRB-
cord-023095-4dannjjm	2986	7	was	be	VBD
cord-023095-4dannjjm	2986	8	recorded	record	VBN
cord-023095-4dannjjm	2986	9	.	.	.
cord-023095-4dannjjm	2987	1	There	there	EX
cord-023095-4dannjjm	2987	2	was	be	VBD
cord-023095-4dannjjm	2987	3	a	a	DT
cord-023095-4dannjjm	2987	4	significant	significant	JJ
cord-023095-4dannjjm	2987	5	increase	increase	NN
cord-023095-4dannjjm	2987	6	in	in	IN
cord-023095-4dannjjm	2987	7	collagen	collagen	NN
cord-023095-4dannjjm	2987	8	-	-	HYPH
cord-023095-4dannjjm	2987	9	induced	induce	VBN
cord-023095-4dannjjm	2987	10	platelet	platelet	NN
cord-023095-4dannjjm	2987	11	aggregation	aggregation	NN
cord-023095-4dannjjm	2987	12	from	from	IN
cord-023095-4dannjjm	2987	13	the	the	DT
cord-023095-4dannjjm	2987	14	hirudinated	hirudinate	VBN
cord-023095-4dannjjm	2987	15	samples	sample	NNS
cord-023095-4dannjjm	2987	16	compared	compare	VBN
cord-023095-4dannjjm	2987	17	to	to	IN
cord-023095-4dannjjm	2987	18	the	the	DT
cord-023095-4dannjjm	2987	19	citrated	citrate	VBN
cord-023095-4dannjjm	2987	20	samples	sample	NNS
cord-023095-4dannjjm	2987	21	(	(	-LRB-
cord-023095-4dannjjm	2987	22	31.2	31.2	CD
cord-023095-4dannjjm	2987	23	AE	AE	NNP
cord-023095-4dannjjm	2987	24	6.1	6.1	CD
cord-023095-4dannjjm	2987	25	vs.	vs.	NN
cord-023095-4dannjjm	2987	26	17.2	17.2	CD
cord-023095-4dannjjm	2987	27	AE	AE	NNP
cord-023095-4dannjjm	2987	28	8.6	8.6	CD
cord-023095-4dannjjm	2987	29	O	o	NN
cord-023095-4dannjjm	2987	30	,	,	,
cord-023095-4dannjjm	2987	31	p	p	NN
cord-023095-4dannjjm	2987	32	o	o	NN
cord-023095-4dannjjm	2987	33	0.0005	0.0005	CD
cord-023095-4dannjjm	2987	34	)	)	-RRB-
cord-023095-4dannjjm	2987	35	.	.	.
cord-023095-4dannjjm	2988	1	There	there	EX
cord-023095-4dannjjm	2988	2	was	be	VBD
cord-023095-4dannjjm	2988	3	also	also	RB
cord-023095-4dannjjm	2988	4	a	a	DT
cord-023095-4dannjjm	2988	5	significant	significant	JJ
cord-023095-4dannjjm	2988	6	increase	increase	NN
cord-023095-4dannjjm	2988	7	in	in	IN
cord-023095-4dannjjm	2988	8	ADP	ADP	NNP
cord-023095-4dannjjm	2988	9	-	-	HYPH
cord-023095-4dannjjm	2988	10	induced	induce	VBN
cord-023095-4dannjjm	2988	11	platelet	platelet	NN
cord-023095-4dannjjm	2988	12	aggregation	aggregation	NN
cord-023095-4dannjjm	2988	13	from	from	IN
cord-023095-4dannjjm	2988	14	the	the	DT
cord-023095-4dannjjm	2988	15	hirudinated	hirudinate	VBN
cord-023095-4dannjjm	2988	16	samples	sample	NNS
cord-023095-4dannjjm	2988	17	compared	compare	VBN
cord-023095-4dannjjm	2988	18	to	to	IN
cord-023095-4dannjjm	2988	19	the	the	DT
cord-023095-4dannjjm	2988	20	citrated	citrate	VBN
cord-023095-4dannjjm	2988	21	samples	sample	NNS
cord-023095-4dannjjm	2988	22	(	(	-LRB-
cord-023095-4dannjjm	2988	23	15.6	15.6	CD
cord-023095-4dannjjm	2988	24	AE	AE	NNP
cord-023095-4dannjjm	2988	25	6.0	6.0	CD
cord-023095-4dannjjm	2988	26	vs.	vs.	IN
cord-023095-4dannjjm	2988	27	2.6	2.6	CD
cord-023095-4dannjjm	2988	28	AE	AE	NNP
cord-023095-4dannjjm	2988	29	2.6	2.6	CD
cord-023095-4dannjjm	2988	30	O	o	NN
cord-023095-4dannjjm	2988	31	,	,	,
cord-023095-4dannjjm	2988	32	p	p	NN
cord-023095-4dannjjm	2988	33	5	5	CD
cord-023095-4dannjjm	2988	34	0.0001	0.0001	CD
cord-023095-4dannjjm	2988	35	)	)	-RRB-
cord-023095-4dannjjm	2988	36	.	.	.
cord-023095-4dannjjm	2989	1	The	the	DT
cord-023095-4dannjjm	2989	2	results	result	NNS
cord-023095-4dannjjm	2989	3	of	of	IN
cord-023095-4dannjjm	2989	4	this	this	DT
cord-023095-4dannjjm	2989	5	study	study	NN
cord-023095-4dannjjm	2989	6	show	show	VBP
cord-023095-4dannjjm	2989	7	a	a	DT
cord-023095-4dannjjm	2989	8	significant	significant	JJ
cord-023095-4dannjjm	2989	9	difference	difference	NN
cord-023095-4dannjjm	2989	10	in	in	IN
cord-023095-4dannjjm	2989	11	platelet	platelet	NN
cord-023095-4dannjjm	2989	12	responsiveness	responsiveness	NN
cord-023095-4dannjjm	2989	13	between	between	IN
cord-023095-4dannjjm	2989	14	citrated	citrated	JJ
cord-023095-4dannjjm	2989	15	and	and	CC
cord-023095-4dannjjm	2989	16	hirudinated	hirudinate	VBN
cord-023095-4dannjjm	2989	17	whole	whole	JJ
cord-023095-4dannjjm	2989	18	blood	blood	NN
cord-023095-4dannjjm	2989	19	using	use	VBG
cord-023095-4dannjjm	2989	20	the	the	DT
cord-023095-4dannjjm	2989	21	Chrono	chrono	NN
cord-023095-4dannjjm	2989	22	-	-	HYPH
cord-023095-4dannjjm	2989	23	log	log	NN
cord-023095-4dannjjm	2989	24	impedance	impedance	NN
cord-023095-4dannjjm	2989	25	aggregometer	aggregometer	NN
cord-023095-4dannjjm	2989	26	.	.	.
cord-023095-4dannjjm	2990	1	While	while	IN
cord-023095-4dannjjm	2990	2	both	both	CC
cord-023095-4dannjjm	2990	3	collagen	collagen	NN
cord-023095-4dannjjm	2990	4	and	and	CC
cord-023095-4dannjjm	2990	5	ADP	ADP	NNP
cord-023095-4dannjjm	2990	6	-	-	HYPH
cord-023095-4dannjjm	2990	7	induced	induce	VBN
cord-023095-4dannjjm	2990	8	platelet	platelet	NN
cord-023095-4dannjjm	2990	9	aggregation	aggregation	NN
cord-023095-4dannjjm	2990	10	was	be	VBD
cord-023095-4dannjjm	2990	11	attenuated	attenuate	VBN
cord-023095-4dannjjm	2990	12	from	from	IN
cord-023095-4dannjjm	2990	13	citrated	citrate	VBN
cord-023095-4dannjjm	2990	14	blood	blood	NN
cord-023095-4dannjjm	2990	15	samples	sample	NNS
cord-023095-4dannjjm	2990	16	,	,	,
cord-023095-4dannjjm	2990	17	this	this	DT
cord-023095-4dannjjm	2990	18	was	be	VBD
cord-023095-4dannjjm	2990	19	most	most	RBS
cord-023095-4dannjjm	2990	20	notable	notable	JJ
cord-023095-4dannjjm	2990	21	for	for	IN
cord-023095-4dannjjm	2990	22	ADPinduced	adpinduced	JJ
cord-023095-4dannjjm	2990	23	aggregation	aggregation	NN
cord-023095-4dannjjm	2990	24	where	where	WRB
cord-023095-4dannjjm	2990	25	almost	almost	RB
cord-023095-4dannjjm	2990	26	all	all	DT
cord-023095-4dannjjm	2990	27	samples	sample	NNS
cord-023095-4dannjjm	2990	28	had	have	VBD
cord-023095-4dannjjm	2990	29	no	no	DT
cord-023095-4dannjjm	2990	30	objective	objective	JJ
cord-023095-4dannjjm	2990	31	measurable	measurable	JJ
cord-023095-4dannjjm	2990	32	platelet	platelet	NN
cord-023095-4dannjjm	2990	33	aggregation	aggregation	NN
cord-023095-4dannjjm	2990	34	.	.	.
cord-023095-4dannjjm	2991	1	It	-PRON-	PRP
cord-023095-4dannjjm	2991	2	is	be	VBZ
cord-023095-4dannjjm	2991	3	suggested	suggest	VBN
cord-023095-4dannjjm	2991	4	from	from	IN
cord-023095-4dannjjm	2991	5	this	this	DT
cord-023095-4dannjjm	2991	6	data	datum	NNS
cord-023095-4dannjjm	2991	7	that	that	WDT
cord-023095-4dannjjm	2991	8	future	future	VBP
cord-023095-4dannjjm	2991	9	whole	whole	JJ
cord-023095-4dannjjm	2991	10	blood	blood	NN
cord-023095-4dannjjm	2991	11	platelet	platelet	NN
cord-023095-4dannjjm	2991	12	aggregation	aggregation	NN
cord-023095-4dannjjm	2991	13	studies	study	NNS
cord-023095-4dannjjm	2991	14	performed	perform	VBN
cord-023095-4dannjjm	2991	15	on	on	IN
cord-023095-4dannjjm	2991	16	the	the	DT
cord-023095-4dannjjm	2991	17	Chrono	chrono	NN
cord-023095-4dannjjm	2991	18	-	-	HYPH
cord-023095-4dannjjm	2991	19	log	log	NN
cord-023095-4dannjjm	2991	20	impedance	impedance	NN
cord-023095-4dannjjm	2991	21	aggregometer	aggregometer	NN
cord-023095-4dannjjm	2991	22	should	should	MD
cord-023095-4dannjjm	2991	23	use	use	VB
cord-023095-4dannjjm	2991	24	hirudinated	hirudinated	JJ
cord-023095-4dannjjm	2991	25	blood	blood	NN
cord-023095-4dannjjm	2991	26	samples	sample	NNS
cord-023095-4dannjjm	2991	27	although	although	IN
cord-023095-4dannjjm	2991	28	new	new	JJ
cord-023095-4dannjjm	2991	29	reference	reference	NN
cord-023095-4dannjjm	2991	30	limits	limit	NNS
cord-023095-4dannjjm	2991	31	would	would	MD
cord-023095-4dannjjm	2991	32	need	need	VB
cord-023095-4dannjjm	2991	33	to	to	TO
cord-023095-4dannjjm	2991	34	be	be	VB
cord-023095-4dannjjm	2991	35	established	establish	VBN
cord-023095-4dannjjm	2991	36	.	.	.
cord-023095-4dannjjm	2992	1	Low	low	JJ
cord-023095-4dannjjm	2992	2	-	-	HYPH
cord-023095-4dannjjm	2992	3	molecular	molecular	JJ
cord-023095-4dannjjm	2992	4	-	-	HYPH
cord-023095-4dannjjm	2992	5	weight	weight	NN
cord-023095-4dannjjm	2992	6	heparin	heparin	NN
cord-023095-4dannjjm	2992	7	(	(	-LRB-
cord-023095-4dannjjm	2992	8	LMWH	LMWH	NNP
cord-023095-4dannjjm	2992	9	)	)	-RRB-
cord-023095-4dannjjm	2992	10	is	be	VBZ
cord-023095-4dannjjm	2992	11	now	now	RB
cord-023095-4dannjjm	2992	12	used	use	VBN
cord-023095-4dannjjm	2992	13	to	to	TO
cord-023095-4dannjjm	2992	14	prevent	prevent	VB
cord-023095-4dannjjm	2992	15	thrombotic	thrombotic	JJ
cord-023095-4dannjjm	2992	16	complications	complication	NNS
cord-023095-4dannjjm	2992	17	in	in	IN
cord-023095-4dannjjm	2992	18	dogs	dog	NNS
cord-023095-4dannjjm	2992	19	.	.	.
cord-023095-4dannjjm	2993	1	A	a	DT
cord-023095-4dannjjm	2993	2	functional	functional	JJ
cord-023095-4dannjjm	2993	3	assay	assay	NN
cord-023095-4dannjjm	2993	4	such	such	JJ
cord-023095-4dannjjm	2993	5	as	as	IN
cord-023095-4dannjjm	2993	6	the	the	DT
cord-023095-4dannjjm	2993	7	Calibrated	Calibrated	NNP
cord-023095-4dannjjm	2993	8	Automated	Automated	NNP
cord-023095-4dannjjm	2993	9	Thrombogram	Thrombogram	NNP
cord-023095-4dannjjm	2993	10	(	(	-LRB-
cord-023095-4dannjjm	2993	11	CAT	cat	NN
cord-023095-4dannjjm	2993	12	)	)	-RRB-
cord-023095-4dannjjm	2993	13	may	may	MD
cord-023095-4dannjjm	2993	14	provide	provide	VB
cord-023095-4dannjjm	2993	15	a	a	DT
cord-023095-4dannjjm	2993	16	new	new	JJ
cord-023095-4dannjjm	2993	17	approach	approach	NN
cord-023095-4dannjjm	2993	18	for	for	IN
cord-023095-4dannjjm	2993	19	monitoring	monitor	VBG
cord-023095-4dannjjm	2993	20	LMWH	LMWH	NNP
cord-023095-4dannjjm	2993	21	therapy	therapy	NN
cord-023095-4dannjjm	2993	22	.	.	.
cord-023095-4dannjjm	2994	1	We	-PRON-	PRP
cord-023095-4dannjjm	2994	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	2994	3	that	that	IN
cord-023095-4dannjjm	2994	4	CAT	cat	NN
cord-023095-4dannjjm	2994	5	would	would	MD
cord-023095-4dannjjm	2994	6	detect	detect	VB
cord-023095-4dannjjm	2994	7	decreased	decrease	VBN
cord-023095-4dannjjm	2994	8	endogenous	endogenous	JJ
cord-023095-4dannjjm	2994	9	thrombin	thrombin	NN
cord-023095-4dannjjm	2994	10	potential	potential	NN
cord-023095-4dannjjm	2994	11	(	(	-LRB-
cord-023095-4dannjjm	2994	12	ETP	ETP	NNP
cord-023095-4dannjjm	2994	13	)	)	-RRB-
cord-023095-4dannjjm	2994	14	in	in	IN
cord-023095-4dannjjm	2994	15	healthy	healthy	JJ
cord-023095-4dannjjm	2994	16	dogs	dog	NNS
cord-023095-4dannjjm	2994	17	receiving	receive	VBG
cord-023095-4dannjjm	2994	18	LMWH	LMWH	NNP
cord-023095-4dannjjm	2994	19	(	(	-LRB-
cord-023095-4dannjjm	2994	20	Fragmin	Fragmin	NNP
cord-023095-4dannjjm	2994	21	s	s	NNP
cord-023095-4dannjjm	2994	22	)	)	-RRB-
cord-023095-4dannjjm	2994	23	.	.	.
cord-023095-4dannjjm	2995	1	Twenty	twenty	CD
cord-023095-4dannjjm	2995	2	-	-	HYPH
cord-023095-4dannjjm	2995	3	four	four	CD
cord-023095-4dannjjm	2995	4	healthy	healthy	JJ
cord-023095-4dannjjm	2995	5	adult	adult	NN
cord-023095-4dannjjm	2995	6	Beagles	Beagles	NNPS
cord-023095-4dannjjm	2995	7	were	be	VBD
cord-023095-4dannjjm	2995	8	included	include	VBN
cord-023095-4dannjjm	2995	9	in	in	IN
cord-023095-4dannjjm	2995	10	this	this	DT
cord-023095-4dannjjm	2995	11	study	study	NN
cord-023095-4dannjjm	2995	12	and	and	CC
cord-023095-4dannjjm	2995	13	divided	divide	VBD
cord-023095-4dannjjm	2995	14	equally	equally	RB
cord-023095-4dannjjm	2995	15	in	in	IN
cord-023095-4dannjjm	2995	16	four	four	CD
cord-023095-4dannjjm	2995	17	groups	group	NNS
cord-023095-4dannjjm	2995	18	.	.	.
cord-023095-4dannjjm	2996	1	One	one	CD
cord-023095-4dannjjm	2996	2	dose	dose	NN
cord-023095-4dannjjm	2996	3	of	of	IN
cord-023095-4dannjjm	2996	4	50	50	CD
cord-023095-4dannjjm	2996	5	U	u	NN
cord-023095-4dannjjm	2996	6	/	/	SYM
cord-023095-4dannjjm	2996	7	kg	kg	NNS
cord-023095-4dannjjm	2996	8	,	,	,
cord-023095-4dannjjm	2996	9	100	100	CD
cord-023095-4dannjjm	2996	10	U	u	NN
cord-023095-4dannjjm	2996	11	/	/	SYM
cord-023095-4dannjjm	2996	12	kg	kg	NNS
cord-023095-4dannjjm	2996	13	or	or	CC
cord-023095-4dannjjm	2996	14	150	150	CD
cord-023095-4dannjjm	2996	15	U	u	NN
cord-023095-4dannjjm	2996	16	/	/	SYM
cord-023095-4dannjjm	2996	17	kg	kg	NNS
cord-023095-4dannjjm	2996	18	of	of	IN
cord-023095-4dannjjm	2996	19	LMWH	LMWH	NNP
cord-023095-4dannjjm	2996	20	were	be	VBD
cord-023095-4dannjjm	2996	21	given	give	VBN
cord-023095-4dannjjm	2996	22	subcutaneously	subcutaneously	RB
cord-023095-4dannjjm	2996	23	to	to	IN
cord-023095-4dannjjm	2996	24	healthy	healthy	JJ
cord-023095-4dannjjm	2996	25	dogs	dog	NNS
cord-023095-4dannjjm	2996	26	and	and	CC
cord-023095-4dannjjm	2996	27	compared	compare	VBN
cord-023095-4dannjjm	2996	28	to	to	IN
cord-023095-4dannjjm	2996	29	a	a	DT
cord-023095-4dannjjm	2996	30	control	control	NN
cord-023095-4dannjjm	2996	31	group	group	NN
cord-023095-4dannjjm	2996	32	.	.	.
cord-023095-4dannjjm	2997	1	Platelet	platelet	NN
cord-023095-4dannjjm	2997	2	poor	poor	JJ
cord-023095-4dannjjm	2997	3	plasma	plasma	NN
cord-023095-4dannjjm	2997	4	(	(	-LRB-
cord-023095-4dannjjm	2997	5	PPP	PPP	NNP
cord-023095-4dannjjm	2997	6	)	)	-RRB-
cord-023095-4dannjjm	2997	7	was	be	VBD
cord-023095-4dannjjm	2997	8	collected	collect	VBN
cord-023095-4dannjjm	2997	9	over	over	IN
cord-023095-4dannjjm	2997	10	a	a	DT
cord-023095-4dannjjm	2997	11	24	24	CD
cord-023095-4dannjjm	2997	12	hour	hour	NN
cord-023095-4dannjjm	2997	13	period	period	NN
cord-023095-4dannjjm	2997	14	.	.	.
cord-023095-4dannjjm	2998	1	Using	use	VBG
cord-023095-4dannjjm	2998	2	a	a	DT
cord-023095-4dannjjm	2998	3	repeated	repeat	VBN
cord-023095-4dannjjm	2998	4	-	-	HYPH
cord-023095-4dannjjm	2998	5	measure	measure	NN
cord-023095-4dannjjm	2998	6	linear	linear	JJ
cord-023095-4dannjjm	2998	7	model	model	NN
cord-023095-4dannjjm	2998	8	,	,	,
cord-023095-4dannjjm	2998	9	effect	effect	NN
cord-023095-4dannjjm	2998	10	of	of	IN
cord-023095-4dannjjm	2998	11	LMWH	LMWH	NNP
cord-023095-4dannjjm	2998	12	on	on	IN
cord-023095-4dannjjm	2998	13	ETP	ETP	NNP
cord-023095-4dannjjm	2998	14	was	be	VBD
cord-023095-4dannjjm	2998	15	time	time	NN
cord-023095-4dannjjm	2998	16	and	and	CC
cord-023095-4dannjjm	2998	17	dose	dose	NN
cord-023095-4dannjjm	2998	18	dependent	dependent	JJ
cord-023095-4dannjjm	2998	19	with	with	IN
cord-023095-4dannjjm	2998	20	a	a	DT
cord-023095-4dannjjm	2998	21	significant	significant	JJ
cord-023095-4dannjjm	2998	22	interaction	interaction	NN
cord-023095-4dannjjm	2998	23	(	(	-LRB-
cord-023095-4dannjjm	2998	24	p	p	NN
cord-023095-4dannjjm	2998	25	o	o	NN
cord-023095-4dannjjm	2998	26	0.0001	0.0001	CD
cord-023095-4dannjjm	2998	27	)	)	-RRB-
cord-023095-4dannjjm	2998	28	.	.	.
cord-023095-4dannjjm	2999	1	Compared	compare	VBN
cord-023095-4dannjjm	2999	2	to	to	TO
cord-023095-4dannjjm	2999	3	control	control	VB
cord-023095-4dannjjm	2999	4	dogs	dog	NNS
cord-023095-4dannjjm	2999	5	,	,	,
cord-023095-4dannjjm	2999	6	significant	significant	JJ
cord-023095-4dannjjm	2999	7	differences	difference	NNS
cord-023095-4dannjjm	2999	8	were	be	VBD
cord-023095-4dannjjm	2999	9	obtained	obtain	VBN
cord-023095-4dannjjm	2999	10	for	for	IN
cord-023095-4dannjjm	2999	11	group	group	NN
cord-023095-4dannjjm	2999	12	50	50	CD
cord-023095-4dannjjm	2999	13	U	U	NNP
cord-023095-4dannjjm	2999	14	/	/	SYM
cord-023095-4dannjjm	2999	15	kg	kg	NNS
cord-023095-4dannjjm	2999	16	at	at	IN
cord-023095-4dannjjm	2999	17	T60	T60	NNP
cord-023095-4dannjjm	2999	18	(	(	-LRB-
cord-023095-4dannjjm	2999	19	p	p	NN
cord-023095-4dannjjm	2999	20	5	5	CD
cord-023095-4dannjjm	2999	21	0.037	0.037	CD
cord-023095-4dannjjm	2999	22	)	)	-RRB-
cord-023095-4dannjjm	2999	23	,	,	,
cord-023095-4dannjjm	2999	24	for	for	IN
cord-023095-4dannjjm	2999	25	group	group	NN
cord-023095-4dannjjm	2999	26	100	100	CD
cord-023095-4dannjjm	2999	27	U	U	NNP
cord-023095-4dannjjm	2999	28	/	/	SYM
cord-023095-4dannjjm	2999	29	kg	kg	NNS
cord-023095-4dannjjm	2999	30	at	at	IN
cord-023095-4dannjjm	2999	31	T15	T15	NNP
cord-023095-4dannjjm	2999	32	(	(	-LRB-
cord-023095-4dannjjm	2999	33	p	p	NN
cord-023095-4dannjjm	2999	34	5	5	CD
cord-023095-4dannjjm	2999	35	0.013	0.013	CD
cord-023095-4dannjjm	2999	36	)	)	-RRB-
cord-023095-4dannjjm	2999	37	and	and	CC
cord-023095-4dannjjm	2999	38	between	between	IN
cord-023095-4dannjjm	2999	39	T30-T240	T30-T240	NNP
cord-023095-4dannjjm	2999	40	minutes	minute	NNS
cord-023095-4dannjjm	2999	41	(	(	-LRB-
cord-023095-4dannjjm	2999	42	p	p	NN
cord-023095-4dannjjm	2999	43	o	o	NN
cord-023095-4dannjjm	2999	44	0.0001	0.0001	CD
cord-023095-4dannjjm	2999	45	)	)	-RRB-
cord-023095-4dannjjm	2999	46	respectively	respectively	RB
cord-023095-4dannjjm	2999	47	,	,	,
cord-023095-4dannjjm	2999	48	and	and	CC
cord-023095-4dannjjm	2999	49	for	for	IN
cord-023095-4dannjjm	2999	50	group	group	NN
cord-023095-4dannjjm	2999	51	150	150	CD
cord-023095-4dannjjm	2999	52	U/	U/	NNS
cord-023095-4dannjjm	2999	53	at	at	IN
cord-023095-4dannjjm	2999	54	T15	T15	NNP
cord-023095-4dannjjm	2999	55	(	(	-LRB-
cord-023095-4dannjjm	2999	56	p	p	NN
cord-023095-4dannjjm	2999	57	5	5	CD
cord-023095-4dannjjm	2999	58	0.011	0.011	CD
cord-023095-4dannjjm	2999	59	)	)	-RRB-
cord-023095-4dannjjm	2999	60	,	,	,
cord-023095-4dannjjm	2999	61	between	between	IN
cord-023095-4dannjjm	2999	62	T30-T300	T30-T300	NNP
cord-023095-4dannjjm	2999	63	minutes	minute	NNS
cord-023095-4dannjjm	2999	64	(	(	-LRB-
cord-023095-4dannjjm	2999	65	p	p	NN
cord-023095-4dannjjm	2999	66	o	o	NN
cord-023095-4dannjjm	2999	67	0.0001	0.0001	CD
cord-023095-4dannjjm	2999	68	)	)	-RRB-
cord-023095-4dannjjm	2999	69	respectively	respectively	RB
cord-023095-4dannjjm	2999	70	and	and	CC
cord-023095-4dannjjm	2999	71	at	at	IN
cord-023095-4dannjjm	2999	72	T360	t360	CD
cord-023095-4dannjjm	2999	73	(	(	-LRB-
cord-023095-4dannjjm	2999	74	p	p	NN
cord-023095-4dannjjm	2999	75	5	5	CD
cord-023095-4dannjjm	2999	76	0.004	0.004	CD
cord-023095-4dannjjm	3000	1	The	the	DT
cord-023095-4dannjjm	3000	2	CAT	cat	NN
cord-023095-4dannjjm	3000	3	assay	assay	NN
cord-023095-4dannjjm	3000	4	can	can	MD
cord-023095-4dannjjm	3000	5	be	be	VB
cord-023095-4dannjjm	3000	6	employed	employ	VBN
cord-023095-4dannjjm	3000	7	to	to	TO
cord-023095-4dannjjm	3000	8	measure	measure	VB
cord-023095-4dannjjm	3000	9	the	the	DT
cord-023095-4dannjjm	3000	10	effects	effect	NNS
cord-023095-4dannjjm	3000	11	of	of	IN
cord-023095-4dannjjm	3000	12	LMWH	LMWH	NNP
cord-023095-4dannjjm	3000	13	at	at	IN
cord-023095-4dannjjm	3000	14	different	different	JJ
cord-023095-4dannjjm	3000	15	doses	dose	NNS
cord-023095-4dannjjm	3000	16	in	in	IN
cord-023095-4dannjjm	3000	17	healthy	healthy	JJ
cord-023095-4dannjjm	3000	18	dogs	dog	NNS
cord-023095-4dannjjm	3000	19	,	,	,
cord-023095-4dannjjm	3000	20	resulting	result	VBG
cord-023095-4dannjjm	3000	21	in	in	IN
cord-023095-4dannjjm	3000	22	significant	significant	JJ
cord-023095-4dannjjm	3000	23	time	time	NN
cord-023095-4dannjjm	3000	24	and	and	CC
cord-023095-4dannjjm	3000	25	dose	dose	NN
cord-023095-4dannjjm	3000	26	-	-	HYPH
cord-023095-4dannjjm	3000	27	dependent	dependent	JJ
cord-023095-4dannjjm	3000	28	decreases	decrease	NNS
cord-023095-4dannjjm	3000	29	in	in	IN
cord-023095-4dannjjm	3000	30	ETP	ETP	NNP
cord-023095-4dannjjm	3000	31	and	and	CC
cord-023095-4dannjjm	3000	32	warrants	warrant	NNS
cord-023095-4dannjjm	3000	33	further	further	JJ
cord-023095-4dannjjm	3000	34	investigation	investigation	NN
cord-023095-4dannjjm	3000	35	as	as	IN
cord-023095-4dannjjm	3000	36	a	a	DT
cord-023095-4dannjjm	3000	37	tool	tool	NN
cord-023095-4dannjjm	3000	38	for	for	IN
cord-023095-4dannjjm	3000	39	monitoring	monitor	VBG
cord-023095-4dannjjm	3000	40	LMWH	LMWH	NNP
cord-023095-4dannjjm	3000	41	therapy	therapy	NN
cord-023095-4dannjjm	3000	42	in	in	IN
cord-023095-4dannjjm	3000	43	dogs	dog	NNS
cord-023095-4dannjjm	3000	44	.	.	.
cord-023095-4dannjjm	3001	1	The	the	DT
cord-023095-4dannjjm	3001	2	purpose	purpose	NN
cord-023095-4dannjjm	3001	3	of	of	IN
cord-023095-4dannjjm	3001	4	this	this	DT
cord-023095-4dannjjm	3001	5	study	study	NN
cord-023095-4dannjjm	3001	6	was	be	VBD
cord-023095-4dannjjm	3001	7	to	to	TO
cord-023095-4dannjjm	3001	8	determine	determine	VB
cord-023095-4dannjjm	3001	9	the	the	DT
cord-023095-4dannjjm	3001	10	effects	effect	NNS
cord-023095-4dannjjm	3001	11	of	of	IN
cord-023095-4dannjjm	3001	12	prednisone	prednisone	NN
cord-023095-4dannjjm	3001	13	and	and	CC
cord-023095-4dannjjm	3001	14	prednisone	prednisone	NNP
cord-023095-4dannjjm	3001	15	plus	plus	CC
cord-023095-4dannjjm	3001	16	ultralow	ultralow	JJ
cord-023095-4dannjjm	3001	17	-	-	HYPH
cord-023095-4dannjjm	3001	18	dose	dose	NN
cord-023095-4dannjjm	3001	19	aspirin	aspirin	NN
cord-023095-4dannjjm	3001	20	on	on	IN
cord-023095-4dannjjm	3001	21	coagulation	coagulation	NN
cord-023095-4dannjjm	3001	22	parameters	parameter	NNS
cord-023095-4dannjjm	3001	23	in	in	IN
cord-023095-4dannjjm	3001	24	healthy	healthy	JJ
cord-023095-4dannjjm	3001	25	dogs	dog	NNS
cord-023095-4dannjjm	3001	26	,	,	,
cord-023095-4dannjjm	3001	27	with	with	IN
cord-023095-4dannjjm	3001	28	an	an	DT
cord-023095-4dannjjm	3001	29	emphasis	emphasis	NN
cord-023095-4dannjjm	3001	30	on	on	IN
cord-023095-4dannjjm	3001	31	thromboelastography	thromboelastography	NNP
cord-023095-4dannjjm	3001	32	(	(	-LRB-
cord-023095-4dannjjm	3001	33	TEG	TEG	NNP
cord-023095-4dannjjm	3001	34	)	)	-RRB-
cord-023095-4dannjjm	3001	35	.	.	.
cord-023095-4dannjjm	3002	1	This	this	DT
cord-023095-4dannjjm	3002	2	was	be	VBD
cord-023095-4dannjjm	3002	3	a	a	DT
cord-023095-4dannjjm	3002	4	prospective	prospective	JJ
cord-023095-4dannjjm	3002	5	,	,	,
cord-023095-4dannjjm	3002	6	randomized	randomized	JJ
cord-023095-4dannjjm	3002	7	,	,	,
cord-023095-4dannjjm	3002	8	blinded	blinded	JJ
cord-023095-4dannjjm	3002	9	study	study	NN
cord-023095-4dannjjm	3002	10	utilizing	utilize	VBG
cord-023095-4dannjjm	3002	11	fourteen	fourteen	CD
cord-023095-4dannjjm	3002	12	dogs	dog	NNS
cord-023095-4dannjjm	3002	13	determined	determine	VBN
cord-023095-4dannjjm	3002	14	to	to	TO
cord-023095-4dannjjm	3002	15	be	be	VB
cord-023095-4dannjjm	3002	16	healthy	healthy	JJ
cord-023095-4dannjjm	3002	17	based	base	VBN
cord-023095-4dannjjm	3002	18	on	on	IN
cord-023095-4dannjjm	3002	19	normal	normal	JJ
cord-023095-4dannjjm	3002	20	physical	physical	JJ
cord-023095-4dannjjm	3002	21	examination	examination	NN
cord-023095-4dannjjm	3002	22	,	,	,
cord-023095-4dannjjm	3002	23	complete	complete	JJ
cord-023095-4dannjjm	3002	24	blood	blood	NN
cord-023095-4dannjjm	3002	25	count	count	NN
cord-023095-4dannjjm	3002	26	,	,	,
cord-023095-4dannjjm	3002	27	biochemistry	biochemistry	NN
cord-023095-4dannjjm	3002	28	,	,	,
cord-023095-4dannjjm	3002	29	urinalysis	urinalysis	NN
cord-023095-4dannjjm	3002	30	,	,	,
cord-023095-4dannjjm	3002	31	and	and	CC
cord-023095-4dannjjm	3002	32	fecal	fecal	JJ
cord-023095-4dannjjm	3002	33	floatation	floatation	NN
cord-023095-4dannjjm	3002	34	.	.	.
cord-023095-4dannjjm	3003	1	Dogs	dog	NNS
cord-023095-4dannjjm	3003	2	were	be	VBD
cord-023095-4dannjjm	3003	3	evenly	evenly	RB
cord-023095-4dannjjm	3003	4	divided	divide	VBN
cord-023095-4dannjjm	3003	5	into	into	IN
cord-023095-4dannjjm	3003	6	either	either	CC
cord-023095-4dannjjm	3003	7	prednisone	prednisone	NNP
cord-023095-4dannjjm	3003	8	plus	plus	CC
cord-023095-4dannjjm	3003	9	aspirin	aspirin	NNP
cord-023095-4dannjjm	3003	10	(	(	-LRB-
cord-023095-4dannjjm	3003	11	PA	PA	NNP
cord-023095-4dannjjm	3003	12	)	)	-RRB-
cord-023095-4dannjjm	3003	13	or	or	CC
cord-023095-4dannjjm	3003	14	prednisone	prednisone	NNP
cord-023095-4dannjjm	3003	15	plus	plus	CC
cord-023095-4dannjjm	3003	16	placebo	placebo	NN
cord-023095-4dannjjm	3003	17	(	(	-LRB-
cord-023095-4dannjjm	3003	18	PP	PP	NNP
cord-023095-4dannjjm	3003	19	)	)	-RRB-
cord-023095-4dannjjm	3003	20	groups	group	NNS
cord-023095-4dannjjm	3003	21	.	.	.
cord-023095-4dannjjm	3004	1	Baseline	baseline	JJ
cord-023095-4dannjjm	3004	2	values	value	NNS
cord-023095-4dannjjm	3004	3	for	for	IN
cord-023095-4dannjjm	3004	4	TEG	TEG	NNP
cord-023095-4dannjjm	3004	5	parameters	parameter	NNS
cord-023095-4dannjjm	3004	6	(	(	-LRB-
cord-023095-4dannjjm	3005	1	R	r	NN
cord-023095-4dannjjm	3005	2	,	,	,
cord-023095-4dannjjm	3005	3	K	K	NNP
cord-023095-4dannjjm	3005	4	,	,	,
cord-023095-4dannjjm	3005	5	angle	angle	NN
cord-023095-4dannjjm	3005	6	,	,	,
cord-023095-4dannjjm	3005	7	MA	MA	NNP
cord-023095-4dannjjm	3005	8	,	,	,
cord-023095-4dannjjm	3005	9	Ly30	Ly30	NNP
cord-023095-4dannjjm	3005	10	,	,	,
cord-023095-4dannjjm	3005	11	Ly60	Ly60	NNP
cord-023095-4dannjjm	3005	12	,	,	,
cord-023095-4dannjjm	3005	13	G	G	NNP
cord-023095-4dannjjm	3005	14	,	,	,
cord-023095-4dannjjm	3005	15	CI	CI	NNP
cord-023095-4dannjjm	3005	16	)	)	-RRB-
cord-023095-4dannjjm	3005	17	were	be	VBD
cord-023095-4dannjjm	3005	18	measured	measure	VBN
cord-023095-4dannjjm	3005	19	twice	twice	RB
cord-023095-4dannjjm	3005	20	two	two	CD
cord-023095-4dannjjm	3005	21	days	day	NNS
cord-023095-4dannjjm	3005	22	apart	apart	RB
cord-023095-4dannjjm	3005	23	,	,	,
cord-023095-4dannjjm	3005	24	and	and	CC
cord-023095-4dannjjm	3005	25	thrombin	thrombin	NN
cord-023095-4dannjjm	3005	26	-	-	HYPH
cord-023095-4dannjjm	3005	27	antithrombin	antithrombin	NN
cord-023095-4dannjjm	3005	28	complexes	complex	NNS
cord-023095-4dannjjm	3005	29	(	(	-LRB-
cord-023095-4dannjjm	3005	30	TAT	TAT	NNP
cord-023095-4dannjjm	3005	31	)	)	-RRB-
cord-023095-4dannjjm	3005	32	,	,	,
cord-023095-4dannjjm	3005	33	and	and	CC
cord-023095-4dannjjm	3005	34	traditional	traditional	JJ
cord-023095-4dannjjm	3005	35	coagulation	coagulation	NN
cord-023095-4dannjjm	3005	36	parameters	parameter	NNS
cord-023095-4dannjjm	3005	37	(	(	-LRB-
cord-023095-4dannjjm	3005	38	prothrombin	prothrombin	JJ
cord-023095-4dannjjm	3005	39	time	time	NN
cord-023095-4dannjjm	3005	40	,	,	,
cord-023095-4dannjjm	3005	41	activated	activate	VBD
cord-023095-4dannjjm	3005	42	partial	partial	JJ
cord-023095-4dannjjm	3005	43	thromboplastin	thromboplastin	NNP
cord-023095-4dannjjm	3005	44	time	time	NN
cord-023095-4dannjjm	3005	45	,	,	,
cord-023095-4dannjjm	3005	46	d	d	NN
cord-023095-4dannjjm	3005	47	-	-	HYPH
cord-023095-4dannjjm	3005	48	dimer	dimer	JJ
cord-023095-4dannjjm	3005	49	,	,	,
cord-023095-4dannjjm	3005	50	antithrombin	antithrombin	NN
cord-023095-4dannjjm	3005	51	(	(	-LRB-
cord-023095-4dannjjm	3005	52	AT	AT	NNP
cord-023095-4dannjjm	3005	53	)	)	-RRB-
cord-023095-4dannjjm	3005	54	,	,	,
cord-023095-4dannjjm	3005	55	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	3005	56	)	)	-RRB-
cord-023095-4dannjjm	3005	57	were	be	VBD
cord-023095-4dannjjm	3005	58	measured	measure	VBN
cord-023095-4dannjjm	3005	59	once	once	RB
cord-023095-4dannjjm	3005	60	.	.	.
cord-023095-4dannjjm	3006	1	Each	each	DT
cord-023095-4dannjjm	3006	2	dog	dog	NN
cord-023095-4dannjjm	3006	3	received	receive	VBD
cord-023095-4dannjjm	3006	4	2	2	CD
cord-023095-4dannjjm	3006	5	mg	mg	NNP
cord-023095-4dannjjm	3006	6	/	/	SYM
cord-023095-4dannjjm	3006	7	kg/	kg/	NNP
cord-023095-4dannjjm	3006	8	day	day	NN
cord-023095-4dannjjm	3006	9	of	of	IN
cord-023095-4dannjjm	3006	10	prednisone	prednisone	NNP
cord-023095-4dannjjm	3006	11	,	,	,
cord-023095-4dannjjm	3006	12	and	and	CC
cord-023095-4dannjjm	3006	13	either	either	RB
cord-023095-4dannjjm	3006	14	0.5	0.5	CD
cord-023095-4dannjjm	3006	15	mg	mg	NNP
cord-023095-4dannjjm	3006	16	/	/	SYM
cord-023095-4dannjjm	3006	17	kg	kg	NNP
cord-023095-4dannjjm	3006	18	/	/	SYM
cord-023095-4dannjjm	3006	19	day	day	NN
cord-023095-4dannjjm	3006	20	of	of	IN
cord-023095-4dannjjm	3006	21	aspirin	aspirin	NN
cord-023095-4dannjjm	3006	22	(	(	-LRB-
cord-023095-4dannjjm	3006	23	PA	PA	NNP
cord-023095-4dannjjm	3006	24	group	group	NN
cord-023095-4dannjjm	3006	25	)	)	-RRB-
cord-023095-4dannjjm	3006	26	or	or	CC
cord-023095-4dannjjm	3006	27	placebo	placebo	NN
cord-023095-4dannjjm	3006	28	(	(	-LRB-
cord-023095-4dannjjm	3006	29	PP	PP	NNP
cord-023095-4dannjjm	3006	30	group	group	NN
cord-023095-4dannjjm	3006	31	)	)	-RRB-
cord-023095-4dannjjm	3006	32	for	for	IN
cord-023095-4dannjjm	3006	33	14	14	CD
cord-023095-4dannjjm	3006	34	days	day	NNS
cord-023095-4dannjjm	3006	35	.	.	.
cord-023095-4dannjjm	3007	1	A	a	DT
cord-023095-4dannjjm	3007	2	complete	complete	JJ
cord-023095-4dannjjm	3007	3	blood	blood	NN
cord-023095-4dannjjm	3007	4	count	count	NN
cord-023095-4dannjjm	3007	5	,	,	,
cord-023095-4dannjjm	3007	6	biochemistry	biochemistry	NN
cord-023095-4dannjjm	3007	7	profile	profile	NN
cord-023095-4dannjjm	3007	8	,	,	,
cord-023095-4dannjjm	3007	9	TEG	TEG	NNP
cord-023095-4dannjjm	3007	10	,	,	,
cord-023095-4dannjjm	3007	11	TAT	TAT	NNP
cord-023095-4dannjjm	3007	12	,	,	,
cord-023095-4dannjjm	3007	13	and	and	CC
cord-023095-4dannjjm	3007	14	traditional	traditional	JJ
cord-023095-4dannjjm	3007	15	coagulation	coagulation	NN
cord-023095-4dannjjm	3007	16	parameters	parameter	NNS
cord-023095-4dannjjm	3007	17	were	be	VBD
cord-023095-4dannjjm	3007	18	then	then	RB
cord-023095-4dannjjm	3007	19	repeated	repeat	VBN
cord-023095-4dannjjm	3007	20	on	on	IN
cord-023095-4dannjjm	3007	21	each	each	DT
cord-023095-4dannjjm	3007	22	dog	dog	NN
cord-023095-4dannjjm	3007	23	.	.	.
cord-023095-4dannjjm	3008	1	Day	day	NN
cord-023095-4dannjjm	3008	2	to	to	IN
cord-023095-4dannjjm	3008	3	day	day	NN
cord-023095-4dannjjm	3008	4	variation	variation	NN
cord-023095-4dannjjm	3008	5	was	be	VBD
cord-023095-4dannjjm	3008	6	calculated	calculate	VBN
cord-023095-4dannjjm	3008	7	for	for	IN
cord-023095-4dannjjm	3008	8	the	the	DT
cord-023095-4dannjjm	3008	9	TEG	TEG	NNP
cord-023095-4dannjjm	3008	10	parameters	parameter	NNS
cord-023095-4dannjjm	3008	11	using	use	VBG
cord-023095-4dannjjm	3008	12	the	the	DT
cord-023095-4dannjjm	3008	13	two	two	CD
cord-023095-4dannjjm	3008	14	baseline	baseline	JJ
cord-023095-4dannjjm	3008	15	measurements	measurement	NNS
cord-023095-4dannjjm	3008	16	.	.	.
cord-023095-4dannjjm	3009	1	The	the	DT
cord-023095-4dannjjm	3009	2	change	change	NN
cord-023095-4dannjjm	3009	3	from	from	IN
cord-023095-4dannjjm	3009	4	baseline	baseline	NN
cord-023095-4dannjjm	3009	5	between	between	IN
cord-023095-4dannjjm	3009	6	and	and	CC
cord-023095-4dannjjm	3009	7	within	within	IN
cord-023095-4dannjjm	3009	8	each	each	DT
cord-023095-4dannjjm	3009	9	group	group	NN
cord-023095-4dannjjm	3009	10	were	be	VBD
cord-023095-4dannjjm	3009	11	compared	compare	VBN
cord-023095-4dannjjm	3009	12	using	use	VBG
cord-023095-4dannjjm	3009	13	t	t	NN
cord-023095-4dannjjm	3009	14	-	-	HYPH
cord-023095-4dannjjm	3009	15	tests	test	NNS
cord-023095-4dannjjm	3009	16	,	,	,
cord-023095-4dannjjm	3009	17	or	or	CC
cord-023095-4dannjjm	3009	18	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	3009	19	2	2	CD
cord-023095-4dannjjm	3009	20	sample	sample	NN
cord-023095-4dannjjm	3009	21	test	test	NN
cord-023095-4dannjjm	3009	22	where	where	WRB
cord-023095-4dannjjm	3009	23	appropriate	appropriate	JJ
cord-023095-4dannjjm	3009	24	,	,	,
cord-023095-4dannjjm	3009	25	for	for	IN
cord-023095-4dannjjm	3009	26	TEG	TEG	NNP
cord-023095-4dannjjm	3009	27	,	,	,
cord-023095-4dannjjm	3009	28	TAT	TAT	NNP
cord-023095-4dannjjm	3009	29	,	,	,
cord-023095-4dannjjm	3009	30	traditional	traditional	JJ
cord-023095-4dannjjm	3009	31	coagulation	coagulation	NN
cord-023095-4dannjjm	3009	32	parameters	parameter	NNS
cord-023095-4dannjjm	3009	33	,	,	,
cord-023095-4dannjjm	3009	34	and	and	CC
cord-023095-4dannjjm	3009	35	hematocrit	hematocrit	NN
cord-023095-4dannjjm	3009	36	.	.	.
cord-023095-4dannjjm	3010	1	Day	day	NN
cord-023095-4dannjjm	3010	2	to	to	IN
cord-023095-4dannjjm	3010	3	day	day	NN
cord-023095-4dannjjm	3010	4	variation	variation	NN
cord-023095-4dannjjm	3010	5	in	in	IN
cord-023095-4dannjjm	3010	6	TEG	TEG	NNP
cord-023095-4dannjjm	3010	7	was	be	VBD
cord-023095-4dannjjm	3010	8	acceptable	acceptable	JJ
cord-023095-4dannjjm	3010	9	(	(	-LRB-
cord-023095-4dannjjm	3010	10	10	10	CD
cord-023095-4dannjjm	3010	11	%	%	NN
cord-023095-4dannjjm	3010	12	)	)	-RRB-
cord-023095-4dannjjm	3010	13	for	for	IN
cord-023095-4dannjjm	3010	14	MA	MA	NNP
cord-023095-4dannjjm	3010	15	,	,	,
cord-023095-4dannjjm	3010	16	G	G	NNP
cord-023095-4dannjjm	3010	17	,	,	,
cord-023095-4dannjjm	3010	18	and	and	CC
cord-023095-4dannjjm	3010	19	angle	angle	NN
cord-023095-4dannjjm	3010	20	,	,	,
cord-023095-4dannjjm	3010	21	unacceptable	unacceptable	JJ
cord-023095-4dannjjm	3010	22	(	(	-LRB-
cord-023095-4dannjjm	3010	23	4	4	CD
cord-023095-4dannjjm	3010	24	10	10	CD
cord-023095-4dannjjm	3010	25	%	%	NN
cord-023095-4dannjjm	3010	26	)	)	-RRB-
cord-023095-4dannjjm	3010	27	for	for	IN
cord-023095-4dannjjm	3010	28	R	r	NN
cord-023095-4dannjjm	3010	29	,	,	,
cord-023095-4dannjjm	3010	30	K	K	NNP
cord-023095-4dannjjm	3010	31	,	,	,
cord-023095-4dannjjm	3010	32	Ly30	Ly30	NNP
cord-023095-4dannjjm	3010	33	and	and	CC
cord-023095-4dannjjm	3010	34	Ly60	Ly60	NNP
cord-023095-4dannjjm	3010	35	,	,	,
cord-023095-4dannjjm	3010	36	and	and	CC
cord-023095-4dannjjm	3010	37	not	not	RB
cord-023095-4dannjjm	3010	38	meaningful	meaningful	JJ
cord-023095-4dannjjm	3010	39	for	for	IN
cord-023095-4dannjjm	3010	40	CI	CI	NNP
cord-023095-4dannjjm	3010	41	.	.	.
cord-023095-4dannjjm	3011	1	Within	within	IN
cord-023095-4dannjjm	3011	2	both	both	DT
cord-023095-4dannjjm	3011	3	groups	group	NNS
cord-023095-4dannjjm	3011	4	,	,	,
cord-023095-4dannjjm	3011	5	MA	MA	NNP
cord-023095-4dannjjm	3011	6	,	,	,
cord-023095-4dannjjm	3011	7	G	G	NNP
cord-023095-4dannjjm	3011	8	,	,	,
cord-023095-4dannjjm	3011	9	CI	CI	NNP
cord-023095-4dannjjm	3011	10	and	and	CC
cord-023095-4dannjjm	3011	11	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	3011	12	significantly	significantly	RB
cord-023095-4dannjjm	3011	13	increased	increase	VBD
cord-023095-4dannjjm	3011	14	from	from	IN
cord-023095-4dannjjm	3011	15	baseline	baseline	NN
cord-023095-4dannjjm	3011	16	(	(	-LRB-
cord-023095-4dannjjm	3011	17	p	p	NN
cord-023095-4dannjjm	3011	18	o	o	NN
cord-023095-4dannjjm	3011	19	0.05	0.05	CD
cord-023095-4dannjjm	3011	20	)	)	-RRB-
cord-023095-4dannjjm	3011	21	.	.	.
cord-023095-4dannjjm	3012	1	Within	within	IN
cord-023095-4dannjjm	3012	2	both	both	DT
cord-023095-4dannjjm	3012	3	groups	group	NNS
cord-023095-4dannjjm	3012	4	,	,	,
cord-023095-4dannjjm	3012	5	Ly30	Ly30	NNP
cord-023095-4dannjjm	3012	6	and	and	CC
cord-023095-4dannjjm	3012	7	AT	at	IN
cord-023095-4dannjjm	3012	8	significantly	significantly	RB
cord-023095-4dannjjm	3012	9	decreased	decrease	VBD
cord-023095-4dannjjm	3012	10	from	from	IN
cord-023095-4dannjjm	3012	11	baseline	baseline	NN
cord-023095-4dannjjm	3012	12	(	(	-LRB-
cord-023095-4dannjjm	3012	13	p	p	NN
cord-023095-4dannjjm	3012	14	o	o	NN
cord-023095-4dannjjm	3012	15	0.05	0.05	CD
cord-023095-4dannjjm	3012	16	)	)	-RRB-
cord-023095-4dannjjm	3012	17	.	.	.
cord-023095-4dannjjm	3013	1	For	for	IN
cord-023095-4dannjjm	3013	2	the	the	DT
cord-023095-4dannjjm	3013	3	PP	PP	NNP
cord-023095-4dannjjm	3013	4	group	group	NN
cord-023095-4dannjjm	3013	5	,	,	,
cord-023095-4dannjjm	3013	6	Ly60	Ly60	NNP
cord-023095-4dannjjm	3013	7	significantly	significantly	RB
cord-023095-4dannjjm	3013	8	decreased	decrease	VBD
cord-023095-4dannjjm	3013	9	from	from	IN
cord-023095-4dannjjm	3013	10	baseline	baseline	NN
cord-023095-4dannjjm	3013	11	(	(	-LRB-
cord-023095-4dannjjm	3013	12	p	p	NN
cord-023095-4dannjjm	3013	13	5	5	CD
cord-023095-4dannjjm	3013	14	0.03	0.03	CD
cord-023095-4dannjjm	3013	15	)	)	-RRB-
cord-023095-4dannjjm	3013	16	,	,	,
cord-023095-4dannjjm	3013	17	and	and	CC
cord-023095-4dannjjm	3013	18	approached	approach	VBD
cord-023095-4dannjjm	3013	19	significance	significance	NN
cord-023095-4dannjjm	3013	20	for	for	IN
cord-023095-4dannjjm	3013	21	the	the	DT
cord-023095-4dannjjm	3013	22	PA	PA	NNP
cord-023095-4dannjjm	3013	23	group	group	NN
cord-023095-4dannjjm	3013	24	(	(	-LRB-
cord-023095-4dannjjm	3013	25	p	p	NN
cord-023095-4dannjjm	3013	26	5	5	CD
cord-023095-4dannjjm	3013	27	0.0504	0.0504	CD
cord-023095-4dannjjm	3013	28	)	)	-RRB-
cord-023095-4dannjjm	3013	29	.	.	.
cord-023095-4dannjjm	3014	1	All	all	DT
cord-023095-4dannjjm	3014	2	other	other	JJ
cord-023095-4dannjjm	3014	3	within	within	IN
cord-023095-4dannjjm	3014	4	group	group	NN
cord-023095-4dannjjm	3014	5	changes	change	NNS
cord-023095-4dannjjm	3014	6	from	from	IN
cord-023095-4dannjjm	3014	7	baseline	baseline	NN
cord-023095-4dannjjm	3014	8	were	be	VBD
cord-023095-4dannjjm	3014	9	not	not	RB
cord-023095-4dannjjm	3014	10	statistically	statistically	RB
cord-023095-4dannjjm	3014	11	significant	significant	JJ
cord-023095-4dannjjm	3014	12	(	(	-LRB-
cord-023095-4dannjjm	3014	13	p	p	NN
cord-023095-4dannjjm	3014	14	-	-	HYPH
cord-023095-4dannjjm	3014	15	values	value	NNS
cord-023095-4dannjjm	3014	16	4	4	CD
cord-023095-4dannjjm	3014	17	0.05	0.05	CD
cord-023095-4dannjjm	3014	18	)	)	-RRB-
cord-023095-4dannjjm	3014	19	.	.	.
cord-023095-4dannjjm	3015	1	For	for	IN
cord-023095-4dannjjm	3015	2	all	all	DT
cord-023095-4dannjjm	3015	3	parameters	parameter	NNS
cord-023095-4dannjjm	3015	4	,	,	,
cord-023095-4dannjjm	3015	5	there	there	EX
cord-023095-4dannjjm	3015	6	was	be	VBD
cord-023095-4dannjjm	3015	7	no	no	DT
cord-023095-4dannjjm	3015	8	difference	difference	NN
cord-023095-4dannjjm	3015	9	between	between	IN
cord-023095-4dannjjm	3015	10	groups	group	NNS
cord-023095-4dannjjm	3015	11	for	for	IN
cord-023095-4dannjjm	3015	12	change	change	NN
cord-023095-4dannjjm	3015	13	from	from	IN
cord-023095-4dannjjm	3015	14	baseline	baseline	NN
cord-023095-4dannjjm	3015	15	(	(	-LRB-
cord-023095-4dannjjm	3015	16	p	p	IN
cord-023095-4dannjjm	3015	17	values	value	NNS
cord-023095-4dannjjm	3015	18	4	4	CD
cord-023095-4dannjjm	3015	19	0.05	0.05	CD
cord-023095-4dannjjm	3015	20	)	)	-RRB-
cord-023095-4dannjjm	3015	21	.	.	.
cord-023095-4dannjjm	3016	1	Day	day	NN
cord-023095-4dannjjm	3016	2	to	to	IN
cord-023095-4dannjjm	3016	3	day	day	NN
cord-023095-4dannjjm	3016	4	variation	variation	NN
cord-023095-4dannjjm	3016	5	in	in	IN
cord-023095-4dannjjm	3016	6	some	some	DT
cord-023095-4dannjjm	3016	7	TEG	TEG	NNP
cord-023095-4dannjjm	3016	8	parameters	parameter	NNS
cord-023095-4dannjjm	3016	9	is	be	VBZ
cord-023095-4dannjjm	3016	10	high	high	JJ
cord-023095-4dannjjm	3016	11	and	and	CC
cord-023095-4dannjjm	3016	12	may	may	MD
cord-023095-4dannjjm	3016	13	preclude	preclude	VB
cord-023095-4dannjjm	3016	14	their	-PRON-	PRP$
cord-023095-4dannjjm	3016	15	clinical	clinical	JJ
cord-023095-4dannjjm	3016	16	utility	utility	NN
cord-023095-4dannjjm	3016	17	.	.	.
cord-023095-4dannjjm	3017	1	Prednisone	Prednisone	NNP
cord-023095-4dannjjm	3017	2	causes	cause	VBZ
cord-023095-4dannjjm	3017	3	hypercoagulability	hypercoagulability	NN
cord-023095-4dannjjm	3017	4	in	in	IN
cord-023095-4dannjjm	3017	5	healthy	healthy	JJ
cord-023095-4dannjjm	3017	6	dogs	dog	NNS
cord-023095-4dannjjm	3017	7	based	base	VBN
cord-023095-4dannjjm	3017	8	on	on	IN
cord-023095-4dannjjm	3017	9	increased	increase	VBN
cord-023095-4dannjjm	3017	10	G	g	NN
cord-023095-4dannjjm	3017	11	,	,	,
cord-023095-4dannjjm	3017	12	MA	MA	NNP
cord-023095-4dannjjm	3017	13	,	,	,
cord-023095-4dannjjm	3017	14	and	and	CC
cord-023095-4dannjjm	3017	15	CI	CI	NNP
cord-023095-4dannjjm	3017	16	.	.	.
cord-023095-4dannjjm	3018	1	The	the	DT
cord-023095-4dannjjm	3018	2	addition	addition	NN
cord-023095-4dannjjm	3018	3	of	of	IN
cord-023095-4dannjjm	3018	4	ultra	ultra	JJ
cord-023095-4dannjjm	3018	5	-	-	JJ
cord-023095-4dannjjm	3018	6	low	low	JJ
cord-023095-4dannjjm	3018	7	dose	dose	NN
cord-023095-4dannjjm	3018	8	aspirin	aspirin	NN
cord-023095-4dannjjm	3018	9	to	to	IN
cord-023095-4dannjjm	3018	10	prednisone	prednisone	NNP
cord-023095-4dannjjm	3018	11	has	have	VBZ
cord-023095-4dannjjm	3018	12	no	no	DT
cord-023095-4dannjjm	3018	13	effect	effect	NN
cord-023095-4dannjjm	3018	14	on	on	IN
cord-023095-4dannjjm	3018	15	the	the	DT
cord-023095-4dannjjm	3018	16	parameters	parameter	NNS
cord-023095-4dannjjm	3018	17	measured	measure	VBN
cord-023095-4dannjjm	3018	18	in	in	IN
cord-023095-4dannjjm	3018	19	this	this	DT
cord-023095-4dannjjm	3018	20	study	study	NN
cord-023095-4dannjjm	3018	21	.	.	.
cord-023095-4dannjjm	3018	22	'	'	''
cord-023095-4dannjjm	3019	1	Aspirin	aspirin	NN
cord-023095-4dannjjm	3019	2	resistance	resistance	NN
cord-023095-4dannjjm	3019	3	'	'	''
cord-023095-4dannjjm	3019	4	has	have	VBZ
cord-023095-4dannjjm	3019	5	been	be	VBN
cord-023095-4dannjjm	3019	6	identified	identify	VBN
cord-023095-4dannjjm	3019	7	in	in	IN
cord-023095-4dannjjm	3019	8	people	people	NNS
cord-023095-4dannjjm	3019	9	and	and	CC
cord-023095-4dannjjm	3019	10	dogs	dog	NNS
cord-023095-4dannjjm	3019	11	that	that	WDT
cord-023095-4dannjjm	3019	12	develop	develop	VBP
cord-023095-4dannjjm	3019	13	thrombi	thrombi	NNP
cord-023095-4dannjjm	3019	14	despite	despite	IN
cord-023095-4dannjjm	3019	15	low	low	JJ
cord-023095-4dannjjm	3019	16	dose	dose	NN
cord-023095-4dannjjm	3019	17	aspirin	aspirin	NN
cord-023095-4dannjjm	3019	18	therapy	therapy	NN
cord-023095-4dannjjm	3019	19	.	.	.
cord-023095-4dannjjm	3020	1	Variability	variability	NN
cord-023095-4dannjjm	3020	2	in	in	IN
cord-023095-4dannjjm	3020	3	platelet	platelet	NN
cord-023095-4dannjjm	3020	4	cyclooxygenase	cyclooxygenase	NN
cord-023095-4dannjjm	3020	5	(	(	-LRB-
cord-023095-4dannjjm	3020	6	COX	COX	NNP
cord-023095-4dannjjm	3020	7	)	)	-RRB-
cord-023095-4dannjjm	3020	8	isoform	isoform	NN
cord-023095-4dannjjm	3020	9	expression	expression	NN
cord-023095-4dannjjm	3020	10	is	be	VBZ
cord-023095-4dannjjm	3020	11	one	one	CD
cord-023095-4dannjjm	3020	12	proposed	propose	VBN
cord-023095-4dannjjm	3020	13	mechanism	mechanism	NN
cord-023095-4dannjjm	3020	14	for	for	IN
cord-023095-4dannjjm	3020	15	aspirin	aspirin	NN
cord-023095-4dannjjm	3020	16	resistance	resistance	NN
cord-023095-4dannjjm	3020	17	in	in	IN
cord-023095-4dannjjm	3020	18	people	people	NNS
cord-023095-4dannjjm	3020	19	.	.	.
cord-023095-4dannjjm	3021	1	Two	two	CD
cord-023095-4dannjjm	3021	2	isoforms	isoform	NNS
cord-023095-4dannjjm	3021	3	(	(	-LRB-
cord-023095-4dannjjm	3021	4	COX-1	cox-1	JJ
cord-023095-4dannjjm	3021	5	and	and	CC
cord-023095-4dannjjm	3021	6	COX-2	COX-2	NNP
cord-023095-4dannjjm	3021	7	)	)	-RRB-
cord-023095-4dannjjm	3021	8	have	have	VBP
cord-023095-4dannjjm	3021	9	been	be	VBN
cord-023095-4dannjjm	3021	10	identified	identify	VBN
cord-023095-4dannjjm	3021	11	in	in	IN
cord-023095-4dannjjm	3021	12	canine	canine	JJ
cord-023095-4dannjjm	3021	13	platelets	platelet	NNS
cord-023095-4dannjjm	3021	14	.	.	.
cord-023095-4dannjjm	3022	1	High	high	JJ
cord-023095-4dannjjm	3022	2	(	(	-LRB-
cord-023095-4dannjjm	3022	3	antiinflammatory	antiinflammatory	JJ
cord-023095-4dannjjm	3022	4	)	)	-RRB-
cord-023095-4dannjjm	3022	5	dose	dose	NN
cord-023095-4dannjjm	3022	6	aspirin	aspirin	NN
cord-023095-4dannjjm	3022	7	inhibits	inhibit	VBZ
cord-023095-4dannjjm	3022	8	platelet	platelet	NN
cord-023095-4dannjjm	3022	9	function	function	NN
cord-023095-4dannjjm	3022	10	and	and	CC
cord-023095-4dannjjm	3022	11	alters	alter	VBZ
cord-023095-4dannjjm	3022	12	expression	expression	NN
cord-023095-4dannjjm	3022	13	of	of	IN
cord-023095-4dannjjm	3022	14	both	both	CC
cord-023095-4dannjjm	3022	15	COX	COX	NNP
cord-023095-4dannjjm	3022	16	isoforms	isoform	NNS
cord-023095-4dannjjm	3022	17	in	in	IN
cord-023095-4dannjjm	3022	18	most	most	JJS
cord-023095-4dannjjm	3022	19	dogs	dog	NNS
cord-023095-4dannjjm	3022	20	.	.	.
cord-023095-4dannjjm	3023	1	This	this	DT
cord-023095-4dannjjm	3023	2	study	study	NN
cord-023095-4dannjjm	3023	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	3023	4	the	the	DT
cord-023095-4dannjjm	3023	5	effects	effect	NNS
cord-023095-4dannjjm	3023	6	of	of	IN
cord-023095-4dannjjm	3023	7	low	low	JJ
cord-023095-4dannjjm	3023	8	dose	dose	NN
cord-023095-4dannjjm	3023	9	aspirin	aspirin	NN
cord-023095-4dannjjm	3023	10	on	on	IN
cord-023095-4dannjjm	3023	11	platelet	platelet	NN
cord-023095-4dannjjm	3023	12	function	function	NN
cord-023095-4dannjjm	3023	13	and	and	CC
cord-023095-4dannjjm	3023	14	COX	COX	NNP
cord-023095-4dannjjm	3023	15	expression	expression	NN
cord-023095-4dannjjm	3023	16	in	in	IN
cord-023095-4dannjjm	3023	17	normal	normal	JJ
cord-023095-4dannjjm	3023	18	dogs	dog	NNS
cord-023095-4dannjjm	3023	19	.	.	.
cord-023095-4dannjjm	3024	1	Twenty	twenty	CD
cord-023095-4dannjjm	3024	2	-	-	HYPH
cord-023095-4dannjjm	3024	3	five	five	CD
cord-023095-4dannjjm	3024	4	healthy	healthy	JJ
cord-023095-4dannjjm	3024	5	client	client	NN
cord-023095-4dannjjm	3024	6	-	-	HYPH
cord-023095-4dannjjm	3024	7	owned	own	VBN
cord-023095-4dannjjm	3024	8	dogs	dog	NNS
cord-023095-4dannjjm	3024	9	were	be	VBD
cord-023095-4dannjjm	3024	10	evaluated	evaluate	VBN
cord-023095-4dannjjm	3024	11	before	before	IN
cord-023095-4dannjjm	3024	12	and	and	CC
cord-023095-4dannjjm	3024	13	at	at	IN
cord-023095-4dannjjm	3024	14	two	two	CD
cord-023095-4dannjjm	3024	15	time	time	NN
cord-023095-4dannjjm	3024	16	points	point	NNS
cord-023095-4dannjjm	3024	17	(	(	-LRB-
cord-023095-4dannjjm	3024	18	Days	day	NNS
cord-023095-4dannjjm	3024	19	3	3	CD
cord-023095-4dannjjm	3024	20	and	and	CC
cord-023095-4dannjjm	3024	21	10	10	CD
cord-023095-4dannjjm	3024	22	)	)	-RRB-
cord-023095-4dannjjm	3024	23	during	during	IN
cord-023095-4dannjjm	3024	24	aspirin	aspirin	NN
cord-023095-4dannjjm	3024	25	therapy	therapy	NN
cord-023095-4dannjjm	3024	26	(	(	-LRB-
cord-023095-4dannjjm	3024	27	1	1	CD
cord-023095-4dannjjm	3024	28	mg	mg	NNP
cord-023095-4dannjjm	3024	29	/	/	SYM
cord-023095-4dannjjm	3024	30	kg	kg	NNP
cord-023095-4dannjjm	3024	31	PO	PO	NNP
cord-023095-4dannjjm	3024	32	SID	SID	NNP
cord-023095-4dannjjm	3024	33	)	)	-RRB-
cord-023095-4dannjjm	3024	34	.	.	.
cord-023095-4dannjjm	3025	1	Platelet	platelet	NN
cord-023095-4dannjjm	3025	2	response	response	NN
cord-023095-4dannjjm	3025	3	to	to	IN
cord-023095-4dannjjm	3025	4	aspirin	aspirin	NN
cord-023095-4dannjjm	3026	1	(	(	-LRB-
cord-023095-4dannjjm	3026	2	Siemens	Siemens	NNP
cord-023095-4dannjjm	3026	3	PFA-100	PFA-100	NNP
cord-023095-4dannjjm	3026	4	s	s	XX
cord-023095-4dannjjm	3026	5	;	;	:
cord-023095-4dannjjm	3026	6	collagen/	collagen/	CD
cord-023095-4dannjjm	3026	7	epinephrine	epinephrine	NN
cord-023095-4dannjjm	3026	8	cartridges	cartridge	NNS
cord-023095-4dannjjm	3026	9	)	)	-RRB-
cord-023095-4dannjjm	3026	10	,	,	,
cord-023095-4dannjjm	3026	11	was	be	VBD
cord-023095-4dannjjm	3026	12	stratified	stratify	VBN
cord-023095-4dannjjm	3026	13	into	into	IN
cord-023095-4dannjjm	3026	14	one	one	CD
cord-023095-4dannjjm	3026	15	of	of	IN
cord-023095-4dannjjm	3026	16	three	three	CD
cord-023095-4dannjjm	3026	17	groups	group	NNS
cord-023095-4dannjjm	3026	18	[	[	-LRB-
cord-023095-4dannjjm	3026	19	aspirin	aspirin	NN
cord-023095-4dannjjm	3026	20	responders	responder	NNS
cord-023095-4dannjjm	3026	21	(	(	-LRB-
cord-023095-4dannjjm	3026	22	9	9	CD
cord-023095-4dannjjm	3026	23	dogs	dog	NNS
cord-023095-4dannjjm	3026	24	)	)	-RRB-
cord-023095-4dannjjm	3026	25	,	,	,
cord-023095-4dannjjm	3026	26	non	non	NNS
cord-023095-4dannjjm	3026	27	-	-	NNS
cord-023095-4dannjjm	3026	28	responders	responder	NNS
cord-023095-4dannjjm	3026	29	(	(	-LRB-
cord-023095-4dannjjm	3026	30	8	8	CD
cord-023095-4dannjjm	3026	31	dogs	dog	NNS
cord-023095-4dannjjm	3026	32	)	)	-RRB-
cord-023095-4dannjjm	3026	33	,	,	,
cord-023095-4dannjjm	3026	34	or	or	CC
cord-023095-4dannjjm	3026	35	inconsistent	inconsistent	JJ
cord-023095-4dannjjm	3026	36	responders	responder	NNS
cord-023095-4dannjjm	3026	37	(	(	-LRB-
cord-023095-4dannjjm	3026	38	8	8	CD
cord-023095-4dannjjm	3026	39	dogs	dog	NNS
cord-023095-4dannjjm	3026	40	)	)	-RRB-
cord-023095-4dannjjm	3026	41	]	]	-RRB-
cord-023095-4dannjjm	3026	42	.	.	.
cord-023095-4dannjjm	3027	1	Flow	flow	NN
cord-023095-4dannjjm	3027	2	cytometry	cytometry	NN
cord-023095-4dannjjm	3027	3	identified	identify	VBD
cord-023095-4dannjjm	3027	4	platelet	platelet	NN
cord-023095-4dannjjm	3027	5	COX-1	cox-1	JJ
cord-023095-4dannjjm	3027	6	and	and	CC
cord-023095-4dannjjm	3027	7	COX-2	cox-2	JJ
cord-023095-4dannjjm	3027	8	expression	expression	NN
cord-023095-4dannjjm	3027	9	.	.	.
cord-023095-4dannjjm	3028	1	An	an	DT
cord-023095-4dannjjm	3028	2	ELISA	ELISA	NNP
cord-023095-4dannjjm	3028	3	was	be	VBD
cord-023095-4dannjjm	3028	4	used	use	VBN
cord-023095-4dannjjm	3028	5	to	to	TO
cord-023095-4dannjjm	3028	6	measure	measure	VB
cord-023095-4dannjjm	3028	7	urine	urine	NN
cord-023095-4dannjjm	3028	8	11-dehydro	11-dehydro	CD
cord-023095-4dannjjm	3028	9	-	-	HYPH
cord-023095-4dannjjm	3028	10	thromboxane	thromboxane	NN
cord-023095-4dannjjm	3028	11	B	b	NN
cord-023095-4dannjjm	3028	12	2	2	CD
cord-023095-4dannjjm	3028	13	(	(	-LRB-
cord-023095-4dannjjm	3028	14	11-dTXB	11-dtxb	CD
cord-023095-4dannjjm	3028	15	2	2	CD
cord-023095-4dannjjm	3028	16	)	)	-RRB-
cord-023095-4dannjjm	3028	17	.	.	.
cord-023095-4dannjjm	3029	1	There	there	EX
cord-023095-4dannjjm	3029	2	were	be	VBD
cord-023095-4dannjjm	3029	3	no	no	DT
cord-023095-4dannjjm	3029	4	significant	significant	JJ
cord-023095-4dannjjm	3029	5	differences	difference	NNS
cord-023095-4dannjjm	3029	6	between	between	IN
cord-023095-4dannjjm	3029	7	groups	group	NNS
cord-023095-4dannjjm	3029	8	for	for	IN
cord-023095-4dannjjm	3029	9	COX-1	COX-1	NNP
cord-023095-4dannjjm	3029	10	,	,	,
cord-023095-4dannjjm	3029	11	COX-2	COX-2	NNP
cord-023095-4dannjjm	3029	12	or	or	CC
cord-023095-4dannjjm	3029	13	11-dTXB	11-dtxb	CD
cord-023095-4dannjjm	3029	14	2	2	CD
cord-023095-4dannjjm	3029	15	at	at	IN
cord-023095-4dannjjm	3029	16	any	any	DT
cord-023095-4dannjjm	3029	17	time	time	NN
cord-023095-4dannjjm	3029	18	point	point	NN
cord-023095-4dannjjm	3029	19	.	.	.
cord-023095-4dannjjm	3030	1	When	when	WRB
cord-023095-4dannjjm	3030	2	all	all	DT
cord-023095-4dannjjm	3030	3	dogs	dog	NNS
cord-023095-4dannjjm	3030	4	were	be	VBD
cord-023095-4dannjjm	3030	5	considered	consider	VBN
cord-023095-4dannjjm	3030	6	as	as	IN
cord-023095-4dannjjm	3030	7	a	a	DT
cord-023095-4dannjjm	3030	8	single	single	JJ
cord-023095-4dannjjm	3030	9	group	group	NN
cord-023095-4dannjjm	3030	10	,	,	,
cord-023095-4dannjjm	3030	11	there	there	EX
cord-023095-4dannjjm	3030	12	was	be	VBD
cord-023095-4dannjjm	3030	13	a	a	DT
cord-023095-4dannjjm	3030	14	significant	significant	JJ
cord-023095-4dannjjm	3030	15	increase	increase	NN
cord-023095-4dannjjm	3030	16	(	(	-LRB-
cord-023095-4dannjjm	3030	17	p	p	NN
cord-023095-4dannjjm	3030	18	o	o	NN
cord-023095-4dannjjm	3030	19	0.0001Ã	0.0001ã	CD
cord-023095-4dannjjm	3030	20	)	)	-RRB-
cord-023095-4dannjjm	3030	21	in	in	IN
cord-023095-4dannjjm	3030	22	COX-1	COX-1	NNP
cord-023095-4dannjjm	3030	23	and	and	CC
cord-023095-4dannjjm	3030	24	COX-2	COX-2	NNP
cord-023095-4dannjjm	3030	25	mean	mean	VB
cord-023095-4dannjjm	3030	26	fluorescent	fluorescent	JJ
cord-023095-4dannjjm	3030	27	intensity	intensity	NN
cord-023095-4dannjjm	3030	28	(	(	-LRB-
cord-023095-4dannjjm	3030	29	MFI	MFI	NNP
cord-023095-4dannjjm	3030	30	)	)	-RRB-
cord-023095-4dannjjm	3030	31	from	from	IN
cord-023095-4dannjjm	3030	32	baseline	baseline	NN
cord-023095-4dannjjm	3030	33	to	to	IN
cord-023095-4dannjjm	3030	34	Day	Day	NNP
cord-023095-4dannjjm	3030	35	10	10	CD
cord-023095-4dannjjm	3030	36	,	,	,
cord-023095-4dannjjm	3030	37	70.1	70.1	CD
cord-023095-4dannjjm	3030	38	%	%	NN
cord-023095-4dannjjm	3030	39	AE	AE	NNP
cord-023095-4dannjjm	3030	40	38.0	38.0	CD
cord-023095-4dannjjm	3030	41	(	(	-LRB-
cord-023095-4dannjjm	3030	42	mean	mean	UH
cord-023095-4dannjjm	3030	43	AE	AE	NNP
cord-023095-4dannjjm	3030	44	SD	SD	NNP
cord-023095-4dannjjm	3030	45	)	)	-RRB-
cord-023095-4dannjjm	3030	46	and	and	CC
cord-023095-4dannjjm	3030	47	70.8	70.8	CD
cord-023095-4dannjjm	3030	48	%	%	NN
cord-023095-4dannjjm	3030	49	AE	AE	NNP
cord-023095-4dannjjm	3030	50	71.2	71.2	CD
cord-023095-4dannjjm	3030	51	,	,	,
cord-023095-4dannjjm	3030	52	respectively	respectively	RB
cord-023095-4dannjjm	3030	53	.	.	.
cord-023095-4dannjjm	3031	1	There	there	EX
cord-023095-4dannjjm	3031	2	was	be	VBD
cord-023095-4dannjjm	3031	3	a	a	DT
cord-023095-4dannjjm	3031	4	significant	significant	JJ
cord-023095-4dannjjm	3031	5	decrease	decrease	NN
cord-023095-4dannjjm	3031	6	in	in	IN
cord-023095-4dannjjm	3031	7	mean	mean	JJ
cord-023095-4dannjjm	3031	8	urine	urine	NN
cord-023095-4dannjjm	3031	9	11-dTXB	11-dtxb	CD
cord-023095-4dannjjm	3031	10	2	2	CD
cord-023095-4dannjjm	3032	1	:	:	:
cord-023095-4dannjjm	3032	2	creatinine	creatinine	NN
cord-023095-4dannjjm	3032	3	on	on	IN
cord-023095-4dannjjm	3032	4	Day	Day	NNP
cord-023095-4dannjjm	3032	5	3	3	CD
cord-023095-4dannjjm	3032	6	and	and	CC
cord-023095-4dannjjm	3032	7	10	10	CD
cord-023095-4dannjjm	3032	8	by	by	IN
cord-023095-4dannjjm	3032	9	23.4	23.4	CD
cord-023095-4dannjjm	3032	10	%	%	NN
cord-023095-4dannjjm	3032	11	(	(	-LRB-
cord-023095-4dannjjm	3032	12	p	p	NN
cord-023095-4dannjjm	3032	13	5	5	CD
cord-023095-4dannjjm	3032	14	0.0044	0.0044	CD
cord-023095-4dannjjm	3032	15	Ã	Ã	NNP
cord-023095-4dannjjm	3032	16	)	)	-RRB-
cord-023095-4dannjjm	3032	17	and	and	CC
cord-023095-4dannjjm	3032	18	45	45	CD
cord-023095-4dannjjm	3032	19	%	%	NN
cord-023095-4dannjjm	3032	20	(	(	-LRB-
cord-023095-4dannjjm	3032	21	p	p	NN
cord-023095-4dannjjm	3032	22	o	o	NN
cord-023095-4dannjjm	3032	23	0.0001	0.0001	CD
cord-023095-4dannjjm	3032	24	Ã	Ã	NNP
cord-023095-4dannjjm	3032	25	)	)	-RRB-
cord-023095-4dannjjm	3032	26	.	.	.
cord-023095-4dannjjm	3033	1	As	as	IN
cord-023095-4dannjjm	3033	2	with	with	IN
cord-023095-4dannjjm	3033	3	our	-PRON-	PRP$
cord-023095-4dannjjm	3033	4	previous	previous	JJ
cord-023095-4dannjjm	3033	5	high	high	JJ
cord-023095-4dannjjm	3033	6	dose	dose	NN
cord-023095-4dannjjm	3033	7	studies	study	NNS
cord-023095-4dannjjm	3033	8	,	,	,
cord-023095-4dannjjm	3033	9	COX-1	cox-1	JJ
cord-023095-4dannjjm	3033	10	expression	expression	NN
cord-023095-4dannjjm	3033	11	was	be	VBD
cord-023095-4dannjjm	3033	12	increased	increase	VBN
cord-023095-4dannjjm	3033	13	with	with	IN
cord-023095-4dannjjm	3033	14	aspirin	aspirin	NN
cord-023095-4dannjjm	3033	15	exposure	exposure	NN
cord-023095-4dannjjm	3033	16	.	.	.
cord-023095-4dannjjm	3034	1	However	however	RB
cord-023095-4dannjjm	3034	2	,	,	,
cord-023095-4dannjjm	3034	3	there	there	EX
cord-023095-4dannjjm	3034	4	was	be	VBD
cord-023095-4dannjjm	3034	5	a	a	DT
cord-023095-4dannjjm	3034	6	significant	significant	JJ
cord-023095-4dannjjm	3034	7	increase	increase	NN
cord-023095-4dannjjm	3034	8	in	in	IN
cord-023095-4dannjjm	3034	9	COX-2	cox-2	JJ
cord-023095-4dannjjm	3034	10	expression	expression	NN
cord-023095-4dannjjm	3034	11	with	with	IN
cord-023095-4dannjjm	3034	12	low	low	JJ
cord-023095-4dannjjm	3034	13	dose	dose	NN
cord-023095-4dannjjm	3034	14	aspirin	aspirin	NN
cord-023095-4dannjjm	3034	15	in	in	IN
cord-023095-4dannjjm	3034	16	contrast	contrast	NN
cord-023095-4dannjjm	3034	17	to	to	IN
cord-023095-4dannjjm	3034	18	the	the	DT
cord-023095-4dannjjm	3034	19	decrease	decrease	NN
cord-023095-4dannjjm	3034	20	seen	see	VBN
cord-023095-4dannjjm	3034	21	at	at	IN
cord-023095-4dannjjm	3034	22	higher	high	JJR
cord-023095-4dannjjm	3034	23	doses	dose	NNS
cord-023095-4dannjjm	3034	24	.	.	.
cord-023095-4dannjjm	3035	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	3035	2	study	study	NN
cord-023095-4dannjjm	3035	3	suggests	suggest	VBZ
cord-023095-4dannjjm	3035	4	that	that	IN
cord-023095-4dannjjm	3035	5	levels	level	NNS
cord-023095-4dannjjm	3035	6	of	of	IN
cord-023095-4dannjjm	3035	7	platelet	platelet	NN
cord-023095-4dannjjm	3035	8	COX-1	cox-1	JJ
cord-023095-4dannjjm	3035	9	and	and	CC
cord-023095-4dannjjm	3035	10	COX-2	cox-2	JJ
cord-023095-4dannjjm	3035	11	expression	expression	NN
cord-023095-4dannjjm	3035	12	do	do	VBP
cord-023095-4dannjjm	3035	13	not	not	RB
cord-023095-4dannjjm	3035	14	influence	influence	VB
cord-023095-4dannjjm	3035	15	aspirin	aspirin	NN
cord-023095-4dannjjm	3035	16	response	response	NN
cord-023095-4dannjjm	3035	17	in	in	IN
cord-023095-4dannjjm	3035	18	dogs	dog	NNS
cord-023095-4dannjjm	3035	19	.	.	.
cord-023095-4dannjjm	3036	1	Although	although	IN
cord-023095-4dannjjm	3036	2	thromboxane	thromboxane	NN
cord-023095-4dannjjm	3036	3	levels	level	NNS
cord-023095-4dannjjm	3036	4	decreased	decrease	VBD
cord-023095-4dannjjm	3036	5	in	in	IN
cord-023095-4dannjjm	3036	6	most	most	RBS
cord-023095-4dannjjm	3036	7	(	(	-LRB-
cord-023095-4dannjjm	3036	8	23	23	CD
cord-023095-4dannjjm	3036	9	of	of	IN
cord-023095-4dannjjm	3036	10	25	25	CD
cord-023095-4dannjjm	3036	11	)	)	-RRB-
cord-023095-4dannjjm	3036	12	dogs	dog	NNS
cord-023095-4dannjjm	3036	13	on	on	IN
cord-023095-4dannjjm	3036	14	low	low	JJ
cord-023095-4dannjjm	3036	15	dose	dose	NN
cord-023095-4dannjjm	3036	16	aspirin	aspirin	NN
cord-023095-4dannjjm	3036	17	,	,	,
cord-023095-4dannjjm	3036	18	platelet	platelet	NN
cord-023095-4dannjjm	3036	19	function	function	NN
cord-023095-4dannjjm	3036	20	was	be	VBD
cord-023095-4dannjjm	3036	21	consistently	consistently	RB
cord-023095-4dannjjm	3036	22	affected	affect	VBN
cord-023095-4dannjjm	3036	23	in	in	IN
cord-023095-4dannjjm	3036	24	only	only	RB
cord-023095-4dannjjm	3036	25	36	36	CD
cord-023095-4dannjjm	3036	26	%	%	NN
cord-023095-4dannjjm	3036	27	of	of	IN
cord-023095-4dannjjm	3036	28	dogs	dog	NNS
cord-023095-4dannjjm	3036	29	,	,	,
cord-023095-4dannjjm	3036	30	suggesting	suggest	VBG
cord-023095-4dannjjm	3036	31	that	that	IN
cord-023095-4dannjjm	3036	32	differences	difference	NNS
cord-023095-4dannjjm	3036	33	in	in	IN
cord-023095-4dannjjm	3036	34	response	response	NN
cord-023095-4dannjjm	3036	35	to	to	IN
cord-023095-4dannjjm	3036	36	thromboxane	thromboxane	NN
cord-023095-4dannjjm	3036	37	may	may	MD
cord-023095-4dannjjm	3036	38	play	play	VB
cord-023095-4dannjjm	3036	39	a	a	DT
cord-023095-4dannjjm	3036	40	role	role	NN
cord-023095-4dannjjm	3036	41	in	in	IN
cord-023095-4dannjjm	3036	42	the	the	DT
cord-023095-4dannjjm	3036	43	variable	variable	JJ
cord-023095-4dannjjm	3036	44	affects	affect	NNS
cord-023095-4dannjjm	3036	45	of	of	IN
cord-023095-4dannjjm	3036	46	low	low	JJ
cord-023095-4dannjjm	3036	47	dose	dose	NN
cord-023095-4dannjjm	3036	48	aspirin	aspirin	NN
cord-023095-4dannjjm	3036	49	on	on	IN
cord-023095-4dannjjm	3036	50	canine	canine	JJ
cord-023095-4dannjjm	3036	51	platelet	platelet	NN
cord-023095-4dannjjm	3036	52	function	function	NN
cord-023095-4dannjjm	3036	53	.	.	.
cord-023095-4dannjjm	3037	1	Delayed	delayed	JJ
cord-023095-4dannjjm	3037	2	postoperative	postoperative	JJ
cord-023095-4dannjjm	3037	3	bleeding	bleeding	NN
cord-023095-4dannjjm	3037	4	is	be	VBZ
cord-023095-4dannjjm	3037	5	common	common	JJ
cord-023095-4dannjjm	3037	6	in	in	IN
cord-023095-4dannjjm	3037	7	retired	retired	JJ
cord-023095-4dannjjm	3037	8	racing	racing	NN
cord-023095-4dannjjm	3037	9	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	3037	10	(	(	-LRB-
cord-023095-4dannjjm	3037	11	RRGs	RRGs	NNP
cord-023095-4dannjjm	3037	12	)	)	-RRB-
cord-023095-4dannjjm	3037	13	,	,	,
cord-023095-4dannjjm	3037	14	despite	despite	IN
cord-023095-4dannjjm	3037	15	normal	normal	JJ
cord-023095-4dannjjm	3037	16	results	result	NNS
cord-023095-4dannjjm	3037	17	of	of	IN
cord-023095-4dannjjm	3037	18	routine	routine	JJ
cord-023095-4dannjjm	3037	19	hemostasis	hemostasis	NN
cord-023095-4dannjjm	3037	20	assays	assay	NNS
cord-023095-4dannjjm	3037	21	.	.	.
cord-023095-4dannjjm	3038	1	The	the	DT
cord-023095-4dannjjm	3038	2	excessive	excessive	JJ
cord-023095-4dannjjm	3038	3	postoperative	postoperative	JJ
cord-023095-4dannjjm	3038	4	bleeding	bleeding	NN
cord-023095-4dannjjm	3038	5	in	in	IN
cord-023095-4dannjjm	3038	6	the	the	DT
cord-023095-4dannjjm	3038	7	RRGs	rrg	NNS
cord-023095-4dannjjm	3038	8	is	be	VBZ
cord-023095-4dannjjm	3038	9	not	not	RB
cord-023095-4dannjjm	3038	10	due	due	JJ
cord-023095-4dannjjm	3038	11	to	to	IN
cord-023095-4dannjjm	3038	12	primary	primary	JJ
cord-023095-4dannjjm	3038	13	or	or	CC
cord-023095-4dannjjm	3038	14	secondary	secondary	JJ
cord-023095-4dannjjm	3038	15	hemostatic	hemostatic	JJ
cord-023095-4dannjjm	3038	16	defects	defect	NNS
cord-023095-4dannjjm	3038	17	,	,	,
cord-023095-4dannjjm	3038	18	and	and	CC
cord-023095-4dannjjm	3038	19	may	may	MD
cord-023095-4dannjjm	3038	20	be	be	VB
cord-023095-4dannjjm	3038	21	due	due	JJ
cord-023095-4dannjjm	3038	22	to	to	IN
cord-023095-4dannjjm	3038	23	enhanced	enhance	VBN
cord-023095-4dannjjm	3038	24	fibrinolysis	fibrinolysis	NN
cord-023095-4dannjjm	3038	25	or	or	CC
cord-023095-4dannjjm	3038	26	to	to	IN
cord-023095-4dannjjm	3038	27	a	a	DT
cord-023095-4dannjjm	3038	28	clot	clot	NN
cord-023095-4dannjjm	3038	29	maintenance	maintenance	NN
cord-023095-4dannjjm	3038	30	dysfunction	dysfunction	NN
cord-023095-4dannjjm	3038	31	.	.	.
cord-023095-4dannjjm	3039	1	Providing	provide	VBG
cord-023095-4dannjjm	3039	2	a	a	DT
cord-023095-4dannjjm	3039	3	method	method	NN
cord-023095-4dannjjm	3039	4	to	to	TO
cord-023095-4dannjjm	3039	5	prevent	prevent	VB
cord-023095-4dannjjm	3039	6	or	or	CC
cord-023095-4dannjjm	3039	7	minimize	minimize	VB
cord-023095-4dannjjm	3039	8	the	the	DT
cord-023095-4dannjjm	3039	9	severity	severity	NN
cord-023095-4dannjjm	3039	10	of	of	IN
cord-023095-4dannjjm	3039	11	postoperative	postoperative	JJ
cord-023095-4dannjjm	3039	12	bleeding	bleeding	NN
cord-023095-4dannjjm	3039	13	in	in	IN
cord-023095-4dannjjm	3039	14	RRGs	rrg	NNS
cord-023095-4dannjjm	3039	15	will	will	MD
cord-023095-4dannjjm	3039	16	not	not	RB
cord-023095-4dannjjm	3039	17	only	only	RB
cord-023095-4dannjjm	3039	18	have	have	VB
cord-023095-4dannjjm	3039	19	major	major	JJ
cord-023095-4dannjjm	3039	20	economic	economic	JJ
cord-023095-4dannjjm	3039	21	impact	impact	NN
cord-023095-4dannjjm	3039	22	for	for	IN
cord-023095-4dannjjm	3039	23	owners	owner	NNS
cord-023095-4dannjjm	3039	24	,	,	,
cord-023095-4dannjjm	3039	25	but	but	CC
cord-023095-4dannjjm	3039	26	also	also	RB
cord-023095-4dannjjm	3039	27	will	will	MD
cord-023095-4dannjjm	3039	28	markedly	markedly	RB
cord-023095-4dannjjm	3039	29	decrease	decrease	VB
cord-023095-4dannjjm	3039	30	the	the	DT
cord-023095-4dannjjm	3039	31	associated	associate	VBN
cord-023095-4dannjjm	3039	32	complications	complication	NNS
cord-023095-4dannjjm	3039	33	of	of	IN
cord-023095-4dannjjm	3039	34	minor	minor	JJ
cord-023095-4dannjjm	3039	35	or	or	CC
cord-023095-4dannjjm	3039	36	major	major	JJ
cord-023095-4dannjjm	3039	37	surgeries	surgery	NNS
cord-023095-4dannjjm	3039	38	in	in	IN
cord-023095-4dannjjm	3039	39	the	the	DT
cord-023095-4dannjjm	3039	40	breed	breed	NN
cord-023095-4dannjjm	3039	41	.	.	.
cord-023095-4dannjjm	3040	1	Epsilon	Epsilon	NNP
cord-023095-4dannjjm	3040	2	aminocaproic	aminocaproic	NNP
cord-023095-4dannjjm	3040	3	acid	acid	NN
cord-023095-4dannjjm	3040	4	(	(	-LRB-
cord-023095-4dannjjm	3040	5	EACA	EACA	NNP
cord-023095-4dannjjm	3040	6	)	)	-RRB-
cord-023095-4dannjjm	3040	7	is	be	VBZ
cord-023095-4dannjjm	3040	8	a	a	DT
cord-023095-4dannjjm	3040	9	potent	potent	JJ
cord-023095-4dannjjm	3040	10	inhibitor	inhibitor	NN
cord-023095-4dannjjm	3040	11	of	of	IN
cord-023095-4dannjjm	3040	12	fibrinolysis	fibrinolysis	NN
cord-023095-4dannjjm	3040	13	that	that	WDT
cord-023095-4dannjjm	3040	14	also	also	RB
cord-023095-4dannjjm	3040	15	supports	support	VBZ
cord-023095-4dannjjm	3040	16	clot	clot	NN
cord-023095-4dannjjm	3040	17	maintenance	maintenance	NN
cord-023095-4dannjjm	3040	18	due	due	JJ
cord-023095-4dannjjm	3040	19	to	to	IN
cord-023095-4dannjjm	3040	20	unknown	unknown	JJ
cord-023095-4dannjjm	3040	21	mechanisms	mechanism	NNS
cord-023095-4dannjjm	3040	22	.	.	.
cord-023095-4dannjjm	3041	1	The	the	DT
cord-023095-4dannjjm	3041	2	objective	objective	NN
cord-023095-4dannjjm	3041	3	of	of	IN
cord-023095-4dannjjm	3041	4	this	this	DT
cord-023095-4dannjjm	3041	5	double	double	JJ
cord-023095-4dannjjm	3041	6	-	-	HYPH
cord-023095-4dannjjm	3041	7	blinded	blinded	JJ
cord-023095-4dannjjm	3041	8	,	,	,
cord-023095-4dannjjm	3041	9	prospective	prospective	JJ
cord-023095-4dannjjm	3041	10	,	,	,
cord-023095-4dannjjm	3041	11	randomized	randomized	JJ
cord-023095-4dannjjm	3041	12	study	study	NN
cord-023095-4dannjjm	3041	13	was	be	VBD
cord-023095-4dannjjm	3041	14	to	to	TO
cord-023095-4dannjjm	3041	15	evaluate	evaluate	VB
cord-023095-4dannjjm	3041	16	the	the	DT
cord-023095-4dannjjm	3041	17	effects	effect	NNS
cord-023095-4dannjjm	3041	18	of	of	IN
cord-023095-4dannjjm	3041	19	EACA	EACA	NNS
cord-023095-4dannjjm	3041	20	versus	versus	IN
cord-023095-4dannjjm	3041	21	placebo	placebo	NN
cord-023095-4dannjjm	3041	22	on	on	IN
cord-023095-4dannjjm	3041	23	the	the	DT
cord-023095-4dannjjm	3041	24	prevalence	prevalence	NN
cord-023095-4dannjjm	3041	25	of	of	IN
cord-023095-4dannjjm	3041	26	bleeding	bleed	VBG
cord-023095-4dannjjm	3041	27	in	in	IN
cord-023095-4dannjjm	3041	28	RRGs	rrg	NNS
cord-023095-4dannjjm	3041	29	,	,	,
cord-023095-4dannjjm	3041	30	and	and	CC
cord-023095-4dannjjm	3041	31	to	to	TO
cord-023095-4dannjjm	3041	32	investigate	investigate	VB
cord-023095-4dannjjm	3041	33	its	-PRON-	PRP$
cord-023095-4dannjjm	3041	34	mechanism	mechanism	NN
cord-023095-4dannjjm	3041	35	of	of	IN
cord-023095-4dannjjm	3041	36	action	action	NN
cord-023095-4dannjjm	3041	37	by	by	IN
cord-023095-4dannjjm	3041	38	using	use	VBG
cord-023095-4dannjjm	3041	39	thromboelastography	thromboelastography	NNP
cord-023095-4dannjjm	3041	40	(	(	-LRB-
cord-023095-4dannjjm	3041	41	TEG	TEG	NNP
cord-023095-4dannjjm	3041	42	)	)	-RRB-
cord-023095-4dannjjm	3041	43	.	.	.
cord-023095-4dannjjm	3042	1	We	-PRON-	PRP
cord-023095-4dannjjm	3042	2	compared	compare	VBD
cord-023095-4dannjjm	3042	3	the	the	DT
cord-023095-4dannjjm	3042	4	effects	effect	NNS
cord-023095-4dannjjm	3042	5	of	of	IN
cord-023095-4dannjjm	3042	6	EACA	EACA	NNS
cord-023095-4dannjjm	3042	7	and	and	CC
cord-023095-4dannjjm	3042	8	placebo	placebo	NN
cord-023095-4dannjjm	3042	9	in	in	IN
cord-023095-4dannjjm	3042	10	100	100	CD
cord-023095-4dannjjm	3042	11	RRGs	rrg	NNS
cord-023095-4dannjjm	3042	12	that	that	WDT
cord-023095-4dannjjm	3042	13	underwent	undergo	VBD
cord-023095-4dannjjm	3042	14	elective	elective	JJ
cord-023095-4dannjjm	3042	15	ovariohysterectomy	ovariohysterectomy	NN
cord-023095-4dannjjm	3042	16	or	or	CC
cord-023095-4dannjjm	3042	17	orchiectomy	orchiectomy	NN
cord-023095-4dannjjm	3042	18	at	at	IN
cord-023095-4dannjjm	3042	19	the	the	DT
cord-023095-4dannjjm	3042	20	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	3042	21	Medical	Medical	NNP
cord-023095-4dannjjm	3042	22	Center	Center	NNP
cord-023095-4dannjjm	3042	23	,	,	,
cord-023095-4dannjjm	3042	24	The	the	DT
cord-023095-4dannjjm	3042	25	Ohio	Ohio	NNP
cord-023095-4dannjjm	3042	26	State	State	NNP
cord-023095-4dannjjm	3042	27	University	University	NNP
cord-023095-4dannjjm	3042	28	during	during	IN
cord-023095-4dannjjm	3042	29	2	2	CD
cord-023095-4dannjjm	3042	30	years	year	NNS
cord-023095-4dannjjm	3042	31	.	.	.
cord-023095-4dannjjm	3043	1	The	the	DT
cord-023095-4dannjjm	3043	2	main	main	JJ
cord-023095-4dannjjm	3043	3	endpoint	endpoint	NN
cord-023095-4dannjjm	3043	4	was	be	VBD
cord-023095-4dannjjm	3043	5	bleeding	bleed	VBG
cord-023095-4dannjjm	3043	6	(	(	-LRB-
cord-023095-4dannjjm	3043	7	prevalence	prevalence	NN
cord-023095-4dannjjm	3043	8	and	and	CC
cord-023095-4dannjjm	3043	9	severity	severity	NN
cord-023095-4dannjjm	3043	10	)	)	-RRB-
cord-023095-4dannjjm	3043	11	;	;	,
cord-023095-4dannjjm	3043	12	minor	minor	JJ
cord-023095-4dannjjm	3043	13	endpoints	endpoint	NNS
cord-023095-4dannjjm	3043	14	included	include	VBD
cord-023095-4dannjjm	3043	15	most	most	JJS
cord-023095-4dannjjm	3043	16	TEG	TEG	NNP
cord-023095-4dannjjm	3043	17	parameters	parameter	NNS
cord-023095-4dannjjm	3043	18	.	.	.
cord-023095-4dannjjm	3044	1	Thirty	thirty	CD
cord-023095-4dannjjm	3044	2	percent	percent	NN
cord-023095-4dannjjm	3044	3	(	(	-LRB-
cord-023095-4dannjjm	3044	4	15/50	15/50	CD
cord-023095-4dannjjm	3044	5	)	)	-RRB-
cord-023095-4dannjjm	3044	6	of	of	IN
cord-023095-4dannjjm	3044	7	the	the	DT
cord-023095-4dannjjm	3044	8	RRGs	rrg	NNS
cord-023095-4dannjjm	3044	9	in	in	IN
cord-023095-4dannjjm	3044	10	the	the	DT
cord-023095-4dannjjm	3044	11	placebo	placebo	NN
cord-023095-4dannjjm	3044	12	group	group	NN
cord-023095-4dannjjm	3044	13	had	have	VBD
cord-023095-4dannjjm	3044	14	delayed	delay	VBN
cord-023095-4dannjjm	3044	15	postoperative	postoperative	JJ
cord-023095-4dannjjm	3044	16	bleeding	bleeding	NN
cord-023095-4dannjjm	3044	17	starting	start	VBG
cord-023095-4dannjjm	3044	18	36	36	CD
cord-023095-4dannjjm	3044	19	to	to	TO
cord-023095-4dannjjm	3044	20	48	48	CD
cord-023095-4dannjjm	3044	21	hours	hour	NNS
cord-023095-4dannjjm	3044	22	after	after	IN
cord-023095-4dannjjm	3044	23	surgery	surgery	NN
cord-023095-4dannjjm	3044	24	,	,	,
cord-023095-4dannjjm	3044	25	compared	compare	VBN
cord-023095-4dannjjm	3044	26	to	to	IN
cord-023095-4dannjjm	3044	27	10	10	CD
cord-023095-4dannjjm	3044	28	%	%	NN
cord-023095-4dannjjm	3044	29	(	(	-LRB-
cord-023095-4dannjjm	3044	30	5/50	5/50	CD
cord-023095-4dannjjm	3044	31	)	)	-RRB-
cord-023095-4dannjjm	3044	32	in	in	IN
cord-023095-4dannjjm	3044	33	the	the	DT
cord-023095-4dannjjm	3044	34	EACA	EACA	NNP
cord-023095-4dannjjm	3044	35	group	group	NN
cord-023095-4dannjjm	3044	36	(	(	-LRB-
cord-023095-4dannjjm	3044	37	P	p	NN
cord-023095-4dannjjm	3044	38	5	5	CD
cord-023095-4dannjjm	3044	39	0.0124	0.0124	CD
cord-023095-4dannjjm	3044	40	)	)	-RRB-
cord-023095-4dannjjm	3044	41	.	.	.
cord-023095-4dannjjm	3045	1	On	on	IN
cord-023095-4dannjjm	3045	2	the	the	DT
cord-023095-4dannjjm	3045	3	TEG	TEG	NNP
cord-023095-4dannjjm	3045	4	parameters	parameter	NNS
cord-023095-4dannjjm	3045	5	,	,	,
cord-023095-4dannjjm	3045	6	the	the	DT
cord-023095-4dannjjm	3045	7	R	R	NNP
cord-023095-4dannjjm	3045	8	time	time	NN
cord-023095-4dannjjm	3045	9	(	(	-LRB-
cord-023095-4dannjjm	3045	10	clot	clot	NN
cord-023095-4dannjjm	3045	11	formation	formation	NN
cord-023095-4dannjjm	3045	12	time	time	NN
cord-023095-4dannjjm	3045	13	)	)	-RRB-
cord-023095-4dannjjm	3045	14	was	be	VBD
cord-023095-4dannjjm	3045	15	significantly	significantly	RB
cord-023095-4dannjjm	3045	16	different	different	JJ
cord-023095-4dannjjm	3045	17	between	between	IN
cord-023095-4dannjjm	3045	18	treatment	treatment	NN
cord-023095-4dannjjm	3045	19	groups	group	NNS
cord-023095-4dannjjm	3045	20	(	(	-LRB-
cord-023095-4dannjjm	3045	21	P	p	NN
cord-023095-4dannjjm	3045	22	5	5	CD
cord-023095-4dannjjm	3045	23	0.0321	0.0321	CD
cord-023095-4dannjjm	3045	24	)	)	-RRB-
cord-023095-4dannjjm	3045	25	.	.	.
cord-023095-4dannjjm	3046	1	The	the	DT
cord-023095-4dannjjm	3046	2	postoperative	postoperative	JJ
cord-023095-4dannjjm	3046	3	administration	administration	NN
cord-023095-4dannjjm	3046	4	of	of	IN
cord-023095-4dannjjm	3046	5	EACA	EACA	NNP
cord-023095-4dannjjm	3046	6	significantly	significantly	RB
cord-023095-4dannjjm	3046	7	decreased	decrease	VBD
cord-023095-4dannjjm	3046	8	the	the	DT
cord-023095-4dannjjm	3046	9	prevalence	prevalence	NN
cord-023095-4dannjjm	3046	10	of	of	IN
cord-023095-4dannjjm	3046	11	postoperative	postoperative	JJ
cord-023095-4dannjjm	3046	12	bleeding	bleeding	NN
cord-023095-4dannjjm	3046	13	in	in	IN
cord-023095-4dannjjm	3046	14	RRGs	rrg	NNS
cord-023095-4dannjjm	3046	15	.	.	.
cord-023095-4dannjjm	3047	1	Thromboembolism	Thromboembolism	NNP
cord-023095-4dannjjm	3047	2	associated	associate	VBN
cord-023095-4dannjjm	3047	3	with	with	IN
cord-023095-4dannjjm	3047	4	protein	protein	NN
cord-023095-4dannjjm	3047	5	losing	lose	VBG
cord-023095-4dannjjm	3047	6	nephropathy	nephropathy	NN
cord-023095-4dannjjm	3047	7	(	(	-LRB-
cord-023095-4dannjjm	3047	8	PLN	PLN	NNP
cord-023095-4dannjjm	3047	9	)	)	-RRB-
cord-023095-4dannjjm	3047	10	has	have	VBZ
cord-023095-4dannjjm	3047	11	been	be	VBN
cord-023095-4dannjjm	3047	12	long	long	RB
cord-023095-4dannjjm	3047	13	recognized	recognize	VBN
cord-023095-4dannjjm	3047	14	as	as	IN
cord-023095-4dannjjm	3047	15	a	a	DT
cord-023095-4dannjjm	3047	16	serious	serious	JJ
cord-023095-4dannjjm	3047	17	and	and	CC
cord-023095-4dannjjm	3047	18	unpredictable	unpredictable	JJ
cord-023095-4dannjjm	3047	19	complication	complication	NN
cord-023095-4dannjjm	3047	20	in	in	IN
cord-023095-4dannjjm	3047	21	dogs	dog	NNS
cord-023095-4dannjjm	3047	22	,	,	,
cord-023095-4dannjjm	3047	23	however	however	RB
cord-023095-4dannjjm	3047	24	its	-PRON-	PRP$
cord-023095-4dannjjm	3047	25	prevalence	prevalence	NN
cord-023095-4dannjjm	3047	26	remains	remain	VBZ
cord-023095-4dannjjm	3047	27	unknown	unknown	JJ
cord-023095-4dannjjm	3047	28	.	.	.
cord-023095-4dannjjm	3048	1	In	in	IN
cord-023095-4dannjjm	3048	2	humans	human	NNS
cord-023095-4dannjjm	3048	3	,	,	,
cord-023095-4dannjjm	3048	4	surrogate	surrogate	JJ
cord-023095-4dannjjm	3048	5	indicators	indicator	NNS
cord-023095-4dannjjm	3048	6	are	be	VBP
cord-023095-4dannjjm	3048	7	frequently	frequently	RB
cord-023095-4dannjjm	3048	8	used	use	VBN
cord-023095-4dannjjm	3048	9	to	to	TO
cord-023095-4dannjjm	3048	10	assess	assess	VB
cord-023095-4dannjjm	3048	11	thromboembolic	thromboembolic	JJ
cord-023095-4dannjjm	3048	12	risk	risk	NN
cord-023095-4dannjjm	3048	13	.	.	.
cord-023095-4dannjjm	3049	1	This	this	DT
cord-023095-4dannjjm	3049	2	study	study	NN
cord-023095-4dannjjm	3049	3	aimed	aim	VBD
cord-023095-4dannjjm	3049	4	to	to	TO
cord-023095-4dannjjm	3049	5	investigate	investigate	VB
cord-023095-4dannjjm	3049	6	the	the	DT
cord-023095-4dannjjm	3049	7	prevalence	prevalence	NN
cord-023095-4dannjjm	3049	8	of	of	IN
cord-023095-4dannjjm	3049	9	hypercoagulability	hypercoagulability	NN
cord-023095-4dannjjm	3049	10	in	in	IN
cord-023095-4dannjjm	3049	11	PLN	PLN	NNP
cord-023095-4dannjjm	3049	12	dogs	dog	NNS
cord-023095-4dannjjm	3049	13	based	base	VBN
cord-023095-4dannjjm	3049	14	on	on	IN
cord-023095-4dannjjm	3049	15	thromboelastography	thromboelastography	NNP
cord-023095-4dannjjm	3049	16	(	(	-LRB-
cord-023095-4dannjjm	3049	17	TEG	TEG	NNP
cord-023095-4dannjjm	3049	18	)	)	-RRB-
cord-023095-4dannjjm	3049	19	,	,	,
cord-023095-4dannjjm	3049	20	and	and	CC
cord-023095-4dannjjm	3049	21	to	to	TO
cord-023095-4dannjjm	3049	22	determine	determine	VB
cord-023095-4dannjjm	3049	23	whether	whether	IN
cord-023095-4dannjjm	3049	24	hypercoagulability	hypercoagulability	NN
cord-023095-4dannjjm	3049	25	in	in	IN
cord-023095-4dannjjm	3049	26	these	these	DT
cord-023095-4dannjjm	3049	27	patients	patient	NNS
cord-023095-4dannjjm	3049	28	could	could	MD
cord-023095-4dannjjm	3049	29	be	be	VB
cord-023095-4dannjjm	3049	30	predicted	predict	VBN
cord-023095-4dannjjm	3049	31	by	by	IN
cord-023095-4dannjjm	3049	32	clinical	clinical	JJ
cord-023095-4dannjjm	3049	33	assessments	assessment	NNS
cord-023095-4dannjjm	3049	34	that	that	WDT
cord-023095-4dannjjm	3049	35	identify	identify	VBP
cord-023095-4dannjjm	3049	36	systemic	systemic	JJ
cord-023095-4dannjjm	3049	37	hypertension	hypertension	NN
cord-023095-4dannjjm	3049	38	(	(	-LRB-
cord-023095-4dannjjm	3049	39	systolic	systolic	JJ
cord-023095-4dannjjm	3049	40	blood	blood	NN
cord-023095-4dannjjm	3049	41	pressure	pressure	NN
cord-023095-4dannjjm	3049	42	4	4	CD
cord-023095-4dannjjm	3049	43	160	160	CD
cord-023095-4dannjjm	3049	44	mmHg	mmHg	NNPS
cord-023095-4dannjjm	3049	45	)	)	-RRB-
cord-023095-4dannjjm	3049	46	,	,	,
cord-023095-4dannjjm	3049	47	hypoalbuminemia	hypoalbuminemia	NNP
cord-023095-4dannjjm	3049	48	(	(	-LRB-
cord-023095-4dannjjm	3049	49	serum	serum	NN
cord-023095-4dannjjm	3049	50	albumin	albumin	NN
cord-023095-4dannjjm	3049	51	o	o	NNP
cord-023095-4dannjjm	3049	52	2.7	2.7	CD
cord-023095-4dannjjm	3049	53	mg	mg	NNP
cord-023095-4dannjjm	3049	54	/	/	SYM
cord-023095-4dannjjm	3049	55	dl	dl	NNP
cord-023095-4dannjjm	3049	56	)	)	-RRB-
cord-023095-4dannjjm	3049	57	,	,	,
cord-023095-4dannjjm	3049	58	antithrombin	antithrombin	NN
cord-023095-4dannjjm	3049	59	activity	activity	NN
cord-023095-4dannjjm	3049	60	(	(	-LRB-
cord-023095-4dannjjm	3049	61	o	o	UH
cord-023095-4dannjjm	3049	62	70	70	CD
cord-023095-4dannjjm	3049	63	%	%	NN
cord-023095-4dannjjm	3049	64	)	)	-RRB-
cord-023095-4dannjjm	3049	65	,	,	,
cord-023095-4dannjjm	3049	66	and	and	CC
cord-023095-4dannjjm	3049	67	degree	degree	NN
cord-023095-4dannjjm	3049	68	of	of	IN
cord-023095-4dannjjm	3049	69	proteinuria	proteinuria	NN
cord-023095-4dannjjm	3049	70	(	(	-LRB-
cord-023095-4dannjjm	3049	71	urine	urine	NN
cord-023095-4dannjjm	3049	72	protein	protein	NN
cord-023095-4dannjjm	3049	73	:	:	:
cord-023095-4dannjjm	3049	74	creatinine	creatinine	NN
cord-023095-4dannjjm	3049	75	ratio	ratio	NN
cord-023095-4dannjjm	3049	76	[	[	-LRB-
cord-023095-4dannjjm	3049	77	UPC	UPC	NNP
cord-023095-4dannjjm	3049	78	]	]	-RRB-
cord-023095-4dannjjm	3049	79	!	!	.
cord-023095-4dannjjm	3049	80	2	2	CD
cord-023095-4dannjjm	3049	81	)	)	-RRB-
cord-023095-4dannjjm	3049	82	.	.	.
cord-023095-4dannjjm	3050	1	Between	between	IN
cord-023095-4dannjjm	3050	2	March	March	NNP
cord-023095-4dannjjm	3050	3	2009-September	2009-september	CD
cord-023095-4dannjjm	3050	4	2010	2010	CD
cord-023095-4dannjjm	3050	5	,	,	,
cord-023095-4dannjjm	3050	6	twenty	twenty	CD
cord-023095-4dannjjm	3050	7	-	-	HYPH
cord-023095-4dannjjm	3050	8	seven	seven	CD
cord-023095-4dannjjm	3050	9	dogs	dog	NNS
cord-023095-4dannjjm	3050	10	were	be	VBD
cord-023095-4dannjjm	3050	11	identified	identify	VBN
cord-023095-4dannjjm	3050	12	with	with	IN
cord-023095-4dannjjm	3050	13	PLN	PLN	NNP
cord-023095-4dannjjm	3050	14	at	at	IN
cord-023095-4dannjjm	3050	15	the	the	DT
cord-023095-4dannjjm	3050	16	Animal	Animal	NNP
cord-023095-4dannjjm	3050	17	Medical	Medical	NNP
cord-023095-4dannjjm	3050	18	Center	Center	NNP
cord-023095-4dannjjm	3050	19	.	.	.
cord-023095-4dannjjm	3051	1	The	the	DT
cord-023095-4dannjjm	3051	2	prevalence	prevalence	NN
cord-023095-4dannjjm	3051	3	of	of	IN
cord-023095-4dannjjm	3051	4	hypercoagulability	hypercoagulability	NN
cord-023095-4dannjjm	3051	5	based	base	VBN
cord-023095-4dannjjm	3051	6	on	on	IN
cord-023095-4dannjjm	3051	7	a	a	DT
cord-023095-4dannjjm	3051	8	TEG	TEG	NNP
cord-023095-4dannjjm	3051	9	G	g	NN
cord-023095-4dannjjm	3051	10	-	-	HYPH
cord-023095-4dannjjm	3051	11	value	value	NN
cord-023095-4dannjjm	3051	12	4	4	CD
cord-023095-4dannjjm	3051	13	9.6	9.6	CD
cord-023095-4dannjjm	3051	14	was	be	VBD
cord-023095-4dannjjm	3051	15	83.3	83.3	CD
cord-023095-4dannjjm	3051	16	%	%	NN
cord-023095-4dannjjm	3051	17	.	.	.
cord-023095-4dannjjm	3052	1	There	there	EX
cord-023095-4dannjjm	3052	2	was	be	VBD
cord-023095-4dannjjm	3052	3	no	no	DT
cord-023095-4dannjjm	3052	4	statistically	statistically	RB
cord-023095-4dannjjm	3052	5	significant	significant	JJ
cord-023095-4dannjjm	3052	6	relationship	relationship	NN
cord-023095-4dannjjm	3052	7	,	,	,
cord-023095-4dannjjm	3052	8	either	either	CC
cord-023095-4dannjjm	3052	9	categorically	categorically	RB
cord-023095-4dannjjm	3052	10	or	or	CC
cord-023095-4dannjjm	3052	11	continuously	continuously	RB
cord-023095-4dannjjm	3052	12	,	,	,
cord-023095-4dannjjm	3052	13	in	in	IN
cord-023095-4dannjjm	3052	14	univariate	univariate	JJ
cord-023095-4dannjjm	3052	15	as	as	RB
cord-023095-4dannjjm	3052	16	well	well	RB
cord-023095-4dannjjm	3052	17	as	as	IN
cord-023095-4dannjjm	3052	18	multivariate	multivariate	JJ
cord-023095-4dannjjm	3052	19	analyses	analysis	NNS
cord-023095-4dannjjm	3052	20	of	of	IN
cord-023095-4dannjjm	3052	21	all	all	DT
cord-023095-4dannjjm	3052	22	variables	variable	NNS
cord-023095-4dannjjm	3052	23	.	.	.
cord-023095-4dannjjm	3053	1	Univariate	univariate	JJ
cord-023095-4dannjjm	3053	2	logistic	logistic	JJ
cord-023095-4dannjjm	3053	3	regression	regression	NN
cord-023095-4dannjjm	3053	4	(	(	-LRB-
cord-023095-4dannjjm	3053	5	odds	odd	NNS
cord-023095-4dannjjm	3053	6	ratio	ratio	NN
cord-023095-4dannjjm	3053	7	;	;	:
cord-023095-4dannjjm	3053	8	lower	low	JJR
cord-023095-4dannjjm	3053	9	and	and	CC
cord-023095-4dannjjm	3053	10	upper	upper	JJ
cord-023095-4dannjjm	3053	11	confidence	confidence	NN
cord-023095-4dannjjm	3053	12	limit	limit	NN
cord-023095-4dannjjm	3053	13	;	;	:
cord-023095-4dannjjm	3053	14	P	p	NN
cord-023095-4dannjjm	3053	15	value	value	NN
cord-023095-4dannjjm	3053	16	)	)	-RRB-
cord-023095-4dannjjm	3053	17	for	for	IN
cord-023095-4dannjjm	3053	18	hypertension	hypertension	NN
cord-023095-4dannjjm	3053	19	was	be	VBD
cord-023095-4dannjjm	3053	20	À1.18	À1.18	VBN
cord-023095-4dannjjm	3053	21	;	;	:
cord-023095-4dannjjm	3053	22	0.201	0.201	CD
cord-023095-4dannjjm	3053	23	,	,	,
cord-023095-4dannjjm	3053	24	6.99	6.99	CD
cord-023095-4dannjjm	3053	25	;	;	:
cord-023095-4dannjjm	3053	26	0.851	0.851	CD
cord-023095-4dannjjm	3053	27	;	;	:
cord-023095-4dannjjm	3053	28	for	for	IN
cord-023095-4dannjjm	3053	29	albumin	albumin	NN
cord-023095-4dannjjm	3053	30	-1.37	-1.37	CD
cord-023095-4dannjjm	3053	31	;	;	:
cord-023095-4dannjjm	3053	32	0.228	0.228	CD
cord-023095-4dannjjm	3053	33	,	,	,
cord-023095-4dannjjm	3053	34	8.26	8.26	CD
cord-023095-4dannjjm	3053	35	;	;	:
cord-023095-4dannjjm	3053	36	0.728	0.728	CD
cord-023095-4dannjjm	3053	37	;	;	:
cord-023095-4dannjjm	3053	38	and	and	CC
cord-023095-4dannjjm	3053	39	for	for	IN
cord-023095-4dannjjm	3053	40	antithrombin	antithrombin	NN
cord-023095-4dannjjm	3053	41	activity	activity	NN
cord-023095-4dannjjm	3053	42	-0.73	-0.73	CD
cord-023095-4dannjjm	3053	43	;	;	:
cord-023095-4dannjjm	3053	44	0.12	0.12	CD
cord-023095-4dannjjm	3053	45	,	,	,
cord-023095-4dannjjm	3053	46	4.39	4.39	CD
cord-023095-4dannjjm	3053	47	;	;	:
cord-023095-4dannjjm	3053	48	0.728	0.728	CD
cord-023095-4dannjjm	3053	49	.	.	.
cord-023095-4dannjjm	3054	1	Thus	thus	RB
cord-023095-4dannjjm	3054	2	,	,	,
cord-023095-4dannjjm	3054	3	in	in	IN
cord-023095-4dannjjm	3054	4	this	this	DT
cord-023095-4dannjjm	3054	5	patient	patient	JJ
cord-023095-4dannjjm	3054	6	population	population	NN
cord-023095-4dannjjm	3054	7	,	,	,
cord-023095-4dannjjm	3054	8	in	in	IN
cord-023095-4dannjjm	3054	9	the	the	DT
cord-023095-4dannjjm	3054	10	absence	absence	NN
cord-023095-4dannjjm	3054	11	of	of	IN
cord-023095-4dannjjm	3054	12	TEG	TEG	NNP
cord-023095-4dannjjm	3054	13	,	,	,
cord-023095-4dannjjm	3054	14	prediction	prediction	NN
cord-023095-4dannjjm	3054	15	of	of	IN
cord-023095-4dannjjm	3054	16	hypercoagulability	hypercoagulability	NN
cord-023095-4dannjjm	3054	17	using	use	VBG
cord-023095-4dannjjm	3054	18	abnormalities	abnormality	NNS
cord-023095-4dannjjm	3054	19	in	in	IN
cord-023095-4dannjjm	3054	20	commonly	commonly	RB
cord-023095-4dannjjm	3054	21	measured	measure	VBN
cord-023095-4dannjjm	3054	22	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	3054	23	variables	variable	NNS
cord-023095-4dannjjm	3054	24	was	be	VBD
cord-023095-4dannjjm	3054	25	not	not	RB
cord-023095-4dannjjm	3054	26	helpful	helpful	JJ
cord-023095-4dannjjm	3054	27	.	.	.
cord-023095-4dannjjm	3055	1	However	however	RB
cord-023095-4dannjjm	3055	2	,	,	,
cord-023095-4dannjjm	3055	3	given	give	VBN
cord-023095-4dannjjm	3055	4	the	the	DT
cord-023095-4dannjjm	3055	5	documented	document	VBN
cord-023095-4dannjjm	3055	6	high	high	JJ
cord-023095-4dannjjm	3055	7	prevalence	prevalence	NN
cord-023095-4dannjjm	3055	8	of	of	IN
cord-023095-4dannjjm	3055	9	hypercoagulability	hypercoagulability	NN
cord-023095-4dannjjm	3055	10	in	in	IN
cord-023095-4dannjjm	3055	11	patients	patient	NNS
cord-023095-4dannjjm	3055	12	with	with	IN
cord-023095-4dannjjm	3055	13	PLN	PLN	NNP
cord-023095-4dannjjm	3055	14	,	,	,
cord-023095-4dannjjm	3055	15	early	early	JJ
cord-023095-4dannjjm	3055	16	institution	institution	NN
cord-023095-4dannjjm	3055	17	of	of	IN
cord-023095-4dannjjm	3055	18	prophylactic	prophylactic	JJ
cord-023095-4dannjjm	3055	19	anti	anti	JJ
cord-023095-4dannjjm	3055	20	-	-	JJ
cord-023095-4dannjjm	3055	21	platelet	platelet	JJ
cord-023095-4dannjjm	3055	22	or	or	CC
cord-023095-4dannjjm	3055	23	anticoagulant	anticoagulant	JJ
cord-023095-4dannjjm	3055	24	therapies	therapy	NNS
cord-023095-4dannjjm	3055	25	should	should	MD
cord-023095-4dannjjm	3055	26	be	be	VB
cord-023095-4dannjjm	3055	27	considered	consider	VBN
cord-023095-4dannjjm	3055	28	.	.	.
cord-023095-4dannjjm	3056	1	Thromboelastography	Thromboelastography	NNP
cord-023095-4dannjjm	3056	2	(	(	-LRB-
cord-023095-4dannjjm	3056	3	TEG	TEG	NNP
cord-023095-4dannjjm	3056	4	)	)	-RRB-
cord-023095-4dannjjm	3056	5	is	be	VBZ
cord-023095-4dannjjm	3056	6	a	a	DT
cord-023095-4dannjjm	3056	7	test	test	NN
cord-023095-4dannjjm	3056	8	of	of	IN
cord-023095-4dannjjm	3056	9	global	global	JJ
cord-023095-4dannjjm	3056	10	hemostasis	hemostasis	NN
cord-023095-4dannjjm	3056	11	.	.	.
cord-023095-4dannjjm	3057	1	Due	due	IN
cord-023095-4dannjjm	3057	2	to	to	IN
cord-023095-4dannjjm	3057	3	the	the	DT
cord-023095-4dannjjm	3057	4	effects	effect	NNS
cord-023095-4dannjjm	3057	5	of	of	IN
cord-023095-4dannjjm	3057	6	extrinsic	extrinsic	JJ
cord-023095-4dannjjm	3057	7	factors	factor	NNS
cord-023095-4dannjjm	3057	8	on	on	IN
cord-023095-4dannjjm	3057	9	whole	whole	JJ
cord-023095-4dannjjm	3057	10	blood	blood	NN
cord-023095-4dannjjm	3057	11	coagulation	coagulation	NN
cord-023095-4dannjjm	3057	12	,	,	,
cord-023095-4dannjjm	3057	13	sample	sample	NN
cord-023095-4dannjjm	3057	14	collection	collection	NN
cord-023095-4dannjjm	3057	15	method	method	NN
cord-023095-4dannjjm	3057	16	(	(	-LRB-
cord-023095-4dannjjm	3057	17	SCM	SCM	NNP
cord-023095-4dannjjm	3057	18	)	)	-RRB-
cord-023095-4dannjjm	3057	19	may	may	MD
cord-023095-4dannjjm	3057	20	influence	influence	VB
cord-023095-4dannjjm	3057	21	results	result	NNS
cord-023095-4dannjjm	3057	22	.	.	.
cord-023095-4dannjjm	3058	1	The	the	DT
cord-023095-4dannjjm	3058	2	purpose	purpose	NN
cord-023095-4dannjjm	3058	3	was	be	VBD
cord-023095-4dannjjm	3058	4	to	to	TO
cord-023095-4dannjjm	3058	5	determine	determine	VB
cord-023095-4dannjjm	3058	6	if	if	IN
cord-023095-4dannjjm	3058	7	SCM	SCM	NNP
cord-023095-4dannjjm	3058	8	influenced	influence	VBD
cord-023095-4dannjjm	3058	9	TEG	TEG	NNP
cord-023095-4dannjjm	3058	10	using	use	VBG
cord-023095-4dannjjm	3058	11	kaolin	kaolin	NN
cord-023095-4dannjjm	3058	12	-	-	HYPH
cord-023095-4dannjjm	3058	13	activated	activate	VBN
cord-023095-4dannjjm	3058	14	citrated	citrate	VBN
cord-023095-4dannjjm	3058	15	whole	whole	JJ
cord-023095-4dannjjm	3058	16	blood	blood	NN
cord-023095-4dannjjm	3058	17	(	(	-LRB-
cord-023095-4dannjjm	3058	18	WB	WB	NNP
cord-023095-4dannjjm	3058	19	)	)	-RRB-
cord-023095-4dannjjm	3058	20	.	.	.
cord-023095-4dannjjm	3059	1	Healthy	healthy	JJ
cord-023095-4dannjjm	3059	2	dogs	dog	NNS
cord-023095-4dannjjm	3059	3	with	with	IN
cord-023095-4dannjjm	3059	4	normal	normal	JJ
cord-023095-4dannjjm	3059	5	platelet	platelet	NN
cord-023095-4dannjjm	3059	6	counts	count	NNS
cord-023095-4dannjjm	3059	7	were	be	VBD
cord-023095-4dannjjm	3059	8	prospectively	prospectively	RB
cord-023095-4dannjjm	3059	9	enrolled	enrol	VBN
cord-023095-4dannjjm	3059	10	.	.	.
cord-023095-4dannjjm	3060	1	Three	three	CD
cord-023095-4dannjjm	3060	2	WB	WB	NNP
cord-023095-4dannjjm	3060	3	samples	sample	NNS
cord-023095-4dannjjm	3060	4	were	be	VBD
cord-023095-4dannjjm	3060	5	obtained	obtain	VBN
cord-023095-4dannjjm	3060	6	from	from	IN
cord-023095-4dannjjm	3060	7	each	each	DT
cord-023095-4dannjjm	3060	8	dog	dog	NN
cord-023095-4dannjjm	3060	9	at	at	IN
cord-023095-4dannjjm	3060	10	least	least	JJS
cord-023095-4dannjjm	3060	11	48	48	CD
cord-023095-4dannjjm	3060	12	hours	hour	NNS
cord-023095-4dannjjm	3060	13	apart	apart	RB
cord-023095-4dannjjm	3060	14	from	from	IN
cord-023095-4dannjjm	3060	15	alternating	alternate	VBG
cord-023095-4dannjjm	3060	16	jugular	jugular	NN
cord-023095-4dannjjm	3060	17	veins	vein	NNS
cord-023095-4dannjjm	3060	18	in	in	IN
cord-023095-4dannjjm	3060	19	a	a	DT
cord-023095-4dannjjm	3060	20	randomized	randomized	JJ
cord-023095-4dannjjm	3060	21	order	order	NN
cord-023095-4dannjjm	3060	22	of	of	IN
cord-023095-4dannjjm	3060	23	three	three	CD
cord-023095-4dannjjm	3060	24	methods	method	NNS
cord-023095-4dannjjm	3060	25	:	:	:
cord-023095-4dannjjm	3060	26	1	1	LS
cord-023095-4dannjjm	3060	27	)	)	-RRB-
cord-023095-4dannjjm	3060	28	vacutainer	vacutainer	NNP
cord-023095-4dannjjm	3060	29	s	s	VBZ
cord-023095-4dannjjm	3060	30	into	into	IN
cord-023095-4dannjjm	3060	31	citrated	citrated	JJ
cord-023095-4dannjjm	3060	32	tube	tube	NN
cord-023095-4dannjjm	3060	33	(	(	-LRB-
cord-023095-4dannjjm	3060	34	VAC	VAC	NNP
cord-023095-4dannjjm	3060	35	)	)	-RRB-
cord-023095-4dannjjm	3060	36	,	,	,
cord-023095-4dannjjm	3060	37	2	2	CD
cord-023095-4dannjjm	3060	38	)	)	-RRB-
cord-023095-4dannjjm	3060	39	citrated	citrate	VBN
cord-023095-4dannjjm	3060	40	syringe	syringe	NN
cord-023095-4dannjjm	3060	41	with	with	IN
cord-023095-4dannjjm	3060	42	transfer	transfer	NN
cord-023095-4dannjjm	3060	43	into	into	IN
cord-023095-4dannjjm	3060	44	plain	plain	JJ
cord-023095-4dannjjm	3060	45	tube	tube	NN
cord-023095-4dannjjm	3060	46	(	(	-LRB-
cord-023095-4dannjjm	3060	47	CIT	CIT	NNP
cord-023095-4dannjjm	3060	48	)	)	-RRB-
cord-023095-4dannjjm	3060	49	,	,	,
cord-023095-4dannjjm	3060	50	or	or	CC
cord-023095-4dannjjm	3060	51	3	3	LS
cord-023095-4dannjjm	3060	52	)	)	-RRB-
cord-023095-4dannjjm	3060	53	plain	plain	JJ
cord-023095-4dannjjm	3060	54	syringe	syringe	NN
cord-023095-4dannjjm	3060	55	with	with	IN
cord-023095-4dannjjm	3060	56	transfer	transfer	NN
cord-023095-4dannjjm	3060	57	into	into	IN
cord-023095-4dannjjm	3060	58	citrated	citrated	JJ
cord-023095-4dannjjm	3060	59	tube	tube	NN
cord-023095-4dannjjm	3060	60	(	(	-LRB-
cord-023095-4dannjjm	3060	61	PLAIN	PLAIN	NNP
cord-023095-4dannjjm	3060	62	)	)	-RRB-
cord-023095-4dannjjm	3060	63	.	.	.
cord-023095-4dannjjm	3061	1	Draw	draw	VB
cord-023095-4dannjjm	3061	2	time	time	NN
cord-023095-4dannjjm	3061	3	was	be	VBD
cord-023095-4dannjjm	3061	4	recorded	record	VBN
cord-023095-4dannjjm	3061	5	in	in	IN
cord-023095-4dannjjm	3061	6	seconds	second	NNS
cord-023095-4dannjjm	3061	7	.	.	.
cord-023095-4dannjjm	3062	1	Kaolin	kaolin	NN
cord-023095-4dannjjm	3062	2	-	-	HYPH
cord-023095-4dannjjm	3062	3	activated	activate	VBN
cord-023095-4dannjjm	3062	4	TEG	TEG	NNP
cord-023095-4dannjjm	3062	5	was	be	VBD
cord-023095-4dannjjm	3062	6	performed	perform	VBN
cord-023095-4dannjjm	3062	7	,	,	,
cord-023095-4dannjjm	3062	8	with	with	IN
cord-023095-4dannjjm	3062	9	measurement	measurement	NN
cord-023095-4dannjjm	3062	10	of	of	IN
cord-023095-4dannjjm	3062	11	reaction	reaction	NN
cord-023095-4dannjjm	3062	12	time	time	NN
cord-023095-4dannjjm	3062	13	(	(	-LRB-
cord-023095-4dannjjm	3062	14	R	r	NN
cord-023095-4dannjjm	3062	15	)	)	-RRB-
cord-023095-4dannjjm	3062	16	,	,	,
cord-023095-4dannjjm	3062	17	clot	clot	NN
cord-023095-4dannjjm	3062	18	formation	formation	NN
cord-023095-4dannjjm	3062	19	time	time	NN
cord-023095-4dannjjm	3062	20	(	(	-LRB-
cord-023095-4dannjjm	3062	21	K	K	NNP
cord-023095-4dannjjm	3062	22	)	)	-RRB-
cord-023095-4dannjjm	3062	23	,	,	,
cord-023095-4dannjjm	3062	24	maximum	maximum	JJ
cord-023095-4dannjjm	3062	25	amplitude	amplitude	NN
cord-023095-4dannjjm	3062	26	(	(	-LRB-
cord-023095-4dannjjm	3062	27	MA	MA	NNP
cord-023095-4dannjjm	3062	28	)	)	-RRB-
cord-023095-4dannjjm	3062	29	,	,	,
cord-023095-4dannjjm	3062	30	and	and	CC
cord-023095-4dannjjm	3062	31	alpha	alpha	NN
cord-023095-4dannjjm	3062	32	angle	angle	NN
cord-023095-4dannjjm	3062	33	.	.	.
cord-023095-4dannjjm	3063	1	Eleven	eleven	CD
cord-023095-4dannjjm	3063	2	dogs	dog	NNS
cord-023095-4dannjjm	3063	3	were	be	VBD
cord-023095-4dannjjm	3063	4	enrolled	enrol	VBN
cord-023095-4dannjjm	3063	5	.	.	.
cord-023095-4dannjjm	3064	1	There	there	EX
cord-023095-4dannjjm	3064	2	were	be	VBD
cord-023095-4dannjjm	3064	3	no	no	DT
cord-023095-4dannjjm	3064	4	significant	significant	JJ
cord-023095-4dannjjm	3064	5	differences	difference	NNS
cord-023095-4dannjjm	3064	6	in	in	IN
cord-023095-4dannjjm	3064	7	TEG	TEG	NNP
cord-023095-4dannjjm	3064	8	indices	index	NNS
cord-023095-4dannjjm	3064	9	between	between	IN
cord-023095-4dannjjm	3064	10	VAC	vac	NN
cord-023095-4dannjjm	3064	11	samples	sample	NNS
cord-023095-4dannjjm	3064	12	and	and	CC
cord-023095-4dannjjm	3064	13	either	either	CC
cord-023095-4dannjjm	3064	14	CIT	CIT	NNP
cord-023095-4dannjjm	3064	15	or	or	CC
cord-023095-4dannjjm	3064	16	PLAIN	plain	JJ
cord-023095-4dannjjm	3064	17	samples	sample	NNS
cord-023095-4dannjjm	3064	18	.	.	.
cord-023095-4dannjjm	3065	1	CIT	CIT	NNP
cord-023095-4dannjjm	3065	2	samples	sample	NNS
cord-023095-4dannjjm	3065	3	had	have	VBD
cord-023095-4dannjjm	3065	4	a	a	DT
cord-023095-4dannjjm	3065	5	significantly	significantly	RB
cord-023095-4dannjjm	3065	6	higher	high	JJR
cord-023095-4dannjjm	3065	7	K	K	NNP
cord-023095-4dannjjm	3065	8	value	value	NN
cord-023095-4dannjjm	3065	9	(	(	-LRB-
cord-023095-4dannjjm	3065	10	p	p	NN
cord-023095-4dannjjm	3065	11	5	5	CD
cord-023095-4dannjjm	3065	12	0.004	0.004	CD
cord-023095-4dannjjm	3065	13	)	)	-RRB-
cord-023095-4dannjjm	3065	14	and	and	CC
cord-023095-4dannjjm	3065	15	a	a	DT
cord-023095-4dannjjm	3065	16	lower	low	JJR
cord-023095-4dannjjm	3065	17	alpha	alpha	NN
cord-023095-4dannjjm	3065	18	angle	angle	NN
cord-023095-4dannjjm	3065	19	(	(	-LRB-
cord-023095-4dannjjm	3065	20	p	p	NN
cord-023095-4dannjjm	3065	21	5	5	CD
cord-023095-4dannjjm	3065	22	0.004	0.004	CD
cord-023095-4dannjjm	3065	23	)	)	-RRB-
cord-023095-4dannjjm	3065	24	compared	compare	VBN
cord-023095-4dannjjm	3065	25	to	to	IN
cord-023095-4dannjjm	3065	26	PLAIN	plain	JJ
cord-023095-4dannjjm	3065	27	samples	sample	NNS
cord-023095-4dannjjm	3065	28	.	.	.
cord-023095-4dannjjm	3066	1	Draw	draw	VB
cord-023095-4dannjjm	3066	2	times	time	NNS
cord-023095-4dannjjm	3066	3	ranged	range	VBD
cord-023095-4dannjjm	3066	4	from	from	IN
cord-023095-4dannjjm	3066	5	2	2	CD
cord-023095-4dannjjm	3066	6	-	-	SYM
cord-023095-4dannjjm	3066	7	10	10	CD
cord-023095-4dannjjm	3066	8	seconds	second	NNS
cord-023095-4dannjjm	3066	9	.	.	.
cord-023095-4dannjjm	3067	1	A	a	DT
cord-023095-4dannjjm	3067	2	longer	longer	RB
cord-023095-4dannjjm	3067	3	draw	draw	VBP
cord-023095-4dannjjm	3067	4	time	time	NN
cord-023095-4dannjjm	3067	5	was	be	VBD
cord-023095-4dannjjm	3067	6	significantly	significantly	RB
cord-023095-4dannjjm	3067	7	correlated	correlate	VBN
cord-023095-4dannjjm	3067	8	(	(	-LRB-
cord-023095-4dannjjm	3067	9	p	p	NN
cord-023095-4dannjjm	3067	10	5	5	CD
cord-023095-4dannjjm	3067	11	0.046	0.046	CD
cord-023095-4dannjjm	3067	12	;	;	:
cord-023095-4dannjjm	3068	1	R	r	NN
cord-023095-4dannjjm	3068	2	5	5	CD
cord-023095-4dannjjm	3068	3	À0.35	À0.35	NNP
cord-023095-4dannjjm	3068	4	)	)	-RRB-
cord-023095-4dannjjm	3068	5	with	with	IN
cord-023095-4dannjjm	3068	6	a	a	DT
cord-023095-4dannjjm	3068	7	shorter	short	JJR
cord-023095-4dannjjm	3068	8	R	r	NN
cord-023095-4dannjjm	3068	9	time	time	NN
cord-023095-4dannjjm	3068	10	.	.	.
cord-023095-4dannjjm	3069	1	Higher	high	JJR
cord-023095-4dannjjm	3069	2	platelet	platelet	NN
cord-023095-4dannjjm	3069	3	count	count	NN
cord-023095-4dannjjm	3069	4	was	be	VBD
cord-023095-4dannjjm	3069	5	significantly	significantly	RB
cord-023095-4dannjjm	3069	6	correlated	correlate	VBN
cord-023095-4dannjjm	3069	7	(	(	-LRB-
cord-023095-4dannjjm	3069	8	p	p	NN
cord-023095-4dannjjm	3069	9	5	5	CD
cord-023095-4dannjjm	3069	10	0.001	0.001	CD
cord-023095-4dannjjm	3069	11	;	;	:
cord-023095-4dannjjm	3069	12	R	r	NN
cord-023095-4dannjjm	3069	13	5	5	CD
cord-023095-4dannjjm	3069	14	0.575	0.575	CD
cord-023095-4dannjjm	3069	15	)	)	-RRB-
cord-023095-4dannjjm	3069	16	with	with	IN
cord-023095-4dannjjm	3069	17	a	a	DT
cord-023095-4dannjjm	3069	18	higher	high	JJR
cord-023095-4dannjjm	3069	19	MA	MA	NNP
cord-023095-4dannjjm	3069	20	.	.	.
cord-023095-4dannjjm	3070	1	SCM	SCM	NNP
cord-023095-4dannjjm	3070	2	did	do	VBD
cord-023095-4dannjjm	3070	3	not	not	RB
cord-023095-4dannjjm	3070	4	have	have	VB
cord-023095-4dannjjm	3070	5	a	a	DT
cord-023095-4dannjjm	3070	6	significant	significant	JJ
cord-023095-4dannjjm	3070	7	effect	effect	NN
cord-023095-4dannjjm	3070	8	on	on	IN
cord-023095-4dannjjm	3070	9	TEG	TEG	NNP
cord-023095-4dannjjm	3070	10	parameters	parameter	NNS
cord-023095-4dannjjm	3070	11	when	when	WRB
cord-023095-4dannjjm	3070	12	comparing	compare	VBG
cord-023095-4dannjjm	3070	13	VAC	vac	NN
cord-023095-4dannjjm	3070	14	samples	sample	NNS
cord-023095-4dannjjm	3070	15	to	to	IN
cord-023095-4dannjjm	3070	16	either	either	CC
cord-023095-4dannjjm	3070	17	CIT	CIT	NNP
cord-023095-4dannjjm	3070	18	or	or	CC
cord-023095-4dannjjm	3070	19	PLAIN	plain	JJ
cord-023095-4dannjjm	3070	20	samples	sample	NNS
cord-023095-4dannjjm	3070	21	.	.	.
cord-023095-4dannjjm	3071	1	Minimizing	minimize	VBG
cord-023095-4dannjjm	3071	2	sample	sample	NN
cord-023095-4dannjjm	3071	3	collection	collection	NN
cord-023095-4dannjjm	3071	4	time	time	NN
cord-023095-4dannjjm	3071	5	and	and	CC
cord-023095-4dannjjm	3071	6	trauma	trauma	NN
cord-023095-4dannjjm	3071	7	during	during	IN
cord-023095-4dannjjm	3071	8	venipuncture	venipuncture	NN
cord-023095-4dannjjm	3071	9	may	may	MD
cord-023095-4dannjjm	3071	10	be	be	VB
cord-023095-4dannjjm	3071	11	important	important	JJ
cord-023095-4dannjjm	3071	12	in	in	IN
cord-023095-4dannjjm	3071	13	minimizing	minimize	VBG
cord-023095-4dannjjm	3071	14	hypercoagulable	hypercoagulable	JJ
cord-023095-4dannjjm	3071	15	changes	change	NNS
cord-023095-4dannjjm	3071	16	in	in	IN
cord-023095-4dannjjm	3071	17	TEG	TEG	NNP
cord-023095-4dannjjm	3071	18	indices	index	NNS
cord-023095-4dannjjm	3071	19	.	.	.
cord-023095-4dannjjm	3072	1	Liquid	liquid	NN
cord-023095-4dannjjm	3072	2	plasma	plasma	NN
cord-023095-4dannjjm	3072	3	(	(	-LRB-
cord-023095-4dannjjm	3072	4	LP	LP	NNP
cord-023095-4dannjjm	3072	5	)	)	-RRB-
cord-023095-4dannjjm	3072	6	is	be	VBZ
cord-023095-4dannjjm	3072	7	defined	define	VBN
cord-023095-4dannjjm	3072	8	as	as	IN
cord-023095-4dannjjm	3072	9	either	either	DT
cord-023095-4dannjjm	3072	10	plasma	plasma	NN
cord-023095-4dannjjm	3072	11	collected	collect	VBD
cord-023095-4dannjjm	3072	12	and	and	CC
cord-023095-4dannjjm	3072	13	refrigerated	refrigerate	VBN
cord-023095-4dannjjm	3072	14	immediately	immediately	RB
cord-023095-4dannjjm	3072	15	after	after	IN
cord-023095-4dannjjm	3072	16	collection	collection	NN
cord-023095-4dannjjm	3072	17	or	or	CC
cord-023095-4dannjjm	3072	18	fresh	fresh	JJ
cord-023095-4dannjjm	3072	19	frozen	frozen	JJ
cord-023095-4dannjjm	3072	20	plasma	plasma	NN
cord-023095-4dannjjm	3072	21	(	(	-LRB-
cord-023095-4dannjjm	3072	22	FFP	FFP	NNP
cord-023095-4dannjjm	3072	23	)	)	-RRB-
cord-023095-4dannjjm	3072	24	that	that	WDT
cord-023095-4dannjjm	3072	25	is	be	VBZ
cord-023095-4dannjjm	3072	26	thawed	thaw	VBN
cord-023095-4dannjjm	3072	27	and	and	CC
cord-023095-4dannjjm	3072	28	stored	store	VBN
cord-023095-4dannjjm	3072	29	refrigerated	refrigerated	JJ
cord-023095-4dannjjm	3072	30	until	until	IN
cord-023095-4dannjjm	3072	31	use	use	NN
cord-023095-4dannjjm	3072	32	.	.	.
cord-023095-4dannjjm	3073	1	Stability	stability	NN
cord-023095-4dannjjm	3073	2	studies	study	NNS
cord-023095-4dannjjm	3073	3	in	in	IN
cord-023095-4dannjjm	3073	4	people	people	NNS
cord-023095-4dannjjm	3073	5	have	have	VBP
cord-023095-4dannjjm	3073	6	shown	show	VBN
cord-023095-4dannjjm	3073	7	that	that	IN
cord-023095-4dannjjm	3073	8	adequate	adequate	JJ
cord-023095-4dannjjm	3073	9	clotting	clotting	NN
cord-023095-4dannjjm	3073	10	factor	factor	NN
cord-023095-4dannjjm	3073	11	activity	activity	NN
cord-023095-4dannjjm	3073	12	is	be	VBZ
cord-023095-4dannjjm	3073	13	preserved	preserve	VBN
cord-023095-4dannjjm	3073	14	for	for	IN
cord-023095-4dannjjm	3073	15	at	at	RB
cord-023095-4dannjjm	3073	16	least	least	RBS
cord-023095-4dannjjm	3073	17	14	14	CD
cord-023095-4dannjjm	3073	18	days	day	NNS
cord-023095-4dannjjm	3073	19	.	.	.
cord-023095-4dannjjm	3074	1	LP	LP	NNP
cord-023095-4dannjjm	3074	2	is	be	VBZ
cord-023095-4dannjjm	3074	3	transfused	transfuse	VBN
cord-023095-4dannjjm	3074	4	in	in	IN
cord-023095-4dannjjm	3074	5	human	human	JJ
cord-023095-4dannjjm	3074	6	Level	level	NN
cord-023095-4dannjjm	3074	7	I	I	NNP
cord-023095-4dannjjm	3074	8	trauma	trauma	NN
cord-023095-4dannjjm	3074	9	centers	center	NNS
cord-023095-4dannjjm	3074	10	to	to	TO
cord-023095-4dannjjm	3074	11	critically	critically	RB
cord-023095-4dannjjm	3074	12	ill	ill	VB
cord-023095-4dannjjm	3074	13	people	people	NNS
cord-023095-4dannjjm	3074	14	requiring	require	VBG
cord-023095-4dannjjm	3074	15	rapid	rapid	JJ
cord-023095-4dannjjm	3074	16	infusion	infusion	NN
cord-023095-4dannjjm	3074	17	of	of	IN
cord-023095-4dannjjm	3074	18	clotting	clotting	NN
cord-023095-4dannjjm	3074	19	factors	factor	NNS
cord-023095-4dannjjm	3074	20	as	as	IN
cord-023095-4dannjjm	3074	21	the	the	DT
cord-023095-4dannjjm	3074	22	time	time	NN
cord-023095-4dannjjm	3074	23	required	require	VBN
cord-023095-4dannjjm	3074	24	to	to	TO
cord-023095-4dannjjm	3074	25	defrost	defrost	VB
cord-023095-4dannjjm	3074	26	FFP	FFP	NNP
cord-023095-4dannjjm	3074	27	is	be	VBZ
cord-023095-4dannjjm	3074	28	considered	consider	VBN
cord-023095-4dannjjm	3074	29	prohibitive	prohibitive	JJ
cord-023095-4dannjjm	3074	30	.	.	.
cord-023095-4dannjjm	3075	1	The	the	DT
cord-023095-4dannjjm	3075	2	use	use	NN
cord-023095-4dannjjm	3075	3	of	of	IN
cord-023095-4dannjjm	3075	4	LP	LP	NNP
cord-023095-4dannjjm	3075	5	has	have	VBZ
cord-023095-4dannjjm	3075	6	not	not	RB
cord-023095-4dannjjm	3075	7	been	be	VBN
cord-023095-4dannjjm	3075	8	described	describe	VBN
cord-023095-4dannjjm	3075	9	in	in	IN
cord-023095-4dannjjm	3075	10	veterinary	veterinary	JJ
cord-023095-4dannjjm	3075	11	critical	critical	JJ
cord-023095-4dannjjm	3075	12	care	care	NN
cord-023095-4dannjjm	3075	13	.	.	.
cord-023095-4dannjjm	3076	1	The	the	DT
cord-023095-4dannjjm	3076	2	purposes	purpose	NNS
cord-023095-4dannjjm	3076	3	of	of	IN
cord-023095-4dannjjm	3076	4	this	this	DT
cord-023095-4dannjjm	3076	5	study	study	NN
cord-023095-4dannjjm	3076	6	were	be	VBD
cord-023095-4dannjjm	3076	7	to	to	IN
cord-023095-4dannjjm	3076	8	1	1	CD
cord-023095-4dannjjm	3076	9	)	)	-RRB-
cord-023095-4dannjjm	3076	10	determine	determine	VB
cord-023095-4dannjjm	3076	11	the	the	DT
cord-023095-4dannjjm	3076	12	length	length	NN
cord-023095-4dannjjm	3076	13	of	of	IN
cord-023095-4dannjjm	3076	14	time	time	NN
cord-023095-4dannjjm	3076	15	required	require	VBN
cord-023095-4dannjjm	3076	16	in	in	IN
cord-023095-4dannjjm	3076	17	a	a	DT
cord-023095-4dannjjm	3076	18	water	water	NN
cord-023095-4dannjjm	3076	19	bath	bath	NN
cord-023095-4dannjjm	3076	20	for	for	IN
cord-023095-4dannjjm	3076	21	a	a	DT
cord-023095-4dannjjm	3076	22	unit	unit	NN
cord-023095-4dannjjm	3076	23	of	of	IN
cord-023095-4dannjjm	3076	24	canine	canine	JJ
cord-023095-4dannjjm	3076	25	FFP	FFP	NNP
cord-023095-4dannjjm	3076	26	to	to	TO
cord-023095-4dannjjm	3076	27	thaw	thaw	VB
cord-023095-4dannjjm	3076	28	and	and	CC
cord-023095-4dannjjm	3076	29	2	2	LS
cord-023095-4dannjjm	3076	30	)	)	-RRB-
cord-023095-4dannjjm	3076	31	describe	describe	VBP
cord-023095-4dannjjm	3076	32	the	the	DT
cord-023095-4dannjjm	3076	33	use	use	NN
cord-023095-4dannjjm	3076	34	of	of	IN
cord-023095-4dannjjm	3076	35	LP	LP	NNP
cord-023095-4dannjjm	3076	36	in	in	IN
cord-023095-4dannjjm	3076	37	a	a	DT
cord-023095-4dannjjm	3076	38	busy	busy	JJ
cord-023095-4dannjjm	3076	39	university	university	NN
cord-023095-4dannjjm	3076	40	emergency	emergency	NN
cord-023095-4dannjjm	3076	41	room	room	NN
cord-023095-4dannjjm	3076	42	(	(	-LRB-
cord-023095-4dannjjm	3076	43	ER	ER	NNP
cord-023095-4dannjjm	3076	44	)	)	-RRB-
cord-023095-4dannjjm	3076	45	.	.	.
cord-023095-4dannjjm	3077	1	For	for	IN
cord-023095-4dannjjm	3077	2	part	part	NN
cord-023095-4dannjjm	3077	3	1	1	CD
cord-023095-4dannjjm	3077	4	:	:	:
cord-023095-4dannjjm	3077	5	Six	six	CD
cord-023095-4dannjjm	3077	6	units	unit	NNS
cord-023095-4dannjjm	3077	7	(	(	-LRB-
cord-023095-4dannjjm	3077	8	250	250	CD
cord-023095-4dannjjm	3077	9	ml	ml	NNS
cord-023095-4dannjjm	3077	10	)	)	-RRB-
cord-023095-4dannjjm	3077	11	of	of	IN
cord-023095-4dannjjm	3077	12	canine	canine	JJ
cord-023095-4dannjjm	3077	13	FFP	FFP	NNP
cord-023095-4dannjjm	3077	14	were	be	VBD
cord-023095-4dannjjm	3077	15	individually	individually	RB
cord-023095-4dannjjm	3077	16	thawed	thaw	VBN
cord-023095-4dannjjm	3077	17	in	in	IN
cord-023095-4dannjjm	3077	18	a	a	DT
cord-023095-4dannjjm	3077	19	371C	371c	CD
cord-023095-4dannjjm	3077	20	water	water	NN
cord-023095-4dannjjm	3077	21	bath	bath	NN
cord-023095-4dannjjm	3077	22	.	.	.
cord-023095-4dannjjm	3078	1	The	the	DT
cord-023095-4dannjjm	3078	2	duration	duration	NN
cord-023095-4dannjjm	3078	3	of	of	IN
cord-023095-4dannjjm	3078	4	time	time	NN
cord-023095-4dannjjm	3078	5	(	(	-LRB-
cord-023095-4dannjjm	3078	6	in	in	IN
cord-023095-4dannjjm	3078	7	minutes	minute	NNS
cord-023095-4dannjjm	3078	8	)	)	-RRB-
cord-023095-4dannjjm	3078	9	to	to	TO
cord-023095-4dannjjm	3078	10	thaw	thaw	VB
cord-023095-4dannjjm	3078	11	was	be	VBD
cord-023095-4dannjjm	3078	12	recorded	record	VBN
cord-023095-4dannjjm	3078	13	.	.	.
cord-023095-4dannjjm	3079	1	For	for	IN
cord-023095-4dannjjm	3079	2	part	part	NN
cord-023095-4dannjjm	3079	3	2	2	CD
cord-023095-4dannjjm	3079	4	:	:	:
cord-023095-4dannjjm	3079	5	The	the	DT
cord-023095-4dannjjm	3079	6	transfusion	transfusion	NN
cord-023095-4dannjjm	3079	7	log	log	NN
cord-023095-4dannjjm	3079	8	was	be	VBD
cord-023095-4dannjjm	3079	9	reviewed	review	VBN
cord-023095-4dannjjm	3079	10	for	for	IN
cord-023095-4dannjjm	3079	11	dogs	dog	NNS
cord-023095-4dannjjm	3079	12	receiving	receive	VBG
cord-023095-4dannjjm	3079	13	LP	LP	NNP
cord-023095-4dannjjm	3079	14	in	in	IN
cord-023095-4dannjjm	3079	15	the	the	DT
cord-023095-4dannjjm	3079	16	last	last	JJ
cord-023095-4dannjjm	3079	17	6	6	CD
cord-023095-4dannjjm	3079	18	months	month	NNS
cord-023095-4dannjjm	3079	19	.	.	.
cord-023095-4dannjjm	3080	1	The	the	DT
cord-023095-4dannjjm	3080	2	indications	indication	NNS
cord-023095-4dannjjm	3080	3	and	and	CC
cord-023095-4dannjjm	3080	4	outcome	outcome	NN
cord-023095-4dannjjm	3080	5	were	be	VBD
cord-023095-4dannjjm	3080	6	recorded	record	VBN
cord-023095-4dannjjm	3080	7	.	.	.
cord-023095-4dannjjm	3081	1	The	the	DT
cord-023095-4dannjjm	3081	2	mean	mean	JJ
cord-023095-4dannjjm	3081	3	time	time	NN
cord-023095-4dannjjm	3081	4	AE	AE	NNP
cord-023095-4dannjjm	3081	5	SD	SD	NNP
cord-023095-4dannjjm	3081	6	thaw	thaw	NN
cord-023095-4dannjjm	3081	7	time	time	NN
cord-023095-4dannjjm	3081	8	was	be	VBD
cord-023095-4dannjjm	3081	9	34.7	34.7	CD
cord-023095-4dannjjm	3081	10	AE	AE	NNP
cord-023095-4dannjjm	3081	11	1.38	1.38	CD
cord-023095-4dannjjm	3081	12	minutes	minute	NNS
cord-023095-4dannjjm	3081	13	.	.	.
cord-023095-4dannjjm	3082	1	Ten	ten	CD
cord-023095-4dannjjm	3082	2	units	unit	NNS
cord-023095-4dannjjm	3082	3	of	of	IN
cord-023095-4dannjjm	3082	4	LP	LP	NNP
cord-023095-4dannjjm	3082	5	were	be	VBD
cord-023095-4dannjjm	3082	6	transfused	transfuse	VBN
cord-023095-4dannjjm	3082	7	to	to	IN
cord-023095-4dannjjm	3082	8	7	7	CD
cord-023095-4dannjjm	3082	9	critically	critically	RB
cord-023095-4dannjjm	3082	10	ill	ill	JJ
cord-023095-4dannjjm	3082	11	or	or	CC
cord-023095-4dannjjm	3082	12	injured	injure	VBN
cord-023095-4dannjjm	3082	13	dogs	dog	NNS
cord-023095-4dannjjm	3082	14	during	during	IN
cord-023095-4dannjjm	3082	15	the	the	DT
cord-023095-4dannjjm	3082	16	study	study	NN
cord-023095-4dannjjm	3082	17	time	time	NN
cord-023095-4dannjjm	3082	18	.	.	.
cord-023095-4dannjjm	3083	1	Indications	indication	NNS
cord-023095-4dannjjm	3083	2	for	for	IN
cord-023095-4dannjjm	3083	3	LP	LP	NNP
cord-023095-4dannjjm	3083	4	transfusion	transfusion	NN
cord-023095-4dannjjm	3083	5	included	include	VBD
cord-023095-4dannjjm	3083	6	hypovolemic	hypovolemic	JJ
cord-023095-4dannjjm	3083	7	shock	shock	NN
cord-023095-4dannjjm	3083	8	due	due	IN
cord-023095-4dannjjm	3083	9	to	to	IN
cord-023095-4dannjjm	3083	10	intra	intra	JJ
cord-023095-4dannjjm	3083	11	-	-	JJ
cord-023095-4dannjjm	3083	12	abdominal	abdominal	JJ
cord-023095-4dannjjm	3083	13	hemorrhage	hemorrhage	NN
cord-023095-4dannjjm	3083	14	in	in	IN
cord-023095-4dannjjm	3083	15	6	6	CD
cord-023095-4dannjjm	3083	16	dogs	dog	NNS
cord-023095-4dannjjm	3083	17	(	(	-LRB-
cord-023095-4dannjjm	3083	18	2	2	CD
cord-023095-4dannjjm	3083	19	traumatic	traumatic	JJ
cord-023095-4dannjjm	3083	20	,	,	,
cord-023095-4dannjjm	3083	21	4	4	CD
cord-023095-4dannjjm	3083	22	non	non	JJ
cord-023095-4dannjjm	3083	23	-	-	JJ
cord-023095-4dannjjm	3083	24	traumatic	traumatic	JJ
cord-023095-4dannjjm	3083	25	)	)	-RRB-
cord-023095-4dannjjm	3083	26	and	and	CC
cord-023095-4dannjjm	3083	27	rapid	rapid	JJ
cord-023095-4dannjjm	3083	28	correction	correction	NN
cord-023095-4dannjjm	3083	29	of	of	IN
cord-023095-4dannjjm	3083	30	hemorrhage	hemorrhage	NN
cord-023095-4dannjjm	3083	31	following	follow	VBG
cord-023095-4dannjjm	3083	32	parenteral	parenteral	JJ
cord-023095-4dannjjm	3083	33	tissue	tissue	NN
cord-023095-4dannjjm	3083	34	plasminogen	plasminogen	NN
cord-023095-4dannjjm	3083	35	activator	activator	NN
cord-023095-4dannjjm	3083	36	administration	administration	NN
cord-023095-4dannjjm	3083	37	in	in	IN
cord-023095-4dannjjm	3083	38	1	1	CD
cord-023095-4dannjjm	3083	39	dog	dog	NN
cord-023095-4dannjjm	3083	40	.	.	.
cord-023095-4dannjjm	3084	1	LP	LP	NNP
cord-023095-4dannjjm	3084	2	volume	volume	NN
cord-023095-4dannjjm	3084	3	transfused	transfuse	VBN
cord-023095-4dannjjm	3084	4	ranged	range	VBD
cord-023095-4dannjjm	3084	5	from	from	IN
cord-023095-4dannjjm	3084	6	11.1	11.1	CD
cord-023095-4dannjjm	3084	7	to	to	IN
cord-023095-4dannjjm	3084	8	50.5	50.5	CD
cord-023095-4dannjjm	3084	9	ml	ml	NNS
cord-023095-4dannjjm	3084	10	/	/	SYM
cord-023095-4dannjjm	3084	11	kg	kg	NN
cord-023095-4dannjjm	3084	12	.	.	.
cord-023095-4dannjjm	3085	1	No	no	DT
cord-023095-4dannjjm	3085	2	transfusion	transfusion	NN
cord-023095-4dannjjm	3085	3	reactions	reaction	NNS
cord-023095-4dannjjm	3085	4	were	be	VBD
cord-023095-4dannjjm	3085	5	identified	identify	VBN
cord-023095-4dannjjm	3085	6	.	.	.
cord-023095-4dannjjm	3086	1	Effect	effect	NN
cord-023095-4dannjjm	3086	2	on	on	IN
cord-023095-4dannjjm	3086	3	coagulation	coagulation	NN
cord-023095-4dannjjm	3086	4	was	be	VBD
cord-023095-4dannjjm	3086	5	not	not	RB
cord-023095-4dannjjm	3086	6	consistently	consistently	RB
cord-023095-4dannjjm	3086	7	evaluated	evaluate	VBN
cord-023095-4dannjjm	3086	8	.	.	.
cord-023095-4dannjjm	3087	1	Time	time	NN
cord-023095-4dannjjm	3087	2	required	require	VBN
cord-023095-4dannjjm	3087	3	to	to	TO
cord-023095-4dannjjm	3087	4	thaw	thaw	VB
cord-023095-4dannjjm	3087	5	a	a	DT
cord-023095-4dannjjm	3087	6	unit	unit	NN
cord-023095-4dannjjm	3087	7	of	of	IN
cord-023095-4dannjjm	3087	8	FFP	FFP	NNP
cord-023095-4dannjjm	3087	9	is	be	VBZ
cord-023095-4dannjjm	3087	10	greater	great	JJR
cord-023095-4dannjjm	3087	11	than	than	IN
cord-023095-4dannjjm	3087	12	30	30	CD
cord-023095-4dannjjm	3087	13	minutes	minute	NNS
cord-023095-4dannjjm	3087	14	which	which	WDT
cord-023095-4dannjjm	3087	15	could	could	MD
cord-023095-4dannjjm	3087	16	be	be	VB
cord-023095-4dannjjm	3087	17	detrimental	detrimental	JJ
cord-023095-4dannjjm	3087	18	in	in	IN
cord-023095-4dannjjm	3087	19	a	a	DT
cord-023095-4dannjjm	3087	20	bleeding	bleeding	NN
cord-023095-4dannjjm	3087	21	,	,	,
cord-023095-4dannjjm	3087	22	coagulopathic	coagulopathic	JJ
cord-023095-4dannjjm	3087	23	dog	dog	NN
cord-023095-4dannjjm	3087	24	.	.	.
cord-023095-4dannjjm	3088	1	LP	LP	NNP
cord-023095-4dannjjm	3088	2	was	be	VBD
cord-023095-4dannjjm	3088	3	transfused	transfuse	VBN
cord-023095-4dannjjm	3088	4	without	without	IN
cord-023095-4dannjjm	3088	5	incident	incident	NN
cord-023095-4dannjjm	3088	6	to	to	TO
cord-023095-4dannjjm	3088	7	critically	critically	RB
cord-023095-4dannjjm	3088	8	ill	ill	VB
cord-023095-4dannjjm	3088	9	and	and	CC
cord-023095-4dannjjm	3088	10	injured	injure	VBN
cord-023095-4dannjjm	3088	11	dogs	dog	NNS
cord-023095-4dannjjm	3088	12	and	and	CC
cord-023095-4dannjjm	3088	13	represents	represent	VBZ
cord-023095-4dannjjm	3088	14	a	a	DT
cord-023095-4dannjjm	3088	15	potential	potential	JJ
cord-023095-4dannjjm	3088	16	new	new	JJ
cord-023095-4dannjjm	3088	17	addition	addition	NN
cord-023095-4dannjjm	3088	18	to	to	IN
cord-023095-4dannjjm	3088	19	the	the	DT
cord-023095-4dannjjm	3088	20	armamentarium	armamentarium	NN
cord-023095-4dannjjm	3088	21	of	of	IN
cord-023095-4dannjjm	3088	22	treatments	treatment	NNS
cord-023095-4dannjjm	3088	23	in	in	IN
cord-023095-4dannjjm	3088	24	a	a	DT
cord-023095-4dannjjm	3088	25	veterinary	veterinary	JJ
cord-023095-4dannjjm	3088	26	ER	er	NN
cord-023095-4dannjjm	3088	27	setting	setting	NN
cord-023095-4dannjjm	3088	28	.	.	.
cord-023095-4dannjjm	3089	1	Further	further	JJ
cord-023095-4dannjjm	3089	2	investigation	investigation	NN
cord-023095-4dannjjm	3089	3	of	of	IN
cord-023095-4dannjjm	3089	4	canine	canine	JJ
cord-023095-4dannjjm	3089	5	LP	LP	NNP
cord-023095-4dannjjm	3089	6	is	be	VBZ
cord-023095-4dannjjm	3089	7	warranted	warrant	VBN
cord-023095-4dannjjm	3089	8	including	include	VBG
cord-023095-4dannjjm	3089	9	evaluation	evaluation	NN
cord-023095-4dannjjm	3089	10	of	of	IN
cord-023095-4dannjjm	3089	11	in	in	IN
cord-023095-4dannjjm	3089	12	vitro	vitro	FW
cord-023095-4dannjjm	3089	13	factor	factor	NN
cord-023095-4dannjjm	3089	14	stability	stability	NN
cord-023095-4dannjjm	3089	15	and	and	CC
cord-023095-4dannjjm	3089	16	in	in	IN
cord-023095-4dannjjm	3089	17	vivo	vivo	NN
cord-023095-4dannjjm	3089	18	efficacy	efficacy	NN
cord-023095-4dannjjm	3089	19	in	in	IN
cord-023095-4dannjjm	3089	20	correcting	correct	VBG
cord-023095-4dannjjm	3089	21	coagulopathy	coagulopathy	NN
cord-023095-4dannjjm	3089	22	.	.	.
cord-023095-4dannjjm	3090	1	Immune	immune	JJ
cord-023095-4dannjjm	3090	2	mediated	mediate	VBN
cord-023095-4dannjjm	3090	3	thrombocytopenia	thrombocytopenia	NN
cord-023095-4dannjjm	3090	4	(	(	-LRB-
cord-023095-4dannjjm	3090	5	IMT	IMT	NNP
cord-023095-4dannjjm	3090	6	)	)	-RRB-
cord-023095-4dannjjm	3090	7	is	be	VBZ
cord-023095-4dannjjm	3090	8	associated	associate	VBN
cord-023095-4dannjjm	3090	9	with	with	IN
cord-023095-4dannjjm	3090	10	increased	increase	VBN
cord-023095-4dannjjm	3090	11	morbidity	morbidity	NN
cord-023095-4dannjjm	3090	12	and	and	CC
cord-023095-4dannjjm	3090	13	mortality	mortality	NN
cord-023095-4dannjjm	3090	14	.	.	.
cord-023095-4dannjjm	3091	1	Large	large	JJ
cord-023095-4dannjjm	3091	2	prospective	prospective	JJ
cord-023095-4dannjjm	3091	3	research	research	NN
cord-023095-4dannjjm	3091	4	studies	study	NNS
cord-023095-4dannjjm	3091	5	in	in	IN
cord-023095-4dannjjm	3091	6	dog	dog	NN
cord-023095-4dannjjm	3091	7	platelet	platelet	NN
cord-023095-4dannjjm	3091	8	antibodies	antibody	NNS
cord-023095-4dannjjm	3091	9	and	and	CC
cord-023095-4dannjjm	3091	10	clinical	clinical	JJ
cord-023095-4dannjjm	3091	11	utilization	utilization	NN
cord-023095-4dannjjm	3091	12	of	of	IN
cord-023095-4dannjjm	3091	13	platelet	platelet	NN
cord-023095-4dannjjm	3091	14	immunoglobulin	immunoglobulin	NN
cord-023095-4dannjjm	3091	15	assays	assay	NNS
cord-023095-4dannjjm	3091	16	are	be	VBP
cord-023095-4dannjjm	3091	17	limited	limited	JJ
cord-023095-4dannjjm	3091	18	.	.	.
cord-023095-4dannjjm	3092	1	Potential	potential	JJ
cord-023095-4dannjjm	3092	2	explanations	explanation	NNS
cord-023095-4dannjjm	3092	3	include	include	VBP
cord-023095-4dannjjm	3092	4	limited	limited	JJ
cord-023095-4dannjjm	3092	5	availability	availability	NN
cord-023095-4dannjjm	3092	6	and	and	CC
cord-023095-4dannjjm	3092	7	low	low	JJ
cord-023095-4dannjjm	3092	8	specificity	specificity	NN
cord-023095-4dannjjm	3092	9	due	due	IN
cord-023095-4dannjjm	3092	10	to	to	IN
cord-023095-4dannjjm	3092	11	nonspecific	nonspecific	JJ
cord-023095-4dannjjm	3092	12	binding	binding	NN
cord-023095-4dannjjm	3092	13	.	.	.
cord-023095-4dannjjm	3093	1	The	the	DT
cord-023095-4dannjjm	3093	2	focus	focus	NN
cord-023095-4dannjjm	3093	3	of	of	IN
cord-023095-4dannjjm	3093	4	this	this	DT
cord-023095-4dannjjm	3093	5	study	study	NN
cord-023095-4dannjjm	3093	6	is	be	VBZ
cord-023095-4dannjjm	3093	7	to	to	TO
cord-023095-4dannjjm	3093	8	evaluate	evaluate	VB
cord-023095-4dannjjm	3093	9	optimized	optimize	VBN
cord-023095-4dannjjm	3093	10	direct	direct	JJ
cord-023095-4dannjjm	3093	11	and	and	CC
cord-023095-4dannjjm	3093	12	indirect	indirect	JJ
cord-023095-4dannjjm	3093	13	platelet	platelet	NN
cord-023095-4dannjjm	3093	14	surface	surface	NN
cord-023095-4dannjjm	3093	15	associated	associate	VBN
cord-023095-4dannjjm	3093	16	immunoglobulin	immunoglobulin	NN
cord-023095-4dannjjm	3093	17	(	(	-LRB-
cord-023095-4dannjjm	3093	18	pSAIG	pSAIG	NNP
cord-023095-4dannjjm	3093	19	)	)	-RRB-
cord-023095-4dannjjm	3093	20	and	and	CC
cord-023095-4dannjjm	3093	21	staining	stain	VBG
cord-023095-4dannjjm	3093	22	with	with	IN
cord-023095-4dannjjm	3093	23	anti	anti	JJ
cord-023095-4dannjjm	3093	24	-	-	JJ
cord-023095-4dannjjm	3093	25	CD61	cd61	JJ
cord-023095-4dannjjm	3093	26	antibodies	antibody	NNS
cord-023095-4dannjjm	3093	27	(	(	-LRB-
cord-023095-4dannjjm	3093	28	CD61ab	CD61ab	NNP
cord-023095-4dannjjm	3093	29	)	)	-RRB-
cord-023095-4dannjjm	3093	30	for	for	IN
cord-023095-4dannjjm	3093	31	the	the	DT
cord-023095-4dannjjm	3093	32	utilization	utilization	NN
cord-023095-4dannjjm	3093	33	in	in	IN
cord-023095-4dannjjm	3093	34	classifying	classify	VBG
cord-023095-4dannjjm	3093	35	thrombocytopenic	thrombocytopenic	JJ
cord-023095-4dannjjm	3093	36	dogs	dog	NNS
cord-023095-4dannjjm	3093	37	.	.	.
cord-023095-4dannjjm	3094	1	One	one	CD
cord-023095-4dannjjm	3094	2	hundred	hundred	CD
cord-023095-4dannjjm	3094	3	clinically	clinically	RB
cord-023095-4dannjjm	3094	4	ill	ill	JJ
cord-023095-4dannjjm	3094	5	and	and	CC
cord-023095-4dannjjm	3094	6	30	30	CD
cord-023095-4dannjjm	3095	1	apparently	apparently	RB
cord-023095-4dannjjm	3095	2	healthy	healthy	JJ
cord-023095-4dannjjm	3095	3	dogs	dog	NNS
cord-023095-4dannjjm	3095	4	were	be	VBD
cord-023095-4dannjjm	3095	5	prospectively	prospectively	RB
cord-023095-4dannjjm	3095	6	evaluated	evaluate	VBN
cord-023095-4dannjjm	3095	7	.	.	.
cord-023095-4dannjjm	3096	1	Data	datum	NNS
cord-023095-4dannjjm	3096	2	collected	collect	VBD
cord-023095-4dannjjm	3096	3	included	include	VBD
cord-023095-4dannjjm	3096	4	a	a	DT
cord-023095-4dannjjm	3096	5	history	history	NN
cord-023095-4dannjjm	3096	6	of	of	IN
cord-023095-4dannjjm	3096	7	hemorrhage	hemorrhage	NN
cord-023095-4dannjjm	3096	8	,	,	,
cord-023095-4dannjjm	3096	9	physical	physical	JJ
cord-023095-4dannjjm	3096	10	examination	examination	NN
cord-023095-4dannjjm	3096	11	evidence	evidence	NN
cord-023095-4dannjjm	3096	12	of	of	IN
cord-023095-4dannjjm	3096	13	bleeding	bleed	VBG
cord-023095-4dannjjm	3096	14	,	,	,
cord-023095-4dannjjm	3096	15	complete	complete	JJ
cord-023095-4dannjjm	3096	16	blood	blood	NN
cord-023095-4dannjjm	3096	17	count	count	NN
cord-023095-4dannjjm	3096	18	,	,	,
cord-023095-4dannjjm	3096	19	and	and	CC
cord-023095-4dannjjm	3096	20	measurement	measurement	NN
cord-023095-4dannjjm	3096	21	of	of	IN
cord-023095-4dannjjm	3096	22	pSAIG	pSAIG	NNP
cord-023095-4dannjjm	3096	23	and	and	CC
cord-023095-4dannjjm	3096	24	CD61ab	CD61ab	NNP
cord-023095-4dannjjm	3096	25	.	.	.
cord-023095-4dannjjm	3097	1	The	the	DT
cord-023095-4dannjjm	3097	2	pSAIG	pSAIG	NNP
cord-023095-4dannjjm	3097	3	assay	assay	NN
cord-023095-4dannjjm	3097	4	utilized	utilize	VBN
cord-023095-4dannjjm	3097	5	polyvalent	polyvalent	JJ
cord-023095-4dannjjm	3097	6	antibodies	antibody	NNS
cord-023095-4dannjjm	3097	7	with	with	IN
cord-023095-4dannjjm	3097	8	correction	correction	NN
cord-023095-4dannjjm	3097	9	for	for	IN
cord-023095-4dannjjm	3097	10	non	non	JJ
cord-023095-4dannjjm	3097	11	-	-	JJ
cord-023095-4dannjjm	3097	12	specific	specific	JJ
cord-023095-4dannjjm	3097	13	binding	binding	NN
cord-023095-4dannjjm	3097	14	by	by	IN
cord-023095-4dannjjm	3097	15	subtraction	subtraction	NN
cord-023095-4dannjjm	3097	16	of	of	IN
cord-023095-4dannjjm	3097	17	background	background	NN
cord-023095-4dannjjm	3097	18	fluorescence	fluorescence	NN
cord-023095-4dannjjm	3097	19	with	with	IN
cord-023095-4dannjjm	3097	20	control	control	NN
cord-023095-4dannjjm	3097	21	antiserum	antiserum	NN
cord-023095-4dannjjm	3097	22	.	.	.
cord-023095-4dannjjm	3098	1	Thrombocytopenia	Thrombocytopenia	NNP
cord-023095-4dannjjm	3098	2	was	be	VBD
cord-023095-4dannjjm	3098	3	defined	define	VBN
cord-023095-4dannjjm	3098	4	as	as	IN
cord-023095-4dannjjm	3098	5	o	o	CD
cord-023095-4dannjjm	3098	6	164,000	164,000	CD
cord-023095-4dannjjm	3098	7	/	/	SYM
cord-023095-4dannjjm	3098	8	mL	ml	NN
cord-023095-4dannjjm	3098	9	and	and	CC
cord-023095-4dannjjm	3098	10	all	all	DT
cord-023095-4dannjjm	3098	11	dogs	dog	NNS
cord-023095-4dannjjm	3098	12	were	be	VBD
cord-023095-4dannjjm	3098	13	clinically	clinically	RB
cord-023095-4dannjjm	3098	14	classified	classify	VBN
cord-023095-4dannjjm	3098	15	into	into	IN
cord-023095-4dannjjm	3098	16	1	1	CD
cord-023095-4dannjjm	3098	17	of	of	IN
cord-023095-4dannjjm	3098	18	4	4	CD
cord-023095-4dannjjm	3098	19	groups	group	NNS
cord-023095-4dannjjm	3098	20	(	(	-LRB-
cord-023095-4dannjjm	3098	21	g	g	NN
cord-023095-4dannjjm	3098	22	)	)	-RRB-
cord-023095-4dannjjm	3098	23	:	:	:
cord-023095-4dannjjm	3099	1	g1	g1	NNP
cord-023095-4dannjjm	3099	2	IMT	IMT	NNP
cord-023095-4dannjjm	3099	3	,	,	,
cord-023095-4dannjjm	3099	4	n	n	NN
cord-023095-4dannjjm	3099	5	5	5	CD
cord-023095-4dannjjm	3099	6	45	45	CD
cord-023095-4dannjjm	3099	7	,	,	,
cord-023095-4dannjjm	3099	8	g2	g2	NNP
cord-023095-4dannjjm	3099	9	Thrombocytopenia	Thrombocytopenia	NNP
cord-023095-4dannjjm	3099	10	from	from	IN
cord-023095-4dannjjm	3099	11	non	non	JJ
cord-023095-4dannjjm	3099	12	-	-	JJ
cord-023095-4dannjjm	3099	13	immune	immune	JJ
cord-023095-4dannjjm	3099	14	mediated	mediate	VBN
cord-023095-4dannjjm	3099	15	diseases	disease	NNS
cord-023095-4dannjjm	3099	16	,	,	,
cord-023095-4dannjjm	3099	17	n	n	NN
cord-023095-4dannjjm	3099	18	5	5	CD
cord-023095-4dannjjm	3099	19	37	37	CD
cord-023095-4dannjjm	3099	20	,	,	,
cord-023095-4dannjjm	3100	1	g3	g3	NNP
cord-023095-4dannjjm	3100	2	Ill	Ill	NNP
cord-023095-4dannjjm	3100	3	with	with	IN
cord-023095-4dannjjm	3100	4	normal	normal	JJ
cord-023095-4dannjjm	3100	5	platelet	platelet	NN
cord-023095-4dannjjm	3100	6	counts	count	NNS
cord-023095-4dannjjm	3100	7	,	,	,
cord-023095-4dannjjm	3100	8	n	n	NN
cord-023095-4dannjjm	3100	9	5	5	CD
cord-023095-4dannjjm	3100	10	18	18	CD
cord-023095-4dannjjm	3100	11	,	,	,
cord-023095-4dannjjm	3100	12	g4	g4	NNP
cord-023095-4dannjjm	3100	13	Healthy	Healthy	NNP
cord-023095-4dannjjm	3100	14	dogs	dog	NNS
cord-023095-4dannjjm	3100	15	,	,	,
cord-023095-4dannjjm	3100	16	n	n	NN
cord-023095-4dannjjm	3100	17	5	5	CD
cord-023095-4dannjjm	3100	18	30	30	CD
cord-023095-4dannjjm	3100	19	.	.	.
cord-023095-4dannjjm	3101	1	Median	median	JJ
cord-023095-4dannjjm	3101	2	platelet	platelet	NN
cord-023095-4dannjjm	3101	3	counts	count	NNS
cord-023095-4dannjjm	3101	4	,	,	,
cord-023095-4dannjjm	3101	5	by	by	IN
cord-023095-4dannjjm	3101	6	groups	group	NNS
cord-023095-4dannjjm	3101	7	,	,	,
cord-023095-4dannjjm	3101	8	were	be	VBD
cord-023095-4dannjjm	3101	9	g1	g1	NNP
cord-023095-4dannjjm	3101	10	,	,	,
cord-023095-4dannjjm	3101	11	20,000	20,000	CD
cord-023095-4dannjjm	3101	12	;	;	:
cord-023095-4dannjjm	3101	13	g2	g2	NNP
cord-023095-4dannjjm	3101	14	,	,	,
cord-023095-4dannjjm	3101	15	69,000	69,000	CD
cord-023095-4dannjjm	3101	16	;	;	:
cord-023095-4dannjjm	3101	17	g3	g3	NNP
cord-023095-4dannjjm	3101	18	,	,	,
cord-023095-4dannjjm	3101	19	324,500	324,500	CD
cord-023095-4dannjjm	3101	20	;	;	:
cord-023095-4dannjjm	3101	21	and	and	CC
cord-023095-4dannjjm	3101	22	g4	g4	NNP
cord-023095-4dannjjm	3101	23	,	,	,
cord-023095-4dannjjm	3101	24	212,000	212,000	CD
cord-023095-4dannjjm	3101	25	/	/	SYM
cord-023095-4dannjjm	3101	26	mL.	mL.	NNS
cord-023095-4dannjjm	3102	1	For	for	IN
cord-023095-4dannjjm	3102	2	the	the	DT
cord-023095-4dannjjm	3102	3	direct	direct	JJ
cord-023095-4dannjjm	3102	4	and	and	CC
cord-023095-4dannjjm	3102	5	indirect	indirect	JJ
cord-023095-4dannjjm	3102	6	pSAIGs	psaigs	NN
cord-023095-4dannjjm	3102	7	in	in	IN
cord-023095-4dannjjm	3102	8	dogs	dog	NNS
cord-023095-4dannjjm	3102	9	with	with	IN
cord-023095-4dannjjm	3102	10	ITP	ITP	NNP
cord-023095-4dannjjm	3102	11	(	(	-LRB-
cord-023095-4dannjjm	3102	12	g1	g1	NNP
cord-023095-4dannjjm	3102	13	)	)	-RRB-
cord-023095-4dannjjm	3102	14	,	,	,
cord-023095-4dannjjm	3102	15	more	more	JJR
cord-023095-4dannjjm	3102	16	dogs	dog	NNS
cord-023095-4dannjjm	3102	17	(	(	-LRB-
cord-023095-4dannjjm	3102	18	n	n	NN
cord-023095-4dannjjm	3102	19	5	5	CD
cord-023095-4dannjjm	3102	20	6	6	CD
cord-023095-4dannjjm	3102	21	and	and	CC
cord-023095-4dannjjm	3102	22	n	n	NN
cord-023095-4dannjjm	3102	23	5	5	CD
cord-023095-4dannjjm	3102	24	9	9	CD
cord-023095-4dannjjm	3102	25	)	)	-RRB-
cord-023095-4dannjjm	3102	26	with	with	IN
cord-023095-4dannjjm	3102	27	clinical	clinical	JJ
cord-023095-4dannjjm	3102	28	evidence	evidence	NN
cord-023095-4dannjjm	3102	29	of	of	IN
cord-023095-4dannjjm	3102	30	bleeding	bleed	VBG
cord-023095-4dannjjm	3102	31	had	have	VBD
cord-023095-4dannjjm	3102	32	antibodies	antibody	NNS
cord-023095-4dannjjm	3102	33	compared	compare	VBN
cord-023095-4dannjjm	3102	34	to	to	IN
cord-023095-4dannjjm	3102	35	those	those	DT
cord-023095-4dannjjm	3102	36	who	who	WP
cord-023095-4dannjjm	3102	37	were	be	VBD
cord-023095-4dannjjm	3102	38	not	not	RB
cord-023095-4dannjjm	3102	39	bleeding	bleed	VBG
cord-023095-4dannjjm	3102	40	(	(	-LRB-
cord-023095-4dannjjm	3102	41	n	n	NN
cord-023095-4dannjjm	3102	42	5	5	CD
cord-023095-4dannjjm	3102	43	3	3	CD
cord-023095-4dannjjm	3102	44	and	and	CC
cord-023095-4dannjjm	3102	45	n	n	NN
cord-023095-4dannjjm	3102	46	5	5	CD
cord-023095-4dannjjm	3102	47	6	6	CD
cord-023095-4dannjjm	3102	48	)	)	-RRB-
cord-023095-4dannjjm	3102	49	.	.	.
cord-023095-4dannjjm	3103	1	Considering	consider	VBG
cord-023095-4dannjjm	3103	2	only	only	RB
cord-023095-4dannjjm	3103	3	direct	direct	VB
cord-023095-4dannjjm	3103	4	pSAIG	psaig	XX
cord-023095-4dannjjm	3103	5	the	the	DT
cord-023095-4dannjjm	3103	6	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3103	7	and	and	CC
cord-023095-4dannjjm	3103	8	specificity	specificity	NN
cord-023095-4dannjjm	3103	9	was	be	VBD
cord-023095-4dannjjm	3103	10	13	13	CD
cord-023095-4dannjjm	3103	11	%	%	NN
cord-023095-4dannjjm	3103	12	and	and	CC
cord-023095-4dannjjm	3103	13	95	95	CD
cord-023095-4dannjjm	3103	14	%	%	NN
cord-023095-4dannjjm	3103	15	,	,	,
cord-023095-4dannjjm	3103	16	respectively	respectively	RB
cord-023095-4dannjjm	3103	17	for	for	IN
cord-023095-4dannjjm	3103	18	the	the	DT
cord-023095-4dannjjm	3103	19	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3103	20	of	of	IN
cord-023095-4dannjjm	3103	21	IMT	IMT	NNP
cord-023095-4dannjjm	3103	22	.	.	.
cord-023095-4dannjjm	3104	1	For	for	IN
cord-023095-4dannjjm	3104	2	indirect	indirect	JJ
cord-023095-4dannjjm	3104	3	pSAIG	psaig	XX
cord-023095-4dannjjm	3104	4	the	the	DT
cord-023095-4dannjjm	3104	5	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3104	6	and	and	CC
cord-023095-4dannjjm	3104	7	specificity	specificity	NN
cord-023095-4dannjjm	3104	8	was	be	VBD
cord-023095-4dannjjm	3104	9	27	27	CD
cord-023095-4dannjjm	3104	10	%	%	NN
cord-023095-4dannjjm	3104	11	and	and	CC
cord-023095-4dannjjm	3104	12	97	97	CD
cord-023095-4dannjjm	3104	13	%	%	NN
cord-023095-4dannjjm	3104	14	,	,	,
cord-023095-4dannjjm	3104	15	respectively	respectively	RB
cord-023095-4dannjjm	3104	16	,	,	,
cord-023095-4dannjjm	3104	17	for	for	IN
cord-023095-4dannjjm	3104	18	the	the	DT
cord-023095-4dannjjm	3104	19	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3104	20	of	of	IN
cord-023095-4dannjjm	3104	21	IMT	IMT	NNP
cord-023095-4dannjjm	3104	22	.	.	.
cord-023095-4dannjjm	3105	1	When	when	WRB
cord-023095-4dannjjm	3105	2	considering	consider	VBG
cord-023095-4dannjjm	3105	3	both	both	CC
cord-023095-4dannjjm	3105	4	direct	direct	JJ
cord-023095-4dannjjm	3105	5	and	and	CC
cord-023095-4dannjjm	3105	6	indirect	indirect	JJ
cord-023095-4dannjjm	3105	7	pSAIG	psaig	XX
cord-023095-4dannjjm	3106	1	together	together	RB
cord-023095-4dannjjm	3106	2	,	,	,
cord-023095-4dannjjm	3106	3	the	the	DT
cord-023095-4dannjjm	3106	4	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3106	5	was	be	VBD
cord-023095-4dannjjm	3106	6	33	33	CD
cord-023095-4dannjjm	3106	7	%	%	NN
cord-023095-4dannjjm	3106	8	with	with	IN
cord-023095-4dannjjm	3106	9	a	a	DT
cord-023095-4dannjjm	3106	10	specificity	specificity	NN
cord-023095-4dannjjm	3106	11	of	of	IN
cord-023095-4dannjjm	3106	12	93	93	CD
cord-023095-4dannjjm	3106	13	%	%	NN
cord-023095-4dannjjm	3106	14	.	.	.
cord-023095-4dannjjm	3107	1	In	in	IN
cord-023095-4dannjjm	3107	2	g1	g1	NNP
cord-023095-4dannjjm	3107	3	interference	interference	NN
cord-023095-4dannjjm	3107	4	from	from	IN
cord-023095-4dannjjm	3107	5	high	high	JJ
cord-023095-4dannjjm	3107	6	control	control	NN
cord-023095-4dannjjm	3107	7	antiserum	antiserum	NN
cord-023095-4dannjjm	3107	8	background	background	NN
cord-023095-4dannjjm	3107	9	staining	staining	NN
cord-023095-4dannjjm	3107	10	was	be	VBD
cord-023095-4dannjjm	3107	11	noted	note	VBN
cord-023095-4dannjjm	3107	12	in	in	IN
cord-023095-4dannjjm	3107	13	26.7	26.7	CD
cord-023095-4dannjjm	3107	14	%	%	NN
cord-023095-4dannjjm	3107	15	of	of	IN
cord-023095-4dannjjm	3107	16	dogs	dog	NNS
cord-023095-4dannjjm	3107	17	and	and	CC
cord-023095-4dannjjm	3107	18	resulted	result	VBD
cord-023095-4dannjjm	3107	19	in	in	IN
cord-023095-4dannjjm	3107	20	a	a	DT
cord-023095-4dannjjm	3107	21	negative	negative	JJ
cord-023095-4dannjjm	3107	22	direct	direct	JJ
cord-023095-4dannjjm	3107	23	pSAIG	psaig	NN
cord-023095-4dannjjm	3107	24	classification	classification	NN
cord-023095-4dannjjm	3107	25	.	.	.
cord-023095-4dannjjm	3108	1	Minimal	minimal	JJ
cord-023095-4dannjjm	3108	2	background	background	NN
cord-023095-4dannjjm	3108	3	interference	interference	NN
cord-023095-4dannjjm	3108	4	was	be	VBD
cord-023095-4dannjjm	3108	5	noted	note	VBN
cord-023095-4dannjjm	3108	6	in	in	IN
cord-023095-4dannjjm	3108	7	g2	g2	NNP
cord-023095-4dannjjm	3108	8	,	,	,
cord-023095-4dannjjm	3108	9	g3	g3	NNP
cord-023095-4dannjjm	3108	10	,	,	,
cord-023095-4dannjjm	3108	11	or	or	CC
cord-023095-4dannjjm	3108	12	g4	g4	NNP
cord-023095-4dannjjm	3108	13	.	.	.
cord-023095-4dannjjm	3109	1	The	the	DT
cord-023095-4dannjjm	3109	2	percentage	percentage	NN
cord-023095-4dannjjm	3109	3	of	of	IN
cord-023095-4dannjjm	3109	4	platelets	platelet	NNS
cord-023095-4dannjjm	3109	5	stained	stain	VBN
cord-023095-4dannjjm	3109	6	with	with	IN
cord-023095-4dannjjm	3109	7	CD61ab	CD61ab	NNP
cord-023095-4dannjjm	3109	8	was	be	VBD
cord-023095-4dannjjm	3109	9	significantly	significantly	RB
cord-023095-4dannjjm	3109	10	less	less	JJR
cord-023095-4dannjjm	3109	11	in	in	IN
cord-023095-4dannjjm	3109	12	g1	g1	NNP
cord-023095-4dannjjm	3109	13	(	(	-LRB-
cord-023095-4dannjjm	3109	14	median	median	NN
cord-023095-4dannjjm	3109	15	38	38	CD
cord-023095-4dannjjm	3109	16	,	,	,
cord-023095-4dannjjm	3109	17	p	p	NN
cord-023095-4dannjjm	3109	18	5	5	CD
cord-023095-4dannjjm	3109	19	0.0001	0.0001	CD
cord-023095-4dannjjm	3109	20	)	)	-RRB-
cord-023095-4dannjjm	3109	21	vs.	vs.	IN
cord-023095-4dannjjm	3109	22	g2	g2	NNP
cord-023095-4dannjjm	3109	23	(	(	-LRB-
cord-023095-4dannjjm	3109	24	median	median	NN
cord-023095-4dannjjm	3109	25	74	74	CD
cord-023095-4dannjjm	3109	26	,	,	,
cord-023095-4dannjjm	3109	27	p	p	NN
cord-023095-4dannjjm	3109	28	5	5	CD
cord-023095-4dannjjm	3109	29	0.007	0.007	CD
cord-023095-4dannjjm	3109	30	)	)	-RRB-
cord-023095-4dannjjm	3109	31	vs.	vs.	IN
cord-023095-4dannjjm	3109	32	g3	g3	NNP
cord-023095-4dannjjm	3109	33	(	(	-LRB-
cord-023095-4dannjjm	3109	34	median	median	NN
cord-023095-4dannjjm	3109	35	95.1	95.1	CD
cord-023095-4dannjjm	3109	36	,	,	,
cord-023095-4dannjjm	3109	37	p	p	NN
cord-023095-4dannjjm	3109	38	5	5	CD
cord-023095-4dannjjm	3109	39	0.857	0.857	CD
cord-023095-4dannjjm	3109	40	)	)	-RRB-
cord-023095-4dannjjm	3109	41	and	and	CC
cord-023095-4dannjjm	3109	42	g4	g4	NNP
cord-023095-4dannjjm	3109	43	(	(	-LRB-
cord-023095-4dannjjm	3109	44	median	median	JJ
cord-023095-4dannjjm	3109	45	95.6	95.6	CD
cord-023095-4dannjjm	3109	46	)	)	-RRB-
cord-023095-4dannjjm	3109	47	.	.	.
cord-023095-4dannjjm	3110	1	These	these	DT
cord-023095-4dannjjm	3110	2	findings	finding	NNS
cord-023095-4dannjjm	3110	3	indicate	indicate	VBP
cord-023095-4dannjjm	3110	4	the	the	DT
cord-023095-4dannjjm	3110	5	optimized	optimize	VBN
cord-023095-4dannjjm	3110	6	platelet	platelet	NN
cord-023095-4dannjjm	3110	7	surface	surface	NN
cord-023095-4dannjjm	3110	8	associated	associate	VBN
cord-023095-4dannjjm	3110	9	immunoglobulin	immunoglobulin	NN
cord-023095-4dannjjm	3110	10	assay	assay	NN
cord-023095-4dannjjm	3110	11	has	have	VBZ
cord-023095-4dannjjm	3110	12	a	a	DT
cord-023095-4dannjjm	3110	13	high	high	JJ
cord-023095-4dannjjm	3110	14	specificity	specificity	NN
cord-023095-4dannjjm	3110	15	,	,	,
cord-023095-4dannjjm	3110	16	however	however	RB
cord-023095-4dannjjm	3110	17	poor	poor	JJ
cord-023095-4dannjjm	3110	18	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3110	19	,	,	,
cord-023095-4dannjjm	3110	20	for	for	IN
cord-023095-4dannjjm	3110	21	the	the	DT
cord-023095-4dannjjm	3110	22	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3110	23	of	of	IN
cord-023095-4dannjjm	3110	24	IMT	IMT	NNP
cord-023095-4dannjjm	3110	25	.	.	.
cord-023095-4dannjjm	3111	1	The	the	DT
cord-023095-4dannjjm	3111	2	decreased	decrease	VBN
cord-023095-4dannjjm	3111	3	CD61	CD61	NNP
cord-023095-4dannjjm	3111	4	staining	stain	VBG
cord-023095-4dannjjm	3111	5	in	in	IN
cord-023095-4dannjjm	3111	6	g1	g1	NNP
cord-023095-4dannjjm	3111	7	(	(	-LRB-
cord-023095-4dannjjm	3111	8	IMT	IMT	NNP
cord-023095-4dannjjm	3111	9	group	group	NN
cord-023095-4dannjjm	3111	10	)	)	-RRB-
cord-023095-4dannjjm	3111	11	may	may	MD
cord-023095-4dannjjm	3111	12	reflect	reflect	VB
cord-023095-4dannjjm	3111	13	decreased	decrease	VBN
cord-023095-4dannjjm	3111	14	surface	surface	NN
cord-023095-4dannjjm	3111	15	gpIIIa	gpiiia	JJ
cord-023095-4dannjjm	3111	16	expression	expression	NN
cord-023095-4dannjjm	3111	17	,	,	,
cord-023095-4dannjjm	3111	18	blocking	block	VBG
cord-023095-4dannjjm	3111	19	by	by	IN
cord-023095-4dannjjm	3111	20	anti	anti	JJ
cord-023095-4dannjjm	3111	21	-	-	JJ
cord-023095-4dannjjm	3111	22	gpIIIa	gpiiia	JJ
cord-023095-4dannjjm	3111	23	antibodies	antibody	NNS
cord-023095-4dannjjm	3111	24	or	or	CC
cord-023095-4dannjjm	3111	25	other	other	JJ
cord-023095-4dannjjm	3111	26	proteins	protein	NNS
cord-023095-4dannjjm	3111	27	,	,	,
cord-023095-4dannjjm	3111	28	clearance	clearance	NN
cord-023095-4dannjjm	3111	29	by	by	IN
cord-023095-4dannjjm	3111	30	macrophages	macrophage	NNS
cord-023095-4dannjjm	3111	31	,	,	,
cord-023095-4dannjjm	3111	32	or	or	CC
cord-023095-4dannjjm	3111	33	increased	increase	VBN
cord-023095-4dannjjm	3111	34	non	non	JJ
cord-023095-4dannjjm	3111	35	-	-	JJ
cord-023095-4dannjjm	3111	36	platelet	platelet	JJ
cord-023095-4dannjjm	3111	37	debris	debris	NN
cord-023095-4dannjjm	3111	38	and	and	CC
cord-023095-4dannjjm	3111	39	has	have	VBZ
cord-023095-4dannjjm	3111	40	potential	potential	JJ
cord-023095-4dannjjm	3111	41	applications	application	NNS
cord-023095-4dannjjm	3111	42	in	in	IN
cord-023095-4dannjjm	3111	43	the	the	DT
cord-023095-4dannjjm	3111	44	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3111	45	and	and	CC
cord-023095-4dannjjm	3111	46	treatment	treatment	NN
cord-023095-4dannjjm	3111	47	of	of	IN
cord-023095-4dannjjm	3111	48	IMT	IMT	NNP
cord-023095-4dannjjm	3111	49	.	.	.
cord-023095-4dannjjm	3112	1	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	3112	2	have	have	VBP
cord-023095-4dannjjm	3112	3	lower	low	JJR
cord-023095-4dannjjm	3112	4	serum	serum	NN
cord-023095-4dannjjm	3112	5	concentrations	concentration	NNS
cord-023095-4dannjjm	3112	6	of	of	IN
cord-023095-4dannjjm	3112	7	a	a	DT
cord-023095-4dannjjm	3112	8	-	-	HYPH
cord-023095-4dannjjm	3112	9	globulin	globulin	NN
cord-023095-4dannjjm	3112	10	than	than	IN
cord-023095-4dannjjm	3112	11	other	other	JJ
cord-023095-4dannjjm	3112	12	breeds	breed	NNS
cord-023095-4dannjjm	3112	13	,	,	,
cord-023095-4dannjjm	3112	14	explained	explain	VBN
cord-023095-4dannjjm	3112	15	by	by	IN
cord-023095-4dannjjm	3112	16	negligible	negligible	JJ
cord-023095-4dannjjm	3112	17	levels	level	NNS
cord-023095-4dannjjm	3112	18	of	of	IN
cord-023095-4dannjjm	3112	19	haptoglobin	haptoglobin	NN
cord-023095-4dannjjm	3112	20	(	(	-LRB-
cord-023095-4dannjjm	3112	21	HP	HP	NNP
cord-023095-4dannjjm	3112	22	)	)	-RRB-
cord-023095-4dannjjm	3112	23	measured	measure	VBD
cord-023095-4dannjjm	3112	24	using	use	VBG
cord-023095-4dannjjm	3112	25	different	different	JJ
cord-023095-4dannjjm	3112	26	methods	method	NNS
cord-023095-4dannjjm	3112	27	(	(	-LRB-
cord-023095-4dannjjm	3112	28	colorimetric	colorimetric	JJ
cord-023095-4dannjjm	3112	29	,	,	,
cord-023095-4dannjjm	3112	30	immunoturbidimetric	immunoturbidimetric	JJ
cord-023095-4dannjjm	3112	31	and	and	CC
cord-023095-4dannjjm	3112	32	protein	protein	NN
cord-023095-4dannjjm	3112	33	electrophoresis	electrophoresis	NN
cord-023095-4dannjjm	3112	34	)	)	-RRB-
cord-023095-4dannjjm	3112	35	.	.	.
cord-023095-4dannjjm	3113	1	The	the	DT
cord-023095-4dannjjm	3113	2	purpose	purpose	NN
cord-023095-4dannjjm	3113	3	of	of	IN
cord-023095-4dannjjm	3113	4	the	the	DT
cord-023095-4dannjjm	3113	5	present	present	JJ
cord-023095-4dannjjm	3113	6	study	study	NN
cord-023095-4dannjjm	3113	7	was	be	VBD
cord-023095-4dannjjm	3113	8	to	to	TO
cord-023095-4dannjjm	3113	9	characterize	characterize	VB
cord-023095-4dannjjm	3113	10	the	the	DT
cord-023095-4dannjjm	3113	11	HP	HP	NNP
cord-023095-4dannjjm	3113	12	gene	gene	NN
cord-023095-4dannjjm	3113	13	in	in	IN
cord-023095-4dannjjm	3113	14	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	3113	15	.	.	.
cord-023095-4dannjjm	3114	1	We	-PRON-	PRP
cord-023095-4dannjjm	3114	2	isolated	isolate	VBD
cord-023095-4dannjjm	3114	3	DNA	DNA	NNP
cord-023095-4dannjjm	3114	4	and	and	CC
cord-023095-4dannjjm	3114	5	RNA	RNA	NNP
cord-023095-4dannjjm	3114	6	from	from	IN
cord-023095-4dannjjm	3114	7	blood	blood	NN
cord-023095-4dannjjm	3114	8	samples	sample	NNS
cord-023095-4dannjjm	3114	9	of	of	IN
cord-023095-4dannjjm	3114	10	AKC	AKC	NNP
cord-023095-4dannjjm	3114	11	-	-	HYPH
cord-023095-4dannjjm	3114	12	registered	register	VBN
cord-023095-4dannjjm	3114	13	and	and	CC
cord-023095-4dannjjm	3114	14	retired	retired	JJ
cord-023095-4dannjjm	3114	15	racing	racing	NN
cord-023095-4dannjjm	3114	16	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	3114	17	(	(	-LRB-
cord-023095-4dannjjm	3114	18	AKCG	AKCG	NNP
cord-023095-4dannjjm	3114	19	,	,	,
cord-023095-4dannjjm	3114	20	RRG	RRG	NNP
cord-023095-4dannjjm	3114	21	)	)	-RRB-
cord-023095-4dannjjm	3114	22	,	,	,
cord-023095-4dannjjm	3114	23	and	and	CC
cord-023095-4dannjjm	3114	24	a	a	DT
cord-023095-4dannjjm	3114	25	German	german	JJ
cord-023095-4dannjjm	3114	26	Shepherd	Shepherd	NNP
cord-023095-4dannjjm	3114	27	Dog	Dog	NNP
cord-023095-4dannjjm	3114	28	(	(	-LRB-
cord-023095-4dannjjm	3114	29	GSD	GSD	NNP
cord-023095-4dannjjm	3114	30	)	)	-RRB-
cord-023095-4dannjjm	3114	31	.	.	.
cord-023095-4dannjjm	3115	1	We	-PRON-	PRP
cord-023095-4dannjjm	3115	2	sequenced	sequence	VBD
cord-023095-4dannjjm	3115	3	the	the	DT
cord-023095-4dannjjm	3115	4	HP	HP	NNP
cord-023095-4dannjjm	3115	5	exons	exon	NNS
cord-023095-4dannjjm	3115	6	and	and	CC
cord-023095-4dannjjm	3115	7	splice	splice	NN
cord-023095-4dannjjm	3115	8	sites	site	NNS
cord-023095-4dannjjm	3115	9	,	,	,
cord-023095-4dannjjm	3115	10	and	and	CC
cord-023095-4dannjjm	3115	11	conducted	conduct	VBN
cord-023095-4dannjjm	3115	12	array	array	NN
cord-023095-4dannjjm	3115	13	comparative	comparative	JJ
cord-023095-4dannjjm	3115	14	genomic	genomic	JJ
cord-023095-4dannjjm	3115	15	hybridization	hybridization	NN
cord-023095-4dannjjm	3115	16	to	to	TO
cord-023095-4dannjjm	3115	17	identify	identify	VB
cord-023095-4dannjjm	3115	18	associated	associate	VBN
cord-023095-4dannjjm	3115	19	DNA	dna	NN
cord-023095-4dannjjm	3115	20	structural	structural	JJ
cord-023095-4dannjjm	3115	21	variation	variation	NN
cord-023095-4dannjjm	3115	22	(	(	-LRB-
cord-023095-4dannjjm	3115	23	custom	custom	NN
cord-023095-4dannjjm	3115	24	1	1	CD
cord-023095-4dannjjm	3115	25	M	M	NNP
cord-023095-4dannjjm	3115	26	Agilent	Agilent	NNP
cord-023095-4dannjjm	3115	27	oligonucleotide	oligonucleotide	JJ
cord-023095-4dannjjm	3115	28	array	array	NN
cord-023095-4dannjjm	3115	29	)	)	-RRB-
cord-023095-4dannjjm	3115	30	.	.	.
cord-023095-4dannjjm	3116	1	Additionally	additionally	RB
cord-023095-4dannjjm	3116	2	,	,	,
cord-023095-4dannjjm	3116	3	we	-PRON-	PRP
cord-023095-4dannjjm	3116	4	tested	test	VBD
cord-023095-4dannjjm	3116	5	for	for	IN
cord-023095-4dannjjm	3116	6	the	the	DT
cord-023095-4dannjjm	3116	7	presence	presence	NN
cord-023095-4dannjjm	3116	8	of	of	IN
cord-023095-4dannjjm	3116	9	one	one	CD
cord-023095-4dannjjm	3116	10	or	or	CC
cord-023095-4dannjjm	3116	11	multiple	multiple	JJ
cord-023095-4dannjjm	3116	12	haplotypes	haplotype	NNS
cord-023095-4dannjjm	3116	13	spanning	span	VBG
cord-023095-4dannjjm	3116	14	HP	HP	NNP
cord-023095-4dannjjm	3116	15	in	in	IN
cord-023095-4dannjjm	3116	16	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	3116	17	using	use	VBG
cord-023095-4dannjjm	3116	18	a	a	DT
cord-023095-4dannjjm	3116	19	high	high	JJ
cord-023095-4dannjjm	3116	20	density	density	NN
cord-023095-4dannjjm	3116	21	SNP	SNP	NNP
cord-023095-4dannjjm	3116	22	array	array	NN
cord-023095-4dannjjm	3116	23	(	(	-LRB-
cord-023095-4dannjjm	3116	24	180k	180k	CD
cord-023095-4dannjjm	3116	25	Illumina	Illumina	NNP
cord-023095-4dannjjm	3116	26	HD	HD	NNP
cord-023095-4dannjjm	3116	27	)	)	-RRB-
cord-023095-4dannjjm	3116	28	.	.	.
cord-023095-4dannjjm	3117	1	Sequencing	sequencing	NN
cord-023095-4dannjjm	3117	2	results	result	NNS
cord-023095-4dannjjm	3117	3	of	of	IN
cord-023095-4dannjjm	3117	4	HP	HP	NNP
cord-023095-4dannjjm	3117	5	in	in	IN
cord-023095-4dannjjm	3117	6	both	both	CC
cord-023095-4dannjjm	3117	7	DNA	DNA	NNP
cord-023095-4dannjjm	3117	8	and	and	CC
cord-023095-4dannjjm	3117	9	cDNA	cdna	NN
cord-023095-4dannjjm	3117	10	revealed	reveal	VBD
cord-023095-4dannjjm	3117	11	three	three	CD
cord-023095-4dannjjm	3117	12	synonymous	synonymous	JJ
cord-023095-4dannjjm	3117	13	SNPs	snp	NNS
cord-023095-4dannjjm	3117	14	in	in	IN
cord-023095-4dannjjm	3117	15	the	the	DT
cord-023095-4dannjjm	3117	16	racing	race	VBG
cord-023095-4dannjjm	3117	17	Greyhound	Greyhound	NNP
cord-023095-4dannjjm	3117	18	.	.	.
cord-023095-4dannjjm	3118	1	We	-PRON-	PRP
cord-023095-4dannjjm	3118	2	did	do	VBD
cord-023095-4dannjjm	3118	3	not	not	RB
cord-023095-4dannjjm	3118	4	identify	identify	VB
cord-023095-4dannjjm	3118	5	structural	structural	JJ
cord-023095-4dannjjm	3118	6	variation	variation	NN
cord-023095-4dannjjm	3118	7	overlapping	overlap	VBG
cord-023095-4dannjjm	3118	8	or	or	CC
cord-023095-4dannjjm	3118	9	near	near	IN
cord-023095-4dannjjm	3118	10	the	the	DT
cord-023095-4dannjjm	3118	11	HP	HP	NNP
cord-023095-4dannjjm	3118	12	gene	gene	NN
cord-023095-4dannjjm	3118	13	.	.	.
cord-023095-4dannjjm	3119	1	Notably	notably	RB
cord-023095-4dannjjm	3119	2	,	,	,
cord-023095-4dannjjm	3119	3	we	-PRON-	PRP
cord-023095-4dannjjm	3119	4	detected	detect	VBD
cord-023095-4dannjjm	3119	5	that	that	IN
cord-023095-4dannjjm	3119	6	the	the	DT
cord-023095-4dannjjm	3119	7	RRG	RRG	NNP
cord-023095-4dannjjm	3119	8	and	and	CC
cord-023095-4dannjjm	3119	9	AKCG	AKCG	NNP
cord-023095-4dannjjm	3119	10	do	do	VBP
cord-023095-4dannjjm	3119	11	not	not	RB
cord-023095-4dannjjm	3119	12	appear	appear	VB
cord-023095-4dannjjm	3119	13	to	to	TO
cord-023095-4dannjjm	3119	14	share	share	VB
cord-023095-4dannjjm	3119	15	a	a	DT
cord-023095-4dannjjm	3119	16	specific	specific	JJ
cord-023095-4dannjjm	3119	17	haplotype	haplotype	NN
cord-023095-4dannjjm	3119	18	spanning	span	VBG
cord-023095-4dannjjm	3119	19	HP	HP	NNP
cord-023095-4dannjjm	3119	20	.	.	.
cord-023095-4dannjjm	3120	1	Despite	despite	IN
cord-023095-4dannjjm	3120	2	having	have	VBG
cord-023095-4dannjjm	3120	3	low	low	JJ
cord-023095-4dannjjm	3120	4	or	or	CC
cord-023095-4dannjjm	3120	5	undetectable	undetectable	JJ
cord-023095-4dannjjm	3120	6	serum	serum	NN
cord-023095-4dannjjm	3120	7	concentrations	concentration	NNS
cord-023095-4dannjjm	3120	8	of	of	IN
cord-023095-4dannjjm	3120	9	HP	HP	NNP
cord-023095-4dannjjm	3120	10	,	,	,
cord-023095-4dannjjm	3120	11	we	-PRON-	PRP
cord-023095-4dannjjm	3120	12	did	do	VBD
cord-023095-4dannjjm	3120	13	find	find	VB
cord-023095-4dannjjm	3120	14	that	that	IN
cord-023095-4dannjjm	3120	15	RRG	RRG	NNP
cord-023095-4dannjjm	3120	16	HP	HP	NNP
cord-023095-4dannjjm	3120	17	mRNA	mrna	NN
cord-023095-4dannjjm	3120	18	is	be	VBZ
cord-023095-4dannjjm	3120	19	expressed	express	VBN
cord-023095-4dannjjm	3120	20	and	and	CC
cord-023095-4dannjjm	3120	21	lacks	lack	VBZ
cord-023095-4dannjjm	3120	22	amino	amino	JJ
cord-023095-4dannjjm	3120	23	acid	acid	NN
cord-023095-4dannjjm	3120	24	variation	variation	NN
cord-023095-4dannjjm	3120	25	.	.	.
cord-023095-4dannjjm	3121	1	This	this	DT
cord-023095-4dannjjm	3121	2	suggests	suggest	VBZ
cord-023095-4dannjjm	3121	3	that	that	IN
cord-023095-4dannjjm	3121	4	the	the	DT
cord-023095-4dannjjm	3121	5	clinical	clinical	JJ
cord-023095-4dannjjm	3121	6	absence	absence	NN
cord-023095-4dannjjm	3121	7	of	of	IN
cord-023095-4dannjjm	3121	8	the	the	DT
cord-023095-4dannjjm	3121	9	HP	HP	NNP
cord-023095-4dannjjm	3121	10	is	be	VBZ
cord-023095-4dannjjm	3121	11	attributable	attributable	JJ
cord-023095-4dannjjm	3121	12	to	to	IN
cord-023095-4dannjjm	3121	13	post	post	JJ
cord-023095-4dannjjm	3121	14	-	-	JJ
cord-023095-4dannjjm	3121	15	transcriptional	transcriptional	JJ
cord-023095-4dannjjm	3121	16	HP	HP	NNP
cord-023095-4dannjjm	3121	17	effects	effect	NNS
cord-023095-4dannjjm	3121	18	or	or	CC
cord-023095-4dannjjm	3121	19	to	to	IN
cord-023095-4dannjjm	3121	20	an	an	DT
cord-023095-4dannjjm	3121	21	unknown	unknown	JJ
cord-023095-4dannjjm	3121	22	physiological	physiological	JJ
cord-023095-4dannjjm	3121	23	interaction	interaction	NN
cord-023095-4dannjjm	3121	24	.	.	.
cord-023095-4dannjjm	3122	1	Finally	finally	RB
cord-023095-4dannjjm	3122	2	,	,	,
cord-023095-4dannjjm	3122	3	given	give	VBN
cord-023095-4dannjjm	3122	4	the	the	DT
cord-023095-4dannjjm	3122	5	existence	existence	NN
cord-023095-4dannjjm	3122	6	of	of	IN
cord-023095-4dannjjm	3122	7	distinct	distinct	JJ
cord-023095-4dannjjm	3122	8	RRG	RRG	NNP
cord-023095-4dannjjm	3122	9	and	and	CC
cord-023095-4dannjjm	3122	10	AKCG	AKCG	NNP
cord-023095-4dannjjm	3122	11	haplotypes	haplotype	NNS
cord-023095-4dannjjm	3122	12	spanning	span	VBG
cord-023095-4dannjjm	3122	13	HP	HP	NNP
cord-023095-4dannjjm	3122	14	,	,	,
cord-023095-4dannjjm	3122	15	it	-PRON-	PRP
cord-023095-4dannjjm	3122	16	is	be	VBZ
cord-023095-4dannjjm	3122	17	important	important	JJ
cord-023095-4dannjjm	3122	18	to	to	TO
cord-023095-4dannjjm	3122	19	characterize	characterize	VB
cord-023095-4dannjjm	3122	20	serum	serum	NN
cord-023095-4dannjjm	3122	21	levels	level	NNS
cord-023095-4dannjjm	3122	22	of	of	IN
cord-023095-4dannjjm	3122	23	HP	HP	NNP
cord-023095-4dannjjm	3122	24	in	in	IN
cord-023095-4dannjjm	3122	25	AKCG	AKCG	NNP
cord-023095-4dannjjm	3122	26	in	in	IN
cord-023095-4dannjjm	3122	27	follow	follow	NN
cord-023095-4dannjjm	3122	28	on	on	IN
cord-023095-4dannjjm	3122	29	studies	study	NNS
cord-023095-4dannjjm	3122	30	.	.	.
cord-023095-4dannjjm	3123	1	We	-PRON-	PRP
cord-023095-4dannjjm	3123	2	reported	report	VBD
cord-023095-4dannjjm	3123	3	that	that	DT
cord-023095-4dannjjm	3123	4	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	3123	5	in	in	IN
cord-023095-4dannjjm	3123	6	retired	retired	JJ
cord-023095-4dannjjm	3123	7	racing	racing	NN
cord-023095-4dannjjm	3123	8	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	3123	9	(	(	-LRB-
cord-023095-4dannjjm	3123	10	RRG	RRG	NNP
cord-023095-4dannjjm	3123	11	)	)	-RRB-
cord-023095-4dannjjm	3123	12	has	have	VBZ
cord-023095-4dannjjm	3123	13	higher	high	JJR
cord-023095-4dannjjm	3123	14	oxygen	oxygen	NN
cord-023095-4dannjjm	3123	15	carrying	carry	VBG
cord-023095-4dannjjm	3123	16	properties	property	NNS
cord-023095-4dannjjm	3123	17	and	and	CC
cord-023095-4dannjjm	3123	18	affinity	affinity	NN
cord-023095-4dannjjm	3123	19	than	than	IN
cord-023095-4dannjjm	3123	20	other	other	JJ
cord-023095-4dannjjm	3123	21	breeds	breed	NNS
cord-023095-4dannjjm	3123	22	.	.	.
cord-023095-4dannjjm	3124	1	Surprisingly	surprisingly	RB
cord-023095-4dannjjm	3124	2	,	,	,
cord-023095-4dannjjm	3124	3	very	very	RB
cord-023095-4dannjjm	3124	4	little	little	JJ
cord-023095-4dannjjm	3124	5	is	be	VBZ
cord-023095-4dannjjm	3124	6	known	know	VBN
cord-023095-4dannjjm	3124	7	about	about	IN
cord-023095-4dannjjm	3124	8	canine	canine	JJ
cord-023095-4dannjjm	3124	9	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	3124	10	genetics	genetic	NNS
cord-023095-4dannjjm	3124	11	.	.	.
cord-023095-4dannjjm	3125	1	The	the	DT
cord-023095-4dannjjm	3125	2	purpose	purpose	NN
cord-023095-4dannjjm	3125	3	of	of	IN
cord-023095-4dannjjm	3125	4	this	this	DT
cord-023095-4dannjjm	3125	5	study	study	NN
cord-023095-4dannjjm	3125	6	was	be	VBD
cord-023095-4dannjjm	3125	7	to	to	TO
cord-023095-4dannjjm	3125	8	characterize	characterize	VB
cord-023095-4dannjjm	3125	9	genetics	genetic	NNS
cord-023095-4dannjjm	3125	10	of	of	IN
cord-023095-4dannjjm	3125	11	canine	canine	JJ
cord-023095-4dannjjm	3125	12	beta	beta	NN
cord-023095-4dannjjm	3125	13	globins	globin	NNS
cord-023095-4dannjjm	3125	14	.	.	.
cord-023095-4dannjjm	3126	1	Using	use	VBG
cord-023095-4dannjjm	3126	2	computational	computational	JJ
cord-023095-4dannjjm	3126	3	BLAST	blast	NN
cord-023095-4dannjjm	3126	4	analysis	analysis	NN
cord-023095-4dannjjm	3126	5	of	of	IN
cord-023095-4dannjjm	3126	6	the	the	DT
cord-023095-4dannjjm	3126	7	dog	dog	NN
cord-023095-4dannjjm	3126	8	genome	genome	NN
cord-023095-4dannjjm	3126	9	,	,	,
cord-023095-4dannjjm	3126	10	we	-PRON-	PRP
cord-023095-4dannjjm	3126	11	identified	identify	VBD
cord-023095-4dannjjm	3126	12	five	five	CD
cord-023095-4dannjjm	3126	13	beta	beta	NN
cord-023095-4dannjjm	3126	14	globin	globin	NN
cord-023095-4dannjjm	3126	15	genes	gene	NNS
cord-023095-4dannjjm	3126	16	in	in	IN
cord-023095-4dannjjm	3126	17	a	a	DT
cord-023095-4dannjjm	3126	18	single	single	JJ
cord-023095-4dannjjm	3126	19	locus	locus	NN
cord-023095-4dannjjm	3126	20	:	:	:
cord-023095-4dannjjm	3126	21	two	two	CD
cord-023095-4dannjjm	3126	22	human	human	JJ
cord-023095-4dannjjm	3126	23	HBElike	hbelike	NN
cord-023095-4dannjjm	3126	24	followed	follow	VBN
cord-023095-4dannjjm	3126	25	by	by	IN
cord-023095-4dannjjm	3126	26	three	three	CD
cord-023095-4dannjjm	3126	27	HBB	HBB	NNP
cord-023095-4dannjjm	3126	28	-	-	HYPH
cord-023095-4dannjjm	3126	29	like	like	JJ
cord-023095-4dannjjm	3126	30	genes	gene	NNS
cord-023095-4dannjjm	3126	31	.	.	.
cord-023095-4dannjjm	3127	1	We	-PRON-	PRP
cord-023095-4dannjjm	3127	2	isolated	isolate	VBD
cord-023095-4dannjjm	3127	3	DNA	DNA	NNP
cord-023095-4dannjjm	3127	4	and	and	CC
cord-023095-4dannjjm	3127	5	RNA	RNA	NNP
cord-023095-4dannjjm	3127	6	from	from	IN
cord-023095-4dannjjm	3127	7	blood	blood	NN
cord-023095-4dannjjm	3127	8	of	of	IN
cord-023095-4dannjjm	3127	9	RRGs	rrg	NNS
cord-023095-4dannjjm	3127	10	,	,	,
cord-023095-4dannjjm	3127	11	AKC	AKC	NNP
cord-023095-4dannjjm	3127	12	registered	register	VBN
cord-023095-4dannjjm	3127	13	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	3127	14	(	(	-LRB-
cord-023095-4dannjjm	3127	15	AKCG	AKCG	NNP
cord-023095-4dannjjm	3127	16	)	)	-RRB-
cord-023095-4dannjjm	3127	17	,	,	,
cord-023095-4dannjjm	3127	18	and	and	CC
cord-023095-4dannjjm	3127	19	German	german	JJ
cord-023095-4dannjjm	3127	20	Shepherd	Shepherd	NNP
cord-023095-4dannjjm	3127	21	Dog	Dog	NNP
cord-023095-4dannjjm	3127	22	(	(	-LRB-
cord-023095-4dannjjm	3127	23	GSD	GSD	NNP
cord-023095-4dannjjm	3127	24	)	)	-RRB-
cord-023095-4dannjjm	3127	25	.	.	.
cord-023095-4dannjjm	3128	1	All	all	DT
cord-023095-4dannjjm	3128	2	beta	beta	NN
cord-023095-4dannjjm	3128	3	globin	globin	NN
cord-023095-4dannjjm	3128	4	exons	exon	NNS
cord-023095-4dannjjm	3128	5	and	and	CC
cord-023095-4dannjjm	3128	6	splice	splice	NN
cord-023095-4dannjjm	3128	7	sites	site	NNS
cord-023095-4dannjjm	3128	8	were	be	VBD
cord-023095-4dannjjm	3128	9	sequenced	sequence	VBN
cord-023095-4dannjjm	3128	10	,	,	,
cord-023095-4dannjjm	3128	11	and	and	CC
cord-023095-4dannjjm	3128	12	the	the	DT
cord-023095-4dannjjm	3128	13	beta	beta	JJ
cord-023095-4dannjjm	3128	14	globin	globin	NN
cord-023095-4dannjjm	3128	15	locus	locus	NN
cord-023095-4dannjjm	3128	16	was	be	VBD
cord-023095-4dannjjm	3128	17	examined	examine	VBN
cord-023095-4dannjjm	3128	18	by	by	IN
cord-023095-4dannjjm	3128	19	array	array	NN
cord-023095-4dannjjm	3128	20	comparative	comparative	JJ
cord-023095-4dannjjm	3128	21	genomic	genomic	JJ
cord-023095-4dannjjm	3128	22	hybridization	hybridization	NN
cord-023095-4dannjjm	3128	23	(	(	-LRB-
cord-023095-4dannjjm	3128	24	custom	custom	NN
cord-023095-4dannjjm	3128	25	1	1	CD
cord-023095-4dannjjm	3128	26	M	M	NNP
cord-023095-4dannjjm	3128	27	Agilent	Agilent	NNP
cord-023095-4dannjjm	3128	28	array	array	NN
cord-023095-4dannjjm	3128	29	)	)	-RRB-
cord-023095-4dannjjm	3128	30	.	.	.
cord-023095-4dannjjm	3129	1	Additionally	additionally	RB
cord-023095-4dannjjm	3129	2	,	,	,
cord-023095-4dannjjm	3129	3	we	-PRON-	PRP
cord-023095-4dannjjm	3129	4	determined	determine	VBD
cord-023095-4dannjjm	3129	5	the	the	DT
cord-023095-4dannjjm	3129	6	number	number	NN
cord-023095-4dannjjm	3129	7	of	of	IN
cord-023095-4dannjjm	3129	8	common	common	JJ
cord-023095-4dannjjm	3129	9	haplotypes	haplotype	NNS
cord-023095-4dannjjm	3129	10	that	that	WDT
cord-023095-4dannjjm	3129	11	span	span	VBP
cord-023095-4dannjjm	3129	12	this	this	DT
cord-023095-4dannjjm	3129	13	locus	locus	NN
cord-023095-4dannjjm	3129	14	in	in	IN
cord-023095-4dannjjm	3129	15	RRGs	rrg	NNS
cord-023095-4dannjjm	3129	16	and	and	CC
cord-023095-4dannjjm	3129	17	AKCGs	akcg	NNS
cord-023095-4dannjjm	3129	18	using	use	VBG
cord-023095-4dannjjm	3129	19	high	high	JJ
cord-023095-4dannjjm	3129	20	density	density	NN
cord-023095-4dannjjm	3129	21	SNP	SNP	NNP
cord-023095-4dannjjm	3129	22	array	array	NN
cord-023095-4dannjjm	3129	23	(	(	-LRB-
cord-023095-4dannjjm	3129	24	180k	180k	CD
cord-023095-4dannjjm	3129	25	Illumina	Illumina	NNP
cord-023095-4dannjjm	3129	26	HD	HD	NNP
cord-023095-4dannjjm	3129	27	)	)	-RRB-
cord-023095-4dannjjm	3129	28	.	.	.
cord-023095-4dannjjm	3130	1	Expression	expression	NN
cord-023095-4dannjjm	3130	2	and	and	CC
cord-023095-4dannjjm	3130	3	sequence	sequence	NN
cord-023095-4dannjjm	3130	4	analysis	analysis	NN
cord-023095-4dannjjm	3130	5	of	of	IN
cord-023095-4dannjjm	3130	6	cDNA	cdna	NN
cord-023095-4dannjjm	3130	7	showed	show	VBD
cord-023095-4dannjjm	3130	8	all	all	DT
cord-023095-4dannjjm	3130	9	five	five	CD
cord-023095-4dannjjm	3130	10	beta	beta	JJ
cord-023095-4dannjjm	3130	11	globin	globin	NN
cord-023095-4dannjjm	3130	12	genes	gene	NNS
cord-023095-4dannjjm	3130	13	are	be	VBP
cord-023095-4dannjjm	3130	14	actively	actively	RB
cord-023095-4dannjjm	3130	15	expressed	express	VBN
cord-023095-4dannjjm	3130	16	in	in	IN
cord-023095-4dannjjm	3130	17	adults	adult	NNS
cord-023095-4dannjjm	3130	18	.	.	.
cord-023095-4dannjjm	3131	1	CanHBB1	CanHBB1	NNP
cord-023095-4dannjjm	3131	2	and	and	CC
cord-023095-4dannjjm	3131	3	2	2	CD
cord-023095-4dannjjm	3131	4	were	be	VBD
cord-023095-4dannjjm	3131	5	created	create	VBN
cord-023095-4dannjjm	3131	6	by	by	IN
cord-023095-4dannjjm	3131	7	relatively	relatively	RB
cord-023095-4dannjjm	3131	8	recent	recent	JJ
cord-023095-4dannjjm	3131	9	segmental	segmental	JJ
cord-023095-4dannjjm	3131	10	duplication	duplication	NN
cord-023095-4dannjjm	3131	11	and	and	CC
cord-023095-4dannjjm	3131	12	have	have	VBP
cord-023095-4dannjjm	3131	13	identical	identical	JJ
cord-023095-4dannjjm	3131	14	protein	protein	NN
cord-023095-4dannjjm	3131	15	sequence	sequence	NN
cord-023095-4dannjjm	3131	16	.	.	.
cord-023095-4dannjjm	3132	1	CanHBB1/2	CanHBB1/2	NNP
cord-023095-4dannjjm	3132	2	are	be	VBP
cord-023095-4dannjjm	3132	3	abundantly	abundantly	RB
cord-023095-4dannjjm	3132	4	expressed	express	VBN
cord-023095-4dannjjm	3132	5	in	in	IN
cord-023095-4dannjjm	3132	6	adults	adult	NNS
cord-023095-4dannjjm	3132	7	;	;	:
cord-023095-4dannjjm	3132	8	CanHBB3	CanHBB3	NNS
cord-023095-4dannjjm	3132	9	is	be	VBZ
cord-023095-4dannjjm	3132	10	expressed	express	VBN
cord-023095-4dannjjm	3132	11	at	at	IN
cord-023095-4dannjjm	3132	12	greatly	greatly	RB
cord-023095-4dannjjm	3132	13	reduced	reduce	VBN
cord-023095-4dannjjm	3132	14	levels	level	NNS
cord-023095-4dannjjm	3132	15	.	.	.
cord-023095-4dannjjm	3133	1	Sequencing	sequencing	NN
cord-023095-4dannjjm	3133	2	results	result	NNS
cord-023095-4dannjjm	3133	3	revealed	reveal	VBD
cord-023095-4dannjjm	3133	4	one	one	CD
cord-023095-4dannjjm	3133	5	rare	rare	JJ
cord-023095-4dannjjm	3133	6	non	non	JJ
cord-023095-4dannjjm	3133	7	-	-	JJ
cord-023095-4dannjjm	3133	8	synonymous	synonymous	JJ
cord-023095-4dannjjm	3133	9	single	single	JJ
cord-023095-4dannjjm	3133	10	nucleotide	nucleotide	JJ
cord-023095-4dannjjm	3133	11	polymorphism	polymorphism	NN
cord-023095-4dannjjm	3133	12	(	(	-LRB-
cord-023095-4dannjjm	3133	13	SNP	SNP	NNP
cord-023095-4dannjjm	3133	14	)	)	-RRB-
cord-023095-4dannjjm	3133	15	in	in	IN
cord-023095-4dannjjm	3133	16	HBE1	HBE1	NNP
cord-023095-4dannjjm	3133	17	of	of	IN
cord-023095-4dannjjm	3133	18	RRGs	rrg	NNS
cord-023095-4dannjjm	3133	19	,	,	,
cord-023095-4dannjjm	3133	20	but	but	CC
cord-023095-4dannjjm	3133	21	no	no	DT
cord-023095-4dannjjm	3133	22	variation	variation	NN
cord-023095-4dannjjm	3133	23	that	that	WDT
cord-023095-4dannjjm	3133	24	could	could	MD
cord-023095-4dannjjm	3133	25	explain	explain	VB
cord-023095-4dannjjm	3133	26	their	-PRON-	PRP$
cord-023095-4dannjjm	3133	27	abnormal	abnormal	JJ
cord-023095-4dannjjm	3133	28	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	3133	29	.	.	.
cord-023095-4dannjjm	3134	1	We	-PRON-	PRP
cord-023095-4dannjjm	3134	2	did	do	VBD
cord-023095-4dannjjm	3134	3	not	not	RB
cord-023095-4dannjjm	3134	4	detect	detect	VB
cord-023095-4dannjjm	3134	5	structural	structural	JJ
cord-023095-4dannjjm	3134	6	variation	variation	NN
cord-023095-4dannjjm	3134	7	overlapping	overlap	VBG
cord-023095-4dannjjm	3134	8	or	or	CC
cord-023095-4dannjjm	3134	9	near	near	IN
cord-023095-4dannjjm	3134	10	the	the	DT
cord-023095-4dannjjm	3134	11	beta	beta	JJ
cord-023095-4dannjjm	3134	12	globin	globin	NN
cord-023095-4dannjjm	3134	13	locus	locus	NN
cord-023095-4dannjjm	3134	14	.	.	.
cord-023095-4dannjjm	3135	1	Notably	notably	RB
cord-023095-4dannjjm	3135	2	,	,	,
cord-023095-4dannjjm	3135	3	RRG	RRG	NNP
cord-023095-4dannjjm	3135	4	and	and	CC
cord-023095-4dannjjm	3135	5	AKCG	AKCG	NNP
cord-023095-4dannjjm	3135	6	do	do	VBP
cord-023095-4dannjjm	3135	7	not	not	RB
cord-023095-4dannjjm	3135	8	share	share	VB
cord-023095-4dannjjm	3135	9	haplotypes	haplotype	NNS
cord-023095-4dannjjm	3135	10	spanning	span	VBG
cord-023095-4dannjjm	3135	11	the	the	DT
cord-023095-4dannjjm	3135	12	beta	beta	JJ
cord-023095-4dannjjm	3135	13	globin	globin	NN
cord-023095-4dannjjm	3135	14	locus	locus	NN
cord-023095-4dannjjm	3135	15	.	.	.
cord-023095-4dannjjm	3136	1	This	this	DT
cord-023095-4dannjjm	3136	2	is	be	VBZ
cord-023095-4dannjjm	3136	3	the	the	DT
cord-023095-4dannjjm	3136	4	first	first	JJ
cord-023095-4dannjjm	3136	5	characterization	characterization	NN
cord-023095-4dannjjm	3136	6	of	of	IN
cord-023095-4dannjjm	3136	7	canine	canine	JJ
cord-023095-4dannjjm	3136	8	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	3136	9	genetics	genetic	NNS
cord-023095-4dannjjm	3136	10	,	,	,
cord-023095-4dannjjm	3136	11	and	and	CC
cord-023095-4dannjjm	3136	12	the	the	DT
cord-023095-4dannjjm	3136	13	first	first	JJ
cord-023095-4dannjjm	3136	14	report	report	NN
cord-023095-4dannjjm	3136	15	of	of	IN
cord-023095-4dannjjm	3136	16	canine	canine	JJ
cord-023095-4dannjjm	3136	17	embryonic	embryonic	JJ
cord-023095-4dannjjm	3136	18	hemoglobins	hemoglobin	NNS
cord-023095-4dannjjm	3136	19	and	and	CC
cord-023095-4dannjjm	3136	20	their	-PRON-	PRP$
cord-023095-4dannjjm	3136	21	expression	expression	NN
cord-023095-4dannjjm	3136	22	in	in	IN
cord-023095-4dannjjm	3136	23	adults	adult	NNS
cord-023095-4dannjjm	3136	24	.	.	.
cord-023095-4dannjjm	3137	1	Sampling	sampling	NN
cord-023095-4dannjjm	3137	2	of	of	IN
cord-023095-4dannjjm	3137	3	the	the	DT
cord-023095-4dannjjm	3137	4	bone	bone	NN
cord-023095-4dannjjm	3137	5	marrow	marrow	NN
cord-023095-4dannjjm	3137	6	in	in	IN
cord-023095-4dannjjm	3137	7	the	the	DT
cord-023095-4dannjjm	3137	8	dog	dog	NN
cord-023095-4dannjjm	3137	9	from	from	IN
cord-023095-4dannjjm	3137	10	the	the	DT
cord-023095-4dannjjm	3137	11	costochondral	costochondral	JJ
cord-023095-4dannjjm	3137	12	(	(	-LRB-
cord-023095-4dannjjm	3137	13	CC	CC	NNP
cord-023095-4dannjjm	3137	14	)	)	-RRB-
cord-023095-4dannjjm	3137	15	junction	junction	NN
cord-023095-4dannjjm	3137	16	can	can	MD
cord-023095-4dannjjm	3137	17	be	be	VB
cord-023095-4dannjjm	3137	18	performed	perform	VBN
cord-023095-4dannjjm	3137	19	with	with	IN
cord-023095-4dannjjm	3137	20	minimal	minimal	JJ
cord-023095-4dannjjm	3137	21	to	to	IN
cord-023095-4dannjjm	3137	22	no	no	DT
cord-023095-4dannjjm	3137	23	sedation	sedation	NN
cord-023095-4dannjjm	3137	24	and	and	CC
cord-023095-4dannjjm	3137	25	readily	readily	RB
cord-023095-4dannjjm	3137	26	available	available	JJ
cord-023095-4dannjjm	3137	27	equipment	equipment	NN
cord-023095-4dannjjm	3137	28	but	but	CC
cord-023095-4dannjjm	3137	29	is	be	VBZ
cord-023095-4dannjjm	3137	30	not	not	RB
cord-023095-4dannjjm	3137	31	in	in	IN
cord-023095-4dannjjm	3137	32	widespread	widespread	JJ
cord-023095-4dannjjm	3137	33	use	use	NN
cord-023095-4dannjjm	3137	34	in	in	IN
cord-023095-4dannjjm	3137	35	the	the	DT
cord-023095-4dannjjm	3137	36	United	United	NNP
cord-023095-4dannjjm	3137	37	States	States	NNP
cord-023095-4dannjjm	3137	38	.	.	.
cord-023095-4dannjjm	3138	1	The	the	DT
cord-023095-4dannjjm	3138	2	aim	aim	NN
cord-023095-4dannjjm	3138	3	of	of	IN
cord-023095-4dannjjm	3138	4	this	this	DT
cord-023095-4dannjjm	3138	5	study	study	NN
cord-023095-4dannjjm	3138	6	was	be	VBD
cord-023095-4dannjjm	3138	7	to	to	TO
cord-023095-4dannjjm	3138	8	compare	compare	VB
cord-023095-4dannjjm	3138	9	the	the	DT
cord-023095-4dannjjm	3138	10	number	number	NN
cord-023095-4dannjjm	3138	11	of	of	IN
cord-023095-4dannjjm	3138	12	attempts	attempt	NNS
cord-023095-4dannjjm	3138	13	needed	need	VBN
cord-023095-4dannjjm	3138	14	to	to	TO
cord-023095-4dannjjm	3138	15	successfully	successfully	RB
cord-023095-4dannjjm	3138	16	obtain	obtain	VB
cord-023095-4dannjjm	3138	17	a	a	DT
cord-023095-4dannjjm	3138	18	sample	sample	NN
cord-023095-4dannjjm	3138	19	,	,	,
cord-023095-4dannjjm	3138	20	the	the	DT
cord-023095-4dannjjm	3138	21	time	time	NN
cord-023095-4dannjjm	3138	22	needed	need	VBN
cord-023095-4dannjjm	3138	23	for	for	IN
cord-023095-4dannjjm	3138	24	the	the	DT
cord-023095-4dannjjm	3138	25	procedure	procedure	NN
cord-023095-4dannjjm	3138	26	,	,	,
cord-023095-4dannjjm	3138	27	and	and	CC
cord-023095-4dannjjm	3138	28	the	the	DT
cord-023095-4dannjjm	3138	29	sample	sample	NN
cord-023095-4dannjjm	3138	30	quality	quality	NN
cord-023095-4dannjjm	3138	31	between	between	IN
cord-023095-4dannjjm	3138	32	aspirates	aspirate	NNS
cord-023095-4dannjjm	3138	33	obtained	obtain	VBN
cord-023095-4dannjjm	3138	34	from	from	IN
cord-023095-4dannjjm	3138	35	the	the	DT
cord-023095-4dannjjm	3138	36	CC	CC	NNP
cord-023095-4dannjjm	3138	37	junction	junction	NN
cord-023095-4dannjjm	3138	38	and	and	CC
cord-023095-4dannjjm	3138	39	more	more	JJR
cord-023095-4dannjjm	3138	40	traditional	traditional	JJ
cord-023095-4dannjjm	3138	41	sites	site	NNS
cord-023095-4dannjjm	3138	42	(	(	-LRB-
cord-023095-4dannjjm	3138	43	humerus	humerus	NN
cord-023095-4dannjjm	3138	44	or	or	CC
cord-023095-4dannjjm	3138	45	femur	femur	NN
cord-023095-4dannjjm	3138	46	)	)	-RRB-
cord-023095-4dannjjm	3138	47	in	in	IN
cord-023095-4dannjjm	3138	48	healthy	healthy	JJ
cord-023095-4dannjjm	3138	49	dogs	dog	NNS
cord-023095-4dannjjm	3138	50	when	when	WRB
cord-023095-4dannjjm	3138	51	performed	perform	VBN
cord-023095-4dannjjm	3138	52	by	by	IN
cord-023095-4dannjjm	3138	53	novice	novice	NN
cord-023095-4dannjjm	3138	54	and	and	CC
cord-023095-4dannjjm	3138	55	seasoned	seasoned	JJ
cord-023095-4dannjjm	3138	56	practitioners	practitioner	NNS
cord-023095-4dannjjm	3138	57	.	.	.
cord-023095-4dannjjm	3139	1	Samples	sample	NNS
cord-023095-4dannjjm	3139	2	were	be	VBD
cord-023095-4dannjjm	3139	3	obtained	obtain	VBN
cord-023095-4dannjjm	3139	4	from	from	IN
cord-023095-4dannjjm	3139	5	healthy	healthy	JJ
cord-023095-4dannjjm	3139	6	anesthetized	anesthetized	JJ
cord-023095-4dannjjm	3139	7	laboratory	laboratory	NN
cord-023095-4dannjjm	3139	8	reared	rear	VBD
cord-023095-4dannjjm	3139	9	adult	adult	NN
cord-023095-4dannjjm	3139	10	dogs	dog	NNS
cord-023095-4dannjjm	3139	11	after	after	IN
cord-023095-4dannjjm	3139	12	undergoing	undergo	VBG
cord-023095-4dannjjm	3139	13	terminal	terminal	JJ
cord-023095-4dannjjm	3139	14	endoscopic	endoscopic	NNS
cord-023095-4dannjjm	3139	15	surgery	surgery	NN
cord-023095-4dannjjm	3139	16	.	.	.
cord-023095-4dannjjm	3140	1	Paired	pair	VBN
cord-023095-4dannjjm	3140	2	samples	sample	NNS
cord-023095-4dannjjm	3140	3	from	from	IN
cord-023095-4dannjjm	3140	4	separate	separate	JJ
cord-023095-4dannjjm	3140	5	dogs	dog	NNS
cord-023095-4dannjjm	3140	6	were	be	VBD
cord-023095-4dannjjm	3140	7	obtained	obtain	VBN
cord-023095-4dannjjm	3140	8	by	by	IN
cord-023095-4dannjjm	3140	9	each	each	DT
cord-023095-4dannjjm	3140	10	practitioner	practitioner	NN
cord-023095-4dannjjm	3140	11	using	use	VBG
cord-023095-4dannjjm	3140	12	either	either	CC
cord-023095-4dannjjm	3140	13	a	a	DT
cord-023095-4dannjjm	3140	14	22	22	CD
cord-023095-4dannjjm	3140	15	gauge	gauge	NN
cord-023095-4dannjjm	3140	16	needle	needle	NN
cord-023095-4dannjjm	3140	17	and	and	CC
cord-023095-4dannjjm	3140	18	6	6	CD
cord-023095-4dannjjm	3140	19	cc	cc	NN
cord-023095-4dannjjm	3140	20	syringe	syringe	NN
cord-023095-4dannjjm	3140	21	at	at	IN
cord-023095-4dannjjm	3140	22	the	the	DT
cord-023095-4dannjjm	3140	23	CC	CC	NNP
cord-023095-4dannjjm	3140	24	junction	junction	NN
cord-023095-4dannjjm	3140	25	or	or	CC
cord-023095-4dannjjm	3140	26	an	an	DT
cord-023095-4dannjjm	3140	27	18	18	CD
cord-023095-4dannjjm	3140	28	gauge	gauge	NN
cord-023095-4dannjjm	3140	29	Rosenthal	Rosenthal	NNP
cord-023095-4dannjjm	3140	30	needle	needle	NN
cord-023095-4dannjjm	3140	31	and	and	CC
cord-023095-4dannjjm	3140	32	12	12	CD
cord-023095-4dannjjm	3140	33	cc	cc	NN
cord-023095-4dannjjm	3140	34	syringe	syringe	NN
cord-023095-4dannjjm	3140	35	from	from	IN
cord-023095-4dannjjm	3140	36	either	either	CC
cord-023095-4dannjjm	3140	37	the	the	DT
cord-023095-4dannjjm	3140	38	proximal	proximal	JJ
cord-023095-4dannjjm	3140	39	humerus	humerus	NN
cord-023095-4dannjjm	3140	40	or	or	CC
cord-023095-4dannjjm	3140	41	femur	femur	NN
cord-023095-4dannjjm	3140	42	(	(	-LRB-
cord-023095-4dannjjm	3140	43	clinician	clinician	NN
cord-023095-4dannjjm	3140	44	preference	preference	NN
cord-023095-4dannjjm	3140	45	)	)	-RRB-
cord-023095-4dannjjm	3140	46	.	.	.
cord-023095-4dannjjm	3141	1	Three	three	CD
cord-023095-4dannjjm	3141	2	small	small	JJ
cord-023095-4dannjjm	3141	3	animal	animal	NN
cord-023095-4dannjjm	3141	4	veterinary	veterinary	JJ
cord-023095-4dannjjm	3141	5	interns	intern	NNS
cord-023095-4dannjjm	3141	6	,	,	,
cord-023095-4dannjjm	3141	7	one	one	CD
cord-023095-4dannjjm	3141	8	experienced	experienced	JJ
cord-023095-4dannjjm	3141	9	technician	technician	NN
cord-023095-4dannjjm	3141	10	and	and	CC
cord-023095-4dannjjm	3141	11	one	one	CD
cord-023095-4dannjjm	3141	12	boarded	board	VBN
cord-023095-4dannjjm	3141	13	internist	internist	NN
cord-023095-4dannjjm	3141	14	were	be	VBD
cord-023095-4dannjjm	3141	15	monitored	monitor	VBN
cord-023095-4dannjjm	3141	16	for	for	IN
cord-023095-4dannjjm	3141	17	number	number	NN
cord-023095-4dannjjm	3141	18	of	of	IN
cord-023095-4dannjjm	3141	19	attempts	attempt	NNS
cord-023095-4dannjjm	3141	20	to	to	IN
cord-023095-4dannjjm	3141	21	success	success	NN
cord-023095-4dannjjm	3141	22	and	and	CC
cord-023095-4dannjjm	3141	23	length	length	NN
cord-023095-4dannjjm	3141	24	of	of	IN
cord-023095-4dannjjm	3141	25	time	time	NN
cord-023095-4dannjjm	3141	26	needed	need	VBN
cord-023095-4dannjjm	3141	27	for	for	IN
cord-023095-4dannjjm	3141	28	success	success	NN
cord-023095-4dannjjm	3141	29	of	of	IN
cord-023095-4dannjjm	3141	30	each	each	DT
cord-023095-4dannjjm	3141	31	procedure	procedure	NN
cord-023095-4dannjjm	3141	32	.	.	.
cord-023095-4dannjjm	3142	1	Slides	slide	NNS
cord-023095-4dannjjm	3142	2	were	be	VBD
cord-023095-4dannjjm	3142	3	prepared	prepare	VBN
cord-023095-4dannjjm	3142	4	by	by	IN
cord-023095-4dannjjm	3142	5	a	a	DT
cord-023095-4dannjjm	3142	6	single	single	JJ
cord-023095-4dannjjm	3142	7	investigator	investigator	NN
cord-023095-4dannjjm	3142	8	and	and	CC
cord-023095-4dannjjm	3142	9	read	read	VBN
cord-023095-4dannjjm	3142	10	by	by	IN
cord-023095-4dannjjm	3142	11	a	a	DT
cord-023095-4dannjjm	3142	12	blinded	blind	VBN
cord-023095-4dannjjm	3142	13	clinical	clinical	JJ
cord-023095-4dannjjm	3142	14	pathologist	pathologist	NN
cord-023095-4dannjjm	3142	15	.	.	.
cord-023095-4dannjjm	3143	1	Data	datum	NNS
cord-023095-4dannjjm	3143	2	were	be	VBD
cord-023095-4dannjjm	3143	3	compared	compare	VBN
cord-023095-4dannjjm	3143	4	using	use	VBG
cord-023095-4dannjjm	3143	5	the	the	DT
cord-023095-4dannjjm	3143	6	paired	paired	JJ
cord-023095-4dannjjm	3143	7	t	t	NN
cord-023095-4dannjjm	3143	8	-	-	HYPH
cord-023095-4dannjjm	3143	9	test	test	NN
cord-023095-4dannjjm	3143	10	for	for	IN
cord-023095-4dannjjm	3143	11	normally	normally	RB
cord-023095-4dannjjm	3143	12	distributed	distribute	VBN
cord-023095-4dannjjm	3143	13	data	datum	NNS
cord-023095-4dannjjm	3143	14	and	and	CC
cord-023095-4dannjjm	3143	15	Wilcoxen	Wilcoxen	NNP
cord-023095-4dannjjm	3143	16	signed	sign	VBD
cord-023095-4dannjjm	3143	17	rank	rank	NN
cord-023095-4dannjjm	3143	18	test	test	NN
cord-023095-4dannjjm	3143	19	for	for	IN
cord-023095-4dannjjm	3143	20	non	non	JJ
cord-023095-4dannjjm	3143	21	-	-	JJ
cord-023095-4dannjjm	3143	22	Gaussian	gaussian	JJ
cord-023095-4dannjjm	3143	23	distributions	distribution	NNS
cord-023095-4dannjjm	3143	24	.	.	.
cord-023095-4dannjjm	3144	1	Five	five	CD
cord-023095-4dannjjm	3144	2	pairs	pair	NNS
cord-023095-4dannjjm	3144	3	of	of	IN
cord-023095-4dannjjm	3144	4	samples	sample	NNS
cord-023095-4dannjjm	3144	5	from	from	IN
cord-023095-4dannjjm	3144	6	three	three	CD
cord-023095-4dannjjm	3144	7	dogs	dog	NNS
cord-023095-4dannjjm	3144	8	were	be	VBD
cord-023095-4dannjjm	3144	9	evaluated	evaluate	VBN
cord-023095-4dannjjm	3144	10	.	.	.
cord-023095-4dannjjm	3145	1	Two	two	CD
cord-023095-4dannjjm	3145	2	dogs	dog	NNS
cord-023095-4dannjjm	3145	3	had	have	VBD
cord-023095-4dannjjm	3145	4	two	two	CD
cord-023095-4dannjjm	3145	5	pairs	pair	NNS
cord-023095-4dannjjm	3145	6	drawn	draw	VBN
cord-023095-4dannjjm	3145	7	from	from	IN
cord-023095-4dannjjm	3145	8	opposite	opposite	JJ
cord-023095-4dannjjm	3145	9	limbs	limb	NNS
cord-023095-4dannjjm	3145	10	and	and	CC
cord-023095-4dannjjm	3145	11	ribs	rib	NNS
cord-023095-4dannjjm	3145	12	.	.	.
cord-023095-4dannjjm	3146	1	Mean	mean	JJ
cord-023095-4dannjjm	3146	2	number	number	NN
cord-023095-4dannjjm	3146	3	of	of	IN
cord-023095-4dannjjm	3146	4	attempts	attempt	NNS
cord-023095-4dannjjm	3146	5	to	to	IN
cord-023095-4dannjjm	3146	6	success	success	NN
cord-023095-4dannjjm	3146	7	for	for	IN
cord-023095-4dannjjm	3146	8	traditional	traditional	JJ
cord-023095-4dannjjm	3146	9	sampling	sampling	NN
cord-023095-4dannjjm	3146	10	sites	site	NNS
cord-023095-4dannjjm	3146	11	(	(	-LRB-
cord-023095-4dannjjm	3146	12	1.4	1.4	CD
cord-023095-4dannjjm	3146	13	1	1	CD
cord-023095-4dannjjm	3146	14	/	/	SYM
cord-023095-4dannjjm	3146	15	À0.54	À0.54	NNP
cord-023095-4dannjjm	3146	16	)	)	-RRB-
cord-023095-4dannjjm	3146	17	and	and	CC
cord-023095-4dannjjm	3146	18	time	time	NN
cord-023095-4dannjjm	3146	19	to	to	IN
cord-023095-4dannjjm	3146	20	success	success	NN
cord-023095-4dannjjm	3146	21	(	(	-LRB-
cord-023095-4dannjjm	3146	22	8.6	8.6	CD
cord-023095-4dannjjm	3146	23	minutes	minute	NNS
cord-023095-4dannjjm	3146	24	1	1	CD
cord-023095-4dannjjm	3146	25	/	/	SYM
cord-023095-4dannjjm	3146	26	À5.2	à5.2	NN
cord-023095-4dannjjm	3146	27	)	)	-RRB-
cord-023095-4dannjjm	3146	28	did	do	VBD
cord-023095-4dannjjm	3146	29	not	not	RB
cord-023095-4dannjjm	3146	30	differ	differ	VB
cord-023095-4dannjjm	3146	31	significantly	significantly	RB
cord-023095-4dannjjm	3146	32	from	from	IN
cord-023095-4dannjjm	3146	33	attempts	attempt	NNS
cord-023095-4dannjjm	3146	34	(	(	-LRB-
cord-023095-4dannjjm	3146	35	2.01/-0.70	2.01/-0.70	CD
cord-023095-4dannjjm	3146	36	,	,	,
cord-023095-4dannjjm	3146	37	p	p	NN
cord-023095-4dannjjm	3146	38	5	5	CD
cord-023095-4dannjjm	3146	39	0.25	0.25	CD
cord-023095-4dannjjm	3146	40	)	)	-RRB-
cord-023095-4dannjjm	3146	41	or	or	CC
cord-023095-4dannjjm	3146	42	time	time	NN
cord-023095-4dannjjm	3146	43	(	(	-LRB-
cord-023095-4dannjjm	3146	44	2.7	2.7	CD
cord-023095-4dannjjm	3146	45	1/-0.98	1/-0.98	CD
cord-023095-4dannjjm	3146	46	,	,	,
cord-023095-4dannjjm	3146	47	0.06	0.06	CD
cord-023095-4dannjjm	3146	48	)	)	-RRB-
cord-023095-4dannjjm	3146	49	needed	need	VBD
cord-023095-4dannjjm	3146	50	when	when	WRB
cord-023095-4dannjjm	3146	51	aspirating	aspirate	VBG
cord-023095-4dannjjm	3146	52	from	from	IN
cord-023095-4dannjjm	3146	53	the	the	DT
cord-023095-4dannjjm	3146	54	CC	CC	NNP
cord-023095-4dannjjm	3146	55	junction	junction	NN
cord-023095-4dannjjm	3146	56	.	.	.
cord-023095-4dannjjm	3147	1	Subjectively	subjectively	RB
cord-023095-4dannjjm	3147	2	,	,	,
cord-023095-4dannjjm	3147	3	samples	sample	NNS
cord-023095-4dannjjm	3147	4	were	be	VBD
cord-023095-4dannjjm	3147	5	of	of	IN
cord-023095-4dannjjm	3147	6	similar	similar	JJ
cord-023095-4dannjjm	3147	7	quality	quality	NN
cord-023095-4dannjjm	3147	8	with	with	IN
cord-023095-4dannjjm	3147	9	regards	regard	NNS
cord-023095-4dannjjm	3147	10	to	to	IN
cord-023095-4dannjjm	3147	11	cellularity	cellularity	NN
cord-023095-4dannjjm	3147	12	and	and	CC
cord-023095-4dannjjm	3147	13	number	number	NN
cord-023095-4dannjjm	3147	14	of	of	IN
cord-023095-4dannjjm	3147	15	particles	particle	NNS
cord-023095-4dannjjm	3147	16	present	present	JJ
cord-023095-4dannjjm	3147	17	when	when	WRB
cord-023095-4dannjjm	3147	18	compared	compare	VBN
cord-023095-4dannjjm	3147	19	within	within	IN
cord-023095-4dannjjm	3147	20	practitioners	practitioner	NNS
cord-023095-4dannjjm	3147	21	.	.	.
cord-023095-4dannjjm	3148	1	Myeloid	myeloid	NN
cord-023095-4dannjjm	3148	2	:	:	:
cord-023095-4dannjjm	3148	3	erythroid	erythroid	NN
cord-023095-4dannjjm	3148	4	ratio	ratio	NN
cord-023095-4dannjjm	3148	5	and	and	CC
cord-023095-4dannjjm	3148	6	percentage	percentage	NN
cord-023095-4dannjjm	3148	7	of	of	IN
cord-023095-4dannjjm	3148	8	lymphocytes	lymphocyte	NNS
cord-023095-4dannjjm	3148	9	were	be	VBD
cord-023095-4dannjjm	3148	10	also	also	RB
cord-023095-4dannjjm	3148	11	not	not	RB
cord-023095-4dannjjm	3148	12	significantly	significantly	RB
cord-023095-4dannjjm	3148	13	different	different	JJ
cord-023095-4dannjjm	3148	14	between	between	IN
cord-023095-4dannjjm	3148	15	sites	site	NNS
cord-023095-4dannjjm	3148	16	(	(	-LRB-
cord-023095-4dannjjm	3148	17	M	m	NN
cord-023095-4dannjjm	3148	18	:	:	:
cord-023095-4dannjjm	3148	19	E	e	NN
cord-023095-4dannjjm	3148	20	ratio	ratio	NN
cord-023095-4dannjjm	3148	21	p	p	NN
cord-023095-4dannjjm	3148	22	5	5	CD
cord-023095-4dannjjm	3148	23	0.37	0.37	CD
cord-023095-4dannjjm	3148	24	,	,	,
cord-023095-4dannjjm	3148	25	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	3148	26	%	%	NN
cord-023095-4dannjjm	3148	27	p	p	NN
cord-023095-4dannjjm	3148	28	5	5	CD
cord-023095-4dannjjm	3148	29	0.07	0.07	CD
cord-023095-4dannjjm	3148	30	)	)	-RRB-
cord-023095-4dannjjm	3148	31	and	and	CC
cord-023095-4dannjjm	3148	32	were	be	VBD
cord-023095-4dannjjm	3148	33	within	within	IN
cord-023095-4dannjjm	3148	34	normal	normal	JJ
cord-023095-4dannjjm	3148	35	limits	limit	NNS
cord-023095-4dannjjm	3148	36	.	.	.
cord-023095-4dannjjm	3149	1	While	while	IN
cord-023095-4dannjjm	3149	2	there	there	EX
cord-023095-4dannjjm	3149	3	were	be	VBD
cord-023095-4dannjjm	3149	4	no	no	DT
cord-023095-4dannjjm	3149	5	significant	significant	JJ
cord-023095-4dannjjm	3149	6	differences	difference	NNS
cord-023095-4dannjjm	3149	7	between	between	IN
cord-023095-4dannjjm	3149	8	the	the	DT
cord-023095-4dannjjm	3149	9	two	two	CD
cord-023095-4dannjjm	3149	10	sites	site	NNS
cord-023095-4dannjjm	3149	11	in	in	IN
cord-023095-4dannjjm	3149	12	terms	term	NNS
cord-023095-4dannjjm	3149	13	of	of	IN
cord-023095-4dannjjm	3149	14	number	number	NN
cord-023095-4dannjjm	3149	15	of	of	IN
cord-023095-4dannjjm	3149	16	attempts	attempt	NNS
cord-023095-4dannjjm	3149	17	or	or	CC
cord-023095-4dannjjm	3149	18	time	time	NN
cord-023095-4dannjjm	3149	19	to	to	IN
cord-023095-4dannjjm	3149	20	success	success	NN
cord-023095-4dannjjm	3149	21	,	,	,
cord-023095-4dannjjm	3149	22	it	-PRON-	PRP
cord-023095-4dannjjm	3149	23	should	should	MD
cord-023095-4dannjjm	3149	24	be	be	VB
cord-023095-4dannjjm	3149	25	noted	note	VBN
cord-023095-4dannjjm	3149	26	that	that	IN
cord-023095-4dannjjm	3149	27	the	the	DT
cord-023095-4dannjjm	3149	28	'	'	``
cord-023095-4dannjjm	3149	29	'	'	``
cord-023095-4dannjjm	3149	30	seasoned	season	VBN
cord-023095-4dannjjm	3149	31	'	'	''
cord-023095-4dannjjm	3149	32	'	'	''
cord-023095-4dannjjm	3149	33	practitioners	practitioner	NNS
cord-023095-4dannjjm	3149	34	had	have	VBD
cord-023095-4dannjjm	3149	35	never	never	RB
cord-023095-4dannjjm	3149	36	performed	perform	VBN
cord-023095-4dannjjm	3149	37	an	an	DT
cord-023095-4dannjjm	3149	38	aspirate	aspirate	NN
cord-023095-4dannjjm	3149	39	at	at	IN
cord-023095-4dannjjm	3149	40	the	the	DT
cord-023095-4dannjjm	3149	41	CC	CC	NNP
cord-023095-4dannjjm	3149	42	site	site	NN
cord-023095-4dannjjm	3149	43	and	and	CC
cord-023095-4dannjjm	3149	44	had	have	VBD
cord-023095-4dannjjm	3149	45	an	an	DT
cord-023095-4dannjjm	3149	46	increased	increase	VBN
cord-023095-4dannjjm	3149	47	number	number	NN
cord-023095-4dannjjm	3149	48	of	of	IN
cord-023095-4dannjjm	3149	49	attempts	attempt	NNS
cord-023095-4dannjjm	3149	50	compared	compare	VBN
cord-023095-4dannjjm	3149	51	to	to	IN
cord-023095-4dannjjm	3149	52	the	the	DT
cord-023095-4dannjjm	3149	53	traditional	traditional	JJ
cord-023095-4dannjjm	3149	54	sites	site	NNS
cord-023095-4dannjjm	3149	55	.	.	.
cord-023095-4dannjjm	3150	1	If	if	IN
cord-023095-4dannjjm	3150	2	the	the	DT
cord-023095-4dannjjm	3150	3	number	number	NN
cord-023095-4dannjjm	3150	4	of	of	IN
cord-023095-4dannjjm	3150	5	attempts	attempt	NNS
cord-023095-4dannjjm	3150	6	needed	need	VBN
cord-023095-4dannjjm	3150	7	for	for	IN
cord-023095-4dannjjm	3150	8	success	success	NN
cord-023095-4dannjjm	3150	9	decreases	decrease	VBZ
cord-023095-4dannjjm	3150	10	with	with	IN
cord-023095-4dannjjm	3150	11	experience	experience	NN
cord-023095-4dannjjm	3150	12	,	,	,
cord-023095-4dannjjm	3150	13	it	-PRON-	PRP
cord-023095-4dannjjm	3150	14	is	be	VBZ
cord-023095-4dannjjm	3150	15	likely	likely	RB
cord-023095-4dannjjm	3150	16	the	the	DT
cord-023095-4dannjjm	3150	17	time	time	NN
cord-023095-4dannjjm	3150	18	required	require	VBN
cord-023095-4dannjjm	3150	19	would	would	MD
cord-023095-4dannjjm	3150	20	decrease	decrease	VB
cord-023095-4dannjjm	3150	21	as	as	RB
cord-023095-4dannjjm	3150	22	well	well	RB
cord-023095-4dannjjm	3150	23	.	.	.
cord-023095-4dannjjm	3151	1	Both	both	DT
cord-023095-4dannjjm	3151	2	subjectively	subjectively	RB
cord-023095-4dannjjm	3151	3	and	and	CC
cord-023095-4dannjjm	3151	4	objectively	objectively	RB
cord-023095-4dannjjm	3151	5	,	,	,
cord-023095-4dannjjm	3151	6	there	there	EX
cord-023095-4dannjjm	3151	7	were	be	VBD
cord-023095-4dannjjm	3151	8	no	no	DT
cord-023095-4dannjjm	3151	9	significant	significant	JJ
cord-023095-4dannjjm	3151	10	differences	difference	NNS
cord-023095-4dannjjm	3151	11	in	in	IN
cord-023095-4dannjjm	3151	12	quality	quality	NN
cord-023095-4dannjjm	3151	13	or	or	CC
cord-023095-4dannjjm	3151	14	cell	cell	NN
cord-023095-4dannjjm	3151	15	populations	population	NNS
cord-023095-4dannjjm	3151	16	between	between	IN
cord-023095-4dannjjm	3151	17	the	the	DT
cord-023095-4dannjjm	3151	18	two	two	CD
cord-023095-4dannjjm	3151	19	sampling	sampling	NN
cord-023095-4dannjjm	3151	20	sites	site	NNS
cord-023095-4dannjjm	3151	21	in	in	IN
cord-023095-4dannjjm	3151	22	healthy	healthy	JJ
cord-023095-4dannjjm	3151	23	dogs	dog	NNS
cord-023095-4dannjjm	3151	24	.	.	.
cord-023095-4dannjjm	3152	1	Based	base	VBN
cord-023095-4dannjjm	3152	2	on	on	IN
cord-023095-4dannjjm	3152	3	this	this	DT
cord-023095-4dannjjm	3152	4	data	data	NN
cord-023095-4dannjjm	3152	5	,	,	,
cord-023095-4dannjjm	3152	6	bone	bone	NN
cord-023095-4dannjjm	3152	7	marrow	marrow	NN
cord-023095-4dannjjm	3152	8	aspiration	aspiration	NN
cord-023095-4dannjjm	3152	9	from	from	IN
cord-023095-4dannjjm	3152	10	the	the	DT
cord-023095-4dannjjm	3152	11	CC	CC	NNP
cord-023095-4dannjjm	3152	12	junction	junction	NN
cord-023095-4dannjjm	3152	13	appears	appear	VBZ
cord-023095-4dannjjm	3152	14	to	to	TO
cord-023095-4dannjjm	3152	15	be	be	VB
cord-023095-4dannjjm	3152	16	equivalent	equivalent	JJ
cord-023095-4dannjjm	3152	17	to	to	IN
cord-023095-4dannjjm	3152	18	more	more	JJR
cord-023095-4dannjjm	3152	19	traditional	traditional	JJ
cord-023095-4dannjjm	3152	20	sampling	sampling	NN
cord-023095-4dannjjm	3152	21	sites	site	NNS
cord-023095-4dannjjm	3152	22	in	in	IN
cord-023095-4dannjjm	3152	23	healthy	healthy	JJ
cord-023095-4dannjjm	3152	24	dogs	dog	NNS
cord-023095-4dannjjm	3152	25	.	.	.
cord-023095-4dannjjm	3153	1	Larger	large	JJR
cord-023095-4dannjjm	3153	2	studies	study	NNS
cord-023095-4dannjjm	3153	3	in	in	IN
cord-023095-4dannjjm	3153	4	clinically	clinically	RB
cord-023095-4dannjjm	3153	5	ill	ill	JJ
cord-023095-4dannjjm	3153	6	dogs	dog	NNS
cord-023095-4dannjjm	3153	7	should	should	MD
cord-023095-4dannjjm	3153	8	be	be	VB
cord-023095-4dannjjm	3153	9	performed	perform	VBN
cord-023095-4dannjjm	3153	10	before	before	IN
cord-023095-4dannjjm	3153	11	routinely	routinely	RB
cord-023095-4dannjjm	3153	12	using	use	VBG
cord-023095-4dannjjm	3153	13	the	the	DT
cord-023095-4dannjjm	3153	14	site	site	NN
cord-023095-4dannjjm	3153	15	in	in	IN
cord-023095-4dannjjm	3153	16	the	the	DT
cord-023095-4dannjjm	3153	17	clinical	clinical	JJ
cord-023095-4dannjjm	3153	18	setting	setting	NN
cord-023095-4dannjjm	3153	19	.	.	.
cord-023095-4dannjjm	3154	1	Recent	recent	JJ
cord-023095-4dannjjm	3154	2	research	research	NN
cord-023095-4dannjjm	3154	3	on	on	IN
cord-023095-4dannjjm	3154	4	iron	iron	NN
cord-023095-4dannjjm	3154	5	homeostasis	homeostasis	NN
cord-023095-4dannjjm	3154	6	has	have	VBZ
cord-023095-4dannjjm	3154	7	elucidated	elucidate	VBN
cord-023095-4dannjjm	3154	8	the	the	DT
cord-023095-4dannjjm	3154	9	tightly	tightly	RB
cord-023095-4dannjjm	3154	10	controlled	control	VBN
cord-023095-4dannjjm	3154	11	intestinal	intestinal	JJ
cord-023095-4dannjjm	3154	12	uptake	uptake	NN
cord-023095-4dannjjm	3154	13	of	of	IN
cord-023095-4dannjjm	3154	14	iron	iron	NN
cord-023095-4dannjjm	3154	15	.	.	.
cord-023095-4dannjjm	3155	1	Hepcidin	Hepcidin	NNP
cord-023095-4dannjjm	3155	2	,	,	,
cord-023095-4dannjjm	3155	3	the	the	DT
cord-023095-4dannjjm	3155	4	major	major	JJ
cord-023095-4dannjjm	3155	5	hormone	hormone	NN
cord-023095-4dannjjm	3155	6	limiting	limit	VBG
cord-023095-4dannjjm	3155	7	iron	iron	NN
cord-023095-4dannjjm	3155	8	absorption	absorption	NN
cord-023095-4dannjjm	3155	9	and	and	CC
cord-023095-4dannjjm	3155	10	release	release	NN
cord-023095-4dannjjm	3155	11	from	from	IN
cord-023095-4dannjjm	3155	12	macrophages	macrophage	NNS
cord-023095-4dannjjm	3155	13	,	,	,
cord-023095-4dannjjm	3155	14	is	be	VBZ
cord-023095-4dannjjm	3155	15	downregulated	downregulate	VBN
cord-023095-4dannjjm	3155	16	by	by	IN
cord-023095-4dannjjm	3155	17	matriptase-2	matriptase-2	NNP
cord-023095-4dannjjm	3155	18	,	,	,
cord-023095-4dannjjm	3155	19	a	a	DT
cord-023095-4dannjjm	3155	20	transmembrane	transmembrane	NN
cord-023095-4dannjjm	3155	21	serine	serine	NN
cord-023095-4dannjjm	3155	22	protease	protease	NN
cord-023095-4dannjjm	3155	23	(	(	-LRB-
cord-023095-4dannjjm	3155	24	Tmprss6	Tmprss6	NNP
cord-023095-4dannjjm	3155	25	)	)	-RRB-
cord-023095-4dannjjm	3155	26	produced	produce	VBN
cord-023095-4dannjjm	3155	27	by	by	IN
cord-023095-4dannjjm	3155	28	the	the	DT
cord-023095-4dannjjm	3155	29	liver	liver	NN
cord-023095-4dannjjm	3155	30	.	.	.
cord-023095-4dannjjm	3156	1	While	while	IN
cord-023095-4dannjjm	3156	2	iron	iron	NN
cord-023095-4dannjjm	3156	3	deficiency	deficiency	NN
cord-023095-4dannjjm	3156	4	is	be	VBZ
cord-023095-4dannjjm	3156	5	commonly	commonly	RB
cord-023095-4dannjjm	3156	6	caused	cause	VBN
cord-023095-4dannjjm	3156	7	by	by	IN
cord-023095-4dannjjm	3156	8	chronic	chronic	JJ
cord-023095-4dannjjm	3156	9	blood	blood	NN
cord-023095-4dannjjm	3156	10	loss	loss	NN
cord-023095-4dannjjm	3156	11	anemia	anemia	NN
cord-023095-4dannjjm	3156	12	and	and	CC
cord-023095-4dannjjm	3156	13	rarely	rarely	RB
cord-023095-4dannjjm	3156	14	dietary	dietary	JJ
cord-023095-4dannjjm	3156	15	deficiency	deficiency	NN
cord-023095-4dannjjm	3156	16	or	or	CC
cord-023095-4dannjjm	3156	17	intestinal	intestinal	JJ
cord-023095-4dannjjm	3156	18	disorders	disorder	NNS
cord-023095-4dannjjm	3156	19	in	in	IN
cord-023095-4dannjjm	3156	20	dogs	dog	NNS
cord-023095-4dannjjm	3156	21	and	and	CC
cord-023095-4dannjjm	3156	22	other	other	JJ
cord-023095-4dannjjm	3156	23	species	specie	NNS
cord-023095-4dannjjm	3156	24	,	,	,
cord-023095-4dannjjm	3156	25	we	-PRON-	PRP
cord-023095-4dannjjm	3156	26	report	report	VBP
cord-023095-4dannjjm	3156	27	here	here	RB
cord-023095-4dannjjm	3156	28	the	the	DT
cord-023095-4dannjjm	3156	29	clinical	clinical	JJ
cord-023095-4dannjjm	3156	30	to	to	IN
cord-023095-4dannjjm	3156	31	molecular	molecular	JJ
cord-023095-4dannjjm	3156	32	investigations	investigation	NNS
cord-023095-4dannjjm	3156	33	of	of	IN
cord-023095-4dannjjm	3156	34	a	a	DT
cord-023095-4dannjjm	3156	35	dog	dog	NN
cord-023095-4dannjjm	3156	36	with	with	IN
cord-023095-4dannjjm	3156	37	iron	iron	NN
cord-023095-4dannjjm	3156	38	-	-	HYPH
cord-023095-4dannjjm	3156	39	refractory	refractory	JJ
cord-023095-4dannjjm	3156	40	iron	iron	NN
cord-023095-4dannjjm	3156	41	deficiency	deficiency	NN
cord-023095-4dannjjm	3156	42	anemia	anemia	NN
cord-023095-4dannjjm	3156	43	(	(	-LRB-
cord-023095-4dannjjm	3156	44	IRIDA	IRIDA	NNP
cord-023095-4dannjjm	3156	45	)	)	-RRB-
cord-023095-4dannjjm	3156	46	caused	cause	VBN
cord-023095-4dannjjm	3156	47	by	by	IN
cord-023095-4dannjjm	3156	48	a	a	DT
cord-023095-4dannjjm	3156	49	matriptase-2	matriptase-2	NNP
cord-023095-4dannjjm	3156	50	deficiency	deficiency	NN
cord-023095-4dannjjm	3156	51	homologous	homologous	JJ
cord-023095-4dannjjm	3156	52	to	to	IN
cord-023095-4dannjjm	3156	53	a	a	DT
cord-023095-4dannjjm	3156	54	recently	recently	RB
cord-023095-4dannjjm	3156	55	described	describe	VBN
cord-023095-4dannjjm	3156	56	autosomal	autosomal	JJ
cord-023095-4dannjjm	3156	57	recessive	recessive	JJ
cord-023095-4dannjjm	3156	58	disorder	disorder	NN
cord-023095-4dannjjm	3156	59	in	in	IN
cord-023095-4dannjjm	3156	60	humans	human	NNS
cord-023095-4dannjjm	3156	61	.	.	.
cord-023095-4dannjjm	3157	1	The	the	DT
cord-023095-4dannjjm	3157	2	proband	proband	NN
cord-023095-4dannjjm	3157	3	,	,	,
cord-023095-4dannjjm	3157	4	a	a	DT
cord-023095-4dannjjm	3157	5	spayed	spay	VBN
cord-023095-4dannjjm	3157	6	female	female	JJ
cord-023095-4dannjjm	3157	7	Cocker	Cocker	NNP
cord-023095-4dannjjm	3157	8	Spaniel	Spaniel	NNP
cord-023095-4dannjjm	3157	9	without	without	IN
cord-023095-4dannjjm	3157	10	any	any	DT
cord-023095-4dannjjm	3157	11	clinical	clinical	JJ
cord-023095-4dannjjm	3157	12	signs	sign	NNS
cord-023095-4dannjjm	3157	13	except	except	IN
cord-023095-4dannjjm	3157	14	for	for	IN
cord-023095-4dannjjm	3157	15	recent	recent	JJ
cord-023095-4dannjjm	3157	16	occasional	occasional	JJ
cord-023095-4dannjjm	3157	17	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	3157	18	seizures	seizure	NNS
cord-023095-4dannjjm	3157	19	,	,	,
cord-023095-4dannjjm	3157	20	exhibited	exhibit	VBD
cord-023095-4dannjjm	3157	21	a	a	DT
cord-023095-4dannjjm	3157	22	lifelong	lifelong	JJ
cord-023095-4dannjjm	3157	23	history	history	NN
cord-023095-4dannjjm	3157	24	of	of	IN
cord-023095-4dannjjm	3157	25	microcytosis	microcytosis	NNP
cord-023095-4dannjjm	3157	26	and	and	CC
cord-023095-4dannjjm	3157	27	hypochromasia	hypochromasia	NNP
cord-023095-4dannjjm	3157	28	but	but	CC
cord-023095-4dannjjm	3157	29	not	not	RB
cord-023095-4dannjjm	3157	30	anemia	anemia	NN
cord-023095-4dannjjm	3157	31	.	.	.
cord-023095-4dannjjm	3158	1	There	there	EX
cord-023095-4dannjjm	3158	2	was	be	VBD
cord-023095-4dannjjm	3158	3	no	no	DT
cord-023095-4dannjjm	3158	4	evidence	evidence	NN
cord-023095-4dannjjm	3158	5	of	of	IN
cord-023095-4dannjjm	3158	6	any	any	DT
cord-023095-4dannjjm	3158	7	blood	blood	NN
cord-023095-4dannjjm	3158	8	loss	loss	NN
cord-023095-4dannjjm	3158	9	and	and	CC
cord-023095-4dannjjm	3158	10	the	the	DT
cord-023095-4dannjjm	3158	11	dog	dog	NN
cord-023095-4dannjjm	3158	12	was	be	VBD
cord-023095-4dannjjm	3158	13	receiving	receive	VBG
cord-023095-4dannjjm	3158	14	an	an	DT
cord-023095-4dannjjm	3158	15	appropriate	appropriate	JJ
cord-023095-4dannjjm	3158	16	meat	meat	NN
cord-023095-4dannjjm	3158	17	-	-	HYPH
cord-023095-4dannjjm	3158	18	based	base	VBN
cord-023095-4dannjjm	3158	19	diet	diet	NN
cord-023095-4dannjjm	3158	20	.	.	.
cord-023095-4dannjjm	3159	1	Mean	mean	JJ
cord-023095-4dannjjm	3159	2	values	value	NNS
cord-023095-4dannjjm	3159	3	of	of	IN
cord-023095-4dannjjm	3159	4	complete	complete	JJ
cord-023095-4dannjjm	3159	5	blood	blood	NN
cord-023095-4dannjjm	3159	6	cell	cell	NN
cord-023095-4dannjjm	3159	7	counts	count	NNS
cord-023095-4dannjjm	3159	8	,	,	,
cord-023095-4dannjjm	3159	9	performed	perform	VBN
cord-023095-4dannjjm	3159	10	from	from	IN
cord-023095-4dannjjm	3159	11	0.5	0.5	CD
cord-023095-4dannjjm	3159	12	-	-	SYM
cord-023095-4dannjjm	3159	13	5	5	CD
cord-023095-4dannjjm	3159	14	years	year	NNS
cord-023095-4dannjjm	3159	15	of	of	IN
cord-023095-4dannjjm	3159	16	age	age	NN
cord-023095-4dannjjm	3159	17	,	,	,
cord-023095-4dannjjm	3159	18	were	be	VBD
cord-023095-4dannjjm	3159	19	:	:	:
cord-023095-4dannjjm	3159	20	hematocrit	hematocrit	NN
cord-023095-4dannjjm	3159	21	41	41	CD
cord-023095-4dannjjm	3159	22	%	%	NN
cord-023095-4dannjjm	3159	23	(	(	-LRB-
cord-023095-4dannjjm	3159	24	normal	normal	JJ
cord-023095-4dannjjm	3159	25	reference	reference	NN
cord-023095-4dannjjm	3159	26	range	range	NN
cord-023095-4dannjjm	3159	27	39	39	CD
cord-023095-4dannjjm	3159	28	-	-	SYM
cord-023095-4dannjjm	3159	29	56	56	CD
cord-023095-4dannjjm	3159	30	)	)	-RRB-
cord-023095-4dannjjm	3159	31	;	;	:
cord-023095-4dannjjm	3159	32	RBC	RBC	NNP
cord-023095-4dannjjm	3159	33	count	count	VBP
cord-023095-4dannjjm	3159	34	9.6	9.6	CD
cord-023095-4dannjjm	3159	35	Â	â	CD
cord-023095-4dannjjm	3159	36	10	10	CD
cord-023095-4dannjjm	3159	37	6	6	CD
cord-023095-4dannjjm	3159	38	/mL	/mL	.
cord-023095-4dannjjm	3160	1	(	(	-LRB-
cord-023095-4dannjjm	3160	2	5.8	5.8	CD
cord-023095-4dannjjm	3160	3	-	-	SYM
cord-023095-4dannjjm	3160	4	8.5	8.5	CD
cord-023095-4dannjjm	3160	5	x	x	SYM
cord-023095-4dannjjm	3160	6	10	10	CD
cord-023095-4dannjjm	3160	7	6	6	CD
cord-023095-4dannjjm	3160	8	)	)	-RRB-
cord-023095-4dannjjm	3160	9	;	;	:
cord-023095-4dannjjm	3160	10	MCV	MCV	NNP
cord-023095-4dannjjm	3160	11	43	43	CD
cord-023095-4dannjjm	3160	12	fL	fl	CD
cord-023095-4dannjjm	3161	1	(	(	-LRB-
cord-023095-4dannjjm	3161	2	62	62	CD
cord-023095-4dannjjm	3161	3	-	-	SYM
cord-023095-4dannjjm	3161	4	72	72	CD
cord-023095-4dannjjm	3161	5	)	)	-RRB-
cord-023095-4dannjjm	3161	6	;	;	:
cord-023095-4dannjjm	3161	7	MCHC	MCHC	NNP
cord-023095-4dannjjm	3161	8	31	31	CD
cord-023095-4dannjjm	3162	1	g	g	NNP
cord-023095-4dannjjm	3162	2	/	/	SYM
cord-023095-4dannjjm	3162	3	dL	dl	NN
cord-023095-4dannjjm	3162	4	(	(	-LRB-
cord-023095-4dannjjm	3162	5	33	33	CD
cord-023095-4dannjjm	3162	6	-	-	SYM
cord-023095-4dannjjm	3162	7	36	36	CD
cord-023095-4dannjjm	3162	8	)	)	-RRB-
cord-023095-4dannjjm	3162	9	.	.	.
cord-023095-4dannjjm	3163	1	Serum	serum	NN
cord-023095-4dannjjm	3163	2	iron	iron	NN
cord-023095-4dannjjm	3163	3	parameters	parameter	NNS
cord-023095-4dannjjm	3163	4	revealed	reveal	VBD
cord-023095-4dannjjm	3163	5	severe	severe	JJ
cord-023095-4dannjjm	3163	6	iron	iron	NN
cord-023095-4dannjjm	3163	7	deficiency	deficiency	NN
cord-023095-4dannjjm	3163	8	with	with	IN
cord-023095-4dannjjm	3163	9	serum	serum	NN
cord-023095-4dannjjm	3163	10	iron	iron	NN
cord-023095-4dannjjm	3163	11	34	34	CD
cord-023095-4dannjjm	3163	12	mg	mg	NNP
cord-023095-4dannjjm	3163	13	/	/	SYM
cord-023095-4dannjjm	3163	14	dL	dl	NN
cord-023095-4dannjjm	3163	15	(	(	-LRB-
cord-023095-4dannjjm	3163	16	88	88	CD
cord-023095-4dannjjm	3163	17	-	-	SYM
cord-023095-4dannjjm	3163	18	238	238	CD
cord-023095-4dannjjm	3163	19	)	)	-RRB-
cord-023095-4dannjjm	3163	20	;	;	:
cord-023095-4dannjjm	3163	21	Total	Total	NNP
cord-023095-4dannjjm	3163	22	Iron	Iron	NNP
cord-023095-4dannjjm	3163	23	Binding	Binding	NNP
cord-023095-4dannjjm	3163	24	Capacity	Capacity	NNP
cord-023095-4dannjjm	3163	25	378	378	CD
cord-023095-4dannjjm	3163	26	mg	mg	NNP
cord-023095-4dannjjm	3163	27	/	/	SYM
cord-023095-4dannjjm	3163	28	dL	dl	NN
cord-023095-4dannjjm	3163	29	(	(	-LRB-
cord-023095-4dannjjm	3163	30	246	246	CD
cord-023095-4dannjjm	3163	31	-	-	SYM
cord-023095-4dannjjm	3163	32	450	450	CD
cord-023095-4dannjjm	3163	33	)	)	-RRB-
cord-023095-4dannjjm	3163	34	;	;	:
cord-023095-4dannjjm	3163	35	serum	serum	NN
cord-023095-4dannjjm	3163	36	iron	iron	NN
cord-023095-4dannjjm	3163	37	saturation	saturation	NN
cord-023095-4dannjjm	3163	38	o	o	NN
cord-023095-4dannjjm	3163	39	9	9	CD
cord-023095-4dannjjm	3163	40	%	%	NN
cord-023095-4dannjjm	3163	41	(	(	-LRB-
cord-023095-4dannjjm	3163	42	15	15	CD
cord-023095-4dannjjm	3163	43	-	-	SYM
cord-023095-4dannjjm	3163	44	50	50	CD
cord-023095-4dannjjm	3163	45	%	%	NN
cord-023095-4dannjjm	3163	46	)	)	-RRB-
cord-023095-4dannjjm	3163	47	,	,	,
cord-023095-4dannjjm	3163	48	and	and	CC
cord-023095-4dannjjm	3163	49	ferritin	ferritin	NN
cord-023095-4dannjjm	3163	50	410	410	CD
cord-023095-4dannjjm	3163	51	ng	ng	NNP
cord-023095-4dannjjm	3163	52	/	/	SYM
cord-023095-4dannjjm	3163	53	dL	dl	NN
cord-023095-4dannjjm	3163	54	(	(	-LRB-
cord-023095-4dannjjm	3163	55	80	80	CD
cord-023095-4dannjjm	3163	56	-	-	SYM
cord-023095-4dannjjm	3163	57	800	800	CD
cord-023095-4dannjjm	3163	58	)	)	-RRB-
cord-023095-4dannjjm	3163	59	.	.	.
cord-023095-4dannjjm	3164	1	Prolonged	prolonged	JJ
cord-023095-4dannjjm	3164	2	courses	course	NNS
cord-023095-4dannjjm	3164	3	of	of	IN
cord-023095-4dannjjm	3164	4	oral	oral	JJ
cord-023095-4dannjjm	3164	5	ferrous	ferrous	JJ
cord-023095-4dannjjm	3164	6	sulfate	sulfate	NN
cord-023095-4dannjjm	3164	7	supplementation	supplementation	NN
cord-023095-4dannjjm	3164	8	and	and	CC
cord-023095-4dannjjm	3164	9	several	several	JJ
cord-023095-4dannjjm	3164	10	short	short	JJ
cord-023095-4dannjjm	3164	11	courses	course	NNS
cord-023095-4dannjjm	3164	12	of	of	IN
cord-023095-4dannjjm	3164	13	intramuscular	intramuscular	JJ
cord-023095-4dannjjm	3164	14	(	(	-LRB-
cord-023095-4dannjjm	3164	15	Dextran	dextran	NN
cord-023095-4dannjjm	3164	16	)	)	-RRB-
cord-023095-4dannjjm	3164	17	injections	injection	NNS
cord-023095-4dannjjm	3164	18	and	and	CC
cord-023095-4dannjjm	3164	19	intravenous	intravenous	JJ
cord-023095-4dannjjm	3164	20	iron	iron	NN
cord-023095-4dannjjm	3164	21	infusions	infusion	NNS
cord-023095-4dannjjm	3164	22	did	do	VBD
cord-023095-4dannjjm	3164	23	not	not	RB
cord-023095-4dannjjm	3164	24	result	result	VB
cord-023095-4dannjjm	3164	25	in	in	IN
cord-023095-4dannjjm	3164	26	improvement	improvement	NN
cord-023095-4dannjjm	3164	27	of	of	IN
cord-023095-4dannjjm	3164	28	any	any	DT
cord-023095-4dannjjm	3164	29	red	red	JJ
cord-023095-4dannjjm	3164	30	cell	cell	NN
cord-023095-4dannjjm	3164	31	or	or	CC
cord-023095-4dannjjm	3164	32	serum	serum	NN
cord-023095-4dannjjm	3164	33	iron	iron	NN
cord-023095-4dannjjm	3164	34	parameters	parameter	NNS
cord-023095-4dannjjm	3164	35	.	.	.
cord-023095-4dannjjm	3165	1	However	however	RB
cord-023095-4dannjjm	3165	2	,	,	,
cord-023095-4dannjjm	3165	3	this	this	DT
cord-023095-4dannjjm	3165	4	dog	dog	NN
cord-023095-4dannjjm	3165	5	was	be	VBD
cord-023095-4dannjjm	3165	6	never	never	RB
cord-023095-4dannjjm	3165	7	anemic	anemic	JJ
cord-023095-4dannjjm	3165	8	and	and	CC
cord-023095-4dannjjm	3165	9	the	the	DT
cord-023095-4dannjjm	3165	10	partial	partial	JJ
cord-023095-4dannjjm	3165	11	seizures	seizure	NNS
cord-023095-4dannjjm	3165	12	could	could	MD
cord-023095-4dannjjm	3165	13	not	not	RB
cord-023095-4dannjjm	3165	14	be	be	VB
cord-023095-4dannjjm	3165	15	directly	directly	RB
cord-023095-4dannjjm	3165	16	related	relate	VBN
cord-023095-4dannjjm	3165	17	to	to	IN
cord-023095-4dannjjm	3165	18	the	the	DT
cord-023095-4dannjjm	3165	19	iron	iron	NN
cord-023095-4dannjjm	3165	20	deficiency	deficiency	NN
cord-023095-4dannjjm	3165	21	status	status	NN
cord-023095-4dannjjm	3165	22	.	.	.
cord-023095-4dannjjm	3166	1	No	no	DT
cord-023095-4dannjjm	3166	2	family	family	NN
cord-023095-4dannjjm	3166	3	members	member	NNS
cord-023095-4dannjjm	3166	4	were	be	VBD
cord-023095-4dannjjm	3166	5	available	available	JJ
cord-023095-4dannjjm	3166	6	for	for	IN
cord-023095-4dannjjm	3166	7	further	further	JJ
cord-023095-4dannjjm	3166	8	studies	study	NNS
cord-023095-4dannjjm	3166	9	.	.	.
cord-023095-4dannjjm	3167	1	Genomic	genomic	JJ
cord-023095-4dannjjm	3167	2	DNA	dna	NN
cord-023095-4dannjjm	3167	3	was	be	VBD
cord-023095-4dannjjm	3167	4	extracted	extract	VBN
cord-023095-4dannjjm	3167	5	from	from	IN
cord-023095-4dannjjm	3167	6	the	the	DT
cord-023095-4dannjjm	3167	7	proband	proband	NN
cord-023095-4dannjjm	3167	8	's	's	POS
cord-023095-4dannjjm	3167	9	EDTA	EDTA	NNP
cord-023095-4dannjjm	3167	10	blood	blood	NN
cord-023095-4dannjjm	3167	11	and	and	CC
cord-023095-4dannjjm	3167	12	the	the	DT
cord-023095-4dannjjm	3167	13	exons	exon	NNS
cord-023095-4dannjjm	3167	14	of	of	IN
cord-023095-4dannjjm	3167	15	the	the	DT
cord-023095-4dannjjm	3167	16	TMPRSS6	TMPRSS6	NNP
cord-023095-4dannjjm	3167	17	gene	gene	NN
cord-023095-4dannjjm	3167	18	were	be	VBD
cord-023095-4dannjjm	3167	19	amplified	amplify	VBN
cord-023095-4dannjjm	3167	20	with	with	IN
cord-023095-4dannjjm	3167	21	flanking	flank	VBG
cord-023095-4dannjjm	3167	22	primers	primer	NNS
cord-023095-4dannjjm	3167	23	and	and	CC
cord-023095-4dannjjm	3167	24	then	then	RB
cord-023095-4dannjjm	3167	25	sequenced	sequence	VBN
cord-023095-4dannjjm	3167	26	.	.	.
cord-023095-4dannjjm	3168	1	In	in	IN
cord-023095-4dannjjm	3168	2	comparison	comparison	NN
cord-023095-4dannjjm	3168	3	to	to	IN
cord-023095-4dannjjm	3168	4	the	the	DT
cord-023095-4dannjjm	3168	5	normal	normal	JJ
cord-023095-4dannjjm	3168	6	canine	canine	JJ
cord-023095-4dannjjm	3168	7	TMPRSS6	tmprss6	XX
cord-023095-4dannjjm	3168	8	sequence	sequence	NN
cord-023095-4dannjjm	3168	9	and	and	CC
cord-023095-4dannjjm	3168	10	that	that	DT
cord-023095-4dannjjm	3168	11	of	of	IN
cord-023095-4dannjjm	3168	12	a	a	DT
cord-023095-4dannjjm	3168	13	sequenced	sequence	VBN
cord-023095-4dannjjm	3168	14	control	control	NN
cord-023095-4dannjjm	3168	15	dog	dog	NN
cord-023095-4dannjjm	3168	16	we	-PRON-	PRP
cord-023095-4dannjjm	3168	17	found	find	VBD
cord-023095-4dannjjm	3168	18	a	a	DT
cord-023095-4dannjjm	3168	19	homozygous	homozygous	JJ
cord-023095-4dannjjm	3168	20	missense	missense	NN
cord-023095-4dannjjm	3168	21	muation	muation	NN
cord-023095-4dannjjm	3168	22	,	,	,
cord-023095-4dannjjm	3168	23	R723H	R723H	NNP
cord-023095-4dannjjm	3168	24	,	,	,
cord-023095-4dannjjm	3168	25	toward	toward	IN
cord-023095-4dannjjm	3168	26	the	the	DT
cord-023095-4dannjjm	3168	27	C	c	NN
cord-023095-4dannjjm	3168	28	-	-	HYPH
cord-023095-4dannjjm	3168	29	terminal	terminal	JJ
cord-023095-4dannjjm	3168	30	end	end	NN
cord-023095-4dannjjm	3168	31	of	of	IN
cord-023095-4dannjjm	3168	32	the	the	DT
cord-023095-4dannjjm	3168	33	protein	protein	NN
cord-023095-4dannjjm	3168	34	in	in	IN
cord-023095-4dannjjm	3168	35	the	the	DT
cord-023095-4dannjjm	3168	36	proband	proband	NN
cord-023095-4dannjjm	3168	37	's	's	POS
cord-023095-4dannjjm	3168	38	gene	gene	NN
cord-023095-4dannjjm	3168	39	.	.	.
cord-023095-4dannjjm	3169	1	In	in	IN
cord-023095-4dannjjm	3169	2	conclusion	conclusion	NN
cord-023095-4dannjjm	3169	3	,	,	,
cord-023095-4dannjjm	3169	4	the	the	DT
cord-023095-4dannjjm	3169	5	severe	severe	JJ
cord-023095-4dannjjm	3169	6	microcytosis	microcytosis	NN
cord-023095-4dannjjm	3169	7	and	and	CC
cord-023095-4dannjjm	3169	8	hypochromasia	hypochromasia	NNP
cord-023095-4dannjjm	3169	9	,	,	,
cord-023095-4dannjjm	3169	10	low	low	JJ
cord-023095-4dannjjm	3169	11	serum	serum	NN
cord-023095-4dannjjm	3169	12	iron	iron	NN
cord-023095-4dannjjm	3169	13	parameters	parameter	NNS
cord-023095-4dannjjm	3169	14	and	and	CC
cord-023095-4dannjjm	3169	15	lack	lack	NN
cord-023095-4dannjjm	3169	16	of	of	IN
cord-023095-4dannjjm	3169	17	a	a	DT
cord-023095-4dannjjm	3169	18	response	response	NN
cord-023095-4dannjjm	3169	19	to	to	IN
cord-023095-4dannjjm	3169	20	oral	oral	JJ
cord-023095-4dannjjm	3169	21	and	and	CC
cord-023095-4dannjjm	3169	22	parenteral	parenteral	JJ
cord-023095-4dannjjm	3169	23	iron	iron	NN
cord-023095-4dannjjm	3169	24	therapy	therapy	NN
cord-023095-4dannjjm	3169	25	led	lead	VBD
cord-023095-4dannjjm	3169	26	to	to	IN
cord-023095-4dannjjm	3169	27	the	the	DT
cord-023095-4dannjjm	3169	28	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3169	29	of	of	IN
cord-023095-4dannjjm	3169	30	IRIDA	IRIDA	NNP
cord-023095-4dannjjm	3169	31	.	.	.
cord-023095-4dannjjm	3170	1	The	the	DT
cord-023095-4dannjjm	3170	2	missense	missense	NN
cord-023095-4dannjjm	3170	3	mutation	mutation	NN
cord-023095-4dannjjm	3170	4	in	in	IN
cord-023095-4dannjjm	3170	5	the	the	DT
cord-023095-4dannjjm	3170	6	matriptase-2	matriptase-2	NNP
cord-023095-4dannjjm	3170	7	at	at	IN
cord-023095-4dannjjm	3170	8	position	position	NN
cord-023095-4dannjjm	3170	9	723	723	CD
cord-023095-4dannjjm	3170	10	from	from	IN
cord-023095-4dannjjm	3170	11	an	an	DT
cord-023095-4dannjjm	3170	12	arginine	arginine	NN
cord-023095-4dannjjm	3170	13	,	,	,
cord-023095-4dannjjm	3170	14	which	which	WDT
cord-023095-4dannjjm	3170	15	is	be	VBZ
cord-023095-4dannjjm	3170	16	conserved	conserve	VBN
cord-023095-4dannjjm	3170	17	across	across	IN
cord-023095-4dannjjm	3170	18	all	all	DT
cord-023095-4dannjjm	3170	19	species	specie	NNS
cord-023095-4dannjjm	3170	20	currently	currently	RB
cord-023095-4dannjjm	3170	21	deposited	deposit	VBN
cord-023095-4dannjjm	3170	22	in	in	IN
cord-023095-4dannjjm	3170	23	the	the	DT
cord-023095-4dannjjm	3170	24	Genbank	Genbank	NNP
cord-023095-4dannjjm	3170	25	,	,	,
cord-023095-4dannjjm	3170	26	to	to	IN
cord-023095-4dannjjm	3170	27	a	a	DT
cord-023095-4dannjjm	3170	28	histidine	histidine	NN
cord-023095-4dannjjm	3170	29	is	be	VBZ
cord-023095-4dannjjm	3170	30	likely	likely	RB
cord-023095-4dannjjm	3170	31	the	the	DT
cord-023095-4dannjjm	3170	32	disease	disease	NN
cord-023095-4dannjjm	3170	33	-	-	HYPH
cord-023095-4dannjjm	3170	34	causing	cause	VBG
cord-023095-4dannjjm	3170	35	mutation	mutation	NN
cord-023095-4dannjjm	3170	36	.	.	.
cord-023095-4dannjjm	3171	1	This	this	DT
cord-023095-4dannjjm	3171	2	is	be	VBZ
cord-023095-4dannjjm	3171	3	the	the	DT
cord-023095-4dannjjm	3171	4	first	first	JJ
cord-023095-4dannjjm	3171	5	report	report	NN
cord-023095-4dannjjm	3171	6	of	of	IN
cord-023095-4dannjjm	3171	7	an	an	DT
cord-023095-4dannjjm	3171	8	IRIDA	IRIDA	NNP
cord-023095-4dannjjm	3171	9	in	in	IN
cord-023095-4dannjjm	3171	10	the	the	DT
cord-023095-4dannjjm	3171	11	dog	dog	NN
cord-023095-4dannjjm	3171	12	with	with	IN
cord-023095-4dannjjm	3171	13	features	feature	VBZ
cord-023095-4dannjjm	3171	14	very	very	RB
cord-023095-4dannjjm	3171	15	similar	similar	JJ
cord-023095-4dannjjm	3171	16	to	to	IN
cord-023095-4dannjjm	3171	17	those	those	DT
cord-023095-4dannjjm	3171	18	observed	observe	VBN
cord-023095-4dannjjm	3171	19	in	in	IN
cord-023095-4dannjjm	3171	20	humans	human	NNS
cord-023095-4dannjjm	3171	21	.	.	.
cord-023095-4dannjjm	3172	1	Dogs	dog	NNS
cord-023095-4dannjjm	3172	2	with	with	IN
cord-023095-4dannjjm	3172	3	naturally	naturally	RB
cord-023095-4dannjjm	3172	4	-	-	HYPH
cord-023095-4dannjjm	3172	5	occurring	occur	VBG
cord-023095-4dannjjm	3172	6	IRIDA	IRIDA	NNP
cord-023095-4dannjjm	3172	7	may	may	MD
cord-023095-4dannjjm	3172	8	be	be	VB
cord-023095-4dannjjm	3172	9	helpful	helpful	JJ
cord-023095-4dannjjm	3172	10	in	in	IN
cord-023095-4dannjjm	3172	11	developing	develop	VBG
cord-023095-4dannjjm	3172	12	and	and	CC
cord-023095-4dannjjm	3172	13	assessing	assess	VBG
cord-023095-4dannjjm	3172	14	novel	novel	JJ
cord-023095-4dannjjm	3172	15	therapies	therapy	NNS
cord-023095-4dannjjm	3172	16	.	.	.
cord-023095-4dannjjm	3173	1	Accidental	accidental	JJ
cord-023095-4dannjjm	3173	2	ingestion	ingestion	NN
cord-023095-4dannjjm	3173	3	of	of	IN
cord-023095-4dannjjm	3173	4	copper	copper	NN
cord-023095-4dannjjm	3173	5	-	-	HYPH
cord-023095-4dannjjm	3173	6	coated	coat	VBN
cord-023095-4dannjjm	3173	7	zinc	zinc	NN
cord-023095-4dannjjm	3173	8	pennies	penny	NNS
cord-023095-4dannjjm	3173	9	minted	mint	VBN
cord-023095-4dannjjm	3173	10	after	after	IN
cord-023095-4dannjjm	3173	11	1982	1982	CD
cord-023095-4dannjjm	3173	12	is	be	VBZ
cord-023095-4dannjjm	3173	13	the	the	DT
cord-023095-4dannjjm	3173	14	most	most	RBS
cord-023095-4dannjjm	3173	15	common	common	JJ
cord-023095-4dannjjm	3173	16	causes	cause	NNS
cord-023095-4dannjjm	3173	17	of	of	IN
cord-023095-4dannjjm	3173	18	zinc	zinc	NN
cord-023095-4dannjjm	3173	19	toxicity	toxicity	NN
cord-023095-4dannjjm	3173	20	anemia	anemia	NN
cord-023095-4dannjjm	3173	21	in	in	IN
cord-023095-4dannjjm	3173	22	the	the	DT
cord-023095-4dannjjm	3173	23	dog	dog	NN
cord-023095-4dannjjm	3173	24	.	.	.
cord-023095-4dannjjm	3174	1	Zinc	zinc	NN
cord-023095-4dannjjm	3174	2	toxicity	toxicity	NN
cord-023095-4dannjjm	3174	3	anemia	anemia	NN
cord-023095-4dannjjm	3174	4	may	may	MD
cord-023095-4dannjjm	3174	5	also	also	RB
cord-023095-4dannjjm	3174	6	be	be	VB
cord-023095-4dannjjm	3174	7	seen	see	VBN
cord-023095-4dannjjm	3174	8	with	with	IN
cord-023095-4dannjjm	3174	9	ingestion	ingestion	NN
cord-023095-4dannjjm	3174	10	of	of	IN
cord-023095-4dannjjm	3174	11	zinc	zinc	NN
cord-023095-4dannjjm	3174	12	from	from	IN
cord-023095-4dannjjm	3174	13	other	other	JJ
cord-023095-4dannjjm	3174	14	sources	source	NNS
cord-023095-4dannjjm	3174	15	as	as	IN
cord-023095-4dannjjm	3174	16	ingestion	ingestion	NN
cord-023095-4dannjjm	3174	17	of	of	IN
cord-023095-4dannjjm	3174	18	metallic	metallic	JJ
cord-023095-4dannjjm	3174	19	foreign	foreign	JJ
cord-023095-4dannjjm	3174	20	material	material	NN
cord-023095-4dannjjm	3174	21	other	other	JJ
cord-023095-4dannjjm	3174	22	than	than	IN
cord-023095-4dannjjm	3174	23	pennies	penny	NNS
cord-023095-4dannjjm	3174	24	,	,	,
cord-023095-4dannjjm	3174	25	medicines	medicine	NNS
cord-023095-4dannjjm	3174	26	containing	contain	VBG
cord-023095-4dannjjm	3174	27	zinc	zinc	NN
cord-023095-4dannjjm	3174	28	,	,	,
cord-023095-4dannjjm	3174	29	and	and	CC
cord-023095-4dannjjm	3174	30	zinc	zinc	NN
cord-023095-4dannjjm	3174	31	supplements	supplement	NNS
cord-023095-4dannjjm	3174	32	.	.	.
cord-023095-4dannjjm	3175	1	The	the	DT
cord-023095-4dannjjm	3175	2	purpose	purpose	NN
cord-023095-4dannjjm	3175	3	of	of	IN
cord-023095-4dannjjm	3175	4	this	this	DT
cord-023095-4dannjjm	3175	5	study	study	NN
cord-023095-4dannjjm	3175	6	was	be	VBD
cord-023095-4dannjjm	3175	7	to	to	TO
cord-023095-4dannjjm	3175	8	determine	determine	VB
cord-023095-4dannjjm	3175	9	if	if	IN
cord-023095-4dannjjm	3175	10	there	there	EX
cord-023095-4dannjjm	3175	11	is	be	VBZ
cord-023095-4dannjjm	3175	12	a	a	DT
cord-023095-4dannjjm	3175	13	weight	weight	NN
cord-023095-4dannjjm	3175	14	below	below	IN
cord-023095-4dannjjm	3175	15	which	which	WDT
cord-023095-4dannjjm	3175	16	dogs	dog	NNS
cord-023095-4dannjjm	3175	17	are	be	VBP
cord-023095-4dannjjm	3175	18	more	more	RBR
cord-023095-4dannjjm	3175	19	susceptible	susceptible	JJ
cord-023095-4dannjjm	3175	20	to	to	IN
cord-023095-4dannjjm	3175	21	zinc	zinc	NN
cord-023095-4dannjjm	3175	22	toxicity	toxicity	NN
cord-023095-4dannjjm	3175	23	anemia	anemia	NN
cord-023095-4dannjjm	3175	24	secondary	secondary	JJ
cord-023095-4dannjjm	3175	25	to	to	IN
cord-023095-4dannjjm	3175	26	metallic	metallic	JJ
cord-023095-4dannjjm	3175	27	foreign	foreign	JJ
cord-023095-4dannjjm	3175	28	body	body	NN
cord-023095-4dannjjm	3175	29	ingestion	ingestion	NN
cord-023095-4dannjjm	3175	30	.	.	.
cord-023095-4dannjjm	3176	1	Records	record	NNS
cord-023095-4dannjjm	3176	2	of	of	IN
cord-023095-4dannjjm	3176	3	dogs	dog	NNS
cord-023095-4dannjjm	3176	4	presented	present	VBN
cord-023095-4dannjjm	3176	5	to	to	IN
cord-023095-4dannjjm	3176	6	the	the	DT
cord-023095-4dannjjm	3176	7	Internal	Internal	NNP
cord-023095-4dannjjm	3176	8	Medicine	Medicine	NNP
cord-023095-4dannjjm	3176	9	service	service	NN
cord-023095-4dannjjm	3176	10	at	at	IN
cord-023095-4dannjjm	3176	11	the	the	DT
cord-023095-4dannjjm	3176	12	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	3176	13	Medical	Medical	NNP
cord-023095-4dannjjm	3176	14	Center	Center	NNP
cord-023095-4dannjjm	3176	15	of	of	IN
cord-023095-4dannjjm	3176	16	Long	Long	NNP
cord-023095-4dannjjm	3176	17	Island	Island	NNP
cord-023095-4dannjjm	3176	18	for	for	IN
cord-023095-4dannjjm	3176	19	metallic	metallic	JJ
cord-023095-4dannjjm	3176	20	foreign	foreign	JJ
cord-023095-4dannjjm	3176	21	body	body	NN
cord-023095-4dannjjm	3176	22	ingestion	ingestion	NN
cord-023095-4dannjjm	3176	23	were	be	VBD
cord-023095-4dannjjm	3176	24	reviewed	review	VBN
cord-023095-4dannjjm	3176	25	for	for	IN
cord-023095-4dannjjm	3176	26	signalment	signalment	JJ
cord-023095-4dannjjm	3176	27	,	,	,
cord-023095-4dannjjm	3176	28	weight	weight	NN
cord-023095-4dannjjm	3176	29	,	,	,
cord-023095-4dannjjm	3176	30	presenting	present	VBG
cord-023095-4dannjjm	3176	31	PCV	pcv	NN
cord-023095-4dannjjm	3176	32	,	,	,
cord-023095-4dannjjm	3176	33	and	and	CC
cord-023095-4dannjjm	3176	34	type	type	NN
cord-023095-4dannjjm	3176	35	of	of	IN
cord-023095-4dannjjm	3176	36	metallic	metallic	JJ
cord-023095-4dannjjm	3176	37	foreign	foreign	JJ
cord-023095-4dannjjm	3176	38	body	body	NN
cord-023095-4dannjjm	3176	39	ingested	ingest	VBN
cord-023095-4dannjjm	3176	40	.	.	.
cord-023095-4dannjjm	3177	1	Eighteen	eighteen	CD
cord-023095-4dannjjm	3177	2	dogs	dog	NNS
cord-023095-4dannjjm	3177	3	met	meet	VBD
cord-023095-4dannjjm	3177	4	the	the	DT
cord-023095-4dannjjm	3177	5	inclusion	inclusion	NN
cord-023095-4dannjjm	3177	6	criteria	criterion	NNS
cord-023095-4dannjjm	3177	7	and	and	CC
cord-023095-4dannjjm	3177	8	were	be	VBD
cord-023095-4dannjjm	3177	9	compared	compare	VBN
cord-023095-4dannjjm	3177	10	.	.	.
cord-023095-4dannjjm	3178	1	Of	of	IN
cord-023095-4dannjjm	3178	2	the	the	DT
cord-023095-4dannjjm	3178	3	18	18	CD
cord-023095-4dannjjm	3178	4	dogs	dog	NNS
cord-023095-4dannjjm	3178	5	,	,	,
cord-023095-4dannjjm	3178	6	there	there	EX
cord-023095-4dannjjm	3178	7	were	be	VBD
cord-023095-4dannjjm	3178	8	15	15	CD
cord-023095-4dannjjm	3178	9	cases	case	NNS
cord-023095-4dannjjm	3178	10	of	of	IN
cord-023095-4dannjjm	3178	11	coin	coin	NN
cord-023095-4dannjjm	3178	12	ingestion	ingestion	NN
cord-023095-4dannjjm	3178	13	(	(	-LRB-
cord-023095-4dannjjm	3178	14	83	83	CD
cord-023095-4dannjjm	3178	15	%	%	NN
cord-023095-4dannjjm	3178	16	)	)	-RRB-
cord-023095-4dannjjm	3178	17	,	,	,
cord-023095-4dannjjm	3178	18	with	with	IN
cord-023095-4dannjjm	3178	19	11	11	CD
cord-023095-4dannjjm	3178	20	(	(	-LRB-
cord-023095-4dannjjm	3178	21	73	73	CD
cord-023095-4dannjjm	3178	22	%	%	NN
cord-023095-4dannjjm	3178	23	)	)	-RRB-
cord-023095-4dannjjm	3178	24	involving	involve	VBG
cord-023095-4dannjjm	3178	25	ingestion	ingestion	NN
cord-023095-4dannjjm	3178	26	of	of	IN
cord-023095-4dannjjm	3178	27	1	1	CD
cord-023095-4dannjjm	3178	28	or	or	CC
cord-023095-4dannjjm	3178	29	more	more	JJR
cord-023095-4dannjjm	3178	30	pennies	penny	NNS
cord-023095-4dannjjm	3178	31	.	.	.
cord-023095-4dannjjm	3179	1	The	the	DT
cord-023095-4dannjjm	3179	2	other	other	JJ
cord-023095-4dannjjm	3179	3	3	3	CD
cord-023095-4dannjjm	3179	4	cases	case	NNS
cord-023095-4dannjjm	3179	5	involved	involve	VBD
cord-023095-4dannjjm	3179	6	ingestion	ingestion	NN
cord-023095-4dannjjm	3179	7	of	of	IN
cord-023095-4dannjjm	3179	8	a	a	DT
cord-023095-4dannjjm	3179	9	metallic	metallic	JJ
cord-023095-4dannjjm	3179	10	object	object	NN
cord-023095-4dannjjm	3179	11	(	(	-LRB-
cord-023095-4dannjjm	3179	12	1	1	CD
cord-023095-4dannjjm	3179	13	)	)	-RRB-
cord-023095-4dannjjm	3179	14	,	,	,
cord-023095-4dannjjm	3179	15	decorative	decorative	JJ
cord-023095-4dannjjm	3179	16	garland	garland	NN
cord-023095-4dannjjm	3179	17	(	(	-LRB-
cord-023095-4dannjjm	3179	18	1	1	CD
cord-023095-4dannjjm	3179	19	)	)	-RRB-
cord-023095-4dannjjm	3179	20	,	,	,
cord-023095-4dannjjm	3179	21	and	and	CC
cord-023095-4dannjjm	3179	22	BB	BB	NNP
cord-023095-4dannjjm	3179	23	pellets	pellet	NNS
cord-023095-4dannjjm	3180	1	(	(	-LRB-
cord-023095-4dannjjm	3180	2	1).Of	1).of	CD
cord-023095-4dannjjm	3180	3	the	the	DT
cord-023095-4dannjjm	3180	4	14	14	CD
cord-023095-4dannjjm	3180	5	dogs	dog	NNS
cord-023095-4dannjjm	3180	6	exposed	expose	VBN
cord-023095-4dannjjm	3180	7	to	to	IN
cord-023095-4dannjjm	3180	8	zinc	zinc	NN
cord-023095-4dannjjm	3180	9	,	,	,
cord-023095-4dannjjm	3180	10	13	13	CD
cord-023095-4dannjjm	3180	11	(	(	-LRB-
cord-023095-4dannjjm	3180	12	93	93	CD
cord-023095-4dannjjm	3180	13	%	%	NN
cord-023095-4dannjjm	3180	14	)	)	-RRB-
cord-023095-4dannjjm	3180	15	were	be	VBD
cord-023095-4dannjjm	3180	16	less	less	JJR
cord-023095-4dannjjm	3180	17	than	than	IN
cord-023095-4dannjjm	3180	18	27	27	CD
cord-023095-4dannjjm	3180	19	pounds	pound	NNS
cord-023095-4dannjjm	3180	20	(	(	-LRB-
cord-023095-4dannjjm	3180	21	12.3	12.3	CD
cord-023095-4dannjjm	3180	22	kgs	kgs	NNP
cord-023095-4dannjjm	3180	23	)	)	-RRB-
cord-023095-4dannjjm	3180	24	.	.	.
cord-023095-4dannjjm	3181	1	Of	of	IN
cord-023095-4dannjjm	3181	2	those	those	DT
cord-023095-4dannjjm	3181	3	13	13	CD
cord-023095-4dannjjm	3181	4	cases	case	NNS
cord-023095-4dannjjm	3181	5	11	11	CD
cord-023095-4dannjjm	3181	6	(	(	-LRB-
cord-023095-4dannjjm	3181	7	85	85	CD
cord-023095-4dannjjm	3181	8	%	%	NN
cord-023095-4dannjjm	3181	9	)	)	-RRB-
cord-023095-4dannjjm	3181	10	had	have	VBD
cord-023095-4dannjjm	3181	11	ingested	ingest	VBN
cord-023095-4dannjjm	3181	12	one	one	CD
cord-023095-4dannjjm	3181	13	or	or	CC
cord-023095-4dannjjm	3181	14	more	more	JJR
cord-023095-4dannjjm	3181	15	pennies	penny	NNS
cord-023095-4dannjjm	3181	16	.	.	.
cord-023095-4dannjjm	3182	1	Eleven	eleven	CD
cord-023095-4dannjjm	3182	2	out	out	IN
cord-023095-4dannjjm	3182	3	of	of	IN
cord-023095-4dannjjm	3182	4	the	the	DT
cord-023095-4dannjjm	3182	5	14	14	CD
cord-023095-4dannjjm	3182	6	(	(	-LRB-
cord-023095-4dannjjm	3182	7	79	79	CD
cord-023095-4dannjjm	3182	8	%	%	NN
cord-023095-4dannjjm	3182	9	)	)	-RRB-
cord-023095-4dannjjm	3183	1	zinc	zinc	NN
cord-023095-4dannjjm	3183	2	exposure	exposure	NN
cord-023095-4dannjjm	3183	3	dogs	dog	NNS
cord-023095-4dannjjm	3183	4	were	be	VBD
cord-023095-4dannjjm	3183	5	anemic	anemic	JJ
cord-023095-4dannjjm	3183	6	at	at	IN
cord-023095-4dannjjm	3183	7	presentation	presentation	NN
cord-023095-4dannjjm	3183	8	.	.	.
cord-023095-4dannjjm	3184	1	The	the	DT
cord-023095-4dannjjm	3184	2	average	average	JJ
cord-023095-4dannjjm	3184	3	weight	weight	NN
cord-023095-4dannjjm	3184	4	of	of	IN
cord-023095-4dannjjm	3184	5	the	the	DT
cord-023095-4dannjjm	3184	6	11	11	CD
cord-023095-4dannjjm	3184	7	dogs	dog	NNS
cord-023095-4dannjjm	3184	8	was	be	VBD
cord-023095-4dannjjm	3184	9	17.5	17.5	CD
cord-023095-4dannjjm	3184	10	pounds	pound	NNS
cord-023095-4dannjjm	3184	11	(	(	-LRB-
cord-023095-4dannjjm	3184	12	8	8	CD
cord-023095-4dannjjm	3184	13	kg	kg	NN
cord-023095-4dannjjm	3184	14	)	)	-RRB-
cord-023095-4dannjjm	3184	15	.	.	.
cord-023095-4dannjjm	3185	1	This	this	DT
cord-023095-4dannjjm	3185	2	study	study	NN
cord-023095-4dannjjm	3185	3	showed	show	VBD
cord-023095-4dannjjm	3185	4	that	that	IN
cord-023095-4dannjjm	3185	5	dogs	dog	NNS
cord-023095-4dannjjm	3185	6	less	less	JJR
cord-023095-4dannjjm	3185	7	than	than	IN
cord-023095-4dannjjm	3185	8	27	27	CD
cord-023095-4dannjjm	3185	9	pounds	pound	NNS
cord-023095-4dannjjm	3185	10	appear	appear	VBP
cord-023095-4dannjjm	3185	11	to	to	TO
cord-023095-4dannjjm	3185	12	be	be	VB
cord-023095-4dannjjm	3185	13	more	more	RBR
cord-023095-4dannjjm	3185	14	susceptible	susceptible	JJ
cord-023095-4dannjjm	3185	15	to	to	IN
cord-023095-4dannjjm	3185	16	developing	develop	VBG
cord-023095-4dannjjm	3185	17	anemia	anemia	NN
cord-023095-4dannjjm	3185	18	secondary	secondary	JJ
cord-023095-4dannjjm	3185	19	to	to	IN
cord-023095-4dannjjm	3185	20	zinc	zinc	NN
cord-023095-4dannjjm	3185	21	toxicosis	toxicosis	NN
cord-023095-4dannjjm	3185	22	,	,	,
cord-023095-4dannjjm	3185	23	with	with	IN
cord-023095-4dannjjm	3185	24	the	the	DT
cord-023095-4dannjjm	3185	25	majority	majority	NN
cord-023095-4dannjjm	3185	26	of	of	IN
cord-023095-4dannjjm	3185	27	cases	case	NNS
cord-023095-4dannjjm	3185	28	due	due	JJ
cord-023095-4dannjjm	3185	29	to	to	IN
cord-023095-4dannjjm	3185	30	ingestion	ingestion	NN
cord-023095-4dannjjm	3185	31	of	of	IN
cord-023095-4dannjjm	3185	32	pennies	penny	NNS
cord-023095-4dannjjm	3185	33	minted	mint	VBN
cord-023095-4dannjjm	3185	34	after	after	IN
cord-023095-4dannjjm	3185	35	1982	1982	CD
cord-023095-4dannjjm	3185	36	.	.	.
cord-023095-4dannjjm	3186	1	Zinc	zinc	NN
cord-023095-4dannjjm	3186	2	toxicity	toxicity	NN
cord-023095-4dannjjm	3186	3	anemia	anemia	NN
cord-023095-4dannjjm	3186	4	secondary	secondary	JJ
cord-023095-4dannjjm	3186	5	to	to	TO
cord-023095-4dannjjm	3186	6	penny	penny	NN
cord-023095-4dannjjm	3186	7	ingestion	ingestion	NN
cord-023095-4dannjjm	3186	8	is	be	VBZ
cord-023095-4dannjjm	3186	9	more	more	RBR
cord-023095-4dannjjm	3186	10	commonly	commonly	RB
cord-023095-4dannjjm	3186	11	seen	see	VBN
cord-023095-4dannjjm	3186	12	in	in	IN
cord-023095-4dannjjm	3186	13	small	small	JJ
cord-023095-4dannjjm	3186	14	dogs	dog	NNS
cord-023095-4dannjjm	3186	15	.	.	.
cord-023095-4dannjjm	3187	1	We	-PRON-	PRP
cord-023095-4dannjjm	3187	2	suspect	suspect	VBP
cord-023095-4dannjjm	3187	3	larger	large	JJR
cord-023095-4dannjjm	3187	4	dogs	dog	NNS
cord-023095-4dannjjm	3187	5	are	be	VBP
cord-023095-4dannjjm	3187	6	able	able	JJ
cord-023095-4dannjjm	3187	7	to	to	TO
cord-023095-4dannjjm	3187	8	pass	pass	VB
cord-023095-4dannjjm	3187	9	pennies	penny	NNS
cord-023095-4dannjjm	3187	10	through	through	IN
cord-023095-4dannjjm	3187	11	the	the	DT
cord-023095-4dannjjm	3187	12	pyloric	pyloric	JJ
cord-023095-4dannjjm	3187	13	sphincter	sphincter	NN
cord-023095-4dannjjm	3187	14	and	and	CC
cord-023095-4dannjjm	3187	15	thus	thus	RB
cord-023095-4dannjjm	3187	16	not	not	RB
cord-023095-4dannjjm	3187	17	develop	develop	VB
cord-023095-4dannjjm	3187	18	clinical	clinical	JJ
cord-023095-4dannjjm	3187	19	signs	sign	NNS
cord-023095-4dannjjm	3187	20	.	.	.
cord-023095-4dannjjm	3188	1	Although	although	IN
cord-023095-4dannjjm	3188	2	thrombocytopenia	thrombocytopenia	NN
cord-023095-4dannjjm	3188	3	is	be	VBZ
cord-023095-4dannjjm	3188	4	common	common	JJ
cord-023095-4dannjjm	3188	5	in	in	IN
cord-023095-4dannjjm	3188	6	hospitalized	hospitalize	VBN
cord-023095-4dannjjm	3188	7	dogs	dog	NNS
cord-023095-4dannjjm	3188	8	,	,	,
cord-023095-4dannjjm	3188	9	canine	canine	JJ
cord-023095-4dannjjm	3188	10	cryopreserved	cryopreserved	JJ
cord-023095-4dannjjm	3188	11	platelet	platelet	NN
cord-023095-4dannjjm	3188	12	concentrate	concentrate	NN
cord-023095-4dannjjm	3188	13	(	(	-LRB-
cord-023095-4dannjjm	3188	14	PC	pc	NN
cord-023095-4dannjjm	3188	15	)	)	-RRB-
cord-023095-4dannjjm	3188	16	is	be	VBZ
cord-023095-4dannjjm	3188	17	used	use	VBN
cord-023095-4dannjjm	3188	18	infrequently	infrequently	RB
cord-023095-4dannjjm	3188	19	.	.	.
cord-023095-4dannjjm	3189	1	Data	datum	NNS
cord-023095-4dannjjm	3189	2	suggest	suggest	VBP
cord-023095-4dannjjm	3189	3	in	in	IN
cord-023095-4dannjjm	3189	4	vitro	vitro	FW
cord-023095-4dannjjm	3189	5	efficacy	efficacy	NN
cord-023095-4dannjjm	3189	6	of	of	IN
cord-023095-4dannjjm	3189	7	PC	pc	NN
cord-023095-4dannjjm	3189	8	and	and	CC
cord-023095-4dannjjm	3189	9	when	when	WRB
cord-023095-4dannjjm	3189	10	administered	administer	VBN
cord-023095-4dannjjm	3189	11	to	to	TO
cord-023095-4dannjjm	3189	12	research	research	VB
cord-023095-4dannjjm	3189	13	dogs	dog	NNS
cord-023095-4dannjjm	3189	14	,	,	,
cord-023095-4dannjjm	3189	15	but	but	CC
cord-023095-4dannjjm	3189	16	efficacy	efficacy	NN
cord-023095-4dannjjm	3189	17	is	be	VBZ
cord-023095-4dannjjm	3189	18	unknown	unknown	JJ
cord-023095-4dannjjm	3189	19	in	in	IN
cord-023095-4dannjjm	3189	20	clinical	clinical	JJ
cord-023095-4dannjjm	3189	21	patients	patient	NNS
cord-023095-4dannjjm	3189	22	.	.	.
cord-023095-4dannjjm	3190	1	Study	study	NN
cord-023095-4dannjjm	3190	2	objectives	objective	NNS
cord-023095-4dannjjm	3190	3	were	be	VBD
cord-023095-4dannjjm	3190	4	to	to	TO
cord-023095-4dannjjm	3190	5	determine	determine	VB
cord-023095-4dannjjm	3190	6	clinical	clinical	JJ
cord-023095-4dannjjm	3190	7	characteristics	characteristic	NNS
cord-023095-4dannjjm	3190	8	of	of	IN
cord-023095-4dannjjm	3190	9	dogs	dog	NNS
cord-023095-4dannjjm	3190	10	receiving	receive	VBG
cord-023095-4dannjjm	3190	11	PC	pc	NN
cord-023095-4dannjjm	3190	12	as	as	RB
cord-023095-4dannjjm	3190	13	well	well	RB
cord-023095-4dannjjm	3190	14	as	as	IN
cord-023095-4dannjjm	3190	15	safety	safety	NN
cord-023095-4dannjjm	3190	16	and	and	CC
cord-023095-4dannjjm	3190	17	efficacy	efficacy	NN
cord-023095-4dannjjm	3190	18	of	of	IN
cord-023095-4dannjjm	3190	19	PC	pc	NN
cord-023095-4dannjjm	3190	20	in	in	IN
cord-023095-4dannjjm	3190	21	thrombocytopenic	thrombocytopenic	JJ
cord-023095-4dannjjm	3190	22	dogs	dog	NNS
cord-023095-4dannjjm	3190	23	.	.	.
cord-023095-4dannjjm	3191	1	Medical	medical	JJ
cord-023095-4dannjjm	3191	2	records	record	NNS
cord-023095-4dannjjm	3191	3	were	be	VBD
cord-023095-4dannjjm	3191	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	3191	5	retrospectively	retrospectively	RB
cord-023095-4dannjjm	3191	6	to	to	TO
cord-023095-4dannjjm	3191	7	identify	identify	VB
cord-023095-4dannjjm	3191	8	dogs	dog	NNS
cord-023095-4dannjjm	3191	9	that	that	DT
cord-023095-4dannjjm	3191	10	received	receive	VBD
cord-023095-4dannjjm	3191	11	PC	pc	NN
cord-023095-4dannjjm	3191	12	.	.	.
cord-023095-4dannjjm	3192	1	Information	information	NN
cord-023095-4dannjjm	3192	2	evaluated	evaluate	VBD
cord-023095-4dannjjm	3192	3	included	include	VBN
cord-023095-4dannjjm	3192	4	patient	patient	JJ
cord-023095-4dannjjm	3192	5	characteristics	characteristic	NNS
cord-023095-4dannjjm	3192	6	,	,	,
cord-023095-4dannjjm	3192	7	platelet	platelet	NN
cord-023095-4dannjjm	3192	8	count	count	NN
cord-023095-4dannjjm	3192	9	,	,	,
cord-023095-4dannjjm	3192	10	acute	acute	JJ
cord-023095-4dannjjm	3192	11	transfusion	transfusion	NN
cord-023095-4dannjjm	3192	12	reactions	reaction	NNS
cord-023095-4dannjjm	3192	13	,	,	,
cord-023095-4dannjjm	3192	14	and	and	CC
cord-023095-4dannjjm	3192	15	survival	survival	NN
cord-023095-4dannjjm	3192	16	.	.	.
cord-023095-4dannjjm	3193	1	Twenty	twenty	CD
cord-023095-4dannjjm	3193	2	six	six	CD
cord-023095-4dannjjm	3193	3	dogs	dog	NNS
cord-023095-4dannjjm	3193	4	met	meet	VBD
cord-023095-4dannjjm	3193	5	study	study	NN
cord-023095-4dannjjm	3193	6	criteria	criterion	NNS
cord-023095-4dannjjm	3193	7	.	.	.
cord-023095-4dannjjm	3194	1	Dogs	dog	NNS
cord-023095-4dannjjm	3194	2	receiving	receive	VBG
cord-023095-4dannjjm	3194	3	PC	pc	NN
cord-023095-4dannjjm	3194	4	ranged	range	VBD
cord-023095-4dannjjm	3194	5	in	in	IN
cord-023095-4dannjjm	3194	6	age	age	NN
cord-023095-4dannjjm	3194	7	from	from	IN
cord-023095-4dannjjm	3194	8	1	1	CD
cord-023095-4dannjjm	3194	9	-	-	SYM
cord-023095-4dannjjm	3194	10	13	13	CD
cord-023095-4dannjjm	3194	11	years	year	NNS
cord-023095-4dannjjm	3194	12	(	(	-LRB-
cord-023095-4dannjjm	3194	13	mean	mean	VB
cord-023095-4dannjjm	3194	14	7.8	7.8	CD
cord-023095-4dannjjm	3194	15	years	year	NNS
cord-023095-4dannjjm	3194	16	)	)	-RRB-
cord-023095-4dannjjm	3194	17	and	and	CC
cord-023095-4dannjjm	3194	18	17/26	17/26	CD
cord-023095-4dannjjm	3194	19	(	(	-LRB-
cord-023095-4dannjjm	3194	20	65.4	65.4	CD
cord-023095-4dannjjm	3194	21	%	%	NN
cord-023095-4dannjjm	3194	22	)	)	-RRB-
cord-023095-4dannjjm	3194	23	were	be	VBD
cord-023095-4dannjjm	3194	24	spayed	spay	VBN
cord-023095-4dannjjm	3194	25	or	or	CC
cord-023095-4dannjjm	3194	26	intact	intact	JJ
cord-023095-4dannjjm	3194	27	females	female	NNS
cord-023095-4dannjjm	3194	28	.	.	.
cord-023095-4dannjjm	3195	1	Hemorrhage	hemorrhage	NN
cord-023095-4dannjjm	3195	2	was	be	VBD
cord-023095-4dannjjm	3195	3	reported	report	VBN
cord-023095-4dannjjm	3195	4	in	in	IN
cord-023095-4dannjjm	3195	5	20/26	20/26	CD
cord-023095-4dannjjm	3195	6	dogs	dog	NNS
cord-023095-4dannjjm	3195	7	(	(	-LRB-
cord-023095-4dannjjm	3195	8	76.9	76.9	CD
cord-023095-4dannjjm	3195	9	%	%	NN
cord-023095-4dannjjm	3195	10	)	)	-RRB-
cord-023095-4dannjjm	3195	11	prior	prior	RB
cord-023095-4dannjjm	3195	12	to	to	IN
cord-023095-4dannjjm	3195	13	PC	pc	NN
cord-023095-4dannjjm	3195	14	transfusion	transfusion	NN
cord-023095-4dannjjm	3195	15	.	.	.
cord-023095-4dannjjm	3196	1	Platelet	platelet	NN
cord-023095-4dannjjm	3196	2	counts	count	VBZ
cord-023095-4dannjjm	3196	3	prior	prior	RB
cord-023095-4dannjjm	3196	4	to	to	IN
cord-023095-4dannjjm	3196	5	transfusion	transfusion	NN
cord-023095-4dannjjm	3196	6	ranged	range	VBD
cord-023095-4dannjjm	3196	7	from	from	IN
cord-023095-4dannjjm	3196	8	0	0	CD
cord-023095-4dannjjm	3196	9	to	to	IN
cord-023095-4dannjjm	3196	10	77	77	CD
cord-023095-4dannjjm	3196	11	Â	â	CD
cord-023095-4dannjjm	3196	12	10	10	CD
cord-023095-4dannjjm	3196	13	3	3	CD
cord-023095-4dannjjm	3196	14	/ul	/ul	.
cord-023095-4dannjjm	3197	1	(	(	-LRB-
cord-023095-4dannjjm	3197	2	mean	mean	VB
cord-023095-4dannjjm	3197	3	29.9	29.9	CD
cord-023095-4dannjjm	3197	4	1	1	CD
cord-023095-4dannjjm	3198	1	/À43.9	/À43.9	.
cord-023095-4dannjjm	3199	1	Â	â	CD
cord-023095-4dannjjm	3199	2	10	10	CD
cord-023095-4dannjjm	3199	3	3	3	CD
cord-023095-4dannjjm	3199	4	/ul	/ul	.
cord-023095-4dannjjm	3199	5	)	)	-RRB-
cord-023095-4dannjjm	3199	6	.	.	.
cord-023095-4dannjjm	3200	1	Change	change	VB
cord-023095-4dannjjm	3200	2	in	in	IN
cord-023095-4dannjjm	3200	3	platelet	platelet	NN
cord-023095-4dannjjm	3200	4	count	count	NN
cord-023095-4dannjjm	3200	5	was	be	VBD
cord-023095-4dannjjm	3200	6	measured	measure	VBN
cord-023095-4dannjjm	3200	7	in	in	IN
cord-023095-4dannjjm	3200	8	23	23	CD
cord-023095-4dannjjm	3200	9	dogs	dog	NNS
cord-023095-4dannjjm	3200	10	and	and	CC
cord-023095-4dannjjm	3200	11	the	the	DT
cord-023095-4dannjjm	3200	12	mean	mean	JJ
cord-023095-4dannjjm	3200	13	change	change	NN
cord-023095-4dannjjm	3200	14	was17.1	was17.1	NNP
cord-023095-4dannjjm	3200	15	1	1	CD
cord-023095-4dannjjm	3200	16	/	/	SYM
cord-023095-4dannjjm	3200	17	À	à	NN
cord-023095-4dannjjm	3200	18	45.5	45.5	CD
cord-023095-4dannjjm	3200	19	Â	â	CD
cord-023095-4dannjjm	3200	20	10	10	CD
cord-023095-4dannjjm	3200	21	3	3	CD
cord-023095-4dannjjm	3200	22	/ul	/ul	.
cord-023095-4dannjjm	3200	23	.	.	.
cord-023095-4dannjjm	3201	1	Dose	dose	NN
cord-023095-4dannjjm	3201	2	of	of	IN
cord-023095-4dannjjm	3201	3	PC	pc	NN
cord-023095-4dannjjm	3201	4	administered	administer	VBN
cord-023095-4dannjjm	3201	5	ranged	range	VBD
cord-023095-4dannjjm	3201	6	from	from	IN
cord-023095-4dannjjm	3201	7	4.8	4.8	CD
cord-023095-4dannjjm	3201	8	to	to	IN
cord-023095-4dannjjm	3201	9	40	40	CD
cord-023095-4dannjjm	3201	10	ml	ml	NNS
cord-023095-4dannjjm	3201	11	/	/	SYM
cord-023095-4dannjjm	3201	12	kg	kg	NN
cord-023095-4dannjjm	3201	13	with	with	IN
cord-023095-4dannjjm	3201	14	a	a	DT
cord-023095-4dannjjm	3201	15	mean	mean	NN
cord-023095-4dannjjm	3201	16	of	of	IN
cord-023095-4dannjjm	3201	17	14.5	14.5	CD
cord-023095-4dannjjm	3201	18	1	1	CD
cord-023095-4dannjjm	3201	19	/	/	SYM
cord-023095-4dannjjm	3201	20	À	à	NN
cord-023095-4dannjjm	3201	21	8.8	8.8	CD
cord-023095-4dannjjm	3201	22	ml	ml	NNS
cord-023095-4dannjjm	3201	23	/	/	SYM
cord-023095-4dannjjm	3201	24	kg	kg	NN
cord-023095-4dannjjm	3201	25	.	.	.
cord-023095-4dannjjm	3202	1	No	no	DT
cord-023095-4dannjjm	3202	2	acute	acute	JJ
cord-023095-4dannjjm	3202	3	adverse	adverse	JJ
cord-023095-4dannjjm	3202	4	reactions	reaction	NNS
cord-023095-4dannjjm	3202	5	were	be	VBD
cord-023095-4dannjjm	3202	6	reported	report	VBN
cord-023095-4dannjjm	3202	7	.	.	.
cord-023095-4dannjjm	3203	1	There	there	EX
cord-023095-4dannjjm	3203	2	was	be	VBD
cord-023095-4dannjjm	3203	3	no	no	DT
cord-023095-4dannjjm	3203	4	correlation	correlation	NN
cord-023095-4dannjjm	3203	5	between	between	IN
cord-023095-4dannjjm	3203	6	transfusion	transfusion	NN
cord-023095-4dannjjm	3203	7	dosage	dosage	NN
cord-023095-4dannjjm	3203	8	and	and	CC
cord-023095-4dannjjm	3203	9	platelet	platelet	NN
cord-023095-4dannjjm	3203	10	count	count	NN
cord-023095-4dannjjm	3203	11	change	change	NN
cord-023095-4dannjjm	3203	12	post	post	NN
cord-023095-4dannjjm	3203	13	transfusion	transfusion	NN
cord-023095-4dannjjm	3203	14	.	.	.
cord-023095-4dannjjm	3204	1	Survival	survival	NN
cord-023095-4dannjjm	3204	2	to	to	TO
cord-023095-4dannjjm	3204	3	discharge	discharge	NN
cord-023095-4dannjjm	3204	4	occurred	occur	VBD
cord-023095-4dannjjm	3204	5	in	in	IN
cord-023095-4dannjjm	3204	6	15/26	15/26	CD
cord-023095-4dannjjm	3204	7	(	(	-LRB-
cord-023095-4dannjjm	3204	8	57.7	57.7	CD
cord-023095-4dannjjm	3204	9	%	%	NN
cord-023095-4dannjjm	3204	10	)	)	-RRB-
cord-023095-4dannjjm	3204	11	of	of	IN
cord-023095-4dannjjm	3204	12	dogs	dog	NNS
cord-023095-4dannjjm	3204	13	.	.	.
cord-023095-4dannjjm	3205	1	The	the	DT
cord-023095-4dannjjm	3205	2	only	only	JJ
cord-023095-4dannjjm	3205	3	variable	variable	NN
cord-023095-4dannjjm	3205	4	correlated	correlate	VBN
cord-023095-4dannjjm	3205	5	with	with	IN
cord-023095-4dannjjm	3205	6	survival	survival	NN
cord-023095-4dannjjm	3205	7	was	be	VBD
cord-023095-4dannjjm	3205	8	age	age	NN
cord-023095-4dannjjm	3205	9	with	with	IN
cord-023095-4dannjjm	3205	10	survivors	survivor	NNS
cord-023095-4dannjjm	3205	11	being	be	VBG
cord-023095-4dannjjm	3205	12	younger	young	JJR
cord-023095-4dannjjm	3205	13	than	than	IN
cord-023095-4dannjjm	3205	14	non	non	NNS
cord-023095-4dannjjm	3205	15	-	-	NNS
cord-023095-4dannjjm	3205	16	survivors	survivor	NNS
cord-023095-4dannjjm	3205	17	(	(	-LRB-
cord-023095-4dannjjm	3205	18	6.4	6.4	CD
cord-023095-4dannjjm	3205	19	years	year	NNS
cord-023095-4dannjjm	3205	20	-	-	HYPH
cord-023095-4dannjjm	3205	21	old	old	JJ
cord-023095-4dannjjm	3205	22	AE	AE	NNP
cord-023095-4dannjjm	3205	23	3.9	3.9	CD
cord-023095-4dannjjm	3205	24	vs.	vs.	NN
cord-023095-4dannjjm	3205	25	10.1	10.1	CD
cord-023095-4dannjjm	3205	26	years	year	NNS
cord-023095-4dannjjm	3205	27	-	-	HYPH
cord-023095-4dannjjm	3205	28	old	old	JJ
cord-023095-4dannjjm	3205	29	AE	AE	NNP
cord-023095-4dannjjm	3205	30	3.1	3.1	CD
cord-023095-4dannjjm	3205	31	.	.	.
cord-023095-4dannjjm	3205	32	;	;	:
cord-023095-4dannjjm	3205	33	p	p	NN
cord-023095-4dannjjm	3205	34	5	5	CD
cord-023095-4dannjjm	3205	35	0.02	0.02	CD
cord-023095-4dannjjm	3205	36	)	)	-RRB-
cord-023095-4dannjjm	3205	37	.	.	.
cord-023095-4dannjjm	3206	1	Efficacy	efficacy	NN
cord-023095-4dannjjm	3206	2	of	of	IN
cord-023095-4dannjjm	3206	3	cryopreserved	cryopreserved	JJ
cord-023095-4dannjjm	3206	4	PC	pc	NN
cord-023095-4dannjjm	3206	5	transfusions	transfusion	NNS
cord-023095-4dannjjm	3206	6	for	for	IN
cord-023095-4dannjjm	3206	7	improving	improve	VBG
cord-023095-4dannjjm	3206	8	clinical	clinical	JJ
cord-023095-4dannjjm	3206	9	outcome	outcome	NN
cord-023095-4dannjjm	3206	10	in	in	IN
cord-023095-4dannjjm	3206	11	dogs	dog	NNS
cord-023095-4dannjjm	3206	12	with	with	IN
cord-023095-4dannjjm	3206	13	thrombocytopenia	thrombocytopenia	NN
cord-023095-4dannjjm	3206	14	is	be	VBZ
cord-023095-4dannjjm	3206	15	yet	yet	RB
cord-023095-4dannjjm	3206	16	to	to	TO
cord-023095-4dannjjm	3206	17	be	be	VB
cord-023095-4dannjjm	3206	18	determined	determine	VBN
cord-023095-4dannjjm	3206	19	;	;	:
cord-023095-4dannjjm	3206	20	however	however	RB
cord-023095-4dannjjm	3206	21	,	,	,
cord-023095-4dannjjm	3206	22	PC	PC	NNP
cord-023095-4dannjjm	3206	23	is	be	VBZ
cord-023095-4dannjjm	3206	24	well	well	RB
cord-023095-4dannjjm	3206	25	tolerated	tolerate	VBN
cord-023095-4dannjjm	3206	26	in	in	IN
cord-023095-4dannjjm	3206	27	clinical	clinical	JJ
cord-023095-4dannjjm	3206	28	patients	patient	NNS
cord-023095-4dannjjm	3206	29	.	.	.
cord-023095-4dannjjm	3207	1	Fresh	fresh	JJ
cord-023095-4dannjjm	3207	2	frozen	frozen	JJ
cord-023095-4dannjjm	3207	3	plasma	plasma	NN
cord-023095-4dannjjm	3207	4	(	(	-LRB-
cord-023095-4dannjjm	3207	5	FFP	FFP	NNP
cord-023095-4dannjjm	3207	6	)	)	-RRB-
cord-023095-4dannjjm	3207	7	is	be	VBZ
cord-023095-4dannjjm	3207	8	used	use	VBN
cord-023095-4dannjjm	3207	9	to	to	TO
cord-023095-4dannjjm	3207	10	treat	treat	VB
cord-023095-4dannjjm	3207	11	coagulopathies	coagulopathie	NNS
cord-023095-4dannjjm	3207	12	in	in	IN
cord-023095-4dannjjm	3207	13	dogs	dog	NNS
cord-023095-4dannjjm	3207	14	.	.	.
cord-023095-4dannjjm	3208	1	Current	current	JJ
cord-023095-4dannjjm	3208	2	transfusion	transfusion	NN
cord-023095-4dannjjm	3208	3	guidelines	guideline	NNS
cord-023095-4dannjjm	3208	4	recommend	recommend	VBP
cord-023095-4dannjjm	3208	5	that	that	IN
cord-023095-4dannjjm	3208	6	FFP	FFP	NNP
cord-023095-4dannjjm	3208	7	be	be	VB
cord-023095-4dannjjm	3208	8	administered	administer	VBN
cord-023095-4dannjjm	3208	9	within	within	IN
cord-023095-4dannjjm	3208	10	4	4	CD
cord-023095-4dannjjm	3208	11	hours	hour	NNS
cord-023095-4dannjjm	3208	12	of	of	IN
cord-023095-4dannjjm	3208	13	thawing	thawing	NN
cord-023095-4dannjjm	3208	14	to	to	TO
cord-023095-4dannjjm	3208	15	avoid	avoid	VB
cord-023095-4dannjjm	3208	16	decreasing	decrease	VBG
cord-023095-4dannjjm	3208	17	clotting	clotting	NN
cord-023095-4dannjjm	3208	18	factor	factor	NN
cord-023095-4dannjjm	3208	19	function	function	NN
cord-023095-4dannjjm	3208	20	and	and	CC
cord-023095-4dannjjm	3208	21	bacterial	bacterial	JJ
cord-023095-4dannjjm	3208	22	contamination	contamination	NN
cord-023095-4dannjjm	3208	23	.	.	.
cord-023095-4dannjjm	3209	1	The	the	DT
cord-023095-4dannjjm	3209	2	purpose	purpose	NN
cord-023095-4dannjjm	3209	3	of	of	IN
cord-023095-4dannjjm	3209	4	this	this	DT
cord-023095-4dannjjm	3209	5	study	study	NN
cord-023095-4dannjjm	3209	6	was	be	VBD
cord-023095-4dannjjm	3209	7	to	to	TO
cord-023095-4dannjjm	3209	8	assess	assess	VB
cord-023095-4dannjjm	3209	9	clotting	clotting	NN
cord-023095-4dannjjm	3209	10	factor	factor	NN
cord-023095-4dannjjm	3209	11	activity	activity	NN
cord-023095-4dannjjm	3209	12	and	and	CC
cord-023095-4dannjjm	3209	13	bacterial	bacterial	JJ
cord-023095-4dannjjm	3209	14	contamination	contamination	NN
cord-023095-4dannjjm	3209	15	of	of	IN
cord-023095-4dannjjm	3209	16	FFP	FFP	NNP
cord-023095-4dannjjm	3209	17	that	that	WDT
cord-023095-4dannjjm	3209	18	had	have	VBD
cord-023095-4dannjjm	3209	19	been	be	VBN
cord-023095-4dannjjm	3209	20	thawed	thaw	VBN
cord-023095-4dannjjm	3209	21	and	and	CC
cord-023095-4dannjjm	3209	22	refrigerated	refrigerate	VBN
cord-023095-4dannjjm	3209	23	for	for	IN
cord-023095-4dannjjm	3209	24	5	5	CD
cord-023095-4dannjjm	3209	25	days	day	NNS
cord-023095-4dannjjm	3209	26	.	.	.
cord-023095-4dannjjm	3210	1	Blood	blood	NN
cord-023095-4dannjjm	3210	2	was	be	VBD
cord-023095-4dannjjm	3210	3	collected	collect	VBN
cord-023095-4dannjjm	3210	4	from	from	IN
cord-023095-4dannjjm	3210	5	10	10	CD
cord-023095-4dannjjm	3210	6	client	client	NN
cord-023095-4dannjjm	3210	7	-	-	HYPH
cord-023095-4dannjjm	3210	8	owned	own	VBN
cord-023095-4dannjjm	3210	9	healthy	healthy	JJ
cord-023095-4dannjjm	3210	10	dogs	dog	NNS
cord-023095-4dannjjm	3210	11	with	with	IN
cord-023095-4dannjjm	3210	12	no	no	DT
cord-023095-4dannjjm	3210	13	known	know	VBN
cord-023095-4dannjjm	3210	14	history	history	NN
cord-023095-4dannjjm	3210	15	of	of	IN
cord-023095-4dannjjm	3210	16	coagulopathy	coagulopathy	NN
cord-023095-4dannjjm	3210	17	or	or	CC
cord-023095-4dannjjm	3210	18	of	of	IN
cord-023095-4dannjjm	3210	19	administration	administration	NN
cord-023095-4dannjjm	3210	20	of	of	IN
cord-023095-4dannjjm	3210	21	drugs	drug	NNS
cord-023095-4dannjjm	3210	22	affecting	affect	VBG
cord-023095-4dannjjm	3210	23	coagulation	coagulation	NN
cord-023095-4dannjjm	3210	24	.	.	.
cord-023095-4dannjjm	3211	1	Plasma	plasma	NN
cord-023095-4dannjjm	3211	2	was	be	VBD
cord-023095-4dannjjm	3211	3	separated	separate	VBN
cord-023095-4dannjjm	3211	4	from	from	IN
cord-023095-4dannjjm	3211	5	whole	whole	JJ
cord-023095-4dannjjm	3211	6	blood	blood	NN
cord-023095-4dannjjm	3211	7	and	and	CC
cord-023095-4dannjjm	3211	8	frozen	frozen	JJ
cord-023095-4dannjjm	3211	9	(	(	-LRB-
cord-023095-4dannjjm	3211	10	À201C	À201C	NNP
cord-023095-4dannjjm	3211	11	)	)	-RRB-
cord-023095-4dannjjm	3211	12	within	within	IN
cord-023095-4dannjjm	3211	13	30	30	CD
cord-023095-4dannjjm	3211	14	minutes	minute	NNS
cord-023095-4dannjjm	3211	15	of	of	IN
cord-023095-4dannjjm	3211	16	collection	collection	NN
cord-023095-4dannjjm	3211	17	.	.	.
cord-023095-4dannjjm	3212	1	Thawed	thawed	JJ
cord-023095-4dannjjm	3212	2	plasma	plasma	NN
cord-023095-4dannjjm	3212	3	was	be	VBD
cord-023095-4dannjjm	3212	4	maintained	maintain	VBN
cord-023095-4dannjjm	3212	5	at	at	IN
cord-023095-4dannjjm	3212	6	41C	41c	CD
cord-023095-4dannjjm	3212	7	(	(	-LRB-
cord-023095-4dannjjm	3212	8	1	1	CD
cord-023095-4dannjjm	3212	9	/	/	SYM
cord-023095-4dannjjm	3212	10	À21C	À21C	NNP
cord-023095-4dannjjm	3212	11	)	)	-RRB-
cord-023095-4dannjjm	3212	12	.	.	.
cord-023095-4dannjjm	3213	1	Aerobic	aerobic	JJ
cord-023095-4dannjjm	3213	2	and	and	CC
cord-023095-4dannjjm	3213	3	anaerobic	anaerobic	JJ
cord-023095-4dannjjm	3213	4	bacterial	bacterial	JJ
cord-023095-4dannjjm	3213	5	culture	culture	NN
cord-023095-4dannjjm	3213	6	,	,	,
cord-023095-4dannjjm	3213	7	prothrombin	prothrombin	JJ
cord-023095-4dannjjm	3213	8	time	time	NN
cord-023095-4dannjjm	3213	9	(	(	-LRB-
cord-023095-4dannjjm	3213	10	PT	PT	NNP
cord-023095-4dannjjm	3213	11	)	)	-RRB-
cord-023095-4dannjjm	3213	12	,	,	,
cord-023095-4dannjjm	3213	13	activated	activate	VBD
cord-023095-4dannjjm	3213	14	partial	partial	JJ
cord-023095-4dannjjm	3213	15	thromboplastin	thromboplastin	NNP
cord-023095-4dannjjm	3213	16	time	time	NN
cord-023095-4dannjjm	3213	17	(	(	-LRB-
cord-023095-4dannjjm	3213	18	PTT	PTT	NNP
cord-023095-4dannjjm	3213	19	)	)	-RRB-
cord-023095-4dannjjm	3213	20	,	,	,
cord-023095-4dannjjm	3213	21	and	and	CC
cord-023095-4dannjjm	3213	22	factor	factor	NN
cord-023095-4dannjjm	3213	23	II	II	NNP
cord-023095-4dannjjm	3213	24	,	,	,
cord-023095-4dannjjm	3213	25	VII	VII	NNP
cord-023095-4dannjjm	3213	26	,	,	,
cord-023095-4dannjjm	3213	27	IX	IX	NNP
cord-023095-4dannjjm	3213	28	,	,	,
cord-023095-4dannjjm	3213	29	and	and	CC
cord-023095-4dannjjm	3213	30	X	x	NN
cord-023095-4dannjjm	3213	31	analyses	analysis	NNS
cord-023095-4dannjjm	3213	32	were	be	VBD
cord-023095-4dannjjm	3213	33	tested	test	VBN
cord-023095-4dannjjm	3213	34	at	at	IN
cord-023095-4dannjjm	3213	35	time	time	NN
cord-023095-4dannjjm	3213	36	of	of	IN
cord-023095-4dannjjm	3213	37	whole	whole	JJ
cord-023095-4dannjjm	3213	38	blood	blood	NN
cord-023095-4dannjjm	3213	39	collection	collection	NN
cord-023095-4dannjjm	3213	40	,	,	,
cord-023095-4dannjjm	3213	41	FFP	FFP	NNP
cord-023095-4dannjjm	3213	42	thaw	thaw	NN
cord-023095-4dannjjm	3213	43	,	,	,
cord-023095-4dannjjm	3213	44	24	24	CD
cord-023095-4dannjjm	3213	45	hours	hour	NNS
cord-023095-4dannjjm	3213	46	post	post	NN
cord-023095-4dannjjm	3213	47	-	-	NN
cord-023095-4dannjjm	3213	48	thaw	thaw	JJ
cord-023095-4dannjjm	3213	49	,	,	,
cord-023095-4dannjjm	3213	50	72	72	CD
cord-023095-4dannjjm	3213	51	hours	hour	NNS
cord-023095-4dannjjm	3213	52	post	post	NN
cord-023095-4dannjjm	3213	53	-	-	NN
cord-023095-4dannjjm	3213	54	thaw	thaw	VB
cord-023095-4dannjjm	3213	55	,	,	,
cord-023095-4dannjjm	3213	56	and	and	CC
cord-023095-4dannjjm	3213	57	120	120	CD
cord-023095-4dannjjm	3213	58	hours	hour	NNS
cord-023095-4dannjjm	3213	59	post	post	NN
cord-023095-4dannjjm	3213	60	-	-	NN
cord-023095-4dannjjm	3213	61	thaw	thaw	NN
cord-023095-4dannjjm	3213	62	.	.	.
cord-023095-4dannjjm	3214	1	There	there	EX
cord-023095-4dannjjm	3214	2	were	be	VBD
cord-023095-4dannjjm	3214	3	no	no	DT
cord-023095-4dannjjm	3214	4	statistically	statistically	RB
cord-023095-4dannjjm	3214	5	significant	significant	JJ
cord-023095-4dannjjm	3214	6	differences	difference	NNS
cord-023095-4dannjjm	3214	7	in	in	IN
cord-023095-4dannjjm	3214	8	PT	PT	NNP
cord-023095-4dannjjm	3214	9	and	and	CC
cord-023095-4dannjjm	3214	10	PTT	PTT	NNP
cord-023095-4dannjjm	3214	11	at	at	IN
cord-023095-4dannjjm	3214	12	any	any	DT
cord-023095-4dannjjm	3214	13	of	of	IN
cord-023095-4dannjjm	3214	14	the	the	DT
cord-023095-4dannjjm	3214	15	measured	measure	VBN
cord-023095-4dannjjm	3214	16	time	time	NN
cord-023095-4dannjjm	3214	17	points	point	NNS
cord-023095-4dannjjm	3214	18	.	.	.
cord-023095-4dannjjm	3215	1	Statistically	statistically	RB
cord-023095-4dannjjm	3215	2	significant	significant	JJ
cord-023095-4dannjjm	3215	3	differences	difference	NNS
cord-023095-4dannjjm	3215	4	occurred	occur	VBD
cord-023095-4dannjjm	3215	5	between	between	IN
cord-023095-4dannjjm	3215	6	initial	initial	JJ
cord-023095-4dannjjm	3215	7	measurements	measurement	NNS
cord-023095-4dannjjm	3215	8	of	of	IN
cord-023095-4dannjjm	3215	9	factors	factor	NNS
cord-023095-4dannjjm	3215	10	II	II	NNP
cord-023095-4dannjjm	3215	11	,	,	,
cord-023095-4dannjjm	3215	12	VII	VII	NNP
cord-023095-4dannjjm	3215	13	,	,	,
cord-023095-4dannjjm	3215	14	IX	IX	NNP
cord-023095-4dannjjm	3215	15	,	,	,
cord-023095-4dannjjm	3215	16	and	and	CC
cord-023095-4dannjjm	3215	17	X	x	NN
cord-023095-4dannjjm	3215	18	and	and	CC
cord-023095-4dannjjm	3215	19	subsequent	subsequent	JJ
cord-023095-4dannjjm	3215	20	time	time	NN
cord-023095-4dannjjm	3215	21	points	point	NNS
cord-023095-4dannjjm	3215	22	,	,	,
cord-023095-4dannjjm	3215	23	but	but	CC
cord-023095-4dannjjm	3215	24	there	there	EX
cord-023095-4dannjjm	3215	25	was	be	VBD
cord-023095-4dannjjm	3215	26	no	no	DT
cord-023095-4dannjjm	3215	27	difference	difference	NN
cord-023095-4dannjjm	3215	28	in	in	IN
cord-023095-4dannjjm	3215	29	activity	activity	NN
cord-023095-4dannjjm	3215	30	levels	level	NNS
cord-023095-4dannjjm	3215	31	of	of	IN
cord-023095-4dannjjm	3215	32	the	the	DT
cord-023095-4dannjjm	3215	33	factors	factor	NNS
cord-023095-4dannjjm	3215	34	once	once	IN
cord-023095-4dannjjm	3215	35	FFP	FFP	NNP
cord-023095-4dannjjm	3215	36	was	be	VBD
cord-023095-4dannjjm	3215	37	thawed	thaw	VBN
cord-023095-4dannjjm	3215	38	.	.	.
cord-023095-4dannjjm	3216	1	One	one	CD
cord-023095-4dannjjm	3216	2	bacterial	bacterial	JJ
cord-023095-4dannjjm	3216	3	colony	colony	NN
cord-023095-4dannjjm	3216	4	was	be	VBD
cord-023095-4dannjjm	3216	5	grown	grow	VBN
cord-023095-4dannjjm	3216	6	from	from	IN
cord-023095-4dannjjm	3216	7	each	each	DT
cord-023095-4dannjjm	3216	8	of	of	IN
cord-023095-4dannjjm	3216	9	two	two	CD
cord-023095-4dannjjm	3216	10	samples	sample	NNS
cord-023095-4dannjjm	3216	11	from	from	IN
cord-023095-4dannjjm	3216	12	post	post	JJ
cord-023095-4dannjjm	3216	13	-	-	JJ
cord-023095-4dannjjm	3216	14	thaw	thaw	JJ
cord-023095-4dannjjm	3216	15	plasma	plasma	NN
cord-023095-4dannjjm	3216	16	.	.	.
cord-023095-4dannjjm	3217	1	Thawed	thawed	JJ
cord-023095-4dannjjm	3217	2	plasma	plasma	NN
cord-023095-4dannjjm	3217	3	protocols	protocol	NNS
cord-023095-4dannjjm	3217	4	do	do	VBP
cord-023095-4dannjjm	3217	5	not	not	RB
cord-023095-4dannjjm	3217	6	significantly	significantly	RB
cord-023095-4dannjjm	3217	7	decrease	decrease	VB
cord-023095-4dannjjm	3217	8	the	the	DT
cord-023095-4dannjjm	3217	9	function	function	NN
cord-023095-4dannjjm	3217	10	of	of	IN
cord-023095-4dannjjm	3217	11	factors	factor	NNS
cord-023095-4dannjjm	3217	12	II	II	NNP
cord-023095-4dannjjm	3217	13	,	,	,
cord-023095-4dannjjm	3217	14	VII	VII	NNP
cord-023095-4dannjjm	3217	15	,	,	,
cord-023095-4dannjjm	3217	16	IX	IX	NNP
cord-023095-4dannjjm	3217	17	,	,	,
cord-023095-4dannjjm	3217	18	and	and	CC
cord-023095-4dannjjm	3217	19	X	x	NN
cord-023095-4dannjjm	3217	20	or	or	CC
cord-023095-4dannjjm	3217	21	prolong	prolong	VB
cord-023095-4dannjjm	3217	22	PT	PT	NNP
cord-023095-4dannjjm	3217	23	and	and	CC
cord-023095-4dannjjm	3217	24	PTT	PTT	NNP
cord-023095-4dannjjm	3217	25	.	.	.
cord-023095-4dannjjm	3218	1	Bacterial	bacterial	JJ
cord-023095-4dannjjm	3218	2	contamination	contamination	NN
cord-023095-4dannjjm	3218	3	of	of	IN
cord-023095-4dannjjm	3218	4	the	the	DT
cord-023095-4dannjjm	3218	5	plasma	plasma	NN
cord-023095-4dannjjm	3218	6	supply	supply	NN
cord-023095-4dannjjm	3218	7	seems	seem	VBZ
cord-023095-4dannjjm	3218	8	unlikely	unlikely	JJ
cord-023095-4dannjjm	3218	9	,	,	,
cord-023095-4dannjjm	3218	10	but	but	CC
cord-023095-4dannjjm	3218	11	strict	strict	JJ
cord-023095-4dannjjm	3218	12	aseptic	aseptic	JJ
cord-023095-4dannjjm	3218	13	technique	technique	NN
cord-023095-4dannjjm	3218	14	should	should	MD
cord-023095-4dannjjm	3218	15	be	be	VB
cord-023095-4dannjjm	3218	16	used	use	VBN
cord-023095-4dannjjm	3218	17	when	when	WRB
cord-023095-4dannjjm	3218	18	obtaining	obtain	VBG
cord-023095-4dannjjm	3218	19	plasma	plasma	NN
cord-023095-4dannjjm	3218	20	for	for	IN
cord-023095-4dannjjm	3218	21	patient	patient	JJ
cord-023095-4dannjjm	3218	22	use	use	NN
cord-023095-4dannjjm	3218	23	.	.	.
cord-023095-4dannjjm	3219	1	Erythrocyte	Erythrocyte	NNP
cord-023095-4dannjjm	3219	2	pyruvate	pyruvate	NN
cord-023095-4dannjjm	3219	3	kinase	kinase	NN
cord-023095-4dannjjm	3219	4	(	(	-LRB-
cord-023095-4dannjjm	3219	5	PK	PK	NNP
cord-023095-4dannjjm	3219	6	)	)	-RRB-
cord-023095-4dannjjm	3219	7	deficiency	deficiency	NN
cord-023095-4dannjjm	3219	8	is	be	VBZ
cord-023095-4dannjjm	3219	9	the	the	DT
cord-023095-4dannjjm	3219	10	first	first	JJ
cord-023095-4dannjjm	3219	11	and	and	CC
cord-023095-4dannjjm	3219	12	most	most	RBS
cord-023095-4dannjjm	3219	13	common	common	JJ
cord-023095-4dannjjm	3219	14	erythroenzymopathy	erythroenzymopathy	NNS
cord-023095-4dannjjm	3219	15	described	describe	VBN
cord-023095-4dannjjm	3219	16	in	in	IN
cord-023095-4dannjjm	3219	17	dogs	dog	NNS
cord-023095-4dannjjm	3219	18	,	,	,
cord-023095-4dannjjm	3219	19	cats	cat	NNS
cord-023095-4dannjjm	3219	20	,	,	,
cord-023095-4dannjjm	3219	21	and	and	CC
cord-023095-4dannjjm	3219	22	humans	human	NNS
cord-023095-4dannjjm	3219	23	.	.	.
cord-023095-4dannjjm	3220	1	The	the	DT
cord-023095-4dannjjm	3220	2	PK	PK	NNP
cord-023095-4dannjjm	3220	3	enzyme	enzyme	NN
cord-023095-4dannjjm	3220	4	plays	play	VBZ
cord-023095-4dannjjm	3220	5	a	a	DT
cord-023095-4dannjjm	3220	6	crucial	crucial	JJ
cord-023095-4dannjjm	3220	7	role	role	NN
cord-023095-4dannjjm	3220	8	in	in	IN
cord-023095-4dannjjm	3220	9	the	the	DT
cord-023095-4dannjjm	3220	10	erythrocyte	erythrocyte	NN
cord-023095-4dannjjm	3220	11	energy	energy	NN
cord-023095-4dannjjm	3220	12	metabolism	metabolism	NN
cord-023095-4dannjjm	3220	13	and	and	CC
cord-023095-4dannjjm	3220	14	its	-PRON-	PRP$
cord-023095-4dannjjm	3220	15	absence	absence	NN
cord-023095-4dannjjm	3220	16	causes	cause	VBZ
cord-023095-4dannjjm	3220	17	severe	severe	JJ
cord-023095-4dannjjm	3220	18	hemolytic	hemolytic	JJ
cord-023095-4dannjjm	3220	19	anemia	anemia	NN
cord-023095-4dannjjm	3220	20	,	,	,
cord-023095-4dannjjm	3220	21	often	often	RB
cord-023095-4dannjjm	3220	22	misdiagnosed	misdiagnose	VBN
cord-023095-4dannjjm	3220	23	as	as	IN
cord-023095-4dannjjm	3220	24	autoimmune	autoimmune	JJ
cord-023095-4dannjjm	3220	25	hemolytic	hemolytic	JJ
cord-023095-4dannjjm	3220	26	anemia	anemia	NN
cord-023095-4dannjjm	3220	27	.	.	.
cord-023095-4dannjjm	3221	1	The	the	DT
cord-023095-4dannjjm	3221	2	disease	disease	NN
cord-023095-4dannjjm	3221	3	is	be	VBZ
cord-023095-4dannjjm	3221	4	inherited	inherit	VBN
cord-023095-4dannjjm	3221	5	as	as	IN
cord-023095-4dannjjm	3221	6	an	an	DT
cord-023095-4dannjjm	3221	7	autosomal	autosomal	JJ
cord-023095-4dannjjm	3221	8	recessive	recessive	JJ
cord-023095-4dannjjm	3221	9	trait	trait	NN
cord-023095-4dannjjm	3221	10	and	and	CC
cord-023095-4dannjjm	3221	11	affected	affect	VBN
cord-023095-4dannjjm	3221	12	dogs	dog	NNS
cord-023095-4dannjjm	3221	13	also	also	RB
cord-023095-4dannjjm	3221	14	develop	develop	VBP
cord-023095-4dannjjm	3221	15	osteosclerosis	osteosclerosis	NN
cord-023095-4dannjjm	3221	16	.	.	.
cord-023095-4dannjjm	3222	1	In	in	IN
cord-023095-4dannjjm	3222	2	dogs	dog	NNS
cord-023095-4dannjjm	3222	3	,	,	,
cord-023095-4dannjjm	3222	4	the	the	DT
cord-023095-4dannjjm	3222	5	enzymatic	enzymatic	JJ
cord-023095-4dannjjm	3222	6	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3222	7	is	be	VBZ
cord-023095-4dannjjm	3222	8	complicated	complicate	VBN
cord-023095-4dannjjm	3222	9	by	by	IN
cord-023095-4dannjjm	3222	10	the	the	DT
cord-023095-4dannjjm	3222	11	anomalous	anomalous	JJ
cord-023095-4dannjjm	3222	12	expression	expression	NN
cord-023095-4dannjjm	3222	13	of	of	IN
cord-023095-4dannjjm	3222	14	malfunctioning	malfunction	VBG
cord-023095-4dannjjm	3222	15	M	M	NNP
cord-023095-4dannjjm	3222	16	2	2	CD
cord-023095-4dannjjm	3222	17	-PK	-pk	NN
cord-023095-4dannjjm	3222	18	expression	expression	NN
cord-023095-4dannjjm	3222	19	,	,	,
cord-023095-4dannjjm	3222	20	but	but	CC
cord-023095-4dannjjm	3222	21	breed	breed	NN
cord-023095-4dannjjm	3222	22	-	-	HYPH
cord-023095-4dannjjm	3222	23	specific	specific	JJ
cord-023095-4dannjjm	3222	24	R	r	NN
cord-023095-4dannjjm	3222	25	-	-	HYPH
cord-023095-4dannjjm	3222	26	PK	pk	NN
cord-023095-4dannjjm	3222	27	mutation	mutation	NN
cord-023095-4dannjjm	3222	28	tests	test	NNS
cord-023095-4dannjjm	3222	29	have	have	VBP
cord-023095-4dannjjm	3222	30	been	be	VBN
cord-023095-4dannjjm	3222	31	reported	report	VBN
cord-023095-4dannjjm	3222	32	for	for	IN
cord-023095-4dannjjm	3222	33	Basenjis	Basenjis	NNP
cord-023095-4dannjjm	3222	34	,	,	,
cord-023095-4dannjjm	3222	35	West	West	NNP
cord-023095-4dannjjm	3222	36	Highland	Highland	NNP
cord-023095-4dannjjm	3222	37	White	White	NNP
cord-023095-4dannjjm	3222	38	Terriers	Terriers	NNPS
cord-023095-4dannjjm	3222	39	(	(	-LRB-
cord-023095-4dannjjm	3222	40	WHWT	WHWT	NNP
cord-023095-4dannjjm	3222	41	)	)	-RRB-
cord-023095-4dannjjm	3222	42	,	,	,
cord-023095-4dannjjm	3222	43	and	and	CC
cord-023095-4dannjjm	3222	44	Beagles	beagle	NNS
cord-023095-4dannjjm	3222	45	.	.	.
cord-023095-4dannjjm	3223	1	We	-PRON-	PRP
cord-023095-4dannjjm	3223	2	report	report	VBP
cord-023095-4dannjjm	3223	3	here	here	RB
cord-023095-4dannjjm	3223	4	on	on	IN
cord-023095-4dannjjm	3223	5	a	a	DT
cord-023095-4dannjjm	3223	6	survey	survey	NN
cord-023095-4dannjjm	3223	7	of	of	IN
cord-023095-4dannjjm	3223	8	canine	canine	JJ
cord-023095-4dannjjm	3223	9	PK	PK	NNP
cord-023095-4dannjjm	3223	10	deficiency	deficiency	NN
cord-023095-4dannjjm	3223	11	studied	study	VBD
cord-023095-4dannjjm	3223	12	at	at	IN
cord-023095-4dannjjm	3223	13	the	the	DT
cord-023095-4dannjjm	3223	14	PennGen	PennGen	NNP
cord-023095-4dannjjm	3223	15	Laboratory	Laboratory	NNP
cord-023095-4dannjjm	3223	16	.	.	.
cord-023095-4dannjjm	3224	1	A	a	DT
cord-023095-4dannjjm	3224	2	biased	biased	JJ
cord-023095-4dannjjm	3224	3	group	group	NN
cord-023095-4dannjjm	3224	4	of	of	IN
cord-023095-4dannjjm	3224	5	samples	sample	NNS
cord-023095-4dannjjm	3224	6	were	be	VBD
cord-023095-4dannjjm	3224	7	received	receive	VBN
cord-023095-4dannjjm	3224	8	for	for	IN
cord-023095-4dannjjm	3224	9	screening	screening	NN
cord-023095-4dannjjm	3224	10	from	from	IN
cord-023095-4dannjjm	3224	11	dog	dog	NN
cord-023095-4dannjjm	3224	12	breeds	breed	NNS
cord-023095-4dannjjm	3224	13	with	with	IN
cord-023095-4dannjjm	3224	14	known	know	VBN
cord-023095-4dannjjm	3224	15	mutations	mutation	NNS
cord-023095-4dannjjm	3224	16	as	as	RB
cord-023095-4dannjjm	3224	17	well	well	RB
cord-023095-4dannjjm	3224	18	as	as	IN
cord-023095-4dannjjm	3224	19	from	from	IN
cord-023095-4dannjjm	3224	20	dogs	dog	NNS
cord-023095-4dannjjm	3224	21	with	with	IN
cord-023095-4dannjjm	3224	22	chronic	chronic	JJ
cord-023095-4dannjjm	3224	23	,	,	,
cord-023095-4dannjjm	3224	24	prednisone	prednisone	NN
cord-023095-4dannjjm	3224	25	-	-	HYPH
cord-023095-4dannjjm	3224	26	and	and	CC
cord-023095-4dannjjm	3224	27	antibiotic	antibiotic	JJ
cord-023095-4dannjjm	3224	28	-	-	HYPH
cord-023095-4dannjjm	3224	29	resistant	resistant	JJ
cord-023095-4dannjjm	3224	30	hemolytic	hemolytic	JJ
cord-023095-4dannjjm	3224	31	anemia	anemia	NN
cord-023095-4dannjjm	3224	32	and	and	CC
cord-023095-4dannjjm	3224	33	their	-PRON-	PRP$
cord-023095-4dannjjm	3224	34	relatives	relative	NNS
cord-023095-4dannjjm	3224	35	.	.	.
cord-023095-4dannjjm	3225	1	EDTA	EDTA	NNP
cord-023095-4dannjjm	3225	2	blood	blood	NN
cord-023095-4dannjjm	3225	3	samples	sample	NNS
cord-023095-4dannjjm	3225	4	and/or	and/or	CC
cord-023095-4dannjjm	3225	5	cheek	cheek	NN
cord-023095-4dannjjm	3225	6	swabs	swab	NNS
cord-023095-4dannjjm	3225	7	as	as	RB
cord-023095-4dannjjm	3225	8	well	well	RB
cord-023095-4dannjjm	3225	9	as	as	IN
cord-023095-4dannjjm	3225	10	medical	medical	JJ
cord-023095-4dannjjm	3225	11	record	record	NN
cord-023095-4dannjjm	3225	12	information	information	NN
cord-023095-4dannjjm	3225	13	were	be	VBD
cord-023095-4dannjjm	3225	14	received	receive	VBN
cord-023095-4dannjjm	3225	15	and	and	CC
cord-023095-4dannjjm	3225	16	genomic	genomic	JJ
cord-023095-4dannjjm	3225	17	DNA	DNA	NNP
cord-023095-4dannjjm	3225	18	and/	and/	NNP
cord-023095-4dannjjm	3225	19	or	or	CC
cord-023095-4dannjjm	3225	20	enzyme	enzyme	NN
cord-023095-4dannjjm	3225	21	activity	activity	NN
cord-023095-4dannjjm	3225	22	testing	testing	NN
cord-023095-4dannjjm	3225	23	were	be	VBD
cord-023095-4dannjjm	3225	24	performed	perform	VBN
cord-023095-4dannjjm	3225	25	.	.	.
cord-023095-4dannjjm	3226	1	Among	among	IN
cord-023095-4dannjjm	3226	2	the	the	DT
cord-023095-4dannjjm	3226	3	237	237	CD
cord-023095-4dannjjm	3226	4	WHWTs	whwts	JJ
cord-023095-4dannjjm	3226	5	7	7	CD
cord-023095-4dannjjm	3226	6	%	%	NN
cord-023095-4dannjjm	3226	7	and	and	CC
cord-023095-4dannjjm	3226	8	37	37	CD
cord-023095-4dannjjm	3226	9	%	%	NN
cord-023095-4dannjjm	3226	10	were	be	VBD
cord-023095-4dannjjm	3226	11	found	find	VBN
cord-023095-4dannjjm	3226	12	to	to	TO
cord-023095-4dannjjm	3226	13	be	be	VB
cord-023095-4dannjjm	3226	14	homozygous	homozygous	JJ
cord-023095-4dannjjm	3226	15	deficient	deficient	JJ
cord-023095-4dannjjm	3226	16	dogs	dog	NNS
cord-023095-4dannjjm	3226	17	or	or	CC
cord-023095-4dannjjm	3226	18	carriers	carrier	NNS
cord-023095-4dannjjm	3226	19	,	,	,
cord-023095-4dannjjm	3226	20	respectively	respectively	RB
cord-023095-4dannjjm	3226	21	,	,	,
cord-023095-4dannjjm	3226	22	with	with	IN
cord-023095-4dannjjm	3226	23	a	a	DT
cord-023095-4dannjjm	3226	24	mutant	mutant	JJ
cord-023095-4dannjjm	3226	25	allele	allele	NN
cord-023095-4dannjjm	3226	26	frequency	frequency	NN
cord-023095-4dannjjm	3226	27	of	of	IN
cord-023095-4dannjjm	3226	28	0.26	0.26	CD
cord-023095-4dannjjm	3226	29	.	.	.
cord-023095-4dannjjm	3227	1	The	the	DT
cord-023095-4dannjjm	3227	2	average	average	JJ
cord-023095-4dannjjm	3227	3	age	age	NN
cord-023095-4dannjjm	3227	4	at	at	IN
cord-023095-4dannjjm	3227	5	the	the	DT
cord-023095-4dannjjm	3227	6	time	time	NN
cord-023095-4dannjjm	3227	7	of	of	IN
cord-023095-4dannjjm	3227	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3227	9	was	be	VBD
cord-023095-4dannjjm	3227	10	1.5	1.5	CD
cord-023095-4dannjjm	3227	11	years	year	NNS
cord-023095-4dannjjm	3227	12	ranging	range	VBG
cord-023095-4dannjjm	3227	13	from	from	IN
cord-023095-4dannjjm	3227	14	2	2	CD
cord-023095-4dannjjm	3227	15	months	month	NNS
cord-023095-4dannjjm	3227	16	to	to	IN
cord-023095-4dannjjm	3227	17	5	5	CD
cord-023095-4dannjjm	3227	18	years	year	NNS
cord-023095-4dannjjm	3227	19	of	of	IN
cord-023095-4dannjjm	3227	20	age	age	NN
cord-023095-4dannjjm	3227	21	;	;	,
cord-023095-4dannjjm	3227	22	some	some	DT
cord-023095-4dannjjm	3227	23	samples	sample	NNS
cord-023095-4dannjjm	3227	24	came	come	VBD
cord-023095-4dannjjm	3227	25	from	from	IN
cord-023095-4dannjjm	3227	26	Europe	Europe	NNP
cord-023095-4dannjjm	3227	27	and	and	CC
cord-023095-4dannjjm	3227	28	South	South	NNP
cord-023095-4dannjjm	3227	29	America	America	NNP
cord-023095-4dannjjm	3227	30	.	.	.
cord-023095-4dannjjm	3228	1	Of	of	IN
cord-023095-4dannjjm	3228	2	the	the	DT
cord-023095-4dannjjm	3228	3	67	67	CD
cord-023095-4dannjjm	3228	4	Beagles	Beagles	NNPS
cord-023095-4dannjjm	3228	5	studied	study	VBD
cord-023095-4dannjjm	3228	6	,	,	,
cord-023095-4dannjjm	3228	7	36	36	CD
cord-023095-4dannjjm	3228	8	%	%	NN
cord-023095-4dannjjm	3228	9	were	be	VBD
cord-023095-4dannjjm	3228	10	affected	affect	VBN
cord-023095-4dannjjm	3228	11	and	and	CC
cord-023095-4dannjjm	3228	12	3	3	CD
cord-023095-4dannjjm	3228	13	%	%	NN
cord-023095-4dannjjm	3228	14	were	be	VBD
cord-023095-4dannjjm	3228	15	carriers	carrier	NNS
cord-023095-4dannjjm	3228	16	(	(	-LRB-
cord-023095-4dannjjm	3228	17	mutant	mutant	JJ
cord-023095-4dannjjm	3228	18	allele	allele	NN
cord-023095-4dannjjm	3228	19	frequency	frequency	NN
cord-023095-4dannjjm	3228	20	0.37	0.37	CD
cord-023095-4dannjjm	3228	21	)	)	-RRB-
cord-023095-4dannjjm	3228	22	.	.	.
cord-023095-4dannjjm	3229	1	The	the	DT
cord-023095-4dannjjm	3229	2	average	average	JJ
cord-023095-4dannjjm	3229	3	age	age	NN
cord-023095-4dannjjm	3229	4	at	at	IN
cord-023095-4dannjjm	3229	5	the	the	DT
cord-023095-4dannjjm	3229	6	time	time	NN
cord-023095-4dannjjm	3229	7	of	of	IN
cord-023095-4dannjjm	3229	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3229	9	was	be	VBD
cord-023095-4dannjjm	3229	10	2	2	CD
cord-023095-4dannjjm	3229	11	years	year	NNS
cord-023095-4dannjjm	3229	12	ranging	range	VBG
cord-023095-4dannjjm	3229	13	from	from	IN
cord-023095-4dannjjm	3229	14	7	7	CD
cord-023095-4dannjjm	3229	15	months	month	NNS
cord-023095-4dannjjm	3229	16	to	to	IN
cord-023095-4dannjjm	3229	17	9	9	CD
cord-023095-4dannjjm	3229	18	years	year	NNS
cord-023095-4dannjjm	3229	19	.	.	.
cord-023095-4dannjjm	3230	1	Surprisingly	surprisingly	RB
cord-023095-4dannjjm	3230	2	,	,	,
cord-023095-4dannjjm	3230	3	very	very	RB
cord-023095-4dannjjm	3230	4	few	few	JJ
cord-023095-4dannjjm	3230	5	samples	sample	NNS
cord-023095-4dannjjm	3230	6	from	from	IN
cord-023095-4dannjjm	3230	7	Basenjis	Basenjis	NNPS
cord-023095-4dannjjm	3230	8	were	be	VBD
cord-023095-4dannjjm	3230	9	received	receive	VBN
cord-023095-4dannjjm	3230	10	for	for	IN
cord-023095-4dannjjm	3230	11	screening	screening	NN
cord-023095-4dannjjm	3230	12	,	,	,
cord-023095-4dannjjm	3230	13	and	and	CC
cord-023095-4dannjjm	3230	14	none	none	NN
cord-023095-4dannjjm	3230	15	showed	show	VBD
cord-023095-4dannjjm	3230	16	the	the	DT
cord-023095-4dannjjm	3230	17	mutant	mutant	JJ
cord-023095-4dannjjm	3230	18	allele	allele	NN
cord-023095-4dannjjm	3230	19	.	.	.
cord-023095-4dannjjm	3231	1	While	while	IN
cord-023095-4dannjjm	3231	2	PK	PK	NNP
cord-023095-4dannjjm	3231	3	-	-	HYPH
cord-023095-4dannjjm	3231	4	deficient	deficient	JJ
cord-023095-4dannjjm	3231	5	Basenjis	Basenjis	NNPS
cord-023095-4dannjjm	3231	6	lived	live	VBD
cord-023095-4dannjjm	3231	7	o	o	NN
cord-023095-4dannjjm	3231	8	5	5	CD
cord-023095-4dannjjm	3231	9	years	year	NNS
cord-023095-4dannjjm	3231	10	,	,	,
cord-023095-4dannjjm	3231	11	WHWT	WHWT	NNP
cord-023095-4dannjjm	3231	12	and	and	CC
cord-023095-4dannjjm	3231	13	Beagles	Beagles	NNPS
cord-023095-4dannjjm	3231	14	often	often	RB
cord-023095-4dannjjm	3231	15	show	show	VBP
cord-023095-4dannjjm	3231	16	milder	mild	JJR
cord-023095-4dannjjm	3231	17	signs	sign	NNS
cord-023095-4dannjjm	3231	18	and	and	CC
cord-023095-4dannjjm	3231	19	can	can	MD
cord-023095-4dannjjm	3231	20	reach	reach	VB
cord-023095-4dannjjm	3231	21	9	9	CD
cord-023095-4dannjjm	3231	22	years	year	NNS
cord-023095-4dannjjm	3231	23	of	of	IN
cord-023095-4dannjjm	3231	24	age	age	NN
cord-023095-4dannjjm	3231	25	.	.	.
cord-023095-4dannjjm	3232	1	Several	several	JJ
cord-023095-4dannjjm	3232	2	dogs	dog	NNS
cord-023095-4dannjjm	3232	3	from	from	IN
cord-023095-4dannjjm	3232	4	other	other	JJ
cord-023095-4dannjjm	3232	5	breeds	breed	NNS
cord-023095-4dannjjm	3232	6	were	be	VBD
cord-023095-4dannjjm	3232	7	also	also	RB
cord-023095-4dannjjm	3232	8	examined	examine	VBN
cord-023095-4dannjjm	3232	9	because	because	IN
cord-023095-4dannjjm	3232	10	of	of	IN
cord-023095-4dannjjm	3232	11	chronic	chronic	JJ
cord-023095-4dannjjm	3232	12	regenerative	regenerative	JJ
cord-023095-4dannjjm	3232	13	anemia	anemia	NN
cord-023095-4dannjjm	3232	14	and	and	CC
cord-023095-4dannjjm	3232	15	none	none	NN
cord-023095-4dannjjm	3232	16	had	have	VBD
cord-023095-4dannjjm	3232	17	any	any	DT
cord-023095-4dannjjm	3232	18	of	of	IN
cord-023095-4dannjjm	3232	19	the	the	DT
cord-023095-4dannjjm	3232	20	known	know	VBN
cord-023095-4dannjjm	3232	21	mutations	mutation	NNS
cord-023095-4dannjjm	3232	22	seen	see	VBN
cord-023095-4dannjjm	3232	23	in	in	IN
cord-023095-4dannjjm	3232	24	the	the	DT
cord-023095-4dannjjm	3232	25	other	other	JJ
cord-023095-4dannjjm	3232	26	breeds	breed	NNS
cord-023095-4dannjjm	3232	27	.	.	.
cord-023095-4dannjjm	3233	1	However	however	RB
cord-023095-4dannjjm	3233	2	,	,	,
cord-023095-4dannjjm	3233	3	based	base	VBN
cord-023095-4dannjjm	3233	4	upon	upon	IN
cord-023095-4dannjjm	3233	5	PK	PK	NNP
cord-023095-4dannjjm	3233	6	enzyme	enzyme	NN
cord-023095-4dannjjm	3233	7	activity	activity	NN
cord-023095-4dannjjm	3233	8	studies	study	NNS
cord-023095-4dannjjm	3233	9	,	,	,
cord-023095-4dannjjm	3233	10	Chihuahua	Chihuahua	NNP
cord-023095-4dannjjm	3233	11	,	,	,
cord-023095-4dannjjm	3233	12	Dachshund	Dachshund	NNP
cord-023095-4dannjjm	3233	13	,	,	,
cord-023095-4dannjjm	3233	14	Miniature	Miniature	NNP
cord-023095-4dannjjm	3233	15	Poodle	Poodle	NNP
cord-023095-4dannjjm	3233	16	,	,	,
cord-023095-4dannjjm	3233	17	Spitz	Spitz	NNP
cord-023095-4dannjjm	3233	18	,	,	,
cord-023095-4dannjjm	3233	19	Eskimo	Eskimo	NNP
cord-023095-4dannjjm	3233	20	Toy	Toy	NNP
cord-023095-4dannjjm	3233	21	,	,	,
cord-023095-4dannjjm	3233	22	and	and	CC
cord-023095-4dannjjm	3233	23	Labrador	Labrador	NNP
cord-023095-4dannjjm	3233	24	Retriever	Retriever	NNP
cord-023095-4dannjjm	3233	25	dogs	dog	NNS
cord-023095-4dannjjm	3233	26	were	be	VBD
cord-023095-4dannjjm	3233	27	found	find	VBN
cord-023095-4dannjjm	3233	28	to	to	TO
cord-023095-4dannjjm	3233	29	be	be	VB
cord-023095-4dannjjm	3233	30	affected	affect	VBN
cord-023095-4dannjjm	3233	31	;	;	:
cord-023095-4dannjjm	3233	32	they	-PRON-	PRP
cord-023095-4dannjjm	3233	33	also	also	RB
cord-023095-4dannjjm	3233	34	had	have	VBD
cord-023095-4dannjjm	3233	35	osteosclerosis	osteosclerosis	NN
cord-023095-4dannjjm	3233	36	and	and	CC
cord-023095-4dannjjm	3234	1	at	at	RB
cord-023095-4dannjjm	3234	2	least	least	RBS
cord-023095-4dannjjm	3234	3	one	one	CD
cord-023095-4dannjjm	3234	4	Labrador	Labrador	NNP
cord-023095-4dannjjm	3234	5	Retriever	Retriever	NNP
cord-023095-4dannjjm	3234	6	developed	develop	VBD
cord-023095-4dannjjm	3234	7	severe	severe	JJ
cord-023095-4dannjjm	3234	8	hemochromatosis	hemochromatosis	NN
cord-023095-4dannjjm	3234	9	(	(	-LRB-
cord-023095-4dannjjm	3234	10	hepatic	hepatic	JJ
cord-023095-4dannjjm	3234	11	iron	iron	NN
cord-023095-4dannjjm	3234	12	37,300	37,300	CD
cord-023095-4dannjjm	3234	13	ppm	ppm	NN
cord-023095-4dannjjm	3234	14	;	;	:
cord-023095-4dannjjm	3234	15	normal	normal	JJ
cord-023095-4dannjjm	3234	16	o	o	NN
cord-023095-4dannjjm	3234	17	1,200	1,200	CD
cord-023095-4dannjjm	3234	18	ppm	ppm	NN
cord-023095-4dannjjm	3234	19	,	,	,
cord-023095-4dannjjm	3234	20	analyzed	analyze	VBN
cord-023095-4dannjjm	3234	21	on	on	IN
cord-023095-4dannjjm	3234	22	a	a	DT
cord-023095-4dannjjm	3234	23	dry	dry	JJ
cord-023095-4dannjjm	3234	24	weight	weight	NN
cord-023095-4dannjjm	3234	25	basis	basis	NN
cord-023095-4dannjjm	3234	26	)	)	-RRB-
cord-023095-4dannjjm	3234	27	.	.	.
cord-023095-4dannjjm	3235	1	Moreover	moreover	RB
cord-023095-4dannjjm	3235	2	,	,	,
cord-023095-4dannjjm	3235	3	sequencing	sequencing	NN
cord-023095-4dannjjm	3235	4	of	of	IN
cord-023095-4dannjjm	3235	5	the	the	DT
cord-023095-4dannjjm	3235	6	R	R	NNP
cord-023095-4dannjjm	3235	7	-	-	HYPH
cord-023095-4dannjjm	3235	8	PK	PK	NNP
cord-023095-4dannjjm	3235	9	cDNA	cdna	NN
cord-023095-4dannjjm	3235	10	from	from	IN
cord-023095-4dannjjm	3235	11	a	a	DT
cord-023095-4dannjjm	3235	12	PK	PK	NNP
cord-023095-4dannjjm	3235	13	-	-	HYPH
cord-023095-4dannjjm	3235	14	deficient	deficient	JJ
cord-023095-4dannjjm	3235	15	Labrador	Labrador	NNP
cord-023095-4dannjjm	3235	16	Retriever	Retriever	NNP
cord-023095-4dannjjm	3235	17	revealed	reveal	VBD
cord-023095-4dannjjm	3235	18	a	a	DT
cord-023095-4dannjjm	3235	19	new	new	JJ
cord-023095-4dannjjm	3235	20	nonsense	nonsense	NN
cord-023095-4dannjjm	3235	21	mutation	mutation	NN
cord-023095-4dannjjm	3235	22	in	in	IN
cord-023095-4dannjjm	3235	23	exon	exon	NN
cord-023095-4dannjjm	3235	24	6	6	CD
cord-023095-4dannjjm	3235	25	.	.	.
cord-023095-4dannjjm	3236	1	In	in	IN
cord-023095-4dannjjm	3236	2	conclusion	conclusion	NN
cord-023095-4dannjjm	3236	3	,	,	,
cord-023095-4dannjjm	3236	4	PK	PK	NNP
cord-023095-4dannjjm	3236	5	deficiency	deficiency	NN
cord-023095-4dannjjm	3236	6	appears	appear	VBZ
cord-023095-4dannjjm	3236	7	to	to	TO
cord-023095-4dannjjm	3236	8	be	be	VB
cord-023095-4dannjjm	3236	9	a	a	DT
cord-023095-4dannjjm	3236	10	common	common	JJ
cord-023095-4dannjjm	3236	11	cause	cause	NN
cord-023095-4dannjjm	3236	12	for	for	IN
cord-023095-4dannjjm	3236	13	hemolytic	hemolytic	JJ
cord-023095-4dannjjm	3236	14	anemia	anemia	NN
cord-023095-4dannjjm	3236	15	in	in	IN
cord-023095-4dannjjm	3236	16	certain	certain	JJ
cord-023095-4dannjjm	3236	17	breeds	breed	NNS
cord-023095-4dannjjm	3236	18	,	,	,
cord-023095-4dannjjm	3236	19	and	and	CC
cord-023095-4dannjjm	3236	20	mutation	mutation	NN
cord-023095-4dannjjm	3236	21	testing	testing	NN
cord-023095-4dannjjm	3236	22	makes	make	VBZ
cord-023095-4dannjjm	3236	23	screening	screening	NN
cord-023095-4dannjjm	3236	24	simple	simple	JJ
cord-023095-4dannjjm	3236	25	.	.	.
cord-023095-4dannjjm	3237	1	PK	PK	NNP
cord-023095-4dannjjm	3237	2	deficiency	deficiency	NN
cord-023095-4dannjjm	3237	3	should	should	MD
cord-023095-4dannjjm	3237	4	also	also	RB
cord-023095-4dannjjm	3237	5	be	be	VB
cord-023095-4dannjjm	3237	6	considered	consider	VBN
cord-023095-4dannjjm	3237	7	in	in	IN
cord-023095-4dannjjm	3237	8	dogs	dog	NNS
cord-023095-4dannjjm	3237	9	of	of	IN
cord-023095-4dannjjm	3237	10	other	other	JJ
cord-023095-4dannjjm	3237	11	breeds	breed	NNS
cord-023095-4dannjjm	3237	12	which	which	WDT
cord-023095-4dannjjm	3237	13	may	may	MD
cord-023095-4dannjjm	3237	14	require	require	VB
cord-023095-4dannjjm	3237	15	the	the	DT
cord-023095-4dannjjm	3237	16	more	more	RBR
cord-023095-4dannjjm	3237	17	cumbersome	cumbersome	JJ
cord-023095-4dannjjm	3237	18	enzyme	enzyme	NN
cord-023095-4dannjjm	3237	19	testing	testing	NN
cord-023095-4dannjjm	3237	20	.	.	.
cord-023095-4dannjjm	3238	1	Studies	study	NNS
cord-023095-4dannjjm	3238	2	to	to	TO
cord-023095-4dannjjm	3238	3	identify	identify	VB
cord-023095-4dannjjm	3238	4	new	new	JJ
cord-023095-4dannjjm	3238	5	mutations	mutation	NNS
cord-023095-4dannjjm	3238	6	will	will	MD
cord-023095-4dannjjm	3238	7	confirm	confirm	VB
cord-023095-4dannjjm	3238	8	and	and	CC
cord-023095-4dannjjm	3238	9	simplify	simplify	VB
cord-023095-4dannjjm	3238	10	the	the	DT
cord-023095-4dannjjm	3238	11	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3238	12	.	.	.
cord-023095-4dannjjm	3239	1	Supported	support	VBN
cord-023095-4dannjjm	3239	2	in	in	IN
cord-023095-4dannjjm	3239	3	part	part	NN
cord-023095-4dannjjm	3239	4	by	by	IN
cord-023095-4dannjjm	3239	5	NIH	NIH	NNP
cord-023095-4dannjjm	3240	1	grant	grant	NNP
cord-023095-4dannjjm	3240	2	RR02512	RR02512	NNP
cord-023095-4dannjjm	3240	3	.	.	.
cord-023095-4dannjjm	3241	1	Immune	immune	NN
cord-023095-4dannjjm	3241	2	-	-	HYPH
cord-023095-4dannjjm	3241	3	mediated	mediate	VBN
cord-023095-4dannjjm	3241	4	hemolytic	hemolytic	JJ
cord-023095-4dannjjm	3241	5	anemia	anemia	NN
cord-023095-4dannjjm	3241	6	(	(	-LRB-
cord-023095-4dannjjm	3241	7	IMHA	IMHA	NNP
cord-023095-4dannjjm	3241	8	)	)	-RRB-
cord-023095-4dannjjm	3241	9	is	be	VBZ
cord-023095-4dannjjm	3241	10	a	a	DT
cord-023095-4dannjjm	3241	11	common	common	JJ
cord-023095-4dannjjm	3241	12	hematological	hematological	JJ
cord-023095-4dannjjm	3241	13	condition	condition	NN
cord-023095-4dannjjm	3241	14	observed	observe	VBN
cord-023095-4dannjjm	3241	15	in	in	IN
cord-023095-4dannjjm	3241	16	dogs	dog	NNS
cord-023095-4dannjjm	3241	17	.	.	.
cord-023095-4dannjjm	3242	1	The	the	DT
cord-023095-4dannjjm	3242	2	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3242	3	is	be	VBZ
cord-023095-4dannjjm	3242	4	based	base	VBN
cord-023095-4dannjjm	3242	5	on	on	IN
cord-023095-4dannjjm	3242	6	clinical	clinical	JJ
cord-023095-4dannjjm	3242	7	history	history	NN
cord-023095-4dannjjm	3242	8	,	,	,
cord-023095-4dannjjm	3242	9	presenting	present	VBG
cord-023095-4dannjjm	3242	10	signs	sign	NNS
cord-023095-4dannjjm	3242	11	and	and	CC
cord-023095-4dannjjm	3242	12	hematological	hematological	JJ
cord-023095-4dannjjm	3242	13	evidence	evidence	NN
cord-023095-4dannjjm	3242	14	of	of	IN
cord-023095-4dannjjm	3242	15	IMHA	IMHA	NNP
cord-023095-4dannjjm	3242	16	such	such	JJ
cord-023095-4dannjjm	3242	17	as	as	IN
cord-023095-4dannjjm	3242	18	regenerative	regenerative	JJ
cord-023095-4dannjjm	3242	19	anemia	anemia	NN
cord-023095-4dannjjm	3242	20	,	,	,
cord-023095-4dannjjm	3242	21	leucocytosis	leucocytosis	NNP
cord-023095-4dannjjm	3242	22	and	and	CC
cord-023095-4dannjjm	3242	23	presence	presence	NN
cord-023095-4dannjjm	3242	24	of	of	IN
cord-023095-4dannjjm	3242	25	spherocytes	spherocyte	NNS
cord-023095-4dannjjm	3242	26	.	.	.
cord-023095-4dannjjm	3243	1	The	the	DT
cord-023095-4dannjjm	3243	2	definitive	definitive	JJ
cord-023095-4dannjjm	3243	3	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3243	4	procedure	procedure	NN
cord-023095-4dannjjm	3243	5	is	be	VBZ
cord-023095-4dannjjm	3243	6	the	the	DT
cord-023095-4dannjjm	3243	7	Coomb	Coomb	NNP
cord-023095-4dannjjm	3243	8	's	's	POS
cord-023095-4dannjjm	3243	9	test	test	NN
cord-023095-4dannjjm	3243	10	(	(	-LRB-
cord-023095-4dannjjm	3243	11	direct	direct	JJ
cord-023095-4dannjjm	3243	12	antiglobulin	antiglobulin	NN
cord-023095-4dannjjm	3243	13	test	test	NN
cord-023095-4dannjjm	3243	14	,	,	,
cord-023095-4dannjjm	3243	15	DAT	DAT	NNP
cord-023095-4dannjjm	3243	16	)	)	-RRB-
cord-023095-4dannjjm	3243	17	which	which	WDT
cord-023095-4dannjjm	3243	18	is	be	VBZ
cord-023095-4dannjjm	3243	19	known	know	VBN
cord-023095-4dannjjm	3243	20	to	to	TO
cord-023095-4dannjjm	3243	21	be	be	VB
cord-023095-4dannjjm	3243	22	highly	highly	RB
cord-023095-4dannjjm	3243	23	specific	specific	JJ
cord-023095-4dannjjm	3243	24	but	but	CC
cord-023095-4dannjjm	3243	25	lacks	lack	VBZ
cord-023095-4dannjjm	3243	26	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3243	27	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3243	28	.	.	.
cord-023095-4dannjjm	3244	1	Direct	direct	JJ
cord-023095-4dannjjm	3244	2	flow	flow	NN
cord-023095-4dannjjm	3244	3	cytometric	cytometric	NN
cord-023095-4dannjjm	3244	4	assay	assay	NN
cord-023095-4dannjjm	3244	5	(	(	-LRB-
cord-023095-4dannjjm	3244	6	FCA	FCA	NNP
cord-023095-4dannjjm	3244	7	)	)	-RRB-
cord-023095-4dannjjm	3244	8	for	for	IN
cord-023095-4dannjjm	3244	9	IgG	IgG	NNP
cord-023095-4dannjjm	3244	10	,	,	,
cord-023095-4dannjjm	3244	11	IgM	IgM	NNP
cord-023095-4dannjjm	3244	12	or	or	CC
cord-023095-4dannjjm	3244	13	C3	C3	NNP
cord-023095-4dannjjm	3244	14	coated	coat	VBN
cord-023095-4dannjjm	3244	15	red	red	JJ
cord-023095-4dannjjm	3244	16	blood	blood	NN
cord-023095-4dannjjm	3244	17	cells	cell	NNS
cord-023095-4dannjjm	3244	18	(	(	-LRB-
cord-023095-4dannjjm	3244	19	RBCs	rbc	NNS
cord-023095-4dannjjm	3244	20	)	)	-RRB-
cord-023095-4dannjjm	3244	21	detection	detection	NN
cord-023095-4dannjjm	3244	22	might	may	MD
cord-023095-4dannjjm	3244	23	be	be	VB
cord-023095-4dannjjm	3244	24	more	more	RBR
cord-023095-4dannjjm	3244	25	sensitive	sensitive	JJ
cord-023095-4dannjjm	3244	26	and	and	CC
cord-023095-4dannjjm	3244	27	thus	thus	RB
cord-023095-4dannjjm	3244	28	could	could	MD
cord-023095-4dannjjm	3244	29	be	be	VB
cord-023095-4dannjjm	3244	30	introduced	introduce	VBN
cord-023095-4dannjjm	3244	31	as	as	IN
cord-023095-4dannjjm	3244	32	an	an	DT
cord-023095-4dannjjm	3244	33	alternative	alternative	JJ
cord-023095-4dannjjm	3244	34	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3244	35	tool	tool	NN
cord-023095-4dannjjm	3244	36	.	.	.
cord-023095-4dannjjm	3245	1	To	to	TO
cord-023095-4dannjjm	3245	2	investigate	investigate	VB
cord-023095-4dannjjm	3245	3	the	the	DT
cord-023095-4dannjjm	3245	4	usefulness	usefulness	NN
cord-023095-4dannjjm	3245	5	of	of	IN
cord-023095-4dannjjm	3245	6	FCA	FCA	NNP
cord-023095-4dannjjm	3245	7	for	for	IN
cord-023095-4dannjjm	3245	8	IMHA	IMHA	NNP
cord-023095-4dannjjm	3245	9	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3245	10	,	,	,
cord-023095-4dannjjm	3245	11	evaluation	evaluation	NN
cord-023095-4dannjjm	3245	12	of	of	IN
cord-023095-4dannjjm	3245	13	IgG	IgG	NNP
cord-023095-4dannjjm	3245	14	,	,	,
cord-023095-4dannjjm	3245	15	IgM	IgM	NNP
cord-023095-4dannjjm	3245	16	or	or	CC
cord-023095-4dannjjm	3245	17	C3	C3	NNP
cord-023095-4dannjjm	3245	18	coated	coated	JJ
cord-023095-4dannjjm	3245	19	RBCs	rbc	NNS
cord-023095-4dannjjm	3245	20	was	be	VBD
cord-023095-4dannjjm	3245	21	performed	perform	VBN
cord-023095-4dannjjm	3245	22	from	from	IN
cord-023095-4dannjjm	3245	23	15	15	CD
cord-023095-4dannjjm	3245	24	dogs	dog	NNS
cord-023095-4dannjjm	3245	25	presented	present	VBN
cord-023095-4dannjjm	3245	26	at	at	IN
cord-023095-4dannjjm	3245	27	the	the	DT
cord-023095-4dannjjm	3245	28	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	3245	29	Hospital	Hospital	NNP
cord-023095-4dannjjm	3245	30	at	at	IN
cord-023095-4dannjjm	3245	31	USP	USP	NNP
cord-023095-4dannjjm	3245	32	that	that	WDT
cord-023095-4dannjjm	3245	33	fulfilled	fulfil	VBD
cord-023095-4dannjjm	3245	34	clinical	clinical	JJ
cord-023095-4dannjjm	3245	35	and	and	CC
cord-023095-4dannjjm	3245	36	hematological	hematological	JJ
cord-023095-4dannjjm	3245	37	criteria	criterion	NNS
cord-023095-4dannjjm	3245	38	for	for	IN
cord-023095-4dannjjm	3245	39	IMHA	IMHA	NNP
cord-023095-4dannjjm	3245	40	.	.	.
cord-023095-4dannjjm	3246	1	Thirty	thirty	CD
cord-023095-4dannjjm	3246	2	eight	eight	CD
cord-023095-4dannjjm	3246	3	healthy	healthy	JJ
cord-023095-4dannjjm	3246	4	dogs	dog	NNS
cord-023095-4dannjjm	3246	5	were	be	VBD
cord-023095-4dannjjm	3246	6	included	include	VBN
cord-023095-4dannjjm	3246	7	as	as	IN
cord-023095-4dannjjm	3246	8	controls	control	NNS
cord-023095-4dannjjm	3246	9	.	.	.
cord-023095-4dannjjm	3247	1	DAT	DAT	NNP
cord-023095-4dannjjm	3247	2	was	be	VBD
cord-023095-4dannjjm	3247	3	performed	perform	VBN
cord-023095-4dannjjm	3247	4	with	with	IN
cord-023095-4dannjjm	3247	5	polyvalent	polyvalent	JJ
cord-023095-4dannjjm	3247	6	and	and	CC
cord-023095-4dannjjm	3247	7	monovalent	monovalent	JJ
cord-023095-4dannjjm	3247	8	anti	anti	JJ
cord-023095-4dannjjm	3247	9	-	-	JJ
cord-023095-4dannjjm	3247	10	dog	dog	JJ
cord-023095-4dannjjm	3247	11	sera	sera	NNP
cord-023095-4dannjjm	3247	12	with	with	IN
cord-023095-4dannjjm	3247	13	twofold	twofold	JJ
cord-023095-4dannjjm	3247	14	serial	serial	JJ
cord-023095-4dannjjm	3247	15	dilutions	dilution	NNS
cord-023095-4dannjjm	3247	16	of	of	IN
cord-023095-4dannjjm	3247	17	each	each	DT
cord-023095-4dannjjm	3247	18	one	one	CD
cord-023095-4dannjjm	3247	19	,	,	,
cord-023095-4dannjjm	3247	20	incubated	incubate	VBN
cord-023095-4dannjjm	3247	21	with	with	IN
cord-023095-4dannjjm	3247	22	2	2	CD
cord-023095-4dannjjm	3247	23	%	%	NN
cord-023095-4dannjjm	3247	24	RBCs	rbc	NNS
cord-023095-4dannjjm	3247	25	suspension	suspension	NN
cord-023095-4dannjjm	3247	26	at	at	IN
cord-023095-4dannjjm	3247	27	371C	371c	CD
cord-023095-4dannjjm	3247	28	and	and	CC
cord-023095-4dannjjm	3247	29	41C.	41c.	CD
cord-023095-4dannjjm	3247	30	For	for	IN
cord-023095-4dannjjm	3247	31	FCA	FCA	NNP
cord-023095-4dannjjm	3247	32	,	,	,
cord-023095-4dannjjm	3247	33	2	2	CD
cord-023095-4dannjjm	3247	34	%	%	NN
cord-023095-4dannjjm	3247	35	RBCs	rbc	NNS
cord-023095-4dannjjm	3247	36	from	from	IN
cord-023095-4dannjjm	3247	37	anemic	anemic	JJ
cord-023095-4dannjjm	3247	38	and	and	CC
cord-023095-4dannjjm	3247	39	healthy	healthy	JJ
cord-023095-4dannjjm	3247	40	dogs	dog	NNS
cord-023095-4dannjjm	3247	41	were	be	VBD
cord-023095-4dannjjm	3247	42	incubated	incubate	VBN
cord-023095-4dannjjm	3247	43	with	with	IN
cord-023095-4dannjjm	3247	44	FITC	FITC	NNP
cord-023095-4dannjjm	3247	45	anti	anti	JJ
cord-023095-4dannjjm	3247	46	-	-	JJ
cord-023095-4dannjjm	3247	47	dog	dog	JJ
cord-023095-4dannjjm	3247	48	IgG	igg	NN
cord-023095-4dannjjm	3247	49	,	,	,
cord-023095-4dannjjm	3247	50	anti	anti	JJ
cord-023095-4dannjjm	3247	51	-	-	JJ
cord-023095-4dannjjm	3247	52	dog	dog	JJ
cord-023095-4dannjjm	3247	53	IgM	IgM	NNP
cord-023095-4dannjjm	3247	54	and	and	CC
cord-023095-4dannjjm	3247	55	anti	anti	JJ
cord-023095-4dannjjm	3247	56	-	-	JJ
cord-023095-4dannjjm	3247	57	dog	dog	NN
cord-023095-4dannjjm	3247	58	C3	c3	NN
cord-023095-4dannjjm	3247	59	and	and	CC
cord-023095-4dannjjm	3247	60	submitted	submit	VBN
cord-023095-4dannjjm	3247	61	to	to	TO
cord-023095-4dannjjm	3247	62	flow	flow	VB
cord-023095-4dannjjm	3247	63	cytometry	cytometry	NN
cord-023095-4dannjjm	3247	64	evaluation	evaluation	NN
cord-023095-4dannjjm	3247	65	.	.	.
cord-023095-4dannjjm	3248	1	Specific	specific	JJ
cord-023095-4dannjjm	3248	2	software	software	NN
cord-023095-4dannjjm	3248	3	and	and	CC
cord-023095-4dannjjm	3248	4	Mann	Mann	NNP
cord-023095-4dannjjm	3248	5	Whitney	Whitney	NNP
cord-023095-4dannjjm	3248	6	U	U	NNP
cord-023095-4dannjjm	3248	7	test	test	NN
cord-023095-4dannjjm	3248	8	were	be	VBD
cord-023095-4dannjjm	3248	9	used	use	VBN
cord-023095-4dannjjm	3248	10	for	for	IN
cord-023095-4dannjjm	3248	11	data	datum	NNS
cord-023095-4dannjjm	3248	12	analysis	analysis	NN
cord-023095-4dannjjm	3248	13	.	.	.
cord-023095-4dannjjm	3249	1	Five	five	CD
cord-023095-4dannjjm	3249	2	dogs	dog	NNS
cord-023095-4dannjjm	3249	3	showed	show	VBD
cord-023095-4dannjjm	3249	4	positive	positive	JJ
cord-023095-4dannjjm	3249	5	results	result	NNS
cord-023095-4dannjjm	3249	6	for	for	IN
cord-023095-4dannjjm	3249	7	DAT	DAT	NNP
cord-023095-4dannjjm	3249	8	with	with	IN
cord-023095-4dannjjm	3249	9	polyvalent	polyvalent	JJ
cord-023095-4dannjjm	3249	10	Coombs	Coombs	NNP
cord-023095-4dannjjm	3249	11	reagent	reagent	NN
cord-023095-4dannjjm	3249	12	at	at	IN
cord-023095-4dannjjm	3249	13	41C	41c	CD
cord-023095-4dannjjm	3249	14	(	(	-LRB-
cord-023095-4dannjjm	3249	15	titer	titer	NN
cord-023095-4dannjjm	3249	16	64	64	CD
cord-023095-4dannjjm	3249	17	to	to	IN
cord-023095-4dannjjm	3249	18	4096	4096	CD
cord-023095-4dannjjm	3249	19	)	)	-RRB-
cord-023095-4dannjjm	3249	20	and	and	CC
cord-023095-4dannjjm	3249	21	371C	371C	NNP
cord-023095-4dannjjm	3249	22	(	(	-LRB-
cord-023095-4dannjjm	3249	23	titer	titer	NN
cord-023095-4dannjjm	3249	24	64	64	CD
cord-023095-4dannjjm	3249	25	to	to	IN
cord-023095-4dannjjm	3249	26	2048	2048	CD
cord-023095-4dannjjm	3249	27	)	)	-RRB-
cord-023095-4dannjjm	3249	28	but	but	CC
cord-023095-4dannjjm	3249	29	only	only	RB
cord-023095-4dannjjm	3249	30	three	three	CD
cord-023095-4dannjjm	3249	31	of	of	IN
cord-023095-4dannjjm	3249	32	them	-PRON-	PRP
cord-023095-4dannjjm	3249	33	had	have	VBD
cord-023095-4dannjjm	3249	34	agglutination	agglutination	NN
cord-023095-4dannjjm	3249	35	titer	titer	NN
cord-023095-4dannjjm	3249	36	for	for	IN
cord-023095-4dannjjm	3249	37	anti	anti	JJ
cord-023095-4dannjjm	3249	38	-	-	JJ
cord-023095-4dannjjm	3249	39	IgG	igg	NN
cord-023095-4dannjjm	3249	40	at	at	IN
cord-023095-4dannjjm	3249	41	4	4	CD
cord-023095-4dannjjm	3249	42	0	0	CD
cord-023095-4dannjjm	3249	43	C	c	NN
cord-023095-4dannjjm	3249	44	(	(	-LRB-
cord-023095-4dannjjm	3249	45	1024	1024	CD
cord-023095-4dannjjm	3249	46	to	to	IN
cord-023095-4dannjjm	3249	47	8192	8192	CD
cord-023095-4dannjjm	3249	48	)	)	-RRB-
cord-023095-4dannjjm	3249	49	and	and	CC
cord-023095-4dannjjm	3249	50	371C	371C	NNP
cord-023095-4dannjjm	3249	51	(	(	-LRB-
cord-023095-4dannjjm	3249	52	512	512	CD
cord-023095-4dannjjm	3249	53	to	to	IN
cord-023095-4dannjjm	3249	54	4096	4096	CD
cord-023095-4dannjjm	3249	55	)	)	-RRB-
cord-023095-4dannjjm	3249	56	.	.	.
cord-023095-4dannjjm	3250	1	No	no	DT
cord-023095-4dannjjm	3250	2	positive	positive	JJ
cord-023095-4dannjjm	3250	3	results	result	NNS
cord-023095-4dannjjm	3250	4	were	be	VBD
cord-023095-4dannjjm	3250	5	observed	observe	VBN
cord-023095-4dannjjm	3250	6	for	for	IN
cord-023095-4dannjjm	3250	7	anti	anti	JJ
cord-023095-4dannjjm	3250	8	-	-	JJ
cord-023095-4dannjjm	3250	9	IgM	igm	JJ
cord-023095-4dannjjm	3250	10	and	and	CC
cord-023095-4dannjjm	3250	11	anti	anti	JJ
cord-023095-4dannjjm	3250	12	-	-	JJ
cord-023095-4dannjjm	3250	13	C3	c3	JJ
cord-023095-4dannjjm	3250	14	DAT	DAT	NNP
cord-023095-4dannjjm	3250	15	.	.	.
cord-023095-4dannjjm	3251	1	By	by	IN
cord-023095-4dannjjm	3251	2	FC	FC	NNP
cord-023095-4dannjjm	3251	3	,	,	,
cord-023095-4dannjjm	3251	4	percentage	percentage	NN
cord-023095-4dannjjm	3251	5	of	of	IN
cord-023095-4dannjjm	3251	6	IgG	IgG	NNP
cord-023095-4dannjjm	3251	7	,	,	,
cord-023095-4dannjjm	3251	8	IgM	IgM	NNP
cord-023095-4dannjjm	3251	9	and	and	CC
cord-023095-4dannjjm	3251	10	C3	C3	NNP
cord-023095-4dannjjm	3251	11	coated	coated	JJ
cord-023095-4dannjjm	3251	12	RBCs	rbc	NNS
cord-023095-4dannjjm	3251	13	in	in	IN
cord-023095-4dannjjm	3251	14	normal	normal	JJ
cord-023095-4dannjjm	3251	15	and	and	CC
cord-023095-4dannjjm	3251	16	anemic	anemic	JJ
cord-023095-4dannjjm	3251	17	dogs	dog	NNS
cord-023095-4dannjjm	3251	18	were	be	VBD
cord-023095-4dannjjm	3251	19	,	,	,
cord-023095-4dannjjm	3251	20	respectively	respectively	RB
cord-023095-4dannjjm	3251	21	,	,	,
cord-023095-4dannjjm	3251	22	1,18	1,18	CD
cord-023095-4dannjjm	3251	23	%	%	NN
cord-023095-4dannjjm	3251	24	and	and	CC
cord-023095-4dannjjm	3251	25	17,11	17,11	CD
cord-023095-4dannjjm	3251	26	%	%	NN
cord-023095-4dannjjm	3251	27	(	(	-LRB-
cord-023095-4dannjjm	3251	28	p	p	NN
cord-023095-4dannjjm	3251	29	o	o	NN
cord-023095-4dannjjm	3251	30	0,001	0,001	CD
cord-023095-4dannjjm	3251	31	)	)	-RRB-
cord-023095-4dannjjm	3251	32	;	;	:
cord-023095-4dannjjm	3251	33	1,15	1,15	CD
cord-023095-4dannjjm	3251	34	%	%	NN
cord-023095-4dannjjm	3251	35	and	and	CC
cord-023095-4dannjjm	3251	36	21,29	21,29	CD
cord-023095-4dannjjm	3251	37	%	%	NN
cord-023095-4dannjjm	3251	38	(	(	-LRB-
cord-023095-4dannjjm	3251	39	p	p	NN
cord-023095-4dannjjm	3251	40	o	o	NN
cord-023095-4dannjjm	3251	41	0,001	0,001	CD
cord-023095-4dannjjm	3251	42	)	)	-RRB-
cord-023095-4dannjjm	3251	43	;	;	:
cord-023095-4dannjjm	3251	44	0,66	0,66	CD
cord-023095-4dannjjm	3251	45	%	%	NN
cord-023095-4dannjjm	3251	46	and	and	CC
cord-023095-4dannjjm	3251	47	6,99	6,99	CD
cord-023095-4dannjjm	3251	48	%	%	NN
cord-023095-4dannjjm	3252	1	(	(	-LRB-
cord-023095-4dannjjm	3252	2	p	p	NN
cord-023095-4dannjjm	3252	3	o	o	NN
cord-023095-4dannjjm	3252	4	0,001	0,001	CD
cord-023095-4dannjjm	3252	5	)	)	-RRB-
cord-023095-4dannjjm	3252	6	.	.	.
cord-023095-4dannjjm	3253	1	IgG	IgG	NNP
cord-023095-4dannjjm	3253	2	coated	coat	VBD
cord-023095-4dannjjm	3253	3	RBCs	rbc	NNS
cord-023095-4dannjjm	3253	4	percentage	percentage	NN
cord-023095-4dannjjm	3253	5	were	be	VBD
cord-023095-4dannjjm	3253	6	higher	high	JJR
cord-023095-4dannjjm	3253	7	in	in	IN
cord-023095-4dannjjm	3253	8	dogs	dog	NNS
cord-023095-4dannjjm	3253	9	showing	show	VBG
cord-023095-4dannjjm	3253	10	DAT	DAT	NNP
cord-023095-4dannjjm	3253	11	positive	positive	JJ
cord-023095-4dannjjm	3253	12	results	result	NNS
cord-023095-4dannjjm	3253	13	(	(	-LRB-
cord-023095-4dannjjm	3253	14	min	min	NN
cord-023095-4dannjjm	3253	15	.	.	.
cord-023095-4dannjjm	3253	16	33,94	33,94	CD
cord-023095-4dannjjm	3253	17	%	%	NN
cord-023095-4dannjjm	3253	18	;	;	:
cord-023095-4dannjjm	3253	19	max	max	NNP
cord-023095-4dannjjm	3253	20	.	.	.
cord-023095-4dannjjm	3254	1	99,96	99,96	CD
cord-023095-4dannjjm	3254	2	%	%	NN
cord-023095-4dannjjm	3254	3	;	;	:
cord-023095-4dannjjm	3254	4	median	median	JJ
cord-023095-4dannjjm	3254	5	54,25	54,25	CD
cord-023095-4dannjjm	3254	6	%	%	NN
cord-023095-4dannjjm	3254	7	)	)	-RRB-
cord-023095-4dannjjm	3254	8	.	.	.
cord-023095-4dannjjm	3255	1	Direct	direct	JJ
cord-023095-4dannjjm	3255	2	flow	flow	NN
cord-023095-4dannjjm	3255	3	cytometric	cytometric	NN
cord-023095-4dannjjm	3255	4	erythrocyte	erythrocyte	NN
cord-023095-4dannjjm	3255	5	immunofluorescence	immunofluorescence	NN
cord-023095-4dannjjm	3255	6	assay	assay	NN
cord-023095-4dannjjm	3255	7	is	be	VBZ
cord-023095-4dannjjm	3255	8	more	more	RBR
cord-023095-4dannjjm	3255	9	sensitive	sensitive	JJ
cord-023095-4dannjjm	3255	10	than	than	IN
cord-023095-4dannjjm	3255	11	DAT	DAT	NNP
cord-023095-4dannjjm	3255	12	for	for	IN
cord-023095-4dannjjm	3255	13	detection	detection	NN
cord-023095-4dannjjm	3255	14	of	of	IN
cord-023095-4dannjjm	3255	15	antibodies	antibody	NNS
cord-023095-4dannjjm	3255	16	coated	coat	VBD
cord-023095-4dannjjm	3255	17	RBC	RBC	NNP
cord-023095-4dannjjm	3255	18	in	in	IN
cord-023095-4dannjjm	3255	19	anemic	anemic	JJ
cord-023095-4dannjjm	3255	20	dogs	dog	NNS
cord-023095-4dannjjm	3255	21	and	and	CC
cord-023095-4dannjjm	3255	22	may	may	MD
cord-023095-4dannjjm	3255	23	provide	provide	VB
cord-023095-4dannjjm	3255	24	quantitative	quantitative	JJ
cord-023095-4dannjjm	3255	25	data	datum	NNS
cord-023095-4dannjjm	3255	26	useful	useful	JJ
cord-023095-4dannjjm	3255	27	for	for	IN
cord-023095-4dannjjm	3255	28	laboratorial	laboratorial	JJ
cord-023095-4dannjjm	3255	29	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3255	30	of	of	IN
cord-023095-4dannjjm	3255	31	IMzHA	IMzHA	NNP
cord-023095-4dannjjm	3255	32	.	.	.
cord-023095-4dannjjm	3256	1	Bone	bone	NN
cord-023095-4dannjjm	3256	2	marrow	marrow	NN
cord-023095-4dannjjm	3256	3	aspirates	aspirate	NNS
cord-023095-4dannjjm	3256	4	from	from	IN
cord-023095-4dannjjm	3256	5	cats	cat	NNS
cord-023095-4dannjjm	3256	6	are	be	VBP
cord-023095-4dannjjm	3256	7	typically	typically	RB
cord-023095-4dannjjm	3256	8	obtained	obtain	VBN
cord-023095-4dannjjm	3256	9	from	from	IN
cord-023095-4dannjjm	3256	10	the	the	DT
cord-023095-4dannjjm	3256	11	ilium	ilium	NNP
cord-023095-4dannjjm	3256	12	,	,	,
cord-023095-4dannjjm	3256	13	humerus	humerus	NN
cord-023095-4dannjjm	3256	14	or	or	CC
cord-023095-4dannjjm	3256	15	femur	femur	NN
cord-023095-4dannjjm	3256	16	,	,	,
cord-023095-4dannjjm	3256	17	but	but	CC
cord-023095-4dannjjm	3256	18	may	may	MD
cord-023095-4dannjjm	3256	19	be	be	VB
cord-023095-4dannjjm	3256	20	difficult	difficult	JJ
cord-023095-4dannjjm	3256	21	to	to	TO
cord-023095-4dannjjm	3256	22	obtain	obtain	VB
cord-023095-4dannjjm	3256	23	and/or	and/or	CC
cord-023095-4dannjjm	3256	24	of	of	IN
cord-023095-4dannjjm	3256	25	poor	poor	JJ
cord-023095-4dannjjm	3256	26	quality	quality	NN
cord-023095-4dannjjm	3256	27	.	.	.
cord-023095-4dannjjm	3257	1	In	in	IN
cord-023095-4dannjjm	3257	2	this	this	DT
cord-023095-4dannjjm	3257	3	study	study	NN
cord-023095-4dannjjm	3257	4	the	the	DT
cord-023095-4dannjjm	3257	5	feasibility	feasibility	NN
cord-023095-4dannjjm	3257	6	,	,	,
cord-023095-4dannjjm	3257	7	safety	safety	NN
cord-023095-4dannjjm	3257	8	,	,	,
cord-023095-4dannjjm	3257	9	and	and	CC
cord-023095-4dannjjm	3257	10	nature	nature	NN
cord-023095-4dannjjm	3257	11	of	of	IN
cord-023095-4dannjjm	3257	12	sternal	sternal	JJ
cord-023095-4dannjjm	3257	13	aspiration	aspiration	NN
cord-023095-4dannjjm	3257	14	in	in	IN
cord-023095-4dannjjm	3257	15	cats	cat	NNS
cord-023095-4dannjjm	3257	16	was	be	VBD
cord-023095-4dannjjm	3257	17	investigated	investigate	VBN
cord-023095-4dannjjm	3257	18	.	.	.
cord-023095-4dannjjm	3258	1	Under	under	IN
cord-023095-4dannjjm	3258	2	general	general	JJ
cord-023095-4dannjjm	3258	3	anesthesia	anesthesia	NN
cord-023095-4dannjjm	3258	4	,	,	,
cord-023095-4dannjjm	3258	5	bone	bone	NN
cord-023095-4dannjjm	3258	6	marrow	marrow	NN
cord-023095-4dannjjm	3258	7	aspirates	aspirate	NNS
cord-023095-4dannjjm	3258	8	were	be	VBD
cord-023095-4dannjjm	3258	9	obtained	obtain	VBN
cord-023095-4dannjjm	3258	10	in	in	IN
cord-023095-4dannjjm	3258	11	a	a	DT
cord-023095-4dannjjm	3258	12	randomized	randomized	JJ
cord-023095-4dannjjm	3258	13	order	order	NN
cord-023095-4dannjjm	3258	14	by	by	IN
cord-023095-4dannjjm	3258	15	a	a	DT
cord-023095-4dannjjm	3258	16	single	single	JJ
cord-023095-4dannjjm	3258	17	investigator	investigator	NN
cord-023095-4dannjjm	3258	18	from	from	IN
cord-023095-4dannjjm	3258	19	the	the	DT
cord-023095-4dannjjm	3258	20	sternum	sternum	NN
cord-023095-4dannjjm	3258	21	and	and	CC
cord-023095-4dannjjm	3258	22	ilium	ilium	NN
cord-023095-4dannjjm	3258	23	of	of	IN
cord-023095-4dannjjm	3258	24	10	10	CD
cord-023095-4dannjjm	3258	25	healthy	healthy	JJ
cord-023095-4dannjjm	3258	26	cats	cat	NNS
cord-023095-4dannjjm	3258	27	weighing	weigh	VBG
cord-023095-4dannjjm	3258	28	3.4	3.4	CD
cord-023095-4dannjjm	3258	29	-	-	HYPH
cord-023095-4dannjjm	3258	30	8.4	8.4	CD
cord-023095-4dannjjm	3258	31	kg	kg	NNS
cord-023095-4dannjjm	3258	32	,	,	,
cord-023095-4dannjjm	3258	33	with	with	IN
cord-023095-4dannjjm	3258	34	body	body	NN
cord-023095-4dannjjm	3258	35	condition	condition	NN
cord-023095-4dannjjm	3258	36	scores	score	NNS
cord-023095-4dannjjm	3258	37	of	of	IN
cord-023095-4dannjjm	3258	38	5	5	CD
cord-023095-4dannjjm	3258	39	-	-	SYM
cord-023095-4dannjjm	3258	40	9	9	CD
cord-023095-4dannjjm	3258	41	(	(	-LRB-
cord-023095-4dannjjm	3258	42	on	on	IN
cord-023095-4dannjjm	3258	43	a	a	DT
cord-023095-4dannjjm	3258	44	scale	scale	NN
cord-023095-4dannjjm	3258	45	of	of	IN
cord-023095-4dannjjm	3258	46	1	1	CD
cord-023095-4dannjjm	3258	47	-	-	SYM
cord-023095-4dannjjm	3258	48	9	9	CD
cord-023095-4dannjjm	3258	49	)	)	-RRB-
cord-023095-4dannjjm	3258	50	.	.	.
cord-023095-4dannjjm	3259	1	For	for	IN
cord-023095-4dannjjm	3259	2	sternal	sternal	JJ
cord-023095-4dannjjm	3259	3	aspirates	aspirate	NNS
cord-023095-4dannjjm	3259	4	,	,	,
cord-023095-4dannjjm	3259	5	cats	cat	NNS
cord-023095-4dannjjm	3259	6	were	be	VBD
cord-023095-4dannjjm	3259	7	positioned	position	VBN
cord-023095-4dannjjm	3259	8	in	in	IN
cord-023095-4dannjjm	3259	9	sternal	sternal	JJ
cord-023095-4dannjjm	3259	10	recumbency	recumbency	NN
cord-023095-4dannjjm	3259	11	and	and	CC
cord-023095-4dannjjm	3259	12	a	a	DT
cord-023095-4dannjjm	3259	13	1-inch	1-inch	CD
cord-023095-4dannjjm	3259	14	,	,	,
cord-023095-4dannjjm	3259	15	22	22	CD
cord-023095-4dannjjm	3259	16	-	-	SYM
cord-023095-4dannjjm	3259	17	23	23	CD
cord-023095-4dannjjm	3259	18	ga	ga	NNP
cord-023095-4dannjjm	3259	19	hypodermic	hypodermic	NNP
cord-023095-4dannjjm	3259	20	needle	needle	NN
cord-023095-4dannjjm	3259	21	attached	attach	VBN
cord-023095-4dannjjm	3259	22	to	to	IN
cord-023095-4dannjjm	3259	23	a	a	DT
cord-023095-4dannjjm	3259	24	12cc	12cc	JJ
cord-023095-4dannjjm	3259	25	syringe	syringe	NN
cord-023095-4dannjjm	3259	26	was	be	VBD
cord-023095-4dannjjm	3259	27	inserted	insert	VBN
cord-023095-4dannjjm	3259	28	into	into	IN
cord-023095-4dannjjm	3259	29	the	the	DT
cord-023095-4dannjjm	3259	30	cranial	cranial	JJ
cord-023095-4dannjjm	3259	31	manubrium	manubrium	NN
cord-023095-4dannjjm	3259	32	and	and	CC
cord-023095-4dannjjm	3259	33	directed	direct	VBD
cord-023095-4dannjjm	3259	34	caudally	caudally	RB
cord-023095-4dannjjm	3259	35	along	along	IN
cord-023095-4dannjjm	3259	36	the	the	DT
cord-023095-4dannjjm	3259	37	long	long	JJ
cord-023095-4dannjjm	3259	38	axis	axis	NN
cord-023095-4dannjjm	3259	39	of	of	IN
cord-023095-4dannjjm	3259	40	the	the	DT
cord-023095-4dannjjm	3259	41	sternum	sternum	NN
cord-023095-4dannjjm	3259	42	.	.	.
cord-023095-4dannjjm	3260	1	Aspirates	Aspirates	NNP
cord-023095-4dannjjm	3260	2	were	be	VBD
cord-023095-4dannjjm	3260	3	also	also	RB
cord-023095-4dannjjm	3260	4	obtained	obtain	VBN
cord-023095-4dannjjm	3260	5	from	from	IN
cord-023095-4dannjjm	3260	6	the	the	DT
cord-023095-4dannjjm	3260	7	right	right	NNP
cord-023095-4dannjjm	3260	8	iliac	iliac	NNP
cord-023095-4dannjjm	3260	9	crest	crest	NN
cord-023095-4dannjjm	3260	10	using	use	VBG
cord-023095-4dannjjm	3260	11	an	an	DT
cord-023095-4dannjjm	3260	12	18	18	CD
cord-023095-4dannjjm	3260	13	ga	ga	NNP
cord-023095-4dannjjm	3260	14	Illinois	Illinois	NNP
cord-023095-4dannjjm	3260	15	needle	needle	NN
cord-023095-4dannjjm	3260	16	attached	attach	VBN
cord-023095-4dannjjm	3260	17	to	to	IN
cord-023095-4dannjjm	3260	18	a	a	DT
cord-023095-4dannjjm	3260	19	12cc	12cc	JJ
cord-023095-4dannjjm	3260	20	syringe	syringe	NN
cord-023095-4dannjjm	3260	21	.	.	.
cord-023095-4dannjjm	3261	1	Difficulty	difficulty	NN
cord-023095-4dannjjm	3261	2	of	of	IN
cord-023095-4dannjjm	3261	3	site	site	NN
cord-023095-4dannjjm	3261	4	localization	localization	NN
cord-023095-4dannjjm	3261	5	,	,	,
cord-023095-4dannjjm	3261	6	needle	needle	NN
cord-023095-4dannjjm	3261	7	insertion	insertion	NN
cord-023095-4dannjjm	3261	8	and	and	CC
cord-023095-4dannjjm	3261	9	advancement	advancement	NN
cord-023095-4dannjjm	3261	10	,	,	,
cord-023095-4dannjjm	3261	11	and	and	CC
cord-023095-4dannjjm	3261	12	specimen	specimen	JJ
cord-023095-4dannjjm	3261	13	aspiration	aspiration	NN
cord-023095-4dannjjm	3261	14	,	,	,
cord-023095-4dannjjm	3261	15	were	be	VBD
cord-023095-4dannjjm	3261	16	scored	score	VBN
cord-023095-4dannjjm	3261	17	from	from	IN
cord-023095-4dannjjm	3261	18	1	1	CD
cord-023095-4dannjjm	3261	19	(	(	-LRB-
cord-023095-4dannjjm	3261	20	easiest	easy	JJS
cord-023095-4dannjjm	3261	21	)	)	-RRB-
cord-023095-4dannjjm	3261	22	to	to	IN
cord-023095-4dannjjm	3261	23	5	5	CD
cord-023095-4dannjjm	3261	24	(	(	-LRB-
cord-023095-4dannjjm	3261	25	hardest	hard	RBS
cord-023095-4dannjjm	3261	26	)	)	-RRB-
cord-023095-4dannjjm	3261	27	.	.	.
cord-023095-4dannjjm	3262	1	Bone	bone	NN
cord-023095-4dannjjm	3262	2	marrow	marrow	NN
cord-023095-4dannjjm	3262	3	smears	smear	NNS
cord-023095-4dannjjm	3262	4	were	be	VBD
cord-023095-4dannjjm	3262	5	prepared	prepare	VBN
cord-023095-4dannjjm	3262	6	by	by	IN
cord-023095-4dannjjm	3262	7	one	one	CD
cord-023095-4dannjjm	3262	8	investigator	investigator	NN
cord-023095-4dannjjm	3262	9	and	and	CC
cord-023095-4dannjjm	3262	10	reviewed	review	VBN
cord-023095-4dannjjm	3262	11	by	by	IN
cord-023095-4dannjjm	3262	12	a	a	DT
cord-023095-4dannjjm	3262	13	pathologist	pathologist	NN
cord-023095-4dannjjm	3262	14	blinded	blind	VBN
cord-023095-4dannjjm	3262	15	to	to	IN
cord-023095-4dannjjm	3262	16	aspiration	aspiration	NN
cord-023095-4dannjjm	3262	17	site	site	NN
cord-023095-4dannjjm	3262	18	and	and	CC
cord-023095-4dannjjm	3262	19	cat	cat	NN
cord-023095-4dannjjm	3262	20	.	.	.
cord-023095-4dannjjm	3263	1	Sample	sample	JJ
cord-023095-4dannjjm	3263	2	quality	quality	NN
cord-023095-4dannjjm	3263	3	was	be	VBD
cord-023095-4dannjjm	3263	4	scored	score	VBN
cord-023095-4dannjjm	3263	5	from	from	IN
cord-023095-4dannjjm	3263	6	0	0	NFP
cord-023095-4dannjjm	3263	7	(	(	-LRB-
cord-023095-4dannjjm	3263	8	no	no	DT
cord-023095-4dannjjm	3263	9	marrow	marrow	NN
cord-023095-4dannjjm	3263	10	particles	particle	NNS
cord-023095-4dannjjm	3263	11	)	)	-RRB-
cord-023095-4dannjjm	3263	12	to	to	IN
cord-023095-4dannjjm	3263	13	5	5	CD
cord-023095-4dannjjm	3263	14	(	(	-LRB-
cord-023095-4dannjjm	3263	15	excellent	excellent	NN
cord-023095-4dannjjm	3263	16	)	)	-RRB-
cord-023095-4dannjjm	3263	17	based	base	VBN
cord-023095-4dannjjm	3263	18	on	on	IN
cord-023095-4dannjjm	3263	19	the	the	DT
cord-023095-4dannjjm	3263	20	number	number	NN
cord-023095-4dannjjm	3263	21	of	of	IN
cord-023095-4dannjjm	3263	22	wellsmeared	wellsmeare	VBN
cord-023095-4dannjjm	3263	23	marrow	marrow	NN
cord-023095-4dannjjm	3263	24	particles	particle	NNS
cord-023095-4dannjjm	3263	25	on	on	IN
cord-023095-4dannjjm	3263	26	the	the	DT
cord-023095-4dannjjm	3263	27	slide	slide	NN
cord-023095-4dannjjm	3263	28	.	.	.
cord-023095-4dannjjm	3264	1	Particle	particle	NN
cord-023095-4dannjjm	3264	2	cellularity	cellularity	NN
cord-023095-4dannjjm	3264	3	was	be	VBD
cord-023095-4dannjjm	3264	4	scored	score	VBN
cord-023095-4dannjjm	3264	5	from	from	IN
cord-023095-4dannjjm	3264	6	1	1	CD
cord-023095-4dannjjm	3264	7	(	(	-LRB-
cord-023095-4dannjjm	3264	8	4	4	CD
cord-023095-4dannjjm	3264	9	75	75	CD
cord-023095-4dannjjm	3264	10	%	%	NN
cord-023095-4dannjjm	3264	11	fat	fat	NN
cord-023095-4dannjjm	3264	12	)	)	-RRB-
cord-023095-4dannjjm	3264	13	to	to	IN
cord-023095-4dannjjm	3264	14	3	3	CD
cord-023095-4dannjjm	3264	15	(	(	-LRB-
cord-023095-4dannjjm	3264	16	o	o	NN
cord-023095-4dannjjm	3264	17	25	25	CD
cord-023095-4dannjjm	3264	18	%	%	NN
cord-023095-4dannjjm	3264	19	fat	fat	NN
cord-023095-4dannjjm	3264	20	)	)	-RRB-
cord-023095-4dannjjm	3264	21	.	.	.
cord-023095-4dannjjm	3265	1	Post	post	NN
cord-023095-4dannjjm	3265	2	-	-	NN
cord-023095-4dannjjm	3265	3	procedure	procedure	NN
cord-023095-4dannjjm	3265	4	,	,	,
cord-023095-4dannjjm	3265	5	cats	cat	NNS
cord-023095-4dannjjm	3265	6	were	be	VBD
cord-023095-4dannjjm	3265	7	treated	treat	VBN
cord-023095-4dannjjm	3265	8	with	with	IN
cord-023095-4dannjjm	3265	9	tramadol	tramadol	NN
cord-023095-4dannjjm	3265	10	(	(	-LRB-
cord-023095-4dannjjm	3265	11	4	4	CD
cord-023095-4dannjjm	3265	12	-	-	SYM
cord-023095-4dannjjm	3265	13	5	5	CD
cord-023095-4dannjjm	3265	14	mg	mg	NNP
cord-023095-4dannjjm	3265	15	/	/	SYM
cord-023095-4dannjjm	3265	16	kg	kg	NNP
cord-023095-4dannjjm	3265	17	,	,	,
cord-023095-4dannjjm	3265	18	PO	PO	NNP
cord-023095-4dannjjm	3265	19	,	,	,
cord-023095-4dannjjm	3265	20	q12h	q12h	CD
cord-023095-4dannjjm	3265	21	)	)	-RRB-
cord-023095-4dannjjm	3265	22	for	for	IN
cord-023095-4dannjjm	3265	23	3	3	CD
cord-023095-4dannjjm	3265	24	days	day	NNS
cord-023095-4dannjjm	3265	25	,	,	,
cord-023095-4dannjjm	3265	26	and	and	CC
cord-023095-4dannjjm	3265	27	assessed	assess	VBN
cord-023095-4dannjjm	3265	28	for	for	IN
cord-023095-4dannjjm	3265	29	post	post	JJ
cord-023095-4dannjjm	3265	30	-	-	JJ
cord-023095-4dannjjm	3265	31	biopsy	biopsy	JJ
cord-023095-4dannjjm	3265	32	pain	pain	NN
cord-023095-4dannjjm	3265	33	(	(	-LRB-
cord-023095-4dannjjm	3265	34	Colorado	Colorado	NNP
cord-023095-4dannjjm	3265	35	State	State	NNP
cord-023095-4dannjjm	3265	36	University	University	NNP
cord-023095-4dannjjm	3265	37	Feline	Feline	NNP
cord-023095-4dannjjm	3265	38	Acute	acute	JJ
cord-023095-4dannjjm	3265	39	Pain	pain	NN
cord-023095-4dannjjm	3265	40	Scale	scale	NN
cord-023095-4dannjjm	3265	41	,	,	,
cord-023095-4dannjjm	3265	42	range	range	VBP
cord-023095-4dannjjm	3265	43	0	0	NFP
cord-023095-4dannjjm	3265	44	[	[	-LRB-
cord-023095-4dannjjm	3265	45	no	no	DT
cord-023095-4dannjjm	3265	46	pain	pain	NN
cord-023095-4dannjjm	3265	47	]	]	-RRB-
cord-023095-4dannjjm	3265	48	-4	-4	FW
cord-023095-4dannjjm	3265	49	[	[	-LRB-
cord-023095-4dannjjm	3265	50	maximum	maximum	NN
cord-023095-4dannjjm	3265	51	]	]	-RRB-
cord-023095-4dannjjm	3265	52	)	)	-RRB-
cord-023095-4dannjjm	3265	53	and	and	CC
cord-023095-4dannjjm	3265	54	site	site	NN
cord-023095-4dannjjm	3265	55	swelling	swelling	NN
cord-023095-4dannjjm	3265	56	(	(	-LRB-
cord-023095-4dannjjm	3265	57	range	range	NN
cord-023095-4dannjjm	3265	58	0	0	NFP
cord-023095-4dannjjm	3265	59	[	[	-LRB-
cord-023095-4dannjjm	3265	60	none	none	NN
cord-023095-4dannjjm	3265	61	]	]	-RRB-
cord-023095-4dannjjm	3265	62	-3	-3	NNP
cord-023095-4dannjjm	3265	63	[	[	-LRB-
cord-023095-4dannjjm	3265	64	marked	mark	VBN
cord-023095-4dannjjm	3265	65	]	]	-RRB-
cord-023095-4dannjjm	3265	66	)	)	-RRB-
cord-023095-4dannjjm	3265	67	.	.	.
cord-023095-4dannjjm	3266	1	Data	datum	NNS
cord-023095-4dannjjm	3266	2	were	be	VBD
cord-023095-4dannjjm	3266	3	analyzed	analyze	VBN
cord-023095-4dannjjm	3266	4	by	by	IN
cord-023095-4dannjjm	3266	5	ANCOVA	ANCOVA	NNP
cord-023095-4dannjjm	3266	6	accounting	accounting	NN
cord-023095-4dannjjm	3266	7	for	for	IN
cord-023095-4dannjjm	3266	8	effects	effect	NNS
cord-023095-4dannjjm	3266	9	of	of	IN
cord-023095-4dannjjm	3266	10	weight	weight	NN
cord-023095-4dannjjm	3266	11	and	and	CC
cord-023095-4dannjjm	3266	12	body	body	NN
cord-023095-4dannjjm	3266	13	condition	condition	NN
cord-023095-4dannjjm	3266	14	score	score	NN
cord-023095-4dannjjm	3266	15	.	.	.
cord-023095-4dannjjm	3267	1	Pneumothorax	pneumothorax	NN
cord-023095-4dannjjm	3267	2	was	be	VBD
cord-023095-4dannjjm	3267	3	not	not	RB
cord-023095-4dannjjm	3267	4	identified	identify	VBN
cord-023095-4dannjjm	3267	5	.	.	.
cord-023095-4dannjjm	3268	1	It	-PRON-	PRP
cord-023095-4dannjjm	3268	2	was	be	VBD
cord-023095-4dannjjm	3268	3	significantly	significantly	RB
cord-023095-4dannjjm	3268	4	easier	easy	JJR
cord-023095-4dannjjm	3268	5	to	to	TO
cord-023095-4dannjjm	3268	6	perform	perform	VB
cord-023095-4dannjjm	3268	7	sternal	sternal	JJ
cord-023095-4dannjjm	3268	8	than	than	IN
cord-023095-4dannjjm	3268	9	iliac	iliac	JJ
cord-023095-4dannjjm	3268	10	aspiration	aspiration	NN
cord-023095-4dannjjm	3268	11	,	,	,
cord-023095-4dannjjm	3268	12	but	but	CC
cord-023095-4dannjjm	3268	13	the	the	DT
cord-023095-4dannjjm	3268	14	quality	quality	NN
cord-023095-4dannjjm	3268	15	of	of	IN
cord-023095-4dannjjm	3268	16	the	the	DT
cord-023095-4dannjjm	3268	17	sample	sample	NN
cord-023095-4dannjjm	3268	18	was	be	VBD
cord-023095-4dannjjm	3268	19	significantly	significantly	RB
cord-023095-4dannjjm	3268	20	better	well	JJR
cord-023095-4dannjjm	3268	21	for	for	IN
cord-023095-4dannjjm	3268	22	iliac	iliac	NN
cord-023095-4dannjjm	3268	23	than	than	IN
cord-023095-4dannjjm	3268	24	for	for	IN
cord-023095-4dannjjm	3268	25	sternal	sternal	JJ
cord-023095-4dannjjm	3268	26	aspirates	aspirate	NNS
cord-023095-4dannjjm	3268	27	.	.	.
cord-023095-4dannjjm	3269	1	Because	because	IN
cord-023095-4dannjjm	3269	2	of	of	IN
cord-023095-4dannjjm	3269	3	limitations	limitation	NNS
cord-023095-4dannjjm	3269	4	due	due	JJ
cord-023095-4dannjjm	3269	5	to	to	TO
cord-023095-4dannjjm	3269	6	sample	sample	VB
cord-023095-4dannjjm	3269	7	quality	quality	NN
cord-023095-4dannjjm	3269	8	,	,	,
cord-023095-4dannjjm	3269	9	bone	bone	NN
cord-023095-4dannjjm	3269	10	marrow	marrow	NN
cord-023095-4dannjjm	3269	11	morphology	morphology	NN
cord-023095-4dannjjm	3269	12	in	in	IN
cord-023095-4dannjjm	3269	13	sternal	sternal	JJ
cord-023095-4dannjjm	3269	14	samples	sample	NNS
cord-023095-4dannjjm	3269	15	could	could	MD
cord-023095-4dannjjm	3269	16	not	not	RB
cord-023095-4dannjjm	3269	17	be	be	VB
cord-023095-4dannjjm	3269	18	compared	compare	VBN
cord-023095-4dannjjm	3269	19	to	to	IN
cord-023095-4dannjjm	3269	20	iliac	iliac	NN
cord-023095-4dannjjm	3269	21	samples	sample	NNS
cord-023095-4dannjjm	3269	22	in	in	IN
cord-023095-4dannjjm	3269	23	all	all	DT
cord-023095-4dannjjm	3269	24	cats	cat	NNS
cord-023095-4dannjjm	3269	25	.	.	.
cord-023095-4dannjjm	3270	1	For	for	IN
cord-023095-4dannjjm	3270	2	samples	sample	NNS
cord-023095-4dannjjm	3270	3	that	that	WDT
cord-023095-4dannjjm	3270	4	could	could	MD
cord-023095-4dannjjm	3270	5	be	be	VB
cord-023095-4dannjjm	3270	6	compared	compare	VBN
cord-023095-4dannjjm	3270	7	,	,	,
cord-023095-4dannjjm	3270	8	cellularity	cellularity	NN
cord-023095-4dannjjm	3270	9	was	be	VBD
cord-023095-4dannjjm	3270	10	identical	identical	JJ
cord-023095-4dannjjm	3270	11	for	for	IN
cord-023095-4dannjjm	3270	12	sternal	sternal	JJ
cord-023095-4dannjjm	3270	13	and	and	CC
cord-023095-4dannjjm	3270	14	iliac	iliac	JJ
cord-023095-4dannjjm	3270	15	samples	sample	NNS
cord-023095-4dannjjm	3270	16	from	from	IN
cord-023095-4dannjjm	3270	17	1	1	CD
cord-023095-4dannjjm	3270	18	cat	cat	NN
cord-023095-4dannjjm	3270	19	but	but	CC
cord-023095-4dannjjm	3270	20	underestimated	underestimate	VBN
cord-023095-4dannjjm	3270	21	in	in	IN
cord-023095-4dannjjm	3270	22	the	the	DT
cord-023095-4dannjjm	3270	23	sternal	sternal	JJ
cord-023095-4dannjjm	3270	24	sample	sample	NN
cord-023095-4dannjjm	3270	25	from	from	IN
cord-023095-4dannjjm	3270	26	another	another	DT
cord-023095-4dannjjm	3270	27	cat	cat	NN
cord-023095-4dannjjm	3270	28	.	.	.
cord-023095-4dannjjm	3271	1	Myeloid	myeloid	NN
cord-023095-4dannjjm	3271	2	:	:	:
cord-023095-4dannjjm	3271	3	erythroid	erythroid	NN
cord-023095-4dannjjm	3271	4	ratios	ratio	NNS
cord-023095-4dannjjm	3271	5	and	and	CC
cord-023095-4dannjjm	3271	6	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	3271	7	numbers	number	NNS
cord-023095-4dannjjm	3271	8	were	be	VBD
cord-023095-4dannjjm	3271	9	the	the	DT
cord-023095-4dannjjm	3271	10	same	same	JJ
cord-023095-4dannjjm	3271	11	for	for	IN
cord-023095-4dannjjm	3271	12	sternal	sternal	JJ
cord-023095-4dannjjm	3271	13	and	and	CC
cord-023095-4dannjjm	3271	14	iliac	iliac	JJ
cord-023095-4dannjjm	3271	15	samples	sample	NNS
cord-023095-4dannjjm	3271	16	in	in	IN
cord-023095-4dannjjm	3271	17	2	2	CD
cord-023095-4dannjjm	3271	18	and	and	CC
cord-023095-4dannjjm	3271	19	3	3	CD
cord-023095-4dannjjm	3271	20	cats	cat	NNS
cord-023095-4dannjjm	3271	21	,	,	,
cord-023095-4dannjjm	3271	22	respectively	respectively	RB
cord-023095-4dannjjm	3271	23	.	.	.
cord-023095-4dannjjm	3272	1	Megakaryocyte	Megakaryocyte	NNP
cord-023095-4dannjjm	3272	2	numbers	number	NNS
cord-023095-4dannjjm	3272	3	were	be	VBD
cord-023095-4dannjjm	3272	4	the	the	DT
cord-023095-4dannjjm	3272	5	same	same	JJ
cord-023095-4dannjjm	3272	6	in	in	IN
cord-023095-4dannjjm	3272	7	one	one	CD
cord-023095-4dannjjm	3272	8	sample	sample	NN
cord-023095-4dannjjm	3272	9	,	,	,
cord-023095-4dannjjm	3272	10	less	less	JJR
cord-023095-4dannjjm	3272	11	in	in	IN
cord-023095-4dannjjm	3272	12	sternal	sternal	JJ
cord-023095-4dannjjm	3272	13	samples	sample	NNS
cord-023095-4dannjjm	3272	14	compared	compare	VBN
cord-023095-4dannjjm	3272	15	to	to	IN
cord-023095-4dannjjm	3272	16	iliac	iliac	NN
cord-023095-4dannjjm	3272	17	samples	sample	NNS
cord-023095-4dannjjm	3272	18	from	from	IN
cord-023095-4dannjjm	3272	19	2	2	CD
cord-023095-4dannjjm	3272	20	cats	cat	NNS
cord-023095-4dannjjm	3272	21	,	,	,
cord-023095-4dannjjm	3272	22	and	and	CC
cord-023095-4dannjjm	3272	23	overestimated	overestimate	VBN
cord-023095-4dannjjm	3272	24	in	in	IN
cord-023095-4dannjjm	3272	25	the	the	DT
cord-023095-4dannjjm	3272	26	sternal	sternal	JJ
cord-023095-4dannjjm	3272	27	sample	sample	NN
cord-023095-4dannjjm	3272	28	from	from	IN
cord-023095-4dannjjm	3272	29	1	1	CD
cord-023095-4dannjjm	3272	30	cat	cat	NN
cord-023095-4dannjjm	3272	31	.	.	.
cord-023095-4dannjjm	3273	1	Bone	bone	NN
cord-023095-4dannjjm	3273	2	marrow	marrow	NN
cord-023095-4dannjjm	3273	3	cell	cell	NN
cord-023095-4dannjjm	3273	4	morphology	morphology	NN
cord-023095-4dannjjm	3273	5	was	be	VBD
cord-023095-4dannjjm	3273	6	normal	normal	JJ
cord-023095-4dannjjm	3273	7	in	in	IN
cord-023095-4dannjjm	3273	8	all	all	DT
cord-023095-4dannjjm	3273	9	acceptable	acceptable	JJ
cord-023095-4dannjjm	3273	10	samples	sample	NNS
cord-023095-4dannjjm	3273	11	.	.	.
cord-023095-4dannjjm	3274	1	It	-PRON-	PRP
cord-023095-4dannjjm	3274	2	was	be	VBD
cord-023095-4dannjjm	3274	3	concluded	conclude	VBN
cord-023095-4dannjjm	3274	4	that	that	IN
cord-023095-4dannjjm	3274	5	sternal	sternal	JJ
cord-023095-4dannjjm	3274	6	aspiration	aspiration	NN
cord-023095-4dannjjm	3274	7	of	of	IN
cord-023095-4dannjjm	3274	8	bone	bone	NN
cord-023095-4dannjjm	3274	9	marrow	marrow	NN
cord-023095-4dannjjm	3274	10	using	use	VBG
cord-023095-4dannjjm	3274	11	a	a	DT
cord-023095-4dannjjm	3274	12	22	22	CD
cord-023095-4dannjjm	3274	13	-	-	SYM
cord-023095-4dannjjm	3274	14	23	23	CD
cord-023095-4dannjjm	3274	15	ga	ga	NNP
cord-023095-4dannjjm	3274	16	hypodermic	hypodermic	NNP
cord-023095-4dannjjm	3274	17	needle	needle	NN
cord-023095-4dannjjm	3274	18	is	be	VBZ
cord-023095-4dannjjm	3274	19	1	1	CD
cord-023095-4dannjjm	3274	20	)	)	-RRB-
cord-023095-4dannjjm	3274	21	easier	easy	JJR
cord-023095-4dannjjm	3274	22	to	to	TO
cord-023095-4dannjjm	3274	23	perform	perform	VB
cord-023095-4dannjjm	3274	24	than	than	IN
cord-023095-4dannjjm	3274	25	iliac	iliac	JJ
cord-023095-4dannjjm	3274	26	aspiration	aspiration	NN
cord-023095-4dannjjm	3274	27	;	;	:
cord-023095-4dannjjm	3274	28	2	2	LS
cord-023095-4dannjjm	3274	29	)	)	-RRB-
cord-023095-4dannjjm	3274	30	safe	safe	JJ
cord-023095-4dannjjm	3274	31	;	;	:
cord-023095-4dannjjm	3274	32	but	but	CC
cord-023095-4dannjjm	3274	33	3	3	LS
cord-023095-4dannjjm	3274	34	)	)	-RRB-
cord-023095-4dannjjm	3274	35	provides	provide	VBZ
cord-023095-4dannjjm	3274	36	samples	sample	NNS
cord-023095-4dannjjm	3274	37	of	of	IN
cord-023095-4dannjjm	3274	38	lower	low	JJR
cord-023095-4dannjjm	3274	39	quality	quality	NN
cord-023095-4dannjjm	3274	40	than	than	IN
cord-023095-4dannjjm	3274	41	iliac	iliac	JJ
cord-023095-4dannjjm	3274	42	aspiration	aspiration	NN
cord-023095-4dannjjm	3274	43	in	in	IN
cord-023095-4dannjjm	3274	44	cats	cat	NNS
cord-023095-4dannjjm	3274	45	.	.	.
cord-023095-4dannjjm	3275	1	The	the	DT
cord-023095-4dannjjm	3275	2	diameter	diameter	NN
cord-023095-4dannjjm	3275	3	of	of	IN
cord-023095-4dannjjm	3275	4	11	11	CD
cord-023095-4dannjjm	3275	5	-	-	HYPH
cord-023095-4dannjjm	3275	6	13ga	13ga	NN
cord-023095-4dannjjm	3275	7	Jamshidi	Jamshidi	NNP
cord-023095-4dannjjm	3275	8	-	-	HYPH
cord-023095-4dannjjm	3275	9	type	type	NN
cord-023095-4dannjjm	3275	10	needles	needle	NNS
cord-023095-4dannjjm	3275	11	makes	make	VBZ
cord-023095-4dannjjm	3275	12	bone	bone	NN
cord-023095-4dannjjm	3275	13	marrow	marrow	NN
cord-023095-4dannjjm	3275	14	core	core	NN
cord-023095-4dannjjm	3275	15	biopsy	biopsy	NN
cord-023095-4dannjjm	3275	16	difficult	difficult	JJ
cord-023095-4dannjjm	3275	17	in	in	IN
cord-023095-4dannjjm	3275	18	cats	cat	NNS
cord-023095-4dannjjm	3275	19	.	.	.
cord-023095-4dannjjm	3276	1	In	in	IN
cord-023095-4dannjjm	3276	2	this	this	DT
cord-023095-4dannjjm	3276	3	study	study	NN
cord-023095-4dannjjm	3276	4	,	,	,
cord-023095-4dannjjm	3276	5	biopsies	biopsy	NNS
cord-023095-4dannjjm	3276	6	of	of	IN
cord-023095-4dannjjm	3276	7	the	the	DT
cord-023095-4dannjjm	3276	8	left	left	JJ
cord-023095-4dannjjm	3276	9	humeral	humeral	JJ
cord-023095-4dannjjm	3276	10	head	head	NN
cord-023095-4dannjjm	3276	11	were	be	VBD
cord-023095-4dannjjm	3276	12	taken	take	VBN
cord-023095-4dannjjm	3276	13	under	under	IN
cord-023095-4dannjjm	3276	14	anesthesia	anesthesia	NN
cord-023095-4dannjjm	3276	15	using	use	VBG
cord-023095-4dannjjm	3276	16	a	a	DT
cord-023095-4dannjjm	3276	17	1-inch	1-inch	CD
cord-023095-4dannjjm	3276	18	,	,	,
cord-023095-4dannjjm	3276	19	15ga	15ga	JJ
cord-023095-4dannjjm	3276	20	needle	needle	NN
cord-023095-4dannjjm	3276	21	(	(	-LRB-
cord-023095-4dannjjm	3276	22	EZ	EZ	NNP
cord-023095-4dannjjm	3276	23	-	-	HYPH
cord-023095-4dannjjm	3276	24	IO	IO	NNP
cord-023095-4dannjjm	3276	25	s	s	POS
cord-023095-4dannjjm	3276	26	Intraosseous	Intraosseous	NNP
cord-023095-4dannjjm	3276	27	Infusion	Infusion	NNP
cord-023095-4dannjjm	3276	28	System	System	NNP
cord-023095-4dannjjm	3276	29	,	,	,
cord-023095-4dannjjm	3276	30	Vidacare	Vidacare	NNP
cord-023095-4dannjjm	3276	31	)	)	-RRB-
cord-023095-4dannjjm	3276	32	from	from	IN
cord-023095-4dannjjm	3276	33	10	10	CD
cord-023095-4dannjjm	3276	34	healthy	healthy	JJ
cord-023095-4dannjjm	3276	35	cats	cat	NNS
cord-023095-4dannjjm	3276	36	weighing	weigh	VBG
cord-023095-4dannjjm	3276	37	3.4	3.4	CD
cord-023095-4dannjjm	3276	38	-	-	SYM
cord-023095-4dannjjm	3276	39	8.4	8.4	CD
cord-023095-4dannjjm	3276	40	kg	kg	NNS
cord-023095-4dannjjm	3276	41	with	with	IN
cord-023095-4dannjjm	3276	42	body	body	NN
cord-023095-4dannjjm	3276	43	condition	condition	NN
cord-023095-4dannjjm	3276	44	scores	score	NNS
cord-023095-4dannjjm	3276	45	of	of	IN
cord-023095-4dannjjm	3276	46	5	5	CD
cord-023095-4dannjjm	3276	47	-	-	SYM
cord-023095-4dannjjm	3276	48	9	9	CD
cord-023095-4dannjjm	3276	49	(	(	-LRB-
cord-023095-4dannjjm	3276	50	on	on	IN
cord-023095-4dannjjm	3276	51	a	a	DT
cord-023095-4dannjjm	3276	52	scale	scale	NN
cord-023095-4dannjjm	3276	53	of	of	IN
cord-023095-4dannjjm	3276	54	1	1	CD
cord-023095-4dannjjm	3276	55	-	-	SYM
cord-023095-4dannjjm	3276	56	9	9	CD
cord-023095-4dannjjm	3276	57	)	)	-RRB-
cord-023095-4dannjjm	3276	58	.	.	.
cord-023095-4dannjjm	3277	1	Humeral	Humeral	NNP
cord-023095-4dannjjm	3277	2	biopsies	biopsy	NNS
cord-023095-4dannjjm	3277	3	were	be	VBD
cord-023095-4dannjjm	3277	4	compared	compare	VBN
cord-023095-4dannjjm	3277	5	to	to	IN
cord-023095-4dannjjm	3277	6	biopsies	biopsy	NNS
cord-023095-4dannjjm	3277	7	taken	take	VBN
cord-023095-4dannjjm	3277	8	from	from	IN
cord-023095-4dannjjm	3277	9	the	the	DT
cord-023095-4dannjjm	3277	10	left	left	JJ
cord-023095-4dannjjm	3277	11	iliac	iliac	NNP
cord-023095-4dannjjm	3277	12	crest	crest	NN
cord-023095-4dannjjm	3277	13	using	use	VBG
cord-023095-4dannjjm	3277	14	a	a	DT
cord-023095-4dannjjm	3277	15	2-inch	2-inch	CD
cord-023095-4dannjjm	3277	16	,	,	,
cord-023095-4dannjjm	3277	17	13ga	13ga	NN
cord-023095-4dannjjm	3277	18	Jamshidi	Jamshidi	NNP
cord-023095-4dannjjm	3277	19	needle	needle	NN
cord-023095-4dannjjm	3277	20	.	.	.
cord-023095-4dannjjm	3278	1	Biopsies	biopsy	NNS
cord-023095-4dannjjm	3278	2	were	be	VBD
cord-023095-4dannjjm	3278	3	performed	perform	VBN
cord-023095-4dannjjm	3278	4	in	in	IN
cord-023095-4dannjjm	3278	5	randomized	randomized	JJ
cord-023095-4dannjjm	3278	6	order	order	NN
cord-023095-4dannjjm	3278	7	by	by	IN
cord-023095-4dannjjm	3278	8	one	one	CD
cord-023095-4dannjjm	3278	9	investigator	investigator	NN
cord-023095-4dannjjm	3278	10	.	.	.
cord-023095-4dannjjm	3279	1	Biopsy	Biopsy	NNP
cord-023095-4dannjjm	3279	2	was	be	VBD
cord-023095-4dannjjm	3279	3	repeated	repeat	VBN
cord-023095-4dannjjm	3279	4	to	to	IN
cord-023095-4dannjjm	3279	5	a	a	DT
cord-023095-4dannjjm	3279	6	maximum	maximum	NN
cord-023095-4dannjjm	3279	7	of	of	IN
cord-023095-4dannjjm	3279	8	3	3	CD
cord-023095-4dannjjm	3279	9	attempts	attempt	NNS
cord-023095-4dannjjm	3279	10	until	until	IN
cord-023095-4dannjjm	3279	11	a	a	DT
cord-023095-4dannjjm	3279	12	specimen	specimen	NN
cord-023095-4dannjjm	3279	13	!	!	.
cord-023095-4dannjjm	3280	1	5	5	CD
cord-023095-4dannjjm	3280	2	mm	mm	NNP
cord-023095-4dannjjm	3280	3	long	long	RB
cord-023095-4dannjjm	3280	4	was	be	VBD
cord-023095-4dannjjm	3280	5	obtained	obtain	VBN
cord-023095-4dannjjm	3280	6	.	.	.
cord-023095-4dannjjm	3281	1	Difficulty	difficulty	NN
cord-023095-4dannjjm	3281	2	of	of	IN
cord-023095-4dannjjm	3281	3	site	site	NN
cord-023095-4dannjjm	3281	4	localization	localization	NN
cord-023095-4dannjjm	3281	5	,	,	,
cord-023095-4dannjjm	3281	6	needle	needle	NN
cord-023095-4dannjjm	3281	7	insertion	insertion	NN
cord-023095-4dannjjm	3281	8	and	and	CC
cord-023095-4dannjjm	3281	9	needle	needle	NN
cord-023095-4dannjjm	3281	10	advancement	advancement	NN
cord-023095-4dannjjm	3281	11	were	be	VBD
cord-023095-4dannjjm	3281	12	scored	score	VBN
cord-023095-4dannjjm	3281	13	from	from	IN
cord-023095-4dannjjm	3281	14	1	1	CD
cord-023095-4dannjjm	3281	15	(	(	-LRB-
cord-023095-4dannjjm	3281	16	easiest	easy	JJS
cord-023095-4dannjjm	3281	17	)	)	-RRB-
cord-023095-4dannjjm	3281	18	to	to	IN
cord-023095-4dannjjm	3281	19	5	5	CD
cord-023095-4dannjjm	3281	20	(	(	-LRB-
cord-023095-4dannjjm	3281	21	hardest	hard	RBS
cord-023095-4dannjjm	3281	22	)	)	-RRB-
cord-023095-4dannjjm	3281	23	.	.	.
cord-023095-4dannjjm	3282	1	Specimens	specimen	NNS
cord-023095-4dannjjm	3282	2	were	be	VBD
cord-023095-4dannjjm	3282	3	wrapped	wrap	VBN
cord-023095-4dannjjm	3282	4	in	in	IN
cord-023095-4dannjjm	3282	5	tissue	tissue	NN
cord-023095-4dannjjm	3282	6	paper	paper	NN
cord-023095-4dannjjm	3282	7	and	and	CC
cord-023095-4dannjjm	3282	8	placed	place	VBN
cord-023095-4dannjjm	3282	9	in	in	IN
cord-023095-4dannjjm	3282	10	Davidson	Davidson	NNP
cord-023095-4dannjjm	3282	11	's	's	POS
cord-023095-4dannjjm	3282	12	fixative	fixative	NN
cord-023095-4dannjjm	3282	13	for	for	IN
cord-023095-4dannjjm	3282	14	15	15	CD
cord-023095-4dannjjm	3282	15	min	min	NN
cord-023095-4dannjjm	3282	16	and	and	CC
cord-023095-4dannjjm	3282	17	then	then	RB
cord-023095-4dannjjm	3282	18	transferred	transfer	VBD
cord-023095-4dannjjm	3282	19	to	to	IN
cord-023095-4dannjjm	3282	20	formalin	formalin	NN
cord-023095-4dannjjm	3282	21	.	.	.
cord-023095-4dannjjm	3283	1	Biopsy	biopsy	NN
cord-023095-4dannjjm	3283	2	sections	section	NNS
cord-023095-4dannjjm	3283	3	were	be	VBD
cord-023095-4dannjjm	3283	4	reviewed	review	VBN
cord-023095-4dannjjm	3283	5	by	by	IN
cord-023095-4dannjjm	3283	6	a	a	DT
cord-023095-4dannjjm	3283	7	pathologist	pathologist	NN
cord-023095-4dannjjm	3283	8	blinded	blind	VBN
cord-023095-4dannjjm	3283	9	to	to	IN
cord-023095-4dannjjm	3283	10	biopsy	biopsy	NN
cord-023095-4dannjjm	3283	11	site	site	NN
cord-023095-4dannjjm	3283	12	and	and	CC
cord-023095-4dannjjm	3283	13	cat	cat	NN
cord-023095-4dannjjm	3283	14	.	.	.
cord-023095-4dannjjm	3284	1	Biopsy	biopsy	JJ
cord-023095-4dannjjm	3284	2	length	length	NN
cord-023095-4dannjjm	3284	3	on	on	IN
cord-023095-4dannjjm	3284	4	the	the	DT
cord-023095-4dannjjm	3284	5	slide	slide	NN
cord-023095-4dannjjm	3284	6	was	be	VBD
cord-023095-4dannjjm	3284	7	measured	measure	VBN
cord-023095-4dannjjm	3284	8	,	,	,
cord-023095-4dannjjm	3284	9	and	and	CC
cord-023095-4dannjjm	3284	10	biopsy	biopsy	NN
cord-023095-4dannjjm	3284	11	quality	quality	NN
cord-023095-4dannjjm	3284	12	was	be	VBD
cord-023095-4dannjjm	3284	13	scored	score	VBN
cord-023095-4dannjjm	3284	14	from	from	IN
cord-023095-4dannjjm	3284	15	0	0	NFP
cord-023095-4dannjjm	3284	16	(	(	-LRB-
cord-023095-4dannjjm	3284	17	no	no	DT
cord-023095-4dannjjm	3284	18	hematopoietic	hematopoietic	JJ
cord-023095-4dannjjm	3284	19	tissue	tissue	NN
cord-023095-4dannjjm	3284	20	)	)	-RRB-
cord-023095-4dannjjm	3284	21	to	to	IN
cord-023095-4dannjjm	3284	22	5	5	CD
cord-023095-4dannjjm	3284	23	(	(	-LRB-
cord-023095-4dannjjm	3284	24	!	!	.
cord-023095-4dannjjm	3284	25	5	5	CD
cord-023095-4dannjjm	3284	26	intertrabecular	intertrabecular	JJ
cord-023095-4dannjjm	3284	27	spaces	space	NNS
cord-023095-4dannjjm	3284	28	free	free	JJ
cord-023095-4dannjjm	3284	29	of	of	IN
cord-023095-4dannjjm	3284	30	artifact	artifact	NN
cord-023095-4dannjjm	3284	31	)	)	-RRB-
cord-023095-4dannjjm	3284	32	.	.	.
cord-023095-4dannjjm	3285	1	Post	post	NN
cord-023095-4dannjjm	3285	2	-	-	NN
cord-023095-4dannjjm	3285	3	procedure	procedure	NN
cord-023095-4dannjjm	3285	4	,	,	,
cord-023095-4dannjjm	3285	5	cats	cat	NNS
cord-023095-4dannjjm	3285	6	were	be	VBD
cord-023095-4dannjjm	3285	7	treated	treat	VBN
cord-023095-4dannjjm	3285	8	with	with	IN
cord-023095-4dannjjm	3285	9	tramadol	tramadol	NN
cord-023095-4dannjjm	3285	10	(	(	-LRB-
cord-023095-4dannjjm	3285	11	4	4	CD
cord-023095-4dannjjm	3285	12	-	-	SYM
cord-023095-4dannjjm	3285	13	5	5	CD
cord-023095-4dannjjm	3285	14	mg	mg	NNP
cord-023095-4dannjjm	3285	15	/	/	SYM
cord-023095-4dannjjm	3285	16	kg	kg	NNP
cord-023095-4dannjjm	3285	17	,	,	,
cord-023095-4dannjjm	3285	18	PO	PO	NNP
cord-023095-4dannjjm	3285	19	,	,	,
cord-023095-4dannjjm	3285	20	q12h	q12h	CD
cord-023095-4dannjjm	3285	21	)	)	-RRB-
cord-023095-4dannjjm	3285	22	for	for	IN
cord-023095-4dannjjm	3285	23	3	3	CD
cord-023095-4dannjjm	3285	24	days	day	NNS
cord-023095-4dannjjm	3285	25	,	,	,
cord-023095-4dannjjm	3285	26	and	and	CC
cord-023095-4dannjjm	3285	27	assessed	assess	VBN
cord-023095-4dannjjm	3285	28	for	for	IN
cord-023095-4dannjjm	3285	29	postbiopsy	postbiopsy	JJ
cord-023095-4dannjjm	3285	30	pain	pain	NN
cord-023095-4dannjjm	3285	31	(	(	-LRB-
cord-023095-4dannjjm	3285	32	Colorado	Colorado	NNP
cord-023095-4dannjjm	3285	33	State	State	NNP
cord-023095-4dannjjm	3285	34	University	University	NNP
cord-023095-4dannjjm	3285	35	Feline	Feline	NNP
cord-023095-4dannjjm	3285	36	Acute	acute	JJ
cord-023095-4dannjjm	3285	37	Pain	pain	NN
cord-023095-4dannjjm	3285	38	Scale	scale	NN
cord-023095-4dannjjm	3285	39	,	,	,
cord-023095-4dannjjm	3285	40	range	range	VBP
cord-023095-4dannjjm	3285	41	0	0	NFP
cord-023095-4dannjjm	3285	42	[	[	-LRB-
cord-023095-4dannjjm	3285	43	no	no	DT
cord-023095-4dannjjm	3285	44	pain	pain	NN
cord-023095-4dannjjm	3285	45	]	]	-RRB-
cord-023095-4dannjjm	3285	46	-4	-4	FW
cord-023095-4dannjjm	3285	47	[	[	-LRB-
cord-023095-4dannjjm	3285	48	maximum	maximum	NN
cord-023095-4dannjjm	3285	49	]	]	-RRB-
cord-023095-4dannjjm	3285	50	)	)	-RRB-
cord-023095-4dannjjm	3285	51	and	and	CC
cord-023095-4dannjjm	3285	52	swelling	swelling	NN
cord-023095-4dannjjm	3285	53	of	of	IN
cord-023095-4dannjjm	3285	54	biopsy	biopsy	NN
cord-023095-4dannjjm	3285	55	sites	site	NNS
cord-023095-4dannjjm	3285	56	(	(	-LRB-
cord-023095-4dannjjm	3285	57	range	range	NN
cord-023095-4dannjjm	3285	58	0	0	CD
cord-023095-4dannjjm	3286	1	[	[	-LRB-
cord-023095-4dannjjm	3286	2	none	none	NN
cord-023095-4dannjjm	3286	3	]	]	-RRB-
cord-023095-4dannjjm	3286	4	-3	-3	NNP
cord-023095-4dannjjm	3287	1	[	[	-LRB-
cord-023095-4dannjjm	3287	2	marked	mark	VBN
cord-023095-4dannjjm	3287	3	]	]	-RRB-
cord-023095-4dannjjm	3287	4	)	)	-RRB-
cord-023095-4dannjjm	3287	5	.	.	.
cord-023095-4dannjjm	3288	1	Data	datum	NNS
cord-023095-4dannjjm	3288	2	were	be	VBD
cord-023095-4dannjjm	3288	3	analyzed	analyze	VBN
cord-023095-4dannjjm	3288	4	by	by	IN
cord-023095-4dannjjm	3288	5	ANCOVA	ANCOVA	NNP
cord-023095-4dannjjm	3288	6	accounting	accounting	NN
cord-023095-4dannjjm	3288	7	for	for	IN
cord-023095-4dannjjm	3288	8	effects	effect	NNS
cord-023095-4dannjjm	3288	9	of	of	IN
cord-023095-4dannjjm	3288	10	weight	weight	NN
cord-023095-4dannjjm	3288	11	and	and	CC
cord-023095-4dannjjm	3288	12	body	body	NN
cord-023095-4dannjjm	3288	13	condition	condition	NN
cord-023095-4dannjjm	3288	14	score	score	NN
cord-023095-4dannjjm	3288	15	.	.	.
cord-023095-4dannjjm	3289	1	There	there	EX
cord-023095-4dannjjm	3289	2	were	be	VBD
cord-023095-4dannjjm	3289	3	no	no	DT
cord-023095-4dannjjm	3289	4	significant	significant	JJ
cord-023095-4dannjjm	3289	5	differences	difference	NNS
cord-023095-4dannjjm	3289	6	between	between	IN
cord-023095-4dannjjm	3289	7	15ga	15ga	NN
cord-023095-4dannjjm	3289	8	and	and	CC
cord-023095-4dannjjm	3289	9	13ga	13ga	NN
cord-023095-4dannjjm	3289	10	biopsies	biopsy	NNS
cord-023095-4dannjjm	3289	11	except	except	IN
cord-023095-4dannjjm	3289	12	for	for	IN
cord-023095-4dannjjm	3289	13	post	post	JJ
cord-023095-4dannjjm	3289	14	-	-	JJ
cord-023095-4dannjjm	3289	15	biopsy	biopsy	JJ
cord-023095-4dannjjm	3289	16	swelling	swelling	NN
cord-023095-4dannjjm	3289	17	,	,	,
cord-023095-4dannjjm	3289	18	and	and	CC
cord-023095-4dannjjm	3289	19	there	there	EX
cord-023095-4dannjjm	3289	20	were	be	VBD
cord-023095-4dannjjm	3289	21	no	no	DT
cord-023095-4dannjjm	3289	22	significant	significant	JJ
cord-023095-4dannjjm	3289	23	effects	effect	NNS
cord-023095-4dannjjm	3289	24	of	of	IN
cord-023095-4dannjjm	3289	25	body	body	NN
cord-023095-4dannjjm	3289	26	weight	weight	NN
cord-023095-4dannjjm	3289	27	and	and	CC
cord-023095-4dannjjm	3289	28	body	body	NN
cord-023095-4dannjjm	3289	29	condition	condition	NN
cord-023095-4dannjjm	3289	30	.	.	.
cord-023095-4dannjjm	3290	1	Six	six	CD
cord-023095-4dannjjm	3290	2	(	(	-LRB-
cord-023095-4dannjjm	3290	3	60	60	CD
cord-023095-4dannjjm	3290	4	%	%	NN
cord-023095-4dannjjm	3290	5	)	)	-RRB-
cord-023095-4dannjjm	3290	6	of	of	IN
cord-023095-4dannjjm	3290	7	15	15	CD
cord-023095-4dannjjm	3290	8	ga	ga	NNP
cord-023095-4dannjjm	3290	9	and	and	CC
cord-023095-4dannjjm	3290	10	5	5	CD
cord-023095-4dannjjm	3290	11	(	(	-LRB-
cord-023095-4dannjjm	3290	12	50	50	CD
cord-023095-4dannjjm	3290	13	%	%	NN
cord-023095-4dannjjm	3290	14	)	)	-RRB-
cord-023095-4dannjjm	3290	15	of	of	IN
cord-023095-4dannjjm	3290	16	13ga	13ga	NN
cord-023095-4dannjjm	3290	17	biopsies	biopsy	NNS
cord-023095-4dannjjm	3290	18	were	be	VBD
cord-023095-4dannjjm	3290	19	considered	consider	VBN
cord-023095-4dannjjm	3290	20	acceptable	acceptable	JJ
cord-023095-4dannjjm	3290	21	specimens	specimen	NNS
cord-023095-4dannjjm	3290	22	for	for	IN
cord-023095-4dannjjm	3290	23	assessment	assessment	NN
cord-023095-4dannjjm	3290	24	of	of	IN
cord-023095-4dannjjm	3290	25	bone	bone	NN
cord-023095-4dannjjm	3290	26	marrow	marrow	NN
cord-023095-4dannjjm	3290	27	architecture	architecture	NN
cord-023095-4dannjjm	3290	28	and	and	CC
cord-023095-4dannjjm	3290	29	morphology	morphology	NN
cord-023095-4dannjjm	3290	30	;	;	:
cord-023095-4dannjjm	3290	31	all	all	DT
cord-023095-4dannjjm	3290	32	intact	intact	JJ
cord-023095-4dannjjm	3290	33	spaces	space	NNS
cord-023095-4dannjjm	3290	34	in	in	IN
cord-023095-4dannjjm	3290	35	these	these	DT
cord-023095-4dannjjm	3290	36	biopsies	biopsy	NNS
cord-023095-4dannjjm	3290	37	had	have	VBD
cord-023095-4dannjjm	3290	38	normal	normal	JJ
cord-023095-4dannjjm	3290	39	hematopoiesis	hematopoiesis	NN
cord-023095-4dannjjm	3290	40	and	and	CC
cord-023095-4dannjjm	3290	41	cell	cell	NN
cord-023095-4dannjjm	3290	42	morphology	morphology	NN
cord-023095-4dannjjm	3290	43	.	.	.
cord-023095-4dannjjm	3291	1	Comparison	comparison	NN
cord-023095-4dannjjm	3291	2	of	of	IN
cord-023095-4dannjjm	3291	3	acceptable	acceptable	JJ
cord-023095-4dannjjm	3291	4	15	15	CD
cord-023095-4dannjjm	3291	5	ga	ga	NNP
cord-023095-4dannjjm	3291	6	to	to	IN
cord-023095-4dannjjm	3291	7	13	13	CD
cord-023095-4dannjjm	3291	8	ga	ga	NNP
cord-023095-4dannjjm	3291	9	biopsy	biopsy	NN
cord-023095-4dannjjm	3291	10	specimens	specimen	NNS
cord-023095-4dannjjm	3291	11	from	from	IN
cord-023095-4dannjjm	3291	12	4	4	CD
cord-023095-4dannjjm	3291	13	cats	cat	NNS
cord-023095-4dannjjm	3291	14	showed	show	VBD
cord-023095-4dannjjm	3291	15	no	no	DT
cord-023095-4dannjjm	3291	16	significant	significant	JJ
cord-023095-4dannjjm	3291	17	differences	difference	NNS
cord-023095-4dannjjm	3291	18	for	for	IN
cord-023095-4dannjjm	3291	19	cell	cell	NN
cord-023095-4dannjjm	3291	20	density	density	NN
cord-023095-4dannjjm	3291	21	and	and	CC
cord-023095-4dannjjm	3291	22	lymphocytes	lymphocyte	NNS
cord-023095-4dannjjm	3291	23	/	/	SYM
cord-023095-4dannjjm	3291	24	plasma	plasma	NN
cord-023095-4dannjjm	3291	25	cells	cell	NNS
cord-023095-4dannjjm	3291	26	,	,	,
cord-023095-4dannjjm	3291	27	while	while	IN
cord-023095-4dannjjm	3291	28	cellularity	cellularity	NN
cord-023095-4dannjjm	3291	29	,	,	,
cord-023095-4dannjjm	3291	30	assessed	assess	VBN
cord-023095-4dannjjm	3291	31	as	as	RB
cord-023095-4dannjjm	3291	32	high	high	JJ
cord-023095-4dannjjm	3291	33	in	in	IN
cord-023095-4dannjjm	3291	34	2	2	CD
cord-023095-4dannjjm	3291	35	of	of	IN
cord-023095-4dannjjm	3291	36	the	the	DT
cord-023095-4dannjjm	3291	37	13	13	CD
cord-023095-4dannjjm	3291	38	ga	ga	NNP
cord-023095-4dannjjm	3291	39	biopsies	biopsy	NNS
cord-023095-4dannjjm	3291	40	,	,	,
cord-023095-4dannjjm	3291	41	was	be	VBD
cord-023095-4dannjjm	3291	42	assessed	assess	VBN
cord-023095-4dannjjm	3291	43	as	as	IN
cord-023095-4dannjjm	3291	44	medium	medium	NN
cord-023095-4dannjjm	3291	45	in	in	IN
cord-023095-4dannjjm	3291	46	corresponding	correspond	VBG
cord-023095-4dannjjm	3291	47	15ga	15ga	JJ
cord-023095-4dannjjm	3291	48	biopsies	biopsy	NNS
cord-023095-4dannjjm	3291	49	;	;	:
cord-023095-4dannjjm	3291	50	and	and	CC
cord-023095-4dannjjm	3291	51	megakaryocytes	megakaryocytes	NNP
cord-023095-4dannjjm	3291	52	,	,	,
cord-023095-4dannjjm	3291	53	assessed	assess	VBN
cord-023095-4dannjjm	3291	54	as	as	IN
cord-023095-4dannjjm	3291	55	4	4	CD
cord-023095-4dannjjm	3291	56	-	-	SYM
cord-023095-4dannjjm	3291	57	9	9	CD
cord-023095-4dannjjm	3291	58	/	/	SYM
cord-023095-4dannjjm	3291	59	low	low	JJ
cord-023095-4dannjjm	3291	60	-	-	HYPH
cord-023095-4dannjjm	3291	61	power	power	NN
cord-023095-4dannjjm	3291	62	field	field	NN
cord-023095-4dannjjm	3291	63	in	in	IN
cord-023095-4dannjjm	3291	64	one	one	CD
cord-023095-4dannjjm	3291	65	13ga	13ga	NN
cord-023095-4dannjjm	3291	66	biopsy	biopsy	NN
cord-023095-4dannjjm	3291	67	,	,	,
cord-023095-4dannjjm	3291	68	were	be	VBD
cord-023095-4dannjjm	3291	69	assessed	assess	VBN
cord-023095-4dannjjm	3291	70	as	as	IN
cord-023095-4dannjjm	3291	71	3	3	CD
cord-023095-4dannjjm	3291	72	/	/	SYM
cord-023095-4dannjjm	3291	73	low	low	JJ
cord-023095-4dannjjm	3291	74	-	-	HYPH
cord-023095-4dannjjm	3291	75	power	power	NN
cord-023095-4dannjjm	3291	76	field	field	NN
cord-023095-4dannjjm	3291	77	in	in	IN
cord-023095-4dannjjm	3291	78	the	the	DT
cord-023095-4dannjjm	3291	79	15	15	CD
cord-023095-4dannjjm	3291	80	ga	ga	NNP
cord-023095-4dannjjm	3291	81	biopsy	biopsy	NNP
cord-023095-4dannjjm	3291	82	.	.	.
cord-023095-4dannjjm	3292	1	Myeloid	myeloid	NN
cord-023095-4dannjjm	3292	2	:	:	:
cord-023095-4dannjjm	3292	3	erythroid	erythroid	NN
cord-023095-4dannjjm	3292	4	ratios	ratio	NNS
cord-023095-4dannjjm	3292	5	were	be	VBD
cord-023095-4dannjjm	3292	6	greater	great	JJR
cord-023095-4dannjjm	3292	7	in	in	IN
cord-023095-4dannjjm	3292	8	15	15	CD
cord-023095-4dannjjm	3292	9	ga	ga	NNP
cord-023095-4dannjjm	3292	10	biopsies	biopsy	NNS
cord-023095-4dannjjm	3292	11	compared	compare	VBN
cord-023095-4dannjjm	3292	12	to	to	IN
cord-023095-4dannjjm	3292	13	13	13	CD
cord-023095-4dannjjm	3292	14	ga	ga	NNP
cord-023095-4dannjjm	3292	15	biopsies	biopsy	NNS
cord-023095-4dannjjm	3292	16	in	in	IN
cord-023095-4dannjjm	3292	17	2	2	CD
cord-023095-4dannjjm	3292	18	cats	cat	NNS
cord-023095-4dannjjm	3292	19	,	,	,
cord-023095-4dannjjm	3292	20	and	and	CC
cord-023095-4dannjjm	3292	21	less	less	JJR
cord-023095-4dannjjm	3292	22	in	in	IN
cord-023095-4dannjjm	3292	23	the	the	DT
cord-023095-4dannjjm	3292	24	15	15	CD
cord-023095-4dannjjm	3292	25	ga	ga	NNP
cord-023095-4dannjjm	3292	26	biopsy	biopsy	NNP
cord-023095-4dannjjm	3292	27	in	in	IN
cord-023095-4dannjjm	3292	28	one	one	CD
cord-023095-4dannjjm	3292	29	cat	cat	NN
cord-023095-4dannjjm	3292	30	.	.	.
cord-023095-4dannjjm	3293	1	Discordant	discordant	JJ
cord-023095-4dannjjm	3293	2	results	result	NNS
cord-023095-4dannjjm	3293	3	between	between	IN
cord-023095-4dannjjm	3293	4	biopsies	biopsy	NNS
cord-023095-4dannjjm	3293	5	were	be	VBD
cord-023095-4dannjjm	3293	6	not	not	RB
cord-023095-4dannjjm	3293	7	related	relate	VBN
cord-023095-4dannjjm	3293	8	to	to	IN
cord-023095-4dannjjm	3293	9	differences	difference	NNS
cord-023095-4dannjjm	3293	10	in	in	IN
cord-023095-4dannjjm	3293	11	quality	quality	NN
cord-023095-4dannjjm	3293	12	.	.	.
cord-023095-4dannjjm	3294	1	In	in	IN
cord-023095-4dannjjm	3294	2	conclusion	conclusion	NN
cord-023095-4dannjjm	3294	3	,	,	,
cord-023095-4dannjjm	3294	4	15	15	CD
cord-023095-4dannjjm	3294	5	ga	ga	NNP
cord-023095-4dannjjm	3294	6	bone	bone	NN
cord-023095-4dannjjm	3294	7	marrow	marrow	NN
cord-023095-4dannjjm	3294	8	biopsy	biopsy	NN
cord-023095-4dannjjm	3294	9	of	of	IN
cord-023095-4dannjjm	3294	10	the	the	DT
cord-023095-4dannjjm	3294	11	humerus	humerus	NN
cord-023095-4dannjjm	3294	12	was	be	VBD
cord-023095-4dannjjm	3294	13	as	as	RB
cord-023095-4dannjjm	3294	14	likely	likely	JJ
cord-023095-4dannjjm	3294	15	to	to	TO
cord-023095-4dannjjm	3294	16	yield	yield	VB
cord-023095-4dannjjm	3294	17	a	a	DT
cord-023095-4dannjjm	3294	18	specimen	specimen	NN
cord-023095-4dannjjm	3294	19	of	of	IN
cord-023095-4dannjjm	3294	20	acceptable	acceptable	JJ
cord-023095-4dannjjm	3294	21	quality	quality	NN
cord-023095-4dannjjm	3294	22	as	as	IN
cord-023095-4dannjjm	3294	23	was	be	VBD
cord-023095-4dannjjm	3294	24	13	13	CD
cord-023095-4dannjjm	3294	25	ga	ga	NNP
cord-023095-4dannjjm	3294	26	biopsy	biopsy	NNP
cord-023095-4dannjjm	3294	27	of	of	IN
cord-023095-4dannjjm	3294	28	the	the	DT
cord-023095-4dannjjm	3294	29	ilium	ilium	NNP
cord-023095-4dannjjm	3294	30	,	,	,
cord-023095-4dannjjm	3294	31	and	and	CC
cord-023095-4dannjjm	3294	32	resulted	result	VBD
cord-023095-4dannjjm	3294	33	in	in	IN
cord-023095-4dannjjm	3294	34	less	less	JJR
cord-023095-4dannjjm	3294	35	post	post	JJ
cord-023095-4dannjjm	3294	36	-	-	JJ
cord-023095-4dannjjm	3294	37	biopsy	biopsy	JJ
cord-023095-4dannjjm	3294	38	swelling	swelling	NN
cord-023095-4dannjjm	3294	39	.	.	.
cord-023095-4dannjjm	3295	1	Reports	report	NNS
cord-023095-4dannjjm	3295	2	on	on	IN
cord-023095-4dannjjm	3295	3	canine	canine	JJ
cord-023095-4dannjjm	3295	4	acute	acute	JJ
cord-023095-4dannjjm	3295	5	liver	liver	NN
cord-023095-4dannjjm	3295	6	failure	failure	NN
cord-023095-4dannjjm	3295	7	(	(	-LRB-
cord-023095-4dannjjm	3295	8	ALF	ALF	NNP
cord-023095-4dannjjm	3295	9	)	)	-RRB-
cord-023095-4dannjjm	3295	10	include	include	VBP
cord-023095-4dannjjm	3295	11	individual	individual	JJ
cord-023095-4dannjjm	3295	12	or	or	CC
cord-023095-4dannjjm	3295	13	small	small	JJ
cord-023095-4dannjjm	3295	14	case	case	NN
cord-023095-4dannjjm	3295	15	series	series	NN
cord-023095-4dannjjm	3295	16	of	of	IN
cord-023095-4dannjjm	3295	17	animals	animal	NNS
cord-023095-4dannjjm	3295	18	with	with	IN
cord-023095-4dannjjm	3295	19	a	a	DT
cord-023095-4dannjjm	3295	20	specific	specific	JJ
cord-023095-4dannjjm	3295	21	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3295	22	.	.	.
cord-023095-4dannjjm	3296	1	The	the	DT
cord-023095-4dannjjm	3296	2	aim	aim	NN
cord-023095-4dannjjm	3296	3	of	of	IN
cord-023095-4dannjjm	3296	4	this	this	DT
cord-023095-4dannjjm	3296	5	study	study	NN
cord-023095-4dannjjm	3296	6	was	be	VBD
cord-023095-4dannjjm	3296	7	to	to	TO
cord-023095-4dannjjm	3296	8	describe	describe	VB
cord-023095-4dannjjm	3296	9	the	the	DT
cord-023095-4dannjjm	3296	10	clinical	clinical	JJ
cord-023095-4dannjjm	3296	11	course	course	NN
cord-023095-4dannjjm	3296	12	,	,	,
cord-023095-4dannjjm	3296	13	outcome	outcome	NN
cord-023095-4dannjjm	3296	14	and	and	CC
cord-023095-4dannjjm	3296	15	etiology	etiology	NN
cord-023095-4dannjjm	3296	16	of	of	IN
cord-023095-4dannjjm	3296	17	ALF	ALF	NNP
cord-023095-4dannjjm	3296	18	in	in	IN
cord-023095-4dannjjm	3296	19	dogs	dog	NNS
cord-023095-4dannjjm	3296	20	presenting	present	VBG
cord-023095-4dannjjm	3296	21	to	to	IN
cord-023095-4dannjjm	3296	22	a	a	DT
cord-023095-4dannjjm	3296	23	referral	referral	JJ
cord-023095-4dannjjm	3296	24	hospital	hospital	NN
cord-023095-4dannjjm	3296	25	.	.	.
cord-023095-4dannjjm	3297	1	Medical	medical	JJ
cord-023095-4dannjjm	3297	2	records	record	NNS
cord-023095-4dannjjm	3297	3	(	(	-LRB-
cord-023095-4dannjjm	3297	4	1995	1995	CD
cord-023095-4dannjjm	3297	5	)	)	-RRB-
cord-023095-4dannjjm	3297	6	(	(	-LRB-
cord-023095-4dannjjm	3297	7	1996	1996	CD
cord-023095-4dannjjm	3297	8	)	)	-RRB-
cord-023095-4dannjjm	3297	9	(	(	-LRB-
cord-023095-4dannjjm	3297	10	1997	1997	CD
cord-023095-4dannjjm	3297	11	)	)	-RRB-
cord-023095-4dannjjm	3297	12	(	(	-LRB-
cord-023095-4dannjjm	3297	13	1998	1998	CD
cord-023095-4dannjjm	3297	14	)	)	-RRB-
cord-023095-4dannjjm	3297	15	(	(	-LRB-
cord-023095-4dannjjm	3297	16	1999	1999	CD
cord-023095-4dannjjm	3297	17	)	)	-RRB-
cord-023095-4dannjjm	3297	18	(	(	-LRB-
cord-023095-4dannjjm	3297	19	2000	2000	CD
cord-023095-4dannjjm	3297	20	)	)	-RRB-
cord-023095-4dannjjm	3297	21	(	(	-LRB-
cord-023095-4dannjjm	3297	22	2001	2001	CD
cord-023095-4dannjjm	3297	23	)	)	-RRB-
cord-023095-4dannjjm	3297	24	(	(	-LRB-
cord-023095-4dannjjm	3297	25	2002	2002	CD
cord-023095-4dannjjm	3297	26	)	)	-RRB-
cord-023095-4dannjjm	3297	27	(	(	-LRB-
cord-023095-4dannjjm	3297	28	2003	2003	CD
cord-023095-4dannjjm	3297	29	)	)	-RRB-
cord-023095-4dannjjm	3297	30	(	(	-LRB-
cord-023095-4dannjjm	3297	31	2004	2004	CD
cord-023095-4dannjjm	3297	32	)	)	-RRB-
cord-023095-4dannjjm	3297	33	(	(	-LRB-
cord-023095-4dannjjm	3297	34	2005	2005	CD
cord-023095-4dannjjm	3297	35	)	)	-RRB-
cord-023095-4dannjjm	3297	36	(	(	-LRB-
cord-023095-4dannjjm	3297	37	2006	2006	CD
cord-023095-4dannjjm	3297	38	)	)	-RRB-
cord-023095-4dannjjm	3297	39	(	(	-LRB-
cord-023095-4dannjjm	3297	40	2007	2007	CD
cord-023095-4dannjjm	3297	41	)	)	-RRB-
cord-023095-4dannjjm	3297	42	(	(	-LRB-
cord-023095-4dannjjm	3297	43	2008	2008	CD
cord-023095-4dannjjm	3297	44	)	)	-RRB-
cord-023095-4dannjjm	3297	45	(	(	-LRB-
cord-023095-4dannjjm	3297	46	2009	2009	CD
cord-023095-4dannjjm	3297	47	)	)	-RRB-
cord-023095-4dannjjm	3297	48	(	(	-LRB-
cord-023095-4dannjjm	3297	49	2010	2010	CD
cord-023095-4dannjjm	3297	50	)	)	-RRB-
cord-023095-4dannjjm	3297	51	were	be	VBD
cord-023095-4dannjjm	3297	52	reviewed	review	VBN
cord-023095-4dannjjm	3297	53	for	for	IN
cord-023095-4dannjjm	3297	54	a	a	DT
cord-023095-4dannjjm	3297	55	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3297	56	of	of	IN
cord-023095-4dannjjm	3297	57	ALF	ALF	NNP
cord-023095-4dannjjm	3297	58	(	(	-LRB-
cord-023095-4dannjjm	3297	59	elevated	elevated	JJ
cord-023095-4dannjjm	3297	60	serum	serum	NN
cord-023095-4dannjjm	3297	61	bilirubin	bilirubin	NN
cord-023095-4dannjjm	3297	62	or	or	CC
cord-023095-4dannjjm	3297	63	icterus	icterus	NN
cord-023095-4dannjjm	3297	64	with	with	IN
cord-023095-4dannjjm	3297	65	concurrent	concurrent	JJ
cord-023095-4dannjjm	3297	66	coagulopathy	coagulopathy	NN
cord-023095-4dannjjm	3297	67	or	or	CC
cord-023095-4dannjjm	3297	68	hepatic	hepatic	JJ
cord-023095-4dannjjm	3297	69	encephalopathy	encephalopathy	NN
cord-023095-4dannjjm	3297	70	(	(	-LRB-
cord-023095-4dannjjm	3297	71	HE	he	NN
cord-023095-4dannjjm	3297	72	)	)	-RRB-
cord-023095-4dannjjm	3297	73	)	)	-RRB-
cord-023095-4dannjjm	3297	74	.	.	.
cord-023095-4dannjjm	3298	1	Fifty	fifty	CD
cord-023095-4dannjjm	3298	2	cases	case	NNS
cord-023095-4dannjjm	3298	3	were	be	VBD
cord-023095-4dannjjm	3298	4	identified	identify	VBN
cord-023095-4dannjjm	3298	5	representing	represent	VBG
cord-023095-4dannjjm	3298	6	22	22	CD
cord-023095-4dannjjm	3298	7	breeds	breed	NNS
cord-023095-4dannjjm	3298	8	:	:	:
cord-023095-4dannjjm	3298	9	7	7	CD
cord-023095-4dannjjm	3298	10	Labradors	Labradors	NNP
cord-023095-4dannjjm	3298	11	retrievers	retriever	NNS
cord-023095-4dannjjm	3298	12	,	,	,
cord-023095-4dannjjm	3298	13	6	6	CD
cord-023095-4dannjjm	3298	14	Golden	golden	JJ
cord-023095-4dannjjm	3298	15	retrievers	retriever	NNS
cord-023095-4dannjjm	3298	16	,	,	,
cord-023095-4dannjjm	3298	17	3	3	CD
cord-023095-4dannjjm	3298	18	German	german	JJ
cord-023095-4dannjjm	3298	19	shepherds	shepherd	NNS
cord-023095-4dannjjm	3298	20	,	,	,
cord-023095-4dannjjm	3298	21	and	and	CC
cord-023095-4dannjjm	3298	22	3	3	CD
cord-023095-4dannjjm	3298	23	Cocker	Cocker	NNP
cord-023095-4dannjjm	3298	24	spaniels	spaniel	NNS
cord-023095-4dannjjm	3298	25	.	.	.
cord-023095-4dannjjm	3299	1	Median	median	JJ
cord-023095-4dannjjm	3299	2	age	age	NN
cord-023095-4dannjjm	3299	3	was	be	VBD
cord-023095-4dannjjm	3299	4	6	6	CD
cord-023095-4dannjjm	3299	5	years	year	NNS
cord-023095-4dannjjm	3299	6	(	(	-LRB-
cord-023095-4dannjjm	3299	7	1	1	CD
cord-023095-4dannjjm	3299	8	m	m	NN
cord-023095-4dannjjm	3299	9	to	to	IN
cord-023095-4dannjjm	3299	10	Humerus	Humerus	NNP
cord-023095-4dannjjm	3299	11	,	,	,
cord-023095-4dannjjm	3299	12	15	15	CD
cord-023095-4dannjjm	3299	13	ga	ga	NNP
cord-023095-4dannjjm	3299	14	5.1	5.1	CD
cord-023095-4dannjjm	3299	15	AE	AE	NNP
cord-023095-4dannjjm	3299	16	0.9	0.9	CD
cord-023095-4dannjjm	3299	17	5.6	5.6	CD
cord-023095-4dannjjm	3299	18	AE	AE	NNP
cord-023095-4dannjjm	3299	19	0.6	0.6	CD
cord-023095-4dannjjm	3299	20	2.1	2.1	CD
cord-023095-4dannjjm	3299	21	AE	AE	NNP
cord-023095-4dannjjm	3299	22	0.5	0.5	CD
cord-023095-4dannjjm	3300	1	6.0	6.0	CD
cord-023095-4dannjjm	3300	2	AE	AE	NNP
cord-023095-4dannjjm	3300	3	0.7	0.7	CD
cord-023095-4dannjjm	3300	4	0	0	SYM
cord-023095-4dannjjm	3300	5	0	0	NFP
cord-023095-4dannjjm	3300	6	Ã	ã	NN
cord-023095-4dannjjm	3300	7	(	(	-LRB-
cord-023095-4dannjjm	3300	8	2.2	2.2	CD
cord-023095-4dannjjm	3300	9	-	-	SYM
cord-023095-4dannjjm	3300	10	9.3	9.3	CD
cord-023095-4dannjjm	3300	11	)	)	-RRB-
cord-023095-4dannjjm	3300	12	(	(	-LRB-
cord-023095-4dannjjm	3300	13	3	3	CD
cord-023095-4dannjjm	3300	14	-	-	SYM
cord-023095-4dannjjm	3300	15	9	9	CD
cord-023095-4dannjjm	3300	16	)	)	-RRB-
cord-023095-4dannjjm	3300	17	(	(	-LRB-
cord-023095-4dannjjm	3300	18	0	0	CD
cord-023095-4dannjjm	3300	19	-	-	SYM
cord-023095-4dannjjm	3300	20	4	4	CD
cord-023095-4dannjjm	3300	21	)	)	-RRB-
cord-023095-4dannjjm	3300	22	(	(	-LRB-
cord-023095-4dannjjm	3300	23	3	3	CD
cord-023095-4dannjjm	3300	24	-	-	SYM
cord-023095-4dannjjm	3300	25	10	10	CD
cord-023095-4dannjjm	3300	26	)	)	-RRB-
cord-023095-4dannjjm	3300	27	Ilium	Ilium	NNP
cord-023095-4dannjjm	3300	28	,	,	,
cord-023095-4dannjjm	3300	29	13	13	CD
cord-023095-4dannjjm	3300	30	ga	ga	NNP
cord-023095-4dannjjm	3300	31	6.1	6.1	CD
cord-023095-4dannjjm	3300	32	AE	AE	NNP
cord-023095-4dannjjm	3300	33	0.6	0.6	CD
cord-023095-4dannjjm	3300	34	9.0	9.0	CD
cord-023095-4dannjjm	3300	35	AE	AE	NNP
cord-023095-4dannjjm	3300	36	0.7	0.7	CD
cord-023095-4dannjjm	3300	37	1.9	1.9	CD
cord-023095-4dannjjm	3300	38	AE	AE	NNP
cord-023095-4dannjjm	3300	39	0.6	0.6	CD
cord-023095-4dannjjm	3300	40	7.5	7.5	CD
cord-023095-4dannjjm	3300	41	AE	AE	NNP
cord-023095-4dannjjm	3300	42	0.8	0.8	CD
cord-023095-4dannjjm	3300	43	0.2	0.2	CD
cord-023095-4dannjjm	3300	44	AE	AE	NNP
cord-023095-4dannjjm	3300	45	0.1	0.1	CD
cord-023095-4dannjjm	3300	46	0.9	0.9	CD
cord-023095-4dannjjm	3300	47	AE	AE	NNP
cord-023095-4dannjjm	3300	48	0.1	0.1	CD
cord-023095-4dannjjm	3300	49	Ã	ã	NN
cord-023095-4dannjjm	3300	50	(	(	-LRB-
cord-023095-4dannjjm	3300	51	4.5	4.5	CD
cord-023095-4dannjjm	3300	52	-	-	SYM
cord-023095-4dannjjm	3300	53	9.5	9.5	CD
cord-023095-4dannjjm	3300	54	)	)	-RRB-
cord-023095-4dannjjm	3300	55	(	(	-LRB-
cord-023095-4dannjjm	3300	56	6	6	CD
cord-023095-4dannjjm	3300	57	-	-	SYM
cord-023095-4dannjjm	3300	58	12	12	CD
cord-023095-4dannjjm	3300	59	)	)	-RRB-
cord-023095-4dannjjm	3300	60	(	(	-LRB-
cord-023095-4dannjjm	3300	61	0	0	CD
cord-023095-4dannjjm	3300	62	-	-	SYM
cord-023095-4dannjjm	3300	63	5	5	CD
cord-023095-4dannjjm	3300	64	)	)	-RRB-
cord-023095-4dannjjm	3300	65	(	(	-LRB-
cord-023095-4dannjjm	3300	66	5	5	CD
cord-023095-4dannjjm	3300	67	-	-	SYM
cord-023095-4dannjjm	3300	68	12	12	CD
cord-023095-4dannjjm	3300	69	)	)	-RRB-
cord-023095-4dannjjm	3300	70	(	(	-LRB-
cord-023095-4dannjjm	3300	71	0	0	CD
cord-023095-4dannjjm	3300	72	-	-	SYM
cord-023095-4dannjjm	3300	73	1	1	CD
cord-023095-4dannjjm	3300	74	)	)	-RRB-
cord-023095-4dannjjm	3300	75	(	(	-LRB-
cord-023095-4dannjjm	3300	76	0	0	CD
cord-023095-4dannjjm	3300	77	-	-	SYM
cord-023095-4dannjjm	3300	78	1	1	CD
cord-023095-4dannjjm	3300	79	)	)	-RRB-
cord-023095-4dannjjm	3300	80	13	13	CD
cord-023095-4dannjjm	3300	81	yrs	yr	NNS
cord-023095-4dannjjm	3300	82	)	)	-RRB-
cord-023095-4dannjjm	3300	83	.	.	.
cord-023095-4dannjjm	3301	1	Presenting	present	VBG
cord-023095-4dannjjm	3301	2	signs	sign	NNS
cord-023095-4dannjjm	3301	3	included	include	VBD
cord-023095-4dannjjm	3301	4	anorexia	anorexia	NN
cord-023095-4dannjjm	3301	5	(	(	-LRB-
cord-023095-4dannjjm	3301	6	31/50	31/50	CD
cord-023095-4dannjjm	3301	7	)	)	-RRB-
cord-023095-4dannjjm	3301	8	,	,	,
cord-023095-4dannjjm	3301	9	vomiting	vomit	VBG
cord-023095-4dannjjm	3301	10	(	(	-LRB-
cord-023095-4dannjjm	3301	11	26/50	26/50	CD
cord-023095-4dannjjm	3301	12	)	)	-RRB-
cord-023095-4dannjjm	3301	13	,	,	,
cord-023095-4dannjjm	3301	14	polydipsia	polydipsia	NN
cord-023095-4dannjjm	3301	15	(	(	-LRB-
cord-023095-4dannjjm	3301	16	9/50	9/50	CD
cord-023095-4dannjjm	3301	17	)	)	-RRB-
cord-023095-4dannjjm	3301	18	and	and	CC
cord-023095-4dannjjm	3301	19	neurologic	neurologic	JJ
cord-023095-4dannjjm	3301	20	signs	sign	NNS
cord-023095-4dannjjm	3301	21	(	(	-LRB-
cord-023095-4dannjjm	3301	22	6/50	6/50	CD
cord-023095-4dannjjm	3301	23	Granulomatous	granulomatous	JJ
cord-023095-4dannjjm	3301	24	hepatitis	hepatitis	NN
cord-023095-4dannjjm	3301	25	(	(	-LRB-
cord-023095-4dannjjm	3301	26	GH	GH	NNP
cord-023095-4dannjjm	3301	27	)	)	-RRB-
cord-023095-4dannjjm	3301	28	is	be	VBZ
cord-023095-4dannjjm	3301	29	a	a	DT
cord-023095-4dannjjm	3301	30	histopathological	histopathological	JJ
cord-023095-4dannjjm	3301	31	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3301	32	characterized	characterize	VBN
cord-023095-4dannjjm	3301	33	by	by	IN
cord-023095-4dannjjm	3301	34	focal	focal	JJ
cord-023095-4dannjjm	3301	35	aggregations	aggregation	NNS
cord-023095-4dannjjm	3301	36	of	of	IN
cord-023095-4dannjjm	3301	37	activated	activate	VBN
cord-023095-4dannjjm	3301	38	macrophages	macrophage	NNS
cord-023095-4dannjjm	3301	39	mixed	mix	VBN
cord-023095-4dannjjm	3301	40	with	with	IN
cord-023095-4dannjjm	3301	41	other	other	JJ
cord-023095-4dannjjm	3301	42	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3301	43	cells	cell	NNS
cord-023095-4dannjjm	3301	44	that	that	WDT
cord-023095-4dannjjm	3301	45	is	be	VBZ
cord-023095-4dannjjm	3301	46	usually	usually	RB
cord-023095-4dannjjm	3301	47	part	part	NN
cord-023095-4dannjjm	3301	48	of	of	IN
cord-023095-4dannjjm	3301	49	a	a	DT
cord-023095-4dannjjm	3301	50	systemic	systemic	JJ
cord-023095-4dannjjm	3301	51	disease	disease	NN
cord-023095-4dannjjm	3301	52	process	process	NN
cord-023095-4dannjjm	3301	53	(	(	-LRB-
cord-023095-4dannjjm	3301	54	WSAVA	WSAVA	NNP
cord-023095-4dannjjm	3301	55	)	)	-RRB-
cord-023095-4dannjjm	3301	56	.	.	.
cord-023095-4dannjjm	3302	1	Published	publish	VBN
cord-023095-4dannjjm	3302	2	case	case	NN
cord-023095-4dannjjm	3302	3	reports	report	NNS
cord-023095-4dannjjm	3302	4	describe	describe	VBP
cord-023095-4dannjjm	3302	5	many	many	JJ
cord-023095-4dannjjm	3302	6	potential	potential	JJ
cord-023095-4dannjjm	3302	7	infectious	infectious	JJ
cord-023095-4dannjjm	3302	8	causes	cause	NNS
cord-023095-4dannjjm	3302	9	,	,	,
cord-023095-4dannjjm	3302	10	but	but	CC
cord-023095-4dannjjm	3302	11	only	only	RB
cord-023095-4dannjjm	3302	12	one	one	CD
cord-023095-4dannjjm	3302	13	retrospective	retrospective	JJ
cord-023095-4dannjjm	3302	14	study	study	NN
cord-023095-4dannjjm	3302	15	involving	involve	VBG
cord-023095-4dannjjm	3302	16	nine	nine	CD
cord-023095-4dannjjm	3302	17	dogs	dog	NNS
cord-023095-4dannjjm	3302	18	with	with	IN
cord-023095-4dannjjm	3302	19	GH	GH	NNP
cord-023095-4dannjjm	3302	20	has	have	VBZ
cord-023095-4dannjjm	3302	21	detailed	detail	VBN
cord-023095-4dannjjm	3302	22	clinically	clinically	RB
cord-023095-4dannjjm	3302	23	relevant	relevant	JJ
cord-023095-4dannjjm	3302	24	findings	finding	NNS
cord-023095-4dannjjm	3302	25	.	.	.
cord-023095-4dannjjm	3303	1	The	the	DT
cord-023095-4dannjjm	3303	2	aims	aim	NNS
cord-023095-4dannjjm	3303	3	of	of	IN
cord-023095-4dannjjm	3303	4	this	this	DT
cord-023095-4dannjjm	3303	5	study	study	NN
cord-023095-4dannjjm	3303	6	were	be	VBD
cord-023095-4dannjjm	3303	7	to	to	TO
cord-023095-4dannjjm	3303	8	describe	describe	VB
cord-023095-4dannjjm	3303	9	the	the	DT
cord-023095-4dannjjm	3303	10	clinical	clinical	JJ
cord-023095-4dannjjm	3303	11	and	and	CC
cord-023095-4dannjjm	3303	12	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	3303	13	findings	finding	NNS
cord-023095-4dannjjm	3303	14	in	in	IN
cord-023095-4dannjjm	3303	15	dogs	dog	NNS
cord-023095-4dannjjm	3303	16	with	with	IN
cord-023095-4dannjjm	3303	17	a	a	DT
cord-023095-4dannjjm	3303	18	histopathological	histopathological	JJ
cord-023095-4dannjjm	3303	19	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3303	20	of	of	IN
cord-023095-4dannjjm	3303	21	GH	GH	NNP
cord-023095-4dannjjm	3303	22	,	,	,
cord-023095-4dannjjm	3303	23	and	and	CC
cord-023095-4dannjjm	3303	24	to	to	TO
cord-023095-4dannjjm	3303	25	identify	identify	VB
cord-023095-4dannjjm	3303	26	infectious	infectious	JJ
cord-023095-4dannjjm	3303	27	agents	agent	NNS
cord-023095-4dannjjm	3303	28	using	use	VBG
cord-023095-4dannjjm	3303	29	differential	differential	JJ
cord-023095-4dannjjm	3303	30	staining	staining	NN
cord-023095-4dannjjm	3303	31	techniques	technique	NNS
cord-023095-4dannjjm	3303	32	,	,	,
cord-023095-4dannjjm	3303	33	PCR	PCR	NNP
cord-023095-4dannjjm	3303	34	,	,	,
cord-023095-4dannjjm	3303	35	and	and	CC
cord-023095-4dannjjm	3303	36	fluorescence	fluorescence	NN
cord-023095-4dannjjm	3303	37	in	in	IN
cord-023095-4dannjjm	3303	38	-	-	HYPH
cord-023095-4dannjjm	3303	39	situ	situ	NN
cord-023095-4dannjjm	3303	40	hybridization	hybridization	NN
cord-023095-4dannjjm	3303	41	(	(	-LRB-
cord-023095-4dannjjm	3303	42	FISH	fish	NN
cord-023095-4dannjjm	3303	43	)	)	-RRB-
cord-023095-4dannjjm	3303	44	in	in	IN
cord-023095-4dannjjm	3303	45	archival	archival	JJ
cord-023095-4dannjjm	3303	46	paraffin	paraffin	NN
cord-023095-4dannjjm	3303	47	-	-	HYPH
cord-023095-4dannjjm	3303	48	embedded	embed	VBN
cord-023095-4dannjjm	3303	49	tissues	tissue	NNS
cord-023095-4dannjjm	3303	50	from	from	IN
cord-023095-4dannjjm	3303	51	dogs	dog	NNS
cord-023095-4dannjjm	3303	52	with	with	IN
cord-023095-4dannjjm	3303	53	GH	GH	NNP
cord-023095-4dannjjm	3303	54	.	.	.
cord-023095-4dannjjm	3304	1	Medical	medical	JJ
cord-023095-4dannjjm	3304	2	records	record	NNS
cord-023095-4dannjjm	3304	3	of	of	IN
cord-023095-4dannjjm	3304	4	dogs	dog	NNS
cord-023095-4dannjjm	3304	5	with	with	IN
cord-023095-4dannjjm	3304	6	a	a	DT
cord-023095-4dannjjm	3304	7	histopathological	histopathological	JJ
cord-023095-4dannjjm	3304	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3304	9	of	of	IN
cord-023095-4dannjjm	3304	10	GH	GH	NNP
cord-023095-4dannjjm	3304	11	(	(	-LRB-
cord-023095-4dannjjm	3304	12	n	n	NN
cord-023095-4dannjjm	3304	13	5	5	CD
cord-023095-4dannjjm	3304	14	22	22	CD
cord-023095-4dannjjm	3304	15	)	)	-RRB-
cord-023095-4dannjjm	3304	16	were	be	VBD
cord-023095-4dannjjm	3304	17	reviewed	review	VBN
cord-023095-4dannjjm	3304	18	and	and	CC
cord-023095-4dannjjm	3304	19	signalment	signalment	JJ
cord-023095-4dannjjm	3304	20	,	,	,
cord-023095-4dannjjm	3304	21	historical	historical	JJ
cord-023095-4dannjjm	3304	22	toxin	toxin	NN
cord-023095-4dannjjm	3304	23	exposure	exposure	NN
cord-023095-4dannjjm	3304	24	or	or	CC
cord-023095-4dannjjm	3304	25	evidence	evidence	NN
cord-023095-4dannjjm	3304	26	of	of	IN
cord-023095-4dannjjm	3304	27	other	other	JJ
cord-023095-4dannjjm	3304	28	systemic	systemic	JJ
cord-023095-4dannjjm	3304	29	diseases	disease	NNS
cord-023095-4dannjjm	3304	30	,	,	,
cord-023095-4dannjjm	3304	31	clinical	clinical	JJ
cord-023095-4dannjjm	3304	32	signs	sign	NNS
cord-023095-4dannjjm	3304	33	,	,	,
cord-023095-4dannjjm	3304	34	physical	physical	JJ
cord-023095-4dannjjm	3304	35	exam	exam	NN
cord-023095-4dannjjm	3304	36	findings	finding	NNS
cord-023095-4dannjjm	3304	37	,	,	,
cord-023095-4dannjjm	3304	38	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	3304	39	test	test	NN
cord-023095-4dannjjm	3304	40	results	result	NNS
cord-023095-4dannjjm	3304	41	,	,	,
cord-023095-4dannjjm	3304	42	imaging	image	VBG
cord-023095-4dannjjm	3304	43	findings	finding	NNS
cord-023095-4dannjjm	3304	44	,	,	,
cord-023095-4dannjjm	3304	45	concurrent	concurrent	JJ
cord-023095-4dannjjm	3304	46	diagnoses	diagnosis	NNS
cord-023095-4dannjjm	3304	47	,	,	,
cord-023095-4dannjjm	3304	48	treatments	treatment	NNS
cord-023095-4dannjjm	3304	49	administered	administer	VBN
cord-023095-4dannjjm	3304	50	,	,	,
cord-023095-4dannjjm	3304	51	and	and	CC
cord-023095-4dannjjm	3304	52	case	case	NN
cord-023095-4dannjjm	3304	53	outcome	outcome	NN
cord-023095-4dannjjm	3304	54	,	,	,
cord-023095-4dannjjm	3304	55	when	when	WRB
cord-023095-4dannjjm	3304	56	available	available	JJ
cord-023095-4dannjjm	3304	57	,	,	,
cord-023095-4dannjjm	3304	58	were	be	VBD
cord-023095-4dannjjm	3304	59	extracted	extract	VBN
cord-023095-4dannjjm	3304	60	and	and	CC
cord-023095-4dannjjm	3304	61	summarized	summarize	VBN
cord-023095-4dannjjm	3304	62	.	.	.
cord-023095-4dannjjm	3305	1	Twelve	twelve	CD
cord-023095-4dannjjm	3305	2	archival	archival	JJ
cord-023095-4dannjjm	3305	3	formalin	formalin	NN
cord-023095-4dannjjm	3305	4	-	-	HYPH
cord-023095-4dannjjm	3305	5	fixed	fix	VBN
cord-023095-4dannjjm	3305	6	,	,	,
cord-023095-4dannjjm	3305	7	paraffin	paraffin	NN
cord-023095-4dannjjm	3305	8	-	-	HYPH
cord-023095-4dannjjm	3305	9	embedded	embed	VBN
cord-023095-4dannjjm	3305	10	hepatic	hepatic	JJ
cord-023095-4dannjjm	3305	11	tissue	tissue	NN
cord-023095-4dannjjm	3305	12	samples	sample	NNS
cord-023095-4dannjjm	3305	13	were	be	VBD
cord-023095-4dannjjm	3305	14	available	available	JJ
cord-023095-4dannjjm	3305	15	for	for	IN
cord-023095-4dannjjm	3305	16	special	special	JJ
cord-023095-4dannjjm	3305	17	staining	staining	NN
cord-023095-4dannjjm	3305	18	and	and	CC
cord-023095-4dannjjm	3305	19	molecular	molecular	JJ
cord-023095-4dannjjm	3305	20	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3305	21	testing	testing	NN
cord-023095-4dannjjm	3305	22	.	.	.
cord-023095-4dannjjm	3306	1	Two	two	CD
cord-023095-4dannjjm	3306	2	of	of	IN
cord-023095-4dannjjm	3306	3	these	these	DT
cord-023095-4dannjjm	3306	4	samples	sample	NNS
cord-023095-4dannjjm	3306	5	had	have	VBD
cord-023095-4dannjjm	3306	6	sufficient	sufficient	JJ
cord-023095-4dannjjm	3306	7	tissue	tissue	NN
cord-023095-4dannjjm	3306	8	for	for	IN
cord-023095-4dannjjm	3306	9	only	only	JJ
cord-023095-4dannjjm	3306	10	PCR	PCR	NNP
cord-023095-4dannjjm	3306	11	.	.	.
cord-023095-4dannjjm	3307	1	The	the	DT
cord-023095-4dannjjm	3307	2	mean	mean	JJ
cord-023095-4dannjjm	3307	3	age	age	NN
cord-023095-4dannjjm	3307	4	of	of	IN
cord-023095-4dannjjm	3307	5	dogs	dog	NNS
cord-023095-4dannjjm	3307	6	with	with	IN
cord-023095-4dannjjm	3307	7	GH	GH	NNP
cord-023095-4dannjjm	3307	8	was	be	VBD
cord-023095-4dannjjm	3307	9	7	7	CD
cord-023095-4dannjjm	3307	10	years	year	NNS
cord-023095-4dannjjm	3307	11	(	(	-LRB-
cord-023095-4dannjjm	3307	12	median	median	JJ
cord-023095-4dannjjm	3307	13	6.5	6.5	CD
cord-023095-4dannjjm	3307	14	years	year	NNS
cord-023095-4dannjjm	3307	15	;	;	:
cord-023095-4dannjjm	3307	16	range	range	VBP
cord-023095-4dannjjm	3307	17	2	2	CD
cord-023095-4dannjjm	3307	18	to	to	TO
cord-023095-4dannjjm	3307	19	17	17	CD
cord-023095-4dannjjm	3307	20	years	year	NNS
cord-023095-4dannjjm	3307	21	)	)	-RRB-
cord-023095-4dannjjm	3307	22	and	and	CC
cord-023095-4dannjjm	3307	23	included	include	VBD
cord-023095-4dannjjm	3307	24	12	12	CD
cord-023095-4dannjjm	3307	25	males	male	NNS
cord-023095-4dannjjm	3307	26	and	and	CC
cord-023095-4dannjjm	3307	27	10	10	CD
cord-023095-4dannjjm	3307	28	females	female	NNS
cord-023095-4dannjjm	3307	29	representing	represent	VBG
cord-023095-4dannjjm	3307	30	14	14	CD
cord-023095-4dannjjm	3307	31	different	different	JJ
cord-023095-4dannjjm	3307	32	breeds	breed	NNS
cord-023095-4dannjjm	3307	33	.	.	.
cord-023095-4dannjjm	3308	1	Common	common	JJ
cord-023095-4dannjjm	3308	2	presenting	present	VBG
cord-023095-4dannjjm	3308	3	complaints	complaint	NNS
cord-023095-4dannjjm	3308	4	included	include	VBD
cord-023095-4dannjjm	3308	5	inappetance	inappetance	NN
cord-023095-4dannjjm	3308	6	or	or	CC
cord-023095-4dannjjm	3308	7	anorexia	anorexia	NN
cord-023095-4dannjjm	3308	8	(	(	-LRB-
cord-023095-4dannjjm	3308	9	n	n	NN
cord-023095-4dannjjm	3308	10	5	5	CD
cord-023095-4dannjjm	3308	11	12	12	CD
cord-023095-4dannjjm	3308	12	)	)	-RRB-
cord-023095-4dannjjm	3308	13	,	,	,
cord-023095-4dannjjm	3308	14	weight	weight	NN
cord-023095-4dannjjm	3308	15	loss	loss	NN
cord-023095-4dannjjm	3308	16	(	(	-LRB-
cord-023095-4dannjjm	3308	17	n	n	NN
cord-023095-4dannjjm	3308	18	5	5	CD
cord-023095-4dannjjm	3308	19	11	11	CD
cord-023095-4dannjjm	3308	20	)	)	-RRB-
cord-023095-4dannjjm	3308	21	,	,	,
cord-023095-4dannjjm	3308	22	lethargy	lethargy	NN
cord-023095-4dannjjm	3308	23	(	(	-LRB-
cord-023095-4dannjjm	3308	24	n	n	NN
cord-023095-4dannjjm	3308	25	5	5	CD
cord-023095-4dannjjm	3308	26	9	9	CD
cord-023095-4dannjjm	3308	27	)	)	-RRB-
cord-023095-4dannjjm	3308	28	,	,	,
cord-023095-4dannjjm	3308	29	fever	fever	NN
cord-023095-4dannjjm	3308	30	(	(	-LRB-
cord-023095-4dannjjm	3308	31	n	n	NN
cord-023095-4dannjjm	3308	32	5	5	CD
cord-023095-4dannjjm	3308	33	8)	8)	NNP
cord-023095-4dannjjm	3308	34	,	,	,
cord-023095-4dannjjm	3308	35	and	and	CC
cord-023095-4dannjjm	3308	36	vomiting	vomiting	NN
cord-023095-4dannjjm	3308	37	(	(	-LRB-
cord-023095-4dannjjm	3308	38	n	n	NN
cord-023095-4dannjjm	3308	39	5	5	CD
cord-023095-4dannjjm	3308	40	8)	8)	NN
cord-023095-4dannjjm	3308	41	.	.	.
cord-023095-4dannjjm	3309	1	High	high	JJ
cord-023095-4dannjjm	3309	2	mixed	mixed	JJ
cord-023095-4dannjjm	3309	3	liver	liver	NN
cord-023095-4dannjjm	3309	4	enzyme	enzyme	NN
cord-023095-4dannjjm	3309	5	activity	activity	NN
cord-023095-4dannjjm	3309	6	(	(	-LRB-
cord-023095-4dannjjm	3309	7	14/22	14/22	CD
cord-023095-4dannjjm	3309	8	)	)	-RRB-
cord-023095-4dannjjm	3309	9	was	be	VBD
cord-023095-4dannjjm	3309	10	the	the	DT
cord-023095-4dannjjm	3309	11	most	most	RBS
cord-023095-4dannjjm	3309	12	common	common	JJ
cord-023095-4dannjjm	3309	13	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	3309	14	abnormality	abnormality	NN
cord-023095-4dannjjm	3309	15	.	.	.
cord-023095-4dannjjm	3310	1	Leukemia	leukemia	NN
cord-023095-4dannjjm	3310	2	was	be	VBD
cord-023095-4dannjjm	3310	3	diagnosed	diagnose	VBN
cord-023095-4dannjjm	3310	4	in	in	IN
cord-023095-4dannjjm	3310	5	one	one	CD
cord-023095-4dannjjm	3310	6	dog	dog	NN
cord-023095-4dannjjm	3310	7	and	and	CC
cord-023095-4dannjjm	3310	8	copper	copper	NN
cord-023095-4dannjjm	3310	9	-	-	HYPH
cord-023095-4dannjjm	3310	10	associated	associate	VBN
cord-023095-4dannjjm	3310	11	hepatopathy	hepatopathy	NNP
cord-023095-4dannjjm	3310	12	in	in	IN
cord-023095-4dannjjm	3310	13	6	6	CD
cord-023095-4dannjjm	3310	14	dogs	dog	NNS
cord-023095-4dannjjm	3310	15	.	.	.
cord-023095-4dannjjm	3311	1	No	no	DT
cord-023095-4dannjjm	3311	2	infectious	infectious	JJ
cord-023095-4dannjjm	3311	3	agents	agent	NNS
cord-023095-4dannjjm	3311	4	were	be	VBD
cord-023095-4dannjjm	3311	5	identified	identify	VBN
cord-023095-4dannjjm	3311	6	using	use	VBG
cord-023095-4dannjjm	3311	7	differential	differential	JJ
cord-023095-4dannjjm	3311	8	staining	staining	NN
cord-023095-4dannjjm	3311	9	techniques	technique	NNS
cord-023095-4dannjjm	3311	10	.	.	.
cord-023095-4dannjjm	3312	1	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3312	2	species	species	NN
cord-023095-4dannjjm	3312	3	DNA	DNA	NNP
cord-023095-4dannjjm	3312	4	was	be	VBD
cord-023095-4dannjjm	3312	5	not	not	RB
cord-023095-4dannjjm	3312	6	PCR	PCR	NNP
cord-023095-4dannjjm	3312	7	amplified	amplify	VBN
cord-023095-4dannjjm	3312	8	from	from	IN
cord-023095-4dannjjm	3312	9	the	the	DT
cord-023095-4dannjjm	3312	10	extracted	extract	VBN
cord-023095-4dannjjm	3312	11	archival	archival	JJ
cord-023095-4dannjjm	3312	12	tissue	tissue	NN
cord-023095-4dannjjm	3312	13	.	.	.
cord-023095-4dannjjm	3313	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	3313	2	,	,	,
cord-023095-4dannjjm	3313	3	no	no	DT
cord-023095-4dannjjm	3313	4	bacteria	bacteria	NNS
cord-023095-4dannjjm	3313	5	were	be	VBD
cord-023095-4dannjjm	3313	6	identified	identify	VBN
cord-023095-4dannjjm	3313	7	by	by	IN
cord-023095-4dannjjm	3313	8	means	mean	NNS
cord-023095-4dannjjm	3313	9	of	of	IN
cord-023095-4dannjjm	3313	10	FISH	fish	NN
cord-023095-4dannjjm	3313	11	using	use	VBG
cord-023095-4dannjjm	3313	12	a	a	DT
cord-023095-4dannjjm	3313	13	universal	universal	JJ
cord-023095-4dannjjm	3313	14	eubacterial	eubacterial	JJ
cord-023095-4dannjjm	3313	15	probe	probe	NN
cord-023095-4dannjjm	3313	16	.	.	.
cord-023095-4dannjjm	3314	1	These	these	DT
cord-023095-4dannjjm	3314	2	data	datum	NNS
cord-023095-4dannjjm	3314	3	suggest	suggest	VBP
cord-023095-4dannjjm	3314	4	a	a	DT
cord-023095-4dannjjm	3314	5	possible	possible	JJ
cord-023095-4dannjjm	3314	6	role	role	NN
cord-023095-4dannjjm	3314	7	for	for	IN
cord-023095-4dannjjm	3314	8	copper	copper	NN
cord-023095-4dannjjm	3314	9	accumulation	accumulation	NN
cord-023095-4dannjjm	3314	10	in	in	IN
cord-023095-4dannjjm	3314	11	the	the	DT
cord-023095-4dannjjm	3314	12	genesis	genesis	NN
cord-023095-4dannjjm	3314	13	of	of	IN
cord-023095-4dannjjm	3314	14	GH	GH	NNP
cord-023095-4dannjjm	3314	15	in	in	IN
cord-023095-4dannjjm	3314	16	dogs	dog	NNS
cord-023095-4dannjjm	3314	17	and	and	CC
cord-023095-4dannjjm	3314	18	support	support	VB
cord-023095-4dannjjm	3314	19	further	further	JJ
cord-023095-4dannjjm	3314	20	evaluation	evaluation	NN
cord-023095-4dannjjm	3314	21	of	of	IN
cord-023095-4dannjjm	3314	22	dogs	dog	NNS
cord-023095-4dannjjm	3314	23	with	with	IN
cord-023095-4dannjjm	3314	24	GH	GH	NNP
cord-023095-4dannjjm	3314	25	for	for	IN
cord-023095-4dannjjm	3314	26	evidence	evidence	NN
cord-023095-4dannjjm	3314	27	of	of	IN
cord-023095-4dannjjm	3314	28	copper	copper	NN
cord-023095-4dannjjm	3314	29	-	-	HYPH
cord-023095-4dannjjm	3314	30	associated	associate	VBN
cord-023095-4dannjjm	3314	31	hepatopathy	hepatopathy	NNP
cord-023095-4dannjjm	3314	32	.	.	.
cord-023095-4dannjjm	3315	1	Future	future	JJ
cord-023095-4dannjjm	3315	2	studies	study	NNS
cord-023095-4dannjjm	3315	3	should	should	MD
cord-023095-4dannjjm	3315	4	include	include	VB
cord-023095-4dannjjm	3315	5	detailed	detailed	JJ
cord-023095-4dannjjm	3315	6	environmental	environmental	JJ
cord-023095-4dannjjm	3315	7	histories	history	NNS
cord-023095-4dannjjm	3315	8	,	,	,
cord-023095-4dannjjm	3315	9	the	the	DT
cord-023095-4dannjjm	3315	10	collection	collection	NN
cord-023095-4dannjjm	3315	11	of	of	IN
cord-023095-4dannjjm	3315	12	adequate	adequate	JJ
cord-023095-4dannjjm	3315	13	sample	sample	NN
cord-023095-4dannjjm	3315	14	volumes	volume	NNS
cord-023095-4dannjjm	3315	15	for	for	IN
cord-023095-4dannjjm	3315	16	quantification	quantification	NN
cord-023095-4dannjjm	3315	17	of	of	IN
cord-023095-4dannjjm	3315	18	hepatic	hepatic	JJ
cord-023095-4dannjjm	3315	19	copper	copper	NN
cord-023095-4dannjjm	3315	20	content	content	NN
cord-023095-4dannjjm	3315	21	and	and	CC
cord-023095-4dannjjm	3315	22	the	the	DT
cord-023095-4dannjjm	3315	23	examination	examination	NN
cord-023095-4dannjjm	3315	24	of	of	IN
cord-023095-4dannjjm	3315	25	frozen	frozen	JJ
cord-023095-4dannjjm	3315	26	tissues	tissue	NNS
cord-023095-4dannjjm	3315	27	using	use	VBG
cord-023095-4dannjjm	3315	28	novel	novel	JJ
cord-023095-4dannjjm	3315	29	molecular	molecular	JJ
cord-023095-4dannjjm	3315	30	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3315	31	platforms	platform	NNS
cord-023095-4dannjjm	3315	32	.	.	.
cord-023095-4dannjjm	3316	1	Hepatocyte	Hepatocyte	NNP
cord-023095-4dannjjm	3316	2	copper	copper	NN
cord-023095-4dannjjm	3316	3	and	and	CC
cord-023095-4dannjjm	3316	4	iron	iron	NN
cord-023095-4dannjjm	3316	5	accumulation	accumulation	NN
cord-023095-4dannjjm	3316	6	contribute	contribute	VBP
cord-023095-4dannjjm	3316	7	to	to	IN
cord-023095-4dannjjm	3316	8	cell	cell	NN
cord-023095-4dannjjm	3316	9	loss	loss	NN
cord-023095-4dannjjm	3316	10	,	,	,
cord-023095-4dannjjm	3316	11	inflammation	inflammation	NN
cord-023095-4dannjjm	3316	12	,	,	,
cord-023095-4dannjjm	3316	13	and	and	CC
cord-023095-4dannjjm	3316	14	fibrosis	fibrosis	NN
cord-023095-4dannjjm	3316	15	.	.	.
cord-023095-4dannjjm	3317	1	The	the	DT
cord-023095-4dannjjm	3317	2	purpose	purpose	NN
cord-023095-4dannjjm	3317	3	of	of	IN
cord-023095-4dannjjm	3317	4	this	this	DT
cord-023095-4dannjjm	3317	5	study	study	NN
cord-023095-4dannjjm	3317	6	was	be	VBD
cord-023095-4dannjjm	3317	7	to	to	TO
cord-023095-4dannjjm	3317	8	compare	compare	VB
cord-023095-4dannjjm	3317	9	copper	copper	NN
cord-023095-4dannjjm	3317	10	and	and	CC
cord-023095-4dannjjm	3317	11	iron	iron	NN
cord-023095-4dannjjm	3317	12	accumulation	accumulation	NN
cord-023095-4dannjjm	3317	13	in	in	IN
cord-023095-4dannjjm	3317	14	feline	feline	JJ
cord-023095-4dannjjm	3317	15	liver	liver	NN
cord-023095-4dannjjm	3317	16	samples	sample	NNS
cord-023095-4dannjjm	3317	17	with	with	IN
cord-023095-4dannjjm	3317	18	different	different	JJ
cord-023095-4dannjjm	3317	19	disease	disease	NN
cord-023095-4dannjjm	3317	20	processes	process	NNS
cord-023095-4dannjjm	3317	21	.	.	.
cord-023095-4dannjjm	3318	1	Liver	liver	NN
cord-023095-4dannjjm	3318	2	biopsies	biopsy	NNS
cord-023095-4dannjjm	3318	3	(	(	-LRB-
cord-023095-4dannjjm	3318	4	n	n	NN
cord-023095-4dannjjm	3318	5	5	5	CD
cord-023095-4dannjjm	3318	6	104	104	CD
cord-023095-4dannjjm	3318	7	)	)	-RRB-
cord-023095-4dannjjm	3318	8	submitted	submit	VBN
cord-023095-4dannjjm	3318	9	between	between	IN
cord-023095-4dannjjm	3318	10	July	July	NNP
cord-023095-4dannjjm	3318	11	1	1	CD
cord-023095-4dannjjm	3318	12	,	,	,
cord-023095-4dannjjm	3318	13	2007	2007	CD
cord-023095-4dannjjm	3318	14	and	and	CC
cord-023095-4dannjjm	3318	15	June	June	NNP
cord-023095-4dannjjm	3318	16	30	30	CD
cord-023095-4dannjjm	3318	17	,	,	,
cord-023095-4dannjjm	3318	18	2009	2009	CD
cord-023095-4dannjjm	3318	19	were	be	VBD
cord-023095-4dannjjm	3318	20	evaluated	evaluate	VBN
cord-023095-4dannjjm	3318	21	using	use	VBG
cord-023095-4dannjjm	3318	22	WSAVA	WSAVA	NNP
cord-023095-4dannjjm	3318	23	guidelines	guideline	NNS
cord-023095-4dannjjm	3318	24	and	and	CC
cord-023095-4dannjjm	3318	25	categorized	categorize	VBN
cord-023095-4dannjjm	3318	26	as	as	IN
cord-023095-4dannjjm	3318	27	non	non	JJ
cord-023095-4dannjjm	3318	28	-	-	JJ
cord-023095-4dannjjm	3318	29	hepatic	hepatic	JJ
cord-023095-4dannjjm	3318	30	/	/	SYM
cord-023095-4dannjjm	3318	31	normal	normal	JJ
cord-023095-4dannjjm	3318	32	,	,	,
cord-023095-4dannjjm	3318	33	congenital	congenital	JJ
cord-023095-4dannjjm	3318	34	,	,	,
cord-023095-4dannjjm	3318	35	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3318	36	/	/	SYM
cord-023095-4dannjjm	3318	37	infectious	infectious	JJ
cord-023095-4dannjjm	3318	38	,	,	,
cord-023095-4dannjjm	3318	39	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	3318	40	,	,	,
cord-023095-4dannjjm	3318	41	and	and	CC
cord-023095-4dannjjm	3318	42	other	other	JJ
cord-023095-4dannjjm	3318	43	.	.	.
cord-023095-4dannjjm	3319	1	Copper	copper	NN
cord-023095-4dannjjm	3319	2	(	(	-LRB-
cord-023095-4dannjjm	3319	3	by	by	IN
cord-023095-4dannjjm	3319	4	rubeanic	rubeanic	JJ
cord-023095-4dannjjm	3319	5	acid	acid	NN
cord-023095-4dannjjm	3319	6	)	)	-RRB-
cord-023095-4dannjjm	3319	7	and	and	CC
cord-023095-4dannjjm	3319	8	iron	iron	NN
cord-023095-4dannjjm	3319	9	(	(	-LRB-
cord-023095-4dannjjm	3319	10	by	by	IN
cord-023095-4dannjjm	3319	11	Prussian	prussian	JJ
cord-023095-4dannjjm	3319	12	blue	blue	JJ
cord-023095-4dannjjm	3319	13	)	)	-RRB-
cord-023095-4dannjjm	3319	14	accumulation	accumulation	NN
cord-023095-4dannjjm	3319	15	were	be	VBD
cord-023095-4dannjjm	3319	16	graded	grade	VBN
cord-023095-4dannjjm	3319	17	by	by	IN
cord-023095-4dannjjm	3319	18	increasing	increase	VBG
cord-023095-4dannjjm	3319	19	amounts	amount	NNS
cord-023095-4dannjjm	3319	20	(	(	-LRB-
cord-023095-4dannjjm	3319	21	0	0	CD
cord-023095-4dannjjm	3319	22	-	-	SYM
cord-023095-4dannjjm	3319	23	3	3	CD
cord-023095-4dannjjm	3319	24	)	)	-RRB-
cord-023095-4dannjjm	3319	25	and	and	CC
cord-023095-4dannjjm	3319	26	location	location	NN
cord-023095-4dannjjm	3319	27	(	(	-LRB-
cord-023095-4dannjjm	3319	28	centrilobular	centrilobular	NNP
cord-023095-4dannjjm	3319	29	5	5	CD
cord-023095-4dannjjm	3319	30	CL	CL	NNP
cord-023095-4dannjjm	3319	31	,	,	,
cord-023095-4dannjjm	3319	32	midzonal	midzonal	JJ
cord-023095-4dannjjm	3319	33	5	5	CD
cord-023095-4dannjjm	3319	34	MZ	MZ	NNP
cord-023095-4dannjjm	3319	35	,	,	,
cord-023095-4dannjjm	3319	36	periportal	periportal	NNP
cord-023095-4dannjjm	3319	37	5	5	CD
cord-023095-4dannjjm	3319	38	PP	PP	NNP
cord-023095-4dannjjm	3319	39	,	,	,
cord-023095-4dannjjm	3319	40	random	random	JJ
cord-023095-4dannjjm	3319	41	5	5	CD
cord-023095-4dannjjm	3319	42	R	r	NN
cord-023095-4dannjjm	3319	43	)	)	-RRB-
cord-023095-4dannjjm	3319	44	.	.	.
cord-023095-4dannjjm	3320	1	Associations	association	NNS
cord-023095-4dannjjm	3320	2	between	between	IN
cord-023095-4dannjjm	3320	3	metal	metal	NN
cord-023095-4dannjjm	3320	4	scores	score	NNS
cord-023095-4dannjjm	3320	5	and	and	CC
cord-023095-4dannjjm	3320	6	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3320	7	category	category	NN
cord-023095-4dannjjm	3320	8	were	be	VBD
cord-023095-4dannjjm	3320	9	assessed	assess	VBN
cord-023095-4dannjjm	3320	10	using	use	VBG
cord-023095-4dannjjm	3320	11	the	the	DT
cord-023095-4dannjjm	3320	12	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	3320	13	-	-	HYPH
cord-023095-4dannjjm	3320	14	Wallis	Wallis	NNP
cord-023095-4dannjjm	3320	15	test	test	NN
cord-023095-4dannjjm	3320	16	.	.	.
cord-023095-4dannjjm	3321	1	Histologic	Histologic	NNP
cord-023095-4dannjjm	3321	2	diagnoses	diagnosis	NNS
cord-023095-4dannjjm	3321	3	were	be	VBD
cord-023095-4dannjjm	3321	4	non	non	JJ
cord-023095-4dannjjm	3321	5	-	-	JJ
cord-023095-4dannjjm	3321	6	hepatic	hepatic	JJ
cord-023095-4dannjjm	3321	7	/	/	SYM
cord-023095-4dannjjm	3321	8	normal	normal	JJ
cord-023095-4dannjjm	3322	1	(	(	-LRB-
cord-023095-4dannjjm	3322	2	n	n	NN
cord-023095-4dannjjm	3322	3	5	5	CD
cord-023095-4dannjjm	3322	4	12	12	CD
cord-023095-4dannjjm	3322	5	)	)	-RRB-
cord-023095-4dannjjm	3323	1	,	,	,
cord-023095-4dannjjm	3323	2	congenital	congenital	JJ
cord-023095-4dannjjm	3323	3	(	(	-LRB-
cord-023095-4dannjjm	3323	4	n	n	NN
cord-023095-4dannjjm	3323	5	5	5	CD
cord-023095-4dannjjm	3323	6	6	6	CD
cord-023095-4dannjjm	3323	7	)	)	-RRB-
cord-023095-4dannjjm	3323	8	,	,	,
cord-023095-4dannjjm	3323	9	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	3323	10	(	(	-LRB-
cord-023095-4dannjjm	3323	11	n	n	NN
cord-023095-4dannjjm	3323	12	5	5	CD
cord-023095-4dannjjm	3323	13	16	16	CD
cord-023095-4dannjjm	3323	14	)	)	-RRB-
cord-023095-4dannjjm	3323	15	,	,	,
cord-023095-4dannjjm	3323	16	infectious	infectious	JJ
cord-023095-4dannjjm	3323	17	/	/	SYM
cord-023095-4dannjjm	3323	18	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3323	19	(	(	-LRB-
cord-023095-4dannjjm	3323	20	n	n	NN
cord-023095-4dannjjm	3323	21	5	5	CD
cord-023095-4dannjjm	3323	22	39	39	CD
cord-023095-4dannjjm	3323	23	)	)	-RRB-
cord-023095-4dannjjm	3323	24	,	,	,
cord-023095-4dannjjm	3323	25	and	and	CC
cord-023095-4dannjjm	3323	26	other	other	JJ
cord-023095-4dannjjm	3323	27	(	(	-LRB-
cord-023095-4dannjjm	3323	28	n	n	NN
cord-023095-4dannjjm	3323	29	5	5	CD
cord-023095-4dannjjm	3323	30	31	31	CD
cord-023095-4dannjjm	3323	31	)	)	-RRB-
cord-023095-4dannjjm	3323	32	.	.	.
cord-023095-4dannjjm	3324	1	Ninety	ninety	CD
cord-023095-4dannjjm	3324	2	-	-	HYPH
cord-023095-4dannjjm	3324	3	two	two	CD
cord-023095-4dannjjm	3324	4	samples	sample	NNS
cord-023095-4dannjjm	3324	5	were	be	VBD
cord-023095-4dannjjm	3324	6	negative	negative	JJ
cord-023095-4dannjjm	3324	7	for	for	IN
cord-023095-4dannjjm	3324	8	copper	copper	NN
cord-023095-4dannjjm	3324	9	;	;	,
cord-023095-4dannjjm	3324	10	remaining	remain	VBG
cord-023095-4dannjjm	3324	11	samples	sample	NNS
cord-023095-4dannjjm	3324	12	were	be	VBD
cord-023095-4dannjjm	3324	13	graded	grade	VBN
cord-023095-4dannjjm	3324	14	1	1	CD
cord-023095-4dannjjm	3325	1	(	(	-LRB-
cord-023095-4dannjjm	3325	2	n	n	NN
cord-023095-4dannjjm	3325	3	5	5	CD
cord-023095-4dannjjm	3325	4	5	5	CD
cord-023095-4dannjjm	3325	5	)	)	-RRB-
cord-023095-4dannjjm	3325	6	,	,	,
cord-023095-4dannjjm	3325	7	2	2	CD
cord-023095-4dannjjm	3325	8	(	(	-LRB-
cord-023095-4dannjjm	3325	9	n	n	NN
cord-023095-4dannjjm	3325	10	5	5	CD
cord-023095-4dannjjm	3325	11	6	6	CD
cord-023095-4dannjjm	3325	12	)	)	-RRB-
cord-023095-4dannjjm	3325	13	,	,	,
cord-023095-4dannjjm	3325	14	and	and	CC
cord-023095-4dannjjm	3325	15	3	3	LS
cord-023095-4dannjjm	3325	16	(	(	-LRB-
cord-023095-4dannjjm	3325	17	n	n	NN
cord-023095-4dannjjm	3325	18	5	5	CD
cord-023095-4dannjjm	3325	19	1	1	CD
cord-023095-4dannjjm	3325	20	)	)	-RRB-
cord-023095-4dannjjm	3325	21	.	.	.
cord-023095-4dannjjm	3326	1	Histologic	Histologic	NNP
cord-023095-4dannjjm	3326	2	diagnoses	diagnosis	NNS
cord-023095-4dannjjm	3326	3	(	(	-LRB-
cord-023095-4dannjjm	3326	4	pattern	pattern	NN
cord-023095-4dannjjm	3326	5	)	)	-RRB-
cord-023095-4dannjjm	3326	6	for	for	IN
cord-023095-4dannjjm	3326	7	positive	positive	JJ
cord-023095-4dannjjm	3326	8	samples	sample	NNS
cord-023095-4dannjjm	3326	9	were	be	VBD
cord-023095-4dannjjm	3326	10	congenital	congenital	JJ
cord-023095-4dannjjm	3326	11	(	(	-LRB-
cord-023095-4dannjjm	3326	12	1CL	1cl	CD
cord-023095-4dannjjm	3326	13	)	)	-RRB-
cord-023095-4dannjjm	3326	14	,	,	,
cord-023095-4dannjjm	3326	15	infectious	infectious	JJ
cord-023095-4dannjjm	3326	16	/	/	SYM
cord-023095-4dannjjm	3326	17	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3326	18	(	(	-LRB-
cord-023095-4dannjjm	3326	19	7	7	CD
cord-023095-4dannjjm	3326	20	:	:	SYM
cord-023095-4dannjjm	3326	21	2CL	2cl	CD
cord-023095-4dannjjm	3326	22	,	,	,
cord-023095-4dannjjm	3326	23	1MZ	1mz	CD
cord-023095-4dannjjm	3326	24	,	,	,
cord-023095-4dannjjm	3326	25	2PP	2pp	CD
cord-023095-4dannjjm	3326	26	,	,	,
cord-023095-4dannjjm	3326	27	2R	2R	NNP
cord-023095-4dannjjm	3326	28	)	)	-RRB-
cord-023095-4dannjjm	3326	29	,	,	,
cord-023095-4dannjjm	3326	30	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	3326	31	(	(	-LRB-
cord-023095-4dannjjm	3326	32	2PP	2pp	CD
cord-023095-4dannjjm	3326	33	)	)	-RRB-
cord-023095-4dannjjm	3326	34	,	,	,
cord-023095-4dannjjm	3326	35	and	and	CC
cord-023095-4dannjjm	3326	36	other	other	JJ
cord-023095-4dannjjm	3326	37	(	(	-LRB-
cord-023095-4dannjjm	3326	38	2CL	2cl	CD
cord-023095-4dannjjm	3326	39	)	)	-RRB-
cord-023095-4dannjjm	3326	40	.	.	.
cord-023095-4dannjjm	3327	1	Iron	iron	NN
cord-023095-4dannjjm	3327	2	staining	staining	NN
cord-023095-4dannjjm	3327	3	was	be	VBD
cord-023095-4dannjjm	3327	4	negative	negative	JJ
cord-023095-4dannjjm	3327	5	in	in	IN
cord-023095-4dannjjm	3327	6	18	18	CD
cord-023095-4dannjjm	3327	7	samples	sample	NNS
cord-023095-4dannjjm	3327	8	;	;	,
cord-023095-4dannjjm	3327	9	remaining	remain	VBG
cord-023095-4dannjjm	3327	10	samples	sample	NNS
cord-023095-4dannjjm	3327	11	were	be	VBD
cord-023095-4dannjjm	3327	12	graded	grade	VBN
cord-023095-4dannjjm	3327	13	1	1	CD
cord-023095-4dannjjm	3328	1	(	(	-LRB-
cord-023095-4dannjjm	3328	2	n	n	NN
cord-023095-4dannjjm	3328	3	5	5	CD
cord-023095-4dannjjm	3328	4	38	38	CD
cord-023095-4dannjjm	3328	5	)	)	-RRB-
cord-023095-4dannjjm	3328	6	,	,	,
cord-023095-4dannjjm	3328	7	2	2	CD
cord-023095-4dannjjm	3328	8	(	(	-LRB-
cord-023095-4dannjjm	3328	9	n	n	NN
cord-023095-4dannjjm	3328	10	5	5	CD
cord-023095-4dannjjm	3328	11	40	40	CD
cord-023095-4dannjjm	3328	12	)	)	-RRB-
cord-023095-4dannjjm	3328	13	,	,	,
cord-023095-4dannjjm	3328	14	and	and	CC
cord-023095-4dannjjm	3328	15	3	3	LS
cord-023095-4dannjjm	3328	16	(	(	-LRB-
cord-023095-4dannjjm	3328	17	n	n	NN
cord-023095-4dannjjm	3328	18	5	5	CD
cord-023095-4dannjjm	3328	19	8)	8)	NN
cord-023095-4dannjjm	3328	20	.	.	.
cord-023095-4dannjjm	3329	1	Distribution	distribution	NN
cord-023095-4dannjjm	3329	2	was	be	VBD
cord-023095-4dannjjm	3329	3	primarily	primarily	RB
cord-023095-4dannjjm	3329	4	CL	CL	NNP
cord-023095-4dannjjm	3329	5	(	(	-LRB-
cord-023095-4dannjjm	3329	6	n	n	NN
cord-023095-4dannjjm	3329	7	5	5	CD
cord-023095-4dannjjm	3329	8	38	38	CD
cord-023095-4dannjjm	3329	9	)	)	-RRB-
cord-023095-4dannjjm	3329	10	or	or	CC
cord-023095-4dannjjm	3329	11	R	r	NN
cord-023095-4dannjjm	3329	12	(	(	-LRB-
cord-023095-4dannjjm	3329	13	n	n	NN
cord-023095-4dannjjm	3329	14	5	5	CD
cord-023095-4dannjjm	3329	15	33	33	CD
cord-023095-4dannjjm	3329	16	)	)	-RRB-
cord-023095-4dannjjm	3329	17	,	,	,
cord-023095-4dannjjm	3329	18	though	though	IN
cord-023095-4dannjjm	3329	19	MZ	MZ	NNP
cord-023095-4dannjjm	3329	20	(	(	-LRB-
cord-023095-4dannjjm	3329	21	n	n	NN
cord-023095-4dannjjm	3329	22	5	5	CD
cord-023095-4dannjjm	3329	23	13	13	CD
cord-023095-4dannjjm	3329	24	)	)	-RRB-
cord-023095-4dannjjm	3329	25	and	and	CC
cord-023095-4dannjjm	3329	26	PP	PP	NNP
cord-023095-4dannjjm	3329	27	(	(	-LRB-
cord-023095-4dannjjm	3329	28	n	n	NN
cord-023095-4dannjjm	3329	29	5	5	CD
cord-023095-4dannjjm	3329	30	2	2	CD
cord-023095-4dannjjm	3329	31	)	)	-RRB-
cord-023095-4dannjjm	3329	32	distribution	distribution	NN
cord-023095-4dannjjm	3329	33	occurred	occur	VBD
cord-023095-4dannjjm	3329	34	.	.	.
cord-023095-4dannjjm	3330	1	There	there	EX
cord-023095-4dannjjm	3330	2	were	be	VBD
cord-023095-4dannjjm	3330	3	no	no	DT
cord-023095-4dannjjm	3330	4	significant	significant	JJ
cord-023095-4dannjjm	3330	5	differences	difference	NNS
cord-023095-4dannjjm	3330	6	by	by	IN
cord-023095-4dannjjm	3330	7	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	3330	8	-	-	HYPH
cord-023095-4dannjjm	3330	9	Wallis	Wallis	NNP
cord-023095-4dannjjm	3330	10	analysis	analysis	NN
cord-023095-4dannjjm	3330	11	for	for	IN
cord-023095-4dannjjm	3330	12	amount	amount	NN
cord-023095-4dannjjm	3330	13	or	or	CC
cord-023095-4dannjjm	3330	14	location	location	NN
cord-023095-4dannjjm	3330	15	of	of	IN
cord-023095-4dannjjm	3330	16	hepatocellular	hepatocellular	JJ
cord-023095-4dannjjm	3330	17	iron	iron	NN
cord-023095-4dannjjm	3330	18	or	or	CC
cord-023095-4dannjjm	3330	19	copper	copper	NN
cord-023095-4dannjjm	3330	20	for	for	IN
cord-023095-4dannjjm	3330	21	the	the	DT
cord-023095-4dannjjm	3330	22	different	different	JJ
cord-023095-4dannjjm	3330	23	disease	disease	NN
cord-023095-4dannjjm	3330	24	categories	category	NNS
cord-023095-4dannjjm	3330	25	.	.	.
cord-023095-4dannjjm	3331	1	In	in	IN
cord-023095-4dannjjm	3331	2	this	this	DT
cord-023095-4dannjjm	3331	3	study	study	NN
cord-023095-4dannjjm	3331	4	,	,	,
cord-023095-4dannjjm	3331	5	copper	copper	NN
cord-023095-4dannjjm	3331	6	accumulation	accumulation	NN
cord-023095-4dannjjm	3331	7	was	be	VBD
cord-023095-4dannjjm	3331	8	rare	rare	JJ
cord-023095-4dannjjm	3331	9	,	,	,
cord-023095-4dannjjm	3331	10	had	have	VBD
cord-023095-4dannjjm	3331	11	variable	variable	JJ
cord-023095-4dannjjm	3331	12	distribution	distribution	NN
cord-023095-4dannjjm	3331	13	and	and	CC
cord-023095-4dannjjm	3331	14	occurred	occur	VBD
cord-023095-4dannjjm	3331	15	primarily	primarily	RB
cord-023095-4dannjjm	3331	16	in	in	IN
cord-023095-4dannjjm	3331	17	samples	sample	NNS
cord-023095-4dannjjm	3331	18	with	with	IN
cord-023095-4dannjjm	3331	19	inflammatory/	inflammatory/	HYPH
cord-023095-4dannjjm	3331	20	infectious	infectious	JJ
cord-023095-4dannjjm	3331	21	disease	disease	NN
cord-023095-4dannjjm	3331	22	.	.	.
cord-023095-4dannjjm	3332	1	In	in	IN
cord-023095-4dannjjm	3332	2	contrast	contrast	NN
cord-023095-4dannjjm	3332	3	,	,	,
cord-023095-4dannjjm	3332	4	iron	iron	NN
cord-023095-4dannjjm	3332	5	accumulation	accumulation	NN
cord-023095-4dannjjm	3332	6	was	be	VBD
cord-023095-4dannjjm	3332	7	common	common	JJ
cord-023095-4dannjjm	3332	8	and	and	CC
cord-023095-4dannjjm	3332	9	did	do	VBD
cord-023095-4dannjjm	3332	10	not	not	RB
cord-023095-4dannjjm	3332	11	correlate	correlate	VB
cord-023095-4dannjjm	3332	12	with	with	IN
cord-023095-4dannjjm	3332	13	disease	disease	NN
cord-023095-4dannjjm	3332	14	category	category	NN
cord-023095-4dannjjm	3332	15	.	.	.
cord-023095-4dannjjm	3333	1	Further	further	JJ
cord-023095-4dannjjm	3333	2	prospective	prospective	JJ
cord-023095-4dannjjm	3333	3	evaluation	evaluation	NN
cord-023095-4dannjjm	3333	4	of	of	IN
cord-023095-4dannjjm	3333	5	copper	copper	NN
cord-023095-4dannjjm	3333	6	and	and	CC
cord-023095-4dannjjm	3333	7	iron	iron	NN
cord-023095-4dannjjm	3333	8	accumulation	accumulation	NN
cord-023095-4dannjjm	3333	9	in	in	IN
cord-023095-4dannjjm	3333	10	feline	feline	JJ
cord-023095-4dannjjm	3333	11	liver	liver	NN
cord-023095-4dannjjm	3333	12	disease	disease	NN
cord-023095-4dannjjm	3333	13	and	and	CC
cord-023095-4dannjjm	3333	14	association	association	NN
cord-023095-4dannjjm	3333	15	with	with	IN
cord-023095-4dannjjm	3333	16	outcome	outcome	NN
cord-023095-4dannjjm	3333	17	may	may	MD
cord-023095-4dannjjm	3333	18	be	be	VB
cord-023095-4dannjjm	3333	19	warranted	warrant	VBN
cord-023095-4dannjjm	3333	20	.	.	.
cord-023095-4dannjjm	3334	1	Chronic	chronic	JJ
cord-023095-4dannjjm	3334	2	hepatitis	hepatitis	NN
cord-023095-4dannjjm	3334	3	(	(	-LRB-
cord-023095-4dannjjm	3334	4	CH	CH	NNP
cord-023095-4dannjjm	3334	5	)	)	-RRB-
cord-023095-4dannjjm	3334	6	in	in	IN
cord-023095-4dannjjm	3334	7	dogs	dog	NNS
cord-023095-4dannjjm	3334	8	is	be	VBZ
cord-023095-4dannjjm	3334	9	a	a	DT
cord-023095-4dannjjm	3334	10	progressive	progressive	JJ
cord-023095-4dannjjm	3334	11	condition	condition	NN
cord-023095-4dannjjm	3334	12	without	without	IN
cord-023095-4dannjjm	3334	13	clearly	clearly	RB
cord-023095-4dannjjm	3334	14	defined	define	VBN
cord-023095-4dannjjm	3334	15	treatment	treatment	NN
cord-023095-4dannjjm	3334	16	.	.	.
cord-023095-4dannjjm	3335	1	Glucocorticoids	Glucocorticoids	NNP
cord-023095-4dannjjm	3335	2	are	be	VBP
cord-023095-4dannjjm	3335	3	commonly	commonly	RB
cord-023095-4dannjjm	3335	4	used	use	VBN
cord-023095-4dannjjm	3335	5	to	to	TO
cord-023095-4dannjjm	3335	6	stop	stop	VB
cord-023095-4dannjjm	3335	7	progressive	progressive	JJ
cord-023095-4dannjjm	3335	8	inflammation	inflammation	NN
cord-023095-4dannjjm	3335	9	and	and	CC
cord-023095-4dannjjm	3335	10	fibrosis	fibrosis	NN
cord-023095-4dannjjm	3335	11	but	but	CC
cord-023095-4dannjjm	3335	12	are	be	VBP
cord-023095-4dannjjm	3335	13	associated	associate	VBN
cord-023095-4dannjjm	3335	14	with	with	IN
cord-023095-4dannjjm	3335	15	significant	significant	JJ
cord-023095-4dannjjm	3335	16	side	side	NN
cord-023095-4dannjjm	3335	17	effects	effect	NNS
cord-023095-4dannjjm	3335	18	including	include	VBG
cord-023095-4dannjjm	3335	19	a	a	DT
cord-023095-4dannjjm	3335	20	steroid	steroid	JJ
cord-023095-4dannjjm	3335	21	hepatopathy	hepatopathy	NN
cord-023095-4dannjjm	3335	22	that	that	WDT
cord-023095-4dannjjm	3335	23	complicates	complicate	VBZ
cord-023095-4dannjjm	3335	24	enzyme	enzyme	NN
cord-023095-4dannjjm	3335	25	monitoring	monitoring	NN
cord-023095-4dannjjm	3335	26	.	.	.
cord-023095-4dannjjm	3336	1	Cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3336	2	is	be	VBZ
cord-023095-4dannjjm	3336	3	proposed	propose	VBN
cord-023095-4dannjjm	3336	4	as	as	IN
cord-023095-4dannjjm	3336	5	an	an	DT
cord-023095-4dannjjm	3336	6	alternative	alternative	JJ
cord-023095-4dannjjm	3336	7	therapy	therapy	NN
cord-023095-4dannjjm	3336	8	,	,	,
cord-023095-4dannjjm	3336	9	but	but	CC
cord-023095-4dannjjm	3336	10	there	there	EX
cord-023095-4dannjjm	3336	11	are	be	VBP
cord-023095-4dannjjm	3336	12	no	no	DT
cord-023095-4dannjjm	3336	13	published	publish	VBN
cord-023095-4dannjjm	3336	14	reports	report	NNS
cord-023095-4dannjjm	3336	15	of	of	IN
cord-023095-4dannjjm	3336	16	its	-PRON-	PRP$
cord-023095-4dannjjm	3336	17	use	use	NN
cord-023095-4dannjjm	3336	18	for	for	IN
cord-023095-4dannjjm	3336	19	canine	canine	JJ
cord-023095-4dannjjm	3336	20	CH	ch	NN
cord-023095-4dannjjm	3336	21	.	.	.
cord-023095-4dannjjm	3337	1	Patient	patient	JJ
cord-023095-4dannjjm	3337	2	records	record	NNS
cord-023095-4dannjjm	3337	3	at	at	IN
cord-023095-4dannjjm	3337	4	the	the	DT
cord-023095-4dannjjm	3337	5	CSU	CSU	NNP
cord-023095-4dannjjm	3337	6	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	3337	7	Teaching	Teaching	NNP
cord-023095-4dannjjm	3337	8	Hospital	Hospital	NNP
cord-023095-4dannjjm	3337	9	were	be	VBD
cord-023095-4dannjjm	3337	10	searched	search	VBN
cord-023095-4dannjjm	3337	11	for	for	IN
cord-023095-4dannjjm	3337	12	histologically	histologically	RB
cord-023095-4dannjjm	3337	13	confirmed	confirm	VBN
cord-023095-4dannjjm	3337	14	cases	case	NNS
cord-023095-4dannjjm	3337	15	of	of	IN
cord-023095-4dannjjm	3337	16	CH	CH	NNP
cord-023095-4dannjjm	3337	17	treated	treat	VBN
cord-023095-4dannjjm	3337	18	with	with	IN
cord-023095-4dannjjm	3337	19	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3337	20	.	.	.
cord-023095-4dannjjm	3338	1	Data	datum	NNS
cord-023095-4dannjjm	3338	2	were	be	VBD
cord-023095-4dannjjm	3338	3	compiled	compile	VBN
cord-023095-4dannjjm	3338	4	on	on	IN
cord-023095-4dannjjm	3338	5	cyclosporine	cyclosporine	JJ
cord-023095-4dannjjm	3338	6	dosing	dosing	NN
cord-023095-4dannjjm	3338	7	,	,	,
cord-023095-4dannjjm	3338	8	concurrent	concurrent	JJ
cord-023095-4dannjjm	3338	9	medications	medication	NNS
cord-023095-4dannjjm	3338	10	,	,	,
cord-023095-4dannjjm	3338	11	clinical	clinical	JJ
cord-023095-4dannjjm	3338	12	course	course	NN
cord-023095-4dannjjm	3338	13	and	and	CC
cord-023095-4dannjjm	3338	14	biochemical	biochemical	JJ
cord-023095-4dannjjm	3338	15	parameters	parameter	NNS
cord-023095-4dannjjm	3338	16	.	.	.
cord-023095-4dannjjm	3339	1	13	13	CD
cord-023095-4dannjjm	3339	2	patients	patient	NNS
cord-023095-4dannjjm	3339	3	over	over	IN
cord-023095-4dannjjm	3339	4	a	a	DT
cord-023095-4dannjjm	3339	5	50-month	50-month	CD
cord-023095-4dannjjm	3339	6	period	period	NN
cord-023095-4dannjjm	3339	7	were	be	VBD
cord-023095-4dannjjm	3339	8	identified	identify	VBN
cord-023095-4dannjjm	3339	9	.	.	.
cord-023095-4dannjjm	3340	1	Serum	serum	NN
cord-023095-4dannjjm	3340	2	alanine	alanine	NN
cord-023095-4dannjjm	3340	3	aminotransferase	aminotransferase	NN
cord-023095-4dannjjm	3340	4	(	(	-LRB-
cord-023095-4dannjjm	3340	5	ALT	ALT	NNP
cord-023095-4dannjjm	3340	6	)	)	-RRB-
cord-023095-4dannjjm	3340	7	decreased	decrease	VBD
cord-023095-4dannjjm	3340	8	by	by	IN
cord-023095-4dannjjm	3340	9	an	an	DT
cord-023095-4dannjjm	3340	10	average	average	NN
cord-023095-4dannjjm	3340	11	of	of	IN
cord-023095-4dannjjm	3340	12	71	71	CD
cord-023095-4dannjjm	3340	13	%	%	NN
cord-023095-4dannjjm	3340	14	in	in	IN
cord-023095-4dannjjm	3340	15	12	12	CD
cord-023095-4dannjjm	3340	16	dogs	dog	NNS
cord-023095-4dannjjm	3340	17	.	.	.
cord-023095-4dannjjm	3341	1	The	the	DT
cord-023095-4dannjjm	3341	2	ALT	alt	NN
cord-023095-4dannjjm	3341	3	normalized	normalize	VBN
cord-023095-4dannjjm	3341	4	completely	completely	RB
cord-023095-4dannjjm	3341	5	in	in	IN
cord-023095-4dannjjm	3341	6	6	6	CD
cord-023095-4dannjjm	3341	7	of	of	IN
cord-023095-4dannjjm	3341	8	10	10	CD
cord-023095-4dannjjm	3341	9	dogs	dog	NNS
cord-023095-4dannjjm	3341	10	treated	treat	VBN
cord-023095-4dannjjm	3341	11	for	for	IN
cord-023095-4dannjjm	3341	12	4	4	CD
cord-023095-4dannjjm	3341	13	60	60	CD
cord-023095-4dannjjm	3341	14	days	day	NNS
cord-023095-4dannjjm	3341	15	.	.	.
cord-023095-4dannjjm	3342	1	In	in	IN
cord-023095-4dannjjm	3342	2	5	5	CD
cord-023095-4dannjjm	3342	3	of	of	IN
cord-023095-4dannjjm	3342	4	6	6	CD
cord-023095-4dannjjm	3342	5	dogs	dog	NNS
cord-023095-4dannjjm	3342	6	on	on	IN
cord-023095-4dannjjm	3342	7	4	4	CD
cord-023095-4dannjjm	3342	8	9	9	CD
cord-023095-4dannjjm	3343	1	mg	mg	NNP
cord-023095-4dannjjm	3343	2	/	/	SYM
cord-023095-4dannjjm	3343	3	kg	kg	NNP
cord-023095-4dannjjm	3343	4	/	/	SYM
cord-023095-4dannjjm	3343	5	day	day	NN
cord-023095-4dannjjm	3343	6	,	,	,
cord-023095-4dannjjm	3343	7	the	the	DT
cord-023095-4dannjjm	3343	8	ALT	ALT	NNP
cord-023095-4dannjjm	3343	9	also	also	RB
cord-023095-4dannjjm	3343	10	normalized	normalize	VBD
cord-023095-4dannjjm	3343	11	.	.	.
cord-023095-4dannjjm	3344	1	Five	five	CD
cord-023095-4dannjjm	3344	2	of	of	IN
cord-023095-4dannjjm	3344	3	the	the	DT
cord-023095-4dannjjm	3344	4	6	6	CD
cord-023095-4dannjjm	3344	5	patients	patient	NNS
cord-023095-4dannjjm	3344	6	that	that	WDT
cord-023095-4dannjjm	3344	7	exhibited	exhibit	VBD
cord-023095-4dannjjm	3344	8	clinical	clinical	JJ
cord-023095-4dannjjm	3344	9	signs	sign	NNS
cord-023095-4dannjjm	3344	10	prior	prior	RB
cord-023095-4dannjjm	3344	11	to	to	IN
cord-023095-4dannjjm	3344	12	treatment	treatment	NN
cord-023095-4dannjjm	3344	13	showed	show	VBD
cord-023095-4dannjjm	3344	14	measurable	measurable	JJ
cord-023095-4dannjjm	3344	15	improvement	improvement	NN
cord-023095-4dannjjm	3344	16	(	(	-LRB-
cord-023095-4dannjjm	3344	17	weight	weight	NN
cord-023095-4dannjjm	3344	18	gain	gain	NN
cord-023095-4dannjjm	3344	19	,	,	,
cord-023095-4dannjjm	3344	20	fewer	few	JJR
cord-023095-4dannjjm	3344	21	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	3344	22	signs	sign	NNS
cord-023095-4dannjjm	3344	23	)	)	-RRB-
cord-023095-4dannjjm	3344	24	.	.	.
cord-023095-4dannjjm	3345	1	Eight	eight	CD
cord-023095-4dannjjm	3345	2	patients	patient	NNS
cord-023095-4dannjjm	3345	3	had	have	VBD
cord-023095-4dannjjm	3345	4	hyperbilirubinemia	hyperbilirubinemia	NN
cord-023095-4dannjjm	3345	5	or	or	CC
cord-023095-4dannjjm	3345	6	ascites	ascites	NN
cord-023095-4dannjjm	3345	7	prior	prior	RB
cord-023095-4dannjjm	3345	8	to	to	IN
cord-023095-4dannjjm	3345	9	treatment	treatment	NN
cord-023095-4dannjjm	3345	10	;	;	:
cord-023095-4dannjjm	3345	11	these	these	DT
cord-023095-4dannjjm	3345	12	resolved	resolve	VBD
cord-023095-4dannjjm	3345	13	in	in	IN
cord-023095-4dannjjm	3345	14	7	7	CD
cord-023095-4dannjjm	3345	15	.	.	.
cord-023095-4dannjjm	3346	1	Post	post	JJ
cord-023095-4dannjjm	3346	2	-	-	JJ
cord-023095-4dannjjm	3346	3	treatment	treatment	JJ
cord-023095-4dannjjm	3346	4	histopathology	histopathology	NN
cord-023095-4dannjjm	3346	5	,	,	,
cord-023095-4dannjjm	3346	6	available	available	JJ
cord-023095-4dannjjm	3346	7	in	in	IN
cord-023095-4dannjjm	3346	8	one	one	CD
cord-023095-4dannjjm	3346	9	patient	patient	NN
cord-023095-4dannjjm	3346	10	,	,	,
cord-023095-4dannjjm	3346	11	revealed	reveal	VBD
cord-023095-4dannjjm	3346	12	decreased	decreased	JJ
cord-023095-4dannjjm	3346	13	severity	severity	NN
cord-023095-4dannjjm	3346	14	of	of	IN
cord-023095-4dannjjm	3346	15	CH	CH	NNP
cord-023095-4dannjjm	3346	16	.	.	.
cord-023095-4dannjjm	3347	1	Five	five	CD
cord-023095-4dannjjm	3347	2	patients	patient	NNS
cord-023095-4dannjjm	3347	3	exhibited	exhibit	VBD
cord-023095-4dannjjm	3347	4	adverse	adverse	JJ
cord-023095-4dannjjm	3347	5	effects	effect	NNS
cord-023095-4dannjjm	3347	6	including	include	VBG
cord-023095-4dannjjm	3347	7	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	3347	8	signs	sign	NNS
cord-023095-4dannjjm	3347	9	(	(	-LRB-
cord-023095-4dannjjm	3347	10	3	3	CD
cord-023095-4dannjjm	3347	11	)	)	-RRB-
cord-023095-4dannjjm	3347	12	,	,	,
cord-023095-4dannjjm	3347	13	gingival	gingival	JJ
cord-023095-4dannjjm	3347	14	hyperplasia	hyperplasia	NN
cord-023095-4dannjjm	3347	15	(	(	-LRB-
cord-023095-4dannjjm	3347	16	1	1	CD
cord-023095-4dannjjm	3347	17	)	)	-RRB-
cord-023095-4dannjjm	3347	18	,	,	,
cord-023095-4dannjjm	3347	19	and	and	CC
cord-023095-4dannjjm	3347	20	papillomatosis	papillomatosis	NNP
cord-023095-4dannjjm	3347	21	(	(	-LRB-
cord-023095-4dannjjm	3347	22	1	1	CD
cord-023095-4dannjjm	3347	23	)	)	-RRB-
cord-023095-4dannjjm	3347	24	.	.	.
cord-023095-4dannjjm	3348	1	Cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3348	2	was	be	VBD
cord-023095-4dannjjm	3348	3	discontinued	discontinue	VBN
cord-023095-4dannjjm	3348	4	in	in	IN
cord-023095-4dannjjm	3348	5	2	2	CD
cord-023095-4dannjjm	3348	6	dogs	dog	NNS
cord-023095-4dannjjm	3348	7	with	with	IN
cord-023095-4dannjjm	3348	8	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	3348	9	signs	sign	NNS
cord-023095-4dannjjm	3348	10	.	.	.
cord-023095-4dannjjm	3349	1	Cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3349	2	was	be	VBD
cord-023095-4dannjjm	3349	3	an	an	DT
cord-023095-4dannjjm	3349	4	effective	effective	JJ
cord-023095-4dannjjm	3349	5	therapy	therapy	NN
cord-023095-4dannjjm	3349	6	for	for	IN
cord-023095-4dannjjm	3349	7	many	many	JJ
cord-023095-4dannjjm	3349	8	cases	case	NNS
cord-023095-4dannjjm	3349	9	of	of	IN
cord-023095-4dannjjm	3349	10	CH	CH	NNP
cord-023095-4dannjjm	3349	11	and	and	CC
cord-023095-4dannjjm	3349	12	should	should	MD
cord-023095-4dannjjm	3349	13	be	be	VB
cord-023095-4dannjjm	3349	14	considered	consider	VBN
cord-023095-4dannjjm	3349	15	for	for	IN
cord-023095-4dannjjm	3349	16	patients	patient	NNS
cord-023095-4dannjjm	3349	17	who	who	WP
cord-023095-4dannjjm	3349	18	are	be	VBP
cord-023095-4dannjjm	3349	19	refractory	refractory	JJ
cord-023095-4dannjjm	3349	20	to	to	IN
cord-023095-4dannjjm	3349	21	or	or	CC
cord-023095-4dannjjm	3349	22	can	can	MD
cord-023095-4dannjjm	3349	23	not	not	RB
cord-023095-4dannjjm	3349	24	tolerate	tolerate	VB
cord-023095-4dannjjm	3349	25	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	3349	26	.	.	.
cord-023095-4dannjjm	3350	1	Prospective	prospective	JJ
cord-023095-4dannjjm	3350	2	clinical	clinical	JJ
cord-023095-4dannjjm	3350	3	trials	trial	NNS
cord-023095-4dannjjm	3350	4	with	with	IN
cord-023095-4dannjjm	3350	5	histological	histological	JJ
cord-023095-4dannjjm	3350	6	documentation	documentation	NN
cord-023095-4dannjjm	3350	7	are	be	VBP
cord-023095-4dannjjm	3350	8	needed	need	VBN
cord-023095-4dannjjm	3350	9	to	to	TO
cord-023095-4dannjjm	3350	10	better	well	RBR
cord-023095-4dannjjm	3350	11	define	define	VB
cord-023095-4dannjjm	3350	12	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3350	13	's	's	POS
cord-023095-4dannjjm	3350	14	effectiveness	effectiveness	NN
cord-023095-4dannjjm	3350	15	in	in	IN
cord-023095-4dannjjm	3350	16	CH	CH	NNP
cord-023095-4dannjjm	3350	17	.	.	.
cord-023095-4dannjjm	3351	1	Insertion	insertion	NN
cord-023095-4dannjjm	3351	2	of	of	IN
cord-023095-4dannjjm	3351	3	the	the	DT
cord-023095-4dannjjm	3351	4	Veress	Veress	NNP
cord-023095-4dannjjm	3351	5	needle	needle	NN
cord-023095-4dannjjm	3351	6	and	and	CC
cord-023095-4dannjjm	3351	7	establishment	establishment	NN
cord-023095-4dannjjm	3351	8	of	of	IN
cord-023095-4dannjjm	3351	9	pneumoperitoneum	pneumoperitoneum	NNP
cord-023095-4dannjjm	3351	10	is	be	VBZ
cord-023095-4dannjjm	3351	11	associated	associate	VBN
cord-023095-4dannjjm	3351	12	with	with	IN
cord-023095-4dannjjm	3351	13	22	22	CD
cord-023095-4dannjjm	3351	14	to	to	TO
cord-023095-4dannjjm	3351	15	57	57	CD
cord-023095-4dannjjm	3351	16	%	%	NN
cord-023095-4dannjjm	3351	17	of	of	IN
cord-023095-4dannjjm	3351	18	all	all	DT
cord-023095-4dannjjm	3351	19	laparoscopic	laparoscopic	JJ
cord-023095-4dannjjm	3351	20	complications	complication	NNS
cord-023095-4dannjjm	3351	21	in	in	IN
cord-023095-4dannjjm	3351	22	humans	human	NNS
cord-023095-4dannjjm	3351	23	.	.	.
cord-023095-4dannjjm	3352	1	The	the	DT
cord-023095-4dannjjm	3352	2	purpose	purpose	NN
cord-023095-4dannjjm	3352	3	of	of	IN
cord-023095-4dannjjm	3352	4	this	this	DT
cord-023095-4dannjjm	3352	5	study	study	NN
cord-023095-4dannjjm	3352	6	was	be	VBD
cord-023095-4dannjjm	3352	7	to	to	TO
cord-023095-4dannjjm	3352	8	determine	determine	VB
cord-023095-4dannjjm	3352	9	the	the	DT
cord-023095-4dannjjm	3352	10	accuracy	accuracy	NN
cord-023095-4dannjjm	3352	11	of	of	IN
cord-023095-4dannjjm	3352	12	interpretation	interpretation	NN
cord-023095-4dannjjm	3352	13	of	of	IN
cord-023095-4dannjjm	3352	14	tissue	tissue	NN
cord-023095-4dannjjm	3352	15	impedance	impedance	NN
cord-023095-4dannjjm	3352	16	measurements	measurement	NNS
cord-023095-4dannjjm	3352	17	for	for	IN
cord-023095-4dannjjm	3352	18	Veress	Veress	NNP
cord-023095-4dannjjm	3352	19	needle	needle	NN
cord-023095-4dannjjm	3352	20	location	location	NN
cord-023095-4dannjjm	3352	21	.	.	.
cord-023095-4dannjjm	3353	1	Two	two	CD
cord-023095-4dannjjm	3353	2	laparoscopists	laparoscopist	NNS
cord-023095-4dannjjm	3353	3	,	,	,
cord-023095-4dannjjm	3353	4	blinded	blind	VBN
cord-023095-4dannjjm	3353	5	to	to	TO
cord-023095-4dannjjm	3353	6	impedance	impedance	VB
cord-023095-4dannjjm	3353	7	measurements	measurement	NNS
cord-023095-4dannjjm	3353	8	,	,	,
cord-023095-4dannjjm	3353	9	placed	place	VBD
cord-023095-4dannjjm	3353	10	reusable	reusable	JJ
cord-023095-4dannjjm	3353	11	Veress	Veress	NNP
cord-023095-4dannjjm	3353	12	needles	needle	NNS
cord-023095-4dannjjm	3353	13	in	in	IN
cord-023095-4dannjjm	3353	14	20	20	CD
cord-023095-4dannjjm	3353	15	cadaverous	cadaverous	JJ
cord-023095-4dannjjm	3353	16	dogs	dog	NNS
cord-023095-4dannjjm	3353	17	euthanized	euthanize	VBN
cord-023095-4dannjjm	3353	18	for	for	IN
cord-023095-4dannjjm	3353	19	reasons	reason	NNS
cord-023095-4dannjjm	3353	20	unrelated	unrelated	JJ
cord-023095-4dannjjm	3353	21	to	to	IN
cord-023095-4dannjjm	3353	22	the	the	DT
cord-023095-4dannjjm	3353	23	study	study	NN
cord-023095-4dannjjm	3353	24	.	.	.
cord-023095-4dannjjm	3354	1	Placement	placement	NN
cord-023095-4dannjjm	3354	2	order	order	NN
cord-023095-4dannjjm	3354	3	was	be	VBD
cord-023095-4dannjjm	3354	4	randomized	randomized	JJ
cord-023095-4dannjjm	3354	5	.	.	.
cord-023095-4dannjjm	3355	1	A	a	DT
cord-023095-4dannjjm	3355	2	third	third	JJ
cord-023095-4dannjjm	3355	3	individual	individual	NN
cord-023095-4dannjjm	3355	4	evaluated	evaluate	VBD
cord-023095-4dannjjm	3355	5	impedance	impedance	NN
cord-023095-4dannjjm	3355	6	measurements	measurement	NNS
cord-023095-4dannjjm	3355	7	using	use	VBG
cord-023095-4dannjjm	3355	8	a	a	DT
cord-023095-4dannjjm	3355	9	handheld	handheld	JJ
cord-023095-4dannjjm	3355	10	device	device	NN
cord-023095-4dannjjm	3355	11	(	(	-LRB-
cord-023095-4dannjjm	3355	12	SensorMed	SensorMed	NNP
cord-023095-4dannjjm	3355	13	,	,	,
cord-023095-4dannjjm	3355	14	Knoxville	Knoxville	NNP
cord-023095-4dannjjm	3355	15	TN	TN	NNP
cord-023095-4dannjjm	3355	16	)	)	-RRB-
cord-023095-4dannjjm	3355	17	to	to	TO
cord-023095-4dannjjm	3355	18	determine	determine	VB
cord-023095-4dannjjm	3355	19	correct	correct	JJ
cord-023095-4dannjjm	3355	20	versus	versus	IN
cord-023095-4dannjjm	3355	21	incorrect	incorrect	JJ
cord-023095-4dannjjm	3355	22	needle	needle	NN
cord-023095-4dannjjm	3355	23	placement	placement	NN
cord-023095-4dannjjm	3355	24	.	.	.
cord-023095-4dannjjm	3356	1	Veress	Veress	NNP
cord-023095-4dannjjm	3356	2	needle	needle	NN
cord-023095-4dannjjm	3356	3	locations	location	NNS
cord-023095-4dannjjm	3356	4	were	be	VBD
cord-023095-4dannjjm	3356	5	marked	mark	VBN
cord-023095-4dannjjm	3356	6	using	use	VBG
cord-023095-4dannjjm	3356	7	contrasting	contrast	VBG
cord-023095-4dannjjm	3356	8	colors	color	NNS
cord-023095-4dannjjm	3356	9	of	of	IN
cord-023095-4dannjjm	3356	10	India	India	NNP
cord-023095-4dannjjm	3356	11	Ink	Ink	NNP
cord-023095-4dannjjm	3356	12	;	;	:
cord-023095-4dannjjm	3356	13	tissues	tissue	NNS
cord-023095-4dannjjm	3356	14	were	be	VBD
cord-023095-4dannjjm	3356	15	dissected	dissect	VBN
cord-023095-4dannjjm	3356	16	to	to	TO
cord-023095-4dannjjm	3356	17	determine	determine	VB
cord-023095-4dannjjm	3356	18	ink	ink	NN
cord-023095-4dannjjm	3356	19	locations	location	NNS
cord-023095-4dannjjm	3356	20	.	.	.
cord-023095-4dannjjm	3357	1	Impedance	impedance	NN
cord-023095-4dannjjm	3357	2	measurement	measurement	NN
cord-023095-4dannjjm	3357	3	interpretation	interpretation	NN
cord-023095-4dannjjm	3357	4	identified	identify	VBD
cord-023095-4dannjjm	3357	5	29/33	29/33	CD
cord-023095-4dannjjm	3357	6	correct	correct	NN
cord-023095-4dannjjm	3357	7	and	and	CC
cord-023095-4dannjjm	3357	8	7/	7/	CD
cord-023095-4dannjjm	3357	9	7	7	CD
cord-023095-4dannjjm	3357	10	incorrect	incorrect	JJ
cord-023095-4dannjjm	3357	11	placements	placement	NNS
cord-023095-4dannjjm	3357	12	,	,	,
cord-023095-4dannjjm	3357	13	respectively	respectively	RB
cord-023095-4dannjjm	3357	14	.	.	.
cord-023095-4dannjjm	3358	1	Sensitivity	sensitivity	NN
cord-023095-4dannjjm	3358	2	,	,	,
cord-023095-4dannjjm	3358	3	specificity	specificity	NN
cord-023095-4dannjjm	3358	4	,	,	,
cord-023095-4dannjjm	3358	5	accuracy	accuracy	NN
cord-023095-4dannjjm	3358	6	,	,	,
cord-023095-4dannjjm	3358	7	and	and	CC
cord-023095-4dannjjm	3358	8	precision	precision	NN
cord-023095-4dannjjm	3358	9	for	for	IN
cord-023095-4dannjjm	3358	10	correct	correct	JJ
cord-023095-4dannjjm	3358	11	Veress	Veress	NNP
cord-023095-4dannjjm	3358	12	needle	needle	NN
cord-023095-4dannjjm	3358	13	placement	placement	NN
cord-023095-4dannjjm	3358	14	are	be	VBP
cord-023095-4dannjjm	3358	15	listed	list	VBN
cord-023095-4dannjjm	3358	16	below	below	RB
cord-023095-4dannjjm	3358	17	.	.	.
cord-023095-4dannjjm	3359	1	Agreement	agreement	NN
cord-023095-4dannjjm	3359	2	was	be	VBD
cord-023095-4dannjjm	3359	3	moderate	moderate	JJ
cord-023095-4dannjjm	3359	4	(	(	-LRB-
cord-023095-4dannjjm	3359	5	Kappa	Kappa	NNP
cord-023095-4dannjjm	3359	6	0.50	0.50	CD
cord-023095-4dannjjm	3359	7	,	,	,
cord-023095-4dannjjm	3359	8	p	p	NN
cord-023095-4dannjjm	3359	9	5	5	CD
cord-023095-4dannjjm	3359	10	0.01	0.01	CD
cord-023095-4dannjjm	3359	11	)	)	-RRB-
cord-023095-4dannjjm	3359	12	for	for	IN
cord-023095-4dannjjm	3359	13	placements	placement	NNS
cord-023095-4dannjjm	3359	14	by	by	IN
cord-023095-4dannjjm	3359	15	Operator	Operator	NNP
cord-023095-4dannjjm	3359	16	1	1	CD
cord-023095-4dannjjm	3359	17	and	and	CC
cord-023095-4dannjjm	3359	18	very	very	RB
cord-023095-4dannjjm	3359	19	high	high	JJ
cord-023095-4dannjjm	3360	1	(	(	-LRB-
cord-023095-4dannjjm	3360	2	Kappa	Kappa	NNP
cord-023095-4dannjjm	3360	3	5	5	CD
cord-023095-4dannjjm	3360	4	0.88	0.88	CD
cord-023095-4dannjjm	3360	5	,	,	,
cord-023095-4dannjjm	3360	6	p	p	NN
cord-023095-4dannjjm	3360	7	o	o	NN
cord-023095-4dannjjm	3360	8	0.01	0.01	CD
cord-023095-4dannjjm	3360	9	)	)	-RRB-
cord-023095-4dannjjm	3360	10	for	for	IN
cord-023095-4dannjjm	3360	11	placements	placement	NNS
cord-023095-4dannjjm	3360	12	by	by	IN
cord-023095-4dannjjm	3360	13	Operator	Operator	NNP
cord-023095-4dannjjm	3360	14	2	2	CD
cord-023095-4dannjjm	3360	15	.	.	.
cord-023095-4dannjjm	3361	1	Results	result	NNS
cord-023095-4dannjjm	3361	2	for	for	IN
cord-023095-4dannjjm	3361	3	tissue	tissue	NN
cord-023095-4dannjjm	3361	4	impedance	impedance	NN
cord-023095-4dannjjm	3361	5	measurement	measurement	NN
cord-023095-4dannjjm	3361	6	interpretation	interpretation	NN
cord-023095-4dannjjm	3361	7	are	be	VBP
cord-023095-4dannjjm	3361	8	superior	superior	JJ
cord-023095-4dannjjm	3361	9	to	to	IN
cord-023095-4dannjjm	3361	10	published	publish	VBN
cord-023095-4dannjjm	3361	11	data	datum	NNS
cord-023095-4dannjjm	3361	12	for	for	IN
cord-023095-4dannjjm	3361	13	currently	currently	RB
cord-023095-4dannjjm	3361	14	available	available	JJ
cord-023095-4dannjjm	3361	15	tests	test	NNS
cord-023095-4dannjjm	3361	16	.	.	.
cord-023095-4dannjjm	3362	1	Impedance	impedance	NN
cord-023095-4dannjjm	3362	2	measurements	measurement	NNS
cord-023095-4dannjjm	3362	3	accurately	accurately	RB
cord-023095-4dannjjm	3362	4	detected	detect	VBD
cord-023095-4dannjjm	3362	5	all	all	DT
cord-023095-4dannjjm	3362	6	incorrect	incorrect	JJ
cord-023095-4dannjjm	3362	7	needle	needle	NN
cord-023095-4dannjjm	3362	8	placements	placement	NNS
cord-023095-4dannjjm	3362	9	.	.	.
cord-023095-4dannjjm	3363	1	Comparison	comparison	NN
cord-023095-4dannjjm	3363	2	of	of	IN
cord-023095-4dannjjm	3363	3	needle	needle	NN
cord-023095-4dannjjm	3363	4	placement	placement	NN
cord-023095-4dannjjm	3363	5	with	with	IN
cord-023095-4dannjjm	3363	6	and	and	CC
cord-023095-4dannjjm	3363	7	without	without	IN
cord-023095-4dannjjm	3363	8	tissue	tissue	NN
cord-023095-4dannjjm	3363	9	impedance	impedance	NN
cord-023095-4dannjjm	3363	10	feedback	feedback	NN
cord-023095-4dannjjm	3363	11	will	will	MD
cord-023095-4dannjjm	3363	12	be	be	VB
cord-023095-4dannjjm	3363	13	necessary	necessary	JJ
cord-023095-4dannjjm	3363	14	to	to	TO
cord-023095-4dannjjm	3363	15	determine	determine	VB
cord-023095-4dannjjm	3363	16	whether	whether	IN
cord-023095-4dannjjm	3363	17	it	-PRON-	PRP
cord-023095-4dannjjm	3363	18	increases	increase	VBZ
cord-023095-4dannjjm	3363	19	operator	operator	NN
cord-023095-4dannjjm	3363	20	detection	detection	NN
cord-023095-4dannjjm	3363	21	of	of	IN
cord-023095-4dannjjm	3363	22	inappropriate	inappropriate	JJ
cord-023095-4dannjjm	3363	23	Veress	Veress	NNP
cord-023095-4dannjjm	3363	24	needle	needle	NN
cord-023095-4dannjjm	3363	25	placement	placement	NN
cord-023095-4dannjjm	3363	26	and	and	CC
cord-023095-4dannjjm	3363	27	decreases	decrease	VBZ
cord-023095-4dannjjm	3363	28	installment	installment	NN
cord-023095-4dannjjm	3363	29	phase	phase	NN
cord-023095-4dannjjm	3363	30	complication	complication	NN
cord-023095-4dannjjm	3363	31	rates	rate	NNS
cord-023095-4dannjjm	3363	32	.	.	.
cord-023095-4dannjjm	3364	1	Delayed	delay	VBN
cord-023095-4dannjjm	3364	2	detection	detection	NN
cord-023095-4dannjjm	3364	3	of	of	IN
cord-023095-4dannjjm	3364	4	intestinal	intestinal	JJ
cord-023095-4dannjjm	3364	5	perforation	perforation	NN
cord-023095-4dannjjm	3364	6	during	during	IN
cord-023095-4dannjjm	3364	7	Veress	Veress	NNP
cord-023095-4dannjjm	3364	8	needle	needle	NN
cord-023095-4dannjjm	3364	9	insertion	insertion	NN
cord-023095-4dannjjm	3364	10	is	be	VBZ
cord-023095-4dannjjm	3364	11	associated	associate	VBN
cord-023095-4dannjjm	3364	12	with	with	IN
cord-023095-4dannjjm	3364	13	high	high	JJ
cord-023095-4dannjjm	3364	14	mortality	mortality	NN
cord-023095-4dannjjm	3364	15	.	.	.
cord-023095-4dannjjm	3365	1	The	the	DT
cord-023095-4dannjjm	3365	2	purpose	purpose	NN
cord-023095-4dannjjm	3365	3	of	of	IN
cord-023095-4dannjjm	3365	4	this	this	DT
cord-023095-4dannjjm	3365	5	study	study	NN
cord-023095-4dannjjm	3365	6	was	be	VBD
cord-023095-4dannjjm	3365	7	to	to	TO
cord-023095-4dannjjm	3365	8	evaluate	evaluate	VB
cord-023095-4dannjjm	3365	9	the	the	DT
cord-023095-4dannjjm	3365	10	accuracy	accuracy	NN
cord-023095-4dannjjm	3365	11	of	of	IN
cord-023095-4dannjjm	3365	12	tissue	tissue	NN
cord-023095-4dannjjm	3365	13	impedance	impedance	NN
cord-023095-4dannjjm	3365	14	measurement	measurement	NN
cord-023095-4dannjjm	3365	15	interpretation	interpretation	NN
cord-023095-4dannjjm	3365	16	for	for	IN
cord-023095-4dannjjm	3365	17	Veress	Veress	NNP
cord-023095-4dannjjm	3365	18	needle	needle	NN
cord-023095-4dannjjm	3365	19	location	location	NN
cord-023095-4dannjjm	3365	20	.	.	.
cord-023095-4dannjjm	3366	1	Two	two	CD
cord-023095-4dannjjm	3366	2	laparoscopists	laparoscopist	NNS
cord-023095-4dannjjm	3366	3	,	,	,
cord-023095-4dannjjm	3366	4	blinded	blind	VBN
cord-023095-4dannjjm	3366	5	to	to	TO
cord-023095-4dannjjm	3366	6	impedance	impedance	VB
cord-023095-4dannjjm	3366	7	measurements	measurement	NNS
cord-023095-4dannjjm	3366	8	,	,	,
cord-023095-4dannjjm	3366	9	placed	place	VBD
cord-023095-4dannjjm	3366	10	reusable	reusable	JJ
cord-023095-4dannjjm	3366	11	Veress	Veress	NNP
cord-023095-4dannjjm	3366	12	needles	needle	NNS
cord-023095-4dannjjm	3366	13	in	in	IN
cord-023095-4dannjjm	3366	14	24	24	CD
cord-023095-4dannjjm	3366	15	cadaverous	cadaverous	JJ
cord-023095-4dannjjm	3366	16	cats	cat	NNS
cord-023095-4dannjjm	3366	17	.	.	.
cord-023095-4dannjjm	3367	1	Placement	placement	NN
cord-023095-4dannjjm	3367	2	order	order	NN
cord-023095-4dannjjm	3367	3	was	be	VBD
cord-023095-4dannjjm	3367	4	randomized	randomized	JJ
cord-023095-4dannjjm	3367	5	.	.	.
cord-023095-4dannjjm	3368	1	A	a	DT
cord-023095-4dannjjm	3368	2	third	third	JJ
cord-023095-4dannjjm	3368	3	individual	individual	NN
cord-023095-4dannjjm	3368	4	evaluated	evaluate	VBD
cord-023095-4dannjjm	3368	5	impedance	impedance	NN
cord-023095-4dannjjm	3368	6	measurements	measurement	NNS
cord-023095-4dannjjm	3368	7	(	(	-LRB-
cord-023095-4dannjjm	3368	8	SensorMed	SensorMed	NNP
cord-023095-4dannjjm	3368	9	,	,	,
cord-023095-4dannjjm	3368	10	Knoxville	Knoxville	NNP
cord-023095-4dannjjm	3368	11	,	,	,
cord-023095-4dannjjm	3368	12	TN	TN	NNP
cord-023095-4dannjjm	3368	13	)	)	-RRB-
cord-023095-4dannjjm	3368	14	to	to	TO
cord-023095-4dannjjm	3368	15	determine	determine	VB
cord-023095-4dannjjm	3368	16	placement	placement	NN
cord-023095-4dannjjm	3368	17	location	location	NN
cord-023095-4dannjjm	3368	18	.	.	.
cord-023095-4dannjjm	3369	1	Needle	needle	NN
cord-023095-4dannjjm	3369	2	locations	location	NNS
cord-023095-4dannjjm	3369	3	were	be	VBD
cord-023095-4dannjjm	3369	4	marked	mark	VBN
cord-023095-4dannjjm	3369	5	using	use	VBG
cord-023095-4dannjjm	3369	6	India	India	NNP
cord-023095-4dannjjm	3369	7	Ink	ink	NN
cord-023095-4dannjjm	3369	8	;	;	:
cord-023095-4dannjjm	3369	9	tissues	tissue	NNS
cord-023095-4dannjjm	3369	10	were	be	VBD
cord-023095-4dannjjm	3369	11	dissected	dissect	VBN
cord-023095-4dannjjm	3369	12	to	to	TO
cord-023095-4dannjjm	3369	13	determine	determine	VB
cord-023095-4dannjjm	3369	14	ink	ink	NN
cord-023095-4dannjjm	3369	15	locations	location	NNS
cord-023095-4dannjjm	3369	16	.	.	.
cord-023095-4dannjjm	3370	1	Impedance	impedance	NN
cord-023095-4dannjjm	3370	2	measurement	measurement	NN
cord-023095-4dannjjm	3370	3	interpretation	interpretation	NN
cord-023095-4dannjjm	3370	4	identified	identify	VBD
cord-023095-4dannjjm	3370	5	36/38	36/38	CD
cord-023095-4dannjjm	3370	6	correct	correct	JJ
cord-023095-4dannjjm	3370	7	and	and	CC
cord-023095-4dannjjm	3370	8	2/10	2/10	CD
cord-023095-4dannjjm	3370	9	incorrect	incorrect	JJ
cord-023095-4dannjjm	3370	10	placements	placement	NNS
cord-023095-4dannjjm	3370	11	.	.	.
cord-023095-4dannjjm	3371	1	All	all	DT
cord-023095-4dannjjm	3371	2	8	8	CD
cord-023095-4dannjjm	3371	3	undetected	undetected	JJ
cord-023095-4dannjjm	3371	4	incorrect	incorrect	JJ
cord-023095-4dannjjm	3371	5	placements	placement	NNS
cord-023095-4dannjjm	3371	6	were	be	VBD
cord-023095-4dannjjm	3371	7	located	locate	VBN
cord-023095-4dannjjm	3371	8	within	within	IN
cord-023095-4dannjjm	3371	9	the	the	DT
cord-023095-4dannjjm	3371	10	retroperitoneal	retroperitoneal	JJ
cord-023095-4dannjjm	3371	11	fat	fat	JJ
cord-023095-4dannjjm	3371	12	pad	pad	NN
cord-023095-4dannjjm	3371	13	.	.	.
cord-023095-4dannjjm	3372	1	Sensitivity	sensitivity	NN
cord-023095-4dannjjm	3372	2	,	,	,
cord-023095-4dannjjm	3372	3	specificity	specificity	NN
cord-023095-4dannjjm	3372	4	,	,	,
cord-023095-4dannjjm	3372	5	accuracy	accuracy	NN
cord-023095-4dannjjm	3372	6	,	,	,
cord-023095-4dannjjm	3372	7	and	and	CC
cord-023095-4dannjjm	3372	8	precision	precision	NN
cord-023095-4dannjjm	3372	9	for	for	IN
cord-023095-4dannjjm	3372	10	correct	correct	JJ
cord-023095-4dannjjm	3372	11	Veress	Veress	NNP
cord-023095-4dannjjm	3372	12	needle	needle	NN
cord-023095-4dannjjm	3372	13	placement	placement	NN
cord-023095-4dannjjm	3372	14	are	be	VBP
cord-023095-4dannjjm	3372	15	listed	list	VBN
cord-023095-4dannjjm	3372	16	below	below	RB
cord-023095-4dannjjm	3372	17	.	.	.
cord-023095-4dannjjm	3373	1	Correlation	correlation	NN
cord-023095-4dannjjm	3373	2	was	be	VBD
cord-023095-4dannjjm	3373	3	absent	absent	JJ
cord-023095-4dannjjm	3373	4	(	(	-LRB-
cord-023095-4dannjjm	3373	5	Kappa	Kappa	NNP
cord-023095-4dannjjm	3373	6	À0.15	À0.15	NNP
cord-023095-4dannjjm	3373	7	,	,	,
cord-023095-4dannjjm	3373	8	p	p	NN
cord-023095-4dannjjm	3373	9	5	5	CD
cord-023095-4dannjjm	3373	10	0.34	0.34	CD
cord-023095-4dannjjm	3373	11	)	)	-RRB-
cord-023095-4dannjjm	3373	12	for	for	IN
cord-023095-4dannjjm	3373	13	placements	placement	NNS
cord-023095-4dannjjm	3373	14	by	by	IN
cord-023095-4dannjjm	3373	15	Operator	Operator	NNP
cord-023095-4dannjjm	3373	16	1	1	CD
cord-023095-4dannjjm	3373	17	and	and	CC
cord-023095-4dannjjm	3373	18	substantial	substantial	JJ
cord-023095-4dannjjm	3373	19	(	(	-LRB-
cord-023095-4dannjjm	3373	20	Kappa	Kappa	NNP
cord-023095-4dannjjm	3373	21	0.78	0.78	CD
cord-023095-4dannjjm	3373	22	,	,	,
cord-023095-4dannjjm	3373	23	p	p	NN
cord-023095-4dannjjm	3373	24	o	o	NN
cord-023095-4dannjjm	3373	25	0.01	0.01	CD
cord-023095-4dannjjm	3373	26	)	)	-RRB-
cord-023095-4dannjjm	3373	27	for	for	IN
cord-023095-4dannjjm	3373	28	Operator	operator	NN
cord-023095-4dannjjm	3373	29	2	2	CD
cord-023095-4dannjjm	3373	30	.	.	.
cord-023095-4dannjjm	3374	1	There	there	EX
cord-023095-4dannjjm	3374	2	was	be	VBD
cord-023095-4dannjjm	3374	3	no	no	DT
cord-023095-4dannjjm	3374	4	association	association	NN
cord-023095-4dannjjm	3374	5	between	between	IN
cord-023095-4dannjjm	3374	6	correct	correct	JJ
cord-023095-4dannjjm	3374	7	or	or	CC
cord-023095-4dannjjm	3374	8	incorrect	incorrect	JJ
cord-023095-4dannjjm	3374	9	placement	placement	NN
cord-023095-4dannjjm	3374	10	and	and	CC
cord-023095-4dannjjm	3374	11	operator	operator	NN
cord-023095-4dannjjm	3374	12	on	on	IN
cord-023095-4dannjjm	3374	13	Chi	Chi	NNP
cord-023095-4dannjjm	3374	14	-	-	HYPH
cord-023095-4dannjjm	3374	15	squared	squared	JJ
cord-023095-4dannjjm	3374	16	analysis	analysis	NN
cord-023095-4dannjjm	3374	17	.	.	.
cord-023095-4dannjjm	3375	1	Failure	failure	NN
cord-023095-4dannjjm	3375	2	of	of	IN
cord-023095-4dannjjm	3375	3	impedance	impedance	NN
cord-023095-4dannjjm	3375	4	measurements	measurement	NNS
cord-023095-4dannjjm	3375	5	to	to	TO
cord-023095-4dannjjm	3375	6	identify	identify	VB
cord-023095-4dannjjm	3375	7	placement	placement	NN
cord-023095-4dannjjm	3375	8	in	in	IN
cord-023095-4dannjjm	3375	9	the	the	DT
cord-023095-4dannjjm	3375	10	retroperitoneal	retroperitoneal	JJ
cord-023095-4dannjjm	3375	11	fat	fat	JJ
cord-023095-4dannjjm	3375	12	pad	pad	NN
cord-023095-4dannjjm	3375	13	resulted	result	VBN
cord-023095-4dannjjm	3375	14	in	in	IN
cord-023095-4dannjjm	3375	15	poor	poor	JJ
cord-023095-4dannjjm	3375	16	accuracy	accuracy	NN
cord-023095-4dannjjm	3375	17	and	and	CC
cord-023095-4dannjjm	3375	18	discordant	discordant	JJ
cord-023095-4dannjjm	3375	19	Kappa	Kappa	NNP
cord-023095-4dannjjm	3375	20	statistics	statistic	NNS
cord-023095-4dannjjm	3375	21	.	.	.
cord-023095-4dannjjm	3376	1	Small	small	JJ
cord-023095-4dannjjm	3376	2	cat	cat	NN
cord-023095-4dannjjm	3376	3	size	size	NN
cord-023095-4dannjjm	3376	4	limited	limit	VBD
cord-023095-4dannjjm	3376	5	the	the	DT
cord-023095-4dannjjm	3376	6	number	number	NN
cord-023095-4dannjjm	3376	7	of	of	IN
cord-023095-4dannjjm	3376	8	appropriate	appropriate	JJ
cord-023095-4dannjjm	3376	9	placement	placement	NN
cord-023095-4dannjjm	3376	10	sites	site	NNS
cord-023095-4dannjjm	3376	11	,	,	,
cord-023095-4dannjjm	3376	12	perhaps	perhaps	RB
cord-023095-4dannjjm	3376	13	resulting	result	VBG
cord-023095-4dannjjm	3376	14	in	in	IN
cord-023095-4dannjjm	3376	15	excessively	excessively	RB
cord-023095-4dannjjm	3376	16	dorsal	dorsal	JJ
cord-023095-4dannjjm	3376	17	placement	placement	NN
cord-023095-4dannjjm	3376	18	.	.	.
cord-023095-4dannjjm	3377	1	Comparison	comparison	NN
cord-023095-4dannjjm	3377	2	of	of	IN
cord-023095-4dannjjm	3377	3	needle	needle	NN
cord-023095-4dannjjm	3377	4	placement	placement	NN
cord-023095-4dannjjm	3377	5	with	with	IN
cord-023095-4dannjjm	3377	6	and	and	CC
cord-023095-4dannjjm	3377	7	without	without	IN
cord-023095-4dannjjm	3377	8	tissue	tissue	NN
cord-023095-4dannjjm	3377	9	impedance	impedance	NN
cord-023095-4dannjjm	3377	10	feedback	feedback	NN
cord-023095-4dannjjm	3377	11	will	will	MD
cord-023095-4dannjjm	3377	12	be	be	VB
cord-023095-4dannjjm	3377	13	necessary	necessary	JJ
cord-023095-4dannjjm	3377	14	to	to	TO
cord-023095-4dannjjm	3377	15	determine	determine	VB
cord-023095-4dannjjm	3377	16	whether	whether	IN
cord-023095-4dannjjm	3377	17	impedance	impedance	NN
cord-023095-4dannjjm	3377	18	measurements	measurement	NNS
cord-023095-4dannjjm	3377	19	increase	increase	VBP
cord-023095-4dannjjm	3377	20	detection	detection	NN
cord-023095-4dannjjm	3377	21	of	of	IN
cord-023095-4dannjjm	3377	22	inappropriate	inappropriate	JJ
cord-023095-4dannjjm	3377	23	Veress	Veress	NNP
cord-023095-4dannjjm	3377	24	needle	needle	NN
cord-023095-4dannjjm	3377	25	placements	placement	NNS
cord-023095-4dannjjm	3377	26	or	or	CC
cord-023095-4dannjjm	3377	27	decrease	decrease	VB
cord-023095-4dannjjm	3377	28	installment	installment	NN
cord-023095-4dannjjm	3377	29	phase	phase	NN
cord-023095-4dannjjm	3377	30	complication	complication	NN
cord-023095-4dannjjm	3377	31	rates	rate	NNS
cord-023095-4dannjjm	3377	32	.	.	.
cord-023095-4dannjjm	3378	1	Best	good	JJS
cord-023095-4dannjjm	3378	2	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	3378	3	tests	test	NNS
cord-023095-4dannjjm	3378	4	detecting	detect	VBG
cord-023095-4dannjjm	3378	5	portosystemic	portosystemic	JJ
cord-023095-4dannjjm	3378	6	shunting	shunting	NN
cord-023095-4dannjjm	3378	7	(	(	-LRB-
cord-023095-4dannjjm	3378	8	PSS	PSS	NNP
cord-023095-4dannjjm	3378	9	)	)	-RRB-
cord-023095-4dannjjm	3378	10	in	in	IN
cord-023095-4dannjjm	3378	11	dogs	dog	NNS
cord-023095-4dannjjm	3378	12	remains	remain	VBZ
cord-023095-4dannjjm	3378	13	controversial	controversial	JJ
cord-023095-4dannjjm	3378	14	.	.	.
cord-023095-4dannjjm	3379	1	This	this	DT
cord-023095-4dannjjm	3379	2	retrospective	retrospective	JJ
cord-023095-4dannjjm	3379	3	study	study	NN
cord-023095-4dannjjm	3379	4	examined	examine	VBD
cord-023095-4dannjjm	3379	5	performance	performance	NN
cord-023095-4dannjjm	3379	6	of	of	IN
cord-023095-4dannjjm	3379	7	single	single	JJ
cord-023095-4dannjjm	3379	8	random	random	JJ
cord-023095-4dannjjm	3379	9	"	"	``
cord-023095-4dannjjm	3379	10	fasting	fast	VBG
cord-023095-4dannjjm	3379	11	"	"	''
cord-023095-4dannjjm	3379	12	and	and	CC
cord-023095-4dannjjm	3379	13	paired	pair	VBN
cord-023095-4dannjjm	3379	14	serum	serum	NN
cord-023095-4dannjjm	3379	15	bile	bile	NN
cord-023095-4dannjjm	3379	16	acids	acid	NNS
cord-023095-4dannjjm	3379	17	(	(	-LRB-
cord-023095-4dannjjm	3379	18	SBA	SBA	NNP
cord-023095-4dannjjm	3379	19	;	;	:
cord-023095-4dannjjm	3379	20	pre	pre	JJ
cord-023095-4dannjjm	3379	21	-	-	JJ
cord-023095-4dannjjm	3379	22	and	and	CC
cord-023095-4dannjjm	3379	23	2-hr	2-hr	JJ
cord-023095-4dannjjm	3379	24	post	post	NN
cord-023095-4dannjjm	3379	25	-	-	JJ
cord-023095-4dannjjm	3379	26	feeding	feed	VBG
cord-023095-4dannjjm	3379	27	)	)	-RRB-
cord-023095-4dannjjm	3379	28	in	in	IN
cord-023095-4dannjjm	3379	29	a	a	DT
cord-023095-4dannjjm	3379	30	large	large	JJ
cord-023095-4dannjjm	3379	31	population	population	NN
cord-023095-4dannjjm	3379	32	of	of	IN
cord-023095-4dannjjm	3379	33	non	non	JJ
cord-023095-4dannjjm	3379	34	-	-	JJ
cord-023095-4dannjjm	3379	35	icteric	icteric	JJ
cord-023095-4dannjjm	3379	36	dogs	dog	NNS
cord-023095-4dannjjm	3379	37	with	with	IN
cord-023095-4dannjjm	3379	38	confirmed	confirm	VBN
cord-023095-4dannjjm	3379	39	PSS	PSS	NNP
cord-023095-4dannjjm	3379	40	(	(	-LRB-
cord-023095-4dannjjm	3379	41	abdominal	abdominal	JJ
cord-023095-4dannjjm	3379	42	ultrasound	ultrasound	NN
cord-023095-4dannjjm	3379	43	,	,	,
cord-023095-4dannjjm	3379	44	colorectal	colorectal	JJ
cord-023095-4dannjjm	3379	45	scintigraphy	scintigraphy	NN
cord-023095-4dannjjm	3379	46	,	,	,
cord-023095-4dannjjm	3379	47	radiographic	radiographic	JJ
cord-023095-4dannjjm	3379	48	or	or	CC
cord-023095-4dannjjm	3379	49	spiral	spiral	JJ
cord-023095-4dannjjm	3379	50	-	-	HYPH
cord-023095-4dannjjm	3379	51	CT	ct	NN
cord-023095-4dannjjm	3379	52	portography	portography	NN
cord-023095-4dannjjm	3379	53	,	,	,
cord-023095-4dannjjm	3379	54	laparotomy	laparotomy	NN
cord-023095-4dannjjm	3379	55	,	,	,
cord-023095-4dannjjm	3379	56	or	or	CC
cord-023095-4dannjjm	3379	57	necropsy	necropsy	JJ
cord-023095-4dannjjm	3379	58	)	)	-RRB-
cord-023095-4dannjjm	3379	59	.	.	.
cord-023095-4dannjjm	3380	1	SBA	SBA	NNP
cord-023095-4dannjjm	3380	2	were	be	VBD
cord-023095-4dannjjm	3380	3	measured	measure	VBN
cord-023095-4dannjjm	3380	4	by	by	IN
cord-023095-4dannjjm	3380	5	enzymatic	enzymatic	JJ
cord-023095-4dannjjm	3380	6	colorimetric	colorimetric	JJ
cord-023095-4dannjjm	3380	7	method	method	NN
cord-023095-4dannjjm	3380	8	with	with	IN
cord-023095-4dannjjm	3380	9	normal	normal	JJ
cord-023095-4dannjjm	3380	10	o	o	NN
cord-023095-4dannjjm	3380	11	25	25	CD
cord-023095-4dannjjm	3380	12	mmol	mmol	JJ
cord-023095-4dannjjm	3380	13	/	/	SYM
cord-023095-4dannjjm	3380	14	L.	L.	NNP
cord-023095-4dannjjm	3380	15	Dogs	Dogs	NNP
cord-023095-4dannjjm	3380	16	meeting	meeting	NN
cord-023095-4dannjjm	3380	17	inclusion	inclusion	NN
cord-023095-4dannjjm	3380	18	criteria	criterion	NNS
cord-023095-4dannjjm	3381	1	(	(	-LRB-
cord-023095-4dannjjm	3381	2	n	n	NN
cord-023095-4dannjjm	3381	3	5	5	CD
cord-023095-4dannjjm	3381	4	568	568	CD
cord-023095-4dannjjm	3381	5	)	)	-RRB-
cord-023095-4dannjjm	3381	6	included	include	VBD
cord-023095-4dannjjm	3381	7	467	467	CD
cord-023095-4dannjjm	3381	8	portosystemic	portosystemic	JJ
cord-023095-4dannjjm	3381	9	vascular	vascular	JJ
cord-023095-4dannjjm	3381	10	anomalies	anomaly	NNS
cord-023095-4dannjjm	3381	11	(	(	-LRB-
cord-023095-4dannjjm	3381	12	PSVA	PSVA	NNP
cord-023095-4dannjjm	3381	13	;	;	:
cord-023095-4dannjjm	3381	14	368	368	CD
cord-023095-4dannjjm	3381	15	extrahepatic	extrahepatic	NN
cord-023095-4dannjjm	3381	16	[	[	-LRB-
cord-023095-4dannjjm	3381	17	E	E	NNP
cord-023095-4dannjjm	3381	18	-	-	JJ
cord-023095-4dannjjm	3381	19	PSVA	PSVA	NNP
cord-023095-4dannjjm	3381	20	]	]	-RRB-
cord-023095-4dannjjm	3381	21	,	,	,
cord-023095-4dannjjm	3381	22	99	99	CD
cord-023095-4dannjjm	3381	23	intrahepatic	intrahepatic	JJ
cord-023095-4dannjjm	3382	1	[	[	-LRB-
cord-023095-4dannjjm	3382	2	I	I	NNP
cord-023095-4dannjjm	3382	3	-	-	HYPH
cord-023095-4dannjjm	3382	4	PSVA	PSVA	NNP
cord-023095-4dannjjm	3382	5	]	]	-RRB-
cord-023095-4dannjjm	3382	6	)	)	-RRB-
cord-023095-4dannjjm	3382	7	,	,	,
cord-023095-4dannjjm	3382	8	and	and	CC
cord-023095-4dannjjm	3382	9	101	101	CD
cord-023095-4dannjjm	3382	10	acquired	acquire	VBD
cord-023095-4dannjjm	3382	11	PSS	PSS	NNP
cord-023095-4dannjjm	3382	12	(	(	-LRB-
cord-023095-4dannjjm	3382	13	APSS	APSS	NNP
cord-023095-4dannjjm	3382	14	)	)	-RRB-
cord-023095-4dannjjm	3382	15	.	.	.
cord-023095-4dannjjm	3383	1	Signalment	signalment	JJ
cord-023095-4dannjjm	3383	2	and	and	CC
cord-023095-4dannjjm	3383	3	laboratory	laboratory	NN
cord-023095-4dannjjm	3383	4	parameters	parameter	NNS
cord-023095-4dannjjm	3383	5	were	be	VBD
cord-023095-4dannjjm	3383	6	recorded	record	VBN
cord-023095-4dannjjm	3383	7	.	.	.
cord-023095-4dannjjm	3384	1	Non	non	JJ
cord-023095-4dannjjm	3384	2	-	-	JJ
cord-023095-4dannjjm	3384	3	parametric	parametric	JJ
cord-023095-4dannjjm	3384	4	statistical	statistical	JJ
cord-023095-4dannjjm	3384	5	analyses	analysis	NNS
cord-023095-4dannjjm	3384	6	were	be	VBD
cord-023095-4dannjjm	3384	7	used	use	VBN
cord-023095-4dannjjm	3384	8	,	,	,
cord-023095-4dannjjm	3384	9	two	two	CD
cord-023095-4dannjjm	3384	10	-	-	HYPH
cord-023095-4dannjjm	3384	11	tailed	tailed	JJ
cord-023095-4dannjjm	3384	12	P	p	NN
cord-023095-4dannjjm	3384	13	o	o	NN
cord-023095-4dannjjm	3384	14	0.05	0.05	CD
cord-023095-4dannjjm	3384	15	applied	apply	VBN
cord-023095-4dannjjm	3384	16	with	with	IN
cord-023095-4dannjjm	3384	17	Bonferroni	Bonferroni	NNP
cord-023095-4dannjjm	3384	18	corrections	correction	NNS
cord-023095-4dannjjm	3384	19	.	.	.
cord-023095-4dannjjm	3385	1	Median	median	JJ
cord-023095-4dannjjm	3385	2	age	age	NN
cord-023095-4dannjjm	3385	3	and	and	CC
cord-023095-4dannjjm	3385	4	weight	weight	NN
cord-023095-4dannjjm	3385	5	of	of	IN
cord-023095-4dannjjm	3385	6	74	74	CD
cord-023095-4dannjjm	3385	7	breeds	breed	NNS
cord-023095-4dannjjm	3385	8	were	be	VBD
cord-023095-4dannjjm	3385	9	1.2	1.2	CD
cord-023095-4dannjjm	3385	10	(	(	-LRB-
cord-023095-4dannjjm	3385	11	0.2	0.2	CD
cord-023095-4dannjjm	3385	12	-	-	SYM
cord-023095-4dannjjm	3385	13	12	12	CD
cord-023095-4dannjjm	3385	14	)	)	-RRB-
cord-023095-4dannjjm	3385	15	yrs	yr	NNS
cord-023095-4dannjjm	3385	16	and	and	CC
cord-023095-4dannjjm	3385	17	6.6	6.6	CD
cord-023095-4dannjjm	3385	18	(	(	-LRB-
cord-023095-4dannjjm	3385	19	0.2	0.2	CD
cord-023095-4dannjjm	3385	20	-	-	SYM
cord-023095-4dannjjm	3385	21	48	48	CD
cord-023095-4dannjjm	3385	22	)	)	-RRB-
cord-023095-4dannjjm	3385	23	kg	kg	NNS
cord-023095-4dannjjm	3385	24	,	,	,
cord-023095-4dannjjm	3385	25	with	with	IN
cord-023095-4dannjjm	3385	26	equal	equal	JJ
cord-023095-4dannjjm	3385	27	gender	gender	NN
cord-023095-4dannjjm	3385	28	distribution	distribution	NN
cord-023095-4dannjjm	3385	29	.	.	.
cord-023095-4dannjjm	3386	1	Random	random	JJ
cord-023095-4dannjjm	3386	2	"	"	``
cord-023095-4dannjjm	3386	3	fasting	fast	VBG
cord-023095-4dannjjm	3386	4	"	"	''
cord-023095-4dannjjm	3386	5	SBA	SBA	NNP
cord-023095-4dannjjm	3386	6	detected	detect	VBD
cord-023095-4dannjjm	3386	7	90	90	CD
cord-023095-4dannjjm	3386	8	%	%	NN
cord-023095-4dannjjm	3386	9	PSVA	PSVA	NNP
cord-023095-4dannjjm	3386	10	and	and	CC
cord-023095-4dannjjm	3386	11	81	81	CD
cord-023095-4dannjjm	3386	12	%	%	NN
cord-023095-4dannjjm	3386	13	APSS	APSS	NNP
cord-023095-4dannjjm	3386	14	,	,	,
cord-023095-4dannjjm	3386	15	whereas	whereas	IN
cord-023095-4dannjjm	3386	16	post	post	NN
cord-023095-4dannjjm	3386	17	-	-	JJ
cord-023095-4dannjjm	3386	18	feeding	feeding	JJ
cord-023095-4dannjjm	3386	19	SBA	SBA	NNP
cord-023095-4dannjjm	3386	20	detected	detect	VBD
cord-023095-4dannjjm	3386	21	100	100	CD
cord-023095-4dannjjm	3386	22	%	%	NN
cord-023095-4dannjjm	3386	23	PSVA	PSVA	NNP
cord-023095-4dannjjm	3386	24	and	and	CC
cord-023095-4dannjjm	3386	25	98	98	CD
cord-023095-4dannjjm	3386	26	%	%	NN
cord-023095-4dannjjm	3386	27	APSS	APSS	NNP
cord-023095-4dannjjm	3386	28	.	.	.
cord-023095-4dannjjm	3387	1	Low	Low	NNP
cord-023095-4dannjjm	3387	2	Protein	Protein	NNP
cord-023095-4dannjjm	3387	3	-	-	HYPH
cord-023095-4dannjjm	3387	4	C	C	NNP
cord-023095-4dannjjm	3387	5	(	(	-LRB-
cord-023095-4dannjjm	3387	6	o	o	NN
cord-023095-4dannjjm	3387	7	70	70	CD
cord-023095-4dannjjm	3387	8	%	%	NN
cord-023095-4dannjjm	3387	9	activity	activity	NN
cord-023095-4dannjjm	3387	10	)	)	-RRB-
cord-023095-4dannjjm	3387	11	occurred	occur	VBD
cord-023095-4dannjjm	3387	12	in	in	IN
cord-023095-4dannjjm	3387	13	96	96	CD
cord-023095-4dannjjm	3387	14	%	%	NN
cord-023095-4dannjjm	3387	15	PSVA	PSVA	NNP
cord-023095-4dannjjm	3387	16	and	and	CC
cord-023095-4dannjjm	3387	17	74	74	CD
cord-023095-4dannjjm	3387	18	%	%	NN
cord-023095-4dannjjm	3387	19	APSS	APSS	NNP
cord-023095-4dannjjm	3387	20	.	.	.
cord-023095-4dannjjm	3388	1	Low	low	JJ
cord-023095-4dannjjm	3388	2	MCV	MCV	NNP
cord-023095-4dannjjm	3388	3	and	and	CC
cord-023095-4dannjjm	3388	4	creatinine	creatinine	NN
cord-023095-4dannjjm	3388	5	occurred	occur	VBD
cord-023095-4dannjjm	3388	6	in	in	IN
cord-023095-4dannjjm	3388	7	82	82	CD
cord-023095-4dannjjm	3388	8	%	%	NN
cord-023095-4dannjjm	3388	9	and	and	CC
cord-023095-4dannjjm	3388	10	94	94	CD
cord-023095-4dannjjm	3388	11	%	%	NN
cord-023095-4dannjjm	3388	12	of	of	IN
cord-023095-4dannjjm	3388	13	PSVA	PSVA	NNP
cord-023095-4dannjjm	3388	14	dogs	dog	NNS
cord-023095-4dannjjm	3388	15	,	,	,
cord-023095-4dannjjm	3388	16	respectively	respectively	RB
cord-023095-4dannjjm	3388	17	;	;	:
cord-023095-4dannjjm	3388	18	other	other	JJ
cord-023095-4dannjjm	3388	19	tests	test	NNS
cord-023095-4dannjjm	3388	20	were	be	VBD
cord-023095-4dannjjm	3388	21	less	less	RBR
cord-023095-4dannjjm	3388	22	helpful	helpful	JJ
cord-023095-4dannjjm	3388	23	.	.	.
cord-023095-4dannjjm	3389	1	In	in	IN
cord-023095-4dannjjm	3389	2	APSS	APSS	NNP
cord-023095-4dannjjm	3389	3	,	,	,
cord-023095-4dannjjm	3389	4	post	post	NN
cord-023095-4dannjjm	3389	5	-	-	JJ
cord-023095-4dannjjm	3389	6	feeding	feeding	JJ
cord-023095-4dannjjm	3389	7	SBA	SBA	NNP
cord-023095-4dannjjm	3389	8	was	be	VBD
cord-023095-4dannjjm	3389	9	superior	superior	JJ
cord-023095-4dannjjm	3389	10	.	.	.
cord-023095-4dannjjm	3390	1	Compared	compare	VBN
cord-023095-4dannjjm	3390	2	to	to	IN
cord-023095-4dannjjm	3390	3	APSS	APSS	NNP
cord-023095-4dannjjm	3390	4	,	,	,
cord-023095-4dannjjm	3390	5	PSVA	PSVA	NNP
cord-023095-4dannjjm	3390	6	had	have	VBD
cord-023095-4dannjjm	3390	7	significantly	significantly	RB
cord-023095-4dannjjm	3390	8	(	(	-LRB-
cord-023095-4dannjjm	3390	9	P	p	NN
cord-023095-4dannjjm	3390	10	0.002	0.002	CD
cord-023095-4dannjjm	3390	11	)	)	-RRB-
cord-023095-4dannjjm	3391	1	lower	low	JJR
cord-023095-4dannjjm	3391	2	MCV	MCV	NNP
cord-023095-4dannjjm	3391	3	,	,	,
cord-023095-4dannjjm	3391	4	cholesterol	cholesterol	NN
cord-023095-4dannjjm	3391	5	,	,	,
cord-023095-4dannjjm	3391	6	BUN	bun	NN
cord-023095-4dannjjm	3391	7	,	,	,
cord-023095-4dannjjm	3391	8	creatinine	creatinine	NN
cord-023095-4dannjjm	3391	9	,	,	,
cord-023095-4dannjjm	3391	10	glucose	glucose	NN
cord-023095-4dannjjm	3391	11	,	,	,
cord-023095-4dannjjm	3391	12	and	and	CC
cord-023095-4dannjjm	3391	13	Protein	Protein	NNP
cord-023095-4dannjjm	3391	14	-	-	HYPH
cord-023095-4dannjjm	3391	15	C.	C.	NNP
cord-023095-4dannjjm	3392	1	Compared	compare	VBN
cord-023095-4dannjjm	3392	2	to	to	IN
cord-023095-4dannjjm	3392	3	E	E	NNP
cord-023095-4dannjjm	3392	4	-	-	JJ
cord-023095-4dannjjm	3392	5	PSVA	PSVA	NNP
cord-023095-4dannjjm	3392	6	,	,	,
cord-023095-4dannjjm	3392	7	I	I	NNP
cord-023095-4dannjjm	3392	8	-	-	HYPH
cord-023095-4dannjjm	3392	9	PSVA	PSVA	NNP
cord-023095-4dannjjm	3392	10	had	have	VBD
cord-023095-4dannjjm	3392	11	significantly	significantly	RB
cord-023095-4dannjjm	3392	12	(	(	-LRB-
cord-023095-4dannjjm	3392	13	P	p	NN
cord-023095-4dannjjm	3392	14	0.009	0.009	CD
cord-023095-4dannjjm	3392	15	)	)	-RRB-
cord-023095-4dannjjm	3393	1	lower	low	JJR
cord-023095-4dannjjm	3393	2	post	post	NN
cord-023095-4dannjjm	3393	3	-	-	JJ
cord-023095-4dannjjm	3393	4	feeding	feeding	JJ
cord-023095-4dannjjm	3393	5	SBA	SBA	NNP
cord-023095-4dannjjm	3393	6	,	,	,
cord-023095-4dannjjm	3393	7	MCV	MCV	NNP
cord-023095-4dannjjm	3393	8	,	,	,
cord-023095-4dannjjm	3393	9	albumin	albumin	NN
cord-023095-4dannjjm	3393	10	,	,	,
cord-023095-4dannjjm	3393	11	urine	urine	NN
cord-023095-4dannjjm	3393	12	specific	specific	JJ
cord-023095-4dannjjm	3393	13	gravity	gravity	NN
cord-023095-4dannjjm	3393	14	,	,	,
cord-023095-4dannjjm	3393	15	and	and	CC
cord-023095-4dannjjm	3393	16	Protein	Protein	NNP
cord-023095-4dannjjm	3393	17	-	-	HYPH
cord-023095-4dannjjm	3393	18	C	C	NNP
cord-023095-4dannjjm	3393	19	but	but	CC
cord-023095-4dannjjm	3393	20	higher	high	JJR
cord-023095-4dannjjm	3393	21	cholesterol	cholesterol	NN
cord-023095-4dannjjm	3393	22	and	and	CC
cord-023095-4dannjjm	3393	23	glucose	glucose	NN
cord-023095-4dannjjm	3393	24	.	.	.
cord-023095-4dannjjm	3394	1	Post	post	NN
cord-023095-4dannjjm	3394	2	-	-	JJ
cord-023095-4dannjjm	3394	3	feeding	feed	VBG
cord-023095-4dannjjm	3394	4	SBA	SBA	NNP
cord-023095-4dannjjm	3394	5	reflect	reflect	VBP
cord-023095-4dannjjm	3394	6	physiologically	physiologically	RB
cord-023095-4dannjjm	3394	7	provoked	provoke	VBN
cord-023095-4dannjjm	3394	8	bile	bile	NN
cord-023095-4dannjjm	3394	9	acid	acid	NN
cord-023095-4dannjjm	3394	10	challenge	challenge	NN
cord-023095-4dannjjm	3394	11	and	and	CC
cord-023095-4dannjjm	3394	12	should	should	MD
cord-023095-4dannjjm	3394	13	be	be	VB
cord-023095-4dannjjm	3394	14	the	the	DT
cord-023095-4dannjjm	3394	15	preferred	preferred	JJ
cord-023095-4dannjjm	3394	16	SBA	SBA	NNP
cord-023095-4dannjjm	3394	17	test	test	NN
cord-023095-4dannjjm	3394	18	in	in	IN
cord-023095-4dannjjm	3394	19	non	non	JJ
cord-023095-4dannjjm	3394	20	-	-	JJ
cord-023095-4dannjjm	3394	21	icteric	icteric	JJ
cord-023095-4dannjjm	3394	22	dogs	dog	NNS
cord-023095-4dannjjm	3394	23	for	for	IN
cord-023095-4dannjjm	3394	24	PSS	PSS	NNP
cord-023095-4dannjjm	3394	25	detection	detection	NN
cord-023095-4dannjjm	3394	26	.	.	.
cord-023095-4dannjjm	3395	1	Protein	protein	NN
cord-023095-4dannjjm	3395	2	-	-	HYPH
cord-023095-4dannjjm	3395	3	C	C	NNP
cord-023095-4dannjjm	3395	4	assists	assist	VBZ
cord-023095-4dannjjm	3395	5	in	in	IN
cord-023095-4dannjjm	3395	6	identifying	identify	VBG
cord-023095-4dannjjm	3395	7	PSVA	PSVA	NNP
cord-023095-4dannjjm	3395	8	but	but	CC
cord-023095-4dannjjm	3395	9	its	-PRON-	PRP$
cord-023095-4dannjjm	3395	10	utility	utility	NN
cord-023095-4dannjjm	3395	11	in	in	IN
cord-023095-4dannjjm	3395	12	APSS	APSS	NNP
cord-023095-4dannjjm	3395	13	may	may	MD
cord-023095-4dannjjm	3395	14	be	be	VB
cord-023095-4dannjjm	3395	15	complicated	complicate	VBN
cord-023095-4dannjjm	3395	16	by	by	IN
cord-023095-4dannjjm	3395	17	concurrent	concurrent	JJ
cord-023095-4dannjjm	3395	18	coagulopathies	coagulopathie	NNS
cord-023095-4dannjjm	3395	19	and	and	CC
cord-023095-4dannjjm	3395	20	inflammation	inflammation	NN
cord-023095-4dannjjm	3395	21	.	.	.
cord-023095-4dannjjm	3396	1	This	this	DT
cord-023095-4dannjjm	3396	2	study	study	NN
cord-023095-4dannjjm	3396	3	compared	compare	VBD
cord-023095-4dannjjm	3396	4	outcomes	outcome	NNS
cord-023095-4dannjjm	3396	5	of	of	IN
cord-023095-4dannjjm	3396	6	treatment	treatment	NN
cord-023095-4dannjjm	3396	7	with	with	IN
cord-023095-4dannjjm	3396	8	adjunctive	adjunctive	JJ
cord-023095-4dannjjm	3396	9	nonsteroidal	nonsteroidal	JJ
cord-023095-4dannjjm	3396	10	anti	anti	JJ
cord-023095-4dannjjm	3396	11	-	-	JJ
cord-023095-4dannjjm	3396	12	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3396	13	drugs	drug	NNS
cord-023095-4dannjjm	3396	14	(	(	-LRB-
cord-023095-4dannjjm	3396	15	NSAIDs	nsaid	NNS
cord-023095-4dannjjm	3396	16	)	)	-RRB-
cord-023095-4dannjjm	3396	17	or	or	CC
cord-023095-4dannjjm	3396	18	anti	anti	JJ
cord-023095-4dannjjm	3396	19	-	-	JJ
cord-023095-4dannjjm	3396	20	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3396	21	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	3396	22	in	in	IN
cord-023095-4dannjjm	3396	23	dogs	dog	NNS
cord-023095-4dannjjm	3396	24	with	with	IN
cord-023095-4dannjjm	3396	25	severe	severe	JJ
cord-023095-4dannjjm	3396	26	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	3396	27	blastomycosis	blastomycosis	NN
cord-023095-4dannjjm	3396	28	.	.	.
cord-023095-4dannjjm	3397	1	Medical	medical	JJ
cord-023095-4dannjjm	3397	2	records	record	NNS
cord-023095-4dannjjm	3397	3	were	be	VBD
cord-023095-4dannjjm	3397	4	reviewed	review	VBN
cord-023095-4dannjjm	3397	5	for	for	IN
cord-023095-4dannjjm	3397	6	dogs	dog	NNS
cord-023095-4dannjjm	3397	7	diagnosed	diagnose	VBN
cord-023095-4dannjjm	3397	8	with	with	IN
cord-023095-4dannjjm	3397	9	blastomycosis	blastomycosis	NN
cord-023095-4dannjjm	3397	10	at	at	IN
cord-023095-4dannjjm	3397	11	the	the	DT
cord-023095-4dannjjm	3397	12	University	University	NNP
cord-023095-4dannjjm	3397	13	of	of	IN
cord-023095-4dannjjm	3397	14	Illinois	Illinois	NNP
cord-023095-4dannjjm	3397	15	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	3397	16	Teaching	Teaching	NNP
cord-023095-4dannjjm	3397	17	Hospital	Hospital	NNP
cord-023095-4dannjjm	3397	18	between	between	IN
cord-023095-4dannjjm	3397	19	1992	1992	CD
cord-023095-4dannjjm	3397	20	and	and	CC
cord-023095-4dannjjm	3397	21	2007	2007	CD
cord-023095-4dannjjm	3397	22	.	.	.
cord-023095-4dannjjm	3398	1	Dogs	dog	NNS
cord-023095-4dannjjm	3398	2	with	with	IN
cord-023095-4dannjjm	3398	3	a	a	DT
cord-023095-4dannjjm	3398	4	presenting	present	VBG
cord-023095-4dannjjm	3398	5	PaO	pao	NN
cord-023095-4dannjjm	3398	6	2	2	CD
cord-023095-4dannjjm	3398	7	of	of	IN
cord-023095-4dannjjm	3398	8	80	80	CD
cord-023095-4dannjjm	3398	9	mmHg	mmHg	NNS
cord-023095-4dannjjm	3398	10	,	,	,
cord-023095-4dannjjm	3398	11	and	and	CC
cord-023095-4dannjjm	3398	12	clinical	clinical	JJ
cord-023095-4dannjjm	3398	13	or	or	CC
cord-023095-4dannjjm	3398	14	radiographic	radiographic	JJ
cord-023095-4dannjjm	3398	15	signs	sign	NNS
cord-023095-4dannjjm	3398	16	of	of	IN
cord-023095-4dannjjm	3398	17	respiratory	respiratory	JJ
cord-023095-4dannjjm	3398	18	blastomycosis	blastomycosis	NN
cord-023095-4dannjjm	3398	19	were	be	VBD
cord-023095-4dannjjm	3398	20	included	include	VBN
cord-023095-4dannjjm	3398	21	.	.	.
cord-023095-4dannjjm	3399	1	All	all	DT
cord-023095-4dannjjm	3399	2	dogs	dog	NNS
cord-023095-4dannjjm	3399	3	were	be	VBD
cord-023095-4dannjjm	3399	4	treated	treat	VBN
cord-023095-4dannjjm	3399	5	with	with	IN
cord-023095-4dannjjm	3399	6	either	either	DT
cord-023095-4dannjjm	3399	7	itraconazole	itraconazole	NNP
cord-023095-4dannjjm	3399	8	,	,	,
cord-023095-4dannjjm	3399	9	fluconazole	fluconazole	NN
cord-023095-4dannjjm	3399	10	,	,	,
cord-023095-4dannjjm	3399	11	amphotericin	amphotericin	NNS
cord-023095-4dannjjm	3399	12	B	b	NN
cord-023095-4dannjjm	3399	13	,	,	,
cord-023095-4dannjjm	3399	14	or	or	CC
cord-023095-4dannjjm	3399	15	a	a	DT
cord-023095-4dannjjm	3399	16	combination	combination	NN
cord-023095-4dannjjm	3399	17	of	of	IN
cord-023095-4dannjjm	3399	18	these	these	DT
cord-023095-4dannjjm	3399	19	.	.	.
cord-023095-4dannjjm	3400	1	Group	group	NN
cord-023095-4dannjjm	3400	2	1	1	CD
cord-023095-4dannjjm	3400	3	(	(	-LRB-
cord-023095-4dannjjm	3400	4	G1	G1	NNP
cord-023095-4dannjjm	3400	5	)	)	-RRB-
cord-023095-4dannjjm	3400	6	dogs	dog	NNS
cord-023095-4dannjjm	3400	7	were	be	VBD
cord-023095-4dannjjm	3400	8	treated	treat	VBN
cord-023095-4dannjjm	3400	9	with	with	IN
cord-023095-4dannjjm	3400	10	NSAIDs	NSAIDs	NNP
cord-023095-4dannjjm	3400	11	and	and	CC
cord-023095-4dannjjm	3400	12	Group	Group	NNP
cord-023095-4dannjjm	3400	13	2	2	CD
cord-023095-4dannjjm	3400	14	(	(	-LRB-
cord-023095-4dannjjm	3400	15	G2	G2	NNP
cord-023095-4dannjjm	3400	16	)	)	-RRB-
cord-023095-4dannjjm	3400	17	dogs	dog	NNS
cord-023095-4dannjjm	3400	18	were	be	VBD
cord-023095-4dannjjm	3400	19	treated	treat	VBN
cord-023095-4dannjjm	3400	20	with	with	IN
cord-023095-4dannjjm	3400	21	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	3400	22	as	as	IN
cord-023095-4dannjjm	3400	23	anti	anti	JJ
cord-023095-4dannjjm	3400	24	-	-	JJ
cord-023095-4dannjjm	3400	25	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3400	26	adjunctive	adjunctive	JJ
cord-023095-4dannjjm	3400	27	therapy	therapy	NN
cord-023095-4dannjjm	3400	28	.	.	.
cord-023095-4dannjjm	3401	1	The	the	DT
cord-023095-4dannjjm	3401	2	following	following	JJ
cord-023095-4dannjjm	3401	3	comparisons	comparison	NNS
cord-023095-4dannjjm	3401	4	were	be	VBD
cord-023095-4dannjjm	3401	5	made	make	VBN
cord-023095-4dannjjm	3401	6	:	:	:
cord-023095-4dannjjm	3401	7	days	day	NNS
cord-023095-4dannjjm	3401	8	of	of	IN
cord-023095-4dannjjm	3401	9	oxygen	oxygen	NN
cord-023095-4dannjjm	3401	10	supplementation	supplementation	NN
cord-023095-4dannjjm	3401	11	,	,	,
cord-023095-4dannjjm	3401	12	days	day	NNS
cord-023095-4dannjjm	3401	13	in	in	IN
cord-023095-4dannjjm	3401	14	hospital	hospital	NN
cord-023095-4dannjjm	3401	15	,	,	,
cord-023095-4dannjjm	3401	16	survival	survival	NN
cord-023095-4dannjjm	3401	17	to	to	TO
cord-023095-4dannjjm	3401	18	discharge	discharge	NN
cord-023095-4dannjjm	3401	19	,	,	,
cord-023095-4dannjjm	3401	20	and	and	CC
cord-023095-4dannjjm	3401	21	long	long	JJ
cord-023095-4dannjjm	3401	22	term	term	NN
cord-023095-4dannjjm	3401	23	patient	patient	NN
cord-023095-4dannjjm	3401	24	survival	survival	NN
cord-023095-4dannjjm	3401	25	.	.	.
cord-023095-4dannjjm	3402	1	Mann	Mann	NNP
cord-023095-4dannjjm	3402	2	-	-	HYPH
cord-023095-4dannjjm	3402	3	Whitney	Whitney	NNP
cord-023095-4dannjjm	3402	4	U	U	NNP
cord-023095-4dannjjm	3402	5	tests	test	NNS
cord-023095-4dannjjm	3402	6	and	and	CC
cord-023095-4dannjjm	3402	7	Chi	Chi	NNP
cord-023095-4dannjjm	3402	8	-	-	HYPH
cord-023095-4dannjjm	3402	9	squared	square	VBN
cord-023095-4dannjjm	3402	10	tests	test	NNS
cord-023095-4dannjjm	3402	11	were	be	VBD
cord-023095-4dannjjm	3402	12	performed	perform	VBN
cord-023095-4dannjjm	3402	13	on	on	IN
cord-023095-4dannjjm	3402	14	continuous	continuous	JJ
cord-023095-4dannjjm	3402	15	and	and	CC
cord-023095-4dannjjm	3402	16	categorical	categorical	JJ
cord-023095-4dannjjm	3402	17	data	datum	NNS
cord-023095-4dannjjm	3402	18	,	,	,
cord-023095-4dannjjm	3402	19	respectively	respectively	RB
cord-023095-4dannjjm	3402	20	.	.	.
cord-023095-4dannjjm	3403	1	P	p	NN
cord-023095-4dannjjm	3403	2	o	o	NN
cord-023095-4dannjjm	3403	3	0.05	0.05	CD
cord-023095-4dannjjm	3403	4	was	be	VBD
cord-023095-4dannjjm	3403	5	considered	consider	VBN
cord-023095-4dannjjm	3403	6	significant	significant	JJ
cord-023095-4dannjjm	3403	7	.	.	.
cord-023095-4dannjjm	3404	1	Sixty	sixty	CD
cord-023095-4dannjjm	3404	2	-	-	HYPH
cord-023095-4dannjjm	3404	3	eight	eight	CD
cord-023095-4dannjjm	3404	4	dogs	dog	NNS
cord-023095-4dannjjm	3404	5	fit	fit	VBP
cord-023095-4dannjjm	3404	6	the	the	DT
cord-023095-4dannjjm	3404	7	inclusion	inclusion	NN
cord-023095-4dannjjm	3404	8	criteria	criterion	NNS
cord-023095-4dannjjm	3404	9	.	.	.
cord-023095-4dannjjm	3405	1	G1	G1	NNP
cord-023095-4dannjjm	3405	2	consisted	consist	VBD
cord-023095-4dannjjm	3405	3	of	of	IN
cord-023095-4dannjjm	3405	4	31	31	CD
cord-023095-4dannjjm	3405	5	dogs	dog	NNS
cord-023095-4dannjjm	3405	6	and	and	CC
cord-023095-4dannjjm	3405	7	G2	G2	NNP
cord-023095-4dannjjm	3405	8	consisted	consist	VBD
cord-023095-4dannjjm	3405	9	of	of	IN
cord-023095-4dannjjm	3405	10	37	37	CD
cord-023095-4dannjjm	3405	11	dogs	dog	NNS
cord-023095-4dannjjm	3405	12	.	.	.
cord-023095-4dannjjm	3406	1	The	the	DT
cord-023095-4dannjjm	3406	2	two	two	CD
cord-023095-4dannjjm	3406	3	groups	group	NNS
cord-023095-4dannjjm	3406	4	were	be	VBD
cord-023095-4dannjjm	3406	5	found	find	VBN
cord-023095-4dannjjm	3406	6	to	to	TO
cord-023095-4dannjjm	3406	7	be	be	VB
cord-023095-4dannjjm	3406	8	similar	similar	JJ
cord-023095-4dannjjm	3406	9	in	in	IN
cord-023095-4dannjjm	3406	10	weight	weight	NN
cord-023095-4dannjjm	3406	11	,	,	,
cord-023095-4dannjjm	3406	12	age	age	NN
cord-023095-4dannjjm	3406	13	,	,	,
cord-023095-4dannjjm	3406	14	and	and	CC
cord-023095-4dannjjm	3406	15	sex	sex	NN
cord-023095-4dannjjm	3406	16	distribution	distribution	NN
cord-023095-4dannjjm	3406	17	.	.	.
cord-023095-4dannjjm	3407	1	There	there	EX
cord-023095-4dannjjm	3407	2	was	be	VBD
cord-023095-4dannjjm	3407	3	no	no	DT
cord-023095-4dannjjm	3407	4	significant	significant	JJ
cord-023095-4dannjjm	3407	5	difference	difference	NN
cord-023095-4dannjjm	3407	6	between	between	IN
cord-023095-4dannjjm	3407	7	the	the	DT
cord-023095-4dannjjm	3407	8	two	two	CD
cord-023095-4dannjjm	3407	9	groups	group	NNS
cord-023095-4dannjjm	3407	10	with	with	IN
cord-023095-4dannjjm	3407	11	regard	regard	NN
cord-023095-4dannjjm	3407	12	to	to	IN
cord-023095-4dannjjm	3407	13	duration	duration	NN
cord-023095-4dannjjm	3407	14	of	of	IN
cord-023095-4dannjjm	3407	15	oxygen	oxygen	NN
cord-023095-4dannjjm	3407	16	supplementation	supplementation	NN
cord-023095-4dannjjm	3407	17	,	,	,
cord-023095-4dannjjm	3407	18	duration	duration	NN
cord-023095-4dannjjm	3407	19	of	of	IN
cord-023095-4dannjjm	3407	20	hospitalization	hospitalization	NN
cord-023095-4dannjjm	3407	21	,	,	,
cord-023095-4dannjjm	3407	22	survival	survival	NN
cord-023095-4dannjjm	3407	23	to	to	TO
cord-023095-4dannjjm	3407	24	discharge	discharge	NN
cord-023095-4dannjjm	3407	25	,	,	,
cord-023095-4dannjjm	3407	26	and	and	CC
cord-023095-4dannjjm	3407	27	patient	patient	JJ
cord-023095-4dannjjm	3407	28	survival	survival	NN
cord-023095-4dannjjm	3407	29	.	.	.
cord-023095-4dannjjm	3408	1	There	there	EX
cord-023095-4dannjjm	3408	2	does	do	VBZ
cord-023095-4dannjjm	3408	3	not	not	RB
cord-023095-4dannjjm	3408	4	appear	appear	VB
cord-023095-4dannjjm	3408	5	to	to	TO
cord-023095-4dannjjm	3408	6	be	be	VB
cord-023095-4dannjjm	3408	7	a	a	DT
cord-023095-4dannjjm	3408	8	difference	difference	NN
cord-023095-4dannjjm	3408	9	between	between	IN
cord-023095-4dannjjm	3408	10	the	the	DT
cord-023095-4dannjjm	3408	11	clinical	clinical	JJ
cord-023095-4dannjjm	3408	12	course	course	NN
cord-023095-4dannjjm	3408	13	or	or	CC
cord-023095-4dannjjm	3408	14	patient	patient	JJ
cord-023095-4dannjjm	3408	15	outcomes	outcome	NNS
cord-023095-4dannjjm	3408	16	between	between	IN
cord-023095-4dannjjm	3408	17	groups	group	NNS
cord-023095-4dannjjm	3408	18	of	of	IN
cord-023095-4dannjjm	3408	19	dogs	dog	NNS
cord-023095-4dannjjm	3408	20	with	with	IN
cord-023095-4dannjjm	3408	21	severe	severe	JJ
cord-023095-4dannjjm	3408	22	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	3408	23	blastomycosis	blastomycosis	NN
cord-023095-4dannjjm	3408	24	treated	treat	VBN
cord-023095-4dannjjm	3408	25	with	with	IN
cord-023095-4dannjjm	3408	26	NSAIDs	nsaids	JJ
cord-023095-4dannjjm	3408	27	or	or	CC
cord-023095-4dannjjm	3408	28	anti	anti	JJ
cord-023095-4dannjjm	3408	29	-	-	JJ
cord-023095-4dannjjm	3408	30	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3408	31	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	3408	32	.	.	.
cord-023095-4dannjjm	3409	1	Further	further	JJ
cord-023095-4dannjjm	3409	2	studies	study	NNS
cord-023095-4dannjjm	3409	3	need	need	VBP
cord-023095-4dannjjm	3409	4	to	to	TO
cord-023095-4dannjjm	3409	5	be	be	VB
cord-023095-4dannjjm	3409	6	performed	perform	VBN
cord-023095-4dannjjm	3409	7	to	to	TO
cord-023095-4dannjjm	3409	8	fully	fully	RB
cord-023095-4dannjjm	3409	9	evaluate	evaluate	VB
cord-023095-4dannjjm	3409	10	the	the	DT
cord-023095-4dannjjm	3409	11	impact	impact	NN
cord-023095-4dannjjm	3409	12	these	these	DT
cord-023095-4dannjjm	3409	13	adjunct	adjunct	JJ
cord-023095-4dannjjm	3409	14	treatments	treatment	NNS
cord-023095-4dannjjm	3409	15	have	have	VBP
cord-023095-4dannjjm	3409	16	on	on	IN
cord-023095-4dannjjm	3409	17	prevention	prevention	NN
cord-023095-4dannjjm	3409	18	of	of	IN
cord-023095-4dannjjm	3409	19	ARDs	ard	NNS
cord-023095-4dannjjm	3409	20	and	and	CC
cord-023095-4dannjjm	3409	21	additional	additional	JJ
cord-023095-4dannjjm	3409	22	respiratory	respiratory	JJ
cord-023095-4dannjjm	3409	23	complications	complication	NNS
cord-023095-4dannjjm	3409	24	.	.	.
cord-023095-4dannjjm	3410	1	Diagnosis	diagnosis	NN
cord-023095-4dannjjm	3410	2	of	of	IN
cord-023095-4dannjjm	3410	3	feline	feline	JJ
cord-023095-4dannjjm	3410	4	Histoplasma	Histoplasma	NNP
cord-023095-4dannjjm	3410	5	capsulatum	capsulatum	NN
cord-023095-4dannjjm	3410	6	infection	infection	NN
cord-023095-4dannjjm	3410	7	traditionally	traditionally	RB
cord-023095-4dannjjm	3410	8	relies	rely	VBZ
cord-023095-4dannjjm	3410	9	upon	upon	IN
cord-023095-4dannjjm	3410	10	identification	identification	NN
cord-023095-4dannjjm	3410	11	of	of	IN
cord-023095-4dannjjm	3410	12	organisms	organism	NNS
cord-023095-4dannjjm	3410	13	in	in	IN
cord-023095-4dannjjm	3410	14	circulating	circulate	VBG
cord-023095-4dannjjm	3410	15	monocytes	monocyte	NNS
cord-023095-4dannjjm	3410	16	or	or	CC
cord-023095-4dannjjm	3410	17	affected	affect	VBN
cord-023095-4dannjjm	3410	18	organs	organ	NNS
cord-023095-4dannjjm	3410	19	.	.	.
cord-023095-4dannjjm	3411	1	In	in	IN
cord-023095-4dannjjm	3411	2	recent	recent	JJ
cord-023095-4dannjjm	3411	3	years	year	NNS
cord-023095-4dannjjm	3411	4	,	,	,
cord-023095-4dannjjm	3411	5	an	an	DT
cord-023095-4dannjjm	3411	6	antigen	antigen	NN
cord-023095-4dannjjm	3411	7	assay	assay	NN
cord-023095-4dannjjm	3411	8	(	(	-LRB-
cord-023095-4dannjjm	3411	9	AA	AA	NNP
cord-023095-4dannjjm	3411	10	)	)	-RRB-
cord-023095-4dannjjm	3411	11	was	be	VBD
cord-023095-4dannjjm	3411	12	developed	develop	VBN
cord-023095-4dannjjm	3411	13	for	for	IN
cord-023095-4dannjjm	3411	14	the	the	DT
cord-023095-4dannjjm	3411	15	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3411	16	of	of	IN
cord-023095-4dannjjm	3411	17	disseminated	disseminate	VBN
cord-023095-4dannjjm	3411	18	histoplasmosis	histoplasmosis	NN
cord-023095-4dannjjm	3411	19	in	in	IN
cord-023095-4dannjjm	3411	20	human	human	JJ
cord-023095-4dannjjm	3411	21	patients	patient	NNS
cord-023095-4dannjjm	3411	22	,	,	,
cord-023095-4dannjjm	3411	23	but	but	CC
cord-023095-4dannjjm	3411	24	there	there	EX
cord-023095-4dannjjm	3411	25	is	be	VBZ
cord-023095-4dannjjm	3411	26	little	little	JJ
cord-023095-4dannjjm	3411	27	information	information	NN
cord-023095-4dannjjm	3411	28	describing	describe	VBG
cord-023095-4dannjjm	3411	29	this	this	DT
cord-023095-4dannjjm	3411	30	test	test	NN
cord-023095-4dannjjm	3411	31	in	in	IN
cord-023095-4dannjjm	3411	32	cats	cat	NNS
cord-023095-4dannjjm	3411	33	.	.	.
cord-023095-4dannjjm	3412	1	The	the	DT
cord-023095-4dannjjm	3412	2	goal	goal	NN
cord-023095-4dannjjm	3412	3	of	of	IN
cord-023095-4dannjjm	3412	4	this	this	DT
cord-023095-4dannjjm	3412	5	study	study	NN
cord-023095-4dannjjm	3412	6	was	be	VBD
cord-023095-4dannjjm	3412	7	to	to	TO
cord-023095-4dannjjm	3412	8	determine	determine	VB
cord-023095-4dannjjm	3412	9	the	the	DT
cord-023095-4dannjjm	3412	10	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3412	11	and	and	CC
cord-023095-4dannjjm	3412	12	specificity	specificity	NN
cord-023095-4dannjjm	3412	13	of	of	IN
cord-023095-4dannjjm	3412	14	H.	H.	NNP
cord-023095-4dannjjm	3412	15	capsulatum	capsulatum	NN
cord-023095-4dannjjm	3412	16	AA	AA	NNP
cord-023095-4dannjjm	3412	17	in	in	IN
cord-023095-4dannjjm	3412	18	cats	cat	NNS
cord-023095-4dannjjm	3412	19	with	with	IN
cord-023095-4dannjjm	3412	20	clinical	clinical	JJ
cord-023095-4dannjjm	3412	21	disorders	disorder	NNS
cord-023095-4dannjjm	3412	22	suggestive	suggestive	JJ
cord-023095-4dannjjm	3412	23	of	of	IN
cord-023095-4dannjjm	3412	24	histoplasmosis	histoplasmosis	NN
cord-023095-4dannjjm	3412	25	.	.	.
cord-023095-4dannjjm	3413	1	Urine	urine	NN
cord-023095-4dannjjm	3413	2	and	and	CC
cord-023095-4dannjjm	3413	3	serum	serum	NN
cord-023095-4dannjjm	3413	4	H.	h.	NN
cord-023095-4dannjjm	3413	5	capsulatum	capsulatum	NN
cord-023095-4dannjjm	3413	6	AA	AA	NNP
cord-023095-4dannjjm	3413	7	results	result	NNS
cord-023095-4dannjjm	3413	8	for	for	IN
cord-023095-4dannjjm	3413	9	feline	feline	JJ
cord-023095-4dannjjm	3413	10	patients	patient	NNS
cord-023095-4dannjjm	3413	11	from	from	IN
cord-023095-4dannjjm	3413	12	3	3	CD
cord-023095-4dannjjm	3413	13	veterinary	veterinary	JJ
cord-023095-4dannjjm	3413	14	hospitals	hospital	NNS
cord-023095-4dannjjm	3413	15	were	be	VBD
cord-023095-4dannjjm	3413	16	evaluated	evaluate	VBN
cord-023095-4dannjjm	3413	17	.	.	.
cord-023095-4dannjjm	3414	1	Medical	medical	JJ
cord-023095-4dannjjm	3414	2	records	record	NNS
cord-023095-4dannjjm	3414	3	were	be	VBD
cord-023095-4dannjjm	3414	4	reviewed	review	VBN
cord-023095-4dannjjm	3414	5	for	for	IN
cord-023095-4dannjjm	3414	6	confirmatory	confirmatory	JJ
cord-023095-4dannjjm	3414	7	evidence	evidence	NN
cord-023095-4dannjjm	3414	8	of	of	IN
cord-023095-4dannjjm	3414	9	histoplasmosis	histoplasmosis	NN
cord-023095-4dannjjm	3414	10	(	(	-LRB-
cord-023095-4dannjjm	3414	11	based	base	VBN
cord-023095-4dannjjm	3414	12	on	on	IN
cord-023095-4dannjjm	3414	13	cytological	cytological	JJ
cord-023095-4dannjjm	3414	14	or	or	CC
cord-023095-4dannjjm	3414	15	histopathological	histopathological	JJ
cord-023095-4dannjjm	3414	16	findings	finding	NNS
cord-023095-4dannjjm	3414	17	)	)	-RRB-
cord-023095-4dannjjm	3414	18	or	or	CC
cord-023095-4dannjjm	3414	19	an	an	DT
cord-023095-4dannjjm	3414	20	appropriately	appropriately	RB
cord-023095-4dannjjm	3414	21	supported	support	VBN
cord-023095-4dannjjm	3414	22	alternate	alternate	JJ
cord-023095-4dannjjm	3414	23	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3414	24	.	.	.
cord-023095-4dannjjm	3415	1	AA	AA	NNP
cord-023095-4dannjjm	3415	2	results	result	NNS
cord-023095-4dannjjm	3415	3	were	be	VBD
cord-023095-4dannjjm	3415	4	available	available	JJ
cord-023095-4dannjjm	3415	5	for	for	IN
cord-023095-4dannjjm	3415	6	78	78	CD
cord-023095-4dannjjm	3415	7	cats	cat	NNS
cord-023095-4dannjjm	3415	8	;	;	:
cord-023095-4dannjjm	3415	9	initial	initial	JJ
cord-023095-4dannjjm	3415	10	testing	testing	NN
cord-023095-4dannjjm	3415	11	was	be	VBD
cord-023095-4dannjjm	3415	12	performed	perform	VBN
cord-023095-4dannjjm	3415	13	on	on	IN
cord-023095-4dannjjm	3415	14	72	72	CD
cord-023095-4dannjjm	3415	15	urine	urine	NN
cord-023095-4dannjjm	3415	16	samples	sample	NNS
cord-023095-4dannjjm	3415	17	,	,	,
cord-023095-4dannjjm	3415	18	6	6	CD
cord-023095-4dannjjm	3415	19	serum	serum	NN
cord-023095-4dannjjm	3415	20	samples	sample	NNS
cord-023095-4dannjjm	3415	21	,	,	,
cord-023095-4dannjjm	3415	22	and	and	CC
cord-023095-4dannjjm	3415	23	1	1	CD
cord-023095-4dannjjm	3415	24	unspecified	unspecified	JJ
cord-023095-4dannjjm	3415	25	sample	sample	NN
cord-023095-4dannjjm	3415	26	.	.	.
cord-023095-4dannjjm	3416	1	Of	of	IN
cord-023095-4dannjjm	3416	2	these	these	DT
cord-023095-4dannjjm	3416	3	cats	cat	NNS
cord-023095-4dannjjm	3416	4	,	,	,
cord-023095-4dannjjm	3416	5	17/78	17/78	CD
cord-023095-4dannjjm	3416	6	had	have	VBD
cord-023095-4dannjjm	3416	7	a	a	DT
cord-023095-4dannjjm	3416	8	definitive	definitive	JJ
cord-023095-4dannjjm	3416	9	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3416	10	of	of	IN
cord-023095-4dannjjm	3416	11	histoplasmosis	histoplasmosis	NN
cord-023095-4dannjjm	3416	12	based	base	VBN
cord-023095-4dannjjm	3416	13	on	on	IN
cord-023095-4dannjjm	3416	14	organism	organism	NN
cord-023095-4dannjjm	3416	15	identification	identification	NN
cord-023095-4dannjjm	3416	16	,	,	,
cord-023095-4dannjjm	3416	17	and	and	CC
cord-023095-4dannjjm	3416	18	10	10	CD
cord-023095-4dannjjm	3416	19	had	have	VBD
cord-023095-4dannjjm	3416	20	a	a	DT
cord-023095-4dannjjm	3416	21	definitive	definitive	JJ
cord-023095-4dannjjm	3416	22	alternate	alternate	JJ
cord-023095-4dannjjm	3416	23	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3416	24	(	(	-LRB-
cord-023095-4dannjjm	3416	25	e.g.	e.g.	RB
cord-023095-4dannjjm	3416	26	,	,	,
cord-023095-4dannjjm	3416	27	neoplasia	neoplasia	NN
cord-023095-4dannjjm	3416	28	,	,	,
cord-023095-4dannjjm	3416	29	other	other	JJ
cord-023095-4dannjjm	3416	30	infection	infection	NN
cord-023095-4dannjjm	3416	31	)	)	-RRB-
cord-023095-4dannjjm	3416	32	based	base	VBN
cord-023095-4dannjjm	3416	33	on	on	IN
cord-023095-4dannjjm	3416	34	necropsy	necropsy	JJ
cord-023095-4dannjjm	3416	35	findings	finding	NNS
cord-023095-4dannjjm	3416	36	(	(	-LRB-
cord-023095-4dannjjm	3416	37	n	n	NN
cord-023095-4dannjjm	3416	38	5	5	CD
cord-023095-4dannjjm	3416	39	5	5	CD
cord-023095-4dannjjm	3416	40	)	)	-RRB-
cord-023095-4dannjjm	3416	41	or	or	CC
cord-023095-4dannjjm	3416	42	other	other	JJ
cord-023095-4dannjjm	3416	43	clinical	clinical	JJ
cord-023095-4dannjjm	3416	44	data	datum	NNS
cord-023095-4dannjjm	3416	45	(	(	-LRB-
cord-023095-4dannjjm	3416	46	n	n	NN
cord-023095-4dannjjm	3416	47	5	5	CD
cord-023095-4dannjjm	3416	48	5	5	CD
cord-023095-4dannjjm	3416	49	)	)	-RRB-
cord-023095-4dannjjm	3416	50	.	.	.
cord-023095-4dannjjm	3417	1	An	an	DT
cord-023095-4dannjjm	3417	2	additional	additional	JJ
cord-023095-4dannjjm	3417	3	16	16	CD
cord-023095-4dannjjm	3417	4	cats	cat	NNS
cord-023095-4dannjjm	3417	5	had	have	VBD
cord-023095-4dannjjm	3417	6	a	a	DT
cord-023095-4dannjjm	3417	7	clinical	clinical	JJ
cord-023095-4dannjjm	3417	8	alternate	alternate	JJ
cord-023095-4dannjjm	3417	9	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3417	10	with	with	IN
cord-023095-4dannjjm	3417	11	no	no	DT
cord-023095-4dannjjm	3417	12	cytological	cytological	JJ
cord-023095-4dannjjm	3417	13	or	or	CC
cord-023095-4dannjjm	3417	14	histopathological	histopathological	JJ
cord-023095-4dannjjm	3417	15	evidence	evidence	NN
cord-023095-4dannjjm	3417	16	of	of	IN
cord-023095-4dannjjm	3417	17	histoplasmosis	histoplasmosis	NN
cord-023095-4dannjjm	3417	18	in	in	IN
cord-023095-4dannjjm	3417	19	the	the	DT
cord-023095-4dannjjm	3417	20	affected	affected	JJ
cord-023095-4dannjjm	3417	21	body	body	NN
cord-023095-4dannjjm	3417	22	system(s	system(s	NNP
cord-023095-4dannjjm	3417	23	)	)	-RRB-
cord-023095-4dannjjm	3417	24	.	.	.
cord-023095-4dannjjm	3418	1	The	the	DT
cord-023095-4dannjjm	3418	2	remaining	remain	VBG
cord-023095-4dannjjm	3418	3	cats	cat	NNS
cord-023095-4dannjjm	3418	4	had	have	VBD
cord-023095-4dannjjm	3418	5	unverified	unverified	JJ
cord-023095-4dannjjm	3418	6	histoplasmosis	histoplasmosis	NN
cord-023095-4dannjjm	3418	7	(	(	-LRB-
cord-023095-4dannjjm	3418	8	n	n	NN
cord-023095-4dannjjm	3418	9	5	5	CD
cord-023095-4dannjjm	3418	10	9	9	CD
cord-023095-4dannjjm	3418	11	)	)	-RRB-
cord-023095-4dannjjm	3418	12	or	or	CC
cord-023095-4dannjjm	3418	13	an	an	DT
cord-023095-4dannjjm	3418	14	open	open	JJ
cord-023095-4dannjjm	3418	15	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3418	16	(	(	-LRB-
cord-023095-4dannjjm	3418	17	n	n	NN
cord-023095-4dannjjm	3418	18	5	5	CD
cord-023095-4dannjjm	3418	19	26	26	CD
cord-023095-4dannjjm	3418	20	)	)	-RRB-
cord-023095-4dannjjm	3418	21	.	.	.
cord-023095-4dannjjm	3419	1	Of	of	IN
cord-023095-4dannjjm	3419	2	the	the	DT
cord-023095-4dannjjm	3419	3	17	17	CD
cord-023095-4dannjjm	3419	4	cats	cat	NNS
cord-023095-4dannjjm	3419	5	with	with	IN
cord-023095-4dannjjm	3419	6	confirmed	confirm	VBN
cord-023095-4dannjjm	3419	7	histoplasmosis	histoplasmosis	NN
cord-023095-4dannjjm	3419	8	,	,	,
cord-023095-4dannjjm	3419	9	16	16	CD
cord-023095-4dannjjm	3419	10	were	be	VBD
cord-023095-4dannjjm	3419	11	positive	positive	JJ
cord-023095-4dannjjm	3419	12	on	on	IN
cord-023095-4dannjjm	3419	13	initial	initial	JJ
cord-023095-4dannjjm	3419	14	urine	urine	NN
cord-023095-4dannjjm	3419	15	AA	AA	NNP
cord-023095-4dannjjm	3419	16	.	.	.
cord-023095-4dannjjm	3420	1	One	one	CD
cord-023095-4dannjjm	3420	2	cat	cat	NN
cord-023095-4dannjjm	3420	3	(	(	-LRB-
cord-023095-4dannjjm	3420	4	with	with	IN
cord-023095-4dannjjm	3420	5	rectal	rectal	JJ
cord-023095-4dannjjm	3420	6	involvement	involvement	NN
cord-023095-4dannjjm	3420	7	)	)	-RRB-
cord-023095-4dannjjm	3420	8	was	be	VBD
cord-023095-4dannjjm	3420	9	negative	negative	JJ
cord-023095-4dannjjm	3420	10	,	,	,
cord-023095-4dannjjm	3420	11	indicating	indicate	VBG
cord-023095-4dannjjm	3420	12	a	a	DT
cord-023095-4dannjjm	3420	13	test	test	NN
cord-023095-4dannjjm	3420	14	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3420	15	of	of	IN
cord-023095-4dannjjm	3420	16	94	94	CD
cord-023095-4dannjjm	3420	17	%	%	NN
cord-023095-4dannjjm	3420	18	.	.	.
cord-023095-4dannjjm	3421	1	One	one	CD
cord-023095-4dannjjm	3421	2	cat	cat	NN
cord-023095-4dannjjm	3421	3	was	be	VBD
cord-023095-4dannjjm	3421	4	positive	positive	JJ
cord-023095-4dannjjm	3421	5	on	on	IN
cord-023095-4dannjjm	3421	6	urine	urine	NN
cord-023095-4dannjjm	3421	7	AA	aa	NN
cord-023095-4dannjjm	3421	8	but	but	CC
cord-023095-4dannjjm	3421	9	negative	negative	JJ
cord-023095-4dannjjm	3421	10	on	on	IN
cord-023095-4dannjjm	3421	11	serum	serum	NN
cord-023095-4dannjjm	3421	12	AA	aa	NN
cord-023095-4dannjjm	3421	13	.	.	.
cord-023095-4dannjjm	3422	1	All	all	DT
cord-023095-4dannjjm	3422	2	of	of	IN
cord-023095-4dannjjm	3422	3	the	the	DT
cord-023095-4dannjjm	3422	4	26	26	CD
cord-023095-4dannjjm	3422	5	cats	cat	NNS
cord-023095-4dannjjm	3422	6	with	with	IN
cord-023095-4dannjjm	3422	7	definitive	definitive	JJ
cord-023095-4dannjjm	3422	8	or	or	CC
cord-023095-4dannjjm	3422	9	clinical	clinical	JJ
cord-023095-4dannjjm	3422	10	alternate	alternate	JJ
cord-023095-4dannjjm	3422	11	diagnoses	diagnosis	NNS
cord-023095-4dannjjm	3422	12	had	have	VBD
cord-023095-4dannjjm	3422	13	negative	negative	JJ
cord-023095-4dannjjm	3422	14	results	result	NNS
cord-023095-4dannjjm	3422	15	on	on	IN
cord-023095-4dannjjm	3422	16	the	the	DT
cord-023095-4dannjjm	3422	17	AA	AA	NNP
cord-023095-4dannjjm	3422	18	,	,	,
cord-023095-4dannjjm	3422	19	suggesting	suggest	VBG
cord-023095-4dannjjm	3422	20	an	an	DT
cord-023095-4dannjjm	3422	21	excellent	excellent	JJ
cord-023095-4dannjjm	3422	22	specificity	specificity	NN
cord-023095-4dannjjm	3422	23	(	(	-LRB-
cord-023095-4dannjjm	3422	24	100	100	CD
cord-023095-4dannjjm	3422	25	%	%	NN
cord-023095-4dannjjm	3422	26	)	)	-RRB-
cord-023095-4dannjjm	3422	27	.	.	.
cord-023095-4dannjjm	3423	1	However	however	RB
cord-023095-4dannjjm	3423	2	,	,	,
cord-023095-4dannjjm	3423	3	this	this	DT
cord-023095-4dannjjm	3423	4	result	result	NN
cord-023095-4dannjjm	3423	5	should	should	MD
cord-023095-4dannjjm	3423	6	be	be	VB
cord-023095-4dannjjm	3423	7	interpreted	interpret	VBN
cord-023095-4dannjjm	3423	8	with	with	IN
cord-023095-4dannjjm	3423	9	caution	caution	NN
cord-023095-4dannjjm	3423	10	,	,	,
cord-023095-4dannjjm	3423	11	as	as	IN
cord-023095-4dannjjm	3423	12	the	the	DT
cord-023095-4dannjjm	3423	13	possibility	possibility	NN
cord-023095-4dannjjm	3423	14	of	of	IN
cord-023095-4dannjjm	3423	15	primary	primary	JJ
cord-023095-4dannjjm	3423	16	or	or	CC
cord-023095-4dannjjm	3423	17	concurrent	concurrent	JJ
cord-023095-4dannjjm	3423	18	histoplasmosis	histoplasmosis	NN
cord-023095-4dannjjm	3423	19	was	be	VBD
cord-023095-4dannjjm	3423	20	only	only	RB
cord-023095-4dannjjm	3423	21	definitively	definitively	RB
cord-023095-4dannjjm	3423	22	excluded	exclude	VBN
cord-023095-4dannjjm	3423	23	in	in	IN
cord-023095-4dannjjm	3423	24	the	the	DT
cord-023095-4dannjjm	3423	25	5	5	CD
cord-023095-4dannjjm	3423	26	patients	patient	NNS
cord-023095-4dannjjm	3423	27	who	who	WP
cord-023095-4dannjjm	3423	28	underwent	undergo	VBD
cord-023095-4dannjjm	3423	29	necropsy	necropsy	JJ
cord-023095-4dannjjm	3423	30	examination	examination	NN
cord-023095-4dannjjm	3423	31	.	.	.
cord-023095-4dannjjm	3424	1	These	these	DT
cord-023095-4dannjjm	3424	2	findings	finding	NNS
cord-023095-4dannjjm	3424	3	suggest	suggest	VBP
cord-023095-4dannjjm	3424	4	that	that	IN
cord-023095-4dannjjm	3424	5	the	the	DT
cord-023095-4dannjjm	3424	6	AA	AA	NNP
cord-023095-4dannjjm	3424	7	for	for	IN
cord-023095-4dannjjm	3424	8	H.	H.	NNP
cord-023095-4dannjjm	3424	9	capsulatum	capsulatum	NNP
cord-023095-4dannjjm	3424	10	is	be	VBZ
cord-023095-4dannjjm	3424	11	a	a	DT
cord-023095-4dannjjm	3424	12	reliable	reliable	JJ
cord-023095-4dannjjm	3424	13	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3424	14	tool	tool	NN
cord-023095-4dannjjm	3424	15	in	in	IN
cord-023095-4dannjjm	3424	16	this	this	DT
cord-023095-4dannjjm	3424	17	species	specie	NNS
cord-023095-4dannjjm	3424	18	.	.	.
cord-023095-4dannjjm	3425	1	A	a	DT
cord-023095-4dannjjm	3425	2	positive	positive	JJ
cord-023095-4dannjjm	3425	3	result	result	NN
cord-023095-4dannjjm	3425	4	appears	appear	VBZ
cord-023095-4dannjjm	3425	5	to	to	TO
cord-023095-4dannjjm	3425	6	reliably	reliably	RB
cord-023095-4dannjjm	3425	7	support	support	VB
cord-023095-4dannjjm	3425	8	the	the	DT
cord-023095-4dannjjm	3425	9	presence	presence	NN
cord-023095-4dannjjm	3425	10	of	of	IN
cord-023095-4dannjjm	3425	11	infection	infection	NN
cord-023095-4dannjjm	3425	12	,	,	,
cord-023095-4dannjjm	3425	13	but	but	CC
cord-023095-4dannjjm	3425	14	a	a	DT
cord-023095-4dannjjm	3425	15	small	small	JJ
cord-023095-4dannjjm	3425	16	percentage	percentage	NN
cord-023095-4dannjjm	3425	17	of	of	IN
cord-023095-4dannjjm	3425	18	infected	infected	JJ
cord-023095-4dannjjm	3425	19	cats	cat	NNS
cord-023095-4dannjjm	3425	20	may	may	MD
cord-023095-4dannjjm	3425	21	be	be	VB
cord-023095-4dannjjm	3425	22	negative	negative	JJ
cord-023095-4dannjjm	3425	23	on	on	IN
cord-023095-4dannjjm	3425	24	AA	AA	NNP
cord-023095-4dannjjm	3425	25	.	.	.
cord-023095-4dannjjm	3426	1	In	in	IN
cord-023095-4dannjjm	3426	2	addition	addition	NN
cord-023095-4dannjjm	3426	3	,	,	,
cord-023095-4dannjjm	3426	4	tests	test	NNS
cord-023095-4dannjjm	3426	5	performed	perform	VBN
cord-023095-4dannjjm	3426	6	on	on	IN
cord-023095-4dannjjm	3426	7	urine	urine	NN
cord-023095-4dannjjm	3426	8	may	may	MD
cord-023095-4dannjjm	3426	9	be	be	VB
cord-023095-4dannjjm	3426	10	more	more	RBR
cord-023095-4dannjjm	3426	11	sensitive	sensitive	JJ
cord-023095-4dannjjm	3426	12	that	that	IN
cord-023095-4dannjjm	3426	13	those	those	DT
cord-023095-4dannjjm	3426	14	performed	perform	VBN
cord-023095-4dannjjm	3426	15	on	on	IN
cord-023095-4dannjjm	3426	16	serum	serum	NN
cord-023095-4dannjjm	3426	17	.	.	.
cord-023095-4dannjjm	3427	1	The	the	DT
cord-023095-4dannjjm	3427	2	purpose	purpose	NN
cord-023095-4dannjjm	3427	3	of	of	IN
cord-023095-4dannjjm	3427	4	this	this	DT
cord-023095-4dannjjm	3427	5	study	study	NN
cord-023095-4dannjjm	3427	6	was	be	VBD
cord-023095-4dannjjm	3427	7	to	to	TO
cord-023095-4dannjjm	3427	8	evaluate	evaluate	VB
cord-023095-4dannjjm	3427	9	the	the	DT
cord-023095-4dannjjm	3427	10	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3427	11	and	and	CC
cord-023095-4dannjjm	3427	12	specificity	specificity	NN
cord-023095-4dannjjm	3427	13	of	of	IN
cord-023095-4dannjjm	3427	14	an	an	DT
cord-023095-4dannjjm	3427	15	Aspergillus	Aspergillus	NNP
cord-023095-4dannjjm	3427	16	galactomannan	galactomannan	NN
cord-023095-4dannjjm	3427	17	antigen	antigen	NN
cord-023095-4dannjjm	3427	18	enzyme	enzyme	NN
cord-023095-4dannjjm	3427	19	immunoassay	immunoassay	NN
cord-023095-4dannjjm	3427	20	(	(	-LRB-
cord-023095-4dannjjm	3427	21	GA	GA	NNP
cord-023095-4dannjjm	3427	22	-	-	HYPH
cord-023095-4dannjjm	3427	23	EIA	EIA	NNP
cord-023095-4dannjjm	3427	24	)	)	-RRB-
cord-023095-4dannjjm	3427	25	for	for	IN
cord-023095-4dannjjm	3427	26	the	the	DT
cord-023095-4dannjjm	3427	27	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3427	28	of	of	IN
cord-023095-4dannjjm	3427	29	canine	canine	JJ
cord-023095-4dannjjm	3427	30	systemic	systemic	JJ
cord-023095-4dannjjm	3427	31	aspergillosis	aspergillosis	NN
cord-023095-4dannjjm	3427	32	.	.	.
cord-023095-4dannjjm	3428	1	Serum	serum	NN
cord-023095-4dannjjm	3428	2	and	and	CC
cord-023095-4dannjjm	3428	3	urine	urine	NN
cord-023095-4dannjjm	3428	4	samples	sample	NNS
cord-023095-4dannjjm	3428	5	were	be	VBD
cord-023095-4dannjjm	3428	6	collected	collect	VBN
cord-023095-4dannjjm	3428	7	from	from	IN
cord-023095-4dannjjm	3428	8	sick	sick	JJ
cord-023095-4dannjjm	3428	9	dogs	dog	NNS
cord-023095-4dannjjm	3428	10	at	at	IN
cord-023095-4dannjjm	3428	11	2	2	CD
cord-023095-4dannjjm	3428	12	hospitals	hospital	NNS
cord-023095-4dannjjm	3428	13	(	(	-LRB-
cord-023095-4dannjjm	3428	14	UCD	UCD	NNP
cord-023095-4dannjjm	3428	15	and	and	CC
cord-023095-4dannjjm	3428	16	TAMU	TAMU	NNP
cord-023095-4dannjjm	3428	17	)	)	-RRB-
cord-023095-4dannjjm	3428	18	.	.	.
cord-023095-4dannjjm	3429	1	Group	group	NN
cord-023095-4dannjjm	3429	2	1	1	CD
cord-023095-4dannjjm	3429	3	dogs	dog	NNS
cord-023095-4dannjjm	3429	4	were	be	VBD
cord-023095-4dannjjm	3429	5	diagnosed	diagnose	VBN
cord-023095-4dannjjm	3429	6	with	with	IN
cord-023095-4dannjjm	3429	7	systemic	systemic	JJ
cord-023095-4dannjjm	3429	8	aspergillosis	aspergillosis	NN
cord-023095-4dannjjm	3429	9	using	use	VBG
cord-023095-4dannjjm	3429	10	culture	culture	NN
cord-023095-4dannjjm	3429	11	(	(	-LRB-
cord-023095-4dannjjm	3429	12	sterile	sterile	JJ
cord-023095-4dannjjm	3429	13	site	site	NN
cord-023095-4dannjjm	3429	14	)	)	-RRB-
cord-023095-4dannjjm	3429	15	or	or	CC
cord-023095-4dannjjm	3429	16	microscopy	microscopy	NN
cord-023095-4dannjjm	3429	17	and	and	CC
cord-023095-4dannjjm	3429	18	culture	culture	NN
cord-023095-4dannjjm	3429	19	(	(	-LRB-
cord-023095-4dannjjm	3429	20	non	non	JJ
cord-023095-4dannjjm	3429	21	-	-	JJ
cord-023095-4dannjjm	3429	22	sterile	sterile	JJ
cord-023095-4dannjjm	3429	23	site	site	NN
cord-023095-4dannjjm	3429	24	)	)	-RRB-
cord-023095-4dannjjm	3429	25	.	.	.
cord-023095-4dannjjm	3430	1	Group	group	NN
cord-023095-4dannjjm	3430	2	2	2	CD
cord-023095-4dannjjm	3430	3	dogs	dog	NNS
cord-023095-4dannjjm	3430	4	had	have	VBD
cord-023095-4dannjjm	3430	5	clinical	clinical	JJ
cord-023095-4dannjjm	3430	6	findings	finding	NNS
cord-023095-4dannjjm	3430	7	suggestive	suggestive	JJ
cord-023095-4dannjjm	3430	8	of	of	IN
cord-023095-4dannjjm	3430	9	aspergillosis	aspergillosis	NN
cord-023095-4dannjjm	3430	10	but	but	CC
cord-023095-4dannjjm	3430	11	an	an	DT
cord-023095-4dannjjm	3430	12	alternate	alternate	JJ
cord-023095-4dannjjm	3430	13	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3430	14	was	be	VBD
cord-023095-4dannjjm	3430	15	established	establish	VBN
cord-023095-4dannjjm	3430	16	.	.	.
cord-023095-4dannjjm	3431	1	Group	group	NN
cord-023095-4dannjjm	3431	2	3	3	CD
cord-023095-4dannjjm	3431	3	dogs	dog	NNS
cord-023095-4dannjjm	3431	4	were	be	VBD
cord-023095-4dannjjm	3431	5	not	not	RB
cord-023095-4dannjjm	3431	6	suspected	suspect	VBN
cord-023095-4dannjjm	3431	7	to	to	TO
cord-023095-4dannjjm	3431	8	have	have	VB
cord-023095-4dannjjm	3431	9	aspergillosis	aspergillosis	NN
cord-023095-4dannjjm	3431	10	.	.	.
cord-023095-4dannjjm	3432	1	Samples	sample	NNS
cord-023095-4dannjjm	3432	2	were	be	VBD
cord-023095-4dannjjm	3432	3	tested	test	VBN
cord-023095-4dannjjm	3432	4	using	use	VBG
cord-023095-4dannjjm	3432	5	the	the	DT
cord-023095-4dannjjm	3432	6	GA	GA	NNP
cord-023095-4dannjjm	3432	7	-	-	HYPH
cord-023095-4dannjjm	3432	8	EIA	EIA	NNP
cord-023095-4dannjjm	3432	9	and	and	CC
cord-023095-4dannjjm	3432	10	results	result	NNS
cord-023095-4dannjjm	3432	11	expressed	express	VBN
cord-023095-4dannjjm	3432	12	as	as	IN
cord-023095-4dannjjm	3432	13	a	a	DT
cord-023095-4dannjjm	3432	14	galactomannan	galactomannan	NNP
cord-023095-4dannjjm	3432	15	index	index	NN
cord-023095-4dannjjm	3432	16	(	(	-LRB-
cord-023095-4dannjjm	3432	17	GMI	GMI	NNP
cord-023095-4dannjjm	3432	18	)	)	-RRB-
cord-023095-4dannjjm	3432	19	.	.	.
cord-023095-4dannjjm	3433	1	GMIs	gmi	NNS
cord-023095-4dannjjm	3433	2	4	4	CD
cord-023095-4dannjjm	3433	3	0.5	0.5	CD
cord-023095-4dannjjm	3433	4	were	be	VBD
cord-023095-4dannjjm	3433	5	considered	consider	VBN
cord-023095-4dannjjm	3433	6	positive	positive	JJ
cord-023095-4dannjjm	3433	7	.	.	.
cord-023095-4dannjjm	3434	1	Comparisons	comparison	NNS
cord-023095-4dannjjm	3434	2	were	be	VBD
cord-023095-4dannjjm	3434	3	performed	perform	VBN
cord-023095-4dannjjm	3434	4	using	use	VBG
cord-023095-4dannjjm	3434	5	the	the	DT
cord-023095-4dannjjm	3434	6	Mann	Mann	NNP
cord-023095-4dannjjm	3434	7	-	-	HYPH
cord-023095-4dannjjm	3434	8	Whitney	Whitney	NNP
cord-023095-4dannjjm	3434	9	test	test	NN
cord-023095-4dannjjm	3434	10	.	.	.
cord-023095-4dannjjm	3435	1	There	there	EX
cord-023095-4dannjjm	3435	2	were	be	VBD
cord-023095-4dannjjm	3435	3	10	10	CD
cord-023095-4dannjjm	3435	4	dogs	dog	NNS
cord-023095-4dannjjm	3435	5	in	in	IN
cord-023095-4dannjjm	3435	6	Group	Group	NNP
cord-023095-4dannjjm	3435	7	1	1	CD
cord-023095-4dannjjm	3435	8	,	,	,
cord-023095-4dannjjm	3435	9	22	22	CD
cord-023095-4dannjjm	3435	10	in	in	IN
cord-023095-4dannjjm	3435	11	Group	Group	NNP
cord-023095-4dannjjm	3435	12	2	2	CD
cord-023095-4dannjjm	3435	13	,	,	,
cord-023095-4dannjjm	3435	14	and	and	CC
cord-023095-4dannjjm	3435	15	23	23	CD
cord-023095-4dannjjm	3435	16	in	in	IN
cord-023095-4dannjjm	3435	17	Group	Group	NNP
cord-023095-4dannjjm	3435	18	3	3	CD
cord-023095-4dannjjm	3435	19	.	.	.
cord-023095-4dannjjm	3436	1	Serum	serum	NN
cord-023095-4dannjjm	3436	2	was	be	VBD
cord-023095-4dannjjm	3436	3	collected	collect	VBN
cord-023095-4dannjjm	3436	4	from	from	IN
cord-023095-4dannjjm	3436	5	all	all	DT
cord-023095-4dannjjm	3436	6	dogs	dog	NNS
cord-023095-4dannjjm	3436	7	,	,	,
cord-023095-4dannjjm	3436	8	and	and	CC
cord-023095-4dannjjm	3436	9	urine	urine	NN
cord-023095-4dannjjm	3436	10	from	from	IN
cord-023095-4dannjjm	3436	11	6	6	CD
cord-023095-4dannjjm	3436	12	,	,	,
cord-023095-4dannjjm	3436	13	9	9	CD
cord-023095-4dannjjm	3436	14	,	,	,
cord-023095-4dannjjm	3436	15	and	and	CC
cord-023095-4dannjjm	3436	16	10	10	CD
cord-023095-4dannjjm	3436	17	dogs	dog	NNS
cord-023095-4dannjjm	3436	18	,	,	,
cord-023095-4dannjjm	3436	19	respectively	respectively	RB
cord-023095-4dannjjm	3436	20	.	.	.
cord-023095-4dannjjm	3437	1	Serum	serum	NN
cord-023095-4dannjjm	3437	2	GMIs	gmi	NNS
cord-023095-4dannjjm	3437	3	did	do	VBD
cord-023095-4dannjjm	3437	4	not	not	RB
cord-023095-4dannjjm	3437	5	differ	differ	VB
cord-023095-4dannjjm	3437	6	from	from	IN
cord-023095-4dannjjm	3437	7	urine	urine	NN
cord-023095-4dannjjm	3437	8	GMIs	gmi	NNS
cord-023095-4dannjjm	3437	9	across	across	IN
cord-023095-4dannjjm	3437	10	groups	group	NNS
cord-023095-4dannjjm	3437	11	.	.	.
cord-023095-4dannjjm	3438	1	Serum	serum	NN
cord-023095-4dannjjm	3438	2	GMIs	gmi	NNS
cord-023095-4dannjjm	3438	3	of	of	IN
cord-023095-4dannjjm	3438	4	Group	group	NN
cord-023095-4dannjjm	3438	5	1	1	CD
cord-023095-4dannjjm	3438	6	dogs	dog	NNS
cord-023095-4dannjjm	3438	7	were	be	VBD
cord-023095-4dannjjm	3438	8	higher	high	JJR
cord-023095-4dannjjm	3438	9	than	than	IN
cord-023095-4dannjjm	3438	10	those	those	DT
cord-023095-4dannjjm	3438	11	of	of	IN
cord-023095-4dannjjm	3438	12	Group	Group	NNP
cord-023095-4dannjjm	3438	13	2	2	CD
cord-023095-4dannjjm	3438	14	and	and	CC
cord-023095-4dannjjm	3438	15	Group	Group	NNP
cord-023095-4dannjjm	3438	16	3	3	CD
cord-023095-4dannjjm	3438	17	dogs	dog	NNS
cord-023095-4dannjjm	3438	18	(	(	-LRB-
cord-023095-4dannjjm	3438	19	p	p	NN
cord-023095-4dannjjm	3438	20	o	o	NN
cord-023095-4dannjjm	3438	21	0.0001	0.0001	CD
cord-023095-4dannjjm	3438	22	)	)	-RRB-
cord-023095-4dannjjm	3438	23	.	.	.
cord-023095-4dannjjm	3439	1	Results	result	NNS
cord-023095-4dannjjm	3439	2	from	from	IN
cord-023095-4dannjjm	3439	3	dogs	dog	NNS
cord-023095-4dannjjm	3439	4	in	in	IN
cord-023095-4dannjjm	3439	5	Group	Group	NNP
cord-023095-4dannjjm	3439	6	2	2	CD
cord-023095-4dannjjm	3439	7	did	do	VBD
cord-023095-4dannjjm	3439	8	not	not	RB
cord-023095-4dannjjm	3439	9	differ	differ	VB
cord-023095-4dannjjm	3439	10	from	from	IN
cord-023095-4dannjjm	3439	11	those	those	DT
cord-023095-4dannjjm	3439	12	in	in	IN
cord-023095-4dannjjm	3439	13	Group	Group	NNP
cord-023095-4dannjjm	3439	14	3	3	CD
cord-023095-4dannjjm	3439	15	(	(	-LRB-
cord-023095-4dannjjm	3439	16	p	p	NN
cord-023095-4dannjjm	3439	17	5	5	CD
cord-023095-4dannjjm	3439	18	0.43	0.43	CD
cord-023095-4dannjjm	3439	19	)	)	-RRB-
cord-023095-4dannjjm	3439	20	.	.	.
cord-023095-4dannjjm	3440	1	Two	two	CD
cord-023095-4dannjjm	3440	2	dogs	dog	NNS
cord-023095-4dannjjm	3440	3	in	in	IN
cord-023095-4dannjjm	3440	4	Group	Group	NNP
cord-023095-4dannjjm	3440	5	1	1	CD
cord-023095-4dannjjm	3440	6	tested	test	VBD
cord-023095-4dannjjm	3440	7	negative	negative	JJ
cord-023095-4dannjjm	3440	8	,	,	,
cord-023095-4dannjjm	3440	9	but	but	CC
cord-023095-4dannjjm	3440	10	had	have	VBD
cord-023095-4dannjjm	3440	11	localized	localize	VBN
cord-023095-4dannjjm	3440	12	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	3440	13	infections	infection	NNS
cord-023095-4dannjjm	3440	14	.	.	.
cord-023095-4dannjjm	3441	1	One	one	CD
cord-023095-4dannjjm	3441	2	dog	dog	NN
cord-023095-4dannjjm	3441	3	in	in	IN
cord-023095-4dannjjm	3441	4	Group	Group	NNP
cord-023095-4dannjjm	3441	5	2	2	CD
cord-023095-4dannjjm	3441	6	,	,	,
cord-023095-4dannjjm	3441	7	which	which	WDT
cord-023095-4dannjjm	3441	8	had	have	VBD
cord-023095-4dannjjm	3441	9	paecilomycosis	paecilomycosis	NN
cord-023095-4dannjjm	3441	10	,	,	,
cord-023095-4dannjjm	3441	11	tested	test	VBD
cord-023095-4dannjjm	3441	12	positive	positive	JJ
cord-023095-4dannjjm	3441	13	.	.	.
cord-023095-4dannjjm	3442	1	Two	two	CD
cord-023095-4dannjjm	3442	2	dogs	dog	NNS
cord-023095-4dannjjm	3442	3	in	in	IN
cord-023095-4dannjjm	3442	4	Group	Group	NNP
cord-023095-4dannjjm	3442	5	3	3	CD
cord-023095-4dannjjm	3442	6	tested	test	VBD
cord-023095-4dannjjm	3442	7	positive	positive	JJ
cord-023095-4dannjjm	3442	8	.	.	.
cord-023095-4dannjjm	3443	1	One	one	CD
cord-023095-4dannjjm	3443	2	was	be	VBD
cord-023095-4dannjjm	3443	3	being	be	VBG
cord-023095-4dannjjm	3443	4	treated	treat	VBN
cord-023095-4dannjjm	3443	5	with	with	IN
cord-023095-4dannjjm	3443	6	Plasmalyte	Plasmalyte	NNP
cord-023095-4dannjjm	3443	7	.	.	.
cord-023095-4dannjjm	3444	1	The	the	DT
cord-023095-4dannjjm	3444	2	other	other	JJ
cord-023095-4dannjjm	3444	3	had	have	VBD
cord-023095-4dannjjm	3444	4	a	a	DT
cord-023095-4dannjjm	3444	5	cutaneous	cutaneous	JJ
cord-023095-4dannjjm	3444	6	opportunistic	opportunistic	JJ
cord-023095-4dannjjm	3444	7	mycosis	mycosis	NN
cord-023095-4dannjjm	3444	8	.	.	.
cord-023095-4dannjjm	3445	1	These	these	DT
cord-023095-4dannjjm	3445	2	data	datum	NNS
cord-023095-4dannjjm	3445	3	support	support	VBP
cord-023095-4dannjjm	3445	4	the	the	DT
cord-023095-4dannjjm	3445	5	utility	utility	NN
cord-023095-4dannjjm	3445	6	of	of	IN
cord-023095-4dannjjm	3445	7	this	this	DT
cord-023095-4dannjjm	3445	8	assay	assay	NN
cord-023095-4dannjjm	3445	9	to	to	TO
cord-023095-4dannjjm	3445	10	aid	aid	VB
cord-023095-4dannjjm	3445	11	in	in	IN
cord-023095-4dannjjm	3445	12	the	the	DT
cord-023095-4dannjjm	3445	13	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3445	14	of	of	IN
cord-023095-4dannjjm	3445	15	systemic	systemic	JJ
cord-023095-4dannjjm	3445	16	aspergillosis	aspergillosis	NN
cord-023095-4dannjjm	3445	17	in	in	IN
cord-023095-4dannjjm	3445	18	dogs	dog	NNS
cord-023095-4dannjjm	3445	19	.	.	.
cord-023095-4dannjjm	3446	1	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3446	2	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3446	3	,	,	,
cord-023095-4dannjjm	3446	4	an	an	DT
cord-023095-4dannjjm	3446	5	Ixodes	Ixodes	NNP
cord-023095-4dannjjm	3446	6	tick	tick	VB
cord-023095-4dannjjm	3446	7	transmitted	transmit	VBN
cord-023095-4dannjjm	3446	8	rickettsial	rickettsial	JJ
cord-023095-4dannjjm	3446	9	bacterium	bacterium	NN
cord-023095-4dannjjm	3446	10	has	have	VBZ
cord-023095-4dannjjm	3446	11	a	a	DT
cord-023095-4dannjjm	3446	12	wide	wide	JJ
cord-023095-4dannjjm	3446	13	mammalian	mammalian	JJ
cord-023095-4dannjjm	3446	14	host	host	NN
cord-023095-4dannjjm	3446	15	range	range	NN
cord-023095-4dannjjm	3446	16	that	that	WDT
cord-023095-4dannjjm	3446	17	is	be	VBZ
cord-023095-4dannjjm	3446	18	not	not	RB
cord-023095-4dannjjm	3446	19	commonly	commonly	RB
cord-023095-4dannjjm	3446	20	reported	report	VBN
cord-023095-4dannjjm	3446	21	in	in	IN
cord-023095-4dannjjm	3446	22	cats	cat	NNS
cord-023095-4dannjjm	3446	23	.	.	.
cord-023095-4dannjjm	3447	1	Clinical	clinical	JJ
cord-023095-4dannjjm	3447	2	signs	sign	NNS
cord-023095-4dannjjm	3447	3	in	in	IN
cord-023095-4dannjjm	3447	4	humans	human	NNS
cord-023095-4dannjjm	3447	5	,	,	,
cord-023095-4dannjjm	3447	6	dogs	dog	NNS
cord-023095-4dannjjm	3447	7	and	and	CC
cord-023095-4dannjjm	3447	8	cats	cat	NNS
cord-023095-4dannjjm	3447	9	are	be	VBP
cord-023095-4dannjjm	3447	10	often	often	RB
cord-023095-4dannjjm	3447	11	vague	vague	JJ
cord-023095-4dannjjm	3447	12	and	and	CC
cord-023095-4dannjjm	3447	13	include	include	VBP
cord-023095-4dannjjm	3447	14	lethargy	lethargy	NN
cord-023095-4dannjjm	3447	15	,	,	,
cord-023095-4dannjjm	3447	16	anorexia	anorexia	NN
cord-023095-4dannjjm	3447	17	and	and	CC
cord-023095-4dannjjm	3447	18	malaise	malaise	NN
cord-023095-4dannjjm	3447	19	.	.	.
cord-023095-4dannjjm	3448	1	The	the	DT
cord-023095-4dannjjm	3448	2	purpose	purpose	NN
cord-023095-4dannjjm	3448	3	of	of	IN
cord-023095-4dannjjm	3448	4	this	this	DT
cord-023095-4dannjjm	3448	5	retrospective	retrospective	JJ
cord-023095-4dannjjm	3448	6	study	study	NN
cord-023095-4dannjjm	3448	7	was	be	VBD
cord-023095-4dannjjm	3448	8	to	to	TO
cord-023095-4dannjjm	3448	9	describe	describe	VB
cord-023095-4dannjjm	3448	10	the	the	DT
cord-023095-4dannjjm	3448	11	clinical	clinical	JJ
cord-023095-4dannjjm	3448	12	signs	sign	NNS
cord-023095-4dannjjm	3448	13	,	,	,
cord-023095-4dannjjm	3448	14	laboratory	laboratory	NN
cord-023095-4dannjjm	3448	15	data	datum	NNS
cord-023095-4dannjjm	3448	16	and	and	CC
cord-023095-4dannjjm	3448	17	response	response	NN
cord-023095-4dannjjm	3448	18	to	to	IN
cord-023095-4dannjjm	3448	19	treatment	treatment	NN
cord-023095-4dannjjm	3448	20	in	in	IN
cord-023095-4dannjjm	3448	21	cats	cat	NNS
cord-023095-4dannjjm	3448	22	that	that	WDT
cord-023095-4dannjjm	3448	23	tested	test	VBD
cord-023095-4dannjjm	3448	24	positive	positive	JJ
cord-023095-4dannjjm	3448	25	for	for	IN
cord-023095-4dannjjm	3448	26	A.	a.	NN
cord-023095-4dannjjm	3448	27	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3448	28	on	on	IN
cord-023095-4dannjjm	3448	29	a	a	DT
cord-023095-4dannjjm	3448	30	commercially	commercially	RB
cord-023095-4dannjjm	3448	31	available	available	JJ
cord-023095-4dannjjm	3448	32	PCR	pcr	NN
cord-023095-4dannjjm	3448	33	of	of	IN
cord-023095-4dannjjm	3448	34	peripheral	peripheral	JJ
cord-023095-4dannjjm	3448	35	blood	blood	NN
cord-023095-4dannjjm	3448	36	(	(	-LRB-
cord-023095-4dannjjm	3448	37	FastPanel	FastPanel	NNP
cord-023095-4dannjjm	3448	38	TM	TM	NNP
cord-023095-4dannjjm	3448	39	)	)	-RRB-
cord-023095-4dannjjm	3448	40	.	.	.
cord-023095-4dannjjm	3449	1	This	this	DT
cord-023095-4dannjjm	3449	2	study	study	NN
cord-023095-4dannjjm	3449	3	describes	describe	VBZ
cord-023095-4dannjjm	3449	4	and	and	CC
cord-023095-4dannjjm	3449	5	reports	report	VBZ
cord-023095-4dannjjm	3449	6	the	the	DT
cord-023095-4dannjjm	3449	7	appearance	appearance	NN
cord-023095-4dannjjm	3449	8	of	of	IN
cord-023095-4dannjjm	3449	9	intracellular	intracellular	JJ
cord-023095-4dannjjm	3449	10	morulae	morulae	NN
cord-023095-4dannjjm	3449	11	in	in	IN
cord-023095-4dannjjm	3449	12	feline	feline	JJ
cord-023095-4dannjjm	3449	13	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	3449	14	contributing	contribute	VBG
cord-023095-4dannjjm	3449	15	to	to	IN
cord-023095-4dannjjm	3449	16	the	the	DT
cord-023095-4dannjjm	3449	17	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3449	18	of	of	IN
cord-023095-4dannjjm	3449	19	A.	A.	NNP
cord-023095-4dannjjm	3449	20	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3449	21	.	.	.
cord-023095-4dannjjm	3450	1	The	the	DT
cord-023095-4dannjjm	3450	2	A.	a.	NN
cord-023095-4dannjjm	3450	3	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3450	4	real	real	JJ
cord-023095-4dannjjm	3450	5	-	-	HYPH
cord-023095-4dannjjm	3450	6	time	time	NN
cord-023095-4dannjjm	3450	7	PCR	PCR	NNP
cord-023095-4dannjjm	3450	8	(	(	-LRB-
cord-023095-4dannjjm	3450	9	RT	RT	NNP
cord-023095-4dannjjm	3450	10	PCR	PCR	NNP
cord-023095-4dannjjm	3450	11	)	)	-RRB-
cord-023095-4dannjjm	3450	12	assay	assay	NN
cord-023095-4dannjjm	3450	13	consists	consist	VBZ
cord-023095-4dannjjm	3450	14	of	of	IN
cord-023095-4dannjjm	3450	15	four	four	CD
cord-023095-4dannjjm	3450	16	multiplexed	multiplexed	JJ
cord-023095-4dannjjm	3450	17	primer	primer	NN
cord-023095-4dannjjm	3450	18	systems	system	NNS
cord-023095-4dannjjm	3450	19	designed	design	VBN
cord-023095-4dannjjm	3450	20	to	to	TO
cord-023095-4dannjjm	3450	21	detect	detect	VB
cord-023095-4dannjjm	3450	22	a	a	DT
cord-023095-4dannjjm	3450	23	total	total	NN
cord-023095-4dannjjm	3450	24	of	of	IN
cord-023095-4dannjjm	3450	25	three	three	CD
cord-023095-4dannjjm	3450	26	distinct	distinct	JJ
cord-023095-4dannjjm	3450	27	genes	gene	NNS
cord-023095-4dannjjm	3450	28	.	.	.
cord-023095-4dannjjm	3451	1	Amplicons	Amplicons	NNP
cord-023095-4dannjjm	3451	2	were	be	VBD
cord-023095-4dannjjm	3451	3	confirmed	confirm	VBN
cord-023095-4dannjjm	3451	4	as	as	IN
cord-023095-4dannjjm	3451	5	A.	a.	NN
cord-023095-4dannjjm	3451	6	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3451	7	by	by	IN
cord-023095-4dannjjm	3451	8	DNA	dna	NN
cord-023095-4dannjjm	3451	9	sequencing	sequencing	NN
cord-023095-4dannjjm	3451	10	.	.	.
cord-023095-4dannjjm	3452	1	Clinicopathologic	Clinicopathologic	NNP
cord-023095-4dannjjm	3452	2	data	datum	NNS
cord-023095-4dannjjm	3452	3	was	be	VBD
cord-023095-4dannjjm	3452	4	obtained	obtain	VBN
cord-023095-4dannjjm	3452	5	by	by	IN
cord-023095-4dannjjm	3452	6	review	review	NN
cord-023095-4dannjjm	3452	7	of	of	IN
cord-023095-4dannjjm	3452	8	medical	medical	JJ
cord-023095-4dannjjm	3452	9	records	record	NNS
cord-023095-4dannjjm	3452	10	and	and	CC
cord-023095-4dannjjm	3452	11	interview	interview	NN
cord-023095-4dannjjm	3452	12	of	of	IN
cord-023095-4dannjjm	3452	13	primary	primary	JJ
cord-023095-4dannjjm	3452	14	veterinarians	veterinarian	NNS
cord-023095-4dannjjm	3452	15	.	.	.
cord-023095-4dannjjm	3453	1	Complete	complete	JJ
cord-023095-4dannjjm	3453	2	blood	blood	NN
cord-023095-4dannjjm	3453	3	counts	count	NNS
cord-023095-4dannjjm	3453	4	were	be	VBD
cord-023095-4dannjjm	3453	5	available	available	JJ
cord-023095-4dannjjm	3453	6	from	from	IN
cord-023095-4dannjjm	3453	7	13/15	13/15	CD
cord-023095-4dannjjm	3453	8	cats	cat	NNS
cord-023095-4dannjjm	3453	9	and	and	CC
cord-023095-4dannjjm	3453	10	10/13	10/13	CD
cord-023095-4dannjjm	3453	11	blood	blood	NN
cord-023095-4dannjjm	3453	12	smears	smear	NNS
cord-023095-4dannjjm	3453	13	were	be	VBD
cord-023095-4dannjjm	3453	14	reviewed	review	VBN
cord-023095-4dannjjm	3453	15	.	.	.
cord-023095-4dannjjm	3454	1	The	the	DT
cord-023095-4dannjjm	3454	2	cats	cat	NNS
cord-023095-4dannjjm	3454	3	included	include	VBD
cord-023095-4dannjjm	3454	4	in	in	IN
cord-023095-4dannjjm	3454	5	this	this	DT
cord-023095-4dannjjm	3454	6	study	study	NN
cord-023095-4dannjjm	3454	7	were	be	VBD
cord-023095-4dannjjm	3454	8	all	all	DT
cord-023095-4dannjjm	3454	9	positive	positive	JJ
cord-023095-4dannjjm	3454	10	for	for	IN
cord-023095-4dannjjm	3454	11	A.	a.	NN
cord-023095-4dannjjm	3454	12	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3454	13	by	by	IN
cord-023095-4dannjjm	3454	14	real	real	JJ
cord-023095-4dannjjm	3454	15	-	-	HYPH
cord-023095-4dannjjm	3454	16	time	time	NN
cord-023095-4dannjjm	3454	17	PCR	PCR	NNP
cord-023095-4dannjjm	3454	18	.	.	.
cord-023095-4dannjjm	3455	1	The	the	DT
cord-023095-4dannjjm	3455	2	cats	cat	NNS
cord-023095-4dannjjm	3455	3	ranged	range	VBD
cord-023095-4dannjjm	3455	4	from	from	IN
cord-023095-4dannjjm	3455	5	4	4	CD
cord-023095-4dannjjm	3455	6	months	month	NNS
cord-023095-4dannjjm	3455	7	to	to	IN
cord-023095-4dannjjm	3455	8	13	13	CD
cord-023095-4dannjjm	3455	9	years	year	NNS
cord-023095-4dannjjm	3455	10	of	of	IN
cord-023095-4dannjjm	3455	11	age	age	NN
cord-023095-4dannjjm	3455	12	with	with	IN
cord-023095-4dannjjm	3455	13	an	an	DT
cord-023095-4dannjjm	3455	14	average	average	JJ
cord-023095-4dannjjm	3455	15	age	age	NN
cord-023095-4dannjjm	3455	16	of	of	IN
cord-023095-4dannjjm	3455	17	3.7	3.7	CD
cord-023095-4dannjjm	3455	18	years	year	NNS
cord-023095-4dannjjm	3455	19	.	.	.
cord-023095-4dannjjm	3456	1	Fifteen	fifteen	CD
cord-023095-4dannjjm	3456	2	of	of	IN
cord-023095-4dannjjm	3456	3	15	15	CD
cord-023095-4dannjjm	3456	4	cats	cat	NNS
cord-023095-4dannjjm	3456	5	had	have	VBD
cord-023095-4dannjjm	3456	6	a	a	DT
cord-023095-4dannjjm	3456	7	history	history	NN
cord-023095-4dannjjm	3456	8	of	of	IN
cord-023095-4dannjjm	3456	9	tick	tick	NN
cord-023095-4dannjjm	3456	10	exposure	exposure	NN
cord-023095-4dannjjm	3456	11	and	and	CC
cord-023095-4dannjjm	3456	12	lived	live	VBD
cord-023095-4dannjjm	3456	13	in	in	IN
cord-023095-4dannjjm	3456	14	the	the	DT
cord-023095-4dannjjm	3456	15	northeastern	northeastern	JJ
cord-023095-4dannjjm	3456	16	region	region	NN
cord-023095-4dannjjm	3456	17	of	of	IN
cord-023095-4dannjjm	3456	18	the	the	DT
cord-023095-4dannjjm	3456	19	US	US	NNP
cord-023095-4dannjjm	3456	20	,	,	,
cord-023095-4dannjjm	3456	21	an	an	DT
cord-023095-4dannjjm	3456	22	Ixodes	Ixodes	NNP
cord-023095-4dannjjm	3456	23	endemic	endemic	JJ
cord-023095-4dannjjm	3456	24	area	area	NN
cord-023095-4dannjjm	3456	25	.	.	.
cord-023095-4dannjjm	3457	1	All	all	DT
cord-023095-4dannjjm	3457	2	cats	cat	NNS
cord-023095-4dannjjm	3457	3	presented	present	VBN
cord-023095-4dannjjm	3457	4	with	with	IN
cord-023095-4dannjjm	3457	5	lethargy	lethargy	NN
cord-023095-4dannjjm	3457	6	,	,	,
cord-023095-4dannjjm	3457	7	13/15	13/15	CD
cord-023095-4dannjjm	3457	8	were	be	VBD
cord-023095-4dannjjm	3457	9	anorexic	anorexic	JJ
cord-023095-4dannjjm	3457	10	and	and	CC
cord-023095-4dannjjm	3457	11	14/15	14/15	CD
cord-023095-4dannjjm	3457	12	had	have	VBD
cord-023095-4dannjjm	3457	13	a	a	DT
cord-023095-4dannjjm	3457	14	fever	fever	NN
cord-023095-4dannjjm	3457	15	(	(	-LRB-
cord-023095-4dannjjm	3457	16	temperature	temperature	NN
cord-023095-4dannjjm	3457	17	4	4	CD
cord-023095-4dannjjm	3457	18	103	103	CD
cord-023095-4dannjjm	3457	19	o	o	NN
cord-023095-4dannjjm	3457	20	F	f	NN
cord-023095-4dannjjm	3457	21	)	)	-RRB-
cord-023095-4dannjjm	3457	22	.	.	.
cord-023095-4dannjjm	3458	1	Other	other	JJ
cord-023095-4dannjjm	3458	2	clinical	clinical	JJ
cord-023095-4dannjjm	3458	3	findings	finding	NNS
cord-023095-4dannjjm	3458	4	included	include	VBD
cord-023095-4dannjjm	3458	5	hepatomegaly	hepatomegaly	NNP
cord-023095-4dannjjm	3458	6	,	,	,
cord-023095-4dannjjm	3458	7	splenomegaly	splenomegaly	NN
cord-023095-4dannjjm	3458	8	,	,	,
cord-023095-4dannjjm	3458	9	ataxia	ataxia	NN
cord-023095-4dannjjm	3458	10	and	and	CC
cord-023095-4dannjjm	3458	11	ocular	ocular	JJ
cord-023095-4dannjjm	3458	12	changes	change	NNS
cord-023095-4dannjjm	3458	13	of	of	IN
cord-023095-4dannjjm	3458	14	conjunctivitis	conjunctivitis	NN
cord-023095-4dannjjm	3458	15	and	and	CC
cord-023095-4dannjjm	3458	16	elevation	elevation	NN
cord-023095-4dannjjm	3458	17	of	of	IN
cord-023095-4dannjjm	3458	18	the	the	DT
cord-023095-4dannjjm	3458	19	nictitating	nictitate	VBG
cord-023095-4dannjjm	3458	20	membrane	membrane	NN
cord-023095-4dannjjm	3458	21	.	.	.
cord-023095-4dannjjm	3459	1	Hematologic	Hematologic	NNP
cord-023095-4dannjjm	3459	2	findings	finding	NNS
cord-023095-4dannjjm	3459	3	included	include	VBD
cord-023095-4dannjjm	3459	4	leukopenia	leukopenia	NN
cord-023095-4dannjjm	3459	5	(	(	-LRB-
cord-023095-4dannjjm	3459	6	1/13	1/13	CD
cord-023095-4dannjjm	3459	7	)	)	-RRB-
cord-023095-4dannjjm	3459	8	,	,	,
cord-023095-4dannjjm	3459	9	neutropenia	neutropenia	FW
cord-023095-4dannjjm	3459	10	(	(	-LRB-
cord-023095-4dannjjm	3459	11	1/13	1/13	CD
cord-023095-4dannjjm	3459	12	)	)	-RRB-
cord-023095-4dannjjm	3459	13	and	and	CC
cord-023095-4dannjjm	3459	14	lymphopenia	lymphopenia	NNP
cord-023095-4dannjjm	3459	15	(	(	-LRB-
cord-023095-4dannjjm	3459	16	4/13	4/13	CD
cord-023095-4dannjjm	3459	17	)	)	-RRB-
cord-023095-4dannjjm	3459	18	.	.	.
cord-023095-4dannjjm	3460	1	Thrombocytopenia	Thrombocytopenia	NNP
cord-023095-4dannjjm	3460	2	was	be	VBD
cord-023095-4dannjjm	3460	3	not	not	RB
cord-023095-4dannjjm	3460	4	noted	note	VBN
cord-023095-4dannjjm	3460	5	in	in	IN
cord-023095-4dannjjm	3460	6	any	any	DT
cord-023095-4dannjjm	3460	7	case	case	NN
cord-023095-4dannjjm	3460	8	.	.	.
cord-023095-4dannjjm	3461	1	Morulae	Morulae	NNP
cord-023095-4dannjjm	3461	2	were	be	VBD
cord-023095-4dannjjm	3461	3	seen	see	VBN
cord-023095-4dannjjm	3461	4	within	within	IN
cord-023095-4dannjjm	3461	5	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	3461	6	in	in	IN
cord-023095-4dannjjm	3461	7	2/13	2/13	CD
cord-023095-4dannjjm	3461	8	cases	case	NNS
cord-023095-4dannjjm	3461	9	.	.	.
cord-023095-4dannjjm	3462	1	All	all	DT
cord-023095-4dannjjm	3462	2	cases	case	NNS
cord-023095-4dannjjm	3462	3	in	in	IN
cord-023095-4dannjjm	3462	4	this	this	DT
cord-023095-4dannjjm	3462	5	report	report	NN
cord-023095-4dannjjm	3462	6	responded	respond	VBD
cord-023095-4dannjjm	3462	7	to	to	IN
cord-023095-4dannjjm	3462	8	treatment	treatment	NN
cord-023095-4dannjjm	3462	9	with	with	IN
cord-023095-4dannjjm	3462	10	doxycycline	doxycycline	NNP
cord-023095-4dannjjm	3462	11	.	.	.
cord-023095-4dannjjm	3463	1	This	this	DT
cord-023095-4dannjjm	3463	2	is	be	VBZ
cord-023095-4dannjjm	3463	3	the	the	DT
cord-023095-4dannjjm	3463	4	first	first	JJ
cord-023095-4dannjjm	3463	5	report	report	NN
cord-023095-4dannjjm	3463	6	of	of	IN
cord-023095-4dannjjm	3463	7	the	the	DT
cord-023095-4dannjjm	3463	8	identification	identification	NN
cord-023095-4dannjjm	3463	9	of	of	IN
cord-023095-4dannjjm	3463	10	morulae	morulae	NNP
cord-023095-4dannjjm	3463	11	within	within	IN
cord-023095-4dannjjm	3463	12	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	3463	13	via	via	IN
cord-023095-4dannjjm	3463	14	peripheral	peripheral	JJ
cord-023095-4dannjjm	3463	15	blood	blood	NN
cord-023095-4dannjjm	3463	16	smear	smear	NN
cord-023095-4dannjjm	3463	17	review	review	NN
cord-023095-4dannjjm	3463	18	in	in	IN
cord-023095-4dannjjm	3463	19	cats	cat	NNS
cord-023095-4dannjjm	3463	20	confirmed	confirm	VBN
cord-023095-4dannjjm	3463	21	by	by	IN
cord-023095-4dannjjm	3463	22	RT	RT	NNP
cord-023095-4dannjjm	3463	23	PCR	PCR	NNP
cord-023095-4dannjjm	3463	24	to	to	TO
cord-023095-4dannjjm	3463	25	be	be	VB
cord-023095-4dannjjm	3463	26	infected	infect	VBN
cord-023095-4dannjjm	3463	27	with	with	IN
cord-023095-4dannjjm	3463	28	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3463	29	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3463	30	in	in	IN
cord-023095-4dannjjm	3463	31	North	North	NNP
cord-023095-4dannjjm	3463	32	America	America	NNP
cord-023095-4dannjjm	3463	33	.	.	.
cord-023095-4dannjjm	3464	1	Infection	infection	NN
cord-023095-4dannjjm	3464	2	with	with	IN
cord-023095-4dannjjm	3464	3	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3464	4	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3464	5	should	should	MD
cord-023095-4dannjjm	3464	6	be	be	VB
cord-023095-4dannjjm	3464	7	considered	consider	VBN
cord-023095-4dannjjm	3464	8	in	in	IN
cord-023095-4dannjjm	3464	9	a	a	DT
cord-023095-4dannjjm	3464	10	clinically	clinically	RB
cord-023095-4dannjjm	3464	11	ill	ill	JJ
cord-023095-4dannjjm	3464	12	cat	cat	NN
cord-023095-4dannjjm	3464	13	with	with	IN
cord-023095-4dannjjm	3464	14	tick	tick	NN
cord-023095-4dannjjm	3464	15	exposure	exposure	NN
cord-023095-4dannjjm	3464	16	,	,	,
cord-023095-4dannjjm	3464	17	living	live	VBG
cord-023095-4dannjjm	3464	18	in	in	IN
cord-023095-4dannjjm	3464	19	an	an	DT
cord-023095-4dannjjm	3464	20	Ixodes	Ixodes	NNP
cord-023095-4dannjjm	3464	21	endemic	endemic	JJ
cord-023095-4dannjjm	3464	22	area	area	NN
cord-023095-4dannjjm	3464	23	that	that	WDT
cord-023095-4dannjjm	3464	24	presents	present	VBZ
cord-023095-4dannjjm	3464	25	to	to	IN
cord-023095-4dannjjm	3464	26	a	a	DT
cord-023095-4dannjjm	3464	27	veterinarian	veterinarian	NN
cord-023095-4dannjjm	3464	28	for	for	IN
cord-023095-4dannjjm	3464	29	lethargy	lethargy	NN
cord-023095-4dannjjm	3464	30	,	,	,
cord-023095-4dannjjm	3464	31	anorexia	anorexia	NN
cord-023095-4dannjjm	3464	32	and	and	CC
cord-023095-4dannjjm	3464	33	fever	fever	NN
cord-023095-4dannjjm	3464	34	.	.	.
cord-023095-4dannjjm	3465	1	The	the	DT
cord-023095-4dannjjm	3465	2	spectrum	spectrum	NN
cord-023095-4dannjjm	3465	3	of	of	IN
cord-023095-4dannjjm	3465	4	disease	disease	NN
cord-023095-4dannjjm	3465	5	manifestations	manifestation	NNS
cord-023095-4dannjjm	3465	6	and	and	CC
cord-023095-4dannjjm	3465	7	the	the	DT
cord-023095-4dannjjm	3465	8	accompanying	accompany	VBG
cord-023095-4dannjjm	3465	9	clinicopathological	clinicopathological	NN
cord-023095-4dannjjm	3465	10	abnormalities	abnormality	NNS
cord-023095-4dannjjm	3465	11	indicative	indicative	JJ
cord-023095-4dannjjm	3465	12	of	of	IN
cord-023095-4dannjjm	3465	13	bartonellosis	bartonellosis	NN
cord-023095-4dannjjm	3465	14	in	in	IN
cord-023095-4dannjjm	3465	15	dogs	dog	NNS
cord-023095-4dannjjm	3465	16	have	have	VBP
cord-023095-4dannjjm	3465	17	not	not	RB
cord-023095-4dannjjm	3465	18	been	be	VBN
cord-023095-4dannjjm	3465	19	thoroughly	thoroughly	RB
cord-023095-4dannjjm	3465	20	characterized	characterize	VBN
cord-023095-4dannjjm	3465	21	.	.	.
cord-023095-4dannjjm	3466	1	The	the	DT
cord-023095-4dannjjm	3466	2	objective	objective	NN
cord-023095-4dannjjm	3466	3	of	of	IN
cord-023095-4dannjjm	3466	4	this	this	DT
cord-023095-4dannjjm	3466	5	unmatched	unmatched	JJ
cord-023095-4dannjjm	3466	6	case	case	NN
cord-023095-4dannjjm	3466	7	-	-	HYPH
cord-023095-4dannjjm	3466	8	control	control	NN
cord-023095-4dannjjm	3466	9	study	study	NN
cord-023095-4dannjjm	3466	10	was	be	VBD
cord-023095-4dannjjm	3466	11	to	to	TO
cord-023095-4dannjjm	3466	12	compare	compare	VB
cord-023095-4dannjjm	3466	13	signalment	signalment	JJ
cord-023095-4dannjjm	3466	14	,	,	,
cord-023095-4dannjjm	3466	15	clinical	clinical	JJ
cord-023095-4dannjjm	3466	16	and	and	CC
cord-023095-4dannjjm	3466	17	pathologic	pathologic	JJ
cord-023095-4dannjjm	3466	18	findings	finding	NNS
cord-023095-4dannjjm	3466	19	in	in	IN
cord-023095-4dannjjm	3466	20	clinically	clinically	RB
cord-023095-4dannjjm	3466	21	-	-	HYPH
cord-023095-4dannjjm	3466	22	ill	ill	JJ
cord-023095-4dannjjm	3466	23	dogs	dog	NNS
cord-023095-4dannjjm	3466	24	suspected	suspect	VBN
cord-023095-4dannjjm	3466	25	of	of	IN
cord-023095-4dannjjm	3466	26	a	a	DT
cord-023095-4dannjjm	3466	27	tick	tick	VB
cord-023095-4dannjjm	3466	28	-	-	HYPH
cord-023095-4dannjjm	3466	29	borne	bear	VBN
cord-023095-4dannjjm	3466	30	disease	disease	NN
cord-023095-4dannjjm	3466	31	that	that	WDT
cord-023095-4dannjjm	3466	32	were	be	VBD
cord-023095-4dannjjm	3466	33	negative	negative	JJ
cord-023095-4dannjjm	3466	34	for	for	IN
cord-023095-4dannjjm	3466	35	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3466	36	sp	sp	NN
cord-023095-4dannjjm	3466	37	.	.	.
cord-023095-4dannjjm	3467	1	DNA	DNA	NNP
cord-023095-4dannjjm	3467	2	(	(	-LRB-
cord-023095-4dannjjm	3467	3	controls	control	NNS
cord-023095-4dannjjm	3467	4	)	)	-RRB-
cord-023095-4dannjjm	3467	5	as	as	IN
cord-023095-4dannjjm	3467	6	were	be	VBD
cord-023095-4dannjjm	3467	7	the	the	DT
cord-023095-4dannjjm	3467	8	dogs	dog	NNS
cord-023095-4dannjjm	3467	9	diagnosed	diagnose	VBN
cord-023095-4dannjjm	3467	10	with	with	IN
cord-023095-4dannjjm	3467	11	bartonellosis	bartonellosis	NN
cord-023095-4dannjjm	3467	12	by	by	IN
cord-023095-4dannjjm	3467	13	PCR	PCR	NNP
cord-023095-4dannjjm	3467	14	amplification	amplification	NN
cord-023095-4dannjjm	3467	15	,	,	,
cord-023095-4dannjjm	3467	16	DNA	dna	NN
cord-023095-4dannjjm	3467	17	sequencing	sequencing	NN
cord-023095-4dannjjm	3467	18	and	and	CC
cord-023095-4dannjjm	3467	19	the	the	DT
cord-023095-4dannjjm	3467	20	BAPGM	BAPGM	NNP
cord-023095-4dannjjm	3467	21	(	(	-LRB-
cord-023095-4dannjjm	3467	22	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3467	23	alpha	alpha	NN
cord-023095-4dannjjm	3467	24	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	3467	25	growth	growth	NN
cord-023095-4dannjjm	3467	26	medium	medium	NN
cord-023095-4dannjjm	3467	27	)	)	-RRB-
cord-023095-4dannjjm	3467	28	enrichment	enrichment	NN
cord-023095-4dannjjm	3467	29	culture	culture	NN
cord-023095-4dannjjm	3467	30	approach	approach	NN
cord-023095-4dannjjm	3467	31	.	.	.
cord-023095-4dannjjm	3468	1	Both	both	DT
cord-023095-4dannjjm	3468	2	groups	group	NNS
cord-023095-4dannjjm	3468	3	were	be	VBD
cord-023095-4dannjjm	3468	4	tested	test	VBN
cord-023095-4dannjjm	3468	5	under	under	IN
cord-023095-4dannjjm	3468	6	the	the	DT
cord-023095-4dannjjm	3468	7	same	same	JJ
cord-023095-4dannjjm	3468	8	laboratory	laboratory	NN
cord-023095-4dannjjm	3468	9	conditions	condition	NNS
cord-023095-4dannjjm	3468	10	and	and	CC
cord-023095-4dannjjm	3468	11	in	in	IN
cord-023095-4dannjjm	3468	12	the	the	DT
cord-023095-4dannjjm	3468	13	same	same	JJ
cord-023095-4dannjjm	3468	14	time	time	NN
cord-023095-4dannjjm	3468	15	frame	frame	NN
cord-023095-4dannjjm	3468	16	.	.	.
cord-023095-4dannjjm	3469	1	Medical	medical	JJ
cord-023095-4dannjjm	3469	2	records	record	NNS
cord-023095-4dannjjm	3469	3	were	be	VBD
cord-023095-4dannjjm	3469	4	reviewed	review	VBN
cord-023095-4dannjjm	3469	5	for	for	IN
cord-023095-4dannjjm	3469	6	information	information	NN
cord-023095-4dannjjm	3469	7	regarding	regard	VBG
cord-023095-4dannjjm	3469	8	signalment	signalment	JJ
cord-023095-4dannjjm	3469	9	,	,	,
cord-023095-4dannjjm	3469	10	medical	medical	JJ
cord-023095-4dannjjm	3469	11	history	history	NN
cord-023095-4dannjjm	3469	12	,	,	,
cord-023095-4dannjjm	3469	13	physical	physical	JJ
cord-023095-4dannjjm	3469	14	examination	examination	NN
cord-023095-4dannjjm	3469	15	findings	finding	NNS
cord-023095-4dannjjm	3469	16	,	,	,
cord-023095-4dannjjm	3469	17	clinicopathological	clinicopathological	JJ
cord-023095-4dannjjm	3469	18	abnormalities	abnormality	NNS
cord-023095-4dannjjm	3469	19	,	,	,
cord-023095-4dannjjm	3469	20	microbiological	microbiological	JJ
cord-023095-4dannjjm	3469	21	data	datum	NNS
cord-023095-4dannjjm	3469	22	and	and	CC
cord-023095-4dannjjm	3469	23	treatment	treatment	NN
cord-023095-4dannjjm	3469	24	.	.	.
cord-023095-4dannjjm	3470	1	The	the	DT
cord-023095-4dannjjm	3470	2	study	study	NN
cord-023095-4dannjjm	3470	3	population	population	NN
cord-023095-4dannjjm	3470	4	consisted	consist	VBD
cord-023095-4dannjjm	3470	5	of	of	IN
cord-023095-4dannjjm	3470	6	47	47	CD
cord-023095-4dannjjm	3470	7	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3470	8	-	-	HYPH
cord-023095-4dannjjm	3470	9	infected	infect	VBN
cord-023095-4dannjjm	3470	10	dogs	dog	NNS
cord-023095-4dannjjm	3470	11	and	and	CC
cord-023095-4dannjjm	3470	12	93	93	CD
cord-023095-4dannjjm	3470	13	non	non	JJ
cord-023095-4dannjjm	3470	14	-	-	JJ
cord-023095-4dannjjm	3470	15	infected	infected	JJ
cord-023095-4dannjjm	3470	16	dogs	dog	NNS
cord-023095-4dannjjm	3470	17	.	.	.
cord-023095-4dannjjm	3471	1	Healthy	healthy	JJ
cord-023095-4dannjjm	3471	2	dogs	dog	NNS
cord-023095-4dannjjm	3471	3	with	with	IN
cord-023095-4dannjjm	3471	4	no	no	DT
cord-023095-4dannjjm	3471	5	historical	historical	JJ
cord-023095-4dannjjm	3471	6	illnesses	illness	NNS
cord-023095-4dannjjm	3471	7	,	,	,
cord-023095-4dannjjm	3471	8	such	such	JJ
cord-023095-4dannjjm	3471	9	as	as	IN
cord-023095-4dannjjm	3471	10	blood	blood	NN
cord-023095-4dannjjm	3471	11	donors	donor	NNS
cord-023095-4dannjjm	3471	12	,	,	,
cord-023095-4dannjjm	3471	13	were	be	VBD
cord-023095-4dannjjm	3471	14	excluded	exclude	VBN
cord-023095-4dannjjm	3471	15	.	.	.
cord-023095-4dannjjm	3472	1	The	the	DT
cord-023095-4dannjjm	3472	2	following	follow	VBG
cord-023095-4dannjjm	3472	3	species	specie	NNS
cord-023095-4dannjjm	3472	4	were	be	VBD
cord-023095-4dannjjm	3472	5	amplified	amplify	VBN
cord-023095-4dannjjm	3472	6	:	:	:
cord-023095-4dannjjm	3472	7	B.	B.	NNP
cord-023095-4dannjjm	3472	8	henselae	henselae	NNP
cord-023095-4dannjjm	3472	9	(	(	-LRB-
cord-023095-4dannjjm	3472	10	n	n	NN
cord-023095-4dannjjm	3472	11	5	5	CD
cord-023095-4dannjjm	3472	12	28	28	CD
cord-023095-4dannjjm	3472	13	,	,	,
cord-023095-4dannjjm	3472	14	59.6	59.6	CD
cord-023095-4dannjjm	3472	15	%	%	NN
cord-023095-4dannjjm	3472	16	)	)	-RRB-
cord-023095-4dannjjm	3472	17	,	,	,
cord-023095-4dannjjm	3472	18	B.	B.	NNP
cord-023095-4dannjjm	3472	19	vinsonii	vinsonii	NNP
cord-023095-4dannjjm	3472	20	subsp	subsp	NNP
cord-023095-4dannjjm	3472	21	.	.	.
cord-023095-4dannjjm	3473	1	berkhoffii	berkhoffii	NNP
cord-023095-4dannjjm	3473	2	(	(	-LRB-
cord-023095-4dannjjm	3473	3	n	n	NN
cord-023095-4dannjjm	3473	4	5	5	CD
cord-023095-4dannjjm	3473	5	20	20	CD
cord-023095-4dannjjm	3473	6	,	,	,
cord-023095-4dannjjm	3473	7	42.6	42.6	CD
cord-023095-4dannjjm	3473	8	%	%	NN
cord-023095-4dannjjm	3473	9	)	)	-RRB-
cord-023095-4dannjjm	3473	10	,	,	,
cord-023095-4dannjjm	3473	11	B.	B.	NNP
cord-023095-4dannjjm	3473	12	koehlerae	koehlerae	NNP
cord-023095-4dannjjm	3473	13	(	(	-LRB-
cord-023095-4dannjjm	3473	14	n	n	NN
cord-023095-4dannjjm	3473	15	5	5	CD
cord-023095-4dannjjm	3473	16	3	3	CD
cord-023095-4dannjjm	3473	17	,	,	,
cord-023095-4dannjjm	3473	18	6.4	6.4	CD
cord-023095-4dannjjm	3473	19	%	%	NN
cord-023095-4dannjjm	3473	20	)	)	-RRB-
cord-023095-4dannjjm	3473	21	,	,	,
cord-023095-4dannjjm	3473	22	B.	B.	NNP
cord-023095-4dannjjm	3473	23	volans	volans	NNP
cord-023095-4dannjjm	3473	24	-	-	HYPH
cord-023095-4dannjjm	3473	25	like	like	JJ
cord-023095-4dannjjm	3473	26	(	(	-LRB-
cord-023095-4dannjjm	3473	27	n	n	NN
cord-023095-4dannjjm	3473	28	5	5	CD
cord-023095-4dannjjm	3473	29	3	3	CD
cord-023095-4dannjjm	3473	30	,	,	,
cord-023095-4dannjjm	3473	31	6.4	6.4	CD
cord-023095-4dannjjm	3473	32	%	%	NN
cord-023095-4dannjjm	3473	33	)	)	-RRB-
cord-023095-4dannjjm	3473	34	,	,	,
cord-023095-4dannjjm	3473	35	B.	B.	NNP
cord-023095-4dannjjm	3473	36	bovis	bovis	NNP
cord-023095-4dannjjm	3473	37	(	(	-LRB-
cord-023095-4dannjjm	3473	38	n	n	NN
cord-023095-4dannjjm	3473	39	5	5	CD
cord-023095-4dannjjm	3473	40	1	1	CD
cord-023095-4dannjjm	3473	41	,	,	,
cord-023095-4dannjjm	3473	42	2.1	2.1	CD
cord-023095-4dannjjm	3473	43	%	%	NN
cord-023095-4dannjjm	3473	44	)	)	-RRB-
cord-023095-4dannjjm	3473	45	.	.	.
cord-023095-4dannjjm	3474	1	Nineteen	nineteen	CD
cord-023095-4dannjjm	3474	2	(	(	-LRB-
cord-023095-4dannjjm	3474	3	40.4	40.4	CD
cord-023095-4dannjjm	3474	4	%	%	NN
cord-023095-4dannjjm	3474	5	)	)	-RRB-
cord-023095-4dannjjm	3475	1	Bartonella	bartonella	NN
cord-023095-4dannjjm	3475	2	-	-	HYPH
cord-023095-4dannjjm	3475	3	infected	infect	VBN
cord-023095-4dannjjm	3475	4	dogs	dog	NNS
cord-023095-4dannjjm	3475	5	were	be	VBD
cord-023095-4dannjjm	3475	6	febrile	febrile	JJ
cord-023095-4dannjjm	3475	7	and	and	CC
cord-023095-4dannjjm	3475	8	lethargic	lethargic	JJ
cord-023095-4dannjjm	3475	9	and	and	CC
cord-023095-4dannjjm	3475	10	ten	ten	JJ
cord-023095-4dannjjm	3475	11	(	(	-LRB-
cord-023095-4dannjjm	3475	12	21.3	21.3	CD
cord-023095-4dannjjm	3475	13	%	%	NN
cord-023095-4dannjjm	3475	14	)	)	-RRB-
cord-023095-4dannjjm	3475	15	had	have	VBD
cord-023095-4dannjjm	3475	16	neurological	neurological	JJ
cord-023095-4dannjjm	3475	17	signs	sign	NNS
cord-023095-4dannjjm	3475	18	.	.	.
cord-023095-4dannjjm	3476	1	Laboratory	laboratory	NN
cord-023095-4dannjjm	3476	2	abnormalities	abnormality	NNS
cord-023095-4dannjjm	3476	3	for	for	IN
cord-023095-4dannjjm	3476	4	both	both	DT
cord-023095-4dannjjm	3476	5	groups	group	NNS
cord-023095-4dannjjm	3476	6	are	be	VBP
cord-023095-4dannjjm	3476	7	summarized	summarize	VBN
cord-023095-4dannjjm	3476	8	below	below	IN
cord-023095-4dannjjm	3476	9	(	(	-LRB-
cord-023095-4dannjjm	3476	10	number	number	NN
cord-023095-4dannjjm	3476	11	of	of	IN
cord-023095-4dannjjm	3476	12	affected	affect	VBN
cord-023095-4dannjjm	3476	13	dogs	dog	NNS
cord-023095-4dannjjm	3476	14	provided	provide	VBN
cord-023095-4dannjjm	3476	15	in	in	IN
cord-023095-4dannjjm	3476	16	parenthesis	parenthesis	NN
cord-023095-4dannjjm	3476	17	)	)	-RRB-
cord-023095-4dannjjm	3476	18	:	:	:
cord-023095-4dannjjm	3476	19	Multivariate	multivariate	JJ
cord-023095-4dannjjm	3476	20	logistic	logistic	JJ
cord-023095-4dannjjm	3476	21	regression	regression	NN
cord-023095-4dannjjm	3476	22	using	use	VBG
cord-023095-4dannjjm	3476	23	confounding	confounding	JJ
cord-023095-4dannjjm	3476	24	factors	factor	NNS
cord-023095-4dannjjm	3476	25	was	be	VBD
cord-023095-4dannjjm	3476	26	performed	perform	VBN
cord-023095-4dannjjm	3476	27	to	to	TO
cord-023095-4dannjjm	3476	28	establish	establish	VB
cord-023095-4dannjjm	3476	29	potential	potential	JJ
cord-023095-4dannjjm	3476	30	associations	association	NNS
cord-023095-4dannjjm	3476	31	between	between	IN
cord-023095-4dannjjm	3476	32	specific	specific	JJ
cord-023095-4dannjjm	3476	33	variables	variable	NNS
cord-023095-4dannjjm	3476	34	and	and	CC
cord-023095-4dannjjm	3476	35	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3476	36	sp	sp	NN
cord-023095-4dannjjm	3476	37	.	.	.
cord-023095-4dannjjm	3476	38	infection	infection	NN
cord-023095-4dannjjm	3476	39	.	.	.
cord-023095-4dannjjm	3477	1	There	there	EX
cord-023095-4dannjjm	3477	2	were	be	VBD
cord-023095-4dannjjm	3477	3	no	no	DT
cord-023095-4dannjjm	3477	4	differences	difference	NNS
cord-023095-4dannjjm	3477	5	in	in	IN
cord-023095-4dannjjm	3477	6	signalment	signalment	JJ
cord-023095-4dannjjm	3477	7	,	,	,
cord-023095-4dannjjm	3477	8	age	age	NN
cord-023095-4dannjjm	3477	9	,	,	,
cord-023095-4dannjjm	3477	10	sex	sex	NN
cord-023095-4dannjjm	3477	11	,	,	,
cord-023095-4dannjjm	3477	12	body	body	NN
cord-023095-4dannjjm	3477	13	weight	weight	NN
cord-023095-4dannjjm	3477	14	and	and	CC
cord-023095-4dannjjm	3477	15	duration	duration	NN
cord-023095-4dannjjm	3477	16	of	of	IN
cord-023095-4dannjjm	3477	17	clinical	clinical	JJ
cord-023095-4dannjjm	3477	18	signs	sign	NNS
cord-023095-4dannjjm	3477	19	between	between	IN
cord-023095-4dannjjm	3477	20	the	the	DT
cord-023095-4dannjjm	3477	21	two	two	CD
cord-023095-4dannjjm	3477	22	groups	group	NNS
cord-023095-4dannjjm	3477	23	.	.	.
cord-023095-4dannjjm	3478	1	Compared	compare	VBN
cord-023095-4dannjjm	3478	2	to	to	IN
cord-023095-4dannjjm	3478	3	the	the	DT
cord-023095-4dannjjm	3478	4	control	control	NN
cord-023095-4dannjjm	3478	5	population	population	NN
cord-023095-4dannjjm	3478	6	,	,	,
cord-023095-4dannjjm	3478	7	infection	infection	NN
cord-023095-4dannjjm	3478	8	with	with	IN
cord-023095-4dannjjm	3478	9	the	the	DT
cord-023095-4dannjjm	3478	10	genus	genus	NN
cord-023095-4dannjjm	3478	11	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3478	12	was	be	VBD
cord-023095-4dannjjm	3478	13	associated	associate	VBN
cord-023095-4dannjjm	3478	14	with	with	IN
cord-023095-4dannjjm	3478	15	a	a	DT
cord-023095-4dannjjm	3478	16	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3478	17	of	of	IN
cord-023095-4dannjjm	3478	18	endocarditis	endocarditis	NN
cord-023095-4dannjjm	3478	19	(	(	-LRB-
cord-023095-4dannjjm	3478	20	P	p	NN
cord-023095-4dannjjm	3478	21	5	5	CD
cord-023095-4dannjjm	3478	22	0.0196	0.0196	CD
cord-023095-4dannjjm	3478	23	,	,	,
cord-023095-4dannjjm	3478	24	OR	or	CC
cord-023095-4dannjjm	3478	25	5	5	CD
cord-023095-4dannjjm	3478	26	7.95	7.95	CD
cord-023095-4dannjjm	3478	27	,	,	,
cord-023095-4dannjjm	3478	28	95%CI	95%ci	CD
cord-023095-4dannjjm	3478	29	5	5	CD
cord-023095-4dannjjm	3478	30	1.39	1.39	CD
cord-023095-4dannjjm	3478	31	-	-	HYPH
cord-023095-4dannjjm	3478	32	51.11	51.11	CD
cord-023095-4dannjjm	3478	33	)	)	-RRB-
cord-023095-4dannjjm	3478	34	and	and	CC
cord-023095-4dannjjm	3478	35	hypoglobulinemia	hypoglobulinemia	NNP
cord-023095-4dannjjm	3478	36	(	(	-LRB-
cord-023095-4dannjjm	3478	37	P	p	NN
cord-023095-4dannjjm	3478	38	5	5	CD
cord-023095-4dannjjm	3478	39	0.0057	0.0057	CD
cord-023095-4dannjjm	3478	40	,	,	,
cord-023095-4dannjjm	3478	41	OR	or	CC
cord-023095-4dannjjm	3478	42	5	5	CD
cord-023095-4dannjjm	3478	43	5.30	5.30	CD
cord-023095-4dannjjm	3479	1	,	,	,
cord-023095-4dannjjm	3479	2	95	95	CD
cord-023095-4dannjjm	3479	3	%	%	NN
cord-023095-4dannjjm	3479	4	CI	CI	NNP
cord-023095-4dannjjm	3479	5	5	5	CD
cord-023095-4dannjjm	3479	6	1.62	1.62	CD
cord-023095-4dannjjm	3479	7	-	-	HYPH
cord-023095-4dannjjm	3479	8	18.55	18.55	CD
cord-023095-4dannjjm	3479	9	)	)	-RRB-
cord-023095-4dannjjm	3479	10	.	.	.
cord-023095-4dannjjm	3480	1	Controls	control	NNS
cord-023095-4dannjjm	3480	2	were	be	VBD
cord-023095-4dannjjm	3480	3	more	more	RBR
cord-023095-4dannjjm	3480	4	likely	likely	JJ
cord-023095-4dannjjm	3480	5	to	to	TO
cord-023095-4dannjjm	3480	6	have	have	VB
cord-023095-4dannjjm	3480	7	joint	joint	JJ
cord-023095-4dannjjm	3480	8	effusion	effusion	NN
cord-023095-4dannjjm	3480	9	(	(	-LRB-
cord-023095-4dannjjm	3480	10	P	p	NN
cord-023095-4dannjjm	3480	11	5	5	CD
cord-023095-4dannjjm	3480	12	0.0059	0.0059	CD
cord-023095-4dannjjm	3480	13	,	,	,
cord-023095-4dannjjm	3480	14	OR	or	CC
cord-023095-4dannjjm	3480	15	5	5	CD
cord-023095-4dannjjm	3480	16	5.89	5.89	CD
cord-023095-4dannjjm	3480	17	,	,	,
cord-023095-4dannjjm	3480	18	95	95	CD
cord-023095-4dannjjm	3480	19	%	%	NN
cord-023095-4dannjjm	3480	20	CI	CI	NNP
cord-023095-4dannjjm	3480	21	5	5	CD
cord-023095-4dannjjm	3480	22	1.62	1.62	CD
cord-023095-4dannjjm	3480	23	-	-	HYPH
cord-023095-4dannjjm	3480	24	27.22	27.22	CD
cord-023095-4dannjjm	3480	25	)	)	-RRB-
cord-023095-4dannjjm	3480	26	and	and	CC
cord-023095-4dannjjm	3480	27	azotemia	azotemia	NNP
cord-023095-4dannjjm	3480	28	(	(	-LRB-
cord-023095-4dannjjm	3480	29	P	p	NN
cord-023095-4dannjjm	3480	30	5	5	CD
cord-023095-4dannjjm	3480	31	0.0353	0.0353	CD
cord-023095-4dannjjm	3480	32	,	,	,
cord-023095-4dannjjm	3480	33	OR	or	CC
cord-023095-4dannjjm	3481	1	5	5	CD
cord-023095-4dannjjm	3481	2	2.93	2.93	CD
cord-023095-4dannjjm	3481	3	,	,	,
cord-023095-4dannjjm	3482	1	95%CI	95%ci	CD
cord-023095-4dannjjm	3482	2	5	5	CD
cord-023095-4dannjjm	3482	3	1.07	1.07	CD
cord-023095-4dannjjm	3482	4	-	-	HYPH
cord-023095-4dannjjm	3482	5	8.86	8.86	CD
cord-023095-4dannjjm	3482	6	)	)	-RRB-
cord-023095-4dannjjm	3482	7	than	than	IN
cord-023095-4dannjjm	3482	8	were	be	VBD
cord-023095-4dannjjm	3482	9	the	the	DT
cord-023095-4dannjjm	3482	10	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3482	11	sp	sp	NN
cord-023095-4dannjjm	3482	12	.	.	.
cord-023095-4dannjjm	3483	1	infected	infected	JJ
cord-023095-4dannjjm	3483	2	dogs	dog	NNS
cord-023095-4dannjjm	3483	3	.	.	.
cord-023095-4dannjjm	3484	1	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3484	2	was	be	VBD
cord-023095-4dannjjm	3484	3	detected	detect	VBN
cord-023095-4dannjjm	3484	4	in	in	IN
cord-023095-4dannjjm	3484	5	dogs	dog	NNS
cord-023095-4dannjjm	3484	6	with	with	IN
cord-023095-4dannjjm	3484	7	signs	sign	NNS
cord-023095-4dannjjm	3484	8	such	such	JJ
cord-023095-4dannjjm	3484	9	as	as	IN
cord-023095-4dannjjm	3484	10	fever	fever	NN
cord-023095-4dannjjm	3484	11	,	,	,
cord-023095-4dannjjm	3484	12	anemia	anemia	NN
cord-023095-4dannjjm	3484	13	,	,	,
cord-023095-4dannjjm	3484	14	thrombocytopenia	thrombocytopenia	NN
cord-023095-4dannjjm	3484	15	,	,	,
cord-023095-4dannjjm	3484	16	hyperglobulinemia	hyperglobulinemia	NN
cord-023095-4dannjjm	3484	17	and	and	CC
cord-023095-4dannjjm	3484	18	proteinuria	proteinuria	NN
cord-023095-4dannjjm	3484	19	that	that	WDT
cord-023095-4dannjjm	3484	20	are	be	VBP
cord-023095-4dannjjm	3484	21	typically	typically	RB
cord-023095-4dannjjm	3484	22	associated	associate	VBN
cord-023095-4dannjjm	3484	23	with	with	IN
cord-023095-4dannjjm	3484	24	tick	tick	NN
cord-023095-4dannjjm	3484	25	-	-	HYPH
cord-023095-4dannjjm	3484	26	borne	bear	VBN
cord-023095-4dannjjm	3484	27	diseases	disease	NNS
cord-023095-4dannjjm	3484	28	.	.	.
cord-023095-4dannjjm	3485	1	When	when	WRB
cord-023095-4dannjjm	3485	2	endocarditis	endocarditis	NN
cord-023095-4dannjjm	3485	3	or	or	CC
cord-023095-4dannjjm	3485	4	hypoglobulinemia	hypoglobulinemia	NN
cord-023095-4dannjjm	3485	5	are	be	VBP
cord-023095-4dannjjm	3485	6	detected	detect	VBN
cord-023095-4dannjjm	3485	7	,	,	,
cord-023095-4dannjjm	3485	8	testing	test	VBG
cord-023095-4dannjjm	3485	9	for	for	IN
cord-023095-4dannjjm	3485	10	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3485	11	should	should	MD
cord-023095-4dannjjm	3485	12	be	be	VB
cord-023095-4dannjjm	3485	13	prioritized	prioritize	VBN
cord-023095-4dannjjm	3485	14	.	.	.
cord-023095-4dannjjm	3486	1	Likewise	likewise	RB
cord-023095-4dannjjm	3486	2	,	,	,
cord-023095-4dannjjm	3486	3	the	the	DT
cord-023095-4dannjjm	3486	4	detection	detection	NN
cord-023095-4dannjjm	3486	5	of	of	IN
cord-023095-4dannjjm	3486	6	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3486	7	should	should	MD
cord-023095-4dannjjm	3486	8	prompt	prompt	VB
cord-023095-4dannjjm	3486	9	further	further	JJ
cord-023095-4dannjjm	3486	10	testing	testing	NN
cord-023095-4dannjjm	3486	11	for	for	IN
cord-023095-4dannjjm	3486	12	endocarditis	endocarditis	NN
cord-023095-4dannjjm	3486	13	,	,	,
cord-023095-4dannjjm	3486	14	if	if	IN
cord-023095-4dannjjm	3486	15	not	not	RB
cord-023095-4dannjjm	3486	16	already	already	RB
cord-023095-4dannjjm	3486	17	investigated	investigate	VBN
cord-023095-4dannjjm	3486	18	.	.	.
cord-023095-4dannjjm	3486	19	 	 	_SP
cord-023095-4dannjjm	3487	1	Surveillance	surveillance	NN
cord-023095-4dannjjm	3487	2	studies	study	NNS
cord-023095-4dannjjm	3487	3	in	in	IN
cord-023095-4dannjjm	3487	4	other	other	JJ
cord-023095-4dannjjm	3487	5	species	specie	NNS
cord-023095-4dannjjm	3487	6	depend	depend	VBP
cord-023095-4dannjjm	3487	7	on	on	IN
cord-023095-4dannjjm	3487	8	detection	detection	NN
cord-023095-4dannjjm	3487	9	of	of	IN
cord-023095-4dannjjm	3487	10	antibodies	antibody	NNS
cord-023095-4dannjjm	3487	11	to	to	IN
cord-023095-4dannjjm	3487	12	the	the	DT
cord-023095-4dannjjm	3487	13	highly	highly	RB
cord-023095-4dannjjm	3487	14	conserved	conserve	VBN
cord-023095-4dannjjm	3487	15	influenza	influenza	NN
cord-023095-4dannjjm	3487	16	A	a	DT
cord-023095-4dannjjm	3487	17	nucleoprotein	nucleoprotein	JJ
cord-023095-4dannjjm	3487	18	(	(	-LRB-
cord-023095-4dannjjm	3487	19	NP	NP	NNP
cord-023095-4dannjjm	3487	20	)	)	-RRB-
cord-023095-4dannjjm	3487	21	;	;	:
cord-023095-4dannjjm	3487	22	however	however	RB
cord-023095-4dannjjm	3487	23	,	,	,
cord-023095-4dannjjm	3487	24	no	no	DT
cord-023095-4dannjjm	3487	25	such	such	JJ
cord-023095-4dannjjm	3487	26	antibody	antibody	NN
cord-023095-4dannjjm	3487	27	detection	detection	NN
cord-023095-4dannjjm	3487	28	assay	assay	NN
cord-023095-4dannjjm	3487	29	is	be	VBZ
cord-023095-4dannjjm	3487	30	approved	approve	VBN
cord-023095-4dannjjm	3487	31	for	for	IN
cord-023095-4dannjjm	3487	32	canine	canine	JJ
cord-023095-4dannjjm	3487	33	use	use	NN
cord-023095-4dannjjm	3487	34	in	in	IN
cord-023095-4dannjjm	3487	35	the	the	DT
cord-023095-4dannjjm	3487	36	U.S.	U.S.	NNP
cord-023095-4dannjjm	3488	1	The	the	DT
cord-023095-4dannjjm	3488	2	purpose	purpose	NN
cord-023095-4dannjjm	3488	3	of	of	IN
cord-023095-4dannjjm	3488	4	this	this	DT
cord-023095-4dannjjm	3488	5	study	study	NN
cord-023095-4dannjjm	3488	6	was	be	VBD
cord-023095-4dannjjm	3488	7	to	to	TO
cord-023095-4dannjjm	3488	8	determine	determine	VB
cord-023095-4dannjjm	3488	9	the	the	DT
cord-023095-4dannjjm	3488	10	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3488	11	accuracy	accuracy	NN
cord-023095-4dannjjm	3488	12	of	of	IN
cord-023095-4dannjjm	3488	13	a	a	DT
cord-023095-4dannjjm	3488	14	commercial	commercial	JJ
cord-023095-4dannjjm	3488	15	blocking	block	VBG
cord-023095-4dannjjm	3488	16	ELISA	ELISA	NNP
cord-023095-4dannjjm	3488	17	used	use	VBN
cord-023095-4dannjjm	3488	18	for	for	IN
cord-023095-4dannjjm	3488	19	avian	avian	JJ
cord-023095-4dannjjm	3488	20	species	specie	NNS
cord-023095-4dannjjm	3488	21	in	in	IN
cord-023095-4dannjjm	3488	22	detecting	detect	VBG
cord-023095-4dannjjm	3488	23	influenza	influenza	NN
cord-023095-4dannjjm	3488	24	A	a	DT
cord-023095-4dannjjm	3488	25	NP	NP	NNP
cord-023095-4dannjjm	3488	26	antibody	antibody	NN
cord-023095-4dannjjm	3488	27	in	in	IN
cord-023095-4dannjjm	3488	28	dogs	dog	NNS
cord-023095-4dannjjm	3488	29	.	.	.
cord-023095-4dannjjm	3489	1	Since	since	IN
cord-023095-4dannjjm	3489	2	the	the	DT
cord-023095-4dannjjm	3489	3	blocking	block	VBG
cord-023095-4dannjjm	3489	4	ELISA	ELISA	NNP
cord-023095-4dannjjm	3489	5	is	be	VBZ
cord-023095-4dannjjm	3489	6	not	not	RB
cord-023095-4dannjjm	3489	7	a	a	DT
cord-023095-4dannjjm	3489	8	species	species	NN
cord-023095-4dannjjm	3489	9	-	-	HYPH
cord-023095-4dannjjm	3489	10	specific	specific	JJ
cord-023095-4dannjjm	3489	11	or	or	CC
cord-023095-4dannjjm	3489	12	viral	viral	JJ
cord-023095-4dannjjm	3489	13	subtype	subtype	NN
cord-023095-4dannjjm	3489	14	-	-	HYPH
cord-023095-4dannjjm	3489	15	specific	specific	JJ
cord-023095-4dannjjm	3489	16	format	format	NN
cord-023095-4dannjjm	3489	17	,	,	,
cord-023095-4dannjjm	3489	18	we	-PRON-	PRP
cord-023095-4dannjjm	3489	19	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	3489	20	that	that	IN
cord-023095-4dannjjm	3489	21	it	-PRON-	PRP
cord-023095-4dannjjm	3489	22	would	would	MD
cord-023095-4dannjjm	3489	23	detect	detect	VB
cord-023095-4dannjjm	3489	24	NP	NP	NNP
cord-023095-4dannjjm	3489	25	antibodies	antibody	NNS
cord-023095-4dannjjm	3489	26	in	in	IN
cord-023095-4dannjjm	3489	27	dogs	dog	NNS
cord-023095-4dannjjm	3489	28	infected	infect	VBN
cord-023095-4dannjjm	3489	29	by	by	IN
cord-023095-4dannjjm	3489	30	influenza	influenza	NN
cord-023095-4dannjjm	3489	31	A	a	DT
cord-023095-4dannjjm	3489	32	virus	virus	NN
cord-023095-4dannjjm	3489	33	.	.	.
cord-023095-4dannjjm	3490	1	Serum	serum	NN
cord-023095-4dannjjm	3490	2	samples	sample	NNS
cord-023095-4dannjjm	3490	3	from	from	IN
cord-023095-4dannjjm	3490	4	uninfected	uninfected	JJ
cord-023095-4dannjjm	3490	5	dogs	dog	NNS
cord-023095-4dannjjm	3490	6	(	(	-LRB-
cord-023095-4dannjjm	3490	7	n	n	NN
cord-023095-4dannjjm	3490	8	5	5	CD
cord-023095-4dannjjm	3490	9	204	204	CD
cord-023095-4dannjjm	3490	10	)	)	-RRB-
cord-023095-4dannjjm	3490	11	and	and	CC
cord-023095-4dannjjm	3490	12	dogs	dog	NNS
cord-023095-4dannjjm	3490	13	naturally	naturally	RB
cord-023095-4dannjjm	3490	14	infected	infect	VBN
cord-023095-4dannjjm	3490	15	with	with	IN
cord-023095-4dannjjm	3490	16	canine	canine	JJ
cord-023095-4dannjjm	3490	17	influenza	influenza	NN
cord-023095-4dannjjm	3490	18	H3N8	H3N8	NNP
cord-023095-4dannjjm	3490	19	(	(	-LRB-
cord-023095-4dannjjm	3490	20	n	n	NN
cord-023095-4dannjjm	3490	21	5	5	CD
cord-023095-4dannjjm	3490	22	150	150	CD
cord-023095-4dannjjm	3490	23	)	)	-RRB-
cord-023095-4dannjjm	3490	24	were	be	VBD
cord-023095-4dannjjm	3490	25	tested	test	VBN
cord-023095-4dannjjm	3490	26	using	use	VBG
cord-023095-4dannjjm	3490	27	the	the	DT
cord-023095-4dannjjm	3490	28	IDEXX	IDEXX	NNP
cord-023095-4dannjjm	3490	29	FlockChek	FlockChek	NNP
cord-023095-4dannjjm	3490	30	blocking	block	VBG
cord-023095-4dannjjm	3490	31	ELISA	ELISA	NNP
cord-023095-4dannjjm	3490	32	for	for	IN
cord-023095-4dannjjm	3490	33	influenza	influenza	NN
cord-023095-4dannjjm	3490	34	A	a	DT
cord-023095-4dannjjm	3490	35	NP	NP	NNP
cord-023095-4dannjjm	3490	36	antibody	antibody	NN
cord-023095-4dannjjm	3490	37	according	accord	VBG
cord-023095-4dannjjm	3490	38	to	to	IN
cord-023095-4dannjjm	3490	39	manufacturer	manufacturer	NN
cord-023095-4dannjjm	3490	40	instructions	instruction	NNS
cord-023095-4dannjjm	3490	41	.	.	.
cord-023095-4dannjjm	3491	1	The	the	DT
cord-023095-4dannjjm	3491	2	sample	sample	NN
cord-023095-4dannjjm	3491	3	/	/	SYM
cord-023095-4dannjjm	3491	4	negative	negative	JJ
cord-023095-4dannjjm	3491	5	control	control	NN
cord-023095-4dannjjm	3491	6	(	(	-LRB-
cord-023095-4dannjjm	3491	7	S	S	NNP
cord-023095-4dannjjm	3491	8	/	/	SYM
cord-023095-4dannjjm	3491	9	N	N	NNP
cord-023095-4dannjjm	3491	10	)	)	-RRB-
cord-023095-4dannjjm	3491	11	absorbance	absorbance	NN
cord-023095-4dannjjm	3491	12	ratios	ratio	NNS
cord-023095-4dannjjm	3491	13	for	for	IN
cord-023095-4dannjjm	3491	14	infected	infected	JJ
cord-023095-4dannjjm	3491	15	dogs	dog	NNS
cord-023095-4dannjjm	3491	16	ranged	range	VBD
cord-023095-4dannjjm	3491	17	from	from	IN
cord-023095-4dannjjm	3491	18	0.12	0.12	CD
cord-023095-4dannjjm	3491	19	to	to	IN
cord-023095-4dannjjm	3491	20	0.67	0.67	CD
cord-023095-4dannjjm	3491	21	compared	compare	VBN
cord-023095-4dannjjm	3491	22	to	to	IN
cord-023095-4dannjjm	3491	23	0.53	0.53	CD
cord-023095-4dannjjm	3491	24	to	to	IN
cord-023095-4dannjjm	3491	25	1.40	1.40	CD
cord-023095-4dannjjm	3491	26	for	for	IN
cord-023095-4dannjjm	3491	27	uninfected	uninfected	JJ
cord-023095-4dannjjm	3491	28	dogs	dog	NNS
cord-023095-4dannjjm	3491	29	.	.	.
cord-023095-4dannjjm	3492	1	A	a	DT
cord-023095-4dannjjm	3492	2	receiver	receiver	NN
cord-023095-4dannjjm	3492	3	operating	operating	NN
cord-023095-4dannjjm	3492	4	characteristic	characteristic	NN
cord-023095-4dannjjm	3492	5	(	(	-LRB-
cord-023095-4dannjjm	3492	6	ROC	ROC	NNP
cord-023095-4dannjjm	3492	7	)	)	-RRB-
cord-023095-4dannjjm	3492	8	curve	curve	NN
cord-023095-4dannjjm	3492	9	analysis	analysis	NN
cord-023095-4dannjjm	3492	10	determined	determine	VBD
cord-023095-4dannjjm	3492	11	optimum	optimum	JJ
cord-023095-4dannjjm	3492	12	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3492	13	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3492	14	(	(	-LRB-
cord-023095-4dannjjm	3492	15	99.3	99.3	CD
cord-023095-4dannjjm	3492	16	%	%	NN
cord-023095-4dannjjm	3492	17	)	)	-RRB-
cord-023095-4dannjjm	3492	18	and	and	CC
cord-023095-4dannjjm	3492	19	specificity	specificity	NN
cord-023095-4dannjjm	3492	20	(	(	-LRB-
cord-023095-4dannjjm	3492	21	99.0	99.0	CD
cord-023095-4dannjjm	3492	22	%	%	NN
cord-023095-4dannjjm	3492	23	)	)	-RRB-
cord-023095-4dannjjm	3492	24	at	at	IN
cord-023095-4dannjjm	3492	25	a	a	DT
cord-023095-4dannjjm	3492	26	S	S	NNP
cord-023095-4dannjjm	3492	27	/	/	SYM
cord-023095-4dannjjm	3492	28	N	n	CD
cord-023095-4dannjjm	3492	29	cutoff	cutoff	NN
cord-023095-4dannjjm	3492	30	ratio	ratio	NN
cord-023095-4dannjjm	3492	31	of	of	IN
cord-023095-4dannjjm	3492	32	0.647	0.647	CD
cord-023095-4dannjjm	3492	33	.	.	.
cord-023095-4dannjjm	3493	1	Using	use	VBG
cord-023095-4dannjjm	3493	2	this	this	DT
cord-023095-4dannjjm	3493	3	cutoff	cutoff	NN
cord-023095-4dannjjm	3493	4	ratio	ratio	NN
cord-023095-4dannjjm	3493	5	,	,	,
cord-023095-4dannjjm	3493	6	the	the	DT
cord-023095-4dannjjm	3493	7	overall	overall	JJ
cord-023095-4dannjjm	3493	8	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3493	9	accuracy	accuracy	NN
cord-023095-4dannjjm	3493	10	was	be	VBD
cord-023095-4dannjjm	3493	11	99.2	99.2	CD
cord-023095-4dannjjm	3493	12	%	%	NN
cord-023095-4dannjjm	3493	13	.	.	.
cord-023095-4dannjjm	3494	1	Coefficients	coefficient	NNS
cord-023095-4dannjjm	3494	2	of	of	IN
cord-023095-4dannjjm	3494	3	variation	variation	NN
cord-023095-4dannjjm	3494	4	for	for	IN
cord-023095-4dannjjm	3494	5	intra	intra	JJ
cord-023095-4dannjjm	3494	6	-	-	JJ
cord-023095-4dannjjm	3494	7	assay	assay	JJ
cord-023095-4dannjjm	3494	8	(	(	-LRB-
cord-023095-4dannjjm	3494	9	4.7	4.7	CD
cord-023095-4dannjjm	3494	10	%	%	NN
cord-023095-4dannjjm	3494	11	)	)	-RRB-
cord-023095-4dannjjm	3494	12	and	and	CC
cord-023095-4dannjjm	3494	13	inter	inter	JJ
cord-023095-4dannjjm	3494	14	-	-	NN
cord-023095-4dannjjm	3494	15	assay	assay	NN
cord-023095-4dannjjm	3494	16	(	(	-LRB-
cord-023095-4dannjjm	3494	17	6.1	6.1	CD
cord-023095-4dannjjm	3494	18	%	%	NN
cord-023095-4dannjjm	3494	19	)	)	-RRB-
cord-023095-4dannjjm	3494	20	testing	testing	NN
cord-023095-4dannjjm	3494	21	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	3494	22	good	good	JJ
cord-023095-4dannjjm	3494	23	repeatability	repeatability	NN
cord-023095-4dannjjm	3494	24	with	with	IN
cord-023095-4dannjjm	3494	25	canine	canine	JJ
cord-023095-4dannjjm	3494	26	sera	sera	NNP
cord-023095-4dannjjm	3494	27	.	.	.
cord-023095-4dannjjm	3495	1	The	the	DT
cord-023095-4dannjjm	3495	2	excellent	excellent	JJ
cord-023095-4dannjjm	3495	3	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3495	4	accuracy	accuracy	NN
cord-023095-4dannjjm	3495	5	of	of	IN
cord-023095-4dannjjm	3495	6	the	the	DT
cord-023095-4dannjjm	3495	7	commercial	commercial	JJ
cord-023095-4dannjjm	3495	8	blocking	block	VBG
cord-023095-4dannjjm	3495	9	ELISA	ELISA	NNP
cord-023095-4dannjjm	3495	10	makes	make	VBZ
cord-023095-4dannjjm	3495	11	it	-PRON-	PRP
cord-023095-4dannjjm	3495	12	a	a	DT
cord-023095-4dannjjm	3495	13	suitable	suitable	JJ
cord-023095-4dannjjm	3495	14	tool	tool	NN
cord-023095-4dannjjm	3495	15	for	for	IN
cord-023095-4dannjjm	3495	16	large	large	JJ
cord-023095-4dannjjm	3495	17	-	-	HYPH
cord-023095-4dannjjm	3495	18	scale	scale	NN
cord-023095-4dannjjm	3495	19	surveillance	surveillance	NN
cord-023095-4dannjjm	3495	20	of	of	IN
cord-023095-4dannjjm	3495	21	influenza	influenza	NN
cord-023095-4dannjjm	3495	22	A	a	DT
cord-023095-4dannjjm	3495	23	virus	virus	NN
cord-023095-4dannjjm	3495	24	exposure	exposure	NN
cord-023095-4dannjjm	3495	25	in	in	IN
cord-023095-4dannjjm	3495	26	dogs	dog	NNS
cord-023095-4dannjjm	3495	27	.	.	.
cord-023095-4dannjjm	3496	1	Upper	upper	JJ
cord-023095-4dannjjm	3496	2	respiratory	respiratory	JJ
cord-023095-4dannjjm	3496	3	disease	disease	NN
cord-023095-4dannjjm	3496	4	(	(	-LRB-
cord-023095-4dannjjm	3496	5	URD	URD	NNP
cord-023095-4dannjjm	3496	6	)	)	-RRB-
cord-023095-4dannjjm	3496	7	can	can	MD
cord-023095-4dannjjm	3496	8	affect	affect	VB
cord-023095-4dannjjm	3496	9	a	a	DT
cord-023095-4dannjjm	3496	10	majority	majority	NN
cord-023095-4dannjjm	3496	11	of	of	IN
cord-023095-4dannjjm	3496	12	cats	cat	NNS
cord-023095-4dannjjm	3496	13	in	in	IN
cord-023095-4dannjjm	3496	14	shelters	shelter	NNS
cord-023095-4dannjjm	3496	15	and	and	CC
cord-023095-4dannjjm	3496	16	is	be	VBZ
cord-023095-4dannjjm	3496	17	one	one	CD
cord-023095-4dannjjm	3496	18	of	of	IN
cord-023095-4dannjjm	3496	19	the	the	DT
cord-023095-4dannjjm	3496	20	leading	lead	VBG
cord-023095-4dannjjm	3496	21	reasons	reason	NNS
cord-023095-4dannjjm	3496	22	for	for	IN
cord-023095-4dannjjm	3496	23	euthanasia	euthanasia	NN
cord-023095-4dannjjm	3496	24	of	of	IN
cord-023095-4dannjjm	3496	25	otherwise	otherwise	RB
cord-023095-4dannjjm	3496	26	adoptable	adoptable	JJ
cord-023095-4dannjjm	3496	27	cats	cat	NNS
cord-023095-4dannjjm	3496	28	.	.	.
cord-023095-4dannjjm	3497	1	The	the	DT
cord-023095-4dannjjm	3497	2	purpose	purpose	NN
cord-023095-4dannjjm	3497	3	of	of	IN
cord-023095-4dannjjm	3497	4	this	this	DT
cord-023095-4dannjjm	3497	5	study	study	NN
cord-023095-4dannjjm	3497	6	was	be	VBD
cord-023095-4dannjjm	3497	7	to	to	TO
cord-023095-4dannjjm	3497	8	determine	determine	VB
cord-023095-4dannjjm	3497	9	prevalence	prevalence	NN
cord-023095-4dannjjm	3497	10	and	and	CC
cord-023095-4dannjjm	3497	11	risk	risk	NN
cord-023095-4dannjjm	3497	12	factors	factor	NNS
cord-023095-4dannjjm	3497	13	for	for	IN
cord-023095-4dannjjm	3497	14	upper	upper	JJ
cord-023095-4dannjjm	3497	15	respiratory	respiratory	JJ
cord-023095-4dannjjm	3497	16	pathogens	pathogen	NNS
cord-023095-4dannjjm	3497	17	in	in	IN
cord-023095-4dannjjm	3497	18	four	four	CD
cord-023095-4dannjjm	3497	19	different	different	JJ
cord-023095-4dannjjm	3497	20	models	model	NNS
cord-023095-4dannjjm	3497	21	for	for	IN
cord-023095-4dannjjm	3497	22	managing	manage	VBG
cord-023095-4dannjjm	3497	23	unowned	unowned	JJ
cord-023095-4dannjjm	3497	24	cats	cat	NNS
cord-023095-4dannjjm	3497	25	:	:	:
cord-023095-4dannjjm	3497	26	short	short	JJ
cord-023095-4dannjjm	3497	27	-	-	HYPH
cord-023095-4dannjjm	3497	28	term	term	NN
cord-023095-4dannjjm	3497	29	animal	animal	NN
cord-023095-4dannjjm	3497	30	shelters	shelter	NNS
cord-023095-4dannjjm	3497	31	(	(	-LRB-
cord-023095-4dannjjm	3497	32	SHEL	SHEL	NNP
cord-023095-4dannjjm	3497	33	)	)	-RRB-
cord-023095-4dannjjm	3497	34	,	,	,
cord-023095-4dannjjm	3497	35	long	long	JJ
cord-023095-4dannjjm	3497	36	-	-	HYPH
cord-023095-4dannjjm	3497	37	term	term	NN
cord-023095-4dannjjm	3497	38	sanctuaries	sanctuary	NNS
cord-023095-4dannjjm	3497	39	(	(	-LRB-
cord-023095-4dannjjm	3497	40	SANC	SANC	NNP
cord-023095-4dannjjm	3497	41	)	)	-RRB-
cord-023095-4dannjjm	3497	42	,	,	,
cord-023095-4dannjjm	3497	43	home	home	NN
cord-023095-4dannjjm	3497	44	-	-	HYPH
cord-023095-4dannjjm	3497	45	based	base	VBN
cord-023095-4dannjjm	3497	46	foster	foster	JJ
cord-023095-4dannjjm	3497	47	care	care	NN
cord-023095-4dannjjm	3497	48	(	(	-LRB-
cord-023095-4dannjjm	3497	49	FOST	FOST	NNP
cord-023095-4dannjjm	3497	50	)	)	-RRB-
cord-023095-4dannjjm	3497	51	,	,	,
cord-023095-4dannjjm	3497	52	and	and	CC
cord-023095-4dannjjm	3497	53	trap	trap	NN
cord-023095-4dannjjm	3497	54	-	-	HYPH
cord-023095-4dannjjm	3497	55	neuter	neuter	NN
cord-023095-4dannjjm	3497	56	-	-	JJ
cord-023095-4dannjjm	3497	57	return	return	NN
cord-023095-4dannjjm	3497	58	(	(	-LRB-
cord-023095-4dannjjm	3497	59	TNR	TNR	NNP
cord-023095-4dannjjm	3497	60	)	)	-RRB-
cord-023095-4dannjjm	3497	61	programs	program	NNS
cord-023095-4dannjjm	3497	62	.	.	.
cord-023095-4dannjjm	3498	1	Conjunctival	conjunctival	NN
cord-023095-4dannjjm	3498	2	and	and	CC
cord-023095-4dannjjm	3498	3	oropharyngeal	oropharyngeal	JJ
cord-023095-4dannjjm	3498	4	swabs	swab	NNS
cord-023095-4dannjjm	3498	5	were	be	VBD
cord-023095-4dannjjm	3498	6	collected	collect	VBN
cord-023095-4dannjjm	3498	7	from	from	IN
cord-023095-4dannjjm	3498	8	543	543	CD
cord-023095-4dannjjm	3498	9	cats	cat	NNS
cord-023095-4dannjjm	3498	10	,	,	,
cord-023095-4dannjjm	3498	11	half	half	NN
cord-023095-4dannjjm	3498	12	of	of	IN
cord-023095-4dannjjm	3498	13	which	which	WDT
cord-023095-4dannjjm	3498	14	had	have	VBD
cord-023095-4dannjjm	3498	15	clinical	clinical	JJ
cord-023095-4dannjjm	3498	16	signs	sign	NNS
cord-023095-4dannjjm	3498	17	of	of	IN
cord-023095-4dannjjm	3498	18	URD	URD	NNP
cord-023095-4dannjjm	3498	19	,	,	,
cord-023095-4dannjjm	3498	20	and	and	CC
cord-023095-4dannjjm	3498	21	tested	test	VBN
cord-023095-4dannjjm	3498	22	for	for	IN
cord-023095-4dannjjm	3498	23	feline	feline	JJ
cord-023095-4dannjjm	3498	24	herpesvirus	herpesvirus	NN
cord-023095-4dannjjm	3498	25	(	(	-LRB-
cord-023095-4dannjjm	3498	26	FHV	FHV	NNP
cord-023095-4dannjjm	3498	27	)	)	-RRB-
cord-023095-4dannjjm	3498	28	,	,	,
cord-023095-4dannjjm	3498	29	feline	feline	JJ
cord-023095-4dannjjm	3498	30	calicivirus	calicivirus	NNP
cord-023095-4dannjjm	3498	31	(	(	-LRB-
cord-023095-4dannjjm	3498	32	FCV	FCV	NNP
cord-023095-4dannjjm	3498	33	)	)	-RRB-
cord-023095-4dannjjm	3498	34	,	,	,
cord-023095-4dannjjm	3498	35	Chlamydiophila	Chlamydiophila	NNP
cord-023095-4dannjjm	3498	36	felis	felis	NN
cord-023095-4dannjjm	3498	37	,	,	,
cord-023095-4dannjjm	3498	38	Bordetella	Bordetella	NNP
cord-023095-4dannjjm	3498	39	bronchiseptica	bronchiseptica	NNP
cord-023095-4dannjjm	3498	40	(	(	-LRB-
cord-023095-4dannjjm	3498	41	Bb	Bb	NNP
cord-023095-4dannjjm	3498	42	)	)	-RRB-
cord-023095-4dannjjm	3498	43	and	and	CC
cord-023095-4dannjjm	3498	44	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	3498	45	felis	felis	NN
cord-023095-4dannjjm	3498	46	by	by	IN
cord-023095-4dannjjm	3498	47	real	real	JJ
cord-023095-4dannjjm	3498	48	-	-	HYPH
cord-023095-4dannjjm	3498	49	time	time	NN
cord-023095-4dannjjm	3498	50	PCR	PCR	NNP
cord-023095-4dannjjm	3498	51	.	.	.
cord-023095-4dannjjm	3499	1	Management	management	NN
cord-023095-4dannjjm	3499	2	model	model	NN
cord-023095-4dannjjm	3499	3	,	,	,
cord-023095-4dannjjm	3499	4	vaccination	vaccination	NN
cord-023095-4dannjjm	3499	5	,	,	,
cord-023095-4dannjjm	3499	6	sex	sex	NN
cord-023095-4dannjjm	3499	7	,	,	,
cord-023095-4dannjjm	3499	8	age	age	NN
cord-023095-4dannjjm	3499	9	,	,	,
cord-023095-4dannjjm	3499	10	body	body	NN
cord-023095-4dannjjm	3499	11	condition	condition	NN
cord-023095-4dannjjm	3499	12	,	,	,
cord-023095-4dannjjm	3499	13	and	and	CC
cord-023095-4dannjjm	3499	14	clinical	clinical	JJ
cord-023095-4dannjjm	3499	15	signs	sign	NNS
cord-023095-4dannjjm	3499	16	were	be	VBD
cord-023095-4dannjjm	3499	17	evaluated	evaluate	VBN
cord-023095-4dannjjm	3499	18	as	as	IN
cord-023095-4dannjjm	3499	19	risk	risk	NN
cord-023095-4dannjjm	3499	20	factors	factor	NNS
cord-023095-4dannjjm	3499	21	for	for	IN
cord-023095-4dannjjm	3499	22	infection	infection	NN
cord-023095-4dannjjm	3499	23	.	.	.
cord-023095-4dannjjm	3500	1	A	a	DT
cord-023095-4dannjjm	3500	2	majority	majority	NN
cord-023095-4dannjjm	3500	3	of	of	IN
cord-023095-4dannjjm	3500	4	cats	cat	NNS
cord-023095-4dannjjm	3500	5	in	in	IN
cord-023095-4dannjjm	3500	6	all	all	DT
cord-023095-4dannjjm	3500	7	management	management	NN
cord-023095-4dannjjm	3500	8	models	model	NNS
cord-023095-4dannjjm	3500	9	carried	carry	VBD
cord-023095-4dannjjm	3500	10	one	one	CD
cord-023095-4dannjjm	3500	11	or	or	CC
cord-023095-4dannjjm	3500	12	more	more	JJR
cord-023095-4dannjjm	3500	13	organisms	organism	NNS
cord-023095-4dannjjm	3500	14	capable	capable	JJ
cord-023095-4dannjjm	3500	15	of	of	IN
cord-023095-4dannjjm	3500	16	causing	cause	VBG
cord-023095-4dannjjm	3500	17	URD	URD	NNP
cord-023095-4dannjjm	3500	18	.	.	.
cord-023095-4dannjjm	3501	1	In	in	IN
cord-023095-4dannjjm	3501	2	many	many	JJ
cord-023095-4dannjjm	3501	3	cases	case	NNS
cord-023095-4dannjjm	3501	4	,	,	,
cord-023095-4dannjjm	3501	5	prevalence	prevalence	NN
cord-023095-4dannjjm	3501	6	was	be	VBD
cord-023095-4dannjjm	3501	7	similar	similar	JJ
cord-023095-4dannjjm	3501	8	in	in	IN
cord-023095-4dannjjm	3501	9	cats	cat	NNS
cord-023095-4dannjjm	3501	10	with	with	IN
cord-023095-4dannjjm	3501	11	or	or	CC
cord-023095-4dannjjm	3501	12	without	without	IN
cord-023095-4dannjjm	3501	13	clinical	clinical	JJ
cord-023095-4dannjjm	3501	14	signs	sign	NNS
cord-023095-4dannjjm	3501	15	.	.	.
cord-023095-4dannjjm	3502	1	Unlike	unlike	IN
cord-023095-4dannjjm	3502	2	diseases	disease	NNS
cord-023095-4dannjjm	3502	3	that	that	WDT
cord-023095-4dannjjm	3502	4	can	can	MD
cord-023095-4dannjjm	3502	5	be	be	VB
cord-023095-4dannjjm	3502	6	controlled	control	VBN
cord-023095-4dannjjm	3502	7	by	by	IN
cord-023095-4dannjjm	3502	8	segregation	segregation	NN
cord-023095-4dannjjm	3502	9	of	of	IN
cord-023095-4dannjjm	3502	10	symptomatic	symptomatic	JJ
cord-023095-4dannjjm	3502	11	animals	animal	NNS
cord-023095-4dannjjm	3502	12	,	,	,
cord-023095-4dannjjm	3502	13	the	the	DT
cord-023095-4dannjjm	3502	14	lack	lack	NN
cord-023095-4dannjjm	3502	15	of	of	IN
cord-023095-4dannjjm	3502	16	strong	strong	JJ
cord-023095-4dannjjm	3502	17	correlation	correlation	NN
cord-023095-4dannjjm	3502	18	between	between	IN
cord-023095-4dannjjm	3502	19	the	the	DT
cord-023095-4dannjjm	3502	20	presence	presence	NN
cord-023095-4dannjjm	3502	21	of	of	IN
cord-023095-4dannjjm	3502	22	pathogens	pathogen	NNS
cord-023095-4dannjjm	3502	23	with	with	IN
cord-023095-4dannjjm	3502	24	the	the	DT
cord-023095-4dannjjm	3502	25	presence	presence	NN
cord-023095-4dannjjm	3502	26	of	of	IN
cord-023095-4dannjjm	3502	27	clinical	clinical	JJ
cord-023095-4dannjjm	3502	28	signs	sign	NNS
cord-023095-4dannjjm	3502	29	suggests	suggest	VBZ
cord-023095-4dannjjm	3502	30	that	that	IN
cord-023095-4dannjjm	3502	31	feline	feline	JJ
cord-023095-4dannjjm	3502	32	URD	URD	NNP
cord-023095-4dannjjm	3502	33	control	control	NN
cord-023095-4dannjjm	3502	34	should	should	MD
cord-023095-4dannjjm	3502	35	be	be	VB
cord-023095-4dannjjm	3502	36	managed	manage	VBN
cord-023095-4dannjjm	3502	37	by	by	IN
cord-023095-4dannjjm	3502	38	vaccination	vaccination	NN
cord-023095-4dannjjm	3502	39	before	before	IN
cord-023095-4dannjjm	3502	40	or	or	CC
cord-023095-4dannjjm	3502	41	at	at	IN
cord-023095-4dannjjm	3502	42	the	the	DT
cord-023095-4dannjjm	3502	43	time	time	NN
cord-023095-4dannjjm	3502	44	of	of	IN
cord-023095-4dannjjm	3502	45	intake	intake	NN
cord-023095-4dannjjm	3502	46	,	,	,
cord-023095-4dannjjm	3502	47	biosecurity	biosecurity	NN
cord-023095-4dannjjm	3502	48	protocols	protocol	NNS
cord-023095-4dannjjm	3502	49	that	that	WDT
cord-023095-4dannjjm	3502	50	presume	presume	VBP
cord-023095-4dannjjm	3502	51	all	all	DT
cord-023095-4dannjjm	3502	52	cats	cat	NNS
cord-023095-4dannjjm	3502	53	may	may	MD
cord-023095-4dannjjm	3502	54	be	be	VB
cord-023095-4dannjjm	3502	55	shedding	shed	VBG
cord-023095-4dannjjm	3502	56	pathogens	pathogen	NNS
cord-023095-4dannjjm	3502	57	,	,	,
cord-023095-4dannjjm	3502	58	and	and	CC
cord-023095-4dannjjm	3502	59	minimizing	minimize	VBG
cord-023095-4dannjjm	3502	60	stressful	stressful	JJ
cord-023095-4dannjjm	3502	61	conditions	condition	NNS
cord-023095-4dannjjm	3502	62	that	that	WDT
cord-023095-4dannjjm	3502	63	contribute	contribute	VBP
cord-023095-4dannjjm	3502	64	to	to	IN
cord-023095-4dannjjm	3502	65	disease	disease	NN
cord-023095-4dannjjm	3502	66	susceptibility	susceptibility	NN
cord-023095-4dannjjm	3502	67	.	.	.
cord-023095-4dannjjm	3503	1	Depending	depend	VBG
cord-023095-4dannjjm	3503	2	on	on	IN
cord-023095-4dannjjm	3503	3	geographical	geographical	JJ
cord-023095-4dannjjm	3503	4	location	location	NN
cord-023095-4dannjjm	3503	5	,	,	,
cord-023095-4dannjjm	3503	6	sex	sex	NN
cord-023095-4dannjjm	3503	7	,	,	,
cord-023095-4dannjjm	3503	8	age	age	NN
cord-023095-4dannjjm	3503	9	and	and	CC
cord-023095-4dannjjm	3503	10	environment	environment	NN
cord-023095-4dannjjm	3503	11	,	,	,
cord-023095-4dannjjm	3503	12	2	2	CD
cord-023095-4dannjjm	3503	13	-	-	SYM
cord-023095-4dannjjm	3503	14	40	40	CD
cord-023095-4dannjjm	3503	15	%	%	NN
cord-023095-4dannjjm	3503	16	of	of	IN
cord-023095-4dannjjm	3503	17	cats	cat	NNS
cord-023095-4dannjjm	3503	18	worldwide	worldwide	RB
cord-023095-4dannjjm	3503	19	are	be	VBP
cord-023095-4dannjjm	3503	20	infected	infect	VBN
cord-023095-4dannjjm	3503	21	with	with	IN
cord-023095-4dannjjm	3503	22	the	the	DT
cord-023095-4dannjjm	3503	23	feline	feline	JJ
cord-023095-4dannjjm	3503	24	immunodeficiency	immunodeficiency	NN
cord-023095-4dannjjm	3503	25	virus	virus	NN
cord-023095-4dannjjm	3503	26	(	(	-LRB-
cord-023095-4dannjjm	3503	27	FIV	FIV	NNP
cord-023095-4dannjjm	3503	28	)	)	-RRB-
cord-023095-4dannjjm	3503	29	.	.	.
cord-023095-4dannjjm	3504	1	Knowledge	knowledge	NN
cord-023095-4dannjjm	3504	2	of	of	IN
cord-023095-4dannjjm	3504	3	the	the	DT
cord-023095-4dannjjm	3504	4	FIV	FIV	NNP
cord-023095-4dannjjm	3504	5	status	status	NN
cord-023095-4dannjjm	3504	6	of	of	IN
cord-023095-4dannjjm	3504	7	cats	cat	NNS
cord-023095-4dannjjm	3504	8	is	be	VBZ
cord-023095-4dannjjm	3504	9	important	important	JJ
cord-023095-4dannjjm	3504	10	to	to	TO
cord-023095-4dannjjm	3504	11	limit	limit	VB
cord-023095-4dannjjm	3504	12	the	the	DT
cord-023095-4dannjjm	3504	13	spread	spread	NN
cord-023095-4dannjjm	3504	14	of	of	IN
cord-023095-4dannjjm	3504	15	disease	disease	NN
cord-023095-4dannjjm	3504	16	and	and	CC
cord-023095-4dannjjm	3504	17	to	to	TO
cord-023095-4dannjjm	3504	18	institute	institute	VB
cord-023095-4dannjjm	3504	19	appropriate	appropriate	JJ
cord-023095-4dannjjm	3504	20	health	health	NN
cord-023095-4dannjjm	3504	21	management	management	NN
cord-023095-4dannjjm	3504	22	.	.	.
cord-023095-4dannjjm	3505	1	However	however	RB
cord-023095-4dannjjm	3505	2	,	,	,
cord-023095-4dannjjm	3505	3	like	like	IN
cord-023095-4dannjjm	3505	4	all	all	DT
cord-023095-4dannjjm	3505	5	lentiviruses	lentiviruse	NNS
cord-023095-4dannjjm	3505	6	,	,	,
cord-023095-4dannjjm	3505	7	FIV	FIV	NNP
cord-023095-4dannjjm	3505	8	is	be	VBZ
cord-023095-4dannjjm	3505	9	highly	highly	RB
cord-023095-4dannjjm	3505	10	variable	variable	JJ
cord-023095-4dannjjm	3505	11	in	in	IN
cord-023095-4dannjjm	3505	12	nucleotide	nucleotide	JJ
cord-023095-4dannjjm	3505	13	sequence	sequence	NN
cord-023095-4dannjjm	3505	14	,	,	,
cord-023095-4dannjjm	3505	15	and	and	CC
cord-023095-4dannjjm	3505	16	viral	viral	JJ
cord-023095-4dannjjm	3505	17	load	load	NN
cord-023095-4dannjjm	3505	18	in	in	IN
cord-023095-4dannjjm	3505	19	cats	cat	NNS
cord-023095-4dannjjm	3505	20	is	be	VBZ
cord-023095-4dannjjm	3505	21	variable	variable	JJ
cord-023095-4dannjjm	3505	22	during	during	IN
cord-023095-4dannjjm	3505	23	different	different	JJ
cord-023095-4dannjjm	3505	24	disease	disease	NN
cord-023095-4dannjjm	3505	25	stages	stage	NNS
cord-023095-4dannjjm	3505	26	.	.	.
cord-023095-4dannjjm	3506	1	Detection	detection	NN
cord-023095-4dannjjm	3506	2	of	of	IN
cord-023095-4dannjjm	3506	3	antibodies	antibody	NNS
cord-023095-4dannjjm	3506	4	is	be	VBZ
cord-023095-4dannjjm	3506	5	the	the	DT
cord-023095-4dannjjm	3506	6	most	most	RBS
cord-023095-4dannjjm	3506	7	widely	widely	RB
cord-023095-4dannjjm	3506	8	employed	employ	VBN
cord-023095-4dannjjm	3506	9	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3506	10	approach	approach	NN
cord-023095-4dannjjm	3506	11	,	,	,
cord-023095-4dannjjm	3506	12	but	but	CC
cord-023095-4dannjjm	3506	13	does	do	VBZ
cord-023095-4dannjjm	3506	14	not	not	RB
cord-023095-4dannjjm	3506	15	distinguish	distinguish	VB
cord-023095-4dannjjm	3506	16	FIV	FIV	NNP
cord-023095-4dannjjm	3506	17	-	-	HYPH
cord-023095-4dannjjm	3506	18	infected	infect	VBN
cord-023095-4dannjjm	3506	19	from	from	IN
cord-023095-4dannjjm	3506	20	FIV	fiv	NN
cord-023095-4dannjjm	3506	21	-	-	HYPH
cord-023095-4dannjjm	3506	22	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	3506	23	cats	cat	NNS
cord-023095-4dannjjm	3506	24	.	.	.
cord-023095-4dannjjm	3507	1	In	in	IN
cord-023095-4dannjjm	3507	2	this	this	DT
cord-023095-4dannjjm	3507	3	study	study	NN
cord-023095-4dannjjm	3507	4	,	,	,
cord-023095-4dannjjm	3507	5	samples	sample	NNS
cord-023095-4dannjjm	3507	6	from	from	IN
cord-023095-4dannjjm	3507	7	30	30	CD
cord-023095-4dannjjm	3507	8	FIV	fiv	NN
cord-023095-4dannjjm	3507	9	-	-	HYPH
cord-023095-4dannjjm	3507	10	seronegative	seronegative	JJ
cord-023095-4dannjjm	3507	11	cats	cat	NNS
cord-023095-4dannjjm	3507	12	,	,	,
cord-023095-4dannjjm	3507	13	30	30	CD
cord-023095-4dannjjm	3507	14	FIVseropositive	fivseropositive	NN
cord-023095-4dannjjm	3507	15	cats	cat	NNS
cord-023095-4dannjjm	3507	16	,	,	,
cord-023095-4dannjjm	3507	17	and	and	CC
cord-023095-4dannjjm	3507	18	30	30	CD
cord-023095-4dannjjm	3507	19	FIV	fiv	NN
cord-023095-4dannjjm	3507	20	-	-	HYPH
cord-023095-4dannjjm	3507	21	historically	historically	RB
cord-023095-4dannjjm	3507	22	seronegative	seronegative	JJ
cord-023095-4dannjjm	3507	23	but	but	CC
cord-023095-4dannjjm	3507	24	vaccinated	vaccinated	JJ
cord-023095-4dannjjm	3507	25	cats	cat	NNS
cord-023095-4dannjjm	3507	26	,	,	,
cord-023095-4dannjjm	3507	27	were	be	VBD
cord-023095-4dannjjm	3507	28	analyzed	analyze	VBN
cord-023095-4dannjjm	3507	29	by	by	IN
cord-023095-4dannjjm	3507	30	a	a	DT
cord-023095-4dannjjm	3507	31	commercial	commercial	JJ
cord-023095-4dannjjm	3507	32	quantitative	quantitative	JJ
cord-023095-4dannjjm	3507	33	PCR	PCR	NNP
cord-023095-4dannjjm	3507	34	(	(	-LRB-
cord-023095-4dannjjm	3507	35	qPCR	qPCR	NNP
cord-023095-4dannjjm	3507	36	)	)	-RRB-
cord-023095-4dannjjm	3507	37	assay	assay	NN
cord-023095-4dannjjm	3507	38	and	and	CC
cord-023095-4dannjjm	3507	39	virus	virus	NN
cord-023095-4dannjjm	3507	40	isolation	isolation	NN
cord-023095-4dannjjm	3507	41	.	.	.
cord-023095-4dannjjm	3508	1	Replicate	replicate	VB
cord-023095-4dannjjm	3508	2	blood	blood	NN
cord-023095-4dannjjm	3508	3	samples	sample	NNS
cord-023095-4dannjjm	3508	4	were	be	VBD
cord-023095-4dannjjm	3508	5	coded	code	VBN
cord-023095-4dannjjm	3508	6	,	,	,
cord-023095-4dannjjm	3508	7	and	and	CC
cord-023095-4dannjjm	3508	8	then	then	RB
cord-023095-4dannjjm	3508	9	submitted	submit	VBD
cord-023095-4dannjjm	3508	10	for	for	IN
cord-023095-4dannjjm	3508	11	1	1	CD
cord-023095-4dannjjm	3508	12	)	)	-RRB-
cord-023095-4dannjjm	3509	1	qPCR	qPCR	NNP
cord-023095-4dannjjm	3509	2	(	(	-LRB-
cord-023095-4dannjjm	3509	3	Idexx	Idexx	NNP
cord-023095-4dannjjm	3509	4	)	)	-RRB-
cord-023095-4dannjjm	3509	5	;	;	:
cord-023095-4dannjjm	3509	6	and	and	CC
cord-023095-4dannjjm	3509	7	2	2	LS
cord-023095-4dannjjm	3509	8	)	)	-RRB-
cord-023095-4dannjjm	3509	9	mononuclear	mononuclear	JJ
cord-023095-4dannjjm	3509	10	cell	cell	NN
cord-023095-4dannjjm	3509	11	isolation	isolation	NN
cord-023095-4dannjjm	3509	12	with	with	IN
cord-023095-4dannjjm	3509	13	7-day	7-day	JJ
cord-023095-4dannjjm	3509	14	culture	culture	NN
cord-023095-4dannjjm	3509	15	and	and	CC
cord-023095-4dannjjm	3509	16	viral	viral	JJ
cord-023095-4dannjjm	3509	17	p24	p24	NN
cord-023095-4dannjjm	3509	18	antigen	antigen	NN
cord-023095-4dannjjm	3509	19	detection	detection	NN
cord-023095-4dannjjm	3509	20	by	by	IN
cord-023095-4dannjjm	3509	21	ELISA	ELISA	NNP
cord-023095-4dannjjm	3509	22	.	.	.
cord-023095-4dannjjm	3510	1	For	for	IN
cord-023095-4dannjjm	3510	2	the	the	DT
cord-023095-4dannjjm	3510	3	p24	p24	NN
cord-023095-4dannjjm	3510	4	antigen	antigen	NN
cord-023095-4dannjjm	3510	5	ELISA	ELISA	NNP
cord-023095-4dannjjm	3510	6	,	,	,
cord-023095-4dannjjm	3510	7	cutoff	cutoff	NN
cord-023095-4dannjjm	3510	8	absorbance	absorbance	NN
cord-023095-4dannjjm	3510	9	values	value	NNS
cord-023095-4dannjjm	3510	10	were	be	VBD
cord-023095-4dannjjm	3510	11	established	establish	VBN
cord-023095-4dannjjm	3510	12	from	from	IN
cord-023095-4dannjjm	3510	13	analysis	analysis	NN
cord-023095-4dannjjm	3510	14	of	of	IN
cord-023095-4dannjjm	3510	15	10	10	CD
cord-023095-4dannjjm	3510	16	FIV	fiv	JJ
cord-023095-4dannjjm	3510	17	-	-	HYPH
cord-023095-4dannjjm	3510	18	negative	negative	JJ
cord-023095-4dannjjm	3510	19	samples	sample	NNS
cord-023095-4dannjjm	3510	20	.	.	.
cord-023095-4dannjjm	3511	1	FIV	fiv	NN
cord-023095-4dannjjm	3511	2	infection	infection	NN
cord-023095-4dannjjm	3511	3	status	status	NN
cord-023095-4dannjjm	3511	4	was	be	VBD
cord-023095-4dannjjm	3511	5	pre	pre	JJ
cord-023095-4dannjjm	3511	6	-	-	JJ
cord-023095-4dannjjm	3511	7	determined	determined	JJ
cord-023095-4dannjjm	3511	8	based	base	VBN
cord-023095-4dannjjm	3511	9	on	on	IN
cord-023095-4dannjjm	3511	10	2	2	CD
cord-023095-4dannjjm	3511	11	antibody	antibody	NN
cord-023095-4dannjjm	3511	12	-	-	HYPH
cord-023095-4dannjjm	3511	13	ELISA	ELISA	NNP
cord-023095-4dannjjm	3511	14	results	result	NNS
cord-023095-4dannjjm	3511	15	and	and	CC
cord-023095-4dannjjm	3511	16	vaccination	vaccination	NN
cord-023095-4dannjjm	3511	17	history	history	NN
cord-023095-4dannjjm	3511	18	.	.	.
cord-023095-4dannjjm	3512	1	Results	result	NNS
cord-023095-4dannjjm	3512	2	indicated	indicate	VBD
cord-023095-4dannjjm	3512	3	that	that	IN
cord-023095-4dannjjm	3512	4	qPCR	qPCR	NNP
cord-023095-4dannjjm	3512	5	had	have	VBD
cord-023095-4dannjjm	3512	6	a	a	DT
cord-023095-4dannjjm	3512	7	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3512	8	of	of	IN
cord-023095-4dannjjm	3512	9	76	76	CD
cord-023095-4dannjjm	3512	10	%	%	NN
cord-023095-4dannjjm	3512	11	for	for	IN
cord-023095-4dannjjm	3512	12	samples	sample	NNS
cord-023095-4dannjjm	3512	13	from	from	IN
cord-023095-4dannjjm	3512	14	FIV	fiv	NN
cord-023095-4dannjjm	3512	15	-	-	HYPH
cord-023095-4dannjjm	3512	16	seropositive	seropositive	JJ
cord-023095-4dannjjm	3512	17	cats	cat	NNS
cord-023095-4dannjjm	3512	18	,	,	,
cord-023095-4dannjjm	3512	19	and	and	CC
cord-023095-4dannjjm	3512	20	a	a	DT
cord-023095-4dannjjm	3512	21	specificity	specificity	NN
cord-023095-4dannjjm	3512	22	of	of	IN
cord-023095-4dannjjm	3512	23	100	100	CD
cord-023095-4dannjjm	3512	24	%	%	NN
cord-023095-4dannjjm	3512	25	and	and	CC
cord-023095-4dannjjm	3512	26	94.1	94.1	CD
cord-023095-4dannjjm	3512	27	%	%	NN
cord-023095-4dannjjm	3512	28	for	for	IN
cord-023095-4dannjjm	3512	29	samples	sample	NNS
cord-023095-4dannjjm	3512	30	from	from	IN
cord-023095-4dannjjm	3512	31	FIV	fiv	NN
cord-023095-4dannjjm	3512	32	-	-	HYPH
cord-023095-4dannjjm	3512	33	seronegative	seronegative	JJ
cord-023095-4dannjjm	3512	34	and	and	CC
cord-023095-4dannjjm	3512	35	FIV	fiv	NN
cord-023095-4dannjjm	3512	36	-	-	HYPH
cord-023095-4dannjjm	3512	37	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	3512	38	cats	cat	NNS
cord-023095-4dannjjm	3512	39	,	,	,
cord-023095-4dannjjm	3512	40	respectively	respectively	RB
cord-023095-4dannjjm	3512	41	.	.	.
cord-023095-4dannjjm	3513	1	At	at	IN
cord-023095-4dannjjm	3513	2	a	a	DT
cord-023095-4dannjjm	3513	3	cutoff	cutoff	NN
cord-023095-4dannjjm	3513	4	value	value	NN
cord-023095-4dannjjm	3513	5	of	of	IN
cord-023095-4dannjjm	3513	6	3	3	CD
cord-023095-4dannjjm	3513	7	standard	standard	JJ
cord-023095-4dannjjm	3513	8	deviations	deviation	NNS
cord-023095-4dannjjm	3513	9	above	above	IN
cord-023095-4dannjjm	3513	10	the	the	DT
cord-023095-4dannjjm	3513	11	mean	mean	JJ
cord-023095-4dannjjm	3513	12	absorbance	absorbance	NN
cord-023095-4dannjjm	3513	13	for	for	IN
cord-023095-4dannjjm	3513	14	p24	p24	NN
cord-023095-4dannjjm	3513	15	antigen	antigen	NN
cord-023095-4dannjjm	3513	16	ELISA	ELISA	NNP
cord-023095-4dannjjm	3513	17	,	,	,
cord-023095-4dannjjm	3513	18	results	result	VBZ
cord-023095-4dannjjm	3513	19	from	from	IN
cord-023095-4dannjjm	3513	20	FIV	fiv	JJ
cord-023095-4dannjjm	3513	21	-	-	HYPH
cord-023095-4dannjjm	3513	22	negative	negative	JJ
cord-023095-4dannjjm	3513	23	samples	sample	NNS
cord-023095-4dannjjm	3513	24	yielded	yield	VBD
cord-023095-4dannjjm	3513	25	a	a	DT
cord-023095-4dannjjm	3513	26	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3513	27	of	of	IN
cord-023095-4dannjjm	3513	28	69.2	69.2	CD
cord-023095-4dannjjm	3513	29	%	%	NN
cord-023095-4dannjjm	3513	30	for	for	IN
cord-023095-4dannjjm	3513	31	samples	sample	NNS
cord-023095-4dannjjm	3513	32	from	from	IN
cord-023095-4dannjjm	3513	33	FIV	fiv	NN
cord-023095-4dannjjm	3513	34	-	-	HYPH
cord-023095-4dannjjm	3513	35	seropositive	seropositive	JJ
cord-023095-4dannjjm	3513	36	cats	cat	NNS
cord-023095-4dannjjm	3513	37	,	,	,
cord-023095-4dannjjm	3513	38	and	and	CC
cord-023095-4dannjjm	3513	39	a	a	DT
cord-023095-4dannjjm	3513	40	specificity	specificity	NN
cord-023095-4dannjjm	3513	41	of	of	IN
cord-023095-4dannjjm	3513	42	77.1	77.1	CD
cord-023095-4dannjjm	3513	43	%	%	NN
cord-023095-4dannjjm	3513	44	and	and	CC
cord-023095-4dannjjm	3513	45	64.7	64.7	CD
cord-023095-4dannjjm	3513	46	%	%	NN
cord-023095-4dannjjm	3513	47	for	for	IN
cord-023095-4dannjjm	3513	48	samples	sample	NNS
cord-023095-4dannjjm	3513	49	from	from	IN
cord-023095-4dannjjm	3513	50	FIV	fiv	NN
cord-023095-4dannjjm	3513	51	-	-	HYPH
cord-023095-4dannjjm	3513	52	seronegative	seronegative	JJ
cord-023095-4dannjjm	3513	53	and	and	CC
cord-023095-4dannjjm	3513	54	FIV	fiv	NN
cord-023095-4dannjjm	3513	55	-	-	HYPH
cord-023095-4dannjjm	3513	56	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	3513	57	cats	cat	NNS
cord-023095-4dannjjm	3513	58	,	,	,
cord-023095-4dannjjm	3513	59	respectively	respectively	RB
cord-023095-4dannjjm	3513	60	.	.	.
cord-023095-4dannjjm	3514	1	Conclusions	conclusion	NNS
cord-023095-4dannjjm	3514	2	from	from	IN
cord-023095-4dannjjm	3514	3	this	this	DT
cord-023095-4dannjjm	3514	4	study	study	NN
cord-023095-4dannjjm	3514	5	are	be	VBP
cord-023095-4dannjjm	3514	6	1	1	CD
cord-023095-4dannjjm	3514	7	)	)	-RRB-
cord-023095-4dannjjm	3515	1	the	the	DT
cord-023095-4dannjjm	3515	2	commercial	commercial	JJ
cord-023095-4dannjjm	3515	3	FIV	FIV	NNP
cord-023095-4dannjjm	3515	4	qPCR	qpcr	NN
cord-023095-4dannjjm	3515	5	assay	assay	NN
cord-023095-4dannjjm	3515	6	has	have	VBZ
cord-023095-4dannjjm	3515	7	high	high	JJ
cord-023095-4dannjjm	3515	8	specificity	specificity	NN
cord-023095-4dannjjm	3515	9	but	but	CC
cord-023095-4dannjjm	3515	10	limited	limited	JJ
cord-023095-4dannjjm	3515	11	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3515	12	for	for	IN
cord-023095-4dannjjm	3515	13	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3515	14	of	of	IN
cord-023095-4dannjjm	3515	15	FIV	FIV	NNP
cord-023095-4dannjjm	3515	16	infection	infection	NN
cord-023095-4dannjjm	3515	17	;	;	:
cord-023095-4dannjjm	3515	18	2	2	LS
cord-023095-4dannjjm	3515	19	)	)	-RRB-
cord-023095-4dannjjm	3515	20	7-day	7-day	JJ
cord-023095-4dannjjm	3515	21	virus	virus	NN
cord-023095-4dannjjm	3515	22	culture	culture	NN
cord-023095-4dannjjm	3515	23	has	have	VBZ
cord-023095-4dannjjm	3515	24	limited	limit	VBN
cord-023095-4dannjjm	3515	25	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3515	26	and	and	CC
cord-023095-4dannjjm	3515	27	specificity	specificity	NN
cord-023095-4dannjjm	3515	28	.	.	.
cord-023095-4dannjjm	3516	1	Hence	hence	RB
cord-023095-4dannjjm	3516	2	,	,	,
cord-023095-4dannjjm	3516	3	detection	detection	NN
cord-023095-4dannjjm	3516	4	of	of	IN
cord-023095-4dannjjm	3516	5	antibodies	antibody	NNS
cord-023095-4dannjjm	3516	6	remains	remain	VBZ
cord-023095-4dannjjm	3516	7	the	the	DT
cord-023095-4dannjjm	3516	8	most	most	RBS
cord-023095-4dannjjm	3516	9	reliable	reliable	JJ
cord-023095-4dannjjm	3516	10	test	test	NN
cord-023095-4dannjjm	3516	11	for	for	IN
cord-023095-4dannjjm	3516	12	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3516	13	of	of	IN
cord-023095-4dannjjm	3516	14	FIV	FIV	NNP
cord-023095-4dannjjm	3516	15	infection	infection	NN
cord-023095-4dannjjm	3516	16	,	,	,
cord-023095-4dannjjm	3516	17	but	but	CC
cord-023095-4dannjjm	3516	18	qPCR	qPCR	NNP
cord-023095-4dannjjm	3516	19	may	may	MD
cord-023095-4dannjjm	3516	20	be	be	VB
cord-023095-4dannjjm	3516	21	suitable	suitable	JJ
cord-023095-4dannjjm	3516	22	to	to	TO
cord-023095-4dannjjm	3516	23	rule	rule	VB
cord-023095-4dannjjm	3516	24	out	out	RP
cord-023095-4dannjjm	3516	25	infection	infection	NN
cord-023095-4dannjjm	3516	26	.	.	.
cord-023095-4dannjjm	3517	1	Oral	oral	JJ
cord-023095-4dannjjm	3517	2	disease	disease	NN
cord-023095-4dannjjm	3517	3	is	be	VBZ
cord-023095-4dannjjm	3517	4	an	an	DT
cord-023095-4dannjjm	3517	5	important	important	JJ
cord-023095-4dannjjm	3517	6	clinical	clinical	JJ
cord-023095-4dannjjm	3517	7	problem	problem	NN
cord-023095-4dannjjm	3517	8	in	in	IN
cord-023095-4dannjjm	3517	9	feline	feline	JJ
cord-023095-4dannjjm	3517	10	medicine	medicine	NN
cord-023095-4dannjjm	3517	11	and	and	CC
cord-023095-4dannjjm	3517	12	includes	include	VBZ
cord-023095-4dannjjm	3517	13	common	common	JJ
cord-023095-4dannjjm	3517	14	painful	painful	JJ
cord-023095-4dannjjm	3517	15	conditions	condition	NNS
cord-023095-4dannjjm	3517	16	such	such	JJ
cord-023095-4dannjjm	3517	17	as	as	IN
cord-023095-4dannjjm	3517	18	oropharyngeal	oropharyngeal	JJ
cord-023095-4dannjjm	3517	19	inflammation	inflammation	NN
cord-023095-4dannjjm	3517	20	(	(	-LRB-
cord-023095-4dannjjm	3517	21	formerly	formerly	RB
cord-023095-4dannjjm	3517	22	known	know	VBN
cord-023095-4dannjjm	3517	23	as	as	IN
cord-023095-4dannjjm	3517	24	gingivostomatitis	gingivostomatitis	NNP
cord-023095-4dannjjm	3517	25	)	)	-RRB-
cord-023095-4dannjjm	3517	26	and	and	CC
cord-023095-4dannjjm	3517	27	tooth	tooth	NN
cord-023095-4dannjjm	3517	28	resorptive	resorptive	JJ
cord-023095-4dannjjm	3517	29	lesions	lesion	NNS
cord-023095-4dannjjm	3517	30	.	.	.
cord-023095-4dannjjm	3518	1	A	a	DT
cord-023095-4dannjjm	3518	2	number	number	NN
cord-023095-4dannjjm	3518	3	of	of	IN
cord-023095-4dannjjm	3518	4	infectious	infectious	JJ
cord-023095-4dannjjm	3518	5	agents	agent	NNS
cord-023095-4dannjjm	3518	6	have	have	VBP
cord-023095-4dannjjm	3518	7	been	be	VBN
cord-023095-4dannjjm	3518	8	associated	associate	VBN
cord-023095-4dannjjm	3518	9	with	with	IN
cord-023095-4dannjjm	3518	10	Private	private	JJ
cord-023095-4dannjjm	3518	11	veterinary	veterinary	JJ
cord-023095-4dannjjm	3518	12	clinics	clinic	NNS
cord-023095-4dannjjm	3518	13	in	in	IN
cord-023095-4dannjjm	3518	14	the	the	DT
cord-023095-4dannjjm	3518	15	U.S.	U.S.	NNP
cord-023095-4dannjjm	3518	16	were	be	VBD
cord-023095-4dannjjm	3518	17	recruited	recruit	VBN
cord-023095-4dannjjm	3518	18	to	to	TO
cord-023095-4dannjjm	3518	19	test	test	VB
cord-023095-4dannjjm	3518	20	feline	feline	JJ
cord-023095-4dannjjm	3518	21	patients	patient	NNS
cord-023095-4dannjjm	3518	22	presenting	present	VBG
cord-023095-4dannjjm	3518	23	with	with	IN
cord-023095-4dannjjm	3518	24	oral	oral	JJ
cord-023095-4dannjjm	3518	25	disease	disease	NN
cord-023095-4dannjjm	3518	26	.	.	.
cord-023095-4dannjjm	3519	1	Presenting	present	VBG
cord-023095-4dannjjm	3519	2	cases	case	NNS
cord-023095-4dannjjm	3519	3	included	include	VBD
cord-023095-4dannjjm	3519	4	cats	cat	NNS
cord-023095-4dannjjm	3519	5	with	with	IN
cord-023095-4dannjjm	3519	6	plaque	plaque	NN
cord-023095-4dannjjm	3519	7	,	,	,
cord-023095-4dannjjm	3519	8	calculus	calculus	NN
cord-023095-4dannjjm	3519	9	,	,	,
cord-023095-4dannjjm	3519	10	gingivitis	gingivitis	NN
cord-023095-4dannjjm	3519	11	,	,	,
cord-023095-4dannjjm	3519	12	stomatitis	stomatitis	NN
cord-023095-4dannjjm	3519	13	,	,	,
cord-023095-4dannjjm	3519	14	periodontal	periodontal	JJ
cord-023095-4dannjjm	3519	15	disease	disease	NN
cord-023095-4dannjjm	3519	16	,	,	,
cord-023095-4dannjjm	3519	17	tooth	tooth	NN
cord-023095-4dannjjm	3519	18	resorptive	resorptive	JJ
cord-023095-4dannjjm	3519	19	lesions	lesion	NNS
cord-023095-4dannjjm	3519	20	and	and	CC
cord-023095-4dannjjm	3519	21	other	other	JJ
cord-023095-4dannjjm	3519	22	oral	oral	JJ
cord-023095-4dannjjm	3519	23	diseases	disease	NNS
cord-023095-4dannjjm	3519	24	as	as	IN
cord-023095-4dannjjm	3519	25	defined	define	VBN
cord-023095-4dannjjm	3519	26	by	by	IN
cord-023095-4dannjjm	3519	27	the	the	DT
cord-023095-4dannjjm	3519	28	practitioner	practitioner	NN
cord-023095-4dannjjm	3519	29	.	.	.
cord-023095-4dannjjm	3520	1	All	all	DT
cord-023095-4dannjjm	3520	2	cats	cat	NNS
cord-023095-4dannjjm	3520	3	were	be	VBD
cord-023095-4dannjjm	3520	4	tested	test	VBN
cord-023095-4dannjjm	3520	5	using	use	VBG
cord-023095-4dannjjm	3520	6	a	a	DT
cord-023095-4dannjjm	3520	7	commercially	commercially	RB
cord-023095-4dannjjm	3520	8	available	available	JJ
cord-023095-4dannjjm	3520	9	point	point	NN
cord-023095-4dannjjm	3520	10	-	-	HYPH
cord-023095-4dannjjm	3520	11	of	of	IN
cord-023095-4dannjjm	3520	12	-	-	HYPH
cord-023095-4dannjjm	3520	13	care	care	NN
cord-023095-4dannjjm	3520	14	ELISA	ELISA	NNP
cord-023095-4dannjjm	3520	15	test	test	NN
cord-023095-4dannjjm	3520	16	(	(	-LRB-
cord-023095-4dannjjm	3520	17	IDEXX	IDEXX	NNP
cord-023095-4dannjjm	3520	18	Snap	Snap	NNP
cord-023095-4dannjjm	3520	19	Combo	Combo	NNP
cord-023095-4dannjjm	3520	20	)	)	-RRB-
cord-023095-4dannjjm	3520	21	.	.	.
cord-023095-4dannjjm	3521	1	Confirmatory	confirmatory	JJ
cord-023095-4dannjjm	3521	2	tests	test	NNS
cord-023095-4dannjjm	3521	3	were	be	VBD
cord-023095-4dannjjm	3521	4	not	not	RB
cord-023095-4dannjjm	3521	5	performed	perform	VBN
cord-023095-4dannjjm	3521	6	as	as	IN
cord-023095-4dannjjm	3521	7	part	part	NN
cord-023095-4dannjjm	3521	8	of	of	IN
cord-023095-4dannjjm	3521	9	the	the	DT
cord-023095-4dannjjm	3521	10	study	study	NN
cord-023095-4dannjjm	3521	11	.	.	.
cord-023095-4dannjjm	3522	1	Seroprevalence	Seroprevalence	NNP
cord-023095-4dannjjm	3522	2	was	be	VBD
cord-023095-4dannjjm	3522	3	calculated	calculate	VBN
cord-023095-4dannjjm	3522	4	as	as	IN
cord-023095-4dannjjm	3522	5	the	the	DT
cord-023095-4dannjjm	3522	6	percentage	percentage	NN
cord-023095-4dannjjm	3522	7	of	of	IN
cord-023095-4dannjjm	3522	8	positive	positive	JJ
cord-023095-4dannjjm	3522	9	tests	test	NNS
cord-023095-4dannjjm	3522	10	in	in	IN
cord-023095-4dannjjm	3522	11	the	the	DT
cord-023095-4dannjjm	3522	12	study	study	NN
cord-023095-4dannjjm	3522	13	population	population	NN
cord-023095-4dannjjm	3522	14	for	for	IN
cord-023095-4dannjjm	3522	15	each	each	DT
cord-023095-4dannjjm	3522	16	virus	virus	NN
cord-023095-4dannjjm	3522	17	.	.	.
cord-023095-4dannjjm	3523	1	A	a	DT
cord-023095-4dannjjm	3523	2	total	total	NN
cord-023095-4dannjjm	3523	3	of	of	IN
cord-023095-4dannjjm	3523	4	11,262	11,262	CD
cord-023095-4dannjjm	3523	5	cats	cat	NNS
cord-023095-4dannjjm	3523	6	were	be	VBD
cord-023095-4dannjjm	3523	7	tested	test	VBN
cord-023095-4dannjjm	3523	8	.	.	.
cord-023095-4dannjjm	3524	1	Seroprevalence	Seroprevalence	NNP
cord-023095-4dannjjm	3524	2	for	for	IN
cord-023095-4dannjjm	3524	3	FeLV	FeLV	NNP
cord-023095-4dannjjm	3524	4	was	be	VBD
cord-023095-4dannjjm	3524	5	6.8	6.8	CD
cord-023095-4dannjjm	3524	6	%	%	NN
cord-023095-4dannjjm	3524	7	and	and	CC
cord-023095-4dannjjm	3524	8	for	for	IN
cord-023095-4dannjjm	3524	9	FIV	FIV	NNP
cord-023095-4dannjjm	3524	10	was	be	VBD
cord-023095-4dannjjm	3524	11	7.1	7.1	CD
cord-023095-4dannjjm	3524	12	%	%	NN
cord-023095-4dannjjm	3524	13	.	.	.
cord-023095-4dannjjm	3525	1	Of	of	IN
cord-023095-4dannjjm	3525	2	these	these	DT
cord-023095-4dannjjm	3525	3	,	,	,
cord-023095-4dannjjm	3525	4	119	119	CD
cord-023095-4dannjjm	3525	5	cats	cat	NNS
cord-023095-4dannjjm	3525	6	(	(	-LRB-
cord-023095-4dannjjm	3525	7	1.0	1.0	CD
cord-023095-4dannjjm	3525	8	%	%	NN
cord-023095-4dannjjm	3525	9	)	)	-RRB-
cord-023095-4dannjjm	3525	10	were	be	VBD
cord-023095-4dannjjm	3525	11	infected	infect	VBN
cord-023095-4dannjjm	3525	12	with	with	IN
cord-023095-4dannjjm	3525	13	both	both	DT
cord-023095-4dannjjm	3525	14	viruses	virus	NNS
cord-023095-4dannjjm	3525	15	.	.	.
cord-023095-4dannjjm	3526	1	Seroprevalence	Seroprevalence	NNP
cord-023095-4dannjjm	3526	2	was	be	VBD
cord-023095-4dannjjm	3526	3	higher	high	JJR
cord-023095-4dannjjm	3526	4	in	in	IN
cord-023095-4dannjjm	3526	5	cats	cat	NNS
cord-023095-4dannjjm	3526	6	with	with	IN
cord-023095-4dannjjm	3526	7	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3526	8	oral	oral	JJ
cord-023095-4dannjjm	3526	9	disease	disease	NN
cord-023095-4dannjjm	3526	10	than	than	IN
cord-023095-4dannjjm	3526	11	in	in	IN
cord-023095-4dannjjm	3526	12	cats	cat	NNS
cord-023095-4dannjjm	3526	13	characterized	characterize	VBN
cord-023095-4dannjjm	3526	14	with	with	IN
cord-023095-4dannjjm	3526	15	other	other	JJ
cord-023095-4dannjjm	3526	16	types	type	NNS
cord-023095-4dannjjm	3526	17	of	of	IN
cord-023095-4dannjjm	3526	18	oral	oral	JJ
cord-023095-4dannjjm	3526	19	disease	disease	NN
cord-023095-4dannjjm	3526	20	.	.	.
cord-023095-4dannjjm	3527	1	Of	of	IN
cord-023095-4dannjjm	3527	2	7,805	7,805	CD
cord-023095-4dannjjm	3527	3	cats	cat	NNS
cord-023095-4dannjjm	3527	4	with	with	IN
cord-023095-4dannjjm	3527	5	gingivitis	gingivitis	NN
cord-023095-4dannjjm	3527	6	,	,	,
cord-023095-4dannjjm	3527	7	seroprevalence	seroprevalence	NN
cord-023095-4dannjjm	3527	8	for	for	IN
cord-023095-4dannjjm	3527	9	FeLV	FeLV	NNP
cord-023095-4dannjjm	3527	10	was	be	VBD
cord-023095-4dannjjm	3527	11	7.4	7.4	CD
cord-023095-4dannjjm	3527	12	%	%	NN
cord-023095-4dannjjm	3527	13	and	and	CC
cord-023095-4dannjjm	3527	14	for	for	IN
cord-023095-4dannjjm	3527	15	FIV	FIV	NNP
cord-023095-4dannjjm	3527	16	was	be	VBD
cord-023095-4dannjjm	3527	17	7.9	7.9	CD
cord-023095-4dannjjm	3527	18	%	%	NN
cord-023095-4dannjjm	3527	19	,	,	,
cord-023095-4dannjjm	3527	20	with	with	IN
cord-023095-4dannjjm	3527	21	1.1	1.1	CD
cord-023095-4dannjjm	3527	22	%	%	NN
cord-023095-4dannjjm	3527	23	of	of	IN
cord-023095-4dannjjm	3527	24	cats	cat	NNS
cord-023095-4dannjjm	3527	25	co	co	VBP
cord-023095-4dannjjm	3527	26	-	-	VBN
cord-023095-4dannjjm	3527	27	infected	infected	JJ
cord-023095-4dannjjm	3527	28	.	.	.
cord-023095-4dannjjm	3528	1	Of	of	IN
cord-023095-4dannjjm	3528	2	1,953	1,953	CD
cord-023095-4dannjjm	3528	3	cats	cat	NNS
cord-023095-4dannjjm	3528	4	with	with	IN
cord-023095-4dannjjm	3528	5	stomatitis	stomatitis	NN
cord-023095-4dannjjm	3528	6	,	,	,
cord-023095-4dannjjm	3528	7	seroprevalence	seroprevalence	NN
cord-023095-4dannjjm	3528	8	for	for	IN
cord-023095-4dannjjm	3528	9	FeLV	FeLV	NNP
cord-023095-4dannjjm	3528	10	was	be	VBD
cord-023095-4dannjjm	3528	11	12.2	12.2	CD
cord-023095-4dannjjm	3528	12	%	%	NN
cord-023095-4dannjjm	3528	13	and	and	CC
cord-023095-4dannjjm	3528	14	for	for	IN
cord-023095-4dannjjm	3528	15	FIV	FIV	NNP
cord-023095-4dannjjm	3528	16	was	be	VBD
cord-023095-4dannjjm	3528	17	13.9	13.9	CD
cord-023095-4dannjjm	3528	18	%	%	NN
cord-023095-4dannjjm	3528	19	,	,	,
cord-023095-4dannjjm	3528	20	with	with	IN
cord-023095-4dannjjm	3528	21	2.2	2.2	CD
cord-023095-4dannjjm	3528	22	%	%	NN
cord-023095-4dannjjm	3528	23	of	of	IN
cord-023095-4dannjjm	3528	24	cats	cat	NNS
cord-023095-4dannjjm	3528	25	co	co	VBP
cord-023095-4dannjjm	3528	26	-	-	VBN
cord-023095-4dannjjm	3528	27	infected	infected	JJ
cord-023095-4dannjjm	3528	28	.	.	.
cord-023095-4dannjjm	3529	1	The	the	DT
cord-023095-4dannjjm	3529	2	seroprevalence	seroprevalence	NN
cord-023095-4dannjjm	3529	3	for	for	IN
cord-023095-4dannjjm	3529	4	FeLV	FeLV	NNP
cord-023095-4dannjjm	3529	5	and	and	CC
cord-023095-4dannjjm	3529	6	FIV	FIV	NNP
cord-023095-4dannjjm	3529	7	reported	report	VBN
cord-023095-4dannjjm	3529	8	in	in	IN
cord-023095-4dannjjm	3529	9	this	this	DT
cord-023095-4dannjjm	3529	10	population	population	NN
cord-023095-4dannjjm	3529	11	of	of	IN
cord-023095-4dannjjm	3529	12	cats	cat	NNS
cord-023095-4dannjjm	3529	13	with	with	IN
cord-023095-4dannjjm	3529	14	oral	oral	JJ
cord-023095-4dannjjm	3529	15	disease	disease	NN
cord-023095-4dannjjm	3529	16	was	be	VBD
cord-023095-4dannjjm	3529	17	higher	high	JJR
cord-023095-4dannjjm	3529	18	than	than	IN
cord-023095-4dannjjm	3529	19	in	in	IN
cord-023095-4dannjjm	3529	20	a	a	DT
cord-023095-4dannjjm	3529	21	recent	recent	JJ
cord-023095-4dannjjm	3529	22	large	large	JJ
cord-023095-4dannjjm	3529	23	study	study	NN
cord-023095-4dannjjm	3529	24	where	where	WRB
cord-023095-4dannjjm	3529	25	samples	sample	NNS
cord-023095-4dannjjm	3529	26	from	from	IN
cord-023095-4dannjjm	3529	27	U.S.	U.S.	NNP
cord-023095-4dannjjm	3529	28	cats	cat	NNS
cord-023095-4dannjjm	3529	29	not	not	RB
cord-023095-4dannjjm	3529	30	specifically	specifically	RB
cord-023095-4dannjjm	3529	31	selected	select	VBN
cord-023095-4dannjjm	3529	32	for	for	IN
cord-023095-4dannjjm	3529	33	oral	oral	JJ
cord-023095-4dannjjm	3529	34	disease	disease	NN
cord-023095-4dannjjm	3529	35	were	be	VBD
cord-023095-4dannjjm	3529	36	tested	test	VBN
cord-023095-4dannjjm	3529	37	(	(	-LRB-
cord-023095-4dannjjm	3529	38	FeLV	FeLV	NNP
cord-023095-4dannjjm	3529	39	2.3	2.3	CD
cord-023095-4dannjjm	3529	40	%	%	NN
cord-023095-4dannjjm	3529	41	,	,	,
cord-023095-4dannjjm	3529	42	FIV	FIV	NNP
cord-023095-4dannjjm	3529	43	2.5	2.5	CD
cord-023095-4dannjjm	3529	44	%	%	NN
cord-023095-4dannjjm	3529	45	)	)	-RRB-
cord-023095-4dannjjm	3529	46	.	.	.
cord-023095-4dannjjm	3530	1	Results	result	NNS
cord-023095-4dannjjm	3530	2	of	of	IN
cord-023095-4dannjjm	3530	3	this	this	DT
cord-023095-4dannjjm	3530	4	study	study	NN
cord-023095-4dannjjm	3530	5	indicate	indicate	VBP
cord-023095-4dannjjm	3530	6	that	that	IN
cord-023095-4dannjjm	3530	7	further	further	JJ
cord-023095-4dannjjm	3530	8	investigation	investigation	NN
cord-023095-4dannjjm	3530	9	of	of	IN
cord-023095-4dannjjm	3530	10	the	the	DT
cord-023095-4dannjjm	3530	11	role	role	NN
cord-023095-4dannjjm	3530	12	of	of	IN
cord-023095-4dannjjm	3530	13	retroviruses	retrovirus	NNS
cord-023095-4dannjjm	3530	14	in	in	IN
cord-023095-4dannjjm	3530	15	cats	cat	NNS
cord-023095-4dannjjm	3530	16	with	with	IN
cord-023095-4dannjjm	3530	17	oropharyngeal	oropharyngeal	JJ
cord-023095-4dannjjm	3530	18	inflammation	inflammation	NN
cord-023095-4dannjjm	3530	19	is	be	VBZ
cord-023095-4dannjjm	3530	20	warranted	warrant	VBN
cord-023095-4dannjjm	3530	21	.	.	.
cord-023095-4dannjjm	3531	1	Reliable	reliable	JJ
cord-023095-4dannjjm	3531	2	tests	test	NNS
cord-023095-4dannjjm	3531	3	and	and	CC
cord-023095-4dannjjm	3531	4	preventive	preventive	JJ
cord-023095-4dannjjm	3531	5	vaccines	vaccine	NNS
cord-023095-4dannjjm	3531	6	and	and	CC
cord-023095-4dannjjm	3531	7	medications	medication	NNS
cord-023095-4dannjjm	3531	8	for	for	IN
cord-023095-4dannjjm	3531	9	feline	feline	JJ
cord-023095-4dannjjm	3531	10	retroviral	retroviral	NN
cord-023095-4dannjjm	3531	11	and	and	CC
cord-023095-4dannjjm	3531	12	heartworm	heartworm	NN
cord-023095-4dannjjm	3532	1	(	(	-LRB-
cord-023095-4dannjjm	3532	2	HW	HW	NNP
cord-023095-4dannjjm	3532	3	)	)	-RRB-
cord-023095-4dannjjm	3532	4	infections	infection	NNS
cord-023095-4dannjjm	3532	5	are	be	VBP
cord-023095-4dannjjm	3532	6	available	available	JJ
cord-023095-4dannjjm	3532	7	,	,	,
cord-023095-4dannjjm	3532	8	but	but	CC
cord-023095-4dannjjm	3532	9	compliance	compliance	NN
cord-023095-4dannjjm	3532	10	with	with	IN
cord-023095-4dannjjm	3532	11	protocols	protocol	NNS
cord-023095-4dannjjm	3532	12	to	to	TO
cord-023095-4dannjjm	3532	13	reduce	reduce	VB
cord-023095-4dannjjm	3532	14	transmission	transmission	NN
cord-023095-4dannjjm	3532	15	is	be	VBZ
cord-023095-4dannjjm	3532	16	unknown	unknown	JJ
cord-023095-4dannjjm	3532	17	.	.	.
cord-023095-4dannjjm	3533	1	No	no	DT
cord-023095-4dannjjm	3533	2	largescale	largescale	JJ
cord-023095-4dannjjm	3533	3	longitudinal	longitudinal	JJ
cord-023095-4dannjjm	3533	4	studies	study	NNS
cord-023095-4dannjjm	3533	5	evaluating	evaluate	VBG
cord-023095-4dannjjm	3533	6	prevalence	prevalence	NN
cord-023095-4dannjjm	3533	7	over	over	IN
cord-023095-4dannjjm	3533	8	time	time	NN
cord-023095-4dannjjm	3533	9	have	have	VBP
cord-023095-4dannjjm	3533	10	been	be	VBN
cord-023095-4dannjjm	3533	11	reported	report	VBN
cord-023095-4dannjjm	3533	12	.	.	.
cord-023095-4dannjjm	3534	1	The	the	DT
cord-023095-4dannjjm	3534	2	purpose	purpose	NN
cord-023095-4dannjjm	3534	3	of	of	IN
cord-023095-4dannjjm	3534	4	this	this	DT
cord-023095-4dannjjm	3534	5	study	study	NN
cord-023095-4dannjjm	3534	6	was	be	VBD
cord-023095-4dannjjm	3534	7	to	to	TO
cord-023095-4dannjjm	3534	8	determine	determine	VB
cord-023095-4dannjjm	3534	9	the	the	DT
cord-023095-4dannjjm	3534	10	prevalence	prevalence	NN
cord-023095-4dannjjm	3534	11	and	and	CC
cord-023095-4dannjjm	3534	12	risk	risk	NN
cord-023095-4dannjjm	3534	13	factors	factor	NNS
cord-023095-4dannjjm	3534	14	for	for	IN
cord-023095-4dannjjm	3534	15	infection	infection	NN
cord-023095-4dannjjm	3534	16	compared	compare	VBN
cord-023095-4dannjjm	3534	17	with	with	IN
cord-023095-4dannjjm	3534	18	a	a	DT
cord-023095-4dannjjm	3534	19	similar	similar	JJ
cord-023095-4dannjjm	3534	20	study	study	NN
cord-023095-4dannjjm	3534	21	completed	complete	VBN
cord-023095-4dannjjm	3534	22	for	for	IN
cord-023095-4dannjjm	3534	23	the	the	DT
cord-023095-4dannjjm	3534	24	first	first	JJ
cord-023095-4dannjjm	3534	25	time	time	NN
cord-023095-4dannjjm	3534	26	5	5	CD
cord-023095-4dannjjm	3534	27	years	year	NNS
cord-023095-4dannjjm	3534	28	previously	previously	RB
cord-023095-4dannjjm	3534	29	.	.	.
cord-023095-4dannjjm	3535	1	Veterinary	veterinary	JJ
cord-023095-4dannjjm	3535	2	clinics	clinic	NNS
cord-023095-4dannjjm	3535	3	and	and	CC
cord-023095-4dannjjm	3535	4	animal	animal	NN
cord-023095-4dannjjm	3535	5	shelters	shelter	NNS
cord-023095-4dannjjm	3535	6	in	in	IN
cord-023095-4dannjjm	3535	7	the	the	DT
cord-023095-4dannjjm	3535	8	US	US	NNP
cord-023095-4dannjjm	3535	9	and	and	CC
cord-023095-4dannjjm	3535	10	Canada	Canada	NNP
cord-023095-4dannjjm	3535	11	submitted	submit	VBD
cord-023095-4dannjjm	3535	12	results	result	NNS
cord-023095-4dannjjm	3535	13	of	of	IN
cord-023095-4dannjjm	3535	14	testing	testing	NN
cord-023095-4dannjjm	3535	15	using	use	VBG
cord-023095-4dannjjm	3535	16	a	a	DT
cord-023095-4dannjjm	3535	17	point	point	NN
cord-023095-4dannjjm	3535	18	-	-	HYPH
cord-023095-4dannjjm	3535	19	of	of	IN
cord-023095-4dannjjm	3535	20	-	-	HYPH
cord-023095-4dannjjm	3535	21	care	care	NN
cord-023095-4dannjjm	3535	22	ELISA	ELISA	NNP
cord-023095-4dannjjm	3535	23	for	for	IN
cord-023095-4dannjjm	3535	24	FeLV	FeLV	NNP
cord-023095-4dannjjm	3535	25	antigen	antigen	NN
cord-023095-4dannjjm	3535	26	,	,	,
cord-023095-4dannjjm	3535	27	FIV	FIV	NNP
cord-023095-4dannjjm	3535	28	antibody	antibody	NN
cord-023095-4dannjjm	3535	29	,	,	,
cord-023095-4dannjjm	3535	30	and	and	CC
cord-023095-4dannjjm	3535	31	HW	HW	NNP
cord-023095-4dannjjm	3535	32	antigen	antigen	NN
cord-023095-4dannjjm	3535	33	(	(	-LRB-
cord-023095-4dannjjm	3536	1	IDEXX	IDEXX	NNP
cord-023095-4dannjjm	3536	2	SNAP	SNAP	NNP
cord-023095-4dannjjm	3536	3	Triple	Triple	NNP
cord-023095-4dannjjm	3536	4	)	)	-RRB-
cord-023095-4dannjjm	3536	5	and	and	CC
cord-023095-4dannjjm	3536	6	risk	risk	NN
cord-023095-4dannjjm	3536	7	factor	factor	NN
cord-023095-4dannjjm	3536	8	information	information	NN
cord-023095-4dannjjm	3536	9	for	for	IN
cord-023095-4dannjjm	3536	10	cats	cat	NNS
cord-023095-4dannjjm	3536	11	tested	test	VBN
cord-023095-4dannjjm	3536	12	during	during	IN
cord-023095-4dannjjm	3536	13	March	March	NNP
cord-023095-4dannjjm	3536	14	-	-	HYPH
cord-023095-4dannjjm	3536	15	September	September	NNP
cord-023095-4dannjjm	3536	16	2010	2010	CD
cord-023095-4dannjjm	3536	17	.	.	.
cord-023095-4dannjjm	3537	1	Bivariable	bivariable	JJ
cord-023095-4dannjjm	3537	2	and	and	CC
cord-023095-4dannjjm	3537	3	multivariable	multivariable	JJ
cord-023095-4dannjjm	3537	4	analyses	analysis	NNS
cord-023095-4dannjjm	3537	5	were	be	VBD
cord-023095-4dannjjm	3537	6	used	use	VBN
cord-023095-4dannjjm	3537	7	to	to	TO
cord-023095-4dannjjm	3537	8	evaluate	evaluate	VB
cord-023095-4dannjjm	3537	9	risk	risk	NN
cord-023095-4dannjjm	3537	10	factors	factor	NNS
cord-023095-4dannjjm	3537	11	for	for	IN
cord-023095-4dannjjm	3537	12	infections	infection	NNS
cord-023095-4dannjjm	3537	13	.	.	.
cord-023095-4dannjjm	3538	1	A	a	DT
cord-023095-4dannjjm	3538	2	total	total	NN
cord-023095-4dannjjm	3538	3	of	of	IN
cord-023095-4dannjjm	3538	4	62,301	62,301	CD
cord-023095-4dannjjm	3538	5	cats	cat	NNS
cord-023095-4dannjjm	3538	6	were	be	VBD
cord-023095-4dannjjm	3538	7	tested	test	VBN
cord-023095-4dannjjm	3538	8	.	.	.
cord-023095-4dannjjm	3539	1	Only	only	RB
cord-023095-4dannjjm	3539	2	16	16	CD
cord-023095-4dannjjm	3539	3	%	%	NN
cord-023095-4dannjjm	3539	4	of	of	IN
cord-023095-4dannjjm	3539	5	owned	own	VBN
cord-023095-4dannjjm	3539	6	cats	cat	NNS
cord-023095-4dannjjm	3539	7	were	be	VBD
cord-023095-4dannjjm	3539	8	prescribed	prescribe	VBN
cord-023095-4dannjjm	3539	9	HW	HW	NNP
cord-023095-4dannjjm	3539	10	preventive	preventive	JJ
cord-023095-4dannjjm	3539	11	.	.	.
cord-023095-4dannjjm	3540	1	Risk	risk	NN
cord-023095-4dannjjm	3540	2	of	of	IN
cord-023095-4dannjjm	3540	3	retroviral	retroviral	JJ
cord-023095-4dannjjm	3540	4	infections	infection	NNS
cord-023095-4dannjjm	3540	5	was	be	VBD
cord-023095-4dannjjm	3540	6	increased	increase	VBN
cord-023095-4dannjjm	3540	7	by	by	IN
cord-023095-4dannjjm	3540	8	outdoor	outdoor	JJ
cord-023095-4dannjjm	3540	9	access	access	NN
cord-023095-4dannjjm	3540	10	,	,	,
cord-023095-4dannjjm	3540	11	adulthood	adulthood	NN
cord-023095-4dannjjm	3540	12	,	,	,
cord-023095-4dannjjm	3540	13	and	and	CC
cord-023095-4dannjjm	3540	14	male	male	JJ
cord-023095-4dannjjm	3540	15	gender	gender	NN
cord-023095-4dannjjm	3540	16	.	.	.
cord-023095-4dannjjm	3541	1	The	the	DT
cord-023095-4dannjjm	3541	2	most	most	RBS
cord-023095-4dannjjm	3541	3	important	important	JJ
cord-023095-4dannjjm	3541	4	risk	risk	NN
cord-023095-4dannjjm	3541	5	factor	factor	NN
cord-023095-4dannjjm	3541	6	associated	associate	VBN
cord-023095-4dannjjm	3541	7	with	with	IN
cord-023095-4dannjjm	3541	8	all	all	DT
cord-023095-4dannjjm	3541	9	3	3	CD
cord-023095-4dannjjm	3541	10	infections	infection	NNS
cord-023095-4dannjjm	3541	11	was	be	VBD
cord-023095-4dannjjm	3541	12	clinical	clinical	JJ
cord-023095-4dannjjm	3541	13	disease	disease	NN
cord-023095-4dannjjm	3541	14	;	;	:
cord-023095-4dannjjm	3541	15	in	in	IN
cord-023095-4dannjjm	3541	16	particular	particular	JJ
cord-023095-4dannjjm	3541	17	,	,	,
cord-023095-4dannjjm	3541	18	respiratory	respiratory	JJ
cord-023095-4dannjjm	3541	19	and	and	CC
cord-023095-4dannjjm	3541	20	oral	oral	JJ
cord-023095-4dannjjm	3541	21	diseases	disease	NNS
cord-023095-4dannjjm	3541	22	and	and	CC
cord-023095-4dannjjm	3541	23	abscesses	abscess	NNS
cord-023095-4dannjjm	3541	24	or	or	CC
cord-023095-4dannjjm	3541	25	bite	bite	NN
cord-023095-4dannjjm	3541	26	wounds	wound	NNS
cord-023095-4dannjjm	3541	27	.	.	.
cord-023095-4dannjjm	3542	1	Multivariate	multivariate	JJ
cord-023095-4dannjjm	3542	2	analysis	analysis	NN
cord-023095-4dannjjm	3542	3	revealed	reveal	VBD
cord-023095-4dannjjm	3542	4	differences	difference	NNS
cord-023095-4dannjjm	3542	5	among	among	IN
cord-023095-4dannjjm	3542	6	geodivisions	geodivision	NNS
cord-023095-4dannjjm	3542	7	and	and	CC
cord-023095-4dannjjm	3542	8	across	across	IN
cord-023095-4dannjjm	3542	9	infection	infection	NN
cord-023095-4dannjjm	3542	10	types	type	NNS
cord-023095-4dannjjm	3542	11	.	.	.
cord-023095-4dannjjm	3543	1	Feline	feline	JJ
cord-023095-4dannjjm	3543	2	retroviral	retroviral	NN
cord-023095-4dannjjm	3543	3	and	and	CC
cord-023095-4dannjjm	3543	4	heartworm	heartworm	NN
cord-023095-4dannjjm	3543	5	infections	infection	NNS
cord-023095-4dannjjm	3543	6	are	be	VBP
cord-023095-4dannjjm	3543	7	easily	easily	RB
cord-023095-4dannjjm	3543	8	prevented	prevent	VBN
cord-023095-4dannjjm	3543	9	,	,	,
cord-023095-4dannjjm	3543	10	but	but	CC
cord-023095-4dannjjm	3543	11	difficult	difficult	JJ
cord-023095-4dannjjm	3543	12	to	to	TO
cord-023095-4dannjjm	3543	13	treat	treat	VB
cord-023095-4dannjjm	3543	14	.	.	.
cord-023095-4dannjjm	3544	1	Despite	despite	IN
cord-023095-4dannjjm	3544	2	availability	availability	NN
cord-023095-4dannjjm	3544	3	of	of	IN
cord-023095-4dannjjm	3544	4	effective	effective	JJ
cord-023095-4dannjjm	3544	5	management	management	NN
cord-023095-4dannjjm	3544	6	protocols	protocol	NNS
cord-023095-4dannjjm	3544	7	,	,	,
cord-023095-4dannjjm	3544	8	compliance	compliance	NN
cord-023095-4dannjjm	3544	9	remains	remain	VBZ
cord-023095-4dannjjm	3544	10	inadequate	inadequate	JJ
cord-023095-4dannjjm	3544	11	to	to	TO
cord-023095-4dannjjm	3544	12	reduce	reduce	VB
cord-023095-4dannjjm	3544	13	the	the	DT
cord-023095-4dannjjm	3544	14	prevalence	prevalence	NN
cord-023095-4dannjjm	3544	15	of	of	IN
cord-023095-4dannjjm	3544	16	these	these	DT
cord-023095-4dannjjm	3544	17	infections	infection	NNS
cord-023095-4dannjjm	3544	18	.	.	.
cord-023095-4dannjjm	3545	1	Improved	improve	VBN
cord-023095-4dannjjm	3545	2	use	use	NN
cord-023095-4dannjjm	3545	3	of	of	IN
cord-023095-4dannjjm	3545	4	preventive	preventive	JJ
cord-023095-4dannjjm	3545	5	care	care	NN
cord-023095-4dannjjm	3545	6	and	and	CC
cord-023095-4dannjjm	3545	7	testing	testing	NN
cord-023095-4dannjjm	3545	8	to	to	TO
cord-023095-4dannjjm	3545	9	identify	identify	VB
cord-023095-4dannjjm	3545	10	and	and	CC
cord-023095-4dannjjm	3545	11	segregate	segregate	VB
cord-023095-4dannjjm	3545	12	contagious	contagious	JJ
cord-023095-4dannjjm	3545	13	cats	cat	NNS
cord-023095-4dannjjm	3545	14	,	,	,
cord-023095-4dannjjm	3545	15	particularly	particularly	RB
cord-023095-4dannjjm	3545	16	those	those	DT
cord-023095-4dannjjm	3545	17	at	at	IN
cord-023095-4dannjjm	3545	18	high	high	JJ
cord-023095-4dannjjm	3545	19	-	-	HYPH
cord-023095-4dannjjm	3545	20	risk	risk	NN
cord-023095-4dannjjm	3545	21	,	,	,
cord-023095-4dannjjm	3545	22	is	be	VBZ
cord-023095-4dannjjm	3545	23	required	require	VBN
cord-023095-4dannjjm	3545	24	to	to	TO
cord-023095-4dannjjm	3545	25	reduce	reduce	VB
cord-023095-4dannjjm	3545	26	the	the	DT
cord-023095-4dannjjm	3545	27	morbidity	morbidity	NN
cord-023095-4dannjjm	3545	28	of	of	IN
cord-023095-4dannjjm	3545	29	these	these	DT
cord-023095-4dannjjm	3545	30	preventable	preventable	JJ
cord-023095-4dannjjm	3545	31	infections	infection	NNS
cord-023095-4dannjjm	3545	32	.	.	.
cord-023095-4dannjjm	3546	1	Infectious	infectious	JJ
cord-023095-4dannjjm	3546	2	disease	disease	NN
cord-023095-4dannjjm	3546	3	outbreaks	outbreak	NNS
cord-023095-4dannjjm	3546	4	are	be	VBP
cord-023095-4dannjjm	3546	5	common	common	JJ
cord-023095-4dannjjm	3546	6	in	in	IN
cord-023095-4dannjjm	3546	7	animal	animal	NN
cord-023095-4dannjjm	3546	8	shelters	shelter	NNS
cord-023095-4dannjjm	3546	9	and	and	CC
cord-023095-4dannjjm	3546	10	are	be	VBP
cord-023095-4dannjjm	3546	11	frequently	frequently	RB
cord-023095-4dannjjm	3546	12	managed	manage	VBN
cord-023095-4dannjjm	3546	13	by	by	IN
cord-023095-4dannjjm	3546	14	depopulation	depopulation	NN
cord-023095-4dannjjm	3546	15	when	when	WRB
cord-023095-4dannjjm	3546	16	risk	risk	NN
cord-023095-4dannjjm	3546	17	-	-	HYPH
cord-023095-4dannjjm	3546	18	assessment	assessment	NN
cord-023095-4dannjjm	3546	19	tools	tool	NNS
cord-023095-4dannjjm	3546	20	are	be	VBP
cord-023095-4dannjjm	3546	21	not	not	RB
cord-023095-4dannjjm	3546	22	available	available	JJ
cord-023095-4dannjjm	3546	23	.	.	.
cord-023095-4dannjjm	3547	1	During	during	IN
cord-023095-4dannjjm	3547	2	a	a	DT
cord-023095-4dannjjm	3547	3	canine	canine	JJ
cord-023095-4dannjjm	3547	4	distemper	distemper	NN
cord-023095-4dannjjm	3547	5	virus	virus	NN
cord-023095-4dannjjm	3547	6	(	(	-LRB-
cord-023095-4dannjjm	3547	7	CDV	CDV	NNP
cord-023095-4dannjjm	3547	8	)	)	-RRB-
cord-023095-4dannjjm	3547	9	and	and	CC
cord-023095-4dannjjm	3547	10	parvovirus	parvovirus	NN
cord-023095-4dannjjm	3547	11	(	(	-LRB-
cord-023095-4dannjjm	3547	12	CPV	CPV	NNP
cord-023095-4dannjjm	3547	13	)	)	-RRB-
cord-023095-4dannjjm	3547	14	outbreak	outbreak	NN
cord-023095-4dannjjm	3547	15	in	in	IN
cord-023095-4dannjjm	3547	16	sheltered	sheltered	JJ
cord-023095-4dannjjm	3547	17	dogs	dog	NNS
cord-023095-4dannjjm	3547	18	,	,	,
cord-023095-4dannjjm	3547	19	we	-PRON-	PRP
cord-023095-4dannjjm	3547	20	used	use	VBD
cord-023095-4dannjjm	3547	21	a	a	DT
cord-023095-4dannjjm	3547	22	CDV	CDV	NNP
cord-023095-4dannjjm	3547	23	/	/	SYM
cord-023095-4dannjjm	3547	24	CPV	cpv	NN
cord-023095-4dannjjm	3547	25	point	point	NN
cord-023095-4dannjjm	3547	26	-	-	HYPH
cord-023095-4dannjjm	3547	27	of	of	IN
cord-023095-4dannjjm	3547	28	-	-	HYPH
cord-023095-4dannjjm	3547	29	care	care	NN
cord-023095-4dannjjm	3547	30	antibody	antibody	NN
cord-023095-4dannjjm	3547	31	titer	titer	NN
cord-023095-4dannjjm	3547	32	ELISA	ELISA	NNP
cord-023095-4dannjjm	3547	33	,	,	,
cord-023095-4dannjjm	3547	34	a	a	DT
cord-023095-4dannjjm	3547	35	CDV	CDV	NNP
cord-023095-4dannjjm	3547	36	quantitative	quantitative	JJ
cord-023095-4dannjjm	3547	37	RT	rt	NN
cord-023095-4dannjjm	3547	38	-	-	HYPH
cord-023095-4dannjjm	3547	39	PCR	PCR	NNP
cord-023095-4dannjjm	3547	40	test	test	NN
cord-023095-4dannjjm	3547	41	,	,	,
cord-023095-4dannjjm	3547	42	and	and	CC
cord-023095-4dannjjm	3547	43	a	a	DT
cord-023095-4dannjjm	3547	44	CPV	cpv	JJ
cord-023095-4dannjjm	3547	45	fecal	fecal	JJ
cord-023095-4dannjjm	3547	46	antigen	antigen	NN
cord-023095-4dannjjm	3547	47	test	test	NN
cord-023095-4dannjjm	3547	48	as	as	IN
cord-023095-4dannjjm	3547	49	risk	risk	NN
cord-023095-4dannjjm	3547	50	assessment	assessment	NN
cord-023095-4dannjjm	3547	51	tools	tool	NNS
cord-023095-4dannjjm	3547	52	to	to	TO
cord-023095-4dannjjm	3547	53	guide	guide	VB
cord-023095-4dannjjm	3547	54	release	release	NN
cord-023095-4dannjjm	3547	55	of	of	IN
cord-023095-4dannjjm	3547	56	exposed	expose	VBN
cord-023095-4dannjjm	3547	57	dogs	dog	NNS
cord-023095-4dannjjm	3547	58	from	from	IN
cord-023095-4dannjjm	3547	59	quarantine	quarantine	NN
cord-023095-4dannjjm	3547	60	and	and	CC
cord-023095-4dannjjm	3547	61	euthanasia	euthanasia	NN
cord-023095-4dannjjm	3547	62	of	of	IN
cord-023095-4dannjjm	3547	63	diseased	diseased	JJ
cord-023095-4dannjjm	3547	64	dogs	dog	NNS
cord-023095-4dannjjm	3547	65	.	.	.
cord-023095-4dannjjm	3548	1	Serum	serum	NN
cord-023095-4dannjjm	3548	2	samples	sample	NNS
cord-023095-4dannjjm	3548	3	(	(	-LRB-
cord-023095-4dannjjm	3548	4	for	for	IN
cord-023095-4dannjjm	3548	5	antibody	antibody	NN
cord-023095-4dannjjm	3548	6	titers	titer	NNS
cord-023095-4dannjjm	3548	7	)	)	-RRB-
cord-023095-4dannjjm	3548	8	and	and	CC
cord-023095-4dannjjm	3548	9	swabs	swab	NNS
cord-023095-4dannjjm	3548	10	of	of	IN
cord-023095-4dannjjm	3548	11	the	the	DT
cord-023095-4dannjjm	3548	12	conjunctiva	conjunctiva	NN
cord-023095-4dannjjm	3548	13	and	and	CC
cord-023095-4dannjjm	3548	14	upper	upper	JJ
cord-023095-4dannjjm	3548	15	respiratory	respiratory	JJ
cord-023095-4dannjjm	3548	16	tract	tract	NN
cord-023095-4dannjjm	3548	17	(	(	-LRB-
cord-023095-4dannjjm	3548	18	for	for	IN
cord-023095-4dannjjm	3548	19	CDV	CDV	NNP
cord-023095-4dannjjm	3548	20	PCR	PCR	NNP
cord-023095-4dannjjm	3548	21	)	)	-RRB-
cord-023095-4dannjjm	3548	22	were	be	VBD
cord-023095-4dannjjm	3548	23	collected	collect	VBN
cord-023095-4dannjjm	3548	24	from	from	IN
cord-023095-4dannjjm	3548	25	111	111	CD
cord-023095-4dannjjm	3548	26	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	3548	27	dogs	dog	NNS
cord-023095-4dannjjm	3548	28	starting	start	VBG
cord-023095-4dannjjm	3548	29	on	on	IN
cord-023095-4dannjjm	3548	30	Day	Day	NNP
cord-023095-4dannjjm	3548	31	4	4	CD
cord-023095-4dannjjm	3548	32	of	of	IN
cord-023095-4dannjjm	3548	33	the	the	DT
cord-023095-4dannjjm	3548	34	outbreak	outbreak	NN
cord-023095-4dannjjm	3548	35	.	.	.
cord-023095-4dannjjm	3549	1	Dogs	dog	NNS
cord-023095-4dannjjm	3549	2	with	with	IN
cord-023095-4dannjjm	3549	3	positive	positive	JJ
cord-023095-4dannjjm	3549	4	CDV	CDV	NNP
cord-023095-4dannjjm	3549	5	PCR	PCR	NNP
cord-023095-4dannjjm	3549	6	tests	test	NNS
cord-023095-4dannjjm	3549	7	were	be	VBD
cord-023095-4dannjjm	3549	8	retested	reteste	VBN
cord-023095-4dannjjm	3549	9	every	every	DT
cord-023095-4dannjjm	3549	10	2	2	CD
cord-023095-4dannjjm	3549	11	weeks	week	NNS
cord-023095-4dannjjm	3549	12	until	until	IN
cord-023095-4dannjjm	3549	13	euthanized	euthanize	VBN
cord-023095-4dannjjm	3549	14	for	for	IN
cord-023095-4dannjjm	3549	15	progressive	progressive	JJ
cord-023095-4dannjjm	3549	16	disease	disease	NN
cord-023095-4dannjjm	3549	17	or	or	CC
cord-023095-4dannjjm	3549	18	released	release	VBN
cord-023095-4dannjjm	3549	19	following	follow	VBG
cord-023095-4dannjjm	3549	20	recovery	recovery	NN
cord-023095-4dannjjm	3549	21	from	from	IN
cord-023095-4dannjjm	3549	22	infection	infection	NN
cord-023095-4dannjjm	3549	23	.	.	.
cord-023095-4dannjjm	3550	1	Dogs	dog	NNS
cord-023095-4dannjjm	3550	2	with	with	IN
cord-023095-4dannjjm	3550	3	clinical	clinical	JJ
cord-023095-4dannjjm	3550	4	signs	sign	NNS
cord-023095-4dannjjm	3550	5	of	of	IN
cord-023095-4dannjjm	3550	6	parvoviral	parvoviral	JJ
cord-023095-4dannjjm	3550	7	infection	infection	NN
cord-023095-4dannjjm	3550	8	were	be	VBD
cord-023095-4dannjjm	3550	9	tested	test	VBN
cord-023095-4dannjjm	3550	10	using	use	VBG
cord-023095-4dannjjm	3550	11	a	a	DT
cord-023095-4dannjjm	3550	12	CPV	CPV	NNP
cord-023095-4dannjjm	3550	13	fecal	fecal	JJ
cord-023095-4dannjjm	3550	14	antigen	antigen	NN
cord-023095-4dannjjm	3550	15	test	test	NN
cord-023095-4dannjjm	3550	16	.	.	.
cord-023095-4dannjjm	3551	1	For	for	IN
cord-023095-4dannjjm	3551	2	dogs	dog	NNS
cord-023095-4dannjjm	3551	3	!	!	.
cord-023095-4dannjjm	3551	4	4	4	CD
cord-023095-4dannjjm	3551	5	months	month	NNS
cord-023095-4dannjjm	3551	6	old	old	JJ
cord-023095-4dannjjm	3551	7	,	,	,
cord-023095-4dannjjm	3551	8	protective	protective	JJ
cord-023095-4dannjjm	3551	9	antibody	antibody	NN
cord-023095-4dannjjm	3551	10	titers	titer	NNS
cord-023095-4dannjjm	3551	11	correlated	correlate	VBD
cord-023095-4dannjjm	3551	12	with	with	IN
cord-023095-4dannjjm	3551	13	resistance	resistance	NN
cord-023095-4dannjjm	3551	14	to	to	IN
cord-023095-4dannjjm	3551	15	clinical	clinical	JJ
cord-023095-4dannjjm	3551	16	disease	disease	NN
cord-023095-4dannjjm	3551	17	,	,	,
cord-023095-4dannjjm	3551	18	but	but	CC
cord-023095-4dannjjm	3551	19	10	10	CD
cord-023095-4dannjjm	3551	20	%	%	NN
cord-023095-4dannjjm	3551	21	of	of	IN
cord-023095-4dannjjm	3551	22	dogs	dog	NNS
cord-023095-4dannjjm	3551	23	shed	shed	VBD
cord-023095-4dannjjm	3551	24	CDV	CDV	NNP
cord-023095-4dannjjm	3551	25	.	.	.
cord-023095-4dannjjm	3552	1	Lack	lack	NN
cord-023095-4dannjjm	3552	2	of	of	IN
cord-023095-4dannjjm	3552	3	protective	protective	JJ
cord-023095-4dannjjm	3552	4	CDV	CDV	NNP
cord-023095-4dannjjm	3552	5	antibody	antibody	NN
cord-023095-4dannjjm	3552	6	titers	titer	NNS
cord-023095-4dannjjm	3552	7	correlated	correlate	VBD
cord-023095-4dannjjm	3552	8	with	with	IN
cord-023095-4dannjjm	3552	9	susceptibility	susceptibility	NN
cord-023095-4dannjjm	3552	10	to	to	IN
cord-023095-4dannjjm	3552	11	clinical	clinical	JJ
cord-023095-4dannjjm	3552	12	infection	infection	NN
cord-023095-4dannjjm	3552	13	,	,	,
cord-023095-4dannjjm	3552	14	but	but	CC
cord-023095-4dannjjm	3552	15	most	most	JJS
cord-023095-4dannjjm	3552	16	dogs	dog	NNS
cord-023095-4dannjjm	3552	17	recovered	recover	VBD
cord-023095-4dannjjm	3552	18	.	.	.
cord-023095-4dannjjm	3553	1	Risk	risk	NN
cord-023095-4dannjjm	3553	2	assessment	assessment	NN
cord-023095-4dannjjm	3553	3	and	and	CC
cord-023095-4dannjjm	3553	4	outcome	outcome	NN
cord-023095-4dannjjm	3553	5	in	in	IN
cord-023095-4dannjjm	3553	6	60	60	CD
cord-023095-4dannjjm	3553	7	dogs	dog	NNS
cord-023095-4dannjjm	3553	8	!	!	.
cord-023095-4dannjjm	3554	1	4	4	CD
cord-023095-4dannjjm	3554	2	months	month	NNS
cord-023095-4dannjjm	3554	3	of	of	IN
cord-023095-4dannjjm	3554	4	age	age	NN
cord-023095-4dannjjm	3554	5	Feline	feline	JJ
cord-023095-4dannjjm	3554	6	herpesvirus	herpesvirus	NN
cord-023095-4dannjjm	3554	7	1	1	CD
cord-023095-4dannjjm	3554	8	(	(	-LRB-
cord-023095-4dannjjm	3554	9	FHV-1	FHV-1	NNP
cord-023095-4dannjjm	3554	10	)	)	-RRB-
cord-023095-4dannjjm	3554	11	is	be	VBZ
cord-023095-4dannjjm	3554	12	a	a	DT
cord-023095-4dannjjm	3554	13	common	common	JJ
cord-023095-4dannjjm	3554	14	ocular	ocular	JJ
cord-023095-4dannjjm	3554	15	and	and	CC
cord-023095-4dannjjm	3554	16	respiratory	respiratory	JJ
cord-023095-4dannjjm	3554	17	pathogen	pathogen	NN
cord-023095-4dannjjm	3554	18	of	of	IN
cord-023095-4dannjjm	3554	19	cats	cat	NNS
cord-023095-4dannjjm	3554	20	that	that	WDT
cord-023095-4dannjjm	3554	21	can	can	MD
cord-023095-4dannjjm	3554	22	have	have	VB
cord-023095-4dannjjm	3554	23	clinical	clinical	JJ
cord-023095-4dannjjm	3554	24	illness	illness	NN
cord-023095-4dannjjm	3554	25	exacerbated	exacerbate	VBN
cord-023095-4dannjjm	3554	26	by	by	IN
cord-023095-4dannjjm	3554	27	stress	stress	NN
cord-023095-4dannjjm	3554	28	.	.	.
cord-023095-4dannjjm	3555	1	Cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3555	2	(	(	-LRB-
cord-023095-4dannjjm	3555	3	CsA	CsA	NNP
cord-023095-4dannjjm	3555	4	)	)	-RRB-
cord-023095-4dannjjm	3555	5	is	be	VBZ
cord-023095-4dannjjm	3555	6	commonly	commonly	RB
cord-023095-4dannjjm	3555	7	used	use	VBN
cord-023095-4dannjjm	3555	8	for	for	IN
cord-023095-4dannjjm	3555	9	the	the	DT
cord-023095-4dannjjm	3555	10	treatment	treatment	NN
cord-023095-4dannjjm	3555	11	of	of	IN
cord-023095-4dannjjm	3555	12	a	a	DT
cord-023095-4dannjjm	3555	13	number	number	NN
cord-023095-4dannjjm	3555	14	of	of	IN
cord-023095-4dannjjm	3555	15	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3555	16	diseases	disease	NNS
cord-023095-4dannjjm	3555	17	in	in	IN
cord-023095-4dannjjm	3555	18	cats	cat	NNS
cord-023095-4dannjjm	3555	19	and	and	CC
cord-023095-4dannjjm	3555	20	can	can	MD
cord-023095-4dannjjm	3555	21	induce	induce	VB
cord-023095-4dannjjm	3555	22	immune	immune	JJ
cord-023095-4dannjjm	3555	23	suppression	suppression	NN
cord-023095-4dannjjm	3555	24	.	.	.
cord-023095-4dannjjm	3556	1	A	a	DT
cord-023095-4dannjjm	3556	2	small	small	JJ
cord-023095-4dannjjm	3556	3	number	number	NN
cord-023095-4dannjjm	3556	4	of	of	IN
cord-023095-4dannjjm	3556	5	cats	cat	NNS
cord-023095-4dannjjm	3556	6	administered	administer	VBD
cord-023095-4dannjjm	3556	7	CsA	CsA	NNP
cord-023095-4dannjjm	3556	8	to	to	TO
cord-023095-4dannjjm	3556	9	block	block	VB
cord-023095-4dannjjm	3556	10	renal	renal	JJ
cord-023095-4dannjjm	3556	11	transplant	transplant	NN
cord-023095-4dannjjm	3556	12	rejection	rejection	NN
cord-023095-4dannjjm	3556	13	have	have	VBP
cord-023095-4dannjjm	3556	14	developed	develop	VBN
cord-023095-4dannjjm	3556	15	clinical	clinical	JJ
cord-023095-4dannjjm	3556	16	signs	sign	NNS
cord-023095-4dannjjm	3556	17	of	of	IN
cord-023095-4dannjjm	3556	18	upper	upper	JJ
cord-023095-4dannjjm	3556	19	respiratory	respiratory	JJ
cord-023095-4dannjjm	3556	20	tract	tract	NN
cord-023095-4dannjjm	3556	21	disease	disease	NN
cord-023095-4dannjjm	3556	22	that	that	WDT
cord-023095-4dannjjm	3556	23	may	may	MD
cord-023095-4dannjjm	3556	24	have	have	VB
cord-023095-4dannjjm	3556	25	been	be	VBN
cord-023095-4dannjjm	3556	26	from	from	IN
cord-023095-4dannjjm	3556	27	activated	activate	VBN
cord-023095-4dannjjm	3556	28	FHV-1	FHV-1	NNP
cord-023095-4dannjjm	3556	29	.	.	.
cord-023095-4dannjjm	3557	1	In	in	IN
cord-023095-4dannjjm	3557	2	this	this	DT
cord-023095-4dannjjm	3557	3	study	study	NN
cord-023095-4dannjjm	3557	4	,	,	,
cord-023095-4dannjjm	3557	5	young	young	JJ
cord-023095-4dannjjm	3557	6	adult	adult	NN
cord-023095-4dannjjm	3557	7	cats	cat	NNS
cord-023095-4dannjjm	3557	8	experimentally	experimentally	RB
cord-023095-4dannjjm	3557	9	inoculated	inoculate	VBD
cord-023095-4dannjjm	3557	10	with	with	IN
cord-023095-4dannjjm	3557	11	FHV-1	FHV-1	NNP
cord-023095-4dannjjm	3557	12	several	several	JJ
cord-023095-4dannjjm	3557	13	months	month	NNS
cord-023095-4dannjjm	3557	14	previously	previously	RB
cord-023095-4dannjjm	3557	15	were	be	VBD
cord-023095-4dannjjm	3557	16	divided	divide	VBN
cord-023095-4dannjjm	3557	17	into	into	IN
cord-023095-4dannjjm	3557	18	three	three	CD
cord-023095-4dannjjm	3557	19	groups	group	NNS
cord-023095-4dannjjm	3557	20	and	and	CC
cord-023095-4dannjjm	3557	21	administered	administer	VBN
cord-023095-4dannjjm	3557	22	methylprednisolone	methylprednisolone	NN
cord-023095-4dannjjm	3557	23	acetate	acetate	NN
cord-023095-4dannjjm	3557	24	(	(	-LRB-
cord-023095-4dannjjm	3557	25	8	8	CD
cord-023095-4dannjjm	3557	26	cats	cat	NNS
cord-023095-4dannjjm	3557	27	,	,	,
cord-023095-4dannjjm	3557	28	5	5	CD
cord-023095-4dannjjm	3557	29	mg	mg	NNP
cord-023095-4dannjjm	3557	30	/	/	SYM
cord-023095-4dannjjm	3557	31	kg	kg	NNP
cord-023095-4dannjjm	3557	32	,	,	,
cord-023095-4dannjjm	3557	33	IM	im	UH
cord-023095-4dannjjm	3557	34	,	,	,
cord-023095-4dannjjm	3557	35	Day	Day	NNP
cord-023095-4dannjjm	3557	36	0	0	NFP
cord-023095-4dannjjm	3557	37	and	and	CC
cord-023095-4dannjjm	3557	38	Day	Day	NNP
cord-023095-4dannjjm	3557	39	21	21	CD
cord-023095-4dannjjm	3557	40	)	)	-RRB-
cord-023095-4dannjjm	3557	41	,	,	,
cord-023095-4dannjjm	3557	42	CsA	CsA	NNP
cord-023095-4dannjjm	3557	43	(	(	-LRB-
cord-023095-4dannjjm	3557	44	8	8	CD
cord-023095-4dannjjm	3557	45	cats	cat	NNS
cord-023095-4dannjjm	3557	46	,	,	,
cord-023095-4dannjjm	3557	47	7.0	7.0	CD
cord-023095-4dannjjm	3557	48	mg	mg	NNP
cord-023095-4dannjjm	3557	49	/	/	SYM
cord-023095-4dannjjm	3557	50	kg	kg	NNP
cord-023095-4dannjjm	3557	51	,	,	,
cord-023095-4dannjjm	3557	52	PO	PO	NNP
cord-023095-4dannjjm	3557	53	,	,	,
cord-023095-4dannjjm	3557	54	daily	daily	RB
cord-023095-4dannjjm	3557	55	for	for	IN
cord-023095-4dannjjm	3557	56	42	42	CD
cord-023095-4dannjjm	3557	57	days	day	NNS
cord-023095-4dannjjm	3557	58	)	)	-RRB-
cord-023095-4dannjjm	3557	59	,	,	,
cord-023095-4dannjjm	3557	60	or	or	CC
cord-023095-4dannjjm	3557	61	a	a	DT
cord-023095-4dannjjm	3557	62	placebo	placebo	NN
cord-023095-4dannjjm	3557	63	(	(	-LRB-
cord-023095-4dannjjm	3557	64	7	7	CD
cord-023095-4dannjjm	3557	65	cats	cat	NNS
cord-023095-4dannjjm	3557	66	,	,	,
cord-023095-4dannjjm	3557	67	corn	corn	NN
cord-023095-4dannjjm	3557	68	syrup	syrup	NN
cord-023095-4dannjjm	3557	69	;	;	:
cord-023095-4dannjjm	3557	70	0.075	0.075	CD
cord-023095-4dannjjm	3557	71	mL	ml	NN
cord-023095-4dannjjm	3557	72	/	/	SYM
cord-023095-4dannjjm	3557	73	kg	kg	NNS
cord-023095-4dannjjm	3557	74	,	,	,
cord-023095-4dannjjm	3557	75	PO	PO	NNP
cord-023095-4dannjjm	3557	76	,	,	,
cord-023095-4dannjjm	3557	77	daily	daily	RB
cord-023095-4dannjjm	3557	78	for	for	IN
cord-023095-4dannjjm	3557	79	42	42	CD
cord-023095-4dannjjm	3557	80	days	day	NNS
cord-023095-4dannjjm	3557	81	)	)	-RRB-
cord-023095-4dannjjm	3557	82	.	.	.
cord-023095-4dannjjm	3558	1	Each	each	DT
cord-023095-4dannjjm	3558	2	cat	cat	NN
cord-023095-4dannjjm	3558	3	was	be	VBD
cord-023095-4dannjjm	3558	4	assigned	assign	VBN
cord-023095-4dannjjm	3558	5	a	a	DT
cord-023095-4dannjjm	3558	6	daily	daily	JJ
cord-023095-4dannjjm	3558	7	individual	individual	JJ
cord-023095-4dannjjm	3558	8	clinical	clinical	JJ
cord-023095-4dannjjm	3558	9	score	score	NN
cord-023095-4dannjjm	3558	10	by	by	IN
cord-023095-4dannjjm	3558	11	a	a	DT
cord-023095-4dannjjm	3558	12	trained	train	VBN
cord-023095-4dannjjm	3558	13	,	,	,
cord-023095-4dannjjm	3558	14	masked	masked	JJ
cord-023095-4dannjjm	3558	15	observer	observer	NN
cord-023095-4dannjjm	3558	16	using	use	VBG
cord-023095-4dannjjm	3558	17	a	a	DT
cord-023095-4dannjjm	3558	18	standardized	standardized	JJ
cord-023095-4dannjjm	3558	19	score	score	NN
cord-023095-4dannjjm	3558	20	sheet	sheet	NN
cord-023095-4dannjjm	3558	21	during	during	IN
cord-023095-4dannjjm	3558	22	the	the	DT
cord-023095-4dannjjm	3558	23	initial	initial	JJ
cord-023095-4dannjjm	3558	24	pre	pre	JJ
cord-023095-4dannjjm	3558	25	-	-	JJ
cord-023095-4dannjjm	3558	26	treatment	treatment	JJ
cord-023095-4dannjjm	3558	27	time	time	NN
cord-023095-4dannjjm	3558	28	period	period	NN
cord-023095-4dannjjm	3558	29	(	(	-LRB-
cord-023095-4dannjjm	3558	30	Day	day	NN
cord-023095-4dannjjm	3558	31	-14	-14	NN
cord-023095-4dannjjm	3558	32	to	to	IN
cord-023095-4dannjjm	3558	33	Day	day	NN
cord-023095-4dannjjm	3558	34	0	0	CD
cord-023095-4dannjjm	3558	35	)	)	-RRB-
cord-023095-4dannjjm	3558	36	and	and	CC
cord-023095-4dannjjm	3558	37	throughout	throughout	IN
cord-023095-4dannjjm	3558	38	the	the	DT
cord-023095-4dannjjm	3558	39	42	42	CD
cord-023095-4dannjjm	3558	40	day	day	NN
cord-023095-4dannjjm	3558	41	treatment	treatment	NN
cord-023095-4dannjjm	3558	42	period	period	NN
cord-023095-4dannjjm	3558	43	.	.	.
cord-023095-4dannjjm	3559	1	Each	each	DT
cord-023095-4dannjjm	3559	2	individual	individual	JJ
cord-023095-4dannjjm	3559	3	clinical	clinical	JJ
cord-023095-4dannjjm	3559	4	score	score	NN
cord-023095-4dannjjm	3559	5	(	(	-LRB-
cord-023095-4dannjjm	3559	6	conjunctivitis	conjunctivitis	NN
cord-023095-4dannjjm	3559	7	,	,	,
cord-023095-4dannjjm	3559	8	blepharospasm	blepharospasm	NN
cord-023095-4dannjjm	3559	9	,	,	,
cord-023095-4dannjjm	3559	10	ocular	ocular	JJ
cord-023095-4dannjjm	3559	11	discharge	discharge	NN
cord-023095-4dannjjm	3559	12	,	,	,
cord-023095-4dannjjm	3559	13	sneezing	sneezing	NN
cord-023095-4dannjjm	3559	14	,	,	,
cord-023095-4dannjjm	3559	15	nasal	nasal	NN
cord-023095-4dannjjm	3559	16	discharge	discharge	NN
cord-023095-4dannjjm	3559	17	,	,	,
cord-023095-4dannjjm	3559	18	nasal	nasal	NN
cord-023095-4dannjjm	3559	19	congestion	congestion	NN
cord-023095-4dannjjm	3559	20	,	,	,
cord-023095-4dannjjm	3559	21	and	and	CC
cord-023095-4dannjjm	3559	22	body	body	NN
cord-023095-4dannjjm	3559	23	temperature	temperature	NN
cord-023095-4dannjjm	3559	24	scores	score	NNS
cord-023095-4dannjjm	3559	25	)	)	-RRB-
cord-023095-4dannjjm	3559	26	,	,	,
cord-023095-4dannjjm	3559	27	the	the	DT
cord-023095-4dannjjm	3559	28	total	total	JJ
cord-023095-4dannjjm	3559	29	clinical	clinical	JJ
cord-023095-4dannjjm	3559	30	score	score	NN
cord-023095-4dannjjm	3559	31	(	(	-LRB-
cord-023095-4dannjjm	3559	32	sum	sum	NN
cord-023095-4dannjjm	3559	33	of	of	IN
cord-023095-4dannjjm	3559	34	all	all	DT
cord-023095-4dannjjm	3559	35	parameters	parameter	NNS
cord-023095-4dannjjm	3559	36	)	)	-RRB-
cord-023095-4dannjjm	3559	37	,	,	,
cord-023095-4dannjjm	3559	38	the	the	DT
cord-023095-4dannjjm	3559	39	total	total	JJ
cord-023095-4dannjjm	3559	40	ocular	ocular	JJ
cord-023095-4dannjjm	3559	41	score	score	NN
cord-023095-4dannjjm	3559	42	(	(	-LRB-
cord-023095-4dannjjm	3559	43	sum	sum	NN
cord-023095-4dannjjm	3559	44	of	of	IN
cord-023095-4dannjjm	3559	45	conjunctivitis	conjunctivitis	NN
cord-023095-4dannjjm	3559	46	,	,	,
cord-023095-4dannjjm	3559	47	blepharospasm	blepharospasm	NN
cord-023095-4dannjjm	3559	48	,	,	,
cord-023095-4dannjjm	3559	49	ocular	ocular	JJ
cord-023095-4dannjjm	3559	50	discharge	discharge	NN
cord-023095-4dannjjm	3559	51	)	)	-RRB-
cord-023095-4dannjjm	3559	52	,	,	,
cord-023095-4dannjjm	3559	53	and	and	CC
cord-023095-4dannjjm	3559	54	total	total	JJ
cord-023095-4dannjjm	3559	55	respiratory	respiratory	JJ
cord-023095-4dannjjm	3559	56	score	score	NN
cord-023095-4dannjjm	3559	57	(	(	-LRB-
cord-023095-4dannjjm	3559	58	sum	sum	NN
cord-023095-4dannjjm	3559	59	of	of	IN
cord-023095-4dannjjm	3559	60	ocular	ocular	JJ
cord-023095-4dannjjm	3559	61	discharge	discharge	NN
cord-023095-4dannjjm	3559	62	,	,	,
cord-023095-4dannjjm	3559	63	sneezing	sneezing	NN
cord-023095-4dannjjm	3559	64	,	,	,
cord-023095-4dannjjm	3559	65	nasal	nasal	NN
cord-023095-4dannjjm	3559	66	discharge	discharge	NN
cord-023095-4dannjjm	3559	67	,	,	,
cord-023095-4dannjjm	3559	68	nasal	nasal	NN
cord-023095-4dannjjm	3559	69	congestion	congestion	NN
cord-023095-4dannjjm	3559	70	)	)	-RRB-
cord-023095-4dannjjm	3559	71	were	be	VBD
cord-023095-4dannjjm	3559	72	analyzed	analyze	VBN
cord-023095-4dannjjm	3559	73	using	use	VBG
cord-023095-4dannjjm	3559	74	SAS	SAS	NNP
cord-023095-4dannjjm	3559	75	PROC	PROC	NNP
cord-023095-4dannjjm	3559	76	GLIMMIX	GLIMMIX	NNP
cord-023095-4dannjjm	3559	77	with	with	IN
cord-023095-4dannjjm	3559	78	'	'	``
cord-023095-4dannjjm	3559	79	Treatment	Treatment	NNP
cord-023095-4dannjjm	3559	80	'	'	''
cord-023095-4dannjjm	3559	81	,	,	,
cord-023095-4dannjjm	3559	82	'	'	''
cord-023095-4dannjjm	3559	83	Time	Time	NNP
cord-023095-4dannjjm	3559	84	'	'	''
cord-023095-4dannjjm	3559	85	,	,	,
cord-023095-4dannjjm	3559	86	and	and	CC
cord-023095-4dannjjm	3559	87	the	the	DT
cord-023095-4dannjjm	3559	88	two	two	CD
cord-023095-4dannjjm	3559	89	-	-	HYPH
cord-023095-4dannjjm	3559	90	way	way	NN
cord-023095-4dannjjm	3559	91	interaction	interaction	NN
cord-023095-4dannjjm	3559	92	'	'	''
cord-023095-4dannjjm	3559	93	Treatment	treatment	NN
cord-023095-4dannjjm	3559	94	by	by	IN
cord-023095-4dannjjm	3559	95	Time	Time	NNP
cord-023095-4dannjjm	3559	96	'	'	''
cord-023095-4dannjjm	3559	97	all	all	DT
cord-023095-4dannjjm	3559	98	as	as	IN
cord-023095-4dannjjm	3559	99	fixed	fix	VBN
cord-023095-4dannjjm	3559	100	effects	effect	NNS
cord-023095-4dannjjm	3559	101	.	.	.
cord-023095-4dannjjm	3560	1	Statistical	statistical	JJ
cord-023095-4dannjjm	3560	2	significance	significance	NN
cord-023095-4dannjjm	3560	3	was	be	VBD
cord-023095-4dannjjm	3560	4	defined	define	VBN
cord-023095-4dannjjm	3560	5	as	as	IN
cord-023095-4dannjjm	3560	6	p	p	NN
cord-023095-4dannjjm	3560	7	o	o	NN
cord-023095-4dannjjm	3560	8	0.05	0.05	CD
cord-023095-4dannjjm	3560	9	.	.	.
cord-023095-4dannjjm	3561	1	On	on	IN
cord-023095-4dannjjm	3561	2	Day	Day	NNP
cord-023095-4dannjjm	3561	3	42	42	CD
cord-023095-4dannjjm	3561	4	of	of	IN
cord-023095-4dannjjm	3561	5	the	the	DT
cord-023095-4dannjjm	3561	6	study	study	NN
cord-023095-4dannjjm	3561	7	,	,	,
cord-023095-4dannjjm	3561	8	all	all	DT
cord-023095-4dannjjm	3561	9	of	of	IN
cord-023095-4dannjjm	3561	10	the	the	DT
cord-023095-4dannjjm	3561	11	CsA	CsA	NNP
cord-023095-4dannjjm	3561	12	treated	treat	VBN
cord-023095-4dannjjm	3561	13	cats	cat	NNS
cord-023095-4dannjjm	3561	14	had	have	VBD
cord-023095-4dannjjm	3561	15	detectable	detectable	JJ
cord-023095-4dannjjm	3561	16	concentrations	concentration	NNS
cord-023095-4dannjjm	3561	17	of	of	IN
cord-023095-4dannjjm	3561	18	CsA	csa	NN
cord-023095-4dannjjm	3561	19	in	in	IN
cord-023095-4dannjjm	3561	20	serum	serum	NN
cord-023095-4dannjjm	3562	1	(	(	-LRB-
cord-023095-4dannjjm	3562	2	Mean	mean	JJ
cord-023095-4dannjjm	3562	3	5	5	CD
cord-023095-4dannjjm	3562	4	406.1	406.1	CD
cord-023095-4dannjjm	3562	5	ng	ng	NN
cord-023095-4dannjjm	3562	6	/	/	SYM
cord-023095-4dannjjm	3562	7	ml	ml	NN
cord-023095-4dannjjm	3562	8	;	;	:
cord-023095-4dannjjm	3562	9	standard	standard	JJ
cord-023095-4dannjjm	3562	10	deviation	deviation	NN
cord-023095-4dannjjm	3562	11	5	5	CD
cord-023095-4dannjjm	3562	12	291.8	291.8	CD
cord-023095-4dannjjm	3562	13	ng	ng	NN
cord-023095-4dannjjm	3562	14	/	/	SYM
cord-023095-4dannjjm	3562	15	ml	ml	NN
cord-023095-4dannjjm	3562	16	;	;	:
cord-023095-4dannjjm	3563	1	Median	median	JJ
cord-023095-4dannjjm	3563	2	5	5	CD
cord-023095-4dannjjm	3563	3	388.5	388.5	CD
cord-023095-4dannjjm	3563	4	ng	ng	NN
cord-023095-4dannjjm	3563	5	/	/	SYM
cord-023095-4dannjjm	3563	6	ml	ml	NN
cord-023095-4dannjjm	3563	7	)	)	-RRB-
cord-023095-4dannjjm	3563	8	.	.	.
cord-023095-4dannjjm	3564	1	When	when	WRB
cord-023095-4dannjjm	3564	2	group	group	NN
cord-023095-4dannjjm	3564	3	mean	mean	JJ
cord-023095-4dannjjm	3564	4	values	value	NNS
cord-023095-4dannjjm	3564	5	for	for	IN
cord-023095-4dannjjm	3564	6	clinical	clinical	JJ
cord-023095-4dannjjm	3564	7	signs	sign	NNS
cord-023095-4dannjjm	3564	8	were	be	VBD
cord-023095-4dannjjm	3564	9	compared	compare	VBN
cord-023095-4dannjjm	3564	10	over	over	IN
cord-023095-4dannjjm	3564	11	time	time	NN
cord-023095-4dannjjm	3564	12	as	as	IN
cord-023095-4dannjjm	3564	13	described	describe	VBN
cord-023095-4dannjjm	3564	14	,	,	,
cord-023095-4dannjjm	3564	15	significant	significant	JJ
cord-023095-4dannjjm	3564	16	differences	difference	NNS
cord-023095-4dannjjm	3564	17	in	in	IN
cord-023095-4dannjjm	3564	18	individual	individual	JJ
cord-023095-4dannjjm	3564	19	clinical	clinical	JJ
cord-023095-4dannjjm	3564	20	score	score	NN
cord-023095-4dannjjm	3564	21	measurements	measurement	NNS
cord-023095-4dannjjm	3564	22	,	,	,
cord-023095-4dannjjm	3564	23	in	in	IN
cord-023095-4dannjjm	3564	24	total	total	JJ
cord-023095-4dannjjm	3564	25	score	score	NN
cord-023095-4dannjjm	3564	26	,	,	,
cord-023095-4dannjjm	3564	27	total	total	JJ
cord-023095-4dannjjm	3564	28	ocular	ocular	JJ
cord-023095-4dannjjm	3564	29	score	score	NN
cord-023095-4dannjjm	3564	30	,	,	,
cord-023095-4dannjjm	3564	31	or	or	CC
cord-023095-4dannjjm	3564	32	total	total	JJ
cord-023095-4dannjjm	3564	33	respiratory	respiratory	JJ
cord-023095-4dannjjm	3564	34	score	score	NN
cord-023095-4dannjjm	3564	35	were	be	VBD
cord-023095-4dannjjm	3564	36	not	not	RB
cord-023095-4dannjjm	3564	37	detected	detect	VBN
cord-023095-4dannjjm	3564	38	over	over	IN
cord-023095-4dannjjm	3564	39	time	time	NN
cord-023095-4dannjjm	3564	40	among	among	IN
cord-023095-4dannjjm	3564	41	any	any	DT
cord-023095-4dannjjm	3564	42	of	of	IN
cord-023095-4dannjjm	3564	43	the	the	DT
cord-023095-4dannjjm	3564	44	treatment	treatment	NN
cord-023095-4dannjjm	3564	45	groups	group	NNS
cord-023095-4dannjjm	3564	46	.	.	.
cord-023095-4dannjjm	3565	1	While	while	IN
cord-023095-4dannjjm	3565	2	clinical	clinical	JJ
cord-023095-4dannjjm	3565	3	signs	sign	NNS
cord-023095-4dannjjm	3565	4	of	of	IN
cord-023095-4dannjjm	3565	5	activated	activate	VBN
cord-023095-4dannjjm	3565	6	FHV-1	FHV-1	NNP
cord-023095-4dannjjm	3565	7	occurred	occur	VBD
cord-023095-4dannjjm	3565	8	in	in	IN
cord-023095-4dannjjm	3565	9	some	some	DT
cord-023095-4dannjjm	3565	10	cats	cat	NNS
cord-023095-4dannjjm	3565	11	administered	administer	VBD
cord-023095-4dannjjm	3565	12	methylprednisolone	methylprednisolone	NNP
cord-023095-4dannjjm	3565	13	or	or	CC
cord-023095-4dannjjm	3565	14	CsA	CsA	NNP
cord-023095-4dannjjm	3565	15	,	,	,
cord-023095-4dannjjm	3565	16	disease	disease	NN
cord-023095-4dannjjm	3565	17	was	be	VBD
cord-023095-4dannjjm	3565	18	mild	mild	JJ
cord-023095-4dannjjm	3565	19	and	and	CC
cord-023095-4dannjjm	3565	20	self	self	NN
cord-023095-4dannjjm	3565	21	-	-	HYPH
cord-023095-4dannjjm	3565	22	limited	limit	VBN
cord-023095-4dannjjm	3565	23	in	in	IN
cord-023095-4dannjjm	3565	24	most	most	JJS
cord-023095-4dannjjm	3565	25	cats	cat	NNS
cord-023095-4dannjjm	3565	26	and	and	CC
cord-023095-4dannjjm	3565	27	there	there	EX
cord-023095-4dannjjm	3565	28	were	be	VBD
cord-023095-4dannjjm	3565	29	no	no	DT
cord-023095-4dannjjm	3565	30	significant	significant	JJ
cord-023095-4dannjjm	3565	31	CsA	csa	NN
cord-023095-4dannjjm	3565	32	sideeffects	sideeffect	NNS
cord-023095-4dannjjm	3565	33	.	.	.
cord-023095-4dannjjm	3566	1	These	these	DT
cord-023095-4dannjjm	3566	2	results	result	NNS
cord-023095-4dannjjm	3566	3	suggest	suggest	VBP
cord-023095-4dannjjm	3566	4	that	that	IN
cord-023095-4dannjjm	3566	5	the	the	DT
cord-023095-4dannjjm	3566	6	CsA	CsA	NNP
cord-023095-4dannjjm	3566	7	protocol	protocol	NN
cord-023095-4dannjjm	3566	8	described	describe	VBN
cord-023095-4dannjjm	3566	9	here	here	RB
cord-023095-4dannjjm	3566	10	is	be	VBZ
cord-023095-4dannjjm	3566	11	unlikely	unlikely	JJ
cord-023095-4dannjjm	3566	12	to	to	TO
cord-023095-4dannjjm	3566	13	reactivate	reactivate	VB
cord-023095-4dannjjm	3566	14	latent	latent	JJ
cord-023095-4dannjjm	3566	15	FHV-1	FHV-1	NNP
cord-023095-4dannjjm	3566	16	infection	infection	NN
cord-023095-4dannjjm	3566	17	and	and	CC
cord-023095-4dannjjm	3566	18	cause	cause	VB
cord-023095-4dannjjm	3566	19	significant	significant	JJ
cord-023095-4dannjjm	3566	20	clinical	clinical	JJ
cord-023095-4dannjjm	3566	21	illness	illness	NN
cord-023095-4dannjjm	3566	22	.	.	.
cord-023095-4dannjjm	3567	1	The	the	DT
cord-023095-4dannjjm	3567	2	purpose	purpose	NN
cord-023095-4dannjjm	3567	3	of	of	IN
cord-023095-4dannjjm	3567	4	this	this	DT
cord-023095-4dannjjm	3567	5	study	study	NN
cord-023095-4dannjjm	3567	6	was	be	VBD
cord-023095-4dannjjm	3567	7	to	to	TO
cord-023095-4dannjjm	3567	8	determine	determine	VB
cord-023095-4dannjjm	3567	9	the	the	DT
cord-023095-4dannjjm	3567	10	prevalence	prevalence	NN
cord-023095-4dannjjm	3567	11	and	and	CC
cord-023095-4dannjjm	3567	12	risk	risk	NN
cord-023095-4dannjjm	3567	13	factors	factor	NNS
cord-023095-4dannjjm	3567	14	for	for	IN
cord-023095-4dannjjm	3567	15	enteropathogens	enteropathogen	NNS
cord-023095-4dannjjm	3567	16	in	in	IN
cord-023095-4dannjjm	3567	17	four	four	CD
cord-023095-4dannjjm	3567	18	different	different	JJ
cord-023095-4dannjjm	3567	19	models	model	NNS
cord-023095-4dannjjm	3567	20	for	for	IN
cord-023095-4dannjjm	3567	21	managing	manage	VBG
cord-023095-4dannjjm	3567	22	unowned	unowned	JJ
cord-023095-4dannjjm	3567	23	cats	cat	NNS
cord-023095-4dannjjm	3567	24	:	:	:
cord-023095-4dannjjm	3567	25	short	short	JJ
cord-023095-4dannjjm	3567	26	-	-	HYPH
cord-023095-4dannjjm	3567	27	term	term	NN
cord-023095-4dannjjm	3567	28	shelter	shelter	NN
cord-023095-4dannjjm	3567	29	,	,	,
cord-023095-4dannjjm	3567	30	long	long	JJ
cord-023095-4dannjjm	3567	31	-	-	HYPH
cord-023095-4dannjjm	3567	32	term	term	NN
cord-023095-4dannjjm	3567	33	sanctuary	sanctuary	NN
cord-023095-4dannjjm	3567	34	,	,	,
cord-023095-4dannjjm	3567	35	home	home	NN
cord-023095-4dannjjm	3567	36	-	-	HYPH
cord-023095-4dannjjm	3567	37	based	base	VBN
cord-023095-4dannjjm	3567	38	foster	foster	JJ
cord-023095-4dannjjm	3567	39	care	care	NN
cord-023095-4dannjjm	3567	40	,	,	,
cord-023095-4dannjjm	3567	41	and	and	CC
cord-023095-4dannjjm	3567	42	trap	trap	NN
cord-023095-4dannjjm	3567	43	-	-	HYPH
cord-023095-4dannjjm	3567	44	neuter	neuter	NN
cord-023095-4dannjjm	3567	45	-	-	JJ
cord-023095-4dannjjm	3567	46	return	return	NN
cord-023095-4dannjjm	3567	47	(	(	-LRB-
cord-023095-4dannjjm	3567	48	TNR	TNR	NNP
cord-023095-4dannjjm	3567	49	)	)	-RRB-
cord-023095-4dannjjm	3567	50	programs	program	NNS
cord-023095-4dannjjm	3567	51	.	.	.
cord-023095-4dannjjm	3568	1	Fecal	fecal	JJ
cord-023095-4dannjjm	3568	2	samples	sample	NNS
cord-023095-4dannjjm	3568	3	were	be	VBD
cord-023095-4dannjjm	3568	4	collected	collect	VBN
cord-023095-4dannjjm	3568	5	from	from	IN
cord-023095-4dannjjm	3568	6	482	482	CD
cord-023095-4dannjjm	3568	7	cats	cat	NNS
cord-023095-4dannjjm	3568	8	,	,	,
cord-023095-4dannjjm	3568	9	half	half	NN
cord-023095-4dannjjm	3568	10	with	with	IN
cord-023095-4dannjjm	3568	11	diarrhea	diarrhea	NN
cord-023095-4dannjjm	3568	12	(	(	-LRB-
cord-023095-4dannjjm	3568	13	D	D	NNP
cord-023095-4dannjjm	3568	14	)	)	-RRB-
cord-023095-4dannjjm	3568	15	and	and	CC
cord-023095-4dannjjm	3568	16	half	half	NN
cord-023095-4dannjjm	3568	17	with	with	IN
cord-023095-4dannjjm	3568	18	normal	normal	JJ
cord-023095-4dannjjm	3568	19	feces	fece	NNS
cord-023095-4dannjjm	3568	20	(	(	-LRB-
cord-023095-4dannjjm	3568	21	N	N	NNP
cord-023095-4dannjjm	3568	22	)	)	-RRB-
cord-023095-4dannjjm	3568	23	,	,	,
cord-023095-4dannjjm	3568	24	and	and	CC
cord-023095-4dannjjm	3568	25	tested	test	VBN
cord-023095-4dannjjm	3568	26	for	for	IN
cord-023095-4dannjjm	3568	27	a	a	DT
cord-023095-4dannjjm	3568	28	panel	panel	NN
cord-023095-4dannjjm	3568	29	of	of	IN
cord-023095-4dannjjm	3568	30	feline	feline	JJ
cord-023095-4dannjjm	3568	31	and	and	CC
cord-023095-4dannjjm	3568	32	zoonotic	zoonotic	JJ
cord-023095-4dannjjm	3568	33	enteropathogens	enteropathogen	NNS
cord-023095-4dannjjm	3568	34	by	by	IN
cord-023095-4dannjjm	3568	35	polymerase	polymerase	NN
cord-023095-4dannjjm	3568	36	chain	chain	NN
cord-023095-4dannjjm	3568	37	reaction	reaction	NN
cord-023095-4dannjjm	3568	38	,	,	,
cord-023095-4dannjjm	3568	39	antigen	antigen	NN
cord-023095-4dannjjm	3568	40	,	,	,
cord-023095-4dannjjm	3568	41	and	and	CC
cord-023095-4dannjjm	3568	42	fecal	fecal	JJ
cord-023095-4dannjjm	3568	43	flotation	flotation	NN
cord-023095-4dannjjm	3568	44	.	.	.
cord-023095-4dannjjm	3569	1	Risk	risk	NN
cord-023095-4dannjjm	3569	2	factors	factor	NNS
cord-023095-4dannjjm	3569	3	for	for	IN
cord-023095-4dannjjm	3569	4	infection	infection	NN
cord-023095-4dannjjm	3569	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	3569	6	include	include	VBP
cord-023095-4dannjjm	3569	7	management	management	NN
cord-023095-4dannjjm	3569	8	practices	practice	NNS
cord-023095-4dannjjm	3569	9	,	,	,
cord-023095-4dannjjm	3569	10	fecal	fecal	JJ
cord-023095-4dannjjm	3569	11	consistency	consistency	NN
cord-023095-4dannjjm	3569	12	,	,	,
cord-023095-4dannjjm	3569	13	and	and	CC
cord-023095-4dannjjm	3569	14	signalment	signalment	JJ
cord-023095-4dannjjm	3569	15	.	.	.
cord-023095-4dannjjm	3570	1	A	a	DT
cord-023095-4dannjjm	3570	2	majority	majority	NN
cord-023095-4dannjjm	3570	3	of	of	IN
cord-023095-4dannjjm	3570	4	cats	cat	NNS
cord-023095-4dannjjm	3570	5	had	have	VBD
cord-023095-4dannjjm	3570	6	at	at	RB
cord-023095-4dannjjm	3570	7	least	least	RBS
cord-023095-4dannjjm	3570	8	one	one	CD
cord-023095-4dannjjm	3570	9	enteropathogen	enteropathogen	NN
cord-023095-4dannjjm	3570	10	of	of	IN
cord-023095-4dannjjm	3570	11	feline	feline	JJ
cord-023095-4dannjjm	3570	12	or	or	CC
cord-023095-4dannjjm	3570	13	zoonotic	zoonotic	JJ
cord-023095-4dannjjm	3570	14	importance	importance	NN
cord-023095-4dannjjm	3570	15	,	,	,
cord-023095-4dannjjm	3570	16	regardless	regardless	RB
cord-023095-4dannjjm	3570	17	of	of	IN
cord-023095-4dannjjm	3570	18	management	management	NN
cord-023095-4dannjjm	3570	19	model	model	NN
cord-023095-4dannjjm	3570	20	or	or	CC
cord-023095-4dannjjm	3570	21	preventive	preventive	JJ
cord-023095-4dannjjm	3570	22	healthcare	healthcare	NN
cord-023095-4dannjjm	3570	23	protocol	protocol	NN
cord-023095-4dannjjm	3570	24	.	.	.
cord-023095-4dannjjm	3571	1	For	for	IN
cord-023095-4dannjjm	3571	2	most	most	JJS
cord-023095-4dannjjm	3571	3	enteropathogens	enteropathogen	NNS
cord-023095-4dannjjm	3571	4	,	,	,
cord-023095-4dannjjm	3571	5	the	the	DT
cord-023095-4dannjjm	3571	6	presence	presence	NN
cord-023095-4dannjjm	3571	7	or	or	CC
cord-023095-4dannjjm	3571	8	absence	absence	NN
cord-023095-4dannjjm	3571	9	of	of	IN
cord-023095-4dannjjm	3571	10	diarrhea	diarrhea	NN
cord-023095-4dannjjm	3571	11	did	do	VBD
cord-023095-4dannjjm	3571	12	not	not	RB
cord-023095-4dannjjm	3571	13	correlate	correlate	VB
cord-023095-4dannjjm	3571	14	with	with	IN
cord-023095-4dannjjm	3571	15	infection	infection	NN
cord-023095-4dannjjm	3571	16	,	,	,
cord-023095-4dannjjm	3571	17	the	the	DT
cord-023095-4dannjjm	3571	18	exceptions	exception	NNS
cord-023095-4dannjjm	3571	19	being	be	VBG
cord-023095-4dannjjm	3571	20	T.	t.	NN
cord-023095-4dannjjm	3571	21	foetus	foetus	NN
cord-023095-4dannjjm	3571	22	in	in	IN
cord-023095-4dannjjm	3571	23	sanctuary	sanctuary	NN
cord-023095-4dannjjm	3571	24	cats	cat	NNS
cord-023095-4dannjjm	3571	25	and	and	CC
cord-023095-4dannjjm	3571	26	FCoV	FCoV	NNP
cord-023095-4dannjjm	3571	27	in	in	IN
cord-023095-4dannjjm	3571	28	foster	foster	JJ
cord-023095-4dannjjm	3571	29	cats	cat	NNS
cord-023095-4dannjjm	3571	30	.	.	.
cord-023095-4dannjjm	3572	1	Prevalence	prevalence	NN
cord-023095-4dannjjm	3572	2	of	of	IN
cord-023095-4dannjjm	3572	3	specific	specific	JJ
cord-023095-4dannjjm	3572	4	enteropathogens	enteropathogen	NNS
cord-023095-4dannjjm	3572	5	varied	varied	JJ
cord-023095-4dannjjm	3572	6	between	between	IN
cord-023095-4dannjjm	3572	7	management	management	NN
cord-023095-4dannjjm	3572	8	models	model	NNS
cord-023095-4dannjjm	3572	9	,	,	,
cord-023095-4dannjjm	3572	10	reflecting	reflect	VBG
cord-023095-4dannjjm	3572	11	differences	difference	NNS
cord-023095-4dannjjm	3572	12	in	in	IN
cord-023095-4dannjjm	3572	13	preventive	preventive	JJ
cord-023095-4dannjjm	3572	14	healthcare	healthcare	NN
cord-023095-4dannjjm	3572	15	and	and	CC
cord-023095-4dannjjm	3572	16	housing	housing	NN
cord-023095-4dannjjm	3572	17	conditions	condition	NNS
cord-023095-4dannjjm	3572	18	.	.	.
cord-023095-4dannjjm	3573	1	Management	management	NN
cord-023095-4dannjjm	3573	2	protocols	protocol	NNS
cord-023095-4dannjjm	3573	3	for	for	IN
cord-023095-4dannjjm	3573	4	unowned	unowned	JJ
cord-023095-4dannjjm	3573	5	cats	cat	NNS
cord-023095-4dannjjm	3573	6	were	be	VBD
cord-023095-4dannjjm	3573	7	inadequate	inadequate	JJ
cord-023095-4dannjjm	3573	8	for	for	IN
cord-023095-4dannjjm	3573	9	elimination	elimination	NN
cord-023095-4dannjjm	3573	10	of	of	IN
cord-023095-4dannjjm	3573	11	infections	infection	NNS
cord-023095-4dannjjm	3573	12	present	present	JJ
cord-023095-4dannjjm	3573	13	at	at	IN
cord-023095-4dannjjm	3573	14	the	the	DT
cord-023095-4dannjjm	3573	15	time	time	NN
cord-023095-4dannjjm	3573	16	of	of	IN
cord-023095-4dannjjm	3573	17	intake	intake	NN
cord-023095-4dannjjm	3573	18	and	and	CC
cord-023095-4dannjjm	3573	19	for	for	IN
cord-023095-4dannjjm	3573	20	prevention	prevention	NN
cord-023095-4dannjjm	3573	21	of	of	IN
cord-023095-4dannjjm	3573	22	transmission	transmission	NN
cord-023095-4dannjjm	3573	23	of	of	IN
cord-023095-4dannjjm	3573	24	enteropathogens	enteropathogen	NNS
cord-023095-4dannjjm	3573	25	among	among	IN
cord-023095-4dannjjm	3573	26	shelter	shelter	NN
cord-023095-4dannjjm	3573	27	cats	cat	NNS
cord-023095-4dannjjm	3573	28	.	.	.
cord-023095-4dannjjm	3574	1	Improved	improve	VBN
cord-023095-4dannjjm	3574	2	compliance	compliance	NN
cord-023095-4dannjjm	3574	3	with	with	IN
cord-023095-4dannjjm	3574	4	effective	effective	JJ
cord-023095-4dannjjm	3574	5	vaccination	vaccination	NN
cord-023095-4dannjjm	3574	6	,	,	,
cord-023095-4dannjjm	3574	7	deworming	deworming	NN
cord-023095-4dannjjm	3574	8	,	,	,
cord-023095-4dannjjm	3574	9	sanitation	sanitation	NN
cord-023095-4dannjjm	3574	10	,	,	,
cord-023095-4dannjjm	3574	11	and	and	CC
cord-023095-4dannjjm	3574	12	housing	housing	NN
cord-023095-4dannjjm	3574	13	protocols	protocol	NNS
cord-023095-4dannjjm	3574	14	is	be	VBZ
cord-023095-4dannjjm	3574	15	needed	need	VBN
cord-023095-4dannjjm	3574	16	to	to	TO
cord-023095-4dannjjm	3574	17	reduce	reduce	VB
cord-023095-4dannjjm	3574	18	zoonotic	zoonotic	JJ
cord-023095-4dannjjm	3574	19	and	and	CC
cord-023095-4dannjjm	3574	20	feline	feline	JJ
cord-023095-4dannjjm	3574	21	health	health	NN
cord-023095-4dannjjm	3574	22	risks	risk	NNS
cord-023095-4dannjjm	3574	23	.	.	.
cord-023095-4dannjjm	3575	1	Several	several	JJ
cord-023095-4dannjjm	3575	2	allergic	allergic	JJ
cord-023095-4dannjjm	3575	3	diseases	disease	NNS
cord-023095-4dannjjm	3575	4	of	of	IN
cord-023095-4dannjjm	3575	5	cats	cat	NNS
cord-023095-4dannjjm	3575	6	,	,	,
cord-023095-4dannjjm	3575	7	including	include	VBG
cord-023095-4dannjjm	3575	8	atopy	atopy	NN
cord-023095-4dannjjm	3575	9	and	and	CC
cord-023095-4dannjjm	3575	10	gingivostomatitis	gingivostomatitis	NN
cord-023095-4dannjjm	3575	11	,	,	,
cord-023095-4dannjjm	3575	12	can	can	MD
cord-023095-4dannjjm	3575	13	be	be	VB
cord-023095-4dannjjm	3575	14	resistant	resistant	JJ
cord-023095-4dannjjm	3575	15	to	to	IN
cord-023095-4dannjjm	3575	16	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	3575	17	but	but	CC
cord-023095-4dannjjm	3575	18	responsive	responsive	JJ
cord-023095-4dannjjm	3575	19	to	to	IN
cord-023095-4dannjjm	3575	20	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3575	21	.	.	.
cord-023095-4dannjjm	3576	1	Toxoplasma	toxoplasma	NN
cord-023095-4dannjjm	3576	2	gondii	gondii	NN
cord-023095-4dannjjm	3576	3	infection	infection	NN
cord-023095-4dannjjm	3576	4	occurs	occur	VBZ
cord-023095-4dannjjm	3576	5	in	in	IN
cord-023095-4dannjjm	3576	6	approximately	approximately	RB
cord-023095-4dannjjm	3576	7	30	30	CD
cord-023095-4dannjjm	3576	8	%	%	NN
cord-023095-4dannjjm	3576	9	of	of	IN
cord-023095-4dannjjm	3576	10	cats	cat	NNS
cord-023095-4dannjjm	3576	11	and	and	CC
cord-023095-4dannjjm	3576	12	the	the	DT
cord-023095-4dannjjm	3576	13	effect	effect	NN
cord-023095-4dannjjm	3576	14	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3576	15	therapy	therapy	NN
cord-023095-4dannjjm	3576	16	has	have	VBZ
cord-023095-4dannjjm	3576	17	on	on	IN
cord-023095-4dannjjm	3576	18	the	the	DT
cord-023095-4dannjjm	3576	19	T.	T.	NNP
cord-023095-4dannjjm	3576	20	gondii	gondii	NNP
cord-023095-4dannjjm	3576	21	oocyst	oocyst	VBN
cord-023095-4dannjjm	3576	22	shedding	shed	VBG
cord-023095-4dannjjm	3576	23	period	period	NN
cord-023095-4dannjjm	3576	24	is	be	VBZ
cord-023095-4dannjjm	3576	25	unknown	unknown	JJ
cord-023095-4dannjjm	3576	26	.	.	.
cord-023095-4dannjjm	3577	1	The	the	DT
cord-023095-4dannjjm	3577	2	objective	objective	NN
cord-023095-4dannjjm	3577	3	of	of	IN
cord-023095-4dannjjm	3577	4	this	this	DT
cord-023095-4dannjjm	3577	5	study	study	NN
cord-023095-4dannjjm	3577	6	was	be	VBD
cord-023095-4dannjjm	3577	7	to	to	TO
cord-023095-4dannjjm	3577	8	determine	determine	VB
cord-023095-4dannjjm	3577	9	whether	whether	IN
cord-023095-4dannjjm	3577	10	administration	administration	NN
cord-023095-4dannjjm	3577	11	of	of	IN
cord-023095-4dannjjm	3577	12	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3577	13	before	before	RB
cord-023095-4dannjjm	3577	14	or	or	CC
cord-023095-4dannjjm	3577	15	after	after	IN
cord-023095-4dannjjm	3577	16	T.	T.	NNP
cord-023095-4dannjjm	3577	17	gondii	gondii	NNP
cord-023095-4dannjjm	3577	18	infection	infection	NN
cord-023095-4dannjjm	3577	19	influences	influence	VBZ
cord-023095-4dannjjm	3577	20	the	the	DT
cord-023095-4dannjjm	3577	21	oocyst	oocyst	JJ
cord-023095-4dannjjm	3577	22	shedding	shed	VBG
cord-023095-4dannjjm	3577	23	period	period	NN
cord-023095-4dannjjm	3577	24	.	.	.
cord-023095-4dannjjm	3578	1	The	the	DT
cord-023095-4dannjjm	3578	2	young	young	JJ
cord-023095-4dannjjm	3578	3	adult	adult	NN
cord-023095-4dannjjm	3578	4	cats	cat	NNS
cord-023095-4dannjjm	3578	5	were	be	VBD
cord-023095-4dannjjm	3578	6	T.	t.	NN
cord-023095-4dannjjm	3578	7	gondii	gondii	NNP
cord-023095-4dannjjm	3578	8	seronegative	seronegative	JJ
cord-023095-4dannjjm	3578	9	when	when	WRB
cord-023095-4dannjjm	3578	10	administered	administer	VBN
cord-023095-4dannjjm	3578	11	1,000	1,000	CD
cord-023095-4dannjjm	3578	12	T.	t.	NN
cord-023095-4dannjjm	3578	13	gondii	gondii	NN
cord-023095-4dannjjm	3578	14	tissue	tissue	NN
cord-023095-4dannjjm	3578	15	cysts	cyst	NNS
cord-023095-4dannjjm	3578	16	orally	orally	RB
cord-023095-4dannjjm	3578	17	on	on	IN
cord-023095-4dannjjm	3578	18	day	day	NN
cord-023095-4dannjjm	3578	19	42	42	CD
cord-023095-4dannjjm	3578	20	.	.	.
cord-023095-4dannjjm	3579	1	Group	group	NN
cord-023095-4dannjjm	3579	2	1	1	CD
cord-023095-4dannjjm	3579	3	cats	cat	NNS
cord-023095-4dannjjm	3579	4	(	(	-LRB-
cord-023095-4dannjjm	3579	5	n	n	NN
cord-023095-4dannjjm	3579	6	5	5	CD
cord-023095-4dannjjm	3579	7	10	10	CD
cord-023095-4dannjjm	3579	8	)	)	-RRB-
cord-023095-4dannjjm	3579	9	were	be	VBD
cord-023095-4dannjjm	3579	10	never	never	RB
cord-023095-4dannjjm	3579	11	administered	administer	VBN
cord-023095-4dannjjm	3579	12	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3579	13	;	;	:
cord-023095-4dannjjm	3579	14	Group	group	NN
cord-023095-4dannjjm	3579	15	2	2	CD
cord-023095-4dannjjm	3579	16	cats	cat	NNS
cord-023095-4dannjjm	3579	17	(	(	-LRB-
cord-023095-4dannjjm	3579	18	n	n	NN
cord-023095-4dannjjm	3579	19	5	5	CD
cord-023095-4dannjjm	3579	20	10	10	CD
cord-023095-4dannjjm	3579	21	)	)	-RRB-
cord-023095-4dannjjm	3579	22	were	be	VBD
cord-023095-4dannjjm	3579	23	administered	administer	VBN
cord-023095-4dannjjm	3579	24	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3579	25	(	(	-LRB-
cord-023095-4dannjjm	3579	26	7.5	7.5	CD
cord-023095-4dannjjm	3579	27	mg	mg	NNP
cord-023095-4dannjjm	3579	28	/	/	SYM
cord-023095-4dannjjm	3579	29	kg	kg	NNP
cord-023095-4dannjjm	3579	30	,	,	,
cord-023095-4dannjjm	3579	31	PO	PO	NNP
cord-023095-4dannjjm	3579	32	)	)	-RRB-
cord-023095-4dannjjm	3580	1	daily	daily	RB
cord-023095-4dannjjm	3580	2	on	on	IN
cord-023095-4dannjjm	3580	3	Days	Days	NNPS
cord-023095-4dannjjm	3580	4	84	84	CD
cord-023095-4dannjjm	3580	5	-	-	SYM
cord-023095-4dannjjm	3580	6	126	126	CD
cord-023095-4dannjjm	3580	7	;	;	:
cord-023095-4dannjjm	3580	8	and	and	CC
cord-023095-4dannjjm	3580	9	Group	group	NN
cord-023095-4dannjjm	3580	10	3	3	CD
cord-023095-4dannjjm	3580	11	cats	cat	NNS
cord-023095-4dannjjm	3580	12	(	(	-LRB-
cord-023095-4dannjjm	3580	13	n	n	NN
cord-023095-4dannjjm	3580	14	5	5	CD
cord-023095-4dannjjm	3580	15	10	10	CD
cord-023095-4dannjjm	3580	16	)	)	-RRB-
cord-023095-4dannjjm	3580	17	were	be	VBD
cord-023095-4dannjjm	3580	18	administered	administer	VBN
cord-023095-4dannjjm	3580	19	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3580	20	(	(	-LRB-
cord-023095-4dannjjm	3580	21	7.5	7.5	CD
cord-023095-4dannjjm	3580	22	mg	mg	NNP
cord-023095-4dannjjm	3580	23	/	/	SYM
cord-023095-4dannjjm	3580	24	kg	kg	NNP
cord-023095-4dannjjm	3580	25	,	,	,
cord-023095-4dannjjm	3580	26	PO	PO	NNP
cord-023095-4dannjjm	3580	27	)	)	-RRB-
cord-023095-4dannjjm	3580	28	daily	daily	RB
cord-023095-4dannjjm	3580	29	from	from	IN
cord-023095-4dannjjm	3580	30	days	day	NNS
cord-023095-4dannjjm	3580	31	0	0	CD
cord-023095-4dannjjm	3580	32	-	-	SYM
cord-023095-4dannjjm	3580	33	126	126	CD
cord-023095-4dannjjm	3580	34	.	.	.
cord-023095-4dannjjm	3581	1	Available	available	JJ
cord-023095-4dannjjm	3581	2	feces	fece	NNS
cord-023095-4dannjjm	3581	3	from	from	IN
cord-023095-4dannjjm	3581	4	individual	individual	JJ
cord-023095-4dannjjm	3581	5	cages	cage	NNS
cord-023095-4dannjjm	3581	6	were	be	VBD
cord-023095-4dannjjm	3581	7	collected	collect	VBN
cord-023095-4dannjjm	3581	8	daily	daily	JJ
cord-023095-4dannjjm	3581	9	and	and	CC
cord-023095-4dannjjm	3581	10	fecal	fecal	JJ
cord-023095-4dannjjm	3581	11	flotation	flotation	NN
cord-023095-4dannjjm	3581	12	by	by	IN
cord-023095-4dannjjm	3581	13	sugar	sugar	NN
cord-023095-4dannjjm	3581	14	centrifugation	centrifugation	NN
cord-023095-4dannjjm	3581	15	was	be	VBD
cord-023095-4dannjjm	3581	16	performed	perform	VBN
cord-023095-4dannjjm	3581	17	for	for	IN
cord-023095-4dannjjm	3581	18	84	84	CD
cord-023095-4dannjjm	3581	19	days	day	NNS
cord-023095-4dannjjm	3581	20	after	after	IN
cord-023095-4dannjjm	3581	21	T.	t.	NN
cord-023095-4dannjjm	3581	22	gondii	gondii	NN
cord-023095-4dannjjm	3581	23	inoculation	inoculation	NN
cord-023095-4dannjjm	3581	24	.	.	.
cord-023095-4dannjjm	3582	1	Group	group	NN
cord-023095-4dannjjm	3582	2	3	3	CD
cord-023095-4dannjjm	3582	3	shed	shed	VBD
cord-023095-4dannjjm	3582	4	oocysts	oocyst	NNS
cord-023095-4dannjjm	3582	5	for	for	IN
cord-023095-4dannjjm	3582	6	a	a	DT
cord-023095-4dannjjm	3582	7	significantly	significantly	RB
cord-023095-4dannjjm	3582	8	shorter	short	JJR
cord-023095-4dannjjm	3582	9	period	period	NN
cord-023095-4dannjjm	3582	10	than	than	IN
cord-023095-4dannjjm	3582	11	Groups	group	NNS
cord-023095-4dannjjm	3582	12	1	1	CD
cord-023095-4dannjjm	3582	13	or	or	CC
cord-023095-4dannjjm	3582	14	2	2	CD
cord-023095-4dannjjm	3582	15	and	and	CC
cord-023095-4dannjjm	3582	16	had	have	VBD
cord-023095-4dannjjm	3582	17	a	a	DT
cord-023095-4dannjjm	3582	18	significantly	significantly	RB
cord-023095-4dannjjm	3582	19	lower	low	JJR
cord-023095-4dannjjm	3582	20	oocyst	oocyst	NN
cord-023095-4dannjjm	3582	21	shedding	shed	VBG
cord-023095-4dannjjm	3582	22	scores	score	NNS
cord-023095-4dannjjm	3582	23	than	than	IN
cord-023095-4dannjjm	3582	24	Groups	group	NNS
cord-023095-4dannjjm	3582	25	1	1	CD
cord-023095-4dannjjm	3582	26	and	and	CC
cord-023095-4dannjjm	3582	27	2	2	CD
cord-023095-4dannjjm	3582	28	on	on	IN
cord-023095-4dannjjm	3582	29	days	day	NNS
cord-023095-4dannjjm	3582	30	5	5	CD
cord-023095-4dannjjm	3582	31	-	-	SYM
cord-023095-4dannjjm	3582	32	11	11	CD
cord-023095-4dannjjm	3582	33	after	after	IN
cord-023095-4dannjjm	3582	34	T.	T.	NNP
cord-023095-4dannjjm	3582	35	gondii	gondii	NN
cord-023095-4dannjjm	3582	36	inoculation	inoculation	NN
cord-023095-4dannjjm	3582	37	.	.	.
cord-023095-4dannjjm	3583	1	Group	group	NN
cord-023095-4dannjjm	3583	2	2	2	CD
cord-023095-4dannjjm	3583	3	cats	cat	NNS
cord-023095-4dannjjm	3583	4	had	have	VBD
cord-023095-4dannjjm	3583	5	completed	complete	VBN
cord-023095-4dannjjm	3583	6	the	the	DT
cord-023095-4dannjjm	3583	7	oocyst	oocyst	JJ
cord-023095-4dannjjm	3583	8	shedding	shed	VBG
cord-023095-4dannjjm	3583	9	period	period	NN
cord-023095-4dannjjm	3583	10	prior	prior	RB
cord-023095-4dannjjm	3583	11	to	to	IN
cord-023095-4dannjjm	3583	12	being	be	VBG
cord-023095-4dannjjm	3583	13	administered	administer	VBN
cord-023095-4dannjjm	3583	14	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3583	15	and	and	CC
cord-023095-4dannjjm	3583	16	repeat	repeat	VB
cord-023095-4dannjjm	3583	17	oocyst	oocyst	NNP
cord-023095-4dannjjm	3583	18	shedding	shedding	NN
cord-023095-4dannjjm	3583	19	was	be	VBD
cord-023095-4dannjjm	3583	20	not	not	RB
cord-023095-4dannjjm	3583	21	detected	detect	VBN
cord-023095-4dannjjm	3583	22	during	during	IN
cord-023095-4dannjjm	3583	23	administration	administration	NN
cord-023095-4dannjjm	3583	24	of	of	IN
cord-023095-4dannjjm	3583	25	the	the	DT
cord-023095-4dannjjm	3583	26	drug	drug	NN
cord-023095-4dannjjm	3583	27	.	.	.
cord-023095-4dannjjm	3584	1	Administration	administration	NN
cord-023095-4dannjjm	3584	2	of	of	IN
cord-023095-4dannjjm	3584	3	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3584	4	prior	prior	RB
cord-023095-4dannjjm	3584	5	to	to	IN
cord-023095-4dannjjm	3584	6	T.	t.	NN
cord-023095-4dannjjm	3584	7	gondii	gondii	NNP
cord-023095-4dannjjm	3584	8	infection	infection	NN
cord-023095-4dannjjm	3584	9	lessened	lessen	VBD
cord-023095-4dannjjm	3584	10	oocyst	oocyst	NNP
cord-023095-4dannjjm	3584	11	shedding	shedding	NN
cord-023095-4dannjjm	3584	12	which	which	WDT
cord-023095-4dannjjm	3584	13	is	be	VBZ
cord-023095-4dannjjm	3584	14	likely	likely	JJ
cord-023095-4dannjjm	3584	15	from	from	IN
cord-023095-4dannjjm	3584	16	the	the	DT
cord-023095-4dannjjm	3584	17	anti	anti	JJ
cord-023095-4dannjjm	3584	18	-	-	JJ
cord-023095-4dannjjm	3584	19	T.	t.	JJ
cord-023095-4dannjjm	3584	20	gondii	gondii	NN
cord-023095-4dannjjm	3584	21	effects	effect	NNS
cord-023095-4dannjjm	3584	22	of	of	IN
cord-023095-4dannjjm	3584	23	the	the	DT
cord-023095-4dannjjm	3584	24	drug	drug	NN
cord-023095-4dannjjm	3584	25	.	.	.
cord-023095-4dannjjm	3585	1	Administration	administration	NN
cord-023095-4dannjjm	3585	2	of	of	IN
cord-023095-4dannjjm	3585	3	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3585	4	using	use	VBG
cord-023095-4dannjjm	3585	5	this	this	DT
cord-023095-4dannjjm	3585	6	protocol	protocol	NN
cord-023095-4dannjjm	3585	7	is	be	VBZ
cord-023095-4dannjjm	3585	8	unlikely	unlikely	JJ
cord-023095-4dannjjm	3585	9	to	to	TO
cord-023095-4dannjjm	3585	10	induce	induce	VB
cord-023095-4dannjjm	3585	11	repeat	repeat	NN
cord-023095-4dannjjm	3586	1	T.	T.	NNP
cord-023095-4dannjjm	3586	2	gondii	gondii	NNP
cord-023095-4dannjjm	3586	3	oocyst	oocyst	VBN
cord-023095-4dannjjm	3586	4	shedding	shed	VBG
cord-023095-4dannjjm	3586	5	in	in	IN
cord-023095-4dannjjm	3586	6	client	client	NN
cord-023095-4dannjjm	3586	7	-	-	HYPH
cord-023095-4dannjjm	3586	8	owned	own	VBN
cord-023095-4dannjjm	3586	9	cats	cat	NNS
cord-023095-4dannjjm	3586	10	.	.	.
cord-023095-4dannjjm	3587	1	Ã	ã	NN
cord-023095-4dannjjm	3587	2	5	5	CD
cord-023095-4dannjjm	3587	3	group	group	NN
cord-023095-4dannjjm	3587	4	with	with	IN
cord-023095-4dannjjm	3587	5	diarrhea	diarrhea	NN
cord-023095-4dannjjm	3587	6	significantly	significantly	RB
cord-023095-4dannjjm	3587	7	different	different	JJ
cord-023095-4dannjjm	3587	8	than	than	IN
cord-023095-4dannjjm	3587	9	group	group	NN
cord-023095-4dannjjm	3587	10	with	with	IN
cord-023095-4dannjjm	3587	11	normal	normal	JJ
cord-023095-4dannjjm	3587	12	feces	fece	NNS
cord-023095-4dannjjm	3588	1	P	p	NN
cord-023095-4dannjjm	3588	2	o	o	NN
cord-023095-4dannjjm	3588	3	0.05	0.05	CD
cord-023095-4dannjjm	3588	4	known	know	VBN
cord-023095-4dannjjm	3588	5	about	about	IN
cord-023095-4dannjjm	3588	6	its	-PRON-	PRP$
cord-023095-4dannjjm	3588	7	metabolic	metabolic	JJ
cord-023095-4dannjjm	3588	8	pathways	pathway	NNS
cord-023095-4dannjjm	3588	9	or	or	CC
cord-023095-4dannjjm	3588	10	mechanism	mechanism	NN
cord-023095-4dannjjm	3588	11	of	of	IN
cord-023095-4dannjjm	3588	12	pathogenicity	pathogenicity	NN
cord-023095-4dannjjm	3588	13	and	and	CC
cord-023095-4dannjjm	3588	14	whole	whole	JJ
cord-023095-4dannjjm	3588	15	genome	genome	NN
cord-023095-4dannjjm	3588	16	sequencing	sequencing	NN
cord-023095-4dannjjm	3588	17	of	of	IN
cord-023095-4dannjjm	3588	18	feline	feline	JJ
cord-023095-4dannjjm	3588	19	hemoplasmas	hemoplasmas	NN
cord-023095-4dannjjm	3588	20	has	have	VBZ
cord-023095-4dannjjm	3588	21	not	not	RB
cord-023095-4dannjjm	3588	22	yet	yet	RB
cord-023095-4dannjjm	3588	23	been	be	VBN
cord-023095-4dannjjm	3588	24	reported	report	VBN
cord-023095-4dannjjm	3588	25	.	.	.
cord-023095-4dannjjm	3589	1	The	the	DT
cord-023095-4dannjjm	3589	2	aim	aim	NN
cord-023095-4dannjjm	3589	3	of	of	IN
cord-023095-4dannjjm	3589	4	this	this	DT
cord-023095-4dannjjm	3589	5	study	study	NN
cord-023095-4dannjjm	3589	6	was	be	VBD
cord-023095-4dannjjm	3589	7	to	to	TO
cord-023095-4dannjjm	3589	8	completely	completely	RB
cord-023095-4dannjjm	3589	9	sequence	sequence	VB
cord-023095-4dannjjm	3589	10	the	the	DT
cord-023095-4dannjjm	3589	11	genome	genome	NN
cord-023095-4dannjjm	3589	12	of	of	IN
cord-023095-4dannjjm	3589	13	M.	M.	NNP
cord-023095-4dannjjm	3589	14	haemofelis	haemofelis	JJ
cord-023095-4dannjjm	3589	15	to	to	TO
cord-023095-4dannjjm	3589	16	further	further	RB
cord-023095-4dannjjm	3589	17	characterise	characterise	VB
cord-023095-4dannjjm	3589	18	this	this	DT
cord-023095-4dannjjm	3589	19	important	important	JJ
cord-023095-4dannjjm	3589	20	pathogen	pathogen	NN
cord-023095-4dannjjm	3589	21	.	.	.
cord-023095-4dannjjm	3590	1	Mycoplasma	mycoplasma	NN
cord-023095-4dannjjm	3590	2	haemofelis	haemofeli	VBD
cord-023095-4dannjjm	3590	3	genomic	genomic	JJ
cord-023095-4dannjjm	3590	4	DNA	dna	NN
cord-023095-4dannjjm	3590	5	was	be	VBD
cord-023095-4dannjjm	3590	6	purified	purify	VBN
cord-023095-4dannjjm	3590	7	and	and	CC
cord-023095-4dannjjm	3590	8	subjected	subject	VBN
cord-023095-4dannjjm	3590	9	to	to	IN
cord-023095-4dannjjm	3590	10	whole	whole	JJ
cord-023095-4dannjjm	3590	11	shotgun	shotgun	NN
cord-023095-4dannjjm	3590	12	Roche	Roche	NNP
cord-023095-4dannjjm	3590	13	454	454	CD
cord-023095-4dannjjm	3590	14	sequencing	sequencing	NN
cord-023095-4dannjjm	3590	15	.	.	.
cord-023095-4dannjjm	3591	1	Gaps	gap	NNS
cord-023095-4dannjjm	3591	2	were	be	VBD
cord-023095-4dannjjm	3591	3	closed	close	VBN
cord-023095-4dannjjm	3591	4	using	use	VBG
cord-023095-4dannjjm	3591	5	targeted	target	VBN
cord-023095-4dannjjm	3591	6	PCR	PCR	NNP
cord-023095-4dannjjm	3591	7	and	and	CC
cord-023095-4dannjjm	3591	8	amplicon	amplicon	NN
cord-023095-4dannjjm	3591	9	sequencing	sequencing	NN
cord-023095-4dannjjm	3591	10	.	.	.
cord-023095-4dannjjm	3592	1	Ribosomal	ribosomal	JJ
cord-023095-4dannjjm	3592	2	genes	gene	NNS
cord-023095-4dannjjm	3592	3	and	and	CC
cord-023095-4dannjjm	3592	4	potential	potential	JJ
cord-023095-4dannjjm	3592	5	open	open	JJ
cord-023095-4dannjjm	3592	6	reading	reading	NN
cord-023095-4dannjjm	3592	7	frames	frame	NNS
cord-023095-4dannjjm	3592	8	(	(	-LRB-
cord-023095-4dannjjm	3592	9	ORFs	ORFs	NNP
cord-023095-4dannjjm	3592	10	)	)	-RRB-
cord-023095-4dannjjm	3592	11	were	be	VBD
cord-023095-4dannjjm	3592	12	predicted	predict	VBN
cord-023095-4dannjjm	3592	13	in	in	IN
cord-023095-4dannjjm	3592	14	silico	silico	NNS
cord-023095-4dannjjm	3592	15	.	.	.
cord-023095-4dannjjm	3593	1	Putative	putative	JJ
cord-023095-4dannjjm	3593	2	ORFs	orf	NNS
cord-023095-4dannjjm	3593	3	were	be	VBD
cord-023095-4dannjjm	3593	4	annotated	annotate	VBN
cord-023095-4dannjjm	3593	5	and	and	CC
cord-023095-4dannjjm	3593	6	orthologous	orthologous	JJ
cord-023095-4dannjjm	3593	7	groups	group	NNS
cord-023095-4dannjjm	3593	8	identified	identify	VBD
cord-023095-4dannjjm	3593	9	.	.	.
cord-023095-4dannjjm	3594	1	Analysis	analysis	NN
cord-023095-4dannjjm	3594	2	showed	show	VBD
cord-023095-4dannjjm	3594	3	a	a	DT
cord-023095-4dannjjm	3594	4	circular	circular	JJ
cord-023095-4dannjjm	3594	5	genome	genome	NN
cord-023095-4dannjjm	3594	6	of	of	IN
cord-023095-4dannjjm	3594	7	1.15	1.15	CD
cord-023095-4dannjjm	3594	8	Mbp	Mbp	NNP
cord-023095-4dannjjm	3594	9	with	with	IN
cord-023095-4dannjjm	3594	10	a	a	DT
cord-023095-4dannjjm	3594	11	GC	GC	NNP
cord-023095-4dannjjm	3594	12	content	content	NN
cord-023095-4dannjjm	3594	13	of	of	IN
cord-023095-4dannjjm	3594	14	38.9	38.9	CD
cord-023095-4dannjjm	3594	15	%	%	NN
cord-023095-4dannjjm	3594	16	.	.	.
cord-023095-4dannjjm	3595	1	Thirty	thirty	CD
cord-023095-4dannjjm	3595	2	-	-	HYPH
cord-023095-4dannjjm	3595	3	one	one	CD
cord-023095-4dannjjm	3595	4	transfer	transfer	NN
cord-023095-4dannjjm	3595	5	RNAs	rna	NNS
cord-023095-4dannjjm	3595	6	(	(	-LRB-
cord-023095-4dannjjm	3595	7	tRNAs	trna	NNS
cord-023095-4dannjjm	3595	8	)	)	-RRB-
cord-023095-4dannjjm	3595	9	were	be	VBD
cord-023095-4dannjjm	3595	10	identified	identify	VBN
cord-023095-4dannjjm	3595	11	,	,	,
cord-023095-4dannjjm	3595	12	accounting	account	VBG
cord-023095-4dannjjm	3595	13	for	for	IN
cord-023095-4dannjjm	3595	14	all	all	DT
cord-023095-4dannjjm	3595	15	amino	amino	NN
cord-023095-4dannjjm	3595	16	acids	acid	NNS
cord-023095-4dannjjm	3595	17	,	,	,
cord-023095-4dannjjm	3595	18	including	include	VBG
cord-023095-4dannjjm	3595	19	a	a	DT
cord-023095-4dannjjm	3595	20	tryptophan	tryptophan	NN
cord-023095-4dannjjm	3595	21	tRNA	trna	NN
cord-023095-4dannjjm	3595	22	for	for	IN
cord-023095-4dannjjm	3595	23	the	the	DT
cord-023095-4dannjjm	3595	24	opal	opal	NN
cord-023095-4dannjjm	3595	25	codon	codon	NN
cord-023095-4dannjjm	3595	26	(	(	-LRB-
cord-023095-4dannjjm	3595	27	UGA	UGA	NNP
cord-023095-4dannjjm	3595	28	)	)	-RRB-
cord-023095-4dannjjm	3595	29	.	.	.
cord-023095-4dannjjm	3596	1	Of	of	IN
cord-023095-4dannjjm	3596	2	the	the	DT
cord-023095-4dannjjm	3596	3	1,545	1,545	CD
cord-023095-4dannjjm	3596	4	putative	putative	JJ
cord-023095-4dannjjm	3596	5	proteins	protein	NNS
cord-023095-4dannjjm	3596	6	identified	identify	VBN
cord-023095-4dannjjm	3596	7	,	,	,
cord-023095-4dannjjm	3596	8	328	328	CD
cord-023095-4dannjjm	3596	9	(	(	-LRB-
cord-023095-4dannjjm	3596	10	21.2	21.2	CD
cord-023095-4dannjjm	3596	11	%	%	NN
cord-023095-4dannjjm	3596	12	)	)	-RRB-
cord-023095-4dannjjm	3596	13	matched	match	VBN
cord-023095-4dannjjm	3596	14	to	to	IN
cord-023095-4dannjjm	3596	15	proteins	protein	NNS
cord-023095-4dannjjm	3596	16	from	from	IN
cord-023095-4dannjjm	3596	17	other	other	JJ
cord-023095-4dannjjm	3596	18	bacterial	bacterial	JJ
cord-023095-4dannjjm	3596	19	species	specie	NNS
cord-023095-4dannjjm	3596	20	.	.	.
cord-023095-4dannjjm	3597	1	In	in	IN
cord-023095-4dannjjm	3597	2	common	common	JJ
cord-023095-4dannjjm	3597	3	with	with	IN
cord-023095-4dannjjm	3597	4	the	the	DT
cord-023095-4dannjjm	3597	5	pneumoniae	pneumoniae	NN
cord-023095-4dannjjm	3597	6	group	group	NN
cord-023095-4dannjjm	3597	7	of	of	IN
cord-023095-4dannjjm	3597	8	mycoplasmas	mycoplasmas	NNP
cord-023095-4dannjjm	3597	9	,	,	,
cord-023095-4dannjjm	3597	10	the	the	DT
cord-023095-4dannjjm	3597	11	closest	close	JJS
cord-023095-4dannjjm	3597	12	phylogenetic	phylogenetic	JJ
cord-023095-4dannjjm	3597	13	relatives	relative	NNS
cord-023095-4dannjjm	3597	14	of	of	IN
cord-023095-4dannjjm	3597	15	the	the	DT
cord-023095-4dannjjm	3597	16	hemoplasmas	hemoplasmas	NNP
cord-023095-4dannjjm	3597	17	,	,	,
cord-023095-4dannjjm	3597	18	genes	gene	NNS
cord-023095-4dannjjm	3597	19	involved	involve	VBN
cord-023095-4dannjjm	3597	20	in	in	IN
cord-023095-4dannjjm	3597	21	carbohydrate	carbohydrate	NN
cord-023095-4dannjjm	3597	22	metabolism	metabolism	NN
cord-023095-4dannjjm	3597	23	were	be	VBD
cord-023095-4dannjjm	3597	24	limited	limit	VBN
cord-023095-4dannjjm	3597	25	to	to	IN
cord-023095-4dannjjm	3597	26	enzymes	enzyme	NNS
cord-023095-4dannjjm	3597	27	of	of	IN
cord-023095-4dannjjm	3597	28	the	the	DT
cord-023095-4dannjjm	3597	29	glycolytic	glycolytic	JJ
cord-023095-4dannjjm	3597	30	pathway	pathway	NN
cord-023095-4dannjjm	3597	31	,	,	,
cord-023095-4dannjjm	3597	32	with	with	IN
cord-023095-4dannjjm	3597	33	glucose	glucose	NN
cord-023095-4dannjjm	3597	34	appearing	appear	VBG
cord-023095-4dannjjm	3597	35	to	to	TO
cord-023095-4dannjjm	3597	36	be	be	VB
cord-023095-4dannjjm	3597	37	the	the	DT
cord-023095-4dannjjm	3597	38	sole	sole	JJ
cord-023095-4dannjjm	3597	39	energy	energy	NN
cord-023095-4dannjjm	3597	40	source	source	NN
cord-023095-4dannjjm	3597	41	for	for	IN
cord-023095-4dannjjm	3597	42	M.	M.	NNP
cord-023095-4dannjjm	3597	43	haemofelis	haemofelis	NNP
cord-023095-4dannjjm	3597	44	.	.	.
cord-023095-4dannjjm	3598	1	The	the	DT
cord-023095-4dannjjm	3598	2	majority	majority	NN
cord-023095-4dannjjm	3598	3	of	of	IN
cord-023095-4dannjjm	3598	4	the	the	DT
cord-023095-4dannjjm	3598	5	pentose	pentose	NN
cord-023095-4dannjjm	3598	6	phosphate	phosphate	NN
cord-023095-4dannjjm	3598	7	pathway	pathway	NN
cord-023095-4dannjjm	3598	8	genes	gene	NNS
cord-023095-4dannjjm	3598	9	present	present	JJ
cord-023095-4dannjjm	3598	10	in	in	IN
cord-023095-4dannjjm	3598	11	other	other	JJ
cord-023095-4dannjjm	3598	12	cultivatable	cultivatable	NN
cord-023095-4dannjjm	3598	13	mycoplasmas	mycoplasma	NNS
cord-023095-4dannjjm	3598	14	appear	appear	VBP
cord-023095-4dannjjm	3598	15	to	to	TO
cord-023095-4dannjjm	3598	16	be	be	VB
cord-023095-4dannjjm	3598	17	incomplete	incomplete	JJ
cord-023095-4dannjjm	3598	18	or	or	CC
cord-023095-4dannjjm	3598	19	absent	absent	JJ
cord-023095-4dannjjm	3598	20	in	in	IN
cord-023095-4dannjjm	3598	21	M.	M.	NNP
cord-023095-4dannjjm	3598	22	haemofelis	haemofelis	NNP
cord-023095-4dannjjm	3598	23	,	,	,
cord-023095-4dannjjm	3598	24	suggesting	suggest	VBG
cord-023095-4dannjjm	3598	25	an	an	DT
cord-023095-4dannjjm	3598	26	alternative	alternative	JJ
cord-023095-4dannjjm	3598	27	mechanism	mechanism	NN
cord-023095-4dannjjm	3598	28	for	for	IN
cord-023095-4dannjjm	3598	29	sourcing	source	VBG
cord-023095-4dannjjm	3598	30	purine	purine	NNP
cord-023095-4dannjjm	3598	31	and	and	CC
cord-023095-4dannjjm	3598	32	pyramidine	pyramidine	NN
cord-023095-4dannjjm	3598	33	bases	basis	NNS
cord-023095-4dannjjm	3598	34	such	such	JJ
cord-023095-4dannjjm	3598	35	as	as	IN
cord-023095-4dannjjm	3598	36	scavenging	scavenge	VBG
cord-023095-4dannjjm	3598	37	from	from	IN
cord-023095-4dannjjm	3598	38	the	the	DT
cord-023095-4dannjjm	3598	39	host	host	NN
cord-023095-4dannjjm	3598	40	.	.	.
cord-023095-4dannjjm	3599	1	A	a	DT
cord-023095-4dannjjm	3599	2	gene	gene	NN
cord-023095-4dannjjm	3599	3	encoding	encode	VBG
cord-023095-4dannjjm	3599	4	a	a	DT
cord-023095-4dannjjm	3599	5	glyceraldehyde-3-phosphate	glyceraldehyde-3-phosphate	NNP
cord-023095-4dannjjm	3599	6	dehydrogenase	dehydrogenase	NN
cord-023095-4dannjjm	3599	7	homolog	homolog	NN
cord-023095-4dannjjm	3599	8	of	of	IN
cord-023095-4dannjjm	3599	9	the	the	DT
cord-023095-4dannjjm	3599	10	immunogenic	immunogenic	JJ
cord-023095-4dannjjm	3599	11	MSG1	MSG1	NNP
cord-023095-4dannjjm	3599	12	protein	protein	NN
cord-023095-4dannjjm	3599	13	of	of	IN
cord-023095-4dannjjm	3599	14	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	3599	15	suis	suis	NN
cord-023095-4dannjjm	3599	16	was	be	VBD
cord-023095-4dannjjm	3599	17	present	present	JJ
cord-023095-4dannjjm	3599	18	.	.	.
cord-023095-4dannjjm	3600	1	Of	of	IN
cord-023095-4dannjjm	3600	2	the	the	DT
cord-023095-4dannjjm	3600	3	uncharacterized	uncharacterized	JJ
cord-023095-4dannjjm	3600	4	hypothetical	hypothetical	JJ
cord-023095-4dannjjm	3600	5	proteins	protein	NNS
cord-023095-4dannjjm	3600	6	,	,	,
cord-023095-4dannjjm	3600	7	1,115	1,115	CD
cord-023095-4dannjjm	3600	8	were	be	VBD
cord-023095-4dannjjm	3600	9	arranged	arrange	VBN
cord-023095-4dannjjm	3600	10	in	in	IN
cord-023095-4dannjjm	3600	11	series	series	NN
cord-023095-4dannjjm	3600	12	of	of	IN
cord-023095-4dannjjm	3600	13	orthologous	orthologous	NNP
cord-023095-4dannjjm	3600	14	repeats	repeat	VBZ
cord-023095-4dannjjm	3600	15	,	,	,
cord-023095-4dannjjm	3600	16	or	or	CC
cord-023095-4dannjjm	3600	17	comprised	comprise	VBN
cord-023095-4dannjjm	3600	18	fragments	fragment	NNS
cord-023095-4dannjjm	3600	19	there	there	RB
cord-023095-4dannjjm	3600	20	-	-	:
cord-023095-4dannjjm	3600	21	of	of	IN
cord-023095-4dannjjm	3600	22	,	,	,
cord-023095-4dannjjm	3600	23	encoding	encode	VBG
cord-023095-4dannjjm	3600	24	putative	putative	JJ
cord-023095-4dannjjm	3600	25	proteins	protein	NNS
cord-023095-4dannjjm	3600	26	of	of	IN
cord-023095-4dannjjm	3600	27	approximately	approximately	RB
cord-023095-4dannjjm	3600	28	200	200	CD
cord-023095-4dannjjm	3600	29	amino	amino	JJ
cord-023095-4dannjjm	3600	30	acids	acid	NNS
cord-023095-4dannjjm	3600	31	.	.	.
cord-023095-4dannjjm	3601	1	The	the	DT
cord-023095-4dannjjm	3601	2	predicted	predict	VBN
cord-023095-4dannjjm	3601	3	motifs	motif	NNS
cord-023095-4dannjjm	3601	4	of	of	IN
cord-023095-4dannjjm	3601	5	the	the	DT
cord-023095-4dannjjm	3601	6	majority	majority	NN
cord-023095-4dannjjm	3601	7	of	of	IN
cord-023095-4dannjjm	3601	8	these	these	DT
cord-023095-4dannjjm	3601	9	putative	putative	JJ
cord-023095-4dannjjm	3601	10	proteins	protein	NNS
cord-023095-4dannjjm	3601	11	were	be	VBD
cord-023095-4dannjjm	3601	12	consistent	consistent	JJ
cord-023095-4dannjjm	3601	13	with	with	IN
cord-023095-4dannjjm	3601	14	these	these	DT
cord-023095-4dannjjm	3601	15	proteins	protein	NNS
cord-023095-4dannjjm	3601	16	being	be	VBG
cord-023095-4dannjjm	3601	17	presented	present	VBN
cord-023095-4dannjjm	3601	18	on	on	IN
cord-023095-4dannjjm	3601	19	the	the	DT
cord-023095-4dannjjm	3601	20	cell	cell	NN
cord-023095-4dannjjm	3601	21	surface	surface	NN
cord-023095-4dannjjm	3601	22	;	;	:
cord-023095-4dannjjm	3601	23	an	an	DT
cord-023095-4dannjjm	3601	24	N	n	NN
cord-023095-4dannjjm	3601	25	'	'	POS
cord-023095-4dannjjm	3601	26	terminal	terminal	NN
cord-023095-4dannjjm	3601	27	signal	signal	NN
cord-023095-4dannjjm	3601	28	peptide	peptide	NN
cord-023095-4dannjjm	3601	29	or	or	CC
cord-023095-4dannjjm	3601	30	transmembrane	transmembrane	NN
cord-023095-4dannjjm	3601	31	region	region	NN
cord-023095-4dannjjm	3601	32	followed	follow	VBN
cord-023095-4dannjjm	3601	33	by	by	IN
cord-023095-4dannjjm	3601	34	a	a	DT
cord-023095-4dannjjm	3601	35	non	non	JJ
cord-023095-4dannjjm	3601	36	-	-	JJ
cord-023095-4dannjjm	3601	37	cytoplasmic	cytoplasmic	JJ
cord-023095-4dannjjm	3601	38	tail	tail	NN
cord-023095-4dannjjm	3601	39	.	.	.
cord-023095-4dannjjm	3602	1	These	these	DT
cord-023095-4dannjjm	3602	2	data	datum	NNS
cord-023095-4dannjjm	3602	3	have	have	VBP
cord-023095-4dannjjm	3602	4	provided	provide	VBN
cord-023095-4dannjjm	3602	5	valuable	valuable	JJ
cord-023095-4dannjjm	3602	6	information	information	NN
cord-023095-4dannjjm	3602	7	as	as	IN
cord-023095-4dannjjm	3602	8	to	to	IN
cord-023095-4dannjjm	3602	9	why	why	WRB
cord-023095-4dannjjm	3602	10	this	this	DT
cord-023095-4dannjjm	3602	11	pathogen	pathogen	NN
cord-023095-4dannjjm	3602	12	remains	remain	VBZ
cord-023095-4dannjjm	3602	13	highly	highly	RB
cord-023095-4dannjjm	3602	14	fastidious	fastidious	JJ
cord-023095-4dannjjm	3602	15	;	;	:
cord-023095-4dannjjm	3602	16	it	-PRON-	PRP
cord-023095-4dannjjm	3602	17	lacks	lack	VBZ
cord-023095-4dannjjm	3602	18	some	some	DT
cord-023095-4dannjjm	3602	19	of	of	IN
cord-023095-4dannjjm	3602	20	the	the	DT
cord-023095-4dannjjm	3602	21	metabolic	metabolic	JJ
cord-023095-4dannjjm	3602	22	pathways	pathway	NNS
cord-023095-4dannjjm	3602	23	found	find	VBN
cord-023095-4dannjjm	3602	24	in	in	IN
cord-023095-4dannjjm	3602	25	cultivatable	cultivatable	JJ
cord-023095-4dannjjm	3602	26	mycoplasmas	mycoplasmas	NN
cord-023095-4dannjjm	3602	27	.	.	.
cord-023095-4dannjjm	3603	1	We	-PRON-	PRP
cord-023095-4dannjjm	3603	2	have	have	VBP
cord-023095-4dannjjm	3603	3	also	also	RB
cord-023095-4dannjjm	3603	4	identified	identify	VBN
cord-023095-4dannjjm	3603	5	a	a	DT
cord-023095-4dannjjm	3603	6	homolog	homolog	NN
cord-023095-4dannjjm	3603	7	of	of	IN
cord-023095-4dannjjm	3603	8	a	a	DT
cord-023095-4dannjjm	3603	9	known	know	VBN
cord-023095-4dannjjm	3603	10	M.	m.	NN
cord-023095-4dannjjm	3603	11	suis	suis	FW
cord-023095-4dannjjm	3603	12	immunogenic	immunogenic	JJ
cord-023095-4dannjjm	3603	13	protein	protein	NN
cord-023095-4dannjjm	3603	14	,	,	,
cord-023095-4dannjjm	3603	15	and	and	CC
cord-023095-4dannjjm	3603	16	identified	identify	VBD
cord-023095-4dannjjm	3603	17	a	a	DT
cord-023095-4dannjjm	3603	18	potential	potential	JJ
cord-023095-4dannjjm	3603	19	mechanism	mechanism	NN
cord-023095-4dannjjm	3603	20	for	for	IN
cord-023095-4dannjjm	3603	21	host	host	NN
cord-023095-4dannjjm	3603	22	immune	immune	JJ
cord-023095-4dannjjm	3603	23	system	system	NN
cord-023095-4dannjjm	3603	24	evasion	evasion	NN
cord-023095-4dannjjm	3603	25	by	by	IN
cord-023095-4dannjjm	3603	26	way	way	NN
cord-023095-4dannjjm	3603	27	of	of	IN
cord-023095-4dannjjm	3603	28	highly	highly	RB
cord-023095-4dannjjm	3603	29	repetitive	repetitive	JJ
cord-023095-4dannjjm	3603	30	,	,	,
cord-023095-4dannjjm	3603	31	putatively	putatively	RB
cord-023095-4dannjjm	3603	32	surface	surface	NN
cord-023095-4dannjjm	3603	33	-	-	HYPH
cord-023095-4dannjjm	3603	34	expressed	express	VBN
cord-023095-4dannjjm	3603	35	hypothetical	hypothetical	JJ
cord-023095-4dannjjm	3603	36	proteins	protein	NNS
cord-023095-4dannjjm	3603	37	with	with	IN
cord-023095-4dannjjm	3603	38	variable	variable	JJ
cord-023095-4dannjjm	3603	39	sequences	sequence	NNS
cord-023095-4dannjjm	3603	40	.	.	.
cord-023095-4dannjjm	3604	1	Canine	canine	JJ
cord-023095-4dannjjm	3604	2	leptospirosis	leptospirosis	NN
cord-023095-4dannjjm	3604	3	has	have	VBZ
cord-023095-4dannjjm	3604	4	been	be	VBN
cord-023095-4dannjjm	3604	5	recognized	recognize	VBN
cord-023095-4dannjjm	3604	6	as	as	IN
cord-023095-4dannjjm	3604	7	a	a	DT
cord-023095-4dannjjm	3604	8	re	re	NN
cord-023095-4dannjjm	3604	9	-	-	JJ
cord-023095-4dannjjm	3604	10	emerging	emerge	VBG
cord-023095-4dannjjm	3604	11	disease	disease	NN
cord-023095-4dannjjm	3604	12	in	in	IN
cord-023095-4dannjjm	3604	13	the	the	DT
cord-023095-4dannjjm	3604	14	U.S.	U.S.	NNP
cord-023095-4dannjjm	3604	15	over	over	IN
cord-023095-4dannjjm	3604	16	the	the	DT
cord-023095-4dannjjm	3604	17	past	past	JJ
cord-023095-4dannjjm	3604	18	20	20	CD
cord-023095-4dannjjm	3604	19	years	year	NNS
cord-023095-4dannjjm	3604	20	,	,	,
cord-023095-4dannjjm	3604	21	and	and	CC
cord-023095-4dannjjm	3604	22	several	several	JJ
cord-023095-4dannjjm	3604	23	serosurveys	serosurvey	NNS
cord-023095-4dannjjm	3604	24	of	of	IN
cord-023095-4dannjjm	3604	25	the	the	DT
cord-023095-4dannjjm	3604	26	prevalence	prevalence	NN
cord-023095-4dannjjm	3604	27	of	of	IN
cord-023095-4dannjjm	3604	28	leptospiral	leptospiral	JJ
cord-023095-4dannjjm	3604	29	antibodies	antibody	NNS
cord-023095-4dannjjm	3604	30	in	in	IN
cord-023095-4dannjjm	3604	31	dogs	dog	NNS
cord-023095-4dannjjm	3604	32	have	have	VBP
cord-023095-4dannjjm	3604	33	been	be	VBN
cord-023095-4dannjjm	3604	34	published	publish	VBN
cord-023095-4dannjjm	3604	35	during	during	IN
cord-023095-4dannjjm	3604	36	that	that	DT
cord-023095-4dannjjm	3604	37	time	time	NN
cord-023095-4dannjjm	3604	38	.	.	.
cord-023095-4dannjjm	3605	1	The	the	DT
cord-023095-4dannjjm	3605	2	role	role	NN
cord-023095-4dannjjm	3605	3	of	of	IN
cord-023095-4dannjjm	3605	4	cats	cat	NNS
cord-023095-4dannjjm	3605	5	in	in	IN
cord-023095-4dannjjm	3605	6	the	the	DT
cord-023095-4dannjjm	3605	7	epidemiology	epidemiology	NN
cord-023095-4dannjjm	3605	8	of	of	IN
cord-023095-4dannjjm	3605	9	leptospirosis	leptospirosis	NN
cord-023095-4dannjjm	3605	10	has	have	VBZ
cord-023095-4dannjjm	3605	11	received	receive	VBN
cord-023095-4dannjjm	3605	12	little	little	JJ
cord-023095-4dannjjm	3605	13	attention	attention	NN
cord-023095-4dannjjm	3605	14	.	.	.
cord-023095-4dannjjm	3606	1	Serosurveys	Serosurveys	NNP
cord-023095-4dannjjm	3606	2	of	of	IN
cord-023095-4dannjjm	3606	3	cats	cat	NNS
cord-023095-4dannjjm	3606	4	for	for	IN
cord-023095-4dannjjm	3606	5	exposure	exposure	NN
cord-023095-4dannjjm	3606	6	to	to	IN
cord-023095-4dannjjm	3606	7	or	or	CC
cord-023095-4dannjjm	3606	8	infection	infection	NN
cord-023095-4dannjjm	3606	9	with	with	IN
cord-023095-4dannjjm	3606	10	leptospires	leptospire	NNS
cord-023095-4dannjjm	3606	11	have	have	VBP
cord-023095-4dannjjm	3606	12	been	be	VBN
cord-023095-4dannjjm	3606	13	published	publish	VBN
cord-023095-4dannjjm	3606	14	from	from	IN
cord-023095-4dannjjm	3606	15	other	other	JJ
cord-023095-4dannjjm	3606	16	geographic	geographic	JJ
cord-023095-4dannjjm	3606	17	areas	area	NNS
cord-023095-4dannjjm	3606	18	,	,	,
cord-023095-4dannjjm	3606	19	but	but	CC
cord-023095-4dannjjm	3606	20	none	none	NN
cord-023095-4dannjjm	3606	21	for	for	IN
cord-023095-4dannjjm	3606	22	cats	cat	NNS
cord-023095-4dannjjm	3606	23	in	in	IN
cord-023095-4dannjjm	3606	24	the	the	DT
cord-023095-4dannjjm	3606	25	U.S.	U.S.	NNP
cord-023095-4dannjjm	3606	26	in	in	IN
cord-023095-4dannjjm	3606	27	the	the	DT
cord-023095-4dannjjm	3606	28	past	past	JJ
cord-023095-4dannjjm	3606	29	four	four	CD
cord-023095-4dannjjm	3606	30	decades	decade	NNS
cord-023095-4dannjjm	3606	31	.	.	.
cord-023095-4dannjjm	3607	1	The	the	DT
cord-023095-4dannjjm	3607	2	New	New	NNP
cord-023095-4dannjjm	3607	3	England	England	NNP
cord-023095-4dannjjm	3607	4	states	state	NNS
cord-023095-4dannjjm	3607	5	have	have	VBP
cord-023095-4dannjjm	3607	6	been	be	VBN
cord-023095-4dannjjm	3607	7	found	find	VBN
cord-023095-4dannjjm	3607	8	to	to	TO
cord-023095-4dannjjm	3607	9	have	have	VB
cord-023095-4dannjjm	3607	10	a	a	DT
cord-023095-4dannjjm	3607	11	high	high	JJ
cord-023095-4dannjjm	3607	12	incidence	incidence	NN
cord-023095-4dannjjm	3607	13	of	of	IN
cord-023095-4dannjjm	3607	14	canine	canine	JJ
cord-023095-4dannjjm	3607	15	leptospirosis	leptospirosis	NN
cord-023095-4dannjjm	3607	16	.	.	.
cord-023095-4dannjjm	3608	1	The	the	DT
cord-023095-4dannjjm	3608	2	purpose	purpose	NN
cord-023095-4dannjjm	3608	3	of	of	IN
cord-023095-4dannjjm	3608	4	this	this	DT
cord-023095-4dannjjm	3608	5	pilot	pilot	NN
cord-023095-4dannjjm	3608	6	study	study	NN
cord-023095-4dannjjm	3608	7	was	be	VBD
cord-023095-4dannjjm	3608	8	to	to	TO
cord-023095-4dannjjm	3608	9	determine	determine	VB
cord-023095-4dannjjm	3608	10	the	the	DT
cord-023095-4dannjjm	3608	11	prevalence	prevalence	NN
cord-023095-4dannjjm	3608	12	of	of	IN
cord-023095-4dannjjm	3608	13	leptospiral	leptospiral	JJ
cord-023095-4dannjjm	3608	14	antibodies	antibody	NNS
cord-023095-4dannjjm	3608	15	in	in	IN
cord-023095-4dannjjm	3608	16	a	a	DT
cord-023095-4dannjjm	3608	17	population	population	NN
cord-023095-4dannjjm	3608	18	of	of	IN
cord-023095-4dannjjm	3608	19	feral	feral	JJ
cord-023095-4dannjjm	3608	20	cats	cat	NNS
cord-023095-4dannjjm	3608	21	in	in	IN
cord-023095-4dannjjm	3608	22	central	central	JJ
cord-023095-4dannjjm	3608	23	Massachusetts	Massachusetts	NNP
cord-023095-4dannjjm	3608	24	.	.	.
cord-023095-4dannjjm	3609	1	Blood	blood	NN
cord-023095-4dannjjm	3609	2	was	be	VBD
cord-023095-4dannjjm	3609	3	collected	collect	VBN
cord-023095-4dannjjm	3609	4	from	from	IN
cord-023095-4dannjjm	3609	5	63	63	CD
cord-023095-4dannjjm	3609	6	sexually	sexually	RB
cord-023095-4dannjjm	3609	7	intact	intact	JJ
cord-023095-4dannjjm	3609	8	feral	feral	JJ
cord-023095-4dannjjm	3609	9	cats	cat	NNS
cord-023095-4dannjjm	3609	10	presented	present	VBN
cord-023095-4dannjjm	3609	11	to	to	IN
cord-023095-4dannjjm	3609	12	a	a	DT
cord-023095-4dannjjm	3609	13	spay	spay	NN
cord-023095-4dannjjm	3609	14	and	and	CC
cord-023095-4dannjjm	3609	15	neuter	neuter	JJ
cord-023095-4dannjjm	3609	16	program	program	NN
cord-023095-4dannjjm	3609	17	.	.	.
cord-023095-4dannjjm	3610	1	Microagglutination	microagglutination	NN
cord-023095-4dannjjm	3610	2	titers	titer	NNS
cord-023095-4dannjjm	3610	3	to	to	IN
cord-023095-4dannjjm	3610	4	Leptospira	Leptospira	NNP
cord-023095-4dannjjm	3610	5	serovars	serovar	NNS
cord-023095-4dannjjm	3610	6	autumnalis	autumnalis	NNP
cord-023095-4dannjjm	3610	7	,	,	,
cord-023095-4dannjjm	3610	8	hardjo	hardjo	NNP
cord-023095-4dannjjm	3610	9	,	,	,
cord-023095-4dannjjm	3610	10	bratislava	bratislava	NNP
cord-023095-4dannjjm	3610	11	,	,	,
cord-023095-4dannjjm	3610	12	icterohaemorrhagiae	icterohaemorrhagiae	NN
cord-023095-4dannjjm	3610	13	,	,	,
cord-023095-4dannjjm	3610	14	canicola	canicola	NNP
cord-023095-4dannjjm	3610	15	,	,	,
cord-023095-4dannjjm	3610	16	pomona	pomona	NNP
cord-023095-4dannjjm	3610	17	,	,	,
cord-023095-4dannjjm	3610	18	and	and	CC
cord-023095-4dannjjm	3610	19	grippotyphosa	grippotyphosa	NNP
cord-023095-4dannjjm	3610	20	were	be	VBD
cord-023095-4dannjjm	3610	21	determined	determine	VBN
cord-023095-4dannjjm	3610	22	.	.	.
cord-023095-4dannjjm	3611	1	Three	three	CD
cord-023095-4dannjjm	3611	2	of	of	IN
cord-023095-4dannjjm	3611	3	63	63	CD
cord-023095-4dannjjm	3611	4	cats	cat	NNS
cord-023095-4dannjjm	3611	5	(	(	-LRB-
cord-023095-4dannjjm	3611	6	4.8	4.8	CD
cord-023095-4dannjjm	3611	7	%	%	NN
cord-023095-4dannjjm	3611	8	)	)	-RRB-
cord-023095-4dannjjm	3611	9	had	have	VBD
cord-023095-4dannjjm	3611	10	a	a	DT
cord-023095-4dannjjm	3611	11	positive	positive	JJ
cord-023095-4dannjjm	3611	12	titer	titer	NN
cord-023095-4dannjjm	3611	13	to	to	IN
cord-023095-4dannjjm	3611	14	one	one	CD
cord-023095-4dannjjm	3611	15	or	or	CC
cord-023095-4dannjjm	3611	16	more	more	JJR
cord-023095-4dannjjm	3611	17	serovars	serovar	NNS
cord-023095-4dannjjm	3611	18	,	,	,
cord-023095-4dannjjm	3611	19	with	with	IN
cord-023095-4dannjjm	3611	20	autumnalis	autumnalis	NNP
cord-023095-4dannjjm	3611	21	being	be	VBG
cord-023095-4dannjjm	3611	22	the	the	DT
cord-023095-4dannjjm	3611	23	most	most	RBS
cord-023095-4dannjjm	3611	24	common	common	JJ
cord-023095-4dannjjm	3611	25	.	.	.
cord-023095-4dannjjm	3612	1	These	these	DT
cord-023095-4dannjjm	3612	2	results	result	NNS
cord-023095-4dannjjm	3612	3	are	be	VBP
cord-023095-4dannjjm	3612	4	consistent	consistent	JJ
cord-023095-4dannjjm	3612	5	with	with	IN
cord-023095-4dannjjm	3612	6	previously	previously	RB
cord-023095-4dannjjm	3612	7	published	publish	VBN
cord-023095-4dannjjm	3612	8	prevalence	prevalence	NN
cord-023095-4dannjjm	3612	9	rates	rate	NNS
cord-023095-4dannjjm	3612	10	in	in	IN
cord-023095-4dannjjm	3612	11	feral	feral	JJ
cord-023095-4dannjjm	3612	12	cats	cat	NNS
cord-023095-4dannjjm	3612	13	.	.	.
cord-023095-4dannjjm	3613	1	Further	further	JJ
cord-023095-4dannjjm	3613	2	studies	study	NNS
cord-023095-4dannjjm	3613	3	are	be	VBP
cord-023095-4dannjjm	3613	4	required	require	VBN
cord-023095-4dannjjm	3613	5	to	to	TO
cord-023095-4dannjjm	3613	6	determine	determine	VB
cord-023095-4dannjjm	3613	7	the	the	DT
cord-023095-4dannjjm	3613	8	role	role	NN
cord-023095-4dannjjm	3613	9	of	of	IN
cord-023095-4dannjjm	3613	10	leptosporosis	leptosporosis	NN
cord-023095-4dannjjm	3613	11	in	in	IN
cord-023095-4dannjjm	3613	12	clinical	clinical	JJ
cord-023095-4dannjjm	3613	13	disease	disease	NN
cord-023095-4dannjjm	3613	14	in	in	IN
cord-023095-4dannjjm	3613	15	the	the	DT
cord-023095-4dannjjm	3613	16	domestic	domestic	JJ
cord-023095-4dannjjm	3613	17	cat	cat	NN
cord-023095-4dannjjm	3613	18	.	.	.
cord-023095-4dannjjm	3614	1	Since	since	IN
cord-023095-4dannjjm	3614	2	years	year	NNS
cord-023095-4dannjjm	3614	3	the	the	DT
cord-023095-4dannjjm	3614	4	Rivalta	Rivalta	NNP
cord-023095-4dannjjm	3614	5	's	's	POS
cord-023095-4dannjjm	3614	6	test	test	NN
cord-023095-4dannjjm	3614	7	is	be	VBZ
cord-023095-4dannjjm	3614	8	routinely	routinely	RB
cord-023095-4dannjjm	3614	9	used	use	VBN
cord-023095-4dannjjm	3614	10	in	in	IN
cord-023095-4dannjjm	3614	11	several	several	JJ
cord-023095-4dannjjm	3614	12	European	european	JJ
cord-023095-4dannjjm	3614	13	countries	country	NNS
cord-023095-4dannjjm	3614	14	as	as	IN
cord-023095-4dannjjm	3614	15	a	a	DT
cord-023095-4dannjjm	3614	16	tool	tool	NN
cord-023095-4dannjjm	3614	17	to	to	TO
cord-023095-4dannjjm	3614	18	diagnose	diagnose	VB
cord-023095-4dannjjm	3614	19	feline	feline	JJ
cord-023095-4dannjjm	3614	20	infectious	infectious	JJ
cord-023095-4dannjjm	3614	21	peritonitis	peritonitis	NN
cord-023095-4dannjjm	3614	22	(	(	-LRB-
cord-023095-4dannjjm	3614	23	FIP	FIP	NNP
cord-023095-4dannjjm	3614	24	)	)	-RRB-
cord-023095-4dannjjm	3614	25	in	in	IN
cord-023095-4dannjjm	3614	26	cats	cat	NNS
cord-023095-4dannjjm	3614	27	with	with	IN
cord-023095-4dannjjm	3614	28	effusion	effusion	NN
cord-023095-4dannjjm	3614	29	.	.	.
cord-023095-4dannjjm	3615	1	It	-PRON-	PRP
cord-023095-4dannjjm	3615	2	is	be	VBZ
cord-023095-4dannjjm	3615	3	inexpensive	inexpensive	JJ
cord-023095-4dannjjm	3615	4	and	and	CC
cord-023095-4dannjjm	3615	5	easy	easy	JJ
cord-023095-4dannjjm	3615	6	to	to	TO
cord-023095-4dannjjm	3615	7	perform	perform	VB
cord-023095-4dannjjm	3615	8	in	in	IN
cord-023095-4dannjjm	3615	9	private	private	JJ
cord-023095-4dannjjm	3615	10	practice	practice	NN
cord-023095-4dannjjm	3615	11	.	.	.
cord-023095-4dannjjm	3616	1	There	there	EX
cord-023095-4dannjjm	3616	2	is	be	VBZ
cord-023095-4dannjjm	3616	3	,	,	,
cord-023095-4dannjjm	3616	4	however	however	RB
cord-023095-4dannjjm	3616	5	,	,	,
cord-023095-4dannjjm	3616	6	only	only	RB
cord-023095-4dannjjm	3616	7	little	little	JJ
cord-023095-4dannjjm	3616	8	information	information	NN
cord-023095-4dannjjm	3616	9	about	about	IN
cord-023095-4dannjjm	3616	10	mode	mode	NN
cord-023095-4dannjjm	3616	11	of	of	IN
cord-023095-4dannjjm	3616	12	action	action	NN
cord-023095-4dannjjm	3616	13	or	or	CC
cord-023095-4dannjjm	3616	14	its	-PRON-	PRP$
cord-023095-4dannjjm	3616	15	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3616	16	value	value	NN
cord-023095-4dannjjm	3616	17	.	.	.
cord-023095-4dannjjm	3617	1	The	the	DT
cord-023095-4dannjjm	3617	2	objectives	objective	NNS
cord-023095-4dannjjm	3617	3	of	of	IN
cord-023095-4dannjjm	3617	4	this	this	DT
cord-023095-4dannjjm	3617	5	study	study	NN
cord-023095-4dannjjm	3617	6	were	be	VBD
cord-023095-4dannjjm	3617	7	to	to	TO
cord-023095-4dannjjm	3617	8	evaluate	evaluate	VB
cord-023095-4dannjjm	3617	9	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3617	10	,	,	,
cord-023095-4dannjjm	3617	11	specificity	specificity	NN
cord-023095-4dannjjm	3617	12	,	,	,
cord-023095-4dannjjm	3617	13	positive	positive	JJ
cord-023095-4dannjjm	3617	14	(	(	-LRB-
cord-023095-4dannjjm	3617	15	PPV	PPV	NNP
cord-023095-4dannjjm	3617	16	)	)	-RRB-
cord-023095-4dannjjm	3617	17	and	and	CC
cord-023095-4dannjjm	3617	18	negative	negative	JJ
cord-023095-4dannjjm	3617	19	predic	predic	JJ
cord-023095-4dannjjm	3617	20	-	-	HYPH
cord-023095-4dannjjm	3617	21	tive	tive	JJ
cord-023095-4dannjjm	3617	22	values	value	NNS
cord-023095-4dannjjm	3617	23	of	of	IN
cord-023095-4dannjjm	3617	24	the	the	DT
cord-023095-4dannjjm	3617	25	Rivalta	Rivalta	NNP
cord-023095-4dannjjm	3617	26	's	's	POS
cord-023095-4dannjjm	3617	27	test	test	NN
cord-023095-4dannjjm	3617	28	to	to	IN
cord-023095-4dannjjm	3617	29	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3617	30	of	of	IN
cord-023095-4dannjjm	3617	31	FIP	FIP	NNP
cord-023095-4dannjjm	3617	32	and	and	CC
cord-023095-4dannjjm	3617	33	to	to	TO
cord-023095-4dannjjm	3617	34	examine	examine	VB
cord-023095-4dannjjm	3617	35	if	if	IN
cord-023095-4dannjjm	3617	36	there	there	EX
cord-023095-4dannjjm	3617	37	is	be	VBZ
cord-023095-4dannjjm	3617	38	a	a	DT
cord-023095-4dannjjm	3617	39	correlation	correlation	NN
cord-023095-4dannjjm	3617	40	with	with	IN
cord-023095-4dannjjm	3617	41	any	any	DT
cord-023095-4dannjjm	3617	42	effusion	effusion	NN
cord-023095-4dannjjm	3617	43	or	or	CC
cord-023095-4dannjjm	3617	44	blood	blood	NN
cord-023095-4dannjjm	3617	45	parameters	parameter	NNS
cord-023095-4dannjjm	3617	46	.	.	.
cord-023095-4dannjjm	3618	1	Medical	medical	JJ
cord-023095-4dannjjm	3618	2	records	record	NNS
cord-023095-4dannjjm	3618	3	of	of	IN
cord-023095-4dannjjm	3618	4	782	782	CD
cord-023095-4dannjjm	3618	5	cats	cat	NNS
cord-023095-4dannjjm	3618	6	with	with	IN
cord-023095-4dannjjm	3618	7	effusion	effusion	NN
cord-023095-4dannjjm	3618	8	in	in	IN
cord-023095-4dannjjm	3618	9	which	which	WDT
cord-023095-4dannjjm	3618	10	the	the	DT
cord-023095-4dannjjm	3618	11	Rivalta	Rivalta	NNP
cord-023095-4dannjjm	3618	12	's	's	POS
cord-023095-4dannjjm	3618	13	test	test	NN
cord-023095-4dannjjm	3618	14	was	be	VBD
cord-023095-4dannjjm	3618	15	performed	perform	VBN
cord-023095-4dannjjm	3618	16	between	between	IN
cord-023095-4dannjjm	3618	17	1999	1999	CD
cord-023095-4dannjjm	3618	18	and	and	CC
cord-023095-4dannjjm	3618	19	2010	2010	CD
cord-023095-4dannjjm	3618	20	were	be	VBD
cord-023095-4dannjjm	3618	21	reviewed	review	VBN
cord-023095-4dannjjm	3618	22	concerning	concern	VBG
cord-023095-4dannjjm	3618	23	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3618	24	,	,	,
cord-023095-4dannjjm	3618	25	blood	blood	NN
cord-023095-4dannjjm	3618	26	and	and	CC
cord-023095-4dannjjm	3618	27	effusion	effusion	NN
cord-023095-4dannjjm	3618	28	parameters	parameter	NNS
cord-023095-4dannjjm	3618	29	,	,	,
cord-023095-4dannjjm	3618	30	and	and	CC
cord-023095-4dannjjm	3618	31	survival	survival	NN
cord-023095-4dannjjm	3618	32	time	time	NN
cord-023095-4dannjjm	3618	33	.	.	.
cord-023095-4dannjjm	3619	1	Effusion	effusion	NN
cord-023095-4dannjjm	3619	2	and	and	CC
cord-023095-4dannjjm	3619	3	blood	blood	NN
cord-023095-4dannjjm	3619	4	parameters	parameter	NNS
cord-023095-4dannjjm	3619	5	were	be	VBD
cord-023095-4dannjjm	3619	6	compared	compare	VBN
cord-023095-4dannjjm	3619	7	between	between	IN
cord-023095-4dannjjm	3619	8	Rivalta	Rivalta	NNP
cord-023095-4dannjjm	3619	9	-	-	HYPH
cord-023095-4dannjjm	3619	10	positive	positive	JJ
cord-023095-4dannjjm	3619	11	and	and	CC
cord-023095-4dannjjm	3619	12	-negative	-negative	JJ
cord-023095-4dannjjm	3619	13	effusions	effusion	NNS
cord-023095-4dannjjm	3619	14	using	use	VBG
cord-023095-4dannjjm	3619	15	the	the	DT
cord-023095-4dannjjm	3619	16	Mann	Mann	NNP
cord-023095-4dannjjm	3619	17	Whitney	Whitney	NNP
cord-023095-4dannjjm	3619	18	U	U	NNP
cord-023095-4dannjjm	3619	19	test	test	NN
cord-023095-4dannjjm	3619	20	.	.	.
cord-023095-4dannjjm	3620	1	Prevalence	prevalence	NN
cord-023095-4dannjjm	3620	2	of	of	IN
cord-023095-4dannjjm	3620	3	FIP	fip	NN
cord-023095-4dannjjm	3620	4	in	in	IN
cord-023095-4dannjjm	3620	5	cats	cat	NNS
cord-023095-4dannjjm	3620	6	with	with	IN
cord-023095-4dannjjm	3620	7	effusion	effusion	NN
cord-023095-4dannjjm	3620	8	was	be	VBD
cord-023095-4dannjjm	3620	9	31.7	31.7	CD
cord-023095-4dannjjm	3620	10	%	%	NN
cord-023095-4dannjjm	3620	11	.	.	.
cord-023095-4dannjjm	3621	1	The	the	DT
cord-023095-4dannjjm	3621	2	Rivalta	Rivalta	NNP
cord-023095-4dannjjm	3621	3	's	's	POS
cord-023095-4dannjjm	3621	4	test	test	NN
cord-023095-4dannjjm	3621	5	showed	show	VBD
cord-023095-4dannjjm	3621	6	a	a	DT
cord-023095-4dannjjm	3621	7	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3621	8	of	of	IN
cord-023095-4dannjjm	3621	9	91.3	91.3	CD
cord-023095-4dannjjm	3621	10	%	%	NN
cord-023095-4dannjjm	3621	11	,	,	,
cord-023095-4dannjjm	3621	12	a	a	DT
cord-023095-4dannjjm	3621	13	specificity	specificity	NN
cord-023095-4dannjjm	3621	14	of	of	IN
cord-023095-4dannjjm	3621	15	66.6	66.6	CD
cord-023095-4dannjjm	3621	16	%	%	NN
cord-023095-4dannjjm	3621	17	,	,	,
cord-023095-4dannjjm	3621	18	a	a	DT
cord-023095-4dannjjm	3621	19	PPV	PPV	NNP
cord-023095-4dannjjm	3621	20	of	of	IN
cord-023095-4dannjjm	3621	21	55.9	55.9	CD
cord-023095-4dannjjm	3621	22	%	%	NN
cord-023095-4dannjjm	3621	23	,	,	,
cord-023095-4dannjjm	3621	24	and	and	CC
cord-023095-4dannjjm	3621	25	a	a	DT
cord-023095-4dannjjm	3621	26	NPV	NPV	NNP
cord-023095-4dannjjm	3621	27	of	of	IN
cord-023095-4dannjjm	3621	28	94.3	94.3	CD
cord-023095-4dannjjm	3621	29	%	%	NN
cord-023095-4dannjjm	3621	30	for	for	IN
cord-023095-4dannjjm	3621	31	the	the	DT
cord-023095-4dannjjm	3621	32	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3621	33	of	of	IN
cord-023095-4dannjjm	3621	34	FIP	FIP	NNP
cord-023095-4dannjjm	3621	35	.	.	.
cord-023095-4dannjjm	3622	1	The	the	DT
cord-023095-4dannjjm	3622	2	PPV	PPV	NNP
cord-023095-4dannjjm	3622	3	improved	improve	VBD
cord-023095-4dannjjm	3622	4	,	,	,
cord-023095-4dannjjm	3622	5	when	when	WRB
cord-023095-4dannjjm	3622	6	cats	cat	NNS
cord-023095-4dannjjm	3622	7	with	with	IN
cord-023095-4dannjjm	3622	8	lymphoma	lymphoma	NN
cord-023095-4dannjjm	3622	9	or	or	CC
cord-023095-4dannjjm	3622	10	bacterial	bacterial	JJ
cord-023095-4dannjjm	3622	11	infection	infection	NN
cord-023095-4dannjjm	3622	12	were	be	VBD
cord-023095-4dannjjm	3622	13	excluded	exclude	VBN
cord-023095-4dannjjm	3622	14	(	(	-LRB-
cord-023095-4dannjjm	3622	15	PPV	PPV	NNP
cord-023095-4dannjjm	3622	16	69.2	69.2	CD
cord-023095-4dannjjm	3622	17	%	%	NN
cord-023095-4dannjjm	3622	18	)	)	-RRB-
cord-023095-4dannjjm	3622	19	and	and	CC
cord-023095-4dannjjm	3622	20	also	also	RB
cord-023095-4dannjjm	3622	21	,	,	,
cord-023095-4dannjjm	3622	22	when	when	WRB
cord-023095-4dannjjm	3622	23	only	only	RB
cord-023095-4dannjjm	3622	24	cats	cat	NNS
cord-023095-4dannjjm	3622	25	younger	young	JJR
cord-023095-4dannjjm	3622	26	than	than	IN
cord-023095-4dannjjm	3622	27	2	2	CD
cord-023095-4dannjjm	3622	28	years	year	NNS
cord-023095-4dannjjm	3622	29	(	(	-LRB-
cord-023095-4dannjjm	3622	30	PPV	PPV	NNP
cord-023095-4dannjjm	3622	31	87.5	87.5	CD
cord-023095-4dannjjm	3622	32	%	%	NN
cord-023095-4dannjjm	3622	33	)	)	-RRB-
cord-023095-4dannjjm	3622	34	or	or	CC
cord-023095-4dannjjm	3622	35	1	1	CD
cord-023095-4dannjjm	3622	36	year	year	NN
cord-023095-4dannjjm	3622	37	(	(	-LRB-
cord-023095-4dannjjm	3622	38	PPV	PPV	NNP
cord-023095-4dannjjm	3622	39	90.8	90.8	CD
cord-023095-4dannjjm	3622	40	%	%	NN
cord-023095-4dannjjm	3622	41	)	)	-RRB-
cord-023095-4dannjjm	3622	42	of	of	IN
cord-023095-4dannjjm	3622	43	age	age	NN
cord-023095-4dannjjm	3622	44	were	be	VBD
cord-023095-4dannjjm	3622	45	included	include	VBN
cord-023095-4dannjjm	3622	46	.	.	.
cord-023095-4dannjjm	3623	1	The	the	DT
cord-023095-4dannjjm	3623	2	most	most	RBS
cord-023095-4dannjjm	3623	3	important	important	JJ
cord-023095-4dannjjm	3623	4	significantly	significantly	RB
cord-023095-4dannjjm	3623	5	different	different	JJ
cord-023095-4dannjjm	3623	6	parameters	parameter	NNS
cord-023095-4dannjjm	3623	7	between	between	IN
cord-023095-4dannjjm	3623	8	Rivalta	Rivalta	NNP
cord-023095-4dannjjm	3623	9	-	-	HYPH
cord-023095-4dannjjm	3623	10	positive	positive	JJ
cord-023095-4dannjjm	3623	11	and	and	CC
cord-023095-4dannjjm	3623	12	-negative	-negative	JJ
cord-023095-4dannjjm	3623	13	effusions	effusion	NNS
cord-023095-4dannjjm	3623	14	were	be	VBD
cord-023095-4dannjjm	3623	15	specific	specific	JJ
cord-023095-4dannjjm	3623	16	gravity	gravity	NN
cord-023095-4dannjjm	3623	17	as	as	RB
cord-023095-4dannjjm	3623	18	well	well	RB
cord-023095-4dannjjm	3623	19	as	as	IN
cord-023095-4dannjjm	3623	20	cholesterol	cholesterol	NN
cord-023095-4dannjjm	3623	21	,	,	,
cord-023095-4dannjjm	3623	22	triglyceride	triglyceride	NN
cord-023095-4dannjjm	3623	23	,	,	,
cord-023095-4dannjjm	3623	24	and	and	CC
cord-023095-4dannjjm	3623	25	glucose	glucose	NN
cord-023095-4dannjjm	3623	26	concentration	concentration	NN
cord-023095-4dannjjm	3623	27	in	in	IN
cord-023095-4dannjjm	3623	28	the	the	DT
cord-023095-4dannjjm	3623	29	effusion	effusion	NN
cord-023095-4dannjjm	3623	30	.	.	.
cord-023095-4dannjjm	3624	1	The	the	DT
cord-023095-4dannjjm	3624	2	Rivalta	Rivalta	NNP
cord-023095-4dannjjm	3624	3	's	's	POS
cord-023095-4dannjjm	3624	4	test	test	NN
cord-023095-4dannjjm	3624	5	in	in	IN
cord-023095-4dannjjm	3624	6	general	general	JJ
cord-023095-4dannjjm	3624	7	is	be	VBZ
cord-023095-4dannjjm	3624	8	a	a	DT
cord-023095-4dannjjm	3624	9	useful	useful	JJ
cord-023095-4dannjjm	3624	10	tool	tool	NN
cord-023095-4dannjjm	3624	11	to	to	TO
cord-023095-4dannjjm	3624	12	diagnose	diagnose	VB
cord-023095-4dannjjm	3624	13	FIP	FIP	NNP
cord-023095-4dannjjm	3624	14	,	,	,
cord-023095-4dannjjm	3624	15	but	but	CC
cord-023095-4dannjjm	3624	16	its	-PRON-	PRP$
cord-023095-4dannjjm	3624	17	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3624	18	and	and	CC
cord-023095-4dannjjm	3624	19	specificity	specificity	NN
cord-023095-4dannjjm	3624	20	are	be	VBP
cord-023095-4dannjjm	3624	21	not	not	RB
cord-023095-4dannjjm	3624	22	as	as	RB
cord-023095-4dannjjm	3624	23	high	high	JJ
cord-023095-4dannjjm	3624	24	as	as	IN
cord-023095-4dannjjm	3624	25	previously	previously	RB
cord-023095-4dannjjm	3624	26	assumed	assume	VBN
cord-023095-4dannjjm	3624	27	.	.	.
cord-023095-4dannjjm	3625	1	If	if	IN
cord-023095-4dannjjm	3625	2	the	the	DT
cord-023095-4dannjjm	3625	3	Rivalta	Rivalta	NNP
cord-023095-4dannjjm	3625	4	's	's	POS
cord-023095-4dannjjm	3625	5	test	test	NN
cord-023095-4dannjjm	3625	6	,	,	,
cord-023095-4dannjjm	3625	7	however	however	RB
cord-023095-4dannjjm	3625	8	,	,	,
cord-023095-4dannjjm	3625	9	is	be	VBZ
cord-023095-4dannjjm	3625	10	performed	perform	VBN
cord-023095-4dannjjm	3625	11	in	in	IN
cord-023095-4dannjjm	3625	12	young	young	JJ
cord-023095-4dannjjm	3625	13	cats	cat	NNS
cord-023095-4dannjjm	3625	14	or	or	CC
cord-023095-4dannjjm	3625	15	if	if	IN
cord-023095-4dannjjm	3625	16	certain	certain	JJ
cord-023095-4dannjjm	3625	17	diseases	disease	NNS
cord-023095-4dannjjm	3625	18	have	have	VBP
cord-023095-4dannjjm	3625	19	been	be	VBN
cord-023095-4dannjjm	3625	20	ruled	rule	VBN
cord-023095-4dannjjm	3625	21	-	-	HYPH
cord-023095-4dannjjm	3625	22	out	out	RP
cord-023095-4dannjjm	3625	23	,	,	,
cord-023095-4dannjjm	3625	24	its	-PRON-	PRP$
cord-023095-4dannjjm	3625	25	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3625	26	value	value	NN
cord-023095-4dannjjm	3625	27	is	be	VBZ
cord-023095-4dannjjm	3625	28	high	high	JJ
cord-023095-4dannjjm	3625	29	.	.	.
cord-023095-4dannjjm	3626	1	Effusion	Effusion	NNP
cord-023095-4dannjjm	3626	2	total	total	JJ
cord-023095-4dannjjm	3626	3	protein	protein	NN
cord-023095-4dannjjm	3626	4	is	be	VBZ
cord-023095-4dannjjm	3626	5	not	not	RB
cord-023095-4dannjjm	3626	6	highly	highly	RB
cord-023095-4dannjjm	3626	7	correlated	correlate	VBN
cord-023095-4dannjjm	3626	8	with	with	IN
cord-023095-4dannjjm	3626	9	test	test	NN
cord-023095-4dannjjm	3626	10	outcome	outcome	NN
cord-023095-4dannjjm	3626	11	.	.	.
cord-023095-4dannjjm	3627	1	Therefore	therefore	RB
cord-023095-4dannjjm	3627	2	,	,	,
cord-023095-4dannjjm	3627	3	it	-PRON-	PRP
cord-023095-4dannjjm	3627	4	is	be	VBZ
cord-023095-4dannjjm	3627	5	still	still	RB
cord-023095-4dannjjm	3627	6	unclear	unclear	JJ
cord-023095-4dannjjm	3627	7	,	,	,
cord-023095-4dannjjm	3627	8	which	which	WDT
cord-023095-4dannjjm	3627	9	components	component	NNS
cord-023095-4dannjjm	3627	10	in	in	IN
cord-023095-4dannjjm	3627	11	the	the	DT
cord-023095-4dannjjm	3627	12	effusion	effusion	NN
cord-023095-4dannjjm	3627	13	of	of	IN
cord-023095-4dannjjm	3627	14	cats	cat	NNS
cord-023095-4dannjjm	3627	15	with	with	IN
cord-023095-4dannjjm	3627	16	FIP	FIP	NNP
cord-023095-4dannjjm	3627	17	lead	lead	NN
cord-023095-4dannjjm	3627	18	to	to	IN
cord-023095-4dannjjm	3627	19	a	a	DT
cord-023095-4dannjjm	3627	20	positive	positive	JJ
cord-023095-4dannjjm	3627	21	Rivalta	Rivalta	NNP
cord-023095-4dannjjm	3627	22	's	's	POS
cord-023095-4dannjjm	3627	23	test	test	NN
cord-023095-4dannjjm	3627	24	.	.	.
cord-023095-4dannjjm	3628	1	Canine	canine	JJ
cord-023095-4dannjjm	3628	2	parvovirus	parvovirus	NN
cord-023095-4dannjjm	3628	3	(	(	-LRB-
cord-023095-4dannjjm	3628	4	CPV	CPV	NNP
cord-023095-4dannjjm	3628	5	)	)	-RRB-
cord-023095-4dannjjm	3628	6	and	and	CC
cord-023095-4dannjjm	3628	7	canine	canine	JJ
cord-023095-4dannjjm	3628	8	distemper	distemper	NN
cord-023095-4dannjjm	3628	9	virus	virus	NN
cord-023095-4dannjjm	3628	10	(	(	-LRB-
cord-023095-4dannjjm	3628	11	CDV	CDV	NNP
cord-023095-4dannjjm	3628	12	)	)	-RRB-
cord-023095-4dannjjm	3628	13	infections	infection	NNS
cord-023095-4dannjjm	3628	14	are	be	VBP
cord-023095-4dannjjm	3628	15	relatively	relatively	RB
cord-023095-4dannjjm	3628	16	common	common	JJ
cord-023095-4dannjjm	3628	17	in	in	IN
cord-023095-4dannjjm	3628	18	animal	animal	NN
cord-023095-4dannjjm	3628	19	shelters	shelter	NNS
cord-023095-4dannjjm	3628	20	and	and	CC
cord-023095-4dannjjm	3628	21	are	be	VBP
cord-023095-4dannjjm	3628	22	important	important	JJ
cord-023095-4dannjjm	3628	23	population	population	NN
cord-023095-4dannjjm	3628	24	management	management	NN
cord-023095-4dannjjm	3628	25	issues	issue	NNS
cord-023095-4dannjjm	3628	26	since	since	IN
cord-023095-4dannjjm	3628	27	the	the	DT
cord-023095-4dannjjm	3628	28	immune	immune	JJ
cord-023095-4dannjjm	3628	29	status	status	NN
cord-023095-4dannjjm	3628	30	of	of	IN
cord-023095-4dannjjm	3628	31	incoming	incoming	JJ
cord-023095-4dannjjm	3628	32	dogs	dog	NNS
cord-023095-4dannjjm	3628	33	is	be	VBZ
cord-023095-4dannjjm	3628	34	usually	usually	RB
cord-023095-4dannjjm	3628	35	unknown	unknown	JJ
cord-023095-4dannjjm	3628	36	.	.	.
cord-023095-4dannjjm	3629	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	3629	2	study	study	NN
cord-023095-4dannjjm	3629	3	aimed	aim	VBD
cord-023095-4dannjjm	3629	4	to	to	TO
cord-023095-4dannjjm	3629	5	determine	determine	VB
cord-023095-4dannjjm	3629	6	the	the	DT
cord-023095-4dannjjm	3629	7	antibody	antibody	NN
cord-023095-4dannjjm	3629	8	protection	protection	NN
cord-023095-4dannjjm	3629	9	status	status	NN
cord-023095-4dannjjm	3629	10	of	of	IN
cord-023095-4dannjjm	3629	11	dogs	dog	NNS
cord-023095-4dannjjm	3629	12	at	at	IN
cord-023095-4dannjjm	3629	13	the	the	DT
cord-023095-4dannjjm	3629	14	time	time	NN
cord-023095-4dannjjm	3629	15	of	of	IN
cord-023095-4dannjjm	3629	16	admission	admission	NN
cord-023095-4dannjjm	3629	17	into	into	IN
cord-023095-4dannjjm	3629	18	an	an	DT
cord-023095-4dannjjm	3629	19	animal	animal	NN
cord-023095-4dannjjm	3629	20	shelter	shelter	NN
cord-023095-4dannjjm	3629	21	(	(	-LRB-
cord-023095-4dannjjm	3629	22	pre	pre	JJ
cord-023095-4dannjjm	3629	23	-	-	JJ
cord-023095-4dannjjm	3629	24	vaccination	vaccination	JJ
cord-023095-4dannjjm	3629	25	)	)	-RRB-
cord-023095-4dannjjm	3629	26	and	and	CC
cord-023095-4dannjjm	3629	27	over	over	IN
cord-023095-4dannjjm	3629	28	the	the	DT
cord-023095-4dannjjm	3629	29	following	follow	VBG
cord-023095-4dannjjm	3629	30	2	2	CD
cord-023095-4dannjjm	3629	31	weeks	week	NNS
cord-023095-4dannjjm	3629	32	after	after	IN
cord-023095-4dannjjm	3629	33	vaccination	vaccination	NN
cord-023095-4dannjjm	3629	34	.	.	.
cord-023095-4dannjjm	3630	1	Serum	serum	NN
cord-023095-4dannjjm	3630	2	samples	sample	NNS
cord-023095-4dannjjm	3630	3	were	be	VBD
cord-023095-4dannjjm	3630	4	obtained	obtain	VBN
cord-023095-4dannjjm	3630	5	from	from	IN
cord-023095-4dannjjm	3630	6	57	57	CD
cord-023095-4dannjjm	3630	7	incoming	incoming	JJ
cord-023095-4dannjjm	3630	8	shelter	shelter	NN
cord-023095-4dannjjm	3630	9	dogs	dog	NNS
cord-023095-4dannjjm	3630	10	aged	age	VBN
cord-023095-4dannjjm	3630	11	4	4	CD
cord-023095-4dannjjm	3630	12	months	month	NNS
cord-023095-4dannjjm	3630	13	and	and	CC
cord-023095-4dannjjm	3630	14	older	old	JJR
cord-023095-4dannjjm	3630	15	with	with	IN
cord-023095-4dannjjm	3630	16	no	no	DT
cord-023095-4dannjjm	3630	17	known	know	VBN
cord-023095-4dannjjm	3630	18	history	history	NN
cord-023095-4dannjjm	3630	19	of	of	IN
cord-023095-4dannjjm	3630	20	vaccination	vaccination	NN
cord-023095-4dannjjm	3630	21	.	.	.
cord-023095-4dannjjm	3631	1	Immediately	immediately	RB
cord-023095-4dannjjm	3631	2	following	follow	VBG
cord-023095-4dannjjm	3631	3	serum	serum	NN
cord-023095-4dannjjm	3631	4	collection	collection	NN
cord-023095-4dannjjm	3631	5	,	,	,
cord-023095-4dannjjm	3631	6	the	the	DT
cord-023095-4dannjjm	3631	7	dogs	dog	NNS
cord-023095-4dannjjm	3631	8	were	be	VBD
cord-023095-4dannjjm	3631	9	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	3631	10	against	against	IN
cord-023095-4dannjjm	3631	11	CPV	CPV	NNP
cord-023095-4dannjjm	3631	12	and	and	CC
cord-023095-4dannjjm	3631	13	CDV	CDV	NNP
cord-023095-4dannjjm	3631	14	using	use	VBG
cord-023095-4dannjjm	3631	15	a	a	DT
cord-023095-4dannjjm	3631	16	modified	modify	VBN
cord-023095-4dannjjm	3631	17	live	live	JJ
cord-023095-4dannjjm	3631	18	vaccine	vaccine	NN
cord-023095-4dannjjm	3631	19	(	(	-LRB-
cord-023095-4dannjjm	3631	20	MLV	MLV	NNP
cord-023095-4dannjjm	3631	21	)	)	-RRB-
cord-023095-4dannjjm	3631	22	.	.	.
cord-023095-4dannjjm	3632	1	CPV	CPV	NNP
cord-023095-4dannjjm	3632	2	and	and	CC
cord-023095-4dannjjm	3632	3	CDV	CDV	NNP
cord-023095-4dannjjm	3632	4	antibody	antibody	NN
cord-023095-4dannjjm	3632	5	protection	protection	NN
cord-023095-4dannjjm	3632	6	status	status	NN
cord-023095-4dannjjm	3632	7	was	be	VBD
cord-023095-4dannjjm	3632	8	determined	determine	VBN
cord-023095-4dannjjm	3632	9	using	use	VBG
cord-023095-4dannjjm	3633	1	Synbiotics	Synbiotics	NNP
cord-023095-4dannjjm	3633	2	TiterCHEK	TiterCHEK	NNP
cord-023095-4dannjjm	3633	3	.	.	.
cord-023095-4dannjjm	3633	4	Dogs	dog	NNS
cord-023095-4dannjjm	3633	5	with	with	IN
cord-023095-4dannjjm	3633	6	unprotective	unprotective	JJ
cord-023095-4dannjjm	3633	7	serum	serum	NN
cord-023095-4dannjjm	3633	8	antibody	antibody	NN
cord-023095-4dannjjm	3633	9	levels	level	NNS
cord-023095-4dannjjm	3633	10	against	against	IN
cord-023095-4dannjjm	3633	11	CPV	CPV	NNP
cord-023095-4dannjjm	3633	12	and/or	and/or	CC
cord-023095-4dannjjm	3633	13	CDV	CDV	NNP
cord-023095-4dannjjm	3633	14	were	be	VBD
cord-023095-4dannjjm	3633	15	retested	reteste	VBN
cord-023095-4dannjjm	3633	16	at	at	IN
cord-023095-4dannjjm	3633	17	6	6	CD
cord-023095-4dannjjm	3633	18	-	-	SYM
cord-023095-4dannjjm	3633	19	8	8	CD
cord-023095-4dannjjm	3633	20	days	day	NNS
cord-023095-4dannjjm	3633	21	post	post	NN
cord-023095-4dannjjm	3633	22	-	-	NN
cord-023095-4dannjjm	3633	23	vaccination	vaccination	NN
cord-023095-4dannjjm	3633	24	and	and	CC
cord-023095-4dannjjm	3633	25	again	again	RB
cord-023095-4dannjjm	3633	26	at	at	IN
cord-023095-4dannjjm	3633	27	13	13	CD
cord-023095-4dannjjm	3633	28	-	-	SYM
cord-023095-4dannjjm	3633	29	15	15	CD
cord-023095-4dannjjm	3633	30	days	day	NNS
cord-023095-4dannjjm	3633	31	post	post	NN
cord-023095-4dannjjm	3633	32	-	-	NN
cord-023095-4dannjjm	3633	33	vaccination	vaccination	NN
cord-023095-4dannjjm	3633	34	,	,	,
cord-023095-4dannjjm	3633	35	if	if	IN
cord-023095-4dannjjm	3633	36	antibody	antibody	NN
cord-023095-4dannjjm	3633	37	levels	level	NNS
cord-023095-4dannjjm	3633	38	were	be	VBD
cord-023095-4dannjjm	3633	39	still	still	RB
cord-023095-4dannjjm	3633	40	unprotective	unprotective	JJ
cord-023095-4dannjjm	3633	41	against	against	IN
cord-023095-4dannjjm	3633	42	CPV	CPV	NNP
cord-023095-4dannjjm	3633	43	and	and	CC
cord-023095-4dannjjm	3633	44	/or	/or	.
cord-023095-4dannjjm	3633	45	CDV	CDV	NNP
cord-023095-4dannjjm	3633	46	.	.	.
cord-023095-4dannjjm	3634	1	At	at	IN
cord-023095-4dannjjm	3634	2	the	the	DT
cord-023095-4dannjjm	3634	3	conclusion	conclusion	NN
cord-023095-4dannjjm	3634	4	of	of	IN
cord-023095-4dannjjm	3634	5	the	the	DT
cord-023095-4dannjjm	3634	6	study	study	NN
cord-023095-4dannjjm	3634	7	,	,	,
cord-023095-4dannjjm	3634	8	stored	store	VBN
cord-023095-4dannjjm	3634	9	duplicate	duplicate	JJ
cord-023095-4dannjjm	3634	10	sera	sera	NNP
cord-023095-4dannjjm	3634	11	were	be	VBD
cord-023095-4dannjjm	3634	12	submitted	submit	VBN
cord-023095-4dannjjm	3634	13	for	for	IN
cord-023095-4dannjjm	3634	14	batch	batch	NN
cord-023095-4dannjjm	3634	15	'	'	``
cord-023095-4dannjjm	3634	16	gold	gold	NN
cord-023095-4dannjjm	3634	17	standard	standard	NN
cord-023095-4dannjjm	3634	18	'	'	''
cord-023095-4dannjjm	3634	19	testing	testing	NN
cord-023095-4dannjjm	3634	20	to	to	TO
cord-023095-4dannjjm	3634	21	determine	determine	VB
cord-023095-4dannjjm	3634	22	canine	canine	JJ
cord-023095-4dannjjm	3634	23	distemper	distemper	NN
cord-023095-4dannjjm	3634	24	virus	virus	NN
cord-023095-4dannjjm	3634	25	serum	serum	NN
cord-023095-4dannjjm	3634	26	neutralization	neutralization	NN
cord-023095-4dannjjm	3634	27	and	and	CC
cord-023095-4dannjjm	3634	28	canine	canine	JJ
cord-023095-4dannjjm	3634	29	parvovirus	parvovirus	NN
cord-023095-4dannjjm	3634	30	hemagglutination	hemagglutination	NN
cord-023095-4dannjjm	3634	31	inhibition	inhibition	NN
cord-023095-4dannjjm	3634	32	antibody	antibody	NN
cord-023095-4dannjjm	3634	33	titers	titer	NNS
cord-023095-4dannjjm	3634	34	.	.	.
cord-023095-4dannjjm	3635	1	Based	base	VBN
cord-023095-4dannjjm	3635	2	on	on	IN
cord-023095-4dannjjm	3635	3	the	the	DT
cord-023095-4dannjjm	3635	4	Synbiotics	Synbiotics	NNP
cord-023095-4dannjjm	3635	5	TiterCHEK	TiterCHEK	NNP
cord-023095-4dannjjm	3635	6	results	result	VBZ
cord-023095-4dannjjm	3635	7	,	,	,
cord-023095-4dannjjm	3635	8	43/57	43/57	CD
cord-023095-4dannjjm	3635	9	dogs	dog	NNS
cord-023095-4dannjjm	3635	10	(	(	-LRB-
cord-023095-4dannjjm	3635	11	75.4	75.4	CD
cord-023095-4dannjjm	3635	12	%	%	NN
cord-023095-4dannjjm	3635	13	)	)	-RRB-
cord-023095-4dannjjm	3635	14	were	be	VBD
cord-023095-4dannjjm	3635	15	protected	protect	VBN
cord-023095-4dannjjm	3635	16	against	against	IN
cord-023095-4dannjjm	3635	17	CPV	CPV	NNP
cord-023095-4dannjjm	3635	18	and	and	CC
cord-023095-4dannjjm	3635	19	21/57	21/57	CD
cord-023095-4dannjjm	3635	20	(	(	-LRB-
cord-023095-4dannjjm	3635	21	36.8	36.8	CD
cord-023095-4dannjjm	3635	22	%	%	NN
cord-023095-4dannjjm	3635	23	)	)	-RRB-
cord-023095-4dannjjm	3635	24	were	be	VBD
cord-023095-4dannjjm	3635	25	protected	protect	VBN
cord-023095-4dannjjm	3635	26	against	against	IN
cord-023095-4dannjjm	3635	27	CDV	CDV	NNP
cord-023095-4dannjjm	3635	28	at	at	IN
cord-023095-4dannjjm	3635	29	intake	intake	NN
cord-023095-4dannjjm	3635	30	.	.	.
cord-023095-4dannjjm	3636	1	Older	old	JJR
cord-023095-4dannjjm	3636	2	incoming	incoming	JJ
cord-023095-4dannjjm	3636	3	dogs	dog	NNS
cord-023095-4dannjjm	3636	4	were	be	VBD
cord-023095-4dannjjm	3636	5	more	more	RBR
cord-023095-4dannjjm	3636	6	likely	likely	JJ
cord-023095-4dannjjm	3636	7	to	to	TO
cord-023095-4dannjjm	3636	8	be	be	VB
cord-023095-4dannjjm	3636	9	protected	protect	VBN
cord-023095-4dannjjm	3636	10	against	against	IN
cord-023095-4dannjjm	3636	11	CPV	CPV	NNP
cord-023095-4dannjjm	3636	12	(	(	-LRB-
cord-023095-4dannjjm	3636	13	P	p	NN
cord-023095-4dannjjm	3636	14	o	o	NN
cord-023095-4dannjjm	3636	15	0.0001	0.0001	CD
cord-023095-4dannjjm	3636	16	)	)	-RRB-
cord-023095-4dannjjm	3636	17	and	and	CC
cord-023095-4dannjjm	3636	18	CDV	CDV	NNP
cord-023095-4dannjjm	3636	19	(	(	-LRB-
cord-023095-4dannjjm	3636	20	P	p	NN
cord-023095-4dannjjm	3636	21	5	5	CD
cord-023095-4dannjjm	3636	22	0.0174	0.0174	CD
cord-023095-4dannjjm	3636	23	)	)	-RRB-
cord-023095-4dannjjm	3636	24	.	.	.
cord-023095-4dannjjm	3637	1	Dogs	dog	NNS
cord-023095-4dannjjm	3637	2	that	that	WDT
cord-023095-4dannjjm	3637	3	were	be	VBD
cord-023095-4dannjjm	3637	4	spayed	spay	VBN
cord-023095-4dannjjm	3637	5	/	/	SYM
cord-023095-4dannjjm	3637	6	neutered	neuter	VBN
cord-023095-4dannjjm	3637	7	were	be	VBD
cord-023095-4dannjjm	3637	8	more	more	RBR
cord-023095-4dannjjm	3637	9	likely	likely	JJ
cord-023095-4dannjjm	3637	10	to	to	TO
cord-023095-4dannjjm	3637	11	be	be	VB
cord-023095-4dannjjm	3637	12	protected	protect	VBN
cord-023095-4dannjjm	3637	13	against	against	IN
cord-023095-4dannjjm	3637	14	CPV	cpv	NN
cord-023095-4dannjjm	3637	15	on	on	IN
cord-023095-4dannjjm	3637	16	intake	intake	NN
cord-023095-4dannjjm	3637	17	than	than	IN
cord-023095-4dannjjm	3637	18	intact	intact	JJ
cord-023095-4dannjjm	3637	19	animals	animal	NNS
cord-023095-4dannjjm	3637	20	,	,	,
cord-023095-4dannjjm	3637	21	although	although	IN
cord-023095-4dannjjm	3637	22	this	this	DT
cord-023095-4dannjjm	3637	23	result	result	NN
cord-023095-4dannjjm	3637	24	was	be	VBD
cord-023095-4dannjjm	3637	25	not	not	RB
cord-023095-4dannjjm	3637	26	statistically	statistically	RB
cord-023095-4dannjjm	3637	27	significant	significant	JJ
cord-023095-4dannjjm	3637	28	(	(	-LRB-
cord-023095-4dannjjm	3637	29	P	p	NN
cord-023095-4dannjjm	3637	30	5	5	CD
cord-023095-4dannjjm	3637	31	0.0627	0.0627	CD
cord-023095-4dannjjm	3637	32	)	)	-RRB-
cord-023095-4dannjjm	3637	33	.	.	.
cord-023095-4dannjjm	3638	1	The	the	DT
cord-023095-4dannjjm	3638	2	number	number	NN
cord-023095-4dannjjm	3638	3	of	of	IN
cord-023095-4dannjjm	3638	4	dogs	dog	NNS
cord-023095-4dannjjm	3638	5	with	with	IN
cord-023095-4dannjjm	3638	6	protective	protective	JJ
cord-023095-4dannjjm	3638	7	titers	titer	NNS
cord-023095-4dannjjm	3638	8	against	against	IN
cord-023095-4dannjjm	3638	9	CPV	CPV	NNP
cord-023095-4dannjjm	3638	10	/	/	SYM
cord-023095-4dannjjm	3638	11	CDV	CDV	NNP
cord-023095-4dannjjm	3638	12	was	be	VBD
cord-023095-4dannjjm	3638	13	increased	increase	VBN
cord-023095-4dannjjm	3638	14	at	at	IN
cord-023095-4dannjjm	3638	15	6	6	CD
cord-023095-4dannjjm	3638	16	-	-	SYM
cord-023095-4dannjjm	3638	17	8	8	CD
cord-023095-4dannjjm	3638	18	days	day	NNS
cord-023095-4dannjjm	3638	19	post	post	NN
cord-023095-4dannjjm	3638	20	-	-	JJ
cord-023095-4dannjjm	3638	21	MLV	mlv	JJ
cord-023095-4dannjjm	3638	22	(	(	-LRB-
cord-023095-4dannjjm	3638	23	CPV	CPV	NNP
cord-023095-4dannjjm	3638	24	-48/56	-48/56	ADD
cord-023095-4dannjjm	3638	25	,	,	,
cord-023095-4dannjjm	3638	26	85.7	85.7	CD
cord-023095-4dannjjm	3638	27	%	%	NN
cord-023095-4dannjjm	3638	28	;	;	:
cord-023095-4dannjjm	3638	29	CDV	CDV	NNP
cord-023095-4dannjjm	3638	30	-31/52	-31/52	NNP
cord-023095-4dannjjm	3638	31	,	,	,
cord-023095-4dannjjm	3638	32	59.6	59.6	CD
cord-023095-4dannjjm	3638	33	%	%	NN
cord-023095-4dannjjm	3638	34	)	)	-RRB-
cord-023095-4dannjjm	3638	35	and	and	CC
cord-023095-4dannjjm	3638	36	further	further	RB
cord-023095-4dannjjm	3638	37	increased	increase	VBD
cord-023095-4dannjjm	3638	38	at	at	IN
cord-023095-4dannjjm	3638	39	13	13	CD
cord-023095-4dannjjm	3638	40	-	-	SYM
cord-023095-4dannjjm	3638	41	15	15	CD
cord-023095-4dannjjm	3638	42	days	day	NNS
cord-023095-4dannjjm	3638	43	post	post	NN
cord-023095-4dannjjm	3638	44	-	-	JJ
cord-023095-4dannjjm	3638	45	MLV	MLV	NNP
cord-023095-4dannjjm	3638	46	(	(	-LRB-
cord-023095-4dannjjm	3638	47	CPV	CPV	NNP
cord-023095-4dannjjm	3638	48	-54/54	-54/54	NNP
cord-023095-4dannjjm	3638	49	,	,	,
cord-023095-4dannjjm	3638	50	100.0	100.0	CD
cord-023095-4dannjjm	3638	51	%	%	NN
cord-023095-4dannjjm	3638	52	;	;	:
cord-023095-4dannjjm	3638	53	CDV	CDV	NNP
cord-023095-4dannjjm	3638	54	-47/48	-47/48	NNPS
cord-023095-4dannjjm	3638	55	,	,	,
cord-023095-4dannjjm	3638	56	97.9	97.9	CD
cord-023095-4dannjjm	3638	57	%	%	NN
cord-023095-4dannjjm	3638	58	)	)	-RRB-
cord-023095-4dannjjm	3638	59	.	.	.
cord-023095-4dannjjm	3639	1	We	-PRON-	PRP
cord-023095-4dannjjm	3639	2	conclude	conclude	VBP
cord-023095-4dannjjm	3639	3	that	that	IN
cord-023095-4dannjjm	3639	4	incoming	incoming	JJ
cord-023095-4dannjjm	3639	5	shelter	shelter	NN
cord-023095-4dannjjm	3639	6	dogs	dog	NNS
cord-023095-4dannjjm	3639	7	often	often	RB
cord-023095-4dannjjm	3639	8	do	do	VBP
cord-023095-4dannjjm	3639	9	not	not	RB
cord-023095-4dannjjm	3639	10	have	have	VB
cord-023095-4dannjjm	3639	11	protective	protective	JJ
cord-023095-4dannjjm	3639	12	antibody	antibody	NN
cord-023095-4dannjjm	3639	13	titers	titer	NNS
cord-023095-4dannjjm	3639	14	against	against	IN
cord-023095-4dannjjm	3639	15	CPV	CPV	NNP
cord-023095-4dannjjm	3639	16	and	and	CC
cord-023095-4dannjjm	3639	17	CDV	CDV	NNP
cord-023095-4dannjjm	3639	18	,	,	,
cord-023095-4dannjjm	3639	19	but	but	CC
cord-023095-4dannjjm	3639	20	older	old	JJR
cord-023095-4dannjjm	3639	21	shelter	shelter	NN
cord-023095-4dannjjm	3639	22	dogs	dog	NNS
cord-023095-4dannjjm	3639	23	are	be	VBP
cord-023095-4dannjjm	3639	24	more	more	RBR
cord-023095-4dannjjm	3639	25	likely	likely	JJ
cord-023095-4dannjjm	3639	26	to	to	TO
cord-023095-4dannjjm	3639	27	be	be	VB
cord-023095-4dannjjm	3639	28	protected	protect	VBN
cord-023095-4dannjjm	3639	29	against	against	IN
cord-023095-4dannjjm	3639	30	CPV	CPV	NNP
cord-023095-4dannjjm	3639	31	.	.	.
cord-023095-4dannjjm	3640	1	Based	base	VBN
cord-023095-4dannjjm	3640	2	on	on	IN
cord-023095-4dannjjm	3640	3	this	this	DT
cord-023095-4dannjjm	3640	4	population	population	NN
cord-023095-4dannjjm	3640	5	,	,	,
cord-023095-4dannjjm	3640	6	we	-PRON-	PRP
cord-023095-4dannjjm	3640	7	further	further	RB
cord-023095-4dannjjm	3640	8	conclude	conclude	VBP
cord-023095-4dannjjm	3640	9	that	that	IN
cord-023095-4dannjjm	3640	10	a	a	DT
cord-023095-4dannjjm	3640	11	large	large	JJ
cord-023095-4dannjjm	3640	12	percentage	percentage	NN
cord-023095-4dannjjm	3640	13	of	of	IN
cord-023095-4dannjjm	3640	14	dogs	dog	NNS
cord-023095-4dannjjm	3640	15	develop	develop	VBP
cord-023095-4dannjjm	3640	16	protective	protective	JJ
cord-023095-4dannjjm	3640	17	antibody	antibody	NN
cord-023095-4dannjjm	3640	18	titers	titer	NNS
cord-023095-4dannjjm	3640	19	to	to	IN
cord-023095-4dannjjm	3640	20	CPV	CPV	NNP
cord-023095-4dannjjm	3640	21	and	and	CC
cord-023095-4dannjjm	3640	22	CDV	CDV	NNP
cord-023095-4dannjjm	3640	23	within	within	IN
cord-023095-4dannjjm	3640	24	1	1	CD
cord-023095-4dannjjm	3640	25	to	to	IN
cord-023095-4dannjjm	3640	26	2	2	CD
cord-023095-4dannjjm	3640	27	weeks	week	NNS
cord-023095-4dannjjm	3640	28	when	when	WRB
cord-023095-4dannjjm	3640	29	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	3640	30	with	with	IN
cord-023095-4dannjjm	3640	31	a	a	DT
cord-023095-4dannjjm	3640	32	MLV	MLV	NNP
cord-023095-4dannjjm	3640	33	.	.	.
cord-023095-4dannjjm	3641	1	Mycoplasma	mycoplasma	NN
cord-023095-4dannjjm	3641	2	spp	spp	NNS
cord-023095-4dannjjm	3641	3	.	.	.
cord-023095-4dannjjm	3642	1	are	be	VBP
cord-023095-4dannjjm	3642	2	common	common	JJ
cord-023095-4dannjjm	3642	3	inhabitants	inhabitant	NNS
cord-023095-4dannjjm	3642	4	of	of	IN
cord-023095-4dannjjm	3642	5	the	the	DT
cord-023095-4dannjjm	3642	6	feline	feline	JJ
cord-023095-4dannjjm	3642	7	oral	oral	JJ
cord-023095-4dannjjm	3642	8	cavity	cavity	NN
cord-023095-4dannjjm	3642	9	and	and	CC
cord-023095-4dannjjm	3642	10	so	so	RB
cord-023095-4dannjjm	3642	11	likely	likely	RB
cord-023095-4dannjjm	3642	12	contaminate	contaminate	VB
cord-023095-4dannjjm	3642	13	many	many	JJ
cord-023095-4dannjjm	3642	14	cat	cat	NN
cord-023095-4dannjjm	3642	15	bite	bite	NN
cord-023095-4dannjjm	3642	16	abscesses	abscess	NNS
cord-023095-4dannjjm	3642	17	.	.	.
cord-023095-4dannjjm	3643	1	Mycoplasma	mycoplasma	NN
cord-023095-4dannjjm	3643	2	spp	spp	NNS
cord-023095-4dannjjm	3643	3	.	.	.
cord-023095-4dannjjm	3644	1	are	be	VBP
cord-023095-4dannjjm	3644	2	cell	cell	NN
cord-023095-4dannjjm	3644	3	-	-	HYPH
cord-023095-4dannjjm	3644	4	wall	wall	NN
cord-023095-4dannjjm	3644	5	deficient	deficient	JJ
cord-023095-4dannjjm	3644	6	and	and	CC
cord-023095-4dannjjm	3644	7	so	so	RB
cord-023095-4dannjjm	3644	8	do	do	VB
cord-023095-4dannjjm	3644	9	not	not	RB
cord-023095-4dannjjm	3644	10	respond	respond	VB
cord-023095-4dannjjm	3644	11	to	to	IN
cord-023095-4dannjjm	3644	12	beta	beta	NN
cord-023095-4dannjjm	3644	13	-	-	HYPH
cord-023095-4dannjjm	3644	14	lactam	lactam	NN
cord-023095-4dannjjm	3644	15	class	class	NN
cord-023095-4dannjjm	3644	16	antibiotics	antibiotic	NNS
cord-023095-4dannjjm	3644	17	,	,	,
cord-023095-4dannjjm	3644	18	the	the	DT
cord-023095-4dannjjm	3644	19	class	class	NN
cord-023095-4dannjjm	3644	20	most	most	RBS
cord-023095-4dannjjm	3644	21	commonly	commonly	RB
cord-023095-4dannjjm	3644	22	use	use	VBP
cord-023095-4dannjjm	3644	23	for	for	IN
cord-023095-4dannjjm	3644	24	the	the	DT
cord-023095-4dannjjm	3644	25	treatment	treatment	NN
cord-023095-4dannjjm	3644	26	of	of	IN
cord-023095-4dannjjm	3644	27	cat	cat	NN
cord-023095-4dannjjm	3644	28	bite	bite	NN
cord-023095-4dannjjm	3644	29	abscesses	abscess	NNS
cord-023095-4dannjjm	3644	30	.	.	.
cord-023095-4dannjjm	3645	1	The	the	DT
cord-023095-4dannjjm	3645	2	objectives	objective	NNS
cord-023095-4dannjjm	3645	3	of	of	IN
cord-023095-4dannjjm	3645	4	this	this	DT
cord-023095-4dannjjm	3645	5	study	study	NN
cord-023095-4dannjjm	3645	6	was	be	VBD
cord-023095-4dannjjm	3645	7	to	to	TO
cord-023095-4dannjjm	3645	8	determine	determine	VB
cord-023095-4dannjjm	3645	9	whether	whether	IN
cord-023095-4dannjjm	3645	10	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	3645	11	spp	spp	NNS
cord-023095-4dannjjm	3645	12	.	.	.
cord-023095-4dannjjm	3646	1	are	be	VBP
cord-023095-4dannjjm	3646	2	common	common	JJ
cord-023095-4dannjjm	3646	3	contaminants	contaminant	NNS
cord-023095-4dannjjm	3646	4	of	of	IN
cord-023095-4dannjjm	3646	5	cat	cat	NN
cord-023095-4dannjjm	3646	6	bite	bite	NN
cord-023095-4dannjjm	3646	7	abscesses	abscess	NNS
cord-023095-4dannjjm	3646	8	and	and	CC
cord-023095-4dannjjm	3646	9	are	be	VBP
cord-023095-4dannjjm	3646	10	associated	associate	VBN
cord-023095-4dannjjm	3646	11	with	with	IN
cord-023095-4dannjjm	3646	12	beta	beta	NN
cord-023095-4dannjjm	3646	13	-	-	HYPH
cord-023095-4dannjjm	3646	14	lactam	lactam	NN
cord-023095-4dannjjm	3646	15	resistant	resistant	JJ
cord-023095-4dannjjm	3646	16	clinical	clinical	JJ
cord-023095-4dannjjm	3646	17	disease	disease	NN
cord-023095-4dannjjm	3646	18	.	.	.
cord-023095-4dannjjm	3647	1	Privately	privately	RB
cord-023095-4dannjjm	3647	2	owned	own	VBN
cord-023095-4dannjjm	3647	3	cats	cat	NNS
cord-023095-4dannjjm	3647	4	with	with	IN
cord-023095-4dannjjm	3647	5	clinical	clinical	JJ
cord-023095-4dannjjm	3647	6	evidence	evidence	NN
cord-023095-4dannjjm	3647	7	of	of	IN
cord-023095-4dannjjm	3647	8	an	an	DT
cord-023095-4dannjjm	3647	9	acute	acute	JJ
cord-023095-4dannjjm	3647	10	abscess	abscess	NN
cord-023095-4dannjjm	3647	11	suspected	suspect	VBN
cord-023095-4dannjjm	3647	12	to	to	TO
cord-023095-4dannjjm	3647	13	be	be	VB
cord-023095-4dannjjm	3647	14	from	from	IN
cord-023095-4dannjjm	3647	15	a	a	DT
cord-023095-4dannjjm	3647	16	cat	cat	NN
cord-023095-4dannjjm	3647	17	bite	bite	NN
cord-023095-4dannjjm	3647	18	were	be	VBD
cord-023095-4dannjjm	3647	19	included	include	VBN
cord-023095-4dannjjm	3647	20	in	in	IN
cord-023095-4dannjjm	3647	21	the	the	DT
cord-023095-4dannjjm	3647	22	study	study	NN
cord-023095-4dannjjm	3647	23	.	.	.
cord-023095-4dannjjm	3648	1	Participants	participant	NNS
cord-023095-4dannjjm	3648	2	were	be	VBD
cord-023095-4dannjjm	3648	3	given	give	VBN
cord-023095-4dannjjm	3648	4	a	a	DT
cord-023095-4dannjjm	3648	5	free	free	JJ
cord-023095-4dannjjm	3648	6	aerobic	aerobic	JJ
cord-023095-4dannjjm	3648	7	and	and	CC
cord-023095-4dannjjm	3648	8	anaerobic	anaerobic	JJ
cord-023095-4dannjjm	3648	9	culture	culture	NN
cord-023095-4dannjjm	3648	10	as	as	RB
cord-023095-4dannjjm	3648	11	well	well	RB
cord-023095-4dannjjm	3648	12	as	as	IN
cord-023095-4dannjjm	3648	13	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	3648	14	spp	spp	NNS
cord-023095-4dannjjm	3648	15	.	.	.
cord-023095-4dannjjm	3649	1	culture	culture	NN
cord-023095-4dannjjm	3649	2	and	and	CC
cord-023095-4dannjjm	3649	3	polymerase	polymerase	NN
cord-023095-4dannjjm	3649	4	chain	chain	NN
cord-023095-4dannjjm	3649	5	reaction	reaction	NN
cord-023095-4dannjjm	3649	6	using	use	VBG
cord-023095-4dannjjm	3649	7	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	3649	8	genus	genus	VBP
cord-023095-4dannjjm	3649	9	specific	specific	JJ
cord-023095-4dannjjm	3649	10	primers	primer	NNS
cord-023095-4dannjjm	3649	11	.	.	.
cord-023095-4dannjjm	3650	1	Mycoplasma	mycoplasma	NN
cord-023095-4dannjjm	3650	2	spp	spp	NNS
cord-023095-4dannjjm	3650	3	.	.	.
cord-023095-4dannjjm	3651	1	amplicons	amplicon	NNS
cord-023095-4dannjjm	3651	2	were	be	VBD
cord-023095-4dannjjm	3651	3	sequenced	sequence	VBN
cord-023095-4dannjjm	3651	4	to	to	TO
cord-023095-4dannjjm	3651	5	determine	determine	VB
cord-023095-4dannjjm	3651	6	the	the	DT
cord-023095-4dannjjm	3651	7	species	specie	NNS
cord-023095-4dannjjm	3651	8	.	.	.
cord-023095-4dannjjm	3652	1	All	all	DT
cord-023095-4dannjjm	3652	2	cats	cat	NNS
cord-023095-4dannjjm	3652	3	were	be	VBD
cord-023095-4dannjjm	3652	4	initially	initially	RB
cord-023095-4dannjjm	3652	5	treated	treat	VBN
cord-023095-4dannjjm	3652	6	with	with	IN
cord-023095-4dannjjm	3652	7	appropriate	appropriate	JJ
cord-023095-4dannjjm	3652	8	wound	wound	NN
cord-023095-4dannjjm	3652	9	management	management	NN
cord-023095-4dannjjm	3652	10	,	,	,
cord-023095-4dannjjm	3652	11	were	be	VBD
cord-023095-4dannjjm	3652	12	administered	administer	VBN
cord-023095-4dannjjm	3652	13	an	an	DT
cord-023095-4dannjjm	3652	14	antibiotic	antibiotic	NN
cord-023095-4dannjjm	3652	15	in	in	IN
cord-023095-4dannjjm	3652	16	the	the	DT
cord-023095-4dannjjm	3652	17	beta	beta	NN
cord-023095-4dannjjm	3652	18	lactam	lactam	NNS
cord-023095-4dannjjm	3652	19	class	class	NN
cord-023095-4dannjjm	3652	20	(	(	-LRB-
cord-023095-4dannjjm	3652	21	amoxicillin	amoxicillin	NNP
cord-023095-4dannjjm	3652	22	-	-	HYPH
cord-023095-4dannjjm	3652	23	clavulanate	clavulanate	NNP
cord-023095-4dannjjm	3652	24	or	or	CC
cord-023095-4dannjjm	3652	25	cefovicin	cefovicin	NNP
cord-023095-4dannjjm	3652	26	)	)	-RRB-
cord-023095-4dannjjm	3652	27	,	,	,
cord-023095-4dannjjm	3652	28	and	and	CC
cord-023095-4dannjjm	3652	29	were	be	VBD
cord-023095-4dannjjm	3652	30	rechecked	rechecke	VBN
cord-023095-4dannjjm	3652	31	in	in	IN
cord-023095-4dannjjm	3652	32	person	person	NN
cord-023095-4dannjjm	3652	33	or	or	CC
cord-023095-4dannjjm	3652	34	by	by	IN
cord-023095-4dannjjm	3652	35	phone	phone	NN
cord-023095-4dannjjm	3652	36	7	7	CD
cord-023095-4dannjjm	3652	37	days	day	NNS
cord-023095-4dannjjm	3652	38	after	after	IN
cord-023095-4dannjjm	3652	39	beginning	begin	VBG
cord-023095-4dannjjm	3652	40	treatment	treatment	NN
cord-023095-4dannjjm	3652	41	.	.	.
cord-023095-4dannjjm	3653	1	Of	of	IN
cord-023095-4dannjjm	3653	2	the	the	DT
cord-023095-4dannjjm	3653	3	26	26	CD
cord-023095-4dannjjm	3653	4	cats	cat	NNS
cord-023095-4dannjjm	3653	5	entered	enter	VBD
cord-023095-4dannjjm	3653	6	into	into	IN
cord-023095-4dannjjm	3653	7	the	the	DT
cord-023095-4dannjjm	3653	8	study	study	NN
cord-023095-4dannjjm	3653	9	to	to	IN
cord-023095-4dannjjm	3653	10	date	date	NN
cord-023095-4dannjjm	3653	11	,	,	,
cord-023095-4dannjjm	3653	12	Mycoplasma	mycoplasma	NN
cord-023095-4dannjjm	3653	13	spp	spp	NNS
cord-023095-4dannjjm	3653	14	.	.	.
cord-023095-4dannjjm	3653	15	were	be	VBD
cord-023095-4dannjjm	3653	16	amplified	amplify	VBN
cord-023095-4dannjjm	3653	17	from	from	IN
cord-023095-4dannjjm	3653	18	4	4	CD
cord-023095-4dannjjm	3653	19	cats	cat	NNS
cord-023095-4dannjjm	3653	20	(	(	-LRB-
cord-023095-4dannjjm	3653	21	15.4	15.4	CD
cord-023095-4dannjjm	3653	22	%	%	NN
cord-023095-4dannjjm	3653	23	)	)	-RRB-
cord-023095-4dannjjm	3653	24	.	.	.
cord-023095-4dannjjm	3654	1	Of	of	IN
cord-023095-4dannjjm	3654	2	the	the	DT
cord-023095-4dannjjm	3654	3	2	2	CD
cord-023095-4dannjjm	3654	4	positive	positive	JJ
cord-023095-4dannjjm	3654	5	samples	sample	NNS
cord-023095-4dannjjm	3654	6	with	with	IN
cord-023095-4dannjjm	3654	7	adequate	adequate	JJ
cord-023095-4dannjjm	3654	8	DNA	dna	NN
cord-023095-4dannjjm	3654	9	for	for	IN
cord-023095-4dannjjm	3654	10	sequencing	sequencing	NN
cord-023095-4dannjjm	3654	11	,	,	,
cord-023095-4dannjjm	3654	12	one	one	CD
cord-023095-4dannjjm	3654	13	was	be	VBD
cord-023095-4dannjjm	3654	14	consistent	consistent	JJ
cord-023095-4dannjjm	3654	15	with	with	IN
cord-023095-4dannjjm	3654	16	M.	M.	NNP
cord-023095-4dannjjm	3654	17	felis	felis	NN
cord-023095-4dannjjm	3654	18	and	and	CC
cord-023095-4dannjjm	3654	19	the	the	DT
cord-023095-4dannjjm	3654	20	other	other	JJ
cord-023095-4dannjjm	3654	21	was	be	VBD
cord-023095-4dannjjm	3654	22	consistent	consistent	JJ
cord-023095-4dannjjm	3654	23	with	with	IN
cord-023095-4dannjjm	3654	24	M.	M.	NNP
cord-023095-4dannjjm	3654	25	equigenitalium	equigenitalium	NN
cord-023095-4dannjjm	3654	26	.	.	.
cord-023095-4dannjjm	3655	1	Of	of	IN
cord-023095-4dannjjm	3655	2	the	the	DT
cord-023095-4dannjjm	3655	3	26	26	CD
cord-023095-4dannjjm	3655	4	cats	cat	NNS
cord-023095-4dannjjm	3655	5	,	,	,
cord-023095-4dannjjm	3655	6	25	25	CD
cord-023095-4dannjjm	3655	7	responded	respond	VBD
cord-023095-4dannjjm	3655	8	by	by	IN
cord-023095-4dannjjm	3655	9	Day	Day	NNP
cord-023095-4dannjjm	3655	10	7	7	CD
cord-023095-4dannjjm	3655	11	to	to	IN
cord-023095-4dannjjm	3655	12	the	the	DT
cord-023095-4dannjjm	3655	13	initial	initial	JJ
cord-023095-4dannjjm	3655	14	treatment	treatment	NN
cord-023095-4dannjjm	3655	15	,	,	,
cord-023095-4dannjjm	3655	16	including	include	VBG
cord-023095-4dannjjm	3655	17	3	3	CD
cord-023095-4dannjjm	3655	18	of	of	IN
cord-023095-4dannjjm	3655	19	the	the	DT
cord-023095-4dannjjm	3655	20	4	4	CD
cord-023095-4dannjjm	3655	21	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	3655	22	spp	spp	NNS
cord-023095-4dannjjm	3655	23	.	.	.
cord-023095-4dannjjm	3656	1	positive	positive	JJ
cord-023095-4dannjjm	3656	2	cats	cat	NNS
cord-023095-4dannjjm	3656	3	.	.	.
cord-023095-4dannjjm	3657	1	The	the	DT
cord-023095-4dannjjm	3657	2	cat	cat	NN
cord-023095-4dannjjm	3657	3	that	that	WDT
cord-023095-4dannjjm	3657	4	failed	fail	VBD
cord-023095-4dannjjm	3657	5	initial	initial	JJ
cord-023095-4dannjjm	3657	6	treatment	treatment	NN
cord-023095-4dannjjm	3657	7	was	be	VBD
cord-023095-4dannjjm	3657	8	positive	positive	JJ
cord-023095-4dannjjm	3657	9	for	for	IN
cord-023095-4dannjjm	3657	10	M.	M.	NNP
cord-023095-4dannjjm	3657	11	equigenitalium	equigenitalium	NN
cord-023095-4dannjjm	3657	12	on	on	IN
cord-023095-4dannjjm	3657	13	both	both	DT
cord-023095-4dannjjm	3657	14	Day	day	NN
cord-023095-4dannjjm	3657	15	0	0	CD
cord-023095-4dannjjm	3657	16	and	and	CC
cord-023095-4dannjjm	3657	17	Day	Day	NNP
cord-023095-4dannjjm	3657	18	7	7	CD
cord-023095-4dannjjm	3657	19	and	and	CC
cord-023095-4dannjjm	3657	20	ultimately	ultimately	RB
cord-023095-4dannjjm	3657	21	responded	respond	VBD
cord-023095-4dannjjm	3657	22	to	to	IN
cord-023095-4dannjjm	3657	23	administration	administration	NN
cord-023095-4dannjjm	3657	24	of	of	IN
cord-023095-4dannjjm	3657	25	a	a	DT
cord-023095-4dannjjm	3657	26	fluoroquinolone	fluoroquinolone	NN
cord-023095-4dannjjm	3657	27	.	.	.
cord-023095-4dannjjm	3658	1	The	the	DT
cord-023095-4dannjjm	3658	2	results	result	NNS
cord-023095-4dannjjm	3658	3	suggest	suggest	VBP
cord-023095-4dannjjm	3658	4	that	that	IN
cord-023095-4dannjjm	3658	5	while	while	IN
cord-023095-4dannjjm	3658	6	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	3658	7	spp	spp	NNS
cord-023095-4dannjjm	3658	8	.	.	.
cord-023095-4dannjjm	3659	1	commonly	commonly	RB
cord-023095-4dannjjm	3659	2	contaminate	contaminate	VB
cord-023095-4dannjjm	3659	3	cat	cat	NN
cord-023095-4dannjjm	3659	4	bite	bite	NN
cord-023095-4dannjjm	3659	5	abscesses	abscess	NNS
cord-023095-4dannjjm	3659	6	,	,	,
cord-023095-4dannjjm	3659	7	routine	routine	JJ
cord-023095-4dannjjm	3659	8	wound	wound	NN
cord-023095-4dannjjm	3659	9	management	management	NN
cord-023095-4dannjjm	3659	10	and	and	CC
cord-023095-4dannjjm	3659	11	antibiotic	antibiotic	JJ
cord-023095-4dannjjm	3659	12	therapy	therapy	NN
cord-023095-4dannjjm	3659	13	is	be	VBZ
cord-023095-4dannjjm	3659	14	adequate	adequate	JJ
cord-023095-4dannjjm	3659	15	for	for	IN
cord-023095-4dannjjm	3659	16	control	control	NN
cord-023095-4dannjjm	3659	17	.	.	.
cord-023095-4dannjjm	3660	1	However	however	RB
cord-023095-4dannjjm	3660	2	,	,	,
cord-023095-4dannjjm	3660	3	as	as	IN
cord-023095-4dannjjm	3660	4	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	3660	5	spp	spp	NNS
cord-023095-4dannjjm	3660	6	.	.	.
cord-023095-4dannjjm	3661	1	infections	infection	NNS
cord-023095-4dannjjm	3661	2	do	do	VBP
cord-023095-4dannjjm	3661	3	not	not	RB
cord-023095-4dannjjm	3661	4	respond	respond	VB
cord-023095-4dannjjm	3661	5	to	to	IN
cord-023095-4dannjjm	3661	6	beta	beta	NN
cord-023095-4dannjjm	3661	7	lactam	lactam	NN
cord-023095-4dannjjm	3661	8	class	class	NN
cord-023095-4dannjjm	3661	9	antibiotic	antibiotic	NN
cord-023095-4dannjjm	3661	10	therapy	therapy	NN
cord-023095-4dannjjm	3661	11	,	,	,
cord-023095-4dannjjm	3661	12	these	these	DT
cord-023095-4dannjjm	3661	13	organisms	organism	NNS
cord-023095-4dannjjm	3661	14	should	should	MD
cord-023095-4dannjjm	3661	15	be	be	VB
cord-023095-4dannjjm	3661	16	on	on	IN
cord-023095-4dannjjm	3661	17	the	the	DT
cord-023095-4dannjjm	3661	18	differential	differential	JJ
cord-023095-4dannjjm	3661	19	list	list	NN
cord-023095-4dannjjm	3661	20	for	for	IN
cord-023095-4dannjjm	3661	21	cats	cat	NNS
cord-023095-4dannjjm	3661	22	with	with	IN
cord-023095-4dannjjm	3661	23	abscesses	abscess	NNS
cord-023095-4dannjjm	3661	24	that	that	WDT
cord-023095-4dannjjm	3661	25	fail	fail	VBP
cord-023095-4dannjjm	3661	26	treatment	treatment	NN
cord-023095-4dannjjm	3661	27	with	with	IN
cord-023095-4dannjjm	3661	28	this	this	DT
cord-023095-4dannjjm	3661	29	antibiotic	antibiotic	JJ
cord-023095-4dannjjm	3661	30	class	class	NN
cord-023095-4dannjjm	3661	31	.	.	.
cord-023095-4dannjjm	3662	1	Molecular	molecular	JJ
cord-023095-4dannjjm	3662	2	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3662	3	assays	assay	NNS
cord-023095-4dannjjm	3662	4	are	be	VBP
cord-023095-4dannjjm	3662	5	frequently	frequently	RB
cord-023095-4dannjjm	3662	6	used	use	VBN
cord-023095-4dannjjm	3662	7	in	in	IN
cord-023095-4dannjjm	3662	8	clinical	clinical	JJ
cord-023095-4dannjjm	3662	9	practice	practice	NN
cord-023095-4dannjjm	3662	10	to	to	TO
cord-023095-4dannjjm	3662	11	aid	aid	VB
cord-023095-4dannjjm	3662	12	in	in	IN
cord-023095-4dannjjm	3662	13	the	the	DT
cord-023095-4dannjjm	3662	14	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3662	15	of	of	IN
cord-023095-4dannjjm	3662	16	suspected	suspect	VBN
cord-023095-4dannjjm	3662	17	infectious	infectious	JJ
cord-023095-4dannjjm	3662	18	respiratory	respiratory	JJ
cord-023095-4dannjjm	3662	19	diseases	disease	NNS
cord-023095-4dannjjm	3662	20	in	in	IN
cord-023095-4dannjjm	3662	21	dogs	dog	NNS
cord-023095-4dannjjm	3662	22	.	.	.
cord-023095-4dannjjm	3663	1	However	however	RB
cord-023095-4dannjjm	3663	2	,	,	,
cord-023095-4dannjjm	3663	3	most	most	RBS
cord-023095-4dannjjm	3663	4	currently	currently	RB
cord-023095-4dannjjm	3663	5	available	available	JJ
cord-023095-4dannjjm	3663	6	assays	assay	NNS
cord-023095-4dannjjm	3663	7	can	can	MD
cord-023095-4dannjjm	3663	8	not	not	RB
cord-023095-4dannjjm	3663	9	distinguish	distinguish	VB
cord-023095-4dannjjm	3663	10	strains	strain	NNS
cord-023095-4dannjjm	3663	11	of	of	IN
cord-023095-4dannjjm	3663	12	the	the	DT
cord-023095-4dannjjm	3663	13	organisms	organism	NNS
cord-023095-4dannjjm	3663	14	used	use	VBN
cord-023095-4dannjjm	3663	15	in	in	IN
cord-023095-4dannjjm	3663	16	vaccines	vaccine	NNS
cord-023095-4dannjjm	3663	17	from	from	IN
cord-023095-4dannjjm	3663	18	naturally	naturally	RB
cord-023095-4dannjjm	3663	19	occurring	occur	VBG
cord-023095-4dannjjm	3663	20	strains	strain	NNS
cord-023095-4dannjjm	3663	21	.	.	.
cord-023095-4dannjjm	3664	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	3664	2	prior	prior	JJ
cord-023095-4dannjjm	3664	3	studies	study	NNS
cord-023095-4dannjjm	3664	4	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	3664	5	that	that	IN
cord-023095-4dannjjm	3664	6	previously	previously	RB
cord-023095-4dannjjm	3664	7	immune	immune	JJ
cord-023095-4dannjjm	3664	8	adult	adult	NN
cord-023095-4dannjjm	3664	9	dogs	dog	NNS
cord-023095-4dannjjm	3664	10	are	be	VBP
cord-023095-4dannjjm	3664	11	unlikely	unlikely	JJ
cord-023095-4dannjjm	3664	12	to	to	TO
cord-023095-4dannjjm	3664	13	shed	shed	VB
cord-023095-4dannjjm	3664	14	nucleic	nucleic	JJ
cord-023095-4dannjjm	3664	15	acids	acid	NNS
cord-023095-4dannjjm	3664	16	of	of	IN
cord-023095-4dannjjm	3664	17	vaccine	vaccine	NN
cord-023095-4dannjjm	3664	18	strains	strain	NNS
cord-023095-4dannjjm	3664	19	of	of	IN
cord-023095-4dannjjm	3664	20	adenovirus	adenovirus	NN
cord-023095-4dannjjm	3664	21	2	2	CD
cord-023095-4dannjjm	3664	22	,	,	,
cord-023095-4dannjjm	3664	23	parainfluenza	parainfluenza	NNP
cord-023095-4dannjjm	3664	24	,	,	,
cord-023095-4dannjjm	3664	25	or	or	CC
cord-023095-4dannjjm	3664	26	Bordetella	Bordetella	NNP
cord-023095-4dannjjm	3664	27	bronchiseptica	bronchiseptica	NNP
cord-023095-4dannjjm	3664	28	.	.	.
cord-023095-4dannjjm	3665	1	However	however	RB
cord-023095-4dannjjm	3665	2	,	,	,
cord-023095-4dannjjm	3665	3	whether	whether	IN
cord-023095-4dannjjm	3665	4	this	this	DT
cord-023095-4dannjjm	3665	5	is	be	VBZ
cord-023095-4dannjjm	3665	6	true	true	JJ
cord-023095-4dannjjm	3665	7	for	for	IN
cord-023095-4dannjjm	3665	8	puppies	puppy	NNS
cord-023095-4dannjjm	3665	9	is	be	VBZ
cord-023095-4dannjjm	3665	10	unknown	unknown	JJ
cord-023095-4dannjjm	3665	11	.	.	.
cord-023095-4dannjjm	3666	1	Puppies	puppy	NNS
cord-023095-4dannjjm	3666	2	(	(	-LRB-
cord-023095-4dannjjm	3666	3	n	n	NN
cord-023095-4dannjjm	3666	4	5	5	CD
cord-023095-4dannjjm	3666	5	8)	8)	NN
cord-023095-4dannjjm	3666	6	at	at	IN
cord-023095-4dannjjm	3666	7	a	a	DT
cord-023095-4dannjjm	3666	8	breeding	breeding	NN
cord-023095-4dannjjm	3666	9	facility	facility	NN
cord-023095-4dannjjm	3666	10	were	be	VBD
cord-023095-4dannjjm	3666	11	moved	move	VBN
cord-023095-4dannjjm	3666	12	into	into	IN
cord-023095-4dannjjm	3666	13	area	area	NN
cord-023095-4dannjjm	3666	14	without	without	IN
cord-023095-4dannjjm	3666	15	other	other	JJ
cord-023095-4dannjjm	3666	16	dogs	dog	NNS
cord-023095-4dannjjm	3666	17	at	at	IN
cord-023095-4dannjjm	3666	18	6	6	CD
cord-023095-4dannjjm	3666	19	weeks	week	NNS
cord-023095-4dannjjm	3666	20	of	of	IN
cord-023095-4dannjjm	3666	21	age	age	NN
cord-023095-4dannjjm	3666	22	.	.	.
cord-023095-4dannjjm	3667	1	Swabs	swab	NNS
cord-023095-4dannjjm	3667	2	of	of	IN
cord-023095-4dannjjm	3667	3	the	the	DT
cord-023095-4dannjjm	3667	4	nasal	nasal	NN
cord-023095-4dannjjm	3667	5	and	and	CC
cord-023095-4dannjjm	3667	6	pharyngeal	pharyngeal	JJ
cord-023095-4dannjjm	3667	7	mucosa	mucosa	NN
cord-023095-4dannjjm	3667	8	were	be	VBD
cord-023095-4dannjjm	3667	9	collected	collect	VBN
cord-023095-4dannjjm	3667	10	prior	prior	RB
cord-023095-4dannjjm	3667	11	to	to	IN
cord-023095-4dannjjm	3667	12	vaccination	vaccination	NN
cord-023095-4dannjjm	3667	13	and	and	CC
cord-023095-4dannjjm	3667	14	on	on	IN
cord-023095-4dannjjm	3667	15	days	day	NNS
cord-023095-4dannjjm	3667	16	0	0	CD
cord-023095-4dannjjm	3667	17	,	,	,
cord-023095-4dannjjm	3667	18	1	1	CD
cord-023095-4dannjjm	3667	19	,	,	,
cord-023095-4dannjjm	3667	20	2	2	CD
cord-023095-4dannjjm	3667	21	,	,	,
cord-023095-4dannjjm	3667	22	3	3	CD
cord-023095-4dannjjm	3667	23	,	,	,
cord-023095-4dannjjm	3667	24	4	4	CD
cord-023095-4dannjjm	3667	25	,	,	,
cord-023095-4dannjjm	3667	26	5	5	CD
cord-023095-4dannjjm	3667	27	,	,	,
cord-023095-4dannjjm	3667	28	6	6	CD
cord-023095-4dannjjm	3667	29	,	,	,
cord-023095-4dannjjm	3667	30	7	7	CD
cord-023095-4dannjjm	3667	31	,	,	,
cord-023095-4dannjjm	3667	32	10	10	CD
cord-023095-4dannjjm	3667	33	,	,	,
cord-023095-4dannjjm	3667	34	14	14	CD
cord-023095-4dannjjm	3667	35	,	,	,
cord-023095-4dannjjm	3667	36	17	17	CD
cord-023095-4dannjjm	3667	37	,	,	,
cord-023095-4dannjjm	3667	38	21	21	CD
cord-023095-4dannjjm	3667	39	,	,	,
cord-023095-4dannjjm	3667	40	24	24	CD
cord-023095-4dannjjm	3667	41	,	,	,
cord-023095-4dannjjm	3667	42	and	and	CC
cord-023095-4dannjjm	3667	43	28	28	CD
cord-023095-4dannjjm	3667	44	after	after	IN
cord-023095-4dannjjm	3667	45	vaccination	vaccination	NN
cord-023095-4dannjjm	3667	46	with	with	IN
cord-023095-4dannjjm	3667	47	an	an	DT
cord-023095-4dannjjm	3667	48	intranasal	intranasal	NN
cord-023095-4dannjjm	3667	49	adenovirus	adenovirus	NN
cord-023095-4dannjjm	3667	50	2	2	CD
cord-023095-4dannjjm	3667	51	,	,	,
cord-023095-4dannjjm	3667	52	parainfluenza	parainfluenza	NNP
cord-023095-4dannjjm	3667	53	,	,	,
cord-023095-4dannjjm	3667	54	and	and	CC
cord-023095-4dannjjm	3667	55	B.	B.	NNP
cord-023095-4dannjjm	3667	56	bronchiseptica	bronchiseptica	NNP
cord-023095-4dannjjm	3667	57	vaccine	vaccine	NN
cord-023095-4dannjjm	3667	58	(	(	-LRB-
cord-023095-4dannjjm	3667	59	IntraTrac	IntraTrac	NNP
cord-023095-4dannjjm	3667	60	3	3	CD
cord-023095-4dannjjm	3667	61	,	,	,
cord-023095-4dannjjm	3667	62	Schering	Schering	NNP
cord-023095-4dannjjm	3667	63	Plough	Plough	NNP
cord-023095-4dannjjm	3667	64	)	)	-RRB-
cord-023095-4dannjjm	3667	65	.	.	.
cord-023095-4dannjjm	3668	1	The	the	DT
cord-023095-4dannjjm	3668	2	swabs	swab	NNS
cord-023095-4dannjjm	3668	3	were	be	VBD
cord-023095-4dannjjm	3668	4	shipped	ship	VBN
cord-023095-4dannjjm	3668	5	on	on	IN
cord-023095-4dannjjm	3668	6	cold	cold	JJ
cord-023095-4dannjjm	3668	7	packs	pack	NNS
cord-023095-4dannjjm	3668	8	by	by	IN
cord-023095-4dannjjm	3668	9	overnight	overnight	JJ
cord-023095-4dannjjm	3668	10	express	express	NN
cord-023095-4dannjjm	3668	11	for	for	IN
cord-023095-4dannjjm	3668	12	DNA	DNA	NNP
cord-023095-4dannjjm	3668	13	/	/	SYM
cord-023095-4dannjjm	3668	14	RNA	RNA	NNP
cord-023095-4dannjjm	3668	15	extraction	extraction	NN
cord-023095-4dannjjm	3668	16	and	and	CC
cord-023095-4dannjjm	3668	17	assay	assay	NN
cord-023095-4dannjjm	3668	18	in	in	IN
cord-023095-4dannjjm	3668	19	the	the	DT
cord-023095-4dannjjm	3668	20	FastPanel	FastPanel	NNP
cord-023095-4dannjjm	3668	21	TM	TM	NNP
cord-023095-4dannjjm	3668	22	PCR	PCR	NNP
cord-023095-4dannjjm	3668	23	Canine	Canine	NNP
cord-023095-4dannjjm	3668	24	Respiratory	Respiratory	NNP
cord-023095-4dannjjm	3668	25	Disease	Disease	NNP
cord-023095-4dannjjm	3668	26	Profile	Profile	NNP
cord-023095-4dannjjm	3668	27	at	at	IN
cord-023095-4dannjjm	3668	28	Antech	Antech	NNP
cord-023095-4dannjjm	3668	29	Diagnostics	Diagnostics	NNP
cord-023095-4dannjjm	3668	30	.	.	.
cord-023095-4dannjjm	3669	1	All	all	DT
cord-023095-4dannjjm	3669	2	puppies	puppy	NNS
cord-023095-4dannjjm	3669	3	were	be	VBD
cord-023095-4dannjjm	3669	4	negative	negative	JJ
cord-023095-4dannjjm	3669	5	for	for	IN
cord-023095-4dannjjm	3669	6	the	the	DT
cord-023095-4dannjjm	3669	7	infectious	infectious	JJ
cord-023095-4dannjjm	3669	8	agents	agent	NNS
cord-023095-4dannjjm	3669	9	prior	prior	RB
cord-023095-4dannjjm	3669	10	to	to	IN
cord-023095-4dannjjm	3669	11	vaccination	vaccination	NN
cord-023095-4dannjjm	3669	12	.	.	.
cord-023095-4dannjjm	3670	1	After	after	IN
cord-023095-4dannjjm	3670	2	vaccination	vaccination	NN
cord-023095-4dannjjm	3670	3	,	,	,
cord-023095-4dannjjm	3670	4	positive	positive	JJ
cord-023095-4dannjjm	3670	5	assay	assay	NN
cord-023095-4dannjjm	3670	6	results	result	NNS
cord-023095-4dannjjm	3670	7	for	for	IN
cord-023095-4dannjjm	3670	8	parainfluenza	parainfluenza	NNP
cord-023095-4dannjjm	3670	9	and	and	CC
cord-023095-4dannjjm	3670	10	B.	B.	NNP
cord-023095-4dannjjm	3670	11	bronchiseptica	bronchiseptica	NNP
cord-023095-4dannjjm	3670	12	were	be	VBD
cord-023095-4dannjjm	3670	13	first	first	RB
cord-023095-4dannjjm	3670	14	detected	detect	VBN
cord-023095-4dannjjm	3670	15	on	on	IN
cord-023095-4dannjjm	3670	16	Day	day	NN
cord-023095-4dannjjm	3670	17	1	1	CD
cord-023095-4dannjjm	3670	18	and	and	CC
cord-023095-4dannjjm	3670	19	on	on	IN
cord-023095-4dannjjm	3670	20	Day	day	NN
cord-023095-4dannjjm	3670	21	2	2	CD
cord-023095-4dannjjm	3670	22	for	for	IN
cord-023095-4dannjjm	3670	23	adenovirus	adenovirus	NN
cord-023095-4dannjjm	3670	24	2	2	CD
cord-023095-4dannjjm	3670	25	.	.	.
cord-023095-4dannjjm	3671	1	By	by	IN
cord-023095-4dannjjm	3671	2	Day	Day	NNP
cord-023095-4dannjjm	3671	3	3	3	CD
cord-023095-4dannjjm	3671	4	,	,	,
cord-023095-4dannjjm	3671	5	DNA	DNA	NNP
cord-023095-4dannjjm	3671	6	or	or	CC
cord-023095-4dannjjm	3671	7	RNA	RNA	NNP
cord-023095-4dannjjm	3671	8	of	of	IN
cord-023095-4dannjjm	3671	9	the	the	DT
cord-023095-4dannjjm	3671	10	agents	agent	NNS
cord-023095-4dannjjm	3671	11	were	be	VBD
cord-023095-4dannjjm	3671	12	amplified	amplify	VBN
cord-023095-4dannjjm	3671	13	from	from	IN
cord-023095-4dannjjm	3671	14	all	all	DT
cord-023095-4dannjjm	3671	15	puppies	puppy	NNS
cord-023095-4dannjjm	3671	16	from	from	IN
cord-023095-4dannjjm	3671	17	both	both	CC
cord-023095-4dannjjm	3671	18	sample	sample	NN
cord-023095-4dannjjm	3671	19	sites	site	NNS
cord-023095-4dannjjm	3671	20	and	and	CC
cord-023095-4dannjjm	3671	21	most	most	JJS
cord-023095-4dannjjm	3671	22	samples	sample	NNS
cord-023095-4dannjjm	3671	23	were	be	VBD
cord-023095-4dannjjm	3671	24	positive	positive	JJ
cord-023095-4dannjjm	3671	25	for	for	IN
cord-023095-4dannjjm	3671	26	all	all	DT
cord-023095-4dannjjm	3671	27	3	3	CD
cord-023095-4dannjjm	3671	28	agents	agent	NNS
cord-023095-4dannjjm	3671	29	through	through	IN
cord-023095-4dannjjm	3671	30	Day	Day	NNP
cord-023095-4dannjjm	3671	31	10	10	CD
cord-023095-4dannjjm	3671	32	.	.	.
cord-023095-4dannjjm	3672	1	By	by	IN
cord-023095-4dannjjm	3672	2	day	day	NN
cord-023095-4dannjjm	3672	3	24	24	CD
cord-023095-4dannjjm	3672	4	,	,	,
cord-023095-4dannjjm	3672	5	only	only	RB
cord-023095-4dannjjm	3672	6	one	one	CD
cord-023095-4dannjjm	3672	7	dog	dog	NN
cord-023095-4dannjjm	3672	8	was	be	VBD
cord-023095-4dannjjm	3672	9	still	still	RB
cord-023095-4dannjjm	3672	10	positive	positive	JJ
cord-023095-4dannjjm	3672	11	for	for	IN
cord-023095-4dannjjm	3672	12	B.	B.	NNP
cord-023095-4dannjjm	3672	13	bronchiseptica	bronchiseptica	NNP
cord-023095-4dannjjm	3672	14	.	.	.
cord-023095-4dannjjm	3673	1	The	the	DT
cord-023095-4dannjjm	3673	2	results	result	NNS
cord-023095-4dannjjm	3673	3	indicate	indicate	VBP
cord-023095-4dannjjm	3673	4	that	that	IN
cord-023095-4dannjjm	3673	5	intranasal	intranasal	NNP
cord-023095-4dannjjm	3673	6	administration	administration	NN
cord-023095-4dannjjm	3673	7	of	of	IN
cord-023095-4dannjjm	3673	8	adenovirus	adenovirus	NNP
cord-023095-4dannjjm	3673	9	2	2	CD
cord-023095-4dannjjm	3673	10	,	,	,
cord-023095-4dannjjm	3673	11	parainfluenza	parainfluenza	NNP
cord-023095-4dannjjm	3673	12	,	,	,
cord-023095-4dannjjm	3673	13	or	or	CC
cord-023095-4dannjjm	3673	14	Bordetella	Bordetella	NNP
cord-023095-4dannjjm	3673	15	bronchiseptica	bronchiseptica	NNP
cord-023095-4dannjjm	3673	16	vaccines	vaccine	NNS
cord-023095-4dannjjm	3673	17	commonly	commonly	RB
cord-023095-4dannjjm	3673	18	leads	lead	VBZ
cord-023095-4dannjjm	3673	19	to	to	IN
cord-023095-4dannjjm	3673	20	positive	positive	JJ
cord-023095-4dannjjm	3673	21	molecular	molecular	JJ
cord-023095-4dannjjm	3673	22	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3673	23	assay	assay	NN
cord-023095-4dannjjm	3673	24	results	result	VBZ
cord-023095-4dannjjm	3673	25	for	for	IN
cord-023095-4dannjjm	3673	26	a	a	DT
cord-023095-4dannjjm	3673	27	short	short	JJ
cord-023095-4dannjjm	3673	28	time	time	NN
cord-023095-4dannjjm	3673	29	period	period	NN
cord-023095-4dannjjm	3673	30	after	after	IN
cord-023095-4dannjjm	3673	31	primary	primary	JJ
cord-023095-4dannjjm	3673	32	vaccination	vaccination	NN
cord-023095-4dannjjm	3673	33	.	.	.
cord-023095-4dannjjm	3674	1	These	these	DT
cord-023095-4dannjjm	3674	2	findings	finding	NNS
cord-023095-4dannjjm	3674	3	should	should	MD
cord-023095-4dannjjm	3674	4	be	be	VB
cord-023095-4dannjjm	3674	5	considered	consider	VBN
cord-023095-4dannjjm	3674	6	when	when	WRB
cord-023095-4dannjjm	3674	7	assessing	assess	VBG
cord-023095-4dannjjm	3674	8	the	the	DT
cord-023095-4dannjjm	3674	9	results	result	NNS
cord-023095-4dannjjm	3674	10	of	of	IN
cord-023095-4dannjjm	3674	11	these	these	DT
cord-023095-4dannjjm	3674	12	assays	assay	NNS
cord-023095-4dannjjm	3674	13	in	in	IN
cord-023095-4dannjjm	3674	14	client	client	NN
cord-023095-4dannjjm	3674	15	-	-	HYPH
cord-023095-4dannjjm	3674	16	owned	own	VBN
cord-023095-4dannjjm	3674	17	puppies	puppy	NNS
cord-023095-4dannjjm	3674	18	with	with	IN
cord-023095-4dannjjm	3674	19	respiratory	respiratory	JJ
cord-023095-4dannjjm	3674	20	disease	disease	NN
cord-023095-4dannjjm	3674	21	.	.	.
cord-023095-4dannjjm	3675	1	Antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	3675	2	resistance	resistance	NN
cord-023095-4dannjjm	3675	3	in	in	IN
cord-023095-4dannjjm	3675	4	Escherichia	Escherichia	NNP
cord-023095-4dannjjm	3675	5	coli	coli	NNS
cord-023095-4dannjjm	3675	6	is	be	VBZ
cord-023095-4dannjjm	3675	7	an	an	DT
cord-023095-4dannjjm	3675	8	increasing	increase	VBG
cord-023095-4dannjjm	3675	9	concern	concern	NN
cord-023095-4dannjjm	3675	10	in	in	IN
cord-023095-4dannjjm	3675	11	both	both	CC
cord-023095-4dannjjm	3675	12	human	human	JJ
cord-023095-4dannjjm	3675	13	and	and	CC
cord-023095-4dannjjm	3675	14	veterinary	veterinary	JJ
cord-023095-4dannjjm	3675	15	hospitals	hospital	NNS
cord-023095-4dannjjm	3675	16	'	'	POS
cord-023095-4dannjjm	3675	17	patients	patient	NNS
cord-023095-4dannjjm	3675	18	.	.	.
cord-023095-4dannjjm	3676	1	The	the	DT
cord-023095-4dannjjm	3676	2	choice	choice	NN
cord-023095-4dannjjm	3676	3	drug	drug	NN
cord-023095-4dannjjm	3676	4	for	for	IN
cord-023095-4dannjjm	3676	5	treatment	treatment	NN
cord-023095-4dannjjm	3676	6	in	in	IN
cord-023095-4dannjjm	3676	7	dogs	dog	NNS
cord-023095-4dannjjm	3676	8	is	be	VBZ
cord-023095-4dannjjm	3676	9	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	3676	10	,	,	,
cord-023095-4dannjjm	3676	11	a	a	DT
cord-023095-4dannjjm	3676	12	second	second	JJ
cord-023095-4dannjjm	3676	13	generation	generation	NN
cord-023095-4dannjjm	3676	14	fluoroquinolone	fluoroquinolone	NN
cord-023095-4dannjjm	3676	15	(	(	-LRB-
cord-023095-4dannjjm	3676	16	FQ	FQ	NNP
cord-023095-4dannjjm	3676	17	)	)	-RRB-
cord-023095-4dannjjm	3676	18	whose	whose	WP$
cord-023095-4dannjjm	3676	19	activity	activity	NN
cord-023095-4dannjjm	3676	20	reflects	reflect	VBZ
cord-023095-4dannjjm	3676	21	,	,	,
cord-023095-4dannjjm	3676	22	in	in	IN
cord-023095-4dannjjm	3676	23	part	part	NN
cord-023095-4dannjjm	3676	24	,	,	,
cord-023095-4dannjjm	3676	25	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	3676	26	.	.	.
cord-023095-4dannjjm	3677	1	Among	among	IN
cord-023095-4dannjjm	3677	2	the	the	DT
cord-023095-4dannjjm	3677	3	difficulties	difficulty	NNS
cord-023095-4dannjjm	3677	4	in	in	IN
cord-023095-4dannjjm	3677	5	effective	effective	JJ
cord-023095-4dannjjm	3677	6	E.	E.	NNP
cord-023095-4dannjjm	3677	7	coli	coli	NNS
cord-023095-4dannjjm	3677	8	treatment	treatment	NN
cord-023095-4dannjjm	3677	9	is	be	VBZ
cord-023095-4dannjjm	3677	10	rapid	rapid	JJ
cord-023095-4dannjjm	3677	11	detection	detection	NN
cord-023095-4dannjjm	3677	12	of	of	IN
cord-023095-4dannjjm	3677	13	FQ	FQ	NNP
cord-023095-4dannjjm	3677	14	resistance	resistance	NN
cord-023095-4dannjjm	3677	15	.	.	.
cord-023095-4dannjjm	3678	1	The	the	DT
cord-023095-4dannjjm	3678	2	purpose	purpose	NN
cord-023095-4dannjjm	3678	3	of	of	IN
cord-023095-4dannjjm	3678	4	this	this	DT
cord-023095-4dannjjm	3678	5	study	study	NN
cord-023095-4dannjjm	3678	6	was	be	VBD
cord-023095-4dannjjm	3678	7	to	to	TO
cord-023095-4dannjjm	3678	8	determine	determine	VB
cord-023095-4dannjjm	3678	9	the	the	DT
cord-023095-4dannjjm	3678	10	specificity	specificity	NN
cord-023095-4dannjjm	3678	11	and	and	CC
cord-023095-4dannjjm	3678	12	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3678	13	of	of	IN
cord-023095-4dannjjm	3678	14	a	a	DT
cord-023095-4dannjjm	3678	15	FRET	fret	NN
cord-023095-4dannjjm	3678	16	based	base	VBN
cord-023095-4dannjjm	3678	17	assay	assay	NN
cord-023095-4dannjjm	3678	18	for	for	IN
cord-023095-4dannjjm	3678	19	the	the	DT
cord-023095-4dannjjm	3678	20	rapid	rapid	JJ
cord-023095-4dannjjm	3678	21	detection	detection	NN
cord-023095-4dannjjm	3678	22	of	of	IN
cord-023095-4dannjjm	3678	23	urinary	urinary	JJ
cord-023095-4dannjjm	3678	24	tract	tract	NN
cord-023095-4dannjjm	3678	25	infections	infection	NNS
cord-023095-4dannjjm	3678	26	caused	cause	VBN
cord-023095-4dannjjm	3678	27	by	by	IN
cord-023095-4dannjjm	3678	28	FQ	FQ	NNP
cord-023095-4dannjjm	3678	29	associated	associate	VBD
cord-023095-4dannjjm	3678	30	multi	multi	JJ
cord-023095-4dannjjm	3678	31	-	-	JJ
cord-023095-4dannjjm	3678	32	drug	drug	JJ
cord-023095-4dannjjm	3678	33	resistant	resistant	JJ
cord-023095-4dannjjm	3678	34	E.coli	E.coli	NNS
cord-023095-4dannjjm	3678	35	.	.	.
cord-023095-4dannjjm	3679	1	306	306	CD
cord-023095-4dannjjm	3679	2	clinical	clinical	JJ
cord-023095-4dannjjm	3679	3	E.	E.	NNP
cord-023095-4dannjjm	3679	4	coli	coli	NNS
cord-023095-4dannjjm	3679	5	isolated	isolate	VBN
cord-023095-4dannjjm	3679	6	from	from	IN
cord-023095-4dannjjm	3679	7	canine	canine	JJ
cord-023095-4dannjjm	3679	8	urine	urine	NN
cord-023095-4dannjjm	3679	9	and	and	CC
cord-023095-4dannjjm	3679	10	120	120	CD
cord-023095-4dannjjm	3679	11	clinical	clinical	JJ
cord-023095-4dannjjm	3679	12	veterinary	veterinary	JJ
cord-023095-4dannjjm	3679	13	urine	urine	NN
cord-023095-4dannjjm	3679	14	samples	sample	NNS
cord-023095-4dannjjm	3679	15	being	be	VBG
cord-023095-4dannjjm	3679	16	examined	examine	VBN
cord-023095-4dannjjm	3679	17	for	for	IN
cord-023095-4dannjjm	3679	18	E.	E.	NNP
cord-023095-4dannjjm	3679	19	coli	coli	NNS
cord-023095-4dannjjm	3679	20	were	be	VBD
cord-023095-4dannjjm	3679	21	subjected	subject	VBN
cord-023095-4dannjjm	3679	22	to	to	IN
cord-023095-4dannjjm	3679	23	susceptibility	susceptibility	NN
cord-023095-4dannjjm	3679	24	testing	testing	NN
cord-023095-4dannjjm	3679	25	for	for	IN
cord-023095-4dannjjm	3679	26	14	14	CD
cord-023095-4dannjjm	3679	27	drugs	drug	NNS
cord-023095-4dannjjm	3679	28	representing	represent	VBG
cord-023095-4dannjjm	3679	29	6	6	CD
cord-023095-4dannjjm	3679	30	drug	drug	NN
cord-023095-4dannjjm	3679	31	classes	class	NNS
cord-023095-4dannjjm	3679	32	.	.	.
cord-023095-4dannjjm	3680	1	Pure	pure	JJ
cord-023095-4dannjjm	3680	2	isolates	isolate	NNS
cord-023095-4dannjjm	3680	3	were	be	VBD
cord-023095-4dannjjm	3680	4	designated	designate	VBN
cord-023095-4dannjjm	3680	5	NDR	NDR	NNP
cord-023095-4dannjjm	3680	6	(	(	-LRB-
cord-023095-4dannjjm	3680	7	no	no	DT
cord-023095-4dannjjm	3680	8	drug	drug	NN
cord-023095-4dannjjm	3680	9	resistance	resistance	NN
cord-023095-4dannjjm	3680	10	)	)	-RRB-
cord-023095-4dannjjm	3680	11	,	,	,
cord-023095-4dannjjm	3680	12	SDR	SDR	NNP
cord-023095-4dannjjm	3680	13	(	(	-LRB-
cord-023095-4dannjjm	3680	14	single	single	JJ
cord-023095-4dannjjm	3680	15	drug	drug	NN
cord-023095-4dannjjm	3680	16	resistance	resistance	NN
cord-023095-4dannjjm	3680	17	)	)	-RRB-
cord-023095-4dannjjm	3680	18	and	and	CC
cord-023095-4dannjjm	3680	19	MDR	MDR	NNP
cord-023095-4dannjjm	3680	20	(	(	-LRB-
cord-023095-4dannjjm	3680	21	multi	multi	JJ
cord-023095-4dannjjm	3680	22	-	-	JJ
cord-023095-4dannjjm	3680	23	drug	drug	JJ
cord-023095-4dannjjm	3680	24	resistant	resistant	NN
cord-023095-4dannjjm	3680	25	)	)	-RRB-
cord-023095-4dannjjm	3680	26	(	(	-LRB-
cord-023095-4dannjjm	3680	27	n	n	NN
cord-023095-4dannjjm	3680	28	5	5	CD
cord-023095-4dannjjm	3680	29	101	101	CD
cord-023095-4dannjjm	3680	30	MDR	MDR	NNP
cord-023095-4dannjjm	3680	31	,	,	,
cord-023095-4dannjjm	3680	32	116	116	CD
cord-023095-4dannjjm	3680	33	SDR	SDR	NNP
cord-023095-4dannjjm	3680	34	and	and	CC
cord-023095-4dannjjm	3680	35	89	89	CD
cord-023095-4dannjjm	3680	36	NDR	NDR	NNP
cord-023095-4dannjjm	3680	37	)	)	-RRB-
cord-023095-4dannjjm	3680	38	.	.	.
cord-023095-4dannjjm	3681	1	Minimum	minimum	JJ
cord-023095-4dannjjm	3681	2	inhibitory	inhibitory	JJ
cord-023095-4dannjjm	3681	3	concentration	concentration	NN
cord-023095-4dannjjm	3681	4	(	(	-LRB-
cord-023095-4dannjjm	3681	5	MIC	MIC	NNP
cord-023095-4dannjjm	3681	6	)	)	-RRB-
cord-023095-4dannjjm	3681	7	for	for	IN
cord-023095-4dannjjm	3681	8	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	3681	9	ranged	range	VBD
cord-023095-4dannjjm	3681	10	from	from	IN
cord-023095-4dannjjm	3681	11	0.03	0.03	CD
cord-023095-4dannjjm	3681	12	mg	mg	NNP
cord-023095-4dannjjm	3681	13	/	/	SYM
cord-023095-4dannjjm	3681	14	ml	ml	NN
cord-023095-4dannjjm	3681	15	to	to	IN
cord-023095-4dannjjm	3681	16	512	512	CD
cord-023095-4dannjjm	3681	17	mg	mg	NNP
cord-023095-4dannjjm	3681	18	/	/	SYM
cord-023095-4dannjjm	3681	19	ml	ml	NNP
cord-023095-4dannjjm	3681	20	,	,	,
cord-023095-4dannjjm	3681	21	with	with	IN
cord-023095-4dannjjm	3681	22	high	high	JJ
cord-023095-4dannjjm	3681	23	MIC	MIC	NNP
cord-023095-4dannjjm	3681	24	generally	generally	RB
cord-023095-4dannjjm	3681	25	associated	associate	VBN
cord-023095-4dannjjm	3681	26	with	with	IN
cord-023095-4dannjjm	3681	27	MDR	MDR	NNP
cord-023095-4dannjjm	3681	28	.	.	.
cord-023095-4dannjjm	3682	1	Extracted	extract	VBN
cord-023095-4dannjjm	3682	2	DNA	DNA	NNP
cord-023095-4dannjjm	3682	3	from	from	IN
cord-023095-4dannjjm	3682	4	culture	culture	NN
cord-023095-4dannjjm	3682	5	and	and	CC
cord-023095-4dannjjm	3682	6	from	from	IN
cord-023095-4dannjjm	3682	7	urine	urine	NN
cord-023095-4dannjjm	3682	8	were	be	VBD
cord-023095-4dannjjm	3682	9	subjected	subject	VBN
cord-023095-4dannjjm	3682	10	to	to	IN
cord-023095-4dannjjm	3682	11	FRET	FRET	NNP
cord-023095-4dannjjm	3682	12	-	-	HYPH
cord-023095-4dannjjm	3682	13	PCR	pcr	NN
cord-023095-4dannjjm	3682	14	targeting	target	VBG
cord-023095-4dannjjm	3682	15	single	single	JJ
cord-023095-4dannjjm	3682	16	nucleotide	nucleotide	JJ
cord-023095-4dannjjm	3682	17	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	3682	18	in	in	IN
cord-023095-4dannjjm	3682	19	gyrA.	gyrA.	NNP
cord-023095-4dannjjm	3683	1	The	the	DT
cord-023095-4dannjjm	3683	2	resulting	result	VBG
cord-023095-4dannjjm	3683	3	product	product	NN
cord-023095-4dannjjm	3683	4	was	be	VBD
cord-023095-4dannjjm	3683	5	sequenced	sequence	VBN
cord-023095-4dannjjm	3683	6	to	to	TO
cord-023095-4dannjjm	3683	7	detect	detect	VB
cord-023095-4dannjjm	3683	8	other	other	JJ
cord-023095-4dannjjm	3683	9	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	3683	10	.	.	.
cord-023095-4dannjjm	3684	1	Further	further	RB
cord-023095-4dannjjm	3684	2	,	,	,
cord-023095-4dannjjm	3684	3	to	to	TO
cord-023095-4dannjjm	3684	4	determine	determine	VB
cord-023095-4dannjjm	3684	5	the	the	DT
cord-023095-4dannjjm	3684	6	level	level	NN
cord-023095-4dannjjm	3684	7	of	of	IN
cord-023095-4dannjjm	3684	8	detection	detection	NN
cord-023095-4dannjjm	3684	9	,	,	,
cord-023095-4dannjjm	3684	10	microbial	microbial	JJ
cord-023095-4dannjjm	3684	11	free	free	JJ
cord-023095-4dannjjm	3684	12	canine	canine	JJ
cord-023095-4dannjjm	3684	13	urine	urine	NN
cord-023095-4dannjjm	3684	14	was	be	VBD
cord-023095-4dannjjm	3684	15	inoculated	inoculate	VBN
cord-023095-4dannjjm	3684	16	with	with	IN
cord-023095-4dannjjm	3684	17	10	10	CD
cord-023095-4dannjjm	3684	18	6	6	CD
cord-023095-4dannjjm	3684	19	to	to	TO
cord-023095-4dannjjm	3684	20	10	10	CD
cord-023095-4dannjjm	3684	21	1	1	CD
cord-023095-4dannjjm	3684	22	CFU	CFU	NNP
cord-023095-4dannjjm	3684	23	/	/	SYM
cord-023095-4dannjjm	3684	24	ml	ml	NNS
cord-023095-4dannjjm	3684	25	of	of	IN
cord-023095-4dannjjm	3684	26	7	7	CD
cord-023095-4dannjjm	3684	27	isolates	isolate	NNS
cord-023095-4dannjjm	3684	28	characterized	characterize	VBN
cord-023095-4dannjjm	3684	29	by	by	IN
cord-023095-4dannjjm	3684	30	variable	variable	JJ
cord-023095-4dannjjm	3684	31	susceptibility	susceptibility	NN
cord-023095-4dannjjm	3684	32	to	to	IN
cord-023095-4dannjjm	3684	33	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	3684	34	(	(	-LRB-
cord-023095-4dannjjm	3684	35	MIC	MIC	NNP
cord-023095-4dannjjm	3684	36	Enro	Enro	NNP
cord-023095-4dannjjm	3684	37	5	5	CD
cord-023095-4dannjjm	3684	38	0.03	0.03	CD
cord-023095-4dannjjm	3684	39	,	,	,
cord-023095-4dannjjm	3684	40	0.06	0.06	CD
cord-023095-4dannjjm	3684	41	,	,	,
cord-023095-4dannjjm	3684	42	0.15	0.15	CD
cord-023095-4dannjjm	3684	43	,	,	,
cord-023095-4dannjjm	3684	44	1	1	CD
cord-023095-4dannjjm	3684	45	,	,	,
cord-023095-4dannjjm	3684	46	64	64	CD
cord-023095-4dannjjm	3684	47	,	,	,
cord-023095-4dannjjm	3684	48	128	128	CD
cord-023095-4dannjjm	3684	49	,	,	,
cord-023095-4dannjjm	3684	50	256	256	CD
cord-023095-4dannjjm	3684	51	mg	mg	NNP
cord-023095-4dannjjm	3684	52	/	/	SYM
cord-023095-4dannjjm	3684	53	ml	ml	NNP
cord-023095-4dannjjm	3684	54	)	)	-RRB-
cord-023095-4dannjjm	3684	55	.	.	.
cord-023095-4dannjjm	3685	1	Of	of	IN
cord-023095-4dannjjm	3685	2	306	306	CD
cord-023095-4dannjjm	3685	3	pure	pure	JJ
cord-023095-4dannjjm	3685	4	isolates	isolate	NNS
cord-023095-4dannjjm	3685	5	,	,	,
cord-023095-4dannjjm	3685	6	50	50	CD
cord-023095-4dannjjm	3685	7	were	be	VBD
cord-023095-4dannjjm	3685	8	confirmed	confirm	VBN
cord-023095-4dannjjm	3685	9	positive	positive	JJ
cord-023095-4dannjjm	3685	10	for	for	IN
cord-023095-4dannjjm	3685	11	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	3685	12	resistance	resistance	NN
cord-023095-4dannjjm	3685	13	(	(	-LRB-
cord-023095-4dannjjm	3685	14	MIC	MIC	NNP
cord-023095-4dannjjm	3685	15	Enro	Enro	NNP
cord-023095-4dannjjm	3685	16	4	4	CD
cord-023095-4dannjjm	3685	17	4	4	CD
cord-023095-4dannjjm	3685	18	mg	mg	NNP
cord-023095-4dannjjm	3685	19	/	/	SYM
cord-023095-4dannjjm	3685	20	ml	ml	NNP
cord-023095-4dannjjm	3685	21	)	)	-RRB-
cord-023095-4dannjjm	3685	22	,	,	,
cord-023095-4dannjjm	3685	23	43	43	CD
cord-023095-4dannjjm	3685	24	of	of	IN
cord-023095-4dannjjm	3685	25	which	which	WDT
cord-023095-4dannjjm	3685	26	were	be	VBD
cord-023095-4dannjjm	3685	27	positively	positively	RB
cord-023095-4dannjjm	3685	28	identified	identify	VBN
cord-023095-4dannjjm	3685	29	by	by	IN
cord-023095-4dannjjm	3685	30	the	the	DT
cord-023095-4dannjjm	3685	31	FRET	FRET	NNP
cord-023095-4dannjjm	3685	32	-	-	HYPH
cord-023095-4dannjjm	3685	33	PCR	pcr	NN
cord-023095-4dannjjm	3685	34	assay	assay	NN
cord-023095-4dannjjm	3685	35	giving	give	VBG
cord-023095-4dannjjm	3685	36	a	a	DT
cord-023095-4dannjjm	3685	37	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3685	38	of	of	IN
cord-023095-4dannjjm	3685	39	86.00	86.00	CD
cord-023095-4dannjjm	3685	40	%	%	NN
cord-023095-4dannjjm	3685	41	.	.	.
cord-023095-4dannjjm	3686	1	Only	only	RB
cord-023095-4dannjjm	3686	2	1	1	CD
cord-023095-4dannjjm	3686	3	isolate	isolate	NN
cord-023095-4dannjjm	3686	4	that	that	WDT
cord-023095-4dannjjm	3686	5	was	be	VBD
cord-023095-4dannjjm	3686	6	resistant	resistant	JJ
cord-023095-4dannjjm	3686	7	was	be	VBD
cord-023095-4dannjjm	3686	8	not	not	RB
cord-023095-4dannjjm	3686	9	detected	detect	VBN
cord-023095-4dannjjm	3686	10	(	(	-LRB-
cord-023095-4dannjjm	3686	11	specificity	specificity	NN
cord-023095-4dannjjm	3686	12	of	of	IN
cord-023095-4dannjjm	3686	13	96.66	96.66	CD
cord-023095-4dannjjm	3686	14	%	%	NN
cord-023095-4dannjjm	3686	15	)	)	-RRB-
cord-023095-4dannjjm	3686	16	.	.	.
cord-023095-4dannjjm	3687	1	However	however	RB
cord-023095-4dannjjm	3687	2	,	,	,
cord-023095-4dannjjm	3687	3	of	of	IN
cord-023095-4dannjjm	3687	4	the	the	DT
cord-023095-4dannjjm	3687	5	isolates	isolate	NNS
cord-023095-4dannjjm	3687	6	expressing	express	VBG
cord-023095-4dannjjm	3687	7	high	high	JJ
cord-023095-4dannjjm	3687	8	level	level	NN
cord-023095-4dannjjm	3687	9	resistance	resistance	NN
cord-023095-4dannjjm	3687	10	(	(	-LRB-
cord-023095-4dannjjm	3687	11	MIC	MIC	NNP
cord-023095-4dannjjm	3687	12	4	4	CD
cord-023095-4dannjjm	3687	13	8	8	CD
cord-023095-4dannjjm	3687	14	X	x	NN
cord-023095-4dannjjm	3687	15	breakpoint	breakpoint	NN
cord-023095-4dannjjm	3687	16	[	[	-LRB-
cord-023095-4dannjjm	3687	17	64	64	CD
cord-023095-4dannjjm	3687	18	mcg	mcg	NN
cord-023095-4dannjjm	3687	19	/	/	SYM
cord-023095-4dannjjm	3687	20	ml	ml	NN
cord-023095-4dannjjm	3687	21	]	]	-RRB-
cord-023095-4dannjjm	3687	22	)	)	-RRB-
cord-023095-4dannjjm	3687	23	,	,	,
cord-023095-4dannjjm	3687	24	and	and	CC
cord-023095-4dannjjm	3687	25	MDR	MDR	NNP
cord-023095-4dannjjm	3687	26	(	(	-LRB-
cord-023095-4dannjjm	3687	27	n	n	NN
cord-023095-4dannjjm	3687	28	5	5	CD
cord-023095-4dannjjm	3687	29	34	34	CD
cord-023095-4dannjjm	3687	30	)	)	-RRB-
cord-023095-4dannjjm	3687	31	,	,	,
cord-023095-4dannjjm	3687	32	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3687	33	5	5	CD
cord-023095-4dannjjm	3687	34	97.06	97.06	CD
cord-023095-4dannjjm	3687	35	%	%	NN
cord-023095-4dannjjm	3687	36	.	.	.
cord-023095-4dannjjm	3688	1	Of	of	IN
cord-023095-4dannjjm	3688	2	the	the	DT
cord-023095-4dannjjm	3688	3	120	120	CD
cord-023095-4dannjjm	3688	4	urine	urine	NN
cord-023095-4dannjjm	3688	5	samples	sample	NNS
cord-023095-4dannjjm	3688	6	27	27	CD
cord-023095-4dannjjm	3688	7	contained	contain	VBD
cord-023095-4dannjjm	3688	8	E.	E.	NNP
cord-023095-4dannjjm	3688	9	coli	coli	NNS
cord-023095-4dannjjm	3688	10	7	7	CD
cord-023095-4dannjjm	3688	11	of	of	IN
cord-023095-4dannjjm	3688	12	which	which	WDT
cord-023095-4dannjjm	3688	13	determined	determine	VBD
cord-023095-4dannjjm	3688	14	to	to	TO
cord-023095-4dannjjm	3688	15	be	be	VB
cord-023095-4dannjjm	3688	16	FQ	FQ	NNP
cord-023095-4dannjjm	3688	17	-	-	HYPH
cord-023095-4dannjjm	3688	18	resistant	resistant	JJ
cord-023095-4dannjjm	3688	19	by	by	IN
cord-023095-4dannjjm	3688	20	the	the	DT
cord-023095-4dannjjm	3688	21	assay	assay	NN
cord-023095-4dannjjm	3688	22	.	.	.
cord-023095-4dannjjm	3689	1	Colony	colony	NN
cord-023095-4dannjjm	3689	2	dilutions	dilution	NNS
cord-023095-4dannjjm	3689	3	of	of	IN
cord-023095-4dannjjm	3689	4	E.	E.	NNP
cord-023095-4dannjjm	3689	5	coli	coli	NNS
cord-023095-4dannjjm	3689	6	confirmed	confirm	VBD
cord-023095-4dannjjm	3689	7	the	the	DT
cord-023095-4dannjjm	3689	8	assay	assay	NN
cord-023095-4dannjjm	3689	9	able	able	JJ
cord-023095-4dannjjm	3689	10	to	to	TO
cord-023095-4dannjjm	3689	11	detect	detect	VB
cord-023095-4dannjjm	3689	12	enrofloxacin	enrofloxacin	JJ
cord-023095-4dannjjm	3689	13	resistance	resistance	NN
cord-023095-4dannjjm	3689	14	at	at	IN
cord-023095-4dannjjm	3689	15	as	as	RB
cord-023095-4dannjjm	3689	16	low	low	JJ
cord-023095-4dannjjm	3689	17	as	as	IN
cord-023095-4dannjjm	3689	18	101	101	CD
cord-023095-4dannjjm	3689	19	CFU	CFU	NNP
cord-023095-4dannjjm	3689	20	/	/	SYM
cord-023095-4dannjjm	3689	21	ml	ml	NN
cord-023095-4dannjjm	3689	22	.	.	.
cord-023095-4dannjjm	3690	1	The	the	DT
cord-023095-4dannjjm	3690	2	relationship	relationship	NN
cord-023095-4dannjjm	3690	3	between	between	IN
cord-023095-4dannjjm	3690	4	CFUs	cfus	NN
cord-023095-4dannjjm	3690	5	and	and	CC
cord-023095-4dannjjm	3690	6	the	the	DT
cord-023095-4dannjjm	3690	7	peak	peak	NN
cord-023095-4dannjjm	3690	8	of	of	IN
cord-023095-4dannjjm	3690	9	the	the	DT
cord-023095-4dannjjm	3690	10	-(d	-(d	NN
cord-023095-4dannjjm	3690	11	/	/	SYM
cord-023095-4dannjjm	3690	12	dt	dt	NN
cord-023095-4dannjjm	3690	13	)	)	-RRB-
cord-023095-4dannjjm	3690	14	fluorescence	fluorescence	NN
cord-023095-4dannjjm	3690	15	of	of	IN
cord-023095-4dannjjm	3690	16	the	the	DT
cord-023095-4dannjjm	3690	17	melting	melting	NN
cord-023095-4dannjjm	3690	18	curve	curve	NN
cord-023095-4dannjjm	3690	19	was	be	VBD
cord-023095-4dannjjm	3690	20	R2	R2	NNP
cord-023095-4dannjjm	3690	21	5	5	CD
cord-023095-4dannjjm	3690	22	0.988	0.988	CD
cord-023095-4dannjjm	3690	23	.	.	.
cord-023095-4dannjjm	3691	1	These	these	DT
cord-023095-4dannjjm	3691	2	results	result	NNS
cord-023095-4dannjjm	3691	3	conclude	conclude	VBP
cord-023095-4dannjjm	3691	4	that	that	IN
cord-023095-4dannjjm	3691	5	the	the	DT
cord-023095-4dannjjm	3691	6	assay	assay	NN
cord-023095-4dannjjm	3691	7	is	be	VBZ
cord-023095-4dannjjm	3691	8	capable	capable	JJ
cord-023095-4dannjjm	3691	9	of	of	IN
cord-023095-4dannjjm	3691	10	detecting	detect	VBG
cord-023095-4dannjjm	3691	11	not	not	RB
cord-023095-4dannjjm	3691	12	only	only	RB
cord-023095-4dannjjm	3691	13	the	the	DT
cord-023095-4dannjjm	3691	14	presence	presence	NN
cord-023095-4dannjjm	3691	15	of	of	IN
cord-023095-4dannjjm	3691	16	Escherichia	Escherichia	NNP
cord-023095-4dannjjm	3691	17	coli	coli	NNS
cord-023095-4dannjjm	3691	18	in	in	IN
cord-023095-4dannjjm	3691	19	clinical	clinical	JJ
cord-023095-4dannjjm	3691	20	samples	sample	NNS
cord-023095-4dannjjm	3691	21	,	,	,
cord-023095-4dannjjm	3691	22	but	but	CC
cord-023095-4dannjjm	3691	23	also	also	RB
cord-023095-4dannjjm	3691	24	detecting	detect	VBG
cord-023095-4dannjjm	3691	25	severity	severity	NN
cord-023095-4dannjjm	3691	26	of	of	IN
cord-023095-4dannjjm	3691	27	fluroquinolone	fluroquinolone	NN
cord-023095-4dannjjm	3691	28	resistance	resistance	NN
cord-023095-4dannjjm	3691	29	and	and	CC
cord-023095-4dannjjm	3691	30	infection	infection	NN
cord-023095-4dannjjm	3691	31	.	.	.
cord-023095-4dannjjm	3692	1	The	the	DT
cord-023095-4dannjjm	3692	2	fluoroquinolones	fluoroquinolone	NNS
cord-023095-4dannjjm	3692	3	(	(	-LRB-
cord-023095-4dannjjm	3692	4	FQs	fq	NNS
cord-023095-4dannjjm	3692	5	)	)	-RRB-
cord-023095-4dannjjm	3692	6	are	be	VBP
cord-023095-4dannjjm	3692	7	a	a	DT
cord-023095-4dannjjm	3692	8	key	key	JJ
cord-023095-4dannjjm	3692	9	class	class	NN
cord-023095-4dannjjm	3692	10	of	of	IN
cord-023095-4dannjjm	3692	11	synthetic	synthetic	JJ
cord-023095-4dannjjm	3692	12	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	3692	13	agents	agent	NNS
cord-023095-4dannjjm	3692	14	with	with	IN
cord-023095-4dannjjm	3692	15	an	an	DT
cord-023095-4dannjjm	3692	16	established	establish	VBN
cord-023095-4dannjjm	3692	17	history	history	NN
cord-023095-4dannjjm	3692	18	in	in	IN
cord-023095-4dannjjm	3692	19	both	both	DT
cord-023095-4dannjjm	3692	20	humans	human	NNS
cord-023095-4dannjjm	3692	21	and	and	CC
cord-023095-4dannjjm	3692	22	companion	companion	NN
cord-023095-4dannjjm	3692	23	animals	animal	NNS
cord-023095-4dannjjm	3692	24	of	of	IN
cord-023095-4dannjjm	3692	25	efficacy	efficacy	NN
cord-023095-4dannjjm	3692	26	for	for	IN
cord-023095-4dannjjm	3692	27	treatment	treatment	NN
cord-023095-4dannjjm	3692	28	of	of	IN
cord-023095-4dannjjm	3692	29	urinary	urinary	JJ
cord-023095-4dannjjm	3692	30	tract	tract	NN
cord-023095-4dannjjm	3692	31	infections	infection	NNS
cord-023095-4dannjjm	3692	32	(	(	-LRB-
cord-023095-4dannjjm	3692	33	UTIs	uti	NNS
cord-023095-4dannjjm	3692	34	)	)	-RRB-
cord-023095-4dannjjm	3692	35	caused	cause	VBN
cord-023095-4dannjjm	3692	36	by	by	IN
cord-023095-4dannjjm	3692	37	E.	E.	NNP
cord-023095-4dannjjm	3692	38	coli	coli	NNS
cord-023095-4dannjjm	3692	39	,	,	,
cord-023095-4dannjjm	3692	40	and	and	CC
cord-023095-4dannjjm	3692	41	fluoroquinolones	fluoroquinolone	NNS
cord-023095-4dannjjm	3692	42	are	be	VBP
cord-023095-4dannjjm	3692	43	common	common	JJ
cord-023095-4dannjjm	3692	44	therapy	therapy	NN
cord-023095-4dannjjm	3692	45	.	.	.
cord-023095-4dannjjm	3693	1	Among	among	IN
cord-023095-4dannjjm	3693	2	the	the	DT
cord-023095-4dannjjm	3693	3	commonly	commonly	RB
cord-023095-4dannjjm	3693	4	used	use	VBN
cord-023095-4dannjjm	3693	5	FQs	fq	NNS
cord-023095-4dannjjm	3693	6	in	in	IN
cord-023095-4dannjjm	3693	7	dogs	dog	NNS
cord-023095-4dannjjm	3693	8	and	and	CC
cord-023095-4dannjjm	3693	9	cats	cat	NNS
cord-023095-4dannjjm	3693	10	are	be	VBP
cord-023095-4dannjjm	3693	11	the	the	DT
cord-023095-4dannjjm	3693	12	2nd	2nd	JJ
cord-023095-4dannjjm	3693	13	generation	generation	NN
cord-023095-4dannjjm	3693	14	drugs	drug	NNS
cord-023095-4dannjjm	3693	15	,	,	,
cord-023095-4dannjjm	3693	16	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	3693	17	,	,	,
cord-023095-4dannjjm	3693	18	marbofloxacin	marbofloxacin	NNS
cord-023095-4dannjjm	3693	19	,	,	,
cord-023095-4dannjjm	3693	20	orbifloxacin	orbifloxacin	NNP
cord-023095-4dannjjm	3693	21	(	(	-LRB-
cord-023095-4dannjjm	3693	22	all	all	DT
cord-023095-4dannjjm	3693	23	veterinary	veterinary	JJ
cord-023095-4dannjjm	3693	24	approved	approve	VBN
cord-023095-4dannjjm	3693	25	)	)	-RRB-
cord-023095-4dannjjm	3693	26	and	and	CC
cord-023095-4dannjjm	3693	27	the	the	DT
cord-023095-4dannjjm	3693	28	human	human	JJ
cord-023095-4dannjjm	3693	29	drug	drug	NN
cord-023095-4dannjjm	3693	30	ciprofloxacin	ciprofloxacin	NNP
cord-023095-4dannjjm	3693	31	;	;	:
cord-023095-4dannjjm	3693	32	no	no	DT
cord-023095-4dannjjm	3693	33	3rd	3rd	JJ
cord-023095-4dannjjm	3693	34	and	and	CC
cord-023095-4dannjjm	3693	35	4th	4th	JJ
cord-023095-4dannjjm	3693	36	generation	generation	NN
cord-023095-4dannjjm	3693	37	FQ	FQ	NNP
cord-023095-4dannjjm	3693	38	is	be	VBZ
cord-023095-4dannjjm	3693	39	routinely	routinely	RB
cord-023095-4dannjjm	3693	40	used	use	VBN
cord-023095-4dannjjm	3693	41	.	.	.
cord-023095-4dannjjm	3694	1	The	the	DT
cord-023095-4dannjjm	3694	2	purpose	purpose	NN
cord-023095-4dannjjm	3694	3	of	of	IN
cord-023095-4dannjjm	3694	4	this	this	DT
cord-023095-4dannjjm	3694	5	study	study	NN
cord-023095-4dannjjm	3694	6	was	be	VBD
cord-023095-4dannjjm	3694	7	to	to	TO
cord-023095-4dannjjm	3694	8	assess	assess	VB
cord-023095-4dannjjm	3694	9	the	the	DT
cord-023095-4dannjjm	3694	10	in	in	FW
cord-023095-4dannjjm	3694	11	vitro	vitro	FW
cord-023095-4dannjjm	3694	12	activity	activity	NN
cord-023095-4dannjjm	3694	13	of	of	IN
cord-023095-4dannjjm	3694	14	different	different	JJ
cord-023095-4dannjjm	3694	15	generation	generation	NN
cord-023095-4dannjjm	3694	16	FQs	fq	NNS
cord-023095-4dannjjm	3694	17	toward	toward	IN
cord-023095-4dannjjm	3694	18	E.coli	e.coli	JJ
cord-023095-4dannjjm	3694	19	uropathogens	uropathogen	NNS
cord-023095-4dannjjm	3694	20	whose	whose	WP$
cord-023095-4dannjjm	3694	21	phenotype	phenotype	NN
cord-023095-4dannjjm	3694	22	ranges	range	VBZ
cord-023095-4dannjjm	3694	23	from	from	IN
cord-023095-4dannjjm	3694	24	no	no	DT
cord-023095-4dannjjm	3694	25	resistance	resistance	NN
cord-023095-4dannjjm	3694	26	to	to	IN
cord-023095-4dannjjm	3694	27	multidrug	multidrug	NN
cord-023095-4dannjjm	3694	28	resistance	resistance	NN
cord-023095-4dannjjm	3694	29	.	.	.
cord-023095-4dannjjm	3695	1	A	a	DT
cord-023095-4dannjjm	3695	2	total	total	JJ
cord-023095-4dannjjm	3695	3	number	number	NN
cord-023095-4dannjjm	3695	4	of	of	IN
cord-023095-4dannjjm	3695	5	51	51	CD
cord-023095-4dannjjm	3695	6	canine	canine	JJ
cord-023095-4dannjjm	3695	7	uropathogenic	uropathogenic	JJ
cord-023095-4dannjjm	3695	8	canine	canine	JJ
cord-023095-4dannjjm	3695	9	or	or	CC
cord-023095-4dannjjm	3695	10	feline	feline	JJ
cord-023095-4dannjjm	3695	11	E.coli	e.coli	NN
cord-023095-4dannjjm	3695	12	isolates	isolate	NNS
cord-023095-4dannjjm	3695	13	had	have	VBD
cord-023095-4dannjjm	3695	14	been	be	VBN
cord-023095-4dannjjm	3695	15	subjected	subject	VBN
cord-023095-4dannjjm	3695	16	to	to	IN
cord-023095-4dannjjm	3695	17	susceptibility	susceptibility	NN
cord-023095-4dannjjm	3695	18	testing	testing	NN
cord-023095-4dannjjm	3695	19	to	to	IN
cord-023095-4dannjjm	3695	20	6	6	CD
cord-023095-4dannjjm	3695	21	drugs	drug	NNS
cord-023095-4dannjjm	3695	22	classes	class	NNS
cord-023095-4dannjjm	3695	23	(	(	-LRB-
cord-023095-4dannjjm	3695	24	15	15	CD
cord-023095-4dannjjm	3695	25	drugs	drug	NNS
cord-023095-4dannjjm	3695	26	)	)	-RRB-
cord-023095-4dannjjm	3695	27	and	and	CC
cord-023095-4dannjjm	3695	28	phenotyped	phenotype	VBN
cord-023095-4dannjjm	3695	29	as	as	IN
cord-023095-4dannjjm	3695	30	to	to	IN
cord-023095-4dannjjm	3695	31	resistance	resistance	NN
cord-023095-4dannjjm	3695	32	:	:	:
cord-023095-4dannjjm	3695	33	none	none	NN
cord-023095-4dannjjm	3695	34	(	(	-LRB-
cord-023095-4dannjjm	3695	35	NDR	NDR	NNP
cord-023095-4dannjjm	3695	36	,	,	,
cord-023095-4dannjjm	3695	37	n	n	NN
cord-023095-4dannjjm	3695	38	5	5	CD
cord-023095-4dannjjm	3695	39	12	12	CD
cord-023095-4dannjjm	3695	40	)	)	-RRB-
cord-023095-4dannjjm	3695	41	,	,	,
cord-023095-4dannjjm	3695	42	single	single	JJ
cord-023095-4dannjjm	3695	43	(	(	-LRB-
cord-023095-4dannjjm	3695	44	SDR	SDR	NNP
cord-023095-4dannjjm	3695	45	,	,	,
cord-023095-4dannjjm	3695	46	n	n	NN
cord-023095-4dannjjm	3695	47	5	5	CD
cord-023095-4dannjjm	3695	48	15	15	CD
cord-023095-4dannjjm	3695	49	)	)	-RRB-
cord-023095-4dannjjm	3695	50	,	,	,
cord-023095-4dannjjm	3695	51	or	or	CC
cord-023095-4dannjjm	3695	52	multiple	multiple	NN
cord-023095-4dannjjm	3695	53	,	,	,
cord-023095-4dannjjm	3695	54	MDR	MDR	NNP
cord-023095-4dannjjm	3695	55	(	(	-LRB-
cord-023095-4dannjjm	3695	56	resistance	resistance	NN
cord-023095-4dannjjm	3695	57	to	to	IN
cord-023095-4dannjjm	3695	58	2	2	CD
cord-023095-4dannjjm	3695	59	-	-	SYM
cord-023095-4dannjjm	3695	60	6	6	CD
cord-023095-4dannjjm	3695	61	drug	drug	NN
cord-023095-4dannjjm	3695	62	classes	class	NNS
cord-023095-4dannjjm	3695	63	;	;	:
cord-023095-4dannjjm	3695	64	n	n	NN
cord-023095-4dannjjm	3695	65	5	5	CD
cord-023095-4dannjjm	3695	66	24	24	CD
cord-023095-4dannjjm	3695	67	)	)	-RRB-
cord-023095-4dannjjm	3695	68	.	.	.
cord-023095-4dannjjm	3696	1	MDR	MDR	NNP
cord-023095-4dannjjm	3696	2	included	include	VBD
cord-023095-4dannjjm	3696	3	isolates	isolate	NNS
cord-023095-4dannjjm	3696	4	susceptible	susceptible	JJ
cord-023095-4dannjjm	3696	5	(	(	-LRB-
cord-023095-4dannjjm	3696	6	ENR	ENR	NNP
cord-023095-4dannjjm	3696	7	S	S	NNP
cord-023095-4dannjjm	3696	8	-MDR	-MDR	-RRB-
cord-023095-4dannjjm	3696	9	,	,	,
cord-023095-4dannjjm	3696	10	n	n	NN
cord-023095-4dannjjm	3696	11	5	5	CD
cord-023095-4dannjjm	3696	12	12	12	CD
cord-023095-4dannjjm	3696	13	)	)	-RRB-
cord-023095-4dannjjm	3696	14	or	or	CC
cord-023095-4dannjjm	3696	15	resistant	resistant	JJ
cord-023095-4dannjjm	3696	16	(	(	-LRB-
cord-023095-4dannjjm	3696	17	ENR	ENR	NNP
cord-023095-4dannjjm	3696	18	R	R	NNP
cord-023095-4dannjjm	3696	19	-MDR	-MDR	-RRB-
cord-023095-4dannjjm	3696	20	)	)	-RRB-
cord-023095-4dannjjm	3696	21	to	to	IN
cord-023095-4dannjjm	3696	22	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	3696	23	.	.	.
cord-023095-4dannjjm	3697	1	The	the	DT
cord-023095-4dannjjm	3697	2	minimum	minimum	JJ
cord-023095-4dannjjm	3697	3	inhibition	inhibition	NN
cord-023095-4dannjjm	3697	4	concentrations	concentration	NNS
cord-023095-4dannjjm	3697	5	(	(	-LRB-
cord-023095-4dannjjm	3697	6	MICs	mic	NNS
cord-023095-4dannjjm	3697	7	)	)	-RRB-
cord-023095-4dannjjm	3697	8	for	for	IN
cord-023095-4dannjjm	3697	9	11	11	CD
cord-023095-4dannjjm	3697	10	quinolones	quinolone	NNS
cord-023095-4dannjjm	3697	11	(	(	-LRB-
cord-023095-4dannjjm	3697	12	1	1	CD
cord-023095-4dannjjm	3697	13	-	-	HYPH
cord-023095-4dannjjm	3697	14	1st	1st	JJ
cord-023095-4dannjjm	3697	15	generation	generation	NN
cord-023095-4dannjjm	3697	16	,	,	,
cord-023095-4dannjjm	3697	17	3	3	CD
cord-023095-4dannjjm	3697	18	-	-	HYPH
cord-023095-4dannjjm	3697	19	2nd	2nd	JJ
cord-023095-4dannjjm	3697	20	generation	generation	NN
cord-023095-4dannjjm	3697	21	,	,	,
cord-023095-4dannjjm	3697	22	4	4	CD
cord-023095-4dannjjm	3697	23	-	-	HYPH
cord-023095-4dannjjm	3697	24	3rd	3rd	JJ
cord-023095-4dannjjm	3697	25	generation	generation	NN
cord-023095-4dannjjm	3697	26	and	and	CC
cord-023095-4dannjjm	3697	27	3	3	CD
cord-023095-4dannjjm	3697	28	-	-	HYPH
cord-023095-4dannjjm	3697	29	4th	4th	JJ
cord-023095-4dannjjm	3697	30	generation	generation	NN
cord-023095-4dannjjm	3697	31	)	)	-RRB-
cord-023095-4dannjjm	3697	32	were	be	VBD
cord-023095-4dannjjm	3697	33	determined	determine	VBN
cord-023095-4dannjjm	3697	34	for	for	IN
cord-023095-4dannjjm	3697	35	these	these	DT
cord-023095-4dannjjm	3697	36	isolates	isolate	NNS
cord-023095-4dannjjm	3697	37	using	use	VBG
cord-023095-4dannjjm	3697	38	broth	broth	NN
cord-023095-4dannjjm	3697	39	microdilution	microdilution	NN
cord-023095-4dannjjm	3697	40	methods	method	NNS
cord-023095-4dannjjm	3697	41	according	accord	VBG
cord-023095-4dannjjm	3697	42	to	to	IN
cord-023095-4dannjjm	3697	43	CLSI	CLSI	NNP
cord-023095-4dannjjm	3697	44	guidelines	guideline	NNS
cord-023095-4dannjjm	3697	45	(	(	-LRB-
cord-023095-4dannjjm	3697	46	E.	E.	NNP
cord-023095-4dannjjm	3697	47	coli	coli	VBZ
cord-023095-4dannjjm	3697	48	ATCC	ATCC	NNP
cord-023095-4dannjjm	3697	49	s	s	POS
cord-023095-4dannjjm	3697	50	25922	25922	CD
cord-023095-4dannjjm	3697	51	served	serve	VBD
cord-023095-4dannjjm	3697	52	as	as	IN
cord-023095-4dannjjm	3697	53	a	a	DT
cord-023095-4dannjjm	3697	54	negative	negative	JJ
cord-023095-4dannjjm	3697	55	control	control	NN
cord-023095-4dannjjm	3697	56	)	)	-RRB-
cord-023095-4dannjjm	3697	57	.	.	.
cord-023095-4dannjjm	3698	1	MIC	mic	NN
cord-023095-4dannjjm	3698	2	statistics	statistic	NNS
cord-023095-4dannjjm	3698	3	were	be	VBD
cord-023095-4dannjjm	3698	4	generated	generate	VBN
cord-023095-4dannjjm	3698	5	for	for	IN
cord-023095-4dannjjm	3698	6	each	each	DT
cord-023095-4dannjjm	3698	7	drug	drug	NN
cord-023095-4dannjjm	3698	8	among	among	IN
cord-023095-4dannjjm	3698	9	phenotypes	phenotype	NNS
cord-023095-4dannjjm	3698	10	.	.	.
cord-023095-4dannjjm	3699	1	The	the	DT
cord-023095-4dannjjm	3699	2	results	result	NNS
cord-023095-4dannjjm	3699	3	showed	show	VBD
cord-023095-4dannjjm	3699	4	that	that	IN
cord-023095-4dannjjm	3699	5	companion	companion	NN
cord-023095-4dannjjm	3699	6	animal	animal	NN
cord-023095-4dannjjm	3699	7	E.	E.	NNP
cord-023095-4dannjjm	3699	8	coli	coli	NNS
cord-023095-4dannjjm	3699	9	expressing	express	VBG
cord-023095-4dannjjm	3699	10	NDR	NDR	NNP
cord-023095-4dannjjm	3699	11	or	or	CC
cord-023095-4dannjjm	3699	12	SDR	SDR	NNP
cord-023095-4dannjjm	3699	13	are	be	VBP
cord-023095-4dannjjm	3699	14	largely	largely	RB
cord-023095-4dannjjm	3699	15	susceptible	susceptible	JJ
cord-023095-4dannjjm	3699	16	to	to	IN
cord-023095-4dannjjm	3699	17	2nd	2nd	JJ
cord-023095-4dannjjm	3699	18	to	to	IN
cord-023095-4dannjjm	3699	19	4th	4th	JJ
cord-023095-4dannjjm	3699	20	generation	generation	NN
cord-023095-4dannjjm	3699	21	FQs	fq	NNS
cord-023095-4dannjjm	3699	22	.	.	.
cord-023095-4dannjjm	3700	1	However	however	RB
cord-023095-4dannjjm	3700	2	,	,	,
cord-023095-4dannjjm	3700	3	isolates	isolate	NNS
cord-023095-4dannjjm	3700	4	expressing	express	VBG
cord-023095-4dannjjm	3700	5	resistance	resistance	NN
cord-023095-4dannjjm	3700	6	to	to	IN
cord-023095-4dannjjm	3700	7	1st	1st	JJ
cord-023095-4dannjjm	3700	8	or	or	CC
cord-023095-4dannjjm	3700	9	2nd	2nd	JJ
cord-023095-4dannjjm	3700	10	generation	generation	NN
cord-023095-4dannjjm	3700	11	quinolone	quinolone	NNP
cord-023095-4dannjjm	3700	12	also	also	RB
cord-023095-4dannjjm	3700	13	express	express	VBP
cord-023095-4dannjjm	3700	14	high	high	JJ
cord-023095-4dannjjm	3700	15	level	level	NN
cord-023095-4dannjjm	3700	16	resistance	resistance	NN
cord-023095-4dannjjm	3700	17	based	base	VBN
cord-023095-4dannjjm	3700	18	on	on	IN
cord-023095-4dannjjm	3700	19	the	the	DT
cord-023095-4dannjjm	3700	20	MIC	MIC	NNP
cord-023095-4dannjjm	3700	21	90	90	CD
cord-023095-4dannjjm	3700	22	to	to	IN
cord-023095-4dannjjm	3700	23	3rd	3rd	JJ
cord-023095-4dannjjm	3700	24	and	and	CC
cord-023095-4dannjjm	3700	25	4th	4th	JJ
cord-023095-4dannjjm	3700	26	generation	generation	NN
cord-023095-4dannjjm	3700	27	FQs	fq	NNS
cord-023095-4dannjjm	3700	28	.	.	.
cord-023095-4dannjjm	3701	1	The	the	DT
cord-023095-4dannjjm	3701	2	overall	overall	JJ
cord-023095-4dannjjm	3701	3	potency	potency	NN
cord-023095-4dannjjm	3701	4	(	(	-LRB-
cord-023095-4dannjjm	3701	5	MIC	MIC	NNP
cord-023095-4dannjjm	3701	6	)	)	-RRB-
cord-023095-4dannjjm	3701	7	for	for	IN
cord-023095-4dannjjm	3701	8	the	the	DT
cord-023095-4dannjjm	3701	9	11	11	CD
cord-023095-4dannjjm	3701	10	drugs	drug	NNS
cord-023095-4dannjjm	3701	11	for	for	IN
cord-023095-4dannjjm	3701	12	isolates	isolate	NNS
cord-023095-4dannjjm	3701	13	not	not	RB
cord-023095-4dannjjm	3701	14	expressing	express	VBG
cord-023095-4dannjjm	3701	15	ENR	ENR	NNP
cord-023095-4dannjjm	3701	16	resistance	resistance	NN
cord-023095-4dannjjm	3701	17	(	(	-LRB-
cord-023095-4dannjjm	3701	18	that	that	RB
cord-023095-4dannjjm	3701	19	is	is	RB
cord-023095-4dannjjm	3701	20	,	,	,
cord-023095-4dannjjm	3701	21	NDR	NDR	NNP
cord-023095-4dannjjm	3701	22	,	,	,
cord-023095-4dannjjm	3701	23	SDR	SDR	NNP
cord-023095-4dannjjm	3701	24	and	and	CC
cord-023095-4dannjjm	3701	25	ENR	ENR	NNP
cord-023095-4dannjjm	3701	26	S	S	NNP
cord-023095-4dannjjm	3701	27	-MDR	-MDR	-RRB-
cord-023095-4dannjjm	3701	28	)	)	-RRB-
cord-023095-4dannjjm	3701	29	is	be	VBZ
cord-023095-4dannjjm	3701	30	GAT	GAT	NNP
cord-023095-4dannjjm	3701	31	Canine	canine	JJ
cord-023095-4dannjjm	3701	32	leproid	leproid	NN
cord-023095-4dannjjm	3701	33	granuloma	granuloma	NN
cord-023095-4dannjjm	3701	34	(	(	-LRB-
cord-023095-4dannjjm	3701	35	CLG	CLG	NNP
cord-023095-4dannjjm	3701	36	)	)	-RRB-
cord-023095-4dannjjm	3701	37	was	be	VBD
cord-023095-4dannjjm	3701	38	first	first	RB
cord-023095-4dannjjm	3701	39	reported	report	VBN
cord-023095-4dannjjm	3701	40	in	in	IN
cord-023095-4dannjjm	3701	41	Brazil	Brazil	NNP
cord-023095-4dannjjm	3701	42	in	in	IN
cord-023095-4dannjjm	3701	43	1990	1990	CD
cord-023095-4dannjjm	3701	44	.	.	.
cord-023095-4dannjjm	3702	1	Over	over	IN
cord-023095-4dannjjm	3702	2	the	the	DT
cord-023095-4dannjjm	3702	3	past	past	JJ
cord-023095-4dannjjm	3702	4	20	20	CD
cord-023095-4dannjjm	3702	5	years	year	NNS
cord-023095-4dannjjm	3702	6	,	,	,
cord-023095-4dannjjm	3702	7	37	37	CD
cord-023095-4dannjjm	3702	8	cases	case	NNS
cord-023095-4dannjjm	3702	9	of	of	IN
cord-023095-4dannjjm	3702	10	CLG	CLG	NNP
cord-023095-4dannjjm	3702	11	were	be	VBD
cord-023095-4dannjjm	3702	12	diagnosed	diagnose	VBN
cord-023095-4dannjjm	3702	13	in	in	IN
cord-023095-4dannjjm	3702	14	Sa˜o	Sa˜o	NNP
cord-023095-4dannjjm	3702	15	Paulo	Paulo	NNP
cord-023095-4dannjjm	3702	16	,	,	,
cord-023095-4dannjjm	3702	17	Brazil	Brazil	NNP
cord-023095-4dannjjm	3702	18	,	,	,
cord-023095-4dannjjm	3702	19	and	and	CC
cord-023095-4dannjjm	3702	20	clinical	clinical	JJ
cord-023095-4dannjjm	3702	21	and	and	CC
cord-023095-4dannjjm	3702	22	epidemiological	epidemiological	JJ
cord-023095-4dannjjm	3702	23	findings	finding	NNS
cord-023095-4dannjjm	3702	24	were	be	VBD
cord-023095-4dannjjm	3702	25	similar	similar	JJ
cord-023095-4dannjjm	3702	26	to	to	IN
cord-023095-4dannjjm	3702	27	those	those	DT
cord-023095-4dannjjm	3702	28	reported	report	VBN
cord-023095-4dannjjm	3702	29	in	in	IN
cord-023095-4dannjjm	3702	30	Australia	Australia	NNP
cord-023095-4dannjjm	3702	31	.	.	.
cord-023095-4dannjjm	3703	1	All	all	DT
cord-023095-4dannjjm	3703	2	dogs	dog	NNS
cord-023095-4dannjjm	3703	3	presented	present	VBN
cord-023095-4dannjjm	3703	4	with	with	IN
cord-023095-4dannjjm	3703	5	one	one	CD
cord-023095-4dannjjm	3703	6	or	or	CC
cord-023095-4dannjjm	3703	7	more	more	JJR
cord-023095-4dannjjm	3703	8	,	,	,
cord-023095-4dannjjm	3703	9	uni	uni	NN
cord-023095-4dannjjm	3703	10	or	or	CC
cord-023095-4dannjjm	3703	11	bilateral	bilateral	JJ
cord-023095-4dannjjm	3703	12	,	,	,
cord-023095-4dannjjm	3703	13	ulcerated	ulcerated	JJ
cord-023095-4dannjjm	3703	14	or	or	CC
cord-023095-4dannjjm	3703	15	not	not	RB
cord-023095-4dannjjm	3703	16	,	,	,
cord-023095-4dannjjm	3703	17	papular	papular	JJ
cord-023095-4dannjjm	3703	18	,	,	,
cord-023095-4dannjjm	3703	19	nodular	nodular	JJ
cord-023095-4dannjjm	3703	20	or	or	CC
cord-023095-4dannjjm	3703	21	tumoral	tumoral	JJ
cord-023095-4dannjjm	3703	22	lesions	lesion	NNS
cord-023095-4dannjjm	3703	23	,	,	,
cord-023095-4dannjjm	3703	24	mainly	mainly	RB
cord-023095-4dannjjm	3703	25	observed	observe	VBD
cord-023095-4dannjjm	3703	26	in	in	IN
cord-023095-4dannjjm	3703	27	the	the	DT
cord-023095-4dannjjm	3703	28	dorsal	dorsal	JJ
cord-023095-4dannjjm	3703	29	surface	surface	NN
cord-023095-4dannjjm	3703	30	of	of	IN
cord-023095-4dannjjm	3703	31	the	the	DT
cord-023095-4dannjjm	3703	32	ear	ear	NN
cord-023095-4dannjjm	3703	33	,	,	,
cord-023095-4dannjjm	3703	34	site	site	NN
cord-023095-4dannjjm	3703	35	usually	usually	RB
cord-023095-4dannjjm	3703	36	more	more	RBR
cord-023095-4dannjjm	3703	37	affected	affected	JJ
cord-023095-4dannjjm	3703	38	.	.	.
cord-023095-4dannjjm	3704	1	In	in	IN
cord-023095-4dannjjm	3704	2	general	general	JJ
cord-023095-4dannjjm	3704	3	,	,	,
cord-023095-4dannjjm	3704	4	the	the	DT
cord-023095-4dannjjm	3704	5	lesions	lesion	NNS
cord-023095-4dannjjm	3704	6	are	be	VBP
cord-023095-4dannjjm	3704	7	painless	painless	JJ
cord-023095-4dannjjm	3704	8	and	and	CC
cord-023095-4dannjjm	3704	9	confined	confine	VBN
cord-023095-4dannjjm	3704	10	to	to	IN
cord-023095-4dannjjm	3704	11	the	the	DT
cord-023095-4dannjjm	3704	12	subcutis	subcutis	NN
cord-023095-4dannjjm	3704	13	and	and	CC
cord-023095-4dannjjm	3704	14	skin	skin	NN
cord-023095-4dannjjm	3704	15	,	,	,
cord-023095-4dannjjm	3704	16	and	and	CC
cord-023095-4dannjjm	3704	17	it	-PRON-	PRP
cord-023095-4dannjjm	3704	18	does	do	VBZ
cord-023095-4dannjjm	3704	19	not	not	RB
cord-023095-4dannjjm	3704	20	involve	involve	VB
cord-023095-4dannjjm	3704	21	regional	regional	JJ
cord-023095-4dannjjm	3704	22	lymph	lymph	NN
cord-023095-4dannjjm	3704	23	nodes	node	NNS
cord-023095-4dannjjm	3704	24	,	,	,
cord-023095-4dannjjm	3704	25	nerves	nerve	NNS
cord-023095-4dannjjm	3704	26	or	or	CC
cord-023095-4dannjjm	3704	27	internal	internal	JJ
cord-023095-4dannjjm	3704	28	organs	organ	NNS
cord-023095-4dannjjm	3704	29	,	,	,
cord-023095-4dannjjm	3704	30	and	and	CC
cord-023095-4dannjjm	3704	31	systemic	systemic	JJ
cord-023095-4dannjjm	3704	32	clinical	clinical	JJ
cord-023095-4dannjjm	3704	33	signs	sign	NNS
cord-023095-4dannjjm	3704	34	frequently	frequently	RB
cord-023095-4dannjjm	3704	35	are	be	VBP
cord-023095-4dannjjm	3704	36	absent	absent	JJ
cord-023095-4dannjjm	3704	37	.	.	.
cord-023095-4dannjjm	3705	1	Short	short	JJ
cord-023095-4dannjjm	3705	2	-	-	HYPH
cord-023095-4dannjjm	3705	3	coated	coated	JJ
cord-023095-4dannjjm	3705	4	breeds	breed	NNS
cord-023095-4dannjjm	3705	5	show	show	VBP
cord-023095-4dannjjm	3705	6	a	a	DT
cord-023095-4dannjjm	3705	7	marked	marked	JJ
cord-023095-4dannjjm	3705	8	predisposition	predisposition	NN
cord-023095-4dannjjm	3705	9	for	for	IN
cord-023095-4dannjjm	3705	10	this	this	DT
cord-023095-4dannjjm	3705	11	disease	disease	NN
cord-023095-4dannjjm	3705	12	.	.	.
cord-023095-4dannjjm	3706	1	The	the	DT
cord-023095-4dannjjm	3706	2	definitive	definitive	JJ
cord-023095-4dannjjm	3706	3	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3706	4	of	of	IN
cord-023095-4dannjjm	3706	5	CLG	CLG	NNP
cord-023095-4dannjjm	3706	6	was	be	VBD
cord-023095-4dannjjm	3706	7	obtained	obtain	VBN
cord-023095-4dannjjm	3706	8	by	by	IN
cord-023095-4dannjjm	3706	9	histological	histological	JJ
cord-023095-4dannjjm	3706	10	examination	examination	NN
cord-023095-4dannjjm	3706	11	of	of	IN
cord-023095-4dannjjm	3706	12	skin	skin	NN
cord-023095-4dannjjm	3706	13	biopsies	biopsy	NNS
cord-023095-4dannjjm	3706	14	that	that	WDT
cord-023095-4dannjjm	3706	15	were	be	VBD
cord-023095-4dannjjm	3706	16	stained	stain	VBN
cord-023095-4dannjjm	3706	17	with	with	IN
cord-023095-4dannjjm	3706	18	acid	acid	NN
cord-023095-4dannjjm	3706	19	fast	fast	RB
cord-023095-4dannjjm	3707	1	(	(	-LRB-
cord-023095-4dannjjm	3707	2	Ziehl	Ziehl	NNP
cord-023095-4dannjjm	3707	3	-	-	HYPH
cord-023095-4dannjjm	3707	4	Neelsen	Neelsen	NNP
cord-023095-4dannjjm	3707	5	)	)	-RRB-
cord-023095-4dannjjm	3707	6	and	and	CC
cord-023095-4dannjjm	3707	7	DiffQuik	DiffQuik	NNP
cord-023095-4dannjjm	3707	8	s	s	NNP
cord-023095-4dannjjm	3707	9	.	.	.
cord-023095-4dannjjm	3708	1	Thirty	thirty	CD
cord-023095-4dannjjm	3708	2	one	one	CD
cord-023095-4dannjjm	3708	3	(	(	-LRB-
cord-023095-4dannjjm	3708	4	83.7	83.7	CD
cord-023095-4dannjjm	3708	5	%	%	NN
cord-023095-4dannjjm	3708	6	)	)	-RRB-
cord-023095-4dannjjm	3708	7	of	of	IN
cord-023095-4dannjjm	3708	8	the	the	DT
cord-023095-4dannjjm	3708	9	dogs	dog	NNS
cord-023095-4dannjjm	3708	10	were	be	VBD
cord-023095-4dannjjm	3708	11	purebred	purebred	JJ
cord-023095-4dannjjm	3708	12	;	;	:
cord-023095-4dannjjm	3708	13	in	in	IN
cord-023095-4dannjjm	3708	14	this	this	DT
cord-023095-4dannjjm	3708	15	study	study	NN
cord-023095-4dannjjm	3708	16	the	the	DT
cord-023095-4dannjjm	3708	17	breed	breed	NN
cord-023095-4dannjjm	3708	18	pattern	pattern	NN
cord-023095-4dannjjm	3708	19	comprised	comprise	VBN
cord-023095-4dannjjm	3708	20	19	19	CD
cord-023095-4dannjjm	3708	21	(	(	-LRB-
cord-023095-4dannjjm	3708	22	61.3	61.3	CD
cord-023095-4dannjjm	3708	23	%	%	NN
cord-023095-4dannjjm	3708	24	)	)	-RRB-
cord-023095-4dannjjm	3708	25	Boxers	Boxers	NNPS
cord-023095-4dannjjm	3708	26	,	,	,
cord-023095-4dannjjm	3708	27	2	2	CD
cord-023095-4dannjjm	3708	28	(	(	-LRB-
cord-023095-4dannjjm	3708	29	6.5	6.5	CD
cord-023095-4dannjjm	3708	30	%	%	NN
cord-023095-4dannjjm	3708	31	)	)	-RRB-
cord-023095-4dannjjm	3709	1	German	german	JJ
cord-023095-4dannjjm	3709	2	Shepherd	Shepherd	NNP
cord-023095-4dannjjm	3709	3	and	and	CC
cord-023095-4dannjjm	3709	4	Labrador	Labrador	NNP
cord-023095-4dannjjm	3709	5	Retriever	Retriever	NNP
cord-023095-4dannjjm	3709	6	,	,	,
cord-023095-4dannjjm	3709	7	1	1	CD
cord-023095-4dannjjm	3709	8	(	(	-LRB-
cord-023095-4dannjjm	3709	9	3.2	3.2	CD
cord-023095-4dannjjm	3709	10	%	%	NN
cord-023095-4dannjjm	3709	11	)	)	-RRB-
cord-023095-4dannjjm	3710	1	Dobermann	Dobermann	NNP
cord-023095-4dannjjm	3710	2	,	,	,
cord-023095-4dannjjm	3710	3	1	1	CD
cord-023095-4dannjjm	3710	4	(	(	-LRB-
cord-023095-4dannjjm	3710	5	3.2	3.2	CD
cord-023095-4dannjjm	3710	6	%	%	NN
cord-023095-4dannjjm	3710	7	)	)	-RRB-
cord-023095-4dannjjm	3711	1	Brazilian	Brazilian	NNP
cord-023095-4dannjjm	3711	2	Terrier	Terrier	NNP
cord-023095-4dannjjm	3711	3	,	,	,
cord-023095-4dannjjm	3711	4	1	1	CD
cord-023095-4dannjjm	3711	5	(	(	-LRB-
cord-023095-4dannjjm	3711	6	3.2	3.2	CD
cord-023095-4dannjjm	3711	7	%	%	NN
cord-023095-4dannjjm	3711	8	)	)	-RRB-
cord-023095-4dannjjm	3712	1	Golden	Golden	NNP
cord-023095-4dannjjm	3712	2	Retriever	Retriever	NNP
cord-023095-4dannjjm	3712	3	,	,	,
cord-023095-4dannjjm	3712	4	1	1	CD
cord-023095-4dannjjm	3712	5	(	(	-LRB-
cord-023095-4dannjjm	3712	6	3.2	3.2	CD
cord-023095-4dannjjm	3712	7	%	%	NN
cord-023095-4dannjjm	3712	8	)	)	-RRB-
cord-023095-4dannjjm	3712	9	Bulldog	Bulldog	NNP
cord-023095-4dannjjm	3712	10	,	,	,
cord-023095-4dannjjm	3712	11	1	1	CD
cord-023095-4dannjjm	3712	12	(	(	-LRB-
cord-023095-4dannjjm	3712	13	2.8	2.8	CD
cord-023095-4dannjjm	3712	14	%	%	NN
cord-023095-4dannjjm	3712	15	)	)	-RRB-
cord-023095-4dannjjm	3712	16	American	american	JJ
cord-023095-4dannjjm	3712	17	Pitbull	Pitbull	NNP
cord-023095-4dannjjm	3712	18	,	,	,
cord-023095-4dannjjm	3712	19	1	1	CD
cord-023095-4dannjjm	3712	20	(	(	-LRB-
cord-023095-4dannjjm	3712	21	3.2	3.2	CD
cord-023095-4dannjjm	3712	22	%	%	NN
cord-023095-4dannjjm	3712	23	)	)	-RRB-
cord-023095-4dannjjm	3712	24	Mastiff	Mastiff	NNP
cord-023095-4dannjjm	3712	25	,	,	,
cord-023095-4dannjjm	3712	26	1	1	CD
cord-023095-4dannjjm	3712	27	(	(	-LRB-
cord-023095-4dannjjm	3712	28	3.2	3.2	CD
cord-023095-4dannjjm	3712	29	%	%	NN
cord-023095-4dannjjm	3712	30	)	)	-RRB-
cord-023095-4dannjjm	3713	1	Fila	Fila	NNP
cord-023095-4dannjjm	3713	2	Brasileiro	Brasileiro	NNP
cord-023095-4dannjjm	3713	3	and	and	CC
cord-023095-4dannjjm	3713	4	1	1	CD
cord-023095-4dannjjm	3713	5	(	(	-LRB-
cord-023095-4dannjjm	3713	6	3.2	3.2	CD
cord-023095-4dannjjm	3713	7	%	%	NN
cord-023095-4dannjjm	3713	8	)	)	-RRB-
cord-023095-4dannjjm	3714	1	Cocker	Cocker	NNP
cord-023095-4dannjjm	3714	2	spaniel	spaniel	NN
cord-023095-4dannjjm	3714	3	,	,	,
cord-023095-4dannjjm	3714	4	6	6	CD
cord-023095-4dannjjm	3714	5	(	(	-LRB-
cord-023095-4dannjjm	3714	6	16.3	16.3	CD
cord-023095-4dannjjm	3714	7	%	%	NN
cord-023095-4dannjjm	3714	8	)	)	-RRB-
cord-023095-4dannjjm	3714	9	were	be	VBD
cord-023095-4dannjjm	3714	10	of	of	IN
cord-023095-4dannjjm	3714	11	unknown	unknown	JJ
cord-023095-4dannjjm	3714	12	breed	breed	NN
cord-023095-4dannjjm	3714	13	.	.	.
cord-023095-4dannjjm	3715	1	Nineteen	nineteen	CD
cord-023095-4dannjjm	3715	2	(	(	-LRB-
cord-023095-4dannjjm	3715	3	51.4	51.4	CD
cord-023095-4dannjjm	3715	4	%	%	NN
cord-023095-4dannjjm	3715	5	)	)	-RRB-
cord-023095-4dannjjm	3715	6	of	of	IN
cord-023095-4dannjjm	3715	7	the	the	DT
cord-023095-4dannjjm	3715	8	thirty	thirty	CD
cord-023095-4dannjjm	3715	9	seven	seven	CD
cord-023095-4dannjjm	3715	10	dogs	dog	NNS
cord-023095-4dannjjm	3715	11	were	be	VBD
cord-023095-4dannjjm	3715	12	males	male	NNS
cord-023095-4dannjjm	3715	13	.	.	.
cord-023095-4dannjjm	3716	1	Twenty	twenty	CD
cord-023095-4dannjjm	3716	2	(	(	-LRB-
cord-023095-4dannjjm	3716	3	54.1	54.1	CD
cord-023095-4dannjjm	3716	4	%	%	NN
cord-023095-4dannjjm	3716	5	)	)	-RRB-
cord-023095-4dannjjm	3716	6	dogs	dog	NNS
cord-023095-4dannjjm	3716	7	were	be	VBD
cord-023095-4dannjjm	3716	8	4	4	CD
cord-023095-4dannjjm	3716	9	-	-	SYM
cord-023095-4dannjjm	3716	10	6	6	CD
cord-023095-4dannjjm	3716	11	years	year	NNS
cord-023095-4dannjjm	3716	12	old	old	JJ
cord-023095-4dannjjm	3716	13	.	.	.
cord-023095-4dannjjm	3717	1	In	in	IN
cord-023095-4dannjjm	3717	2	most	most	JJS
cord-023095-4dannjjm	3717	3	cases	case	NNS
cord-023095-4dannjjm	3717	4	,	,	,
cord-023095-4dannjjm	3717	5	dogs	dog	NNS
cord-023095-4dannjjm	3717	6	presented	present	VBN
cord-023095-4dannjjm	3717	7	with	with	IN
cord-023095-4dannjjm	3717	8	unilateral	unilateral	JJ
cord-023095-4dannjjm	3717	9	or	or	CC
cord-023095-4dannjjm	3717	10	bilateral	bilateral	JJ
cord-023095-4dannjjm	3717	11	ear	ear	NN
cord-023095-4dannjjm	3717	12	lesions	lesion	NNS
cord-023095-4dannjjm	3717	13	,	,	,
cord-023095-4dannjjm	3717	14	but	but	CC
cord-023095-4dannjjm	3717	15	rarely	rarely	RB
cord-023095-4dannjjm	3717	16	thoracic	thoracic	JJ
cord-023095-4dannjjm	3717	17	,	,	,
cord-023095-4dannjjm	3717	18	foot	foot	NN
cord-023095-4dannjjm	3717	19	and	and	CC
cord-023095-4dannjjm	3717	20	caudal	caudal	JJ
cord-023095-4dannjjm	3717	21	lesions	lesion	NNS
cord-023095-4dannjjm	3717	22	.	.	.
cord-023095-4dannjjm	3718	1	The	the	DT
cord-023095-4dannjjm	3718	2	animals	animal	NNS
cord-023095-4dannjjm	3718	3	were	be	VBD
cord-023095-4dannjjm	3718	4	successfully	successfully	RB
cord-023095-4dannjjm	3718	5	treated	treat	VBN
cord-023095-4dannjjm	3718	6	by	by	IN
cord-023095-4dannjjm	3718	7	use	use	NN
cord-023095-4dannjjm	3718	8	of	of	IN
cord-023095-4dannjjm	3718	9	rifampicin	rifampicin	NNS
cord-023095-4dannjjm	3718	10	orally	orally	RB
cord-023095-4dannjjm	3718	11	(	(	-LRB-
cord-023095-4dannjjm	3718	12	'	'	``
cord-023095-4dannjjm	3718	13	'	'	''
cord-023095-4dannjjm	3718	14	the	the	DT
cord-023095-4dannjjm	3718	15	brazilian	brazilian	JJ
cord-023095-4dannjjm	3718	16	protocol	protocol	NN
cord-023095-4dannjjm	3718	17	'	'	''
cord-023095-4dannjjm	3718	18	'	'	''
cord-023095-4dannjjm	3718	19	)	)	-RRB-
cord-023095-4dannjjm	3718	20	or	or	CC
cord-023095-4dannjjm	3718	21	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	3718	22	orally	orally	RB
cord-023095-4dannjjm	3718	23	and	and	CC
cord-023095-4dannjjm	3718	24	topical	topical	JJ
cord-023095-4dannjjm	3718	25	rifamicin	rifamicin	NNS
cord-023095-4dannjjm	3718	26	.	.	.
cord-023095-4dannjjm	3719	1	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3719	2	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3719	3	is	be	VBZ
cord-023095-4dannjjm	3719	4	being	be	VBG
cord-023095-4dannjjm	3719	5	recognized	recognize	VBN
cord-023095-4dannjjm	3719	6	more	more	RBR
cord-023095-4dannjjm	3719	7	frequently	frequently	RB
cord-023095-4dannjjm	3719	8	in	in	IN
cord-023095-4dannjjm	3719	9	dogs	dog	NNS
cord-023095-4dannjjm	3719	10	in	in	IN
cord-023095-4dannjjm	3719	11	endemic	endemic	JJ
cord-023095-4dannjjm	3719	12	areas	area	NNS
cord-023095-4dannjjm	3719	13	.	.	.
cord-023095-4dannjjm	3720	1	Currently	currently	RB
cord-023095-4dannjjm	3720	2	,	,	,
cord-023095-4dannjjm	3720	3	most	most	RBS
cord-023095-4dannjjm	3720	4	suspected	suspect	VBN
cord-023095-4dannjjm	3720	5	cases	case	NNS
cord-023095-4dannjjm	3720	6	are	be	VBP
cord-023095-4dannjjm	3720	7	evaluated	evaluate	VBN
cord-023095-4dannjjm	3720	8	for	for	IN
cord-023095-4dannjjm	3720	9	A.	a.	JJ
cord-023095-4dannjjm	3720	10	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3720	11	antibodies	antibody	NNS
cord-023095-4dannjjm	3720	12	by	by	IN
cord-023095-4dannjjm	3720	13	immunofluorescence	immunofluorescence	NN
cord-023095-4dannjjm	3720	14	assay	assay	NN
cord-023095-4dannjjm	3720	15	(	(	-LRB-
cord-023095-4dannjjm	3720	16	IFA	IFA	NNP
cord-023095-4dannjjm	3720	17	)	)	-RRB-
cord-023095-4dannjjm	3720	18	or	or	CC
cord-023095-4dannjjm	3720	19	ELISA	ELISA	NNP
cord-023095-4dannjjm	3720	20	.	.	.
cord-023095-4dannjjm	3721	1	Since	since	IN
cord-023095-4dannjjm	3721	2	A.	a.	NN
cord-023095-4dannjjm	3721	3	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3721	4	is	be	VBZ
cord-023095-4dannjjm	3721	5	an	an	DT
cord-023095-4dannjjm	3721	6	acute	acute	JJ
cord-023095-4dannjjm	3721	7	disease	disease	NN
cord-023095-4dannjjm	3721	8	,	,	,
cord-023095-4dannjjm	3721	9	detection	detection	NN
cord-023095-4dannjjm	3721	10	by	by	IN
cord-023095-4dannjjm	3721	11	antibody	antibody	NN
cord-023095-4dannjjm	3721	12	measurement	measurement	NN
cord-023095-4dannjjm	3721	13	may	may	MD
cord-023095-4dannjjm	3721	14	be	be	VB
cord-023095-4dannjjm	3721	15	negative	negative	JJ
cord-023095-4dannjjm	3721	16	on	on	IN
cord-023095-4dannjjm	3721	17	initial	initial	JJ
cord-023095-4dannjjm	3721	18	evaluation	evaluation	NN
cord-023095-4dannjjm	3721	19	.	.	.
cord-023095-4dannjjm	3722	1	It	-PRON-	PRP
cord-023095-4dannjjm	3722	2	is	be	VBZ
cord-023095-4dannjjm	3722	3	possible	possible	JJ
cord-023095-4dannjjm	3722	4	that	that	IN
cord-023095-4dannjjm	3722	5	A.	a.	NN
cord-023095-4dannjjm	3722	6	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3722	7	DNA	dna	NN
cord-023095-4dannjjm	3722	8	can	can	MD
cord-023095-4dannjjm	3722	9	be	be	VB
cord-023095-4dannjjm	3722	10	amplified	amplify	VBN
cord-023095-4dannjjm	3722	11	from	from	IN
cord-023095-4dannjjm	3722	12	blood	blood	NN
cord-023095-4dannjjm	3722	13	or	or	CC
cord-023095-4dannjjm	3722	14	synovial	synovial	JJ
cord-023095-4dannjjm	3722	15	fluid	fluid	NN
cord-023095-4dannjjm	3722	16	prior	prior	RB
cord-023095-4dannjjm	3722	17	to	to	IN
cord-023095-4dannjjm	3722	18	seroconversion	seroconversion	NN
cord-023095-4dannjjm	3722	19	.	.	.
cord-023095-4dannjjm	3723	1	Wild	wild	NN
cord-023095-4dannjjm	3723	2	caught	catch	VBD
cord-023095-4dannjjm	3723	3	Ixodes	Ixodes	NNP
cord-023095-4dannjjm	3723	4	scapularis	scapularis	JJ
cord-023095-4dannjjm	3723	5	adult	adult	NN
cord-023095-4dannjjm	3723	6	ticks	tick	NNS
cord-023095-4dannjjm	3723	7	from	from	IN
cord-023095-4dannjjm	3723	8	Rhode	Rhode	NNP
cord-023095-4dannjjm	3723	9	Island	Island	NNP
cord-023095-4dannjjm	3723	10	were	be	VBD
cord-023095-4dannjjm	3723	11	allowed	allow	VBN
cord-023095-4dannjjm	3723	12	to	to	TO
cord-023095-4dannjjm	3723	13	feed	feed	VB
cord-023095-4dannjjm	3723	14	on	on	IN
cord-023095-4dannjjm	3723	15	18	18	CD
cord-023095-4dannjjm	3723	16	young	young	JJ
cord-023095-4dannjjm	3723	17	adult	adult	NN
cord-023095-4dannjjm	3723	18	(	(	-LRB-
cord-023095-4dannjjm	3723	19	2	2	CD
cord-023095-4dannjjm	3723	20	-	-	SYM
cord-023095-4dannjjm	3723	21	3	3	CD
cord-023095-4dannjjm	3723	22	years	year	NNS
cord-023095-4dannjjm	3723	23	)	)	-RRB-
cord-023095-4dannjjm	3723	24	,	,	,
cord-023095-4dannjjm	3723	25	mixed	mixed	JJ
cord-023095-4dannjjm	3723	26	sex	sex	NN
cord-023095-4dannjjm	3723	27	beagles	beagle	NNS
cord-023095-4dannjjm	3723	28	for	for	IN
cord-023095-4dannjjm	3723	29	up	up	IN
cord-023095-4dannjjm	3723	30	to	to	TO
cord-023095-4dannjjm	3723	31	7	7	CD
cord-023095-4dannjjm	3723	32	days	day	NNS
cord-023095-4dannjjm	3723	33	.	.	.
cord-023095-4dannjjm	3724	1	Blood	blood	NN
cord-023095-4dannjjm	3724	2	(	(	-LRB-
cord-023095-4dannjjm	3724	3	weekly	weekly	NN
cord-023095-4dannjjm	3724	4	for	for	IN
cord-023095-4dannjjm	3724	5	12	12	CD
cord-023095-4dannjjm	3724	6	weeks	week	NNS
cord-023095-4dannjjm	3724	7	)	)	-RRB-
cord-023095-4dannjjm	3724	8	,	,	,
cord-023095-4dannjjm	3724	9	serum	serum	NN
cord-023095-4dannjjm	3724	10	(	(	-LRB-
cord-023095-4dannjjm	3724	11	weekly	weekly	NN
cord-023095-4dannjjm	3724	12	for	for	IN
cord-023095-4dannjjm	3724	13	12	12	CD
cord-023095-4dannjjm	3724	14	weeks	week	NNS
cord-023095-4dannjjm	3724	15	)	)	-RRB-
cord-023095-4dannjjm	3724	16	,	,	,
cord-023095-4dannjjm	3724	17	and	and	CC
cord-023095-4dannjjm	3724	18	synovial	synovial	JJ
cord-023095-4dannjjm	3724	19	fluid	fluid	NN
cord-023095-4dannjjm	3724	20	(	(	-LRB-
cord-023095-4dannjjm	3724	21	radiocarpal	radiocarpal	NNP
cord-023095-4dannjjm	3724	22	joint	joint	NN
cord-023095-4dannjjm	3724	23	;	;	:
cord-023095-4dannjjm	3724	24	alternating	alternate	VBG
cord-023095-4dannjjm	3724	25	arthrocentesis	arthrocentesis	NNP
cord-023095-4dannjjm	3724	26	weekly	weekly	NN
cord-023095-4dannjjm	3724	27	for	for	IN
cord-023095-4dannjjm	3724	28	6	6	CD
cord-023095-4dannjjm	3724	29	weeks	week	NNS
cord-023095-4dannjjm	3724	30	)	)	-RRB-
cord-023095-4dannjjm	3724	31	were	be	VBD
cord-023095-4dannjjm	3724	32	collected	collect	VBN
cord-023095-4dannjjm	3724	33	prior	prior	RB
cord-023095-4dannjjm	3724	34	to	to	TO
cord-023095-4dannjjm	3724	35	tick	tick	VB
cord-023095-4dannjjm	3724	36	attachment	attachment	NN
cord-023095-4dannjjm	3724	37	and	and	CC
cord-023095-4dannjjm	3724	38	then	then	RB
cord-023095-4dannjjm	3724	39	weekly	weekly	RB
cord-023095-4dannjjm	3724	40	after	after	IN
cord-023095-4dannjjm	3724	41	tick	tick	NN
cord-023095-4dannjjm	3724	42	attachment	attachment	NN
cord-023095-4dannjjm	3724	43	.	.	.
cord-023095-4dannjjm	3725	1	Joint	joint	JJ
cord-023095-4dannjjm	3725	2	fluid	fluid	JJ
cord-023095-4dannjjm	3725	3	cytology	cytology	NN
cord-023095-4dannjjm	3725	4	was	be	VBD
cord-023095-4dannjjm	3725	5	performed	perform	VBN
cord-023095-4dannjjm	3725	6	and	and	CC
cord-023095-4dannjjm	3725	7	total	total	JJ
cord-023095-4dannjjm	3725	8	DNA	DNA	NNP
cord-023095-4dannjjm	3725	9	was	be	VBD
cord-023095-4dannjjm	3725	10	extracted	extract	VBN
cord-023095-4dannjjm	3725	11	from	from	IN
cord-023095-4dannjjm	3725	12	blood	blood	NN
cord-023095-4dannjjm	3725	13	and	and	CC
cord-023095-4dannjjm	3725	14	synovial	synovial	JJ
cord-023095-4dannjjm	3725	15	fluid	fluid	NN
cord-023095-4dannjjm	3725	16	and	and	CC
cord-023095-4dannjjm	3725	17	assayed	assay	VBN
cord-023095-4dannjjm	3725	18	in	in	IN
cord-023095-4dannjjm	3725	19	a	a	DT
cord-023095-4dannjjm	3725	20	proprietary	proprietary	JJ
cord-023095-4dannjjm	3725	21	real	real	JJ
cord-023095-4dannjjm	3725	22	time	time	NN
cord-023095-4dannjjm	3725	23	PCR	pcr	NN
cord-023095-4dannjjm	3725	24	assay	assay	NN
cord-023095-4dannjjm	3725	25	(	(	-LRB-
cord-023095-4dannjjm	3725	26	FastPanel	FastPanel	NNP
cord-023095-4dannjjm	3725	27	TM	TM	NNP
cord-023095-4dannjjm	3725	28	)	)	-RRB-
cord-023095-4dannjjm	3725	29	that	that	WDT
cord-023095-4dannjjm	3725	30	amplifies	amplify	VBZ
cord-023095-4dannjjm	3725	31	the	the	DT
cord-023095-4dannjjm	3725	32	DNA	DNA	NNP
cord-023095-4dannjjm	3725	33	of	of	IN
cord-023095-4dannjjm	3725	34	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3725	35	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3725	36	,	,	,
cord-023095-4dannjjm	3725	37	A.	a.	NN
cord-023095-4dannjjm	3725	38	platys	platy	NNS
cord-023095-4dannjjm	3725	39	,	,	,
cord-023095-4dannjjm	3725	40	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3725	41	canis	canis	NN
cord-023095-4dannjjm	3725	42	,	,	,
cord-023095-4dannjjm	3725	43	E.	E.	NNP
cord-023095-4dannjjm	3725	44	chaffeensis	chaffeensis	NN
cord-023095-4dannjjm	3725	45	,	,	,
cord-023095-4dannjjm	3725	46	and	and	CC
cord-023095-4dannjjm	3725	47	E.	E.	NNP
cord-023095-4dannjjm	3725	48	ewingii	ewingii	NNP
cord-023095-4dannjjm	3725	49	.	.	.
cord-023095-4dannjjm	3726	1	Serum	serum	NN
cord-023095-4dannjjm	3726	2	was	be	VBD
cord-023095-4dannjjm	3726	3	assayed	assay	VBN
cord-023095-4dannjjm	3726	4	for	for	IN
cord-023095-4dannjjm	3726	5	A.	a.	JJ
cord-023095-4dannjjm	3726	6	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3726	7	antibodies	antibody	NNS
cord-023095-4dannjjm	3726	8	by	by	IN
cord-023095-4dannjjm	3726	9	IFA	IFA	NNP
cord-023095-4dannjjm	3726	10	.	.	.
cord-023095-4dannjjm	3727	1	Time	time	NN
cord-023095-4dannjjm	3727	2	to	to	IN
cord-023095-4dannjjm	3727	3	first	first	JJ
cord-023095-4dannjjm	3727	4	positive	positive	JJ
cord-023095-4dannjjm	3727	5	results	result	NNS
cord-023095-4dannjjm	3727	6	for	for	IN
cord-023095-4dannjjm	3727	7	serology	serology	NN
cord-023095-4dannjjm	3727	8	and	and	CC
cord-023095-4dannjjm	3727	9	PCR	PCR	NNP
cord-023095-4dannjjm	3727	10	were	be	VBD
cord-023095-4dannjjm	3727	11	compared	compare	VBN
cord-023095-4dannjjm	3727	12	by	by	IN
cord-023095-4dannjjm	3727	13	paired	pair	VBN
cord-023095-4dannjjm	3727	14	Student	Student	NNP
cord-023095-4dannjjm	3727	15	's	's	POS
cord-023095-4dannjjm	3727	16	t	t	NN
cord-023095-4dannjjm	3727	17	test	test	NN
cord-023095-4dannjjm	3727	18	.	.	.
cord-023095-4dannjjm	3728	1	None	none	NN
cord-023095-4dannjjm	3728	2	of	of	IN
cord-023095-4dannjjm	3728	3	the	the	DT
cord-023095-4dannjjm	3728	4	beagles	beagle	NNS
cord-023095-4dannjjm	3728	5	developed	develop	VBD
cord-023095-4dannjjm	3728	6	clinical	clinical	JJ
cord-023095-4dannjjm	3728	7	evidence	evidence	NN
cord-023095-4dannjjm	3728	8	of	of	IN
cord-023095-4dannjjm	3728	9	disease	disease	NN
cord-023095-4dannjjm	3728	10	,	,	,
cord-023095-4dannjjm	3728	11	and	and	CC
cord-023095-4dannjjm	3728	12	no	no	DT
cord-023095-4dannjjm	3728	13	major	major	JJ
cord-023095-4dannjjm	3728	14	changes	change	NNS
cord-023095-4dannjjm	3728	15	in	in	IN
cord-023095-4dannjjm	3728	16	synovial	synovial	JJ
cord-023095-4dannjjm	3728	17	fluid	fluid	NN
cord-023095-4dannjjm	3728	18	cytology	cytology	NN
cord-023095-4dannjjm	3728	19	were	be	VBD
cord-023095-4dannjjm	3728	20	detected	detect	VBN
cord-023095-4dannjjm	3728	21	over	over	IN
cord-023095-4dannjjm	3728	22	time	time	NN
cord-023095-4dannjjm	3728	23	.	.	.
cord-023095-4dannjjm	3729	1	Of	of	IN
cord-023095-4dannjjm	3729	2	the	the	DT
cord-023095-4dannjjm	3729	3	18	18	CD
cord-023095-4dannjjm	3729	4	beagles	beagle	NNS
cord-023095-4dannjjm	3729	5	,	,	,
cord-023095-4dannjjm	3729	6	15	15	CD
cord-023095-4dannjjm	3729	7	were	be	VBD
cord-023095-4dannjjm	3729	8	positive	positive	JJ
cord-023095-4dannjjm	3729	9	for	for	IN
cord-023095-4dannjjm	3729	10	A.	a.	NN
cord-023095-4dannjjm	3729	11	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3729	12	DNA	dna	NN
cord-023095-4dannjjm	3729	13	in	in	IN
cord-023095-4dannjjm	3729	14	blood	blood	NN
cord-023095-4dannjjm	3729	15	or	or	CC
cord-023095-4dannjjm	3729	16	synovial	synovial	JJ
cord-023095-4dannjjm	3729	17	fluid	fluid	NN
cord-023095-4dannjjm	3729	18	or	or	CC
cord-023095-4dannjjm	3729	19	IFA	IFA	NNP
cord-023095-4dannjjm	3730	1	antibodies	antibody	NNS
cord-023095-4dannjjm	3730	2	in	in	IN
cord-023095-4dannjjm	3730	3	at	at	RB
cord-023095-4dannjjm	3730	4	least	least	RBS
cord-023095-4dannjjm	3730	5	one	one	CD
cord-023095-4dannjjm	3730	6	sample	sample	NN
cord-023095-4dannjjm	3730	7	after	after	IN
cord-023095-4dannjjm	3730	8	tick	tick	NN
cord-023095-4dannjjm	3730	9	attachment	attachment	NN
cord-023095-4dannjjm	3730	10	.	.	.
cord-023095-4dannjjm	3731	1	Antibody	antibody	NN
cord-023095-4dannjjm	3731	2	titers	titer	NNS
cord-023095-4dannjjm	3731	3	appeared	appear	VBD
cord-023095-4dannjjm	3731	4	in	in	IN
cord-023095-4dannjjm	3731	5	14	14	CD
cord-023095-4dannjjm	3731	6	of	of	IN
cord-023095-4dannjjm	3731	7	15	15	CD
cord-023095-4dannjjm	3731	8	dogs	dog	NNS
cord-023095-4dannjjm	3731	9	from	from	IN
cord-023095-4dannjjm	3731	10	weeks	week	NNS
cord-023095-4dannjjm	3731	11	2	2	CD
cord-023095-4dannjjm	3731	12	to	to	IN
cord-023095-4dannjjm	3731	13	12	12	CD
cord-023095-4dannjjm	3731	14	(	(	-LRB-
cord-023095-4dannjjm	3731	15	median	median	NN
cord-023095-4dannjjm	3731	16	to	to	IN
cord-023095-4dannjjm	3731	17	1	1	CD
cord-023095-4dannjjm	3731	18	st	st	NNP
cord-023095-4dannjjm	3731	19	positive	positive	JJ
cord-023095-4dannjjm	3731	20	5	5	CD
cord-023095-4dannjjm	3731	21	3	3	CD
cord-023095-4dannjjm	3731	22	weeks	week	NNS
cord-023095-4dannjjm	3731	23	AE	AE	NNP
cord-023095-4dannjjm	3731	24	1	1	CD
cord-023095-4dannjjm	3731	25	)	)	-RRB-
cord-023095-4dannjjm	3731	26	.	.	.
cord-023095-4dannjjm	3732	1	Titer	titer	NN
cord-023095-4dannjjm	3732	2	magnitude	magnitude	NN
cord-023095-4dannjjm	3732	3	ranged	range	VBD
cord-023095-4dannjjm	3732	4	from	from	IN
cord-023095-4dannjjm	3732	5	1:40	1:40	CD
cord-023095-4dannjjm	3732	6	to	to	IN
cord-023095-4dannjjm	3732	7	1:10,240	1:10,240	CD
cord-023095-4dannjjm	3732	8	.	.	.
cord-023095-4dannjjm	3733	1	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3733	2	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3733	3	DNA	DNA	NNP
cord-023095-4dannjjm	3733	4	was	be	VBD
cord-023095-4dannjjm	3733	5	amplified	amplify	VBN
cord-023095-4dannjjm	3733	6	from	from	IN
cord-023095-4dannjjm	3733	7	the	the	DT
cord-023095-4dannjjm	3733	8	blood	blood	NN
cord-023095-4dannjjm	3733	9	of	of	IN
cord-023095-4dannjjm	3733	10	14	14	CD
cord-023095-4dannjjm	3733	11	of	of	IN
cord-023095-4dannjjm	3733	12	15	15	CD
cord-023095-4dannjjm	3733	13	dogs	dog	NNS
cord-023095-4dannjjm	3733	14	with	with	IN
cord-023095-4dannjjm	3733	15	positive	positive	JJ
cord-023095-4dannjjm	3733	16	test	test	NN
cord-023095-4dannjjm	3733	17	results	result	NNS
cord-023095-4dannjjm	3733	18	ranging	range	VBG
cord-023095-4dannjjm	3733	19	from	from	IN
cord-023095-4dannjjm	3733	20	1	1	CD
cord-023095-4dannjjm	3733	21	to	to	TO
cord-023095-4dannjjm	3733	22	12	12	CD
cord-023095-4dannjjm	3733	23	weeks	week	NNS
cord-023095-4dannjjm	3733	24	(	(	-LRB-
cord-023095-4dannjjm	3733	25	median	median	NN
cord-023095-4dannjjm	3733	26	to	to	IN
cord-023095-4dannjjm	3733	27	1	1	CD
cord-023095-4dannjjm	3733	28	st	st	NNP
cord-023095-4dannjjm	3733	29	positive	positive	JJ
cord-023095-4dannjjm	3733	30	5	5	CD
cord-023095-4dannjjm	3733	31	2	2	CD
cord-023095-4dannjjm	3733	32	weeks	week	NNS
cord-023095-4dannjjm	3733	33	AE	AE	NNP
cord-023095-4dannjjm	3733	34	1.5	1.5	CD
cord-023095-4dannjjm	3733	35	)	)	-RRB-
cord-023095-4dannjjm	3733	36	.	.	.
cord-023095-4dannjjm	3734	1	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3734	2	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3734	3	DNA	DNA	NNP
cord-023095-4dannjjm	3734	4	was	be	VBD
cord-023095-4dannjjm	3734	5	amplified	amplify	VBN
cord-023095-4dannjjm	3734	6	from	from	IN
cord-023095-4dannjjm	3734	7	synovial	synovial	JJ
cord-023095-4dannjjm	3734	8	fluid	fluid	NN
cord-023095-4dannjjm	3734	9	from	from	IN
cord-023095-4dannjjm	3734	10	8	8	CD
cord-023095-4dannjjm	3734	11	of	of	IN
cord-023095-4dannjjm	3734	12	15	15	CD
cord-023095-4dannjjm	3734	13	dogs	dog	NNS
cord-023095-4dannjjm	3734	14	between	between	IN
cord-023095-4dannjjm	3734	15	weeks	week	NNS
cord-023095-4dannjjm	3734	16	1	1	CD
cord-023095-4dannjjm	3734	17	to	to	IN
cord-023095-4dannjjm	3734	18	4	4	CD
cord-023095-4dannjjm	3734	19	(	(	-LRB-
cord-023095-4dannjjm	3734	20	median	median	NN
cord-023095-4dannjjm	3734	21	to	to	IN
cord-023095-4dannjjm	3734	22	1	1	CD
cord-023095-4dannjjm	3734	23	st	st	NNP
cord-023095-4dannjjm	3734	24	positive	positive	JJ
cord-023095-4dannjjm	3734	25	5	5	CD
cord-023095-4dannjjm	3734	26	4	4	CD
cord-023095-4dannjjm	3734	27	weeks	week	NNS
cord-023095-4dannjjm	3734	28	AE	AE	NNP
cord-023095-4dannjjm	3734	29	1	1	CD
cord-023095-4dannjjm	3734	30	)	)	-RRB-
cord-023095-4dannjjm	3734	31	.	.	.
cord-023095-4dannjjm	3735	1	Of	of	IN
cord-023095-4dannjjm	3735	2	the	the	DT
cord-023095-4dannjjm	3735	3	8	8	CD
cord-023095-4dannjjm	3735	4	dogs	dog	NNS
cord-023095-4dannjjm	3735	5	,	,	,
cord-023095-4dannjjm	3735	6	7	7	CD
cord-023095-4dannjjm	3735	7	were	be	VBD
cord-023095-4dannjjm	3735	8	PCR	PCR	NNP
cord-023095-4dannjjm	3735	9	positive	positive	JJ
cord-023095-4dannjjm	3735	10	for	for	IN
cord-023095-4dannjjm	3735	11	only	only	RB
cord-023095-4dannjjm	3735	12	one	one	CD
cord-023095-4dannjjm	3735	13	week	week	NN
cord-023095-4dannjjm	3735	14	and	and	CC
cord-023095-4dannjjm	3735	15	1	1	CD
cord-023095-4dannjjm	3735	16	dog	dog	NN
cord-023095-4dannjjm	3735	17	was	be	VBD
cord-023095-4dannjjm	3735	18	PCR	PCR	NNP
cord-023095-4dannjjm	3735	19	positive	positive	JJ
cord-023095-4dannjjm	3735	20	for	for	IN
cord-023095-4dannjjm	3735	21	two	two	CD
cord-023095-4dannjjm	3735	22	consecutive	consecutive	JJ
cord-023095-4dannjjm	3735	23	weeks	week	NNS
cord-023095-4dannjjm	3735	24	.	.	.
cord-023095-4dannjjm	3736	1	Of	of	IN
cord-023095-4dannjjm	3736	2	the	the	DT
cord-023095-4dannjjm	3736	3	15	15	CD
cord-023095-4dannjjm	3736	4	dogs	dog	NNS
cord-023095-4dannjjm	3736	5	,	,	,
cord-023095-4dannjjm	3736	6	13	13	CD
cord-023095-4dannjjm	3736	7	were	be	VBD
cord-023095-4dannjjm	3736	8	positive	positive	JJ
cord-023095-4dannjjm	3736	9	for	for	IN
cord-023095-4dannjjm	3736	10	A.	a.	NN
cord-023095-4dannjjm	3736	11	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3736	12	in	in	IN
cord-023095-4dannjjm	3736	13	both	both	CC
cord-023095-4dannjjm	3736	14	blood	blood	NN
cord-023095-4dannjjm	3736	15	and	and	CC
cord-023095-4dannjjm	3736	16	joints	joint	NNS
cord-023095-4dannjjm	3736	17	by	by	IN
cord-023095-4dannjjm	3736	18	DNA	dna	NN
cord-023095-4dannjjm	3736	19	analysis	analysis	NN
cord-023095-4dannjjm	3736	20	.	.	.
cord-023095-4dannjjm	3737	1	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3737	2	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3737	3	DNA	DNA	NNP
cord-023095-4dannjjm	3737	4	was	be	VBD
cord-023095-4dannjjm	3737	5	amplified	amplify	VBN
cord-023095-4dannjjm	3737	6	from	from	IN
cord-023095-4dannjjm	3737	7	blood	blood	NN
cord-023095-4dannjjm	3737	8	more	more	RBR
cord-023095-4dannjjm	3737	9	quickly	quickly	RB
cord-023095-4dannjjm	3737	10	than	than	IN
cord-023095-4dannjjm	3737	11	seroconversion	seroconversion	NN
cord-023095-4dannjjm	3737	12	was	be	VBD
cord-023095-4dannjjm	3737	13	detected	detect	VBN
cord-023095-4dannjjm	3737	14	by	by	IN
cord-023095-4dannjjm	3737	15	IFA	IFA	NNP
cord-023095-4dannjjm	3737	16	antibody	antibody	NN
cord-023095-4dannjjm	3737	17	titer	titer	NN
cord-023095-4dannjjm	3737	18	(	(	-LRB-
cord-023095-4dannjjm	3737	19	t	t	NN
cord-023095-4dannjjm	3737	20	5	5	CD
cord-023095-4dannjjm	3737	21	À3.4	À3.4	NNP
cord-023095-4dannjjm	3737	22	,	,	,
cord-023095-4dannjjm	3737	23	P	p	NN
cord-023095-4dannjjm	3737	24	o	o	NN
cord-023095-4dannjjm	3737	25	0.01	0.01	CD
cord-023095-4dannjjm	3737	26	)	)	-RRB-
cord-023095-4dannjjm	3737	27	or	or	CC
cord-023095-4dannjjm	3737	28	DNA	DNA	NNP
cord-023095-4dannjjm	3737	29	was	be	VBD
cord-023095-4dannjjm	3737	30	amplified	amplify	VBN
cord-023095-4dannjjm	3737	31	from	from	IN
cord-023095-4dannjjm	3737	32	synovial	synovial	JJ
cord-023095-4dannjjm	3737	33	fluid	fluid	NN
cord-023095-4dannjjm	3737	34	(	(	-LRB-
cord-023095-4dannjjm	3737	35	t	t	NN
cord-023095-4dannjjm	3737	36	5	5	CD
cord-023095-4dannjjm	3737	37	5.4	5.4	CD
cord-023095-4dannjjm	3737	38	,	,	,
cord-023095-4dannjjm	3737	39	P	p	NN
cord-023095-4dannjjm	3737	40	o	o	NN
cord-023095-4dannjjm	3737	41	0.001	0.001	CD
cord-023095-4dannjjm	3737	42	)	)	-RRB-
cord-023095-4dannjjm	3737	43	.	.	.
cord-023095-4dannjjm	3738	1	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3738	2	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3738	3	DNA	dna	NN
cord-023095-4dannjjm	3738	4	can	can	MD
cord-023095-4dannjjm	3738	5	be	be	VB
cord-023095-4dannjjm	3738	6	amplified	amplify	VBN
cord-023095-4dannjjm	3738	7	from	from	IN
cord-023095-4dannjjm	3738	8	the	the	DT
cord-023095-4dannjjm	3738	9	blood	blood	NN
cord-023095-4dannjjm	3738	10	prior	prior	RB
cord-023095-4dannjjm	3738	11	to	to	IN
cord-023095-4dannjjm	3738	12	development	development	NN
cord-023095-4dannjjm	3738	13	of	of	IN
cord-023095-4dannjjm	3738	14	detectable	detectable	JJ
cord-023095-4dannjjm	3738	15	antibody	antibody	NN
cord-023095-4dannjjm	3738	16	titers	titer	NNS
cord-023095-4dannjjm	3738	17	by	by	IN
cord-023095-4dannjjm	3738	18	IFA	IFA	NNP
cord-023095-4dannjjm	3738	19	.	.	.
cord-023095-4dannjjm	3739	1	Amplification	amplification	NN
cord-023095-4dannjjm	3739	2	of	of	IN
cord-023095-4dannjjm	3739	3	A.	a.	JJ
cord-023095-4dannjjm	3739	4	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3739	5	DNA	dna	NN
cord-023095-4dannjjm	3739	6	from	from	IN
cord-023095-4dannjjm	3739	7	synovial	synovial	JJ
cord-023095-4dannjjm	3739	8	fluid	fluid	NN
cord-023095-4dannjjm	3739	9	does	do	VBZ
cord-023095-4dannjjm	3739	10	not	not	RB
cord-023095-4dannjjm	3739	11	occur	occur	VB
cord-023095-4dannjjm	3739	12	in	in	IN
cord-023095-4dannjjm	3739	13	all	all	DT
cord-023095-4dannjjm	3739	14	dogs	dog	NNS
cord-023095-4dannjjm	3739	15	,	,	,
cord-023095-4dannjjm	3739	16	appears	appear	VBZ
cord-023095-4dannjjm	3739	17	to	to	TO
cord-023095-4dannjjm	3739	18	be	be	VB
cord-023095-4dannjjm	3739	19	transient	transient	JJ
cord-023095-4dannjjm	3739	20	in	in	IN
cord-023095-4dannjjm	3739	21	most	most	JJS
cord-023095-4dannjjm	3739	22	dogs	dog	NNS
cord-023095-4dannjjm	3739	23	,	,	,
cord-023095-4dannjjm	3739	24	and	and	CC
cord-023095-4dannjjm	3739	25	a	a	DT
cord-023095-4dannjjm	3739	26	negative	negative	JJ
cord-023095-4dannjjm	3739	27	test	test	NN
cord-023095-4dannjjm	3739	28	result	result	NN
cord-023095-4dannjjm	3739	29	does	do	VBZ
cord-023095-4dannjjm	3739	30	not	not	RB
cord-023095-4dannjjm	3739	31	preclude	preclude	VB
cord-023095-4dannjjm	3739	32	a	a	DT
cord-023095-4dannjjm	3739	33	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3739	34	of	of	IN
cord-023095-4dannjjm	3739	35	A.	a.	JJ
cord-023095-4dannjjm	3739	36	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3739	37	infection	infection	NN
cord-023095-4dannjjm	3739	38	.	.	.
cord-023095-4dannjjm	3740	1	Canine	canine	JJ
cord-023095-4dannjjm	3740	2	granulocytic	granulocytic	JJ
cord-023095-4dannjjm	3740	3	anaplasmosis	anaplasmosis	NN
cord-023095-4dannjjm	3740	4	and	and	CC
cord-023095-4dannjjm	3740	5	granulocytic	granulocytic	NNP
cord-023095-4dannjjm	3740	6	ehrlichiosis	ehrlichiosis	NNP
cord-023095-4dannjjm	3740	7	are	be	VBP
cord-023095-4dannjjm	3740	8	tick	tick	NN
cord-023095-4dannjjm	3740	9	-	-	HYPH
cord-023095-4dannjjm	3740	10	transmitted	transmit	VBN
cord-023095-4dannjjm	3740	11	infections	infection	NNS
cord-023095-4dannjjm	3740	12	caused	cause	VBN
cord-023095-4dannjjm	3740	13	by	by	IN
cord-023095-4dannjjm	3740	14	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3740	15	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3740	16	(	(	-LRB-
cord-023095-4dannjjm	3740	17	Aph	Aph	NNP
cord-023095-4dannjjm	3740	18	)	)	-RRB-
cord-023095-4dannjjm	3740	19	and	and	CC
cord-023095-4dannjjm	3740	20	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3740	21	ewingii	ewingii	NNS
cord-023095-4dannjjm	3740	22	(	(	-LRB-
cord-023095-4dannjjm	3740	23	Eew	Eew	NNP
cord-023095-4dannjjm	3740	24	)	)	-RRB-
cord-023095-4dannjjm	3740	25	,	,	,
cord-023095-4dannjjm	3740	26	respectively	respectively	RB
cord-023095-4dannjjm	3740	27	.	.	.
cord-023095-4dannjjm	3741	1	Both	both	DT
cord-023095-4dannjjm	3741	2	organisms	organism	NNS
cord-023095-4dannjjm	3741	3	induce	induce	VBP
cord-023095-4dannjjm	3741	4	an	an	DT
cord-023095-4dannjjm	3741	5	acute	acute	JJ
cord-023095-4dannjjm	3741	6	clinical	clinical	JJ
cord-023095-4dannjjm	3741	7	disease	disease	NN
cord-023095-4dannjjm	3741	8	,	,	,
cord-023095-4dannjjm	3741	9	frequently	frequently	RB
cord-023095-4dannjjm	3741	10	accompanied	accompany	VBN
cord-023095-4dannjjm	3741	11	by	by	IN
cord-023095-4dannjjm	3741	12	fever	fever	NN
cord-023095-4dannjjm	3741	13	,	,	,
cord-023095-4dannjjm	3741	14	polyarthropathy	polyarthropathy	NNP
cord-023095-4dannjjm	3741	15	and	and	CC
cord-023095-4dannjjm	3741	16	thrombocytopenia	thrombocytopenia	NN
cord-023095-4dannjjm	3741	17	.	.	.
cord-023095-4dannjjm	3742	1	However	however	RB
cord-023095-4dannjjm	3742	2	,	,	,
cord-023095-4dannjjm	3742	3	Aph	Aph	NNP
cord-023095-4dannjjm	3742	4	and	and	CC
cord-023095-4dannjjm	3742	5	Eew	Eew	NNP
cord-023095-4dannjjm	3742	6	have	have	VBP
cord-023095-4dannjjm	3742	7	different	different	JJ
cord-023095-4dannjjm	3742	8	tick	tick	NN
cord-023095-4dannjjm	3742	9	vectors	vector	NNS
cord-023095-4dannjjm	3742	10	,	,	,
cord-023095-4dannjjm	3742	11	i.e.	i.e.	FW
cord-023095-4dannjjm	3742	12	Ixodes	Ixodes	NNP
cord-023095-4dannjjm	3742	13	scapularis	scapularis	NN
cord-023095-4dannjjm	3742	14	and	and	CC
cord-023095-4dannjjm	3742	15	Ambylomma	Ambylomma	NNP
cord-023095-4dannjjm	3742	16	americanum	americanum	NN
cord-023095-4dannjjm	3742	17	,	,	,
cord-023095-4dannjjm	3742	18	respectively	respectively	RB
cord-023095-4dannjjm	3742	19	,	,	,
cord-023095-4dannjjm	3742	20	with	with	IN
cord-023095-4dannjjm	3742	21	different	different	JJ
cord-023095-4dannjjm	3742	22	,	,	,
cord-023095-4dannjjm	3742	23	but	but	CC
cord-023095-4dannjjm	3742	24	overlapping	overlap	VBG
cord-023095-4dannjjm	3742	25	geographic	geographic	JJ
cord-023095-4dannjjm	3742	26	distributions	distribution	NNS
cord-023095-4dannjjm	3742	27	.	.	.
cord-023095-4dannjjm	3743	1	In	in	IN
cord-023095-4dannjjm	3743	2	addition	addition	NN
cord-023095-4dannjjm	3743	3	,	,	,
cord-023095-4dannjjm	3743	4	infection	infection	NN
cord-023095-4dannjjm	3743	5	outcome	outcome	NN
cord-023095-4dannjjm	3743	6	may	may	MD
cord-023095-4dannjjm	3743	7	be	be	VB
cord-023095-4dannjjm	3743	8	affected	affect	VBN
cord-023095-4dannjjm	3743	9	by	by	IN
cord-023095-4dannjjm	3743	10	other	other	JJ
cord-023095-4dannjjm	3743	11	regional	regional	JJ
cord-023095-4dannjjm	3743	12	ticktransmitted	ticktransmitte	VBN
cord-023095-4dannjjm	3743	13	pathogens	pathogen	NNS
cord-023095-4dannjjm	3743	14	,	,	,
cord-023095-4dannjjm	3743	15	such	such	JJ
cord-023095-4dannjjm	3743	16	as	as	IN
cord-023095-4dannjjm	3743	17	Borrelia	Borrelia	NNP
cord-023095-4dannjjm	3743	18	burgdorferi	burgdorferi	NN
cord-023095-4dannjjm	3743	19	(	(	-LRB-
cord-023095-4dannjjm	3743	20	MN	MN	NNP
cord-023095-4dannjjm	3743	21	)	)	-RRB-
cord-023095-4dannjjm	3743	22	or	or	CC
cord-023095-4dannjjm	3743	23	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3743	24	chaffeensis	chaffeensis	NN
cord-023095-4dannjjm	3743	25	(	(	-LRB-
cord-023095-4dannjjm	3743	26	AR	AR	NNP
cord-023095-4dannjjm	3743	27	)	)	-RRB-
cord-023095-4dannjjm	3743	28	.	.	.
cord-023095-4dannjjm	3744	1	Therefore	therefore	RB
cord-023095-4dannjjm	3744	2	,	,	,
cord-023095-4dannjjm	3744	3	we	-PRON-	PRP
cord-023095-4dannjjm	3744	4	compared	compare	VBD
cord-023095-4dannjjm	3744	5	serology	serology	NN
cord-023095-4dannjjm	3744	6	and	and	CC
cord-023095-4dannjjm	3744	7	PCR	PCR	NNP
cord-023095-4dannjjm	3744	8	results	result	NNS
cord-023095-4dannjjm	3744	9	derived	derive	VBN
cord-023095-4dannjjm	3744	10	from	from	IN
cord-023095-4dannjjm	3744	11	dogs	dog	NNS
cord-023095-4dannjjm	3744	12	examined	examine	VBD
cord-023095-4dannjjm	3744	13	at	at	IN
cord-023095-4dannjjm	3744	14	two	two	CD
cord-023095-4dannjjm	3744	15	private	private	JJ
cord-023095-4dannjjm	3744	16	practices	practice	NNS
cord-023095-4dannjjm	3744	17	located	locate	VBN
cord-023095-4dannjjm	3744	18	in	in	IN
cord-023095-4dannjjm	3744	19	highly	highly	RB
cord-023095-4dannjjm	3744	20	endemic	endemic	JJ
cord-023095-4dannjjm	3744	21	areas	area	NNS
cord-023095-4dannjjm	3744	22	for	for	IN
cord-023095-4dannjjm	3744	23	either	either	CC
cord-023095-4dannjjm	3744	24	Aph	Aph	NNP
cord-023095-4dannjjm	3744	25	or	or	CC
cord-023095-4dannjjm	3744	26	Eew	Eew	NNP
cord-023095-4dannjjm	3744	27	.	.	.
cord-023095-4dannjjm	3745	1	Serum	serum	NN
cord-023095-4dannjjm	3745	2	collected	collect	VBN
cord-023095-4dannjjm	3745	3	between	between	IN
cord-023095-4dannjjm	3745	4	April	April	NNP
cord-023095-4dannjjm	3745	5	-	-	HYPH
cord-023095-4dannjjm	3745	6	December	December	NNP
cord-023095-4dannjjm	3745	7	,	,	,
cord-023095-4dannjjm	3745	8	2005	2005	CD
cord-023095-4dannjjm	3745	9	from	from	IN
cord-023095-4dannjjm	3745	10	Minnesota	Minnesota	NNP
cord-023095-4dannjjm	3745	11	dogs	dog	NNS
cord-023095-4dannjjm	3745	12	(	(	-LRB-
cord-023095-4dannjjm	3745	13	n	n	NN
cord-023095-4dannjjm	3745	14	5	5	CD
cord-023095-4dannjjm	3745	15	420	420	CD
cord-023095-4dannjjm	3745	16	)	)	-RRB-
cord-023095-4dannjjm	3745	17	was	be	VBD
cord-023095-4dannjjm	3745	18	tested	test	VBN
cord-023095-4dannjjm	3745	19	by	by	IN
cord-023095-4dannjjm	3745	20	SNAP	SNAP	NNP
cord-023095-4dannjjm	3745	21	s	s	NNP
cord-023095-4dannjjm	3745	22	4Dx	4dx	JJ
cord-023095-4dannjjm	3745	23	s	s	NNS
cord-023095-4dannjjm	3745	24	and	and	CC
cord-023095-4dannjjm	3745	25	whole	whole	JJ
cord-023095-4dannjjm	3745	26	blood	blood	NN
cord-023095-4dannjjm	3745	27	was	be	VBD
cord-023095-4dannjjm	3745	28	tested	test	VBN
cord-023095-4dannjjm	3745	29	by	by	IN
cord-023095-4dannjjm	3745	30	Aph	Aph	NNP
cord-023095-4dannjjm	3745	31	PCR	PCR	NNP
cord-023095-4dannjjm	3745	32	.	.	.
cord-023095-4dannjjm	3746	1	Serum	serum	NN
cord-023095-4dannjjm	3746	2	collected	collect	VBN
cord-023095-4dannjjm	3746	3	from	from	IN
cord-023095-4dannjjm	3746	4	Arkansas	Arkansas	NNP
cord-023095-4dannjjm	3746	5	dogs	dog	NNS
cord-023095-4dannjjm	3746	6	(	(	-LRB-
cord-023095-4dannjjm	3746	7	n	n	NN
cord-023095-4dannjjm	3746	8	5	5	CD
cord-023095-4dannjjm	3746	9	708	708	CD
cord-023095-4dannjjm	3746	10	)	)	-RRB-
cord-023095-4dannjjm	3746	11	for	for	IN
cord-023095-4dannjjm	3746	12	1	1	CD
cord-023095-4dannjjm	3746	13	year	year	NN
cord-023095-4dannjjm	3746	14	beginning	beginning	NN
cord-023095-4dannjjm	3746	15	in	in	IN
cord-023095-4dannjjm	3746	16	August	August	NNP
cord-023095-4dannjjm	3746	17	2009	2009	CD
cord-023095-4dannjjm	3746	18	was	be	VBD
cord-023095-4dannjjm	3746	19	tested	test	VBN
cord-023095-4dannjjm	3746	20	using	use	VBG
cord-023095-4dannjjm	3746	21	microtiter	microtiter	NN
cord-023095-4dannjjm	3746	22	plate	plate	NN
cord-023095-4dannjjm	3746	23	ELISAs	elisa	NNS
cord-023095-4dannjjm	3746	24	for	for	IN
cord-023095-4dannjjm	3746	25	antibodies	antibody	NNS
cord-023095-4dannjjm	3746	26	to	to	IN
cord-023095-4dannjjm	3746	27	Eew	Eew	NNP
cord-023095-4dannjjm	3746	28	,	,	,
cord-023095-4dannjjm	3746	29	E.	E.	NNP
cord-023095-4dannjjm	3746	30	canis	canis	NNP
cord-023095-4dannjjm	3746	31	,	,	,
cord-023095-4dannjjm	3746	32	and	and	CC
cord-023095-4dannjjm	3746	33	E.	E.	NNP
cord-023095-4dannjjm	3746	34	chaffeensis	chaffeensis	FW
cord-023095-4dannjjm	3746	35	(	(	-LRB-
cord-023095-4dannjjm	3746	36	Ech	Ech	NNP
cord-023095-4dannjjm	3746	37	)	)	-RRB-
cord-023095-4dannjjm	3746	38	while	while	IN
cord-023095-4dannjjm	3746	39	whole	whole	JJ
cord-023095-4dannjjm	3746	40	blood	blood	NN
cord-023095-4dannjjm	3746	41	was	be	VBD
cord-023095-4dannjjm	3746	42	tested	test	VBN
cord-023095-4dannjjm	3746	43	by	by	IN
cord-023095-4dannjjm	3746	44	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3746	45	PCR	PCR	NNP
cord-023095-4dannjjm	3746	46	.	.	.
cord-023095-4dannjjm	3747	1	Comparisons	comparison	NNS
cord-023095-4dannjjm	3747	2	were	be	VBD
cord-023095-4dannjjm	3747	3	evaluated	evaluate	VBN
cord-023095-4dannjjm	3747	4	using	use	VBG
cord-023095-4dannjjm	3747	5	Chi	Chi	NNP
cord-023095-4dannjjm	3747	6	Square	Square	NNP
cord-023095-4dannjjm	3747	7	(	(	-LRB-
cord-023095-4dannjjm	3747	8	Ã	Ã	NNP
cord-023095-4dannjjm	3747	9	)	)	-RRB-
cord-023095-4dannjjm	3747	10	and	and	CC
cord-023095-4dannjjm	3747	11	Binomial	Binomial	NNP
cord-023095-4dannjjm	3747	12	(	(	-LRB-
cord-023095-4dannjjm	3747	13	w	w	NN
cord-023095-4dannjjm	3747	14	)	)	-RRB-
cord-023095-4dannjjm	3747	15	tests	test	VBZ
cord-023095-4dannjjm	3747	16	with	with	IN
cord-023095-4dannjjm	3747	17	an	an	DT
cord-023095-4dannjjm	3747	18	alpha	alpha	NN
cord-023095-4dannjjm	3747	19	of	of	IN
cord-023095-4dannjjm	3747	20	5	5	CD
cord-023095-4dannjjm	3747	21	%	%	NN
cord-023095-4dannjjm	3747	22	.	.	.
cord-023095-4dannjjm	3748	1	The	the	DT
cord-023095-4dannjjm	3748	2	above	above	JJ
cord-023095-4dannjjm	3748	3	results	result	NNS
cord-023095-4dannjjm	3748	4	indicated	indicate	VBD
cord-023095-4dannjjm	3748	5	that	that	IN
cord-023095-4dannjjm	3748	6	dogs	dog	NNS
cord-023095-4dannjjm	3748	7	are	be	VBP
cord-023095-4dannjjm	3748	8	frequently	frequently	RB
cord-023095-4dannjjm	3748	9	exposed	expose	VBN
cord-023095-4dannjjm	3748	10	to	to	IN
cord-023095-4dannjjm	3748	11	both	both	CC
cord-023095-4dannjjm	3748	12	Aph	Aph	NNP
cord-023095-4dannjjm	3748	13	and	and	CC
cord-023095-4dannjjm	3748	14	Bb	Bb	NNP
cord-023095-4dannjjm	3748	15	in	in	IN
cord-023095-4dannjjm	3748	16	MN	MN	NNP
cord-023095-4dannjjm	3748	17	,	,	,
cord-023095-4dannjjm	3748	18	whereas	whereas	IN
cord-023095-4dannjjm	3748	19	AR	AR	NNP
cord-023095-4dannjjm	3748	20	dogs	dog	NNS
cord-023095-4dannjjm	3748	21	are	be	VBP
cord-023095-4dannjjm	3748	22	often	often	RB
cord-023095-4dannjjm	3748	23	exposed	expose	VBN
cord-023095-4dannjjm	3748	24	to	to	IN
cord-023095-4dannjjm	3748	25	Eew	Eew	NNP
cord-023095-4dannjjm	3748	26	,	,	,
cord-023095-4dannjjm	3748	27	but	but	CC
cord-023095-4dannjjm	3748	28	less	less	RBR
cord-023095-4dannjjm	3748	29	frequently	frequently	RB
cord-023095-4dannjjm	3748	30	to	to	IN
cord-023095-4dannjjm	3748	31	Ech	Ech	NNP
cord-023095-4dannjjm	3748	32	.	.	.
cord-023095-4dannjjm	3749	1	Antibodies	antibody	NNS
cord-023095-4dannjjm	3749	2	to	to	IN
cord-023095-4dannjjm	3749	3	E.	E.	NNP
cord-023095-4dannjjm	3749	4	canis	canis	NN
cord-023095-4dannjjm	3749	5	peptides	peptide	NNS
cord-023095-4dannjjm	3749	6	were	be	VBD
cord-023095-4dannjjm	3749	7	found	find	VBN
cord-023095-4dannjjm	3749	8	infrequently	infrequently	RB
cord-023095-4dannjjm	3749	9	in	in	IN
cord-023095-4dannjjm	3749	10	both	both	CC
cord-023095-4dannjjm	3749	11	MN	MN	NNP
cord-023095-4dannjjm	3749	12	and	and	CC
cord-023095-4dannjjm	3749	13	AR	AR	NNP
cord-023095-4dannjjm	3749	14	with	with	IN
cord-023095-4dannjjm	3749	15	only	only	RB
cord-023095-4dannjjm	3749	16	10	10	CD
cord-023095-4dannjjm	3749	17	seroreactive	seroreactive	JJ
cord-023095-4dannjjm	3749	18	dogs	dog	NNS
cord-023095-4dannjjm	3749	19	detected	detect	VBD
cord-023095-4dannjjm	3749	20	in	in	IN
cord-023095-4dannjjm	3749	21	both	both	DT
cord-023095-4dannjjm	3749	22	locations	location	NNS
cord-023095-4dannjjm	3749	23	.	.	.
cord-023095-4dannjjm	3750	1	Active	active	JJ
cord-023095-4dannjjm	3750	2	Eew	Eew	NNP
cord-023095-4dannjjm	3750	3	infection	infection	NN
cord-023095-4dannjjm	3750	4	,	,	,
cord-023095-4dannjjm	3750	5	as	as	IN
cord-023095-4dannjjm	3750	6	determined	determine	VBN
cord-023095-4dannjjm	3750	7	by	by	IN
cord-023095-4dannjjm	3750	8	PCR	PCR	NNP
cord-023095-4dannjjm	3750	9	,	,	,
cord-023095-4dannjjm	3750	10	was	be	VBD
cord-023095-4dannjjm	3750	11	four	four	CD
cord-023095-4dannjjm	3750	12	times	time	NNS
cord-023095-4dannjjm	3750	13	more	more	RBR
cord-023095-4dannjjm	3750	14	frequent	frequent	JJ
cord-023095-4dannjjm	3750	15	in	in	IN
cord-023095-4dannjjm	3750	16	AR	AR	NNP
cord-023095-4dannjjm	3750	17	pet	pet	JJ
cord-023095-4dannjjm	3750	18	dog	dog	NN
cord-023095-4dannjjm	3750	19	seroreactors	seroreactor	NNS
cord-023095-4dannjjm	3750	20	as	as	IN
cord-023095-4dannjjm	3750	21	compared	compare	VBN
cord-023095-4dannjjm	3750	22	to	to	IN
cord-023095-4dannjjm	3750	23	active	active	JJ
cord-023095-4dannjjm	3750	24	Aph	Aph	NNP
cord-023095-4dannjjm	3750	25	infections	infection	NNS
cord-023095-4dannjjm	3750	26	among	among	IN
cord-023095-4dannjjm	3750	27	Aph	Aph	NNP
cord-023095-4dannjjm	3750	28	seroreactors	seroreactor	NNS
cord-023095-4dannjjm	3750	29	.	.	.
cord-023095-4dannjjm	3751	1	Although	although	IN
cord-023095-4dannjjm	3751	2	both	both	DT
cord-023095-4dannjjm	3751	3	organisms	organism	NNS
cord-023095-4dannjjm	3751	4	induce	induce	VBP
cord-023095-4dannjjm	3751	5	acute	acute	JJ
cord-023095-4dannjjm	3751	6	disease	disease	NN
cord-023095-4dannjjm	3751	7	,	,	,
cord-023095-4dannjjm	3751	8	the	the	DT
cord-023095-4dannjjm	3751	9	number	number	NN
cord-023095-4dannjjm	3751	10	of	of	IN
cord-023095-4dannjjm	3751	11	Aph	Aph	NNP
cord-023095-4dannjjm	3751	12	and	and	CC
cord-023095-4dannjjm	3751	13	Eew	Eew	NNP
cord-023095-4dannjjm	3751	14	PCR	PCR	NNP
cord-023095-4dannjjm	3751	15	positive	positive	JJ
cord-023095-4dannjjm	3751	16	dogs	dog	NNS
cord-023095-4dannjjm	3751	17	that	that	WDT
cord-023095-4dannjjm	3751	18	were	be	VBD
cord-023095-4dannjjm	3751	19	also	also	RB
cord-023095-4dannjjm	3751	20	seropositive	seropositive	JJ
cord-023095-4dannjjm	3751	21	was	be	VBD
cord-023095-4dannjjm	3751	22	relatively	relatively	RB
cord-023095-4dannjjm	3751	23	high	high	JJ
cord-023095-4dannjjm	3751	24	suggesting	suggest	VBG
cord-023095-4dannjjm	3751	25	that	that	IN
cord-023095-4dannjjm	3751	26	both	both	DT
cord-023095-4dannjjm	3751	27	organisms	organism	NNS
cord-023095-4dannjjm	3751	28	induce	induce	VBP
cord-023095-4dannjjm	3751	29	persistent	persistent	JJ
cord-023095-4dannjjm	3751	30	infections	infection	NNS
cord-023095-4dannjjm	3751	31	or	or	CC
cord-023095-4dannjjm	3751	32	that	that	IN
cord-023095-4dannjjm	3751	33	dogs	dog	NNS
cord-023095-4dannjjm	3751	34	are	be	VBP
cord-023095-4dannjjm	3751	35	frequently	frequently	RB
cord-023095-4dannjjm	3751	36	re	re	VBN
cord-023095-4dannjjm	3751	37	-	-	JJ
cord-023095-4dannjjm	3751	38	infected	infected	JJ
cord-023095-4dannjjm	3751	39	,	,	,
cord-023095-4dannjjm	3751	40	despite	despite	IN
cord-023095-4dannjjm	3751	41	the	the	DT
cord-023095-4dannjjm	3751	42	presence	presence	NN
cord-023095-4dannjjm	3751	43	of	of	IN
cord-023095-4dannjjm	3751	44	a	a	DT
cord-023095-4dannjjm	3751	45	measurable	measurable	JJ
cord-023095-4dannjjm	3751	46	humoral	humoral	JJ
cord-023095-4dannjjm	3751	47	immune	immune	JJ
cord-023095-4dannjjm	3751	48	response	response	NN
cord-023095-4dannjjm	3751	49	.	.	.
cord-023095-4dannjjm	3752	1	Additional	additional	JJ
cord-023095-4dannjjm	3752	2	studies	study	NNS
cord-023095-4dannjjm	3752	3	are	be	VBP
cord-023095-4dannjjm	3752	4	needed	need	VBN
cord-023095-4dannjjm	3752	5	to	to	TO
cord-023095-4dannjjm	3752	6	determine	determine	VB
cord-023095-4dannjjm	3752	7	regional	regional	JJ
cord-023095-4dannjjm	3752	8	infection	infection	NN
cord-023095-4dannjjm	3752	9	profiles	profile	NNS
cord-023095-4dannjjm	3752	10	in	in	IN
cord-023095-4dannjjm	3752	11	other	other	JJ
cord-023095-4dannjjm	3752	12	areas	area	NNS
cord-023095-4dannjjm	3752	13	that	that	WDT
cord-023095-4dannjjm	3752	14	are	be	VBP
cord-023095-4dannjjm	3752	15	endemic	endemic	JJ
cord-023095-4dannjjm	3752	16	for	for	IN
cord-023095-4dannjjm	3752	17	these	these	DT
cord-023095-4dannjjm	3752	18	pathogens	pathogen	NNS
cord-023095-4dannjjm	3752	19	.	.	.
cord-023095-4dannjjm	3753	1	Anaplasma	anaplasma	NN
cord-023095-4dannjjm	3753	2	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3753	3	and	and	CC
cord-023095-4dannjjm	3753	4	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3753	5	canis	cani	NNS
cord-023095-4dannjjm	3753	6	are	be	VBP
cord-023095-4dannjjm	3753	7	two	two	CD
cord-023095-4dannjjm	3753	8	of	of	IN
cord-023095-4dannjjm	3753	9	the	the	DT
cord-023095-4dannjjm	3753	10	most	most	RBS
cord-023095-4dannjjm	3753	11	common	common	JJ
cord-023095-4dannjjm	3753	12	vector	vector	NN
cord-023095-4dannjjm	3753	13	borne	bear	VBN
cord-023095-4dannjjm	3753	14	disease	disease	NN
cord-023095-4dannjjm	3753	15	agents	agent	NNS
cord-023095-4dannjjm	3753	16	that	that	WDT
cord-023095-4dannjjm	3753	17	infect	infect	VBP
cord-023095-4dannjjm	3753	18	dogs	dog	NNS
cord-023095-4dannjjm	3753	19	and	and	CC
cord-023095-4dannjjm	3753	20	cats	cat	NNS
cord-023095-4dannjjm	3753	21	.	.	.
cord-023095-4dannjjm	3754	1	While	while	IN
cord-023095-4dannjjm	3754	2	PCR	PCR	NNP
cord-023095-4dannjjm	3754	3	assays	assay	NNS
cord-023095-4dannjjm	3754	4	that	that	WDT
cord-023095-4dannjjm	3754	5	amplify	amplify	VBP
cord-023095-4dannjjm	3754	6	the	the	DT
cord-023095-4dannjjm	3754	7	DNA	dna	NN
cord-023095-4dannjjm	3754	8	of	of	IN
cord-023095-4dannjjm	3754	9	these	these	DT
cord-023095-4dannjjm	3754	10	agents	agent	NNS
cord-023095-4dannjjm	3754	11	from	from	IN
cord-023095-4dannjjm	3754	12	blood	blood	NN
cord-023095-4dannjjm	3754	13	are	be	VBP
cord-023095-4dannjjm	3754	14	currently	currently	RB
cord-023095-4dannjjm	3754	15	available	available	JJ
cord-023095-4dannjjm	3754	16	,	,	,
cord-023095-4dannjjm	3754	17	there	there	EX
cord-023095-4dannjjm	3754	18	is	be	VBZ
cord-023095-4dannjjm	3754	19	minimal	minimal	JJ
cord-023095-4dannjjm	3754	20	information	information	NN
cord-023095-4dannjjm	3754	21	concerning	concern	VBG
cord-023095-4dannjjm	3754	22	the	the	DT
cord-023095-4dannjjm	3754	23	performance	performance	NN
cord-023095-4dannjjm	3754	24	of	of	IN
cord-023095-4dannjjm	3754	25	these	these	DT
cord-023095-4dannjjm	3754	26	assays	assay	NNS
cord-023095-4dannjjm	3754	27	in	in	IN
cord-023095-4dannjjm	3754	28	different	different	JJ
cord-023095-4dannjjm	3754	29	commercial	commercial	JJ
cord-023095-4dannjjm	3754	30	laboratories	laboratory	NNS
cord-023095-4dannjjm	3754	31	that	that	WDT
cord-023095-4dannjjm	3754	32	utilize	utilize	VBP
cord-023095-4dannjjm	3754	33	different	different	JJ
cord-023095-4dannjjm	3754	34	techniques	technique	NNS
cord-023095-4dannjjm	3754	35	.	.	.
cord-023095-4dannjjm	3755	1	The	the	DT
cord-023095-4dannjjm	3755	2	purpose	purpose	NN
cord-023095-4dannjjm	3755	3	of	of	IN
cord-023095-4dannjjm	3755	4	this	this	DT
cord-023095-4dannjjm	3755	5	study	study	NN
cord-023095-4dannjjm	3755	6	was	be	VBD
cord-023095-4dannjjm	3755	7	to	to	TO
cord-023095-4dannjjm	3755	8	compare	compare	VB
cord-023095-4dannjjm	3755	9	the	the	DT
cord-023095-4dannjjm	3755	10	E.	E.	NNP
cord-023095-4dannjjm	3755	11	canis	canis	NN
cord-023095-4dannjjm	3755	12	and	and	CC
cord-023095-4dannjjm	3755	13	A.	a.	JJ
cord-023095-4dannjjm	3755	14	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3755	15	results	result	NNS
cord-023095-4dannjjm	3755	16	of	of	IN
cord-023095-4dannjjm	3755	17	two	two	CD
cord-023095-4dannjjm	3755	18	different	different	JJ
cord-023095-4dannjjm	3755	19	laboratories	laboratory	NNS
cord-023095-4dannjjm	3755	20	on	on	IN
cord-023095-4dannjjm	3755	21	the	the	DT
cord-023095-4dannjjm	3755	22	same	same	JJ
cord-023095-4dannjjm	3755	23	samples	sample	NNS
cord-023095-4dannjjm	3755	24	collected	collect	VBN
cord-023095-4dannjjm	3755	25	from	from	IN
cord-023095-4dannjjm	3755	26	client	client	NN
cord-023095-4dannjjm	3755	27	-	-	HYPH
cord-023095-4dannjjm	3755	28	owned	own	VBN
cord-023095-4dannjjm	3755	29	animals	animal	NNS
cord-023095-4dannjjm	3755	30	.	.	.
cord-023095-4dannjjm	3756	1	Veterinarians	veterinarian	NNS
cord-023095-4dannjjm	3756	2	in	in	IN
cord-023095-4dannjjm	3756	3	3	3	CD
cord-023095-4dannjjm	3756	4	states	state	NNS
cord-023095-4dannjjm	3756	5	(	(	-LRB-
cord-023095-4dannjjm	3756	6	AZ	AZ	NNP
cord-023095-4dannjjm	3756	7	,	,	,
cord-023095-4dannjjm	3756	8	MD	MD	NNP
cord-023095-4dannjjm	3756	9	,	,	,
cord-023095-4dannjjm	3756	10	CT	CT	NNP
cord-023095-4dannjjm	3756	11	)	)	-RRB-
cord-023095-4dannjjm	3756	12	were	be	VBD
cord-023095-4dannjjm	3756	13	recruited	recruit	VBN
cord-023095-4dannjjm	3756	14	to	to	TO
cord-023095-4dannjjm	3756	15	participate	participate	VB
cord-023095-4dannjjm	3756	16	in	in	IN
cord-023095-4dannjjm	3756	17	the	the	DT
cord-023095-4dannjjm	3756	18	study	study	NN
cord-023095-4dannjjm	3756	19	based	base	VBN
cord-023095-4dannjjm	3756	20	on	on	IN
cord-023095-4dannjjm	3756	21	high	high	JJ
cord-023095-4dannjjm	3756	22	prevalence	prevalence	NN
cord-023095-4dannjjm	3756	23	rates	rate	NNS
cord-023095-4dannjjm	3756	24	for	for	IN
cord-023095-4dannjjm	3756	25	E.	E.	NNP
cord-023095-4dannjjm	3756	26	canis	canis	NNP
cord-023095-4dannjjm	3756	27	or	or	CC
cord-023095-4dannjjm	3756	28	A.	a.	JJ
cord-023095-4dannjjm	3756	29	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3756	30	infection	infection	NN
cord-023095-4dannjjm	3756	31	.	.	.
cord-023095-4dannjjm	3757	1	Blood	blood	NN
cord-023095-4dannjjm	3757	2	in	in	IN
cord-023095-4dannjjm	3757	3	EDTA	EDTA	NNP
cord-023095-4dannjjm	3757	4	was	be	VBD
cord-023095-4dannjjm	3757	5	collected	collect	VBN
cord-023095-4dannjjm	3757	6	from	from	IN
cord-023095-4dannjjm	3757	7	dogs	dog	NNS
cord-023095-4dannjjm	3757	8	or	or	CC
cord-023095-4dannjjm	3757	9	cats	cat	NNS
cord-023095-4dannjjm	3757	10	with	with	IN
cord-023095-4dannjjm	3757	11	fever	fever	NN
cord-023095-4dannjjm	3757	12	,	,	,
cord-023095-4dannjjm	3757	13	thrombocytopenia	thrombocytopenia	NN
cord-023095-4dannjjm	3757	14	,	,	,
cord-023095-4dannjjm	3757	15	or	or	CC
cord-023095-4dannjjm	3757	16	clinical	clinical	JJ
cord-023095-4dannjjm	3757	17	evidence	evidence	NN
cord-023095-4dannjjm	3757	18	of	of	IN
cord-023095-4dannjjm	3757	19	polyarthritis	polyarthritis	NNP
cord-023095-4dannjjm	3757	20	and	and	CC
cord-023095-4dannjjm	3757	21	an	an	DT
cord-023095-4dannjjm	3757	22	equal	equal	JJ
cord-023095-4dannjjm	3757	23	volume	volume	NN
cord-023095-4dannjjm	3757	24	of	of	IN
cord-023095-4dannjjm	3757	25	the	the	DT
cord-023095-4dannjjm	3757	26	same	same	JJ
cord-023095-4dannjjm	3757	27	blood	blood	NN
cord-023095-4dannjjm	3757	28	sample	sample	NN
cord-023095-4dannjjm	3757	29	was	be	VBD
cord-023095-4dannjjm	3757	30	simultaneously	simultaneously	RB
cord-023095-4dannjjm	3757	31	shipped	ship	VBN
cord-023095-4dannjjm	3757	32	on	on	IN
cord-023095-4dannjjm	3757	33	cold	cold	JJ
cord-023095-4dannjjm	3757	34	packs	pack	NNS
cord-023095-4dannjjm	3757	35	by	by	IN
cord-023095-4dannjjm	3757	36	overnight	overnight	JJ
cord-023095-4dannjjm	3757	37	express	express	NN
cord-023095-4dannjjm	3757	38	to	to	IN
cord-023095-4dannjjm	3757	39	Colorado	Colorado	NNP
cord-023095-4dannjjm	3757	40	State	State	NNP
cord-023095-4dannjjm	3757	41	and	and	CC
cord-023095-4dannjjm	3757	42	to	to	IN
cord-023095-4dannjjm	3757	43	Antech	Antech	NNP
cord-023095-4dannjjm	3757	44	Diagnostics	Diagnostics	NNP
cord-023095-4dannjjm	3757	45	.	.	.
cord-023095-4dannjjm	3758	1	Standard	standard	JJ
cord-023095-4dannjjm	3758	2	operating	operating	NN
cord-023095-4dannjjm	3758	3	procedures	procedure	NNS
cord-023095-4dannjjm	3758	4	at	at	IN
cord-023095-4dannjjm	3758	5	each	each	DT
cord-023095-4dannjjm	3758	6	laboratory	laboratory	NN
cord-023095-4dannjjm	3758	7	were	be	VBD
cord-023095-4dannjjm	3758	8	followed	follow	VBN
cord-023095-4dannjjm	3758	9	for	for	IN
cord-023095-4dannjjm	3758	10	total	total	JJ
cord-023095-4dannjjm	3758	11	DNA	dna	NN
cord-023095-4dannjjm	3758	12	extraction	extraction	NN
cord-023095-4dannjjm	3758	13	and	and	CC
cord-023095-4dannjjm	3758	14	amplification	amplification	NN
cord-023095-4dannjjm	3758	15	of	of	IN
cord-023095-4dannjjm	3758	16	GAPDH	GAPDH	NNP
cord-023095-4dannjjm	3758	17	as	as	IN
cord-023095-4dannjjm	3758	18	the	the	DT
cord-023095-4dannjjm	3758	19	DNA	dna	NN
cord-023095-4dannjjm	3758	20	control	control	NN
cord-023095-4dannjjm	3758	21	.	.	.
cord-023095-4dannjjm	3759	1	At	at	IN
cord-023095-4dannjjm	3759	2	Colorado	Colorado	NNP
cord-023095-4dannjjm	3759	3	State	State	NNP
cord-023095-4dannjjm	3759	4	University	University	NNP
cord-023095-4dannjjm	3759	5	,	,	,
cord-023095-4dannjjm	3759	6	a	a	DT
cord-023095-4dannjjm	3759	7	previously	previously	RB
cord-023095-4dannjjm	3759	8	published	publish	VBN
cord-023095-4dannjjm	3759	9	PCR	PCR	NNP
cord-023095-4dannjjm	3759	10	assay	assay	NN
cord-023095-4dannjjm	3759	11	that	that	WDT
cord-023095-4dannjjm	3759	12	amplifies	amplify	VBZ
cord-023095-4dannjjm	3759	13	the	the	DT
cord-023095-4dannjjm	3759	14	DNA	dna	NN
cord-023095-4dannjjm	3759	15	of	of	IN
cord-023095-4dannjjm	3759	16	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3759	17	spp	spp	NNS
cord-023095-4dannjjm	3759	18	.	.	.
cord-023095-4dannjjm	3760	1	,	,	,
cord-023095-4dannjjm	3760	2	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3760	3	spp	spp	NNS
cord-023095-4dannjjm	3760	4	.	.	.
cord-023095-4dannjjm	3761	1	,	,	,
cord-023095-4dannjjm	3761	2	Neorickettsia	Neorickettsia	NNP
cord-023095-4dannjjm	3761	3	spp	spp	NNS
cord-023095-4dannjjm	3761	4	.	.	.
cord-023095-4dannjjm	3762	1	,	,	,
cord-023095-4dannjjm	3763	1	and	and	CC
cord-023095-4dannjjm	3763	2	Wolbachia	Wolbachia	NNP
cord-023095-4dannjjm	3763	3	was	be	VBD
cord-023095-4dannjjm	3763	4	performed	perform	VBN
cord-023095-4dannjjm	3763	5	on	on	IN
cord-023095-4dannjjm	3763	6	each	each	DT
cord-023095-4dannjjm	3763	7	sample	sample	NN
cord-023095-4dannjjm	3763	8	with	with	IN
cord-023095-4dannjjm	3763	9	positive	positive	JJ
cord-023095-4dannjjm	3763	10	amplicons	amplicon	NNS
cord-023095-4dannjjm	3763	11	sequenced	sequence	VBN
cord-023095-4dannjjm	3763	12	to	to	TO
cord-023095-4dannjjm	3763	13	determine	determine	VB
cord-023095-4dannjjm	3763	14	the	the	DT
cord-023095-4dannjjm	3763	15	species	specie	NNS
cord-023095-4dannjjm	3763	16	.	.	.
cord-023095-4dannjjm	3764	1	At	at	IN
cord-023095-4dannjjm	3764	2	Antech	Antech	NNP
cord-023095-4dannjjm	3764	3	Diagnostics	Diagnostics	NNP
cord-023095-4dannjjm	3764	4	,	,	,
cord-023095-4dannjjm	3764	5	a	a	DT
cord-023095-4dannjjm	3764	6	proprietary	proprietary	JJ
cord-023095-4dannjjm	3764	7	real	real	JJ
cord-023095-4dannjjm	3764	8	time	time	NN
cord-023095-4dannjjm	3764	9	PCR	pcr	NN
cord-023095-4dannjjm	3764	10	assay	assay	NN
cord-023095-4dannjjm	3764	11	(	(	-LRB-
cord-023095-4dannjjm	3764	12	FastPanel	FastPanel	NNP
cord-023095-4dannjjm	3764	13	TM	TM	NNP
cord-023095-4dannjjm	3764	14	)	)	-RRB-
cord-023095-4dannjjm	3764	15	that	that	WDT
cord-023095-4dannjjm	3764	16	amplifies	amplify	VBZ
cord-023095-4dannjjm	3764	17	the	the	DT
cord-023095-4dannjjm	3764	18	DNA	DNA	NNP
cord-023095-4dannjjm	3764	19	of	of	IN
cord-023095-4dannjjm	3764	20	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3764	21	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3764	22	,	,	,
cord-023095-4dannjjm	3764	23	A.	a.	NN
cord-023095-4dannjjm	3764	24	platys	platy	NNS
cord-023095-4dannjjm	3764	25	,	,	,
cord-023095-4dannjjm	3764	26	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3764	27	canis	canis	NN
cord-023095-4dannjjm	3764	28	,	,	,
cord-023095-4dannjjm	3764	29	E.	E.	NNP
cord-023095-4dannjjm	3764	30	chaffeensis	chaffeensis	NN
cord-023095-4dannjjm	3764	31	,	,	,
cord-023095-4dannjjm	3764	32	and	and	CC
cord-023095-4dannjjm	3764	33	E.	E.	NNP
cord-023095-4dannjjm	3764	34	ewingii	ewingii	NNP
cord-023095-4dannjjm	3764	35	was	be	VBD
cord-023095-4dannjjm	3764	36	performed	perform	VBN
cord-023095-4dannjjm	3764	37	.	.	.
cord-023095-4dannjjm	3765	1	In	in	IN
cord-023095-4dannjjm	3765	2	the	the	DT
cord-023095-4dannjjm	3765	3	study	study	NN
cord-023095-4dannjjm	3765	4	to	to	IN
cord-023095-4dannjjm	3765	5	date	date	NN
cord-023095-4dannjjm	3765	6	,	,	,
cord-023095-4dannjjm	3765	7	samples	sample	NNS
cord-023095-4dannjjm	3765	8	from	from	IN
cord-023095-4dannjjm	3765	9	35	35	CD
cord-023095-4dannjjm	3765	10	animals	animal	NNS
cord-023095-4dannjjm	3765	11	(	(	-LRB-
cord-023095-4dannjjm	3765	12	30	30	CD
cord-023095-4dannjjm	3765	13	dogs	dog	NNS
cord-023095-4dannjjm	3765	14	and	and	CC
cord-023095-4dannjjm	3765	15	5	5	CD
cord-023095-4dannjjm	3765	16	cats	cat	NNS
cord-023095-4dannjjm	3765	17	)	)	-RRB-
cord-023095-4dannjjm	3765	18	have	have	VBP
cord-023095-4dannjjm	3765	19	been	be	VBN
cord-023095-4dannjjm	3765	20	assayed	assay	VBN
cord-023095-4dannjjm	3765	21	at	at	IN
cord-023095-4dannjjm	3765	22	both	both	DT
cord-023095-4dannjjm	3765	23	laboratories	laboratory	NNS
cord-023095-4dannjjm	3765	24	.	.	.
cord-023095-4dannjjm	3766	1	DNA	DNA	NNP
cord-023095-4dannjjm	3766	2	of	of	IN
cord-023095-4dannjjm	3766	3	A.	A.	NNP
cord-023095-4dannjjm	3766	4	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3766	5	(	(	-LRB-
cord-023095-4dannjjm	3766	6	2	2	CD
cord-023095-4dannjjm	3766	7	cats	cat	NNS
cord-023095-4dannjjm	3766	8	and	and	CC
cord-023095-4dannjjm	3766	9	2	2	CD
cord-023095-4dannjjm	3766	10	dogs	dog	NNS
cord-023095-4dannjjm	3766	11	)	)	-RRB-
cord-023095-4dannjjm	3766	12	and	and	CC
cord-023095-4dannjjm	3766	13	E.	E.	NNP
cord-023095-4dannjjm	3766	14	canis	canis	NNP
cord-023095-4dannjjm	3766	15	(	(	-LRB-
cord-023095-4dannjjm	3766	16	1	1	CD
cord-023095-4dannjjm	3766	17	dog	dog	NN
cord-023095-4dannjjm	3766	18	)	)	-RRB-
cord-023095-4dannjjm	3766	19	were	be	VBD
cord-023095-4dannjjm	3766	20	amplified	amplify	VBN
cord-023095-4dannjjm	3766	21	at	at	IN
cord-023095-4dannjjm	3766	22	both	both	DT
cord-023095-4dannjjm	3766	23	laboratories	laboratory	NNS
cord-023095-4dannjjm	3766	24	with	with	IN
cord-023095-4dannjjm	3766	25	a	a	DT
cord-023095-4dannjjm	3766	26	percentage	percentage	NN
cord-023095-4dannjjm	3766	27	agreement	agreement	NN
cord-023095-4dannjjm	3766	28	between	between	IN
cord-023095-4dannjjm	3766	29	laboratories	laboratory	NNS
cord-023095-4dannjjm	3766	30	of	of	IN
cord-023095-4dannjjm	3766	31	100	100	CD
cord-023095-4dannjjm	3766	32	%	%	NN
cord-023095-4dannjjm	3766	33	.	.	.
cord-023095-4dannjjm	3767	1	The	the	DT
cord-023095-4dannjjm	3767	2	results	result	NNS
cord-023095-4dannjjm	3767	3	to	to	IN
cord-023095-4dannjjm	3767	4	date	date	NN
cord-023095-4dannjjm	3767	5	suggest	suggest	VBP
cord-023095-4dannjjm	3767	6	that	that	IN
cord-023095-4dannjjm	3767	7	the	the	DT
cord-023095-4dannjjm	3767	8	assay	assay	NN
cord-023095-4dannjjm	3767	9	results	result	NNS
cord-023095-4dannjjm	3767	10	of	of	IN
cord-023095-4dannjjm	3767	11	the	the	DT
cord-023095-4dannjjm	3767	12	two	two	CD
cord-023095-4dannjjm	3767	13	laboratories	laboratory	NNS
cord-023095-4dannjjm	3767	14	for	for	IN
cord-023095-4dannjjm	3767	15	A.	a.	NN
cord-023095-4dannjjm	3767	16	phagocytophilum	phagocytophilum	NN
cord-023095-4dannjjm	3767	17	and	and	CC
cord-023095-4dannjjm	3767	18	E.	E.	NNP
cord-023095-4dannjjm	3767	19	canis	canis	NNP
cord-023095-4dannjjm	3767	20	are	be	VBP
cord-023095-4dannjjm	3767	21	comparable	comparable	JJ
cord-023095-4dannjjm	3767	22	.	.	.
cord-023095-4dannjjm	3768	1	Ehrlichiosis	Ehrlichiosis	NNP
cord-023095-4dannjjm	3768	2	and	and	CC
cord-023095-4dannjjm	3768	3	Bartonellosis	Bartonellosis	NNP
cord-023095-4dannjjm	3768	4	are	be	VBP
cord-023095-4dannjjm	3768	5	zoonotic	zoonotic	JJ
cord-023095-4dannjjm	3768	6	diseases	disease	NNS
cord-023095-4dannjjm	3768	7	caused	cause	VBN
cord-023095-4dannjjm	3768	8	by	by	IN
cord-023095-4dannjjm	3768	9	extremely	extremely	RB
cord-023095-4dannjjm	3768	10	small	small	JJ
cord-023095-4dannjjm	3768	11	,	,	,
cord-023095-4dannjjm	3768	12	obligate	obligate	VBP
cord-023095-4dannjjm	3768	13	intracellular	intracellular	JJ
cord-023095-4dannjjm	3768	14	bacteria	bacteria	NNS
cord-023095-4dannjjm	3768	15	that	that	WDT
cord-023095-4dannjjm	3768	16	require	require	VBP
cord-023095-4dannjjm	3768	17	a	a	DT
cord-023095-4dannjjm	3768	18	mammalian	mammalian	JJ
cord-023095-4dannjjm	3768	19	reservoir	reservoir	NN
cord-023095-4dannjjm	3768	20	and	and	CC
cord-023095-4dannjjm	3768	21	a	a	DT
cord-023095-4dannjjm	3768	22	blood	blood	NN
cord-023095-4dannjjm	3768	23	sucking	suck	VBG
cord-023095-4dannjjm	3768	24	arthropod	arthropod	JJ
cord-023095-4dannjjm	3768	25	vector	vector	NN
cord-023095-4dannjjm	3768	26	.	.	.
cord-023095-4dannjjm	3769	1	Human	human	JJ
cord-023095-4dannjjm	3769	2	ehrlichiosis	ehrlichiosis	NN
cord-023095-4dannjjm	3769	3	is	be	VBZ
cord-023095-4dannjjm	3769	4	present	present	JJ
cord-023095-4dannjjm	3769	5	in	in	IN
cord-023095-4dannjjm	3769	6	Peru	Peru	NNP
cord-023095-4dannjjm	3769	7	,	,	,
cord-023095-4dannjjm	3769	8	with	with	IN
cord-023095-4dannjjm	3769	9	a	a	DT
cord-023095-4dannjjm	3769	10	seroprevalence	seroprevalence	NN
cord-023095-4dannjjm	3769	11	as	as	RB
cord-023095-4dannjjm	3769	12	high	high	JJ
cord-023095-4dannjjm	3769	13	as	as	IN
cord-023095-4dannjjm	3769	14	23	23	CD
cord-023095-4dannjjm	3769	15	%	%	NN
cord-023095-4dannjjm	3769	16	in	in	IN
cord-023095-4dannjjm	3769	17	the	the	DT
cord-023095-4dannjjm	3769	18	highlands	highland	NNS
cord-023095-4dannjjm	3769	19	.	.	.
cord-023095-4dannjjm	3770	1	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3770	2	species	specie	NNS
cord-023095-4dannjjm	3770	3	in	in	IN
cord-023095-4dannjjm	3770	4	humans	human	NNS
cord-023095-4dannjjm	3770	5	were	be	VBD
cord-023095-4dannjjm	3770	6	also	also	RB
cord-023095-4dannjjm	3770	7	identified	identify	VBN
cord-023095-4dannjjm	3770	8	in	in	IN
cord-023095-4dannjjm	3770	9	Peru	Peru	NNP
cord-023095-4dannjjm	3770	10	since	since	IN
cord-023095-4dannjjm	3770	11	1905	1905	CD
cord-023095-4dannjjm	3770	12	(	(	-LRB-
cord-023095-4dannjjm	3770	13	B.	B.	NNP
cord-023095-4dannjjm	3770	14	bacilliformis	bacilliformis	NNP
cord-023095-4dannjjm	3770	15	)	)	-RRB-
cord-023095-4dannjjm	3770	16	.	.	.
cord-023095-4dannjjm	3771	1	Recently	recently	RB
cord-023095-4dannjjm	3771	2	,	,	,
cord-023095-4dannjjm	3771	3	a	a	DT
cord-023095-4dannjjm	3771	4	new	new	JJ
cord-023095-4dannjjm	3771	5	species	specie	NNS
cord-023095-4dannjjm	3771	6	(	(	-LRB-
cord-023095-4dannjjm	3771	7	B.	B.	NNP
cord-023095-4dannjjm	3771	8	rochalimae	rochalimae	NNP
cord-023095-4dannjjm	3771	9	)	)	-RRB-
cord-023095-4dannjjm	3771	10	was	be	VBD
cord-023095-4dannjjm	3771	11	isolated	isolate	VBN
cord-023095-4dannjjm	3771	12	from	from	IN
cord-023095-4dannjjm	3771	13	an	an	DT
cord-023095-4dannjjm	3771	14	American	american	JJ
cord-023095-4dannjjm	3771	15	woman	woman	NN
cord-023095-4dannjjm	3771	16	who	who	WP
cord-023095-4dannjjm	3771	17	became	become	VBD
cord-023095-4dannjjm	3771	18	febrile	febrile	JJ
cord-023095-4dannjjm	3771	19	after	after	IN
cord-023095-4dannjjm	3771	20	travelling	travel	VBG
cord-023095-4dannjjm	3771	21	to	to	IN
cord-023095-4dannjjm	3771	22	Peru	Peru	NNP
cord-023095-4dannjjm	3771	23	.	.	.
cord-023095-4dannjjm	3772	1	Dogs	dog	NNS
cord-023095-4dannjjm	3772	2	can	can	MD
cord-023095-4dannjjm	3772	3	become	become	VB
cord-023095-4dannjjm	3772	4	infected	infect	VBN
cord-023095-4dannjjm	3772	5	with	with	IN
cord-023095-4dannjjm	3772	6	the	the	DT
cord-023095-4dannjjm	3772	7	same	same	JJ
cord-023095-4dannjjm	3772	8	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3772	9	species	specie	NNS
cord-023095-4dannjjm	3772	10	,	,	,
cord-023095-4dannjjm	3772	11	and	and	CC
cord-023095-4dannjjm	3772	12	the	the	DT
cord-023095-4dannjjm	3772	13	majority	majority	NN
cord-023095-4dannjjm	3772	14	of	of	IN
cord-023095-4dannjjm	3772	15	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3772	16	species	specie	NNS
cord-023095-4dannjjm	3772	17	that	that	WDT
cord-023095-4dannjjm	3772	18	affect	affect	VBP
cord-023095-4dannjjm	3772	19	human	human	JJ
cord-023095-4dannjjm	3772	20	beings	being	NNS
cord-023095-4dannjjm	3772	21	.	.	.
cord-023095-4dannjjm	3773	1	The	the	DT
cord-023095-4dannjjm	3773	2	role	role	NN
cord-023095-4dannjjm	3773	3	of	of	IN
cord-023095-4dannjjm	3773	4	dogs	dog	NNS
cord-023095-4dannjjm	3773	5	as	as	IN
cord-023095-4dannjjm	3773	6	reservoirs	reservoir	NNS
cord-023095-4dannjjm	3773	7	for	for	IN
cord-023095-4dannjjm	3773	8	human	human	JJ
cord-023095-4dannjjm	3773	9	infections	infection	NNS
cord-023095-4dannjjm	3773	10	has	have	VBZ
cord-023095-4dannjjm	3773	11	not	not	RB
cord-023095-4dannjjm	3773	12	been	be	VBN
cord-023095-4dannjjm	3773	13	clearly	clearly	RB
cord-023095-4dannjjm	3773	14	established	establish	VBN
cord-023095-4dannjjm	3773	15	,	,	,
cord-023095-4dannjjm	3773	16	but	but	CC
cord-023095-4dannjjm	3773	17	exposure	exposure	NN
cord-023095-4dannjjm	3773	18	and/or	and/or	CC
cord-023095-4dannjjm	3773	19	infection	infection	NN
cord-023095-4dannjjm	3773	20	in	in	IN
cord-023095-4dannjjm	3773	21	dogs	dog	NNS
cord-023095-4dannjjm	3773	22	has	have	VBZ
cord-023095-4dannjjm	3773	23	been	be	VBN
cord-023095-4dannjjm	3773	24	used	use	VBN
cord-023095-4dannjjm	3773	25	to	to	TO
cord-023095-4dannjjm	3773	26	monitor	monitor	VB
cord-023095-4dannjjm	3773	27	human	human	JJ
cord-023095-4dannjjm	3773	28	exposure	exposure	NN
cord-023095-4dannjjm	3773	29	to	to	TO
cord-023095-4dannjjm	3773	30	tick	tick	VB
cord-023095-4dannjjm	3773	31	-	-	HYPH
cord-023095-4dannjjm	3773	32	borne	bear	VBN
cord-023095-4dannjjm	3773	33	disease	disease	NN
cord-023095-4dannjjm	3773	34	(	(	-LRB-
cord-023095-4dannjjm	3773	35	TBD	TBD	NNP
cord-023095-4dannjjm	3773	36	)	)	-RRB-
cord-023095-4dannjjm	3773	37	,	,	,
cord-023095-4dannjjm	3773	38	since	since	IN
cord-023095-4dannjjm	3773	39	they	-PRON-	PRP
cord-023095-4dannjjm	3773	40	share	share	VBP
cord-023095-4dannjjm	3773	41	the	the	DT
cord-023095-4dannjjm	3773	42	same	same	JJ
cord-023095-4dannjjm	3773	43	environment	environment	NN
cord-023095-4dannjjm	3773	44	.	.	.
cord-023095-4dannjjm	3774	1	The	the	DT
cord-023095-4dannjjm	3774	2	objective	objective	NN
cord-023095-4dannjjm	3774	3	of	of	IN
cord-023095-4dannjjm	3774	4	this	this	DT
cord-023095-4dannjjm	3774	5	study	study	NN
cord-023095-4dannjjm	3774	6	was	be	VBD
cord-023095-4dannjjm	3774	7	to	to	TO
cord-023095-4dannjjm	3774	8	determine	determine	VB
cord-023095-4dannjjm	3774	9	the	the	DT
cord-023095-4dannjjm	3774	10	serological	serological	JJ
cord-023095-4dannjjm	3774	11	and	and	CC
cord-023095-4dannjjm	3774	12	molecular	molecular	JJ
cord-023095-4dannjjm	3774	13	prevalence	prevalence	NN
cord-023095-4dannjjm	3774	14	of	of	IN
cord-023095-4dannjjm	3774	15	Anaplasmosis	Anaplasmosis	NNP
cord-023095-4dannjjm	3774	16	,	,	,
cord-023095-4dannjjm	3774	17	Ehrlichiosis	Ehrlichiosis	NNP
cord-023095-4dannjjm	3774	18	and	and	CC
cord-023095-4dannjjm	3774	19	Bartonellosis	Bartonellosis	NNP
cord-023095-4dannjjm	3774	20	in	in	IN
cord-023095-4dannjjm	3774	21	rural	rural	JJ
cord-023095-4dannjjm	3774	22	dogs	dog	NNS
cord-023095-4dannjjm	3774	23	in	in	IN
cord-023095-4dannjjm	3774	24	the	the	DT
cord-023095-4dannjjm	3774	25	highlands	highland	NNS
cord-023095-4dannjjm	3774	26	of	of	IN
cord-023095-4dannjjm	3774	27	Peru	Peru	NNP
cord-023095-4dannjjm	3774	28	.	.	.
cord-023095-4dannjjm	3775	1	A	a	DT
cord-023095-4dannjjm	3775	2	total	total	NN
cord-023095-4dannjjm	3775	3	of	of	IN
cord-023095-4dannjjm	3775	4	122	122	CD
cord-023095-4dannjjm	3775	5	healthy	healthy	JJ
cord-023095-4dannjjm	3775	6	adult	adult	NN
cord-023095-4dannjjm	3775	7	dogs	dog	NNS
cord-023095-4dannjjm	3775	8	were	be	VBD
cord-023095-4dannjjm	3775	9	enrolled	enrol	VBN
cord-023095-4dannjjm	3775	10	in	in	IN
cord-023095-4dannjjm	3775	11	this	this	DT
cord-023095-4dannjjm	3775	12	study	study	NN
cord-023095-4dannjjm	3775	13	from	from	IN
cord-023095-4dannjjm	3775	14	four	four	CD
cord-023095-4dannjjm	3775	15	communities	community	NNS
cord-023095-4dannjjm	3775	16	in	in	IN
cord-023095-4dannjjm	3775	17	the	the	DT
cord-023095-4dannjjm	3775	18	central	central	JJ
cord-023095-4dannjjm	3775	19	highlands	highland	NNS
cord-023095-4dannjjm	3775	20	of	of	IN
cord-023095-4dannjjm	3775	21	Peru	Peru	NNP
cord-023095-4dannjjm	3775	22	:	:	:
cord-023095-4dannjjm	3775	23	Ondores	Ondores	NNP
cord-023095-4dannjjm	3775	24	,	,	,
cord-023095-4dannjjm	3775	25	Pachacayo	Pachacayo	NNP
cord-023095-4dannjjm	3775	26	,	,	,
cord-023095-4dannjjm	3775	27	San	San	NNP
cord-023095-4dannjjm	3775	28	Juan	Juan	NNP
cord-023095-4dannjjm	3775	29	de	de	NNP
cord-023095-4dannjjm	3775	30	Pachayo	Pachayo	NNP
cord-023095-4dannjjm	3775	31	,	,	,
cord-023095-4dannjjm	3775	32	and	and	CC
cord-023095-4dannjjm	3775	33	Canchayllo	Canchayllo	NNP
cord-023095-4dannjjm	3775	34	.	.	.
cord-023095-4dannjjm	3776	1	EDTA	edta	NN
cord-023095-4dannjjm	3776	2	-	-	HYPH
cord-023095-4dannjjm	3776	3	blood	blood	NN
cord-023095-4dannjjm	3776	4	samples	sample	NNS
cord-023095-4dannjjm	3776	5	were	be	VBD
cord-023095-4dannjjm	3776	6	collected	collect	VBN
cord-023095-4dannjjm	3776	7	from	from	IN
cord-023095-4dannjjm	3776	8	108	108	CD
cord-023095-4dannjjm	3776	9	dogs	dog	NNS
cord-023095-4dannjjm	3776	10	,	,	,
cord-023095-4dannjjm	3776	11	whereas	whereas	IN
cord-023095-4dannjjm	3776	12	serum	serum	NN
cord-023095-4dannjjm	3776	13	samples	sample	NNS
cord-023095-4dannjjm	3776	14	were	be	VBD
cord-023095-4dannjjm	3776	15	available	available	JJ
cord-023095-4dannjjm	3776	16	from	from	IN
cord-023095-4dannjjm	3776	17	110	110	CD
cord-023095-4dannjjm	3776	18	dogs	dog	NNS
cord-023095-4dannjjm	3776	19	.	.	.
cord-023095-4dannjjm	3777	1	Serum	serum	NN
cord-023095-4dannjjm	3777	2	samples	sample	NNS
cord-023095-4dannjjm	3777	3	were	be	VBD
cord-023095-4dannjjm	3777	4	tested	test	VBN
cord-023095-4dannjjm	3777	5	for	for	IN
cord-023095-4dannjjm	3777	6	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3777	7	canis	canis	NN
cord-023095-4dannjjm	3777	8	,	,	,
cord-023095-4dannjjm	3777	9	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3777	10	,	,	,
cord-023095-4dannjjm	3777	11	Borrelia	Borrelia	NNP
cord-023095-4dannjjm	3777	12	burgdorferi	burgdorferi	NN
cord-023095-4dannjjm	3777	13	and	and	CC
cord-023095-4dannjjm	3777	14	Dirofilaria	Dirofilaria	NNP
cord-023095-4dannjjm	3777	15	immitis	immitis	NNP
cord-023095-4dannjjm	3777	16	infections	infection	NNS
cord-023095-4dannjjm	3777	17	using	use	VBG
cord-023095-4dannjjm	3777	18	a	a	DT
cord-023095-4dannjjm	3777	19	qualitative	qualitative	JJ
cord-023095-4dannjjm	3777	20	dot	dot	NN
cord-023095-4dannjjm	3777	21	-	-	HYPH
cord-023095-4dannjjm	3777	22	ELISA	ELISA	NNP
cord-023095-4dannjjm	3777	23	(	(	-LRB-
cord-023095-4dannjjm	3777	24	Snap	snap	VB
cord-023095-4dannjjm	3777	25	s	s	POS
cord-023095-4dannjjm	3777	26	4Dx	4dx	CD
cord-023095-4dannjjm	3777	27	)	)	-RRB-
cord-023095-4dannjjm	3777	28	.	.	.
cord-023095-4dannjjm	3778	1	The	the	DT
cord-023095-4dannjjm	3778	2	EDTA	edta	NN
cord-023095-4dannjjm	3778	3	-	-	HYPH
cord-023095-4dannjjm	3778	4	blood	blood	NN
cord-023095-4dannjjm	3778	5	samples	sample	NNS
cord-023095-4dannjjm	3778	6	were	be	VBD
cord-023095-4dannjjm	3778	7	screened	screen	VBN
cord-023095-4dannjjm	3778	8	by	by	IN
cord-023095-4dannjjm	3778	9	conventional	conventional	JJ
cord-023095-4dannjjm	3778	10	PCR	PCR	NNP
cord-023095-4dannjjm	3778	11	for	for	IN
cord-023095-4dannjjm	3778	12	the	the	DT
cord-023095-4dannjjm	3778	13	groEL	groel	JJ
cord-023095-4dannjjm	3778	14	gene	gene	NN
cord-023095-4dannjjm	3778	15	of	of	IN
cord-023095-4dannjjm	3778	16	the	the	DT
cord-023095-4dannjjm	3778	17	genus	genus	NNP
cord-023095-4dannjjm	3778	18	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3778	19	and	and	CC
cord-023095-4dannjjm	3778	20	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3778	21	,	,	,
cord-023095-4dannjjm	3778	22	and	and	CC
cord-023095-4dannjjm	3778	23	for	for	IN
cord-023095-4dannjjm	3778	24	the	the	DT
cord-023095-4dannjjm	3778	25	intergenic	intergenic	JJ
cord-023095-4dannjjm	3778	26	transcribed	transcribe	VBN
cord-023095-4dannjjm	3778	27	spacer	spacer	NN
cord-023095-4dannjjm	3778	28	of	of	IN
cord-023095-4dannjjm	3778	29	the	the	DT
cord-023095-4dannjjm	3778	30	genus	genus	NN
cord-023095-4dannjjm	3778	31	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3778	32	.	.	.
cord-023095-4dannjjm	3779	1	Speciation	speciation	NN
cord-023095-4dannjjm	3779	2	was	be	VBD
cord-023095-4dannjjm	3779	3	conducted	conduct	VBN
cord-023095-4dannjjm	3779	4	by	by	IN
cord-023095-4dannjjm	3779	5	nucleotide	nucleotide	JJ
cord-023095-4dannjjm	3779	6	sequencing	sequencing	NN
cord-023095-4dannjjm	3779	7	.	.	.
cord-023095-4dannjjm	3780	1	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3780	2	genus	genus	NN
cord-023095-4dannjjm	3780	3	DNA	dna	NN
cord-023095-4dannjjm	3780	4	was	be	VBD
cord-023095-4dannjjm	3780	5	detected	detect	VBN
cord-023095-4dannjjm	3780	6	from	from	IN
cord-023095-4dannjjm	3780	7	seven	seven	CD
cord-023095-4dannjjm	3780	8	of	of	IN
cord-023095-4dannjjm	3780	9	the	the	DT
cord-023095-4dannjjm	3780	10	108	108	CD
cord-023095-4dannjjm	3780	11	dogs	dog	NNS
cord-023095-4dannjjm	3780	12	(	(	-LRB-
cord-023095-4dannjjm	3780	13	6.5	6.5	CD
cord-023095-4dannjjm	3780	14	%	%	NN
cord-023095-4dannjjm	3780	15	)	)	-RRB-
cord-023095-4dannjjm	3780	16	and	and	CC
cord-023095-4dannjjm	3780	17	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3780	18	canis	canis	NN
cord-023095-4dannjjm	3780	19	DNA	dna	NN
cord-023095-4dannjjm	3780	20	was	be	VBD
cord-023095-4dannjjm	3780	21	detected	detect	VBN
cord-023095-4dannjjm	3780	22	and	and	CC
cord-023095-4dannjjm	3780	23	sequenced	sequence	VBN
cord-023095-4dannjjm	3780	24	from	from	IN
cord-023095-4dannjjm	3780	25	one	one	CD
cord-023095-4dannjjm	3780	26	dog	dog	NN
cord-023095-4dannjjm	3780	27	(	(	-LRB-
cord-023095-4dannjjm	3780	28	0.9	0.9	CD
cord-023095-4dannjjm	3780	29	%	%	NN
cord-023095-4dannjjm	3780	30	)	)	-RRB-
cord-023095-4dannjjm	3780	31	.	.	.
cord-023095-4dannjjm	3781	1	Four	four	CD
cord-023095-4dannjjm	3781	2	of	of	IN
cord-023095-4dannjjm	3781	3	the	the	DT
cord-023095-4dannjjm	3781	4	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3781	5	positive	positive	JJ
cord-023095-4dannjjm	3781	6	samples	sample	NNS
cord-023095-4dannjjm	3781	7	were	be	VBD
cord-023095-4dannjjm	3781	8	identified	identify	VBN
cord-023095-4dannjjm	3781	9	by	by	IN
cord-023095-4dannjjm	3781	10	DNA	dna	NN
cord-023095-4dannjjm	3781	11	sequencing	sequencing	NN
cord-023095-4dannjjm	3781	12	as	as	IN
cord-023095-4dannjjm	3781	13	B.	B.	NNP
cord-023095-4dannjjm	3781	14	rochalimae	rochalimae	NNP
cord-023095-4dannjjm	3781	15	(	(	-LRB-
cord-023095-4dannjjm	3781	16	GenBank	GenBank	NNP
cord-023095-4dannjjm	3781	17	accession	accession	NN
cord-023095-4dannjjm	3781	18	numbers	number	NNS
cord-023095-4dannjjm	3781	19	HQ185696	hq185696	VBP
cord-023095-4dannjjm	3781	20	and	and	CC
cord-023095-4dannjjm	3781	21	HQ185695	HQ185695	NNP
cord-023095-4dannjjm	3781	22	)	)	-RRB-
cord-023095-4dannjjm	3781	23	.	.	.
cord-023095-4dannjjm	3782	1	The	the	DT
cord-023095-4dannjjm	3782	2	other	other	JJ
cord-023095-4dannjjm	3782	3	three	three	CD
cord-023095-4dannjjm	3782	4	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3782	5	positive	positive	JJ
cord-023095-4dannjjm	3782	6	samples	sample	NNS
cord-023095-4dannjjm	3782	7	were	be	VBD
cord-023095-4dannjjm	3782	8	identified	identify	VBN
cord-023095-4dannjjm	3782	9	as	as	IN
cord-023095-4dannjjm	3782	10	B.	B.	NNP
cord-023095-4dannjjm	3782	11	vinsonii	vinsonii	NNP
cord-023095-4dannjjm	3782	12	subspecies	subspecies	NNP
cord-023095-4dannjjm	3782	13	berkhoffii	berkhoffii	NNP
cord-023095-4dannjjm	3782	14	,	,	,
cord-023095-4dannjjm	3782	15	the	the	DT
cord-023095-4dannjjm	3782	16	causative	causative	JJ
cord-023095-4dannjjm	3782	17	agent	agent	NN
cord-023095-4dannjjm	3782	18	of	of	IN
cord-023095-4dannjjm	3782	19	endocarditis	endocarditis	NN
cord-023095-4dannjjm	3782	20	in	in	IN
cord-023095-4dannjjm	3782	21	dogs	dog	NNS
cord-023095-4dannjjm	3782	22	and	and	CC
cord-023095-4dannjjm	3782	23	humans	human	NNS
cord-023095-4dannjjm	3782	24	.	.	.
cord-023095-4dannjjm	3783	1	No	no	DT
cord-023095-4dannjjm	3783	2	dog	dog	NN
cord-023095-4dannjjm	3783	3	was	be	VBD
cord-023095-4dannjjm	3783	4	infected	infect	VBN
cord-023095-4dannjjm	3783	5	with	with	IN
cord-023095-4dannjjm	3783	6	Anaplasma	Anaplasma	NNP
cord-023095-4dannjjm	3783	7	species	specie	NNS
cord-023095-4dannjjm	3783	8	by	by	IN
cord-023095-4dannjjm	3783	9	DNA	dna	NN
cord-023095-4dannjjm	3783	10	amplification	amplification	NN
cord-023095-4dannjjm	3783	11	,	,	,
cord-023095-4dannjjm	3783	12	but	but	CC
cord-023095-4dannjjm	3783	13	one	one	CD
cord-023095-4dannjjm	3783	14	dog	dog	NN
cord-023095-4dannjjm	3783	15	was	be	VBD
cord-023095-4dannjjm	3783	16	seroreactive	seroreactive	JJ
cord-023095-4dannjjm	3783	17	for	for	IN
cord-023095-4dannjjm	3783	18	this	this	DT
cord-023095-4dannjjm	3783	19	genus	genus	NN
cord-023095-4dannjjm	3783	20	(	(	-LRB-
cord-023095-4dannjjm	3783	21	0.9	0.9	CD
cord-023095-4dannjjm	3783	22	%	%	NN
cord-023095-4dannjjm	3783	23	)	)	-RRB-
cord-023095-4dannjjm	3783	24	.	.	.
cord-023095-4dannjjm	3784	1	No	no	DT
cord-023095-4dannjjm	3784	2	specific	specific	JJ
cord-023095-4dannjjm	3784	3	antibodies	antibody	NNS
cord-023095-4dannjjm	3784	4	against	against	IN
cord-023095-4dannjjm	3784	5	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	3784	6	canis	canis	NN
cord-023095-4dannjjm	3784	7	and	and	CC
cord-023095-4dannjjm	3784	8	Borrelia	Borrelia	NNP
cord-023095-4dannjjm	3784	9	burgdorferi	burgdorferi	NN
cord-023095-4dannjjm	3784	10	and	and	CC
cord-023095-4dannjjm	3784	11	no	no	DT
cord-023095-4dannjjm	3784	12	antigens	antigen	NNS
cord-023095-4dannjjm	3784	13	of	of	IN
cord-023095-4dannjjm	3784	14	Dirofilaria	Dirofilaria	NNP
cord-023095-4dannjjm	3784	15	immitis	immitis	NNP
cord-023095-4dannjjm	3784	16	were	be	VBD
cord-023095-4dannjjm	3784	17	detected	detect	VBN
cord-023095-4dannjjm	3784	18	.	.	.
cord-023095-4dannjjm	3785	1	This	this	DT
cord-023095-4dannjjm	3785	2	study	study	NN
cord-023095-4dannjjm	3785	3	expands	expand	VBZ
cord-023095-4dannjjm	3785	4	the	the	DT
cord-023095-4dannjjm	3785	5	current	current	JJ
cord-023095-4dannjjm	3785	6	knowledge	knowledge	NN
cord-023095-4dannjjm	3785	7	about	about	IN
cord-023095-4dannjjm	3785	8	TBD	TBD	NNP
cord-023095-4dannjjm	3785	9	in	in	IN
cord-023095-4dannjjm	3785	10	Peru	Peru	NNP
cord-023095-4dannjjm	3785	11	and	and	CC
cord-023095-4dannjjm	3785	12	describes	describe	VBZ
cord-023095-4dannjjm	3785	13	for	for	IN
cord-023095-4dannjjm	3785	14	the	the	DT
cord-023095-4dannjjm	3785	15	first	first	JJ
cord-023095-4dannjjm	3785	16	time	time	NN
cord-023095-4dannjjm	3785	17	the	the	DT
cord-023095-4dannjjm	3785	18	infection	infection	NN
cord-023095-4dannjjm	3785	19	of	of	IN
cord-023095-4dannjjm	3785	20	B.	B.	NNP
cord-023095-4dannjjm	3785	21	rochalimae	rochalimae	NNP
cord-023095-4dannjjm	3785	22	in	in	IN
cord-023095-4dannjjm	3785	23	dogs	dog	NNS
cord-023095-4dannjjm	3785	24	in	in	IN
cord-023095-4dannjjm	3785	25	Peru	Peru	NNP
cord-023095-4dannjjm	3785	26	.	.	.
cord-023095-4dannjjm	3786	1	The	the	DT
cord-023095-4dannjjm	3786	2	results	result	NNS
cord-023095-4dannjjm	3786	3	suggest	suggest	VBP
cord-023095-4dannjjm	3786	4	that	that	IN
cord-023095-4dannjjm	3786	5	dogs	dog	NNS
cord-023095-4dannjjm	3786	6	may	may	MD
cord-023095-4dannjjm	3786	7	play	play	VB
cord-023095-4dannjjm	3786	8	an	an	DT
cord-023095-4dannjjm	3786	9	important	important	JJ
cord-023095-4dannjjm	3786	10	role	role	NN
cord-023095-4dannjjm	3786	11	in	in	IN
cord-023095-4dannjjm	3786	12	the	the	DT
cord-023095-4dannjjm	3786	13	epidemiology	epidemiology	NN
cord-023095-4dannjjm	3786	14	of	of	IN
cord-023095-4dannjjm	3786	15	this	this	DT
cord-023095-4dannjjm	3786	16	infection	infection	NN
cord-023095-4dannjjm	3786	17	in	in	IN
cord-023095-4dannjjm	3786	18	humans	human	NNS
cord-023095-4dannjjm	3786	19	,	,	,
cord-023095-4dannjjm	3786	20	since	since	IN
cord-023095-4dannjjm	3786	21	they	-PRON-	PRP
cord-023095-4dannjjm	3786	22	can	can	MD
cord-023095-4dannjjm	3786	23	be	be	VB
cord-023095-4dannjjm	3786	24	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	3786	25	but	but	CC
cord-023095-4dannjjm	3786	26	bacteremic	bacteremic	JJ
cord-023095-4dannjjm	3786	27	.	.	.
cord-023095-4dannjjm	3787	1	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3787	2	spp	spp	NN
cord-023095-4dannjjm	3787	3	.	.	.
cord-023095-4dannjjm	3788	1	DNA	DNA	NNP
cord-023095-4dannjjm	3788	2	is	be	VBZ
cord-023095-4dannjjm	3788	3	commonly	commonly	RB
cord-023095-4dannjjm	3788	4	amplified	amplify	VBN
cord-023095-4dannjjm	3788	5	from	from	IN
cord-023095-4dannjjm	3788	6	the	the	DT
cord-023095-4dannjjm	3788	7	blood	blood	NN
cord-023095-4dannjjm	3788	8	of	of	IN
cord-023095-4dannjjm	3788	9	cats	cat	NNS
cord-023095-4dannjjm	3788	10	exposed	expose	VBN
cord-023095-4dannjjm	3788	11	to	to	IN
cord-023095-4dannjjm	3788	12	Ctenocephalides	Ctenocephalides	NNP
cord-023095-4dannjjm	3788	13	felis	felis	NN
cord-023095-4dannjjm	3788	14	.	.	.
cord-023095-4dannjjm	3789	1	In	in	IN
cord-023095-4dannjjm	3789	2	previous	previous	JJ
cord-023095-4dannjjm	3789	3	work	work	NN
cord-023095-4dannjjm	3789	4	,	,	,
cord-023095-4dannjjm	3789	5	it	-PRON-	PRP
cord-023095-4dannjjm	3789	6	was	be	VBD
cord-023095-4dannjjm	3789	7	shown	show	VBN
cord-023095-4dannjjm	3789	8	that	that	IN
cord-023095-4dannjjm	3789	9	cats	cat	NNS
cord-023095-4dannjjm	3789	10	administered	administer	VBD
cord-023095-4dannjjm	3789	11	imidacloprid	imidacloprid	NNP
cord-023095-4dannjjm	3789	12	and	and	CC
cord-023095-4dannjjm	3789	13	experimentally	experimentally	RB
cord-023095-4dannjjm	3789	14	exposed	expose	VBN
cord-023095-4dannjjm	3789	15	to	to	IN
cord-023095-4dannjjm	3789	16	B.	B.	NNP
cord-023095-4dannjjm	3789	17	henselae	henselae	NNP
cord-023095-4dannjjm	3789	18	infected	infect	VBD
cord-023095-4dannjjm	3789	19	cats	cat	NNS
cord-023095-4dannjjm	3789	20	and	and	CC
cord-023095-4dannjjm	3789	21	C.	C.	NNP
cord-023095-4dannjjm	3789	22	felis	felis	NNP
cord-023095-4dannjjm	3789	23	did	do	VBD
cord-023095-4dannjjm	3789	24	not	not	RB
cord-023095-4dannjjm	3789	25	become	become	VB
cord-023095-4dannjjm	3789	26	PCR	PCR	NNP
cord-023095-4dannjjm	3789	27	positive	positive	JJ
cord-023095-4dannjjm	3789	28	for	for	IN
cord-023095-4dannjjm	3789	29	B.	B.	NNP
cord-023095-4dannjjm	3789	30	henselae	henselae	NNP
cord-023095-4dannjjm	3789	31	whereas	whereas	IN
cord-023095-4dannjjm	3789	32	untreated	untreated	JJ
cord-023095-4dannjjm	3789	33	cats	cat	NNS
cord-023095-4dannjjm	3789	34	all	all	DT
cord-023095-4dannjjm	3789	35	developed	develop	VBD
cord-023095-4dannjjm	3789	36	infection	infection	NN
cord-023095-4dannjjm	3789	37	.	.	.
cord-023095-4dannjjm	3790	1	The	the	DT
cord-023095-4dannjjm	3790	2	purpose	purpose	NN
cord-023095-4dannjjm	3790	3	of	of	IN
cord-023095-4dannjjm	3790	4	this	this	DT
cord-023095-4dannjjm	3790	5	study	study	NN
cord-023095-4dannjjm	3790	6	was	be	VBD
cord-023095-4dannjjm	3790	7	to	to	TO
cord-023095-4dannjjm	3790	8	determine	determine	VB
cord-023095-4dannjjm	3790	9	if	if	IN
cord-023095-4dannjjm	3790	10	administration	administration	NN
cord-023095-4dannjjm	3790	11	of	of	IN
cord-023095-4dannjjm	3790	12	imidacloprid	imidacloprid	NNP
cord-023095-4dannjjm	3790	13	to	to	IN
cord-023095-4dannjjm	3790	14	clientowned	clientowne	VBN
cord-023095-4dannjjm	3790	15	cats	cat	NNS
cord-023095-4dannjjm	3790	16	likely	likely	JJ
cord-023095-4dannjjm	3790	17	to	to	TO
cord-023095-4dannjjm	3790	18	be	be	VB
cord-023095-4dannjjm	3790	19	exposed	expose	VBN
cord-023095-4dannjjm	3790	20	to	to	IN
cord-023095-4dannjjm	3790	21	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3790	22	spp	spp	NNS
cord-023095-4dannjjm	3790	23	.	.	.
cord-023095-4dannjjm	3791	1	and	and	CC
cord-023095-4dannjjm	3791	2	C.	C.	NNP
cord-023095-4dannjjm	3791	3	felis	felis	NN
cord-023095-4dannjjm	3791	4	in	in	IN
cord-023095-4dannjjm	3791	5	the	the	DT
cord-023095-4dannjjm	3791	6	field	field	NN
cord-023095-4dannjjm	3791	7	lessens	lessen	VBZ
cord-023095-4dannjjm	3791	8	prevalence	prevalence	NN
cord-023095-4dannjjm	3791	9	of	of	IN
cord-023095-4dannjjm	3791	10	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3791	11	spp	spp	NNS
cord-023095-4dannjjm	3791	12	.	.	.
cord-023095-4dannjjm	3792	1	infection	infection	NN
cord-023095-4dannjjm	3792	2	.	.	.
cord-023095-4dannjjm	3793	1	Veterinary	veterinary	JJ
cord-023095-4dannjjm	3793	2	students	student	NNS
cord-023095-4dannjjm	3793	3	in	in	IN
cord-023095-4dannjjm	3793	4	Tennessee	Tennessee	NNP
cord-023095-4dannjjm	3793	5	and	and	CC
cord-023095-4dannjjm	3793	6	Florida	Florida	NNP
cord-023095-4dannjjm	3793	7	that	that	WDT
cord-023095-4dannjjm	3793	8	owned	own	VBD
cord-023095-4dannjjm	3793	9	cats	cat	NNS
cord-023095-4dannjjm	3793	10	that	that	WDT
cord-023095-4dannjjm	3793	11	spent	spend	VBD
cord-023095-4dannjjm	3793	12	at	at	IN
cord-023095-4dannjjm	3793	13	least	least	RBS
cord-023095-4dannjjm	3793	14	20	20	CD
cord-023095-4dannjjm	3793	15	days	day	NNS
cord-023095-4dannjjm	3793	16	per	per	IN
cord-023095-4dannjjm	3793	17	month	month	NN
cord-023095-4dannjjm	3793	18	outside	outside	RB
cord-023095-4dannjjm	3794	1	and	and	CC
cord-023095-4dannjjm	3794	2	that	that	DT
cord-023095-4dannjjm	3794	3	were	be	VBD
cord-023095-4dannjjm	3794	4	willing	willing	JJ
cord-023095-4dannjjm	3794	5	to	to	TO
cord-023095-4dannjjm	3794	6	apply	apply	VB
cord-023095-4dannjjm	3794	7	imidacloprid	imidacloprid	NNP
cord-023095-4dannjjm	3794	8	to	to	IN
cord-023095-4dannjjm	3794	9	their	-PRON-	PRP$
cord-023095-4dannjjm	3794	10	cats	cat	NNS
cord-023095-4dannjjm	3794	11	monthly	monthly	JJ
cord-023095-4dannjjm	3794	12	for	for	IN
cord-023095-4dannjjm	3794	13	six	six	CD
cord-023095-4dannjjm	3794	14	months	month	NNS
cord-023095-4dannjjm	3794	15	were	be	VBD
cord-023095-4dannjjm	3794	16	recruited	recruit	VBN
cord-023095-4dannjjm	3794	17	for	for	IN
cord-023095-4dannjjm	3794	18	the	the	DT
cord-023095-4dannjjm	3794	19	study	study	NN
cord-023095-4dannjjm	3794	20	.	.	.
cord-023095-4dannjjm	3795	1	Blood	blood	NN
cord-023095-4dannjjm	3795	2	for	for	IN
cord-023095-4dannjjm	3795	3	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3795	4	spp	spp	NNS
cord-023095-4dannjjm	3795	5	.	.	.
cord-023095-4dannjjm	3796	1	PCR	PCR	NNP
cord-023095-4dannjjm	3796	2	assay	assay	NN
cord-023095-4dannjjm	3796	3	was	be	VBD
cord-023095-4dannjjm	3796	4	collected	collect	VBN
cord-023095-4dannjjm	3796	5	from	from	IN
cord-023095-4dannjjm	3796	6	the	the	DT
cord-023095-4dannjjm	3796	7	cats	cat	NNS
cord-023095-4dannjjm	3796	8	seven	seven	CD
cord-023095-4dannjjm	3796	9	months	month	NNS
cord-023095-4dannjjm	3796	10	after	after	IN
cord-023095-4dannjjm	3796	11	starting	start	VBG
cord-023095-4dannjjm	3796	12	imidacloprid	imidacloprid	NNP
cord-023095-4dannjjm	3796	13	administration	administration	NN
cord-023095-4dannjjm	3796	14	and	and	CC
cord-023095-4dannjjm	3796	15	assayed	assay	VBD
cord-023095-4dannjjm	3796	16	at	at	IN
cord-023095-4dannjjm	3796	17	Colorado	Colorado	NNP
cord-023095-4dannjjm	3796	18	State	State	NNP
cord-023095-4dannjjm	3796	19	University	University	NNP
cord-023095-4dannjjm	3796	20	.	.	.
cord-023095-4dannjjm	3797	1	To	to	TO
cord-023095-4dannjjm	3797	2	serve	serve	VB
cord-023095-4dannjjm	3797	3	as	as	IN
cord-023095-4dannjjm	3797	4	a	a	DT
cord-023095-4dannjjm	3797	5	control	control	NN
cord-023095-4dannjjm	3797	6	group	group	NN
cord-023095-4dannjjm	3797	7	that	that	WDT
cord-023095-4dannjjm	3797	8	was	be	VBD
cord-023095-4dannjjm	3797	9	unlikely	unlikely	JJ
cord-023095-4dannjjm	3797	10	to	to	TO
cord-023095-4dannjjm	3797	11	have	have	VB
cord-023095-4dannjjm	3797	12	been	be	VBN
cord-023095-4dannjjm	3797	13	administered	administer	VBN
cord-023095-4dannjjm	3797	14	flea	flea	NN
cord-023095-4dannjjm	3797	15	control	control	NN
cord-023095-4dannjjm	3797	16	products	product	NNS
cord-023095-4dannjjm	3797	17	in	in	IN
cord-023095-4dannjjm	3797	18	the	the	DT
cord-023095-4dannjjm	3797	19	previous	previous	JJ
cord-023095-4dannjjm	3797	20	6	6	CD
cord-023095-4dannjjm	3797	21	months	month	NNS
cord-023095-4dannjjm	3797	22	,	,	,
cord-023095-4dannjjm	3797	23	blood	blood	NN
cord-023095-4dannjjm	3797	24	was	be	VBD
cord-023095-4dannjjm	3797	25	collected	collect	VBN
cord-023095-4dannjjm	3797	26	from	from	IN
cord-023095-4dannjjm	3797	27	feral	feral	JJ
cord-023095-4dannjjm	3797	28	cats	cat	NNS
cord-023095-4dannjjm	3797	29	during	during	IN
cord-023095-4dannjjm	3797	30	TNR	TNR	NNP
cord-023095-4dannjjm	3797	31	programs	program	NNS
cord-023095-4dannjjm	3797	32	in	in	IN
cord-023095-4dannjjm	3797	33	each	each	DT
cord-023095-4dannjjm	3797	34	of	of	IN
cord-023095-4dannjjm	3797	35	the	the	DT
cord-023095-4dannjjm	3797	36	two	two	CD
cord-023095-4dannjjm	3797	37	cities	city	NNS
cord-023095-4dannjjm	3797	38	and	and	CC
cord-023095-4dannjjm	3797	39	assayed	assay	VBN
cord-023095-4dannjjm	3797	40	for	for	IN
cord-023095-4dannjjm	3797	41	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3797	42	spp	spp	NNS
cord-023095-4dannjjm	3797	43	.	.	.
cord-023095-4dannjjm	3798	1	DNA	DNA	NNP
cord-023095-4dannjjm	3798	2	.	.	.
cord-023095-4dannjjm	3799	1	The	the	DT
cord-023095-4dannjjm	3799	2	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3799	3	spp	spp	NN
cord-023095-4dannjjm	3799	4	.	.	.
cord-023095-4dannjjm	3800	1	DNA	dna	NN
cord-023095-4dannjjm	3800	2	prevalence	prevalence	NN
cord-023095-4dannjjm	3800	3	rates	rate	NNS
cord-023095-4dannjjm	3800	4	between	between	IN
cord-023095-4dannjjm	3800	5	the	the	DT
cord-023095-4dannjjm	3800	6	groups	group	NNS
cord-023095-4dannjjm	3800	7	were	be	VBD
cord-023095-4dannjjm	3800	8	compared	compare	VBN
cord-023095-4dannjjm	3800	9	by	by	IN
cord-023095-4dannjjm	3800	10	chi	chi	NNP
cord-023095-4dannjjm	3800	11	square	square	NNP
cord-023095-4dannjjm	3800	12	analysis	analysis	NN
cord-023095-4dannjjm	3800	13	with	with	IN
cord-023095-4dannjjm	3800	14	significance	significance	NN
cord-023095-4dannjjm	3800	15	defined	define	VBN
cord-023095-4dannjjm	3800	16	as	as	IN
cord-023095-4dannjjm	3800	17	P	p	NN
cord-023095-4dannjjm	3800	18	o	o	NN
cord-023095-4dannjjm	3800	19	0.05	0.05	CD
cord-023095-4dannjjm	3800	20	.	.	.
cord-023095-4dannjjm	3801	1	The	the	DT
cord-023095-4dannjjm	3801	2	overall	overall	JJ
cord-023095-4dannjjm	3801	3	prevalence	prevalence	NN
cord-023095-4dannjjm	3801	4	rates	rate	NNS
cord-023095-4dannjjm	3801	5	for	for	IN
cord-023095-4dannjjm	3801	6	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3801	7	spp	spp	NNS
cord-023095-4dannjjm	3801	8	.	.	.
cord-023095-4dannjjm	3802	1	DNA	DNA	NNP
cord-023095-4dannjjm	3802	2	in	in	IN
cord-023095-4dannjjm	3802	3	the	the	DT
cord-023095-4dannjjm	3802	4	blood	blood	NN
cord-023095-4dannjjm	3802	5	of	of	IN
cord-023095-4dannjjm	3802	6	veterinary	veterinary	JJ
cord-023095-4dannjjm	3802	7	student	student	NN
cord-023095-4dannjjm	3802	8	cats	cat	NNS
cord-023095-4dannjjm	3802	9	(	(	-LRB-
cord-023095-4dannjjm	3802	10	7.4	7.4	CD
cord-023095-4dannjjm	3802	11	%	%	NN
cord-023095-4dannjjm	3802	12	)	)	-RRB-
cord-023095-4dannjjm	3802	13	and	and	CC
cord-023095-4dannjjm	3802	14	the	the	DT
cord-023095-4dannjjm	3802	15	feral	feral	JJ
cord-023095-4dannjjm	3802	16	cats	cat	NNS
cord-023095-4dannjjm	3802	17	(	(	-LRB-
cord-023095-4dannjjm	3802	18	39.1	39.1	CD
cord-023095-4dannjjm	3802	19	%	%	NN
cord-023095-4dannjjm	3802	20	)	)	-RRB-
cord-023095-4dannjjm	3802	21	were	be	VBD
cord-023095-4dannjjm	3802	22	significantly	significantly	RB
cord-023095-4dannjjm	3802	23	different	different	JJ
cord-023095-4dannjjm	3802	24	(	(	-LRB-
cord-023095-4dannjjm	3802	25	P	p	NN
cord-023095-4dannjjm	3802	26	o	o	NN
cord-023095-4dannjjm	3802	27	0.0001	0.0001	CD
cord-023095-4dannjjm	3802	28	)	)	-RRB-
cord-023095-4dannjjm	3802	29	.	.	.
cord-023095-4dannjjm	3803	1	The	the	DT
cord-023095-4dannjjm	3803	2	distribution	distribution	NN
cord-023095-4dannjjm	3803	3	of	of	IN
cord-023095-4dannjjm	3803	4	results	result	NNS
cord-023095-4dannjjm	3803	5	is	be	VBZ
cord-023095-4dannjjm	3803	6	shown	show	VBN
cord-023095-4dannjjm	3803	7	in	in	IN
cord-023095-4dannjjm	3803	8	Table	Table	NNP
cord-023095-4dannjjm	3803	9	1	1	CD
cord-023095-4dannjjm	3803	10	.	.	.
cord-023095-4dannjjm	3804	1	The	the	DT
cord-023095-4dannjjm	3804	2	results	result	NNS
cord-023095-4dannjjm	3804	3	suggest	suggest	VBP
cord-023095-4dannjjm	3804	4	that	that	IN
cord-023095-4dannjjm	3804	5	Florida	Florida	NNP
cord-023095-4dannjjm	3804	6	feral	feral	JJ
cord-023095-4dannjjm	3804	7	cats	cat	NNS
cord-023095-4dannjjm	3804	8	were	be	VBD
cord-023095-4dannjjm	3804	9	more	more	RBR
cord-023095-4dannjjm	3804	10	commonly	commonly	RB
cord-023095-4dannjjm	3804	11	exposed	expose	VBN
cord-023095-4dannjjm	3804	12	to	to	IN
cord-023095-4dannjjm	3804	13	C.	C.	NNP
cord-023095-4dannjjm	3804	14	felis	felis	NN
cord-023095-4dannjjm	3804	15	than	than	IN
cord-023095-4dannjjm	3804	16	Tennessee	Tennessee	NNP
cord-023095-4dannjjm	3804	17	feral	feral	JJ
cord-023095-4dannjjm	3804	18	cats	cat	NNS
cord-023095-4dannjjm	3804	19	.	.	.
cord-023095-4dannjjm	3805	1	While	while	IN
cord-023095-4dannjjm	3805	2	the	the	DT
cord-023095-4dannjjm	3805	3	cats	cat	NNS
cord-023095-4dannjjm	3805	4	in	in	IN
cord-023095-4dannjjm	3805	5	the	the	DT
cord-023095-4dannjjm	3805	6	groups	group	NNS
cord-023095-4dannjjm	3805	7	were	be	VBD
cord-023095-4dannjjm	3805	8	not	not	RB
cord-023095-4dannjjm	3805	9	exactly	exactly	RB
cord-023095-4dannjjm	3805	10	matched	match	VBN
cord-023095-4dannjjm	3805	11	,	,	,
cord-023095-4dannjjm	3805	12	the	the	DT
cord-023095-4dannjjm	3805	13	student	student	NN
cord-023095-4dannjjm	3805	14	cats	cat	NNS
cord-023095-4dannjjm	3805	15	were	be	VBD
cord-023095-4dannjjm	3805	16	allowed	allow	VBN
cord-023095-4dannjjm	3805	17	outdoors	outdoors	RB
cord-023095-4dannjjm	3805	18	for	for	IN
cord-023095-4dannjjm	3805	19	approximately	approximately	RB
cord-023095-4dannjjm	3805	20	20	20	CD
cord-023095-4dannjjm	3805	21	days	day	NNS
cord-023095-4dannjjm	3805	22	per	per	IN
cord-023095-4dannjjm	3805	23	month	month	NN
cord-023095-4dannjjm	3805	24	and	and	CC
cord-023095-4dannjjm	3805	25	lived	live	VBD
cord-023095-4dannjjm	3805	26	in	in	IN
cord-023095-4dannjjm	3805	27	the	the	DT
cord-023095-4dannjjm	3805	28	same	same	JJ
cord-023095-4dannjjm	3805	29	cities	city	NNS
cord-023095-4dannjjm	3805	30	as	as	IN
cord-023095-4dannjjm	3805	31	the	the	DT
cord-023095-4dannjjm	3805	32	feral	feral	JJ
cord-023095-4dannjjm	3805	33	cats	cat	NNS
cord-023095-4dannjjm	3805	34	,	,	,
cord-023095-4dannjjm	3805	35	so	so	RB
cord-023095-4dannjjm	3805	36	C.	C.	NNP
cord-023095-4dannjjm	3805	37	felis	felis	NN
cord-023095-4dannjjm	3805	38	exposure	exposure	NN
cord-023095-4dannjjm	3805	39	rates	rate	NNS
cord-023095-4dannjjm	3805	40	were	be	VBD
cord-023095-4dannjjm	3805	41	likely	likely	RB
cord-023095-4dannjjm	3805	42	similar	similar	JJ
cord-023095-4dannjjm	3805	43	.	.	.
cord-023095-4dannjjm	3806	1	As	as	IN
cord-023095-4dannjjm	3806	2	previously	previously	RB
cord-023095-4dannjjm	3806	3	shown	show	VBN
cord-023095-4dannjjm	3806	4	in	in	IN
cord-023095-4dannjjm	3806	5	experimentally	experimentally	RB
cord-023095-4dannjjm	3806	6	-	-	HYPH
cord-023095-4dannjjm	3806	7	exposed	expose	VBN
cord-023095-4dannjjm	3806	8	cats	cat	NNS
cord-023095-4dannjjm	3806	9	,	,	,
cord-023095-4dannjjm	3806	10	the	the	DT
cord-023095-4dannjjm	3806	11	use	use	NN
cord-023095-4dannjjm	3806	12	of	of	IN
cord-023095-4dannjjm	3806	13	imidacloprid	imidacloprid	NNP
cord-023095-4dannjjm	3806	14	monthly	monthly	JJ
cord-023095-4dannjjm	3806	15	may	may	MD
cord-023095-4dannjjm	3806	16	influence	influence	VB
cord-023095-4dannjjm	3806	17	transmission	transmission	NN
cord-023095-4dannjjm	3806	18	rates	rate	NNS
cord-023095-4dannjjm	3806	19	of	of	IN
cord-023095-4dannjjm	3806	20	Bartonella	Bartonella	NNP
cord-023095-4dannjjm	3806	21	spp	spp	NNS
cord-023095-4dannjjm	3806	22	.	.	.
cord-023095-4dannjjm	3807	1	amongst	amongst	IN
cord-023095-4dannjjm	3807	2	naturally	naturally	RB
cord-023095-4dannjjm	3807	3	-	-	HYPH
cord-023095-4dannjjm	3807	4	exposed	expose	VBN
cord-023095-4dannjjm	3807	5	cats	cat	NNS
cord-023095-4dannjjm	3807	6	.	.	.
cord-023095-4dannjjm	3808	1	In	in	IN
cord-023095-4dannjjm	3808	2	an	an	DT
cord-023095-4dannjjm	3808	3	endemic	endemic	JJ
cord-023095-4dannjjm	3808	4	area	area	NN
cord-023095-4dannjjm	3808	5	for	for	IN
cord-023095-4dannjjm	3808	6	leishmaniosis	leishmaniosis	NNP
cord-023095-4dannjjm	3808	7	and	and	CC
cord-023095-4dannjjm	3808	8	filariosis	filariosis	NNP
cord-023095-4dannjjm	3808	9	,	,	,
cord-023095-4dannjjm	3808	10	coinfection	coinfection	NN
cord-023095-4dannjjm	3808	11	can	can	MD
cord-023095-4dannjjm	3808	12	occur	occur	VB
cord-023095-4dannjjm	3808	13	and	and	CC
cord-023095-4dannjjm	3808	14	immunomodulation	immunomodulation	NN
cord-023095-4dannjjm	3808	15	produced	produce	VBN
cord-023095-4dannjjm	3808	16	by	by	IN
cord-023095-4dannjjm	3808	17	Wolbachia	Wolbachia	NNP
cord-023095-4dannjjm	3808	18	might	may	MD
cord-023095-4dannjjm	3808	19	influence	influence	VB
cord-023095-4dannjjm	3808	20	the	the	DT
cord-023095-4dannjjm	3808	21	clinical	clinical	JJ
cord-023095-4dannjjm	3808	22	signs	sign	NNS
cord-023095-4dannjjm	3808	23	and	and	CC
cord-023095-4dannjjm	3808	24	progression	progression	NN
cord-023095-4dannjjm	3808	25	of	of	IN
cord-023095-4dannjjm	3808	26	both	both	DT
cord-023095-4dannjjm	3808	27	diseases	disease	NNS
cord-023095-4dannjjm	3808	28	.	.	.
cord-023095-4dannjjm	3809	1	The	the	DT
cord-023095-4dannjjm	3809	2	aims	aim	NNS
cord-023095-4dannjjm	3809	3	of	of	IN
cord-023095-4dannjjm	3809	4	the	the	DT
cord-023095-4dannjjm	3809	5	present	present	JJ
cord-023095-4dannjjm	3809	6	study	study	NN
cord-023095-4dannjjm	3809	7	were	be	VBD
cord-023095-4dannjjm	3809	8	1	1	CD
cord-023095-4dannjjm	3809	9	)	)	-RRB-
cord-023095-4dannjjm	3809	10	to	to	TO
cord-023095-4dannjjm	3809	11	determine	determine	VB
cord-023095-4dannjjm	3809	12	the	the	DT
cord-023095-4dannjjm	3809	13	prevalence	prevalence	NN
cord-023095-4dannjjm	3809	14	of	of	IN
cord-023095-4dannjjm	3809	15	Wolbachia	Wolbachia	NNP
cord-023095-4dannjjm	3809	16	in	in	IN
cord-023095-4dannjjm	3809	17	dogs	dog	NNS
cord-023095-4dannjjm	3809	18	infected	infect	VBN
cord-023095-4dannjjm	3809	19	with	with	IN
cord-023095-4dannjjm	3809	20	Dirofilaria	Dirofilaria	NNP
cord-023095-4dannjjm	3809	21	immitis	immitis	NNP
cord-023095-4dannjjm	3809	22	(	(	-LRB-
cord-023095-4dannjjm	3809	23	Di	Di	NNP
cord-023095-4dannjjm	3809	24	)	)	-RRB-
cord-023095-4dannjjm	3809	25	and	and	CC
cord-023095-4dannjjm	3809	26	other	other	JJ
cord-023095-4dannjjm	3809	27	filarial	filarial	JJ
cord-023095-4dannjjm	3809	28	nematodes	nematode	NNS
cord-023095-4dannjjm	3809	29	,	,	,
cord-023095-4dannjjm	3809	30	2	2	CD
cord-023095-4dannjjm	3809	31	)	)	-RRB-
cord-023095-4dannjjm	3809	32	to	to	TO
cord-023095-4dannjjm	3809	33	evaluate	evaluate	VB
cord-023095-4dannjjm	3809	34	the	the	DT
cord-023095-4dannjjm	3809	35	level	level	NN
cord-023095-4dannjjm	3809	36	of	of	IN
cord-023095-4dannjjm	3809	37	coinfection	coinfection	NN
cord-023095-4dannjjm	3809	38	of	of	IN
cord-023095-4dannjjm	3809	39	leishmaniosis	leishmaniosis	NNP
cord-023095-4dannjjm	3809	40	and	and	CC
cord-023095-4dannjjm	3809	41	filariosis	filariosis	NN
cord-023095-4dannjjm	3809	42	by	by	IN
cord-023095-4dannjjm	3809	43	molecular	molecular	JJ
cord-023095-4dannjjm	3809	44	assays	assay	NNS
cord-023095-4dannjjm	3809	45	and	and	CC
cord-023095-4dannjjm	3809	46	3	3	CD
cord-023095-4dannjjm	3809	47	)	)	-RRB-
cord-023095-4dannjjm	3809	48	to	to	TO
cord-023095-4dannjjm	3809	49	evaluate	evaluate	VB
cord-023095-4dannjjm	3809	50	any	any	DT
cord-023095-4dannjjm	3809	51	associations	association	NNS
cord-023095-4dannjjm	3809	52	between	between	IN
cord-023095-4dannjjm	3809	53	Leishmania	Leishmania	NNP
cord-023095-4dannjjm	3809	54	infantum	infantum	NN
cord-023095-4dannjjm	3809	55	(	(	-LRB-
cord-023095-4dannjjm	3809	56	Li	Li	NNP
cord-023095-4dannjjm	3809	57	)	)	-RRB-
cord-023095-4dannjjm	3809	58	infection	infection	NN
cord-023095-4dannjjm	3809	59	,	,	,
cord-023095-4dannjjm	3809	60	filariosis	filariosis	NN
cord-023095-4dannjjm	3809	61	with	with	IN
cord-023095-4dannjjm	3809	62	or	or	CC
cord-023095-4dannjjm	3809	63	without	without	IN
cord-023095-4dannjjm	3809	64	Wolbachia	Wolbachia	NNP
cord-023095-4dannjjm	3809	65	and	and	CC
cord-023095-4dannjjm	3809	66	clinical	clinical	JJ
cord-023095-4dannjjm	3809	67	presentation	presentation	NN
cord-023095-4dannjjm	3809	68	and	and	CC
cord-023095-4dannjjm	3809	69	outcome	outcome	NN
cord-023095-4dannjjm	3809	70	.	.	.
cord-023095-4dannjjm	3810	1	Statistical	statistical	JJ
cord-023095-4dannjjm	3810	2	differences	difference	NNS
cord-023095-4dannjjm	3810	3	between	between	IN
cord-023095-4dannjjm	3810	4	groups	group	NNS
cord-023095-4dannjjm	3810	5	were	be	VBD
cord-023095-4dannjjm	3810	6	tested	test	VBN
cord-023095-4dannjjm	3810	7	for	for	IN
cord-023095-4dannjjm	3810	8	significance	significance	NN
cord-023095-4dannjjm	3810	9	by	by	IN
cord-023095-4dannjjm	3810	10	the	the	DT
cord-023095-4dannjjm	3810	11	Fisher	Fisher	NNP
cord-023095-4dannjjm	3810	12	exact	exact	JJ
cord-023095-4dannjjm	3810	13	test	test	NN
cord-023095-4dannjjm	3810	14	using	use	VBG
cord-023095-4dannjjm	3810	15	SPSS	SPSS	NNP
cord-023095-4dannjjm	3810	16	v.14.0	v.14.0	NNP
cord-023095-4dannjjm	3810	17	software	software	NN
cord-023095-4dannjjm	3810	18	(	(	-LRB-
cord-023095-4dannjjm	3810	19	significance	significance	NN
cord-023095-4dannjjm	3810	20	:	:	:
cord-023095-4dannjjm	3810	21	p	p	NN
cord-023095-4dannjjm	3810	22	-	-	HYPH
cord-023095-4dannjjm	3810	23	value	value	NN
cord-023095-4dannjjm	3810	24	o	o	CD
cord-023095-4dannjjm	3810	25	0.05	0.05	CD
cord-023095-4dannjjm	3810	26	)	)	-RRB-
cord-023095-4dannjjm	3810	27	.	.	.
cord-023095-4dannjjm	3811	1	One	one	CD
cord-023095-4dannjjm	3811	2	-	-	HYPH
cord-023095-4dannjjm	3811	3	hundred	hundred	CD
cord-023095-4dannjjm	3811	4	and	and	CC
cord-023095-4dannjjm	3811	5	eighteen	eighteen	CD
cord-023095-4dannjjm	3811	6	owned	own	VBN
cord-023095-4dannjjm	3811	7	dogs	dog	NNS
cord-023095-4dannjjm	3811	8	from	from	IN
cord-023095-4dannjjm	3811	9	Southeastern	Southeastern	NNP
cord-023095-4dannjjm	3811	10	Spain	Spain	NNP
cord-023095-4dannjjm	3811	11	presenting	present	VBG
cord-023095-4dannjjm	3811	12	for	for	IN
cord-023095-4dannjjm	3811	13	clinical	clinical	JJ
cord-023095-4dannjjm	3811	14	evaluation	evaluation	NN
cord-023095-4dannjjm	3811	15	were	be	VBD
cord-023095-4dannjjm	3811	16	included	include	VBN
cord-023095-4dannjjm	3811	17	in	in	IN
cord-023095-4dannjjm	3811	18	the	the	DT
cord-023095-4dannjjm	3811	19	study	study	NN
cord-023095-4dannjjm	3811	20	.	.	.
cord-023095-4dannjjm	3812	1	Criteria	criterion	NNS
cord-023095-4dannjjm	3813	1	The	the	DT
cord-023095-4dannjjm	3813	2	results	result	NNS
cord-023095-4dannjjm	3813	3	of	of	IN
cord-023095-4dannjjm	3813	4	this	this	DT
cord-023095-4dannjjm	3813	5	study	study	NN
cord-023095-4dannjjm	3813	6	highlight	highlight	VBP
cord-023095-4dannjjm	3813	7	the	the	DT
cord-023095-4dannjjm	3813	8	increased	increase	VBN
cord-023095-4dannjjm	3813	9	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3813	10	of	of	IN
cord-023095-4dannjjm	3813	11	PCR	PCR	NNP
cord-023095-4dannjjm	3813	12	for	for	IN
cord-023095-4dannjjm	3813	13	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3813	14	of	of	IN
cord-023095-4dannjjm	3813	15	filariosis	filariosis	NN
cord-023095-4dannjjm	3813	16	,	,	,
cord-023095-4dannjjm	3813	17	confirm	confirm	VB
cord-023095-4dannjjm	3813	18	the	the	DT
cord-023095-4dannjjm	3813	19	presence	presence	NN
cord-023095-4dannjjm	3813	20	of	of	IN
cord-023095-4dannjjm	3813	21	Wolbachia	Wolbachia	NNP
cord-023095-4dannjjm	3813	22	in	in	IN
cord-023095-4dannjjm	3813	23	dogs	dog	NNS
cord-023095-4dannjjm	3813	24	from	from	IN
cord-023095-4dannjjm	3813	25	the	the	DT
cord-023095-4dannjjm	3813	26	Mediterranean	Mediterranean	NNP
cord-023095-4dannjjm	3813	27	basin	basin	NN
cord-023095-4dannjjm	3813	28	,	,	,
cord-023095-4dannjjm	3813	29	show	show	VB
cord-023095-4dannjjm	3813	30	the	the	DT
cord-023095-4dannjjm	3813	31	increased	increase	VBN
cord-023095-4dannjjm	3813	32	severity	severity	NN
cord-023095-4dannjjm	3813	33	of	of	IN
cord-023095-4dannjjm	3813	34	HWD	HWD	NNP
cord-023095-4dannjjm	3813	35	when	when	WRB
cord-023095-4dannjjm	3813	36	Li	Li	NNP
cord-023095-4dannjjm	3813	37	-	-	HYPH
cord-023095-4dannjjm	3813	38	Filaria	Filaria	NNP
cord-023095-4dannjjm	3813	39	coinfection	coinfection	NN
cord-023095-4dannjjm	3813	40	is	be	VBZ
cord-023095-4dannjjm	3813	41	present	present	JJ
cord-023095-4dannjjm	3813	42	and	and	CC
cord-023095-4dannjjm	3813	43	suggest	suggest	VBP
cord-023095-4dannjjm	3813	44	that	that	IN
cord-023095-4dannjjm	3813	45	Wolbachia	Wolbachia	NNP
cord-023095-4dannjjm	3813	46	could	could	MD
cord-023095-4dannjjm	3813	47	play	play	VB
cord-023095-4dannjjm	3813	48	a	a	DT
cord-023095-4dannjjm	3813	49	protective	protective	JJ
cord-023095-4dannjjm	3813	50	role	role	NN
cord-023095-4dannjjm	3813	51	for	for	IN
cord-023095-4dannjjm	3813	52	leishmaniosis	leishmaniosis	NNP
cord-023095-4dannjjm	3813	53	.	.	.
cord-023095-4dannjjm	3814	1	Wolbachia	Wolbachia	NNP
cord-023095-4dannjjm	3814	2	antigens	antigen	NNS
cord-023095-4dannjjm	3814	3	can	can	MD
cord-023095-4dannjjm	3814	4	stimulate	stimulate	VB
cord-023095-4dannjjm	3814	5	a	a	DT
cord-023095-4dannjjm	3814	6	Th1-type	Th1-type	NNP
cord-023095-4dannjjm	3814	7	immune	immune	JJ
cord-023095-4dannjjm	3814	8	response	response	NN
cord-023095-4dannjjm	3814	9	,	,	,
cord-023095-4dannjjm	3814	10	as	as	IN
cord-023095-4dannjjm	3814	11	has	have	VBZ
cord-023095-4dannjjm	3814	12	been	be	VBN
cord-023095-4dannjjm	3814	13	previously	previously	RB
cord-023095-4dannjjm	3814	14	described	describe	VBN
cord-023095-4dannjjm	3814	15	.	.	.
cord-023095-4dannjjm	3815	1	However	however	WRB
cord-023095-4dannjjm	3815	2	other	other	JJ
cord-023095-4dannjjm	3815	3	factors	factor	NNS
cord-023095-4dannjjm	3815	4	(	(	-LRB-
cord-023095-4dannjjm	3815	5	as	as	IN
cord-023095-4dannjjm	3815	6	treatment	treatment	NN
cord-023095-4dannjjm	3815	7	with	with	IN
cord-023095-4dannjjm	3815	8	doxycicline	doxycicline	NNP
cord-023095-4dannjjm	3815	9	)	)	-RRB-
cord-023095-4dannjjm	3815	10	might	may	MD
cord-023095-4dannjjm	3815	11	be	be	VB
cord-023095-4dannjjm	3815	12	responsible	responsible	JJ
cord-023095-4dannjjm	3815	13	for	for	IN
cord-023095-4dannjjm	3815	14	the	the	DT
cord-023095-4dannjjm	3815	15	lower	low	JJR
cord-023095-4dannjjm	3815	16	prevalence	prevalence	NN
cord-023095-4dannjjm	3815	17	of	of	IN
cord-023095-4dannjjm	3815	18	Wolbachia	Wolbachia	NNP
cord-023095-4dannjjm	3815	19	among	among	IN
cord-023095-4dannjjm	3815	20	filaremic	filaremic	JJ
cord-023095-4dannjjm	3815	21	dogs	dog	NNS
cord-023095-4dannjjm	3815	22	infected	infect	VBN
cord-023095-4dannjjm	3815	23	with	with	IN
cord-023095-4dannjjm	3815	24	Li	Li	NNP
cord-023095-4dannjjm	3815	25	and	and	CC
cord-023095-4dannjjm	3815	26	further	further	JJ
cord-023095-4dannjjm	3815	27	studies	study	NNS
cord-023095-4dannjjm	3815	28	must	must	MD
cord-023095-4dannjjm	3815	29	be	be	VB
cord-023095-4dannjjm	3815	30	done	do	VBN
cord-023095-4dannjjm	3815	31	to	to	TO
cord-023095-4dannjjm	3815	32	clarify	clarify	VB
cord-023095-4dannjjm	3815	33	this	this	DT
cord-023095-4dannjjm	3815	34	interaction	interaction	NN
cord-023095-4dannjjm	3815	35	.	.	.
cord-023095-4dannjjm	3816	1	The	the	DT
cord-023095-4dannjjm	3816	2	purpose	purpose	NN
cord-023095-4dannjjm	3816	3	of	of	IN
cord-023095-4dannjjm	3816	4	the	the	DT
cord-023095-4dannjjm	3816	5	present	present	JJ
cord-023095-4dannjjm	3816	6	study	study	NN
cord-023095-4dannjjm	3816	7	was	be	VBD
cord-023095-4dannjjm	3816	8	investigate	investigate	VB
cord-023095-4dannjjm	3816	9	the	the	DT
cord-023095-4dannjjm	3816	10	occurrence	occurrence	NN
cord-023095-4dannjjm	3816	11	of	of	IN
cord-023095-4dannjjm	3816	12	leishmaniasis	leishmaniasis	NN
cord-023095-4dannjjm	3816	13	in	in	IN
cord-023095-4dannjjm	3816	14	200	200	CD
cord-023095-4dannjjm	3816	15	cats	cat	NNS
cord-023095-4dannjjm	3816	16	in	in	IN
cord-023095-4dannjjm	3816	17	the	the	DT
cord-023095-4dannjjm	3816	18	municipality	municipality	NN
cord-023095-4dannjjm	3816	19	of	of	IN
cord-023095-4dannjjm	3816	20	Arac¸atuba	Arac¸atuba	NNP
cord-023095-4dannjjm	3816	21	,	,	,
cord-023095-4dannjjm	3816	22	Sa˜o	Sa˜o	NNP
cord-023095-4dannjjm	3816	23	Paulo	Paulo	NNP
cord-023095-4dannjjm	3816	24	,	,	,
cord-023095-4dannjjm	3816	25	Brazil	Brazil	NNP
cord-023095-4dannjjm	3816	26	,	,	,
cord-023095-4dannjjm	3816	27	an	an	DT
cord-023095-4dannjjm	3816	28	endemic	endemic	JJ
cord-023095-4dannjjm	3816	29	area	area	NN
cord-023095-4dannjjm	3816	30	for	for	IN
cord-023095-4dannjjm	3816	31	canine	canine	JJ
cord-023095-4dannjjm	3816	32	visceral	visceral	JJ
cord-023095-4dannjjm	3816	33	leishmaniasis	leishmaniasis	NN
cord-023095-4dannjjm	3816	34	.	.	.
cord-023095-4dannjjm	3817	1	Animals	animal	NNS
cord-023095-4dannjjm	3817	2	were	be	VBD
cord-023095-4dannjjm	3817	3	evaluated	evaluate	VBN
cord-023095-4dannjjm	3817	4	by	by	IN
cord-023095-4dannjjm	3817	5	direct	direct	JJ
cord-023095-4dannjjm	3817	6	parasitological	parasitological	JJ
cord-023095-4dannjjm	3817	7	examination	examination	NN
cord-023095-4dannjjm	3817	8	of	of	IN
cord-023095-4dannjjm	3817	9	lymphoid	lymphoid	JJ
cord-023095-4dannjjm	3817	10	organs	organ	NNS
cord-023095-4dannjjm	3817	11	and	and	CC
cord-023095-4dannjjm	3817	12	serology	serology	NN
cord-023095-4dannjjm	3817	13	for	for	IN
cord-023095-4dannjjm	3817	14	visceral	visceral	JJ
cord-023095-4dannjjm	3817	15	leishmaniosis	leishmaniosis	NN
cord-023095-4dannjjm	3817	16	by	by	IN
cord-023095-4dannjjm	3817	17	immunosorbent	immunosorbent	JJ
cord-023095-4dannjjm	3817	18	assay	assay	NN
cord-023095-4dannjjm	3817	19	(	(	-LRB-
cord-023095-4dannjjm	3817	20	ELISA	ELISA	NNP
cord-023095-4dannjjm	3817	21	)	)	-RRB-
cord-023095-4dannjjm	3817	22	and	and	CC
cord-023095-4dannjjm	3817	23	indirect	indirect	JJ
cord-023095-4dannjjm	3817	24	immunofluorescence	immunofluorescence	NN
cord-023095-4dannjjm	3817	25	(	(	-LRB-
cord-023095-4dannjjm	3817	26	IFAT	IFAT	NNP
cord-023095-4dannjjm	3817	27	)	)	-RRB-
cord-023095-4dannjjm	3817	28	.	.	.
cord-023095-4dannjjm	3818	1	Thirteen	thirteen	CD
cord-023095-4dannjjm	3818	2	(	(	-LRB-
cord-023095-4dannjjm	3818	3	6.5	6.5	CD
cord-023095-4dannjjm	3818	4	%	%	NN
cord-023095-4dannjjm	3818	5	)	)	-RRB-
cord-023095-4dannjjm	3818	6	out	out	IN
cord-023095-4dannjjm	3818	7	of	of	IN
cord-023095-4dannjjm	3818	8	200	200	CD
cord-023095-4dannjjm	3818	9	cats	cat	NNS
cord-023095-4dannjjm	3818	10	studied	study	VBN
cord-023095-4dannjjm	3818	11	were	be	VBD
cord-023095-4dannjjm	3818	12	diagnosed	diagnose	VBN
cord-023095-4dannjjm	3818	13	with	with	IN
cord-023095-4dannjjm	3818	14	visceral	visceral	JJ
cord-023095-4dannjjm	3818	15	leishmaniasis	leishmaniasis	NN
cord-023095-4dannjjm	3818	16	;	;	:
cord-023095-4dannjjm	3818	17	eight	eight	CD
cord-023095-4dannjjm	3818	18	(	(	-LRB-
cord-023095-4dannjjm	3818	19	4	4	CD
cord-023095-4dannjjm	3818	20	%	%	NN
cord-023095-4dannjjm	3818	21	)	)	-RRB-
cord-023095-4dannjjm	3818	22	by	by	IN
cord-023095-4dannjjm	3818	23	parasitological	parasitological	NNP
cord-023095-4dannjjm	3818	24	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3818	25	through	through	IN
cord-023095-4dannjjm	3818	26	cytological	cytological	JJ
cord-023095-4dannjjm	3818	27	examination	examination	NN
cord-023095-4dannjjm	3818	28	of	of	IN
cord-023095-4dannjjm	3818	29	lymphoid	lymphoid	JJ
cord-023095-4dannjjm	3818	30	organs	organ	NNS
cord-023095-4dannjjm	3818	31	,	,	,
cord-023095-4dannjjm	3818	32	six	six	CD
cord-023095-4dannjjm	3818	33	(	(	-LRB-
cord-023095-4dannjjm	3818	34	3	3	CD
cord-023095-4dannjjm	3818	35	%	%	NN
cord-023095-4dannjjm	3818	36	)	)	-RRB-
cord-023095-4dannjjm	3818	37	were	be	VBD
cord-023095-4dannjjm	3818	38	considered	consider	VBN
cord-023095-4dannjjm	3818	39	positive	positive	JJ
cord-023095-4dannjjm	3818	40	by	by	IN
cord-023095-4dannjjm	3818	41	ELISA	ELISA	NNP
cord-023095-4dannjjm	3818	42	and	and	CC
cord-023095-4dannjjm	3818	43	one	one	CD
cord-023095-4dannjjm	3818	44	(	(	-LRB-
cord-023095-4dannjjm	3818	45	0.5	0.5	CD
cord-023095-4dannjjm	3818	46	%	%	NN
cord-023095-4dannjjm	3818	47	)	)	-RRB-
cord-023095-4dannjjm	3818	48	by	by	IN
cord-023095-4dannjjm	3818	49	IFAT	IFAT	NNP
cord-023095-4dannjjm	3818	50	.	.	.
cord-023095-4dannjjm	3819	1	Only	only	RB
cord-023095-4dannjjm	3819	2	two	two	CD
cord-023095-4dannjjm	3819	3	(	(	-LRB-
cord-023095-4dannjjm	3819	4	15.38	15.38	CD
cord-023095-4dannjjm	3819	5	%	%	NN
cord-023095-4dannjjm	3819	6	)	)	-RRB-
cord-023095-4dannjjm	3819	7	out	out	IN
cord-023095-4dannjjm	3819	8	of	of	IN
cord-023095-4dannjjm	3819	9	the	the	DT
cord-023095-4dannjjm	3819	10	thirteen	thirteen	CD
cord-023095-4dannjjm	3819	11	infected	infected	JJ
cord-023095-4dannjjm	3819	12	cats	cat	NNS
cord-023095-4dannjjm	3819	13	had	have	VBD
cord-023095-4dannjjm	3819	14	clinical	clinical	JJ
cord-023095-4dannjjm	3819	15	signs	sign	NNS
cord-023095-4dannjjm	3819	16	,	,	,
cord-023095-4dannjjm	3819	17	characterized	characterize	VBN
cord-023095-4dannjjm	3819	18	by	by	IN
cord-023095-4dannjjm	3819	19	the	the	DT
cord-023095-4dannjjm	3819	20	presence	presence	NN
cord-023095-4dannjjm	3819	21	of	of	IN
cord-023095-4dannjjm	3819	22	crusty	crusty	JJ
cord-023095-4dannjjm	3819	23	lesions	lesion	NNS
cord-023095-4dannjjm	3819	24	on	on	IN
cord-023095-4dannjjm	3819	25	the	the	DT
cord-023095-4dannjjm	3819	26	dorsal	dorsal	JJ
cord-023095-4dannjjm	3819	27	cervical	cervical	JJ
cord-023095-4dannjjm	3819	28	region	region	NN
cord-023095-4dannjjm	3819	29	and	and	CC
cord-023095-4dannjjm	3819	30	hepatosplenomegaly	hepatosplenomegaly	NNP
cord-023095-4dannjjm	3819	31	.	.	.
cord-023095-4dannjjm	3820	1	Regarding	regard	VBG
cord-023095-4dannjjm	3820	2	age	age	NN
cord-023095-4dannjjm	3820	3	five	five	CD
cord-023095-4dannjjm	3820	4	cats	cat	NNS
cord-023095-4dannjjm	3820	5	(	(	-LRB-
cord-023095-4dannjjm	3820	6	38.5	38.5	CD
cord-023095-4dannjjm	3820	7	%	%	NN
cord-023095-4dannjjm	3820	8	)	)	-RRB-
cord-023095-4dannjjm	3820	9	had	have	VBD
cord-023095-4dannjjm	3820	10	between	between	IN
cord-023095-4dannjjm	3820	11	six	six	CD
cord-023095-4dannjjm	3820	12	months	month	NNS
cord-023095-4dannjjm	3820	13	and	and	CC
cord-023095-4dannjjm	3820	14	two	two	CD
cord-023095-4dannjjm	3820	15	years	year	NNS
cord-023095-4dannjjm	3820	16	,	,	,
cord-023095-4dannjjm	3820	17	being	be	VBG
cord-023095-4dannjjm	3820	18	the	the	DT
cord-023095-4dannjjm	3820	19	others	other	NNS
cord-023095-4dannjjm	3820	20	older	old	JJR
cord-023095-4dannjjm	3820	21	than	than	IN
cord-023095-4dannjjm	3820	22	2	2	CD
cord-023095-4dannjjm	3820	23	years	year	NNS
cord-023095-4dannjjm	3820	24	(	(	-LRB-
cord-023095-4dannjjm	3820	25	61.5	61.5	CD
cord-023095-4dannjjm	3820	26	%	%	NN
cord-023095-4dannjjm	3820	27	)	)	-RRB-
cord-023095-4dannjjm	3820	28	.	.	.
cord-023095-4dannjjm	3821	1	Only	only	RB
cord-023095-4dannjjm	3821	2	one	one	CD
cord-023095-4dannjjm	3821	3	cat	cat	NN
cord-023095-4dannjjm	3821	4	(	(	-LRB-
cord-023095-4dannjjm	3821	5	7.7	7.7	CD
cord-023095-4dannjjm	3821	6	%	%	NN
cord-023095-4dannjjm	3821	7	)	)	-RRB-
cord-023095-4dannjjm	3821	8	was	be	VBD
cord-023095-4dannjjm	3821	9	positive	positive	JJ
cord-023095-4dannjjm	3821	10	for	for	IN
cord-023095-4dannjjm	3821	11	the	the	DT
cord-023095-4dannjjm	3821	12	three	three	CD
cord-023095-4dannjjm	3821	13	employed	employ	VBN
cord-023095-4dannjjm	3821	14	methods	method	NNS
cord-023095-4dannjjm	3821	15	.	.	.
cord-023095-4dannjjm	3822	1	PCR	PCR	NNP
cord-023095-4dannjjm	3822	2	confirmed	confirm	VBD
cord-023095-4dannjjm	3822	3	Leishmania	Leishmania	NNP
cord-023095-4dannjjm	3822	4	sp	sp	NN
cord-023095-4dannjjm	3822	5	infection	infection	NN
cord-023095-4dannjjm	3822	6	in	in	IN
cord-023095-4dannjjm	3822	7	nine	nine	CD
cord-023095-4dannjjm	3822	8	(	(	-LRB-
cord-023095-4dannjjm	3822	9	69.2	69.2	CD
cord-023095-4dannjjm	3822	10	%	%	NN
cord-023095-4dannjjm	3822	11	)	)	-RRB-
cord-023095-4dannjjm	3822	12	cats	cat	NNS
cord-023095-4dannjjm	3822	13	,	,	,
cord-023095-4dannjjm	3822	14	of	of	IN
cord-023095-4dannjjm	3822	15	which	which	WDT
cord-023095-4dannjjm	3822	16	six	six	CD
cord-023095-4dannjjm	3822	17	were	be	VBD
cord-023095-4dannjjm	3822	18	diagnosed	diagnose	VBN
cord-023095-4dannjjm	3822	19	previously	previously	RB
cord-023095-4dannjjm	3822	20	by	by	IN
cord-023095-4dannjjm	3822	21	cytological	cytological	JJ
cord-023095-4dannjjm	3822	22	examination	examination	NN
cord-023095-4dannjjm	3822	23	,	,	,
cord-023095-4dannjjm	3822	24	two	two	CD
cord-023095-4dannjjm	3822	25	by	by	IN
cord-023095-4dannjjm	3822	26	ELISA	ELISA	NNP
cord-023095-4dannjjm	3822	27	and	and	CC
cord-023095-4dannjjm	3822	28	one	one	CD
cord-023095-4dannjjm	3822	29	by	by	IN
cord-023095-4dannjjm	3822	30	the	the	DT
cord-023095-4dannjjm	3822	31	three	three	CD
cord-023095-4dannjjm	3822	32	techniques	technique	NNS
cord-023095-4dannjjm	3822	33	employed	employ	VBN
cord-023095-4dannjjm	3822	34	.	.	.
cord-023095-4dannjjm	3823	1	Since	since	IN
cord-023095-4dannjjm	3823	2	its	-PRON-	PRP$
cord-023095-4dannjjm	3823	3	first	first	JJ
cord-023095-4dannjjm	3823	4	description	description	NN
cord-023095-4dannjjm	3823	5	in	in	IN
cord-023095-4dannjjm	3823	6	1912	1912	CD
cord-023095-4dannjjm	3823	7	feline	feline	JJ
cord-023095-4dannjjm	3823	8	leishmaniosis	leishmaniosis	NNP
cord-023095-4dannjjm	3823	9	has	have	VBZ
cord-023095-4dannjjm	3823	10	been	be	VBN
cord-023095-4dannjjm	3823	11	reported	report	VBN
cord-023095-4dannjjm	3823	12	in	in	IN
cord-023095-4dannjjm	3823	13	several	several	JJ
cord-023095-4dannjjm	3823	14	countries	country	NNS
cord-023095-4dannjjm	3823	15	.	.	.
cord-023095-4dannjjm	3824	1	The	the	DT
cord-023095-4dannjjm	3824	2	purpose	purpose	NN
cord-023095-4dannjjm	3824	3	of	of	IN
cord-023095-4dannjjm	3824	4	this	this	DT
cord-023095-4dannjjm	3824	5	study	study	NN
cord-023095-4dannjjm	3824	6	was	be	VBD
cord-023095-4dannjjm	3824	7	to	to	TO
cord-023095-4dannjjm	3824	8	assess	assess	VB
cord-023095-4dannjjm	3824	9	the	the	DT
cord-023095-4dannjjm	3824	10	prevalence	prevalence	NN
cord-023095-4dannjjm	3824	11	of	of	IN
cord-023095-4dannjjm	3824	12	Leishmania	Leishmania	NNP
cord-023095-4dannjjm	3824	13	chagasi	chagasi	NN
cord-023095-4dannjjm	3824	14	infection	infection	NN
cord-023095-4dannjjm	3824	15	in	in	IN
cord-023095-4dannjjm	3824	16	cats	cat	NNS
cord-023095-4dannjjm	3824	17	showing	show	VBG
cord-023095-4dannjjm	3824	18	dermatologic	dermatologic	JJ
cord-023095-4dannjjm	3824	19	lesions	lesion	NNS
cord-023095-4dannjjm	3824	20	from	from	IN
cord-023095-4dannjjm	3824	21	an	an	DT
cord-023095-4dannjjm	3824	22	endemic	endemic	JJ
cord-023095-4dannjjm	3824	23	area	area	NN
cord-023095-4dannjjm	3824	24	for	for	IN
cord-023095-4dannjjm	3824	25	visceral	visceral	JJ
cord-023095-4dannjjm	3824	26	leishmaniasis	leishmaniasis	NN
cord-023095-4dannjjm	3824	27	in	in	IN
cord-023095-4dannjjm	3824	28	Brazil	Brazil	NNP
cord-023095-4dannjjm	3824	29	.	.	.
cord-023095-4dannjjm	3825	1	Animals	animal	NNS
cord-023095-4dannjjm	3825	2	were	be	VBD
cord-023095-4dannjjm	3825	3	evaluated	evaluate	VBN
cord-023095-4dannjjm	3825	4	by	by	IN
cord-023095-4dannjjm	3825	5	direct	direct	JJ
cord-023095-4dannjjm	3825	6	parasitological	parasitological	JJ
cord-023095-4dannjjm	3825	7	examination	examination	NN
cord-023095-4dannjjm	3825	8	of	of	IN
cord-023095-4dannjjm	3825	9	lymphoid	lymphoid	JJ
cord-023095-4dannjjm	3825	10	organs	organ	NNS
cord-023095-4dannjjm	3825	11	,	,	,
cord-023095-4dannjjm	3825	12	immunohistochemical	immunohistochemical	JJ
cord-023095-4dannjjm	3825	13	technique	technique	NN
cord-023095-4dannjjm	3825	14	for	for	IN
cord-023095-4dannjjm	3825	15	detection	detection	NN
cord-023095-4dannjjm	3825	16	of	of	IN
cord-023095-4dannjjm	3825	17	amastigotes	amastigote	NNS
cord-023095-4dannjjm	3825	18	in	in	IN
cord-023095-4dannjjm	3825	19	lesioned	lesioned	JJ
cord-023095-4dannjjm	3825	20	skin	skin	NN
cord-023095-4dannjjm	3825	21	and	and	CC
cord-023095-4dannjjm	3825	22	serology	serology	NN
cord-023095-4dannjjm	3825	23	for	for	IN
cord-023095-4dannjjm	3825	24	visceral	visceral	JJ
cord-023095-4dannjjm	3825	25	leishmaniosis	leishmaniosis	NN
cord-023095-4dannjjm	3825	26	by	by	IN
cord-023095-4dannjjm	3825	27	immunosorbent	immunosorbent	JJ
cord-023095-4dannjjm	3825	28	assay	assay	NN
cord-023095-4dannjjm	3825	29	(	(	-LRB-
cord-023095-4dannjjm	3825	30	ELISA	ELISA	NNP
cord-023095-4dannjjm	3825	31	)	)	-RRB-
cord-023095-4dannjjm	3825	32	and	and	CC
cord-023095-4dannjjm	3825	33	indirect	indirect	JJ
cord-023095-4dannjjm	3825	34	immunofluorescence	immunofluorescence	NN
cord-023095-4dannjjm	3825	35	(	(	-LRB-
cord-023095-4dannjjm	3825	36	IFAT	IFAT	NNP
cord-023095-4dannjjm	3825	37	)	)	-RRB-
cord-023095-4dannjjm	3825	38	.	.	.
cord-023095-4dannjjm	3826	1	Twenty	twenty	CD
cord-023095-4dannjjm	3826	2	seven	seven	CD
cord-023095-4dannjjm	3826	3	(	(	-LRB-
cord-023095-4dannjjm	3826	4	49.1	49.1	CD
cord-023095-4dannjjm	3826	5	%	%	NN
cord-023095-4dannjjm	3826	6	)	)	-RRB-
cord-023095-4dannjjm	3826	7	out	out	IN
cord-023095-4dannjjm	3826	8	of	of	IN
cord-023095-4dannjjm	3826	9	the	the	DT
cord-023095-4dannjjm	3826	10	55	55	CD
cord-023095-4dannjjm	3826	11	cats	cat	NNS
cord-023095-4dannjjm	3826	12	studied	study	VBN
cord-023095-4dannjjm	3826	13	were	be	VBD
cord-023095-4dannjjm	3826	14	diagnosed	diagnose	VBN
cord-023095-4dannjjm	3826	15	with	with	IN
cord-023095-4dannjjm	3826	16	visceral	visceral	JJ
cord-023095-4dannjjm	3826	17	leishmaniosis	leishmaniosis	NN
cord-023095-4dannjjm	3826	18	.	.	.
cord-023095-4dannjjm	3827	1	Twelve	twelve	CD
cord-023095-4dannjjm	3827	2	(	(	-LRB-
cord-023095-4dannjjm	3827	3	44.4	44.4	CD
cord-023095-4dannjjm	3827	4	%	%	NN
cord-023095-4dannjjm	3827	5	)	)	-RRB-
cord-023095-4dannjjm	3827	6	were	be	VBD
cord-023095-4dannjjm	3827	7	positive	positive	JJ
cord-023095-4dannjjm	3827	8	by	by	IN
cord-023095-4dannjjm	3827	9	parasitological	parasitological	JJ
cord-023095-4dannjjm	3827	10	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3827	11	;	;	:
cord-023095-4dannjjm	3827	12	amastigote	amastigote	NN
cord-023095-4dannjjm	3827	13	forms	form	NNS
cord-023095-4dannjjm	3827	14	of	of	IN
cord-023095-4dannjjm	3827	15	Leishmania	Leishmania	NNP
cord-023095-4dannjjm	3827	16	sp	sp	NNP
cord-023095-4dannjjm	3827	17	were	be	VBD
cord-023095-4dannjjm	3827	18	identified	identify	VBN
cord-023095-4dannjjm	3827	19	in	in	IN
cord-023095-4dannjjm	3827	20	lymphoid	lymphoid	JJ
cord-023095-4dannjjm	3827	21	organs	organ	NNS
cord-023095-4dannjjm	3827	22	from	from	IN
cord-023095-4dannjjm	3827	23	10/55	10/55	CD
cord-023095-4dannjjm	3827	24	(	(	-LRB-
cord-023095-4dannjjm	3827	25	18.2	18.2	CD
cord-023095-4dannjjm	3827	26	%	%	NN
cord-023095-4dannjjm	3827	27	)	)	-RRB-
cord-023095-4dannjjm	3827	28	infected	infect	VBN
cord-023095-4dannjjm	3827	29	cats	cat	NNS
cord-023095-4dannjjm	3827	30	,	,	,
cord-023095-4dannjjm	3827	31	and	and	CC
cord-023095-4dannjjm	3827	32	immunohistochemical	immunohistochemical	JJ
cord-023095-4dannjjm	3827	33	technique	technique	NN
cord-023095-4dannjjm	3827	34	allowed	allow	VBD
cord-023095-4dannjjm	3827	35	the	the	DT
cord-023095-4dannjjm	3827	36	identification	identification	NN
cord-023095-4dannjjm	3827	37	of	of	IN
cord-023095-4dannjjm	3827	38	nine	nine	CD
cord-023095-4dannjjm	3827	39	(	(	-LRB-
cord-023095-4dannjjm	3827	40	16.4	16.4	CD
cord-023095-4dannjjm	3827	41	%	%	NN
cord-023095-4dannjjm	3827	42	)	)	-RRB-
cord-023095-4dannjjm	3827	43	positive	positive	JJ
cord-023095-4dannjjm	3827	44	animals	animal	NNS
cord-023095-4dannjjm	3827	45	.	.	.
cord-023095-4dannjjm	3828	1	The	the	DT
cord-023095-4dannjjm	3828	2	seroprevalence	seroprevalence	NN
cord-023095-4dannjjm	3828	3	of	of	IN
cord-023095-4dannjjm	3828	4	leishmaniosis	leishmaniosis	NNP
cord-023095-4dannjjm	3828	5	was	be	VBD
cord-023095-4dannjjm	3828	6	25.4	25.4	CD
cord-023095-4dannjjm	3828	7	%	%	NN
cord-023095-4dannjjm	3828	8	(	(	-LRB-
cord-023095-4dannjjm	3828	9	14/55	14/55	CD
cord-023095-4dannjjm	3828	10	)	)	-RRB-
cord-023095-4dannjjm	3828	11	by	by	IN
cord-023095-4dannjjm	3828	12	ELISA	ELISA	NNP
cord-023095-4dannjjm	3828	13	and	and	CC
cord-023095-4dannjjm	3828	14	10.9	10.9	CD
cord-023095-4dannjjm	3828	15	%	%	NN
cord-023095-4dannjjm	3828	16	(	(	-LRB-
cord-023095-4dannjjm	3828	17	6/55	6/55	CD
cord-023095-4dannjjm	3828	18	)	)	-RRB-
cord-023095-4dannjjm	3828	19	by	by	IN
cord-023095-4dannjjm	3828	20	IFAT	IFAT	NNP
cord-023095-4dannjjm	3828	21	.	.	.
cord-023095-4dannjjm	3829	1	FIV	FIV	NNP
cord-023095-4dannjjm	3829	2	specific	specific	JJ
cord-023095-4dannjjm	3829	3	antibodies	antibody	NNS
cord-023095-4dannjjm	3829	4	were	be	VBD
cord-023095-4dannjjm	3829	5	found	find	VBN
cord-023095-4dannjjm	3829	6	in	in	IN
cord-023095-4dannjjm	3829	7	6/55	6/55	CD
cord-023095-4dannjjm	3829	8	cats	cat	NNS
cord-023095-4dannjjm	3829	9	(	(	-LRB-
cord-023095-4dannjjm	3829	10	10.9	10.9	CD
cord-023095-4dannjjm	3829	11	%	%	NN
cord-023095-4dannjjm	3829	12	)	)	-RRB-
cord-023095-4dannjjm	3829	13	,	,	,
cord-023095-4dannjjm	3829	14	of	of	IN
cord-023095-4dannjjm	3829	15	which	which	WDT
cord-023095-4dannjjm	3829	16	5/6	5/6	CD
cord-023095-4dannjjm	3829	17	(	(	-LRB-
cord-023095-4dannjjm	3829	18	83.3	83.3	CD
cord-023095-4dannjjm	3829	19	%	%	NN
cord-023095-4dannjjm	3829	20	)	)	-RRB-
cord-023095-4dannjjm	3829	21	had	have	VBD
cord-023095-4dannjjm	3829	22	leishmaniosis	leishmaniosi	NNS
cord-023095-4dannjjm	3829	23	.	.	.
cord-023095-4dannjjm	3830	1	Real	real	JJ
cord-023095-4dannjjm	3830	2	time	time	NN
cord-023095-4dannjjm	3830	3	PCR	PCR	NNP
cord-023095-4dannjjm	3830	4	confirmed	confirm	VBD
cord-023095-4dannjjm	3830	5	Leishmania	Leishmania	NNP
cord-023095-4dannjjm	3830	6	chagasi	chagasi	NN
cord-023095-4dannjjm	3830	7	infection	infection	NN
cord-023095-4dannjjm	3830	8	in	in	IN
cord-023095-4dannjjm	3830	9	three	three	CD
cord-023095-4dannjjm	3830	10	cats	cat	NNS
cord-023095-4dannjjm	3830	11	.	.	.
cord-023095-4dannjjm	3831	1	Based	base	VBN
cord-023095-4dannjjm	3831	2	on	on	IN
cord-023095-4dannjjm	3831	3	the	the	DT
cord-023095-4dannjjm	3831	4	evidence	evidence	NN
cord-023095-4dannjjm	3831	5	of	of	IN
cord-023095-4dannjjm	3831	6	the	the	DT
cord-023095-4dannjjm	3831	7	high	high	JJ
cord-023095-4dannjjm	3831	8	occurrence	occurrence	NN
cord-023095-4dannjjm	3831	9	of	of	IN
cord-023095-4dannjjm	3831	10	leishmaniosis	leishmaniosis	NN
cord-023095-4dannjjm	3831	11	in	in	IN
cord-023095-4dannjjm	3831	12	cats	cat	NNS
cord-023095-4dannjjm	3831	13	in	in	IN
cord-023095-4dannjjm	3831	14	this	this	DT
cord-023095-4dannjjm	3831	15	study	study	NN
cord-023095-4dannjjm	3831	16	,	,	,
cord-023095-4dannjjm	3831	17	this	this	DT
cord-023095-4dannjjm	3831	18	disease	disease	NN
cord-023095-4dannjjm	3831	19	should	should	MD
cord-023095-4dannjjm	3831	20	be	be	VB
cord-023095-4dannjjm	3831	21	included	include	VBN
cord-023095-4dannjjm	3831	22	in	in	IN
cord-023095-4dannjjm	3831	23	the	the	DT
cord-023095-4dannjjm	3831	24	differential	differential	JJ
cord-023095-4dannjjm	3831	25	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3831	26	of	of	IN
cord-023095-4dannjjm	3831	27	skin	skin	NN
cord-023095-4dannjjm	3831	28	diseases	disease	NNS
cord-023095-4dannjjm	3831	29	of	of	IN
cord-023095-4dannjjm	3831	30	felines	feline	NNS
cord-023095-4dannjjm	3831	31	living	live	VBG
cord-023095-4dannjjm	3831	32	in	in	IN
cord-023095-4dannjjm	3831	33	endemic	endemic	JJ
cord-023095-4dannjjm	3831	34	areas	area	NNS
cord-023095-4dannjjm	3831	35	.	.	.
cord-023095-4dannjjm	3832	1	Blastomyces	Blastomyces	NNP
cord-023095-4dannjjm	3832	2	dermatiditis	dermatiditis	NN
cord-023095-4dannjjm	3832	3	is	be	VBZ
cord-023095-4dannjjm	3832	4	a	a	DT
cord-023095-4dannjjm	3832	5	dimorphic	dimorphic	JJ
cord-023095-4dannjjm	3832	6	fungus	fungus	NN
cord-023095-4dannjjm	3832	7	that	that	WDT
cord-023095-4dannjjm	3832	8	commonly	commonly	RB
cord-023095-4dannjjm	3832	9	affects	affect	VBZ
cord-023095-4dannjjm	3832	10	large	large	JJ
cord-023095-4dannjjm	3832	11	-	-	HYPH
cord-023095-4dannjjm	3832	12	breed	breed	NN
cord-023095-4dannjjm	3832	13	hunting	hunting	NN
cord-023095-4dannjjm	3832	14	dogs	dog	NNS
cord-023095-4dannjjm	3832	15	.	.	.
cord-023095-4dannjjm	3833	1	A	a	DT
cord-023095-4dannjjm	3833	2	recent	recent	JJ
cord-023095-4dannjjm	3833	3	advancement	advancement	NN
cord-023095-4dannjjm	3833	4	in	in	IN
cord-023095-4dannjjm	3833	5	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3833	6	has	have	VBZ
cord-023095-4dannjjm	3833	7	come	come	VBN
cord-023095-4dannjjm	3833	8	with	with	IN
cord-023095-4dannjjm	3833	9	the	the	DT
cord-023095-4dannjjm	3833	10	advent	advent	NN
cord-023095-4dannjjm	3833	11	of	of	IN
cord-023095-4dannjjm	3833	12	a	a	DT
cord-023095-4dannjjm	3833	13	urine	urine	NN
cord-023095-4dannjjm	3833	14	antigen	antigen	NN
cord-023095-4dannjjm	3833	15	screening	screening	NN
cord-023095-4dannjjm	3833	16	test	test	NN
cord-023095-4dannjjm	3833	17	that	that	WDT
cord-023095-4dannjjm	3833	18	has	have	VBZ
cord-023095-4dannjjm	3833	19	both	both	DT
cord-023095-4dannjjm	3833	20	high	high	JJ
cord-023095-4dannjjm	3833	21	sensitivity	sensitivity	NN
cord-023095-4dannjjm	3833	22	and	and	CC
cord-023095-4dannjjm	3833	23	moderately	moderately	RB
cord-023095-4dannjjm	3833	24	high	high	JJ
cord-023095-4dannjjm	3833	25	specificity	specificity	NN
cord-023095-4dannjjm	3833	26	.	.	.
cord-023095-4dannjjm	3834	1	Therapy	therapy	NN
cord-023095-4dannjjm	3834	2	for	for	IN
cord-023095-4dannjjm	3834	3	the	the	DT
cord-023095-4dannjjm	3834	4	disease	disease	NN
cord-023095-4dannjjm	3834	5	involves	involve	VBZ
cord-023095-4dannjjm	3834	6	use	use	NN
cord-023095-4dannjjm	3834	7	of	of	IN
cord-023095-4dannjjm	3834	8	antifungal	antifungal	JJ
cord-023095-4dannjjm	3834	9	agents	agent	NNS
cord-023095-4dannjjm	3834	10	,	,	,
cord-023095-4dannjjm	3834	11	usually	usually	RB
cord-023095-4dannjjm	3834	12	itraconazole	itraconazole	NNP
cord-023095-4dannjjm	3834	13	,	,	,
cord-023095-4dannjjm	3834	14	and	and	CC
cord-023095-4dannjjm	3834	15	length	length	NN
cord-023095-4dannjjm	3834	16	of	of	IN
cord-023095-4dannjjm	3834	17	treatment	treatment	NN
cord-023095-4dannjjm	3834	18	is	be	VBZ
cord-023095-4dannjjm	3834	19	based	base	VBN
cord-023095-4dannjjm	3834	20	chiefly	chiefly	RB
cord-023095-4dannjjm	3834	21	on	on	IN
cord-023095-4dannjjm	3834	22	resolution	resolution	NN
cord-023095-4dannjjm	3834	23	of	of	IN
cord-023095-4dannjjm	3834	24	clinical	clinical	JJ
cord-023095-4dannjjm	3834	25	and	and	CC
cord-023095-4dannjjm	3834	26	radiologic	radiologic	JJ
cord-023095-4dannjjm	3834	27	signs	sign	NNS
cord-023095-4dannjjm	3834	28	.	.	.
cord-023095-4dannjjm	3835	1	With	with	IN
cord-023095-4dannjjm	3835	2	the	the	DT
cord-023095-4dannjjm	3835	3	new	new	JJ
cord-023095-4dannjjm	3835	4	urine	urine	NN
cord-023095-4dannjjm	3835	5	antigen	antigen	NN
cord-023095-4dannjjm	3835	6	test	test	NN
cord-023095-4dannjjm	3835	7	,	,	,
cord-023095-4dannjjm	3835	8	however	however	RB
cord-023095-4dannjjm	3835	9	,	,	,
cord-023095-4dannjjm	3835	10	a	a	DT
cord-023095-4dannjjm	3835	11	noninvasive	noninvasive	JJ
cord-023095-4dannjjm	3835	12	route	route	NN
cord-023095-4dannjjm	3835	13	of	of	IN
cord-023095-4dannjjm	3835	14	monitoring	monitor	VBG
cord-023095-4dannjjm	3835	15	treatment	treatment	NN
cord-023095-4dannjjm	3835	16	progress	progress	NN
cord-023095-4dannjjm	3835	17	is	be	VBZ
cord-023095-4dannjjm	3835	18	available	available	JJ
cord-023095-4dannjjm	3835	19	and	and	CC
cord-023095-4dannjjm	3835	20	could	could	MD
cord-023095-4dannjjm	3835	21	be	be	VB
cord-023095-4dannjjm	3835	22	an	an	DT
cord-023095-4dannjjm	3835	23	adjunct	adjunct	JJ
cord-023095-4dannjjm	3835	24	device	device	NN
cord-023095-4dannjjm	3835	25	utilized	utilize	VBN
cord-023095-4dannjjm	3835	26	to	to	TO
cord-023095-4dannjjm	3835	27	determine	determine	VB
cord-023095-4dannjjm	3835	28	treatment	treatment	NN
cord-023095-4dannjjm	3835	29	efficacy	efficacy	NN
cord-023095-4dannjjm	3835	30	and	and	CC
cord-023095-4dannjjm	3835	31	may	may	MD
cord-023095-4dannjjm	3835	32	even	even	RB
cord-023095-4dannjjm	3835	33	reveal	reveal	VB
cord-023095-4dannjjm	3835	34	a	a	DT
cord-023095-4dannjjm	3835	35	need	need	NN
cord-023095-4dannjjm	3835	36	for	for	IN
cord-023095-4dannjjm	3835	37	prolonged	prolong	VBN
cord-023095-4dannjjm	3835	38	treatment	treatment	NN
cord-023095-4dannjjm	3835	39	.	.	.
cord-023095-4dannjjm	3836	1	Therefore	therefore	RB
cord-023095-4dannjjm	3836	2	,	,	,
cord-023095-4dannjjm	3836	3	the	the	DT
cord-023095-4dannjjm	3836	4	purpose	purpose	NN
cord-023095-4dannjjm	3836	5	of	of	IN
cord-023095-4dannjjm	3836	6	this	this	DT
cord-023095-4dannjjm	3836	7	study	study	NN
cord-023095-4dannjjm	3836	8	was	be	VBD
cord-023095-4dannjjm	3836	9	to	to	TO
cord-023095-4dannjjm	3836	10	determine	determine	VB
cord-023095-4dannjjm	3836	11	if	if	IN
cord-023095-4dannjjm	3836	12	monitoring	monitor	VBG
cord-023095-4dannjjm	3836	13	the	the	DT
cord-023095-4dannjjm	3836	14	Blastomyces	Blastomyces	NNP
cord-023095-4dannjjm	3836	15	urine	urine	NN
cord-023095-4dannjjm	3836	16	antigen	antigen	NN
cord-023095-4dannjjm	3836	17	test	test	NN
cord-023095-4dannjjm	3836	18	and	and	CC
cord-023095-4dannjjm	3836	19	comparing	compare	VBG
cord-023095-4dannjjm	3836	20	to	to	IN
cord-023095-4dannjjm	3836	21	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	3836	22	radiographic	radiographic	JJ
cord-023095-4dannjjm	3836	23	signs	sign	NNS
cord-023095-4dannjjm	3836	24	would	would	MD
cord-023095-4dannjjm	3836	25	elucidate	elucidate	VB
cord-023095-4dannjjm	3836	26	the	the	DT
cord-023095-4dannjjm	3836	27	necessity	necessity	NN
cord-023095-4dannjjm	3836	28	for	for	IN
cord-023095-4dannjjm	3836	29	prolonged	prolong	VBN
cord-023095-4dannjjm	3836	30	antifungal	antifungal	NN
cord-023095-4dannjjm	3836	31	therapy	therapy	NN
cord-023095-4dannjjm	3836	32	,	,	,
cord-023095-4dannjjm	3836	33	even	even	RB
cord-023095-4dannjjm	3836	34	after	after	IN
cord-023095-4dannjjm	3836	35	resolution	resolution	NN
cord-023095-4dannjjm	3836	36	of	of	IN
cord-023095-4dannjjm	3836	37	radiologic	radiologic	JJ
cord-023095-4dannjjm	3836	38	signs	sign	NNS
cord-023095-4dannjjm	3836	39	.	.	.
cord-023095-4dannjjm	3837	1	To	to	IN
cord-023095-4dannjjm	3837	2	this	this	DT
cord-023095-4dannjjm	3837	3	end	end	NN
cord-023095-4dannjjm	3837	4	,	,	,
cord-023095-4dannjjm	3837	5	a	a	DT
cord-023095-4dannjjm	3837	6	retrospective	retrospective	JJ
cord-023095-4dannjjm	3837	7	case	case	NN
cord-023095-4dannjjm	3837	8	review	review	NN
cord-023095-4dannjjm	3837	9	was	be	VBD
cord-023095-4dannjjm	3837	10	performed	perform	VBN
cord-023095-4dannjjm	3837	11	that	that	WDT
cord-023095-4dannjjm	3837	12	identified	identify	VBD
cord-023095-4dannjjm	3837	13	a	a	DT
cord-023095-4dannjjm	3837	14	series	series	NN
cord-023095-4dannjjm	3837	15	of	of	IN
cord-023095-4dannjjm	3837	16	client	client	NN
cord-023095-4dannjjm	3837	17	-	-	HYPH
cord-023095-4dannjjm	3837	18	owned	own	VBN
cord-023095-4dannjjm	3837	19	animals	animal	NNS
cord-023095-4dannjjm	3837	20	with	with	IN
cord-023095-4dannjjm	3837	21	naturally	naturally	RB
cord-023095-4dannjjm	3837	22	occurring	occur	VBG
cord-023095-4dannjjm	3837	23	blastomycosis	blastomycosis	NN
cord-023095-4dannjjm	3837	24	.	.	.
cord-023095-4dannjjm	3838	1	The	the	DT
cord-023095-4dannjjm	3838	2	inclusion	inclusion	NN
cord-023095-4dannjjm	3838	3	criteria	criterion	NNS
cord-023095-4dannjjm	3838	4	were	be	VBD
cord-023095-4dannjjm	3838	5	radiographic	radiographic	JJ
cord-023095-4dannjjm	3838	6	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	3838	7	parenchymal	parenchymal	NN
cord-023095-4dannjjm	3838	8	signs	sign	NNS
cord-023095-4dannjjm	3838	9	consistent	consistent	JJ
cord-023095-4dannjjm	3838	10	with	with	IN
cord-023095-4dannjjm	3838	11	fungal	fungal	JJ
cord-023095-4dannjjm	3838	12	disease	disease	NN
cord-023095-4dannjjm	3838	13	and	and	CC
cord-023095-4dannjjm	3838	14	urine	urine	NN
cord-023095-4dannjjm	3838	15	antigenconfirmed	antigenconfirme	VBN
cord-023095-4dannjjm	3838	16	blastomycosis	blastomycosis	NN
cord-023095-4dannjjm	3838	17	with	with	IN
cord-023095-4dannjjm	3838	18	repeated	repeat	VBN
cord-023095-4dannjjm	3838	19	testing	testing	NN
cord-023095-4dannjjm	3838	20	of	of	IN
cord-023095-4dannjjm	3838	21	both	both	DT
cord-023095-4dannjjm	3838	22	radiographs	radiograph	NNS
cord-023095-4dannjjm	3838	23	and	and	CC
cord-023095-4dannjjm	3838	24	urine	urine	NN
cord-023095-4dannjjm	3838	25	antigen	antigen	NN
cord-023095-4dannjjm	3838	26	quantification	quantification	NN
cord-023095-4dannjjm	3838	27	as	as	IN
cord-023095-4dannjjm	3838	28	monitoring	monitoring	NN
cord-023095-4dannjjm	3838	29	parameters	parameter	NNS
cord-023095-4dannjjm	3838	30	until	until	IN
cord-023095-4dannjjm	3838	31	negative	negative	JJ
cord-023095-4dannjjm	3838	32	results	result	NNS
cord-023095-4dannjjm	3838	33	achieved	achieve	VBN
cord-023095-4dannjjm	3838	34	in	in	IN
cord-023095-4dannjjm	3838	35	each	each	DT
cord-023095-4dannjjm	3838	36	.	.	.
cord-023095-4dannjjm	3839	1	Ideally	ideally	RB
cord-023095-4dannjjm	3839	2	,	,	,
cord-023095-4dannjjm	3839	3	intervals	interval	NNS
cord-023095-4dannjjm	3839	4	between	between	IN
cord-023095-4dannjjm	3839	5	testing	testing	NN
cord-023095-4dannjjm	3839	6	dates	date	NNS
cord-023095-4dannjjm	3839	7	would	would	MD
cord-023095-4dannjjm	3839	8	be	be	VB
cord-023095-4dannjjm	3839	9	between	between	IN
cord-023095-4dannjjm	3839	10	two	two	CD
cord-023095-4dannjjm	3839	11	and	and	CC
cord-023095-4dannjjm	3839	12	five	five	CD
cord-023095-4dannjjm	3839	13	months	month	NNS
cord-023095-4dannjjm	3839	14	.	.	.
cord-023095-4dannjjm	3840	1	Radiographs	radiograph	NNS
cord-023095-4dannjjm	3840	2	were	be	VBD
cord-023095-4dannjjm	3840	3	considered	consider	VBN
cord-023095-4dannjjm	3840	4	negative	negative	JJ
cord-023095-4dannjjm	3840	5	if	if	IN
cord-023095-4dannjjm	3840	6	all	all	DT
cord-023095-4dannjjm	3840	7	radiographic	radiographic	JJ
cord-023095-4dannjjm	3840	8	changes	change	NNS
cord-023095-4dannjjm	3840	9	had	have	VBD
cord-023095-4dannjjm	3840	10	resolved	resolve	VBN
cord-023095-4dannjjm	3840	11	or	or	CC
cord-023095-4dannjjm	3840	12	if	if	IN
cord-023095-4dannjjm	3840	13	repeated	repeat	VBN
cord-023095-4dannjjm	3840	14	radiographs	radiograph	NNS
cord-023095-4dannjjm	3840	15	separated	separate	VBN
cord-023095-4dannjjm	3840	16	by	by	IN
cord-023095-4dannjjm	3840	17	at	at	RB
cord-023095-4dannjjm	3840	18	least	least	RBS
cord-023095-4dannjjm	3840	19	one	one	CD
cord-023095-4dannjjm	3840	20	month	month	NN
cord-023095-4dannjjm	3840	21	were	be	VBD
cord-023095-4dannjjm	3840	22	considered	consider	VBN
cord-023095-4dannjjm	3840	23	static	static	JJ
cord-023095-4dannjjm	3840	24	after	after	IN
cord-023095-4dannjjm	3840	25	documented	document	VBN
cord-023095-4dannjjm	3840	26	improvement	improvement	NN
cord-023095-4dannjjm	3840	27	had	have	VBD
cord-023095-4dannjjm	3840	28	occurred	occur	VBN
cord-023095-4dannjjm	3840	29	from	from	IN
cord-023095-4dannjjm	3840	30	original	original	JJ
cord-023095-4dannjjm	3840	31	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3840	32	radiographs	radiograph	NNS
cord-023095-4dannjjm	3840	33	(	(	-LRB-
cord-023095-4dannjjm	3840	34	suspected	suspect	VBN
cord-023095-4dannjjm	3840	35	scarring	scarring	NN
cord-023095-4dannjjm	3840	36	)	)	-RRB-
cord-023095-4dannjjm	3840	37	.	.	.
cord-023095-4dannjjm	3841	1	Urine	urine	NN
cord-023095-4dannjjm	3841	2	antigen	antigen	NN
cord-023095-4dannjjm	3841	3	testing	testing	NN
cord-023095-4dannjjm	3841	4	was	be	VBD
cord-023095-4dannjjm	3841	5	considered	consider	VBN
cord-023095-4dannjjm	3841	6	negative	negative	JJ
cord-023095-4dannjjm	3841	7	if	if	IN
cord-023095-4dannjjm	3841	8	concentrations	concentration	NNS
cord-023095-4dannjjm	3841	9	were	be	VBD
cord-023095-4dannjjm	3841	10	less	less	JJR
cord-023095-4dannjjm	3841	11	than	than	IN
cord-023095-4dannjjm	3841	12	1.0	1.0	CD
cord-023095-4dannjjm	3841	13	enzyme	enzyme	NN
cord-023095-4dannjjm	3841	14	immunoassay	immunoassay	NN
cord-023095-4dannjjm	3841	15	units	unit	NNS
cord-023095-4dannjjm	3841	16	,	,	,
cord-023095-4dannjjm	3841	17	a	a	DT
cord-023095-4dannjjm	3841	18	reference	reference	NN
cord-023095-4dannjjm	3841	19	interval	interval	NN
cord-023095-4dannjjm	3841	20	set	set	VBN
cord-023095-4dannjjm	3841	21	by	by	IN
cord-023095-4dannjjm	3841	22	the	the	DT
cord-023095-4dannjjm	3841	23	testing	testing	NN
cord-023095-4dannjjm	3841	24	laboratory	laboratory	NN
cord-023095-4dannjjm	3841	25	.	.	.
cord-023095-4dannjjm	3842	1	Preliminary	preliminary	JJ
cord-023095-4dannjjm	3842	2	data	data	NN
cord-023095-4dannjjm	3842	3	analysis	analysis	NN
cord-023095-4dannjjm	3842	4	reveals	reveal	VBZ
cord-023095-4dannjjm	3842	5	resolution	resolution	NN
cord-023095-4dannjjm	3842	6	of	of	IN
cord-023095-4dannjjm	3842	7	radiographic	radiographic	JJ
cord-023095-4dannjjm	3842	8	signs	sign	NNS
cord-023095-4dannjjm	3842	9	of	of	IN
cord-023095-4dannjjm	3842	10	blastomycosis	blastomycosis	NN
cord-023095-4dannjjm	3842	11	occurred	occur	VBD
cord-023095-4dannjjm	3842	12	earlier	early	RBR
cord-023095-4dannjjm	3842	13	in	in	IN
cord-023095-4dannjjm	3842	14	many	many	JJ
cord-023095-4dannjjm	3842	15	of	of	IN
cord-023095-4dannjjm	3842	16	the	the	DT
cord-023095-4dannjjm	3842	17	cases	case	NNS
cord-023095-4dannjjm	3842	18	presented	present	VBN
cord-023095-4dannjjm	3842	19	than	than	IN
cord-023095-4dannjjm	3842	20	did	do	VBD
cord-023095-4dannjjm	3842	21	attaining	attain	VBG
cord-023095-4dannjjm	3842	22	a	a	DT
cord-023095-4dannjjm	3842	23	negative	negative	JJ
cord-023095-4dannjjm	3842	24	urine	urine	NN
cord-023095-4dannjjm	3842	25	antigen	antigen	NN
cord-023095-4dannjjm	3842	26	concentration	concentration	NN
cord-023095-4dannjjm	3842	27	.	.	.
cord-023095-4dannjjm	3843	1	Ceasing	cease	VBG
cord-023095-4dannjjm	3843	2	treatment	treatment	NN
cord-023095-4dannjjm	3843	3	1	1	CD
cord-023095-4dannjjm	3843	4	month	month	NN
cord-023095-4dannjjm	3843	5	after	after	IN
cord-023095-4dannjjm	3843	6	radiographic	radiographic	JJ
cord-023095-4dannjjm	3843	7	resolution	resolution	NN
cord-023095-4dannjjm	3843	8	of	of	IN
cord-023095-4dannjjm	3843	9	signs	sign	NNS
cord-023095-4dannjjm	3843	10	as	as	IN
cord-023095-4dannjjm	3843	11	has	have	VBZ
cord-023095-4dannjjm	3843	12	been	be	VBN
cord-023095-4dannjjm	3843	13	recommended	recommend	VBN
cord-023095-4dannjjm	3843	14	in	in	IN
cord-023095-4dannjjm	3843	15	the	the	DT
cord-023095-4dannjjm	3843	16	past	past	NN
cord-023095-4dannjjm	3843	17	might	may	MD
cord-023095-4dannjjm	3843	18	have	have	VB
cord-023095-4dannjjm	3843	19	resulted	result	VBN
cord-023095-4dannjjm	3843	20	in	in	IN
cord-023095-4dannjjm	3843	21	premature	premature	JJ
cord-023095-4dannjjm	3843	22	discontinuation	discontinuation	NN
cord-023095-4dannjjm	3843	23	of	of	IN
cord-023095-4dannjjm	3843	24	therapy	therapy	NN
cord-023095-4dannjjm	3843	25	in	in	IN
cord-023095-4dannjjm	3843	26	many	many	JJ
cord-023095-4dannjjm	3843	27	of	of	IN
cord-023095-4dannjjm	3843	28	the	the	DT
cord-023095-4dannjjm	3843	29	cases	case	NNS
cord-023095-4dannjjm	3843	30	.	.	.
cord-023095-4dannjjm	3844	1	Monitoring	monitoring	NN
cord-023095-4dannjjm	3844	2	of	of	IN
cord-023095-4dannjjm	3844	3	urine	urine	NN
cord-023095-4dannjjm	3844	4	antigen	antigen	NN
cord-023095-4dannjjm	3844	5	concentrations	concentration	NNS
cord-023095-4dannjjm	3844	6	may	may	MD
cord-023095-4dannjjm	3844	7	be	be	VB
cord-023095-4dannjjm	3844	8	of	of	IN
cord-023095-4dannjjm	3844	9	additional	additional	JJ
cord-023095-4dannjjm	3844	10	clinical	clinical	JJ
cord-023095-4dannjjm	3844	11	use	use	NN
cord-023095-4dannjjm	3844	12	for	for	IN
cord-023095-4dannjjm	3844	13	determining	determine	VBG
cord-023095-4dannjjm	3844	14	when	when	WRB
cord-023095-4dannjjm	3844	15	cessation	cessation	NN
cord-023095-4dannjjm	3844	16	of	of	IN
cord-023095-4dannjjm	3844	17	treatment	treatment	NN
cord-023095-4dannjjm	3844	18	should	should	MD
cord-023095-4dannjjm	3844	19	occur	occur	VB
cord-023095-4dannjjm	3844	20	in	in	IN
cord-023095-4dannjjm	3844	21	cases	case	NNS
cord-023095-4dannjjm	3844	22	of	of	IN
cord-023095-4dannjjm	3844	23	blastomycosis	blastomycosis	NN
cord-023095-4dannjjm	3844	24	.	.	.
cord-023095-4dannjjm	3845	1	Persistent	persistent	JJ
cord-023095-4dannjjm	3845	2	elevation	elevation	NN
cord-023095-4dannjjm	3845	3	of	of	IN
cord-023095-4dannjjm	3845	4	urine	urine	NN
cord-023095-4dannjjm	3845	5	antigen	antigen	NN
cord-023095-4dannjjm	3845	6	concentrations	concentration	NNS
cord-023095-4dannjjm	3845	7	after	after	IN
cord-023095-4dannjjm	3845	8	radiographic	radiographic	JJ
cord-023095-4dannjjm	3845	9	resolution	resolution	NN
cord-023095-4dannjjm	3845	10	of	of	IN
cord-023095-4dannjjm	3845	11	infection	infection	NN
cord-023095-4dannjjm	3845	12	may	may	MD
cord-023095-4dannjjm	3845	13	account	account	VB
cord-023095-4dannjjm	3845	14	for	for	IN
cord-023095-4dannjjm	3845	15	apparent	apparent	JJ
cord-023095-4dannjjm	3845	16	recrudescence	recrudescence	NN
cord-023095-4dannjjm	3845	17	of	of	IN
cord-023095-4dannjjm	3845	18	blastomycosis	blastomycosis	NN
cord-023095-4dannjjm	3845	19	after	after	IN
cord-023095-4dannjjm	3845	20	suspected	suspect	VBN
cord-023095-4dannjjm	3845	21	clinical	clinical	JJ
cord-023095-4dannjjm	3845	22	resolution	resolution	NN
cord-023095-4dannjjm	3845	23	.	.	.
cord-023095-4dannjjm	3846	1	Giardia	Giardia	NNP
cord-023095-4dannjjm	3846	2	spp	spp	NNS
cord-023095-4dannjjm	3846	3	.	.	.
cord-023095-4dannjjm	3847	1	and	and	CC
cord-023095-4dannjjm	3847	2	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3847	3	spp	spp	NNS
cord-023095-4dannjjm	3847	4	.	.	.
cord-023095-4dannjjm	3848	1	are	be	VBP
cord-023095-4dannjjm	3848	2	both	both	DT
cord-023095-4dannjjm	3848	3	known	know	VBN
cord-023095-4dannjjm	3848	4	to	to	TO
cord-023095-4dannjjm	3848	5	cause	cause	VB
cord-023095-4dannjjm	3848	6	infections	infection	NNS
cord-023095-4dannjjm	3848	7	in	in	IN
cord-023095-4dannjjm	3848	8	dogs	dog	NNS
cord-023095-4dannjjm	3848	9	and	and	CC
cord-023095-4dannjjm	3848	10	humans	human	NNS
cord-023095-4dannjjm	3848	11	in	in	IN
cord-023095-4dannjjm	3848	12	the	the	DT
cord-023095-4dannjjm	3848	13	United	United	NNP
cord-023095-4dannjjm	3848	14	States	States	NNP
cord-023095-4dannjjm	3848	15	.	.	.
cord-023095-4dannjjm	3849	1	Nevertheless	nevertheless	RB
cord-023095-4dannjjm	3849	2	,	,	,
cord-023095-4dannjjm	3849	3	prevalence	prevalence	NN
cord-023095-4dannjjm	3849	4	rates	rate	NNS
cord-023095-4dannjjm	3849	5	for	for	IN
cord-023095-4dannjjm	3849	6	dual	dual	JJ
cord-023095-4dannjjm	3849	7	infection	infection	NN
cord-023095-4dannjjm	3849	8	in	in	IN
cord-023095-4dannjjm	3849	9	dogs	dog	NNS
cord-023095-4dannjjm	3849	10	had	have	VBD
cord-023095-4dannjjm	3849	11	not	not	RB
cord-023095-4dannjjm	3849	12	been	be	VBN
cord-023095-4dannjjm	3849	13	widely	widely	RB
cord-023095-4dannjjm	3849	14	reported	report	VBN
cord-023095-4dannjjm	3849	15	.	.	.
cord-023095-4dannjjm	3850	1	In	in	IN
cord-023095-4dannjjm	3850	2	this	this	DT
cord-023095-4dannjjm	3850	3	study	study	NN
cord-023095-4dannjjm	3850	4	,	,	,
cord-023095-4dannjjm	3850	5	fecal	fecal	JJ
cord-023095-4dannjjm	3850	6	samples	sample	NNS
cord-023095-4dannjjm	3850	7	from	from	IN
cord-023095-4dannjjm	3850	8	dogs	dog	NNS
cord-023095-4dannjjm	3850	9	housed	house	VBN
cord-023095-4dannjjm	3850	10	in	in	IN
cord-023095-4dannjjm	3850	11	a	a	DT
cord-023095-4dannjjm	3850	12	northern	northern	JJ
cord-023095-4dannjjm	3850	13	Colorado	Colorado	NNP
cord-023095-4dannjjm	3850	14	animal	animal	NN
cord-023095-4dannjjm	3850	15	shelter	shelter	NN
cord-023095-4dannjjm	3850	16	(	(	-LRB-
cord-023095-4dannjjm	3850	17	n	n	NN
cord-023095-4dannjjm	3850	18	5	5	CD
cord-023095-4dannjjm	3850	19	121	121	CD
cord-023095-4dannjjm	3850	20	)	)	-RRB-
cord-023095-4dannjjm	3850	21	,	,	,
cord-023095-4dannjjm	3850	22	dogs	dog	NNS
cord-023095-4dannjjm	3850	23	owned	own	VBN
cord-023095-4dannjjm	3850	24	by	by	IN
cord-023095-4dannjjm	3850	25	veterinary	veterinary	JJ
cord-023095-4dannjjm	3850	26	students	student	NNS
cord-023095-4dannjjm	3850	27	in	in	IN
cord-023095-4dannjjm	3850	28	northern	northern	JJ
cord-023095-4dannjjm	3850	29	Colorado	Colorado	NNP
cord-023095-4dannjjm	3850	30	(	(	-LRB-
cord-023095-4dannjjm	3850	31	n	n	NN
cord-023095-4dannjjm	3850	32	5	5	CD
cord-023095-4dannjjm	3850	33	132	132	CD
cord-023095-4dannjjm	3850	34	)	)	-RRB-
cord-023095-4dannjjm	3850	35	,	,	,
cord-023095-4dannjjm	3850	36	and	and	CC
cord-023095-4dannjjm	3850	37	dogs	dog	NNS
cord-023095-4dannjjm	3850	38	from	from	IN
cord-023095-4dannjjm	3850	39	the	the	DT
cord-023095-4dannjjm	3850	40	Pine	Pine	NNP
cord-023095-4dannjjm	3850	41	Ridge	Ridge	NNP
cord-023095-4dannjjm	3850	42	reservation	reservation	NN
cord-023095-4dannjjm	3850	43	in	in	IN
cord-023095-4dannjjm	3850	44	South	South	NNP
cord-023095-4dannjjm	3850	45	Dakota	Dakota	NNP
cord-023095-4dannjjm	3850	46	(	(	-LRB-
cord-023095-4dannjjm	3850	47	n	n	NN
cord-023095-4dannjjm	3850	48	5	5	CD
cord-023095-4dannjjm	3850	49	84	84	CD
cord-023095-4dannjjm	3850	50	)	)	-RRB-
cord-023095-4dannjjm	3850	51	were	be	VBD
cord-023095-4dannjjm	3850	52	collected	collect	VBN
cord-023095-4dannjjm	3850	53	.	.	.
cord-023095-4dannjjm	3851	1	Each	each	DT
cord-023095-4dannjjm	3851	2	sample	sample	NN
cord-023095-4dannjjm	3851	3	was	be	VBD
cord-023095-4dannjjm	3851	4	assayed	assay	VBN
cord-023095-4dannjjm	3851	5	with	with	IN
cord-023095-4dannjjm	3851	6	a	a	DT
cord-023095-4dannjjm	3851	7	commercially	commercially	RB
cord-023095-4dannjjm	3851	8	available	available	JJ
cord-023095-4dannjjm	3851	9	fluorescent	fluorescent	JJ
cord-023095-4dannjjm	3851	10	antibody	antibody	NN
cord-023095-4dannjjm	3851	11	assay	assay	NN
cord-023095-4dannjjm	3851	12	that	that	WDT
cord-023095-4dannjjm	3851	13	detects	detect	VBZ
cord-023095-4dannjjm	3851	14	Giardia	Giardia	NNP
cord-023095-4dannjjm	3851	15	spp	spp	NNS
cord-023095-4dannjjm	3851	16	.	.	.
cord-023095-4dannjjm	3852	1	cysts	cyst	NNS
cord-023095-4dannjjm	3852	2	and	and	CC
cord-023095-4dannjjm	3852	3	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3852	4	spp	spp	NNS
cord-023095-4dannjjm	3852	5	.	.	.
cord-023095-4dannjjm	3853	1	oocysts	oocyst	NNS
cord-023095-4dannjjm	3853	2	.	.	.
cord-023095-4dannjjm	3854	1	Those	those	DT
cord-023095-4dannjjm	3854	2	samples	sample	NNS
cord-023095-4dannjjm	3854	3	that	that	WDT
cord-023095-4dannjjm	3854	4	were	be	VBD
cord-023095-4dannjjm	3854	5	positive	positive	JJ
cord-023095-4dannjjm	3854	6	for	for	IN
cord-023095-4dannjjm	3854	7	Giardia	Giardia	NNP
cord-023095-4dannjjm	3854	8	spp	spp	NNS
cord-023095-4dannjjm	3854	9	.	.	.
cord-023095-4dannjjm	3855	1	or	or	CC
cord-023095-4dannjjm	3855	2	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3855	3	spp	spp	NNS
cord-023095-4dannjjm	3855	4	.	.	.
cord-023095-4dannjjm	3856	1	with	with	IN
cord-023095-4dannjjm	3856	2	adequate	adequate	JJ
cord-023095-4dannjjm	3856	3	DNA	dna	NN
cord-023095-4dannjjm	3856	4	available	available	JJ
cord-023095-4dannjjm	3856	5	for	for	IN
cord-023095-4dannjjm	3856	6	sequencing	sequencing	NN
cord-023095-4dannjjm	3856	7	were	be	VBD
cord-023095-4dannjjm	3856	8	genotyped	genotype	VBN
cord-023095-4dannjjm	3856	9	by	by	IN
cord-023095-4dannjjm	3856	10	the	the	DT
cord-023095-4dannjjm	3856	11	glutamate	glutamate	NN
cord-023095-4dannjjm	3856	12	dehydrogenase	dehydrogenase	NN
cord-023095-4dannjjm	3856	13	[	[	-LRB-
cord-023095-4dannjjm	3856	14	gdh	gdh	NN
cord-023095-4dannjjm	3856	15	]	]	-RRB-
cord-023095-4dannjjm	3856	16	and	and	CC
cord-023095-4dannjjm	3856	17	by	by	IN
cord-023095-4dannjjm	3856	18	the	the	DT
cord-023095-4dannjjm	3856	19	heat	heat	NN
cord-023095-4dannjjm	3856	20	shock	shock	NN
cord-023095-4dannjjm	3856	21	protein-70	protein-70	XX
cord-023095-4dannjjm	3856	22	[	[	-LRB-
cord-023095-4dannjjm	3856	23	HSP-70	HSP-70	NNP
cord-023095-4dannjjm	3856	24	]	]	-RRB-
cord-023095-4dannjjm	3856	25	genes	gene	NNS
cord-023095-4dannjjm	3856	26	,	,	,
cord-023095-4dannjjm	3856	27	respectively	respectively	RB
cord-023095-4dannjjm	3856	28	.	.	.
cord-023095-4dannjjm	3857	1	Overall	overall	RB
cord-023095-4dannjjm	3857	2	,	,	,
cord-023095-4dannjjm	3857	3	45	45	CD
cord-023095-4dannjjm	3857	4	(	(	-LRB-
cord-023095-4dannjjm	3857	5	13.3	13.3	CD
cord-023095-4dannjjm	3857	6	%	%	NN
cord-023095-4dannjjm	3857	7	)	)	-RRB-
cord-023095-4dannjjm	3857	8	of	of	IN
cord-023095-4dannjjm	3857	9	the	the	DT
cord-023095-4dannjjm	3857	10	dogs	dog	NNS
cord-023095-4dannjjm	3857	11	had	have	VBD
cord-023095-4dannjjm	3857	12	current	current	JJ
cord-023095-4dannjjm	3857	13	evidence	evidence	NN
cord-023095-4dannjjm	3857	14	of	of	IN
cord-023095-4dannjjm	3857	15	a	a	DT
cord-023095-4dannjjm	3857	16	protozoal	protozoal	JJ
cord-023095-4dannjjm	3857	17	infection	infection	NN
cord-023095-4dannjjm	3857	18	(	(	-LRB-
cord-023095-4dannjjm	3857	19	Table	table	NN
cord-023095-4dannjjm	3857	20	1	1	CD
cord-023095-4dannjjm	3857	21	)	)	-RRB-
cord-023095-4dannjjm	3857	22	.	.	.
cord-023095-4dannjjm	3858	1	The	the	DT
cord-023095-4dannjjm	3858	2	dogs	dog	NNS
cord-023095-4dannjjm	3858	3	from	from	IN
cord-023095-4dannjjm	3858	4	Pine	Pine	NNP
cord-023095-4dannjjm	3858	5	Ridge	Ridge	NNP
cord-023095-4dannjjm	3858	6	reservation	reservation	NN
cord-023095-4dannjjm	3858	7	had	have	VBD
cord-023095-4dannjjm	3858	8	the	the	DT
cord-023095-4dannjjm	3858	9	highest	high	JJS
cord-023095-4dannjjm	3858	10	prevalence	prevalence	NN
cord-023095-4dannjjm	3858	11	rates	rate	NNS
cord-023095-4dannjjm	3858	12	for	for	IN
cord-023095-4dannjjm	3858	13	Giardia	Giardia	NNP
cord-023095-4dannjjm	3858	14	infection	infection	NN
cord-023095-4dannjjm	3858	15	and	and	CC
cord-023095-4dannjjm	3858	16	also	also	RB
cord-023095-4dannjjm	3858	17	for	for	IN
cord-023095-4dannjjm	3858	18	dual	dual	JJ
cord-023095-4dannjjm	3858	19	infections	infection	NNS
cord-023095-4dannjjm	3858	20	.	.	.
cord-023095-4dannjjm	3859	1	From	from	IN
cord-023095-4dannjjm	3859	2	the	the	DT
cord-023095-4dannjjm	3859	3	student	student	NN
cord-023095-4dannjjm	3859	4	dogs	dog	NNS
cord-023095-4dannjjm	3859	5	,	,	,
cord-023095-4dannjjm	3859	6	sequencing	sequencing	NN
cord-023095-4dannjjm	3859	7	was	be	VBD
cord-023095-4dannjjm	3859	8	successful	successful	JJ
cord-023095-4dannjjm	3859	9	for	for	IN
cord-023095-4dannjjm	3859	10	the	the	DT
cord-023095-4dannjjm	3859	11	three	three	CD
cord-023095-4dannjjm	3859	12	Giardia	Giardia	NNP
cord-023095-4dannjjm	3859	13	isolates	isolate	NNS
cord-023095-4dannjjm	3859	14	(	(	-LRB-
cord-023095-4dannjjm	3859	15	assemblage	assemblage	NN
cord-023095-4dannjjm	3859	16	D	d	NN
cord-023095-4dannjjm	3859	17	from	from	IN
cord-023095-4dannjjm	3859	18	2	2	CD
cord-023095-4dannjjm	3859	19	dogs	dog	NNS
cord-023095-4dannjjm	3859	20	;	;	:
cord-023095-4dannjjm	3859	21	assemblage	assemblage	NN
cord-023095-4dannjjm	3859	22	C	c	NN
cord-023095-4dannjjm	3859	23	from	from	IN
cord-023095-4dannjjm	3859	24	one	one	CD
cord-023095-4dannjjm	3859	25	dog	dog	NN
cord-023095-4dannjjm	3859	26	)	)	-RRB-
cord-023095-4dannjjm	3859	27	and	and	CC
cord-023095-4dannjjm	3859	28	one	one	CD
cord-023095-4dannjjm	3859	29	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3859	30	isolate	isolate	NN
cord-023095-4dannjjm	3859	31	(	(	-LRB-
cord-023095-4dannjjm	3859	32	C.	C.	NNP
cord-023095-4dannjjm	3859	33	canis	canis	NNP
cord-023095-4dannjjm	3859	34	)	)	-RRB-
cord-023095-4dannjjm	3859	35	.	.	.
cord-023095-4dannjjm	3860	1	From	from	IN
cord-023095-4dannjjm	3860	2	the	the	DT
cord-023095-4dannjjm	3860	3	reservation	reservation	NN
cord-023095-4dannjjm	3860	4	dogs	dog	NNS
cord-023095-4dannjjm	3860	5	,	,	,
cord-023095-4dannjjm	3860	6	sequencing	sequencing	NN
cord-023095-4dannjjm	3860	7	was	be	VBD
cord-023095-4dannjjm	3860	8	successful	successful	JJ
cord-023095-4dannjjm	3860	9	for	for	IN
cord-023095-4dannjjm	3860	10	nine	nine	CD
cord-023095-4dannjjm	3860	11	Giardia	Giardia	NNP
cord-023095-4dannjjm	3860	12	isolates	isolate	NNS
cord-023095-4dannjjm	3860	13	(	(	-LRB-
cord-023095-4dannjjm	3860	14	assemblage	assemblage	NN
cord-023095-4dannjjm	3860	15	D	d	NN
cord-023095-4dannjjm	3860	16	from	from	IN
cord-023095-4dannjjm	3860	17	4	4	CD
cord-023095-4dannjjm	3860	18	dogs	dog	NNS
cord-023095-4dannjjm	3860	19	;	;	:
cord-023095-4dannjjm	3860	20	assemblage	assemblage	NN
cord-023095-4dannjjm	3860	21	C	c	NN
cord-023095-4dannjjm	3860	22	from	from	IN
cord-023095-4dannjjm	3860	23	5	5	CD
cord-023095-4dannjjm	3860	24	dogs	dog	NNS
cord-023095-4dannjjm	3860	25	)	)	-RRB-
cord-023095-4dannjjm	3860	26	and	and	CC
cord-023095-4dannjjm	3860	27	one	one	CD
cord-023095-4dannjjm	3860	28	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3860	29	isolate	isolate	NN
cord-023095-4dannjjm	3860	30	(	(	-LRB-
cord-023095-4dannjjm	3860	31	C.	C.	NNP
cord-023095-4dannjjm	3860	32	canis	canis	NNP
cord-023095-4dannjjm	3860	33	)	)	-RRB-
cord-023095-4dannjjm	3860	34	.	.	.
cord-023095-4dannjjm	3861	1	Cryptosporidium	Cryptosporidium	NNP
cord-023095-4dannjjm	3861	2	and	and	CC
cord-023095-4dannjjm	3861	3	Giardia	Giardia	NNP
cord-023095-4dannjjm	3861	4	co	co	NNS
cord-023095-4dannjjm	3861	5	-	-	NNS
cord-023095-4dannjjm	3861	6	infections	infection	NNS
cord-023095-4dannjjm	3861	7	are	be	VBP
cord-023095-4dannjjm	3861	8	commonly	commonly	RB
cord-023095-4dannjjm	3861	9	detected	detect	VBN
cord-023095-4dannjjm	3861	10	in	in	IN
cord-023095-4dannjjm	3861	11	dogs	dog	NNS
cord-023095-4dannjjm	3861	12	;	;	:
cord-023095-4dannjjm	3861	13	in	in	IN
cord-023095-4dannjjm	3861	14	this	this	DT
cord-023095-4dannjjm	3861	15	study	study	NN
cord-023095-4dannjjm	3861	16	dual	dual	JJ
cord-023095-4dannjjm	3861	17	infections	infection	NNS
cord-023095-4dannjjm	3861	18	were	be	VBD
cord-023095-4dannjjm	3861	19	more	more	RBR
cord-023095-4dannjjm	3861	20	common	common	JJ
cord-023095-4dannjjm	3861	21	than	than	IN
cord-023095-4dannjjm	3861	22	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3861	23	infections	infection	NNS
cord-023095-4dannjjm	3861	24	alone	alone	RB
cord-023095-4dannjjm	3861	25	.	.	.
cord-023095-4dannjjm	3862	1	Further	further	JJ
cord-023095-4dannjjm	3862	2	studies	study	NNS
cord-023095-4dannjjm	3862	3	will	will	MD
cord-023095-4dannjjm	3862	4	be	be	VB
cord-023095-4dannjjm	3862	5	required	require	VBN
cord-023095-4dannjjm	3862	6	to	to	TO
cord-023095-4dannjjm	3862	7	determine	determine	VB
cord-023095-4dannjjm	3862	8	the	the	DT
cord-023095-4dannjjm	3862	9	clinical	clinical	JJ
cord-023095-4dannjjm	3862	10	importance	importance	NN
cord-023095-4dannjjm	3862	11	of	of	IN
cord-023095-4dannjjm	3862	12	this	this	DT
cord-023095-4dannjjm	3862	13	finding	finding	NN
cord-023095-4dannjjm	3862	14	.	.	.
cord-023095-4dannjjm	3863	1	Although	although	IN
cord-023095-4dannjjm	3863	2	the	the	DT
cord-023095-4dannjjm	3863	3	Giardia	Giardia	NNP
cord-023095-4dannjjm	3863	4	and	and	CC
cord-023095-4dannjjm	3863	5	Cryptosporidium	Cryptosporidium	NNP
cord-023095-4dannjjm	3863	6	isolates	isolate	VBZ
cord-023095-4dannjjm	3863	7	that	that	WDT
cord-023095-4dannjjm	3863	8	were	be	VBD
cord-023095-4dannjjm	3863	9	sequenced	sequence	VBN
cord-023095-4dannjjm	3863	10	were	be	VBD
cord-023095-4dannjjm	3863	11	the	the	DT
cord-023095-4dannjjm	3863	12	dog	dog	NN
cord-023095-4dannjjm	3863	13	specific	specific	JJ
cord-023095-4dannjjm	3863	14	assemblages	assemblage	NNS
cord-023095-4dannjjm	3863	15	/	/	SYM
cord-023095-4dannjjm	3863	16	genotypes	genotype	NNS
cord-023095-4dannjjm	3863	17	,	,	,
cord-023095-4dannjjm	3863	18	more	more	JJR
cord-023095-4dannjjm	3863	19	samples	sample	NNS
cord-023095-4dannjjm	3863	20	should	should	MD
cord-023095-4dannjjm	3863	21	be	be	VB
cord-023095-4dannjjm	3863	22	analyzed	analyze	VBN
cord-023095-4dannjjm	3863	23	in	in	IN
cord-023095-4dannjjm	3863	24	order	order	NN
cord-023095-4dannjjm	3863	25	to	to	TO
cord-023095-4dannjjm	3863	26	assess	assess	VB
cord-023095-4dannjjm	3863	27	the	the	DT
cord-023095-4dannjjm	3863	28	potential	potential	NN
cord-023095-4dannjjm	3863	29	for	for	IN
cord-023095-4dannjjm	3863	30	zoonotic	zoonotic	JJ
cord-023095-4dannjjm	3863	31	transmission	transmission	NN
cord-023095-4dannjjm	3863	32	of	of	IN
cord-023095-4dannjjm	3863	33	either	either	DT
cord-023095-4dannjjm	3863	34	parasite	parasite	NN
cord-023095-4dannjjm	3863	35	.	.	.
cord-023095-4dannjjm	3864	1	The	the	DT
cord-023095-4dannjjm	3864	2	current	current	JJ
cord-023095-4dannjjm	3864	3	study	study	NN
cord-023095-4dannjjm	3864	4	was	be	VBD
cord-023095-4dannjjm	3864	5	conducted	conduct	VBN
cord-023095-4dannjjm	3864	6	to	to	TO
cord-023095-4dannjjm	3864	7	determine	determine	VB
cord-023095-4dannjjm	3864	8	the	the	DT
cord-023095-4dannjjm	3864	9	prevalence	prevalence	NN
cord-023095-4dannjjm	3864	10	of	of	IN
cord-023095-4dannjjm	3864	11	intestinal	intestinal	JJ
cord-023095-4dannjjm	3864	12	parasites	parasite	NNS
cord-023095-4dannjjm	3864	13	in	in	IN
cord-023095-4dannjjm	3864	14	dogs	dog	NNS
cord-023095-4dannjjm	3864	15	visiting	visit	VBG
cord-023095-4dannjjm	3864	16	the	the	DT
cord-023095-4dannjjm	3864	17	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	3864	18	Teaching	Teaching	NNP
cord-023095-4dannjjm	3864	19	Hospital	Hospital	NNP
cord-023095-4dannjjm	3864	20	,	,	,
cord-023095-4dannjjm	3864	21	Chiang	Chiang	NNP
cord-023095-4dannjjm	3864	22	Mai	Mai	NNP
cord-023095-4dannjjm	3864	23	University	University	NNP
cord-023095-4dannjjm	3864	24	,	,	,
cord-023095-4dannjjm	3864	25	Northern	Northern	NNP
cord-023095-4dannjjm	3864	26	Thailand	Thailand	NNP
cord-023095-4dannjjm	3864	27	.	.	.
cord-023095-4dannjjm	3865	1	Fecal	fecal	JJ
cord-023095-4dannjjm	3865	2	samples	sample	NNS
cord-023095-4dannjjm	3865	3	(	(	-LRB-
cord-023095-4dannjjm	3865	4	n	n	NN
cord-023095-4dannjjm	3865	5	5	5	CD
cord-023095-4dannjjm	3865	6	301	301	CD
cord-023095-4dannjjm	3865	7	)	)	-RRB-
cord-023095-4dannjjm	3865	8	were	be	VBD
cord-023095-4dannjjm	3865	9	collected	collect	VBN
cord-023095-4dannjjm	3865	10	and	and	CC
cord-023095-4dannjjm	3865	11	submitted	submit	VBN
cord-023095-4dannjjm	3865	12	by	by	IN
cord-023095-4dannjjm	3865	13	owners	owner	NNS
cord-023095-4dannjjm	3865	14	between	between	IN
cord-023095-4dannjjm	3865	15	August	August	NNP
cord-023095-4dannjjm	3865	16	2009	2009	CD
cord-023095-4dannjjm	3865	17	to	to	IN
cord-023095-4dannjjm	3865	18	February	February	NNP
cord-023095-4dannjjm	3865	19	2010	2010	CD
cord-023095-4dannjjm	3865	20	.	.	.
cord-023095-4dannjjm	3866	1	Demographic	demographic	JJ
cord-023095-4dannjjm	3866	2	and	and	CC
cord-023095-4dannjjm	3866	3	geographic	geographic	JJ
cord-023095-4dannjjm	3866	4	data	datum	NNS
cord-023095-4dannjjm	3866	5	were	be	VBD
cord-023095-4dannjjm	3866	6	recorded	record	VBN
cord-023095-4dannjjm	3866	7	.	.	.
cord-023095-4dannjjm	3867	1	Intestinal	intestinal	JJ
cord-023095-4dannjjm	3867	2	parasitic	parasitic	JJ
cord-023095-4dannjjm	3867	3	infection	infection	NN
cord-023095-4dannjjm	3867	4	was	be	VBD
cord-023095-4dannjjm	3867	5	diagnosed	diagnose	VBN
cord-023095-4dannjjm	3867	6	by	by	IN
cord-023095-4dannjjm	3867	7	both	both	DT
cord-023095-4dannjjm	3867	8	microscopic	microscopic	JJ
cord-023095-4dannjjm	3867	9	examination	examination	NN
cord-023095-4dannjjm	3867	10	after	after	IN
cord-023095-4dannjjm	3867	11	zinc	zinc	NN
cord-023095-4dannjjm	3867	12	sulfate	sulfate	NN
cord-023095-4dannjjm	3867	13	centrifugation	centrifugation	NN
cord-023095-4dannjjm	3867	14	flotation	flotation	NN
cord-023095-4dannjjm	3867	15	and	and	CC
cord-023095-4dannjjm	3867	16	commercially	commercially	RB
cord-023095-4dannjjm	3867	17	available	available	JJ
cord-023095-4dannjjm	3867	18	IFA	IFA	NNP
cord-023095-4dannjjm	3867	19	for	for	IN
cord-023095-4dannjjm	3867	20	Giardia	Giardia	NNP
cord-023095-4dannjjm	3867	21	spp	spp	NNS
cord-023095-4dannjjm	3867	22	.	.	.
cord-023095-4dannjjm	3868	1	and	and	CC
cord-023095-4dannjjm	3868	2	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3868	3	spp	spp	NNS
cord-023095-4dannjjm	3868	4	.	.	.
cord-023095-4dannjjm	3869	1	Polymerase	polymerase	NN
cord-023095-4dannjjm	3869	2	chain	chain	NN
cord-023095-4dannjjm	3869	3	reaction	reaction	NN
cord-023095-4dannjjm	3869	4	and	and	CC
cord-023095-4dannjjm	3869	5	DNA	dna	NN
cord-023095-4dannjjm	3869	6	sequencing	sequencing	NN
cord-023095-4dannjjm	3869	7	were	be	VBD
cord-023095-4dannjjm	3869	8	performed	perform	VBN
cord-023095-4dannjjm	3869	9	on	on	IN
cord-023095-4dannjjm	3869	10	all	all	DT
cord-023095-4dannjjm	3869	11	Giardia	Giardia	NNP
cord-023095-4dannjjm	3869	12	and	and	CC
cord-023095-4dannjjm	3869	13	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3869	14	positive	positive	JJ
cord-023095-4dannjjm	3869	15	samples	sample	NNS
cord-023095-4dannjjm	3869	16	to	to	TO
cord-023095-4dannjjm	3869	17	provide	provide	VB
cord-023095-4dannjjm	3869	18	genotyic	genotyic	NNS
cord-023095-4dannjjm	3869	19	information	information	NN
cord-023095-4dannjjm	3869	20	.	.	.
cord-023095-4dannjjm	3870	1	Overall	overall	JJ
cord-023095-4dannjjm	3870	2	prevalence	prevalence	NN
cord-023095-4dannjjm	3870	3	of	of	IN
cord-023095-4dannjjm	3870	4	intestinal	intestinal	JJ
cord-023095-4dannjjm	3870	5	parasitic	parasitic	JJ
cord-023095-4dannjjm	3870	6	infection	infection	NN
cord-023095-4dannjjm	3870	7	in	in	IN
cord-023095-4dannjjm	3870	8	dogs	dog	NNS
cord-023095-4dannjjm	3870	9	in	in	IN
cord-023095-4dannjjm	3870	10	Chiang	Chiang	NNP
cord-023095-4dannjjm	3870	11	Mai	Mai	NNP
cord-023095-4dannjjm	3870	12	was	be	VBD
cord-023095-4dannjjm	3870	13	38.9	38.9	CD
cord-023095-4dannjjm	3870	14	%	%	NN
cord-023095-4dannjjm	3870	15	.	.	.
cord-023095-4dannjjm	3871	1	The	the	DT
cord-023095-4dannjjm	3871	2	most	most	RBS
cord-023095-4dannjjm	3871	3	prevalent	prevalent	JJ
cord-023095-4dannjjm	3871	4	parasite	parasite	NN
cord-023095-4dannjjm	3871	5	was	be	VBD
cord-023095-4dannjjm	3871	6	Giardia	Giardia	NNP
cord-023095-4dannjjm	3871	7	spp	spp	NNS
cord-023095-4dannjjm	3871	8	.	.	.
cord-023095-4dannjjm	3872	1	(	(	-LRB-
cord-023095-4dannjjm	3872	2	24.9	24.9	CD
cord-023095-4dannjjm	3872	3	%	%	NN
cord-023095-4dannjjm	3872	4	)	)	-RRB-
cord-023095-4dannjjm	3872	5	followed	follow	VBN
cord-023095-4dannjjm	3872	6	by	by	IN
cord-023095-4dannjjm	3872	7	Ancylostoma	Ancylostoma	NNP
cord-023095-4dannjjm	3872	8	spp	spp	NNS
cord-023095-4dannjjm	3872	9	.	.	.
cord-023095-4dannjjm	3873	1	(	(	-LRB-
cord-023095-4dannjjm	3873	2	12.0	12.0	CD
cord-023095-4dannjjm	3873	3	%	%	NN
cord-023095-4dannjjm	3873	4	)	)	-RRB-
cord-023095-4dannjjm	3873	5	,	,	,
cord-023095-4dannjjm	3873	6	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3873	7	spp	spp	NNS
cord-023095-4dannjjm	3873	8	.	.	.
cord-023095-4dannjjm	3874	1	(	(	-LRB-
cord-023095-4dannjjm	3874	2	7.6	7.6	CD
cord-023095-4dannjjm	3874	3	%	%	NN
cord-023095-4dannjjm	3874	4	)	)	-RRB-
cord-023095-4dannjjm	3874	5	,	,	,
cord-023095-4dannjjm	3874	6	Cystoisospora	Cystoisospora	NNP
cord-023095-4dannjjm	3874	7	spp	spp	NNS
cord-023095-4dannjjm	3874	8	.	.	.
cord-023095-4dannjjm	3875	1	(	(	-LRB-
cord-023095-4dannjjm	3875	2	6.0	6.0	CD
cord-023095-4dannjjm	3875	3	%	%	NN
cord-023095-4dannjjm	3875	4	)	)	-RRB-
cord-023095-4dannjjm	3875	5	,	,	,
cord-023095-4dannjjm	3875	6	Toxocara	Toxocara	NNP
cord-023095-4dannjjm	3875	7	canis	canis	NN
cord-023095-4dannjjm	3875	8	(	(	-LRB-
cord-023095-4dannjjm	3875	9	2.7	2.7	CD
cord-023095-4dannjjm	3875	10	%	%	NN
cord-023095-4dannjjm	3875	11	)	)	-RRB-
cord-023095-4dannjjm	3875	12	,	,	,
cord-023095-4dannjjm	3875	13	Trichuris	Trichuris	NNP
cord-023095-4dannjjm	3875	14	vulpis	vulpis	NNP
cord-023095-4dannjjm	3875	15	(	(	-LRB-
cord-023095-4dannjjm	3875	16	2.0	2.0	CD
cord-023095-4dannjjm	3875	17	%	%	NN
cord-023095-4dannjjm	3875	18	)	)	-RRB-
cord-023095-4dannjjm	3875	19	,	,	,
cord-023095-4dannjjm	3875	20	coccidian	coccidian	NN
cord-023095-4dannjjm	3875	21	-	-	HYPH
cord-023095-4dannjjm	3875	22	like	like	JJ
cord-023095-4dannjjm	3875	23	(	(	-LRB-
cord-023095-4dannjjm	3875	24	1.7	1.7	CD
cord-023095-4dannjjm	3875	25	%	%	NN
cord-023095-4dannjjm	3875	26	)	)	-RRB-
cord-023095-4dannjjm	3875	27	,	,	,
cord-023095-4dannjjm	3875	28	Toxascaris	Toxascaris	NNP
cord-023095-4dannjjm	3875	29	leonina	leonina	NNP
cord-023095-4dannjjm	3875	30	(	(	-LRB-
cord-023095-4dannjjm	3875	31	0.7	0.7	CD
cord-023095-4dannjjm	3875	32	%	%	NN
cord-023095-4dannjjm	3875	33	)	)	-RRB-
cord-023095-4dannjjm	3875	34	,	,	,
cord-023095-4dannjjm	3875	35	and	and	CC
cord-023095-4dannjjm	3875	36	Strongyloides	Strongyloides	NNP
cord-023095-4dannjjm	3875	37	spp	spp	NNP
cord-023095-4dannjjm	3875	38	.	.	.
cord-023095-4dannjjm	3876	1	(	(	-LRB-
cord-023095-4dannjjm	3876	2	0.7	0.7	CD
cord-023095-4dannjjm	3876	3	%	%	NN
cord-023095-4dannjjm	3876	4	)	)	-RRB-
cord-023095-4dannjjm	3876	5	.	.	.
cord-023095-4dannjjm	3877	1	The	the	DT
cord-023095-4dannjjm	3877	2	prevalence	prevalence	NN
cord-023095-4dannjjm	3877	3	of	of	IN
cord-023095-4dannjjm	3877	4	having	have	VBG
cord-023095-4dannjjm	3877	5	at	at	RB
cord-023095-4dannjjm	3877	6	least	least	RBS
cord-023095-4dannjjm	3877	7	one	one	CD
cord-023095-4dannjjm	3877	8	parasite	parasite	NN
cord-023095-4dannjjm	3877	9	in	in	IN
cord-023095-4dannjjm	3877	10	dogs	dog	NNS
cord-023095-4dannjjm	3877	11	o	o	NN
cord-023095-4dannjjm	3877	12	1	1	CD
cord-023095-4dannjjm	3877	13	year	year	NN
cord-023095-4dannjjm	3877	14	,	,	,
cord-023095-4dannjjm	3877	15	1	1	CD
cord-023095-4dannjjm	3877	16	-	-	SYM
cord-023095-4dannjjm	3877	17	7	7	CD
cord-023095-4dannjjm	3877	18	years	year	NNS
cord-023095-4dannjjm	3877	19	,	,	,
cord-023095-4dannjjm	3877	20	and	and	CC
cord-023095-4dannjjm	3877	21	4	4	CD
cord-023095-4dannjjm	3877	22	7	7	CD
cord-023095-4dannjjm	3877	23	years	year	NNS
cord-023095-4dannjjm	3877	24	were	be	VBD
cord-023095-4dannjjm	3877	25	49.3	49.3	CD
cord-023095-4dannjjm	3877	26	%	%	NN
cord-023095-4dannjjm	3877	27	,	,	,
cord-023095-4dannjjm	3877	28	39.8	39.8	CD
cord-023095-4dannjjm	3877	29	%	%	NN
cord-023095-4dannjjm	3877	30	,	,	,
cord-023095-4dannjjm	3877	31	and	and	CC
cord-023095-4dannjjm	3877	32	27.4	27.4	CD
cord-023095-4dannjjm	3877	33	%	%	NN
cord-023095-4dannjjm	3877	34	,	,	,
cord-023095-4dannjjm	3877	35	respectively	respectively	RB
cord-023095-4dannjjm	3877	36	.	.	.
cord-023095-4dannjjm	3878	1	Of	of	IN
cord-023095-4dannjjm	3878	2	these	these	DT
cord-023095-4dannjjm	3878	3	infected	infect	VBN
cord-023095-4dannjjm	3878	4	dogs	dog	NNS
cord-023095-4dannjjm	3878	5	,	,	,
cord-023095-4dannjjm	3878	6	59.0	59.0	CD
cord-023095-4dannjjm	3878	7	%	%	NN
cord-023095-4dannjjm	3878	8	,	,	,
cord-023095-4dannjjm	3878	9	34.2	34.2	CD
cord-023095-4dannjjm	3878	10	%	%	NN
cord-023095-4dannjjm	3878	11	,	,	,
cord-023095-4dannjjm	3878	12	5.1	5.1	CD
cord-023095-4dannjjm	3878	13	%	%	NN
cord-023095-4dannjjm	3878	14	,	,	,
cord-023095-4dannjjm	3878	15	and	and	CC
cord-023095-4dannjjm	3878	16	1.7	1.7	CD
cord-023095-4dannjjm	3878	17	%	%	NN
cord-023095-4dannjjm	3878	18	were	be	VBD
cord-023095-4dannjjm	3878	19	infected	infect	VBN
cord-023095-4dannjjm	3878	20	with	with	IN
cord-023095-4dannjjm	3878	21	one	one	CD
cord-023095-4dannjjm	3878	22	,	,	,
cord-023095-4dannjjm	3878	23	two	two	CD
cord-023095-4dannjjm	3878	24	,	,	,
cord-023095-4dannjjm	3878	25	three	three	CD
cord-023095-4dannjjm	3878	26	,	,	,
cord-023095-4dannjjm	3878	27	and	and	CC
cord-023095-4dannjjm	3878	28	four	four	CD
cord-023095-4dannjjm	3878	29	organisms	organism	NNS
cord-023095-4dannjjm	3878	30	,	,	,
cord-023095-4dannjjm	3878	31	respectively	respectively	RB
cord-023095-4dannjjm	3878	32	.	.	.
cord-023095-4dannjjm	3879	1	Available	available	JJ
cord-023095-4dannjjm	3879	2	DNA	dna	NN
cord-023095-4dannjjm	3879	3	sequences	sequence	NNS
cord-023095-4dannjjm	3879	4	from	from	IN
cord-023095-4dannjjm	3879	5	Giardia	Giardia	NNP
cord-023095-4dannjjm	3879	6	spp	spp	NNS
cord-023095-4dannjjm	3879	7	.	.	.
cord-023095-4dannjjm	3880	1	positive	positive	JJ
cord-023095-4dannjjm	3880	2	samples	sample	NNS
cord-023095-4dannjjm	3880	3	were	be	VBD
cord-023095-4dannjjm	3880	4	shown	show	VBN
cord-023095-4dannjjm	3880	5	to	to	TO
cord-023095-4dannjjm	3880	6	be	be	VB
cord-023095-4dannjjm	3880	7	dog	dog	NN
cord-023095-4dannjjm	3880	8	specific	specific	JJ
cord-023095-4dannjjm	3880	9	.	.	.
cord-023095-4dannjjm	3881	1	Only	only	RB
cord-023095-4dannjjm	3881	2	one	one	CD
cord-023095-4dannjjm	3881	3	adequate	adequate	JJ
cord-023095-4dannjjm	3881	4	DNA	dna	NN
cord-023095-4dannjjm	3881	5	sequence	sequence	NN
cord-023095-4dannjjm	3881	6	was	be	VBD
cord-023095-4dannjjm	3881	7	available	available	JJ
cord-023095-4dannjjm	3881	8	for	for	IN
cord-023095-4dannjjm	3881	9	Cryptosporidium	cryptosporidium	NN
cord-023095-4dannjjm	3881	10	spp	spp	NNS
cord-023095-4dannjjm	3881	11	.	.	.
cord-023095-4dannjjm	3882	1	,	,	,
cord-023095-4dannjjm	3882	2	which	which	WDT
cord-023095-4dannjjm	3882	3	was	be	VBD
cord-023095-4dannjjm	3882	4	shown	show	VBN
cord-023095-4dannjjm	3882	5	to	to	TO
cord-023095-4dannjjm	3882	6	be	be	VB
cord-023095-4dannjjm	3882	7	C.	C.	NNP
cord-023095-4dannjjm	3882	8	canis	canis	NNP
cord-023095-4dannjjm	3882	9	.	.	.
cord-023095-4dannjjm	3883	1	The	the	DT
cord-023095-4dannjjm	3883	2	findings	finding	NNS
cord-023095-4dannjjm	3883	3	suggested	suggest	VBD
cord-023095-4dannjjm	3883	4	that	that	IN
cord-023095-4dannjjm	3883	5	intestinal	intestinal	JJ
cord-023095-4dannjjm	3883	6	parasitic	parasitic	JJ
cord-023095-4dannjjm	3883	7	infection	infection	NN
cord-023095-4dannjjm	3883	8	was	be	VBD
cord-023095-4dannjjm	3883	9	common	common	JJ
cord-023095-4dannjjm	3883	10	in	in	IN
cord-023095-4dannjjm	3883	11	dogs	dog	NNS
cord-023095-4dannjjm	3883	12	in	in	IN
cord-023095-4dannjjm	3883	13	Chiang	Chiang	NNP
cord-023095-4dannjjm	3883	14	Mai	Mai	NNP
cord-023095-4dannjjm	3883	15	,	,	,
cord-023095-4dannjjm	3883	16	Thailand	Thailand	NNP
cord-023095-4dannjjm	3883	17	.	.	.
cord-023095-4dannjjm	3884	1	Dogs	dog	NNS
cord-023095-4dannjjm	3884	2	could	could	MD
cord-023095-4dannjjm	3884	3	be	be	VB
cord-023095-4dannjjm	3884	4	potential	potential	JJ
cord-023095-4dannjjm	3884	5	source	source	NN
cord-023095-4dannjjm	3884	6	for	for	IN
cord-023095-4dannjjm	3884	7	zoonotic	zoonotic	JJ
cord-023095-4dannjjm	3884	8	intestinal	intestinal	JJ
cord-023095-4dannjjm	3884	9	parasitic	parasitic	JJ
cord-023095-4dannjjm	3884	10	infection	infection	NN
cord-023095-4dannjjm	3884	11	since	since	IN
cord-023095-4dannjjm	3884	12	dogs	dog	NNS
cord-023095-4dannjjm	3884	13	in	in	IN
cord-023095-4dannjjm	3884	14	this	this	DT
cord-023095-4dannjjm	3884	15	area	area	NN
cord-023095-4dannjjm	3884	16	are	be	VBP
cord-023095-4dannjjm	3884	17	allowed	allow	VBN
cord-023095-4dannjjm	3884	18	for	for	IN
cord-023095-4dannjjm	3884	19	free	free	JJ
cord-023095-4dannjjm	3884	20	roaming	roaming	NN
cord-023095-4dannjjm	3884	21	.	.	.
cord-023095-4dannjjm	3885	1	Regular	regular	JJ
cord-023095-4dannjjm	3885	2	deworming	deworme	VBG
cord-023095-4dannjjm	3885	3	program	program	NN
cord-023095-4dannjjm	3885	4	is	be	VBZ
cord-023095-4dannjjm	3885	5	indicated	indicate	VBN
cord-023095-4dannjjm	3885	6	to	to	TO
cord-023095-4dannjjm	3885	7	prevent	prevent	VB
cord-023095-4dannjjm	3885	8	not	not	RB
cord-023095-4dannjjm	3885	9	only	only	JJ
cord-023095-4dannjjm	3885	10	transmission	transmission	NN
cord-023095-4dannjjm	3885	11	among	among	IN
cord-023095-4dannjjm	3885	12	dogs	dog	NNS
cord-023095-4dannjjm	3885	13	but	but	CC
cord-023095-4dannjjm	3885	14	also	also	RB
cord-023095-4dannjjm	3885	15	to	to	IN
cord-023095-4dannjjm	3885	16	human	human	NN
cord-023095-4dannjjm	3885	17	.	.	.
cord-023095-4dannjjm	3886	1	A	a	DT
cord-023095-4dannjjm	3886	2	retrospective	retrospective	JJ
cord-023095-4dannjjm	3886	3	study	study	NN
cord-023095-4dannjjm	3886	4	was	be	VBD
cord-023095-4dannjjm	3886	5	conducted	conduct	VBN
cord-023095-4dannjjm	3886	6	on	on	IN
cord-023095-4dannjjm	3886	7	135	135	CD
cord-023095-4dannjjm	3886	8	parasite	parasite	NN
cord-023095-4dannjjm	3886	9	positive	positive	JJ
cord-023095-4dannjjm	3886	10	fecal	fecal	JJ
cord-023095-4dannjjm	3886	11	specimens	specimen	NNS
cord-023095-4dannjjm	3886	12	consisting	consist	VBG
cord-023095-4dannjjm	3886	13	of	of	IN
cord-023095-4dannjjm	3886	14	90	90	CD
cord-023095-4dannjjm	3886	15	canine	canine	NN
cord-023095-4dannjjm	3886	16	,	,	,
cord-023095-4dannjjm	3886	17	29	29	CD
cord-023095-4dannjjm	3886	18	feline	feline	NN
cord-023095-4dannjjm	3886	19	,	,	,
cord-023095-4dannjjm	3886	20	14	14	CD
cord-023095-4dannjjm	3886	21	equine	equine	NN
cord-023095-4dannjjm	3886	22	and	and	CC
cord-023095-4dannjjm	3886	23	2	2	CD
cord-023095-4dannjjm	3886	24	from	from	IN
cord-023095-4dannjjm	3886	25	other	other	JJ
cord-023095-4dannjjm	3886	26	host	host	NN
cord-023095-4dannjjm	3886	27	species	specie	NNS
cord-023095-4dannjjm	3886	28	,	,	,
cord-023095-4dannjjm	3886	29	comparing	compare	VBG
cord-023095-4dannjjm	3886	30	recovery	recovery	NN
cord-023095-4dannjjm	3886	31	of	of	IN
cord-023095-4dannjjm	3886	32	eggs	egg	NNS
cord-023095-4dannjjm	3886	33	,	,	,
cord-023095-4dannjjm	3886	34	protozoan	protozoan	NN
cord-023095-4dannjjm	3886	35	cysts	cyst	NNS
cord-023095-4dannjjm	3886	36	and	and	CC
cord-023095-4dannjjm	3886	37	coccidian	coccidian	NN
cord-023095-4dannjjm	3886	38	oocysts	oocyst	NNS
cord-023095-4dannjjm	3886	39	using	use	VBG
cord-023095-4dannjjm	3886	40	2	2	CD
cord-023095-4dannjjm	3886	41	standardized	standardized	JJ
cord-023095-4dannjjm	3886	42	methods	method	NNS
cord-023095-4dannjjm	3886	43	of	of	IN
cord-023095-4dannjjm	3886	44	parasite	parasite	NN
cord-023095-4dannjjm	3886	45	concentration	concentration	NN
cord-023095-4dannjjm	3886	46	:	:	:
cord-023095-4dannjjm	3886	47	the	the	DT
cord-023095-4dannjjm	3886	48	formalin	formalin	NN
cord-023095-4dannjjm	3886	49	/	/	SYM
cord-023095-4dannjjm	3886	50	ethyl	ethyl	NN
cord-023095-4dannjjm	3886	51	acetate	acetate	NN
cord-023095-4dannjjm	3886	52	(	(	-LRB-
cord-023095-4dannjjm	3886	53	F	F	NNP
cord-023095-4dannjjm	3886	54	/	/	SYM
cord-023095-4dannjjm	3886	55	EA	EA	NNP
cord-023095-4dannjjm	3886	56	)	)	-RRB-
cord-023095-4dannjjm	3886	57	sedimentation	sedimentation	NN
cord-023095-4dannjjm	3886	58	concentration	concentration	NN
cord-023095-4dannjjm	3886	59	and	and	CC
cord-023095-4dannjjm	3886	60	the	the	DT
cord-023095-4dannjjm	3886	61	commercial	commercial	JJ
cord-023095-4dannjjm	3886	62	Fecalyzer	Fecalyzer	NNP
cord-023095-4dannjjm	3886	63	(	(	-LRB-
cord-023095-4dannjjm	3886	64	flotation	flotation	NN
cord-023095-4dannjjm	3886	65	)	)	-RRB-
cord-023095-4dannjjm	3886	66	kit	kit	NN
cord-023095-4dannjjm	3886	67	procedures	procedure	NNS
cord-023095-4dannjjm	3886	68	.	.	.
cord-023095-4dannjjm	3887	1	Specimens	specimen	NNS
cord-023095-4dannjjm	3887	2	were	be	VBD
cord-023095-4dannjjm	3887	3	processed	process	VBN
cord-023095-4dannjjm	3887	4	by	by	IN
cord-023095-4dannjjm	3887	5	each	each	DT
cord-023095-4dannjjm	3887	6	technique	technique	NN
cord-023095-4dannjjm	3887	7	either	either	CC
cord-023095-4dannjjm	3887	8	according	accord	VBG
cord-023095-4dannjjm	3887	9	to	to	IN
cord-023095-4dannjjm	3887	10	manufacturer	manufacturer	NN
cord-023095-4dannjjm	3887	11	's	's	POS
cord-023095-4dannjjm	3887	12	instructions	instruction	NNS
cord-023095-4dannjjm	3887	13	or	or	CC
cord-023095-4dannjjm	3887	14	according	accord	VBG
cord-023095-4dannjjm	3887	15	to	to	IN
cord-023095-4dannjjm	3887	16	standard	standard	JJ
cord-023095-4dannjjm	3887	17	laboratory	laboratory	NN
cord-023095-4dannjjm	3887	18	procedures	procedure	NNS
cord-023095-4dannjjm	3887	19	.	.	.
cord-023095-4dannjjm	3888	1	Formalin	Formalin	NNP
cord-023095-4dannjjm	3888	2	/	/	SYM
cord-023095-4dannjjm	3888	3	ethyl	ethyl	NN
cord-023095-4dannjjm	3888	4	acetate	acetate	NN
cord-023095-4dannjjm	3888	5	concentrations	concentration	NNS
cord-023095-4dannjjm	3888	6	used	use	VBN
cord-023095-4dannjjm	3888	7	at	at	IN
cord-023095-4dannjjm	3888	8	a	a	DT
cord-023095-4dannjjm	3888	9	ratio	ratio	NN
cord-023095-4dannjjm	3888	10	of	of	IN
cord-023095-4dannjjm	3888	11	10	10	CD
cord-023095-4dannjjm	3888	12	ml	ml	NN
cord-023095-4dannjjm	3888	13	normal	normal	JJ
cord-023095-4dannjjm	3888	14	saline	saline	NN
cord-023095-4dannjjm	3888	15	to	to	IN
cord-023095-4dannjjm	3888	16	4	4	CD
cord-023095-4dannjjm	3888	17	ml	ml	NN
cord-023095-4dannjjm	3888	18	ethyl	ethyl	NN
cord-023095-4dannjjm	3888	19	acetate	acetate	NN
cord-023095-4dannjjm	3888	20	for	for	IN
cord-023095-4dannjjm	3888	21	extraction	extraction	NN
cord-023095-4dannjjm	3888	22	of	of	IN
cord-023095-4dannjjm	3888	23	lipophilic	lipophilic	JJ
cord-023095-4dannjjm	3888	24	material	material	NN
cord-023095-4dannjjm	3888	25	from	from	IN
cord-023095-4dannjjm	3888	26	pelleted	pelleted	JJ
cord-023095-4dannjjm	3888	27	stool	stool	NN
cord-023095-4dannjjm	3888	28	samples	sample	NNS
cord-023095-4dannjjm	3888	29	,	,	,
cord-023095-4dannjjm	3888	30	previously	previously	RB
cord-023095-4dannjjm	3888	31	fixed	fix	VBN
cord-023095-4dannjjm	3888	32	in	in	IN
cord-023095-4dannjjm	3888	33	sodium	sodium	NN
cord-023095-4dannjjm	3888	34	acetate	acetate	NN
cord-023095-4dannjjm	3888	35	/	/	SYM
cord-023095-4dannjjm	3888	36	acetic	acetic	JJ
cord-023095-4dannjjm	3888	37	/	/	SYM
cord-023095-4dannjjm	3888	38	acid	acid	NN
cord-023095-4dannjjm	3888	39	/	/	SYM
cord-023095-4dannjjm	3888	40	formalin	formalin	NN
cord-023095-4dannjjm	3888	41	(	(	-LRB-
cord-023095-4dannjjm	3888	42	SAF	SAF	NNP
cord-023095-4dannjjm	3888	43	)	)	-RRB-
cord-023095-4dannjjm	3888	44	solution	solution	NN
cord-023095-4dannjjm	3888	45	.	.	.
cord-023095-4dannjjm	3889	1	Flotations	flotation	NNS
cord-023095-4dannjjm	3889	2	with	with	IN
cord-023095-4dannjjm	3889	3	the	the	DT
cord-023095-4dannjjm	3889	4	Fecalyzer	Fecalyzer	NNP
cord-023095-4dannjjm	3889	5	kit	kit	NN
cord-023095-4dannjjm	3889	6	were	be	VBD
cord-023095-4dannjjm	3889	7	performed	perform	VBN
cord-023095-4dannjjm	3889	8	with	with	IN
cord-023095-4dannjjm	3889	9	concentrated	concentrated	JJ
cord-023095-4dannjjm	3889	10	zinc	zinc	NN
cord-023095-4dannjjm	3889	11	sulfate	sulfate	NN
cord-023095-4dannjjm	3889	12	solution	solution	NN
cord-023095-4dannjjm	3889	13	(	(	-LRB-
cord-023095-4dannjjm	3889	14	s.	s.	NNP
cord-023095-4dannjjm	3889	15	g.	g.	NNP
cord-023095-4dannjjm	3889	16	1.22	1.22	CD
cord-023095-4dannjjm	3889	17	)	)	-RRB-
cord-023095-4dannjjm	3889	18	.	.	.
cord-023095-4dannjjm	3890	1	The	the	DT
cord-023095-4dannjjm	3890	2	range	range	NN
cord-023095-4dannjjm	3890	3	of	of	IN
cord-023095-4dannjjm	3890	4	parasites	parasite	NNS
cord-023095-4dannjjm	3890	5	recovered	recover	VBN
cord-023095-4dannjjm	3890	6	from	from	IN
cord-023095-4dannjjm	3890	7	these	these	DT
cord-023095-4dannjjm	3890	8	specimens	specimen	NNS
cord-023095-4dannjjm	3890	9	included	include	VBN
cord-023095-4dannjjm	3890	10	flagellate	flagellate	VBP
cord-023095-4dannjjm	3890	11	cysts	cyst	NNS
cord-023095-4dannjjm	3890	12	(	(	-LRB-
cord-023095-4dannjjm	3890	13	40	40	CD
cord-023095-4dannjjm	3890	14	total	total	NN
cord-023095-4dannjjm	3890	15	)	)	-RRB-
cord-023095-4dannjjm	3890	16	,	,	,
cord-023095-4dannjjm	3890	17	coccidian	coccidian	NNP
cord-023095-4dannjjm	3890	18	oocysts	oocyst	NNS
cord-023095-4dannjjm	3890	19	(	(	-LRB-
cord-023095-4dannjjm	3890	20	28	28	CD
cord-023095-4dannjjm	3890	21	total	total	NN
cord-023095-4dannjjm	3890	22	)	)	-RRB-
cord-023095-4dannjjm	3890	23	,	,	,
cord-023095-4dannjjm	3890	24	ova	ova	NN
cord-023095-4dannjjm	3890	25	and	and	CC
cord-023095-4dannjjm	3890	26	larvae	larva	NNS
cord-023095-4dannjjm	3890	27	of	of	IN
cord-023095-4dannjjm	3890	28	nematodes	nematode	NNS
cord-023095-4dannjjm	3890	29	(	(	-LRB-
cord-023095-4dannjjm	3890	30	80	80	CD
cord-023095-4dannjjm	3890	31	total	total	NN
cord-023095-4dannjjm	3890	32	)	)	-RRB-
cord-023095-4dannjjm	3890	33	,	,	,
cord-023095-4dannjjm	3890	34	and	and	CC
cord-023095-4dannjjm	3890	35	ova	ova	NN
cord-023095-4dannjjm	3890	36	of	of	IN
cord-023095-4dannjjm	3890	37	trematodes	trematode	NNS
cord-023095-4dannjjm	3890	38	(	(	-LRB-
cord-023095-4dannjjm	3890	39	12	12	CD
cord-023095-4dannjjm	3890	40	total	total	NN
cord-023095-4dannjjm	3890	41	)	)	-RRB-
cord-023095-4dannjjm	3890	42	,	,	,
cord-023095-4dannjjm	3890	43	and	and	CC
cord-023095-4dannjjm	3890	44	cestodes	cestodes	NNP
cord-023095-4dannjjm	3890	45	(	(	-LRB-
cord-023095-4dannjjm	3890	46	16	16	CD
cord-023095-4dannjjm	3890	47	total	total	NN
cord-023095-4dannjjm	3890	48	)	)	-RRB-
cord-023095-4dannjjm	3890	49	.	.	.
cord-023095-4dannjjm	3891	1	Recovery	recovery	NN
cord-023095-4dannjjm	3891	2	rates	rate	NNS
cord-023095-4dannjjm	3891	3	by	by	IN
cord-023095-4dannjjm	3891	4	Fecalyzer	Fecalyzer	NNP
cord-023095-4dannjjm	3891	5	flotation	flotation	NN
cord-023095-4dannjjm	3891	6	were	be	VBD
cord-023095-4dannjjm	3891	7	good	good	JJ
cord-023095-4dannjjm	3891	8	for	for	IN
cord-023095-4dannjjm	3891	9	protozoan	protozoan	NN
cord-023095-4dannjjm	3891	10	cysts	cyst	NNS
cord-023095-4dannjjm	3891	11	,	,	,
cord-023095-4dannjjm	3891	12	coccidian	coccidian	JJ
cord-023095-4dannjjm	3891	13	oocysts	oocyst	NNS
cord-023095-4dannjjm	3891	14	and	and	CC
cord-023095-4dannjjm	3891	15	nematode	nematode	NN
cord-023095-4dannjjm	3891	16	eggs	egg	NNS
cord-023095-4dannjjm	3891	17	and	and	CC
cord-023095-4dannjjm	3891	18	larvae	larva	NNS
cord-023095-4dannjjm	3891	19	,	,	,
cord-023095-4dannjjm	3891	20	but	but	CC
cord-023095-4dannjjm	3891	21	very	very	RB
cord-023095-4dannjjm	3891	22	poor	poor	JJ
cord-023095-4dannjjm	3891	23	for	for	IN
cord-023095-4dannjjm	3891	24	cestode	cestode	NN
cord-023095-4dannjjm	3891	25	and	and	CC
cord-023095-4dannjjm	3891	26	trematode	trematode	NN
cord-023095-4dannjjm	3891	27	eggs	egg	NNS
cord-023095-4dannjjm	3891	28	.	.	.
cord-023095-4dannjjm	3892	1	Formalin	Formalin	NNP
cord-023095-4dannjjm	3892	2	/	/	SYM
cord-023095-4dannjjm	3892	3	ethyl	ethyl	NN
cord-023095-4dannjjm	3893	1	acetate	acetate	NN
cord-023095-4dannjjm	3893	2	concentration	concentration	NN
cord-023095-4dannjjm	3893	3	showed	show	VBD
cord-023095-4dannjjm	3893	4	excellent	excellent	JJ
cord-023095-4dannjjm	3893	5	recovery	recovery	NN
cord-023095-4dannjjm	3893	6	of	of	IN
cord-023095-4dannjjm	3893	7	all	all	DT
cord-023095-4dannjjm	3893	8	parasites	parasite	NNS
cord-023095-4dannjjm	3893	9	and	and	CC
cord-023095-4dannjjm	3893	10	consistently	consistently	RB
cord-023095-4dannjjm	3893	11	outperformed	outperform	VBD
cord-023095-4dannjjm	3893	12	Fecalyzer	Fecalyzer	NNP
cord-023095-4dannjjm	3893	13	in	in	IN
cord-023095-4dannjjm	3893	14	recovery	recovery	NN
cord-023095-4dannjjm	3893	15	rates	rate	NNS
cord-023095-4dannjjm	3893	16	.	.	.
cord-023095-4dannjjm	3894	1	Recoveries	recovery	NNS
cord-023095-4dannjjm	3894	2	by	by	IN
cord-023095-4dannjjm	3894	3	F	F	NNP
cord-023095-4dannjjm	3894	4	/	/	SYM
cord-023095-4dannjjm	3894	5	EA	EA	NNP
cord-023095-4dannjjm	3894	6	concentrations	concentration	NNS
cord-023095-4dannjjm	3894	7	were	be	VBD
cord-023095-4dannjjm	3894	8	higher	high	JJR
cord-023095-4dannjjm	3894	9	by	by	IN
cord-023095-4dannjjm	3894	10	27.5	27.5	CD
cord-023095-4dannjjm	3894	11	%	%	NN
cord-023095-4dannjjm	3894	12	for	for	IN
cord-023095-4dannjjm	3894	13	Giardia	Giardia	NNP
cord-023095-4dannjjm	3894	14	,	,	,
cord-023095-4dannjjm	3894	15	by	by	IN
cord-023095-4dannjjm	3894	16	10.7	10.7	CD
cord-023095-4dannjjm	3894	17	%	%	NN
cord-023095-4dannjjm	3894	18	for	for	IN
cord-023095-4dannjjm	3894	19	coccidia	coccidia	NN
cord-023095-4dannjjm	3894	20	and	and	CC
cord-023095-4dannjjm	3894	21	by	by	IN
cord-023095-4dannjjm	3894	22	10.0	10.0	CD
cord-023095-4dannjjm	3894	23	%	%	NN
cord-023095-4dannjjm	3894	24	for	for	IN
cord-023095-4dannjjm	3894	25	nematode	nematode	NN
cord-023095-4dannjjm	3894	26	eggs	egg	NNS
cord-023095-4dannjjm	3894	27	and	and	CC
cord-023095-4dannjjm	3894	28	larvae	larva	NNS
cord-023095-4dannjjm	3894	29	.	.	.
cord-023095-4dannjjm	3895	1	With	with	IN
cord-023095-4dannjjm	3895	2	the	the	DT
cord-023095-4dannjjm	3895	3	exception	exception	NN
cord-023095-4dannjjm	3895	4	of	of	IN
cord-023095-4dannjjm	3895	5	coccidian	coccidian	JJ
cord-023095-4dannjjm	3895	6	oocysts	oocyst	NNS
cord-023095-4dannjjm	3895	7	,	,	,
cord-023095-4dannjjm	3895	8	based	base	VBN
cord-023095-4dannjjm	3895	9	on	on	IN
cord-023095-4dannjjm	3895	10	Z	z	NN
cord-023095-4dannjjm	3895	11	-	-	HYPH
cord-023095-4dannjjm	3895	12	test	test	NN
cord-023095-4dannjjm	3895	13	analyses	analysis	NNS
cord-023095-4dannjjm	3895	14	,	,	,
cord-023095-4dannjjm	3895	15	recovery	recovery	NN
cord-023095-4dannjjm	3895	16	rates	rate	NNS
cord-023095-4dannjjm	3895	17	were	be	VBD
cord-023095-4dannjjm	3895	18	significantly	significantly	RB
cord-023095-4dannjjm	3895	19	higher	high	JJR
cord-023095-4dannjjm	3895	20	,	,	,
cord-023095-4dannjjm	3895	21	at	at	IN
cord-023095-4dannjjm	3895	22	a	a	DT
cord-023095-4dannjjm	3895	23	confidence	confidence	NN
cord-023095-4dannjjm	3895	24	level	level	NN
cord-023095-4dannjjm	3895	25	of	of	IN
cord-023095-4dannjjm	3895	26	at	at	RB
cord-023095-4dannjjm	3895	27	least	least	RBS
cord-023095-4dannjjm	3895	28	95	95	CD
cord-023095-4dannjjm	3895	29	%	%	NN
cord-023095-4dannjjm	3895	30	,	,	,
cord-023095-4dannjjm	3895	31	for	for	IN
cord-023095-4dannjjm	3895	32	all	all	DT
cord-023095-4dannjjm	3895	33	parasites	parasite	NNS
cord-023095-4dannjjm	3895	34	,	,	,
cord-023095-4dannjjm	3895	35	using	use	VBG
cord-023095-4dannjjm	3895	36	formalin	formalin	NN
cord-023095-4dannjjm	3895	37	/	/	SYM
cord-023095-4dannjjm	3895	38	ethyl	ethyl	NN
cord-023095-4dannjjm	3895	39	acetate	acetate	NN
cord-023095-4dannjjm	3895	40	sedimentation	sedimentation	NN
cord-023095-4dannjjm	3895	41	concentration	concentration	NN
cord-023095-4dannjjm	3895	42	.	.	.
cord-023095-4dannjjm	3896	1	Although	although	IN
cord-023095-4dannjjm	3896	2	CAPC	CAPC	NNP
cord-023095-4dannjjm	3896	3	recommends	recommend	VBZ
cord-023095-4dannjjm	3896	4	the	the	DT
cord-023095-4dannjjm	3896	5	use	use	NN
cord-023095-4dannjjm	3896	6	of	of	IN
cord-023095-4dannjjm	3896	7	flotation	flotation	NN
cord-023095-4dannjjm	3896	8	with	with	IN
cord-023095-4dannjjm	3896	9	centrifugation	centrifugation	NN
cord-023095-4dannjjm	3896	10	methods	method	NNS
cord-023095-4dannjjm	3896	11	for	for	IN
cord-023095-4dannjjm	3896	12	standard	standard	JJ
cord-023095-4dannjjm	3896	13	fecal	fecal	JJ
cord-023095-4dannjjm	3896	14	ova	ova	NN
cord-023095-4dannjjm	3896	15	and	and	CC
cord-023095-4dannjjm	3896	16	parasite	parasite	NN
cord-023095-4dannjjm	3896	17	examination	examination	NN
cord-023095-4dannjjm	3896	18	for	for	IN
cord-023095-4dannjjm	3896	19	veterinary	veterinary	JJ
cord-023095-4dannjjm	3896	20	patients	patient	NNS
cord-023095-4dannjjm	3896	21	,	,	,
cord-023095-4dannjjm	3896	22	sedimentation	sedimentation	NN
cord-023095-4dannjjm	3896	23	concentration	concentration	NN
cord-023095-4dannjjm	3896	24	methods	method	NNS
cord-023095-4dannjjm	3896	25	are	be	VBP
cord-023095-4dannjjm	3896	26	widely	widely	RB
cord-023095-4dannjjm	3896	27	and	and	CC
cord-023095-4dannjjm	3896	28	effectively	effectively	RB
cord-023095-4dannjjm	3896	29	used	use	VBN
cord-023095-4dannjjm	3896	30	in	in	IN
cord-023095-4dannjjm	3896	31	human	human	JJ
cord-023095-4dannjjm	3896	32	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	3896	33	parasitology	parasitology	NN
cord-023095-4dannjjm	3896	34	laboratories	laboratory	NNS
cord-023095-4dannjjm	3896	35	.	.	.
cord-023095-4dannjjm	3897	1	These	these	DT
cord-023095-4dannjjm	3897	2	results	result	NNS
cord-023095-4dannjjm	3897	3	provide	provide	VBP
cord-023095-4dannjjm	3897	4	good	good	JJ
cord-023095-4dannjjm	3897	5	evidence	evidence	NN
cord-023095-4dannjjm	3897	6	for	for	IN
cord-023095-4dannjjm	3897	7	the	the	DT
cord-023095-4dannjjm	3897	8	use	use	NN
cord-023095-4dannjjm	3897	9	of	of	IN
cord-023095-4dannjjm	3897	10	F	F	NNP
cord-023095-4dannjjm	3897	11	/	/	SYM
cord-023095-4dannjjm	3897	12	EA	EA	NNP
cord-023095-4dannjjm	3897	13	concentration	concentration	NN
cord-023095-4dannjjm	3897	14	as	as	IN
cord-023095-4dannjjm	3897	15	a	a	DT
cord-023095-4dannjjm	3897	16	preferred	preferred	JJ
cord-023095-4dannjjm	3897	17	method	method	NN
cord-023095-4dannjjm	3897	18	to	to	IN
cord-023095-4dannjjm	3897	19	flotation	flotation	NN
cord-023095-4dannjjm	3897	20	procedures	procedure	NNS
cord-023095-4dannjjm	3897	21	for	for	IN
cord-023095-4dannjjm	3897	22	stool	stool	NN
cord-023095-4dannjjm	3897	23	ova	ova	NN
cord-023095-4dannjjm	3897	24	and	and	CC
cord-023095-4dannjjm	3897	25	parasite	parasite	NN
cord-023095-4dannjjm	3897	26	examinations	examination	NNS
cord-023095-4dannjjm	3897	27	in	in	IN
cord-023095-4dannjjm	3897	28	veterinary	veterinary	JJ
cord-023095-4dannjjm	3897	29	laboratories	laboratory	NNS
cord-023095-4dannjjm	3897	30	.	.	.
cord-023095-4dannjjm	3898	1	Cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3898	2	and	and	CC
cord-023095-4dannjjm	3898	3	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	3898	4	are	be	VBP
cord-023095-4dannjjm	3898	5	powerful	powerful	JJ
cord-023095-4dannjjm	3898	6	immunosuppressive	immunosuppressive	JJ
cord-023095-4dannjjm	3898	7	agents	agent	NNS
cord-023095-4dannjjm	3898	8	used	use	VBN
cord-023095-4dannjjm	3898	9	to	to	TO
cord-023095-4dannjjm	3898	10	treat	treat	VB
cord-023095-4dannjjm	3898	11	many	many	JJ
cord-023095-4dannjjm	3898	12	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	3898	13	diseases	disease	NNS
cord-023095-4dannjjm	3898	14	.	.	.
cord-023095-4dannjjm	3899	1	Cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3899	2	inhibits	inhibit	VBZ
cord-023095-4dannjjm	3899	3	calcineurin	calcineurin	NN
cord-023095-4dannjjm	3899	4	-	-	HYPH
cord-023095-4dannjjm	3899	5	dependent	dependent	JJ
cord-023095-4dannjjm	3899	6	pathways	pathway	NNS
cord-023095-4dannjjm	3899	7	of	of	IN
cord-023095-4dannjjm	3899	8	T	t	NN
cord-023095-4dannjjm	3899	9	-	-	HYPH
cord-023095-4dannjjm	3899	10	cell	cell	NN
cord-023095-4dannjjm	3899	11	activation	activation	NN
cord-023095-4dannjjm	3899	12	and	and	CC
cord-023095-4dannjjm	3899	13	the	the	DT
cord-023095-4dannjjm	3899	14	resultant	resultant	JJ
cord-023095-4dannjjm	3899	15	cytokine	cytokine	NN
cord-023095-4dannjjm	3899	16	production	production	NN
cord-023095-4dannjjm	3899	17	,	,	,
cord-023095-4dannjjm	3899	18	and	and	CC
cord-023095-4dannjjm	3899	19	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	3899	20	directly	directly	RB
cord-023095-4dannjjm	3899	21	inhibit	inhibit	VBP
cord-023095-4dannjjm	3899	22	genes	gene	NNS
cord-023095-4dannjjm	3899	23	coding	code	VBG
cord-023095-4dannjjm	3899	24	for	for	IN
cord-023095-4dannjjm	3899	25	cytokines	cytokine	NNS
cord-023095-4dannjjm	3899	26	.	.	.
cord-023095-4dannjjm	3900	1	Little	little	JJ
cord-023095-4dannjjm	3900	2	work	work	NN
cord-023095-4dannjjm	3900	3	has	have	VBZ
cord-023095-4dannjjm	3900	4	been	be	VBN
cord-023095-4dannjjm	3900	5	done	do	VBN
cord-023095-4dannjjm	3900	6	comparing	compare	VBG
cord-023095-4dannjjm	3900	7	the	the	DT
cord-023095-4dannjjm	3900	8	effects	effect	NNS
cord-023095-4dannjjm	3900	9	of	of	IN
cord-023095-4dannjjm	3900	10	these	these	DT
cord-023095-4dannjjm	3900	11	agents	agent	NNS
cord-023095-4dannjjm	3900	12	on	on	IN
cord-023095-4dannjjm	3900	13	cytokine	cytokine	NN
cord-023095-4dannjjm	3900	14	production	production	NN
cord-023095-4dannjjm	3900	15	in	in	IN
cord-023095-4dannjjm	3900	16	dogs	dog	NNS
cord-023095-4dannjjm	3900	17	.	.	.
cord-023095-4dannjjm	3901	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	3901	2	study	study	NN
cord-023095-4dannjjm	3901	3	assessed	assess	VBD
cord-023095-4dannjjm	3901	4	these	these	DT
cord-023095-4dannjjm	3901	5	effects	effect	NNS
cord-023095-4dannjjm	3901	6	by	by	IN
cord-023095-4dannjjm	3901	7	measuring	measure	VBG
cord-023095-4dannjjm	3901	8	T	t	NN
cord-023095-4dannjjm	3901	9	-	-	HYPH
cord-023095-4dannjjm	3901	10	cell	cell	NN
cord-023095-4dannjjm	3901	11	cytokine	cytokine	NN
cord-023095-4dannjjm	3901	12	production	production	NN
cord-023095-4dannjjm	3901	13	using	use	VBG
cord-023095-4dannjjm	3901	14	flow	flow	NN
cord-023095-4dannjjm	3901	15	cytometry	cytometry	NN
cord-023095-4dannjjm	3901	16	,	,	,
cord-023095-4dannjjm	3901	17	and	and	CC
cord-023095-4dannjjm	3901	18	cytokine	cytokine	NN
cord-023095-4dannjjm	3901	19	gene	gene	NN
cord-023095-4dannjjm	3901	20	expression	expression	NN
cord-023095-4dannjjm	3901	21	using	use	VBG
cord-023095-4dannjjm	3901	22	quantitative	quantitative	JJ
cord-023095-4dannjjm	3901	23	reverse	reverse	JJ
cord-023095-4dannjjm	3901	24	transcriptase	transcriptase	NN
cord-023095-4dannjjm	3901	25	polymerase	polymerase	NN
cord-023095-4dannjjm	3901	26	chain	chain	NN
cord-023095-4dannjjm	3901	27	reaction	reaction	NN
cord-023095-4dannjjm	3901	28	(	(	-LRB-
cord-023095-4dannjjm	3901	29	qRT	qRT	NNP
cord-023095-4dannjjm	3901	30	-	-	HYPH
cord-023095-4dannjjm	3901	31	PCR	PCR	NNP
cord-023095-4dannjjm	3901	32	)	)	-RRB-
cord-023095-4dannjjm	3901	33	in	in	IN
cord-023095-4dannjjm	3901	34	activated	activate	VBN
cord-023095-4dannjjm	3901	35	canine	canine	JJ
cord-023095-4dannjjm	3901	36	T	T	NNP
cord-023095-4dannjjm	3901	37	-	-	HYPH
cord-023095-4dannjjm	3901	38	cells	cell	NNS
cord-023095-4dannjjm	3901	39	treated	treat	VBN
cord-023095-4dannjjm	3901	40	with	with	IN
cord-023095-4dannjjm	3901	41	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3901	42	and	and	CC
cord-023095-4dannjjm	3901	43	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	3901	44	.	.	.
cord-023095-4dannjjm	3902	1	For	for	IN
cord-023095-4dannjjm	3902	2	flow	flow	NN
cord-023095-4dannjjm	3902	3	cytometric	cytometric	NN
cord-023095-4dannjjm	3902	4	assays	assay	NNS
cord-023095-4dannjjm	3902	5	,	,	,
cord-023095-4dannjjm	3902	6	peripheral	peripheral	JJ
cord-023095-4dannjjm	3902	7	blood	blood	NN
cord-023095-4dannjjm	3902	8	mononuclear	mononuclear	NN
cord-023095-4dannjjm	3902	9	cells	cell	NNS
cord-023095-4dannjjm	3902	10	were	be	VBD
cord-023095-4dannjjm	3902	11	separated	separate	VBN
cord-023095-4dannjjm	3902	12	using	use	VBG
cord-023095-4dannjjm	3902	13	density	density	NN
cord-023095-4dannjjm	3902	14	gradients	gradient	NNS
cord-023095-4dannjjm	3902	15	and	and	CC
cord-023095-4dannjjm	3902	16	cultured	culture	VBN
cord-023095-4dannjjm	3902	17	for	for	IN
cord-023095-4dannjjm	3902	18	12	12	CD
cord-023095-4dannjjm	3902	19	hours	hour	NNS
cord-023095-4dannjjm	3902	20	in	in	IN
cord-023095-4dannjjm	3902	21	the	the	DT
cord-023095-4dannjjm	3902	22	presence	presence	NN
cord-023095-4dannjjm	3902	23	of	of	IN
cord-023095-4dannjjm	3902	24	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3902	25	(	(	-LRB-
cord-023095-4dannjjm	3902	26	5	5	CD
cord-023095-4dannjjm	3902	27	,	,	,
cord-023095-4dannjjm	3902	28	25	25	CD
cord-023095-4dannjjm	3902	29	,	,	,
cord-023095-4dannjjm	3902	30	or	or	CC
cord-023095-4dannjjm	3902	31	100	100	CD
cord-023095-4dannjjm	3902	32	ng	ng	NN
cord-023095-4dannjjm	3902	33	/	/	SYM
cord-023095-4dannjjm	3902	34	mL	mL	NNP
cord-023095-4dannjjm	3902	35	)	)	-RRB-
cord-023095-4dannjjm	3902	36	,	,	,
cord-023095-4dannjjm	3902	37	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	3902	38	(	(	-LRB-
cord-023095-4dannjjm	3902	39	10	10	CD
cord-023095-4dannjjm	3902	40	À7	À7	NNP
cord-023095-4dannjjm	3902	41	,	,	,
cord-023095-4dannjjm	3902	42	10	10	CD
cord-023095-4dannjjm	3902	43	À6	à6	CD
cord-023095-4dannjjm	3902	44	,	,	,
cord-023095-4dannjjm	3902	45	10	10	CD
cord-023095-4dannjjm	3902	46	À5	À5	NNP
cord-023095-4dannjjm	3902	47	M	M	NNP
cord-023095-4dannjjm	3902	48	)	)	-RRB-
cord-023095-4dannjjm	3902	49	,	,	,
cord-023095-4dannjjm	3902	50	or	or	CC
cord-023095-4dannjjm	3902	51	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3902	52	plus	plus	CC
cord-023095-4dannjjm	3902	53	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	3902	54	.	.	.
cord-023095-4dannjjm	3903	1	For	for	IN
cord-023095-4dannjjm	3903	2	qRT	qRT	NNP
cord-023095-4dannjjm	3903	3	-	-	HYPH
cord-023095-4dannjjm	3903	4	PCR	PCR	NNP
cord-023095-4dannjjm	3903	5	,	,	,
cord-023095-4dannjjm	3903	6	whole	whole	JJ
cord-023095-4dannjjm	3903	7	blood	blood	NN
cord-023095-4dannjjm	3903	8	was	be	VBD
cord-023095-4dannjjm	3903	9	cultured	culture	VBN
cord-023095-4dannjjm	3903	10	for	for	IN
cord-023095-4dannjjm	3903	11	5	5	CD
cord-023095-4dannjjm	3903	12	hours	hour	NNS
cord-023095-4dannjjm	3903	13	with	with	IN
cord-023095-4dannjjm	3903	14	the	the	DT
cord-023095-4dannjjm	3903	15	same	same	JJ
cord-023095-4dannjjm	3903	16	drugs	drug	NNS
cord-023095-4dannjjm	3903	17	at	at	IN
cord-023095-4dannjjm	3903	18	the	the	DT
cord-023095-4dannjjm	3903	19	same	same	JJ
cord-023095-4dannjjm	3903	20	concentrations	concentration	NNS
cord-023095-4dannjjm	3903	21	,	,	,
cord-023095-4dannjjm	3903	22	and	and	CC
cord-023095-4dannjjm	3903	23	RNA	RNA	NNP
cord-023095-4dannjjm	3903	24	was	be	VBD
cord-023095-4dannjjm	3903	25	then	then	RB
cord-023095-4dannjjm	3903	26	extracted	extract	VBN
cord-023095-4dannjjm	3903	27	from	from	IN
cord-023095-4dannjjm	3903	28	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	3903	29	.	.	.
cord-023095-4dannjjm	3904	1	Expression	expression	NN
cord-023095-4dannjjm	3904	2	of	of	IN
cord-023095-4dannjjm	3904	3	cytokines	cytokine	NNS
cord-023095-4dannjjm	3904	4	IL-2	il-2	NN
cord-023095-4dannjjm	3904	5	and	and	CC
cord-023095-4dannjjm	3904	6	IFN	IFN	NNP
cord-023095-4dannjjm	3904	7	-	-	HYPH
cord-023095-4dannjjm	3904	8	g	g	NNP
cord-023095-4dannjjm	3904	9	was	be	VBD
cord-023095-4dannjjm	3904	10	analyzed	analyze	VBN
cord-023095-4dannjjm	3904	11	in	in	IN
cord-023095-4dannjjm	3904	12	PMA	PMA	NNP
cord-023095-4dannjjm	3904	13	/	/	SYM
cord-023095-4dannjjm	3904	14	ionomycinactivated	ionomycinactivate	VBN
cord-023095-4dannjjm	3904	15	T	T	NNP
cord-023095-4dannjjm	3904	16	-	-	HYPH
cord-023095-4dannjjm	3904	17	cells	cell	NNS
cord-023095-4dannjjm	3904	18	by	by	IN
cord-023095-4dannjjm	3904	19	flow	flow	NN
cord-023095-4dannjjm	3904	20	cytometry	cytometry	NN
cord-023095-4dannjjm	3904	21	,	,	,
cord-023095-4dannjjm	3904	22	and	and	CC
cord-023095-4dannjjm	3904	23	gene	gene	NN
cord-023095-4dannjjm	3904	24	expression	expression	NN
cord-023095-4dannjjm	3904	25	for	for	IN
cord-023095-4dannjjm	3904	26	IL-2	IL-2	NNP
cord-023095-4dannjjm	3904	27	and	and	CC
cord-023095-4dannjjm	3904	28	IFN	IFN	NNP
cord-023095-4dannjjm	3904	29	-	-	HYPH
cord-023095-4dannjjm	3904	30	g	g	NNP
cord-023095-4dannjjm	3904	31	in	in	IN
cord-023095-4dannjjm	3904	32	activated	activate	VBN
cord-023095-4dannjjm	3904	33	T	t	NN
cord-023095-4dannjjm	3904	34	-	-	HYPH
cord-023095-4dannjjm	3904	35	cell	cell	NN
cord-023095-4dannjjm	3904	36	populations	population	NNS
cord-023095-4dannjjm	3904	37	was	be	VBD
cord-023095-4dannjjm	3904	38	assessed	assess	VBN
cord-023095-4dannjjm	3904	39	via	via	IN
cord-023095-4dannjjm	3904	40	qRT	qrt	ADD
cord-023095-4dannjjm	3904	41	-	-	HYPH
cord-023095-4dannjjm	3904	42	PCR	PCR	NNP
cord-023095-4dannjjm	3904	43	.	.	.
cord-023095-4dannjjm	3905	1	Flow	flow	NN
cord-023095-4dannjjm	3905	2	cytometry	cytometry	NN
cord-023095-4dannjjm	3905	3	and	and	CC
cord-023095-4dannjjm	3905	4	qRT	qRT	NNP
cord-023095-4dannjjm	3905	5	-	-	HYPH
cord-023095-4dannjjm	3905	6	PCR	PCR	NNP
cord-023095-4dannjjm	3905	7	both	both	DT
cord-023095-4dannjjm	3905	8	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	3905	9	inhibition	inhibition	NN
cord-023095-4dannjjm	3905	10	of	of	IN
cord-023095-4dannjjm	3905	11	IL-2	IL-2	NNP
cord-023095-4dannjjm	3905	12	and	and	CC
cord-023095-4dannjjm	3905	13	IFN	IFN	NNP
cord-023095-4dannjjm	3905	14	-	-	HYPH
cord-023095-4dannjjm	3905	15	g	g	NNP
cord-023095-4dannjjm	3905	16	that	that	WDT
cord-023095-4dannjjm	3905	17	was	be	VBD
cord-023095-4dannjjm	3905	18	generally	generally	RB
cord-023095-4dannjjm	3905	19	dose	dose	NN
cord-023095-4dannjjm	3905	20	-	-	HYPH
cord-023095-4dannjjm	3905	21	dependent	dependent	JJ
cord-023095-4dannjjm	3905	22	in	in	IN
cord-023095-4dannjjm	3905	23	response	response	NN
cord-023095-4dannjjm	3905	24	to	to	IN
cord-023095-4dannjjm	3905	25	both	both	CC
cord-023095-4dannjjm	3905	26	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3905	27	and	and	CC
cord-023095-4dannjjm	3905	28	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	3905	29	.	.	.
cord-023095-4dannjjm	3906	1	Flow	flow	NN
cord-023095-4dannjjm	3906	2	cytometry	cytometry	NN
cord-023095-4dannjjm	3906	3	results	result	NNS
cord-023095-4dannjjm	3906	4	from	from	IN
cord-023095-4dannjjm	3906	5	the	the	DT
cord-023095-4dannjjm	3906	6	average	average	NN
cord-023095-4dannjjm	3906	7	of	of	IN
cord-023095-4dannjjm	3906	8	samples	sample	NNS
cord-023095-4dannjjm	3906	9	collected	collect	VBN
cord-023095-4dannjjm	3906	10	from	from	IN
cord-023095-4dannjjm	3906	11	3	3	CD
cord-023095-4dannjjm	3906	12	different	different	JJ
cord-023095-4dannjjm	3906	13	dogs	dog	NNS
cord-023095-4dannjjm	3906	14	are	be	VBP
cord-023095-4dannjjm	3906	15	shown	show	VBN
cord-023095-4dannjjm	3906	16	in	in	IN
cord-023095-4dannjjm	3906	17	Figure	Figure	NNP
cord-023095-4dannjjm	3906	18	A	a	NN
cord-023095-4dannjjm	3906	19	.	.	.
cord-023095-4dannjjm	3907	1	Similar	similar	JJ
cord-023095-4dannjjm	3907	2	results	result	NNS
cord-023095-4dannjjm	3907	3	were	be	VBD
cord-023095-4dannjjm	3907	4	achieved	achieve	VBN
cord-023095-4dannjjm	3907	5	using	use	VBG
cord-023095-4dannjjm	3907	6	qRT	qrt	ADD
cord-023095-4dannjjm	3907	7	-	-	HYPH
cord-023095-4dannjjm	3907	8	PCR	PCR	NNP
cord-023095-4dannjjm	3907	9	(	(	-LRB-
cord-023095-4dannjjm	3907	10	Figure	figure	NN
cord-023095-4dannjjm	3907	11	B	b	NN
cord-023095-4dannjjm	3907	12	)	)	-RRB-
cord-023095-4dannjjm	3907	13	.	.	.
cord-023095-4dannjjm	3908	1	Suppression	suppression	NN
cord-023095-4dannjjm	3908	2	of	of	IN
cord-023095-4dannjjm	3908	3	IL-2	IL-2	NNP
cord-023095-4dannjjm	3908	4	and	and	CC
cord-023095-4dannjjm	3908	5	IFN	IFN	NNP
cord-023095-4dannjjm	3908	6	-	-	HYPH
cord-023095-4dannjjm	3908	7	g	g	NNP
cord-023095-4dannjjm	3908	8	in	in	IN
cord-023095-4dannjjm	3908	9	activated	activate	VBN
cord-023095-4dannjjm	3908	10	T	T	NNP
cord-023095-4dannjjm	3908	11	-	-	HYPH
cord-023095-4dannjjm	3908	12	cells	cell	NNS
cord-023095-4dannjjm	3908	13	has	have	VBZ
cord-023095-4dannjjm	3908	14	potential	potential	JJ
cord-023095-4dannjjm	3908	15	as	as	IN
cord-023095-4dannjjm	3908	16	an	an	DT
cord-023095-4dannjjm	3908	17	indicator	indicator	NN
cord-023095-4dannjjm	3908	18	of	of	IN
cord-023095-4dannjjm	3908	19	the	the	DT
cord-023095-4dannjjm	3908	20	efficacy	efficacy	NN
cord-023095-4dannjjm	3908	21	of	of	IN
cord-023095-4dannjjm	3908	22	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	3908	23	and	and	CC
cord-023095-4dannjjm	3908	24	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	3908	25	in	in	IN
cord-023095-4dannjjm	3908	26	suppressing	suppress	VBG
cord-023095-4dannjjm	3908	27	canine	canine	JJ
cord-023095-4dannjjm	3908	28	T	t	NN
cord-023095-4dannjjm	3908	29	-	-	HYPH
cord-023095-4dannjjm	3908	30	cell	cell	NN
cord-023095-4dannjjm	3908	31	function	function	NN
cord-023095-4dannjjm	3908	32	in	in	IN
cord-023095-4dannjjm	3908	33	vivo	vivo	NN
cord-023095-4dannjjm	3908	34	,	,	,
cord-023095-4dannjjm	3908	35	and	and	CC
cord-023095-4dannjjm	3908	36	may	may	MD
cord-023095-4dannjjm	3908	37	therefore	therefore	RB
cord-023095-4dannjjm	3908	38	be	be	VB
cord-023095-4dannjjm	3908	39	of	of	IN
cord-023095-4dannjjm	3908	40	value	value	NN
cord-023095-4dannjjm	3908	41	for	for	IN
cord-023095-4dannjjm	3908	42	characterizing	characterize	VBG
cord-023095-4dannjjm	3908	43	the	the	DT
cord-023095-4dannjjm	3908	44	immunosuppression	immunosuppression	NN
cord-023095-4dannjjm	3908	45	induced	induce	VBN
cord-023095-4dannjjm	3908	46	by	by	IN
cord-023095-4dannjjm	3908	47	these	these	DT
cord-023095-4dannjjm	3908	48	drugs	drug	NNS
cord-023095-4dannjjm	3908	49	in	in	IN
cord-023095-4dannjjm	3908	50	clinical	clinical	JJ
cord-023095-4dannjjm	3908	51	patients	patient	NNS
cord-023095-4dannjjm	3908	52	.	.	.
cord-023095-4dannjjm	3909	1	Idiopathic	idiopathic	JJ
cord-023095-4dannjjm	3909	2	eosinophilic	eosinophilic	JJ
cord-023095-4dannjjm	3909	3	diseases	disease	NNS
cord-023095-4dannjjm	3909	4	are	be	VBP
cord-023095-4dannjjm	3909	5	described	describe	VBN
cord-023095-4dannjjm	3909	6	in	in	IN
cord-023095-4dannjjm	3909	7	several	several	JJ
cord-023095-4dannjjm	3909	8	breeds	breed	NNS
cord-023095-4dannjjm	3909	9	,	,	,
cord-023095-4dannjjm	3909	10	but	but	CC
cord-023095-4dannjjm	3909	11	are	be	VBP
cord-023095-4dannjjm	3909	12	over	over	IN
cord-023095-4dannjjm	3909	13	represented	represent	VBN
cord-023095-4dannjjm	3909	14	in	in	IN
cord-023095-4dannjjm	3909	15	Rottweilers	rottweiler	NNS
cord-023095-4dannjjm	3909	16	.	.	.
cord-023095-4dannjjm	3910	1	The	the	DT
cord-023095-4dannjjm	3910	2	immunopathogenesis	immunopathogenesis	NN
cord-023095-4dannjjm	3910	3	of	of	IN
cord-023095-4dannjjm	3910	4	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	3910	5	eosinophilic	eosinophilic	JJ
cord-023095-4dannjjm	3910	6	disorders	disorder	NNS
cord-023095-4dannjjm	3910	7	is	be	VBZ
cord-023095-4dannjjm	3910	8	poorly	poorly	RB
cord-023095-4dannjjm	3910	9	characterised	characterise	VBN
cord-023095-4dannjjm	3910	10	.	.	.
cord-023095-4dannjjm	3911	1	Studies	study	NNS
cord-023095-4dannjjm	3911	2	in	in	IN
cord-023095-4dannjjm	3911	3	people	people	NNS
cord-023095-4dannjjm	3911	4	highlight	highlight	VBP
cord-023095-4dannjjm	3911	5	the	the	DT
cord-023095-4dannjjm	3911	6	importance	importance	NN
cord-023095-4dannjjm	3911	7	of	of	IN
cord-023095-4dannjjm	3911	8	cytokines	cytokine	NNS
cord-023095-4dannjjm	3911	9	,	,	,
cord-023095-4dannjjm	3911	10	particularly	particularly	RB
cord-023095-4dannjjm	3911	11	interleukin-5	interleukin-5	NNP
cord-023095-4dannjjm	3911	12	(	(	-LRB-
cord-023095-4dannjjm	3911	13	IL-5	IL-5	NNP
cord-023095-4dannjjm	3911	14	)	)	-RRB-
cord-023095-4dannjjm	3911	15	,	,	,
cord-023095-4dannjjm	3911	16	in	in	IN
cord-023095-4dannjjm	3911	17	mediating	mediate	VBG
cord-023095-4dannjjm	3911	18	eosinophil	eosinophil	JJ
cord-023095-4dannjjm	3911	19	maturation	maturation	NN
cord-023095-4dannjjm	3911	20	,	,	,
cord-023095-4dannjjm	3911	21	differentiation	differentiation	NN
cord-023095-4dannjjm	3911	22	,	,	,
cord-023095-4dannjjm	3911	23	egress	egress	NN
cord-023095-4dannjjm	3911	24	from	from	IN
cord-023095-4dannjjm	3911	25	the	the	DT
cord-023095-4dannjjm	3911	26	bone	bone	NN
cord-023095-4dannjjm	3911	27	marrow	marrow	NN
cord-023095-4dannjjm	3911	28	,	,	,
cord-023095-4dannjjm	3911	29	migration	migration	NN
cord-023095-4dannjjm	3911	30	and	and	CC
cord-023095-4dannjjm	3911	31	polyclonal	polyclonal	JJ
cord-023095-4dannjjm	3911	32	expansion	expansion	NN
cord-023095-4dannjjm	3911	33	.	.	.
cord-023095-4dannjjm	3912	1	Eotaxin-2	Eotaxin-2	NNP
cord-023095-4dannjjm	3912	2	and	and	CC
cord-023095-4dannjjm	3912	3	eotaxin-3	eotaxin-3	NNP
cord-023095-4dannjjm	3912	4	also	also	RB
cord-023095-4dannjjm	3912	5	appear	appear	VBP
cord-023095-4dannjjm	3912	6	important	important	JJ
cord-023095-4dannjjm	3912	7	for	for	IN
cord-023095-4dannjjm	3912	8	induction	induction	NN
cord-023095-4dannjjm	3912	9	of	of	IN
cord-023095-4dannjjm	3912	10	chemotaxis	chemotaxis	NN
cord-023095-4dannjjm	3912	11	and	and	CC
cord-023095-4dannjjm	3912	12	release	release	NN
cord-023095-4dannjjm	3912	13	of	of	IN
cord-023095-4dannjjm	3912	14	reactive	reactive	JJ
cord-023095-4dannjjm	3912	15	oxygen	oxygen	NN
cord-023095-4dannjjm	3912	16	species	specie	NNS
cord-023095-4dannjjm	3912	17	from	from	IN
cord-023095-4dannjjm	3912	18	eosinophils	eosinophil	NNS
cord-023095-4dannjjm	3912	19	.	.	.
cord-023095-4dannjjm	3913	1	The	the	DT
cord-023095-4dannjjm	3913	2	aim	aim	NN
cord-023095-4dannjjm	3913	3	of	of	IN
cord-023095-4dannjjm	3913	4	the	the	DT
cord-023095-4dannjjm	3913	5	current	current	JJ
cord-023095-4dannjjm	3913	6	study	study	NN
cord-023095-4dannjjm	3913	7	was	be	VBD
cord-023095-4dannjjm	3913	8	to	to	TO
cord-023095-4dannjjm	3913	9	establish	establish	VB
cord-023095-4dannjjm	3913	10	whether	whether	IN
cord-023095-4dannjjm	3913	11	definable	definable	JJ
cord-023095-4dannjjm	3913	12	differences	difference	NNS
cord-023095-4dannjjm	3913	13	in	in	IN
cord-023095-4dannjjm	3913	14	specific	specific	JJ
cord-023095-4dannjjm	3913	15	cytokines	cytokine	NNS
cord-023095-4dannjjm	3913	16	associated	associate	VBN
cord-023095-4dannjjm	3913	17	with	with	IN
cord-023095-4dannjjm	3913	18	mediation	mediation	NN
cord-023095-4dannjjm	3913	19	of	of	IN
cord-023095-4dannjjm	3913	20	eosinophil	eosinophil	JJ
cord-023095-4dannjjm	3913	21	production	production	NN
cord-023095-4dannjjm	3913	22	and	and	CC
cord-023095-4dannjjm	3913	23	survival	survival	NN
cord-023095-4dannjjm	3913	24	are	be	VBP
cord-023095-4dannjjm	3913	25	present	present	JJ
cord-023095-4dannjjm	3913	26	between	between	IN
cord-023095-4dannjjm	3913	27	healthy	healthy	JJ
cord-023095-4dannjjm	3913	28	Rottweilers	Rottweilers	NNPS
cord-023095-4dannjjm	3913	29	,	,	,
cord-023095-4dannjjm	3913	30	non	non	NNS
cord-023095-4dannjjm	3913	31	-	-	JJ
cord-023095-4dannjjm	3913	32	Rottweilers	Rottweilers	NNPS
cord-023095-4dannjjm	3913	33	and	and	CC
cord-023095-4dannjjm	3913	34	Rottweilers	Rottweilers	NNPS
cord-023095-4dannjjm	3913	35	with	with	IN
cord-023095-4dannjjm	3913	36	non	non	JJ
cord-023095-4dannjjm	3913	37	-	-	JJ
cord-023095-4dannjjm	3913	38	parasitic	parasitic	JJ
cord-023095-4dannjjm	3913	39	eosinophilia	eosinophilia	NN
cord-023095-4dannjjm	3913	40	.	.	.
cord-023095-4dannjjm	3914	1	Secondly	secondly	RB
cord-023095-4dannjjm	3914	2	,	,	,
cord-023095-4dannjjm	3914	3	by	by	IN
cord-023095-4dannjjm	3914	4	evaluating	evaluate	VBG
cord-023095-4dannjjm	3914	5	cytokine	cytokine	NN
cord-023095-4dannjjm	3914	6	profiles	profile	NNS
cord-023095-4dannjjm	3914	7	the	the	DT
cord-023095-4dannjjm	3914	8	study	study	NN
cord-023095-4dannjjm	3914	9	aimed	aim	VBN
cord-023095-4dannjjm	3914	10	to	to	TO
cord-023095-4dannjjm	3914	11	improve	improve	VB
cord-023095-4dannjjm	3914	12	understanding	understanding	NN
cord-023095-4dannjjm	3914	13	of	of	IN
cord-023095-4dannjjm	3914	14	the	the	DT
cord-023095-4dannjjm	3914	15	pathophysiology	pathophysiology	NN
cord-023095-4dannjjm	3914	16	of	of	IN
cord-023095-4dannjjm	3914	17	eosinophilia	eosinophilia	NN
cord-023095-4dannjjm	3914	18	therefore	therefore	RB
cord-023095-4dannjjm	3914	19	assisting	assist	VBG
cord-023095-4dannjjm	3914	20	development	development	NN
cord-023095-4dannjjm	3914	21	of	of	IN
cord-023095-4dannjjm	3914	22	potential	potential	JJ
cord-023095-4dannjjm	3914	23	molecular	molecular	JJ
cord-023095-4dannjjm	3914	24	treatment	treatment	NN
cord-023095-4dannjjm	3914	25	options	option	NNS
cord-023095-4dannjjm	3914	26	.	.	.
cord-023095-4dannjjm	3915	1	Quantitative	quantitative	JJ
cord-023095-4dannjjm	3915	2	real	real	JJ
cord-023095-4dannjjm	3915	3	-	-	HYPH
cord-023095-4dannjjm	3915	4	time	time	NN
cord-023095-4dannjjm	3915	5	reverse	reverse	JJ
cord-023095-4dannjjm	3915	6	transcriptase	transcriptase	NN
cord-023095-4dannjjm	3915	7	polymerase	polymerase	NN
cord-023095-4dannjjm	3915	8	chain	chain	NN
cord-023095-4dannjjm	3915	9	reaction	reaction	NN
cord-023095-4dannjjm	3915	10	(	(	-LRB-
cord-023095-4dannjjm	3916	1	QRT	QRT	NNP
cord-023095-4dannjjm	3916	2	-	-	HYPH
cord-023095-4dannjjm	3916	3	PCR	PCR	NNP
cord-023095-4dannjjm	3916	4	)	)	-RRB-
cord-023095-4dannjjm	3916	5	assays	assay	NNS
cord-023095-4dannjjm	3916	6	were	be	VBD
cord-023095-4dannjjm	3916	7	used	use	VBN
cord-023095-4dannjjm	3916	8	to	to	TO
cord-023095-4dannjjm	3916	9	quantify	quantify	VB
cord-023095-4dannjjm	3916	10	messenger	messenger	NN
cord-023095-4dannjjm	3916	11	RNA	RNA	NNP
cord-023095-4dannjjm	3916	12	(	(	-LRB-
cord-023095-4dannjjm	3916	13	mRNA	mrna	NN
cord-023095-4dannjjm	3916	14	)	)	-RRB-
cord-023095-4dannjjm	3916	15	encoding	encoding	NN
cord-023095-4dannjjm	3916	16	cytokines	cytokine	NNS
cord-023095-4dannjjm	3916	17	IL-4	IL-4	NNP
cord-023095-4dannjjm	3916	18	,	,	,
cord-023095-4dannjjm	3916	19	IL-5	IL-5	NNP
cord-023095-4dannjjm	3916	20	,	,	,
cord-023095-4dannjjm	3916	21	IL-10	IL-10	NNP
cord-023095-4dannjjm	3916	22	,	,	,
cord-023095-4dannjjm	3916	23	IL-23p19	IL-23p19	NNP
cord-023095-4dannjjm	3916	24	,	,	,
cord-023095-4dannjjm	3916	25	IL-12p35	IL-12p35	NNP
cord-023095-4dannjjm	3916	26	,	,	,
cord-023095-4dannjjm	3916	27	IL-12p40	IL-12p40	NNP
cord-023095-4dannjjm	3916	28	,	,	,
cord-023095-4dannjjm	3916	29	IL-18	IL-18	NNP
cord-023095-4dannjjm	3916	30	,	,	,
cord-023095-4dannjjm	3916	31	interferon	interferon	NN
cord-023095-4dannjjm	3916	32	gamma	gamma	NN
cord-023095-4dannjjm	3916	33	(	(	-LRB-
cord-023095-4dannjjm	3916	34	IFN	IFN	NNP
cord-023095-4dannjjm	3916	35	-	-	HYPH
cord-023095-4dannjjm	3916	36	g	g	NNP
cord-023095-4dannjjm	3916	37	)	)	-RRB-
cord-023095-4dannjjm	3916	38	and	and	CC
cord-023095-4dannjjm	3916	39	chemokines	chemokine	NNS
cord-023095-4dannjjm	3916	40	eotaxin-2	eotaxin-2	NNPS
cord-023095-4dannjjm	3916	41	and	and	CC
cord-023095-4dannjjm	3916	42	eotaxin-3	eotaxin-3	NNP
cord-023095-4dannjjm	3916	43	from	from	IN
cord-023095-4dannjjm	3916	44	peripheral	peripheral	JJ
cord-023095-4dannjjm	3916	45	blood	blood	NN
cord-023095-4dannjjm	3916	46	mononuclear	mononuclear	JJ
cord-023095-4dannjjm	3916	47	cell	cell	NN
cord-023095-4dannjjm	3916	48	(	(	-LRB-
cord-023095-4dannjjm	3916	49	PMBC	PMBC	NNP
cord-023095-4dannjjm	3916	50	)	)	-RRB-
cord-023095-4dannjjm	3916	51	samples	sample	NNS
cord-023095-4dannjjm	3916	52	obtained	obtain	VBN
cord-023095-4dannjjm	3916	53	from	from	IN
cord-023095-4dannjjm	3916	54	healthy	healthy	JJ
cord-023095-4dannjjm	3916	55	non	non	JJ
cord-023095-4dannjjm	3916	56	-	-	JJ
cord-023095-4dannjjm	3916	57	Rottweiler	rottweiler	JJ
cord-023095-4dannjjm	3916	58	dogs	dog	NNS
cord-023095-4dannjjm	3916	59	with	with	IN
cord-023095-4dannjjm	3916	60	normal	normal	JJ
cord-023095-4dannjjm	3916	61	eosinophil	eosinophil	JJ
cord-023095-4dannjjm	3916	62	counts	count	NNS
cord-023095-4dannjjm	3916	63	(	(	-LRB-
cord-023095-4dannjjm	3916	64	n	n	NN
cord-023095-4dannjjm	3916	65	5	5	CD
cord-023095-4dannjjm	3916	66	5	5	CD
cord-023095-4dannjjm	3916	67	)	)	-RRB-
cord-023095-4dannjjm	3916	68	and	and	CC
cord-023095-4dannjjm	3916	69	Rottweilers	rottweiler	NNS
cord-023095-4dannjjm	3916	70	with	with	IN
cord-023095-4dannjjm	3916	71	normal	normal	JJ
cord-023095-4dannjjm	3916	72	(	(	-LRB-
cord-023095-4dannjjm	3916	73	n	n	NN
cord-023095-4dannjjm	3916	74	5	5	CD
cord-023095-4dannjjm	3916	75	6	6	CD
cord-023095-4dannjjm	3916	76	)	)	-RRB-
cord-023095-4dannjjm	3916	77	,	,	,
cord-023095-4dannjjm	3916	78	mildly	mildly	RB
cord-023095-4dannjjm	3916	79	increased	increase	VBN
cord-023095-4dannjjm	3916	80	(	(	-LRB-
cord-023095-4dannjjm	3916	81	n	n	NN
cord-023095-4dannjjm	3916	82	5	5	CD
cord-023095-4dannjjm	3916	83	7	7	CD
cord-023095-4dannjjm	3916	84	)	)	-RRB-
cord-023095-4dannjjm	3916	85	and	and	CC
cord-023095-4dannjjm	3916	86	high	high	JJ
cord-023095-4dannjjm	3916	87	(	(	-LRB-
cord-023095-4dannjjm	3916	88	n	n	NN
cord-023095-4dannjjm	3916	89	5	5	CD
cord-023095-4dannjjm	3916	90	3	3	CD
cord-023095-4dannjjm	3916	91	)	)	-RRB-
cord-023095-4dannjjm	3917	1	eosinophil	eosinophil	JJ
cord-023095-4dannjjm	3917	2	counts	count	VBZ
cord-023095-4dannjjm	3917	3	.	.	.
cord-023095-4dannjjm	3918	1	Quantification	quantification	NN
cord-023095-4dannjjm	3918	2	of	of	IN
cord-023095-4dannjjm	3918	3	serum	serum	NN
cord-023095-4dannjjm	3918	4	IFN	IFN	NNP
cord-023095-4dannjjm	3918	5	-	-	HYPH
cord-023095-4dannjjm	3918	6	g	g	NNP
cord-023095-4dannjjm	3918	7	was	be	VBD
cord-023095-4dannjjm	3918	8	also	also	RB
cord-023095-4dannjjm	3918	9	performed	perform	VBN
cord-023095-4dannjjm	3918	10	using	use	VBG
cord-023095-4dannjjm	3918	11	a	a	DT
cord-023095-4dannjjm	3918	12	commercially	commercially	RB
cord-023095-4dannjjm	3918	13	available	available	JJ
cord-023095-4dannjjm	3918	14	canine	canine	JJ
cord-023095-4dannjjm	3918	15	-	-	HYPH
cord-023095-4dannjjm	3918	16	specific	specific	JJ
cord-023095-4dannjjm	3918	17	ELISA	ELISA	NNP
cord-023095-4dannjjm	3918	18	.	.	.
cord-023095-4dannjjm	3919	1	All	all	DT
cord-023095-4dannjjm	3919	2	samples	sample	NNS
cord-023095-4dannjjm	3919	3	were	be	VBD
cord-023095-4dannjjm	3919	4	positive	positive	JJ
cord-023095-4dannjjm	3919	5	for	for	IN
cord-023095-4dannjjm	3919	6	housekeeping	housekeeping	NN
cord-023095-4dannjjm	3919	7	genes	gene	NNS
cord-023095-4dannjjm	3919	8	and	and	CC
cord-023095-4dannjjm	3919	9	all	all	DT
cord-023095-4dannjjm	3919	10	cytokines	cytokine	NNS
cord-023095-4dannjjm	3919	11	could	could	MD
cord-023095-4dannjjm	3919	12	be	be	VB
cord-023095-4dannjjm	3919	13	quantified	quantify	VBN
cord-023095-4dannjjm	3919	14	with	with	IN
cord-023095-4dannjjm	3919	15	the	the	DT
cord-023095-4dannjjm	3919	16	exception	exception	NN
cord-023095-4dannjjm	3919	17	of	of	IN
cord-023095-4dannjjm	3919	18	eotaxin-2	eotaxin-2	NNPS
cord-023095-4dannjjm	3919	19	and	and	CC
cord-023095-4dannjjm	3919	20	-3	-3	NNP
cord-023095-4dannjjm	3919	21	.	.	.
cord-023095-4dannjjm	3920	1	Results	result	NNS
cord-023095-4dannjjm	3920	2	were	be	VBD
cord-023095-4dannjjm	3920	3	normalised	normalise	VBN
cord-023095-4dannjjm	3920	4	using	use	VBG
cord-023095-4dannjjm	3920	5	three	three	CD
cord-023095-4dannjjm	3920	6	stably	stably	RB
cord-023095-4dannjjm	3920	7	expressed	express	VBD
cord-023095-4dannjjm	3920	8	housekeeper	housekeeper	NN
cord-023095-4dannjjm	3920	9	genes	gene	NNS
cord-023095-4dannjjm	3920	10	(	(	-LRB-
cord-023095-4dannjjm	3920	11	RPL13A	RPL13A	NNS
cord-023095-4dannjjm	3920	12	,	,	,
cord-023095-4dannjjm	3920	13	SDHA	SDHA	NNP
cord-023095-4dannjjm	3920	14	and	and	CC
cord-023095-4dannjjm	3920	15	YWAZ	YWAZ	NNP
cord-023095-4dannjjm	3920	16	)	)	-RRB-
cord-023095-4dannjjm	3920	17	and	and	CC
cord-023095-4dannjjm	3920	18	a	a	DT
cord-023095-4dannjjm	3920	19	relative	relative	JJ
cord-023095-4dannjjm	3920	20	copy	copy	NN
cord-023095-4dannjjm	3920	21	number	number	NN
cord-023095-4dannjjm	3920	22	was	be	VBD
cord-023095-4dannjjm	3920	23	calculated	calculate	VBN
cord-023095-4dannjjm	3920	24	for	for	IN
cord-023095-4dannjjm	3920	25	each	each	DT
cord-023095-4dannjjm	3920	26	sample	sample	NN
cord-023095-4dannjjm	3920	27	with	with	IN
cord-023095-4dannjjm	3920	28	the	the	DT
cord-023095-4dannjjm	3920	29	sample	sample	NN
cord-023095-4dannjjm	3920	30	with	with	IN
cord-023095-4dannjjm	3920	31	the	the	DT
cord-023095-4dannjjm	3920	32	fewest	few	JJS
cord-023095-4dannjjm	3920	33	copies	copy	NNS
cord-023095-4dannjjm	3920	34	given	give	VBN
cord-023095-4dannjjm	3920	35	a	a	DT
cord-023095-4dannjjm	3920	36	value	value	NN
cord-023095-4dannjjm	3920	37	of	of	IN
cord-023095-4dannjjm	3920	38	1	1	CD
cord-023095-4dannjjm	3920	39	.	.	.
cord-023095-4dannjjm	3921	1	No	no	DT
cord-023095-4dannjjm	3921	2	significant	significant	JJ
cord-023095-4dannjjm	3921	3	differences	difference	NNS
cord-023095-4dannjjm	3921	4	were	be	VBD
cord-023095-4dannjjm	3921	5	found	find	VBN
cord-023095-4dannjjm	3921	6	between	between	IN
cord-023095-4dannjjm	3921	7	groups	group	NNS
cord-023095-4dannjjm	3921	8	but	but	CC
cord-023095-4dannjjm	3921	9	there	there	EX
cord-023095-4dannjjm	3921	10	was	be	VBD
cord-023095-4dannjjm	3921	11	a	a	DT
cord-023095-4dannjjm	3921	12	tendency	tendency	NN
cord-023095-4dannjjm	3921	13	for	for	IN
cord-023095-4dannjjm	3921	14	IFN	IFN	NNP
cord-023095-4dannjjm	3921	15	-	-	HYPH
cord-023095-4dannjjm	3921	16	g	g	NNP
cord-023095-4dannjjm	3921	17	mRNA	mrna	NN
cord-023095-4dannjjm	3921	18	expression	expression	NN
cord-023095-4dannjjm	3921	19	to	to	TO
cord-023095-4dannjjm	3921	20	be	be	VB
cord-023095-4dannjjm	3921	21	lower	low	JJR
cord-023095-4dannjjm	3921	22	in	in	IN
cord-023095-4dannjjm	3921	23	the	the	DT
cord-023095-4dannjjm	3921	24	Rottweilers	Rottweilers	NNPS
cord-023095-4dannjjm	3921	25	with	with	IN
cord-023095-4dannjjm	3921	26	moderate	moderate	JJ
cord-023095-4dannjjm	3921	27	to	to	IN
cord-023095-4dannjjm	3921	28	severe	severe	JJ
cord-023095-4dannjjm	3921	29	eosinophilia	eosinophilia	NN
cord-023095-4dannjjm	3921	30	versus	versus	IN
cord-023095-4dannjjm	3921	31	control	control	NN
cord-023095-4dannjjm	3921	32	dogs	dog	NNS
cord-023095-4dannjjm	3921	33	(	(	-LRB-
cord-023095-4dannjjm	3921	34	p	p	NN
cord-023095-4dannjjm	3921	35	5	5	CD
cord-023095-4dannjjm	3921	36	0.062	0.062	CD
cord-023095-4dannjjm	3921	37	)	)	-RRB-
cord-023095-4dannjjm	3921	38	.	.	.
cord-023095-4dannjjm	3922	1	This	this	DT
cord-023095-4dannjjm	3922	2	trend	trend	NN
cord-023095-4dannjjm	3922	3	was	be	VBD
cord-023095-4dannjjm	3922	4	not	not	RB
cord-023095-4dannjjm	3922	5	seen	see	VBN
cord-023095-4dannjjm	3922	6	in	in	IN
cord-023095-4dannjjm	3922	7	the	the	DT
cord-023095-4dannjjm	3922	8	concentration	concentration	NN
cord-023095-4dannjjm	3922	9	of	of	IN
cord-023095-4dannjjm	3922	10	serum	serum	NN
cord-023095-4dannjjm	3922	11	IFN	IFN	NNP
cord-023095-4dannjjm	3922	12	-	-	HYPH
cord-023095-4dannjjm	3922	13	g	g	NNP
cord-023095-4dannjjm	3922	14	quantified	quantify	VBN
cord-023095-4dannjjm	3922	15	by	by	IN
cord-023095-4dannjjm	3922	16	ELISA	ELISA	NNP
cord-023095-4dannjjm	3922	17	as	as	IN
cord-023095-4dannjjm	3922	18	there	there	EX
cord-023095-4dannjjm	3922	19	were	be	VBD
cord-023095-4dannjjm	3922	20	no	no	DT
cord-023095-4dannjjm	3922	21	significant	significant	JJ
cord-023095-4dannjjm	3922	22	differences	difference	NNS
cord-023095-4dannjjm	3922	23	between	between	IN
cord-023095-4dannjjm	3922	24	normal	normal	JJ
cord-023095-4dannjjm	3922	25	and	and	CC
cord-023095-4dannjjm	3922	26	diseased	diseased	JJ
cord-023095-4dannjjm	3922	27	animals	animal	NNS
cord-023095-4dannjjm	3922	28	.	.	.
cord-023095-4dannjjm	3923	1	In	in	IN
cord-023095-4dannjjm	3923	2	conclusion	conclusion	NN
cord-023095-4dannjjm	3923	3	,	,	,
cord-023095-4dannjjm	3923	4	there	there	EX
cord-023095-4dannjjm	3923	5	were	be	VBD
cord-023095-4dannjjm	3923	6	no	no	DT
cord-023095-4dannjjm	3923	7	significant	significant	JJ
cord-023095-4dannjjm	3923	8	differences	difference	NNS
cord-023095-4dannjjm	3923	9	in	in	IN
cord-023095-4dannjjm	3924	1	cytokine	cytokine	NN
cord-023095-4dannjjm	3924	2	mRNA	mRNA	NNP
cord-023095-4dannjjm	3924	3	profiles	profile	NNS
cord-023095-4dannjjm	3924	4	between	between	IN
cord-023095-4dannjjm	3924	5	normal	normal	JJ
cord-023095-4dannjjm	3924	6	dogs	dog	NNS
cord-023095-4dannjjm	3924	7	and	and	CC
cord-023095-4dannjjm	3924	8	Rottweilers	rottweiler	NNS
cord-023095-4dannjjm	3924	9	with	with	IN
cord-023095-4dannjjm	3924	10	varying	vary	VBG
cord-023095-4dannjjm	3924	11	degrees	degree	NNS
cord-023095-4dannjjm	3924	12	of	of	IN
cord-023095-4dannjjm	3924	13	eosinophilia	eosinophilia	NN
cord-023095-4dannjjm	3924	14	.	.	.
cord-023095-4dannjjm	3925	1	Additional	additional	JJ
cord-023095-4dannjjm	3925	2	studies	study	NNS
cord-023095-4dannjjm	3925	3	including	include	VBG
cord-023095-4dannjjm	3925	4	larger	large	JJR
cord-023095-4dannjjm	3925	5	numbers	number	NNS
cord-023095-4dannjjm	3925	6	of	of	IN
cord-023095-4dannjjm	3925	7	affected	affect	VBN
cord-023095-4dannjjm	3925	8	dogs	dog	NNS
cord-023095-4dannjjm	3925	9	are	be	VBP
cord-023095-4dannjjm	3925	10	warranted	warrant	VBN
cord-023095-4dannjjm	3925	11	before	before	IN
cord-023095-4dannjjm	3925	12	any	any	DT
cord-023095-4dannjjm	3925	13	accurate	accurate	JJ
cord-023095-4dannjjm	3925	14	conclusions	conclusion	NNS
cord-023095-4dannjjm	3925	15	can	can	MD
cord-023095-4dannjjm	3925	16	be	be	VB
cord-023095-4dannjjm	3925	17	made	make	VBN
cord-023095-4dannjjm	3925	18	.	.	.
cord-023095-4dannjjm	3926	1	The	the	DT
cord-023095-4dannjjm	3926	2	presence	presence	NN
cord-023095-4dannjjm	3926	3	of	of	IN
cord-023095-4dannjjm	3926	4	large	large	JJ
cord-023095-4dannjjm	3926	5	amount	amount	NN
cord-023095-4dannjjm	3926	6	of	of	IN
cord-023095-4dannjjm	3926	7	antibody	antibody	NN
cord-023095-4dannjjm	3926	8	on	on	IN
cord-023095-4dannjjm	3926	9	erythrocyte	erythrocyte	NN
cord-023095-4dannjjm	3926	10	membrane	membrane	NN
cord-023095-4dannjjm	3926	11	can	can	MD
cord-023095-4dannjjm	3926	12	accelerate	accelerate	VB
cord-023095-4dannjjm	3926	13	red	red	JJ
cord-023095-4dannjjm	3926	14	blood	blood	NN
cord-023095-4dannjjm	3926	15	cell	cell	NN
cord-023095-4dannjjm	3926	16	(	(	-LRB-
cord-023095-4dannjjm	3926	17	RBC	RBC	NNP
cord-023095-4dannjjm	3926	18	)	)	-RRB-
cord-023095-4dannjjm	3926	19	removal	removal	NN
cord-023095-4dannjjm	3926	20	process	process	NN
cord-023095-4dannjjm	3926	21	by	by	IN
cord-023095-4dannjjm	3926	22	the	the	DT
cord-023095-4dannjjm	3926	23	mononuclear	mononuclear	JJ
cord-023095-4dannjjm	3926	24	phagocyte	phagocyte	NNP
cord-023095-4dannjjm	3926	25	system	system	NN
cord-023095-4dannjjm	3926	26	.	.	.
cord-023095-4dannjjm	3927	1	An	an	DT
cord-023095-4dannjjm	3927	2	antigenic	antigenic	JJ
cord-023095-4dannjjm	3927	3	stimulus	stimulus	NN
cord-023095-4dannjjm	3927	4	such	such	JJ
cord-023095-4dannjjm	3927	5	as	as	IN
cord-023095-4dannjjm	3927	6	the	the	DT
cord-023095-4dannjjm	3927	7	one	one	CD
cord-023095-4dannjjm	3927	8	promoted	promote	VBN
cord-023095-4dannjjm	3927	9	by	by	IN
cord-023095-4dannjjm	3927	10	vaccines	vaccine	NNS
cord-023095-4dannjjm	3927	11	,	,	,
cord-023095-4dannjjm	3927	12	for	for	IN
cord-023095-4dannjjm	3927	13	example	example	NN
cord-023095-4dannjjm	3927	14	,	,	,
cord-023095-4dannjjm	3927	15	can	can	MD
cord-023095-4dannjjm	3927	16	induce	induce	VB
cord-023095-4dannjjm	3927	17	hypersensitivity	hypersensitivity	NN
cord-023095-4dannjjm	3927	18	reactions	reaction	NNS
cord-023095-4dannjjm	3927	19	and	and	CC
cord-023095-4dannjjm	3927	20	may	may	MD
cord-023095-4dannjjm	3927	21	accelerate	accelerate	VB
cord-023095-4dannjjm	3927	22	RBC	RBC	NNP
cord-023095-4dannjjm	3927	23	destruction	destruction	NN
cord-023095-4dannjjm	3927	24	.	.	.
cord-023095-4dannjjm	3928	1	The	the	DT
cord-023095-4dannjjm	3928	2	study	study	NN
cord-023095-4dannjjm	3928	3	objective	objective	NN
cord-023095-4dannjjm	3928	4	was	be	VBD
cord-023095-4dannjjm	3928	5	to	to	TO
cord-023095-4dannjjm	3928	6	evaluate	evaluate	VB
cord-023095-4dannjjm	3928	7	the	the	DT
cord-023095-4dannjjm	3928	8	erythrocytic	erythrocytic	JJ
cord-023095-4dannjjm	3928	9	membrane	membrane	NN
cord-023095-4dannjjm	3928	10	potential	potential	NN
cord-023095-4dannjjm	3928	11	in	in	IN
cord-023095-4dannjjm	3928	12	inducing	induce	VBG
cord-023095-4dannjjm	3928	13	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	3928	14	proliferative	proliferative	JJ
cord-023095-4dannjjm	3928	15	response	response	NN
cord-023095-4dannjjm	3928	16	of	of	IN
cord-023095-4dannjjm	3928	17	recently	recently	RB
cord-023095-4dannjjm	3928	18	immunized	immunize	VBN
cord-023095-4dannjjm	3928	19	dogs	dog	NNS
cord-023095-4dannjjm	3928	20	.	.	.
cord-023095-4dannjjm	3929	1	Healthy	healthy	JJ
cord-023095-4dannjjm	3929	2	adult	adult	NN
cord-023095-4dannjjm	3929	3	dogs	dog	NNS
cord-023095-4dannjjm	3929	4	(	(	-LRB-
cord-023095-4dannjjm	3929	5	n	n	NN
cord-023095-4dannjjm	3929	6	5	5	CD
cord-023095-4dannjjm	3929	7	17	17	CD
cord-023095-4dannjjm	3929	8	)	)	-RRB-
cord-023095-4dannjjm	3929	9	were	be	VBD
cord-023095-4dannjjm	3929	10	immunized	immunize	VBN
cord-023095-4dannjjm	3929	11	with	with	IN
cord-023095-4dannjjm	3929	12	multiple	multiple	JJ
cord-023095-4dannjjm	3929	13	antigens	antigen	NNS
cord-023095-4dannjjm	3929	14	(	(	-LRB-
cord-023095-4dannjjm	3929	15	commercial	commercial	JJ
cord-023095-4dannjjm	3929	16	vaccine	vaccine	NN
cord-023095-4dannjjm	3929	17	with	with	IN
cord-023095-4dannjjm	3929	18	eight	eight	CD
cord-023095-4dannjjm	3929	19	antigens	antigen	NNS
cord-023095-4dannjjm	3929	20	:	:	:
cord-023095-4dannjjm	3929	21	distemper	distemper	NN
cord-023095-4dannjjm	3929	22	virus	virus	NN
cord-023095-4dannjjm	3929	23	,	,	,
cord-023095-4dannjjm	3929	24	parvovirus	parvovirus	NN
cord-023095-4dannjjm	3929	25	,	,	,
cord-023095-4dannjjm	3929	26	coronavirus	coronavirus	NN
cord-023095-4dannjjm	3929	27	,	,	,
cord-023095-4dannjjm	3929	28	parainfluenza	parainfluenza	NNP
cord-023095-4dannjjm	3929	29	virus	virus	NN
cord-023095-4dannjjm	3929	30	,	,	,
cord-023095-4dannjjm	3929	31	adenovirus	adenovirus	NN
cord-023095-4dannjjm	3929	32	,	,	,
cord-023095-4dannjjm	3929	33	infectious	infectious	JJ
cord-023095-4dannjjm	3929	34	hepatitis	hepatitis	NN
cord-023095-4dannjjm	3929	35	virus	virus	NN
cord-023095-4dannjjm	3929	36	and	and	CC
cord-023095-4dannjjm	3929	37	leptospire	leptospire	NN
cord-023095-4dannjjm	3929	38	;	;	:
cord-023095-4dannjjm	3929	39	and	and	CC
cord-023095-4dannjjm	3929	40	anti	anti	JJ
cord-023095-4dannjjm	3929	41	-	-	JJ
cord-023095-4dannjjm	3929	42	rabies	rabies	JJ
cord-023095-4dannjjm	3929	43	)	)	-RRB-
cord-023095-4dannjjm	3929	44	.	.	.
cord-023095-4dannjjm	3930	1	Blood	blood	NN
cord-023095-4dannjjm	3930	2	samples	sample	NNS
cord-023095-4dannjjm	3930	3	from	from	IN
cord-023095-4dannjjm	3930	4	each	each	DT
cord-023095-4dannjjm	3930	5	animal	animal	NN
cord-023095-4dannjjm	3930	6	were	be	VBD
cord-023095-4dannjjm	3930	7	collected	collect	VBN
cord-023095-4dannjjm	3930	8	into	into	IN
cord-023095-4dannjjm	3930	9	EDTA	EDTA	NNP
cord-023095-4dannjjm	3930	10	tubes	tube	NNS
cord-023095-4dannjjm	3930	11	in	in	IN
cord-023095-4dannjjm	3930	12	two	two	CD
cord-023095-4dannjjm	3930	13	moments	moment	NNS
cord-023095-4dannjjm	3930	14	:	:	:
cord-023095-4dannjjm	3930	15	PRE	pre	VB
cord-023095-4dannjjm	3930	16	(	(	-LRB-
cord-023095-4dannjjm	3930	17	immediately	immediately	RB
cord-023095-4dannjjm	3930	18	before	before	IN
cord-023095-4dannjjm	3930	19	vaccination	vaccination	NN
cord-023095-4dannjjm	3930	20	)	)	-RRB-
cord-023095-4dannjjm	3930	21	and	and	CC
cord-023095-4dannjjm	3930	22	POS	POS	NNP
cord-023095-4dannjjm	3930	23	(	(	-LRB-
cord-023095-4dannjjm	3930	24	28	28	CD
cord-023095-4dannjjm	3930	25	to	to	TO
cord-023095-4dannjjm	3930	26	35	35	CD
cord-023095-4dannjjm	3930	27	days	day	NNS
cord-023095-4dannjjm	3930	28	after	after	IN
cord-023095-4dannjjm	3930	29	vaccination	vaccination	NN
cord-023095-4dannjjm	3930	30	)	)	-RRB-
cord-023095-4dannjjm	3930	31	.	.	.
cord-023095-4dannjjm	3931	1	Mononuclear	Mononuclear	NNP
cord-023095-4dannjjm	3931	2	cells	cell	NNS
cord-023095-4dannjjm	3931	3	were	be	VBD
cord-023095-4dannjjm	3931	4	separated	separate	VBN
cord-023095-4dannjjm	3931	5	by	by	IN
cord-023095-4dannjjm	3931	6	gradient	gradient	NN
cord-023095-4dannjjm	3931	7	,	,	,
cord-023095-4dannjjm	3931	8	marked	mark	VBN
cord-023095-4dannjjm	3931	9	with	with	IN
cord-023095-4dannjjm	3931	10	CFSE	CFSE	NNP
cord-023095-4dannjjm	3931	11	-	-	HYPH
cord-023095-4dannjjm	3931	12	FITC	FITC	NNP
cord-023095-4dannjjm	3931	13	and	and	CC
cord-023095-4dannjjm	3931	14	cultured	cultured	JJ
cord-023095-4dannjjm	3931	15	.	.	.
cord-023095-4dannjjm	3932	1	The	the	DT
cord-023095-4dannjjm	3932	2	stimuli	stimulus	NNS
cord-023095-4dannjjm	3932	3	for	for	IN
cord-023095-4dannjjm	3932	4	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	3932	5	proliferation	proliferation	NN
cord-023095-4dannjjm	3932	6	used	use	VBN
cord-023095-4dannjjm	3932	7	were	be	VBD
cord-023095-4dannjjm	3932	8	autologous	autologous	JJ
cord-023095-4dannjjm	3932	9	erythrocytic	erythrocytic	JJ
cord-023095-4dannjjm	3932	10	membrane	membrane	NN
cord-023095-4dannjjm	3932	11	(	(	-LRB-
cord-023095-4dannjjm	3932	12	AEM	AEM	NNP
cord-023095-4dannjjm	3932	13	)	)	-RRB-
cord-023095-4dannjjm	3932	14	and	and	CC
cord-023095-4dannjjm	3932	15	Concanavalin	Concanavalin	NNP
cord-023095-4dannjjm	3932	16	A	A	NNP
cord-023095-4dannjjm	3932	17	(	(	-LRB-
cord-023095-4dannjjm	3932	18	ConA	ConA	NNP
cord-023095-4dannjjm	3932	19	)	)	-RRB-
cord-023095-4dannjjm	3932	20	.	.	.
cord-023095-4dannjjm	3933	1	AEM	AEM	NNP
cord-023095-4dannjjm	3933	2	was	be	VBD
cord-023095-4dannjjm	3933	3	obtained	obtain	VBN
cord-023095-4dannjjm	3933	4	by	by	IN
cord-023095-4dannjjm	3933	5	hypotonic	hypotonic	JJ
cord-023095-4dannjjm	3933	6	lysis	lysis	NN
cord-023095-4dannjjm	3933	7	and	and	CC
cord-023095-4dannjjm	3933	8	tested	test	VBN
cord-023095-4dannjjm	3933	9	in	in	IN
cord-023095-4dannjjm	3933	10	two	two	CD
cord-023095-4dannjjm	3933	11	concentrations	concentration	NNS
cord-023095-4dannjjm	3933	12	(	(	-LRB-
cord-023095-4dannjjm	3933	13	M1	M1	NNP
cord-023095-4dannjjm	3933	14	:	:	:
cord-023095-4dannjjm	3933	15	0.1ug/100uL	0.1ug/100ul	CD
cord-023095-4dannjjm	3933	16	;	;	:
cord-023095-4dannjjm	3933	17	M2	m2	NN
cord-023095-4dannjjm	3933	18	:	:	:
cord-023095-4dannjjm	3933	19	0.2	0.2	CD
cord-023095-4dannjjm	3933	20	ug/100uL	ug/100uL	NNP
cord-023095-4dannjjm	3933	21	)	)	-RRB-
cord-023095-4dannjjm	3933	22	.	.	.
cord-023095-4dannjjm	3934	1	The	the	DT
cord-023095-4dannjjm	3934	2	proliferation	proliferation	NN
cord-023095-4dannjjm	3934	3	assay	assay	NN
cord-023095-4dannjjm	3934	4	was	be	VBD
cord-023095-4dannjjm	3934	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	3934	6	by	by	IN
cord-023095-4dannjjm	3934	7	flow	flow	NN
cord-023095-4dannjjm	3934	8	cytometry	cytometry	NN
cord-023095-4dannjjm	3934	9	and	and	CC
cord-023095-4dannjjm	3934	10	analyzed	analyze	VBN
cord-023095-4dannjjm	3934	11	with	with	IN
cord-023095-4dannjjm	3934	12	specific	specific	JJ
cord-023095-4dannjjm	3934	13	software	software	NN
cord-023095-4dannjjm	3934	14	.	.	.
cord-023095-4dannjjm	3935	1	The	the	DT
cord-023095-4dannjjm	3935	2	proliferation	proliferation	NN
cord-023095-4dannjjm	3935	3	index	index	NN
cord-023095-4dannjjm	3935	4	(	(	-LRB-
cord-023095-4dannjjm	3935	5	PI	PI	NNP
cord-023095-4dannjjm	3935	6	)	)	-RRB-
cord-023095-4dannjjm	3935	7	was	be	VBD
cord-023095-4dannjjm	3935	8	calculated	calculate	VBN
cord-023095-4dannjjm	3935	9	dividing	divide	VBG
cord-023095-4dannjjm	3935	10	the	the	DT
cord-023095-4dannjjm	3935	11	fluorescence	fluorescence	NN
cord-023095-4dannjjm	3935	12	intensity	intensity	NN
cord-023095-4dannjjm	3935	13	of	of	IN
cord-023095-4dannjjm	3935	14	the	the	DT
cord-023095-4dannjjm	3935	15	basal	basal	NN
cord-023095-4dannjjm	3935	16	sample	sample	NN
cord-023095-4dannjjm	3935	17	by	by	IN
cord-023095-4dannjjm	3935	18	the	the	DT
cord-023095-4dannjjm	3935	19	stimulated	stimulate	VBN
cord-023095-4dannjjm	3935	20	one	one	CD
cord-023095-4dannjjm	3935	21	.	.	.
cord-023095-4dannjjm	3936	1	Statistical	statistical	JJ
cord-023095-4dannjjm	3936	2	analysis	analysis	NN
cord-023095-4dannjjm	3936	3	was	be	VBD
cord-023095-4dannjjm	3936	4	performed	perform	VBN
cord-023095-4dannjjm	3936	5	using	use	VBG
cord-023095-4dannjjm	3936	6	paired	pair	VBN
cord-023095-4dannjjm	3936	7	t	t	NN
cord-023095-4dannjjm	3936	8	-	-	HYPH
cord-023095-4dannjjm	3936	9	test	test	NN
cord-023095-4dannjjm	3936	10	for	for	IN
cord-023095-4dannjjm	3936	11	parametric	parametric	JJ
cord-023095-4dannjjm	3936	12	samples	sample	NNS
cord-023095-4dannjjm	3936	13	and	and	CC
cord-023095-4dannjjm	3936	14	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	3936	15	test	test	NN
cord-023095-4dannjjm	3936	16	for	for	IN
cord-023095-4dannjjm	3936	17	non	non	JJ
cord-023095-4dannjjm	3936	18	-	-	JJ
cord-023095-4dannjjm	3936	19	parametric	parametric	JJ
cord-023095-4dannjjm	3936	20	samples	sample	NNS
cord-023095-4dannjjm	3936	21	(	(	-LRB-
cord-023095-4dannjjm	3936	22	a	a	DT
cord-023095-4dannjjm	3936	23	5	5	CD
cord-023095-4dannjjm	3936	24	0.05	0.05	CD
cord-023095-4dannjjm	3936	25	)	)	-RRB-
cord-023095-4dannjjm	3936	26	.	.	.
cord-023095-4dannjjm	3937	1	The	the	DT
cord-023095-4dannjjm	3937	2	For	for	IN
cord-023095-4dannjjm	3937	3	the	the	DT
cord-023095-4dannjjm	3937	4	tested	test	VBN
cord-023095-4dannjjm	3937	5	concentrations	concentration	NNS
cord-023095-4dannjjm	3937	6	,	,	,
cord-023095-4dannjjm	3937	7	autologous	autologous	JJ
cord-023095-4dannjjm	3937	8	erythrocytic	erythrocytic	JJ
cord-023095-4dannjjm	3937	9	membrane	membrane	NN
cord-023095-4dannjjm	3937	10	does	do	VBZ
cord-023095-4dannjjm	3937	11	not	not	RB
cord-023095-4dannjjm	3937	12	constitute	constitute	VB
cord-023095-4dannjjm	3937	13	a	a	DT
cord-023095-4dannjjm	3937	14	stimulus	stimulus	NN
cord-023095-4dannjjm	3937	15	for	for	IN
cord-023095-4dannjjm	3937	16	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	3937	17	proliferation	proliferation	NN
cord-023095-4dannjjm	3937	18	in	in	IN
cord-023095-4dannjjm	3937	19	vitro	vitro	FW
cord-023095-4dannjjm	3937	20	,	,	,
cord-023095-4dannjjm	3937	21	either	either	CC
cord-023095-4dannjjm	3937	22	before	before	IN
cord-023095-4dannjjm	3937	23	or	or	CC
cord-023095-4dannjjm	3937	24	after	after	IN
cord-023095-4dannjjm	3937	25	vaccination	vaccination	NN
cord-023095-4dannjjm	3937	26	procedure	procedure	NN
cord-023095-4dannjjm	3937	27	.	.	.
cord-023095-4dannjjm	3938	1	Additionally	additionally	RB
cord-023095-4dannjjm	3938	2	,	,	,
cord-023095-4dannjjm	3938	3	there	there	EX
cord-023095-4dannjjm	3938	4	was	be	VBD
cord-023095-4dannjjm	3938	5	no	no	DT
cord-023095-4dannjjm	3938	6	evidence	evidence	NN
cord-023095-4dannjjm	3938	7	of	of	IN
cord-023095-4dannjjm	3938	8	self	self	NN
cord-023095-4dannjjm	3938	9	-	-	HYPH
cord-023095-4dannjjm	3938	10	reagent	reagent	NN
cord-023095-4dannjjm	3938	11	lymphocytes	lymphocyte	NNS
cord-023095-4dannjjm	3938	12	to	to	IN
cord-023095-4dannjjm	3938	13	erythrocyte	erythrocyte	NN
cord-023095-4dannjjm	3938	14	membrane	membrane	NN
cord-023095-4dannjjm	3938	15	after	after	IN
cord-023095-4dannjjm	3938	16	vaccination	vaccination	NN
cord-023095-4dannjjm	3938	17	.	.	.
cord-023095-4dannjjm	3939	1	E.	E.	NNP
cord-023095-4dannjjm	3939	2	coli	coli	NNS
cord-023095-4dannjjm	3939	3	is	be	VBZ
cord-023095-4dannjjm	3939	4	a	a	DT
cord-023095-4dannjjm	3939	5	common	common	JJ
cord-023095-4dannjjm	3939	6	cause	cause	NN
cord-023095-4dannjjm	3939	7	of	of	IN
cord-023095-4dannjjm	3939	8	canine	canine	JJ
cord-023095-4dannjjm	3939	9	urinary	urinary	JJ
cord-023095-4dannjjm	3939	10	tract	tract	NN
cord-023095-4dannjjm	3939	11	infection	infection	NN
cord-023095-4dannjjm	3939	12	.	.	.
cord-023095-4dannjjm	3940	1	Current	current	JJ
cord-023095-4dannjjm	3940	2	treatment	treatment	NN
cord-023095-4dannjjm	3940	3	emphasizes	emphasize	VBZ
cord-023095-4dannjjm	3940	4	eradication	eradication	NN
cord-023095-4dannjjm	3940	5	of	of	IN
cord-023095-4dannjjm	3940	6	established	establish	VBN
cord-023095-4dannjjm	3940	7	infection	infection	NN
cord-023095-4dannjjm	3940	8	rather	rather	RB
cord-023095-4dannjjm	3940	9	than	than	IN
cord-023095-4dannjjm	3940	10	infection	infection	NN
cord-023095-4dannjjm	3940	11	prevention	prevention	NN
cord-023095-4dannjjm	3940	12	but	but	CC
cord-023095-4dannjjm	3940	13	increased	increase	VBD
cord-023095-4dannjjm	3940	14	antibiotic	antibiotic	JJ
cord-023095-4dannjjm	3940	15	resistance	resistance	NN
cord-023095-4dannjjm	3940	16	necessitates	necessitate	VBZ
cord-023095-4dannjjm	3940	17	strategies	strategy	NNS
cord-023095-4dannjjm	3940	18	to	to	TO
cord-023095-4dannjjm	3940	19	prevent	prevent	VB
cord-023095-4dannjjm	3940	20	infection	infection	NN
cord-023095-4dannjjm	3940	21	.	.	.
cord-023095-4dannjjm	3941	1	Proanthocyanidins	Proanthocyanidins	NNP
cord-023095-4dannjjm	3941	2	found	find	VBD
cord-023095-4dannjjm	3941	3	in	in	IN
cord-023095-4dannjjm	3941	4	cranberry	cranberry	NN
cord-023095-4dannjjm	3941	5	juice	juice	NN
cord-023095-4dannjjm	3941	6	inhibit	inhibit	NN
cord-023095-4dannjjm	3941	7	E.	E.	NNP
cord-023095-4dannjjm	3941	8	coli	coli	NN
cord-023095-4dannjjm	3941	9	attachment	attachment	NN
cord-023095-4dannjjm	3941	10	to	to	IN
cord-023095-4dannjjm	3941	11	human	human	JJ
cord-023095-4dannjjm	3941	12	uroepithelial	uroepithelial	JJ
cord-023095-4dannjjm	3941	13	cells	cell	NNS
cord-023095-4dannjjm	3941	14	,	,	,
cord-023095-4dannjjm	3941	15	impairing	impair	VBG
cord-023095-4dannjjm	3941	16	bacterial	bacterial	JJ
cord-023095-4dannjjm	3941	17	adherence	adherence	NN
cord-023095-4dannjjm	3941	18	and	and	CC
cord-023095-4dannjjm	3941	19	colonization	colonization	NN
cord-023095-4dannjjm	3941	20	.	.	.
cord-023095-4dannjjm	3942	1	We	-PRON-	PRP
cord-023095-4dannjjm	3942	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	3942	3	that	that	IN
cord-023095-4dannjjm	3942	4	purified	purify	VBN
cord-023095-4dannjjm	3942	5	cranberry	cranberry	NN
cord-023095-4dannjjm	3942	6	extract	extract	NN
cord-023095-4dannjjm	3942	7	(	(	-LRB-
cord-023095-4dannjjm	3942	8	CE	CE	NNP
cord-023095-4dannjjm	3942	9	)	)	-RRB-
cord-023095-4dannjjm	3942	10	inhibits	inhibit	VBZ
cord-023095-4dannjjm	3942	11	bacterial	bacterial	JJ
cord-023095-4dannjjm	3942	12	adhesion	adhesion	NN
cord-023095-4dannjjm	3942	13	to	to	IN
cord-023095-4dannjjm	3942	14	canine	canine	JJ
cord-023095-4dannjjm	3942	15	uroepithelial	uroepithelial	JJ
cord-023095-4dannjjm	3942	16	cells	cell	NNS
cord-023095-4dannjjm	3942	17	.	.	.
cord-023095-4dannjjm	3943	1	Five	five	CD
cord-023095-4dannjjm	3943	2	healthy	healthy	JJ
cord-023095-4dannjjm	3943	3	female	female	JJ
cord-023095-4dannjjm	3943	4	dogs	dog	NNS
cord-023095-4dannjjm	3943	5	received	receive	VBD
cord-023095-4dannjjm	3943	6	an	an	DT
cord-023095-4dannjjm	3943	7	oral	oral	JJ
cord-023095-4dannjjm	3943	8	CE	ce	NN
cord-023095-4dannjjm	3943	9	supplement	supplement	NN
cord-023095-4dannjjm	3943	10	(	(	-LRB-
cord-023095-4dannjjm	3943	11	Vetoquinol	Vetoquinol	NNP
cord-023095-4dannjjm	3943	12	;	;	:
cord-023095-4dannjjm	3943	13	100	100	CD
cord-023095-4dannjjm	3943	14	mg	mg	NNP
cord-023095-4dannjjm	3943	15	CE	CE	NNP
cord-023095-4dannjjm	3943	16	/	/	SYM
cord-023095-4dannjjm	3943	17	tablet	tablet	NN
cord-023095-4dannjjm	3943	18	)	)	-RRB-
cord-023095-4dannjjm	3943	19	according	accord	VBG
cord-023095-4dannjjm	3943	20	to	to	IN
cord-023095-4dannjjm	3943	21	body	body	NN
cord-023095-4dannjjm	3943	22	weight	weight	NN
cord-023095-4dannjjm	3943	23	for	for	IN
cord-023095-4dannjjm	3943	24	30	30	CD
cord-023095-4dannjjm	3943	25	days	day	NNS
cord-023095-4dannjjm	3943	26	.	.	.
cord-023095-4dannjjm	3944	1	Voided	void	VBN
cord-023095-4dannjjm	3944	2	urine	urine	NN
cord-023095-4dannjjm	3944	3	collected	collect	VBN
cord-023095-4dannjjm	3944	4	from	from	IN
cord-023095-4dannjjm	3944	5	each	each	DT
cord-023095-4dannjjm	3944	6	dog	dog	NN
cord-023095-4dannjjm	3944	7	before	before	IN
cord-023095-4dannjjm	3944	8	(	(	-LRB-
cord-023095-4dannjjm	3944	9	PRE	PRE	NNP
cord-023095-4dannjjm	3944	10	)	)	-RRB-
cord-023095-4dannjjm	3944	11	and	and	CC
cord-023095-4dannjjm	3944	12	after	after	IN
cord-023095-4dannjjm	3944	13	(	(	-LRB-
cord-023095-4dannjjm	3944	14	30-DAY	30-day	CD
cord-023095-4dannjjm	3944	15	)	)	-RRB-
cord-023095-4dannjjm	3944	16	completion	completion	NN
cord-023095-4dannjjm	3944	17	of	of	IN
cord-023095-4dannjjm	3944	18	the	the	DT
cord-023095-4dannjjm	3944	19	protocol	protocol	NN
cord-023095-4dannjjm	3944	20	was	be	VBD
cord-023095-4dannjjm	3944	21	membrane	membrane	NN
cord-023095-4dannjjm	3944	22	filtered	filter	VBN
cord-023095-4dannjjm	3944	23	(	(	-LRB-
cord-023095-4dannjjm	3944	24	22	22	CD
cord-023095-4dannjjm	3944	25	mm	mm	NN
cord-023095-4dannjjm	3944	26	)	)	-RRB-
cord-023095-4dannjjm	3944	27	and	and	CC
cord-023095-4dannjjm	3944	28	stored	store	VBN
cord-023095-4dannjjm	3944	29	frozen	frozen	JJ
cord-023095-4dannjjm	3944	30	(	(	-LRB-
cord-023095-4dannjjm	3944	31	-20C	-20C	NNP
cord-023095-4dannjjm	3944	32	)	)	-RRB-
cord-023095-4dannjjm	3944	33	.	.	.
cord-023095-4dannjjm	3945	1	Bacterial	bacterial	JJ
cord-023095-4dannjjm	3945	2	adhesion	adhesion	NN
cord-023095-4dannjjm	3945	3	was	be	VBD
cord-023095-4dannjjm	3945	4	determined	determine	VBN
cord-023095-4dannjjm	3945	5	using	use	VBG
cord-023095-4dannjjm	3945	6	an	an	DT
cord-023095-4dannjjm	3945	7	in	in	FW
cord-023095-4dannjjm	3945	8	vitro	vitro	FW
cord-023095-4dannjjm	3945	9	assay	assay	NN
cord-023095-4dannjjm	3945	10	.	.	.
cord-023095-4dannjjm	3946	1	Briefly	briefly	RB
cord-023095-4dannjjm	3946	2	,	,	,
cord-023095-4dannjjm	3946	3	urine	urine	NN
cord-023095-4dannjjm	3946	4	samples	sample	NNS
cord-023095-4dannjjm	3946	5	were	be	VBD
cord-023095-4dannjjm	3946	6	incubated	incubate	VBN
cord-023095-4dannjjm	3946	7	with	with	IN
cord-023095-4dannjjm	3946	8	an	an	DT
cord-023095-4dannjjm	3946	9	uropathogenic	uropathogenic	JJ
cord-023095-4dannjjm	3946	10	E.	E.	NNP
cord-023095-4dannjjm	3946	11	coli	coli	NNS
cord-023095-4dannjjm	3946	12	strain	strain	NN
cord-023095-4dannjjm	3946	13	that	that	WDT
cord-023095-4dannjjm	3946	14	had	have	VBD
cord-023095-4dannjjm	3946	15	been	be	VBN
cord-023095-4dannjjm	3946	16	subcultured	subculture	VBN
cord-023095-4dannjjm	3946	17	to	to	TO
cord-023095-4dannjjm	3946	18	promote	promote	VB
cord-023095-4dannjjm	3946	19	fimbriae	fimbriae	NN
cord-023095-4dannjjm	3946	20	expression	expression	NN
cord-023095-4dannjjm	3946	21	.	.	.
cord-023095-4dannjjm	3947	1	Urine	urine	NN
cord-023095-4dannjjm	3947	2	samples	sample	NNS
cord-023095-4dannjjm	3947	3	containing	contain	VBG
cord-023095-4dannjjm	3947	4	E.	E.	NNP
cord-023095-4dannjjm	3947	5	coli	coli	NNS
cord-023095-4dannjjm	3947	6	were	be	VBD
cord-023095-4dannjjm	3947	7	next	next	RB
cord-023095-4dannjjm	3947	8	incubated	incubate	VBN
cord-023095-4dannjjm	3947	9	in	in	IN
cord-023095-4dannjjm	3947	10	96-well	96-well	CD
cord-023095-4dannjjm	3947	11	plates	plate	NNS
cord-023095-4dannjjm	3947	12	containing	contain	VBG
cord-023095-4dannjjm	3947	13	methanol	methanol	NN
cord-023095-4dannjjm	3947	14	-	-	HYPH
cord-023095-4dannjjm	3947	15	fixed	fix	VBN
cord-023095-4dannjjm	3947	16	Madin	Madin	NNP
cord-023095-4dannjjm	3947	17	-	-	HYPH
cord-023095-4dannjjm	3947	18	Darby	Darby	NNP
cord-023095-4dannjjm	3947	19	Canine	Canine	NNP
cord-023095-4dannjjm	3947	20	Kidney	kidney	NN
cord-023095-4dannjjm	3947	21	(	(	-LRB-
cord-023095-4dannjjm	3947	22	MDCK	MDCK	NNP
cord-023095-4dannjjm	3947	23	)	)	-RRB-
cord-023095-4dannjjm	3947	24	cells	cell	NNS
cord-023095-4dannjjm	3947	25	for	for	IN
cord-023095-4dannjjm	3947	26	1-hr	1-hr	CD
cord-023095-4dannjjm	3947	27	(	(	-LRB-
cord-023095-4dannjjm	3947	28	35C	35c	NN
cord-023095-4dannjjm	3947	29	)	)	-RRB-
cord-023095-4dannjjm	3947	30	to	to	TO
cord-023095-4dannjjm	3947	31	permit	permit	VB
cord-023095-4dannjjm	3947	32	bacterial	bacterial	JJ
cord-023095-4dannjjm	3947	33	attachment	attachment	NN
cord-023095-4dannjjm	3947	34	.	.	.
cord-023095-4dannjjm	3948	1	After	after	IN
cord-023095-4dannjjm	3948	2	incubation	incubation	NN
cord-023095-4dannjjm	3948	3	,	,	,
cord-023095-4dannjjm	3948	4	plates	plate	NNS
cord-023095-4dannjjm	3948	5	were	be	VBD
cord-023095-4dannjjm	3948	6	washed	wash	VBN
cord-023095-4dannjjm	3948	7	to	to	TO
cord-023095-4dannjjm	3948	8	remove	remove	VB
cord-023095-4dannjjm	3948	9	nonadherent	nonadherent	NN
cord-023095-4dannjjm	3948	10	bacteria	bacteria	NNS
cord-023095-4dannjjm	3948	11	and	and	CC
cord-023095-4dannjjm	3948	12	fresh	fresh	JJ
cord-023095-4dannjjm	3948	13	media	medium	NNS
cord-023095-4dannjjm	3948	14	added	add	VBD
cord-023095-4dannjjm	3948	15	.	.	.
cord-023095-4dannjjm	3949	1	Plates	plate	NNS
cord-023095-4dannjjm	3949	2	were	be	VBD
cord-023095-4dannjjm	3949	3	incubated	incubate	VBN
cord-023095-4dannjjm	3949	4	(	(	-LRB-
cord-023095-4dannjjm	3949	5	35C	35C	NNP
cord-023095-4dannjjm	3949	6	)	)	-RRB-
cord-023095-4dannjjm	3949	7	for	for	IN
cord-023095-4dannjjm	3949	8	4-hr	4-hr	CD
cord-023095-4dannjjm	3949	9	to	to	TO
cord-023095-4dannjjm	3949	10	grow	grow	VB
cord-023095-4dannjjm	3949	11	attached	attach	VBN
cord-023095-4dannjjm	3949	12	bacteria	bacteria	NNS
cord-023095-4dannjjm	3949	13	to	to	IN
cord-023095-4dannjjm	3949	14	detection	detection	NN
cord-023095-4dannjjm	3949	15	level	level	NN
cord-023095-4dannjjm	3949	16	.	.	.
cord-023095-4dannjjm	3950	1	Bacterial	bacterial	JJ
cord-023095-4dannjjm	3950	2	concentration	concentration	NN
cord-023095-4dannjjm	3950	3	in	in	IN
cord-023095-4dannjjm	3950	4	each	each	DT
cord-023095-4dannjjm	3950	5	well	well	NN
cord-023095-4dannjjm	3950	6	was	be	VBD
cord-023095-4dannjjm	3950	7	determined	determine	VBN
cord-023095-4dannjjm	3950	8	using	use	VBG
cord-023095-4dannjjm	3950	9	a	a	DT
cord-023095-4dannjjm	3950	10	spectrophotometer	spectrophotometer	NN
cord-023095-4dannjjm	3950	11	(	(	-LRB-
cord-023095-4dannjjm	3950	12	650	650	CD
cord-023095-4dannjjm	3950	13	nm	nm	NN
cord-023095-4dannjjm	3950	14	)	)	-RRB-
cord-023095-4dannjjm	3950	15	.	.	.
cord-023095-4dannjjm	3951	1	Results	result	NNS
cord-023095-4dannjjm	3951	2	were	be	VBD
cord-023095-4dannjjm	3951	3	analyzed	analyze	VBN
cord-023095-4dannjjm	3951	4	using	use	VBG
cord-023095-4dannjjm	3951	5	the	the	DT
cord-023095-4dannjjm	3951	6	Chi	Chi	NNP
cord-023095-4dannjjm	3951	7	-	-	HYPH
cord-023095-4dannjjm	3951	8	square	square	JJ
cord-023095-4dannjjm	3951	9	test	test	NN
cord-023095-4dannjjm	3951	10	.	.	.
cord-023095-4dannjjm	3952	1	CE	CE	NNP
cord-023095-4dannjjm	3952	2	significantly	significantly	RB
cord-023095-4dannjjm	3952	3	reduced	reduce	VBD
cord-023095-4dannjjm	3952	4	bacterial	bacterial	JJ
cord-023095-4dannjjm	3952	5	adhesion	adhesion	NN
cord-023095-4dannjjm	3952	6	by	by	IN
cord-023095-4dannjjm	3952	7	30	30	CD
cord-023095-4dannjjm	3952	8	%	%	NN
cord-023095-4dannjjm	3952	9	(	(	-LRB-
cord-023095-4dannjjm	3952	10	n	n	NN
cord-023095-4dannjjm	3952	11	5	5	CD
cord-023095-4dannjjm	3952	12	5	5	CD
cord-023095-4dannjjm	3952	13	;	;	:
cord-023095-4dannjjm	3952	14	p	p	CD
cord-023095-4dannjjm	3952	15	0.5	0.5	CD
cord-023095-4dannjjm	3952	16	)	)	-RRB-
cord-023095-4dannjjm	3952	17	in	in	IN
cord-023095-4dannjjm	3952	18	30-DAY	30-day	CD
cord-023095-4dannjjm	3952	19	urine	urine	NN
cord-023095-4dannjjm	3952	20	samples	sample	NNS
cord-023095-4dannjjm	3952	21	compared	compare	VBN
cord-023095-4dannjjm	3952	22	with	with	IN
cord-023095-4dannjjm	3952	23	PRE	pre	JJ
cord-023095-4dannjjm	3952	24	samples	sample	NNS
cord-023095-4dannjjm	3952	25	.	.	.
cord-023095-4dannjjm	3953	1	The	the	DT
cord-023095-4dannjjm	3953	2	results	result	NNS
cord-023095-4dannjjm	3953	3	show	show	VBP
cord-023095-4dannjjm	3953	4	that	that	IN
cord-023095-4dannjjm	3953	5	CE	CE	NNP
cord-023095-4dannjjm	3953	6	supplementation	supplementation	NN
cord-023095-4dannjjm	3953	7	can	can	MD
cord-023095-4dannjjm	3953	8	reduce	reduce	VB
cord-023095-4dannjjm	3953	9	adhesion	adhesion	NN
cord-023095-4dannjjm	3953	10	of	of	IN
cord-023095-4dannjjm	3953	11	uropathogenic	uropathogenic	JJ
cord-023095-4dannjjm	3953	12	E.	E.	NNP
cord-023095-4dannjjm	3953	13	coli	coli	NNS
cord-023095-4dannjjm	3953	14	to	to	IN
cord-023095-4dannjjm	3953	15	canine	canine	JJ
cord-023095-4dannjjm	3953	16	uroepithelium	uroepithelium	NN
cord-023095-4dannjjm	3953	17	and	and	CC
cord-023095-4dannjjm	3953	18	suggests	suggest	VBZ
cord-023095-4dannjjm	3953	19	one	one	CD
cord-023095-4dannjjm	3953	20	mechanism	mechanism	NN
cord-023095-4dannjjm	3953	21	by	by	IN
cord-023095-4dannjjm	3953	22	which	which	WDT
cord-023095-4dannjjm	3953	23	CE	CE	NNP
cord-023095-4dannjjm	3953	24	might	may	MD
cord-023095-4dannjjm	3953	25	improve	improve	VB
cord-023095-4dannjjm	3953	26	urinary	urinary	JJ
cord-023095-4dannjjm	3953	27	tract	tract	NN
cord-023095-4dannjjm	3953	28	health	health	NN
cord-023095-4dannjjm	3953	29	.	.	.
cord-023095-4dannjjm	3954	1	The	the	DT
cord-023095-4dannjjm	3954	2	purpose	purpose	NN
cord-023095-4dannjjm	3954	3	of	of	IN
cord-023095-4dannjjm	3954	4	this	this	DT
cord-023095-4dannjjm	3954	5	study	study	NN
cord-023095-4dannjjm	3954	6	was	be	VBD
cord-023095-4dannjjm	3954	7	to	to	TO
cord-023095-4dannjjm	3954	8	determine	determine	VB
cord-023095-4dannjjm	3954	9	prevalence	prevalence	NN
cord-023095-4dannjjm	3954	10	of	of	IN
cord-023095-4dannjjm	3954	11	4	4	CD
cord-023095-4dannjjm	3954	12	urovirulence	urovirulence	NN
cord-023095-4dannjjm	3954	13	factors	factor	NNS
cord-023095-4dannjjm	3954	14	(	(	-LRB-
cord-023095-4dannjjm	3954	15	UVFs	uvf	NNS
cord-023095-4dannjjm	3954	16	)	)	-RRB-
cord-023095-4dannjjm	3954	17	and	and	CC
cord-023095-4dannjjm	3954	18	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	3954	19	resistance	resistance	NN
cord-023095-4dannjjm	3954	20	in	in	IN
cord-023095-4dannjjm	3954	21	canine	canine	JJ
cord-023095-4dannjjm	3954	22	uropathogenic	uropathogenic	JJ
cord-023095-4dannjjm	3954	23	E.	E.	NNP
cord-023095-4dannjjm	3954	24	coli	coli	NNS
cord-023095-4dannjjm	3954	25	(	(	-LRB-
cord-023095-4dannjjm	3954	26	UPEC	UPEC	NNP
cord-023095-4dannjjm	3954	27	)	)	-RRB-
cord-023095-4dannjjm	3954	28	and	and	CC
cord-023095-4dannjjm	3954	29	to	to	TO
cord-023095-4dannjjm	3954	30	evaluate	evaluate	VB
cord-023095-4dannjjm	3954	31	associations	association	NNS
cord-023095-4dannjjm	3954	32	between	between	IN
cord-023095-4dannjjm	3954	33	UVFs	uvf	NNS
cord-023095-4dannjjm	3954	34	and	and	CC
cord-023095-4dannjjm	3954	35	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	3954	36	resistance	resistance	NN
cord-023095-4dannjjm	3954	37	.	.	.
cord-023095-4dannjjm	3955	1	Two	two	CD
cord-023095-4dannjjm	3955	2	hundred	hundred	CD
cord-023095-4dannjjm	3955	3	and	and	CC
cord-023095-4dannjjm	3955	4	twenty	twenty	CD
cord-023095-4dannjjm	3955	5	-	-	HYPH
cord-023095-4dannjjm	3955	6	one	one	CD
cord-023095-4dannjjm	3955	7	UPEC	UPEC	NNP
cord-023095-4dannjjm	3955	8	isolates	isolate	NNS
cord-023095-4dannjjm	3955	9	from	from	IN
cord-023095-4dannjjm	3955	10	samples	sample	NNS
cord-023095-4dannjjm	3955	11	collected	collect	VBN
cord-023095-4dannjjm	3955	12	from	from	IN
cord-023095-4dannjjm	3955	13	184	184	CD
cord-023095-4dannjjm	3955	14	different	different	JJ
cord-023095-4dannjjm	3955	15	canine	canine	JJ
cord-023095-4dannjjm	3955	16	patients	patient	NNS
cord-023095-4dannjjm	3955	17	submitted	submit	VBN
cord-023095-4dannjjm	3955	18	to	to	IN
cord-023095-4dannjjm	3955	19	The	the	DT
cord-023095-4dannjjm	3955	20	University	University	NNP
cord-023095-4dannjjm	3955	21	of	of	IN
cord-023095-4dannjjm	3955	22	Tennessee	Tennessee	NNP
cord-023095-4dannjjm	3955	23	Microbiology	Microbiology	NNP
cord-023095-4dannjjm	3955	24	Laboratory	Laboratory	NNP
cord-023095-4dannjjm	3955	25	in	in	IN
cord-023095-4dannjjm	3955	26	2007	2007	CD
cord-023095-4dannjjm	3955	27	were	be	VBD
cord-023095-4dannjjm	3955	28	evaluated	evaluate	VBN
cord-023095-4dannjjm	3955	29	.	.	.
cord-023095-4dannjjm	3956	1	A	a	DT
cord-023095-4dannjjm	3956	2	multiplex	multiplex	JJ
cord-023095-4dannjjm	3956	3	PCR	pcr	NN
cord-023095-4dannjjm	3956	4	assay	assay	NN
cord-023095-4dannjjm	3956	5	was	be	VBD
cord-023095-4dannjjm	3956	6	used	use	VBN
cord-023095-4dannjjm	3956	7	to	to	TO
cord-023095-4dannjjm	3956	8	detect	detect	VB
cord-023095-4dannjjm	3956	9	cnf	cnf	NN
cord-023095-4dannjjm	3956	10	,	,	,
cord-023095-4dannjjm	3956	11	hlyD	hlyd	ADD
cord-023095-4dannjjm	3956	12	,	,	,
cord-023095-4dannjjm	3956	13	sfa	sfa	NNP
cord-023095-4dannjjm	3956	14	/	/	SYM
cord-023095-4dannjjm	3956	15	foc	foc	NNP
cord-023095-4dannjjm	3956	16	,	,	,
cord-023095-4dannjjm	3956	17	and	and	CC
cord-023095-4dannjjm	3956	18	papGIII	papGIII	NNPS
cord-023095-4dannjjm	3956	19	in	in	IN
cord-023095-4dannjjm	3956	20	DNA	dna	NN
cord-023095-4dannjjm	3956	21	lysate	lysate	NN
cord-023095-4dannjjm	3956	22	.	.	.
cord-023095-4dannjjm	3957	1	In	in	IN
cord-023095-4dannjjm	3957	2	vitro	vitro	FW
cord-023095-4dannjjm	3957	3	susceptibility	susceptibility	NN
cord-023095-4dannjjm	3957	4	was	be	VBD
cord-023095-4dannjjm	3957	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	3957	6	and	and	CC
cord-023095-4dannjjm	3957	7	if	if	IN
cord-023095-4dannjjm	3957	8	the	the	DT
cord-023095-4dannjjm	3957	9	isolate	isolate	NN
cord-023095-4dannjjm	3957	10	was	be	VBD
cord-023095-4dannjjm	3957	11	resistant	resistant	JJ
cord-023095-4dannjjm	3957	12	to	to	IN
cord-023095-4dannjjm	3957	13	any	any	DT
cord-023095-4dannjjm	3957	14	antimicrobial	antimicrobial	NN
cord-023095-4dannjjm	3957	15	in	in	IN
cord-023095-4dannjjm	3957	16	a	a	DT
cord-023095-4dannjjm	3957	17	class	class	NN
cord-023095-4dannjjm	3957	18	,	,	,
cord-023095-4dannjjm	3957	19	it	-PRON-	PRP
cord-023095-4dannjjm	3957	20	was	be	VBD
cord-023095-4dannjjm	3957	21	considered	consider	VBN
cord-023095-4dannjjm	3957	22	resistant	resistant	JJ
cord-023095-4dannjjm	3957	23	to	to	IN
cord-023095-4dannjjm	3957	24	that	that	DT
cord-023095-4dannjjm	3957	25	class	class	NN
cord-023095-4dannjjm	3957	26	.	.	.
cord-023095-4dannjjm	3958	1	Of	of	IN
cord-023095-4dannjjm	3958	2	the	the	DT
cord-023095-4dannjjm	3958	3	221	221	CD
cord-023095-4dannjjm	3958	4	samples	sample	NNS
cord-023095-4dannjjm	3958	5	,	,	,
cord-023095-4dannjjm	3958	6	the	the	DT
cord-023095-4dannjjm	3958	7	number	number	NN
cord-023095-4dannjjm	3958	8	of	of	IN
cord-023095-4dannjjm	3958	9	UVF	UVF	NNP
cord-023095-4dannjjm	3958	10	expressed	express	VBD
cord-023095-4dannjjm	3958	11	per	per	IN
cord-023095-4dannjjm	3958	12	isolate	isolate	NN
cord-023095-4dannjjm	3958	13	was	be	VBD
cord-023095-4dannjjm	3958	14	:	:	:
cord-023095-4dannjjm	3958	15	0	0	CD
cord-023095-4dannjjm	3958	16	5	5	CD
cord-023095-4dannjjm	3958	17	127/221	127/221	CD
cord-023095-4dannjjm	3958	18	(	(	-LRB-
cord-023095-4dannjjm	3958	19	57	57	CD
cord-023095-4dannjjm	3958	20	%	%	NN
cord-023095-4dannjjm	3958	21	)	)	-RRB-
cord-023095-4dannjjm	3958	22	,	,	,
cord-023095-4dannjjm	3958	23	1	1	CD
cord-023095-4dannjjm	3958	24	5	5	CD
cord-023095-4dannjjm	3958	25	27/221	27/221	CD
cord-023095-4dannjjm	3958	26	(	(	-LRB-
cord-023095-4dannjjm	3958	27	12	12	CD
cord-023095-4dannjjm	3958	28	%	%	NN
cord-023095-4dannjjm	3958	29	)	)	-RRB-
cord-023095-4dannjjm	3958	30	,	,	,
cord-023095-4dannjjm	3958	31	2	2	CD
cord-023095-4dannjjm	3958	32	5	5	CD
cord-023095-4dannjjm	3958	33	4/221	4/221	CD
cord-023095-4dannjjm	3958	34	(	(	-LRB-
cord-023095-4dannjjm	3958	35	2	2	CD
cord-023095-4dannjjm	3958	36	%	%	NN
cord-023095-4dannjjm	3958	37	)	)	-RRB-
cord-023095-4dannjjm	3958	38	,	,	,
cord-023095-4dannjjm	3958	39	3	3	CD
cord-023095-4dannjjm	3958	40	-	-	SYM
cord-023095-4dannjjm	3958	41	22/221	22/221	CD
cord-023095-4dannjjm	3958	42	(	(	-LRB-
cord-023095-4dannjjm	3958	43	10	10	CD
cord-023095-4dannjjm	3958	44	%	%	NN
cord-023095-4dannjjm	3958	45	)	)	-RRB-
cord-023095-4dannjjm	3958	46	,	,	,
cord-023095-4dannjjm	3958	47	and	and	CC
cord-023095-4dannjjm	3958	48	4	4	CD
cord-023095-4dannjjm	3958	49	5	5	CD
cord-023095-4dannjjm	3958	50	41/221	41/221	CD
cord-023095-4dannjjm	3958	51	(	(	-LRB-
cord-023095-4dannjjm	3958	52	19	19	CD
cord-023095-4dannjjm	3958	53	%	%	NN
cord-023095-4dannjjm	3958	54	)	)	-RRB-
cord-023095-4dannjjm	3958	55	.	.	.
cord-023095-4dannjjm	3959	1	Expression	expression	NN
cord-023095-4dannjjm	3959	2	of	of	IN
cord-023095-4dannjjm	3959	3	UVF	UVF	NNP
cord-023095-4dannjjm	3959	4	was	be	VBD
cord-023095-4dannjjm	3959	5	sfa	sfa	NNP
cord-023095-4dannjjm	3959	6	(	(	-LRB-
cord-023095-4dannjjm	3959	7	33	33	CD
cord-023095-4dannjjm	3959	8	%	%	NN
cord-023095-4dannjjm	3959	9	)	)	-RRB-
cord-023095-4dannjjm	3959	10	,	,	,
cord-023095-4dannjjm	3959	11	hly	hly	NNP
cord-023095-4dannjjm	3959	12	(	(	-LRB-
cord-023095-4dannjjm	3959	13	24	24	CD
cord-023095-4dannjjm	3959	14	%	%	NN
cord-023095-4dannjjm	3959	15	)	)	-RRB-
cord-023095-4dannjjm	3959	16	,	,	,
cord-023095-4dannjjm	3959	17	cnf	cnf	FW
cord-023095-4dannjjm	3959	18	(	(	-LRB-
cord-023095-4dannjjm	3959	19	24	24	CD
cord-023095-4dannjjm	3959	20	%	%	NN
cord-023095-4dannjjm	3959	21	)	)	-RRB-
cord-023095-4dannjjm	3959	22	,	,	,
cord-023095-4dannjjm	3959	23	and	and	CC
cord-023095-4dannjjm	3959	24	pap	pap	NN
cord-023095-4dannjjm	3959	25	(	(	-LRB-
cord-023095-4dannjjm	3959	26	19	19	CD
cord-023095-4dannjjm	3959	27	%	%	NN
cord-023095-4dannjjm	3959	28	)	)	-RRB-
cord-023095-4dannjjm	3959	29	.	.	.
cord-023095-4dannjjm	3960	1	Presence	presence	NN
cord-023095-4dannjjm	3960	2	of	of	IN
cord-023095-4dannjjm	3960	3	4	4	CD
cord-023095-4dannjjm	3960	4	UVFs	uvf	NNS
cord-023095-4dannjjm	3960	5	was	be	VBD
cord-023095-4dannjjm	3960	6	associated	associate	VBN
cord-023095-4dannjjm	3960	7	with	with	IN
cord-023095-4dannjjm	3960	8	less	less	JJR
cord-023095-4dannjjm	3960	9	resistance	resistance	NN
cord-023095-4dannjjm	3960	10	(	(	-LRB-
cord-023095-4dannjjm	3960	11	p	p	NN
cord-023095-4dannjjm	3960	12	o	o	NN
cord-023095-4dannjjm	3960	13	0.0001	0.0001	CD
cord-023095-4dannjjm	3960	14	)	)	-RRB-
cord-023095-4dannjjm	3960	15	.	.	.
cord-023095-4dannjjm	3961	1	The	the	DT
cord-023095-4dannjjm	3961	2	combination	combination	NN
cord-023095-4dannjjm	3961	3	of	of	IN
cord-023095-4dannjjm	3961	4	hly	hly	NNP
cord-023095-4dannjjm	3961	5	,	,	,
cord-023095-4dannjjm	3961	6	cnf	cnf	NN
cord-023095-4dannjjm	3961	7	,	,	,
cord-023095-4dannjjm	3961	8	and	and	CC
cord-023095-4dannjjm	3961	9	sfa	sfa	NNP
cord-023095-4dannjjm	3961	10	was	be	VBD
cord-023095-4dannjjm	3961	11	associated	associate	VBN
cord-023095-4dannjjm	3961	12	with	with	IN
cord-023095-4dannjjm	3961	13	less	less	JJR
cord-023095-4dannjjm	3961	14	resistance	resistance	NN
cord-023095-4dannjjm	3961	15	(	(	-LRB-
cord-023095-4dannjjm	3961	16	p	p	NN
cord-023095-4dannjjm	3961	17	o	o	NN
cord-023095-4dannjjm	3961	18	0.0001	0.0001	CD
cord-023095-4dannjjm	3961	19	)	)	-RRB-
cord-023095-4dannjjm	3961	20	.	.	.
cord-023095-4dannjjm	3962	1	When	when	WRB
cord-023095-4dannjjm	3962	2	sfa	sfa	NNP
cord-023095-4dannjjm	3962	3	was	be	VBD
cord-023095-4dannjjm	3962	4	present	present	JJ
cord-023095-4dannjjm	3962	5	alone	alone	RB
cord-023095-4dannjjm	3962	6	,	,	,
cord-023095-4dannjjm	3962	7	resistance	resistance	NN
cord-023095-4dannjjm	3962	8	was	be	VBD
cord-023095-4dannjjm	3962	9	less	less	JJR
cord-023095-4dannjjm	3962	10	(	(	-LRB-
cord-023095-4dannjjm	3962	11	p	p	NN
cord-023095-4dannjjm	3962	12	o	o	NN
cord-023095-4dannjjm	3962	13	0.0001	0.0001	CD
cord-023095-4dannjjm	3962	14	)	)	-RRB-
cord-023095-4dannjjm	3962	15	.	.	.
cord-023095-4dannjjm	3963	1	Average	average	JJ
cord-023095-4dannjjm	3963	2	resistance	resistance	NN
cord-023095-4dannjjm	3963	3	to	to	IN
cord-023095-4dannjjm	3963	4	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	3963	5	class	class	NN
cord-023095-4dannjjm	3963	6	by	by	IN
cord-023095-4dannjjm	3963	7	number	number	NN
cord-023095-4dannjjm	3963	8	of	of	IN
cord-023095-4dannjjm	3963	9	UVFexpressed	UVFexpressed	NNP
cord-023095-4dannjjm	3963	10	was	be	VBD
cord-023095-4dannjjm	3963	11	:	:	:
cord-023095-4dannjjm	3963	12	0	0	NFP
cord-023095-4dannjjm	3963	13	UVF	UVF	NNP
cord-023095-4dannjjm	3963	14	5	5	CD
cord-023095-4dannjjm	3963	15	4.1	4.1	CD
cord-023095-4dannjjm	3963	16	AE	AE	NNP
cord-023095-4dannjjm	3963	17	3.3	3.3	CD
cord-023095-4dannjjm	3963	18	classes	class	NNS
cord-023095-4dannjjm	3963	19	,	,	,
cord-023095-4dannjjm	3963	20	1	1	CD
cord-023095-4dannjjm	3963	21	UVF	UVF	NNP
cord-023095-4dannjjm	3963	22	5	5	CD
cord-023095-4dannjjm	3963	23	1.2	1.2	CD
cord-023095-4dannjjm	3963	24	AE	AE	NNP
cord-023095-4dannjjm	3963	25	1.1	1.1	CD
cord-023095-4dannjjm	3963	26	classes	class	NNS
cord-023095-4dannjjm	3963	27	,	,	,
cord-023095-4dannjjm	3963	28	2	2	CD
cord-023095-4dannjjm	3963	29	UVF	UVF	NNP
cord-023095-4dannjjm	3963	30	5	5	CD
cord-023095-4dannjjm	3963	31	0.0	0.0	CD
cord-023095-4dannjjm	3963	32	AE	AE	NNP
cord-023095-4dannjjm	3963	33	0.0	0.0	CD
cord-023095-4dannjjm	3963	34	classes	class	NNS
cord-023095-4dannjjm	3963	35	,	,	,
cord-023095-4dannjjm	3963	36	3	3	CD
cord-023095-4dannjjm	3963	37	UVF	UVF	NNP
cord-023095-4dannjjm	3963	38	5	5	CD
cord-023095-4dannjjm	3963	39	0.8	0.8	CD
cord-023095-4dannjjm	3963	40	AE	AE	NNP
cord-023095-4dannjjm	3963	41	1.6	1.6	CD
cord-023095-4dannjjm	3963	42	classes	class	NNS
cord-023095-4dannjjm	3963	43	,	,	,
cord-023095-4dannjjm	3963	44	and	and	CC
cord-023095-4dannjjm	3963	45	4	4	CD
cord-023095-4dannjjm	3963	46	UVF	UVF	NNP
cord-023095-4dannjjm	3963	47	5	5	CD
cord-023095-4dannjjm	3963	48	0.5	0.5	CD
cord-023095-4dannjjm	3963	49	AE	AE	NNP
cord-023095-4dannjjm	3963	50	1.2	1.2	CD
cord-023095-4dannjjm	3963	51	classes	class	NNS
cord-023095-4dannjjm	3963	52	.	.	.
cord-023095-4dannjjm	3964	1	Urovirulence	Urovirulence	NNP
cord-023095-4dannjjm	3964	2	factors	factor	NNS
cord-023095-4dannjjm	3964	3	were	be	VBD
cord-023095-4dannjjm	3964	4	present	present	JJ
cord-023095-4dannjjm	3964	5	in	in	IN
cord-023095-4dannjjm	3964	6	a	a	DT
cord-023095-4dannjjm	3964	7	moderate	moderate	JJ
cord-023095-4dannjjm	3964	8	number	number	NN
cord-023095-4dannjjm	3964	9	of	of	IN
cord-023095-4dannjjm	3964	10	UPEC	UPEC	NNP
cord-023095-4dannjjm	3964	11	and	and	CC
cord-023095-4dannjjm	3964	12	correlated	correlate	VBN
cord-023095-4dannjjm	3964	13	negatively	negatively	RB
cord-023095-4dannjjm	3964	14	with	with	IN
cord-023095-4dannjjm	3964	15	resistance	resistance	NN
cord-023095-4dannjjm	3964	16	.	.	.
cord-023095-4dannjjm	3965	1	Neither	neither	DT
cord-023095-4dannjjm	3965	2	individual	individual	JJ
cord-023095-4dannjjm	3965	3	nor	nor	CC
cord-023095-4dannjjm	3965	4	combinations	combination	NNS
cord-023095-4dannjjm	3965	5	of	of	IN
cord-023095-4dannjjm	3965	6	UVFs	uvf	NNS
cord-023095-4dannjjm	3965	7	were	be	VBD
cord-023095-4dannjjm	3965	8	associated	associate	VBN
cord-023095-4dannjjm	3965	9	with	with	IN
cord-023095-4dannjjm	3965	10	increased	increase	VBN
cord-023095-4dannjjm	3965	11	resistance	resistance	NN
cord-023095-4dannjjm	3965	12	.	.	.
cord-023095-4dannjjm	3966	1	Obesity	obesity	NN
cord-023095-4dannjjm	3966	2	is	be	VBZ
cord-023095-4dannjjm	3966	3	associated	associate	VBN
cord-023095-4dannjjm	3966	4	with	with	IN
cord-023095-4dannjjm	3966	5	several	several	JJ
cord-023095-4dannjjm	3966	6	comorbidities	comorbiditie	NNS
cord-023095-4dannjjm	3966	7	in	in	IN
cord-023095-4dannjjm	3966	8	dogs	dog	NNS
cord-023095-4dannjjm	3966	9	including	include	VBG
cord-023095-4dannjjm	3966	10	pancreatitis	pancreatitis	NN
cord-023095-4dannjjm	3966	11	,	,	,
cord-023095-4dannjjm	3966	12	osteoarthritis	osteoarthritis	NN
cord-023095-4dannjjm	3966	13	,	,	,
cord-023095-4dannjjm	3966	14	oral	oral	JJ
cord-023095-4dannjjm	3966	15	disease	disease	NN
cord-023095-4dannjjm	3966	16	,	,	,
cord-023095-4dannjjm	3966	17	neoplasia	neoplasia	NN
cord-023095-4dannjjm	3966	18	,	,	,
cord-023095-4dannjjm	3966	19	and	and	CC
cord-023095-4dannjjm	3966	20	lower	low	JJR
cord-023095-4dannjjm	3966	21	urinary	urinary	JJ
cord-023095-4dannjjm	3966	22	tract	tract	NN
cord-023095-4dannjjm	3966	23	disease	disease	NN
cord-023095-4dannjjm	3966	24	.	.	.
cord-023095-4dannjjm	3967	1	Investigator	investigator	NN
cord-023095-4dannjjm	3967	2	observations	observation	NNS
cord-023095-4dannjjm	3967	3	led	lead	VBD
cord-023095-4dannjjm	3967	4	to	to	IN
cord-023095-4dannjjm	3967	5	the	the	DT
cord-023095-4dannjjm	3967	6	hypothesis	hypothesis	NN
cord-023095-4dannjjm	3967	7	that	that	IN
cord-023095-4dannjjm	3967	8	morbidly	morbidly	RB
cord-023095-4dannjjm	3967	9	obese	obese	JJ
cord-023095-4dannjjm	3967	10	dogs	dog	NNS
cord-023095-4dannjjm	3967	11	are	be	VBP
cord-023095-4dannjjm	3967	12	more	more	RBR
cord-023095-4dannjjm	3967	13	likely	likely	JJ
cord-023095-4dannjjm	3967	14	to	to	TO
cord-023095-4dannjjm	3967	15	have	have	VB
cord-023095-4dannjjm	3967	16	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	3967	17	bacterial	bacterial	JJ
cord-023095-4dannjjm	3967	18	urinary	urinary	JJ
cord-023095-4dannjjm	3967	19	tract	tract	NN
cord-023095-4dannjjm	3967	20	infections	infection	NNS
cord-023095-4dannjjm	3967	21	(	(	-LRB-
cord-023095-4dannjjm	3967	22	ABUTI	ABUTI	NNP
cord-023095-4dannjjm	3967	23	)	)	-RRB-
cord-023095-4dannjjm	3967	24	than	than	IN
cord-023095-4dannjjm	3967	25	overweight	overweight	JJ
cord-023095-4dannjjm	3967	26	and	and	CC
cord-023095-4dannjjm	3967	27	moderately	moderately	RB
cord-023095-4dannjjm	3967	28	obese	obese	JJ
cord-023095-4dannjjm	3967	29	dogs	dog	NNS
cord-023095-4dannjjm	3967	30	.	.	.
cord-023095-4dannjjm	3968	1	Therefore	therefore	RB
cord-023095-4dannjjm	3968	2	,	,	,
cord-023095-4dannjjm	3968	3	a	a	DT
cord-023095-4dannjjm	3968	4	pilot	pilot	NN
cord-023095-4dannjjm	3968	5	study	study	NN
cord-023095-4dannjjm	3968	6	was	be	VBD
cord-023095-4dannjjm	3968	7	conducted	conduct	VBN
cord-023095-4dannjjm	3968	8	to	to	TO
cord-023095-4dannjjm	3968	9	screen	screen	VB
cord-023095-4dannjjm	3968	10	for	for	IN
cord-023095-4dannjjm	3968	11	ABUTI	ABUTI	NNP
cord-023095-4dannjjm	3968	12	in	in	IN
cord-023095-4dannjjm	3968	13	obese	obese	JJ
cord-023095-4dannjjm	3968	14	dogs	dog	NNS
cord-023095-4dannjjm	3968	15	.	.	.
cord-023095-4dannjjm	3969	1	Urinalysis	urinalysis	NN
cord-023095-4dannjjm	3969	2	with	with	IN
cord-023095-4dannjjm	3969	3	urine	urine	NN
cord-023095-4dannjjm	3969	4	culture	culture	NN
cord-023095-4dannjjm	3969	5	and	and	CC
cord-023095-4dannjjm	3969	6	dual	dual	JJ
cord-023095-4dannjjm	3969	7	energy	energy	NN
cord-023095-4dannjjm	3969	8	x	x	NN
cord-023095-4dannjjm	3969	9	-	-	NN
cord-023095-4dannjjm	3969	10	ray	ray	NNP
cord-023095-4dannjjm	3969	11	absorptiometry	absorptiometry	NN
cord-023095-4dannjjm	3969	12	(	(	-LRB-
cord-023095-4dannjjm	3969	13	DXA	DXA	NNP
cord-023095-4dannjjm	3969	14	)	)	-RRB-
cord-023095-4dannjjm	3969	15	were	be	VBD
cord-023095-4dannjjm	3969	16	performed	perform	VBN
cord-023095-4dannjjm	3969	17	on	on	IN
cord-023095-4dannjjm	3969	18	fortythree	fortythree	JJ
cord-023095-4dannjjm	3969	19	dogs	dog	NNS
cord-023095-4dannjjm	3969	20	with	with	IN
cord-023095-4dannjjm	3969	21	body	body	NN
cord-023095-4dannjjm	3969	22	fat	fat	NN
cord-023095-4dannjjm	3969	23	(	(	-LRB-
cord-023095-4dannjjm	3969	24	BF	bf	NN
cord-023095-4dannjjm	3969	25	)	)	-RRB-
cord-023095-4dannjjm	3969	26	percentages	percentage	NNS
cord-023095-4dannjjm	3969	27	ranging	range	VBG
cord-023095-4dannjjm	3969	28	from	from	IN
cord-023095-4dannjjm	3969	29	36	36	CD
cord-023095-4dannjjm	3969	30	to	to	TO
cord-023095-4dannjjm	3969	31	56	56	CD
cord-023095-4dannjjm	3969	32	%	%	NN
cord-023095-4dannjjm	3969	33	.	.	.
cord-023095-4dannjjm	3970	1	Following	follow	VBG
cord-023095-4dannjjm	3970	2	DXA	DXA	NNP
cord-023095-4dannjjm	3970	3	,	,	,
cord-023095-4dannjjm	3970	4	subjects	subject	NNS
cord-023095-4dannjjm	3970	5	were	be	VBD
cord-023095-4dannjjm	3970	6	categorized	categorize	VBN
cord-023095-4dannjjm	3970	7	as	as	IN
cord-023095-4dannjjm	3970	8	obese	obese	JJ
cord-023095-4dannjjm	3970	9	(	(	-LRB-
cord-023095-4dannjjm	3970	10	O)(BF	o)(bf	VB
cord-023095-4dannjjm	3970	11	5	5	CD
cord-023095-4dannjjm	3970	12	35	35	CD
cord-023095-4dannjjm	3970	13	-	-	SYM
cord-023095-4dannjjm	3970	14	44	44	CD
cord-023095-4dannjjm	3970	15	%	%	NN
cord-023095-4dannjjm	3970	16	,	,	,
cord-023095-4dannjjm	3970	17	n	n	NN
cord-023095-4dannjjm	3970	18	5	5	CD
cord-023095-4dannjjm	3970	19	17	17	CD
cord-023095-4dannjjm	3970	20	)	)	-RRB-
cord-023095-4dannjjm	3970	21	and	and	CC
cord-023095-4dannjjm	3970	22	morbidly	morbidly	RB
cord-023095-4dannjjm	3970	23	obese	obese	JJ
cord-023095-4dannjjm	3970	24	(	(	-LRB-
cord-023095-4dannjjm	3970	25	MO)(BF	MO)(BF	NNS
cord-023095-4dannjjm	3970	26	4	4	CD
cord-023095-4dannjjm	3970	27	45	45	CD
cord-023095-4dannjjm	3970	28	%	%	NN
cord-023095-4dannjjm	3970	29	,	,	,
cord-023095-4dannjjm	3970	30	n	n	NN
cord-023095-4dannjjm	3970	31	5	5	CD
cord-023095-4dannjjm	3970	32	26	26	CD
cord-023095-4dannjjm	3970	33	)	)	-RRB-
cord-023095-4dannjjm	3970	34	.	.	.
cord-023095-4dannjjm	3971	1	No	no	DT
cord-023095-4dannjjm	3971	2	dogs	dog	NNS
cord-023095-4dannjjm	3971	3	had	have	VBD
cord-023095-4dannjjm	3971	4	owner	owner	NN
cord-023095-4dannjjm	3971	5	-	-	HYPH
cord-023095-4dannjjm	3971	6	reported	report	VBN
cord-023095-4dannjjm	3971	7	symptoms	symptom	NNS
cord-023095-4dannjjm	3971	8	indicative	indicative	JJ
cord-023095-4dannjjm	3971	9	of	of	IN
cord-023095-4dannjjm	3971	10	UTI	UTI	NNP
cord-023095-4dannjjm	3971	11	.	.	.
cord-023095-4dannjjm	3972	1	The	the	DT
cord-023095-4dannjjm	3972	2	prevalence	prevalence	NN
cord-023095-4dannjjm	3972	3	of	of	IN
cord-023095-4dannjjm	3972	4	ABUTI	ABUTI	NNP
cord-023095-4dannjjm	3972	5	in	in	IN
cord-023095-4dannjjm	3972	6	O	o	NN
cord-023095-4dannjjm	3972	7	dogs	dog	NNS
cord-023095-4dannjjm	3972	8	was	be	VBD
cord-023095-4dannjjm	3972	9	6	6	CD
cord-023095-4dannjjm	3972	10	%	%	NN
cord-023095-4dannjjm	3972	11	(	(	-LRB-
cord-023095-4dannjjm	3972	12	n	n	NN
cord-023095-4dannjjm	3972	13	5	5	CD
cord-023095-4dannjjm	3972	14	1	1	CD
cord-023095-4dannjjm	3972	15	)	)	-RRB-
cord-023095-4dannjjm	3972	16	and	and	CC
cord-023095-4dannjjm	3972	17	31	31	CD
cord-023095-4dannjjm	3972	18	%	%	NN
cord-023095-4dannjjm	3972	19	(	(	-LRB-
cord-023095-4dannjjm	3972	20	n	n	NN
cord-023095-4dannjjm	3972	21	5	5	CD
cord-023095-4dannjjm	3972	22	8)	8)	NN
cord-023095-4dannjjm	3972	23	in	in	IN
cord-023095-4dannjjm	3972	24	MO	MO	NNP
cord-023095-4dannjjm	3972	25	dogs	dog	NNS
cord-023095-4dannjjm	3972	26	.	.	.
cord-023095-4dannjjm	3973	1	The	the	DT
cord-023095-4dannjjm	3973	2	dog	dog	NN
cord-023095-4dannjjm	3973	3	in	in	IN
cord-023095-4dannjjm	3973	4	the	the	DT
cord-023095-4dannjjm	3973	5	O	o	NN
cord-023095-4dannjjm	3973	6	group	group	NN
cord-023095-4dannjjm	3973	7	with	with	IN
cord-023095-4dannjjm	3973	8	ABUTI	ABUTI	NNP
cord-023095-4dannjjm	3973	9	was	be	VBD
cord-023095-4dannjjm	3973	10	close	close	JJ
cord-023095-4dannjjm	3973	11	to	to	IN
cord-023095-4dannjjm	3973	12	being	be	VBG
cord-023095-4dannjjm	3973	13	MO	MO	NNP
cord-023095-4dannjjm	3973	14	with	with	IN
cord-023095-4dannjjm	3973	15	a	a	DT
cord-023095-4dannjjm	3973	16	BF	bf	NN
cord-023095-4dannjjm	3973	17	equaling	equal	VBG
cord-023095-4dannjjm	3973	18	44.3	44.3	CD
cord-023095-4dannjjm	3973	19	%	%	NN
cord-023095-4dannjjm	3973	20	.	.	.
cord-023095-4dannjjm	3974	1	Of	of	IN
cord-023095-4dannjjm	3974	2	the	the	DT
cord-023095-4dannjjm	3974	3	nine	nine	CD
cord-023095-4dannjjm	3974	4	dogs	dog	NNS
cord-023095-4dannjjm	3974	5	with	with	IN
cord-023095-4dannjjm	3974	6	positive	positive	JJ
cord-023095-4dannjjm	3974	7	cultures	culture	NNS
cord-023095-4dannjjm	3974	8	,	,	,
cord-023095-4dannjjm	3974	9	4	4	CD
cord-023095-4dannjjm	3974	10	were	be	VBD
cord-023095-4dannjjm	3974	11	neutered	neuter	VBN
cord-023095-4dannjjm	3974	12	males	male	NNS
cord-023095-4dannjjm	3974	13	and	and	CC
cord-023095-4dannjjm	3974	14	5	5	CD
cord-023095-4dannjjm	3974	15	were	be	VBD
cord-023095-4dannjjm	3974	16	spayed	spay	VBN
cord-023095-4dannjjm	3974	17	females	female	NNS
cord-023095-4dannjjm	3974	18	.	.	.
cord-023095-4dannjjm	3975	1	The	the	DT
cord-023095-4dannjjm	3975	2	prevalence	prevalence	NN
cord-023095-4dannjjm	3975	3	ratio	ratio	NN
cord-023095-4dannjjm	3975	4	of	of	IN
cord-023095-4dannjjm	3975	5	ABUTI	ABUTI	NNP
cord-023095-4dannjjm	3975	6	in	in	IN
cord-023095-4dannjjm	3975	7	MO	MO	NNP
cord-023095-4dannjjm	3975	8	dogs	dog	NNS
cord-023095-4dannjjm	3975	9	was	be	VBD
cord-023095-4dannjjm	3975	10	7.5	7.5	CD
cord-023095-4dannjjm	3975	11	,	,	,
cord-023095-4dannjjm	3975	12	indicating	indicate	VBG
cord-023095-4dannjjm	3975	13	dogs	dog	NNS
cord-023095-4dannjjm	3975	14	with	with	IN
cord-023095-4dannjjm	3975	15	45	45	CD
cord-023095-4dannjjm	3975	16	%	%	NN
cord-023095-4dannjjm	3975	17	or	or	CC
cord-023095-4dannjjm	3975	18	greater	great	JJR
cord-023095-4dannjjm	3975	19	BF	bf	NN
cord-023095-4dannjjm	3975	20	are	be	VBP
cord-023095-4dannjjm	3975	21	7.5	7.5	CD
cord-023095-4dannjjm	3975	22	times	time	NNS
cord-023095-4dannjjm	3975	23	more	more	RBR
cord-023095-4dannjjm	3975	24	likely	likely	JJ
cord-023095-4dannjjm	3975	25	to	to	TO
cord-023095-4dannjjm	3975	26	have	have	VB
cord-023095-4dannjjm	3975	27	the	the	DT
cord-023095-4dannjjm	3975	28	condition	condition	NN
cord-023095-4dannjjm	3975	29	then	then	RB
cord-023095-4dannjjm	3975	30	dogs	dog	VBZ
cord-023095-4dannjjm	3975	31	o	o	CD
cord-023095-4dannjjm	3975	32	45	45	CD
cord-023095-4dannjjm	3975	33	%	%	NN
cord-023095-4dannjjm	3975	34	BF	bf	NN
cord-023095-4dannjjm	3975	35	.	.	.
cord-023095-4dannjjm	3976	1	The	the	DT
cord-023095-4dannjjm	3976	2	results	result	NNS
cord-023095-4dannjjm	3976	3	of	of	IN
cord-023095-4dannjjm	3976	4	this	this	DT
cord-023095-4dannjjm	3976	5	pilot	pilot	NN
cord-023095-4dannjjm	3976	6	study	study	NN
cord-023095-4dannjjm	3976	7	coincide	coincide	VB
cord-023095-4dannjjm	3976	8	with	with	IN
cord-023095-4dannjjm	3976	9	other	other	JJ
cord-023095-4dannjjm	3976	10	surveillance	surveillance	NN
cord-023095-4dannjjm	3976	11	data	datum	NNS
cord-023095-4dannjjm	3976	12	describing	describe	VBG
cord-023095-4dannjjm	3976	13	an	an	DT
cord-023095-4dannjjm	3976	14	increased	increase	VBN
cord-023095-4dannjjm	3976	15	prevalence	prevalence	NN
cord-023095-4dannjjm	3976	16	of	of	IN
cord-023095-4dannjjm	3976	17	lower	low	JJR
cord-023095-4dannjjm	3976	18	urinary	urinary	JJ
cord-023095-4dannjjm	3976	19	tract	tract	NN
cord-023095-4dannjjm	3976	20	disease	disease	NN
cord-023095-4dannjjm	3976	21	in	in	IN
cord-023095-4dannjjm	3976	22	obese	obese	JJ
cord-023095-4dannjjm	3976	23	dogs	dog	NNS
cord-023095-4dannjjm	3976	24	.	.	.
cord-023095-4dannjjm	3977	1	In	in	IN
cord-023095-4dannjjm	3977	2	conclusion	conclusion	NN
cord-023095-4dannjjm	3977	3	,	,	,
cord-023095-4dannjjm	3977	4	dogs	dog	NNS
cord-023095-4dannjjm	3977	5	with	with	IN
cord-023095-4dannjjm	3977	6	body	body	NN
cord-023095-4dannjjm	3977	7	fat	fat	NN
cord-023095-4dannjjm	3977	8	percentages	percentage	NNS
cord-023095-4dannjjm	3977	9	greater	great	JJR
cord-023095-4dannjjm	3977	10	than	than	IN
cord-023095-4dannjjm	3977	11	45	45	CD
cord-023095-4dannjjm	3977	12	%	%	NN
cord-023095-4dannjjm	3977	13	are	be	VBP
cord-023095-4dannjjm	3977	14	at	at	IN
cord-023095-4dannjjm	3977	15	risk	risk	NN
cord-023095-4dannjjm	3977	16	for	for	IN
cord-023095-4dannjjm	3977	17	ABUTI	ABUTI	NNP
cord-023095-4dannjjm	3977	18	,	,	,
cord-023095-4dannjjm	3977	19	and	and	CC
cord-023095-4dannjjm	3977	20	veterinarians	veterinarian	NNS
cord-023095-4dannjjm	3977	21	should	should	MD
cord-023095-4dannjjm	3977	22	consider	consider	VB
cord-023095-4dannjjm	3977	23	screening	screen	VBG
cord-023095-4dannjjm	3977	24	all	all	DT
cord-023095-4dannjjm	3977	25	morbidly	morbidly	RB
cord-023095-4dannjjm	3977	26	obese	obese	JJ
cord-023095-4dannjjm	3977	27	patients	patient	NNS
cord-023095-4dannjjm	3977	28	for	for	IN
cord-023095-4dannjjm	3977	29	urinary	urinary	JJ
cord-023095-4dannjjm	3977	30	tract	tract	JJ
cord-023095-4dannjjm	3977	31	infections	infection	NNS
cord-023095-4dannjjm	3977	32	.	.	.
cord-023095-4dannjjm	3978	1	Calcium	calcium	NN
cord-023095-4dannjjm	3978	2	carbonate	carbonate	NN
cord-023095-4dannjjm	3978	3	(	(	-LRB-
cord-023095-4dannjjm	3978	4	CaC	CaC	NNP
cord-023095-4dannjjm	3978	5	)	)	-RRB-
cord-023095-4dannjjm	3978	6	is	be	VBZ
cord-023095-4dannjjm	3978	7	recommended	recommend	VBN
cord-023095-4dannjjm	3978	8	to	to	TO
cord-023095-4dannjjm	3978	9	decrease	decrease	VB
cord-023095-4dannjjm	3978	10	phosphate	phosphate	NN
cord-023095-4dannjjm	3978	11	intake	intake	NN
cord-023095-4dannjjm	3978	12	in	in	IN
cord-023095-4dannjjm	3978	13	chronic	chronic	JJ
cord-023095-4dannjjm	3978	14	kidney	kidney	NN
cord-023095-4dannjjm	3978	15	disease	disease	NN
cord-023095-4dannjjm	3978	16	.	.	.
cord-023095-4dannjjm	3979	1	However	however	RB
cord-023095-4dannjjm	3979	2	,	,	,
cord-023095-4dannjjm	3979	3	its	-PRON-	PRP$
cord-023095-4dannjjm	3979	4	effect	effect	NN
cord-023095-4dannjjm	3979	5	is	be	VBZ
cord-023095-4dannjjm	3979	6	poorly	poorly	RB
cord-023095-4dannjjm	3979	7	documented	document	VBN
cord-023095-4dannjjm	3979	8	in	in	IN
cord-023095-4dannjjm	3979	9	dogs	dog	NNS
cord-023095-4dannjjm	3979	10	.	.	.
cord-023095-4dannjjm	3980	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	3980	2	objectives	objective	NNS
cord-023095-4dannjjm	3980	3	were	be	VBD
cord-023095-4dannjjm	3980	4	to	to	TO
cord-023095-4dannjjm	3980	5	assess	assess	VB
cord-023095-4dannjjm	3980	6	within	within	IN
cord-023095-4dannjjm	3980	7	-	-	HYPH
cord-023095-4dannjjm	3980	8	day	day	NN
cord-023095-4dannjjm	3980	9	,	,	,
cord-023095-4dannjjm	3980	10	postprandial	postprandial	JJ
cord-023095-4dannjjm	3980	11	and	and	CC
cord-023095-4dannjjm	3980	12	CaC	CaC	NNP
cord-023095-4dannjjm	3980	13	effects	effect	NNS
cord-023095-4dannjjm	3980	14	on	on	IN
cord-023095-4dannjjm	3980	15	phosphatemia	phosphatemia	NN
cord-023095-4dannjjm	3980	16	variations	variation	NNS
cord-023095-4dannjjm	3980	17	in	in	IN
cord-023095-4dannjjm	3980	18	healthy	healthy	JJ
cord-023095-4dannjjm	3980	19	dogs	dog	NNS
cord-023095-4dannjjm	3980	20	.	.	.
cord-023095-4dannjjm	3981	1	Phosphatemia	Phosphatemia	NNP
cord-023095-4dannjjm	3981	2	was	be	VBD
cord-023095-4dannjjm	3981	3	measured	measure	VBN
cord-023095-4dannjjm	3981	4	every	every	DT
cord-023095-4dannjjm	3981	5	2	2	CD
cord-023095-4dannjjm	3981	6	hours	hour	NNS
cord-023095-4dannjjm	3981	7	for	for	IN
cord-023095-4dannjjm	3981	8	24	24	CD
cord-023095-4dannjjm	3981	9	hours	hour	NNS
cord-023095-4dannjjm	3981	10	in	in	IN
cord-023095-4dannjjm	3981	11	eight	eight	CD
cord-023095-4dannjjm	3981	12	adult	adult	NN
cord-023095-4dannjjm	3981	13	healthy	healthy	JJ
cord-023095-4dannjjm	3981	14	Beagle	Beagle	NNP
cord-023095-4dannjjm	3981	15	dogs	dog	NNS
cord-023095-4dannjjm	3981	16	in	in	IN
cord-023095-4dannjjm	3981	17	i	i	NN
cord-023095-4dannjjm	3981	18	)	)	-RRB-
cord-023095-4dannjjm	3981	19	fasted	fast	VBN
cord-023095-4dannjjm	3981	20	condition	condition	NN
cord-023095-4dannjjm	3981	21	and	and	CC
cord-023095-4dannjjm	3981	22	ii	ii	LS
cord-023095-4dannjjm	3981	23	)	)	-RRB-
cord-023095-4dannjjm	3981	24	a	a	DT
cord-023095-4dannjjm	3981	25	2	2	CD
cord-023095-4dannjjm	3981	26	Â	â	CD
cord-023095-4dannjjm	3981	27	2	2	CD
cord-023095-4dannjjm	3981	28	crossover	crossover	NN
cord-023095-4dannjjm	3981	29	design	design	NN
cord-023095-4dannjjm	3981	30	.	.	.
cord-023095-4dannjjm	3982	1	One	one	CD
cord-023095-4dannjjm	3982	2	group	group	NN
cord-023095-4dannjjm	3982	3	received	receive	VBD
cord-023095-4dannjjm	3982	4	CaC	CaC	NNP
cord-023095-4dannjjm	3982	5	mixed	mix	VBN
cord-023095-4dannjjm	3982	6	with	with	IN
cord-023095-4dannjjm	3982	7	maintenance	maintenance	NN
cord-023095-4dannjjm	3982	8	diet	diet	NN
cord-023095-4dannjjm	3982	9	(	(	-LRB-
cord-023095-4dannjjm	3982	10	0.8	0.8	CD
cord-023095-4dannjjm	3982	11	%	%	NN
cord-023095-4dannjjm	3982	12	phosphorus	phosphorus	NN
cord-023095-4dannjjm	3982	13	)	)	-RRB-
cord-023095-4dannjjm	3982	14	,	,	,
cord-023095-4dannjjm	3982	15	while	while	IN
cord-023095-4dannjjm	3982	16	the	the	DT
cord-023095-4dannjjm	3982	17	second	second	JJ
cord-023095-4dannjjm	3982	18	group	group	NN
cord-023095-4dannjjm	3982	19	received	receive	VBD
cord-023095-4dannjjm	3982	20	the	the	DT
cord-023095-4dannjjm	3982	21	diet	diet	NN
cord-023095-4dannjjm	3982	22	alone	alone	RB
cord-023095-4dannjjm	3982	23	.	.	.
cord-023095-4dannjjm	3983	1	After	after	IN
cord-023095-4dannjjm	3983	2	a	a	DT
cord-023095-4dannjjm	3983	3	1-week	1-week	CD
cord-023095-4dannjjm	3983	4	wash	wash	NN
cord-023095-4dannjjm	3983	5	-	-	HYPH
cord-023095-4dannjjm	3983	6	out	out	RP
cord-023095-4dannjjm	3983	7	period	period	NN
cord-023095-4dannjjm	3983	8	,	,	,
cord-023095-4dannjjm	3983	9	groups	group	NNS
cord-023095-4dannjjm	3983	10	were	be	VBD
cord-023095-4dannjjm	3983	11	switched	switch	VBN
cord-023095-4dannjjm	3983	12	.	.	.
cord-023095-4dannjjm	3984	1	A	a	DT
cord-023095-4dannjjm	3984	2	general	general	JJ
cord-023095-4dannjjm	3984	3	linear	linear	JJ
cord-023095-4dannjjm	3984	4	model	model	NN
cord-023095-4dannjjm	3984	5	was	be	VBD
cord-023095-4dannjjm	3984	6	used	use	VBN
cord-023095-4dannjjm	3984	7	to	to	TO
cord-023095-4dannjjm	3984	8	test	test	VB
cord-023095-4dannjjm	3984	9	the	the	DT
cord-023095-4dannjjm	3984	10	period	period	NN
cord-023095-4dannjjm	3984	11	,	,	,
cord-023095-4dannjjm	3984	12	sequence	sequence	NN
cord-023095-4dannjjm	3984	13	,	,	,
cord-023095-4dannjjm	3984	14	treatment	treatment	NN
cord-023095-4dannjjm	3984	15	,	,	,
cord-023095-4dannjjm	3984	16	dog	dog	NN
cord-023095-4dannjjm	3984	17	and	and	CC
cord-023095-4dannjjm	3984	18	time	time	NN
cord-023095-4dannjjm	3984	19	effects	effect	NNS
cord-023095-4dannjjm	3984	20	on	on	IN
cord-023095-4dannjjm	3984	21	phosphatemia	phosphatemia	NN
cord-023095-4dannjjm	3984	22	and	and	CC
cord-023095-4dannjjm	3984	23	the	the	DT
cord-023095-4dannjjm	3984	24	area	area	NN
cord-023095-4dannjjm	3984	25	under	under	IN
cord-023095-4dannjjm	3984	26	the	the	DT
cord-023095-4dannjjm	3984	27	phosphatemia	phosphatemia	NN
cord-023095-4dannjjm	3984	28	versus	versus	IN
cord-023095-4dannjjm	3984	29	time	time	NN
cord-023095-4dannjjm	3984	30	curve	curve	NN
cord-023095-4dannjjm	3984	31	(	(	-LRB-
cord-023095-4dannjjm	3984	32	AUC	AUC	NNP
cord-023095-4dannjjm	3984	33	0	0	CD
cord-023095-4dannjjm	3984	34	-	-	HYPH
cord-023095-4dannjjm	3984	35	24	24	CD
cord-023095-4dannjjm	3984	36	)	)	-RRB-
cord-023095-4dannjjm	3984	37	.	.	.
cord-023095-4dannjjm	3985	1	A	a	DT
cord-023095-4dannjjm	3985	2	significant	significant	JJ
cord-023095-4dannjjm	3986	1	(	(	-LRB-
cord-023095-4dannjjm	3986	2	p	p	NN
cord-023095-4dannjjm	3986	3	o	o	CD
cord-023095-4dannjjm	3986	4	0.001	0.001	CD
cord-023095-4dannjjm	3986	5	)	)	-RRB-
cord-023095-4dannjjm	3987	1	circadian	circadian	NN
cord-023095-4dannjjm	3987	2	variation	variation	NN
cord-023095-4dannjjm	3987	3	existed	exist	VBD
cord-023095-4dannjjm	3987	4	in	in	IN
cord-023095-4dannjjm	3987	5	fasted	fast	VBN
cord-023095-4dannjjm	3987	6	dogs	dog	NNS
cord-023095-4dannjjm	3987	7	.	.	.
cord-023095-4dannjjm	3988	1	The	the	DT
cord-023095-4dannjjm	3988	2	maximum	maximum	JJ
cord-023095-4dannjjm	3988	3	difference	difference	NN
cord-023095-4dannjjm	3988	4	(	(	-LRB-
cord-023095-4dannjjm	3988	5	mean	mean	VB
cord-023095-4dannjjm	3988	6	:	:	:
cord-023095-4dannjjm	3988	7	À1.9	À1.9	NNP
cord-023095-4dannjjm	3988	8	mg	mg	NNP
cord-023095-4dannjjm	3988	9	/	/	SYM
cord-023095-4dannjjm	3988	10	dL	dl	NN
cord-023095-4dannjjm	3988	11	;	;	:
cord-023095-4dannjjm	3988	12	95	95	CD
cord-023095-4dannjjm	3988	13	%	%	NN
cord-023095-4dannjjm	3988	14	C.I.	C.I.	NNP
cord-023095-4dannjjm	3988	15	:	:	:
cord-023095-4dannjjm	3988	16	À2.4	À2.4	NNP
cord-023095-4dannjjm	3988	17	mg	mg	NNP
cord-023095-4dannjjm	3988	18	/	/	SYM
cord-023095-4dannjjm	3988	19	dL	dl	NN
cord-023095-4dannjjm	3988	20	;	;	:
cord-023095-4dannjjm	3989	1	À1.4	À1.4	NNP
cord-023095-4dannjjm	3989	2	mg	mg	NNP
cord-023095-4dannjjm	3989	3	/	/	SYM
cord-023095-4dannjjm	3989	4	dL	dL	NNP
cord-023095-4dannjjm	3989	5	)	)	-RRB-
cord-023095-4dannjjm	3989	6	was	be	VBD
cord-023095-4dannjjm	3989	7	observed	observe	VBN
cord-023095-4dannjjm	3989	8	between	between	IN
cord-023095-4dannjjm	3989	9	8	8	CD
cord-023095-4dannjjm	3989	10	a.m.	a.m.	NN
cord-023095-4dannjjm	3989	11	and	and	CC
cord-023095-4dannjjm	3989	12	midnight	midnight	NN
cord-023095-4dannjjm	3989	13	.	.	.
cord-023095-4dannjjm	3990	1	The	the	DT
cord-023095-4dannjjm	3990	2	AUC	AUC	NNP
cord-023095-4dannjjm	3990	3	0	0	CD
cord-023095-4dannjjm	3990	4	-	-	HYPH
cord-023095-4dannjjm	3990	5	24	24	CD
cord-023095-4dannjjm	3990	6	with	with	IN
cord-023095-4dannjjm	3990	7	CaC	CaC	NNP
cord-023095-4dannjjm	3990	8	(	(	-LRB-
cord-023095-4dannjjm	3990	9	5936	5936	CD
cord-023095-4dannjjm	3990	10	AE	AE	NNP
cord-023095-4dannjjm	3990	11	533	533	CD
cord-023095-4dannjjm	3990	12	mg.min/dL	mg.min/dl	ADD
cord-023095-4dannjjm	3990	13	)	)	-RRB-
cord-023095-4dannjjm	3990	14	was	be	VBD
cord-023095-4dannjjm	3990	15	mildly	mildly	RB
cord-023095-4dannjjm	3990	16	but	but	CC
cord-023095-4dannjjm	3990	17	significantly	significantly	RB
cord-023095-4dannjjm	3990	18	lower	low	JJR
cord-023095-4dannjjm	3991	1	(	(	-LRB-
cord-023095-4dannjjm	3991	2	p	p	NN
cord-023095-4dannjjm	3991	3	5	5	CD
cord-023095-4dannjjm	3991	4	0.027	0.027	CD
cord-023095-4dannjjm	3991	5	)	)	-RRB-
cord-023095-4dannjjm	3991	6	than	than	IN
cord-023095-4dannjjm	3991	7	without	without	IN
cord-023095-4dannjjm	3991	8	CaC	CaC	NNP
cord-023095-4dannjjm	3991	9	(	(	-LRB-
cord-023095-4dannjjm	3991	10	6239	6239	CD
cord-023095-4dannjjm	3991	11	AE	AE	NNP
cord-023095-4dannjjm	3991	12	631	631	CD
cord-023095-4dannjjm	3991	13	mg.min/dL	mg.min/dl	ADD
cord-023095-4dannjjm	3991	14	)	)	-RRB-
cord-023095-4dannjjm	3991	15	.	.	.
cord-023095-4dannjjm	3992	1	However	however	RB
cord-023095-4dannjjm	3992	2	,	,	,
cord-023095-4dannjjm	3992	3	it	-PRON-	PRP
cord-023095-4dannjjm	3992	4	was	be	VBD
cord-023095-4dannjjm	3992	5	similar	similar	JJ
cord-023095-4dannjjm	3992	6	to	to	IN
cord-023095-4dannjjm	3992	7	the	the	DT
cord-023095-4dannjjm	3992	8	AUC	AUC	NNP
cord-023095-4dannjjm	3992	9	0	0	CD
cord-023095-4dannjjm	3992	10	-	-	SYM
cord-023095-4dannjjm	3992	11	24	24	CD
cord-023095-4dannjjm	3992	12	in	in	IN
cord-023095-4dannjjm	3992	13	fasted	fast	VBN
cord-023095-4dannjjm	3992	14	conditions	condition	NNS
cord-023095-4dannjjm	3992	15	.	.	.
cord-023095-4dannjjm	3993	1	Feeding	feeding	NN
cord-023095-4dannjjm	3993	2	,	,	,
cord-023095-4dannjjm	3993	3	with	with	IN
cord-023095-4dannjjm	3993	4	and	and	CC
cord-023095-4dannjjm	3993	5	without	without	IN
cord-023095-4dannjjm	3993	6	CaC	CaC	NNP
cord-023095-4dannjjm	3993	7	,	,	,
cord-023095-4dannjjm	3993	8	has	have	VBZ
cord-023095-4dannjjm	3993	9	minor	minor	JJ
cord-023095-4dannjjm	3993	10	effect	effect	NN
cord-023095-4dannjjm	3993	11	on	on	IN
cord-023095-4dannjjm	3993	12	phosphatemia	phosphatemia	NN
cord-023095-4dannjjm	3993	13	.	.	.
cord-023095-4dannjjm	3994	1	However	however	RB
cord-023095-4dannjjm	3994	2	,	,	,
cord-023095-4dannjjm	3994	3	circadian	circadian	JJ
cord-023095-4dannjjm	3994	4	variation	variation	NN
cord-023095-4dannjjm	3994	5	of	of	IN
cord-023095-4dannjjm	3994	6	fasted	fast	VBN
cord-023095-4dannjjm	3994	7	phosphatemia	phosphatemia	NN
cord-023095-4dannjjm	3994	8	might	may	MD
cord-023095-4dannjjm	3994	9	affect	affect	VB
cord-023095-4dannjjm	3994	10	its	-PRON-	PRP$
cord-023095-4dannjjm	3994	11	interpretation	interpretation	NN
cord-023095-4dannjjm	3994	12	.	.	.
cord-023095-4dannjjm	3995	1	GFR	GFR	NNP
cord-023095-4dannjjm	3995	2	measurement	measurement	NN
cord-023095-4dannjjm	3995	3	permits	permit	VBZ
cord-023095-4dannjjm	3995	4	diagnosis	diagnosis	NN
cord-023095-4dannjjm	3995	5	of	of	IN
cord-023095-4dannjjm	3995	6	kidney	kidney	NN
cord-023095-4dannjjm	3995	7	injury	injury	NN
cord-023095-4dannjjm	3995	8	prior	prior	RB
cord-023095-4dannjjm	3995	9	to	to	IN
cord-023095-4dannjjm	3995	10	development	development	NN
cord-023095-4dannjjm	3995	11	of	of	IN
cord-023095-4dannjjm	3995	12	azotemia	azotemia	NN
cord-023095-4dannjjm	3995	13	,	,	,
cord-023095-4dannjjm	3995	14	and	and	CC
cord-023095-4dannjjm	3995	15	is	be	VBZ
cord-023095-4dannjjm	3995	16	the	the	DT
cord-023095-4dannjjm	3995	17	gold	gold	NN
cord-023095-4dannjjm	3995	18	standard	standard	NN
cord-023095-4dannjjm	3995	19	for	for	IN
cord-023095-4dannjjm	3995	20	kidney	kidney	NN
cord-023095-4dannjjm	3995	21	function	function	NN
cord-023095-4dannjjm	3995	22	assessment	assessment	NN
cord-023095-4dannjjm	3995	23	.	.	.
cord-023095-4dannjjm	3996	1	Accurate	accurate	JJ
cord-023095-4dannjjm	3996	2	and	and	CC
cord-023095-4dannjjm	3996	3	rapid	rapid	JJ
cord-023095-4dannjjm	3996	4	(	(	-LRB-
cord-023095-4dannjjm	3996	5	o	o	NN
cord-023095-4dannjjm	3996	6	60	60	CD
cord-023095-4dannjjm	3996	7	min	min	NN
cord-023095-4dannjjm	3996	8	)	)	-RRB-
cord-023095-4dannjjm	3996	9	GFR	GFR	NNP
cord-023095-4dannjjm	3996	10	measurement	measurement	NN
cord-023095-4dannjjm	3996	11	has	have	VBZ
cord-023095-4dannjjm	3996	12	been	be	VBN
cord-023095-4dannjjm	3996	13	performed	perform	VBN
cord-023095-4dannjjm	3996	14	in	in	IN
cord-023095-4dannjjm	3996	15	rats	rat	NNS
cord-023095-4dannjjm	3996	16	by	by	IN
cord-023095-4dannjjm	3996	17	simultaneous	simultaneous	JJ
cord-023095-4dannjjm	3996	18	transcutaneous	transcutaneous	JJ
cord-023095-4dannjjm	3996	19	assay	assay	NN
cord-023095-4dannjjm	3996	20	of	of	IN
cord-023095-4dannjjm	3996	21	two	two	CD
cord-023095-4dannjjm	3996	22	intravascular	intravascular	JJ
cord-023095-4dannjjm	3996	23	fluorescently	fluorescently	RB
cord-023095-4dannjjm	3996	24	-	-	HYPH
cord-023095-4dannjjm	3996	25	labeled	label	VBN
cord-023095-4dannjjm	3996	26	markers	marker	NNS
cord-023095-4dannjjm	3996	27	.	.	.
cord-023095-4dannjjm	3997	1	A	a	DT
cord-023095-4dannjjm	3997	2	recently	recently	RB
cord-023095-4dannjjm	3997	3	developed	develop	VBN
cord-023095-4dannjjm	3997	4	analyzer	analyzer	NN
cord-023095-4dannjjm	3997	5	assays	assay	NNS
cord-023095-4dannjjm	3997	6	fluorescence	fluorescence	NN
cord-023095-4dannjjm	3997	7	via	via	IN
cord-023095-4dannjjm	3997	8	a	a	DT
cord-023095-4dannjjm	3997	9	fiberoptic	fiberoptic	JJ
cord-023095-4dannjjm	3997	10	cable	cable	NN
cord-023095-4dannjjm	3997	11	introduced	introduce	VBN
cord-023095-4dannjjm	3997	12	through	through	IN
cord-023095-4dannjjm	3997	13	a	a	DT
cord-023095-4dannjjm	3997	14	peripheral	peripheral	JJ
cord-023095-4dannjjm	3997	15	catheter	catheter	NN
cord-023095-4dannjjm	3997	16	,	,	,
cord-023095-4dannjjm	3997	17	and	and	CC
cord-023095-4dannjjm	3997	18	thus	thus	RB
cord-023095-4dannjjm	3997	19	should	should	MD
cord-023095-4dannjjm	3997	20	also	also	RB
cord-023095-4dannjjm	3997	21	allow	allow	VB
cord-023095-4dannjjm	3997	22	rapid	rapid	JJ
cord-023095-4dannjjm	3997	23	GFR	GFR	NNP
cord-023095-4dannjjm	3997	24	determination	determination	NN
cord-023095-4dannjjm	3997	25	in	in	IN
cord-023095-4dannjjm	3997	26	larger	large	JJR
cord-023095-4dannjjm	3997	27	species	specie	NNS
cord-023095-4dannjjm	3997	28	.	.	.
cord-023095-4dannjjm	3998	1	The	the	DT
cord-023095-4dannjjm	3998	2	purpose	purpose	NN
cord-023095-4dannjjm	3998	3	of	of	IN
cord-023095-4dannjjm	3998	4	this	this	DT
cord-023095-4dannjjm	3998	5	study	study	NN
cord-023095-4dannjjm	3998	6	was	be	VBD
cord-023095-4dannjjm	3998	7	to	to	TO
cord-023095-4dannjjm	3998	8	determine	determine	VB
cord-023095-4dannjjm	3998	9	correlation	correlation	NN
cord-023095-4dannjjm	3998	10	and	and	CC
cord-023095-4dannjjm	3998	11	agreement	agreement	NN
cord-023095-4dannjjm	3998	12	between	between	IN
cord-023095-4dannjjm	3998	13	fluorescent	fluorescent	NN
cord-023095-4dannjjm	3998	14	ratiometry	ratiometry	NN
cord-023095-4dannjjm	3998	15	(	(	-LRB-
cord-023095-4dannjjm	3998	16	FR	FR	NNP
cord-023095-4dannjjm	3998	17	)	)	-RRB-
cord-023095-4dannjjm	3998	18	and	and	CC
cord-023095-4dannjjm	3998	19	iohexol	iohexol	NN
cord-023095-4dannjjm	3998	20	plasma	plasma	NN
cord-023095-4dannjjm	3998	21	clearance	clearance	NN
cord-023095-4dannjjm	3998	22	(	(	-LRB-
cord-023095-4dannjjm	3998	23	IPC	IPC	NNP
cord-023095-4dannjjm	3998	24	)	)	-RRB-
cord-023095-4dannjjm	3998	25	in	in	IN
cord-023095-4dannjjm	3998	26	dogs	dog	NNS
cord-023095-4dannjjm	3998	27	over	over	IN
cord-023095-4dannjjm	3998	28	a	a	DT
cord-023095-4dannjjm	3998	29	range	range	NN
cord-023095-4dannjjm	3998	30	of	of	IN
cord-023095-4dannjjm	3998	31	GFRs	gfr	NNS
cord-023095-4dannjjm	3998	32	.	.	.
cord-023095-4dannjjm	3999	1	Acute	acute	JJ
cord-023095-4dannjjm	3999	2	kidney	kidney	NN
cord-023095-4dannjjm	3999	3	injury	injury	NN
cord-023095-4dannjjm	3999	4	(	(	-LRB-
cord-023095-4dannjjm	3999	5	AKI	AKI	NNP
cord-023095-4dannjjm	3999	6	)	)	-RRB-
cord-023095-4dannjjm	3999	7	was	be	VBD
cord-023095-4dannjjm	3999	8	induced	induce	VBN
cord-023095-4dannjjm	3999	9	in	in	IN
cord-023095-4dannjjm	3999	10	5	5	CD
cord-023095-4dannjjm	3999	11	female	female	JJ
cord-023095-4dannjjm	3999	12	hound	hound	NN
cord-023095-4dannjjm	3999	13	-	-	HYPH
cord-023095-4dannjjm	3999	14	type	type	NN
cord-023095-4dannjjm	3999	15	dogs	dog	NNS
cord-023095-4dannjjm	3999	16	(	(	-LRB-
cord-023095-4dannjjm	3999	17	10	10	CD
cord-023095-4dannjjm	3999	18	mg	mg	NNP
cord-023095-4dannjjm	3999	19	/	/	SYM
cord-023095-4dannjjm	3999	20	kg	kg	NNP
cord-023095-4dannjjm	3999	21	gentamicin	gentamicin	NNS
cord-023095-4dannjjm	3999	22	IV	IV	NNP
cord-023095-4dannjjm	3999	23	q8h	q8h	NNP
cord-023095-4dannjjm	3999	24	)	)	-RRB-
cord-023095-4dannjjm	3999	25	,	,	,
cord-023095-4dannjjm	3999	26	and	and	CC
cord-023095-4dannjjm	3999	27	FR	FR	NNP
cord-023095-4dannjjm	3999	28	and	and	CC
cord-023095-4dannjjm	3999	29	IPC	IPC	NNP
cord-023095-4dannjjm	3999	30	GFR	GFR	NNP
cord-023095-4dannjjm	3999	31	were	be	VBD
cord-023095-4dannjjm	3999	32	simulta	simulta	NNP
cord-023095-4dannjjm	3999	33	-	-	HYPH
cord-023095-4dannjjm	3999	34	neously	neously	NNP
cord-023095-4dannjjm	3999	35	determined	determine	VBN
cord-023095-4dannjjm	3999	36	on	on	IN
cord-023095-4dannjjm	3999	37	days	day	NNS
cord-023095-4dannjjm	3999	38	0	0	CD
cord-023095-4dannjjm	3999	39	,	,	,
cord-023095-4dannjjm	3999	40	3	3	CD
cord-023095-4dannjjm	3999	41	,	,	,
cord-023095-4dannjjm	3999	42	6	6	CD
cord-023095-4dannjjm	3999	43	and	and	CC
cord-023095-4dannjjm	3999	44	9	9	CD
cord-023095-4dannjjm	3999	45	.	.	.
cord-023095-4dannjjm	4000	1	A	a	DT
cord-023095-4dannjjm	4000	2	9-sample	9-sample	CD
cord-023095-4dannjjm	4000	3	,	,	,
cord-023095-4dannjjm	4000	4	5-hr	5-hr	CD
cord-023095-4dannjjm	4000	5	protocol	protocol	NN
cord-023095-4dannjjm	4000	6	was	be	VBD
cord-023095-4dannjjm	4000	7	used	use	VBN
cord-023095-4dannjjm	4000	8	for	for	IN
cord-023095-4dannjjm	4000	9	IPC	IPC	NNP
cord-023095-4dannjjm	4000	10	;	;	:
cord-023095-4dannjjm	4000	11	FR	FR	NNP
cord-023095-4dannjjm	4000	12	was	be	VBD
cord-023095-4dannjjm	4000	13	determined	determine	VBN
cord-023095-4dannjjm	4000	14	following	follow	VBG
cord-023095-4dannjjm	4000	15	bolus	bolus	NN
cord-023095-4dannjjm	4000	16	injection	injection	NN
cord-023095-4dannjjm	4000	17	of	of	IN
cord-023095-4dannjjm	4000	18	a	a	DT
cord-023095-4dannjjm	4000	19	dextran	dextran	NN
cord-023095-4dannjjm	4000	20	conjugate	conjugate	NN
cord-023095-4dannjjm	4000	21	mixture	mixture	NN
cord-023095-4dannjjm	4000	22	(	(	-LRB-
cord-023095-4dannjjm	4000	23	2-sulfohexamine	2-sulfohexamine	CD
cord-023095-4dannjjm	4000	24	rhodamine	rhodamine	NN
cord-023095-4dannjjm	4000	25	-	-	HYPH
cord-023095-4dannjjm	4000	26	carboxymethyl	carboxymethyl	NN
cord-023095-4dannjjm	4000	27	150	150	CD
cord-023095-4dannjjm	4000	28	kD	kd	JJ
cord-023095-4dannjjm	4000	29	dextran	dextran	NN
cord-023095-4dannjjm	4000	30	,	,	,
cord-023095-4dannjjm	4000	31	5-aminofluorescein	5-aminofluorescein	CD
cord-023095-4dannjjm	4000	32	-	-	HYPH
cord-023095-4dannjjm	4000	33	carboxymethyl	carboxymethyl	NNP
cord-023095-4dannjjm	4000	34	5	5	CD
cord-023095-4dannjjm	4000	35	kD	kd	JJ
cord-023095-4dannjjm	4000	36	dextran	dextran	NN
cord-023095-4dannjjm	4000	37	)	)	-RRB-
cord-023095-4dannjjm	4000	38	with	with	IN
cord-023095-4dannjjm	4000	39	fluorescence	fluorescence	NN
cord-023095-4dannjjm	4000	40	measured	measure	VBN
cord-023095-4dannjjm	4000	41	over	over	IN
cord-023095-4dannjjm	4000	42	60	60	CD
cord-023095-4dannjjm	4000	43	min	min	NN
cord-023095-4dannjjm	4000	44	.	.	.
cord-023095-4dannjjm	4001	1	GFR	GFR	NNP
cord-023095-4dannjjm	4001	2	was	be	VBD
cord-023095-4dannjjm	4001	3	calculated	calculate	VBN
cord-023095-4dannjjm	4001	4	using	use	VBG
cord-023095-4dannjjm	4001	5	2-compartment	2-compartment	CD
cord-023095-4dannjjm	4001	6	model	model	NN
cord-023095-4dannjjm	4001	7	concentration	concentration	NN
cord-023095-4dannjjm	4001	8	-	-	HYPH
cord-023095-4dannjjm	4001	9	vs.-time	vs.-time	NN
cord-023095-4dannjjm	4001	10	curves	curve	NNS
cord-023095-4dannjjm	4001	11	for	for	IN
cord-023095-4dannjjm	4001	12	both	both	DT
cord-023095-4dannjjm	4001	13	techniques	technique	NNS
cord-023095-4dannjjm	4001	14	.	.	.
cord-023095-4dannjjm	4002	1	Correlation	correlation	NN
cord-023095-4dannjjm	4002	2	was	be	VBD
cord-023095-4dannjjm	4002	3	determined	determine	VBN
cord-023095-4dannjjm	4002	4	via	via	IN
cord-023095-4dannjjm	4002	5	Spearman	Spearman	NNP
cord-023095-4dannjjm	4002	6	's	's	POS
cord-023095-4dannjjm	4002	7	rho	rho	NN
cord-023095-4dannjjm	4002	8	;	;	:
cord-023095-4dannjjm	4002	9	agreement	agreement	NN
cord-023095-4dannjjm	4002	10	was	be	VBD
cord-023095-4dannjjm	4002	11	analyzed	analyze	VBN
cord-023095-4dannjjm	4002	12	via	via	IN
cord-023095-4dannjjm	4002	13	Bland	Bland	NNP
cord-023095-4dannjjm	4002	14	-	-	HYPH
cord-023095-4dannjjm	4002	15	Altman	Altman	NNP
cord-023095-4dannjjm	4002	16	plots	plot	NNS
cord-023095-4dannjjm	4002	17	.	.	.
cord-023095-4dannjjm	4003	1	IPC	IPC	NNP
cord-023095-4dannjjm	4003	2	GFR	GFR	NNP
cord-023095-4dannjjm	4003	3	and	and	CC
cord-023095-4dannjjm	4003	4	serum	serum	NN
cord-023095-4dannjjm	4003	5	creatinine	creatinine	NN
cord-023095-4dannjjm	4003	6	confirmed	confirm	VBD
cord-023095-4dannjjm	4003	7	progressive	progressive	JJ
cord-023095-4dannjjm	4003	8	AKI	AKI	NNP
cord-023095-4dannjjm	4003	9	in	in	IN
cord-023095-4dannjjm	4003	10	all	all	DT
cord-023095-4dannjjm	4003	11	dogs	dog	NNS
cord-023095-4dannjjm	4003	12	.	.	.
cord-023095-4dannjjm	4004	1	Correlation	correlation	NN
cord-023095-4dannjjm	4004	2	between	between	IN
cord-023095-4dannjjm	4004	3	FR	FR	NNP
cord-023095-4dannjjm	4004	4	and	and	CC
cord-023095-4dannjjm	4004	5	IPC	IPC	NNP
cord-023095-4dannjjm	4004	6	was	be	VBD
cord-023095-4dannjjm	4004	7	0.91	0.91	CD
cord-023095-4dannjjm	4005	1	(	(	-LRB-
cord-023095-4dannjjm	4005	2	p	p	NN
cord-023095-4dannjjm	4005	3	o	o	CD
cord-023095-4dannjjm	4005	4	0.001	0.001	CD
cord-023095-4dannjjm	4005	5	)	)	-RRB-
cord-023095-4dannjjm	4005	6	.	.	.
cord-023095-4dannjjm	4006	1	Bland	Bland	NNP
cord-023095-4dannjjm	4006	2	-	-	HYPH
cord-023095-4dannjjm	4006	3	Altman	Altman	NNP
cord-023095-4dannjjm	4006	4	plots	plot	NNS
cord-023095-4dannjjm	4006	5	confirmed	confirm	VBD
cord-023095-4dannjjm	4006	6	good	good	JJ
cord-023095-4dannjjm	4006	7	agreement	agreement	NN
cord-023095-4dannjjm	4006	8	between	between	IN
cord-023095-4dannjjm	4006	9	techniques	technique	NNS
cord-023095-4dannjjm	4006	10	with	with	IN
cord-023095-4dannjjm	4006	11	slight	slight	JJ
cord-023095-4dannjjm	4006	12	underestimation	underestimation	NN
cord-023095-4dannjjm	4006	13	of	of	IN
cord-023095-4dannjjm	4006	14	GFR	GFR	NNP
cord-023095-4dannjjm	4006	15	by	by	IN
cord-023095-4dannjjm	4006	16	FR	FR	NNP
cord-023095-4dannjjm	4006	17	across	across	IN
cord-023095-4dannjjm	4006	18	most	most	RBS
cord-023095-4dannjjm	4006	19	observed	observe	VBN
cord-023095-4dannjjm	4006	20	values	value	NNS
cord-023095-4dannjjm	4006	21	.	.	.
cord-023095-4dannjjm	4007	1	These	these	DT
cord-023095-4dannjjm	4007	2	results	result	NNS
cord-023095-4dannjjm	4007	3	suggest	suggest	VBP
cord-023095-4dannjjm	4007	4	FR	FR	NNP
cord-023095-4dannjjm	4007	5	is	be	VBZ
cord-023095-4dannjjm	4007	6	suitable	suitable	JJ
cord-023095-4dannjjm	4007	7	for	for	IN
cord-023095-4dannjjm	4007	8	GFR	GFR	NNP
cord-023095-4dannjjm	4007	9	determination	determination	NN
cord-023095-4dannjjm	4007	10	in	in	IN
cord-023095-4dannjjm	4007	11	dogs	dog	NNS
cord-023095-4dannjjm	4007	12	with	with	IN
cord-023095-4dannjjm	4007	13	AKI	AKI	NNP
cord-023095-4dannjjm	4007	14	.	.	.
cord-023095-4dannjjm	4008	1	Importantly	importantly	RB
cord-023095-4dannjjm	4008	2	,	,	,
cord-023095-4dannjjm	4008	3	the	the	DT
cord-023095-4dannjjm	4008	4	portable	portable	JJ
cord-023095-4dannjjm	4008	5	analyzer	analyzer	NN
cord-023095-4dannjjm	4008	6	allowed	allow	VBN
cord-023095-4dannjjm	4008	7	for	for	IN
cord-023095-4dannjjm	4008	8	point	point	NN
cord-023095-4dannjjm	4008	9	-	-	HYPH
cord-023095-4dannjjm	4008	10	of	of	IN
cord-023095-4dannjjm	4008	11	-	-	HYPH
cord-023095-4dannjjm	4008	12	care	care	NN
cord-023095-4dannjjm	4008	13	GFR	GFR	NNP
cord-023095-4dannjjm	4008	14	determination	determination	NN
cord-023095-4dannjjm	4008	15	in	in	IN
cord-023095-4dannjjm	4008	16	o	o	NN
cord-023095-4dannjjm	4008	17	60	60	CD
cord-023095-4dannjjm	4008	18	min	min	NN
cord-023095-4dannjjm	4008	19	using	use	VBG
cord-023095-4dannjjm	4008	20	a	a	DT
cord-023095-4dannjjm	4008	21	peripheral	peripheral	JJ
cord-023095-4dannjjm	4008	22	vein	vein	NN
cord-023095-4dannjjm	4008	23	.	.	.
cord-023095-4dannjjm	4009	1	Previously	previously	RB
cord-023095-4dannjjm	4009	2	presented	present	VBN
cord-023095-4dannjjm	4009	3	at	at	IN
cord-023095-4dannjjm	4009	4	the	the	DT
cord-023095-4dannjjm	4009	5	American	American	NNP
cord-023095-4dannjjm	4009	6	Society	Society	NNP
cord-023095-4dannjjm	4009	7	of	of	IN
cord-023095-4dannjjm	4009	8	Nephrology	Nephrology	NNP
cord-023095-4dannjjm	4009	9	Renal	Renal	NNP
cord-023095-4dannjjm	4009	10	Week	Week	NNP
cord-023095-4dannjjm	4009	11	(	(	-LRB-
cord-023095-4dannjjm	4009	12	related	relate	VBN
cord-023095-4dannjjm	4009	13	but	but	CC
cord-023095-4dannjjm	4009	14	not	not	RB
cord-023095-4dannjjm	4009	15	identical	identical	JJ
cord-023095-4dannjjm	4009	16	abstract	abstract	JJ
cord-023095-4dannjjm	4009	17	)	)	-RRB-
cord-023095-4dannjjm	4009	18	.	.	.
cord-023095-4dannjjm	4010	1	Dogs	dog	NNS
cord-023095-4dannjjm	4010	2	with	with	IN
cord-023095-4dannjjm	4010	3	protein	protein	NN
cord-023095-4dannjjm	4010	4	-	-	HYPH
cord-023095-4dannjjm	4010	5	losing	lose	VBG
cord-023095-4dannjjm	4010	6	nephropathy	nephropathy	NN
cord-023095-4dannjjm	4010	7	(	(	-LRB-
cord-023095-4dannjjm	4010	8	PLN	PLN	NNP
cord-023095-4dannjjm	4010	9	)	)	-RRB-
cord-023095-4dannjjm	4010	10	are	be	VBP
cord-023095-4dannjjm	4010	11	at	at	IN
cord-023095-4dannjjm	4010	12	risk	risk	NN
cord-023095-4dannjjm	4010	13	of	of	IN
cord-023095-4dannjjm	4010	14	thromboembolic	thromboembolic	JJ
cord-023095-4dannjjm	4010	15	disease	disease	NN
cord-023095-4dannjjm	4010	16	,	,	,
cord-023095-4dannjjm	4010	17	but	but	CC
cord-023095-4dannjjm	4010	18	the	the	DT
cord-023095-4dannjjm	4010	19	mechanism	mechanism	NN
cord-023095-4dannjjm	4010	20	of	of	IN
cord-023095-4dannjjm	4010	21	hypercoagulability	hypercoagulability	NN
cord-023095-4dannjjm	4010	22	and	and	CC
cord-023095-4dannjjm	4010	23	the	the	DT
cord-023095-4dannjjm	4010	24	population	population	NN
cord-023095-4dannjjm	4010	25	of	of	IN
cord-023095-4dannjjm	4010	26	dogs	dog	NNS
cord-023095-4dannjjm	4010	27	at	at	IN
cord-023095-4dannjjm	4010	28	risk	risk	NN
cord-023095-4dannjjm	4010	29	are	be	VBP
cord-023095-4dannjjm	4010	30	unknown	unknown	JJ
cord-023095-4dannjjm	4010	31	.	.	.
cord-023095-4dannjjm	4011	1	The	the	DT
cord-023095-4dannjjm	4011	2	purpose	purpose	NN
cord-023095-4dannjjm	4011	3	of	of	IN
cord-023095-4dannjjm	4011	4	this	this	DT
cord-023095-4dannjjm	4011	5	study	study	NN
cord-023095-4dannjjm	4011	6	was	be	VBD
cord-023095-4dannjjm	4011	7	to	to	TO
cord-023095-4dannjjm	4011	8	characterize	characterize	VB
cord-023095-4dannjjm	4011	9	thromboelastography	thromboelastography	NNP
cord-023095-4dannjjm	4011	10	(	(	-LRB-
cord-023095-4dannjjm	4011	11	TEG	TEG	NNP
cord-023095-4dannjjm	4011	12	)	)	-RRB-
cord-023095-4dannjjm	4011	13	in	in	IN
cord-023095-4dannjjm	4011	14	dogs	dog	NNS
cord-023095-4dannjjm	4011	15	with	with	IN
cord-023095-4dannjjm	4011	16	PLN	PLN	NNP
cord-023095-4dannjjm	4011	17	.	.	.
cord-023095-4dannjjm	4012	1	Twenty	twenty	CD
cord-023095-4dannjjm	4012	2	-	-	HYPH
cord-023095-4dannjjm	4012	3	eight	eight	CD
cord-023095-4dannjjm	4012	4	client	client	NN
cord-023095-4dannjjm	4012	5	-	-	HYPH
cord-023095-4dannjjm	4012	6	owned	own	VBN
cord-023095-4dannjjm	4012	7	dogs	dog	NNS
cord-023095-4dannjjm	4012	8	with	with	IN
cord-023095-4dannjjm	4012	9	PLN	PLN	NNP
cord-023095-4dannjjm	4012	10	(	(	-LRB-
cord-023095-4dannjjm	4012	11	urine	urine	NN
cord-023095-4dannjjm	4012	12	protein	protein	NN
cord-023095-4dannjjm	4012	13	:	:	:
cord-023095-4dannjjm	4012	14	creatinine	creatinine	NN
cord-023095-4dannjjm	4012	15	ratio	ratio	NN
cord-023095-4dannjjm	4012	16	(	(	-LRB-
cord-023095-4dannjjm	4012	17	UPC	UPC	NNP
cord-023095-4dannjjm	4012	18	)	)	-RRB-
cord-023095-4dannjjm	4012	19	4	4	CD
cord-023095-4dannjjm	4012	20	2.0	2.0	CD
cord-023095-4dannjjm	4012	21	)	)	-RRB-
cord-023095-4dannjjm	4012	22	and	and	CC
cord-023095-4dannjjm	4012	23	8	8	CD
cord-023095-4dannjjm	4012	24	control	control	NN
cord-023095-4dannjjm	4012	25	dogs	dog	NNS
cord-023095-4dannjjm	4012	26	were	be	VBD
cord-023095-4dannjjm	4012	27	enrolled	enrol	VBN
cord-023095-4dannjjm	4012	28	.	.	.
cord-023095-4dannjjm	4013	1	TEG	TEG	NNP
cord-023095-4dannjjm	4013	2	parameters	parameter	NNS
cord-023095-4dannjjm	4013	3	,	,	,
cord-023095-4dannjjm	4013	4	antithrombin	antithrombin	NN
cord-023095-4dannjjm	4013	5	activity	activity	NN
cord-023095-4dannjjm	4013	6	,	,	,
cord-023095-4dannjjm	4013	7	serum	serum	NN
cord-023095-4dannjjm	4013	8	biochemical	biochemical	JJ
cord-023095-4dannjjm	4013	9	profiles	profile	NNS
cord-023095-4dannjjm	4013	10	,	,	,
cord-023095-4dannjjm	4013	11	and	and	CC
cord-023095-4dannjjm	4013	12	UPC	UPC	NNP
cord-023095-4dannjjm	4013	13	were	be	VBD
cord-023095-4dannjjm	4013	14	measured	measure	VBN
cord-023095-4dannjjm	4013	15	.	.	.
cord-023095-4dannjjm	4014	1	TEG	TEG	NNP
cord-023095-4dannjjm	4014	2	analyses	analysis	NNS
cord-023095-4dannjjm	4014	3	were	be	VBD
cord-023095-4dannjjm	4014	4	run	run	VBN
cord-023095-4dannjjm	4014	5	in	in	IN
cord-023095-4dannjjm	4014	6	duplicate	duplicate	NN
cord-023095-4dannjjm	4014	7	with	with	IN
cord-023095-4dannjjm	4014	8	kaolin	kaolin	NN
cord-023095-4dannjjm	4014	9	activation	activation	NN
cord-023095-4dannjjm	4014	10	;	;	:
cord-023095-4dannjjm	4014	11	reaction	reaction	NN
cord-023095-4dannjjm	4014	12	time	time	NN
cord-023095-4dannjjm	4014	13	(	(	-LRB-
cord-023095-4dannjjm	4014	14	R	r	NN
cord-023095-4dannjjm	4014	15	)	)	-RRB-
cord-023095-4dannjjm	4014	16	,	,	,
cord-023095-4dannjjm	4014	17	clot	clot	NN
cord-023095-4dannjjm	4014	18	formation	formation	NN
cord-023095-4dannjjm	4014	19	time	time	NN
cord-023095-4dannjjm	4014	20	(	(	-LRB-
cord-023095-4dannjjm	4014	21	K	K	NNP
cord-023095-4dannjjm	4014	22	)	)	-RRB-
cord-023095-4dannjjm	4014	23	,	,	,
cord-023095-4dannjjm	4014	24	maximal	maximal	JJ
cord-023095-4dannjjm	4014	25	amplitude	amplitude	NN
cord-023095-4dannjjm	4014	26	(	(	-LRB-
cord-023095-4dannjjm	4014	27	MA	MA	NNP
cord-023095-4dannjjm	4014	28	)	)	-RRB-
cord-023095-4dannjjm	4014	29	,	,	,
cord-023095-4dannjjm	4014	30	and	and	CC
cord-023095-4dannjjm	4014	31	G	G	NNP
cord-023095-4dannjjm	4014	32	(	(	-LRB-
cord-023095-4dannjjm	4014	33	global	global	JJ
cord-023095-4dannjjm	4014	34	clot	clot	NN
cord-023095-4dannjjm	4014	35	strength	strength	NN
cord-023095-4dannjjm	4014	36	)	)	-RRB-
cord-023095-4dannjjm	4014	37	were	be	VBD
cord-023095-4dannjjm	4014	38	analyzed	analyze	VBN
cord-023095-4dannjjm	4014	39	.	.	.
cord-023095-4dannjjm	4015	1	A	a	DT
cord-023095-4dannjjm	4015	2	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	4015	3	Sum	Sum	NNP
cord-023095-4dannjjm	4015	4	Rank	Rank	NNP
cord-023095-4dannjjm	4015	5	Test	Test	NNP
cord-023095-4dannjjm	4015	6	was	be	VBD
cord-023095-4dannjjm	4015	7	used	use	VBN
cord-023095-4dannjjm	4015	8	to	to	TO
cord-023095-4dannjjm	4015	9	evaluate	evaluate	VB
cord-023095-4dannjjm	4015	10	differences	difference	NNS
cord-023095-4dannjjm	4015	11	between	between	IN
cord-023095-4dannjjm	4015	12	groups	group	NNS
cord-023095-4dannjjm	4015	13	.	.	.
cord-023095-4dannjjm	4016	1	Twelve	twelve	CD
cord-023095-4dannjjm	4016	2	PLN	PLN	NNP
cord-023095-4dannjjm	4016	3	dogs	dog	NNS
cord-023095-4dannjjm	4016	4	(	(	-LRB-
cord-023095-4dannjjm	4016	5	42.8	42.8	CD
cord-023095-4dannjjm	4016	6	%	%	NN
cord-023095-4dannjjm	4016	7	)	)	-RRB-
cord-023095-4dannjjm	4016	8	were	be	VBD
cord-023095-4dannjjm	4016	9	azotemic	azotemic	JJ
cord-023095-4dannjjm	4016	10	.	.	.
cord-023095-4dannjjm	4017	1	Nineteen	nineteen	CD
cord-023095-4dannjjm	4017	2	PLN	PLN	NNP
cord-023095-4dannjjm	4017	3	dogs	dog	NNS
cord-023095-4dannjjm	4017	4	(	(	-LRB-
cord-023095-4dannjjm	4017	5	67.8	67.8	CD
cord-023095-4dannjjm	4017	6	%	%	NN
cord-023095-4dannjjm	4017	7	)	)	-RRB-
cord-023095-4dannjjm	4017	8	were	be	VBD
cord-023095-4dannjjm	4017	9	hypoalbuminemic	hypoalbuminemic	JJ
cord-023095-4dannjjm	4017	10	[	[	-LRB-
cord-023095-4dannjjm	4017	11	serum	serum	NN
cord-023095-4dannjjm	4017	12	albumin	albumin	NN
cord-023095-4dannjjm	4017	13	(	(	-LRB-
cord-023095-4dannjjm	4017	14	SALB	SALB	NNP
cord-023095-4dannjjm	4017	15	)	)	-RRB-
cord-023095-4dannjjm	4018	1	o	o	LS
cord-023095-4dannjjm	4018	2	3.0	3.0	CD
cord-023095-4dannjjm	4018	3	g	g	NN
cord-023095-4dannjjm	4018	4	/	/	SYM
cord-023095-4dannjjm	4018	5	dl	dl	NN
cord-023095-4dannjjm	4018	6	]	]	-RRB-
cord-023095-4dannjjm	4018	7	;	;	:
cord-023095-4dannjjm	4018	8	11	11	CD
cord-023095-4dannjjm	4018	9	had	have	VBD
cord-023095-4dannjjm	4018	10	SALB	SALB	NNP
cord-023095-4dannjjm	4018	11	o	o	NN
cord-023095-4dannjjm	4018	12	2.5	2.5	CD
cord-023095-4dannjjm	4018	13	g	g	NN
cord-023095-4dannjjm	4018	14	/	/	SYM
cord-023095-4dannjjm	4018	15	dl	dl	NN
cord-023095-4dannjjm	4018	16	.	.	.
cord-023095-4dannjjm	4019	1	Dogs	dog	NNS
cord-023095-4dannjjm	4019	2	with	with	IN
cord-023095-4dannjjm	4019	3	PLN	PLN	NNP
cord-023095-4dannjjm	4019	4	had	have	VBD
cord-023095-4dannjjm	4019	5	higher	high	JJR
cord-023095-4dannjjm	4019	6	K	k	NN
cord-023095-4dannjjm	4019	7	(	(	-LRB-
cord-023095-4dannjjm	4019	8	p	p	NN
cord-023095-4dannjjm	4019	9	o	o	NN
cord-023095-4dannjjm	4019	10	0.01	0.01	CD
cord-023095-4dannjjm	4019	11	)	)	-RRB-
cord-023095-4dannjjm	4019	12	,	,	,
cord-023095-4dannjjm	4019	13	MA	MA	NNP
cord-023095-4dannjjm	4019	14	(	(	-LRB-
cord-023095-4dannjjm	4019	15	p	p	NN
cord-023095-4dannjjm	4019	16	o	o	NN
cord-023095-4dannjjm	4019	17	0.005	0.005	CD
cord-023095-4dannjjm	4019	18	)	)	-RRB-
cord-023095-4dannjjm	4019	19	and	and	CC
cord-023095-4dannjjm	4019	20	G	g	NN
cord-023095-4dannjjm	4019	21	(	(	-LRB-
cord-023095-4dannjjm	4019	22	p	p	NN
cord-023095-4dannjjm	4019	23	o	o	NN
cord-023095-4dannjjm	4019	24	0.005	0.005	CD
cord-023095-4dannjjm	4019	25	)	)	-RRB-
cord-023095-4dannjjm	4019	26	than	than	IN
cord-023095-4dannjjm	4019	27	controls	control	NNS
cord-023095-4dannjjm	4019	28	.	.	.
cord-023095-4dannjjm	4020	1	R	r	NN
cord-023095-4dannjjm	4020	2	was	be	VBD
cord-023095-4dannjjm	4020	3	similar	similar	JJ
cord-023095-4dannjjm	4020	4	between	between	IN
cord-023095-4dannjjm	4020	5	the	the	DT
cord-023095-4dannjjm	4020	6	two	two	CD
cord-023095-4dannjjm	4020	7	groups	group	NNS
cord-023095-4dannjjm	4020	8	.	.	.
cord-023095-4dannjjm	4021	1	PLN	PLN	NNP
cord-023095-4dannjjm	4021	2	dogs	dog	NNS
cord-023095-4dannjjm	4021	3	with	with	IN
cord-023095-4dannjjm	4021	4	SALB	SALB	NNP
cord-023095-4dannjjm	4021	5	o	o	NN
cord-023095-4dannjjm	4022	1	2.5	2.5	CD
cord-023095-4dannjjm	4022	2	g	g	NN
cord-023095-4dannjjm	4022	3	/	/	SYM
cord-023095-4dannjjm	4022	4	dl	dl	NNP
cord-023095-4dannjjm	4022	5	had	have	VBD
cord-023095-4dannjjm	4022	6	higher	high	JJR
cord-023095-4dannjjm	4022	7	G	g	NN
cord-023095-4dannjjm	4022	8	(	(	-LRB-
cord-023095-4dannjjm	4022	9	p	p	NN
cord-023095-4dannjjm	4022	10	o	o	NN
cord-023095-4dannjjm	4022	11	0.05	0.05	CD
cord-023095-4dannjjm	4022	12	)	)	-RRB-
cord-023095-4dannjjm	4022	13	values	value	NNS
cord-023095-4dannjjm	4022	14	than	than	IN
cord-023095-4dannjjm	4022	15	dogs	dog	NNS
cord-023095-4dannjjm	4022	16	with	with	IN
cord-023095-4dannjjm	4022	17	SALB	SALB	NNP
cord-023095-4dannjjm	4022	18	4	4	CD
cord-023095-4dannjjm	4022	19	2.5	2.5	CD
cord-023095-4dannjjm	4022	20	g	g	NN
cord-023095-4dannjjm	4022	21	/	/	SYM
cord-023095-4dannjjm	4022	22	dl	dl	NN
cord-023095-4dannjjm	4022	23	;	;	:
cord-023095-4dannjjm	4022	24	however	however	RB
cord-023095-4dannjjm	4022	25	,	,	,
cord-023095-4dannjjm	4022	26	even	even	RB
cord-023095-4dannjjm	4022	27	PLN	PLN	NNP
cord-023095-4dannjjm	4022	28	dogs	dog	NNS
cord-023095-4dannjjm	4022	29	with	with	IN
cord-023095-4dannjjm	4022	30	normal	normal	JJ
cord-023095-4dannjjm	4022	31	SALB	SALB	NNP
cord-023095-4dannjjm	4022	32	(	(	-LRB-
cord-023095-4dannjjm	4022	33	4	4	CD
cord-023095-4dannjjm	4022	34	3.0	3.0	CD
cord-023095-4dannjjm	4022	35	g	g	NN
cord-023095-4dannjjm	4022	36	/	/	SYM
cord-023095-4dannjjm	4022	37	dl	dl	NN
cord-023095-4dannjjm	4022	38	)	)	-RRB-
cord-023095-4dannjjm	4022	39	had	have	VBD
cord-023095-4dannjjm	4022	40	significantly	significantly	RB
cord-023095-4dannjjm	4022	41	higher	high	JJR
cord-023095-4dannjjm	4022	42	G	g	NN
cord-023095-4dannjjm	4022	43	values	value	NNS
cord-023095-4dannjjm	4022	44	than	than	IN
cord-023095-4dannjjm	4022	45	controls	control	NNS
cord-023095-4dannjjm	4023	1	(	(	-LRB-
cord-023095-4dannjjm	4023	2	p	p	NN
cord-023095-4dannjjm	4023	3	o	o	NN
cord-023095-4dannjjm	4023	4	0.005	0.005	CD
cord-023095-4dannjjm	4023	5	)	)	-RRB-
cord-023095-4dannjjm	4023	6	.	.	.
cord-023095-4dannjjm	4024	1	No	no	DT
cord-023095-4dannjjm	4024	2	significant	significant	JJ
cord-023095-4dannjjm	4024	3	relationship	relationship	NN
cord-023095-4dannjjm	4024	4	between	between	IN
cord-023095-4dannjjm	4024	5	UPC	UPC	NNP
cord-023095-4dannjjm	4024	6	and	and	CC
cord-023095-4dannjjm	4024	7	G	G	NNP
cord-023095-4dannjjm	4024	8	,	,	,
cord-023095-4dannjjm	4024	9	SALB	SALB	NNP
cord-023095-4dannjjm	4024	10	and	and	CC
cord-023095-4dannjjm	4024	11	G	G	NNP
cord-023095-4dannjjm	4024	12	,	,	,
cord-023095-4dannjjm	4024	13	antithrombin	antithrombin	NN
cord-023095-4dannjjm	4024	14	and	and	CC
cord-023095-4dannjjm	4024	15	G	G	NNP
cord-023095-4dannjjm	4024	16	,	,	,
cord-023095-4dannjjm	4024	17	or	or	CC
cord-023095-4dannjjm	4024	18	SALB	SALB	NNP
cord-023095-4dannjjm	4024	19	and	and	CC
cord-023095-4dannjjm	4024	20	antithrombin	antithrombin	NN
cord-023095-4dannjjm	4024	21	was	be	VBD
cord-023095-4dannjjm	4024	22	noted	note	VBN
cord-023095-4dannjjm	4024	23	using	use	VBG
cord-023095-4dannjjm	4024	24	linear	linear	JJ
cord-023095-4dannjjm	4024	25	regression	regression	NN
cord-023095-4dannjjm	4024	26	analysis	analysis	NN
cord-023095-4dannjjm	4024	27	.	.	.
cord-023095-4dannjjm	4025	1	These	these	DT
cord-023095-4dannjjm	4025	2	results	result	NNS
cord-023095-4dannjjm	4025	3	indicate	indicate	VBP
cord-023095-4dannjjm	4025	4	that	that	IN
cord-023095-4dannjjm	4025	5	antithrombin	antithrombin	NN
cord-023095-4dannjjm	4025	6	,	,	,
cord-023095-4dannjjm	4025	7	SALB	SALB	NNP
cord-023095-4dannjjm	4025	8	,	,	,
cord-023095-4dannjjm	4025	9	and	and	CC
cord-023095-4dannjjm	4025	10	UPC	UPC	NNP
cord-023095-4dannjjm	4025	11	can	can	MD
cord-023095-4dannjjm	4025	12	not	not	RB
cord-023095-4dannjjm	4025	13	be	be	VB
cord-023095-4dannjjm	4025	14	used	use	VBN
cord-023095-4dannjjm	4025	15	alone	alone	RB
cord-023095-4dannjjm	4025	16	to	to	TO
cord-023095-4dannjjm	4025	17	predict	predict	VB
cord-023095-4dannjjm	4025	18	hypercoagulability	hypercoagulability	NN
cord-023095-4dannjjm	4025	19	as	as	IN
cord-023095-4dannjjm	4025	20	assessed	assess	VBN
cord-023095-4dannjjm	4025	21	by	by	IN
cord-023095-4dannjjm	4025	22	TEG	TEG	NNP
cord-023095-4dannjjm	4025	23	in	in	IN
cord-023095-4dannjjm	4025	24	dogs	dog	NNS
cord-023095-4dannjjm	4025	25	with	with	IN
cord-023095-4dannjjm	4025	26	PLN	PLN	NNP
cord-023095-4dannjjm	4025	27	.	.	.
cord-023095-4dannjjm	4026	1	A	a	DT
cord-023095-4dannjjm	4026	2	comprehensive	comprehensive	JJ
cord-023095-4dannjjm	4026	3	evaluation	evaluation	NN
cord-023095-4dannjjm	4026	4	of	of	IN
cord-023095-4dannjjm	4026	5	the	the	DT
cord-023095-4dannjjm	4026	6	coagulation	coagulation	NN
cord-023095-4dannjjm	4026	7	system	system	NN
cord-023095-4dannjjm	4026	8	in	in	IN
cord-023095-4dannjjm	4026	9	individual	individual	JJ
cord-023095-4dannjjm	4026	10	patients	patient	NNS
cord-023095-4dannjjm	4026	11	may	may	MD
cord-023095-4dannjjm	4026	12	be	be	VB
cord-023095-4dannjjm	4026	13	necessary	necessary	JJ
cord-023095-4dannjjm	4026	14	to	to	TO
cord-023095-4dannjjm	4026	15	predict	predict	VB
cord-023095-4dannjjm	4026	16	the	the	DT
cord-023095-4dannjjm	4026	17	point	point	NN
cord-023095-4dannjjm	4026	18	at	at	IN
cord-023095-4dannjjm	4026	19	which	which	WDT
cord-023095-4dannjjm	4026	20	to	to	TO
cord-023095-4dannjjm	4026	21	initiate	initiate	VB
cord-023095-4dannjjm	4026	22	anti	anti	JJ
cord-023095-4dannjjm	4026	23	-	-	JJ
cord-023095-4dannjjm	4026	24	thrombotic	thrombotic	JJ
cord-023095-4dannjjm	4026	25	therapy	therapy	NN
cord-023095-4dannjjm	4026	26	.	.	.
cord-023095-4dannjjm	4027	1	Cystinuria	Cystinuria	NNP
cord-023095-4dannjjm	4027	2	is	be	VBZ
cord-023095-4dannjjm	4027	3	a	a	DT
cord-023095-4dannjjm	4027	4	hereditary	hereditary	JJ
cord-023095-4dannjjm	4027	5	renal	renal	JJ
cord-023095-4dannjjm	4027	6	tubular	tubular	JJ
cord-023095-4dannjjm	4027	7	reabsorption	reabsorption	NN
cord-023095-4dannjjm	4027	8	defect	defect	NN
cord-023095-4dannjjm	4027	9	of	of	IN
cord-023095-4dannjjm	4027	10	cystine	cystine	NN
cord-023095-4dannjjm	4027	11	,	,	,
cord-023095-4dannjjm	4027	12	ornithine	ornithine	NN
cord-023095-4dannjjm	4027	13	,	,	,
cord-023095-4dannjjm	4027	14	lysine	lysine	NN
cord-023095-4dannjjm	4027	15	and	and	CC
cord-023095-4dannjjm	4027	16	arginine	arginine	NN
cord-023095-4dannjjm	4027	17	(	(	-LRB-
cord-023095-4dannjjm	4027	18	collectively	collectively	RB
cord-023095-4dannjjm	4027	19	,	,	,
cord-023095-4dannjjm	4027	20	COLA	COLA	NNP
cord-023095-4dannjjm	4027	21	)	)	-RRB-
cord-023095-4dannjjm	4027	22	.	.	.
cord-023095-4dannjjm	4028	1	The	the	DT
cord-023095-4dannjjm	4028	2	low	low	JJ
cord-023095-4dannjjm	4028	3	solubility	solubility	NN
cord-023095-4dannjjm	4028	4	of	of	IN
cord-023095-4dannjjm	4028	5	cystine	cystine	NN
cord-023095-4dannjjm	4028	6	in	in	IN
cord-023095-4dannjjm	4028	7	acidic	acidic	JJ
cord-023095-4dannjjm	4028	8	urine	urine	NN
cord-023095-4dannjjm	4028	9	predisposes	predispose	VBZ
cord-023095-4dannjjm	4028	10	to	to	IN
cord-023095-4dannjjm	4028	11	the	the	DT
cord-023095-4dannjjm	4028	12	formation	formation	NN
cord-023095-4dannjjm	4028	13	of	of	IN
cord-023095-4dannjjm	4028	14	uroliths	uroliths	NNP
cord-023095-4dannjjm	4028	15	.	.	.
cord-023095-4dannjjm	4029	1	Type	type	NN
cord-023095-4dannjjm	4030	1	I	-PRON-	PRP
cord-023095-4dannjjm	4030	2	cystinuria	cystinuria	VBP
cord-023095-4dannjjm	4030	3	in	in	IN
cord-023095-4dannjjm	4030	4	Newfoundland	Newfoundland	NNP
cord-023095-4dannjjm	4030	5	and	and	CC
cord-023095-4dannjjm	4030	6	Labrador	Labrador	NNP
cord-023095-4dannjjm	4030	7	Retriever	Retriever	NNP
cord-023095-4dannjjm	4030	8	dogs	dog	NNS
cord-023095-4dannjjm	4030	9	is	be	VBZ
cord-023095-4dannjjm	4030	10	an	an	DT
cord-023095-4dannjjm	4030	11	autosomal	autosomal	JJ
cord-023095-4dannjjm	4030	12	recessive	recessive	JJ
cord-023095-4dannjjm	4030	13	trait	trait	NN
cord-023095-4dannjjm	4030	14	caused	cause	VBN
cord-023095-4dannjjm	4030	15	by	by	IN
cord-023095-4dannjjm	4030	16	mutations	mutation	NNS
cord-023095-4dannjjm	4030	17	in	in	IN
cord-023095-4dannjjm	4030	18	the	the	DT
cord-023095-4dannjjm	4030	19	SLC3A1	SLC3A1	NNP
cord-023095-4dannjjm	4030	20	gene	gene	NN
cord-023095-4dannjjm	4030	21	,	,	,
cord-023095-4dannjjm	4030	22	whereas	whereas	IN
cord-023095-4dannjjm	4030	23	in	in	IN
cord-023095-4dannjjm	4030	24	other	other	JJ
cord-023095-4dannjjm	4030	25	breeds	breed	NNS
cord-023095-4dannjjm	4030	26	,	,	,
cord-023095-4dannjjm	4030	27	the	the	DT
cord-023095-4dannjjm	4030	28	cause	cause	NN
cord-023095-4dannjjm	4030	29	of	of	IN
cord-023095-4dannjjm	4030	30	cystinuria	cystinuria	NNS
cord-023095-4dannjjm	4030	31	has	have	VBZ
cord-023095-4dannjjm	4030	32	not	not	RB
cord-023095-4dannjjm	4030	33	yet	yet	RB
cord-023095-4dannjjm	4030	34	been	be	VBN
cord-023095-4dannjjm	4030	35	determined	determine	VBN
cord-023095-4dannjjm	4030	36	.	.	.
cord-023095-4dannjjm	4031	1	We	-PRON-	PRP
cord-023095-4dannjjm	4031	2	report	report	VBP
cord-023095-4dannjjm	4031	3	here	here	RB
cord-023095-4dannjjm	4031	4	on	on	IN
cord-023095-4dannjjm	4031	5	the	the	DT
cord-023095-4dannjjm	4031	6	clinical	clinical	JJ
cord-023095-4dannjjm	4031	7	,	,	,
cord-023095-4dannjjm	4031	8	biochemical	biochemical	JJ
cord-023095-4dannjjm	4031	9	and	and	CC
cord-023095-4dannjjm	4031	10	molecular	molecular	JJ
cord-023095-4dannjjm	4031	11	features	feature	NNS
cord-023095-4dannjjm	4031	12	of	of	IN
cord-023095-4dannjjm	4031	13	cystinuria	cystinuria	NNS
cord-023095-4dannjjm	4031	14	in	in	IN
cord-023095-4dannjjm	4031	15	Irish	irish	JJ
cord-023095-4dannjjm	4031	16	Terriers	terrier	NNS
cord-023095-4dannjjm	4031	17	.	.	.
cord-023095-4dannjjm	4032	1	Urine	urine	NN
cord-023095-4dannjjm	4032	2	and	and	CC
cord-023095-4dannjjm	4032	3	EDTA	EDTA	NNP
cord-023095-4dannjjm	4032	4	blood	blood	NN
cord-023095-4dannjjm	4032	5	were	be	VBD
cord-023095-4dannjjm	4032	6	collected	collect	VBN
cord-023095-4dannjjm	4032	7	from	from	IN
cord-023095-4dannjjm	4032	8	222	222	CD
cord-023095-4dannjjm	4032	9	Irish	irish	JJ
cord-023095-4dannjjm	4032	10	Terriers	Terriers	NNPS
cord-023095-4dannjjm	4032	11	from	from	IN
cord-023095-4dannjjm	4032	12	Europe	Europe	NNP
cord-023095-4dannjjm	4032	13	and	and	CC
cord-023095-4dannjjm	4032	14	Australia	Australia	NNP
cord-023095-4dannjjm	4032	15	.	.	.
cord-023095-4dannjjm	4033	1	A	a	DT
cord-023095-4dannjjm	4033	2	nitroprusside	nitroprusside	JJ
cord-023095-4dannjjm	4033	3	screening	screening	NN
cord-023095-4dannjjm	4033	4	test	test	NN
cord-023095-4dannjjm	4033	5	was	be	VBD
cord-023095-4dannjjm	4033	6	used	use	VBN
cord-023095-4dannjjm	4033	7	to	to	TO
cord-023095-4dannjjm	4033	8	identify	identify	VB
cord-023095-4dannjjm	4033	9	increased	increase	VBN
cord-023095-4dannjjm	4033	10	cystine	cystine	NN
cord-023095-4dannjjm	4033	11	in	in	IN
cord-023095-4dannjjm	4033	12	urine	urine	NN
cord-023095-4dannjjm	4033	13	.	.	.
cord-023095-4dannjjm	4034	1	Urinary	urinary	JJ
cord-023095-4dannjjm	4034	2	amino	amino	NN
cord-023095-4dannjjm	4034	3	acid	acid	NN
cord-023095-4dannjjm	4034	4	concentrations	concentration	NNS
cord-023095-4dannjjm	4034	5	were	be	VBD
cord-023095-4dannjjm	4034	6	determined	determine	VBN
cord-023095-4dannjjm	4034	7	by	by	IN
cord-023095-4dannjjm	4034	8	high	high	JJ
cord-023095-4dannjjm	4034	9	-	-	HYPH
cord-023095-4dannjjm	4034	10	pressure	pressure	NN
cord-023095-4dannjjm	4034	11	liquid	liquid	NN
cord-023095-4dannjjm	4034	12	chromatography	chromatography	NN
cord-023095-4dannjjm	4034	13	.	.	.
cord-023095-4dannjjm	4035	1	Cystinuric	cystinuric	JJ
cord-023095-4dannjjm	4035	2	dogs	dog	NNS
cord-023095-4dannjjm	4035	3	were	be	VBD
cord-023095-4dannjjm	4035	4	defined	define	VBN
cord-023095-4dannjjm	4035	5	as	as	IN
cord-023095-4dannjjm	4035	6	having	have	VBG
cord-023095-4dannjjm	4035	7	cystine	cystine	NN
cord-023095-4dannjjm	4035	8	calculi	calculus	NNS
cord-023095-4dannjjm	4035	9	,	,	,
cord-023095-4dannjjm	4035	10	a	a	DT
cord-023095-4dannjjm	4035	11	positive	positive	JJ
cord-023095-4dannjjm	4035	12	nitroprusside	nitroprusside	JJ
cord-023095-4dannjjm	4035	13	result	result	NN
cord-023095-4dannjjm	4035	14	,	,	,
cord-023095-4dannjjm	4035	15	urinary	urinary	JJ
cord-023095-4dannjjm	4035	16	cystine	cystine	NN
cord-023095-4dannjjm	4035	17	(	(	-LRB-
cord-023095-4dannjjm	4035	18	4	4	CD
cord-023095-4dannjjm	4035	19	179	179	CD
cord-023095-4dannjjm	4035	20	mmol	mmol	JJ
cord-023095-4dannjjm	4035	21	/	/	SYM
cord-023095-4dannjjm	4035	22	g	g	NN
cord-023095-4dannjjm	4035	23	creatinine	creatinine	NN
cord-023095-4dannjjm	4035	24	)	)	-RRB-
cord-023095-4dannjjm	4036	1	and/	and/	NNP
cord-023095-4dannjjm	4036	2	or	or	CC
cord-023095-4dannjjm	4036	3	a	a	DT
cord-023095-4dannjjm	4036	4	COLA	COLA	NNP
cord-023095-4dannjjm	4036	5	concentration	concentration	NN
cord-023095-4dannjjm	4036	6	of	of	IN
cord-023095-4dannjjm	4036	7	4	4	CD
cord-023095-4dannjjm	4036	8	700	700	CD
cord-023095-4dannjjm	4036	9	mmol	mmol	JJ
cord-023095-4dannjjm	4036	10	/	/	SYM
cord-023095-4dannjjm	4036	11	g	g	NN
cord-023095-4dannjjm	4036	12	creatinine	creatinine	NN
cord-023095-4dannjjm	4036	13	.	.	.
cord-023095-4dannjjm	4037	1	All	all	DT
cord-023095-4dannjjm	4037	2	83	83	CD
cord-023095-4dannjjm	4037	3	females	female	NNS
cord-023095-4dannjjm	4037	4	tested	test	VBN
cord-023095-4dannjjm	4037	5	nitroprusside	nitroprusside	RB
cord-023095-4dannjjm	4037	6	negative	negative	JJ
cord-023095-4dannjjm	4037	7	and	and	CC
cord-023095-4dannjjm	4037	8	had	have	VBD
cord-023095-4dannjjm	4037	9	normal	normal	JJ
cord-023095-4dannjjm	4037	10	urinary	urinary	JJ
cord-023095-4dannjjm	4037	11	cystine	cystine	NN
cord-023095-4dannjjm	4037	12	(	(	-LRB-
cord-023095-4dannjjm	4037	13	o	o	UH
cord-023095-4dannjjm	4037	14	150	150	CD
cord-023095-4dannjjm	4037	15	mmol	mmol	JJ
cord-023095-4dannjjm	4037	16	/	/	SYM
cord-023095-4dannjjm	4037	17	g	g	NN
cord-023095-4dannjjm	4037	18	creatinine	creatinine	NN
cord-023095-4dannjjm	4037	19	)	)	-RRB-
cord-023095-4dannjjm	4037	20	and	and	CC
cord-023095-4dannjjm	4037	21	COLA	COLA	NNP
cord-023095-4dannjjm	4037	22	(	(	-LRB-
cord-023095-4dannjjm	4037	23	o	o	NN
cord-023095-4dannjjm	4037	24	500	500	CD
cord-023095-4dannjjm	4037	25	mmol	mmol	JJ
cord-023095-4dannjjm	4037	26	/	/	SYM
cord-023095-4dannjjm	4037	27	g	g	NN
cord-023095-4dannjjm	4037	28	creatinine	creatinine	NN
cord-023095-4dannjjm	4037	29	)	)	-RRB-
cord-023095-4dannjjm	4037	30	concentrations	concentration	NNS
cord-023095-4dannjjm	4037	31	.	.	.
cord-023095-4dannjjm	4038	1	The	the	DT
cord-023095-4dannjjm	4038	2	10	10	CD
cord-023095-4dannjjm	4038	3	intact	intact	JJ
cord-023095-4dannjjm	4038	4	males	male	NNS
cord-023095-4dannjjm	4038	5	that	that	WDT
cord-023095-4dannjjm	4038	6	formed	form	VBD
cord-023095-4dannjjm	4038	7	calculi	calculus	NNS
cord-023095-4dannjjm	4038	8	as	as	IN
cord-023095-4dannjjm	4038	9	adults	adult	NNS
cord-023095-4dannjjm	4038	10	exhibited	exhibit	VBD
cord-023095-4dannjjm	4038	11	cystine	cystine	NN
cord-023095-4dannjjm	4038	12	concentrations	concentration	NNS
cord-023095-4dannjjm	4038	13	ranging	range	VBG
cord-023095-4dannjjm	4038	14	from	from	IN
cord-023095-4dannjjm	4038	15	323	323	CD
cord-023095-4dannjjm	4038	16	-	-	HYPH
cord-023095-4dannjjm	4038	17	1580	1580	CD
cord-023095-4dannjjm	4038	18	and	and	CC
cord-023095-4dannjjm	4038	19	COLA	COLA	NNP
cord-023095-4dannjjm	4038	20	from	from	IN
cord-023095-4dannjjm	4038	21	1029	1029	CD
cord-023095-4dannjjm	4038	22	-	-	HYPH
cord-023095-4dannjjm	4038	23	4302	4302	CD
cord-023095-4dannjjm	4038	24	mmol	mmol	JJ
cord-023095-4dannjjm	4038	25	/	/	SYM
cord-023095-4dannjjm	4038	26	g	g	NN
cord-023095-4dannjjm	4038	27	creatinine	creatinine	NN
cord-023095-4dannjjm	4038	28	.	.	.
cord-023095-4dannjjm	4039	1	An	an	DT
cord-023095-4dannjjm	4039	2	additional	additional	JJ
cord-023095-4dannjjm	4039	3	41	41	CD
cord-023095-4dannjjm	4039	4	males	male	NNS
cord-023095-4dannjjm	4039	5	had	have	VBD
cord-023095-4dannjjm	4039	6	similarly	similarly	RB
cord-023095-4dannjjm	4039	7	high	high	JJ
cord-023095-4dannjjm	4039	8	COLA	COLA	NNP
cord-023095-4dannjjm	4039	9	values	value	NNS
cord-023095-4dannjjm	4039	10	with	with	IN
cord-023095-4dannjjm	4039	11	cystine	cystine	NN
cord-023095-4dannjjm	4039	12	levels	level	NNS
cord-023095-4dannjjm	4039	13	from	from	IN
cord-023095-4dannjjm	4039	14	0	0	CD
cord-023095-4dannjjm	4039	15	-	-	HYPH
cord-023095-4dannjjm	4039	16	1580	1580	CD
cord-023095-4dannjjm	4039	17	mmol	mmol	NNP
cord-023095-4dannjjm	4039	18	/	/	SYM
cord-023095-4dannjjm	4039	19	g	g	NN
cord-023095-4dannjjm	4039	20	creatinine	creatinine	NN
cord-023095-4dannjjm	4039	21	.	.	.
cord-023095-4dannjjm	4040	1	Among	among	IN
cord-023095-4dannjjm	4040	2	the	the	DT
cord-023095-4dannjjm	4040	3	affecteds	affecteds	NNP
cord-023095-4dannjjm	4040	4	tested	test	VBD
cord-023095-4dannjjm	4040	5	,	,	,
cord-023095-4dannjjm	4040	6	75	75	CD
cord-023095-4dannjjm	4040	7	%	%	NN
cord-023095-4dannjjm	4040	8	were	be	VBD
cord-023095-4dannjjm	4040	9	nitroprusside	nitroprusside	RB
cord-023095-4dannjjm	4040	10	positive	positive	JJ
cord-023095-4dannjjm	4040	11	.	.	.
cord-023095-4dannjjm	4041	1	The	the	DT
cord-023095-4dannjjm	4041	2	negative	negative	JJ
cord-023095-4dannjjm	4041	3	nitroprusside	nitroprusside	JJ
cord-023095-4dannjjm	4041	4	results	result	NNS
cord-023095-4dannjjm	4041	5	and/or	and/or	CC
cord-023095-4dannjjm	4041	6	low	low	JJ
cord-023095-4dannjjm	4041	7	urinary	urinary	JJ
cord-023095-4dannjjm	4041	8	cystine	cystine	NN
cord-023095-4dannjjm	4041	9	levels	level	NNS
cord-023095-4dannjjm	4041	10	of	of	IN
cord-023095-4dannjjm	4041	11	affecteds	affecteds	NNPS
cord-023095-4dannjjm	4041	12	may	may	MD
cord-023095-4dannjjm	4041	13	be	be	VB
cord-023095-4dannjjm	4041	14	due	due	JJ
cord-023095-4dannjjm	4041	15	to	to	IN
cord-023095-4dannjjm	4041	16	precipitation	precipitation	NN
cord-023095-4dannjjm	4041	17	of	of	IN
cord-023095-4dannjjm	4041	18	cystine	cystine	NN
cord-023095-4dannjjm	4041	19	in	in	IN
cord-023095-4dannjjm	4041	20	acidic	acidic	JJ
cord-023095-4dannjjm	4041	21	urine	urine	NN
cord-023095-4dannjjm	4041	22	.	.	.
cord-023095-4dannjjm	4042	1	Sequencing	sequence	VBG
cord-023095-4dannjjm	4042	2	the	the	DT
cord-023095-4dannjjm	4042	3	coding	code	VBG
cord-023095-4dannjjm	4042	4	regions	region	NNS
cord-023095-4dannjjm	4042	5	of	of	IN
cord-023095-4dannjjm	4042	6	the	the	DT
cord-023095-4dannjjm	4042	7	SLC3A1	SLC3A1	NNP
cord-023095-4dannjjm	4042	8	and	and	CC
cord-023095-4dannjjm	4042	9	SLC7A9	SLC7A9	NNP
cord-023095-4dannjjm	4042	10	genes	gene	NNS
cord-023095-4dannjjm	4042	11	from	from	IN
cord-023095-4dannjjm	4042	12	EDTA	EDTA	NNP
cord-023095-4dannjjm	4042	13	blood	blood	NN
cord-023095-4dannjjm	4042	14	identified	identify	VBD
cord-023095-4dannjjm	4042	15	no	no	DT
cord-023095-4dannjjm	4042	16	mutations	mutation	NNS
cord-023095-4dannjjm	4042	17	.	.	.
cord-023095-4dannjjm	4043	1	The	the	DT
cord-023095-4dannjjm	4043	2	mode	mode	NN
cord-023095-4dannjjm	4043	3	of	of	IN
cord-023095-4dannjjm	4043	4	inheritance	inheritance	NN
cord-023095-4dannjjm	4043	5	remains	remain	VBZ
cord-023095-4dannjjm	4043	6	undetermined	undetermined	JJ
cord-023095-4dannjjm	4043	7	.	.	.
cord-023095-4dannjjm	4044	1	However	however	RB
cord-023095-4dannjjm	4044	2	,	,	,
cord-023095-4dannjjm	4044	3	castration	castration	NN
cord-023095-4dannjjm	4044	4	appears	appear	VBZ
cord-023095-4dannjjm	4044	5	to	to	TO
cord-023095-4dannjjm	4044	6	lower	lower	VB
cord-023095-4dannjjm	4044	7	the	the	DT
cord-023095-4dannjjm	4044	8	urinary	urinary	JJ
cord-023095-4dannjjm	4044	9	cystine	cystine	NN
cord-023095-4dannjjm	4044	10	and	and	CC
cord-023095-4dannjjm	4044	11	COLA	COLA	NNP
cord-023095-4dannjjm	4044	12	concentrations	concentration	NNS
cord-023095-4dannjjm	4044	13	and	and	CC
cord-023095-4dannjjm	4044	14	to	to	TO
cord-023095-4dannjjm	4044	15	prevent	prevent	VB
cord-023095-4dannjjm	4044	16	cystine	cystine	NN
cord-023095-4dannjjm	4044	17	calculi	calculus	NNS
cord-023095-4dannjjm	4044	18	formation	formation	NN
cord-023095-4dannjjm	4044	19	,	,	,
cord-023095-4dannjjm	4044	20	while	while	IN
cord-023095-4dannjjm	4044	21	diet	diet	NN
cord-023095-4dannjjm	4044	22	changes	change	NNS
cord-023095-4dannjjm	4044	23	have	have	VBP
cord-023095-4dannjjm	4044	24	lesser	less	JJR
cord-023095-4dannjjm	4044	25	effects	effect	NNS
cord-023095-4dannjjm	4044	26	.	.	.
cord-023095-4dannjjm	4045	1	In	in	IN
cord-023095-4dannjjm	4045	2	conclusion	conclusion	NN
cord-023095-4dannjjm	4045	3	,	,	,
cord-023095-4dannjjm	4045	4	non	non	JJ
cord-023095-4dannjjm	4045	5	-	-	JJ
cord-023095-4dannjjm	4045	6	type	type	NN
cord-023095-4dannjjm	4045	7	I	-PRON-	PRP
cord-023095-4dannjjm	4045	8	cystinuria	cystinuria	VBP
cord-023095-4dannjjm	4045	9	in	in	IN
cord-023095-4dannjjm	4045	10	Irish	irish	JJ
cord-023095-4dannjjm	4045	11	Terriers	Terriers	NNPS
cord-023095-4dannjjm	4045	12	(	(	-LRB-
cord-023095-4dannjjm	4045	13	and	and	CC
cord-023095-4dannjjm	4045	14	several	several	JJ
cord-023095-4dannjjm	4045	15	other	other	JJ
cord-023095-4dannjjm	4045	16	breeds	breed	NNS
cord-023095-4dannjjm	4045	17	like	like	IN
cord-023095-4dannjjm	4045	18	Mastiffs	Mastiffs	NNPS
cord-023095-4dannjjm	4045	19	and	and	CC
cord-023095-4dannjjm	4045	20	Scottish	Scottish	NNP
cord-023095-4dannjjm	4045	21	Deerhounds	Deerhounds	NNPS
cord-023095-4dannjjm	4045	22	)	)	-RRB-
cord-023095-4dannjjm	4045	23	is	be	VBZ
cord-023095-4dannjjm	4045	24	a	a	DT
cord-023095-4dannjjm	4045	25	unique	unique	JJ
cord-023095-4dannjjm	4045	26	form	form	NN
cord-023095-4dannjjm	4045	27	characterized	characterize	VBN
cord-023095-4dannjjm	4045	28	by	by	IN
cord-023095-4dannjjm	4045	29	increased	increase	VBN
cord-023095-4dannjjm	4045	30	aminoaciduria	aminoaciduria	NN
cord-023095-4dannjjm	4045	31	only	only	RB
cord-023095-4dannjjm	4045	32	in	in	IN
cord-023095-4dannjjm	4045	33	males	male	NNS
cord-023095-4dannjjm	4045	34	,	,	,
cord-023095-4dannjjm	4045	35	with	with	IN
cord-023095-4dannjjm	4045	36	lower	low	JJR
cord-023095-4dannjjm	4045	37	cystine	cystine	NN
cord-023095-4dannjjm	4045	38	and	and	CC
cord-023095-4dannjjm	4045	39	COLA	COLA	NNP
cord-023095-4dannjjm	4045	40	excretion	excretion	NN
cord-023095-4dannjjm	4045	41	and	and	CC
cord-023095-4dannjjm	4045	42	fewer	few	JJR
cord-023095-4dannjjm	4045	43	and	and	CC
cord-023095-4dannjjm	4045	44	later	later	RB
cord-023095-4dannjjm	4045	45	urolith	urolith	NN
cord-023095-4dannjjm	4045	46	formation	formation	NN
cord-023095-4dannjjm	4045	47	compared	compare	VBN
cord-023095-4dannjjm	4045	48	to	to	IN
cord-023095-4dannjjm	4045	49	type	type	NN
cord-023095-4dannjjm	4045	50	I	-PRON-	PRP
cord-023095-4dannjjm	4045	51	cystinuria	cystinuria	NNS
cord-023095-4dannjjm	4045	52	.	.	.
cord-023095-4dannjjm	4046	1	Castrating	castrate	VBG
cord-023095-4dannjjm	4046	2	cystinuric	cystinuric	NN
cord-023095-4dannjjm	4046	3	Irish	Irish	NNP
cord-023095-4dannjjm	4046	4	Terriers	Terriers	NNPS
cord-023095-4dannjjm	4046	5	lowers	lower	VBZ
cord-023095-4dannjjm	4046	6	their	-PRON-	PRP$
cord-023095-4dannjjm	4046	7	cystine	cystine	NN
cord-023095-4dannjjm	4046	8	and	and	CC
cord-023095-4dannjjm	4046	9	COLA	COLA	NNP
cord-023095-4dannjjm	4046	10	excretion	excretion	NN
cord-023095-4dannjjm	4046	11	and	and	CC
cord-023095-4dannjjm	4046	12	thus	thus	RB
cord-023095-4dannjjm	4046	13	their	-PRON-	PRP$
cord-023095-4dannjjm	4046	14	risk	risk	NN
cord-023095-4dannjjm	4046	15	for	for	IN
cord-023095-4dannjjm	4046	16	calculi	calculus	NNS
cord-023095-4dannjjm	4046	17	formation	formation	NN
cord-023095-4dannjjm	4046	18	.	.	.
cord-023095-4dannjjm	4047	1	Cats	cat	NNS
cord-023095-4dannjjm	4047	2	and	and	CC
cord-023095-4dannjjm	4047	3	dogs	dog	NNS
cord-023095-4dannjjm	4047	4	that	that	WDT
cord-023095-4dannjjm	4047	5	are	be	VBP
cord-023095-4dannjjm	4047	6	diagnosed	diagnose	VBN
cord-023095-4dannjjm	4047	7	with	with	IN
cord-023095-4dannjjm	4047	8	acute	acute	JJ
cord-023095-4dannjjm	4047	9	kidney	kidney	NN
cord-023095-4dannjjm	4047	10	injury	injury	NN
cord-023095-4dannjjm	4047	11	(	(	-LRB-
cord-023095-4dannjjm	4047	12	AKI	AKI	NNP
cord-023095-4dannjjm	4047	13	)	)	-RRB-
cord-023095-4dannjjm	4047	14	and	and	CC
cord-023095-4dannjjm	4047	15	resultant	resultant	JJ
cord-023095-4dannjjm	4047	16	uremia	uremia	NN
cord-023095-4dannjjm	4047	17	that	that	WDT
cord-023095-4dannjjm	4047	18	is	be	VBZ
cord-023095-4dannjjm	4047	19	not	not	RB
cord-023095-4dannjjm	4047	20	responsive	responsive	JJ
cord-023095-4dannjjm	4047	21	to	to	IN
cord-023095-4dannjjm	4047	22	standard	standard	JJ
cord-023095-4dannjjm	4047	23	medical	medical	JJ
cord-023095-4dannjjm	4047	24	therapy	therapy	NN
cord-023095-4dannjjm	4047	25	are	be	VBP
cord-023095-4dannjjm	4047	26	likely	likely	JJ
cord-023095-4dannjjm	4047	27	to	to	TO
cord-023095-4dannjjm	4047	28	benefit	benefit	VB
cord-023095-4dannjjm	4047	29	from	from	IN
cord-023095-4dannjjm	4047	30	renal	renal	JJ
cord-023095-4dannjjm	4047	31	replacement	replacement	NN
cord-023095-4dannjjm	4047	32	therapies	therapy	NNS
cord-023095-4dannjjm	4047	33	,	,	,
cord-023095-4dannjjm	4047	34	such	such	JJ
cord-023095-4dannjjm	4047	35	as	as	IN
cord-023095-4dannjjm	4047	36	intermittent	intermittent	JJ
cord-023095-4dannjjm	4047	37	hemodialysis	hemodialysis	NN
cord-023095-4dannjjm	4047	38	(	(	-LRB-
cord-023095-4dannjjm	4047	39	IHD	IHD	NNP
cord-023095-4dannjjm	4047	40	)	)	-RRB-
cord-023095-4dannjjm	4047	41	.	.	.
cord-023095-4dannjjm	4048	1	The	the	DT
cord-023095-4dannjjm	4048	2	purpose	purpose	NN
cord-023095-4dannjjm	4048	3	of	of	IN
cord-023095-4dannjjm	4048	4	this	this	DT
cord-023095-4dannjjm	4048	5	study	study	NN
cord-023095-4dannjjm	4048	6	was	be	VBD
cord-023095-4dannjjm	4048	7	to	to	TO
cord-023095-4dannjjm	4048	8	evaluate	evaluate	VB
cord-023095-4dannjjm	4048	9	the	the	DT
cord-023095-4dannjjm	4048	10	long	long	JJ
cord-023095-4dannjjm	4048	11	-	-	HYPH
cord-023095-4dannjjm	4048	12	term	term	NN
cord-023095-4dannjjm	4048	13	outcome	outcome	NN
cord-023095-4dannjjm	4048	14	of	of	IN
cord-023095-4dannjjm	4048	15	patients	patient	NNS
cord-023095-4dannjjm	4048	16	with	with	IN
cord-023095-4dannjjm	4048	17	AKI	AKI	NNP
cord-023095-4dannjjm	4048	18	treated	treat	VBN
cord-023095-4dannjjm	4048	19	with	with	IN
cord-023095-4dannjjm	4048	20	IHD	IHD	NNP
cord-023095-4dannjjm	4048	21	,	,	,
cord-023095-4dannjjm	4048	22	and	and	CC
cord-023095-4dannjjm	4048	23	to	to	TO
cord-023095-4dannjjm	4048	24	establish	establish	VB
cord-023095-4dannjjm	4048	25	whether	whether	IN
cord-023095-4dannjjm	4048	26	renal	renal	JJ
cord-023095-4dannjjm	4048	27	function	function	NN
cord-023095-4dannjjm	4048	28	,	,	,
cord-023095-4dannjjm	4048	29	as	as	IN
cord-023095-4dannjjm	4048	30	determined	determine	VBN
cord-023095-4dannjjm	4048	31	by	by	IN
cord-023095-4dannjjm	4048	32	serum	serum	NN
cord-023095-4dannjjm	4048	33	or	or	CC
cord-023095-4dannjjm	4048	34	plasma	plasma	NN
cord-023095-4dannjjm	4048	35	creatinine	creatinine	NN
cord-023095-4dannjjm	4048	36	concentrations	concentration	NNS
cord-023095-4dannjjm	4048	37	,	,	,
cord-023095-4dannjjm	4048	38	is	be	VBZ
cord-023095-4dannjjm	4048	39	associated	associate	VBN
cord-023095-4dannjjm	4048	40	with	with	IN
cord-023095-4dannjjm	4048	41	longterm	longterm	JJ
cord-023095-4dannjjm	4048	42	survival	survival	NN
cord-023095-4dannjjm	4048	43	.	.	.
cord-023095-4dannjjm	4049	1	Medical	medical	JJ
cord-023095-4dannjjm	4049	2	records	record	NNS
cord-023095-4dannjjm	4049	3	of	of	IN
cord-023095-4dannjjm	4049	4	20	20	CD
cord-023095-4dannjjm	4049	5	cats	cat	NNS
cord-023095-4dannjjm	4049	6	and	and	CC
cord-023095-4dannjjm	4049	7	35	35	CD
cord-023095-4dannjjm	4049	8	dogs	dog	NNS
cord-023095-4dannjjm	4049	9	that	that	WDT
cord-023095-4dannjjm	4049	10	were	be	VBD
cord-023095-4dannjjm	4049	11	diagnosed	diagnose	VBN
cord-023095-4dannjjm	4049	12	with	with	IN
cord-023095-4dannjjm	4049	13	AKI	AKI	NNP
cord-023095-4dannjjm	4049	14	,	,	,
cord-023095-4dannjjm	4049	15	treated	treat	VBN
cord-023095-4dannjjm	4049	16	with	with	IN
cord-023095-4dannjjm	4049	17	IHD	IHD	NNP
cord-023095-4dannjjm	4049	18	,	,	,
cord-023095-4dannjjm	4049	19	and	and	CC
cord-023095-4dannjjm	4049	20	survived	survive	VBD
cord-023095-4dannjjm	4049	21	longer	long	RBR
cord-023095-4dannjjm	4049	22	than	than	IN
cord-023095-4dannjjm	4049	23	30	30	CD
cord-023095-4dannjjm	4049	24	days	day	NNS
cord-023095-4dannjjm	4049	25	following	follow	VBG
cord-023095-4dannjjm	4049	26	the	the	DT
cord-023095-4dannjjm	4049	27	last	last	JJ
cord-023095-4dannjjm	4049	28	IHD	IHD	NNP
cord-023095-4dannjjm	4049	29	treatment	treatment	NN
cord-023095-4dannjjm	4049	30	were	be	VBD
cord-023095-4dannjjm	4049	31	retrospectively	retrospectively	RB
cord-023095-4dannjjm	4049	32	analyzed	analyze	VBN
cord-023095-4dannjjm	4049	33	.	.	.
cord-023095-4dannjjm	4050	1	Standard	standard	JJ
cord-023095-4dannjjm	4050	2	methods	method	NNS
cord-023095-4dannjjm	4050	3	of	of	IN
cord-023095-4dannjjm	4050	4	survival	survival	NN
cord-023095-4dannjjm	4050	5	analysis	analysis	NN
cord-023095-4dannjjm	4050	6	using	use	VBG
cord-023095-4dannjjm	4050	7	Kaplan	Kaplan	NNP
cord-023095-4dannjjm	4050	8	-	-	HYPH
cord-023095-4dannjjm	4050	9	Meier	Meier	NNP
cord-023095-4dannjjm	4050	10	product	product	NN
cord-023095-4dannjjm	4050	11	limit	limit	NN
cord-023095-4dannjjm	4050	12	curves	curve	NNS
cord-023095-4dannjjm	4050	13	and	and	CC
cord-023095-4dannjjm	4050	14	the	the	DT
cord-023095-4dannjjm	4050	15	log	log	NN
cord-023095-4dannjjm	4050	16	-	-	HYPH
cord-023095-4dannjjm	4050	17	rank	rank	NN
cord-023095-4dannjjm	4050	18	test	test	NN
cord-023095-4dannjjm	4050	19	were	be	VBD
cord-023095-4dannjjm	4050	20	performed	perform	VBN
cord-023095-4dannjjm	4050	21	.	.	.
cord-023095-4dannjjm	4051	1	For	for	IN
cord-023095-4dannjjm	4051	2	all	all	DT
cord-023095-4dannjjm	4051	3	-	-	HYPH
cord-023095-4dannjjm	4051	4	cause	cause	NN
cord-023095-4dannjjm	4051	5	mortality	mortality	NN
cord-023095-4dannjjm	4051	6	,	,	,
cord-023095-4dannjjm	4051	7	the	the	DT
cord-023095-4dannjjm	4051	8	median	median	JJ
cord-023095-4dannjjm	4051	9	survival	survival	NN
cord-023095-4dannjjm	4051	10	time	time	NN
cord-023095-4dannjjm	4051	11	was	be	VBD
cord-023095-4dannjjm	4051	12	1823	1823	CD
cord-023095-4dannjjm	4051	13	days	day	NNS
cord-023095-4dannjjm	4052	1	(	(	-LRB-
cord-023095-4dannjjm	4052	2	95	95	CD
cord-023095-4dannjjm	4052	3	%	%	NN
cord-023095-4dannjjm	4052	4	confidence	confidence	NN
cord-023095-4dannjjm	4052	5	interval	interval	NN
cord-023095-4dannjjm	4052	6	:	:	:
cord-023095-4dannjjm	4052	7	841	841	CD
cord-023095-4dannjjm	4052	8	,	,	,
cord-023095-4dannjjm	4052	9	4667	4667	CD
cord-023095-4dannjjm	4052	10	)	)	-RRB-
cord-023095-4dannjjm	4052	11	for	for	IN
cord-023095-4dannjjm	4052	12	cats	cat	NNS
cord-023095-4dannjjm	4052	13	and	and	CC
cord-023095-4dannjjm	4052	14	1049	1049	CD
cord-023095-4dannjjm	4052	15	days	day	NNS
cord-023095-4dannjjm	4052	16	(	(	-LRB-
cord-023095-4dannjjm	4052	17	95	95	CD
cord-023095-4dannjjm	4052	18	%	%	NN
cord-023095-4dannjjm	4052	19	confidence	confidence	NN
cord-023095-4dannjjm	4052	20	interval	interval	NN
cord-023095-4dannjjm	4052	21	:	:	:
cord-023095-4dannjjm	4052	22	893	893	CD
cord-023095-4dannjjm	4052	23	,	,	,
cord-023095-4dannjjm	4052	24	1931	1931	CD
cord-023095-4dannjjm	4052	25	)	)	-RRB-
cord-023095-4dannjjm	4052	26	for	for	IN
cord-023095-4dannjjm	4052	27	dogs	dog	NNS
cord-023095-4dannjjm	4052	28	.	.	.
cord-023095-4dannjjm	4053	1	When	when	WRB
cord-023095-4dannjjm	4053	2	only	only	RB
cord-023095-4dannjjm	4053	3	renal	renal	JJ
cord-023095-4dannjjm	4053	4	-	-	HYPH
cord-023095-4dannjjm	4053	5	related	relate	VBN
cord-023095-4dannjjm	4053	6	causes	cause	NNS
cord-023095-4dannjjm	4053	7	of	of	IN
cord-023095-4dannjjm	4053	8	death	death	NN
cord-023095-4dannjjm	4053	9	were	be	VBD
cord-023095-4dannjjm	4053	10	taken	take	VBN
cord-023095-4dannjjm	4053	11	into	into	IN
cord-023095-4dannjjm	4053	12	account	account	NN
cord-023095-4dannjjm	4053	13	,	,	,
cord-023095-4dannjjm	4053	14	the	the	DT
cord-023095-4dannjjm	4053	15	median	median	JJ
cord-023095-4dannjjm	4053	16	survival	survival	NN
cord-023095-4dannjjm	4053	17	time	time	NN
cord-023095-4dannjjm	4053	18	was	be	VBD
cord-023095-4dannjjm	4053	19	not	not	RB
cord-023095-4dannjjm	4053	20	reached	reach	VBN
cord-023095-4dannjjm	4053	21	for	for	IN
cord-023095-4dannjjm	4053	22	cats	cat	NNS
cord-023095-4dannjjm	4053	23	or	or	CC
cord-023095-4dannjjm	4053	24	dogs	dog	NNS
cord-023095-4dannjjm	4053	25	.	.	.
cord-023095-4dannjjm	4054	1	Survival	survival	NN
cord-023095-4dannjjm	4054	2	time	time	NN
cord-023095-4dannjjm	4054	3	for	for	IN
cord-023095-4dannjjm	4054	4	all	all	DT
cord-023095-4dannjjm	4054	5	-	-	HYPH
cord-023095-4dannjjm	4054	6	cause	cause	NN
cord-023095-4dannjjm	4054	7	mortality	mortality	NN
cord-023095-4dannjjm	4054	8	was	be	VBD
cord-023095-4dannjjm	4054	9	inversely	inversely	RB
cord-023095-4dannjjm	4054	10	associated	associate	VBN
cord-023095-4dannjjm	4054	11	with	with	IN
cord-023095-4dannjjm	4054	12	the	the	DT
cord-023095-4dannjjm	4054	13	lowest	low	JJS
cord-023095-4dannjjm	4054	14	creatinine	creatinine	NN
cord-023095-4dannjjm	4054	15	concentration	concentration	NN
cord-023095-4dannjjm	4054	16	within	within	IN
cord-023095-4dannjjm	4054	17	the	the	DT
cord-023095-4dannjjm	4054	18	30	30	CD
cord-023095-4dannjjm	4054	19	to	to	TO
cord-023095-4dannjjm	4054	20	90	90	CD
cord-023095-4dannjjm	4054	21	day	day	NN
cord-023095-4dannjjm	4054	22	period	period	NN
cord-023095-4dannjjm	4054	23	following	follow	VBG
cord-023095-4dannjjm	4054	24	the	the	DT
cord-023095-4dannjjm	4054	25	last	last	JJ
cord-023095-4dannjjm	4054	26	IHD	IHD	NNP
cord-023095-4dannjjm	4054	27	treatment	treatment	NN
cord-023095-4dannjjm	4054	28	(	(	-LRB-
cord-023095-4dannjjm	4054	29	p	p	NN
cord-023095-4dannjjm	4054	30	o	o	NN
cord-023095-4dannjjm	4054	31	0.0011	0.0011	CD
cord-023095-4dannjjm	4054	32	for	for	IN
cord-023095-4dannjjm	4054	33	cats	cat	NNS
cord-023095-4dannjjm	4054	34	,	,	,
cord-023095-4dannjjm	4054	35	p	p	NN
cord-023095-4dannjjm	4054	36	o	o	NN
cord-023095-4dannjjm	4054	37	0.0104	0.0104	CD
cord-023095-4dannjjm	4054	38	for	for	IN
cord-023095-4dannjjm	4054	39	dogs	dog	NNS
cord-023095-4dannjjm	4054	40	)	)	-RRB-
cord-023095-4dannjjm	4054	41	.	.	.
cord-023095-4dannjjm	4055	1	This	this	DT
cord-023095-4dannjjm	4055	2	study	study	NN
cord-023095-4dannjjm	4055	3	demonstrates	demonstrate	VBZ
cord-023095-4dannjjm	4055	4	that	that	IN
cord-023095-4dannjjm	4055	5	veterinary	veterinary	JJ
cord-023095-4dannjjm	4055	6	patients	patient	NNS
cord-023095-4dannjjm	4055	7	that	that	WDT
cord-023095-4dannjjm	4055	8	are	be	VBP
cord-023095-4dannjjm	4055	9	diagnosed	diagnose	VBN
cord-023095-4dannjjm	4055	10	with	with	IN
cord-023095-4dannjjm	4055	11	AKI	AKI	NNP
cord-023095-4dannjjm	4055	12	,	,	,
cord-023095-4dannjjm	4055	13	treated	treat	VBN
cord-023095-4dannjjm	4055	14	with	with	IN
cord-023095-4dannjjm	4055	15	IHD	IHD	NNP
cord-023095-4dannjjm	4055	16	,	,	,
cord-023095-4dannjjm	4055	17	and	and	CC
cord-023095-4dannjjm	4055	18	survive	survive	VB
cord-023095-4dannjjm	4055	19	greater	great	JJR
cord-023095-4dannjjm	4055	20	than	than	IN
cord-023095-4dannjjm	4055	21	30	30	CD
cord-023095-4dannjjm	4055	22	days	day	NNS
cord-023095-4dannjjm	4055	23	after	after	IN
cord-023095-4dannjjm	4055	24	the	the	DT
cord-023095-4dannjjm	4055	25	last	last	JJ
cord-023095-4dannjjm	4055	26	IHD	IHD	NNP
cord-023095-4dannjjm	4055	27	treatment	treatment	NN
cord-023095-4dannjjm	4055	28	have	have	VBP
cord-023095-4dannjjm	4055	29	a	a	DT
cord-023095-4dannjjm	4055	30	good	good	JJ
cord-023095-4dannjjm	4055	31	longterm	longterm	JJ
cord-023095-4dannjjm	4055	32	prognosis	prognosis	NN
cord-023095-4dannjjm	4055	33	and	and	CC
cord-023095-4dannjjm	4055	34	frequently	frequently	RB
cord-023095-4dannjjm	4055	35	die	die	VB
cord-023095-4dannjjm	4055	36	from	from	IN
cord-023095-4dannjjm	4055	37	causes	cause	NNS
cord-023095-4dannjjm	4055	38	that	that	WDT
cord-023095-4dannjjm	4055	39	are	be	VBP
cord-023095-4dannjjm	4055	40	unrelated	unrelated	JJ
cord-023095-4dannjjm	4055	41	to	to	IN
cord-023095-4dannjjm	4055	42	renal	renal	JJ
cord-023095-4dannjjm	4055	43	impairment	impairment	NN
cord-023095-4dannjjm	4055	44	.	.	.
cord-023095-4dannjjm	4056	1	Renal	renal	JJ
cord-023095-4dannjjm	4056	2	fine	fine	JJ
cord-023095-4dannjjm	4056	3	-	-	HYPH
cord-023095-4dannjjm	4056	4	needle	needle	NN
cord-023095-4dannjjm	4056	5	aspiration	aspiration	NN
cord-023095-4dannjjm	4056	6	(	(	-LRB-
cord-023095-4dannjjm	4056	7	R	R	NNP
cord-023095-4dannjjm	4056	8	-	-	HYPH
cord-023095-4dannjjm	4056	9	FNA	FNA	NNP
cord-023095-4dannjjm	4056	10	)	)	-RRB-
cord-023095-4dannjjm	4056	11	is	be	VBZ
cord-023095-4dannjjm	4056	12	oftentimes	oftentimes	RB
cord-023095-4dannjjm	4056	13	attempted	attempt	VBN
cord-023095-4dannjjm	4056	14	during	during	IN
cord-023095-4dannjjm	4056	15	evaluation	evaluation	NN
cord-023095-4dannjjm	4056	16	of	of	IN
cord-023095-4dannjjm	4056	17	dogs	dog	NNS
cord-023095-4dannjjm	4056	18	and	and	CC
cord-023095-4dannjjm	4056	19	cats	cat	NNS
cord-023095-4dannjjm	4056	20	with	with	IN
cord-023095-4dannjjm	4056	21	renomegaly	renomegaly	NNP
cord-023095-4dannjjm	4056	22	,	,	,
cord-023095-4dannjjm	4056	23	mass	mass	NN
cord-023095-4dannjjm	4056	24	lesions	lesion	NNS
cord-023095-4dannjjm	4056	25	,	,	,
cord-023095-4dannjjm	4056	26	or	or	CC
cord-023095-4dannjjm	4056	27	suspected	suspect	VBN
cord-023095-4dannjjm	4056	28	infiltrative	infiltrative	JJ
cord-023095-4dannjjm	4056	29	processes	process	NNS
cord-023095-4dannjjm	4056	30	.	.	.
cord-023095-4dannjjm	4057	1	Diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4057	2	utility	utility	NN
cord-023095-4dannjjm	4057	3	of	of	IN
cord-023095-4dannjjm	4057	4	FNA	FNA	NNP
cord-023095-4dannjjm	4057	5	is	be	VBZ
cord-023095-4dannjjm	4057	6	dependent	dependent	JJ
cord-023095-4dannjjm	4057	7	upon	upon	IN
cord-023095-4dannjjm	4057	8	the	the	DT
cord-023095-4dannjjm	4057	9	organ	organ	NN
cord-023095-4dannjjm	4057	10	being	be	VBG
cord-023095-4dannjjm	4057	11	sampled	sample	VBN
cord-023095-4dannjjm	4057	12	;	;	:
cord-023095-4dannjjm	4057	13	additionally	additionally	RB
cord-023095-4dannjjm	4057	14	,	,	,
cord-023095-4dannjjm	4057	15	in	in	IN
cord-023095-4dannjjm	4057	16	some	some	DT
cord-023095-4dannjjm	4057	17	organs	organ	NNS
cord-023095-4dannjjm	4057	18	,	,	,
cord-023095-4dannjjm	4057	19	certain	certain	JJ
cord-023095-4dannjjm	4057	20	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4057	21	imaging	imaging	NN
cord-023095-4dannjjm	4057	22	findings	finding	NNS
cord-023095-4dannjjm	4057	23	are	be	VBP
cord-023095-4dannjjm	4057	24	associated	associate	VBN
cord-023095-4dannjjm	4057	25	with	with	IN
cord-023095-4dannjjm	4057	26	improved	improved	JJ
cord-023095-4dannjjm	4057	27	concordance	concordance	NN
cord-023095-4dannjjm	4057	28	of	of	IN
cord-023095-4dannjjm	4057	29	FNA	FNA	NNP
cord-023095-4dannjjm	4057	30	with	with	IN
cord-023095-4dannjjm	4057	31	final	final	JJ
cord-023095-4dannjjm	4057	32	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4057	33	.	.	.
cord-023095-4dannjjm	4058	1	Objectives	objective	NNS
cord-023095-4dannjjm	4058	2	of	of	IN
cord-023095-4dannjjm	4058	3	this	this	DT
cord-023095-4dannjjm	4058	4	study	study	NN
cord-023095-4dannjjm	4058	5	were	be	VBD
cord-023095-4dannjjm	4058	6	to	to	TO
cord-023095-4dannjjm	4058	7	evaluate	evaluate	VB
cord-023095-4dannjjm	4058	8	the	the	DT
cord-023095-4dannjjm	4058	9	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4058	10	utility	utility	NN
cord-023095-4dannjjm	4058	11	of	of	IN
cord-023095-4dannjjm	4058	12	R	R	NNP
cord-023095-4dannjjm	4058	13	-	-	HYPH
cord-023095-4dannjjm	4058	14	FNA	FNA	NNP
cord-023095-4dannjjm	4058	15	and	and	CC
cord-023095-4dannjjm	4058	16	determine	determine	VB
cord-023095-4dannjjm	4058	17	whether	whether	IN
cord-023095-4dannjjm	4058	18	concordance	concordance	NN
cord-023095-4dannjjm	4058	19	with	with	IN
cord-023095-4dannjjm	4058	20	final	final	JJ
cord-023095-4dannjjm	4058	21	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4058	22	is	be	VBZ
cord-023095-4dannjjm	4058	23	associated	associate	VBN
cord-023095-4dannjjm	4058	24	with	with	IN
cord-023095-4dannjjm	4058	25	specific	specific	JJ
cord-023095-4dannjjm	4058	26	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	4058	27	or	or	CC
cord-023095-4dannjjm	4058	28	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4058	29	imaging	imaging	NN
cord-023095-4dannjjm	4058	30	findings	finding	NNS
cord-023095-4dannjjm	4058	31	.	.	.
cord-023095-4dannjjm	4059	1	We	-PRON-	PRP
cord-023095-4dannjjm	4059	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	4059	3	that	that	IN
cord-023095-4dannjjm	4059	4	R	R	NNP
cord-023095-4dannjjm	4059	5	-	-	HYPH
cord-023095-4dannjjm	4059	6	FNA	FNA	NNP
cord-023095-4dannjjm	4059	7	is	be	VBZ
cord-023095-4dannjjm	4059	8	most	most	RBS
cord-023095-4dannjjm	4059	9	useful	useful	JJ
cord-023095-4dannjjm	4059	10	in	in	IN
cord-023095-4dannjjm	4059	11	patients	patient	NNS
cord-023095-4dannjjm	4059	12	with	with	IN
cord-023095-4dannjjm	4059	13	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4059	14	imaging	imaging	NN
cord-023095-4dannjjm	4059	15	results	result	NNS
cord-023095-4dannjjm	4059	16	suggestive	suggestive	JJ
cord-023095-4dannjjm	4059	17	of	of	IN
cord-023095-4dannjjm	4059	18	renal	renal	JJ
cord-023095-4dannjjm	4059	19	neoplasia	neoplasia	NNS
cord-023095-4dannjjm	4059	20	(	(	-LRB-
cord-023095-4dannjjm	4059	21	i.e.	i.e.	FW
cord-023095-4dannjjm	4059	22	masses	masse	NNS
cord-023095-4dannjjm	4059	23	or	or	CC
cord-023095-4dannjjm	4059	24	suspected	suspect	VBN
cord-023095-4dannjjm	4059	25	infiltrative	infiltrative	JJ
cord-023095-4dannjjm	4059	26	processes	process	NNS
cord-023095-4dannjjm	4059	27	)	)	-RRB-
cord-023095-4dannjjm	4059	28	.	.	.
cord-023095-4dannjjm	4060	1	Dogs	dog	NNS
cord-023095-4dannjjm	4060	2	and	and	CC
cord-023095-4dannjjm	4060	3	cats	cat	NNS
cord-023095-4dannjjm	4060	4	that	that	WDT
cord-023095-4dannjjm	4060	5	had	have	VBD
cord-023095-4dannjjm	4060	6	undergone	undergo	VBN
cord-023095-4dannjjm	4060	7	R	R	NNP
cord-023095-4dannjjm	4060	8	-	-	HYPH
cord-023095-4dannjjm	4060	9	FNA	FNA	NNP
cord-023095-4dannjjm	4060	10	from	from	IN
cord-023095-4dannjjm	4060	11	Jan	Jan	NNP
cord-023095-4dannjjm	4060	12	1	1	CD
cord-023095-4dannjjm	4060	13	,	,	,
cord-023095-4dannjjm	4060	14	1998	1998	CD
cord-023095-4dannjjm	4060	15	to	to	IN
cord-023095-4dannjjm	4060	16	Dec	Dec	NNP
cord-023095-4dannjjm	4060	17	31	31	CD
cord-023095-4dannjjm	4060	18	,	,	,
cord-023095-4dannjjm	4060	19	2008	2008	CD
cord-023095-4dannjjm	4060	20	were	be	VBD
cord-023095-4dannjjm	4060	21	identified	identify	VBN
cord-023095-4dannjjm	4060	22	by	by	IN
cord-023095-4dannjjm	4060	23	database	database	NN
cord-023095-4dannjjm	4060	24	search	search	NN
cord-023095-4dannjjm	4060	25	.	.	.
cord-023095-4dannjjm	4061	1	Patient	patient	JJ
cord-023095-4dannjjm	4061	2	signalment	signalment	JJ
cord-023095-4dannjjm	4061	3	,	,	,
cord-023095-4dannjjm	4061	4	serum	serum	NN
cord-023095-4dannjjm	4061	5	creatinine	creatinine	NN
cord-023095-4dannjjm	4061	6	and	and	CC
cord-023095-4dannjjm	4061	7	blood	blood	NN
cord-023095-4dannjjm	4061	8	urea	urea	NN
cord-023095-4dannjjm	4061	9	nitrogen	nitrogen	NN
cord-023095-4dannjjm	4061	10	concentration	concentration	NN
cord-023095-4dannjjm	4061	11	,	,	,
cord-023095-4dannjjm	4061	12	urine	urine	NN
cord-023095-4dannjjm	4061	13	specific	specific	JJ
cord-023095-4dannjjm	4061	14	gravity	gravity	NN
cord-023095-4dannjjm	4061	15	,	,	,
cord-023095-4dannjjm	4061	16	dipstick	dipstick	NN
cord-023095-4dannjjm	4061	17	protein	protein	NN
cord-023095-4dannjjm	4061	18	,	,	,
cord-023095-4dannjjm	4061	19	R	R	NNP
cord-023095-4dannjjm	4061	20	-	-	HYPH
cord-023095-4dannjjm	4061	21	FNA	FNA	NNP
cord-023095-4dannjjm	4061	22	result	result	NN
cord-023095-4dannjjm	4061	23	,	,	,
cord-023095-4dannjjm	4061	24	and	and	CC
cord-023095-4dannjjm	4061	25	final	final	JJ
cord-023095-4dannjjm	4061	26	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4061	27	were	be	VBD
cord-023095-4dannjjm	4061	28	recorded	record	VBN
cord-023095-4dannjjm	4061	29	.	.	.
cord-023095-4dannjjm	4062	1	Patients	patient	NNS
cord-023095-4dannjjm	4062	2	were	be	VBD
cord-023095-4dannjjm	4062	3	excluded	exclude	VBN
cord-023095-4dannjjm	4062	4	if	if	IN
cord-023095-4dannjjm	4062	5	abdominal	abdominal	JJ
cord-023095-4dannjjm	4062	6	radiographs	radiograph	NNS
cord-023095-4dannjjm	4062	7	or	or	CC
cord-023095-4dannjjm	4062	8	sonographic	sonographic	JJ
cord-023095-4dannjjm	4062	9	images	image	NNS
cord-023095-4dannjjm	4062	10	were	be	VBD
cord-023095-4dannjjm	4062	11	not	not	RB
cord-023095-4dannjjm	4062	12	available	available	JJ
cord-023095-4dannjjm	4062	13	for	for	IN
cord-023095-4dannjjm	4062	14	review	review	NN
cord-023095-4dannjjm	4062	15	,	,	,
cord-023095-4dannjjm	4062	16	or	or	CC
cord-023095-4dannjjm	4062	17	if	if	IN
cord-023095-4dannjjm	4062	18	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4062	19	test	test	NN
cord-023095-4dannjjm	4062	20	results	result	NNS
cord-023095-4dannjjm	4062	21	were	be	VBD
cord-023095-4dannjjm	4062	22	insufficient	insufficient	JJ
cord-023095-4dannjjm	4062	23	for	for	IN
cord-023095-4dannjjm	4062	24	determination	determination	NN
cord-023095-4dannjjm	4062	25	of	of	IN
cord-023095-4dannjjm	4062	26	final	final	JJ
cord-023095-4dannjjm	4062	27	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4062	28	.	.	.
cord-023095-4dannjjm	4063	1	A	a	DT
cord-023095-4dannjjm	4063	2	single	single	JJ
cord-023095-4dannjjm	4063	3	coauthor	coauthor	NN
cord-023095-4dannjjm	4063	4	blinded	blind	VBN
cord-023095-4dannjjm	4063	5	to	to	IN
cord-023095-4dannjjm	4063	6	final	final	JJ
cord-023095-4dannjjm	4063	7	diagnoses	diagnosis	NNS
cord-023095-4dannjjm	4064	1	interpreted	interpret	VBD
cord-023095-4dannjjm	4064	2	all	all	DT
cord-023095-4dannjjm	4064	3	abdominal	abdominal	JJ
cord-023095-4dannjjm	4064	4	images	image	NNS
cord-023095-4dannjjm	4064	5	using	use	VBG
cord-023095-4dannjjm	4064	6	a	a	DT
cord-023095-4dannjjm	4064	7	pre	pre	JJ
cord-023095-4dannjjm	4064	8	-	-	JJ
cord-023095-4dannjjm	4064	9	set	set	JJ
cord-023095-4dannjjm	4064	10	list	list	NN
cord-023095-4dannjjm	4064	11	of	of	IN
cord-023095-4dannjjm	4064	12	descriptors	descriptor	NNS
cord-023095-4dannjjm	4064	13	and	and	CC
cord-023095-4dannjjm	4064	14	grading	grading	NN
cord-023095-4dannjjm	4064	15	criteria	criterion	NNS
cord-023095-4dannjjm	4064	16	.	.	.
cord-023095-4dannjjm	4065	1	Radiographic	radiographic	JJ
cord-023095-4dannjjm	4065	2	kidney	kidney	NN
cord-023095-4dannjjm	4065	3	shape	shape	NN
cord-023095-4dannjjm	4065	4	,	,	,
cord-023095-4dannjjm	4065	5	margin	margin	NN
cord-023095-4dannjjm	4065	6	distortion	distortion	NN
cord-023095-4dannjjm	4065	7	,	,	,
cord-023095-4dannjjm	4065	8	and	and	CC
cord-023095-4dannjjm	4065	9	ventrodorsal	ventrodorsal	NN
cord-023095-4dannjjm	4065	10	kidney	kidney	NN
cord-023095-4dannjjm	4065	11	-	-	HYPH
cord-023095-4dannjjm	4065	12	to	to	IN
cord-023095-4dannjjm	4065	13	-	-	HYPH
cord-023095-4dannjjm	4065	14	L2	l2	NN
cord-023095-4dannjjm	4065	15	ratio	ratio	NN
cord-023095-4dannjjm	4065	16	were	be	VBD
cord-023095-4dannjjm	4065	17	evaluated	evaluate	VBN
cord-023095-4dannjjm	4065	18	.	.	.
cord-023095-4dannjjm	4066	1	Sonographic	sonographic	JJ
cord-023095-4dannjjm	4066	2	kidney	kidney	NN
cord-023095-4dannjjm	4066	3	margin	margin	NN
cord-023095-4dannjjm	4066	4	distortion	distortion	NN
cord-023095-4dannjjm	4066	5	,	,	,
cord-023095-4dannjjm	4066	6	cortical	cortical	JJ
cord-023095-4dannjjm	4066	7	echogenicity	echogenicity	NN
cord-023095-4dannjjm	4066	8	,	,	,
cord-023095-4dannjjm	4066	9	and	and	CC
cord-023095-4dannjjm	4066	10	corticomedullary	corticomedullary	JJ
cord-023095-4dannjjm	4066	11	junction	junction	NN
cord-023095-4dannjjm	4066	12	distinction	distinction	NN
cord-023095-4dannjjm	4066	13	were	be	VBD
cord-023095-4dannjjm	4066	14	described	describe	VBN
cord-023095-4dannjjm	4066	15	,	,	,
cord-023095-4dannjjm	4066	16	and	and	CC
cord-023095-4dannjjm	4066	17	presence	presence	NN
cord-023095-4dannjjm	4066	18	of	of	IN
cord-023095-4dannjjm	4066	19	nodules	nodule	NNS
cord-023095-4dannjjm	4066	20	or	or	CC
cord-023095-4dannjjm	4066	21	masses	masse	NNS
cord-023095-4dannjjm	4066	22	,	,	,
cord-023095-4dannjjm	4066	23	peri	peri	JJ
cord-023095-4dannjjm	4066	24	-	-	HYPH
cord-023095-4dannjjm	4066	25	renal	renal	JJ
cord-023095-4dannjjm	4066	26	effusion	effusion	NN
cord-023095-4dannjjm	4066	27	,	,	,
cord-023095-4dannjjm	4066	28	or	or	CC
cord-023095-4dannjjm	4066	29	a	a	DT
cord-023095-4dannjjm	4066	30	peripheral	peripheral	JJ
cord-023095-4dannjjm	4066	31	sonolucent	sonolucent	NN
cord-023095-4dannjjm	4066	32	rim	rim	NN
cord-023095-4dannjjm	4066	33	was	be	VBD
cord-023095-4dannjjm	4066	34	noted	note	VBN
cord-023095-4dannjjm	4066	35	.	.	.
cord-023095-4dannjjm	4067	1	Concordance	Concordance	NNP
cord-023095-4dannjjm	4067	2	of	of	IN
cord-023095-4dannjjm	4067	3	R	R	NNP
cord-023095-4dannjjm	4067	4	-	-	HYPH
cord-023095-4dannjjm	4067	5	FNA	FNA	NNP
cord-023095-4dannjjm	4067	6	and	and	CC
cord-023095-4dannjjm	4067	7	final	final	JJ
cord-023095-4dannjjm	4067	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4067	9	was	be	VBD
cord-023095-4dannjjm	4067	10	determined	determine	VBN
cord-023095-4dannjjm	4067	11	,	,	,
cord-023095-4dannjjm	4067	12	and	and	CC
cord-023095-4dannjjm	4067	13	the	the	DT
cord-023095-4dannjjm	4067	14	chi	chi	NN
cord-023095-4dannjjm	4067	15	-	-	HYPH
cord-023095-4dannjjm	4067	16	squared	squared	JJ
cord-023095-4dannjjm	4067	17	or	or	CC
cord-023095-4dannjjm	4067	18	Fisher	Fisher	NNP
cord-023095-4dannjjm	4067	19	's	's	POS
cord-023095-4dannjjm	4067	20	exact	exact	JJ
cord-023095-4dannjjm	4067	21	test	test	NN
cord-023095-4dannjjm	4067	22	were	be	VBD
cord-023095-4dannjjm	4067	23	used	use	VBN
cord-023095-4dannjjm	4067	24	to	to	TO
cord-023095-4dannjjm	4067	25	determine	determine	VB
cord-023095-4dannjjm	4067	26	association	association	NNP
cord-023095-4dannjjm	4067	27	of	of	IN
cord-023095-4dannjjm	4067	28	concordance	concordance	NNP
cord-023095-4dannjjm	4067	29	with	with	IN
cord-023095-4dannjjm	4067	30	the	the	DT
cord-023095-4dannjjm	4067	31	above	above	JJ
cord-023095-4dannjjm	4067	32	variables	variable	NNS
cord-023095-4dannjjm	4067	33	;	;	:
cord-023095-4dannjjm	4067	34	P	p	NN
cord-023095-4dannjjm	4067	35	o	o	NN
cord-023095-4dannjjm	4067	36	0.05	0.05	CD
cord-023095-4dannjjm	4067	37	was	be	VBD
cord-023095-4dannjjm	4067	38	considered	consider	VBN
cord-023095-4dannjjm	4067	39	significant	significant	JJ
cord-023095-4dannjjm	4067	40	.	.	.
cord-023095-4dannjjm	4068	1	37	37	CD
cord-023095-4dannjjm	4068	2	dogs	dog	NNS
cord-023095-4dannjjm	4068	3	and	and	CC
cord-023095-4dannjjm	4068	4	41	41	CD
cord-023095-4dannjjm	4068	5	cats	cat	NNS
cord-023095-4dannjjm	4068	6	(	(	-LRB-
cord-023095-4dannjjm	4068	7	78	78	CD
cord-023095-4dannjjm	4068	8	animals	animal	NNS
cord-023095-4dannjjm	4068	9	)	)	-RRB-
cord-023095-4dannjjm	4068	10	met	meet	VBD
cord-023095-4dannjjm	4068	11	all	all	DT
cord-023095-4dannjjm	4068	12	inclusion	inclusion	NN
cord-023095-4dannjjm	4068	13	criteria	criterion	NNS
cord-023095-4dannjjm	4068	14	.	.	.
cord-023095-4dannjjm	4069	1	R	R	NNP
cord-023095-4dannjjm	4069	2	-	-	HYPH
cord-023095-4dannjjm	4069	3	FNA	FNA	NNP
cord-023095-4dannjjm	4069	4	results	result	NNS
cord-023095-4dannjjm	4069	5	were	be	VBD
cord-023095-4dannjjm	4069	6	concordant	concordant	JJ
cord-023095-4dannjjm	4069	7	with	with	IN
cord-023095-4dannjjm	4069	8	the	the	DT
cord-023095-4dannjjm	4069	9	final	final	JJ
cord-023095-4dannjjm	4069	10	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4069	11	in	in	IN
cord-023095-4dannjjm	4069	12	43	43	CD
cord-023095-4dannjjm	4069	13	(	(	-LRB-
cord-023095-4dannjjm	4069	14	55.1	55.1	CD
cord-023095-4dannjjm	4069	15	%	%	NN
cord-023095-4dannjjm	4069	16	)	)	-RRB-
cord-023095-4dannjjm	4069	17	patients	patient	NNS
cord-023095-4dannjjm	4069	18	,	,	,
cord-023095-4dannjjm	4069	19	discordant	discordant	JJ
cord-023095-4dannjjm	4069	20	in	in	IN
cord-023095-4dannjjm	4069	21	12	12	CD
cord-023095-4dannjjm	4069	22	(	(	-LRB-
cord-023095-4dannjjm	4069	23	15.4	15.4	CD
cord-023095-4dannjjm	4069	24	%	%	NN
cord-023095-4dannjjm	4069	25	)	)	-RRB-
cord-023095-4dannjjm	4069	26	patients	patient	NNS
cord-023095-4dannjjm	4069	27	,	,	,
cord-023095-4dannjjm	4069	28	and	and	CC
cord-023095-4dannjjm	4069	29	inadequate	inadequate	JJ
cord-023095-4dannjjm	4069	30	for	for	IN
cord-023095-4dannjjm	4069	31	cytologic	cytologic	JJ
cord-023095-4dannjjm	4069	32	interpretation	interpretation	NN
cord-023095-4dannjjm	4069	33	in	in	IN
cord-023095-4dannjjm	4069	34	23	23	CD
cord-023095-4dannjjm	4069	35	(	(	-LRB-
cord-023095-4dannjjm	4069	36	29.5	29.5	CD
cord-023095-4dannjjm	4069	37	%	%	NN
cord-023095-4dannjjm	4069	38	)	)	-RRB-
cord-023095-4dannjjm	4069	39	patients	patient	NNS
cord-023095-4dannjjm	4069	40	.	.	.
cord-023095-4dannjjm	4070	1	Neoplasia	Neoplasia	NNP
cord-023095-4dannjjm	4070	2	or	or	CC
cord-023095-4dannjjm	4070	3	FIP	FIP	NNP
cord-023095-4dannjjm	4070	4	were	be	VBD
cord-023095-4dannjjm	4070	5	the	the	DT
cord-023095-4dannjjm	4070	6	final	final	JJ
cord-023095-4dannjjm	4070	7	diagnoses	diagnosis	NNS
cord-023095-4dannjjm	4070	8	in	in	IN
cord-023095-4dannjjm	4070	9	19	19	CD
cord-023095-4dannjjm	4070	10	of	of	IN
cord-023095-4dannjjm	4070	11	43	43	CD
cord-023095-4dannjjm	4070	12	(	(	-LRB-
cord-023095-4dannjjm	4070	13	44.2	44.2	CD
cord-023095-4dannjjm	4070	14	%	%	NN
cord-023095-4dannjjm	4070	15	)	)	-RRB-
cord-023095-4dannjjm	4070	16	and	and	CC
cord-023095-4dannjjm	4070	17	3	3	CD
cord-023095-4dannjjm	4070	18	of	of	IN
cord-023095-4dannjjm	4070	19	43	43	CD
cord-023095-4dannjjm	4070	20	(	(	-LRB-
cord-023095-4dannjjm	4070	21	7.0	7.0	CD
cord-023095-4dannjjm	4070	22	%	%	NN
cord-023095-4dannjjm	4070	23	)	)	-RRB-
cord-023095-4dannjjm	4070	24	patients	patient	NNS
cord-023095-4dannjjm	4070	25	with	with	IN
cord-023095-4dannjjm	4070	26	concordant	concordant	JJ
cord-023095-4dannjjm	4070	27	results	result	NNS
cord-023095-4dannjjm	4070	28	,	,	,
cord-023095-4dannjjm	4070	29	respectively	respectively	RB
cord-023095-4dannjjm	4070	30	.	.	.
cord-023095-4dannjjm	4071	1	Renal	renal	JJ
cord-023095-4dannjjm	4071	2	lymphoma	lymphoma	NN
cord-023095-4dannjjm	4071	3	(	(	-LRB-
cord-023095-4dannjjm	4071	4	P	p	NN
cord-023095-4dannjjm	4071	5	5	5	CD
cord-023095-4dannjjm	4071	6	0.196	0.196	CD
cord-023095-4dannjjm	4071	7	)	)	-RRB-
cord-023095-4dannjjm	4071	8	,	,	,
cord-023095-4dannjjm	4071	9	renal	renal	JJ
cord-023095-4dannjjm	4071	10	carcinoma	carcinoma	NN
cord-023095-4dannjjm	4071	11	(	(	-LRB-
cord-023095-4dannjjm	4071	12	P	p	NN
cord-023095-4dannjjm	4071	13	5	5	CD
cord-023095-4dannjjm	4071	14	0.364	0.364	CD
cord-023095-4dannjjm	4071	15	)	)	-RRB-
cord-023095-4dannjjm	4071	16	,	,	,
cord-023095-4dannjjm	4071	17	and	and	CC
cord-023095-4dannjjm	4071	18	renal	renal	JJ
cord-023095-4dannjjm	4071	19	neoplasia	neoplasia	NN
cord-023095-4dannjjm	4071	20	in	in	IN
cord-023095-4dannjjm	4071	21	general	general	JJ
cord-023095-4dannjjm	4071	22	(	(	-LRB-
cord-023095-4dannjjm	4071	23	P	p	NN
cord-023095-4dannjjm	4071	24	5	5	CD
cord-023095-4dannjjm	4071	25	0.451	0.451	CD
cord-023095-4dannjjm	4071	26	)	)	-RRB-
cord-023095-4dannjjm	4071	27	were	be	VBD
cord-023095-4dannjjm	4071	28	not	not	RB
cord-023095-4dannjjm	4071	29	associated	associate	VBN
cord-023095-4dannjjm	4071	30	with	with	IN
cord-023095-4dannjjm	4071	31	a	a	DT
cord-023095-4dannjjm	4071	32	higher	high	JJR
cord-023095-4dannjjm	4071	33	likelihood	likelihood	NN
cord-023095-4dannjjm	4071	34	of	of	IN
cord-023095-4dannjjm	4071	35	R	R	NNP
cord-023095-4dannjjm	4071	36	-	-	HYPH
cord-023095-4dannjjm	4071	37	FNA	FNA	NNP
cord-023095-4dannjjm	4071	38	and	and	CC
cord-023095-4dannjjm	4071	39	final	final	JJ
cord-023095-4dannjjm	4071	40	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4071	41	concordance	concordance	NN
cord-023095-4dannjjm	4071	42	.	.	.
cord-023095-4dannjjm	4072	1	There	there	EX
cord-023095-4dannjjm	4072	2	was	be	VBD
cord-023095-4dannjjm	4072	3	no	no	DT
cord-023095-4dannjjm	4072	4	association	association	NN
cord-023095-4dannjjm	4072	5	noted	note	VBN
cord-023095-4dannjjm	4072	6	between	between	IN
cord-023095-4dannjjm	4072	7	likelihood	likelihood	NN
cord-023095-4dannjjm	4072	8	of	of	IN
cord-023095-4dannjjm	4072	9	R	R	NNP
cord-023095-4dannjjm	4072	10	-	-	HYPH
cord-023095-4dannjjm	4072	11	FNA	FNA	NNP
cord-023095-4dannjjm	4072	12	and	and	CC
cord-023095-4dannjjm	4072	13	final	final	JJ
cord-023095-4dannjjm	4072	14	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4072	15	concordance	concordance	NN
cord-023095-4dannjjm	4072	16	when	when	WRB
cord-023095-4dannjjm	4072	17	patients	patient	NNS
cord-023095-4dannjjm	4072	18	were	be	VBD
cord-023095-4dannjjm	4072	19	stratified	stratify	VBN
cord-023095-4dannjjm	4072	20	by	by	IN
cord-023095-4dannjjm	4072	21	species	specie	NNS
cord-023095-4dannjjm	4072	22	,	,	,
cord-023095-4dannjjm	4072	23	serum	serum	NN
cord-023095-4dannjjm	4072	24	creatinine	creatinine	NN
cord-023095-4dannjjm	4072	25	or	or	CC
cord-023095-4dannjjm	4072	26	blood	blood	NN
cord-023095-4dannjjm	4072	27	urea	urea	NN
cord-023095-4dannjjm	4072	28	nitrogen	nitrogen	NN
cord-023095-4dannjjm	4072	29	concentration	concentration	NN
cord-023095-4dannjjm	4072	30	,	,	,
cord-023095-4dannjjm	4072	31	urine	urine	NN
cord-023095-4dannjjm	4072	32	specific	specific	JJ
cord-023095-4dannjjm	4072	33	gravity	gravity	NN
cord-023095-4dannjjm	4072	34	,	,	,
cord-023095-4dannjjm	4072	35	dipstick	dipstick	NN
cord-023095-4dannjjm	4072	36	proteinuria	proteinuria	NN
cord-023095-4dannjjm	4072	37	,	,	,
cord-023095-4dannjjm	4072	38	or	or	CC
cord-023095-4dannjjm	4072	39	any	any	DT
cord-023095-4dannjjm	4072	40	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4072	41	imaging	imaging	NN
cord-023095-4dannjjm	4072	42	variables	variable	NNS
cord-023095-4dannjjm	4072	43	.	.	.
cord-023095-4dannjjm	4073	1	This	this	DT
cord-023095-4dannjjm	4073	2	study	study	NN
cord-023095-4dannjjm	4073	3	failed	fail	VBD
cord-023095-4dannjjm	4073	4	to	to	TO
cord-023095-4dannjjm	4073	5	identify	identify	VB
cord-023095-4dannjjm	4073	6	concurrent	concurrent	JJ
cord-023095-4dannjjm	4073	7	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	4073	8	or	or	CC
cord-023095-4dannjjm	4073	9	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4073	10	imaging	imaging	NN
cord-023095-4dannjjm	4073	11	findings	finding	NNS
cord-023095-4dannjjm	4073	12	that	that	WDT
cord-023095-4dannjjm	4073	13	enhanced	enhance	VBD
cord-023095-4dannjjm	4073	14	the	the	DT
cord-023095-4dannjjm	4073	15	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4073	16	utility	utility	NN
cord-023095-4dannjjm	4073	17	of	of	IN
cord-023095-4dannjjm	4073	18	R	R	NNP
cord-023095-4dannjjm	4073	19	-	-	HYPH
cord-023095-4dannjjm	4073	20	FNA	FNA	NNP
cord-023095-4dannjjm	4073	21	.	.	.
cord-023095-4dannjjm	4074	1	Future	future	JJ
cord-023095-4dannjjm	4074	2	studies	study	NNS
cord-023095-4dannjjm	4074	3	should	should	MD
cord-023095-4dannjjm	4074	4	use	use	VB
cord-023095-4dannjjm	4074	5	standardized	standardized	JJ
cord-023095-4dannjjm	4074	6	criteria	criterion	NNS
cord-023095-4dannjjm	4074	7	to	to	TO
cord-023095-4dannjjm	4074	8	prospectively	prospectively	RB
cord-023095-4dannjjm	4074	9	identify	identify	VB
cord-023095-4dannjjm	4074	10	patients	patient	NNS
cord-023095-4dannjjm	4074	11	in	in	IN
cord-023095-4dannjjm	4074	12	which	which	WDT
cord-023095-4dannjjm	4074	13	R	r	NN
cord-023095-4dannjjm	4074	14	-	-	HYPH
cord-023095-4dannjjm	4074	15	FNA	FNA	NNP
cord-023095-4dannjjm	4074	16	will	will	MD
cord-023095-4dannjjm	4074	17	be	be	VB
cord-023095-4dannjjm	4074	18	performed	perform	VBN
cord-023095-4dannjjm	4074	19	,	,	,
cord-023095-4dannjjm	4074	20	evaluate	evaluate	VB
cord-023095-4dannjjm	4074	21	additional	additional	JJ
cord-023095-4dannjjm	4074	22	variables	variable	NNS
cord-023095-4dannjjm	4074	23	that	that	WDT
cord-023095-4dannjjm	4074	24	may	may	MD
cord-023095-4dannjjm	4074	25	be	be	VB
cord-023095-4dannjjm	4074	26	associated	associate	VBN
cord-023095-4dannjjm	4074	27	with	with	IN
cord-023095-4dannjjm	4074	28	increased	increase	VBN
cord-023095-4dannjjm	4074	29	R	R	NNP
cord-023095-4dannjjm	4074	30	-	-	HYPH
cord-023095-4dannjjm	4074	31	FNA	FNA	NNP
cord-023095-4dannjjm	4074	32	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4074	33	utility	utility	NN
cord-023095-4dannjjm	4074	34	,	,	,
cord-023095-4dannjjm	4074	35	and	and	CC
cord-023095-4dannjjm	4074	36	directly	directly	RB
cord-023095-4dannjjm	4074	37	compare	compare	VB
cord-023095-4dannjjm	4074	38	the	the	DT
cord-023095-4dannjjm	4074	39	utility	utility	NN
cord-023095-4dannjjm	4074	40	of	of	IN
cord-023095-4dannjjm	4074	41	R	R	NNP
cord-023095-4dannjjm	4074	42	-	-	HYPH
cord-023095-4dannjjm	4074	43	FNA	FNA	NNP
cord-023095-4dannjjm	4074	44	with	with	IN
cord-023095-4dannjjm	4074	45	that	that	DT
cord-023095-4dannjjm	4074	46	of	of	IN
cord-023095-4dannjjm	4074	47	other	other	JJ
cord-023095-4dannjjm	4074	48	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4074	49	techniques	technique	NNS
cord-023095-4dannjjm	4074	50	.	.	.
cord-023095-4dannjjm	4075	1	Feline	feline	JJ
cord-023095-4dannjjm	4075	2	lower	low	JJR
cord-023095-4dannjjm	4075	3	urinary	urinary	JJ
cord-023095-4dannjjm	4075	4	tract	tract	NN
cord-023095-4dannjjm	4075	5	disease	disease	NN
cord-023095-4dannjjm	4075	6	(	(	-LRB-
cord-023095-4dannjjm	4075	7	FLUTD	FLUTD	NNP
cord-023095-4dannjjm	4075	8	)	)	-RRB-
cord-023095-4dannjjm	4075	9	is	be	VBZ
cord-023095-4dannjjm	4075	10	a	a	DT
cord-023095-4dannjjm	4075	11	disease	disease	NN
cord-023095-4dannjjm	4075	12	with	with	IN
cord-023095-4dannjjm	4075	13	increasing	increase	VBG
cord-023095-4dannjjm	4075	14	prevalence	prevalence	NN
cord-023095-4dannjjm	4075	15	in	in	IN
cord-023095-4dannjjm	4075	16	private	private	JJ
cord-023095-4dannjjm	4075	17	practices	practice	NNS
cord-023095-4dannjjm	4075	18	and	and	CC
cord-023095-4dannjjm	4075	19	veterinary	veterinary	JJ
cord-023095-4dannjjm	4075	20	teaching	teaching	NN
cord-023095-4dannjjm	4075	21	hospitals	hospital	NNS
cord-023095-4dannjjm	4075	22	.	.	.
cord-023095-4dannjjm	4076	1	Although	although	IN
cord-023095-4dannjjm	4076	2	several	several	JJ
cord-023095-4dannjjm	4076	3	underlying	underlie	VBG
cord-023095-4dannjjm	4076	4	causes	cause	NNS
cord-023095-4dannjjm	4076	5	can	can	MD
cord-023095-4dannjjm	4076	6	cause	cause	VB
cord-023095-4dannjjm	4076	7	the	the	DT
cord-023095-4dannjjm	4076	8	obstructive	obstructive	JJ
cord-023095-4dannjjm	4076	9	form	form	NN
cord-023095-4dannjjm	4076	10	in	in	IN
cord-023095-4dannjjm	4076	11	male	male	JJ
cord-023095-4dannjjm	4076	12	cats	cat	NNS
cord-023095-4dannjjm	4076	13	,	,	,
cord-023095-4dannjjm	4076	14	the	the	DT
cord-023095-4dannjjm	4076	15	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	4076	16	form	form	NN
cord-023095-4dannjjm	4076	17	(	(	-LRB-
cord-023095-4dannjjm	4076	18	feline	feline	JJ
cord-023095-4dannjjm	4076	19	interstitial	interstitial	JJ
cord-023095-4dannjjm	4076	20	cystitis	cystitis	NN
cord-023095-4dannjjm	4076	21	)	)	-RRB-
cord-023095-4dannjjm	4076	22	often	often	RB
cord-023095-4dannjjm	4076	23	is	be	VBZ
cord-023095-4dannjjm	4076	24	diagnosed	diagnose	VBN
cord-023095-4dannjjm	4076	25	as	as	IN
cord-023095-4dannjjm	4076	26	underlying	underlying	JJ
cord-023095-4dannjjm	4076	27	reason	reason	NN
cord-023095-4dannjjm	4076	28	in	in	IN
cord-023095-4dannjjm	4076	29	cats	cat	NNS
cord-023095-4dannjjm	4077	1	o	o	LS
cord-023095-4dannjjm	4077	2	10	10	CD
cord-023095-4dannjjm	4077	3	years	year	NNS
cord-023095-4dannjjm	4077	4	.	.	.
cord-023095-4dannjjm	4078	1	The	the	DT
cord-023095-4dannjjm	4078	2	goal	goal	NN
cord-023095-4dannjjm	4078	3	of	of	IN
cord-023095-4dannjjm	4078	4	this	this	DT
cord-023095-4dannjjm	4078	5	retrospective	retrospective	JJ
cord-023095-4dannjjm	4078	6	study	study	NN
cord-023095-4dannjjm	4078	7	was	be	VBD
cord-023095-4dannjjm	4078	8	to	to	TO
cord-023095-4dannjjm	4078	9	identify	identify	VB
cord-023095-4dannjjm	4078	10	possible	possible	JJ
cord-023095-4dannjjm	4078	11	predisposing	predisposing	JJ
cord-023095-4dannjjm	4078	12	factors	factor	NNS
cord-023095-4dannjjm	4078	13	in	in	IN
cord-023095-4dannjjm	4078	14	order	order	NN
cord-023095-4dannjjm	4078	15	to	to	TO
cord-023095-4dannjjm	4078	16	optimize	optimize	VB
cord-023095-4dannjjm	4078	17	the	the	DT
cord-023095-4dannjjm	4078	18	therapy	therapy	NN
cord-023095-4dannjjm	4078	19	of	of	IN
cord-023095-4dannjjm	4078	20	these	these	DT
cord-023095-4dannjjm	4078	21	patients	patient	NNS
cord-023095-4dannjjm	4078	22	.	.	.
cord-023095-4dannjjm	4079	1	As	as	IN
cord-023095-4dannjjm	4079	2	a	a	DT
cord-023095-4dannjjm	4079	3	study	study	NN
cord-023095-4dannjjm	4079	4	group	group	NN
cord-023095-4dannjjm	4079	5	,	,	,
cord-023095-4dannjjm	4079	6	40	40	CD
cord-023095-4dannjjm	4079	7	cats	cat	NNS
cord-023095-4dannjjm	4079	8	hospitalized	hospitalize	VBN
cord-023095-4dannjjm	4079	9	with	with	IN
cord-023095-4dannjjm	4079	10	obstructive	obstructive	JJ
cord-023095-4dannjjm	4079	11	FLUTD	FLUTD	NNP
cord-023095-4dannjjm	4079	12	at	at	IN
cord-023095-4dannjjm	4079	13	the	the	DT
cord-023095-4dannjjm	4079	14	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	4079	15	University	University	NNP
cord-023095-4dannjjm	4079	16	of	of	IN
cord-023095-4dannjjm	4079	17	Vienna	Vienna	NNP
cord-023095-4dannjjm	4079	18	were	be	VBD
cord-023095-4dannjjm	4079	19	examined	examine	VBN
cord-023095-4dannjjm	4079	20	during	during	IN
cord-023095-4dannjjm	4079	21	a	a	DT
cord-023095-4dannjjm	4079	22	2	2	CD
cord-023095-4dannjjm	4079	23	year	year	NN
cord-023095-4dannjjm	4079	24	period	period	NN
cord-023095-4dannjjm	4079	25	(	(	-LRB-
cord-023095-4dannjjm	4079	26	2008	2008	CD
cord-023095-4dannjjm	4079	27	)	)	-RRB-
cord-023095-4dannjjm	4079	28	(	(	-LRB-
cord-023095-4dannjjm	4079	29	2009	2009	CD
cord-023095-4dannjjm	4079	30	)	)	-RRB-
cord-023095-4dannjjm	4079	31	(	(	-LRB-
cord-023095-4dannjjm	4079	32	2010	2010	CD
cord-023095-4dannjjm	4079	33	)	)	-RRB-
cord-023095-4dannjjm	4079	34	.	.	.
cord-023095-4dannjjm	4080	1	As	as	IN
cord-023095-4dannjjm	4080	2	a	a	DT
cord-023095-4dannjjm	4080	3	control	control	NN
cord-023095-4dannjjm	4080	4	group	group	NN
cord-023095-4dannjjm	4080	5	40	40	CD
cord-023095-4dannjjm	4080	6	cats	cat	NNS
cord-023095-4dannjjm	4080	7	presented	present	VBN
cord-023095-4dannjjm	4080	8	for	for	IN
cord-023095-4dannjjm	4080	9	other	other	JJ
cord-023095-4dannjjm	4080	10	reasons	reason	NNS
cord-023095-4dannjjm	4080	11	were	be	VBD
cord-023095-4dannjjm	4080	12	randomly	randomly	RB
cord-023095-4dannjjm	4080	13	chosen	choose	VBN
cord-023095-4dannjjm	4080	14	during	during	IN
cord-023095-4dannjjm	4080	15	the	the	DT
cord-023095-4dannjjm	4080	16	same	same	JJ
cord-023095-4dannjjm	4080	17	time	time	NN
cord-023095-4dannjjm	4080	18	period	period	NN
cord-023095-4dannjjm	4080	19	.	.	.
cord-023095-4dannjjm	4081	1	The	the	DT
cord-023095-4dannjjm	4081	2	data	datum	NNS
cord-023095-4dannjjm	4081	3	were	be	VBD
cord-023095-4dannjjm	4081	4	examined	examine	VBN
cord-023095-4dannjjm	4081	5	concerning	concern	VBG
cord-023095-4dannjjm	4081	6	the	the	DT
cord-023095-4dannjjm	4081	7	signalment	signalment	NN
cord-023095-4dannjjm	4081	8	and	and	CC
cord-023095-4dannjjm	4081	9	history	history	NN
cord-023095-4dannjjm	4081	10	.	.	.
cord-023095-4dannjjm	4082	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	4082	2	,	,	,
cord-023095-4dannjjm	4082	3	the	the	DT
cord-023095-4dannjjm	4082	4	long	long	JJ
cord-023095-4dannjjm	4082	5	-	-	HYPH
cord-023095-4dannjjm	4082	6	term	term	NN
cord-023095-4dannjjm	4082	7	outcome	outcome	NN
cord-023095-4dannjjm	4082	8	was	be	VBD
cord-023095-4dannjjm	4082	9	evaluated	evaluate	VBN
cord-023095-4dannjjm	4082	10	with	with	IN
cord-023095-4dannjjm	4082	11	a	a	DT
cord-023095-4dannjjm	4082	12	questionnaire	questionnaire	NN
cord-023095-4dannjjm	4082	13	.	.	.
cord-023095-4dannjjm	4083	1	Based	base	VBN
cord-023095-4dannjjm	4083	2	on	on	IN
cord-023095-4dannjjm	4083	3	assumptions	assumption	NNS
cord-023095-4dannjjm	4083	4	a	a	DT
cord-023095-4dannjjm	4083	5	student	student	NN
cord-023095-4dannjjm	4083	6	's	's	POS
cord-023095-4dannjjm	4083	7	t	t	NN
cord-023095-4dannjjm	4083	8	-	-	HYPH
cord-023095-4dannjjm	4083	9	test	test	NN
cord-023095-4dannjjm	4083	10	or	or	CC
cord-023095-4dannjjm	4083	11	a	a	DT
cord-023095-4dannjjm	4083	12	chi	chi	JJ
cord-023095-4dannjjm	4083	13	-	-	JJ
cord-023095-4dannjjm	4083	14	square	square	JJ
cord-023095-4dannjjm	4083	15	test	test	NN
cord-023095-4dannjjm	4083	16	was	be	VBD
cord-023095-4dannjjm	4083	17	used	use	VBN
cord-023095-4dannjjm	4083	18	.	.	.
cord-023095-4dannjjm	4084	1	There	there	EX
cord-023095-4dannjjm	4084	2	were	be	VBD
cord-023095-4dannjjm	4084	3	no	no	DT
cord-023095-4dannjjm	4084	4	significant	significant	JJ
cord-023095-4dannjjm	4084	5	differences	difference	NNS
cord-023095-4dannjjm	4084	6	in	in	IN
cord-023095-4dannjjm	4084	7	age	age	NN
cord-023095-4dannjjm	4084	8	and	and	CC
cord-023095-4dannjjm	4084	9	breed	breed	NN
cord-023095-4dannjjm	4084	10	.	.	.
cord-023095-4dannjjm	4085	1	The	the	DT
cord-023095-4dannjjm	4085	2	body	body	NN
cord-023095-4dannjjm	4085	3	weight	weight	NN
cord-023095-4dannjjm	4085	4	was	be	VBD
cord-023095-4dannjjm	4085	5	significant	significant	JJ
cord-023095-4dannjjm	4085	6	higher	higher	RBR
cord-023095-4dannjjm	4085	7	in	in	IN
cord-023095-4dannjjm	4085	8	the	the	DT
cord-023095-4dannjjm	4085	9	FLUTD	FLUTD	NNP
cord-023095-4dannjjm	4085	10	group	group	NN
cord-023095-4dannjjm	4085	11	than	than	IN
cord-023095-4dannjjm	4085	12	in	in	IN
cord-023095-4dannjjm	4085	13	the	the	DT
cord-023095-4dannjjm	4085	14	control	control	NN
cord-023095-4dannjjm	4085	15	group	group	NN
cord-023095-4dannjjm	4085	16	(	(	-LRB-
cord-023095-4dannjjm	4085	17	p	p	NN
cord-023095-4dannjjm	4085	18	o	o	NN
cord-023095-4dannjjm	4085	19	0.01	0.01	CD
cord-023095-4dannjjm	4085	20	)	)	-RRB-
cord-023095-4dannjjm	4085	21	.	.	.
cord-023095-4dannjjm	4086	1	We	-PRON-	PRP
cord-023095-4dannjjm	4086	2	could	could	MD
cord-023095-4dannjjm	4086	3	observe	observe	VB
cord-023095-4dannjjm	4086	4	a	a	DT
cord-023095-4dannjjm	4086	5	significant	significant	JJ
cord-023095-4dannjjm	4086	6	risk	risk	NN
cord-023095-4dannjjm	4086	7	for	for	IN
cord-023095-4dannjjm	4086	8	the	the	DT
cord-023095-4dannjjm	4086	9	disease	disease	NN
cord-023095-4dannjjm	4086	10	of	of	IN
cord-023095-4dannjjm	4086	11	a	a	DT
cord-023095-4dannjjm	4086	12	weight	weight	NN
cord-023095-4dannjjm	4086	13	of	of	IN
cord-023095-4dannjjm	4086	14	4	4	CD
cord-023095-4dannjjm	4086	15	5	5	CD
cord-023095-4dannjjm	4086	16	kg	kg	NNS
cord-023095-4dannjjm	4086	17	(	(	-LRB-
cord-023095-4dannjjm	4086	18	p	p	NN
cord-023095-4dannjjm	4086	19	o	o	NN
cord-023095-4dannjjm	4086	20	0.01	0.01	CD
cord-023095-4dannjjm	4086	21	)	)	-RRB-
cord-023095-4dannjjm	4086	22	.	.	.
cord-023095-4dannjjm	4087	1	There	there	EX
cord-023095-4dannjjm	4087	2	were	be	VBD
cord-023095-4dannjjm	4087	3	significant	significant	JJ
cord-023095-4dannjjm	4087	4	less	less	JJR
cord-023095-4dannjjm	4087	5	cat	cat	NN
cord-023095-4dannjjm	4087	6	toilets	toilet	NNS
cord-023095-4dannjjm	4087	7	in	in	IN
cord-023095-4dannjjm	4087	8	the	the	DT
cord-023095-4dannjjm	4087	9	FLUTD	FLUTD	NNP
cord-023095-4dannjjm	4087	10	group	group	NN
cord-023095-4dannjjm	4087	11	compared	compare	VBN
cord-023095-4dannjjm	4087	12	to	to	IN
cord-023095-4dannjjm	4087	13	the	the	DT
cord-023095-4dannjjm	4087	14	control	control	NN
cord-023095-4dannjjm	4087	15	group	group	NN
cord-023095-4dannjjm	4087	16	(	(	-LRB-
cord-023095-4dannjjm	4087	17	p	p	NN
cord-023095-4dannjjm	4087	18	o	o	NN
cord-023095-4dannjjm	4087	19	0.05	0.05	CD
cord-023095-4dannjjm	4087	20	)	)	-RRB-
cord-023095-4dannjjm	4087	21	.	.	.
cord-023095-4dannjjm	4088	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	4088	2	we	-PRON-	PRP
cord-023095-4dannjjm	4088	3	could	could	MD
cord-023095-4dannjjm	4088	4	observe	observe	VB
cord-023095-4dannjjm	4088	5	that	that	IN
cord-023095-4dannjjm	4088	6	in	in	IN
cord-023095-4dannjjm	4088	7	the	the	DT
cord-023095-4dannjjm	4088	8	households	household	NNS
cord-023095-4dannjjm	4088	9	of	of	IN
cord-023095-4dannjjm	4088	10	FLUTD	FLUTD	NNP
cord-023095-4dannjjm	4088	11	cats	cat	NNS
cord-023095-4dannjjm	4088	12	there	there	EX
cord-023095-4dannjjm	4088	13	was	be	VBD
cord-023095-4dannjjm	4088	14	significant	significant	JJ
cord-023095-4dannjjm	4088	15	less	less	JJR
cord-023095-4dannjjm	4088	16	than	than	IN
cord-023095-4dannjjm	4088	17	one	one	CD
cord-023095-4dannjjm	4088	18	toilet	toilet	NN
cord-023095-4dannjjm	4088	19	per	per	IN
cord-023095-4dannjjm	4088	20	cat	cat	NN
cord-023095-4dannjjm	4088	21	(	(	-LRB-
cord-023095-4dannjjm	4088	22	p	p	NN
cord-023095-4dannjjm	4088	23	o	o	NN
cord-023095-4dannjjm	4088	24	0.01	0.01	CD
cord-023095-4dannjjm	4088	25	)	)	-RRB-
cord-023095-4dannjjm	4088	26	and	and	CC
cord-023095-4dannjjm	4088	27	more	more	JJR
cord-023095-4dannjjm	4088	28	cats	cat	NNS
cord-023095-4dannjjm	4088	29	diseased	disease	VBN
cord-023095-4dannjjm	4088	30	on	on	IN
cord-023095-4dannjjm	4088	31	FLUTD	FLUTD	NNP
cord-023095-4dannjjm	4088	32	lived	live	VBD
cord-023095-4dannjjm	4088	33	strictly	strictly	RB
cord-023095-4dannjjm	4088	34	indoor	indoor	JJ
cord-023095-4dannjjm	4088	35	than	than	IN
cord-023095-4dannjjm	4088	36	outdoor	outdoor	JJ
cord-023095-4dannjjm	4088	37	(	(	-LRB-
cord-023095-4dannjjm	4088	38	p	p	NN
cord-023095-4dannjjm	4088	39	5	5	CD
cord-023095-4dannjjm	4088	40	0.05).There	0.05).there	CD
cord-023095-4dannjjm	4088	41	were	be	VBD
cord-023095-4dannjjm	4088	42	no	no	DT
cord-023095-4dannjjm	4088	43	significant	significant	JJ
cord-023095-4dannjjm	4088	44	differences	difference	NNS
cord-023095-4dannjjm	4088	45	at	at	IN
cord-023095-4dannjjm	4088	46	the	the	DT
cord-023095-4dannjjm	4088	47	time	time	NN
cord-023095-4dannjjm	4088	48	of	of	IN
cord-023095-4dannjjm	4088	49	hospitalization	hospitalization	NN
cord-023095-4dannjjm	4088	50	in	in	IN
cord-023095-4dannjjm	4088	51	age	age	NN
cord-023095-4dannjjm	4088	52	,	,	,
cord-023095-4dannjjm	4088	53	breed	breed	NN
cord-023095-4dannjjm	4088	54	,	,	,
cord-023095-4dannjjm	4088	55	number	number	NN
cord-023095-4dannjjm	4088	56	of	of	IN
cord-023095-4dannjjm	4088	57	cats	cat	NNS
cord-023095-4dannjjm	4088	58	per	per	IN
cord-023095-4dannjjm	4088	59	household	household	NN
cord-023095-4dannjjm	4088	60	or	or	CC
cord-023095-4dannjjm	4088	61	season	season	NN
cord-023095-4dannjjm	4088	62	of	of	IN
cord-023095-4dannjjm	4088	63	the	the	DT
cord-023095-4dannjjm	4088	64	year	year	NN
cord-023095-4dannjjm	4088	65	between	between	IN
cord-023095-4dannjjm	4088	66	the	the	DT
cord-023095-4dannjjm	4088	67	two	two	CD
cord-023095-4dannjjm	4088	68	groups	group	NNS
cord-023095-4dannjjm	4088	69	.	.	.
cord-023095-4dannjjm	4089	1	In	in	IN
cord-023095-4dannjjm	4089	2	summary	summary	NN
cord-023095-4dannjjm	4089	3	,	,	,
cord-023095-4dannjjm	4089	4	we	-PRON-	PRP
cord-023095-4dannjjm	4089	5	could	could	MD
cord-023095-4dannjjm	4089	6	observe	observe	VB
cord-023095-4dannjjm	4089	7	that	that	IN
cord-023095-4dannjjm	4089	8	cats	cat	NNS
cord-023095-4dannjjm	4089	9	over	over	IN
cord-023095-4dannjjm	4089	10	5	5	CD
cord-023095-4dannjjm	4089	11	kg	kg	NN
cord-023095-4dannjjm	4089	12	body	body	NN
cord-023095-4dannjjm	4089	13	weight	weight	NN
cord-023095-4dannjjm	4089	14	kept	keep	VBD
cord-023095-4dannjjm	4089	15	indoor	indoor	JJ
cord-023095-4dannjjm	4089	16	with	with	IN
cord-023095-4dannjjm	4090	1	less	less	JJR
cord-023095-4dannjjm	4090	2	than	than	IN
cord-023095-4dannjjm	4090	3	one	one	CD
cord-023095-4dannjjm	4090	4	toilet	toilet	NN
cord-023095-4dannjjm	4090	5	per	per	IN
cord-023095-4dannjjm	4090	6	cat	cat	NN
cord-023095-4dannjjm	4090	7	have	have	VBP
cord-023095-4dannjjm	4090	8	a	a	DT
cord-023095-4dannjjm	4090	9	significant	significant	JJ
cord-023095-4dannjjm	4090	10	higher	high	JJR
cord-023095-4dannjjm	4090	11	possibility	possibility	NN
cord-023095-4dannjjm	4090	12	to	to	TO
cord-023095-4dannjjm	4090	13	be	be	VB
cord-023095-4dannjjm	4090	14	affected	affect	VBN
cord-023095-4dannjjm	4090	15	by	by	IN
cord-023095-4dannjjm	4090	16	obstructive	obstructive	JJ
cord-023095-4dannjjm	4090	17	FLUTD	FLUTD	NNP
cord-023095-4dannjjm	4090	18	.	.	.
cord-023095-4dannjjm	4091	1	Further	further	JJ
cord-023095-4dannjjm	4091	2	studies	study	NNS
cord-023095-4dannjjm	4091	3	with	with	IN
cord-023095-4dannjjm	4091	4	an	an	DT
cord-023095-4dannjjm	4091	5	extensive	extensive	JJ
cord-023095-4dannjjm	4091	6	history	history	NN
cord-023095-4dannjjm	4091	7	of	of	IN
cord-023095-4dannjjm	4091	8	animal	animal	NN
cord-023095-4dannjjm	4091	9	husbandry	husbandry	NN
cord-023095-4dannjjm	4091	10	are	be	VBP
cord-023095-4dannjjm	4091	11	needed	need	VBN
cord-023095-4dannjjm	4091	12	to	to	TO
cord-023095-4dannjjm	4091	13	identify	identify	VB
cord-023095-4dannjjm	4091	14	risks	risk	NNS
cord-023095-4dannjjm	4091	15	predispoing	predispoe	VBG
cord-023095-4dannjjm	4091	16	cats	cat	NNS
cord-023095-4dannjjm	4091	17	to	to	IN
cord-023095-4dannjjm	4091	18	this	this	DT
cord-023095-4dannjjm	4091	19	frequent	frequent	JJ
cord-023095-4dannjjm	4091	20	and	and	CC
cord-023095-4dannjjm	4091	21	cost	cost	NN
cord-023095-4dannjjm	4091	22	-	-	HYPH
cord-023095-4dannjjm	4091	23	intensive	intensive	JJ
cord-023095-4dannjjm	4091	24	disease	disease	NN
cord-023095-4dannjjm	4091	25	.	.	.
cord-023095-4dannjjm	4092	1	Although	although	IN
cord-023095-4dannjjm	4092	2	purine	purine	NN
cord-023095-4dannjjm	4092	3	uroliths	uroliths	NNP
cord-023095-4dannjjm	4092	4	(	(	-LRB-
cord-023095-4dannjjm	4092	5	ammonium	ammonium	NN
cord-023095-4dannjjm	4092	6	urate	urate	NN
cord-023095-4dannjjm	4092	7	,	,	,
cord-023095-4dannjjm	4092	8	sodium	sodium	NN
cord-023095-4dannjjm	4092	9	urate	urate	NN
cord-023095-4dannjjm	4092	10	,	,	,
cord-023095-4dannjjm	4092	11	xanthine	xanthine	NN
cord-023095-4dannjjm	4092	12	,	,	,
cord-023095-4dannjjm	4092	13	uric	uric	NN
cord-023095-4dannjjm	4092	14	acid	acid	NN
cord-023095-4dannjjm	4092	15	,	,	,
cord-023095-4dannjjm	4092	16	etc	etc	FW
cord-023095-4dannjjm	4092	17	.	.	.
cord-023095-4dannjjm	4092	18	)	)	-RRB-
cord-023095-4dannjjm	4092	19	represent	represent	VB
cord-023095-4dannjjm	4092	20	the	the	DT
cord-023095-4dannjjm	4092	21	third	third	JJ
cord-023095-4dannjjm	4092	22	most	most	RBS
cord-023095-4dannjjm	4092	23	common	common	JJ
cord-023095-4dannjjm	4092	24	stone	stone	NN
cord-023095-4dannjjm	4092	25	type	type	NN
cord-023095-4dannjjm	4092	26	in	in	IN
cord-023095-4dannjjm	4092	27	cats	cat	NNS
cord-023095-4dannjjm	4092	28	,	,	,
cord-023095-4dannjjm	4092	29	purine	purine	NN
cord-023095-4dannjjm	4092	30	uroliths	urolith	NNS
cord-023095-4dannjjm	4092	31	have	have	VBP
cord-023095-4dannjjm	4092	32	the	the	DT
cord-023095-4dannjjm	4092	33	highest	high	JJS
cord-023095-4dannjjm	4092	34	rate	rate	NN
cord-023095-4dannjjm	4092	35	of	of	IN
cord-023095-4dannjjm	4092	36	recurrence	recurrence	NN
cord-023095-4dannjjm	4092	37	(	(	-LRB-
cord-023095-4dannjjm	4092	38	13	13	CD
cord-023095-4dannjjm	4092	39	%	%	NN
cord-023095-4dannjjm	4092	40	in	in	IN
cord-023095-4dannjjm	4092	41	22	22	CD
cord-023095-4dannjjm	4092	42	months	month	NNS
cord-023095-4dannjjm	4092	43	)	)	-RRB-
cord-023095-4dannjjm	4092	44	.	.	.
cord-023095-4dannjjm	4093	1	In	in	IN
cord-023095-4dannjjm	4093	2	dogs	dog	NNS
cord-023095-4dannjjm	4093	3	,	,	,
cord-023095-4dannjjm	4093	4	mutation	mutation	NN
cord-023095-4dannjjm	4093	5	of	of	IN
cord-023095-4dannjjm	4093	6	the	the	DT
cord-023095-4dannjjm	4093	7	urate	urate	NN
cord-023095-4dannjjm	4093	8	transporter	transporter	NN
cord-023095-4dannjjm	4093	9	(	(	-LRB-
cord-023095-4dannjjm	4093	10	SLC2A9	SLC2A9	NNP
cord-023095-4dannjjm	4093	11	)	)	-RRB-
cord-023095-4dannjjm	4093	12	and	and	CC
cord-023095-4dannjjm	4093	13	portovascular	portovascular	NNP
cord-023095-4dannjjm	4093	14	anomalies	anomaly	NNS
cord-023095-4dannjjm	4093	15	are	be	VBP
cord-023095-4dannjjm	4093	16	common	common	JJ
cord-023095-4dannjjm	4093	17	risk	risk	NN
cord-023095-4dannjjm	4093	18	factors	factor	NNS
cord-023095-4dannjjm	4093	19	.	.	.
cord-023095-4dannjjm	4094	1	However	however	RB
cord-023095-4dannjjm	4094	2	the	the	DT
cord-023095-4dannjjm	4094	3	underlying	underlie	VBG
cord-023095-4dannjjm	4094	4	cause(s	cause(s	NNP
cord-023095-4dannjjm	4094	5	)	)	-RRB-
cord-023095-4dannjjm	4094	6	for	for	IN
cord-023095-4dannjjm	4094	7	purine	purine	NNP
cord-023095-4dannjjm	4094	8	urolith	urolith	NNP
cord-023095-4dannjjm	4094	9	formation	formation	NN
cord-023095-4dannjjm	4094	10	in	in	IN
cord-023095-4dannjjm	4094	11	cats	cat	NNS
cord-023095-4dannjjm	4094	12	is	be	VBZ
cord-023095-4dannjjm	4094	13	unknown	unknown	JJ
cord-023095-4dannjjm	4094	14	.	.	.
cord-023095-4dannjjm	4095	1	The	the	DT
cord-023095-4dannjjm	4095	2	purpose	purpose	NN
cord-023095-4dannjjm	4095	3	of	of	IN
cord-023095-4dannjjm	4095	4	this	this	DT
cord-023095-4dannjjm	4095	5	study	study	NN
cord-023095-4dannjjm	4095	6	was	be	VBD
cord-023095-4dannjjm	4095	7	to	to	TO
cord-023095-4dannjjm	4095	8	test	test	VB
cord-023095-4dannjjm	4095	9	the	the	DT
cord-023095-4dannjjm	4095	10	hypothesis	hypothesis	NN
cord-023095-4dannjjm	4095	11	that	that	IN
cord-023095-4dannjjm	4095	12	hyperuricosuria	hyperuricosuria	NNP
cord-023095-4dannjjm	4095	13	without	without	IN
cord-023095-4dannjjm	4095	14	alterations	alteration	NNS
cord-023095-4dannjjm	4095	15	in	in	IN
cord-023095-4dannjjm	4095	16	liver	liver	NN
cord-023095-4dannjjm	4095	17	function	function	NN
cord-023095-4dannjjm	4095	18	is	be	VBZ
cord-023095-4dannjjm	4095	19	common	common	JJ
cord-023095-4dannjjm	4095	20	in	in	IN
cord-023095-4dannjjm	4095	21	cats	cat	NNS
cord-023095-4dannjjm	4095	22	with	with	IN
cord-023095-4dannjjm	4095	23	urate	urate	NN
cord-023095-4dannjjm	4095	24	uroliths	uroliths	NNP
cord-023095-4dannjjm	4095	25	.	.	.
cord-023095-4dannjjm	4096	1	Urine	urine	NN
cord-023095-4dannjjm	4096	2	concentrations	concentration	NNS
cord-023095-4dannjjm	4096	3	of	of	IN
cord-023095-4dannjjm	4096	4	purine	purine	NN
cord-023095-4dannjjm	4096	5	metabolites	metabolite	NNS
cord-023095-4dannjjm	4096	6	were	be	VBD
cord-023095-4dannjjm	4096	7	measured	measure	VBN
cord-023095-4dannjjm	4096	8	by	by	IN
cord-023095-4dannjjm	4096	9	high	high	JJ
cord-023095-4dannjjm	4096	10	-	-	HYPH
cord-023095-4dannjjm	4096	11	performance	performance	NN
cord-023095-4dannjjm	4096	12	liquid	liquid	NN
cord-023095-4dannjjm	4096	13	chromatography	chromatography	NN
cord-023095-4dannjjm	4096	14	in	in	IN
cord-023095-4dannjjm	4096	15	5	5	CD
cord-023095-4dannjjm	4096	16	cats	cat	NNS
cord-023095-4dannjjm	4096	17	with	with	IN
cord-023095-4dannjjm	4096	18	ammonium	ammonium	NN
cord-023095-4dannjjm	4096	19	uroliths	urolith	NNS
cord-023095-4dannjjm	4096	20	(	(	-LRB-
cord-023095-4dannjjm	4096	21	cases	case	NNS
cord-023095-4dannjjm	4096	22	)	)	-RRB-
cord-023095-4dannjjm	4096	23	,	,	,
cord-023095-4dannjjm	4096	24	5	5	CD
cord-023095-4dannjjm	4096	25	clinically	clinically	RB
cord-023095-4dannjjm	4096	26	healthy	healthy	JJ
cord-023095-4dannjjm	4096	27	,	,	,
cord-023095-4dannjjm	4096	28	breed	breed	NN
cord-023095-4dannjjm	4096	29	and	and	CC
cord-023095-4dannjjm	4096	30	gender	gender	NN
cord-023095-4dannjjm	4096	31	matched	match	VBN
cord-023095-4dannjjm	4096	32	cats	cat	NNS
cord-023095-4dannjjm	4096	33	(	(	-LRB-
cord-023095-4dannjjm	4096	34	negative	negative	JJ
cord-023095-4dannjjm	4096	35	controls	control	NNS
cord-023095-4dannjjm	4096	36	)	)	-RRB-
cord-023095-4dannjjm	4096	37	,	,	,
cord-023095-4dannjjm	4096	38	and	and	CC
cord-023095-4dannjjm	4096	39	2	2	CD
cord-023095-4dannjjm	4096	40	cats	cat	NNS
cord-023095-4dannjjm	4096	41	with	with	IN
cord-023095-4dannjjm	4096	42	naturally	naturally	RB
cord-023095-4dannjjm	4096	43	occurring	occur	VBG
cord-023095-4dannjjm	4096	44	xanthine	xanthine	NN
cord-023095-4dannjjm	4096	45	uroliths	urolith	NNS
cord-023095-4dannjjm	4096	46	(	(	-LRB-
cord-023095-4dannjjm	4096	47	positive	positive	JJ
cord-023095-4dannjjm	4096	48	controls	control	NNS
cord-023095-4dannjjm	4096	49	)	)	-RRB-
cord-023095-4dannjjm	4096	50	.	.	.
cord-023095-4dannjjm	4097	1	Prior	prior	RB
cord-023095-4dannjjm	4097	2	to	to	IN
cord-023095-4dannjjm	4097	3	urine	urine	NN
cord-023095-4dannjjm	4097	4	collection	collection	NN
cord-023095-4dannjjm	4097	5	,	,	,
cord-023095-4dannjjm	4097	6	all	all	DT
cord-023095-4dannjjm	4097	7	cats	cat	NNS
cord-023095-4dannjjm	4097	8	were	be	VBD
cord-023095-4dannjjm	4097	9	fed	feed	VBN
cord-023095-4dannjjm	4097	10	a	a	DT
cord-023095-4dannjjm	4097	11	standard	standard	JJ
cord-023095-4dannjjm	4097	12	maintenance	maintenance	NN
cord-023095-4dannjjm	4097	13	food	food	NN
cord-023095-4dannjjm	4097	14	(	(	-LRB-
cord-023095-4dannjjm	4097	15	protein	protein	NN
cord-023095-4dannjjm	4097	16	5	5	CD
cord-023095-4dannjjm	4097	17	7	7	CD
cord-023095-4dannjjm	4097	18	g/100kcal	g/100kcal	NNP
cord-023095-4dannjjm	4097	19	)	)	-RRB-
cord-023095-4dannjjm	4097	20	for	for	IN
cord-023095-4dannjjm	4097	21	4	4	CD
cord-023095-4dannjjm	4097	22	weeks	week	NNS
cord-023095-4dannjjm	4097	23	.	.	.
cord-023095-4dannjjm	4098	1	Urinary	urinary	JJ
cord-023095-4dannjjm	4098	2	xanthine	xanthine	NN
cord-023095-4dannjjm	4098	3	,	,	,
cord-023095-4dannjjm	4098	4	uric	uric	NN
cord-023095-4dannjjm	4098	5	acid	acid	NN
cord-023095-4dannjjm	4098	6	,	,	,
cord-023095-4dannjjm	4098	7	and	and	CC
cord-023095-4dannjjm	4098	8	allantoin	allantoin	NN
cord-023095-4dannjjm	4098	9	concentrations	concentration	NNS
cord-023095-4dannjjm	4098	10	and	and	CC
cord-023095-4dannjjm	4098	11	concentration	concentration	NN
cord-023095-4dannjjm	4098	12	to	to	IN
cord-023095-4dannjjm	4098	13	creatinine	creatinine	NN
cord-023095-4dannjjm	4098	14	ratios	ratio	NNS
cord-023095-4dannjjm	4098	15	were	be	VBD
cord-023095-4dannjjm	4098	16	calculated	calculate	VBN
cord-023095-4dannjjm	4098	17	and	and	CC
cord-023095-4dannjjm	4098	18	compared	compare	VBN
cord-023095-4dannjjm	4098	19	between	between	IN
cord-023095-4dannjjm	4098	20	groups	group	NNS
cord-023095-4dannjjm	4098	21	.	.	.
cord-023095-4dannjjm	4099	1	Also	also	RB
cord-023095-4dannjjm	4099	2	,	,	,
cord-023095-4dannjjm	4099	3	serum	serum	NN
cord-023095-4dannjjm	4099	4	pre	pre	VB
cord-023095-4dannjjm	4099	5	-	-	JJ
cord-023095-4dannjjm	4099	6	and	and	CC
cord-023095-4dannjjm	4099	7	post	post	JJ
cord-023095-4dannjjm	4099	8	-	-	JJ
cord-023095-4dannjjm	4099	9	prandial	prandial	JJ
cord-023095-4dannjjm	4099	10	bile	bile	NN
cord-023095-4dannjjm	4099	11	acid	acid	NN
cord-023095-4dannjjm	4099	12	concentrations	concentration	NNS
cord-023095-4dannjjm	4099	13	were	be	VBD
cord-023095-4dannjjm	4099	14	measured	measure	VBN
cord-023095-4dannjjm	4099	15	.	.	.
cord-023095-4dannjjm	4100	1	When	when	WRB
cord-023095-4dannjjm	4100	2	compared	compare	VBN
cord-023095-4dannjjm	4100	3	to	to	TO
cord-023095-4dannjjm	4100	4	control	control	VB
cord-023095-4dannjjm	4100	5	cats	cat	NNS
cord-023095-4dannjjm	4100	6	,	,	,
cord-023095-4dannjjm	4100	7	urinary	urinary	JJ
cord-023095-4dannjjm	4100	8	uric	uric	NN
cord-023095-4dannjjm	4100	9	acid	acid	NN
cord-023095-4dannjjm	4100	10	concentration	concentration	NN
cord-023095-4dannjjm	4100	11	was	be	VBD
cord-023095-4dannjjm	4100	12	significantly	significantly	RB
cord-023095-4dannjjm	4100	13	higher	high	JJR
cord-023095-4dannjjm	4100	14	in	in	IN
cord-023095-4dannjjm	4100	15	case	case	NN
cord-023095-4dannjjm	4100	16	cats	cat	NNS
cord-023095-4dannjjm	4100	17	(	(	-LRB-
cord-023095-4dannjjm	4100	18	P	p	NN
cord-023095-4dannjjm	4100	19	5	5	CD
cord-023095-4dannjjm	4100	20	0.002	0.002	CD
cord-023095-4dannjjm	4100	21	)	)	-RRB-
cord-023095-4dannjjm	4100	22	.	.	.
cord-023095-4dannjjm	4101	1	Xanthine	Xanthine	NNP
cord-023095-4dannjjm	4101	2	was	be	VBD
cord-023095-4dannjjm	4101	3	not	not	RB
cord-023095-4dannjjm	4101	4	detected	detect	VBN
cord-023095-4dannjjm	4101	5	in	in	IN
cord-023095-4dannjjm	4101	6	the	the	DT
cord-023095-4dannjjm	4101	7	urine	urine	NN
cord-023095-4dannjjm	4101	8	of	of	IN
cord-023095-4dannjjm	4101	9	cases	case	NNS
cord-023095-4dannjjm	4101	10	or	or	CC
cord-023095-4dannjjm	4101	11	negative	negative	JJ
cord-023095-4dannjjm	4101	12	controls	control	NNS
cord-023095-4dannjjm	4101	13	.	.	.
cord-023095-4dannjjm	4102	1	A	a	DT
cord-023095-4dannjjm	4102	2	significant	significant	JJ
cord-023095-4dannjjm	4102	3	difference	difference	NN
cord-023095-4dannjjm	4102	4	in	in	IN
cord-023095-4dannjjm	4102	5	fasted	fast	VBN
cord-023095-4dannjjm	4102	6	and	and	CC
cord-023095-4dannjjm	4102	7	post	post	JJ
cord-023095-4dannjjm	4102	8	-	-	JJ
cord-023095-4dannjjm	4102	9	prandial	prandial	JJ
cord-023095-4dannjjm	4102	10	serum	serum	NN
cord-023095-4dannjjm	4102	11	bile	bile	NN
cord-023095-4dannjjm	4102	12	acid	acid	NN
cord-023095-4dannjjm	4102	13	concentrations	concentration	NNS
cord-023095-4dannjjm	4102	14	was	be	VBD
cord-023095-4dannjjm	4102	15	not	not	RB
cord-023095-4dannjjm	4102	16	detected	detect	VBN
cord-023095-4dannjjm	4102	17	in	in	IN
cord-023095-4dannjjm	4102	18	cases	case	NNS
cord-023095-4dannjjm	4102	19	or	or	CC
cord-023095-4dannjjm	4102	20	controls	control	NNS
cord-023095-4dannjjm	4102	21	(	(	-LRB-
cord-023095-4dannjjm	4102	22	P	p	NN
cord-023095-4dannjjm	4102	23	5	5	CD
cord-023095-4dannjjm	4102	24	0.197	0.197	CD
cord-023095-4dannjjm	4102	25	,	,	,
cord-023095-4dannjjm	4102	26	0.212).Hyperuricosuria	0.212).hyperuricosuria	CD
cord-023095-4dannjjm	4102	27	without	without	IN
cord-023095-4dannjjm	4102	28	increased	increase	VBN
cord-023095-4dannjjm	4102	29	concentrations	concentration	NNS
cord-023095-4dannjjm	4102	30	of	of	IN
cord-023095-4dannjjm	4102	31	urinary	urinary	JJ
cord-023095-4dannjjm	4102	32	xanthine	xanthine	NN
cord-023095-4dannjjm	4102	33	or	or	CC
cord-023095-4dannjjm	4102	34	allantoin	allantoin	NN
cord-023095-4dannjjm	4102	35	appears	appear	VBZ
cord-023095-4dannjjm	4102	36	to	to	TO
cord-023095-4dannjjm	4102	37	be	be	VB
cord-023095-4dannjjm	4102	38	a	a	DT
cord-023095-4dannjjm	4102	39	risk	risk	NN
cord-023095-4dannjjm	4102	40	factor	factor	NN
cord-023095-4dannjjm	4102	41	for	for	IN
cord-023095-4dannjjm	4102	42	ammonium	ammonium	NN
cord-023095-4dannjjm	4102	43	urate	urate	NN
cord-023095-4dannjjm	4102	44	urolith	urolith	NN
cord-023095-4dannjjm	4102	45	formation	formation	NN
cord-023095-4dannjjm	4102	46	in	in	IN
cord-023095-4dannjjm	4102	47	cats	cat	NNS
cord-023095-4dannjjm	4102	48	.	.	.
cord-023095-4dannjjm	4103	1	An	an	DT
cord-023095-4dannjjm	4103	2	association	association	NN
cord-023095-4dannjjm	4103	3	between	between	IN
cord-023095-4dannjjm	4103	4	portovascular	portovascular	NNP
cord-023095-4dannjjm	4103	5	shunts	shunt	NNS
cord-023095-4dannjjm	4103	6	and	and	CC
cord-023095-4dannjjm	4103	7	purine	purine	NNP
cord-023095-4dannjjm	4103	8	urolithiasis	urolithiasis	NN
cord-023095-4dannjjm	4103	9	was	be	VBD
cord-023095-4dannjjm	4103	10	not	not	RB
cord-023095-4dannjjm	4103	11	observed	observe	VBN
cord-023095-4dannjjm	4103	12	in	in	IN
cord-023095-4dannjjm	4103	13	this	this	DT
cord-023095-4dannjjm	4103	14	population	population	NN
cord-023095-4dannjjm	4103	15	of	of	IN
cord-023095-4dannjjm	4103	16	cats	cat	NNS
cord-023095-4dannjjm	4103	17	.	.	.
cord-023095-4dannjjm	4104	1	Studies	study	NNS
cord-023095-4dannjjm	4104	2	indicate	indicate	VBP
cord-023095-4dannjjm	4104	3	that	that	IN
cord-023095-4dannjjm	4104	4	proteinuria	proteinuria	NN
cord-023095-4dannjjm	4104	5	is	be	VBZ
cord-023095-4dannjjm	4104	6	predictive	predictive	JJ
cord-023095-4dannjjm	4104	7	,	,	,
cord-023095-4dannjjm	4104	8	on	on	IN
cord-023095-4dannjjm	4104	9	a	a	DT
cord-023095-4dannjjm	4104	10	population	population	NN
cord-023095-4dannjjm	4104	11	basis	basis	NN
cord-023095-4dannjjm	4104	12	,	,	,
cord-023095-4dannjjm	4104	13	of	of	IN
cord-023095-4dannjjm	4104	14	those	those	DT
cord-023095-4dannjjm	4104	15	cats	cat	NNS
cord-023095-4dannjjm	4104	16	at	at	IN
cord-023095-4dannjjm	4104	17	risk	risk	NN
cord-023095-4dannjjm	4104	18	of	of	IN
cord-023095-4dannjjm	4104	19	developing	develop	VBG
cord-023095-4dannjjm	4104	20	azotemia	azotemia	NN
cord-023095-4dannjjm	4104	21	.	.	.
cord-023095-4dannjjm	4105	1	SELDI	SELDI	NNP
cord-023095-4dannjjm	4105	2	-	-	HYPH
cord-023095-4dannjjm	4105	3	TOF	TOF	NNP
cord-023095-4dannjjm	4105	4	-	-	HYPH
cord-023095-4dannjjm	4105	5	MS	MS	NNP
cord-023095-4dannjjm	4105	6	is	be	VBZ
cord-023095-4dannjjm	4105	7	a	a	DT
cord-023095-4dannjjm	4105	8	sensitive	sensitive	JJ
cord-023095-4dannjjm	4105	9	,	,	,
cord-023095-4dannjjm	4105	10	high	high	JJ
cord-023095-4dannjjm	4105	11	-	-	HYPH
cord-023095-4dannjjm	4105	12	throughput	throughput	NN
cord-023095-4dannjjm	4105	13	,	,	,
cord-023095-4dannjjm	4105	14	proteomic	proteomic	JJ
cord-023095-4dannjjm	4105	15	technique	technique	NN
cord-023095-4dannjjm	4105	16	utilising	utilise	VBG
cord-023095-4dannjjm	4105	17	chromatographic	chromatographic	JJ
cord-023095-4dannjjm	4105	18	surfaces	surface	NNS
cord-023095-4dannjjm	4105	19	to	to	TO
cord-023095-4dannjjm	4105	20	facilitate	facilitate	VB
cord-023095-4dannjjm	4105	21	separation	separation	NN
cord-023095-4dannjjm	4105	22	and	and	CC
cord-023095-4dannjjm	4105	23	detection	detection	NN
cord-023095-4dannjjm	4105	24	of	of	IN
cord-023095-4dannjjm	4105	25	proteins	protein	NNS
cord-023095-4dannjjm	4105	26	and	and	CC
cord-023095-4dannjjm	4105	27	peptides	peptide	NNS
cord-023095-4dannjjm	4105	28	within	within	IN
cord-023095-4dannjjm	4105	29	biological	biological	JJ
cord-023095-4dannjjm	4105	30	fluids	fluid	NNS
cord-023095-4dannjjm	4105	31	such	such	JJ
cord-023095-4dannjjm	4105	32	as	as	IN
cord-023095-4dannjjm	4105	33	urine	urine	NN
cord-023095-4dannjjm	4105	34	.	.	.
cord-023095-4dannjjm	4106	1	Individual	individual	JJ
cord-023095-4dannjjm	4106	2	low	low	JJ
cord-023095-4dannjjm	4106	3	molecular	molecular	JJ
cord-023095-4dannjjm	4106	4	weight	weight	NN
cord-023095-4dannjjm	4106	5	(	(	-LRB-
cord-023095-4dannjjm	4106	6	LMW	LMW	NNP
cord-023095-4dannjjm	4106	7	)	)	-RRB-
cord-023095-4dannjjm	4106	8	urinary	urinary	JJ
cord-023095-4dannjjm	4106	9	proteins	protein	NNS
cord-023095-4dannjjm	4106	10	have	have	VBP
cord-023095-4dannjjm	4106	11	been	be	VBN
cord-023095-4dannjjm	4106	12	considered	consider	VBN
cord-023095-4dannjjm	4106	13	as	as	IN
cord-023095-4dannjjm	4106	14	potential	potential	JJ
cord-023095-4dannjjm	4106	15	biomarkers	biomarker	NNS
cord-023095-4dannjjm	4106	16	for	for	IN
cord-023095-4dannjjm	4106	17	renal	renal	JJ
cord-023095-4dannjjm	4106	18	damage	damage	NN
cord-023095-4dannjjm	4106	19	but	but	CC
cord-023095-4dannjjm	4106	20	provide	provide	VBP
cord-023095-4dannjjm	4106	21	only	only	RB
cord-023095-4dannjjm	4106	22	a	a	DT
cord-023095-4dannjjm	4106	23	limited	limited	JJ
cord-023095-4dannjjm	4106	24	representation	representation	NN
cord-023095-4dannjjm	4106	25	of	of	IN
cord-023095-4dannjjm	4106	26	the	the	DT
cord-023095-4dannjjm	4106	27	urinary	urinary	JJ
cord-023095-4dannjjm	4106	28	proteome	proteome	NN
cord-023095-4dannjjm	4106	29	;	;	:
cord-023095-4dannjjm	4106	30	SELDI	SELDI	NNP
cord-023095-4dannjjm	4106	31	-	-	HYPH
cord-023095-4dannjjm	4106	32	TOF	TOF	NNP
cord-023095-4dannjjm	4106	33	-	-	HYPH
cord-023095-4dannjjm	4106	34	MS	MS	NNP
cord-023095-4dannjjm	4106	35	may	may	MD
cord-023095-4dannjjm	4106	36	provide	provide	VB
cord-023095-4dannjjm	4106	37	a	a	DT
cord-023095-4dannjjm	4106	38	more	more	RBR
cord-023095-4dannjjm	4106	39	global	global	JJ
cord-023095-4dannjjm	4106	40	assessment	assessment	NN
cord-023095-4dannjjm	4106	41	.	.	.
cord-023095-4dannjjm	4107	1	Normotensive	Normotensive	NNP
cord-023095-4dannjjm	4107	2	,	,	,
cord-023095-4dannjjm	4107	3	non	non	JJ
cord-023095-4dannjjm	4107	4	-	-	JJ
cord-023095-4dannjjm	4107	5	azotemic	azotemic	JJ
cord-023095-4dannjjm	4107	6	geriatric	geriatric	JJ
cord-023095-4dannjjm	4107	7	cats	cat	NNS
cord-023095-4dannjjm	4107	8	(	(	-LRB-
cord-023095-4dannjjm	4107	9	4	4	CD
cord-023095-4dannjjm	4107	10	9	9	CD
cord-023095-4dannjjm	4107	11	years	year	NNS
cord-023095-4dannjjm	4107	12	)	)	-RRB-
cord-023095-4dannjjm	4107	13	were	be	VBD
cord-023095-4dannjjm	4107	14	recruited	recruit	VBN
cord-023095-4dannjjm	4107	15	prospectively	prospectively	RB
cord-023095-4dannjjm	4107	16	from	from	IN
cord-023095-4dannjjm	4107	17	two	two	CD
cord-023095-4dannjjm	4107	18	first	first	JJ
cord-023095-4dannjjm	4107	19	-	-	HYPH
cord-023095-4dannjjm	4107	20	opinion	opinion	NN
cord-023095-4dannjjm	4107	21	clinics	clinic	NNS
cord-023095-4dannjjm	4107	22	for	for	IN
cord-023095-4dannjjm	4107	23	routine	routine	JJ
cord-023095-4dannjjm	4107	24	health	health	NN
cord-023095-4dannjjm	4107	25	screening	screening	NN
cord-023095-4dannjjm	4107	26	.	.	.
cord-023095-4dannjjm	4108	1	At	at	IN
cord-023095-4dannjjm	4108	2	entry	entry	NN
cord-023095-4dannjjm	4108	3	cats	cat	NNS
cord-023095-4dannjjm	4108	4	received	receive	VBD
cord-023095-4dannjjm	4108	5	a	a	DT
cord-023095-4dannjjm	4108	6	full	full	JJ
cord-023095-4dannjjm	4108	7	physical	physical	JJ
cord-023095-4dannjjm	4108	8	examination	examination	NN
cord-023095-4dannjjm	4108	9	,	,	,
cord-023095-4dannjjm	4108	10	plasma	plasma	NN
cord-023095-4dannjjm	4108	11	biochemistry	biochemistry	NN
cord-023095-4dannjjm	4108	12	,	,	,
cord-023095-4dannjjm	4108	13	evaluation	evaluation	NN
cord-023095-4dannjjm	4108	14	of	of	IN
cord-023095-4dannjjm	4108	15	total	total	JJ
cord-023095-4dannjjm	4108	16	T4	T4	NNP
cord-023095-4dannjjm	4108	17	concentration	concentration	NN
cord-023095-4dannjjm	4108	18	and	and	CC
cord-023095-4dannjjm	4108	19	urinalysis	urinalysis	NN
cord-023095-4dannjjm	4108	20	including	include	VBG
cord-023095-4dannjjm	4108	21	urine	urine	NN
cord-023095-4dannjjm	4108	22	protein	protein	NN
cord-023095-4dannjjm	4108	23	to	to	IN
cord-023095-4dannjjm	4108	24	creatinine	creatinine	NN
cord-023095-4dannjjm	4108	25	ratio	ratio	NN
cord-023095-4dannjjm	4108	26	.	.	.
cord-023095-4dannjjm	4109	1	Re	re	NN
cord-023095-4dannjjm	4109	2	-	-	NN
cord-023095-4dannjjm	4109	3	examination	examination	NN
cord-023095-4dannjjm	4109	4	was	be	VBD
cord-023095-4dannjjm	4109	5	offered	offer	VBN
cord-023095-4dannjjm	4109	6	at	at	IN
cord-023095-4dannjjm	4109	7	6	6	CD
cord-023095-4dannjjm	4109	8	and	and	CC
cord-023095-4dannjjm	4109	9	12	12	CD
cord-023095-4dannjjm	4109	10	months	month	NNS
cord-023095-4dannjjm	4109	11	.	.	.
cord-023095-4dannjjm	4110	1	Cats	cat	NNS
cord-023095-4dannjjm	4110	2	were	be	VBD
cord-023095-4dannjjm	4110	3	divided	divide	VBN
cord-023095-4dannjjm	4110	4	into	into	IN
cord-023095-4dannjjm	4110	5	two	two	CD
cord-023095-4dannjjm	4110	6	groups	group	NNS
cord-023095-4dannjjm	4110	7	based	base	VBN
cord-023095-4dannjjm	4110	8	on	on	IN
cord-023095-4dannjjm	4110	9	clinical	clinical	JJ
cord-023095-4dannjjm	4110	10	status	status	NN
cord-023095-4dannjjm	4110	11	at	at	IN
cord-023095-4dannjjm	4110	12	the	the	DT
cord-023095-4dannjjm	4110	13	12	12	CD
cord-023095-4dannjjm	4110	14	month	month	NN
cord-023095-4dannjjm	4110	15	re	re	NN
cord-023095-4dannjjm	4110	16	-	-	NN
cord-023095-4dannjjm	4110	17	examination	examination	NN
cord-023095-4dannjjm	4110	18	(	(	-LRB-
cord-023095-4dannjjm	4110	19	azotemic	azotemic	NN
cord-023095-4dannjjm	4110	20	;	;	:
cord-023095-4dannjjm	4110	21	creatinine	creatinine	NN
cord-023095-4dannjjm	4110	22	concentration	concentration	NN
cord-023095-4dannjjm	4110	23	!	!	.
cord-023095-4dannjjm	4111	1	2.0	2.0	CD
cord-023095-4dannjjm	4112	1	mg	mg	NNP
cord-023095-4dannjjm	4112	2	/	/	SYM
cord-023095-4dannjjm	4112	3	dL	dl	NN
cord-023095-4dannjjm	4112	4	and	and	CC
cord-023095-4dannjjm	4112	5	non	non	JJ
cord-023095-4dannjjm	4112	6	-	-	JJ
cord-023095-4dannjjm	4112	7	azotemic	azotemic	JJ
cord-023095-4dannjjm	4112	8	)	)	-RRB-
cord-023095-4dannjjm	4112	9	.	.	.
cord-023095-4dannjjm	4113	1	Optimisation	optimisation	NN
cord-023095-4dannjjm	4113	2	studies	study	NNS
cord-023095-4dannjjm	4113	3	were	be	VBD
cord-023095-4dannjjm	4113	4	performed	perform	VBN
cord-023095-4dannjjm	4113	5	to	to	TO
cord-023095-4dannjjm	4113	6	facilitate	facilitate	VB
cord-023095-4dannjjm	4113	7	the	the	DT
cord-023095-4dannjjm	4113	8	automated	automate	VBN
cord-023095-4dannjjm	4113	9	preparation	preparation	NN
cord-023095-4dannjjm	4113	10	(	(	-LRB-
cord-023095-4dannjjm	4113	11	Biomek	Biomek	NNP
cord-023095-4dannjjm	4113	12	3000	3000	CD
cord-023095-4dannjjm	4113	13	)	)	-RRB-
cord-023095-4dannjjm	4113	14	of	of	IN
cord-023095-4dannjjm	4113	15	CM10	CM10	NNP
cord-023095-4dannjjm	4113	16	(	(	-LRB-
cord-023095-4dannjjm	4113	17	weak	weak	NNP
cord-023095-4dannjjm	4113	18	cation	cation	NNP
cord-023095-4dannjjm	4113	19	exchange	exchange	NN
cord-023095-4dannjjm	4113	20	)	)	-RRB-
cord-023095-4dannjjm	4113	21	arrays	array	NNS
cord-023095-4dannjjm	4113	22	for	for	IN
cord-023095-4dannjjm	4113	23	SELDI	SELDI	NNP
cord-023095-4dannjjm	4113	24	-	-	HYPH
cord-023095-4dannjjm	4113	25	TOF	TOF	NNP
cord-023095-4dannjjm	4113	26	-	-	HYPH
cord-023095-4dannjjm	4113	27	MS	MS	NNP
cord-023095-4dannjjm	4113	28	analysis	analysis	NN
cord-023095-4dannjjm	4114	1	(	(	-LRB-
cord-023095-4dannjjm	4114	2	Ciphergen	Ciphergen	NNP
cord-023095-4dannjjm	4114	3	Enterprise	Enterprise	NNP
cord-023095-4dannjjm	4114	4	4000	4000	CD
cord-023095-4dannjjm	4114	5	)	)	-RRB-
cord-023095-4dannjjm	4114	6	of	of	IN
cord-023095-4dannjjm	4114	7	urine	urine	NN
cord-023095-4dannjjm	4114	8	samples	sample	NNS
cord-023095-4dannjjm	4114	9	from	from	IN
cord-023095-4dannjjm	4114	10	cats	cat	NNS
cord-023095-4dannjjm	4114	11	at	at	IN
cord-023095-4dannjjm	4114	12	entry	entry	NN
cord-023095-4dannjjm	4114	13	to	to	IN
cord-023095-4dannjjm	4114	14	the	the	DT
cord-023095-4dannjjm	4114	15	study	study	NN
cord-023095-4dannjjm	4114	16	.	.	.
cord-023095-4dannjjm	4115	1	Results	result	NNS
cord-023095-4dannjjm	4115	2	are	be	VBP
cord-023095-4dannjjm	4115	3	reported	report	VBN
cord-023095-4dannjjm	4115	4	as	as	IN
cord-023095-4dannjjm	4115	5	median	median	JJ
cord-023095-4dannjjm	4115	6	[	[	-LRB-
cord-023095-4dannjjm	4115	7	25	25	CD
cord-023095-4dannjjm	4115	8	th	th	XX
cord-023095-4dannjjm	4115	9	,	,	,
cord-023095-4dannjjm	4115	10	75	75	CD
cord-023095-4dannjjm	4115	11	th	th	XX
cord-023095-4dannjjm	4115	12	percentile	percentile	NN
cord-023095-4dannjjm	4115	13	]	]	-RRB-
cord-023095-4dannjjm	4115	14	.	.	.
cord-023095-4dannjjm	4116	1	Mann	Mann	NNP
cord-023095-4dannjjm	4116	2	Whitney	Whitney	NNP
cord-023095-4dannjjm	4116	3	U	U	NNP
cord-023095-4dannjjm	4116	4	-	-	HYPH
cord-023095-4dannjjm	4116	5	test	test	NN
cord-023095-4dannjjm	4116	6	and	and	CC
cord-023095-4dannjjm	4116	7	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	4116	8	signed	sign	VBD
cord-023095-4dannjjm	4116	9	rank	rank	NN
cord-023095-4dannjjm	4116	10	test	test	NN
cord-023095-4dannjjm	4116	11	were	be	VBD
cord-023095-4dannjjm	4116	12	used	use	VBN
cord-023095-4dannjjm	4116	13	to	to	TO
cord-023095-4dannjjm	4116	14	compare	compare	VB
cord-023095-4dannjjm	4116	15	variables	variable	NNS
cord-023095-4dannjjm	4116	16	between	between	IN
cord-023095-4dannjjm	4116	17	groups	group	NNS
cord-023095-4dannjjm	4116	18	and	and	CC
cord-023095-4dannjjm	4116	19	between	between	IN
cord-023095-4dannjjm	4116	20	timepoints	timepoint	NNS
cord-023095-4dannjjm	4116	21	,	,	,
cord-023095-4dannjjm	4116	22	respectively	respectively	RB
cord-023095-4dannjjm	4116	23	.	.	.
cord-023095-4dannjjm	4117	1	Ciphergen	Ciphergen	NNP
cord-023095-4dannjjm	4117	2	Express	Express	NNP
cord-023095-4dannjjm	4117	3	(	(	-LRB-
cord-023095-4dannjjm	4117	4	3.06	3.06	CD
cord-023095-4dannjjm	4117	5	)	)	-RRB-
cord-023095-4dannjjm	4117	6	software	software	NN
cord-023095-4dannjjm	4117	7	was	be	VBD
cord-023095-4dannjjm	4117	8	used	use	VBN
cord-023095-4dannjjm	4117	9	to	to	TO
cord-023095-4dannjjm	4117	10	analyse	analyse	VB
cord-023095-4dannjjm	4117	11	spectral	spectral	JJ
cord-023095-4dannjjm	4117	12	data	datum	NNS
cord-023095-4dannjjm	4117	13	and	and	CC
cord-023095-4dannjjm	4117	14	a	a	DT
cord-023095-4dannjjm	4117	15	Mann	Mann	NNP
cord-023095-4dannjjm	4117	16	Whitney	Whitney	NNP
cord-023095-4dannjjm	4117	17	U	U	NNP
cord-023095-4dannjjm	4117	18	-	-	HYPH
cord-023095-4dannjjm	4117	19	test	test	NN
cord-023095-4dannjjm	4117	20	was	be	VBD
cord-023095-4dannjjm	4117	21	used	use	VBN
cord-023095-4dannjjm	4117	22	to	to	TO
cord-023095-4dannjjm	4117	23	identify	identify	VB
cord-023095-4dannjjm	4117	24	clusters	cluster	NNS
cord-023095-4dannjjm	4117	25	which	which	WDT
cord-023095-4dannjjm	4117	26	differed	differ	VBD
cord-023095-4dannjjm	4117	27	significantly	significantly	RB
cord-023095-4dannjjm	4117	28	between	between	IN
cord-023095-4dannjjm	4117	29	groups	group	NNS
cord-023095-4dannjjm	4117	30	(	(	-LRB-
cord-023095-4dannjjm	4117	31	p	p	NN
cord-023095-4dannjjm	4117	32	o	o	NN
cord-023095-4dannjjm	4117	33	0.05	0.05	CD
cord-023095-4dannjjm	4117	34	)	)	-RRB-
cord-023095-4dannjjm	4117	35	at	at	IN
cord-023095-4dannjjm	4117	36	entry	entry	NN
cord-023095-4dannjjm	4117	37	to	to	IN
cord-023095-4dannjjm	4117	38	the	the	DT
cord-023095-4dannjjm	4117	39	study	study	NN
cord-023095-4dannjjm	4117	40	.	.	.
cord-023095-4dannjjm	4118	1	Twenty	twenty	CD
cord-023095-4dannjjm	4118	2	non	non	JJ
cord-023095-4dannjjm	4118	3	-	-	JJ
cord-023095-4dannjjm	4118	4	azotemic	azotemic	JJ
cord-023095-4dannjjm	4118	5	cats	cat	NNS
cord-023095-4dannjjm	4118	6	were	be	VBD
cord-023095-4dannjjm	4118	7	recruited	recruit	VBN
cord-023095-4dannjjm	4118	8	,	,	,
cord-023095-4dannjjm	4118	9	of	of	IN
cord-023095-4dannjjm	4118	10	which	which	WDT
cord-023095-4dannjjm	4118	11	10	10	CD
cord-023095-4dannjjm	4118	12	cats	cat	NNS
cord-023095-4dannjjm	4118	13	developed	develop	VBD
cord-023095-4dannjjm	4118	14	azotemia	azotemia	NN
cord-023095-4dannjjm	4118	15	by	by	IN
cord-023095-4dannjjm	4118	16	12	12	CD
cord-023095-4dannjjm	4118	17	months	month	NNS
cord-023095-4dannjjm	4118	18	.	.	.
cord-023095-4dannjjm	4119	1	No	no	DT
cord-023095-4dannjjm	4119	2	significant	significant	JJ
cord-023095-4dannjjm	4119	3	differences	difference	NNS
cord-023095-4dannjjm	4119	4	in	in	IN
cord-023095-4dannjjm	4119	5	age	age	NN
cord-023095-4dannjjm	4119	6	,	,	,
cord-023095-4dannjjm	4119	7	body	body	NN
cord-023095-4dannjjm	4119	8	weight	weight	NN
cord-023095-4dannjjm	4119	9	,	,	,
cord-023095-4dannjjm	4119	10	biochemical	biochemical	JJ
cord-023095-4dannjjm	4119	11	or	or	CC
cord-023095-4dannjjm	4119	12	urinalysis	urinalysis	JJ
cord-023095-4dannjjm	4119	13	variables	variable	NNS
cord-023095-4dannjjm	4119	14	were	be	VBD
cord-023095-4dannjjm	4119	15	identified	identify	VBN
cord-023095-4dannjjm	4119	16	between	between	IN
cord-023095-4dannjjm	4119	17	groups	group	NNS
cord-023095-4dannjjm	4119	18	at	at	IN
cord-023095-4dannjjm	4119	19	entry	entry	NN
cord-023095-4dannjjm	4119	20	to	to	IN
cord-023095-4dannjjm	4119	21	the	the	DT
cord-023095-4dannjjm	4119	22	study	study	NN
cord-023095-4dannjjm	4119	23	.	.	.
cord-023095-4dannjjm	4120	1	As	as	IN
cord-023095-4dannjjm	4120	2	might	may	MD
cord-023095-4dannjjm	4120	3	be	be	VB
cord-023095-4dannjjm	4120	4	expected	expect	VBN
cord-023095-4dannjjm	4120	5	creatinine	creatinine	NN
cord-023095-4dannjjm	4120	6	increased	increase	VBD
cord-023095-4dannjjm	4120	7	significantly	significantly	RB
cord-023095-4dannjjm	4120	8	(	(	-LRB-
cord-023095-4dannjjm	4120	9	1.73	1.73	CD
cord-023095-4dannjjm	4120	10	mg	mg	NNP
cord-023095-4dannjjm	4120	11	/	/	SYM
cord-023095-4dannjjm	4120	12	dL	dl	NN
cord-023095-4dannjjm	4120	13	[	[	-LRB-
cord-023095-4dannjjm	4120	14	1.58	1.58	CD
cord-023095-4dannjjm	4120	15	,	,	,
cord-023095-4dannjjm	4120	16	1.77	1.77	CD
cord-023095-4dannjjm	4120	17	]	]	-RRB-
cord-023095-4dannjjm	4120	18	,	,	,
cord-023095-4dannjjm	4120	19	2.17	2.17	CD
cord-023095-4dannjjm	4120	20	[	[	-LRB-
cord-023095-4dannjjm	4120	21	2.00	2.00	CD
cord-023095-4dannjjm	4120	22	,	,	,
cord-023095-4dannjjm	4120	23	3.23	3.23	CD
cord-023095-4dannjjm	4120	24	]	]	-RRB-
cord-023095-4dannjjm	4120	25	,	,	,
cord-023095-4dannjjm	4120	26	p	p	NN
cord-023095-4dannjjm	4120	27	5	5	CD
cord-023095-4dannjjm	4120	28	0.002	0.002	CD
cord-023095-4dannjjm	4120	29	)	)	-RRB-
cord-023095-4dannjjm	4120	30	between	between	IN
cord-023095-4dannjjm	4120	31	study	study	NN
cord-023095-4dannjjm	4120	32	entry	entry	NN
cord-023095-4dannjjm	4120	33	and	and	CC
cord-023095-4dannjjm	4120	34	12	12	CD
cord-023095-4dannjjm	4120	35	months	month	NNS
cord-023095-4dannjjm	4120	36	in	in	IN
cord-023095-4dannjjm	4120	37	the	the	DT
cord-023095-4dannjjm	4120	38	cats	cat	NNS
cord-023095-4dannjjm	4120	39	that	that	WDT
cord-023095-4dannjjm	4120	40	developed	develop	VBD
cord-023095-4dannjjm	4120	41	azotaemia	azotaemia	NN
cord-023095-4dannjjm	4120	42	and	and	CC
cord-023095-4dannjjm	4120	43	there	there	EX
cord-023095-4dannjjm	4120	44	was	be	VBD
cord-023095-4dannjjm	4120	45	a	a	DT
cord-023095-4dannjjm	4120	46	commensurate	commensurate	JJ
cord-023095-4dannjjm	4120	47	increase	increase	NN
cord-023095-4dannjjm	4120	48	in	in	IN
cord-023095-4dannjjm	4120	49	phosphate	phosphate	NN
cord-023095-4dannjjm	4120	50	concentration	concentration	NN
cord-023095-4dannjjm	4120	51	(	(	-LRB-
cord-023095-4dannjjm	4120	52	3.81	3.81	CD
cord-023095-4dannjjm	4120	53	mg	mg	NNP
cord-023095-4dannjjm	4120	54	/	/	SYM
cord-023095-4dannjjm	4120	55	dL	dl	NN
cord-023095-4dannjjm	4120	56	[	[	-LRB-
cord-023095-4dannjjm	4120	57	3.60	3.60	CD
cord-023095-4dannjjm	4120	58	,	,	,
cord-023095-4dannjjm	4120	59	4.22	4.22	CD
cord-023095-4dannjjm	4120	60	]	]	-RRB-
cord-023095-4dannjjm	4120	61	,	,	,
cord-023095-4dannjjm	4120	62	4.65[3.94	4.65[3.94	CD
cord-023095-4dannjjm	4120	63	,	,	,
cord-023095-4dannjjm	4120	64	6	6	CD
cord-023095-4dannjjm	4120	65	.48	.48	CD
cord-023095-4dannjjm	4120	66	]	]	-RRB-
cord-023095-4dannjjm	4120	67	,	,	.
cord-023095-4dannjjm	4121	1	p	p	NN
cord-023095-4dannjjm	4121	2	5	5	CD
cord-023095-4dannjjm	4121	3	0.019	0.019	CD
cord-023095-4dannjjm	4121	4	)	)	-RRB-
cord-023095-4dannjjm	4121	5	.	.	.
cord-023095-4dannjjm	4122	1	Creatinine	creatinine	NN
cord-023095-4dannjjm	4122	2	and	and	CC
cord-023095-4dannjjm	4122	3	phosphorus	phosphorus	NN
cord-023095-4dannjjm	4122	4	did	do	VBD
cord-023095-4dannjjm	4122	5	not	not	RB
cord-023095-4dannjjm	4122	6	change	change	VB
cord-023095-4dannjjm	4122	7	significantly	significantly	RB
cord-023095-4dannjjm	4122	8	over	over	IN
cord-023095-4dannjjm	4122	9	time	time	NN
cord-023095-4dannjjm	4122	10	in	in	IN
cord-023095-4dannjjm	4122	11	the	the	DT
cord-023095-4dannjjm	4122	12	cats	cat	NNS
cord-023095-4dannjjm	4122	13	that	that	WDT
cord-023095-4dannjjm	4122	14	did	do	VBD
cord-023095-4dannjjm	4122	15	not	not	RB
cord-023095-4dannjjm	4122	16	develop	develop	VB
cord-023095-4dannjjm	4122	17	azotaemia	azotaemia	NNP
cord-023095-4dannjjm	4122	18	.	.	.
cord-023095-4dannjjm	4123	1	Seven	seven	CD
cord-023095-4dannjjm	4123	2	clusters	cluster	NNS
cord-023095-4dannjjm	4123	3	with	with	IN
cord-023095-4dannjjm	4123	4	m	m	NN
cord-023095-4dannjjm	4123	5	/	/	SYM
cord-023095-4dannjjm	4123	6	z	z	NN
cord-023095-4dannjjm	4123	7	values	value	NNS
cord-023095-4dannjjm	4123	8	of	of	IN
cord-023095-4dannjjm	4123	9	2822	2822	CD
cord-023095-4dannjjm	4123	10	,	,	,
cord-023095-4dannjjm	4123	11	10	10	CD
cord-023095-4dannjjm	4123	12	033	033	CD
cord-023095-4dannjjm	4123	13	,	,	,
cord-023095-4dannjjm	4123	14	10	10	CD
cord-023095-4dannjjm	4123	15	151	151	CD
cord-023095-4dannjjm	4123	16	,	,	,
cord-023095-4dannjjm	4123	17	10	10	CD
cord-023095-4dannjjm	4123	18	234	234	CD
cord-023095-4dannjjm	4123	19	,	,	,
cord-023095-4dannjjm	4123	20	11	11	CD
cord-023095-4dannjjm	4123	21	635	635	CD
cord-023095-4dannjjm	4123	22	,	,	,
cord-023095-4dannjjm	4123	23	11	11	CD
cord-023095-4dannjjm	4123	24	700	700	CD
cord-023095-4dannjjm	4123	25	were	be	VBD
cord-023095-4dannjjm	4123	26	found	find	VBN
cord-023095-4dannjjm	4123	27	to	to	TO
cord-023095-4dannjjm	4123	28	differ	differ	VB
cord-023095-4dannjjm	4123	29	significantly	significantly	RB
cord-023095-4dannjjm	4123	30	between	between	IN
cord-023095-4dannjjm	4123	31	groups	group	NNS
cord-023095-4dannjjm	4123	32	at	at	IN
cord-023095-4dannjjm	4123	33	entry	entry	NN
cord-023095-4dannjjm	4123	34	to	to	IN
cord-023095-4dannjjm	4123	35	the	the	DT
cord-023095-4dannjjm	4123	36	study	study	NN
cord-023095-4dannjjm	4123	37	.	.	.
cord-023095-4dannjjm	4124	1	The	the	DT
cord-023095-4dannjjm	4124	2	low	low	JJ
cord-023095-4dannjjm	4124	3	protein	protein	NN
cord-023095-4dannjjm	4124	4	concentration	concentration	NN
cord-023095-4dannjjm	4124	5	of	of	IN
cord-023095-4dannjjm	4124	6	feline	feline	JJ
cord-023095-4dannjjm	4124	7	urine	urine	NN
cord-023095-4dannjjm	4124	8	makes	make	VBZ
cord-023095-4dannjjm	4124	9	the	the	DT
cord-023095-4dannjjm	4124	10	use	use	NN
cord-023095-4dannjjm	4124	11	of	of	IN
cord-023095-4dannjjm	4124	12	proteomic	proteomic	JJ
cord-023095-4dannjjm	4124	13	techniques	technique	NNS
cord-023095-4dannjjm	4124	14	challenging	challenge	VBG
cord-023095-4dannjjm	4124	15	.	.	.
cord-023095-4dannjjm	4125	1	However	however	RB
cord-023095-4dannjjm	4125	2	,	,	,
cord-023095-4dannjjm	4125	3	this	this	DT
cord-023095-4dannjjm	4125	4	pilot	pilot	NN
cord-023095-4dannjjm	4125	5	study	study	NN
cord-023095-4dannjjm	4125	6	indicates	indicate	VBZ
cord-023095-4dannjjm	4125	7	that	that	IN
cord-023095-4dannjjm	4125	8	SELDI	SELDI	NNP
cord-023095-4dannjjm	4125	9	-	-	HYPH
cord-023095-4dannjjm	4125	10	TOF	TOF	NNP
cord-023095-4dannjjm	4125	11	-	-	HYPH
cord-023095-4dannjjm	4125	12	MS	MS	NNP
cord-023095-4dannjjm	4125	13	can	can	MD
cord-023095-4dannjjm	4125	14	be	be	VB
cord-023095-4dannjjm	4125	15	utilised	utilise	VBN
cord-023095-4dannjjm	4125	16	to	to	TO
cord-023095-4dannjjm	4125	17	examine	examine	VB
cord-023095-4dannjjm	4125	18	the	the	DT
cord-023095-4dannjjm	4125	19	feline	feline	JJ
cord-023095-4dannjjm	4125	20	urinary	urinary	JJ
cord-023095-4dannjjm	4125	21	proteome	proteome	NN
cord-023095-4dannjjm	4125	22	and	and	CC
cord-023095-4dannjjm	4125	23	that	that	IN
cord-023095-4dannjjm	4125	24	differences	difference	NNS
cord-023095-4dannjjm	4125	25	in	in	IN
cord-023095-4dannjjm	4125	26	low	low	JJ
cord-023095-4dannjjm	4125	27	molecular	molecular	JJ
cord-023095-4dannjjm	4125	28	weight	weight	NN
cord-023095-4dannjjm	4125	29	protein	protein	NN
cord-023095-4dannjjm	4125	30	patterns	pattern	NNS
cord-023095-4dannjjm	4125	31	may	may	MD
cord-023095-4dannjjm	4125	32	be	be	VB
cord-023095-4dannjjm	4125	33	useful	useful	JJ
cord-023095-4dannjjm	4125	34	to	to	TO
cord-023095-4dannjjm	4125	35	differentiate	differentiate	VB
cord-023095-4dannjjm	4125	36	those	those	DT
cord-023095-4dannjjm	4125	37	cats	cat	NNS
cord-023095-4dannjjm	4125	38	which	which	WDT
cord-023095-4dannjjm	4125	39	are	be	VBP
cord-023095-4dannjjm	4125	40	at	at	IN
cord-023095-4dannjjm	4125	41	risk	risk	NN
cord-023095-4dannjjm	4125	42	of	of	IN
cord-023095-4dannjjm	4125	43	the	the	DT
cord-023095-4dannjjm	4125	44	development	development	NN
cord-023095-4dannjjm	4125	45	of	of	IN
cord-023095-4dannjjm	4125	46	azotemia	azotemia	NN
cord-023095-4dannjjm	4125	47	.	.	.
cord-023095-4dannjjm	4126	1	Further	further	JJ
cord-023095-4dannjjm	4126	2	work	work	NN
cord-023095-4dannjjm	4126	3	is	be	VBZ
cord-023095-4dannjjm	4126	4	necessary	necessary	JJ
cord-023095-4dannjjm	4126	5	to	to	TO
cord-023095-4dannjjm	4126	6	identify	identify	VB
cord-023095-4dannjjm	4126	7	these	these	DT
cord-023095-4dannjjm	4126	8	proteins	protein	NNS
cord-023095-4dannjjm	4126	9	/	/	SYM
cord-023095-4dannjjm	4126	10	peptides	peptide	NNS
cord-023095-4dannjjm	4126	11	.	.	.
cord-023095-4dannjjm	4127	1	Fibroblastic	Fibroblastic	NNP
cord-023095-4dannjjm	4127	2	Growth	Growth	NNP
cord-023095-4dannjjm	4127	3	Factor	Factor	NNP
cord-023095-4dannjjm	4127	4	23	23	CD
cord-023095-4dannjjm	4127	5	(	(	-LRB-
cord-023095-4dannjjm	4127	6	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4127	7	)	)	-RRB-
cord-023095-4dannjjm	4127	8	is	be	VBZ
cord-023095-4dannjjm	4127	9	a	a	DT
cord-023095-4dannjjm	4127	10	phosphotonin	phosphotonin	NN
cord-023095-4dannjjm	4127	11	with	with	IN
cord-023095-4dannjjm	4127	12	an	an	DT
cord-023095-4dannjjm	4127	13	important	important	JJ
cord-023095-4dannjjm	4127	14	physiological	physiological	JJ
cord-023095-4dannjjm	4127	15	role	role	NN
cord-023095-4dannjjm	4127	16	in	in	IN
cord-023095-4dannjjm	4127	17	the	the	DT
cord-023095-4dannjjm	4127	18	regulation	regulation	NN
cord-023095-4dannjjm	4127	19	of	of	IN
cord-023095-4dannjjm	4127	20	phosphorous	phosphorous	NN
cord-023095-4dannjjm	4127	21	and	and	CC
cord-023095-4dannjjm	4127	22	vitamin	vitamin	NN
cord-023095-4dannjjm	4127	23	D	d	NN
cord-023095-4dannjjm	4127	24	metabolism	metabolism	NN
cord-023095-4dannjjm	4127	25	,	,	,
cord-023095-4dannjjm	4127	26	and	and	CC
cord-023095-4dannjjm	4127	27	may	may	MD
cord-023095-4dannjjm	4127	28	therefore	therefore	RB
cord-023095-4dannjjm	4127	29	play	play	VB
cord-023095-4dannjjm	4127	30	a	a	DT
cord-023095-4dannjjm	4127	31	part	part	NN
cord-023095-4dannjjm	4127	32	in	in	IN
cord-023095-4dannjjm	4127	33	the	the	DT
cord-023095-4dannjjm	4127	34	development	development	NN
cord-023095-4dannjjm	4127	35	of	of	IN
cord-023095-4dannjjm	4127	36	renal	renal	JJ
cord-023095-4dannjjm	4127	37	secondary	secondary	JJ
cord-023095-4dannjjm	4127	38	hyperparathyroidism	hyperparathyroidism	NN
cord-023095-4dannjjm	4127	39	.	.	.
cord-023095-4dannjjm	4128	1	Previous	previous	JJ
cord-023095-4dannjjm	4128	2	studies	study	NNS
cord-023095-4dannjjm	4128	3	in	in	IN
cord-023095-4dannjjm	4128	4	cats	cat	NNS
cord-023095-4dannjjm	4128	5	have	have	VBP
cord-023095-4dannjjm	4128	6	shown	show	VBN
cord-023095-4dannjjm	4128	7	parathyroid	parathyroid	JJ
cord-023095-4dannjjm	4128	8	hormone	hormone	NN
cord-023095-4dannjjm	4128	9	(	(	-LRB-
cord-023095-4dannjjm	4128	10	PTH	PTH	NNP
cord-023095-4dannjjm	4128	11	)	)	-RRB-
cord-023095-4dannjjm	4128	12	to	to	TO
cord-023095-4dannjjm	4128	13	be	be	VB
cord-023095-4dannjjm	4128	14	elevated	elevate	VBN
cord-023095-4dannjjm	4128	15	prior	prior	RB
cord-023095-4dannjjm	4128	16	to	to	IN
cord-023095-4dannjjm	4128	17	the	the	DT
cord-023095-4dannjjm	4128	18	development	development	NN
cord-023095-4dannjjm	4128	19	of	of	IN
cord-023095-4dannjjm	4128	20	azotemia	azotemia	NN
cord-023095-4dannjjm	4128	21	.	.	.
cord-023095-4dannjjm	4129	1	The	the	DT
cord-023095-4dannjjm	4129	2	study	study	NN
cord-023095-4dannjjm	4129	3	objectives	objective	NNS
cord-023095-4dannjjm	4129	4	were	be	VBD
cord-023095-4dannjjm	4129	5	to	to	TO
cord-023095-4dannjjm	4129	6	explore	explore	VB
cord-023095-4dannjjm	4129	7	the	the	DT
cord-023095-4dannjjm	4129	8	hypothesis	hypothesis	NN
cord-023095-4dannjjm	4129	9	that	that	IN
cord-023095-4dannjjm	4129	10	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4129	11	is	be	VBZ
cord-023095-4dannjjm	4129	12	a	a	DT
cord-023095-4dannjjm	4129	13	mediator	mediator	NN
cord-023095-4dannjjm	4129	14	of	of	IN
cord-023095-4dannjjm	4129	15	the	the	DT
cord-023095-4dannjjm	4129	16	development	development	NN
cord-023095-4dannjjm	4129	17	of	of	IN
cord-023095-4dannjjm	4129	18	renal	renal	JJ
cord-023095-4dannjjm	4129	19	secondary	secondary	JJ
cord-023095-4dannjjm	4129	20	hyperparathyroidism	hyperparathyroidism	NN
cord-023095-4dannjjm	4129	21	in	in	IN
cord-023095-4dannjjm	4129	22	the	the	DT
cord-023095-4dannjjm	4129	23	nonazotemic	nonazotemic	JJ
cord-023095-4dannjjm	4129	24	stages	stage	NNS
cord-023095-4dannjjm	4129	25	of	of	IN
cord-023095-4dannjjm	4129	26	feline	feline	JJ
cord-023095-4dannjjm	4129	27	CKD	CKD	NNP
cord-023095-4dannjjm	4129	28	.	.	.
cord-023095-4dannjjm	4130	1	Healthy	healthy	JJ
cord-023095-4dannjjm	4130	2	,	,	,
cord-023095-4dannjjm	4130	3	non	non	JJ
cord-023095-4dannjjm	4130	4	-	-	JJ
cord-023095-4dannjjm	4130	5	azotemic	azotemic	JJ
cord-023095-4dannjjm	4130	6	(	(	-LRB-
cord-023095-4dannjjm	4130	7	plasma	plasma	NN
cord-023095-4dannjjm	4130	8	creatinine	creatinine	NN
cord-023095-4dannjjm	4130	9	concentrations	concentration	NNS
cord-023095-4dannjjm	4131	1	(	(	-LRB-
cord-023095-4dannjjm	4131	2	Cr	Cr	NNP
cord-023095-4dannjjm	4131	3	)	)	-RRB-
cord-023095-4dannjjm	4131	4	o	o	NN
cord-023095-4dannjjm	4131	5	2.0	2.0	CD
cord-023095-4dannjjm	4132	1	mg	mg	NNP
cord-023095-4dannjjm	4132	2	/	/	SYM
cord-023095-4dannjjm	4132	3	dl	dl	NNP
cord-023095-4dannjjm	4132	4	)	)	-RRB-
cord-023095-4dannjjm	4132	5	geriatric	geriatric	JJ
cord-023095-4dannjjm	4132	6	cats	cat	NNS
cord-023095-4dannjjm	4132	7	were	be	VBD
cord-023095-4dannjjm	4132	8	recruited	recruit	VBN
cord-023095-4dannjjm	4132	9	into	into	IN
cord-023095-4dannjjm	4132	10	the	the	DT
cord-023095-4dannjjm	4132	11	study	study	NN
cord-023095-4dannjjm	4132	12	prospectively	prospectively	RB
cord-023095-4dannjjm	4132	13	and	and	CC
cord-023095-4dannjjm	4132	14	followed	follow	VBD
cord-023095-4dannjjm	4132	15	for	for	IN
cord-023095-4dannjjm	4132	16	12	12	CD
cord-023095-4dannjjm	4132	17	months	month	NNS
cord-023095-4dannjjm	4132	18	.	.	.
cord-023095-4dannjjm	4133	1	At	at	IN
cord-023095-4dannjjm	4133	2	the	the	DT
cord-023095-4dannjjm	4133	3	study	study	NN
cord-023095-4dannjjm	4133	4	end	end	NN
cord-023095-4dannjjm	4133	5	point	point	NN
cord-023095-4dannjjm	4133	6	cats	cat	NNS
cord-023095-4dannjjm	4133	7	were	be	VBD
cord-023095-4dannjjm	4133	8	categorised	categorise	VBN
cord-023095-4dannjjm	4133	9	into	into	IN
cord-023095-4dannjjm	4133	10	the	the	DT
cord-023095-4dannjjm	4133	11	following	following	JJ
cord-023095-4dannjjm	4133	12	3	3	CD
cord-023095-4dannjjm	4133	13	groups	group	NNS
cord-023095-4dannjjm	4133	14	:	:	:
cord-023095-4dannjjm	4133	15	group	group	NN
cord-023095-4dannjjm	4133	16	1	1	CD
cord-023095-4dannjjm	4134	1	(	(	-LRB-
cord-023095-4dannjjm	4134	2	N	n	CD
cord-023095-4dannjjm	4134	3	5	5	CD
cord-023095-4dannjjm	4134	4	15)-Cr	15)-cr	CD
cord-023095-4dannjjm	4134	5	1.58	1.58	CD
cord-023095-4dannjjm	4134	6	mg	mg	NNP
cord-023095-4dannjjm	4134	7	/	/	SYM
cord-023095-4dannjjm	4134	8	dl	dl	NNP
cord-023095-4dannjjm	4134	9	,	,	,
cord-023095-4dannjjm	4134	10	group	group	NN
cord-023095-4dannjjm	4134	11	2	2	CD
cord-023095-4dannjjm	4134	12	(	(	-LRB-
cord-023095-4dannjjm	4134	13	N	n	CD
cord-023095-4dannjjm	4134	14	5	5	CD
cord-023095-4dannjjm	4134	15	33)-Cr	33)-cr	CD
cord-023095-4dannjjm	4134	16	!	!	.
cord-023095-4dannjjm	4135	1	1.58	1.58	CD
cord-023095-4dannjjm	4135	2	mg	mg	NNP
cord-023095-4dannjjm	4135	3	/	/	SYM
cord-023095-4dannjjm	4135	4	dl	dl	NN
cord-023095-4dannjjm	4136	1	but	but	CC
cord-023095-4dannjjm	4136	2	did	do	VBD
cord-023095-4dannjjm	4136	3	not	not	RB
cord-023095-4dannjjm	4136	4	meet	meet	VB
cord-023095-4dannjjm	4136	5	the	the	DT
cord-023095-4dannjjm	4136	6	criteria	criterion	NNS
cord-023095-4dannjjm	4136	7	for	for	IN
cord-023095-4dannjjm	4136	8	group	group	NN
cord-023095-4dannjjm	4136	9	3	3	CD
cord-023095-4dannjjm	4136	10	and	and	CC
cord-023095-4dannjjm	4136	11	group	group	NN
cord-023095-4dannjjm	4136	12	3	3	CD
cord-023095-4dannjjm	4137	1	(	(	-LRB-
cord-023095-4dannjjm	4137	2	N	N	NNP
cord-023095-4dannjjm	4137	3	5	5	CD
cord-023095-4dannjjm	4137	4	14)-Cr	14)-cr	CD
cord-023095-4dannjjm	4137	5	4	4	CD
cord-023095-4dannjjm	4137	6	2.0	2.0	CD
cord-023095-4dannjjm	4137	7	mg	mg	NNP
cord-023095-4dannjjm	4137	8	/	/	SYM
cord-023095-4dannjjm	4137	9	dl	dl	NNP
cord-023095-4dannjjm	4137	10	in	in	IN
cord-023095-4dannjjm	4137	11	association	association	NN
cord-023095-4dannjjm	4137	12	with	with	IN
cord-023095-4dannjjm	4137	13	reduced	reduce	VBN
cord-023095-4dannjjm	4137	14	urine	urine	NN
cord-023095-4dannjjm	4137	15	concentrating	concentrate	VBG
cord-023095-4dannjjm	4137	16	ability	ability	NN
cord-023095-4dannjjm	4137	17	(	(	-LRB-
cord-023095-4dannjjm	4137	18	USG	USG	NNP
cord-023095-4dannjjm	4137	19	o	o	CD
cord-023095-4dannjjm	4137	20	1.035	1.035	CD
cord-023095-4dannjjm	4137	21	)	)	-RRB-
cord-023095-4dannjjm	4137	22	or	or	CC
cord-023095-4dannjjm	4137	23	demonstration	demonstration	NN
cord-023095-4dannjjm	4137	24	of	of	IN
cord-023095-4dannjjm	4137	25	persistent	persistent	JJ
cord-023095-4dannjjm	4137	26	azotemia	azotemia	NN
cord-023095-4dannjjm	4138	1	(	(	-LRB-
cord-023095-4dannjjm	4138	2	Cr	Cr	NNP
cord-023095-4dannjjm	4138	3	4	4	CD
cord-023095-4dannjjm	4138	4	2.0	2.0	CD
cord-023095-4dannjjm	4138	5	mg	mg	NNP
cord-023095-4dannjjm	4138	6	/	/	SYM
cord-023095-4dannjjm	4138	7	dl	dl	NNP
cord-023095-4dannjjm	4138	8	)	)	-RRB-
cord-023095-4dannjjm	4138	9	.	.	.
cord-023095-4dannjjm	4139	1	Plasma	plasma	NN
cord-023095-4dannjjm	4139	2	samples	sample	NNS
cord-023095-4dannjjm	4139	3	were	be	VBD
cord-023095-4dannjjm	4139	4	subjected	subject	VBN
cord-023095-4dannjjm	4139	5	to	to	IN
cord-023095-4dannjjm	4139	6	routine	routine	JJ
cord-023095-4dannjjm	4139	7	biochemical	biochemical	JJ
cord-023095-4dannjjm	4139	8	analysis	analysis	NN
cord-023095-4dannjjm	4139	9	,	,	,
cord-023095-4dannjjm	4139	10	intact	intact	JJ
cord-023095-4dannjjm	4139	11	PTH	PTH	NNP
cord-023095-4dannjjm	4139	12	,	,	,
cord-023095-4dannjjm	4139	13	calcitriol	calcitriol	NN
cord-023095-4dannjjm	4139	14	and	and	CC
cord-023095-4dannjjm	4139	15	intact	intact	JJ
cord-023095-4dannjjm	4139	16	FGF-23	fgf-23	CD
cord-023095-4dannjjm	4139	17	assay	assay	NN
cord-023095-4dannjjm	4139	18	.	.	.
cord-023095-4dannjjm	4140	1	Variables	variable	NNS
cord-023095-4dannjjm	4140	2	were	be	VBD
cord-023095-4dannjjm	4140	3	compared	compare	VBN
cord-023095-4dannjjm	4140	4	between	between	IN
cord-023095-4dannjjm	4140	5	the	the	DT
cord-023095-4dannjjm	4140	6	3	3	CD
cord-023095-4dannjjm	4140	7	groups	group	NNS
cord-023095-4dannjjm	4140	8	at	at	IN
cord-023095-4dannjjm	4140	9	the	the	DT
cord-023095-4dannjjm	4140	10	baseline	baseline	JJ
cord-023095-4dannjjm	4140	11	time	time	NN
cord-023095-4dannjjm	4140	12	point	point	NN
cord-023095-4dannjjm	4140	13	.	.	.
cord-023095-4dannjjm	4141	1	GFR	GFR	NNP
cord-023095-4dannjjm	4141	2	was	be	VBD
cord-023095-4dannjjm	4141	3	measured	measure	VBN
cord-023095-4dannjjm	4141	4	in	in	IN
cord-023095-4dannjjm	4141	5	an	an	DT
cord-023095-4dannjjm	4141	6	additional	additional	JJ
cord-023095-4dannjjm	4141	7	group	group	NN
cord-023095-4dannjjm	4141	8	of	of	IN
cord-023095-4dannjjm	4141	9	19	19	CD
cord-023095-4dannjjm	4141	10	cats	cat	NNS
cord-023095-4dannjjm	4141	11	(	(	-LRB-
cord-023095-4dannjjm	4141	12	11	11	CD
cord-023095-4dannjjm	4141	13	non	non	JJ
cord-023095-4dannjjm	4141	14	-	-	JJ
cord-023095-4dannjjm	4141	15	azotemic	azotemic	JJ
cord-023095-4dannjjm	4141	16	,	,	,
cord-023095-4dannjjm	4141	17	4	4	CD
cord-023095-4dannjjm	4141	18	IRIS	IRIS	NNP
cord-023095-4dannjjm	4141	19	stage	stage	NN
cord-023095-4dannjjm	4141	20	II	II	NNP
cord-023095-4dannjjm	4141	21	,	,	,
cord-023095-4dannjjm	4141	22	4	4	CD
cord-023095-4dannjjm	4141	23	IRIS	IRIS	NNP
cord-023095-4dannjjm	4141	24	stage	stage	NN
cord-023095-4dannjjm	4141	25	III	III	NNP
cord-023095-4dannjjm	4141	26	)	)	-RRB-
cord-023095-4dannjjm	4141	27	using	use	VBG
cord-023095-4dannjjm	4141	28	a	a	DT
cord-023095-4dannjjm	4141	29	corrected	correct	VBN
cord-023095-4dannjjm	4141	30	slope	slope	NN
cord-023095-4dannjjm	4141	31	-	-	HYPH
cord-023095-4dannjjm	4141	32	intercept	intercept	VB
cord-023095-4dannjjm	4141	33	iohexol	iohexol	NN
cord-023095-4dannjjm	4141	34	clearance	clearance	NN
cord-023095-4dannjjm	4141	35	method	method	NN
cord-023095-4dannjjm	4141	36	.	.	.
cord-023095-4dannjjm	4142	1	Relationships	relationship	NNS
cord-023095-4dannjjm	4142	2	were	be	VBD
cord-023095-4dannjjm	4142	3	explored	explore	VBN
cord-023095-4dannjjm	4142	4	using	use	VBG
cord-023095-4dannjjm	4142	5	linear	linear	JJ
cord-023095-4dannjjm	4142	6	regression	regression	NN
cord-023095-4dannjjm	4142	7	analysis	analysis	NN
cord-023095-4dannjjm	4142	8	and	and	CC
cord-023095-4dannjjm	4142	9	determining	determine	VBG
cord-023095-4dannjjm	4142	10	the	the	DT
cord-023095-4dannjjm	4142	11	coefficient	coefficient	NN
cord-023095-4dannjjm	4142	12	of	of	IN
cord-023095-4dannjjm	4142	13	determination	determination	NN
cord-023095-4dannjjm	4142	14	(	(	-LRB-
cord-023095-4dannjjm	4142	15	R	R	NNP
cord-023095-4dannjjm	4142	16	2	2	CD
cord-023095-4dannjjm	4142	17	)	)	-RRB-
cord-023095-4dannjjm	4142	18	.	.	.
cord-023095-4dannjjm	4143	1	Results	result	NNS
cord-023095-4dannjjm	4143	2	are	be	VBP
cord-023095-4dannjjm	4143	3	presented	present	VBN
cord-023095-4dannjjm	4143	4	as	as	IN
cord-023095-4dannjjm	4143	5	median	median	JJ
cord-023095-4dannjjm	4143	6	[	[	-LRB-
cord-023095-4dannjjm	4143	7	range	range	NN
cord-023095-4dannjjm	4143	8	]	]	-RRB-
cord-023095-4dannjjm	4143	9	.	.	.
cord-023095-4dannjjm	4144	1	At	at	IN
cord-023095-4dannjjm	4144	2	the	the	DT
cord-023095-4dannjjm	4144	3	baseline	baseline	JJ
cord-023095-4dannjjm	4144	4	time	time	NN
cord-023095-4dannjjm	4144	5	point	point	NN
cord-023095-4dannjjm	4144	6	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4144	7	concentrations	concentration	NNS
cord-023095-4dannjjm	4144	8	were	be	VBD
cord-023095-4dannjjm	4144	9	significantly	significantly	RB
cord-023095-4dannjjm	4144	10	higher	high	JJR
cord-023095-4dannjjm	4144	11	in	in	IN
cord-023095-4dannjjm	4144	12	group	group	NN
cord-023095-4dannjjm	4144	13	2	2	CD
cord-023095-4dannjjm	4144	14	(	(	-LRB-
cord-023095-4dannjjm	4144	15	208.1[51.4	208.1[51.4	CD
cord-023095-4dannjjm	4144	16	-	-	HYPH
cord-023095-4dannjjm	4144	17	814.6	814.6	CD
cord-023095-4dannjjm	4144	18	]	]	-RRB-
cord-023095-4dannjjm	4144	19	,	,	,
cord-023095-4dannjjm	4144	20	P	p	NN
cord-023095-4dannjjm	4144	21	5	5	CD
cord-023095-4dannjjm	4144	22	0.001	0.001	CD
cord-023095-4dannjjm	4144	23	)	)	-RRB-
cord-023095-4dannjjm	4144	24	and	and	CC
cord-023095-4dannjjm	4144	25	group	group	NN
cord-023095-4dannjjm	4144	26	3	3	CD
cord-023095-4dannjjm	4144	27	(	(	-LRB-
cord-023095-4dannjjm	4144	28	237.6[127.4	237.6[127.4	CD
cord-023095-4dannjjm	4144	29	-	-	HYPH
cord-023095-4dannjjm	4144	30	908.1	908.1	CD
cord-023095-4dannjjm	4144	31	]	]	-RRB-
cord-023095-4dannjjm	4144	32	,	,	,
cord-023095-4dannjjm	4144	33	P	p	NN
cord-023095-4dannjjm	4144	34	5	5	CD
cord-023095-4dannjjm	4144	35	0.001	0.001	CD
cord-023095-4dannjjm	4144	36	)	)	-RRB-
cord-023095-4dannjjm	4144	37	compared	compare	VBN
cord-023095-4dannjjm	4144	38	to	to	IN
cord-023095-4dannjjm	4144	39	group	group	NN
cord-023095-4dannjjm	4144	40	1	1	CD
cord-023095-4dannjjm	4144	41	(	(	-LRB-
cord-023095-4dannjjm	4144	42	126.2[69.4	126.2[69.4	NNP
cord-023095-4dannjjm	4144	43	-	-	HYPH
cord-023095-4dannjjm	4144	44	505.2	505.2	CD
cord-023095-4dannjjm	4144	45	]	]	-RRB-
cord-023095-4dannjjm	4144	46	)	)	-RRB-
cord-023095-4dannjjm	4144	47	.	.	.
cord-023095-4dannjjm	4145	1	Weak	weak	JJ
cord-023095-4dannjjm	4145	2	positive	positive	JJ
cord-023095-4dannjjm	4145	3	relationships	relationship	NNS
cord-023095-4dannjjm	4145	4	were	be	VBD
cord-023095-4dannjjm	4145	5	identified	identify	VBN
cord-023095-4dannjjm	4145	6	between	between	IN
cord-023095-4dannjjm	4145	7	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4145	8	and	and	CC
cord-023095-4dannjjm	4145	9	PTH	PTH	NNP
cord-023095-4dannjjm	4145	10	(	(	-LRB-
cord-023095-4dannjjm	4145	11	R	r	NN
cord-023095-4dannjjm	4145	12	2	2	CD
cord-023095-4dannjjm	4145	13	5	5	CD
cord-023095-4dannjjm	4145	14	0.126	0.126	CD
cord-023095-4dannjjm	4145	15	,	,	,
cord-023095-4dannjjm	4145	16	P	p	NN
cord-023095-4dannjjm	4145	17	5	5	CD
cord-023095-4dannjjm	4145	18	0.005	0.005	CD
cord-023095-4dannjjm	4145	19	,	,	,
cord-023095-4dannjjm	4145	20	N	n	CD
cord-023095-4dannjjm	4145	21	5	5	CD
cord-023095-4dannjjm	4145	22	62	62	CD
cord-023095-4dannjjm	4145	23	)	)	-RRB-
cord-023095-4dannjjm	4145	24	and	and	CC
cord-023095-4dannjjm	4146	1	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4146	2	and	and	CC
cord-023095-4dannjjm	4146	3	Cr	Cr	NNP
cord-023095-4dannjjm	4146	4	(	(	-LRB-
cord-023095-4dannjjm	4146	5	R	r	NN
cord-023095-4dannjjm	4146	6	2	2	CD
cord-023095-4dannjjm	4146	7	5	5	CD
cord-023095-4dannjjm	4146	8	0.077	0.077	CD
cord-023095-4dannjjm	4146	9	,	,	,
cord-023095-4dannjjm	4147	1	P	p	NN
cord-023095-4dannjjm	4147	2	5	5	CD
cord-023095-4dannjjm	4147	3	0.029	0.029	CD
cord-023095-4dannjjm	4147	4	,	,	,
cord-023095-4dannjjm	4147	5	N	n	CD
cord-023095-4dannjjm	4147	6	5	5	CD
cord-023095-4dannjjm	4147	7	62	62	CD
cord-023095-4dannjjm	4147	8	)	)	-RRB-
cord-023095-4dannjjm	4147	9	.	.	.
cord-023095-4dannjjm	4148	1	However	however	RB
cord-023095-4dannjjm	4148	2	,	,	,
cord-023095-4dannjjm	4148	3	the	the	DT
cord-023095-4dannjjm	4148	4	positive	positive	JJ
cord-023095-4dannjjm	4148	5	relationships	relationship	NNS
cord-023095-4dannjjm	4148	6	between	between	IN
cord-023095-4dannjjm	4148	7	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4148	8	and	and	CC
cord-023095-4dannjjm	4148	9	phosphate	phosphate	NN
cord-023095-4dannjjm	4148	10	(	(	-LRB-
cord-023095-4dannjjm	4148	11	R	r	NN
cord-023095-4dannjjm	4148	12	2	2	CD
cord-023095-4dannjjm	4148	13	5	5	CD
cord-023095-4dannjjm	4148	14	0.016	0.016	CD
cord-023095-4dannjjm	4148	15	,	,	,
cord-023095-4dannjjm	4148	16	P	p	NN
cord-023095-4dannjjm	4148	17	5	5	CD
cord-023095-4dannjjm	4148	18	0.323	0.323	CD
cord-023095-4dannjjm	4148	19	,	,	,
cord-023095-4dannjjm	4148	20	N	n	CD
cord-023095-4dannjjm	4148	21	5	5	CD
cord-023095-4dannjjm	4148	22	62	62	CD
cord-023095-4dannjjm	4148	23	)	)	-RRB-
cord-023095-4dannjjm	4148	24	and	and	CC
cord-023095-4dannjjm	4148	25	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4149	1	and	and	CC
cord-023095-4dannjjm	4149	2	calcitriol	calcitriol	NNP
cord-023095-4dannjjm	4149	3	(	(	-LRB-
cord-023095-4dannjjm	4149	4	R	R	NNP
cord-023095-4dannjjm	4149	5	2	2	CD
cord-023095-4dannjjm	4149	6	5	5	CD
cord-023095-4dannjjm	4149	7	0.085	0.085	CD
cord-023095-4dannjjm	4149	8	,	,	,
cord-023095-4dannjjm	4149	9	P	p	NN
cord-023095-4dannjjm	4149	10	5	5	CD
cord-023095-4dannjjm	4149	11	0.212	0.212	CD
cord-023095-4dannjjm	4149	12	,	,	.
cord-023095-4dannjjm	4150	1	N	n	NN
cord-023095-4dannjjm	4150	2	5	5	CD
cord-023095-4dannjjm	4150	3	20	20	CD
cord-023095-4dannjjm	4150	4	)	)	-RRB-
cord-023095-4dannjjm	4150	5	were	be	VBD
cord-023095-4dannjjm	4150	6	not	not	RB
cord-023095-4dannjjm	4150	7	significant	significant	JJ
cord-023095-4dannjjm	4150	8	.	.	.
cord-023095-4dannjjm	4151	1	The	the	DT
cord-023095-4dannjjm	4151	2	additional	additional	JJ
cord-023095-4dannjjm	4151	3	group	group	NN
cord-023095-4dannjjm	4151	4	of	of	IN
cord-023095-4dannjjm	4151	5	cats	cat	NNS
cord-023095-4dannjjm	4151	6	in	in	IN
cord-023095-4dannjjm	4151	7	which	which	WDT
cord-023095-4dannjjm	4151	8	GFR	GFR	NNP
cord-023095-4dannjjm	4151	9	measurement	measurement	NN
cord-023095-4dannjjm	4151	10	was	be	VBD
cord-023095-4dannjjm	4151	11	performed	perform	VBN
cord-023095-4dannjjm	4151	12	there	there	EX
cord-023095-4dannjjm	4151	13	was	be	VBD
cord-023095-4dannjjm	4151	14	an	an	DT
cord-023095-4dannjjm	4151	15	inverse	inverse	JJ
cord-023095-4dannjjm	4151	16	relationship	relationship	NN
cord-023095-4dannjjm	4151	17	between	between	IN
cord-023095-4dannjjm	4151	18	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4151	19	and	and	CC
cord-023095-4dannjjm	4151	20	GFR	GFR	NNP
cord-023095-4dannjjm	4152	1	(	(	-LRB-
cord-023095-4dannjjm	4152	2	R	r	NN
cord-023095-4dannjjm	4152	3	2	2	CD
cord-023095-4dannjjm	4152	4	5	5	CD
cord-023095-4dannjjm	4152	5	0.208	0.208	CD
cord-023095-4dannjjm	4152	6	,	,	,
cord-023095-4dannjjm	4152	7	P	p	NN
cord-023095-4dannjjm	4152	8	5	5	CD
cord-023095-4dannjjm	4152	9	0.040	0.040	CD
cord-023095-4dannjjm	4152	10	)	)	-RRB-
cord-023095-4dannjjm	4152	11	.	.	.
cord-023095-4dannjjm	4153	1	In	in	IN
cord-023095-4dannjjm	4153	2	conclusion	conclusion	NN
cord-023095-4dannjjm	4153	3	,	,	,
cord-023095-4dannjjm	4153	4	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4153	5	was	be	VBD
cord-023095-4dannjjm	4153	6	elevated	elevate	VBN
cord-023095-4dannjjm	4153	7	in	in	IN
cord-023095-4dannjjm	4153	8	cats	cat	NNS
cord-023095-4dannjjm	4153	9	prior	prior	RB
cord-023095-4dannjjm	4153	10	to	to	IN
cord-023095-4dannjjm	4153	11	the	the	DT
cord-023095-4dannjjm	4153	12	development	development	NN
cord-023095-4dannjjm	4153	13	of	of	IN
cord-023095-4dannjjm	4153	14	azotemia	azotemia	NN
cord-023095-4dannjjm	4153	15	.	.	.
cord-023095-4dannjjm	4154	1	The	the	DT
cord-023095-4dannjjm	4154	2	role	role	NN
cord-023095-4dannjjm	4154	3	of	of	IN
cord-023095-4dannjjm	4154	4	FGF-23	FGF-23	NNPS
cord-023095-4dannjjm	4154	5	in	in	IN
cord-023095-4dannjjm	4154	6	the	the	DT
cord-023095-4dannjjm	4154	7	development	development	NN
cord-023095-4dannjjm	4154	8	of	of	IN
cord-023095-4dannjjm	4154	9	feline	feline	JJ
cord-023095-4dannjjm	4154	10	renal	renal	JJ
cord-023095-4dannjjm	4154	11	secondary	secondary	JJ
cord-023095-4dannjjm	4154	12	hyperparathyroidism	hyperparathyroidism	NN
cord-023095-4dannjjm	4154	13	remains	remain	VBZ
cord-023095-4dannjjm	4154	14	to	to	TO
cord-023095-4dannjjm	4154	15	be	be	VB
cord-023095-4dannjjm	4154	16	determined	determine	VBN
cord-023095-4dannjjm	4154	17	and	and	CC
cord-023095-4dannjjm	4154	18	should	should	MD
cord-023095-4dannjjm	4154	19	be	be	VB
cord-023095-4dannjjm	4154	20	explored	explore	VBN
cord-023095-4dannjjm	4154	21	through	through	IN
cord-023095-4dannjjm	4154	22	interventional	interventional	JJ
cord-023095-4dannjjm	4154	23	studies	study	NNS
cord-023095-4dannjjm	4154	24	.	.	.
cord-023095-4dannjjm	4155	1	However	however	RB
cord-023095-4dannjjm	4155	2	,	,	,
cord-023095-4dannjjm	4155	3	considering	consider	VBG
cord-023095-4dannjjm	4155	4	the	the	DT
cord-023095-4dannjjm	4155	5	relationship	relationship	NN
cord-023095-4dannjjm	4155	6	between	between	IN
cord-023095-4dannjjm	4155	7	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4155	8	and	and	CC
cord-023095-4dannjjm	4155	9	GFR	GFR	NNP
cord-023095-4dannjjm	4155	10	,	,	,
cord-023095-4dannjjm	4155	11	it	-PRON-	PRP
cord-023095-4dannjjm	4155	12	can	can	MD
cord-023095-4dannjjm	4155	13	not	not	RB
cord-023095-4dannjjm	4155	14	be	be	VB
cord-023095-4dannjjm	4155	15	excluded	exclude	VBN
cord-023095-4dannjjm	4155	16	that	that	IN
cord-023095-4dannjjm	4155	17	the	the	DT
cord-023095-4dannjjm	4155	18	phosphotonin	phosphotonin	NN
cord-023095-4dannjjm	4155	19	is	be	VBZ
cord-023095-4dannjjm	4155	20	simply	simply	RB
cord-023095-4dannjjm	4155	21	a	a	DT
cord-023095-4dannjjm	4155	22	marker	marker	NN
cord-023095-4dannjjm	4155	23	of	of	IN
cord-023095-4dannjjm	4155	24	reduced	reduce	VBN
cord-023095-4dannjjm	4155	25	filtration	filtration	NN
cord-023095-4dannjjm	4155	26	.	.	.
cord-023095-4dannjjm	4156	1	Chronic	chronic	JJ
cord-023095-4dannjjm	4156	2	kidney	kidney	NN
cord-023095-4dannjjm	4156	3	disease	disease	NN
cord-023095-4dannjjm	4156	4	(	(	-LRB-
cord-023095-4dannjjm	4156	5	CKD	CKD	NNP
cord-023095-4dannjjm	4156	6	)	)	-RRB-
cord-023095-4dannjjm	4156	7	is	be	VBZ
cord-023095-4dannjjm	4156	8	common	common	JJ
cord-023095-4dannjjm	4156	9	in	in	IN
cord-023095-4dannjjm	4156	10	geriatric	geriatric	JJ
cord-023095-4dannjjm	4156	11	cats	cat	NNS
cord-023095-4dannjjm	4156	12	and	and	CC
cord-023095-4dannjjm	4156	13	hypoxia	hypoxia	NN
cord-023095-4dannjjm	4156	14	might	may	MD
cord-023095-4dannjjm	4156	15	contribute	contribute	VB
cord-023095-4dannjjm	4156	16	to	to	IN
cord-023095-4dannjjm	4156	17	the	the	DT
cord-023095-4dannjjm	4156	18	progression	progression	NN
cord-023095-4dannjjm	4156	19	of	of	IN
cord-023095-4dannjjm	4156	20	this	this	DT
cord-023095-4dannjjm	4156	21	disease	disease	NN
cord-023095-4dannjjm	4156	22	.	.	.
cord-023095-4dannjjm	4157	1	The	the	DT
cord-023095-4dannjjm	4157	2	aim	aim	NN
cord-023095-4dannjjm	4157	3	of	of	IN
cord-023095-4dannjjm	4157	4	this	this	DT
cord-023095-4dannjjm	4157	5	study	study	NN
cord-023095-4dannjjm	4157	6	was	be	VBD
cord-023095-4dannjjm	4157	7	to	to	TO
cord-023095-4dannjjm	4157	8	evaluate	evaluate	VB
cord-023095-4dannjjm	4157	9	urinary	urinary	JJ
cord-023095-4dannjjm	4157	10	vascular	vascular	JJ
cord-023095-4dannjjm	4157	11	endothelial	endothelial	JJ
cord-023095-4dannjjm	4157	12	growth	growth	NN
cord-023095-4dannjjm	4157	13	factor	factor	NN
cord-023095-4dannjjm	4157	14	(	(	-LRB-
cord-023095-4dannjjm	4157	15	VEGF	VEGF	NNP
cord-023095-4dannjjm	4157	16	)	)	-RRB-
cord-023095-4dannjjm	4157	17	as	as	IN
cord-023095-4dannjjm	4157	18	a	a	DT
cord-023095-4dannjjm	4157	19	marker	marker	NN
cord-023095-4dannjjm	4157	20	of	of	IN
cord-023095-4dannjjm	4157	21	renal	renal	JJ
cord-023095-4dannjjm	4157	22	hypoxia	hypoxia	NN
cord-023095-4dannjjm	4157	23	.	.	.
cord-023095-4dannjjm	4158	1	Cats	cat	NNS
cord-023095-4dannjjm	4158	2	were	be	VBD
cord-023095-4dannjjm	4158	3	recruited	recruit	VBN
cord-023095-4dannjjm	4158	4	through	through	IN
cord-023095-4dannjjm	4158	5	geriatric	geriatric	JJ
cord-023095-4dannjjm	4158	6	clinics	clinic	NNS
cord-023095-4dannjjm	4158	7	held	hold	VBN
cord-023095-4dannjjm	4158	8	at	at	IN
cord-023095-4dannjjm	4158	9	two	two	CD
cord-023095-4dannjjm	4158	10	first	first	JJ
cord-023095-4dannjjm	4158	11	opinion	opinion	NN
cord-023095-4dannjjm	4158	12	London	London	NNP
cord-023095-4dannjjm	4158	13	practices	practice	NNS
cord-023095-4dannjjm	4158	14	.	.	.
cord-023095-4dannjjm	4159	1	VEGF	VEGF	NNP
cord-023095-4dannjjm	4159	2	was	be	VBD
cord-023095-4dannjjm	4159	3	measured	measure	VBN
cord-023095-4dannjjm	4159	4	in	in	IN
cord-023095-4dannjjm	4159	5	stored	store	VBN
cord-023095-4dannjjm	4159	6	samples	sample	NNS
cord-023095-4dannjjm	4159	7	using	use	VBG
cord-023095-4dannjjm	4159	8	a	a	DT
cord-023095-4dannjjm	4159	9	canine	canine	JJ
cord-023095-4dannjjm	4159	10	ELISA	ELISA	NNP
cord-023095-4dannjjm	4159	11	kit	kit	NN
cord-023095-4dannjjm	4159	12	validated	validate	VBN
cord-023095-4dannjjm	4159	13	for	for	IN
cord-023095-4dannjjm	4159	14	use	use	NN
cord-023095-4dannjjm	4159	15	on	on	IN
cord-023095-4dannjjm	4159	16	feline	feline	JJ
cord-023095-4dannjjm	4159	17	urine	urine	NN
cord-023095-4dannjjm	4159	18	and	and	CC
cord-023095-4dannjjm	4159	19	indexed	index	VBN
cord-023095-4dannjjm	4159	20	to	to	IN
cord-023095-4dannjjm	4159	21	creatinine	creatinine	NN
cord-023095-4dannjjm	4159	22	concentration	concentration	NN
cord-023095-4dannjjm	4159	23	to	to	TO
cord-023095-4dannjjm	4159	24	yield	yield	VB
cord-023095-4dannjjm	4159	25	a	a	DT
cord-023095-4dannjjm	4159	26	VEGF	vegf	NN
cord-023095-4dannjjm	4159	27	to	to	TO
cord-023095-4dannjjm	4159	28	creatinine	creatinine	NN
cord-023095-4dannjjm	4159	29	ratio	ratio	NN
cord-023095-4dannjjm	4159	30	(	(	-LRB-
cord-023095-4dannjjm	4159	31	VCR	VCR	NNP
cord-023095-4dannjjm	4159	32	)	)	-RRB-
cord-023095-4dannjjm	4159	33	.	.	.
cord-023095-4dannjjm	4160	1	Two	two	CD
cord-023095-4dannjjm	4160	2	studies	study	NNS
cord-023095-4dannjjm	4160	3	were	be	VBD
cord-023095-4dannjjm	4160	4	undertaken	undertake	VBN
cord-023095-4dannjjm	4160	5	-firstly	-firstly	RB
cord-023095-4dannjjm	4160	6	a	a	DT
cord-023095-4dannjjm	4160	7	cross	cross	JJ
cord-023095-4dannjjm	4160	8	-	-	JJ
cord-023095-4dannjjm	4160	9	sectional	sectional	JJ
cord-023095-4dannjjm	4160	10	analysis	analysis	NN
cord-023095-4dannjjm	4160	11	of	of	IN
cord-023095-4dannjjm	4160	12	clinical	clinical	JJ
cord-023095-4dannjjm	4160	13	variables	variable	NNS
cord-023095-4dannjjm	4160	14	associated	associate	VBN
cord-023095-4dannjjm	4160	15	with	with	IN
cord-023095-4dannjjm	4160	16	VCR	VCR	NNP
cord-023095-4dannjjm	4160	17	in	in	IN
cord-023095-4dannjjm	4160	18	cats	cat	NNS
cord-023095-4dannjjm	4160	19	with	with	IN
cord-023095-4dannjjm	4160	20	CKD	CKD	NNP
cord-023095-4dannjjm	4160	21	.	.	.
cord-023095-4dannjjm	4161	1	Diagnosis	diagnosis	NN
cord-023095-4dannjjm	4161	2	of	of	IN
cord-023095-4dannjjm	4161	3	CKD	CKD	NNP
cord-023095-4dannjjm	4161	4	was	be	VBD
cord-023095-4dannjjm	4161	5	based	base	VBN
cord-023095-4dannjjm	4161	6	on	on	IN
cord-023095-4dannjjm	4161	7	concurrent	concurrent	JJ
cord-023095-4dannjjm	4161	8	findings	finding	NNS
cord-023095-4dannjjm	4161	9	of	of	IN
cord-023095-4dannjjm	4161	10	plasma	plasma	NN
cord-023095-4dannjjm	4161	11	creatinine	creatinine	NN
cord-023095-4dannjjm	4161	12	!	!	.
cord-023095-4dannjjm	4162	1	2	2	LS
cord-023095-4dannjjm	4163	1	mg	mg	NNP
cord-023095-4dannjjm	4163	2	/	/	SYM
cord-023095-4dannjjm	4163	3	dl	dl	NNP
cord-023095-4dannjjm	4163	4	and	and	CC
cord-023095-4dannjjm	4163	5	USG	USG	NNP
cord-023095-4dannjjm	4163	6	1.035	1.035	CD
cord-023095-4dannjjm	4163	7	,	,	,
cord-023095-4dannjjm	4163	8	with	with	IN
cord-023095-4dannjjm	4163	9	persistence	persistence	NN
cord-023095-4dannjjm	4163	10	of	of	IN
cord-023095-4dannjjm	4163	11	azotemia	azotemia	NN
cord-023095-4dannjjm	4163	12	for	for	IN
cord-023095-4dannjjm	4163	13	!	!	.
cord-023095-4dannjjm	4164	1	2	2	CD
cord-023095-4dannjjm	4164	2	weeks	week	NNS
cord-023095-4dannjjm	4164	3	.	.	.
cord-023095-4dannjjm	4165	1	Only	only	RB
cord-023095-4dannjjm	4165	2	patients	patient	NNS
cord-023095-4dannjjm	4165	3	receiving	receive	VBG
cord-023095-4dannjjm	4165	4	no	no	DT
cord-023095-4dannjjm	4165	5	medical	medical	JJ
cord-023095-4dannjjm	4165	6	therapies	therapy	NNS
cord-023095-4dannjjm	4165	7	were	be	VBD
cord-023095-4dannjjm	4165	8	included	include	VBN
cord-023095-4dannjjm	4165	9	.	.	.
cord-023095-4dannjjm	4166	1	Normotensive	Normotensive	NNP
cord-023095-4dannjjm	4166	2	and	and	CC
cord-023095-4dannjjm	4166	3	(	(	-LRB-
cord-023095-4dannjjm	4166	4	pre	pre	JJ
cord-023095-4dannjjm	4166	5	-	-	JJ
cord-023095-4dannjjm	4166	6	treatment	treatment	NN
cord-023095-4dannjjm	4166	7	)	)	-RRB-
cord-023095-4dannjjm	4167	1	hypertensive	hypertensive	JJ
cord-023095-4dannjjm	4167	2	cats	cat	NNS
cord-023095-4dannjjm	4167	3	were	be	VBD
cord-023095-4dannjjm	4167	4	included	include	VBN
cord-023095-4dannjjm	4167	5	,	,	,
cord-023095-4dannjjm	4167	6	but	but	CC
cord-023095-4dannjjm	4167	7	borderline	borderline	JJ
cord-023095-4dannjjm	4167	8	cases	case	NNS
cord-023095-4dannjjm	4167	9	(	(	-LRB-
cord-023095-4dannjjm	4167	10	mean	mean	VB
cord-023095-4dannjjm	4167	11	systolic	systolic	JJ
cord-023095-4dannjjm	4167	12	blood	blood	NN
cord-023095-4dannjjm	4167	13	pressure	pressure	NN
cord-023095-4dannjjm	4167	14	160	160	CD
cord-023095-4dannjjm	4167	15	-	-	SYM
cord-023095-4dannjjm	4167	16	170	170	CD
cord-023095-4dannjjm	4167	17	mmHg	mmHg	NNS
cord-023095-4dannjjm	4167	18	on	on	IN
cord-023095-4dannjjm	4167	19	the	the	DT
cord-023095-4dannjjm	4167	20	date	date	NN
cord-023095-4dannjjm	4167	21	of	of	IN
cord-023095-4dannjjm	4167	22	sampling	sampling	NN
cord-023095-4dannjjm	4167	23	)	)	-RRB-
cord-023095-4dannjjm	4167	24	were	be	VBD
cord-023095-4dannjjm	4167	25	not	not	RB
cord-023095-4dannjjm	4167	26	.	.	.
cord-023095-4dannjjm	4168	1	Hyperthyroid	Hyperthyroid	NNP
cord-023095-4dannjjm	4168	2	cats	cat	NNS
cord-023095-4dannjjm	4168	3	were	be	VBD
cord-023095-4dannjjm	4168	4	also	also	RB
cord-023095-4dannjjm	4168	5	excluded	exclude	VBN
cord-023095-4dannjjm	4168	6	from	from	IN
cord-023095-4dannjjm	4168	7	this	this	DT
cord-023095-4dannjjm	4168	8	cross	cross	JJ
cord-023095-4dannjjm	4168	9	-	-	JJ
cord-023095-4dannjjm	4168	10	sectional	sectional	JJ
cord-023095-4dannjjm	4168	11	study	study	NN
cord-023095-4dannjjm	4168	12	.	.	.
cord-023095-4dannjjm	4169	1	Associations	association	NNS
cord-023095-4dannjjm	4169	2	between	between	IN
cord-023095-4dannjjm	4169	3	VCR	vcr	NN
cord-023095-4dannjjm	4169	4	and	and	CC
cord-023095-4dannjjm	4169	5	clinical	clinical	JJ
cord-023095-4dannjjm	4169	6	data	datum	NNS
cord-023095-4dannjjm	4169	7	were	be	VBD
cord-023095-4dannjjm	4169	8	initially	initially	RB
cord-023095-4dannjjm	4169	9	assessed	assess	VBN
cord-023095-4dannjjm	4169	10	using	use	VBG
cord-023095-4dannjjm	4169	11	the	the	DT
cord-023095-4dannjjm	4169	12	Spearman	Spearman	NNP
cord-023095-4dannjjm	4169	13	's	's	POS
cord-023095-4dannjjm	4169	14	coefficient	coefficient	NN
cord-023095-4dannjjm	4169	15	and	and	CC
cord-023095-4dannjjm	4169	16	Mann	Mann	NNP
cord-023095-4dannjjm	4169	17	Whitney	Whitney	NNP
cord-023095-4dannjjm	4169	18	Test	Test	NNP
cord-023095-4dannjjm	4169	19	.	.	.
cord-023095-4dannjjm	4170	1	Linear	linear	JJ
cord-023095-4dannjjm	4170	2	regression	regression	NN
cord-023095-4dannjjm	4170	3	was	be	VBD
cord-023095-4dannjjm	4170	4	then	then	RB
cord-023095-4dannjjm	4170	5	used	use	VBN
cord-023095-4dannjjm	4170	6	for	for	IN
cord-023095-4dannjjm	4170	7	multivariate	multivariate	JJ
cord-023095-4dannjjm	4170	8	analysis	analysis	NN
cord-023095-4dannjjm	4170	9	.	.	.
cord-023095-4dannjjm	4171	1	The	the	DT
cord-023095-4dannjjm	4171	2	second	second	JJ
cord-023095-4dannjjm	4171	3	study	study	NN
cord-023095-4dannjjm	4171	4	used	use	VBD
cord-023095-4dannjjm	4171	5	samples	sample	NNS
cord-023095-4dannjjm	4171	6	from	from	IN
cord-023095-4dannjjm	4171	7	a	a	DT
cord-023095-4dannjjm	4171	8	trial	trial	NN
cord-023095-4dannjjm	4171	9	in	in	IN
cord-023095-4dannjjm	4171	10	which	which	WDT
cord-023095-4dannjjm	4171	11	hypertensive	hypertensive	JJ
cord-023095-4dannjjm	4171	12	cats	cat	NNS
cord-023095-4dannjjm	4171	13	that	that	WDT
cord-023095-4dannjjm	4171	14	had	have	VBD
cord-023095-4dannjjm	4171	15	been	be	VBN
cord-023095-4dannjjm	4171	16	treated	treat	VBN
cord-023095-4dannjjm	4171	17	with	with	IN
cord-023095-4dannjjm	4171	18	amlodipine	amlodipine	NN
cord-023095-4dannjjm	4171	19	for	for	IN
cord-023095-4dannjjm	4171	20	at	at	RB
cord-023095-4dannjjm	4171	21	least	least	JJS
cord-023095-4dannjjm	4171	22	3	3	CD
cord-023095-4dannjjm	4171	23	months	month	NNS
cord-023095-4dannjjm	4171	24	were	be	VBD
cord-023095-4dannjjm	4171	25	entered	enter	VBN
cord-023095-4dannjjm	4171	26	into	into	IN
cord-023095-4dannjjm	4171	27	a	a	DT
cord-023095-4dannjjm	4171	28	randomised	randomised	JJ
cord-023095-4dannjjm	4171	29	cross	cross	NN
cord-023095-4dannjjm	4171	30	-	-	HYPH
cord-023095-4dannjjm	4171	31	over	over	JJ
cord-023095-4dannjjm	4171	32	study	study	NN
cord-023095-4dannjjm	4171	33	where	where	WRB
cord-023095-4dannjjm	4171	34	they	-PRON-	PRP
cord-023095-4dannjjm	4171	35	received	receive	VBD
cord-023095-4dannjjm	4171	36	placebo	placebo	NN
cord-023095-4dannjjm	4171	37	or	or	CC
cord-023095-4dannjjm	4171	38	benazepril	benazepril	NNP
cord-023095-4dannjjm	4171	39	(	(	-LRB-
cord-023095-4dannjjm	4171	40	0.5	0.5	CD
cord-023095-4dannjjm	4171	41	to	to	IN
cord-023095-4dannjjm	4171	42	1	1	CD
cord-023095-4dannjjm	4171	43	mg	mg	NNP
cord-023095-4dannjjm	4171	44	/	/	SYM
cord-023095-4dannjjm	4171	45	kg	kg	NNP
cord-023095-4dannjjm	4171	46	daily	daily	NN
cord-023095-4dannjjm	4171	47	)	)	-RRB-
cord-023095-4dannjjm	4171	48	for	for	IN
cord-023095-4dannjjm	4171	49	12	12	CD
cord-023095-4dannjjm	4171	50	weeks	week	NNS
cord-023095-4dannjjm	4171	51	in	in	IN
cord-023095-4dannjjm	4171	52	turn	turn	NN
cord-023095-4dannjjm	4171	53	.	.	.
cord-023095-4dannjjm	4172	1	VCR	VCR	NNP
cord-023095-4dannjjm	4172	2	on	on	IN
cord-023095-4dannjjm	4172	3	placebo	placebo	NN
cord-023095-4dannjjm	4172	4	was	be	VBD
cord-023095-4dannjjm	4172	5	compared	compare	VBN
cord-023095-4dannjjm	4172	6	with	with	IN
cord-023095-4dannjjm	4172	7	that	that	DT
cord-023095-4dannjjm	4172	8	on	on	IN
cord-023095-4dannjjm	4172	9	benazepril	benazepril	NNP
cord-023095-4dannjjm	4172	10	using	use	VBG
cord-023095-4dannjjm	4172	11	the	the	DT
cord-023095-4dannjjm	4172	12	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	4172	13	signed	sign	VBD
cord-023095-4dannjjm	4172	14	ranks	rank	NNS
cord-023095-4dannjjm	4172	15	test	test	NN
cord-023095-4dannjjm	4172	16	.	.	.
cord-023095-4dannjjm	4173	1	Cats	cat	NNS
cord-023095-4dannjjm	4173	2	with	with	IN
cord-023095-4dannjjm	4173	3	well	well	RB
cord-023095-4dannjjm	4173	4	controlled	control	VBN
cord-023095-4dannjjm	4173	5	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	4173	6	were	be	VBD
cord-023095-4dannjjm	4173	7	included	include	VBN
cord-023095-4dannjjm	4173	8	in	in	IN
cord-023095-4dannjjm	4173	9	this	this	DT
cord-023095-4dannjjm	4173	10	intervention	intervention	NN
cord-023095-4dannjjm	4173	11	study	study	NN
cord-023095-4dannjjm	4173	12	.	.	.
cord-023095-4dannjjm	4174	1	Results	result	NNS
cord-023095-4dannjjm	4174	2	are	be	VBP
cord-023095-4dannjjm	4174	3	reported	report	VBN
cord-023095-4dannjjm	4174	4	as	as	IN
cord-023095-4dannjjm	4174	5	median	median	JJ
cord-023095-4dannjjm	4174	6	[	[	-LRB-
cord-023095-4dannjjm	4174	7	25th	25th	NN
cord-023095-4dannjjm	4174	8	,	,	,
cord-023095-4dannjjm	4174	9	75th	75th	JJ
cord-023095-4dannjjm	4174	10	percentile	percentile	NN
cord-023095-4dannjjm	4174	11	]	]	-RRB-
cord-023095-4dannjjm	4174	12	.	.	.
cord-023095-4dannjjm	4175	1	VCR	VCR	NNP
cord-023095-4dannjjm	4175	2	was	be	VBD
cord-023095-4dannjjm	4175	3	higher	high	JJR
cord-023095-4dannjjm	4175	4	(	(	-LRB-
cord-023095-4dannjjm	4175	5	49.5[33.3	49.5[33.3	CD
cord-023095-4dannjjm	4175	6	,	,	,
cord-023095-4dannjjm	4175	7	74.1	74.1	CD
cord-023095-4dannjjm	4175	8	]	]	-RRB-
cord-023095-4dannjjm	4175	9	vs.	vs.	FW
cord-023095-4dannjjm	4175	10	36.1[25.6	36.1[25.6	CD
cord-023095-4dannjjm	4175	11	,	,	,
cord-023095-4dannjjm	4175	12	42	42	CD
cord-023095-4dannjjm	4175	13	.1	.1	CD
cord-023095-4dannjjm	4175	14	]	]	-RRB-
cord-023095-4dannjjm	4176	1	fg	fg	NNP
cord-023095-4dannjjm	4176	2	/	/	SYM
cord-023095-4dannjjm	4176	3	g	g	NNP
cord-023095-4dannjjm	4176	4	,	,	,
cord-023095-4dannjjm	4176	5	p	p	NN
cord-023095-4dannjjm	4176	6	5	5	CD
cord-023095-4dannjjm	4176	7	0.010	0.010	CD
cord-023095-4dannjjm	4176	8	)	)	-RRB-
cord-023095-4dannjjm	4176	9	in	in	IN
cord-023095-4dannjjm	4176	10	untreated	untreated	JJ
cord-023095-4dannjjm	4176	11	hypertensives	hypertensive	NNS
cord-023095-4dannjjm	4176	12	(	(	-LRB-
cord-023095-4dannjjm	4176	13	n	n	NN
cord-023095-4dannjjm	4176	14	5	5	CD
cord-023095-4dannjjm	4176	15	30	30	CD
cord-023095-4dannjjm	4176	16	)	)	-RRB-
cord-023095-4dannjjm	4176	17	than	than	IN
cord-023095-4dannjjm	4176	18	normotensives	normotensives	NNP
cord-023095-4dannjjm	4176	19	(	(	-LRB-
cord-023095-4dannjjm	4176	20	n	n	NN
cord-023095-4dannjjm	4176	21	5	5	CD
cord-023095-4dannjjm	4176	22	63	63	CD
cord-023095-4dannjjm	4176	23	)	)	-RRB-
cord-023095-4dannjjm	4176	24	.	.	.
cord-023095-4dannjjm	4177	1	VCR	VCR	NNP
cord-023095-4dannjjm	4177	2	was	be	VBD
cord-023095-4dannjjm	4177	3	correlated	correlate	VBN
cord-023095-4dannjjm	4177	4	with	with	IN
cord-023095-4dannjjm	4177	5	PCV	PCV	NNP
cord-023095-4dannjjm	4177	6	(	(	-LRB-
cord-023095-4dannjjm	4177	7	r	r	NNP
cord-023095-4dannjjm	4177	8	5	5	CD
cord-023095-4dannjjm	4177	9	À0.236	à0.236	CD
cord-023095-4dannjjm	4177	10	,	,	,
cord-023095-4dannjjm	4177	11	p	p	NN
cord-023095-4dannjjm	4177	12	5	5	CD
cord-023095-4dannjjm	4177	13	0.024	0.024	CD
cord-023095-4dannjjm	4177	14	,	,	,
cord-023095-4dannjjm	4177	15	n	n	NN
cord-023095-4dannjjm	4177	16	5	5	CD
cord-023095-4dannjjm	4177	17	92	92	CD
cord-023095-4dannjjm	4177	18	)	)	-RRB-
cord-023095-4dannjjm	4177	19	,	,	,
cord-023095-4dannjjm	4177	20	UPC	UPC	NNP
cord-023095-4dannjjm	4177	21	(	(	-LRB-
cord-023095-4dannjjm	4177	22	r	r	NNP
cord-023095-4dannjjm	4177	23	5	5	CD
cord-023095-4dannjjm	4177	24	0.444	0.444	CD
cord-023095-4dannjjm	4177	25	,	,	,
cord-023095-4dannjjm	4177	26	p	p	NN
cord-023095-4dannjjm	4177	27	o	o	NN
cord-023095-4dannjjm	4177	28	0.001	0.001	CD
cord-023095-4dannjjm	4177	29	,	,	,
cord-023095-4dannjjm	4177	30	n	n	NN
cord-023095-4dannjjm	4177	31	5	5	CD
cord-023095-4dannjjm	4177	32	93	93	CD
cord-023095-4dannjjm	4177	33	)	)	-RRB-
cord-023095-4dannjjm	4177	34	,	,	,
cord-023095-4dannjjm	4177	35	plasma	plasma	NN
cord-023095-4dannjjm	4177	36	phosphate	phosphate	NN
cord-023095-4dannjjm	4177	37	(	(	-LRB-
cord-023095-4dannjjm	4178	1	r	r	LS
cord-023095-4dannjjm	4178	2	5	5	CD
cord-023095-4dannjjm	4178	3	0.286	0.286	CD
cord-023095-4dannjjm	4178	4	,	,	,
cord-023095-4dannjjm	4178	5	p	p	NN
cord-023095-4dannjjm	4178	6	5	5	CD
cord-023095-4dannjjm	4178	7	0.005	0.005	CD
cord-023095-4dannjjm	4178	8	,	,	,
cord-023095-4dannjjm	4178	9	n	n	NN
cord-023095-4dannjjm	4178	10	5	5	CD
cord-023095-4dannjjm	4178	11	93	93	CD
cord-023095-4dannjjm	4178	12	)	)	-RRB-
cord-023095-4dannjjm	4178	13	,	,	,
cord-023095-4dannjjm	4178	14	and	and	CC
cord-023095-4dannjjm	4178	15	USG	USG	NNP
cord-023095-4dannjjm	4178	16	(	(	-LRB-
cord-023095-4dannjjm	4178	17	r	r	NNP
cord-023095-4dannjjm	4178	18	5	5	CD
cord-023095-4dannjjm	4178	19	À0.284	à0.284	CD
cord-023095-4dannjjm	4178	20	,	,	,
cord-023095-4dannjjm	4178	21	p	p	NN
cord-023095-4dannjjm	4178	22	5	5	CD
cord-023095-4dannjjm	4178	23	0.006	0.006	CD
cord-023095-4dannjjm	4178	24	,	,	,
cord-023095-4dannjjm	4178	25	n	n	NN
cord-023095-4dannjjm	4178	26	5	5	CD
cord-023095-4dannjjm	4178	27	93	93	CD
cord-023095-4dannjjm	4178	28	)	)	-RRB-
cord-023095-4dannjjm	4178	29	,	,	,
cord-023095-4dannjjm	4178	30	but	but	CC
cord-023095-4dannjjm	4178	31	not	not	RB
cord-023095-4dannjjm	4178	32	plasma	plasma	NN
cord-023095-4dannjjm	4178	33	creatinine	creatinine	NN
cord-023095-4dannjjm	4178	34	concentration	concentration	NN
cord-023095-4dannjjm	4178	35	.	.	.
cord-023095-4dannjjm	4179	1	In	in	IN
cord-023095-4dannjjm	4179	2	the	the	DT
cord-023095-4dannjjm	4179	3	best	good	JJS
cord-023095-4dannjjm	4179	4	multivariate	multivariate	JJ
cord-023095-4dannjjm	4179	5	model	model	NN
cord-023095-4dannjjm	4179	6	,	,	,
cord-023095-4dannjjm	4179	7	PCV	PCV	NNP
cord-023095-4dannjjm	4179	8	was	be	VBD
cord-023095-4dannjjm	4179	9	associated	associate	VBN
cord-023095-4dannjjm	4179	10	with	with	IN
cord-023095-4dannjjm	4179	11	VCR	VCR	NNP
cord-023095-4dannjjm	4179	12	independently	independently	RB
cord-023095-4dannjjm	4179	13	of	of	IN
cord-023095-4dannjjm	4179	14	UPC	UPC	NNP
cord-023095-4dannjjm	4179	15	(	(	-LRB-
cord-023095-4dannjjm	4179	16	r	r	NN
cord-023095-4dannjjm	4179	17	2	2	CD
cord-023095-4dannjjm	4179	18	5	5	CD
cord-023095-4dannjjm	4179	19	0.435	0.435	CD
cord-023095-4dannjjm	4179	20	,	,	,
cord-023095-4dannjjm	4179	21	n	n	NN
cord-023095-4dannjjm	4179	22	5	5	CD
cord-023095-4dannjjm	4179	23	92	92	CD
cord-023095-4dannjjm	4179	24	)	)	-RRB-
cord-023095-4dannjjm	4179	25	.	.	.
cord-023095-4dannjjm	4180	1	VCR	VCR	NNP
cord-023095-4dannjjm	4180	2	was	be	VBD
cord-023095-4dannjjm	4180	3	significantly	significantly	RB
cord-023095-4dannjjm	4180	4	reduced	reduce	VBN
cord-023095-4dannjjm	4180	5	by	by	IN
cord-023095-4dannjjm	4180	6	Benazepril	Benazepril	NNP
cord-023095-4dannjjm	4180	7	therapy	therapy	NN
cord-023095-4dannjjm	4180	8	(	(	-LRB-
cord-023095-4dannjjm	4180	9	65.3	65.3	CD
cord-023095-4dannjjm	4180	10	[	[	-LRB-
cord-023095-4dannjjm	4180	11	43.1	43.1	CD
cord-023095-4dannjjm	4180	12	,	,	,
cord-023095-4dannjjm	4180	13	92	92	CD
cord-023095-4dannjjm	4180	14	.7	.7	NFP
cord-023095-4dannjjm	4180	15	]	]	-RRB-
cord-023095-4dannjjm	4181	1	fg	fg	NNP
cord-023095-4dannjjm	4181	2	/	/	SYM
cord-023095-4dannjjm	4181	3	g	g	NN
cord-023095-4dannjjm	4181	4	)	)	-RRB-
cord-023095-4dannjjm	4182	1	compared	compare	VBN
cord-023095-4dannjjm	4182	2	with	with	IN
cord-023095-4dannjjm	4182	3	placebo	placebo	NN
cord-023095-4dannjjm	4182	4	(	(	-LRB-
cord-023095-4dannjjm	4182	5	76.0[48.0	76.0[48.0	CD
cord-023095-4dannjjm	4182	6	,	,	,
cord-023095-4dannjjm	4182	7	116.7	116.7	CD
cord-023095-4dannjjm	4182	8	]	]	-RRB-
cord-023095-4dannjjm	4182	9	fg	fg	NN
cord-023095-4dannjjm	4182	10	/	/	SYM
cord-023095-4dannjjm	4182	11	g	g	NN
cord-023095-4dannjjm	4182	12	;	;	:
cord-023095-4dannjjm	4182	13	p	p	NN
cord-023095-4dannjjm	4182	14	5	5	CD
cord-023095-4dannjjm	4182	15	0.031	0.031	CD
cord-023095-4dannjjm	4182	16	,	,	,
cord-023095-4dannjjm	4182	17	n	n	NN
cord-023095-4dannjjm	4182	18	5	5	CD
cord-023095-4dannjjm	4182	19	17	17	CD
cord-023095-4dannjjm	4182	20	)	)	-RRB-
cord-023095-4dannjjm	4182	21	with	with	IN
cord-023095-4dannjjm	4182	22	a	a	DT
cord-023095-4dannjjm	4182	23	reduction	reduction	NN
cord-023095-4dannjjm	4182	24	seen	see	VBN
cord-023095-4dannjjm	4182	25	in	in	IN
cord-023095-4dannjjm	4182	26	76	76	CD
cord-023095-4dannjjm	4182	27	%	%	NN
cord-023095-4dannjjm	4182	28	of	of	IN
cord-023095-4dannjjm	4182	29	cases	case	NNS
cord-023095-4dannjjm	4182	30	.	.	.
cord-023095-4dannjjm	4183	1	These	these	DT
cord-023095-4dannjjm	4183	2	results	result	NNS
cord-023095-4dannjjm	4183	3	suggest	suggest	VBP
cord-023095-4dannjjm	4183	4	urinary	urinary	JJ
cord-023095-4dannjjm	4183	5	VEGF	vegf	NN
cord-023095-4dannjjm	4183	6	excretion	excretion	NN
cord-023095-4dannjjm	4183	7	is	be	VBZ
cord-023095-4dannjjm	4183	8	associated	associate	VBN
cord-023095-4dannjjm	4183	9	with	with	IN
cord-023095-4dannjjm	4183	10	proteinuria	proteinuria	NN
cord-023095-4dannjjm	4183	11	in	in	IN
cord-023095-4dannjjm	4183	12	cats	cat	NNS
cord-023095-4dannjjm	4183	13	with	with	IN
cord-023095-4dannjjm	4183	14	CKD	CKD	NNP
cord-023095-4dannjjm	4183	15	and	and	CC
cord-023095-4dannjjm	4183	16	might	may	MD
cord-023095-4dannjjm	4183	17	be	be	VB
cord-023095-4dannjjm	4183	18	a	a	DT
cord-023095-4dannjjm	4183	19	marker	marker	NN
cord-023095-4dannjjm	4183	20	of	of	IN
cord-023095-4dannjjm	4183	21	renal	renal	JJ
cord-023095-4dannjjm	4183	22	hypoxia	hypoxia	NN
cord-023095-4dannjjm	4183	23	induced	induce	VBN
cord-023095-4dannjjm	4183	24	by	by	IN
cord-023095-4dannjjm	4183	25	low	low	JJ
cord-023095-4dannjjm	4183	26	PCV	pcv	NN
cord-023095-4dannjjm	4183	27	.	.	.
cord-023095-4dannjjm	4184	1	ACE	ace	NN
cord-023095-4dannjjm	4184	2	inhibitor	inhibitor	NN
cord-023095-4dannjjm	4184	3	therapy	therapy	NN
cord-023095-4dannjjm	4184	4	might	may	MD
cord-023095-4dannjjm	4184	5	reduce	reduce	VB
cord-023095-4dannjjm	4184	6	urinary	urinary	JJ
cord-023095-4dannjjm	4184	7	VEGF	vegf	NN
cord-023095-4dannjjm	4184	8	excretion	excretion	NN
cord-023095-4dannjjm	4184	9	because	because	IN
cord-023095-4dannjjm	4184	10	angiotensin	angiotensin	NN
cord-023095-4dannjjm	4184	11	II	II	NNP
cord-023095-4dannjjm	4184	12	causes	cause	VBZ
cord-023095-4dannjjm	4184	13	constriction	constriction	NN
cord-023095-4dannjjm	4184	14	on	on	IN
cord-023095-4dannjjm	4184	15	efferent	efferent	JJ
cord-023095-4dannjjm	4184	16	arterioles	arteriole	NNS
cord-023095-4dannjjm	4184	17	resulting	result	VBG
cord-023095-4dannjjm	4184	18	in	in	IN
cord-023095-4dannjjm	4184	19	tubular	tubular	JJ
cord-023095-4dannjjm	4184	20	hypoxia	hypoxia	NN
cord-023095-4dannjjm	4184	21	.	.	.
cord-023095-4dannjjm	4185	1	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4185	2	is	be	VBZ
cord-023095-4dannjjm	4185	3	a	a	DT
cord-023095-4dannjjm	4185	4	phosphaturic	phosphaturic	JJ
cord-023095-4dannjjm	4185	5	hormone	hormone	NN
cord-023095-4dannjjm	4185	6	.	.	.
cord-023095-4dannjjm	4186	1	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4186	2	concentrations	concentration	NNS
cord-023095-4dannjjm	4186	3	increase	increase	VBP
cord-023095-4dannjjm	4186	4	with	with	IN
cord-023095-4dannjjm	4186	5	declining	decline	VBG
cord-023095-4dannjjm	4186	6	renal	renal	JJ
cord-023095-4dannjjm	4186	7	function	function	NN
cord-023095-4dannjjm	4186	8	in	in	IN
cord-023095-4dannjjm	4186	9	humans	human	NNS
cord-023095-4dannjjm	4186	10	.	.	.
cord-023095-4dannjjm	4187	1	The	the	DT
cord-023095-4dannjjm	4187	2	objectives	objective	NNS
cord-023095-4dannjjm	4187	3	of	of	IN
cord-023095-4dannjjm	4187	4	this	this	DT
cord-023095-4dannjjm	4187	5	study	study	NN
cord-023095-4dannjjm	4187	6	were	be	VBD
cord-023095-4dannjjm	4187	7	to	to	TO
cord-023095-4dannjjm	4187	8	validate	validate	VB
cord-023095-4dannjjm	4187	9	a	a	DT
cord-023095-4dannjjm	4187	10	method	method	NN
cord-023095-4dannjjm	4187	11	for	for	IN
cord-023095-4dannjjm	4187	12	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4187	13	quantification	quantification	NN
cord-023095-4dannjjm	4187	14	in	in	IN
cord-023095-4dannjjm	4187	15	feline	feline	JJ
cord-023095-4dannjjm	4187	16	plasma	plasma	NN
cord-023095-4dannjjm	4187	17	and	and	CC
cord-023095-4dannjjm	4187	18	to	to	TO
cord-023095-4dannjjm	4187	19	assess	assess	VB
cord-023095-4dannjjm	4187	20	the	the	DT
cord-023095-4dannjjm	4187	21	association	association	NN
cord-023095-4dannjjm	4187	22	between	between	IN
cord-023095-4dannjjm	4187	23	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4187	24	concentration	concentration	NN
cord-023095-4dannjjm	4187	25	and	and	CC
cord-023095-4dannjjm	4187	26	plasma	plasma	NN
cord-023095-4dannjjm	4187	27	creatinine	creatinine	NN
cord-023095-4dannjjm	4187	28	or	or	CC
cord-023095-4dannjjm	4187	29	phosphate	phosphate	NN
cord-023095-4dannjjm	4187	30	concentration	concentration	NN
cord-023095-4dannjjm	4187	31	in	in	IN
cord-023095-4dannjjm	4187	32	cats	cat	NNS
cord-023095-4dannjjm	4187	33	with	with	IN
cord-023095-4dannjjm	4187	34	chronic	chronic	JJ
cord-023095-4dannjjm	4187	35	kidney	kidney	NN
cord-023095-4dannjjm	4187	36	disease	disease	NN
cord-023095-4dannjjm	4187	37	(	(	-LRB-
cord-023095-4dannjjm	4187	38	CKD	CKD	NNP
cord-023095-4dannjjm	4187	39	)	)	-RRB-
cord-023095-4dannjjm	4187	40	.	.	.
cord-023095-4dannjjm	4188	1	Non	non	JJ
cord-023095-4dannjjm	4188	2	-	-	NN
cord-023095-4dannjjm	4188	3	azotemic	azotemic	JJ
cord-023095-4dannjjm	4188	4	and	and	CC
cord-023095-4dannjjm	4188	5	azotemic	azotemic	NNP
cord-023095-4dannjjm	4188	6	(	(	-LRB-
cord-023095-4dannjjm	4188	7	plasma	plasma	NN
cord-023095-4dannjjm	4188	8	creatinine	creatinine	NN
cord-023095-4dannjjm	4188	9	concentration	concentration	NN
cord-023095-4dannjjm	4188	10	(	(	-LRB-
cord-023095-4dannjjm	4188	11	Cr	Cr	NNP
cord-023095-4dannjjm	4188	12	)	)	-RRB-
cord-023095-4dannjjm	4188	13	4	4	CD
cord-023095-4dannjjm	4188	14	2.0	2.0	CD
cord-023095-4dannjjm	4188	15	mg	mg	NNP
cord-023095-4dannjjm	4188	16	/	/	SYM
cord-023095-4dannjjm	4188	17	dl	dl	NN
cord-023095-4dannjjm	4188	18	)	)	-RRB-
cord-023095-4dannjjm	4188	19	geriatric	geriatric	NNP
cord-023095-4dannjjm	4188	20	(	(	-LRB-
cord-023095-4dannjjm	4188	21	4	4	CD
cord-023095-4dannjjm	4188	22	9yrs	9yrs	CD
cord-023095-4dannjjm	4188	23	)	)	-RRB-
cord-023095-4dannjjm	4189	1	cats	cat	NNS
cord-023095-4dannjjm	4189	2	were	be	VBD
cord-023095-4dannjjm	4189	3	recruited	recruit	VBN
cord-023095-4dannjjm	4189	4	into	into	IN
cord-023095-4dannjjm	4189	5	the	the	DT
cord-023095-4dannjjm	4189	6	cross	cross	JJ
cord-023095-4dannjjm	4189	7	-	-	JJ
cord-023095-4dannjjm	4189	8	sectional	sectional	JJ
cord-023095-4dannjjm	4189	9	study	study	NN
cord-023095-4dannjjm	4189	10	from	from	IN
cord-023095-4dannjjm	4189	11	two	two	CD
cord-023095-4dannjjm	4189	12	London	London	NNP
cord-023095-4dannjjm	4189	13	first	first	JJ
cord-023095-4dannjjm	4189	14	opinion	opinion	NN
cord-023095-4dannjjm	4189	15	practices	practice	NNS
cord-023095-4dannjjm	4189	16	.	.	.
cord-023095-4dannjjm	4190	1	Cats	cat	NNS
cord-023095-4dannjjm	4190	2	were	be	VBD
cord-023095-4dannjjm	4190	3	excluded	exclude	VBN
cord-023095-4dannjjm	4190	4	from	from	IN
cord-023095-4dannjjm	4190	5	the	the	DT
cord-023095-4dannjjm	4190	6	study	study	NN
cord-023095-4dannjjm	4190	7	if	if	IN
cord-023095-4dannjjm	4190	8	they	-PRON-	PRP
cord-023095-4dannjjm	4190	9	were	be	VBD
cord-023095-4dannjjm	4190	10	fed	feed	VBN
cord-023095-4dannjjm	4190	11	a	a	DT
cord-023095-4dannjjm	4190	12	phosphate	phosphate	NN
cord-023095-4dannjjm	4190	13	restricted	restrict	VBN
cord-023095-4dannjjm	4190	14	diet	diet	NN
cord-023095-4dannjjm	4190	15	,	,	,
cord-023095-4dannjjm	4190	16	or	or	CC
cord-023095-4dannjjm	4190	17	had	have	VBD
cord-023095-4dannjjm	4190	18	evidence	evidence	NN
cord-023095-4dannjjm	4190	19	of	of	IN
cord-023095-4dannjjm	4190	20	concurrent	concurrent	JJ
cord-023095-4dannjjm	4190	21	disease	disease	NN
cord-023095-4dannjjm	4190	22	.	.	.
cord-023095-4dannjjm	4191	1	The	the	DT
cord-023095-4dannjjm	4191	2	cats	cat	NNS
cord-023095-4dannjjm	4191	3	were	be	VBD
cord-023095-4dannjjm	4191	4	categorized	categorize	VBN
cord-023095-4dannjjm	4191	5	,	,	,
cord-023095-4dannjjm	4191	6	using	use	VBG
cord-023095-4dannjjm	4191	7	a	a	DT
cord-023095-4dannjjm	4191	8	modified	modify	VBN
cord-023095-4dannjjm	4191	9	IRIS	IRIS	NNP
cord-023095-4dannjjm	4191	10	staging	stage	VBG
cord-023095-4dannjjm	4191	11	system	system	NN
cord-023095-4dannjjm	4191	12	,	,	,
cord-023095-4dannjjm	4191	13	into	into	IN
cord-023095-4dannjjm	4191	14	the	the	DT
cord-023095-4dannjjm	4191	15	following	follow	VBG
cord-023095-4dannjjm	4191	16	four	four	CD
cord-023095-4dannjjm	4191	17	groups	group	NNS
cord-023095-4dannjjm	4191	18	:	:	:
cord-023095-4dannjjm	4191	19	group	group	NN
cord-023095-4dannjjm	4191	20	1	1	CD
cord-023095-4dannjjm	4191	21	(	(	-LRB-
cord-023095-4dannjjm	4191	22	Cr	Cr	NNP
cord-023095-4dannjjm	4191	23	1.6	1.6	CD
cord-023095-4dannjjm	4191	24	mg	mg	NNP
cord-023095-4dannjjm	4191	25	/	/	SYM
cord-023095-4dannjjm	4191	26	dl	dl	NNP
cord-023095-4dannjjm	4191	27	)	)	-RRB-
cord-023095-4dannjjm	4191	28	,	,	,
cord-023095-4dannjjm	4191	29	group	group	NN
cord-023095-4dannjjm	4191	30	2	2	CD
cord-023095-4dannjjm	4192	1	(	(	-LRB-
cord-023095-4dannjjm	4192	2	Cr	Cr	NNP
cord-023095-4dannjjm	4192	3	2.0	2.0	CD
cord-023095-4dannjjm	4192	4	-	-	HYPH
cord-023095-4dannjjm	4192	5	2.8	2.8	CD
cord-023095-4dannjjm	4192	6	mg	mg	NNP
cord-023095-4dannjjm	4192	7	/	/	SYM
cord-023095-4dannjjm	4192	8	dl	dl	NNP
cord-023095-4dannjjm	4192	9	)	)	-RRB-
cord-023095-4dannjjm	4192	10	,	,	,
cord-023095-4dannjjm	4192	11	group	group	NN
cord-023095-4dannjjm	4192	12	3	3	CD
cord-023095-4dannjjm	4193	1	(	(	-LRB-
cord-023095-4dannjjm	4193	2	Cr	Cr	NNP
cord-023095-4dannjjm	4193	3	2.9	2.9	CD
cord-023095-4dannjjm	4193	4	-	-	HYPH
cord-023095-4dannjjm	4193	5	5.0	5.0	CD
cord-023095-4dannjjm	4193	6	mg	mg	NNP
cord-023095-4dannjjm	4193	7	/	/	SYM
cord-023095-4dannjjm	4193	8	dl	dl	NNP
cord-023095-4dannjjm	4193	9	)	)	-RRB-
cord-023095-4dannjjm	4193	10	,	,	,
cord-023095-4dannjjm	4193	11	group	group	NN
cord-023095-4dannjjm	4193	12	4	4	CD
cord-023095-4dannjjm	4194	1	(	(	-LRB-
cord-023095-4dannjjm	4194	2	Cr	Cr	NNP
cord-023095-4dannjjm	4194	3	4	4	CD
cord-023095-4dannjjm	4194	4	5.0	5.0	CD
cord-023095-4dannjjm	4194	5	mg	mg	NNP
cord-023095-4dannjjm	4194	6	/	/	SYM
cord-023095-4dannjjm	4194	7	dl	dl	NN
cord-023095-4dannjjm	4194	8	)	)	-RRB-
cord-023095-4dannjjm	4194	9	.	.	.
cord-023095-4dannjjm	4195	1	Groups	group	NNS
cord-023095-4dannjjm	4195	2	2	2	CD
cord-023095-4dannjjm	4195	3	and	and	CC
cord-023095-4dannjjm	4195	4	3	3	CD
cord-023095-4dannjjm	4195	5	were	be	VBD
cord-023095-4dannjjm	4195	6	further	further	RB
cord-023095-4dannjjm	4195	7	subdivided	subdivide	VBN
cord-023095-4dannjjm	4195	8	based	base	VBN
cord-023095-4dannjjm	4195	9	on	on	IN
cord-023095-4dannjjm	4195	10	the	the	DT
cord-023095-4dannjjm	4195	11	IRIS	IRIS	NNP
cord-023095-4dannjjm	4195	12	targets	target	NNS
cord-023095-4dannjjm	4195	13	for	for	IN
cord-023095-4dannjjm	4195	14	plasma	plasma	NN
cord-023095-4dannjjm	4195	15	phosphate	phosphate	NN
cord-023095-4dannjjm	4195	16	concentration	concentration	NN
cord-023095-4dannjjm	4195	17	(	(	-LRB-
cord-023095-4dannjjm	4196	1	PO	PO	NNP
cord-023095-4dannjjm	4196	2	4	4	CD
cord-023095-4dannjjm	4196	3	):	):	NNP
cord-023095-4dannjjm	4196	4	group	group	NNP
cord-023095-4dannjjm	4196	5	2a	2a	CD
cord-023095-4dannjjm	4197	1	(	(	-LRB-
cord-023095-4dannjjm	4197	2	PO	PO	NNP
cord-023095-4dannjjm	4197	3	4	4	CD
cord-023095-4dannjjm	4197	4	4.5	4.5	CD
cord-023095-4dannjjm	4197	5	mg	mg	NNP
cord-023095-4dannjjm	4197	6	/	/	SYM
cord-023095-4dannjjm	4197	7	dl	dl	NNP
cord-023095-4dannjjm	4197	8	)	)	-RRB-
cord-023095-4dannjjm	4197	9	,	,	,
cord-023095-4dannjjm	4197	10	group	group	NN
cord-023095-4dannjjm	4197	11	2b	2b	NNP
cord-023095-4dannjjm	4198	1	(	(	-LRB-
cord-023095-4dannjjm	4198	2	PO	PO	NNP
cord-023095-4dannjjm	4198	3	4	4	CD
cord-023095-4dannjjm	4198	4	4	4	CD
cord-023095-4dannjjm	4198	5	4.5	4.5	CD
cord-023095-4dannjjm	4198	6	mg	mg	NNP
cord-023095-4dannjjm	4198	7	/	/	SYM
cord-023095-4dannjjm	4198	8	dl	dl	NNP
cord-023095-4dannjjm	4198	9	)	)	-RRB-
cord-023095-4dannjjm	4198	10	,	,	,
cord-023095-4dannjjm	4198	11	group	group	NN
cord-023095-4dannjjm	4198	12	3a	3a	NNP
cord-023095-4dannjjm	4198	13	(	(	-LRB-
cord-023095-4dannjjm	4198	14	PO	PO	NNP
cord-023095-4dannjjm	4198	15	4	4	CD
cord-023095-4dannjjm	4198	16	5	5	CD
cord-023095-4dannjjm	4198	17	mg	mg	NNP
cord-023095-4dannjjm	4198	18	/	/	SYM
cord-023095-4dannjjm	4198	19	dl	dl	NNP
cord-023095-4dannjjm	4198	20	)	)	-RRB-
cord-023095-4dannjjm	4198	21	,	,	,
cord-023095-4dannjjm	4198	22	group	group	NN
cord-023095-4dannjjm	4198	23	3b	3b	CD
cord-023095-4dannjjm	4198	24	(	(	-LRB-
cord-023095-4dannjjm	4198	25	PO	PO	NNP
cord-023095-4dannjjm	4198	26	4	4	CD
cord-023095-4dannjjm	4199	1	4	4	CD
cord-023095-4dannjjm	4199	2	5	5	CD
cord-023095-4dannjjm	4199	3	mg	mg	NNP
cord-023095-4dannjjm	4199	4	/	/	SYM
cord-023095-4dannjjm	4199	5	dl	dl	NNP
cord-023095-4dannjjm	4199	6	)	)	-RRB-
cord-023095-4dannjjm	4199	7	.	.	.
cord-023095-4dannjjm	4200	1	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4200	2	concentrations	concentration	NNS
cord-023095-4dannjjm	4200	3	were	be	VBD
cord-023095-4dannjjm	4200	4	measured	measure	VBN
cord-023095-4dannjjm	4200	5	in	in	IN
cord-023095-4dannjjm	4200	6	feline	feline	JJ
cord-023095-4dannjjm	4200	7	EDTA	edta	NN
cord-023095-4dannjjm	4200	8	plasma	plasma	NN
cord-023095-4dannjjm	4200	9	using	use	VBG
cord-023095-4dannjjm	4200	10	a	a	DT
cord-023095-4dannjjm	4200	11	human	human	JJ
cord-023095-4dannjjm	4200	12	intact	intact	JJ
cord-023095-4dannjjm	4200	13	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4200	14	ELISA	ELISA	NNP
cord-023095-4dannjjm	4200	15	,	,	,
cord-023095-4dannjjm	4200	16	validated	validate	VBN
cord-023095-4dannjjm	4200	17	by	by	IN
cord-023095-4dannjjm	4200	18	intraand	intraand	NNP
cord-023095-4dannjjm	4200	19	inter	inter	JJ
cord-023095-4dannjjm	4200	20	-	-	JJ
cord-023095-4dannjjm	4200	21	assay	assay	JJ
cord-023095-4dannjjm	4200	22	variability	variability	NN
cord-023095-4dannjjm	4200	23	and	and	CC
cord-023095-4dannjjm	4200	24	assessment	assessment	NN
cord-023095-4dannjjm	4200	25	of	of	IN
cord-023095-4dannjjm	4200	26	dilutional	dilutional	JJ
cord-023095-4dannjjm	4200	27	parallelism	parallelism	NN
cord-023095-4dannjjm	4200	28	.	.	.
cord-023095-4dannjjm	4201	1	Comparisons	comparison	NNS
cord-023095-4dannjjm	4201	2	between	between	IN
cord-023095-4dannjjm	4201	3	groups	group	NNS
cord-023095-4dannjjm	4201	4	were	be	VBD
cord-023095-4dannjjm	4201	5	made	make	VBN
cord-023095-4dannjjm	4201	6	using	use	VBG
cord-023095-4dannjjm	4201	7	the	the	DT
cord-023095-4dannjjm	4201	8	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	4201	9	-	-	HYPH
cord-023095-4dannjjm	4201	10	Wallis	Wallis	NNP
cord-023095-4dannjjm	4201	11	test	test	NN
cord-023095-4dannjjm	4201	12	and	and	CC
cord-023095-4dannjjm	4202	1	Mann	Mann	NNP
cord-023095-4dannjjm	4202	2	-	-	HYPH
cord-023095-4dannjjm	4202	3	Whitney	Whitney	NNP
cord-023095-4dannjjm	4202	4	U	U	NNP
cord-023095-4dannjjm	4202	5	test	test	NN
cord-023095-4dannjjm	4202	6	,	,	,
cord-023095-4dannjjm	4202	7	with	with	IN
cord-023095-4dannjjm	4202	8	statistical	statistical	JJ
cord-023095-4dannjjm	4202	9	significance	significance	NN
cord-023095-4dannjjm	4202	10	defined	define	VBN
cord-023095-4dannjjm	4202	11	as	as	IN
cord-023095-4dannjjm	4202	12	P	p	NN
cord-023095-4dannjjm	4202	13	o	o	NN
cord-023095-4dannjjm	4202	14	0.05	0.05	CD
cord-023095-4dannjjm	4202	15	.	.	.
cord-023095-4dannjjm	4203	1	Bonferroni	bonferroni	JJ
cord-023095-4dannjjm	4203	2	correction	correction	NN
cord-023095-4dannjjm	4203	3	was	be	VBD
cord-023095-4dannjjm	4203	4	applied	apply	VBN
cord-023095-4dannjjm	4203	5	where	where	WRB
cord-023095-4dannjjm	4203	6	appropriate	appropriate	JJ
cord-023095-4dannjjm	4203	7	(	(	-LRB-
cord-023095-4dannjjm	4203	8	statistical	statistical	JJ
cord-023095-4dannjjm	4203	9	significance	significance	NN
cord-023095-4dannjjm	4203	10	then	then	RB
cord-023095-4dannjjm	4203	11	determined	determine	VBD
cord-023095-4dannjjm	4203	12	as	as	IN
cord-023095-4dannjjm	4203	13	P	p	NN
cord-023095-4dannjjm	4203	14	o	o	NN
cord-023095-4dannjjm	4203	15	0.008	0.008	CD
cord-023095-4dannjjm	4203	16	)	)	-RRB-
cord-023095-4dannjjm	4203	17	.	.	.
cord-023095-4dannjjm	4204	1	Results	result	NNS
cord-023095-4dannjjm	4204	2	are	be	VBP
cord-023095-4dannjjm	4204	3	reported	report	VBN
cord-023095-4dannjjm	4204	4	as	as	IN
cord-023095-4dannjjm	4204	5	median	median	JJ
cord-023095-4dannjjm	4204	6	[	[	-LRB-
cord-023095-4dannjjm	4204	7	25th	25th	NN
cord-023095-4dannjjm	4204	8	,	,	,
cord-023095-4dannjjm	4204	9	75th	75th	JJ
cord-023095-4dannjjm	4204	10	percentiles	percentile	NNS
cord-023095-4dannjjm	4204	11	]	]	-RRB-
cord-023095-4dannjjm	4204	12	.	.	.
cord-023095-4dannjjm	4205	1	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4205	2	concentrations	concentration	NNS
cord-023095-4dannjjm	4205	3	!	!	.
cord-023095-4dannjjm	4206	1	800pg	800pg	NNP
cord-023095-4dannjjm	4206	2	/	/	SYM
cord-023095-4dannjjm	4206	3	ml	ml	NN
cord-023095-4dannjjm	4206	4	(	(	-LRB-
cord-023095-4dannjjm	4206	5	upper	upper	JJ
cord-023095-4dannjjm	4206	6	limit	limit	NN
cord-023095-4dannjjm	4206	7	of	of	IN
cord-023095-4dannjjm	4206	8	quantification	quantification	NN
cord-023095-4dannjjm	4206	9	)	)	-RRB-
cord-023095-4dannjjm	4206	10	were	be	VBD
cord-023095-4dannjjm	4206	11	assigned	assign	VBN
cord-023095-4dannjjm	4206	12	the	the	DT
cord-023095-4dannjjm	4206	13	value	value	NN
cord-023095-4dannjjm	4206	14	of	of	IN
cord-023095-4dannjjm	4206	15	800pg	800pg	NNP
cord-023095-4dannjjm	4206	16	/	/	SYM
cord-023095-4dannjjm	4206	17	ml	ml	NN
cord-023095-4dannjjm	4206	18	.	.	.
cord-023095-4dannjjm	4207	1	Intra	Intra	NNP
cord-023095-4dannjjm	4207	2	-	-	:
cord-023095-4dannjjm	4207	3	and	and	CC
cord-023095-4dannjjm	4207	4	inter	inter	JJ
cord-023095-4dannjjm	4207	5	-	-	JJ
cord-023095-4dannjjm	4207	6	assay	assay	JJ
cord-023095-4dannjjm	4207	7	variability	variability	NN
cord-023095-4dannjjm	4207	8	of	of	IN
cord-023095-4dannjjm	4207	9	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4207	10	measurements	measurement	NNS
cord-023095-4dannjjm	4207	11	were	be	VBD
cord-023095-4dannjjm	4207	12	o	o	NN
cord-023095-4dannjjm	4207	13	10.0	10.0	CD
cord-023095-4dannjjm	4207	14	%	%	NN
cord-023095-4dannjjm	4207	15	and	and	CC
cord-023095-4dannjjm	4207	16	dilutional	dilutional	JJ
cord-023095-4dannjjm	4207	17	parallelism	parallelism	NN
cord-023095-4dannjjm	4207	18	between	between	IN
cord-023095-4dannjjm	4207	19	feline	feline	JJ
cord-023095-4dannjjm	4207	20	samples	sample	NNS
cord-023095-4dannjjm	4207	21	and	and	CC
cord-023095-4dannjjm	4207	22	the	the	DT
cord-023095-4dannjjm	4207	23	calibration	calibration	NN
cord-023095-4dannjjm	4207	24	curve	curve	NN
cord-023095-4dannjjm	4207	25	were	be	VBD
cord-023095-4dannjjm	4207	26	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	4207	27	.	.	.
cord-023095-4dannjjm	4208	1	Plasma	plasma	NN
cord-023095-4dannjjm	4208	2	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4208	3	concentrations	concentration	NNS
cord-023095-4dannjjm	4208	4	increased	increase	VBD
cord-023095-4dannjjm	4208	5	with	with	IN
cord-023095-4dannjjm	4208	6	increasing	increase	VBG
cord-023095-4dannjjm	4208	7	creatinine	creatinine	NN
cord-023095-4dannjjm	4208	8	concentrations	concentration	NNS
cord-023095-4dannjjm	4208	9	(	(	-LRB-
cord-023095-4dannjjm	4208	10	group	group	NN
cord-023095-4dannjjm	4208	11	1	1	CD
cord-023095-4dannjjm	4208	12	:	:	:
cord-023095-4dannjjm	4208	13	158	158	CD
cord-023095-4dannjjm	4208	14	[	[	-LRB-
cord-023095-4dannjjm	4208	15	115	115	CD
cord-023095-4dannjjm	4208	16	,	,	,
cord-023095-4dannjjm	4208	17	274	274	CD
cord-023095-4dannjjm	4208	18	]	]	-RRB-
cord-023095-4dannjjm	4208	19	,	,	,
cord-023095-4dannjjm	4208	20	n	n	NN
cord-023095-4dannjjm	4208	21	5	5	CD
cord-023095-4dannjjm	4208	22	20	20	CD
cord-023095-4dannjjm	4208	23	,	,	,
cord-023095-4dannjjm	4208	24	group	group	NN
cord-023095-4dannjjm	4208	25	2	2	CD
cord-023095-4dannjjm	4208	26	:	:	:
cord-023095-4dannjjm	4208	27	354	354	CD
cord-023095-4dannjjm	4208	28	[	[	-LRB-
cord-023095-4dannjjm	4208	29	239	239	CD
cord-023095-4dannjjm	4208	30	,	,	,
cord-023095-4dannjjm	4208	31	473	473	CD
cord-023095-4dannjjm	4208	32	]	]	-RRB-
cord-023095-4dannjjm	4208	33	,	,	,
cord-023095-4dannjjm	4208	34	n	n	NN
cord-023095-4dannjjm	4208	35	5	5	CD
cord-023095-4dannjjm	4208	36	20	20	CD
cord-023095-4dannjjm	4208	37	,	,	,
cord-023095-4dannjjm	4208	38	group	group	NN
cord-023095-4dannjjm	4208	39	3	3	CD
cord-023095-4dannjjm	4208	40	:	:	:
cord-023095-4dannjjm	4208	41	800	800	CD
cord-023095-4dannjjm	4208	42	[	[	-LRB-
cord-023095-4dannjjm	4208	43	425	425	CD
cord-023095-4dannjjm	4208	44	,	,	,
cord-023095-4dannjjm	4208	45	800	800	CD
cord-023095-4dannjjm	4208	46	]	]	-RRB-
cord-023095-4dannjjm	4208	47	,	,	,
cord-023095-4dannjjm	4208	48	n	n	NN
cord-023095-4dannjjm	4208	49	5	5	CD
cord-023095-4dannjjm	4208	50	23	23	CD
cord-023095-4dannjjm	4208	51	,	,	,
cord-023095-4dannjjm	4208	52	group	group	NN
cord-023095-4dannjjm	4208	53	4	4	CD
cord-023095-4dannjjm	4208	54	:	:	:
cord-023095-4dannjjm	4208	55	800	800	CD
cord-023095-4dannjjm	4208	56	[	[	-LRB-
cord-023095-4dannjjm	4208	57	800	800	CD
cord-023095-4dannjjm	4208	58	,	,	,
cord-023095-4dannjjm	4208	59	800	800	CD
cord-023095-4dannjjm	4208	60	]	]	-RRB-
cord-023095-4dannjjm	4208	61	,	,	,
cord-023095-4dannjjm	4208	62	n	n	NN
cord-023095-4dannjjm	4208	63	5	5	CD
cord-023095-4dannjjm	4208	64	14	14	CD
cord-023095-4dannjjm	4208	65	)	)	-RRB-
cord-023095-4dannjjm	4208	66	.	.	.
cord-023095-4dannjjm	4209	1	FGF-23	fgf-23	JJ
cord-023095-4dannjjm	4209	2	measurements	measurement	NNS
cord-023095-4dannjjm	4209	3	were	be	VBD
cord-023095-4dannjjm	4209	4	significantly	significantly	RB
cord-023095-4dannjjm	4209	5	different	different	JJ
cord-023095-4dannjjm	4209	6	between	between	IN
cord-023095-4dannjjm	4209	7	all	all	DT
cord-023095-4dannjjm	4209	8	groups	group	NNS
cord-023095-4dannjjm	4209	9	(	(	-LRB-
cord-023095-4dannjjm	4209	10	P	p	NN
cord-023095-4dannjjm	4209	11	5	5	CD
cord-023095-4dannjjm	4209	12	0.005	0.005	CD
cord-023095-4dannjjm	4209	13	to	to	IN
cord-023095-4dannjjm	4209	14	o	o	CD
cord-023095-4dannjjm	4209	15	0.001	0.001	CD
cord-023095-4dannjjm	4209	16	)	)	-RRB-
cord-023095-4dannjjm	4209	17	except	except	IN
cord-023095-4dannjjm	4209	18	between	between	IN
cord-023095-4dannjjm	4209	19	groups	group	NNS
cord-023095-4dannjjm	4209	20	2	2	CD
cord-023095-4dannjjm	4209	21	and	and	CC
cord-023095-4dannjjm	4209	22	3	3	CD
cord-023095-4dannjjm	4210	1	(	(	-LRB-
cord-023095-4dannjjm	4210	2	P	p	NN
cord-023095-4dannjjm	4210	3	5	5	CD
cord-023095-4dannjjm	4210	4	0.01	0.01	CD
cord-023095-4dannjjm	4210	5	)	)	-RRB-
cord-023095-4dannjjm	4210	6	.	.	.
cord-023095-4dannjjm	4211	1	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4211	2	concentrations	concentration	NNS
cord-023095-4dannjjm	4211	3	were	be	VBD
cord-023095-4dannjjm	4211	4	significantly	significantly	RB
cord-023095-4dannjjm	4211	5	higher	high	JJR
cord-023095-4dannjjm	4211	6	in	in	IN
cord-023095-4dannjjm	4211	7	cats	cat	NNS
cord-023095-4dannjjm	4211	8	with	with	IN
cord-023095-4dannjjm	4211	9	higher	high	JJR
cord-023095-4dannjjm	4211	10	plasma	plasma	NN
cord-023095-4dannjjm	4211	11	phosphate	phosphate	NN
cord-023095-4dannjjm	4211	12	concentrations	concentration	NNS
cord-023095-4dannjjm	4211	13	(	(	-LRB-
cord-023095-4dannjjm	4211	14	group	group	NN
cord-023095-4dannjjm	4211	15	2a	2a	CD
cord-023095-4dannjjm	4211	16	:	:	:
cord-023095-4dannjjm	4211	17	329	329	CD
cord-023095-4dannjjm	4211	18	[	[	-LRB-
cord-023095-4dannjjm	4211	19	237	237	CD
cord-023095-4dannjjm	4211	20	,	,	,
cord-023095-4dannjjm	4211	21	423	423	CD
cord-023095-4dannjjm	4211	22	]	]	-RRB-
cord-023095-4dannjjm	4211	23	,	,	,
cord-023095-4dannjjm	4211	24	n	n	NN
cord-023095-4dannjjm	4211	25	5	5	CD
cord-023095-4dannjjm	4211	26	16	16	CD
cord-023095-4dannjjm	4211	27	vs.	vs.	IN
cord-023095-4dannjjm	4211	28	group	group	NN
cord-023095-4dannjjm	4211	29	2b	2b	CD
cord-023095-4dannjjm	4211	30	:	:	:
cord-023095-4dannjjm	4211	31	576	576	CD
cord-023095-4dannjjm	4211	32	[	[	-LRB-
cord-023095-4dannjjm	4211	33	374	374	CD
cord-023095-4dannjjm	4211	34	,	,	,
cord-023095-4dannjjm	4211	35	793	793	CD
cord-023095-4dannjjm	4211	36	]	]	-RRB-
cord-023095-4dannjjm	4211	37	,	,	,
cord-023095-4dannjjm	4211	38	n	n	NN
cord-023095-4dannjjm	4211	39	5	5	CD
cord-023095-4dannjjm	4211	40	4	4	CD
cord-023095-4dannjjm	4211	41	;	;	:
cord-023095-4dannjjm	4211	42	P	p	NN
cord-023095-4dannjjm	4211	43	5	5	CD
cord-023095-4dannjjm	4211	44	0.047	0.047	CD
cord-023095-4dannjjm	4211	45	)	)	-RRB-
cord-023095-4dannjjm	4211	46	and	and	CC
cord-023095-4dannjjm	4211	47	(	(	-LRB-
cord-023095-4dannjjm	4211	48	group	group	NN
cord-023095-4dannjjm	4211	49	3a	3a	NNP
cord-023095-4dannjjm	4211	50	:	:	:
cord-023095-4dannjjm	4211	51	432	432	CD
cord-023095-4dannjjm	4211	52	[	[	-LRB-
cord-023095-4dannjjm	4211	53	167	167	CD
cord-023095-4dannjjm	4211	54	,	,	,
cord-023095-4dannjjm	4211	55	800	800	CD
cord-023095-4dannjjm	4211	56	]	]	-RRB-
cord-023095-4dannjjm	4211	57	,	,	,
cord-023095-4dannjjm	4211	58	n	n	NN
cord-023095-4dannjjm	4211	59	5	5	CD
cord-023095-4dannjjm	4211	60	10	10	CD
cord-023095-4dannjjm	4211	61	vs.	vs.	IN
cord-023095-4dannjjm	4211	62	group	group	NN
cord-023095-4dannjjm	4211	63	3b	3b	CD
cord-023095-4dannjjm	4211	64	:	:	:
cord-023095-4dannjjm	4211	65	800	800	CD
cord-023095-4dannjjm	4211	66	[	[	-LRB-
cord-023095-4dannjjm	4211	67	625	625	CD
cord-023095-4dannjjm	4211	68	,	,	,
cord-023095-4dannjjm	4211	69	800	800	CD
cord-023095-4dannjjm	4211	70	]	]	-RRB-
cord-023095-4dannjjm	4211	71	,	,	,
cord-023095-4dannjjm	4211	72	n	n	NN
cord-023095-4dannjjm	4211	73	5	5	CD
cord-023095-4dannjjm	4211	74	13	13	CD
cord-023095-4dannjjm	4211	75	;	;	:
cord-023095-4dannjjm	4211	76	P	p	NN
cord-023095-4dannjjm	4211	77	5	5	CD
cord-023095-4dannjjm	4211	78	0.028	0.028	CD
cord-023095-4dannjjm	4211	79	)	)	-RRB-
cord-023095-4dannjjm	4211	80	.	.	.
cord-023095-4dannjjm	4212	1	In	in	IN
cord-023095-4dannjjm	4212	2	conclusion	conclusion	NN
cord-023095-4dannjjm	4212	3	,	,	,
cord-023095-4dannjjm	4212	4	FGF-23	FGF-23	NNP
cord-023095-4dannjjm	4212	5	concentrations	concentration	NNS
cord-023095-4dannjjm	4212	6	were	be	VBD
cord-023095-4dannjjm	4212	7	higher	high	JJR
cord-023095-4dannjjm	4212	8	in	in	IN
cord-023095-4dannjjm	4212	9	cats	cat	NNS
cord-023095-4dannjjm	4212	10	with	with	IN
cord-023095-4dannjjm	4212	11	more	more	RBR
cord-023095-4dannjjm	4212	12	severe	severe	JJ
cord-023095-4dannjjm	4212	13	CKD	CKD	NNP
cord-023095-4dannjjm	4212	14	or	or	CC
cord-023095-4dannjjm	4212	15	higher	high	JJR
cord-023095-4dannjjm	4212	16	plasma	plasma	NN
cord-023095-4dannjjm	4212	17	phosphate	phosphate	NN
cord-023095-4dannjjm	4212	18	concentrations	concentration	NNS
cord-023095-4dannjjm	4212	19	as	as	IN
cord-023095-4dannjjm	4212	20	would	would	MD
cord-023095-4dannjjm	4212	21	be	be	VB
cord-023095-4dannjjm	4212	22	predicted	predict	VBN
cord-023095-4dannjjm	4212	23	from	from	IN
cord-023095-4dannjjm	4212	24	its	-PRON-	PRP$
cord-023095-4dannjjm	4212	25	known	know	VBN
cord-023095-4dannjjm	4212	26	biological	biological	JJ
cord-023095-4dannjjm	4212	27	actions	action	NNS
cord-023095-4dannjjm	4212	28	.	.	.
cord-023095-4dannjjm	4213	1	Further	further	JJ
cord-023095-4dannjjm	4213	2	work	work	NN
cord-023095-4dannjjm	4213	3	is	be	VBZ
cord-023095-4dannjjm	4213	4	warranted	warrant	VBN
cord-023095-4dannjjm	4213	5	to	to	TO
cord-023095-4dannjjm	4213	6	explore	explore	VB
cord-023095-4dannjjm	4213	7	the	the	DT
cord-023095-4dannjjm	4213	8	role	role	NN
cord-023095-4dannjjm	4213	9	of	of	IN
cord-023095-4dannjjm	4213	10	FGF-23	FGF-23	NNPS
cord-023095-4dannjjm	4213	11	in	in	IN
cord-023095-4dannjjm	4213	12	the	the	DT
cord-023095-4dannjjm	4213	13	development	development	NN
cord-023095-4dannjjm	4213	14	of	of	IN
cord-023095-4dannjjm	4213	15	renal	renal	JJ
cord-023095-4dannjjm	4213	16	secondary	secondary	JJ
cord-023095-4dannjjm	4213	17	hyperparathyroidism	hyperparathyroidism	NN
cord-023095-4dannjjm	4213	18	by	by	IN
cord-023095-4dannjjm	4213	19	measuring	measure	VBG
cord-023095-4dannjjm	4213	20	parathyroid	parathyroid	JJ
cord-023095-4dannjjm	4213	21	hormone	hormone	NN
cord-023095-4dannjjm	4213	22	(	(	-LRB-
cord-023095-4dannjjm	4213	23	PTH	PTH	NNP
cord-023095-4dannjjm	4213	24	)	)	-RRB-
cord-023095-4dannjjm	4213	25	and	and	CC
cord-023095-4dannjjm	4213	26	calcitriol	calcitriol	NN
cord-023095-4dannjjm	4213	27	in	in	IN
cord-023095-4dannjjm	4213	28	cats	cat	NNS
cord-023095-4dannjjm	4213	29	at	at	IN
cord-023095-4dannjjm	4213	30	different	different	JJ
cord-023095-4dannjjm	4213	31	stages	stage	NNS
cord-023095-4dannjjm	4213	32	of	of	IN
cord-023095-4dannjjm	4213	33	CKD	CKD	NNP
cord-023095-4dannjjm	4213	34	.	.	.
cord-023095-4dannjjm	4214	1	Progressive	progressive	JJ
cord-023095-4dannjjm	4214	2	non	non	JJ
cord-023095-4dannjjm	4214	3	-	-	JJ
cord-023095-4dannjjm	4214	4	cardiogenic	cardiogenic	JJ
cord-023095-4dannjjm	4214	5	edema	edema	NN
cord-023095-4dannjjm	4214	6	and	and	CC
cord-023095-4dannjjm	4214	7	lung	lung	NN
cord-023095-4dannjjm	4214	8	dysfunction	dysfunction	NN
cord-023095-4dannjjm	4214	9	are	be	VBP
cord-023095-4dannjjm	4214	10	common	common	JJ
cord-023095-4dannjjm	4214	11	complications	complication	NNS
cord-023095-4dannjjm	4214	12	of	of	IN
cord-023095-4dannjjm	4214	13	acute	acute	JJ
cord-023095-4dannjjm	4214	14	kidney	kidney	NN
cord-023095-4dannjjm	4214	15	injury	injury	NN
cord-023095-4dannjjm	4214	16	(	(	-LRB-
cord-023095-4dannjjm	4214	17	AKI	AKI	NNP
cord-023095-4dannjjm	4214	18	)	)	-RRB-
cord-023095-4dannjjm	4214	19	in	in	IN
cord-023095-4dannjjm	4214	20	people	people	NNS
cord-023095-4dannjjm	4214	21	.	.	.
cord-023095-4dannjjm	4215	1	Pulmonary	pulmonary	JJ
cord-023095-4dannjjm	4215	2	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4215	3	have	have	VBP
cord-023095-4dannjjm	4215	4	not	not	RB
cord-023095-4dannjjm	4215	5	been	be	VBN
cord-023095-4dannjjm	4215	6	systematically	systematically	RB
cord-023095-4dannjjm	4215	7	reviewed	review	VBN
cord-023095-4dannjjm	4215	8	in	in	IN
cord-023095-4dannjjm	4215	9	dogs	dog	NNS
cord-023095-4dannjjm	4215	10	with	with	IN
cord-023095-4dannjjm	4215	11	renal	renal	JJ
cord-023095-4dannjjm	4215	12	azotemia	azotemia	NN
cord-023095-4dannjjm	4215	13	,	,	,
cord-023095-4dannjjm	4215	14	but	but	CC
cord-023095-4dannjjm	4215	15	anecdotal	anecdotal	JJ
cord-023095-4dannjjm	4215	16	reports	report	NNS
cord-023095-4dannjjm	4215	17	of	of	IN
cord-023095-4dannjjm	4215	18	dogs	dog	NNS
cord-023095-4dannjjm	4215	19	with	with	IN
cord-023095-4dannjjm	4215	20	AKI	AKI	NNP
cord-023095-4dannjjm	4215	21	and	and	CC
cord-023095-4dannjjm	4215	22	concurrent	concurrent	JJ
cord-023095-4dannjjm	4215	23	non	non	JJ
cord-023095-4dannjjm	4215	24	-	-	JJ
cord-023095-4dannjjm	4215	25	cardiogenic	cardiogenic	JJ
cord-023095-4dannjjm	4215	26	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	4215	27	edema	edema	NN
cord-023095-4dannjjm	4215	28	are	be	VBP
cord-023095-4dannjjm	4215	29	suggestive	suggestive	JJ
cord-023095-4dannjjm	4215	30	of	of	IN
cord-023095-4dannjjm	4215	31	uremic	uremic	JJ
cord-023095-4dannjjm	4215	32	pneumonopathy	pneumonopathy	NN
cord-023095-4dannjjm	4215	33	(	(	-LRB-
cord-023095-4dannjjm	4215	34	UP	UP	NNP
cord-023095-4dannjjm	4215	35	)	)	-RRB-
cord-023095-4dannjjm	4215	36	,	,	,
cord-023095-4dannjjm	4215	37	a	a	DT
cord-023095-4dannjjm	4215	38	centrally	centrally	RB
cord-023095-4dannjjm	4215	39	-	-	HYPH
cord-023095-4dannjjm	4215	40	distributed	distribute	VBN
cord-023095-4dannjjm	4215	41	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	4215	42	edema	edema	NN
cord-023095-4dannjjm	4215	43	syndrome	syndrome	NN
cord-023095-4dannjjm	4215	44	associated	associate	VBN
cord-023095-4dannjjm	4215	45	with	with	IN
cord-023095-4dannjjm	4215	46	kidney	kidney	NN
cord-023095-4dannjjm	4215	47	disease	disease	NN
cord-023095-4dannjjm	4215	48	in	in	IN
cord-023095-4dannjjm	4215	49	people	people	NNS
cord-023095-4dannjjm	4215	50	.	.	.
cord-023095-4dannjjm	4216	1	We	-PRON-	PRP
cord-023095-4dannjjm	4216	2	therefore	therefore	RB
cord-023095-4dannjjm	4216	3	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	4216	4	that	that	IN
cord-023095-4dannjjm	4216	5	pulmonary	pulmonary	NN
cord-023095-4dannjjm	4216	6	-	-	HYPH
cord-023095-4dannjjm	4216	7	associated	associate	VBN
cord-023095-4dannjjm	4216	8	clinical	clinical	JJ
cord-023095-4dannjjm	4216	9	signs	sign	NNS
cord-023095-4dannjjm	4216	10	or	or	CC
cord-023095-4dannjjm	4216	11	thoracic	thoracic	JJ
cord-023095-4dannjjm	4216	12	radiograph	radiograph	NN
cord-023095-4dannjjm	4216	13	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4216	14	are	be	VBP
cord-023095-4dannjjm	4216	15	more	more	RBR
cord-023095-4dannjjm	4216	16	common	common	JJ
cord-023095-4dannjjm	4216	17	in	in	IN
cord-023095-4dannjjm	4216	18	dogs	dog	NNS
cord-023095-4dannjjm	4216	19	with	with	IN
cord-023095-4dannjjm	4216	20	renal	renal	JJ
cord-023095-4dannjjm	4216	21	azotemia	azotemia	NN
cord-023095-4dannjjm	4216	22	than	than	IN
cord-023095-4dannjjm	4216	23	in	in	IN
cord-023095-4dannjjm	4216	24	non	non	JJ
cord-023095-4dannjjm	4216	25	-	-	JJ
cord-023095-4dannjjm	4216	26	azotemic	azotemic	JJ
cord-023095-4dannjjm	4216	27	dogs	dog	NNS
cord-023095-4dannjjm	4216	28	,	,	,
cord-023095-4dannjjm	4216	29	and	and	CC
cord-023095-4dannjjm	4216	30	that	that	IN
cord-023095-4dannjjm	4216	31	this	this	DT
cord-023095-4dannjjm	4216	32	association	association	NN
cord-023095-4dannjjm	4216	33	is	be	VBZ
cord-023095-4dannjjm	4216	34	more	more	RBR
cord-023095-4dannjjm	4216	35	likely	likely	JJ
cord-023095-4dannjjm	4216	36	in	in	IN
cord-023095-4dannjjm	4216	37	dogs	dog	NNS
cord-023095-4dannjjm	4216	38	with	with	IN
cord-023095-4dannjjm	4216	39	AKI	AKI	NNP
cord-023095-4dannjjm	4216	40	than	than	IN
cord-023095-4dannjjm	4216	41	dogs	dog	NNS
cord-023095-4dannjjm	4216	42	with	with	IN
cord-023095-4dannjjm	4216	43	chronic	chronic	JJ
cord-023095-4dannjjm	4216	44	renal	renal	JJ
cord-023095-4dannjjm	4216	45	failure	failure	NN
cord-023095-4dannjjm	4216	46	(	(	-LRB-
cord-023095-4dannjjm	4216	47	CRF	CRF	NNP
cord-023095-4dannjjm	4216	48	)	)	-RRB-
cord-023095-4dannjjm	4216	49	.	.	.
cord-023095-4dannjjm	4217	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	4217	2	study	study	NN
cord-023095-4dannjjm	4217	3	objectives	objective	NNS
cord-023095-4dannjjm	4217	4	were	be	VBD
cord-023095-4dannjjm	4217	5	1	1	CD
cord-023095-4dannjjm	4217	6	)	)	-RRB-
cord-023095-4dannjjm	4217	7	to	to	TO
cord-023095-4dannjjm	4217	8	describe	describe	VB
cord-023095-4dannjjm	4217	9	thoracic	thoracic	JJ
cord-023095-4dannjjm	4217	10	radiograph	radiograph	NN
cord-023095-4dannjjm	4217	11	and	and	CC
cord-023095-4dannjjm	4217	12	lung	lung	NN
cord-023095-4dannjjm	4217	13	histopathologic	histopathologic	NNP
cord-023095-4dannjjm	4217	14	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4217	15	in	in	IN
cord-023095-4dannjjm	4217	16	dogs	dog	NNS
cord-023095-4dannjjm	4217	17	with	with	IN
cord-023095-4dannjjm	4217	18	renal	renal	JJ
cord-023095-4dannjjm	4217	19	azotemia	azotemia	NN
cord-023095-4dannjjm	4217	20	,	,	,
cord-023095-4dannjjm	4217	21	2	2	CD
cord-023095-4dannjjm	4217	22	)	)	-RRB-
cord-023095-4dannjjm	4217	23	to	to	TO
cord-023095-4dannjjm	4217	24	compare	compare	VB
cord-023095-4dannjjm	4217	25	the	the	DT
cord-023095-4dannjjm	4217	26	occurrence	occurrence	NN
cord-023095-4dannjjm	4217	27	of	of	IN
cord-023095-4dannjjm	4217	28	these	these	DT
cord-023095-4dannjjm	4217	29	findings	finding	NNS
cord-023095-4dannjjm	4217	30	in	in	IN
cord-023095-4dannjjm	4217	31	dogs	dog	NNS
cord-023095-4dannjjm	4217	32	with	with	IN
cord-023095-4dannjjm	4217	33	AKI	AKI	NNP
cord-023095-4dannjjm	4217	34	,	,	,
cord-023095-4dannjjm	4217	35	CRF	CRF	NNP
cord-023095-4dannjjm	4217	36	,	,	,
cord-023095-4dannjjm	4217	37	or	or	CC
cord-023095-4dannjjm	4217	38	non	non	JJ
cord-023095-4dannjjm	4217	39	-	-	JJ
cord-023095-4dannjjm	4217	40	systemic	systemic	JJ
cord-023095-4dannjjm	4217	41	illness	illness	NN
cord-023095-4dannjjm	4217	42	,	,	,
cord-023095-4dannjjm	4217	43	and	and	CC
cord-023095-4dannjjm	4217	44	3	3	LS
cord-023095-4dannjjm	4217	45	)	)	-RRB-
cord-023095-4dannjjm	4217	46	to	to	TO
cord-023095-4dannjjm	4217	47	determine	determine	VB
cord-023095-4dannjjm	4217	48	if	if	IN
cord-023095-4dannjjm	4217	49	these	these	DT
cord-023095-4dannjjm	4217	50	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4217	51	are	be	VBP
cord-023095-4dannjjm	4217	52	associated	associate	VBN
cord-023095-4dannjjm	4217	53	with	with	IN
cord-023095-4dannjjm	4217	54	shorter	short	JJR
cord-023095-4dannjjm	4217	55	survival	survival	NN
cord-023095-4dannjjm	4217	56	times	time	NNS
cord-023095-4dannjjm	4217	57	.	.	.
cord-023095-4dannjjm	4218	1	Records	record	NNS
cord-023095-4dannjjm	4218	2	of	of	IN
cord-023095-4dannjjm	4218	3	dogs	dog	NNS
cord-023095-4dannjjm	4218	4	with	with	IN
cord-023095-4dannjjm	4218	5	renal	renal	JJ
cord-023095-4dannjjm	4218	6	azotemia	azotemia	NN
cord-023095-4dannjjm	4218	7	evaluated	evaluate	VBN
cord-023095-4dannjjm	4218	8	from	from	IN
cord-023095-4dannjjm	4218	9	1/1/2000	1/1/2000	CD
cord-023095-4dannjjm	4218	10	to	to	IN
cord-023095-4dannjjm	4218	11	8/20/2010	8/20/2010	CD
cord-023095-4dannjjm	4218	12	were	be	VBD
cord-023095-4dannjjm	4218	13	reviewed	review	VBN
cord-023095-4dannjjm	4218	14	;	;	:
cord-023095-4dannjjm	4218	15	dogs	dog	NNS
cord-023095-4dannjjm	4218	16	which	which	WDT
cord-023095-4dannjjm	4218	17	could	could	MD
cord-023095-4dannjjm	4218	18	be	be	VB
cord-023095-4dannjjm	4218	19	classified	classify	VBN
cord-023095-4dannjjm	4218	20	as	as	IN
cord-023095-4dannjjm	4218	21	having	have	VBG
cord-023095-4dannjjm	4218	22	AKI	AKI	NNP
cord-023095-4dannjjm	4218	23	or	or	CC
cord-023095-4dannjjm	4218	24	CRF	CRF	NNP
cord-023095-4dannjjm	4218	25	and	and	CC
cord-023095-4dannjjm	4218	26	which	which	WDT
cord-023095-4dannjjm	4218	27	had	have	VBD
cord-023095-4dannjjm	4218	28	complete	complete	JJ
cord-023095-4dannjjm	4218	29	thoracic	thoracic	JJ
cord-023095-4dannjjm	4218	30	radiograph	radiograph	NN
cord-023095-4dannjjm	4218	31	studies	study	NNS
cord-023095-4dannjjm	4218	32	available	available	JJ
cord-023095-4dannjjm	4218	33	for	for	IN
cord-023095-4dannjjm	4218	34	review	review	NN
cord-023095-4dannjjm	4218	35	were	be	VBD
cord-023095-4dannjjm	4218	36	included	include	VBN
cord-023095-4dannjjm	4218	37	.	.	.
cord-023095-4dannjjm	4219	1	Dogs	dog	NNS
cord-023095-4dannjjm	4219	2	with	with	IN
cord-023095-4dannjjm	4219	3	primary	primary	JJ
cord-023095-4dannjjm	4219	4	intracranial	intracranial	JJ
cord-023095-4dannjjm	4219	5	disease	disease	NN
cord-023095-4dannjjm	4219	6	and	and	CC
cord-023095-4dannjjm	4219	7	normal	normal	JJ
cord-023095-4dannjjm	4219	8	serum	serum	NN
cord-023095-4dannjjm	4219	9	creatinine	creatinine	NN
cord-023095-4dannjjm	4219	10	and	and	CC
cord-023095-4dannjjm	4219	11	a	a	DT
cord-023095-4dannjjm	4219	12	complete	complete	JJ
cord-023095-4dannjjm	4219	13	thoracic	thoracic	JJ
cord-023095-4dannjjm	4219	14	radiograph	radiograph	NN
cord-023095-4dannjjm	4219	15	study	study	NN
cord-023095-4dannjjm	4219	16	were	be	VBD
cord-023095-4dannjjm	4219	17	selected	select	VBN
cord-023095-4dannjjm	4219	18	as	as	IN
cord-023095-4dannjjm	4219	19	controls	control	NNS
cord-023095-4dannjjm	4219	20	.	.	.
cord-023095-4dannjjm	4220	1	Signalment	signalment	JJ
cord-023095-4dannjjm	4220	2	,	,	,
cord-023095-4dannjjm	4220	3	weight	weight	NN
cord-023095-4dannjjm	4220	4	,	,	,
cord-023095-4dannjjm	4220	5	presence	presence	NN
cord-023095-4dannjjm	4220	6	of	of	IN
cord-023095-4dannjjm	4220	7	pulmonary	pulmonary	NN
cord-023095-4dannjjm	4220	8	-	-	HYPH
cord-023095-4dannjjm	4220	9	related	relate	VBN
cord-023095-4dannjjm	4220	10	clinical	clinical	JJ
cord-023095-4dannjjm	4220	11	signs	sign	NNS
cord-023095-4dannjjm	4220	12	,	,	,
cord-023095-4dannjjm	4220	13	azotemia	azotemia	NN
cord-023095-4dannjjm	4220	14	duration	duration	NN
cord-023095-4dannjjm	4220	15	and	and	CC
cord-023095-4dannjjm	4220	16	severity	severity	NN
cord-023095-4dannjjm	4220	17	at	at	IN
cord-023095-4dannjjm	4220	18	time	time	NN
cord-023095-4dannjjm	4220	19	of	of	IN
cord-023095-4dannjjm	4220	20	radiography	radiography	NN
cord-023095-4dannjjm	4220	21	,	,	,
cord-023095-4dannjjm	4220	22	and	and	CC
cord-023095-4dannjjm	4220	23	leptospirosis	leptospirosis	NN
cord-023095-4dannjjm	4220	24	antibody	antibody	NN
cord-023095-4dannjjm	4220	25	titer	titer	NN
cord-023095-4dannjjm	4220	26	were	be	VBD
cord-023095-4dannjjm	4220	27	noted	note	VBN
cord-023095-4dannjjm	4220	28	.	.	.
cord-023095-4dannjjm	4221	1	Alveolar	alveolar	NN
cord-023095-4dannjjm	4221	2	,	,	,
cord-023095-4dannjjm	4221	3	bronchial	bronchial	JJ
cord-023095-4dannjjm	4221	4	,	,	,
cord-023095-4dannjjm	4221	5	interstitial	interstitial	JJ
cord-023095-4dannjjm	4221	6	,	,	,
cord-023095-4dannjjm	4221	7	or	or	CC
cord-023095-4dannjjm	4221	8	nodular	nodular	JJ
cord-023095-4dannjjm	4221	9	lesions	lesion	NNS
cord-023095-4dannjjm	4221	10	were	be	VBD
cord-023095-4dannjjm	4221	11	described	describe	VBN
cord-023095-4dannjjm	4221	12	using	use	VBG
cord-023095-4dannjjm	4221	13	a	a	DT
cord-023095-4dannjjm	4221	14	4-point	4-point	CD
cord-023095-4dannjjm	4221	15	scale	scale	NN
cord-023095-4dannjjm	4221	16	,	,	,
cord-023095-4dannjjm	4221	17	and	and	CC
cord-023095-4dannjjm	4221	18	lung	lung	NN
cord-023095-4dannjjm	4221	19	tissue	tissue	NN
cord-023095-4dannjjm	4221	20	collected	collect	VBN
cord-023095-4dannjjm	4221	21	at	at	IN
cord-023095-4dannjjm	4221	22	time	time	NN
cord-023095-4dannjjm	4221	23	of	of	IN
cord-023095-4dannjjm	4221	24	necropsy	necropsy	JJ
cord-023095-4dannjjm	4221	25	was	be	VBD
cord-023095-4dannjjm	4221	26	reviewed	review	VBN
cord-023095-4dannjjm	4221	27	;	;	:
cord-023095-4dannjjm	4221	28	both	both	CC
cord-023095-4dannjjm	4221	29	the	the	DT
cord-023095-4dannjjm	4221	30	radiologist	radiologist	NN
cord-023095-4dannjjm	4221	31	and	and	CC
cord-023095-4dannjjm	4221	32	pathologist	pathologist	NN
cord-023095-4dannjjm	4221	33	were	be	VBD
cord-023095-4dannjjm	4221	34	blinded	blind	VBN
cord-023095-4dannjjm	4221	35	to	to	IN
cord-023095-4dannjjm	4221	36	final	final	JJ
cord-023095-4dannjjm	4221	37	diagnoses	diagnosis	NNS
cord-023095-4dannjjm	4221	38	.	.	.
cord-023095-4dannjjm	4222	1	Significance	significance	NN
cord-023095-4dannjjm	4222	2	was	be	VBD
cord-023095-4dannjjm	4222	3	P	p	NN
cord-023095-4dannjjm	4222	4	o	o	NN
cord-023095-4dannjjm	4222	5	0.05	0.05	CD
cord-023095-4dannjjm	4222	6	for	for	IN
cord-023095-4dannjjm	4222	7	all	all	DT
cord-023095-4dannjjm	4222	8	analyses	analysis	NNS
cord-023095-4dannjjm	4222	9	.	.	.
cord-023095-4dannjjm	4223	1	The	the	DT
cord-023095-4dannjjm	4223	2	final	final	JJ
cord-023095-4dannjjm	4223	3	study	study	NN
cord-023095-4dannjjm	4223	4	population	population	NN
cord-023095-4dannjjm	4223	5	included	include	VBD
cord-023095-4dannjjm	4223	6	54	54	CD
cord-023095-4dannjjm	4223	7	AKI	AKI	NNP
cord-023095-4dannjjm	4223	8	,	,	,
cord-023095-4dannjjm	4223	9	50	50	CD
cord-023095-4dannjjm	4223	10	CRF	CRF	NNP
cord-023095-4dannjjm	4223	11	,	,	,
cord-023095-4dannjjm	4223	12	and	and	CC
cord-023095-4dannjjm	4223	13	63	63	CD
cord-023095-4dannjjm	4223	14	control	control	NN
cord-023095-4dannjjm	4223	15	dogs	dog	NNS
cord-023095-4dannjjm	4223	16	.	.	.
cord-023095-4dannjjm	4224	1	CRF	CRF	NNP
cord-023095-4dannjjm	4224	2	dogs	dog	NNS
cord-023095-4dannjjm	4224	3	were	be	VBD
cord-023095-4dannjjm	4224	4	older	old	JJR
cord-023095-4dannjjm	4224	5	(	(	-LRB-
cord-023095-4dannjjm	4224	6	P	p	NN
cord-023095-4dannjjm	4224	7	o	o	NN
cord-023095-4dannjjm	4224	8	0.001	0.001	CD
cord-023095-4dannjjm	4224	9	)	)	-RRB-
cord-023095-4dannjjm	4224	10	than	than	IN
cord-023095-4dannjjm	4224	11	AKI	AKI	NNP
cord-023095-4dannjjm	4224	12	and	and	CC
cord-023095-4dannjjm	4224	13	control	control	NN
cord-023095-4dannjjm	4224	14	dogs	dog	NNS
cord-023095-4dannjjm	4224	15	.	.	.
cord-023095-4dannjjm	4225	1	Pulmonary	pulmonary	NN
cord-023095-4dannjjm	4225	2	-	-	HYPH
cord-023095-4dannjjm	4225	3	related	relate	VBN
cord-023095-4dannjjm	4225	4	clinical	clinical	JJ
cord-023095-4dannjjm	4225	5	signs	sign	NNS
cord-023095-4dannjjm	4225	6	were	be	VBD
cord-023095-4dannjjm	4225	7	more	more	RBR
cord-023095-4dannjjm	4225	8	commonly	commonly	RB
cord-023095-4dannjjm	4225	9	diagnosed	diagnose	VBN
cord-023095-4dannjjm	4225	10	at	at	IN
cord-023095-4dannjjm	4225	11	first	first	JJ
cord-023095-4dannjjm	4225	12	evaluation	evaluation	NN
cord-023095-4dannjjm	4225	13	in	in	IN
cord-023095-4dannjjm	4225	14	AKI	AKI	NNP
cord-023095-4dannjjm	4225	15	dogs	dog	NNS
cord-023095-4dannjjm	4225	16	(	(	-LRB-
cord-023095-4dannjjm	4225	17	29/53	29/53	CD
cord-023095-4dannjjm	4225	18	dogs	dog	NNS
cord-023095-4dannjjm	4225	19	,	,	,
cord-023095-4dannjjm	4225	20	54.7	54.7	CD
cord-023095-4dannjjm	4225	21	%	%	NN
cord-023095-4dannjjm	4225	22	)	)	-RRB-
cord-023095-4dannjjm	4225	23	than	than	IN
cord-023095-4dannjjm	4225	24	in	in	IN
cord-023095-4dannjjm	4225	25	CRF	CRF	NNP
cord-023095-4dannjjm	4225	26	(	(	-LRB-
cord-023095-4dannjjm	4225	27	13/50	13/50	CD
cord-023095-4dannjjm	4225	28	,	,	,
cord-023095-4dannjjm	4225	29	26.0	26.0	CD
cord-023095-4dannjjm	4225	30	%	%	NN
cord-023095-4dannjjm	4225	31	;	;	:
cord-023095-4dannjjm	4225	32	P	p	NN
cord-023095-4dannjjm	4225	33	5	5	CD
cord-023095-4dannjjm	4225	34	0.003	0.003	CD
cord-023095-4dannjjm	4225	35	)	)	-RRB-
cord-023095-4dannjjm	4225	36	or	or	CC
cord-023095-4dannjjm	4225	37	control	control	NN
cord-023095-4dannjjm	4225	38	dogs	dog	NNS
cord-023095-4dannjjm	4225	39	(	(	-LRB-
cord-023095-4dannjjm	4225	40	9/63	9/63	CD
cord-023095-4dannjjm	4225	41	,	,	,
cord-023095-4dannjjm	4225	42	14.3	14.3	CD
cord-023095-4dannjjm	4225	43	%	%	NN
cord-023095-4dannjjm	4225	44	;	;	:
cord-023095-4dannjjm	4225	45	P	p	NN
cord-023095-4dannjjm	4225	46	o	o	NN
cord-023095-4dannjjm	4225	47	0.001	0.001	CD
cord-023095-4dannjjm	4225	48	)	)	-RRB-
cord-023095-4dannjjm	4225	49	.	.	.
cord-023095-4dannjjm	4226	1	Presence	presence	NN
cord-023095-4dannjjm	4226	2	of	of	IN
cord-023095-4dannjjm	4226	3	an	an	DT
cord-023095-4dannjjm	4226	4	alveolar	alveolar	JJ
cord-023095-4dannjjm	4226	5	pattern	pattern	NN
cord-023095-4dannjjm	4226	6	was	be	VBD
cord-023095-4dannjjm	4226	7	the	the	DT
cord-023095-4dannjjm	4226	8	only	only	JJ
cord-023095-4dannjjm	4226	9	radiographic	radiographic	JJ
cord-023095-4dannjjm	4226	10	finding	finding	NN
cord-023095-4dannjjm	4226	11	which	which	WDT
cord-023095-4dannjjm	4226	12	differed	differ	VBD
cord-023095-4dannjjm	4226	13	amongst	amongst	IN
cord-023095-4dannjjm	4226	14	groups	group	NNS
cord-023095-4dannjjm	4226	15	(	(	-LRB-
cord-023095-4dannjjm	4226	16	more	more	RBR
cord-023095-4dannjjm	4226	17	common	common	JJ
cord-023095-4dannjjm	4226	18	in	in	IN
cord-023095-4dannjjm	4226	19	AKI	AKI	NNP
cord-023095-4dannjjm	4226	20	[	[	-LRB-
cord-023095-4dannjjm	4226	21	n	n	NN
cord-023095-4dannjjm	4226	22	5	5	CD
cord-023095-4dannjjm	4226	23	8	8	CD
cord-023095-4dannjjm	4226	24	,	,	,
cord-023095-4dannjjm	4226	25	14.8	14.8	CD
cord-023095-4dannjjm	4226	26	%	%	NN
cord-023095-4dannjjm	4226	27	,	,	,
cord-023095-4dannjjm	4226	28	P	p	NN
cord-023095-4dannjjm	4226	29	5	5	CD
cord-023095-4dannjjm	4226	30	0.047	0.047	CD
cord-023095-4dannjjm	4226	31	]	]	-RRB-
cord-023095-4dannjjm	4226	32	and	and	CC
cord-023095-4dannjjm	4227	1	CRF	CRF	NNP
cord-023095-4dannjjm	4227	2	[	[	-LRB-
cord-023095-4dannjjm	4227	3	n	n	NN
cord-023095-4dannjjm	4227	4	5	5	CD
cord-023095-4dannjjm	4227	5	8	8	CD
cord-023095-4dannjjm	4227	6	,	,	,
cord-023095-4dannjjm	4227	7	16	16	CD
cord-023095-4dannjjm	4227	8	%	%	NN
cord-023095-4dannjjm	4227	9	,	,	,
cord-023095-4dannjjm	4227	10	P	p	NN
cord-023095-4dannjjm	4227	11	5	5	CD
cord-023095-4dannjjm	4227	12	0.028	0.028	CD
cord-023095-4dannjjm	4227	13	]	]	-RRB-
cord-023095-4dannjjm	4227	14	dogs	dog	NNS
cord-023095-4dannjjm	4227	15	than	than	IN
cord-023095-4dannjjm	4227	16	in	in	IN
cord-023095-4dannjjm	4227	17	control	control	NN
cord-023095-4dannjjm	4227	18	dogs	dog	NNS
cord-023095-4dannjjm	4227	19	[	[	-LRB-
cord-023095-4dannjjm	4227	20	n	n	NN
cord-023095-4dannjjm	4227	21	5	5	CD
cord-023095-4dannjjm	4227	22	2	2	CD
cord-023095-4dannjjm	4227	23	,	,	,
cord-023095-4dannjjm	4227	24	3.2	3.2	CD
cord-023095-4dannjjm	4227	25	%	%	NN
cord-023095-4dannjjm	4227	26	]	]	-RRB-
cord-023095-4dannjjm	4227	27	)	)	-RRB-
cord-023095-4dannjjm	4227	28	.	.	.
cord-023095-4dannjjm	4228	1	There	there	EX
cord-023095-4dannjjm	4228	2	was	be	VBD
cord-023095-4dannjjm	4228	3	no	no	DT
cord-023095-4dannjjm	4228	4	association	association	NN
cord-023095-4dannjjm	4228	5	between	between	IN
cord-023095-4dannjjm	4228	6	presence	presence	NN
cord-023095-4dannjjm	4228	7	of	of	IN
cord-023095-4dannjjm	4228	8	an	an	DT
cord-023095-4dannjjm	4228	9	alveolar	alveolar	JJ
cord-023095-4dannjjm	4228	10	pattern	pattern	NN
cord-023095-4dannjjm	4228	11	and	and	CC
cord-023095-4dannjjm	4228	12	any	any	DT
cord-023095-4dannjjm	4228	13	other	other	JJ
cord-023095-4dannjjm	4228	14	variable	variable	NN
cord-023095-4dannjjm	4228	15	.	.	.
cord-023095-4dannjjm	4229	1	Alveolar	alveolar	NN
cord-023095-4dannjjm	4229	2	mineralization	mineralization	NN
cord-023095-4dannjjm	4229	3	was	be	VBD
cord-023095-4dannjjm	4229	4	the	the	DT
cord-023095-4dannjjm	4229	5	most	most	RBS
cord-023095-4dannjjm	4229	6	common	common	JJ
cord-023095-4dannjjm	4229	7	lesion	lesion	NN
cord-023095-4dannjjm	4229	8	in	in	IN
cord-023095-4dannjjm	4229	9	AKI	AKI	NNP
cord-023095-4dannjjm	4229	10	dogs	dog	NNS
cord-023095-4dannjjm	4229	11	(	(	-LRB-
cord-023095-4dannjjm	4229	12	5/8	5/8	CD
cord-023095-4dannjjm	4229	13	dogs	dog	NNS
cord-023095-4dannjjm	4229	14	;	;	:
cord-023095-4dannjjm	4229	15	62.5	62.5	CD
cord-023095-4dannjjm	4229	16	%	%	NN
cord-023095-4dannjjm	4229	17	)	)	-RRB-
cord-023095-4dannjjm	4229	18	,	,	,
cord-023095-4dannjjm	4229	19	with	with	IN
cord-023095-4dannjjm	4229	20	concurrent	concurrent	JJ
cord-023095-4dannjjm	4229	21	alveolar	alveolar	NN
cord-023095-4dannjjm	4229	22	space	space	NN
cord-023095-4dannjjm	4229	23	concretions	concretion	NNS
cord-023095-4dannjjm	4229	24	or	or	CC
cord-023095-4dannjjm	4229	25	mineralization	mineralization	NN
cord-023095-4dannjjm	4229	26	of	of	IN
cord-023095-4dannjjm	4229	27	vessels	vessel	NNS
cord-023095-4dannjjm	4229	28	or	or	CC
cord-023095-4dannjjm	4229	29	bronchioles	bronchiole	NNS
cord-023095-4dannjjm	4229	30	noted	note	VBN
cord-023095-4dannjjm	4229	31	in	in	IN
cord-023095-4dannjjm	4229	32	1	1	CD
cord-023095-4dannjjm	4229	33	dog	dog	NN
cord-023095-4dannjjm	4229	34	each	each	DT
cord-023095-4dannjjm	4229	35	.	.	.
cord-023095-4dannjjm	4230	1	Necropsies	Necropsies	NNP
cord-023095-4dannjjm	4230	2	had	have	VBD
cord-023095-4dannjjm	4230	3	not	not	RB
cord-023095-4dannjjm	4230	4	been	be	VBN
cord-023095-4dannjjm	4230	5	performed	perform	VBN
cord-023095-4dannjjm	4230	6	in	in	IN
cord-023095-4dannjjm	4230	7	any	any	DT
cord-023095-4dannjjm	4230	8	of	of	IN
cord-023095-4dannjjm	4230	9	the	the	DT
cord-023095-4dannjjm	4230	10	CRF	CRF	NNP
cord-023095-4dannjjm	4230	11	dogs	dog	NNS
cord-023095-4dannjjm	4230	12	,	,	,
cord-023095-4dannjjm	4230	13	but	but	CC
cord-023095-4dannjjm	4230	14	mineralization	mineralization	NN
cord-023095-4dannjjm	4230	15	was	be	VBD
cord-023095-4dannjjm	4230	16	not	not	RB
cord-023095-4dannjjm	4230	17	seen	see	VBN
cord-023095-4dannjjm	4230	18	in	in	IN
cord-023095-4dannjjm	4230	19	lung	lung	NN
cord-023095-4dannjjm	4230	20	tissues	tissue	NNS
cord-023095-4dannjjm	4230	21	from	from	IN
cord-023095-4dannjjm	4230	22	any	any	DT
cord-023095-4dannjjm	4230	23	control	control	NN
cord-023095-4dannjjm	4230	24	dogs	dog	NNS
cord-023095-4dannjjm	4230	25	(	(	-LRB-
cord-023095-4dannjjm	4230	26	n	n	NN
cord-023095-4dannjjm	4230	27	5	5	CD
cord-023095-4dannjjm	4230	28	9	9	CD
cord-023095-4dannjjm	4230	29	)	)	-RRB-
cord-023095-4dannjjm	4230	30	.	.	.
cord-023095-4dannjjm	4231	1	Neither	neither	DT
cord-023095-4dannjjm	4231	2	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	4231	3	-	-	HYPH
cord-023095-4dannjjm	4231	4	associated	associate	VBN
cord-023095-4dannjjm	4231	5	clinical	clinical	JJ
cord-023095-4dannjjm	4231	6	signs	sign	NNS
cord-023095-4dannjjm	4231	7	nor	nor	CC
cord-023095-4dannjjm	4231	8	alveolar	alveolar	JJ
cord-023095-4dannjjm	4231	9	pattern	pattern	NN
cord-023095-4dannjjm	4231	10	were	be	VBD
cord-023095-4dannjjm	4231	11	associated	associate	VBN
cord-023095-4dannjjm	4231	12	with	with	IN
cord-023095-4dannjjm	4231	13	median	median	JJ
cord-023095-4dannjjm	4231	14	number	number	NN
cord-023095-4dannjjm	4231	15	of	of	IN
cord-023095-4dannjjm	4231	16	days	day	NNS
cord-023095-4dannjjm	4231	17	from	from	IN
cord-023095-4dannjjm	4231	18	discharge	discharge	NN
cord-023095-4dannjjm	4231	19	until	until	IN
cord-023095-4dannjjm	4231	20	death	death	NN
cord-023095-4dannjjm	4231	21	in	in	IN
cord-023095-4dannjjm	4231	22	dogs	dog	NNS
cord-023095-4dannjjm	4231	23	with	with	IN
cord-023095-4dannjjm	4231	24	AKI	AKI	NNP
cord-023095-4dannjjm	4231	25	(	(	-LRB-
cord-023095-4dannjjm	4231	26	P	p	NN
cord-023095-4dannjjm	4231	27	5	5	CD
cord-023095-4dannjjm	4231	28	0.220	0.220	CD
cord-023095-4dannjjm	4231	29	and	and	CC
cord-023095-4dannjjm	4231	30	0.468	0.468	CD
cord-023095-4dannjjm	4231	31	,	,	,
cord-023095-4dannjjm	4231	32	respectively	respectively	RB
cord-023095-4dannjjm	4231	33	)	)	-RRB-
cord-023095-4dannjjm	4231	34	or	or	CC
cord-023095-4dannjjm	4231	35	CRF	CRF	NNP
cord-023095-4dannjjm	4231	36	(	(	-LRB-
cord-023095-4dannjjm	4231	37	P	p	NN
cord-023095-4dannjjm	4231	38	5	5	CD
cord-023095-4dannjjm	4231	39	0.280	0.280	CD
cord-023095-4dannjjm	4231	40	and	and	CC
cord-023095-4dannjjm	4231	41	0.253	0.253	CD
cord-023095-4dannjjm	4231	42	,	,	,
cord-023095-4dannjjm	4231	43	respectively	respectively	RB
cord-023095-4dannjjm	4231	44	)	)	-RRB-
cord-023095-4dannjjm	4231	45	.	.	.
cord-023095-4dannjjm	4232	1	In	in	IN
cord-023095-4dannjjm	4232	2	this	this	DT
cord-023095-4dannjjm	4232	3	group	group	NN
cord-023095-4dannjjm	4232	4	of	of	IN
cord-023095-4dannjjm	4232	5	dogs	dog	NNS
cord-023095-4dannjjm	4232	6	,	,	,
cord-023095-4dannjjm	4232	7	presence	presence	NN
cord-023095-4dannjjm	4232	8	and	and	CC
cord-023095-4dannjjm	4232	9	type	type	NN
cord-023095-4dannjjm	4232	10	of	of	IN
cord-023095-4dannjjm	4232	11	radiographic	radiographic	JJ
cord-023095-4dannjjm	4232	12	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	4232	13	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4232	14	were	be	VBD
cord-023095-4dannjjm	4232	15	associated	associate	VBN
cord-023095-4dannjjm	4232	16	with	with	IN
cord-023095-4dannjjm	4232	17	renal	renal	JJ
cord-023095-4dannjjm	4232	18	azotemia	azotemia	NN
cord-023095-4dannjjm	4232	19	but	but	CC
cord-023095-4dannjjm	4232	20	not	not	RB
cord-023095-4dannjjm	4232	21	with	with	IN
cord-023095-4dannjjm	4232	22	median	median	JJ
cord-023095-4dannjjm	4232	23	time	time	NN
cord-023095-4dannjjm	4232	24	until	until	IN
cord-023095-4dannjjm	4232	25	death	death	NN
cord-023095-4dannjjm	4232	26	.	.	.
cord-023095-4dannjjm	4233	1	The	the	DT
cord-023095-4dannjjm	4233	2	association	association	NN
cord-023095-4dannjjm	4233	3	between	between	IN
cord-023095-4dannjjm	4233	4	and	and	CC
cord-023095-4dannjjm	4233	5	clinical	clinical	JJ
cord-023095-4dannjjm	4233	6	relevance	relevance	NN
cord-023095-4dannjjm	4233	7	of	of	IN
cord-023095-4dannjjm	4233	8	alveolar	alveolar	JJ
cord-023095-4dannjjm	4233	9	mineralization	mineralization	NN
cord-023095-4dannjjm	4233	10	in	in	IN
cord-023095-4dannjjm	4233	11	AKI	AKI	NNP
cord-023095-4dannjjm	4233	12	dogs	dog	NNS
cord-023095-4dannjjm	4233	13	were	be	VBD
cord-023095-4dannjjm	4233	14	not	not	RB
cord-023095-4dannjjm	4233	15	determined	determine	VBN
cord-023095-4dannjjm	4233	16	,	,	,
cord-023095-4dannjjm	4233	17	but	but	CC
cord-023095-4dannjjm	4233	18	both	both	CC
cord-023095-4dannjjm	4233	19	the	the	DT
cord-023095-4dannjjm	4233	20	radiographic	radiographic	JJ
cord-023095-4dannjjm	4233	21	and	and	CC
cord-023095-4dannjjm	4233	22	histopathologic	histopathologic	JJ
cord-023095-4dannjjm	4233	23	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4233	24	reported	report	VBN
cord-023095-4dannjjm	4233	25	here	here	RB
cord-023095-4dannjjm	4233	26	differ	differ	VBP
cord-023095-4dannjjm	4233	27	from	from	IN
cord-023095-4dannjjm	4233	28	UP	up	RB
cord-023095-4dannjjm	4233	29	in	in	IN
cord-023095-4dannjjm	4233	30	people	people	NNS
cord-023095-4dannjjm	4233	31	.	.	.
cord-023095-4dannjjm	4234	1	Chronic	chronic	JJ
cord-023095-4dannjjm	4234	2	kidney	kidney	NN
cord-023095-4dannjjm	4234	3	disease	disease	NN
cord-023095-4dannjjm	4234	4	(	(	-LRB-
cord-023095-4dannjjm	4234	5	CKD	CKD	NNP
cord-023095-4dannjjm	4234	6	)	)	-RRB-
cord-023095-4dannjjm	4234	7	is	be	VBZ
cord-023095-4dannjjm	4234	8	a	a	DT
cord-023095-4dannjjm	4234	9	common	common	JJ
cord-023095-4dannjjm	4234	10	cause	cause	NN
cord-023095-4dannjjm	4234	11	of	of	IN
cord-023095-4dannjjm	4234	12	morbidity	morbidity	NN
cord-023095-4dannjjm	4234	13	and	and	CC
cord-023095-4dannjjm	4234	14	mortality	mortality	NN
cord-023095-4dannjjm	4234	15	in	in	IN
cord-023095-4dannjjm	4234	16	cats	cat	NNS
cord-023095-4dannjjm	4234	17	.	.	.
cord-023095-4dannjjm	4235	1	The	the	DT
cord-023095-4dannjjm	4235	2	purpose	purpose	NN
cord-023095-4dannjjm	4235	3	of	of	IN
cord-023095-4dannjjm	4235	4	this	this	DT
cord-023095-4dannjjm	4235	5	study	study	NN
cord-023095-4dannjjm	4235	6	was	be	VBD
cord-023095-4dannjjm	4235	7	to	to	TO
cord-023095-4dannjjm	4235	8	investigate	investigate	VB
cord-023095-4dannjjm	4235	9	the	the	DT
cord-023095-4dannjjm	4235	10	effects	effect	NNS
cord-023095-4dannjjm	4235	11	of	of	IN
cord-023095-4dannjjm	4235	12	Chinese	chinese	JJ
cord-023095-4dannjjm	4235	13	rhubarb	rhubarb	NN
cord-023095-4dannjjm	4235	14	(	(	-LRB-
cord-023095-4dannjjm	4235	15	Rheum	Rheum	NNP
cord-023095-4dannjjm	4235	16	officinale	officinale	NN
cord-023095-4dannjjm	4235	17	)	)	-RRB-
cord-023095-4dannjjm	4235	18	supplementation	supplementation	NN
cord-023095-4dannjjm	4235	19	on	on	IN
cord-023095-4dannjjm	4235	20	the	the	DT
cord-023095-4dannjjm	4235	21	progression	progression	NN
cord-023095-4dannjjm	4235	22	of	of	IN
cord-023095-4dannjjm	4235	23	feline	feline	JJ
cord-023095-4dannjjm	4235	24	CKD	CKD	NNP
cord-023095-4dannjjm	4235	25	.	.	.
cord-023095-4dannjjm	4236	1	Cats	cat	NNS
cord-023095-4dannjjm	4236	2	with	with	IN
cord-023095-4dannjjm	4236	3	stable	stable	JJ
cord-023095-4dannjjm	4236	4	IRIS	IRIS	NNP
cord-023095-4dannjjm	4236	5	stage	stage	NN
cord-023095-4dannjjm	4236	6	II	II	NNP
cord-023095-4dannjjm	4236	7	or	or	CC
cord-023095-4dannjjm	4236	8	III	iii	CD
cord-023095-4dannjjm	4236	9	CKD	CKD	NNP
cord-023095-4dannjjm	4236	10	and	and	CC
cord-023095-4dannjjm	4236	11	without	without	IN
cord-023095-4dannjjm	4236	12	comorbidity	comorbidity	NN
cord-023095-4dannjjm	4236	13	were	be	VBD
cord-023095-4dannjjm	4236	14	included	include	VBN
cord-023095-4dannjjm	4236	15	in	in	IN
cord-023095-4dannjjm	4236	16	the	the	DT
cord-023095-4dannjjm	4236	17	study	study	NN
cord-023095-4dannjjm	4236	18	.	.	.
cord-023095-4dannjjm	4237	1	Cats	cat	NNS
cord-023095-4dannjjm	4237	2	were	be	VBD
cord-023095-4dannjjm	4237	3	divided	divide	VBN
cord-023095-4dannjjm	4237	4	into	into	IN
cord-023095-4dannjjm	4237	5	3	3	CD
cord-023095-4dannjjm	4237	6	treatment	treatment	NN
cord-023095-4dannjjm	4237	7	groups	group	NNS
cord-023095-4dannjjm	4237	8	and	and	CC
cord-023095-4dannjjm	4237	9	administered	administer	VBN
cord-023095-4dannjjm	4237	10	rhubarb	rhubarb	NN
cord-023095-4dannjjm	4237	11	extract	extract	NN
cord-023095-4dannjjm	4237	12	(	(	-LRB-
cord-023095-4dannjjm	4237	13	Group	group	NN
cord-023095-4dannjjm	4237	14	1	1	CD
cord-023095-4dannjjm	4237	15	,	,	,
cord-023095-4dannjjm	4237	16	Rubenal	Rubenal	NNP
cord-023095-4dannjjm	4237	17	s	s	NNP
cord-023095-4dannjjm	4237	18	,	,	,
cord-023095-4dannjjm	4237	19	Vetoquinol	Vetoquinol	NNP
cord-023095-4dannjjm	4237	20	,	,	,
cord-023095-4dannjjm	4237	21	75	75	CD
cord-023095-4dannjjm	4237	22	mg	mg	NN
cord-023095-4dannjjm	4237	23	tablet	tablet	NN
cord-023095-4dannjjm	4237	24	PO	PO	NNP
cord-023095-4dannjjm	4237	25	q	q	NNP
cord-023095-4dannjjm	4237	26	12	12	CD
cord-023095-4dannjjm	4237	27	h	h	NNP
cord-023095-4dannjjm	4237	28	)	)	-RRB-
cord-023095-4dannjjm	4237	29	,	,	,
cord-023095-4dannjjm	4237	30	benazepril	benazepril	NNP
cord-023095-4dannjjm	4237	31	as	as	IN
cord-023095-4dannjjm	4237	32	a	a	DT
cord-023095-4dannjjm	4237	33	positive	positive	JJ
cord-023095-4dannjjm	4237	34	control	control	NN
cord-023095-4dannjjm	4237	35	(	(	-LRB-
cord-023095-4dannjjm	4237	36	Group	Group	NNP
cord-023095-4dannjjm	4237	37	2	2	CD
cord-023095-4dannjjm	4237	38	,	,	,
cord-023095-4dannjjm	4237	39	0.5	0.5	CD
cord-023095-4dannjjm	4237	40	mg	mg	NNP
cord-023095-4dannjjm	4237	41	/	/	SYM
cord-023095-4dannjjm	4237	42	kg	kg	NNP
cord-023095-4dannjjm	4237	43	PO	po	NN
cord-023095-4dannjjm	4237	44	q	q	NNP
cord-023095-4dannjjm	4237	45	24	24	CD
cord-023095-4dannjjm	4237	46	h	h	NNP
cord-023095-4dannjjm	4237	47	)	)	-RRB-
cord-023095-4dannjjm	4237	48	,	,	,
cord-023095-4dannjjm	4237	49	or	or	CC
cord-023095-4dannjjm	4237	50	both	both	DT
cord-023095-4dannjjm	4237	51	(	(	-LRB-
cord-023095-4dannjjm	4237	52	Group	Group	NNP
cord-023095-4dannjjm	4237	53	3	3	CD
cord-023095-4dannjjm	4237	54	)	)	-RRB-
cord-023095-4dannjjm	4237	55	.	.	.
cord-023095-4dannjjm	4238	1	Cats	cat	NNS
cord-023095-4dannjjm	4238	2	were	be	VBD
cord-023095-4dannjjm	4238	3	fed	feed	VBN
cord-023095-4dannjjm	4238	4	a	a	DT
cord-023095-4dannjjm	4238	5	commercial	commercial	JJ
cord-023095-4dannjjm	4238	6	renal	renal	JJ
cord-023095-4dannjjm	4238	7	specific	specific	JJ
cord-023095-4dannjjm	4238	8	diet	diet	NN
cord-023095-4dannjjm	4238	9	and	and	CC
cord-023095-4dannjjm	4238	10	enteric	enteric	JJ
cord-023095-4dannjjm	4238	11	phosphate	phosphate	NN
cord-023095-4dannjjm	4238	12	binder	binder	NN
cord-023095-4dannjjm	4238	13	as	as	IN
cord-023095-4dannjjm	4238	14	appropriate	appropriate	JJ
cord-023095-4dannjjm	4238	15	.	.	.
cord-023095-4dannjjm	4239	1	Body	body	NN
cord-023095-4dannjjm	4239	2	weight	weight	NN
cord-023095-4dannjjm	4239	3	,	,	,
cord-023095-4dannjjm	4239	4	laboratory	laboratory	NN
cord-023095-4dannjjm	4239	5	data	datum	NNS
cord-023095-4dannjjm	4239	6	,	,	,
cord-023095-4dannjjm	4239	7	and	and	CC
cord-023095-4dannjjm	4239	8	blood	blood	NN
cord-023095-4dannjjm	4239	9	pressure	pressure	NN
cord-023095-4dannjjm	4239	10	were	be	VBD
cord-023095-4dannjjm	4239	11	recorded	record	VBN
cord-023095-4dannjjm	4239	12	every	every	DT
cord-023095-4dannjjm	4239	13	3	3	CD
cord-023095-4dannjjm	4239	14	months	month	NNS
cord-023095-4dannjjm	4239	15	for	for	IN
cord-023095-4dannjjm	4239	16	up	up	IN
cord-023095-4dannjjm	4239	17	to	to	TO
cord-023095-4dannjjm	4239	18	34	34	CD
cord-023095-4dannjjm	4239	19	months	month	NNS
cord-023095-4dannjjm	4239	20	.	.	.
cord-023095-4dannjjm	4240	1	Variables	variable	NNS
cord-023095-4dannjjm	4240	2	between	between	IN
cord-023095-4dannjjm	4240	3	groups	group	NNS
cord-023095-4dannjjm	4240	4	at	at	IN
cord-023095-4dannjjm	4240	5	enrollment	enrollment	NN
cord-023095-4dannjjm	4240	6	and	and	CC
cord-023095-4dannjjm	4240	7	within	within	IN
cord-023095-4dannjjm	4240	8	groups	group	NNS
cord-023095-4dannjjm	4240	9	over	over	IN
cord-023095-4dannjjm	4240	10	visits	visit	NNS
cord-023095-4dannjjm	4240	11	were	be	VBD
cord-023095-4dannjjm	4240	12	compared	compare	VBN
cord-023095-4dannjjm	4240	13	with	with	IN
cord-023095-4dannjjm	4240	14	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	4240	15	and	and	CC
cord-023095-4dannjjm	4240	16	repeated	repeat	VBN
cord-023095-4dannjjm	4240	17	measures	measure	NNS
cord-023095-4dannjjm	4240	18	ANO	ANO	NNP
cord-023095-4dannjjm	4240	19	-	-	HYPH
cord-023095-4dannjjm	4240	20	VA	VA	NNP
cord-023095-4dannjjm	4240	21	,	,	,
cord-023095-4dannjjm	4240	22	respectively	respectively	RB
cord-023095-4dannjjm	4240	23	.	.	.
cord-023095-4dannjjm	4241	1	A	a	DT
cord-023095-4dannjjm	4241	2	treatment	treatment	NN
cord-023095-4dannjjm	4241	3	by	by	IN
cord-023095-4dannjjm	4241	4	visit	visit	NN
cord-023095-4dannjjm	4241	5	interaction	interaction	NN
cord-023095-4dannjjm	4241	6	term	term	NN
cord-023095-4dannjjm	4241	7	was	be	VBD
cord-023095-4dannjjm	4241	8	included	include	VBN
cord-023095-4dannjjm	4241	9	in	in	IN
cord-023095-4dannjjm	4241	10	all	all	DT
cord-023095-4dannjjm	4241	11	repeated	repeat	VBN
cord-023095-4dannjjm	4241	12	measures	measure	NNS
cord-023095-4dannjjm	4241	13	models	model	NNS
cord-023095-4dannjjm	4241	14	.	.	.
cord-023095-4dannjjm	4242	1	Significance	significance	NN
cord-023095-4dannjjm	4242	2	was	be	VBD
cord-023095-4dannjjm	4242	3	set	set	VBN
cord-023095-4dannjjm	4242	4	at	at	IN
cord-023095-4dannjjm	4242	5	p	p	NN
cord-023095-4dannjjm	4242	6	0.05	0.05	CD
cord-023095-4dannjjm	4242	7	.	.	.
cord-023095-4dannjjm	4243	1	Except	except	IN
cord-023095-4dannjjm	4243	2	for	for	IN
cord-023095-4dannjjm	4243	3	body	body	NN
cord-023095-4dannjjm	4243	4	weight	weight	NN
cord-023095-4dannjjm	4243	5	there	there	EX
cord-023095-4dannjjm	4243	6	was	be	VBD
cord-023095-4dannjjm	4243	7	no	no	DT
cord-023095-4dannjjm	4243	8	significant	significant	JJ
cord-023095-4dannjjm	4243	9	differences	difference	NNS
cord-023095-4dannjjm	4243	10	between	between	IN
cord-023095-4dannjjm	4243	11	treatment	treatment	NN
cord-023095-4dannjjm	4243	12	groups	group	NNS
cord-023095-4dannjjm	4243	13	at	at	IN
cord-023095-4dannjjm	4243	14	enrollment	enrollment	NN
cord-023095-4dannjjm	4243	15	.	.	.
cord-023095-4dannjjm	4244	1	There	there	EX
cord-023095-4dannjjm	4244	2	was	be	VBD
cord-023095-4dannjjm	4244	3	no	no	DT
cord-023095-4dannjjm	4244	4	significant	significant	JJ
cord-023095-4dannjjm	4244	5	change	change	NN
cord-023095-4dannjjm	4244	6	in	in	IN
cord-023095-4dannjjm	4244	7	body	body	NN
cord-023095-4dannjjm	4244	8	weight	weight	NN
cord-023095-4dannjjm	4244	9	,	,	,
cord-023095-4dannjjm	4244	10	hematocrit	hematocrit	NN
cord-023095-4dannjjm	4244	11	(	(	-LRB-
cord-023095-4dannjjm	4244	12	hct	hct	NNP
cord-023095-4dannjjm	4244	13	)	)	-RRB-
cord-023095-4dannjjm	4244	14	,	,	,
cord-023095-4dannjjm	4244	15	UPC	UPC	NNP
cord-023095-4dannjjm	4244	16	,	,	,
cord-023095-4dannjjm	4244	17	or	or	CC
cord-023095-4dannjjm	4244	18	creatinine	creatinine	NN
cord-023095-4dannjjm	4244	19	over	over	IN
cord-023095-4dannjjm	4244	20	time	time	NN
cord-023095-4dannjjm	4244	21	as	as	IN
cord-023095-4dannjjm	4244	22	compared	compare	VBN
cord-023095-4dannjjm	4244	23	to	to	IN
cord-023095-4dannjjm	4244	24	baseline	baseline	NN
cord-023095-4dannjjm	4244	25	within	within	IN
cord-023095-4dannjjm	4244	26	any	any	DT
cord-023095-4dannjjm	4244	27	group	group	NN
cord-023095-4dannjjm	4244	28	.	.	.
cord-023095-4dannjjm	4245	1	There	there	EX
cord-023095-4dannjjm	4245	2	was	be	VBD
cord-023095-4dannjjm	4245	3	no	no	DT
cord-023095-4dannjjm	4245	4	significant	significant	JJ
cord-023095-4dannjjm	4245	5	difference	difference	NN
cord-023095-4dannjjm	4245	6	between	between	IN
cord-023095-4dannjjm	4245	7	groups	group	NNS
cord-023095-4dannjjm	4245	8	over	over	IN
cord-023095-4dannjjm	4245	9	time	time	NN
cord-023095-4dannjjm	4245	10	in	in	IN
cord-023095-4dannjjm	4245	11	regards	regard	NNS
cord-023095-4dannjjm	4245	12	to	to	TO
cord-023095-4dannjjm	4245	13	change	change	VB
cord-023095-4dannjjm	4245	14	in	in	IN
cord-023095-4dannjjm	4245	15	weight	weight	NN
cord-023095-4dannjjm	4245	16	,	,	,
cord-023095-4dannjjm	4245	17	hct	hct	NN
cord-023095-4dannjjm	4245	18	,	,	,
cord-023095-4dannjjm	4245	19	UPC	UPC	NNP
cord-023095-4dannjjm	4245	20	,	,	,
cord-023095-4dannjjm	4245	21	or	or	CC
cord-023095-4dannjjm	4245	22	creatinine	creatinine	NN
cord-023095-4dannjjm	4245	23	.	.	.
cord-023095-4dannjjm	4246	1	The	the	DT
cord-023095-4dannjjm	4246	2	treatment	treatment	NN
cord-023095-4dannjjm	4246	3	by	by	IN
cord-023095-4dannjjm	4246	4	time	time	NN
cord-023095-4dannjjm	4246	5	interaction	interaction	NN
cord-023095-4dannjjm	4246	6	was	be	VBD
cord-023095-4dannjjm	4246	7	non	non	JJ
cord-023095-4dannjjm	4246	8	-	-	JJ
cord-023095-4dannjjm	4246	9	significant	significant	JJ
cord-023095-4dannjjm	4246	10	in	in	IN
cord-023095-4dannjjm	4246	11	all	all	DT
cord-023095-4dannjjm	4246	12	models	model	NNS
cord-023095-4dannjjm	4246	13	.	.	.
cord-023095-4dannjjm	4247	1	Although	although	IN
cord-023095-4dannjjm	4247	2	there	there	EX
cord-023095-4dannjjm	4247	3	was	be	VBD
cord-023095-4dannjjm	4247	4	no	no	DT
cord-023095-4dannjjm	4247	5	benefit	benefit	NN
cord-023095-4dannjjm	4247	6	associated	associate	VBN
cord-023095-4dannjjm	4247	7	with	with	IN
cord-023095-4dannjjm	4247	8	combination	combination	NN
cord-023095-4dannjjm	4247	9	treatment	treatment	NN
cord-023095-4dannjjm	4247	10	,	,	,
cord-023095-4dannjjm	4247	11	the	the	DT
cord-023095-4dannjjm	4247	12	results	result	NNS
cord-023095-4dannjjm	4247	13	for	for	IN
cord-023095-4dannjjm	4247	14	rhubarb	rhubarb	NN
cord-023095-4dannjjm	4247	15	treatment	treatment	NN
cord-023095-4dannjjm	4247	16	alone	alone	RB
cord-023095-4dannjjm	4247	17	were	be	VBD
cord-023095-4dannjjm	4247	18	not	not	RB
cord-023095-4dannjjm	4247	19	different	different	JJ
cord-023095-4dannjjm	4247	20	from	from	IN
cord-023095-4dannjjm	4247	21	benazepril	benazepril	NNP
cord-023095-4dannjjm	4247	22	treatment	treatment	NNP
cord-023095-4dannjjm	4247	23	.	.	.
cord-023095-4dannjjm	4248	1	Azodyl	Azodyl	NNP
cord-023095-4dannjjm	4248	2	,	,	,
cord-023095-4dannjjm	4248	3	an	an	DT
cord-023095-4dannjjm	4248	4	encapsulated	encapsulate	VBN
cord-023095-4dannjjm	4248	5	,	,	,
cord-023095-4dannjjm	4248	6	enteric	enteric	JJ
cord-023095-4dannjjm	4248	7	-	-	HYPH
cord-023095-4dannjjm	4248	8	coated	coat	VBN
cord-023095-4dannjjm	4248	9	probiotic	probiotic	JJ
cord-023095-4dannjjm	4248	10	/	/	SYM
cord-023095-4dannjjm	4248	11	prebiotic	prebiotic	JJ
cord-023095-4dannjjm	4248	12	nutraceutical	nutraceutical	NN
cord-023095-4dannjjm	4248	13	,	,	,
cord-023095-4dannjjm	4248	14	is	be	VBZ
cord-023095-4dannjjm	4248	15	marketed	market	VBN
cord-023095-4dannjjm	4248	16	for	for	IN
cord-023095-4dannjjm	4248	17	reduction	reduction	NN
cord-023095-4dannjjm	4248	18	of	of	IN
cord-023095-4dannjjm	4248	19	azotemia	azotemia	NN
cord-023095-4dannjjm	4248	20	(	(	-LRB-
cord-023095-4dannjjm	4248	21	BUN	BUN	NNP
cord-023095-4dannjjm	4248	22	&	&	CC
cord-023095-4dannjjm	4248	23	Creatinine	Creatinine	NNP
cord-023095-4dannjjm	4248	24	)	)	-RRB-
cord-023095-4dannjjm	4248	25	in	in	IN
cord-023095-4dannjjm	4248	26	dogs	dog	NNS
cord-023095-4dannjjm	4248	27	and	and	CC
cord-023095-4dannjjm	4248	28	cats	cat	NNS
cord-023095-4dannjjm	4248	29	.	.	.
cord-023095-4dannjjm	4249	1	Cat	cat	NN
cord-023095-4dannjjm	4249	2	owners	owner	NNS
cord-023095-4dannjjm	4249	3	often	often	RB
cord-023095-4dannjjm	4249	4	sprinkle	sprinkle	VBP
cord-023095-4dannjjm	4249	5	contents	content	NNS
cord-023095-4dannjjm	4249	6	onto	onto	IN
cord-023095-4dannjjm	4249	7	cat	cat	NN
cord-023095-4dannjjm	4249	8	food	food	NN
cord-023095-4dannjjm	4249	9	to	to	TO
cord-023095-4dannjjm	4249	10	facilitate	facilitate	VB
cord-023095-4dannjjm	4249	11	administration	administration	NN
cord-023095-4dannjjm	4249	12	.	.	.
cord-023095-4dannjjm	4250	1	However	however	RB
cord-023095-4dannjjm	4250	2	,	,	,
cord-023095-4dannjjm	4250	3	exposure	exposure	NN
cord-023095-4dannjjm	4250	4	to	to	IN
cord-023095-4dannjjm	4250	5	air	air	NN
cord-023095-4dannjjm	4250	6	and	and	CC
cord-023095-4dannjjm	4250	7	stomach	stomach	NN
cord-023095-4dannjjm	4250	8	acid	acid	NN
cord-023095-4dannjjm	4250	9	are	be	VBP
cord-023095-4dannjjm	4250	10	thought	think	VBN
cord-023095-4dannjjm	4250	11	to	to	TO
cord-023095-4dannjjm	4250	12	inactivate	inactivate	VB
cord-023095-4dannjjm	4250	13	the	the	DT
cord-023095-4dannjjm	4250	14	lyophilized	lyophilize	VBN
cord-023095-4dannjjm	4250	15	bacteria	bacteria	NNS
cord-023095-4dannjjm	4250	16	within	within	IN
cord-023095-4dannjjm	4250	17	the	the	DT
cord-023095-4dannjjm	4250	18	product	product	NN
cord-023095-4dannjjm	4250	19	.	.	.
cord-023095-4dannjjm	4251	1	Therefore	therefore	RB
cord-023095-4dannjjm	4251	2	,	,	,
cord-023095-4dannjjm	4251	3	we	-PRON-	PRP
cord-023095-4dannjjm	4251	4	examined	examine	VBD
cord-023095-4dannjjm	4251	5	the	the	DT
cord-023095-4dannjjm	4251	6	ability	ability	NN
cord-023095-4dannjjm	4251	7	of	of	IN
cord-023095-4dannjjm	4251	8	foodsprinkled	foodsprinkled	NNP
cord-023095-4dannjjm	4251	9	Azodyl	Azodyl	NNP
cord-023095-4dannjjm	4251	10	to	to	TO
cord-023095-4dannjjm	4251	11	reduce	reduce	VB
cord-023095-4dannjjm	4251	12	azotemia	azotemia	NN
cord-023095-4dannjjm	4251	13	in	in	IN
cord-023095-4dannjjm	4251	14	cats	cat	NNS
cord-023095-4dannjjm	4251	15	with	with	IN
cord-023095-4dannjjm	4251	16	CKD	CKD	NNP
cord-023095-4dannjjm	4251	17	.	.	.
cord-023095-4dannjjm	4252	1	10	10	CD
cord-023095-4dannjjm	4252	2	cats	cat	NNS
cord-023095-4dannjjm	4252	3	with	with	IN
cord-023095-4dannjjm	4252	4	CKD	CKD	NNP
cord-023095-4dannjjm	4252	5	were	be	VBD
cord-023095-4dannjjm	4252	6	enrolled	enrol	VBN
cord-023095-4dannjjm	4252	7	in	in	IN
cord-023095-4dannjjm	4252	8	the	the	DT
cord-023095-4dannjjm	4252	9	study	study	NN
cord-023095-4dannjjm	4252	10	and	and	CC
cord-023095-4dannjjm	4252	11	randomized	randomize	VBD
cord-023095-4dannjjm	4252	12	receive	receive	VBP
cord-023095-4dannjjm	4252	13	Azodyl	Azodyl	NNP
cord-023095-4dannjjm	4252	14	or	or	CC
cord-023095-4dannjjm	4252	15	placebo	placebo	NN
cord-023095-4dannjjm	4252	16	.	.	.
cord-023095-4dannjjm	4253	1	Owners	owner	NNS
cord-023095-4dannjjm	4253	2	were	be	VBD
cord-023095-4dannjjm	4253	3	provided	provide	VBN
cord-023095-4dannjjm	4253	4	with	with	IN
cord-023095-4dannjjm	4253	5	3	3	CD
cord-023095-4dannjjm	4253	6	-	-	SYM
cord-023095-4dannjjm	4253	7	4	4	CD
cord-023095-4dannjjm	4253	8	capsules	capsule	NNS
cord-023095-4dannjjm	4253	9	of	of	IN
cord-023095-4dannjjm	4253	10	Azodyl	Azodyl	NNP
cord-023095-4dannjjm	4253	11	prior	prior	RB
cord-023095-4dannjjm	4253	12	to	to	IN
cord-023095-4dannjjm	4253	13	enrollment	enrollment	NN
cord-023095-4dannjjm	4253	14	to	to	TO
cord-023095-4dannjjm	4253	15	ensure	ensure	VB
cord-023095-4dannjjm	4253	16	compliance	compliance	NN
cord-023095-4dannjjm	4253	17	with	with	IN
cord-023095-4dannjjm	4253	18	administration	administration	NN
cord-023095-4dannjjm	4253	19	.	.	.
cord-023095-4dannjjm	4254	1	2	2	LS
cord-023095-4dannjjm	4254	2	baseline	baseline	JJ
cord-023095-4dannjjm	4254	3	blood	blood	NN
cord-023095-4dannjjm	4254	4	samples	sample	NNS
cord-023095-4dannjjm	4254	5	were	be	VBD
cord-023095-4dannjjm	4254	6	obtained	obtain	VBN
cord-023095-4dannjjm	4254	7	1	1	CD
cord-023095-4dannjjm	4254	8	month	month	NN
cord-023095-4dannjjm	4254	9	apart	apart	RB
cord-023095-4dannjjm	4254	10	,	,	,
cord-023095-4dannjjm	4254	11	and	and	CC
cord-023095-4dannjjm	4255	1	then	then	RB
cord-023095-4dannjjm	4255	2	1	1	CD
cord-023095-4dannjjm	4255	3	&	&	CC
cord-023095-4dannjjm	4255	4	2	2	CD
cord-023095-4dannjjm	4255	5	months	month	NNS
cord-023095-4dannjjm	4255	6	after	after	IN
cord-023095-4dannjjm	4255	7	beginning	begin	VBG
cord-023095-4dannjjm	4255	8	therapy	therapy	NN
cord-023095-4dannjjm	4255	9	.	.	.
cord-023095-4dannjjm	4256	1	Clinicians	clinician	NNS
cord-023095-4dannjjm	4256	2	and	and	CC
cord-023095-4dannjjm	4256	3	owners	owner	NNS
cord-023095-4dannjjm	4256	4	were	be	VBD
cord-023095-4dannjjm	4256	5	masked	mask	VBN
cord-023095-4dannjjm	4256	6	as	as	IN
cord-023095-4dannjjm	4256	7	to	to	IN
cord-023095-4dannjjm	4256	8	medication	medication	NN
cord-023095-4dannjjm	4256	9	assignment	assignment	NN
cord-023095-4dannjjm	4256	10	.	.	.
cord-023095-4dannjjm	4257	1	We	-PRON-	PRP
cord-023095-4dannjjm	4257	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	4257	3	that	that	IN
cord-023095-4dannjjm	4257	4	a	a	DT
cord-023095-4dannjjm	4257	5	30	30	CD
cord-023095-4dannjjm	4257	6	%	%	NN
cord-023095-4dannjjm	4257	7	decrease	decrease	NN
cord-023095-4dannjjm	4257	8	in	in	IN
cord-023095-4dannjjm	4257	9	BUN	bun	NN
cord-023095-4dannjjm	4257	10	and/or	and/or	CC
cord-023095-4dannjjm	4257	11	creat	creat	VB
cord-023095-4dannjjm	4257	12	in	in	IN
cord-023095-4dannjjm	4257	13	the	the	DT
cord-023095-4dannjjm	4257	14	Azodyl	Azodyl	NNP
cord-023095-4dannjjm	4257	15	group	group	NN
cord-023095-4dannjjm	4257	16	would	would	MD
cord-023095-4dannjjm	4257	17	be	be	VB
cord-023095-4dannjjm	4257	18	significant	significant	JJ
cord-023095-4dannjjm	4257	19	,	,	,
cord-023095-4dannjjm	4257	20	and	and	CC
cord-023095-4dannjjm	4257	21	set	set	VBD
cord-023095-4dannjjm	4257	22	a	a	DT
cord-023095-4dannjjm	4257	23	5	5	CD
cord-023095-4dannjjm	4257	24	0.2	0.2	CD
cord-023095-4dannjjm	4257	25	.	.	.
cord-023095-4dannjjm	4258	1	In	in	IN
cord-023095-4dannjjm	4258	2	order	order	NN
cord-023095-4dannjjm	4258	3	to	to	TO
cord-023095-4dannjjm	4258	4	maximize	maximize	VB
cord-023095-4dannjjm	4258	5	the	the	DT
cord-023095-4dannjjm	4258	6	probability	probability	NN
cord-023095-4dannjjm	4258	7	of	of	IN
cord-023095-4dannjjm	4258	8	detecting	detect	VBG
cord-023095-4dannjjm	4258	9	a	a	DT
cord-023095-4dannjjm	4258	10	difference	difference	NN
cord-023095-4dannjjm	4258	11	,	,	,
cord-023095-4dannjjm	4258	12	we	-PRON-	PRP
cord-023095-4dannjjm	4258	13	determined	determine	VBD
cord-023095-4dannjjm	4258	14	the	the	DT
cord-023095-4dannjjm	4258	15	%	%	NN
cord-023095-4dannjjm	4258	16	change	change	NN
cord-023095-4dannjjm	4258	17	as	as	IN
cord-023095-4dannjjm	4258	18	being	be	VBG
cord-023095-4dannjjm	4258	19	the	the	DT
cord-023095-4dannjjm	4258	20	difference	difference	NN
cord-023095-4dannjjm	4258	21	between	between	IN
cord-023095-4dannjjm	4258	22	the	the	DT
cord-023095-4dannjjm	4258	23	maximal	maximal	JJ
cord-023095-4dannjjm	4258	24	baseline	baseline	JJ
cord-023095-4dannjjm	4258	25	analyte	analyte	NN
cord-023095-4dannjjm	4258	26	concentration	concentration	NN
cord-023095-4dannjjm	4258	27	and	and	CC
cord-023095-4dannjjm	4258	28	minimal	minimal	JJ
cord-023095-4dannjjm	4258	29	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	4258	30	concentration	concentration	NN
cord-023095-4dannjjm	4258	31	.	.	.
cord-023095-4dannjjm	4259	1	We	-PRON-	PRP
cord-023095-4dannjjm	4259	2	compared	compare	VBD
cord-023095-4dannjjm	4259	3	the	the	DT
cord-023095-4dannjjm	4259	4	%	%	NN
cord-023095-4dannjjm	4259	5	change	change	NN
cord-023095-4dannjjm	4259	6	between	between	IN
cord-023095-4dannjjm	4259	7	groups	group	NNS
cord-023095-4dannjjm	4259	8	by	by	IN
cord-023095-4dannjjm	4259	9	Mann	Mann	NNP
cord-023095-4dannjjm	4259	10	-	-	HYPH
cord-023095-4dannjjm	4259	11	Whitney	Whitney	NNP
cord-023095-4dannjjm	4259	12	U	U	NNP
cord-023095-4dannjjm	4259	13	Test	Test	NNP
cord-023095-4dannjjm	4259	14	.	.	.
cord-023095-4dannjjm	4260	1	BUN	bun	NN
cord-023095-4dannjjm	4260	2	and	and	CC
cord-023095-4dannjjm	4260	3	creatinine	creatinine	NN
cord-023095-4dannjjm	4260	4	did	do	VBD
cord-023095-4dannjjm	4260	5	not	not	RB
cord-023095-4dannjjm	4260	6	differ	differ	VB
cord-023095-4dannjjm	4260	7	between	between	IN
cord-023095-4dannjjm	4260	8	groups	group	NNS
cord-023095-4dannjjm	4260	9	.	.	.
cord-023095-4dannjjm	4261	1	Based	base	VBN
cord-023095-4dannjjm	4261	2	on	on	IN
cord-023095-4dannjjm	4261	3	these	these	DT
cord-023095-4dannjjm	4261	4	results	result	NNS
cord-023095-4dannjjm	4261	5	,	,	,
cord-023095-4dannjjm	4261	6	Azodyl	Azodyl	NNP
cord-023095-4dannjjm	4261	7	,	,	,
cord-023095-4dannjjm	4261	8	applied	apply	VBN
cord-023095-4dannjjm	4261	9	by	by	IN
cord-023095-4dannjjm	4261	10	sprinkling	sprinkle	VBG
cord-023095-4dannjjm	4261	11	onto	onto	IN
cord-023095-4dannjjm	4261	12	food	food	NN
cord-023095-4dannjjm	4261	13	fails	fail	VBZ
cord-023095-4dannjjm	4261	14	to	to	TO
cord-023095-4dannjjm	4261	15	reduce	reduce	VB
cord-023095-4dannjjm	4261	16	azotemia	azotemia	NN
cord-023095-4dannjjm	4261	17	in	in	IN
cord-023095-4dannjjm	4261	18	cats	cat	NNS
cord-023095-4dannjjm	4261	19	with	with	IN
cord-023095-4dannjjm	4261	20	CKD	CKD	NNP
cord-023095-4dannjjm	4261	21	.	.	.
cord-023095-4dannjjm	4262	1	Whether	whether	IN
cord-023095-4dannjjm	4262	2	intact	intact	JJ
cord-023095-4dannjjm	4262	3	capsule	capsule	NN
cord-023095-4dannjjm	4262	4	administration	administration	NN
cord-023095-4dannjjm	4262	5	reduces	reduce	VBZ
cord-023095-4dannjjm	4262	6	azotemia	azotemia	NN
cord-023095-4dannjjm	4262	7	in	in	IN
cord-023095-4dannjjm	4262	8	cats	cat	NNS
cord-023095-4dannjjm	4262	9	with	with	IN
cord-023095-4dannjjm	4262	10	CKD	CKD	NNP
cord-023095-4dannjjm	4262	11	remains	remain	VBZ
cord-023095-4dannjjm	4262	12	unknown	unknown	JJ
cord-023095-4dannjjm	4262	13	.	.	.
cord-023095-4dannjjm	4263	1	Lower	low	JJR
cord-023095-4dannjjm	4263	2	urinary	urinary	JJ
cord-023095-4dannjjm	4263	3	tract	tract	NN
cord-023095-4dannjjm	4263	4	disease	disease	NN
cord-023095-4dannjjm	4263	5	(	(	-LRB-
cord-023095-4dannjjm	4263	6	LUTD	LUTD	NNP
cord-023095-4dannjjm	4263	7	)	)	-RRB-
cord-023095-4dannjjm	4263	8	occurs	occur	VBZ
cord-023095-4dannjjm	4263	9	commonly	commonly	RB
cord-023095-4dannjjm	4263	10	in	in	IN
cord-023095-4dannjjm	4263	11	cats	cat	NNS
cord-023095-4dannjjm	4263	12	,	,	,
cord-023095-4dannjjm	4263	13	and	and	CC
cord-023095-4dannjjm	4263	14	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	4263	15	cystitis	cystitis	NN
cord-023095-4dannjjm	4263	16	(	(	-LRB-
cord-023095-4dannjjm	4263	17	FIC	fic	NN
cord-023095-4dannjjm	4263	18	)	)	-RRB-
cord-023095-4dannjjm	4263	19	and	and	CC
cord-023095-4dannjjm	4263	20	urolithiasis	urolithiasis	NN
cord-023095-4dannjjm	4263	21	account	account	VBP
cord-023095-4dannjjm	4263	22	for	for	IN
cord-023095-4dannjjm	4263	23	over	over	IN
cord-023095-4dannjjm	4263	24	80	80	CD
cord-023095-4dannjjm	4263	25	%	%	NN
cord-023095-4dannjjm	4263	26	of	of	IN
cord-023095-4dannjjm	4263	27	cases	case	NNS
cord-023095-4dannjjm	4263	28	in	in	IN
cord-023095-4dannjjm	4263	29	cats	cat	NNS
cord-023095-4dannjjm	4263	30	less	less	JJR
cord-023095-4dannjjm	4263	31	than	than	IN
cord-023095-4dannjjm	4263	32	10	10	CD
cord-023095-4dannjjm	4263	33	years	year	NNS
cord-023095-4dannjjm	4263	34	of	of	IN
cord-023095-4dannjjm	4263	35	age	age	NN
cord-023095-4dannjjm	4263	36	.	.	.
cord-023095-4dannjjm	4264	1	Although	although	IN
cord-023095-4dannjjm	4264	2	several	several	JJ
cord-023095-4dannjjm	4264	3	strategies	strategy	NNS
cord-023095-4dannjjm	4264	4	have	have	VBP
cord-023095-4dannjjm	4264	5	been	be	VBN
cord-023095-4dannjjm	4264	6	recommended	recommend	VBN
cord-023095-4dannjjm	4264	7	,	,	,
cord-023095-4dannjjm	4264	8	a	a	DT
cord-023095-4dannjjm	4264	9	common	common	JJ
cord-023095-4dannjjm	4264	10	recommendation	recommendation	NN
cord-023095-4dannjjm	4264	11	is	be	VBZ
cord-023095-4dannjjm	4264	12	to	to	TO
cord-023095-4dannjjm	4264	13	induce	induce	VB
cord-023095-4dannjjm	4264	14	dilute	dilute	JJ
cord-023095-4dannjjm	4264	15	urine	urine	NN
cord-023095-4dannjjm	4264	16	resulting	result	VBG
cord-023095-4dannjjm	4264	17	in	in	IN
cord-023095-4dannjjm	4264	18	more	more	RBR
cord-023095-4dannjjm	4264	19	frequent	frequent	JJ
cord-023095-4dannjjm	4264	20	urination	urination	NN
cord-023095-4dannjjm	4264	21	and	and	CC
cord-023095-4dannjjm	4264	22	to	to	TO
cord-023095-4dannjjm	4264	23	dilute	dilute	VB
cord-023095-4dannjjm	4264	24	calculogenic	calculogenic	JJ
cord-023095-4dannjjm	4264	25	constituents	constituent	NNS
cord-023095-4dannjjm	4264	26	.	.	.
cord-023095-4dannjjm	4265	1	In	in	IN
cord-023095-4dannjjm	4265	2	addition	addition	NN
cord-023095-4dannjjm	4265	3	to	to	IN
cord-023095-4dannjjm	4265	4	conventional	conventional	JJ
cord-023095-4dannjjm	4265	5	therapy	therapy	NN
cord-023095-4dannjjm	4265	6	using	use	VBG
cord-023095-4dannjjm	4265	7	modified	modify	VBN
cord-023095-4dannjjm	4265	8	diets	diet	NNS
cord-023095-4dannjjm	4265	9	,	,	,
cord-023095-4dannjjm	4265	10	traditional	traditional	JJ
cord-023095-4dannjjm	4265	11	Chinese	chinese	JJ
cord-023095-4dannjjm	4265	12	and	and	CC
cord-023095-4dannjjm	4265	13	Western	western	JJ
cord-023095-4dannjjm	4265	14	herbs	herb	NNS
cord-023095-4dannjjm	4265	15	have	have	VBP
cord-023095-4dannjjm	4265	16	been	be	VBN
cord-023095-4dannjjm	4265	17	recommended	recommend	VBN
cord-023095-4dannjjm	4265	18	,	,	,
cord-023095-4dannjjm	4265	19	although	although	IN
cord-023095-4dannjjm	4265	20	only	only	RB
cord-023095-4dannjjm	4265	21	one	one	CD
cord-023095-4dannjjm	4265	22	,	,	,
cord-023095-4dannjjm	4265	23	chorieto	chorieto	NN
cord-023095-4dannjjm	4265	24	,	,	,
cord-023095-4dannjjm	4265	25	has	have	VBZ
cord-023095-4dannjjm	4265	26	published	publish	VBN
cord-023095-4dannjjm	4265	27	data	datum	NNS
cord-023095-4dannjjm	4265	28	.	.	.
cord-023095-4dannjjm	4266	1	We	-PRON-	PRP
cord-023095-4dannjjm	4266	2	evaluated	evaluate	VBD
cord-023095-4dannjjm	4266	3	3	3	CD
cord-023095-4dannjjm	4266	4	commonly	commonly	RB
cord-023095-4dannjjm	4266	5	used	use	VBN
cord-023095-4dannjjm	4266	6	herbal	herbal	JJ
cord-023095-4dannjjm	4266	7	treatments	treatment	NNS
cord-023095-4dannjjm	4266	8	recommended	recommend	VBN
cord-023095-4dannjjm	4266	9	for	for	IN
cord-023095-4dannjjm	4266	10	use	use	NN
cord-023095-4dannjjm	4266	11	in	in	IN
cord-023095-4dannjjm	4266	12	cats	cat	NNS
cord-023095-4dannjjm	4266	13	with	with	IN
cord-023095-4dannjjm	4266	14	LUTD	LUTD	NNP
cord-023095-4dannjjm	4266	15	including	include	VBG
cord-023095-4dannjjm	4266	16	(	(	-LRB-
cord-023095-4dannjjm	4266	17	1	1	CD
cord-023095-4dannjjm	4266	18	)	)	-RRB-
cord-023095-4dannjjm	4266	19	San	San	NNP
cord-023095-4dannjjm	4266	20	Ren	Ren	NNP
cord-023095-4dannjjm	4266	21	Tang	Tang	NNP
cord-023095-4dannjjm	4266	22	,	,	,
cord-023095-4dannjjm	4266	23	(	(	-LRB-
cord-023095-4dannjjm	4266	24	2	2	LS
cord-023095-4dannjjm	4266	25	)	)	-RRB-
cord-023095-4dannjjm	4267	1	Wei	Wei	NNP
cord-023095-4dannjjm	4267	2	Ling	Ling	NNP
cord-023095-4dannjjm	4267	3	Tang	Tang	NNP
cord-023095-4dannjjm	4267	4	,	,	,
cord-023095-4dannjjm	4267	5	and	and	CC
cord-023095-4dannjjm	4268	1	(	(	-LRB-
cord-023095-4dannjjm	4268	2	3	3	LS
cord-023095-4dannjjm	4268	3	)	)	-RRB-
cord-023095-4dannjjm	4268	4	Alisma	Alisma	NNP
cord-023095-4dannjjm	4268	5	.	.	.
cord-023095-4dannjjm	4269	1	We	-PRON-	PRP
cord-023095-4dannjjm	4269	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	4269	3	that	that	IN
cord-023095-4dannjjm	4269	4	these	these	DT
cord-023095-4dannjjm	4269	5	3	3	CD
cord-023095-4dannjjm	4269	6	Chinese	chinese	JJ
cord-023095-4dannjjm	4269	7	herbal	herbal	JJ
cord-023095-4dannjjm	4269	8	preparations	preparation	NNS
cord-023095-4dannjjm	4269	9	would	would	MD
cord-023095-4dannjjm	4269	10	induce	induce	VB
cord-023095-4dannjjm	4269	11	increased	increase	VBN
cord-023095-4dannjjm	4269	12	urine	urine	NN
cord-023095-4dannjjm	4269	13	volume	volume	NN
cord-023095-4dannjjm	4269	14	and	and	CC
cord-023095-4dannjjm	4269	15	decreased	decrease	VBD
cord-023095-4dannjjm	4269	16	urine	urine	NN
cord-023095-4dannjjm	4269	17	saturation	saturation	NN
cord-023095-4dannjjm	4269	18	for	for	IN
cord-023095-4dannjjm	4269	19	calcium	calcium	NN
cord-023095-4dannjjm	4269	20	oxalate	oxalate	NN
cord-023095-4dannjjm	4269	21	and	and	CC
cord-023095-4dannjjm	4269	22	struvite	struvite	NN
cord-023095-4dannjjm	4269	23	.	.	.
cord-023095-4dannjjm	4270	1	Six	six	CD
cord-023095-4dannjjm	4270	2	healthy	healthy	JJ
cord-023095-4dannjjm	4270	3	,	,	,
cord-023095-4dannjjm	4270	4	spayed	spayed	JJ
cord-023095-4dannjjm	4270	5	female	female	JJ
cord-023095-4dannjjm	4270	6	,	,	,
cord-023095-4dannjjm	4270	7	adult	adult	NN
cord-023095-4dannjjm	4270	8	cats	cat	NNS
cord-023095-4dannjjm	4270	9	were	be	VBD
cord-023095-4dannjjm	4270	10	evaluated	evaluate	VBN
cord-023095-4dannjjm	4270	11	in	in	IN
cord-023095-4dannjjm	4270	12	a	a	DT
cord-023095-4dannjjm	4270	13	placebocontrolled	placebocontrolled	JJ
cord-023095-4dannjjm	4270	14	,	,	,
cord-023095-4dannjjm	4270	15	randomized	randomized	JJ
cord-023095-4dannjjm	4270	16	,	,	,
cord-023095-4dannjjm	4270	17	cross	cross	JJ
cord-023095-4dannjjm	4270	18	-	-	HYPH
cord-023095-4dannjjm	4270	19	over	over	RP
cord-023095-4dannjjm	4270	20	design	design	NN
cord-023095-4dannjjm	4270	21	study	study	NN
cord-023095-4dannjjm	4270	22	.	.	.
cord-023095-4dannjjm	4271	1	Cats	cat	NNS
cord-023095-4dannjjm	4271	2	were	be	VBD
cord-023095-4dannjjm	4271	3	randomized	randomize	VBN
cord-023095-4dannjjm	4271	4	to	to	IN
cord-023095-4dannjjm	4271	5	1	1	CD
cord-023095-4dannjjm	4271	6	of	of	IN
cord-023095-4dannjjm	4271	7	4	4	CD
cord-023095-4dannjjm	4271	8	treatments	treatment	NNS
cord-023095-4dannjjm	4271	9	including	include	VBG
cord-023095-4dannjjm	4271	10	placebo	placebo	NN
cord-023095-4dannjjm	4271	11	(	(	-LRB-
cord-023095-4dannjjm	4271	12	P	p	NN
cord-023095-4dannjjm	4271	13	)	)	-RRB-
cord-023095-4dannjjm	4271	14	,	,	,
cord-023095-4dannjjm	4271	15	San	San	NNP
cord-023095-4dannjjm	4271	16	Ren	Ren	NNP
cord-023095-4dannjjm	4271	17	Tang	Tang	NNP
cord-023095-4dannjjm	4271	18	(	(	-LRB-
cord-023095-4dannjjm	4271	19	SRT	SRT	NNP
cord-023095-4dannjjm	4271	20	)	)	-RRB-
cord-023095-4dannjjm	4271	21	,	,	,
cord-023095-4dannjjm	4271	22	Wei	Wei	NNP
cord-023095-4dannjjm	4271	23	Ling	Ling	NNP
cord-023095-4dannjjm	4271	24	Tang	Tang	NNP
cord-023095-4dannjjm	4271	25	(	(	-LRB-
cord-023095-4dannjjm	4271	26	WLT	WLT	NNP
cord-023095-4dannjjm	4271	27	)	)	-RRB-
cord-023095-4dannjjm	4271	28	,	,	,
cord-023095-4dannjjm	4271	29	or	or	CC
cord-023095-4dannjjm	4271	30	Alisma	Alisma	NNP
cord-023095-4dannjjm	4271	31	(	(	-LRB-
cord-023095-4dannjjm	4271	32	A	a	NN
cord-023095-4dannjjm	4271	33	)	)	-RRB-
cord-023095-4dannjjm	4271	34	.	.	.
cord-023095-4dannjjm	4272	1	Treatment	treatment	NN
cord-023095-4dannjjm	4272	2	was	be	VBD
cord-023095-4dannjjm	4272	3	for	for	IN
cord-023095-4dannjjm	4272	4	2	2	CD
cord-023095-4dannjjm	4272	5	weeks	week	NNS
cord-023095-4dannjjm	4272	6	each	each	DT
cord-023095-4dannjjm	4272	7	with	with	IN
cord-023095-4dannjjm	4272	8	a	a	DT
cord-023095-4dannjjm	4272	9	1	1	CD
cord-023095-4dannjjm	4272	10	week	week	NN
cord-023095-4dannjjm	4272	11	washout	washout	NN
cord-023095-4dannjjm	4272	12	period	period	NN
cord-023095-4dannjjm	4272	13	between	between	IN
cord-023095-4dannjjm	4272	14	treatments	treatment	NNS
cord-023095-4dannjjm	4272	15	.	.	.
cord-023095-4dannjjm	4273	1	At	at	IN
cord-023095-4dannjjm	4273	2	end	end	NN
cord-023095-4dannjjm	4273	3	of	of	IN
cord-023095-4dannjjm	4273	4	each	each	DT
cord-023095-4dannjjm	4273	5	treatment	treatment	NN
cord-023095-4dannjjm	4273	6	period	period	NN
cord-023095-4dannjjm	4273	7	,	,	,
cord-023095-4dannjjm	4273	8	a	a	DT
cord-023095-4dannjjm	4273	9	24-hour	24-hour	JJ
cord-023095-4dannjjm	4273	10	urine	urine	NN
cord-023095-4dannjjm	4273	11	sample	sample	NN
cord-023095-4dannjjm	4273	12	was	be	VBD
cord-023095-4dannjjm	4273	13	collected	collect	VBN
cord-023095-4dannjjm	4273	14	using	use	VBG
cord-023095-4dannjjm	4273	15	modified	modify	VBN
cord-023095-4dannjjm	4273	16	litter	litter	NN
cord-023095-4dannjjm	4273	17	boxes	box	NNS
cord-023095-4dannjjm	4273	18	.	.	.
cord-023095-4dannjjm	4274	1	Urine	urine	NN
cord-023095-4dannjjm	4274	2	volume	volume	NN
cord-023095-4dannjjm	4274	3	and	and	CC
cord-023095-4dannjjm	4274	4	biochemistries	biochemistry	NNS
cord-023095-4dannjjm	4274	5	were	be	VBD
cord-023095-4dannjjm	4274	6	measured	measure	VBN
cord-023095-4dannjjm	4274	7	,	,	,
cord-023095-4dannjjm	4274	8	and	and	CC
cord-023095-4dannjjm	4274	9	urine	urine	NN
cord-023095-4dannjjm	4274	10	saturation	saturation	NN
cord-023095-4dannjjm	4274	11	for	for	IN
cord-023095-4dannjjm	4274	12	struvite	struvite	NN
cord-023095-4dannjjm	4274	13	and	and	CC
cord-023095-4dannjjm	4274	14	calcium	calcium	NN
cord-023095-4dannjjm	4274	15	oxalate	oxalate	NN
cord-023095-4dannjjm	4274	16	was	be	VBD
cord-023095-4dannjjm	4274	17	estimated	estimate	VBN
cord-023095-4dannjjm	4274	18	using	use	VBG
cord-023095-4dannjjm	4274	19	EQUIL	EQUIL	NNP
cord-023095-4dannjjm	4274	20	1.5b	1.5b	CD
cord-023095-4dannjjm	4274	21	.	.	.
cord-023095-4dannjjm	4275	1	Analysis	analysis	NN
cord-023095-4dannjjm	4275	2	of	of	IN
cord-023095-4dannjjm	4275	3	Variance	Variance	NNP
cord-023095-4dannjjm	4275	4	(	(	-LRB-
cord-023095-4dannjjm	4275	5	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	4275	6	)	)	-RRB-
cord-023095-4dannjjm	4275	7	was	be	VBD
cord-023095-4dannjjm	4275	8	used	use	VBN
cord-023095-4dannjjm	4275	9	to	to	TO
cord-023095-4dannjjm	4275	10	analyze	analyze	VB
cord-023095-4dannjjm	4275	11	data	datum	NNS
cord-023095-4dannjjm	4275	12	statistically	statistically	RB
cord-023095-4dannjjm	4275	13	if	if	IN
cord-023095-4dannjjm	4275	14	distributed	distribute	VBN
cord-023095-4dannjjm	4275	15	normally	normally	RB
cord-023095-4dannjjm	4275	16	and	and	CC
cord-023095-4dannjjm	4275	17	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	4275	18	-	-	HYPH
cord-023095-4dannjjm	4275	19	Wallis	Wallis	NNP
cord-023095-4dannjjm	4275	20	was	be	VBD
cord-023095-4dannjjm	4275	21	used	use	VBN
cord-023095-4dannjjm	4275	22	to	to	TO
cord-023095-4dannjjm	4275	23	analyze	analyze	VB
cord-023095-4dannjjm	4275	24	data	datum	NNS
cord-023095-4dannjjm	4275	25	statistically	statistically	RB
cord-023095-4dannjjm	4275	26	if	if	IN
cord-023095-4dannjjm	4275	27	data	datum	NNS
cord-023095-4dannjjm	4275	28	were	be	VBD
cord-023095-4dannjjm	4275	29	not	not	RB
cord-023095-4dannjjm	4275	30	distributed	distribute	VBN
cord-023095-4dannjjm	4275	31	normally	normally	RB
cord-023095-4dannjjm	4275	32	.	.	.
cord-023095-4dannjjm	4276	1	A	a	DT
cord-023095-4dannjjm	4276	2	p	p	NN
cord-023095-4dannjjm	4276	3	o	o	NN
cord-023095-4dannjjm	4276	4	0.05	0.05	CD
cord-023095-4dannjjm	4276	5	was	be	VBD
cord-023095-4dannjjm	4276	6	considered	consider	VBN
cord-023095-4dannjjm	4276	7	significant	significant	JJ
cord-023095-4dannjjm	4276	8	.	.	.
cord-023095-4dannjjm	4277	1	Body	body	NN
cord-023095-4dannjjm	4277	2	weights	weight	NNS
cord-023095-4dannjjm	4277	3	were	be	VBD
cord-023095-4dannjjm	4277	4	not	not	RB
cord-023095-4dannjjm	4277	5	different	different	JJ
cord-023095-4dannjjm	4277	6	between	between	IN
cord-023095-4dannjjm	4277	7	treatments	treatment	NNS
cord-023095-4dannjjm	4277	8	.	.	.
cord-023095-4dannjjm	4278	1	No	no	DT
cord-023095-4dannjjm	4278	2	differences	difference	NNS
cord-023095-4dannjjm	4278	3	were	be	VBD
cord-023095-4dannjjm	4278	4	found	find	VBN
cord-023095-4dannjjm	4278	5	in	in	IN
cord-023095-4dannjjm	4278	6	24-hour	24-hour	JJ
cord-023095-4dannjjm	4278	7	urinary	urinary	JJ
cord-023095-4dannjjm	4278	8	analyte	analyte	NN
cord-023095-4dannjjm	4278	9	excretions	excretion	NNS
cord-023095-4dannjjm	4278	10	,	,	,
cord-023095-4dannjjm	4278	11	24-hour	24-hour	JJ
cord-023095-4dannjjm	4278	12	urine	urine	NN
cord-023095-4dannjjm	4278	13	volume	volume	NN
cord-023095-4dannjjm	4278	14	,	,	,
cord-023095-4dannjjm	4278	15	urine	urine	NN
cord-023095-4dannjjm	4278	16	pH	ph	NN
cord-023095-4dannjjm	4278	17	,	,	,
cord-023095-4dannjjm	4278	18	or	or	CC
cord-023095-4dannjjm	4278	19	24-hour	24-hour	JJ
cord-023095-4dannjjm	4278	20	urinary	urinary	JJ
cord-023095-4dannjjm	4278	21	saturation	saturation	NN
cord-023095-4dannjjm	4278	22	for	for	IN
cord-023095-4dannjjm	4278	23	calcium	calcium	NN
cord-023095-4dannjjm	4278	24	oxalate	oxalate	NN
cord-023095-4dannjjm	4278	25	or	or	CC
cord-023095-4dannjjm	4278	26	struvite	struvite	NN
cord-023095-4dannjjm	4278	27	between	between	IN
cord-023095-4dannjjm	4278	28	treatments	treatment	NNS
cord-023095-4dannjjm	4278	29	(	(	-LRB-
cord-023095-4dannjjm	4278	30	Table	table	NN
cord-023095-4dannjjm	4278	31	)	)	-RRB-
cord-023095-4dannjjm	4278	32	.	.	.
cord-023095-4dannjjm	4279	1	Urolithiasis	Urolithiasis	NNP
cord-023095-4dannjjm	4279	2	is	be	VBZ
cord-023095-4dannjjm	4279	3	a	a	DT
cord-023095-4dannjjm	4279	4	multifactorial	multifactorial	JJ
cord-023095-4dannjjm	4279	5	disease	disease	NN
cord-023095-4dannjjm	4279	6	,	,	,
cord-023095-4dannjjm	4279	7	frequent	frequent	JJ
cord-023095-4dannjjm	4279	8	and	and	CC
cord-023095-4dannjjm	4279	9	recurrent	recurrent	JJ
cord-023095-4dannjjm	4279	10	in	in	IN
cord-023095-4dannjjm	4279	11	dogs	dog	NNS
cord-023095-4dannjjm	4279	12	in	in	IN
cord-023095-4dannjjm	4279	13	the	the	DT
cord-023095-4dannjjm	4279	14	worldwide	worldwide	NN
cord-023095-4dannjjm	4279	15	,	,	,
cord-023095-4dannjjm	4279	16	in	in	IN
cord-023095-4dannjjm	4279	17	which	which	WDT
cord-023095-4dannjjm	4279	18	breed	breed	NN
cord-023095-4dannjjm	4279	19	,	,	,
cord-023095-4dannjjm	4279	20	sex	sex	NN
cord-023095-4dannjjm	4279	21	,	,	,
cord-023095-4dannjjm	4279	22	age	age	NN
cord-023095-4dannjjm	4279	23	,	,	,
cord-023095-4dannjjm	4279	24	diet	diet	NN
cord-023095-4dannjjm	4279	25	,	,	,
cord-023095-4dannjjm	4279	26	some	some	DT
cord-023095-4dannjjm	4279	27	anatomical	anatomical	JJ
cord-023095-4dannjjm	4279	28	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4279	29	,	,	,
cord-023095-4dannjjm	4279	30	urinary	urinary	JJ
cord-023095-4dannjjm	4279	31	tract	tract	NN
cord-023095-4dannjjm	4279	32	infection	infection	NN
cord-023095-4dannjjm	4279	33	,	,	,
cord-023095-4dannjjm	4279	34	urine	urine	NN
cord-023095-4dannjjm	4279	35	pH	ph	NN
cord-023095-4dannjjm	4279	36	and	and	CC
cord-023095-4dannjjm	4279	37	some	some	DT
cord-023095-4dannjjm	4279	38	geographical	geographical	JJ
cord-023095-4dannjjm	4279	39	and	and	CC
cord-023095-4dannjjm	4279	40	hereditary	hereditary	JJ
cord-023095-4dannjjm	4279	41	features	feature	NNS
cord-023095-4dannjjm	4279	42	in	in	IN
cord-023095-4dannjjm	4279	43	the	the	DT
cord-023095-4dannjjm	4279	44	populations	population	NNS
cord-023095-4dannjjm	4279	45	studied	study	VBN
cord-023095-4dannjjm	4279	46	have	have	VBP
cord-023095-4dannjjm	4279	47	been	be	VBN
cord-023095-4dannjjm	4279	48	implicated	implicate	VBN
cord-023095-4dannjjm	4279	49	as	as	IN
cord-023095-4dannjjm	4279	50	risk	risk	NN
cord-023095-4dannjjm	4279	51	factors	factor	NNS
cord-023095-4dannjjm	4279	52	.	.	.
cord-023095-4dannjjm	4280	1	The	the	DT
cord-023095-4dannjjm	4280	2	effective	effective	JJ
cord-023095-4dannjjm	4280	3	long	long	JJ
cord-023095-4dannjjm	4280	4	-	-	HYPH
cord-023095-4dannjjm	4280	5	term	term	NN
cord-023095-4dannjjm	4280	6	management	management	NN
cord-023095-4dannjjm	4280	7	of	of	IN
cord-023095-4dannjjm	4280	8	urolithiasis	urolithiasis	NN
cord-023095-4dannjjm	4280	9	depends	depend	VBZ
cord-023095-4dannjjm	4280	10	on	on	IN
cord-023095-4dannjjm	4280	11	identification	identification	NN
cord-023095-4dannjjm	4280	12	and	and	CC
cord-023095-4dannjjm	4280	13	control	control	NN
cord-023095-4dannjjm	4280	14	of	of	IN
cord-023095-4dannjjm	4280	15	the	the	DT
cord-023095-4dannjjm	4280	16	pathophysiological	pathophysiological	JJ
cord-023095-4dannjjm	4280	17	mechanisms	mechanism	NNS
cord-023095-4dannjjm	4280	18	involved	involve	VBN
cord-023095-4dannjjm	4280	19	,	,	,
cord-023095-4dannjjm	4280	20	which	which	WDT
cord-023095-4dannjjm	4280	21	,	,	,
cord-023095-4dannjjm	4280	22	in	in	IN
cord-023095-4dannjjm	4280	23	turn	turn	NN
cord-023095-4dannjjm	4280	24	,	,	,
cord-023095-4dannjjm	4280	25	depend	depend	VB
cord-023095-4dannjjm	4280	26	on	on	IN
cord-023095-4dannjjm	4280	27	accurate	accurate	JJ
cord-023095-4dannjjm	4280	28	knowledge	knowledge	NN
cord-023095-4dannjjm	4280	29	of	of	IN
cord-023095-4dannjjm	4280	30	the	the	DT
cord-023095-4dannjjm	4280	31	mineral	mineral	NN
cord-023095-4dannjjm	4280	32	composition	composition	NN
cord-023095-4dannjjm	4280	33	of	of	IN
cord-023095-4dannjjm	4280	34	the	the	DT
cord-023095-4dannjjm	4280	35	uroliths	urolith	NNS
cord-023095-4dannjjm	4280	36	.	.	.
cord-023095-4dannjjm	4281	1	The	the	DT
cord-023095-4dannjjm	4281	2	aim	aim	NN
cord-023095-4dannjjm	4281	3	of	of	IN
cord-023095-4dannjjm	4281	4	this	this	DT
cord-023095-4dannjjm	4281	5	study	study	NN
cord-023095-4dannjjm	4281	6	was	be	VBD
cord-023095-4dannjjm	4281	7	to	to	TO
cord-023095-4dannjjm	4281	8	determine	determine	VB
cord-023095-4dannjjm	4281	9	for	for	IN
cord-023095-4dannjjm	4281	10	first	first	JJ
cord-023095-4dannjjm	4281	11	occasion	occasion	NN
cord-023095-4dannjjm	4281	12	the	the	DT
cord-023095-4dannjjm	4281	13	main	main	JJ
cord-023095-4dannjjm	4281	14	epidemiological	epidemiological	JJ
cord-023095-4dannjjm	4281	15	data	datum	NNS
cord-023095-4dannjjm	4281	16	of	of	IN
cord-023095-4dannjjm	4281	17	canine	canine	JJ
cord-023095-4dannjjm	4281	18	urolithiasis	urolithiasis	NN
cord-023095-4dannjjm	4281	19	in	in	IN
cord-023095-4dannjjm	4281	20	Mexico	Mexico	NNP
cord-023095-4dannjjm	4281	21	.	.	.
cord-023095-4dannjjm	4282	1	This	this	DT
cord-023095-4dannjjm	4282	2	study	study	NN
cord-023095-4dannjjm	4282	3	was	be	VBD
cord-023095-4dannjjm	4282	4	developed	develop	VBN
cord-023095-4dannjjm	4282	5	with	with	IN
cord-023095-4dannjjm	4282	6	491	491	CD
cord-023095-4dannjjm	4282	7	dogs	dog	NNS
cord-023095-4dannjjm	4282	8	with	with	IN
cord-023095-4dannjjm	4282	9	urolithiasis	urolithiasis	NN
cord-023095-4dannjjm	4282	10	from	from	IN
cord-023095-4dannjjm	4282	11	25	25	CD
cord-023095-4dannjjm	4282	12	of	of	IN
cord-023095-4dannjjm	4282	13	the	the	DT
cord-023095-4dannjjm	4282	14	33	33	CD
cord-023095-4dannjjm	4282	15	states	state	NNS
cord-023095-4dannjjm	4282	16	of	of	IN
cord-023095-4dannjjm	4282	17	the	the	DT
cord-023095-4dannjjm	4282	18	country	country	NN
cord-023095-4dannjjm	4282	19	.	.	.
cord-023095-4dannjjm	4283	1	Chemical	chemical	JJ
cord-023095-4dannjjm	4283	2	composition	composition	NN
cord-023095-4dannjjm	4283	3	of	of	IN
cord-023095-4dannjjm	4283	4	the	the	DT
cord-023095-4dannjjm	4283	5	uroliths	urolith	NNS
cord-023095-4dannjjm	4283	6	was	be	VBD
cord-023095-4dannjjm	4283	7	determined	determine	VBN
cord-023095-4dannjjm	4283	8	by	by	IN
cord-023095-4dannjjm	4283	9	stereoscopic	stereoscopic	JJ
cord-023095-4dannjjm	4283	10	microscopy	microscopy	NNS
cord-023095-4dannjjm	4283	11	,	,	,
cord-023095-4dannjjm	4283	12	infrared	infrared	JJ
cord-023095-4dannjjm	4283	13	spectroscopy	spectroscopy	NN
cord-023095-4dannjjm	4283	14	,	,	,
cord-023095-4dannjjm	4283	15	scanning	scanning	NN
cord-023095-4dannjjm	4283	16	electron	electron	NN
cord-023095-4dannjjm	4283	17	microscopy	microscopy	NN
cord-023095-4dannjjm	4283	18	and	and	CC
cord-023095-4dannjjm	4283	19	X	x	NN
cord-023095-4dannjjm	4283	20	-	-	NN
cord-023095-4dannjjm	4283	21	ray	ray	NN
cord-023095-4dannjjm	4283	22	microanalysis	microanalysis	NN
cord-023095-4dannjjm	4283	23	.	.	.
cord-023095-4dannjjm	4284	1	Urolithiasis	urolithiasis	NN
cord-023095-4dannjjm	4284	2	affected	affect	VBD
cord-023095-4dannjjm	4284	3	nearly	nearly	RB
cord-023095-4dannjjm	4284	4	the	the	DT
cord-023095-4dannjjm	4284	5	same	same	JJ
cord-023095-4dannjjm	4284	6	number	number	NN
cord-023095-4dannjjm	4284	7	of	of	IN
cord-023095-4dannjjm	4284	8	males	male	NNS
cord-023095-4dannjjm	4284	9	and	and	CC
cord-023095-4dannjjm	4284	10	females	female	NNS
cord-023095-4dannjjm	4284	11	;	;	:
cord-023095-4dannjjm	4284	12	with	with	IN
cord-023095-4dannjjm	4284	13	ages	age	NNS
cord-023095-4dannjjm	4284	14	ranging	range	VBG
cord-023095-4dannjjm	4284	15	from	from	IN
cord-023095-4dannjjm	4284	16	two	two	CD
cord-023095-4dannjjm	4284	17	months	month	NNS
cord-023095-4dannjjm	4284	18	to	to	IN
cord-023095-4dannjjm	4284	19	15	15	CD
cord-023095-4dannjjm	4284	20	years	year	NNS
cord-023095-4dannjjm	4284	21	with	with	IN
cord-023095-4dannjjm	4284	22	a	a	DT
cord-023095-4dannjjm	4284	23	median	median	JJ
cord-023095-4dannjjm	4284	24	age	age	NN
cord-023095-4dannjjm	4284	25	of	of	IN
cord-023095-4dannjjm	4284	26	5	5	CD
cord-023095-4dannjjm	4284	27	years	year	NNS
cord-023095-4dannjjm	4284	28	.	.	.
cord-023095-4dannjjm	4285	1	Adult	adult	NN
cord-023095-4dannjjm	4285	2	animals	animal	NNS
cord-023095-4dannjjm	4285	3	were	be	VBD
cord-023095-4dannjjm	4285	4	the	the	DT
cord-023095-4dannjjm	4285	5	most	most	RBS
cord-023095-4dannjjm	4285	6	affected	affected	JJ
cord-023095-4dannjjm	4285	7	.	.	.
cord-023095-4dannjjm	4286	1	Breeds	breed	NNS
cord-023095-4dannjjm	4286	2	more	more	RBR
cord-023095-4dannjjm	4286	3	affected	affected	JJ
cord-023095-4dannjjm	4286	4	were	be	VBD
cord-023095-4dannjjm	4286	5	Schnauzer	Schnauzer	NNP
cord-023095-4dannjjm	4286	6	miniature	miniature	NN
cord-023095-4dannjjm	4286	7	,	,	,
cord-023095-4dannjjm	4286	8	Poodle	Poodle	NNP
cord-023095-4dannjjm	4286	9	,	,	,
cord-023095-4dannjjm	4286	10	Dalmatian	Dalmatian	NNP
cord-023095-4dannjjm	4286	11	,	,	,
cord-023095-4dannjjm	4286	12	Yorkshire	Yorkshire	NNP
cord-023095-4dannjjm	4286	13	terrier	terrier	NN
cord-023095-4dannjjm	4286	14	,	,	,
cord-023095-4dannjjm	4286	15	Scottish	scottish	JJ
cord-023095-4dannjjm	4286	16	terrier	terrier	NN
cord-023095-4dannjjm	4286	17	,	,	,
cord-023095-4dannjjm	4286	18	Chihuahua	Chihuahua	NNP
cord-023095-4dannjjm	4286	19	and	and	CC
cord-023095-4dannjjm	4286	20	Bichon	Bichon	NNP
cord-023095-4dannjjm	4286	21	frisee	frisee	NNP
cord-023095-4dannjjm	4286	22	´	´	CD
cord-023095-4dannjjm	4286	23	.	.	.
cord-023095-4dannjjm	4287	1	Uroliths	Uroliths	NNP
cord-023095-4dannjjm	4287	2	were	be	VBD
cord-023095-4dannjjm	4287	3	found	find	VBN
cord-023095-4dannjjm	4287	4	in	in	IN
cord-023095-4dannjjm	4287	5	the	the	DT
cord-023095-4dannjjm	4287	6	lower	low	JJR
cord-023095-4dannjjm	4287	7	urinary	urinary	JJ
cord-023095-4dannjjm	4287	8	tract	tract	NN
cord-023095-4dannjjm	4287	9	in	in	IN
cord-023095-4dannjjm	4287	10	97.74	97.74	CD
cord-023095-4dannjjm	4287	11	%	%	NN
cord-023095-4dannjjm	4287	12	of	of	IN
cord-023095-4dannjjm	4287	13	the	the	DT
cord-023095-4dannjjm	4287	14	cases	case	NNS
cord-023095-4dannjjm	4287	15	.	.	.
cord-023095-4dannjjm	4288	1	Mineral	mineral	NN
cord-023095-4dannjjm	4288	2	composition	composition	NN
cord-023095-4dannjjm	4288	3	of	of	IN
cord-023095-4dannjjm	4288	4	the	the	DT
cord-023095-4dannjjm	4288	5	uroliths	urolith	NNS
cord-023095-4dannjjm	4288	6	was	be	VBD
cord-023095-4dannjjm	4288	7	:	:	:
cord-023095-4dannjjm	4288	8	Struvite	Struvite	NNP
cord-023095-4dannjjm	4288	9	49.69	49.69	CD
cord-023095-4dannjjm	4288	10	%	%	NN
cord-023095-4dannjjm	4288	11	,	,	,
cord-023095-4dannjjm	4288	12	followed	follow	VBN
cord-023095-4dannjjm	4288	13	by	by	IN
cord-023095-4dannjjm	4288	14	calcium	calcium	NN
cord-023095-4dannjjm	4288	15	oxalate	oxalate	NN
cord-023095-4dannjjm	4288	16	25.46	25.46	CD
cord-023095-4dannjjm	4288	17	%	%	NN
cord-023095-4dannjjm	4288	18	,	,	,
cord-023095-4dannjjm	4288	19	purines	purine	NNS
cord-023095-4dannjjm	4288	20	7.13	7.13	CD
cord-023095-4dannjjm	4288	21	%	%	NN
cord-023095-4dannjjm	4288	22	,	,	,
cord-023095-4dannjjm	4288	23	silicate	silicate	NN
cord-023095-4dannjjm	4288	24	6.72	6.72	CD
cord-023095-4dannjjm	4288	25	%	%	NN
cord-023095-4dannjjm	4288	26	,	,	,
cord-023095-4dannjjm	4288	27	others	other	NNS
cord-023095-4dannjjm	4288	28	0.20	0.20	CD
cord-023095-4dannjjm	4288	29	%	%	NN
cord-023095-4dannjjm	4288	30	,	,	,
cord-023095-4dannjjm	4288	31	mixed	mixed	JJ
cord-023095-4dannjjm	4288	32	8.15	8.15	CD
cord-023095-4dannjjm	4288	33	%	%	NN
cord-023095-4dannjjm	4288	34	and	and	CC
cord-023095-4dannjjm	4288	35	compound	compound	NN
cord-023095-4dannjjm	4288	36	uroliths	uroliths	JJ
cord-023095-4dannjjm	4288	37	2.44	2.44	CD
cord-023095-4dannjjm	4288	38	%	%	NN
cord-023095-4dannjjm	4288	39	.	.	.
cord-023095-4dannjjm	4289	1	Struvite	Struvite	NNP
cord-023095-4dannjjm	4289	2	uroliths	uroliths	NN
cord-023095-4dannjjm	4289	3	affected	affect	VBD
cord-023095-4dannjjm	4289	4	females	female	NNS
cord-023095-4dannjjm	4289	5	in	in	IN
cord-023095-4dannjjm	4289	6	most	most	JJS
cord-023095-4dannjjm	4289	7	cases	case	NNS
cord-023095-4dannjjm	4289	8	,	,	,
cord-023095-4dannjjm	4289	9	whereas	whereas	IN
cord-023095-4dannjjm	4289	10	calcium	calcium	NN
cord-023095-4dannjjm	4289	11	oxalate	oxalate	NN
cord-023095-4dannjjm	4289	12	,	,	,
cord-023095-4dannjjm	4289	13	purines	purine	NNS
cord-023095-4dannjjm	4289	14	and	and	CC
cord-023095-4dannjjm	4289	15	silicate	silicate	NN
cord-023095-4dannjjm	4289	16	uroliths	urolith	NNS
cord-023095-4dannjjm	4289	17	,	,	,
cord-023095-4dannjjm	4289	18	were	be	VBD
cord-023095-4dannjjm	4289	19	mainly	mainly	RB
cord-023095-4dannjjm	4289	20	observed	observe	VBN
cord-023095-4dannjjm	4289	21	in	in	IN
cord-023095-4dannjjm	4289	22	males	male	NNS
cord-023095-4dannjjm	4289	23	.	.	.
cord-023095-4dannjjm	4290	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	4290	2	results	result	NNS
cord-023095-4dannjjm	4290	3	are	be	VBP
cord-023095-4dannjjm	4290	4	similar	similar	JJ
cord-023095-4dannjjm	4290	5	to	to	IN
cord-023095-4dannjjm	4290	6	studies	study	NNS
cord-023095-4dannjjm	4290	7	developed	develop	VBN
cord-023095-4dannjjm	4290	8	in	in	IN
cord-023095-4dannjjm	4290	9	other	other	JJ
cord-023095-4dannjjm	4290	10	countries	country	NNS
cord-023095-4dannjjm	4290	11	and	and	CC
cord-023095-4dannjjm	4290	12	continents	continent	NNS
cord-023095-4dannjjm	4290	13	,	,	,
cord-023095-4dannjjm	4290	14	though	though	IN
cord-023095-4dannjjm	4290	15	we	-PRON-	PRP
cord-023095-4dannjjm	4290	16	found	find	VBD
cord-023095-4dannjjm	4290	17	a	a	DT
cord-023095-4dannjjm	4290	18	higher	high	JJR
cord-023095-4dannjjm	4290	19	frequency	frequency	NN
cord-023095-4dannjjm	4290	20	of	of	IN
cord-023095-4dannjjm	4290	21	uroliths	uroliths	JJ
cord-023095-4dannjjm	4290	22	containing	contain	VBG
cord-023095-4dannjjm	4290	23	silicate	silicate	NN
cord-023095-4dannjjm	4290	24	,	,	,
cord-023095-4dannjjm	4290	25	either	either	CC
cord-023095-4dannjjm	4290	26	pure	pure	JJ
cord-023095-4dannjjm	4290	27	,	,	,
cord-023095-4dannjjm	4290	28	mixed	mixed	JJ
cord-023095-4dannjjm	4290	29	or	or	CC
cord-023095-4dannjjm	4290	30	compounds	compound	NNS
cord-023095-4dannjjm	4290	31	uroliths	uroliths	JJ
cord-023095-4dannjjm	4290	32	(	(	-LRB-
cord-023095-4dannjjm	4290	33	10.79	10.79	CD
cord-023095-4dannjjm	4290	34	%	%	NN
cord-023095-4dannjjm	4290	35	)	)	-RRB-
cord-023095-4dannjjm	4290	36	;	;	:
cord-023095-4dannjjm	4290	37	in	in	IN
cord-023095-4dannjjm	4290	38	Mexico	Mexico	NNP
cord-023095-4dannjjm	4290	39	City	City	NNP
cord-023095-4dannjjm	4290	40	the	the	DT
cord-023095-4dannjjm	4290	41	frequency	frequency	NN
cord-023095-4dannjjm	4290	42	reached	reach	VBD
cord-023095-4dannjjm	4290	43	15	15	CD
cord-023095-4dannjjm	4290	44	%	%	NN
cord-023095-4dannjjm	4290	45	.	.	.
cord-023095-4dannjjm	4291	1	This	this	DT
cord-023095-4dannjjm	4291	2	high	high	JJ
cord-023095-4dannjjm	4291	3	frequency	frequency	NN
cord-023095-4dannjjm	4291	4	may	may	MD
cord-023095-4dannjjm	4291	5	be	be	VB
cord-023095-4dannjjm	4291	6	due	due	JJ
cord-023095-4dannjjm	4291	7	to	to	IN
cord-023095-4dannjjm	4291	8	high	high	JJ
cord-023095-4dannjjm	4291	9	consumption	consumption	NN
cord-023095-4dannjjm	4291	10	of	of	IN
cord-023095-4dannjjm	4291	11	silicate	silicate	NN
cord-023095-4dannjjm	4291	12	in	in	IN
cord-023095-4dannjjm	4291	13	home	home	NN
cord-023095-4dannjjm	4291	14	-	-	HYPH
cord-023095-4dannjjm	4291	15	made	make	VBN
cord-023095-4dannjjm	4291	16	food	food	NN
cord-023095-4dannjjm	4291	17	or	or	CC
cord-023095-4dannjjm	4291	18	in	in	IN
cord-023095-4dannjjm	4291	19	the	the	DT
cord-023095-4dannjjm	4291	20	groundwater	groundwater	NN
cord-023095-4dannjjm	4291	21	derived	derive	VBN
cord-023095-4dannjjm	4291	22	from	from	IN
cord-023095-4dannjjm	4291	23	aquifers	aquifer	NNS
cord-023095-4dannjjm	4291	24	.	.	.
cord-023095-4dannjjm	4292	1	Acknowledgments	acknowledgment	NNS
cord-023095-4dannjjm	4292	2	:	:	:
cord-023095-4dannjjm	4292	3	This	this	DT
cord-023095-4dannjjm	4292	4	work	work	NN
cord-023095-4dannjjm	4292	5	has	have	VBZ
cord-023095-4dannjjm	4292	6	been	be	VBN
cord-023095-4dannjjm	4292	7	partially	partially	RB
cord-023095-4dannjjm	4292	8	supported	support	VBN
cord-023095-4dannjjm	4292	9	by	by	IN
cord-023095-4dannjjm	4292	10	a	a	DT
cord-023095-4dannjjm	4292	11	project	project	NN
cord-023095-4dannjjm	4292	12	of	of	IN
cord-023095-4dannjjm	4292	13	Waltham	Waltham	NNP
cord-023095-4dannjjm	4292	14	Foundation	Foundation	NNP
cord-023095-4dannjjm	4292	15	in	in	IN
cord-023095-4dannjjm	4292	16	Mexico	Mexico	NNP
cord-023095-4dannjjm	4292	17	and	and	CC
cord-023095-4dannjjm	4292	18	the	the	DT
cord-023095-4dannjjm	4292	19	Consejo	Consejo	NNP
cord-023095-4dannjjm	4292	20	Nacional	Nacional	NNP
cord-023095-4dannjjm	4292	21	de	de	NNP
cord-023095-4dannjjm	4292	22	Ciencia	Ciencia	NNP
cord-023095-4dannjjm	4292	23	y	y	NNP
cord-023095-4dannjjm	4292	24	Tecnologı´a	Tecnologı´a	NNP
cord-023095-4dannjjm	4292	25	(	(	-LRB-
cord-023095-4dannjjm	4292	26	CONACyT	CONACyT	NNP
cord-023095-4dannjjm	4292	27	)	)	-RRB-
cord-023095-4dannjjm	4292	28	of	of	IN
cord-023095-4dannjjm	4292	29	Mexico	Mexico	NNP
cord-023095-4dannjjm	4292	30	.	.	.
cord-023095-4dannjjm	4293	1	Voiding	void	VBG
cord-023095-4dannjjm	4293	2	urohydropropulsion	urohydropropulsion	NN
cord-023095-4dannjjm	4293	3	is	be	VBZ
cord-023095-4dannjjm	4293	4	a	a	DT
cord-023095-4dannjjm	4293	5	non	non	JJ
cord-023095-4dannjjm	4293	6	-	-	JJ
cord-023095-4dannjjm	4293	7	invasive	invasive	JJ
cord-023095-4dannjjm	4293	8	method	method	NN
cord-023095-4dannjjm	4293	9	for	for	IN
cord-023095-4dannjjm	4293	10	removing	remove	VBG
cord-023095-4dannjjm	4293	11	small	small	JJ
cord-023095-4dannjjm	4293	12	urocystoliths	urocystolith	NNS
cord-023095-4dannjjm	4293	13	from	from	IN
cord-023095-4dannjjm	4293	14	the	the	DT
cord-023095-4dannjjm	4293	15	dog	dog	NN
cord-023095-4dannjjm	4293	16	,	,	,
cord-023095-4dannjjm	4293	17	most	most	RBS
cord-023095-4dannjjm	4293	18	commonly	commonly	RB
cord-023095-4dannjjm	4293	19	used	use	VBN
cord-023095-4dannjjm	4293	20	in	in	IN
cord-023095-4dannjjm	4293	21	females	female	NNS
cord-023095-4dannjjm	4293	22	due	due	JJ
cord-023095-4dannjjm	4293	23	to	to	IN
cord-023095-4dannjjm	4293	24	the	the	DT
cord-023095-4dannjjm	4293	25	relatively	relatively	RB
cord-023095-4dannjjm	4293	26	wider	wide	JJR
cord-023095-4dannjjm	4293	27	and	and	CC
cord-023095-4dannjjm	4293	28	shorter	short	JJR
cord-023095-4dannjjm	4293	29	urethra	urethra	NN
cord-023095-4dannjjm	4293	30	.	.	.
cord-023095-4dannjjm	4294	1	This	this	DT
cord-023095-4dannjjm	4294	2	procedure	procedure	NN
cord-023095-4dannjjm	4294	3	is	be	VBZ
cord-023095-4dannjjm	4294	4	typically	typically	RB
cord-023095-4dannjjm	4294	5	performed	perform	VBN
cord-023095-4dannjjm	4294	6	under	under	IN
cord-023095-4dannjjm	4294	7	general	general	JJ
cord-023095-4dannjjm	4294	8	anesthesia	anesthesia	NNP
cord-023095-4dannjjm	4294	9	to	to	TO
cord-023095-4dannjjm	4294	10	allow	allow	VB
cord-023095-4dannjjm	4294	11	complete	complete	JJ
cord-023095-4dannjjm	4294	12	relaxation	relaxation	NN
cord-023095-4dannjjm	4294	13	of	of	IN
cord-023095-4dannjjm	4294	14	the	the	DT
cord-023095-4dannjjm	4294	15	urethra	urethra	NN
cord-023095-4dannjjm	4294	16	,	,	,
cord-023095-4dannjjm	4294	17	however	however	RB
cord-023095-4dannjjm	4294	18	,	,	,
cord-023095-4dannjjm	4294	19	anesthesia	anesthesia	NN
cord-023095-4dannjjm	4294	20	results	result	NNS
cord-023095-4dannjjm	4294	21	in	in	IN
cord-023095-4dannjjm	4294	22	longer	long	JJR
cord-023095-4dannjjm	4294	23	procedure	procedure	NN
cord-023095-4dannjjm	4294	24	times	time	NNS
cord-023095-4dannjjm	4294	25	and	and	CC
cord-023095-4dannjjm	4294	26	difficult	difficult	JJ
cord-023095-4dannjjm	4294	27	endotracheal	endotracheal	NN
cord-023095-4dannjjm	4294	28	tube	tube	NN
cord-023095-4dannjjm	4294	29	stabilization	stabilization	NN
cord-023095-4dannjjm	4294	30	due	due	IN
cord-023095-4dannjjm	4294	31	to	to	IN
cord-023095-4dannjjm	4294	32	the	the	DT
cord-023095-4dannjjm	4294	33	vertical	vertical	JJ
cord-023095-4dannjjm	4294	34	positioning	positioning	NN
cord-023095-4dannjjm	4294	35	of	of	IN
cord-023095-4dannjjm	4294	36	animals	animal	NNS
cord-023095-4dannjjm	4294	37	,	,	,
cord-023095-4dannjjm	4294	38	especially	especially	RB
cord-023095-4dannjjm	4294	39	in	in	IN
cord-023095-4dannjjm	4294	40	larger	large	JJR
cord-023095-4dannjjm	4294	41	dogs	dog	NNS
cord-023095-4dannjjm	4294	42	.	.	.
cord-023095-4dannjjm	4295	1	The	the	DT
cord-023095-4dannjjm	4295	2	aim	aim	NN
cord-023095-4dannjjm	4295	3	of	of	IN
cord-023095-4dannjjm	4295	4	this	this	DT
cord-023095-4dannjjm	4295	5	study	study	NN
cord-023095-4dannjjm	4295	6	was	be	VBD
cord-023095-4dannjjm	4295	7	to	to	TO
cord-023095-4dannjjm	4295	8	devise	devise	VB
cord-023095-4dannjjm	4295	9	a	a	DT
cord-023095-4dannjjm	4295	10	novel	novel	JJ
cord-023095-4dannjjm	4295	11	injectable	injectable	JJ
cord-023095-4dannjjm	4295	12	sedation	sedation	NN
cord-023095-4dannjjm	4295	13	protocol	protocol	NN
cord-023095-4dannjjm	4295	14	for	for	IN
cord-023095-4dannjjm	4295	15	urohydropropulsion	urohydropropulsion	NN
cord-023095-4dannjjm	4295	16	when	when	WRB
cord-023095-4dannjjm	4295	17	cystoscopy	cystoscopy	NN
cord-023095-4dannjjm	4295	18	was	be	VBD
cord-023095-4dannjjm	4295	19	not	not	RB
cord-023095-4dannjjm	4295	20	concurrently	concurrently	RB
cord-023095-4dannjjm	4295	21	required	require	VBN
cord-023095-4dannjjm	4295	22	.	.	.
cord-023095-4dannjjm	4296	1	An	an	DT
cord-023095-4dannjjm	4296	2	intravenous	intravenous	JJ
cord-023095-4dannjjm	4296	3	catheter	catheter	NN
cord-023095-4dannjjm	4296	4	was	be	VBD
cord-023095-4dannjjm	4296	5	placed	place	VBN
cord-023095-4dannjjm	4296	6	,	,	,
cord-023095-4dannjjm	4296	7	and	and	CC
cord-023095-4dannjjm	4296	8	a	a	DT
cord-023095-4dannjjm	4296	9	combination	combination	NN
cord-023095-4dannjjm	4296	10	of	of	IN
cord-023095-4dannjjm	4296	11	medetomidine	medetomidine	NN
cord-023095-4dannjjm	4296	12	(	(	-LRB-
cord-023095-4dannjjm	4296	13	10	10	CD
cord-023095-4dannjjm	4296	14	to	to	TO
cord-023095-4dannjjm	4296	15	15	15	CD
cord-023095-4dannjjm	4296	16	mg	mg	NNP
cord-023095-4dannjjm	4296	17	/	/	SYM
cord-023095-4dannjjm	4296	18	kg	kg	NNP
cord-023095-4dannjjm	4296	19	IV	IV	NNP
cord-023095-4dannjjm	4296	20	)	)	-RRB-
cord-023095-4dannjjm	4296	21	and	and	CC
cord-023095-4dannjjm	4296	22	hydromorphone	hydromorphone	NN
cord-023095-4dannjjm	4296	23	(	(	-LRB-
cord-023095-4dannjjm	4296	24	0.025	0.025	CD
cord-023095-4dannjjm	4296	25	to	to	TO
cord-023095-4dannjjm	4296	26	0.05	0.05	CD
cord-023095-4dannjjm	4296	27	mg	mg	NNP
cord-023095-4dannjjm	4296	28	/	/	SYM
cord-023095-4dannjjm	4296	29	kg	kg	NNP
cord-023095-4dannjjm	4296	30	IV	IV	NNP
cord-023095-4dannjjm	4296	31	)	)	-RRB-
cord-023095-4dannjjm	4296	32	was	be	VBD
cord-023095-4dannjjm	4296	33	administered	administer	VBN
cord-023095-4dannjjm	4296	34	,	,	,
cord-023095-4dannjjm	4296	35	with	with	IN
cord-023095-4dannjjm	4296	36	the	the	DT
cord-023095-4dannjjm	4296	37	addition	addition	NN
cord-023095-4dannjjm	4296	38	of	of	IN
cord-023095-4dannjjm	4296	39	ketamine	ketamine	NNP
cord-023095-4dannjjm	4296	40	(	(	-LRB-
cord-023095-4dannjjm	4296	41	2	2	CD
cord-023095-4dannjjm	4296	42	mg/	mg/	NN
cord-023095-4dannjjm	4296	43	kg	kg	NNP
cord-023095-4dannjjm	4296	44	IV	IV	NNP
cord-023095-4dannjjm	4296	45	)	)	-RRB-
cord-023095-4dannjjm	4296	46	in	in	IN
cord-023095-4dannjjm	4296	47	fractious	fractious	JJ
cord-023095-4dannjjm	4296	48	animals	animal	NNS
cord-023095-4dannjjm	4296	49	;	;	:
cord-023095-4dannjjm	4296	50	atipamezole	atipamezole	NNP
cord-023095-4dannjjm	4296	51	(	(	-LRB-
cord-023095-4dannjjm	4296	52	double	double	JJ
cord-023095-4dannjjm	4296	53	volume	volume	NN
cord-023095-4dannjjm	4296	54	of	of	IN
cord-023095-4dannjjm	4296	55	medetomidine	medetomidine	NN
cord-023095-4dannjjm	4296	56	,	,	,
cord-023095-4dannjjm	4296	57	administered	administer	VBN
cord-023095-4dannjjm	4296	58	IM	IM	NNP
cord-023095-4dannjjm	4296	59	)	)	-RRB-
cord-023095-4dannjjm	4296	60	was	be	VBD
cord-023095-4dannjjm	4296	61	used	use	VBN
cord-023095-4dannjjm	4296	62	as	as	IN
cord-023095-4dannjjm	4296	63	a	a	DT
cord-023095-4dannjjm	4296	64	reversal	reversal	NN
cord-023095-4dannjjm	4296	65	agent	agent	NN
cord-023095-4dannjjm	4296	66	upon	upon	IN
cord-023095-4dannjjm	4296	67	procedure	procedure	NN
cord-023095-4dannjjm	4296	68	completion	completion	NN
cord-023095-4dannjjm	4296	69	.	.	.
cord-023095-4dannjjm	4297	1	This	this	DT
cord-023095-4dannjjm	4297	2	protocol	protocol	NN
cord-023095-4dannjjm	4297	3	was	be	VBD
cord-023095-4dannjjm	4297	4	considered	consider	VBN
cord-023095-4dannjjm	4297	5	in	in	IN
cord-023095-4dannjjm	4297	6	cardiovascularly	cardiovascularly	RB
cord-023095-4dannjjm	4297	7	healthy	healthy	JJ
cord-023095-4dannjjm	4297	8	,	,	,
cord-023095-4dannjjm	4297	9	non	non	JJ
cord-023095-4dannjjm	4297	10	-	-	JJ
cord-023095-4dannjjm	4297	11	diabetic	diabetic	JJ
cord-023095-4dannjjm	4297	12	dogs	dog	NNS
cord-023095-4dannjjm	4297	13	without	without	IN
cord-023095-4dannjjm	4297	14	evidence	evidence	NN
cord-023095-4dannjjm	4297	15	of	of	IN
cord-023095-4dannjjm	4297	16	urinary	urinary	JJ
cord-023095-4dannjjm	4297	17	obstruction	obstruction	NN
cord-023095-4dannjjm	4297	18	.	.	.
cord-023095-4dannjjm	4298	1	Monitoring	monitoring	NN
cord-023095-4dannjjm	4298	2	equipment	equipment	NN
cord-023095-4dannjjm	4298	3	included	include	VBD
cord-023095-4dannjjm	4298	4	electrocardiography	electrocardiography	NN
cord-023095-4dannjjm	4298	5	,	,	,
cord-023095-4dannjjm	4298	6	blood	blood	NN
cord-023095-4dannjjm	4298	7	pressure	pressure	NN
cord-023095-4dannjjm	4298	8	measurement	measurement	NN
cord-023095-4dannjjm	4298	9	,	,	,
cord-023095-4dannjjm	4298	10	and	and	CC
cord-023095-4dannjjm	4298	11	pulse	pulse	NN
cord-023095-4dannjjm	4298	12	oximetry	oximetry	NN
cord-023095-4dannjjm	4298	13	,	,	,
cord-023095-4dannjjm	4298	14	and	and	CC
cord-023095-4dannjjm	4298	15	supplemental	supplemental	JJ
cord-023095-4dannjjm	4298	16	flowby	flowby	NN
cord-023095-4dannjjm	4298	17	oxygen	oxygen	NN
cord-023095-4dannjjm	4298	18	was	be	VBD
cord-023095-4dannjjm	4298	19	provided	provide	VBN
cord-023095-4dannjjm	4298	20	.	.	.
cord-023095-4dannjjm	4299	1	Two	two	CD
cord-023095-4dannjjm	4299	2	dogs	dog	NNS
cord-023095-4dannjjm	4299	3	received	receive	VBD
cord-023095-4dannjjm	4299	4	the	the	DT
cord-023095-4dannjjm	4299	5	proposed	propose	VBN
cord-023095-4dannjjm	4299	6	sedation	sedation	NN
cord-023095-4dannjjm	4299	7	protocol	protocol	NN
cord-023095-4dannjjm	4299	8	in	in	IN
cord-023095-4dannjjm	4299	9	order	order	NN
cord-023095-4dannjjm	4299	10	to	to	TO
cord-023095-4dannjjm	4299	11	perform	perform	VB
cord-023095-4dannjjm	4299	12	urohydropropulsion	urohydropropulsion	NN
cord-023095-4dannjjm	4299	13	.	.	.
cord-023095-4dannjjm	4300	1	Dog	dog	NN
cord-023095-4dannjjm	4300	2	one	one	CD
cord-023095-4dannjjm	4300	3	was	be	VBD
cord-023095-4dannjjm	4300	4	a	a	DT
cord-023095-4dannjjm	4300	5	3	3	CD
cord-023095-4dannjjm	4300	6	year	year	NN
cord-023095-4dannjjm	4300	7	old	old	JJ
cord-023095-4dannjjm	4300	8	female	female	NN
cord-023095-4dannjjm	4300	9	spayed	spay	VBN
cord-023095-4dannjjm	4300	10	Shih	Shih	NNP
cord-023095-4dannjjm	4300	11	Tzu	Tzu	NNP
cord-023095-4dannjjm	4300	12	cross	cross	NN
cord-023095-4dannjjm	4300	13	,	,	,
cord-023095-4dannjjm	4300	14	and	and	CC
cord-023095-4dannjjm	4300	15	dog	dog	NN
cord-023095-4dannjjm	4300	16	2	2	CD
cord-023095-4dannjjm	4300	17	was	be	VBD
cord-023095-4dannjjm	4300	18	a	a	DT
cord-023095-4dannjjm	4300	19	2	2	CD
cord-023095-4dannjjm	4300	20	year	year	NN
cord-023095-4dannjjm	4300	21	old	old	JJ
cord-023095-4dannjjm	4300	22	female	female	NN
cord-023095-4dannjjm	4300	23	spayed	spay	VBN
cord-023095-4dannjjm	4300	24	Standard	Standard	NNP
cord-023095-4dannjjm	4300	25	Poodle	Poodle	NNP
cord-023095-4dannjjm	4300	26	.	.	.
cord-023095-4dannjjm	4301	1	Ultrasonography	Ultrasonography	NNP
cord-023095-4dannjjm	4301	2	revealed	reveal	VBD
cord-023095-4dannjjm	4301	3	a	a	DT
cord-023095-4dannjjm	4301	4	moderate	moderate	JJ
cord-023095-4dannjjm	4301	5	number	number	NN
cord-023095-4dannjjm	4301	6	of	of	IN
cord-023095-4dannjjm	4301	7	urocystoliths	urocystolith	NNS
cord-023095-4dannjjm	4301	8	present	present	JJ
cord-023095-4dannjjm	4301	9	in	in	IN
cord-023095-4dannjjm	4301	10	both	both	DT
cord-023095-4dannjjm	4301	11	dogs	dog	NNS
cord-023095-4dannjjm	4301	12	,	,	,
cord-023095-4dannjjm	4301	13	measuring	measure	VBG
cord-023095-4dannjjm	4301	14	up	up	IN
cord-023095-4dannjjm	4301	15	to	to	TO
cord-023095-4dannjjm	4301	16	1	1	CD
cord-023095-4dannjjm	4301	17	mm	mm	NN
cord-023095-4dannjjm	4301	18	in	in	IN
cord-023095-4dannjjm	4301	19	dog	dog	NN
cord-023095-4dannjjm	4301	20	1	1	CD
cord-023095-4dannjjm	4301	21	and	and	CC
cord-023095-4dannjjm	4301	22	2.3	2.3	CD
cord-023095-4dannjjm	4301	23	mm	mm	NNS
cord-023095-4dannjjm	4301	24	in	in	IN
cord-023095-4dannjjm	4301	25	dog	dog	NN
cord-023095-4dannjjm	4301	26	2	2	CD
cord-023095-4dannjjm	4301	27	.	.	.
cord-023095-4dannjjm	4302	1	Urohydropropulsion	Urohydropropulsion	NNP
cord-023095-4dannjjm	4302	2	was	be	VBD
cord-023095-4dannjjm	4302	3	performed	perform	VBN
cord-023095-4dannjjm	4302	4	and	and	CC
cord-023095-4dannjjm	4302	5	resulted	result	VBN
cord-023095-4dannjjm	4302	6	in	in	IN
cord-023095-4dannjjm	4302	7	retrieval	retrieval	NN
cord-023095-4dannjjm	4302	8	of	of	IN
cord-023095-4dannjjm	4302	9	15	15	CD
cord-023095-4dannjjm	4302	10	urocystoliths	urocystolith	NNS
cord-023095-4dannjjm	4302	11	in	in	IN
cord-023095-4dannjjm	4302	12	dog	dog	NN
cord-023095-4dannjjm	4302	13	1	1	CD
cord-023095-4dannjjm	4302	14	,	,	,
cord-023095-4dannjjm	4302	15	and	and	CC
cord-023095-4dannjjm	4302	16	approximately	approximately	RB
cord-023095-4dannjjm	4302	17	20	20	CD
cord-023095-4dannjjm	4302	18	urocystoliths	urocystolith	NNS
cord-023095-4dannjjm	4302	19	in	in	IN
cord-023095-4dannjjm	4302	20	dog	dog	NN
cord-023095-4dannjjm	4302	21	2	2	CD
cord-023095-4dannjjm	4302	22	.	.	.
cord-023095-4dannjjm	4303	1	Repeat	repeat	NN
cord-023095-4dannjjm	4303	2	ultrasonography	ultrasonography	NN
cord-023095-4dannjjm	4303	3	revealed	reveal	VBD
cord-023095-4dannjjm	4303	4	no	no	DT
cord-023095-4dannjjm	4303	5	uroliths	uroliths	JJ
cord-023095-4dannjjm	4303	6	present	present	JJ
cord-023095-4dannjjm	4303	7	after	after	IN
cord-023095-4dannjjm	4303	8	urohydropropulsion	urohydropropulsion	NN
cord-023095-4dannjjm	4303	9	in	in	IN
cord-023095-4dannjjm	4303	10	both	both	DT
cord-023095-4dannjjm	4303	11	dogs	dog	NNS
cord-023095-4dannjjm	4303	12	.	.	.
cord-023095-4dannjjm	4304	1	The	the	DT
cord-023095-4dannjjm	4304	2	time	time	NN
cord-023095-4dannjjm	4304	3	from	from	IN
cord-023095-4dannjjm	4304	4	administration	administration	NN
cord-023095-4dannjjm	4304	5	of	of	IN
cord-023095-4dannjjm	4304	6	sedation	sedation	NN
cord-023095-4dannjjm	4304	7	to	to	IN
cord-023095-4dannjjm	4304	8	administration	administration	NN
cord-023095-4dannjjm	4304	9	of	of	IN
cord-023095-4dannjjm	4304	10	reversal	reversal	NN
cord-023095-4dannjjm	4304	11	agent	agent	NN
cord-023095-4dannjjm	4304	12	was	be	VBD
cord-023095-4dannjjm	4304	13	6	6	CD
cord-023095-4dannjjm	4304	14	minutes	minute	NNS
cord-023095-4dannjjm	4304	15	for	for	IN
cord-023095-4dannjjm	4304	16	dog	dog	NN
cord-023095-4dannjjm	4304	17	1	1	CD
cord-023095-4dannjjm	4304	18	,	,	,
cord-023095-4dannjjm	4304	19	and	and	CC
cord-023095-4dannjjm	4304	20	8.5	8.5	CD
cord-023095-4dannjjm	4304	21	minutes	minute	NNS
cord-023095-4dannjjm	4304	22	for	for	IN
cord-023095-4dannjjm	4304	23	dog	dog	NN
cord-023095-4dannjjm	4304	24	2	2	CD
cord-023095-4dannjjm	4304	25	.	.	.
cord-023095-4dannjjm	4305	1	Records	record	NNS
cord-023095-4dannjjm	4305	2	were	be	VBD
cord-023095-4dannjjm	4305	3	obtained	obtain	VBN
cord-023095-4dannjjm	4305	4	from	from	IN
cord-023095-4dannjjm	4305	5	3	3	CD
cord-023095-4dannjjm	4305	6	dogs	dog	NNS
cord-023095-4dannjjm	4305	7	that	that	WDT
cord-023095-4dannjjm	4305	8	had	have	VBD
cord-023095-4dannjjm	4305	9	traditional	traditional	JJ
cord-023095-4dannjjm	4305	10	general	general	JJ
cord-023095-4dannjjm	4305	11	anesthetic	anesthetic	JJ
cord-023095-4dannjjm	4305	12	protocols	protocol	NNS
cord-023095-4dannjjm	4305	13	for	for	IN
cord-023095-4dannjjm	4305	14	urohydropropulsion	urohydropropulsion	NN
cord-023095-4dannjjm	4305	15	with	with	IN
cord-023095-4dannjjm	4305	16	cystoscopy	cystoscopy	NN
cord-023095-4dannjjm	4305	17	for	for	IN
cord-023095-4dannjjm	4305	18	confirmation	confirmation	NN
cord-023095-4dannjjm	4305	19	of	of	IN
cord-023095-4dannjjm	4305	20	urocystolith	urocystolith	NNP
cord-023095-4dannjjm	4305	21	removal	removal	NN
cord-023095-4dannjjm	4305	22	,	,	,
cord-023095-4dannjjm	4305	23	performed	perform	VBN
cord-023095-4dannjjm	4305	24	within	within	IN
cord-023095-4dannjjm	4305	25	the	the	DT
cord-023095-4dannjjm	4305	26	last	last	JJ
cord-023095-4dannjjm	4305	27	2	2	CD
cord-023095-4dannjjm	4305	28	years	year	NNS
cord-023095-4dannjjm	4305	29	,	,	,
cord-023095-4dannjjm	4305	30	and	and	CC
cord-023095-4dannjjm	4305	31	the	the	DT
cord-023095-4dannjjm	4305	32	average	average	JJ
cord-023095-4dannjjm	4305	33	anesthetic	anesthetic	JJ
cord-023095-4dannjjm	4305	34	time	time	NN
cord-023095-4dannjjm	4305	35	was	be	VBD
cord-023095-4dannjjm	4305	36	64	64	CD
cord-023095-4dannjjm	4305	37	minutes	minute	NNS
cord-023095-4dannjjm	4305	38	.	.	.
cord-023095-4dannjjm	4306	1	Subsequent	subsequent	JJ
cord-023095-4dannjjm	4306	2	to	to	IN
cord-023095-4dannjjm	4306	3	the	the	DT
cord-023095-4dannjjm	4306	4	use	use	NN
cord-023095-4dannjjm	4306	5	of	of	IN
cord-023095-4dannjjm	4306	6	medetomine	medetomine	NN
cord-023095-4dannjjm	4306	7	-	-	HYPH
cord-023095-4dannjjm	4306	8	based	base	VBN
cord-023095-4dannjjm	4306	9	sedation	sedation	NN
cord-023095-4dannjjm	4306	10	protocols	protocol	NNS
cord-023095-4dannjjm	4306	11	for	for	IN
cord-023095-4dannjjm	4306	12	the	the	DT
cord-023095-4dannjjm	4306	13	above	above	JJ
cord-023095-4dannjjm	4306	14	dogs	dog	NNS
cord-023095-4dannjjm	4306	15	,	,	,
cord-023095-4dannjjm	4306	16	cystoscopy	cystoscopy	NN
cord-023095-4dannjjm	4306	17	was	be	VBD
cord-023095-4dannjjm	4306	18	performed	perform	VBN
cord-023095-4dannjjm	4306	19	in	in	IN
cord-023095-4dannjjm	4306	20	a	a	DT
cord-023095-4dannjjm	4306	21	9	9	CD
cord-023095-4dannjjm	4306	22	year	year	NN
cord-023095-4dannjjm	4306	23	old	old	JJ
cord-023095-4dannjjm	4306	24	neutered	neutered	JJ
cord-023095-4dannjjm	4306	25	male	male	JJ
cord-023095-4dannjjm	4306	26	Golden	Golden	NNP
cord-023095-4dannjjm	4306	27	Retriever	Retriever	NNP
cord-023095-4dannjjm	4306	28	with	with	IN
cord-023095-4dannjjm	4306	29	prostatomegaly	prostatomegaly	NNP
cord-023095-4dannjjm	4306	30	.	.	.
cord-023095-4dannjjm	4307	1	Medetomidine	Medetomidine	NNP
cord-023095-4dannjjm	4307	2	(	(	-LRB-
cord-023095-4dannjjm	4307	3	15	15	CD
cord-023095-4dannjjm	4307	4	ug	ug	NNP
cord-023095-4dannjjm	4307	5	/	/	SYM
cord-023095-4dannjjm	4307	6	kg	kg	NNP
cord-023095-4dannjjm	4307	7	IV	IV	NNP
cord-023095-4dannjjm	4307	8	)	)	-RRB-
cord-023095-4dannjjm	4307	9	and	and	CC
cord-023095-4dannjjm	4307	10	butorphanol	butorphanol	NNP
cord-023095-4dannjjm	4307	11	(	(	-LRB-
cord-023095-4dannjjm	4307	12	0.2	0.2	CD
cord-023095-4dannjjm	4307	13	mg	mg	NNP
cord-023095-4dannjjm	4307	14	/	/	SYM
cord-023095-4dannjjm	4307	15	kg	kg	NNP
cord-023095-4dannjjm	4307	16	IV	IV	NNP
cord-023095-4dannjjm	4307	17	)	)	-RRB-
cord-023095-4dannjjm	4307	18	were	be	VBD
cord-023095-4dannjjm	4307	19	administered	administer	VBN
cord-023095-4dannjjm	4307	20	;	;	:
cord-023095-4dannjjm	4307	21	atipamezole	atipamezole	NNP
cord-023095-4dannjjm	4307	22	(	(	-LRB-
cord-023095-4dannjjm	4307	23	double	double	JJ
cord-023095-4dannjjm	4307	24	volume	volume	NN
cord-023095-4dannjjm	4307	25	of	of	IN
cord-023095-4dannjjm	4307	26	medetomidine	medetomidine	NN
cord-023095-4dannjjm	4307	27	,	,	,
cord-023095-4dannjjm	4307	28	administered	administer	VBN
cord-023095-4dannjjm	4307	29	IM	IM	NNP
cord-023095-4dannjjm	4307	30	)	)	-RRB-
cord-023095-4dannjjm	4307	31	was	be	VBD
cord-023095-4dannjjm	4307	32	used	use	VBN
cord-023095-4dannjjm	4307	33	as	as	IN
cord-023095-4dannjjm	4307	34	a	a	DT
cord-023095-4dannjjm	4307	35	reversal	reversal	NN
cord-023095-4dannjjm	4307	36	agent	agent	NN
cord-023095-4dannjjm	4307	37	upon	upon	IN
cord-023095-4dannjjm	4307	38	procedure	procedure	NN
cord-023095-4dannjjm	4307	39	completion	completion	NN
cord-023095-4dannjjm	4307	40	.	.	.
cord-023095-4dannjjm	4308	1	This	this	DT
cord-023095-4dannjjm	4308	2	sedation	sedation	NN
cord-023095-4dannjjm	4308	3	allowed	allow	VBD
cord-023095-4dannjjm	4308	4	adequate	adequate	JJ
cord-023095-4dannjjm	4308	5	immobilization	immobilization	NN
cord-023095-4dannjjm	4308	6	for	for	IN
cord-023095-4dannjjm	4308	7	cystoscopy	cystoscopy	NN
cord-023095-4dannjjm	4308	8	of	of	IN
cord-023095-4dannjjm	4308	9	the	the	DT
cord-023095-4dannjjm	4308	10	urethra	urethra	NN
cord-023095-4dannjjm	4308	11	and	and	CC
cord-023095-4dannjjm	4308	12	urinary	urinary	JJ
cord-023095-4dannjjm	4308	13	bladder	bladder	NN
cord-023095-4dannjjm	4308	14	,	,	,
cord-023095-4dannjjm	4308	15	and	and	CC
cord-023095-4dannjjm	4308	16	endoscopic	endoscopic	NNS
cord-023095-4dannjjm	4308	17	biopsying	biopsying	NN
cord-023095-4dannjjm	4308	18	of	of	IN
cord-023095-4dannjjm	4308	19	the	the	DT
cord-023095-4dannjjm	4308	20	prostatic	prostatic	JJ
cord-023095-4dannjjm	4308	21	urethra	urethra	NN
cord-023095-4dannjjm	4308	22	and	and	CC
cord-023095-4dannjjm	4308	23	urinary	urinary	JJ
cord-023095-4dannjjm	4308	24	bladder	bladder	NN
cord-023095-4dannjjm	4308	25	.	.	.
cord-023095-4dannjjm	4309	1	The	the	DT
cord-023095-4dannjjm	4309	2	time	time	NN
cord-023095-4dannjjm	4309	3	from	from	IN
cord-023095-4dannjjm	4309	4	administration	administration	NN
cord-023095-4dannjjm	4309	5	of	of	IN
cord-023095-4dannjjm	4309	6	sedation	sedation	NN
cord-023095-4dannjjm	4309	7	to	to	IN
cord-023095-4dannjjm	4309	8	administration	administration	NN
cord-023095-4dannjjm	4309	9	of	of	IN
cord-023095-4dannjjm	4309	10	reversal	reversal	NN
cord-023095-4dannjjm	4309	11	agent	agent	NN
cord-023095-4dannjjm	4309	12	was	be	VBD
cord-023095-4dannjjm	4309	13	15	15	CD
cord-023095-4dannjjm	4309	14	minutes	minute	NNS
cord-023095-4dannjjm	4309	15	for	for	IN
cord-023095-4dannjjm	4309	16	this	this	DT
cord-023095-4dannjjm	4309	17	dog	dog	NN
cord-023095-4dannjjm	4309	18	.	.	.
cord-023095-4dannjjm	4310	1	In	in	IN
cord-023095-4dannjjm	4310	2	conclusion	conclusion	NN
cord-023095-4dannjjm	4310	3	,	,	,
cord-023095-4dannjjm	4310	4	a	a	DT
cord-023095-4dannjjm	4310	5	novel	novel	JJ
cord-023095-4dannjjm	4310	6	sedative	sedative	NN
cord-023095-4dannjjm	4310	7	protocol	protocol	NN
cord-023095-4dannjjm	4310	8	for	for	IN
cord-023095-4dannjjm	4310	9	urohydropropulsion	urohydropropulsion	NN
cord-023095-4dannjjm	4310	10	is	be	VBZ
cord-023095-4dannjjm	4310	11	proposed	propose	VBN
cord-023095-4dannjjm	4310	12	which	which	WDT
cord-023095-4dannjjm	4310	13	allows	allow	VBZ
cord-023095-4dannjjm	4310	14	for	for	IN
cord-023095-4dannjjm	4310	15	an	an	DT
cord-023095-4dannjjm	4310	16	appropriate	appropriate	JJ
cord-023095-4dannjjm	4310	17	level	level	NN
cord-023095-4dannjjm	4310	18	of	of	IN
cord-023095-4dannjjm	4310	19	sedation	sedation	NN
cord-023095-4dannjjm	4310	20	along	along	IN
cord-023095-4dannjjm	4310	21	with	with	IN
cord-023095-4dannjjm	4310	22	a	a	DT
cord-023095-4dannjjm	4310	23	short	short	JJ
cord-023095-4dannjjm	4310	24	procedure	procedure	NN
cord-023095-4dannjjm	4310	25	time	time	NN
cord-023095-4dannjjm	4310	26	and	and	CC
cord-023095-4dannjjm	4310	27	rapid	rapid	JJ
cord-023095-4dannjjm	4310	28	recovery	recovery	NN
cord-023095-4dannjjm	4310	29	.	.	.
cord-023095-4dannjjm	4311	1	This	this	DT
cord-023095-4dannjjm	4311	2	sedation	sedation	NN
cord-023095-4dannjjm	4311	3	protocol	protocol	NN
cord-023095-4dannjjm	4311	4	may	may	MD
cord-023095-4dannjjm	4311	5	also	also	RB
cord-023095-4dannjjm	4311	6	be	be	VB
cord-023095-4dannjjm	4311	7	useful	useful	JJ
cord-023095-4dannjjm	4311	8	for	for	IN
cord-023095-4dannjjm	4311	9	certain	certain	JJ
cord-023095-4dannjjm	4311	10	cystoscopic	cystoscopic	JJ
cord-023095-4dannjjm	4311	11	procedures	procedure	NNS
cord-023095-4dannjjm	4311	12	.	.	.
cord-023095-4dannjjm	4312	1	analysis	analysis	NN
cord-023095-4dannjjm	4312	2	may	may	MD
cord-023095-4dannjjm	4312	3	be	be	VB
cord-023095-4dannjjm	4312	4	delayed	delay	VBN
cord-023095-4dannjjm	4312	5	for	for	IN
cord-023095-4dannjjm	4312	6	a	a	DT
cord-023095-4dannjjm	4312	7	variety	variety	NN
cord-023095-4dannjjm	4312	8	of	of	IN
cord-023095-4dannjjm	4312	9	reasons	reason	NNS
cord-023095-4dannjjm	4312	10	,	,	,
cord-023095-4dannjjm	4312	11	including	include	VBG
cord-023095-4dannjjm	4312	12	the	the	DT
cord-023095-4dannjjm	4312	13	need	need	NN
cord-023095-4dannjjm	4312	14	for	for	IN
cord-023095-4dannjjm	4312	15	sample	sample	NN
cord-023095-4dannjjm	4312	16	batching	batching	NN
cord-023095-4dannjjm	4312	17	within	within	IN
cord-023095-4dannjjm	4312	18	the	the	DT
cord-023095-4dannjjm	4312	19	laboratory	laboratory	NN
cord-023095-4dannjjm	4312	20	or	or	CC
cord-023095-4dannjjm	4312	21	shipping	ship	VBG
cord-023095-4dannjjm	4312	22	to	to	IN
cord-023095-4dannjjm	4312	23	an	an	DT
cord-023095-4dannjjm	4312	24	outsourced	outsource	VBN
cord-023095-4dannjjm	4312	25	location	location	NN
cord-023095-4dannjjm	4312	26	.	.	.
cord-023095-4dannjjm	4313	1	Therefore	therefore	RB
cord-023095-4dannjjm	4313	2	,	,	,
cord-023095-4dannjjm	4313	3	it	-PRON-	PRP
cord-023095-4dannjjm	4313	4	is	be	VBZ
cord-023095-4dannjjm	4313	5	important	important	JJ
cord-023095-4dannjjm	4313	6	to	to	TO
cord-023095-4dannjjm	4313	7	know	know	VB
cord-023095-4dannjjm	4313	8	how	how	WRB
cord-023095-4dannjjm	4313	9	storage	storage	NN
cord-023095-4dannjjm	4313	10	of	of	IN
cord-023095-4dannjjm	4313	11	the	the	DT
cord-023095-4dannjjm	4313	12	sample	sample	NN
cord-023095-4dannjjm	4313	13	may	may	MD
cord-023095-4dannjjm	4313	14	affect	affect	VB
cord-023095-4dannjjm	4313	15	enzyme	enzyme	NN
cord-023095-4dannjjm	4313	16	activity	activity	NN
cord-023095-4dannjjm	4313	17	.	.	.
cord-023095-4dannjjm	4314	1	We	-PRON-	PRP
cord-023095-4dannjjm	4314	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	4314	3	that	that	IN
cord-023095-4dannjjm	4314	4	urinary	urinary	JJ
cord-023095-4dannjjm	4314	5	NAG	NAG	NNP
cord-023095-4dannjjm	4314	6	and	and	CC
cord-023095-4dannjjm	4314	7	GGT	GGT	NNP
cord-023095-4dannjjm	4314	8	activity	activity	NN
cord-023095-4dannjjm	4314	9	would	would	MD
cord-023095-4dannjjm	4314	10	be	be	VB
cord-023095-4dannjjm	4314	11	affected	affect	VBN
cord-023095-4dannjjm	4314	12	differently	differently	RB
cord-023095-4dannjjm	4314	13	in	in	IN
cord-023095-4dannjjm	4314	14	samples	sample	NNS
cord-023095-4dannjjm	4314	15	stored	store	VBN
cord-023095-4dannjjm	4314	16	by	by	IN
cord-023095-4dannjjm	4314	17	refrigeration	refrigeration	NN
cord-023095-4dannjjm	4314	18	vs.	vs.	FW
cord-023095-4dannjjm	4314	19	freezing	freezing	NN
cord-023095-4dannjjm	4314	20	.	.	.
cord-023095-4dannjjm	4315	1	Thirty	thirty	CD
cord-023095-4dannjjm	4315	2	-	-	HYPH
cord-023095-4dannjjm	4315	3	four	four	CD
cord-023095-4dannjjm	4315	4	canine	canine	JJ
cord-023095-4dannjjm	4315	5	urine	urine	NN
cord-023095-4dannjjm	4315	6	samples	sample	NNS
cord-023095-4dannjjm	4315	7	submitted	submit	VBN
cord-023095-4dannjjm	4315	8	to	to	IN
cord-023095-4dannjjm	4315	9	the	the	DT
cord-023095-4dannjjm	4315	10	Clinical	Clinical	NNP
cord-023095-4dannjjm	4315	11	Pathology	Pathology	NNP
cord-023095-4dannjjm	4315	12	Laboratory	Laboratory	NNP
cord-023095-4dannjjm	4315	13	at	at	IN
cord-023095-4dannjjm	4315	14	Kansas	Kansas	NNP
cord-023095-4dannjjm	4315	15	State	State	NNP
cord-023095-4dannjjm	4315	16	University	University	NNP
cord-023095-4dannjjm	4315	17	were	be	VBD
cord-023095-4dannjjm	4315	18	included	include	VBN
cord-023095-4dannjjm	4315	19	.	.	.
cord-023095-4dannjjm	4316	1	Samples	sample	NNS
cord-023095-4dannjjm	4316	2	were	be	VBD
cord-023095-4dannjjm	4316	3	collected	collect	VBN
cord-023095-4dannjjm	4316	4	from	from	IN
cord-023095-4dannjjm	4316	5	clinical	clinical	JJ
cord-023095-4dannjjm	4316	6	patients	patient	NNS
cord-023095-4dannjjm	4316	7	with	with	IN
cord-023095-4dannjjm	4316	8	a	a	DT
cord-023095-4dannjjm	4316	9	variety	variety	NN
cord-023095-4dannjjm	4316	10	of	of	IN
cord-023095-4dannjjm	4316	11	medical	medical	JJ
cord-023095-4dannjjm	4316	12	/	/	SYM
cord-023095-4dannjjm	4316	13	surgical	surgical	JJ
cord-023095-4dannjjm	4316	14	disorders	disorder	NNS
cord-023095-4dannjjm	4316	15	and	and	CC
cord-023095-4dannjjm	4316	16	were	be	VBD
cord-023095-4dannjjm	4316	17	selected	select	VBN
cord-023095-4dannjjm	4316	18	based	base	VBN
cord-023095-4dannjjm	4316	19	on	on	IN
cord-023095-4dannjjm	4316	20	the	the	DT
cord-023095-4dannjjm	4316	21	day	day	NN
cord-023095-4dannjjm	4316	22	of	of	IN
cord-023095-4dannjjm	4316	23	the	the	DT
cord-023095-4dannjjm	4316	24	week	week	NN
cord-023095-4dannjjm	4316	25	and	and	CC
cord-023095-4dannjjm	4316	26	a	a	DT
cord-023095-4dannjjm	4316	27	minimum	minimum	JJ
cord-023095-4dannjjm	4316	28	volume	volume	NN
cord-023095-4dannjjm	4316	29	of	of	IN
cord-023095-4dannjjm	4316	30	10	10	CD
cord-023095-4dannjjm	4316	31	ml	ml	NNS
cord-023095-4dannjjm	4316	32	.	.	.
cord-023095-4dannjjm	4317	1	A	a	DT
cord-023095-4dannjjm	4317	2	complete	complete	JJ
cord-023095-4dannjjm	4317	3	urinalysis	urinalysis	NN
cord-023095-4dannjjm	4317	4	was	be	VBD
cord-023095-4dannjjm	4317	5	performed	perform	VBN
cord-023095-4dannjjm	4317	6	on	on	IN
cord-023095-4dannjjm	4317	7	each	each	DT
cord-023095-4dannjjm	4317	8	sample	sample	NN
cord-023095-4dannjjm	4317	9	;	;	:
cord-023095-4dannjjm	4317	10	however	however	RB
cord-023095-4dannjjm	4317	11	there	there	EX
cord-023095-4dannjjm	4317	12	were	be	VBD
cord-023095-4dannjjm	4317	13	no	no	DT
cord-023095-4dannjjm	4317	14	exclusion	exclusion	NN
cord-023095-4dannjjm	4317	15	criteria	criterion	NNS
cord-023095-4dannjjm	4317	16	based	base	VBN
cord-023095-4dannjjm	4317	17	on	on	IN
cord-023095-4dannjjm	4317	18	urinalysis	urinalysis	NN
cord-023095-4dannjjm	4317	19	results	result	NNS
cord-023095-4dannjjm	4317	20	.	.	.
cord-023095-4dannjjm	4318	1	NAG	NAG	NNP
cord-023095-4dannjjm	4318	2	and	and	CC
cord-023095-4dannjjm	4318	3	GGT	GGT	NNP
cord-023095-4dannjjm	4318	4	activity	activity	NN
cord-023095-4dannjjm	4318	5	in	in	IN
cord-023095-4dannjjm	4318	6	the	the	DT
cord-023095-4dannjjm	4318	7	urine	urine	NN
cord-023095-4dannjjm	4318	8	supernatant	supernatant	NN
cord-023095-4dannjjm	4318	9	was	be	VBD
cord-023095-4dannjjm	4318	10	assessed	assess	VBN
cord-023095-4dannjjm	4318	11	by	by	IN
cord-023095-4dannjjm	4318	12	colorimetric	colorimetric	JJ
cord-023095-4dannjjm	4318	13	assay	assay	NN
cord-023095-4dannjjm	4318	14	.	.	.
cord-023095-4dannjjm	4319	1	Aliquots	aliquot	NNS
cord-023095-4dannjjm	4319	2	of	of	IN
cord-023095-4dannjjm	4319	3	each	each	DT
cord-023095-4dannjjm	4319	4	supernatant	supernatant	JJ
cord-023095-4dannjjm	4319	5	were	be	VBD
cord-023095-4dannjjm	4319	6	refrigerated	refrigerate	VBN
cord-023095-4dannjjm	4319	7	for	for	IN
cord-023095-4dannjjm	4319	8	5	5	CD
cord-023095-4dannjjm	4319	9	days	day	NNS
cord-023095-4dannjjm	4319	10	and	and	CC
cord-023095-4dannjjm	4319	11	frozen	freeze	VBN
cord-023095-4dannjjm	4319	12	at	at	IN
cord-023095-4dannjjm	4319	13	À201C	À201C	NNPS
cord-023095-4dannjjm	4319	14	for	for	IN
cord-023095-4dannjjm	4319	15	5	5	CD
cord-023095-4dannjjm	4319	16	and	and	CC
cord-023095-4dannjjm	4319	17	30	30	CD
cord-023095-4dannjjm	4319	18	days	day	NNS
cord-023095-4dannjjm	4319	19	at	at	IN
cord-023095-4dannjjm	4319	20	which	which	WDT
cord-023095-4dannjjm	4319	21	time	time	NN
cord-023095-4dannjjm	4319	22	enzyme	enzyme	NN
cord-023095-4dannjjm	4319	23	activity	activity	NN
cord-023095-4dannjjm	4319	24	was	be	VBD
cord-023095-4dannjjm	4319	25	re	re	VBN
cord-023095-4dannjjm	4319	26	-	-	VBN
cord-023095-4dannjjm	4319	27	assessed	assess	VBN
cord-023095-4dannjjm	4319	28	.	.	.
cord-023095-4dannjjm	4320	1	Compared	compare	VBN
cord-023095-4dannjjm	4320	2	to	to	IN
cord-023095-4dannjjm	4320	3	baseline	baseline	JJ
cord-023095-4dannjjm	4320	4	values	value	NNS
cord-023095-4dannjjm	4320	5	,	,	,
cord-023095-4dannjjm	4320	6	enzyme	enzyme	NN
cord-023095-4dannjjm	4320	7	activity	activity	NN
cord-023095-4dannjjm	4320	8	for	for	IN
cord-023095-4dannjjm	4320	9	both	both	DT
cord-023095-4dannjjm	4320	10	NAG	NAG	NNP
cord-023095-4dannjjm	4320	11	and	and	CC
cord-023095-4dannjjm	4320	12	GGT	GGT	NNP
cord-023095-4dannjjm	4320	13	were	be	VBD
cord-023095-4dannjjm	4320	14	stable	stable	JJ
cord-023095-4dannjjm	4320	15	after	after	IN
cord-023095-4dannjjm	4320	16	5	5	CD
cord-023095-4dannjjm	4320	17	days	day	NNS
cord-023095-4dannjjm	4320	18	of	of	IN
cord-023095-4dannjjm	4320	19	refrigeration	refrigeration	NN
cord-023095-4dannjjm	4320	20	,	,	,
cord-023095-4dannjjm	4320	21	however	however	RB
cord-023095-4dannjjm	4320	22	there	there	EX
cord-023095-4dannjjm	4320	23	were	be	VBD
cord-023095-4dannjjm	4320	24	significant	significant	JJ
cord-023095-4dannjjm	4321	1	(	(	-LRB-
cord-023095-4dannjjm	4321	2	P	p	NN
cord-023095-4dannjjm	4321	3	o	o	NN
cord-023095-4dannjjm	4321	4	0.01	0.01	CD
cord-023095-4dannjjm	4321	5	)	)	-RRB-
cord-023095-4dannjjm	4321	6	declines	decline	NNS
cord-023095-4dannjjm	4321	7	in	in	IN
cord-023095-4dannjjm	4321	8	GGT	GGT	NNP
cord-023095-4dannjjm	4321	9	and	and	CC
cord-023095-4dannjjm	4321	10	NAG	NAG	NNP
cord-023095-4dannjjm	4321	11	activity	activity	NN
cord-023095-4dannjjm	4321	12	when	when	WRB
cord-023095-4dannjjm	4321	13	urine	urine	NN
cord-023095-4dannjjm	4321	14	supernatants	supernatant	NNS
cord-023095-4dannjjm	4321	15	were	be	VBD
cord-023095-4dannjjm	4321	16	frozen	freeze	VBN
cord-023095-4dannjjm	4321	17	for	for	IN
cord-023095-4dannjjm	4321	18	5	5	CD
cord-023095-4dannjjm	4321	19	and	and	CC
cord-023095-4dannjjm	4321	20	30	30	CD
cord-023095-4dannjjm	4321	21	days	day	NNS
cord-023095-4dannjjm	4321	22	.	.	.
cord-023095-4dannjjm	4322	1	Treatment	treatment	NN
cord-023095-4dannjjm	4322	2	for	for	IN
cord-023095-4dannjjm	4322	3	canine	canine	JJ
cord-023095-4dannjjm	4322	4	urinary	urinary	JJ
cord-023095-4dannjjm	4322	5	tract	tract	NN
cord-023095-4dannjjm	4322	6	infections	infection	NNS
cord-023095-4dannjjm	4322	7	(	(	-LRB-
cord-023095-4dannjjm	4322	8	UTI	UTI	NNP
cord-023095-4dannjjm	4322	9	)	)	-RRB-
cord-023095-4dannjjm	4322	10	typically	typically	RB
cord-023095-4dannjjm	4322	11	consists	consist	VBZ
cord-023095-4dannjjm	4322	12	of	of	IN
cord-023095-4dannjjm	4322	13	7	7	CD
cord-023095-4dannjjm	4322	14	-	-	SYM
cord-023095-4dannjjm	4322	15	14	14	CD
cord-023095-4dannjjm	4322	16	days	day	NNS
cord-023095-4dannjjm	4322	17	of	of	IN
cord-023095-4dannjjm	4322	18	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	4322	19	drugs	drug	NNS
cord-023095-4dannjjm	4322	20	in	in	IN
cord-023095-4dannjjm	4322	21	primary	primary	JJ
cord-023095-4dannjjm	4322	22	care	care	NN
cord-023095-4dannjjm	4322	23	veterinary	veterinary	JJ
cord-023095-4dannjjm	4322	24	practice	practice	NN
cord-023095-4dannjjm	4322	25	.	.	.
cord-023095-4dannjjm	4323	1	Compliance	compliance	NN
cord-023095-4dannjjm	4323	2	with	with	IN
cord-023095-4dannjjm	4323	3	this	this	DT
cord-023095-4dannjjm	4323	4	drug	drug	NN
cord-023095-4dannjjm	4323	5	regimen	regimen	NN
cord-023095-4dannjjm	4323	6	can	can	MD
cord-023095-4dannjjm	4323	7	be	be	VB
cord-023095-4dannjjm	4323	8	difficult	difficult	JJ
cord-023095-4dannjjm	4323	9	for	for	IN
cord-023095-4dannjjm	4323	10	some	some	DT
cord-023095-4dannjjm	4323	11	clients	client	NNS
cord-023095-4dannjjm	4323	12	.	.	.
cord-023095-4dannjjm	4324	1	Enrofloxacin	Enrofloxacin	NNP
cord-023095-4dannjjm	4324	2	is	be	VBZ
cord-023095-4dannjjm	4324	3	a	a	DT
cord-023095-4dannjjm	4324	4	veterinary	veterinary	JJ
cord-023095-4dannjjm	4324	5	approved	approve	VBN
cord-023095-4dannjjm	4324	6	fluoroquinolone	fluoroquinolone	NN
cord-023095-4dannjjm	4324	7	antimicrobial	antimicrobial	NN
cord-023095-4dannjjm	4324	8	and	and	CC
cord-023095-4dannjjm	4324	9	is	be	VBZ
cord-023095-4dannjjm	4324	10	useful	useful	JJ
cord-023095-4dannjjm	4324	11	for	for	IN
cord-023095-4dannjjm	4324	12	treatment	treatment	NN
cord-023095-4dannjjm	4324	13	of	of	IN
cord-023095-4dannjjm	4324	14	canine	canine	JJ
cord-023095-4dannjjm	4324	15	UTI	UTI	NNP
cord-023095-4dannjjm	4324	16	.	.	.
cord-023095-4dannjjm	4325	1	Fluoroquinolones	fluoroquinolone	NNS
cord-023095-4dannjjm	4325	2	are	be	VBP
cord-023095-4dannjjm	4325	3	often	often	RB
cord-023095-4dannjjm	4325	4	used	use	VBN
cord-023095-4dannjjm	4325	5	in	in	IN
cord-023095-4dannjjm	4325	6	human	human	JJ
cord-023095-4dannjjm	4325	7	medicine	medicine	NN
cord-023095-4dannjjm	4325	8	to	to	TO
cord-023095-4dannjjm	4325	9	treat	treat	VB
cord-023095-4dannjjm	4325	10	uncomplicated	uncomplicated	JJ
cord-023095-4dannjjm	4325	11	UTIs	uti	NNS
cord-023095-4dannjjm	4325	12	in	in	IN
cord-023095-4dannjjm	4325	13	women	woman	NNS
cord-023095-4dannjjm	4325	14	and	and	CC
cord-023095-4dannjjm	4325	15	can	can	MD
cord-023095-4dannjjm	4325	16	be	be	VB
cord-023095-4dannjjm	4325	17	prescribed	prescribe	VBN
cord-023095-4dannjjm	4325	18	for	for	IN
cord-023095-4dannjjm	4325	19	as	as	RB
cord-023095-4dannjjm	4325	20	little	little	JJ
cord-023095-4dannjjm	4325	21	as	as	IN
cord-023095-4dannjjm	4325	22	3	3	CD
cord-023095-4dannjjm	4325	23	days	day	NNS
cord-023095-4dannjjm	4325	24	.	.	.
cord-023095-4dannjjm	4326	1	The	the	DT
cord-023095-4dannjjm	4326	2	primary	primary	JJ
cord-023095-4dannjjm	4326	3	objective	objective	NN
cord-023095-4dannjjm	4326	4	of	of	IN
cord-023095-4dannjjm	4326	5	this	this	DT
cord-023095-4dannjjm	4326	6	study	study	NN
cord-023095-4dannjjm	4326	7	was	be	VBD
cord-023095-4dannjjm	4326	8	to	to	TO
cord-023095-4dannjjm	4326	9	determine	determine	VB
cord-023095-4dannjjm	4326	10	if	if	IN
cord-023095-4dannjjm	4326	11	dogs	dog	NNS
cord-023095-4dannjjm	4326	12	with	with	IN
cord-023095-4dannjjm	4326	13	naturally	naturally	RB
cord-023095-4dannjjm	4326	14	occurring	occur	VBG
cord-023095-4dannjjm	4326	15	uncomplicated	uncomplicated	JJ
cord-023095-4dannjjm	4326	16	UTI	UTI	NNP
cord-023095-4dannjjm	4326	17	have	have	VBP
cord-023095-4dannjjm	4326	18	equivalent	equivalent	JJ
cord-023095-4dannjjm	4326	19	microbiologic	microbiologic	JJ
cord-023095-4dannjjm	4326	20	cure	cure	NN
cord-023095-4dannjjm	4326	21	with	with	IN
cord-023095-4dannjjm	4326	22	a	a	DT
cord-023095-4dannjjm	4326	23	high	high	JJ
cord-023095-4dannjjm	4326	24	dose	dose	NN
cord-023095-4dannjjm	4326	25	short	short	JJ
cord-023095-4dannjjm	4326	26	duration	duration	NN
cord-023095-4dannjjm	4326	27	protocol	protocol	NN
cord-023095-4dannjjm	4326	28	of	of	IN
cord-023095-4dannjjm	4326	29	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	4326	30	,	,	,
cord-023095-4dannjjm	4326	31	compared	compare	VBN
cord-023095-4dannjjm	4326	32	to	to	IN
cord-023095-4dannjjm	4326	33	a	a	DT
cord-023095-4dannjjm	4326	34	standard	standard	JJ
cord-023095-4dannjjm	4326	35	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	4326	36	protocol	protocol	NN
cord-023095-4dannjjm	4326	37	.	.	.
cord-023095-4dannjjm	4327	1	Client	client	NN
cord-023095-4dannjjm	4327	2	-	-	HYPH
cord-023095-4dannjjm	4327	3	owned	own	VBN
cord-023095-4dannjjm	4327	4	adult	adult	NN
cord-023095-4dannjjm	4327	5	dogs	dog	NNS
cord-023095-4dannjjm	4327	6	with	with	IN
cord-023095-4dannjjm	4327	7	naturally	naturally	RB
cord-023095-4dannjjm	4327	8	occurring	occur	VBG
cord-023095-4dannjjm	4327	9	,	,	,
cord-023095-4dannjjm	4327	10	uncomplicated	uncomplicated	JJ
cord-023095-4dannjjm	4327	11	UTI	UTI	NNP
cord-023095-4dannjjm	4327	12	were	be	VBD
cord-023095-4dannjjm	4327	13	prospectively	prospectively	RB
cord-023095-4dannjjm	4327	14	enrolled	enrol	VBN
cord-023095-4dannjjm	4327	15	in	in	IN
cord-023095-4dannjjm	4327	16	a	a	DT
cord-023095-4dannjjm	4327	17	multi	multi	JJ
cord-023095-4dannjjm	4327	18	-	-	JJ
cord-023095-4dannjjm	4327	19	center	center	JJ
cord-023095-4dannjjm	4327	20	clinical	clinical	JJ
cord-023095-4dannjjm	4327	21	trial	trial	NN
cord-023095-4dannjjm	4327	22	and	and	CC
cord-023095-4dannjjm	4327	23	assigned	assign	VBN
cord-023095-4dannjjm	4327	24	to	to	IN
cord-023095-4dannjjm	4327	25	1	1	CD
cord-023095-4dannjjm	4327	26	of	of	IN
cord-023095-4dannjjm	4327	27	2	2	CD
cord-023095-4dannjjm	4327	28	groups	group	NNS
cord-023095-4dannjjm	4327	29	in	in	IN
cord-023095-4dannjjm	4327	30	a	a	DT
cord-023095-4dannjjm	4327	31	randomized	randomized	JJ
cord-023095-4dannjjm	4327	32	blinded	blinded	JJ
cord-023095-4dannjjm	4327	33	manner	manner	NN
cord-023095-4dannjjm	4327	34	.	.	.
cord-023095-4dannjjm	4328	1	Group	group	NN
cord-023095-4dannjjm	4328	2	1	1	CD
cord-023095-4dannjjm	4328	3	received	receive	VBD
cord-023095-4dannjjm	4328	4	treatment	treatment	NN
cord-023095-4dannjjm	4328	5	with	with	IN
cord-023095-4dannjjm	4328	6	18	18	CD
cord-023095-4dannjjm	4328	7	-	-	SYM
cord-023095-4dannjjm	4328	8	20	20	CD
cord-023095-4dannjjm	4328	9	mg	mg	NNP
cord-023095-4dannjjm	4328	10	/	/	SYM
cord-023095-4dannjjm	4328	11	kg	kg	NN
cord-023095-4dannjjm	4328	12	oral	oral	JJ
cord-023095-4dannjjm	4328	13	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	4328	14	once	once	RB
cord-023095-4dannjjm	4328	15	daily	daily	RB
cord-023095-4dannjjm	4328	16	for	for	IN
cord-023095-4dannjjm	4328	17	3	3	CD
cord-023095-4dannjjm	4328	18	consecutive	consecutive	JJ
cord-023095-4dannjjm	4328	19	days	day	NNS
cord-023095-4dannjjm	4328	20	.	.	.
cord-023095-4dannjjm	4329	1	Group	group	NN
cord-023095-4dannjjm	4329	2	2	2	CD
cord-023095-4dannjjm	4329	3	dogs	dog	NNS
cord-023095-4dannjjm	4329	4	were	be	VBD
cord-023095-4dannjjm	4329	5	treated	treat	VBN
cord-023095-4dannjjm	4329	6	with	with	IN
cord-023095-4dannjjm	4329	7	13.75	13.75	CD
cord-023095-4dannjjm	4329	8	-	-	SYM
cord-023095-4dannjjm	4329	9	25	25	CD
cord-023095-4dannjjm	4329	10	mg	mg	NNP
cord-023095-4dannjjm	4329	11	/	/	SYM
cord-023095-4dannjjm	4329	12	kg	kg	NNP
cord-023095-4dannjjm	4329	13	oral	oral	JJ
cord-023095-4dannjjm	4329	14	amoxicillin	amoxicillin	NNP
cord-023095-4dannjjm	4329	15	-	-	HYPH
cord-023095-4dannjjm	4329	16	clavulante	clavulante	NNP
cord-023095-4dannjjm	4329	17	twice	twice	RB
cord-023095-4dannjjm	4329	18	daily	daily	RB
cord-023095-4dannjjm	4329	19	for	for	IN
cord-023095-4dannjjm	4329	20	14	14	CD
cord-023095-4dannjjm	4329	21	days	day	NNS
cord-023095-4dannjjm	4329	22	.	.	.
cord-023095-4dannjjm	4330	1	Both	both	DT
cord-023095-4dannjjm	4330	2	groups	group	NNS
cord-023095-4dannjjm	4330	3	had	have	VBD
cord-023095-4dannjjm	4330	4	urinalyses	urinalysis	NNS
cord-023095-4dannjjm	4330	5	and	and	CC
cord-023095-4dannjjm	4330	6	urine	urine	NN
cord-023095-4dannjjm	4330	7	cultures	culture	NNS
cord-023095-4dannjjm	4330	8	submitted	submit	VBN
cord-023095-4dannjjm	4330	9	on	on	IN
cord-023095-4dannjjm	4330	10	day	day	NN
cord-023095-4dannjjm	4330	11	0	0	CD
cord-023095-4dannjjm	4330	12	,	,	,
cord-023095-4dannjjm	4330	13	10	10	CD
cord-023095-4dannjjm	4330	14	,	,	,
cord-023095-4dannjjm	4330	15	and	and	CC
cord-023095-4dannjjm	4330	16	21	21	CD
cord-023095-4dannjjm	4330	17	.	.	.
cord-023095-4dannjjm	4331	1	At	at	IN
cord-023095-4dannjjm	4331	2	the	the	DT
cord-023095-4dannjjm	4331	3	time	time	NN
cord-023095-4dannjjm	4331	4	of	of	IN
cord-023095-4dannjjm	4331	5	this	this	DT
cord-023095-4dannjjm	4331	6	interim	interim	JJ
cord-023095-4dannjjm	4331	7	analysis	analysis	NN
cord-023095-4dannjjm	4331	8	,	,	,
cord-023095-4dannjjm	4331	9	thirty	thirty	CD
cord-023095-4dannjjm	4331	10	-	-	HYPH
cord-023095-4dannjjm	4331	11	six	six	CD
cord-023095-4dannjjm	4331	12	dogs	dog	NNS
cord-023095-4dannjjm	4331	13	have	have	VBP
cord-023095-4dannjjm	4331	14	completed	complete	VBN
cord-023095-4dannjjm	4331	15	the	the	DT
cord-023095-4dannjjm	4331	16	trial	trial	NN
cord-023095-4dannjjm	4331	17	.	.	.
cord-023095-4dannjjm	4332	1	Bacteriological	bacteriological	JJ
cord-023095-4dannjjm	4332	2	cure	cure	NN
cord-023095-4dannjjm	4332	3	was	be	VBD
cord-023095-4dannjjm	4332	4	achieved	achieve	VBN
cord-023095-4dannjjm	4332	5	in	in	IN
cord-023095-4dannjjm	4332	6	15	15	CD
cord-023095-4dannjjm	4332	7	dogs	dog	NNS
cord-023095-4dannjjm	4332	8	(	(	-LRB-
cord-023095-4dannjjm	4332	9	83	83	CD
cord-023095-4dannjjm	4332	10	%	%	NN
cord-023095-4dannjjm	4332	11	)	)	-RRB-
cord-023095-4dannjjm	4332	12	treated	treat	VBN
cord-023095-4dannjjm	4332	13	with	with	IN
cord-023095-4dannjjm	4332	14	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	4332	15	and	and	CC
cord-023095-4dannjjm	4332	16	14	14	CD
cord-023095-4dannjjm	4332	17	dogs	dog	NNS
cord-023095-4dannjjm	4332	18	(	(	-LRB-
cord-023095-4dannjjm	4332	19	78	78	CD
cord-023095-4dannjjm	4332	20	%	%	NN
cord-023095-4dannjjm	4332	21	)	)	-RRB-
cord-023095-4dannjjm	4332	22	treated	treat	VBN
cord-023095-4dannjjm	4332	23	with	with	IN
cord-023095-4dannjjm	4332	24	amoxicillinclavulante	amoxicillinclavulante	NNP
cord-023095-4dannjjm	4332	25	,	,	,
cord-023095-4dannjjm	4332	26	respectively	respectively	RB
cord-023095-4dannjjm	4332	27	.	.	.
cord-023095-4dannjjm	4333	1	These	these	DT
cord-023095-4dannjjm	4333	2	data	datum	NNS
cord-023095-4dannjjm	4333	3	suggest	suggest	VBP
cord-023095-4dannjjm	4333	4	that	that	IN
cord-023095-4dannjjm	4333	5	the	the	DT
cord-023095-4dannjjm	4333	6	high	high	JJ
cord-023095-4dannjjm	4333	7	-	-	HYPH
cord-023095-4dannjjm	4333	8	dose	dose	NN
cord-023095-4dannjjm	4333	9	,	,	,
cord-023095-4dannjjm	4333	10	short	short	JJ
cord-023095-4dannjjm	4333	11	-	-	HYPH
cord-023095-4dannjjm	4333	12	duration	duration	NN
cord-023095-4dannjjm	4333	13	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	4333	14	protocol	protocol	NN
cord-023095-4dannjjm	4333	15	was	be	VBD
cord-023095-4dannjjm	4333	16	equally	equally	RB
cord-023095-4dannjjm	4333	17	effective	effective	JJ
cord-023095-4dannjjm	4333	18	to	to	IN
cord-023095-4dannjjm	4333	19	the	the	DT
cord-023095-4dannjjm	4333	20	standard	standard	JJ
cord-023095-4dannjjm	4333	21	protocol	protocol	NN
cord-023095-4dannjjm	4333	22	in	in	IN
cord-023095-4dannjjm	4333	23	treating	treat	VBG
cord-023095-4dannjjm	4333	24	uncomplicated	uncomplicated	JJ
cord-023095-4dannjjm	4333	25	canine	canine	JJ
cord-023095-4dannjjm	4333	26	UTI	UTI	NNP
cord-023095-4dannjjm	4333	27	in	in	IN
cord-023095-4dannjjm	4333	28	the	the	DT
cord-023095-4dannjjm	4333	29	sample	sample	NN
cord-023095-4dannjjm	4333	30	patient	patient	NN
cord-023095-4dannjjm	4333	31	population	population	NN
cord-023095-4dannjjm	4333	32	.	.	.
cord-023095-4dannjjm	4334	1	and	and	CC
cord-023095-4dannjjm	4334	2	may	may	MD
cord-023095-4dannjjm	4334	3	represent	represent	VB
cord-023095-4dannjjm	4334	4	a	a	DT
cord-023095-4dannjjm	4334	5	viable	viable	JJ
cord-023095-4dannjjm	4334	6	alternative	alternative	JJ
cord-023095-4dannjjm	4334	7	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	4334	8	regimen	regimen	NN
cord-023095-4dannjjm	4334	9	for	for	IN
cord-023095-4dannjjm	4334	10	similar	similar	JJ
cord-023095-4dannjjm	4334	11	patients	patient	NNS
cord-023095-4dannjjm	4334	12	.	.	.
cord-023095-4dannjjm	4335	1	Azotemia	Azotemia	NNP
cord-023095-4dannjjm	4335	2	is	be	VBZ
cord-023095-4dannjjm	4335	3	frequent	frequent	JJ
cord-023095-4dannjjm	4335	4	in	in	IN
cord-023095-4dannjjm	4335	5	dogs	dog	NNS
cord-023095-4dannjjm	4335	6	with	with	IN
cord-023095-4dannjjm	4335	7	DMVD	DMVD	NNP
cord-023095-4dannjjm	4336	1	(	(	-LRB-
cord-023095-4dannjjm	4336	2	Nicolle	Nicolle	NNP
cord-023095-4dannjjm	4336	3	et	et	NNP
cord-023095-4dannjjm	4336	4	al	al	NNP
cord-023095-4dannjjm	4336	5	;	;	:
cord-023095-4dannjjm	4336	6	JVIM	JVIM	NNP
cord-023095-4dannjjm	4336	7	2007	2007	CD
cord-023095-4dannjjm	4337	1	;	;	:
cord-023095-4dannjjm	4337	2	21:943	21:943	CD
cord-023095-4dannjjm	4337	3	-	-	SYM
cord-023095-4dannjjm	4337	4	949	949	CD
cord-023095-4dannjjm	4337	5	)	)	-RRB-
cord-023095-4dannjjm	4338	1	and	and	CC
cord-023095-4dannjjm	4338	2	could	could	MD
cord-023095-4dannjjm	4338	3	result	result	VB
cord-023095-4dannjjm	4338	4	from	from	IN
cord-023095-4dannjjm	4338	5	renal	renal	JJ
cord-023095-4dannjjm	4338	6	hemodynamic	hemodynamic	JJ
cord-023095-4dannjjm	4338	7	alterations	alteration	NNS
cord-023095-4dannjjm	4338	8	.	.	.
cord-023095-4dannjjm	4339	1	Renal	renal	JJ
cord-023095-4dannjjm	4339	2	resistive	resistive	JJ
cord-023095-4dannjjm	4339	3	index	index	NN
cord-023095-4dannjjm	4339	4	(	(	-LRB-
cord-023095-4dannjjm	4339	5	RI	RI	NNP
cord-023095-4dannjjm	4339	6	)	)	-RRB-
cord-023095-4dannjjm	4339	7	allows	allow	VBZ
cord-023095-4dannjjm	4339	8	assessment	assessment	NN
cord-023095-4dannjjm	4339	9	of	of	IN
cord-023095-4dannjjm	4339	10	renal	renal	JJ
cord-023095-4dannjjm	4339	11	vascular	vascular	JJ
cord-023095-4dannjjm	4339	12	resistance	resistance	NN
cord-023095-4dannjjm	4339	13	.	.	.
cord-023095-4dannjjm	4340	1	The	the	DT
cord-023095-4dannjjm	4340	2	aim	aim	NN
cord-023095-4dannjjm	4340	3	of	of	IN
cord-023095-4dannjjm	4340	4	this	this	DT
cord-023095-4dannjjm	4340	5	prospective	prospective	JJ
cord-023095-4dannjjm	4340	6	study	study	NN
cord-023095-4dannjjm	4340	7	was	be	VBD
cord-023095-4dannjjm	4340	8	to	to	TO
cord-023095-4dannjjm	4340	9	assess	assess	VB
cord-023095-4dannjjm	4340	10	RI	RI	NNP
cord-023095-4dannjjm	4340	11	in	in	IN
cord-023095-4dannjjm	4340	12	dogs	dog	NNS
cord-023095-4dannjjm	4340	13	with	with	IN
cord-023095-4dannjjm	4340	14	different	different	JJ
cord-023095-4dannjjm	4340	15	DMVD	DMVD	NNS
cord-023095-4dannjjm	4340	16	stages	stage	NNS
cord-023095-4dannjjm	4340	17	.	.	.
cord-023095-4dannjjm	4341	1	Fifty	fifty	CD
cord-023095-4dannjjm	4341	2	-	-	HYPH
cord-023095-4dannjjm	4341	3	five	five	CD
cord-023095-4dannjjm	4341	4	dogs	dog	NNS
cord-023095-4dannjjm	4341	5	with	with	IN
cord-023095-4dannjjm	4341	6	DVMD	DVMD	NNP
cord-023095-4dannjjm	4341	7	were	be	VBD
cord-023095-4dannjjm	4341	8	used	use	VBN
cord-023095-4dannjjm	4341	9	(	(	-LRB-
cord-023095-4dannjjm	4341	10	ISACHC	ISACHC	NNP
cord-023095-4dannjjm	4341	11	class	class	NN
cord-023095-4dannjjm	4341	12	1	1	CD
cord-023095-4dannjjm	4341	13	(	(	-LRB-
cord-023095-4dannjjm	4341	14	n	n	NN
cord-023095-4dannjjm	4341	15	5	5	CD
cord-023095-4dannjjm	4341	16	28	28	CD
cord-023095-4dannjjm	4341	17	)	)	-RRB-
cord-023095-4dannjjm	4341	18	,	,	,
cord-023095-4dannjjm	4341	19	2	2	CD
cord-023095-4dannjjm	4341	20	(	(	-LRB-
cord-023095-4dannjjm	4341	21	n	n	NN
cord-023095-4dannjjm	4341	22	5	5	CD
cord-023095-4dannjjm	4341	23	19	19	CD
cord-023095-4dannjjm	4341	24	)	)	-RRB-
cord-023095-4dannjjm	4341	25	,	,	,
cord-023095-4dannjjm	4341	26	and	and	CC
cord-023095-4dannjjm	4341	27	3	3	LS
cord-023095-4dannjjm	4341	28	(	(	-LRB-
cord-023095-4dannjjm	4341	29	n	n	NN
cord-023095-4dannjjm	4341	30	5	5	CD
cord-023095-4dannjjm	4341	31	8)	8)	NNP
cord-023095-4dannjjm	4341	32	)	)	-RRB-
cord-023095-4dannjjm	4341	33	.	.	.
cord-023095-4dannjjm	4342	1	Physical	physical	JJ
cord-023095-4dannjjm	4342	2	examination	examination	NN
cord-023095-4dannjjm	4342	3	,	,	,
cord-023095-4dannjjm	4342	4	renal	renal	JJ
cord-023095-4dannjjm	4342	5	ultrasonography	ultrasonography	NN
cord-023095-4dannjjm	4342	6	and	and	CC
cord-023095-4dannjjm	4342	7	echo	echo	NN
cord-023095-4dannjjm	4342	8	-	-	HYPH
cord-023095-4dannjjm	4342	9	Doppler	doppler	NN
cord-023095-4dannjjm	4342	10	examinations	examination	NNS
cord-023095-4dannjjm	4342	11	were	be	VBD
cord-023095-4dannjjm	4342	12	performed	perform	VBN
cord-023095-4dannjjm	4342	13	in	in	IN
cord-023095-4dannjjm	4342	14	awake	awake	JJ
cord-023095-4dannjjm	4342	15	dogs	dog	NNS
cord-023095-4dannjjm	4342	16	by	by	IN
cord-023095-4dannjjm	4342	17	trained	train	VBN
cord-023095-4dannjjm	4342	18	observers	observer	NNS
cord-023095-4dannjjm	4342	19	.	.	.
cord-023095-4dannjjm	4343	1	Plasma	plasma	NN
cord-023095-4dannjjm	4343	2	creatinine	creatinine	NN
cord-023095-4dannjjm	4343	3	,	,	,
cord-023095-4dannjjm	4343	4	urea	urea	NN
cord-023095-4dannjjm	4343	5	and	and	CC
cord-023095-4dannjjm	4343	6	NT	NT	NNP
cord-023095-4dannjjm	4343	7	-	-	HYPH
cord-023095-4dannjjm	4343	8	proBNP	proBNP	NNP
cord-023095-4dannjjm	4343	9	were	be	VBD
cord-023095-4dannjjm	4343	10	measured	measure	VBN
cord-023095-4dannjjm	4343	11	.	.	.
cord-023095-4dannjjm	4344	1	Statistical	statistical	JJ
cord-023095-4dannjjm	4344	2	analyses	analysis	NNS
cord-023095-4dannjjm	4344	3	were	be	VBD
cord-023095-4dannjjm	4344	4	performed	perform	VBN
cord-023095-4dannjjm	4344	5	using	use	VBG
cord-023095-4dannjjm	4344	6	a	a	DT
cord-023095-4dannjjm	4344	7	general	general	JJ
cord-023095-4dannjjm	4344	8	linear	linear	JJ
cord-023095-4dannjjm	4344	9	model	model	NN
cord-023095-4dannjjm	4344	10	.	.	.
cord-023095-4dannjjm	4345	1	Whereas	whereas	IN
cord-023095-4dannjjm	4345	2	RI	RI	NNP
cord-023095-4dannjjm	4345	3	of	of	IN
cord-023095-4dannjjm	4345	4	renal	renal	JJ
cord-023095-4dannjjm	4345	5	and	and	CC
cord-023095-4dannjjm	4345	6	arcuate	arcuate	JJ
cord-023095-4dannjjm	4345	7	arteries	artery	NNS
cord-023095-4dannjjm	4345	8	were	be	VBD
cord-023095-4dannjjm	4345	9	unaffected	unaffected	JJ
cord-023095-4dannjjm	4345	10	by	by	IN
cord-023095-4dannjjm	4345	11	ISACHC	ISACHC	NNP
cord-023095-4dannjjm	4345	12	class	class	NN
cord-023095-4dannjjm	4345	13	,	,	,
cord-023095-4dannjjm	4345	14	left	leave	VBD
cord-023095-4dannjjm	4345	15	interlobar	interlobar	NN
cord-023095-4dannjjm	4345	16	RI	RI	NNP
cord-023095-4dannjjm	4345	17	increased	increase	VBN
cord-023095-4dannjjm	4345	18	(	(	-LRB-
cord-023095-4dannjjm	4345	19	P	p	NN
cord-023095-4dannjjm	4345	20	o	o	NN
cord-023095-4dannjjm	4345	21	0.001	0.001	CD
cord-023095-4dannjjm	4345	22	)	)	-RRB-
cord-023095-4dannjjm	4345	23	from	from	IN
cord-023095-4dannjjm	4345	24	0.62	0.62	CD
cord-023095-4dannjjm	4345	25	AE	AE	NNP
cord-023095-4dannjjm	4345	26	0.05	0.05	CD
cord-023095-4dannjjm	4345	27	(	(	-LRB-
cord-023095-4dannjjm	4345	28	mean	mean	VB
cord-023095-4dannjjm	4345	29	AE	AE	NNP
cord-023095-4dannjjm	4345	30	SD	SD	NNP
cord-023095-4dannjjm	4345	31	)	)	-RRB-
cord-023095-4dannjjm	4345	32	in	in	IN
cord-023095-4dannjjm	4345	33	class	class	NN
cord-023095-4dannjjm	4345	34	1	1	CD
cord-023095-4dannjjm	4345	35	to	to	IN
cord-023095-4dannjjm	4345	36	0.76	0.76	CD
cord-023095-4dannjjm	4345	37	AE	AE	NNP
cord-023095-4dannjjm	4345	38	0.08	0.08	CD
cord-023095-4dannjjm	4345	39	in	in	IN
cord-023095-4dannjjm	4345	40	class	class	NN
cord-023095-4dannjjm	4345	41	3	3	CD
cord-023095-4dannjjm	4345	42	.	.	.
cord-023095-4dannjjm	4346	1	Left	leave	VBN
cord-023095-4dannjjm	4346	2	interlobar	interlobar	NN
cord-023095-4dannjjm	4346	3	RI	RI	NNP
cord-023095-4dannjjm	4346	4	was	be	VBD
cord-023095-4dannjjm	4346	5	also	also	RB
cord-023095-4dannjjm	4346	6	higher	high	JJR
cord-023095-4dannjjm	4347	1	(	(	-LRB-
cord-023095-4dannjjm	4347	2	P	p	NN
cord-023095-4dannjjm	4347	3	o	o	NN
cord-023095-4dannjjm	4347	4	0.001	0.001	CD
cord-023095-4dannjjm	4347	5	)	)	-RRB-
cord-023095-4dannjjm	4347	6	in	in	IN
cord-023095-4dannjjm	4347	7	azotemic	azotemic	NNP
cord-023095-4dannjjm	4347	8	(	(	-LRB-
cord-023095-4dannjjm	4347	9	0.74	0.74	CD
cord-023095-4dannjjm	4347	10	AE	AE	NNP
cord-023095-4dannjjm	4347	11	0.008	0.008	CD
cord-023095-4dannjjm	4347	12	)	)	-RRB-
cord-023095-4dannjjm	4347	13	than	than	IN
cord-023095-4dannjjm	4347	14	in	in	IN
cord-023095-4dannjjm	4347	15	non	non	JJ
cord-023095-4dannjjm	4347	16	azotemic	azotemic	NNP
cord-023095-4dannjjm	4348	1	(	(	-LRB-
cord-023095-4dannjjm	4348	2	0.62	0.62	CD
cord-023095-4dannjjm	4348	3	AE	AE	NNP
cord-023095-4dannjjm	4348	4	0.005	0.005	CD
cord-023095-4dannjjm	4348	5	)	)	-RRB-
cord-023095-4dannjjm	4348	6	dogs	dog	NNS
cord-023095-4dannjjm	4348	7	.	.	.
cord-023095-4dannjjm	4349	1	Similar	similar	JJ
cord-023095-4dannjjm	4349	2	findings	finding	NNS
cord-023095-4dannjjm	4349	3	were	be	VBD
cord-023095-4dannjjm	4349	4	observed	observe	VBN
cord-023095-4dannjjm	4349	5	for	for	IN
cord-023095-4dannjjm	4349	6	right	right	JJ
cord-023095-4dannjjm	4349	7	interlobar	interlobar	NN
cord-023095-4dannjjm	4349	8	RI	RI	NNP
cord-023095-4dannjjm	4349	9	.	.	.
cord-023095-4dannjjm	4350	1	A	a	DT
cord-023095-4dannjjm	4350	2	positive	positive	JJ
cord-023095-4dannjjm	4350	3	effect	effect	NN
cord-023095-4dannjjm	4350	4	of	of	IN
cord-023095-4dannjjm	4350	5	NT	NT	NNP
cord-023095-4dannjjm	4350	6	-	-	HYPH
cord-023095-4dannjjm	4350	7	proBNP	proBNP	NNP
cord-023095-4dannjjm	4350	8	(	(	-LRB-
cord-023095-4dannjjm	4350	9	P	p	NN
cord-023095-4dannjjm	4350	10	5	5	CD
cord-023095-4dannjjm	4350	11	0.002	0.002	CD
cord-023095-4dannjjm	4350	12	)	)	-RRB-
cord-023095-4dannjjm	4350	13	,	,	,
cord-023095-4dannjjm	4350	14	urea	urea	NN
cord-023095-4dannjjm	4350	15	(	(	-LRB-
cord-023095-4dannjjm	4350	16	P	p	NN
cord-023095-4dannjjm	4350	17	o	o	NN
cord-023095-4dannjjm	4350	18	0.001	0.001	CD
cord-023095-4dannjjm	4350	19	)	)	-RRB-
cord-023095-4dannjjm	4350	20	,	,	,
cord-023095-4dannjjm	4350	21	creatinine	creatinine	NN
cord-023095-4dannjjm	4350	22	(	(	-LRB-
cord-023095-4dannjjm	4350	23	P	p	NN
cord-023095-4dannjjm	4350	24	5	5	CD
cord-023095-4dannjjm	4350	25	0.002	0.002	CD
cord-023095-4dannjjm	4350	26	)	)	-RRB-
cord-023095-4dannjjm	4350	27	,	,	,
cord-023095-4dannjjm	4350	28	urea	urea	NN
cord-023095-4dannjjm	4350	29	-	-	HYPH
cord-023095-4dannjjm	4350	30	to	to	IN
cord-023095-4dannjjm	4350	31	-	-	HYPH
cord-023095-4dannjjm	4350	32	creatinine	creatinine	NN
cord-023095-4dannjjm	4350	33	ratio	ratio	NN
cord-023095-4dannjjm	4350	34	(	(	-LRB-
cord-023095-4dannjjm	4350	35	P	p	NN
cord-023095-4dannjjm	4350	36	o	o	NN
cord-023095-4dannjjm	4350	37	0.001	0.001	CD
cord-023095-4dannjjm	4350	38	)	)	-RRB-
cord-023095-4dannjjm	4350	39	,	,	,
cord-023095-4dannjjm	4350	40	left	leave	VBD
cord-023095-4dannjjm	4350	41	atrium	atrium	NN
cord-023095-4dannjjm	4350	42	-	-	HYPH
cord-023095-4dannjjm	4350	43	to	to	IN
cord-023095-4dannjjm	4350	44	-	-	HYPH
cord-023095-4dannjjm	4350	45	aorta	aorta	NN
cord-023095-4dannjjm	4350	46	ratio	ratio	NN
cord-023095-4dannjjm	4350	47	(	(	-LRB-
cord-023095-4dannjjm	4350	48	P	p	NN
cord-023095-4dannjjm	4350	49	o	o	NN
cord-023095-4dannjjm	4350	50	0.001	0.001	CD
cord-023095-4dannjjm	4350	51	)	)	-RRB-
cord-023095-4dannjjm	4350	52	,	,	,
cord-023095-4dannjjm	4350	53	regurgitation	regurgitation	NN
cord-023095-4dannjjm	4350	54	fraction	fraction	NN
cord-023095-4dannjjm	4350	55	(	(	-LRB-
cord-023095-4dannjjm	4350	56	P	p	NN
cord-023095-4dannjjm	4350	57	5	5	CD
cord-023095-4dannjjm	4350	58	0.011	0.011	CD
cord-023095-4dannjjm	4350	59	)	)	-RRB-
cord-023095-4dannjjm	4350	60	,	,	,
cord-023095-4dannjjm	4350	61	systolic	systolic	JJ
cord-023095-4dannjjm	4350	62	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	4350	63	arterial	arterial	JJ
cord-023095-4dannjjm	4350	64	pressure	pressure	NN
cord-023095-4dannjjm	4350	65	(	(	-LRB-
cord-023095-4dannjjm	4350	66	P	p	NN
cord-023095-4dannjjm	4350	67	o	o	NN
cord-023095-4dannjjm	4350	68	0.001	0.001	CD
cord-023095-4dannjjm	4350	69	)	)	-RRB-
cord-023095-4dannjjm	4350	70	and	and	CC
cord-023095-4dannjjm	4350	71	shortening	shorten	VBG
cord-023095-4dannjjm	4350	72	fraction	fraction	NN
cord-023095-4dannjjm	4350	73	(	(	-LRB-
cord-023095-4dannjjm	4350	74	P	p	NN
cord-023095-4dannjjm	4350	75	5	5	CD
cord-023095-4dannjjm	4350	76	0.028	0.028	CD
cord-023095-4dannjjm	4350	77	)	)	-RRB-
cord-023095-4dannjjm	4350	78	on	on	IN
cord-023095-4dannjjm	4350	79	RI	RI	NNP
cord-023095-4dannjjm	4350	80	was	be	VBD
cord-023095-4dannjjm	4350	81	also	also	RB
cord-023095-4dannjjm	4350	82	observed	observe	VBN
cord-023095-4dannjjm	4350	83	.	.	.
cord-023095-4dannjjm	4351	1	In	in	IN
cord-023095-4dannjjm	4351	2	conclusion	conclusion	NN
cord-023095-4dannjjm	4351	3	,	,	,
cord-023095-4dannjjm	4351	4	interlobar	interlobar	JJ
cord-023095-4dannjjm	4351	5	RI	RI	NNP
cord-023095-4dannjjm	4351	6	increases	increase	VBZ
cord-023095-4dannjjm	4351	7	with	with	IN
cord-023095-4dannjjm	4351	8	the	the	DT
cord-023095-4dannjjm	4351	9	severity	severity	NN
cord-023095-4dannjjm	4351	10	of	of	IN
cord-023095-4dannjjm	4351	11	DMVD	DMVD	NNP
cord-023095-4dannjjm	4351	12	and	and	CC
cord-023095-4dannjjm	4351	13	azotemia	azotemia	NN
cord-023095-4dannjjm	4351	14	.	.	.
cord-023095-4dannjjm	4352	1	A	a	DT
cord-023095-4dannjjm	4352	2	cause	cause	NN
cord-023095-4dannjjm	4352	3	-	-	HYPH
cord-023095-4dannjjm	4352	4	effect	effect	NN
cord-023095-4dannjjm	4352	5	relationship	relationship	NN
cord-023095-4dannjjm	4352	6	remains	remain	VBZ
cord-023095-4dannjjm	4352	7	however	however	RB
cord-023095-4dannjjm	4352	8	to	to	TO
cord-023095-4dannjjm	4352	9	be	be	VB
cord-023095-4dannjjm	4352	10	established	establish	VBN
cord-023095-4dannjjm	4352	11	.	.	.
cord-023095-4dannjjm	4353	1	Antibodies	antibody	NNS
cord-023095-4dannjjm	4353	2	against	against	IN
cord-023095-4dannjjm	4353	3	alpha	alpha	NN
cord-023095-4dannjjm	4353	4	-	-	HYPH
cord-023095-4dannjjm	4353	5	enolase	enolase	NN
cord-023095-4dannjjm	4353	6	are	be	VBP
cord-023095-4dannjjm	4353	7	associated	associate	VBN
cord-023095-4dannjjm	4353	8	with	with	IN
cord-023095-4dannjjm	4353	9	immunemediated	immunemediated	JJ
cord-023095-4dannjjm	4353	10	nephritis	nephritis	NN
cord-023095-4dannjjm	4353	11	in	in	IN
cord-023095-4dannjjm	4353	12	people	people	NNS
cord-023095-4dannjjm	4353	13	.	.	.
cord-023095-4dannjjm	4354	1	It	-PRON-	PRP
cord-023095-4dannjjm	4354	2	was	be	VBD
cord-023095-4dannjjm	4354	3	previously	previously	RB
cord-023095-4dannjjm	4354	4	shown	show	VBN
cord-023095-4dannjjm	4354	5	that	that	IN
cord-023095-4dannjjm	4354	6	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	4354	7	cats	cat	NNS
cord-023095-4dannjjm	4354	8	commonly	commonly	RB
cord-023095-4dannjjm	4354	9	develop	develop	VBP
cord-023095-4dannjjm	4354	10	antibodies	antibody	NNS
cord-023095-4dannjjm	4354	11	against	against	IN
cord-023095-4dannjjm	4354	12	alpha	alpha	NN
cord-023095-4dannjjm	4354	13	-	-	HYPH
cord-023095-4dannjjm	4354	14	enolase	enolase	NN
cord-023095-4dannjjm	4354	15	.	.	.
cord-023095-4dannjjm	4355	1	The	the	DT
cord-023095-4dannjjm	4355	2	purpose	purpose	NN
cord-023095-4dannjjm	4355	3	of	of	IN
cord-023095-4dannjjm	4355	4	this	this	DT
cord-023095-4dannjjm	4355	5	study	study	NN
cord-023095-4dannjjm	4355	6	was	be	VBD
cord-023095-4dannjjm	4355	7	to	to	TO
cord-023095-4dannjjm	4355	8	assess	assess	VB
cord-023095-4dannjjm	4355	9	for	for	IN
cord-023095-4dannjjm	4355	10	associations	association	NNS
cord-023095-4dannjjm	4355	11	between	between	IN
cord-023095-4dannjjm	4355	12	alphaenolase	alphaenolase	NNP
cord-023095-4dannjjm	4355	13	antibodies	antibody	NNS
cord-023095-4dannjjm	4355	14	and	and	CC
cord-023095-4dannjjm	4355	15	azotemia	azotemia	NN
cord-023095-4dannjjm	4355	16	in	in	IN
cord-023095-4dannjjm	4355	17	privately	privately	RB
cord-023095-4dannjjm	4355	18	-	-	HYPH
cord-023095-4dannjjm	4355	19	owned	own	VBN
cord-023095-4dannjjm	4355	20	cats	cat	NNS
cord-023095-4dannjjm	4355	21	.	.	.
cord-023095-4dannjjm	4356	1	Clinically	clinically	RB
cord-023095-4dannjjm	4356	2	stable	stable	JJ
cord-023095-4dannjjm	4356	3	privately	privately	RB
cord-023095-4dannjjm	4356	4	owned	own	VBN
cord-023095-4dannjjm	4356	5	cats	cat	NNS
cord-023095-4dannjjm	4356	6	!	!	.
cord-023095-4dannjjm	4357	1	10	10	CD
cord-023095-4dannjjm	4357	2	years	year	NNS
cord-023095-4dannjjm	4357	3	of	of	IN
cord-023095-4dannjjm	4357	4	age	age	NN
cord-023095-4dannjjm	4357	5	,	,	,
cord-023095-4dannjjm	4357	6	with	with	IN
cord-023095-4dannjjm	4357	7	and	and	CC
cord-023095-4dannjjm	4357	8	without	without	IN
cord-023095-4dannjjm	4357	9	azotemia	azotemia	NNP
cord-023095-4dannjjm	4357	10	(	(	-LRB-
cord-023095-4dannjjm	4357	11	creatinine	creatinine	NN
cord-023095-4dannjjm	4357	12	4	4	CD
cord-023095-4dannjjm	4357	13	2	2	CD
cord-023095-4dannjjm	4357	14	mg	mg	NNP
cord-023095-4dannjjm	4357	15	/	/	SYM
cord-023095-4dannjjm	4357	16	dl	dl	NNP
cord-023095-4dannjjm	4357	17	)	)	-RRB-
cord-023095-4dannjjm	4357	18	,	,	,
cord-023095-4dannjjm	4357	19	and	and	CC
cord-023095-4dannjjm	4357	20	with	with	IN
cord-023095-4dannjjm	4357	21	an	an	DT
cord-023095-4dannjjm	4357	22	available	available	JJ
cord-023095-4dannjjm	4357	23	vaccine	vaccine	NN
cord-023095-4dannjjm	4357	24	history	history	NN
cord-023095-4dannjjm	4357	25	for	for	IN
cord-023095-4dannjjm	4357	26	!	!	.
cord-023095-4dannjjm	4358	1	5	5	CD
cord-023095-4dannjjm	4358	2	years	year	NNS
cord-023095-4dannjjm	4358	3	were	be	VBD
cord-023095-4dannjjm	4358	4	recruited	recruit	VBN
cord-023095-4dannjjm	4358	5	for	for	IN
cord-023095-4dannjjm	4358	6	the	the	DT
cord-023095-4dannjjm	4358	7	study	study	NN
cord-023095-4dannjjm	4358	8	.	.	.
cord-023095-4dannjjm	4359	1	Sera	Sera	NNP
cord-023095-4dannjjm	4359	2	were	be	VBD
cord-023095-4dannjjm	4359	3	assayed	assay	VBN
cord-023095-4dannjjm	4359	4	for	for	IN
cord-023095-4dannjjm	4359	5	creatinine	creatinine	NN
cord-023095-4dannjjm	4359	6	concentrations	concentration	NNS
cord-023095-4dannjjm	4359	7	and	and	CC
cord-023095-4dannjjm	4359	8	alpha	alpha	NN
cord-023095-4dannjjm	4359	9	-	-	HYPH
cord-023095-4dannjjm	4359	10	enolase	enolase	JJ
cord-023095-4dannjjm	4359	11	antibodies	antibody	NNS
cord-023095-4dannjjm	4359	12	by	by	IN
cord-023095-4dannjjm	4359	13	use	use	NN
cord-023095-4dannjjm	4359	14	of	of	IN
cord-023095-4dannjjm	4359	15	previously	previously	RB
cord-023095-4dannjjm	4359	16	validated	validate	VBN
cord-023095-4dannjjm	4359	17	techniques	technique	NNS
cord-023095-4dannjjm	4359	18	.	.	.
cord-023095-4dannjjm	4360	1	Results	result	NNS
cord-023095-4dannjjm	4360	2	from	from	IN
cord-023095-4dannjjm	4360	3	cats	cat	NNS
cord-023095-4dannjjm	4360	4	with	with	IN
cord-023095-4dannjjm	4360	5	and	and	CC
cord-023095-4dannjjm	4360	6	without	without	IN
cord-023095-4dannjjm	4360	7	azotemia	azotemia	NN
cord-023095-4dannjjm	4360	8	were	be	VBD
cord-023095-4dannjjm	4360	9	compared	compare	VBN
cord-023095-4dannjjm	4360	10	by	by	IN
cord-023095-4dannjjm	4360	11	Student	Student	NNP
cord-023095-4dannjjm	4360	12	's	's	POS
cord-023095-4dannjjm	4360	13	2-tailed	2-tailed	CD
cord-023095-4dannjjm	4360	14	t	t	NN
cord-023095-4dannjjm	4360	15	test	test	NN
cord-023095-4dannjjm	4360	16	or	or	CC
cord-023095-4dannjjm	4360	17	Fisher	Fisher	NNP
cord-023095-4dannjjm	4360	18	's	's	POS
cord-023095-4dannjjm	4360	19	exact	exact	JJ
cord-023095-4dannjjm	4360	20	test	test	NN
cord-023095-4dannjjm	4360	21	with	with	IN
cord-023095-4dannjjm	4360	22	significance	significance	NN
cord-023095-4dannjjm	4360	23	defined	define	VBN
cord-023095-4dannjjm	4360	24	as	as	IN
cord-023095-4dannjjm	4360	25	p	p	NN
cord-023095-4dannjjm	4360	26	o	o	NN
cord-023095-4dannjjm	4360	27	0.05	0.05	CD
cord-023095-4dannjjm	4360	28	.	.	.
cord-023095-4dannjjm	4361	1	Median	median	JJ
cord-023095-4dannjjm	4361	2	ages	age	NNS
cord-023095-4dannjjm	4361	3	were	be	VBD
cord-023095-4dannjjm	4361	4	15	15	CD
cord-023095-4dannjjm	4361	5	years	year	NNS
cord-023095-4dannjjm	4362	1	(	(	-LRB-
cord-023095-4dannjjm	4362	2	range	range	NN
cord-023095-4dannjjm	4362	3	:	:	:
cord-023095-4dannjjm	4362	4	10	10	CD
cord-023095-4dannjjm	4362	5	-	-	SYM
cord-023095-4dannjjm	4362	6	18	18	CD
cord-023095-4dannjjm	4362	7	)	)	-RRB-
cord-023095-4dannjjm	4362	8	and	and	CC
cord-023095-4dannjjm	4362	9	12	12	CD
cord-023095-4dannjjm	4362	10	years	year	NNS
cord-023095-4dannjjm	4362	11	(	(	-LRB-
cord-023095-4dannjjm	4362	12	range	range	NN
cord-023095-4dannjjm	4362	13	:	:	:
cord-023095-4dannjjm	4362	14	10	10	CD
cord-023095-4dannjjm	4362	15	-	-	SYM
cord-023095-4dannjjm	4362	16	15	15	CD
cord-023095-4dannjjm	4362	17	)	)	-RRB-
cord-023095-4dannjjm	4362	18	for	for	IN
cord-023095-4dannjjm	4362	19	cats	cat	NNS
cord-023095-4dannjjm	4362	20	with	with	IN
cord-023095-4dannjjm	4362	21	(	(	-LRB-
cord-023095-4dannjjm	4362	22	n	n	NN
cord-023095-4dannjjm	4362	23	5	5	CD
cord-023095-4dannjjm	4362	24	35	35	CD
cord-023095-4dannjjm	4362	25	)	)	-RRB-
cord-023095-4dannjjm	4362	26	and	and	CC
cord-023095-4dannjjm	4362	27	without	without	IN
cord-023095-4dannjjm	4362	28	azotemia	azotemia	NNP
cord-023095-4dannjjm	4362	29	(	(	-LRB-
cord-023095-4dannjjm	4362	30	n	n	NN
cord-023095-4dannjjm	4362	31	5	5	CD
cord-023095-4dannjjm	4362	32	27	27	CD
cord-023095-4dannjjm	4362	33	)	)	-RRB-
cord-023095-4dannjjm	4362	34	,	,	,
cord-023095-4dannjjm	4362	35	respectively	respectively	RB
cord-023095-4dannjjm	4362	36	.	.	.
cord-023095-4dannjjm	4363	1	There	there	EX
cord-023095-4dannjjm	4363	2	was	be	VBD
cord-023095-4dannjjm	4363	3	no	no	DT
cord-023095-4dannjjm	4363	4	significant	significant	JJ
cord-023095-4dannjjm	4363	5	difference	difference	NN
cord-023095-4dannjjm	4363	6	in	in	IN
cord-023095-4dannjjm	4363	7	vaccine	vaccine	NN
cord-023095-4dannjjm	4363	8	events	event	NNS
cord-023095-4dannjjm	4363	9	(	(	-LRB-
cord-023095-4dannjjm	4363	10	number	number	NN
cord-023095-4dannjjm	4363	11	,	,	,
cord-023095-4dannjjm	4363	12	type	type	NN
cord-023095-4dannjjm	4363	13	,	,	,
cord-023095-4dannjjm	4363	14	or	or	CC
cord-023095-4dannjjm	4363	15	route	route	NN
cord-023095-4dannjjm	4363	16	of	of	IN
cord-023095-4dannjjm	4363	17	administration	administration	NN
cord-023095-4dannjjm	4363	18	)	)	-RRB-
cord-023095-4dannjjm	4363	19	between	between	IN
cord-023095-4dannjjm	4363	20	groups	group	NNS
cord-023095-4dannjjm	4363	21	.	.	.
cord-023095-4dannjjm	4364	1	Azotemic	Azotemic	NNP
cord-023095-4dannjjm	4364	2	cats	cat	NNS
cord-023095-4dannjjm	4364	3	(	(	-LRB-
cord-023095-4dannjjm	4364	4	34.3	34.3	CD
cord-023095-4dannjjm	4364	5	%	%	NN
cord-023095-4dannjjm	4364	6	)	)	-RRB-
cord-023095-4dannjjm	4364	7	were	be	VBD
cord-023095-4dannjjm	4364	8	more	more	RBR
cord-023095-4dannjjm	4364	9	likely	likely	JJ
cord-023095-4dannjjm	4364	10	than	than	IN
cord-023095-4dannjjm	4364	11	normal	normal	JJ
cord-023095-4dannjjm	4364	12	cats	cat	NNS
cord-023095-4dannjjm	4364	13	(	(	-LRB-
cord-023095-4dannjjm	4364	14	12.5	12.5	CD
cord-023095-4dannjjm	4364	15	%	%	NN
cord-023095-4dannjjm	4364	16	)	)	-RRB-
cord-023095-4dannjjm	4364	17	to	to	TO
cord-023095-4dannjjm	4364	18	be	be	VB
cord-023095-4dannjjm	4364	19	positive	positive	JJ
cord-023095-4dannjjm	4364	20	for	for	IN
cord-023095-4dannjjm	4364	21	antibodies	antibody	NNS
cord-023095-4dannjjm	4364	22	against	against	IN
cord-023095-4dannjjm	4364	23	alpha	alpha	NN
cord-023095-4dannjjm	4364	24	-	-	HYPH
cord-023095-4dannjjm	4364	25	enolase	enolase	NN
cord-023095-4dannjjm	4364	26	(	(	-LRB-
cord-023095-4dannjjm	4364	27	p	p	NN
cord-023095-4dannjjm	4364	28	5	5	CD
cord-023095-4dannjjm	4364	29	0.016	0.016	CD
cord-023095-4dannjjm	4364	30	)	)	-RRB-
cord-023095-4dannjjm	4364	31	.	.	.
cord-023095-4dannjjm	4365	1	In	in	IN
cord-023095-4dannjjm	4365	2	addition	addition	NN
cord-023095-4dannjjm	4365	3	,	,	,
cord-023095-4dannjjm	4365	4	alpha	alpha	NN
cord-023095-4dannjjm	4365	5	-	-	HYPH
cord-023095-4dannjjm	4365	6	enolase	enolase	JJ
cord-023095-4dannjjm	4365	7	antibody	antibody	NN
cord-023095-4dannjjm	4365	8	concentrations	concentration	NNS
cord-023095-4dannjjm	4365	9	were	be	VBD
cord-023095-4dannjjm	4365	10	greater	great	JJR
cord-023095-4dannjjm	4365	11	(	(	-LRB-
cord-023095-4dannjjm	4365	12	p	p	NN
cord-023095-4dannjjm	4365	13	5	5	CD
cord-023095-4dannjjm	4365	14	0.041	0.041	CD
cord-023095-4dannjjm	4365	15	)	)	-RRB-
cord-023095-4dannjjm	4365	16	in	in	IN
cord-023095-4dannjjm	4365	17	azotemic	azotemic	JJ
cord-023095-4dannjjm	4365	18	cats	cat	NNS
cord-023095-4dannjjm	4365	19	(	(	-LRB-
cord-023095-4dannjjm	4365	20	mean	mean	VBP
cord-023095-4dannjjm	4365	21	%	%	NN
cord-023095-4dannjjm	4365	22	ELISA	ELISA	NNP
cord-023095-4dannjjm	4365	23	5	5	CD
cord-023095-4dannjjm	4365	24	62.5	62.5	CD
cord-023095-4dannjjm	4365	25	%	%	NN
cord-023095-4dannjjm	4365	26	)	)	-RRB-
cord-023095-4dannjjm	4365	27	than	than	IN
cord-023095-4dannjjm	4365	28	cats	cat	NNS
cord-023095-4dannjjm	4365	29	with	with	IN
cord-023095-4dannjjm	4365	30	normal	normal	JJ
cord-023095-4dannjjm	4365	31	creatinine	creatinine	NN
cord-023095-4dannjjm	4365	32	concentrations	concentration	NNS
cord-023095-4dannjjm	4366	1	(	(	-LRB-
cord-023095-4dannjjm	4366	2	mean	mean	VB
cord-023095-4dannjjm	4366	3	%	%	NN
cord-023095-4dannjjm	4366	4	ELISA	ELISA	NNP
cord-023095-4dannjjm	4366	5	5	5	CD
cord-023095-4dannjjm	4366	6	47.2	47.2	CD
cord-023095-4dannjjm	4366	7	%	%	NN
cord-023095-4dannjjm	4366	8	)	)	-RRB-
cord-023095-4dannjjm	4366	9	.	.	.
cord-023095-4dannjjm	4367	1	Results	result	NNS
cord-023095-4dannjjm	4367	2	of	of	IN
cord-023095-4dannjjm	4367	3	this	this	DT
cord-023095-4dannjjm	4367	4	study	study	NN
cord-023095-4dannjjm	4367	5	suggest	suggest	VBP
cord-023095-4dannjjm	4367	6	that	that	IN
cord-023095-4dannjjm	4367	7	antibodies	antibody	NNS
cord-023095-4dannjjm	4367	8	against	against	IN
cord-023095-4dannjjm	4367	9	alpha	alpha	NN
cord-023095-4dannjjm	4367	10	-	-	NN
cord-023095-4dannjjm	4367	11	enolase	enolase	NN
cord-023095-4dannjjm	4367	12	in	in	IN
cord-023095-4dannjjm	4367	13	cats	cat	NNS
cord-023095-4dannjjm	4367	14	may	may	MD
cord-023095-4dannjjm	4367	15	be	be	VB
cord-023095-4dannjjm	4367	16	associated	associate	VBN
cord-023095-4dannjjm	4367	17	with	with	IN
cord-023095-4dannjjm	4367	18	renal	renal	JJ
cord-023095-4dannjjm	4367	19	disease	disease	NN
cord-023095-4dannjjm	4367	20	.	.	.
cord-023095-4dannjjm	4368	1	Additional	additional	JJ
cord-023095-4dannjjm	4368	2	prospective	prospective	JJ
cord-023095-4dannjjm	4368	3	evaluation	evaluation	NN
cord-023095-4dannjjm	4368	4	in	in	IN
cord-023095-4dannjjm	4368	5	a	a	DT
cord-023095-4dannjjm	4368	6	larger	large	JJR
cord-023095-4dannjjm	4368	7	number	number	NN
cord-023095-4dannjjm	4368	8	of	of	IN
cord-023095-4dannjjm	4368	9	cats	cat	NNS
cord-023095-4dannjjm	4368	10	is	be	VBZ
cord-023095-4dannjjm	4368	11	indicated	indicate	VBN
cord-023095-4dannjjm	4368	12	.	.	.
cord-023095-4dannjjm	4369	1	AKI	AKI	NNP
cord-023095-4dannjjm	4369	2	is	be	VBZ
cord-023095-4dannjjm	4369	3	used	use	VBN
cord-023095-4dannjjm	4369	4	in	in	IN
cord-023095-4dannjjm	4369	5	human	human	JJ
cord-023095-4dannjjm	4369	6	medicine	medicine	NN
cord-023095-4dannjjm	4369	7	as	as	IN
cord-023095-4dannjjm	4369	8	a	a	DT
cord-023095-4dannjjm	4369	9	predictor	predictor	NN
cord-023095-4dannjjm	4369	10	of	of	IN
cord-023095-4dannjjm	4369	11	mortality	mortality	NN
cord-023095-4dannjjm	4369	12	based	base	VBN
cord-023095-4dannjjm	4369	13	on	on	IN
cord-023095-4dannjjm	4369	14	the	the	DT
cord-023095-4dannjjm	4369	15	AKIN	akin	NN
cord-023095-4dannjjm	4369	16	(	(	-LRB-
cord-023095-4dannjjm	4369	17	Acute	acute	JJ
cord-023095-4dannjjm	4369	18	Kidney	Kidney	NNP
cord-023095-4dannjjm	4369	19	Injury	Injury	NNP
cord-023095-4dannjjm	4369	20	Network	Network	NNP
cord-023095-4dannjjm	4369	21	)	)	-RRB-
cord-023095-4dannjjm	4369	22	scoring	score	VBG
cord-023095-4dannjjm	4369	23	system	system	NN
cord-023095-4dannjjm	4369	24	which	which	WDT
cord-023095-4dannjjm	4369	25	utilizes	utilize	VBZ
cord-023095-4dannjjm	4369	26	relative	relative	JJ
cord-023095-4dannjjm	4369	27	increases	increase	NNS
cord-023095-4dannjjm	4369	28	in	in	IN
cord-023095-4dannjjm	4369	29	creatinine	creatinine	NN
cord-023095-4dannjjm	4369	30	to	to	TO
cord-023095-4dannjjm	4369	31	determine	determine	VB
cord-023095-4dannjjm	4369	32	stage	stage	NN
cord-023095-4dannjjm	4369	33	.	.	.
cord-023095-4dannjjm	4370	1	With	with	IN
cord-023095-4dannjjm	4370	2	this	this	DT
cord-023095-4dannjjm	4370	3	scheme	scheme	NN
cord-023095-4dannjjm	4370	4	,	,	,
cord-023095-4dannjjm	4370	5	mortality	mortality	NN
cord-023095-4dannjjm	4370	6	has	have	VBZ
cord-023095-4dannjjm	4370	7	been	be	VBN
cord-023095-4dannjjm	4370	8	shown	show	VBN
cord-023095-4dannjjm	4370	9	to	to	TO
cord-023095-4dannjjm	4370	10	increase	increase	VB
cord-023095-4dannjjm	4370	11	as	as	IN
cord-023095-4dannjjm	4370	12	the	the	DT
cord-023095-4dannjjm	4370	13	stage	stage	NN
cord-023095-4dannjjm	4370	14	of	of	IN
cord-023095-4dannjjm	4370	15	kidney	kidney	NN
cord-023095-4dannjjm	4370	16	injury	injury	NN
cord-023095-4dannjjm	4370	17	(	(	-LRB-
cord-023095-4dannjjm	4370	18	indicated	indicate	VBN
cord-023095-4dannjjm	4370	19	by	by	IN
cord-023095-4dannjjm	4370	20	AKIN	AKIN	NNP
cord-023095-4dannjjm	4370	21	score	score	NN
cord-023095-4dannjjm	4370	22	)	)	-RRB-
cord-023095-4dannjjm	4370	23	increases	increase	NNS
cord-023095-4dannjjm	4370	24	.	.	.
cord-023095-4dannjjm	4371	1	Accordingly	accordingly	RB
cord-023095-4dannjjm	4371	2	,	,	,
cord-023095-4dannjjm	4371	3	we	-PRON-	PRP
cord-023095-4dannjjm	4371	4	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	4371	5	that	that	IN
cord-023095-4dannjjm	4371	6	this	this	DT
cord-023095-4dannjjm	4371	7	system	system	NN
cord-023095-4dannjjm	4371	8	would	would	MD
cord-023095-4dannjjm	4371	9	improve	improve	VB
cord-023095-4dannjjm	4371	10	predicting	predict	VBG
cord-023095-4dannjjm	4371	11	prognosis	prognosis	NN
cord-023095-4dannjjm	4371	12	in	in	IN
cord-023095-4dannjjm	4371	13	dogs	dog	NNS
cord-023095-4dannjjm	4371	14	and	and	CC
cord-023095-4dannjjm	4371	15	cats	cat	NNS
cord-023095-4dannjjm	4371	16	.	.	.
cord-023095-4dannjjm	4372	1	We	-PRON-	PRP
cord-023095-4dannjjm	4372	2	retrospectively	retrospectively	RB
cord-023095-4dannjjm	4372	3	evaluated	evaluate	VBD
cord-023095-4dannjjm	4372	4	1088	1088	CD
cord-023095-4dannjjm	4372	5	dogs	dog	NNS
cord-023095-4dannjjm	4372	6	and	and	CC
cord-023095-4dannjjm	4372	7	856	856	CD
cord-023095-4dannjjm	4372	8	cats	cat	NNS
cord-023095-4dannjjm	4372	9	(	(	-LRB-
cord-023095-4dannjjm	4372	10	2008	2008	CD
cord-023095-4dannjjm	4372	11	)	)	-RRB-
cord-023095-4dannjjm	4372	12	(	(	-LRB-
cord-023095-4dannjjm	4372	13	2009	2009	CD
cord-023095-4dannjjm	4372	14	)	)	-RRB-
cord-023095-4dannjjm	4372	15	)	)	-RRB-
cord-023095-4dannjjm	4372	16	that	that	WDT
cord-023095-4dannjjm	4372	17	had	have	VBD
cord-023095-4dannjjm	4372	18	!	!	.
cord-023095-4dannjjm	4373	1	2	2	CD
cord-023095-4dannjjm	4373	2	creatinine	creatinine	NN
cord-023095-4dannjjm	4373	3	measurements	measurement	NNS
cord-023095-4dannjjm	4373	4	within	within	IN
cord-023095-4dannjjm	4373	5	7	7	CD
cord-023095-4dannjjm	4373	6	days	day	NNS
cord-023095-4dannjjm	4373	7	,	,	,
cord-023095-4dannjjm	4373	8	and	and	CC
cord-023095-4dannjjm	4374	1	whose	whose	WP$
cord-023095-4dannjjm	4374	2	first	first	JJ
cord-023095-4dannjjm	4374	3	creatinine	creatinine	NN
cord-023095-4dannjjm	4374	4	was	be	VBD
cord-023095-4dannjjm	4374	5	o	o	UH
cord-023095-4dannjjm	4375	1	1.6	1.6	CD
cord-023095-4dannjjm	4375	2	mg	mg	NNP
cord-023095-4dannjjm	4375	3	/	/	SYM
cord-023095-4dannjjm	4375	4	dl	dl	NN
cord-023095-4dannjjm	4375	5	.	.	.
cord-023095-4dannjjm	4376	1	Patients	patient	NNS
cord-023095-4dannjjm	4376	2	were	be	VBD
cord-023095-4dannjjm	4376	3	categorized	categorize	VBN
cord-023095-4dannjjm	4376	4	as	as	IN
cord-023095-4dannjjm	4376	5	:	:	:
cord-023095-4dannjjm	4376	6	Level	level	NN
cord-023095-4dannjjm	4376	7	0	0	NFP
cord-023095-4dannjjm	4376	8	(	(	-LRB-
cord-023095-4dannjjm	4376	9	no	no	DT
cord-023095-4dannjjm	4376	10	AKI	AKI	NNP
cord-023095-4dannjjm	4376	11	)	)	-RRB-
cord-023095-4dannjjm	4376	12	;	;	:
cord-023095-4dannjjm	4376	13	Level	level	NN
cord-023095-4dannjjm	4376	14	1	1	CD
cord-023095-4dannjjm	4376	15	(	(	-LRB-
cord-023095-4dannjjm	4376	16	second	second	JJ
cord-023095-4dannjjm	4376	17	creatinine	creatinine	NN
cord-023095-4dannjjm	4376	18	value	value	NN
cord-023095-4dannjjm	4376	19	o	o	NN
cord-023095-4dannjjm	4376	20	1.6	1.6	CD
cord-023095-4dannjjm	4376	21	mg	mg	NNP
cord-023095-4dannjjm	4376	22	/	/	SYM
cord-023095-4dannjjm	4376	23	dL	dl	NN
cord-023095-4dannjjm	4376	24	,	,	,
cord-023095-4dannjjm	4376	25	but	but	CC
cord-023095-4dannjjm	4376	26	creatinine	creatinine	NN
cord-023095-4dannjjm	4376	27	increased	increase	VBD
cord-023095-4dannjjm	4376	28	!	!	.
cord-023095-4dannjjm	4377	1	0.3	0.3	CD
cord-023095-4dannjjm	4377	2	mg	mg	NNP
cord-023095-4dannjjm	4377	3	/	/	SYM
cord-023095-4dannjjm	4377	4	dL	dl	NN
cord-023095-4dannjjm	4377	5	)	)	-RRB-
cord-023095-4dannjjm	4377	6	;	;	:
cord-023095-4dannjjm	4377	7	or	or	CC
cord-023095-4dannjjm	4377	8	Level	Level	NNP
cord-023095-4dannjjm	4377	9	3	3	CD
cord-023095-4dannjjm	4377	10	(	(	-LRB-
cord-023095-4dannjjm	4377	11	second	second	JJ
cord-023095-4dannjjm	4377	12	creatinine	creatinine	NN
cord-023095-4dannjjm	4378	1	4	4	LS
cord-023095-4dannjjm	4378	2	1.6	1.6	CD
cord-023095-4dannjjm	4378	3	mg	mg	NNP
cord-023095-4dannjjm	4378	4	/	/	SYM
cord-023095-4dannjjm	4378	5	dL	dl	NN
cord-023095-4dannjjm	4378	6	with	with	IN
cord-023095-4dannjjm	4378	7	a	a	DT
cord-023095-4dannjjm	4378	8	creatinine	creatinine	NN
cord-023095-4dannjjm	4378	9	increase	increase	NN
cord-023095-4dannjjm	4378	10	!	!	.
cord-023095-4dannjjm	4379	1	0.3	0.3	CD
cord-023095-4dannjjm	4379	2	mg	mg	NNP
cord-023095-4dannjjm	4379	3	/	/	SYM
cord-023095-4dannjjm	4379	4	dL	dl	NN
cord-023095-4dannjjm	4379	5	)	)	-RRB-
cord-023095-4dannjjm	4379	6	.	.	.
cord-023095-4dannjjm	4380	1	Thirty	thirty	CD
cord-023095-4dannjjm	4380	2	and	and	CC
cord-023095-4dannjjm	4380	3	90	90	CD
cord-023095-4dannjjm	4380	4	day	day	NN
cord-023095-4dannjjm	4380	5	survival	survival	NN
cord-023095-4dannjjm	4380	6	for	for	IN
cord-023095-4dannjjm	4380	7	each	each	DT
cord-023095-4dannjjm	4380	8	level	level	NN
cord-023095-4dannjjm	4380	9	was	be	VBD
cord-023095-4dannjjm	4380	10	compared	compare	VBN
cord-023095-4dannjjm	4380	11	to	to	IN
cord-023095-4dannjjm	4380	12	level	level	NN
cord-023095-4dannjjm	4380	13	0	0	CD
cord-023095-4dannjjm	4380	14	.	.	.
cord-023095-4dannjjm	4381	1	Adjusted	adjusted	JJ
cord-023095-4dannjjm	4381	2	odds	odd	NNS
cord-023095-4dannjjm	4381	3	ratio	ratio	NN
cord-023095-4dannjjm	4381	4	(	(	-LRB-
cord-023095-4dannjjm	4381	5	OR	or	NN
cord-023095-4dannjjm	4381	6	)	)	-RRB-
cord-023095-4dannjjm	4382	1	in	in	IN
cord-023095-4dannjjm	4382	2	dogs	dog	NNS
cord-023095-4dannjjm	4382	3	for	for	IN
cord-023095-4dannjjm	4382	4	30	30	CD
cord-023095-4dannjjm	4382	5	day	day	NN
cord-023095-4dannjjm	4382	6	survival	survival	NN
cord-023095-4dannjjm	4382	7	was	be	VBD
cord-023095-4dannjjm	4382	8	1.3	1.3	CD
cord-023095-4dannjjm	4382	9	for	for	IN
cord-023095-4dannjjm	4382	10	Level	level	NN
cord-023095-4dannjjm	4382	11	1	1	CD
cord-023095-4dannjjm	4382	12	(	(	-LRB-
cord-023095-4dannjjm	4382	13	CI	CI	NNP
cord-023095-4dannjjm	4382	14	95	95	CD
cord-023095-4dannjjm	4382	15	%	%	NN
cord-023095-4dannjjm	4382	16	,	,	,
cord-023095-4dannjjm	4382	17	0.8	0.8	CD
cord-023095-4dannjjm	4382	18	-	-	SYM
cord-023095-4dannjjm	4382	19	2.2	2.2	CD
cord-023095-4dannjjm	4382	20	)	)	-RRB-
cord-023095-4dannjjm	4382	21	and	and	CC
cord-023095-4dannjjm	4382	22	3.2	3.2	CD
cord-023095-4dannjjm	4383	1	(	(	-LRB-
cord-023095-4dannjjm	4383	2	CI	CI	NNP
cord-023095-4dannjjm	4383	3	95	95	CD
cord-023095-4dannjjm	4383	4	%	%	NN
cord-023095-4dannjjm	4383	5	,	,	,
cord-023095-4dannjjm	4383	6	1.8	1.8	CD
cord-023095-4dannjjm	4383	7	-	-	SYM
cord-023095-4dannjjm	4383	8	5.5	5.5	CD
cord-023095-4dannjjm	4383	9	)	)	-RRB-
cord-023095-4dannjjm	4383	10	for	for	IN
cord-023095-4dannjjm	4383	11	Level	level	NN
cord-023095-4dannjjm	4383	12	2	2	CD
cord-023095-4dannjjm	4383	13	;	;	:
cord-023095-4dannjjm	4383	14	OR	or	CC
cord-023095-4dannjjm	4383	15	for	for	IN
cord-023095-4dannjjm	4383	16	90	90	CD
cord-023095-4dannjjm	4383	17	day	day	NN
cord-023095-4dannjjm	4383	18	survival	survival	NN
cord-023095-4dannjjm	4383	19	was	be	VBD
cord-023095-4dannjjm	4383	20	1.3	1.3	CD
cord-023095-4dannjjm	4383	21	for	for	IN
cord-023095-4dannjjm	4383	22	Level	level	NN
cord-023095-4dannjjm	4383	23	1	1	CD
cord-023095-4dannjjm	4383	24	(	(	-LRB-
cord-023095-4dannjjm	4383	25	CI	CI	NNP
cord-023095-4dannjjm	4383	26	95	95	CD
cord-023095-4dannjjm	4383	27	%	%	NN
cord-023095-4dannjjm	4383	28	,	,	,
cord-023095-4dannjjm	4383	29	0.8	0.8	CD
cord-023095-4dannjjm	4383	30	-	-	SYM
cord-023095-4dannjjm	4383	31	2.2	2.2	CD
cord-023095-4dannjjm	4383	32	)	)	-RRB-
cord-023095-4dannjjm	4383	33	and	and	CC
cord-023095-4dannjjm	4383	34	3.7	3.7	CD
cord-023095-4dannjjm	4383	35	(	(	-LRB-
cord-023095-4dannjjm	4383	36	CI	CI	NNP
cord-023095-4dannjjm	4383	37	95	95	CD
cord-023095-4dannjjm	4383	38	%	%	NN
cord-023095-4dannjjm	4383	39	,	,	,
cord-023095-4dannjjm	4383	40	2.1	2.1	CD
cord-023095-4dannjjm	4383	41	-	-	SYM
cord-023095-4dannjjm	4383	42	6.5	6.5	CD
cord-023095-4dannjjm	4383	43	)	)	-RRB-
cord-023095-4dannjjm	4383	44	for	for	IN
cord-023095-4dannjjm	4383	45	Level	level	NN
cord-023095-4dannjjm	4383	46	2	2	CD
cord-023095-4dannjjm	4383	47	.	.	.
cord-023095-4dannjjm	4384	1	For	for	IN
cord-023095-4dannjjm	4384	2	cats	cat	NNS
cord-023095-4dannjjm	4384	3	,	,	,
cord-023095-4dannjjm	4384	4	OR	or	CC
cord-023095-4dannjjm	4384	5	at	at	IN
cord-023095-4dannjjm	4384	6	30	30	CD
cord-023095-4dannjjm	4384	7	days	day	NNS
cord-023095-4dannjjm	4384	8	was	be	VBD
cord-023095-4dannjjm	4384	9	1.5	1.5	CD
cord-023095-4dannjjm	4384	10	(	(	-LRB-
cord-023095-4dannjjm	4384	11	CI	CI	NNP
cord-023095-4dannjjm	4384	12	95	95	CD
cord-023095-4dannjjm	4384	13	%	%	NN
cord-023095-4dannjjm	4384	14	,	,	,
cord-023095-4dannjjm	4384	15	0.5	0.5	CD
cord-023095-4dannjjm	4384	16	-	-	SYM
cord-023095-4dannjjm	4384	17	4.6	4.6	CD
cord-023095-4dannjjm	4384	18	)	)	-RRB-
cord-023095-4dannjjm	4384	19	for	for	IN
cord-023095-4dannjjm	4384	20	Level	level	NN
cord-023095-4dannjjm	4384	21	1	1	CD
cord-023095-4dannjjm	4384	22	and	and	CC
cord-023095-4dannjjm	4384	23	3.1	3.1	CD
cord-023095-4dannjjm	4384	24	(	(	-LRB-
cord-023095-4dannjjm	4384	25	CI	CI	NNP
cord-023095-4dannjjm	4384	26	95	95	CD
cord-023095-4dannjjm	4384	27	%	%	NN
cord-023095-4dannjjm	4384	28	,	,	,
cord-023095-4dannjjm	4384	29	1.5	1.5	CD
cord-023095-4dannjjm	4384	30	-	-	SYM
cord-023095-4dannjjm	4384	31	6.7	6.7	CD
cord-023095-4dannjjm	4384	32	)	)	-RRB-
cord-023095-4dannjjm	4384	33	for	for	IN
cord-023095-4dannjjm	4384	34	Level	level	NN
cord-023095-4dannjjm	4384	35	2	2	CD
cord-023095-4dannjjm	4384	36	;	;	:
cord-023095-4dannjjm	4384	37	OR	or	CC
cord-023095-4dannjjm	4384	38	for	for	IN
cord-023095-4dannjjm	4384	39	90	90	CD
cord-023095-4dannjjm	4384	40	day	day	NN
cord-023095-4dannjjm	4384	41	survival	survival	NN
cord-023095-4dannjjm	4384	42	was	be	VBD
cord-023095-4dannjjm	4384	43	0.9	0.9	CD
cord-023095-4dannjjm	4385	1	(	(	-LRB-
cord-023095-4dannjjm	4385	2	CI	CI	NNP
cord-023095-4dannjjm	4385	3	95	95	CD
cord-023095-4dannjjm	4385	4	%	%	NN
cord-023095-4dannjjm	4385	5	,	,	,
cord-023095-4dannjjm	4385	6	0.3	0.3	CD
cord-023095-4dannjjm	4385	7	-	-	SYM
cord-023095-4dannjjm	4385	8	2.8	2.8	CD
cord-023095-4dannjjm	4385	9	)	)	-RRB-
cord-023095-4dannjjm	4385	10	for	for	IN
cord-023095-4dannjjm	4385	11	Level	level	NN
cord-023095-4dannjjm	4385	12	1	1	CD
cord-023095-4dannjjm	4385	13	and	and	CC
cord-023095-4dannjjm	4385	14	4.1	4.1	CD
cord-023095-4dannjjm	4386	1	(	(	-LRB-
cord-023095-4dannjjm	4386	2	CI	CI	NNP
cord-023095-4dannjjm	4386	3	95	95	CD
cord-023095-4dannjjm	4386	4	%	%	NN
cord-023095-4dannjjm	4386	5	,	,	,
cord-023095-4dannjjm	4386	6	1.8	1.8	CD
cord-023095-4dannjjm	4386	7	-	-	SYM
cord-023095-4dannjjm	4386	8	9.3	9.3	CD
cord-023095-4dannjjm	4386	9	)	)	-RRB-
cord-023095-4dannjjm	4386	10	for	for	IN
cord-023095-4dannjjm	4386	11	Level	level	NN
cord-023095-4dannjjm	4386	12	2	2	CD
cord-023095-4dannjjm	4386	13	.	.	.
cord-023095-4dannjjm	4387	1	Thus	thus	RB
cord-023095-4dannjjm	4387	2	,	,	,
cord-023095-4dannjjm	4387	3	detecting	detect	VBG
cord-023095-4dannjjm	4387	4	increasing	increase	VBG
cord-023095-4dannjjm	4387	5	stage	stage	NN
cord-023095-4dannjjm	4387	6	of	of	IN
cord-023095-4dannjjm	4387	7	AKI	AKI	NNP
cord-023095-4dannjjm	4387	8	helps	help	VBZ
cord-023095-4dannjjm	4387	9	predict	predict	VB
cord-023095-4dannjjm	4387	10	mortality	mortality	NN
cord-023095-4dannjjm	4387	11	in	in	IN
cord-023095-4dannjjm	4387	12	dogs	dog	NNS
cord-023095-4dannjjm	4387	13	and	and	CC
cord-023095-4dannjjm	4387	14	cats	cat	NNS
cord-023095-4dannjjm	4387	15	.	.	.
cord-023095-4dannjjm	4388	1	ABSTRACT	ABSTRACT	NNP
cord-023095-4dannjjm	4388	2	N	N	NNP
cord-023095-4dannjjm	4388	3	/	/	SYM
cord-023095-4dannjjm	4388	4	U-27	U-27	NNP
cord-023095-4dannjjm	4388	5	FELINE	feline	JJ
cord-023095-4dannjjm	4388	6	URATE	URATE	NNP
cord-023095-4dannjjm	4388	7	UROLITHIASIS	UROLITHIASIS	NNP
cord-023095-4dannjjm	4388	8	:	:	:
cord-023095-4dannjjm	4388	9	143	143	CD
cord-023095-4dannjjm	4388	10	CASES	case	NNS
cord-023095-4dannjjm	4388	11	(	(	-LRB-
cord-023095-4dannjjm	4388	12	2000	2000	CD
cord-023095-4dannjjm	4388	13	-2008	-2008	NN
cord-023095-4dannjjm	4388	14	.	.	.
cord-023095-4dannjjm	4389	1	J	J	NNP
cord-023095-4dannjjm	4389	2	Dear	Dear	NNP
cord-023095-4dannjjm	4389	3	1	1	CD
cord-023095-4dannjjm	4389	4	,	,	,
cord-023095-4dannjjm	4389	5	R	R	NNP
cord-023095-4dannjjm	4389	6	Shiraki	Shiraki	NNP
cord-023095-4dannjjm	4389	7	2	2	CD
cord-023095-4dannjjm	4389	8	,	,	,
cord-023095-4dannjjm	4389	9	A	a	DT
cord-023095-4dannjjm	4389	10	Ruby	Ruby	NNP
cord-023095-4dannjjm	4389	11	2	2	CD
cord-023095-4dannjjm	4389	12	,	,	,
cord-023095-4dannjjm	4389	13	J	J	NNP
cord-023095-4dannjjm	4389	14	Westropp	Westropp	NNP
cord-023095-4dannjjm	4389	15	3	3	CD
cord-023095-4dannjjm	4389	16	.	.	.
cord-023095-4dannjjm	4390	1	1	1	LS
cord-023095-4dannjjm	4391	1	William	William	NNP
cord-023095-4dannjjm	4391	2	R	R	NNP
cord-023095-4dannjjm	4391	3	Pritchard	Pritchard	NNP
cord-023095-4dannjjm	4391	4	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	4391	5	Medical	Medical	NNP
cord-023095-4dannjjm	4391	6	Teaching	Teaching	NNP
cord-023095-4dannjjm	4391	7	Hospital	Hospital	NNP
cord-023095-4dannjjm	4391	8	,	,	,
cord-023095-4dannjjm	4391	9	University	University	NNP
cord-023095-4dannjjm	4391	10	of	of	IN
cord-023095-4dannjjm	4391	11	California	California	NNP
cord-023095-4dannjjm	4391	12	,	,	,
cord-023095-4dannjjm	4391	13	Davis	Davis	NNP
cord-023095-4dannjjm	4391	14	,	,	,
cord-023095-4dannjjm	4391	15	CA	CA	NNP
cord-023095-4dannjjm	4391	16	,	,	,
cord-023095-4dannjjm	4391	17	2	2	CD
cord-023095-4dannjjm	4391	18	Gerald	Gerald	NNP
cord-023095-4dannjjm	4391	19	V.	V.	NNP
cord-023095-4dannjjm	4391	20	Ling	Ling	NNP
cord-023095-4dannjjm	4391	21	Urinary	Urinary	NNP
cord-023095-4dannjjm	4391	22	Stone	Stone	NNP
cord-023095-4dannjjm	4391	23	Analysis	Analysis	NNP
cord-023095-4dannjjm	4391	24	Laboratory	Laboratory	NNP
cord-023095-4dannjjm	4391	25	,	,	,
cord-023095-4dannjjm	4391	26	University	University	NNP
cord-023095-4dannjjm	4391	27	of	of	IN
cord-023095-4dannjjm	4391	28	California	California	NNP
cord-023095-4dannjjm	4391	29	,	,	,
cord-023095-4dannjjm	4391	30	Davis	Davis	NNP
cord-023095-4dannjjm	4391	31	,	,	,
cord-023095-4dannjjm	4391	32	CA	CA	NNP
cord-023095-4dannjjm	4391	33	and	and	CC
cord-023095-4dannjjm	4391	34	3	3	CD
cord-023095-4dannjjm	4391	35	the	the	DT
cord-023095-4dannjjm	4391	36	Department	Department	NNP
cord-023095-4dannjjm	4391	37	of	of	IN
cord-023095-4dannjjm	4391	38	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	4391	39	Medicine	Medicine	NNP
cord-023095-4dannjjm	4391	40	and	and	CC
cord-023095-4dannjjm	4391	41	Epidemiology	Epidemiology	NNP
cord-023095-4dannjjm	4391	42	,	,	,
cord-023095-4dannjjm	4391	43	University	University	NNP
cord-023095-4dannjjm	4391	44	of	of	IN
cord-023095-4dannjjm	4391	45	California	California	NNP
cord-023095-4dannjjm	4391	46	,	,	,
cord-023095-4dannjjm	4391	47	Davis	Davis	NNP
cord-023095-4dannjjm	4391	48	,	,	,
cord-023095-4dannjjm	4391	49	CA	CA	NNP
cord-023095-4dannjjm	4391	50	.	.	.
cord-023095-4dannjjm	4392	1	Feline	feline	JJ
cord-023095-4dannjjm	4392	2	urate	urate	NN
cord-023095-4dannjjm	4392	3	urolithiasis	urolithiasis	NN
cord-023095-4dannjjm	4392	4	accounts	account	VBZ
cord-023095-4dannjjm	4392	5	for	for	IN
cord-023095-4dannjjm	4392	6	10	10	CD
cord-023095-4dannjjm	4392	7	%	%	NN
cord-023095-4dannjjm	4392	8	of	of	IN
cord-023095-4dannjjm	4392	9	the	the	DT
cord-023095-4dannjjm	4392	10	feline	feline	JJ
cord-023095-4dannjjm	4392	11	stones	stone	NNS
cord-023095-4dannjjm	4392	12	our	-PRON-	PRP$
cord-023095-4dannjjm	4392	13	laboratory	laboratory	NN
cord-023095-4dannjjm	4392	14	analyzes	analyze	VBZ
cord-023095-4dannjjm	4392	15	each	each	DT
cord-023095-4dannjjm	4392	16	year	year	NN
cord-023095-4dannjjm	4392	17	;	;	:
cord-023095-4dannjjm	4392	18	little	little	JJ
cord-023095-4dannjjm	4392	19	information	information	NN
cord-023095-4dannjjm	4392	20	is	be	VBZ
cord-023095-4dannjjm	4392	21	known	know	VBN
cord-023095-4dannjjm	4392	22	about	about	IN
cord-023095-4dannjjm	4392	23	this	this	DT
cord-023095-4dannjjm	4392	24	disease	disease	NN
cord-023095-4dannjjm	4392	25	,	,	,
cord-023095-4dannjjm	4392	26	particularly	particularly	RB
cord-023095-4dannjjm	4392	27	the	the	DT
cord-023095-4dannjjm	4392	28	incidence	incidence	NN
cord-023095-4dannjjm	4392	29	of	of	IN
cord-023095-4dannjjm	4392	30	those	those	DT
cord-023095-4dannjjm	4392	31	cats	cat	NNS
cord-023095-4dannjjm	4392	32	with	with	IN
cord-023095-4dannjjm	4392	33	hepatopathies	hepatopathie	NNS
cord-023095-4dannjjm	4392	34	.	.	.
cord-023095-4dannjjm	4393	1	The	the	DT
cord-023095-4dannjjm	4393	2	objective	objective	NN
cord-023095-4dannjjm	4393	3	of	of	IN
cord-023095-4dannjjm	4393	4	the	the	DT
cord-023095-4dannjjm	4393	5	study	study	NN
cord-023095-4dannjjm	4393	6	was	be	VBD
cord-023095-4dannjjm	4393	7	to	to	TO
cord-023095-4dannjjm	4393	8	characterize	characterize	VB
cord-023095-4dannjjm	4393	9	the	the	DT
cord-023095-4dannjjm	4393	10	signalment	signalment	JJ
cord-023095-4dannjjm	4393	11	,	,	,
cord-023095-4dannjjm	4393	12	clinicopathologic	clinicopathologic	NNP
cord-023095-4dannjjm	4393	13	data	datum	NNS
cord-023095-4dannjjm	4393	14	,	,	,
cord-023095-4dannjjm	4393	15	and	and	CC
cord-023095-4dannjjm	4393	16	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	4393	17	imaging	imaging	NN
cord-023095-4dannjjm	4393	18	of	of	IN
cord-023095-4dannjjm	4393	19	cats	cat	NNS
cord-023095-4dannjjm	4393	20	with	with	IN
cord-023095-4dannjjm	4393	21	this	this	DT
cord-023095-4dannjjm	4393	22	disease	disease	NN
cord-023095-4dannjjm	4393	23	as	as	RB
cord-023095-4dannjjm	4393	24	well	well	RB
cord-023095-4dannjjm	4393	25	as	as	IN
cord-023095-4dannjjm	4393	26	the	the	DT
cord-023095-4dannjjm	4393	27	salts	salt	NNS
cord-023095-4dannjjm	4393	28	of	of	IN
cord-023095-4dannjjm	4393	29	uric	uric	NN
cord-023095-4dannjjm	4393	30	acid	acid	NN
cord-023095-4dannjjm	4393	31	present	present	JJ
cord-023095-4dannjjm	4393	32	.	.	.
cord-023095-4dannjjm	4394	1	A	a	DT
cord-023095-4dannjjm	4394	2	retrospective	retrospective	JJ
cord-023095-4dannjjm	4394	3	analysis	analysis	NN
cord-023095-4dannjjm	4394	4	of	of	IN
cord-023095-4dannjjm	4394	5	feline	feline	JJ
cord-023095-4dannjjm	4394	6	urate	urate	NN
cord-023095-4dannjjm	4394	7	uroliths	urolith	NNS
cord-023095-4dannjjm	4394	8	submitted	submit	VBN
cord-023095-4dannjjm	4394	9	to	to	IN
cord-023095-4dannjjm	4394	10	the	the	DT
cord-023095-4dannjjm	4394	11	Stone	Stone	NNP
cord-023095-4dannjjm	4394	12	Lab	Lab	NNP
cord-023095-4dannjjm	4394	13	between	between	IN
cord-023095-4dannjjm	4394	14	January	January	NNP
cord-023095-4dannjjm	4394	15	2000-December	2000-december	CD
cord-023095-4dannjjm	4394	16	2008	2008	CD
cord-023095-4dannjjm	4394	17	were	be	VBD
cord-023095-4dannjjm	4394	18	included	include	VBN
cord-023095-4dannjjm	4394	19	.	.	.
cord-023095-4dannjjm	4395	1	From	from	IN
cord-023095-4dannjjm	4395	2	these	these	DT
cord-023095-4dannjjm	4395	3	data	datum	NNS
cord-023095-4dannjjm	4395	4	,	,	,
cord-023095-4dannjjm	4395	5	primary	primary	JJ
cord-023095-4dannjjm	4395	6	veterinarians	veterinarian	NNS
cord-023095-4dannjjm	4395	7	were	be	VBD
cord-023095-4dannjjm	4395	8	solicited	solicit	VBN
cord-023095-4dannjjm	4395	9	to	to	TO
cord-023095-4dannjjm	4395	10	submit	submit	VB
cord-023095-4dannjjm	4395	11	records	record	NNS
cord-023095-4dannjjm	4395	12	.	.	.
cord-023095-4dannjjm	4396	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	4396	2	,	,	,
cord-023095-4dannjjm	4396	3	all	all	DT
cord-023095-4dannjjm	4396	4	records	record	NNS
cord-023095-4dannjjm	4396	5	from	from	IN
cord-023095-4dannjjm	4396	6	cats	cat	NNS
cord-023095-4dannjjm	4396	7	with	with	IN
cord-023095-4dannjjm	4396	8	urate	urate	NN
cord-023095-4dannjjm	4396	9	uroliths	urolith	NNS
cord-023095-4dannjjm	4396	10	from	from	IN
cord-023095-4dannjjm	4396	11	the	the	DT
cord-023095-4dannjjm	4396	12	VMTH	VMTH	NNP
cord-023095-4dannjjm	4396	13	were	be	VBD
cord-023095-4dannjjm	4396	14	analyzed	analyze	VBN
cord-023095-4dannjjm	4396	15	separately	separately	RB
cord-023095-4dannjjm	4396	16	.	.	.
cord-023095-4dannjjm	4397	1	143	143	CD
cord-023095-4dannjjm	4397	2	records	record	NNS
cord-023095-4dannjjm	4397	3	were	be	VBD
cord-023095-4dannjjm	4397	4	received	receive	VBN
cord-023095-4dannjjm	4397	5	from	from	IN
cord-023095-4dannjjm	4397	6	the	the	DT
cord-023095-4dannjjm	4397	7	primary	primary	JJ
cord-023095-4dannjjm	4397	8	care	care	NN
cord-023095-4dannjjm	4397	9	veterinarians	veterinarian	NNS
cord-023095-4dannjjm	4397	10	.	.	.
cord-023095-4dannjjm	4398	1	Sixteen	sixteen	CD
cord-023095-4dannjjm	4398	2	cases	case	NNS
cord-023095-4dannjjm	4398	3	were	be	VBD
cord-023095-4dannjjm	4398	4	identified	identify	VBN
cord-023095-4dannjjm	4398	5	from	from	IN
cord-023095-4dannjjm	4398	6	the	the	DT
cord-023095-4dannjjm	4398	7	VMTH	VMTH	NNP
cord-023095-4dannjjm	4398	8	.	.	.
cord-023095-4dannjjm	4399	1	Median	median	JJ
cord-023095-4dannjjm	4399	2	values	value	NNS
cord-023095-4dannjjm	4399	3	for	for	IN
cord-023095-4dannjjm	4399	4	the	the	DT
cord-023095-4dannjjm	4399	5	CBC	CBC	NNP
cord-023095-4dannjjm	4399	6	and	and	CC
cord-023095-4dannjjm	4399	7	chemistry	chemistry	NN
cord-023095-4dannjjm	4399	8	panels	panel	NNS
cord-023095-4dannjjm	4399	9	available	available	JJ
cord-023095-4dannjjm	4399	10	were	be	VBD
cord-023095-4dannjjm	4399	11	within	within	IN
cord-023095-4dannjjm	4399	12	the	the	DT
cord-023095-4dannjjm	4399	13	reference	reference	NN
cord-023095-4dannjjm	4399	14	ranges	range	NNS
cord-023095-4dannjjm	4399	15	provided	provide	VBN
cord-023095-4dannjjm	4399	16	,	,	,
cord-023095-4dannjjm	4399	17	with	with	IN
cord-023095-4dannjjm	4399	18	only	only	RB
cord-023095-4dannjjm	4399	19	a	a	DT
cord-023095-4dannjjm	4399	20	few	few	JJ
cord-023095-4dannjjm	4399	21	outliers	outlier	NNS
cord-023095-4dannjjm	4399	22	present	present	JJ
cord-023095-4dannjjm	4399	23	.	.	.
cord-023095-4dannjjm	4400	1	Of	of	IN
cord-023095-4dannjjm	4400	2	the	the	DT
cord-023095-4dannjjm	4400	3	78	78	CD
cord-023095-4dannjjm	4400	4	cats	cat	NNS
cord-023095-4dannjjm	4400	5	with	with	IN
cord-023095-4dannjjm	4400	6	radiographic	radiographic	JJ
cord-023095-4dannjjm	4400	7	reports	report	NNS
cord-023095-4dannjjm	4400	8	,	,	,
cord-023095-4dannjjm	4400	9	70	70	CD
cord-023095-4dannjjm	4400	10	(	(	-LRB-
cord-023095-4dannjjm	4400	11	90	90	CD
cord-023095-4dannjjm	4400	12	%	%	NN
cord-023095-4dannjjm	4400	13	)	)	-RRB-
cord-023095-4dannjjm	4400	14	had	have	VBD
cord-023095-4dannjjm	4400	15	visible	visible	JJ
cord-023095-4dannjjm	4400	16	evidence	evidence	NN
cord-023095-4dannjjm	4400	17	of	of	IN
cord-023095-4dannjjm	4400	18	uroliths	urolith	NNS
cord-023095-4dannjjm	4400	19	.	.	.
cord-023095-4dannjjm	4401	1	Two	two	CD
cord-023095-4dannjjm	4401	2	external	external	JJ
cord-023095-4dannjjm	4401	3	cases	case	NNS
cord-023095-4dannjjm	4401	4	had	have	VBD
cord-023095-4dannjjm	4401	5	confirmed	confirm	VBN
cord-023095-4dannjjm	4401	6	PSS	PSS	NNP
cord-023095-4dannjjm	4401	7	;	;	:
cord-023095-4dannjjm	4401	8	five	five	CD
cord-023095-4dannjjm	4401	9	cases	case	NNS
cord-023095-4dannjjm	4401	10	from	from	IN
cord-023095-4dannjjm	4401	11	the	the	DT
cord-023095-4dannjjm	4401	12	VMTH	VMTH	NNP
cord-023095-4dannjjm	4401	13	had	have	VBD
cord-023095-4dannjjm	4401	14	a	a	DT
cord-023095-4dannjjm	4401	15	PSS	PSS	NNP
cord-023095-4dannjjm	4401	16	.	.	.
cord-023095-4dannjjm	4402	1	Cats	cat	NNS
cord-023095-4dannjjm	4402	2	with	with	IN
cord-023095-4dannjjm	4402	3	urate	urate	NN
cord-023095-4dannjjm	4402	4	uroliths	urolith	NNS
cord-023095-4dannjjm	4402	5	and	and	CC
cord-023095-4dannjjm	4402	6	PSS	PSS	NNP
cord-023095-4dannjjm	4402	7	were	be	VBD
cord-023095-4dannjjm	4402	8	younger	young	JJR
cord-023095-4dannjjm	4402	9	than	than	IN
cord-023095-4dannjjm	4402	10	cats	cat	NNS
cord-023095-4dannjjm	4402	11	without	without	IN
cord-023095-4dannjjm	4402	12	a	a	DT
cord-023095-4dannjjm	4402	13	documented	document	VBN
cord-023095-4dannjjm	4402	14	hepatopathy	hepatopathy	NN
cord-023095-4dannjjm	4402	15	(	(	-LRB-
cord-023095-4dannjjm	4402	16	2	2	CD
cord-023095-4dannjjm	4402	17	years	year	NNS
cord-023095-4dannjjm	4402	18	vs.	vs.	IN
cord-023095-4dannjjm	4402	19	7	7	CD
cord-023095-4dannjjm	4402	20	years	year	NNS
cord-023095-4dannjjm	4402	21	)	)	-RRB-
cord-023095-4dannjjm	4402	22	.	.	.
cord-023095-4dannjjm	4403	1	The	the	DT
cord-023095-4dannjjm	4403	2	Siamese	siamese	JJ
cord-023095-4dannjjm	4403	3	breed	breed	NN
cord-023095-4dannjjm	4403	4	was	be	VBD
cord-023095-4dannjjm	4403	5	overrepresented	overrepresente	VBN
cord-023095-4dannjjm	4403	6	.	.	.
cord-023095-4dannjjm	4404	1	All	all	DT
cord-023095-4dannjjm	4404	2	stones	stone	NNS
cord-023095-4dannjjm	4404	3	were	be	VBD
cord-023095-4dannjjm	4404	4	ammonium	ammonium	NN
cord-023095-4dannjjm	4404	5	hydrogen	hydrogen	NN
cord-023095-4dannjjm	4404	6	urate	urate	NN
cord-023095-4dannjjm	4404	7	.	.	.
cord-023095-4dannjjm	4405	1	The	the	DT
cord-023095-4dannjjm	4405	2	pathogensis	pathogensis	NN
cord-023095-4dannjjm	4405	3	of	of	IN
cord-023095-4dannjjm	4405	4	urate	urate	NN
cord-023095-4dannjjm	4405	5	uroliths	urolith	NNS
cord-023095-4dannjjm	4405	6	in	in	IN
cord-023095-4dannjjm	4405	7	cats	cat	NNS
cord-023095-4dannjjm	4405	8	is	be	VBZ
cord-023095-4dannjjm	4405	9	poorly	poorly	RB
cord-023095-4dannjjm	4405	10	understood	understand	VBN
cord-023095-4dannjjm	4405	11	.	.	.
cord-023095-4dannjjm	4406	1	Most	Most	JJS
cord-023095-4dannjjm	4406	2	cats	cat	NNS
cord-023095-4dannjjm	4406	3	were	be	VBD
cord-023095-4dannjjm	4406	4	not	not	RB
cord-023095-4dannjjm	4406	5	completely	completely	RB
cord-023095-4dannjjm	4406	6	evaluated	evaluate	VBN
cord-023095-4dannjjm	4406	7	for	for	IN
cord-023095-4dannjjm	4406	8	PSS	PSS	NNP
cord-023095-4dannjjm	4406	9	,	,	,
cord-023095-4dannjjm	4406	10	however	however	RB
cord-023095-4dannjjm	4406	11	,	,	,
cord-023095-4dannjjm	4406	12	there	there	EX
cord-023095-4dannjjm	4406	13	were	be	VBD
cord-023095-4dannjjm	4406	14	few	few	JJ
cord-023095-4dannjjm	4406	15	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	4406	16	parameters	parameter	NNS
cord-023095-4dannjjm	4406	17	which	which	WDT
cord-023095-4dannjjm	4406	18	indicated	indicate	VBD
cord-023095-4dannjjm	4406	19	hepatopathies	hepatopathie	NNS
cord-023095-4dannjjm	4406	20	were	be	VBD
cord-023095-4dannjjm	4406	21	present	present	JJ
cord-023095-4dannjjm	4406	22	.	.	.
cord-023095-4dannjjm	4407	1	Further	further	JJ
cord-023095-4dannjjm	4407	2	studies	study	NNS
cord-023095-4dannjjm	4407	3	are	be	VBP
cord-023095-4dannjjm	4407	4	warranted	warrant	VBN
cord-023095-4dannjjm	4407	5	to	to	TO
cord-023095-4dannjjm	4407	6	evaluate	evaluate	VB
cord-023095-4dannjjm	4407	7	genetics	genetic	NNS
cord-023095-4dannjjm	4407	8	and	and	CC
cord-023095-4dannjjm	4407	9	purine	purine	NN
cord-023095-4dannjjm	4407	10	metabolism	metabolism	NN
cord-023095-4dannjjm	4407	11	in	in	IN
cord-023095-4dannjjm	4407	12	cats	cat	NNS
cord-023095-4dannjjm	4407	13	with	with	IN
cord-023095-4dannjjm	4407	14	urate	urate	NN
cord-023095-4dannjjm	4407	15	uroliths	urolith	NNS
cord-023095-4dannjjm	4407	16	to	to	TO
cord-023095-4dannjjm	4407	17	help	help	VB
cord-023095-4dannjjm	4407	18	tailor	tailor	VB
cord-023095-4dannjjm	4407	19	proper	proper	JJ
cord-023095-4dannjjm	4407	20	management	management	NN
cord-023095-4dannjjm	4407	21	and	and	CC
cord-023095-4dannjjm	4407	22	breeding	breeding	NN
cord-023095-4dannjjm	4407	23	strategies	strategy	NNS
cord-023095-4dannjjm	4407	24	.	.	.
cord-023095-4dannjjm	4408	1	3-Indoxyl	3-Indoxyl	NNP
cord-023095-4dannjjm	4408	2	and	and	CC
cord-023095-4dannjjm	4408	3	p	p	NN
cord-023095-4dannjjm	4408	4	-	-	HYPH
cord-023095-4dannjjm	4408	5	cresyl	cresyl	NN
cord-023095-4dannjjm	4408	6	sulfate	sulfate	NN
cord-023095-4dannjjm	4408	7	(	(	-LRB-
cord-023095-4dannjjm	4408	8	IS	be	VBZ
cord-023095-4dannjjm	4408	9	,	,	,
cord-023095-4dannjjm	4408	10	and	and	CC
cord-023095-4dannjjm	4408	11	CS	CS	NNP
cord-023095-4dannjjm	4408	12	,	,	,
cord-023095-4dannjjm	4408	13	respectively	respectively	RB
cord-023095-4dannjjm	4408	14	)	)	-RRB-
cord-023095-4dannjjm	4408	15	,	,	,
cord-023095-4dannjjm	4408	16	small	small	JJ
cord-023095-4dannjjm	4408	17	protein	protein	NN
cord-023095-4dannjjm	4408	18	-	-	HYPH
cord-023095-4dannjjm	4408	19	bound	bind	VBN
cord-023095-4dannjjm	4408	20	molecules	molecule	NNS
cord-023095-4dannjjm	4408	21	derived	derive	VBN
cord-023095-4dannjjm	4408	22	from	from	IN
cord-023095-4dannjjm	4408	23	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	4408	24	protein	protein	NN
cord-023095-4dannjjm	4408	25	metabolism	metabolism	NN
cord-023095-4dannjjm	4408	26	,	,	,
cord-023095-4dannjjm	4408	27	are	be	VBP
cord-023095-4dannjjm	4408	28	among	among	IN
cord-023095-4dannjjm	4408	29	the	the	DT
cord-023095-4dannjjm	4408	30	most	most	RBS
cord-023095-4dannjjm	4408	31	important	important	JJ
cord-023095-4dannjjm	4408	32	uremic	uremic	JJ
cord-023095-4dannjjm	4408	33	solutes	solute	NNS
cord-023095-4dannjjm	4408	34	affecting	affect	VBG
cord-023095-4dannjjm	4408	35	morbidity	morbidity	NN
cord-023095-4dannjjm	4408	36	and	and	CC
cord-023095-4dannjjm	4408	37	mortality	mortality	NN
cord-023095-4dannjjm	4408	38	in	in	IN
cord-023095-4dannjjm	4408	39	human	human	JJ
cord-023095-4dannjjm	4408	40	chronic	chronic	JJ
cord-023095-4dannjjm	4408	41	kidney	kidney	NN
cord-023095-4dannjjm	4408	42	disease	disease	NN
cord-023095-4dannjjm	4408	43	(	(	-LRB-
cord-023095-4dannjjm	4408	44	CKD	CKD	NNP
cord-023095-4dannjjm	4408	45	)	)	-RRB-
cord-023095-4dannjjm	4408	46	.	.	.
cord-023095-4dannjjm	4409	1	In	in	IN
cord-023095-4dannjjm	4409	2	the	the	DT
cord-023095-4dannjjm	4409	3	blood	blood	NN
cord-023095-4dannjjm	4409	4	stream	stream	NN
cord-023095-4dannjjm	4409	5	,	,	,
cord-023095-4dannjjm	4409	6	these	these	DT
cord-023095-4dannjjm	4409	7	compounds	compound	NNS
cord-023095-4dannjjm	4409	8	are	be	VBP
cord-023095-4dannjjm	4409	9	predominantly	predominantly	RB
cord-023095-4dannjjm	4409	10	bound	bind	VBN
cord-023095-4dannjjm	4409	11	to	to	IN
cord-023095-4dannjjm	4409	12	protein	protein	NN
cord-023095-4dannjjm	4409	13	,	,	,
cord-023095-4dannjjm	4409	14	but	but	CC
cord-023095-4dannjjm	4409	15	their	-PRON-	PRP$
cord-023095-4dannjjm	4409	16	debilitating	debilitating	JJ
cord-023095-4dannjjm	4409	17	effects	effect	NNS
cord-023095-4dannjjm	4409	18	on	on	IN
cord-023095-4dannjjm	4409	19	prognosis	prognosis	NN
cord-023095-4dannjjm	4409	20	and	and	CC
cord-023095-4dannjjm	4409	21	quality	quality	NN
cord-023095-4dannjjm	4409	22	of	of	IN
cord-023095-4dannjjm	4409	23	life	life	NN
cord-023095-4dannjjm	4409	24	in	in	IN
cord-023095-4dannjjm	4409	25	CKD	CKD	NNP
cord-023095-4dannjjm	4409	26	appear	appear	VBP
cord-023095-4dannjjm	4409	27	to	to	TO
cord-023095-4dannjjm	4409	28	be	be	VB
cord-023095-4dannjjm	4409	29	driven	drive	VBN
cord-023095-4dannjjm	4409	30	by	by	IN
cord-023095-4dannjjm	4409	31	the	the	DT
cord-023095-4dannjjm	4409	32	free	free	JJ
cord-023095-4dannjjm	4409	33	fraction	fraction	NN
cord-023095-4dannjjm	4409	34	.	.	.
cord-023095-4dannjjm	4410	1	The	the	DT
cord-023095-4dannjjm	4410	2	objectives	objective	NNS
cord-023095-4dannjjm	4410	3	of	of	IN
cord-023095-4dannjjm	4410	4	the	the	DT
cord-023095-4dannjjm	4410	5	present	present	JJ
cord-023095-4dannjjm	4410	6	study	study	NN
cord-023095-4dannjjm	4410	7	were	be	VBD
cord-023095-4dannjjm	4410	8	to	to	TO
cord-023095-4dannjjm	4410	9	assess	assess	VB
cord-023095-4dannjjm	4410	10	the	the	DT
cord-023095-4dannjjm	4410	11	normal	normal	JJ
cord-023095-4dannjjm	4410	12	,	,	,
cord-023095-4dannjjm	4410	13	physiological	physiological	JJ
cord-023095-4dannjjm	4410	14	levels	level	NNS
cord-023095-4dannjjm	4410	15	of	of	IN
cord-023095-4dannjjm	4410	16	IS	is	NN
cord-023095-4dannjjm	4410	17	and	and	CC
cord-023095-4dannjjm	4410	18	CS	CS	NNP
cord-023095-4dannjjm	4410	19	in	in	IN
cord-023095-4dannjjm	4410	20	healthy	healthy	JJ
cord-023095-4dannjjm	4410	21	cats	cat	NNS
cord-023095-4dannjjm	4410	22	and	and	CC
cord-023095-4dannjjm	4410	23	to	to	TO
cord-023095-4dannjjm	4410	24	evaluate	evaluate	VB
cord-023095-4dannjjm	4410	25	the	the	DT
cord-023095-4dannjjm	4410	26	correlation	correlation	NN
cord-023095-4dannjjm	4410	27	of	of	IN
cord-023095-4dannjjm	4410	28	the	the	DT
cord-023095-4dannjjm	4410	29	respective	respective	JJ
cord-023095-4dannjjm	4410	30	free	free	JJ
cord-023095-4dannjjm	4410	31	and	and	CC
cord-023095-4dannjjm	4410	32	protein	protein	NN
cord-023095-4dannjjm	4410	33	-	-	HYPH
cord-023095-4dannjjm	4410	34	bound	bind	VBN
cord-023095-4dannjjm	4410	35	levels	level	NNS
cord-023095-4dannjjm	4410	36	.	.	.
cord-023095-4dannjjm	4411	1	Blood	blood	NN
cord-023095-4dannjjm	4411	2	samples	sample	NNS
cord-023095-4dannjjm	4411	3	were	be	VBD
cord-023095-4dannjjm	4411	4	taken	take	VBN
cord-023095-4dannjjm	4411	5	from	from	IN
cord-023095-4dannjjm	4411	6	105	105	CD
cord-023095-4dannjjm	4411	7	clinically	clinically	RB
cord-023095-4dannjjm	4411	8	healthy	healthy	JJ
cord-023095-4dannjjm	4411	9	adult	adult	NN
cord-023095-4dannjjm	4411	10	cats	cat	NNS
cord-023095-4dannjjm	4411	11	enrolled	enrol	VBD
cord-023095-4dannjjm	4411	12	at	at	IN
cord-023095-4dannjjm	4411	13	five	five	CD
cord-023095-4dannjjm	4411	14	participating	participate	VBG
cord-023095-4dannjjm	4411	15	veterinary	veterinary	JJ
cord-023095-4dannjjm	4411	16	practices	practice	NNS
cord-023095-4dannjjm	4411	17	in	in	IN
cord-023095-4dannjjm	4411	18	Germany	Germany	NNP
cord-023095-4dannjjm	4411	19	.	.	.
cord-023095-4dannjjm	4412	1	After	after	IN
cord-023095-4dannjjm	4412	2	centrifugation	centrifugation	NN
cord-023095-4dannjjm	4412	3	,	,	,
cord-023095-4dannjjm	4412	4	the	the	DT
cord-023095-4dannjjm	4412	5	serum	serum	NN
cord-023095-4dannjjm	4412	6	was	be	VBD
cord-023095-4dannjjm	4412	7	deep	deep	JJ
cord-023095-4dannjjm	4412	8	frozen	frozen	JJ
cord-023095-4dannjjm	4412	9	until	until	IN
cord-023095-4dannjjm	4412	10	transport	transport	NN
cord-023095-4dannjjm	4412	11	on	on	IN
cord-023095-4dannjjm	4412	12	dry	dry	JJ
cord-023095-4dannjjm	4412	13	ice	ice	NN
cord-023095-4dannjjm	4412	14	to	to	IN
cord-023095-4dannjjm	4412	15	the	the	DT
cord-023095-4dannjjm	4412	16	analytical	analytical	JJ
cord-023095-4dannjjm	4412	17	laboratory	laboratory	NN
cord-023095-4dannjjm	4412	18	.	.	.
cord-023095-4dannjjm	4413	1	Serum	serum	NN
cord-023095-4dannjjm	4413	2	creatinine	creatinine	NN
cord-023095-4dannjjm	4413	3	and	and	CC
cord-023095-4dannjjm	4413	4	urea	urea	NN
cord-023095-4dannjjm	4413	5	levels	level	NNS
cord-023095-4dannjjm	4413	6	were	be	VBD
cord-023095-4dannjjm	4413	7	quantified	quantify	VBN
cord-023095-4dannjjm	4413	8	by	by	IN
cord-023095-4dannjjm	4413	9	VetTest	VetTest	NNP
cord-023095-4dannjjm	4413	10	s	s	NNP
cord-023095-4dannjjm	4413	11	(	(	-LRB-
cord-023095-4dannjjm	4413	12	IDEXX	IDEXX	NNP
cord-023095-4dannjjm	4413	13	Laboratories	Laboratories	NNP
cord-023095-4dannjjm	4413	14	,	,	,
cord-023095-4dannjjm	4413	15	Inc.	Inc.	NNP
cord-023095-4dannjjm	4413	16	)	)	-RRB-
cord-023095-4dannjjm	4413	17	.	.	.
cord-023095-4dannjjm	4414	1	Total	total	JJ
cord-023095-4dannjjm	4414	2	and	and	CC
cord-023095-4dannjjm	4414	3	free	free	JJ
cord-023095-4dannjjm	4414	4	IS	is	NN
cord-023095-4dannjjm	4414	5	and	and	CC
cord-023095-4dannjjm	4414	6	CS	CS	NNP
cord-023095-4dannjjm	4414	7	,	,	,
cord-023095-4dannjjm	4414	8	respectively	respectively	RB
cord-023095-4dannjjm	4414	9	,	,	,
cord-023095-4dannjjm	4414	10	were	be	VBD
cord-023095-4dannjjm	4414	11	quantified	quantify	VBN
cord-023095-4dannjjm	4414	12	by	by	IN
cord-023095-4dannjjm	4414	13	turbulent	turbulent	JJ
cord-023095-4dannjjm	4414	14	flow	flow	NN
cord-023095-4dannjjm	4414	15	chromatography	chromatography	NN
cord-023095-4dannjjm	4414	16	coupled	couple	VBN
cord-023095-4dannjjm	4414	17	with	with	IN
cord-023095-4dannjjm	4414	18	a	a	DT
cord-023095-4dannjjm	4414	19	tandem	tandem	JJ
cord-023095-4dannjjm	4414	20	mass	mass	NN
cord-023095-4dannjjm	4414	21	spectrometry	spectrometry	NN
cord-023095-4dannjjm	4414	22	detector	detector	NN
cord-023095-4dannjjm	4414	23	.	.	.
cord-023095-4dannjjm	4415	1	Statistical	statistical	JJ
cord-023095-4dannjjm	4415	2	analysis	analysis	NN
cord-023095-4dannjjm	4415	3	of	of	IN
cord-023095-4dannjjm	4415	4	the	the	DT
cord-023095-4dannjjm	4415	5	results	result	NNS
cord-023095-4dannjjm	4415	6	comprised	comprise	VBN
cord-023095-4dannjjm	4415	7	i	i	NN
cord-023095-4dannjjm	4415	8	)	)	-RRB-
cord-023095-4dannjjm	4415	9	a	a	DT
cord-023095-4dannjjm	4415	10	descriptive	descriptive	JJ
cord-023095-4dannjjm	4415	11	report	report	NN
cord-023095-4dannjjm	4415	12	of	of	IN
cord-023095-4dannjjm	4415	13	the	the	DT
cord-023095-4dannjjm	4415	14	median	median	NN
cord-023095-4dannjjm	4415	15	with	with	IN
cord-023095-4dannjjm	4415	16	upper	upper	JJ
cord-023095-4dannjjm	4415	17	and	and	CC
cord-023095-4dannjjm	4415	18	lower	low	JJR
cord-023095-4dannjjm	4415	19	bounds	bound	NNS
cord-023095-4dannjjm	4415	20	of	of	IN
cord-023095-4dannjjm	4415	21	the	the	DT
cord-023095-4dannjjm	4415	22	95	95	CD
cord-023095-4dannjjm	4415	23	%	%	NN
cord-023095-4dannjjm	4415	24	confidence	confidence	NN
cord-023095-4dannjjm	4415	25	interval	interval	NN
cord-023095-4dannjjm	4415	26	for	for	IN
cord-023095-4dannjjm	4415	27	reference	reference	NN
cord-023095-4dannjjm	4415	28	values	value	NNS
cord-023095-4dannjjm	4415	29	of	of	IN
cord-023095-4dannjjm	4415	30	IS	is	NN
cord-023095-4dannjjm	4415	31	and	and	CC
cord-023095-4dannjjm	4415	32	CS	CS	NNP
cord-023095-4dannjjm	4415	33	,	,	,
cord-023095-4dannjjm	4415	34	ii	ii	LS
cord-023095-4dannjjm	4415	35	)	)	-RRB-
cord-023095-4dannjjm	4415	36	a	a	DT
cord-023095-4dannjjm	4415	37	calculation	calculation	NN
cord-023095-4dannjjm	4415	38	of	of	IN
cord-023095-4dannjjm	4415	39	various	various	JJ
cord-023095-4dannjjm	4415	40	Pearson	Pearson	NNP
cord-023095-4dannjjm	4415	41	correlation	correlation	NN
cord-023095-4dannjjm	4415	42	coefficients	coefficient	NNS
cord-023095-4dannjjm	4415	43	r	r	NN
cord-023095-4dannjjm	4415	44	,	,	,
cord-023095-4dannjjm	4415	45	also	also	RB
cord-023095-4dannjjm	4415	46	tested	test	VBN
cord-023095-4dannjjm	4415	47	with	with	IN
cord-023095-4dannjjm	4415	48	reference	reference	NN
cord-023095-4dannjjm	4415	49	to	to	IN
cord-023095-4dannjjm	4415	50	the	the	DT
cord-023095-4dannjjm	4415	51	null	null	JJ
cord-023095-4dannjjm	4415	52	hypothesis	hypothesis	NN
cord-023095-4dannjjm	4415	53	of	of	IN
cord-023095-4dannjjm	4415	54	no	no	DT
cord-023095-4dannjjm	4415	55	relationship	relationship	NN
cord-023095-4dannjjm	4415	56	,	,	,
cord-023095-4dannjjm	4415	57	and	and	CC
cord-023095-4dannjjm	4415	58	iii	iii	LS
cord-023095-4dannjjm	4415	59	)	)	-RRB-
cord-023095-4dannjjm	4416	1	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	4416	2	-	-	HYPH
cord-023095-4dannjjm	4416	3	Mann	Mann	NNP
cord-023095-4dannjjm	4416	4	-	-	HYPH
cord-023095-4dannjjm	4416	5	Whitney	Whitney	NNP
cord-023095-4dannjjm	4416	6	Utest	Utest	NNP
cord-023095-4dannjjm	4416	7	for	for	IN
cord-023095-4dannjjm	4416	8	an	an	DT
cord-023095-4dannjjm	4416	9	estimation	estimation	NN
cord-023095-4dannjjm	4416	10	of	of	IN
cord-023095-4dannjjm	4416	11	the	the	DT
cord-023095-4dannjjm	4416	12	effect	effect	NN
cord-023095-4dannjjm	4416	13	of	of	IN
cord-023095-4dannjjm	4416	14	hemolysis	hemolysis	NN
cord-023095-4dannjjm	4416	15	on	on	IN
cord-023095-4dannjjm	4416	16	serum	serum	NN
cord-023095-4dannjjm	4416	17	IS	be	VBZ
cord-023095-4dannjjm	4416	18	or	or	CC
cord-023095-4dannjjm	4416	19	CS	CS	NNP
cord-023095-4dannjjm	4416	20	levels	level	NNS
cord-023095-4dannjjm	4416	21	.	.	.
cord-023095-4dannjjm	4417	1	Six	six	CD
cord-023095-4dannjjm	4417	2	animals	animal	NNS
cord-023095-4dannjjm	4417	3	with	with	IN
cord-023095-4dannjjm	4417	4	serum	serum	NN
cord-023095-4dannjjm	4417	5	creatinine	creatinine	NN
cord-023095-4dannjjm	4417	6	or	or	CC
cord-023095-4dannjjm	4417	7	urea	urea	NN
cord-023095-4dannjjm	4417	8	levels	level	NNS
cord-023095-4dannjjm	4417	9	outside	outside	IN
cord-023095-4dannjjm	4417	10	the	the	DT
cord-023095-4dannjjm	4417	11	reference	reference	NN
cord-023095-4dannjjm	4417	12	range	range	NN
cord-023095-4dannjjm	4417	13	were	be	VBD
cord-023095-4dannjjm	4417	14	excluded	exclude	VBN
cord-023095-4dannjjm	4417	15	from	from	IN
cord-023095-4dannjjm	4417	16	the	the	DT
cord-023095-4dannjjm	4417	17	calculation	calculation	NN
cord-023095-4dannjjm	4417	18	of	of	IN
cord-023095-4dannjjm	4417	19	reference	reference	NN
cord-023095-4dannjjm	4417	20	values	value	NNS
cord-023095-4dannjjm	4417	21	.	.	.
cord-023095-4dannjjm	4418	1	Median	median	JJ
cord-023095-4dannjjm	4418	2	levels	level	NNS
cord-023095-4dannjjm	4418	3	of	of	IN
cord-023095-4dannjjm	4418	4	IS	is	NN
cord-023095-4dannjjm	4418	5	in	in	IN
cord-023095-4dannjjm	4418	6	cat	cat	NN
cord-023095-4dannjjm	4418	7	serum	serum	NN
cord-023095-4dannjjm	4418	8	were	be	VBD
cord-023095-4dannjjm	4418	9	1.19	1.19	CD
cord-023095-4dannjjm	4418	10	mg	mg	NNP
cord-023095-4dannjjm	4418	11	/	/	SYM
cord-023095-4dannjjm	4418	12	L	L	NNP
cord-023095-4dannjjm	4418	13	with	with	IN
cord-023095-4dannjjm	4418	14	upper	upper	JJ
cord-023095-4dannjjm	4418	15	and	and	CC
cord-023095-4dannjjm	4418	16	lower	lower	RBR
cord-023095-4dannjjm	4418	17	bound	bind	VBN
cord-023095-4dannjjm	4418	18	95	95	CD
cord-023095-4dannjjm	4418	19	%	%	NN
cord-023095-4dannjjm	4418	20	confidence	confidence	NN
cord-023095-4dannjjm	4418	21	intervals	interval	NNS
cord-023095-4dannjjm	4418	22	at	at	IN
cord-023095-4dannjjm	4418	23	1.46	1.46	CD
cord-023095-4dannjjm	4418	24	and	and	CC
cord-023095-4dannjjm	4418	25	0.99	0.99	CD
cord-023095-4dannjjm	4418	26	mg	mg	NNP
cord-023095-4dannjjm	4418	27	/	/	SYM
cord-023095-4dannjjm	4418	28	L	L	NNP
cord-023095-4dannjjm	4418	29	,	,	,
cord-023095-4dannjjm	4418	30	respectively	respectively	RB
cord-023095-4dannjjm	4418	31	.	.	.
cord-023095-4dannjjm	4419	1	The	the	DT
cord-023095-4dannjjm	4419	2	corresponding	correspond	VBG
cord-023095-4dannjjm	4419	3	median	median	JJ
cord-023095-4dannjjm	4419	4	levels	level	NNS
cord-023095-4dannjjm	4419	5	of	of	IN
cord-023095-4dannjjm	4419	6	CS	CS	NNP
cord-023095-4dannjjm	4419	7	were	be	VBD
cord-023095-4dannjjm	4419	8	2.11	2.11	CD
cord-023095-4dannjjm	4419	9	mg	mg	NNP
cord-023095-4dannjjm	4419	10	/	/	SYM
cord-023095-4dannjjm	4419	11	L	L	NNP
cord-023095-4dannjjm	4419	12	(	(	-LRB-
cord-023095-4dannjjm	4419	13	median	median	NN
cord-023095-4dannjjm	4419	14	)	)	-RRB-
cord-023095-4dannjjm	4419	15	and	and	CC
cord-023095-4dannjjm	4419	16	2.46	2.46	CD
cord-023095-4dannjjm	4419	17	vs	vs	IN
cord-023095-4dannjjm	4419	18	1.57	1.57	CD
cord-023095-4dannjjm	4419	19	mg	mg	NNP
cord-023095-4dannjjm	4419	20	/	/	SYM
cord-023095-4dannjjm	4419	21	L	L	NNP
cord-023095-4dannjjm	4419	22	(	(	-LRB-
cord-023095-4dannjjm	4419	23	upper	upper	JJ
cord-023095-4dannjjm	4419	24	vs	vs	IN
cord-023095-4dannjjm	4419	25	lower	lower	RBR
cord-023095-4dannjjm	4419	26	bound	bound	JJ
cord-023095-4dannjjm	4419	27	levels	level	NNS
cord-023095-4dannjjm	4419	28	,	,	,
cord-023095-4dannjjm	4419	29	respectively	respectively	RB
cord-023095-4dannjjm	4419	30	)	)	-RRB-
cord-023095-4dannjjm	4419	31	.	.	.
cord-023095-4dannjjm	4420	1	These	these	DT
cord-023095-4dannjjm	4420	2	values	value	NNS
cord-023095-4dannjjm	4420	3	showed	show	VBD
cord-023095-4dannjjm	4420	4	a	a	DT
cord-023095-4dannjjm	4420	5	low	low	JJ
cord-023095-4dannjjm	4420	6	,	,	,
cord-023095-4dannjjm	4420	7	non	non	JJ
cord-023095-4dannjjm	4420	8	-	-	JJ
cord-023095-4dannjjm	4420	9	significant	significant	JJ
cord-023095-4dannjjm	4420	10	correlation	correlation	NN
cord-023095-4dannjjm	4420	11	with	with	IN
cord-023095-4dannjjm	4420	12	serum	serum	NN
cord-023095-4dannjjm	4420	13	creatinine	creatinine	NN
cord-023095-4dannjjm	4420	14	or	or	CC
cord-023095-4dannjjm	4420	15	urea	urea	NN
cord-023095-4dannjjm	4420	16	levels	level	NNS
cord-023095-4dannjjm	4420	17	.	.	.
cord-023095-4dannjjm	4421	1	However	however	RB
cord-023095-4dannjjm	4421	2	,	,	,
cord-023095-4dannjjm	4421	3	IS	be	VBZ
cord-023095-4dannjjm	4421	4	and	and	CC
cord-023095-4dannjjm	4421	5	CS	CS	NNP
cord-023095-4dannjjm	4421	6	serum	serum	NN
cord-023095-4dannjjm	4421	7	levels	level	NNS
cord-023095-4dannjjm	4421	8	were	be	VBD
cord-023095-4dannjjm	4421	9	moderately	moderately	RB
cord-023095-4dannjjm	4421	10	correlated	correlate	VBN
cord-023095-4dannjjm	4421	11	(	(	-LRB-
cord-023095-4dannjjm	4421	12	total	total	JJ
cord-023095-4dannjjm	4421	13	levels	level	NNS
cord-023095-4dannjjm	4421	14	r	r	NNP
cord-023095-4dannjjm	4421	15	5	5	CD
cord-023095-4dannjjm	4421	16	0.4808	0.4808	CD
cord-023095-4dannjjm	4421	17	,	,	,
cord-023095-4dannjjm	4421	18	p	p	NN
cord-023095-4dannjjm	4421	19	o	o	NN
cord-023095-4dannjjm	4421	20	0001	0001	CD
cord-023095-4dannjjm	4421	21	)	)	-RRB-
cord-023095-4dannjjm	4421	22	.	.	.
cord-023095-4dannjjm	4422	1	Their	-PRON-	PRP$
cord-023095-4dannjjm	4422	2	respective	respective	JJ
cord-023095-4dannjjm	4422	3	free	free	JJ
cord-023095-4dannjjm	4422	4	levels	level	NNS
cord-023095-4dannjjm	4422	5	constituted	constitute	VBN
cord-023095-4dannjjm	4422	6	about	about	RB
cord-023095-4dannjjm	4422	7	5	5	CD
cord-023095-4dannjjm	4422	8	%	%	NN
cord-023095-4dannjjm	4422	9	of	of	IN
cord-023095-4dannjjm	4422	10	the	the	DT
cord-023095-4dannjjm	4422	11	total	total	JJ
cord-023095-4dannjjm	4422	12	serum	serum	NN
cord-023095-4dannjjm	4422	13	levels	level	NNS
cord-023095-4dannjjm	4422	14	(	(	-LRB-
cord-023095-4dannjjm	4422	15	r	r	NN
cord-023095-4dannjjm	4422	16	!	!	.
cord-023095-4dannjjm	4422	17	0.8977	0.8977	CD
cord-023095-4dannjjm	4422	18	,	,	,
cord-023095-4dannjjm	4422	19	p	p	NN
cord-023095-4dannjjm	4422	20	o	o	NN
cord-023095-4dannjjm	4422	21	0.001	0.001	CD
cord-023095-4dannjjm	4422	22	)	)	-RRB-
cord-023095-4dannjjm	4422	23	.	.	.
cord-023095-4dannjjm	4423	1	Non	non	JJ
cord-023095-4dannjjm	4423	2	-	-	JJ
cord-023095-4dannjjm	4423	3	hemolytic	hemolytic	JJ
cord-023095-4dannjjm	4423	4	samples	sample	NNS
cord-023095-4dannjjm	4423	5	tended	tend	VBD
cord-023095-4dannjjm	4423	6	to	to	TO
cord-023095-4dannjjm	4423	7	yield	yield	VB
cord-023095-4dannjjm	4423	8	lower	low	JJR
cord-023095-4dannjjm	4423	9	values	value	NNS
cord-023095-4dannjjm	4423	10	than	than	IN
cord-023095-4dannjjm	4423	11	hemolytic	hemolytic	JJ
cord-023095-4dannjjm	4423	12	samples	sample	NNS
cord-023095-4dannjjm	4423	13	.	.	.
cord-023095-4dannjjm	4424	1	Due	due	IN
cord-023095-4dannjjm	4424	2	to	to	IN
cord-023095-4dannjjm	4424	3	the	the	DT
cord-023095-4dannjjm	4424	4	low	low	JJ
cord-023095-4dannjjm	4424	5	number	number	NN
cord-023095-4dannjjm	4424	6	of	of	IN
cord-023095-4dannjjm	4424	7	hemolytic	hemolytic	JJ
cord-023095-4dannjjm	4424	8	samples	sample	NNS
cord-023095-4dannjjm	4424	9	(	(	-LRB-
cord-023095-4dannjjm	4424	10	N	n	CD
cord-023095-4dannjjm	4424	11	5	5	CD
cord-023095-4dannjjm	4424	12	14	14	CD
cord-023095-4dannjjm	4424	13	)	)	-RRB-
cord-023095-4dannjjm	4424	14	,	,	,
cord-023095-4dannjjm	4424	15	the	the	DT
cord-023095-4dannjjm	4424	16	group	group	NN
cord-023095-4dannjjm	4424	17	difference	difference	NN
cord-023095-4dannjjm	4424	18	could	could	MD
cord-023095-4dannjjm	4424	19	,	,	,
cord-023095-4dannjjm	4424	20	however	however	RB
cord-023095-4dannjjm	4424	21	,	,	,
cord-023095-4dannjjm	4424	22	not	not	RB
cord-023095-4dannjjm	4424	23	be	be	VB
cord-023095-4dannjjm	4424	24	statistically	statistically	RB
cord-023095-4dannjjm	4424	25	confirmed	confirm	VBN
cord-023095-4dannjjm	4424	26	.	.	.
cord-023095-4dannjjm	4425	1	The	the	DT
cord-023095-4dannjjm	4425	2	results	result	NNS
cord-023095-4dannjjm	4425	3	indicate	indicate	VBP
cord-023095-4dannjjm	4425	4	that	that	IN
cord-023095-4dannjjm	4425	5	it	-PRON-	PRP
cord-023095-4dannjjm	4425	6	is	be	VBZ
cord-023095-4dannjjm	4425	7	sufficient	sufficient	JJ
cord-023095-4dannjjm	4425	8	to	to	TO
cord-023095-4dannjjm	4425	9	determine	determine	VB
cord-023095-4dannjjm	4425	10	total	total	JJ
cord-023095-4dannjjm	4425	11	levels	level	NNS
cord-023095-4dannjjm	4425	12	of	of	IN
cord-023095-4dannjjm	4425	13	either	either	DT
cord-023095-4dannjjm	4425	14	IS	be	VBZ
cord-023095-4dannjjm	4425	15	or	or	CC
cord-023095-4dannjjm	4425	16	CS	CS	NNP
cord-023095-4dannjjm	4425	17	in	in	IN
cord-023095-4dannjjm	4425	18	serum	serum	NN
cord-023095-4dannjjm	4425	19	while	while	IN
cord-023095-4dannjjm	4425	20	studying	study	VBG
cord-023095-4dannjjm	4425	21	the	the	DT
cord-023095-4dannjjm	4425	22	effects	effect	NNS
cord-023095-4dannjjm	4425	23	of	of	IN
cord-023095-4dannjjm	4425	24	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	4425	25	or	or	CC
cord-023095-4dannjjm	4425	26	dietetic	dietetic	JJ
cord-023095-4dannjjm	4425	27	interventions	intervention	NNS
cord-023095-4dannjjm	4425	28	on	on	IN
cord-023095-4dannjjm	4425	29	the	the	DT
cord-023095-4dannjjm	4425	30	evolution	evolution	NN
cord-023095-4dannjjm	4425	31	of	of	IN
cord-023095-4dannjjm	4425	32	these	these	DT
cord-023095-4dannjjm	4425	33	parameters	parameter	NNS
cord-023095-4dannjjm	4425	34	in	in	IN
cord-023095-4dannjjm	4425	35	feline	feline	JJ
cord-023095-4dannjjm	4425	36	CKD	CKD	NNP
cord-023095-4dannjjm	4425	37	.	.	.
cord-023095-4dannjjm	4426	1	Reference	reference	NN
cord-023095-4dannjjm	4426	2	values	value	NNS
cord-023095-4dannjjm	4426	3	are	be	VBP
cord-023095-4dannjjm	4426	4	provided	provide	VBN
cord-023095-4dannjjm	4426	5	for	for	IN
cord-023095-4dannjjm	4426	6	orientation	orientation	NN
cord-023095-4dannjjm	4426	7	towards	towards	IN
cord-023095-4dannjjm	4426	8	clinically	clinically	RB
cord-023095-4dannjjm	4426	9	relevant	relevant	JJ
cord-023095-4dannjjm	4426	10	changes	change	NNS
cord-023095-4dannjjm	4426	11	.	.	.
cord-023095-4dannjjm	4427	1	Disrupted	disrupt	VBN
cord-023095-4dannjjm	4427	2	urothelial	urothelial	JJ
cord-023095-4dannjjm	4427	3	differentiation	differentiation	NN
cord-023095-4dannjjm	4427	4	has	have	VBZ
cord-023095-4dannjjm	4427	5	been	be	VBN
cord-023095-4dannjjm	4427	6	implicated	implicate	VBN
cord-023095-4dannjjm	4427	7	in	in	IN
cord-023095-4dannjjm	4427	8	the	the	DT
cord-023095-4dannjjm	4427	9	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	4427	10	of	of	IN
cord-023095-4dannjjm	4427	11	feline	feline	JJ
cord-023095-4dannjjm	4427	12	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	4427	13	cystitis	cystitis	NN
cord-023095-4dannjjm	4427	14	(	(	-LRB-
cord-023095-4dannjjm	4427	15	FIC	fic	NN
cord-023095-4dannjjm	4427	16	)	)	-RRB-
cord-023095-4dannjjm	4427	17	.	.	.
cord-023095-4dannjjm	4428	1	Studies	study	NNS
cord-023095-4dannjjm	4428	2	of	of	IN
cord-023095-4dannjjm	4428	3	cultured	cultured	JJ
cord-023095-4dannjjm	4428	4	human	human	JJ
cord-023095-4dannjjm	4428	5	urothelium	urothelium	NN
cord-023095-4dannjjm	4428	6	have	have	VBP
cord-023095-4dannjjm	4428	7	shown	show	VBN
cord-023095-4dannjjm	4428	8	that	that	IN
cord-023095-4dannjjm	4428	9	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4428	10	in	in	IN
cord-023095-4dannjjm	4428	11	urothelial	urothelial	JJ
cord-023095-4dannjjm	4428	12	differentiation	differentiation	NN
cord-023095-4dannjjm	4428	13	and	and	CC
cord-023095-4dannjjm	4428	14	repair	repair	NN
cord-023095-4dannjjm	4428	15	may	may	MD
cord-023095-4dannjjm	4428	16	be	be	VB
cord-023095-4dannjjm	4428	17	mediated	mediate	VBN
cord-023095-4dannjjm	4428	18	by	by	IN
cord-023095-4dannjjm	4428	19	persistent	persistent	JJ
cord-023095-4dannjjm	4428	20	15-hydroxy	15-hydroxy	CD
cord-023095-4dannjjm	4428	21	-	-	HYPH
cord-023095-4dannjjm	4428	22	prostaglandin	prostaglandin	NN
cord-023095-4dannjjm	4428	23	dehydrogenase	dehydrogenase	NN
cord-023095-4dannjjm	4428	24	(	(	-LRB-
cord-023095-4dannjjm	4428	25	PGDH	PGDH	NNP
cord-023095-4dannjjm	4428	26	)	)	-RRB-
cord-023095-4dannjjm	4428	27	activity	activity	NN
cord-023095-4dannjjm	4428	28	and	and	CC
cord-023095-4dannjjm	4428	29	subsequent	subsequent	JJ
cord-023095-4dannjjm	4428	30	metabolism	metabolism	NN
cord-023095-4dannjjm	4428	31	of	of	IN
cord-023095-4dannjjm	4428	32	cytoprotective	cytoprotective	JJ
cord-023095-4dannjjm	4428	33	prostaglandins	prostaglandin	NNS
cord-023095-4dannjjm	4428	34	.	.	.
cord-023095-4dannjjm	4429	1	The	the	DT
cord-023095-4dannjjm	4429	2	goal	goal	NN
cord-023095-4dannjjm	4429	3	of	of	IN
cord-023095-4dannjjm	4429	4	this	this	DT
cord-023095-4dannjjm	4429	5	study	study	NN
cord-023095-4dannjjm	4429	6	was	be	VBD
cord-023095-4dannjjm	4429	7	to	to	TO
cord-023095-4dannjjm	4429	8	confirm	confirm	VB
cord-023095-4dannjjm	4429	9	persistent	persistent	JJ
cord-023095-4dannjjm	4429	10	PGDH	PGDH	NNP
cord-023095-4dannjjm	4429	11	expression	expression	NN
cord-023095-4dannjjm	4429	12	in	in	IN
cord-023095-4dannjjm	4429	13	FIC	fic	NN
cord-023095-4dannjjm	4429	14	bladders	bladder	NNS
cord-023095-4dannjjm	4429	15	compared	compare	VBN
cord-023095-4dannjjm	4429	16	to	to	IN
cord-023095-4dannjjm	4429	17	desmoplakin	desmoplakin	NNP
cord-023095-4dannjjm	4429	18	I1II	i1ii	DT
cord-023095-4dannjjm	4429	19	expression	expression	NN
cord-023095-4dannjjm	4429	20	,	,	,
cord-023095-4dannjjm	4429	21	a	a	DT
cord-023095-4dannjjm	4429	22	marker	marker	NN
cord-023095-4dannjjm	4429	23	of	of	IN
cord-023095-4dannjjm	4429	24	urothelial	urothelial	JJ
cord-023095-4dannjjm	4429	25	differentiation	differentiation	NN
cord-023095-4dannjjm	4429	26	.	.	.
cord-023095-4dannjjm	4430	1	Urinary	urinary	JJ
cord-023095-4dannjjm	4430	2	bladder	bladder	NN
cord-023095-4dannjjm	4430	3	biopsy	biopsy	NN
cord-023095-4dannjjm	4430	4	specimens	specimen	NNS
cord-023095-4dannjjm	4430	5	were	be	VBD
cord-023095-4dannjjm	4430	6	obtained	obtain	VBN
cord-023095-4dannjjm	4430	7	by	by	IN
cord-023095-4dannjjm	4430	8	cystotomy	cystotomy	NN
cord-023095-4dannjjm	4430	9	from	from	IN
cord-023095-4dannjjm	4430	10	9	9	CD
cord-023095-4dannjjm	4430	11	symptomatic	symptomatic	JJ
cord-023095-4dannjjm	4430	12	cats	cat	NNS
cord-023095-4dannjjm	4430	13	with	with	IN
cord-023095-4dannjjm	4430	14	chronic	chronic	JJ
cord-023095-4dannjjm	4430	15	FIC	fic	NN
cord-023095-4dannjjm	4430	16	.	.	.
cord-023095-4dannjjm	4431	1	Cats	cat	NNS
cord-023095-4dannjjm	4431	2	with	with	IN
cord-023095-4dannjjm	4431	3	a	a	DT
cord-023095-4dannjjm	4431	4	history	history	NN
cord-023095-4dannjjm	4431	5	of	of	IN
cord-023095-4dannjjm	4431	6	another	another	DT
cord-023095-4dannjjm	4431	7	major	major	JJ
cord-023095-4dannjjm	4431	8	disease	disease	NN
cord-023095-4dannjjm	4431	9	,	,	,
cord-023095-4dannjjm	4431	10	previous	previous	JJ
cord-023095-4dannjjm	4431	11	cystotomy	cystotomy	NN
cord-023095-4dannjjm	4431	12	,	,	,
cord-023095-4dannjjm	4431	13	or	or	CC
cord-023095-4dannjjm	4431	14	recent	recent	JJ
cord-023095-4dannjjm	4431	15	treatment	treatment	NN
cord-023095-4dannjjm	4431	16	with	with	IN
cord-023095-4dannjjm	4431	17	corticosteroids	corticosteroid	NNS
cord-023095-4dannjjm	4431	18	,	,	,
cord-023095-4dannjjm	4431	19	NSAIDs	nsaid	NNS
cord-023095-4dannjjm	4431	20	,	,	,
cord-023095-4dannjjm	4431	21	antihistamines	antihistamine	NNS
cord-023095-4dannjjm	4431	22	,	,	,
cord-023095-4dannjjm	4431	23	antidepressants	antidepressant	NNS
cord-023095-4dannjjm	4431	24	,	,	,
cord-023095-4dannjjm	4431	25	or	or	CC
cord-023095-4dannjjm	4431	26	glycosaminoglycans	glycosaminoglycan	NNS
cord-023095-4dannjjm	4431	27	were	be	VBD
cord-023095-4dannjjm	4431	28	excluded	exclude	VBN
cord-023095-4dannjjm	4431	29	.	.	.
cord-023095-4dannjjm	4432	1	Urinary	urinary	JJ
cord-023095-4dannjjm	4432	2	bladder	bladder	NN
cord-023095-4dannjjm	4432	3	tissue	tissue	NN
cord-023095-4dannjjm	4432	4	specimens	specimen	NNS
cord-023095-4dannjjm	4432	5	were	be	VBD
cord-023095-4dannjjm	4432	6	also	also	RB
cord-023095-4dannjjm	4432	7	obtained	obtain	VBN
cord-023095-4dannjjm	4432	8	from	from	IN
cord-023095-4dannjjm	4432	9	10	10	CD
cord-023095-4dannjjm	4432	10	untreated	untreated	JJ
cord-023095-4dannjjm	4432	11	clinically	clinically	RB
cord-023095-4dannjjm	4432	12	normal	normal	JJ
cord-023095-4dannjjm	4432	13	specific	specific	JJ
cord-023095-4dannjjm	4432	14	-	-	HYPH
cord-023095-4dannjjm	4432	15	pathogen	pathogen	NN
cord-023095-4dannjjm	4432	16	-	-	HYPH
cord-023095-4dannjjm	4432	17	free	free	JJ
cord-023095-4dannjjm	4432	18	cats	cat	NNS
cord-023095-4dannjjm	4432	19	.	.	.
cord-023095-4dannjjm	4433	1	Tissue	tissue	NN
cord-023095-4dannjjm	4433	2	specimens	specimen	NNS
cord-023095-4dannjjm	4433	3	were	be	VBD
cord-023095-4dannjjm	4433	4	fixed	fix	VBN
cord-023095-4dannjjm	4433	5	in	in	IN
cord-023095-4dannjjm	4433	6	buffered	buffer	VBN
cord-023095-4dannjjm	4433	7	10	10	CD
cord-023095-4dannjjm	4433	8	%	%	NN
cord-023095-4dannjjm	4433	9	formalin	formalin	NN
cord-023095-4dannjjm	4433	10	and	and	CC
cord-023095-4dannjjm	4433	11	embedded	embed	VBN
cord-023095-4dannjjm	4433	12	in	in	IN
cord-023095-4dannjjm	4433	13	paraffin	paraffin	NN
cord-023095-4dannjjm	4433	14	.	.	.
cord-023095-4dannjjm	4434	1	Tissue	tissue	NN
cord-023095-4dannjjm	4434	2	sections	section	NNS
cord-023095-4dannjjm	4434	3	were	be	VBD
cord-023095-4dannjjm	4434	4	deparaffinized	deparaffinize	VBN
cord-023095-4dannjjm	4434	5	and	and	CC
cord-023095-4dannjjm	4434	6	subjected	subject	VBN
cord-023095-4dannjjm	4434	7	to	to	IN
cord-023095-4dannjjm	4434	8	citrate	citrate	NNP
cord-023095-4dannjjm	4434	9	buffer	buffer	NNP
cord-023095-4dannjjm	4434	10	microwave	microwave	NNP
cord-023095-4dannjjm	4434	11	antigen	antigen	NNP
cord-023095-4dannjjm	4434	12	retrieval	retrieval	NNP
cord-023095-4dannjjm	4434	13	.	.	.
cord-023095-4dannjjm	4435	1	Tissues	tissue	NNS
cord-023095-4dannjjm	4435	2	were	be	VBD
cord-023095-4dannjjm	4435	3	stained	stain	VBN
cord-023095-4dannjjm	4435	4	for	for	IN
cord-023095-4dannjjm	4435	5	PGDH	PGDH	NNS
cord-023095-4dannjjm	4435	6	using	use	VBG
cord-023095-4dannjjm	4435	7	a	a	DT
cord-023095-4dannjjm	4435	8	rabbit	rabbit	NN
cord-023095-4dannjjm	4435	9	anti	anti	JJ
cord-023095-4dannjjm	4435	10	-	-	JJ
cord-023095-4dannjjm	4435	11	PGDH	PGDH	NNP
cord-023095-4dannjjm	4435	12	antibody	antibody	NN
cord-023095-4dannjjm	4435	13	,	,	,
cord-023095-4dannjjm	4435	14	an	an	DT
cord-023095-4dannjjm	4435	15	isotype	isotype	JJ
cord-023095-4dannjjm	4435	16	negative	negative	JJ
cord-023095-4dannjjm	4435	17	control	control	NN
cord-023095-4dannjjm	4435	18	or	or	CC
cord-023095-4dannjjm	4435	19	goat	goat	NN
cord-023095-4dannjjm	4435	20	anti	anti	NNP
cord-023095-4dannjjm	4435	21	-	-	JJ
cord-023095-4dannjjm	4435	22	desmoplakin	desmoplakin	JJ
cord-023095-4dannjjm	4435	23	I1II	i1ii	CD
cord-023095-4dannjjm	4435	24	and	and	CC
cord-023095-4dannjjm	4435	25	developed	develop	VBD
cord-023095-4dannjjm	4435	26	using	use	VBG
cord-023095-4dannjjm	4435	27	the	the	DT
cord-023095-4dannjjm	4435	28	avidin	avidin	NN
cord-023095-4dannjjm	4435	29	-	-	HYPH
cord-023095-4dannjjm	4435	30	biotin	biotin	NN
cord-023095-4dannjjm	4435	31	peroxidase	peroxidase	NN
cord-023095-4dannjjm	4435	32	complex	complex	JJ
cord-023095-4dannjjm	4435	33	method	method	NN
cord-023095-4dannjjm	4435	34	.	.	.
cord-023095-4dannjjm	4436	1	All	all	DT
cord-023095-4dannjjm	4436	2	FIC	fic	NN
cord-023095-4dannjjm	4436	3	(	(	-LRB-
cord-023095-4dannjjm	4436	4	9/9	9/9	CD
cord-023095-4dannjjm	4436	5	)	)	-RRB-
cord-023095-4dannjjm	4436	6	and	and	CC
cord-023095-4dannjjm	4436	7	normal	normal	JJ
cord-023095-4dannjjm	4436	8	(	(	-LRB-
cord-023095-4dannjjm	4436	9	10/10	10/10	CD
cord-023095-4dannjjm	4436	10	)	)	-RRB-
cord-023095-4dannjjm	4436	11	cat	cat	NN
cord-023095-4dannjjm	4436	12	bladder	bladder	NN
cord-023095-4dannjjm	4436	13	samples	sample	NNS
cord-023095-4dannjjm	4436	14	showed	show	VBD
cord-023095-4dannjjm	4436	15	similar	similar	JJ
cord-023095-4dannjjm	4436	16	staining	staining	NN
cord-023095-4dannjjm	4436	17	of	of	IN
cord-023095-4dannjjm	4436	18	urothelial	urothelial	JJ
cord-023095-4dannjjm	4436	19	cytoplasm	cytoplasm	NN
cord-023095-4dannjjm	4436	20	for	for	IN
cord-023095-4dannjjm	4436	21	PGDH	PGDH	NNS
cord-023095-4dannjjm	4436	22	.	.	.
cord-023095-4dannjjm	4437	1	However	however	RB
cord-023095-4dannjjm	4437	2	,	,	,
cord-023095-4dannjjm	4437	3	desmoplakin	desmoplakin	NNP
cord-023095-4dannjjm	4437	4	I1II	i1ii	RB
cord-023095-4dannjjm	4437	5	staining	stain	VBG
cord-023095-4dannjjm	4437	6	,	,	,
cord-023095-4dannjjm	4437	7	found	find	VBN
cord-023095-4dannjjm	4437	8	on	on	IN
cord-023095-4dannjjm	4437	9	the	the	DT
cord-023095-4dannjjm	4437	10	luminal	luminal	JJ
cord-023095-4dannjjm	4437	11	cell	cell	NN
cord-023095-4dannjjm	4437	12	surface	surface	NN
cord-023095-4dannjjm	4437	13	in	in	IN
cord-023095-4dannjjm	4437	14	4/4	4/4	CD
cord-023095-4dannjjm	4437	15	normal	normal	JJ
cord-023095-4dannjjm	4437	16	tissues	tissue	NNS
cord-023095-4dannjjm	4437	17	,	,	,
cord-023095-4dannjjm	4437	18	was	be	VBD
cord-023095-4dannjjm	4437	19	disrupted	disrupt	VBN
cord-023095-4dannjjm	4437	20	in	in	IN
cord-023095-4dannjjm	4437	21	6/6	6/6	CD
cord-023095-4dannjjm	4437	22	FIC	fic	NN
cord-023095-4dannjjm	4437	23	bladder	bladder	NN
cord-023095-4dannjjm	4437	24	samples	sample	NNS
cord-023095-4dannjjm	4437	25	.	.	.
cord-023095-4dannjjm	4438	1	Desmoplakin	Desmoplakin	NNP
cord-023095-4dannjjm	4438	2	I1II	i1ii	XX
cord-023095-4dannjjm	4439	1	staining	stain	VBG
cord-023095-4dannjjm	4439	2	confirmed	confirm	VBD
cord-023095-4dannjjm	4439	3	altered	alter	VBN
cord-023095-4dannjjm	4439	4	urothelial	urothelial	JJ
cord-023095-4dannjjm	4439	5	differentiation	differentiation	NN
cord-023095-4dannjjm	4439	6	in	in	IN
cord-023095-4dannjjm	4439	7	FIC	fic	NN
cord-023095-4dannjjm	4439	8	cats	cat	NNS
cord-023095-4dannjjm	4439	9	.	.	.
cord-023095-4dannjjm	4440	1	However	however	RB
cord-023095-4dannjjm	4440	2	,	,	,
cord-023095-4dannjjm	4440	3	PGDH	PGDH	NNP
cord-023095-4dannjjm	4440	4	expression	expression	NN
cord-023095-4dannjjm	4440	5	remained	remain	VBD
cord-023095-4dannjjm	4440	6	intact	intact	JJ
cord-023095-4dannjjm	4440	7	in	in	IN
cord-023095-4dannjjm	4440	8	FIC	fic	NN
cord-023095-4dannjjm	4440	9	samples	sample	NNS
cord-023095-4dannjjm	4440	10	.	.	.
cord-023095-4dannjjm	4441	1	We	-PRON-	PRP
cord-023095-4dannjjm	4441	2	hypothesize	hypothesize	VBP
cord-023095-4dannjjm	4441	3	that	that	IN
cord-023095-4dannjjm	4441	4	PGDH	PGDH	NNP
cord-023095-4dannjjm	4441	5	expression	expression	NN
cord-023095-4dannjjm	4441	6	in	in	IN
cord-023095-4dannjjm	4441	7	FIC	FIC	NNP
cord-023095-4dannjjm	4441	8	may	may	MD
cord-023095-4dannjjm	4441	9	contribute	contribute	VB
cord-023095-4dannjjm	4441	10	to	to	IN
cord-023095-4dannjjm	4441	11	its	-PRON-	PRP$
cord-023095-4dannjjm	4441	12	pathophysiology	pathophysiology	NN
cord-023095-4dannjjm	4441	13	due	due	IN
cord-023095-4dannjjm	4441	14	to	to	IN
cord-023095-4dannjjm	4441	15	breakdown	breakdown	NN
cord-023095-4dannjjm	4441	16	of	of	IN
cord-023095-4dannjjm	4441	17	prostaglandins	prostaglandin	NNS
cord-023095-4dannjjm	4441	18	essential	essential	JJ
cord-023095-4dannjjm	4441	19	for	for	IN
cord-023095-4dannjjm	4441	20	urothelial	urothelial	JJ
cord-023095-4dannjjm	4441	21	healing	healing	NN
cord-023095-4dannjjm	4441	22	.	.	.
cord-023095-4dannjjm	4442	1	Additional	additional	JJ
cord-023095-4dannjjm	4442	2	studies	study	NNS
cord-023095-4dannjjm	4442	3	will	will	MD
cord-023095-4dannjjm	4442	4	explore	explore	VB
cord-023095-4dannjjm	4442	5	this	this	DT
cord-023095-4dannjjm	4442	6	hypothesis	hypothesis	NN
cord-023095-4dannjjm	4442	7	.	.	.
cord-023095-4dannjjm	4443	1	The	the	DT
cord-023095-4dannjjm	4443	2	University	University	NNP
cord-023095-4dannjjm	4443	3	of	of	IN
cord-023095-4dannjjm	4443	4	Tennessee	Tennessee	NNP
cord-023095-4dannjjm	4443	5	College	College	NNP
cord-023095-4dannjjm	4443	6	Of	of	IN
cord-023095-4dannjjm	4443	7	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	4443	8	Medicine	Medicine	NNP
cord-023095-4dannjjm	4443	9	's	's	POS
cord-023095-4dannjjm	4443	10	Picture	Picture	NNP
cord-023095-4dannjjm	4443	11	Archiving	Archiving	NNP
cord-023095-4dannjjm	4443	12	and	and	CC
cord-023095-4dannjjm	4443	13	Communication	Communication	NNP
cord-023095-4dannjjm	4443	14	System	System	NNP
cord-023095-4dannjjm	4443	15	was	be	VBD
cord-023095-4dannjjm	4443	16	searched	search	VBN
cord-023095-4dannjjm	4443	17	over	over	IN
cord-023095-4dannjjm	4443	18	a	a	DT
cord-023095-4dannjjm	4443	19	9	9	CD
cord-023095-4dannjjm	4443	20	month	month	NN
cord-023095-4dannjjm	4443	21	period	period	NN
cord-023095-4dannjjm	4443	22	for	for	IN
cord-023095-4dannjjm	4443	23	cats	cat	NNS
cord-023095-4dannjjm	4443	24	that	that	WDT
cord-023095-4dannjjm	4443	25	had	have	VBD
cord-023095-4dannjjm	4443	26	undergone	undergo	VBN
cord-023095-4dannjjm	4443	27	both	both	DT
cord-023095-4dannjjm	4443	28	abdominal	abdominal	JJ
cord-023095-4dannjjm	4443	29	radiographs	radiograph	NNS
cord-023095-4dannjjm	4443	30	and	and	CC
cord-023095-4dannjjm	4443	31	ultrasound	ultrasound	NN
cord-023095-4dannjjm	4443	32	during	during	IN
cord-023095-4dannjjm	4443	33	the	the	DT
cord-023095-4dannjjm	4443	34	same	same	JJ
cord-023095-4dannjjm	4443	35	visit	visit	NN
cord-023095-4dannjjm	4443	36	.	.	.
cord-023095-4dannjjm	4444	1	One	one	CD
cord-023095-4dannjjm	4444	2	hundred	hundred	CD
cord-023095-4dannjjm	4444	3	and	and	CC
cord-023095-4dannjjm	4444	4	three	three	CD
cord-023095-4dannjjm	4444	5	cats	cat	NNS
cord-023095-4dannjjm	4444	6	were	be	VBD
cord-023095-4dannjjm	4444	7	identified	identify	VBN
cord-023095-4dannjjm	4444	8	(	(	-LRB-
cord-023095-4dannjjm	4444	9	age	age	NN
cord-023095-4dannjjm	4444	10	range	range	NN
cord-023095-4dannjjm	4444	11	o	o	NN
cord-023095-4dannjjm	4444	12	1	1	CD
cord-023095-4dannjjm	4444	13	to	to	IN
cord-023095-4dannjjm	4444	14	18yrs	18yrs	JJ
cord-023095-4dannjjm	4444	15	;	;	:
cord-023095-4dannjjm	4444	16	median	median	JJ
cord-023095-4dannjjm	4444	17	11yrs	11yr	NNS
cord-023095-4dannjjm	4444	18	)	)	-RRB-
cord-023095-4dannjjm	4444	19	.	.	.
cord-023095-4dannjjm	4445	1	Kidney	kidney	NN
cord-023095-4dannjjm	4445	2	size	size	NN
cord-023095-4dannjjm	4445	3	was	be	VBD
cord-023095-4dannjjm	4445	4	determined	determine	VBN
cord-023095-4dannjjm	4445	5	based	base	VBN
cord-023095-4dannjjm	4445	6	on	on	IN
cord-023095-4dannjjm	4445	7	radiographic	radiographic	JJ
cord-023095-4dannjjm	4445	8	and	and	CC
cord-023095-4dannjjm	4445	9	ultrasound	ultrasound	NN
cord-023095-4dannjjm	4445	10	findings	finding	NNS
cord-023095-4dannjjm	4445	11	.	.	.
cord-023095-4dannjjm	4446	1	Of	of	IN
cord-023095-4dannjjm	4446	2	the	the	DT
cord-023095-4dannjjm	4446	3	included	include	VBN
cord-023095-4dannjjm	4446	4	cats	cat	NNS
cord-023095-4dannjjm	4446	5	,	,	,
cord-023095-4dannjjm	4446	6	41.8	41.8	CD
cord-023095-4dannjjm	4446	7	%	%	NN
cord-023095-4dannjjm	4446	8	had	have	VBD
cord-023095-4dannjjm	4446	9	two	two	CD
cord-023095-4dannjjm	4446	10	normal	normal	JJ
cord-023095-4dannjjm	4446	11	sized	sized	JJ
cord-023095-4dannjjm	4446	12	kidneys	kidney	NNS
cord-023095-4dannjjm	4446	13	,	,	,
cord-023095-4dannjjm	4446	14	18.4	18.4	CD
cord-023095-4dannjjm	4446	15	%	%	NN
cord-023095-4dannjjm	4446	16	had	have	VBD
cord-023095-4dannjjm	4446	17	one	one	CD
cord-023095-4dannjjm	4446	18	small	small	JJ
cord-023095-4dannjjm	4446	19	and	and	CC
cord-023095-4dannjjm	4446	20	one	one	CD
cord-023095-4dannjjm	4446	21	normal	normal	JJ
cord-023095-4dannjjm	4446	22	,	,	,
cord-023095-4dannjjm	4446	23	15.5	15.5	CD
cord-023095-4dannjjm	4446	24	%	%	NN
cord-023095-4dannjjm	4446	25	had	have	VBD
cord-023095-4dannjjm	4446	26	one	one	CD
cord-023095-4dannjjm	4446	27	large	large	JJ
cord-023095-4dannjjm	4446	28	and	and	CC
cord-023095-4dannjjm	4446	29	one	one	CD
cord-023095-4dannjjm	4446	30	normal	normal	JJ
cord-023095-4dannjjm	4446	31	,	,	,
cord-023095-4dannjjm	4446	32	11.7	11.7	CD
cord-023095-4dannjjm	4446	33	%	%	NN
cord-023095-4dannjjm	4446	34	had	have	VBD
cord-023095-4dannjjm	4446	35	two	two	CD
cord-023095-4dannjjm	4446	36	small	small	JJ
cord-023095-4dannjjm	4446	37	,	,	,
cord-023095-4dannjjm	4446	38	8.7	8.7	CD
cord-023095-4dannjjm	4446	39	%	%	NN
cord-023095-4dannjjm	4446	40	had	have	VBD
cord-023095-4dannjjm	4446	41	two	two	CD
cord-023095-4dannjjm	4446	42	large	large	JJ
cord-023095-4dannjjm	4446	43	,	,	,
cord-023095-4dannjjm	4446	44	and	and	CC
cord-023095-4dannjjm	4446	45	3.9	3.9	CD
cord-023095-4dannjjm	4446	46	%	%	NN
cord-023095-4dannjjm	4446	47	had	have	VBD
cord-023095-4dannjjm	4446	48	one	one	CD
cord-023095-4dannjjm	4446	49	small	small	JJ
cord-023095-4dannjjm	4446	50	and	and	CC
cord-023095-4dannjjm	4446	51	one	one	CD
cord-023095-4dannjjm	4446	52	large	large	JJ
cord-023095-4dannjjm	4446	53	kidney	kidney	NN
cord-023095-4dannjjm	4446	54	.	.	.
cord-023095-4dannjjm	4447	1	The	the	DT
cord-023095-4dannjjm	4447	2	presence	presence	NN
cord-023095-4dannjjm	4447	3	of	of	IN
cord-023095-4dannjjm	4447	4	mineralization	mineralization	NN
cord-023095-4dannjjm	4447	5	,	,	,
cord-023095-4dannjjm	4447	6	uroliths	urolith	NNS
cord-023095-4dannjjm	4447	7	and	and	CC
cord-023095-4dannjjm	4447	8	hydronephrosis	hydronephrosis	NN
cord-023095-4dannjjm	4447	9	was	be	VBD
cord-023095-4dannjjm	4447	10	also	also	RB
cord-023095-4dannjjm	4447	11	noted	note	VBN
cord-023095-4dannjjm	4447	12	.	.	.
cord-023095-4dannjjm	4448	1	Medical	medical	JJ
cord-023095-4dannjjm	4448	2	records	record	NNS
cord-023095-4dannjjm	4448	3	were	be	VBD
cord-023095-4dannjjm	4448	4	reviewed	review	VBN
cord-023095-4dannjjm	4448	5	for	for	IN
cord-023095-4dannjjm	4448	6	clinical	clinical	JJ
cord-023095-4dannjjm	4448	7	chemistry	chemistry	NN
cord-023095-4dannjjm	4448	8	data	datum	NNS
cord-023095-4dannjjm	4448	9	and	and	CC
cord-023095-4dannjjm	4448	10	historical	historical	JJ
cord-023095-4dannjjm	4448	11	information	information	NN
cord-023095-4dannjjm	4448	12	concerning	concern	VBG
cord-023095-4dannjjm	4448	13	previous	previous	JJ
cord-023095-4dannjjm	4448	14	urinary	urinary	JJ
cord-023095-4dannjjm	4448	15	disease	disease	NN
cord-023095-4dannjjm	4448	16	.	.	.
cord-023095-4dannjjm	4449	1	No	no	DT
cord-023095-4dannjjm	4449	2	significant	significant	JJ
cord-023095-4dannjjm	4449	3	differences	difference	NNS
cord-023095-4dannjjm	4449	4	were	be	VBD
cord-023095-4dannjjm	4449	5	found	find	VBN
cord-023095-4dannjjm	4449	6	between	between	IN
cord-023095-4dannjjm	4449	7	kidney	kidney	NN
cord-023095-4dannjjm	4449	8	size	size	NN
cord-023095-4dannjjm	4449	9	and	and	CC
cord-023095-4dannjjm	4449	10	renal	renal	JJ
cord-023095-4dannjjm	4449	11	function	function	NN
cord-023095-4dannjjm	4449	12	,	,	,
cord-023095-4dannjjm	4449	13	kidney	kidney	NN
cord-023095-4dannjjm	4449	14	size	size	NN
cord-023095-4dannjjm	4449	15	and	and	CC
cord-023095-4dannjjm	4449	16	the	the	DT
cord-023095-4dannjjm	4449	17	presence	presence	NN
cord-023095-4dannjjm	4449	18	of	of	IN
cord-023095-4dannjjm	4449	19	uroliths	uroliths	NNP
cord-023095-4dannjjm	4449	20	,	,	,
cord-023095-4dannjjm	4449	21	renal	renal	JJ
cord-023095-4dannjjm	4449	22	mineralization	mineralization	NN
cord-023095-4dannjjm	4449	23	and	and	CC
cord-023095-4dannjjm	4449	24	function	function	NN
cord-023095-4dannjjm	4449	25	or	or	CC
cord-023095-4dannjjm	4449	26	the	the	DT
cord-023095-4dannjjm	4449	27	presence	presence	NN
cord-023095-4dannjjm	4449	28	of	of	IN
cord-023095-4dannjjm	4449	29	uroliths	uroliths	NNP
cord-023095-4dannjjm	4449	30	and	and	CC
cord-023095-4dannjjm	4449	31	function	function	NN
cord-023095-4dannjjm	4449	32	.	.	.
cord-023095-4dannjjm	4450	1	The	the	DT
cord-023095-4dannjjm	4450	2	presence	presence	NN
cord-023095-4dannjjm	4450	3	of	of	IN
cord-023095-4dannjjm	4450	4	uroliths	uroliths	NNP
cord-023095-4dannjjm	4450	5	was	be	VBD
cord-023095-4dannjjm	4450	6	significantly	significantly	RB
cord-023095-4dannjjm	4450	7	associated	associate	VBN
cord-023095-4dannjjm	4450	8	with	with	IN
cord-023095-4dannjjm	4450	9	hydronephrosis	hydronephrosis	NN
cord-023095-4dannjjm	4450	10	.	.	.
cord-023095-4dannjjm	4451	1	Of	of	IN
cord-023095-4dannjjm	4451	2	the	the	DT
cord-023095-4dannjjm	4451	3	30	30	CD
cord-023095-4dannjjm	4451	4	cats	cat	NNS
cord-023095-4dannjjm	4451	5	with	with	IN
cord-023095-4dannjjm	4451	6	at	at	RB
cord-023095-4dannjjm	4451	7	least	least	RBS
cord-023095-4dannjjm	4451	8	one	one	CD
cord-023095-4dannjjm	4451	9	large	large	JJ
cord-023095-4dannjjm	4451	10	kidney	kidney	NN
cord-023095-4dannjjm	4451	11	,	,	,
cord-023095-4dannjjm	4451	12	9	9	CD
cord-023095-4dannjjm	4451	13	(	(	-LRB-
cord-023095-4dannjjm	4451	14	30	30	CD
cord-023095-4dannjjm	4451	15	%	%	NN
cord-023095-4dannjjm	4451	16	)	)	-RRB-
cord-023095-4dannjjm	4451	17	had	have	VBD
cord-023095-4dannjjm	4451	18	hydronephrosis	hydronephrosis	NN
cord-023095-4dannjjm	4451	19	.	.	.
cord-023095-4dannjjm	4452	1	Of	of	IN
cord-023095-4dannjjm	4452	2	the	the	DT
cord-023095-4dannjjm	4452	3	23	23	CD
cord-023095-4dannjjm	4452	4	cats	cat	NNS
cord-023095-4dannjjm	4452	5	with	with	IN
cord-023095-4dannjjm	4452	6	current	current	JJ
cord-023095-4dannjjm	4452	7	or	or	CC
cord-023095-4dannjjm	4452	8	previously	previously	RB
cord-023095-4dannjjm	4452	9	diagnosed	diagnose	VBN
cord-023095-4dannjjm	4452	10	uroliths	urolith	NNS
cord-023095-4dannjjm	4452	11	,	,	,
cord-023095-4dannjjm	4452	12	urinary	urinary	JJ
cord-023095-4dannjjm	4452	13	tract	tract	NN
cord-023095-4dannjjm	4452	14	infections	infection	NNS
cord-023095-4dannjjm	4452	15	or	or	CC
cord-023095-4dannjjm	4452	16	other	other	JJ
cord-023095-4dannjjm	4452	17	uropathies	uropathy	NNS
cord-023095-4dannjjm	4452	18	,	,	,
cord-023095-4dannjjm	4452	19	10	10	CD
cord-023095-4dannjjm	4452	20	(	(	-LRB-
cord-023095-4dannjjm	4452	21	43.5	43.5	CD
cord-023095-4dannjjm	4452	22	%	%	NN
cord-023095-4dannjjm	4452	23	)	)	-RRB-
cord-023095-4dannjjm	4452	24	had	have	VBD
cord-023095-4dannjjm	4452	25	at	at	RB
cord-023095-4dannjjm	4452	26	least	least	RBS
cord-023095-4dannjjm	4452	27	one	one	CD
cord-023095-4dannjjm	4452	28	small	small	JJ
cord-023095-4dannjjm	4452	29	kidney	kidney	NN
cord-023095-4dannjjm	4452	30	.	.	.
cord-023095-4dannjjm	4453	1	Small	small	JJ
cord-023095-4dannjjm	4453	2	kidneys	kidney	NNS
cord-023095-4dannjjm	4453	3	were	be	VBD
cord-023095-4dannjjm	4453	4	commonly	commonly	RB
cord-023095-4dannjjm	4453	5	found	find	VBN
cord-023095-4dannjjm	4453	6	in	in	IN
cord-023095-4dannjjm	4453	7	older	old	JJR
cord-023095-4dannjjm	4453	8	cats	cat	NNS
cord-023095-4dannjjm	4453	9	,	,	,
cord-023095-4dannjjm	4453	10	however	however	RB
cord-023095-4dannjjm	4453	11	,	,	,
cord-023095-4dannjjm	4453	12	this	this	DT
cord-023095-4dannjjm	4453	13	correlation	correlation	NN
cord-023095-4dannjjm	4453	14	was	be	VBD
cord-023095-4dannjjm	4453	15	not	not	RB
cord-023095-4dannjjm	4453	16	statistically	statistically	RB
cord-023095-4dannjjm	4453	17	significant	significant	JJ
cord-023095-4dannjjm	4453	18	.	.	.
cord-023095-4dannjjm	4454	1	Based	base	VBN
cord-023095-4dannjjm	4454	2	on	on	IN
cord-023095-4dannjjm	4454	3	these	these	DT
cord-023095-4dannjjm	4454	4	findings	finding	NNS
cord-023095-4dannjjm	4454	5	,	,	,
cord-023095-4dannjjm	4454	6	small	small	JJ
cord-023095-4dannjjm	4454	7	kidneys	kidney	NNS
cord-023095-4dannjjm	4454	8	are	be	VBP
cord-023095-4dannjjm	4454	9	more	more	RBR
cord-023095-4dannjjm	4454	10	likely	likely	JJ
cord-023095-4dannjjm	4454	11	to	to	TO
cord-023095-4dannjjm	4454	12	be	be	VB
cord-023095-4dannjjm	4454	13	the	the	DT
cord-023095-4dannjjm	4454	14	result	result	NN
cord-023095-4dannjjm	4454	15	of	of	IN
cord-023095-4dannjjm	4454	16	urinary	urinary	JJ
cord-023095-4dannjjm	4454	17	disease	disease	NN
cord-023095-4dannjjm	4454	18	as	as	IN
cord-023095-4dannjjm	4454	19	opposed	oppose	VBN
cord-023095-4dannjjm	4454	20	to	to	IN
cord-023095-4dannjjm	4454	21	being	be	VBG
cord-023095-4dannjjm	4454	22	either	either	CC
cord-023095-4dannjjm	4454	23	congenital	congenital	JJ
cord-023095-4dannjjm	4454	24	or	or	CC
cord-023095-4dannjjm	4454	25	due	due	JJ
cord-023095-4dannjjm	4454	26	to	to	IN
cord-023095-4dannjjm	4454	27	aging	age	VBG
cord-023095-4dannjjm	4454	28	.	.	.
cord-023095-4dannjjm	4455	1	This	this	DT
cord-023095-4dannjjm	4455	2	study	study	NN
cord-023095-4dannjjm	4455	3	aimed	aim	VBD
cord-023095-4dannjjm	4455	4	to	to	TO
cord-023095-4dannjjm	4455	5	evaluate	evaluate	VB
cord-023095-4dannjjm	4455	6	IFE	IFE	NNP
cord-023095-4dannjjm	4455	7	,	,	,
cord-023095-4dannjjm	4455	8	which	which	WDT
cord-023095-4dannjjm	4455	9	has	have	VBZ
cord-023095-4dannjjm	4455	10	been	be	VBN
cord-023095-4dannjjm	4455	11	advocated	advocate	VBN
cord-023095-4dannjjm	4455	12	for	for	IN
cord-023095-4dannjjm	4455	13	treatment	treatment	NN
cord-023095-4dannjjm	4455	14	of	of	IN
cord-023095-4dannjjm	4455	15	lipid	lipid	NN
cord-023095-4dannjjm	4455	16	-	-	HYPH
cord-023095-4dannjjm	4455	17	soluble	soluble	JJ
cord-023095-4dannjjm	4455	18	drug	drug	NN
cord-023095-4dannjjm	4455	19	intoxication	intoxication	NN
cord-023095-4dannjjm	4455	20	,	,	,
cord-023095-4dannjjm	4455	21	in	in	IN
cord-023095-4dannjjm	4455	22	the	the	DT
cord-023095-4dannjjm	4455	23	treatment	treatment	NN
cord-023095-4dannjjm	4455	24	of	of	IN
cord-023095-4dannjjm	4455	25	clinically	clinically	RB
cord-023095-4dannjjm	4455	26	-	-	HYPH
cord-023095-4dannjjm	4455	27	occurring	occur	VBG
cord-023095-4dannjjm	4455	28	canine	canine	JJ
cord-023095-4dannjjm	4455	29	ivermectin	ivermectin	NN
cord-023095-4dannjjm	4455	30	toxicosis	toxicosis	NN
cord-023095-4dannjjm	4455	31	.	.	.
cord-023095-4dannjjm	4456	1	One	one	CD
cord-023095-4dannjjm	4456	2	Australian	australian	JJ
cord-023095-4dannjjm	4456	3	Shepherd	Shepherd	NNP
cord-023095-4dannjjm	4456	4	and	and	CC
cord-023095-4dannjjm	4456	5	two	two	CD
cord-023095-4dannjjm	4456	6	Miniature	miniature	JJ
cord-023095-4dannjjm	4456	7	Australian	australian	JJ
cord-023095-4dannjjm	4456	8	Shepherds	Shepherds	NNPS
cord-023095-4dannjjm	4456	9	were	be	VBD
cord-023095-4dannjjm	4456	10	included	include	VBN
cord-023095-4dannjjm	4456	11	.	.	.
cord-023095-4dannjjm	4457	1	All	all	DT
cord-023095-4dannjjm	4457	2	three	three	CD
cord-023095-4dannjjm	4457	3	dogs	dog	NNS
cord-023095-4dannjjm	4457	4	were	be	VBD
cord-023095-4dannjjm	4457	5	homozygous	homozygous	JJ
cord-023095-4dannjjm	4457	6	for	for	IN
cord-023095-4dannjjm	4457	7	the	the	DT
cord-023095-4dannjjm	4457	8	MDR-1	MDR-1	NNP
cord-023095-4dannjjm	4457	9	gene	gene	NN
cord-023095-4dannjjm	4457	10	mutation	mutation	NN
cord-023095-4dannjjm	4457	11	.	.	.
cord-023095-4dannjjm	4458	1	Two	two	CD
cord-023095-4dannjjm	4458	2	dogs	dog	NNS
cord-023095-4dannjjm	4458	3	roamed	roam	VBD
cord-023095-4dannjjm	4458	4	on	on	IN
cord-023095-4dannjjm	4458	5	horse	horse	NN
cord-023095-4dannjjm	4458	6	ranches	ranch	NNS
cord-023095-4dannjjm	4458	7	where	where	WRB
cord-023095-4dannjjm	4458	8	ivermectin	ivermectin	NN
cord-023095-4dannjjm	4458	9	-	-	HYPH
cord-023095-4dannjjm	4458	10	based	base	VBN
cord-023095-4dannjjm	4458	11	deworming	deworme	VBG
cord-023095-4dannjjm	4458	12	products	product	NNS
cord-023095-4dannjjm	4458	13	had	have	VBD
cord-023095-4dannjjm	4458	14	recently	recently	RB
cord-023095-4dannjjm	4458	15	been	be	VBN
cord-023095-4dannjjm	4458	16	used	use	VBN
cord-023095-4dannjjm	4458	17	.	.	.
cord-023095-4dannjjm	4459	1	Ivermectin	Ivermectin	NNP
cord-023095-4dannjjm	4459	2	was	be	VBD
cord-023095-4dannjjm	4459	3	administered	administer	VBN
cord-023095-4dannjjm	4459	4	to	to	IN
cord-023095-4dannjjm	4459	5	the	the	DT
cord-023095-4dannjjm	4459	6	third	third	JJ
cord-023095-4dannjjm	4459	7	dog	dog	NN
cord-023095-4dannjjm	4459	8	(	(	-LRB-
cord-023095-4dannjjm	4459	9	165	165	CD
cord-023095-4dannjjm	4459	10	mg	mg	NNP
cord-023095-4dannjjm	4459	11	/	/	SYM
cord-023095-4dannjjm	4459	12	kg	kg	NNP
cord-023095-4dannjjm	4459	13	PO	PO	NNP
cord-023095-4dannjjm	4459	14	)	)	-RRB-
cord-023095-4dannjjm	4459	15	.	.	.
cord-023095-4dannjjm	4460	1	All	all	DT
cord-023095-4dannjjm	4460	2	three	three	CD
cord-023095-4dannjjm	4460	3	dogs	dog	NNS
cord-023095-4dannjjm	4460	4	exhibited	exhibit	VBD
cord-023095-4dannjjm	4460	5	tremors	tremor	NNS
cord-023095-4dannjjm	4460	6	,	,	,
cord-023095-4dannjjm	4460	7	ptyalism	ptyalism	NN
cord-023095-4dannjjm	4460	8	,	,	,
cord-023095-4dannjjm	4460	9	and	and	CC
cord-023095-4dannjjm	4460	10	CNS	CNS	NNP
cord-023095-4dannjjm	4460	11	depression	depression	NN
cord-023095-4dannjjm	4460	12	,	,	,
cord-023095-4dannjjm	4460	13	which	which	WDT
cord-023095-4dannjjm	4460	14	progressed	progress	VBD
cord-023095-4dannjjm	4460	15	over	over	IN
cord-023095-4dannjjm	4460	16	several	several	JJ
cord-023095-4dannjjm	4460	17	hours	hour	NNS
cord-023095-4dannjjm	4460	18	to	to	TO
cord-023095-4dannjjm	4460	19	stupor	stupor	NN
cord-023095-4dannjjm	4460	20	in	in	IN
cord-023095-4dannjjm	4460	21	two	two	CD
cord-023095-4dannjjm	4460	22	dogs	dog	NNS
cord-023095-4dannjjm	4460	23	,	,	,
cord-023095-4dannjjm	4460	24	and	and	CC
cord-023095-4dannjjm	4460	25	to	to	IN
cord-023095-4dannjjm	4460	26	a	a	DT
cord-023095-4dannjjm	4460	27	comatose	comatose	JJ
cord-023095-4dannjjm	4460	28	state	state	NN
cord-023095-4dannjjm	4460	29	requiring	require	VBG
cord-023095-4dannjjm	4460	30	mechanical	mechanical	JJ
cord-023095-4dannjjm	4460	31	ventilation	ventilation	NN
cord-023095-4dannjjm	4460	32	in	in	IN
cord-023095-4dannjjm	4460	33	the	the	DT
cord-023095-4dannjjm	4460	34	remaining	remain	VBG
cord-023095-4dannjjm	4460	35	dog	dog	NN
cord-023095-4dannjjm	4460	36	.	.	.
cord-023095-4dannjjm	4461	1	A	a	DT
cord-023095-4dannjjm	4461	2	20	20	CD
cord-023095-4dannjjm	4461	3	%	%	NN
cord-023095-4dannjjm	4461	4	formulation	formulation	NN
cord-023095-4dannjjm	4461	5	of	of	IN
cord-023095-4dannjjm	4461	6	IFE	IFE	NNP
cord-023095-4dannjjm	4461	7	(	(	-LRB-
cord-023095-4dannjjm	4461	8	Liposyn	Liposyn	NNP
cord-023095-4dannjjm	4461	9	II	II	NNP
cord-023095-4dannjjm	4461	10	,	,	,
cord-023095-4dannjjm	4461	11	Hospira	Hospira	NNP
cord-023095-4dannjjm	4461	12	)	)	-RRB-
cord-023095-4dannjjm	4461	13	was	be	VBD
cord-023095-4dannjjm	4461	14	administered	administer	VBN
cord-023095-4dannjjm	4461	15	as	as	IN
cord-023095-4dannjjm	4461	16	a	a	DT
cord-023095-4dannjjm	4461	17	bolus	bolus	NN
cord-023095-4dannjjm	4461	18	(	(	-LRB-
cord-023095-4dannjjm	4461	19	1.5	1.5	CD
cord-023095-4dannjjm	4461	20	ml	ml	NNS
cord-023095-4dannjjm	4461	21	/	/	SYM
cord-023095-4dannjjm	4461	22	kg	kg	NN
cord-023095-4dannjjm	4461	23	)	)	-RRB-
cord-023095-4dannjjm	4461	24	followed	follow	VBN
cord-023095-4dannjjm	4461	25	by	by	IN
cord-023095-4dannjjm	4461	26	a	a	DT
cord-023095-4dannjjm	4461	27	slow	slow	JJ
cord-023095-4dannjjm	4461	28	IV	IV	NNP
cord-023095-4dannjjm	4461	29	infusion	infusion	NN
cord-023095-4dannjjm	4461	30	(	(	-LRB-
cord-023095-4dannjjm	4461	31	7.5	7.5	CD
cord-023095-4dannjjm	4461	32	-	-	SYM
cord-023095-4dannjjm	4461	33	15	15	CD
cord-023095-4dannjjm	4461	34	ml	ml	NN
cord-023095-4dannjjm	4461	35	/	/	SYM
cord-023095-4dannjjm	4461	36	kg	kg	NN
cord-023095-4dannjjm	4461	37	over	over	IN
cord-023095-4dannjjm	4461	38	30	30	CD
cord-023095-4dannjjm	4461	39	minutes	minute	NNS
cord-023095-4dannjjm	4461	40	)	)	-RRB-
cord-023095-4dannjjm	4461	41	.	.	.
cord-023095-4dannjjm	4462	1	No	no	DT
cord-023095-4dannjjm	4462	2	change	change	NN
cord-023095-4dannjjm	4462	3	was	be	VBD
cord-023095-4dannjjm	4462	4	observed	observe	VBN
cord-023095-4dannjjm	4462	5	in	in	IN
cord-023095-4dannjjm	4462	6	the	the	DT
cord-023095-4dannjjm	4462	7	neurologic	neurologic	JJ
cord-023095-4dannjjm	4462	8	status	status	NN
cord-023095-4dannjjm	4462	9	of	of	IN
cord-023095-4dannjjm	4462	10	any	any	DT
cord-023095-4dannjjm	4462	11	patient	patient	NN
cord-023095-4dannjjm	4462	12	.	.	.
cord-023095-4dannjjm	4463	1	Lipemia	lipemia	NN
cord-023095-4dannjjm	4463	2	visible	visible	JJ
cord-023095-4dannjjm	4463	3	upon	upon	IN
cord-023095-4dannjjm	4463	4	blood	blood	NN
cord-023095-4dannjjm	4463	5	sampling	sampling	NN
cord-023095-4dannjjm	4463	6	persisted	persist	VBD
cord-023095-4dannjjm	4463	7	for	for	IN
cord-023095-4dannjjm	4463	8	36	36	CD
cord-023095-4dannjjm	4463	9	hours	hour	NNS
cord-023095-4dannjjm	4463	10	in	in	IN
cord-023095-4dannjjm	4463	11	one	one	CD
cord-023095-4dannjjm	4463	12	dog	dog	NN
cord-023095-4dannjjm	4463	13	.	.	.
cord-023095-4dannjjm	4464	1	No	no	DT
cord-023095-4dannjjm	4464	2	other	other	JJ
cord-023095-4dannjjm	4464	3	adverse	adverse	JJ
cord-023095-4dannjjm	4464	4	effects	effect	NNS
cord-023095-4dannjjm	4464	5	were	be	VBD
cord-023095-4dannjjm	4464	6	noted	note	VBN
cord-023095-4dannjjm	4464	7	.	.	.
cord-023095-4dannjjm	4465	1	Serum	serum	NN
cord-023095-4dannjjm	4465	2	ivermectin	ivermectin	NNP
cord-023095-4dannjjm	4465	3	levels	level	NNS
cord-023095-4dannjjm	4465	4	confirmed	confirm	VBD
cord-023095-4dannjjm	4465	5	ivermectin	ivermectin	NNP
cord-023095-4dannjjm	4465	6	exposure	exposure	NN
cord-023095-4dannjjm	4465	7	in	in	IN
cord-023095-4dannjjm	4465	8	each	each	DT
cord-023095-4dannjjm	4465	9	case	case	NN
cord-023095-4dannjjm	4465	10	.	.	.
cord-023095-4dannjjm	4466	1	In	in	IN
cord-023095-4dannjjm	4466	2	this	this	DT
cord-023095-4dannjjm	4466	3	study	study	NN
cord-023095-4dannjjm	4466	4	,	,	,
cord-023095-4dannjjm	4466	5	IFE	IFE	NNP
cord-023095-4dannjjm	4466	6	administration	administration	NN
cord-023095-4dannjjm	4466	7	did	do	VBD
cord-023095-4dannjjm	4466	8	not	not	RB
cord-023095-4dannjjm	4466	9	result	result	VB
cord-023095-4dannjjm	4466	10	in	in	IN
cord-023095-4dannjjm	4466	11	clinical	clinical	JJ
cord-023095-4dannjjm	4466	12	benefit	benefit	NN
cord-023095-4dannjjm	4466	13	in	in	IN
cord-023095-4dannjjm	4466	14	cases	case	NNS
cord-023095-4dannjjm	4466	15	of	of	IN
cord-023095-4dannjjm	4466	16	ivermectin	ivermectin	NNP
cord-023095-4dannjjm	4466	17	toxicosis	toxicosis	NN
cord-023095-4dannjjm	4466	18	.	.	.
cord-023095-4dannjjm	4467	1	Brain	Brain	NNP
cord-023095-4dannjjm	4467	2	ivermectin	ivermectin	NNP
cord-023095-4dannjjm	4467	3	concentrations	concentration	NNS
cord-023095-4dannjjm	4467	4	in	in	IN
cord-023095-4dannjjm	4467	5	MDR1	MDR1	NNP
cord-023095-4dannjjm	4467	6	mutant	mutant	JJ
cord-023095-4dannjjm	4467	7	/	/	SYM
cord-023095-4dannjjm	4467	8	mutant	mutant	JJ
cord-023095-4dannjjm	4467	9	genotype	genotype	NN
cord-023095-4dannjjm	4467	10	dogs	dog	NNS
cord-023095-4dannjjm	4467	11	may	may	MD
cord-023095-4dannjjm	4467	12	be	be	VB
cord-023095-4dannjjm	4467	13	too	too	RB
cord-023095-4dannjjm	4467	14	high	high	JJ
cord-023095-4dannjjm	4467	15	to	to	TO
cord-023095-4dannjjm	4467	16	be	be	VB
cord-023095-4dannjjm	4467	17	overcome	overcome	VBN
cord-023095-4dannjjm	4467	18	by	by	IN
cord-023095-4dannjjm	4467	19	IFE	IFE	NNP
cord-023095-4dannjjm	4467	20	.	.	.
cord-023095-4dannjjm	4468	1	Additionally	additionally	RB
cord-023095-4dannjjm	4468	2	,	,	,
cord-023095-4dannjjm	4468	3	these	these	DT
cord-023095-4dannjjm	4468	4	dogs	dog	NNS
cord-023095-4dannjjm	4468	5	may	may	MD
cord-023095-4dannjjm	4468	6	lack	lack	VB
cord-023095-4dannjjm	4468	7	P	p	NN
cord-023095-4dannjjm	4468	8	-	-	HYPH
cord-023095-4dannjjm	4468	9	glycoprotein	glycoprotein	NN
cord-023095-4dannjjm	4468	10	-	-	HYPH
cord-023095-4dannjjm	4468	11	mediated	mediate	VBN
cord-023095-4dannjjm	4468	12	biliary	biliary	JJ
cord-023095-4dannjjm	4468	13	clearance	clearance	NN
cord-023095-4dannjjm	4468	14	mechanisms	mechanism	NNS
cord-023095-4dannjjm	4468	15	needed	need	VBN
cord-023095-4dannjjm	4468	16	for	for	IN
cord-023095-4dannjjm	4468	17	optimal	optimal	JJ
cord-023095-4dannjjm	4468	18	IFE	IFE	NNP
cord-023095-4dannjjm	4468	19	function	function	NN
cord-023095-4dannjjm	4468	20	.	.	.
cord-023095-4dannjjm	4469	1	Further	further	JJ
cord-023095-4dannjjm	4469	2	investigation	investigation	NN
cord-023095-4dannjjm	4469	3	is	be	VBZ
cord-023095-4dannjjm	4469	4	needed	need	VBN
cord-023095-4dannjjm	4469	5	to	to	TO
cord-023095-4dannjjm	4469	6	determine	determine	VB
cord-023095-4dannjjm	4469	7	the	the	DT
cord-023095-4dannjjm	4469	8	utility	utility	NN
cord-023095-4dannjjm	4469	9	and	and	CC
cord-023095-4dannjjm	4469	10	optimal	optimal	JJ
cord-023095-4dannjjm	4469	11	dosing	dosing	NN
cord-023095-4dannjjm	4469	12	of	of	IN
cord-023095-4dannjjm	4469	13	IFE	IFE	NNP
cord-023095-4dannjjm	4469	14	in	in	IN
cord-023095-4dannjjm	4469	15	canine	canine	JJ
cord-023095-4dannjjm	4469	16	toxicoses	toxicose	NNS
cord-023095-4dannjjm	4469	17	,	,	,
cord-023095-4dannjjm	4469	18	to	to	TO
cord-023095-4dannjjm	4469	19	characterize	characterize	VB
cord-023095-4dannjjm	4469	20	its	-PRON-	PRP$
cord-023095-4dannjjm	4469	21	safety	safety	NN
cord-023095-4dannjjm	4469	22	,	,	,
cord-023095-4dannjjm	4469	23	and	and	CC
cord-023095-4dannjjm	4469	24	to	to	TO
cord-023095-4dannjjm	4469	25	determine	determine	VB
cord-023095-4dannjjm	4469	26	how	how	WRB
cord-023095-4dannjjm	4469	27	MDR-1	MDR-1	NNP
cord-023095-4dannjjm	4469	28	status	status	NN
cord-023095-4dannjjm	4469	29	may	may	MD
cord-023095-4dannjjm	4469	30	alter	alter	VB
cord-023095-4dannjjm	4469	31	the	the	DT
cord-023095-4dannjjm	4469	32	efficacy	efficacy	NN
cord-023095-4dannjjm	4469	33	of	of	IN
cord-023095-4dannjjm	4469	34	IFE	IFE	NNP
cord-023095-4dannjjm	4469	35	in	in	IN
cord-023095-4dannjjm	4469	36	treatment	treatment	NN
cord-023095-4dannjjm	4469	37	of	of	IN
cord-023095-4dannjjm	4469	38	canine	canine	JJ
cord-023095-4dannjjm	4469	39	ivermectin	ivermectin	NNP
cord-023095-4dannjjm	4469	40	intoxication	intoxication	NN
cord-023095-4dannjjm	4469	41	.	.	.
cord-023095-4dannjjm	4470	1	Rufinamide	Rufinamide	NNP
cord-023095-4dannjjm	4470	2	is	be	VBZ
cord-023095-4dannjjm	4470	3	a	a	DT
cord-023095-4dannjjm	4470	4	recently	recently	RB
cord-023095-4dannjjm	4470	5	approved	approve	VBN
cord-023095-4dannjjm	4470	6	antiepileptic	antiepileptic	JJ
cord-023095-4dannjjm	4470	7	drug	drug	NN
cord-023095-4dannjjm	4470	8	used	use	VBN
cord-023095-4dannjjm	4470	9	for	for	IN
cord-023095-4dannjjm	4470	10	the	the	DT
cord-023095-4dannjjm	4470	11	treatment	treatment	NN
cord-023095-4dannjjm	4470	12	of	of	IN
cord-023095-4dannjjm	4470	13	seizure	seizure	NN
cord-023095-4dannjjm	4470	14	disorders	disorder	NNS
cord-023095-4dannjjm	4470	15	in	in	IN
cord-023095-4dannjjm	4470	16	human	human	JJ
cord-023095-4dannjjm	4470	17	patients	patient	NNS
cord-023095-4dannjjm	4470	18	.	.	.
cord-023095-4dannjjm	4471	1	Rufinamide	Rufinamide	NNP
cord-023095-4dannjjm	4471	2	is	be	VBZ
cord-023095-4dannjjm	4471	3	administered	administer	VBN
cord-023095-4dannjjm	4471	4	at	at	IN
cord-023095-4dannjjm	4471	5	a	a	DT
cord-023095-4dannjjm	4471	6	dose	dose	NN
cord-023095-4dannjjm	4471	7	of	of	IN
cord-023095-4dannjjm	4471	8	45	45	CD
cord-023095-4dannjjm	4471	9	mg	mg	NNP
cord-023095-4dannjjm	4471	10	/	/	SYM
cord-023095-4dannjjm	4471	11	kg	kg	NNS
cord-023095-4dannjjm	4471	12	divided	divide	VBD
cord-023095-4dannjjm	4471	13	twice	twice	RB
cord-023095-4dannjjm	4471	14	daily	daily	RB
cord-023095-4dannjjm	4471	15	to	to	TO
cord-023095-4dannjjm	4471	16	achieve	achieve	VB
cord-023095-4dannjjm	4471	17	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	4471	18	concentrations	concentration	NNS
cord-023095-4dannjjm	4471	19	of	of	IN
cord-023095-4dannjjm	4471	20	15	15	CD
cord-023095-4dannjjm	4471	21	mg	mg	NNP
cord-023095-4dannjjm	4471	22	/	/	SYM
cord-023095-4dannjjm	4471	23	ml	ml	NN
cord-023095-4dannjjm	4471	24	.	.	.
cord-023095-4dannjjm	4472	1	The	the	DT
cord-023095-4dannjjm	4472	2	objective	objective	NN
cord-023095-4dannjjm	4472	3	of	of	IN
cord-023095-4dannjjm	4472	4	this	this	DT
cord-023095-4dannjjm	4472	5	study	study	NN
cord-023095-4dannjjm	4472	6	was	be	VBD
cord-023095-4dannjjm	4472	7	to	to	TO
cord-023095-4dannjjm	4472	8	determine	determine	VB
cord-023095-4dannjjm	4472	9	the	the	DT
cord-023095-4dannjjm	4472	10	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	4472	11	properties	property	NNS
cord-023095-4dannjjm	4472	12	and	and	CC
cord-023095-4dannjjm	4472	13	short	short	JJ
cord-023095-4dannjjm	4472	14	-	-	HYPH
cord-023095-4dannjjm	4472	15	term	term	NN
cord-023095-4dannjjm	4472	16	adverse	adverse	JJ
cord-023095-4dannjjm	4472	17	effects	effect	NNS
cord-023095-4dannjjm	4472	18	of	of	IN
cord-023095-4dannjjm	4472	19	single	single	JJ
cord-023095-4dannjjm	4472	20	-	-	HYPH
cord-023095-4dannjjm	4472	21	dose	dose	NN
cord-023095-4dannjjm	4472	22	oral	oral	JJ
cord-023095-4dannjjm	4472	23	rufinamide	rufinamide	NN
cord-023095-4dannjjm	4472	24	in	in	IN
cord-023095-4dannjjm	4472	25	healthy	healthy	JJ
cord-023095-4dannjjm	4472	26	dogs	dog	NNS
cord-023095-4dannjjm	4472	27	in	in	IN
cord-023095-4dannjjm	4472	28	preparation	preparation	NN
cord-023095-4dannjjm	4472	29	for	for	IN
cord-023095-4dannjjm	4472	30	a	a	DT
cord-023095-4dannjjm	4472	31	possible	possible	JJ
cord-023095-4dannjjm	4472	32	clinical	clinical	JJ
cord-023095-4dannjjm	4472	33	trial	trial	NN
cord-023095-4dannjjm	4472	34	evaluating	evaluate	VBG
cord-023095-4dannjjm	4472	35	the	the	DT
cord-023095-4dannjjm	4472	36	efficacy	efficacy	NN
cord-023095-4dannjjm	4472	37	of	of	IN
cord-023095-4dannjjm	4472	38	rufinamide	rufinamide	NN
cord-023095-4dannjjm	4472	39	in	in	IN
cord-023095-4dannjjm	4472	40	the	the	DT
cord-023095-4dannjjm	4472	41	treatment	treatment	NN
cord-023095-4dannjjm	4472	42	of	of	IN
cord-023095-4dannjjm	4472	43	canine	canine	JJ
cord-023095-4dannjjm	4472	44	epilepsy	epilepsy	NN
cord-023095-4dannjjm	4472	45	.	.	.
cord-023095-4dannjjm	4473	1	Six	six	CD
cord-023095-4dannjjm	4473	2	healthy	healthy	JJ
cord-023095-4dannjjm	4473	3	adult	adult	NN
cord-023095-4dannjjm	4473	4	dogs	dog	NNS
cord-023095-4dannjjm	4473	5	were	be	VBD
cord-023095-4dannjjm	4473	6	included	include	VBN
cord-023095-4dannjjm	4473	7	.	.	.
cord-023095-4dannjjm	4474	1	The	the	DT
cord-023095-4dannjjm	4474	2	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	4474	3	of	of	IN
cord-023095-4dannjjm	4474	4	rufinamide	rufinamide	NNP
cord-023095-4dannjjm	4474	5	were	be	VBD
cord-023095-4dannjjm	4474	6	calculated	calculate	VBN
cord-023095-4dannjjm	4474	7	following	follow	VBG
cord-023095-4dannjjm	4474	8	administration	administration	NN
cord-023095-4dannjjm	4474	9	of	of	IN
cord-023095-4dannjjm	4474	10	a	a	DT
cord-023095-4dannjjm	4474	11	single	single	JJ
cord-023095-4dannjjm	4474	12	mean	mean	NN
cord-023095-4dannjjm	4474	13	oral	oral	JJ
cord-023095-4dannjjm	4474	14	dose	dose	NN
cord-023095-4dannjjm	4474	15	of	of	IN
cord-023095-4dannjjm	4474	16	20.0	20.0	CD
cord-023095-4dannjjm	4474	17	mg	mg	NNP
cord-023095-4dannjjm	4474	18	/	/	SYM
cord-023095-4dannjjm	4474	19	kg	kg	NNP
cord-023095-4dannjjm	4474	20	(	(	-LRB-
cord-023095-4dannjjm	4474	21	range	range	NNP
cord-023095-4dannjjm	4474	22	18.6	18.6	CD
cord-023095-4dannjjm	4474	23	-	-	HYPH
cord-023095-4dannjjm	4474	24	20.8	20.8	CD
cord-023095-4dannjjm	4474	25	mg	mg	NNP
cord-023095-4dannjjm	4474	26	/	/	SYM
cord-023095-4dannjjm	4474	27	kg	kg	NNP
cord-023095-4dannjjm	4474	28	)	)	-RRB-
cord-023095-4dannjjm	4474	29	,	,	,
cord-023095-4dannjjm	4474	30	extrapolated	extrapolate	VBN
cord-023095-4dannjjm	4474	31	from	from	IN
cord-023095-4dannjjm	4474	32	the	the	DT
cord-023095-4dannjjm	4474	33	dose	dose	NN
cord-023095-4dannjjm	4474	34	used	use	VBN
cord-023095-4dannjjm	4474	35	in	in	IN
cord-023095-4dannjjm	4474	36	human	human	JJ
cord-023095-4dannjjm	4474	37	patients	patient	NNS
cord-023095-4dannjjm	4474	38	.	.	.
cord-023095-4dannjjm	4475	1	Dogs	dog	NNS
cord-023095-4dannjjm	4475	2	were	be	VBD
cord-023095-4dannjjm	4475	3	monitored	monitor	VBN
cord-023095-4dannjjm	4475	4	by	by	IN
cord-023095-4dannjjm	4475	5	repeat	repeat	NN
cord-023095-4dannjjm	4475	6	physical	physical	JJ
cord-023095-4dannjjm	4475	7	examinations	examination	NNS
cord-023095-4dannjjm	4475	8	,	,	,
cord-023095-4dannjjm	4475	9	electrocardiograms	electrocardiogram	NNS
cord-023095-4dannjjm	4475	10	and	and	CC
cord-023095-4dannjjm	4475	11	blood	blood	NN
cord-023095-4dannjjm	4475	12	pressure	pressure	NN
cord-023095-4dannjjm	4475	13	assessments	assessment	NNS
cord-023095-4dannjjm	4475	14	during	during	IN
cord-023095-4dannjjm	4475	15	the	the	DT
cord-023095-4dannjjm	4475	16	course	course	NN
cord-023095-4dannjjm	4475	17	of	of	IN
cord-023095-4dannjjm	4475	18	the	the	DT
cord-023095-4dannjjm	4475	19	study	study	NN
cord-023095-4dannjjm	4475	20	.	.	.
cord-023095-4dannjjm	4476	1	Plasma	plasma	NN
cord-023095-4dannjjm	4476	2	rufinamide	rufinamide	NN
cord-023095-4dannjjm	4476	3	concentrations	concentration	NNS
cord-023095-4dannjjm	4476	4	were	be	VBD
cord-023095-4dannjjm	4476	5	determined	determine	VBN
cord-023095-4dannjjm	4476	6	using	use	VBG
cord-023095-4dannjjm	4476	7	high	high	JJ
cord-023095-4dannjjm	4476	8	-	-	HYPH
cord-023095-4dannjjm	4476	9	performance	performance	NN
cord-023095-4dannjjm	4476	10	liquid	liquid	NN
cord-023095-4dannjjm	4476	11	chromatography	chromatography	NN
cord-023095-4dannjjm	4476	12	.	.	.
cord-023095-4dannjjm	4477	1	Pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	4477	2	data	datum	NNS
cord-023095-4dannjjm	4477	3	were	be	VBD
cord-023095-4dannjjm	4477	4	analyzed	analyze	VBN
cord-023095-4dannjjm	4477	5	using	use	VBG
cord-023095-4dannjjm	4477	6	WinNonlin	WinNonlin	NNP
cord-023095-4dannjjm	4477	7	version	version	NN
cord-023095-4dannjjm	4477	8	1.0	1.0	CD
cord-023095-4dannjjm	4477	9	.	.	.
cord-023095-4dannjjm	4478	1	No	no	DT
cord-023095-4dannjjm	4478	2	adverse	adverse	JJ
cord-023095-4dannjjm	4478	3	effects	effect	NNS
cord-023095-4dannjjm	4478	4	were	be	VBD
cord-023095-4dannjjm	4478	5	observed	observe	VBN
cord-023095-4dannjjm	4478	6	.	.	.
cord-023095-4dannjjm	4479	1	The	the	DT
cord-023095-4dannjjm	4479	2	mean	mean	JJ
cord-023095-4dannjjm	4479	3	terminal	terminal	JJ
cord-023095-4dannjjm	4479	4	half	half	JJ
cord-023095-4dannjjm	4479	5	-	-	HYPH
cord-023095-4dannjjm	4479	6	life	life	NN
cord-023095-4dannjjm	4479	7	was	be	VBD
cord-023095-4dannjjm	4479	8	9.86	9.86	CD
cord-023095-4dannjjm	4479	9	1	1	CD
cord-023095-4dannjjm	4479	10	/	/	SYM
cord-023095-4dannjjm	4479	11	À	à	NN
cord-023095-4dannjjm	4479	12	4.77	4.77	CD
cord-023095-4dannjjm	4479	13	hours	hour	NNS
cord-023095-4dannjjm	4479	14	.	.	.
cord-023095-4dannjjm	4480	1	The	the	DT
cord-023095-4dannjjm	4480	2	mean	mean	JJ
cord-023095-4dannjjm	4480	3	maximum	maximum	JJ
cord-023095-4dannjjm	4480	4	plasma	plasma	NN
cord-023095-4dannjjm	4480	5	concentration	concentration	NN
cord-023095-4dannjjm	4480	6	was	be	VBD
cord-023095-4dannjjm	4480	7	19.561/	19.561/	CD
cord-023095-4dannjjm	4481	1	À5.82	À5.82	NNP
cord-023095-4dannjjm	4482	1	mg	mg	NNP
cord-023095-4dannjjm	4482	2	/	/	SYM
cord-023095-4dannjjm	4482	3	ml	ml	NNP
cord-023095-4dannjjm	4482	4	and	and	CC
cord-023095-4dannjjm	4482	5	the	the	DT
cord-023095-4dannjjm	4482	6	mean	mean	JJ
cord-023095-4dannjjm	4482	7	time	time	NN
cord-023095-4dannjjm	4482	8	to	to	TO
cord-023095-4dannjjm	4482	9	maximum	maximum	VB
cord-023095-4dannjjm	4482	10	plasma	plasma	NN
cord-023095-4dannjjm	4482	11	concentration	concentration	NN
cord-023095-4dannjjm	4482	12	was	be	VBD
cord-023095-4dannjjm	4482	13	9.33	9.33	CD
cord-023095-4dannjjm	4482	14	1	1	CD
cord-023095-4dannjjm	4482	15	/	/	SYM
cord-023095-4dannjjm	4482	16	À	à	NN
cord-023095-4dannjjm	4482	17	4.68	4.68	CD
cord-023095-4dannjjm	4482	18	hours	hour	NNS
cord-023095-4dannjjm	4482	19	.	.	.
cord-023095-4dannjjm	4483	1	Mean	mean	JJ
cord-023095-4dannjjm	4483	2	clearance	clearance	NN
cord-023095-4dannjjm	4483	3	was	be	VBD
cord-023095-4dannjjm	4483	4	1.448	1.448	CD
cord-023095-4dannjjm	4483	5	1	1	CD
cord-023095-4dannjjm	4483	6	/	/	SYM
cord-023095-4dannjjm	4483	7	À	à	NN
cord-023095-4dannjjm	4483	8	0.703	0.703	CD
cord-023095-4dannjjm	4483	9	L	l	NN
cord-023095-4dannjjm	4483	10	/	/	SYM
cord-023095-4dannjjm	4483	11	hr	hr	NN
cord-023095-4dannjjm	4483	12	.	.	.
cord-023095-4dannjjm	4484	1	AUC	AUC	NNP
cord-023095-4dannjjm	4484	2	inf	inf	NNP
cord-023095-4dannjjm	4484	3	was	be	VBD
cord-023095-4dannjjm	4484	4	410.72	410.72	CD
cord-023095-4dannjjm	4484	5	1	1	CD
cord-023095-4dannjjm	4484	6	/	/	SYM
cord-023095-4dannjjm	4484	7	À	à	NN
cord-023095-4dannjjm	4484	8	175.88	175.88	CD
cord-023095-4dannjjm	4484	9	mgÃh	mgãh	NN
cord-023095-4dannjjm	4484	10	/	/	SYM
cord-023095-4dannjjm	4484	11	ml	ml	NN
cord-023095-4dannjjm	4484	12	.	.	.
cord-023095-4dannjjm	4485	1	Results	result	NNS
cord-023095-4dannjjm	4485	2	of	of	IN
cord-023095-4dannjjm	4485	3	this	this	DT
cord-023095-4dannjjm	4485	4	study	study	NN
cord-023095-4dannjjm	4485	5	suggest	suggest	VBP
cord-023095-4dannjjm	4485	6	that	that	IN
cord-023095-4dannjjm	4485	7	rufinamide	rufinamide	NN
cord-023095-4dannjjm	4485	8	given	give	VBN
cord-023095-4dannjjm	4485	9	orally	orally	RB
cord-023095-4dannjjm	4485	10	at	at	IN
cord-023095-4dannjjm	4485	11	20	20	CD
cord-023095-4dannjjm	4485	12	mg/	mg/	NN
cord-023095-4dannjjm	4485	13	kg	kg	NNP
cord-023095-4dannjjm	4485	14	twice	twice	RB
cord-023095-4dannjjm	4485	15	daily	daily	RB
cord-023095-4dannjjm	4485	16	in	in	IN
cord-023095-4dannjjm	4485	17	healthy	healthy	JJ
cord-023095-4dannjjm	4485	18	dogs	dog	NNS
cord-023095-4dannjjm	4485	19	should	should	MD
cord-023095-4dannjjm	4485	20	result	result	VB
cord-023095-4dannjjm	4485	21	in	in	IN
cord-023095-4dannjjm	4485	22	a	a	DT
cord-023095-4dannjjm	4485	23	plasma	plasma	NN
cord-023095-4dannjjm	4485	24	concentration	concentration	NN
cord-023095-4dannjjm	4485	25	and	and	CC
cord-023095-4dannjjm	4485	26	half	half	JJ
cord-023095-4dannjjm	4485	27	-	-	HYPH
cord-023095-4dannjjm	4485	28	life	life	NN
cord-023095-4dannjjm	4485	29	sufficient	sufficient	JJ
cord-023095-4dannjjm	4485	30	to	to	TO
cord-023095-4dannjjm	4485	31	achieve	achieve	VB
cord-023095-4dannjjm	4485	32	the	the	DT
cord-023095-4dannjjm	4485	33	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	4485	34	level	level	NN
cord-023095-4dannjjm	4485	35	extrapolated	extrapolate	VBN
cord-023095-4dannjjm	4485	36	from	from	IN
cord-023095-4dannjjm	4485	37	humans	human	NNS
cord-023095-4dannjjm	4485	38	without	without	IN
cord-023095-4dannjjm	4485	39	short	short	JJ
cord-023095-4dannjjm	4485	40	-	-	HYPH
cord-023095-4dannjjm	4485	41	term	term	NN
cord-023095-4dannjjm	4485	42	adverse	adverse	JJ
cord-023095-4dannjjm	4485	43	effects	effect	NNS
cord-023095-4dannjjm	4485	44	.	.	.
cord-023095-4dannjjm	4486	1	Further	further	JJ
cord-023095-4dannjjm	4486	2	investigation	investigation	NN
cord-023095-4dannjjm	4486	3	into	into	IN
cord-023095-4dannjjm	4486	4	the	the	DT
cord-023095-4dannjjm	4486	5	efficacy	efficacy	NN
cord-023095-4dannjjm	4486	6	and	and	CC
cord-023095-4dannjjm	4486	7	long	long	JJ
cord-023095-4dannjjm	4486	8	-	-	HYPH
cord-023095-4dannjjm	4486	9	term	term	NN
cord-023095-4dannjjm	4486	10	safety	safety	NN
cord-023095-4dannjjm	4486	11	of	of	IN
cord-023095-4dannjjm	4486	12	rufinamide	rufinamide	NN
cord-023095-4dannjjm	4486	13	in	in	IN
cord-023095-4dannjjm	4486	14	the	the	DT
cord-023095-4dannjjm	4486	15	treatment	treatment	NN
cord-023095-4dannjjm	4486	16	of	of	IN
cord-023095-4dannjjm	4486	17	canine	canine	JJ
cord-023095-4dannjjm	4486	18	epilepsy	epilepsy	NN
cord-023095-4dannjjm	4486	19	is	be	VBZ
cord-023095-4dannjjm	4486	20	warranted	warrant	VBN
cord-023095-4dannjjm	4486	21	.	.	.
cord-023095-4dannjjm	4487	1	The	the	DT
cord-023095-4dannjjm	4487	2	aims	aim	NNS
cord-023095-4dannjjm	4487	3	of	of	IN
cord-023095-4dannjjm	4487	4	this	this	DT
cord-023095-4dannjjm	4487	5	study	study	NN
cord-023095-4dannjjm	4487	6	were	be	VBD
cord-023095-4dannjjm	4487	7	to	to	TO
cord-023095-4dannjjm	4487	8	investigate	investigate	VB
cord-023095-4dannjjm	4487	9	the	the	DT
cord-023095-4dannjjm	4487	10	ABG	ABG	NNP
cord-023095-4dannjjm	4487	11	for	for	IN
cord-023095-4dannjjm	4487	12	(	(	-LRB-
cord-023095-4dannjjm	4487	13	i	i	NN
cord-023095-4dannjjm	4487	14	)	)	-RRB-
cord-023095-4dannjjm	4488	1	the	the	DT
cord-023095-4dannjjm	4488	2	prevalence	prevalence	NN
cord-023095-4dannjjm	4488	3	of	of	IN
cord-023095-4dannjjm	4488	4	skull	skull	NN
cord-023095-4dannjjm	4488	5	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4488	6	;	;	,
cord-023095-4dannjjm	4488	7	(	(	-LRB-
cord-023095-4dannjjm	4488	8	ii	ii	NN
cord-023095-4dannjjm	4488	9	)	)	-RRB-
cord-023095-4dannjjm	4489	1	the	the	DT
cord-023095-4dannjjm	4489	2	prevalence	prevalence	NN
cord-023095-4dannjjm	4489	3	of	of	IN
cord-023095-4dannjjm	4489	4	SM	sm	NN
cord-023095-4dannjjm	4489	5	;	;	:
cord-023095-4dannjjm	4489	6	(	(	-LRB-
cord-023095-4dannjjm	4489	7	iii	iii	NN
cord-023095-4dannjjm	4489	8	)	)	-RRB-
cord-023095-4dannjjm	4490	1	an	an	DT
cord-023095-4dannjjm	4490	2	association	association	NN
cord-023095-4dannjjm	4490	3	between	between	IN
cord-023095-4dannjjm	4490	4	lateral	lateral	JJ
cord-023095-4dannjjm	4490	5	ventricular	ventricular	JJ
cord-023095-4dannjjm	4490	6	size	size	NN
cord-023095-4dannjjm	4490	7	,	,	,
cord-023095-4dannjjm	4490	8	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4490	9	size	size	NN
cord-023095-4dannjjm	4490	10	and	and	CC
cord-023095-4dannjjm	4490	11	SM	sm	NN
cord-023095-4dannjjm	4490	12	;	;	:
cord-023095-4dannjjm	4490	13	and	and	CC
cord-023095-4dannjjm	4490	14	(	(	-LRB-
cord-023095-4dannjjm	4490	15	iv	iv	LS
cord-023095-4dannjjm	4490	16	)	)	-RRB-
cord-023095-4dannjjm	4490	17	associations	association	NNS
cord-023095-4dannjjm	4490	18	between	between	IN
cord-023095-4dannjjm	4490	19	SM	sm	NN
cord-023095-4dannjjm	4490	20	,	,	,
cord-023095-4dannjjm	4490	21	skull	skull	NN
cord-023095-4dannjjm	4490	22	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4490	23	,	,	,
cord-023095-4dannjjm	4490	24	CSF	CSF	NNP
cord-023095-4dannjjm	4490	25	pleocytosis	pleocytosis	NNP
cord-023095-4dannjjm	4490	26	and	and	CC
cord-023095-4dannjjm	4490	27	clinical	clinical	JJ
cord-023095-4dannjjm	4490	28	signs	sign	NNS
cord-023095-4dannjjm	4490	29	.	.	.
cord-023095-4dannjjm	4491	1	Seventy	seventy	CD
cord-023095-4dannjjm	4491	2	-	-	HYPH
cord-023095-4dannjjm	4491	3	six	six	CD
cord-023095-4dannjjm	4491	4	ABGs	abg	NNS
cord-023095-4dannjjm	4491	5	,	,	,
cord-023095-4dannjjm	4491	6	recruited	recruit	VBN
cord-023095-4dannjjm	4491	7	as	as	IN
cord-023095-4dannjjm	4491	8	part	part	NN
cord-023095-4dannjjm	4491	9	of	of	IN
cord-023095-4dannjjm	4491	10	a	a	DT
cord-023095-4dannjjm	4491	11	larger	large	JJR
cord-023095-4dannjjm	4491	12	epidemiological	epidemiological	JJ
cord-023095-4dannjjm	4491	13	and	and	CC
cord-023095-4dannjjm	4491	14	genetic	genetic	JJ
cord-023095-4dannjjm	4491	15	study	study	NN
cord-023095-4dannjjm	4491	16	,	,	,
cord-023095-4dannjjm	4491	17	underwent	undergo	VBD
cord-023095-4dannjjm	4491	18	brain	brain	NN
cord-023095-4dannjjm	4491	19	and	and	CC
cord-023095-4dannjjm	4491	20	spinal	spinal	JJ
cord-023095-4dannjjm	4491	21	MRI	mri	NN
cord-023095-4dannjjm	4491	22	evaluation	evaluation	NN
cord-023095-4dannjjm	4491	23	(	(	-LRB-
cord-023095-4dannjjm	4491	24	3.0	3.0	CD
cord-023095-4dannjjm	4491	25	T	T	NNP
cord-023095-4dannjjm	4491	26	General	General	NNP
cord-023095-4dannjjm	4491	27	Electric	Electric	NNP
cord-023095-4dannjjm	4491	28	Signa	Signa	NNP
cord-023095-4dannjjm	4491	29	HDx	HDx	NNS
cord-023095-4dannjjm	4491	30	,	,	,
cord-023095-4dannjjm	4491	31	Milwaukee	Milwaukee	NNP
cord-023095-4dannjjm	4491	32	,	,	,
cord-023095-4dannjjm	4491	33	WI	WI	NNP
cord-023095-4dannjjm	4491	34	)	)	-RRB-
cord-023095-4dannjjm	4491	35	.	.	.
cord-023095-4dannjjm	4492	1	All	all	DT
cord-023095-4dannjjm	4492	2	dogs	dog	NNS
cord-023095-4dannjjm	4492	3	were	be	VBD
cord-023095-4dannjjm	4492	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	4492	5	neurologically	neurologically	RB
cord-023095-4dannjjm	4492	6	,	,	,
cord-023095-4dannjjm	4492	7	recording	record	VBG
cord-023095-4dannjjm	4492	8	deficits	deficit	NNS
cord-023095-4dannjjm	4492	9	and	and	CC
cord-023095-4dannjjm	4492	10	the	the	DT
cord-023095-4dannjjm	4492	11	presence	presence	NN
cord-023095-4dannjjm	4492	12	of	of	IN
cord-023095-4dannjjm	4492	13	spinal	spinal	JJ
cord-023095-4dannjjm	4492	14	pain	pain	NN
cord-023095-4dannjjm	4492	15	.	.	.
cord-023095-4dannjjm	4493	1	Sequences	sequence	NNS
cord-023095-4dannjjm	4493	2	acquired	acquire	VBD
cord-023095-4dannjjm	4493	3	included	include	VBD
cord-023095-4dannjjm	4493	4	T2W	T2W	NNP
cord-023095-4dannjjm	4493	5	,	,	,
cord-023095-4dannjjm	4493	6	T1W	T1W	NNP
cord-023095-4dannjjm	4493	7	pre	pre	JJ
cord-023095-4dannjjm	4493	8	-	-	JJ
cord-023095-4dannjjm	4493	9	and	and	CC
cord-023095-4dannjjm	4493	10	postcontrast	postcontrast	NN
cord-023095-4dannjjm	4493	11	,	,	,
cord-023095-4dannjjm	4493	12	and	and	CC
cord-023095-4dannjjm	4493	13	T2W	t2w	CD
cord-023095-4dannjjm	4493	14	FLAIR	flair	NN
cord-023095-4dannjjm	4493	15	,	,	,
cord-023095-4dannjjm	4493	16	sagittal	sagittal	JJ
cord-023095-4dannjjm	4493	17	and	and	CC
cord-023095-4dannjjm	4493	18	transverse	transverse	JJ
cord-023095-4dannjjm	4493	19	.	.	.
cord-023095-4dannjjm	4494	1	Cervical	cervical	JJ
cord-023095-4dannjjm	4494	2	spinal	spinal	JJ
cord-023095-4dannjjm	4494	3	cord	cord	NN
cord-023095-4dannjjm	4494	4	central	central	JJ
cord-023095-4dannjjm	4494	5	canal	canal	NNP
cord-023095-4dannjjm	4494	6	(	(	-LRB-
cord-023095-4dannjjm	4494	7	CC	CC	NNP
cord-023095-4dannjjm	4494	8	)	)	-RRB-
cord-023095-4dannjjm	4494	9	and	and	CC
cord-023095-4dannjjm	4494	10	or	or	CC
cord-023095-4dannjjm	4494	11	syrinx	syrinx	JJ
cord-023095-4dannjjm	4494	12	size	size	NN
cord-023095-4dannjjm	4494	13	and	and	CC
cord-023095-4dannjjm	4494	14	its	-PRON-	PRP$
cord-023095-4dannjjm	4494	15	percent	percent	NN
cord-023095-4dannjjm	4494	16	area	area	NN
cord-023095-4dannjjm	4494	17	of	of	IN
cord-023095-4dannjjm	4494	18	spinal	spinal	JJ
cord-023095-4dannjjm	4494	19	cord	cord	NN
cord-023095-4dannjjm	4494	20	was	be	VBD
cord-023095-4dannjjm	4494	21	measured	measure	VBN
cord-023095-4dannjjm	4494	22	using	use	VBG
cord-023095-4dannjjm	4494	23	OsiriX	OsiriX	NNP
cord-023095-4dannjjm	4494	24	s	s	NN
cord-023095-4dannjjm	4494	25	.	.	.
cord-023095-4dannjjm	4495	1	The	the	DT
cord-023095-4dannjjm	4495	2	presence	presence	NN
cord-023095-4dannjjm	4495	3	of	of	IN
cord-023095-4dannjjm	4495	4	Chari	Chari	NNP
cord-023095-4dannjjm	4495	5	-	-	HYPH
cord-023095-4dannjjm	4495	6	like	like	JJ
cord-023095-4dannjjm	4495	7	malformation	malformation	NN
cord-023095-4dannjjm	4495	8	(	(	-LRB-
cord-023095-4dannjjm	4495	9	CM	CM	NNP
cord-023095-4dannjjm	4495	10	)	)	-RRB-
cord-023095-4dannjjm	4495	11	was	be	VBD
cord-023095-4dannjjm	4495	12	assessed	assess	VBN
cord-023095-4dannjjm	4495	13	by	by	IN
cord-023095-4dannjjm	4495	14	recording	record	VBG
cord-023095-4dannjjm	4495	15	the	the	DT
cord-023095-4dannjjm	4495	16	presence	presence	NN
cord-023095-4dannjjm	4495	17	of	of	IN
cord-023095-4dannjjm	4495	18	caudal	caudal	JJ
cord-023095-4dannjjm	4495	19	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4495	20	deviation	deviation	NN
cord-023095-4dannjjm	4495	21	and/or	and/or	CC
cord-023095-4dannjjm	4495	22	foramenal	foramenal	JJ
cord-023095-4dannjjm	4495	23	vermal	vermal	NNP
cord-023095-4dannjjm	4495	24	herniation	herniation	NN
cord-023095-4dannjjm	4495	25	.	.	.
cord-023095-4dannjjm	4496	1	Lateral	lateral	JJ
cord-023095-4dannjjm	4496	2	ventricle	ventricle	NN
cord-023095-4dannjjm	4496	3	and	and	CC
cord-023095-4dannjjm	4496	4	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4496	5	volume	volume	NN
cord-023095-4dannjjm	4496	6	was	be	VBD
cord-023095-4dannjjm	4496	7	expressed	express	VBN
cord-023095-4dannjjm	4496	8	as	as	IN
cord-023095-4dannjjm	4496	9	a	a	DT
cord-023095-4dannjjm	4496	10	percent	percent	NN
cord-023095-4dannjjm	4496	11	of	of	IN
cord-023095-4dannjjm	4496	12	the	the	DT
cord-023095-4dannjjm	4496	13	cerebrum	cerebrum	NN
cord-023095-4dannjjm	4496	14	and	and	CC
cord-023095-4dannjjm	4496	15	intracranial	intracranial	JJ
cord-023095-4dannjjm	4496	16	volume2qa	volume2qa	NNP
cord-023095-4dannjjm	4496	17	respectively	respectively	RB
cord-023095-4dannjjm	4496	18	.	.	.
cord-023095-4dannjjm	4497	1	Forty	forty	CD
cord-023095-4dannjjm	4497	2	-	-	HYPH
cord-023095-4dannjjm	4497	3	five	five	CD
cord-023095-4dannjjm	4497	4	dogs	dog	NNS
cord-023095-4dannjjm	4497	5	underwent	undergo	VBD
cord-023095-4dannjjm	4497	6	atlanto	atlanto	NNP
cord-023095-4dannjjm	4497	7	-	-	HYPH
cord-023095-4dannjjm	4497	8	occipital	occipital	JJ
cord-023095-4dannjjm	4497	9	cerebrospinal	cerebrospinal	JJ
cord-023095-4dannjjm	4497	10	fluid	fluid	NN
cord-023095-4dannjjm	4497	11	tap	tap	NN
cord-023095-4dannjjm	4497	12	at	at	IN
cord-023095-4dannjjm	4497	13	the	the	DT
cord-023095-4dannjjm	4497	14	time	time	NN
cord-023095-4dannjjm	4497	15	of	of	IN
cord-023095-4dannjjm	4497	16	MRI	MRI	NNP
cord-023095-4dannjjm	4497	17	and	and	CC
cord-023095-4dannjjm	4497	18	the	the	DT
cord-023095-4dannjjm	4497	19	white	white	JJ
cord-023095-4dannjjm	4497	20	blood	blood	NN
cord-023095-4dannjjm	4497	21	cell	cell	NN
cord-023095-4dannjjm	4498	1	(	(	-LRB-
cord-023095-4dannjjm	4498	2	WBC	WBC	NNP
cord-023095-4dannjjm	4498	3	)	)	-RRB-
cord-023095-4dannjjm	4498	4	count	count	NN
cord-023095-4dannjjm	4498	5	was	be	VBD
cord-023095-4dannjjm	4498	6	recorded	record	VBN
cord-023095-4dannjjm	4498	7	.	.	.
cord-023095-4dannjjm	4499	1	Student	student	NN
cord-023095-4dannjjm	4499	2	's	's	POS
cord-023095-4dannjjm	4499	3	t	t	NN
cord-023095-4dannjjm	4499	4	-	-	HYPH
cord-023095-4dannjjm	4499	5	tests	test	NNS
cord-023095-4dannjjm	4499	6	were	be	VBD
cord-023095-4dannjjm	4499	7	used	use	VBN
cord-023095-4dannjjm	4499	8	to	to	TO
cord-023095-4dannjjm	4499	9	compare	compare	VB
cord-023095-4dannjjm	4499	10	the	the	DT
cord-023095-4dannjjm	4499	11	measured	measure	VBN
cord-023095-4dannjjm	4499	12	variables	variable	NNS
cord-023095-4dannjjm	4499	13	between	between	IN
cord-023095-4dannjjm	4499	14	groups	group	NNS
cord-023095-4dannjjm	4499	15	with	with	IN
cord-023095-4dannjjm	4499	16	and	and	CC
cord-023095-4dannjjm	4499	17	without	without	IN
cord-023095-4dannjjm	4499	18	skull	skull	NN
cord-023095-4dannjjm	4499	19	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4499	20	,	,	,
cord-023095-4dannjjm	4499	21	spinal	spinal	JJ
cord-023095-4dannjjm	4499	22	pain	pain	NN
cord-023095-4dannjjm	4499	23	and	and	CC
cord-023095-4dannjjm	4499	24	neurological	neurological	JJ
cord-023095-4dannjjm	4499	25	signs	sign	NNS
cord-023095-4dannjjm	4499	26	.	.	.
cord-023095-4dannjjm	4500	1	The	the	DT
cord-023095-4dannjjm	4500	2	mean	mean	JJ
cord-023095-4dannjjm	4500	3	age	age	NN
cord-023095-4dannjjm	4500	4	of	of	IN
cord-023095-4dannjjm	4500	5	the	the	DT
cord-023095-4dannjjm	4500	6	30	30	CD
cord-023095-4dannjjm	4500	7	males	male	NNS
cord-023095-4dannjjm	4500	8	(	(	-LRB-
cord-023095-4dannjjm	4500	9	24	24	CD
cord-023095-4dannjjm	4500	10	intact	intact	JJ
cord-023095-4dannjjm	4500	11	)	)	-RRB-
cord-023095-4dannjjm	4500	12	and	and	CC
cord-023095-4dannjjm	4500	13	the	the	DT
cord-023095-4dannjjm	4500	14	46	46	CD
cord-023095-4dannjjm	4500	15	females	female	NNS
cord-023095-4dannjjm	4500	16	(	(	-LRB-
cord-023095-4dannjjm	4500	17	34	34	CD
cord-023095-4dannjjm	4500	18	intact	intact	JJ
cord-023095-4dannjjm	4500	19	)	)	-RRB-
cord-023095-4dannjjm	4500	20	was	be	VBD
cord-023095-4dannjjm	4500	21	50.4	50.4	CD
cord-023095-4dannjjm	4500	22	months	month	NNS
cord-023095-4dannjjm	4501	1	(	(	-LRB-
cord-023095-4dannjjm	4501	2	range	range	NNP
cord-023095-4dannjjm	4501	3	8	8	CD
cord-023095-4dannjjm	4501	4	-	-	SYM
cord-023095-4dannjjm	4501	5	135	135	CD
cord-023095-4dannjjm	4501	6	;	;	:
cord-023095-4dannjjm	4501	7	median	median	NN
cord-023095-4dannjjm	4501	8	44	44	CD
cord-023095-4dannjjm	4501	9	months	month	NNS
cord-023095-4dannjjm	4501	10	)	)	-RRB-
cord-023095-4dannjjm	4501	11	.	.	.
cord-023095-4dannjjm	4502	1	Neurological	neurological	JJ
cord-023095-4dannjjm	4502	2	deficits	deficit	NNS
cord-023095-4dannjjm	4502	3	and	and	CC
cord-023095-4dannjjm	4502	4	neck	neck	NN
cord-023095-4dannjjm	4502	5	pain	pain	NN
cord-023095-4dannjjm	4502	6	were	be	VBD
cord-023095-4dannjjm	4502	7	noted	note	VBN
cord-023095-4dannjjm	4502	8	in	in	IN
cord-023095-4dannjjm	4502	9	21	21	CD
cord-023095-4dannjjm	4502	10	(	(	-LRB-
cord-023095-4dannjjm	4502	11	27	27	CD
cord-023095-4dannjjm	4502	12	%	%	NN
cord-023095-4dannjjm	4502	13	)	)	-RRB-
cord-023095-4dannjjm	4502	14	and	and	CC
cord-023095-4dannjjm	4502	15	15	15	CD
cord-023095-4dannjjm	4502	16	(	(	-LRB-
cord-023095-4dannjjm	4502	17	19.7	19.7	CD
cord-023095-4dannjjm	4502	18	%	%	NN
cord-023095-4dannjjm	4502	19	)	)	-RRB-
cord-023095-4dannjjm	4502	20	of	of	IN
cord-023095-4dannjjm	4502	21	dogs	dog	NNS
cord-023095-4dannjjm	4502	22	respectively	respectively	RB
cord-023095-4dannjjm	4502	23	;	;	:
cord-023095-4dannjjm	4502	24	5	5	CD
cord-023095-4dannjjm	4502	25	dogs	dog	NNS
cord-023095-4dannjjm	4502	26	(	(	-LRB-
cord-023095-4dannjjm	4502	27	6.57	6.57	CD
cord-023095-4dannjjm	4502	28	%	%	NN
cord-023095-4dannjjm	4502	29	)	)	-RRB-
cord-023095-4dannjjm	4502	30	exhibited	exhibit	VBD
cord-023095-4dannjjm	4502	31	both	both	DT
cord-023095-4dannjjm	4502	32	.	.	.
cord-023095-4dannjjm	4503	1	Cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4503	2	deviation	deviation	NN
cord-023095-4dannjjm	4503	3	and	and	CC
cord-023095-4dannjjm	4503	4	vermal	vermal	NN
cord-023095-4dannjjm	4503	5	herniation	herniation	NN
cord-023095-4dannjjm	4503	6	were	be	VBD
cord-023095-4dannjjm	4503	7	present	present	JJ
cord-023095-4dannjjm	4503	8	in	in	IN
cord-023095-4dannjjm	4503	9	37	37	CD
cord-023095-4dannjjm	4503	10	(	(	-LRB-
cord-023095-4dannjjm	4503	11	48.68	48.68	CD
cord-023095-4dannjjm	4503	12	%	%	NN
cord-023095-4dannjjm	4503	13	)	)	-RRB-
cord-023095-4dannjjm	4503	14	and	and	CC
cord-023095-4dannjjm	4503	15	46	46	CD
cord-023095-4dannjjm	4503	16	(	(	-LRB-
cord-023095-4dannjjm	4503	17	60.52	60.52	CD
cord-023095-4dannjjm	4503	18	%	%	NN
cord-023095-4dannjjm	4503	19	)	)	-RRB-
cord-023095-4dannjjm	4503	20	dogs	dog	NNS
cord-023095-4dannjjm	4503	21	respectively	respectively	RB
cord-023095-4dannjjm	4503	22	;	;	:
cord-023095-4dannjjm	4503	23	twenty	twenty	CD
cord-023095-4dannjjm	4503	24	-	-	HYPH
cord-023095-4dannjjm	4503	25	three	three	CD
cord-023095-4dannjjm	4503	26	dogs	dog	NNS
cord-023095-4dannjjm	4503	27	(	(	-LRB-
cord-023095-4dannjjm	4503	28	30.26	30.26	CD
cord-023095-4dannjjm	4503	29	%	%	NN
cord-023095-4dannjjm	4503	30	)	)	-RRB-
cord-023095-4dannjjm	4503	31	had	have	VBD
cord-023095-4dannjjm	4503	32	both	both	DT
cord-023095-4dannjjm	4503	33	.	.	.
cord-023095-4dannjjm	4504	1	Mean	mean	JJ
cord-023095-4dannjjm	4504	2	height	height	NN
cord-023095-4dannjjm	4504	3	of	of	IN
cord-023095-4dannjjm	4504	4	the	the	DT
cord-023095-4dannjjm	4504	5	CC	CC	NNP
cord-023095-4dannjjm	4504	6	was	be	VBD
cord-023095-4dannjjm	4504	7	2.3	2.3	CD
cord-023095-4dannjjm	4504	8	mm	mm	NNS
cord-023095-4dannjjm	4504	9	(	(	-LRB-
cord-023095-4dannjjm	4504	10	0	0	CD
cord-023095-4dannjjm	4504	11	-	-	:
cord-023095-4dannjjm	4504	12	7.2	7.2	CD
cord-023095-4dannjjm	4504	13	mm	mm	NN
cord-023095-4dannjjm	4504	14	)	)	-RRB-
cord-023095-4dannjjm	4504	15	.	.	.
cord-023095-4dannjjm	4505	1	Forty	forty	CD
cord-023095-4dannjjm	4505	2	(	(	-LRB-
cord-023095-4dannjjm	4505	3	52.63	52.63	CD
cord-023095-4dannjjm	4505	4	%	%	NN
cord-023095-4dannjjm	4505	5	)	)	-RRB-
cord-023095-4dannjjm	4505	6	CCs	cc	NNS
cord-023095-4dannjjm	4505	7	were	be	VBD
cord-023095-4dannjjm	4505	8	greater	great	JJR
cord-023095-4dannjjm	4505	9	than	than	IN
cord-023095-4dannjjm	4505	10	2	2	CD
cord-023095-4dannjjm	4505	11	mm	mm	NNS
cord-023095-4dannjjm	4505	12	in	in	IN
cord-023095-4dannjjm	4505	13	height	height	NN
cord-023095-4dannjjm	4505	14	;	;	:
cord-023095-4dannjjm	4505	15	the	the	DT
cord-023095-4dannjjm	4505	16	mean	mean	JJ
cord-023095-4dannjjm	4505	17	length	length	NN
cord-023095-4dannjjm	4505	18	of	of	IN
cord-023095-4dannjjm	4505	19	these	these	DT
cord-023095-4dannjjm	4505	20	lesions	lesion	NNS
cord-023095-4dannjjm	4505	21	was	be	VBD
cord-023095-4dannjjm	4505	22	2.03	2.03	CD
cord-023095-4dannjjm	4505	23	vertebrae	vertebra	NNS
cord-023095-4dannjjm	4505	24	(	(	-LRB-
cord-023095-4dannjjm	4505	25	0.5	0.5	CD
cord-023095-4dannjjm	4505	26	-	-	SYM
cord-023095-4dannjjm	4505	27	7	7	CD
cord-023095-4dannjjm	4505	28	)	)	-RRB-
cord-023095-4dannjjm	4505	29	.	.	.
cord-023095-4dannjjm	4506	1	Mean	mean	JJ
cord-023095-4dannjjm	4506	2	CSF	CSF	NNP
cord-023095-4dannjjm	4506	3	WBC	WBC	NNP
cord-023095-4dannjjm	4506	4	count	count	NN
cord-023095-4dannjjm	4506	5	was	be	VBD
cord-023095-4dannjjm	4506	6	4.97	4.97	CD
cord-023095-4dannjjm	4506	7	/	/	SYM
cord-023095-4dannjjm	4506	8	ml	ml	NN
cord-023095-4dannjjm	4506	9	(	(	-LRB-
cord-023095-4dannjjm	4506	10	0	0	CD
cord-023095-4dannjjm	4506	11	-	-	SYM
cord-023095-4dannjjm	4506	12	39	39	CD
cord-023095-4dannjjm	4506	13	)	)	-RRB-
cord-023095-4dannjjm	4506	14	.	.	.
cord-023095-4dannjjm	4507	1	Syrinx	Syrinx	NNP
cord-023095-4dannjjm	4507	2	height	height	NN
cord-023095-4dannjjm	4507	3	and	and	CC
cord-023095-4dannjjm	4507	4	extent	extent	NN
cord-023095-4dannjjm	4507	5	were	be	VBD
cord-023095-4dannjjm	4507	6	significantly	significantly	RB
cord-023095-4dannjjm	4507	7	higher	high	JJR
cord-023095-4dannjjm	4507	8	in	in	IN
cord-023095-4dannjjm	4507	9	dogs	dog	NNS
cord-023095-4dannjjm	4507	10	with	with	IN
cord-023095-4dannjjm	4507	11	neurological	neurological	JJ
cord-023095-4dannjjm	4507	12	signs	sign	NNS
cord-023095-4dannjjm	4507	13	(	(	-LRB-
cord-023095-4dannjjm	4507	14	size	size	NN
cord-023095-4dannjjm	4507	15	p	p	NN
cord-023095-4dannjjm	4507	16	5	5	CD
cord-023095-4dannjjm	4507	17	0.01	0.01	CD
cord-023095-4dannjjm	4507	18	;	;	:
cord-023095-4dannjjm	4507	19	extent	extent	NN
cord-023095-4dannjjm	4507	20	p	p	NN
cord-023095-4dannjjm	4507	21	5	5	CD
cord-023095-4dannjjm	4507	22	0.0004	0.0004	CD
cord-023095-4dannjjm	4507	23	)	)	-RRB-
cord-023095-4dannjjm	4507	24	.	.	.
cord-023095-4dannjjm	4508	1	There	there	EX
cord-023095-4dannjjm	4508	2	were	be	VBD
cord-023095-4dannjjm	4508	3	no	no	DT
cord-023095-4dannjjm	4508	4	significant	significant	JJ
cord-023095-4dannjjm	4508	5	differences	difference	NNS
cord-023095-4dannjjm	4508	6	in	in	IN
cord-023095-4dannjjm	4508	7	syrinx	syrinx	NNP
cord-023095-4dannjjm	4508	8	sizes	size	NNS
cord-023095-4dannjjm	4508	9	and	and	CC
cord-023095-4dannjjm	4508	10	extent	extent	NN
cord-023095-4dannjjm	4508	11	in	in	IN
cord-023095-4dannjjm	4508	12	dogs	dog	NNS
cord-023095-4dannjjm	4508	13	with	with	IN
cord-023095-4dannjjm	4508	14	or	or	CC
cord-023095-4dannjjm	4508	15	without	without	IN
cord-023095-4dannjjm	4508	16	skull	skull	NN
cord-023095-4dannjjm	4508	17	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4508	18	or	or	CC
cord-023095-4dannjjm	4508	19	spinal	spinal	JJ
cord-023095-4dannjjm	4508	20	pain	pain	NN
cord-023095-4dannjjm	4508	21	.	.	.
cord-023095-4dannjjm	4509	1	There	there	EX
cord-023095-4dannjjm	4509	2	were	be	VBD
cord-023095-4dannjjm	4509	3	no	no	DT
cord-023095-4dannjjm	4509	4	associations	association	NNS
cord-023095-4dannjjm	4509	5	of	of	IN
cord-023095-4dannjjm	4509	6	syrinx	syrinx	NNP
cord-023095-4dannjjm	4509	7	height	height	NN
cord-023095-4dannjjm	4509	8	or	or	CC
cord-023095-4dannjjm	4509	9	extent	extent	NN
cord-023095-4dannjjm	4509	10	with	with	IN
cord-023095-4dannjjm	4509	11	CSF	CSF	NNP
cord-023095-4dannjjm	4509	12	WBC	WBC	NNP
cord-023095-4dannjjm	4509	13	count	count	NN
cord-023095-4dannjjm	4509	14	or	or	CC
cord-023095-4dannjjm	4509	15	age	age	NN
cord-023095-4dannjjm	4509	16	of	of	IN
cord-023095-4dannjjm	4509	17	dog	dog	NN
cord-023095-4dannjjm	4509	18	.	.	.
cord-023095-4dannjjm	4510	1	Intact	intact	JJ
cord-023095-4dannjjm	4510	2	females	female	NNS
cord-023095-4dannjjm	4510	3	had	have	VBD
cord-023095-4dannjjm	4510	4	a	a	DT
cord-023095-4dannjjm	4510	5	significantly	significantly	RB
cord-023095-4dannjjm	4510	6	lower	low	JJR
cord-023095-4dannjjm	4510	7	syrinx	syrinx	JJ
cord-023095-4dannjjm	4510	8	extent	extent	NN
cord-023095-4dannjjm	4510	9	than	than	IN
cord-023095-4dannjjm	4510	10	intact	intact	JJ
cord-023095-4dannjjm	4510	11	males	male	NNS
cord-023095-4dannjjm	4510	12	(	(	-LRB-
cord-023095-4dannjjm	4510	13	p	p	NN
cord-023095-4dannjjm	4510	14	5	5	CD
cord-023095-4dannjjm	4510	15	0.009	0.009	CD
cord-023095-4dannjjm	4510	16	)	)	-RRB-
cord-023095-4dannjjm	4510	17	.	.	.
cord-023095-4dannjjm	4511	1	There	there	EX
cord-023095-4dannjjm	4511	2	were	be	VBD
cord-023095-4dannjjm	4511	3	no	no	DT
cord-023095-4dannjjm	4511	4	significant	significant	JJ
cord-023095-4dannjjm	4511	5	differences	difference	NNS
cord-023095-4dannjjm	4511	6	in	in	IN
cord-023095-4dannjjm	4511	7	presence	presence	NN
cord-023095-4dannjjm	4511	8	of	of	IN
cord-023095-4dannjjm	4511	9	spinal	spinal	JJ
cord-023095-4dannjjm	4511	10	pain	pain	NN
cord-023095-4dannjjm	4511	11	or	or	CC
cord-023095-4dannjjm	4511	12	neurological	neurological	JJ
cord-023095-4dannjjm	4511	13	signs	sign	NNS
cord-023095-4dannjjm	4511	14	between	between	IN
cord-023095-4dannjjm	4511	15	dogs	dog	NNS
cord-023095-4dannjjm	4511	16	with	with	IN
cord-023095-4dannjjm	4511	17	or	or	CC
cord-023095-4dannjjm	4511	18	without	without	IN
cord-023095-4dannjjm	4511	19	skull	skull	NN
cord-023095-4dannjjm	4511	20	abnormalities	abnormality	NNS
cord-023095-4dannjjm	4511	21	.	.	.
cord-023095-4dannjjm	4512	1	There	there	EX
cord-023095-4dannjjm	4512	2	was	be	VBD
cord-023095-4dannjjm	4512	3	a	a	DT
cord-023095-4dannjjm	4512	4	significant	significant	JJ
cord-023095-4dannjjm	4512	5	negative	negative	JJ
cord-023095-4dannjjm	4512	6	association	association	NN
cord-023095-4dannjjm	4512	7	of	of	IN
cord-023095-4dannjjm	4512	8	ventricular	ventricular	JJ
cord-023095-4dannjjm	4512	9	percentage	percentage	NN
cord-023095-4dannjjm	4512	10	and	and	CC
cord-023095-4dannjjm	4512	11	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4512	12	percentage	percentage	NN
cord-023095-4dannjjm	4513	1	(	(	-LRB-
cord-023095-4dannjjm	4513	2	p	p	NN
cord-023095-4dannjjm	4513	3	o	o	CD
cord-023095-4dannjjm	4513	4	0.0001	0.0001	CD
cord-023095-4dannjjm	4513	5	)	)	-RRB-
cord-023095-4dannjjm	4513	6	.	.	.
cord-023095-4dannjjm	4514	1	There	there	EX
cord-023095-4dannjjm	4514	2	was	be	VBD
cord-023095-4dannjjm	4514	3	a	a	DT
cord-023095-4dannjjm	4514	4	significant	significant	JJ
cord-023095-4dannjjm	4514	5	association	association	NN
cord-023095-4dannjjm	4514	6	of	of	IN
cord-023095-4dannjjm	4514	7	ventricular	ventricular	JJ
cord-023095-4dannjjm	4514	8	percentage	percentage	NN
cord-023095-4dannjjm	4514	9	with	with	IN
cord-023095-4dannjjm	4514	10	syrinx	syrinx	NNP
cord-023095-4dannjjm	4514	11	percentage	percentage	NN
cord-023095-4dannjjm	4514	12	(	(	-LRB-
cord-023095-4dannjjm	4514	13	p	p	NN
cord-023095-4dannjjm	4514	14	5	5	CD
cord-023095-4dannjjm	4514	15	0.0015	0.0015	CD
cord-023095-4dannjjm	4514	16	)	)	-RRB-
cord-023095-4dannjjm	4514	17	and	and	CC
cord-023095-4dannjjm	4514	18	height	height	NN
cord-023095-4dannjjm	4514	19	(	(	-LRB-
cord-023095-4dannjjm	4514	20	p	p	NN
cord-023095-4dannjjm	4514	21	5	5	CD
cord-023095-4dannjjm	4514	22	0.0007	0.0007	CD
cord-023095-4dannjjm	4514	23	)	)	-RRB-
cord-023095-4dannjjm	4514	24	.	.	.
cord-023095-4dannjjm	4515	1	This	this	DT
cord-023095-4dannjjm	4515	2	study	study	NN
cord-023095-4dannjjm	4515	3	suggests	suggest	VBZ
cord-023095-4dannjjm	4515	4	that	that	IN
cord-023095-4dannjjm	4515	5	SM	SM	NNP
cord-023095-4dannjjm	4515	6	and	and	CC
cord-023095-4dannjjm	4515	7	CM	CM	NNP
cord-023095-4dannjjm	4515	8	are	be	VBP
cord-023095-4dannjjm	4515	9	prevalent	prevalent	JJ
cord-023095-4dannjjm	4515	10	in	in	IN
cord-023095-4dannjjm	4515	11	ABGs	abg	NNS
cord-023095-4dannjjm	4515	12	.	.	.
cord-023095-4dannjjm	4516	1	Syrinx	Syrinx	NNP
cord-023095-4dannjjm	4516	2	size	size	NN
cord-023095-4dannjjm	4516	3	and	and	CC
cord-023095-4dannjjm	4516	4	extent	extent	NN
cord-023095-4dannjjm	4516	5	are	be	VBP
cord-023095-4dannjjm	4516	6	associated	associate	VBN
cord-023095-4dannjjm	4516	7	with	with	IN
cord-023095-4dannjjm	4516	8	neurological	neurological	JJ
cord-023095-4dannjjm	4516	9	signs	sign	NNS
cord-023095-4dannjjm	4516	10	and	and	CC
cord-023095-4dannjjm	4516	11	ventriculomegaly	ventriculomegaly	NN
cord-023095-4dannjjm	4516	12	is	be	VBZ
cord-023095-4dannjjm	4516	13	associated	associate	VBN
cord-023095-4dannjjm	4516	14	with	with	IN
cord-023095-4dannjjm	4516	15	both	both	DT
cord-023095-4dannjjm	4516	16	small	small	JJ
cord-023095-4dannjjm	4516	17	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4516	18	size	size	NN
cord-023095-4dannjjm	4516	19	and	and	CC
cord-023095-4dannjjm	4516	20	large	large	JJ
cord-023095-4dannjjm	4516	21	syrinx	syrinx	JJ
cord-023095-4dannjjm	4516	22	size	size	NN
cord-023095-4dannjjm	4516	23	.	.	.
cord-023095-4dannjjm	4517	1	However	however	RB
cord-023095-4dannjjm	4517	2	,	,	,
cord-023095-4dannjjm	4517	3	SM	SM	NNP
cord-023095-4dannjjm	4517	4	may	may	MD
cord-023095-4dannjjm	4517	5	not	not	RB
cord-023095-4dannjjm	4517	6	be	be	VB
cord-023095-4dannjjm	4517	7	associated	associate	VBN
cord-023095-4dannjjm	4517	8	with	with	IN
cord-023095-4dannjjm	4517	9	CM	CM	NNP
cord-023095-4dannjjm	4517	10	as	as	IN
cord-023095-4dannjjm	4517	11	defined	define	VBN
cord-023095-4dannjjm	4517	12	by	by	IN
cord-023095-4dannjjm	4517	13	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4517	14	herniation	herniation	NN
cord-023095-4dannjjm	4517	15	and	and	CC
cord-023095-4dannjjm	4517	16	deviation	deviation	NN
cord-023095-4dannjjm	4517	17	and	and	CC
cord-023095-4dannjjm	4517	18	is	be	VBZ
cord-023095-4dannjjm	4517	19	not	not	RB
cord-023095-4dannjjm	4517	20	associated	associate	VBN
cord-023095-4dannjjm	4517	21	with	with	IN
cord-023095-4dannjjm	4517	22	CSF	CSF	NNP
cord-023095-4dannjjm	4517	23	inflammation	inflammation	NN
cord-023095-4dannjjm	4517	24	.	.	.
cord-023095-4dannjjm	4518	1	The	the	DT
cord-023095-4dannjjm	4518	2	power	power	NN
cord-023095-4dannjjm	4518	3	tissue	tissue	NN
cord-023095-4dannjjm	4518	4	resection	resection	NN
cord-023095-4dannjjm	4518	5	device	device	NN
cord-023095-4dannjjm	4518	6	(	(	-LRB-
cord-023095-4dannjjm	4518	7	PTRD	PTRD	NNP
cord-023095-4dannjjm	4518	8	)	)	-RRB-
cord-023095-4dannjjm	4518	9	is	be	VBZ
cord-023095-4dannjjm	4518	10	a	a	DT
cord-023095-4dannjjm	4518	11	hand	hand	NN
cord-023095-4dannjjm	4518	12	-	-	HYPH
cord-023095-4dannjjm	4518	13	piece	piece	NN
cord-023095-4dannjjm	4518	14	comprised	comprise	VBN
cord-023095-4dannjjm	4518	15	of	of	IN
cord-023095-4dannjjm	4518	16	an	an	DT
cord-023095-4dannjjm	4518	17	outer	outer	JJ
cord-023095-4dannjjm	4518	18	cannula	cannula	NN
cord-023095-4dannjjm	4518	19	with	with	IN
cord-023095-4dannjjm	4518	20	motor	motor	NN
cord-023095-4dannjjm	4518	21	driven	drive	VBN
cord-023095-4dannjjm	4518	22	vacuum	vacuum	NN
cord-023095-4dannjjm	4518	23	-	-	HYPH
cord-023095-4dannjjm	4518	24	assisted	assist	VBN
cord-023095-4dannjjm	4518	25	inner	inner	JJ
cord-023095-4dannjjm	4518	26	cutting	cutting	NN
cord-023095-4dannjjm	4518	27	blade	blade	NN
cord-023095-4dannjjm	4518	28	.	.	.
cord-023095-4dannjjm	4519	1	This	this	DT
cord-023095-4dannjjm	4519	2	device	device	NN
cord-023095-4dannjjm	4519	3	was	be	VBD
cord-023095-4dannjjm	4519	4	designed	design	VBN
cord-023095-4dannjjm	4519	5	and	and	CC
cord-023095-4dannjjm	4519	6	is	be	VBZ
cord-023095-4dannjjm	4519	7	marketed	market	VBN
cord-023095-4dannjjm	4519	8	for	for	IN
cord-023095-4dannjjm	4519	9	human	human	JJ
cord-023095-4dannjjm	4519	10	neurosurgical	neurosurgical	JJ
cord-023095-4dannjjm	4519	11	brain	brain	NN
cord-023095-4dannjjm	4519	12	/	/	SYM
cord-023095-4dannjjm	4519	13	spinal	spinal	JJ
cord-023095-4dannjjm	4519	14	cord	cord	NN
cord-023095-4dannjjm	4519	15	tumor	tumor	NN
cord-023095-4dannjjm	4519	16	resection	resection	NN
cord-023095-4dannjjm	4519	17	.	.	.
cord-023095-4dannjjm	4520	1	The	the	DT
cord-023095-4dannjjm	4520	2	purpose	purpose	NN
cord-023095-4dannjjm	4520	3	of	of	IN
cord-023095-4dannjjm	4520	4	this	this	DT
cord-023095-4dannjjm	4520	5	study	study	NN
cord-023095-4dannjjm	4520	6	is	be	VBZ
cord-023095-4dannjjm	4520	7	to	to	TO
cord-023095-4dannjjm	4520	8	describe	describe	VB
cord-023095-4dannjjm	4520	9	the	the	DT
cord-023095-4dannjjm	4520	10	use	use	NN
cord-023095-4dannjjm	4520	11	of	of	IN
cord-023095-4dannjjm	4520	12	the	the	DT
cord-023095-4dannjjm	4520	13	PTRD	PTRD	NNP
cord-023095-4dannjjm	4520	14	for	for	IN
cord-023095-4dannjjm	4520	15	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4520	16	disc	disc	NN
cord-023095-4dannjjm	4520	17	fenestration	fenestration	NN
cord-023095-4dannjjm	4520	18	and	and	CC
cord-023095-4dannjjm	4520	19	to	to	TO
cord-023095-4dannjjm	4520	20	compare	compare	VB
cord-023095-4dannjjm	4520	21	the	the	DT
cord-023095-4dannjjm	4520	22	effectiveness	effectiveness	NN
cord-023095-4dannjjm	4520	23	of	of	IN
cord-023095-4dannjjm	4520	24	manual	manual	JJ
cord-023095-4dannjjm	4520	25	fenestration	fenestration	NN
cord-023095-4dannjjm	4520	26	to	to	IN
cord-023095-4dannjjm	4520	27	that	that	DT
cord-023095-4dannjjm	4520	28	of	of	IN
cord-023095-4dannjjm	4520	29	the	the	DT
cord-023095-4dannjjm	4520	30	PTRD	PTRD	NNP
cord-023095-4dannjjm	4520	31	.	.	.
cord-023095-4dannjjm	4521	1	Fifteen	fifteen	CD
cord-023095-4dannjjm	4521	2	cadaveric	cadaveric	JJ
cord-023095-4dannjjm	4521	3	lumbar	lumbar	NN
cord-023095-4dannjjm	4521	4	spines	spine	NNS
cord-023095-4dannjjm	4521	5	were	be	VBD
cord-023095-4dannjjm	4521	6	randomly	randomly	RB
cord-023095-4dannjjm	4521	7	placed	place	VBN
cord-023095-4dannjjm	4521	8	into	into	IN
cord-023095-4dannjjm	4521	9	three	three	CD
cord-023095-4dannjjm	4521	10	study	study	NN
cord-023095-4dannjjm	4521	11	groups	group	NNS
cord-023095-4dannjjm	4521	12	:	:	:
cord-023095-4dannjjm	4522	1	group	group	NN
cord-023095-4dannjjm	4522	2	1	1	CD
cord-023095-4dannjjm	4522	3	was	be	VBD
cord-023095-4dannjjm	4522	4	the	the	DT
cord-023095-4dannjjm	4522	5	control	control	NN
cord-023095-4dannjjm	4522	6	group	group	NN
cord-023095-4dannjjm	4522	7	on	on	IN
cord-023095-4dannjjm	4522	8	which	which	WDT
cord-023095-4dannjjm	4522	9	no	no	DT
cord-023095-4dannjjm	4522	10	fenestrations	fenestration	NNS
cord-023095-4dannjjm	4522	11	were	be	VBD
cord-023095-4dannjjm	4522	12	performed	perform	VBN
cord-023095-4dannjjm	4522	13	,	,	,
cord-023095-4dannjjm	4522	14	group	group	NN
cord-023095-4dannjjm	4522	15	2	2	CD
cord-023095-4dannjjm	4522	16	was	be	VBD
cord-023095-4dannjjm	4522	17	the	the	DT
cord-023095-4dannjjm	4522	18	manual	manual	JJ
cord-023095-4dannjjm	4522	19	fenestration	fenestration	NN
cord-023095-4dannjjm	4522	20	group	group	NN
cord-023095-4dannjjm	4522	21	and	and	CC
cord-023095-4dannjjm	4522	22	group	group	NN
cord-023095-4dannjjm	4522	23	3	3	CD
cord-023095-4dannjjm	4523	1	was	be	VBD
cord-023095-4dannjjm	4523	2	the	the	DT
cord-023095-4dannjjm	4523	3	PTRD	PTRD	NNP
cord-023095-4dannjjm	4523	4	fenestration	fenestration	NN
cord-023095-4dannjjm	4523	5	group	group	NN
cord-023095-4dannjjm	4523	6	.	.	.
cord-023095-4dannjjm	4524	1	The	the	DT
cord-023095-4dannjjm	4524	2	effectiveness	effectiveness	NN
cord-023095-4dannjjm	4524	3	of	of	IN
cord-023095-4dannjjm	4524	4	fenestration	fenestration	NN
cord-023095-4dannjjm	4524	5	via	via	IN
cord-023095-4dannjjm	4524	6	both	both	CC
cord-023095-4dannjjm	4524	7	manual	manual	NN
cord-023095-4dannjjm	4524	8	and	and	CC
cord-023095-4dannjjm	4524	9	PTRD	PTRD	NNP
cord-023095-4dannjjm	4524	10	was	be	VBD
cord-023095-4dannjjm	4524	11	assessed	assess	VBN
cord-023095-4dannjjm	4524	12	by	by	IN
cord-023095-4dannjjm	4524	13	calculating	calculate	VBG
cord-023095-4dannjjm	4524	14	the	the	DT
cord-023095-4dannjjm	4524	15	ratio	ratio	NN
cord-023095-4dannjjm	4524	16	of	of	IN
cord-023095-4dannjjm	4524	17	remaining	remain	VBG
cord-023095-4dannjjm	4524	18	nuclear	nuclear	JJ
cord-023095-4dannjjm	4524	19	weight	weight	NN
cord-023095-4dannjjm	4524	20	post	post	NN
cord-023095-4dannjjm	4524	21	fenestration	fenestration	NN
cord-023095-4dannjjm	4524	22	to	to	IN
cord-023095-4dannjjm	4524	23	total	total	JJ
cord-023095-4dannjjm	4524	24	nuclear	nuclear	JJ
cord-023095-4dannjjm	4524	25	volume	volume	NN
cord-023095-4dannjjm	4524	26	.	.	.
cord-023095-4dannjjm	4525	1	Discs	disc	NNS
cord-023095-4dannjjm	4525	2	with	with	IN
cord-023095-4dannjjm	4525	3	lower	low	JJR
cord-023095-4dannjjm	4525	4	ratios	ratio	NNS
cord-023095-4dannjjm	4525	5	were	be	VBD
cord-023095-4dannjjm	4525	6	more	more	RBR
cord-023095-4dannjjm	4525	7	effectively	effectively	RB
cord-023095-4dannjjm	4525	8	fenestrated	fenestrate	VBN
cord-023095-4dannjjm	4525	9	.	.	.
cord-023095-4dannjjm	4526	1	Results	result	NNS
cord-023095-4dannjjm	4526	2	showed	show	VBD
cord-023095-4dannjjm	4526	3	a	a	DT
cord-023095-4dannjjm	4526	4	smaller	small	JJR
cord-023095-4dannjjm	4526	5	ratio	ratio	NN
cord-023095-4dannjjm	4526	6	of	of	IN
cord-023095-4dannjjm	4526	7	post	post	JJ
cord-023095-4dannjjm	4526	8	fenestration	fenestration	NN
cord-023095-4dannjjm	4526	9	remaining	remain	VBG
cord-023095-4dannjjm	4526	10	nuclear	nuclear	JJ
cord-023095-4dannjjm	4526	11	weight	weight	NN
cord-023095-4dannjjm	4526	12	to	to	IN
cord-023095-4dannjjm	4526	13	nuclear	nuclear	JJ
cord-023095-4dannjjm	4526	14	volume	volume	NN
cord-023095-4dannjjm	4526	15	following	follow	VBG
cord-023095-4dannjjm	4526	16	fenestration	fenestration	NN
cord-023095-4dannjjm	4526	17	with	with	IN
cord-023095-4dannjjm	4526	18	the	the	DT
cord-023095-4dannjjm	4526	19	PTRD	PTRD	NNP
cord-023095-4dannjjm	4526	20	(	(	-LRB-
cord-023095-4dannjjm	4526	21	0.23	0.23	CD
cord-023095-4dannjjm	4526	22	AE	AE	NNP
cord-023095-4dannjjm	4526	23	0.09	0.09	CD
cord-023095-4dannjjm	4526	24	)	)	-RRB-
cord-023095-4dannjjm	4526	25	as	as	IN
cord-023095-4dannjjm	4526	26	compared	compare	VBN
cord-023095-4dannjjm	4526	27	to	to	IN
cord-023095-4dannjjm	4526	28	manual	manual	JJ
cord-023095-4dannjjm	4526	29	fenestration	fenestration	NN
cord-023095-4dannjjm	4526	30	(	(	-LRB-
cord-023095-4dannjjm	4526	31	0.30	0.30	CD
cord-023095-4dannjjm	4526	32	AE	AE	NNP
cord-023095-4dannjjm	4526	33	0.10	0.10	CD
cord-023095-4dannjjm	4526	34	)	)	-RRB-
cord-023095-4dannjjm	4526	35	.	.	.
cord-023095-4dannjjm	4527	1	These	these	DT
cord-023095-4dannjjm	4527	2	results	result	NNS
cord-023095-4dannjjm	4527	3	did	do	VBD
cord-023095-4dannjjm	4527	4	not	not	RB
cord-023095-4dannjjm	4527	5	show	show	VB
cord-023095-4dannjjm	4527	6	statistical	statistical	JJ
cord-023095-4dannjjm	4527	7	significance	significance	NN
cord-023095-4dannjjm	4527	8	.	.	.
cord-023095-4dannjjm	4528	1	When	when	WRB
cord-023095-4dannjjm	4528	2	fenestrated	fenestrate	VBN
cord-023095-4dannjjm	4528	3	samples	sample	NNS
cord-023095-4dannjjm	4528	4	were	be	VBD
cord-023095-4dannjjm	4528	5	compared	compare	VBN
cord-023095-4dannjjm	4528	6	to	to	TO
cord-023095-4dannjjm	4528	7	control	control	NN
cord-023095-4dannjjm	4528	8	samples	sample	NNS
cord-023095-4dannjjm	4528	9	(	(	-LRB-
cord-023095-4dannjjm	4528	10	0.39	0.39	CD
cord-023095-4dannjjm	4528	11	AE	AE	NNP
cord-023095-4dannjjm	4528	12	0.07	0.07	CD
cord-023095-4dannjjm	4528	13	)	)	-RRB-
cord-023095-4dannjjm	4528	14	,	,	,
cord-023095-4dannjjm	4528	15	there	there	EX
cord-023095-4dannjjm	4528	16	was	be	VBD
cord-023095-4dannjjm	4528	17	a	a	DT
cord-023095-4dannjjm	4528	18	statistically	statistically	RB
cord-023095-4dannjjm	4528	19	significant	significant	JJ
cord-023095-4dannjjm	4528	20	reduction	reduction	NN
cord-023095-4dannjjm	4528	21	in	in	IN
cord-023095-4dannjjm	4528	22	ratios	ratio	NNS
cord-023095-4dannjjm	4528	23	.	.	.
cord-023095-4dannjjm	4529	1	In	in	IN
cord-023095-4dannjjm	4529	2	conclusion	conclusion	NN
cord-023095-4dannjjm	4529	3	,	,	,
cord-023095-4dannjjm	4529	4	the	the	DT
cord-023095-4dannjjm	4529	5	PTRD	PTRD	NNP
cord-023095-4dannjjm	4529	6	is	be	VBZ
cord-023095-4dannjjm	4529	7	easy	easy	JJ
cord-023095-4dannjjm	4529	8	to	to	TO
cord-023095-4dannjjm	4529	9	use	use	VB
cord-023095-4dannjjm	4529	10	and	and	CC
cord-023095-4dannjjm	4529	11	is	be	VBZ
cord-023095-4dannjjm	4529	12	as	as	RB
cord-023095-4dannjjm	4529	13	effective	effective	JJ
cord-023095-4dannjjm	4529	14	as	as	IN
cord-023095-4dannjjm	4529	15	the	the	DT
cord-023095-4dannjjm	4529	16	manual	manual	JJ
cord-023095-4dannjjm	4529	17	technique	technique	NN
cord-023095-4dannjjm	4529	18	for	for	IN
cord-023095-4dannjjm	4529	19	canine	canine	JJ
cord-023095-4dannjjm	4529	20	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4529	21	disc	disc	NN
cord-023095-4dannjjm	4529	22	fenestration	fenestration	NN
cord-023095-4dannjjm	4529	23	.	.	.
cord-023095-4dannjjm	4530	1	According	accord	VBG
cord-023095-4dannjjm	4530	2	to	to	IN
cord-023095-4dannjjm	4530	3	the	the	DT
cord-023095-4dannjjm	4530	4	human	human	NN
cord-023095-4dannjjm	4530	5	WHO	who	WP
cord-023095-4dannjjm	4530	6	classification	classification	NN
cord-023095-4dannjjm	4530	7	gliomatosis	gliomatosis	NN
cord-023095-4dannjjm	4530	8	cerebri	cerebri	NNP
cord-023095-4dannjjm	4530	9	(	(	-LRB-
cord-023095-4dannjjm	4530	10	GC	GC	NNP
cord-023095-4dannjjm	4530	11	)	)	-RRB-
cord-023095-4dannjjm	4530	12	is	be	VBZ
cord-023095-4dannjjm	4530	13	a	a	DT
cord-023095-4dannjjm	4530	14	rare	rare	JJ
cord-023095-4dannjjm	4530	15	astrocytic	astrocytic	JJ
cord-023095-4dannjjm	4530	16	tumor	tumor	NN
cord-023095-4dannjjm	4530	17	affecting	affect	VBG
cord-023095-4dannjjm	4530	18	at	at	RB
cord-023095-4dannjjm	4530	19	least	least	RBS
cord-023095-4dannjjm	4530	20	three	three	CD
cord-023095-4dannjjm	4530	21	lobes	lobe	NNS
cord-023095-4dannjjm	4530	22	of	of	IN
cord-023095-4dannjjm	4530	23	the	the	DT
cord-023095-4dannjjm	4530	24	brain	brain	NN
cord-023095-4dannjjm	4530	25	with	with	IN
cord-023095-4dannjjm	4530	26	extensive	extensive	JJ
cord-023095-4dannjjm	4530	27	infiltration	infiltration	NN
cord-023095-4dannjjm	4530	28	,	,	,
cord-023095-4dannjjm	4530	29	but	but	CC
cord-023095-4dannjjm	4530	30	relative	relative	JJ
cord-023095-4dannjjm	4530	31	preservation	preservation	NN
cord-023095-4dannjjm	4530	32	of	of	IN
cord-023095-4dannjjm	4530	33	brain	brain	NN
cord-023095-4dannjjm	4530	34	architecture	architecture	NN
cord-023095-4dannjjm	4530	35	.	.	.
cord-023095-4dannjjm	4531	1	GC	GC	NNP
cord-023095-4dannjjm	4531	2	has	have	VBZ
cord-023095-4dannjjm	4531	3	not	not	RB
cord-023095-4dannjjm	4531	4	been	be	VBN
cord-023095-4dannjjm	4531	5	reported	report	VBN
cord-023095-4dannjjm	4531	6	to	to	TO
cord-023095-4dannjjm	4531	7	occur	occur	VB
cord-023095-4dannjjm	4531	8	as	as	IN
cord-023095-4dannjjm	4531	9	a	a	DT
cord-023095-4dannjjm	4531	10	hereditary	hereditary	JJ
cord-023095-4dannjjm	4531	11	disease	disease	NN
cord-023095-4dannjjm	4531	12	,	,	,
cord-023095-4dannjjm	4531	13	neither	neither	CC
cord-023095-4dannjjm	4531	14	in	in	IN
cord-023095-4dannjjm	4531	15	man	man	NN
cord-023095-4dannjjm	4531	16	nor	nor	CC
cord-023095-4dannjjm	4531	17	in	in	IN
cord-023095-4dannjjm	4531	18	animals	animal	NNS
cord-023095-4dannjjm	4531	19	.	.	.
cord-023095-4dannjjm	4532	1	Here	here	RB
cord-023095-4dannjjm	4532	2	,	,	,
cord-023095-4dannjjm	4532	3	we	-PRON-	PRP
cord-023095-4dannjjm	4532	4	report	report	VBP
cord-023095-4dannjjm	4532	5	the	the	DT
cord-023095-4dannjjm	4532	6	temporally	temporally	RB
cord-023095-4dannjjm	4532	7	clustered	cluster	VBN
cord-023095-4dannjjm	4532	8	occurrence	occurrence	NN
cord-023095-4dannjjm	4532	9	of	of	IN
cord-023095-4dannjjm	4532	10	GC	GC	NNP
cord-023095-4dannjjm	4532	11	in	in	IN
cord-023095-4dannjjm	4532	12	a	a	DT
cord-023095-4dannjjm	4532	13	family	family	NN
cord-023095-4dannjjm	4532	14	of	of	IN
cord-023095-4dannjjm	4532	15	Bearded	Bearded	NNP
cord-023095-4dannjjm	4532	16	collies	collies	NNPS
cord-023095-4dannjjm	4532	17	.	.	.
cord-023095-4dannjjm	4533	1	A	a	DT
cord-023095-4dannjjm	4533	2	7	7	CD
cord-023095-4dannjjm	4533	3	years	year	NNS
cord-023095-4dannjjm	4533	4	old	old	JJ
cord-023095-4dannjjm	4533	5	female	female	JJ
cord-023095-4dannjjm	4533	6	Bearded	Bearded	NNP
cord-023095-4dannjjm	4533	7	collie	collie	NN
cord-023095-4dannjjm	4533	8	with	with	IN
cord-023095-4dannjjm	4533	9	forebrain	forebrain	NN
cord-023095-4dannjjm	4533	10	signs	sign	NNS
cord-023095-4dannjjm	4533	11	was	be	VBD
cord-023095-4dannjjm	4533	12	presented	present	VBN
cord-023095-4dannjjm	4533	13	.	.	.
cord-023095-4dannjjm	4534	1	Differentials	differential	NNS
cord-023095-4dannjjm	4534	2	included	include	VBD
cord-023095-4dannjjm	4534	3	inflammatory/	inflammatory/	NN
cord-023095-4dannjjm	4534	4	infectious	infectious	JJ
cord-023095-4dannjjm	4534	5	,	,	,
cord-023095-4dannjjm	4534	6	metabolic/	metabolic/	JJ
cord-023095-4dannjjm	4534	7	toxic	toxic	JJ
cord-023095-4dannjjm	4534	8	,	,	,
cord-023095-4dannjjm	4534	9	and	and	CC
cord-023095-4dannjjm	4534	10	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	4534	11	diseases	disease	NNS
cord-023095-4dannjjm	4534	12	.	.	.
cord-023095-4dannjjm	4535	1	Within	within	IN
cord-023095-4dannjjm	4535	2	a	a	DT
cord-023095-4dannjjm	4535	3	time	time	NN
cord-023095-4dannjjm	4535	4	period	period	NN
cord-023095-4dannjjm	4535	5	of	of	IN
cord-023095-4dannjjm	4535	6	12	12	CD
cord-023095-4dannjjm	4535	7	months	month	NNS
cord-023095-4dannjjm	4535	8	,	,	,
cord-023095-4dannjjm	4535	9	3	3	CD
cord-023095-4dannjjm	4535	10	offspring	offspring	NN
cord-023095-4dannjjm	4535	11	of	of	IN
cord-023095-4dannjjm	4535	12	this	this	DT
cord-023095-4dannjjm	4535	13	bitch	bitch	NN
cord-023095-4dannjjm	4535	14	were	be	VBD
cord-023095-4dannjjm	4535	15	presented	present	VBN
cord-023095-4dannjjm	4535	16	with	with	IN
cord-023095-4dannjjm	4535	17	similar	similar	JJ
cord-023095-4dannjjm	4535	18	clinical	clinical	JJ
cord-023095-4dannjjm	4535	19	signs	sign	NNS
cord-023095-4dannjjm	4535	20	.	.	.
cord-023095-4dannjjm	4536	1	Two	two	CD
cord-023095-4dannjjm	4536	2	dogs	dog	NNS
cord-023095-4dannjjm	4536	3	were	be	VBD
cord-023095-4dannjjm	4536	4	full	full	JJ
cord-023095-4dannjjm	4536	5	siblings	sibling	NNS
cord-023095-4dannjjm	4536	6	(	(	-LRB-
cord-023095-4dannjjm	4536	7	2	2	CD
cord-023095-4dannjjm	4536	8	males	male	NNS
cord-023095-4dannjjm	4536	9	)	)	-RRB-
cord-023095-4dannjjm	4536	10	.	.	.
cord-023095-4dannjjm	4537	1	The	the	DT
cord-023095-4dannjjm	4537	2	remaining	remain	VBG
cord-023095-4dannjjm	4537	3	female	female	JJ
cord-023095-4dannjjm	4537	4	dog	dog	NN
cord-023095-4dannjjm	4537	5	originated	originate	VBD
cord-023095-4dannjjm	4537	6	from	from	IN
cord-023095-4dannjjm	4537	7	a	a	DT
cord-023095-4dannjjm	4537	8	match	match	NN
cord-023095-4dannjjm	4537	9	with	with	IN
cord-023095-4dannjjm	4537	10	a	a	DT
cord-023095-4dannjjm	4537	11	different	different	JJ
cord-023095-4dannjjm	4537	12	male	male	JJ
cord-023095-4dannjjm	4537	13	dog	dog	NN
cord-023095-4dannjjm	4537	14	.	.	.
cord-023095-4dannjjm	4538	1	MRI	MRI	NNP
cord-023095-4dannjjm	4538	2	was	be	VBD
cord-023095-4dannjjm	4538	3	performed	perform	VBN
cord-023095-4dannjjm	4538	4	in	in	IN
cord-023095-4dannjjm	4538	5	all	all	DT
cord-023095-4dannjjm	4538	6	4	4	CD
cord-023095-4dannjjm	4538	7	dogs	dog	NNS
cord-023095-4dannjjm	4538	8	and	and	CC
cord-023095-4dannjjm	4538	9	revealed	reveal	VBD
cord-023095-4dannjjm	4538	10	a	a	DT
cord-023095-4dannjjm	4538	11	diffuse	diffuse	JJ
cord-023095-4dannjjm	4538	12	and	and	CC
cord-023095-4dannjjm	4538	13	extensive	extensive	JJ
cord-023095-4dannjjm	4538	14	intra	intra	JJ
cord-023095-4dannjjm	4538	15	-	-	JJ
cord-023095-4dannjjm	4538	16	axial	axial	JJ
cord-023095-4dannjjm	4538	17	lesion	lesion	NN
cord-023095-4dannjjm	4538	18	with	with	IN
cord-023095-4dannjjm	4538	19	moderate	moderate	JJ
cord-023095-4dannjjm	4538	20	mass	mass	JJ
cord-023095-4dannjjm	4538	21	effect	effect	NN
cord-023095-4dannjjm	4538	22	and	and	CC
cord-023095-4dannjjm	4538	23	midline	midline	JJ
cord-023095-4dannjjm	4538	24	shift	shift	NN
cord-023095-4dannjjm	4538	25	.	.	.
cord-023095-4dannjjm	4539	1	The	the	DT
cord-023095-4dannjjm	4539	2	ill	ill	RB
cord-023095-4dannjjm	4539	3	defined	define	VBN
cord-023095-4dannjjm	4539	4	lesion	lesion	NN
cord-023095-4dannjjm	4539	5	showed	show	VBD
cord-023095-4dannjjm	4539	6	mainly	mainly	RB
cord-023095-4dannjjm	4539	7	a	a	DT
cord-023095-4dannjjm	4539	8	white	white	JJ
cord-023095-4dannjjm	4539	9	matter	matter	NN
cord-023095-4dannjjm	4539	10	distribution	distribution	NN
cord-023095-4dannjjm	4539	11	with	with	IN
cord-023095-4dannjjm	4539	12	hyperintense	hyperintense	NN
cord-023095-4dannjjm	4539	13	signal	signal	NN
cord-023095-4dannjjm	4539	14	in	in	IN
cord-023095-4dannjjm	4539	15	T2-w	T2-w	NNP
cord-023095-4dannjjm	4539	16	and	and	CC
cord-023095-4dannjjm	4539	17	FLAIR	flair	NN
cord-023095-4dannjjm	4539	18	images	image	NNS
cord-023095-4dannjjm	4539	19	and	and	CC
cord-023095-4dannjjm	4539	20	iso	iso	NN
cord-023095-4dannjjm	4539	21	-	-	HYPH
cord-023095-4dannjjm	4539	22	to	to	IN
cord-023095-4dannjjm	4539	23	hypointense	hypointense	NN
cord-023095-4dannjjm	4539	24	signal	signal	NN
cord-023095-4dannjjm	4539	25	in	in	IN
cord-023095-4dannjjm	4539	26	T1-w	t1-w	NN
cord-023095-4dannjjm	4539	27	images	image	NNS
cord-023095-4dannjjm	4539	28	without	without	IN
cord-023095-4dannjjm	4539	29	contrast	contrast	NN
cord-023095-4dannjjm	4539	30	enhancement	enhancement	NN
cord-023095-4dannjjm	4539	31	.	.	.
cord-023095-4dannjjm	4540	1	The	the	DT
cord-023095-4dannjjm	4540	2	lesion	lesion	NN
cord-023095-4dannjjm	4540	3	was	be	VBD
cord-023095-4dannjjm	4540	4	bilateral	bilateral	JJ
cord-023095-4dannjjm	4540	5	in	in	IN
cord-023095-4dannjjm	4540	6	all	all	DT
cord-023095-4dannjjm	4540	7	cases	case	NNS
cord-023095-4dannjjm	4540	8	,	,	,
cord-023095-4dannjjm	4540	9	continued	continue	VBD
cord-023095-4dannjjm	4540	10	along	along	IN
cord-023095-4dannjjm	4540	11	the	the	DT
cord-023095-4dannjjm	4540	12	white	white	JJ
cord-023095-4dannjjm	4540	13	matter	matter	NN
cord-023095-4dannjjm	4540	14	extending	extend	VBG
cord-023095-4dannjjm	4540	15	partially	partially	RB
cord-023095-4dannjjm	4540	16	into	into	IN
cord-023095-4dannjjm	4540	17	the	the	DT
cord-023095-4dannjjm	4540	18	gray	gray	JJ
cord-023095-4dannjjm	4540	19	matter	matter	NN
cord-023095-4dannjjm	4540	20	with	with	IN
cord-023095-4dannjjm	4540	21	contact	contact	NN
cord-023095-4dannjjm	4540	22	to	to	IN
cord-023095-4dannjjm	4540	23	the	the	DT
cord-023095-4dannjjm	4540	24	brain	brain	NN
cord-023095-4dannjjm	4540	25	surface	surface	NN
cord-023095-4dannjjm	4540	26	.	.	.
cord-023095-4dannjjm	4541	1	Neuropathology	Neuropathology	NNP
cord-023095-4dannjjm	4541	2	revealed	reveal	VBD
cord-023095-4dannjjm	4541	3	a	a	DT
cord-023095-4dannjjm	4541	4	diffuse	diffuse	JJ
cord-023095-4dannjjm	4541	5	and	and	CC
cord-023095-4dannjjm	4541	6	extensive	extensive	JJ
cord-023095-4dannjjm	4541	7	infiltration	infiltration	NN
cord-023095-4dannjjm	4541	8	of	of	IN
cord-023095-4dannjjm	4541	9	the	the	DT
cord-023095-4dannjjm	4541	10	brain	brain	NN
cord-023095-4dannjjm	4541	11	and	and	CC
cord-023095-4dannjjm	4541	12	spinal	spinal	JJ
cord-023095-4dannjjm	4541	13	cord	cord	NN
cord-023095-4dannjjm	4541	14	by	by	IN
cord-023095-4dannjjm	4541	15	a	a	DT
cord-023095-4dannjjm	4541	16	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	4541	17	glial	glial	JJ
cord-023095-4dannjjm	4541	18	cell	cell	NN
cord-023095-4dannjjm	4541	19	population	population	NN
cord-023095-4dannjjm	4541	20	involving	involve	VBG
cord-023095-4dannjjm	4541	21	white	white	JJ
cord-023095-4dannjjm	4541	22	and	and	CC
cord-023095-4dannjjm	4541	23	gray	gray	JJ
cord-023095-4dannjjm	4541	24	matter	matter	NN
cord-023095-4dannjjm	4541	25	of	of	IN
cord-023095-4dannjjm	4541	26	both	both	DT
cord-023095-4dannjjm	4541	27	hemispheres	hemisphere	NNS
cord-023095-4dannjjm	4541	28	,	,	,
cord-023095-4dannjjm	4541	29	thalamus	thalamus	NN
cord-023095-4dannjjm	4541	30	,	,	,
cord-023095-4dannjjm	4541	31	brainstem	brainstem	NN
cord-023095-4dannjjm	4541	32	and	and	CC
cord-023095-4dannjjm	4541	33	cerebellum	cerebellum	NN
cord-023095-4dannjjm	4541	34	in	in	IN
cord-023095-4dannjjm	4541	35	all	all	DT
cord-023095-4dannjjm	4541	36	4	4	CD
cord-023095-4dannjjm	4541	37	dogs	dog	NNS
cord-023095-4dannjjm	4541	38	.	.	.
cord-023095-4dannjjm	4542	1	Based	base	VBN
cord-023095-4dannjjm	4542	2	on	on	IN
cord-023095-4dannjjm	4542	3	the	the	DT
cord-023095-4dannjjm	4542	4	cell	cell	NN
cord-023095-4dannjjm	4542	5	morphology	morphology	NN
cord-023095-4dannjjm	4542	6	and	and	CC
cord-023095-4dannjjm	4542	7	immunoexpression	immunoexpression	NN
cord-023095-4dannjjm	4542	8	of	of	IN
cord-023095-4dannjjm	4542	9	glial	glial	JJ
cord-023095-4dannjjm	4542	10	fibrillary	fibrillary	JJ
cord-023095-4dannjjm	4542	11	astrocytic	astrocytic	JJ
cord-023095-4dannjjm	4542	12	protein	protein	NN
cord-023095-4dannjjm	4542	13	by	by	IN
cord-023095-4dannjjm	4542	14	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	4542	15	cells	cell	NNS
cord-023095-4dannjjm	4542	16	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4542	17	of	of	IN
cord-023095-4dannjjm	4542	18	GC	GC	NNP
cord-023095-4dannjjm	4542	19	was	be	VBD
cord-023095-4dannjjm	4542	20	made	make	VBN
cord-023095-4dannjjm	4542	21	.	.	.
cord-023095-4dannjjm	4543	1	This	this	DT
cord-023095-4dannjjm	4543	2	is	be	VBZ
cord-023095-4dannjjm	4543	3	the	the	DT
cord-023095-4dannjjm	4543	4	first	first	JJ
cord-023095-4dannjjm	4543	5	report	report	NN
cord-023095-4dannjjm	4543	6	of	of	IN
cord-023095-4dannjjm	4543	7	familial	familial	JJ
cord-023095-4dannjjm	4543	8	occurrence	occurrence	NN
cord-023095-4dannjjm	4543	9	of	of	IN
cord-023095-4dannjjm	4543	10	GC	GC	NNP
cord-023095-4dannjjm	4543	11	,	,	,
cord-023095-4dannjjm	4543	12	which	which	WDT
cord-023095-4dannjjm	4543	13	is	be	VBZ
cord-023095-4dannjjm	4543	14	likely	likely	RB
cord-023095-4dannjjm	4543	15	the	the	DT
cord-023095-4dannjjm	4543	16	result	result	NN
cord-023095-4dannjjm	4543	17	of	of	IN
cord-023095-4dannjjm	4543	18	a	a	DT
cord-023095-4dannjjm	4543	19	germ	germ	NN
cord-023095-4dannjjm	4543	20	-	-	HYPH
cord-023095-4dannjjm	4543	21	line	line	NN
cord-023095-4dannjjm	4543	22	mutation	mutation	NN
cord-023095-4dannjjm	4543	23	.	.	.
cord-023095-4dannjjm	4544	1	Several	several	JJ
cord-023095-4dannjjm	4544	2	human	human	JJ
cord-023095-4dannjjm	4544	3	hereditary	hereditary	JJ
cord-023095-4dannjjm	4544	4	cancer	cancer	NN
cord-023095-4dannjjm	4544	5	syndromes	syndrome	NNS
cord-023095-4dannjjm	4544	6	are	be	VBP
cord-023095-4dannjjm	4544	7	associated	associate	VBN
cord-023095-4dannjjm	4544	8	with	with	IN
cord-023095-4dannjjm	4544	9	CNS	CNS	NNP
cord-023095-4dannjjm	4544	10	tumors	tumor	NNS
cord-023095-4dannjjm	4544	11	including	include	VBG
cord-023095-4dannjjm	4544	12	amongst	amongst	IN
cord-023095-4dannjjm	4544	13	others	other	NNS
cord-023095-4dannjjm	4544	14	the	the	DT
cord-023095-4dannjjm	4544	15	Li	Li	NNP
cord-023095-4dannjjm	4544	16	-	-	HYPH
cord-023095-4dannjjm	4544	17	Fraumeni	Fraumeni	NNP
cord-023095-4dannjjm	4544	18	cancer	cancer	NN
cord-023095-4dannjjm	4544	19	family	family	NN
cord-023095-4dannjjm	4544	20	syndrome	syndrome	NN
cord-023095-4dannjjm	4544	21	(	(	-LRB-
cord-023095-4dannjjm	4544	22	p53	p53	NN
cord-023095-4dannjjm	4544	23	mutation	mutation	NN
cord-023095-4dannjjm	4544	24	)	)	-RRB-
cord-023095-4dannjjm	4544	25	,	,	,
cord-023095-4dannjjm	4544	26	neurofibromatosis	neurofibromatosis	NN
cord-023095-4dannjjm	4544	27	(	(	-LRB-
cord-023095-4dannjjm	4544	28	type	type	NN
cord-023095-4dannjjm	4544	29	1	1	CD
cord-023095-4dannjjm	4544	30	and	and	CC
cord-023095-4dannjjm	4544	31	2	2	CD
cord-023095-4dannjjm	4544	32	)	)	-RRB-
cord-023095-4dannjjm	4544	33	(	(	-LRB-
cord-023095-4dannjjm	4544	34	neurofibromin	neurofibromin	NNP
cord-023095-4dannjjm	4544	35	,	,	,
cord-023095-4dannjjm	4544	36	merlin	merlin	NNP
cord-023095-4dannjjm	4544	37	mutation	mutation	NN
cord-023095-4dannjjm	4544	38	)	)	-RRB-
cord-023095-4dannjjm	4544	39	,	,	,
cord-023095-4dannjjm	4544	40	and	and	CC
cord-023095-4dannjjm	4544	41	tuberous	tuberous	JJ
cord-023095-4dannjjm	4544	42	sclerosis	sclerosis	NN
cord-023095-4dannjjm	4544	43	(	(	-LRB-
cord-023095-4dannjjm	4544	44	hamartin	hamartin	NNP
cord-023095-4dannjjm	4544	45	,	,	,
cord-023095-4dannjjm	4544	46	tuberin	tuberin	NNP
cord-023095-4dannjjm	4544	47	mutation	mutation	NN
cord-023095-4dannjjm	4544	48	)	)	-RRB-
cord-023095-4dannjjm	4544	49	.	.	.
cord-023095-4dannjjm	4545	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	4545	2	,	,	,
cord-023095-4dannjjm	4545	3	familial	familial	JJ
cord-023095-4dannjjm	4545	4	clustering	clustering	NN
cord-023095-4dannjjm	4545	5	of	of	IN
cord-023095-4dannjjm	4545	6	human	human	JJ
cord-023095-4dannjjm	4545	7	gliomas	glioma	NNS
cord-023095-4dannjjm	4545	8	unassociated	unassociate	VBN
cord-023095-4dannjjm	4545	9	to	to	IN
cord-023095-4dannjjm	4545	10	the	the	DT
cord-023095-4dannjjm	4545	11	known	know	VBN
cord-023095-4dannjjm	4545	12	inherited	inherit	VBN
cord-023095-4dannjjm	4545	13	cancer	cancer	NN
cord-023095-4dannjjm	4545	14	syndromes	syndrome	NNS
cord-023095-4dannjjm	4545	15	has	have	VBZ
cord-023095-4dannjjm	4545	16	been	be	VBN
cord-023095-4dannjjm	4545	17	described	describe	VBN
cord-023095-4dannjjm	4545	18	.	.	.
cord-023095-4dannjjm	4546	1	In	in	IN
cord-023095-4dannjjm	4546	2	the	the	DT
cord-023095-4dannjjm	4546	3	dog	dog	NN
cord-023095-4dannjjm	4546	4	,	,	,
cord-023095-4dannjjm	4546	5	hereditary	hereditary	JJ
cord-023095-4dannjjm	4546	6	CNS	CNS	NNP
cord-023095-4dannjjm	4546	7	tumors	tumor	NNS
cord-023095-4dannjjm	4546	8	are	be	VBP
cord-023095-4dannjjm	4546	9	not	not	RB
cord-023095-4dannjjm	4546	10	known	know	VBN
cord-023095-4dannjjm	4546	11	.	.	.
cord-023095-4dannjjm	4547	1	The	the	DT
cord-023095-4dannjjm	4547	2	exact	exact	JJ
cord-023095-4dannjjm	4547	3	mode	mode	NN
cord-023095-4dannjjm	4547	4	of	of	IN
cord-023095-4dannjjm	4547	5	inheritance	inheritance	NN
cord-023095-4dannjjm	4547	6	and	and	CC
cord-023095-4dannjjm	4547	7	putative	putative	JJ
cord-023095-4dannjjm	4547	8	gene	gene	NN
cord-023095-4dannjjm	4547	9	mutations	mutation	NNS
cord-023095-4dannjjm	4547	10	of	of	IN
cord-023095-4dannjjm	4547	11	GC	GC	NNP
cord-023095-4dannjjm	4547	12	in	in	IN
cord-023095-4dannjjm	4547	13	this	this	DT
cord-023095-4dannjjm	4547	14	Bearded	Bearded	NNP
cord-023095-4dannjjm	4547	15	collie	collie	NN
cord-023095-4dannjjm	4547	16	family	family	NN
cord-023095-4dannjjm	4547	17	are	be	VBP
cord-023095-4dannjjm	4547	18	currently	currently	RB
cord-023095-4dannjjm	4547	19	under	under	IN
cord-023095-4dannjjm	4547	20	investigation	investigation	NN
cord-023095-4dannjjm	4547	21	.	.	.
cord-023095-4dannjjm	4548	1	Preliminary	preliminary	JJ
cord-023095-4dannjjm	4548	2	results	result	NNS
cord-023095-4dannjjm	4548	3	are	be	VBP
cord-023095-4dannjjm	4548	4	consistent	consistent	JJ
cord-023095-4dannjjm	4548	5	with	with	IN
cord-023095-4dannjjm	4548	6	a	a	DT
cord-023095-4dannjjm	4548	7	monogenic	monogenic	JJ
cord-023095-4dannjjm	4548	8	autosomal	autosomal	JJ
cord-023095-4dannjjm	4548	9	dominant	dominant	JJ
cord-023095-4dannjjm	4548	10	mode	mode	NN
cord-023095-4dannjjm	4548	11	of	of	IN
cord-023095-4dannjjm	4548	12	inheritance	inheritance	NN
cord-023095-4dannjjm	4548	13	,	,	,
cord-023095-4dannjjm	4548	14	although	although	IN
cord-023095-4dannjjm	4548	15	a	a	DT
cord-023095-4dannjjm	4548	16	recessive	recessive	JJ
cord-023095-4dannjjm	4548	17	inheritance	inheritance	NN
cord-023095-4dannjjm	4548	18	can	can	MD
cord-023095-4dannjjm	4548	19	not	not	RB
cord-023095-4dannjjm	4548	20	be	be	VB
cord-023095-4dannjjm	4548	21	completely	completely	RB
cord-023095-4dannjjm	4548	22	ruled	rule	VBN
cord-023095-4dannjjm	4548	23	out	out	RP
cord-023095-4dannjjm	4548	24	at	at	IN
cord-023095-4dannjjm	4548	25	this	this	DT
cord-023095-4dannjjm	4548	26	time	time	NN
cord-023095-4dannjjm	4548	27	.	.	.
cord-023095-4dannjjm	4549	1	Mutations	mutation	NNS
cord-023095-4dannjjm	4549	2	in	in	IN
cord-023095-4dannjjm	4549	3	the	the	DT
cord-023095-4dannjjm	4549	4	TP53	TP53	NNP
cord-023095-4dannjjm	4549	5	gene	gene	NN
cord-023095-4dannjjm	4549	6	were	be	VBD
cord-023095-4dannjjm	4549	7	not	not	RB
cord-023095-4dannjjm	4549	8	found	find	VBN
cord-023095-4dannjjm	4549	9	following	follow	VBG
cord-023095-4dannjjm	4549	10	amplification	amplification	NN
cord-023095-4dannjjm	4549	11	and	and	CC
cord-023095-4dannjjm	4549	12	sequencing	sequencing	NN
cord-023095-4dannjjm	4549	13	of	of	IN
cord-023095-4dannjjm	4549	14	exons	exon	NNS
cord-023095-4dannjjm	4549	15	5	5	CD
cord-023095-4dannjjm	4549	16	-	-	SYM
cord-023095-4dannjjm	4549	17	8	8	CD
cord-023095-4dannjjm	4549	18	in	in	IN
cord-023095-4dannjjm	4549	19	2	2	CD
cord-023095-4dannjjm	4549	20	affected	affect	VBN
cord-023095-4dannjjm	4549	21	dogs	dog	NNS
cord-023095-4dannjjm	4549	22	.	.	.
cord-023095-4dannjjm	4550	1	Previously	previously	RB
cord-023095-4dannjjm	4550	2	presented	present	VBN
cord-023095-4dannjjm	4550	3	at	at	IN
cord-023095-4dannjjm	4550	4	the	the	DT
cord-023095-4dannjjm	4550	5	ECVN	ECVN	NNP
cord-023095-4dannjjm	4550	6	annual	annual	JJ
cord-023095-4dannjjm	4550	7	meeting	meeting	NN
cord-023095-4dannjjm	4550	8	in	in	IN
cord-023095-4dannjjm	4550	9	Cambridge	Cambridge	NNP
cord-023095-4dannjjm	4550	10	,	,	,
cord-023095-4dannjjm	4550	11	UK	UK	NNP
cord-023095-4dannjjm	4550	12	.	.	.
cord-023095-4dannjjm	4551	1	The	the	DT
cord-023095-4dannjjm	4551	2	GM	GM	NNP
cord-023095-4dannjjm	4551	3	2	2	CD
cord-023095-4dannjjm	4551	4	gangliosidoses	gangliosidose	NNS
cord-023095-4dannjjm	4551	5	are	be	VBP
cord-023095-4dannjjm	4551	6	characterized	characterize	VBN
cord-023095-4dannjjm	4551	7	by	by	IN
cord-023095-4dannjjm	4551	8	a	a	DT
cord-023095-4dannjjm	4551	9	deficiency	deficiency	NN
cord-023095-4dannjjm	4551	10	of	of	IN
cord-023095-4dannjjm	4551	11	bhexosaminidase	bhexosaminidase	NNP
cord-023095-4dannjjm	4551	12	.	.	.
cord-023095-4dannjjm	4552	1	There	there	EX
cord-023095-4dannjjm	4552	2	are	be	VBP
cord-023095-4dannjjm	4552	3	two	two	CD
cord-023095-4dannjjm	4552	4	isoforms	isoform	NNS
cord-023095-4dannjjm	4552	5	:	:	:
cord-023095-4dannjjm	4552	6	Hex	Hex	NNP
cord-023095-4dannjjm	4552	7	A	A	NNP
cord-023095-4dannjjm	4552	8	composed	compose	VBN
cord-023095-4dannjjm	4552	9	of	of	IN
cord-023095-4dannjjm	4552	10	an	an	DT
cord-023095-4dannjjm	4552	11	a	a	NN
cord-023095-4dannjjm	4552	12	and	and	CC
cord-023095-4dannjjm	4552	13	b	b	NN
cord-023095-4dannjjm	4552	14	subunit	subunit	NN
cord-023095-4dannjjm	4552	15	encoded	encode	VBN
cord-023095-4dannjjm	4552	16	by	by	IN
cord-023095-4dannjjm	4552	17	HEXA	HEXA	NNP
cord-023095-4dannjjm	4552	18	and	and	CC
cord-023095-4dannjjm	4552	19	HEXB	HEXB	NNP
cord-023095-4dannjjm	4552	20	genes	gene	NNS
cord-023095-4dannjjm	4552	21	respectively	respectively	RB
cord-023095-4dannjjm	4552	22	and	and	CC
cord-023095-4dannjjm	4552	23	Hex	Hex	NNP
cord-023095-4dannjjm	4552	24	B	B	NNP
cord-023095-4dannjjm	4552	25	with	with	IN
cord-023095-4dannjjm	4552	26	two	two	CD
cord-023095-4dannjjm	4552	27	b	b	NN
cord-023095-4dannjjm	4552	28	subunits	subunit	NNS
cord-023095-4dannjjm	4552	29	.	.	.
cord-023095-4dannjjm	4553	1	Hex	Hex	NNP
cord-023095-4dannjjm	4553	2	A	A	NNP
cord-023095-4dannjjm	4553	3	requires	require	VBZ
cord-023095-4dannjjm	4553	4	an	an	DT
cord-023095-4dannjjm	4553	5	activator	activator	NN
cord-023095-4dannjjm	4553	6	encoded	encode	VBN
cord-023095-4dannjjm	4553	7	by	by	IN
cord-023095-4dannjjm	4553	8	GM2A.	GM2A.	NNPS
cord-023095-4dannjjm	4553	9	Two	two	CD
cord-023095-4dannjjm	4553	10	Japanese	japanese	JJ
cord-023095-4dannjjm	4553	11	chin	chin	NN
cord-023095-4dannjjm	4553	12	dogs	dog	NNS
cord-023095-4dannjjm	4553	13	with	with	IN
cord-023095-4dannjjm	4553	14	confirmed	confirm	VBN
cord-023095-4dannjjm	4553	15	GM	GM	NNP
cord-023095-4dannjjm	4553	16	2	2	CD
cord-023095-4dannjjm	4553	17	gangliosidosis	gangliosidosis	NNP
cord-023095-4dannjjm	4553	18	showed	show	VBD
cord-023095-4dannjjm	4553	19	elevated	elevated	JJ
cord-023095-4dannjjm	4553	20	total	total	JJ
cord-023095-4dannjjm	4553	21	hexosaminidase	hexosaminidase	NN
cord-023095-4dannjjm	4553	22	and	and	CC
cord-023095-4dannjjm	4553	23	normal	normal	JJ
cord-023095-4dannjjm	4554	1	hexosaminidase	hexosaminidase	NNP
cord-023095-4dannjjm	4554	2	A	a	DT
cord-023095-4dannjjm	4554	3	activity	activity	NN
cord-023095-4dannjjm	4554	4	,	,	,
cord-023095-4dannjjm	4554	5	a	a	DT
cord-023095-4dannjjm	4554	6	pattern	pattern	NN
cord-023095-4dannjjm	4554	7	associated	associate	VBN
cord-023095-4dannjjm	4554	8	with	with	IN
cord-023095-4dannjjm	4554	9	the	the	DT
cord-023095-4dannjjm	4554	10	AB	AB	NNP
cord-023095-4dannjjm	4554	11	variant	variant	NN
cord-023095-4dannjjm	4554	12	in	in	IN
cord-023095-4dannjjm	4554	13	humans	human	NNS
cord-023095-4dannjjm	4554	14	and	and	CC
cord-023095-4dannjjm	4554	15	consistent	consistent	JJ
cord-023095-4dannjjm	4554	16	with	with	IN
cord-023095-4dannjjm	4554	17	prior	prior	JJ
cord-023095-4dannjjm	4554	18	reports	report	NNS
cord-023095-4dannjjm	4554	19	in	in	IN
cord-023095-4dannjjm	4554	20	the	the	DT
cord-023095-4dannjjm	4554	21	breed	breed	NN
cord-023095-4dannjjm	4554	22	.	.	.
cord-023095-4dannjjm	4555	1	This	this	DT
cord-023095-4dannjjm	4555	2	study	study	NN
cord-023095-4dannjjm	4555	3	was	be	VBD
cord-023095-4dannjjm	4555	4	performed	perform	VBN
cord-023095-4dannjjm	4555	5	to	to	TO
cord-023095-4dannjjm	4555	6	identify	identify	VB
cord-023095-4dannjjm	4555	7	the	the	DT
cord-023095-4dannjjm	4555	8	mutation	mutation	NN
cord-023095-4dannjjm	4555	9	responsible	responsible	JJ
cord-023095-4dannjjm	4555	10	using	use	VBG
cord-023095-4dannjjm	4555	11	resequencing	resequencing	NN
cord-023095-4dannjjm	4555	12	with	with	IN
cord-023095-4dannjjm	4555	13	an	an	DT
cord-023095-4dannjjm	4555	14	Applied	Applied	NNP
cord-023095-4dannjjm	4555	15	Biosystems	Biosystems	NNP
cord-023095-4dannjjm	4555	16	3730xl	3730xl	NN
cord-023095-4dannjjm	4555	17	DNA	dna	NN
cord-023095-4dannjjm	4555	18	analyzer	analyzer	NN
cord-023095-4dannjjm	4555	19	as	as	IN
cord-023095-4dannjjm	4555	20	previously	previously	RB
cord-023095-4dannjjm	4555	21	described	describe	VBN
cord-023095-4dannjjm	4555	22	(	(	-LRB-
cord-023095-4dannjjm	4555	23	Awano	Awano	NNP
cord-023095-4dannjjm	4555	24	2009	2009	CD
cord-023095-4dannjjm	4555	25	)	)	-RRB-
cord-023095-4dannjjm	4555	26	.	.	.
cord-023095-4dannjjm	4556	1	Mutations	mutation	NNS
cord-023095-4dannjjm	4556	2	in	in	IN
cord-023095-4dannjjm	4556	3	GM2A	GM2A	NNS
cord-023095-4dannjjm	4556	4	cause	cause	VB
cord-023095-4dannjjm	4556	5	the	the	DT
cord-023095-4dannjjm	4556	6	AB	AB	NNP
cord-023095-4dannjjm	4556	7	variant	variant	NN
cord-023095-4dannjjm	4556	8	in	in	IN
cord-023095-4dannjjm	4556	9	humans	human	NNS
cord-023095-4dannjjm	4556	10	,	,	,
cord-023095-4dannjjm	4556	11	but	but	CC
cord-023095-4dannjjm	4556	12	resequencing	resequencing	NN
cord-023095-4dannjjm	4556	13	GM2A	GM2A	NNP
cord-023095-4dannjjm	4556	14	revealed	reveal	VBD
cord-023095-4dannjjm	4556	15	no	no	DT
cord-023095-4dannjjm	4556	16	mutation	mutation	NN
cord-023095-4dannjjm	4556	17	that	that	WDT
cord-023095-4dannjjm	4556	18	could	could	MD
cord-023095-4dannjjm	4556	19	account	account	VB
cord-023095-4dannjjm	4556	20	for	for	IN
cord-023095-4dannjjm	4556	21	the	the	DT
cord-023095-4dannjjm	4556	22	disease	disease	NN
cord-023095-4dannjjm	4556	23	.	.	.
cord-023095-4dannjjm	4557	1	Resequencing	resequence	VBG
cord-023095-4dannjjm	4557	2	HEXA	HEXA	NNP
cord-023095-4dannjjm	4557	3	and	and	CC
cord-023095-4dannjjm	4557	4	HEXB	HEXB	NNP
cord-023095-4dannjjm	4557	5	revealed	reveal	VBD
cord-023095-4dannjjm	4557	6	a	a	DT
cord-023095-4dannjjm	4557	7	c.967	c.967	NN
cord-023095-4dannjjm	4557	8	G	g	NN
cord-023095-4dannjjm	4557	9	4	4	CD
cord-023095-4dannjjm	4557	10	A	a	DT
cord-023095-4dannjjm	4557	11	mutation	mutation	NN
cord-023095-4dannjjm	4557	12	in	in	IN
cord-023095-4dannjjm	4557	13	HEXA	HEXA	NNP
cord-023095-4dannjjm	4557	14	which	which	WDT
cord-023095-4dannjjm	4557	15	was	be	VBD
cord-023095-4dannjjm	4557	16	homozygous	homozygous	JJ
cord-023095-4dannjjm	4557	17	in	in	IN
cord-023095-4dannjjm	4557	18	both	both	DT
cord-023095-4dannjjm	4557	19	affected	affect	VBN
cord-023095-4dannjjm	4557	20	dogs	dog	NNS
cord-023095-4dannjjm	4557	21	.	.	.
cord-023095-4dannjjm	4558	1	Sixty	sixty	CD
cord-023095-4dannjjm	4558	2	-	-	HYPH
cord-023095-4dannjjm	4558	3	five	five	CD
cord-023095-4dannjjm	4558	4	normal	normal	JJ
cord-023095-4dannjjm	4558	5	Japanese	japanese	JJ
cord-023095-4dannjjm	4558	6	Chin	Chin	NNP
cord-023095-4dannjjm	4558	7	dogs	dog	NNS
cord-023095-4dannjjm	4558	8	were	be	VBD
cord-023095-4dannjjm	4558	9	screened	screen	VBN
cord-023095-4dannjjm	4558	10	for	for	IN
cord-023095-4dannjjm	4558	11	the	the	DT
cord-023095-4dannjjm	4558	12	mutant	mutant	JJ
cord-023095-4dannjjm	4558	13	allele	allele	NN
cord-023095-4dannjjm	4558	14	;	;	:
cord-023095-4dannjjm	4558	15	60	60	CD
cord-023095-4dannjjm	4558	16	were	be	VBD
cord-023095-4dannjjm	4558	17	homozygous	homozygous	JJ
cord-023095-4dannjjm	4558	18	for	for	IN
cord-023095-4dannjjm	4558	19	the	the	DT
cord-023095-4dannjjm	4558	20	ancestral	ancestral	JJ
cord-023095-4dannjjm	4558	21	allele	allele	NN
cord-023095-4dannjjm	4558	22	and	and	CC
cord-023095-4dannjjm	4558	23	5	5	CD
cord-023095-4dannjjm	4558	24	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	4558	25	.	.	.
cord-023095-4dannjjm	4559	1	This	this	DT
cord-023095-4dannjjm	4559	2	mutation	mutation	NN
cord-023095-4dannjjm	4559	3	predicts	predict	VBZ
cord-023095-4dannjjm	4559	4	a	a	DT
cord-023095-4dannjjm	4559	5	p.323E	p.323E	NNP
cord-023095-4dannjjm	4559	6	4	4	CD
cord-023095-4dannjjm	4559	7	K	k	NN
cord-023095-4dannjjm	4559	8	substitution	substitution	NN
cord-023095-4dannjjm	4559	9	affecting	affect	VBG
cord-023095-4dannjjm	4559	10	one	one	CD
cord-023095-4dannjjm	4559	11	of	of	IN
cord-023095-4dannjjm	4559	12	two	two	CD
cord-023095-4dannjjm	4559	13	primary	primary	JJ
cord-023095-4dannjjm	4559	14	active	active	JJ
cord-023095-4dannjjm	4559	15	-	-	HYPH
cord-023095-4dannjjm	4559	16	site	site	NN
cord-023095-4dannjjm	4559	17	amino	amino	NN
cord-023095-4dannjjm	4559	18	acids	acid	NNS
cord-023095-4dannjjm	4559	19	that	that	WDT
cord-023095-4dannjjm	4559	20	participate	participate	VBP
cord-023095-4dannjjm	4559	21	in	in	IN
cord-023095-4dannjjm	4559	22	the	the	DT
cord-023095-4dannjjm	4559	23	hydrolysis	hydrolysis	NN
cord-023095-4dannjjm	4559	24	of	of	IN
cord-023095-4dannjjm	4559	25	GM	GM	NNP
cord-023095-4dannjjm	4559	26	2	2	CD
cord-023095-4dannjjm	4559	27	ganglioside	ganglioside	NN
cord-023095-4dannjjm	4559	28	.	.	.
cord-023095-4dannjjm	4560	1	Substitution	substitution	NN
cord-023095-4dannjjm	4560	2	of	of	IN
cord-023095-4dannjjm	4560	3	a	a	DT
cord-023095-4dannjjm	4560	4	lysine	lysine	NN
cord-023095-4dannjjm	4560	5	residue	residue	NN
cord-023095-4dannjjm	4560	6	at	at	IN
cord-023095-4dannjjm	4560	7	this	this	DT
cord-023095-4dannjjm	4560	8	site	site	NN
cord-023095-4dannjjm	4560	9	is	be	VBZ
cord-023095-4dannjjm	4560	10	likely	likely	JJ
cord-023095-4dannjjm	4560	11	to	to	TO
cord-023095-4dannjjm	4560	12	eliminate	eliminate	VB
cord-023095-4dannjjm	4560	13	subunit	subunit	NN
cord-023095-4dannjjm	4560	14	A	a	DT
cord-023095-4dannjjm	4560	15	enzymatic	enzymatic	JJ
cord-023095-4dannjjm	4560	16	activity	activity	NN
cord-023095-4dannjjm	4560	17	.	.	.
cord-023095-4dannjjm	4561	1	The	the	DT
cord-023095-4dannjjm	4561	2	apparently	apparently	RB
cord-023095-4dannjjm	4561	3	normal	normal	JJ
cord-023095-4dannjjm	4561	4	levels	level	NNS
cord-023095-4dannjjm	4561	5	of	of	IN
cord-023095-4dannjjm	4561	6	hexosaminidase	hexosaminidase	NNP
cord-023095-4dannjjm	4561	7	A	a	DT
cord-023095-4dannjjm	4561	8	activity	activity	NN
cord-023095-4dannjjm	4561	9	in	in	IN
cord-023095-4dannjjm	4561	10	affected	affect	VBN
cord-023095-4dannjjm	4561	11	dog	dog	NN
cord-023095-4dannjjm	4561	12	samples	sample	NNS
cord-023095-4dannjjm	4561	13	may	may	MD
cord-023095-4dannjjm	4561	14	be	be	VB
cord-023095-4dannjjm	4561	15	a	a	DT
cord-023095-4dannjjm	4561	16	result	result	NN
cord-023095-4dannjjm	4561	17	of	of	IN
cord-023095-4dannjjm	4561	18	b	b	NN
cord-023095-4dannjjm	4561	19	subunit	subunit	NN
cord-023095-4dannjjm	4561	20	overexpression	overexpression	NN
cord-023095-4dannjjm	4561	21	.	.	.
cord-023095-4dannjjm	4562	1	Human	human	JJ
cord-023095-4dannjjm	4562	2	Hex	Hex	NNP
cord-023095-4dannjjm	4562	3	B	B	NNP
cord-023095-4dannjjm	4562	4	possesses	possess	VBZ
cord-023095-4dannjjm	4562	5	low	low	JJ
cord-023095-4dannjjm	4562	6	levels	level	NNS
cord-023095-4dannjjm	4562	7	activity	activity	NN
cord-023095-4dannjjm	4562	8	against	against	IN
cord-023095-4dannjjm	4562	9	the	the	DT
cord-023095-4dannjjm	4562	10	artificial	artificial	JJ
cord-023095-4dannjjm	4562	11	substrate	substrate	NN
cord-023095-4dannjjm	4562	12	used	use	VBN
cord-023095-4dannjjm	4562	13	to	to	TO
cord-023095-4dannjjm	4562	14	assess	assess	VB
cord-023095-4dannjjm	4562	15	Hex	Hex	NNP
cord-023095-4dannjjm	4562	16	A	A	NNP
cord-023095-4dannjjm	4562	17	activity	activity	NN
cord-023095-4dannjjm	4562	18	,	,	,
cord-023095-4dannjjm	4562	19	but	but	CC
cord-023095-4dannjjm	4562	20	specificity	specificity	NN
cord-023095-4dannjjm	4562	21	of	of	IN
cord-023095-4dannjjm	4562	22	activity	activity	NN
cord-023095-4dannjjm	4562	23	of	of	IN
cord-023095-4dannjjm	4562	24	the	the	DT
cord-023095-4dannjjm	4562	25	canine	canine	JJ
cord-023095-4dannjjm	4562	26	enzyme	enzyme	NN
cord-023095-4dannjjm	4562	27	is	be	VBZ
cord-023095-4dannjjm	4562	28	not	not	RB
cord-023095-4dannjjm	4562	29	known	know	VBN
cord-023095-4dannjjm	4562	30	.	.	.
cord-023095-4dannjjm	4563	1	Previously	previously	RB
cord-023095-4dannjjm	4563	2	presented	present	VBN
cord-023095-4dannjjm	4563	3	at	at	IN
cord-023095-4dannjjm	4563	4	the	the	DT
cord-023095-4dannjjm	4563	5	American	American	NNP
cord-023095-4dannjjm	4563	6	Society	Society	NNP
cord-023095-4dannjjm	4563	7	for	for	IN
cord-023095-4dannjjm	4563	8	Neurochemistry	Neurochemistry	NNP
cord-023095-4dannjjm	4563	9	:	:	:
cord-023095-4dannjjm	4563	10	additional	additional	JJ
cord-023095-4dannjjm	4563	11	data	datum	NNS
cord-023095-4dannjjm	4563	12	in	in	IN
cord-023095-4dannjjm	4563	13	this	this	DT
cord-023095-4dannjjm	4563	14	abstract	abstract	NN
cord-023095-4dannjjm	4563	15	.	.	.
cord-023095-4dannjjm	4564	1	Phenytoin	Phenytoin	NNP
cord-023095-4dannjjm	4564	2	(	(	-LRB-
cord-023095-4dannjjm	4564	3	PHT	PHT	NNP
cord-023095-4dannjjm	4564	4	)	)	-RRB-
cord-023095-4dannjjm	4564	5	is	be	VBZ
cord-023095-4dannjjm	4564	6	the	the	DT
cord-023095-4dannjjm	4564	7	intravenous	intravenous	JJ
cord-023095-4dannjjm	4564	8	drug	drug	NN
cord-023095-4dannjjm	4564	9	of	of	IN
cord-023095-4dannjjm	4564	10	choice	choice	NN
cord-023095-4dannjjm	4564	11	in	in	IN
cord-023095-4dannjjm	4564	12	humans	human	NNS
cord-023095-4dannjjm	4564	13	for	for	IN
cord-023095-4dannjjm	4564	14	seizure	seizure	NN
cord-023095-4dannjjm	4564	15	emergencies	emergency	NNS
cord-023095-4dannjjm	4564	16	following	follow	VBG
cord-023095-4dannjjm	4564	17	benzodiazapines	benzodiazapine	NNS
cord-023095-4dannjjm	4564	18	.	.	.
cord-023095-4dannjjm	4565	1	IV	IV	NNP
cord-023095-4dannjjm	4565	2	fosphenytoin	fosphenytoin	NNP
cord-023095-4dannjjm	4565	3	(	(	-LRB-
cord-023095-4dannjjm	4565	4	FOS	FOS	NNP
cord-023095-4dannjjm	4565	5	)	)	-RRB-
cord-023095-4dannjjm	4565	6	is	be	VBZ
cord-023095-4dannjjm	4565	7	a	a	DT
cord-023095-4dannjjm	4565	8	PHT	PHT	NNP
cord-023095-4dannjjm	4565	9	pro	pro	JJ
cord-023095-4dannjjm	4565	10	-	-	JJ
cord-023095-4dannjjm	4565	11	drug	drug	JJ
cord-023095-4dannjjm	4565	12	which	which	WDT
cord-023095-4dannjjm	4565	13	causes	cause	VBZ
cord-023095-4dannjjm	4565	14	less	less	JJR
cord-023095-4dannjjm	4565	15	administration	administration	NN
cord-023095-4dannjjm	4565	16	related	relate	VBD
cord-023095-4dannjjm	4565	17	adverse	adverse	JJ
cord-023095-4dannjjm	4565	18	events	event	NNS
cord-023095-4dannjjm	4565	19	.	.	.
cord-023095-4dannjjm	4566	1	While	while	IN
cord-023095-4dannjjm	4566	2	the	the	DT
cord-023095-4dannjjm	4566	3	short	short	JJ
cord-023095-4dannjjm	4566	4	half	half	JJ
cord-023095-4dannjjm	4566	5	-	-	HYPH
cord-023095-4dannjjm	4566	6	life	life	NN
cord-023095-4dannjjm	4566	7	of	of	IN
cord-023095-4dannjjm	4566	8	PHT	PHT	NNP
cord-023095-4dannjjm	4566	9	is	be	VBZ
cord-023095-4dannjjm	4566	10	not	not	RB
cord-023095-4dannjjm	4566	11	suitable	suitable	JJ
cord-023095-4dannjjm	4566	12	for	for	IN
cord-023095-4dannjjm	4566	13	chronic	chronic	JJ
cord-023095-4dannjjm	4566	14	oral	oral	JJ
cord-023095-4dannjjm	4566	15	therapy	therapy	NN
cord-023095-4dannjjm	4566	16	in	in	IN
cord-023095-4dannjjm	4566	17	dogs	dog	NNS
cord-023095-4dannjjm	4566	18	,	,	,
cord-023095-4dannjjm	4566	19	IV	IV	NNP
cord-023095-4dannjjm	4566	20	FOS	FOS	NNP
cord-023095-4dannjjm	4566	21	has	have	VBZ
cord-023095-4dannjjm	4566	22	not	not	RB
cord-023095-4dannjjm	4566	23	been	be	VBN
cord-023095-4dannjjm	4566	24	studied	study	VBN
cord-023095-4dannjjm	4566	25	.	.	.
cord-023095-4dannjjm	4567	1	Two	two	CD
cord-023095-4dannjjm	4567	2	dogs	dog	NNS
cord-023095-4dannjjm	4567	3	received	receive	VBD
cord-023095-4dannjjm	4567	4	15	15	CD
cord-023095-4dannjjm	4567	5	mg	mg	NN
cord-023095-4dannjjm	4567	6	/	/	SYM
cord-023095-4dannjjm	4567	7	kg	kg	NN
cord-023095-4dannjjm	4567	8	phenytoin	phenytoin	NN
cord-023095-4dannjjm	4567	9	equivalent	equivalent	NN
cord-023095-4dannjjm	4567	10	(	(	-LRB-
cord-023095-4dannjjm	4567	11	PE	PE	NNP
cord-023095-4dannjjm	4567	12	)	)	-RRB-
cord-023095-4dannjjm	4567	13	and	and	CC
cord-023095-4dannjjm	4567	14	two	two	CD
cord-023095-4dannjjm	4567	15	dogs	dog	NNS
cord-023095-4dannjjm	4567	16	received	receive	VBD
cord-023095-4dannjjm	4567	17	25	25	CD
cord-023095-4dannjjm	4567	18	mg	mg	NNP
cord-023095-4dannjjm	4567	19	/	/	SYM
cord-023095-4dannjjm	4567	20	kg	kg	NNP
cord-023095-4dannjjm	4567	21	PE	PE	NNP
cord-023095-4dannjjm	4567	22	of	of	IN
cord-023095-4dannjjm	4567	23	fosphenytoin	fosphenytoin	NNP
cord-023095-4dannjjm	4567	24	intravenously	intravenously	RB
cord-023095-4dannjjm	4567	25	at	at	IN
cord-023095-4dannjjm	4567	26	a	a	DT
cord-023095-4dannjjm	4567	27	rate	rate	NN
cord-023095-4dannjjm	4567	28	of	of	IN
cord-023095-4dannjjm	4567	29	50	50	CD
cord-023095-4dannjjm	4567	30	mg	mg	NNP
cord-023095-4dannjjm	4567	31	PE	PE	NNP
cord-023095-4dannjjm	4567	32	/	/	SYM
cord-023095-4dannjjm	4567	33	min	min	NN
cord-023095-4dannjjm	4567	34	.	.	.
cord-023095-4dannjjm	4568	1	Blood	blood	NN
cord-023095-4dannjjm	4568	2	for	for	IN
cord-023095-4dannjjm	4568	3	plasma	plasma	NN
cord-023095-4dannjjm	4568	4	levels	level	NNS
cord-023095-4dannjjm	4568	5	were	be	VBD
cord-023095-4dannjjm	4568	6	drawn	draw	VBN
cord-023095-4dannjjm	4568	7	at	at	IN
cord-023095-4dannjjm	4568	8	10	10	CD
cord-023095-4dannjjm	4568	9	time	time	NN
cord-023095-4dannjjm	4568	10	-	-	HYPH
cord-023095-4dannjjm	4568	11	points	point	NNS
cord-023095-4dannjjm	4568	12	over	over	IN
cord-023095-4dannjjm	4568	13	12	12	CD
cord-023095-4dannjjm	4568	14	hours	hour	NNS
cord-023095-4dannjjm	4568	15	;	;	:
cord-023095-4dannjjm	4568	16	total	total	JJ
cord-023095-4dannjjm	4568	17	and	and	CC
cord-023095-4dannjjm	4568	18	unbound	unbound	JJ
cord-023095-4dannjjm	4568	19	drug	drug	NN
cord-023095-4dannjjm	4568	20	levels	level	NNS
cord-023095-4dannjjm	4568	21	were	be	VBD
cord-023095-4dannjjm	4568	22	measured	measure	VBN
cord-023095-4dannjjm	4568	23	by	by	IN
cord-023095-4dannjjm	4568	24	HPLC	HPLC	NNP
cord-023095-4dannjjm	4568	25	.	.	.
cord-023095-4dannjjm	4569	1	Vital	vital	JJ
cord-023095-4dannjjm	4569	2	signs	sign	NNS
cord-023095-4dannjjm	4569	3	including	include	VBG
cord-023095-4dannjjm	4569	4	EKG	ekg	NN
cord-023095-4dannjjm	4569	5	,	,	,
cord-023095-4dannjjm	4569	6	blood	blood	NN
cord-023095-4dannjjm	4569	7	pressure	pressure	NN
cord-023095-4dannjjm	4569	8	,	,	,
cord-023095-4dannjjm	4569	9	and	and	CC
cord-023095-4dannjjm	4569	10	neurological	neurological	JJ
cord-023095-4dannjjm	4569	11	examination	examination	NN
cord-023095-4dannjjm	4569	12	were	be	VBD
cord-023095-4dannjjm	4569	13	monitored	monitor	VBN
cord-023095-4dannjjm	4569	14	.	.	.
cord-023095-4dannjjm	4570	1	The	the	DT
cord-023095-4dannjjm	4570	2	half	half	JJ
cord-023095-4dannjjm	4570	3	-	-	HYPH
cord-023095-4dannjjm	4570	4	life	life	NN
cord-023095-4dannjjm	4570	5	of	of	IN
cord-023095-4dannjjm	4570	6	metabolism	metabolism	NN
cord-023095-4dannjjm	4570	7	of	of	IN
cord-023095-4dannjjm	4570	8	FOS	FOS	NNP
cord-023095-4dannjjm	4570	9	to	to	IN
cord-023095-4dannjjm	4570	10	PHT	PHT	NNP
cord-023095-4dannjjm	4570	11	was	be	VBD
cord-023095-4dannjjm	4570	12	$	$	$
cord-023095-4dannjjm	4570	13	10	10	CD
cord-023095-4dannjjm	4570	14	min	min	NN
cord-023095-4dannjjm	4570	15	,	,	,
cord-023095-4dannjjm	4570	16	with	with	IN
cord-023095-4dannjjm	4570	17	4	4	CD
cord-023095-4dannjjm	4570	18	80	80	CD
cord-023095-4dannjjm	4570	19	%	%	NN
cord-023095-4dannjjm	4570	20	of	of	IN
cord-023095-4dannjjm	4570	21	FOS	FOS	NNP
cord-023095-4dannjjm	4570	22	metabolized	metabolize	VBN
cord-023095-4dannjjm	4570	23	to	to	IN
cord-023095-4dannjjm	4570	24	PHT	PHT	NNP
cord-023095-4dannjjm	4570	25	by	by	IN
cord-023095-4dannjjm	4570	26	30	30	CD
cord-023095-4dannjjm	4570	27	minutes	minute	NNS
cord-023095-4dannjjm	4570	28	.	.	.
cord-023095-4dannjjm	4571	1	Eighty	eighty	CD
cord-023095-4dannjjm	4571	2	to	to	TO
cord-023095-4dannjjm	4571	3	84	84	CD
cord-023095-4dannjjm	4571	4	%	%	NN
cord-023095-4dannjjm	4571	5	of	of	IN
cord-023095-4dannjjm	4571	6	PHT	PHT	NNP
cord-023095-4dannjjm	4571	7	was	be	VBD
cord-023095-4dannjjm	4571	8	protein	protein	NN
cord-023095-4dannjjm	4571	9	-	-	HYPH
cord-023095-4dannjjm	4571	10	bound	bind	VBN
cord-023095-4dannjjm	4571	11	during	during	IN
cord-023095-4dannjjm	4571	12	the	the	DT
cord-023095-4dannjjm	4571	13	first	first	JJ
cord-023095-4dannjjm	4571	14	15	15	CD
cord-023095-4dannjjm	4571	15	minutes	minute	NNS
cord-023095-4dannjjm	4571	16	after	after	IN
cord-023095-4dannjjm	4571	17	dosing	dose	VBG
cord-023095-4dannjjm	4571	18	,	,	,
cord-023095-4dannjjm	4571	19	compared	compare	VBN
cord-023095-4dannjjm	4571	20	to	to	IN
cord-023095-4dannjjm	4571	21	90	90	CD
cord-023095-4dannjjm	4571	22	-	-	SYM
cord-023095-4dannjjm	4571	23	95	95	CD
cord-023095-4dannjjm	4571	24	%	%	NN
cord-023095-4dannjjm	4571	25	in	in	IN
cord-023095-4dannjjm	4571	26	humans	human	NNS
cord-023095-4dannjjm	4571	27	.	.	.
cord-023095-4dannjjm	4572	1	The	the	DT
cord-023095-4dannjjm	4572	2	elimination	elimination	NN
cord-023095-4dannjjm	4572	3	half	half	JJ
cord-023095-4dannjjm	4572	4	-	-	HYPH
cord-023095-4dannjjm	4572	5	life	life	NN
cord-023095-4dannjjm	4572	6	for	for	IN
cord-023095-4dannjjm	4572	7	total	total	JJ
cord-023095-4dannjjm	4572	8	PHT	PHT	NNP
cord-023095-4dannjjm	4572	9	ranged	range	VBD
cord-023095-4dannjjm	4572	10	from	from	IN
cord-023095-4dannjjm	4572	11	2.8	2.8	CD
cord-023095-4dannjjm	4572	12	-	-	SYM
cord-023095-4dannjjm	4572	13	3.5	3.5	CD
cord-023095-4dannjjm	4572	14	hours	hour	NNS
cord-023095-4dannjjm	4572	15	and	and	CC
cord-023095-4dannjjm	4572	16	for	for	IN
cord-023095-4dannjjm	4572	17	unbound	unbound	JJ
cord-023095-4dannjjm	4572	18	PHT	PHT	NNP
cord-023095-4dannjjm	4572	19	ranged	range	VBD
cord-023095-4dannjjm	4572	20	from	from	IN
cord-023095-4dannjjm	4572	21	1.9	1.9	CD
cord-023095-4dannjjm	4572	22	-	-	SYM
cord-023095-4dannjjm	4572	23	5.4	5.4	CD
cord-023095-4dannjjm	4572	24	hours	hour	NNS
cord-023095-4dannjjm	4572	25	.	.	.
cord-023095-4dannjjm	4573	1	Dogs	dog	NNS
cord-023095-4dannjjm	4573	2	receiving	receive	VBG
cord-023095-4dannjjm	4573	3	15	15	CD
cord-023095-4dannjjm	4573	4	mg	mg	NNP
cord-023095-4dannjjm	4573	5	/	/	SYM
cord-023095-4dannjjm	4573	6	kg	kg	NNP
cord-023095-4dannjjm	4573	7	PE	PE	NNP
cord-023095-4dannjjm	4573	8	intravenously	intravenously	RB
cord-023095-4dannjjm	4573	9	achieved	achieve	VBD
cord-023095-4dannjjm	4573	10	unbound	unbound	JJ
cord-023095-4dannjjm	4573	11	PHT	pht	NN
cord-023095-4dannjjm	4573	12	plasma	plasma	NN
cord-023095-4dannjjm	4573	13	maximum	maximum	JJ
cord-023095-4dannjjm	4573	14	concentrations	concentration	NNS
cord-023095-4dannjjm	4573	15	of	of	IN
cord-023095-4dannjjm	4573	16	2.2	2.2	CD
cord-023095-4dannjjm	4573	17	-	-	HYPH
cord-023095-4dannjjm	4573	18	2.4ug	2.4ug	CD
cord-023095-4dannjjm	4573	19	/	/	SYM
cord-023095-4dannjjm	4573	20	ml	ml	NN
cord-023095-4dannjjm	4573	21	at	at	IN
cord-023095-4dannjjm	4573	22	5	5	CD
cord-023095-4dannjjm	4573	23	minutes	minute	NNS
cord-023095-4dannjjm	4573	24	,	,	,
cord-023095-4dannjjm	4573	25	consistent	consistent	JJ
cord-023095-4dannjjm	4573	26	with	with	IN
cord-023095-4dannjjm	4573	27	human	human	JJ
cord-023095-4dannjjm	4573	28	loading	loading	NN
cord-023095-4dannjjm	4573	29	dose	dose	NN
cord-023095-4dannjjm	4573	30	levels	level	NNS
cord-023095-4dannjjm	4573	31	.	.	.
cord-023095-4dannjjm	4574	1	Adverse	adverse	JJ
cord-023095-4dannjjm	4574	2	events	event	NNS
cord-023095-4dannjjm	4574	3	observed	observe	VBN
cord-023095-4dannjjm	4574	4	in	in	IN
cord-023095-4dannjjm	4574	5	some	some	DT
cord-023095-4dannjjm	4574	6	dogs	dog	NNS
cord-023095-4dannjjm	4574	7	included	include	VBD
cord-023095-4dannjjm	4574	8	vomiting	vomit	VBG
cord-023095-4dannjjm	4574	9	,	,	,
cord-023095-4dannjjm	4574	10	mild	mild	JJ
cord-023095-4dannjjm	4574	11	ataxia	ataxia	NN
cord-023095-4dannjjm	4574	12	,	,	,
cord-023095-4dannjjm	4574	13	and	and	CC
cord-023095-4dannjjm	4574	14	short	short	JJ
cord-023095-4dannjjm	4574	15	lived	live	VBN
cord-023095-4dannjjm	4574	16	tremors	tremor	NNS
cord-023095-4dannjjm	4574	17	,	,	,
cord-023095-4dannjjm	4574	18	the	the	DT
cord-023095-4dannjjm	4574	19	severity	severity	NN
cord-023095-4dannjjm	4574	20	of	of	IN
cord-023095-4dannjjm	4574	21	which	which	WDT
cord-023095-4dannjjm	4574	22	appeared	appear	VBD
cord-023095-4dannjjm	4574	23	dose	dose	RB
cord-023095-4dannjjm	4574	24	dependent	dependent	JJ
cord-023095-4dannjjm	4574	25	.	.	.
cord-023095-4dannjjm	4575	1	All	all	DT
cord-023095-4dannjjm	4575	2	dogs	dog	NNS
cord-023095-4dannjjm	4575	3	were	be	VBD
cord-023095-4dannjjm	4575	4	clinically	clinically	RB
cord-023095-4dannjjm	4575	5	normal	normal	JJ
cord-023095-4dannjjm	4575	6	within	within	IN
cord-023095-4dannjjm	4575	7	30	30	CD
cord-023095-4dannjjm	4575	8	minutes	minute	NNS
cord-023095-4dannjjm	4575	9	of	of	IN
cord-023095-4dannjjm	4575	10	all	all	DT
cord-023095-4dannjjm	4575	11	doses	dose	NNS
cord-023095-4dannjjm	4575	12	.	.	.
cord-023095-4dannjjm	4576	1	A	a	DT
cord-023095-4dannjjm	4576	2	15	15	CD
cord-023095-4dannjjm	4576	3	mg	mg	NN
cord-023095-4dannjjm	4576	4	/	/	SYM
cord-023095-4dannjjm	4576	5	kg	kg	NNP
cord-023095-4dannjjm	4576	6	PE	PE	NNP
cord-023095-4dannjjm	4576	7	dose	dose	NN
cord-023095-4dannjjm	4576	8	of	of	IN
cord-023095-4dannjjm	4576	9	IV	IV	NNP
cord-023095-4dannjjm	4576	10	FOS	FOS	NNP
cord-023095-4dannjjm	4576	11	appears	appear	VBZ
cord-023095-4dannjjm	4576	12	adequate	adequate	JJ
cord-023095-4dannjjm	4576	13	for	for	IN
cord-023095-4dannjjm	4576	14	production	production	NN
cord-023095-4dannjjm	4576	15	of	of	IN
cord-023095-4dannjjm	4576	16	PHT	PHT	NNP
cord-023095-4dannjjm	4576	17	levels	level	NNS
cord-023095-4dannjjm	4576	18	predicted	predict	VBN
cord-023095-4dannjjm	4576	19	to	to	TO
cord-023095-4dannjjm	4576	20	be	be	VB
cord-023095-4dannjjm	4576	21	effective	effective	JJ
cord-023095-4dannjjm	4576	22	for	for	IN
cord-023095-4dannjjm	4576	23	the	the	DT
cord-023095-4dannjjm	4576	24	treatment	treatment	NN
cord-023095-4dannjjm	4576	25	of	of	IN
cord-023095-4dannjjm	4576	26	canine	canine	JJ
cord-023095-4dannjjm	4576	27	seizure	seizure	NN
cord-023095-4dannjjm	4576	28	emergencies	emergency	NNS
cord-023095-4dannjjm	4576	29	.	.	.
cord-023095-4dannjjm	4577	1	Further	further	JJ
cord-023095-4dannjjm	4577	2	studies	study	NNS
cord-023095-4dannjjm	4577	3	in	in	IN
cord-023095-4dannjjm	4577	4	clinical	clinical	JJ
cord-023095-4dannjjm	4577	5	canine	canine	JJ
cord-023095-4dannjjm	4577	6	patients	patient	NNS
cord-023095-4dannjjm	4577	7	are	be	VBP
cord-023095-4dannjjm	4577	8	warranted	warrant	VBN
cord-023095-4dannjjm	4577	9	.	.	.
cord-023095-4dannjjm	4578	1	Acquired	acquire	VBN
cord-023095-4dannjjm	4578	2	myasthenia	myasthenia	NN
cord-023095-4dannjjm	4578	3	gravis	gravis	NN
cord-023095-4dannjjm	4578	4	(	(	-LRB-
cord-023095-4dannjjm	4578	5	MG	MG	NNP
cord-023095-4dannjjm	4578	6	)	)	-RRB-
cord-023095-4dannjjm	4578	7	is	be	VBZ
cord-023095-4dannjjm	4578	8	caused	cause	VBN
cord-023095-4dannjjm	4578	9	by	by	IN
cord-023095-4dannjjm	4578	10	antibodymediated	antibodymediated	JJ
cord-023095-4dannjjm	4578	11	inactivation	inactivation	NN
cord-023095-4dannjjm	4578	12	of	of	IN
cord-023095-4dannjjm	4578	13	the	the	DT
cord-023095-4dannjjm	4578	14	acetylcholine	acetylcholine	NN
cord-023095-4dannjjm	4578	15	receptor	receptor	NN
cord-023095-4dannjjm	4578	16	on	on	IN
cord-023095-4dannjjm	4578	17	the	the	DT
cord-023095-4dannjjm	4578	18	neuromuscular	neuromuscular	JJ
cord-023095-4dannjjm	4578	19	endplate	endplate	NN
cord-023095-4dannjjm	4578	20	causing	cause	VBG
cord-023095-4dannjjm	4578	21	focal	focal	JJ
cord-023095-4dannjjm	4578	22	,	,	,
cord-023095-4dannjjm	4578	23	regional	regional	JJ
cord-023095-4dannjjm	4578	24	or	or	CC
cord-023095-4dannjjm	4578	25	generalized	generalized	JJ
cord-023095-4dannjjm	4578	26	muscle	muscle	NN
cord-023095-4dannjjm	4578	27	weakness	weakness	NN
cord-023095-4dannjjm	4578	28	.	.	.
cord-023095-4dannjjm	4579	1	Many	many	JJ
cord-023095-4dannjjm	4579	2	medical	medical	JJ
cord-023095-4dannjjm	4579	3	treatments	treatment	NNS
cord-023095-4dannjjm	4579	4	have	have	VBP
cord-023095-4dannjjm	4579	5	been	be	VBN
cord-023095-4dannjjm	4579	6	reported	report	VBN
cord-023095-4dannjjm	4579	7	;	;	:
cord-023095-4dannjjm	4579	8	however	however	RB
cord-023095-4dannjjm	4579	9	,	,	,
cord-023095-4dannjjm	4579	10	responses	response	NNS
cord-023095-4dannjjm	4579	11	to	to	IN
cord-023095-4dannjjm	4579	12	therapy	therapy	NN
cord-023095-4dannjjm	4579	13	and	and	CC
cord-023095-4dannjjm	4579	14	outcomes	outcome	NNS
cord-023095-4dannjjm	4579	15	are	be	VBP
cord-023095-4dannjjm	4579	16	unpredictable	unpredictable	JJ
cord-023095-4dannjjm	4579	17	and	and	CC
cord-023095-4dannjjm	4579	18	death	death	NN
cord-023095-4dannjjm	4579	19	often	often	RB
cord-023095-4dannjjm	4579	20	results	result	VBZ
cord-023095-4dannjjm	4579	21	from	from	IN
cord-023095-4dannjjm	4579	22	aspiration	aspiration	NN
cord-023095-4dannjjm	4579	23	pneumonia	pneumonia	NN
cord-023095-4dannjjm	4579	24	.	.	.
cord-023095-4dannjjm	4580	1	Therapeutic	therapeutic	JJ
cord-023095-4dannjjm	4580	2	apheresis	apheresis	NN
cord-023095-4dannjjm	4580	3	is	be	VBZ
cord-023095-4dannjjm	4580	4	an	an	DT
cord-023095-4dannjjm	4580	5	extracorporeal	extracorporeal	JJ
cord-023095-4dannjjm	4580	6	procedure	procedure	NN
cord-023095-4dannjjm	4580	7	that	that	WDT
cord-023095-4dannjjm	4580	8	separates	separate	VBZ
cord-023095-4dannjjm	4580	9	blood	blood	NN
cord-023095-4dannjjm	4580	10	into	into	IN
cord-023095-4dannjjm	4580	11	its	-PRON-	PRP$
cord-023095-4dannjjm	4580	12	components	component	NNS
cord-023095-4dannjjm	4580	13	for	for	IN
cord-023095-4dannjjm	4580	14	removal	removal	NN
cord-023095-4dannjjm	4580	15	or	or	CC
cord-023095-4dannjjm	4580	16	specific	specific	JJ
cord-023095-4dannjjm	4580	17	alteration	alteration	NN
cord-023095-4dannjjm	4580	18	prior	prior	RB
cord-023095-4dannjjm	4580	19	to	to	TO
cord-023095-4dannjjm	4580	20	return	return	VB
cord-023095-4dannjjm	4580	21	to	to	IN
cord-023095-4dannjjm	4580	22	the	the	DT
cord-023095-4dannjjm	4580	23	patient	patient	NN
cord-023095-4dannjjm	4580	24	.	.	.
cord-023095-4dannjjm	4581	1	Therapeutic	therapeutic	JJ
cord-023095-4dannjjm	4581	2	plasma	plasma	NN
cord-023095-4dannjjm	4581	3	exchange	exchange	NN
cord-023095-4dannjjm	4581	4	(	(	-LRB-
cord-023095-4dannjjm	4581	5	TPE	TPE	NNP
cord-023095-4dannjjm	4581	6	)	)	-RRB-
cord-023095-4dannjjm	4581	7	is	be	VBZ
cord-023095-4dannjjm	4581	8	an	an	DT
cord-023095-4dannjjm	4581	9	apheresis	apheresis	NN
cord-023095-4dannjjm	4581	10	treatment	treatment	NN
cord-023095-4dannjjm	4581	11	in	in	IN
cord-023095-4dannjjm	4581	12	which	which	WDT
cord-023095-4dannjjm	4581	13	plasma	plasma	NN
cord-023095-4dannjjm	4581	14	(	(	-LRB-
cord-023095-4dannjjm	4581	15	containing	contain	VBG
cord-023095-4dannjjm	4581	16	pathologic	pathologic	JJ
cord-023095-4dannjjm	4581	17	antibodies	antibody	NNS
cord-023095-4dannjjm	4581	18	)	)	-RRB-
cord-023095-4dannjjm	4581	19	is	be	VBZ
cord-023095-4dannjjm	4581	20	removed	remove	VBN
cord-023095-4dannjjm	4581	21	and	and	CC
cord-023095-4dannjjm	4581	22	exchanged	exchange	VBN
cord-023095-4dannjjm	4581	23	with	with	IN
cord-023095-4dannjjm	4581	24	donor	donor	NN
cord-023095-4dannjjm	4581	25	plasma	plasma	NN
cord-023095-4dannjjm	4581	26	.	.	.
cord-023095-4dannjjm	4582	1	TPE	TPE	NNP
cord-023095-4dannjjm	4582	2	is	be	VBZ
cord-023095-4dannjjm	4582	3	used	use	VBN
cord-023095-4dannjjm	4582	4	routinely	routinely	RB
cord-023095-4dannjjm	4582	5	to	to	TO
cord-023095-4dannjjm	4582	6	treat	treat	VB
cord-023095-4dannjjm	4582	7	MG	MG	NNP
cord-023095-4dannjjm	4582	8	in	in	IN
cord-023095-4dannjjm	4582	9	human	human	JJ
cord-023095-4dannjjm	4582	10	patients	patient	NNS
cord-023095-4dannjjm	4582	11	with	with	IN
cord-023095-4dannjjm	4582	12	severe	severe	JJ
cord-023095-4dannjjm	4582	13	disease	disease	NN
cord-023095-4dannjjm	4582	14	or	or	CC
cord-023095-4dannjjm	4582	15	disease	disease	NN
cord-023095-4dannjjm	4582	16	unresponsive	unresponsive	JJ
cord-023095-4dannjjm	4582	17	to	to	IN
cord-023095-4dannjjm	4582	18	conventional	conventional	JJ
cord-023095-4dannjjm	4582	19	therapy	therapy	NN
cord-023095-4dannjjm	4582	20	.	.	.
cord-023095-4dannjjm	4583	1	We	-PRON-	PRP
cord-023095-4dannjjm	4583	2	report	report	VBP
cord-023095-4dannjjm	4583	3	the	the	DT
cord-023095-4dannjjm	4583	4	successful	successful	JJ
cord-023095-4dannjjm	4583	5	use	use	NN
cord-023095-4dannjjm	4583	6	of	of	IN
cord-023095-4dannjjm	4583	7	TPE	TPE	NNP
cord-023095-4dannjjm	4583	8	to	to	TO
cord-023095-4dannjjm	4583	9	treat	treat	VB
cord-023095-4dannjjm	4583	10	2	2	CD
cord-023095-4dannjjm	4583	11	large	large	JJ
cord-023095-4dannjjm	4583	12	breed	breed	NN
cord-023095-4dannjjm	4583	13	dogs	dog	NNS
cord-023095-4dannjjm	4583	14	with	with	IN
cord-023095-4dannjjm	4583	15	confirmed	confirm	VBN
cord-023095-4dannjjm	4583	16	MG	MG	NNP
cord-023095-4dannjjm	4583	17	(	(	-LRB-
cord-023095-4dannjjm	4583	18	aceytlcholine	aceytlcholine	NNP
cord-023095-4dannjjm	4583	19	receptor	receptor	NNP
cord-023095-4dannjjm	4583	20	antibody	antibody	NN
cord-023095-4dannjjm	4583	21	concentration	concentration	NN
cord-023095-4dannjjm	4583	22	:	:	:
cord-023095-4dannjjm	4583	23	3.05	3.05	CD
cord-023095-4dannjjm	4583	24	and	and	CC
cord-023095-4dannjjm	4583	25	3.32	3.32	CD
cord-023095-4dannjjm	4583	26	nM	nM	NNP
cord-023095-4dannjjm	4583	27	/	/	SYM
cord-023095-4dannjjm	4583	28	L	L	NNP
cord-023095-4dannjjm	4583	29	,	,	,
cord-023095-4dannjjm	4583	30	respectively	respectively	RB
cord-023095-4dannjjm	4583	31	;	;	:
cord-023095-4dannjjm	4583	32	normal	normal	JJ
cord-023095-4dannjjm	4583	33	concentration	concentration	NN
cord-023095-4dannjjm	4583	34	:	:	:
cord-023095-4dannjjm	4583	35	o	o	LS
cord-023095-4dannjjm	4583	36	0.6	0.6	CD
cord-023095-4dannjjm	4583	37	nM/	nM/	NNP
cord-023095-4dannjjm	4583	38	L	L	NNP
cord-023095-4dannjjm	4583	39	)	)	-RRB-
cord-023095-4dannjjm	4583	40	that	that	WDT
cord-023095-4dannjjm	4583	41	was	be	VBD
cord-023095-4dannjjm	4583	42	severe	severe	JJ
cord-023095-4dannjjm	4583	43	and	and	CC
cord-023095-4dannjjm	4583	44	not	not	RB
cord-023095-4dannjjm	4583	45	adequately	adequately	RB
cord-023095-4dannjjm	4583	46	responsive	responsive	JJ
cord-023095-4dannjjm	4583	47	to	to	IN
cord-023095-4dannjjm	4583	48	traditional	traditional	JJ
cord-023095-4dannjjm	4583	49	therapies	therapy	NNS
cord-023095-4dannjjm	4583	50	.	.	.
cord-023095-4dannjjm	4584	1	Both	both	DT
cord-023095-4dannjjm	4584	2	dogs	dog	NNS
cord-023095-4dannjjm	4584	3	were	be	VBD
cord-023095-4dannjjm	4584	4	non	non	JJ
cord-023095-4dannjjm	4584	5	-	-	JJ
cord-023095-4dannjjm	4584	6	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	4584	7	,	,	,
cord-023095-4dannjjm	4584	8	recumbent	recumbent	JJ
cord-023095-4dannjjm	4584	9	,	,	,
cord-023095-4dannjjm	4584	10	and	and	CC
cord-023095-4dannjjm	4584	11	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	4584	12	megaesophagus	megaesophagus	NNP
cord-023095-4dannjjm	4584	13	and	and	CC
cord-023095-4dannjjm	4584	14	aspiration	aspiration	NN
cord-023095-4dannjjm	4584	15	pneumonia	pneumonia	NN
cord-023095-4dannjjm	4584	16	.	.	.
cord-023095-4dannjjm	4585	1	Three	three	CD
cord-023095-4dannjjm	4585	2	TPE	TPE	NNP
cord-023095-4dannjjm	4585	3	treatments	treatment	NNS
cord-023095-4dannjjm	4585	4	(	(	-LRB-
cord-023095-4dannjjm	4585	5	1	1	CD
cord-023095-4dannjjm	4585	6	plasma	plasma	NN
cord-023095-4dannjjm	4585	7	exchange	exchange	NN
cord-023095-4dannjjm	4585	8	each	each	DT
cord-023095-4dannjjm	4585	9	)	)	-RRB-
cord-023095-4dannjjm	4585	10	were	be	VBD
cord-023095-4dannjjm	4585	11	performed	perform	VBN
cord-023095-4dannjjm	4585	12	over	over	IN
cord-023095-4dannjjm	4585	13	5	5	CD
cord-023095-4dannjjm	4585	14	and	and	CC
cord-023095-4dannjjm	4585	15	7	7	CD
cord-023095-4dannjjm	4585	16	days	day	NNS
cord-023095-4dannjjm	4585	17	,	,	,
cord-023095-4dannjjm	4585	18	respectively	respectively	RB
cord-023095-4dannjjm	4585	19	,	,	,
cord-023095-4dannjjm	4585	20	in	in	IN
cord-023095-4dannjjm	4585	21	each	each	DT
cord-023095-4dannjjm	4585	22	dog	dog	NN
cord-023095-4dannjjm	4585	23	without	without	IN
cord-023095-4dannjjm	4585	24	complication	complication	NN
cord-023095-4dannjjm	4585	25	.	.	.
cord-023095-4dannjjm	4586	1	Both	both	DT
cord-023095-4dannjjm	4586	2	dogs	dog	NNS
cord-023095-4dannjjm	4586	3	became	become	VBD
cord-023095-4dannjjm	4586	4	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	4586	5	within	within	IN
cord-023095-4dannjjm	4586	6	3	3	CD
cord-023095-4dannjjm	4586	7	days	day	NNS
cord-023095-4dannjjm	4586	8	of	of	IN
cord-023095-4dannjjm	4586	9	starting	start	VBG
cord-023095-4dannjjm	4586	10	TPE	TPE	NNP
cord-023095-4dannjjm	4586	11	treatment	treatment	NN
cord-023095-4dannjjm	4586	12	with	with	IN
cord-023095-4dannjjm	4586	13	subsequent	subsequent	JJ
cord-023095-4dannjjm	4586	14	resolution	resolution	NN
cord-023095-4dannjjm	4586	15	of	of	IN
cord-023095-4dannjjm	4586	16	regurgitation	regurgitation	NN
cord-023095-4dannjjm	4586	17	and	and	CC
cord-023095-4dannjjm	4586	18	megaesophagus	megaesophagus	NNP
cord-023095-4dannjjm	4586	19	.	.	.
cord-023095-4dannjjm	4587	1	Pyridostigmine	Pyridostigmine	NNP
cord-023095-4dannjjm	4587	2	was	be	VBD
cord-023095-4dannjjm	4587	3	continued	continue	VBN
cord-023095-4dannjjm	4587	4	during	during	IN
cord-023095-4dannjjm	4587	5	TPE	TPE	NNP
cord-023095-4dannjjm	4587	6	sessions	session	NNS
cord-023095-4dannjjm	4587	7	and	and	CC
cord-023095-4dannjjm	4587	8	discontinued	discontinue	VBD
cord-023095-4dannjjm	4587	9	in	in	IN
cord-023095-4dannjjm	4587	10	both	both	DT
cord-023095-4dannjjm	4587	11	dogs	dog	NNS
cord-023095-4dannjjm	4587	12	within	within	IN
cord-023095-4dannjjm	4587	13	3	3	CD
cord-023095-4dannjjm	4587	14	-	-	SYM
cord-023095-4dannjjm	4587	15	6	6	CD
cord-023095-4dannjjm	4587	16	months	month	NNS
cord-023095-4dannjjm	4587	17	.	.	.
cord-023095-4dannjjm	4588	1	Both	both	DT
cord-023095-4dannjjm	4588	2	dogs	dog	NNS
cord-023095-4dannjjm	4588	3	remain	remain	VBP
cord-023095-4dannjjm	4588	4	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	4588	5	and	and	CC
cord-023095-4dannjjm	4588	6	have	have	VBP
cord-023095-4dannjjm	4588	7	had	have	VBN
cord-023095-4dannjjm	4588	8	no	no	DT
cord-023095-4dannjjm	4588	9	recurrence	recurrence	NN
cord-023095-4dannjjm	4588	10	of	of	IN
cord-023095-4dannjjm	4588	11	MG	MG	NNP
cord-023095-4dannjjm	4588	12	during	during	IN
cord-023095-4dannjjm	4588	13	16	16	CD
cord-023095-4dannjjm	4588	14	and	and	CC
cord-023095-4dannjjm	4588	15	4	4	CD
cord-023095-4dannjjm	4588	16	months	month	NNS
cord-023095-4dannjjm	4588	17	of	of	IN
cord-023095-4dannjjm	4588	18	follow	follow	NN
cord-023095-4dannjjm	4588	19	-	-	HYPH
cord-023095-4dannjjm	4588	20	up	up	NN
cord-023095-4dannjjm	4588	21	,	,	,
cord-023095-4dannjjm	4588	22	respectively	respectively	RB
cord-023095-4dannjjm	4588	23	.	.	.
cord-023095-4dannjjm	4589	1	TPE	TPE	NNP
cord-023095-4dannjjm	4589	2	is	be	VBZ
cord-023095-4dannjjm	4589	3	a	a	DT
cord-023095-4dannjjm	4589	4	viable	viable	JJ
cord-023095-4dannjjm	4589	5	treatment	treatment	NN
cord-023095-4dannjjm	4589	6	option	option	NN
cord-023095-4dannjjm	4589	7	for	for	IN
cord-023095-4dannjjm	4589	8	dogs	dog	NNS
cord-023095-4dannjjm	4589	9	with	with	IN
cord-023095-4dannjjm	4589	10	MG	MG	NNP
cord-023095-4dannjjm	4589	11	that	that	WDT
cord-023095-4dannjjm	4589	12	have	have	VBP
cord-023095-4dannjjm	4589	13	severe	severe	JJ
cord-023095-4dannjjm	4589	14	disease	disease	NN
cord-023095-4dannjjm	4589	15	,	,	,
cord-023095-4dannjjm	4589	16	life	life	NN
cord-023095-4dannjjm	4589	17	-	-	HYPH
cord-023095-4dannjjm	4589	18	threatening	threaten	VBG
cord-023095-4dannjjm	4589	19	complications	complication	NNS
cord-023095-4dannjjm	4589	20	or	or	CC
cord-023095-4dannjjm	4589	21	that	that	WDT
cord-023095-4dannjjm	4589	22	remain	remain	VBP
cord-023095-4dannjjm	4589	23	unresponsive	unresponsive	JJ
cord-023095-4dannjjm	4589	24	to	to	IN
cord-023095-4dannjjm	4589	25	traditional	traditional	JJ
cord-023095-4dannjjm	4589	26	therapies	therapy	NNS
cord-023095-4dannjjm	4589	27	.	.	.
cord-023095-4dannjjm	4590	1	TPE	TPE	NNP
cord-023095-4dannjjm	4590	2	may	may	MD
cord-023095-4dannjjm	4590	3	alleviate	alleviate	VB
cord-023095-4dannjjm	4590	4	clinical	clinical	JJ
cord-023095-4dannjjm	4590	5	signs	sign	NNS
cord-023095-4dannjjm	4590	6	more	more	RBR
cord-023095-4dannjjm	4590	7	rapidly	rapidly	RB
cord-023095-4dannjjm	4590	8	,	,	,
cord-023095-4dannjjm	4590	9	and	and	CC
cord-023095-4dannjjm	4590	10	improve	improve	VB
cord-023095-4dannjjm	4590	11	long	long	JJ
cord-023095-4dannjjm	4590	12	-	-	HYPH
cord-023095-4dannjjm	4590	13	term	term	NN
cord-023095-4dannjjm	4590	14	outcomes	outcome	NNS
cord-023095-4dannjjm	4590	15	when	when	WRB
cord-023095-4dannjjm	4590	16	compared	compare	VBN
cord-023095-4dannjjm	4590	17	to	to	IN
cord-023095-4dannjjm	4590	18	historical	historical	JJ
cord-023095-4dannjjm	4590	19	experiences	experience	NNS
cord-023095-4dannjjm	4590	20	in	in	IN
cord-023095-4dannjjm	4590	21	patients	patient	NNS
cord-023095-4dannjjm	4590	22	with	with	IN
cord-023095-4dannjjm	4590	23	comparable	comparable	JJ
cord-023095-4dannjjm	4590	24	disease	disease	NN
cord-023095-4dannjjm	4590	25	.	.	.
cord-023095-4dannjjm	4591	1	Clinical	clinical	JJ
cord-023095-4dannjjm	4591	2	findings	finding	NNS
cord-023095-4dannjjm	4591	3	,	,	,
cord-023095-4dannjjm	4591	4	clinicopathologic	clinicopathologic	NNP
cord-023095-4dannjjm	4591	5	data	datum	NNS
cord-023095-4dannjjm	4591	6	,	,	,
cord-023095-4dannjjm	4591	7	imaging	imaging	NN
cord-023095-4dannjjm	4591	8	features	feature	NNS
cord-023095-4dannjjm	4591	9	,	,	,
cord-023095-4dannjjm	4591	10	and	and	CC
cord-023095-4dannjjm	4591	11	treatment	treatment	NN
cord-023095-4dannjjm	4591	12	of	of	IN
cord-023095-4dannjjm	4591	13	canine	canine	JJ
cord-023095-4dannjjm	4591	14	spinal	spinal	JJ
cord-023095-4dannjjm	4591	15	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4591	16	have	have	VBP
cord-023095-4dannjjm	4591	17	been	be	VBN
cord-023095-4dannjjm	4591	18	described	describe	VBN
cord-023095-4dannjjm	4591	19	in	in	IN
cord-023095-4dannjjm	4591	20	the	the	DT
cord-023095-4dannjjm	4591	21	veterinary	veterinary	JJ
cord-023095-4dannjjm	4591	22	literature	literature	NN
cord-023095-4dannjjm	4591	23	,	,	,
cord-023095-4dannjjm	4591	24	but	but	CC
cord-023095-4dannjjm	4591	25	histological	histological	JJ
cord-023095-4dannjjm	4591	26	characteristics	characteristic	NNS
cord-023095-4dannjjm	4591	27	and	and	CC
cord-023095-4dannjjm	4591	28	tumor	tumor	NN
cord-023095-4dannjjm	4591	29	grading	grading	NN
cord-023095-4dannjjm	4591	30	have	have	VBP
cord-023095-4dannjjm	4591	31	less	less	RBR
cord-023095-4dannjjm	4591	32	commonly	commonly	RB
cord-023095-4dannjjm	4591	33	been	be	VBN
cord-023095-4dannjjm	4591	34	reported	report	VBN
cord-023095-4dannjjm	4591	35	.	.	.
cord-023095-4dannjjm	4592	1	The	the	DT
cord-023095-4dannjjm	4592	2	aims	aim	NNS
cord-023095-4dannjjm	4592	3	of	of	IN
cord-023095-4dannjjm	4592	4	this	this	DT
cord-023095-4dannjjm	4592	5	retrospective	retrospective	JJ
cord-023095-4dannjjm	4592	6	case	case	NN
cord-023095-4dannjjm	4592	7	series	series	NN
cord-023095-4dannjjm	4592	8	were	be	VBD
cord-023095-4dannjjm	4592	9	to	to	TO
cord-023095-4dannjjm	4592	10	describe	describe	VB
cord-023095-4dannjjm	4592	11	the	the	DT
cord-023095-4dannjjm	4592	12	clinical	clinical	JJ
cord-023095-4dannjjm	4592	13	,	,	,
cord-023095-4dannjjm	4592	14	imaging	imaging	NN
cord-023095-4dannjjm	4592	15	,	,	,
cord-023095-4dannjjm	4592	16	and	and	CC
cord-023095-4dannjjm	4592	17	histologic	histologic	JJ
cord-023095-4dannjjm	4592	18	features	feature	NNS
cord-023095-4dannjjm	4592	19	of	of	IN
cord-023095-4dannjjm	4592	20	seven	seven	CD
cord-023095-4dannjjm	4592	21	canine	canine	JJ
cord-023095-4dannjjm	4592	22	spinal	spinal	JJ
cord-023095-4dannjjm	4592	23	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4592	24	including	include	VBG
cord-023095-4dannjjm	4592	25	a	a	DT
cord-023095-4dannjjm	4592	26	cervical	cervical	JJ
cord-023095-4dannjjm	4592	27	spinal	spinal	JJ
cord-023095-4dannjjm	4592	28	cystic	cystic	JJ
cord-023095-4dannjjm	4592	29	meningioma	meningioma	NN
cord-023095-4dannjjm	4592	30	that	that	WDT
cord-023095-4dannjjm	4592	31	had	have	VBD
cord-023095-4dannjjm	4592	32	imaging	image	VBG
cord-023095-4dannjjm	4592	33	and	and	CC
cord-023095-4dannjjm	4592	34	intraoperative	intraoperative	JJ
cord-023095-4dannjjm	4592	35	features	feature	NNS
cord-023095-4dannjjm	4592	36	of	of	IN
cord-023095-4dannjjm	4592	37	a	a	DT
cord-023095-4dannjjm	4592	38	subarachnoid	subarachnoid	NN
cord-023095-4dannjjm	4592	39	cyst	cyst	NN
cord-023095-4dannjjm	4592	40	.	.	.
cord-023095-4dannjjm	4593	1	Medical	medical	JJ
cord-023095-4dannjjm	4593	2	records	record	NNS
cord-023095-4dannjjm	4593	3	from	from	IN
cord-023095-4dannjjm	4593	4	dogs	dog	NNS
cord-023095-4dannjjm	4593	5	with	with	IN
cord-023095-4dannjjm	4593	6	a	a	DT
cord-023095-4dannjjm	4593	7	histopathological	histopathological	JJ
cord-023095-4dannjjm	4593	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4593	9	of	of	IN
cord-023095-4dannjjm	4593	10	spinal	spinal	JJ
cord-023095-4dannjjm	4593	11	cord	cord	NN
cord-023095-4dannjjm	4593	12	meningioma	meningioma	NN
cord-023095-4dannjjm	4593	13	presented	present	VBN
cord-023095-4dannjjm	4593	14	to	to	IN
cord-023095-4dannjjm	4593	15	the	the	DT
cord-023095-4dannjjm	4593	16	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	4593	17	Teaching	Teaching	NNP
cord-023095-4dannjjm	4593	18	Hospital	Hospital	NNP
cord-023095-4dannjjm	4593	19	between	between	IN
cord-023095-4dannjjm	4593	20	2006	2006	CD
cord-023095-4dannjjm	4593	21	and	and	CC
cord-023095-4dannjjm	4593	22	2010	2010	CD
cord-023095-4dannjjm	4593	23	were	be	VBD
cord-023095-4dannjjm	4593	24	reviewed	review	VBN
cord-023095-4dannjjm	4593	25	.	.	.
cord-023095-4dannjjm	4594	1	Signalment	Signalment	NNP
cord-023095-4dannjjm	4594	2	,	,	,
cord-023095-4dannjjm	4594	3	presenting	present	VBG
cord-023095-4dannjjm	4594	4	clinical	clinical	JJ
cord-023095-4dannjjm	4594	5	signs	sign	NNS
cord-023095-4dannjjm	4594	6	,	,	,
cord-023095-4dannjjm	4594	7	physical	physical	JJ
cord-023095-4dannjjm	4594	8	and	and	CC
cord-023095-4dannjjm	4594	9	neurologic	neurologic	JJ
cord-023095-4dannjjm	4594	10	examination	examination	NN
cord-023095-4dannjjm	4594	11	,	,	,
cord-023095-4dannjjm	4594	12	clinicopathologic	clinicopathologic	NNP
cord-023095-4dannjjm	4594	13	data	datum	NNS
cord-023095-4dannjjm	4594	14	,	,	,
cord-023095-4dannjjm	4594	15	surgery	surgery	NN
cord-023095-4dannjjm	4594	16	reports	report	NNS
cord-023095-4dannjjm	4594	17	and	and	CC
cord-023095-4dannjjm	4594	18	available	available	JJ
cord-023095-4dannjjm	4594	19	images	image	NNS
cord-023095-4dannjjm	4594	20	were	be	VBD
cord-023095-4dannjjm	4594	21	reviewed	review	VBN
cord-023095-4dannjjm	4594	22	.	.	.
cord-023095-4dannjjm	4595	1	All	all	DT
cord-023095-4dannjjm	4595	2	meningiomas	meningioma	NNS
cord-023095-4dannjjm	4595	3	were	be	VBD
cord-023095-4dannjjm	4595	4	histologically	histologically	RB
cord-023095-4dannjjm	4595	5	classified	classify	VBN
cord-023095-4dannjjm	4595	6	and	and	CC
cord-023095-4dannjjm	4595	7	graded	grade	VBD
cord-023095-4dannjjm	4595	8	following	follow	VBG
cord-023095-4dannjjm	4595	9	the	the	DT
cord-023095-4dannjjm	4595	10	international	international	JJ
cord-023095-4dannjjm	4595	11	WHO	WHO	NNP
cord-023095-4dannjjm	4595	12	human	human	JJ
cord-023095-4dannjjm	4595	13	classification	classification	NN
cord-023095-4dannjjm	4595	14	for	for	IN
cord-023095-4dannjjm	4595	15	CNS	CNS	NNP
cord-023095-4dannjjm	4595	16	tumors	tumor	NNS
cord-023095-4dannjjm	4595	17	.	.	.
cord-023095-4dannjjm	4596	1	Seven	seven	CD
cord-023095-4dannjjm	4596	2	dogs	dog	NNS
cord-023095-4dannjjm	4596	3	were	be	VBD
cord-023095-4dannjjm	4596	4	included	include	VBN
cord-023095-4dannjjm	4596	5	,	,	,
cord-023095-4dannjjm	4596	6	4	4	CD
cord-023095-4dannjjm	4596	7	males	male	NNS
cord-023095-4dannjjm	4596	8	and	and	CC
cord-023095-4dannjjm	4596	9	3	3	CD
cord-023095-4dannjjm	4596	10	females	female	NNS
cord-023095-4dannjjm	4596	11	.	.	.
cord-023095-4dannjjm	4597	1	Median	median	JJ
cord-023095-4dannjjm	4597	2	age	age	NN
cord-023095-4dannjjm	4597	3	at	at	IN
cord-023095-4dannjjm	4597	4	presentation	presentation	NN
cord-023095-4dannjjm	4597	5	was	be	VBD
cord-023095-4dannjjm	4597	6	8.7	8.7	CD
cord-023095-4dannjjm	4597	7	years	year	NNS
cord-023095-4dannjjm	4597	8	(	(	-LRB-
cord-023095-4dannjjm	4597	9	range	range	NN
cord-023095-4dannjjm	4597	10	,	,	,
cord-023095-4dannjjm	4597	11	3.5	3.5	CD
cord-023095-4dannjjm	4597	12	-	-	HYPH
cord-023095-4dannjjm	4597	13	11.4	11.4	CD
cord-023095-4dannjjm	4597	14	years	year	NNS
cord-023095-4dannjjm	4597	15	)	)	-RRB-
cord-023095-4dannjjm	4597	16	,	,	,
cord-023095-4dannjjm	4597	17	and	and	CC
cord-023095-4dannjjm	4597	18	median	median	JJ
cord-023095-4dannjjm	4597	19	weight	weight	NN
cord-023095-4dannjjm	4597	20	was	be	VBD
cord-023095-4dannjjm	4597	21	35	35	CD
cord-023095-4dannjjm	4597	22	kg	kg	NN
cord-023095-4dannjjm	4597	23	(	(	-LRB-
cord-023095-4dannjjm	4597	24	range	range	NN
cord-023095-4dannjjm	4597	25	,	,	,
cord-023095-4dannjjm	4597	26	8	8	CD
cord-023095-4dannjjm	4597	27	-	-	SYM
cord-023095-4dannjjm	4597	28	45	45	CD
cord-023095-4dannjjm	4597	29	kg	kg	NNS
cord-023095-4dannjjm	4597	30	)	)	-RRB-
cord-023095-4dannjjm	4597	31	.	.	.
cord-023095-4dannjjm	4598	1	Median	median	JJ
cord-023095-4dannjjm	4598	2	time	time	NN
cord-023095-4dannjjm	4598	3	between	between	IN
cord-023095-4dannjjm	4598	4	onset	onset	NN
cord-023095-4dannjjm	4598	5	of	of	IN
cord-023095-4dannjjm	4598	6	clinical	clinical	JJ
cord-023095-4dannjjm	4598	7	signs	sign	NNS
cord-023095-4dannjjm	4598	8	and	and	CC
cord-023095-4dannjjm	4598	9	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4598	10	was	be	VBD
cord-023095-4dannjjm	4598	11	108	108	CD
cord-023095-4dannjjm	4598	12	days	day	NNS
cord-023095-4dannjjm	4598	13	(	(	-LRB-
cord-023095-4dannjjm	4598	14	range	range	NN
cord-023095-4dannjjm	4598	15	,	,	,
cord-023095-4dannjjm	4598	16	45	45	CD
cord-023095-4dannjjm	4598	17	days	day	NNS
cord-023095-4dannjjm	4598	18	-1	-1	NNP
cord-023095-4dannjjm	4598	19	year	year	NN
cord-023095-4dannjjm	4598	20	)	)	-RRB-
cord-023095-4dannjjm	4598	21	.	.	.
cord-023095-4dannjjm	4599	1	Cerebrospinal	cerebrospinal	NN
cord-023095-4dannjjm	4599	2	fluid	fluid	NN
cord-023095-4dannjjm	4599	3	(	(	-LRB-
cord-023095-4dannjjm	4599	4	CSF	CSF	NNP
cord-023095-4dannjjm	4599	5	)	)	-RRB-
cord-023095-4dannjjm	4599	6	analysis	analysis	NN
cord-023095-4dannjjm	4599	7	was	be	VBD
cord-023095-4dannjjm	4599	8	performed	perform	VBN
cord-023095-4dannjjm	4599	9	in	in	IN
cord-023095-4dannjjm	4599	10	4	4	CD
cord-023095-4dannjjm	4599	11	dogs	dog	NNS
cord-023095-4dannjjm	4599	12	,	,	,
cord-023095-4dannjjm	4599	13	showing	show	VBG
cord-023095-4dannjjm	4599	14	increased	increase	VBN
cord-023095-4dannjjm	4599	15	protein	protein	NN
cord-023095-4dannjjm	4599	16	concentration	concentration	NN
cord-023095-4dannjjm	4599	17	in	in	IN
cord-023095-4dannjjm	4599	18	2	2	CD
cord-023095-4dannjjm	4599	19	cases	case	NNS
cord-023095-4dannjjm	4599	20	,	,	,
cord-023095-4dannjjm	4599	21	and	and	CC
cord-023095-4dannjjm	4599	22	being	be	VBG
cord-023095-4dannjjm	4599	23	normal	normal	JJ
cord-023095-4dannjjm	4599	24	in	in	IN
cord-023095-4dannjjm	4599	25	the	the	DT
cord-023095-4dannjjm	4599	26	other	other	JJ
cord-023095-4dannjjm	4599	27	2	2	CD
cord-023095-4dannjjm	4599	28	.	.	.
cord-023095-4dannjjm	4600	1	Spinal	spinal	JJ
cord-023095-4dannjjm	4600	2	radiographs	radiograph	NNS
cord-023095-4dannjjm	4600	3	revealed	reveal	VBD
cord-023095-4dannjjm	4600	4	vertebral	vertebral	JJ
cord-023095-4dannjjm	4600	5	canal	canal	NN
cord-023095-4dannjjm	4600	6	widening	widen	VBG
cord-023095-4dannjjm	4600	7	in	in	IN
cord-023095-4dannjjm	4600	8	one	one	CD
cord-023095-4dannjjm	4600	9	case	case	NN
cord-023095-4dannjjm	4600	10	.	.	.
cord-023095-4dannjjm	4601	1	Myelography	Myelography	NNP
cord-023095-4dannjjm	4601	2	(	(	-LRB-
cord-023095-4dannjjm	4601	3	4/7	4/7	CD
cord-023095-4dannjjm	4601	4	)	)	-RRB-
cord-023095-4dannjjm	4601	5	showed	show	VBD
cord-023095-4dannjjm	4601	6	intradural	intradural	JJ
cord-023095-4dannjjm	4601	7	/	/	SYM
cord-023095-4dannjjm	4601	8	extramedullary	extramedullary	JJ
cord-023095-4dannjjm	4601	9	lesions	lesion	NNS
cord-023095-4dannjjm	4601	10	in	in	IN
cord-023095-4dannjjm	4601	11	three	three	CD
cord-023095-4dannjjm	4601	12	cases	case	NNS
cord-023095-4dannjjm	4601	13	,	,	,
cord-023095-4dannjjm	4601	14	one	one	CD
cord-023095-4dannjjm	4601	15	of	of	IN
cord-023095-4dannjjm	4601	16	them	-PRON-	PRP
cord-023095-4dannjjm	4601	17	consistent	consistent	JJ
cord-023095-4dannjjm	4601	18	with	with	IN
cord-023095-4dannjjm	4601	19	a	a	DT
cord-023095-4dannjjm	4601	20	CSF	CSF	NNP
cord-023095-4dannjjm	4601	21	-	-	HYPH
cord-023095-4dannjjm	4601	22	filled	fill	VBN
cord-023095-4dannjjm	4601	23	subarachnoid	subarachnoid	NN
cord-023095-4dannjjm	4601	24	cavity	cavity	NN
cord-023095-4dannjjm	4601	25	,	,	,
cord-023095-4dannjjm	4601	26	and	and	CC
cord-023095-4dannjjm	4601	27	an	an	DT
cord-023095-4dannjjm	4601	28	extradural	extradural	JJ
cord-023095-4dannjjm	4601	29	lesion	lesion	NN
cord-023095-4dannjjm	4601	30	in	in	IN
cord-023095-4dannjjm	4601	31	one	one	CD
cord-023095-4dannjjm	4601	32	case	case	NN
cord-023095-4dannjjm	4601	33	.	.	.
cord-023095-4dannjjm	4602	1	Magnetic	magnetic	JJ
cord-023095-4dannjjm	4602	2	resonance	resonance	NN
cord-023095-4dannjjm	4602	3	imaging	imaging	NN
cord-023095-4dannjjm	4602	4	(	(	-LRB-
cord-023095-4dannjjm	4602	5	MRI	MRI	NNP
cord-023095-4dannjjm	4602	6	)	)	-RRB-
cord-023095-4dannjjm	4602	7	was	be	VBD
cord-023095-4dannjjm	4602	8	performed	perform	VBN
cord-023095-4dannjjm	4602	9	in	in	IN
cord-023095-4dannjjm	4602	10	all	all	DT
cord-023095-4dannjjm	4602	11	cases	case	NNS
cord-023095-4dannjjm	4602	12	and	and	CC
cord-023095-4dannjjm	4602	13	revealed	reveal	VBD
cord-023095-4dannjjm	4602	14	mild	mild	JJ
cord-023095-4dannjjm	4602	15	to	to	IN
cord-023095-4dannjjm	4602	16	marked	mark	VBN
cord-023095-4dannjjm	4602	17	hyperintensity	hyperintensity	NN
cord-023095-4dannjjm	4602	18	on	on	IN
cord-023095-4dannjjm	4602	19	T2W	t2w	CD
cord-023095-4dannjjm	4602	20	and	and	CC
cord-023095-4dannjjm	4602	21	precontrast	precontrast	NN
cord-023095-4dannjjm	4602	22	T1W	t1w	CD
cord-023095-4dannjjm	4602	23	images	image	NNS
cord-023095-4dannjjm	4602	24	and	and	CC
cord-023095-4dannjjm	4602	25	homogeneous	homogeneous	JJ
cord-023095-4dannjjm	4602	26	contrast	contrast	NN
cord-023095-4dannjjm	4602	27	enhancing	enhance	VBG
cord-023095-4dannjjm	4602	28	(	(	-LRB-
cord-023095-4dannjjm	4602	29	CE	CE	NNP
cord-023095-4dannjjm	4602	30	)	)	-RRB-
cord-023095-4dannjjm	4602	31	intradural	intradural	JJ
cord-023095-4dannjjm	4602	32	/	/	SYM
cord-023095-4dannjjm	4602	33	extramedullary	extramedullary	JJ
cord-023095-4dannjjm	4602	34	masses	masse	NNS
cord-023095-4dannjjm	4602	35	(	(	-LRB-
cord-023095-4dannjjm	4602	36	4	4	CD
cord-023095-4dannjjm	4602	37	cervical	cervical	JJ
cord-023095-4dannjjm	4602	38	and	and	CC
cord-023095-4dannjjm	4602	39	2	2	CD
cord-023095-4dannjjm	4602	40	thoracic	thoracic	JJ
cord-023095-4dannjjm	4602	41	)	)	-RRB-
cord-023095-4dannjjm	4602	42	in	in	IN
cord-023095-4dannjjm	4602	43	six	six	CD
cord-023095-4dannjjm	4602	44	cases	case	NNS
cord-023095-4dannjjm	4602	45	,	,	,
cord-023095-4dannjjm	4602	46	with	with	IN
cord-023095-4dannjjm	4602	47	one	one	CD
cord-023095-4dannjjm	4602	48	of	of	IN
cord-023095-4dannjjm	4602	49	these	these	DT
cord-023095-4dannjjm	4602	50	showing	show	VBG
cord-023095-4dannjjm	4602	51	an	an	DT
cord-023095-4dannjjm	4602	52	additional	additional	JJ
cord-023095-4dannjjm	4602	53	intramedullary	intramedullary	JJ
cord-023095-4dannjjm	4602	54	CE	ce	NN
cord-023095-4dannjjm	4602	55	pattern	pattern	NN
cord-023095-4dannjjm	4602	56	.	.	.
cord-023095-4dannjjm	4603	1	A	a	DT
cord-023095-4dannjjm	4603	2	dural	dural	JJ
cord-023095-4dannjjm	4603	3	tail	tail	NN
cord-023095-4dannjjm	4603	4	was	be	VBD
cord-023095-4dannjjm	4603	5	identified	identify	VBN
cord-023095-4dannjjm	4603	6	in	in	IN
cord-023095-4dannjjm	4603	7	two	two	CD
cord-023095-4dannjjm	4603	8	dogs	dog	NNS
cord-023095-4dannjjm	4603	9	.	.	.
cord-023095-4dannjjm	4604	1	One	one	CD
cord-023095-4dannjjm	4604	2	dog	dog	NN
cord-023095-4dannjjm	4604	3	had	have	VBD
cord-023095-4dannjjm	4604	4	a	a	DT
cord-023095-4dannjjm	4604	5	fluid	fluid	NN
cord-023095-4dannjjm	4604	6	-	-	HYPH
cord-023095-4dannjjm	4604	7	filled	fill	VBN
cord-023095-4dannjjm	4604	8	subarachnoid	subarachnoid	NN
cord-023095-4dannjjm	4604	9	enlargement	enlargement	NN
cord-023095-4dannjjm	4604	10	located	locate	VBN
cord-023095-4dannjjm	4604	11	dorsally	dorsally	RB
cord-023095-4dannjjm	4604	12	to	to	IN
cord-023095-4dannjjm	4604	13	the	the	DT
cord-023095-4dannjjm	4604	14	spinal	spinal	JJ
cord-023095-4dannjjm	4604	15	cord	cord	NN
cord-023095-4dannjjm	4604	16	.	.	.
cord-023095-4dannjjm	4605	1	This	this	DT
cord-023095-4dannjjm	4605	2	lesion	lesion	NN
cord-023095-4dannjjm	4605	3	was	be	VBD
cord-023095-4dannjjm	4605	4	hyperintense	hyperintense	NN
cord-023095-4dannjjm	4605	5	on	on	IN
cord-023095-4dannjjm	4605	6	T2W	T2W	NNP
cord-023095-4dannjjm	4605	7	,	,	,
cord-023095-4dannjjm	4605	8	hypointense	hypointense	NN
cord-023095-4dannjjm	4605	9	on	on	IN
cord-023095-4dannjjm	4605	10	T1W	T1W	NNP
cord-023095-4dannjjm	4605	11	and	and	CC
cord-023095-4dannjjm	4605	12	FLAIR	flair	NN
cord-023095-4dannjjm	4605	13	images	image	NNS
cord-023095-4dannjjm	4605	14	,	,	,
cord-023095-4dannjjm	4605	15	and	and	CC
cord-023095-4dannjjm	4605	16	did	do	VBD
cord-023095-4dannjjm	4605	17	not	not	RB
cord-023095-4dannjjm	4605	18	enhance	enhance	VB
cord-023095-4dannjjm	4605	19	.	.	.
cord-023095-4dannjjm	4606	1	It	-PRON-	PRP
cord-023095-4dannjjm	4606	2	was	be	VBD
cord-023095-4dannjjm	4606	3	diagnosed	diagnose	VBN
cord-023095-4dannjjm	4606	4	as	as	IN
cord-023095-4dannjjm	4606	5	a	a	DT
cord-023095-4dannjjm	4606	6	spinal	spinal	JJ
cord-023095-4dannjjm	4606	7	subarachnoid	subarachnoid	NN
cord-023095-4dannjjm	4606	8	cyst	cyst	NN
cord-023095-4dannjjm	4606	9	,	,	,
cord-023095-4dannjjm	4606	10	but	but	CC
cord-023095-4dannjjm	4606	11	the	the	DT
cord-023095-4dannjjm	4606	12	histopathological	histopathological	JJ
cord-023095-4dannjjm	4606	13	study	study	NN
cord-023095-4dannjjm	4606	14	of	of	IN
cord-023095-4dannjjm	4606	15	the	the	DT
cord-023095-4dannjjm	4606	16	surgically	surgically	RB
cord-023095-4dannjjm	4606	17	resected	resect	VBN
cord-023095-4dannjjm	4606	18	mass	mass	NN
cord-023095-4dannjjm	4606	19	revealed	reveal	VBD
cord-023095-4dannjjm	4606	20	a	a	DT
cord-023095-4dannjjm	4606	21	grade	grade	NN
cord-023095-4dannjjm	4606	22	I	-PRON-	PRP
cord-023095-4dannjjm	4606	23	cystic	cystic	JJ
cord-023095-4dannjjm	4606	24	meningioma	meningioma	NN
cord-023095-4dannjjm	4606	25	.	.	.
cord-023095-4dannjjm	4607	1	Five	five	CD
cord-023095-4dannjjm	4607	2	other	other	JJ
cord-023095-4dannjjm	4607	3	cases	case	NNS
cord-023095-4dannjjm	4607	4	underwent	undergo	VBD
cord-023095-4dannjjm	4607	5	cytoreductive	cytoreductive	JJ
cord-023095-4dannjjm	4607	6	surgery	surgery	NN
cord-023095-4dannjjm	4607	7	,	,	,
cord-023095-4dannjjm	4607	8	two	two	CD
cord-023095-4dannjjm	4607	9	transitional	transitional	JJ
cord-023095-4dannjjm	4607	10	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4607	11	(	(	-LRB-
cord-023095-4dannjjm	4607	12	grade	grade	NN
cord-023095-4dannjjm	4607	13	I	I	NNP
cord-023095-4dannjjm	4607	14	)	)	-RRB-
cord-023095-4dannjjm	4607	15	that	that	WDT
cord-023095-4dannjjm	4607	16	survived	survive	VBD
cord-023095-4dannjjm	4607	17	3	3	CD
cord-023095-4dannjjm	4607	18	(	(	-LRB-
cord-023095-4dannjjm	4607	19	alive	alive	JJ
cord-023095-4dannjjm	4607	20	at	at	IN
cord-023095-4dannjjm	4607	21	the	the	DT
cord-023095-4dannjjm	4607	22	time	time	NN
cord-023095-4dannjjm	4607	23	of	of	IN
cord-023095-4dannjjm	4607	24	writing	writing	NN
cord-023095-4dannjjm	4607	25	)	)	-RRB-
cord-023095-4dannjjm	4607	26	and	and	CC
cord-023095-4dannjjm	4607	27	7	7	CD
cord-023095-4dannjjm	4607	28	months	month	NNS
cord-023095-4dannjjm	4607	29	;	;	:
cord-023095-4dannjjm	4607	30	and	and	CC
cord-023095-4dannjjm	4607	31	three	three	CD
cord-023095-4dannjjm	4607	32	anaplastic	anaplastic	JJ
cord-023095-4dannjjm	4607	33	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4607	34	(	(	-LRB-
cord-023095-4dannjjm	4607	35	grade	grade	NN
cord-023095-4dannjjm	4607	36	III	iii	CD
cord-023095-4dannjjm	4607	37	)	)	-RRB-
cord-023095-4dannjjm	4607	38	that	that	WDT
cord-023095-4dannjjm	4607	39	survived	survive	VBD
cord-023095-4dannjjm	4607	40	10	10	CD
cord-023095-4dannjjm	4607	41	-	-	SYM
cord-023095-4dannjjm	4607	42	16.6	16.6	CD
cord-023095-4dannjjm	4607	43	months	month	NNS
cord-023095-4dannjjm	4607	44	before	before	IN
cord-023095-4dannjjm	4607	45	neurological	neurological	JJ
cord-023095-4dannjjm	4607	46	deterioration	deterioration	NN
cord-023095-4dannjjm	4607	47	and	and	CC
cord-023095-4dannjjm	4607	48	euthanasia	euthanasia	NN
cord-023095-4dannjjm	4607	49	.	.	.
cord-023095-4dannjjm	4608	1	Another	another	DT
cord-023095-4dannjjm	4608	2	anaplastic	anaplastic	JJ
cord-023095-4dannjjm	4608	3	meningioma	meningioma	NN
cord-023095-4dannjjm	4608	4	was	be	VBD
cord-023095-4dannjjm	4608	5	euthanized	euthanize	VBN
cord-023095-4dannjjm	4608	6	right	right	RB
cord-023095-4dannjjm	4608	7	after	after	IN
cord-023095-4dannjjm	4608	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4608	9	.	.	.
cord-023095-4dannjjm	4609	1	There	there	EX
cord-023095-4dannjjm	4609	2	are	be	VBP
cord-023095-4dannjjm	4609	3	few	few	JJ
cord-023095-4dannjjm	4609	4	reports	report	NNS
cord-023095-4dannjjm	4609	5	grading	grade	VBG
cord-023095-4dannjjm	4609	6	canine	canine	JJ
cord-023095-4dannjjm	4609	7	spinal	spinal	JJ
cord-023095-4dannjjm	4609	8	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4609	9	,	,	,
cord-023095-4dannjjm	4609	10	with	with	IN
cord-023095-4dannjjm	4609	11	most	most	JJS
cord-023095-4dannjjm	4609	12	being	be	VBG
cord-023095-4dannjjm	4609	13	grade	grade	NN
cord-023095-4dannjjm	4609	14	I	-PRON-	PRP
cord-023095-4dannjjm	4609	15	or	or	CC
cord-023095-4dannjjm	4609	16	II	II	NNP
cord-023095-4dannjjm	4609	17	.	.	.
cord-023095-4dannjjm	4610	1	Of	of	IN
cord-023095-4dannjjm	4610	2	the	the	DT
cord-023095-4dannjjm	4610	3	few	few	JJ
cord-023095-4dannjjm	4610	4	grade	grade	NN
cord-023095-4dannjjm	4610	5	III	iii	CD
cord-023095-4dannjjm	4610	6	tumors	tumor	NNS
cord-023095-4dannjjm	4610	7	reported	report	VBN
cord-023095-4dannjjm	4610	8	,	,	,
cord-023095-4dannjjm	4610	9	only	only	RB
cord-023095-4dannjjm	4610	10	one	one	CD
cord-023095-4dannjjm	4610	11	had	have	VBD
cord-023095-4dannjjm	4610	12	been	be	VBN
cord-023095-4dannjjm	4610	13	treated	treat	VBN
cord-023095-4dannjjm	4610	14	surgically	surgically	RB
cord-023095-4dannjjm	4610	15	and	and	CC
cord-023095-4dannjjm	4610	16	was	be	VBD
cord-023095-4dannjjm	4610	17	euthanized	euthanize	VBN
cord-023095-4dannjjm	4610	18	90	90	CD
cord-023095-4dannjjm	4610	19	days	day	NNS
cord-023095-4dannjjm	4610	20	later	later	RB
cord-023095-4dannjjm	4610	21	because	because	IN
cord-023095-4dannjjm	4610	22	of	of	IN
cord-023095-4dannjjm	4610	23	neurological	neurological	JJ
cord-023095-4dannjjm	4610	24	deterioration	deterioration	NN
cord-023095-4dannjjm	4610	25	.	.	.
cord-023095-4dannjjm	4611	1	We	-PRON-	PRP
cord-023095-4dannjjm	4611	2	report	report	VBP
cord-023095-4dannjjm	4611	3	four	four	CD
cord-023095-4dannjjm	4611	4	grade	grade	NN
cord-023095-4dannjjm	4611	5	III	iii	CD
cord-023095-4dannjjm	4611	6	(	(	-LRB-
cord-023095-4dannjjm	4611	7	anaplastic	anaplastic	JJ
cord-023095-4dannjjm	4611	8	)	)	-RRB-
cord-023095-4dannjjm	4611	9	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4611	10	,	,	,
cord-023095-4dannjjm	4611	11	three	three	CD
cord-023095-4dannjjm	4611	12	of	of	IN
cord-023095-4dannjjm	4611	13	which	which	WDT
cord-023095-4dannjjm	4611	14	surgically	surgically	RB
cord-023095-4dannjjm	4611	15	treated	treat	VBN
cord-023095-4dannjjm	4611	16	and	and	CC
cord-023095-4dannjjm	4611	17	with	with	IN
cord-023095-4dannjjm	4611	18	longer	long	JJR
cord-023095-4dannjjm	4611	19	survival	survival	NN
cord-023095-4dannjjm	4611	20	times	time	NNS
cord-023095-4dannjjm	4611	21	.	.	.
cord-023095-4dannjjm	4612	1	Finally	finally	RB
cord-023095-4dannjjm	4612	2	,	,	,
cord-023095-4dannjjm	4612	3	cystic	cystic	JJ
cord-023095-4dannjjm	4612	4	meningioma	meningioma	NN
cord-023095-4dannjjm	4612	5	should	should	MD
cord-023095-4dannjjm	4612	6	be	be	VB
cord-023095-4dannjjm	4612	7	considered	consider	VBN
cord-023095-4dannjjm	4612	8	in	in	IN
cord-023095-4dannjjm	4612	9	the	the	DT
cord-023095-4dannjjm	4612	10	differential	differential	JJ
cord-023095-4dannjjm	4612	11	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4612	12	of	of	IN
cord-023095-4dannjjm	4612	13	cases	case	NNS
cord-023095-4dannjjm	4612	14	with	with	IN
cord-023095-4dannjjm	4612	15	imaging	imaging	NN
cord-023095-4dannjjm	4612	16	features	feature	NNS
cord-023095-4dannjjm	4612	17	consistent	consistent	JJ
cord-023095-4dannjjm	4612	18	with	with	IN
cord-023095-4dannjjm	4612	19	arachnoid	arachnoid	JJ
cord-023095-4dannjjm	4612	20	cyst	cyst	NN
cord-023095-4dannjjm	4612	21	because	because	IN
cord-023095-4dannjjm	4612	22	of	of	IN
cord-023095-4dannjjm	4612	23	their	-PRON-	PRP$
cord-023095-4dannjjm	4612	24	similar	similar	JJ
cord-023095-4dannjjm	4612	25	appearance	appearance	NN
cord-023095-4dannjjm	4612	26	,	,	,
cord-023095-4dannjjm	4612	27	making	make	VBG
cord-023095-4dannjjm	4612	28	histopathological	histopathological	JJ
cord-023095-4dannjjm	4612	29	analysis	analysis	NN
cord-023095-4dannjjm	4612	30	essential	essential	JJ
cord-023095-4dannjjm	4612	31	for	for	IN
cord-023095-4dannjjm	4612	32	a	a	DT
cord-023095-4dannjjm	4612	33	definitive	definitive	JJ
cord-023095-4dannjjm	4612	34	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4612	35	.	.	.
cord-023095-4dannjjm	4613	1	Head	Head	NNP
cord-023095-4dannjjm	4613	2	trauma	trauma	NN
cord-023095-4dannjjm	4613	3	is	be	VBZ
cord-023095-4dannjjm	4613	4	a	a	DT
cord-023095-4dannjjm	4613	5	common	common	JJ
cord-023095-4dannjjm	4613	6	veterinary	veterinary	JJ
cord-023095-4dannjjm	4613	7	emergency	emergency	NN
cord-023095-4dannjjm	4613	8	,	,	,
cord-023095-4dannjjm	4613	9	but	but	CC
cord-023095-4dannjjm	4613	10	few	few	JJ
cord-023095-4dannjjm	4613	11	prognostic	prognostic	JJ
cord-023095-4dannjjm	4613	12	indicators	indicator	NNS
cord-023095-4dannjjm	4613	13	have	have	VBP
cord-023095-4dannjjm	4613	14	been	be	VBN
cord-023095-4dannjjm	4613	15	studied	study	VBN
cord-023095-4dannjjm	4613	16	in	in	IN
cord-023095-4dannjjm	4613	17	dogs	dog	NNS
cord-023095-4dannjjm	4613	18	,	,	,
cord-023095-4dannjjm	4613	19	making	make	VBG
cord-023095-4dannjjm	4613	20	it	-PRON-	PRP
cord-023095-4dannjjm	4613	21	challenging	challenging	JJ
cord-023095-4dannjjm	4613	22	for	for	IN
cord-023095-4dannjjm	4613	23	clinicians	clinician	NNS
cord-023095-4dannjjm	4613	24	to	to	TO
cord-023095-4dannjjm	4613	25	counsel	counsel	VB
cord-023095-4dannjjm	4613	26	clients	client	NNS
cord-023095-4dannjjm	4613	27	about	about	IN
cord-023095-4dannjjm	4613	28	the	the	DT
cord-023095-4dannjjm	4613	29	odds	odd	NNS
cord-023095-4dannjjm	4613	30	of	of	IN
cord-023095-4dannjjm	4613	31	recovery	recovery	NN
cord-023095-4dannjjm	4613	32	.	.	.
cord-023095-4dannjjm	4614	1	A	a	DT
cord-023095-4dannjjm	4614	2	recent	recent	JJ
cord-023095-4dannjjm	4614	3	meta	meta	JJ
cord-023095-4dannjjm	4614	4	-	-	HYPH
cord-023095-4dannjjm	4614	5	analysis	analysis	NN
cord-023095-4dannjjm	4614	6	showed	show	VBD
cord-023095-4dannjjm	4614	7	that	that	IN
cord-023095-4dannjjm	4614	8	higher	high	JJR
cord-023095-4dannjjm	4614	9	plasma	plasma	NN
cord-023095-4dannjjm	4614	10	glucose	glucose	NN
cord-023095-4dannjjm	4614	11	,	,	,
cord-023095-4dannjjm	4614	12	lower	low	JJR
cord-023095-4dannjjm	4614	13	plasma	plasma	NN
cord-023095-4dannjjm	4614	14	pH	ph	NN
cord-023095-4dannjjm	4614	15	and	and	CC
cord-023095-4dannjjm	4614	16	lower	low	JJR
cord-023095-4dannjjm	4614	17	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	4614	18	at	at	IN
cord-023095-4dannjjm	4614	19	admission	admission	NN
cord-023095-4dannjjm	4614	20	were	be	VBD
cord-023095-4dannjjm	4614	21	associated	associate	VBN
cord-023095-4dannjjm	4614	22	with	with	IN
cord-023095-4dannjjm	4614	23	increased	increase	VBN
cord-023095-4dannjjm	4614	24	risk	risk	NN
cord-023095-4dannjjm	4614	25	of	of	IN
cord-023095-4dannjjm	4614	26	death	death	NN
cord-023095-4dannjjm	4614	27	in	in	IN
cord-023095-4dannjjm	4614	28	human	human	JJ
cord-023095-4dannjjm	4614	29	head	head	NN
cord-023095-4dannjjm	4614	30	trauma	trauma	NN
cord-023095-4dannjjm	4614	31	.	.	.
cord-023095-4dannjjm	4615	1	The	the	DT
cord-023095-4dannjjm	4615	2	goal	goal	NN
cord-023095-4dannjjm	4615	3	of	of	IN
cord-023095-4dannjjm	4615	4	this	this	DT
cord-023095-4dannjjm	4615	5	retrospective	retrospective	JJ
cord-023095-4dannjjm	4615	6	study	study	NN
cord-023095-4dannjjm	4615	7	was	be	VBD
cord-023095-4dannjjm	4615	8	to	to	TO
cord-023095-4dannjjm	4615	9	investigate	investigate	VB
cord-023095-4dannjjm	4615	10	the	the	DT
cord-023095-4dannjjm	4615	11	association	association	NN
cord-023095-4dannjjm	4615	12	between	between	IN
cord-023095-4dannjjm	4615	13	admission	admission	NN
cord-023095-4dannjjm	4615	14	point	point	NN
cord-023095-4dannjjm	4615	15	of	of	IN
cord-023095-4dannjjm	4615	16	care	care	NN
cord-023095-4dannjjm	4615	17	blood	blood	NN
cord-023095-4dannjjm	4615	18	gas	gas	NN
cord-023095-4dannjjm	4615	19	parameters	parameter	NNS
cord-023095-4dannjjm	4615	20	and	and	CC
cord-023095-4dannjjm	4615	21	survival	survival	NN
cord-023095-4dannjjm	4615	22	to	to	TO
cord-023095-4dannjjm	4615	23	discharge	discharge	VB
cord-023095-4dannjjm	4615	24	in	in	IN
cord-023095-4dannjjm	4615	25	dogs	dog	NNS
cord-023095-4dannjjm	4615	26	with	with	IN
cord-023095-4dannjjm	4615	27	head	head	NN
cord-023095-4dannjjm	4615	28	trauma	trauma	NN
cord-023095-4dannjjm	4615	29	.	.	.
cord-023095-4dannjjm	4616	1	Fifty	fifty	CD
cord-023095-4dannjjm	4616	2	one	one	CD
cord-023095-4dannjjm	4616	3	dogs	dog	NNS
cord-023095-4dannjjm	4616	4	presenting	present	VBG
cord-023095-4dannjjm	4616	5	to	to	IN
cord-023095-4dannjjm	4616	6	the	the	DT
cord-023095-4dannjjm	4616	7	Cornell	Cornell	NNP
cord-023095-4dannjjm	4616	8	University	University	NNP
cord-023095-4dannjjm	4616	9	Hospital	Hospital	NNP
cord-023095-4dannjjm	4616	10	for	for	IN
cord-023095-4dannjjm	4616	11	Animals	animal	NNS
cord-023095-4dannjjm	4616	12	with	with	IN
cord-023095-4dannjjm	4616	13	head	head	NN
cord-023095-4dannjjm	4616	14	trauma	trauma	NN
cord-023095-4dannjjm	4616	15	from	from	IN
cord-023095-4dannjjm	4616	16	2007	2007	CD
cord-023095-4dannjjm	4616	17	to	to	IN
cord-023095-4dannjjm	4616	18	2010	2010	CD
cord-023095-4dannjjm	4616	19	that	that	WDT
cord-023095-4dannjjm	4616	20	had	have	VBD
cord-023095-4dannjjm	4616	21	a	a	DT
cord-023095-4dannjjm	4616	22	blood	blood	NN
cord-023095-4dannjjm	4616	23	gas	gas	NN
cord-023095-4dannjjm	4616	24	analysis	analysis	NN
cord-023095-4dannjjm	4616	25	done	do	VBN
cord-023095-4dannjjm	4616	26	within	within	IN
cord-023095-4dannjjm	4616	27	1	1	CD
cord-023095-4dannjjm	4616	28	hour	hour	NN
cord-023095-4dannjjm	4616	29	of	of	IN
cord-023095-4dannjjm	4616	30	presentation	presentation	NN
cord-023095-4dannjjm	4616	31	were	be	VBD
cord-023095-4dannjjm	4616	32	eligible	eligible	JJ
cord-023095-4dannjjm	4616	33	for	for	IN
cord-023095-4dannjjm	4616	34	inclusion	inclusion	NN
cord-023095-4dannjjm	4616	35	.	.	.
cord-023095-4dannjjm	4617	1	Parameters	parameter	NNS
cord-023095-4dannjjm	4617	2	assessed	assess	VBD
cord-023095-4dannjjm	4617	3	included	include	VBD
cord-023095-4dannjjm	4617	4	glucose	glucose	NN
cord-023095-4dannjjm	4617	5	,	,	,
cord-023095-4dannjjm	4617	6	base	base	NN
cord-023095-4dannjjm	4617	7	excess	excess	NN
cord-023095-4dannjjm	4617	8	(	(	-LRB-
cord-023095-4dannjjm	4617	9	BE	be	VB
cord-023095-4dannjjm	4617	10	)	)	-RRB-
cord-023095-4dannjjm	4617	11	,	,	,
cord-023095-4dannjjm	4617	12	anion	anion	NN
cord-023095-4dannjjm	4617	13	gap	gap	NN
cord-023095-4dannjjm	4617	14	(	(	-LRB-
cord-023095-4dannjjm	4617	15	AG	AG	NNP
cord-023095-4dannjjm	4617	16	)	)	-RRB-
cord-023095-4dannjjm	4617	17	,	,	,
cord-023095-4dannjjm	4617	18	pH	ph	NN
cord-023095-4dannjjm	4617	19	,	,	,
cord-023095-4dannjjm	4617	20	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	4617	21	,	,	,
cord-023095-4dannjjm	4617	22	and	and	CC
cord-023095-4dannjjm	4617	23	sodium	sodium	NN
cord-023095-4dannjjm	4617	24	.	.	.
cord-023095-4dannjjm	4618	1	Biochemical	biochemical	JJ
cord-023095-4dannjjm	4618	2	data	datum	NNS
cord-023095-4dannjjm	4618	3	were	be	VBD
cord-023095-4dannjjm	4618	4	found	find	VBN
cord-023095-4dannjjm	4618	5	to	to	TO
cord-023095-4dannjjm	4618	6	be	be	VB
cord-023095-4dannjjm	4618	7	normally	normally	RB
cord-023095-4dannjjm	4618	8	distributed	distribute	VBN
cord-023095-4dannjjm	4618	9	using	use	VBG
cord-023095-4dannjjm	4618	10	the	the	DT
cord-023095-4dannjjm	4618	11	Kolmogorov	Kolmogorov	NNP
cord-023095-4dannjjm	4618	12	-	-	HYPH
cord-023095-4dannjjm	4618	13	Smirnov	Smirnov	NNP
cord-023095-4dannjjm	4618	14	test	test	NN
cord-023095-4dannjjm	4618	15	.	.	.
cord-023095-4dannjjm	4619	1	T	t	NN
cord-023095-4dannjjm	4619	2	-	-	HYPH
cord-023095-4dannjjm	4619	3	tests	test	NNS
cord-023095-4dannjjm	4619	4	or	or	CC
cord-023095-4dannjjm	4619	5	Welch	Welch	NNP
cord-023095-4dannjjm	4619	6	tests	test	NNS
cord-023095-4dannjjm	4619	7	were	be	VBD
cord-023095-4dannjjm	4619	8	used	use	VBN
cord-023095-4dannjjm	4619	9	to	to	TO
cord-023095-4dannjjm	4619	10	compare	compare	VB
cord-023095-4dannjjm	4619	11	parameters	parameter	NNS
cord-023095-4dannjjm	4619	12	between	between	IN
cord-023095-4dannjjm	4619	13	survivors	survivor	NNS
cord-023095-4dannjjm	4619	14	(	(	-LRB-
cord-023095-4dannjjm	4619	15	S	S	NNP
cord-023095-4dannjjm	4619	16	,	,	,
cord-023095-4dannjjm	4619	17	n	n	NN
cord-023095-4dannjjm	4619	18	5	5	CD
cord-023095-4dannjjm	4619	19	42	42	CD
cord-023095-4dannjjm	4619	20	)	)	-RRB-
cord-023095-4dannjjm	4619	21	and	and	CC
cord-023095-4dannjjm	4619	22	non	non	NNS
cord-023095-4dannjjm	4619	23	-	-	NNS
cord-023095-4dannjjm	4619	24	survivors	survivor	NNS
cord-023095-4dannjjm	4619	25	(	(	-LRB-
cord-023095-4dannjjm	4619	26	NS	NS	NNP
cord-023095-4dannjjm	4619	27	,	,	,
cord-023095-4dannjjm	4619	28	n	n	NN
cord-023095-4dannjjm	4619	29	5	5	CD
cord-023095-4dannjjm	4619	30	9	9	CD
cord-023095-4dannjjm	4619	31	)	)	-RRB-
cord-023095-4dannjjm	4619	32	.	.	.
cord-023095-4dannjjm	4620	1	Of	of	IN
cord-023095-4dannjjm	4620	2	glucose	glucose	NN
cord-023095-4dannjjm	4620	3	,	,	,
cord-023095-4dannjjm	4620	4	BE	be	VB
cord-023095-4dannjjm	4620	5	,	,	,
cord-023095-4dannjjm	4620	6	AG	AG	NNP
cord-023095-4dannjjm	4620	7	,	,	,
cord-023095-4dannjjm	4620	8	pH	ph	NN
cord-023095-4dannjjm	4620	9	,	,	,
cord-023095-4dannjjm	4620	10	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	4620	11	,	,	,
cord-023095-4dannjjm	4620	12	and	and	CC
cord-023095-4dannjjm	4620	13	sodium	sodium	NN
cord-023095-4dannjjm	4620	14	,	,	,
cord-023095-4dannjjm	4620	15	only	only	RB
cord-023095-4dannjjm	4620	16	mean	mean	VBP
cord-023095-4dannjjm	4620	17	glucose	glucose	NN
cord-023095-4dannjjm	4620	18	(	(	-LRB-
cord-023095-4dannjjm	4620	19	S	S	NNP
cord-023095-4dannjjm	4620	20	5	5	CD
cord-023095-4dannjjm	4620	21	131	131	CD
cord-023095-4dannjjm	4620	22	mg	mg	NNP
cord-023095-4dannjjm	4620	23	/	/	SYM
cord-023095-4dannjjm	4620	24	dl	dl	NNP
cord-023095-4dannjjm	4620	25	,	,	,
cord-023095-4dannjjm	4621	1	NS	NS	NNP
cord-023095-4dannjjm	4621	2	5	5	CD
cord-023095-4dannjjm	4622	1	171.4	171.4	CD
cord-023095-4dannjjm	4622	2	mg	mg	NNP
cord-023095-4dannjjm	4622	3	/	/	SYM
cord-023095-4dannjjm	4622	4	dl	dl	NNP
cord-023095-4dannjjm	4622	5	,	,	,
cord-023095-4dannjjm	4622	6	p	p	NN
cord-023095-4dannjjm	4622	7	5	5	CD
cord-023095-4dannjjm	4622	8	0.029	0.029	CD
cord-023095-4dannjjm	4622	9	)	)	-RRB-
cord-023095-4dannjjm	4622	10	was	be	VBD
cord-023095-4dannjjm	4622	11	significantly	significantly	RB
cord-023095-4dannjjm	4622	12	different	different	JJ
cord-023095-4dannjjm	4622	13	between	between	IN
cord-023095-4dannjjm	4622	14	groups	group	NNS
cord-023095-4dannjjm	4622	15	,	,	,
cord-023095-4dannjjm	4622	16	although	although	IN
cord-023095-4dannjjm	4622	17	there	there	EX
cord-023095-4dannjjm	4622	18	was	be	VBD
cord-023095-4dannjjm	4622	19	a	a	DT
cord-023095-4dannjjm	4622	20	trend	trend	NN
cord-023095-4dannjjm	4622	21	for	for	IN
cord-023095-4dannjjm	4622	22	a	a	DT
cord-023095-4dannjjm	4622	23	difference	difference	NN
cord-023095-4dannjjm	4622	24	in	in	IN
cord-023095-4dannjjm	4622	25	mean	mean	JJ
cord-023095-4dannjjm	4622	26	BE	BE	NNP
cord-023095-4dannjjm	4622	27	(	(	-LRB-
cord-023095-4dannjjm	4622	28	S	s	NN
cord-023095-4dannjjm	4622	29	5	5	CD
cord-023095-4dannjjm	4622	30	À3.6	À3.6	NNP
cord-023095-4dannjjm	4622	31	,	,	,
cord-023095-4dannjjm	4622	32	NS	NS	NNP
cord-023095-4dannjjm	4622	33	5	5	CD
cord-023095-4dannjjm	4623	1	À8,5	À8,5	NNP
cord-023095-4dannjjm	4623	2	,	,	,
cord-023095-4dannjjm	4623	3	p	p	NN
cord-023095-4dannjjm	4623	4	5	5	CD
cord-023095-4dannjjm	4623	5	0.055	0.055	CD
cord-023095-4dannjjm	4623	6	)	)	-RRB-
cord-023095-4dannjjm	4623	7	.	.	.
cord-023095-4dannjjm	4624	1	Logistic	logistic	JJ
cord-023095-4dannjjm	4624	2	regression	regression	NN
cord-023095-4dannjjm	4624	3	analysis	analysis	NN
cord-023095-4dannjjm	4624	4	showed	show	VBD
cord-023095-4dannjjm	4624	5	that	that	DT
cord-023095-4dannjjm	4624	6	of	of	IN
cord-023095-4dannjjm	4624	7	the	the	DT
cord-023095-4dannjjm	4624	8	parameters	parameter	NNS
cord-023095-4dannjjm	4624	9	,	,	,
cord-023095-4dannjjm	4624	10	only	only	RB
cord-023095-4dannjjm	4624	11	BE	BE	NNP
cord-023095-4dannjjm	4624	12	was	be	VBD
cord-023095-4dannjjm	4624	13	independently	independently	RB
cord-023095-4dannjjm	4624	14	associated	associate	VBN
cord-023095-4dannjjm	4624	15	with	with	IN
cord-023095-4dannjjm	4624	16	outcome	outcome	NN
cord-023095-4dannjjm	4624	17	(	(	-LRB-
cord-023095-4dannjjm	4624	18	odds	odd	NNS
cord-023095-4dannjjm	4624	19	ratio	ratio	NN
cord-023095-4dannjjm	4624	20	0.79	0.79	CD
cord-023095-4dannjjm	4624	21	,	,	,
cord-023095-4dannjjm	4624	22	95	95	CD
cord-023095-4dannjjm	4624	23	%	%	NN
cord-023095-4dannjjm	4624	24	CI	CI	NNP
cord-023095-4dannjjm	4624	25	5	5	CD
cord-023095-4dannjjm	4624	26	0.63	0.63	CD
cord-023095-4dannjjm	4624	27	-	-	HYPH
cord-023095-4dannjjm	4624	28	0.98	0.98	CD
cord-023095-4dannjjm	4624	29	,	,	,
cord-023095-4dannjjm	4624	30	p	p	NN
cord-023095-4dannjjm	4624	31	5	5	CD
cord-023095-4dannjjm	4624	32	0.036	0.036	CD
cord-023095-4dannjjm	4624	33	)	)	-RRB-
cord-023095-4dannjjm	4624	34	.	.	.
cord-023095-4dannjjm	4625	1	These	these	DT
cord-023095-4dannjjm	4625	2	results	result	NNS
cord-023095-4dannjjm	4625	3	suggest	suggest	VBP
cord-023095-4dannjjm	4625	4	that	that	IN
cord-023095-4dannjjm	4625	5	two	two	CD
cord-023095-4dannjjm	4625	6	easily	easily	RB
cord-023095-4dannjjm	4625	7	measured	measure	VBD
cord-023095-4dannjjm	4625	8	biochemical	biochemical	JJ
cord-023095-4dannjjm	4625	9	parameters	parameter	NNS
cord-023095-4dannjjm	4625	10	(	(	-LRB-
cord-023095-4dannjjm	4625	11	glucose	glucose	NN
cord-023095-4dannjjm	4625	12	and	and	CC
cord-023095-4dannjjm	4625	13	BE	be	VB
cord-023095-4dannjjm	4625	14	)	)	-RRB-
cord-023095-4dannjjm	4625	15	may	may	MD
cord-023095-4dannjjm	4625	16	yield	yield	VB
cord-023095-4dannjjm	4625	17	useful	useful	JJ
cord-023095-4dannjjm	4625	18	prognostic	prognostic	JJ
cord-023095-4dannjjm	4625	19	information	information	NN
cord-023095-4dannjjm	4625	20	in	in	IN
cord-023095-4dannjjm	4625	21	dogs	dog	NNS
cord-023095-4dannjjm	4625	22	with	with	IN
cord-023095-4dannjjm	4625	23	head	head	NN
cord-023095-4dannjjm	4625	24	trauma	trauma	NN
cord-023095-4dannjjm	4625	25	,	,	,
cord-023095-4dannjjm	4625	26	but	but	CC
cord-023095-4dannjjm	4625	27	further	further	JJ
cord-023095-4dannjjm	4625	28	studies	study	NNS
cord-023095-4dannjjm	4625	29	are	be	VBP
cord-023095-4dannjjm	4625	30	needed	need	VBN
cord-023095-4dannjjm	4625	31	to	to	TO
cord-023095-4dannjjm	4625	32	further	further	RB
cord-023095-4dannjjm	4625	33	elucidate	elucidate	VB
cord-023095-4dannjjm	4625	34	these	these	DT
cord-023095-4dannjjm	4625	35	findings	finding	NNS
cord-023095-4dannjjm	4625	36	.	.	.
cord-023095-4dannjjm	4626	1	Type	type	NN
cord-023095-4dannjjm	4626	2	I	-PRON-	PRP
cord-023095-4dannjjm	4626	3	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4626	4	disc	disc	NN
cord-023095-4dannjjm	4626	5	disease	disease	NN
cord-023095-4dannjjm	4626	6	(	(	-LRB-
cord-023095-4dannjjm	4626	7	IVDD	IVDD	NNP
cord-023095-4dannjjm	4626	8	)	)	-RRB-
cord-023095-4dannjjm	4626	9	commonly	commonly	RB
cord-023095-4dannjjm	4626	10	affects	affect	VBZ
cord-023095-4dannjjm	4626	11	chondrodystrophic	chondrodystrophic	JJ
cord-023095-4dannjjm	4626	12	dogs	dog	NNS
cord-023095-4dannjjm	4626	13	.	.	.
cord-023095-4dannjjm	4627	1	Neurological	neurological	JJ
cord-023095-4dannjjm	4627	2	recovery	recovery	NN
cord-023095-4dannjjm	4627	3	and	and	CC
cord-023095-4dannjjm	4627	4	outcome	outcome	NN
cord-023095-4dannjjm	4627	5	following	follow	VBG
cord-023095-4dannjjm	4627	6	surgical	surgical	JJ
cord-023095-4dannjjm	4627	7	decompression	decompression	NN
cord-023095-4dannjjm	4627	8	may	may	MD
cord-023095-4dannjjm	4627	9	be	be	VB
cord-023095-4dannjjm	4627	10	unpredictable	unpredictable	JJ
cord-023095-4dannjjm	4627	11	due	due	IN
cord-023095-4dannjjm	4627	12	to	to	IN
cord-023095-4dannjjm	4627	13	suspected	suspect	VBN
cord-023095-4dannjjm	4627	14	ischemic	ischemic	JJ
cord-023095-4dannjjm	4627	15	neuronal	neuronal	JJ
cord-023095-4dannjjm	4627	16	injury	injury	NN
cord-023095-4dannjjm	4627	17	.	.	.
cord-023095-4dannjjm	4628	1	Hyperlactatemia	Hyperlactatemia	NNP
cord-023095-4dannjjm	4628	2	has	have	VBZ
cord-023095-4dannjjm	4628	3	been	be	VBN
cord-023095-4dannjjm	4628	4	associated	associate	VBN
cord-023095-4dannjjm	4628	5	with	with	IN
cord-023095-4dannjjm	4628	6	spinal	spinal	JJ
cord-023095-4dannjjm	4628	7	cord	cord	NN
cord-023095-4dannjjm	4628	8	injury	injury	NN
cord-023095-4dannjjm	4628	9	in	in	IN
cord-023095-4dannjjm	4628	10	humans	human	NNS
cord-023095-4dannjjm	4628	11	and	and	CC
cord-023095-4dannjjm	4628	12	experimental	experimental	JJ
cord-023095-4dannjjm	4628	13	animals	animal	NNS
cord-023095-4dannjjm	4628	14	.	.	.
cord-023095-4dannjjm	4629	1	The	the	DT
cord-023095-4dannjjm	4629	2	purpose	purpose	NN
cord-023095-4dannjjm	4629	3	of	of	IN
cord-023095-4dannjjm	4629	4	the	the	DT
cord-023095-4dannjjm	4629	5	study	study	NN
cord-023095-4dannjjm	4629	6	was	be	VBD
cord-023095-4dannjjm	4629	7	1	1	CD
cord-023095-4dannjjm	4629	8	)	)	-RRB-
cord-023095-4dannjjm	4629	9	to	to	TO
cord-023095-4dannjjm	4629	10	determine	determine	VB
cord-023095-4dannjjm	4629	11	the	the	DT
cord-023095-4dannjjm	4629	12	relationship	relationship	NN
cord-023095-4dannjjm	4629	13	between	between	IN
cord-023095-4dannjjm	4629	14	serum	serum	NN
cord-023095-4dannjjm	4629	15	and	and	CC
cord-023095-4dannjjm	4629	16	CSF	csf	NN
cord-023095-4dannjjm	4629	17	lactate	lactate	NN
cord-023095-4dannjjm	4629	18	levels	level	NNS
cord-023095-4dannjjm	4629	19	and	and	CC
cord-023095-4dannjjm	4629	20	2	2	CD
cord-023095-4dannjjm	4629	21	)	)	-RRB-
cord-023095-4dannjjm	4629	22	to	to	TO
cord-023095-4dannjjm	4629	23	compare	compare	VB
cord-023095-4dannjjm	4629	24	lactate	lactate	NN
cord-023095-4dannjjm	4629	25	levels	level	NNS
cord-023095-4dannjjm	4629	26	with	with	IN
cord-023095-4dannjjm	4629	27	neurological	neurological	JJ
cord-023095-4dannjjm	4629	28	outcome	outcome	NN
cord-023095-4dannjjm	4629	29	following	follow	VBG
cord-023095-4dannjjm	4629	30	decompressive	decompressive	JJ
cord-023095-4dannjjm	4629	31	surgery	surgery	NN
cord-023095-4dannjjm	4629	32	in	in	IN
cord-023095-4dannjjm	4629	33	dogs	dog	NNS
cord-023095-4dannjjm	4629	34	with	with	IN
cord-023095-4dannjjm	4629	35	IVDD	IVDD	NNP
cord-023095-4dannjjm	4629	36	.	.	.
cord-023095-4dannjjm	4630	1	Healthy	healthy	JJ
cord-023095-4dannjjm	4630	2	,	,	,
cord-023095-4dannjjm	4630	3	chondrodystrophic	chondrodystrophic	JJ
cord-023095-4dannjjm	4630	4	dogs	dog	NNS
cord-023095-4dannjjm	4630	5	diagnosed	diagnose	VBN
cord-023095-4dannjjm	4630	6	with	with	IN
cord-023095-4dannjjm	4630	7	IVDD	IVDD	NNP
cord-023095-4dannjjm	4630	8	localized	localize	VBN
cord-023095-4dannjjm	4630	9	to	to	IN
cord-023095-4dannjjm	4630	10	the	the	DT
cord-023095-4dannjjm	4630	11	T3-L3	T3-L3	NNP
cord-023095-4dannjjm	4630	12	spinal	spinal	JJ
cord-023095-4dannjjm	4630	13	cord	cord	NN
cord-023095-4dannjjm	4630	14	were	be	VBD
cord-023095-4dannjjm	4630	15	included	include	VBN
cord-023095-4dannjjm	4630	16	.	.	.
cord-023095-4dannjjm	4631	1	Serum	serum	NN
cord-023095-4dannjjm	4631	2	lactate	lactate	NN
cord-023095-4dannjjm	4631	3	levels	level	NNS
cord-023095-4dannjjm	4631	4	were	be	VBD
cord-023095-4dannjjm	4631	5	obtained	obtain	VBN
cord-023095-4dannjjm	4631	6	at	at	IN
cord-023095-4dannjjm	4631	7	:	:	:
cord-023095-4dannjjm	4631	8	anaesthetic	anaesthetic	JJ
cord-023095-4dannjjm	4631	9	induction	induction	NN
cord-023095-4dannjjm	4631	10	,	,	,
cord-023095-4dannjjm	4631	11	skin	skin	NN
cord-023095-4dannjjm	4631	12	incision	incision	NN
cord-023095-4dannjjm	4631	13	,	,	,
cord-023095-4dannjjm	4631	14	muscle	muscle	NN
cord-023095-4dannjjm	4631	15	dissection	dissection	NN
cord-023095-4dannjjm	4631	16	,	,	,
cord-023095-4dannjjm	4631	17	and	and	CC
cord-023095-4dannjjm	4631	18	extubation	extubation	NN
cord-023095-4dannjjm	4631	19	.	.	.
cord-023095-4dannjjm	4632	1	In	in	IN
cord-023095-4dannjjm	4632	2	patients	patient	NNS
cord-023095-4dannjjm	4632	3	with	with	IN
cord-023095-4dannjjm	4632	4	hyperlacatemia	hyperlacatemia	NN
cord-023095-4dannjjm	4632	5	at	at	IN
cord-023095-4dannjjm	4632	6	extubation	extubation	NN
cord-023095-4dannjjm	4632	7	,	,	,
cord-023095-4dannjjm	4632	8	additional	additional	JJ
cord-023095-4dannjjm	4632	9	samples	sample	NNS
cord-023095-4dannjjm	4632	10	were	be	VBD
cord-023095-4dannjjm	4632	11	obtained	obtain	VBN
cord-023095-4dannjjm	4632	12	.	.	.
cord-023095-4dannjjm	4633	1	CSF	CSF	NNP
cord-023095-4dannjjm	4633	2	was	be	VBD
cord-023095-4dannjjm	4633	3	analyzed	analyze	VBN
cord-023095-4dannjjm	4633	4	for	for	IN
cord-023095-4dannjjm	4633	5	lactate	lactate	NN
cord-023095-4dannjjm	4633	6	concentration	concentration	NN
cord-023095-4dannjjm	4633	7	.	.	.
cord-023095-4dannjjm	4634	1	Neurological	neurological	JJ
cord-023095-4dannjjm	4634	2	status	status	NN
cord-023095-4dannjjm	4634	3	was	be	VBD
cord-023095-4dannjjm	4634	4	recorded	record	VBN
cord-023095-4dannjjm	4634	5	at	at	IN
cord-023095-4dannjjm	4634	6	presentation	presentation	NN
cord-023095-4dannjjm	4634	7	and	and	CC
cord-023095-4dannjjm	4634	8	multiple	multiple	JJ
cord-023095-4dannjjm	4634	9	times	time	NNS
cord-023095-4dannjjm	4634	10	during	during	IN
cord-023095-4dannjjm	4634	11	the	the	DT
cord-023095-4dannjjm	4634	12	recovery	recovery	NN
cord-023095-4dannjjm	4634	13	period	period	NN
cord-023095-4dannjjm	4634	14	.	.	.
cord-023095-4dannjjm	4635	1	31	31	CD
cord-023095-4dannjjm	4635	2	dogs	dog	NNS
cord-023095-4dannjjm	4635	3	were	be	VBD
cord-023095-4dannjjm	4635	4	included	include	VBN
cord-023095-4dannjjm	4635	5	in	in	IN
cord-023095-4dannjjm	4635	6	the	the	DT
cord-023095-4dannjjm	4635	7	study	study	NN
cord-023095-4dannjjm	4635	8	(	(	-LRB-
cord-023095-4dannjjm	4635	9	3	3	CD
cord-023095-4dannjjm	4635	10	-	-	SYM
cord-023095-4dannjjm	4635	11	12	12	CD
cord-023095-4dannjjm	4635	12	years	year	NNS
cord-023095-4dannjjm	4635	13	old	old	JJ
cord-023095-4dannjjm	4635	14	)	)	-RRB-
cord-023095-4dannjjm	4635	15	.	.	.
cord-023095-4dannjjm	4636	1	22/31	22/31	CD
cord-023095-4dannjjm	4636	2	dogs	dog	NNS
cord-023095-4dannjjm	4636	3	had	have	VBD
cord-023095-4dannjjm	4636	4	normal	normal	JJ
cord-023095-4dannjjm	4636	5	lactate	lactate	NN
cord-023095-4dannjjm	4636	6	levels	level	NNS
cord-023095-4dannjjm	4636	7	throughout	throughout	IN
cord-023095-4dannjjm	4636	8	the	the	DT
cord-023095-4dannjjm	4636	9	study	study	NN
cord-023095-4dannjjm	4636	10	.	.	.
cord-023095-4dannjjm	4637	1	9/31	9/31	CD
cord-023095-4dannjjm	4637	2	dogs	dog	NNS
cord-023095-4dannjjm	4637	3	had	have	VBD
cord-023095-4dannjjm	4637	4	serum	serum	NN
cord-023095-4dannjjm	4637	5	hyperlactatemia	hyperlactatemia	NN
cord-023095-4dannjjm	4637	6	prior	prior	RB
cord-023095-4dannjjm	4637	7	to	to	IN
cord-023095-4dannjjm	4637	8	anaesthetic	anaesthetic	JJ
cord-023095-4dannjjm	4637	9	induction	induction	NN
cord-023095-4dannjjm	4637	10	;	;	:
cord-023095-4dannjjm	4637	11	6/9	6/9	CD
cord-023095-4dannjjm	4637	12	dogs	dog	NNS
cord-023095-4dannjjm	4637	13	returned	return	VBD
cord-023095-4dannjjm	4637	14	to	to	IN
cord-023095-4dannjjm	4637	15	normal	normal	JJ
cord-023095-4dannjjm	4637	16	during	during	IN
cord-023095-4dannjjm	4637	17	anaesthesia	anaesthesia	NN
cord-023095-4dannjjm	4637	18	and	and	CC
cord-023095-4dannjjm	4637	19	3/9	3/9	CD
cord-023095-4dannjjm	4637	20	dogs	dog	NNS
cord-023095-4dannjjm	4637	21	had	have	VBD
cord-023095-4dannjjm	4637	22	continued	continue	VBN
cord-023095-4dannjjm	4637	23	hyperlactatemia	hyperlactatemia	NN
cord-023095-4dannjjm	4637	24	until	until	IN
cord-023095-4dannjjm	4637	25	the	the	DT
cord-023095-4dannjjm	4637	26	end	end	NN
cord-023095-4dannjjm	4637	27	of	of	IN
cord-023095-4dannjjm	4637	28	the	the	DT
cord-023095-4dannjjm	4637	29	observation	observation	NN
cord-023095-4dannjjm	4637	30	period	period	NN
cord-023095-4dannjjm	4637	31	.	.	.
cord-023095-4dannjjm	4638	1	Neurological	neurological	JJ
cord-023095-4dannjjm	4638	2	status	status	NN
cord-023095-4dannjjm	4638	3	of	of	IN
cord-023095-4dannjjm	4638	4	the	the	DT
cord-023095-4dannjjm	4638	5	dogs	dog	NNS
cord-023095-4dannjjm	4638	6	varied	vary	VBN
cord-023095-4dannjjm	4638	7	similarly	similarly	RB
cord-023095-4dannjjm	4638	8	between	between	IN
cord-023095-4dannjjm	4638	9	all	all	DT
cord-023095-4dannjjm	4638	10	groups	group	NNS
cord-023095-4dannjjm	4638	11	.	.	.
cord-023095-4dannjjm	4639	1	In	in	IN
cord-023095-4dannjjm	4639	2	12/14	12/14	CD
cord-023095-4dannjjm	4639	3	dogs	dog	NNS
cord-023095-4dannjjm	4639	4	where	where	WRB
cord-023095-4dannjjm	4639	5	CSF	csf	NN
cord-023095-4dannjjm	4639	6	lactate	lactate	NN
cord-023095-4dannjjm	4639	7	levels	level	NNS
cord-023095-4dannjjm	4639	8	were	be	VBD
cord-023095-4dannjjm	4639	9	measured	measure	VBN
cord-023095-4dannjjm	4639	10	,	,	,
cord-023095-4dannjjm	4639	11	initial	initial	JJ
cord-023095-4dannjjm	4639	12	serum	serum	NN
cord-023095-4dannjjm	4639	13	levels	level	NNS
cord-023095-4dannjjm	4639	14	were	be	VBD
cord-023095-4dannjjm	4639	15	lower	low	JJR
cord-023095-4dannjjm	4639	16	than	than	IN
cord-023095-4dannjjm	4639	17	CSF	csf	NN
cord-023095-4dannjjm	4639	18	lactate	lactate	NN
cord-023095-4dannjjm	4639	19	levels	level	NNS
cord-023095-4dannjjm	4639	20	;	;	:
cord-023095-4dannjjm	4639	21	in	in	IN
cord-023095-4dannjjm	4639	22	5/14	5/14	CD
cord-023095-4dannjjm	4639	23	dogs	dog	NNS
cord-023095-4dannjjm	4639	24	where	where	WRB
cord-023095-4dannjjm	4639	25	CSF	CSF	NNP
cord-023095-4dannjjm	4639	26	and	and	CC
cord-023095-4dannjjm	4639	27	serum	serum	NN
cord-023095-4dannjjm	4639	28	were	be	VBD
cord-023095-4dannjjm	4639	29	collected	collect	VBN
cord-023095-4dannjjm	4639	30	simultaneously	simultaneously	RB
cord-023095-4dannjjm	4639	31	,	,	,
cord-023095-4dannjjm	4639	32	serum	serum	NN
cord-023095-4dannjjm	4639	33	lactate	lactate	NN
cord-023095-4dannjjm	4639	34	concentration	concentration	NN
cord-023095-4dannjjm	4639	35	was	be	VBD
cord-023095-4dannjjm	4639	36	consistently	consistently	RB
cord-023095-4dannjjm	4639	37	lower	low	JJR
cord-023095-4dannjjm	4639	38	than	than	IN
cord-023095-4dannjjm	4639	39	CSF	CSF	NNP
cord-023095-4dannjjm	4639	40	lactate	lactate	NN
cord-023095-4dannjjm	4639	41	.	.	.
cord-023095-4dannjjm	4640	1	No	no	DT
cord-023095-4dannjjm	4640	2	association	association	NN
cord-023095-4dannjjm	4640	3	between	between	IN
cord-023095-4dannjjm	4640	4	presenting	present	VBG
cord-023095-4dannjjm	4640	5	neurological	neurological	JJ
cord-023095-4dannjjm	4640	6	status	status	NN
cord-023095-4dannjjm	4640	7	or	or	CC
cord-023095-4dannjjm	4640	8	neurological	neurological	JJ
cord-023095-4dannjjm	4640	9	outcome	outcome	NN
cord-023095-4dannjjm	4640	10	and	and	CC
cord-023095-4dannjjm	4640	11	serum	serum	NN
cord-023095-4dannjjm	4640	12	or	or	CC
cord-023095-4dannjjm	4640	13	CSF	CSF	NNP
cord-023095-4dannjjm	4640	14	lactate	lactate	NN
cord-023095-4dannjjm	4640	15	concentration	concentration	NN
cord-023095-4dannjjm	4640	16	was	be	VBD
cord-023095-4dannjjm	4640	17	made	make	VBN
cord-023095-4dannjjm	4640	18	.	.	.
cord-023095-4dannjjm	4641	1	Neither	neither	DT
cord-023095-4dannjjm	4641	2	serum	serum	NN
cord-023095-4dannjjm	4641	3	nor	nor	CC
cord-023095-4dannjjm	4641	4	CSF	csf	NN
cord-023095-4dannjjm	4641	5	lactate	lactate	NN
cord-023095-4dannjjm	4641	6	concentration	concentration	NN
cord-023095-4dannjjm	4641	7	is	be	VBZ
cord-023095-4dannjjm	4641	8	useful	useful	JJ
cord-023095-4dannjjm	4641	9	for	for	IN
cord-023095-4dannjjm	4641	10	predicting	predict	VBG
cord-023095-4dannjjm	4641	11	neurological	neurological	JJ
cord-023095-4dannjjm	4641	12	outcome	outcome	NN
cord-023095-4dannjjm	4641	13	in	in	IN
cord-023095-4dannjjm	4641	14	dogs	dog	NNS
cord-023095-4dannjjm	4641	15	with	with	IN
cord-023095-4dannjjm	4641	16	IVDD	IVDD	NNP
cord-023095-4dannjjm	4641	17	.	.	.
cord-023095-4dannjjm	4642	1	Chiari	Chiari	NNP
cord-023095-4dannjjm	4642	2	-	-	HYPH
cord-023095-4dannjjm	4642	3	like	like	JJ
cord-023095-4dannjjm	4642	4	Malformation	Malformation	NNP
cord-023095-4dannjjm	4642	5	(	(	-LRB-
cord-023095-4dannjjm	4642	6	CM	CM	NNP
cord-023095-4dannjjm	4642	7	)	)	-RRB-
cord-023095-4dannjjm	4642	8	has	have	VBZ
cord-023095-4dannjjm	4642	9	been	be	VBN
cord-023095-4dannjjm	4642	10	associated	associate	VBN
cord-023095-4dannjjm	4642	11	with	with	IN
cord-023095-4dannjjm	4642	12	syringomyelia	syringomyelia	NN
cord-023095-4dannjjm	4642	13	(	(	-LRB-
cord-023095-4dannjjm	4642	14	SM	SM	NNP
cord-023095-4dannjjm	4642	15	)	)	-RRB-
cord-023095-4dannjjm	4642	16	in	in	IN
cord-023095-4dannjjm	4642	17	Cavalier	Cavalier	NNP
cord-023095-4dannjjm	4642	18	King	King	NNP
cord-023095-4dannjjm	4642	19	Charles	Charles	NNP
cord-023095-4dannjjm	4642	20	Spaniel	Spaniel	NNP
cord-023095-4dannjjm	4642	21	(	(	-LRB-
cord-023095-4dannjjm	4642	22	CKCS	CKCS	NNP
cord-023095-4dannjjm	4642	23	)	)	-RRB-
cord-023095-4dannjjm	4642	24	and	and	CC
cord-023095-4dannjjm	4642	25	is	be	VBZ
cord-023095-4dannjjm	4642	26	postulated	postulate	VBN
cord-023095-4dannjjm	4642	27	to	to	TO
cord-023095-4dannjjm	4642	28	result	result	VB
cord-023095-4dannjjm	4642	29	from	from	IN
cord-023095-4dannjjm	4642	30	a	a	DT
cord-023095-4dannjjm	4642	31	mismatch	mismatch	NN
cord-023095-4dannjjm	4642	32	between	between	IN
cord-023095-4dannjjm	4642	33	the	the	DT
cord-023095-4dannjjm	4642	34	volume	volume	NN
cord-023095-4dannjjm	4642	35	of	of	IN
cord-023095-4dannjjm	4642	36	the	the	DT
cord-023095-4dannjjm	4642	37	caudal	caudal	JJ
cord-023095-4dannjjm	4642	38	cranial	cranial	JJ
cord-023095-4dannjjm	4642	39	fossa	fossa	NN
cord-023095-4dannjjm	4642	40	and	and	CC
cord-023095-4dannjjm	4642	41	the	the	DT
cord-023095-4dannjjm	4642	42	brain	brain	NN
cord-023095-4dannjjm	4642	43	parenchyma	parenchyma	NNS
cord-023095-4dannjjm	4642	44	contained	contain	VBN
cord-023095-4dannjjm	4642	45	within	within	IN
cord-023095-4dannjjm	4642	46	.	.	.
cord-023095-4dannjjm	4643	1	The	the	DT
cord-023095-4dannjjm	4643	2	objective	objective	NN
cord-023095-4dannjjm	4643	3	of	of	IN
cord-023095-4dannjjm	4643	4	this	this	DT
cord-023095-4dannjjm	4643	5	study	study	NN
cord-023095-4dannjjm	4643	6	was	be	VBD
cord-023095-4dannjjm	4643	7	to	to	TO
cord-023095-4dannjjm	4643	8	assess	assess	VB
cord-023095-4dannjjm	4643	9	the	the	DT
cord-023095-4dannjjm	4643	10	role	role	NN
cord-023095-4dannjjm	4643	11	of	of	IN
cord-023095-4dannjjm	4643	12	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4643	13	volume	volume	NN
cord-023095-4dannjjm	4643	14	in	in	IN
cord-023095-4dannjjm	4643	15	caudal	caudal	JJ
cord-023095-4dannjjm	4643	16	cranial	cranial	JJ
cord-023095-4dannjjm	4643	17	fossa	fossa	NN
cord-023095-4dannjjm	4643	18	overcrowding	overcrowding	NN
cord-023095-4dannjjm	4643	19	and	and	CC
cord-023095-4dannjjm	4643	20	syringomyelia	syringomyelia	NN
cord-023095-4dannjjm	4643	21	.	.	.
cord-023095-4dannjjm	4644	1	Three	three	CD
cord-023095-4dannjjm	4644	2	dimensional	dimensional	JJ
cord-023095-4dannjjm	4644	3	models	model	NNS
cord-023095-4dannjjm	4644	4	were	be	VBD
cord-023095-4dannjjm	4644	5	created	create	VBN
cord-023095-4dannjjm	4644	6	using	use	VBG
cord-023095-4dannjjm	4644	7	T2-weighted	t2-weighte	VBN
cord-023095-4dannjjm	4644	8	transverse	transverse	JJ
cord-023095-4dannjjm	4644	9	magnetic	magnetic	JJ
cord-023095-4dannjjm	4644	10	resonance	resonance	NN
cord-023095-4dannjjm	4644	11	images	image	NNS
cord-023095-4dannjjm	4644	12	in	in	IN
cord-023095-4dannjjm	4644	13	the	the	DT
cord-023095-4dannjjm	4644	14	commercial	commercial	JJ
cord-023095-4dannjjm	4644	15	software	software	NN
cord-023095-4dannjjm	4644	16	package	package	NN
cord-023095-4dannjjm	4644	17	Mimics	mimic	VBZ
cord-023095-4dannjjm	4644	18	s	s	NNP
cord-023095-4dannjjm	4644	19	.	.	.
cord-023095-4dannjjm	4645	1	Volumes	volume	NNS
cord-023095-4dannjjm	4645	2	of	of	IN
cord-023095-4dannjjm	4645	3	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4645	4	parenchyma	parenchyma	NNS
cord-023095-4dannjjm	4645	5	were	be	VBD
cord-023095-4dannjjm	4645	6	analyzed	analyze	VBN
cord-023095-4dannjjm	4645	7	as	as	IN
cord-023095-4dannjjm	4645	8	percentages	percentage	NNS
cord-023095-4dannjjm	4645	9	of	of	IN
cord-023095-4dannjjm	4645	10	caudal	caudal	JJ
cord-023095-4dannjjm	4645	11	cranial	cranial	JJ
cord-023095-4dannjjm	4645	12	fossa	fossa	NN
cord-023095-4dannjjm	4645	13	volume	volume	NN
cord-023095-4dannjjm	4645	14	(	(	-LRB-
cord-023095-4dannjjm	4645	15	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4645	16	caudal	caudal	JJ
cord-023095-4dannjjm	4645	17	cranial	cranial	JJ
cord-023095-4dannjjm	4645	18	fossa	fossa	NN
cord-023095-4dannjjm	4645	19	percentage	percentage	NN
cord-023095-4dannjjm	4645	20	)	)	-RRB-
cord-023095-4dannjjm	4645	21	and	and	CC
cord-023095-4dannjjm	4645	22	total	total	JJ
cord-023095-4dannjjm	4645	23	brain	brain	NN
cord-023095-4dannjjm	4645	24	parenchyma	parenchyma	NN
cord-023095-4dannjjm	4645	25	volume	volume	NN
cord-023095-4dannjjm	4645	26	(	(	-LRB-
cord-023095-4dannjjm	4645	27	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4645	28	brain	brain	NN
cord-023095-4dannjjm	4645	29	percentage	percentage	NN
cord-023095-4dannjjm	4645	30	)	)	-RRB-
cord-023095-4dannjjm	4645	31	.	.	.
cord-023095-4dannjjm	4646	1	Data	datum	NNS
cord-023095-4dannjjm	4646	2	was	be	VBD
cord-023095-4dannjjm	4646	3	assessed	assess	VBN
cord-023095-4dannjjm	4646	4	for	for	IN
cord-023095-4dannjjm	4646	5	normality	normality	NN
cord-023095-4dannjjm	4646	6	and	and	CC
cord-023095-4dannjjm	4646	7	the	the	DT
cord-023095-4dannjjm	4646	8	appropriate	appropriate	JJ
cord-023095-4dannjjm	4646	9	statistical	statistical	JJ
cord-023095-4dannjjm	4646	10	test	test	NN
cord-023095-4dannjjm	4646	11	was	be	VBD
cord-023095-4dannjjm	4646	12	used	use	VBN
cord-023095-4dannjjm	4646	13	to	to	TO
cord-023095-4dannjjm	4646	14	compare	compare	VB
cord-023095-4dannjjm	4646	15	means	mean	NNS
cord-023095-4dannjjm	4646	16	/	/	SYM
cord-023095-4dannjjm	4646	17	medians	median	NNS
cord-023095-4dannjjm	4646	18	between	between	IN
cord-023095-4dannjjm	4646	19	groups	group	NNS
cord-023095-4dannjjm	4646	20	.	.	.
cord-023095-4dannjjm	4647	1	Forty	forty	CD
cord-023095-4dannjjm	4647	2	-	-	HYPH
cord-023095-4dannjjm	4647	3	five	five	CD
cord-023095-4dannjjm	4647	4	small	small	JJ
cord-023095-4dannjjm	4647	5	breed	breed	NN
cord-023095-4dannjjm	4647	6	dogs	dog	NNS
cord-023095-4dannjjm	4647	7	(	(	-LRB-
cord-023095-4dannjjm	4647	8	SB	SB	NNP
cord-023095-4dannjjm	4647	9	)	)	-RRB-
cord-023095-4dannjjm	4647	10	,	,	,
cord-023095-4dannjjm	4647	11	58	58	CD
cord-023095-4dannjjm	4647	12	CKCS	CKCS	NNP
cord-023095-4dannjjm	4647	13	and	and	CC
cord-023095-4dannjjm	4647	14	31	31	CD
cord-023095-4dannjjm	4647	15	Labradors	labrador	NNS
cord-023095-4dannjjm	4647	16	(	(	-LRB-
cord-023095-4dannjjm	4647	17	LD	LD	NNP
cord-023095-4dannjjm	4647	18	)	)	-RRB-
cord-023095-4dannjjm	4647	19	were	be	VBD
cord-023095-4dannjjm	4647	20	compared	compare	VBN
cord-023095-4dannjjm	4647	21	.	.	.
cord-023095-4dannjjm	4648	1	As	as	IN
cord-023095-4dannjjm	4648	2	SM	SM	NNP
cord-023095-4dannjjm	4648	3	is	be	VBZ
cord-023095-4dannjjm	4648	4	thought	think	VBN
cord-023095-4dannjjm	4648	5	to	to	TO
cord-023095-4dannjjm	4648	6	be	be	VB
cord-023095-4dannjjm	4648	7	a	a	DT
cord-023095-4dannjjm	4648	8	late	late	JJ
cord-023095-4dannjjm	4648	9	onset	onset	NN
cord-023095-4dannjjm	4648	10	disease	disease	NN
cord-023095-4dannjjm	4648	11	process	process	NN
cord-023095-4dannjjm	4648	12	,	,	,
cord-023095-4dannjjm	4648	13	two	two	CD
cord-023095-4dannjjm	4648	14	subgroups	subgroup	NNS
cord-023095-4dannjjm	4648	15	were	be	VBD
cord-023095-4dannjjm	4648	16	formed	form	VBN
cord-023095-4dannjjm	4648	17	for	for	IN
cord-023095-4dannjjm	4648	18	comparison	comparison	NN
cord-023095-4dannjjm	4648	19	:	:	:
cord-023095-4dannjjm	4649	1	21	21	CD
cord-023095-4dannjjm	4649	2	CKCS	CKCS	NNP
cord-023095-4dannjjm	4649	3	younger	young	JJR
cord-023095-4dannjjm	4649	4	than	than	IN
cord-023095-4dannjjm	4649	5	2	2	CD
cord-023095-4dannjjm	4649	6	years	year	NNS
cord-023095-4dannjjm	4649	7	with	with	IN
cord-023095-4dannjjm	4649	8	SM	SM	NNP
cord-023095-4dannjjm	4649	9	(	(	-LRB-
cord-023095-4dannjjm	4649	10	group	group	NN
cord-023095-4dannjjm	4649	11	1	1	CD
cord-023095-4dannjjm	4649	12	)	)	-RRB-
cord-023095-4dannjjm	4649	13	and	and	CC
cord-023095-4dannjjm	4650	1	13	13	CD
cord-023095-4dannjjm	4650	2	CKCS	CKCS	NNP
cord-023095-4dannjjm	4650	3	older	old	JJR
cord-023095-4dannjjm	4650	4	than	than	IN
cord-023095-4dannjjm	4650	5	5	5	CD
cord-023095-4dannjjm	4650	6	years	year	NNS
cord-023095-4dannjjm	4650	7	without	without	IN
cord-023095-4dannjjm	4650	8	SM	SM	NNP
cord-023095-4dannjjm	4650	9	(	(	-LRB-
cord-023095-4dannjjm	4650	10	group	group	NN
cord-023095-4dannjjm	4650	11	2	2	CD
cord-023095-4dannjjm	4650	12	)	)	-RRB-
cord-023095-4dannjjm	4650	13	.	.	.
cord-023095-4dannjjm	4651	1	CKCS	CKCS	NNP
cord-023095-4dannjjm	4651	2	had	have	VBD
cord-023095-4dannjjm	4651	3	a	a	DT
cord-023095-4dannjjm	4651	4	larger	large	JJR
cord-023095-4dannjjm	4651	5	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4651	6	caudal	caudal	JJ
cord-023095-4dannjjm	4651	7	cranial	cranial	JJ
cord-023095-4dannjjm	4651	8	fossa	fossa	NN
cord-023095-4dannjjm	4651	9	percentage	percentage	NN
cord-023095-4dannjjm	4651	10	than	than	IN
cord-023095-4dannjjm	4651	11	the	the	DT
cord-023095-4dannjjm	4651	12	other	other	JJ
cord-023095-4dannjjm	4651	13	groups	group	NNS
cord-023095-4dannjjm	4651	14	.76	.76	CD
cord-023095-4dannjjm	4651	15	%	%	NN
cord-023095-4dannjjm	4651	16	]	]	-RRB-
cord-023095-4dannjjm	4651	17	vs.	vs.	FW
cord-023095-4dannjjm	4651	18	SB	SB	NNP
cord-023095-4dannjjm	4651	19	47.81	47.81	CD
cord-023095-4dannjjm	4651	20	%	%	NN
cord-023095-4dannjjm	4651	21	[	[	-LRB-
cord-023095-4dannjjm	4651	22	40.36	40.36	CD
cord-023095-4dannjjm	4651	23	-	-	SYM
cord-023095-4dannjjm	4651	24	62.91	62.91	CD
cord-023095-4dannjjm	4651	25	%	%	NN
cord-023095-4dannjjm	4651	26	]	]	-RRB-
cord-023095-4dannjjm	4651	27	and	and	CC
cord-023095-4dannjjm	4651	28	LD	LD	NNP
cord-023095-4dannjjm	4651	29	41.32	41.32	CD
cord-023095-4dannjjm	4651	30	%	%	NN
cord-023095-4dannjjm	4651	31	[	[	-LRB-
cord-023095-4dannjjm	4651	32	32.59	32.59	CD
cord-023095-4dannjjm	4651	33	-	-	SYM
cord-023095-4dannjjm	4651	34	52.95	52.95	CD
cord-023095-4dannjjm	4651	35	%	%	NN
cord-023095-4dannjjm	4651	36	]	]	-RRB-
cord-023095-4dannjjm	4651	37	;	;	:
cord-023095-4dannjjm	4651	38	p	p	NN
cord-023095-4dannjjm	4651	39	o	o	CD
cord-023095-4dannjjm	4651	40	0.001	0.001	CD
cord-023095-4dannjjm	4651	41	)	)	-RRB-
cord-023095-4dannjjm	4651	42	.	.	.
cord-023095-4dannjjm	4652	1	The	the	DT
cord-023095-4dannjjm	4652	2	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4652	3	brain	brain	NN
cord-023095-4dannjjm	4652	4	percentage	percentage	NN
cord-023095-4dannjjm	4652	5	was	be	VBD
cord-023095-4dannjjm	4652	6	also	also	RB
cord-023095-4dannjjm	4652	7	larger	large	JJR
cord-023095-4dannjjm	4652	8	in	in	IN
cord-023095-4dannjjm	4652	9	CKCS	CKCS	NNP
cord-023095-4dannjjm	4652	10	compared	compare	VBN
cord-023095-4dannjjm	4652	11	to	to	IN
cord-023095-4dannjjm	4652	12	the	the	DT
cord-023095-4dannjjm	4652	13	other	other	JJ
cord-023095-4dannjjm	4652	14	groups	group	NNS
cord-023095-4dannjjm	4652	15	(	(	-LRB-
cord-023095-4dannjjm	4652	16	CKCS	CKCS	NNP
cord-023095-4dannjjm	4652	17	8.90	8.90	CD
cord-023095-4dannjjm	4652	18	%	%	NN
cord-023095-4dannjjm	4652	19	[	[	-LRB-
cord-023095-4dannjjm	4652	20	6.62	6.62	CD
cord-023095-4dannjjm	4652	21	-	-	SYM
cord-023095-4dannjjm	4652	22	11.46	11.46	CD
cord-023095-4dannjjm	4652	23	%	%	NN
cord-023095-4dannjjm	4652	24	]	]	-RRB-
cord-023095-4dannjjm	4652	25	vs.	vs.	FW
cord-023095-4dannjjm	4652	26	SB	SB	NNP
cord-023095-4dannjjm	4652	27	7.37	7.37	CD
cord-023095-4dannjjm	4652	28	%	%	NN
cord-023095-4dannjjm	4652	29	[	[	-LRB-
cord-023095-4dannjjm	4652	30	5.25	5.25	CD
cord-023095-4dannjjm	4652	31	-	-	SYM
cord-023095-4dannjjm	4652	32	11.34	11.34	CD
cord-023095-4dannjjm	4652	33	%	%	NN
cord-023095-4dannjjm	4652	34	]	]	-RRB-
cord-023095-4dannjjm	4652	35	and	and	CC
cord-023095-4dannjjm	4652	36	LD	LD	NNP
cord-023095-4dannjjm	4652	37	7.23	7.23	CD
cord-023095-4dannjjm	4652	38	%	%	NN
cord-023095-4dannjjm	4652	39	[	[	-LRB-
cord-023095-4dannjjm	4652	40	6.36	6.36	CD
cord-023095-4dannjjm	4652	41	-	-	SYM
cord-023095-4dannjjm	4652	42	9.54	9.54	CD
cord-023095-4dannjjm	4652	43	%	%	NN
cord-023095-4dannjjm	4652	44	]	]	-RRB-
cord-023095-4dannjjm	4652	45	;	;	.
cord-023095-4dannjjm	4653	1	p	p	NN
cord-023095-4dannjjm	4653	2	o	o	NN
cord-023095-4dannjjm	4653	3	0.001	0.001	CD
cord-023095-4dannjjm	4653	4	)	)	-RRB-
cord-023095-4dannjjm	4653	5	.	.	.
cord-023095-4dannjjm	4654	1	Group	group	NN
cord-023095-4dannjjm	4654	2	1	1	CD
cord-023095-4dannjjm	4654	3	had	have	VBD
cord-023095-4dannjjm	4654	4	a	a	DT
cord-023095-4dannjjm	4654	5	significantly	significantly	RB
cord-023095-4dannjjm	4654	6	larger	large	JJR
cord-023095-4dannjjm	4654	7	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4654	8	caudal	caudal	JJ
cord-023095-4dannjjm	4654	9	cranial	cranial	JJ
cord-023095-4dannjjm	4654	10	fossa	fossa	NN
cord-023095-4dannjjm	4654	11	percentage	percentage	NN
cord-023095-4dannjjm	4654	12	than	than	IN
cord-023095-4dannjjm	4654	13	group	group	NN
cord-023095-4dannjjm	4654	14	2	2	CD
cord-023095-4dannjjm	4654	15	(	(	-LRB-
cord-023095-4dannjjm	4654	16	53.71	53.71	CD
cord-023095-4dannjjm	4654	17	%	%	NN
cord-023095-4dannjjm	4654	18	AE	AE	NNP
cord-023095-4dannjjm	4654	19	1.27	1.27	CD
cord-023095-4dannjjm	4654	20	vs.	vs.	NN
cord-023095-4dannjjm	4654	21	49.31	49.31	CD
cord-023095-4dannjjm	4654	22	%	%	NN
cord-023095-4dannjjm	4654	23	AE	AE	NNP
cord-023095-4dannjjm	4654	24	2.35	2.35	CD
cord-023095-4dannjjm	4654	25	,	,	,
cord-023095-4dannjjm	4654	26	p	p	NN
cord-023095-4dannjjm	4654	27	5	5	CD
cord-023095-4dannjjm	4654	28	0.001	0.001	CD
cord-023095-4dannjjm	4654	29	)	)	-RRB-
cord-023095-4dannjjm	4654	30	and	and	CC
cord-023095-4dannjjm	4654	31	a	a	DT
cord-023095-4dannjjm	4654	32	significantly	significantly	RB
cord-023095-4dannjjm	4654	33	larger	large	JJR
cord-023095-4dannjjm	4654	34	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4654	35	brain	brain	NN
cord-023095-4dannjjm	4654	36	percentage	percentage	NN
cord-023095-4dannjjm	4654	37	(	(	-LRB-
cord-023095-4dannjjm	4654	38	9.45	9.45	CD
cord-023095-4dannjjm	4654	39	%	%	NN
cord-023095-4dannjjm	4654	40	AE	AE	NNP
cord-023095-4dannjjm	4654	41	0.43	0.43	CD
cord-023095-4dannjjm	4654	42	vs.	vs.	IN
cord-023095-4dannjjm	4654	43	8.58	8.58	CD
cord-023095-4dannjjm	4654	44	%	%	NN
cord-023095-4dannjjm	4654	45	AE	AE	NNP
cord-023095-4dannjjm	4654	46	0.55	0.55	CD
cord-023095-4dannjjm	4654	47	,	,	,
cord-023095-4dannjjm	4654	48	p	p	NN
cord-023095-4dannjjm	4654	49	5	5	CD
cord-023095-4dannjjm	4654	50	0.021	0.021	CD
cord-023095-4dannjjm	4654	51	)	)	-RRB-
cord-023095-4dannjjm	4654	52	.	.	.
cord-023095-4dannjjm	4655	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	4655	2	findings	finding	NNS
cord-023095-4dannjjm	4655	3	show	show	VBP
cord-023095-4dannjjm	4655	4	that	that	IN
cord-023095-4dannjjm	4655	5	the	the	DT
cord-023095-4dannjjm	4655	6	CKCS	CKCS	NNP
cord-023095-4dannjjm	4655	7	has	have	VBZ
cord-023095-4dannjjm	4655	8	a	a	DT
cord-023095-4dannjjm	4655	9	relatively	relatively	RB
cord-023095-4dannjjm	4655	10	larger	large	JJR
cord-023095-4dannjjm	4655	11	cerebellum	cerebellum	NN
cord-023095-4dannjjm	4655	12	than	than	IN
cord-023095-4dannjjm	4655	13	small	small	JJ
cord-023095-4dannjjm	4655	14	breed	breed	NN
cord-023095-4dannjjm	4655	15	dogs	dog	NNS
cord-023095-4dannjjm	4655	16	and	and	CC
cord-023095-4dannjjm	4655	17	Labradors	Labradors	NNPS
cord-023095-4dannjjm	4655	18	and	and	CC
cord-023095-4dannjjm	4655	19	there	there	EX
cord-023095-4dannjjm	4655	20	is	be	VBZ
cord-023095-4dannjjm	4655	21	an	an	DT
cord-023095-4dannjjm	4655	22	association	association	NN
cord-023095-4dannjjm	4655	23	between	between	IN
cord-023095-4dannjjm	4655	24	increased	increase	VBN
cord-023095-4dannjjm	4655	25	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4655	26	volume	volume	NN
cord-023095-4dannjjm	4655	27	and	and	CC
cord-023095-4dannjjm	4655	28	SM	SM	NNP
cord-023095-4dannjjm	4655	29	in	in	IN
cord-023095-4dannjjm	4655	30	CKCS	CKCS	NNP
cord-023095-4dannjjm	4655	31	.	.	.
cord-023095-4dannjjm	4656	1	Chiari	Chiari	NNP
cord-023095-4dannjjm	4656	2	-	-	HYPH
cord-023095-4dannjjm	4656	3	like	like	JJ
cord-023095-4dannjjm	4656	4	malformation	malformation	NN
cord-023095-4dannjjm	4656	5	(	(	-LRB-
cord-023095-4dannjjm	4656	6	CM	CM	NNP
cord-023095-4dannjjm	4656	7	)	)	-RRB-
cord-023095-4dannjjm	4656	8	is	be	VBZ
cord-023095-4dannjjm	4656	9	nearly	nearly	RB
cord-023095-4dannjjm	4656	10	omnipresent	omnipresent	JJ
cord-023095-4dannjjm	4656	11	in	in	IN
cord-023095-4dannjjm	4656	12	the	the	DT
cord-023095-4dannjjm	4656	13	Cavalier	Cavalier	NNP
cord-023095-4dannjjm	4656	14	King	King	NNP
cord-023095-4dannjjm	4656	15	Charles	Charles	NNP
cord-023095-4dannjjm	4656	16	Spaniel	Spaniel	NNP
cord-023095-4dannjjm	4656	17	(	(	-LRB-
cord-023095-4dannjjm	4656	18	CKCS	CKCS	NNP
cord-023095-4dannjjm	4656	19	)	)	-RRB-
cord-023095-4dannjjm	4656	20	breed	breed	NN
cord-023095-4dannjjm	4656	21	.	.	.
cord-023095-4dannjjm	4657	1	The	the	DT
cord-023095-4dannjjm	4657	2	mis	mis	NN
cord-023095-4dannjjm	4657	3	-	-	HYPH
cord-023095-4dannjjm	4657	4	match	match	NN
cord-023095-4dannjjm	4657	5	of	of	IN
cord-023095-4dannjjm	4657	6	the	the	DT
cord-023095-4dannjjm	4657	7	caudal	caudal	JJ
cord-023095-4dannjjm	4657	8	cranial	cranial	JJ
cord-023095-4dannjjm	4657	9	fossa	fossa	NN
cord-023095-4dannjjm	4657	10	and	and	CC
cord-023095-4dannjjm	4657	11	the	the	DT
cord-023095-4dannjjm	4657	12	parenchyma	parenchyma	NN
cord-023095-4dannjjm	4657	13	within	within	RB
cord-023095-4dannjjm	4657	14	is	be	VBZ
cord-023095-4dannjjm	4657	15	thought	think	VBN
cord-023095-4dannjjm	4657	16	to	to	TO
cord-023095-4dannjjm	4657	17	lead	lead	VB
cord-023095-4dannjjm	4657	18	to	to	IN
cord-023095-4dannjjm	4657	19	syringomyelia	syringomyelia	NN
cord-023095-4dannjjm	4657	20	(	(	-LRB-
cord-023095-4dannjjm	4657	21	SM	SM	NNP
cord-023095-4dannjjm	4657	22	)	)	-RRB-
cord-023095-4dannjjm	4657	23	.	.	.
cord-023095-4dannjjm	4658	1	There	there	EX
cord-023095-4dannjjm	4658	2	is	be	VBZ
cord-023095-4dannjjm	4658	3	currently	currently	RB
cord-023095-4dannjjm	4658	4	a	a	DT
cord-023095-4dannjjm	4658	5	lack	lack	NN
cord-023095-4dannjjm	4658	6	of	of	IN
cord-023095-4dannjjm	4658	7	information	information	NN
cord-023095-4dannjjm	4658	8	if	if	IN
cord-023095-4dannjjm	4658	9	the	the	DT
cord-023095-4dannjjm	4658	10	morphological	morphological	JJ
cord-023095-4dannjjm	4658	11	changes	change	NNS
cord-023095-4dannjjm	4658	12	seen	see	VBN
cord-023095-4dannjjm	4658	13	in	in	IN
cord-023095-4dannjjm	4658	14	CKCS	CKCS	NNP
cord-023095-4dannjjm	4658	15	with	with	IN
cord-023095-4dannjjm	4658	16	CM	CM	NNP
cord-023095-4dannjjm	4658	17	are	be	VBP
cord-023095-4dannjjm	4658	18	progressive	progressive	JJ
cord-023095-4dannjjm	4658	19	or	or	CC
cord-023095-4dannjjm	4658	20	non	non	JJ
cord-023095-4dannjjm	4658	21	-	-	JJ
cord-023095-4dannjjm	4658	22	progressive	progressive	JJ
cord-023095-4dannjjm	4658	23	.	.	.
cord-023095-4dannjjm	4659	1	In	in	IN
cord-023095-4dannjjm	4659	2	this	this	DT
cord-023095-4dannjjm	4659	3	retrospective	retrospective	JJ
cord-023095-4dannjjm	4659	4	study	study	NN
cord-023095-4dannjjm	4659	5	we	-PRON-	PRP
cord-023095-4dannjjm	4659	6	used	use	VBD
cord-023095-4dannjjm	4659	7	established	establish	VBD
cord-023095-4dannjjm	4659	8	measurements	measurement	NNS
cord-023095-4dannjjm	4659	9	of	of	IN
cord-023095-4dannjjm	4659	10	cerebral	cerebral	JJ
cord-023095-4dannjjm	4659	11	volumes	volume	NNS
cord-023095-4dannjjm	4659	12	,	,	,
cord-023095-4dannjjm	4659	13	foramen	foramen	NNP
cord-023095-4dannjjm	4659	14	magnum	magnum	NNP
cord-023095-4dannjjm	4659	15	height	height	NN
cord-023095-4dannjjm	4659	16	and	and	CC
cord-023095-4dannjjm	4659	17	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4659	18	herniation	herniation	NN
cord-023095-4dannjjm	4659	19	length	length	NN
cord-023095-4dannjjm	4659	20	to	to	TO
cord-023095-4dannjjm	4659	21	assess	assess	VB
cord-023095-4dannjjm	4659	22	if	if	IN
cord-023095-4dannjjm	4659	23	there	there	EX
cord-023095-4dannjjm	4659	24	is	be	VBZ
cord-023095-4dannjjm	4659	25	a	a	DT
cord-023095-4dannjjm	4659	26	significant	significant	JJ
cord-023095-4dannjjm	4659	27	difference	difference	NN
cord-023095-4dannjjm	4659	28	between	between	IN
cord-023095-4dannjjm	4659	29	subsequent	subsequent	JJ
cord-023095-4dannjjm	4659	30	magnetic	magnetic	JJ
cord-023095-4dannjjm	4659	31	resonance	resonance	NN
cord-023095-4dannjjm	4659	32	(	(	-LRB-
cord-023095-4dannjjm	4659	33	MR	MR	NNP
cord-023095-4dannjjm	4659	34	)	)	-RRB-
cord-023095-4dannjjm	4659	35	imaging	imaging	NN
cord-023095-4dannjjm	4659	36	of	of	IN
cord-023095-4dannjjm	4659	37	the	the	DT
cord-023095-4dannjjm	4659	38	brain	brain	NN
cord-023095-4dannjjm	4659	39	of	of	IN
cord-023095-4dannjjm	4659	40	the	the	DT
cord-023095-4dannjjm	4659	41	same	same	JJ
cord-023095-4dannjjm	4659	42	dog	dog	NN
cord-023095-4dannjjm	4659	43	.	.	.
cord-023095-4dannjjm	4660	1	Electronic	electronic	JJ
cord-023095-4dannjjm	4660	2	patient	patient	NN
cord-023095-4dannjjm	4660	3	records	record	NNS
cord-023095-4dannjjm	4660	4	were	be	VBD
cord-023095-4dannjjm	4660	5	reviewed	review	VBN
cord-023095-4dannjjm	4660	6	for	for	IN
cord-023095-4dannjjm	4660	7	CKCS	CKCS	NNP
cord-023095-4dannjjm	4660	8	with	with	IN
cord-023095-4dannjjm	4660	9	CM	CM	NNP
cord-023095-4dannjjm	4660	10	which	which	WDT
cord-023095-4dannjjm	4660	11	had	have	VBD
cord-023095-4dannjjm	4660	12	two	two	CD
cord-023095-4dannjjm	4660	13	separate	separate	JJ
cord-023095-4dannjjm	4660	14	MRI	MRI	NNP
cord-023095-4dannjjm	4660	15	scans	scan	NNS
cord-023095-4dannjjm	4660	16	,	,	,
cord-023095-4dannjjm	4660	17	which	which	WDT
cord-023095-4dannjjm	4660	18	were	be	VBD
cord-023095-4dannjjm	4660	19	a	a	DT
cord-023095-4dannjjm	4660	20	minimum	minimum	NN
cord-023095-4dannjjm	4660	21	of	of	IN
cord-023095-4dannjjm	4660	22	3	3	CD
cord-023095-4dannjjm	4660	23	months	month	NNS
cord-023095-4dannjjm	4660	24	apart	apart	RB
cord-023095-4dannjjm	4660	25	.	.	.
cord-023095-4dannjjm	4661	1	CKCS	CKCS	NNP
cord-023095-4dannjjm	4661	2	with	with	IN
cord-023095-4dannjjm	4661	3	diseases	disease	NNS
cord-023095-4dannjjm	4661	4	affecting	affect	VBG
cord-023095-4dannjjm	4661	5	measurements	measurement	NNS
cord-023095-4dannjjm	4661	6	were	be	VBD
cord-023095-4dannjjm	4661	7	excluded	exclude	VBN
cord-023095-4dannjjm	4661	8	.	.	.
cord-023095-4dannjjm	4662	1	For	for	IN
cord-023095-4dannjjm	4662	2	the	the	DT
cord-023095-4dannjjm	4662	3	volumetric	volumetric	JJ
cord-023095-4dannjjm	4662	4	measurements	measurement	NNS
cord-023095-4dannjjm	4662	5	three	three	CD
cord-023095-4dannjjm	4662	6	-	-	HYPH
cord-023095-4dannjjm	4662	7	dimensional	dimensional	JJ
cord-023095-4dannjjm	4662	8	models	model	NNS
cord-023095-4dannjjm	4662	9	were	be	VBD
cord-023095-4dannjjm	4662	10	created	create	VBN
cord-023095-4dannjjm	4662	11	using	use	VBG
cord-023095-4dannjjm	4662	12	T2-weighted	t2-weighte	VBN
cord-023095-4dannjjm	4662	13	transverse	transverse	JJ
cord-023095-4dannjjm	4662	14	MR	MR	NNP
cord-023095-4dannjjm	4662	15	images	image	NNS
cord-023095-4dannjjm	4662	16	in	in	IN
cord-023095-4dannjjm	4662	17	the	the	DT
cord-023095-4dannjjm	4662	18	medical	medical	JJ
cord-023095-4dannjjm	4662	19	imaging	imaging	NN
cord-023095-4dannjjm	4662	20	software	software	NN
cord-023095-4dannjjm	4662	21	(	(	-LRB-
cord-023095-4dannjjm	4662	22	Mimics	mimic	VBZ
cord-023095-4dannjjm	4662	23	v12.0	v12.0	NN
cord-023095-4dannjjm	4662	24	,	,	,
cord-023095-4dannjjm	4662	25	Materialise	Materialise	NNP
cord-023095-4dannjjm	4662	26	n.v	n.v	NNP
cord-023095-4dannjjm	4662	27	,	,	,
cord-023095-4dannjjm	4662	28	2008	2008	CD
cord-023095-4dannjjm	4662	29	)	)	-RRB-
cord-023095-4dannjjm	4662	30	.	.	.
cord-023095-4dannjjm	4663	1	Volumes	volume	NNS
cord-023095-4dannjjm	4663	2	of	of	IN
cord-023095-4dannjjm	4663	3	the	the	DT
cord-023095-4dannjjm	4663	4	caudal	caudal	JJ
cord-023095-4dannjjm	4663	5	cranial	cranial	JJ
cord-023095-4dannjjm	4663	6	fossa	fossa	NN
cord-023095-4dannjjm	4663	7	parenchyma	parenchyma	NNS
cord-023095-4dannjjm	4663	8	were	be	VBD
cord-023095-4dannjjm	4663	9	analyzed	analyze	VBN
cord-023095-4dannjjm	4663	10	as	as	IN
cord-023095-4dannjjm	4663	11	percentages	percentage	NNS
cord-023095-4dannjjm	4663	12	of	of	IN
cord-023095-4dannjjm	4663	13	caudal	caudal	JJ
cord-023095-4dannjjm	4663	14	cranial	cranial	JJ
cord-023095-4dannjjm	4663	15	fossa	fossa	NN
cord-023095-4dannjjm	4663	16	volume	volume	NN
cord-023095-4dannjjm	4663	17	and	and	CC
cord-023095-4dannjjm	4663	18	caudal	caudal	JJ
cord-023095-4dannjjm	4663	19	cranial	cranial	JJ
cord-023095-4dannjjm	4663	20	fossa	fossa	NN
cord-023095-4dannjjm	4663	21	volume	volume	NN
cord-023095-4dannjjm	4663	22	was	be	VBD
cord-023095-4dannjjm	4663	23	analyzed	analyze	VBN
cord-023095-4dannjjm	4663	24	as	as	IN
cord-023095-4dannjjm	4663	25	a	a	DT
cord-023095-4dannjjm	4663	26	percentage	percentage	NN
cord-023095-4dannjjm	4663	27	of	of	IN
cord-023095-4dannjjm	4663	28	total	total	JJ
cord-023095-4dannjjm	4663	29	cranial	cranial	JJ
cord-023095-4dannjjm	4663	30	cavity	cavity	NN
cord-023095-4dannjjm	4663	31	volume	volume	NN
cord-023095-4dannjjm	4663	32	.	.	.
cord-023095-4dannjjm	4664	1	The	the	DT
cord-023095-4dannjjm	4664	2	volume	volume	NN
cord-023095-4dannjjm	4664	3	of	of	IN
cord-023095-4dannjjm	4664	4	the	the	DT
cord-023095-4dannjjm	4664	5	ventricular	ventricular	JJ
cord-023095-4dannjjm	4664	6	system	system	NN
cord-023095-4dannjjm	4664	7	was	be	VBD
cord-023095-4dannjjm	4664	8	recorded	record	VBN
cord-023095-4dannjjm	4664	9	as	as	IN
cord-023095-4dannjjm	4664	10	a	a	DT
cord-023095-4dannjjm	4664	11	percentage	percentage	NN
cord-023095-4dannjjm	4664	12	of	of	IN
cord-023095-4dannjjm	4664	13	total	total	JJ
cord-023095-4dannjjm	4664	14	parenchymal	parenchymal	NN
cord-023095-4dannjjm	4664	15	volume	volume	NN
cord-023095-4dannjjm	4664	16	.	.	.
cord-023095-4dannjjm	4665	1	Data	datum	NNS
cord-023095-4dannjjm	4665	2	was	be	VBD
cord-023095-4dannjjm	4665	3	assessed	assess	VBN
cord-023095-4dannjjm	4665	4	for	for	IN
cord-023095-4dannjjm	4665	5	normality	normality	NN
cord-023095-4dannjjm	4665	6	and	and	CC
cord-023095-4dannjjm	4665	7	the	the	DT
cord-023095-4dannjjm	4665	8	appropriate	appropriate	JJ
cord-023095-4dannjjm	4665	9	statistical	statistical	JJ
cord-023095-4dannjjm	4665	10	test	test	NN
cord-023095-4dannjjm	4665	11	was	be	VBD
cord-023095-4dannjjm	4665	12	used	use	VBN
cord-023095-4dannjjm	4665	13	to	to	TO
cord-023095-4dannjjm	4665	14	compare	compare	VB
cord-023095-4dannjjm	4665	15	means	mean	NNS
cord-023095-4dannjjm	4665	16	/	/	SYM
cord-023095-4dannjjm	4665	17	medians	median	NNS
cord-023095-4dannjjm	4665	18	.	.	.
cord-023095-4dannjjm	4666	1	Twelve	twelve	CD
cord-023095-4dannjjm	4666	2	CKCS	CKCS	NNP
cord-023095-4dannjjm	4666	3	were	be	VBD
cord-023095-4dannjjm	4666	4	included	include	VBN
cord-023095-4dannjjm	4666	5	with	with	IN
cord-023095-4dannjjm	4666	6	a	a	DT
cord-023095-4dannjjm	4666	7	median	median	JJ
cord-023095-4dannjjm	4666	8	scan	scan	JJ
cord-023095-4dannjjm	4666	9	interval	interval	NN
cord-023095-4dannjjm	4666	10	of	of	IN
cord-023095-4dannjjm	4666	11	9.5	9.5	CD
cord-023095-4dannjjm	4666	12	months	month	NNS
cord-023095-4dannjjm	4666	13	(	(	-LRB-
cord-023095-4dannjjm	4666	14	3	3	CD
cord-023095-4dannjjm	4666	15	-	-	SYM
cord-023095-4dannjjm	4666	16	83	83	CD
cord-023095-4dannjjm	4666	17	months	month	NNS
cord-023095-4dannjjm	4666	18	)	)	-RRB-
cord-023095-4dannjjm	4666	19	.	.	.
cord-023095-4dannjjm	4667	1	The	the	DT
cord-023095-4dannjjm	4667	2	size	size	NN
cord-023095-4dannjjm	4667	3	of	of	IN
cord-023095-4dannjjm	4667	4	the	the	DT
cord-023095-4dannjjm	4667	5	foramen	foramen	NNP
cord-023095-4dannjjm	4667	6	magnum	magnum	NNP
cord-023095-4dannjjm	4667	7	increased	increase	VBD
cord-023095-4dannjjm	4667	8	significantly	significantly	RB
cord-023095-4dannjjm	4667	9	between	between	IN
cord-023095-4dannjjm	4667	10	the	the	DT
cord-023095-4dannjjm	4667	11	first	first	JJ
cord-023095-4dannjjm	4667	12	and	and	CC
cord-023095-4dannjjm	4667	13	second	second	JJ
cord-023095-4dannjjm	4667	14	scan	scan	NN
cord-023095-4dannjjm	4667	15	(	(	-LRB-
cord-023095-4dannjjm	4667	16	1.52	1.52	CD
cord-023095-4dannjjm	4667	17	AE	AE	NNP
cord-023095-4dannjjm	4667	18	0.08	0.08	CD
cord-023095-4dannjjm	4667	19	cm	cm	NNS
cord-023095-4dannjjm	4667	20	vs.	vs.	NN
cord-023095-4dannjjm	4667	21	1.59	1.59	CD
cord-023095-4dannjjm	4667	22	AE	AE	NNP
cord-023095-4dannjjm	4667	23	0.09	0.09	CD
cord-023095-4dannjjm	4667	24	cm	cm	NNS
cord-023095-4dannjjm	4667	25	;	;	:
cord-023095-4dannjjm	4667	26	p	p	NN
cord-023095-4dannjjm	4667	27	5	5	CD
cord-023095-4dannjjm	4667	28	0.03	0.03	CD
cord-023095-4dannjjm	4667	29	)	)	-RRB-
cord-023095-4dannjjm	4667	30	,	,	,
cord-023095-4dannjjm	4667	31	as	as	IN
cord-023095-4dannjjm	4667	32	did	do	VBD
cord-023095-4dannjjm	4667	33	the	the	DT
cord-023095-4dannjjm	4667	34	length	length	NN
cord-023095-4dannjjm	4667	35	of	of	IN
cord-023095-4dannjjm	4667	36	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4667	37	herniation	herniation	NN
cord-023095-4dannjjm	4667	38	(	(	-LRB-
cord-023095-4dannjjm	4667	39	0.17	0.17	CD
cord-023095-4dannjjm	4667	40	AE	AE	NNP
cord-023095-4dannjjm	4667	41	0.05	0.05	CD
cord-023095-4dannjjm	4667	42	cm	cm	NNS
cord-023095-4dannjjm	4667	43	vs.	vs.	NN
cord-023095-4dannjjm	4667	44	0.22	0.22	CD
cord-023095-4dannjjm	4667	45	AE	AE	NNP
cord-023095-4dannjjm	4667	46	0.09	0.09	CD
cord-023095-4dannjjm	4667	47	cm	cm	NNS
cord-023095-4dannjjm	4667	48	;	;	:
cord-023095-4dannjjm	4667	49	p	p	NN
cord-023095-4dannjjm	4667	50	5	5	CD
cord-023095-4dannjjm	4667	51	0.02	0.02	CD
cord-023095-4dannjjm	4667	52	)	)	-RRB-
cord-023095-4dannjjm	4667	53	and	and	CC
cord-023095-4dannjjm	4667	54	the	the	DT
cord-023095-4dannjjm	4667	55	caudal	caudal	JJ
cord-023095-4dannjjm	4667	56	cranial	cranial	JJ
cord-023095-4dannjjm	4667	57	fossa	fossa	NN
cord-023095-4dannjjm	4667	58	percentage	percentage	NN
cord-023095-4dannjjm	4667	59	(	(	-LRB-
cord-023095-4dannjjm	4667	60	13.44	13.44	CD
cord-023095-4dannjjm	4667	61	%	%	NN
cord-023095-4dannjjm	4667	62	[	[	-LRB-
cord-023095-4dannjjm	4667	63	9.9	9.9	CD
cord-023095-4dannjjm	4667	64	-	-	HYPH
cord-023095-4dannjjm	4667	65	15.28	15.28	CD
cord-023095-4dannjjm	4667	66	%	%	NN
cord-023095-4dannjjm	4667	67	]	]	-RRB-
cord-023095-4dannjjm	4667	68	vs.	vs.	IN
cord-023095-4dannjjm	4667	69	13.96	13.96	CD
cord-023095-4dannjjm	4667	70	%	%	NN
cord-023095-4dannjjm	4667	71	[	[	-LRB-
cord-023095-4dannjjm	4667	72	9.9	9.9	CD
cord-023095-4dannjjm	4667	73	-	-	HYPH
cord-023095-4dannjjm	4667	74	15.48	15.48	CD
cord-023095-4dannjjm	4667	75	%	%	NN
cord-023095-4dannjjm	4667	76	]	]	-RRB-
cord-023095-4dannjjm	4667	77	;	;	:
cord-023095-4dannjjm	4667	78	p	p	NN
cord-023095-4dannjjm	4667	79	5	5	CD
cord-023095-4dannjjm	4667	80	0.02	0.02	CD
cord-023095-4dannjjm	4667	81	)	)	-RRB-
cord-023095-4dannjjm	4667	82	.	.	.
cord-023095-4dannjjm	4668	1	There	there	EX
cord-023095-4dannjjm	4668	2	was	be	VBD
cord-023095-4dannjjm	4668	3	no	no	DT
cord-023095-4dannjjm	4668	4	significant	significant	JJ
cord-023095-4dannjjm	4668	5	difference	difference	NN
cord-023095-4dannjjm	4668	6	noted	note	VBN
cord-023095-4dannjjm	4668	7	between	between	IN
cord-023095-4dannjjm	4668	8	the	the	DT
cord-023095-4dannjjm	4668	9	two	two	CD
cord-023095-4dannjjm	4668	10	time	time	NN
cord-023095-4dannjjm	4668	11	points	point	NNS
cord-023095-4dannjjm	4668	12	in	in	IN
cord-023095-4dannjjm	4668	13	any	any	DT
cord-023095-4dannjjm	4668	14	of	of	IN
cord-023095-4dannjjm	4668	15	the	the	DT
cord-023095-4dannjjm	4668	16	other	other	JJ
cord-023095-4dannjjm	4668	17	volumetric	volumetric	JJ
cord-023095-4dannjjm	4668	18	measurements	measurement	NNS
cord-023095-4dannjjm	4669	1	(	(	-LRB-
cord-023095-4dannjjm	4669	2	This	this	DT
cord-023095-4dannjjm	4669	3	work	work	NN
cord-023095-4dannjjm	4669	4	could	could	MD
cord-023095-4dannjjm	4669	5	suggest	suggest	VB
cord-023095-4dannjjm	4669	6	that	that	IN
cord-023095-4dannjjm	4669	7	overcrowding	overcrowding	NN
cord-023095-4dannjjm	4669	8	of	of	IN
cord-023095-4dannjjm	4669	9	the	the	DT
cord-023095-4dannjjm	4669	10	caudal	caudal	JJ
cord-023095-4dannjjm	4669	11	cranial	cranial	JJ
cord-023095-4dannjjm	4669	12	fossa	fossa	NN
cord-023095-4dannjjm	4669	13	in	in	IN
cord-023095-4dannjjm	4669	14	conjunction	conjunction	NN
cord-023095-4dannjjm	4669	15	with	with	IN
cord-023095-4dannjjm	4669	16	the	the	DT
cord-023095-4dannjjm	4669	17	movements	movement	NNS
cord-023095-4dannjjm	4669	18	of	of	IN
cord-023095-4dannjjm	4669	19	cerebrospinal	cerebrospinal	JJ
cord-023095-4dannjjm	4669	20	fluid	fluid	NN
cord-023095-4dannjjm	4669	21	and	and	CC
cord-023095-4dannjjm	4669	22	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4669	23	tissue	tissue	NN
cord-023095-4dannjjm	4669	24	secondary	secondary	JJ
cord-023095-4dannjjm	4669	25	to	to	TO
cord-023095-4dannjjm	4669	26	pulse	pulse	NN
cord-023095-4dannjjm	4669	27	pressures	pressure	NNS
cord-023095-4dannjjm	4669	28	created	create	VBN
cord-023095-4dannjjm	4669	29	during	during	IN
cord-023095-4dannjjm	4669	30	the	the	DT
cord-023095-4dannjjm	4669	31	cardiac	cardiac	JJ
cord-023095-4dannjjm	4669	32	cycle	cycle	NN
cord-023095-4dannjjm	4669	33	causes	cause	VBZ
cord-023095-4dannjjm	4669	34	pressures	pressure	NNS
cord-023095-4dannjjm	4669	35	on	on	IN
cord-023095-4dannjjm	4669	36	the	the	DT
cord-023095-4dannjjm	4669	37	occipital	occipital	JJ
cord-023095-4dannjjm	4669	38	bone	bone	NN
cord-023095-4dannjjm	4669	39	.	.	.
cord-023095-4dannjjm	4670	1	This	this	DT
cord-023095-4dannjjm	4670	2	leads	lead	VBZ
cord-023095-4dannjjm	4670	3	to	to	IN
cord-023095-4dannjjm	4670	4	a	a	DT
cord-023095-4dannjjm	4670	5	resorption	resorption	NN
cord-023095-4dannjjm	4670	6	of	of	IN
cord-023095-4dannjjm	4670	7	the	the	DT
cord-023095-4dannjjm	4670	8	bone	bone	NN
cord-023095-4dannjjm	4670	9	and	and	CC
cord-023095-4dannjjm	4670	10	therefore	therefore	RB
cord-023095-4dannjjm	4670	11	an	an	DT
cord-023095-4dannjjm	4670	12	increase	increase	NN
cord-023095-4dannjjm	4670	13	in	in	IN
cord-023095-4dannjjm	4670	14	caudal	caudal	JJ
cord-023095-4dannjjm	4670	15	cranial	cranial	JJ
cord-023095-4dannjjm	4670	16	fossa	fossa	NN
cord-023095-4dannjjm	4670	17	and	and	CC
cord-023095-4dannjjm	4670	18	foramen	foramen	NNP
cord-023095-4dannjjm	4670	19	magnum	magnum	NNP
cord-023095-4dannjjm	4670	20	size	size	NN
cord-023095-4dannjjm	4670	21	allowing	allow	VBG
cord-023095-4dannjjm	4670	22	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	4670	23	herniation	herniation	NN
cord-023095-4dannjjm	4670	24	length	length	NN
cord-023095-4dannjjm	4670	25	to	to	TO
cord-023095-4dannjjm	4670	26	increase	increase	VB
cord-023095-4dannjjm	4670	27	.	.	.
cord-023095-4dannjjm	4671	1	The	the	DT
cord-023095-4dannjjm	4671	2	cord	cord	NN
cord-023095-4dannjjm	4671	3	dorsum	dorsum	NN
cord-023095-4dannjjm	4671	4	potential	potential	NN
cord-023095-4dannjjm	4671	5	(	(	-LRB-
cord-023095-4dannjjm	4671	6	CDP	CDP	NNP
cord-023095-4dannjjm	4671	7	)	)	-RRB-
cord-023095-4dannjjm	4671	8	is	be	VBZ
cord-023095-4dannjjm	4671	9	a	a	DT
cord-023095-4dannjjm	4671	10	stationary	stationary	JJ
cord-023095-4dannjjm	4671	11	potential	potential	NN
cord-023095-4dannjjm	4671	12	arising	arise	VBG
cord-023095-4dannjjm	4671	13	in	in	IN
cord-023095-4dannjjm	4671	14	dorsal	dorsal	JJ
cord-023095-4dannjjm	4671	15	horn	horn	NN
cord-023095-4dannjjm	4671	16	interneurons	interneuron	NNS
cord-023095-4dannjjm	4671	17	after	after	IN
cord-023095-4dannjjm	4671	18	stimulation	stimulation	NN
cord-023095-4dannjjm	4671	19	of	of	IN
cord-023095-4dannjjm	4671	20	sensory	sensory	JJ
cord-023095-4dannjjm	4671	21	nerves	nerve	NNS
cord-023095-4dannjjm	4671	22	.	.	.
cord-023095-4dannjjm	4672	1	CDPs	cdp	NNS
cord-023095-4dannjjm	4672	2	have	have	VBP
cord-023095-4dannjjm	4672	3	been	be	VBN
cord-023095-4dannjjm	4672	4	recorded	record	VBN
cord-023095-4dannjjm	4672	5	in	in	IN
cord-023095-4dannjjm	4672	6	normal	normal	JJ
cord-023095-4dannjjm	4672	7	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	4672	8	dogs	dog	NNS
cord-023095-4dannjjm	4672	9	previously	previously	RB
cord-023095-4dannjjm	4672	10	,	,	,
cord-023095-4dannjjm	4672	11	and	and	CC
cord-023095-4dannjjm	4672	12	normal	normal	JJ
cord-023095-4dannjjm	4672	13	latency	latency	NN
cord-023095-4dannjjm	4672	14	values	value	NNS
cord-023095-4dannjjm	4672	15	have	have	VBP
cord-023095-4dannjjm	4672	16	been	be	VBN
cord-023095-4dannjjm	4672	17	determined	determine	VBN
cord-023095-4dannjjm	4672	18	for	for	IN
cord-023095-4dannjjm	4672	19	tibial	tibial	JJ
cord-023095-4dannjjm	4672	20	and	and	CC
cord-023095-4dannjjm	4672	21	radial	radial	JJ
cord-023095-4dannjjm	4672	22	nerves	nerve	NNS
cord-023095-4dannjjm	4672	23	.	.	.
cord-023095-4dannjjm	4673	1	This	this	DT
cord-023095-4dannjjm	4673	2	study	study	NN
cord-023095-4dannjjm	4673	3	was	be	VBD
cord-023095-4dannjjm	4673	4	undertaken	undertake	VBN
cord-023095-4dannjjm	4673	5	to	to	TO
cord-023095-4dannjjm	4673	6	determine	determine	VB
cord-023095-4dannjjm	4673	7	whether	whether	IN
cord-023095-4dannjjm	4673	8	CDPs	cdp	NNS
cord-023095-4dannjjm	4673	9	could	could	MD
cord-023095-4dannjjm	4673	10	be	be	VB
cord-023095-4dannjjm	4673	11	reliably	reliably	RB
cord-023095-4dannjjm	4673	12	recorded	record	VBN
cord-023095-4dannjjm	4673	13	from	from	IN
cord-023095-4dannjjm	4673	14	the	the	DT
cord-023095-4dannjjm	4673	15	caudal	caudal	JJ
cord-023095-4dannjjm	4673	16	nerves	nerve	NNS
cord-023095-4dannjjm	4673	17	in	in	IN
cord-023095-4dannjjm	4673	18	normal	normal	JJ
cord-023095-4dannjjm	4673	19	dogs	dog	NNS
cord-023095-4dannjjm	4673	20	,	,	,
cord-023095-4dannjjm	4673	21	thus	thus	RB
cord-023095-4dannjjm	4673	22	allowing	allow	VBG
cord-023095-4dannjjm	4673	23	electrophysiological	electrophysiological	JJ
cord-023095-4dannjjm	4673	24	assessment	assessment	NN
cord-023095-4dannjjm	4673	25	of	of	IN
cord-023095-4dannjjm	4673	26	the	the	DT
cord-023095-4dannjjm	4673	27	cauda	cauda	FW
cord-023095-4dannjjm	4673	28	equina	equina	NN
cord-023095-4dannjjm	4673	29	,	,	,
cord-023095-4dannjjm	4673	30	and	and	CC
cord-023095-4dannjjm	4673	31	whether	whether	IN
cord-023095-4dannjjm	4673	32	neuromuscular	neuromuscular	JJ
cord-023095-4dannjjm	4673	33	blockade	blockade	NN
cord-023095-4dannjjm	4673	34	improved	improve	VBN
cord-023095-4dannjjm	4673	35	recording	record	VBG
cord-023095-4dannjjm	4673	36	quality	quality	NN
cord-023095-4dannjjm	4673	37	.	.	.
cord-023095-4dannjjm	4674	1	Ten	ten	CD
cord-023095-4dannjjm	4674	2	adult	adult	NN
cord-023095-4dannjjm	4674	3	dogs	dog	NNS
cord-023095-4dannjjm	4674	4	weighing	weigh	VBG
cord-023095-4dannjjm	4674	5	from	from	IN
cord-023095-4dannjjm	4674	6	23.2	23.2	CD
cord-023095-4dannjjm	4674	7	to	to	IN
cord-023095-4dannjjm	4674	8	32.0	32.0	CD
cord-023095-4dannjjm	4674	9	kg	kg	NNS
cord-023095-4dannjjm	4674	10	were	be	VBD
cord-023095-4dannjjm	4674	11	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	4674	12	and	and	CC
cord-023095-4dannjjm	4674	13	cord	cord	NN
cord-023095-4dannjjm	4674	14	dorsum	dorsum	NN
cord-023095-4dannjjm	4674	15	recordings	recording	NNS
cord-023095-4dannjjm	4674	16	were	be	VBD
cord-023095-4dannjjm	4674	17	compared	compare	VBN
cord-023095-4dannjjm	4674	18	before	before	IN
cord-023095-4dannjjm	4674	19	and	and	CC
cord-023095-4dannjjm	4674	20	after	after	IN
cord-023095-4dannjjm	4674	21	administration	administration	NN
cord-023095-4dannjjm	4674	22	of	of	IN
cord-023095-4dannjjm	4674	23	atracurium	atracurium	NNP
cord-023095-4dannjjm	4674	24	.	.	.
cord-023095-4dannjjm	4675	1	Recording	record	VBG
cord-023095-4dannjjm	4675	2	needles	needle	NNS
cord-023095-4dannjjm	4675	3	were	be	VBD
cord-023095-4dannjjm	4675	4	placed	place	VBN
cord-023095-4dannjjm	4675	5	onto	onto	IN
cord-023095-4dannjjm	4675	6	the	the	DT
cord-023095-4dannjjm	4675	7	dorsal	dorsal	JJ
cord-023095-4dannjjm	4675	8	lamina	lamina	NN
cord-023095-4dannjjm	4675	9	at	at	IN
cord-023095-4dannjjm	4675	10	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4675	11	sites	site	NNS
cord-023095-4dannjjm	4675	12	from	from	IN
cord-023095-4dannjjm	4675	13	L7	L7	NNP
cord-023095-4dannjjm	4675	14	/	/	SYM
cord-023095-4dannjjm	4675	15	S1	S1	NNP
cord-023095-4dannjjm	4675	16	to	to	IN
cord-023095-4dannjjm	4675	17	L2/3	L2/3	NNP
cord-023095-4dannjjm	4675	18	.	.	.
cord-023095-4dannjjm	4676	1	Stimulations	Stimulations	NNPS
cord-023095-4dannjjm	4676	2	were	be	VBD
cord-023095-4dannjjm	4676	3	made	make	VBN
cord-023095-4dannjjm	4676	4	on	on	IN
cord-023095-4dannjjm	4676	5	the	the	DT
cord-023095-4dannjjm	4676	6	lateral	lateral	JJ
cord-023095-4dannjjm	4676	7	aspect	aspect	NN
cord-023095-4dannjjm	4676	8	of	of	IN
cord-023095-4dannjjm	4676	9	the	the	DT
cord-023095-4dannjjm	4676	10	caudal	caudal	JJ
cord-023095-4dannjjm	4676	11	vertebrae	vertebrae	NN
cord-023095-4dannjjm	4676	12	approximately	approximately	RB
cord-023095-4dannjjm	4676	13	5	5	CD
cord-023095-4dannjjm	4676	14	-	-	SYM
cord-023095-4dannjjm	4676	15	8	8	CD
cord-023095-4dannjjm	4676	16	cm	cm	NNS
cord-023095-4dannjjm	4676	17	from	from	IN
cord-023095-4dannjjm	4676	18	the	the	DT
cord-023095-4dannjjm	4676	19	tail	tail	NN
cord-023095-4dannjjm	4676	20	base	base	NN
cord-023095-4dannjjm	4676	21	.	.	.
cord-023095-4dannjjm	4677	1	Recordings	recording	NNS
cord-023095-4dannjjm	4677	2	from	from	IN
cord-023095-4dannjjm	4677	3	500	500	CD
cord-023095-4dannjjm	4677	4	stimulations	stimulation	NNS
cord-023095-4dannjjm	4677	5	were	be	VBD
cord-023095-4dannjjm	4677	6	averaged	average	VBN
cord-023095-4dannjjm	4677	7	.	.	.
cord-023095-4dannjjm	4678	1	CDPs	CDPs	NNP
cord-023095-4dannjjm	4678	2	were	be	VBD
cord-023095-4dannjjm	4678	3	recorded	record	VBN
cord-023095-4dannjjm	4678	4	successfully	successfully	RB
cord-023095-4dannjjm	4678	5	in	in	IN
cord-023095-4dannjjm	4678	6	all	all	DT
cord-023095-4dannjjm	4678	7	dogs	dog	NNS
cord-023095-4dannjjm	4678	8	.	.	.
cord-023095-4dannjjm	4679	1	Onset	onset	NN
cord-023095-4dannjjm	4679	2	latency	latency	NN
cord-023095-4dannjjm	4679	3	varied	varied	JJ
cord-023095-4dannjjm	4679	4	from	from	IN
cord-023095-4dannjjm	4679	5	2.2	2.2	CD
cord-023095-4dannjjm	4679	6	to	to	IN
cord-023095-4dannjjm	4679	7	4.7	4.7	CD
cord-023095-4dannjjm	4679	8	ms	m	NNS
cord-023095-4dannjjm	4679	9	.	.	.
cord-023095-4dannjjm	4680	1	The	the	DT
cord-023095-4dannjjm	4680	2	CDP	CDP	NNP
cord-023095-4dannjjm	4680	3	was	be	VBD
cord-023095-4dannjjm	4680	4	largest	large	JJS
cord-023095-4dannjjm	4680	5	when	when	WRB
cord-023095-4dannjjm	4680	6	recorded	record	VBN
cord-023095-4dannjjm	4680	7	closest	close	JJS
cord-023095-4dannjjm	4680	8	to	to	IN
cord-023095-4dannjjm	4680	9	the	the	DT
cord-023095-4dannjjm	4680	10	site	site	NN
cord-023095-4dannjjm	4680	11	of	of	IN
cord-023095-4dannjjm	4680	12	entry	entry	NN
cord-023095-4dannjjm	4680	13	of	of	IN
cord-023095-4dannjjm	4680	14	the	the	DT
cord-023095-4dannjjm	4680	15	stimulated	stimulated	JJ
cord-023095-4dannjjm	4680	16	nerve	nerve	NN
cord-023095-4dannjjm	4680	17	into	into	IN
cord-023095-4dannjjm	4680	18	the	the	DT
cord-023095-4dannjjm	4680	19	cord	cord	NN
cord-023095-4dannjjm	4680	20	,	,	,
cord-023095-4dannjjm	4680	21	as	as	IN
cord-023095-4dannjjm	4680	22	determined	determine	VBN
cord-023095-4dannjjm	4680	23	by	by	IN
cord-023095-4dannjjm	4680	24	post	post	JJ
cord-023095-4dannjjm	4680	25	-	-	JJ
cord-023095-4dannjjm	4680	26	mortem	mortem	JJ
cord-023095-4dannjjm	4680	27	examination	examination	NN
cord-023095-4dannjjm	4680	28	immediately	immediately	RB
cord-023095-4dannjjm	4680	29	after	after	IN
cord-023095-4dannjjm	4680	30	testing	test	VBG
cord-023095-4dannjjm	4680	31	in	in	IN
cord-023095-4dannjjm	4680	32	6	6	CD
cord-023095-4dannjjm	4680	33	dogs	dog	NNS
cord-023095-4dannjjm	4680	34	.	.	.
cord-023095-4dannjjm	4681	1	Administration	Administration	NNP
cord-023095-4dannjjm	4681	2	of	of	IN
cord-023095-4dannjjm	4681	3	atracurium	atracurium	NNP
cord-023095-4dannjjm	4681	4	did	do	VBD
cord-023095-4dannjjm	4681	5	decrease	decrease	VB
cord-023095-4dannjjm	4681	6	muscle	muscle	NN
cord-023095-4dannjjm	4681	7	artifact	artifact	NN
cord-023095-4dannjjm	4681	8	,	,	,
cord-023095-4dannjjm	4681	9	and	and	CC
cord-023095-4dannjjm	4681	10	in	in	IN
cord-023095-4dannjjm	4681	11	some	some	DT
cord-023095-4dannjjm	4681	12	cases	case	NNS
cord-023095-4dannjjm	4681	13	helped	help	VBD
cord-023095-4dannjjm	4681	14	isolate	isolate	VB
cord-023095-4dannjjm	4681	15	the	the	DT
cord-023095-4dannjjm	4681	16	origin	origin	NN
cord-023095-4dannjjm	4681	17	of	of	IN
cord-023095-4dannjjm	4681	18	the	the	DT
cord-023095-4dannjjm	4681	19	CDP	CDP	NNP
cord-023095-4dannjjm	4681	20	.	.	.
cord-023095-4dannjjm	4682	1	These	these	DT
cord-023095-4dannjjm	4682	2	data	datum	NNS
cord-023095-4dannjjm	4682	3	show	show	VBP
cord-023095-4dannjjm	4682	4	that	that	IN
cord-023095-4dannjjm	4682	5	CDPs	cdp	NNS
cord-023095-4dannjjm	4682	6	can	can	MD
cord-023095-4dannjjm	4682	7	be	be	VB
cord-023095-4dannjjm	4682	8	readily	readily	RB
cord-023095-4dannjjm	4682	9	assessed	assess	VBN
cord-023095-4dannjjm	4682	10	from	from	IN
cord-023095-4dannjjm	4682	11	the	the	DT
cord-023095-4dannjjm	4682	12	caudal	caudal	JJ
cord-023095-4dannjjm	4682	13	nerves	nerve	NNS
cord-023095-4dannjjm	4682	14	of	of	IN
cord-023095-4dannjjm	4682	15	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	4682	16	dogs	dog	NNS
cord-023095-4dannjjm	4682	17	,	,	,
cord-023095-4dannjjm	4682	18	with	with	IN
cord-023095-4dannjjm	4682	19	or	or	CC
cord-023095-4dannjjm	4682	20	without	without	IN
cord-023095-4dannjjm	4682	21	atracurium	atracurium	NN
cord-023095-4dannjjm	4682	22	.	.	.
cord-023095-4dannjjm	4683	1	Cord	cord	NN
cord-023095-4dannjjm	4683	2	dorsum	dorsum	NN
cord-023095-4dannjjm	4683	3	potentials	potential	NNS
cord-023095-4dannjjm	4683	4	from	from	IN
cord-023095-4dannjjm	4683	5	caudal	caudal	JJ
cord-023095-4dannjjm	4683	6	nerves	nerve	NNS
cord-023095-4dannjjm	4683	7	may	may	MD
cord-023095-4dannjjm	4683	8	add	add	VB
cord-023095-4dannjjm	4683	9	important	important	JJ
cord-023095-4dannjjm	4683	10	information	information	NN
cord-023095-4dannjjm	4683	11	about	about	IN
cord-023095-4dannjjm	4683	12	the	the	DT
cord-023095-4dannjjm	4683	13	integrity	integrity	NN
cord-023095-4dannjjm	4683	14	of	of	IN
cord-023095-4dannjjm	4683	15	the	the	DT
cord-023095-4dannjjm	4683	16	cauda	cauda	FW
cord-023095-4dannjjm	4683	17	equina	equina	NN
cord-023095-4dannjjm	4683	18	in	in	IN
cord-023095-4dannjjm	4683	19	dogs	dog	NNS
cord-023095-4dannjjm	4683	20	with	with	IN
cord-023095-4dannjjm	4683	21	suspected	suspect	VBN
cord-023095-4dannjjm	4683	22	degenerative	degenerative	JJ
cord-023095-4dannjjm	4683	23	lumbosacral	lumbosacral	JJ
cord-023095-4dannjjm	4683	24	stenosis	stenosis	NN
cord-023095-4dannjjm	4683	25	.	.	.
cord-023095-4dannjjm	4684	1	Canine	canine	JJ
cord-023095-4dannjjm	4684	2	intracranial	intracranial	JJ
cord-023095-4dannjjm	4684	3	glial	glial	JJ
cord-023095-4dannjjm	4684	4	tumors	tumor	NNS
cord-023095-4dannjjm	4684	5	and	and	CC
cord-023095-4dannjjm	4684	6	many	many	JJ
cord-023095-4dannjjm	4684	7	human	human	JJ
cord-023095-4dannjjm	4684	8	brain	brain	NN
cord-023095-4dannjjm	4684	9	tumors	tumor	NNS
cord-023095-4dannjjm	4684	10	express	express	VBP
cord-023095-4dannjjm	4684	11	heat	heat	NN
cord-023095-4dannjjm	4684	12	shock	shock	NN
cord-023095-4dannjjm	4684	13	proteins	protein	NNS
cord-023095-4dannjjm	4684	14	(	(	-LRB-
cord-023095-4dannjjm	4684	15	HSPs	HSPs	NNP
cord-023095-4dannjjm	4684	16	)	)	-RRB-
cord-023095-4dannjjm	4684	17	associated	associate	VBN
cord-023095-4dannjjm	4684	18	with	with	IN
cord-023095-4dannjjm	4684	19	their	-PRON-	PRP$
cord-023095-4dannjjm	4684	20	degree	degree	NN
cord-023095-4dannjjm	4684	21	of	of	IN
cord-023095-4dannjjm	4684	22	malignancy	malignancy	NN
cord-023095-4dannjjm	4684	23	.	.	.
cord-023095-4dannjjm	4685	1	The	the	DT
cord-023095-4dannjjm	4685	2	up	up	JJ
cord-023095-4dannjjm	4685	3	-	-	HYPH
cord-023095-4dannjjm	4685	4	regulation	regulation	NN
cord-023095-4dannjjm	4685	5	of	of	IN
cord-023095-4dannjjm	4685	6	HSPs	hsp	NNS
cord-023095-4dannjjm	4685	7	during	during	IN
cord-023095-4dannjjm	4685	8	tumor	tumor	NN
cord-023095-4dannjjm	4685	9	cell	cell	NN
cord-023095-4dannjjm	4685	10	growth	growth	NN
cord-023095-4dannjjm	4685	11	helps	help	VBZ
cord-023095-4dannjjm	4685	12	keep	keep	VB
cord-023095-4dannjjm	4685	13	tumor	tumor	NN
cord-023095-4dannjjm	4685	14	proteins	protein	NNS
cord-023095-4dannjjm	4685	15	stable	stable	JJ
cord-023095-4dannjjm	4685	16	and	and	CC
cord-023095-4dannjjm	4685	17	therefore	therefore	RB
cord-023095-4dannjjm	4685	18	makes	make	VBZ
cord-023095-4dannjjm	4685	19	them	-PRON-	PRP
cord-023095-4dannjjm	4685	20	a	a	DT
cord-023095-4dannjjm	4685	21	reasonable	reasonable	JJ
cord-023095-4dannjjm	4685	22	target	target	NN
cord-023095-4dannjjm	4685	23	for	for	IN
cord-023095-4dannjjm	4685	24	therapy	therapy	NN
cord-023095-4dannjjm	4685	25	.	.	.
cord-023095-4dannjjm	4686	1	Ki67	Ki67	NNP
cord-023095-4dannjjm	4686	2	expression	expression	NN
cord-023095-4dannjjm	4686	3	and	and	CC
cord-023095-4dannjjm	4686	4	EC	EC	NNP
cord-023095-4dannjjm	4686	5	have	have	VBP
cord-023095-4dannjjm	4686	6	been	be	VBN
cord-023095-4dannjjm	4686	7	strong	strong	JJ
cord-023095-4dannjjm	4686	8	indicators	indicator	NNS
cord-023095-4dannjjm	4686	9	of	of	IN
cord-023095-4dannjjm	4686	10	cell	cell	NN
cord-023095-4dannjjm	4686	11	proliferation	proliferation	NN
cord-023095-4dannjjm	4686	12	and	and	CC
cord-023095-4dannjjm	4686	13	dedifferentiation	dedifferentiation	NN
cord-023095-4dannjjm	4686	14	,	,	,
cord-023095-4dannjjm	4686	15	respectively	respectively	RB
cord-023095-4dannjjm	4686	16	.	.	.
cord-023095-4dannjjm	4687	1	The	the	DT
cord-023095-4dannjjm	4687	2	aims	aim	NNS
cord-023095-4dannjjm	4687	3	of	of	IN
cord-023095-4dannjjm	4687	4	this	this	DT
cord-023095-4dannjjm	4687	5	study	study	NN
cord-023095-4dannjjm	4687	6	were	be	VBD
cord-023095-4dannjjm	4687	7	to	to	TO
cord-023095-4dannjjm	4687	8	determine	determine	VB
cord-023095-4dannjjm	4687	9	(	(	-LRB-
cord-023095-4dannjjm	4687	10	i	i	NN
cord-023095-4dannjjm	4687	11	)	)	-RRB-
cord-023095-4dannjjm	4687	12	if	if	IN
cord-023095-4dannjjm	4687	13	canine	canine	JJ
cord-023095-4dannjjm	4687	14	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4687	15	express	expres	VBD
cord-023095-4dannjjm	4687	16	HSP	HSP	NNP
cord-023095-4dannjjm	4687	17	27	27	CD
cord-023095-4dannjjm	4687	18	and/or	and/or	CC
cord-023095-4dannjjm	4687	19	HSP	HSP	NNP
cord-023095-4dannjjm	4687	20	72	72	CD
cord-023095-4dannjjm	4687	21	;	;	:
cord-023095-4dannjjm	4687	22	(	(	-LRB-
cord-023095-4dannjjm	4687	23	ii	ii	NN
cord-023095-4dannjjm	4687	24	)	)	-RRB-
cord-023095-4dannjjm	4688	1	whether	whether	IN
cord-023095-4dannjjm	4688	2	the	the	DT
cord-023095-4dannjjm	4688	3	expression	expression	NN
cord-023095-4dannjjm	4688	4	of	of	IN
cord-023095-4dannjjm	4688	5	the	the	DT
cord-023095-4dannjjm	4688	6	HSPs	hsp	NNS
cord-023095-4dannjjm	4688	7	was	be	VBD
cord-023095-4dannjjm	4688	8	associated	associate	VBN
cord-023095-4dannjjm	4688	9	with	with	IN
cord-023095-4dannjjm	4688	10	Ki67	Ki67	NNP
cord-023095-4dannjjm	4689	1	and/or	and/or	CC
cord-023095-4dannjjm	4689	2	E	e	NN
cord-023095-4dannjjm	4689	3	-	-	NN
cord-023095-4dannjjm	4689	4	cadherin	cadherin	NN
cord-023095-4dannjjm	4689	5	(	(	-LRB-
cord-023095-4dannjjm	4689	6	EC	EC	NNP
cord-023095-4dannjjm	4689	7	)	)	-RRB-
cord-023095-4dannjjm	4689	8	expression	expression	NN
cord-023095-4dannjjm	4689	9	;	;	:
cord-023095-4dannjjm	4689	10	and	and	CC
cord-023095-4dannjjm	4689	11	(	(	-LRB-
cord-023095-4dannjjm	4689	12	iii	iii	NN
cord-023095-4dannjjm	4689	13	)	)	-RRB-
cord-023095-4dannjjm	4690	1	whether	whether	IN
cord-023095-4dannjjm	4690	2	peritumoral	peritumoral	JJ
cord-023095-4dannjjm	4690	3	edema	edema	NN
cord-023095-4dannjjm	4690	4	was	be	VBD
cord-023095-4dannjjm	4690	5	associated	associate	VBN
cord-023095-4dannjjm	4690	6	with	with	IN
cord-023095-4dannjjm	4690	7	HSP	HSP	NNP
cord-023095-4dannjjm	4690	8	,	,	,
cord-023095-4dannjjm	4690	9	Ki67	Ki67	NNP
cord-023095-4dannjjm	4690	10	and/or	and/or	CC
cord-023095-4dannjjm	4690	11	EC	EC	NNP
cord-023095-4dannjjm	4690	12	expression	expression	NN
cord-023095-4dannjjm	4690	13	.	.	.
cord-023095-4dannjjm	4691	1	Forty	forty	CD
cord-023095-4dannjjm	4691	2	-	-	HYPH
cord-023095-4dannjjm	4691	3	one	one	CD
cord-023095-4dannjjm	4692	1	formalin	formalin	NN
cord-023095-4dannjjm	4692	2	-	-	HYPH
cord-023095-4dannjjm	4692	3	fixed	fix	VBN
cord-023095-4dannjjm	4692	4	,	,	,
cord-023095-4dannjjm	4692	5	paraffin	paraffin	NN
cord-023095-4dannjjm	4692	6	-	-	HYPH
cord-023095-4dannjjm	4692	7	embedded	embed	VBN
cord-023095-4dannjjm	4692	8	canine	canine	JJ
cord-023095-4dannjjm	4692	9	intracranial	intracranial	JJ
cord-023095-4dannjjm	4692	10	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4692	11	underwent	undergo	VBD
cord-023095-4dannjjm	4692	12	immunohistochemical	immunohistochemical	JJ
cord-023095-4dannjjm	4692	13	staining	stain	VBG
cord-023095-4dannjjm	4692	14	using	use	VBG
cord-023095-4dannjjm	4692	15	anti	anti	JJ
cord-023095-4dannjjm	4692	16	-	-	JJ
cord-023095-4dannjjm	4692	17	HSP	HSP	NNP
cord-023095-4dannjjm	4692	18	27	27	CD
cord-023095-4dannjjm	4692	19	,	,	,
cord-023095-4dannjjm	4692	20	or	or	CC
cord-023095-4dannjjm	4692	21	72	72	CD
cord-023095-4dannjjm	4692	22	antibodies	antibody	NNS
cord-023095-4dannjjm	4692	23	.	.	.
cord-023095-4dannjjm	4693	1	These	these	DT
cord-023095-4dannjjm	4693	2	tumor	tumor	NN
cord-023095-4dannjjm	4693	3	samples	sample	NNS
cord-023095-4dannjjm	4693	4	were	be	VBD
cord-023095-4dannjjm	4693	5	also	also	RB
cord-023095-4dannjjm	4693	6	immunohistochemically	immunohistochemically	RB
cord-023095-4dannjjm	4693	7	stained	stain	VBN
cord-023095-4dannjjm	4693	8	for	for	IN
cord-023095-4dannjjm	4693	9	Ki67	Ki67	NNP
cord-023095-4dannjjm	4693	10	and	and	CC
cord-023095-4dannjjm	4693	11	EC	EC	NNP
cord-023095-4dannjjm	4693	12	expression	expression	NN
cord-023095-4dannjjm	4693	13	.	.	.
cord-023095-4dannjjm	4694	1	Canine	canine	JJ
cord-023095-4dannjjm	4694	2	mammary	mammary	JJ
cord-023095-4dannjjm	4694	3	carcinoma	carcinoma	NN
cord-023095-4dannjjm	4694	4	and	and	CC
cord-023095-4dannjjm	4694	5	squamous	squamous	JJ
cord-023095-4dannjjm	4694	6	cell	cell	NN
cord-023095-4dannjjm	4694	7	carcinoma	carcinoma	NN
cord-023095-4dannjjm	4694	8	tissues	tissue	NNS
cord-023095-4dannjjm	4694	9	served	serve	VBD
cord-023095-4dannjjm	4694	10	as	as	IN
cord-023095-4dannjjm	4694	11	the	the	DT
cord-023095-4dannjjm	4694	12	control	control	NN
cord-023095-4dannjjm	4694	13	samples	sample	NNS
cord-023095-4dannjjm	4694	14	,	,	,
cord-023095-4dannjjm	4694	15	as	as	IN
cord-023095-4dannjjm	4694	16	both	both	DT
cord-023095-4dannjjm	4694	17	have	have	VBP
cord-023095-4dannjjm	4694	18	previously	previously	RB
cord-023095-4dannjjm	4694	19	been	be	VBN
cord-023095-4dannjjm	4694	20	shown	show	VBN
cord-023095-4dannjjm	4694	21	to	to	TO
cord-023095-4dannjjm	4694	22	express	express	VB
cord-023095-4dannjjm	4694	23	HSPs	hsp	NNS
cord-023095-4dannjjm	4694	24	.	.	.
cord-023095-4dannjjm	4695	1	Skin	skin	NN
cord-023095-4dannjjm	4695	2	was	be	VBD
cord-023095-4dannjjm	4695	3	used	use	VBN
cord-023095-4dannjjm	4695	4	as	as	IN
cord-023095-4dannjjm	4695	5	control	control	NN
cord-023095-4dannjjm	4695	6	for	for	IN
cord-023095-4dannjjm	4695	7	Ki67	Ki67	NNP
cord-023095-4dannjjm	4695	8	and	and	CC
cord-023095-4dannjjm	4695	9	EC	EC	NNP
cord-023095-4dannjjm	4695	10	.	.	.
cord-023095-4dannjjm	4696	1	Four	four	CD
cord-023095-4dannjjm	4696	2	non	non	JJ
cord-023095-4dannjjm	4696	3	-	-	JJ
cord-023095-4dannjjm	4696	4	overlapping	overlapping	JJ
cord-023095-4dannjjm	4696	5	high	high	JJ
cord-023095-4dannjjm	4696	6	power	power	NN
cord-023095-4dannjjm	4696	7	fields	field	NNS
cord-023095-4dannjjm	4696	8	of	of	IN
cord-023095-4dannjjm	4696	9	each	each	DT
cord-023095-4dannjjm	4696	10	stained	stain	VBN
cord-023095-4dannjjm	4696	11	sample	sample	NN
cord-023095-4dannjjm	4696	12	were	be	VBD
cord-023095-4dannjjm	4696	13	selected	select	VBN
cord-023095-4dannjjm	4696	14	and	and	CC
cord-023095-4dannjjm	4696	15	cell	cell	NN
cord-023095-4dannjjm	4696	16	staining	staining	NN
cord-023095-4dannjjm	4696	17	was	be	VBD
cord-023095-4dannjjm	4696	18	analyzed	analyze	VBN
cord-023095-4dannjjm	4696	19	using	use	VBG
cord-023095-4dannjjm	4696	20	a	a	DT
cord-023095-4dannjjm	4696	21	semi	semi	JJ
cord-023095-4dannjjm	4696	22	-	-	JJ
cord-023095-4dannjjm	4696	23	quantitative	quantitative	JJ
cord-023095-4dannjjm	4696	24	method	method	NN
cord-023095-4dannjjm	4696	25	for	for	IN
cord-023095-4dannjjm	4696	26	HSPs	hsp	NNS
cord-023095-4dannjjm	4696	27	and	and	CC
cord-023095-4dannjjm	4696	28	Ki67	Ki67	NNP
cord-023095-4dannjjm	4696	29	;	;	:
cord-023095-4dannjjm	4696	30	a	a	DT
cord-023095-4dannjjm	4696	31	qualitative	qualitative	JJ
cord-023095-4dannjjm	4696	32	assessment	assessment	NN
cord-023095-4dannjjm	4696	33	was	be	VBD
cord-023095-4dannjjm	4696	34	used	use	VBN
cord-023095-4dannjjm	4696	35	for	for	IN
cord-023095-4dannjjm	4696	36	EC	EC	NNP
cord-023095-4dannjjm	4696	37	.	.	.
cord-023095-4dannjjm	4697	1	All	all	DT
cord-023095-4dannjjm	4697	2	analyses	analysis	NNS
cord-023095-4dannjjm	4697	3	were	be	VBD
cord-023095-4dannjjm	4697	4	performed	perform	VBN
cord-023095-4dannjjm	4697	5	using	use	VBG
cord-023095-4dannjjm	4697	6	SAS	SAS	NNP
cord-023095-4dannjjm	4697	7	V	V	NNP
cord-023095-4dannjjm	4697	8	9.2	9.2	CD
cord-023095-4dannjjm	4697	9	(	(	-LRB-
cord-023095-4dannjjm	4697	10	Cary	Cary	NNP
cord-023095-4dannjjm	4697	11	,	,	,
cord-023095-4dannjjm	4697	12	NC	NC	NNP
cord-023095-4dannjjm	4697	13	)	)	-RRB-
cord-023095-4dannjjm	4697	14	.	.	.
cord-023095-4dannjjm	4698	1	Descriptive	descriptive	JJ
cord-023095-4dannjjm	4698	2	statistics	statistic	NNS
cord-023095-4dannjjm	4698	3	of	of	IN
cord-023095-4dannjjm	4698	4	staining	stain	VBG
cord-023095-4dannjjm	4698	5	percentages	percentage	NNS
cord-023095-4dannjjm	4698	6	were	be	VBD
cord-023095-4dannjjm	4698	7	calculated	calculate	VBN
cord-023095-4dannjjm	4698	8	for	for	IN
cord-023095-4dannjjm	4698	9	all	all	DT
cord-023095-4dannjjm	4698	10	tumors	tumor	NNS
cord-023095-4dannjjm	4698	11	tested	test	VBN
cord-023095-4dannjjm	4698	12	.	.	.
cord-023095-4dannjjm	4699	1	Simple	Simple	NNP
cord-023095-4dannjjm	4699	2	Pearson	Pearson	NNP
cord-023095-4dannjjm	4699	3	's	's	POS
cord-023095-4dannjjm	4699	4	correlation	correlation	NN
cord-023095-4dannjjm	4699	5	was	be	VBD
cord-023095-4dannjjm	4699	6	used	use	VBN
cord-023095-4dannjjm	4699	7	to	to	TO
cord-023095-4dannjjm	4699	8	test	test	VB
cord-023095-4dannjjm	4699	9	for	for	IN
cord-023095-4dannjjm	4699	10	correlations	correlation	NNS
cord-023095-4dannjjm	4699	11	of	of	IN
cord-023095-4dannjjm	4699	12	EC	EC	NNP
cord-023095-4dannjjm	4699	13	area	area	NN
cord-023095-4dannjjm	4699	14	with	with	IN
cord-023095-4dannjjm	4699	15	HSP	HSP	NNP
cord-023095-4dannjjm	4699	16	areas	area	NNS
cord-023095-4dannjjm	4699	17	and	and	CC
cord-023095-4dannjjm	4699	18	Ki-67	Ki-67	NNP
cord-023095-4dannjjm	4699	19	percent	percent	NN
cord-023095-4dannjjm	4699	20	positive	positive	JJ
cord-023095-4dannjjm	4699	21	cells	cell	NNS
cord-023095-4dannjjm	4699	22	and	and	CC
cord-023095-4dannjjm	4699	23	of	of	IN
cord-023095-4dannjjm	4699	24	EC	EC	NNP
cord-023095-4dannjjm	4699	25	intensity	intensity	NN
cord-023095-4dannjjm	4699	26	with	with	IN
cord-023095-4dannjjm	4699	27	HSP	HSP	NNP
cord-023095-4dannjjm	4699	28	intensities	intensity	NNS
cord-023095-4dannjjm	4699	29	and	and	CC
cord-023095-4dannjjm	4699	30	Ki-67	Ki-67	NNP
cord-023095-4dannjjm	4699	31	percent	percent	NN
cord-023095-4dannjjm	4699	32	positive	positive	JJ
cord-023095-4dannjjm	4699	33	cells	cell	NNS
cord-023095-4dannjjm	4699	34	.	.	.
cord-023095-4dannjjm	4700	1	All	all	DT
cord-023095-4dannjjm	4700	2	hypothesis	hypothesis	NN
cord-023095-4dannjjm	4700	3	tests	test	NNS
cord-023095-4dannjjm	4700	4	were	be	VBD
cord-023095-4dannjjm	4700	5	2sided	2sided	CD
cord-023095-4dannjjm	4700	6	and	and	CC
cord-023095-4dannjjm	4700	7	the	the	DT
cord-023095-4dannjjm	4700	8	significance	significance	NN
cord-023095-4dannjjm	4700	9	level	level	NN
cord-023095-4dannjjm	4700	10	was	be	VBD
cord-023095-4dannjjm	4700	11	a	a	DT
cord-023095-4dannjjm	4700	12	5	5	CD
cord-023095-4dannjjm	4700	13	0.05	0.05	CD
cord-023095-4dannjjm	4700	14	.	.	.
cord-023095-4dannjjm	4701	1	Thirteen	thirteen	CD
cord-023095-4dannjjm	4701	2	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4701	3	had	have	VBD
cord-023095-4dannjjm	4701	4	MR	MR	NNP
cord-023095-4dannjjm	4701	5	images	image	NNS
cord-023095-4dannjjm	4701	6	quantitatively	quantitatively	RB
cord-023095-4dannjjm	4701	7	evaluated	evaluate	VBN
cord-023095-4dannjjm	4701	8	for	for	IN
cord-023095-4dannjjm	4701	9	peritumoral	peritumoral	JJ
cord-023095-4dannjjm	4701	10	edema	edema	NN
cord-023095-4dannjjm	4701	11	using	use	VBG
cord-023095-4dannjjm	4701	12	T2FLAIR	T2FLAIR	NNP
cord-023095-4dannjjm	4701	13	sequences	sequence	NNS
cord-023095-4dannjjm	4701	14	.	.	.
cord-023095-4dannjjm	4702	1	The	the	DT
cord-023095-4dannjjm	4702	2	edema	edema	NN
cord-023095-4dannjjm	4702	3	index	index	NN
cord-023095-4dannjjm	4702	4	(	(	-LRB-
cord-023095-4dannjjm	4702	5	EI	EI	NNP
cord-023095-4dannjjm	4702	6	)	)	-RRB-
cord-023095-4dannjjm	4702	7	was	be	VBD
cord-023095-4dannjjm	4702	8	evaluated	evaluate	VBN
cord-023095-4dannjjm	4702	9	for	for	IN
cord-023095-4dannjjm	4702	10	an	an	DT
cord-023095-4dannjjm	4702	11	association	association	NN
cord-023095-4dannjjm	4702	12	with	with	IN
cord-023095-4dannjjm	4702	13	HSP	HSP	NNP
cord-023095-4dannjjm	4702	14	27	27	CD
cord-023095-4dannjjm	4702	15	,	,	,
cord-023095-4dannjjm	4702	16	HSP	HSP	NNP
cord-023095-4dannjjm	4702	17	72	72	CD
cord-023095-4dannjjm	4702	18	,	,	,
cord-023095-4dannjjm	4702	19	EC	EC	NNP
cord-023095-4dannjjm	4702	20	and	and	CC
cord-023095-4dannjjm	4702	21	Ki67	Ki67	NNP
cord-023095-4dannjjm	4702	22	expression	expression	NN
cord-023095-4dannjjm	4702	23	.	.	.
cord-023095-4dannjjm	4703	1	HSP	HSP	NNP
cord-023095-4dannjjm	4703	2	27	27	CD
cord-023095-4dannjjm	4703	3	was	be	VBD
cord-023095-4dannjjm	4703	4	expressed	express	VBN
cord-023095-4dannjjm	4703	5	in	in	IN
cord-023095-4dannjjm	4703	6	36	36	CD
cord-023095-4dannjjm	4703	7	%	%	NN
cord-023095-4dannjjm	4703	8	(	(	-LRB-
cord-023095-4dannjjm	4703	9	mean	mean	VB
cord-023095-4dannjjm	4703	10	8.7	8.7	CD
cord-023095-4dannjjm	4703	11	%	%	NN
cord-023095-4dannjjm	4703	12	of	of	IN
cord-023095-4dannjjm	4703	13	cells	cell	NNS
cord-023095-4dannjjm	4703	14	;	;	:
cord-023095-4dannjjm	4703	15	range	range	VBP
cord-023095-4dannjjm	4703	16	0	0	CD
cord-023095-4dannjjm	4703	17	-	-	SYM
cord-023095-4dannjjm	4703	18	58	58	CD
cord-023095-4dannjjm	4703	19	%	%	NN
cord-023095-4dannjjm	4703	20	)	)	-RRB-
cord-023095-4dannjjm	4703	21	,	,	,
cord-023095-4dannjjm	4703	22	HSP	HSP	NNP
cord-023095-4dannjjm	4703	23	72	72	CD
cord-023095-4dannjjm	4703	24	in	in	IN
cord-023095-4dannjjm	4703	25	52	52	CD
cord-023095-4dannjjm	4703	26	%	%	NN
cord-023095-4dannjjm	4703	27	(	(	-LRB-
cord-023095-4dannjjm	4703	28	mean	mean	VB
cord-023095-4dannjjm	4703	29	5.2	5.2	CD
cord-023095-4dannjjm	4703	30	%	%	NN
cord-023095-4dannjjm	4703	31	of	of	IN
cord-023095-4dannjjm	4703	32	cells	cell	NNS
cord-023095-4dannjjm	4703	33	;	;	:
cord-023095-4dannjjm	4703	34	range	range	VBP
cord-023095-4dannjjm	4703	35	0	0	CD
cord-023095-4dannjjm	4703	36	-	-	SYM
cord-023095-4dannjjm	4703	37	26	26	CD
cord-023095-4dannjjm	4703	38	%	%	NN
cord-023095-4dannjjm	4703	39	)	)	-RRB-
cord-023095-4dannjjm	4703	40	and	and	CC
cord-023095-4dannjjm	4703	41	EC	EC	NNP
cord-023095-4dannjjm	4703	42	in	in	IN
cord-023095-4dannjjm	4703	43	68	68	CD
cord-023095-4dannjjm	4703	44	%	%	NN
cord-023095-4dannjjm	4703	45	of	of	IN
cord-023095-4dannjjm	4703	46	meningiomas	meningiomas	NNP
cord-023095-4dannjjm	4703	47	.	.	.
cord-023095-4dannjjm	4704	1	There	there	EX
cord-023095-4dannjjm	4704	2	was	be	VBD
cord-023095-4dannjjm	4704	3	no	no	DT
cord-023095-4dannjjm	4704	4	association	association	NN
cord-023095-4dannjjm	4704	5	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	4704	6	between	between	IN
cord-023095-4dannjjm	4704	7	either	either	CC
cord-023095-4dannjjm	4704	8	HSP	HSP	NNP
cord-023095-4dannjjm	4704	9	expression	expression	NN
cord-023095-4dannjjm	4704	10	variable	variable	NN
cord-023095-4dannjjm	4704	11	and	and	CC
cord-023095-4dannjjm	4704	12	EC	EC	NNP
cord-023095-4dannjjm	4704	13	or	or	CC
cord-023095-4dannjjm	4704	14	Ki-67	Ki-67	NNP
cord-023095-4dannjjm	4704	15	expression	expression	NN
cord-023095-4dannjjm	4704	16	.	.	.
cord-023095-4dannjjm	4705	1	There	there	EX
cord-023095-4dannjjm	4705	2	was	be	VBD
cord-023095-4dannjjm	4705	3	also	also	RB
cord-023095-4dannjjm	4705	4	no	no	DT
cord-023095-4dannjjm	4705	5	association	association	NN
cord-023095-4dannjjm	4705	6	between	between	IN
cord-023095-4dannjjm	4705	7	the	the	DT
cord-023095-4dannjjm	4705	8	EC	EC	NNP
cord-023095-4dannjjm	4705	9	expression	expression	NN
cord-023095-4dannjjm	4705	10	variables	variable	NNS
cord-023095-4dannjjm	4705	11	and	and	CC
cord-023095-4dannjjm	4706	1	Ki-67	Ki-67	NNS
cord-023095-4dannjjm	4706	2	.	.	.
cord-023095-4dannjjm	4707	1	However	however	RB
cord-023095-4dannjjm	4707	2	,	,	,
cord-023095-4dannjjm	4707	3	there	there	EX
cord-023095-4dannjjm	4707	4	was	be	VBD
cord-023095-4dannjjm	4707	5	a	a	DT
cord-023095-4dannjjm	4707	6	significant	significant	JJ
cord-023095-4dannjjm	4707	7	negative	negative	JJ
cord-023095-4dannjjm	4707	8	association	association	NN
cord-023095-4dannjjm	4707	9	between	between	IN
cord-023095-4dannjjm	4707	10	HSP	HSP	NNP
cord-023095-4dannjjm	4707	11	72	72	CD
cord-023095-4dannjjm	4707	12	extent	extent	NN
cord-023095-4dannjjm	4707	13	(	(	-LRB-
cord-023095-4dannjjm	4707	14	p	p	NN
cord-023095-4dannjjm	4707	15	5	5	CD
cord-023095-4dannjjm	4707	16	0.03	0.03	CD
cord-023095-4dannjjm	4707	17	)	)	-RRB-
cord-023095-4dannjjm	4707	18	and	and	CC
cord-023095-4dannjjm	4707	19	area	area	NN
cord-023095-4dannjjm	4707	20	(	(	-LRB-
cord-023095-4dannjjm	4707	21	p	p	NN
cord-023095-4dannjjm	4707	22	5	5	CD
cord-023095-4dannjjm	4707	23	0.04	0.04	CD
cord-023095-4dannjjm	4707	24	)	)	-RRB-
cord-023095-4dannjjm	4707	25	with	with	IN
cord-023095-4dannjjm	4707	26	EI	EI	NNP
cord-023095-4dannjjm	4707	27	.	.	.
cord-023095-4dannjjm	4708	1	In	in	IN
cord-023095-4dannjjm	4708	2	conclusion	conclusion	NN
cord-023095-4dannjjm	4708	3	,	,	,
cord-023095-4dannjjm	4708	4	HSP	HSP	NNP
cord-023095-4dannjjm	4708	5	27	27	CD
cord-023095-4dannjjm	4708	6	and	and	CC
cord-023095-4dannjjm	4708	7	72	72	CD
cord-023095-4dannjjm	4708	8	expression	expression	NN
cord-023095-4dannjjm	4708	9	was	be	VBD
cord-023095-4dannjjm	4708	10	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	4708	11	in	in	IN
cord-023095-4dannjjm	4708	12	canine	canine	JJ
cord-023095-4dannjjm	4708	13	intracranial	intracranial	JJ
cord-023095-4dannjjm	4708	14	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4708	15	but	but	CC
cord-023095-4dannjjm	4708	16	was	be	VBD
cord-023095-4dannjjm	4708	17	not	not	RB
cord-023095-4dannjjm	4708	18	associated	associate	VBN
cord-023095-4dannjjm	4708	19	with	with	IN
cord-023095-4dannjjm	4708	20	Ki-67	Ki-67	NNPS
cord-023095-4dannjjm	4708	21	or	or	CC
cord-023095-4dannjjm	4708	22	EC	EC	NNP
cord-023095-4dannjjm	4708	23	expression	expression	NN
cord-023095-4dannjjm	4708	24	.	.	.
cord-023095-4dannjjm	4709	1	This	this	DT
cord-023095-4dannjjm	4709	2	study	study	NN
cord-023095-4dannjjm	4709	3	suggests	suggest	VBZ
cord-023095-4dannjjm	4709	4	that	that	IN
cord-023095-4dannjjm	4709	5	HSPs	hsp	NNS
cord-023095-4dannjjm	4709	6	may	may	MD
cord-023095-4dannjjm	4709	7	not	not	RB
cord-023095-4dannjjm	4709	8	have	have	VB
cord-023095-4dannjjm	4709	9	a	a	DT
cord-023095-4dannjjm	4709	10	significant	significant	JJ
cord-023095-4dannjjm	4709	11	role	role	NN
cord-023095-4dannjjm	4709	12	in	in	IN
cord-023095-4dannjjm	4709	13	the	the	DT
cord-023095-4dannjjm	4709	14	maintenance	maintenance	NN
cord-023095-4dannjjm	4709	15	of	of	IN
cord-023095-4dannjjm	4709	16	canine	canine	JJ
cord-023095-4dannjjm	4709	17	meningiomas	meningiomas	NN
cord-023095-4dannjjm	4709	18	and	and	CC
cord-023095-4dannjjm	4709	19	so	so	RB
cord-023095-4dannjjm	4709	20	do	do	VB
cord-023095-4dannjjm	4709	21	not	not	RB
cord-023095-4dannjjm	4709	22	represent	represent	VB
cord-023095-4dannjjm	4709	23	a	a	DT
cord-023095-4dannjjm	4709	24	novel	novel	JJ
cord-023095-4dannjjm	4709	25	treatment	treatment	NN
cord-023095-4dannjjm	4709	26	target	target	NN
cord-023095-4dannjjm	4709	27	for	for	IN
cord-023095-4dannjjm	4709	28	this	this	DT
cord-023095-4dannjjm	4709	29	group	group	NN
cord-023095-4dannjjm	4709	30	of	of	IN
cord-023095-4dannjjm	4709	31	tumors	tumor	NNS
cord-023095-4dannjjm	4709	32	unlike	unlike	IN
cord-023095-4dannjjm	4709	33	canine	canine	JJ
cord-023095-4dannjjm	4709	34	glial	glial	JJ
cord-023095-4dannjjm	4709	35	cell	cell	NN
cord-023095-4dannjjm	4709	36	tumors	tumor	NNS
cord-023095-4dannjjm	4709	37	.	.	.
cord-023095-4dannjjm	4710	1	However	however	RB
cord-023095-4dannjjm	4710	2	,	,	,
cord-023095-4dannjjm	4710	3	HSP	HSP	NNP
cord-023095-4dannjjm	4710	4	72	72	CD
cord-023095-4dannjjm	4710	5	may	may	MD
cord-023095-4dannjjm	4710	6	be	be	VB
cord-023095-4dannjjm	4710	7	involved	involve	VBN
cord-023095-4dannjjm	4710	8	in	in	IN
cord-023095-4dannjjm	4710	9	the	the	DT
cord-023095-4dannjjm	4710	10	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	4710	11	of	of	IN
cord-023095-4dannjjm	4710	12	peritumoral	peritumoral	JJ
cord-023095-4dannjjm	4710	13	edema	edema	NN
cord-023095-4dannjjm	4710	14	in	in	IN
cord-023095-4dannjjm	4710	15	meningiomas	meningiomas	NNP
cord-023095-4dannjjm	4710	16	and	and	CC
cord-023095-4dannjjm	4710	17	warrants	warrant	NNS
cord-023095-4dannjjm	4710	18	further	further	JJ
cord-023095-4dannjjm	4710	19	investigation	investigation	NN
cord-023095-4dannjjm	4710	20	.	.	.
cord-023095-4dannjjm	4711	1	An	an	DT
cord-023095-4dannjjm	4711	2	extended	extended	JJ
cord-023095-4dannjjm	4711	3	release	release	NN
cord-023095-4dannjjm	4711	4	(	(	-LRB-
cord-023095-4dannjjm	4711	5	XR	XR	NNP
cord-023095-4dannjjm	4711	6	)	)	-RRB-
cord-023095-4dannjjm	4711	7	formulation	formulation	NN
cord-023095-4dannjjm	4711	8	of	of	IN
cord-023095-4dannjjm	4711	9	levetiracetam	levetiracetam	NNP
cord-023095-4dannjjm	4711	10	,	,	,
cord-023095-4dannjjm	4711	11	a	a	DT
cord-023095-4dannjjm	4711	12	second	second	JJ
cord-023095-4dannjjm	4711	13	generation	generation	NN
cord-023095-4dannjjm	4711	14	antiepileptic	antiepileptic	JJ
cord-023095-4dannjjm	4711	15	drug	drug	NN
cord-023095-4dannjjm	4711	16	,	,	,
cord-023095-4dannjjm	4711	17	was	be	VBD
cord-023095-4dannjjm	4711	18	recently	recently	RB
cord-023095-4dannjjm	4711	19	approved	approve	VBN
cord-023095-4dannjjm	4711	20	for	for	IN
cord-023095-4dannjjm	4711	21	human	human	JJ
cord-023095-4dannjjm	4711	22	use	use	NN
cord-023095-4dannjjm	4711	23	on	on	IN
cord-023095-4dannjjm	4711	24	a	a	DT
cord-023095-4dannjjm	4711	25	once	once	RB
cord-023095-4dannjjm	4711	26	daily	daily	JJ
cord-023095-4dannjjm	4711	27	basis	basis	NN
cord-023095-4dannjjm	4711	28	.	.	.
cord-023095-4dannjjm	4712	1	Although	although	IN
cord-023095-4dannjjm	4712	2	levetiracetam	levetiracetam	NNP
cord-023095-4dannjjm	4712	3	is	be	VBZ
cord-023095-4dannjjm	4712	4	clinically	clinically	RB
cord-023095-4dannjjm	4712	5	effective	effective	JJ
cord-023095-4dannjjm	4712	6	for	for	IN
cord-023095-4dannjjm	4712	7	seizure	seizure	NN
cord-023095-4dannjjm	4712	8	control	control	NN
cord-023095-4dannjjm	4712	9	in	in	IN
cord-023095-4dannjjm	4712	10	dogs	dog	NNS
cord-023095-4dannjjm	4712	11	,	,	,
cord-023095-4dannjjm	4712	12	it	-PRON-	PRP
cord-023095-4dannjjm	4712	13	requires	require	VBZ
cord-023095-4dannjjm	4712	14	a	a	DT
cord-023095-4dannjjm	4712	15	three	three	CD
cord-023095-4dannjjm	4712	16	times	time	NNS
cord-023095-4dannjjm	4712	17	daily	daily	JJ
cord-023095-4dannjjm	4712	18	administration	administration	NN
cord-023095-4dannjjm	4712	19	.	.	.
cord-023095-4dannjjm	4713	1	The	the	DT
cord-023095-4dannjjm	4713	2	potential	potential	JJ
cord-023095-4dannjjm	4713	3	benefits	benefit	NNS
cord-023095-4dannjjm	4713	4	of	of	IN
cord-023095-4dannjjm	4713	5	the	the	DT
cord-023095-4dannjjm	4713	6	XR	XR	NNP
cord-023095-4dannjjm	4713	7	formulation	formulation	NN
cord-023095-4dannjjm	4713	8	include	include	VBP
cord-023095-4dannjjm	4713	9	reduced	reduce	VBN
cord-023095-4dannjjm	4713	10	daily	daily	RB
cord-023095-4dannjjm	4713	11	dosing	dose	VBG
cord-023095-4dannjjm	4713	12	leading	lead	VBG
cord-023095-4dannjjm	4713	13	to	to	IN
cord-023095-4dannjjm	4713	14	improved	improved	JJ
cord-023095-4dannjjm	4713	15	compliance	compliance	NN
cord-023095-4dannjjm	4713	16	and	and	CC
cord-023095-4dannjjm	4713	17	relatively	relatively	RB
cord-023095-4dannjjm	4713	18	constant	constant	JJ
cord-023095-4dannjjm	4713	19	plasma	plasma	NN
cord-023095-4dannjjm	4713	20	concentrations	concentration	NNS
cord-023095-4dannjjm	4713	21	.	.	.
cord-023095-4dannjjm	4714	1	The	the	DT
cord-023095-4dannjjm	4714	2	aim	aim	NN
cord-023095-4dannjjm	4714	3	of	of	IN
cord-023095-4dannjjm	4714	4	this	this	DT
cord-023095-4dannjjm	4714	5	study	study	NN
cord-023095-4dannjjm	4714	6	was	be	VBD
cord-023095-4dannjjm	4714	7	to	to	TO
cord-023095-4dannjjm	4714	8	compare	compare	VB
cord-023095-4dannjjm	4714	9	the	the	DT
cord-023095-4dannjjm	4714	10	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	4714	11	of	of	IN
cord-023095-4dannjjm	4714	12	levetiracetam	levetiracetam	NNP
cord-023095-4dannjjm	4714	13	XR	XR	NNP
cord-023095-4dannjjm	4714	14	tablets	tablet	NNS
cord-023095-4dannjjm	4714	15	with	with	IN
cord-023095-4dannjjm	4714	16	immediate	immediate	JJ
cord-023095-4dannjjm	4714	17	release	release	NN
cord-023095-4dannjjm	4714	18	(	(	-LRB-
cord-023095-4dannjjm	4714	19	IR	IR	NNP
cord-023095-4dannjjm	4714	20	)	)	-RRB-
cord-023095-4dannjjm	4714	21	tablets	tablet	NNS
cord-023095-4dannjjm	4714	22	following	follow	VBG
cord-023095-4dannjjm	4714	23	single	single	JJ
cord-023095-4dannjjm	4714	24	dosing	dosing	NN
cord-023095-4dannjjm	4714	25	in	in	IN
cord-023095-4dannjjm	4714	26	dogs	dog	NNS
cord-023095-4dannjjm	4714	27	.	.	.
cord-023095-4dannjjm	4715	1	Five	five	CD
cord-023095-4dannjjm	4715	2	clinically	clinically	RB
cord-023095-4dannjjm	4715	3	and	and	CC
cord-023095-4dannjjm	4715	4	neurologically	neurologically	RB
cord-023095-4dannjjm	4715	5	normal	normal	JJ
cord-023095-4dannjjm	4715	6	mixed	mixed	JJ
cord-023095-4dannjjm	4715	7	breed	breed	NN
cord-023095-4dannjjm	4715	8	dogs	dog	NNS
cord-023095-4dannjjm	4715	9	were	be	VBD
cord-023095-4dannjjm	4715	10	used	use	VBN
cord-023095-4dannjjm	4715	11	in	in	IN
cord-023095-4dannjjm	4715	12	a	a	DT
cord-023095-4dannjjm	4715	13	cross	cross	NN
cord-023095-4dannjjm	4715	14	-	-	HYPH
cord-023095-4dannjjm	4715	15	over	over	RP
cord-023095-4dannjjm	4715	16	design	design	NN
cord-023095-4dannjjm	4715	17	.	.	.
cord-023095-4dannjjm	4716	1	All	all	DT
cord-023095-4dannjjm	4716	2	dogs	dog	NNS
cord-023095-4dannjjm	4716	3	(	(	-LRB-
cord-023095-4dannjjm	4716	4	mean	mean	VB
cord-023095-4dannjjm	4716	5	body	body	NN
cord-023095-4dannjjm	4716	6	weight	weight	NN
cord-023095-4dannjjm	4716	7	25.9	25.9	CD
cord-023095-4dannjjm	4716	8	kg	kg	NNS
cord-023095-4dannjjm	4716	9	;	;	:
cord-023095-4dannjjm	4716	10	range	range	VBP
cord-023095-4dannjjm	4716	11	23.2	23.2	CD
cord-023095-4dannjjm	4716	12	-	-	HYPH
cord-023095-4dannjjm	4716	13	30.5	30.5	CD
cord-023095-4dannjjm	4716	14	)	)	-RRB-
cord-023095-4dannjjm	4716	15	had	have	VBD
cord-023095-4dannjjm	4716	16	normal	normal	JJ
cord-023095-4dannjjm	4716	17	hematology	hematology	NN
cord-023095-4dannjjm	4716	18	,	,	,
cord-023095-4dannjjm	4716	19	serum	serum	NN
cord-023095-4dannjjm	4716	20	chemistry	chemistry	NN
cord-023095-4dannjjm	4716	21	and	and	CC
cord-023095-4dannjjm	4716	22	urinalyses	urinalysis	NNS
cord-023095-4dannjjm	4716	23	.	.	.
cord-023095-4dannjjm	4717	1	Following	follow	VBG
cord-023095-4dannjjm	4717	2	a	a	DT
cord-023095-4dannjjm	4717	3	12	12	CD
cord-023095-4dannjjm	4717	4	hour	hour	NN
cord-023095-4dannjjm	4717	5	fast	fast	RB
cord-023095-4dannjjm	4717	6	,	,	,
cord-023095-4dannjjm	4717	7	each	each	DT
cord-023095-4dannjjm	4717	8	dog	dog	NN
cord-023095-4dannjjm	4717	9	was	be	VBD
cord-023095-4dannjjm	4717	10	administered	administer	VBN
cord-023095-4dannjjm	4717	11	oral	oral	JJ
cord-023095-4dannjjm	4717	12	IR	IR	NNP
cord-023095-4dannjjm	4717	13	levetiracetam	levetiracetam	NNP
cord-023095-4dannjjm	4717	14	(	(	-LRB-
cord-023095-4dannjjm	4717	15	500	500	CD
cord-023095-4dannjjm	4717	16	mg	mg	NN
cord-023095-4dannjjm	4717	17	;	;	:
cord-023095-4dannjjm	4717	18	mean	mean	VB
cord-023095-4dannjjm	4717	19	dose	dose	NN
cord-023095-4dannjjm	4717	20	19.3	19.3	CD
cord-023095-4dannjjm	4717	21	mg	mg	NNP
cord-023095-4dannjjm	4717	22	/	/	SYM
cord-023095-4dannjjm	4717	23	kg	kg	NNP
cord-023095-4dannjjm	4717	24	;	;	:
cord-023095-4dannjjm	4717	25	range	range	VBP
cord-023095-4dannjjm	4717	26	16.4	16.4	CD
cord-023095-4dannjjm	4717	27	-	-	HYPH
cord-023095-4dannjjm	4717	28	21.6	21.6	CD
cord-023095-4dannjjm	4717	29	)	)	-RRB-
cord-023095-4dannjjm	4717	30	.	.	.
cord-023095-4dannjjm	4718	1	Heparinized	heparinize	VBN
cord-023095-4dannjjm	4718	2	blood	blood	NN
cord-023095-4dannjjm	4718	3	for	for	IN
cord-023095-4dannjjm	4718	4	drug	drug	NN
cord-023095-4dannjjm	4718	5	analysis	analysis	NN
cord-023095-4dannjjm	4718	6	was	be	VBD
cord-023095-4dannjjm	4718	7	taken	take	VBN
cord-023095-4dannjjm	4718	8	from	from	IN
cord-023095-4dannjjm	4718	9	each	each	DT
cord-023095-4dannjjm	4718	10	dog	dog	NN
cord-023095-4dannjjm	4718	11	prior	prior	RB
cord-023095-4dannjjm	4718	12	to	to	IN
cord-023095-4dannjjm	4718	13	administration	administration	NN
cord-023095-4dannjjm	4718	14	and	and	CC
cord-023095-4dannjjm	4718	15	0.25	0.25	CD
cord-023095-4dannjjm	4718	16	,	,	,
cord-023095-4dannjjm	4718	17	0.5	0.5	CD
cord-023095-4dannjjm	4718	18	,	,	,
cord-023095-4dannjjm	4718	19	0.75	0.75	CD
cord-023095-4dannjjm	4718	20	,	,	,
cord-023095-4dannjjm	4718	21	1	1	CD
cord-023095-4dannjjm	4718	22	,	,	,
cord-023095-4dannjjm	4718	23	2	2	CD
cord-023095-4dannjjm	4718	24	,	,	,
cord-023095-4dannjjm	4718	25	4	4	CD
cord-023095-4dannjjm	4718	26	and	and	CC
cord-023095-4dannjjm	4718	27	8	8	CD
cord-023095-4dannjjm	4718	28	hours	hour	NNS
cord-023095-4dannjjm	4718	29	after	after	RB
cord-023095-4dannjjm	4718	30	.	.	.
cord-023095-4dannjjm	4719	1	Blood	blood	NN
cord-023095-4dannjjm	4719	2	was	be	VBD
cord-023095-4dannjjm	4719	3	immediately	immediately	RB
cord-023095-4dannjjm	4719	4	centrifuged	centrifuge	VBN
cord-023095-4dannjjm	4719	5	and	and	CC
cord-023095-4dannjjm	4719	6	supernatant	supernatant	JJ
cord-023095-4dannjjm	4719	7	plasma	plasma	NN
cord-023095-4dannjjm	4719	8	was	be	VBD
cord-023095-4dannjjm	4719	9	stored	store	VBN
cord-023095-4dannjjm	4719	10	at	at	IN
cord-023095-4dannjjm	4719	11	À801C	À801C	NNPS
cord-023095-4dannjjm	4719	12	until	until	IN
cord-023095-4dannjjm	4719	13	analysis	analysis	NN
cord-023095-4dannjjm	4719	14	.	.	.
cord-023095-4dannjjm	4720	1	After	after	IN
cord-023095-4dannjjm	4720	2	a	a	DT
cord-023095-4dannjjm	4720	3	4	4	CD
cord-023095-4dannjjm	4720	4	day	day	NN
cord-023095-4dannjjm	4720	5	wash	wash	NN
cord-023095-4dannjjm	4720	6	-	-	HYPH
cord-023095-4dannjjm	4720	7	out	out	RP
cord-023095-4dannjjm	4720	8	period	period	NN
cord-023095-4dannjjm	4720	9	,	,	,
cord-023095-4dannjjm	4720	10	each	each	DT
cord-023095-4dannjjm	4720	11	dog	dog	NN
cord-023095-4dannjjm	4720	12	was	be	VBD
cord-023095-4dannjjm	4720	13	administered	administer	VBN
cord-023095-4dannjjm	4720	14	500	500	CD
cord-023095-4dannjjm	4720	15	mg	mg	NNP
cord-023095-4dannjjm	4720	16	oral	oral	JJ
cord-023095-4dannjjm	4720	17	XR	XR	NNP
cord-023095-4dannjjm	4720	18	levetiracetam	levetiracetam	NNS
cord-023095-4dannjjm	4720	19	and	and	CC
cord-023095-4dannjjm	4720	20	blood	blood	NN
cord-023095-4dannjjm	4720	21	samples	sample	NNS
cord-023095-4dannjjm	4720	22	were	be	VBD
cord-023095-4dannjjm	4720	23	taken	take	VBN
cord-023095-4dannjjm	4720	24	at	at	IN
cord-023095-4dannjjm	4720	25	identical	identical	JJ
cord-023095-4dannjjm	4720	26	timings	timing	NNS
cord-023095-4dannjjm	4720	27	.	.	.
cord-023095-4dannjjm	4721	1	Plasma	plasma	NN
cord-023095-4dannjjm	4721	2	samples	sample	NNS
cord-023095-4dannjjm	4721	3	were	be	VBD
cord-023095-4dannjjm	4721	4	thawed	thaw	VBN
cord-023095-4dannjjm	4721	5	at	at	IN
cord-023095-4dannjjm	4721	6	room	room	NN
cord-023095-4dannjjm	4721	7	temperature	temperature	NN
cord-023095-4dannjjm	4721	8	before	before	IN
cord-023095-4dannjjm	4721	9	preparation	preparation	NN
cord-023095-4dannjjm	4721	10	by	by	IN
cord-023095-4dannjjm	4721	11	solid	solid	JJ
cord-023095-4dannjjm	4721	12	phase	phase	NN
cord-023095-4dannjjm	4721	13	extraction	extraction	NN
cord-023095-4dannjjm	4721	14	for	for	IN
cord-023095-4dannjjm	4721	15	HPLC	HPLC	NNP
cord-023095-4dannjjm	4721	16	analysis	analysis	NN
cord-023095-4dannjjm	4721	17	.	.	.
cord-023095-4dannjjm	4722	1	Reverse	reverse	JJ
cord-023095-4dannjjm	4722	2	phase	phase	NN
cord-023095-4dannjjm	4722	3	chromatographic	chromatographic	JJ
cord-023095-4dannjjm	4722	4	separation	separation	NN
cord-023095-4dannjjm	4722	5	was	be	VBD
cord-023095-4dannjjm	4722	6	performed	perform	VBN
cord-023095-4dannjjm	4722	7	.	.	.
cord-023095-4dannjjm	4723	1	Levetiracetam	Levetiracetam	NNS
cord-023095-4dannjjm	4723	2	and	and	CC
cord-023095-4dannjjm	4723	3	an	an	DT
cord-023095-4dannjjm	4723	4	internal	internal	JJ
cord-023095-4dannjjm	4723	5	standard	standard	NN
cord-023095-4dannjjm	4723	6	were	be	VBD
cord-023095-4dannjjm	4723	7	detected	detect	VBN
cord-023095-4dannjjm	4723	8	using	use	VBG
cord-023095-4dannjjm	4723	9	ultraviolet	ultraviolet	NN
cord-023095-4dannjjm	4723	10	spectroscopy	spectroscopy	NN
cord-023095-4dannjjm	4723	11	at	at	IN
cord-023095-4dannjjm	4723	12	205	205	CD
cord-023095-4dannjjm	4723	13	nm	nm	NN
cord-023095-4dannjjm	4723	14	.	.	.
cord-023095-4dannjjm	4724	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	4724	2	of	of	IN
cord-023095-4dannjjm	4724	3	levetiracetam	levetiracetam	NNS
cord-023095-4dannjjm	4724	4	were	be	VBD
cord-023095-4dannjjm	4724	5	determined	determine	VBN
cord-023095-4dannjjm	4724	6	by	by	IN
cord-023095-4dannjjm	4724	7	peak	peak	NN
cord-023095-4dannjjm	4724	8	area	area	NN
cord-023095-4dannjjm	4724	9	comparison	comparison	NN
cord-023095-4dannjjm	4724	10	to	to	IN
cord-023095-4dannjjm	4724	11	the	the	DT
cord-023095-4dannjjm	4724	12	internal	internal	JJ
cord-023095-4dannjjm	4724	13	standard	standard	NN
cord-023095-4dannjjm	4724	14	.	.	.
cord-023095-4dannjjm	4725	1	Mean	mean	JJ
cord-023095-4dannjjm	4725	2	data	datum	NNS
cord-023095-4dannjjm	4725	3	were	be	VBD
cord-023095-4dannjjm	4725	4	fit	fit	JJ
cord-023095-4dannjjm	4725	5	to	to	IN
cord-023095-4dannjjm	4725	6	a	a	DT
cord-023095-4dannjjm	4725	7	one	one	CD
cord-023095-4dannjjm	4725	8	compartment	compartment	NN
cord-023095-4dannjjm	4725	9	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	4725	10	model	model	NN
cord-023095-4dannjjm	4725	11	with	with	IN
cord-023095-4dannjjm	4725	12	first	first	JJ
cord-023095-4dannjjm	4725	13	order	order	NN
cord-023095-4dannjjm	4725	14	elimination	elimination	NN
cord-023095-4dannjjm	4725	15	and	and	CC
cord-023095-4dannjjm	4725	16	absorption	absorption	NN
cord-023095-4dannjjm	4725	17	and	and	CC
cord-023095-4dannjjm	4725	18	included	include	VBD
cord-023095-4dannjjm	4725	19	a	a	DT
cord-023095-4dannjjm	4725	20	lag	lag	NN
cord-023095-4dannjjm	4725	21	-	-	HYPH
cord-023095-4dannjjm	4725	22	phase	phase	NN
cord-023095-4dannjjm	4725	23	for	for	IN
cord-023095-4dannjjm	4725	24	XR	XR	NNP
cord-023095-4dannjjm	4725	25	formulation	formulation	NN
cord-023095-4dannjjm	4725	26	.	.	.
cord-023095-4dannjjm	4726	1	No	no	DT
cord-023095-4dannjjm	4726	2	adverse	adverse	JJ
cord-023095-4dannjjm	4726	3	clinical	clinical	JJ
cord-023095-4dannjjm	4726	4	effects	effect	NNS
cord-023095-4dannjjm	4726	5	were	be	VBD
cord-023095-4dannjjm	4726	6	noted	note	VBN
cord-023095-4dannjjm	4726	7	in	in	IN
cord-023095-4dannjjm	4726	8	any	any	DT
cord-023095-4dannjjm	4726	9	of	of	IN
cord-023095-4dannjjm	4726	10	the	the	DT
cord-023095-4dannjjm	4726	11	dogs	dog	NNS
cord-023095-4dannjjm	4726	12	.	.	.
cord-023095-4dannjjm	4727	1	The	the	DT
cord-023095-4dannjjm	4727	2	AUC	AUC	NNP
cord-023095-4dannjjm	4727	3	associated	associate	VBN
cord-023095-4dannjjm	4727	4	with	with	IN
cord-023095-4dannjjm	4727	5	XR	XR	NNP
cord-023095-4dannjjm	4727	6	was	be	VBD
cord-023095-4dannjjm	4727	7	230	230	CD
cord-023095-4dannjjm	4727	8	hr	hr	NN
cord-023095-4dannjjm	4727	9	ug	ug	NNP
cord-023095-4dannjjm	4727	10	/	/	SYM
cord-023095-4dannjjm	4727	11	mL	mL	NNP
cord-023095-4dannjjm	4727	12	,	,	,
cord-023095-4dannjjm	4727	13	a	a	DT
cord-023095-4dannjjm	4727	14	5.14	5.14	CD
cord-023095-4dannjjm	4727	15	fold	fold	NN
cord-023095-4dannjjm	4727	16	increase	increase	NN
cord-023095-4dannjjm	4727	17	over	over	IN
cord-023095-4dannjjm	4727	18	that	that	DT
cord-023095-4dannjjm	4727	19	with	with	IN
cord-023095-4dannjjm	4727	20	IR	IR	NNP
cord-023095-4dannjjm	4727	21	(	(	-LRB-
cord-023095-4dannjjm	4727	22	44.8	44.8	CD
cord-023095-4dannjjm	4727	23	hr	hr	NN
cord-023095-4dannjjm	4727	24	ug	ug	NNP
cord-023095-4dannjjm	4727	25	/	/	SYM
cord-023095-4dannjjm	4727	26	mL	mL	NNP
cord-023095-4dannjjm	4727	27	)	)	-RRB-
cord-023095-4dannjjm	4727	28	.	.	.
cord-023095-4dannjjm	4728	1	The	the	DT
cord-023095-4dannjjm	4728	2	absorption	absorption	NN
cord-023095-4dannjjm	4728	3	half	half	JJ
cord-023095-4dannjjm	4728	4	-	-	HYPH
cord-023095-4dannjjm	4728	5	life	life	NN
cord-023095-4dannjjm	4728	6	was	be	VBD
cord-023095-4dannjjm	4728	7	3.2	3.2	CD
cord-023095-4dannjjm	4728	8	hr	hr	NN
cord-023095-4dannjjm	4728	9	with	with	IN
cord-023095-4dannjjm	4728	10	XR	XR	NNP
cord-023095-4dannjjm	4728	11	and	and	CC
cord-023095-4dannjjm	4728	12	0.41	0.41	CD
cord-023095-4dannjjm	4728	13	hr	hr	NN
cord-023095-4dannjjm	4728	14	with	with	IN
cord-023095-4dannjjm	4728	15	IR	IR	NNP
cord-023095-4dannjjm	4728	16	,	,	,
cord-023095-4dannjjm	4728	17	a	a	DT
cord-023095-4dannjjm	4728	18	7.75	7.75	CD
cord-023095-4dannjjm	4728	19	fold	fold	JJ
cord-023095-4dannjjm	4728	20	difference	difference	NN
cord-023095-4dannjjm	4728	21	.	.	.
cord-023095-4dannjjm	4729	1	The	the	DT
cord-023095-4dannjjm	4729	2	elimination	elimination	NN
cord-023095-4dannjjm	4729	3	halflife	halflife	NN
cord-023095-4dannjjm	4729	4	was	be	VBD
cord-023095-4dannjjm	4729	5	3.13	3.13	CD
cord-023095-4dannjjm	4729	6	hr	hr	NN
cord-023095-4dannjjm	4729	7	with	with	IN
cord-023095-4dannjjm	4729	8	XR	XR	NNP
cord-023095-4dannjjm	4729	9	and	and	CC
cord-023095-4dannjjm	4729	10	2.19hr	2.19hr	CD
cord-023095-4dannjjm	4729	11	with	with	IN
cord-023095-4dannjjm	4729	12	IR	IR	NNP
cord-023095-4dannjjm	4729	13	,	,	,
cord-023095-4dannjjm	4729	14	a	a	DT
cord-023095-4dannjjm	4729	15	1.43	1.43	CD
cord-023095-4dannjjm	4729	16	fold	fold	NN
cord-023095-4dannjjm	4729	17	difference	difference	NN
cord-023095-4dannjjm	4729	18	.	.	.
cord-023095-4dannjjm	4730	1	The	the	DT
cord-023095-4dannjjm	4730	2	Tmax	Tmax	NNP
cord-023095-4dannjjm	4730	3	associated	associate	VBD
cord-023095-4dannjjm	4730	4	with	with	IN
cord-023095-4dannjjm	4730	5	XR	XR	NNP
cord-023095-4dannjjm	4730	6	5.01	5.01	CD
cord-023095-4dannjjm	4730	7	hr	hr	NN
cord-023095-4dannjjm	4730	8	and	and	CC
cord-023095-4dannjjm	4730	9	1.22	1.22	CD
cord-023095-4dannjjm	4730	10	hr	hr	NN
cord-023095-4dannjjm	4730	11	with	with	IN
cord-023095-4dannjjm	4730	12	IR	IR	NNP
cord-023095-4dannjjm	4730	13	,	,	,
cord-023095-4dannjjm	4730	14	a	a	DT
cord-023095-4dannjjm	4730	15	4.21	4.21	CD
cord-023095-4dannjjm	4730	16	fold	fold	JJ
cord-023095-4dannjjm	4730	17	difference	difference	NN
cord-023095-4dannjjm	4730	18	.	.	.
cord-023095-4dannjjm	4731	1	The	the	DT
cord-023095-4dannjjm	4731	2	Cmax	Cmax	NNP
cord-023095-4dannjjm	4731	3	associated	associate	VBD
cord-023095-4dannjjm	4731	4	with	with	IN
cord-023095-4dannjjm	4731	5	XR	XR	NNP
cord-023095-4dannjjm	4731	6	was	be	VBD
cord-023095-4dannjjm	4731	7	18.5	18.5	CD
cord-023095-4dannjjm	4731	8	mg	mg	NNP
cord-023095-4dannjjm	4731	9	/	/	SYM
cord-023095-4dannjjm	4731	10	mL	mL	NNP
cord-023095-4dannjjm	4731	11	and	and	CC
cord-023095-4dannjjm	4731	12	9.62	9.62	CD
cord-023095-4dannjjm	4731	13	mg	mg	NNP
cord-023095-4dannjjm	4731	14	/	/	SYM
cord-023095-4dannjjm	4731	15	mL	ml	NN
cord-023095-4dannjjm	4731	16	with	with	IN
cord-023095-4dannjjm	4731	17	IR	IR	NNP
cord-023095-4dannjjm	4731	18	,	,	,
cord-023095-4dannjjm	4731	19	a	a	DT
cord-023095-4dannjjm	4731	20	1.92	1.92	CD
cord-023095-4dannjjm	4731	21	fold	fold	NN
cord-023095-4dannjjm	4731	22	difference	difference	NN
cord-023095-4dannjjm	4731	23	.	.	.
cord-023095-4dannjjm	4732	1	The	the	DT
cord-023095-4dannjjm	4732	2	plasma	plasma	NN
cord-023095-4dannjjm	4732	3	concentration	concentration	NN
cord-023095-4dannjjm	4732	4	of	of	IN
cord-023095-4dannjjm	4732	5	IR	IR	NNP
cord-023095-4dannjjm	4732	6	levetiracetam	levetiracetam	NNP
cord-023095-4dannjjm	4732	7	was	be	VBD
cord-023095-4dannjjm	4732	8	not	not	RB
cord-023095-4dannjjm	4732	9	detectable	detectable	JJ
cord-023095-4dannjjm	4732	10	at	at	IN
cord-023095-4dannjjm	4732	11	8hr	8hr	NN
cord-023095-4dannjjm	4732	12	after	after	IN
cord-023095-4dannjjm	4732	13	administration	administration	NN
cord-023095-4dannjjm	4732	14	whereas	whereas	IN
cord-023095-4dannjjm	4732	15	it	-PRON-	PRP
cord-023095-4dannjjm	4732	16	was	be	VBD
cord-023095-4dannjjm	4732	17	greater	great	JJR
cord-023095-4dannjjm	4732	18	than	than	IN
cord-023095-4dannjjm	4732	19	10	10	CD
cord-023095-4dannjjm	4732	20	mg	mg	NN
cord-023095-4dannjjm	4732	21	/	/	SYM
cord-023095-4dannjjm	4732	22	mL	ml	NN
cord-023095-4dannjjm	4732	23	at	at	IN
cord-023095-4dannjjm	4732	24	8hr	8hr	NN
cord-023095-4dannjjm	4732	25	after	after	IN
cord-023095-4dannjjm	4732	26	XR	XR	NNP
cord-023095-4dannjjm	4732	27	administration	administration	NN
cord-023095-4dannjjm	4732	28	.	.	.
cord-023095-4dannjjm	4733	1	Based	base	VBN
cord-023095-4dannjjm	4733	2	on	on	IN
cord-023095-4dannjjm	4733	3	the	the	DT
cord-023095-4dannjjm	4733	4	AUC	AUC	NNP
cord-023095-4dannjjm	4733	5	data	datum	NNS
cord-023095-4dannjjm	4733	6	,	,	,
cord-023095-4dannjjm	4733	7	there	there	EX
cord-023095-4dannjjm	4733	8	is	be	VBZ
cord-023095-4dannjjm	4733	9	an	an	DT
cord-023095-4dannjjm	4733	10	approximately	approximately	RB
cord-023095-4dannjjm	4733	11	5	5	CD
cord-023095-4dannjjm	4733	12	fold	fold	JJ
cord-023095-4dannjjm	4733	13	increase	increase	NN
cord-023095-4dannjjm	4733	14	in	in	IN
cord-023095-4dannjjm	4733	15	bioavailability	bioavailability	NN
cord-023095-4dannjjm	4733	16	of	of	IN
cord-023095-4dannjjm	4733	17	the	the	DT
cord-023095-4dannjjm	4733	18	XR	XR	NNP
cord-023095-4dannjjm	4733	19	compared	compare	VBN
cord-023095-4dannjjm	4733	20	to	to	IN
cord-023095-4dannjjm	4733	21	the	the	DT
cord-023095-4dannjjm	4733	22	IR	IR	NNP
cord-023095-4dannjjm	4733	23	formulation	formulation	NN
cord-023095-4dannjjm	4733	24	.	.	.
cord-023095-4dannjjm	4734	1	The	the	DT
cord-023095-4dannjjm	4734	2	Cmax	Cmax	NNP
cord-023095-4dannjjm	4734	3	was	be	VBD
cord-023095-4dannjjm	4734	4	approximately	approximately	RB
cord-023095-4dannjjm	4734	5	2	2	CD
cord-023095-4dannjjm	4734	6	times	time	NNS
cord-023095-4dannjjm	4734	7	greater	great	JJR
cord-023095-4dannjjm	4734	8	following	follow	VBG
cord-023095-4dannjjm	4734	9	XR	XR	NNP
cord-023095-4dannjjm	4734	10	administration	administration	NN
cord-023095-4dannjjm	4734	11	and	and	CC
cord-023095-4dannjjm	4734	12	a	a	DT
cord-023095-4dannjjm	4734	13	high	high	JJ
cord-023095-4dannjjm	4734	14	plasma	plasma	NN
cord-023095-4dannjjm	4734	15	level	level	NN
cord-023095-4dannjjm	4734	16	in	in	IN
cord-023095-4dannjjm	4734	17	excess	excess	NN
cord-023095-4dannjjm	4734	18	of	of	IN
cord-023095-4dannjjm	4734	19	the	the	DT
cord-023095-4dannjjm	4734	20	suggested	suggest	VBN
cord-023095-4dannjjm	4734	21	canine	canine	JJ
cord-023095-4dannjjm	4734	22	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	4734	23	concentration	concentration	NN
cord-023095-4dannjjm	4734	24	(	(	-LRB-
cord-023095-4dannjjm	4734	25	5	5	CD
cord-023095-4dannjjm	4734	26	mg	mg	NNP
cord-023095-4dannjjm	4734	27	/	/	SYM
cord-023095-4dannjjm	4734	28	mL	mL	NNP
cord-023095-4dannjjm	4734	29	)	)	-RRB-
cord-023095-4dannjjm	4734	30	for	for	IN
cord-023095-4dannjjm	4734	31	at	at	RB
cord-023095-4dannjjm	4734	32	least	least	JJS
cord-023095-4dannjjm	4734	33	8	8	CD
cord-023095-4dannjjm	4734	34	hours	hour	NNS
cord-023095-4dannjjm	4734	35	.	.	.
cord-023095-4dannjjm	4735	1	Although	although	IN
cord-023095-4dannjjm	4735	2	specific	specific	JJ
cord-023095-4dannjjm	4735	3	dosing	dosing	NN
cord-023095-4dannjjm	4735	4	recommendations	recommendation	NNS
cord-023095-4dannjjm	4735	5	can	can	MD
cord-023095-4dannjjm	4735	6	not	not	RB
cord-023095-4dannjjm	4735	7	be	be	VB
cord-023095-4dannjjm	4735	8	made	make	VBN
cord-023095-4dannjjm	4735	9	from	from	IN
cord-023095-4dannjjm	4735	10	this	this	DT
cord-023095-4dannjjm	4735	11	data	data	NN
cord-023095-4dannjjm	4735	12	,	,	,
cord-023095-4dannjjm	4735	13	the	the	DT
cord-023095-4dannjjm	4735	14	favorable	favorable	JJ
cord-023095-4dannjjm	4735	15	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	4735	16	of	of	IN
cord-023095-4dannjjm	4735	17	XR	XR	NNP
cord-023095-4dannjjm	4735	18	over	over	IN
cord-023095-4dannjjm	4735	19	IR	IR	NNP
cord-023095-4dannjjm	4735	20	suggests	suggest	VBZ
cord-023095-4dannjjm	4735	21	that	that	IN
cord-023095-4dannjjm	4735	22	single	single	JJ
cord-023095-4dannjjm	4735	23	,	,	,
cord-023095-4dannjjm	4735	24	daily	daily	JJ
cord-023095-4dannjjm	4735	25	administration	administration	NN
cord-023095-4dannjjm	4735	26	could	could	MD
cord-023095-4dannjjm	4735	27	be	be	VB
cord-023095-4dannjjm	4735	28	efficacious	efficacious	JJ
cord-023095-4dannjjm	4735	29	.	.	.
cord-023095-4dannjjm	4736	1	Thoracic	thoracic	JJ
cord-023095-4dannjjm	4736	2	and	and	CC
cord-023095-4dannjjm	4736	3	lumbar	lumbar	JJ
cord-023095-4dannjjm	4736	4	vertebrae	vertebra	NNS
cord-023095-4dannjjm	4736	5	are	be	VBP
cord-023095-4dannjjm	4736	6	frequently	frequently	RB
cord-023095-4dannjjm	4736	7	affected	affect	VBN
cord-023095-4dannjjm	4736	8	by	by	IN
cord-023095-4dannjjm	4736	9	fractures	fracture	NNS
cord-023095-4dannjjm	4736	10	and	and	CC
cord-023095-4dannjjm	4736	11	or	or	CC
cord-023095-4dannjjm	4736	12	luxations	luxation	NNS
cord-023095-4dannjjm	4736	13	in	in	IN
cord-023095-4dannjjm	4736	14	dogs	dog	NNS
cord-023095-4dannjjm	4736	15	following	follow	VBG
cord-023095-4dannjjm	4736	16	trauma	trauma	NN
cord-023095-4dannjjm	4736	17	.	.	.
cord-023095-4dannjjm	4737	1	Surgical	surgical	JJ
cord-023095-4dannjjm	4737	2	repair	repair	NN
cord-023095-4dannjjm	4737	3	is	be	VBZ
cord-023095-4dannjjm	4737	4	part	part	NN
cord-023095-4dannjjm	4737	5	of	of	IN
cord-023095-4dannjjm	4737	6	the	the	DT
cord-023095-4dannjjm	4737	7	emergency	emergency	NN
cord-023095-4dannjjm	4737	8	treatment	treatment	NN
cord-023095-4dannjjm	4737	9	described	describe	VBN
cord-023095-4dannjjm	4737	10	for	for	IN
cord-023095-4dannjjm	4737	11	this	this	DT
cord-023095-4dannjjm	4737	12	disorder	disorder	NN
cord-023095-4dannjjm	4737	13	but	but	CC
cord-023095-4dannjjm	4737	14	does	do	VBZ
cord-023095-4dannjjm	4737	15	not	not	RB
cord-023095-4dannjjm	4737	16	guarantee	guarantee	VB
cord-023095-4dannjjm	4737	17	improvement	improvement	NN
cord-023095-4dannjjm	4737	18	of	of	IN
cord-023095-4dannjjm	4737	19	the	the	DT
cord-023095-4dannjjm	4737	20	associated	associate	VBN
cord-023095-4dannjjm	4737	21	clinical	clinical	JJ
cord-023095-4dannjjm	4737	22	signs	sign	NNS
cord-023095-4dannjjm	4737	23	.	.	.
cord-023095-4dannjjm	4738	1	Multiple	multiple	JJ
cord-023095-4dannjjm	4738	2	surgical	surgical	JJ
cord-023095-4dannjjm	4738	3	repair	repair	NN
cord-023095-4dannjjm	4738	4	techniques	technique	NNS
cord-023095-4dannjjm	4738	5	have	have	VBP
cord-023095-4dannjjm	4738	6	been	be	VBN
cord-023095-4dannjjm	4738	7	described	describe	VBN
cord-023095-4dannjjm	4738	8	but	but	CC
cord-023095-4dannjjm	4738	9	have	have	VBP
cord-023095-4dannjjm	4738	10	not	not	RB
cord-023095-4dannjjm	4738	11	been	be	VBN
cord-023095-4dannjjm	4738	12	compared	compare	VBN
cord-023095-4dannjjm	4738	13	in	in	IN
cord-023095-4dannjjm	4738	14	terms	term	NNS
cord-023095-4dannjjm	4738	15	of	of	IN
cord-023095-4dannjjm	4738	16	their	-PRON-	PRP$
cord-023095-4dannjjm	4738	17	success	success	NN
cord-023095-4dannjjm	4738	18	and	and	CC
cord-023095-4dannjjm	4738	19	the	the	DT
cord-023095-4dannjjm	4738	20	factors	factor	NNS
cord-023095-4dannjjm	4738	21	associated	associate	VBN
cord-023095-4dannjjm	4738	22	with	with	IN
cord-023095-4dannjjm	4738	23	a	a	DT
cord-023095-4dannjjm	4738	24	positive	positive	JJ
cord-023095-4dannjjm	4738	25	outcome	outcome	NN
cord-023095-4dannjjm	4738	26	.	.	.
cord-023095-4dannjjm	4739	1	The	the	DT
cord-023095-4dannjjm	4739	2	aims	aim	NNS
cord-023095-4dannjjm	4739	3	of	of	IN
cord-023095-4dannjjm	4739	4	this	this	DT
cord-023095-4dannjjm	4739	5	study	study	NN
cord-023095-4dannjjm	4739	6	were	be	VBD
cord-023095-4dannjjm	4739	7	to	to	TO
cord-023095-4dannjjm	4739	8	retrospectively	retrospectively	RB
cord-023095-4dannjjm	4739	9	evaluate	evaluate	VB
cord-023095-4dannjjm	4739	10	the	the	DT
cord-023095-4dannjjm	4739	11	effect	effect	NN
cord-023095-4dannjjm	4739	12	of	of	IN
cord-023095-4dannjjm	4739	13	3	3	CD
cord-023095-4dannjjm	4739	14	different	different	JJ
cord-023095-4dannjjm	4739	15	types	type	NNS
cord-023095-4dannjjm	4739	16	of	of	IN
cord-023095-4dannjjm	4739	17	vertebral	vertebral	JJ
cord-023095-4dannjjm	4739	18	repair	repair	NN
cord-023095-4dannjjm	4739	19	,	,	,
cord-023095-4dannjjm	4739	20	injury	injury	NN
cord-023095-4dannjjm	4739	21	type	type	NN
cord-023095-4dannjjm	4739	22	and	and	CC
cord-023095-4dannjjm	4739	23	injury	injury	NN
cord-023095-4dannjjm	4739	24	location	location	NN
cord-023095-4dannjjm	4739	25	on	on	IN
cord-023095-4dannjjm	4739	26	outcome	outcome	NN
cord-023095-4dannjjm	4739	27	in	in	IN
cord-023095-4dannjjm	4739	28	dogs	dog	NNS
cord-023095-4dannjjm	4739	29	with	with	IN
cord-023095-4dannjjm	4739	30	thoracolumbar	thoracolumbar	NN
cord-023095-4dannjjm	4739	31	(	(	-LRB-
cord-023095-4dannjjm	4739	32	TL	TL	NNP
cord-023095-4dannjjm	4739	33	)	)	-RRB-
cord-023095-4dannjjm	4739	34	and	and	CC
cord-023095-4dannjjm	4739	35	lumbosacral	lumbosacral	NNP
cord-023095-4dannjjm	4739	36	(	(	-LRB-
cord-023095-4dannjjm	4739	37	LS	LS	NNP
cord-023095-4dannjjm	4739	38	)	)	-RRB-
cord-023095-4dannjjm	4739	39	spinal	spinal	JJ
cord-023095-4dannjjm	4739	40	trauma	trauma	NN
cord-023095-4dannjjm	4739	41	.	.	.
cord-023095-4dannjjm	4740	1	Medical	medical	JJ
cord-023095-4dannjjm	4740	2	records	record	NNS
cord-023095-4dannjjm	4740	3	were	be	VBD
cord-023095-4dannjjm	4740	4	searched	search	VBN
cord-023095-4dannjjm	4740	5	for	for	IN
cord-023095-4dannjjm	4740	6	dogs	dog	NNS
cord-023095-4dannjjm	4740	7	with	with	IN
cord-023095-4dannjjm	4740	8	radiographic	radiographic	JJ
cord-023095-4dannjjm	4740	9	evidence	evidence	NN
cord-023095-4dannjjm	4740	10	of	of	IN
cord-023095-4dannjjm	4740	11	a	a	DT
cord-023095-4dannjjm	4740	12	TL	TL	NNP
cord-023095-4dannjjm	4740	13	or	or	CC
cord-023095-4dannjjm	4740	14	LS	ls	NN
cord-023095-4dannjjm	4740	15	vertebral	vertebral	JJ
cord-023095-4dannjjm	4740	16	fracture	fracture	NN
cord-023095-4dannjjm	4740	17	and	and	CC
cord-023095-4dannjjm	4740	18	or	or	CC
cord-023095-4dannjjm	4740	19	luxation	luxation	NN
cord-023095-4dannjjm	4740	20	(	(	-LRB-
cord-023095-4dannjjm	4740	21	1995	1995	CD
cord-023095-4dannjjm	4740	22	)	)	-RRB-
cord-023095-4dannjjm	4741	1	(	(	-LRB-
cord-023095-4dannjjm	4741	2	1996	1996	CD
cord-023095-4dannjjm	4741	3	)	)	-RRB-
cord-023095-4dannjjm	4742	1	(	(	-LRB-
cord-023095-4dannjjm	4742	2	1997	1997	CD
cord-023095-4dannjjm	4742	3	)	)	-RRB-
cord-023095-4dannjjm	4743	1	(	(	-LRB-
cord-023095-4dannjjm	4743	2	1998	1998	CD
cord-023095-4dannjjm	4743	3	)	)	-RRB-
cord-023095-4dannjjm	4744	1	(	(	-LRB-
cord-023095-4dannjjm	4744	2	1999	1999	CD
cord-023095-4dannjjm	4744	3	)	)	-RRB-
cord-023095-4dannjjm	4745	1	(	(	-LRB-
cord-023095-4dannjjm	4745	2	2000	2000	CD
cord-023095-4dannjjm	4745	3	)	)	-RRB-
cord-023095-4dannjjm	4746	1	(	(	-LRB-
cord-023095-4dannjjm	4746	2	2001	2001	CD
cord-023095-4dannjjm	4746	3	)	)	-RRB-
cord-023095-4dannjjm	4746	4	(	(	-LRB-
cord-023095-4dannjjm	4746	5	2002	2002	CD
cord-023095-4dannjjm	4746	6	)	)	-RRB-
cord-023095-4dannjjm	4747	1	(	(	-LRB-
cord-023095-4dannjjm	4747	2	2003	2003	CD
cord-023095-4dannjjm	4747	3	)	)	-RRB-
cord-023095-4dannjjm	4748	1	(	(	-LRB-
cord-023095-4dannjjm	4748	2	2004	2004	CD
cord-023095-4dannjjm	4748	3	)	)	-RRB-
cord-023095-4dannjjm	4749	1	(	(	-LRB-
cord-023095-4dannjjm	4749	2	2005	2005	CD
cord-023095-4dannjjm	4749	3	)	)	-RRB-
cord-023095-4dannjjm	4750	1	(	(	-LRB-
cord-023095-4dannjjm	4750	2	2006	2006	CD
cord-023095-4dannjjm	4750	3	)	)	-RRB-
cord-023095-4dannjjm	4751	1	(	(	-LRB-
cord-023095-4dannjjm	4751	2	2007	2007	CD
cord-023095-4dannjjm	4751	3	)	)	-RRB-
cord-023095-4dannjjm	4752	1	(	(	-LRB-
cord-023095-4dannjjm	4752	2	2008	2008	CD
cord-023095-4dannjjm	4752	3	)	)	-RRB-
cord-023095-4dannjjm	4753	1	(	(	-LRB-
cord-023095-4dannjjm	4753	2	2009	2009	CD
cord-023095-4dannjjm	4753	3	)	)	-RRB-
cord-023095-4dannjjm	4754	1	(	(	-LRB-
cord-023095-4dannjjm	4754	2	2010	2010	CD
cord-023095-4dannjjm	4754	3	)	)	-RRB-
cord-023095-4dannjjm	4754	4	;	;	:
cord-023095-4dannjjm	4754	5	signalment	signalment	JJ
cord-023095-4dannjjm	4754	6	,	,	,
cord-023095-4dannjjm	4754	7	body	body	NN
cord-023095-4dannjjm	4754	8	weight	weight	NN
cord-023095-4dannjjm	4754	9	and	and	CC
cord-023095-4dannjjm	4754	10	duration	duration	NN
cord-023095-4dannjjm	4754	11	of	of	IN
cord-023095-4dannjjm	4754	12	disease	disease	NN
cord-023095-4dannjjm	4754	13	were	be	VBD
cord-023095-4dannjjm	4754	14	recorded	record	VBN
cord-023095-4dannjjm	4754	15	.	.	.
cord-023095-4dannjjm	4755	1	Dogs	dog	NNS
cord-023095-4dannjjm	4755	2	were	be	VBD
cord-023095-4dannjjm	4755	3	retrospectively	retrospectively	RB
cord-023095-4dannjjm	4755	4	scored	score	VBN
cord-023095-4dannjjm	4755	5	neurologically	neurologically	RB
cord-023095-4dannjjm	4755	6	(	(	-LRB-
cord-023095-4dannjjm	4755	7	0	0	CD
cord-023095-4dannjjm	4755	8	-	-	SYM
cord-023095-4dannjjm	4755	9	5	5	CD
cord-023095-4dannjjm	4755	10	;	;	,
cord-023095-4dannjjm	4755	11	normal	normal	JJ
cord-023095-4dannjjm	4755	12	to	to	IN
cord-023095-4dannjjm	4755	13	plegic	plegic	VB
cord-023095-4dannjjm	4755	14	with	with	IN
cord-023095-4dannjjm	4755	15	absent	absent	JJ
cord-023095-4dannjjm	4755	16	pain	pain	NN
cord-023095-4dannjjm	4755	17	perception	perception	NN
cord-023095-4dannjjm	4755	18	)	)	-RRB-
cord-023095-4dannjjm	4755	19	on	on	IN
cord-023095-4dannjjm	4755	20	admission	admission	NN
cord-023095-4dannjjm	4755	21	and	and	CC
cord-023095-4dannjjm	4755	22	at	at	IN
cord-023095-4dannjjm	4755	23	re	re	NN
cord-023095-4dannjjm	4755	24	-	-	NN
cord-023095-4dannjjm	4755	25	evaluation	evaluation	JJ
cord-023095-4dannjjm	4755	26	following	follow	VBG
cord-023095-4dannjjm	4755	27	surgery	surgery	NN
cord-023095-4dannjjm	4755	28	.	.	.
cord-023095-4dannjjm	4756	1	Lesion	lesion	NN
cord-023095-4dannjjm	4756	2	location	location	NN
cord-023095-4dannjjm	4756	3	was	be	VBD
cord-023095-4dannjjm	4756	4	classed	class	VBN
cord-023095-4dannjjm	4756	5	as	as	IN
cord-023095-4dannjjm	4756	6	T3-L3	T3-L3	NNP
cord-023095-4dannjjm	4756	7	and	and	CC
cord-023095-4dannjjm	4756	8	L4-S3	L4-S3	NNP
cord-023095-4dannjjm	4756	9	;	;	:
cord-023095-4dannjjm	4756	10	dogs	dog	NNS
cord-023095-4dannjjm	4756	11	were	be	VBD
cord-023095-4dannjjm	4756	12	evaluated	evaluate	VBN
cord-023095-4dannjjm	4756	13	as	as	IN
cord-023095-4dannjjm	4756	14	one	one	CD
cord-023095-4dannjjm	4756	15	group	group	NN
cord-023095-4dannjjm	4756	16	and	and	CC
cord-023095-4dannjjm	4756	17	as	as	IN
cord-023095-4dannjjm	4756	18	two	two	CD
cord-023095-4dannjjm	4756	19	separate	separate	JJ
cord-023095-4dannjjm	4756	20	groups	group	NNS
cord-023095-4dannjjm	4756	21	with	with	IN
cord-023095-4dannjjm	4756	22	respect	respect	NN
cord-023095-4dannjjm	4756	23	to	to	IN
cord-023095-4dannjjm	4756	24	outcome	outcome	NN
cord-023095-4dannjjm	4756	25	.	.	.
cord-023095-4dannjjm	4757	1	A	a	DT
cord-023095-4dannjjm	4757	2	subset	subset	NN
cord-023095-4dannjjm	4757	3	of	of	IN
cord-023095-4dannjjm	4757	4	lesions	lesion	NNS
cord-023095-4dannjjm	4757	5	were	be	VBD
cord-023095-4dannjjm	4757	6	classed	class	VBN
cord-023095-4dannjjm	4757	7	as	as	IN
cord-023095-4dannjjm	4757	8	cord	cord	NN
cord-023095-4dannjjm	4757	9	compression	compression	NN
cord-023095-4dannjjm	4757	10	or	or	CC
cord-023095-4dannjjm	4757	11	not	not	RB
cord-023095-4dannjjm	4757	12	based	base	VBN
cord-023095-4dannjjm	4757	13	on	on	IN
cord-023095-4dannjjm	4757	14	advanced	advanced	JJ
cord-023095-4dannjjm	4757	15	imaging	imaging	NN
cord-023095-4dannjjm	4757	16	.	.	.
cord-023095-4dannjjm	4758	1	Three	three	CD
cord-023095-4dannjjm	4758	2	repair	repair	NN
cord-023095-4dannjjm	4758	3	techniques	technique	NNS
cord-023095-4dannjjm	4758	4	were	be	VBD
cord-023095-4dannjjm	4758	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	4758	6	(	(	-LRB-
cord-023095-4dannjjm	4758	7	i	i	NN
cord-023095-4dannjjm	4758	8	)	)	-RRB-
cord-023095-4dannjjm	4758	9	pins	pin	NNS
cord-023095-4dannjjm	4758	10	and	and	CC
cord-023095-4dannjjm	4758	11	polymethylmethacrylate	polymethylmethacrylate	NNP
cord-023095-4dannjjm	4758	12	(	(	-LRB-
cord-023095-4dannjjm	4758	13	PMMA	PMMA	NNP
cord-023095-4dannjjm	4758	14	)	)	-RRB-
cord-023095-4dannjjm	4758	15	;	;	:
cord-023095-4dannjjm	4758	16	(	(	-LRB-
cord-023095-4dannjjm	4758	17	ii	ii	NN
cord-023095-4dannjjm	4758	18	)	)	-RRB-
cord-023095-4dannjjm	4758	19	screws	screw	NNS
cord-023095-4dannjjm	4758	20	and	and	CC
cord-023095-4dannjjm	4758	21	PMMA	PMMA	NNP
cord-023095-4dannjjm	4758	22	;	;	:
cord-023095-4dannjjm	4758	23	and	and	CC
cord-023095-4dannjjm	4758	24	(	(	-LRB-
cord-023095-4dannjjm	4758	25	iii	iii	NN
cord-023095-4dannjjm	4758	26	)	)	-RRB-
cord-023095-4dannjjm	4758	27	spinal	spinal	JJ
cord-023095-4dannjjm	4758	28	stapling	stapling	NN
cord-023095-4dannjjm	4758	29	.	.	.
cord-023095-4dannjjm	4759	1	Regression	regression	NN
cord-023095-4dannjjm	4759	2	analysis	analysis	NN
cord-023095-4dannjjm	4759	3	was	be	VBD
cord-023095-4dannjjm	4759	4	applied	apply	VBN
cord-023095-4dannjjm	4759	5	to	to	TO
cord-023095-4dannjjm	4759	6	test	test	VB
cord-023095-4dannjjm	4759	7	for	for	IN
cord-023095-4dannjjm	4759	8	an	an	DT
cord-023095-4dannjjm	4759	9	association	association	NN
cord-023095-4dannjjm	4759	10	between	between	IN
cord-023095-4dannjjm	4759	11	the	the	DT
cord-023095-4dannjjm	4759	12	type	type	NN
cord-023095-4dannjjm	4759	13	of	of	IN
cord-023095-4dannjjm	4759	14	surgery	surgery	NN
cord-023095-4dannjjm	4759	15	and	and	CC
cord-023095-4dannjjm	4759	16	a	a	DT
cord-023095-4dannjjm	4759	17	successful	successful	JJ
cord-023095-4dannjjm	4759	18	outcome	outcome	NN
cord-023095-4dannjjm	4759	19	(	(	-LRB-
cord-023095-4dannjjm	4759	20	non	non	JJ
cord-023095-4dannjjm	4759	21	-	-	JJ
cord-023095-4dannjjm	4759	22	painful	painful	JJ
cord-023095-4dannjjm	4759	23	and	and	CC
cord-023095-4dannjjm	4759	24	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	4759	25	)	)	-RRB-
cord-023095-4dannjjm	4759	26	.	.	.
cord-023095-4dannjjm	4760	1	Simple	simple	JJ
cord-023095-4dannjjm	4760	2	bivariate	bivariate	JJ
cord-023095-4dannjjm	4760	3	analyses	analysis	NNS
cord-023095-4dannjjm	4760	4	were	be	VBD
cord-023095-4dannjjm	4760	5	performed	perform	VBN
cord-023095-4dannjjm	4760	6	to	to	TO
cord-023095-4dannjjm	4760	7	investigate	investigate	VB
cord-023095-4dannjjm	4760	8	for	for	IN
cord-023095-4dannjjm	4760	9	variables	variable	NNS
cord-023095-4dannjjm	4760	10	predictive	predictive	JJ
cord-023095-4dannjjm	4760	11	of	of	IN
cord-023095-4dannjjm	4760	12	a	a	DT
cord-023095-4dannjjm	4760	13	successful	successful	JJ
cord-023095-4dannjjm	4760	14	outcome	outcome	NN
cord-023095-4dannjjm	4760	15	.	.	.
cord-023095-4dannjjm	4761	1	Fifty	fifty	CD
cord-023095-4dannjjm	4761	2	-	-	HYPH
cord-023095-4dannjjm	4761	3	nine	nine	CD
cord-023095-4dannjjm	4761	4	dogs	dog	NNS
cord-023095-4dannjjm	4761	5	were	be	VBD
cord-023095-4dannjjm	4761	6	included	include	VBN
cord-023095-4dannjjm	4761	7	.	.	.
cord-023095-4dannjjm	4762	1	Twenty	twenty	CD
cord-023095-4dannjjm	4762	2	-	-	HYPH
cord-023095-4dannjjm	4762	3	eight	eight	CD
cord-023095-4dannjjm	4762	4	dogs	dog	NNS
cord-023095-4dannjjm	4762	5	were	be	VBD
cord-023095-4dannjjm	4762	6	classed	class	VBN
cord-023095-4dannjjm	4762	7	as	as	IN
cord-023095-4dannjjm	4762	8	T3-L3	T3-L3	NNP
cord-023095-4dannjjm	4762	9	and	and	CC
cord-023095-4dannjjm	4762	10	31	31	CD
cord-023095-4dannjjm	4762	11	were	be	VBD
cord-023095-4dannjjm	4762	12	L4-S3	L4-S3	NNP
cord-023095-4dannjjm	4762	13	.	.	.
cord-023095-4dannjjm	4763	1	There	there	EX
cord-023095-4dannjjm	4763	2	were	be	VBD
cord-023095-4dannjjm	4763	3	55	55	CD
cord-023095-4dannjjm	4763	4	dogs	dog	NNS
cord-023095-4dannjjm	4763	5	with	with	IN
cord-023095-4dannjjm	4763	6	fractures	fracture	NNS
cord-023095-4dannjjm	4763	7	and	and	CC
cord-023095-4dannjjm	4763	8	43	43	CD
cord-023095-4dannjjm	4763	9	with	with	IN
cord-023095-4dannjjm	4763	10	luxations	luxation	NNS
cord-023095-4dannjjm	4763	11	;	;	:
cord-023095-4dannjjm	4763	12	23	23	CD
cord-023095-4dannjjm	4763	13	dogs	dog	NNS
cord-023095-4dannjjm	4763	14	had	have	VBD
cord-023095-4dannjjm	4763	15	both	both	DT
cord-023095-4dannjjm	4763	16	.	.	.
cord-023095-4dannjjm	4764	1	Thirty	thirty	CD
cord-023095-4dannjjm	4764	2	-	-	HYPH
cord-023095-4dannjjm	4764	3	one	one	CD
cord-023095-4dannjjm	4764	4	of	of	IN
cord-023095-4dannjjm	4764	5	35	35	CD
cord-023095-4dannjjm	4764	6	dogs	dog	NNS
cord-023095-4dannjjm	4764	7	evaluated	evaluate	VBN
cord-023095-4dannjjm	4764	8	had	have	VBD
cord-023095-4dannjjm	4764	9	spinal	spinal	JJ
cord-023095-4dannjjm	4764	10	cord	cord	NN
cord-023095-4dannjjm	4764	11	compression	compression	NN
cord-023095-4dannjjm	4764	12	.	.	.
cord-023095-4dannjjm	4765	1	Ten	ten	CD
cord-023095-4dannjjm	4765	2	dogs	dog	NNS
cord-023095-4dannjjm	4765	3	were	be	VBD
cord-023095-4dannjjm	4765	4	repaired	repair	VBN
cord-023095-4dannjjm	4765	5	with	with	IN
cord-023095-4dannjjm	4765	6	IM	im	JJ
cord-023095-4dannjjm	4765	7	pins	pin	NNS
cord-023095-4dannjjm	4765	8	and	and	CC
cord-023095-4dannjjm	4765	9	PMMA	PMMA	NNP
cord-023095-4dannjjm	4765	10	,	,	,
cord-023095-4dannjjm	4765	11	18	18	CD
cord-023095-4dannjjm	4765	12	dogs	dog	NNS
cord-023095-4dannjjm	4765	13	with	with	IN
cord-023095-4dannjjm	4765	14	screws	screw	NNS
cord-023095-4dannjjm	4765	15	and	and	CC
cord-023095-4dannjjm	4765	16	PMMA	PMMA	NNP
cord-023095-4dannjjm	4765	17	and	and	CC
cord-023095-4dannjjm	4765	18	31	31	CD
cord-023095-4dannjjm	4765	19	dogs	dog	NNS
cord-023095-4dannjjm	4765	20	with	with	IN
cord-023095-4dannjjm	4765	21	spinal	spinal	JJ
cord-023095-4dannjjm	4765	22	stapling	stapling	NN
cord-023095-4dannjjm	4765	23	.	.	.
cord-023095-4dannjjm	4766	1	Overall	overall	RB
cord-023095-4dannjjm	4766	2	,	,	,
cord-023095-4dannjjm	4766	3	there	there	EX
cord-023095-4dannjjm	4766	4	was	be	VBD
cord-023095-4dannjjm	4766	5	a	a	DT
cord-023095-4dannjjm	4766	6	78.7	78.7	CD
cord-023095-4dannjjm	4766	7	%	%	NN
cord-023095-4dannjjm	4766	8	success	success	NN
cord-023095-4dannjjm	4766	9	rate	rate	NN
cord-023095-4dannjjm	4766	10	;	;	:
cord-023095-4dannjjm	4766	11	there	there	EX
cord-023095-4dannjjm	4766	12	was	be	VBD
cord-023095-4dannjjm	4766	13	no	no	DT
cord-023095-4dannjjm	4766	14	significant	significant	JJ
cord-023095-4dannjjm	4766	15	difference	difference	NN
cord-023095-4dannjjm	4766	16	in	in	IN
cord-023095-4dannjjm	4766	17	outcome	outcome	NN
cord-023095-4dannjjm	4766	18	between	between	IN
cord-023095-4dannjjm	4766	19	the	the	DT
cord-023095-4dannjjm	4766	20	anatomic	anatomic	JJ
cord-023095-4dannjjm	4766	21	sites	site	NNS
cord-023095-4dannjjm	4766	22	(	(	-LRB-
cord-023095-4dannjjm	4766	23	p	p	NN
cord-023095-4dannjjm	4766	24	5	5	CD
cord-023095-4dannjjm	4766	25	0.5	0.5	CD
cord-023095-4dannjjm	4766	26	)	)	-RRB-
cord-023095-4dannjjm	4766	27	.	.	.
cord-023095-4dannjjm	4767	1	All	all	DT
cord-023095-4dannjjm	4767	2	dogs	dog	NNS
cord-023095-4dannjjm	4767	3	initially	initially	RB
cord-023095-4dannjjm	4767	4	graded	grade	VBD
cord-023095-4dannjjm	4767	5	as	as	IN
cord-023095-4dannjjm	4767	6	1	1	CD
cord-023095-4dannjjm	4767	7	-	-	SYM
cord-023095-4dannjjm	4767	8	3	3	CD
cord-023095-4dannjjm	4767	9	pre	pre	NN
cord-023095-4dannjjm	4767	10	-	-	NN
cord-023095-4dannjjm	4767	11	operation	operation	NN
cord-023095-4dannjjm	4767	12	were	be	VBD
cord-023095-4dannjjm	4767	13	classed	class	VBN
cord-023095-4dannjjm	4767	14	as	as	IN
cord-023095-4dannjjm	4767	15	a	a	DT
cord-023095-4dannjjm	4767	16	successful	successful	JJ
cord-023095-4dannjjm	4767	17	outcome	outcome	NN
cord-023095-4dannjjm	4767	18	after	after	IN
cord-023095-4dannjjm	4767	19	at	at	RB
cord-023095-4dannjjm	4767	20	least	least	RBS
cord-023095-4dannjjm	4767	21	one	one	CD
cord-023095-4dannjjm	4767	22	week	week	NN
cord-023095-4dannjjm	4767	23	following	follow	VBG
cord-023095-4dannjjm	4767	24	surgery	surgery	NN
cord-023095-4dannjjm	4767	25	;	;	:
cord-023095-4dannjjm	4767	26	79	79	CD
cord-023095-4dannjjm	4767	27	%	%	NN
cord-023095-4dannjjm	4767	28	of	of	IN
cord-023095-4dannjjm	4767	29	dogs	dog	NNS
cord-023095-4dannjjm	4767	30	initially	initially	RB
cord-023095-4dannjjm	4767	31	graded	grade	VBD
cord-023095-4dannjjm	4767	32	as	as	IN
cord-023095-4dannjjm	4767	33	4	4	CD
cord-023095-4dannjjm	4767	34	(	(	-LRB-
cord-023095-4dannjjm	4767	35	plegic	plegic	NNP
cord-023095-4dannjjm	4767	36	with	with	IN
cord-023095-4dannjjm	4767	37	pain	pain	NN
cord-023095-4dannjjm	4767	38	perception	perception	NN
cord-023095-4dannjjm	4767	39	)	)	-RRB-
cord-023095-4dannjjm	4767	40	were	be	VBD
cord-023095-4dannjjm	4767	41	classed	class	VBN
cord-023095-4dannjjm	4767	42	as	as	IN
cord-023095-4dannjjm	4767	43	successful	successful	JJ
cord-023095-4dannjjm	4767	44	recovery	recovery	NN
cord-023095-4dannjjm	4767	45	.	.	.
cord-023095-4dannjjm	4768	1	One	one	CD
cord-023095-4dannjjm	4768	2	dog	dog	NN
cord-023095-4dannjjm	4768	3	(	(	-LRB-
cord-023095-4dannjjm	4768	4	12.5	12.5	CD
cord-023095-4dannjjm	4768	5	%	%	NN
cord-023095-4dannjjm	4768	6	)	)	-RRB-
cord-023095-4dannjjm	4768	7	initially	initially	RB
cord-023095-4dannjjm	4768	8	as	as	RB
cord-023095-4dannjjm	4768	9	graded	grade	VBN
cord-023095-4dannjjm	4768	10	as	as	IN
cord-023095-4dannjjm	4768	11	5	5	CD
cord-023095-4dannjjm	4768	12	(	(	-LRB-
cord-023095-4dannjjm	4768	13	plegic	plegic	NNP
cord-023095-4dannjjm	4768	14	with	with	IN
cord-023095-4dannjjm	4768	15	no	no	DT
cord-023095-4dannjjm	4768	16	pain	pain	NN
cord-023095-4dannjjm	4768	17	perception	perception	NN
cord-023095-4dannjjm	4768	18	)	)	-RRB-
cord-023095-4dannjjm	4768	19	had	have	VBD
cord-023095-4dannjjm	4768	20	a	a	DT
cord-023095-4dannjjm	4768	21	successful	successful	JJ
cord-023095-4dannjjm	4768	22	outcome	outcome	NN
cord-023095-4dannjjm	4768	23	.	.	.
cord-023095-4dannjjm	4769	1	A	a	DT
cord-023095-4dannjjm	4769	2	low	low	JJ
cord-023095-4dannjjm	4769	3	admission	admission	NN
cord-023095-4dannjjm	4769	4	score	score	NN
cord-023095-4dannjjm	4769	5	was	be	VBD
cord-023095-4dannjjm	4769	6	statistically	statistically	RB
cord-023095-4dannjjm	4769	7	predictive	predictive	JJ
cord-023095-4dannjjm	4769	8	of	of	IN
cord-023095-4dannjjm	4769	9	a	a	DT
cord-023095-4dannjjm	4769	10	successful	successful	JJ
cord-023095-4dannjjm	4769	11	outcome	outcome	NN
cord-023095-4dannjjm	4769	12	(	(	-LRB-
cord-023095-4dannjjm	4769	13	p	p	NN
cord-023095-4dannjjm	4769	14	o	o	NN
cord-023095-4dannjjm	4769	15	0.0001	0.0001	CD
cord-023095-4dannjjm	4769	16	)	)	-RRB-
cord-023095-4dannjjm	4769	17	.	.	.
cord-023095-4dannjjm	4770	1	Surgery	surgery	NN
cord-023095-4dannjjm	4770	2	type	type	NN
cord-023095-4dannjjm	4770	3	was	be	VBD
cord-023095-4dannjjm	4770	4	not	not	RB
cord-023095-4dannjjm	4770	5	associated	associate	VBN
cord-023095-4dannjjm	4770	6	with	with	IN
cord-023095-4dannjjm	4770	7	a	a	DT
cord-023095-4dannjjm	4770	8	successful	successful	JJ
cord-023095-4dannjjm	4770	9	recovery	recovery	NN
cord-023095-4dannjjm	4770	10	(	(	-LRB-
cord-023095-4dannjjm	4770	11	p	p	NN
cord-023095-4dannjjm	4770	12	5	5	CD
cord-023095-4dannjjm	4770	13	0.13	0.13	CD
cord-023095-4dannjjm	4770	14	)	)	-RRB-
cord-023095-4dannjjm	4770	15	.	.	.
cord-023095-4dannjjm	4771	1	Signalment	signalment	JJ
cord-023095-4dannjjm	4771	2	,	,	,
cord-023095-4dannjjm	4771	3	body	body	NN
cord-023095-4dannjjm	4771	4	weight	weight	NN
cord-023095-4dannjjm	4771	5	,	,	,
cord-023095-4dannjjm	4771	6	location	location	NN
cord-023095-4dannjjm	4771	7	of	of	IN
cord-023095-4dannjjm	4771	8	injury	injury	NN
cord-023095-4dannjjm	4771	9	,	,	,
cord-023095-4dannjjm	4771	10	injury	injury	NN
cord-023095-4dannjjm	4771	11	type	type	NN
cord-023095-4dannjjm	4771	12	(	(	-LRB-
cord-023095-4dannjjm	4771	13	fracture	fracture	NN
cord-023095-4dannjjm	4771	14	,	,	,
cord-023095-4dannjjm	4771	15	luxation	luxation	NN
cord-023095-4dannjjm	4771	16	or	or	CC
cord-023095-4dannjjm	4771	17	both	both	DT
cord-023095-4dannjjm	4771	18	)	)	-RRB-
cord-023095-4dannjjm	4771	19	,	,	,
cord-023095-4dannjjm	4771	20	presence	presence	NN
cord-023095-4dannjjm	4771	21	of	of	IN
cord-023095-4dannjjm	4771	22	compression	compression	NN
cord-023095-4dannjjm	4771	23	,	,	,
cord-023095-4dannjjm	4771	24	and	and	CC
cord-023095-4dannjjm	4771	25	duration	duration	NN
cord-023095-4dannjjm	4771	26	of	of	IN
cord-023095-4dannjjm	4771	27	disease	disease	NN
cord-023095-4dannjjm	4771	28	did	do	VBD
cord-023095-4dannjjm	4771	29	not	not	RB
cord-023095-4dannjjm	4771	30	predict	predict	VB
cord-023095-4dannjjm	4771	31	outcome	outcome	NN
cord-023095-4dannjjm	4771	32	.	.	.
cord-023095-4dannjjm	4772	1	From	from	IN
cord-023095-4dannjjm	4772	2	this	this	DT
cord-023095-4dannjjm	4772	3	study	study	NN
cord-023095-4dannjjm	4772	4	,	,	,
cord-023095-4dannjjm	4772	5	the	the	DT
cord-023095-4dannjjm	4772	6	successful	successful	JJ
cord-023095-4dannjjm	4772	7	recovery	recovery	NN
cord-023095-4dannjjm	4772	8	of	of	IN
cord-023095-4dannjjm	4772	9	dogs	dog	NNS
cord-023095-4dannjjm	4772	10	following	follow	VBG
cord-023095-4dannjjm	4772	11	surgical	surgical	JJ
cord-023095-4dannjjm	4772	12	fixation	fixation	NN
cord-023095-4dannjjm	4772	13	is	be	VBZ
cord-023095-4dannjjm	4772	14	high	high	JJ
cord-023095-4dannjjm	4772	15	and	and	CC
cord-023095-4dannjjm	4772	16	is	be	VBZ
cord-023095-4dannjjm	4772	17	only	only	RB
cord-023095-4dannjjm	4772	18	dependent	dependent	JJ
cord-023095-4dannjjm	4772	19	on	on	IN
cord-023095-4dannjjm	4772	20	the	the	DT
cord-023095-4dannjjm	4772	21	neurological	neurological	JJ
cord-023095-4dannjjm	4772	22	score	score	NN
cord-023095-4dannjjm	4772	23	at	at	IN
cord-023095-4dannjjm	4772	24	the	the	DT
cord-023095-4dannjjm	4772	25	time	time	NN
cord-023095-4dannjjm	4772	26	of	of	IN
cord-023095-4dannjjm	4772	27	admission	admission	NN
cord-023095-4dannjjm	4772	28	.	.	.
cord-023095-4dannjjm	4773	1	The	the	DT
cord-023095-4dannjjm	4773	2	choice	choice	NN
cord-023095-4dannjjm	4773	3	of	of	IN
cord-023095-4dannjjm	4773	4	surgical	surgical	JJ
cord-023095-4dannjjm	4773	5	technique	technique	NN
cord-023095-4dannjjm	4773	6	does	do	VBZ
cord-023095-4dannjjm	4773	7	not	not	RB
cord-023095-4dannjjm	4773	8	seem	seem	VB
cord-023095-4dannjjm	4773	9	to	to	TO
cord-023095-4dannjjm	4773	10	influence	influence	VB
cord-023095-4dannjjm	4773	11	outcome	outcome	NN
cord-023095-4dannjjm	4773	12	although	although	IN
cord-023095-4dannjjm	4773	13	a	a	DT
cord-023095-4dannjjm	4773	14	prospective	prospective	JJ
cord-023095-4dannjjm	4773	15	study	study	NN
cord-023095-4dannjjm	4773	16	comparing	compare	VBG
cord-023095-4dannjjm	4773	17	two	two	CD
cord-023095-4dannjjm	4773	18	surgery	surgery	NN
cord-023095-4dannjjm	4773	19	types	type	NNS
cord-023095-4dannjjm	4773	20	is	be	VBZ
cord-023095-4dannjjm	4773	21	warranted	warrant	VBN
cord-023095-4dannjjm	4773	22	to	to	TO
cord-023095-4dannjjm	4773	23	further	further	RB
cord-023095-4dannjjm	4773	24	investigate	investigate	VB
cord-023095-4dannjjm	4773	25	this	this	DT
cord-023095-4dannjjm	4773	26	issue	issue	NN
cord-023095-4dannjjm	4773	27	the	the	DT
cord-023095-4dannjjm	4773	28	results	result	NNS
cord-023095-4dannjjm	4773	29	of	of	IN
cord-023095-4dannjjm	4773	30	which	which	WDT
cord-023095-4dannjjm	4773	31	can	can	MD
cord-023095-4dannjjm	4773	32	be	be	VB
cord-023095-4dannjjm	4773	33	confounded	confound	VBN
cord-023095-4dannjjm	4773	34	by	by	IN
cord-023095-4dannjjm	4773	35	surgeon	surgeon	NN
cord-023095-4dannjjm	4773	36	experience	experience	NN
cord-023095-4dannjjm	4773	37	and	and	CC
cord-023095-4dannjjm	4773	38	variable	variable	JJ
cord-023095-4dannjjm	4773	39	follow	follow	NN
cord-023095-4dannjjm	4773	40	-	-	HYPH
cord-023095-4dannjjm	4773	41	up	up	NN
cord-023095-4dannjjm	4773	42	.	.	.
cord-023095-4dannjjm	4774	1	Cranial	cranial	JJ
cord-023095-4dannjjm	4774	2	thoracic	thoracic	JJ
cord-023095-4dannjjm	4774	3	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4774	4	disc	disc	NN
cord-023095-4dannjjm	4774	5	disease	disease	NN
cord-023095-4dannjjm	4774	6	(	(	-LRB-
cord-023095-4dannjjm	4774	7	IVDD	IVDD	NNP
cord-023095-4dannjjm	4774	8	)	)	-RRB-
cord-023095-4dannjjm	4774	9	is	be	VBZ
cord-023095-4dannjjm	4774	10	extremely	extremely	RB
cord-023095-4dannjjm	4774	11	rare	rare	JJ
cord-023095-4dannjjm	4774	12	due	due	IN
cord-023095-4dannjjm	4774	13	to	to	IN
cord-023095-4dannjjm	4774	14	the	the	DT
cord-023095-4dannjjm	4774	15	presence	presence	NN
cord-023095-4dannjjm	4774	16	of	of	IN
cord-023095-4dannjjm	4774	17	the	the	DT
cord-023095-4dannjjm	4774	18	intercapital	intercapital	NNP
cord-023095-4dannjjm	4774	19	ligament	ligament	NN
cord-023095-4dannjjm	4774	20	,	,	,
cord-023095-4dannjjm	4774	21	although	although	IN
cord-023095-4dannjjm	4774	22	anecdotic	anecdotic	JJ
cord-023095-4dannjjm	4774	23	data	datum	NNS
cord-023095-4dannjjm	4774	24	suggest	suggest	VBP
cord-023095-4dannjjm	4774	25	German	german	JJ
cord-023095-4dannjjm	4774	26	shepherd	shepherd	NN
cord-023095-4dannjjm	4774	27	dogs	dog	NNS
cord-023095-4dannjjm	4774	28	(	(	-LRB-
cord-023095-4dannjjm	4774	29	GSD	GSD	NNP
cord-023095-4dannjjm	4774	30	)	)	-RRB-
cord-023095-4dannjjm	4774	31	can	can	MD
cord-023095-4dannjjm	4774	32	share	share	VB
cord-023095-4dannjjm	4774	33	some	some	DT
cord-023095-4dannjjm	4774	34	predisposition	predisposition	NN
cord-023095-4dannjjm	4774	35	for	for	IN
cord-023095-4dannjjm	4774	36	this	this	DT
cord-023095-4dannjjm	4774	37	disorder	disorder	NN
cord-023095-4dannjjm	4774	38	.	.	.
cord-023095-4dannjjm	4775	1	The	the	DT
cord-023095-4dannjjm	4775	2	objective	objective	NN
cord-023095-4dannjjm	4775	3	of	of	IN
cord-023095-4dannjjm	4775	4	the	the	DT
cord-023095-4dannjjm	4775	5	study	study	NN
cord-023095-4dannjjm	4775	6	was	be	VBD
cord-023095-4dannjjm	4775	7	to	to	TO
cord-023095-4dannjjm	4775	8	retrospectively	retrospectively	RB
cord-023095-4dannjjm	4775	9	evaluate	evaluate	VB
cord-023095-4dannjjm	4775	10	through	through	IN
cord-023095-4dannjjm	4775	11	MRI	MRI	NNP
cord-023095-4dannjjm	4775	12	if	if	IN
cord-023095-4dannjjm	4775	13	cranial	cranial	JJ
cord-023095-4dannjjm	4775	14	thoracic	thoracic	JJ
cord-023095-4dannjjm	4775	15	IVDD	IVDD	NNP
cord-023095-4dannjjm	4775	16	is	be	VBZ
cord-023095-4dannjjm	4775	17	significantly	significantly	RB
cord-023095-4dannjjm	4775	18	more	more	RBR
cord-023095-4dannjjm	4775	19	common	common	JJ
cord-023095-4dannjjm	4775	20	in	in	IN
cord-023095-4dannjjm	4775	21	GSD	GSD	NNP
cord-023095-4dannjjm	4775	22	compare	compare	VB
cord-023095-4dannjjm	4775	23	to	to	IN
cord-023095-4dannjjm	4775	24	other	other	JJ
cord-023095-4dannjjm	4775	25	large	large	JJ
cord-023095-4dannjjm	4775	26	breed	breed	NN
cord-023095-4dannjjm	4775	27	dogs	dog	NNS
cord-023095-4dannjjm	4775	28	.	.	.
cord-023095-4dannjjm	4776	1	A	a	DT
cord-023095-4dannjjm	4776	2	search	search	NN
cord-023095-4dannjjm	4776	3	was	be	VBD
cord-023095-4dannjjm	4776	4	done	do	VBN
cord-023095-4dannjjm	4776	5	through	through	IN
cord-023095-4dannjjm	4776	6	database	database	NN
cord-023095-4dannjjm	4776	7	of	of	IN
cord-023095-4dannjjm	4776	8	the	the	DT
cord-023095-4dannjjm	4776	9	Ontario	Ontario	NNP
cord-023095-4dannjjm	4776	10	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	4776	11	College	College	NNP
cord-023095-4dannjjm	4776	12	.	.	.
cord-023095-4dannjjm	4777	1	Any	any	DT
cord-023095-4dannjjm	4777	2	GSD	GSD	NNP
cord-023095-4dannjjm	4777	3	were	be	VBD
cord-023095-4dannjjm	4778	1	a	a	DT
cord-023095-4dannjjm	4778	2	spinal	spinal	JJ
cord-023095-4dannjjm	4778	3	MRI	MRI	NNP
cord-023095-4dannjjm	4778	4	including	include	VBG
cord-023095-4dannjjm	4778	5	T1-T10	T1-T10	NNP
cord-023095-4dannjjm	4778	6	spine	spine	NN
cord-023095-4dannjjm	4778	7	was	be	VBD
cord-023095-4dannjjm	4778	8	performed	perform	VBN
cord-023095-4dannjjm	4778	9	was	be	VBD
cord-023095-4dannjjm	4778	10	recruited	recruit	VBN
cord-023095-4dannjjm	4778	11	.	.	.
cord-023095-4dannjjm	4779	1	A	a	DT
cord-023095-4dannjjm	4779	2	group	group	NN
cord-023095-4dannjjm	4779	3	of	of	IN
cord-023095-4dannjjm	4779	4	large	large	JJ
cord-023095-4dannjjm	4779	5	-	-	HYPH
cord-023095-4dannjjm	4779	6	breed	breed	NN
cord-023095-4dannjjm	4779	7	non	non	JJ
cord-023095-4dannjjm	4779	8	-	-	JJ
cord-023095-4dannjjm	4779	9	GSD	GSD	NNP
cord-023095-4dannjjm	4779	10	was	be	VBD
cord-023095-4dannjjm	4779	11	used	use	VBN
cord-023095-4dannjjm	4779	12	as	as	IN
cord-023095-4dannjjm	4779	13	a	a	DT
cord-023095-4dannjjm	4779	14	control	control	NN
cord-023095-4dannjjm	4779	15	.	.	.
cord-023095-4dannjjm	4780	1	In	in	IN
cord-023095-4dannjjm	4780	2	the	the	DT
cord-023095-4dannjjm	4780	3	midsaggital	midsaggital	JJ
cord-023095-4dannjjm	4780	4	T2WI	T2WI	NNP
cord-023095-4dannjjm	4780	5	plane	plane	NN
cord-023095-4dannjjm	4780	6	,	,	,
cord-023095-4dannjjm	4780	7	three	three	CD
cord-023095-4dannjjm	4780	8	variables	variable	NNS
cord-023095-4dannjjm	4780	9	were	be	VBD
cord-023095-4dannjjm	4780	10	assessed	assess	VBN
cord-023095-4dannjjm	4780	11	and	and	CC
cord-023095-4dannjjm	4780	12	graded	grade	VBN
cord-023095-4dannjjm	4780	13	for	for	IN
cord-023095-4dannjjm	4780	14	each	each	DT
cord-023095-4dannjjm	4780	15	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4780	16	disc	disc	NN
cord-023095-4dannjjm	4780	17	space	space	NN
cord-023095-4dannjjm	4780	18	T1-T9	T1-T9	NNP
cord-023095-4dannjjm	4780	19	:	:	:
cord-023095-4dannjjm	4780	20	spinal	spinal	JJ
cord-023095-4dannjjm	4780	21	cord	cord	NN
cord-023095-4dannjjm	4780	22	compression	compression	NN
cord-023095-4dannjjm	4780	23	(	(	-LRB-
cord-023095-4dannjjm	4780	24	SCC	SCC	NNP
cord-023095-4dannjjm	4780	25	)	)	-RRB-
cord-023095-4dannjjm	4780	26	,	,	,
cord-023095-4dannjjm	4780	27	disc	disc	NN
cord-023095-4dannjjm	4780	28	degeneration	degeneration	NN
cord-023095-4dannjjm	4780	29	(	(	-LRB-
cord-023095-4dannjjm	4780	30	DD	DD	NNP
cord-023095-4dannjjm	4780	31	)	)	-RRB-
cord-023095-4dannjjm	4780	32	,	,	,
cord-023095-4dannjjm	4780	33	and	and	CC
cord-023095-4dannjjm	4780	34	herniation	herniation	NN
cord-023095-4dannjjm	4780	35	.	.	.
cord-023095-4dannjjm	4781	1	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	4781	2	sign	sign	NN
cord-023095-4dannjjm	4781	3	rank	rank	NN
cord-023095-4dannjjm	4781	4	test	test	NN
cord-023095-4dannjjm	4781	5	was	be	VBD
cord-023095-4dannjjm	4781	6	used	use	VBN
cord-023095-4dannjjm	4781	7	to	to	TO
cord-023095-4dannjjm	4781	8	assess	assess	VB
cord-023095-4dannjjm	4781	9	if	if	IN
cord-023095-4dannjjm	4781	10	scores	score	NNS
cord-023095-4dannjjm	4781	11	were	be	VBD
cord-023095-4dannjjm	4781	12	different	different	JJ
cord-023095-4dannjjm	4781	13	between	between	IN
cord-023095-4dannjjm	4781	14	groups	group	NNS
cord-023095-4dannjjm	4781	15	.	.	.
cord-023095-4dannjjm	4782	1	Exact	exact	JJ
cord-023095-4dannjjm	4782	2	conditional	conditional	JJ
cord-023095-4dannjjm	4782	3	logistic	logistic	JJ
cord-023095-4dannjjm	4782	4	regression	regression	NN
cord-023095-4dannjjm	4782	5	was	be	VBD
cord-023095-4dannjjm	4782	6	used	use	VBN
cord-023095-4dannjjm	4782	7	to	to	TO
cord-023095-4dannjjm	4782	8	determine	determine	VB
cord-023095-4dannjjm	4782	9	whether	whether	IN
cord-023095-4dannjjm	4782	10	any	any	DT
cord-023095-4dannjjm	4782	11	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4782	12	disc	disc	NN
cord-023095-4dannjjm	4782	13	space	space	NN
cord-023095-4dannjjm	4782	14	was	be	VBD
cord-023095-4dannjjm	4782	15	a	a	DT
cord-023095-4dannjjm	4782	16	risk	risk	NN
cord-023095-4dannjjm	4782	17	factor	factor	NN
cord-023095-4dannjjm	4782	18	.	.	.
cord-023095-4dannjjm	4783	1	22	22	CD
cord-023095-4dannjjm	4783	2	GSD	GSD	NNP
cord-023095-4dannjjm	4783	3	and	and	CC
cord-023095-4dannjjm	4783	4	46	46	CD
cord-023095-4dannjjm	4783	5	large	large	JJ
cord-023095-4dannjjm	4783	6	breed	breed	NN
cord-023095-4dannjjm	4783	7	non	non	JJ
cord-023095-4dannjjm	4783	8	-	-	JJ
cord-023095-4dannjjm	4783	9	GSDs	gsds	NN
cord-023095-4dannjjm	4783	10	were	be	VBD
cord-023095-4dannjjm	4783	11	recruited	recruit	VBN
cord-023095-4dannjjm	4783	12	.	.	.
cord-023095-4dannjjm	4784	1	The	the	DT
cord-023095-4dannjjm	4784	2	GSD	GSD	NNP
cord-023095-4dannjjm	4784	3	group	group	NN
cord-023095-4dannjjm	4784	4	had	have	VBD
cord-023095-4dannjjm	4784	5	significantly	significantly	RB
cord-023095-4dannjjm	4784	6	higher	high	JJR
cord-023095-4dannjjm	4784	7	scores	score	NNS
cord-023095-4dannjjm	4784	8	than	than	IN
cord-023095-4dannjjm	4784	9	the	the	DT
cord-023095-4dannjjm	4784	10	non	non	JJ
cord-023095-4dannjjm	4784	11	-	-	JJ
cord-023095-4dannjjm	4784	12	GSD	GSD	NNP
cord-023095-4dannjjm	4784	13	for	for	IN
cord-023095-4dannjjm	4784	14	SCC	SCC	NNP
cord-023095-4dannjjm	4784	15	,	,	,
cord-023095-4dannjjm	4784	16	and	and	CC
cord-023095-4dannjjm	4784	17	herniation	herniation	NN
cord-023095-4dannjjm	4784	18	.	.	.
cord-023095-4dannjjm	4785	1	Regarding	regard	VBG
cord-023095-4dannjjm	4785	2	the	the	DT
cord-023095-4dannjjm	4785	3	individual	individual	JJ
cord-023095-4dannjjm	4785	4	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4785	5	discs	disc	NNS
cord-023095-4dannjjm	4785	6	,	,	,
cord-023095-4dannjjm	4785	7	in	in	IN
cord-023095-4dannjjm	4785	8	the	the	DT
cord-023095-4dannjjm	4785	9	GSD	GSD	NNP
cord-023095-4dannjjm	4785	10	group	group	NN
cord-023095-4dannjjm	4785	11	T2	T2	NNP
cord-023095-4dannjjm	4785	12	-	-	HYPH
cord-023095-4dannjjm	4785	13	3	3	NNP
cord-023095-4dannjjm	4785	14	,	,	,
cord-023095-4dannjjm	4785	15	T3	T3	NNP
cord-023095-4dannjjm	4785	16	-	-	HYPH
cord-023095-4dannjjm	4785	17	4	4	CD
cord-023095-4dannjjm	4785	18	,	,	,
cord-023095-4dannjjm	4785	19	T4	T4	NNP
cord-023095-4dannjjm	4785	20	-	-	HYPH
cord-023095-4dannjjm	4785	21	5	5	CD
cord-023095-4dannjjm	4785	22	discs	disc	NNS
cord-023095-4dannjjm	4785	23	had	have	VBD
cord-023095-4dannjjm	4785	24	significantly	significantly	RB
cord-023095-4dannjjm	4785	25	an	an	DT
cord-023095-4dannjjm	4785	26	increased	increase	VBN
cord-023095-4dannjjm	4785	27	risk	risk	NN
cord-023095-4dannjjm	4785	28	for	for	IN
cord-023095-4dannjjm	4785	29	SCC	SCC	NNP
cord-023095-4dannjjm	4785	30	,	,	,
cord-023095-4dannjjm	4785	31	and	and	CC
cord-023095-4dannjjm	4785	32	T3	T3	NNP
cord-023095-4dannjjm	4785	33	-	-	HYPH
cord-023095-4dannjjm	4785	34	4	4	CD
cord-023095-4dannjjm	4785	35	for	for	IN
cord-023095-4dannjjm	4785	36	herniation	herniation	NN
cord-023095-4dannjjm	4785	37	.	.	.
cord-023095-4dannjjm	4786	1	The	the	DT
cord-023095-4dannjjm	4786	2	results	result	NNS
cord-023095-4dannjjm	4786	3	of	of	IN
cord-023095-4dannjjm	4786	4	this	this	DT
cord-023095-4dannjjm	4786	5	study	study	NN
cord-023095-4dannjjm	4786	6	show	show	NN
cord-023095-4dannjjm	4786	7	that	that	IN
cord-023095-4dannjjm	4786	8	GSD	GSD	NNP
cord-023095-4dannjjm	4786	9	have	have	VBP
cord-023095-4dannjjm	4786	10	a	a	DT
cord-023095-4dannjjm	4786	11	higher	high	JJR
cord-023095-4dannjjm	4786	12	risk	risk	NN
cord-023095-4dannjjm	4786	13	of	of	IN
cord-023095-4dannjjm	4786	14	cranial	cranial	JJ
cord-023095-4dannjjm	4786	15	thoracic	thoracic	JJ
cord-023095-4dannjjm	4786	16	disc	disc	NN
cord-023095-4dannjjm	4786	17	IVDD	IVDD	NNP
cord-023095-4dannjjm	4786	18	than	than	IN
cord-023095-4dannjjm	4786	19	other	other	JJ
cord-023095-4dannjjm	4786	20	large	large	JJ
cord-023095-4dannjjm	4786	21	breed	breed	NN
cord-023095-4dannjjm	4786	22	dogs	dog	NNS
cord-023095-4dannjjm	4786	23	.	.	.
cord-023095-4dannjjm	4787	1	That	that	DT
cord-023095-4dannjjm	4787	2	risk	risk	NN
cord-023095-4dannjjm	4787	3	was	be	VBD
cord-023095-4dannjjm	4787	4	higher	high	JJR
cord-023095-4dannjjm	4787	5	in	in	IN
cord-023095-4dannjjm	4787	6	discs	disc	NNS
cord-023095-4dannjjm	4788	1	T2-T3	T2-T3	NNP
cord-023095-4dannjjm	4788	2	,	,	,
cord-023095-4dannjjm	4788	3	T3	T3	NNP
cord-023095-4dannjjm	4788	4	-	-	HYPH
cord-023095-4dannjjm	4788	5	4	4	CD
cord-023095-4dannjjm	4788	6	,	,	,
cord-023095-4dannjjm	4788	7	and	and	CC
cord-023095-4dannjjm	4788	8	T4	T4	NNP
cord-023095-4dannjjm	4788	9	-	-	HYPH
cord-023095-4dannjjm	4788	10	5	5	CD
cord-023095-4dannjjm	4788	11	,	,	,
cord-023095-4dannjjm	4788	12	particularly	particularly	RB
cord-023095-4dannjjm	4788	13	in	in	IN
cord-023095-4dannjjm	4788	14	T3	T3	NNP
cord-023095-4dannjjm	4788	15	-	-	HYPH
cord-023095-4dannjjm	4788	16	4	4	CD
cord-023095-4dannjjm	4788	17	.	.	.
cord-023095-4dannjjm	4789	1	Genetic	genetic	JJ
cord-023095-4dannjjm	4789	2	and/or	and/or	CC
cord-023095-4dannjjm	4789	3	conformational	conformational	JJ
cord-023095-4dannjjm	4789	4	factors	factor	NNS
cord-023095-4dannjjm	4789	5	,	,	,
cord-023095-4dannjjm	4789	6	such	such	JJ
cord-023095-4dannjjm	4789	7	as	as	IN
cord-023095-4dannjjm	4789	8	weakness	weakness	NN
cord-023095-4dannjjm	4789	9	of	of	IN
cord-023095-4dannjjm	4789	10	the	the	DT
cord-023095-4dannjjm	4789	11	intercapital	intercapital	NNP
cord-023095-4dannjjm	4789	12	ligament	ligament	NN
cord-023095-4dannjjm	4789	13	,	,	,
cord-023095-4dannjjm	4789	14	may	may	MD
cord-023095-4dannjjm	4789	15	predispose	predispose	VB
cord-023095-4dannjjm	4789	16	GSD	GSD	NNP
cord-023095-4dannjjm	4789	17	to	to	IN
cord-023095-4dannjjm	4789	18	this	this	DT
cord-023095-4dannjjm	4789	19	lesion	lesion	NN
cord-023095-4dannjjm	4789	20	.	.	.
cord-023095-4dannjjm	4790	1	Diskospondylitis	Diskospondylitis	NNP
cord-023095-4dannjjm	4790	2	is	be	VBZ
cord-023095-4dannjjm	4790	3	a	a	DT
cord-023095-4dannjjm	4790	4	common	common	JJ
cord-023095-4dannjjm	4790	5	disease	disease	NN
cord-023095-4dannjjm	4790	6	of	of	IN
cord-023095-4dannjjm	4790	7	the	the	DT
cord-023095-4dannjjm	4790	8	canine	canine	JJ
cord-023095-4dannjjm	4790	9	spine	spine	NN
cord-023095-4dannjjm	4790	10	;	;	:
cord-023095-4dannjjm	4790	11	however	however	RB
cord-023095-4dannjjm	4790	12	,	,	,
cord-023095-4dannjjm	4790	13	few	few	JJ
cord-023095-4dannjjm	4790	14	reports	report	NNS
cord-023095-4dannjjm	4790	15	of	of	IN
cord-023095-4dannjjm	4790	16	MR	MR	NNP
cord-023095-4dannjjm	4790	17	imaging	image	VBG
cord-023095-4dannjjm	4790	18	findings	finding	NNS
cord-023095-4dannjjm	4790	19	in	in	IN
cord-023095-4dannjjm	4790	20	dogs	dog	NNS
cord-023095-4dannjjm	4790	21	are	be	VBP
cord-023095-4dannjjm	4790	22	available	available	JJ
cord-023095-4dannjjm	4790	23	.	.	.
cord-023095-4dannjjm	4791	1	The	the	DT
cord-023095-4dannjjm	4791	2	purpose	purpose	NN
cord-023095-4dannjjm	4791	3	of	of	IN
cord-023095-4dannjjm	4791	4	this	this	DT
cord-023095-4dannjjm	4791	5	study	study	NN
cord-023095-4dannjjm	4791	6	was	be	VBD
cord-023095-4dannjjm	4791	7	to	to	TO
cord-023095-4dannjjm	4791	8	describe	describe	VB
cord-023095-4dannjjm	4791	9	the	the	DT
cord-023095-4dannjjm	4791	10	signalment	signalment	JJ
cord-023095-4dannjjm	4791	11	,	,	,
cord-023095-4dannjjm	4791	12	clinical	clinical	JJ
cord-023095-4dannjjm	4791	13	and	and	CC
cord-023095-4dannjjm	4791	14	MR	MR	NNP
cord-023095-4dannjjm	4791	15	imaging	imaging	NN
cord-023095-4dannjjm	4791	16	features	feature	NNS
cord-023095-4dannjjm	4791	17	in	in	IN
cord-023095-4dannjjm	4791	18	affected	affect	VBN
cord-023095-4dannjjm	4791	19	dogs	dog	NNS
cord-023095-4dannjjm	4791	20	.	.	.
cord-023095-4dannjjm	4792	1	Twenty	twenty	CD
cord-023095-4dannjjm	4792	2	-	-	HYPH
cord-023095-4dannjjm	4792	3	three	three	CD
cord-023095-4dannjjm	4792	4	dogs	dog	NNS
cord-023095-4dannjjm	4792	5	with	with	IN
cord-023095-4dannjjm	4792	6	a	a	DT
cord-023095-4dannjjm	4792	7	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4792	8	of	of	IN
cord-023095-4dannjjm	4792	9	diskospondylitis	diskospondylitis	NNP
cord-023095-4dannjjm	4792	10	based	base	VBN
cord-023095-4dannjjm	4792	11	on	on	IN
cord-023095-4dannjjm	4792	12	clinical	clinical	JJ
cord-023095-4dannjjm	4792	13	signs	sign	NNS
cord-023095-4dannjjm	4792	14	,	,	,
cord-023095-4dannjjm	4792	15	MR	MR	NNP
cord-023095-4dannjjm	4792	16	imaging	imaging	NN
cord-023095-4dannjjm	4792	17	,	,	,
cord-023095-4dannjjm	4792	18	and	and	CC
cord-023095-4dannjjm	4792	19	urine	urine	NN
cord-023095-4dannjjm	4792	20	,	,	,
cord-023095-4dannjjm	4792	21	blood	blood	NN
cord-023095-4dannjjm	4792	22	,	,	,
cord-023095-4dannjjm	4792	23	CSF	CSF	NNP
cord-023095-4dannjjm	4792	24	and/or	and/or	CC
cord-023095-4dannjjm	4792	25	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4792	26	disk	disk	NN
cord-023095-4dannjjm	4792	27	cultures	culture	NNS
cord-023095-4dannjjm	4792	28	were	be	VBD
cord-023095-4dannjjm	4792	29	included	include	VBN
cord-023095-4dannjjm	4792	30	.	.	.
cord-023095-4dannjjm	4793	1	Large	large	JJ
cord-023095-4dannjjm	4793	2	breed	breed	NN
cord-023095-4dannjjm	4793	3	dogs	dog	NNS
cord-023095-4dannjjm	4793	4	(	(	-LRB-
cord-023095-4dannjjm	4793	5	4	4	CD
cord-023095-4dannjjm	4793	6	25	25	CD
cord-023095-4dannjjm	4793	7	kg	kg	NNS
cord-023095-4dannjjm	4793	8	)	)	-RRB-
cord-023095-4dannjjm	4793	9	accounted	account	VBD
cord-023095-4dannjjm	4793	10	for	for	IN
cord-023095-4dannjjm	4793	11	21of	21of	NN
cord-023095-4dannjjm	4793	12	the	the	DT
cord-023095-4dannjjm	4793	13	cases	case	NNS
cord-023095-4dannjjm	4793	14	.	.	.
cord-023095-4dannjjm	4794	1	The	the	DT
cord-023095-4dannjjm	4794	2	mean	mean	JJ
cord-023095-4dannjjm	4794	3	age	age	NN
cord-023095-4dannjjm	4794	4	was	be	VBD
cord-023095-4dannjjm	4794	5	6.8	6.8	CD
cord-023095-4dannjjm	4794	6	years	year	NNS
cord-023095-4dannjjm	4794	7	with	with	IN
cord-023095-4dannjjm	4794	8	males	male	NNS
cord-023095-4dannjjm	4794	9	and	and	CC
cord-023095-4dannjjm	4794	10	females	female	NNS
cord-023095-4dannjjm	4794	11	equally	equally	RB
cord-023095-4dannjjm	4794	12	represented	represent	VBD
cord-023095-4dannjjm	4794	13	.	.	.
cord-023095-4dannjjm	4795	1	Most	Most	JJS
cord-023095-4dannjjm	4795	2	dogs	dog	NNS
cord-023095-4dannjjm	4795	3	(	(	-LRB-
cord-023095-4dannjjm	4795	4	15/23	15/23	CD
cord-023095-4dannjjm	4795	5	)	)	-RRB-
cord-023095-4dannjjm	4795	6	were	be	VBD
cord-023095-4dannjjm	4795	7	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	4795	8	with	with	IN
cord-023095-4dannjjm	4795	9	varying	vary	VBG
cord-023095-4dannjjm	4795	10	degrees	degree	NNS
cord-023095-4dannjjm	4795	11	of	of	IN
cord-023095-4dannjjm	4795	12	pain	pain	NN
cord-023095-4dannjjm	4795	13	and	and	CC
cord-023095-4dannjjm	4795	14	paresis	paresis	NN
cord-023095-4dannjjm	4795	15	.	.	.
cord-023095-4dannjjm	4796	1	MR	MR	NNP
cord-023095-4dannjjm	4796	2	imaging	imaging	NN
cord-023095-4dannjjm	4796	3	characteristics	characteristic	NNS
cord-023095-4dannjjm	4796	4	of	of	IN
cord-023095-4dannjjm	4796	5	27	27	CD
cord-023095-4dannjjm	4796	6	sites	site	NNS
cord-023095-4dannjjm	4796	7	were	be	VBD
cord-023095-4dannjjm	4796	8	reviewed	review	VBN
cord-023095-4dannjjm	4796	9	.	.	.
cord-023095-4dannjjm	4797	1	On	on	IN
cord-023095-4dannjjm	4797	2	T2W	t2w	CD
cord-023095-4dannjjm	4797	3	images	image	NNS
cord-023095-4dannjjm	4797	4	,	,	,
cord-023095-4dannjjm	4797	5	vertebral	vertebral	JJ
cord-023095-4dannjjm	4797	6	endplates	endplate	NNS
cord-023095-4dannjjm	4797	7	were	be	VBD
cord-023095-4dannjjm	4797	8	of	of	IN
cord-023095-4dannjjm	4797	9	mixed	mixed	JJ
cord-023095-4dannjjm	4797	10	signal	signal	NN
cord-023095-4dannjjm	4797	11	intensity	intensity	NN
cord-023095-4dannjjm	4797	12	(	(	-LRB-
cord-023095-4dannjjm	4797	13	16/27	16/27	CD
cord-023095-4dannjjm	4797	14	)	)	-RRB-
cord-023095-4dannjjm	4797	15	while	while	IN
cord-023095-4dannjjm	4797	16	the	the	DT
cord-023095-4dannjjm	4797	17	vertebral	vertebral	JJ
cord-023095-4dannjjm	4797	18	body	body	NN
cord-023095-4dannjjm	4797	19	was	be	VBD
cord-023095-4dannjjm	4797	20	hypointense	hypointense	NN
cord-023095-4dannjjm	4797	21	(	(	-LRB-
cord-023095-4dannjjm	4797	22	11/27	11/27	CD
cord-023095-4dannjjm	4797	23	)	)	-RRB-
cord-023095-4dannjjm	4797	24	.	.	.
cord-023095-4dannjjm	4798	1	The	the	DT
cord-023095-4dannjjm	4798	2	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4798	3	disk	disk	NN
cord-023095-4dannjjm	4798	4	space	space	NN
cord-023095-4dannjjm	4798	5	was	be	VBD
cord-023095-4dannjjm	4798	6	hyperintense	hyperintense	NN
cord-023095-4dannjjm	4798	7	on	on	IN
cord-023095-4dannjjm	4798	8	T2W	T2W	NNP
cord-023095-4dannjjm	4798	9	(	(	-LRB-
cord-023095-4dannjjm	4798	10	16/27	16/27	CD
cord-023095-4dannjjm	4798	11	)	)	-RRB-
cord-023095-4dannjjm	4798	12	and	and	CC
cord-023095-4dannjjm	4798	13	STIR	stir	VB
cord-023095-4dannjjm	4798	14	(	(	-LRB-
cord-023095-4dannjjm	4798	15	14/15	14/15	CD
cord-023095-4dannjjm	4798	16	)	)	-RRB-
cord-023095-4dannjjm	4798	17	images	image	NNS
cord-023095-4dannjjm	4798	18	and	and	CC
cord-023095-4dannjjm	4798	19	mixed	mixed	JJ
cord-023095-4dannjjm	4798	20	signal	signal	NN
cord-023095-4dannjjm	4798	21	intensity	intensity	NN
cord-023095-4dannjjm	4798	22	(	(	-LRB-
cord-023095-4dannjjm	4798	23	7/13	7/13	CD
cord-023095-4dannjjm	4798	24	)	)	-RRB-
cord-023095-4dannjjm	4798	25	on	on	IN
cord-023095-4dannjjm	4798	26	T1W	t1w	DT
cord-023095-4dannjjm	4798	27	images	image	NNS
cord-023095-4dannjjm	4798	28	.	.	.
cord-023095-4dannjjm	4799	1	Paravertebral	Paravertebral	NNP
cord-023095-4dannjjm	4799	2	soft	soft	JJ
cord-023095-4dannjjm	4799	3	tissue	tissue	NN
cord-023095-4dannjjm	4799	4	hyperintensities	hyperintensitie	NNS
cord-023095-4dannjjm	4799	5	were	be	VBD
cord-023095-4dannjjm	4799	6	noted	note	VBN
cord-023095-4dannjjm	4799	7	on	on	IN
cord-023095-4dannjjm	4799	8	10/27	10/27	CD
cord-023095-4dannjjm	4799	9	T2W	t2w	CD
cord-023095-4dannjjm	4799	10	and	and	CC
cord-023095-4dannjjm	4799	11	12/16	12/16	CD
cord-023095-4dannjjm	4799	12	STIR	stir	VB
cord-023095-4dannjjm	4799	13	images	image	NNS
cord-023095-4dannjjm	4799	14	.	.	.
cord-023095-4dannjjm	4800	1	Contrast	contrast	NN
cord-023095-4dannjjm	4800	2	enhancement	enhancement	NN
cord-023095-4dannjjm	4800	3	occurred	occur	VBD
cord-023095-4dannjjm	4800	4	at	at	IN
cord-023095-4dannjjm	4800	5	12/19	12/19	CD
cord-023095-4dannjjm	4800	6	endplates	endplate	NNS
cord-023095-4dannjjm	4800	7	and	and	CC
cord-023095-4dannjjm	4800	8	15/19	15/19	CD
cord-023095-4dannjjm	4800	9	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4800	10	disk	disk	NN
cord-023095-4dannjjm	4800	11	spaces	space	NNS
cord-023095-4dannjjm	4800	12	.	.	.
cord-023095-4dannjjm	4801	1	Only	only	RB
cord-023095-4dannjjm	4801	2	4/18	4/18	CD
cord-023095-4dannjjm	4801	3	vertebral	vertebral	JJ
cord-023095-4dannjjm	4801	4	bodies	body	NNS
cord-023095-4dannjjm	4801	5	and	and	CC
cord-023095-4dannjjm	4801	6	7/18	7/18	CD
cord-023095-4dannjjm	4801	7	parvertebral	parvertebral	JJ
cord-023095-4dannjjm	4801	8	soft	soft	JJ
cord-023095-4dannjjm	4801	9	tissues	tissue	NNS
cord-023095-4dannjjm	4801	10	contrast	contrast	NN
cord-023095-4dannjjm	4801	11	enhanced	enhance	VBN
cord-023095-4dannjjm	4801	12	.	.	.
cord-023095-4dannjjm	4802	1	Intramedullary	intramedullary	JJ
cord-023095-4dannjjm	4802	2	spinal	spinal	JJ
cord-023095-4dannjjm	4802	3	cord	cord	NN
cord-023095-4dannjjm	4802	4	T2W	t2w	CD
cord-023095-4dannjjm	4802	5	hyperintensity	hyperintensity	NN
cord-023095-4dannjjm	4802	6	was	be	VBD
cord-023095-4dannjjm	4802	7	noted	note	VBN
cord-023095-4dannjjm	4802	8	at	at	IN
cord-023095-4dannjjm	4802	9	10/23	10/23	CD
cord-023095-4dannjjm	4802	10	sites	site	NNS
cord-023095-4dannjjm	4802	11	.	.	.
cord-023095-4dannjjm	4803	1	Spinal	spinal	JJ
cord-023095-4dannjjm	4803	2	cord	cord	NN
cord-023095-4dannjjm	4803	3	or	or	CC
cord-023095-4dannjjm	4803	4	cauda	cauda	NN
cord-023095-4dannjjm	4803	5	equina	equina	NN
cord-023095-4dannjjm	4803	6	compression	compression	NN
cord-023095-4dannjjm	4803	7	occurred	occur	VBD
cord-023095-4dannjjm	4803	8	at	at	IN
cord-023095-4dannjjm	4803	9	22/27	22/27	CD
cord-023095-4dannjjm	4803	10	sites	site	NNS
cord-023095-4dannjjm	4803	11	.	.	.
cord-023095-4dannjjm	4804	1	Based	base	VBN
cord-023095-4dannjjm	4804	2	on	on	IN
cord-023095-4dannjjm	4804	3	the	the	DT
cord-023095-4dannjjm	4804	4	Spearman	Spearman	NNP
cord-023095-4dannjjm	4804	5	correlation	correlation	NN
cord-023095-4dannjjm	4804	6	coefficient	coefficient	NN
cord-023095-4dannjjm	4804	7	,	,	,
cord-023095-4dannjjm	4804	8	a	a	DT
cord-023095-4dannjjm	4804	9	significant	significant	JJ
cord-023095-4dannjjm	4804	10	direct	direct	JJ
cord-023095-4dannjjm	4804	11	correlation	correlation	NN
cord-023095-4dannjjm	4804	12	was	be	VBD
cord-023095-4dannjjm	4804	13	found	find	VBN
cord-023095-4dannjjm	4804	14	between	between	IN
cord-023095-4dannjjm	4804	15	the	the	DT
cord-023095-4dannjjm	4804	16	degree	degree	NN
cord-023095-4dannjjm	4804	17	of	of	IN
cord-023095-4dannjjm	4804	18	spinal	spinal	JJ
cord-023095-4dannjjm	4804	19	cord	cord	NN
cord-023095-4dannjjm	4804	20	or	or	CC
cord-023095-4dannjjm	4804	21	cauda	cauda	FW
cord-023095-4dannjjm	4804	22	equina	equina	NN
cord-023095-4dannjjm	4804	23	compression	compression	NN
cord-023095-4dannjjm	4804	24	and	and	CC
cord-023095-4dannjjm	4804	25	the	the	DT
cord-023095-4dannjjm	4804	26	patient	patient	NN
cord-023095-4dannjjm	4804	27	's	's	POS
cord-023095-4dannjjm	4804	28	neurologic	neurologic	JJ
cord-023095-4dannjjm	4804	29	status	status	NN
cord-023095-4dannjjm	4804	30	(	(	-LRB-
cord-023095-4dannjjm	4804	31	P	p	NN
cord-023095-4dannjjm	4804	32	5	5	CD
cord-023095-4dannjjm	4804	33	0.0011	0.0011	CD
cord-023095-4dannjjm	4804	34	)	)	-RRB-
cord-023095-4dannjjm	4804	35	.	.	.
cord-023095-4dannjjm	4805	1	The	the	DT
cord-023095-4dannjjm	4805	2	incidence	incidence	NN
cord-023095-4dannjjm	4805	3	and	and	CC
cord-023095-4dannjjm	4805	4	severity	severity	NN
cord-023095-4dannjjm	4805	5	of	of	IN
cord-023095-4dannjjm	4805	6	spinal	spinal	JJ
cord-023095-4dannjjm	4805	7	cord	cord	NN
cord-023095-4dannjjm	4805	8	compression	compression	NN
cord-023095-4dannjjm	4805	9	in	in	IN
cord-023095-4dannjjm	4805	10	canine	canine	JJ
cord-023095-4dannjjm	4805	11	diskospondylitis	diskospondylitis	NN
cord-023095-4dannjjm	4805	12	may	may	MD
cord-023095-4dannjjm	4805	13	have	have	VB
cord-023095-4dannjjm	4805	14	prognostic	prognostic	JJ
cord-023095-4dannjjm	4805	15	value	value	NN
cord-023095-4dannjjm	4805	16	and	and	CC
cord-023095-4dannjjm	4805	17	may	may	MD
cord-023095-4dannjjm	4805	18	have	have	VB
cord-023095-4dannjjm	4805	19	been	be	VBN
cord-023095-4dannjjm	4805	20	previously	previously	RB
cord-023095-4dannjjm	4805	21	underestimated	underestimate	VBN
cord-023095-4dannjjm	4805	22	using	use	VBG
cord-023095-4dannjjm	4805	23	other	other	JJ
cord-023095-4dannjjm	4805	24	imaging	imaging	NN
cord-023095-4dannjjm	4805	25	modalities	modality	NNS
cord-023095-4dannjjm	4805	26	.	.	.
cord-023095-4dannjjm	4806	1	Hemilaminectomy	Hemilaminectomy	NNP
cord-023095-4dannjjm	4806	2	and	and	CC
cord-023095-4dannjjm	4806	3	pediculectomy	pediculectomy	NN
cord-023095-4dannjjm	4806	4	are	be	VBP
cord-023095-4dannjjm	4806	5	both	both	DT
cord-023095-4dannjjm	4806	6	well	well	RB
cord-023095-4dannjjm	4806	7	described	describe	VBN
cord-023095-4dannjjm	4806	8	and	and	CC
cord-023095-4dannjjm	4806	9	commonly	commonly	RB
cord-023095-4dannjjm	4806	10	utilized	utilize	VBN
cord-023095-4dannjjm	4806	11	techniques	technique	NNS
cord-023095-4dannjjm	4806	12	to	to	TO
cord-023095-4dannjjm	4806	13	access	access	VB
cord-023095-4dannjjm	4806	14	the	the	DT
cord-023095-4dannjjm	4806	15	spinal	spinal	JJ
cord-023095-4dannjjm	4806	16	canal	canal	NN
cord-023095-4dannjjm	4806	17	.	.	.
cord-023095-4dannjjm	4807	1	These	these	DT
cord-023095-4dannjjm	4807	2	procedures	procedure	NNS
cord-023095-4dannjjm	4807	3	are	be	VBP
cord-023095-4dannjjm	4807	4	most	most	RBS
cord-023095-4dannjjm	4807	5	often	often	RB
cord-023095-4dannjjm	4807	6	performed	perform	VBN
cord-023095-4dannjjm	4807	7	to	to	TO
cord-023095-4dannjjm	4807	8	approach	approach	VB
cord-023095-4dannjjm	4807	9	a	a	DT
cord-023095-4dannjjm	4807	10	compressive	compressive	JJ
cord-023095-4dannjjm	4807	11	lesion	lesion	NN
cord-023095-4dannjjm	4807	12	,	,	,
cord-023095-4dannjjm	4807	13	such	such	JJ
cord-023095-4dannjjm	4807	14	as	as	IN
cord-023095-4dannjjm	4807	15	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4807	16	disc	disc	NN
cord-023095-4dannjjm	4807	17	disease	disease	NN
cord-023095-4dannjjm	4807	18	and	and	CC
cord-023095-4dannjjm	4807	19	neoplasia	neoplasia	NN
cord-023095-4dannjjm	4807	20	,	,	,
cord-023095-4dannjjm	4807	21	the	the	DT
cord-023095-4dannjjm	4807	22	goal	goal	NN
cord-023095-4dannjjm	4807	23	being	be	VBG
cord-023095-4dannjjm	4807	24	adequate	adequate	JJ
cord-023095-4dannjjm	4807	25	visualization	visualization	NN
cord-023095-4dannjjm	4807	26	of	of	IN
cord-023095-4dannjjm	4807	27	the	the	DT
cord-023095-4dannjjm	4807	28	spinal	spinal	JJ
cord-023095-4dannjjm	4807	29	canal	canal	NN
cord-023095-4dannjjm	4807	30	and	and	CC
cord-023095-4dannjjm	4807	31	access	access	NN
cord-023095-4dannjjm	4807	32	to	to	IN
cord-023095-4dannjjm	4807	33	the	the	DT
cord-023095-4dannjjm	4807	34	offending	offending	JJ
cord-023095-4dannjjm	4807	35	lesion	lesion	NN
cord-023095-4dannjjm	4807	36	.	.	.
cord-023095-4dannjjm	4808	1	A	a	DT
cord-023095-4dannjjm	4808	2	proposed	propose	VBN
cord-023095-4dannjjm	4808	3	benefit	benefit	NN
cord-023095-4dannjjm	4808	4	of	of	IN
cord-023095-4dannjjm	4808	5	pediculectomy	pediculectomy	NN
cord-023095-4dannjjm	4808	6	is	be	VBZ
cord-023095-4dannjjm	4808	7	preservation	preservation	NN
cord-023095-4dannjjm	4808	8	of	of	IN
cord-023095-4dannjjm	4808	9	the	the	DT
cord-023095-4dannjjm	4808	10	articular	articular	JJ
cord-023095-4dannjjm	4808	11	facets	facet	NNS
cord-023095-4dannjjm	4808	12	and	and	CC
cord-023095-4dannjjm	4808	13	thus	thus	RB
cord-023095-4dannjjm	4808	14	better	well	RBR
cord-023095-4dannjjm	4808	15	maintaining	maintain	VBG
cord-023095-4dannjjm	4808	16	stability	stability	NN
cord-023095-4dannjjm	4808	17	of	of	IN
cord-023095-4dannjjm	4808	18	the	the	DT
cord-023095-4dannjjm	4808	19	vertebral	vertebral	JJ
cord-023095-4dannjjm	4808	20	column	column	NN
cord-023095-4dannjjm	4808	21	,	,	,
cord-023095-4dannjjm	4808	22	but	but	CC
cord-023095-4dannjjm	4808	23	at	at	IN
cord-023095-4dannjjm	4808	24	the	the	DT
cord-023095-4dannjjm	4808	25	cost	cost	NN
cord-023095-4dannjjm	4808	26	of	of	IN
cord-023095-4dannjjm	4808	27	reduced	reduce	VBN
cord-023095-4dannjjm	4808	28	access	access	NN
cord-023095-4dannjjm	4808	29	to	to	IN
cord-023095-4dannjjm	4808	30	the	the	DT
cord-023095-4dannjjm	4808	31	spinal	spinal	JJ
cord-023095-4dannjjm	4808	32	canal	canal	NN
cord-023095-4dannjjm	4808	33	.	.	.
cord-023095-4dannjjm	4809	1	The	the	DT
cord-023095-4dannjjm	4809	2	purpose	purpose	NN
cord-023095-4dannjjm	4809	3	of	of	IN
cord-023095-4dannjjm	4809	4	this	this	DT
cord-023095-4dannjjm	4809	5	study	study	NN
cord-023095-4dannjjm	4809	6	was	be	VBD
cord-023095-4dannjjm	4809	7	to	to	TO
cord-023095-4dannjjm	4809	8	describe	describe	VB
cord-023095-4dannjjm	4809	9	standardized	standardized	JJ
cord-023095-4dannjjm	4809	10	anatomical	anatomical	JJ
cord-023095-4dannjjm	4809	11	limits	limit	NNS
cord-023095-4dannjjm	4809	12	of	of	IN
cord-023095-4dannjjm	4809	13	each	each	DT
cord-023095-4dannjjm	4809	14	technique	technique	NN
cord-023095-4dannjjm	4809	15	and	and	CC
cord-023095-4dannjjm	4809	16	report	report	VB
cord-023095-4dannjjm	4809	17	any	any	DT
cord-023095-4dannjjm	4809	18	observed	observed	JJ
cord-023095-4dannjjm	4809	19	differences	difference	NNS
cord-023095-4dannjjm	4809	20	that	that	WDT
cord-023095-4dannjjm	4809	21	could	could	MD
cord-023095-4dannjjm	4809	22	be	be	VB
cord-023095-4dannjjm	4809	23	considered	consider	VBN
cord-023095-4dannjjm	4809	24	during	during	IN
cord-023095-4dannjjm	4809	25	presurgical	presurgical	JJ
cord-023095-4dannjjm	4809	26	planning	planning	NN
cord-023095-4dannjjm	4809	27	.	.	.
cord-023095-4dannjjm	4810	1	Ten	ten	CD
cord-023095-4dannjjm	4810	2	canine	canine	JJ
cord-023095-4dannjjm	4810	3	cadavers	cadaver	NNS
cord-023095-4dannjjm	4810	4	had	have	VBD
cord-023095-4dannjjm	4810	5	both	both	DT
cord-023095-4dannjjm	4810	6	procedures	procedure	NNS
cord-023095-4dannjjm	4810	7	performed	perform	VBN
cord-023095-4dannjjm	4810	8	on	on	IN
cord-023095-4dannjjm	4810	9	opposite	opposite	JJ
cord-023095-4dannjjm	4810	10	sides	side	NNS
cord-023095-4dannjjm	4810	11	to	to	TO
cord-023095-4dannjjm	4810	12	access	access	VB
cord-023095-4dannjjm	4810	13	the	the	DT
cord-023095-4dannjjm	4810	14	T11	T11	NNP
cord-023095-4dannjjm	4810	15	-	-	HYPH
cord-023095-4dannjjm	4810	16	12	12	CD
cord-023095-4dannjjm	4810	17	,	,	,
cord-023095-4dannjjm	4810	18	T13-L1	T13-L1	NNP
cord-023095-4dannjjm	4810	19	,	,	,
cord-023095-4dannjjm	4810	20	and	and	CC
cord-023095-4dannjjm	4810	21	L2	L2	NNP
cord-023095-4dannjjm	4810	22	-	-	HYPH
cord-023095-4dannjjm	4810	23	3	3	CD
cord-023095-4dannjjm	4810	24	spinal	spinal	JJ
cord-023095-4dannjjm	4810	25	canal	canal	NN
cord-023095-4dannjjm	4810	26	.	.	.
cord-023095-4dannjjm	4811	1	Measurements	measurement	NNS
cord-023095-4dannjjm	4811	2	were	be	VBD
cord-023095-4dannjjm	4811	3	obtained	obtain	VBN
cord-023095-4dannjjm	4811	4	after	after	IN
cord-023095-4dannjjm	4811	5	performing	perform	VBG
cord-023095-4dannjjm	4811	6	a	a	DT
cord-023095-4dannjjm	4811	7	computed	compute	VBN
cord-023095-4dannjjm	4811	8	tomography	tomography	NN
cord-023095-4dannjjm	4811	9	study	study	NN
cord-023095-4dannjjm	4811	10	of	of	IN
cord-023095-4dannjjm	4811	11	the	the	DT
cord-023095-4dannjjm	4811	12	spine	spine	NN
cord-023095-4dannjjm	4811	13	and	and	CC
cord-023095-4dannjjm	4811	14	recorded	record	VBD
cord-023095-4dannjjm	4811	15	from	from	IN
cord-023095-4dannjjm	4811	16	the	the	DT
cord-023095-4dannjjm	4811	17	transverse	transverse	JJ
cord-023095-4dannjjm	4811	18	slice	slice	NN
cord-023095-4dannjjm	4811	19	most	most	JJS
cord-023095-4dannjjm	4811	20	representative	representative	NN
cord-023095-4dannjjm	4811	21	of	of	IN
cord-023095-4dannjjm	4811	22	the	the	DT
cord-023095-4dannjjm	4811	23	defect	defect	NN
cord-023095-4dannjjm	4811	24	.	.	.
cord-023095-4dannjjm	4812	1	The	the	DT
cord-023095-4dannjjm	4812	2	surgical	surgical	JJ
cord-023095-4dannjjm	4812	3	technique	technique	NN
cord-023095-4dannjjm	4812	4	,	,	,
cord-023095-4dannjjm	4812	5	vertebral	vertebral	JJ
cord-023095-4dannjjm	4812	6	site	site	NN
cord-023095-4dannjjm	4812	7	,	,	,
cord-023095-4dannjjm	4812	8	and	and	CC
cord-023095-4dannjjm	4812	9	side	side	NN
cord-023095-4dannjjm	4812	10	of	of	IN
cord-023095-4dannjjm	4812	11	vertebral	vertebral	JJ
cord-023095-4dannjjm	4812	12	column	column	NN
cord-023095-4dannjjm	4812	13	were	be	VBD
cord-023095-4dannjjm	4812	14	compared	compare	VBN
cord-023095-4dannjjm	4812	15	with	with	IN
cord-023095-4dannjjm	4812	16	the	the	DT
cord-023095-4dannjjm	4812	17	mean	mean	JJ
cord-023095-4dannjjm	4812	18	spinal	spinal	JJ
cord-023095-4dannjjm	4812	19	canal	canal	NN
cord-023095-4dannjjm	4812	20	and	and	CC
cord-023095-4dannjjm	4812	21	defect	defect	NN
cord-023095-4dannjjm	4812	22	height	height	NN
cord-023095-4dannjjm	4812	23	using	use	VBG
cord-023095-4dannjjm	4812	24	a	a	DT
cord-023095-4dannjjm	4812	25	covariate	covariate	NN
cord-023095-4dannjjm	4812	26	model	model	NN
cord-023095-4dannjjm	4812	27	.	.	.
cord-023095-4dannjjm	4813	1	Dorsal	dorsal	JJ
cord-023095-4dannjjm	4813	2	and	and	CC
cord-023095-4dannjjm	4813	3	ventral	ventral	JJ
cord-023095-4dannjjm	4813	4	remnant	remnant	JJ
cord-023095-4dannjjm	4813	5	lamina	lamina	NNP
cord-023095-4dannjjm	4813	6	heights	height	NNS
cord-023095-4dannjjm	4813	7	were	be	VBD
cord-023095-4dannjjm	4813	8	also	also	RB
cord-023095-4dannjjm	4813	9	compared	compare	VBN
cord-023095-4dannjjm	4813	10	.	.	.
cord-023095-4dannjjm	4814	1	The	the	DT
cord-023095-4dannjjm	4814	2	height	height	NN
cord-023095-4dannjjm	4814	3	of	of	IN
cord-023095-4dannjjm	4814	4	the	the	DT
cord-023095-4dannjjm	4814	5	defect	defect	NN
cord-023095-4dannjjm	4814	6	relative	relative	JJ
cord-023095-4dannjjm	4814	7	to	to	IN
cord-023095-4dannjjm	4814	8	the	the	DT
cord-023095-4dannjjm	4814	9	spinal	spinal	JJ
cord-023095-4dannjjm	4814	10	canal	canal	NN
cord-023095-4dannjjm	4814	11	was	be	VBD
cord-023095-4dannjjm	4814	12	76	76	CD
cord-023095-4dannjjm	4814	13	-	-	SYM
cord-023095-4dannjjm	4814	14	87	87	CD
cord-023095-4dannjjm	4814	15	%	%	NN
cord-023095-4dannjjm	4814	16	with	with	IN
cord-023095-4dannjjm	4814	17	hemilaminectomy	hemilaminectomy	NN
cord-023095-4dannjjm	4814	18	and	and	CC
cord-023095-4dannjjm	4814	19	58	58	CD
cord-023095-4dannjjm	4814	20	-	-	SYM
cord-023095-4dannjjm	4814	21	75	75	CD
cord-023095-4dannjjm	4814	22	%	%	NN
cord-023095-4dannjjm	4814	23	with	with	IN
cord-023095-4dannjjm	4814	24	pediculectomy	pediculectomy	NN
cord-023095-4dannjjm	4814	25	.	.	.
cord-023095-4dannjjm	4815	1	The	the	DT
cord-023095-4dannjjm	4815	2	observed	observed	JJ
cord-023095-4dannjjm	4815	3	difference	difference	NN
cord-023095-4dannjjm	4815	4	in	in	IN
cord-023095-4dannjjm	4815	5	defect	defect	NN
cord-023095-4dannjjm	4815	6	height	height	NN
cord-023095-4dannjjm	4815	7	of	of	IN
cord-023095-4dannjjm	4815	8	12	12	CD
cord-023095-4dannjjm	4815	9	-	-	SYM
cord-023095-4dannjjm	4815	10	18	18	CD
cord-023095-4dannjjm	4815	11	%	%	NN
cord-023095-4dannjjm	4815	12	(	(	-LRB-
cord-023095-4dannjjm	4815	13	p	p	NN
cord-023095-4dannjjm	4815	14	o	o	NN
cord-023095-4dannjjm	4815	15	0.0001	0.0001	CD
cord-023095-4dannjjm	4815	16	)	)	-RRB-
cord-023095-4dannjjm	4815	17	and	and	CC
cord-023095-4dannjjm	4815	18	varied	vary	VBN
cord-023095-4dannjjm	4815	19	with	with	IN
cord-023095-4dannjjm	4815	20	spinal	spinal	JJ
cord-023095-4dannjjm	4815	21	canal	canal	NN
cord-023095-4dannjjm	4815	22	height	height	NN
cord-023095-4dannjjm	4815	23	.	.	.
cord-023095-4dannjjm	4816	1	Dorsal	dorsal	JJ
cord-023095-4dannjjm	4816	2	remnant	remnant	NN
cord-023095-4dannjjm	4816	3	lamina	lamina	NNP
cord-023095-4dannjjm	4816	4	height	height	NN
cord-023095-4dannjjm	4816	5	was	be	VBD
cord-023095-4dannjjm	4816	6	0.9	0.9	CD
cord-023095-4dannjjm	4816	7	-	-	SYM
cord-023095-4dannjjm	4816	8	2.4	2.4	CD
cord-023095-4dannjjm	4816	9	%	%	NN
cord-023095-4dannjjm	4816	10	of	of	IN
cord-023095-4dannjjm	4816	11	spinal	spinal	JJ
cord-023095-4dannjjm	4816	12	canal	canal	NN
cord-023095-4dannjjm	4816	13	height	height	NN
cord-023095-4dannjjm	4816	14	with	with	IN
cord-023095-4dannjjm	4816	15	hemilaminectomy	hemilaminectomy	NN
cord-023095-4dannjjm	4816	16	and	and	CC
cord-023095-4dannjjm	4816	17	7	7	CD
cord-023095-4dannjjm	4816	18	-	-	SYM
cord-023095-4dannjjm	4816	19	19	19	CD
cord-023095-4dannjjm	4816	20	%	%	NN
cord-023095-4dannjjm	4816	21	with	with	IN
cord-023095-4dannjjm	4816	22	pediculectomy	pediculectomy	NN
cord-023095-4dannjjm	4816	23	.	.	.
cord-023095-4dannjjm	4817	1	Ventral	ventral	JJ
cord-023095-4dannjjm	4817	2	remnant	remnant	JJ
cord-023095-4dannjjm	4817	3	lamina	lamina	NN
cord-023095-4dannjjm	4817	4	height	height	NN
cord-023095-4dannjjm	4817	5	ranged	range	VBD
cord-023095-4dannjjm	4817	6	from	from	IN
cord-023095-4dannjjm	4817	7	1	1	CD
cord-023095-4dannjjm	4817	8	-	-	SYM
cord-023095-4dannjjm	4817	9	2	2	CD
cord-023095-4dannjjm	4817	10	%	%	NN
cord-023095-4dannjjm	4817	11	and	and	CC
cord-023095-4dannjjm	4817	12	0.6	0.6	CD
cord-023095-4dannjjm	4817	13	-	-	SYM
cord-023095-4dannjjm	4817	14	2.3	2.3	CD
cord-023095-4dannjjm	4817	15	%	%	NN
cord-023095-4dannjjm	4817	16	,	,	,
cord-023095-4dannjjm	4817	17	respectively	respectively	RB
cord-023095-4dannjjm	4817	18	,	,	,
cord-023095-4dannjjm	4817	19	though	though	IN
cord-023095-4dannjjm	4817	20	the	the	DT
cord-023095-4dannjjm	4817	21	difference	difference	NN
cord-023095-4dannjjm	4817	22	was	be	VBD
cord-023095-4dannjjm	4817	23	not	not	RB
cord-023095-4dannjjm	4817	24	statistically	statistically	RB
cord-023095-4dannjjm	4817	25	significant	significant	JJ
cord-023095-4dannjjm	4817	26	.	.	.
cord-023095-4dannjjm	4818	1	While	while	IN
cord-023095-4dannjjm	4818	2	a	a	DT
cord-023095-4dannjjm	4818	3	larger	large	JJR
cord-023095-4dannjjm	4818	4	defect	defect	NN
cord-023095-4dannjjm	4818	5	is	be	VBZ
cord-023095-4dannjjm	4818	6	expected	expect	VBN
cord-023095-4dannjjm	4818	7	with	with	IN
cord-023095-4dannjjm	4818	8	a	a	DT
cord-023095-4dannjjm	4818	9	hemilaminectomy	hemilaminectomy	NN
cord-023095-4dannjjm	4818	10	procedure	procedure	NN
cord-023095-4dannjjm	4818	11	,	,	,
cord-023095-4dannjjm	4818	12	our	-PRON-	PRP$
cord-023095-4dannjjm	4818	13	results	result	NNS
cord-023095-4dannjjm	4818	14	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	4818	15	that	that	IN
cord-023095-4dannjjm	4818	16	this	this	DT
cord-023095-4dannjjm	4818	17	difference	difference	NN
cord-023095-4dannjjm	4818	18	increases	increase	VBZ
cord-023095-4dannjjm	4818	19	with	with	IN
cord-023095-4dannjjm	4818	20	increasing	increase	VBG
cord-023095-4dannjjm	4818	21	spinal	spinal	JJ
cord-023095-4dannjjm	4818	22	canal	canal	NN
cord-023095-4dannjjm	4818	23	height	height	NN
cord-023095-4dannjjm	4818	24	.	.	.
cord-023095-4dannjjm	4819	1	Interestingly	interestingly	RB
cord-023095-4dannjjm	4819	2	,	,	,
cord-023095-4dannjjm	4819	3	the	the	DT
cord-023095-4dannjjm	4819	4	proportion	proportion	NN
cord-023095-4dannjjm	4819	5	of	of	IN
cord-023095-4dannjjm	4819	6	exposed	expose	VBN
cord-023095-4dannjjm	4819	7	spinal	spinal	JJ
cord-023095-4dannjjm	4819	8	canal	canal	NN
cord-023095-4dannjjm	4819	9	decreases	decrease	NNS
cord-023095-4dannjjm	4819	10	with	with	IN
cord-023095-4dannjjm	4819	11	increasing	increase	VBG
cord-023095-4dannjjm	4819	12	canal	canal	NN
cord-023095-4dannjjm	4819	13	height	height	NN
cord-023095-4dannjjm	4819	14	for	for	IN
cord-023095-4dannjjm	4819	15	both	both	DT
cord-023095-4dannjjm	4819	16	procedures	procedure	NNS
cord-023095-4dannjjm	4819	17	.	.	.
cord-023095-4dannjjm	4820	1	The	the	DT
cord-023095-4dannjjm	4820	2	difference	difference	NN
cord-023095-4dannjjm	4820	3	in	in	IN
cord-023095-4dannjjm	4820	4	defect	defect	NN
cord-023095-4dannjjm	4820	5	height	height	NN
cord-023095-4dannjjm	4820	6	between	between	IN
cord-023095-4dannjjm	4820	7	techniques	technique	NNS
cord-023095-4dannjjm	4820	8	was	be	VBD
cord-023095-4dannjjm	4820	9	due	due	JJ
cord-023095-4dannjjm	4820	10	to	to	IN
cord-023095-4dannjjm	4820	11	greater	great	JJR
cord-023095-4dannjjm	4820	12	removal	removal	NN
cord-023095-4dannjjm	4820	13	of	of	IN
cord-023095-4dannjjm	4820	14	the	the	DT
cord-023095-4dannjjm	4820	15	dorsal	dorsal	JJ
cord-023095-4dannjjm	4820	16	spinal	spinal	JJ
cord-023095-4dannjjm	4820	17	canal	canal	NN
cord-023095-4dannjjm	4820	18	,	,	,
cord-023095-4dannjjm	4820	19	possibly	possibly	RB
cord-023095-4dannjjm	4820	20	making	make	VBG
cord-023095-4dannjjm	4820	21	the	the	DT
cord-023095-4dannjjm	4820	22	hemilaminectomy	hemilaminectomy	NN
cord-023095-4dannjjm	4820	23	technique	technique	NN
cord-023095-4dannjjm	4820	24	better	well	RBR
cord-023095-4dannjjm	4820	25	suited	suited	JJ
cord-023095-4dannjjm	4820	26	for	for	IN
cord-023095-4dannjjm	4820	27	more	more	JJR
cord-023095-4dannjjm	4820	28	dorsal	dorsal	JJ
cord-023095-4dannjjm	4820	29	lesions	lesion	NNS
cord-023095-4dannjjm	4820	30	,	,	,
cord-023095-4dannjjm	4820	31	while	while	IN
cord-023095-4dannjjm	4820	32	no	no	DT
cord-023095-4dannjjm	4820	33	statistically	statistically	RB
cord-023095-4dannjjm	4820	34	difference	difference	NN
cord-023095-4dannjjm	4820	35	in	in	IN
cord-023095-4dannjjm	4820	36	access	access	NN
cord-023095-4dannjjm	4820	37	to	to	IN
cord-023095-4dannjjm	4820	38	the	the	DT
cord-023095-4dannjjm	4820	39	ventral	ventral	JJ
cord-023095-4dannjjm	4820	40	canal	canal	NN
cord-023095-4dannjjm	4820	41	is	be	VBZ
cord-023095-4dannjjm	4820	42	observed	observe	VBN
cord-023095-4dannjjm	4820	43	.	.	.
cord-023095-4dannjjm	4821	1	No	no	DT
cord-023095-4dannjjm	4821	2	effect	effect	NN
cord-023095-4dannjjm	4821	3	of	of	IN
cord-023095-4dannjjm	4821	4	vertebral	vertebral	JJ
cord-023095-4dannjjm	4821	5	site	site	NN
cord-023095-4dannjjm	4821	6	was	be	VBD
cord-023095-4dannjjm	4821	7	detected	detect	VBN
cord-023095-4dannjjm	4821	8	.	.	.
cord-023095-4dannjjm	4822	1	Of	of	IN
cord-023095-4dannjjm	4822	2	note	note	NN
cord-023095-4dannjjm	4822	3	was	be	VBD
cord-023095-4dannjjm	4822	4	the	the	DT
cord-023095-4dannjjm	4822	5	involvement	involvement	NN
cord-023095-4dannjjm	4822	6	of	of	IN
cord-023095-4dannjjm	4822	7	articular	articular	JJ
cord-023095-4dannjjm	4822	8	facets	facet	NNS
cord-023095-4dannjjm	4822	9	in	in	IN
cord-023095-4dannjjm	4822	10	half	half	NN
cord-023095-4dannjjm	4822	11	of	of	IN
cord-023095-4dannjjm	4822	12	the	the	DT
cord-023095-4dannjjm	4822	13	pediculectomy	pediculectomy	NN
cord-023095-4dannjjm	4822	14	defects	defect	NNS
cord-023095-4dannjjm	4822	15	,	,	,
cord-023095-4dannjjm	4822	16	involving	involve	VBG
cord-023095-4dannjjm	4822	17	an	an	DT
cord-023095-4dannjjm	4822	18	average	average	NN
cord-023095-4dannjjm	4822	19	of	of	IN
cord-023095-4dannjjm	4822	20	22	22	CD
cord-023095-4dannjjm	4822	21	%	%	NN
cord-023095-4dannjjm	4822	22	of	of	IN
cord-023095-4dannjjm	4822	23	the	the	DT
cord-023095-4dannjjm	4822	24	articular	articular	JJ
cord-023095-4dannjjm	4822	25	facet	facet	NN
cord-023095-4dannjjm	4822	26	height	height	NN
cord-023095-4dannjjm	4822	27	.	.	.
cord-023095-4dannjjm	4823	1	This	this	DT
cord-023095-4dannjjm	4823	2	result	result	NN
cord-023095-4dannjjm	4823	3	questions	question	VBZ
cord-023095-4dannjjm	4823	4	the	the	DT
cord-023095-4dannjjm	4823	5	suggested	suggest	VBN
cord-023095-4dannjjm	4823	6	benefit	benefit	NN
cord-023095-4dannjjm	4823	7	for	for	IN
cord-023095-4dannjjm	4823	8	the	the	DT
cord-023095-4dannjjm	4823	9	vertebral	vertebral	JJ
cord-023095-4dannjjm	4823	10	stability	stability	NN
cord-023095-4dannjjm	4823	11	,	,	,
cord-023095-4dannjjm	4823	12	but	but	CC
cord-023095-4dannjjm	4823	13	further	further	JJ
cord-023095-4dannjjm	4823	14	biomechanical	biomechanical	JJ
cord-023095-4dannjjm	4823	15	studies	study	NNS
cord-023095-4dannjjm	4823	16	would	would	MD
cord-023095-4dannjjm	4823	17	be	be	VB
cord-023095-4dannjjm	4823	18	required	require	VBN
cord-023095-4dannjjm	4823	19	.	.	.
cord-023095-4dannjjm	4824	1	Low	low	JJ
cord-023095-4dannjjm	4824	2	level	level	NN
cord-023095-4dannjjm	4824	3	laser	laser	NN
cord-023095-4dannjjm	4824	4	therapy	therapy	NN
cord-023095-4dannjjm	4824	5	(	(	-LRB-
cord-023095-4dannjjm	4824	6	LLLT	LLLT	NNP
cord-023095-4dannjjm	4824	7	)	)	-RRB-
cord-023095-4dannjjm	4824	8	is	be	VBZ
cord-023095-4dannjjm	4824	9	a	a	DT
cord-023095-4dannjjm	4824	10	treatment	treatment	NN
cord-023095-4dannjjm	4824	11	used	use	VBN
cord-023095-4dannjjm	4824	12	in	in	IN
cord-023095-4dannjjm	4824	13	human	human	JJ
cord-023095-4dannjjm	4824	14	and	and	CC
cord-023095-4dannjjm	4824	15	veterinary	veterinary	JJ
cord-023095-4dannjjm	4824	16	medicine	medicine	NN
cord-023095-4dannjjm	4824	17	for	for	IN
cord-023095-4dannjjm	4824	18	a	a	DT
cord-023095-4dannjjm	4824	19	variety	variety	NN
cord-023095-4dannjjm	4824	20	of	of	IN
cord-023095-4dannjjm	4824	21	clinical	clinical	JJ
cord-023095-4dannjjm	4824	22	syndromes	syndrome	NNS
cord-023095-4dannjjm	4824	23	.	.	.
cord-023095-4dannjjm	4825	1	Some	some	DT
cord-023095-4dannjjm	4825	2	uses	use	NNS
cord-023095-4dannjjm	4825	3	in	in	IN
cord-023095-4dannjjm	4825	4	human	human	JJ
cord-023095-4dannjjm	4825	5	medicine	medicine	NN
cord-023095-4dannjjm	4825	6	include	include	VBP
cord-023095-4dannjjm	4825	7	acute	acute	JJ
cord-023095-4dannjjm	4825	8	pain	pain	NN
cord-023095-4dannjjm	4825	9	associated	associate	VBN
cord-023095-4dannjjm	4825	10	with	with	IN
cord-023095-4dannjjm	4825	11	osteoarthritis	osteoarthritis	NN
cord-023095-4dannjjm	4825	12	,	,	,
cord-023095-4dannjjm	4825	13	rheumatoid	rheumatoid	NN
cord-023095-4dannjjm	4825	14	arthritis	arthritis	NN
cord-023095-4dannjjm	4825	15	,	,	,
cord-023095-4dannjjm	4825	16	tendonitis	tendonitis	NN
cord-023095-4dannjjm	4825	17	,	,	,
cord-023095-4dannjjm	4825	18	TMJ	TMJ	NNP
cord-023095-4dannjjm	4825	19	disorders	disorder	NNS
cord-023095-4dannjjm	4825	20	,	,	,
cord-023095-4dannjjm	4825	21	chronic	chronic	JJ
cord-023095-4dannjjm	4825	22	joint	joint	JJ
cord-023095-4dannjjm	4825	23	disorders	disorder	NNS
cord-023095-4dannjjm	4825	24	,	,	,
cord-023095-4dannjjm	4825	25	and	and	CC
cord-023095-4dannjjm	4825	26	wound	wind	VBD
cord-023095-4dannjjm	4825	27	healing	healing	NN
cord-023095-4dannjjm	4825	28	.	.	.
cord-023095-4dannjjm	4826	1	Research	research	NN
cord-023095-4dannjjm	4826	2	is	be	VBZ
cord-023095-4dannjjm	4826	3	currently	currently	RB
cord-023095-4dannjjm	4826	4	on	on	RB
cord-023095-4dannjjm	4826	5	-	-	HYPH
cord-023095-4dannjjm	4826	6	going	go	VBG
cord-023095-4dannjjm	4826	7	to	to	TO
cord-023095-4dannjjm	4826	8	determine	determine	VB
cord-023095-4dannjjm	4826	9	the	the	DT
cord-023095-4dannjjm	4826	10	adequate	adequate	JJ
cord-023095-4dannjjm	4826	11	wavelengths	wavelength	NNS
cord-023095-4dannjjm	4826	12	to	to	TO
cord-023095-4dannjjm	4826	13	promote	promote	VB
cord-023095-4dannjjm	4826	14	effective	effective	JJ
cord-023095-4dannjjm	4826	15	treatment	treatment	NN
cord-023095-4dannjjm	4826	16	results	result	NNS
cord-023095-4dannjjm	4826	17	with	with	IN
cord-023095-4dannjjm	4826	18	LLLT	LLLT	NNP
cord-023095-4dannjjm	4826	19	in	in	IN
cord-023095-4dannjjm	4826	20	these	these	DT
cord-023095-4dannjjm	4826	21	conditions	condition	NNS
cord-023095-4dannjjm	4826	22	.	.	.
cord-023095-4dannjjm	4827	1	It	-PRON-	PRP
cord-023095-4dannjjm	4827	2	is	be	VBZ
cord-023095-4dannjjm	4827	3	purported	purport	VBN
cord-023095-4dannjjm	4827	4	that	that	IN
cord-023095-4dannjjm	4827	5	LLLT	LLLT	NNP
cord-023095-4dannjjm	4827	6	acts	act	VBZ
cord-023095-4dannjjm	4827	7	via	via	IN
cord-023095-4dannjjm	4827	8	the	the	DT
cord-023095-4dannjjm	4827	9	mitochondria	mitochondrion	NNS
cord-023095-4dannjjm	4827	10	to	to	TO
cord-023095-4dannjjm	4827	11	increase	increase	VB
cord-023095-4dannjjm	4827	12	cellular	cellular	JJ
cord-023095-4dannjjm	4827	13	metabolism	metabolism	NN
cord-023095-4dannjjm	4827	14	promoting	promote	VBG
cord-023095-4dannjjm	4827	15	wound	wound	NN
cord-023095-4dannjjm	4827	16	healing	healing	NN
cord-023095-4dannjjm	4827	17	and	and	CC
cord-023095-4dannjjm	4827	18	a	a	DT
cord-023095-4dannjjm	4827	19	decrease	decrease	NN
cord-023095-4dannjjm	4827	20	in	in	IN
cord-023095-4dannjjm	4827	21	pain	pain	NN
cord-023095-4dannjjm	4827	22	and	and	CC
cord-023095-4dannjjm	4827	23	inflammation	inflammation	NN
cord-023095-4dannjjm	4827	24	.	.	.
cord-023095-4dannjjm	4828	1	In	in	IN
cord-023095-4dannjjm	4828	2	this	this	DT
cord-023095-4dannjjm	4828	3	study	study	NN
cord-023095-4dannjjm	4828	4	,	,	,
cord-023095-4dannjjm	4828	5	we	-PRON-	PRP
cord-023095-4dannjjm	4828	6	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	4828	7	that	that	IN
cord-023095-4dannjjm	4828	8	dogs	dog	NNS
cord-023095-4dannjjm	4828	9	treated	treat	VBN
cord-023095-4dannjjm	4828	10	with	with	IN
cord-023095-4dannjjm	4828	11	LLLT	LLLT	NNP
cord-023095-4dannjjm	4828	12	in	in	IN
cord-023095-4dannjjm	4828	13	conjunction	conjunction	NN
cord-023095-4dannjjm	4828	14	with	with	IN
cord-023095-4dannjjm	4828	15	hemilaminectomy	hemilaminectomy	NN
cord-023095-4dannjjm	4828	16	would	would	MD
cord-023095-4dannjjm	4828	17	display	display	VB
cord-023095-4dannjjm	4828	18	quicker	quick	JJR
cord-023095-4dannjjm	4828	19	recovery	recovery	NN
cord-023095-4dannjjm	4828	20	times	time	NNS
cord-023095-4dannjjm	4828	21	regardless	regardless	RB
cord-023095-4dannjjm	4828	22	of	of	IN
cord-023095-4dannjjm	4828	23	the	the	DT
cord-023095-4dannjjm	4828	24	presence	presence	NN
cord-023095-4dannjjm	4828	25	or	or	CC
cord-023095-4dannjjm	4828	26	absence	absence	NN
cord-023095-4dannjjm	4828	27	of	of	IN
cord-023095-4dannjjm	4828	28	deep	deep	JJ
cord-023095-4dannjjm	4828	29	pain	pain	NN
cord-023095-4dannjjm	4828	30	sensation	sensation	NN
cord-023095-4dannjjm	4828	31	.	.	.
cord-023095-4dannjjm	4829	1	Seventeen	seventeen	CD
cord-023095-4dannjjm	4829	2	dogs	dog	NNS
cord-023095-4dannjjm	4829	3	(	(	-LRB-
cord-023095-4dannjjm	4829	4	9	9	CD
cord-023095-4dannjjm	4829	5	Dachshunds	Dachshunds	NNPS
cord-023095-4dannjjm	4829	6	,	,	,
cord-023095-4dannjjm	4829	7	2	2	CD
cord-023095-4dannjjm	4829	8	Chihuahuas	Chihuahuas	NNPS
cord-023095-4dannjjm	4829	9	,	,	,
cord-023095-4dannjjm	4829	10	2	2	CD
cord-023095-4dannjjm	4829	11	French	French	NNP
cord-023095-4dannjjm	4829	12	Bulldogs	Bulldogs	NNPS
cord-023095-4dannjjm	4829	13	,	,	,
cord-023095-4dannjjm	4829	14	2	2	CD
cord-023095-4dannjjm	4829	15	Lhasa	Lhasa	NNP
cord-023095-4dannjjm	4829	16	Ahpsos	Ahpsos	NNP
cord-023095-4dannjjm	4829	17	,	,	,
cord-023095-4dannjjm	4829	18	and	and	CC
cord-023095-4dannjjm	4829	19	1	1	CD
cord-023095-4dannjjm	4829	20	each	each	DT
cord-023095-4dannjjm	4829	21	of	of	IN
cord-023095-4dannjjm	4829	22	a	a	DT
cord-023095-4dannjjm	4829	23	Pembroke	Pembroke	NNP
cord-023095-4dannjjm	4829	24	Welsch	Welsch	NNP
cord-023095-4dannjjm	4829	25	Corgi	Corgi	NNP
cord-023095-4dannjjm	4829	26	,	,	,
cord-023095-4dannjjm	4829	27	and	and	CC
cord-023095-4dannjjm	4829	28	a	a	DT
cord-023095-4dannjjm	4829	29	Miniature	Miniature	NNP
cord-023095-4dannjjm	4829	30	Poodle	Poodle	NNP
cord-023095-4dannjjm	4829	31	)	)	-RRB-
cord-023095-4dannjjm	4829	32	were	be	VBD
cord-023095-4dannjjm	4829	33	selected	select	VBN
cord-023095-4dannjjm	4829	34	and	and	CC
cord-023095-4dannjjm	4829	35	divided	divide	VBN
cord-023095-4dannjjm	4829	36	into	into	IN
cord-023095-4dannjjm	4829	37	two	two	CD
cord-023095-4dannjjm	4829	38	groups	group	NNS
cord-023095-4dannjjm	4829	39	.	.	.
cord-023095-4dannjjm	4830	1	The	the	DT
cord-023095-4dannjjm	4830	2	dogs	dog	NNS
cord-023095-4dannjjm	4830	3	ranged	range	VBD
cord-023095-4dannjjm	4830	4	in	in	IN
cord-023095-4dannjjm	4830	5	age	age	NN
cord-023095-4dannjjm	4830	6	from	from	IN
cord-023095-4dannjjm	4830	7	2	2	CD
cord-023095-4dannjjm	4830	8	to	to	IN
cord-023095-4dannjjm	4830	9	11	11	CD
cord-023095-4dannjjm	4830	10	years	year	NNS
cord-023095-4dannjjm	4830	11	old	old	JJ
cord-023095-4dannjjm	4830	12	,	,	,
cord-023095-4dannjjm	4830	13	weighed	weigh	VBD
cord-023095-4dannjjm	4830	14	between	between	IN
cord-023095-4dannjjm	4830	15	7	7	CD
cord-023095-4dannjjm	4830	16	and	and	CC
cord-023095-4dannjjm	4830	17	33	33	CD
cord-023095-4dannjjm	4830	18	pounds	pound	NNS
cord-023095-4dannjjm	4830	19	,	,	,
cord-023095-4dannjjm	4830	20	and	and	CC
cord-023095-4dannjjm	4830	21	underwent	undergo	VBD
cord-023095-4dannjjm	4830	22	hemilaminectamies	hemilaminectamie	NNS
cord-023095-4dannjjm	4830	23	after	after	IN
cord-023095-4dannjjm	4830	24	acute	acute	JJ
cord-023095-4dannjjm	4830	25	onset	onset	NN
cord-023095-4dannjjm	4830	26	of	of	IN
cord-023095-4dannjjm	4830	27	paraplegia	paraplegia	NN
cord-023095-4dannjjm	4830	28	secondary	secondary	JJ
cord-023095-4dannjjm	4830	29	to	to	IN
cord-023095-4dannjjm	4830	30	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4830	31	disc	disc	NN
cord-023095-4dannjjm	4830	32	disease	disease	NN
cord-023095-4dannjjm	4830	33	(	(	-LRB-
cord-023095-4dannjjm	4830	34	surgically	surgically	RB
cord-023095-4dannjjm	4830	35	confirmed	confirm	VBN
cord-023095-4dannjjm	4830	36	)	)	-RRB-
cord-023095-4dannjjm	4830	37	.	.	.
cord-023095-4dannjjm	4831	1	One	one	CD
cord-023095-4dannjjm	4831	2	group	group	NN
cord-023095-4dannjjm	4831	3	received	receive	VBD
cord-023095-4dannjjm	4831	4	laser	laser	NN
cord-023095-4dannjjm	4831	5	treatments	treatment	NNS
cord-023095-4dannjjm	4831	6	on	on	IN
cord-023095-4dannjjm	4831	7	days	day	NNS
cord-023095-4dannjjm	4831	8	1	1	CD
cord-023095-4dannjjm	4831	9	through	through	IN
cord-023095-4dannjjm	4831	10	4	4	CD
cord-023095-4dannjjm	4831	11	of	of	IN
cord-023095-4dannjjm	4831	12	hospitalization	hospitalization	NN
cord-023095-4dannjjm	4831	13	.	.	.
cord-023095-4dannjjm	4832	1	The	the	DT
cord-023095-4dannjjm	4832	2	second	second	JJ
cord-023095-4dannjjm	4832	3	group	group	NN
cord-023095-4dannjjm	4832	4	did	do	VBD
cord-023095-4dannjjm	4832	5	not	not	RB
cord-023095-4dannjjm	4832	6	receive	receive	VB
cord-023095-4dannjjm	4832	7	LLLT	LLLT	NNP
cord-023095-4dannjjm	4832	8	,	,	,
cord-023095-4dannjjm	4832	9	but	but	CC
cord-023095-4dannjjm	4832	10	followed	follow	VBD
cord-023095-4dannjjm	4832	11	the	the	DT
cord-023095-4dannjjm	4832	12	same	same	JJ
cord-023095-4dannjjm	4832	13	peri	peri	JJ
cord-023095-4dannjjm	4832	14	-	-	HYPH
cord-023095-4dannjjm	4832	15	operative	operative	JJ
cord-023095-4dannjjm	4832	16	medication	medication	NN
cord-023095-4dannjjm	4832	17	protocol	protocol	NN
cord-023095-4dannjjm	4832	18	.	.	.
cord-023095-4dannjjm	4833	1	The	the	DT
cord-023095-4dannjjm	4833	2	laser	laser	NN
cord-023095-4dannjjm	4833	3	used	use	VBN
cord-023095-4dannjjm	4833	4	in	in	IN
cord-023095-4dannjjm	4833	5	this	this	DT
cord-023095-4dannjjm	4833	6	study	study	NN
cord-023095-4dannjjm	4833	7	was	be	VBD
cord-023095-4dannjjm	4833	8	an	an	DT
cord-023095-4dannjjm	4833	9	Erchonia	Erchonia	NNP
cord-023095-4dannjjm	4833	10	laser	laser	NN
cord-023095-4dannjjm	4833	11	model	model	NN
cord-023095-4dannjjm	4833	12	PL5000	pl5000	NN
cord-023095-4dannjjm	4833	13	(	(	-LRB-
cord-023095-4dannjjm	4833	14	635	635	CD
cord-023095-4dannjjm	4833	15	nm	nm	NN
cord-023095-4dannjjm	4833	16	)	)	-RRB-
cord-023095-4dannjjm	4833	17	.	.	.
cord-023095-4dannjjm	4834	1	The	the	DT
cord-023095-4dannjjm	4834	2	hertz	hertz	NNP
cord-023095-4dannjjm	4834	3	setting	set	VBG
cord-023095-4dannjjm	4834	4	was	be	VBD
cord-023095-4dannjjm	4834	5	similar	similar	JJ
cord-023095-4dannjjm	4834	6	for	for	IN
cord-023095-4dannjjm	4834	7	each	each	DT
cord-023095-4dannjjm	4834	8	patient	patient	NN
cord-023095-4dannjjm	4834	9	using	use	VBG
cord-023095-4dannjjm	4834	10	the	the	DT
cord-023095-4dannjjm	4834	11	previously	previously	RB
cord-023095-4dannjjm	4834	12	established	establish	VBN
cord-023095-4dannjjm	4834	13	protocol	protocol	NN
cord-023095-4dannjjm	4834	14	for	for	IN
cord-023095-4dannjjm	4834	15	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	4834	16	disc	disc	NN
cord-023095-4dannjjm	4834	17	disease	disease	NN
cord-023095-4dannjjm	4834	18	(	(	-LRB-
cord-023095-4dannjjm	4834	19	IVDD	IVDD	NNP
cord-023095-4dannjjm	4834	20	)	)	-RRB-
cord-023095-4dannjjm	4834	21	with	with	IN
cord-023095-4dannjjm	4834	22	pulse	pulse	NN
cord-023095-4dannjjm	4834	23	rate	rate	NN
cord-023095-4dannjjm	4834	24	ranging	range	VBG
cord-023095-4dannjjm	4834	25	from	from	IN
cord-023095-4dannjjm	4834	26	9Hz	9hz	CD
cord-023095-4dannjjm	4834	27	to	to	IN
cord-023095-4dannjjm	4834	28	1151	1151	CD
cord-023095-4dannjjm	4834	29	Hz	Hz	NNP
cord-023095-4dannjjm	4834	30	.	.	.
cord-023095-4dannjjm	4835	1	All	all	DT
cord-023095-4dannjjm	4835	2	dogs	dog	NNS
cord-023095-4dannjjm	4835	3	received	receive	VBD
cord-023095-4dannjjm	4835	4	advanced	advanced	JJ
cord-023095-4dannjjm	4835	5	imaging	imaging	NN
cord-023095-4dannjjm	4835	6	pre	pre	NN
cord-023095-4dannjjm	4835	7	-	-	VBN
cord-023095-4dannjjm	4835	8	operatively	operatively	RB
cord-023095-4dannjjm	4835	9	with	with	IN
cord-023095-4dannjjm	4835	10	myelogram	myelogram	NNP
cord-023095-4dannjjm	4835	11	or	or	CC
cord-023095-4dannjjm	4835	12	MRI	MRI	NNP
cord-023095-4dannjjm	4835	13	.	.	.
cord-023095-4dannjjm	4836	1	Results	result	NNS
cord-023095-4dannjjm	4836	2	of	of	IN
cord-023095-4dannjjm	4836	3	the	the	DT
cord-023095-4dannjjm	4836	4	study	study	NN
cord-023095-4dannjjm	4836	5	revealed	reveal	VBD
cord-023095-4dannjjm	4836	6	that	that	IN
cord-023095-4dannjjm	4836	7	treatment	treatment	NN
cord-023095-4dannjjm	4836	8	with	with	IN
cord-023095-4dannjjm	4836	9	LLLT	LLLT	NNP
cord-023095-4dannjjm	4836	10	of	of	IN
cord-023095-4dannjjm	4836	11	635	635	CD
cord-023095-4dannjjm	4836	12	nm	nm	NN
cord-023095-4dannjjm	4836	13	wavelength	wavelength	NN
cord-023095-4dannjjm	4836	14	did	do	VBD
cord-023095-4dannjjm	4836	15	not	not	RB
cord-023095-4dannjjm	4836	16	shorten	shorten	VB
cord-023095-4dannjjm	4836	17	or	or	CC
cord-023095-4dannjjm	4836	18	improve	improve	VB
cord-023095-4dannjjm	4836	19	recovery	recovery	NN
cord-023095-4dannjjm	4836	20	times	time	NNS
cord-023095-4dannjjm	4836	21	for	for	IN
cord-023095-4dannjjm	4836	22	dogs	dog	NNS
cord-023095-4dannjjm	4836	23	with	with	IN
cord-023095-4dannjjm	4836	24	acute	acute	JJ
cord-023095-4dannjjm	4836	25	onset	onset	NN
cord-023095-4dannjjm	4836	26	paraplegia	paraplegia	NN
cord-023095-4dannjjm	4836	27	secondary	secondary	JJ
cord-023095-4dannjjm	4836	28	to	to	IN
cord-023095-4dannjjm	4836	29	IVDD	IVDD	NNP
cord-023095-4dannjjm	4836	30	after	after	IN
cord-023095-4dannjjm	4836	31	hemilaminectomy	hemilaminectomy	NN
cord-023095-4dannjjm	4836	32	procedures	procedure	NNS
cord-023095-4dannjjm	4836	33	.	.	.
cord-023095-4dannjjm	4837	1	Dogs	dog	NNS
cord-023095-4dannjjm	4837	2	that	that	WDT
cord-023095-4dannjjm	4837	3	showed	show	VBD
cord-023095-4dannjjm	4837	4	recovery	recovery	NN
cord-023095-4dannjjm	4837	5	to	to	IN
cord-023095-4dannjjm	4837	6	ambulation	ambulation	NN
cord-023095-4dannjjm	4837	7	at	at	IN
cord-023095-4dannjjm	4837	8	the	the	DT
cord-023095-4dannjjm	4837	9	two	two	CD
cord-023095-4dannjjm	4837	10	week	week	NN
cord-023095-4dannjjm	4837	11	recheck	recheck	NN
cord-023095-4dannjjm	4837	12	were	be	VBD
cord-023095-4dannjjm	4837	13	consistently	consistently	RB
cord-023095-4dannjjm	4837	14	dogs	dog	NNS
cord-023095-4dannjjm	4837	15	that	that	WDT
cord-023095-4dannjjm	4837	16	were	be	VBD
cord-023095-4dannjjm	4837	17	deep	deep	JJ
cord-023095-4dannjjm	4837	18	pain	pain	NN
cord-023095-4dannjjm	4837	19	positive	positive	JJ
cord-023095-4dannjjm	4837	20	on	on	IN
cord-023095-4dannjjm	4837	21	presentation	presentation	NN
cord-023095-4dannjjm	4837	22	.	.	.
cord-023095-4dannjjm	4838	1	A	a	DT
cord-023095-4dannjjm	4838	2	lengthened	lengthen	VBN
cord-023095-4dannjjm	4838	3	recovery	recovery	NN
cord-023095-4dannjjm	4838	4	time	time	NN
cord-023095-4dannjjm	4838	5	or	or	CC
cord-023095-4dannjjm	4838	6	no	no	DT
cord-023095-4dannjjm	4838	7	recovery	recovery	NN
cord-023095-4dannjjm	4838	8	was	be	VBD
cord-023095-4dannjjm	4838	9	seen	see	VBN
cord-023095-4dannjjm	4838	10	in	in	IN
cord-023095-4dannjjm	4838	11	the	the	DT
cord-023095-4dannjjm	4838	12	majority	majority	NN
cord-023095-4dannjjm	4838	13	of	of	IN
cord-023095-4dannjjm	4838	14	those	those	DT
cord-023095-4dannjjm	4838	15	dogs	dog	NNS
cord-023095-4dannjjm	4838	16	with	with	IN
cord-023095-4dannjjm	4838	17	absent	absent	JJ
cord-023095-4dannjjm	4838	18	deep	deep	JJ
cord-023095-4dannjjm	4838	19	pain	pain	NN
cord-023095-4dannjjm	4838	20	on	on	IN
cord-023095-4dannjjm	4838	21	presentation	presentation	NN
cord-023095-4dannjjm	4838	22	as	as	IN
cord-023095-4dannjjm	4838	23	has	have	VBZ
cord-023095-4dannjjm	4838	24	been	be	VBN
cord-023095-4dannjjm	4838	25	revealed	reveal	VBN
cord-023095-4dannjjm	4838	26	historically	historically	RB
cord-023095-4dannjjm	4838	27	in	in	IN
cord-023095-4dannjjm	4838	28	past	past	JJ
cord-023095-4dannjjm	4838	29	studies	study	NNS
cord-023095-4dannjjm	4838	30	.	.	.
cord-023095-4dannjjm	4839	1	LLLT	LLLT	NNP
cord-023095-4dannjjm	4839	2	did	do	VBD
cord-023095-4dannjjm	4839	3	not	not	RB
cord-023095-4dannjjm	4839	4	appear	appear	VB
cord-023095-4dannjjm	4839	5	to	to	TO
cord-023095-4dannjjm	4839	6	have	have	VB
cord-023095-4dannjjm	4839	7	an	an	DT
cord-023095-4dannjjm	4839	8	effect	effect	NN
cord-023095-4dannjjm	4839	9	on	on	IN
cord-023095-4dannjjm	4839	10	this	this	DT
cord-023095-4dannjjm	4839	11	result	result	NN
cord-023095-4dannjjm	4839	12	.	.	.
cord-023095-4dannjjm	4840	1	However	however	RB
cord-023095-4dannjjm	4840	2	,	,	,
cord-023095-4dannjjm	4840	3	there	there	EX
cord-023095-4dannjjm	4840	4	are	be	VBP
cord-023095-4dannjjm	4840	5	few	few	JJ
cord-023095-4dannjjm	4840	6	data	datum	NNS
cord-023095-4dannjjm	4840	7	describing	describe	VBG
cord-023095-4dannjjm	4840	8	normal	normal	JJ
cord-023095-4dannjjm	4840	9	glucose	glucose	NN
cord-023095-4dannjjm	4840	10	uptake	uptake	NN
cord-023095-4dannjjm	4840	11	of	of	IN
cord-023095-4dannjjm	4840	12	the	the	DT
cord-023095-4dannjjm	4840	13	canine	canine	JJ
cord-023095-4dannjjm	4840	14	brain	brain	NN
cord-023095-4dannjjm	4840	15	for	for	IN
cord-023095-4dannjjm	4840	16	comparison	comparison	NN
cord-023095-4dannjjm	4840	17	with	with	IN
cord-023095-4dannjjm	4840	18	suspected	suspect	VBN
cord-023095-4dannjjm	4840	19	or	or	CC
cord-023095-4dannjjm	4840	20	confirmed	confirm	VBN
cord-023095-4dannjjm	4840	21	disease	disease	NN
cord-023095-4dannjjm	4840	22	.	.	.
cord-023095-4dannjjm	4841	1	Thus	thus	RB
cord-023095-4dannjjm	4841	2	the	the	DT
cord-023095-4dannjjm	4841	3	purpose	purpose	NN
cord-023095-4dannjjm	4841	4	of	of	IN
cord-023095-4dannjjm	4841	5	this	this	DT
cord-023095-4dannjjm	4841	6	study	study	NN
cord-023095-4dannjjm	4841	7	was	be	VBD
cord-023095-4dannjjm	4841	8	to	to	TO
cord-023095-4dannjjm	4841	9	assess	assess	VB
cord-023095-4dannjjm	4841	10	the	the	DT
cord-023095-4dannjjm	4841	11	normal	normal	JJ
cord-023095-4dannjjm	4841	12	distribution	distribution	NN
cord-023095-4dannjjm	4841	13	of	of	IN
cord-023095-4dannjjm	4841	14	FDG	FDG	NNP
cord-023095-4dannjjm	4841	15	uptake	uptake	NN
cord-023095-4dannjjm	4841	16	of	of	IN
cord-023095-4dannjjm	4841	17	canine	canine	JJ
cord-023095-4dannjjm	4841	18	brain	brain	NN
cord-023095-4dannjjm	4841	19	structures	structure	NNS
cord-023095-4dannjjm	4841	20	using	use	VBG
cord-023095-4dannjjm	4841	21	a	a	DT
cord-023095-4dannjjm	4841	22	high	high	JJ
cord-023095-4dannjjm	4841	23	-	-	HYPH
cord-023095-4dannjjm	4841	24	resolution	resolution	NN
cord-023095-4dannjjm	4841	25	research	research	NN
cord-023095-4dannjjm	4841	26	tomography	tomography	NN
cord-023095-4dannjjm	4841	27	-	-	HYPH
cord-023095-4dannjjm	4841	28	PET	pet	NN
cord-023095-4dannjjm	4841	29	and	and	CC
cord-023095-4dannjjm	4841	30	7	7	CD
cord-023095-4dannjjm	4841	31	T	t	NN
cord-023095-4dannjjm	4841	32	-	-	HYPH
cord-023095-4dannjjm	4841	33	magnetic	magnetic	JJ
cord-023095-4dannjjm	4841	34	resonance	resonance	NN
cord-023095-4dannjjm	4841	35	imaging	imaging	NN
cord-023095-4dannjjm	4841	36	(	(	-LRB-
cord-023095-4dannjjm	4841	37	MRI	MRI	NNP
cord-023095-4dannjjm	4841	38	)	)	-RRB-
cord-023095-4dannjjm	4841	39	fusion	fusion	NN
cord-023095-4dannjjm	4841	40	system	system	NN
cord-023095-4dannjjm	4841	41	.	.	.
cord-023095-4dannjjm	4842	1	FDG	FDG	NNP
cord-023095-4dannjjm	4842	2	-	-	HYPH
cord-023095-4dannjjm	4842	3	PET	PET	NNP
cord-023095-4dannjjm	4842	4	and	and	CC
cord-023095-4dannjjm	4842	5	T2-weighted	t2-weighte	VBD
cord-023095-4dannjjm	4842	6	MR	MR	NNP
cord-023095-4dannjjm	4842	7	imaging	imaging	NN
cord-023095-4dannjjm	4842	8	of	of	IN
cord-023095-4dannjjm	4842	9	the	the	DT
cord-023095-4dannjjm	4842	10	brain	brain	NN
cord-023095-4dannjjm	4842	11	were	be	VBD
cord-023095-4dannjjm	4842	12	performed	perform	VBN
cord-023095-4dannjjm	4842	13	on	on	IN
cord-023095-4dannjjm	4842	14	4	4	CD
cord-023095-4dannjjm	4842	15	healthy	healthy	JJ
cord-023095-4dannjjm	4842	16	laboratory	laboratory	NN
cord-023095-4dannjjm	4842	17	beagle	beagle	NN
cord-023095-4dannjjm	4842	18	dogs	dog	NNS
cord-023095-4dannjjm	4842	19	.	.	.
cord-023095-4dannjjm	4843	1	Acquired	acquire	VBN
cord-023095-4dannjjm	4843	2	PET	PET	NNP
cord-023095-4dannjjm	4843	3	and	and	CC
cord-023095-4dannjjm	4843	4	MR	MR	NNP
cord-023095-4dannjjm	4843	5	images	image	NNS
cord-023095-4dannjjm	4843	6	were	be	VBD
cord-023095-4dannjjm	4843	7	automatically	automatically	RB
cord-023095-4dannjjm	4843	8	co	co	JJ
cord-023095-4dannjjm	4843	9	-	-	VBN
cord-023095-4dannjjm	4843	10	registered	register	VBN
cord-023095-4dannjjm	4843	11	by	by	IN
cord-023095-4dannjjm	4843	12	the	the	DT
cord-023095-4dannjjm	4843	13	image	image	NN
cord-023095-4dannjjm	4843	14	analysis	analysis	NN
cord-023095-4dannjjm	4843	15	software	software	NN
cord-023095-4dannjjm	4843	16	.	.	.
cord-023095-4dannjjm	4844	1	On	on	IN
cord-023095-4dannjjm	4844	2	MR	MR	NNP
cord-023095-4dannjjm	4844	3	images	image	NNS
cord-023095-4dannjjm	4844	4	,	,	,
cord-023095-4dannjjm	4844	5	regions	region	NNS
cord-023095-4dannjjm	4844	6	of	of	IN
cord-023095-4dannjjm	4844	7	interest	interest	NN
cord-023095-4dannjjm	4844	8	(	(	-LRB-
cord-023095-4dannjjm	4844	9	ROI	ROI	NNP
cord-023095-4dannjjm	4844	10	)	)	-RRB-
cord-023095-4dannjjm	4844	11	were	be	VBD
cord-023095-4dannjjm	4844	12	manually	manually	RB
cord-023095-4dannjjm	4844	13	drawn	draw	VBN
cord-023095-4dannjjm	4844	14	over	over	IN
cord-023095-4dannjjm	4844	15	48	48	CD
cord-023095-4dannjjm	4844	16	intracranial	intracranial	JJ
cord-023095-4dannjjm	4844	17	structures	structure	NNS
cord-023095-4dannjjm	4844	18	,	,	,
cord-023095-4dannjjm	4844	19	including	include	VBG
cord-023095-4dannjjm	4844	20	6	6	CD
cord-023095-4dannjjm	4844	21	gross	gross	JJ
cord-023095-4dannjjm	4844	22	structures	structure	NNS
cord-023095-4dannjjm	4844	23	(	(	-LRB-
cord-023095-4dannjjm	4844	24	whole	whole	JJ
cord-023095-4dannjjm	4844	25	brain	brain	NN
cord-023095-4dannjjm	4844	26	,	,	,
cord-023095-4dannjjm	4844	27	telencephalon	telencephalon	NNP
cord-023095-4dannjjm	4844	28	,	,	,
cord-023095-4dannjjm	4844	29	diencephalon	diencephalon	NNP
cord-023095-4dannjjm	4844	30	,	,	,
cord-023095-4dannjjm	4844	31	mesencephalon	mesencephalon	NNP
cord-023095-4dannjjm	4844	32	,	,	,
cord-023095-4dannjjm	4844	33	dorsal	dorsal	NNP
cord-023095-4dannjjm	4844	34	metencephalon	metencephalon	NNP
cord-023095-4dannjjm	4844	35	,	,	,
cord-023095-4dannjjm	4844	36	ventral	ventral	NNP
cord-023095-4dannjjm	4844	37	metencephalon	metencephalon	NNP
cord-023095-4dannjjm	4844	38	and	and	CC
cord-023095-4dannjjm	4844	39	myelencephalon	myelencephalon	NNP
cord-023095-4dannjjm	4844	40	)	)	-RRB-
cord-023095-4dannjjm	4844	41	.	.	.
cord-023095-4dannjjm	4845	1	A	a	DT
cord-023095-4dannjjm	4845	2	standard	standard	JJ
cord-023095-4dannjjm	4845	3	uptake	uptake	NN
cord-023095-4dannjjm	4845	4	value	value	NN
cord-023095-4dannjjm	4845	5	(	(	-LRB-
cord-023095-4dannjjm	4845	6	SUV	SUV	NNP
cord-023095-4dannjjm	4845	7	)	)	-RRB-
cord-023095-4dannjjm	4845	8	and	and	CC
cord-023095-4dannjjm	4845	9	relative	relative	JJ
cord-023095-4dannjjm	4845	10	SUV	SUV	NNP
cord-023095-4dannjjm	4845	11	ratio	ratio	NN
cord-023095-4dannjjm	4845	12	(	(	-LRB-
cord-023095-4dannjjm	4845	13	rSUV	rsuv	RB
cord-023095-4dannjjm	4845	14	5	5	CD
cord-023095-4dannjjm	4845	15	SUV	SUV	NNP
cord-023095-4dannjjm	4845	16	of	of	IN
cord-023095-4dannjjm	4845	17	ROI	ROI	NNP
cord-023095-4dannjjm	4845	18	/	/	SYM
cord-023095-4dannjjm	4845	19	SUV	SUV	NNP
cord-023095-4dannjjm	4845	20	of	of	IN
cord-023095-4dannjjm	4845	21	whole	whole	JJ
cord-023095-4dannjjm	4845	22	brain	brain	NN
cord-023095-4dannjjm	4845	23	)	)	-RRB-
cord-023095-4dannjjm	4845	24	were	be	VBD
cord-023095-4dannjjm	4845	25	calculated	calculate	VBN
cord-023095-4dannjjm	4845	26	for	for	IN
cord-023095-4dannjjm	4845	27	each	each	DT
cord-023095-4dannjjm	4845	28	ROI	ROI	NNP
cord-023095-4dannjjm	4845	29	.	.	.
cord-023095-4dannjjm	4846	1	7	7	CD
cord-023095-4dannjjm	4846	2	T	T	NNP
cord-023095-4dannjjm	4846	3	-	-	HYPH
cord-023095-4dannjjm	4846	4	MR	MR	NNP
cord-023095-4dannjjm	4846	5	images	image	NNS
cord-023095-4dannjjm	4846	6	compensated	compensate	VBD
cord-023095-4dannjjm	4846	7	the	the	DT
cord-023095-4dannjjm	4846	8	low	low	JJ
cord-023095-4dannjjm	4846	9	anatomical	anatomical	JJ
cord-023095-4dannjjm	4846	10	resolution	resolution	NN
cord-023095-4dannjjm	4846	11	of	of	IN
cord-023095-4dannjjm	4846	12	PET	PET	NNP
cord-023095-4dannjjm	4846	13	QJ;by	QJ;by	NNP
cord-023095-4dannjjm	4846	14	proving	prove	VBG
cord-023095-4dannjjm	4846	15	good	good	JJ
cord-023095-4dannjjm	4846	16	spatial	spatial	JJ
cord-023095-4dannjjm	4846	17	and	and	CC
cord-023095-4dannjjm	4846	18	contrast	contrast	JJ
cord-023095-4dannjjm	4846	19	resolution	resolution	NN
cord-023095-4dannjjm	4846	20	for	for	IN
cord-023095-4dannjjm	4846	21	the	the	DT
cord-023095-4dannjjm	4846	22	identification	identification	NN
cord-023095-4dannjjm	4846	23	of	of	IN
cord-023095-4dannjjm	4846	24	the	the	DT
cord-023095-4dannjjm	4846	25	clinically	clinically	RB
cord-023095-4dannjjm	4846	26	relevant	relevant	JJ
cord-023095-4dannjjm	4846	27	brain	brain	NN
cord-023095-4dannjjm	4846	28	anatomy	anatomy	NN
cord-023095-4dannjjm	4846	29	.	.	.
cord-023095-4dannjjm	4847	1	Among	among	IN
cord-023095-4dannjjm	4847	2	gross	gross	JJ
cord-023095-4dannjjm	4847	3	structures	structure	NNS
cord-023095-4dannjjm	4847	4	,	,	,
cord-023095-4dannjjm	4847	5	mesencephalon	mesencephalon	NN
cord-023095-4dannjjm	4847	6	and	and	CC
cord-023095-4dannjjm	4847	7	ventral	ventral	NNP
cord-023095-4dannjjm	4847	8	metencephalon	metencephalon	NNP
cord-023095-4dannjjm	4847	9	had	have	VBD
cord-023095-4dannjjm	4847	10	the	the	DT
cord-023095-4dannjjm	4847	11	highest	high	JJS
cord-023095-4dannjjm	4847	12	(	(	-LRB-
cord-023095-4dannjjm	4847	13	SUV	SUV	NNP
cord-023095-4dannjjm	4847	14	:	:	:
cord-023095-4dannjjm	4847	15	4.17	4.17	CD
cord-023095-4dannjjm	4847	16	AE	AE	NNP
cord-023095-4dannjjm	4847	17	0.23	0.23	CD
cord-023095-4dannjjm	4847	18	;	;	:
cord-023095-4dannjjm	4847	19	rSUV	rSUV	NNP
cord-023095-4dannjjm	4847	20	:	:	:
cord-023095-4dannjjm	4847	21	1.12	1.12	CD
cord-023095-4dannjjm	4847	22	AE	AE	NNP
cord-023095-4dannjjm	4847	23	0.03	0.03	CD
cord-023095-4dannjjm	4847	24	)	)	-RRB-
cord-023095-4dannjjm	4847	25	and	and	CC
cord-023095-4dannjjm	4847	26	the	the	DT
cord-023095-4dannjjm	4847	27	lowest	low	JJS
cord-023095-4dannjjm	4847	28	(	(	-LRB-
cord-023095-4dannjjm	4847	29	SUV	SUV	NNP
cord-023095-4dannjjm	4847	30	:	:	:
cord-023095-4dannjjm	4847	31	3.34	3.34	CD
cord-023095-4dannjjm	4847	32	AE	AE	NNP
cord-023095-4dannjjm	4847	33	0.35	0.35	CD
cord-023095-4dannjjm	4847	34	;	;	:
cord-023095-4dannjjm	4847	35	rSUV	rSUV	NNP
cord-023095-4dannjjm	4847	36	:	:	:
cord-023095-4dannjjm	4847	37	0.90	0.90	CD
cord-023095-4dannjjm	4847	38	AE	AE	NNP
cord-023095-4dannjjm	4847	39	0.06	0.06	CD
cord-023095-4dannjjm	4847	40	)	)	-RRB-
cord-023095-4dannjjm	4848	1	FDG	FDG	NNP
cord-023095-4dannjjm	4848	2	uptake	uptake	NN
cord-023095-4dannjjm	4848	3	respectively	respectively	RB
cord-023095-4dannjjm	4848	4	.	.	.
cord-023095-4dannjjm	4849	1	When	when	WRB
cord-023095-4dannjjm	4849	2	SUVs	suv	NNS
cord-023095-4dannjjm	4849	3	were	be	VBD
cord-023095-4dannjjm	4849	4	calculated	calculate	VBN
cord-023095-4dannjjm	4849	5	on	on	IN
cord-023095-4dannjjm	4849	6	42	42	CD
cord-023095-4dannjjm	4849	7	detailed	detailed	JJ
cord-023095-4dannjjm	4849	8	regions	region	NNS
cord-023095-4dannjjm	4849	9	,	,	,
cord-023095-4dannjjm	4849	10	rostral	rostral	NNP
cord-023095-4dannjjm	4849	11	colliculus	colliculus	NNP
cord-023095-4dannjjm	4849	12	and	and	CC
cord-023095-4dannjjm	4849	13	corpus	corpus	NNP
cord-023095-4dannjjm	4849	14	callosum	callosum	NNP
cord-023095-4dannjjm	4849	15	had	have	VBD
cord-023095-4dannjjm	4849	16	the	the	DT
cord-023095-4dannjjm	4849	17	highest	high	JJS
cord-023095-4dannjjm	4849	18	(	(	-LRB-
cord-023095-4dannjjm	4849	19	SUV	SUV	NNP
cord-023095-4dannjjm	4849	20	:	:	:
cord-023095-4dannjjm	4849	21	6.00	6.00	CD
cord-023095-4dannjjm	4849	22	AE	AE	NNP
cord-023095-4dannjjm	4849	23	0.16	0.16	CD
cord-023095-4dannjjm	4849	24	;	;	:
cord-023095-4dannjjm	4849	25	rSUV	rsuv	JJ
cord-023095-4dannjjm	4849	26	:	:	:
cord-023095-4dannjjm	4849	27	1.62	1.62	CD
cord-023095-4dannjjm	4849	28	AE	AE	NNP
cord-023095-4dannjjm	4849	29	0.05	0.05	CD
cord-023095-4dannjjm	4849	30	)	)	-RRB-
cord-023095-4dannjjm	4849	31	and	and	CC
cord-023095-4dannjjm	4849	32	the	the	DT
cord-023095-4dannjjm	4849	33	lowest	low	JJS
cord-023095-4dannjjm	4849	34	(	(	-LRB-
cord-023095-4dannjjm	4849	35	SUV	SUV	NNP
cord-023095-4dannjjm	4849	36	:	:	:
cord-023095-4dannjjm	4849	37	2.81	2.81	CD
cord-023095-4dannjjm	4849	38	AE	AE	NNP
cord-023095-4dannjjm	4849	39	0.12	0.12	CD
cord-023095-4dannjjm	4849	40	;	;	:
cord-023095-4dannjjm	4849	41	rSUV	rSUV	NNP
cord-023095-4dannjjm	4849	42	:	:	:
cord-023095-4dannjjm	4849	43	0.76	0.76	CD
cord-023095-4dannjjm	4849	44	AE	AE	NNP
cord-023095-4dannjjm	4849	45	0.06	0.06	CD
cord-023095-4dannjjm	4849	46	)	)	-RRB-
cord-023095-4dannjjm	4849	47	value	value	NN
cord-023095-4dannjjm	4849	48	respectively	respectively	RB
cord-023095-4dannjjm	4849	49	.	.	.
cord-023095-4dannjjm	4850	1	These	these	DT
cord-023095-4dannjjm	4850	2	data	datum	NNS
cord-023095-4dannjjm	4850	3	acquired	acquire	VBD
cord-023095-4dannjjm	4850	4	from	from	IN
cord-023095-4dannjjm	4850	5	normal	normal	JJ
cord-023095-4dannjjm	4850	6	dog	dog	NN
cord-023095-4dannjjm	4850	7	brain	brain	NN
cord-023095-4dannjjm	4850	8	will	will	MD
cord-023095-4dannjjm	4850	9	be	be	VB
cord-023095-4dannjjm	4850	10	used	use	VBN
cord-023095-4dannjjm	4850	11	in	in	IN
cord-023095-4dannjjm	4850	12	clinical	clinical	JJ
cord-023095-4dannjjm	4850	13	neurology	neurology	NN
cord-023095-4dannjjm	4850	14	to	to	TO
cord-023095-4dannjjm	4850	15	investigate	investigate	VB
cord-023095-4dannjjm	4850	16	various	various	JJ
cord-023095-4dannjjm	4850	17	intracranial	intracranial	JJ
cord-023095-4dannjjm	4850	18	diseases	disease	NNS
cord-023095-4dannjjm	4850	19	such	such	JJ
cord-023095-4dannjjm	4850	20	as	as	IN
cord-023095-4dannjjm	4850	21	inflammation	inflammation	NN
cord-023095-4dannjjm	4850	22	,	,	,
cord-023095-4dannjjm	4850	23	neoplasm	neoplasm	NN
cord-023095-4dannjjm	4850	24	and	and	CC
cord-023095-4dannjjm	4850	25	behavioral	behavioral	JJ
cord-023095-4dannjjm	4850	26	disorders	disorder	NNS
cord-023095-4dannjjm	4850	27	.	.	.
cord-023095-4dannjjm	4851	1	Degenerative	degenerative	JJ
cord-023095-4dannjjm	4851	2	lumbosacral	lumbosacral	JJ
cord-023095-4dannjjm	4851	3	stenosis	stenosis	NN
cord-023095-4dannjjm	4851	4	(	(	-LRB-
cord-023095-4dannjjm	4851	5	DLSS	DLSS	NNP
cord-023095-4dannjjm	4851	6	)	)	-RRB-
cord-023095-4dannjjm	4851	7	is	be	VBZ
cord-023095-4dannjjm	4851	8	a	a	DT
cord-023095-4dannjjm	4851	9	multifactorial	multifactorial	JJ
cord-023095-4dannjjm	4851	10	condition	condition	NN
cord-023095-4dannjjm	4851	11	affecting	affect	VBG
cord-023095-4dannjjm	4851	12	predominantly	predominantly	RB
cord-023095-4dannjjm	4851	13	large	large	JJ
cord-023095-4dannjjm	4851	14	breed	breed	NN
cord-023095-4dannjjm	4851	15	dogs	dog	NNS
cord-023095-4dannjjm	4851	16	.	.	.
cord-023095-4dannjjm	4852	1	The	the	DT
cord-023095-4dannjjm	4852	2	combination	combination	NN
cord-023095-4dannjjm	4852	3	of	of	IN
cord-023095-4dannjjm	4852	4	stenosis	stenosis	NN
cord-023095-4dannjjm	4852	5	and	and	CC
cord-023095-4dannjjm	4852	6	compressive	compressive	JJ
cord-023095-4dannjjm	4852	7	neuropathy	neuropathy	NN
cord-023095-4dannjjm	4852	8	cause	cause	VB
cord-023095-4dannjjm	4852	9	lumbar	lumbar	JJ
cord-023095-4dannjjm	4852	10	pain	pain	NN
cord-023095-4dannjjm	4852	11	,	,	,
cord-023095-4dannjjm	4852	12	lameness	lameness	NN
cord-023095-4dannjjm	4852	13	and	and	CC
cord-023095-4dannjjm	4852	14	neurologic	neurologic	JJ
cord-023095-4dannjjm	4852	15	dysfunction	dysfunction	NN
cord-023095-4dannjjm	4852	16	.	.	.
cord-023095-4dannjjm	4853	1	Previous	previous	JJ
cord-023095-4dannjjm	4853	2	reports	report	NNS
cord-023095-4dannjjm	4853	3	describe	describe	VBP
cord-023095-4dannjjm	4853	4	urinary	urinary	JJ
cord-023095-4dannjjm	4853	5	and	and	CC
cord-023095-4dannjjm	4853	6	fecal	fecal	JJ
cord-023095-4dannjjm	4853	7	incontinence	incontinence	NN
cord-023095-4dannjjm	4853	8	in	in	IN
cord-023095-4dannjjm	4853	9	severely	severely	RB
cord-023095-4dannjjm	4853	10	affected	affect	VBN
cord-023095-4dannjjm	4853	11	dogs	dog	NNS
cord-023095-4dannjjm	4853	12	.	.	.
cord-023095-4dannjjm	4854	1	The	the	DT
cord-023095-4dannjjm	4854	2	objectives	objective	NNS
cord-023095-4dannjjm	4854	3	of	of	IN
cord-023095-4dannjjm	4854	4	this	this	DT
cord-023095-4dannjjm	4854	5	retrospective	retrospective	JJ
cord-023095-4dannjjm	4854	6	case	case	NN
cord-023095-4dannjjm	4854	7	series	series	NN
cord-023095-4dannjjm	4854	8	were	be	VBD
cord-023095-4dannjjm	4854	9	to	to	TO
cord-023095-4dannjjm	4854	10	describe	describe	VB
cord-023095-4dannjjm	4854	11	the	the	DT
cord-023095-4dannjjm	4854	12	clinical	clinical	JJ
cord-023095-4dannjjm	4854	13	signs	sign	NNS
cord-023095-4dannjjm	4854	14	associated	associate	VBN
cord-023095-4dannjjm	4854	15	with	with	IN
cord-023095-4dannjjm	4854	16	dysuria	dysuria	NNS
cord-023095-4dannjjm	4854	17	and	and	CC
cord-023095-4dannjjm	4854	18	eventual	eventual	JJ
cord-023095-4dannjjm	4854	19	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4854	20	of	of	IN
cord-023095-4dannjjm	4854	21	DLSS	dls	NNS
cord-023095-4dannjjm	4854	22	in	in	IN
cord-023095-4dannjjm	4854	23	dogs	dog	NNS
cord-023095-4dannjjm	4854	24	,	,	,
cord-023095-4dannjjm	4854	25	and	and	CC
cord-023095-4dannjjm	4854	26	to	to	TO
cord-023095-4dannjjm	4854	27	describe	describe	VB
cord-023095-4dannjjm	4854	28	factors	factor	NNS
cord-023095-4dannjjm	4854	29	associated	associate	VBN
cord-023095-4dannjjm	4854	30	with	with	IN
cord-023095-4dannjjm	4854	31	regained	regained	JJ
cord-023095-4dannjjm	4854	32	micturition	micturition	NN
cord-023095-4dannjjm	4854	33	following	follow	VBG
cord-023095-4dannjjm	4854	34	prompt	prompt	JJ
cord-023095-4dannjjm	4854	35	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4854	36	and	and	CC
cord-023095-4dannjjm	4854	37	treatment	treatment	NN
cord-023095-4dannjjm	4854	38	.	.	.
cord-023095-4dannjjm	4855	1	Medical	medical	JJ
cord-023095-4dannjjm	4855	2	records	record	NNS
cord-023095-4dannjjm	4855	3	from	from	IN
cord-023095-4dannjjm	4855	4	the	the	DT
cord-023095-4dannjjm	4855	5	University	University	NNP
cord-023095-4dannjjm	4855	6	of	of	IN
cord-023095-4dannjjm	4855	7	Georgia	Georgia	NNP
cord-023095-4dannjjm	4855	8	and	and	CC
cord-023095-4dannjjm	4855	9	the	the	DT
cord-023095-4dannjjm	4855	10	University	University	NNP
cord-023095-4dannjjm	4855	11	of	of	IN
cord-023095-4dannjjm	4855	12	Missouri	Missouri	NNP
cord-023095-4dannjjm	4855	13	between	between	IN
cord-023095-4dannjjm	4855	14	1995	1995	CD
cord-023095-4dannjjm	4855	15	and	and	CC
cord-023095-4dannjjm	4855	16	2009	2009	CD
cord-023095-4dannjjm	4855	17	of	of	IN
cord-023095-4dannjjm	4855	18	11	11	CD
cord-023095-4dannjjm	4855	19	dogs	dog	NNS
cord-023095-4dannjjm	4855	20	were	be	VBD
cord-023095-4dannjjm	4855	21	reviewed	review	VBN
cord-023095-4dannjjm	4855	22	.	.	.
cord-023095-4dannjjm	4856	1	Inclusion	inclusion	NN
cord-023095-4dannjjm	4856	2	required	require	VBN
cord-023095-4dannjjm	4856	3	observation	observation	NN
cord-023095-4dannjjm	4856	4	of	of	IN
cord-023095-4dannjjm	4856	5	dysuria	dysuria	NNP
cord-023095-4dannjjm	4856	6	,	,	,
cord-023095-4dannjjm	4856	7	urine	urine	NN
cord-023095-4dannjjm	4856	8	retention	retention	NN
cord-023095-4dannjjm	4856	9	,	,	,
cord-023095-4dannjjm	4856	10	absence	absence	NN
cord-023095-4dannjjm	4856	11	of	of	IN
cord-023095-4dannjjm	4856	12	structural	structural	JJ
cord-023095-4dannjjm	4856	13	lower	low	JJR
cord-023095-4dannjjm	4856	14	urinary	urinary	JJ
cord-023095-4dannjjm	4856	15	tract	tract	NN
cord-023095-4dannjjm	4856	16	disease	disease	NN
cord-023095-4dannjjm	4856	17	and	and	CC
cord-023095-4dannjjm	4856	18	concurrent	concurrent	JJ
cord-023095-4dannjjm	4856	19	presumptive	presumptive	JJ
cord-023095-4dannjjm	4856	20	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4856	21	of	of	IN
cord-023095-4dannjjm	4856	22	DLSS	DLSS	NNP
cord-023095-4dannjjm	4856	23	.	.	.
cord-023095-4dannjjm	4857	1	Dysuria	Dysuria	NNP
cord-023095-4dannjjm	4857	2	was	be	VBD
cord-023095-4dannjjm	4857	3	defined	define	VBN
cord-023095-4dannjjm	4857	4	as	as	IN
cord-023095-4dannjjm	4857	5	inability	inability	NN
cord-023095-4dannjjm	4857	6	to	to	TO
cord-023095-4dannjjm	4857	7	initiate	initiate	VB
cord-023095-4dannjjm	4857	8	or	or	CC
cord-023095-4dannjjm	4857	9	sustain	sustain	VB
cord-023095-4dannjjm	4857	10	a	a	DT
cord-023095-4dannjjm	4857	11	urine	urine	NN
cord-023095-4dannjjm	4857	12	stream	stream	NN
cord-023095-4dannjjm	4857	13	.	.	.
cord-023095-4dannjjm	4858	1	Urine	urine	NN
cord-023095-4dannjjm	4858	2	residual	residual	JJ
cord-023095-4dannjjm	4858	3	volume	volume	NN
cord-023095-4dannjjm	4858	4	was	be	VBD
cord-023095-4dannjjm	4858	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	4858	6	postvoiding	postvoide	VBG
cord-023095-4dannjjm	4858	7	.	.	.
cord-023095-4dannjjm	4859	1	Dysuria	Dysuria	NNP
cord-023095-4dannjjm	4859	2	was	be	VBD
cord-023095-4dannjjm	4859	3	further	further	RB
cord-023095-4dannjjm	4859	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	4859	5	using	use	VBG
cord-023095-4dannjjm	4859	6	urethral	urethral	JJ
cord-023095-4dannjjm	4859	7	contrast	contrast	NN
cord-023095-4dannjjm	4859	8	studies	study	NNS
cord-023095-4dannjjm	4859	9	,	,	,
cord-023095-4dannjjm	4859	10	urodynamic	urodynamic	JJ
cord-023095-4dannjjm	4859	11	testing	testing	NN
cord-023095-4dannjjm	4859	12	(	(	-LRB-
cord-023095-4dannjjm	4859	13	urethral	urethral	NNP
cord-023095-4dannjjm	4859	14	profilometry	profilometry	NNP
cord-023095-4dannjjm	4859	15	(	(	-LRB-
cord-023095-4dannjjm	4859	16	4	4	CD
cord-023095-4dannjjm	4859	17	)	)	-RRB-
cord-023095-4dannjjm	4859	18	and	and	CC
cord-023095-4dannjjm	4859	19	cystometry	cystometry	NNP
cord-023095-4dannjjm	4859	20	(	(	-LRB-
cord-023095-4dannjjm	4859	21	4	4	CD
cord-023095-4dannjjm	4859	22	)	)	-RRB-
cord-023095-4dannjjm	4859	23	)	)	-RRB-
cord-023095-4dannjjm	4859	24	,	,	,
cord-023095-4dannjjm	4859	25	ultrasonography	ultrasonography	NN
cord-023095-4dannjjm	4859	26	(	(	-LRB-
cord-023095-4dannjjm	4859	27	5	5	CD
cord-023095-4dannjjm	4859	28	)	)	-RRB-
cord-023095-4dannjjm	4859	29	,	,	,
cord-023095-4dannjjm	4859	30	and	and	CC
cord-023095-4dannjjm	4859	31	urine	urine	NN
cord-023095-4dannjjm	4859	32	culture	culture	NN
cord-023095-4dannjjm	4859	33	(	(	-LRB-
cord-023095-4dannjjm	4859	34	8)	8)	NN
cord-023095-4dannjjm	4859	35	.	.	.
cord-023095-4dannjjm	4860	1	Presumptive	presumptive	JJ
cord-023095-4dannjjm	4860	2	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4860	3	of	of	IN
cord-023095-4dannjjm	4860	4	DLSS	DLSS	NNP
cord-023095-4dannjjm	4860	5	was	be	VBD
cord-023095-4dannjjm	4860	6	based	base	VBN
cord-023095-4dannjjm	4860	7	on	on	IN
cord-023095-4dannjjm	4860	8	imaging	image	VBG
cord-023095-4dannjjm	4860	9	using	use	VBG
cord-023095-4dannjjm	4860	10	plain	plain	JJ
cord-023095-4dannjjm	4860	11	radiography	radiography	NN
cord-023095-4dannjjm	4860	12	and	and	CC
cord-023095-4dannjjm	4860	13	epidurography	epidurography	NN
cord-023095-4dannjjm	4860	14	(	(	-LRB-
cord-023095-4dannjjm	4860	15	8)	8)	NNP
cord-023095-4dannjjm	4860	16	,	,	,
cord-023095-4dannjjm	4860	17	computed	compute	VBN
cord-023095-4dannjjm	4860	18	tomography	tomography	NN
cord-023095-4dannjjm	4860	19	(	(	-LRB-
cord-023095-4dannjjm	4860	20	1	1	CD
cord-023095-4dannjjm	4860	21	)	)	-RRB-
cord-023095-4dannjjm	4860	22	or	or	CC
cord-023095-4dannjjm	4860	23	magnetic	magnetic	JJ
cord-023095-4dannjjm	4860	24	resonance	resonance	NN
cord-023095-4dannjjm	4860	25	imaging	imaging	NN
cord-023095-4dannjjm	4860	26	(	(	-LRB-
cord-023095-4dannjjm	4860	27	2	2	CD
cord-023095-4dannjjm	4860	28	)	)	-RRB-
cord-023095-4dannjjm	4860	29	.	.	.
cord-023095-4dannjjm	4861	1	Breeds	breed	NNS
cord-023095-4dannjjm	4861	2	represented	represent	VBN
cord-023095-4dannjjm	4861	3	included	include	VBD
cord-023095-4dannjjm	4861	4	the	the	DT
cord-023095-4dannjjm	4861	5	German	german	JJ
cord-023095-4dannjjm	4861	6	Shepherd	Shepherd	NNP
cord-023095-4dannjjm	4861	7	Dog	Dog	NNP
cord-023095-4dannjjm	4861	8	(	(	-LRB-
cord-023095-4dannjjm	4861	9	n	n	NN
cord-023095-4dannjjm	4861	10	5	5	CD
cord-023095-4dannjjm	4861	11	3	3	CD
cord-023095-4dannjjm	4861	12	)	)	-RRB-
cord-023095-4dannjjm	4861	13	,	,	,
cord-023095-4dannjjm	4861	14	Golden	Golden	NNP
cord-023095-4dannjjm	4861	15	Retriever	Retriever	NNP
cord-023095-4dannjjm	4861	16	(	(	-LRB-
cord-023095-4dannjjm	4861	17	n	n	NN
cord-023095-4dannjjm	4861	18	5	5	CD
cord-023095-4dannjjm	4861	19	2	2	CD
cord-023095-4dannjjm	4861	20	)	)	-RRB-
cord-023095-4dannjjm	4861	21	,	,	,
cord-023095-4dannjjm	4861	22	Burnese	Burnese	NNP
cord-023095-4dannjjm	4861	23	Mountain	Mountain	NNP
cord-023095-4dannjjm	4861	24	Dog	Dog	NNP
cord-023095-4dannjjm	4861	25	(	(	-LRB-
cord-023095-4dannjjm	4861	26	n	n	NN
cord-023095-4dannjjm	4861	27	5	5	CD
cord-023095-4dannjjm	4861	28	2	2	CD
cord-023095-4dannjjm	4861	29	)	)	-RRB-
cord-023095-4dannjjm	4861	30	,	,	,
cord-023095-4dannjjm	4861	31	and	and	CC
cord-023095-4dannjjm	4861	32	1	1	CD
cord-023095-4dannjjm	4861	33	each	each	DT
cord-023095-4dannjjm	4861	34	Labrador	Labrador	NNP
cord-023095-4dannjjm	4861	35	Retriever	Retriever	NNP
cord-023095-4dannjjm	4861	36	,	,	,
cord-023095-4dannjjm	4861	37	Weimaraner	Weimaraner	NNP
cord-023095-4dannjjm	4861	38	,	,	,
cord-023095-4dannjjm	4861	39	Rottweiler	Rottweiler	NNP
cord-023095-4dannjjm	4861	40	and	and	CC
cord-023095-4dannjjm	4861	41	mixed	mix	VBN
cord-023095-4dannjjm	4861	42	-	-	HYPH
cord-023095-4dannjjm	4861	43	breed	breed	NN
cord-023095-4dannjjm	4861	44	.	.	.
cord-023095-4dannjjm	4862	1	All	all	DT
cord-023095-4dannjjm	4862	2	dogs	dog	NNS
cord-023095-4dannjjm	4862	3	were	be	VBD
cord-023095-4dannjjm	4862	4	male	male	JJ
cord-023095-4dannjjm	4862	5	.	.	.
cord-023095-4dannjjm	4863	1	8	8	CD
cord-023095-4dannjjm	4863	2	were	be	VBD
cord-023095-4dannjjm	4863	3	intact	intact	JJ
cord-023095-4dannjjm	4863	4	at	at	IN
cord-023095-4dannjjm	4863	5	onset	onset	NN
cord-023095-4dannjjm	4863	6	of	of	IN
cord-023095-4dannjjm	4863	7	clinical	clinical	JJ
cord-023095-4dannjjm	4863	8	signs	sign	NNS
cord-023095-4dannjjm	4863	9	.	.	.
cord-023095-4dannjjm	4864	1	Median	median	JJ
cord-023095-4dannjjm	4864	2	body	body	NN
cord-023095-4dannjjm	4864	3	weight	weight	NN
cord-023095-4dannjjm	4864	4	was	be	VBD
cord-023095-4dannjjm	4864	5	38.5	38.5	CD
cord-023095-4dannjjm	4864	6	kg	kg	NNS
cord-023095-4dannjjm	4864	7	(	(	-LRB-
cord-023095-4dannjjm	4864	8	range	range	VBP
cord-023095-4dannjjm	4864	9	29.5	29.5	CD
cord-023095-4dannjjm	4864	10	-	-	SYM
cord-023095-4dannjjm	4864	11	46	46	CD
cord-023095-4dannjjm	4864	12	)	)	-RRB-
cord-023095-4dannjjm	4864	13	and	and	CC
cord-023095-4dannjjm	4864	14	median	median	JJ
cord-023095-4dannjjm	4864	15	age	age	NN
cord-023095-4dannjjm	4864	16	was	be	VBD
cord-023095-4dannjjm	4864	17	5	5	CD
cord-023095-4dannjjm	4864	18	years	year	NNS
cord-023095-4dannjjm	4864	19	(	(	-LRB-
cord-023095-4dannjjm	4864	20	range	range	VBP
cord-023095-4dannjjm	4864	21	2	2	CD
cord-023095-4dannjjm	4864	22	-	-	SYM
cord-023095-4dannjjm	4864	23	10	10	CD
cord-023095-4dannjjm	4864	24	)	)	-RRB-
cord-023095-4dannjjm	4864	25	.	.	.
cord-023095-4dannjjm	4865	1	Median	median	JJ
cord-023095-4dannjjm	4865	2	duration	duration	NN
cord-023095-4dannjjm	4865	3	of	of	IN
cord-023095-4dannjjm	4865	4	clinical	clinical	JJ
cord-023095-4dannjjm	4865	5	signs	sign	NNS
cord-023095-4dannjjm	4865	6	prior	prior	RB
cord-023095-4dannjjm	4865	7	to	to	IN
cord-023095-4dannjjm	4865	8	admission	admission	NN
cord-023095-4dannjjm	4865	9	was	be	VBD
cord-023095-4dannjjm	4865	10	2	2	CD
cord-023095-4dannjjm	4865	11	months	month	NNS
cord-023095-4dannjjm	4865	12	(	(	-LRB-
cord-023095-4dannjjm	4865	13	range	range	VBP
cord-023095-4dannjjm	4865	14	0.25	0.25	CD
cord-023095-4dannjjm	4865	15	-	-	SYM
cord-023095-4dannjjm	4865	16	12	12	CD
cord-023095-4dannjjm	4865	17	)	)	-RRB-
cord-023095-4dannjjm	4865	18	.	.	.
cord-023095-4dannjjm	4866	1	Other	other	JJ
cord-023095-4dannjjm	4866	2	pertinent	pertinent	JJ
cord-023095-4dannjjm	4866	3	presenting	present	VBG
cord-023095-4dannjjm	4866	4	clinical	clinical	JJ
cord-023095-4dannjjm	4866	5	signs	sign	NNS
cord-023095-4dannjjm	4866	6	included	include	VBD
cord-023095-4dannjjm	4866	7	dyschezia	dyschezia	NNP
cord-023095-4dannjjm	4866	8	(	(	-LRB-
cord-023095-4dannjjm	4866	9	2	2	CD
cord-023095-4dannjjm	4866	10	)	)	-RRB-
cord-023095-4dannjjm	4866	11	,	,	,
cord-023095-4dannjjm	4866	12	fecal	fecal	JJ
cord-023095-4dannjjm	4866	13	incontinence	incontinence	NN
cord-023095-4dannjjm	4866	14	(	(	-LRB-
cord-023095-4dannjjm	4866	15	4	4	CD
cord-023095-4dannjjm	4866	16	)	)	-RRB-
cord-023095-4dannjjm	4866	17	,	,	,
cord-023095-4dannjjm	4866	18	general	general	JJ
cord-023095-4dannjjm	4866	19	proprioceptive	proprioceptive	JJ
cord-023095-4dannjjm	4866	20	ataxia	ataxia	NN
cord-023095-4dannjjm	4866	21	(	(	-LRB-
cord-023095-4dannjjm	4866	22	2	2	CD
cord-023095-4dannjjm	4866	23	)	)	-RRB-
cord-023095-4dannjjm	4866	24	,	,	,
cord-023095-4dannjjm	4866	25	weakness	weakness	NN
cord-023095-4dannjjm	4866	26	(	(	-LRB-
cord-023095-4dannjjm	4866	27	2	2	CD
cord-023095-4dannjjm	4866	28	)	)	-RRB-
cord-023095-4dannjjm	4866	29	,	,	,
cord-023095-4dannjjm	4866	30	and	and	CC
cord-023095-4dannjjm	4866	31	difficulty	difficulty	NN
cord-023095-4dannjjm	4866	32	rising	rise	VBG
cord-023095-4dannjjm	4866	33	(	(	-LRB-
cord-023095-4dannjjm	4866	34	1	1	CD
cord-023095-4dannjjm	4866	35	)	)	-RRB-
cord-023095-4dannjjm	4866	36	.	.	.
cord-023095-4dannjjm	4867	1	Physical	physical	JJ
cord-023095-4dannjjm	4867	2	examination	examination	NN
cord-023095-4dannjjm	4867	3	findings	finding	NNS
cord-023095-4dannjjm	4867	4	included	include	VBD
cord-023095-4dannjjm	4867	5	pelvic	pelvic	JJ
cord-023095-4dannjjm	4867	6	limb	limb	NN
cord-023095-4dannjjm	4867	7	muscle	muscle	NN
cord-023095-4dannjjm	4867	8	atrophy	atrophy	NN
cord-023095-4dannjjm	4867	9	(	(	-LRB-
cord-023095-4dannjjm	4867	10	2	2	CD
cord-023095-4dannjjm	4867	11	)	)	-RRB-
cord-023095-4dannjjm	4867	12	and	and	CC
cord-023095-4dannjjm	4867	13	prostatomegaly	prostatomegaly	NNP
cord-023095-4dannjjm	4867	14	(	(	-LRB-
cord-023095-4dannjjm	4867	15	1	1	CD
cord-023095-4dannjjm	4867	16	)	)	-RRB-
cord-023095-4dannjjm	4867	17	.	.	.
cord-023095-4dannjjm	4868	1	Abnormal	abnormal	JJ
cord-023095-4dannjjm	4868	2	neurologic	neurologic	JJ
cord-023095-4dannjjm	4868	3	examination	examination	NN
cord-023095-4dannjjm	4868	4	findings	finding	NNS
cord-023095-4dannjjm	4868	5	included	include	VBD
cord-023095-4dannjjm	4868	6	postural	postural	JJ
cord-023095-4dannjjm	4868	7	reaction	reaction	NN
cord-023095-4dannjjm	4868	8	deficits	deficit	NNS
cord-023095-4dannjjm	4868	9	(	(	-LRB-
cord-023095-4dannjjm	4868	10	6	6	CD
cord-023095-4dannjjm	4868	11	)	)	-RRB-
cord-023095-4dannjjm	4868	12	,	,	,
cord-023095-4dannjjm	4868	13	hyporeflexia	hyporeflexia	NNP
cord-023095-4dannjjm	4868	14	(	(	-LRB-
cord-023095-4dannjjm	4868	15	4	4	CD
cord-023095-4dannjjm	4868	16	)	)	-RRB-
cord-023095-4dannjjm	4868	17	,	,	,
cord-023095-4dannjjm	4868	18	decreased	decrease	VBD
cord-023095-4dannjjm	4868	19	tail	tail	NN
cord-023095-4dannjjm	4868	20	tone	tone	NN
cord-023095-4dannjjm	4868	21	(	(	-LRB-
cord-023095-4dannjjm	4868	22	3	3	CD
cord-023095-4dannjjm	4868	23	)	)	-RRB-
cord-023095-4dannjjm	4868	24	and	and	CC
cord-023095-4dannjjm	4868	25	lumbosacral	lumbosacral	NNP
cord-023095-4dannjjm	4868	26	hyperesthesia	hyperesthesia	NNP
cord-023095-4dannjjm	4868	27	(	(	-LRB-
cord-023095-4dannjjm	4868	28	6	6	CD
cord-023095-4dannjjm	4868	29	)	)	-RRB-
cord-023095-4dannjjm	4868	30	.	.	.
cord-023095-4dannjjm	4869	1	Neurologic	neurologic	JJ
cord-023095-4dannjjm	4869	2	examination	examination	NN
cord-023095-4dannjjm	4869	3	was	be	VBD
cord-023095-4dannjjm	4869	4	normal	normal	JJ
cord-023095-4dannjjm	4869	5	in	in	IN
cord-023095-4dannjjm	4869	6	3	3	CD
cord-023095-4dannjjm	4869	7	dogs	dog	NNS
cord-023095-4dannjjm	4869	8	.	.	.
cord-023095-4dannjjm	4870	1	Dorsal	dorsal	JJ
cord-023095-4dannjjm	4870	2	laminectomy	laminectomy	NN
cord-023095-4dannjjm	4870	3	was	be	VBD
cord-023095-4dannjjm	4870	4	performed	perform	VBN
cord-023095-4dannjjm	4870	5	and	and	CC
cord-023095-4dannjjm	4870	6	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4870	7	confirmed	confirm	VBD
cord-023095-4dannjjm	4870	8	in	in	IN
cord-023095-4dannjjm	4870	9	9	9	CD
cord-023095-4dannjjm	4870	10	dogs	dog	NNS
cord-023095-4dannjjm	4870	11	;	;	:
cord-023095-4dannjjm	4870	12	recovery	recovery	NN
cord-023095-4dannjjm	4870	13	was	be	VBD
cord-023095-4dannjjm	4870	14	monitored	monitor	VBN
cord-023095-4dannjjm	4870	15	for	for	IN
cord-023095-4dannjjm	4870	16	a	a	DT
cord-023095-4dannjjm	4870	17	median	median	NN
cord-023095-4dannjjm	4870	18	of	of	IN
cord-023095-4dannjjm	4870	19	5.5	5.5	CD
cord-023095-4dannjjm	4870	20	months	month	NNS
cord-023095-4dannjjm	4870	21	(	(	-LRB-
cord-023095-4dannjjm	4870	22	range	range	VBP
cord-023095-4dannjjm	4870	23	0.25	0.25	CD
cord-023095-4dannjjm	4870	24	-	-	SYM
cord-023095-4dannjjm	4870	25	9	9	CD
cord-023095-4dannjjm	4870	26	)	)	-RRB-
cord-023095-4dannjjm	4870	27	.	.	.
cord-023095-4dannjjm	4871	1	Three	three	CD
cord-023095-4dannjjm	4871	2	of	of	IN
cord-023095-4dannjjm	4871	3	the	the	DT
cord-023095-4dannjjm	4871	4	9	9	CD
cord-023095-4dannjjm	4871	5	dogs	dog	NNS
cord-023095-4dannjjm	4871	6	(	(	-LRB-
cord-023095-4dannjjm	4871	7	33	33	CD
cord-023095-4dannjjm	4871	8	%	%	NN
cord-023095-4dannjjm	4871	9	)	)	-RRB-
cord-023095-4dannjjm	4871	10	regained	regain	VBD
cord-023095-4dannjjm	4871	11	normal	normal	JJ
cord-023095-4dannjjm	4871	12	micturition	micturition	NN
cord-023095-4dannjjm	4871	13	within	within	IN
cord-023095-4dannjjm	4871	14	0.25	0.25	CD
cord-023095-4dannjjm	4871	15	-	-	SYM
cord-023095-4dannjjm	4871	16	1.5	1.5	CD
cord-023095-4dannjjm	4871	17	months	month	NNS
cord-023095-4dannjjm	4871	18	of	of	IN
cord-023095-4dannjjm	4871	19	surgery	surgery	NN
cord-023095-4dannjjm	4871	20	.	.	.
cord-023095-4dannjjm	4872	1	Though	though	IN
cord-023095-4dannjjm	4872	2	not	not	RB
cord-023095-4dannjjm	4872	3	statistically	statistically	RB
cord-023095-4dannjjm	4872	4	significant	significant	JJ
cord-023095-4dannjjm	4872	5	,	,	,
cord-023095-4dannjjm	4872	6	dogs	dog	NNS
cord-023095-4dannjjm	4872	7	that	that	WDT
cord-023095-4dannjjm	4872	8	regained	regain	VBD
cord-023095-4dannjjm	4872	9	micturition	micturition	NN
cord-023095-4dannjjm	4872	10	tended	tend	VBD
cord-023095-4dannjjm	4872	11	to	to	TO
cord-023095-4dannjjm	4872	12	have	have	VB
cord-023095-4dannjjm	4872	13	a	a	DT
cord-023095-4dannjjm	4872	14	shorter	short	JJR
cord-023095-4dannjjm	4872	15	duration	duration	NN
cord-023095-4dannjjm	4872	16	of	of	IN
cord-023095-4dannjjm	4872	17	clinical	clinical	JJ
cord-023095-4dannjjm	4872	18	signs	sign	NNS
cord-023095-4dannjjm	4872	19	(	(	-LRB-
cord-023095-4dannjjm	4872	20	median	median	NN
cord-023095-4dannjjm	4872	21	0.25	0.25	CD
cord-023095-4dannjjm	4872	22	months	month	NNS
cord-023095-4dannjjm	4872	23	,	,	,
cord-023095-4dannjjm	4872	24	range	range	VBP
cord-023095-4dannjjm	4872	25	0.25	0.25	CD
cord-023095-4dannjjm	4872	26	-	-	SYM
cord-023095-4dannjjm	4872	27	2	2	CD
cord-023095-4dannjjm	4872	28	)	)	-RRB-
cord-023095-4dannjjm	4872	29	versus	versus	IN
cord-023095-4dannjjm	4872	30	dogs	dog	NNS
cord-023095-4dannjjm	4872	31	that	that	WDT
cord-023095-4dannjjm	4872	32	remained	remain	VBD
cord-023095-4dannjjm	4872	33	dysuric	dysuric	NNP
cord-023095-4dannjjm	4872	34	(	(	-LRB-
cord-023095-4dannjjm	4872	35	median	median	JJ
cord-023095-4dannjjm	4872	36	5	5	CD
cord-023095-4dannjjm	4872	37	months	month	NNS
cord-023095-4dannjjm	4872	38	,	,	,
cord-023095-4dannjjm	4872	39	range	range	VBP
cord-023095-4dannjjm	4872	40	2	2	CD
cord-023095-4dannjjm	4872	41	-	-	SYM
cord-023095-4dannjjm	4872	42	12	12	CD
cord-023095-4dannjjm	4872	43	)	)	-RRB-
cord-023095-4dannjjm	4872	44	.	.	.
cord-023095-4dannjjm	4873	1	Two	two	CD
cord-023095-4dannjjm	4873	2	of	of	IN
cord-023095-4dannjjm	4873	3	the	the	DT
cord-023095-4dannjjm	4873	4	3	3	CD
cord-023095-4dannjjm	4873	5	dogs	dog	NNS
cord-023095-4dannjjm	4873	6	that	that	WDT
cord-023095-4dannjjm	4873	7	regained	regain	VBD
cord-023095-4dannjjm	4873	8	micturition	micturition	NN
cord-023095-4dannjjm	4873	9	were	be	VBD
cord-023095-4dannjjm	4873	10	neutered	neuter	VBN
cord-023095-4dannjjm	4873	11	at	at	IN
cord-023095-4dannjjm	4873	12	the	the	DT
cord-023095-4dannjjm	4873	13	onset	onset	NN
cord-023095-4dannjjm	4873	14	of	of	IN
cord-023095-4dannjjm	4873	15	clinical	clinical	JJ
cord-023095-4dannjjm	4873	16	signs	sign	NNS
cord-023095-4dannjjm	4873	17	,	,	,
cord-023095-4dannjjm	4873	18	but	but	CC
cord-023095-4dannjjm	4873	19	only	only	RB
cord-023095-4dannjjm	4873	20	1of	1of	NN
cord-023095-4dannjjm	4873	21	6	6	CD
cord-023095-4dannjjm	4873	22	dogs	dog	NNS
cord-023095-4dannjjm	4873	23	that	that	WDT
cord-023095-4dannjjm	4873	24	remained	remain	VBD
cord-023095-4dannjjm	4873	25	dysuric	dysuric	NNP
cord-023095-4dannjjm	4873	26	was	be	VBD
cord-023095-4dannjjm	4873	27	neutered	neuter	VBN
cord-023095-4dannjjm	4873	28	.	.	.
cord-023095-4dannjjm	4874	1	Signs	sign	NNS
cord-023095-4dannjjm	4874	2	improved	improve	VBN
cord-023095-4dannjjm	4874	3	in	in	IN
cord-023095-4dannjjm	4874	4	all	all	DT
cord-023095-4dannjjm	4874	5	dogs	dog	NNS
cord-023095-4dannjjm	4874	6	with	with	IN
cord-023095-4dannjjm	4874	7	postural	postural	JJ
cord-023095-4dannjjm	4874	8	reaction	reaction	NN
cord-023095-4dannjjm	4874	9	deficits	deficit	NNS
cord-023095-4dannjjm	4874	10	and	and	CC
cord-023095-4dannjjm	4874	11	decreased	decrease	VBD
cord-023095-4dannjjm	4874	12	tail	tail	NN
cord-023095-4dannjjm	4874	13	tone	tone	NN
cord-023095-4dannjjm	4874	14	.	.	.
cord-023095-4dannjjm	4875	1	Hyperesthesia	Hyperesthesia	NNP
cord-023095-4dannjjm	4875	2	resolved	resolve	VBD
cord-023095-4dannjjm	4875	3	in	in	IN
cord-023095-4dannjjm	4875	4	5	5	CD
cord-023095-4dannjjm	4875	5	of	of	IN
cord-023095-4dannjjm	4875	6	6	6	CD
cord-023095-4dannjjm	4875	7	dogs	dog	NNS
cord-023095-4dannjjm	4875	8	(	(	-LRB-
cord-023095-4dannjjm	4875	9	83	83	CD
cord-023095-4dannjjm	4875	10	%	%	NN
cord-023095-4dannjjm	4875	11	)	)	-RRB-
cord-023095-4dannjjm	4875	12	and	and	CC
cord-023095-4dannjjm	4875	13	fecal	fecal	JJ
cord-023095-4dannjjm	4875	14	continence	continence	NN
cord-023095-4dannjjm	4875	15	returned	return	VBD
cord-023095-4dannjjm	4875	16	in	in	IN
cord-023095-4dannjjm	4875	17	2	2	CD
cord-023095-4dannjjm	4875	18	of	of	IN
cord-023095-4dannjjm	4875	19	4	4	CD
cord-023095-4dannjjm	4875	20	dogs	dog	NNS
cord-023095-4dannjjm	4875	21	(	(	-LRB-
cord-023095-4dannjjm	4875	22	50	50	CD
cord-023095-4dannjjm	4875	23	%	%	NN
cord-023095-4dannjjm	4875	24	)	)	-RRB-
cord-023095-4dannjjm	4875	25	.	.	.
cord-023095-4dannjjm	4876	1	These	these	DT
cord-023095-4dannjjm	4876	2	findings	finding	NNS
cord-023095-4dannjjm	4876	3	suggest	suggest	VBP
cord-023095-4dannjjm	4876	4	that	that	IN
cord-023095-4dannjjm	4876	5	following	follow	VBG
cord-023095-4dannjjm	4876	6	prompt	prompt	JJ
cord-023095-4dannjjm	4876	7	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4876	8	and	and	CC
cord-023095-4dannjjm	4876	9	surgical	surgical	JJ
cord-023095-4dannjjm	4876	10	decompression	decompression	NN
cord-023095-4dannjjm	4876	11	,	,	,
cord-023095-4dannjjm	4876	12	normal	normal	JJ
cord-023095-4dannjjm	4876	13	micturition	micturition	NN
cord-023095-4dannjjm	4876	14	could	could	MD
cord-023095-4dannjjm	4876	15	be	be	VB
cord-023095-4dannjjm	4876	16	regained	regain	VBN
cord-023095-4dannjjm	4876	17	in	in	IN
cord-023095-4dannjjm	4876	18	DLSS	DLSS	NNP
cord-023095-4dannjjm	4876	19	affected	affect	VBD
cord-023095-4dannjjm	4876	20	dogs	dog	NNS
cord-023095-4dannjjm	4876	21	presenting	present	VBG
cord-023095-4dannjjm	4876	22	with	with	IN
cord-023095-4dannjjm	4876	23	signs	sign	NNS
cord-023095-4dannjjm	4876	24	of	of	IN
cord-023095-4dannjjm	4876	25	dysuria	dysuria	NNS
cord-023095-4dannjjm	4876	26	.	.	.
cord-023095-4dannjjm	4877	1	Glycogen	glycogen	NN
cord-023095-4dannjjm	4877	2	storage	storage	NN
cord-023095-4dannjjm	4877	3	disease	disease	NN
cord-023095-4dannjjm	4877	4	type	type	NN
cord-023095-4dannjjm	4878	1	Ia	Ia	NNP
cord-023095-4dannjjm	4878	2	(	(	-LRB-
cord-023095-4dannjjm	4878	3	GSDIa	GSDIa	NNS
cord-023095-4dannjjm	4878	4	;	;	:
cord-023095-4dannjjm	4878	5	von	von	NNP
cord-023095-4dannjjm	4878	6	Gierke	Gierke	NNP
cord-023095-4dannjjm	4878	7	disease	disease	NN
cord-023095-4dannjjm	4878	8	)	)	-RRB-
cord-023095-4dannjjm	4878	9	is	be	VBZ
cord-023095-4dannjjm	4878	10	an	an	DT
cord-023095-4dannjjm	4878	11	inherited	inherit	VBN
cord-023095-4dannjjm	4878	12	metabolic	metabolic	JJ
cord-023095-4dannjjm	4878	13	disorder	disorder	NN
cord-023095-4dannjjm	4878	14	resulting	result	VBG
cord-023095-4dannjjm	4878	15	from	from	IN
cord-023095-4dannjjm	4878	16	a	a	DT
cord-023095-4dannjjm	4878	17	deficiency	deficiency	NN
cord-023095-4dannjjm	4878	18	of	of	IN
cord-023095-4dannjjm	4878	19	glucose	glucose	NN
cord-023095-4dannjjm	4878	20	6-phosphatase	6-phosphatase	CD
cord-023095-4dannjjm	4878	21	-	-	HYPH
cord-023095-4dannjjm	4878	22	a	a	NN
cord-023095-4dannjjm	4878	23	(	(	-LRB-
cord-023095-4dannjjm	4878	24	G6Pase	G6Pase	NNP
cord-023095-4dannjjm	4878	25	)	)	-RRB-
cord-023095-4dannjjm	4878	26	.	.	.
cord-023095-4dannjjm	4879	1	Previous	previous	JJ
cord-023095-4dannjjm	4879	2	reports	report	NNS
cord-023095-4dannjjm	4879	3	indicate	indicate	VBP
cord-023095-4dannjjm	4879	4	that	that	IN
cord-023095-4dannjjm	4879	5	clinical	clinical	JJ
cord-023095-4dannjjm	4879	6	manifestations	manifestation	NNS
cord-023095-4dannjjm	4879	7	of	of	IN
cord-023095-4dannjjm	4879	8	GSDIa	GSDIa	NNS
cord-023095-4dannjjm	4879	9	occur	occur	VBP
cord-023095-4dannjjm	4879	10	only	only	RB
cord-023095-4dannjjm	4879	11	in	in	IN
cord-023095-4dannjjm	4879	12	individuals	individual	NNS
cord-023095-4dannjjm	4879	13	with	with	IN
cord-023095-4dannjjm	4879	14	homozygous	homozygous	JJ
cord-023095-4dannjjm	4879	15	expression	expression	NN
cord-023095-4dannjjm	4879	16	of	of	IN
cord-023095-4dannjjm	4879	17	a	a	DT
cord-023095-4dannjjm	4879	18	p.	p.	NN
cord-023095-4dannjjm	4880	1	I121L	I121L	NNP
cord-023095-4dannjjm	4880	2	mutation	mutation	NN
cord-023095-4dannjjm	4880	3	.	.	.
cord-023095-4dannjjm	4881	1	Heterozygote	Heterozygote	NNP
cord-023095-4dannjjm	4881	2	dogs	dog	NNS
cord-023095-4dannjjm	4881	3	(	(	-LRB-
cord-023095-4dannjjm	4881	4	Het	Het	NNP
cord-023095-4dannjjm	4881	5	)	)	-RRB-
cord-023095-4dannjjm	4881	6	have	have	VBP
cord-023095-4dannjjm	4881	7	been	be	VBN
cord-023095-4dannjjm	4881	8	previously	previously	RB
cord-023095-4dannjjm	4881	9	reported	report	VBN
cord-023095-4dannjjm	4881	10	to	to	TO
cord-023095-4dannjjm	4881	11	exhibit	exhibit	VB
cord-023095-4dannjjm	4881	12	an	an	DT
cord-023095-4dannjjm	4881	13	overall	overall	JJ
cord-023095-4dannjjm	4881	14	normal	normal	JJ
cord-023095-4dannjjm	4881	15	outward	outward	JJ
cord-023095-4dannjjm	4881	16	phenotype	phenotype	NN
cord-023095-4dannjjm	4881	17	.	.	.
cord-023095-4dannjjm	4882	1	The	the	DT
cord-023095-4dannjjm	4882	2	purpose	purpose	NN
cord-023095-4dannjjm	4882	3	of	of	IN
cord-023095-4dannjjm	4882	4	this	this	DT
cord-023095-4dannjjm	4882	5	report	report	NN
cord-023095-4dannjjm	4882	6	is	be	VBZ
cord-023095-4dannjjm	4882	7	to	to	TO
cord-023095-4dannjjm	4882	8	briefly	briefly	RB
cord-023095-4dannjjm	4882	9	describe	describe	VB
cord-023095-4dannjjm	4882	10	some	some	DT
cord-023095-4dannjjm	4882	11	differences	difference	NNS
cord-023095-4dannjjm	4882	12	that	that	WDT
cord-023095-4dannjjm	4882	13	have	have	VBP
cord-023095-4dannjjm	4882	14	been	be	VBN
cord-023095-4dannjjm	4882	15	observed	observe	VBN
cord-023095-4dannjjm	4882	16	between	between	IN
cord-023095-4dannjjm	4882	17	Het	Het	NNP
cord-023095-4dannjjm	4882	18	and	and	CC
cord-023095-4dannjjm	4882	19	homozygous	homozygous	JJ
cord-023095-4dannjjm	4882	20	wild	wild	JJ
cord-023095-4dannjjm	4882	21	type	type	NN
cord-023095-4dannjjm	4882	22	(	(	-LRB-
cord-023095-4dannjjm	4882	23	WT	WT	NNP
cord-023095-4dannjjm	4882	24	)	)	-RRB-
cord-023095-4dannjjm	4882	25	dogs	dog	NNS
cord-023095-4dannjjm	4882	26	.	.	.
cord-023095-4dannjjm	4883	1	A	a	DT
cord-023095-4dannjjm	4883	2	colony	colony	NN
cord-023095-4dannjjm	4883	3	of	of	IN
cord-023095-4dannjjm	4883	4	dogs	dog	NNS
cord-023095-4dannjjm	4883	5	at	at	IN
cord-023095-4dannjjm	4883	6	the	the	DT
cord-023095-4dannjjm	4883	7	University	University	NNP
cord-023095-4dannjjm	4883	8	of	of	IN
cord-023095-4dannjjm	4883	9	Florida	Florida	NNP
cord-023095-4dannjjm	4883	10	contains	contain	VBZ
cord-023095-4dannjjm	4883	11	a	a	DT
cord-023095-4dannjjm	4883	12	mix	mix	NN
cord-023095-4dannjjm	4883	13	of	of	IN
cord-023095-4dannjjm	4883	14	affected	affect	VBN
cord-023095-4dannjjm	4883	15	,	,	,
cord-023095-4dannjjm	4883	16	WT	WT	NNP
cord-023095-4dannjjm	4883	17	,	,	,
cord-023095-4dannjjm	4883	18	and	and	CC
cord-023095-4dannjjm	4883	19	Het	Het	NNP
cord-023095-4dannjjm	4883	20	individuals	individual	NNS
cord-023095-4dannjjm	4883	21	.	.	.
cord-023095-4dannjjm	4884	1	In	in	IN
cord-023095-4dannjjm	4884	2	the	the	DT
cord-023095-4dannjjm	4884	3	course	course	NN
cord-023095-4dannjjm	4884	4	of	of	IN
cord-023095-4dannjjm	4884	5	studies	study	NNS
cord-023095-4dannjjm	4884	6	designed	design	VBN
cord-023095-4dannjjm	4884	7	to	to	TO
cord-023095-4dannjjm	4884	8	determine	determine	VB
cord-023095-4dannjjm	4884	9	the	the	DT
cord-023095-4dannjjm	4884	10	effectiveness	effectiveness	NN
cord-023095-4dannjjm	4884	11	of	of	IN
cord-023095-4dannjjm	4884	12	gene	gene	NN
cord-023095-4dannjjm	4884	13	therapy	therapy	NN
cord-023095-4dannjjm	4884	14	for	for	IN
cord-023095-4dannjjm	4884	15	correction	correction	NN
cord-023095-4dannjjm	4884	16	of	of	IN
cord-023095-4dannjjm	4884	17	GSDIa	GSDIa	NNS
cord-023095-4dannjjm	4884	18	in	in	IN
cord-023095-4dannjjm	4884	19	dogs	dog	NNS
cord-023095-4dannjjm	4884	20	,	,	,
cord-023095-4dannjjm	4884	21	both	both	CC
cord-023095-4dannjjm	4884	22	WT	WT	NNP
cord-023095-4dannjjm	4884	23	and	and	CC
cord-023095-4dannjjm	4884	24	Het	Het	NNP
cord-023095-4dannjjm	4884	25	dogs	dog	NNS
cord-023095-4dannjjm	4884	26	have	have	VBP
cord-023095-4dannjjm	4884	27	been	be	VBN
cord-023095-4dannjjm	4884	28	utilized	utilize	VBN
cord-023095-4dannjjm	4884	29	as	as	IN
cord-023095-4dannjjm	4884	30	controls	control	NNS
cord-023095-4dannjjm	4884	31	.	.	.
cord-023095-4dannjjm	4885	1	Available	available	JJ
cord-023095-4dannjjm	4885	2	information	information	NN
cord-023095-4dannjjm	4885	3	about	about	IN
cord-023095-4dannjjm	4885	4	body	body	NN
cord-023095-4dannjjm	4885	5	weights	weight	NNS
cord-023095-4dannjjm	4885	6	,	,	,
cord-023095-4dannjjm	4885	7	clinical	clinical	JJ
cord-023095-4dannjjm	4885	8	pathology	pathology	NN
cord-023095-4dannjjm	4885	9	tests	test	NNS
cord-023095-4dannjjm	4885	10	,	,	,
cord-023095-4dannjjm	4885	11	fasting	fast	VBG
cord-023095-4dannjjm	4885	12	studies	study	NNS
cord-023095-4dannjjm	4885	13	,	,	,
cord-023095-4dannjjm	4885	14	and	and	CC
cord-023095-4dannjjm	4885	15	liver	liver	NN
cord-023095-4dannjjm	4885	16	biopsies	biopsy	NNS
cord-023095-4dannjjm	4885	17	was	be	VBD
cord-023095-4dannjjm	4885	18	retrieved	retrieve	VBN
cord-023095-4dannjjm	4885	19	from	from	IN
cord-023095-4dannjjm	4885	20	records	record	NNS
cord-023095-4dannjjm	4885	21	for	for	IN
cord-023095-4dannjjm	4885	22	both	both	DT
cord-023095-4dannjjm	4885	23	WT	WT	NNP
cord-023095-4dannjjm	4885	24	and	and	CC
cord-023095-4dannjjm	4885	25	Het	Het	NNP
cord-023095-4dannjjm	4885	26	dogs	dog	NNS
cord-023095-4dannjjm	4885	27	and	and	CC
cord-023095-4dannjjm	4885	28	compared	compare	VBN
cord-023095-4dannjjm	4885	29	.	.	.
cord-023095-4dannjjm	4886	1	Although	although	IN
cord-023095-4dannjjm	4886	2	birth	birth	NN
cord-023095-4dannjjm	4886	3	weights	weight	NNS
cord-023095-4dannjjm	4886	4	are	be	VBP
cord-023095-4dannjjm	4886	5	similar	similar	JJ
cord-023095-4dannjjm	4886	6	,	,	,
cord-023095-4dannjjm	4886	7	Het	Het	NNP
cord-023095-4dannjjm	4886	8	dogs	dog	NNS
cord-023095-4dannjjm	4886	9	have	have	VBP
cord-023095-4dannjjm	4886	10	a	a	DT
cord-023095-4dannjjm	4886	11	slower	slow	JJR
cord-023095-4dannjjm	4886	12	average	average	JJ
cord-023095-4dannjjm	4886	13	rate	rate	NN
cord-023095-4dannjjm	4886	14	of	of	IN
cord-023095-4dannjjm	4886	15	weight	weight	NN
cord-023095-4dannjjm	4886	16	gain	gain	NN
cord-023095-4dannjjm	4886	17	than	than	IN
cord-023095-4dannjjm	4886	18	WT	WT	NNP
cord-023095-4dannjjm	4886	19	dogs	dog	NNS
cord-023095-4dannjjm	4886	20	and	and	CC
cord-023095-4dannjjm	4886	21	this	this	DT
cord-023095-4dannjjm	4886	22	difference	difference	NN
cord-023095-4dannjjm	4886	23	is	be	VBZ
cord-023095-4dannjjm	4886	24	especially	especially	RB
cord-023095-4dannjjm	4886	25	prominent	prominent	JJ
cord-023095-4dannjjm	4886	26	during	during	IN
cord-023095-4dannjjm	4886	27	the	the	DT
cord-023095-4dannjjm	4886	28	first	first	JJ
cord-023095-4dannjjm	4886	29	few	few	JJ
cord-023095-4dannjjm	4886	30	months	month	NNS
cord-023095-4dannjjm	4886	31	of	of	IN
cord-023095-4dannjjm	4886	32	life	life	NN
cord-023095-4dannjjm	4886	33	(	(	-LRB-
cord-023095-4dannjjm	4886	34	Figure	figure	NN
cord-023095-4dannjjm	4886	35	1	1	CD
cord-023095-4dannjjm	4886	36	)	)	-RRB-
cord-023095-4dannjjm	4886	37	.	.	.
cord-023095-4dannjjm	4887	1	In	in	IN
cord-023095-4dannjjm	4887	2	contrast	contrast	NN
cord-023095-4dannjjm	4887	3	to	to	IN
cord-023095-4dannjjm	4887	4	affected	affect	VBN
cord-023095-4dannjjm	4887	5	dogs	dog	NNS
cord-023095-4dannjjm	4887	6	,	,	,
cord-023095-4dannjjm	4887	7	both	both	CC
cord-023095-4dannjjm	4887	8	WT	WT	NNP
cord-023095-4dannjjm	4887	9	and	and	CC
cord-023095-4dannjjm	4887	10	Het	Het	NNP
cord-023095-4dannjjm	4887	11	dogs	dog	NNS
cord-023095-4dannjjm	4887	12	are	be	VBP
cord-023095-4dannjjm	4887	13	able	able	JJ
cord-023095-4dannjjm	4887	14	to	to	TO
cord-023095-4dannjjm	4887	15	maintain	maintain	VB
cord-023095-4dannjjm	4887	16	normal	normal	JJ
cord-023095-4dannjjm	4887	17	blood	blood	NN
cord-023095-4dannjjm	4887	18	glucose	glucose	NN
cord-023095-4dannjjm	4887	19	concentrations	concentration	NNS
cord-023095-4dannjjm	4887	20	for	for	IN
cord-023095-4dannjjm	4887	21	up	up	IN
cord-023095-4dannjjm	4887	22	to	to	TO
cord-023095-4dannjjm	4887	23	10	10	CD
cord-023095-4dannjjm	4887	24	-	-	SYM
cord-023095-4dannjjm	4887	25	12	12	CD
cord-023095-4dannjjm	4887	26	hours	hour	NNS
cord-023095-4dannjjm	4887	27	of	of	IN
cord-023095-4dannjjm	4887	28	fasting	fasting	NN
cord-023095-4dannjjm	4887	29	,	,	,
cord-023095-4dannjjm	4887	30	however	however	RB
cord-023095-4dannjjm	4887	31	,	,	,
cord-023095-4dannjjm	4887	32	after	after	IN
cord-023095-4dannjjm	4887	33	longer	long	JJR
cord-023095-4dannjjm	4887	34	fasts	fast	NNS
cord-023095-4dannjjm	4887	35	of	of	IN
cord-023095-4dannjjm	4887	36	12	12	CD
cord-023095-4dannjjm	4887	37	-	-	SYM
cord-023095-4dannjjm	4887	38	17	17	CD
cord-023095-4dannjjm	4887	39	hours	hour	NNS
cord-023095-4dannjjm	4887	40	,	,	,
cord-023095-4dannjjm	4887	41	Het	Het	NNP
cord-023095-4dannjjm	4887	42	dogs	dog	NNS
cord-023095-4dannjjm	4887	43	have	have	VBP
cord-023095-4dannjjm	4887	44	lower	low	JJR
cord-023095-4dannjjm	4887	45	glucose	glucose	NN
cord-023095-4dannjjm	4887	46	and	and	CC
cord-023095-4dannjjm	4887	47	higher	high	JJR
cord-023095-4dannjjm	4887	48	lactate	lactate	NN
cord-023095-4dannjjm	4887	49	concentrations	concentration	NNS
cord-023095-4dannjjm	4887	50	(	(	-LRB-
cord-023095-4dannjjm	4887	51	Table	Table	NNP
cord-023095-4dannjjm	4887	52	2	2	CD
cord-023095-4dannjjm	4887	53	)	)	-RRB-
cord-023095-4dannjjm	4887	54	.	.	.
cord-023095-4dannjjm	4888	1	In	in	IN
cord-023095-4dannjjm	4888	2	addition	addition	NN
cord-023095-4dannjjm	4888	3	,	,	,
cord-023095-4dannjjm	4888	4	liver	liver	NN
cord-023095-4dannjjm	4888	5	biopsy	biopsy	NN
cord-023095-4dannjjm	4888	6	samples	sample	NNS
cord-023095-4dannjjm	4888	7	from	from	IN
cord-023095-4dannjjm	4888	8	Het	Het	NNP
cord-023095-4dannjjm	4888	9	dogs	dog	NNS
cord-023095-4dannjjm	4888	10	had	have	VBD
cord-023095-4dannjjm	4888	11	greater	great	JJR
cord-023095-4dannjjm	4888	12	apparent	apparent	JJ
cord-023095-4dannjjm	4888	13	levels	level	NNS
cord-023095-4dannjjm	4888	14	of	of	IN
cord-023095-4dannjjm	4888	15	glycogen	glycogen	NN
cord-023095-4dannjjm	4888	16	suggested	suggest	VBN
cord-023095-4dannjjm	4888	17	by	by	IN
cord-023095-4dannjjm	4888	18	PAS	pas	NN
cord-023095-4dannjjm	4888	19	staining	staining	NN
cord-023095-4dannjjm	4888	20	than	than	IN
cord-023095-4dannjjm	4888	21	did	do	VBD
cord-023095-4dannjjm	4888	22	samples	sample	NNS
cord-023095-4dannjjm	4888	23	from	from	IN
cord-023095-4dannjjm	4888	24	WT	wt	NN
cord-023095-4dannjjm	4888	25	dogs	dog	NNS
cord-023095-4dannjjm	4888	26	,	,	,
cord-023095-4dannjjm	4888	27	and	and	CC
cord-023095-4dannjjm	4888	28	this	this	DT
cord-023095-4dannjjm	4888	29	correlated	correlate	VBD
cord-023095-4dannjjm	4888	30	with	with	IN
cord-023095-4dannjjm	4888	31	the	the	DT
cord-023095-4dannjjm	4888	32	results	result	NNS
cord-023095-4dannjjm	4888	33	of	of	IN
cord-023095-4dannjjm	4888	34	proton	proton	NN
cord-023095-4dannjjm	4888	35	magnetic	magnetic	JJ
cord-023095-4dannjjm	4888	36	resonance	resonance	NN
cord-023095-4dannjjm	4888	37	spectroscopy	spectroscopy	NN
cord-023095-4dannjjm	4888	38	which	which	WDT
cord-023095-4dannjjm	4888	39	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	4888	40	2.9	2.9	CD
cord-023095-4dannjjm	4888	41	times	time	NNS
cord-023095-4dannjjm	4888	42	greater	great	JJR
cord-023095-4dannjjm	4888	43	glycogen	glycogen	NN
cord-023095-4dannjjm	4888	44	content	content	NN
cord-023095-4dannjjm	4888	45	in	in	IN
cord-023095-4dannjjm	4888	46	a	a	DT
cord-023095-4dannjjm	4888	47	liver	liver	NN
cord-023095-4dannjjm	4888	48	biopsy	biopsy	NN
cord-023095-4dannjjm	4888	49	sample	sample	NN
cord-023095-4dannjjm	4888	50	from	from	IN
cord-023095-4dannjjm	4888	51	a	a	DT
cord-023095-4dannjjm	4888	52	Het	Het	NNP
cord-023095-4dannjjm	4888	53	dog	dog	NN
cord-023095-4dannjjm	4888	54	compared	compare	VBN
cord-023095-4dannjjm	4888	55	to	to	IN
cord-023095-4dannjjm	4888	56	a	a	DT
cord-023095-4dannjjm	4888	57	sample	sample	NN
cord-023095-4dannjjm	4888	58	from	from	IN
cord-023095-4dannjjm	4888	59	a	a	DT
cord-023095-4dannjjm	4888	60	WT	WT	NNP
cord-023095-4dannjjm	4888	61	dog	dog	NN
cord-023095-4dannjjm	4888	62	.	.	.
cord-023095-4dannjjm	4889	1	Together	together	RB
cord-023095-4dannjjm	4889	2	,	,	,
cord-023095-4dannjjm	4889	3	these	these	DT
cord-023095-4dannjjm	4889	4	findings	finding	NNS
cord-023095-4dannjjm	4889	5	suggest	suggest	VBP
cord-023095-4dannjjm	4889	6	that	that	IN
cord-023095-4dannjjm	4889	7	the	the	DT
cord-023095-4dannjjm	4889	8	level	level	NN
cord-023095-4dannjjm	4889	9	of	of	IN
cord-023095-4dannjjm	4889	10	G6Pase	G6Pase	NNP
cord-023095-4dannjjm	4889	11	activity	activity	NN
cord-023095-4dannjjm	4889	12	in	in	IN
cord-023095-4dannjjm	4889	13	heterozygote	heterozygote	NN
cord-023095-4dannjjm	4889	14	dogs	dog	NNS
cord-023095-4dannjjm	4889	15	does	do	VBZ
cord-023095-4dannjjm	4889	16	not	not	RB
cord-023095-4dannjjm	4889	17	provide	provide	VB
cord-023095-4dannjjm	4889	18	a	a	DT
cord-023095-4dannjjm	4889	19	completely	completely	RB
cord-023095-4dannjjm	4889	20	normal	normal	JJ
cord-023095-4dannjjm	4889	21	physiological	physiological	JJ
cord-023095-4dannjjm	4889	22	,	,	,
cord-023095-4dannjjm	4889	23	biochemical	biochemical	JJ
cord-023095-4dannjjm	4889	24	,	,	,
cord-023095-4dannjjm	4889	25	or	or	CC
cord-023095-4dannjjm	4889	26	histological	histological	JJ
cord-023095-4dannjjm	4889	27	phenotype	phenotype	NN
cord-023095-4dannjjm	4889	28	as	as	IN
cord-023095-4dannjjm	4889	29	previously	previously	RB
cord-023095-4dannjjm	4889	30	reported	report	VBN
cord-023095-4dannjjm	4889	31	.	.	.
cord-023095-4dannjjm	4890	1	The	the	DT
cord-023095-4dannjjm	4890	2	glucokinase	glucokinase	NN
cord-023095-4dannjjm	4890	3	gene	gene	NN
cord-023095-4dannjjm	4890	4	(	(	-LRB-
cord-023095-4dannjjm	4890	5	GCK	GCK	NNP
cord-023095-4dannjjm	4890	6	)	)	-RRB-
cord-023095-4dannjjm	4890	7	encodes	encode	VBZ
cord-023095-4dannjjm	4890	8	an	an	DT
cord-023095-4dannjjm	4890	9	enzyme	enzyme	NN
cord-023095-4dannjjm	4890	10	involved	involve	VBN
cord-023095-4dannjjm	4890	11	in	in	IN
cord-023095-4dannjjm	4890	12	cellular	cellular	JJ
cord-023095-4dannjjm	4890	13	glucose	glucose	NN
cord-023095-4dannjjm	4890	14	-	-	HYPH
cord-023095-4dannjjm	4890	15	sensing	sense	VBG
cord-023095-4dannjjm	4890	16	mechanisms	mechanism	NNS
cord-023095-4dannjjm	4890	17	in	in	IN
cord-023095-4dannjjm	4890	18	pancreatic	pancreatic	JJ
cord-023095-4dannjjm	4890	19	beta	beta	NN
cord-023095-4dannjjm	4890	20	cells	cell	NNS
cord-023095-4dannjjm	4890	21	and	and	CC
cord-023095-4dannjjm	4890	22	hepatocytes	hepatocyte	NNS
cord-023095-4dannjjm	4890	23	.	.	.
cord-023095-4dannjjm	4891	1	GCK	GCK	NNP
cord-023095-4dannjjm	4891	2	mRNA	mRNA	NNP
cord-023095-4dannjjm	4891	3	is	be	VBZ
cord-023095-4dannjjm	4891	4	present	present	JJ
cord-023095-4dannjjm	4891	5	in	in	IN
cord-023095-4dannjjm	4891	6	feline	feline	JJ
cord-023095-4dannjjm	4891	7	pancreas	pancrea	NNS
cord-023095-4dannjjm	4891	8	but	but	CC
cord-023095-4dannjjm	4891	9	the	the	DT
cord-023095-4dannjjm	4891	10	gene	gene	NN
cord-023095-4dannjjm	4891	11	is	be	VBZ
cord-023095-4dannjjm	4891	12	not	not	RB
cord-023095-4dannjjm	4891	13	expressed	express	VBN
cord-023095-4dannjjm	4891	14	in	in	IN
cord-023095-4dannjjm	4891	15	feline	feline	JJ
cord-023095-4dannjjm	4891	16	liver	liver	NN
cord-023095-4dannjjm	4891	17	.	.	.
cord-023095-4dannjjm	4892	1	Hepatic	hepatic	JJ
cord-023095-4dannjjm	4892	2	GCK	GCK	NNP
cord-023095-4dannjjm	4892	3	expression	expression	NN
cord-023095-4dannjjm	4892	4	is	be	VBZ
cord-023095-4dannjjm	4892	5	abundant	abundant	JJ
cord-023095-4dannjjm	4892	6	in	in	IN
cord-023095-4dannjjm	4892	7	omnivores	omnivore	NNS
cord-023095-4dannjjm	4892	8	so	so	IN
cord-023095-4dannjjm	4892	9	its	-PRON-	PRP$
cord-023095-4dannjjm	4892	10	absence	absence	NN
cord-023095-4dannjjm	4892	11	may	may	MD
cord-023095-4dannjjm	4892	12	reflect	reflect	VB
cord-023095-4dannjjm	4892	13	an	an	DT
cord-023095-4dannjjm	4892	14	evolutionary	evolutionary	JJ
cord-023095-4dannjjm	4892	15	adaptation	adaptation	NN
cord-023095-4dannjjm	4892	16	of	of	IN
cord-023095-4dannjjm	4892	17	strict	strict	JJ
cord-023095-4dannjjm	4892	18	carnivores	carnivore	NNS
cord-023095-4dannjjm	4892	19	,	,	,
cord-023095-4dannjjm	4892	20	like	like	IN
cord-023095-4dannjjm	4892	21	feline	feline	JJ
cord-023095-4dannjjm	4892	22	species	specie	NNS
cord-023095-4dannjjm	4892	23	.	.	.
cord-023095-4dannjjm	4893	1	We	-PRON-	PRP
cord-023095-4dannjjm	4893	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	4893	3	speciesspecific	speciesspecific	NN
cord-023095-4dannjjm	4893	4	features	feature	NNS
cord-023095-4dannjjm	4893	5	in	in	IN
cord-023095-4dannjjm	4893	6	the	the	DT
cord-023095-4dannjjm	4893	7	GCK	GCK	NNP
cord-023095-4dannjjm	4893	8	hepatic	hepatic	JJ
cord-023095-4dannjjm	4893	9	promoter	promoter	NN
cord-023095-4dannjjm	4893	10	may	may	MD
cord-023095-4dannjjm	4893	11	underlie	underlie	VB
cord-023095-4dannjjm	4893	12	the	the	DT
cord-023095-4dannjjm	4893	13	gene	gene	NN
cord-023095-4dannjjm	4893	14	expression	expression	NN
cord-023095-4dannjjm	4893	15	pattern	pattern	NN
cord-023095-4dannjjm	4893	16	observed	observe	VBN
cord-023095-4dannjjm	4893	17	in	in	IN
cord-023095-4dannjjm	4893	18	cats	cat	NNS
cord-023095-4dannjjm	4893	19	.	.	.
cord-023095-4dannjjm	4894	1	The	the	DT
cord-023095-4dannjjm	4894	2	putative	putative	JJ
cord-023095-4dannjjm	4894	3	feline	feline	JJ
cord-023095-4dannjjm	4894	4	GCK	GCK	NNP
cord-023095-4dannjjm	4894	5	(	(	-LRB-
cord-023095-4dannjjm	4894	6	fGCK	fgck	NN
cord-023095-4dannjjm	4894	7	)	)	-RRB-
cord-023095-4dannjjm	4894	8	promoter	promoter	NN
cord-023095-4dannjjm	4894	9	region	region	NN
cord-023095-4dannjjm	4894	10	was	be	VBD
cord-023095-4dannjjm	4894	11	located	locate	VBN
cord-023095-4dannjjm	4894	12	using	use	VBG
cord-023095-4dannjjm	4894	13	bioinformatic	bioinformatic	JJ
cord-023095-4dannjjm	4894	14	software	software	NN
cord-023095-4dannjjm	4894	15	to	to	TO
cord-023095-4dannjjm	4894	16	identify	identify	VB
cord-023095-4dannjjm	4894	17	homology	homology	NN
cord-023095-4dannjjm	4894	18	with	with	IN
cord-023095-4dannjjm	4894	19	human	human	JJ
cord-023095-4dannjjm	4894	20	GCK	GCK	NNP
cord-023095-4dannjjm	4894	21	(	(	-LRB-
cord-023095-4dannjjm	4894	22	hGCK	hgck	NN
cord-023095-4dannjjm	4894	23	)	)	-RRB-
cord-023095-4dannjjm	4894	24	.	.	.
cord-023095-4dannjjm	4895	1	Genomic	genomic	JJ
cord-023095-4dannjjm	4895	2	DNA	dna	NN
cord-023095-4dannjjm	4895	3	from	from	IN
cord-023095-4dannjjm	4895	4	a	a	DT
cord-023095-4dannjjm	4895	5	DSH	DSH	NNP
cord-023095-4dannjjm	4895	6	cat	cat	NN
cord-023095-4dannjjm	4895	7	was	be	VBD
cord-023095-4dannjjm	4895	8	subjected	subject	VBN
cord-023095-4dannjjm	4895	9	to	to	IN
cord-023095-4dannjjm	4895	10	direct	direct	JJ
cord-023095-4dannjjm	4895	11	sequencing	sequencing	NN
cord-023095-4dannjjm	4895	12	using	use	VBG
cord-023095-4dannjjm	4895	13	a	a	DT
cord-023095-4dannjjm	4895	14	series	series	NN
cord-023095-4dannjjm	4895	15	of	of	IN
cord-023095-4dannjjm	4895	16	PCR	PCR	NNP
cord-023095-4dannjjm	4895	17	reactions	reaction	NNS
cord-023095-4dannjjm	4895	18	with	with	IN
cord-023095-4dannjjm	4895	19	speciesspecific	speciesspecific	NN
cord-023095-4dannjjm	4895	20	primers	primer	NNS
cord-023095-4dannjjm	4895	21	.	.	.
cord-023095-4dannjjm	4896	1	DNA	DNA	NNP
cord-023095-4dannjjm	4896	2	clones	clone	NNS
cord-023095-4dannjjm	4896	3	thus	thus	RB
cord-023095-4dannjjm	4896	4	obtained	obtain	VBN
cord-023095-4dannjjm	4896	5	were	be	VBD
cord-023095-4dannjjm	4896	6	aligned	align	VBN
cord-023095-4dannjjm	4896	7	to	to	TO
cord-023095-4dannjjm	4896	8	generate	generate	VB
cord-023095-4dannjjm	4896	9	the	the	DT
cord-023095-4dannjjm	4896	10	feline	feline	JJ
cord-023095-4dannjjm	4896	11	sequence	sequence	NN
cord-023095-4dannjjm	4896	12	.	.	.
cord-023095-4dannjjm	4897	1	Direct	direct	JJ
cord-023095-4dannjjm	4897	2	sequencing	sequencing	NN
cord-023095-4dannjjm	4897	3	yielded	yield	VBD
cord-023095-4dannjjm	4897	4	8.9	8.9	CD
cord-023095-4dannjjm	4897	5	kb	kb	CD
cord-023095-4dannjjm	4897	6	of	of	IN
cord-023095-4dannjjm	4897	7	genomic	genomic	JJ
cord-023095-4dannjjm	4897	8	DNA	dna	NN
cord-023095-4dannjjm	4897	9	sequence	sequence	NN
cord-023095-4dannjjm	4897	10	with	with	IN
cord-023095-4dannjjm	4897	11	high	high	JJ
cord-023095-4dannjjm	4897	12	homology	homology	NN
cord-023095-4dannjjm	4897	13	with	with	IN
cord-023095-4dannjjm	4897	14	sequences	sequence	NNS
cord-023095-4dannjjm	4897	15	(	(	-LRB-
cord-023095-4dannjjm	4897	16	ACBE01359231	ACBE01359231	NNP
cord-023095-4dannjjm	4897	17	,	,	,
cord-023095-4dannjjm	4897	18	ACBE01359221	acbe01359221	ADD
cord-023095-4dannjjm	4897	19	)	)	-RRB-
cord-023095-4dannjjm	4897	20	archived	archive	VBN
cord-023095-4dannjjm	4897	21	in	in	IN
cord-023095-4dannjjm	4897	22	the	the	DT
cord-023095-4dannjjm	4897	23	feline	feline	JJ
cord-023095-4dannjjm	4897	24	genome	genome	NN
cord-023095-4dannjjm	4897	25	project	project	NN
cord-023095-4dannjjm	4897	26	.	.	.
cord-023095-4dannjjm	4898	1	The	the	DT
cord-023095-4dannjjm	4898	2	feline	feline	JJ
cord-023095-4dannjjm	4898	3	sequence	sequence	NN
cord-023095-4dannjjm	4898	4	had	have	VBD
cord-023095-4dannjjm	4898	5	six	six	CD
cord-023095-4dannjjm	4898	6	regions	region	NNS
cord-023095-4dannjjm	4898	7	homologous	homologous	JJ
cord-023095-4dannjjm	4898	8	with	with	IN
cord-023095-4dannjjm	4898	9	non	non	JJ
cord-023095-4dannjjm	4898	10	-	-	JJ
cord-023095-4dannjjm	4898	11	coding	coding	JJ
cord-023095-4dannjjm	4898	12	regions	region	NNS
cord-023095-4dannjjm	4898	13	of	of	IN
cord-023095-4dannjjm	4898	14	hGCK	hgck	NN
cord-023095-4dannjjm	4898	15	;	;	:
cord-023095-4dannjjm	4898	16	four	four	CD
cord-023095-4dannjjm	4898	17	of	of	IN
cord-023095-4dannjjm	4898	18	these	these	DT
cord-023095-4dannjjm	4898	19	conserved	conserve	VBN
cord-023095-4dannjjm	4898	20	regions	region	NNS
cord-023095-4dannjjm	4898	21	are	be	VBP
cord-023095-4dannjjm	4898	22	upstream	upstream	RB
cord-023095-4dannjjm	4898	23	of	of	IN
cord-023095-4dannjjm	4898	24	the	the	DT
cord-023095-4dannjjm	4898	25	putative	putative	JJ
cord-023095-4dannjjm	4898	26	fGCK	fgck	NN
cord-023095-4dannjjm	4898	27	start	start	NN
cord-023095-4dannjjm	4898	28	.	.	.
cord-023095-4dannjjm	4899	1	A	a	DT
cord-023095-4dannjjm	4899	2	0.8	0.8	CD
cord-023095-4dannjjm	4899	3	kb	kb	NNP
cord-023095-4dannjjm	4899	4	segment	segment	NN
cord-023095-4dannjjm	4899	5	immediately	immediately	RB
cord-023095-4dannjjm	4899	6	upstream	upstream	RB
cord-023095-4dannjjm	4899	7	of	of	IN
cord-023095-4dannjjm	4899	8	feline	feline	JJ
cord-023095-4dannjjm	4899	9	hepatic	hepatic	JJ
cord-023095-4dannjjm	4899	10	exon	exon	NN
cord-023095-4dannjjm	4899	11	1	1	CD
cord-023095-4dannjjm	4899	12	is	be	VBZ
cord-023095-4dannjjm	4899	13	not	not	RB
cord-023095-4dannjjm	4899	14	present	present	JJ
cord-023095-4dannjjm	4899	15	in	in	IN
cord-023095-4dannjjm	4899	16	hGCK	hgck	NN
cord-023095-4dannjjm	4899	17	.	.	.
cord-023095-4dannjjm	4900	1	The	the	DT
cord-023095-4dannjjm	4900	2	0.8	0.8	CD
cord-023095-4dannjjm	4900	3	kb	kb	NNP
cord-023095-4dannjjm	4900	4	insert	insert	NN
cord-023095-4dannjjm	4900	5	is	be	VBZ
cord-023095-4dannjjm	4900	6	the	the	DT
cord-023095-4dannjjm	4900	7	reverse	reverse	JJ
cord-023095-4dannjjm	4900	8	complement	complement	NN
cord-023095-4dannjjm	4900	9	of	of	IN
cord-023095-4dannjjm	4900	10	a	a	DT
cord-023095-4dannjjm	4900	11	conserved	conserve	VBN
cord-023095-4dannjjm	4900	12	sequence	sequence	NN
cord-023095-4dannjjm	4900	13	located	locate	VBN
cord-023095-4dannjjm	4900	14	downstream	downstream	RB
cord-023095-4dannjjm	4900	15	of	of	IN
cord-023095-4dannjjm	4900	16	exon	exon	NN
cord-023095-4dannjjm	4900	17	1	1	CD
cord-023095-4dannjjm	4900	18	in	in	IN
cord-023095-4dannjjm	4900	19	feline	feline	JJ
cord-023095-4dannjjm	4900	20	and	and	CC
cord-023095-4dannjjm	4900	21	human	human	JJ
cord-023095-4dannjjm	4900	22	sequences	sequence	NNS
cord-023095-4dannjjm	4900	23	.	.	.
cord-023095-4dannjjm	4901	1	In	in	IN
cord-023095-4dannjjm	4901	2	conclusion	conclusion	NN
cord-023095-4dannjjm	4901	3	,	,	,
cord-023095-4dannjjm	4901	4	the	the	DT
cord-023095-4dannjjm	4901	5	putative	putative	JJ
cord-023095-4dannjjm	4901	6	hepatic	hepatic	JJ
cord-023095-4dannjjm	4901	7	promoter	promoter	NN
cord-023095-4dannjjm	4901	8	of	of	IN
cord-023095-4dannjjm	4901	9	fGCK	fgck	NN
cord-023095-4dannjjm	4901	10	shares	share	NNS
cord-023095-4dannjjm	4901	11	extensive	extensive	JJ
cord-023095-4dannjjm	4901	12	homology	homology	NN
cord-023095-4dannjjm	4901	13	with	with	IN
cord-023095-4dannjjm	4901	14	the	the	DT
cord-023095-4dannjjm	4901	15	hGCK	hgck	NN
cord-023095-4dannjjm	4901	16	promoter	promoter	NN
cord-023095-4dannjjm	4901	17	but	but	CC
cord-023095-4dannjjm	4901	18	contains	contain	VBZ
cord-023095-4dannjjm	4901	19	a	a	DT
cord-023095-4dannjjm	4901	20	0.8	0.8	CD
cord-023095-4dannjjm	4901	21	kb	kb	NNP
cord-023095-4dannjjm	4901	22	insert	insert	NN
cord-023095-4dannjjm	4901	23	not	not	RB
cord-023095-4dannjjm	4901	24	found	find	VBN
cord-023095-4dannjjm	4901	25	in	in	IN
cord-023095-4dannjjm	4901	26	hGCK	hgck	NN
cord-023095-4dannjjm	4901	27	.	.	.
cord-023095-4dannjjm	4902	1	Functional	functional	JJ
cord-023095-4dannjjm	4902	2	studies	study	NNS
cord-023095-4dannjjm	4902	3	are	be	VBP
cord-023095-4dannjjm	4902	4	needed	need	VBN
cord-023095-4dannjjm	4902	5	to	to	TO
cord-023095-4dannjjm	4902	6	confirm	confirm	VB
cord-023095-4dannjjm	4902	7	the	the	DT
cord-023095-4dannjjm	4902	8	role	role	NN
cord-023095-4dannjjm	4902	9	of	of	IN
cord-023095-4dannjjm	4902	10	the	the	DT
cord-023095-4dannjjm	4902	11	unique	unique	JJ
cord-023095-4dannjjm	4902	12	insert	insert	NN
cord-023095-4dannjjm	4902	13	in	in	IN
cord-023095-4dannjjm	4902	14	regulation	regulation	NN
cord-023095-4dannjjm	4902	15	of	of	IN
cord-023095-4dannjjm	4902	16	fGCK	fgck	NN
cord-023095-4dannjjm	4902	17	gene	gene	NN
cord-023095-4dannjjm	4902	18	expression	expression	NN
cord-023095-4dannjjm	4902	19	.	.	.
cord-023095-4dannjjm	4903	1	Deuterium	deuterium	NN
cord-023095-4dannjjm	4903	2	oxide	oxide	NN
cord-023095-4dannjjm	4903	3	(	(	-LRB-
cord-023095-4dannjjm	4903	4	D	d	NN
cord-023095-4dannjjm	4903	5	2	2	CD
cord-023095-4dannjjm	4903	6	O	o	NN
cord-023095-4dannjjm	4903	7	)	)	-RRB-
cord-023095-4dannjjm	4903	8	dilution	dilution	NN
cord-023095-4dannjjm	4903	9	has	have	VBZ
cord-023095-4dannjjm	4903	10	been	be	VBN
cord-023095-4dannjjm	4903	11	proposed	propose	VBN
cord-023095-4dannjjm	4903	12	for	for	IN
cord-023095-4dannjjm	4903	13	quantifying	quantify	VBG
cord-023095-4dannjjm	4903	14	body	body	NN
cord-023095-4dannjjm	4903	15	water	water	NN
cord-023095-4dannjjm	4903	16	content	content	NN
cord-023095-4dannjjm	4903	17	,	,	,
cord-023095-4dannjjm	4903	18	but	but	CC
cord-023095-4dannjjm	4903	19	remains	remain	VBZ
cord-023095-4dannjjm	4903	20	difficult	difficult	JJ
cord-023095-4dannjjm	4903	21	to	to	TO
cord-023095-4dannjjm	4903	22	perform	perform	VB
cord-023095-4dannjjm	4903	23	routinely	routinely	RB
cord-023095-4dannjjm	4903	24	.	.	.
cord-023095-4dannjjm	4904	1	The	the	DT
cord-023095-4dannjjm	4904	2	objective	objective	NN
cord-023095-4dannjjm	4904	3	of	of	IN
cord-023095-4dannjjm	4904	4	this	this	DT
cord-023095-4dannjjm	4904	5	study	study	NN
cord-023095-4dannjjm	4904	6	was	be	VBD
cord-023095-4dannjjm	4904	7	to	to	TO
cord-023095-4dannjjm	4904	8	assess	assess	VB
cord-023095-4dannjjm	4904	9	if	if	IN
cord-023095-4dannjjm	4904	10	the	the	DT
cord-023095-4dannjjm	4904	11	volume	volume	NN
cord-023095-4dannjjm	4904	12	of	of	IN
cord-023095-4dannjjm	4904	13	distribution	distribution	NN
cord-023095-4dannjjm	4904	14	(	(	-LRB-
cord-023095-4dannjjm	4904	15	Vd	Vd	NNP
cord-023095-4dannjjm	4904	16	)	)	-RRB-
cord-023095-4dannjjm	4904	17	of	of	IN
cord-023095-4dannjjm	4904	18	creatinine	creatinine	NN
cord-023095-4dannjjm	4904	19	could	could	MD
cord-023095-4dannjjm	4904	20	be	be	VB
cord-023095-4dannjjm	4904	21	proposed	propose	VBN
cord-023095-4dannjjm	4904	22	as	as	IN
cord-023095-4dannjjm	4904	23	an	an	DT
cord-023095-4dannjjm	4904	24	alternative	alternative	NN
cord-023095-4dannjjm	4904	25	in	in	IN
cord-023095-4dannjjm	4904	26	dogs	dog	NNS
cord-023095-4dannjjm	4904	27	for	for	IN
cord-023095-4dannjjm	4904	28	such	such	PDT
cord-023095-4dannjjm	4904	29	a	a	DT
cord-023095-4dannjjm	4904	30	measurement	measurement	NN
cord-023095-4dannjjm	4904	31	.	.	.
cord-023095-4dannjjm	4905	1	Creatinine	creatinine	NN
cord-023095-4dannjjm	4905	2	and	and	CC
cord-023095-4dannjjm	4905	3	D	d	NN
cord-023095-4dannjjm	4905	4	2	2	CD
cord-023095-4dannjjm	4905	5	O	o	NN
cord-023095-4dannjjm	4905	6	Vd	vd	NN
cord-023095-4dannjjm	4905	7	were	be	VBD
cord-023095-4dannjjm	4905	8	measured	measure	VBN
cord-023095-4dannjjm	4905	9	before	before	RB
cord-023095-4dannjjm	4905	10	(	(	-LRB-
cord-023095-4dannjjm	4905	11	C	C	NNP
cord-023095-4dannjjm	4905	12	)	)	-RRB-
cord-023095-4dannjjm	4905	13	and	and	CC
cord-023095-4dannjjm	4905	14	after	after	IN
cord-023095-4dannjjm	4905	15	induction	induction	NN
cord-023095-4dannjjm	4905	16	(	(	-LRB-
cord-023095-4dannjjm	4905	17	O	o	UH
cord-023095-4dannjjm	4905	18	)	)	-RRB-
cord-023095-4dannjjm	4905	19	of	of	IN
cord-023095-4dannjjm	4905	20	obesity	obesity	NN
cord-023095-4dannjjm	4905	21	(	(	-LRB-
cord-023095-4dannjjm	4905	22	by	by	IN
cord-023095-4dannjjm	4905	23	giving	give	VBG
cord-023095-4dannjjm	4905	24	an	an	DT
cord-023095-4dannjjm	4905	25	hypercaloric	hypercaloric	NN
cord-023095-4dannjjm	4905	26	diet	diet	NN
cord-023095-4dannjjm	4905	27	(	(	-LRB-
cord-023095-4dannjjm	4905	28	6100	6100	CD
cord-023095-4dannjjm	4905	29	kcal/	kcal/	CD
cord-023095-4dannjjm	4905	30	kg	kg	NNP
cord-023095-4dannjjm	4905	31	)	)	-RRB-
cord-023095-4dannjjm	4905	32	for	for	IN
cord-023095-4dannjjm	4905	33	6	6	CD
cord-023095-4dannjjm	4905	34	months	month	NNS
cord-023095-4dannjjm	4905	35	)	)	-RRB-
cord-023095-4dannjjm	4905	36	in	in	IN
cord-023095-4dannjjm	4905	37	six	six	CD
cord-023095-4dannjjm	4905	38	healthy	healthy	JJ
cord-023095-4dannjjm	4905	39	adult	adult	NN
cord-023095-4dannjjm	4905	40	Beagle	Beagle	NNP
cord-023095-4dannjjm	4905	41	dogs	dog	NNS
cord-023095-4dannjjm	4905	42	.	.	.
cord-023095-4dannjjm	4906	1	Creatinine	creatinine	NN
cord-023095-4dannjjm	4906	2	(	(	-LRB-
cord-023095-4dannjjm	4906	3	40	40	CD
cord-023095-4dannjjm	4906	4	mg	mg	NNP
cord-023095-4dannjjm	4906	5	/	/	SYM
cord-023095-4dannjjm	4906	6	kg	kg	NNP
cord-023095-4dannjjm	4906	7	)	)	-RRB-
cord-023095-4dannjjm	4906	8	and	and	CC
cord-023095-4dannjjm	4906	9	D	D	NNP
cord-023095-4dannjjm	4906	10	2	2	CD
cord-023095-4dannjjm	4906	11	O	o	NN
cord-023095-4dannjjm	4906	12	(	(	-LRB-
cord-023095-4dannjjm	4906	13	200	200	CD
cord-023095-4dannjjm	4906	14	mg	mg	NNP
cord-023095-4dannjjm	4906	15	/	/	SYM
cord-023095-4dannjjm	4906	16	kg	kg	NNP
cord-023095-4dannjjm	4906	17	)	)	-RRB-
cord-023095-4dannjjm	4906	18	were	be	VBD
cord-023095-4dannjjm	4906	19	simultaneously	simultaneously	RB
cord-023095-4dannjjm	4906	20	injected	inject	VBN
cord-023095-4dannjjm	4906	21	by	by	IN
cord-023095-4dannjjm	4906	22	bolus	bolus	NN
cord-023095-4dannjjm	4906	23	iv	iv	NNP
cord-023095-4dannjjm	4906	24	.	.	.
cord-023095-4dannjjm	4907	1	Blood	blood	NN
cord-023095-4dannjjm	4907	2	was	be	VBD
cord-023095-4dannjjm	4907	3	collected	collect	VBN
cord-023095-4dannjjm	4907	4	before	before	IN
cord-023095-4dannjjm	4907	5	administration	administration	NN
cord-023095-4dannjjm	4907	6	and	and	CC
cord-023095-4dannjjm	4907	7	then	then	RB
cord-023095-4dannjjm	4907	8	at	at	IN
cord-023095-4dannjjm	4907	9	5	5	CD
cord-023095-4dannjjm	4907	10	,	,	,
cord-023095-4dannjjm	4907	11	10	10	CD
cord-023095-4dannjjm	4907	12	,	,	,
cord-023095-4dannjjm	4907	13	30	30	CD
cord-023095-4dannjjm	4907	14	,	,	,
cord-023095-4dannjjm	4907	15	60	60	CD
cord-023095-4dannjjm	4907	16	,	,	,
cord-023095-4dannjjm	4907	17	120	120	CD
cord-023095-4dannjjm	4907	18	,	,	,
cord-023095-4dannjjm	4907	19	180	180	CD
cord-023095-4dannjjm	4907	20	,	,	,
cord-023095-4dannjjm	4907	21	240	240	CD
cord-023095-4dannjjm	4907	22	,	,	,
cord-023095-4dannjjm	4907	23	360	360	CD
cord-023095-4dannjjm	4907	24	,	,	,
cord-023095-4dannjjm	4907	25	and	and	CC
cord-023095-4dannjjm	4907	26	480	480	CD
cord-023095-4dannjjm	4907	27	min	min	NN
cord-023095-4dannjjm	4907	28	post	post	NN
cord-023095-4dannjjm	4907	29	-	-	NN
cord-023095-4dannjjm	4907	30	injection	injection	NN
cord-023095-4dannjjm	4907	31	(	(	-LRB-
cord-023095-4dannjjm	4907	32	creatinine	creatinine	NN
cord-023095-4dannjjm	4907	33	)	)	-RRB-
cord-023095-4dannjjm	4907	34	,	,	,
cord-023095-4dannjjm	4907	35	and	and	CC
cord-023095-4dannjjm	4907	36	10	10	CD
cord-023095-4dannjjm	4907	37	,	,	,
cord-023095-4dannjjm	4907	38	30	30	CD
cord-023095-4dannjjm	4907	39	,	,	,
cord-023095-4dannjjm	4907	40	60	60	CD
cord-023095-4dannjjm	4907	41	,	,	,
cord-023095-4dannjjm	4907	42	90	90	CD
cord-023095-4dannjjm	4907	43	,	,	,
cord-023095-4dannjjm	4907	44	120	120	CD
cord-023095-4dannjjm	4907	45	,	,	,
cord-023095-4dannjjm	4907	46	150	150	CD
cord-023095-4dannjjm	4907	47	,	,	,
cord-023095-4dannjjm	4907	48	180	180	CD
cord-023095-4dannjjm	4907	49	and	and	CC
cord-023095-4dannjjm	4907	50	240	240	CD
cord-023095-4dannjjm	4907	51	min	min	NN
cord-023095-4dannjjm	4907	52	(	(	-LRB-
cord-023095-4dannjjm	4907	53	D	d	NN
cord-023095-4dannjjm	4907	54	2	2	CD
cord-023095-4dannjjm	4907	55	O	o	NN
cord-023095-4dannjjm	4907	56	)	)	-RRB-
cord-023095-4dannjjm	4907	57	.	.	.
cord-023095-4dannjjm	4908	1	Plasma	plasma	NN
cord-023095-4dannjjm	4908	2	concentrations	concentration	NNS
cord-023095-4dannjjm	4908	3	of	of	IN
cord-023095-4dannjjm	4908	4	both	both	DT
cord-023095-4dannjjm	4908	5	markers	marker	NNS
cord-023095-4dannjjm	4908	6	were	be	VBD
cord-023095-4dannjjm	4908	7	determined	determine	VBN
cord-023095-4dannjjm	4908	8	.	.	.
cord-023095-4dannjjm	4909	1	Vd	Vd	NNP
cord-023095-4dannjjm	4909	2	was	be	VBD
cord-023095-4dannjjm	4909	3	calculated	calculate	VBN
cord-023095-4dannjjm	4909	4	using	use	VBG
cord-023095-4dannjjm	4909	5	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	4909	6	equations	equation	NNS
cord-023095-4dannjjm	4909	7	.	.	.
cord-023095-4dannjjm	4910	1	The	the	DT
cord-023095-4dannjjm	4910	2	body	body	NN
cord-023095-4dannjjm	4910	3	weight	weight	NN
cord-023095-4dannjjm	4910	4	increased	increase	VBD
cord-023095-4dannjjm	4910	5	from	from	IN
cord-023095-4dannjjm	4910	6	10.7	10.7	CD
cord-023095-4dannjjm	4910	7	AE	AE	NNP
cord-023095-4dannjjm	4910	8	0.6	0.6	CD
cord-023095-4dannjjm	4910	9	(	(	-LRB-
cord-023095-4dannjjm	4910	10	C	C	NNP
cord-023095-4dannjjm	4910	11	)	)	-RRB-
cord-023095-4dannjjm	4910	12	(	(	-LRB-
cord-023095-4dannjjm	4910	13	mean	mean	VB
cord-023095-4dannjjm	4910	14	AE	AE	NNP
cord-023095-4dannjjm	4910	15	SD	SD	NNP
cord-023095-4dannjjm	4910	16	)	)	-RRB-
cord-023095-4dannjjm	4910	17	to	to	IN
cord-023095-4dannjjm	4910	18	15.8	15.8	CD
cord-023095-4dannjjm	4910	19	AE	AE	NNP
cord-023095-4dannjjm	4910	20	1.0	1.0	CD
cord-023095-4dannjjm	4910	21	kg	kg	NNS
cord-023095-4dannjjm	4910	22	(	(	-LRB-
cord-023095-4dannjjm	4910	23	O	o	UH
cord-023095-4dannjjm	4910	24	)	)	-RRB-
cord-023095-4dannjjm	4910	25	.	.	.
cord-023095-4dannjjm	4911	1	D	d	NN
cord-023095-4dannjjm	4911	2	2	2	CD
cord-023095-4dannjjm	4911	3	O	o	NN
cord-023095-4dannjjm	4911	4	Vd	vd	NN
cord-023095-4dannjjm	4911	5	decreased	decrease	VBD
cord-023095-4dannjjm	4911	6	from	from	IN
cord-023095-4dannjjm	4911	7	636	636	CD
cord-023095-4dannjjm	4911	8	AE	AE	NNP
cord-023095-4dannjjm	4911	9	18	18	CD
cord-023095-4dannjjm	4911	10	(	(	-LRB-
cord-023095-4dannjjm	4911	11	C	C	NNP
cord-023095-4dannjjm	4911	12	)	)	-RRB-
cord-023095-4dannjjm	4911	13	to	to	IN
cord-023095-4dannjjm	4911	14	468	468	CD
cord-023095-4dannjjm	4911	15	AE	AE	NNP
cord-023095-4dannjjm	4911	16	19	19	CD
cord-023095-4dannjjm	4912	1	(	(	-LRB-
cord-023095-4dannjjm	4912	2	O	o	UH
cord-023095-4dannjjm	4912	3	)	)	-RRB-
cord-023095-4dannjjm	4912	4	mL	ml	NN
cord-023095-4dannjjm	4912	5	/	/	SYM
cord-023095-4dannjjm	4912	6	kg	kg	NN
cord-023095-4dannjjm	4912	7	.	.	.
cord-023095-4dannjjm	4913	1	Similarly	similarly	RB
cord-023095-4dannjjm	4913	2	,	,	,
cord-023095-4dannjjm	4913	3	creatinine	creatinine	NN
cord-023095-4dannjjm	4913	4	Vd	Vd	NNP
cord-023095-4dannjjm	4913	5	decreased	decrease	VBD
cord-023095-4dannjjm	4913	6	from	from	IN
cord-023095-4dannjjm	4913	7	624	624	CD
cord-023095-4dannjjm	4913	8	AE	AE	NNP
cord-023095-4dannjjm	4913	9	31	31	CD
cord-023095-4dannjjm	4913	10	(	(	-LRB-
cord-023095-4dannjjm	4913	11	C	C	NNP
cord-023095-4dannjjm	4913	12	)	)	-RRB-
cord-023095-4dannjjm	4913	13	to	to	IN
cord-023095-4dannjjm	4913	14	420	420	CD
cord-023095-4dannjjm	4913	15	AE	AE	NNP
cord-023095-4dannjjm	4913	16	25	25	CD
cord-023095-4dannjjm	4914	1	(	(	-LRB-
cord-023095-4dannjjm	4914	2	O	o	UH
cord-023095-4dannjjm	4914	3	)	)	-RRB-
cord-023095-4dannjjm	4914	4	mL	ml	NN
cord-023095-4dannjjm	4914	5	/	/	SYM
cord-023095-4dannjjm	4914	6	kg	kg	NN
cord-023095-4dannjjm	4914	7	.	.	.
cord-023095-4dannjjm	4915	1	The	the	DT
cord-023095-4dannjjm	4915	2	individual	individual	JJ
cord-023095-4dannjjm	4915	3	difference	difference	NN
cord-023095-4dannjjm	4915	4	between	between	IN
cord-023095-4dannjjm	4915	5	creatinine	creatinine	NN
cord-023095-4dannjjm	4915	6	and	and	CC
cord-023095-4dannjjm	4915	7	D	d	NN
cord-023095-4dannjjm	4915	8	2	2	CD
cord-023095-4dannjjm	4915	9	O	o	NN
cord-023095-4dannjjm	4915	10	Vd	vd	NN
cord-023095-4dannjjm	4915	11	(	(	-LRB-
cord-023095-4dannjjm	4915	12	expressed	express	VBN
cord-023095-4dannjjm	4915	13	in	in	IN
cord-023095-4dannjjm	4915	14	%	%	NN
cord-023095-4dannjjm	4915	15	of	of	IN
cord-023095-4dannjjm	4915	16	D	d	NN
cord-023095-4dannjjm	4915	17	2	2	CD
cord-023095-4dannjjm	4915	18	O	o	NN
cord-023095-4dannjjm	4915	19	Vd	vd	NN
cord-023095-4dannjjm	4915	20	)	)	-RRB-
cord-023095-4dannjjm	4915	21	ranged	range	VBD
cord-023095-4dannjjm	4915	22	from	from	IN
cord-023095-4dannjjm	4915	23	À9.5	À9.5	NNP
cord-023095-4dannjjm	4915	24	to	to	IN
cord-023095-4dannjjm	4915	25	1.0	1.0	CD
cord-023095-4dannjjm	4915	26	%	%	NN
cord-023095-4dannjjm	4915	27	(	(	-LRB-
cord-023095-4dannjjm	4915	28	C	C	NNP
cord-023095-4dannjjm	4915	29	)	)	-RRB-
cord-023095-4dannjjm	4915	30	and	and	CC
cord-023095-4dannjjm	4915	31	from	from	IN
cord-023095-4dannjjm	4915	32	À17.3	À17.3	NNS
cord-023095-4dannjjm	4915	33	to	to	IN
cord-023095-4dannjjm	4915	34	À7.1	À7.1	NNP
cord-023095-4dannjjm	4915	35	%	%	NN
cord-023095-4dannjjm	4915	36	(	(	-LRB-
cord-023095-4dannjjm	4915	37	O	o	UH
cord-023095-4dannjjm	4915	38	)	)	-RRB-
cord-023095-4dannjjm	4915	39	.	.	.
cord-023095-4dannjjm	4916	1	In	in	IN
cord-023095-4dannjjm	4916	2	conclusion	conclusion	NN
cord-023095-4dannjjm	4916	3	,	,	,
cord-023095-4dannjjm	4916	4	creatinine	creatinine	NN
cord-023095-4dannjjm	4916	5	Vd	Vd	NNP
cord-023095-4dannjjm	4916	6	provides	provide	VBZ
cord-023095-4dannjjm	4916	7	a	a	DT
cord-023095-4dannjjm	4916	8	good	good	JJ
cord-023095-4dannjjm	4916	9	estimate	estimate	NN
cord-023095-4dannjjm	4916	10	of	of	IN
cord-023095-4dannjjm	4916	11	D	d	NN
cord-023095-4dannjjm	4916	12	2	2	CD
cord-023095-4dannjjm	4916	13	O	o	NN
cord-023095-4dannjjm	4916	14	Vd	vd	NN
cord-023095-4dannjjm	4916	15	in	in	IN
cord-023095-4dannjjm	4916	16	both	both	CC
cord-023095-4dannjjm	4916	17	normal	normal	JJ
cord-023095-4dannjjm	4916	18	and	and	CC
cord-023095-4dannjjm	4916	19	obese	obese	JJ
cord-023095-4dannjjm	4916	20	conditions	condition	NNS
cord-023095-4dannjjm	4916	21	.	.	.
cord-023095-4dannjjm	4917	1	A	a	DT
cord-023095-4dannjjm	4917	2	16	16	CD
cord-023095-4dannjjm	4917	3	wk	wk	NN
cord-023095-4dannjjm	4917	4	double	double	JJ
cord-023095-4dannjjm	4917	5	blinded	blinded	JJ
cord-023095-4dannjjm	4917	6	study	study	NN
cord-023095-4dannjjm	4917	7	was	be	VBD
cord-023095-4dannjjm	4917	8	conducted	conduct	VBN
cord-023095-4dannjjm	4917	9	comparing	compare	VBG
cord-023095-4dannjjm	4917	10	the	the	DT
cord-023095-4dannjjm	4917	11	affect	affect	NN
cord-023095-4dannjjm	4917	12	of	of	IN
cord-023095-4dannjjm	4917	13	two	two	CD
cord-023095-4dannjjm	4917	14	foods	food	NNS
cord-023095-4dannjjm	4917	15	on	on	IN
cord-023095-4dannjjm	4917	16	mobility	mobility	NN
cord-023095-4dannjjm	4917	17	in	in	IN
cord-023095-4dannjjm	4917	18	dogs	dog	NNS
cord-023095-4dannjjm	4917	19	.	.	.
cord-023095-4dannjjm	4918	1	All	all	DT
cord-023095-4dannjjm	4918	2	work	work	NN
cord-023095-4dannjjm	4918	3	was	be	VBD
cord-023095-4dannjjm	4918	4	approved	approve	VBN
cord-023095-4dannjjm	4918	5	by	by	IN
cord-023095-4dannjjm	4918	6	an	an	DT
cord-023095-4dannjjm	4918	7	IACUC	IACUC	NNP
cord-023095-4dannjjm	4918	8	.	.	.
cord-023095-4dannjjm	4919	1	53	53	CD
cord-023095-4dannjjm	4919	2	healthy	healthy	JJ
cord-023095-4dannjjm	4919	3	beagle	beagle	NN
cord-023095-4dannjjm	4919	4	dogs	dog	NNS
cord-023095-4dannjjm	4919	5	(	(	-LRB-
cord-023095-4dannjjm	4919	6	7	7	CD
cord-023095-4dannjjm	4919	7	-	-	SYM
cord-023095-4dannjjm	4919	8	15	15	CD
cord-023095-4dannjjm	4919	9	years	year	NNS
cord-023095-4dannjjm	4919	10	old	old	JJ
cord-023095-4dannjjm	4919	11	,	,	,
cord-023095-4dannjjm	4919	12	mixed	mixed	JJ
cord-023095-4dannjjm	4919	13	gender	gender	NN
cord-023095-4dannjjm	4919	14	)	)	-RRB-
cord-023095-4dannjjm	4919	15	were	be	VBD
cord-023095-4dannjjm	4919	16	used	use	VBN
cord-023095-4dannjjm	4919	17	.	.	.
cord-023095-4dannjjm	4920	1	33	33	CD
cord-023095-4dannjjm	4920	2	affected	affected	JJ
cord-023095-4dannjjm	4920	3	(	(	-LRB-
cord-023095-4dannjjm	4920	4	A	a	NN
cord-023095-4dannjjm	4920	5	)	)	-RRB-
cord-023095-4dannjjm	4920	6	and	and	CC
cord-023095-4dannjjm	4920	7	20	20	CD
cord-023095-4dannjjm	4920	8	non	non	JJ
cord-023095-4dannjjm	4920	9	-	-	JJ
cord-023095-4dannjjm	4920	10	affected	affected	JJ
cord-023095-4dannjjm	4920	11	(	(	-LRB-
cord-023095-4dannjjm	4920	12	NA	NA	NNP
cord-023095-4dannjjm	4920	13	)	)	-RRB-
cord-023095-4dannjjm	4920	14	dogs	dog	NNS
cord-023095-4dannjjm	4920	15	were	be	VBD
cord-023095-4dannjjm	4920	16	identified	identify	VBN
cord-023095-4dannjjm	4920	17	based	base	VBN
cord-023095-4dannjjm	4920	18	on	on	IN
cord-023095-4dannjjm	4920	19	orthopedic	orthopedic	JJ
cord-023095-4dannjjm	4920	20	examination	examination	NN
cord-023095-4dannjjm	4920	21	and	and	CC
cord-023095-4dannjjm	4920	22	radiography	radiography	NN
cord-023095-4dannjjm	4920	23	as	as	IN
cord-023095-4dannjjm	4920	24	having	have	VBG
cord-023095-4dannjjm	4920	25	or	or	CC
cord-023095-4dannjjm	4920	26	not	not	RB
cord-023095-4dannjjm	4920	27	having	have	VBG
cord-023095-4dannjjm	4920	28	evidence	evidence	NN
cord-023095-4dannjjm	4920	29	of	of	IN
cord-023095-4dannjjm	4920	30	naturally	naturally	RB
cord-023095-4dannjjm	4920	31	occurring	occur	VBG
cord-023095-4dannjjm	4920	32	joint	joint	JJ
cord-023095-4dannjjm	4920	33	pathology	pathology	NN
cord-023095-4dannjjm	4920	34	(	(	-LRB-
cord-023095-4dannjjm	4920	35	presence	presence	NN
cord-023095-4dannjjm	4920	36	of	of	IN
cord-023095-4dannjjm	4920	37	osteophytes	osteophytes	NNP
cord-023095-4dannjjm	4920	38	,	,	,
cord-023095-4dannjjm	4920	39	dysplasia	dysplasia	NN
cord-023095-4dannjjm	4920	40	,	,	,
cord-023095-4dannjjm	4920	41	effusion	effusion	NN
cord-023095-4dannjjm	4920	42	,	,	,
cord-023095-4dannjjm	4920	43	pain	pain	NN
cord-023095-4dannjjm	4920	44	on	on	IN
cord-023095-4dannjjm	4920	45	manipulation	manipulation	NN
cord-023095-4dannjjm	4920	46	etc	etc	NN
cord-023095-4dannjjm	4920	47	)	)	-RRB-
cord-023095-4dannjjm	4920	48	in	in	IN
cord-023095-4dannjjm	4920	49	one	one	CD
cord-023095-4dannjjm	4920	50	or	or	CC
cord-023095-4dannjjm	4920	51	more	more	JJR
cord-023095-4dannjjm	4920	52	joints	joint	NNS
cord-023095-4dannjjm	4920	53	.	.	.
cord-023095-4dannjjm	4921	1	A	a	NN
cord-023095-4dannjjm	4921	2	and	and	CC
cord-023095-4dannjjm	4921	3	NA	NA	NNP
cord-023095-4dannjjm	4921	4	dogs	dog	NNS
cord-023095-4dannjjm	4921	5	were	be	VBD
cord-023095-4dannjjm	4921	6	evenly	evenly	RB
cord-023095-4dannjjm	4921	7	distributed	distribute	VBN
cord-023095-4dannjjm	4921	8	between	between	IN
cord-023095-4dannjjm	4921	9	two	two	CD
cord-023095-4dannjjm	4921	10	locations	location	NNS
cord-023095-4dannjjm	4921	11	.	.	.
cord-023095-4dannjjm	4922	1	Foods	food	NNS
cord-023095-4dannjjm	4922	2	had	have	VBD
cord-023095-4dannjjm	4922	3	nutrient	nutrient	NN
cord-023095-4dannjjm	4922	4	profiles	profile	NNS
cord-023095-4dannjjm	4922	5	adequate	adequate	JJ
cord-023095-4dannjjm	4922	6	for	for	IN
cord-023095-4dannjjm	4922	7	maintenance	maintenance	NN
cord-023095-4dannjjm	4922	8	according	accord	VBG
cord-023095-4dannjjm	4922	9	to	to	IN
cord-023095-4dannjjm	4922	10	the	the	DT
cord-023095-4dannjjm	4922	11	2009	2009	CD
cord-023095-4dannjjm	4922	12	AAFCO	AAFCO	NNP
cord-023095-4dannjjm	4922	13	Official	Official	NNP
cord-023095-4dannjjm	4922	14	Publication	Publication	NNP
cord-023095-4dannjjm	4922	15	.	.	.
cord-023095-4dannjjm	4923	1	The	the	DT
cord-023095-4dannjjm	4923	2	Test	test	NN
cord-023095-4dannjjm	4923	3	food	food	NN
cord-023095-4dannjjm	4923	4	contained	contain	VBD
cord-023095-4dannjjm	4923	5	greater	great	JJR
cord-023095-4dannjjm	4923	6	amounts	amount	NNS
cord-023095-4dannjjm	4923	7	of	of	IN
cord-023095-4dannjjm	4923	8	methionine	methionine	NN
cord-023095-4dannjjm	4923	9	,	,	,
cord-023095-4dannjjm	4923	10	manganese	manganese	NN
cord-023095-4dannjjm	4923	11	,	,	,
cord-023095-4dannjjm	4923	12	carnitine	carnitine	NN
cord-023095-4dannjjm	4923	13	,	,	,
cord-023095-4dannjjm	4923	14	vit	vit	NNP
cord-023095-4dannjjm	4923	15	.	.	.
cord-023095-4dannjjm	4924	1	E	E	NNP
cord-023095-4dannjjm	4924	2	,	,	,
cord-023095-4dannjjm	4924	3	,	,	,
cord-023095-4dannjjm	4924	4	vit	vit	NNP
cord-023095-4dannjjm	4924	5	.	.	.
cord-023095-4dannjjm	4925	1	C	C	NNP
cord-023095-4dannjjm	4925	2	,	,	,
cord-023095-4dannjjm	4925	3	alpha	alpha	NN
cord-023095-4dannjjm	4925	4	linolenic	linolenic	NN
cord-023095-4dannjjm	4925	5	acid	acid	NN
cord-023095-4dannjjm	4925	6	(	(	-LRB-
cord-023095-4dannjjm	4925	7	ALA	ALA	NNP
cord-023095-4dannjjm	4925	8	)	)	-RRB-
cord-023095-4dannjjm	4925	9	,	,	,
cord-023095-4dannjjm	4925	10	and	and	CC
cord-023095-4dannjjm	4925	11	eicosapentaenoic	eicosapentaenoic	JJ
cord-023095-4dannjjm	4925	12	(	(	-LRB-
cord-023095-4dannjjm	4925	13	EPA	EPA	NNP
cord-023095-4dannjjm	4925	14	)	)	-RRB-
cord-023095-4dannjjm	4925	15	acid	acid	NN
cord-023095-4dannjjm	4925	16	:	:	:
cord-023095-4dannjjm	4925	17	the	the	DT
cord-023095-4dannjjm	4925	18	food	food	NN
cord-023095-4dannjjm	4925	19	provided	provide	VBD
cord-023095-4dannjjm	4925	20	388	388	CD
cord-023095-4dannjjm	4925	21	mg	mg	NN
cord-023095-4dannjjm	4925	22	n3	n3	NN
cord-023095-4dannjjm	4925	23	fatty	fatty	JJ
cord-023095-4dannjjm	4925	24	acids	acid	NNS
cord-023095-4dannjjm	4925	25	and	and	CC
cord-023095-4dannjjm	4925	26	847	847	CD
cord-023095-4dannjjm	4925	27	mg	mg	NN
cord-023095-4dannjjm	4925	28	n6	n6	NNP
cord-023095-4dannjjm	4925	29	fatty	fatty	JJ
cord-023095-4dannjjm	4925	30	acids	acid	NNS
cord-023095-4dannjjm	4925	31	per	per	IN
cord-023095-4dannjjm	4925	32	100kcal	100kcal	CD
cord-023095-4dannjjm	4925	33	.	.	.
cord-023095-4dannjjm	4926	1	All	all	DT
cord-023095-4dannjjm	4926	2	dogs	dog	NNS
cord-023095-4dannjjm	4926	3	were	be	VBD
cord-023095-4dannjjm	4926	4	fed	feed	VBN
cord-023095-4dannjjm	4926	5	the	the	DT
cord-023095-4dannjjm	4926	6	Control	Control	NNP
cord-023095-4dannjjm	4926	7	food	food	NN
cord-023095-4dannjjm	4926	8	for	for	IN
cord-023095-4dannjjm	4926	9	4	4	CD
cord-023095-4dannjjm	4926	10	wks	wks	NN
cord-023095-4dannjjm	4926	11	followed	follow	VBN
cord-023095-4dannjjm	4926	12	by	by	IN
cord-023095-4dannjjm	4926	13	a	a	DT
cord-023095-4dannjjm	4926	14	12	12	CD
cord-023095-4dannjjm	4926	15	wk	wk	NN
cord-023095-4dannjjm	4926	16	feeding	feeding	NN
cord-023095-4dannjjm	4926	17	period	period	NN
cord-023095-4dannjjm	4926	18	where	where	WRB
cord-023095-4dannjjm	4926	19	17	17	CD
cord-023095-4dannjjm	4926	20	A	a	NN
cord-023095-4dannjjm	4926	21	and	and	CC
cord-023095-4dannjjm	4926	22	10	10	CD
cord-023095-4dannjjm	4926	23	NA	NA	NNP
cord-023095-4dannjjm	4926	24	dogs	dog	NNS
cord-023095-4dannjjm	4926	25	consumed	consume	VBD
cord-023095-4dannjjm	4926	26	the	the	DT
cord-023095-4dannjjm	4926	27	Test	test	NN
cord-023095-4dannjjm	4926	28	food	food	NN
cord-023095-4dannjjm	4926	29	and	and	CC
cord-023095-4dannjjm	4926	30	16	16	CD
cord-023095-4dannjjm	4926	31	A	a	NN
cord-023095-4dannjjm	4926	32	and	and	CC
cord-023095-4dannjjm	4926	33	10	10	CD
cord-023095-4dannjjm	4926	34	NA	NA	NNP
cord-023095-4dannjjm	4926	35	dogs	dog	NNS
cord-023095-4dannjjm	4926	36	the	the	DT
cord-023095-4dannjjm	4926	37	Control	Control	NNP
cord-023095-4dannjjm	4926	38	.	.	.
cord-023095-4dannjjm	4927	1	Blood	blood	NN
cord-023095-4dannjjm	4927	2	and	and	CC
cord-023095-4dannjjm	4927	3	urine	urine	NN
cord-023095-4dannjjm	4927	4	were	be	VBD
cord-023095-4dannjjm	4927	5	collected	collect	VBN
cord-023095-4dannjjm	4927	6	at	at	IN
cord-023095-4dannjjm	4927	7	weeks	week	NNS
cord-023095-4dannjjm	4927	8	0	0	CD
cord-023095-4dannjjm	4927	9	,	,	,
cord-023095-4dannjjm	4927	10	4	4	CD
cord-023095-4dannjjm	4927	11	,	,	,
cord-023095-4dannjjm	4927	12	8	8	CD
cord-023095-4dannjjm	4927	13	and	and	CC
cord-023095-4dannjjm	4927	14	12	12	CD
cord-023095-4dannjjm	4927	15	and	and	CC
cord-023095-4dannjjm	4927	16	analyzed	analyze	VBD
cord-023095-4dannjjm	4927	17	for	for	IN
cord-023095-4dannjjm	4927	18	serum	serum	NN
cord-023095-4dannjjm	4927	19	fatty	fatty	JJ
cord-023095-4dannjjm	4927	20	acids	acid	NNS
cord-023095-4dannjjm	4927	21	and	and	CC
cord-023095-4dannjjm	4927	22	urine	urine	NN
cord-023095-4dannjjm	4927	23	thromboxane	thromboxane	NN
cord-023095-4dannjjm	4927	24	:	:	:
cord-023095-4dannjjm	4927	25	creatinine	creatinine	NN
cord-023095-4dannjjm	4927	26	ratios	ratio	NNS
cord-023095-4dannjjm	4927	27	were	be	VBD
cord-023095-4dannjjm	4927	28	determined	determine	VBN
cord-023095-4dannjjm	4927	29	.	.	.
cord-023095-4dannjjm	4928	1	Evaluators	evaluator	NNS
cord-023095-4dannjjm	4928	2	in	in	IN
cord-023095-4dannjjm	4928	3	this	this	DT
cord-023095-4dannjjm	4928	4	study	study	NN
cord-023095-4dannjjm	4928	5	were	be	VBD
cord-023095-4dannjjm	4928	6	different	different	JJ
cord-023095-4dannjjm	4928	7	than	than	IN
cord-023095-4dannjjm	4928	8	those	those	DT
cord-023095-4dannjjm	4928	9	making	make	VBG
cord-023095-4dannjjm	4928	10	the	the	DT
cord-023095-4dannjjm	4928	11	original	original	JJ
cord-023095-4dannjjm	4928	12	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4928	13	and	and	CC
cord-023095-4dannjjm	4928	14	so	so	RB
cord-023095-4dannjjm	4928	15	were	be	VBD
cord-023095-4dannjjm	4928	16	blinded	blind	VBN
cord-023095-4dannjjm	4928	17	as	as	IN
cord-023095-4dannjjm	4928	18	to	to	IN
cord-023095-4dannjjm	4928	19	treatment	treatment	NN
cord-023095-4dannjjm	4928	20	and	and	CC
cord-023095-4dannjjm	4928	21	diagnosis	diagnosis	NN
cord-023095-4dannjjm	4928	22	.	.	.
cord-023095-4dannjjm	4929	1	Orthopedic	orthopedic	NN
cord-023095-4dannjjm	4929	2	exams	exam	NNS
cord-023095-4dannjjm	4929	3	were	be	VBD
cord-023095-4dannjjm	4929	4	performed	perform	VBN
cord-023095-4dannjjm	4929	5	by	by	IN
cord-023095-4dannjjm	4929	6	two	two	CD
cord-023095-4dannjjm	4929	7	veterinary	veterinary	JJ
cord-023095-4dannjjm	4929	8	surgeons	surgeon	NNS
cord-023095-4dannjjm	4929	9	at	at	IN
cord-023095-4dannjjm	4929	10	each	each	DT
cord-023095-4dannjjm	4929	11	site	site	NN
cord-023095-4dannjjm	4929	12	on	on	IN
cord-023095-4dannjjm	4929	13	weeks	week	NNS
cord-023095-4dannjjm	4929	14	0	0	CD
cord-023095-4dannjjm	4929	15	,	,	,
cord-023095-4dannjjm	4929	16	4	4	CD
cord-023095-4dannjjm	4929	17	,	,	,
cord-023095-4dannjjm	4929	18	8	8	CD
cord-023095-4dannjjm	4929	19	and	and	CC
cord-023095-4dannjjm	4929	20	12	12	CD
cord-023095-4dannjjm	4929	21	.	.	.
cord-023095-4dannjjm	4930	1	The	the	DT
cord-023095-4dannjjm	4930	2	same	same	JJ
cord-023095-4dannjjm	4930	3	two	two	CD
cord-023095-4dannjjm	4930	4	evaluators	evaluator	NNS
cord-023095-4dannjjm	4930	5	examined	examine	VBD
cord-023095-4dannjjm	4930	6	the	the	DT
cord-023095-4dannjjm	4930	7	same	same	JJ
cord-023095-4dannjjm	4930	8	dogs	dog	NNS
cord-023095-4dannjjm	4930	9	throughout	throughout	RB
cord-023095-4dannjjm	4930	10	.	.	.
cord-023095-4dannjjm	4931	1	The	the	DT
cord-023095-4dannjjm	4931	2	data	datum	NNS
cord-023095-4dannjjm	4931	3	was	be	VBD
cord-023095-4dannjjm	4931	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	4931	5	for	for	IN
cord-023095-4dannjjm	4931	6	the	the	DT
cord-023095-4dannjjm	4931	7	difference	difference	NN
cord-023095-4dannjjm	4931	8	between	between	IN
cord-023095-4dannjjm	4931	9	A	a	NN
cord-023095-4dannjjm	4931	10	and	and	CC
cord-023095-4dannjjm	4931	11	NA	NA	NNP
cord-023095-4dannjjm	4931	12	dogs	dog	NNS
cord-023095-4dannjjm	4931	13	and	and	CC
cord-023095-4dannjjm	4931	14	between	between	IN
cord-023095-4dannjjm	4931	15	foods	food	NNS
cord-023095-4dannjjm	4931	16	with	with	IN
cord-023095-4dannjjm	4931	17	age	age	NN
cord-023095-4dannjjm	4931	18	,	,	,
cord-023095-4dannjjm	4931	19	gender	gender	NN
cord-023095-4dannjjm	4931	20	and	and	CC
cord-023095-4dannjjm	4931	21	location	location	NN
cord-023095-4dannjjm	4931	22	as	as	IN
cord-023095-4dannjjm	4931	23	covariates	covariate	NNS
cord-023095-4dannjjm	4931	24	.	.	.
cord-023095-4dannjjm	4932	1	Body	body	NN
cord-023095-4dannjjm	4932	2	weight	weight	NN
cord-023095-4dannjjm	4932	3	,	,	,
cord-023095-4dannjjm	4932	4	disease	disease	NN
cord-023095-4dannjjm	4932	5	status	status	NN
cord-023095-4dannjjm	4932	6	,	,	,
cord-023095-4dannjjm	4932	7	age	age	NN
cord-023095-4dannjjm	4932	8	and	and	CC
cord-023095-4dannjjm	4932	9	gender	gender	NN
cord-023095-4dannjjm	4932	10	were	be	VBD
cord-023095-4dannjjm	4932	11	blocked	block	VBN
cord-023095-4dannjjm	4932	12	.	.	.
cord-023095-4dannjjm	4933	1	Analysis	analysis	NN
cord-023095-4dannjjm	4933	2	included	include	VBD
cord-023095-4dannjjm	4933	3	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	4933	4	repeated	repeat	VBD
cord-023095-4dannjjm	4933	5	measures	measure	NNS
cord-023095-4dannjjm	4933	6	mixed	mixed	JJ
cord-023095-4dannjjm	4933	7	procedure	procedure	NN
cord-023095-4dannjjm	4933	8	(	(	-LRB-
cord-023095-4dannjjm	4933	9	SAS	SAS	NNP
cord-023095-4dannjjm	4933	10	version	version	NN
cord-023095-4dannjjm	4933	11	9.0	9.0	CD
cord-023095-4dannjjm	4933	12	)	)	-RRB-
cord-023095-4dannjjm	4933	13	to	to	TO
cord-023095-4dannjjm	4933	14	determine	determine	VB
cord-023095-4dannjjm	4933	15	treatment	treatment	NN
cord-023095-4dannjjm	4933	16	effects	effect	NNS
cord-023095-4dannjjm	4933	17	over	over	IN
cord-023095-4dannjjm	4933	18	time	time	NN
cord-023095-4dannjjm	4933	19	.	.	.
cord-023095-4dannjjm	4934	1	Serum	serum	NN
cord-023095-4dannjjm	4934	2	EPA	EPA	NNP
cord-023095-4dannjjm	4934	3	was	be	VBD
cord-023095-4dannjjm	4934	4	greater	great	JJR
cord-023095-4dannjjm	4934	5	and	and	CC
cord-023095-4dannjjm	4934	6	arachidonic	arachidonic	JJ
cord-023095-4dannjjm	4934	7	acid	acid	NN
cord-023095-4dannjjm	4934	8	lower	lower	RBR
cord-023095-4dannjjm	4934	9	at	at	IN
cord-023095-4dannjjm	4934	10	weeks	week	NNS
cord-023095-4dannjjm	4934	11	4	4	CD
cord-023095-4dannjjm	4934	12	,	,	,
cord-023095-4dannjjm	4934	13	8	8	CD
cord-023095-4dannjjm	4934	14	and	and	CC
cord-023095-4dannjjm	4934	15	12	12	CD
cord-023095-4dannjjm	4934	16	in	in	IN
cord-023095-4dannjjm	4934	17	the	the	DT
cord-023095-4dannjjm	4934	18	Test	test	NN
cord-023095-4dannjjm	4934	19	food	food	NN
cord-023095-4dannjjm	4934	20	fed	feed	VBD
cord-023095-4dannjjm	4934	21	dogs	dog	NNS
cord-023095-4dannjjm	4934	22	(	(	-LRB-
cord-023095-4dannjjm	4934	23	p	p	NN
cord-023095-4dannjjm	4934	24	o	o	NN
cord-023095-4dannjjm	4934	25	0.05	0.05	CD
cord-023095-4dannjjm	4934	26	)	)	-RRB-
cord-023095-4dannjjm	4934	27	.	.	.
cord-023095-4dannjjm	4935	1	Urine	Urine	NNP
cord-023095-4dannjjm	4935	2	thromboxane	thromboxane	NN
cord-023095-4dannjjm	4935	3	:	:	:
cord-023095-4dannjjm	4936	1	creatinine	creatinine	NN
cord-023095-4dannjjm	4936	2	ratios	ratio	NNS
cord-023095-4dannjjm	4936	3	were	be	VBD
cord-023095-4dannjjm	4936	4	decreased	decrease	VBN
cord-023095-4dannjjm	4936	5	in	in	IN
cord-023095-4dannjjm	4936	6	the	the	DT
cord-023095-4dannjjm	4936	7	A	A	NNP
cord-023095-4dannjjm	4936	8	dogs	dog	NNS
cord-023095-4dannjjm	4936	9	fed	feed	VBD
cord-023095-4dannjjm	4936	10	the	the	DT
cord-023095-4dannjjm	4936	11	Test	test	NN
cord-023095-4dannjjm	4936	12	food	food	NN
cord-023095-4dannjjm	4936	13	compared	compare	VBN
cord-023095-4dannjjm	4936	14	to	to	IN
cord-023095-4dannjjm	4936	15	the	the	DT
cord-023095-4dannjjm	4936	16	A	A	NNP
cord-023095-4dannjjm	4936	17	dogs	dog	NNS
cord-023095-4dannjjm	4936	18	fed	feed	VBD
cord-023095-4dannjjm	4936	19	the	the	DT
cord-023095-4dannjjm	4936	20	Control	Control	NNP
cord-023095-4dannjjm	4936	21	food	food	NN
cord-023095-4dannjjm	4936	22	at	at	IN
cord-023095-4dannjjm	4936	23	12	12	CD
cord-023095-4dannjjm	4936	24	wks	wks	NN
cord-023095-4dannjjm	4937	1	(	(	-LRB-
cord-023095-4dannjjm	4937	2	p	p	NN
cord-023095-4dannjjm	4937	3	o	o	NN
cord-023095-4dannjjm	4937	4	0.05	0.05	CD
cord-023095-4dannjjm	4937	5	)	)	-RRB-
cord-023095-4dannjjm	4937	6	.	.	.
cord-023095-4dannjjm	4938	1	Lameness	lameness	NN
cord-023095-4dannjjm	4938	2	score	score	NN
cord-023095-4dannjjm	4938	3	was	be	VBD
cord-023095-4dannjjm	4938	4	significantly	significantly	RB
cord-023095-4dannjjm	4938	5	improved	improve	VBN
cord-023095-4dannjjm	4938	6	(	(	-LRB-
cord-023095-4dannjjm	4938	7	p	p	NN
cord-023095-4dannjjm	4938	8	o	o	NN
cord-023095-4dannjjm	4938	9	0.05	0.05	CD
cord-023095-4dannjjm	4938	10	)	)	-RRB-
cord-023095-4dannjjm	4938	11	within	within	IN
cord-023095-4dannjjm	4938	12	and	and	CC
cord-023095-4dannjjm	4938	13	between	between	IN
cord-023095-4dannjjm	4938	14	groups	group	NNS
cord-023095-4dannjjm	4938	15	of	of	IN
cord-023095-4dannjjm	4938	16	dogs	dog	NNS
cord-023095-4dannjjm	4938	17	fed	feed	VBD
cord-023095-4dannjjm	4938	18	the	the	DT
cord-023095-4dannjjm	4938	19	Test	test	NN
cord-023095-4dannjjm	4938	20	food	food	NN
cord-023095-4dannjjm	4938	21	.	.	.
cord-023095-4dannjjm	4939	1	A	a	DT
cord-023095-4dannjjm	4939	2	significantly	significantly	RB
cord-023095-4dannjjm	4939	3	greater	great	JJR
cord-023095-4dannjjm	4939	4	proportion	proportion	NN
cord-023095-4dannjjm	4939	5	of	of	IN
cord-023095-4dannjjm	4939	6	A	a	DT
cord-023095-4dannjjm	4939	7	dogs	dog	NNS
cord-023095-4dannjjm	4939	8	fed	feed	VBD
cord-023095-4dannjjm	4939	9	the	the	DT
cord-023095-4dannjjm	4939	10	Test	test	NN
cord-023095-4dannjjm	4939	11	food	food	NN
cord-023095-4dannjjm	4939	12	had	have	VBD
cord-023095-4dannjjm	4939	13	improvement	improvement	NN
cord-023095-4dannjjm	4939	14	in	in	IN
cord-023095-4dannjjm	4939	15	total	total	JJ
cord-023095-4dannjjm	4939	16	 	 	_SP
cord-023095-4dannjjm	4939	17	Het	Het	NNP
cord-023095-4dannjjm	4939	18	(	(	-LRB-
cord-023095-4dannjjm	4939	19	n511	n511	NNP
cord-023095-4dannjjm	4939	20	)	)	-RRB-
cord-023095-4dannjjm	4939	21	Blood	blood	NN
cord-023095-4dannjjm	4939	22	glucose	glucose	NN
cord-023095-4dannjjm	4939	23	(	(	-LRB-
cord-023095-4dannjjm	4939	24	mg	mg	NNP
cord-023095-4dannjjm	4939	25	/	/	SYM
cord-023095-4dannjjm	4939	26	dL	dl	NN
cord-023095-4dannjjm	4939	27	)	)	-RRB-
cord-023095-4dannjjm	4939	28	78	78	CD
cord-023095-4dannjjm	4940	1	(	(	-LRB-
cord-023095-4dannjjm	4940	2	AE17	AE17	NNP
cord-023095-4dannjjm	4940	3	)	)	-RRB-
cord-023095-4dannjjm	4940	4	64	64	CD
cord-023095-4dannjjm	4941	1	(	(	-LRB-
cord-023095-4dannjjm	4941	2	AE13	AE13	NNP
cord-023095-4dannjjm	4941	3	)	)	-RRB-
cord-023095-4dannjjm	4941	4	Blood	blood	NN
cord-023095-4dannjjm	4941	5	lactate	lactate	NN
cord-023095-4dannjjm	4941	6	(	(	-LRB-
cord-023095-4dannjjm	4941	7	mmol	mmol	NNP
cord-023095-4dannjjm	4941	8	/	/	SYM
cord-023095-4dannjjm	4941	9	L	l	NN
cord-023095-4dannjjm	4941	10	)	)	-RRB-
cord-023095-4dannjjm	4941	11	1.1	1.1	CD
cord-023095-4dannjjm	4941	12	(	(	-LRB-
cord-023095-4dannjjm	4941	13	AE0.5	AE0.5	NNP
cord-023095-4dannjjm	4941	14	)	)	-RRB-
cord-023095-4dannjjm	4941	15	1.7	1.7	CD
cord-023095-4dannjjm	4941	16	(	(	-LRB-
cord-023095-4dannjjm	4941	17	AE1.1	AE1.1	NNP
cord-023095-4dannjjm	4941	18	)	)	-RRB-
cord-023095-4dannjjm	4941	19	joint	joint	JJ
cord-023095-4dannjjm	4941	20	score	score	NN
cord-023095-4dannjjm	4941	21	,	,	,
cord-023095-4dannjjm	4941	22	lameness	lameness	NN
cord-023095-4dannjjm	4941	23	,	,	,
cord-023095-4dannjjm	4941	24	functional	functional	JJ
cord-023095-4dannjjm	4941	25	disability	disability	NN
cord-023095-4dannjjm	4941	26	and	and	CC
cord-023095-4dannjjm	4941	27	overall	overall	JJ
cord-023095-4dannjjm	4941	28	assessment	assessment	NN
cord-023095-4dannjjm	4941	29	score	score	NN
cord-023095-4dannjjm	4941	30	at	at	IN
cord-023095-4dannjjm	4941	31	12	12	CD
cord-023095-4dannjjm	4941	32	wks	wks	NN
cord-023095-4dannjjm	4941	33	compared	compare	VBN
cord-023095-4dannjjm	4941	34	to	to	IN
cord-023095-4dannjjm	4941	35	A	a	DT
cord-023095-4dannjjm	4941	36	dogs	dog	NNS
cord-023095-4dannjjm	4941	37	fed	feed	VBD
cord-023095-4dannjjm	4941	38	the	the	DT
cord-023095-4dannjjm	4941	39	Control	Control	NNP
cord-023095-4dannjjm	4941	40	food	food	NN
cord-023095-4dannjjm	4941	41	.	.	.
cord-023095-4dannjjm	4942	1	69	69	CD
cord-023095-4dannjjm	4942	2	%	%	NN
cord-023095-4dannjjm	4942	3	of	of	IN
cord-023095-4dannjjm	4942	4	A	a	DT
cord-023095-4dannjjm	4942	5	dogs	dog	NNS
cord-023095-4dannjjm	4942	6	had	have	VBD
cord-023095-4dannjjm	4942	7	an	an	DT
cord-023095-4dannjjm	4942	8	improved	improve	VBN
cord-023095-4dannjjm	4942	9	Overall	Overall	NNP
cord-023095-4dannjjm	4942	10	Assessment	Assessment	NNP
cord-023095-4dannjjm	4942	11	score	score	NN
cord-023095-4dannjjm	4942	12	on	on	IN
cord-023095-4dannjjm	4942	13	the	the	DT
cord-023095-4dannjjm	4942	14	Test	test	NN
cord-023095-4dannjjm	4942	15	food	food	NN
cord-023095-4dannjjm	4942	16	after	after	IN
cord-023095-4dannjjm	4942	17	4	4	CD
cord-023095-4dannjjm	4942	18	wks	wks	NN
cord-023095-4dannjjm	4942	19	and	and	CC
cord-023095-4dannjjm	4942	20	at	at	IN
cord-023095-4dannjjm	4942	21	12	12	CD
cord-023095-4dannjjm	4942	22	wks	wks	NN
cord-023095-4dannjjm	4942	23	compared	compare	VBN
cord-023095-4dannjjm	4942	24	to	to	IN
cord-023095-4dannjjm	4942	25	40	40	CD
cord-023095-4dannjjm	4942	26	%	%	NN
cord-023095-4dannjjm	4942	27	at	at	IN
cord-023095-4dannjjm	4942	28	4	4	CD
cord-023095-4dannjjm	4942	29	wks	wks	NN
cord-023095-4dannjjm	4942	30	and	and	CC
cord-023095-4dannjjm	4942	31	27	27	CD
cord-023095-4dannjjm	4942	32	%	%	NN
cord-023095-4dannjjm	4942	33	at	at	IN
cord-023095-4dannjjm	4942	34	12	12	CD
cord-023095-4dannjjm	4942	35	wks	wks	NN
cord-023095-4dannjjm	4942	36	of	of	IN
cord-023095-4dannjjm	4942	37	A	a	DT
cord-023095-4dannjjm	4942	38	dogs	dog	NNS
cord-023095-4dannjjm	4942	39	consuming	consume	VBG
cord-023095-4dannjjm	4942	40	the	the	DT
cord-023095-4dannjjm	4942	41	Control	Control	NNP
cord-023095-4dannjjm	4942	42	food	food	NN
cord-023095-4dannjjm	4942	43	.	.	.
cord-023095-4dannjjm	4943	1	This	this	DT
cord-023095-4dannjjm	4943	2	study	study	NN
cord-023095-4dannjjm	4943	3	shows	show	VBZ
cord-023095-4dannjjm	4943	4	that	that	IN
cord-023095-4dannjjm	4943	5	a	a	DT
cord-023095-4dannjjm	4943	6	food	food	NN
cord-023095-4dannjjm	4943	7	with	with	IN
cord-023095-4dannjjm	4943	8	moderate	moderate	JJ
cord-023095-4dannjjm	4943	9	amounts	amount	NNS
cord-023095-4dannjjm	4943	10	of	of	IN
cord-023095-4dannjjm	4943	11	added	add	VBN
cord-023095-4dannjjm	4943	12	linolenic	linolenic	JJ
cord-023095-4dannjjm	4943	13	acid	acid	NN
cord-023095-4dannjjm	4943	14	and	and	CC
cord-023095-4dannjjm	4943	15	EPA	EPA	NNP
cord-023095-4dannjjm	4943	16	can	can	MD
cord-023095-4dannjjm	4943	17	have	have	VB
cord-023095-4dannjjm	4943	18	a	a	DT
cord-023095-4dannjjm	4943	19	positive	positive	JJ
cord-023095-4dannjjm	4943	20	impact	impact	NN
cord-023095-4dannjjm	4943	21	on	on	IN
cord-023095-4dannjjm	4943	22	systemic	systemic	JJ
cord-023095-4dannjjm	4943	23	inflammation	inflammation	NN
cord-023095-4dannjjm	4943	24	and	and	CC
cord-023095-4dannjjm	4943	25	mobility	mobility	NN
cord-023095-4dannjjm	4943	26	in	in	IN
cord-023095-4dannjjm	4943	27	4	4	CD
cord-023095-4dannjjm	4943	28	-	-	SYM
cord-023095-4dannjjm	4943	29	12	12	CD
cord-023095-4dannjjm	4943	30	weeks	week	NNS
cord-023095-4dannjjm	4943	31	.	.	.
cord-023095-4dannjjm	4944	1	A	a	DT
cord-023095-4dannjjm	4944	2	similar	similar	JJ
cord-023095-4dannjjm	4944	3	abstract	abstract	NN
cord-023095-4dannjjm	4944	4	will	will	MD
cord-023095-4dannjjm	4944	5	be	be	VB
cord-023095-4dannjjm	4944	6	presented	present	VBN
cord-023095-4dannjjm	4944	7	at	at	IN
cord-023095-4dannjjm	4944	8	the	the	DT
cord-023095-4dannjjm	4944	9	Orthopedic	Orthopedic	NNP
cord-023095-4dannjjm	4944	10	Research	Research	NNP
cord-023095-4dannjjm	4944	11	Society	Society	NNP
cord-023095-4dannjjm	4944	12	meeting	meeting	NN
cord-023095-4dannjjm	4944	13	in	in	IN
cord-023095-4dannjjm	4944	14	January	January	NNP
cord-023095-4dannjjm	4944	15	2011	2011	CD
cord-023095-4dannjjm	4944	16	to	to	IN
cord-023095-4dannjjm	4944	17	an	an	DT
cord-023095-4dannjjm	4944	18	audience	audience	NN
cord-023095-4dannjjm	4944	19	largely	largely	RB
cord-023095-4dannjjm	4944	20	of	of	IN
cord-023095-4dannjjm	4944	21	orthopedic	orthopedic	JJ
cord-023095-4dannjjm	4944	22	researchers	researcher	NNS
cord-023095-4dannjjm	4944	23	interested	interested	JJ
cord-023095-4dannjjm	4944	24	in	in	IN
cord-023095-4dannjjm	4944	25	human	human	JJ
cord-023095-4dannjjm	4944	26	orthopedics	orthopedic	NNS
cord-023095-4dannjjm	4944	27	.	.	.
cord-023095-4dannjjm	4945	1	Fat	fat	NN
cord-023095-4dannjjm	4945	2	is	be	VBZ
cord-023095-4dannjjm	4945	3	an	an	DT
cord-023095-4dannjjm	4945	4	important	important	JJ
cord-023095-4dannjjm	4945	5	dietary	dietary	JJ
cord-023095-4dannjjm	4945	6	component	component	NN
cord-023095-4dannjjm	4945	7	,	,	,
cord-023095-4dannjjm	4945	8	serving	serve	VBG
cord-023095-4dannjjm	4945	9	both	both	DT
cord-023095-4dannjjm	4945	10	as	as	IN
cord-023095-4dannjjm	4945	11	a	a	DT
cord-023095-4dannjjm	4945	12	source	source	NN
cord-023095-4dannjjm	4945	13	of	of	IN
cord-023095-4dannjjm	4945	14	energy	energy	NN
cord-023095-4dannjjm	4945	15	and	and	CC
cord-023095-4dannjjm	4945	16	as	as	IN
cord-023095-4dannjjm	4945	17	a	a	DT
cord-023095-4dannjjm	4945	18	supplier	supplier	NN
cord-023095-4dannjjm	4945	19	of	of	IN
cord-023095-4dannjjm	4945	20	essential	essential	JJ
cord-023095-4dannjjm	4945	21	fatty	fatty	JJ
cord-023095-4dannjjm	4945	22	acids	acid	NNS
cord-023095-4dannjjm	4945	23	(	(	-LRB-
cord-023095-4dannjjm	4945	24	FA	FA	NNP
cord-023095-4dannjjm	4945	25	)	)	-RRB-
cord-023095-4dannjjm	4945	26	.	.	.
cord-023095-4dannjjm	4946	1	Medium	medium	NN
cord-023095-4dannjjm	4946	2	-	-	HYPH
cord-023095-4dannjjm	4946	3	chain	chain	NN
cord-023095-4dannjjm	4946	4	triglycerides	triglyceride	NNS
cord-023095-4dannjjm	4946	5	(	(	-LRB-
cord-023095-4dannjjm	4946	6	MCT	MCT	NNP
cord-023095-4dannjjm	4946	7	)	)	-RRB-
cord-023095-4dannjjm	4946	8	contain	contain	VBP
cord-023095-4dannjjm	4946	9	intermediate	intermediate	JJ
cord-023095-4dannjjm	4946	10	length	length	NN
cord-023095-4dannjjm	4946	11	FA	FA	NNP
cord-023095-4dannjjm	4946	12	that	that	WDT
cord-023095-4dannjjm	4946	13	do	do	VBP
cord-023095-4dannjjm	4946	14	not	not	RB
cord-023095-4dannjjm	4946	15	rely	rely	VB
cord-023095-4dannjjm	4946	16	on	on	IN
cord-023095-4dannjjm	4946	17	L	l	NN
cord-023095-4dannjjm	4946	18	-	-	HYPH
cord-023095-4dannjjm	4946	19	carnitine	carnitine	NN
cord-023095-4dannjjm	4946	20	for	for	IN
cord-023095-4dannjjm	4946	21	transport	transport	NN
cord-023095-4dannjjm	4946	22	across	across	IN
cord-023095-4dannjjm	4946	23	the	the	DT
cord-023095-4dannjjm	4946	24	inner	inner	JJ
cord-023095-4dannjjm	4946	25	mitochondrial	mitochondrial	NN
cord-023095-4dannjjm	4946	26	membrane	membrane	NN
cord-023095-4dannjjm	4946	27	,	,	,
cord-023095-4dannjjm	4946	28	bypassing	bypass	VBG
cord-023095-4dannjjm	4946	29	this	this	DT
cord-023095-4dannjjm	4946	30	rate	rate	NN
cord-023095-4dannjjm	4946	31	-	-	HYPH
cord-023095-4dannjjm	4946	32	limiting	limit	VBG
cord-023095-4dannjjm	4946	33	step	step	NN
cord-023095-4dannjjm	4946	34	in	in	IN
cord-023095-4dannjjm	4946	35	FA	FA	NNP
cord-023095-4dannjjm	4946	36	oxidation	oxidation	NN
cord-023095-4dannjjm	4946	37	.	.	.
cord-023095-4dannjjm	4947	1	Longchain	Longchain	NNP
cord-023095-4dannjjm	4947	2	(	(	-LRB-
cord-023095-4dannjjm	4947	3	n-3	n-3	NN
cord-023095-4dannjjm	4947	4	)	)	-RRB-
cord-023095-4dannjjm	4947	5	polyunsaturated	polyunsaturated	JJ
cord-023095-4dannjjm	4947	6	fatty	fatty	JJ
cord-023095-4dannjjm	4947	7	acids	acid	NNS
cord-023095-4dannjjm	4947	8	(	(	-LRB-
cord-023095-4dannjjm	4947	9	PUFA	PUFA	NNP
cord-023095-4dannjjm	4947	10	)	)	-RRB-
cord-023095-4dannjjm	4947	11	from	from	IN
cord-023095-4dannjjm	4947	12	fish	fish	NN
cord-023095-4dannjjm	4947	13	oil	oil	NN
cord-023095-4dannjjm	4947	14	(	(	-LRB-
cord-023095-4dannjjm	4947	15	FO	FO	NNP
cord-023095-4dannjjm	4947	16	)	)	-RRB-
cord-023095-4dannjjm	4947	17	,	,	,
cord-023095-4dannjjm	4947	18	and	and	CC
cord-023095-4dannjjm	4947	19	in	in	IN
cord-023095-4dannjjm	4947	20	particular	particular	JJ
cord-023095-4dannjjm	4947	21	eicosanoids	eicosanoid	NNS
cord-023095-4dannjjm	4947	22	derived	derive	VBN
cord-023095-4dannjjm	4947	23	from	from	IN
cord-023095-4dannjjm	4947	24	eicosapentaenoic	eicosapentaenoic	JJ
cord-023095-4dannjjm	4947	25	acid	acid	NN
cord-023095-4dannjjm	4947	26	(	(	-LRB-
cord-023095-4dannjjm	4947	27	EPA	EPA	NNP
cord-023095-4dannjjm	4947	28	)	)	-RRB-
cord-023095-4dannjjm	4947	29	,	,	,
cord-023095-4dannjjm	4947	30	may	may	MD
cord-023095-4dannjjm	4947	31	protect	protect	VB
cord-023095-4dannjjm	4947	32	against	against	IN
cord-023095-4dannjjm	4947	33	excessive	excessive	JJ
cord-023095-4dannjjm	4947	34	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	4947	35	reactions	reaction	NNS
cord-023095-4dannjjm	4947	36	,	,	,
cord-023095-4dannjjm	4947	37	which	which	WDT
cord-023095-4dannjjm	4947	38	may	may	MD
cord-023095-4dannjjm	4947	39	be	be	VB
cord-023095-4dannjjm	4947	40	exacerbated	exacerbate	VBN
cord-023095-4dannjjm	4947	41	by	by	IN
cord-023095-4dannjjm	4947	42	eicosanoids	eicosanoid	NNS
cord-023095-4dannjjm	4947	43	derived	derive	VBN
cord-023095-4dannjjm	4947	44	from	from	IN
cord-023095-4dannjjm	4947	45	(	(	-LRB-
cord-023095-4dannjjm	4947	46	n-6	n-6	NN
cord-023095-4dannjjm	4947	47	)	)	-RRB-
cord-023095-4dannjjm	4947	48	arachidonic	arachidonic	NN
cord-023095-4dannjjm	4947	49	acid	acid	NN
cord-023095-4dannjjm	4947	50	(	(	-LRB-
cord-023095-4dannjjm	4947	51	AA	AA	NNP
cord-023095-4dannjjm	4947	52	)	)	-RRB-
cord-023095-4dannjjm	4947	53	.	.	.
cord-023095-4dannjjm	4948	1	This	this	DT
cord-023095-4dannjjm	4948	2	study	study	NN
cord-023095-4dannjjm	4948	3	investigated	investigate	VBD
cord-023095-4dannjjm	4948	4	the	the	DT
cord-023095-4dannjjm	4948	5	effects	effect	NNS
cord-023095-4dannjjm	4948	6	of	of	IN
cord-023095-4dannjjm	4948	7	adding	add	VBG
cord-023095-4dannjjm	4948	8	MCT	MCT	NNP
cord-023095-4dannjjm	4948	9	:	:	:
cord-023095-4dannjjm	4948	10	FO	FO	NNP
cord-023095-4dannjjm	4948	11	and	and	CC
cord-023095-4dannjjm	4948	12	L	l	NN
cord-023095-4dannjjm	4948	13	-	-	HYPH
cord-023095-4dannjjm	4948	14	carnitine	carnitine	NN
cord-023095-4dannjjm	4948	15	to	to	IN
cord-023095-4dannjjm	4948	16	a	a	DT
cord-023095-4dannjjm	4948	17	control	control	NN
cord-023095-4dannjjm	4948	18	diet	diet	NN
cord-023095-4dannjjm	4948	19	(	(	-LRB-
cord-023095-4dannjjm	4948	20	Prescription	Prescription	NNP
cord-023095-4dannjjm	4948	21	Diet	Diet	NNP
cord-023095-4dannjjm	4948	22	s	s	POS
cord-023095-4dannjjm	4948	23	k	k	NNP
cord-023095-4dannjjm	4948	24	/	/	SYM
cord-023095-4dannjjm	4948	25	d	d	NNP
cord-023095-4dannjjm	4948	26	s	s	NNP
cord-023095-4dannjjm	4948	27	)	)	-RRB-
cord-023095-4dannjjm	4948	28	on	on	IN
cord-023095-4dannjjm	4948	29	lean	lean	JJ
cord-023095-4dannjjm	4948	30	body	body	NN
cord-023095-4dannjjm	4948	31	mass	mass	NN
cord-023095-4dannjjm	4948	32	,	,	,
cord-023095-4dannjjm	4948	33	and	and	CC
cord-023095-4dannjjm	4948	34	serum	serum	NN
cord-023095-4dannjjm	4948	35	FA	fa	NN
cord-023095-4dannjjm	4948	36	and	and	CC
cord-023095-4dannjjm	4948	37	metabolites	metabolite	NNS
cord-023095-4dannjjm	4948	38	.	.	.
cord-023095-4dannjjm	4949	1	Forty	forty	CD
cord-023095-4dannjjm	4949	2	healthy	healthy	JJ
cord-023095-4dannjjm	4949	3	Beagles	Beagles	NNPS
cord-023095-4dannjjm	4949	4	(	(	-LRB-
cord-023095-4dannjjm	4949	5	3.1	3.1	CD
cord-023095-4dannjjm	4949	6	to	to	IN
cord-023095-4dannjjm	4949	7	14.8	14.8	CD
cord-023095-4dannjjm	4949	8	y	y	NNP
cord-023095-4dannjjm	4949	9	)	)	-RRB-
cord-023095-4dannjjm	4949	10	were	be	VBD
cord-023095-4dannjjm	4949	11	fed	feed	VBN
cord-023095-4dannjjm	4949	12	one	one	CD
cord-023095-4dannjjm	4949	13	of	of	IN
cord-023095-4dannjjm	4949	14	three	three	CD
cord-023095-4dannjjm	4949	15	foods	food	NNS
cord-023095-4dannjjm	4949	16	(	(	-LRB-
cord-023095-4dannjjm	4949	17	n	n	NN
cord-023095-4dannjjm	4949	18	5	5	CD
cord-023095-4dannjjm	4949	19	13	13	CD
cord-023095-4dannjjm	4949	20	to	to	TO
cord-023095-4dannjjm	4949	21	14	14	CD
cord-023095-4dannjjm	4949	22	dogs	dog	NNS
cord-023095-4dannjjm	4949	23	each	each	DT
cord-023095-4dannjjm	4949	24	)	)	-RRB-
cord-023095-4dannjjm	4949	25	for	for	IN
cord-023095-4dannjjm	4949	26	6	6	CD
cord-023095-4dannjjm	4949	27	mo	mo	NN
cord-023095-4dannjjm	4949	28	.	.	.
cord-023095-4dannjjm	4950	1	The	the	DT
cord-023095-4dannjjm	4950	2	study	study	NN
cord-023095-4dannjjm	4950	3	protocol	protocol	NN
cord-023095-4dannjjm	4950	4	was	be	VBD
cord-023095-4dannjjm	4950	5	reviewed	review	VBN
cord-023095-4dannjjm	4950	6	and	and	CC
cord-023095-4dannjjm	4950	7	approved	approve	VBN
cord-023095-4dannjjm	4950	8	by	by	IN
cord-023095-4dannjjm	4950	9	IACUC	IACUC	NNP
cord-023095-4dannjjm	4950	10	,	,	,
cord-023095-4dannjjm	4950	11	Hill	Hill	NNP
cord-023095-4dannjjm	4950	12	's	's	POS
cord-023095-4dannjjm	4950	13	Pet	Pet	NNP
cord-023095-4dannjjm	4950	14	Nutrition	Nutrition	NNP
cord-023095-4dannjjm	4950	15	,	,	,
cord-023095-4dannjjm	4951	1	Inc.	Inc.	NNP
cord-023095-4dannjjm	4951	2	All	all	DT
cord-023095-4dannjjm	4951	3	foods	food	NNS
cord-023095-4dannjjm	4951	4	were	be	VBD
cord-023095-4dannjjm	4951	5	complete	complete	JJ
cord-023095-4dannjjm	4951	6	,	,	,
cord-023095-4dannjjm	4951	7	balanced	balanced	JJ
cord-023095-4dannjjm	4951	8	,	,	,
cord-023095-4dannjjm	4951	9	and	and	CC
cord-023095-4dannjjm	4951	10	sufficient	sufficient	JJ
cord-023095-4dannjjm	4951	11	for	for	IN
cord-023095-4dannjjm	4951	12	maintenance	maintenance	NN
cord-023095-4dannjjm	4951	13	of	of	IN
cord-023095-4dannjjm	4951	14	adult	adult	NN
cord-023095-4dannjjm	4951	15	dogs	dog	NNS
cord-023095-4dannjjm	4951	16	;	;	:
cord-023095-4dannjjm	4951	17	and	and	CC
cord-023095-4dannjjm	4951	18	had	have	VBD
cord-023095-4dannjjm	4951	19	similar	similar	JJ
cord-023095-4dannjjm	4951	20	concentrations	concentration	NNS
cord-023095-4dannjjm	4951	21	of	of	IN
cord-023095-4dannjjm	4951	22	moisture	moisture	NN
cord-023095-4dannjjm	4951	23	,	,	,
cord-023095-4dannjjm	4951	24	protein	protein	NN
cord-023095-4dannjjm	4951	25	,	,	,
cord-023095-4dannjjm	4951	26	and	and	CC
cord-023095-4dannjjm	4951	27	fat	fat	JJ
cord-023095-4dannjjm	4951	28	(	(	-LRB-
cord-023095-4dannjjm	4951	29	approx	approx	NN
cord-023095-4dannjjm	4951	30	.	.	.
cord-023095-4dannjjm	4951	31	7.4	7.4	CD
cord-023095-4dannjjm	4951	32	%	%	NN
cord-023095-4dannjjm	4951	33	,	,	,
cord-023095-4dannjjm	4951	34	14.0	14.0	CD
cord-023095-4dannjjm	4951	35	%	%	NN
cord-023095-4dannjjm	4951	36	,	,	,
cord-023095-4dannjjm	4951	37	18.1	18.1	CD
cord-023095-4dannjjm	4951	38	%	%	NN
cord-023095-4dannjjm	4951	39	,	,	,
cord-023095-4dannjjm	4951	40	respectively	respectively	RB
cord-023095-4dannjjm	4951	41	)	)	-RRB-
cord-023095-4dannjjm	4951	42	.	.	.
cord-023095-4dannjjm	4952	1	Composition	composition	NN
cord-023095-4dannjjm	4952	2	of	of	IN
cord-023095-4dannjjm	4952	3	serum	serum	NN
cord-023095-4dannjjm	4952	4	FA	FA	NNP
cord-023095-4dannjjm	4952	5	was	be	VBD
cord-023095-4dannjjm	4952	6	determined	determine	VBN
cord-023095-4dannjjm	4952	7	by	by	IN
cord-023095-4dannjjm	4952	8	gas	gas	NN
cord-023095-4dannjjm	4952	9	chromatography	chromatography	NN
cord-023095-4dannjjm	4952	10	of	of	IN
cord-023095-4dannjjm	4952	11	FA	FA	NNP
cord-023095-4dannjjm	4952	12	methyl	methyl	NN
cord-023095-4dannjjm	4952	13	esters	ester	NNS
cord-023095-4dannjjm	4952	14	.	.	.
cord-023095-4dannjjm	4953	1	Metabolomic	metabolomic	JJ
cord-023095-4dannjjm	4953	2	profiles	profile	NNS
cord-023095-4dannjjm	4953	3	of	of	IN
cord-023095-4dannjjm	4953	4	serum	serum	NN
cord-023095-4dannjjm	4953	5	samples	sample	NNS
cord-023095-4dannjjm	4953	6	were	be	VBD
cord-023095-4dannjjm	4953	7	determined	determine	VBN
cord-023095-4dannjjm	4953	8	from	from	IN
cord-023095-4dannjjm	4953	9	extracted	extract	VBN
cord-023095-4dannjjm	4953	10	supernatants	supernatant	NNS
cord-023095-4dannjjm	4953	11	that	that	WDT
cord-023095-4dannjjm	4953	12	were	be	VBD
cord-023095-4dannjjm	4953	13	split	split	VBN
cord-023095-4dannjjm	4953	14	and	and	CC
cord-023095-4dannjjm	4953	15	run	run	VB
cord-023095-4dannjjm	4953	16	on	on	IN
cord-023095-4dannjjm	4953	17	GC	GC	NNP
cord-023095-4dannjjm	4953	18	/	/	SYM
cord-023095-4dannjjm	4953	19	MS	MS	NNP
cord-023095-4dannjjm	4953	20	and	and	CC
cord-023095-4dannjjm	4953	21	LC/	LC/	NNP
cord-023095-4dannjjm	4953	22	MS	MS	NNP
cord-023095-4dannjjm	4953	23	/	/	SYM
cord-023095-4dannjjm	4953	24	MS	MS	NNP
cord-023095-4dannjjm	4953	25	platforms	platform	NNS
cord-023095-4dannjjm	4953	26	,	,	,
cord-023095-4dannjjm	4953	27	for	for	IN
cord-023095-4dannjjm	4953	28	identification	identification	NN
cord-023095-4dannjjm	4953	29	and	and	CC
cord-023095-4dannjjm	4953	30	relative	relative	JJ
cord-023095-4dannjjm	4953	31	quantification	quantification	NN
cord-023095-4dannjjm	4953	32	of	of	IN
cord-023095-4dannjjm	4953	33	small	small	JJ
cord-023095-4dannjjm	4953	34	metabolites	metabolite	NNS
cord-023095-4dannjjm	4953	35	.	.	.
cord-023095-4dannjjm	4954	1	Body	body	NN
cord-023095-4dannjjm	4954	2	composition	composition	NN
cord-023095-4dannjjm	4954	3	was	be	VBD
cord-023095-4dannjjm	4954	4	determined	determine	VBN
cord-023095-4dannjjm	4954	5	by	by	IN
cord-023095-4dannjjm	4954	6	dual	dual	JJ
cord-023095-4dannjjm	4954	7	energy	energy	NN
cord-023095-4dannjjm	4954	8	x	x	NN
cord-023095-4dannjjm	4954	9	-	-	NN
cord-023095-4dannjjm	4954	10	ray	ray	NNP
cord-023095-4dannjjm	4954	11	absorptiometry	absorptiometry	NN
cord-023095-4dannjjm	4954	12	.	.	.
cord-023095-4dannjjm	4955	1	Serum	serum	NN
cord-023095-4dannjjm	4955	2	concentrations	concentration	NNS
cord-023095-4dannjjm	4955	3	of	of	IN
cord-023095-4dannjjm	4955	4	lauric	lauric	JJ
cord-023095-4dannjjm	4955	5	and	and	CC
cord-023095-4dannjjm	4955	6	myristic	myristic	JJ
cord-023095-4dannjjm	4955	7	FA	FA	NNP
cord-023095-4dannjjm	4955	8	increased	increase	VBD
cord-023095-4dannjjm	4955	9	;	;	:
cord-023095-4dannjjm	4955	10	EPA	EPA	NNP
cord-023095-4dannjjm	4955	11	and	and	CC
cord-023095-4dannjjm	4955	12	DHA	DHA	NNP
cord-023095-4dannjjm	4955	13	increased	increase	VBD
cord-023095-4dannjjm	4955	14	in	in	IN
cord-023095-4dannjjm	4955	15	a	a	DT
cord-023095-4dannjjm	4955	16	dose	dose	NN
cord-023095-4dannjjm	4955	17	-	-	HYPH
cord-023095-4dannjjm	4955	18	dependent	dependent	JJ
cord-023095-4dannjjm	4955	19	manner	manner	NN
cord-023095-4dannjjm	4955	20	;	;	:
cord-023095-4dannjjm	4955	21	and	and	CC
cord-023095-4dannjjm	4955	22	AA	AA	NNP
cord-023095-4dannjjm	4955	23	decreased	decrease	VBD
cord-023095-4dannjjm	4955	24	in	in	IN
cord-023095-4dannjjm	4955	25	dogs	dog	NNS
cord-023095-4dannjjm	4955	26	fed	fed	NNP
cord-023095-4dannjjm	4955	27	treatment	treatment	NN
cord-023095-4dannjjm	4955	28	food	food	NN
cord-023095-4dannjjm	4955	29	3	3	CD
cord-023095-4dannjjm	4955	30	(	(	-LRB-
cord-023095-4dannjjm	4955	31	proc	proc	VB
cord-023095-4dannjjm	4955	32	-	-	HYPH
cord-023095-4dannjjm	4955	33	mixed	mix	VBN
cord-023095-4dannjjm	4955	34	procedure	procedure	NN
cord-023095-4dannjjm	4955	35	in	in	IN
cord-023095-4dannjjm	4955	36	SAS	SAS	NNP
cord-023095-4dannjjm	4955	37	;	;	:
cord-023095-4dannjjm	4955	38	all	all	DT
cord-023095-4dannjjm	4955	39	P	p	NN
cord-023095-4dannjjm	4955	40	0.05	0.05	CD
cord-023095-4dannjjm	4955	41	)	)	-RRB-
cord-023095-4dannjjm	4955	42	when	when	WRB
cord-023095-4dannjjm	4955	43	compared	compare	VBN
cord-023095-4dannjjm	4955	44	to	to	IN
cord-023095-4dannjjm	4955	45	dogs	dog	NNS
cord-023095-4dannjjm	4955	46	fed	fed	NNP
cord-023095-4dannjjm	4955	47	treatment	treatment	NN
cord-023095-4dannjjm	4955	48	foods	food	NNS
cord-023095-4dannjjm	4955	49	1	1	CD
cord-023095-4dannjjm	4955	50	or	or	CC
cord-023095-4dannjjm	4955	51	2	2	CD
cord-023095-4dannjjm	4955	52	.	.	.
cord-023095-4dannjjm	4956	1	Serum	serum	NN
cord-023095-4dannjjm	4956	2	concentrations	concentration	NNS
cord-023095-4dannjjm	4956	3	of	of	IN
cord-023095-4dannjjm	4956	4	acetylcarnitine	acetylcarnitine	NNP
cord-023095-4dannjjm	4956	5	and	and	CC
cord-023095-4dannjjm	4956	6	succinylcarnitine	succinylcarnitine	NNP
cord-023095-4dannjjm	4956	7	increased	increase	VBD
cord-023095-4dannjjm	4956	8	,	,	,
cord-023095-4dannjjm	4956	9	indicating	indicate	VBG
cord-023095-4dannjjm	4956	10	Lcarnitine	Lcarnitine	NNP
cord-023095-4dannjjm	4956	11	incorporation	incorporation	NN
cord-023095-4dannjjm	4956	12	,	,	,
cord-023095-4dannjjm	4956	13	in	in	IN
cord-023095-4dannjjm	4956	14	dogs	dog	NNS
cord-023095-4dannjjm	4956	15	fed	feed	VBD
cord-023095-4dannjjm	4956	16	treatment	treatment	NN
cord-023095-4dannjjm	4956	17	foods	food	NNS
cord-023095-4dannjjm	4956	18	2	2	CD
cord-023095-4dannjjm	4956	19	and	and	CC
cord-023095-4dannjjm	4956	20	3	3	CD
cord-023095-4dannjjm	4956	21	.	.	.
cord-023095-4dannjjm	4957	1	Thus	thus	RB
cord-023095-4dannjjm	4957	2	,	,	,
cord-023095-4dannjjm	4957	3	a	a	DT
cord-023095-4dannjjm	4957	4	diet	diet	NN
cord-023095-4dannjjm	4957	5	enriched	enrich	VBN
cord-023095-4dannjjm	4957	6	with	with	IN
cord-023095-4dannjjm	4957	7	MCT	MCT	NNP
cord-023095-4dannjjm	4957	8	:	:	:
cord-023095-4dannjjm	4957	9	FO	FO	NNP
cord-023095-4dannjjm	4957	10	significantly	significantly	RB
cord-023095-4dannjjm	4957	11	altered	alter	VBD
cord-023095-4dannjjm	4957	12	serum	serum	NN
cord-023095-4dannjjm	4957	13	FA	fa	NN
cord-023095-4dannjjm	4957	14	composition	composition	NN
cord-023095-4dannjjm	4957	15	,	,	,
cord-023095-4dannjjm	4957	16	enriching	enrich	VBG
cord-023095-4dannjjm	4957	17	(	(	-LRB-
cord-023095-4dannjjm	4957	18	n-3	n-3	NN
cord-023095-4dannjjm	4957	19	)	)	-RRB-
cord-023095-4dannjjm	4957	20	PUFA	PUFA	NNP
cord-023095-4dannjjm	4957	21	and	and	CC
cord-023095-4dannjjm	4957	22	lowering	lower	VBG
cord-023095-4dannjjm	4957	23	AA	AA	NNP
cord-023095-4dannjjm	4957	24	concentrations	concentration	NNS
cord-023095-4dannjjm	4957	25	.	.	.
cord-023095-4dannjjm	4958	1	There	there	EX
cord-023095-4dannjjm	4958	2	was	be	VBD
cord-023095-4dannjjm	4958	3	no	no	DT
cord-023095-4dannjjm	4958	4	change	change	NN
cord-023095-4dannjjm	4958	5	in	in	IN
cord-023095-4dannjjm	4958	6	lean	lean	JJ
cord-023095-4dannjjm	4958	7	body	body	NN
cord-023095-4dannjjm	4958	8	mass	mass	NN
cord-023095-4dannjjm	4958	9	for	for	IN
cord-023095-4dannjjm	4958	10	any	any	DT
cord-023095-4dannjjm	4958	11	of	of	IN
cord-023095-4dannjjm	4958	12	the	the	DT
cord-023095-4dannjjm	4958	13	diets	diet	NNS
cord-023095-4dannjjm	4958	14	compared	compare	VBN
cord-023095-4dannjjm	4958	15	to	to	IN
cord-023095-4dannjjm	4958	16	baseline	baseline	JJ
cord-023095-4dannjjm	4958	17	values	value	NNS
cord-023095-4dannjjm	4958	18	,	,	,
cord-023095-4dannjjm	4958	19	and	and	CC
cord-023095-4dannjjm	4958	20	no	no	DT
cord-023095-4dannjjm	4958	21	difference	difference	NN
cord-023095-4dannjjm	4958	22	between	between	IN
cord-023095-4dannjjm	4958	23	treatments	treatment	NNS
cord-023095-4dannjjm	4958	24	,	,	,
cord-023095-4dannjjm	4958	25	showing	show	VBG
cord-023095-4dannjjm	4958	26	that	that	IN
cord-023095-4dannjjm	4958	27	all	all	DT
cord-023095-4dannjjm	4958	28	three	three	CD
cord-023095-4dannjjm	4958	29	treatment	treatment	NN
cord-023095-4dannjjm	4958	30	foods	food	NNS
cord-023095-4dannjjm	4958	31	met	meet	VBD
cord-023095-4dannjjm	4958	32	protein	protein	NN
cord-023095-4dannjjm	4958	33	requirements	requirement	NNS
cord-023095-4dannjjm	4958	34	.	.	.
cord-023095-4dannjjm	4959	1	Ten	ten	CD
cord-023095-4dannjjm	4959	2	owned	own	VBN
cord-023095-4dannjjm	4959	3	dogs	dog	NNS
cord-023095-4dannjjm	4959	4	,	,	,
cord-023095-4dannjjm	4959	5	obese	obese	JJ
cord-023095-4dannjjm	4959	6	for	for	IN
cord-023095-4dannjjm	4959	7	more	more	JJR
cord-023095-4dannjjm	4959	8	than	than	IN
cord-023095-4dannjjm	4959	9	12	12	CD
cord-023095-4dannjjm	4959	10	months	month	NNS
cord-023095-4dannjjm	4959	11	(	(	-LRB-
cord-023095-4dannjjm	4959	12	body	body	NN
cord-023095-4dannjjm	4959	13	condition	condition	NN
cord-023095-4dannjjm	4959	14	score	score	NN
cord-023095-4dannjjm	4959	15	[	[	-LRB-
cord-023095-4dannjjm	4959	16	BCS	BCS	NNP
cord-023095-4dannjjm	4959	17	]	]	-RRB-
cord-023095-4dannjjm	4959	18	of	of	IN
cord-023095-4dannjjm	4959	19	9	9	CD
cord-023095-4dannjjm	4959	20	;	;	:
cord-023095-4dannjjm	4959	21	fat	fat	JJ
cord-023095-4dannjjm	4959	22	mass	mass	NN
cord-023095-4dannjjm	4959	23	[	[	-LRB-
cord-023095-4dannjjm	4959	24	FM	FM	NNP
cord-023095-4dannjjm	4959	25	]	]	-RRB-
cord-023095-4dannjjm	4959	26	5	5	CD
cord-023095-4dannjjm	4959	27	45.7	45.7	CD
cord-023095-4dannjjm	4959	28	AE	AE	NNP
cord-023095-4dannjjm	4959	29	1.51	1.51	CD
cord-023095-4dannjjm	4959	30	%	%	NN
cord-023095-4dannjjm	4959	31	)	)	-RRB-
cord-023095-4dannjjm	4959	32	were	be	VBD
cord-023095-4dannjjm	4959	33	studied	study	VBN
cord-023095-4dannjjm	4959	34	.	.	.
cord-023095-4dannjjm	4960	1	These	these	DT
cord-023095-4dannjjm	4960	2	dogs	dog	NNS
cord-023095-4dannjjm	4960	3	had	have	VBD
cord-023095-4dannjjm	4960	4	their	-PRON-	PRP$
cord-023095-4dannjjm	4960	5	weight	weight	NN
cord-023095-4dannjjm	4960	6	reduced	reduce	VBN
cord-023095-4dannjjm	4960	7	by	by	IN
cord-023095-4dannjjm	4960	8	20	20	CD
cord-023095-4dannjjm	4960	9	%	%	NN
cord-023095-4dannjjm	4960	10	(	(	-LRB-
cord-023095-4dannjjm	4960	11	BCS	BCS	NNP
cord-023095-4dannjjm	4960	12	5	5	CD
cord-023095-4dannjjm	4960	13	8	8	CD
cord-023095-4dannjjm	4960	14	;	;	:
cord-023095-4dannjjm	4960	15	FM	FM	NNP
cord-023095-4dannjjm	4960	16	5	5	CD
cord-023095-4dannjjm	4960	17	33.5	33.5	CD
cord-023095-4dannjjm	4960	18	AE	AE	NNP
cord-023095-4dannjjm	4960	19	1.92	1.92	CD
cord-023095-4dannjjm	4960	20	%	%	NN
cord-023095-4dannjjm	4960	21	;	;	:
cord-023095-4dannjjm	4960	22	P	p	NN
cord-023095-4dannjjm	4960	23	o	o	NN
cord-023095-4dannjjm	4960	24	0.001	0.001	CD
cord-023095-4dannjjm	4960	25	)	)	-RRB-
cord-023095-4dannjjm	4960	26	being	be	VBG
cord-023095-4dannjjm	4960	27	designated	designate	VBN
cord-023095-4dannjjm	4960	28	weight	weight	NN
cord-023095-4dannjjm	4960	29	reduced	reduce	VBN
cord-023095-4dannjjm	4960	30	(	(	-LRB-
cord-023095-4dannjjm	4960	31	WR	WR	NNP
cord-023095-4dannjjm	4960	32	)	)	-RRB-
cord-023095-4dannjjm	4960	33	group	group	NN
cord-023095-4dannjjm	4961	1	and	and	CC
cord-023095-4dannjjm	4961	2	then	then	RB
cord-023095-4dannjjm	4961	3	were	be	VBD
cord-023095-4dannjjm	4961	4	fed	feed	VBN
cord-023095-4dannjjm	4961	5	to	to	TO
cord-023095-4dannjjm	4961	6	maintain	maintain	VB
cord-023095-4dannjjm	4961	7	constant	constant	JJ
cord-023095-4dannjjm	4961	8	body	body	NN
cord-023095-4dannjjm	4961	9	weight	weight	NN
cord-023095-4dannjjm	4961	10	during	during	IN
cord-023095-4dannjjm	4961	11	150	150	CD
cord-023095-4dannjjm	4961	12	days	day	NNS
cord-023095-4dannjjm	4962	1	(	(	-LRB-
cord-023095-4dannjjm	4962	2	BCS	BCS	NNP
cord-023095-4dannjjm	4962	3	5	5	CD
cord-023095-4dannjjm	4962	4	8.2	8.2	CD
cord-023095-4dannjjm	4962	5	;	;	:
cord-023095-4dannjjm	4962	6	P	p	NN
cord-023095-4dannjjm	4962	7	5	5	CD
cord-023095-4dannjjm	4962	8	0.6	0.6	CD
cord-023095-4dannjjm	4962	9	)	)	-RRB-
cord-023095-4dannjjm	4962	10	,	,	,
cord-023095-4dannjjm	4962	11	designated	designated	JJ
cord-023095-4dannjjm	4962	12	maintenance	maintenance	NN
cord-023095-4dannjjm	4962	13	(	(	-LRB-
cord-023095-4dannjjm	4962	14	MAIN	MAIN	NNP
cord-023095-4dannjjm	4962	15	)	)	-RRB-
cord-023095-4dannjjm	4962	16	group	group	NN
cord-023095-4dannjjm	4962	17	.	.	.
cord-023095-4dannjjm	4963	1	A	a	DT
cord-023095-4dannjjm	4963	2	control	control	NN
cord-023095-4dannjjm	4963	3	(	(	-LRB-
cord-023095-4dannjjm	4963	4	CT	CT	NNP
cord-023095-4dannjjm	4963	5	)	)	-RRB-
cord-023095-4dannjjm	4963	6	group	group	NN
cord-023095-4dannjjm	4963	7	of	of	IN
cord-023095-4dannjjm	4963	8	10	10	CD
cord-023095-4dannjjm	4963	9	beagles	beagle	NNS
cord-023095-4dannjjm	4963	10	was	be	VBD
cord-023095-4dannjjm	4963	11	also	also	RB
cord-023095-4dannjjm	4963	12	included	include	VBN
cord-023095-4dannjjm	4963	13	(	(	-LRB-
cord-023095-4dannjjm	4963	14	BCS	BCS	NNP
cord-023095-4dannjjm	4963	15	5	5	CD
cord-023095-4dannjjm	4963	16	4.5	4.5	CD
cord-023095-4dannjjm	4963	17	;	;	:
cord-023095-4dannjjm	4963	18	FM	FM	NNP
cord-023095-4dannjjm	4963	19	5	5	CD
cord-023095-4dannjjm	4963	20	18.3	18.3	CD
cord-023095-4dannjjm	4963	21	AE	AE	NNP
cord-023095-4dannjjm	4963	22	1.38	1.38	CD
cord-023095-4dannjjm	4963	23	%	%	NN
cord-023095-4dannjjm	4963	24	;	;	:
cord-023095-4dannjjm	4963	25	P	p	NN
cord-023095-4dannjjm	4963	26	o	o	NN
cord-023095-4dannjjm	4963	27	0.01	0.01	CD
cord-023095-4dannjjm	4963	28	)	)	-RRB-
cord-023095-4dannjjm	4963	29	.	.	.
cord-023095-4dannjjm	4964	1	In	in	IN
cord-023095-4dannjjm	4964	2	all	all	DT
cord-023095-4dannjjm	4964	3	groups	group	NNS
cord-023095-4dannjjm	4964	4	the	the	DT
cord-023095-4dannjjm	4964	5	glucose	glucose	NN
cord-023095-4dannjjm	4964	6	postprandial	postprandial	JJ
cord-023095-4dannjjm	4964	7	response	response	NN
cord-023095-4dannjjm	4964	8	test	test	NN
cord-023095-4dannjjm	4964	9	was	be	VBD
cord-023095-4dannjjm	4964	10	performed	perform	VBN
cord-023095-4dannjjm	4964	11	after	after	IN
cord-023095-4dannjjm	4964	12	12	12	CD
cord-023095-4dannjjm	4964	13	hours	hour	NNS
cord-023095-4dannjjm	4964	14	of	of	IN
cord-023095-4dannjjm	4964	15	fasting	fast	VBG
cord-023095-4dannjjm	4964	16	.	.	.
cord-023095-4dannjjm	4965	1	Blood	blood	NN
cord-023095-4dannjjm	4965	2	samples	sample	NNS
cord-023095-4dannjjm	4965	3	were	be	VBD
cord-023095-4dannjjm	4965	4	taken	take	VBN
cord-023095-4dannjjm	4965	5	prefeeding	prefeede	VBG
cord-023095-4dannjjm	4965	6	and	and	CC
cord-023095-4dannjjm	4965	7	after	after	IN
cord-023095-4dannjjm	4965	8	5	5	CD
cord-023095-4dannjjm	4965	9	,	,	,
cord-023095-4dannjjm	4965	10	10	10	CD
cord-023095-4dannjjm	4965	11	,	,	,
cord-023095-4dannjjm	4965	12	15	15	CD
cord-023095-4dannjjm	4965	13	,	,	,
cord-023095-4dannjjm	4965	14	30	30	CD
cord-023095-4dannjjm	4965	15	,	,	,
cord-023095-4dannjjm	4965	16	45	45	CD
cord-023095-4dannjjm	4965	17	,	,	,
cord-023095-4dannjjm	4965	18	60	60	CD
cord-023095-4dannjjm	4965	19	,	,	,
cord-023095-4dannjjm	4965	20	120	120	CD
cord-023095-4dannjjm	4965	21	,	,	,
cord-023095-4dannjjm	4965	22	180	180	CD
cord-023095-4dannjjm	4965	23	,	,	,
cord-023095-4dannjjm	4965	24	240	240	CD
cord-023095-4dannjjm	4965	25	,	,	,
cord-023095-4dannjjm	4965	26	300	300	CD
cord-023095-4dannjjm	4965	27	and	and	CC
cord-023095-4dannjjm	4965	28	360	360	CD
cord-023095-4dannjjm	4965	29	minutes	minute	NNS
cord-023095-4dannjjm	4965	30	of	of	IN
cord-023095-4dannjjm	4965	31	the	the	DT
cord-023095-4dannjjm	4965	32	consumption	consumption	NN
cord-023095-4dannjjm	4965	33	of	of	IN
cord-023095-4dannjjm	4965	34	cooked	cook	VBN
cord-023095-4dannjjm	4965	35	rice	rice	NN
cord-023095-4dannjjm	4965	36	enough	enough	RB
cord-023095-4dannjjm	4965	37	to	to	IN
cord-023095-4dannjjm	4965	38	the	the	DT
cord-023095-4dannjjm	4965	39	ingestion	ingestion	NN
cord-023095-4dannjjm	4965	40	of	of	IN
cord-023095-4dannjjm	4965	41	6	6	CD
cord-023095-4dannjjm	4965	42	g	g	NN
cord-023095-4dannjjm	4965	43	of	of	IN
cord-023095-4dannjjm	4965	44	starch	starch	NN
cord-023095-4dannjjm	4965	45	/	/	SYM
cord-023095-4dannjjm	4965	46	kg	kg	NN
cord-023095-4dannjjm	4965	47	body	body	NN
cord-023095-4dannjjm	4965	48	weight	weight	NN
cord-023095-4dannjjm	4965	49	.	.	.
cord-023095-4dannjjm	4966	1	TNF	TNF	NNP
cord-023095-4dannjjm	4966	2	-	-	:
cord-023095-4dannjjm	4966	3	a	a	DT
cord-023095-4dannjjm	4967	1	and	and	CC
cord-023095-4dannjjm	4967	2	IL-6	IL-6	NNP
cord-023095-4dannjjm	4967	3	were	be	VBD
cord-023095-4dannjjm	4967	4	dosed	dose	VBN
cord-023095-4dannjjm	4967	5	in	in	IN
cord-023095-4dannjjm	4967	6	MILLIPLEX	MILLIPLEX	NNP
cord-023095-4dannjjm	4967	7	TM	TM	NNP
cord-023095-4dannjjm	4967	8	MAP	MAP	NNP
cord-023095-4dannjjm	4967	9	panel	panel	NN
cord-023095-4dannjjm	4967	10	,	,	,
cord-023095-4dannjjm	4967	11	insulin	insulin	NN
cord-023095-4dannjjm	4967	12	and	and	CC
cord-023095-4dannjjm	4967	13	leptin	leptin	NN
cord-023095-4dannjjm	4967	14	by	by	IN
cord-023095-4dannjjm	4967	15	radioimmunoassay	radioimmunoassay	JJ
cord-023095-4dannjjm	4967	16	.	.	.
cord-023095-4dannjjm	4968	1	Statistical	statistical	JJ
cord-023095-4dannjjm	4968	2	analysis	analysis	NN
cord-023095-4dannjjm	4968	3	included	include	VBD
cord-023095-4dannjjm	4968	4	paired	pair	VBN
cord-023095-4dannjjm	4968	5	or	or	CC
cord-023095-4dannjjm	4968	6	non	non	JJ
cord-023095-4dannjjm	4968	7	-	-	JJ
cord-023095-4dannjjm	4968	8	paired	paired	JJ
cord-023095-4dannjjm	4968	9	T	t	NN
cord-023095-4dannjjm	4968	10	-	-	HYPH
cord-023095-4dannjjm	4968	11	tests	test	NNS
cord-023095-4dannjjm	4968	12	and	and	CC
cord-023095-4dannjjm	4968	13	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	4968	14	(	(	-LRB-
cord-023095-4dannjjm	4968	15	P	p	NN
cord-023095-4dannjjm	4968	16	o	o	NN
cord-023095-4dannjjm	4968	17	0.05	0.05	CD
cord-023095-4dannjjm	4968	18	)	)	-RRB-
cord-023095-4dannjjm	4968	19	.	.	.
cord-023095-4dannjjm	4969	1	The	the	DT
cord-023095-4dannjjm	4969	2	regimen	regimen	NN
cord-023095-4dannjjm	4969	3	normalized	normalize	VBD
cord-023095-4dannjjm	4969	4	meal	meal	NN
cord-023095-4dannjjm	4969	5	glucose	glucose	NN
cord-023095-4dannjjm	4969	6	response	response	NN
cord-023095-4dannjjm	4969	7	,	,	,
cord-023095-4dannjjm	4969	8	the	the	DT
cord-023095-4dannjjm	4969	9	area	area	NN
cord-023095-4dannjjm	4969	10	under	under	IN
cord-023095-4dannjjm	4969	11	the	the	DT
cord-023095-4dannjjm	4969	12	curve	curve	NN
cord-023095-4dannjjm	4969	13	(	(	-LRB-
cord-023095-4dannjjm	4969	14	AUC	AUC	NNP
cord-023095-4dannjjm	4969	15	)	)	-RRB-
cord-023095-4dannjjm	4969	16	of	of	IN
cord-023095-4dannjjm	4969	17	glucose	glucose	NN
cord-023095-4dannjjm	4969	18	for	for	IN
cord-023095-4dannjjm	4969	19	WR	WR	NNP
cord-023095-4dannjjm	4969	20	was	be	VBD
cord-023095-4dannjjm	4969	21	lower	low	JJR
cord-023095-4dannjjm	4969	22	than	than	IN
cord-023095-4dannjjm	4969	23	for	for	IN
cord-023095-4dannjjm	4969	24	obese	obese	JJ
cord-023095-4dannjjm	4969	25	(	(	-LRB-
cord-023095-4dannjjm	4969	26	P	p	NN
cord-023095-4dannjjm	4969	27	o	o	NN
cord-023095-4dannjjm	4969	28	0.05	0.05	CD
cord-023095-4dannjjm	4969	29	)	)	-RRB-
cord-023095-4dannjjm	4969	30	and	and	CC
cord-023095-4dannjjm	4969	31	similar	similar	JJ
cord-023095-4dannjjm	4969	32	to	to	IN
cord-023095-4dannjjm	4969	33	MAIN	MAIN	NNP
cord-023095-4dannjjm	4969	34	and	and	CC
cord-023095-4dannjjm	4969	35	CT	CT	NNP
cord-023095-4dannjjm	4969	36	(	(	-LRB-
cord-023095-4dannjjm	4969	37	P	p	NN
cord-023095-4dannjjm	4969	38	4	4	CD
cord-023095-4dannjjm	4969	39	0.05	0.05	CD
cord-023095-4dannjjm	4969	40	)	)	-RRB-
cord-023095-4dannjjm	4969	41	.	.	.
cord-023095-4dannjjm	4970	1	Insulin	insulin	NN
cord-023095-4dannjjm	4970	2	secretion	secretion	NN
cord-023095-4dannjjm	4970	3	did	do	VBD
cord-023095-4dannjjm	4970	4	not	not	RB
cord-023095-4dannjjm	4970	5	normalize	normalize	VB
cord-023095-4dannjjm	4970	6	immediately	immediately	RB
cord-023095-4dannjjm	4970	7	,	,	,
cord-023095-4dannjjm	4970	8	as	as	IN
cord-023095-4dannjjm	4970	9	obese	obese	JJ
cord-023095-4dannjjm	4970	10	and	and	CC
cord-023095-4dannjjm	4970	11	WR	WR	NNP
cord-023095-4dannjjm	4970	12	exhibited	exhibit	VBD
cord-023095-4dannjjm	4970	13	similar	similar	JJ
cord-023095-4dannjjm	4970	14	AUC	auc	NN
cord-023095-4dannjjm	4970	15	of	of	IN
cord-023095-4dannjjm	4970	16	insulin	insulin	NN
cord-023095-4dannjjm	4970	17	and	and	CC
cord-023095-4dannjjm	4970	18	higher	high	JJR
cord-023095-4dannjjm	4970	19	values	value	NNS
cord-023095-4dannjjm	4970	20	than	than	IN
cord-023095-4dannjjm	4970	21	for	for	IN
cord-023095-4dannjjm	4970	22	CT	CT	NNP
cord-023095-4dannjjm	4970	23	(	(	-LRB-
cord-023095-4dannjjm	4970	24	P	p	NN
cord-023095-4dannjjm	4970	25	o	o	NN
cord-023095-4dannjjm	4970	26	0.05	0.05	CD
cord-023095-4dannjjm	4970	27	)	)	-RRB-
cord-023095-4dannjjm	4970	28	.	.	.
cord-023095-4dannjjm	4971	1	MAIN	MAIN	NNP
cord-023095-4dannjjm	4971	2	,	,	,
cord-023095-4dannjjm	4971	3	however	however	RB
cord-023095-4dannjjm	4971	4	,	,	,
cord-023095-4dannjjm	4971	5	presented	present	VBD
cord-023095-4dannjjm	4971	6	similar	similar	JJ
cord-023095-4dannjjm	4971	7	AUC	auc	NN
cord-023095-4dannjjm	4971	8	of	of	IN
cord-023095-4dannjjm	4971	9	insulin	insulin	NN
cord-023095-4dannjjm	4971	10	than	than	IN
cord-023095-4dannjjm	4971	11	CT	CT	NNP
cord-023095-4dannjjm	4971	12	,	,	,
cord-023095-4dannjjm	4971	13	with	with	IN
cord-023095-4dannjjm	4971	14	lower	low	JJR
cord-023095-4dannjjm	4971	15	values	value	NNS
cord-023095-4dannjjm	4971	16	than	than	IN
cord-023095-4dannjjm	4971	17	obese	obese	JJ
cord-023095-4dannjjm	4971	18	and	and	CC
cord-023095-4dannjjm	4971	19	WR	WR	NNP
cord-023095-4dannjjm	4971	20	(	(	-LRB-
cord-023095-4dannjjm	4971	21	P	p	NN
cord-023095-4dannjjm	4971	22	o	o	NN
cord-023095-4dannjjm	4971	23	0.01	0.01	CD
cord-023095-4dannjjm	4971	24	)	)	-RRB-
cord-023095-4dannjjm	4971	25	,	,	,
cord-023095-4dannjjm	4971	26	suggesting	suggest	VBG
cord-023095-4dannjjm	4971	27	that	that	IN
cord-023095-4dannjjm	4971	28	dogs	dog	NNS
cord-023095-4dannjjm	4971	29	require	require	VBP
cord-023095-4dannjjm	4971	30	some	some	DT
cord-023095-4dannjjm	4971	31	time	time	NN
cord-023095-4dannjjm	4971	32	to	to	TO
cord-023095-4dannjjm	4971	33	adapt	adapt	VB
cord-023095-4dannjjm	4971	34	their	-PRON-	PRP$
cord-023095-4dannjjm	4971	35	metabolism	metabolism	NN
cord-023095-4dannjjm	4971	36	.	.	.
cord-023095-4dannjjm	4972	1	Leptin	Leptin	NNP
cord-023095-4dannjjm	4972	2	,	,	,
cord-023095-4dannjjm	4972	3	TNF	TNF	NNP
cord-023095-4dannjjm	4972	4	-	-	HYPH
cord-023095-4dannjjm	4972	5	a	a	NNP
cord-023095-4dannjjm	4972	6	,	,	,
cord-023095-4dannjjm	4972	7	and	and	CC
cord-023095-4dannjjm	4972	8	IL-6	IL-6	NNP
cord-023095-4dannjjm	4972	9	presented	present	VBD
cord-023095-4dannjjm	4972	10	significant	significant	JJ
cord-023095-4dannjjm	4972	11	reductions	reduction	NNS
cord-023095-4dannjjm	4972	12	after	after	IN
cord-023095-4dannjjm	4972	13	weight	weight	NN
cord-023095-4dannjjm	4972	14	loss	loss	NN
cord-023095-4dannjjm	4972	15	(	(	-LRB-
cord-023095-4dannjjm	4972	16	P	p	NN
cord-023095-4dannjjm	4972	17	o	o	NN
cord-023095-4dannjjm	4972	18	0.05	0.05	CD
cord-023095-4dannjjm	4972	19	)	)	-RRB-
cord-023095-4dannjjm	4972	20	,	,	,
cord-023095-4dannjjm	4972	21	without	without	IN
cord-023095-4dannjjm	4972	22	differences	difference	NNS
cord-023095-4dannjjm	4972	23	between	between	IN
cord-023095-4dannjjm	4972	24	WR	WR	NNP
cord-023095-4dannjjm	4972	25	,	,	,
cord-023095-4dannjjm	4972	26	MAIN	MAIN	NNP
cord-023095-4dannjjm	4972	27	and	and	CC
cord-023095-4dannjjm	4972	28	CT	CT	NNP
cord-023095-4dannjjm	4972	29	(	(	-LRB-
cord-023095-4dannjjm	4972	30	P	p	NN
cord-023095-4dannjjm	4972	31	4	4	CD
cord-023095-4dannjjm	4972	32	0.05	0.05	CD
cord-023095-4dannjjm	4972	33	)	)	-RRB-
cord-023095-4dannjjm	4972	34	,	,	,
cord-023095-4dannjjm	4972	35	suggesting	suggest	VBG
cord-023095-4dannjjm	4972	36	an	an	DT
cord-023095-4dannjjm	4972	37	improvement	improvement	NN
cord-023095-4dannjjm	4972	38	of	of	IN
cord-023095-4dannjjm	4972	39	the	the	DT
cord-023095-4dannjjm	4972	40	pro	pro	JJ
cord-023095-4dannjjm	4972	41	-	-	JJ
cord-023095-4dannjjm	4972	42	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	4972	43	state	state	NN
cord-023095-4dannjjm	4972	44	consequent	consequent	NN
cord-023095-4dannjjm	4972	45	to	to	IN
cord-023095-4dannjjm	4972	46	obesity	obesity	NN
cord-023095-4dannjjm	4972	47	.	.	.
cord-023095-4dannjjm	4973	1	Studying	study	VBG
cord-023095-4dannjjm	4973	2	food	food	NN
cord-023095-4dannjjm	4973	3	base	base	NN
cord-023095-4dannjjm	4973	4	excess	excess	NN
cord-023095-4dannjjm	4973	5	(	(	-LRB-
cord-023095-4dannjjm	4973	6	BE	be	VB
cord-023095-4dannjjm	4973	7	)	)	-RRB-
cord-023095-4dannjjm	4973	8	modification	modification	NN
cord-023095-4dannjjm	4973	9	,	,	,
cord-023095-4dannjjm	4973	10	methionine	methionine	NN
cord-023095-4dannjjm	4973	11	intoxication	intoxication	NN
cord-023095-4dannjjm	4973	12	was	be	VBD
cord-023095-4dannjjm	4973	13	described	describe	VBN
cord-023095-4dannjjm	4973	14	.	.	.
cord-023095-4dannjjm	4974	1	In	in	IN
cord-023095-4dannjjm	4974	2	a	a	DT
cord-023095-4dannjjm	4974	3	basal	basal	NN
cord-023095-4dannjjm	4974	4	kibble	kibble	NN
cord-023095-4dannjjm	4974	5	dog	dog	NN
cord-023095-4dannjjm	4974	6	diet	diet	NN
cord-023095-4dannjjm	4974	7	(	(	-LRB-
cord-023095-4dannjjm	4974	8	BE	be	VB
cord-023095-4dannjjm	4974	9	5	5	CD
cord-023095-4dannjjm	4974	10	305	305	CD
cord-023095-4dannjjm	4974	11	mEq	mEq	NNS
cord-023095-4dannjjm	4974	12	/	/	SYM
cord-023095-4dannjjm	4974	13	kg	kg	NNS
cord-023095-4dannjjm	4974	14	;	;	:
cord-023095-4dannjjm	4974	15	1.98	1.98	CD
cord-023095-4dannjjm	4974	16	g	g	NN
cord-023095-4dannjjm	4974	17	/	/	SYM
cord-023095-4dannjjm	4974	18	kg	kg	NN
cord-023095-4dannjjm	4974	19	of	of	IN
cord-023095-4dannjjm	4974	20	S	S	NNP
cord-023095-4dannjjm	4974	21	)	)	-RRB-
cord-023095-4dannjjm	4975	1	two	two	CD
cord-023095-4dannjjm	4975	2	dosages	dosage	NNS
cord-023095-4dannjjm	4975	3	of	of	IN
cord-023095-4dannjjm	4975	4	ammonium	ammonium	NN
cord-023095-4dannjjm	4975	5	sulphate	sulphate	NN
cord-023095-4dannjjm	4975	6	and	and	CC
cord-023095-4dannjjm	4975	7	Methionine	Methionine	NNP
cord-023095-4dannjjm	4975	8	was	be	VBD
cord-023095-4dannjjm	4975	9	added	add	VBN
cord-023095-4dannjjm	4975	10	,	,	,
cord-023095-4dannjjm	4975	11	resulting	result	VBG
cord-023095-4dannjjm	4975	12	in	in	IN
cord-023095-4dannjjm	4975	13	diets	diet	NNS
cord-023095-4dannjjm	4975	14	with	with	IN
cord-023095-4dannjjm	4975	15	BE	be	NN
cord-023095-4dannjjm	4975	16	of	of	IN
cord-023095-4dannjjm	4975	17	135	135	CD
cord-023095-4dannjjm	4975	18	mEq	mEq	NNS
cord-023095-4dannjjm	4975	19	/	/	SYM
cord-023095-4dannjjm	4975	20	kg	kg	NNP
cord-023095-4dannjjm	4975	21	(	(	-LRB-
cord-023095-4dannjjm	4975	22	4.26	4.26	CD
cord-023095-4dannjjm	4975	23	g	g	NN
cord-023095-4dannjjm	4975	24	/	/	SYM
cord-023095-4dannjjm	4975	25	kg	kg	NN
cord-023095-4dannjjm	4975	26	of	of	IN
cord-023095-4dannjjm	4975	27	S	S	NNP
cord-023095-4dannjjm	4975	28	)	)	-RRB-
cord-023095-4dannjjm	4975	29	and	and	CC
cord-023095-4dannjjm	4975	30	À51	À51	NNP
cord-023095-4dannjjm	4975	31	mEq	mEq	NNS
cord-023095-4dannjjm	4975	32	/	/	SYM
cord-023095-4dannjjm	4975	33	kg	kg	NN
cord-023095-4dannjjm	4975	34	(	(	-LRB-
cord-023095-4dannjjm	4975	35	6.65	6.65	CD
cord-023095-4dannjjm	4975	36	g	g	NN
cord-023095-4dannjjm	4975	37	/	/	SYM
cord-023095-4dannjjm	4975	38	kg	kg	NN
cord-023095-4dannjjm	4975	39	of	of	IN
cord-023095-4dannjjm	4975	40	S	S	NNP
cord-023095-4dannjjm	4975	41	)	)	-RRB-
cord-023095-4dannjjm	4975	42	,	,	,
cord-023095-4dannjjm	4975	43	or	or	CC
cord-023095-4dannjjm	4975	44	BE	be	VB
cord-023095-4dannjjm	4975	45	of	of	IN
cord-023095-4dannjjm	4975	46	142	142	CD
cord-023095-4dannjjm	4975	47	mEq	mEq	NNS
cord-023095-4dannjjm	4975	48	/	/	SYM
cord-023095-4dannjjm	4975	49	kg	kg	NNP
cord-023095-4dannjjm	4975	50	(	(	-LRB-
cord-023095-4dannjjm	4975	51	4.68	4.68	CD
cord-023095-4dannjjm	4975	52	g	g	NN
cord-023095-4dannjjm	4975	53	/	/	SYM
cord-023095-4dannjjm	4975	54	kg	kg	NN
cord-023095-4dannjjm	4975	55	of	of	IN
cord-023095-4dannjjm	4975	56	S	S	NNP
cord-023095-4dannjjm	4975	57	)	)	-RRB-
cord-023095-4dannjjm	4975	58	and	and	CC
cord-023095-4dannjjm	4975	59	4	4	CD
cord-023095-4dannjjm	4975	60	mEq	mEq	NNS
cord-023095-4dannjjm	4975	61	/	/	SYM
cord-023095-4dannjjm	4975	62	kg	kg	NNP
cord-023095-4dannjjm	4975	63	(	(	-LRB-
cord-023095-4dannjjm	4975	64	7.49	7.49	CD
cord-023095-4dannjjm	4975	65	g	g	NN
cord-023095-4dannjjm	4975	66	/	/	SYM
cord-023095-4dannjjm	4975	67	kg	kg	NN
cord-023095-4dannjjm	4975	68	of	of	IN
cord-023095-4dannjjm	4975	69	S	S	NNP
cord-023095-4dannjjm	4975	70	)	)	-RRB-
cord-023095-4dannjjm	4975	71	,	,	,
cord-023095-4dannjjm	4975	72	respectively	respectively	RB
cord-023095-4dannjjm	4975	73	.	.	.
cord-023095-4dannjjm	4976	1	A	a	DT
cord-023095-4dannjjm	4976	2	2	2	CD
cord-023095-4dannjjm	4976	3	Â	â	CD
cord-023095-4dannjjm	4976	4	2	2	CD
cord-023095-4dannjjm	4976	5	factorial	factorial	NN
cord-023095-4dannjjm	4976	6	plus	plus	CC
cord-023095-4dannjjm	4976	7	a	a	DT
cord-023095-4dannjjm	4976	8	control	control	NN
cord-023095-4dannjjm	4976	9	diet	diet	NN
cord-023095-4dannjjm	4976	10	design	design	NN
cord-023095-4dannjjm	4976	11	,	,	,
cord-023095-4dannjjm	4976	12	resulting	result	VBG
cord-023095-4dannjjm	4976	13	in	in	IN
cord-023095-4dannjjm	4976	14	five	five	CD
cord-023095-4dannjjm	4976	15	treatments	treatment	NNS
cord-023095-4dannjjm	4976	16	,	,	,
cord-023095-4dannjjm	4976	17	and	and	CC
cord-023095-4dannjjm	4976	18	32	32	CD
cord-023095-4dannjjm	4976	19	adult	adult	NN
cord-023095-4dannjjm	4976	20	health	health	NN
cord-023095-4dannjjm	4976	21	beagle	beagle	NN
cord-023095-4dannjjm	4976	22	dogs	dog	NNS
cord-023095-4dannjjm	4976	23	were	be	VBD
cord-023095-4dannjjm	4976	24	used	use	VBN
cord-023095-4dannjjm	4976	25	,	,	,
cord-023095-4dannjjm	4976	26	in	in	IN
cord-023095-4dannjjm	4976	27	a	a	DT
cord-023095-4dannjjm	4976	28	completed	complete	VBN
cord-023095-4dannjjm	4976	29	randomized	randomized	JJ
cord-023095-4dannjjm	4976	30	design	design	NN
cord-023095-4dannjjm	4976	31	with	with	IN
cord-023095-4dannjjm	4976	32	six	six	CD
cord-023095-4dannjjm	4976	33	dogs	dog	NNS
cord-023095-4dannjjm	4976	34	per	per	IN
cord-023095-4dannjjm	4976	35	diet	diet	NN
cord-023095-4dannjjm	4976	36	.	.	.
cord-023095-4dannjjm	4977	1	A	a	DT
cord-023095-4dannjjm	4977	2	5-d	5-d	CD
cord-023095-4dannjjm	4977	3	adaptation	adaptation	NN
cord-023095-4dannjjm	4977	4	phase	phase	NN
cord-023095-4dannjjm	4977	5	followed	follow	VBD
cord-023095-4dannjjm	4977	6	3-d	3-d	CD
cord-023095-4dannjjm	4977	7	of	of	IN
cord-023095-4dannjjm	4977	8	total	total	JJ
cord-023095-4dannjjm	4977	9	urine	urine	NN
cord-023095-4dannjjm	4977	10	collection	collection	NN
cord-023095-4dannjjm	4977	11	(	(	-LRB-
cord-023095-4dannjjm	4977	12	in	in	IN
cord-023095-4dannjjm	4977	13	bottles	bottle	NNS
cord-023095-4dannjjm	4977	14	with	with	IN
cord-023095-4dannjjm	4977	15	100	100	CD
cord-023095-4dannjjm	4977	16	mg	mg	NNS
cord-023095-4dannjjm	4977	17	of	of	IN
cord-023095-4dannjjm	4977	18	thymol	thymol	NN
cord-023095-4dannjjm	4977	19	)	)	-RRB-
cord-023095-4dannjjm	4977	20	.	.	.
cord-023095-4dannjjm	4978	1	Urine	urine	NN
cord-023095-4dannjjm	4978	2	were	be	VBD
cord-023095-4dannjjm	4978	3	pooled	pool	VBN
cord-023095-4dannjjm	4978	4	by	by	IN
cord-023095-4dannjjm	4978	5	dog	dog	NN
cord-023095-4dannjjm	4978	6	and	and	CC
cord-023095-4dannjjm	4978	7	analyzed	analyze	VBD
cord-023095-4dannjjm	4978	8	for	for	IN
cord-023095-4dannjjm	4978	9	density	density	NN
cord-023095-4dannjjm	4978	10	,	,	,
cord-023095-4dannjjm	4978	11	volume	volume	NN
cord-023095-4dannjjm	4978	12	and	and	CC
cord-023095-4dannjjm	4978	13	pH.	ph.	NN
cord-023095-4dannjjm	4978	14	Food	Food	NNP
cord-023095-4dannjjm	4978	15	macroelements	macroelement	NNS
cord-023095-4dannjjm	4978	16	were	be	VBD
cord-023095-4dannjjm	4978	17	determined	determine	VBN
cord-023095-4dannjjm	4978	18	by	by	IN
cord-023095-4dannjjm	4978	19	standards	standard	NNS
cord-023095-4dannjjm	4978	20	methods	method	NNS
cord-023095-4dannjjm	4978	21	(	(	-LRB-
cord-023095-4dannjjm	4978	22	AOAC	AOAC	NNP
cord-023095-4dannjjm	4978	23	,	,	,
cord-023095-4dannjjm	4978	24	1995	1995	CD
cord-023095-4dannjjm	4978	25	)	)	-RRB-
cord-023095-4dannjjm	4978	26	and	and	CC
cord-023095-4dannjjm	4978	27	used	use	VBN
cord-023095-4dannjjm	4978	28	for	for	IN
cord-023095-4dannjjm	4978	29	BE	BE	NNP
cord-023095-4dannjjm	4978	30	calculation	calculation	NN
cord-023095-4dannjjm	4978	31	.	.	.
cord-023095-4dannjjm	4979	1	Dog	Dog	NNP
cord-023095-4dannjjm	4979	2	's	's	POS
cord-023095-4dannjjm	4979	3	acid	acid	NN
cord-023095-4dannjjm	4979	4	-	-	HYPH
cord-023095-4dannjjm	4979	5	basic	basic	JJ
cord-023095-4dannjjm	4979	6	status	status	NN
cord-023095-4dannjjm	4979	7	was	be	VBD
cord-023095-4dannjjm	4979	8	studied	study	VBN
cord-023095-4dannjjm	4979	9	by	by	IN
cord-023095-4dannjjm	4979	10	blood	blood	NN
cord-023095-4dannjjm	4979	11	gas	gas	NN
cord-023095-4dannjjm	4979	12	analysis	analysis	NN
cord-023095-4dannjjm	4979	13	of	of	IN
cord-023095-4dannjjm	4979	14	venous	venous	JJ
cord-023095-4dannjjm	4979	15	blood	blood	NN
cord-023095-4dannjjm	4979	16	,	,	,
cord-023095-4dannjjm	4979	17	at	at	IN
cord-023095-4dannjjm	4979	18	8:00h	8:00h	CD
cord-023095-4dannjjm	4979	19	(	(	-LRB-
cord-023095-4dannjjm	4979	20	pre	pre	JJ
cord-023095-4dannjjm	4979	21	feeding	feeding	NN
cord-023095-4dannjjm	4979	22	)	)	-RRB-
cord-023095-4dannjjm	4979	23	and	and	CC
cord-023095-4dannjjm	4979	24	6	6	CD
cord-023095-4dannjjm	4979	25	hours	hour	NNS
cord-023095-4dannjjm	4979	26	after	after	IN
cord-023095-4dannjjm	4979	27	meal	meal	NN
cord-023095-4dannjjm	4979	28	.	.	.
cord-023095-4dannjjm	4980	1	A	a	DT
cord-023095-4dannjjm	4980	2	dose	dose	RB
cord-023095-4dannjjm	4980	3	-	-	HYPH
cord-023095-4dannjjm	4980	4	dependent	dependent	JJ
cord-023095-4dannjjm	4980	5	reduction	reduction	NN
cord-023095-4dannjjm	4980	6	of	of	IN
cord-023095-4dannjjm	4980	7	urinary	urinary	JJ
cord-023095-4dannjjm	4980	8	pH	pH	NNP
cord-023095-4dannjjm	4980	9	was	be	VBD
cord-023095-4dannjjm	4980	10	verified	verify	VBN
cord-023095-4dannjjm	4980	11	for	for	IN
cord-023095-4dannjjm	4980	12	both	both	DT
cord-023095-4dannjjm	4980	13	compounds	compound	NNS
cord-023095-4dannjjm	4980	14	(	(	-LRB-
cord-023095-4dannjjm	4980	15	P	p	NN
cord-023095-4dannjjm	4980	16	o	o	NN
cord-023095-4dannjjm	4980	17	0.01	0.01	CD
cord-023095-4dannjjm	4980	18	)	)	-RRB-
cord-023095-4dannjjm	4980	19	.	.	.
cord-023095-4dannjjm	4981	1	Blood	blood	NN
cord-023095-4dannjjm	4981	2	bicarbonate	bicarbonate	NN
cord-023095-4dannjjm	4981	3	(	(	-LRB-
cord-023095-4dannjjm	4981	4	r	r	NN
cord-023095-4dannjjm	4981	5	5	5	CD
cord-023095-4dannjjm	4981	6	0.98	0.98	CD
cord-023095-4dannjjm	4981	7	;	;	:
cord-023095-4dannjjm	4981	8	P	p	NN
cord-023095-4dannjjm	4981	9	o	o	NN
cord-023095-4dannjjm	4981	10	0.01	0.01	CD
cord-023095-4dannjjm	4981	11	)	)	-RRB-
cord-023095-4dannjjm	4981	12	,	,	,
cord-023095-4dannjjm	4981	13	and	and	CC
cord-023095-4dannjjm	4981	14	blood	blood	NN
cord-023095-4dannjjm	4981	15	base	base	NN
cord-023095-4dannjjm	4981	16	excess	excess	NN
cord-023095-4dannjjm	4982	1	(	(	-LRB-
cord-023095-4dannjjm	4982	2	r	r	NN
cord-023095-4dannjjm	4982	3	5	5	CD
cord-023095-4dannjjm	4982	4	0.75	0.75	CD
cord-023095-4dannjjm	4982	5	;	;	:
cord-023095-4dannjjm	4982	6	P	p	NN
cord-023095-4dannjjm	4982	7	o	o	NN
cord-023095-4dannjjm	4982	8	0.01	0.01	CD
cord-023095-4dannjjm	4982	9	)	)	-RRB-
cord-023095-4dannjjm	4982	10	were	be	VBD
cord-023095-4dannjjm	4982	11	highly	highly	RB
cord-023095-4dannjjm	4982	12	correlated	correlate	VBN
cord-023095-4dannjjm	4982	13	with	with	IN
cord-023095-4dannjjm	4982	14	food	food	NN
cord-023095-4dannjjm	4982	15	BE	be	VB
cord-023095-4dannjjm	4982	16	.	.	.
cord-023095-4dannjjm	4983	1	Acidemia	Acidemia	NNP
cord-023095-4dannjjm	4983	2	and	and	CC
cord-023095-4dannjjm	4983	3	reduced	reduce	VBN
cord-023095-4dannjjm	4983	4	blood	blood	NN
cord-023095-4dannjjm	4983	5	BE	be	VB
cord-023095-4dannjjm	4983	6	were	be	VBD
cord-023095-4dannjjm	4983	7	verified	verify	VBN
cord-023095-4dannjjm	4983	8	in	in	IN
cord-023095-4dannjjm	4983	9	diets	diet	NNS
cord-023095-4dannjjm	4983	10	with	with	IN
cord-023095-4dannjjm	4983	11	BE	be	VB
cord-023095-4dannjjm	4983	12	close	close	JJ
cord-023095-4dannjjm	4983	13	to	to	IN
cord-023095-4dannjjm	4983	14	zero	zero	CD
cord-023095-4dannjjm	4983	15	(	(	-LRB-
cord-023095-4dannjjm	4983	16	higher	high	JJR
cord-023095-4dannjjm	4983	17	dose	dose	NN
cord-023095-4dannjjm	4983	18	of	of	IN
cord-023095-4dannjjm	4983	19	both	both	DT
cord-023095-4dannjjm	4983	20	compounds	compound	NNS
cord-023095-4dannjjm	4983	21	,	,	,
cord-023095-4dannjjm	4983	22	or	or	CC
cord-023095-4dannjjm	4983	23	4	4	CD
cord-023095-4dannjjm	4983	24	6.6	6.6	CD
cord-023095-4dannjjm	4983	25	g	g	NN
cord-023095-4dannjjm	4983	26	/	/	SYM
cord-023095-4dannjjm	4983	27	kg	kg	NN
cord-023095-4dannjjm	4983	28	of	of	IN
cord-023095-4dannjjm	4983	29	S	S	NNP
cord-023095-4dannjjm	4983	30	)	)	-RRB-
cord-023095-4dannjjm	4983	31	,	,	,
cord-023095-4dannjjm	4983	32	resulting	result	VBG
cord-023095-4dannjjm	4983	33	in	in	IN
cord-023095-4dannjjm	4983	34	daily	daily	JJ
cord-023095-4dannjjm	4983	35	or	or	CC
cord-023095-4dannjjm	4983	36	each	each	DT
cord-023095-4dannjjm	4983	37	other	other	JJ
cord-023095-4dannjjm	4983	38	day	day	NN
cord-023095-4dannjjm	4983	39	vomiting	vomit	VBG
cord-023095-4dannjjm	4983	40	episodes	episode	NNS
cord-023095-4dannjjm	4983	41	in	in	IN
cord-023095-4dannjjm	4983	42	the	the	DT
cord-023095-4dannjjm	4983	43	dogs	dog	NNS
cord-023095-4dannjjm	4983	44	.	.	.
cord-023095-4dannjjm	4984	1	Ataxia	ataxia	JJ
cord-023095-4dannjjm	4984	2	,	,	,
cord-023095-4dannjjm	4984	3	seizures	seizure	NNS
cord-023095-4dannjjm	4984	4	,	,	,
cord-023095-4dannjjm	4984	5	and	and	CC
cord-023095-4dannjjm	4984	6	vomiting	vomiting	NN
cord-023095-4dannjjm	4984	7	were	be	VBD
cord-023095-4dannjjm	4984	8	previously	previously	RB
cord-023095-4dannjjm	4984	9	describe	describe	JJ
cord-023095-4dannjjm	4984	10	in	in	IN
cord-023095-4dannjjm	4984	11	dogs	dog	NNS
cord-023095-4dannjjm	4984	12	fed	feed	VBD
cord-023095-4dannjjm	4984	13	47	47	CD
cord-023095-4dannjjm	4984	14	g	g	NN
cord-023095-4dannjjm	4984	15	/	/	SYM
cord-023095-4dannjjm	4984	16	kg	kg	NN
cord-023095-4dannjjm	4984	17	of	of	IN
cord-023095-4dannjjm	4984	18	methionine	methionine	NN
cord-023095-4dannjjm	4984	19	,	,	,
cord-023095-4dannjjm	4984	20	but	but	CC
cord-023095-4dannjjm	4984	21	our	-PRON-	PRP$
cord-023095-4dannjjm	4984	22	results	result	NNS
cord-023095-4dannjjm	4984	23	suggest	suggest	VBP
cord-023095-4dannjjm	4984	24	that	that	IN
cord-023095-4dannjjm	4984	25	a	a	DT
cord-023095-4dannjjm	4984	26	much	much	RB
cord-023095-4dannjjm	4984	27	lower	low	JJR
cord-023095-4dannjjm	4984	28	value	value	NN
cord-023095-4dannjjm	4984	29	(	(	-LRB-
cord-023095-4dannjjm	4984	30	27.7	27.7	CD
cord-023095-4dannjjm	4984	31	g	g	NN
cord-023095-4dannjjm	4984	32	/	/	SYM
cord-023095-4dannjjm	4984	33	kg	kg	NNP
cord-023095-4dannjjm	4984	34	)	)	-RRB-
cord-023095-4dannjjm	4984	35	was	be	VBD
cord-023095-4dannjjm	4984	36	toxic	toxic	JJ
cord-023095-4dannjjm	4984	37	and	and	CC
cord-023095-4dannjjm	4984	38	that	that	IN
cord-023095-4dannjjm	4984	39	the	the	DT
cord-023095-4dannjjm	4984	40	safe	safe	JJ
cord-023095-4dannjjm	4984	41	upper	upper	JJ
cord-023095-4dannjjm	4984	42	limit	limit	NN
cord-023095-4dannjjm	4984	43	should	should	MD
cord-023095-4dannjjm	4984	44	be	be	VB
cord-023095-4dannjjm	4984	45	between	between	IN
cord-023095-4dannjjm	4984	46	this	this	DT
cord-023095-4dannjjm	4984	47	value	value	NN
cord-023095-4dannjjm	4984	48	and	and	CC
cord-023095-4dannjjm	4984	49	15.7	15.7	CD
cord-023095-4dannjjm	4984	50	g	g	NN
cord-023095-4dannjjm	4984	51	/	/	SYM
cord-023095-4dannjjm	4984	52	kg	kg	NNP
cord-023095-4dannjjm	4985	1	(	(	-LRB-
cord-023095-4dannjjm	4985	2	the	the	DT
cord-023095-4dannjjm	4985	3	lower	lower	RBR
cord-023095-4dannjjm	4985	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	4985	5	dose	dose	NN
cord-023095-4dannjjm	4985	6	)	)	-RRB-
cord-023095-4dannjjm	4985	7	.	.	.
cord-023095-4dannjjm	4986	1	In	in	IN
cord-023095-4dannjjm	4986	2	people	people	NNS
cord-023095-4dannjjm	4986	3	with	with	IN
cord-023095-4dannjjm	4986	4	chronic	chronic	JJ
cord-023095-4dannjjm	4986	5	kidney	kidney	NN
cord-023095-4dannjjm	4986	6	disease	disease	NN
cord-023095-4dannjjm	4986	7	and	and	CC
cord-023095-4dannjjm	4986	8	heart	heart	NN
cord-023095-4dannjjm	4986	9	failure	failure	NN
cord-023095-4dannjjm	4986	10	,	,	,
cord-023095-4dannjjm	4986	11	obesity	obesity	NN
cord-023095-4dannjjm	4986	12	is	be	VBZ
cord-023095-4dannjjm	4986	13	associated	associate	VBN
cord-023095-4dannjjm	4986	14	with	with	IN
cord-023095-4dannjjm	4986	15	longer	long	JJR
cord-023095-4dannjjm	4986	16	survival	survival	NN
cord-023095-4dannjjm	4986	17	times	time	NNS
cord-023095-4dannjjm	4986	18	.	.	.
cord-023095-4dannjjm	4987	1	This	this	DT
cord-023095-4dannjjm	4987	2	association	association	NN
cord-023095-4dannjjm	4987	3	,	,	,
cord-023095-4dannjjm	4987	4	called	call	VBD
cord-023095-4dannjjm	4987	5	the	the	DT
cord-023095-4dannjjm	4987	6	"	"	``
cord-023095-4dannjjm	4987	7	obesity	obesity	NN
cord-023095-4dannjjm	4987	8	paradox	paradox	NN
cord-023095-4dannjjm	4987	9	,	,	,
cord-023095-4dannjjm	4987	10	"	"	''
cord-023095-4dannjjm	4987	11	also	also	RB
cord-023095-4dannjjm	4987	12	has	have	VBZ
cord-023095-4dannjjm	4987	13	been	be	VBN
cord-023095-4dannjjm	4987	14	recognized	recognize	VBN
cord-023095-4dannjjm	4987	15	in	in	IN
cord-023095-4dannjjm	4987	16	dogs	dog	NNS
cord-023095-4dannjjm	4987	17	and	and	CC
cord-023095-4dannjjm	4987	18	cats	cat	NNS
cord-023095-4dannjjm	4987	19	with	with	IN
cord-023095-4dannjjm	4987	20	heart	heart	NN
cord-023095-4dannjjm	4987	21	failure	failure	NN
cord-023095-4dannjjm	4987	22	.	.	.
cord-023095-4dannjjm	4988	1	Excess	excess	JJ
cord-023095-4dannjjm	4988	2	weight	weight	NN
cord-023095-4dannjjm	4988	3	appears	appear	VBZ
cord-023095-4dannjjm	4988	4	to	to	TO
cord-023095-4dannjjm	4988	5	modulate	modulate	VB
cord-023095-4dannjjm	4988	6	the	the	DT
cord-023095-4dannjjm	4988	7	serious	serious	JJ
cord-023095-4dannjjm	4988	8	deleterious	deleterious	JJ
cord-023095-4dannjjm	4988	9	effects	effect	NNS
cord-023095-4dannjjm	4988	10	of	of	IN
cord-023095-4dannjjm	4988	11	muscle	muscle	NN
cord-023095-4dannjjm	4988	12	loss	loss	NN
cord-023095-4dannjjm	4988	13	in	in	IN
cord-023095-4dannjjm	4988	14	these	these	DT
cord-023095-4dannjjm	4988	15	diseases	disease	NNS
cord-023095-4dannjjm	4988	16	.	.	.
cord-023095-4dannjjm	4989	1	The	the	DT
cord-023095-4dannjjm	4989	2	purpose	purpose	NN
cord-023095-4dannjjm	4989	3	of	of	IN
cord-023095-4dannjjm	4989	4	this	this	DT
cord-023095-4dannjjm	4989	5	study	study	NN
cord-023095-4dannjjm	4989	6	was	be	VBD
cord-023095-4dannjjm	4989	7	to	to	TO
cord-023095-4dannjjm	4989	8	determine	determine	VB
cord-023095-4dannjjm	4989	9	the	the	DT
cord-023095-4dannjjm	4989	10	effects	effect	NNS
cord-023095-4dannjjm	4989	11	of	of	IN
cord-023095-4dannjjm	4989	12	body	body	NN
cord-023095-4dannjjm	4989	13	condition	condition	NN
cord-023095-4dannjjm	4989	14	and	and	CC
cord-023095-4dannjjm	4989	15	body	body	NN
cord-023095-4dannjjm	4989	16	weight	weight	NN
cord-023095-4dannjjm	4989	17	changes	change	NNS
cord-023095-4dannjjm	4989	18	in	in	IN
cord-023095-4dannjjm	4989	19	dogs	dog	NNS
cord-023095-4dannjjm	4989	20	with	with	IN
cord-023095-4dannjjm	4989	21	naturally	naturally	RB
cord-023095-4dannjjm	4989	22	-	-	HYPH
cord-023095-4dannjjm	4989	23	occurring	occur	VBG
cord-023095-4dannjjm	4989	24	chronic	chronic	JJ
cord-023095-4dannjjm	4989	25	kidney	kidney	NN
cord-023095-4dannjjm	4989	26	disease	disease	NN
cord-023095-4dannjjm	4989	27	(	(	-LRB-
cord-023095-4dannjjm	4989	28	CKD	CKD	NNP
cord-023095-4dannjjm	4989	29	)	)	-RRB-
cord-023095-4dannjjm	4989	30	.	.	.
cord-023095-4dannjjm	4990	1	Dogs	dog	NNS
cord-023095-4dannjjm	4990	2	diagnosed	diagnose	VBD
cord-023095-4dannjjm	4990	3	with	with	IN
cord-023095-4dannjjm	4990	4	!	!	.
cord-023095-4dannjjm	4991	1	IRIS	IRIS	NNP
cord-023095-4dannjjm	4991	2	stage	stage	NN
cord-023095-4dannjjm	4991	3	II	II	NNP
cord-023095-4dannjjm	4991	4	CKD	CKD	NNP
cord-023095-4dannjjm	4991	5	between	between	IN
cord-023095-4dannjjm	4991	6	2008	2008	CD
cord-023095-4dannjjm	4991	7	and	and	CC
cord-023095-4dannjjm	4991	8	2009	2009	CD
cord-023095-4dannjjm	4991	9	at	at	IN
cord-023095-4dannjjm	4992	1	Iowa	Iowa	NNP
cord-023095-4dannjjm	4992	2	State	State	NNP
cord-023095-4dannjjm	4992	3	University	University	NNP
cord-023095-4dannjjm	4992	4	and	and	CC
cord-023095-4dannjjm	4992	5	Tufts	Tufts	NNP
cord-023095-4dannjjm	4992	6	Cummings	Cummings	NNP
cord-023095-4dannjjm	4992	7	School	School	NNP
cord-023095-4dannjjm	4992	8	of	of	IN
cord-023095-4dannjjm	4992	9	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	4992	10	Medicine	Medicine	NNP
cord-023095-4dannjjm	4992	11	were	be	VBD
cord-023095-4dannjjm	4992	12	eligible	eligible	JJ
cord-023095-4dannjjm	4992	13	for	for	IN
cord-023095-4dannjjm	4992	14	the	the	DT
cord-023095-4dannjjm	4992	15	study	study	NN
cord-023095-4dannjjm	4992	16	.	.	.
cord-023095-4dannjjm	4993	1	Dogs	Dogs	NNP
cord-023095-4dannjjm	4993	2	o	o	NN
cord-023095-4dannjjm	4993	3	1	1	CD
cord-023095-4dannjjm	4993	4	year	year	NN
cord-023095-4dannjjm	4993	5	of	of	IN
cord-023095-4dannjjm	4993	6	age	age	NN
cord-023095-4dannjjm	4993	7	and	and	CC
cord-023095-4dannjjm	4993	8	those	those	DT
cord-023095-4dannjjm	4993	9	with	with	IN
cord-023095-4dannjjm	4993	10	acute	acute	JJ
cord-023095-4dannjjm	4993	11	renal	renal	JJ
cord-023095-4dannjjm	4993	12	failure	failure	NN
cord-023095-4dannjjm	4993	13	or	or	CC
cord-023095-4dannjjm	4993	14	suspected	suspect	VBN
cord-023095-4dannjjm	4993	15	congenital	congenital	JJ
cord-023095-4dannjjm	4993	16	renal	renal	JJ
cord-023095-4dannjjm	4993	17	diseases	disease	NNS
cord-023095-4dannjjm	4993	18	were	be	VBD
cord-023095-4dannjjm	4993	19	excluded	exclude	VBN
cord-023095-4dannjjm	4993	20	.	.	.
cord-023095-4dannjjm	4994	1	Medical	medical	JJ
cord-023095-4dannjjm	4994	2	records	record	NNS
cord-023095-4dannjjm	4994	3	were	be	VBD
cord-023095-4dannjjm	4994	4	reviewed	review	VBN
cord-023095-4dannjjm	4994	5	using	use	VBG
cord-023095-4dannjjm	4994	6	a	a	DT
cord-023095-4dannjjm	4994	7	standardized	standardized	JJ
cord-023095-4dannjjm	4994	8	data	data	NN
cord-023095-4dannjjm	4994	9	form	form	NN
cord-023095-4dannjjm	4994	10	,	,	,
cord-023095-4dannjjm	4994	11	and	and	CC
cord-023095-4dannjjm	4994	12	data	datum	NNS
cord-023095-4dannjjm	4994	13	were	be	VBD
cord-023095-4dannjjm	4994	14	collected	collect	VBN
cord-023095-4dannjjm	4994	15	for	for	IN
cord-023095-4dannjjm	4994	16	initial	initial	JJ
cord-023095-4dannjjm	4994	17	body	body	NN
cord-023095-4dannjjm	4994	18	weight	weight	NN
cord-023095-4dannjjm	4994	19	and	and	CC
cord-023095-4dannjjm	4994	20	body	body	NN
cord-023095-4dannjjm	4994	21	condition	condition	NN
cord-023095-4dannjjm	4994	22	score	score	NN
cord-023095-4dannjjm	4994	23	(	(	-LRB-
cord-023095-4dannjjm	4994	24	BCS	BCS	NNP
cord-023095-4dannjjm	4994	25	,	,	,
cord-023095-4dannjjm	4994	26	1	1	CD
cord-023095-4dannjjm	4994	27	-	-	SYM
cord-023095-4dannjjm	4994	28	9	9	CD
cord-023095-4dannjjm	4994	29	scale	scale	NN
cord-023095-4dannjjm	4994	30	)	)	-RRB-
cord-023095-4dannjjm	4994	31	,	,	,
cord-023095-4dannjjm	4994	32	clinicopathologic	clinicopathologic	JJ
cord-023095-4dannjjm	4994	33	values	value	NNS
cord-023095-4dannjjm	4994	34	,	,	,
cord-023095-4dannjjm	4994	35	changes	change	NNS
cord-023095-4dannjjm	4994	36	in	in	IN
cord-023095-4dannjjm	4994	37	body	body	NN
cord-023095-4dannjjm	4994	38	weight	weight	NN
cord-023095-4dannjjm	4994	39	and	and	CC
cord-023095-4dannjjm	4994	40	BCS	BCS	NNP
cord-023095-4dannjjm	4994	41	,	,	,
cord-023095-4dannjjm	4994	42	comorbidities	comorbiditie	NNS
cord-023095-4dannjjm	4994	43	,	,	,
cord-023095-4dannjjm	4994	44	and	and	CC
cord-023095-4dannjjm	4994	45	treatments	treatment	NNS
cord-023095-4dannjjm	4994	46	.	.	.
cord-023095-4dannjjm	4995	1	Dogs	dog	NNS
cord-023095-4dannjjm	4995	2	were	be	VBD
cord-023095-4dannjjm	4995	3	classified	classify	VBN
cord-023095-4dannjjm	4995	4	as	as	IN
cord-023095-4dannjjm	4995	5	underweight	underweight	JJ
cord-023095-4dannjjm	4995	6	(	(	-LRB-
cord-023095-4dannjjm	4995	7	BCS	BCS	NNP
cord-023095-4dannjjm	4995	8	5	5	CD
cord-023095-4dannjjm	4995	9	1	1	CD
cord-023095-4dannjjm	4995	10	-	-	SYM
cord-023095-4dannjjm	4995	11	3	3	CD
cord-023095-4dannjjm	4995	12	)	)	-RRB-
cord-023095-4dannjjm	4995	13	,	,	,
cord-023095-4dannjjm	4995	14	moderate	moderate	JJ
cord-023095-4dannjjm	4995	15	weight	weight	NN
cord-023095-4dannjjm	4995	16	(	(	-LRB-
cord-023095-4dannjjm	4995	17	BCS	BCS	NNP
cord-023095-4dannjjm	4995	18	5	5	CD
cord-023095-4dannjjm	4995	19	4	4	CD
cord-023095-4dannjjm	4995	20	-	-	SYM
cord-023095-4dannjjm	4995	21	6	6	CD
cord-023095-4dannjjm	4995	22	)	)	-RRB-
cord-023095-4dannjjm	4995	23	,	,	,
cord-023095-4dannjjm	4995	24	or	or	CC
cord-023095-4dannjjm	4995	25	overweight	overweight	JJ
cord-023095-4dannjjm	4995	26	(	(	-LRB-
cord-023095-4dannjjm	4995	27	BCS	BCS	NNP
cord-023095-4dannjjm	4995	28	5	5	CD
cord-023095-4dannjjm	4995	29	7	7	CD
cord-023095-4dannjjm	4995	30	-	-	SYM
cord-023095-4dannjjm	4995	31	9	9	CD
cord-023095-4dannjjm	4995	32	)	)	-RRB-
cord-023095-4dannjjm	4995	33	.	.	.
cord-023095-4dannjjm	4996	1	A	a	DT
cord-023095-4dannjjm	4996	2	change	change	NN
cord-023095-4dannjjm	4996	3	in	in	IN
cord-023095-4dannjjm	4996	4	body	body	NN
cord-023095-4dannjjm	4996	5	weight	weight	NN
cord-023095-4dannjjm	4996	6	was	be	VBD
cord-023095-4dannjjm	4996	7	defined	define	VBN
cord-023095-4dannjjm	4996	8	as	as	IN
cord-023095-4dannjjm	4996	9	4	4	CD
cord-023095-4dannjjm	4996	10	0.2	0.2	CD
cord-023095-4dannjjm	4996	11	kg	kg	NNS
cord-023095-4dannjjm	4996	12	.	.	.
cord-023095-4dannjjm	4997	1	Survival	survival	NN
cord-023095-4dannjjm	4997	2	times	time	NNS
cord-023095-4dannjjm	4997	3	were	be	VBD
cord-023095-4dannjjm	4997	4	determined	determine	VBN
cord-023095-4dannjjm	4997	5	for	for	IN
cord-023095-4dannjjm	4997	6	all	all	DT
cord-023095-4dannjjm	4997	7	dogs	dog	NNS
cord-023095-4dannjjm	4997	8	that	that	WDT
cord-023095-4dannjjm	4997	9	were	be	VBD
cord-023095-4dannjjm	4997	10	discharged	discharge	VBN
cord-023095-4dannjjm	4997	11	from	from	IN
cord-023095-4dannjjm	4997	12	the	the	DT
cord-023095-4dannjjm	4997	13	hospital	hospital	NN
cord-023095-4dannjjm	4997	14	and	and	CC
cord-023095-4dannjjm	4997	15	lived	live	VBD
cord-023095-4dannjjm	4997	16	4	4	CD
cord-023095-4dannjjm	4997	17	1	1	CD
cord-023095-4dannjjm	4997	18	day	day	NN
cord-023095-4dannjjm	4997	19	.	.	.
cord-023095-4dannjjm	4998	1	Associations	association	NNS
cord-023095-4dannjjm	4998	2	between	between	IN
cord-023095-4dannjjm	4998	3	survival	survival	NN
cord-023095-4dannjjm	4998	4	and	and	CC
cord-023095-4dannjjm	4998	5	BCS	BCS	NNP
cord-023095-4dannjjm	4998	6	or	or	CC
cord-023095-4dannjjm	4998	7	body	body	NN
cord-023095-4dannjjm	4998	8	weight	weight	NN
cord-023095-4dannjjm	4998	9	changes	change	NNS
cord-023095-4dannjjm	4998	10	were	be	VBD
cord-023095-4dannjjm	4998	11	analyzed	analyze	VBN
cord-023095-4dannjjm	4998	12	using	use	VBG
cord-023095-4dannjjm	4998	13	Cox	Cox	NNP
cord-023095-4dannjjm	4998	14	proportional	proportional	JJ
cord-023095-4dannjjm	4998	15	hazards	hazard	NNS
cord-023095-4dannjjm	4998	16	models	model	NNS
cord-023095-4dannjjm	4998	17	.	.	.
cord-023095-4dannjjm	4999	1	One	one	CD
cord-023095-4dannjjm	4999	2	hundred	hundred	CD
cord-023095-4dannjjm	4999	3	two	two	CD
cord-023095-4dannjjm	4999	4	dogs	dog	NNS
cord-023095-4dannjjm	4999	5	were	be	VBD
cord-023095-4dannjjm	4999	6	enrolled	enrol	VBN
cord-023095-4dannjjm	4999	7	in	in	IN
cord-023095-4dannjjm	4999	8	the	the	DT
cord-023095-4dannjjm	4999	9	study	study	NN
cord-023095-4dannjjm	4999	10	.	.	.
cord-023095-4dannjjm	5000	1	At	at	IN
cord-023095-4dannjjm	5000	2	the	the	DT
cord-023095-4dannjjm	5000	3	time	time	NN
cord-023095-4dannjjm	5000	4	of	of	IN
cord-023095-4dannjjm	5000	5	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5000	6	,	,	,
cord-023095-4dannjjm	5000	7	21	21	CD
cord-023095-4dannjjm	5000	8	dogs	dog	NNS
cord-023095-4dannjjm	5000	9	were	be	VBD
cord-023095-4dannjjm	5000	10	classified	classify	VBN
cord-023095-4dannjjm	5000	11	as	as	IN
cord-023095-4dannjjm	5000	12	IRIS	IRIS	NNP
cord-023095-4dannjjm	5000	13	Stage	Stage	NNP
cord-023095-4dannjjm	5000	14	II	II	NNP
cord-023095-4dannjjm	5000	15	,	,	,
cord-023095-4dannjjm	5000	16	57	57	CD
cord-023095-4dannjjm	5000	17	dogs	dog	NNS
cord-023095-4dannjjm	5000	18	were	be	VBD
cord-023095-4dannjjm	5000	19	Stage	Stage	NNP
cord-023095-4dannjjm	5000	20	III	III	NNP
cord-023095-4dannjjm	5000	21	and	and	CC
cord-023095-4dannjjm	5000	22	24	24	CD
cord-023095-4dannjjm	5000	23	dogs	dog	NNS
cord-023095-4dannjjm	5001	1	were	be	VBD
cord-023095-4dannjjm	5001	2	Stage	Stage	NNP
cord-023095-4dannjjm	5001	3	IV	IV	NNP
cord-023095-4dannjjm	5001	4	.	.	.
cord-023095-4dannjjm	5002	1	Median	median	JJ
cord-023095-4dannjjm	5002	2	body	body	NN
cord-023095-4dannjjm	5002	3	weight	weight	NN
cord-023095-4dannjjm	5002	4	at	at	IN
cord-023095-4dannjjm	5002	5	baseline	baseline	NN
cord-023095-4dannjjm	5002	6	was	be	VBD
cord-023095-4dannjjm	5002	7	18.7	18.7	CD
cord-023095-4dannjjm	5002	8	kg	kg	NNS
cord-023095-4dannjjm	5002	9	(	(	-LRB-
cord-023095-4dannjjm	5002	10	range	range	NN
cord-023095-4dannjjm	5002	11	,	,	,
cord-023095-4dannjjm	5002	12	2.4	2.4	CD
cord-023095-4dannjjm	5002	13	-	-	SYM
cord-023095-4dannjjm	5002	14	50.1	50.1	CD
cord-023095-4dannjjm	5002	15	kg	kg	NNS
cord-023095-4dannjjm	5002	16	)	)	-RRB-
cord-023095-4dannjjm	5002	17	.	.	.
cord-023095-4dannjjm	5003	1	For	for	IN
cord-023095-4dannjjm	5003	2	dogs	dog	NNS
cord-023095-4dannjjm	5003	3	with	with	IN
cord-023095-4dannjjm	5003	4	body	body	NN
cord-023095-4dannjjm	5003	5	condition	condition	NN
cord-023095-4dannjjm	5003	6	scores	score	NNS
cord-023095-4dannjjm	5003	7	recorded	record	VBD
cord-023095-4dannjjm	5003	8	(	(	-LRB-
cord-023095-4dannjjm	5003	9	n	n	NN
cord-023095-4dannjjm	5003	10	5	5	CD
cord-023095-4dannjjm	5003	11	74	74	CD
cord-023095-4dannjjm	5003	12	)	)	-RRB-
cord-023095-4dannjjm	5003	13	,	,	,
cord-023095-4dannjjm	5003	14	13	13	CD
cord-023095-4dannjjm	5003	15	were	be	VBD
cord-023095-4dannjjm	5003	16	underweight	underweight	JJ
cord-023095-4dannjjm	5003	17	(	(	-LRB-
cord-023095-4dannjjm	5003	18	18	18	CD
cord-023095-4dannjjm	5003	19	%	%	NN
cord-023095-4dannjjm	5003	20	)	)	-RRB-
cord-023095-4dannjjm	5003	21	,	,	,
cord-023095-4dannjjm	5003	22	51	51	CD
cord-023095-4dannjjm	5003	23	were	be	VBD
cord-023095-4dannjjm	5003	24	moderate	moderate	JJ
cord-023095-4dannjjm	5003	25	(	(	-LRB-
cord-023095-4dannjjm	5003	26	69	69	CD
cord-023095-4dannjjm	5003	27	%	%	NN
cord-023095-4dannjjm	5003	28	)	)	-RRB-
cord-023095-4dannjjm	5003	29	,	,	,
cord-023095-4dannjjm	5003	30	and	and	CC
cord-023095-4dannjjm	5003	31	10	10	CD
cord-023095-4dannjjm	5003	32	were	be	VBD
cord-023095-4dannjjm	5003	33	overweight	overweight	JJ
cord-023095-4dannjjm	5003	34	(	(	-LRB-
cord-023095-4dannjjm	5003	35	14	14	CD
cord-023095-4dannjjm	5003	36	%	%	NN
cord-023095-4dannjjm	5003	37	)	)	-RRB-
cord-023095-4dannjjm	5003	38	.	.	.
cord-023095-4dannjjm	5004	1	For	for	IN
cord-023095-4dannjjm	5004	2	dogs	dog	NNS
cord-023095-4dannjjm	5004	3	that	that	WDT
cord-023095-4dannjjm	5004	4	had	have	VBD
cord-023095-4dannjjm	5004	5	at	at	RB
cord-023095-4dannjjm	5004	6	least	least	RBS
cord-023095-4dannjjm	5004	7	two	two	CD
cord-023095-4dannjjm	5004	8	body	body	NN
cord-023095-4dannjjm	5004	9	weights	weight	NNS
cord-023095-4dannjjm	5004	10	recorded	record	VBN
cord-023095-4dannjjm	5004	11	over	over	IN
cord-023095-4dannjjm	5004	12	the	the	DT
cord-023095-4dannjjm	5004	13	course	course	NN
cord-023095-4dannjjm	5004	14	of	of	IN
cord-023095-4dannjjm	5004	15	their	-PRON-	PRP$
cord-023095-4dannjjm	5004	16	disease	disease	NN
cord-023095-4dannjjm	5004	17	,	,	,
cord-023095-4dannjjm	5004	18	22	22	CD
cord-023095-4dannjjm	5004	19	gained	gain	VBD
cord-023095-4dannjjm	5004	20	weight	weight	NN
cord-023095-4dannjjm	5004	21	,	,	,
cord-023095-4dannjjm	5004	22	46	46	CD
cord-023095-4dannjjm	5004	23	lost	lose	VBN
cord-023095-4dannjjm	5004	24	weight	weight	NN
cord-023095-4dannjjm	5004	25	,	,	,
cord-023095-4dannjjm	5004	26	and	and	CC
cord-023095-4dannjjm	5004	27	10	10	CD
cord-023095-4dannjjm	5004	28	had	have	VBD
cord-023095-4dannjjm	5004	29	no	no	DT
cord-023095-4dannjjm	5004	30	change	change	NN
cord-023095-4dannjjm	5004	31	in	in	IN
cord-023095-4dannjjm	5004	32	weight	weight	NN
cord-023095-4dannjjm	5004	33	.	.	.
cord-023095-4dannjjm	5005	1	Changes	change	NNS
cord-023095-4dannjjm	5005	2	in	in	IN
cord-023095-4dannjjm	5005	3	body	body	NN
cord-023095-4dannjjm	5005	4	weight	weight	NN
cord-023095-4dannjjm	5005	5	were	be	VBD
cord-023095-4dannjjm	5005	6	not	not	RB
cord-023095-4dannjjm	5005	7	associated	associate	VBN
cord-023095-4dannjjm	5005	8	with	with	IN
cord-023095-4dannjjm	5005	9	survival	survival	NN
cord-023095-4dannjjm	5005	10	;	;	:
cord-023095-4dannjjm	5005	11	however	however	RB
cord-023095-4dannjjm	5005	12	,	,	,
cord-023095-4dannjjm	5005	13	BCS	BCS	NNP
cord-023095-4dannjjm	5005	14	at	at	IN
cord-023095-4dannjjm	5005	15	the	the	DT
cord-023095-4dannjjm	5005	16	time	time	NN
cord-023095-4dannjjm	5005	17	of	of	IN
cord-023095-4dannjjm	5005	18	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5005	19	was	be	VBD
cord-023095-4dannjjm	5005	20	significantly	significantly	RB
cord-023095-4dannjjm	5005	21	associated	associate	VBN
cord-023095-4dannjjm	5005	22	with	with	IN
cord-023095-4dannjjm	5005	23	survival	survival	NN
cord-023095-4dannjjm	5005	24	.	.	.
cord-023095-4dannjjm	5006	1	Dogs	dog	NNS
cord-023095-4dannjjm	5006	2	classified	classify	VBD
cord-023095-4dannjjm	5006	3	as	as	IN
cord-023095-4dannjjm	5006	4	underweight	underweight	JJ
cord-023095-4dannjjm	5006	5	had	have	VBD
cord-023095-4dannjjm	5006	6	a	a	DT
cord-023095-4dannjjm	5006	7	significantly	significantly	RB
cord-023095-4dannjjm	5006	8	shorter	short	JJR
cord-023095-4dannjjm	5006	9	survival	survival	NN
cord-023095-4dannjjm	5006	10	time	time	NN
cord-023095-4dannjjm	5006	11	compared	compare	VBN
cord-023095-4dannjjm	5006	12	to	to	IN
cord-023095-4dannjjm	5006	13	both	both	CC
cord-023095-4dannjjm	5006	14	moderate	moderate	JJ
cord-023095-4dannjjm	5006	15	(	(	-LRB-
cord-023095-4dannjjm	5006	16	P	p	NN
cord-023095-4dannjjm	5006	17	o	o	NN
cord-023095-4dannjjm	5006	18	0.001	0.001	CD
cord-023095-4dannjjm	5006	19	)	)	-RRB-
cord-023095-4dannjjm	5006	20	and	and	CC
cord-023095-4dannjjm	5006	21	overweight	overweight	JJ
cord-023095-4dannjjm	5006	22	dogs	dog	NNS
cord-023095-4dannjjm	5006	23	(	(	-LRB-
cord-023095-4dannjjm	5006	24	P	p	NN
cord-023095-4dannjjm	5006	25	o	o	NN
cord-023095-4dannjjm	5006	26	0.001	0.001	CD
cord-023095-4dannjjm	5006	27	)	)	-RRB-
cord-023095-4dannjjm	5006	28	.	.	.
cord-023095-4dannjjm	5007	1	These	these	DT
cord-023095-4dannjjm	5007	2	results	result	NNS
cord-023095-4dannjjm	5007	3	suggest	suggest	VBP
cord-023095-4dannjjm	5007	4	that	that	IN
cord-023095-4dannjjm	5007	5	body	body	NN
cord-023095-4dannjjm	5007	6	condition	condition	NN
cord-023095-4dannjjm	5007	7	is	be	VBZ
cord-023095-4dannjjm	5007	8	an	an	DT
cord-023095-4dannjjm	5007	9	important	important	JJ
cord-023095-4dannjjm	5007	10	consideration	consideration	NN
cord-023095-4dannjjm	5007	11	in	in	IN
cord-023095-4dannjjm	5007	12	dogs	dog	NNS
cord-023095-4dannjjm	5007	13	with	with	IN
cord-023095-4dannjjm	5007	14	acquired	acquire	VBN
cord-023095-4dannjjm	5007	15	chronic	chronic	JJ
cord-023095-4dannjjm	5007	16	kidney	kidney	NN
cord-023095-4dannjjm	5007	17	disease	disease	NN
cord-023095-4dannjjm	5007	18	.	.	.
cord-023095-4dannjjm	5008	1	Further	further	JJ
cord-023095-4dannjjm	5008	2	studies	study	NNS
cord-023095-4dannjjm	5008	3	are	be	VBP
cord-023095-4dannjjm	5008	4	warranted	warrant	VBN
cord-023095-4dannjjm	5008	5	to	to	TO
cord-023095-4dannjjm	5008	6	evaluate	evaluate	VB
cord-023095-4dannjjm	5008	7	the	the	DT
cord-023095-4dannjjm	5008	8	relationship	relationship	NN
cord-023095-4dannjjm	5008	9	between	between	IN
cord-023095-4dannjjm	5008	10	obesity	obesity	NN
cord-023095-4dannjjm	5008	11	and	and	CC
cord-023095-4dannjjm	5008	12	longer	long	JJR
cord-023095-4dannjjm	5008	13	survival	survival	NN
cord-023095-4dannjjm	5008	14	in	in	IN
cord-023095-4dannjjm	5008	15	dogs	dog	NNS
cord-023095-4dannjjm	5008	16	with	with	IN
cord-023095-4dannjjm	5008	17	CKD	CKD	NNP
cord-023095-4dannjjm	5008	18	.	.	.
cord-023095-4dannjjm	5009	1	Protein	protein	NN
cord-023095-4dannjjm	5009	2	restriction	restriction	NN
cord-023095-4dannjjm	5009	3	is	be	VBZ
cord-023095-4dannjjm	5009	4	the	the	DT
cord-023095-4dannjjm	5009	5	cornerstone	cornerstone	NN
cord-023095-4dannjjm	5009	6	of	of	IN
cord-023095-4dannjjm	5009	7	dietary	dietary	JJ
cord-023095-4dannjjm	5009	8	management	management	NN
cord-023095-4dannjjm	5009	9	of	of	IN
cord-023095-4dannjjm	5009	10	kidney	kidney	NN
cord-023095-4dannjjm	5009	11	disease	disease	NN
cord-023095-4dannjjm	5009	12	.	.	.
cord-023095-4dannjjm	5010	1	The	the	DT
cord-023095-4dannjjm	5010	2	National	National	NNP
cord-023095-4dannjjm	5010	3	Research	Research	NNP
cord-023095-4dannjjm	5010	4	Council	Council	NNP
cord-023095-4dannjjm	5010	5	recommends	recommend	VBZ
cord-023095-4dannjjm	5010	6	20	20	CD
cord-023095-4dannjjm	5010	7	%	%	NN
cord-023095-4dannjjm	5010	8	crude	crude	JJ
cord-023095-4dannjjm	5010	9	protein	protein	NN
cord-023095-4dannjjm	5010	10	and	and	CC
cord-023095-4dannjjm	5010	11	the	the	DT
cord-023095-4dannjjm	5010	12	American	American	NNP
cord-023095-4dannjjm	5010	13	Association	Association	NNP
cord-023095-4dannjjm	5010	14	of	of	IN
cord-023095-4dannjjm	5010	15	Feed	Feed	NNP
cord-023095-4dannjjm	5010	16	Control	Control	NNP
cord-023095-4dannjjm	5010	17	Officials	Officials	NNPS
cord-023095-4dannjjm	5010	18	(	(	-LRB-
cord-023095-4dannjjm	5010	19	AAFCO	AAFCO	NNP
cord-023095-4dannjjm	5010	20	)	)	-RRB-
cord-023095-4dannjjm	5010	21	recommends	recommend	VBZ
cord-023095-4dannjjm	5010	22	a	a	DT
cord-023095-4dannjjm	5010	23	minimum	minimum	NN
cord-023095-4dannjjm	5010	24	of	of	IN
cord-023095-4dannjjm	5010	25	26	26	CD
cord-023095-4dannjjm	5010	26	%	%	NN
cord-023095-4dannjjm	5010	27	crude	crude	JJ
cord-023095-4dannjjm	5010	28	protein	protein	NN
cord-023095-4dannjjm	5010	29	for	for	IN
cord-023095-4dannjjm	5010	30	maintenance	maintenance	NN
cord-023095-4dannjjm	5010	31	for	for	IN
cord-023095-4dannjjm	5010	32	healthy	healthy	JJ
cord-023095-4dannjjm	5010	33	adult	adult	NN
cord-023095-4dannjjm	5010	34	cats	cat	NNS
cord-023095-4dannjjm	5010	35	.	.	.
cord-023095-4dannjjm	5011	1	Protein	protein	NN
cord-023095-4dannjjm	5011	2	requirement	requirement	NN
cord-023095-4dannjjm	5011	3	is	be	VBZ
cord-023095-4dannjjm	5011	4	unknown	unknown	JJ
cord-023095-4dannjjm	5011	5	for	for	IN
cord-023095-4dannjjm	5011	6	adult	adult	NN
cord-023095-4dannjjm	5011	7	cats	cat	NNS
cord-023095-4dannjjm	5011	8	with	with	IN
cord-023095-4dannjjm	5011	9	kidney	kidney	NN
cord-023095-4dannjjm	5011	10	disease	disease	NN
cord-023095-4dannjjm	5011	11	.	.	.
cord-023095-4dannjjm	5012	1	Most	most	RBS
cord-023095-4dannjjm	5012	2	commercially	commercially	RB
cord-023095-4dannjjm	5012	3	produced	produce	VBN
cord-023095-4dannjjm	5012	4	cat	cat	NN
cord-023095-4dannjjm	5012	5	foods	food	NNS
cord-023095-4dannjjm	5012	6	for	for	IN
cord-023095-4dannjjm	5012	7	adult	adult	NN
cord-023095-4dannjjm	5012	8	maintenance	maintenance	NN
cord-023095-4dannjjm	5012	9	contains	contain	VBZ
cord-023095-4dannjjm	5012	10	30	30	CD
cord-023095-4dannjjm	5012	11	%	%	NN
cord-023095-4dannjjm	5012	12	or	or	CC
cord-023095-4dannjjm	5012	13	more	more	JJR
cord-023095-4dannjjm	5012	14	crude	crude	JJ
cord-023095-4dannjjm	5012	15	protein	protein	NN
cord-023095-4dannjjm	5012	16	on	on	IN
cord-023095-4dannjjm	5012	17	a	a	DT
cord-023095-4dannjjm	5012	18	dry	dry	JJ
cord-023095-4dannjjm	5012	19	matter	matter	NN
cord-023095-4dannjjm	5012	20	basis	basis	NN
cord-023095-4dannjjm	5012	21	.	.	.
cord-023095-4dannjjm	5013	1	A	a	DT
cord-023095-4dannjjm	5013	2	typical	typical	JJ
cord-023095-4dannjjm	5013	3	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5013	4	food	food	NN
cord-023095-4dannjjm	5013	5	for	for	IN
cord-023095-4dannjjm	5013	6	cats	cat	NNS
cord-023095-4dannjjm	5013	7	with	with	IN
cord-023095-4dannjjm	5013	8	kidney	kidney	NN
cord-023095-4dannjjm	5013	9	disease	disease	NN
cord-023095-4dannjjm	5013	10	contains	contain	VBZ
cord-023095-4dannjjm	5013	11	about	about	IN
cord-023095-4dannjjm	5013	12	28	28	CD
cord-023095-4dannjjm	5013	13	%	%	NN
cord-023095-4dannjjm	5013	14	crude	crude	JJ
cord-023095-4dannjjm	5013	15	protein	protein	NN
cord-023095-4dannjjm	5013	16	.	.	.
cord-023095-4dannjjm	5014	1	The	the	DT
cord-023095-4dannjjm	5014	2	objective	objective	NN
cord-023095-4dannjjm	5014	3	of	of	IN
cord-023095-4dannjjm	5014	4	the	the	DT
cord-023095-4dannjjm	5014	5	present	present	JJ
cord-023095-4dannjjm	5014	6	study	study	NN
cord-023095-4dannjjm	5014	7	was	be	VBD
cord-023095-4dannjjm	5014	8	to	to	TO
cord-023095-4dannjjm	5014	9	investigate	investigate	VB
cord-023095-4dannjjm	5014	10	whether	whether	IN
cord-023095-4dannjjm	5014	11	dietary	dietary	JJ
cord-023095-4dannjjm	5014	12	crude	crude	JJ
cord-023095-4dannjjm	5014	13	protein	protein	NN
cord-023095-4dannjjm	5014	14	at	at	IN
cord-023095-4dannjjm	5014	15	28.5	28.5	CD
cord-023095-4dannjjm	5014	16	%	%	NN
cord-023095-4dannjjm	5014	17	would	would	MD
cord-023095-4dannjjm	5014	18	be	be	VB
cord-023095-4dannjjm	5014	19	adequate	adequate	JJ
cord-023095-4dannjjm	5014	20	for	for	IN
cord-023095-4dannjjm	5014	21	the	the	DT
cord-023095-4dannjjm	5014	22	maintenance	maintenance	NN
cord-023095-4dannjjm	5014	23	for	for	IN
cord-023095-4dannjjm	5014	24	adult	adult	NN
cord-023095-4dannjjm	5014	25	cats	cat	NNS
cord-023095-4dannjjm	5014	26	with	with	IN
cord-023095-4dannjjm	5014	27	impaired	impaired	JJ
cord-023095-4dannjjm	5014	28	kidney	kidney	NN
cord-023095-4dannjjm	5014	29	function	function	NN
cord-023095-4dannjjm	5014	30	.	.	.
cord-023095-4dannjjm	5015	1	Seven	seven	CD
cord-023095-4dannjjm	5015	2	adult	adult	NN
cord-023095-4dannjjm	5015	3	cats	cat	NNS
cord-023095-4dannjjm	5015	4	,	,	,
cord-023095-4dannjjm	5015	5	3	3	CD
cord-023095-4dannjjm	5015	6	female	female	NN
cord-023095-4dannjjm	5015	7	and	and	CC
cord-023095-4dannjjm	5015	8	4	4	CD
cord-023095-4dannjjm	5015	9	male	male	NN
cord-023095-4dannjjm	5015	10	,	,	,
cord-023095-4dannjjm	5015	11	with	with	IN
cord-023095-4dannjjm	5015	12	age	age	NN
cord-023095-4dannjjm	5015	13	ranging	range	VBG
cord-023095-4dannjjm	5015	14	from	from	IN
cord-023095-4dannjjm	5015	15	5	5	CD
cord-023095-4dannjjm	5015	16	to	to	IN
cord-023095-4dannjjm	5015	17	13.7	13.7	CD
cord-023095-4dannjjm	5015	18	years	year	NNS
cord-023095-4dannjjm	5015	19	old	old	JJ
cord-023095-4dannjjm	5015	20	(	(	-LRB-
cord-023095-4dannjjm	5015	21	mean	mean	VB
cord-023095-4dannjjm	5015	22	:	:	:
cord-023095-4dannjjm	5015	23	8.1	8.1	CD
cord-023095-4dannjjm	5015	24	years	year	NNS
cord-023095-4dannjjm	5015	25	)	)	-RRB-
cord-023095-4dannjjm	5015	26	were	be	VBD
cord-023095-4dannjjm	5015	27	used	use	VBN
cord-023095-4dannjjm	5015	28	in	in	IN
cord-023095-4dannjjm	5015	29	the	the	DT
cord-023095-4dannjjm	5015	30	study	study	NN
cord-023095-4dannjjm	5015	31	.	.	.
cord-023095-4dannjjm	5016	1	All	all	DT
cord-023095-4dannjjm	5016	2	cats	cat	NNS
cord-023095-4dannjjm	5016	3	had	have	VBD
cord-023095-4dannjjm	5016	4	elevated	elevate	VBN
cord-023095-4dannjjm	5016	5	serum	serum	NN
cord-023095-4dannjjm	5016	6	creatinine	creatinine	NN
cord-023095-4dannjjm	5016	7	concentration	concentration	NN
cord-023095-4dannjjm	5016	8	(	(	-LRB-
cord-023095-4dannjjm	5016	9	4	4	CD
cord-023095-4dannjjm	5016	10	1.6	1.6	CD
cord-023095-4dannjjm	5016	11	mg	mg	NNP
cord-023095-4dannjjm	5016	12	/	/	SYM
cord-023095-4dannjjm	5016	13	dl	dl	NN
cord-023095-4dannjjm	5016	14	,	,	,
cord-023095-4dannjjm	5016	15	range	range	NN
cord-023095-4dannjjm	5016	16	:	:	:
cord-023095-4dannjjm	5016	17	1.61	1.61	CD
cord-023095-4dannjjm	5016	18	-	-	SYM
cord-023095-4dannjjm	5016	19	2.10	2.10	CD
cord-023095-4dannjjm	5016	20	mg	mg	NNP
cord-023095-4dannjjm	5016	21	/	/	SYM
cord-023095-4dannjjm	5016	22	dl	dl	NNP
cord-023095-4dannjjm	5016	23	)	)	-RRB-
cord-023095-4dannjjm	5016	24	and	and	CC
cord-023095-4dannjjm	5016	25	reduced	reduce	VBN
cord-023095-4dannjjm	5016	26	glomerula	glomerula	JJ
cord-023095-4dannjjm	5016	27	filtration	filtration	NN
cord-023095-4dannjjm	5016	28	rate	rate	NN
cord-023095-4dannjjm	5016	29	(	(	-LRB-
cord-023095-4dannjjm	5016	30	mean	mean	VB
cord-023095-4dannjjm	5016	31	:	:	:
cord-023095-4dannjjm	5016	32	32	32	CD
cord-023095-4dannjjm	5016	33	%	%	NN
cord-023095-4dannjjm	5016	34	reduction	reduction	NN
cord-023095-4dannjjm	5016	35	;	;	:
cord-023095-4dannjjm	5016	36	range	range	NN
cord-023095-4dannjjm	5016	37	:	:	:
cord-023095-4dannjjm	5016	38	12	12	CD
cord-023095-4dannjjm	5016	39	-	-	SYM
cord-023095-4dannjjm	5016	40	60	60	CD
cord-023095-4dannjjm	5016	41	%	%	NN
cord-023095-4dannjjm	5016	42	reduction	reduction	NN
cord-023095-4dannjjm	5016	43	)	)	-RRB-
cord-023095-4dannjjm	5016	44	during	during	IN
cord-023095-4dannjjm	5016	45	the	the	DT
cord-023095-4dannjjm	5016	46	study	study	NN
cord-023095-4dannjjm	5016	47	.	.	.
cord-023095-4dannjjm	5017	1	They	-PRON-	PRP
cord-023095-4dannjjm	5017	2	did	do	VBD
cord-023095-4dannjjm	5017	3	not	not	RB
cord-023095-4dannjjm	5017	4	have	have	VB
cord-023095-4dannjjm	5017	5	other	other	JJ
cord-023095-4dannjjm	5017	6	systematic	systematic	JJ
cord-023095-4dannjjm	5017	7	diseases	disease	NNS
cord-023095-4dannjjm	5017	8	,	,	,
cord-023095-4dannjjm	5017	9	e.g.	e.g.	RB
cord-023095-4dannjjm	5017	10	,	,	,
cord-023095-4dannjjm	5017	11	hyperthyroidism	hyperthyroidism	NN
cord-023095-4dannjjm	5017	12	,	,	,
cord-023095-4dannjjm	5017	13	at	at	IN
cord-023095-4dannjjm	5017	14	the	the	DT
cord-023095-4dannjjm	5017	15	beginning	beginning	NN
cord-023095-4dannjjm	5017	16	of	of	IN
cord-023095-4dannjjm	5017	17	the	the	DT
cord-023095-4dannjjm	5017	18	study	study	NN
cord-023095-4dannjjm	5017	19	.	.	.
cord-023095-4dannjjm	5018	1	Cats	cat	NNS
cord-023095-4dannjjm	5018	2	were	be	VBD
cord-023095-4dannjjm	5018	3	fed	feed	VBN
cord-023095-4dannjjm	5018	4	an	an	DT
cord-023095-4dannjjm	5018	5	expanded	expand	VBN
cord-023095-4dannjjm	5018	6	dry	dry	JJ
cord-023095-4dannjjm	5018	7	food	food	NN
cord-023095-4dannjjm	5018	8	made	make	VBN
cord-023095-4dannjjm	5018	9	with	with	IN
cord-023095-4dannjjm	5018	10	ingredients	ingredient	NNS
cord-023095-4dannjjm	5018	11	commonly	commonly	RB
cord-023095-4dannjjm	5018	12	used	use	VBN
cord-023095-4dannjjm	5018	13	in	in	IN
cord-023095-4dannjjm	5018	14	commercial	commercial	JJ
cord-023095-4dannjjm	5018	15	dry	dry	JJ
cord-023095-4dannjjm	5018	16	cat	cat	NN
cord-023095-4dannjjm	5018	17	foods	food	NNS
cord-023095-4dannjjm	5018	18	.	.	.
cord-023095-4dannjjm	5019	1	The	the	DT
cord-023095-4dannjjm	5019	2	food	food	NN
cord-023095-4dannjjm	5019	3	contained	contain	VBD
cord-023095-4dannjjm	5019	4	28.5	28.5	CD
cord-023095-4dannjjm	5019	5	%	%	NN
cord-023095-4dannjjm	5019	6	crude	crude	JJ
cord-023095-4dannjjm	5019	7	protein	protein	NN
cord-023095-4dannjjm	5019	8	(	(	-LRB-
cord-023095-4dannjjm	5019	9	chemical	chemical	NN
cord-023095-4dannjjm	5019	10	analysis	analysis	NN
cord-023095-4dannjjm	5019	11	)	)	-RRB-
cord-023095-4dannjjm	5019	12	and	and	CC
cord-023095-4dannjjm	5019	13	4366	4366	CD
cord-023095-4dannjjm	5019	14	kcal	kcal	NNP
cord-023095-4dannjjm	5019	15	/	/	SYM
cord-023095-4dannjjm	5019	16	kg	kg	NNP
cord-023095-4dannjjm	5019	17	(	(	-LRB-
cord-023095-4dannjjm	5019	18	calculated	calculate	VBN
cord-023095-4dannjjm	5019	19	)	)	-RRB-
cord-023095-4dannjjm	5019	20	on	on	IN
cord-023095-4dannjjm	5019	21	a	a	DT
cord-023095-4dannjjm	5019	22	dry	dry	JJ
cord-023095-4dannjjm	5019	23	matter	matter	NN
cord-023095-4dannjjm	5019	24	basis	basis	NN
cord-023095-4dannjjm	5019	25	,	,	,
cord-023095-4dannjjm	5019	26	or	or	CC
cord-023095-4dannjjm	5019	27	65.3	65.3	CD
cord-023095-4dannjjm	5019	28	g	g	NN
cord-023095-4dannjjm	5019	29	protein/1000	protein/1000	NNS
cord-023095-4dannjjm	5019	30	kcal	kcal	NNP
cord-023095-4dannjjm	5019	31	.	.	.
cord-023095-4dannjjm	5020	1	Each	each	DT
cord-023095-4dannjjm	5020	2	essential	essential	JJ
cord-023095-4dannjjm	5020	3	amino	amino	NN
cord-023095-4dannjjm	5020	4	acid	acid	NN
cord-023095-4dannjjm	5020	5	in	in	IN
cord-023095-4dannjjm	5020	6	the	the	DT
cord-023095-4dannjjm	5020	7	food	food	NN
cord-023095-4dannjjm	5020	8	was	be	VBD
cord-023095-4dannjjm	5020	9	at	at	RB
cord-023095-4dannjjm	5020	10	least	least	RBS
cord-023095-4dannjjm	5020	11	130	130	CD
cord-023095-4dannjjm	5020	12	%	%	NN
cord-023095-4dannjjm	5020	13	of	of	IN
cord-023095-4dannjjm	5020	14	that	that	DT
cord-023095-4dannjjm	5020	15	recommended	recommend	VBN
cord-023095-4dannjjm	5020	16	by	by	IN
cord-023095-4dannjjm	5020	17	AAFCO	AAFCO	NNP
cord-023095-4dannjjm	5020	18	.	.	.
cord-023095-4dannjjm	5021	1	Other	other	JJ
cord-023095-4dannjjm	5021	2	nutrients	nutrient	NNS
cord-023095-4dannjjm	5021	3	in	in	IN
cord-023095-4dannjjm	5021	4	the	the	DT
cord-023095-4dannjjm	5021	5	food	food	NN
cord-023095-4dannjjm	5021	6	also	also	RB
cord-023095-4dannjjm	5021	7	exceeded	exceed	VBD
cord-023095-4dannjjm	5021	8	AAFCO	AAFCO	NNP
cord-023095-4dannjjm	5021	9	's	's	POS
cord-023095-4dannjjm	5021	10	recommendations	recommendation	NNS
cord-023095-4dannjjm	5021	11	for	for	IN
cord-023095-4dannjjm	5021	12	maintenance	maintenance	NN
cord-023095-4dannjjm	5021	13	for	for	IN
cord-023095-4dannjjm	5021	14	adult	adult	NN
cord-023095-4dannjjm	5021	15	cats	cat	NNS
cord-023095-4dannjjm	5021	16	.	.	.
cord-023095-4dannjjm	5022	1	Cats	cat	NNS
cord-023095-4dannjjm	5022	2	were	be	VBD
cord-023095-4dannjjm	5022	3	fed	feed	VBN
cord-023095-4dannjjm	5022	4	the	the	DT
cord-023095-4dannjjm	5022	5	food	food	NN
cord-023095-4dannjjm	5022	6	for	for	IN
cord-023095-4dannjjm	5022	7	30	30	CD
cord-023095-4dannjjm	5022	8	weeks	week	NNS
cord-023095-4dannjjm	5022	9	.	.	.
cord-023095-4dannjjm	5023	1	Lean	lean	JJ
cord-023095-4dannjjm	5023	2	body	body	NN
cord-023095-4dannjjm	5023	3	mass	mass	NN
cord-023095-4dannjjm	5023	4	(	(	-LRB-
cord-023095-4dannjjm	5023	5	dual	dual	NNP
cord-023095-4dannjjm	5023	6	x	x	NN
cord-023095-4dannjjm	5023	7	-	-	NN
cord-023095-4dannjjm	5023	8	ray	ray	NNP
cord-023095-4dannjjm	5023	9	absorptionmetry	absorptionmetry	NN
cord-023095-4dannjjm	5023	10	;	;	:
cord-023095-4dannjjm	5023	11	Hologic	Hologic	NNP
cord-023095-4dannjjm	5023	12	,	,	,
cord-023095-4dannjjm	5023	13	Hologic	Hologic	NNP
cord-023095-4dannjjm	5023	14	,	,	,
cord-023095-4dannjjm	5023	15	Inc	Inc	NNP
cord-023095-4dannjjm	5023	16	,	,	,
cord-023095-4dannjjm	5023	17	MA	MA	NNP
cord-023095-4dannjjm	5023	18	)	)	-RRB-
cord-023095-4dannjjm	5023	19	and	and	CC
cord-023095-4dannjjm	5023	20	serum	serum	NN
cord-023095-4dannjjm	5023	21	albumin	albumin	NN
cord-023095-4dannjjm	5023	22	concentration	concentration	NN
cord-023095-4dannjjm	5023	23	were	be	VBD
cord-023095-4dannjjm	5023	24	measured	measure	VBN
cord-023095-4dannjjm	5023	25	periodically	periodically	RB
cord-023095-4dannjjm	5023	26	to	to	TO
cord-023095-4dannjjm	5023	27	monitor	monitor	VB
cord-023095-4dannjjm	5023	28	protein	protein	NN
cord-023095-4dannjjm	5023	29	status	status	NN
cord-023095-4dannjjm	5023	30	of	of	IN
cord-023095-4dannjjm	5023	31	cats	cat	NNS
cord-023095-4dannjjm	5023	32	.	.	.
cord-023095-4dannjjm	5024	1	The	the	DT
cord-023095-4dannjjm	5024	2	average	average	JJ
cord-023095-4dannjjm	5024	3	lean	lean	JJ
cord-023095-4dannjjm	5024	4	body	body	NN
cord-023095-4dannjjm	5024	5	mass	mass	NN
cord-023095-4dannjjm	5024	6	(	(	-LRB-
cord-023095-4dannjjm	5024	7	mean	mean	VB
cord-023095-4dannjjm	5024	8	AE	AE	NNP
cord-023095-4dannjjm	5024	9	SD	SD	NNP
cord-023095-4dannjjm	5024	10	)	)	-RRB-
cord-023095-4dannjjm	5024	11	was	be	VBD
cord-023095-4dannjjm	5024	12	3.63	3.63	CD
cord-023095-4dannjjm	5024	13	AE	AE	NNP
cord-023095-4dannjjm	5024	14	0.82	0.82	CD
cord-023095-4dannjjm	5024	15	kg	kg	NN
cord-023095-4dannjjm	5024	16	,	,	,
cord-023095-4dannjjm	5024	17	3.72	3.72	CD
cord-023095-4dannjjm	5024	18	AE	AE	NNP
cord-023095-4dannjjm	5024	19	0.85	0.85	CD
cord-023095-4dannjjm	5024	20	kg	kg	NNS
cord-023095-4dannjjm	5024	21	,	,	,
cord-023095-4dannjjm	5024	22	3.74	3.74	CD
cord-023095-4dannjjm	5024	23	AE	AE	NNP
cord-023095-4dannjjm	5024	24	0.84	0.84	CD
cord-023095-4dannjjm	5024	25	kg	kg	NNS
cord-023095-4dannjjm	5024	26	,	,	,
cord-023095-4dannjjm	5024	27	and	and	CC
cord-023095-4dannjjm	5024	28	3.75	3.75	CD
cord-023095-4dannjjm	5024	29	AE	AE	NNP
cord-023095-4dannjjm	5024	30	0.89	0.89	CD
cord-023095-4dannjjm	5024	31	kg	kg	NNS
cord-023095-4dannjjm	5024	32	in	in	IN
cord-023095-4dannjjm	5024	33	weeks	week	NNS
cord-023095-4dannjjm	5024	34	3	3	CD
cord-023095-4dannjjm	5024	35	,	,	,
cord-023095-4dannjjm	5024	36	11	11	CD
cord-023095-4dannjjm	5024	37	,	,	,
cord-023095-4dannjjm	5024	38	17	17	CD
cord-023095-4dannjjm	5024	39	,	,	,
cord-023095-4dannjjm	5024	40	and	and	CC
cord-023095-4dannjjm	5024	41	30	30	CD
cord-023095-4dannjjm	5024	42	of	of	IN
cord-023095-4dannjjm	5024	43	the	the	DT
cord-023095-4dannjjm	5024	44	study	study	NN
cord-023095-4dannjjm	5024	45	,	,	,
cord-023095-4dannjjm	5024	46	respectively	respectively	RB
cord-023095-4dannjjm	5024	47	.	.	.
cord-023095-4dannjjm	5025	1	Paired	paired	JJ
cord-023095-4dannjjm	5025	2	t	t	NN
cord-023095-4dannjjm	5025	3	-	-	HYPH
cord-023095-4dannjjm	5025	4	test	test	NN
cord-023095-4dannjjm	5025	5	did	do	VBD
cord-023095-4dannjjm	5025	6	not	not	RB
cord-023095-4dannjjm	5025	7	detect	detect	VB
cord-023095-4dannjjm	5025	8	statistical	statistical	JJ
cord-023095-4dannjjm	5025	9	difference	difference	NN
cord-023095-4dannjjm	5025	10	(	(	-LRB-
cord-023095-4dannjjm	5025	11	p	p	NN
cord-023095-4dannjjm	5025	12	4	4	CD
cord-023095-4dannjjm	5025	13	0.05	0.05	CD
cord-023095-4dannjjm	5025	14	)	)	-RRB-
cord-023095-4dannjjm	5025	15	when	when	WRB
cord-023095-4dannjjm	5025	16	comparing	compare	VBG
cord-023095-4dannjjm	5025	17	the	the	DT
cord-023095-4dannjjm	5025	18	lean	lean	JJ
cord-023095-4dannjjm	5025	19	body	body	NN
cord-023095-4dannjjm	5025	20	mass	mass	NN
cord-023095-4dannjjm	5025	21	in	in	IN
cord-023095-4dannjjm	5025	22	weeks	week	NNS
cord-023095-4dannjjm	5025	23	3	3	CD
cord-023095-4dannjjm	5025	24	versus	versus	IN
cord-023095-4dannjjm	5025	25	weeks	week	NNS
cord-023095-4dannjjm	5025	26	11	11	CD
cord-023095-4dannjjm	5025	27	,	,	,
cord-023095-4dannjjm	5025	28	17	17	CD
cord-023095-4dannjjm	5025	29	,	,	,
cord-023095-4dannjjm	5025	30	and	and	CC
cord-023095-4dannjjm	5025	31	30	30	CD
cord-023095-4dannjjm	5025	32	,	,	,
cord-023095-4dannjjm	5025	33	respectively	respectively	RB
cord-023095-4dannjjm	5025	34	.	.	.
cord-023095-4dannjjm	5026	1	Serum	serum	NN
cord-023095-4dannjjm	5026	2	albumin	albumin	NN
cord-023095-4dannjjm	5026	3	concentration	concentration	NN
cord-023095-4dannjjm	5026	4	were	be	VBD
cord-023095-4dannjjm	5026	5	within	within	IN
cord-023095-4dannjjm	5026	6	the	the	DT
cord-023095-4dannjjm	5026	7	normal	normal	JJ
cord-023095-4dannjjm	5026	8	reference	reference	NN
cord-023095-4dannjjm	5026	9	range	range	NN
cord-023095-4dannjjm	5026	10	during	during	IN
cord-023095-4dannjjm	5026	11	the	the	DT
cord-023095-4dannjjm	5026	12	study	study	NN
cord-023095-4dannjjm	5026	13	(	(	-LRB-
cord-023095-4dannjjm	5026	14	mean	mean	VB
cord-023095-4dannjjm	5026	15	AE	AE	NNP
cord-023095-4dannjjm	5026	16	SD	SD	NNP
cord-023095-4dannjjm	5026	17	:	:	:
cord-023095-4dannjjm	5026	18	3.04	3.04	CD
cord-023095-4dannjjm	5026	19	AE	AE	NNP
cord-023095-4dannjjm	5026	20	0.35	0.35	CD
cord-023095-4dannjjm	5026	21	%	%	NN
cord-023095-4dannjjm	5026	22	,	,	,
cord-023095-4dannjjm	5026	23	2.80	2.80	CD
cord-023095-4dannjjm	5026	24	AE	AE	NNP
cord-023095-4dannjjm	5026	25	0.35	0.35	CD
cord-023095-4dannjjm	5026	26	%	%	NN
cord-023095-4dannjjm	5026	27	,	,	,
cord-023095-4dannjjm	5026	28	3.04	3.04	CD
cord-023095-4dannjjm	5026	29	AE	AE	NNP
cord-023095-4dannjjm	5026	30	0.32	0.32	CD
cord-023095-4dannjjm	5026	31	%	%	NN
cord-023095-4dannjjm	5026	32	,	,	,
cord-023095-4dannjjm	5026	33	and	and	CC
cord-023095-4dannjjm	5026	34	3.07	3.07	CD
cord-023095-4dannjjm	5026	35	AE	AE	NNP
cord-023095-4dannjjm	5026	36	0.40	0.40	CD
cord-023095-4dannjjm	5026	37	%	%	NN
cord-023095-4dannjjm	5026	38	in	in	IN
cord-023095-4dannjjm	5026	39	weeks	week	NNS
cord-023095-4dannjjm	5026	40	3	3	CD
cord-023095-4dannjjm	5026	41	,	,	,
cord-023095-4dannjjm	5026	42	11	11	CD
cord-023095-4dannjjm	5026	43	,	,	,
cord-023095-4dannjjm	5026	44	17	17	CD
cord-023095-4dannjjm	5026	45	,	,	,
cord-023095-4dannjjm	5026	46	and	and	CC
cord-023095-4dannjjm	5026	47	30	30	CD
cord-023095-4dannjjm	5026	48	,	,	,
cord-023095-4dannjjm	5026	49	respectively	respectively	RB
cord-023095-4dannjjm	5026	50	)	)	-RRB-
cord-023095-4dannjjm	5026	51	.	.	.
cord-023095-4dannjjm	5027	1	These	these	DT
cord-023095-4dannjjm	5027	2	data	datum	NNS
cord-023095-4dannjjm	5027	3	show	show	VBP
cord-023095-4dannjjm	5027	4	that	that	IN
cord-023095-4dannjjm	5027	5	28.5	28.5	CD
cord-023095-4dannjjm	5027	6	%	%	NN
cord-023095-4dannjjm	5027	7	dietary	dietary	JJ
cord-023095-4dannjjm	5027	8	crude	crude	JJ
cord-023095-4dannjjm	5027	9	protein	protein	NN
cord-023095-4dannjjm	5027	10	in	in	IN
cord-023095-4dannjjm	5027	11	a	a	DT
cord-023095-4dannjjm	5027	12	dry	dry	JJ
cord-023095-4dannjjm	5027	13	food	food	NN
cord-023095-4dannjjm	5027	14	with	with	IN
cord-023095-4dannjjm	5027	15	4366	4366	CD
cord-023095-4dannjjm	5027	16	kcal	kcal	NNP
cord-023095-4dannjjm	5027	17	/	/	SYM
cord-023095-4dannjjm	5027	18	kg	kg	NNS
cord-023095-4dannjjm	5027	19	on	on	IN
cord-023095-4dannjjm	5027	20	a	a	DT
cord-023095-4dannjjm	5027	21	dry	dry	JJ
cord-023095-4dannjjm	5027	22	matter	matter	NN
cord-023095-4dannjjm	5027	23	basis	basis	NN
cord-023095-4dannjjm	5027	24	,	,	,
cord-023095-4dannjjm	5027	25	or	or	CC
cord-023095-4dannjjm	5027	26	65.3	65.3	CD
cord-023095-4dannjjm	5027	27	g	g	NN
cord-023095-4dannjjm	5027	28	protein/1000	protein/1000	NNS
cord-023095-4dannjjm	5027	29	kcal	kcal	NNP
cord-023095-4dannjjm	5027	30	,	,	,
cord-023095-4dannjjm	5027	31	is	be	VBZ
cord-023095-4dannjjm	5027	32	adequate	adequate	JJ
cord-023095-4dannjjm	5027	33	for	for	IN
cord-023095-4dannjjm	5027	34	maintenance	maintenance	NN
cord-023095-4dannjjm	5027	35	for	for	IN
cord-023095-4dannjjm	5027	36	cats	cat	NNS
cord-023095-4dannjjm	5027	37	with	with	IN
cord-023095-4dannjjm	5027	38	impaired	impaired	JJ
cord-023095-4dannjjm	5027	39	kidney	kidney	NN
cord-023095-4dannjjm	5027	40	function	function	NN
cord-023095-4dannjjm	5027	41	.	.	.
cord-023095-4dannjjm	5028	1	In	in	IN
cord-023095-4dannjjm	5028	2	humans	human	NNS
cord-023095-4dannjjm	5028	3	,	,	,
cord-023095-4dannjjm	5028	4	several	several	JJ
cord-023095-4dannjjm	5028	5	disease	disease	NN
cord-023095-4dannjjm	5028	6	conditions	condition	NNS
cord-023095-4dannjjm	5028	7	exist	exist	VBP
cord-023095-4dannjjm	5028	8	that	that	WDT
cord-023095-4dannjjm	5028	9	involve	involve	VBP
cord-023095-4dannjjm	5028	10	abnormal	abnormal	JJ
cord-023095-4dannjjm	5028	11	patterns	pattern	NNS
cord-023095-4dannjjm	5028	12	of	of	IN
cord-023095-4dannjjm	5028	13	polyunsaturated	polyunsaturated	JJ
cord-023095-4dannjjm	5028	14	fatty	fatty	JJ
cord-023095-4dannjjm	5028	15	acids	acid	NNS
cord-023095-4dannjjm	5028	16	and	and	CC
cord-023095-4dannjjm	5028	17	similar	similar	JJ
cord-023095-4dannjjm	5028	18	abnormalities	abnormality	NNS
cord-023095-4dannjjm	5028	19	may	may	MD
cord-023095-4dannjjm	5028	20	be	be	VB
cord-023095-4dannjjm	5028	21	present	present	JJ
cord-023095-4dannjjm	5028	22	in	in	IN
cord-023095-4dannjjm	5028	23	companion	companion	NN
cord-023095-4dannjjm	5028	24	animals	animal	NNS
cord-023095-4dannjjm	5028	25	.	.	.
cord-023095-4dannjjm	5029	1	Indeed	indeed	RB
cord-023095-4dannjjm	5029	2	there	there	EX
cord-023095-4dannjjm	5029	3	have	have	VBP
cord-023095-4dannjjm	5029	4	been	be	VBN
cord-023095-4dannjjm	5029	5	reports	report	NNS
cord-023095-4dannjjm	5029	6	of	of	IN
cord-023095-4dannjjm	5029	7	decreased	decrease	VBN
cord-023095-4dannjjm	5029	8	plasma	plasma	NN
cord-023095-4dannjjm	5029	9	arachidonic	arachidonic	NN
cord-023095-4dannjjm	5029	10	acid	acid	NN
cord-023095-4dannjjm	5029	11	and	and	CC
cord-023095-4dannjjm	5029	12	reduced	reduce	VBN
cord-023095-4dannjjm	5029	13	delta-6	delta-6	NNP
cord-023095-4dannjjm	5029	14	desaturase	desaturase	NN
cord-023095-4dannjjm	5029	15	activities	activity	NNS
cord-023095-4dannjjm	5029	16	in	in	IN
cord-023095-4dannjjm	5029	17	dogs	dog	NNS
cord-023095-4dannjjm	5029	18	with	with	IN
cord-023095-4dannjjm	5029	19	atopy	atopy	NN
cord-023095-4dannjjm	5029	20	and	and	CC
cord-023095-4dannjjm	5029	21	other	other	JJ
cord-023095-4dannjjm	5029	22	skin	skin	NN
cord-023095-4dannjjm	5029	23	disorders	disorder	NNS
cord-023095-4dannjjm	5029	24	.	.	.
cord-023095-4dannjjm	5030	1	The	the	DT
cord-023095-4dannjjm	5030	2	present	present	JJ
cord-023095-4dannjjm	5030	3	study	study	NN
cord-023095-4dannjjm	5030	4	investigated	investigate	VBD
cord-023095-4dannjjm	5030	5	serum	serum	JJ
cord-023095-4dannjjm	5030	6	fatty	fatty	JJ
cord-023095-4dannjjm	5030	7	acid	acid	NN
cord-023095-4dannjjm	5030	8	profiles	profile	NNS
cord-023095-4dannjjm	5030	9	in	in	IN
cord-023095-4dannjjm	5030	10	dogs	dog	NNS
cord-023095-4dannjjm	5030	11	and	and	CC
cord-023095-4dannjjm	5030	12	cats	cat	NNS
cord-023095-4dannjjm	5030	13	presented	present	VBN
cord-023095-4dannjjm	5030	14	to	to	IN
cord-023095-4dannjjm	5030	15	the	the	DT
cord-023095-4dannjjm	5030	16	Texas	Texas	NNP
cord-023095-4dannjjm	5030	17	A&M	A&M	NNP
cord-023095-4dannjjm	5030	18	University	University	NNP
cord-023095-4dannjjm	5030	19	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	5030	20	Teaching	Teaching	NNP
cord-023095-4dannjjm	5030	21	Hospital	Hospital	NNP
cord-023095-4dannjjm	5030	22	,	,	,
cord-023095-4dannjjm	5030	23	Clinical	Clinical	NNP
cord-023095-4dannjjm	5030	24	Pathology	Pathology	NNP
cord-023095-4dannjjm	5030	25	Laboratory	Laboratory	NNP
cord-023095-4dannjjm	5030	26	over	over	IN
cord-023095-4dannjjm	5030	27	the	the	DT
cord-023095-4dannjjm	5030	28	past	past	JJ
cord-023095-4dannjjm	5030	29	one	one	CD
cord-023095-4dannjjm	5030	30	year	year	NN
cord-023095-4dannjjm	5030	31	period	period	NN
cord-023095-4dannjjm	5030	32	.	.	.
cord-023095-4dannjjm	5031	1	Results	result	NNS
cord-023095-4dannjjm	5031	2	were	be	VBD
cord-023095-4dannjjm	5031	3	compared	compare	VBN
cord-023095-4dannjjm	5031	4	with	with	IN
cord-023095-4dannjjm	5031	5	normative	normative	JJ
cord-023095-4dannjjm	5031	6	data	datum	NNS
cord-023095-4dannjjm	5031	7	generated	generate	VBN
cord-023095-4dannjjm	5031	8	among	among	IN
cord-023095-4dannjjm	5031	9	dogs	dog	NNS
cord-023095-4dannjjm	5031	10	and	and	CC
cord-023095-4dannjjm	5031	11	cats	cat	NNS
cord-023095-4dannjjm	5031	12	from	from	IN
cord-023095-4dannjjm	5031	13	earlier	early	JJR
cord-023095-4dannjjm	5031	14	feeding	feeding	NN
cord-023095-4dannjjm	5031	15	studies	study	NNS
cord-023095-4dannjjm	5031	16	.	.	.
cord-023095-4dannjjm	5032	1	Sera	Sera	NNP
cord-023095-4dannjjm	5032	2	used	use	VBD
cord-023095-4dannjjm	5032	3	were	be	VBD
cord-023095-4dannjjm	5032	4	residual	residual	JJ
cord-023095-4dannjjm	5032	5	samples	sample	NNS
cord-023095-4dannjjm	5032	6	submitted	submit	VBN
cord-023095-4dannjjm	5032	7	to	to	IN
cord-023095-4dannjjm	5032	8	the	the	DT
cord-023095-4dannjjm	5032	9	laboratory	laboratory	NN
cord-023095-4dannjjm	5032	10	for	for	IN
cord-023095-4dannjjm	5032	11	other	other	JJ
cord-023095-4dannjjm	5032	12	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	5032	13	procedures	procedure	NNS
cord-023095-4dannjjm	5032	14	and	and	CC
cord-023095-4dannjjm	5032	15	stored	store	VBD
cord-023095-4dannjjm	5032	16	frozen	frozen	JJ
cord-023095-4dannjjm	5032	17	for	for	IN
cord-023095-4dannjjm	5032	18	no	no	DT
cord-023095-4dannjjm	5032	19	more	more	JJR
cord-023095-4dannjjm	5032	20	than	than	IN
cord-023095-4dannjjm	5032	21	2	2	CD
cord-023095-4dannjjm	5032	22	months	month	NNS
cord-023095-4dannjjm	5032	23	after	after	IN
cord-023095-4dannjjm	5032	24	collection	collection	NN
cord-023095-4dannjjm	5032	25	.	.	.
cord-023095-4dannjjm	5033	1	The	the	DT
cord-023095-4dannjjm	5033	2	samples	sample	NNS
cord-023095-4dannjjm	5033	3	were	be	VBD
cord-023095-4dannjjm	5033	4	grouped	group	VBN
cord-023095-4dannjjm	5033	5	according	accord	VBG
cord-023095-4dannjjm	5033	6	to	to	IN
cord-023095-4dannjjm	5033	7	presenting	present	VBG
cord-023095-4dannjjm	5033	8	disorders	disorder	NNS
cord-023095-4dannjjm	5033	9	involving	involve	VBG
cord-023095-4dannjjm	5033	10	liver	liver	NN
cord-023095-4dannjjm	5033	11	,	,	,
cord-023095-4dannjjm	5033	12	kidney	kidney	NN
cord-023095-4dannjjm	5033	13	,	,	,
cord-023095-4dannjjm	5033	14	digestive	digestive	JJ
cord-023095-4dannjjm	5033	15	,	,	,
cord-023095-4dannjjm	5033	16	and	and	CC
cord-023095-4dannjjm	5033	17	cardiac	cardiac	JJ
cord-023095-4dannjjm	5033	18	diseases	disease	NNS
cord-023095-4dannjjm	5033	19	.	.	.
cord-023095-4dannjjm	5034	1	Total	total	JJ
cord-023095-4dannjjm	5034	2	lipids	lipid	NNS
cord-023095-4dannjjm	5034	3	were	be	VBD
cord-023095-4dannjjm	5034	4	extracted	extract	VBN
cord-023095-4dannjjm	5034	5	using	use	VBG
cord-023095-4dannjjm	5034	6	chloroform	chloroform	NN
cord-023095-4dannjjm	5034	7	:	:	:
cord-023095-4dannjjm	5034	8	methanol	methanol	NN
cord-023095-4dannjjm	5034	9	(	(	-LRB-
cord-023095-4dannjjm	5034	10	2:1	2:1	CD
cord-023095-4dannjjm	5034	11	v	v	NN
cord-023095-4dannjjm	5034	12	/	/	SYM
cord-023095-4dannjjm	5034	13	v	v	NN
cord-023095-4dannjjm	5034	14	)	)	-RRB-
cord-023095-4dannjjm	5034	15	and	and	CC
cord-023095-4dannjjm	5034	16	fatty	fatty	JJ
cord-023095-4dannjjm	5034	17	acid	acid	NN
cord-023095-4dannjjm	5034	18	methyl	methyl	NN
cord-023095-4dannjjm	5034	19	esters	ester	NNS
cord-023095-4dannjjm	5034	20	were	be	VBD
cord-023095-4dannjjm	5034	21	prepared	prepare	VBN
cord-023095-4dannjjm	5034	22	for	for	IN
cord-023095-4dannjjm	5034	23	capillary	capillary	JJ
cord-023095-4dannjjm	5034	24	gas	gas	NN
cord-023095-4dannjjm	5034	25	chromatography	chromatography	NN
cord-023095-4dannjjm	5034	26	.	.	.
cord-023095-4dannjjm	5035	1	Relative	relative	JJ
cord-023095-4dannjjm	5035	2	percentage	percentage	NN
cord-023095-4dannjjm	5035	3	distribution	distribution	NN
cord-023095-4dannjjm	5035	4	of	of	IN
cord-023095-4dannjjm	5035	5	individual	individual	JJ
cord-023095-4dannjjm	5035	6	serum	serum	NN
cord-023095-4dannjjm	5035	7	fatty	fatty	JJ
cord-023095-4dannjjm	5035	8	acids	acid	NNS
cord-023095-4dannjjm	5035	9	for	for	IN
cord-023095-4dannjjm	5035	10	each	each	DT
cord-023095-4dannjjm	5035	11	animal	animal	NN
cord-023095-4dannjjm	5035	12	were	be	VBD
cord-023095-4dannjjm	5035	13	then	then	RB
cord-023095-4dannjjm	5035	14	compared	compare	VBN
cord-023095-4dannjjm	5035	15	with	with	IN
cord-023095-4dannjjm	5035	16	average	average	JJ
cord-023095-4dannjjm	5035	17	normative	normative	JJ
cord-023095-4dannjjm	5035	18	serum	serum	NN
cord-023095-4dannjjm	5035	19	phospholipid	phospholipid	NN
cord-023095-4dannjjm	5035	20	fatty	fatty	JJ
cord-023095-4dannjjm	5035	21	acid	acid	NN
cord-023095-4dannjjm	5035	22	values	value	NNS
cord-023095-4dannjjm	5035	23	(	(	-LRB-
cord-023095-4dannjjm	5035	24	dogs	dog	NNS
cord-023095-4dannjjm	5035	25	,	,	,
cord-023095-4dannjjm	5035	26	n	n	NN
cord-023095-4dannjjm	5035	27	5	5	CD
cord-023095-4dannjjm	5035	28	44	44	CD
cord-023095-4dannjjm	5035	29	;	;	:
cord-023095-4dannjjm	5035	30	cats	cat	NNS
cord-023095-4dannjjm	5035	31	,	,	,
cord-023095-4dannjjm	5035	32	n	n	NN
cord-023095-4dannjjm	5035	33	5	5	CD
cord-023095-4dannjjm	5035	34	29	29	CD
cord-023095-4dannjjm	5035	35	)	)	-RRB-
cord-023095-4dannjjm	5035	36	by	by	IN
cord-023095-4dannjjm	5035	37	calculating	calculate	VBG
cord-023095-4dannjjm	5035	38	the	the	DT
cord-023095-4dannjjm	5035	39	ratio	ratio	NN
cord-023095-4dannjjm	5035	40	of	of	IN
cord-023095-4dannjjm	5035	41	the	the	DT
cord-023095-4dannjjm	5035	42	value	value	NN
cord-023095-4dannjjm	5035	43	in	in	IN
cord-023095-4dannjjm	5035	44	the	the	DT
cord-023095-4dannjjm	5035	45	diseased	diseased	JJ
cord-023095-4dannjjm	5035	46	individual	individual	NN
cord-023095-4dannjjm	5035	47	to	to	IN
cord-023095-4dannjjm	5035	48	the	the	DT
cord-023095-4dannjjm	5035	49	normal	normal	JJ
cord-023095-4dannjjm	5035	50	mean	mean	JJ
cord-023095-4dannjjm	5035	51	value	value	NN
cord-023095-4dannjjm	5035	52	and	and	CC
cord-023095-4dannjjm	5035	53	used	use	VBD
cord-023095-4dannjjm	5035	54	as	as	IN
cord-023095-4dannjjm	5035	55	an	an	DT
cord-023095-4dannjjm	5035	56	index	index	NN
cord-023095-4dannjjm	5035	57	of	of	IN
cord-023095-4dannjjm	5035	58	normalcy	normalcy	NN
cord-023095-4dannjjm	5035	59	.	.	.
cord-023095-4dannjjm	5036	1	Normalcy	normalcy	NN
cord-023095-4dannjjm	5036	2	ratios	ratio	NNS
cord-023095-4dannjjm	5036	3	were	be	VBD
cord-023095-4dannjjm	5036	4	then	then	RB
cord-023095-4dannjjm	5036	5	plotted	plot	VBN
cord-023095-4dannjjm	5036	6	on	on	IN
cord-023095-4dannjjm	5036	7	a	a	DT
cord-023095-4dannjjm	5036	8	logarithmic	logarithmic	JJ
cord-023095-4dannjjm	5036	9	scale	scale	NN
cord-023095-4dannjjm	5036	10	with	with	IN
cord-023095-4dannjjm	5036	11	normal	normal	JJ
cord-023095-4dannjjm	5036	12	at	at	IN
cord-023095-4dannjjm	5036	13	1.0	1.0	CD
cord-023095-4dannjjm	5036	14	.	.	.
cord-023095-4dannjjm	5037	1	The	the	DT
cord-023095-4dannjjm	5037	2	ratio	ratio	NN
cord-023095-4dannjjm	5037	3	was	be	VBD
cord-023095-4dannjjm	5037	4	then	then	RB
cord-023095-4dannjjm	5037	5	compared	compare	VBN
cord-023095-4dannjjm	5037	6	to	to	IN
cord-023095-4dannjjm	5037	7	changes	change	NNS
cord-023095-4dannjjm	5037	8	greater	great	JJR
cord-023095-4dannjjm	5037	9	than	than	IN
cord-023095-4dannjjm	5037	10	3	3	CD
cord-023095-4dannjjm	5037	11	,	,	,
cord-023095-4dannjjm	5037	12	2	2	CD
cord-023095-4dannjjm	5037	13	and	and	CC
cord-023095-4dannjjm	5037	14	1	1	CD
cord-023095-4dannjjm	5037	15	standard	standard	JJ
cord-023095-4dannjjm	5037	16	deviations	deviation	NNS
cord-023095-4dannjjm	5037	17	of	of	IN
cord-023095-4dannjjm	5037	18	the	the	DT
cord-023095-4dannjjm	5037	19	normal	normal	JJ
cord-023095-4dannjjm	5037	20	mean	mean	JJ
cord-023095-4dannjjm	5037	21	values	value	NNS
cord-023095-4dannjjm	5037	22	.	.	.
cord-023095-4dannjjm	5038	1	In	in	IN
cord-023095-4dannjjm	5038	2	this	this	DT
cord-023095-4dannjjm	5038	3	way	way	NN
cord-023095-4dannjjm	5038	4	a	a	DT
cord-023095-4dannjjm	5038	5	graphical	graphical	JJ
cord-023095-4dannjjm	5038	6	presentation	presentation	NN
cord-023095-4dannjjm	5038	7	of	of	IN
cord-023095-4dannjjm	5038	8	resultant	resultant	JJ
cord-023095-4dannjjm	5038	9	values	value	NNS
cord-023095-4dannjjm	5038	10	was	be	VBD
cord-023095-4dannjjm	5038	11	obtained	obtain	VBN
cord-023095-4dannjjm	5038	12	.	.	.
cord-023095-4dannjjm	5039	1	Although	although	IN
cord-023095-4dannjjm	5039	2	the	the	DT
cord-023095-4dannjjm	5039	3	animals	animal	NNS
cord-023095-4dannjjm	5039	4	had	have	VBD
cord-023095-4dannjjm	5039	5	been	be	VBN
cord-023095-4dannjjm	5039	6	fed	feed	VBN
cord-023095-4dannjjm	5039	7	various	various	JJ
cord-023095-4dannjjm	5039	8	commercial	commercial	JJ
cord-023095-4dannjjm	5039	9	diets	diet	NNS
cord-023095-4dannjjm	5039	10	and	and	CC
cord-023095-4dannjjm	5039	11	some	some	DT
cord-023095-4dannjjm	5039	12	home	home	NN
cord-023095-4dannjjm	5039	13	-	-	HYPH
cord-023095-4dannjjm	5039	14	prepared	prepare	VBN
cord-023095-4dannjjm	5039	15	foods	food	NNS
cord-023095-4dannjjm	5039	16	,	,	,
cord-023095-4dannjjm	5039	17	a	a	DT
cord-023095-4dannjjm	5039	18	number	number	NN
cord-023095-4dannjjm	5039	19	of	of	IN
cord-023095-4dannjjm	5039	20	noteworthy	noteworthy	JJ
cord-023095-4dannjjm	5039	21	patterns	pattern	NNS
cord-023095-4dannjjm	5039	22	emerged	emerge	VBD
cord-023095-4dannjjm	5039	23	from	from	IN
cord-023095-4dannjjm	5039	24	this	this	DT
cord-023095-4dannjjm	5039	25	analysis	analysis	NN
cord-023095-4dannjjm	5039	26	.	.	.
cord-023095-4dannjjm	5040	1	Dogs	dog	NNS
cord-023095-4dannjjm	5040	2	showed	show	VBD
cord-023095-4dannjjm	5040	3	increased	increase	VBN
cord-023095-4dannjjm	5040	4	linoleic	linoleic	NN
cord-023095-4dannjjm	5040	5	acid	acid	NN
cord-023095-4dannjjm	5040	6	,	,	,
cord-023095-4dannjjm	5040	7	decreased	decrease	VBD
cord-023095-4dannjjm	5040	8	arachidonic	arachidonic	JJ
cord-023095-4dannjjm	5040	9	acid	acid	NN
cord-023095-4dannjjm	5040	10	,	,	,
cord-023095-4dannjjm	5040	11	increased	increase	VBD
cord-023095-4dannjjm	5040	12	total	total	JJ
cord-023095-4dannjjm	5040	13	monounsaturated	monounsaturated	NN
cord-023095-4dannjjm	5040	14	and	and	CC
cord-023095-4dannjjm	5040	15	decreased	decrease	VBD
cord-023095-4dannjjm	5040	16	saturated	saturated	JJ
cord-023095-4dannjjm	5040	17	fatty	fatty	JJ
cord-023095-4dannjjm	5040	18	acids	acid	NNS
cord-023095-4dannjjm	5040	19	at	at	IN
cord-023095-4dannjjm	5040	20	P	p	NN
cord-023095-4dannjjm	5040	21	o	o	NN
cord-023095-4dannjjm	5040	22	0.001	0.001	CD
cord-023095-4dannjjm	5040	23	;	;	:
cord-023095-4dannjjm	5040	24	oleic	oleic	JJ
cord-023095-4dannjjm	5040	25	acid	acid	NN
cord-023095-4dannjjm	5040	26	was	be	VBD
cord-023095-4dannjjm	5040	27	increased	increase	VBN
cord-023095-4dannjjm	5040	28	at	at	IN
cord-023095-4dannjjm	5040	29	p	p	NN
cord-023095-4dannjjm	5040	30	o	o	NN
cord-023095-4dannjjm	5040	31	0.01	0.01	CD
cord-023095-4dannjjm	5040	32	.	.	.
cord-023095-4dannjjm	5041	1	Remarkably	remarkably	RB
cord-023095-4dannjjm	5041	2	,	,	,
cord-023095-4dannjjm	5041	3	these	these	DT
cord-023095-4dannjjm	5041	4	findings	finding	NNS
cord-023095-4dannjjm	5041	5	were	be	VBD
cord-023095-4dannjjm	5041	6	similar	similar	JJ
cord-023095-4dannjjm	5041	7	for	for	IN
cord-023095-4dannjjm	5041	8	all	all	DT
cord-023095-4dannjjm	5041	9	canine	canine	JJ
cord-023095-4dannjjm	5041	10	disease	disease	NN
cord-023095-4dannjjm	5041	11	categories	category	NNS
cord-023095-4dannjjm	5041	12	evaluated	evaluate	VBN
cord-023095-4dannjjm	5041	13	(	(	-LRB-
cord-023095-4dannjjm	5041	14	n	n	NN
cord-023095-4dannjjm	5041	15	5	5	CD
cord-023095-4dannjjm	5041	16	30	30	CD
cord-023095-4dannjjm	5041	17	,	,	,
cord-023095-4dannjjm	5041	18	heart	heart	NN
cord-023095-4dannjjm	5041	19	;	;	:
cord-023095-4dannjjm	5041	20	n	n	NN
cord-023095-4dannjjm	5041	21	5	5	CD
cord-023095-4dannjjm	5041	22	17	17	CD
cord-023095-4dannjjm	5041	23	,	,	,
cord-023095-4dannjjm	5041	24	kidney	kidney	NN
cord-023095-4dannjjm	5041	25	;	;	:
cord-023095-4dannjjm	5041	26	n	n	NN
cord-023095-4dannjjm	5041	27	5	5	CD
cord-023095-4dannjjm	5041	28	28	28	CD
cord-023095-4dannjjm	5041	29	,	,	,
cord-023095-4dannjjm	5041	30	liver	liver	NN
cord-023095-4dannjjm	5041	31	,	,	,
cord-023095-4dannjjm	5041	32	and	and	CC
cord-023095-4dannjjm	5041	33	n	n	NN
cord-023095-4dannjjm	5041	34	5	5	CD
cord-023095-4dannjjm	5041	35	28	28	CD
cord-023095-4dannjjm	5041	36	digestive	digestive	JJ
cord-023095-4dannjjm	5041	37	disorders	disorder	NNS
cord-023095-4dannjjm	5041	38	)	)	-RRB-
cord-023095-4dannjjm	5041	39	.	.	.
cord-023095-4dannjjm	5042	1	In	in	IN
cord-023095-4dannjjm	5042	2	cats	cat	NNS
cord-023095-4dannjjm	5042	3	,	,	,
cord-023095-4dannjjm	5042	4	a	a	DT
cord-023095-4dannjjm	5042	5	slight	slight	JJ
cord-023095-4dannjjm	5042	6	decrease	decrease	NN
cord-023095-4dannjjm	5042	7	in	in	IN
cord-023095-4dannjjm	5042	8	arachidonic	arachidonic	JJ
cord-023095-4dannjjm	5042	9	acid	acid	NN
cord-023095-4dannjjm	5042	10	and	and	CC
cord-023095-4dannjjm	5042	11	large	large	JJ
cord-023095-4dannjjm	5042	12	decrease	decrease	NN
cord-023095-4dannjjm	5042	13	in	in	IN
cord-023095-4dannjjm	5042	14	22:0	22:0	CD
cord-023095-4dannjjm	5042	15	was	be	VBD
cord-023095-4dannjjm	5042	16	observed	observe	VBN
cord-023095-4dannjjm	5042	17	but	but	CC
cord-023095-4dannjjm	5042	18	only	only	RB
cord-023095-4dannjjm	5042	19	in	in	IN
cord-023095-4dannjjm	5042	20	heart	heart	NN
cord-023095-4dannjjm	5042	21	disorders	disorder	NNS
cord-023095-4dannjjm	5042	22	.	.	.
cord-023095-4dannjjm	5043	1	By	by	IN
cord-023095-4dannjjm	5043	2	contrast	contrast	NN
cord-023095-4dannjjm	5043	3	,	,	,
cord-023095-4dannjjm	5043	4	modest	modest	JJ
cord-023095-4dannjjm	5043	5	elevations	elevation	NNS
cord-023095-4dannjjm	5043	6	of	of	IN
cord-023095-4dannjjm	5043	7	arachidonate	arachidonate	NNP
cord-023095-4dannjjm	5043	8	were	be	VBD
cord-023095-4dannjjm	5043	9	observed	observe	VBN
cord-023095-4dannjjm	5043	10	in	in	IN
cord-023095-4dannjjm	5043	11	kidney	kidney	NN
cord-023095-4dannjjm	5043	12	,	,	,
cord-023095-4dannjjm	5043	13	liver	liver	NN
cord-023095-4dannjjm	5043	14	,	,	,
cord-023095-4dannjjm	5043	15	and	and	CC
cord-023095-4dannjjm	5043	16	digestive	digestive	JJ
cord-023095-4dannjjm	5043	17	disease	disease	NN
cord-023095-4dannjjm	5043	18	groups	group	NNS
cord-023095-4dannjjm	5043	19	but	but	CC
cord-023095-4dannjjm	5043	20	at	at	IN
cord-023095-4dannjjm	5043	21	p	p	NN
cord-023095-4dannjjm	5043	22	o	o	NN
cord-023095-4dannjjm	5043	23	0.01	0.01	CD
cord-023095-4dannjjm	5043	24	.	.	.
cord-023095-4dannjjm	5044	1	Sample	sample	NN
cord-023095-4dannjjm	5044	2	sizes	size	NNS
cord-023095-4dannjjm	5044	3	of	of	IN
cord-023095-4dannjjm	5044	4	the	the	DT
cord-023095-4dannjjm	5044	5	feline	feline	JJ
cord-023095-4dannjjm	5044	6	sera	sera	NNP
cord-023095-4dannjjm	5044	7	were	be	VBD
cord-023095-4dannjjm	5044	8	considerably	considerably	RB
cord-023095-4dannjjm	5044	9	smaller	small	JJR
cord-023095-4dannjjm	5044	10	(	(	-LRB-
cord-023095-4dannjjm	5044	11	range	range	NN
cord-023095-4dannjjm	5044	12	of	of	IN
cord-023095-4dannjjm	5044	13	4	4	CD
cord-023095-4dannjjm	5044	14	-	-	SYM
cord-023095-4dannjjm	5044	15	13	13	CD
cord-023095-4dannjjm	5044	16	per	per	IN
cord-023095-4dannjjm	5044	17	group	group	NN
cord-023095-4dannjjm	5044	18	)	)	-RRB-
cord-023095-4dannjjm	5044	19	.	.	.
cord-023095-4dannjjm	5045	1	A	a	DT
cord-023095-4dannjjm	5045	2	limitation	limitation	NN
cord-023095-4dannjjm	5045	3	of	of	IN
cord-023095-4dannjjm	5045	4	this	this	DT
cord-023095-4dannjjm	5045	5	analysis	analysis	NN
cord-023095-4dannjjm	5045	6	is	be	VBZ
cord-023095-4dannjjm	5045	7	that	that	DT
cord-023095-4dannjjm	5045	8	variability	variability	NN
cord-023095-4dannjjm	5045	9	of	of	IN
cord-023095-4dannjjm	5045	10	normal	normal	JJ
cord-023095-4dannjjm	5045	11	data	datum	NNS
cord-023095-4dannjjm	5045	12	may	may	MD
cord-023095-4dannjjm	5045	13	exist	exist	VB
cord-023095-4dannjjm	5045	14	depending	depend	VBG
cord-023095-4dannjjm	5045	15	on	on	IN
cord-023095-4dannjjm	5045	16	diet	diet	NN
cord-023095-4dannjjm	5045	17	fed	fed	NNP
cord-023095-4dannjjm	5045	18	making	make	VBG
cord-023095-4dannjjm	5045	19	comparisons	comparison	NNS
cord-023095-4dannjjm	5045	20	less	less	RBR
cord-023095-4dannjjm	5045	21	reliable	reliable	JJ
cord-023095-4dannjjm	5045	22	However	however	RB
cord-023095-4dannjjm	5045	23	,	,	,
cord-023095-4dannjjm	5045	24	these	these	DT
cord-023095-4dannjjm	5045	25	preliminary	preliminary	JJ
cord-023095-4dannjjm	5045	26	data	datum	NNS
cord-023095-4dannjjm	5045	27	suggest	suggest	VBP
cord-023095-4dannjjm	5045	28	that	that	IN
cord-023095-4dannjjm	5045	29	metabolic	metabolic	JJ
cord-023095-4dannjjm	5045	30	diseases	disease	NNS
cord-023095-4dannjjm	5045	31	of	of	IN
cord-023095-4dannjjm	5045	32	dogs	dog	NNS
cord-023095-4dannjjm	5045	33	may	may	MD
cord-023095-4dannjjm	5045	34	depress	depress	VB
cord-023095-4dannjjm	5045	35	plasma	plasma	NN
cord-023095-4dannjjm	5045	36	arachidonic	arachidonic	NN
cord-023095-4dannjjm	5045	37	acid	acid	NN
cord-023095-4dannjjm	5045	38	independent	independent	JJ
cord-023095-4dannjjm	5045	39	of	of	IN
cord-023095-4dannjjm	5045	40	diet	diet	NN
cord-023095-4dannjjm	5045	41	fed	fed	NNP
cord-023095-4dannjjm	5045	42	suggesting	suggest	VBG
cord-023095-4dannjjm	5045	43	either	either	CC
cord-023095-4dannjjm	5045	44	reduced	reduce	VBN
cord-023095-4dannjjm	5045	45	conversion	conversion	NN
cord-023095-4dannjjm	5045	46	from	from	IN
cord-023095-4dannjjm	5045	47	linoleic	linoleic	JJ
cord-023095-4dannjjm	5045	48	acid	acid	NN
cord-023095-4dannjjm	5045	49	or	or	CC
cord-023095-4dannjjm	5045	50	increased	increase	VBN
cord-023095-4dannjjm	5045	51	utilization	utilization	NN
cord-023095-4dannjjm	5045	52	of	of	IN
cord-023095-4dannjjm	5045	53	arachidonate	arachidonate	NN
cord-023095-4dannjjm	5045	54	for	for	IN
cord-023095-4dannjjm	5045	55	eicosanoid	eicosanoid	JJ
cord-023095-4dannjjm	5045	56	production	production	NN
cord-023095-4dannjjm	5045	57	during	during	IN
cord-023095-4dannjjm	5045	58	times	time	NNS
cord-023095-4dannjjm	5045	59	of	of	IN
cord-023095-4dannjjm	5045	60	metabolic	metabolic	JJ
cord-023095-4dannjjm	5045	61	stress	stress	NN
cord-023095-4dannjjm	5045	62	.	.	.
cord-023095-4dannjjm	5046	1	Conversely	conversely	RB
cord-023095-4dannjjm	5046	2	,	,	,
cord-023095-4dannjjm	5046	3	in	in	IN
cord-023095-4dannjjm	5046	4	cats	cat	NNS
cord-023095-4dannjjm	5046	5	,	,	,
cord-023095-4dannjjm	5046	6	increases	increase	NNS
cord-023095-4dannjjm	5046	7	in	in	IN
cord-023095-4dannjjm	5046	8	arachidonic	arachidonic	JJ
cord-023095-4dannjjm	5046	9	acid	acid	NN
cord-023095-4dannjjm	5046	10	may	may	MD
cord-023095-4dannjjm	5046	11	be	be	VB
cord-023095-4dannjjm	5046	12	associated	associate	VBN
cord-023095-4dannjjm	5046	13	with	with	IN
cord-023095-4dannjjm	5046	14	diet	diet	NN
cord-023095-4dannjjm	5046	15	arachidonate	arachidonate	NN
cord-023095-4dannjjm	5046	16	or	or	CC
cord-023095-4dannjjm	5046	17	other	other	JJ
cord-023095-4dannjjm	5046	18	mechanisms	mechanism	NNS
cord-023095-4dannjjm	5046	19	.	.	.
cord-023095-4dannjjm	5047	1	Additional	additional	JJ
cord-023095-4dannjjm	5047	2	studies	study	NNS
cord-023095-4dannjjm	5047	3	to	to	TO
cord-023095-4dannjjm	5047	4	verify	verify	VB
cord-023095-4dannjjm	5047	5	these	these	DT
cord-023095-4dannjjm	5047	6	findings	finding	NNS
cord-023095-4dannjjm	5047	7	are	be	VBP
cord-023095-4dannjjm	5047	8	warranted	warrant	VBN
cord-023095-4dannjjm	5047	9	.	.	.
cord-023095-4dannjjm	5048	1	The	the	DT
cord-023095-4dannjjm	5048	2	objective	objective	NN
cord-023095-4dannjjm	5048	3	of	of	IN
cord-023095-4dannjjm	5048	4	this	this	DT
cord-023095-4dannjjm	5048	5	study	study	NN
cord-023095-4dannjjm	5048	6	was	be	VBD
cord-023095-4dannjjm	5048	7	to	to	TO
cord-023095-4dannjjm	5048	8	determine	determine	VB
cord-023095-4dannjjm	5048	9	whether	whether	IN
cord-023095-4dannjjm	5048	10	or	or	CC
cord-023095-4dannjjm	5048	11	not	not	RB
cord-023095-4dannjjm	5048	12	Lalanyl	Lalanyl	NNP
cord-023095-4dannjjm	5048	13	-	-	HYPH
cord-023095-4dannjjm	5048	14	L	l	NN
cord-023095-4dannjjm	5048	15	-	-	HYPH
cord-023095-4dannjjm	5048	16	glutamine	glutamine	NN
cord-023095-4dannjjm	5048	17	(	(	-LRB-
cord-023095-4dannjjm	5048	18	Ala	Ala	NNP
cord-023095-4dannjjm	5048	19	-	-	HYPH
cord-023095-4dannjjm	5048	20	Gln	Gln	NNP
cord-023095-4dannjjm	5048	21	)	)	-RRB-
cord-023095-4dannjjm	5048	22	supplementation	supplementation	NN
cord-023095-4dannjjm	5048	23	in	in	IN
cord-023095-4dannjjm	5048	24	dogs	dog	NNS
cord-023095-4dannjjm	5048	25	with	with	IN
cord-023095-4dannjjm	5048	26	parvoviral	parvoviral	JJ
cord-023095-4dannjjm	5048	27	enteritis	enteritis	NN
cord-023095-4dannjjm	5048	28	improves	improve	VBZ
cord-023095-4dannjjm	5048	29	the	the	DT
cord-023095-4dannjjm	5048	30	survival	survival	NN
cord-023095-4dannjjm	5048	31	rate	rate	NN
cord-023095-4dannjjm	5048	32	and	and	CC
cord-023095-4dannjjm	5048	33	ameliorates	ameliorate	VBZ
cord-023095-4dannjjm	5048	34	clinical	clinical	JJ
cord-023095-4dannjjm	5048	35	signs	sign	NNS
cord-023095-4dannjjm	5048	36	without	without	IN
cord-023095-4dannjjm	5048	37	side	side	NN
cord-023095-4dannjjm	5048	38	effects	effect	NNS
cord-023095-4dannjjm	5048	39	.	.	.
cord-023095-4dannjjm	5049	1	This	this	DT
cord-023095-4dannjjm	5049	2	randomized	randomized	JJ
cord-023095-4dannjjm	5049	3	,	,	,
cord-023095-4dannjjm	5049	4	double	double	JJ
cord-023095-4dannjjm	5049	5	-	-	HYPH
cord-023095-4dannjjm	5049	6	blinded	blinded	JJ
cord-023095-4dannjjm	5049	7	,	,	,
cord-023095-4dannjjm	5049	8	placebo	placebo	NN
cord-023095-4dannjjm	5049	9	-	-	HYPH
cord-023095-4dannjjm	5049	10	controlled	control	VBN
cord-023095-4dannjjm	5049	11	clinical	clinical	JJ
cord-023095-4dannjjm	5049	12	trial	trial	NN
cord-023095-4dannjjm	5049	13	included	include	VBD
cord-023095-4dannjjm	5049	14	39	39	CD
cord-023095-4dannjjm	5049	15	client	client	NN
cord-023095-4dannjjm	5049	16	-	-	HYPH
cord-023095-4dannjjm	5049	17	owned	own	VBN
cord-023095-4dannjjm	5049	18	dogs	dog	NNS
cord-023095-4dannjjm	5049	19	.	.	.
cord-023095-4dannjjm	5050	1	The	the	DT
cord-023095-4dannjjm	5050	2	dogs	dog	NNS
cord-023095-4dannjjm	5050	3	were	be	VBD
cord-023095-4dannjjm	5050	4	randomly	randomly	RB
cord-023095-4dannjjm	5050	5	assigned	assign	VBN
cord-023095-4dannjjm	5050	6	into	into	IN
cord-023095-4dannjjm	5050	7	two	two	CD
cord-023095-4dannjjm	5050	8	groups	group	NNS
cord-023095-4dannjjm	5050	9	and	and	CC
cord-023095-4dannjjm	5050	10	administered	administer	VBN
cord-023095-4dannjjm	5050	11	Ala	Ala	NNP
cord-023095-4dannjjm	5050	12	-	-	HYPH
cord-023095-4dannjjm	5050	13	Gln	Gln	NNP
cord-023095-4dannjjm	5050	14	solution	solution	NN
cord-023095-4dannjjm	5050	15	(	(	-LRB-
cord-023095-4dannjjm	5050	16	Dipeptiven	Dipeptiven	NNP
cord-023095-4dannjjm	5050	17	;	;	:
cord-023095-4dannjjm	5050	18	0.4	0.4	CD
cord-023095-4dannjjm	5050	19	g	g	NN
cord-023095-4dannjjm	5050	20	/	/	SYM
cord-023095-4dannjjm	5050	21	kg	kg	NNP
cord-023095-4dannjjm	5050	22	)	)	-RRB-
cord-023095-4dannjjm	5050	23	or	or	CC
cord-023095-4dannjjm	5050	24	an	an	DT
cord-023095-4dannjjm	5050	25	equivalent	equivalent	JJ
cord-023095-4dannjjm	5050	26	volume	volume	NN
cord-023095-4dannjjm	5050	27	of	of	IN
cord-023095-4dannjjm	5050	28	placebo	placebo	NN
cord-023095-4dannjjm	5050	29	orally	orally	RB
cord-023095-4dannjjm	5050	30	twice	twice	PDT
cord-023095-4dannjjm	5050	31	a	a	DT
cord-023095-4dannjjm	5050	32	day	day	NN
cord-023095-4dannjjm	5050	33	.	.	.
cord-023095-4dannjjm	5051	1	All	all	DT
cord-023095-4dannjjm	5051	2	of	of	IN
cord-023095-4dannjjm	5051	3	the	the	DT
cord-023095-4dannjjm	5051	4	dogs	dog	NNS
cord-023095-4dannjjm	5051	5	(	(	-LRB-
cord-023095-4dannjjm	5051	6	Ala	Ala	NNP
cord-023095-4dannjjm	5051	7	-	-	HYPH
cord-023095-4dannjjm	5051	8	Gln	Gln	NNP
cord-023095-4dannjjm	5051	9	group	group	NN
cord-023095-4dannjjm	5051	10	[	[	-LRB-
cord-023095-4dannjjm	5051	11	n	n	NN
cord-023095-4dannjjm	5051	12	5	5	CD
cord-023095-4dannjjm	5051	13	20	20	CD
cord-023095-4dannjjm	5051	14	]	]	-RRB-
cord-023095-4dannjjm	5051	15	and	and	CC
cord-023095-4dannjjm	5051	16	placebo	placebo	NN
cord-023095-4dannjjm	5051	17	group	group	NN
cord-023095-4dannjjm	5051	18	[	[	-LRB-
cord-023095-4dannjjm	5051	19	n	n	NN
cord-023095-4dannjjm	5051	20	5	5	CD
cord-023095-4dannjjm	5051	21	19	19	CD
cord-023095-4dannjjm	5051	22	]	]	-RRB-
cord-023095-4dannjjm	5051	23	)	)	-RRB-
cord-023095-4dannjjm	5051	24	received	receive	VBD
cord-023095-4dannjjm	5051	25	standard	standard	JJ
cord-023095-4dannjjm	5051	26	treatment	treatment	NN
cord-023095-4dannjjm	5051	27	while	while	IN
cord-023095-4dannjjm	5051	28	hospitalized	hospitalize	VBN
cord-023095-4dannjjm	5051	29	and	and	CC
cord-023095-4dannjjm	5051	30	were	be	VBD
cord-023095-4dannjjm	5051	31	monitored	monitor	VBN
cord-023095-4dannjjm	5051	32	daily	daily	RB
cord-023095-4dannjjm	5051	33	according	accord	VBG
cord-023095-4dannjjm	5051	34	to	to	IN
cord-023095-4dannjjm	5051	35	a	a	DT
cord-023095-4dannjjm	5051	36	clinical	clinical	JJ
cord-023095-4dannjjm	5051	37	scoring	scoring	NN
cord-023095-4dannjjm	5051	38	system	system	NN
cord-023095-4dannjjm	5051	39	and	and	CC
cord-023095-4dannjjm	5051	40	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	5051	41	evaluation	evaluation	NN
cord-023095-4dannjjm	5051	42	for	for	IN
cord-023095-4dannjjm	5051	43	11	11	CD
cord-023095-4dannjjm	5051	44	days	day	NNS
cord-023095-4dannjjm	5051	45	.	.	.
cord-023095-4dannjjm	5052	1	Among	among	IN
cord-023095-4dannjjm	5052	2	the	the	DT
cord-023095-4dannjjm	5052	3	39	39	CD
cord-023095-4dannjjm	5052	4	dogs	dog	NNS
cord-023095-4dannjjm	5052	5	,	,	,
cord-023095-4dannjjm	5052	6	17	17	CD
cord-023095-4dannjjm	5052	7	(	(	-LRB-
cord-023095-4dannjjm	5052	8	Ala	Ala	NNP
cord-023095-4dannjjm	5052	9	-	-	HYPH
cord-023095-4dannjjm	5052	10	Gln	Gln	NNP
cord-023095-4dannjjm	5052	11	-	-	HYPH
cord-023095-4dannjjm	5052	12	treated	treat	VBN
cord-023095-4dannjjm	5052	13	group	group	NN
cord-023095-4dannjjm	5052	14	[	[	-LRB-
cord-023095-4dannjjm	5052	15	n	n	NN
cord-023095-4dannjjm	5052	16	5	5	CD
cord-023095-4dannjjm	5052	17	8	8	CD
cord-023095-4dannjjm	5052	18	]	]	-RRB-
cord-023095-4dannjjm	5052	19	and	and	CC
cord-023095-4dannjjm	5052	20	placebo	placebo	NN
cord-023095-4dannjjm	5052	21	group	group	NN
cord-023095-4dannjjm	5052	22	[	[	-LRB-
cord-023095-4dannjjm	5052	23	n	n	NN
cord-023095-4dannjjm	5052	24	5	5	CD
cord-023095-4dannjjm	5052	25	9	9	CD
cord-023095-4dannjjm	5052	26	]	]	-RRB-
cord-023095-4dannjjm	5052	27	)	)	-RRB-
cord-023095-4dannjjm	5052	28	were	be	VBD
cord-023095-4dannjjm	5052	29	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	5052	30	and	and	CC
cord-023095-4dannjjm	5052	31	22	22	CD
cord-023095-4dannjjm	5053	1	(	(	-LRB-
cord-023095-4dannjjm	5053	2	Ala	Ala	NNP
cord-023095-4dannjjm	5053	3	-	-	HYPH
cord-023095-4dannjjm	5053	4	Gln	Gln	NNP
cord-023095-4dannjjm	5053	5	-	-	HYPH
cord-023095-4dannjjm	5053	6	treated	treat	VBN
cord-023095-4dannjjm	5053	7	group	group	NN
cord-023095-4dannjjm	5053	8	[	[	-LRB-
cord-023095-4dannjjm	5053	9	n	n	NN
cord-023095-4dannjjm	5053	10	5	5	CD
cord-023095-4dannjjm	5053	11	12	12	CD
cord-023095-4dannjjm	5053	12	]	]	-RRB-
cord-023095-4dannjjm	5053	13	and	and	CC
cord-023095-4dannjjm	5053	14	placebo	placebo	NN
cord-023095-4dannjjm	5053	15	group	group	NN
cord-023095-4dannjjm	5053	16	[	[	-LRB-
cord-023095-4dannjjm	5053	17	n	n	NN
cord-023095-4dannjjm	5053	18	5	5	CD
cord-023095-4dannjjm	5053	19	10	10	CD
cord-023095-4dannjjm	5053	20	]	]	-RRB-
cord-023095-4dannjjm	5053	21	)	)	-RRB-
cord-023095-4dannjjm	5053	22	were	be	VBD
cord-023095-4dannjjm	5053	23	not	not	RB
cord-023095-4dannjjm	5053	24	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	5053	25	.	.	.
cord-023095-4dannjjm	5054	1	The	the	DT
cord-023095-4dannjjm	5054	2	population	population	NN
cord-023095-4dannjjm	5054	3	consisted	consist	VBD
cord-023095-4dannjjm	5054	4	of	of	IN
cord-023095-4dannjjm	5054	5	29	29	CD
cord-023095-4dannjjm	5054	6	purebreds	purebred	NNS
cord-023095-4dannjjm	5054	7	and	and	CC
cord-023095-4dannjjm	5054	8	10	10	CD
cord-023095-4dannjjm	5054	9	mixed	mixed	JJ
cord-023095-4dannjjm	5054	10	breed	breed	NN
cord-023095-4dannjjm	5054	11	dogs	dog	NNS
cord-023095-4dannjjm	5054	12	,	,	,
cord-023095-4dannjjm	5054	13	with	with	IN
cord-023095-4dannjjm	5054	14	a	a	DT
cord-023095-4dannjjm	5054	15	mean	mean	JJ
cord-023095-4dannjjm	5054	16	age	age	NN
cord-023095-4dannjjm	5054	17	of	of	IN
cord-023095-4dannjjm	5054	18	12.2	12.2	CD
cord-023095-4dannjjm	5054	19	AE	AE	NNP
cord-023095-4dannjjm	5054	20	2.2	2.2	CD
cord-023095-4dannjjm	5054	21	weeks	week	NNS
cord-023095-4dannjjm	5054	22	.	.	.
cord-023095-4dannjjm	5055	1	The	the	DT
cord-023095-4dannjjm	5055	2	survival	survival	NN
cord-023095-4dannjjm	5055	3	data	datum	NNS
cord-023095-4dannjjm	5055	4	were	be	VBD
cord-023095-4dannjjm	5055	5	compared	compare	VBN
cord-023095-4dannjjm	5055	6	statistically	statistically	RB
cord-023095-4dannjjm	5055	7	by	by	IN
cord-023095-4dannjjm	5055	8	means	mean	NNS
cord-023095-4dannjjm	5055	9	of	of	IN
cord-023095-4dannjjm	5055	10	a	a	DT
cord-023095-4dannjjm	5055	11	log	log	NN
cord-023095-4dannjjm	5055	12	-	-	HYPH
cord-023095-4dannjjm	5055	13	rank	rank	NN
cord-023095-4dannjjm	5055	14	test	test	NN
cord-023095-4dannjjm	5055	15	for	for	IN
cord-023095-4dannjjm	5055	16	the	the	DT
cord-023095-4dannjjm	5055	17	Kaplan	Kaplan	NNP
cord-023095-4dannjjm	5055	18	-	-	HYPH
cord-023095-4dannjjm	5055	19	Meier	Meier	NNP
cord-023095-4dannjjm	5055	20	survival	survival	NN
cord-023095-4dannjjm	5055	21	curves	curve	NNS
cord-023095-4dannjjm	5055	22	.	.	.
cord-023095-4dannjjm	5056	1	The	the	DT
cord-023095-4dannjjm	5056	2	clinical	clinical	JJ
cord-023095-4dannjjm	5056	3	scores	score	NNS
cord-023095-4dannjjm	5056	4	of	of	IN
cord-023095-4dannjjm	5056	5	Ala	Ala	NNP
cord-023095-4dannjjm	5056	6	-	-	HYPH
cord-023095-4dannjjm	5056	7	Gln	Gln	NNP
cord-023095-4dannjjm	5056	8	-	-	HYPH
cord-023095-4dannjjm	5056	9	treated	treat	VBN
cord-023095-4dannjjm	5056	10	dogs	dog	NNS
cord-023095-4dannjjm	5056	11	improved	improve	VBD
cord-023095-4dannjjm	5056	12	significantly	significantly	RB
cord-023095-4dannjjm	5056	13	relative	relative	JJ
cord-023095-4dannjjm	5056	14	to	to	IN
cord-023095-4dannjjm	5056	15	the	the	DT
cord-023095-4dannjjm	5056	16	placebo	placebo	NN
cord-023095-4dannjjm	5056	17	group	group	NN
cord-023095-4dannjjm	5056	18	.	.	.
cord-023095-4dannjjm	5057	1	There	there	EX
cord-023095-4dannjjm	5057	2	was	be	VBD
cord-023095-4dannjjm	5057	3	a	a	DT
cord-023095-4dannjjm	5057	4	significant	significant	JJ
cord-023095-4dannjjm	5057	5	difference	difference	NN
cord-023095-4dannjjm	5057	6	between	between	IN
cord-023095-4dannjjm	5057	7	the	the	DT
cord-023095-4dannjjm	5057	8	two	two	CD
cord-023095-4dannjjm	5057	9	groups	group	NNS
cord-023095-4dannjjm	5057	10	in	in	IN
cord-023095-4dannjjm	5057	11	the	the	DT
cord-023095-4dannjjm	5057	12	survival	survival	NN
cord-023095-4dannjjm	5057	13	distribution	distribution	NN
cord-023095-4dannjjm	5057	14	(	(	-LRB-
cord-023095-4dannjjm	5057	15	P	p	NN
cord-023095-4dannjjm	5057	16	5	5	CD
cord-023095-4dannjjm	5057	17	0.038	0.038	CD
cord-023095-4dannjjm	5057	18	)	)	-RRB-
cord-023095-4dannjjm	5057	19	;	;	:
cord-023095-4dannjjm	5057	20	specifically	specifically	RB
cord-023095-4dannjjm	5057	21	,	,	,
cord-023095-4dannjjm	5057	22	3	3	CD
cord-023095-4dannjjm	5057	23	of	of	IN
cord-023095-4dannjjm	5057	24	the	the	DT
cord-023095-4dannjjm	5057	25	Ala	Ala	NNP
cord-023095-4dannjjm	5057	26	-	-	HYPH
cord-023095-4dannjjm	5057	27	Gln	Gln	NNP
cord-023095-4dannjjm	5057	28	-	-	HYPH
cord-023095-4dannjjm	5057	29	treated	treat	VBN
cord-023095-4dannjjm	5057	30	dogs	dog	NNS
cord-023095-4dannjjm	5057	31	(	(	-LRB-
cord-023095-4dannjjm	5057	32	15.0	15.0	CD
cord-023095-4dannjjm	5057	33	%	%	NN
cord-023095-4dannjjm	5057	34	)	)	-RRB-
cord-023095-4dannjjm	5057	35	died	die	VBD
cord-023095-4dannjjm	5057	36	,	,	,
cord-023095-4dannjjm	5057	37	whereas	whereas	IN
cord-023095-4dannjjm	5057	38	8	8	CD
cord-023095-4dannjjm	5057	39	of	of	IN
cord-023095-4dannjjm	5057	40	the	the	DT
cord-023095-4dannjjm	5057	41	dogs	dog	NNS
cord-023095-4dannjjm	5057	42	in	in	IN
cord-023095-4dannjjm	5057	43	the	the	DT
cord-023095-4dannjjm	5057	44	placebo	placebo	NN
cord-023095-4dannjjm	5057	45	group	group	NN
cord-023095-4dannjjm	5057	46	(	(	-LRB-
cord-023095-4dannjjm	5057	47	42.1	42.1	CD
cord-023095-4dannjjm	5057	48	%	%	NN
cord-023095-4dannjjm	5057	49	)	)	-RRB-
cord-023095-4dannjjm	5057	50	died	die	VBD
cord-023095-4dannjjm	5057	51	.	.	.
cord-023095-4dannjjm	5058	1	No	no	DT
cord-023095-4dannjjm	5058	2	side	side	NN
cord-023095-4dannjjm	5058	3	effects	effect	NNS
cord-023095-4dannjjm	5058	4	were	be	VBD
cord-023095-4dannjjm	5058	5	associated	associate	VBN
cord-023095-4dannjjm	5058	6	with	with	IN
cord-023095-4dannjjm	5058	7	the	the	DT
cord-023095-4dannjjm	5058	8	administration	administration	NN
cord-023095-4dannjjm	5058	9	of	of	IN
cord-023095-4dannjjm	5058	10	Ala	Ala	NNP
cord-023095-4dannjjm	5058	11	-	-	HYPH
cord-023095-4dannjjm	5058	12	Gln	Gln	NNP
cord-023095-4dannjjm	5058	13	.	.	.
cord-023095-4dannjjm	5059	1	These	these	DT
cord-023095-4dannjjm	5059	2	results	result	NNS
cord-023095-4dannjjm	5059	3	suggest	suggest	VBP
cord-023095-4dannjjm	5059	4	that	that	IN
cord-023095-4dannjjm	5059	5	the	the	DT
cord-023095-4dannjjm	5059	6	oral	oral	JJ
cord-023095-4dannjjm	5059	7	administration	administration	NN
cord-023095-4dannjjm	5059	8	of	of	IN
cord-023095-4dannjjm	5059	9	Ala	Ala	NNP
cord-023095-4dannjjm	5059	10	-	-	HYPH
cord-023095-4dannjjm	5059	11	Gln	Gln	NNP
cord-023095-4dannjjm	5059	12	is	be	VBZ
cord-023095-4dannjjm	5059	13	effective	effective	JJ
cord-023095-4dannjjm	5059	14	in	in	IN
cord-023095-4dannjjm	5059	15	improving	improve	VBG
cord-023095-4dannjjm	5059	16	clinical	clinical	JJ
cord-023095-4dannjjm	5059	17	signs	sign	NNS
cord-023095-4dannjjm	5059	18	and	and	CC
cord-023095-4dannjjm	5059	19	survival	survival	NN
cord-023095-4dannjjm	5059	20	rate	rate	NN
cord-023095-4dannjjm	5059	21	in	in	IN
cord-023095-4dannjjm	5059	22	dogs	dog	NNS
cord-023095-4dannjjm	5059	23	with	with	IN
cord-023095-4dannjjm	5059	24	parvoviral	parvoviral	JJ
cord-023095-4dannjjm	5059	25	enteritis	enteritis	NN
cord-023095-4dannjjm	5059	26	.	.	.
cord-023095-4dannjjm	5060	1	Bleeding	bleed	VBG
cord-023095-4dannjjm	5060	2	disorders	disorder	NNS
cord-023095-4dannjjm	5060	3	,	,	,
cord-023095-4dannjjm	5060	4	thrombocytopenia	thrombocytopenia	NN
cord-023095-4dannjjm	5060	5	and	and	CC
cord-023095-4dannjjm	5060	6	alterations	alteration	NNS
cord-023095-4dannjjm	5060	7	in	in	IN
cord-023095-4dannjjm	5060	8	platelet	platelet	NN
cord-023095-4dannjjm	5060	9	function	function	NN
cord-023095-4dannjjm	5060	10	have	have	VBP
cord-023095-4dannjjm	5060	11	been	be	VBN
cord-023095-4dannjjm	5060	12	documented	document	VBN
cord-023095-4dannjjm	5060	13	in	in	IN
cord-023095-4dannjjm	5060	14	humans	human	NNS
cord-023095-4dannjjm	5060	15	receiving	receive	VBG
cord-023095-4dannjjm	5060	16	lipid	lipid	NN
cord-023095-4dannjjm	5060	17	-	-	HYPH
cord-023095-4dannjjm	5060	18	containing	contain	VBG
cord-023095-4dannjjm	5060	19	parenteral	parenteral	JJ
cord-023095-4dannjjm	5060	20	nutrition	nutrition	NN
cord-023095-4dannjjm	5060	21	formulations	formulation	NNS
cord-023095-4dannjjm	5060	22	.	.	.
cord-023095-4dannjjm	5061	1	Despite	despite	IN
cord-023095-4dannjjm	5061	2	a	a	DT
cord-023095-4dannjjm	5061	3	lack	lack	NN
cord-023095-4dannjjm	5061	4	of	of	IN
cord-023095-4dannjjm	5061	5	evidence	evidence	NN
cord-023095-4dannjjm	5061	6	in	in	IN
cord-023095-4dannjjm	5061	7	the	the	DT
cord-023095-4dannjjm	5061	8	veterinary	veterinary	JJ
cord-023095-4dannjjm	5061	9	literature	literature	NN
cord-023095-4dannjjm	5061	10	,	,	,
cord-023095-4dannjjm	5061	11	it	-PRON-	PRP
cord-023095-4dannjjm	5061	12	is	be	VBZ
cord-023095-4dannjjm	5061	13	believed	believe	VBN
cord-023095-4dannjjm	5061	14	that	that	IN
cord-023095-4dannjjm	5061	15	parenteral	parenteral	JJ
cord-023095-4dannjjm	5061	16	lipids	lipid	NNS
cord-023095-4dannjjm	5061	17	are	be	VBP
cord-023095-4dannjjm	5061	18	contraindicated	contraindicated	JJ
cord-023095-4dannjjm	5061	19	in	in	IN
cord-023095-4dannjjm	5061	20	critical	critical	JJ
cord-023095-4dannjjm	5061	21	illness	illness	NN
cord-023095-4dannjjm	5061	22	when	when	WRB
cord-023095-4dannjjm	5061	23	the	the	DT
cord-023095-4dannjjm	5061	24	development	development	NN
cord-023095-4dannjjm	5061	25	of	of	IN
cord-023095-4dannjjm	5061	26	bleeding	bleed	VBG
cord-023095-4dannjjm	5061	27	disorders	disorder	NNS
cord-023095-4dannjjm	5061	28	is	be	VBZ
cord-023095-4dannjjm	5061	29	likely	likely	JJ
cord-023095-4dannjjm	5061	30	.	.	.
cord-023095-4dannjjm	5062	1	The	the	DT
cord-023095-4dannjjm	5062	2	objective	objective	NN
cord-023095-4dannjjm	5062	3	of	of	IN
cord-023095-4dannjjm	5062	4	this	this	DT
cord-023095-4dannjjm	5062	5	study	study	NN
cord-023095-4dannjjm	5062	6	was	be	VBD
cord-023095-4dannjjm	5062	7	to	to	TO
cord-023095-4dannjjm	5062	8	determine	determine	VB
cord-023095-4dannjjm	5062	9	if	if	IN
cord-023095-4dannjjm	5062	10	there	there	EX
cord-023095-4dannjjm	5062	11	is	be	VBZ
cord-023095-4dannjjm	5062	12	an	an	DT
cord-023095-4dannjjm	5062	13	in	in	FW
cord-023095-4dannjjm	5062	14	vitro	vitro	FW
cord-023095-4dannjjm	5062	15	effect	effect	NN
cord-023095-4dannjjm	5062	16	on	on	IN
cord-023095-4dannjjm	5062	17	platelet	platelet	NN
cord-023095-4dannjjm	5062	18	function	function	NN
cord-023095-4dannjjm	5062	19	and	and	CC
cord-023095-4dannjjm	5062	20	thromboelastography	thromboelastography	NNP
cord-023095-4dannjjm	5062	21	(	(	-LRB-
cord-023095-4dannjjm	5062	22	TEG	TEG	NNP
cord-023095-4dannjjm	5062	23	)	)	-RRB-
cord-023095-4dannjjm	5062	24	in	in	IN
cord-023095-4dannjjm	5062	25	normal	normal	JJ
cord-023095-4dannjjm	5062	26	dogs	dog	NNS
cord-023095-4dannjjm	5062	27	with	with	IN
cord-023095-4dannjjm	5062	28	varying	vary	VBG
cord-023095-4dannjjm	5062	29	concentrations	concentration	NNS
cord-023095-4dannjjm	5062	30	of	of	IN
cord-023095-4dannjjm	5062	31	a	a	DT
cord-023095-4dannjjm	5062	32	20	20	CD
cord-023095-4dannjjm	5062	33	%	%	NN
cord-023095-4dannjjm	5062	34	soybean	soybean	NN
cord-023095-4dannjjm	5062	35	oil	oil	NN
cord-023095-4dannjjm	5062	36	emulsion	emulsion	NN
cord-023095-4dannjjm	5062	37	(	(	-LRB-
cord-023095-4dannjjm	5062	38	Intralipid	Intralipid	NNP
cord-023095-4dannjjm	5062	39	s	s	POS
cord-023095-4dannjjm	5062	40	)	)	-RRB-
cord-023095-4dannjjm	5062	41	.	.	.
cord-023095-4dannjjm	5063	1	Twelve	twelve	CD
cord-023095-4dannjjm	5063	2	clinically	clinically	RB
cord-023095-4dannjjm	5063	3	healthy	healthy	JJ
cord-023095-4dannjjm	5063	4	dogs	dog	NNS
cord-023095-4dannjjm	5063	5	were	be	VBD
cord-023095-4dannjjm	5063	6	used	use	VBN
cord-023095-4dannjjm	5063	7	for	for	IN
cord-023095-4dannjjm	5063	8	this	this	DT
cord-023095-4dannjjm	5063	9	study	study	NN
cord-023095-4dannjjm	5063	10	.	.	.
cord-023095-4dannjjm	5064	1	Whole	whole	JJ
cord-023095-4dannjjm	5064	2	blood	blood	NN
cord-023095-4dannjjm	5064	3	platelet	platelet	NN
cord-023095-4dannjjm	5064	4	aggregation	aggregation	NN
cord-023095-4dannjjm	5064	5	,	,	,
cord-023095-4dannjjm	5064	6	using	use	VBG
cord-023095-4dannjjm	5064	7	ADP	ADP	NNP
cord-023095-4dannjjm	5064	8	and	and	CC
cord-023095-4dannjjm	5064	9	collagen	collagen	NN
cord-023095-4dannjjm	5064	10	agonists	agonist	NNS
cord-023095-4dannjjm	5064	11	,	,	,
cord-023095-4dannjjm	5064	12	was	be	VBD
cord-023095-4dannjjm	5064	13	measured	measure	VBN
cord-023095-4dannjjm	5064	14	using	use	VBG
cord-023095-4dannjjm	5064	15	multiple	multiple	JJ
cord-023095-4dannjjm	5064	16	electrode	electrode	NN
cord-023095-4dannjjm	5064	17	aggregometry	aggregometry	NN
cord-023095-4dannjjm	5064	18	in	in	IN
cord-023095-4dannjjm	5064	19	hirudinated	hirudinate	VBN
cord-023095-4dannjjm	5064	20	blood	blood	NN
cord-023095-4dannjjm	5064	21	with	with	IN
cord-023095-4dannjjm	5064	22	final	final	JJ
cord-023095-4dannjjm	5064	23	lipid	lipid	NN
cord-023095-4dannjjm	5064	24	concentrations	concentration	NNS
cord-023095-4dannjjm	5064	25	of	of	IN
cord-023095-4dannjjm	5064	26	0	0	CD
cord-023095-4dannjjm	5064	27	,	,	,
cord-023095-4dannjjm	5064	28	1	1	CD
cord-023095-4dannjjm	5064	29	,	,	,
cord-023095-4dannjjm	5064	30	10	10	CD
cord-023095-4dannjjm	5064	31	,	,	,
cord-023095-4dannjjm	5064	32	and	and	CC
cord-023095-4dannjjm	5064	33	30	30	CD
cord-023095-4dannjjm	5064	34	mg	mg	NN
cord-023095-4dannjjm	5064	35	/	/	SYM
cord-023095-4dannjjm	5064	36	ml	ml	NN
cord-023095-4dannjjm	5064	37	.	.	.
cord-023095-4dannjjm	5065	1	The	the	DT
cord-023095-4dannjjm	5065	2	TEG	TEG	NNP
cord-023095-4dannjjm	5065	3	parameters	parameter	NNS
cord-023095-4dannjjm	5065	4	R	r	NN
cord-023095-4dannjjm	5065	5	,	,	,
cord-023095-4dannjjm	5065	6	K	K	NNP
cord-023095-4dannjjm	5065	7	,	,	,
cord-023095-4dannjjm	5065	8	a	a	DT
cord-023095-4dannjjm	5065	9	-	-	HYPH
cord-023095-4dannjjm	5065	10	angle	angle	NN
cord-023095-4dannjjm	5065	11	,	,	,
cord-023095-4dannjjm	5065	12	and	and	CC
cord-023095-4dannjjm	5065	13	maximum	maximum	JJ
cord-023095-4dannjjm	5065	14	amplitude	amplitude	NN
cord-023095-4dannjjm	5065	15	(	(	-LRB-
cord-023095-4dannjjm	5065	16	MA	MA	NNP
cord-023095-4dannjjm	5065	17	)	)	-RRB-
cord-023095-4dannjjm	5065	18	were	be	VBD
cord-023095-4dannjjm	5065	19	evaluated	evaluate	VBN
cord-023095-4dannjjm	5065	20	from	from	IN
cord-023095-4dannjjm	5065	21	citrated	citrate	VBN
cord-023095-4dannjjm	5065	22	whole	whole	JJ
cord-023095-4dannjjm	5065	23	blood	blood	NN
cord-023095-4dannjjm	5065	24	with	with	IN
cord-023095-4dannjjm	5065	25	equivalent	equivalent	JJ
cord-023095-4dannjjm	5065	26	final	final	JJ
cord-023095-4dannjjm	5065	27	lipid	lipid	NN
cord-023095-4dannjjm	5065	28	concentrations	concentration	NNS
cord-023095-4dannjjm	5065	29	as	as	IN
cord-023095-4dannjjm	5065	30	platelet	platelet	NN
cord-023095-4dannjjm	5065	31	aggregation	aggregation	NN
cord-023095-4dannjjm	5065	32	.	.	.
cord-023095-4dannjjm	5066	1	There	there	EX
cord-023095-4dannjjm	5066	2	was	be	VBD
cord-023095-4dannjjm	5066	3	no	no	DT
cord-023095-4dannjjm	5066	4	significant	significant	JJ
cord-023095-4dannjjm	5066	5	difference	difference	NN
cord-023095-4dannjjm	5066	6	between	between	IN
cord-023095-4dannjjm	5066	7	groups	group	NNS
cord-023095-4dannjjm	5066	8	with	with	IN
cord-023095-4dannjjm	5066	9	collageninduced	collageninduced	JJ
cord-023095-4dannjjm	5066	10	platelet	platelet	NN
cord-023095-4dannjjm	5066	11	aggregation	aggregation	NN
cord-023095-4dannjjm	5066	12	.	.	.
cord-023095-4dannjjm	5067	1	There	there	EX
cord-023095-4dannjjm	5067	2	was	be	VBD
cord-023095-4dannjjm	5067	3	a	a	DT
cord-023095-4dannjjm	5067	4	significant	significant	JJ
cord-023095-4dannjjm	5067	5	increase	increase	NN
cord-023095-4dannjjm	5067	6	in	in	IN
cord-023095-4dannjjm	5067	7	the	the	DT
cord-023095-4dannjjm	5067	8	area	area	NN
cord-023095-4dannjjm	5067	9	under	under	IN
cord-023095-4dannjjm	5067	10	the	the	DT
cord-023095-4dannjjm	5067	11	curve	curve	NN
cord-023095-4dannjjm	5067	12	(	(	-LRB-
cord-023095-4dannjjm	5067	13	AUC	AUC	NNP
cord-023095-4dannjjm	5067	14	)	)	-RRB-
cord-023095-4dannjjm	5067	15	with	with	IN
cord-023095-4dannjjm	5067	16	ADP	ADP	NNP
cord-023095-4dannjjm	5067	17	-	-	HYPH
cord-023095-4dannjjm	5067	18	induced	induce	VBN
cord-023095-4dannjjm	5067	19	aggregation	aggregation	NN
cord-023095-4dannjjm	5067	20	at	at	IN
cord-023095-4dannjjm	5067	21	a	a	DT
cord-023095-4dannjjm	5067	22	lipid	lipid	NN
cord-023095-4dannjjm	5067	23	concentration	concentration	NN
cord-023095-4dannjjm	5067	24	of	of	IN
cord-023095-4dannjjm	5067	25	30	30	CD
cord-023095-4dannjjm	5067	26	mg	mg	NNP
cord-023095-4dannjjm	5067	27	/	/	SYM
cord-023095-4dannjjm	5067	28	ml	ml	NN
cord-023095-4dannjjm	5067	29	(	(	-LRB-
cord-023095-4dannjjm	5067	30	p	p	NN
cord-023095-4dannjjm	5067	31	5	5	CD
cord-023095-4dannjjm	5067	32	0.027	0.027	CD
cord-023095-4dannjjm	5067	33	)	)	-RRB-
cord-023095-4dannjjm	5067	34	.	.	.
cord-023095-4dannjjm	5068	1	The	the	DT
cord-023095-4dannjjm	5068	2	MA	MA	NNP
cord-023095-4dannjjm	5068	3	was	be	VBD
cord-023095-4dannjjm	5068	4	significantly	significantly	RB
cord-023095-4dannjjm	5068	5	reduced	reduce	VBN
cord-023095-4dannjjm	5068	6	at	at	IN
cord-023095-4dannjjm	5068	7	both	both	CC
cord-023095-4dannjjm	5068	8	the	the	DT
cord-023095-4dannjjm	5068	9	10	10	CD
cord-023095-4dannjjm	5068	10	mg	mg	NNP
cord-023095-4dannjjm	5068	11	/	/	SYM
cord-023095-4dannjjm	5068	12	ml	ml	NN
cord-023095-4dannjjm	5068	13	(	(	-LRB-
cord-023095-4dannjjm	5069	1	p	p	NN
cord-023095-4dannjjm	5069	2	o	o	NN
cord-023095-4dannjjm	5069	3	0.001	0.001	CD
cord-023095-4dannjjm	5069	4	)	)	-RRB-
cord-023095-4dannjjm	5069	5	and	and	CC
cord-023095-4dannjjm	5069	6	30	30	CD
cord-023095-4dannjjm	5069	7	mg	mg	NN
cord-023095-4dannjjm	5069	8	/	/	SYM
cord-023095-4dannjjm	5069	9	ml	ml	NN
cord-023095-4dannjjm	5070	1	(	(	-LRB-
cord-023095-4dannjjm	5070	2	p	p	NN
cord-023095-4dannjjm	5070	3	o	o	NN
cord-023095-4dannjjm	5070	4	0.001	0.001	CD
cord-023095-4dannjjm	5070	5	)	)	-RRB-
cord-023095-4dannjjm	5070	6	lipid	lipid	NN
cord-023095-4dannjjm	5070	7	concentration	concentration	NN
cord-023095-4dannjjm	5070	8	.	.	.
cord-023095-4dannjjm	5071	1	There	there	EX
cord-023095-4dannjjm	5071	2	was	be	VBD
cord-023095-4dannjjm	5071	3	no	no	DT
cord-023095-4dannjjm	5071	4	statistical	statistical	JJ
cord-023095-4dannjjm	5071	5	difference	difference	NN
cord-023095-4dannjjm	5071	6	between	between	IN
cord-023095-4dannjjm	5071	7	groups	group	NNS
cord-023095-4dannjjm	5071	8	evaluating	evaluate	VBG
cord-023095-4dannjjm	5071	9	the	the	DT
cord-023095-4dannjjm	5071	10	other	other	JJ
cord-023095-4dannjjm	5071	11	TEG	TEG	NNP
cord-023095-4dannjjm	5071	12	parameters	parameter	NNS
cord-023095-4dannjjm	5071	13	.	.	.
cord-023095-4dannjjm	5072	1	While	while	IN
cord-023095-4dannjjm	5072	2	platelet	platelet	NN
cord-023095-4dannjjm	5072	3	aggregation	aggregation	NN
cord-023095-4dannjjm	5072	4	appeared	appear	VBD
cord-023095-4dannjjm	5072	5	enhanced	enhance	VBN
cord-023095-4dannjjm	5072	6	at	at	IN
cord-023095-4dannjjm	5072	7	the	the	DT
cord-023095-4dannjjm	5072	8	highest	high	JJS
cord-023095-4dannjjm	5072	9	concentration	concentration	NN
cord-023095-4dannjjm	5072	10	evaluated	evaluate	VBN
cord-023095-4dannjjm	5072	11	,	,	,
cord-023095-4dannjjm	5072	12	this	this	DT
cord-023095-4dannjjm	5072	13	concentration	concentration	NN
cord-023095-4dannjjm	5072	14	is	be	VBZ
cord-023095-4dannjjm	5072	15	not	not	RB
cord-023095-4dannjjm	5072	16	clinically	clinically	RB
cord-023095-4dannjjm	5072	17	relevant	relevant	JJ
cord-023095-4dannjjm	5072	18	.	.	.
cord-023095-4dannjjm	5073	1	The	the	DT
cord-023095-4dannjjm	5073	2	reduction	reduction	NN
cord-023095-4dannjjm	5073	3	in	in	IN
cord-023095-4dannjjm	5073	4	MA	MA	NNP
cord-023095-4dannjjm	5073	5	seems	seem	VBZ
cord-023095-4dannjjm	5073	6	discordant	discordant	JJ
cord-023095-4dannjjm	5073	7	but	but	CC
cord-023095-4dannjjm	5073	8	both	both	CC
cord-023095-4dannjjm	5073	9	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	5073	10	and	and	CC
cord-023095-4dannjjm	5073	11	platelets	platelet	NNS
cord-023095-4dannjjm	5073	12	contribute	contribute	VBP
cord-023095-4dannjjm	5073	13	to	to	IN
cord-023095-4dannjjm	5073	14	the	the	DT
cord-023095-4dannjjm	5073	15	MA	MA	NNP
cord-023095-4dannjjm	5073	16	.	.	.
cord-023095-4dannjjm	5074	1	Therefore	therefore	RB
cord-023095-4dannjjm	5074	2	the	the	DT
cord-023095-4dannjjm	5074	3	higher	high	JJR
cord-023095-4dannjjm	5074	4	lipid	lipid	NN
cord-023095-4dannjjm	5074	5	concentrations	concentration	NNS
cord-023095-4dannjjm	5074	6	may	may	MD
cord-023095-4dannjjm	5074	7	be	be	VB
cord-023095-4dannjjm	5074	8	interfering	interfere	VBG
cord-023095-4dannjjm	5074	9	with	with	IN
cord-023095-4dannjjm	5074	10	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	5074	11	kinetics	kinetic	NNS
cord-023095-4dannjjm	5074	12	or	or	CC
cord-023095-4dannjjm	5074	13	fibrinogenplatelet	fibrinogenplatelet	NN
cord-023095-4dannjjm	5074	14	interaction	interaction	NN
cord-023095-4dannjjm	5074	15	.	.	.
cord-023095-4dannjjm	5075	1	In	in	IN
cord-023095-4dannjjm	5075	2	vivo	vivo	NNP
cord-023095-4dannjjm	5075	3	studies	study	NNS
cord-023095-4dannjjm	5075	4	are	be	VBP
cord-023095-4dannjjm	5075	5	indicated	indicate	VBN
cord-023095-4dannjjm	5075	6	to	to	TO
cord-023095-4dannjjm	5075	7	determine	determine	VB
cord-023095-4dannjjm	5075	8	if	if	IN
cord-023095-4dannjjm	5075	9	any	any	DT
cord-023095-4dannjjm	5075	10	of	of	IN
cord-023095-4dannjjm	5075	11	these	these	DT
cord-023095-4dannjjm	5075	12	changes	change	NNS
cord-023095-4dannjjm	5075	13	are	be	VBP
cord-023095-4dannjjm	5075	14	clinically	clinically	RB
cord-023095-4dannjjm	5075	15	significant	significant	JJ
cord-023095-4dannjjm	5075	16	.	.	.
cord-023095-4dannjjm	5076	1	Rosiglitazone	rosiglitazone	NN
cord-023095-4dannjjm	5076	2	is	be	VBZ
cord-023095-4dannjjm	5076	3	a	a	DT
cord-023095-4dannjjm	5076	4	peroxisome	peroxisome	NN
cord-023095-4dannjjm	5076	5	proliferator	proliferator	NN
cord-023095-4dannjjm	5076	6	-	-	HYPH
cord-023095-4dannjjm	5076	7	activated	activate	VBN
cord-023095-4dannjjm	5076	8	receptor	receptor	NN
cord-023095-4dannjjm	5076	9	gamma	gamma	NN
cord-023095-4dannjjm	5076	10	(	(	-LRB-
cord-023095-4dannjjm	5076	11	PPARg	PPARg	NNS
cord-023095-4dannjjm	5076	12	)	)	-RRB-
cord-023095-4dannjjm	5076	13	agonist	agonist	NN
cord-023095-4dannjjm	5076	14	and	and	CC
cord-023095-4dannjjm	5076	15	an	an	DT
cord-023095-4dannjjm	5076	16	FDA	FDA	NNP
cord-023095-4dannjjm	5076	17	-	-	HYPH
cord-023095-4dannjjm	5076	18	approved	approve	VBN
cord-023095-4dannjjm	5076	19	anti	anti	JJ
cord-023095-4dannjjm	5076	20	-	-	JJ
cord-023095-4dannjjm	5076	21	diabetic	diabetic	JJ
cord-023095-4dannjjm	5076	22	agent	agent	NN
cord-023095-4dannjjm	5076	23	in	in	IN
cord-023095-4dannjjm	5076	24	humans	human	NNS
cord-023095-4dannjjm	5076	25	that	that	WDT
cord-023095-4dannjjm	5076	26	has	have	VBZ
cord-023095-4dannjjm	5076	27	been	be	VBN
cord-023095-4dannjjm	5076	28	investigated	investigate	VBN
cord-023095-4dannjjm	5076	29	for	for	IN
cord-023095-4dannjjm	5076	30	its	-PRON-	PRP$
cord-023095-4dannjjm	5076	31	ability	ability	NN
cord-023095-4dannjjm	5076	32	to	to	TO
cord-023095-4dannjjm	5076	33	reduce	reduce	VB
cord-023095-4dannjjm	5076	34	tumor	tumor	NN
cord-023095-4dannjjm	5076	35	cell	cell	NN
cord-023095-4dannjjm	5076	36	growth	growth	NN
cord-023095-4dannjjm	5076	37	.	.	.
cord-023095-4dannjjm	5077	1	Specifically	specifically	RB
cord-023095-4dannjjm	5077	2	,	,	,
cord-023095-4dannjjm	5077	3	the	the	DT
cord-023095-4dannjjm	5077	4	combination	combination	NN
cord-023095-4dannjjm	5077	5	of	of	IN
cord-023095-4dannjjm	5077	6	rosiglitazone	rosiglitazone	NN
cord-023095-4dannjjm	5077	7	and	and	CC
cord-023095-4dannjjm	5077	8	carboplatin	carboplatin	NNP
cord-023095-4dannjjm	5077	9	has	have	VBZ
cord-023095-4dannjjm	5077	10	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	5077	11	enhanced	enhanced	JJ
cord-023095-4dannjjm	5077	12	tumor	tumor	NN
cord-023095-4dannjjm	5077	13	control	control	NN
cord-023095-4dannjjm	5077	14	.	.	.
cord-023095-4dannjjm	5078	1	The	the	DT
cord-023095-4dannjjm	5078	2	purpose	purpose	NN
cord-023095-4dannjjm	5078	3	of	of	IN
cord-023095-4dannjjm	5078	4	this	this	DT
cord-023095-4dannjjm	5078	5	study	study	NN
cord-023095-4dannjjm	5078	6	was	be	VBD
cord-023095-4dannjjm	5078	7	to	to	TO
cord-023095-4dannjjm	5078	8	determine	determine	VB
cord-023095-4dannjjm	5078	9	the	the	DT
cord-023095-4dannjjm	5078	10	peak	peak	NN
cord-023095-4dannjjm	5078	11	plasma	plasma	NN
cord-023095-4dannjjm	5078	12	concentrations	concentration	NNS
cord-023095-4dannjjm	5078	13	and	and	CC
cord-023095-4dannjjm	5078	14	side	side	NN
cord-023095-4dannjjm	5078	15	effect	effect	NN
cord-023095-4dannjjm	5078	16	profile	profile	NN
cord-023095-4dannjjm	5078	17	of	of	IN
cord-023095-4dannjjm	5078	18	rosiglitazone	rosiglitazone	NN
cord-023095-4dannjjm	5078	19	after	after	IN
cord-023095-4dannjjm	5078	20	oral	oral	JJ
cord-023095-4dannjjm	5078	21	administration	administration	NN
cord-023095-4dannjjm	5078	22	in	in	IN
cord-023095-4dannjjm	5078	23	dogs	dog	NNS
cord-023095-4dannjjm	5078	24	with	with	IN
cord-023095-4dannjjm	5078	25	spontaneously	spontaneously	RB
cord-023095-4dannjjm	5078	26	occurring	occur	VBG
cord-023095-4dannjjm	5078	27	cancer	cancer	NN
cord-023095-4dannjjm	5078	28	.	.	.
cord-023095-4dannjjm	5079	1	All	all	DT
cord-023095-4dannjjm	5079	2	dogs	dog	NNS
cord-023095-4dannjjm	5079	3	received	receive	VBD
cord-023095-4dannjjm	5079	4	carboplatin	carboplatin	NNS
cord-023095-4dannjjm	5079	5	intravenously	intravenously	RB
cord-023095-4dannjjm	5079	6	concurrently	concurrently	RB
cord-023095-4dannjjm	5079	7	with	with	IN
cord-023095-4dannjjm	5079	8	oral	oral	JJ
cord-023095-4dannjjm	5079	9	rosiglitazone	rosiglitazone	NN
cord-023095-4dannjjm	5079	10	.	.	.
cord-023095-4dannjjm	5080	1	Ten	ten	CD
cord-023095-4dannjjm	5080	2	cancer	cancer	NN
cord-023095-4dannjjm	5080	3	-	-	HYPH
cord-023095-4dannjjm	5080	4	bearing	bear	VBG
cord-023095-4dannjjm	5080	5	dogs	dog	NNS
cord-023095-4dannjjm	5080	6	with	with	IN
cord-023095-4dannjjm	5080	7	normal	normal	JJ
cord-023095-4dannjjm	5080	8	pre	pre	JJ
cord-023095-4dannjjm	5080	9	-	-	JJ
cord-023095-4dannjjm	5080	10	treatment	treatment	JJ
cord-023095-4dannjjm	5080	11	hepatic	hepatic	JJ
cord-023095-4dannjjm	5080	12	and	and	CC
cord-023095-4dannjjm	5080	13	renal	renal	JJ
cord-023095-4dannjjm	5080	14	function	function	NN
cord-023095-4dannjjm	5080	15	were	be	VBD
cord-023095-4dannjjm	5080	16	enrolled	enrol	VBN
cord-023095-4dannjjm	5080	17	.	.	.
cord-023095-4dannjjm	5081	1	Complete	complete	JJ
cord-023095-4dannjjm	5081	2	pre	pre	JJ
cord-023095-4dannjjm	5081	3	-	-	JJ
cord-023095-4dannjjm	5081	4	treatment	treatment	JJ
cord-023095-4dannjjm	5081	5	hematological	hematological	JJ
cord-023095-4dannjjm	5081	6	and	and	CC
cord-023095-4dannjjm	5081	7	biochemical	biochemical	JJ
cord-023095-4dannjjm	5081	8	parameters	parameter	NNS
cord-023095-4dannjjm	5081	9	were	be	VBD
cord-023095-4dannjjm	5081	10	available	available	JJ
cord-023095-4dannjjm	5081	11	in	in	IN
cord-023095-4dannjjm	5081	12	ten	ten	CD
cord-023095-4dannjjm	5081	13	dogs	dog	NNS
cord-023095-4dannjjm	5081	14	and	and	CC
cord-023095-4dannjjm	5081	15	post	post	JJ
cord-023095-4dannjjm	5081	16	-	-	JJ
cord-023095-4dannjjm	5081	17	treatment	treatment	JJ
cord-023095-4dannjjm	5081	18	parameters	parameter	NNS
cord-023095-4dannjjm	5081	19	in	in	IN
cord-023095-4dannjjm	5081	20	nine	nine	CD
cord-023095-4dannjjm	5081	21	dogs	dog	NNS
cord-023095-4dannjjm	5081	22	.	.	.
cord-023095-4dannjjm	5082	1	Peak	peak	NN
cord-023095-4dannjjm	5082	2	plasma	plasma	NN
cord-023095-4dannjjm	5082	3	concentrations	concentration	NNS
cord-023095-4dannjjm	5082	4	varied	varied	JJ
cord-023095-4dannjjm	5082	5	with	with	IN
cord-023095-4dannjjm	5082	6	dose	dose	NN
cord-023095-4dannjjm	5082	7	and	and	CC
cord-023095-4dannjjm	5082	8	ranged	range	VBD
cord-023095-4dannjjm	5082	9	from	from	IN
cord-023095-4dannjjm	5082	10	150.3	150.3	CD
cord-023095-4dannjjm	5082	11	-	-	SYM
cord-023095-4dannjjm	5082	12	959.4	959.4	CD
cord-023095-4dannjjm	5082	13	ng	ng	NN
cord-023095-4dannjjm	5082	14	/	/	SYM
cord-023095-4dannjjm	5082	15	mL	ml	NN
cord-023095-4dannjjm	5082	16	and	and	CC
cord-023095-4dannjjm	5082	17	occurred	occur	VBD
cord-023095-4dannjjm	5082	18	between	between	IN
cord-023095-4dannjjm	5082	19	30	30	CD
cord-023095-4dannjjm	5082	20	minutes	minute	NNS
cord-023095-4dannjjm	5082	21	and	and	CC
cord-023095-4dannjjm	5082	22	4	4	CD
cord-023095-4dannjjm	5082	23	hours	hour	NNS
cord-023095-4dannjjm	5082	24	post	post	NN
cord-023095-4dannjjm	5082	25	administration	administration	NN
cord-023095-4dannjjm	5082	26	and	and	CC
cord-023095-4dannjjm	5082	27	rapidly	rapidly	RB
cord-023095-4dannjjm	5082	28	declined	decline	VBD
cord-023095-4dannjjm	5082	29	after	after	IN
cord-023095-4dannjjm	5082	30	the	the	DT
cord-023095-4dannjjm	5082	31	peak	peak	NN
cord-023095-4dannjjm	5082	32	.	.	.
cord-023095-4dannjjm	5083	1	The	the	DT
cord-023095-4dannjjm	5083	2	dose	dose	NN
cord-023095-4dannjjm	5083	3	limiting	limit	VBG
cord-023095-4dannjjm	5083	4	toxicity	toxicity	NN
cord-023095-4dannjjm	5083	5	was	be	VBD
cord-023095-4dannjjm	5083	6	hepatic	hepatic	JJ
cord-023095-4dannjjm	5083	7	at	at	IN
cord-023095-4dannjjm	5083	8	a	a	DT
cord-023095-4dannjjm	5083	9	dose	dose	NN
cord-023095-4dannjjm	5083	10	of	of	IN
cord-023095-4dannjjm	5083	11	9	9	CD
cord-023095-4dannjjm	5083	12	mg	mg	NNP
cord-023095-4dannjjm	5083	13	/	/	SYM
cord-023095-4dannjjm	5083	14	m	m	NN
cord-023095-4dannjjm	5083	15	2	2	CD
cord-023095-4dannjjm	5083	16	.	.	.
cord-023095-4dannjjm	5084	1	There	there	EX
cord-023095-4dannjjm	5084	2	was	be	VBD
cord-023095-4dannjjm	5084	3	one	one	CD
cord-023095-4dannjjm	5084	4	Grade	Grade	NNP
cord-023095-4dannjjm	5084	5	III	III	NNP
cord-023095-4dannjjm	5084	6	,	,	,
cord-023095-4dannjjm	5084	7	two	two	CD
cord-023095-4dannjjm	5084	8	Grade	grade	NN
cord-023095-4dannjjm	5084	9	I	-PRON-	PRP
cord-023095-4dannjjm	5084	10	ALT	alt	NN
cord-023095-4dannjjm	5084	11	,	,	,
cord-023095-4dannjjm	5084	12	and	and	CC
cord-023095-4dannjjm	5084	13	one	one	CD
cord-023095-4dannjjm	5084	14	Grade	grade	NN
cord-023095-4dannjjm	5084	15	III	III	NNP
cord-023095-4dannjjm	5084	16	AST	AST	NNP
cord-023095-4dannjjm	5084	17	elevations	elevation	NNS
cord-023095-4dannjjm	5084	18	noted	note	VBD
cord-023095-4dannjjm	5084	19	.	.	.
cord-023095-4dannjjm	5085	1	No	no	DT
cord-023095-4dannjjm	5085	2	changes	change	NNS
cord-023095-4dannjjm	5085	3	in	in	IN
cord-023095-4dannjjm	5085	4	total	total	JJ
cord-023095-4dannjjm	5085	5	bilirubin	bilirubin	NN
cord-023095-4dannjjm	5085	6	,	,	,
cord-023095-4dannjjm	5085	7	alkaline	alkaline	JJ
cord-023095-4dannjjm	5085	8	phosphatase	phosphatase	NN
cord-023095-4dannjjm	5085	9	,	,	,
cord-023095-4dannjjm	5085	10	or	or	CC
cord-023095-4dannjjm	5085	11	GGT	GGT	NNP
cord-023095-4dannjjm	5085	12	values	value	NNS
cord-023095-4dannjjm	5085	13	were	be	VBD
cord-023095-4dannjjm	5085	14	noted	note	VBN
cord-023095-4dannjjm	5085	15	.	.	.
cord-023095-4dannjjm	5086	1	Blood	blood	NN
cord-023095-4dannjjm	5086	2	glucose	glucose	NN
cord-023095-4dannjjm	5086	3	values	value	NNS
cord-023095-4dannjjm	5086	4	remained	remain	VBD
cord-023095-4dannjjm	5086	5	within	within	IN
cord-023095-4dannjjm	5086	6	normal	normal	JJ
cord-023095-4dannjjm	5086	7	limits	limit	NNS
cord-023095-4dannjjm	5086	8	.	.	.
cord-023095-4dannjjm	5087	1	Mild	mild	JJ
cord-023095-4dannjjm	5087	2	,	,	,
cord-023095-4dannjjm	5087	3	self	self	NN
cord-023095-4dannjjm	5087	4	-	-	HYPH
cord-023095-4dannjjm	5087	5	limiting	limit	VBG
cord-023095-4dannjjm	5087	6	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	5087	7	and	and	CC
cord-023095-4dannjjm	5087	8	hematologic	hematologic	JJ
cord-023095-4dannjjm	5087	9	toxicities	toxicity	NNS
cord-023095-4dannjjm	5087	10	were	be	VBD
cord-023095-4dannjjm	5087	11	observed	observe	VBN
cord-023095-4dannjjm	5087	12	when	when	WRB
cord-023095-4dannjjm	5087	13	rosiglitazone	rosiglitazone	NN
cord-023095-4dannjjm	5087	14	was	be	VBD
cord-023095-4dannjjm	5087	15	administered	administer	VBN
cord-023095-4dannjjm	5087	16	in	in	IN
cord-023095-4dannjjm	5087	17	combination	combination	NN
cord-023095-4dannjjm	5087	18	with	with	IN
cord-023095-4dannjjm	5087	19	carboplatin	carboplatin	NNS
cord-023095-4dannjjm	5087	20	.	.	.
cord-023095-4dannjjm	5088	1	Based	base	VBN
cord-023095-4dannjjm	5088	2	on	on	IN
cord-023095-4dannjjm	5088	3	this	this	DT
cord-023095-4dannjjm	5088	4	study	study	NN
cord-023095-4dannjjm	5088	5	,	,	,
cord-023095-4dannjjm	5088	6	the	the	DT
cord-023095-4dannjjm	5088	7	recommended	recommend	VBN
cord-023095-4dannjjm	5088	8	dose	dose	NN
cord-023095-4dannjjm	5088	9	of	of	IN
cord-023095-4dannjjm	5088	10	rosiglitazone	rosiglitazone	NN
cord-023095-4dannjjm	5088	11	in	in	IN
cord-023095-4dannjjm	5088	12	cancer	cancer	NN
cord-023095-4dannjjm	5088	13	-	-	HYPH
cord-023095-4dannjjm	5088	14	bearing	bear	VBG
cord-023095-4dannjjm	5088	15	dogs	dog	NNS
cord-023095-4dannjjm	5088	16	with	with	IN
cord-023095-4dannjjm	5088	17	normal	normal	JJ
cord-023095-4dannjjm	5088	18	hepatic	hepatic	JJ
cord-023095-4dannjjm	5088	19	function	function	NN
cord-023095-4dannjjm	5088	20	is	be	VBZ
cord-023095-4dannjjm	5088	21	6	6	CD
cord-023095-4dannjjm	5088	22	mg	mg	NNP
cord-023095-4dannjjm	5088	23	/	/	SYM
cord-023095-4dannjjm	5088	24	m	m	NN
cord-023095-4dannjjm	5088	25	2	2	CD
cord-023095-4dannjjm	5088	26	orally	orally	RB
cord-023095-4dannjjm	5088	27	once	once	RB
cord-023095-4dannjjm	5088	28	daily	daily	RB
cord-023095-4dannjjm	5088	29	.	.	.
cord-023095-4dannjjm	5089	1	Side	side	JJ
cord-023095-4dannjjm	5089	2	effects	effect	NNS
cord-023095-4dannjjm	5089	3	of	of	IN
cord-023095-4dannjjm	5089	4	the	the	DT
cord-023095-4dannjjm	5089	5	combination	combination	NN
cord-023095-4dannjjm	5089	6	appear	appear	VBP
cord-023095-4dannjjm	5089	7	similar	similar	JJ
cord-023095-4dannjjm	5089	8	to	to	IN
cord-023095-4dannjjm	5089	9	side	side	JJ
cord-023095-4dannjjm	5089	10	effects	effect	NNS
cord-023095-4dannjjm	5089	11	noted	note	VBN
cord-023095-4dannjjm	5089	12	with	with	IN
cord-023095-4dannjjm	5089	13	carboplatin	carboplatin	NNS
cord-023095-4dannjjm	5089	14	alone	alone	RB
cord-023095-4dannjjm	5089	15	.	.	.
cord-023095-4dannjjm	5090	1	Further	further	JJ
cord-023095-4dannjjm	5090	2	study	study	NN
cord-023095-4dannjjm	5090	3	is	be	VBZ
cord-023095-4dannjjm	5090	4	needed	need	VBN
cord-023095-4dannjjm	5090	5	to	to	TO
cord-023095-4dannjjm	5090	6	determine	determine	VB
cord-023095-4dannjjm	5090	7	efficacy	efficacy	NN
cord-023095-4dannjjm	5090	8	of	of	IN
cord-023095-4dannjjm	5090	9	this	this	DT
cord-023095-4dannjjm	5090	10	combination	combination	NN
cord-023095-4dannjjm	5090	11	and	and	CC
cord-023095-4dannjjm	5090	12	if	if	IN
cord-023095-4dannjjm	5090	13	more	more	RBR
cord-023095-4dannjjm	5090	14	frequent	frequent	JJ
cord-023095-4dannjjm	5090	15	dosing	dosing	NN
cord-023095-4dannjjm	5090	16	is	be	VBZ
cord-023095-4dannjjm	5090	17	required	require	VBN
cord-023095-4dannjjm	5090	18	to	to	TO
cord-023095-4dannjjm	5090	19	maintain	maintain	VB
cord-023095-4dannjjm	5090	20	plasma	plasma	NN
cord-023095-4dannjjm	5090	21	concentrations	concentration	NNS
cord-023095-4dannjjm	5090	22	.	.	.
cord-023095-4dannjjm	5091	1	Carboplatin	Carboplatin	NNP
cord-023095-4dannjjm	5091	2	has	have	VBZ
cord-023095-4dannjjm	5091	3	shown	show	VBN
cord-023095-4dannjjm	5091	4	little	little	JJ
cord-023095-4dannjjm	5091	5	activity	activity	NN
cord-023095-4dannjjm	5091	6	as	as	IN
cord-023095-4dannjjm	5091	7	a	a	DT
cord-023095-4dannjjm	5091	8	single	single	JJ
cord-023095-4dannjjm	5091	9	agent	agent	NN
cord-023095-4dannjjm	5091	10	for	for	IN
cord-023095-4dannjjm	5091	11	the	the	DT
cord-023095-4dannjjm	5091	12	treatment	treatment	NN
cord-023095-4dannjjm	5091	13	of	of	IN
cord-023095-4dannjjm	5091	14	canine	canine	JJ
cord-023095-4dannjjm	5091	15	transitional	transitional	JJ
cord-023095-4dannjjm	5091	16	cell	cell	NN
cord-023095-4dannjjm	5091	17	carcinoma	carcinoma	NN
cord-023095-4dannjjm	5091	18	(	(	-LRB-
cord-023095-4dannjjm	5091	19	TCC	tcc	NN
cord-023095-4dannjjm	5091	20	)	)	-RRB-
cord-023095-4dannjjm	5091	21	.	.	.
cord-023095-4dannjjm	5092	1	However	however	RB
cord-023095-4dannjjm	5092	2	,	,	,
cord-023095-4dannjjm	5092	3	gemcitabine	gemcitabine	NNP
cord-023095-4dannjjm	5092	4	has	have	VBZ
cord-023095-4dannjjm	5092	5	shown	show	VBN
cord-023095-4dannjjm	5092	6	synergism	synergism	NN
cord-023095-4dannjjm	5092	7	with	with	IN
cord-023095-4dannjjm	5092	8	carboplatin	carboplatin	NNS
cord-023095-4dannjjm	5092	9	in	in	IN
cord-023095-4dannjjm	5092	10	human	human	JJ
cord-023095-4dannjjm	5092	11	cell	cell	NN
cord-023095-4dannjjm	5092	12	lines	line	NNS
cord-023095-4dannjjm	5092	13	.	.	.
cord-023095-4dannjjm	5093	1	The	the	DT
cord-023095-4dannjjm	5093	2	purpose	purpose	NN
cord-023095-4dannjjm	5093	3	of	of	IN
cord-023095-4dannjjm	5093	4	this	this	DT
cord-023095-4dannjjm	5093	5	study	study	NN
cord-023095-4dannjjm	5093	6	was	be	VBD
cord-023095-4dannjjm	5093	7	to	to	TO
cord-023095-4dannjjm	5093	8	evaluate	evaluate	VB
cord-023095-4dannjjm	5093	9	the	the	DT
cord-023095-4dannjjm	5093	10	activity	activity	NN
cord-023095-4dannjjm	5093	11	of	of	IN
cord-023095-4dannjjm	5093	12	gemcitabine	gemcitabine	NN
cord-023095-4dannjjm	5093	13	against	against	IN
cord-023095-4dannjjm	5093	14	canine	canine	JJ
cord-023095-4dannjjm	5093	15	TCC	TCC	NNP
cord-023095-4dannjjm	5093	16	cell	cell	NN
cord-023095-4dannjjm	5093	17	lines	line	NNS
cord-023095-4dannjjm	5093	18	alone	alone	RB
cord-023095-4dannjjm	5093	19	or	or	CC
cord-023095-4dannjjm	5093	20	in	in	IN
cord-023095-4dannjjm	5093	21	combination	combination	NN
cord-023095-4dannjjm	5093	22	with	with	IN
cord-023095-4dannjjm	5093	23	carboplatin	carboplatin	NNS
cord-023095-4dannjjm	5093	24	.	.	.
cord-023095-4dannjjm	5094	1	We	-PRON-	PRP
cord-023095-4dannjjm	5094	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	5094	3	that	that	IN
cord-023095-4dannjjm	5094	4	gemcitabine	gemcitabine	NN
cord-023095-4dannjjm	5094	5	in	in	IN
cord-023095-4dannjjm	5094	6	combination	combination	NN
cord-023095-4dannjjm	5094	7	with	with	IN
cord-023095-4dannjjm	5094	8	carboplatin	carboplatin	NNS
cord-023095-4dannjjm	5094	9	would	would	MD
cord-023095-4dannjjm	5094	10	have	have	VB
cord-023095-4dannjjm	5094	11	synergistic	synergistic	JJ
cord-023095-4dannjjm	5094	12	effects	effect	NNS
cord-023095-4dannjjm	5094	13	in	in	IN
cord-023095-4dannjjm	5094	14	vitro	vitro	FW
cord-023095-4dannjjm	5094	15	.	.	.
cord-023095-4dannjjm	5095	1	The	the	DT
cord-023095-4dannjjm	5095	2	results	result	NNS
cord-023095-4dannjjm	5095	3	of	of	IN
cord-023095-4dannjjm	5095	4	this	this	DT
cord-023095-4dannjjm	5095	5	study	study	NN
cord-023095-4dannjjm	5095	6	could	could	MD
cord-023095-4dannjjm	5095	7	provide	provide	VB
cord-023095-4dannjjm	5095	8	a	a	DT
cord-023095-4dannjjm	5095	9	rationale	rationale	NN
cord-023095-4dannjjm	5095	10	for	for	IN
cord-023095-4dannjjm	5095	11	treatment	treatment	NN
cord-023095-4dannjjm	5095	12	of	of	IN
cord-023095-4dannjjm	5095	13	canine	canine	JJ
cord-023095-4dannjjm	5095	14	TCC	tcc	NN
cord-023095-4dannjjm	5095	15	with	with	IN
cord-023095-4dannjjm	5095	16	the	the	DT
cord-023095-4dannjjm	5095	17	combination	combination	NN
cord-023095-4dannjjm	5095	18	of	of	IN
cord-023095-4dannjjm	5095	19	these	these	DT
cord-023095-4dannjjm	5095	20	drugs	drug	NNS
cord-023095-4dannjjm	5095	21	.	.	.
cord-023095-4dannjjm	5096	1	TCC	TCC	NNP
cord-023095-4dannjjm	5096	2	cell	cell	NN
cord-023095-4dannjjm	5096	3	lines	line	NNS
cord-023095-4dannjjm	5097	1	TCC	TCC	NNP
cord-023095-4dannjjm	5097	2	-	-	HYPH
cord-023095-4dannjjm	5097	3	Kiss	Kiss	NNP
cord-023095-4dannjjm	5097	4	,	,	,
cord-023095-4dannjjm	5097	5	TCC	TCC	NNP
cord-023095-4dannjjm	5097	6	-	-	HYPH
cord-023095-4dannjjm	5097	7	Knapp	Knapp	NNP
cord-023095-4dannjjm	5097	8	-	-	HYPH
cord-023095-4dannjjm	5097	9	JS	JS	NNP
cord-023095-4dannjjm	5097	10	,	,	,
cord-023095-4dannjjm	5097	11	TCC	TCC	NNP
cord-023095-4dannjjm	5097	12	-	-	HYPH
cord-023095-4dannjjm	5097	13	AXA	AXA	NNP
cord-023095-4dannjjm	5097	14	,	,	,
cord-023095-4dannjjm	5097	15	TCC	TCC	NNP
cord-023095-4dannjjm	5097	16	-	-	HYPH
cord-023095-4dannjjm	5097	17	HXC	HXC	NNP
cord-023095-4dannjjm	5097	18	,	,	,
cord-023095-4dannjjm	5097	19	and	and	CC
cord-023095-4dannjjm	5097	20	TCC	tcc	NN
cord-023095-4dannjjm	5097	21	-	-	HYPH
cord-023095-4dannjjm	5097	22	SH	SH	NNP
cord-023095-4dannjjm	5097	23	were	be	VBD
cord-023095-4dannjjm	5097	24	treated	treat	VBN
cord-023095-4dannjjm	5097	25	with	with	IN
cord-023095-4dannjjm	5097	26	gemcitabine	gemcitabine	NNP
cord-023095-4dannjjm	5097	27	,	,	,
cord-023095-4dannjjm	5097	28	carboplatin	carboplatin	NNP
cord-023095-4dannjjm	5097	29	,	,	,
cord-023095-4dannjjm	5097	30	or	or	CC
cord-023095-4dannjjm	5097	31	the	the	DT
cord-023095-4dannjjm	5097	32	combination	combination	NN
cord-023095-4dannjjm	5097	33	.	.	.
cord-023095-4dannjjm	5098	1	Cell	cell	NN
cord-023095-4dannjjm	5098	2	proliferation	proliferation	NN
cord-023095-4dannjjm	5098	3	was	be	VBD
cord-023095-4dannjjm	5098	4	assessed	assess	VBN
cord-023095-4dannjjm	5098	5	using	use	VBG
cord-023095-4dannjjm	5098	6	CyQUANT	CyQUANT	NNP
cord-023095-4dannjjm	5098	7	assay	assay	NN
cord-023095-4dannjjm	5098	8	,	,	,
cord-023095-4dannjjm	5098	9	cell	cell	NN
cord-023095-4dannjjm	5098	10	cycle	cycle	NN
cord-023095-4dannjjm	5098	11	was	be	VBD
cord-023095-4dannjjm	5098	12	evaluated	evaluate	VBN
cord-023095-4dannjjm	5098	13	using	use	VBG
cord-023095-4dannjjm	5098	14	propidium	propidium	NN
cord-023095-4dannjjm	5098	15	iodide	iodide	NN
cord-023095-4dannjjm	5098	16	staining	staining	NN
cord-023095-4dannjjm	5098	17	,	,	,
cord-023095-4dannjjm	5098	18	and	and	CC
cord-023095-4dannjjm	5098	19	apoptosis	apoptosis	NN
cord-023095-4dannjjm	5098	20	was	be	VBD
cord-023095-4dannjjm	5098	21	assessed	assess	VBN
cord-023095-4dannjjm	5098	22	by	by	IN
cord-023095-4dannjjm	5098	23	measuring	measure	VBG
cord-023095-4dannjjm	5098	24	caspase-3/7	caspase-3/7	NNP
cord-023095-4dannjjm	5098	25	activation	activation	NN
cord-023095-4dannjjm	5098	26	.	.	.
cord-023095-4dannjjm	5099	1	Synergy	Synergy	NNP
cord-023095-4dannjjm	5099	2	was	be	VBD
cord-023095-4dannjjm	5099	3	quantified	quantify	VBN
cord-023095-4dannjjm	5099	4	by	by	IN
cord-023095-4dannjjm	5099	5	combination	combination	NN
cord-023095-4dannjjm	5099	6	index	index	NN
cord-023095-4dannjjm	5099	7	analysis	analysis	NN
cord-023095-4dannjjm	5099	8	using	use	VBG
cord-023095-4dannjjm	5099	9	Compusyn	Compusyn	NNP
cord-023095-4dannjjm	5099	10	software	software	NN
cord-023095-4dannjjm	5099	11	.	.	.
cord-023095-4dannjjm	5100	1	Treatment	treatment	NN
cord-023095-4dannjjm	5100	2	of	of	IN
cord-023095-4dannjjm	5100	3	canine	canine	JJ
cord-023095-4dannjjm	5100	4	TCC	TCC	NNP
cord-023095-4dannjjm	5100	5	cell	cell	NN
cord-023095-4dannjjm	5100	6	lines	line	NNS
cord-023095-4dannjjm	5100	7	with	with	IN
cord-023095-4dannjjm	5100	8	carboplatin	carboplatin	NNP
cord-023095-4dannjjm	5100	9	or	or	CC
cord-023095-4dannjjm	5100	10	gemcitabine	gemcitabine	NNP
cord-023095-4dannjjm	5100	11	decreased	decrease	VBD
cord-023095-4dannjjm	5100	12	cell	cell	NN
cord-023095-4dannjjm	5100	13	proliferation	proliferation	NN
cord-023095-4dannjjm	5100	14	,	,	,
cord-023095-4dannjjm	5100	15	induced	induce	VBN
cord-023095-4dannjjm	5100	16	cell	cell	NN
cord-023095-4dannjjm	5100	17	cycle	cycle	NN
cord-023095-4dannjjm	5100	18	arrest	arrest	NN
cord-023095-4dannjjm	5100	19	,	,	,
cord-023095-4dannjjm	5100	20	and	and	CC
cord-023095-4dannjjm	5100	21	apoptosis	apoptosis	NN
cord-023095-4dannjjm	5100	22	.	.	.
cord-023095-4dannjjm	5101	1	When	when	WRB
cord-023095-4dannjjm	5101	2	TCC	TCC	NNP
cord-023095-4dannjjm	5101	3	cell	cell	NN
cord-023095-4dannjjm	5101	4	lines	line	NNS
cord-023095-4dannjjm	5101	5	were	be	VBD
cord-023095-4dannjjm	5101	6	treated	treat	VBN
cord-023095-4dannjjm	5101	7	with	with	IN
cord-023095-4dannjjm	5101	8	gemcitabine	gemcitabine	NNP
cord-023095-4dannjjm	5101	9	and	and	CC
cord-023095-4dannjjm	5101	10	carboplatin	carboplatin	NNPS
cord-023095-4dannjjm	5101	11	in	in	IN
cord-023095-4dannjjm	5101	12	combination	combination	NN
cord-023095-4dannjjm	5101	13	at	at	IN
cord-023095-4dannjjm	5101	14	a	a	DT
cord-023095-4dannjjm	5101	15	therapeutically	therapeutically	RB
cord-023095-4dannjjm	5101	16	relevant	relevant	JJ
cord-023095-4dannjjm	5101	17	concentration	concentration	NN
cord-023095-4dannjjm	5101	18	(	(	-LRB-
cord-023095-4dannjjm	5101	19	gemcitabine	gemcitabine	NNP
cord-023095-4dannjjm	5101	20	o	o	NNP
cord-023095-4dannjjm	5101	21	100uM	100uM	NNP
cord-023095-4dannjjm	5101	22	,	,	,
cord-023095-4dannjjm	5101	23	carboplatin	carboplatin	NNP
cord-023095-4dannjjm	5101	24	o	o	NNP
cord-023095-4dannjjm	5101	25	250uM	250uM	NNP
cord-023095-4dannjjm	5101	26	)	)	-RRB-
cord-023095-4dannjjm	5101	27	,	,	,
cord-023095-4dannjjm	5101	28	a	a	DT
cord-023095-4dannjjm	5101	29	significant	significant	JJ
cord-023095-4dannjjm	5101	30	decrease	decrease	NN
cord-023095-4dannjjm	5101	31	in	in	IN
cord-023095-4dannjjm	5101	32	cell	cell	NN
cord-023095-4dannjjm	5101	33	proliferation	proliferation	NN
cord-023095-4dannjjm	5101	34	was	be	VBD
cord-023095-4dannjjm	5101	35	observed	observe	VBN
cord-023095-4dannjjm	5101	36	compared	compare	VBN
cord-023095-4dannjjm	5101	37	to	to	IN
cord-023095-4dannjjm	5101	38	gemcitabine	gemcitabine	NNP
cord-023095-4dannjjm	5101	39	or	or	CC
cord-023095-4dannjjm	5101	40	carboplatin	carboplatin	VB
cord-023095-4dannjjm	5101	41	alone	alone	RB
cord-023095-4dannjjm	5101	42	,	,	,
cord-023095-4dannjjm	5101	43	and	and	CC
cord-023095-4dannjjm	5101	44	the	the	DT
cord-023095-4dannjjm	5101	45	drug	drug	NN
cord-023095-4dannjjm	5101	46	combination	combination	NN
cord-023095-4dannjjm	5101	47	was	be	VBD
cord-023095-4dannjjm	5101	48	synergistic	synergistic	JJ
cord-023095-4dannjjm	5101	49	in	in	IN
cord-023095-4dannjjm	5101	50	3	3	CD
cord-023095-4dannjjm	5101	51	of	of	IN
cord-023095-4dannjjm	5101	52	5	5	CD
cord-023095-4dannjjm	5101	53	cell	cell	NN
cord-023095-4dannjjm	5101	54	lines	line	NNS
cord-023095-4dannjjm	5101	55	,	,	,
cord-023095-4dannjjm	5101	56	and	and	CC
cord-023095-4dannjjm	5101	57	additive	additive	NN
cord-023095-4dannjjm	5101	58	in	in	IN
cord-023095-4dannjjm	5101	59	the	the	DT
cord-023095-4dannjjm	5101	60	remaining	remain	VBG
cord-023095-4dannjjm	5101	61	2	2	CD
cord-023095-4dannjjm	5101	62	lines	line	NNS
cord-023095-4dannjjm	5101	63	.	.	.
cord-023095-4dannjjm	5102	1	Gemcitabine	Gemcitabine	NNP
cord-023095-4dannjjm	5102	2	exhibits	exhibit	VBZ
cord-023095-4dannjjm	5102	3	biologic	biologic	JJ
cord-023095-4dannjjm	5102	4	activity	activity	NN
cord-023095-4dannjjm	5102	5	against	against	IN
cord-023095-4dannjjm	5102	6	canine	canine	JJ
cord-023095-4dannjjm	5102	7	TCC	TCC	NNP
cord-023095-4dannjjm	5102	8	cell	cell	NN
cord-023095-4dannjjm	5102	9	lines	line	NNS
cord-023095-4dannjjm	5102	10	and	and	CC
cord-023095-4dannjjm	5102	11	carboplatin	carboplatin	NNS
cord-023095-4dannjjm	5102	12	combined	combine	VBN
cord-023095-4dannjjm	5102	13	with	with	IN
cord-023095-4dannjjm	5102	14	gemcitabine	gemcitabine	NNP
cord-023095-4dannjjm	5103	1	exhibits	exhibit	VBZ
cord-023095-4dannjjm	5103	2	synergistic	synergistic	JJ
cord-023095-4dannjjm	5103	3	activity	activity	NN
cord-023095-4dannjjm	5103	4	at	at	IN
cord-023095-4dannjjm	5103	5	biologically	biologically	RB
cord-023095-4dannjjm	5103	6	relevant	relevant	JJ
cord-023095-4dannjjm	5103	7	concentrations	concentration	NNS
cord-023095-4dannjjm	5103	8	.	.	.
cord-023095-4dannjjm	5104	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	5104	2	results	result	NNS
cord-023095-4dannjjm	5104	3	support	support	VBP
cord-023095-4dannjjm	5104	4	further	further	JJ
cord-023095-4dannjjm	5104	5	evaluation	evaluation	NN
cord-023095-4dannjjm	5104	6	of	of	IN
cord-023095-4dannjjm	5104	7	these	these	DT
cord-023095-4dannjjm	5104	8	drugs	drug	NNS
cord-023095-4dannjjm	5104	9	in	in	IN
cord-023095-4dannjjm	5104	10	dogs	dog	NNS
cord-023095-4dannjjm	5104	11	with	with	IN
cord-023095-4dannjjm	5104	12	TCC	TCC	NNP
cord-023095-4dannjjm	5104	13	to	to	TO
cord-023095-4dannjjm	5104	14	determine	determine	VB
cord-023095-4dannjjm	5104	15	the	the	DT
cord-023095-4dannjjm	5104	16	clinical	clinical	JJ
cord-023095-4dannjjm	5104	17	efficacy	efficacy	NN
cord-023095-4dannjjm	5104	18	of	of	IN
cord-023095-4dannjjm	5104	19	this	this	DT
cord-023095-4dannjjm	5104	20	combination	combination	NN
cord-023095-4dannjjm	5104	21	.	.	.
cord-023095-4dannjjm	5105	1	Metronomic	metronomic	JJ
cord-023095-4dannjjm	5105	2	chemotherapy	chemotherapy	NN
cord-023095-4dannjjm	5105	3	has	have	VBZ
cord-023095-4dannjjm	5105	4	been	be	VBN
cord-023095-4dannjjm	5105	5	shown	show	VBN
cord-023095-4dannjjm	5105	6	in	in	IN
cord-023095-4dannjjm	5105	7	murine	murine	JJ
cord-023095-4dannjjm	5105	8	models	model	NNS
cord-023095-4dannjjm	5105	9	and	and	CC
cord-023095-4dannjjm	5105	10	humans	human	NNS
cord-023095-4dannjjm	5105	11	to	to	TO
cord-023095-4dannjjm	5105	12	improve	improve	VB
cord-023095-4dannjjm	5105	13	tumor	tumor	NN
cord-023095-4dannjjm	5105	14	control	control	NN
cord-023095-4dannjjm	5105	15	by	by	IN
cord-023095-4dannjjm	5105	16	inhibiting	inhibit	VBG
cord-023095-4dannjjm	5105	17	tumor	tumor	NN
cord-023095-4dannjjm	5105	18	angiogenesis	angiogenesis	NN
cord-023095-4dannjjm	5105	19	and	and	CC
cord-023095-4dannjjm	5105	20	suppressing	suppress	VBG
cord-023095-4dannjjm	5105	21	regulatory	regulatory	JJ
cord-023095-4dannjjm	5105	22	T	t	NN
cord-023095-4dannjjm	5105	23	cells	cell	NNS
cord-023095-4dannjjm	5105	24	(	(	-LRB-
cord-023095-4dannjjm	5105	25	Treg	Treg	NNP
cord-023095-4dannjjm	5105	26	)	)	-RRB-
cord-023095-4dannjjm	5105	27	.	.	.
cord-023095-4dannjjm	5106	1	Treg	Treg	NNP
cord-023095-4dannjjm	5106	2	are	be	VBP
cord-023095-4dannjjm	5106	3	a	a	DT
cord-023095-4dannjjm	5106	4	subset	subset	NN
cord-023095-4dannjjm	5106	5	of	of	IN
cord-023095-4dannjjm	5106	6	T	t	NN
cord-023095-4dannjjm	5106	7	lymphocytes	lymphocyte	NNS
cord-023095-4dannjjm	5106	8	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	5106	9	to	to	TO
cord-023095-4dannjjm	5106	10	be	be	VB
cord-023095-4dannjjm	5106	11	increased	increase	VBN
cord-023095-4dannjjm	5106	12	in	in	IN
cord-023095-4dannjjm	5106	13	humans	human	NNS
cord-023095-4dannjjm	5106	14	and	and	CC
cord-023095-4dannjjm	5106	15	dogs	dog	NNS
cord-023095-4dannjjm	5106	16	with	with	IN
cord-023095-4dannjjm	5106	17	cancer	cancer	NN
cord-023095-4dannjjm	5106	18	and	and	CC
cord-023095-4dannjjm	5106	19	are	be	VBP
cord-023095-4dannjjm	5106	20	thought	think	VBN
cord-023095-4dannjjm	5106	21	to	to	TO
cord-023095-4dannjjm	5106	22	suppress	suppress	VB
cord-023095-4dannjjm	5106	23	cellular	cellular	JJ
cord-023095-4dannjjm	5106	24	immune	immune	JJ
cord-023095-4dannjjm	5106	25	responses	response	NNS
cord-023095-4dannjjm	5106	26	against	against	IN
cord-023095-4dannjjm	5106	27	tumors	tumor	NNS
cord-023095-4dannjjm	5106	28	.	.	.
cord-023095-4dannjjm	5107	1	The	the	DT
cord-023095-4dannjjm	5107	2	purpose	purpose	NN
cord-023095-4dannjjm	5107	3	of	of	IN
cord-023095-4dannjjm	5107	4	this	this	DT
cord-023095-4dannjjm	5107	5	study	study	NN
cord-023095-4dannjjm	5107	6	was	be	VBD
cord-023095-4dannjjm	5107	7	to	to	TO
cord-023095-4dannjjm	5107	8	determine	determine	VB
cord-023095-4dannjjm	5107	9	whether	whether	IN
cord-023095-4dannjjm	5107	10	metronomic	metronomic	JJ
cord-023095-4dannjjm	5107	11	cyclophosphamide	cyclophosphamide	JJ
cord-023095-4dannjjm	5107	12	therapy	therapy	NN
cord-023095-4dannjjm	5107	13	depletes	deplete	VBZ
cord-023095-4dannjjm	5107	14	Treg	Treg	NNP
cord-023095-4dannjjm	5107	15	and/or	and/or	CC
cord-023095-4dannjjm	5107	16	exhibits	exhibit	VBZ
cord-023095-4dannjjm	5107	17	antiangiogenic	antiangiogenic	JJ
cord-023095-4dannjjm	5107	18	activity	activity	NN
cord-023095-4dannjjm	5107	19	in	in	IN
cord-023095-4dannjjm	5107	20	dogs	dog	NNS
cord-023095-4dannjjm	5107	21	with	with	IN
cord-023095-4dannjjm	5107	22	soft	soft	JJ
cord-023095-4dannjjm	5107	23	tissue	tissue	NN
cord-023095-4dannjjm	5107	24	sarcoma	sarcoma	NN
cord-023095-4dannjjm	5107	25	.	.	.
cord-023095-4dannjjm	5108	1	Client	client	NN
cord-023095-4dannjjm	5108	2	owned	own	VBD
cord-023095-4dannjjm	5108	3	dogs	dog	NNS
cord-023095-4dannjjm	5109	1	with	with	IN
cord-023095-4dannjjm	5109	2	histologically	histologically	RB
cord-023095-4dannjjm	5109	3	confirmed	confirm	VBN
cord-023095-4dannjjm	5109	4	grade	grade	NN
cord-023095-4dannjjm	5109	5	I	-PRON-	PRP
cord-023095-4dannjjm	5109	6	or	or	CC
cord-023095-4dannjjm	5109	7	II	ii	CD
cord-023095-4dannjjm	5109	8	soft	soft	JJ
cord-023095-4dannjjm	5109	9	tissue	tissue	NN
cord-023095-4dannjjm	5109	10	sarcoma	sarcoma	NN
cord-023095-4dannjjm	5109	11	were	be	VBD
cord-023095-4dannjjm	5109	12	administered	administer	VBN
cord-023095-4dannjjm	5109	13	cyclophosphamide	cyclophosphamide	RB
cord-023095-4dannjjm	5109	14	at	at	IN
cord-023095-4dannjjm	5109	15	12.5	12.5	CD
cord-023095-4dannjjm	5109	16	mg	mg	NNP
cord-023095-4dannjjm	5109	17	/	/	SYM
cord-023095-4dannjjm	5109	18	m	m	NNP
cord-023095-4dannjjm	5109	19	2	2	CD
cord-023095-4dannjjm	5109	20	or	or	CC
cord-023095-4dannjjm	5109	21	15	15	CD
cord-023095-4dannjjm	5110	1	mg	mg	NNP
cord-023095-4dannjjm	5110	2	/	/	SYM
cord-023095-4dannjjm	5110	3	m	m	NNP
cord-023095-4dannjjm	5110	4	2	2	CD
cord-023095-4dannjjm	5110	5	orally	orally	RB
cord-023095-4dannjjm	5110	6	once	once	RB
cord-023095-4dannjjm	5110	7	daily	daily	RB
cord-023095-4dannjjm	5110	8	for	for	IN
cord-023095-4dannjjm	5110	9	28	28	CD
cord-023095-4dannjjm	5110	10	days	day	NNS
cord-023095-4dannjjm	5110	11	.	.	.
cord-023095-4dannjjm	5111	1	Whole	whole	JJ
cord-023095-4dannjjm	5111	2	blood	blood	NN
cord-023095-4dannjjm	5111	3	and	and	CC
cord-023095-4dannjjm	5111	4	tumor	tumor	NN
cord-023095-4dannjjm	5111	5	biopsies	biopsy	NNS
cord-023095-4dannjjm	5111	6	were	be	VBD
cord-023095-4dannjjm	5111	7	obtained	obtain	VBN
cord-023095-4dannjjm	5111	8	on	on	IN
cord-023095-4dannjjm	5111	9	days	day	NNS
cord-023095-4dannjjm	5111	10	0	0	CD
cord-023095-4dannjjm	5111	11	,	,	,
cord-023095-4dannjjm	5111	12	14	14	CD
cord-023095-4dannjjm	5111	13	,	,	,
cord-023095-4dannjjm	5111	14	and	and	CC
cord-023095-4dannjjm	5111	15	28	28	CD
cord-023095-4dannjjm	5111	16	.	.	.
cord-023095-4dannjjm	5112	1	Flow	flow	VB
cord-023095-4dannjjm	5112	2	cytometric	cytometric	NN
cord-023095-4dannjjm	5112	3	analysis	analysis	NN
cord-023095-4dannjjm	5112	4	of	of	IN
cord-023095-4dannjjm	5112	5	blood	blood	NN
cord-023095-4dannjjm	5112	6	was	be	VBD
cord-023095-4dannjjm	5112	7	performed	perform	VBN
cord-023095-4dannjjm	5112	8	to	to	TO
cord-023095-4dannjjm	5112	9	assess	assess	VB
cord-023095-4dannjjm	5112	10	changes	change	NNS
cord-023095-4dannjjm	5112	11	in	in	IN
cord-023095-4dannjjm	5112	12	T	T	NNP
cord-023095-4dannjjm	5112	13	lymphocyte	lymphocyte	NN
cord-023095-4dannjjm	5112	14	subsets	subset	NNS
cord-023095-4dannjjm	5112	15	,	,	,
cord-023095-4dannjjm	5112	16	including	include	VBG
cord-023095-4dannjjm	5112	17	CD4	CD4	NNP
cord-023095-4dannjjm	5112	18	1	1	CD
cord-023095-4dannjjm	5112	19	and	and	CC
cord-023095-4dannjjm	5112	20	CD8	CD8	NNP
cord-023095-4dannjjm	5112	21	1	1	CD
cord-023095-4dannjjm	5112	22	cells	cell	NNS
cord-023095-4dannjjm	5112	23	as	as	RB
cord-023095-4dannjjm	5112	24	well	well	RB
cord-023095-4dannjjm	5112	25	as	as	IN
cord-023095-4dannjjm	5112	26	CD4	CD4	NNP
cord-023095-4dannjjm	5112	27	1	1	CD
cord-023095-4dannjjm	5112	28	FoxP3	FoxP3	NNP
cord-023095-4dannjjm	5112	29	1	1	CD
cord-023095-4dannjjm	5112	30	Treg	Treg	NNP
cord-023095-4dannjjm	5112	31	.	.	.
cord-023095-4dannjjm	5113	1	Tumor	tumor	NN
cord-023095-4dannjjm	5113	2	microvessel	microvessel	NN
cord-023095-4dannjjm	5113	3	density	density	NN
cord-023095-4dannjjm	5113	4	(	(	-LRB-
cord-023095-4dannjjm	5113	5	MVD	MVD	NNP
cord-023095-4dannjjm	5113	6	)	)	-RRB-
cord-023095-4dannjjm	5113	7	was	be	VBD
cord-023095-4dannjjm	5113	8	assessed	assess	VBN
cord-023095-4dannjjm	5113	9	by	by	IN
cord-023095-4dannjjm	5113	10	performing	perform	VBG
cord-023095-4dannjjm	5113	11	immunohistochemistry	immunohistochemistry	NN
cord-023095-4dannjjm	5113	12	for	for	IN
cord-023095-4dannjjm	5113	13	CD146	CD146	NNP
cord-023095-4dannjjm	5113	14	.	.	.
cord-023095-4dannjjm	5114	1	Five	five	CD
cord-023095-4dannjjm	5114	2	dogs	dog	NNS
cord-023095-4dannjjm	5114	3	were	be	VBD
cord-023095-4dannjjm	5114	4	enrolled	enrol	VBN
cord-023095-4dannjjm	5114	5	in	in	IN
cord-023095-4dannjjm	5114	6	the	the	DT
cord-023095-4dannjjm	5114	7	12.5	12.5	CD
cord-023095-4dannjjm	5114	8	mg	mg	NNP
cord-023095-4dannjjm	5114	9	/	/	SYM
cord-023095-4dannjjm	5114	10	m	m	NNP
cord-023095-4dannjjm	5114	11	2	2	CD
cord-023095-4dannjjm	5114	12	/day	/day	CD
cord-023095-4dannjjm	5114	13	dose	dose	NN
cord-023095-4dannjjm	5114	14	cohort	cohort	NN
cord-023095-4dannjjm	5114	15	and	and	CC
cord-023095-4dannjjm	5114	16	six	six	CD
cord-023095-4dannjjm	5114	17	dogs	dog	NNS
cord-023095-4dannjjm	5114	18	were	be	VBD
cord-023095-4dannjjm	5114	19	enrolled	enrol	VBN
cord-023095-4dannjjm	5114	20	in	in	IN
cord-023095-4dannjjm	5114	21	the	the	DT
cord-023095-4dannjjm	5114	22	15.0	15.0	CD
cord-023095-4dannjjm	5114	23	mg	mg	NNP
cord-023095-4dannjjm	5114	24	/	/	SYM
cord-023095-4dannjjm	5114	25	m	m	NN
cord-023095-4dannjjm	5114	26	2	2	CD
cord-023095-4dannjjm	5114	27	/day	/day	CD
cord-023095-4dannjjm	5114	28	dose	dose	NN
cord-023095-4dannjjm	5114	29	cohort	cohort	NN
cord-023095-4dannjjm	5114	30	.	.	.
cord-023095-4dannjjm	5115	1	In	in	IN
cord-023095-4dannjjm	5115	2	patients	patient	NNS
cord-023095-4dannjjm	5115	3	that	that	WDT
cord-023095-4dannjjm	5115	4	received	receive	VBD
cord-023095-4dannjjm	5115	5	cyclophosphamide	cyclophosphamide	RB
cord-023095-4dannjjm	5115	6	at	at	IN
cord-023095-4dannjjm	5115	7	12.5	12.5	CD
cord-023095-4dannjjm	5115	8	mg	mg	NNP
cord-023095-4dannjjm	5115	9	/	/	SYM
cord-023095-4dannjjm	5115	10	m	m	NNP
cord-023095-4dannjjm	5115	11	2	2	CD
cord-023095-4dannjjm	5115	12	/day	/day	CD
cord-023095-4dannjjm	5115	13	,	,	,
cord-023095-4dannjjm	5115	14	the	the	DT
cord-023095-4dannjjm	5115	15	mean	mean	JJ
cord-023095-4dannjjm	5115	16	number	number	NN
cord-023095-4dannjjm	5115	17	of	of	IN
cord-023095-4dannjjm	5115	18	Treg	Treg	NNP
cord-023095-4dannjjm	5115	19	decreased	decrease	VBD
cord-023095-4dannjjm	5115	20	from	from	IN
cord-023095-4dannjjm	5115	21	day	day	NN
cord-023095-4dannjjm	5115	22	0	0	CD
cord-023095-4dannjjm	5115	23	to	to	IN
cord-023095-4dannjjm	5115	24	28	28	CD
cord-023095-4dannjjm	5115	25	but	but	CC
cord-023095-4dannjjm	5115	26	there	there	EX
cord-023095-4dannjjm	5115	27	was	be	VBD
cord-023095-4dannjjm	5115	28	no	no	DT
cord-023095-4dannjjm	5115	29	change	change	NN
cord-023095-4dannjjm	5115	30	in	in	IN
cord-023095-4dannjjm	5115	31	the	the	DT
cord-023095-4dannjjm	5115	32	mean	mean	JJ
cord-023095-4dannjjm	5115	33	percentage	percentage	NN
cord-023095-4dannjjm	5115	34	of	of	IN
cord-023095-4dannjjm	5115	35	Treg	Treg	NNP
cord-023095-4dannjjm	5115	36	or	or	CC
cord-023095-4dannjjm	5115	37	MVD	MVD	NNP
cord-023095-4dannjjm	5115	38	.	.	.
cord-023095-4dannjjm	5116	1	For	for	IN
cord-023095-4dannjjm	5116	2	patients	patient	NNS
cord-023095-4dannjjm	5116	3	that	that	WDT
cord-023095-4dannjjm	5116	4	received	receive	VBD
cord-023095-4dannjjm	5116	5	15.0	15.0	CD
cord-023095-4dannjjm	5116	6	mg	mg	NNP
cord-023095-4dannjjm	5116	7	/	/	SYM
cord-023095-4dannjjm	5116	8	m	m	NN
cord-023095-4dannjjm	5116	9	2	2	CD
cord-023095-4dannjjm	5116	10	/day	/day	CD
cord-023095-4dannjjm	5116	11	,	,	,
cord-023095-4dannjjm	5116	12	both	both	CC
cord-023095-4dannjjm	5116	13	the	the	DT
cord-023095-4dannjjm	5116	14	mean	mean	JJ
cord-023095-4dannjjm	5116	15	number	number	NN
cord-023095-4dannjjm	5116	16	and	and	CC
cord-023095-4dannjjm	5116	17	percent	percent	NN
cord-023095-4dannjjm	5116	18	of	of	IN
cord-023095-4dannjjm	5116	19	Treg	Treg	NNP
cord-023095-4dannjjm	5116	20	as	as	RB
cord-023095-4dannjjm	5116	21	well	well	RB
cord-023095-4dannjjm	5116	22	as	as	IN
cord-023095-4dannjjm	5116	23	MVD	MVD	NNP
cord-023095-4dannjjm	5116	24	decreased	decrease	VBD
cord-023095-4dannjjm	5116	25	over	over	IN
cord-023095-4dannjjm	5116	26	the	the	DT
cord-023095-4dannjjm	5116	27	28	28	CD
cord-023095-4dannjjm	5116	28	day	day	NN
cord-023095-4dannjjm	5116	29	time	time	NN
cord-023095-4dannjjm	5116	30	period	period	NN
cord-023095-4dannjjm	5116	31	.	.	.
cord-023095-4dannjjm	5117	1	Cyclophosphamide	Cyclophosphamide	NNP
cord-023095-4dannjjm	5117	2	at	at	IN
cord-023095-4dannjjm	5117	3	15.0	15.0	CD
cord-023095-4dannjjm	5117	4	mg	mg	NNP
cord-023095-4dannjjm	5117	5	/	/	SYM
cord-023095-4dannjjm	5117	6	m	m	NN
cord-023095-4dannjjm	5117	7	2	2	CD
cord-023095-4dannjjm	5117	8	/day	/day	.
cord-023095-4dannjjm	5117	9	or	or	CC
cord-023095-4dannjjm	5117	10	greater	great	JJR
cord-023095-4dannjjm	5117	11	selectively	selectively	RB
cord-023095-4dannjjm	5117	12	depletes	deplete	VBZ
cord-023095-4dannjjm	5117	13	Treg	Treg	NNP
cord-023095-4dannjjm	5117	14	and	and	CC
cord-023095-4dannjjm	5117	15	inhibits	inhibit	VBZ
cord-023095-4dannjjm	5117	16	angiogenesis	angiogenesis	NN
cord-023095-4dannjjm	5117	17	in	in	IN
cord-023095-4dannjjm	5117	18	dogs	dog	NNS
cord-023095-4dannjjm	5117	19	with	with	IN
cord-023095-4dannjjm	5117	20	soft	soft	JJ
cord-023095-4dannjjm	5117	21	tissue	tissue	NN
cord-023095-4dannjjm	5117	22	sarcoma	sarcoma	NN
cord-023095-4dannjjm	5117	23	.	.	.
cord-023095-4dannjjm	5118	1	Arsenic	arsenic	NN
cord-023095-4dannjjm	5118	2	trioxide	trioxide	NN
cord-023095-4dannjjm	5118	3	(	(	-LRB-
cord-023095-4dannjjm	5118	4	ATO	ATO	NNP
cord-023095-4dannjjm	5118	5	)	)	-RRB-
cord-023095-4dannjjm	5118	6	is	be	VBZ
cord-023095-4dannjjm	5118	7	used	use	VBN
cord-023095-4dannjjm	5118	8	to	to	TO
cord-023095-4dannjjm	5118	9	treat	treat	VB
cord-023095-4dannjjm	5118	10	leukemias	leukemia	NNS
cord-023095-4dannjjm	5118	11	,	,	,
cord-023095-4dannjjm	5118	12	multiple	multiple	JJ
cord-023095-4dannjjm	5118	13	myeloma	myeloma	NN
cord-023095-4dannjjm	5118	14	,	,	,
cord-023095-4dannjjm	5118	15	and	and	CC
cord-023095-4dannjjm	5118	16	relapsed	relapse	VBN
cord-023095-4dannjjm	5118	17	lymphoid	lymphoid	JJ
cord-023095-4dannjjm	5118	18	malignancies	malignancy	NNS
cord-023095-4dannjjm	5118	19	in	in	IN
cord-023095-4dannjjm	5118	20	humans	human	NNS
cord-023095-4dannjjm	5118	21	;	;	:
cord-023095-4dannjjm	5118	22	its	-PRON-	PRP$
cord-023095-4dannjjm	5118	23	use	use	NN
cord-023095-4dannjjm	5118	24	has	have	VBZ
cord-023095-4dannjjm	5118	25	not	not	RB
cord-023095-4dannjjm	5118	26	been	be	VBN
cord-023095-4dannjjm	5118	27	explored	explore	VBN
cord-023095-4dannjjm	5118	28	in	in	IN
cord-023095-4dannjjm	5118	29	veterinary	veterinary	JJ
cord-023095-4dannjjm	5118	30	oncology	oncology	NN
cord-023095-4dannjjm	5118	31	.	.	.
cord-023095-4dannjjm	5119	1	Prior	prior	JJ
cord-023095-4dannjjm	5119	2	therapy	therapy	NN
cord-023095-4dannjjm	5119	3	with	with	IN
cord-023095-4dannjjm	5119	4	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	5119	5	decreases	decrease	VBZ
cord-023095-4dannjjm	5119	6	likelihood	likelihood	NN
cord-023095-4dannjjm	5119	7	and	and	CC
cord-023095-4dannjjm	5119	8	duration	duration	NN
cord-023095-4dannjjm	5119	9	of	of	IN
cord-023095-4dannjjm	5119	10	remission	remission	NN
cord-023095-4dannjjm	5119	11	for	for	IN
cord-023095-4dannjjm	5119	12	dogs	dog	NNS
cord-023095-4dannjjm	5119	13	with	with	IN
cord-023095-4dannjjm	5119	14	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5119	15	treated	treat	VBN
cord-023095-4dannjjm	5119	16	with	with	IN
cord-023095-4dannjjm	5119	17	chemotherapy	chemotherapy	NN
cord-023095-4dannjjm	5119	18	.	.	.
cord-023095-4dannjjm	5120	1	We	-PRON-	PRP
cord-023095-4dannjjm	5120	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	5120	3	that	that	IN
cord-023095-4dannjjm	5120	4	ATO	ATO	NNP
cord-023095-4dannjjm	5120	5	will	will	MD
cord-023095-4dannjjm	5120	6	re	re	VB
cord-023095-4dannjjm	5120	7	-	-	VB
cord-023095-4dannjjm	5120	8	sensitize	sensitize	VB
cord-023095-4dannjjm	5120	9	glucocorticoid	glucocorticoid	NN
cord-023095-4dannjjm	5120	10	-	-	HYPH
cord-023095-4dannjjm	5120	11	resistant	resistant	JJ
cord-023095-4dannjjm	5120	12	canine	canine	JJ
cord-023095-4dannjjm	5120	13	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5120	14	cells	cell	NNS
cord-023095-4dannjjm	5120	15	to	to	IN
cord-023095-4dannjjm	5120	16	glucocorticoid	glucocorticoid	NN
cord-023095-4dannjjm	5120	17	-	-	HYPH
cord-023095-4dannjjm	5120	18	induced	induce	VBN
cord-023095-4dannjjm	5120	19	apoptotic	apoptotic	JJ
cord-023095-4dannjjm	5120	20	death	death	NN
cord-023095-4dannjjm	5120	21	.	.	.
cord-023095-4dannjjm	5121	1	The	the	DT
cord-023095-4dannjjm	5121	2	OSW	OSW	NNP
cord-023095-4dannjjm	5121	3	canine	canine	JJ
cord-023095-4dannjjm	5121	4	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5121	5	cell	cell	NN
cord-023095-4dannjjm	5121	6	line	line	NN
cord-023095-4dannjjm	5121	7	was	be	VBD
cord-023095-4dannjjm	5121	8	cultured	culture	VBN
cord-023095-4dannjjm	5121	9	with	with	IN
cord-023095-4dannjjm	5121	10	200	200	CD
cord-023095-4dannjjm	5121	11	uM	um	UH
cord-023095-4dannjjm	5121	12	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	5121	13	.	.	.
cord-023095-4dannjjm	5122	1	Remaining	remain	VBG
cord-023095-4dannjjm	5122	2	viable	viable	JJ
cord-023095-4dannjjm	5122	3	dividing	dividing	NN
cord-023095-4dannjjm	5122	4	cells	cell	NNS
cord-023095-4dannjjm	5122	5	were	be	VBD
cord-023095-4dannjjm	5122	6	considered	consider	VBN
cord-023095-4dannjjm	5122	7	resistant	resistant	JJ
cord-023095-4dannjjm	5122	8	.	.	.
cord-023095-4dannjjm	5123	1	Resistant	resistant	JJ
cord-023095-4dannjjm	5123	2	cells	cell	NNS
cord-023095-4dannjjm	5123	3	were	be	VBD
cord-023095-4dannjjm	5123	4	exposed	expose	VBN
cord-023095-4dannjjm	5123	5	to	to	IN
cord-023095-4dannjjm	5123	6	0.01	0.01	CD
cord-023095-4dannjjm	5123	7	uM	um	UH
cord-023095-4dannjjm	5123	8	and	and	CC
cord-023095-4dannjjm	5123	9	0.02	0.02	CD
cord-023095-4dannjjm	5123	10	uM	um	UH
cord-023095-4dannjjm	5123	11	of	of	IN
cord-023095-4dannjjm	5123	12	ATO	ATO	NNP
cord-023095-4dannjjm	5123	13	without	without	IN
cord-023095-4dannjjm	5123	14	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	5123	15	,	,	,
cord-023095-4dannjjm	5123	16	after	after	IN
cord-023095-4dannjjm	5123	17	which	which	WDT
cord-023095-4dannjjm	5123	18	cells	cell	NNS
cord-023095-4dannjjm	5123	19	were	be	VBD
cord-023095-4dannjjm	5123	20	washed	wash	VBN
cord-023095-4dannjjm	5123	21	and	and	CC
cord-023095-4dannjjm	5123	22	re	re	VBN
cord-023095-4dannjjm	5123	23	-	-	VBN
cord-023095-4dannjjm	5123	24	exposed	expose	VBN
cord-023095-4dannjjm	5123	25	to	to	IN
cord-023095-4dannjjm	5123	26	200	200	CD
cord-023095-4dannjjm	5123	27	uM	um	UH
cord-023095-4dannjjm	5123	28	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	5123	29	.	.	.
cord-023095-4dannjjm	5124	1	After	after	IN
cord-023095-4dannjjm	5124	2	24	24	CD
cord-023095-4dannjjm	5124	3	,	,	,
cord-023095-4dannjjm	5124	4	48	48	CD
cord-023095-4dannjjm	5124	5	and	and	CC
cord-023095-4dannjjm	5124	6	72	72	CD
cord-023095-4dannjjm	5124	7	hours	hour	NNS
cord-023095-4dannjjm	5124	8	of	of	IN
cord-023095-4dannjjm	5124	9	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	5124	10	exposure	exposure	NN
cord-023095-4dannjjm	5124	11	,	,	,
cord-023095-4dannjjm	5124	12	cells	cell	NNS
cord-023095-4dannjjm	5124	13	were	be	VBD
cord-023095-4dannjjm	5124	14	counted	count	VBN
cord-023095-4dannjjm	5124	15	using	use	VBG
cord-023095-4dannjjm	5124	16	Trypan	Trypan	NNP
cord-023095-4dannjjm	5124	17	blue	blue	JJ
cord-023095-4dannjjm	5124	18	stain	stain	NN
cord-023095-4dannjjm	5124	19	.	.	.
cord-023095-4dannjjm	5125	1	Apoptosis	apoptosis	NN
cord-023095-4dannjjm	5125	2	was	be	VBD
cord-023095-4dannjjm	5125	3	assessed	assess	VBN
cord-023095-4dannjjm	5125	4	by	by	IN
cord-023095-4dannjjm	5125	5	TUNEL	TUNEL	NNP
cord-023095-4dannjjm	5125	6	assays	assay	NNS
cord-023095-4dannjjm	5125	7	on	on	IN
cord-023095-4dannjjm	5125	8	cytospin	cytospin	NNP
cord-023095-4dannjjm	5125	9	preparations	preparation	NNS
cord-023095-4dannjjm	5125	10	collected	collect	VBD
cord-023095-4dannjjm	5125	11	at	at	IN
cord-023095-4dannjjm	5125	12	24	24	CD
cord-023095-4dannjjm	5125	13	,	,	,
cord-023095-4dannjjm	5125	14	48	48	CD
cord-023095-4dannjjm	5125	15	,	,	,
cord-023095-4dannjjm	5125	16	and	and	CC
cord-023095-4dannjjm	5125	17	72	72	CD
cord-023095-4dannjjm	5125	18	hours	hour	NNS
cord-023095-4dannjjm	5125	19	from	from	IN
cord-023095-4dannjjm	5125	20	ATO	ATO	NNP
cord-023095-4dannjjm	5125	21	-	-	HYPH
cord-023095-4dannjjm	5125	22	exposed	expose	VBN
cord-023095-4dannjjm	5125	23	and	and	CC
cord-023095-4dannjjm	5125	24	control	control	NN
cord-023095-4dannjjm	5125	25	groups	group	NNS
cord-023095-4dannjjm	5125	26	.	.	.
cord-023095-4dannjjm	5126	1	Statistical	statistical	JJ
cord-023095-4dannjjm	5126	2	analysis	analysis	NN
cord-023095-4dannjjm	5126	3	was	be	VBD
cord-023095-4dannjjm	5126	4	performed	perform	VBN
cord-023095-4dannjjm	5126	5	using	use	VBG
cord-023095-4dannjjm	5126	6	1	1	CD
cord-023095-4dannjjm	5126	7	way	way	NN
cord-023095-4dannjjm	5126	8	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	5126	9	and	and	CC
cord-023095-4dannjjm	5126	10	Tukey	Tukey	NNP
cord-023095-4dannjjm	5126	11	's	's	POS
cord-023095-4dannjjm	5126	12	test	test	NN
cord-023095-4dannjjm	5126	13	.	.	.
cord-023095-4dannjjm	5127	1	The	the	DT
cord-023095-4dannjjm	5127	2	proportion	proportion	NN
cord-023095-4dannjjm	5127	3	of	of	IN
cord-023095-4dannjjm	5127	4	dead	dead	JJ
cord-023095-4dannjjm	5127	5	cells	cell	NNS
cord-023095-4dannjjm	5127	6	increased	increase	VBD
cord-023095-4dannjjm	5127	7	over	over	IN
cord-023095-4dannjjm	5127	8	time	time	NN
cord-023095-4dannjjm	5127	9	in	in	IN
cord-023095-4dannjjm	5127	10	both	both	DT
cord-023095-4dannjjm	5127	11	0.01	0.01	CD
cord-023095-4dannjjm	5127	12	uM	um	UH
cord-023095-4dannjjm	5127	13	and	and	CC
cord-023095-4dannjjm	5127	14	0.02	0.02	CD
cord-023095-4dannjjm	5127	15	uM	um	UH
cord-023095-4dannjjm	5127	16	ATO	ATO	NNP
cord-023095-4dannjjm	5127	17	exposed	expose	VBD
cord-023095-4dannjjm	5127	18	groups	group	NNS
cord-023095-4dannjjm	5127	19	.	.	.
cord-023095-4dannjjm	5128	1	The	the	DT
cord-023095-4dannjjm	5128	2	proportion	proportion	NN
cord-023095-4dannjjm	5128	3	of	of	IN
cord-023095-4dannjjm	5128	4	dead	dead	JJ
cord-023095-4dannjjm	5128	5	cells	cell	NNS
cord-023095-4dannjjm	5128	6	was	be	VBD
cord-023095-4dannjjm	5128	7	greater	great	JJR
cord-023095-4dannjjm	5128	8	for	for	IN
cord-023095-4dannjjm	5128	9	0.01	0.01	CD
cord-023095-4dannjjm	5128	10	uM	um	UH
cord-023095-4dannjjm	5128	11	ATO	ATO	NNP
cord-023095-4dannjjm	5128	12	(	(	-LRB-
cord-023095-4dannjjm	5128	13	p	p	NN
cord-023095-4dannjjm	5128	14	o	o	CD
cord-023095-4dannjjm	5128	15	0.001	0.001	CD
cord-023095-4dannjjm	5128	16	)	)	-RRB-
cord-023095-4dannjjm	5128	17	and	and	CC
cord-023095-4dannjjm	5128	18	0.02	0.02	CD
cord-023095-4dannjjm	5128	19	uM	um	UH
cord-023095-4dannjjm	5128	20	(	(	-LRB-
cord-023095-4dannjjm	5128	21	p	p	NN
cord-023095-4dannjjm	5128	22	o	o	NN
cord-023095-4dannjjm	5128	23	0.001	0.001	CD
cord-023095-4dannjjm	5128	24	)	)	-RRB-
cord-023095-4dannjjm	5128	25	groups	group	NNS
cord-023095-4dannjjm	5128	26	compared	compare	VBN
cord-023095-4dannjjm	5128	27	to	to	IN
cord-023095-4dannjjm	5128	28	control	control	NN
cord-023095-4dannjjm	5128	29	.	.	.
cord-023095-4dannjjm	5129	1	Apoptosis	apoptosis	NN
cord-023095-4dannjjm	5129	2	increased	increase	VBD
cord-023095-4dannjjm	5129	3	with	with	IN
cord-023095-4dannjjm	5129	4	increasing	increase	VBG
cord-023095-4dannjjm	5129	5	ATO	ATO	NNP
cord-023095-4dannjjm	5129	6	concentration	concentration	NN
cord-023095-4dannjjm	5129	7	and	and	CC
cord-023095-4dannjjm	5129	8	duration	duration	NN
cord-023095-4dannjjm	5129	9	of	of	IN
cord-023095-4dannjjm	5129	10	dexamethasone	dexamethasone	NN
cord-023095-4dannjjm	5129	11	exposure	exposure	NN
cord-023095-4dannjjm	5129	12	compared	compare	VBN
cord-023095-4dannjjm	5129	13	to	to	IN
cord-023095-4dannjjm	5129	14	control	control	NN
cord-023095-4dannjjm	5129	15	.	.	.
cord-023095-4dannjjm	5130	1	These	these	DT
cord-023095-4dannjjm	5130	2	results	result	NNS
cord-023095-4dannjjm	5130	3	support	support	VBP
cord-023095-4dannjjm	5130	4	the	the	DT
cord-023095-4dannjjm	5130	5	effectiveness	effectiveness	NN
cord-023095-4dannjjm	5130	6	of	of	IN
cord-023095-4dannjjm	5130	7	ATO	ATO	NNP
cord-023095-4dannjjm	5130	8	at	at	IN
cord-023095-4dannjjm	5130	9	re	re	NN
cord-023095-4dannjjm	5130	10	-	-	JJ
cord-023095-4dannjjm	5130	11	sensitizing	sensitize	VBG
cord-023095-4dannjjm	5130	12	glucocorticoid	glucocorticoid	NN
cord-023095-4dannjjm	5130	13	-	-	HYPH
cord-023095-4dannjjm	5130	14	resistant	resistant	JJ
cord-023095-4dannjjm	5130	15	canine	canine	JJ
cord-023095-4dannjjm	5130	16	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5130	17	cells	cell	NNS
cord-023095-4dannjjm	5130	18	to	to	IN
cord-023095-4dannjjm	5130	19	apoptotic	apoptotic	JJ
cord-023095-4dannjjm	5130	20	death	death	NN
cord-023095-4dannjjm	5130	21	following	follow	VBG
cord-023095-4dannjjm	5130	22	re	re	NN
cord-023095-4dannjjm	5130	23	-	-	NN
cord-023095-4dannjjm	5130	24	exposure	exposure	NN
cord-023095-4dannjjm	5130	25	to	to	IN
cord-023095-4dannjjm	5130	26	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	5130	27	.	.	.
cord-023095-4dannjjm	5131	1	Ongoing	ongoing	JJ
cord-023095-4dannjjm	5131	2	gene	gene	NN
cord-023095-4dannjjm	5131	3	expression	expression	NN
cord-023095-4dannjjm	5131	4	studies	study	NNS
cord-023095-4dannjjm	5131	5	aim	aim	VBP
cord-023095-4dannjjm	5131	6	to	to	TO
cord-023095-4dannjjm	5131	7	elucidate	elucidate	VB
cord-023095-4dannjjm	5131	8	this	this	DT
cord-023095-4dannjjm	5131	9	mechanism	mechanism	NN
cord-023095-4dannjjm	5131	10	.	.	.
cord-023095-4dannjjm	5132	1	Additional	additional	JJ
cord-023095-4dannjjm	5132	2	studies	study	NNS
cord-023095-4dannjjm	5132	3	to	to	TO
cord-023095-4dannjjm	5132	4	determine	determine	VB
cord-023095-4dannjjm	5132	5	if	if	IN
cord-023095-4dannjjm	5132	6	this	this	DT
cord-023095-4dannjjm	5132	7	effect	effect	NN
cord-023095-4dannjjm	5132	8	is	be	VBZ
cord-023095-4dannjjm	5132	9	seen	see	VBN
cord-023095-4dannjjm	5132	10	with	with	IN
cord-023095-4dannjjm	5132	11	other	other	JJ
cord-023095-4dannjjm	5132	12	chemotherapeutic	chemotherapeutic	JJ
cord-023095-4dannjjm	5132	13	agents	agent	NNS
cord-023095-4dannjjm	5132	14	are	be	VBP
cord-023095-4dannjjm	5132	15	warranted	warrant	VBN
cord-023095-4dannjjm	5132	16	.	.	.
cord-023095-4dannjjm	5133	1	Lymphoma	Lymphoma	NNP
cord-023095-4dannjjm	5133	2	is	be	VBZ
cord-023095-4dannjjm	5133	3	the	the	DT
cord-023095-4dannjjm	5133	4	most	most	RBS
cord-023095-4dannjjm	5133	5	common	common	JJ
cord-023095-4dannjjm	5133	6	hematopoietic	hematopoietic	JJ
cord-023095-4dannjjm	5133	7	tumor	tumor	NN
cord-023095-4dannjjm	5133	8	of	of	IN
cord-023095-4dannjjm	5133	9	dogs	dog	NNS
cord-023095-4dannjjm	5133	10	.	.	.
cord-023095-4dannjjm	5134	1	Protein	protein	NN
cord-023095-4dannjjm	5134	2	disturbances	disturbance	NNS
cord-023095-4dannjjm	5134	3	may	may	MD
cord-023095-4dannjjm	5134	4	be	be	VB
cord-023095-4dannjjm	5134	5	associated	associate	VBN
cord-023095-4dannjjm	5134	6	with	with	IN
cord-023095-4dannjjm	5134	7	this	this	DT
cord-023095-4dannjjm	5134	8	disease	disease	NN
cord-023095-4dannjjm	5134	9	including	include	VBG
cord-023095-4dannjjm	5134	10	monoclonal	monoclonal	JJ
cord-023095-4dannjjm	5134	11	gammopathies	gammopathy	NNS
cord-023095-4dannjjm	5134	12	in	in	IN
cord-023095-4dannjjm	5134	13	a	a	DT
cord-023095-4dannjjm	5134	14	low	low	JJ
cord-023095-4dannjjm	5134	15	percentage	percentage	NN
cord-023095-4dannjjm	5134	16	of	of	IN
cord-023095-4dannjjm	5134	17	cases	case	NNS
cord-023095-4dannjjm	5134	18	.	.	.
cord-023095-4dannjjm	5135	1	Serum	serum	NN
cord-023095-4dannjjm	5135	2	protein	protein	NN
cord-023095-4dannjjm	5135	3	electrophoresis	electrophoresis	NN
cord-023095-4dannjjm	5135	4	(	(	-LRB-
cord-023095-4dannjjm	5135	5	SPE	SPE	NNP
cord-023095-4dannjjm	5135	6	)	)	-RRB-
cord-023095-4dannjjm	5135	7	is	be	VBZ
cord-023095-4dannjjm	5135	8	routinely	routinely	RB
cord-023095-4dannjjm	5135	9	used	use	VBN
cord-023095-4dannjjm	5135	10	to	to	TO
cord-023095-4dannjjm	5135	11	aid	aid	VB
cord-023095-4dannjjm	5135	12	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5135	13	of	of	IN
cord-023095-4dannjjm	5135	14	various	various	JJ
cord-023095-4dannjjm	5135	15	canine	canine	JJ
cord-023095-4dannjjm	5135	16	diseases	disease	NNS
cord-023095-4dannjjm	5135	17	including	include	VBG
cord-023095-4dannjjm	5135	18	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5135	19	when	when	WRB
cord-023095-4dannjjm	5135	20	total	total	JJ
cord-023095-4dannjjm	5135	21	protein	protein	NN
cord-023095-4dannjjm	5135	22	concentration	concentration	NN
cord-023095-4dannjjm	5135	23	is	be	VBZ
cord-023095-4dannjjm	5135	24	elevated	elevate	VBN
cord-023095-4dannjjm	5135	25	.	.	.
cord-023095-4dannjjm	5136	1	The	the	DT
cord-023095-4dannjjm	5136	2	purpose	purpose	NN
cord-023095-4dannjjm	5136	3	of	of	IN
cord-023095-4dannjjm	5136	4	this	this	DT
cord-023095-4dannjjm	5136	5	study	study	NN
cord-023095-4dannjjm	5136	6	was	be	VBD
cord-023095-4dannjjm	5136	7	to	to	TO
cord-023095-4dannjjm	5136	8	compare	compare	VB
cord-023095-4dannjjm	5136	9	SPE	SPE	NNP
cord-023095-4dannjjm	5136	10	changes	change	NNS
cord-023095-4dannjjm	5136	11	in	in	IN
cord-023095-4dannjjm	5136	12	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5136	13	patients	patient	NNS
cord-023095-4dannjjm	5136	14	without	without	IN
cord-023095-4dannjjm	5136	15	elevated	elevated	JJ
cord-023095-4dannjjm	5136	16	total	total	JJ
cord-023095-4dannjjm	5136	17	proteins	protein	NNS
cord-023095-4dannjjm	5136	18	with	with	IN
cord-023095-4dannjjm	5136	19	a	a	DT
cord-023095-4dannjjm	5136	20	population	population	NN
cord-023095-4dannjjm	5136	21	of	of	IN
cord-023095-4dannjjm	5136	22	healthy	healthy	JJ
cord-023095-4dannjjm	5136	23	dogs	dog	NNS
cord-023095-4dannjjm	5136	24	.	.	.
cord-023095-4dannjjm	5137	1	Agarose	Agarose	NNP
cord-023095-4dannjjm	5137	2	gel	gel	NN
cord-023095-4dannjjm	5137	3	electrophoresis	electrophoresis	NN
cord-023095-4dannjjm	5137	4	was	be	VBD
cord-023095-4dannjjm	5137	5	performed	perform	VBN
cord-023095-4dannjjm	5137	6	on	on	IN
cord-023095-4dannjjm	5137	7	residual	residual	JJ
cord-023095-4dannjjm	5137	8	serum	serum	NN
cord-023095-4dannjjm	5137	9	from	from	IN
cord-023095-4dannjjm	5137	10	17	17	CD
cord-023095-4dannjjm	5137	11	healthy	healthy	JJ
cord-023095-4dannjjm	5137	12	control	control	NN
cord-023095-4dannjjm	5137	13	dogs	dog	NNS
cord-023095-4dannjjm	5137	14	and	and	CC
cord-023095-4dannjjm	5137	15	21	21	CD
cord-023095-4dannjjm	5137	16	untreated	untreated	JJ
cord-023095-4dannjjm	5137	17	dogs	dog	NNS
cord-023095-4dannjjm	5137	18	with	with	IN
cord-023095-4dannjjm	5137	19	multicentric	multicentric	JJ
cord-023095-4dannjjm	5137	20	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5137	21	(	(	-LRB-
cord-023095-4dannjjm	5137	22	stage	stage	NN
cord-023095-4dannjjm	5137	23	III	III	NNP
cord-023095-4dannjjm	5137	24	-V	-V	NFP
cord-023095-4dannjjm	5137	25	)	)	-RRB-
cord-023095-4dannjjm	5137	26	after	after	IN
cord-023095-4dannjjm	5137	27	measuring	measure	VBG
cord-023095-4dannjjm	5137	28	total	total	JJ
cord-023095-4dannjjm	5137	29	protein	protein	NN
cord-023095-4dannjjm	5137	30	(	(	-LRB-
cord-023095-4dannjjm	5137	31	TP	TP	NNP
cord-023095-4dannjjm	5137	32	)	)	-RRB-
cord-023095-4dannjjm	5137	33	using	use	VBG
cord-023095-4dannjjm	5137	34	the	the	DT
cord-023095-4dannjjm	5137	35	biuret	biuret	NN
cord-023095-4dannjjm	5137	36	method	method	NN
cord-023095-4dannjjm	5137	37	.	.	.
cord-023095-4dannjjm	5138	1	Densitometric	Densitometric	NNP
cord-023095-4dannjjm	5138	2	traces	trace	NNS
cord-023095-4dannjjm	5138	3	of	of	IN
cord-023095-4dannjjm	5138	4	the	the	DT
cord-023095-4dannjjm	5138	5	protein	protein	NN
cord-023095-4dannjjm	5138	6	bands	band	NNS
cord-023095-4dannjjm	5138	7	were	be	VBD
cord-023095-4dannjjm	5138	8	obtained	obtain	VBN
cord-023095-4dannjjm	5138	9	using	use	VBG
cord-023095-4dannjjm	5138	10	computer	computer	NN
cord-023095-4dannjjm	5138	11	software	software	NN
cord-023095-4dannjjm	5138	12	(	(	-LRB-
cord-023095-4dannjjm	5138	13	Totallab	Totallab	NNP
cord-023095-4dannjjm	5138	14	100	100	CD
cord-023095-4dannjjm	5138	15	)	)	-RRB-
cord-023095-4dannjjm	5138	16	and	and	CC
cord-023095-4dannjjm	5138	17	the	the	DT
cord-023095-4dannjjm	5138	18	albumin	albumin	NN
cord-023095-4dannjjm	5138	19	,	,	,
cord-023095-4dannjjm	5138	20	alpha-1	alpha-1	NNP
cord-023095-4dannjjm	5138	21	,	,	,
cord-023095-4dannjjm	5138	22	alpha-2	alpha-2	NN
cord-023095-4dannjjm	5138	23	,	,	,
cord-023095-4dannjjm	5138	24	beta-2	beta-2	NN
cord-023095-4dannjjm	5138	25	and	and	CC
cord-023095-4dannjjm	5138	26	gamma	gamma	NN
cord-023095-4dannjjm	5138	27	globulin	globulin	NN
cord-023095-4dannjjm	5138	28	subfractions	subfraction	NNS
cord-023095-4dannjjm	5138	29	were	be	VBD
cord-023095-4dannjjm	5138	30	identified	identify	VBN
cord-023095-4dannjjm	5138	31	by	by	IN
cord-023095-4dannjjm	5138	32	visual	visual	JJ
cord-023095-4dannjjm	5138	33	inspection	inspection	NN
cord-023095-4dannjjm	5138	34	.	.	.
cord-023095-4dannjjm	5139	1	The	the	DT
cord-023095-4dannjjm	5139	2	total	total	JJ
cord-023095-4dannjjm	5139	3	protein	protein	NN
cord-023095-4dannjjm	5139	4	concentration	concentration	NN
cord-023095-4dannjjm	5139	5	,	,	,
cord-023095-4dannjjm	5139	6	the	the	DT
cord-023095-4dannjjm	5139	7	number	number	NN
cord-023095-4dannjjm	5139	8	of	of	IN
cord-023095-4dannjjm	5139	9	subfractions	subfraction	NNS
cord-023095-4dannjjm	5139	10	and	and	CC
cord-023095-4dannjjm	5139	11	the	the	DT
cord-023095-4dannjjm	5139	12	relative	relative	JJ
cord-023095-4dannjjm	5139	13	and	and	CC
cord-023095-4dannjjm	5139	14	absolute	absolute	JJ
cord-023095-4dannjjm	5139	15	protein	protein	NN
cord-023095-4dannjjm	5139	16	subfraction	subfraction	NN
cord-023095-4dannjjm	5139	17	concentrations	concentration	NNS
cord-023095-4dannjjm	5139	18	were	be	VBD
cord-023095-4dannjjm	5139	19	then	then	RB
cord-023095-4dannjjm	5139	20	compared	compare	VBN
cord-023095-4dannjjm	5139	21	statistically	statistically	RB
cord-023095-4dannjjm	5139	22	between	between	IN
cord-023095-4dannjjm	5139	23	the	the	DT
cord-023095-4dannjjm	5139	24	two	two	CD
cord-023095-4dannjjm	5139	25	populations	population	NNS
cord-023095-4dannjjm	5139	26	.	.	.
cord-023095-4dannjjm	5140	1	In	in	IN
cord-023095-4dannjjm	5140	2	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5140	3	dogs	dog	NNS
cord-023095-4dannjjm	5140	4	,	,	,
cord-023095-4dannjjm	5140	5	TP	tp	NN
cord-023095-4dannjjm	5140	6	,	,	,
cord-023095-4dannjjm	5140	7	absolute	absolute	JJ
cord-023095-4dannjjm	5140	8	albumin	albumin	NN
cord-023095-4dannjjm	5140	9	,	,	,
cord-023095-4dannjjm	5140	10	beta-2	beta-2	NN
cord-023095-4dannjjm	5140	11	and	and	CC
cord-023095-4dannjjm	5140	12	gamma	gamma	NN
cord-023095-4dannjjm	5140	13	globulin	globulin	NN
cord-023095-4dannjjm	5140	14	concentrations	concentration	NNS
cord-023095-4dannjjm	5140	15	and	and	CC
cord-023095-4dannjjm	5140	16	both	both	CC
cord-023095-4dannjjm	5140	17	relative	relative	JJ
cord-023095-4dannjjm	5140	18	and	and	CC
cord-023095-4dannjjm	5140	19	absolute	absolute	JJ
cord-023095-4dannjjm	5140	20	concentrations	concentration	NNS
cord-023095-4dannjjm	5140	21	of	of	IN
cord-023095-4dannjjm	5140	22	the	the	DT
cord-023095-4dannjjm	5140	23	alpha-1	alpha-1	NNP
cord-023095-4dannjjm	5140	24	globulins	globulin	NNS
cord-023095-4dannjjm	5140	25	were	be	VBD
cord-023095-4dannjjm	5140	26	significantly	significantly	RB
cord-023095-4dannjjm	5140	27	lower	low	JJR
cord-023095-4dannjjm	5140	28	however	however	RB
cord-023095-4dannjjm	5140	29	relative	relative	JJ
cord-023095-4dannjjm	5140	30	and	and	CC
cord-023095-4dannjjm	5140	31	absolute	absolute	JJ
cord-023095-4dannjjm	5140	32	alpha-2	alpha-2	NN
cord-023095-4dannjjm	5140	33	globulin	globulin	NN
cord-023095-4dannjjm	5140	34	concentrations	concentration	NNS
cord-023095-4dannjjm	5140	35	were	be	VBD
cord-023095-4dannjjm	5140	36	significantly	significantly	RB
cord-023095-4dannjjm	5140	37	elevated	elevate	VBN
cord-023095-4dannjjm	5140	38	.	.	.
cord-023095-4dannjjm	5141	1	No	no	DT
cord-023095-4dannjjm	5141	2	monoclonal	monoclonal	JJ
cord-023095-4dannjjm	5141	3	gammopathies	gammopathy	NNS
cord-023095-4dannjjm	5141	4	were	be	VBD
cord-023095-4dannjjm	5141	5	identified	identify	VBN
cord-023095-4dannjjm	5141	6	in	in	IN
cord-023095-4dannjjm	5141	7	any	any	DT
cord-023095-4dannjjm	5141	8	of	of	IN
cord-023095-4dannjjm	5141	9	the	the	DT
cord-023095-4dannjjm	5141	10	dogs	dog	NNS
cord-023095-4dannjjm	5141	11	and	and	CC
cord-023095-4dannjjm	5142	1	not	not	RB
cord-023095-4dannjjm	5142	2	every	every	DT
cord-023095-4dannjjm	5142	3	patient	patient	NN
cord-023095-4dannjjm	5142	4	with	with	IN
cord-023095-4dannjjm	5142	5	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5142	6	had	have	VBD
cord-023095-4dannjjm	5142	7	the	the	DT
cord-023095-4dannjjm	5142	8	above	above	JJ
cord-023095-4dannjjm	5142	9	changes	change	NNS
cord-023095-4dannjjm	5142	10	in	in	IN
cord-023095-4dannjjm	5142	11	their	-PRON-	PRP$
cord-023095-4dannjjm	5142	12	electrophoretogram	electrophoretogram	NN
cord-023095-4dannjjm	5142	13	.	.	.
cord-023095-4dannjjm	5143	1	This	this	DT
cord-023095-4dannjjm	5143	2	study	study	NN
cord-023095-4dannjjm	5143	3	has	have	VBZ
cord-023095-4dannjjm	5143	4	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	5143	5	that	that	IN
cord-023095-4dannjjm	5143	6	significant	significant	JJ
cord-023095-4dannjjm	5143	7	changes	change	NNS
cord-023095-4dannjjm	5143	8	occur	occur	VBP
cord-023095-4dannjjm	5143	9	in	in	IN
cord-023095-4dannjjm	5143	10	the	the	DT
cord-023095-4dannjjm	5143	11	albumin	albumin	NN
cord-023095-4dannjjm	5143	12	and	and	CC
cord-023095-4dannjjm	5143	13	globulin	globulin	NN
cord-023095-4dannjjm	5143	14	fractions	fraction	NNS
cord-023095-4dannjjm	5143	15	of	of	IN
cord-023095-4dannjjm	5143	16	canine	canine	JJ
cord-023095-4dannjjm	5143	17	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5143	18	patients	patient	NNS
cord-023095-4dannjjm	5143	19	despite	despite	IN
cord-023095-4dannjjm	5143	20	no	no	DT
cord-023095-4dannjjm	5143	21	obvious	obvious	JJ
cord-023095-4dannjjm	5143	22	increase	increase	NN
cord-023095-4dannjjm	5143	23	in	in	IN
cord-023095-4dannjjm	5143	24	TP	TP	NNP
cord-023095-4dannjjm	5143	25	.	.	.
cord-023095-4dannjjm	5144	1	Further	further	JJ
cord-023095-4dannjjm	5144	2	investigation	investigation	NN
cord-023095-4dannjjm	5144	3	is	be	VBZ
cord-023095-4dannjjm	5144	4	required	require	VBN
cord-023095-4dannjjm	5144	5	to	to	TO
cord-023095-4dannjjm	5144	6	identify	identify	VB
cord-023095-4dannjjm	5144	7	the	the	DT
cord-023095-4dannjjm	5144	8	proteins	protein	NNS
cord-023095-4dannjjm	5144	9	responsible	responsible	JJ
cord-023095-4dannjjm	5144	10	for	for	IN
cord-023095-4dannjjm	5144	11	these	these	DT
cord-023095-4dannjjm	5144	12	changes	change	NNS
cord-023095-4dannjjm	5144	13	.	.	.
cord-023095-4dannjjm	5145	1	It	-PRON-	PRP
cord-023095-4dannjjm	5145	2	is	be	VBZ
cord-023095-4dannjjm	5145	3	well	well	RB
cord-023095-4dannjjm	5145	4	known	know	VBN
cord-023095-4dannjjm	5145	5	that	that	IN
cord-023095-4dannjjm	5145	6	immunophenotype	immunophenotype	NN
cord-023095-4dannjjm	5145	7	has	have	VBZ
cord-023095-4dannjjm	5145	8	a	a	DT
cord-023095-4dannjjm	5145	9	prognostic	prognostic	JJ
cord-023095-4dannjjm	5145	10	value	value	NN
cord-023095-4dannjjm	5145	11	for	for	IN
cord-023095-4dannjjm	5145	12	the	the	DT
cord-023095-4dannjjm	5145	13	outcome	outcome	NN
cord-023095-4dannjjm	5145	14	of	of	IN
cord-023095-4dannjjm	5145	15	canine	canine	JJ
cord-023095-4dannjjm	5145	16	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5145	17	,	,	,
cord-023095-4dannjjm	5145	18	with	with	IN
cord-023095-4dannjjm	5145	19	T	t	NN
cord-023095-4dannjjm	5145	20	-	-	HYPH
cord-023095-4dannjjm	5145	21	cell	cell	NN
cord-023095-4dannjjm	5145	22	lymphomas	lymphoma	NNS
cord-023095-4dannjjm	5145	23	having	have	VBG
cord-023095-4dannjjm	5145	24	a	a	DT
cord-023095-4dannjjm	5145	25	worse	bad	JJR
cord-023095-4dannjjm	5145	26	prognosis	prognosis	NN
cord-023095-4dannjjm	5145	27	than	than	IN
cord-023095-4dannjjm	5145	28	B	b	NN
cord-023095-4dannjjm	5145	29	-	-	HYPH
cord-023095-4dannjjm	5145	30	cell	cell	NN
cord-023095-4dannjjm	5145	31	lymphomas	lymphoma	NNS
cord-023095-4dannjjm	5145	32	.	.	.
cord-023095-4dannjjm	5146	1	The	the	DT
cord-023095-4dannjjm	5146	2	recent	recent	JJ
cord-023095-4dannjjm	5146	3	advent	advent	NN
cord-023095-4dannjjm	5146	4	of	of	IN
cord-023095-4dannjjm	5146	5	flowcytometric	flowcytometric	JJ
cord-023095-4dannjjm	5146	6	techniques	technique	NNS
cord-023095-4dannjjm	5146	7	allowed	allow	VBD
cord-023095-4dannjjm	5146	8	easy	easy	JJ
cord-023095-4dannjjm	5146	9	detection	detection	NN
cord-023095-4dannjjm	5146	10	of	of	IN
cord-023095-4dannjjm	5146	11	many	many	JJ
cord-023095-4dannjjm	5146	12	different	different	JJ
cord-023095-4dannjjm	5146	13	markers	marker	NNS
cord-023095-4dannjjm	5146	14	on	on	IN
cord-023095-4dannjjm	5146	15	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5146	16	cells	cell	NNS
cord-023095-4dannjjm	5146	17	and	and	CC
cord-023095-4dannjjm	5146	18	therefore	therefore	RB
cord-023095-4dannjjm	5146	19	,	,	,
cord-023095-4dannjjm	5146	20	not	not	RB
cord-023095-4dannjjm	5146	21	only	only	RB
cord-023095-4dannjjm	5146	22	distinguish	distinguish	VB
cord-023095-4dannjjm	5146	23	between	between	IN
cord-023095-4dannjjm	5146	24	T	t	NN
cord-023095-4dannjjm	5146	25	and	and	CC
cord-023095-4dannjjm	5146	26	B	b	NN
cord-023095-4dannjjm	5146	27	cells	cell	NNS
cord-023095-4dannjjm	5146	28	,	,	,
cord-023095-4dannjjm	5146	29	but	but	CC
cord-023095-4dannjjm	5146	30	also	also	RB
cord-023095-4dannjjm	5146	31	estimate	estimate	VBP
cord-023095-4dannjjm	5146	32	possible	possible	JJ
cord-023095-4dannjjm	5146	33	aberration	aberration	NN
cord-023095-4dannjjm	5146	34	on	on	IN
cord-023095-4dannjjm	5146	35	immunophenotype	immunophenotype	NN
cord-023095-4dannjjm	5146	36	.	.	.
cord-023095-4dannjjm	5147	1	In	in	IN
cord-023095-4dannjjm	5147	2	human	human	JJ
cord-023095-4dannjjm	5147	3	oncology	oncology	NN
cord-023095-4dannjjm	5147	4	,	,	,
cord-023095-4dannjjm	5147	5	although	although	IN
cord-023095-4dannjjm	5147	6	some	some	DT
cord-023095-4dannjjm	5147	7	controversy	controversy	NN
cord-023095-4dannjjm	5147	8	persists	persist	VBZ
cord-023095-4dannjjm	5147	9	,	,	,
cord-023095-4dannjjm	5147	10	it	-PRON-	PRP
cord-023095-4dannjjm	5147	11	seems	seem	VBZ
cord-023095-4dannjjm	5147	12	that	that	IN
cord-023095-4dannjjm	5147	13	non	non	JJ
cord-023095-4dannjjm	5147	14	-	-	JJ
cord-023095-4dannjjm	5147	15	Hodgkins	hodgkins	JJ
cord-023095-4dannjjm	5147	16	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5147	17	and	and	CC
cord-023095-4dannjjm	5147	18	acute	acute	JJ
cord-023095-4dannjjm	5147	19	leukemia	leukemia	NN
cord-023095-4dannjjm	5147	20	carrying	carry	VBG
cord-023095-4dannjjm	5147	21	aberrations	aberration	NNS
cord-023095-4dannjjm	5147	22	have	have	VBP
cord-023095-4dannjjm	5147	23	a	a	DT
cord-023095-4dannjjm	5147	24	worse	bad	JJR
cord-023095-4dannjjm	5147	25	prognosis	prognosis	NN
cord-023095-4dannjjm	5147	26	.	.	.
cord-023095-4dannjjm	5148	1	The	the	DT
cord-023095-4dannjjm	5148	2	aim	aim	NN
cord-023095-4dannjjm	5148	3	of	of	IN
cord-023095-4dannjjm	5148	4	this	this	DT
cord-023095-4dannjjm	5148	5	study	study	NN
cord-023095-4dannjjm	5148	6	was	be	VBD
cord-023095-4dannjjm	5148	7	to	to	TO
cord-023095-4dannjjm	5148	8	evaluate	evaluate	VB
cord-023095-4dannjjm	5148	9	the	the	DT
cord-023095-4dannjjm	5148	10	role	role	NN
cord-023095-4dannjjm	5148	11	of	of	IN
cord-023095-4dannjjm	5148	12	immunophenotype	immunophenotype	NN
cord-023095-4dannjjm	5148	13	aberration	aberration	NN
cord-023095-4dannjjm	5148	14	in	in	IN
cord-023095-4dannjjm	5148	15	canine	canine	JJ
cord-023095-4dannjjm	5148	16	high	high	JJ
cord-023095-4dannjjm	5148	17	-	-	HYPH
cord-023095-4dannjjm	5148	18	grade	grade	NN
cord-023095-4dannjjm	5148	19	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5148	20	considering	consider	VBG
cord-023095-4dannjjm	5148	21	outcome	outcome	NN
cord-023095-4dannjjm	5148	22	and	and	CC
cord-023095-4dannjjm	5148	23	time	time	NN
cord-023095-4dannjjm	5148	24	span	span	NN
cord-023095-4dannjjm	5148	25	to	to	TO
cord-023095-4dannjjm	5148	26	achieve	achieve	VB
cord-023095-4dannjjm	5148	27	complete	complete	JJ
cord-023095-4dannjjm	5148	28	response	response	NN
cord-023095-4dannjjm	5148	29	under	under	IN
cord-023095-4dannjjm	5148	30	chemotherapy	chemotherapy	NN
cord-023095-4dannjjm	5148	31	.	.	.
cord-023095-4dannjjm	5149	1	Samples	sample	NNS
cord-023095-4dannjjm	5149	2	of	of	IN
cord-023095-4dannjjm	5149	3	bone	bone	NN
cord-023095-4dannjjm	5149	4	marrow	marrow	NN
cord-023095-4dannjjm	5149	5	,	,	,
cord-023095-4dannjjm	5149	6	blood	blood	NN
cord-023095-4dannjjm	5149	7	and	and	CC
cord-023095-4dannjjm	5149	8	lymph	lymph	NN
cord-023095-4dannjjm	5149	9	node	node	NN
cord-023095-4dannjjm	5149	10	suspensions	suspension	NNS
cord-023095-4dannjjm	5149	11	from	from	IN
cord-023095-4dannjjm	5149	12	twentythree	twentythree	NNP
cord-023095-4dannjjm	5149	13	dogs	dog	NNS
cord-023095-4dannjjm	5149	14	were	be	VBD
cord-023095-4dannjjm	5149	15	evaluated	evaluate	VBN
cord-023095-4dannjjm	5149	16	with	with	IN
cord-023095-4dannjjm	5149	17	flow	flow	NN
cord-023095-4dannjjm	5149	18	-	-	HYPH
cord-023095-4dannjjm	5149	19	cytometry	cytometry	NN
cord-023095-4dannjjm	5149	20	.	.	.
cord-023095-4dannjjm	5150	1	Eleven	eleven	CD
cord-023095-4dannjjm	5150	2	dogs	dog	NNS
cord-023095-4dannjjm	5150	3	had	have	VBD
cord-023095-4dannjjm	5150	4	aberrant	aberrant	JJ
cord-023095-4dannjjm	5150	5	expression	expression	NN
cord-023095-4dannjjm	5150	6	of	of	IN
cord-023095-4dannjjm	5150	7	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	5150	8	lymphocytes	lymphocyte	NNS
cord-023095-4dannjjm	5150	9	and	and	CC
cord-023095-4dannjjm	5150	10	twelve	twelve	CD
cord-023095-4dannjjm	5150	11	were	be	VBD
cord-023095-4dannjjm	5150	12	non	non	JJ
cord-023095-4dannjjm	5150	13	-	-	JJ
cord-023095-4dannjjm	5150	14	aberrant	aberrant	JJ
cord-023095-4dannjjm	5150	15	.	.	.
cord-023095-4dannjjm	5151	1	The	the	DT
cord-023095-4dannjjm	5151	2	most	most	RBS
cord-023095-4dannjjm	5151	3	common	common	JJ
cord-023095-4dannjjm	5151	4	aberrations	aberration	NNS
cord-023095-4dannjjm	5151	5	found	find	VBN
cord-023095-4dannjjm	5151	6	were	be	VBD
cord-023095-4dannjjm	5151	7	:	:	:
cord-023095-4dannjjm	5151	8	positivity	positivity	NN
cord-023095-4dannjjm	5151	9	to	to	IN
cord-023095-4dannjjm	5151	10	CD34	CD34	NNP
cord-023095-4dannjjm	5151	11	,	,	,
cord-023095-4dannjjm	5151	12	biphenotypes	biphenotype	NNS
cord-023095-4dannjjm	5151	13	,	,	,
cord-023095-4dannjjm	5151	14	double	double	JJ
cord-023095-4dannjjm	5151	15	expression	expression	NN
cord-023095-4dannjjm	5151	16	of	of	IN
cord-023095-4dannjjm	5151	17	Tantigens	Tantigens	NNP
cord-023095-4dannjjm	5151	18	(	(	-LRB-
cord-023095-4dannjjm	5151	19	CD41	CD41	NNP
cord-023095-4dannjjm	5151	20	,	,	,
cord-023095-4dannjjm	5151	21	CD81	CD81	NNP
cord-023095-4dannjjm	5151	22	)	)	-RRB-
cord-023095-4dannjjm	5151	23	,	,	,
cord-023095-4dannjjm	5151	24	diminished	diminish	VBD
cord-023095-4dannjjm	5151	25	expression	expression	NN
cord-023095-4dannjjm	5151	26	of	of	IN
cord-023095-4dannjjm	5151	27	CD45	CD45	NNP
cord-023095-4dannjjm	5151	28	.	.	.
cord-023095-4dannjjm	5152	1	All	all	DT
cord-023095-4dannjjm	5152	2	dogs	dog	NNS
cord-023095-4dannjjm	5152	3	were	be	VBD
cord-023095-4dannjjm	5152	4	treated	treat	VBN
cord-023095-4dannjjm	5152	5	with	with	IN
cord-023095-4dannjjm	5152	6	a	a	DT
cord-023095-4dannjjm	5152	7	CHOP	chop	NN
cord-023095-4dannjjm	5152	8	-	-	HYPH
cord-023095-4dannjjm	5152	9	based	base	VBN
cord-023095-4dannjjm	5152	10	protocol	protocol	NN
cord-023095-4dannjjm	5152	11	.	.	.
cord-023095-4dannjjm	5153	1	There	there	EX
cord-023095-4dannjjm	5153	2	was	be	VBD
cord-023095-4dannjjm	5153	3	a	a	DT
cord-023095-4dannjjm	5153	4	significant	significant	JJ
cord-023095-4dannjjm	5153	5	difference	difference	NN
cord-023095-4dannjjm	5153	6	for	for	IN
cord-023095-4dannjjm	5153	7	the	the	DT
cord-023095-4dannjjm	5153	8	time	time	NN
cord-023095-4dannjjm	5153	9	to	to	TO
cord-023095-4dannjjm	5153	10	achieve	achieve	VB
cord-023095-4dannjjm	5153	11	response	response	NN
cord-023095-4dannjjm	5153	12	to	to	IN
cord-023095-4dannjjm	5153	13	chemotherapy	chemotherapy	NN
cord-023095-4dannjjm	5153	14	(	(	-LRB-
cord-023095-4dannjjm	5153	15	partial	partial	JJ
cord-023095-4dannjjm	5153	16	or	or	CC
cord-023095-4dannjjm	5153	17	complete	complete	JJ
cord-023095-4dannjjm	5153	18	)	)	-RRB-
cord-023095-4dannjjm	5153	19	.	.	.
cord-023095-4dannjjm	5154	1	12/12	12/12	CD
cord-023095-4dannjjm	5154	2	non	non	JJ
cord-023095-4dannjjm	5154	3	aberrant	aberrant	JJ
cord-023095-4dannjjm	5154	4	lymphomas	lymphoma	NNS
cord-023095-4dannjjm	5154	5	went	go	VBD
cord-023095-4dannjjm	5154	6	into	into	IN
cord-023095-4dannjjm	5154	7	CR	CR	NNP
cord-023095-4dannjjm	5154	8	or	or	CC
cord-023095-4dannjjm	5154	9	PR	PR	NNP
cord-023095-4dannjjm	5154	10	after	after	IN
cord-023095-4dannjjm	5154	11	the	the	DT
cord-023095-4dannjjm	5154	12	first	first	JJ
cord-023095-4dannjjm	5154	13	treatment	treatment	NN
cord-023095-4dannjjm	5154	14	(	(	-LRB-
cord-023095-4dannjjm	5154	15	L	l	NN
cord-023095-4dannjjm	5154	16	-	-	HYPH
cord-023095-4dannjjm	5154	17	Asparaginase	Asparaginase	NNP
cord-023095-4dannjjm	5154	18	)	)	-RRB-
cord-023095-4dannjjm	5154	19	,	,	,
cord-023095-4dannjjm	5154	20	while	while	IN
cord-023095-4dannjjm	5154	21	aberrant	aberrant	JJ
cord-023095-4dannjjm	5154	22	lympho	lympho	NNP
cord-023095-4dannjjm	5154	23	-	-	HYPH
cord-023095-4dannjjm	5154	24	mas	mas	NNP
cord-023095-4dannjjm	5154	25	needed	need	VBD
cord-023095-4dannjjm	5154	26	more	more	JJR
cord-023095-4dannjjm	5154	27	than	than	IN
cord-023095-4dannjjm	5154	28	2	2	CD
cord-023095-4dannjjm	5154	29	treatment	treatment	NN
cord-023095-4dannjjm	5154	30	to	to	TO
cord-023095-4dannjjm	5154	31	reach	reach	VB
cord-023095-4dannjjm	5154	32	CR	CR	NNP
cord-023095-4dannjjm	5154	33	or	or	CC
cord-023095-4dannjjm	5154	34	PR	pr	NN
cord-023095-4dannjjm	5154	35	.	.	.
cord-023095-4dannjjm	5155	1	There	there	EX
cord-023095-4dannjjm	5155	2	was	be	VBD
cord-023095-4dannjjm	5155	3	a	a	DT
cord-023095-4dannjjm	5155	4	trend	trend	NN
cord-023095-4dannjjm	5155	5	for	for	IN
cord-023095-4dannjjm	5155	6	a	a	DT
cord-023095-4dannjjm	5155	7	prolonged	prolonged	JJ
cord-023095-4dannjjm	5155	8	disease	disease	NN
cord-023095-4dannjjm	5155	9	free	free	JJ
cord-023095-4dannjjm	5155	10	interval	interval	NN
cord-023095-4dannjjm	5155	11	with	with	IN
cord-023095-4dannjjm	5155	12	non	non	JJ
cord-023095-4dannjjm	5155	13	-	-	JJ
cord-023095-4dannjjm	5155	14	aberrant	aberrant	JJ
cord-023095-4dannjjm	5155	15	versus	versus	IN
cord-023095-4dannjjm	5155	16	aberrant	aberrant	JJ
cord-023095-4dannjjm	5155	17	,	,	,
cord-023095-4dannjjm	5155	18	although	although	IN
cord-023095-4dannjjm	5155	19	it	-PRON-	PRP
cord-023095-4dannjjm	5155	20	was	be	VBD
cord-023095-4dannjjm	5155	21	not	not	RB
cord-023095-4dannjjm	5155	22	statistically	statistically	RB
cord-023095-4dannjjm	5155	23	significant	significant	JJ
cord-023095-4dannjjm	5155	24	.	.	.
cord-023095-4dannjjm	5156	1	Aberration	aberration	NN
cord-023095-4dannjjm	5156	2	of	of	IN
cord-023095-4dannjjm	5156	3	immunophenotype	immunophenotype	NN
cord-023095-4dannjjm	5156	4	may	may	MD
cord-023095-4dannjjm	5156	5	be	be	VB
cord-023095-4dannjjm	5156	6	a	a	DT
cord-023095-4dannjjm	5156	7	prognostic	prognostic	JJ
cord-023095-4dannjjm	5156	8	factor	factor	NN
cord-023095-4dannjjm	5156	9	for	for	IN
cord-023095-4dannjjm	5156	10	canine	canine	JJ
cord-023095-4dannjjm	5156	11	lymphomas	lymphoma	NNS
cord-023095-4dannjjm	5156	12	,	,	,
cord-023095-4dannjjm	5156	13	but	but	CC
cord-023095-4dannjjm	5156	14	further	further	JJ
cord-023095-4dannjjm	5156	15	studies	study	NNS
cord-023095-4dannjjm	5156	16	with	with	IN
cord-023095-4dannjjm	5156	17	larger	large	JJR
cord-023095-4dannjjm	5156	18	groups	group	NNS
cord-023095-4dannjjm	5156	19	are	be	VBP
cord-023095-4dannjjm	5156	20	needed	need	VBN
cord-023095-4dannjjm	5156	21	.	.	.
cord-023095-4dannjjm	5157	1	Class	Class	NNP
cord-023095-4dannjjm	5157	2	II	II	NNP
cord-023095-4dannjjm	5157	3	major	major	JJ
cord-023095-4dannjjm	5157	4	histocompatibility	histocompatibility	NN
cord-023095-4dannjjm	5157	5	expression	expression	NN
cord-023095-4dannjjm	5157	6	is	be	VBZ
cord-023095-4dannjjm	5157	7	a	a	DT
cord-023095-4dannjjm	5157	8	significant	significant	JJ
cord-023095-4dannjjm	5157	9	and	and	CC
cord-023095-4dannjjm	5157	10	independent	independent	JJ
cord-023095-4dannjjm	5157	11	predictor	predictor	NN
cord-023095-4dannjjm	5157	12	of	of	IN
cord-023095-4dannjjm	5157	13	prognosis	prognosis	NN
cord-023095-4dannjjm	5157	14	in	in	IN
cord-023095-4dannjjm	5157	15	human	human	JJ
cord-023095-4dannjjm	5157	16	B	B	NNP
cord-023095-4dannjjm	5157	17	cell	cell	NN
cord-023095-4dannjjm	5157	18	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5157	19	.	.	.
cord-023095-4dannjjm	5158	1	Low	low	JJ
cord-023095-4dannjjm	5158	2	class	class	NN
cord-023095-4dannjjm	5158	3	II	II	NNP
cord-023095-4dannjjm	5158	4	MHC	MHC	NNP
cord-023095-4dannjjm	5158	5	is	be	VBZ
cord-023095-4dannjjm	5158	6	consistently	consistently	RB
cord-023095-4dannjjm	5158	7	associated	associate	VBN
cord-023095-4dannjjm	5158	8	with	with	IN
cord-023095-4dannjjm	5158	9	poorer	poor	JJR
cord-023095-4dannjjm	5158	10	outcome	outcome	NN
cord-023095-4dannjjm	5158	11	.	.	.
cord-023095-4dannjjm	5159	1	The	the	DT
cord-023095-4dannjjm	5159	2	mechanism	mechanism	NN
cord-023095-4dannjjm	5159	3	underlying	underlie	VBG
cord-023095-4dannjjm	5159	4	this	this	DT
cord-023095-4dannjjm	5159	5	relationship	relationship	NN
cord-023095-4dannjjm	5159	6	is	be	VBZ
cord-023095-4dannjjm	5159	7	not	not	RB
cord-023095-4dannjjm	5159	8	clear	clear	JJ
cord-023095-4dannjjm	5159	9	,	,	,
cord-023095-4dannjjm	5159	10	but	but	CC
cord-023095-4dannjjm	5159	11	one	one	CD
cord-023095-4dannjjm	5159	12	hypothesis	hypothesis	NN
cord-023095-4dannjjm	5159	13	is	be	VBZ
cord-023095-4dannjjm	5159	14	that	that	IN
cord-023095-4dannjjm	5159	15	high	high	JJ
cord-023095-4dannjjm	5159	16	class	class	NN
cord-023095-4dannjjm	5159	17	II	II	NNP
cord-023095-4dannjjm	5159	18	MHC	MHC	NNP
cord-023095-4dannjjm	5159	19	allows	allow	VBZ
cord-023095-4dannjjm	5159	20	for	for	IN
cord-023095-4dannjjm	5159	21	better	well	JJR
cord-023095-4dannjjm	5159	22	antigen	antigen	NN
cord-023095-4dannjjm	5159	23	presentation	presentation	NN
cord-023095-4dannjjm	5159	24	and	and	CC
cord-023095-4dannjjm	5159	25	tumor	tumor	NN
cord-023095-4dannjjm	5159	26	-	-	HYPH
cord-023095-4dannjjm	5159	27	specific	specific	JJ
cord-023095-4dannjjm	5159	28	immune	immune	JJ
cord-023095-4dannjjm	5159	29	responses	response	NNS
cord-023095-4dannjjm	5159	30	.	.	.
cord-023095-4dannjjm	5160	1	In	in	IN
cord-023095-4dannjjm	5160	2	the	the	DT
cord-023095-4dannjjm	5160	3	this	this	DT
cord-023095-4dannjjm	5160	4	study	study	NN
cord-023095-4dannjjm	5160	5	,	,	,
cord-023095-4dannjjm	5160	6	we	-PRON-	PRP
cord-023095-4dannjjm	5160	7	investigated	investigate	VBD
cord-023095-4dannjjm	5160	8	whether	whether	IN
cord-023095-4dannjjm	5160	9	that	that	DT
cord-023095-4dannjjm	5160	10	class	class	NN
cord-023095-4dannjjm	5160	11	II	II	NNP
cord-023095-4dannjjm	5160	12	MHC	MHC	NNP
cord-023095-4dannjjm	5160	13	expression	expression	NN
cord-023095-4dannjjm	5160	14	in	in	IN
cord-023095-4dannjjm	5160	15	canine	canine	JJ
cord-023095-4dannjjm	5160	16	B	B	NNP
cord-023095-4dannjjm	5160	17	cell	cell	NN
cord-023095-4dannjjm	5160	18	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5160	19	was	be	VBD
cord-023095-4dannjjm	5160	20	associated	associate	VBN
cord-023095-4dannjjm	5160	21	with	with	IN
cord-023095-4dannjjm	5160	22	remission	remission	NN
cord-023095-4dannjjm	5160	23	and	and	CC
cord-023095-4dannjjm	5160	24	survival	survival	NN
cord-023095-4dannjjm	5160	25	times	time	NNS
cord-023095-4dannjjm	5160	26	.	.	.
cord-023095-4dannjjm	5161	1	A	a	DT
cord-023095-4dannjjm	5161	2	total	total	NN
cord-023095-4dannjjm	5161	3	of	of	IN
cord-023095-4dannjjm	5161	4	160	160	CD
cord-023095-4dannjjm	5161	5	patients	patient	NNS
cord-023095-4dannjjm	5161	6	were	be	VBD
cord-023095-4dannjjm	5161	7	categorized	categorize	VBN
cord-023095-4dannjjm	5161	8	by	by	IN
cord-023095-4dannjjm	5161	9	level	level	NN
cord-023095-4dannjjm	5161	10	of	of	IN
cord-023095-4dannjjm	5161	11	class	class	NN
cord-023095-4dannjjm	5161	12	II	II	NNP
cord-023095-4dannjjm	5161	13	MHC	MHC	NNP
cord-023095-4dannjjm	5161	14	,	,	,
cord-023095-4dannjjm	5161	15	expression	expression	NN
cord-023095-4dannjjm	5161	16	of	of	IN
cord-023095-4dannjjm	5161	17	CD34	CD34	NNP
cord-023095-4dannjjm	5161	18	and	and	CC
cord-023095-4dannjjm	5161	19	cell	cell	NN
cord-023095-4dannjjm	5161	20	size	size	NN
cord-023095-4dannjjm	5161	21	for	for	IN
cord-023095-4dannjjm	5161	22	on	on	IN
cord-023095-4dannjjm	5161	23	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	5161	24	B	b	NN
cord-023095-4dannjjm	5161	25	cells	cell	NNS
cord-023095-4dannjjm	5161	26	.	.	.
cord-023095-4dannjjm	5162	1	Multivariable	Multivariable	NNP
cord-023095-4dannjjm	5162	2	Cox	Cox	NNP
cord-023095-4dannjjm	5162	3	-	-	HYPH
cord-023095-4dannjjm	5162	4	proportional	proportional	JJ
cord-023095-4dannjjm	5162	5	hazard	hazard	NN
cord-023095-4dannjjm	5162	6	analysis	analysis	NN
cord-023095-4dannjjm	5162	7	was	be	VBD
cord-023095-4dannjjm	5162	8	used	use	VBN
cord-023095-4dannjjm	5162	9	investigate	investigate	VB
cord-023095-4dannjjm	5162	10	this	this	DT
cord-023095-4dannjjm	5162	11	research	research	NN
cord-023095-4dannjjm	5162	12	question	question	NN
cord-023095-4dannjjm	5162	13	using	use	VBG
cord-023095-4dannjjm	5162	14	a	a	DT
cord-023095-4dannjjm	5162	15	randomly	randomly	RB
cord-023095-4dannjjm	5162	16	selected	select	VBN
cord-023095-4dannjjm	5162	17	subset	subset	JJ
cord-023095-4dannjjm	5162	18	of	of	IN
cord-023095-4dannjjm	5162	19	the	the	DT
cord-023095-4dannjjm	5162	20	data	datum	NNS
cord-023095-4dannjjm	5162	21	,	,	,
cord-023095-4dannjjm	5162	22	and	and	CC
cord-023095-4dannjjm	5162	23	the	the	DT
cord-023095-4dannjjm	5162	24	predictive	predictive	JJ
cord-023095-4dannjjm	5162	25	ability	ability	NN
cord-023095-4dannjjm	5162	26	of	of	IN
cord-023095-4dannjjm	5162	27	this	this	DT
cord-023095-4dannjjm	5162	28	model	model	NN
cord-023095-4dannjjm	5162	29	was	be	VBD
cord-023095-4dannjjm	5162	30	validated	validate	VBN
cord-023095-4dannjjm	5162	31	on	on	IN
cord-023095-4dannjjm	5162	32	the	the	DT
cord-023095-4dannjjm	5162	33	remaining	remain	VBG
cord-023095-4dannjjm	5162	34	1/3	1/3	CD
cord-023095-4dannjjm	5162	35	of	of	IN
cord-023095-4dannjjm	5162	36	patient	patient	JJ
cord-023095-4dannjjm	5162	37	data	datum	NNS
cord-023095-4dannjjm	5162	38	.	.	.
cord-023095-4dannjjm	5163	1	Results	result	NNS
cord-023095-4dannjjm	5163	2	suggested	suggest	VBD
cord-023095-4dannjjm	5163	3	that	that	IN
cord-023095-4dannjjm	5163	4	low	low	JJ
cord-023095-4dannjjm	5163	5	class	class	NN
cord-023095-4dannjjm	5163	6	II	II	NNP
cord-023095-4dannjjm	5163	7	MHC	MHC	NNP
cord-023095-4dannjjm	5163	8	expression	expression	NN
cord-023095-4dannjjm	5163	9	was	be	VBD
cord-023095-4dannjjm	5163	10	associated	associate	VBN
cord-023095-4dannjjm	5163	11	with	with	IN
cord-023095-4dannjjm	5163	12	decreased	decreased	JJ
cord-023095-4dannjjm	5163	13	times	time	NNS
cord-023095-4dannjjm	5163	14	to	to	TO
cord-023095-4dannjjm	5163	15	relapse	relapse	VB
cord-023095-4dannjjm	5163	16	and	and	CC
cord-023095-4dannjjm	5163	17	death	death	NN
cord-023095-4dannjjm	5163	18	as	as	IN
cord-023095-4dannjjm	5163	19	is	be	VBZ
cord-023095-4dannjjm	5163	20	seen	see	VBN
cord-023095-4dannjjm	5163	21	in	in	IN
cord-023095-4dannjjm	5163	22	human	human	JJ
cord-023095-4dannjjm	5163	23	B	b	NN
cord-023095-4dannjjm	5163	24	cell	cell	NN
cord-023095-4dannjjm	5163	25	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5163	26	,	,	,
cord-023095-4dannjjm	5163	27	and	and	CC
cord-023095-4dannjjm	5163	28	that	that	IN
cord-023095-4dannjjm	5163	29	large	large	JJ
cord-023095-4dannjjm	5163	30	neoplastic	neoplastic	JJ
cord-023095-4dannjjm	5163	31	cells	cell	NNS
cord-023095-4dannjjm	5163	32	were	be	VBD
cord-023095-4dannjjm	5163	33	associated	associate	VBN
cord-023095-4dannjjm	5163	34	with	with	IN
cord-023095-4dannjjm	5163	35	decreased	decreased	JJ
cord-023095-4dannjjm	5163	36	survival	survival	NN
cord-023095-4dannjjm	5163	37	time	time	NN
cord-023095-4dannjjm	5163	38	.	.	.
cord-023095-4dannjjm	5164	1	CD34	CD34	NNP
cord-023095-4dannjjm	5164	2	expression	expression	NN
cord-023095-4dannjjm	5164	3	was	be	VBD
cord-023095-4dannjjm	5164	4	not	not	RB
cord-023095-4dannjjm	5164	5	associated	associate	VBN
cord-023095-4dannjjm	5164	6	with	with	IN
cord-023095-4dannjjm	5164	7	patient	patient	JJ
cord-023095-4dannjjm	5164	8	outcomes	outcome	NNS
cord-023095-4dannjjm	5164	9	.	.	.
cord-023095-4dannjjm	5165	1	These	these	DT
cord-023095-4dannjjm	5165	2	findings	finding	NNS
cord-023095-4dannjjm	5165	3	have	have	VBP
cord-023095-4dannjjm	5165	4	implications	implication	NNS
cord-023095-4dannjjm	5165	5	for	for	IN
cord-023095-4dannjjm	5165	6	the	the	DT
cord-023095-4dannjjm	5165	7	use	use	NN
cord-023095-4dannjjm	5165	8	of	of	IN
cord-023095-4dannjjm	5165	9	dogs	dog	NNS
cord-023095-4dannjjm	5165	10	to	to	TO
cord-023095-4dannjjm	5165	11	model	model	VB
cord-023095-4dannjjm	5165	12	human	human	JJ
cord-023095-4dannjjm	5165	13	lymphomas	lymphoma	NNS
cord-023095-4dannjjm	5165	14	,	,	,
cord-023095-4dannjjm	5165	15	for	for	IN
cord-023095-4dannjjm	5165	16	the	the	DT
cord-023095-4dannjjm	5165	17	study	study	NN
cord-023095-4dannjjm	5165	18	of	of	IN
cord-023095-4dannjjm	5165	19	tumor	tumor	NN
cord-023095-4dannjjm	5165	20	vaccines	vaccine	NNS
cord-023095-4dannjjm	5165	21	,	,	,
cord-023095-4dannjjm	5165	22	and	and	CC
cord-023095-4dannjjm	5165	23	for	for	IN
cord-023095-4dannjjm	5165	24	prediction	prediction	NN
cord-023095-4dannjjm	5165	25	of	of	IN
cord-023095-4dannjjm	5165	26	mortality	mortality	NN
cord-023095-4dannjjm	5165	27	in	in	IN
cord-023095-4dannjjm	5165	28	dogs	dog	NNS
cord-023095-4dannjjm	5165	29	with	with	IN
cord-023095-4dannjjm	5165	30	B	b	NN
cord-023095-4dannjjm	5165	31	cell	cell	NN
cord-023095-4dannjjm	5165	32	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5165	33	with	with	IN
cord-023095-4dannjjm	5165	34	a	a	DT
cord-023095-4dannjjm	5165	35	high	high	JJ
cord-023095-4dannjjm	5165	36	level	level	NN
cord-023095-4dannjjm	5165	37	of	of	IN
cord-023095-4dannjjm	5165	38	specificity	specificity	NN
cord-023095-4dannjjm	5165	39	.	.	.
cord-023095-4dannjjm	5166	1	One	one	CD
cord-023095-4dannjjm	5166	2	of	of	IN
cord-023095-4dannjjm	5166	3	the	the	DT
cord-023095-4dannjjm	5166	4	reasons	reason	NNS
cord-023095-4dannjjm	5166	5	for	for	IN
cord-023095-4dannjjm	5166	6	the	the	DT
cord-023095-4dannjjm	5166	7	failure	failure	NN
cord-023095-4dannjjm	5166	8	of	of	IN
cord-023095-4dannjjm	5166	9	canine	canine	JJ
cord-023095-4dannjjm	5166	10	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5166	11	treatment	treatment	NN
cord-023095-4dannjjm	5166	12	is	be	VBZ
cord-023095-4dannjjm	5166	13	related	relate	VBN
cord-023095-4dannjjm	5166	14	to	to	IN
cord-023095-4dannjjm	5166	15	the	the	DT
cord-023095-4dannjjm	5166	16	resistance	resistance	NN
cord-023095-4dannjjm	5166	17	of	of	IN
cord-023095-4dannjjm	5166	18	tumor	tumor	NN
cord-023095-4dannjjm	5166	19	cells	cell	NNS
cord-023095-4dannjjm	5166	20	against	against	IN
cord-023095-4dannjjm	5166	21	chemotherapy	chemotherapy	NN
cord-023095-4dannjjm	5166	22	drugs	drug	NNS
cord-023095-4dannjjm	5166	23	.	.	.
cord-023095-4dannjjm	5167	1	The	the	DT
cord-023095-4dannjjm	5167	2	major	major	JJ
cord-023095-4dannjjm	5167	3	form	form	NN
cord-023095-4dannjjm	5167	4	of	of	IN
cord-023095-4dannjjm	5167	5	this	this	DT
cord-023095-4dannjjm	5167	6	resistance	resistance	NN
cord-023095-4dannjjm	5167	7	is	be	VBZ
cord-023095-4dannjjm	5167	8	provide	provide	JJ
cord-023095-4dannjjm	5167	9	by	by	IN
cord-023095-4dannjjm	5167	10	multidrug	multidrug	NN
cord-023095-4dannjjm	5167	11	resistance	resistance	NN
cord-023095-4dannjjm	5167	12	ABC	ABC	NNP
cord-023095-4dannjjm	5167	13	transporters	transporter	NNS
cord-023095-4dannjjm	5167	14	.	.	.
cord-023095-4dannjjm	5168	1	ABC	ABC	NNP
cord-023095-4dannjjm	5168	2	transporters	transporter	NNS
cord-023095-4dannjjm	5168	3	proteins	protein	NNS
cord-023095-4dannjjm	5168	4	comprise	comprise	VBP
cord-023095-4dannjjm	5168	5	a	a	DT
cord-023095-4dannjjm	5168	6	large	large	JJ
cord-023095-4dannjjm	5168	7	superfamily	superfamily	NN
cord-023095-4dannjjm	5168	8	of	of	IN
cord-023095-4dannjjm	5168	9	transmembrane	transmembrane	JJ
cord-023095-4dannjjm	5168	10	proteins	protein	NNS
cord-023095-4dannjjm	5168	11	,	,	,
cord-023095-4dannjjm	5168	12	ATP	ATP	NNP
cord-023095-4dannjjm	5168	13	-	-	HYPH
cord-023095-4dannjjm	5168	14	dependent	dependent	JJ
cord-023095-4dannjjm	5168	15	,	,	,
cord-023095-4dannjjm	5168	16	that	that	WDT
cord-023095-4dannjjm	5168	17	extrude	extrude	VBP
cord-023095-4dannjjm	5168	18	a	a	DT
cord-023095-4dannjjm	5168	19	large	large	JJ
cord-023095-4dannjjm	5168	20	variety	variety	NN
cord-023095-4dannjjm	5168	21	of	of	IN
cord-023095-4dannjjm	5168	22	drugs	drug	NNS
cord-023095-4dannjjm	5168	23	from	from	IN
cord-023095-4dannjjm	5168	24	the	the	DT
cord-023095-4dannjjm	5168	25	cells	cell	NNS
cord-023095-4dannjjm	5168	26	.	.	.
cord-023095-4dannjjm	5169	1	Multidrug	multidrug	JJ
cord-023095-4dannjjm	5169	2	resistance	resistance	NN
cord-023095-4dannjjm	5169	3	phenotype	phenotype	NN
cord-023095-4dannjjm	5169	4	in	in	IN
cord-023095-4dannjjm	5169	5	cancer	cancer	NN
cord-023095-4dannjjm	5169	6	cells	cell	NNS
cord-023095-4dannjjm	5169	7	is	be	VBZ
cord-023095-4dannjjm	5169	8	associated	associate	VBN
cord-023095-4dannjjm	5169	9	with	with	IN
cord-023095-4dannjjm	5169	10	overexpression	overexpression	NN
cord-023095-4dannjjm	5169	11	of	of	IN
cord-023095-4dannjjm	5169	12	these	these	DT
cord-023095-4dannjjm	5169	13	transmembrane	transmembrane	NN
cord-023095-4dannjjm	5169	14	proteins	protein	NNS
cord-023095-4dannjjm	5169	15	.	.	.
cord-023095-4dannjjm	5170	1	ABCG2	ABCG2	NNS
cord-023095-4dannjjm	5170	2	,	,	,
cord-023095-4dannjjm	5170	3	also	also	RB
cord-023095-4dannjjm	5170	4	known	know	VBN
cord-023095-4dannjjm	5170	5	as	as	IN
cord-023095-4dannjjm	5170	6	BCRP	BCRP	NNP
cord-023095-4dannjjm	5170	7	,	,	,
cord-023095-4dannjjm	5170	8	is	be	VBZ
cord-023095-4dannjjm	5170	9	a	a	DT
cord-023095-4dannjjm	5170	10	655	655	CD
cord-023095-4dannjjm	5170	11	residue	residue	JJ
cord-023095-4dannjjm	5170	12	half	half	JJ
cord-023095-4dannjjm	5170	13	-	-	HYPH
cord-023095-4dannjjm	5170	14	transporter	transporter	NN
cord-023095-4dannjjm	5170	15	protein	protein	NN
cord-023095-4dannjjm	5170	16	that	that	WDT
cord-023095-4dannjjm	5170	17	protect	protect	VBP
cord-023095-4dannjjm	5170	18	hematopoetic	hematopoetic	JJ
cord-023095-4dannjjm	5170	19	stem	stem	NN
cord-023095-4dannjjm	5170	20	cells	cell	NNS
cord-023095-4dannjjm	5170	21	against	against	IN
cord-023095-4dannjjm	5170	22	toxic	toxic	JJ
cord-023095-4dannjjm	5170	23	compounds	compound	NNS
cord-023095-4dannjjm	5170	24	.	.	.
cord-023095-4dannjjm	5171	1	The	the	DT
cord-023095-4dannjjm	5171	2	aim	aim	NN
cord-023095-4dannjjm	5171	3	of	of	IN
cord-023095-4dannjjm	5171	4	this	this	DT
cord-023095-4dannjjm	5171	5	study	study	NN
cord-023095-4dannjjm	5171	6	was	be	VBD
cord-023095-4dannjjm	5171	7	to	to	TO
cord-023095-4dannjjm	5171	8	investigate	investigate	VB
cord-023095-4dannjjm	5171	9	the	the	DT
cord-023095-4dannjjm	5171	10	expression	expression	NN
cord-023095-4dannjjm	5171	11	of	of	IN
cord-023095-4dannjjm	5171	12	BCRP	BCRP	NNP
cord-023095-4dannjjm	5171	13	(	(	-LRB-
cord-023095-4dannjjm	5171	14	ABCG2	abcg2	NN
cord-023095-4dannjjm	5171	15	)	)	-RRB-
cord-023095-4dannjjm	5171	16	in	in	IN
cord-023095-4dannjjm	5171	17	canine	canine	JJ
cord-023095-4dannjjm	5171	18	multicentric	multicentric	JJ
cord-023095-4dannjjm	5171	19	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5171	20	.	.	.
cord-023095-4dannjjm	5172	1	Samples	sample	NNS
cord-023095-4dannjjm	5172	2	were	be	VBD
cord-023095-4dannjjm	5172	3	collected	collect	VBN
cord-023095-4dannjjm	5172	4	by	by	IN
cord-023095-4dannjjm	5172	5	fine	fine	JJ
cord-023095-4dannjjm	5172	6	needle	needle	NN
cord-023095-4dannjjm	5172	7	aspiration	aspiration	NN
cord-023095-4dannjjm	5172	8	of	of	IN
cord-023095-4dannjjm	5172	9	an	an	DT
cord-023095-4dannjjm	5172	10	enlarged	enlarged	JJ
cord-023095-4dannjjm	5172	11	lymph	lymph	NN
cord-023095-4dannjjm	5172	12	nodes	node	NNS
cord-023095-4dannjjm	5172	13	,	,	,
cord-023095-4dannjjm	5172	14	from	from	IN
cord-023095-4dannjjm	5172	15	25	25	CD
cord-023095-4dannjjm	5172	16	dogs	dog	NNS
cord-023095-4dannjjm	5172	17	with	with	IN
cord-023095-4dannjjm	5172	18	multicentric	multicentric	JJ
cord-023095-4dannjjm	5172	19	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5172	20	(	(	-LRB-
cord-023095-4dannjjm	5172	21	stage	stage	NN
cord-023095-4dannjjm	5172	22	III	III	NNP
cord-023095-4dannjjm	5172	23	to	to	IN
cord-023095-4dannjjm	5172	24	V	v	NN
cord-023095-4dannjjm	5172	25	)	)	-RRB-
cord-023095-4dannjjm	5172	26	at	at	IN
cord-023095-4dannjjm	5172	27	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5172	28	,	,	,
cord-023095-4dannjjm	5172	29	and	and	CC
cord-023095-4dannjjm	5172	30	8	8	CD
cord-023095-4dannjjm	5172	31	normal	normal	JJ
cord-023095-4dannjjm	5172	32	lymph	lymph	NN
cord-023095-4dannjjm	5172	33	nodes	node	NNS
cord-023095-4dannjjm	5172	34	(	(	-LRB-
cord-023095-4dannjjm	5172	35	control	control	NN
cord-023095-4dannjjm	5172	36	)	)	-RRB-
cord-023095-4dannjjm	5172	37	.	.	.
cord-023095-4dannjjm	5173	1	Dogs	dog	NNS
cord-023095-4dannjjm	5173	2	that	that	WDT
cord-023095-4dannjjm	5173	3	were	be	VBD
cord-023095-4dannjjm	5173	4	previously	previously	RB
cord-023095-4dannjjm	5173	5	treated	treat	VBN
cord-023095-4dannjjm	5173	6	with	with	IN
cord-023095-4dannjjm	5173	7	prednisone	prednisone	NN
cord-023095-4dannjjm	5173	8	or	or	CC
cord-023095-4dannjjm	5173	9	chemotherapy	chemotherapy	NN
cord-023095-4dannjjm	5173	10	were	be	VBD
cord-023095-4dannjjm	5173	11	excluded	exclude	VBN
cord-023095-4dannjjm	5173	12	from	from	IN
cord-023095-4dannjjm	5173	13	the	the	DT
cord-023095-4dannjjm	5173	14	study	study	NN
cord-023095-4dannjjm	5173	15	.	.	.
cord-023095-4dannjjm	5174	1	Quantitative	quantitative	JJ
cord-023095-4dannjjm	5174	2	RT	RT	NNP
cord-023095-4dannjjm	5174	3	-	-	HYPH
cord-023095-4dannjjm	5174	4	PCR	PCR	NNP
cord-023095-4dannjjm	5174	5	was	be	VBD
cord-023095-4dannjjm	5174	6	used	use	VBN
cord-023095-4dannjjm	5174	7	to	to	TO
cord-023095-4dannjjm	5174	8	measure	measure	VB
cord-023095-4dannjjm	5174	9	the	the	DT
cord-023095-4dannjjm	5174	10	mRNA	mRNA	NNP
cord-023095-4dannjjm	5174	11	expression	expression	NN
cord-023095-4dannjjm	5174	12	level	level	NN
cord-023095-4dannjjm	5174	13	of	of	IN
cord-023095-4dannjjm	5174	14	BCRP	BCRP	NNP
cord-023095-4dannjjm	5174	15	and	and	CC
cord-023095-4dannjjm	5174	16	FLNB	FLNB	NNP
cord-023095-4dannjjm	5174	17	expression	expression	NN
cord-023095-4dannjjm	5174	18	as	as	IN
cord-023095-4dannjjm	5174	19	a	a	DT
cord-023095-4dannjjm	5174	20	endogenous	endogenous	JJ
cord-023095-4dannjjm	5174	21	reference	reference	NN
cord-023095-4dannjjm	5174	22	canine	canine	JJ
cord-023095-4dannjjm	5174	23	gene	gene	NN
cord-023095-4dannjjm	5174	24	.	.	.
cord-023095-4dannjjm	5175	1	A	a	DT
cord-023095-4dannjjm	5175	2	widely	widely	RB
cord-023095-4dannjjm	5175	3	range	range	JJ
cord-023095-4dannjjm	5175	4	expression	expression	NN
cord-023095-4dannjjm	5175	5	value	value	NN
cord-023095-4dannjjm	5175	6	for	for	IN
cord-023095-4dannjjm	5175	7	ABCG2	abcg2	NN
cord-023095-4dannjjm	5175	8	expression	expression	NN
cord-023095-4dannjjm	5175	9	was	be	VBD
cord-023095-4dannjjm	5175	10	found	find	VBN
cord-023095-4dannjjm	5175	11	for	for	IN
cord-023095-4dannjjm	5175	12	canine	canine	JJ
cord-023095-4dannjjm	5175	13	multicentric	multicentric	JJ
cord-023095-4dannjjm	5175	14	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5175	15	.	.	.
cord-023095-4dannjjm	5176	1	High	high	JJ
cord-023095-4dannjjm	5176	2	gene	gene	NN
cord-023095-4dannjjm	5176	3	expression	expression	NN
cord-023095-4dannjjm	5176	4	was	be	VBD
cord-023095-4dannjjm	5176	5	observed	observe	VBN
cord-023095-4dannjjm	5176	6	in	in	IN
cord-023095-4dannjjm	5176	7	52	52	CD
cord-023095-4dannjjm	5176	8	%	%	NN
cord-023095-4dannjjm	5176	9	(	(	-LRB-
cord-023095-4dannjjm	5176	10	13/25	13/25	CD
cord-023095-4dannjjm	5176	11	)	)	-RRB-
cord-023095-4dannjjm	5176	12	canine	canine	JJ
cord-023095-4dannjjm	5176	13	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5176	14	,	,	,
cord-023095-4dannjjm	5176	15	but	but	CC
cord-023095-4dannjjm	5176	16	48	48	CD
cord-023095-4dannjjm	5176	17	%	%	NN
cord-023095-4dannjjm	5176	18	of	of	IN
cord-023095-4dannjjm	5176	19	dogs	dog	NNS
cord-023095-4dannjjm	5176	20	had	have	VBD
cord-023095-4dannjjm	5176	21	a	a	DT
cord-023095-4dannjjm	5176	22	lower	low	JJR
cord-023095-4dannjjm	5176	23	expression	expression	NN
cord-023095-4dannjjm	5176	24	when	when	WRB
cord-023095-4dannjjm	5176	25	compared	compare	VBN
cord-023095-4dannjjm	5176	26	with	with	IN
cord-023095-4dannjjm	5176	27	normal	normal	JJ
cord-023095-4dannjjm	5176	28	lymph	lymph	NN
cord-023095-4dannjjm	5176	29	node	node	NN
cord-023095-4dannjjm	5176	30	.	.	.
cord-023095-4dannjjm	5177	1	Gene	gene	NN
cord-023095-4dannjjm	5177	2	expression	expression	NN
cord-023095-4dannjjm	5177	3	was	be	VBD
cord-023095-4dannjjm	5177	4	not	not	RB
cord-023095-4dannjjm	5177	5	associated	associate	VBN
cord-023095-4dannjjm	5177	6	with	with	IN
cord-023095-4dannjjm	5177	7	clinical	clinical	JJ
cord-023095-4dannjjm	5177	8	staging	staging	NN
cord-023095-4dannjjm	5177	9	,	,	,
cord-023095-4dannjjm	5177	10	complete	complete	JJ
cord-023095-4dannjjm	5177	11	or	or	CC
cord-023095-4dannjjm	5177	12	partial	partial	JJ
cord-023095-4dannjjm	5177	13	remission	remission	NN
cord-023095-4dannjjm	5177	14	,	,	,
cord-023095-4dannjjm	5177	15	relapse	relapse	NN
cord-023095-4dannjjm	5177	16	and	and	CC
cord-023095-4dannjjm	5177	17	survival	survival	NN
cord-023095-4dannjjm	5177	18	time	time	NN
cord-023095-4dannjjm	5177	19	.	.	.
cord-023095-4dannjjm	5178	1	In	in	IN
cord-023095-4dannjjm	5178	2	conclusion	conclusion	NN
cord-023095-4dannjjm	5178	3	,	,	,
cord-023095-4dannjjm	5178	4	ABCG2	ABCG2	NNP
cord-023095-4dannjjm	5178	5	was	be	VBD
cord-023095-4dannjjm	5178	6	expressed	express	VBN
cord-023095-4dannjjm	5178	7	in	in	IN
cord-023095-4dannjjm	5178	8	canine	canine	JJ
cord-023095-4dannjjm	5178	9	lymph	lymph	NN
cord-023095-4dannjjm	5178	10	node	node	NN
cord-023095-4dannjjm	5178	11	and	and	CC
cord-023095-4dannjjm	5178	12	canine	canine	JJ
cord-023095-4dannjjm	5178	13	multicentric	multicentric	JJ
cord-023095-4dannjjm	5178	14	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5178	15	at	at	IN
cord-023095-4dannjjm	5178	16	the	the	DT
cord-023095-4dannjjm	5178	17	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5178	18	,	,	,
cord-023095-4dannjjm	5178	19	and	and	CC
cord-023095-4dannjjm	5178	20	it	-PRON-	PRP
cord-023095-4dannjjm	5178	21	was	be	VBD
cord-023095-4dannjjm	5178	22	not	not	RB
cord-023095-4dannjjm	5178	23	correlated	correlate	VBN
cord-023095-4dannjjm	5178	24	with	with	IN
cord-023095-4dannjjm	5178	25	clinical	clinical	JJ
cord-023095-4dannjjm	5178	26	response	response	NN
cord-023095-4dannjjm	5178	27	.	.	.
cord-023095-4dannjjm	5179	1	Osteosarcoma	Osteosarcoma	NNP
cord-023095-4dannjjm	5179	2	(	(	-LRB-
cord-023095-4dannjjm	5179	3	OSA	OSA	NNP
cord-023095-4dannjjm	5179	4	)	)	-RRB-
cord-023095-4dannjjm	5179	5	,	,	,
cord-023095-4dannjjm	5179	6	the	the	DT
cord-023095-4dannjjm	5179	7	most	most	RBS
cord-023095-4dannjjm	5179	8	frequent	frequent	JJ
cord-023095-4dannjjm	5179	9	primary	primary	JJ
cord-023095-4dannjjm	5179	10	malignant	malignant	JJ
cord-023095-4dannjjm	5179	11	bone	bone	NN
cord-023095-4dannjjm	5179	12	tumor	tumor	NN
cord-023095-4dannjjm	5179	13	of	of	IN
cord-023095-4dannjjm	5179	14	dogs	dog	NNS
cord-023095-4dannjjm	5179	15	,	,	,
cord-023095-4dannjjm	5179	16	is	be	VBZ
cord-023095-4dannjjm	5179	17	both	both	DT
cord-023095-4dannjjm	5179	18	locally	locally	RB
cord-023095-4dannjjm	5179	19	aggressive	aggressive	JJ
cord-023095-4dannjjm	5179	20	and	and	CC
cord-023095-4dannjjm	5179	21	highly	highly	RB
cord-023095-4dannjjm	5179	22	metastatic	metastatic	JJ
cord-023095-4dannjjm	5179	23	.	.	.
cord-023095-4dannjjm	5180	1	Prognostic	prognostic	JJ
cord-023095-4dannjjm	5180	2	factors	factor	NNS
cord-023095-4dannjjm	5180	3	for	for	IN
cord-023095-4dannjjm	5180	4	canine	canine	JJ
cord-023095-4dannjjm	5180	5	OSA	OSA	NNP
cord-023095-4dannjjm	5180	6	include	include	VBP
cord-023095-4dannjjm	5180	7	tumor	tumor	NN
cord-023095-4dannjjm	5180	8	location	location	NN
cord-023095-4dannjjm	5180	9	,	,	,
cord-023095-4dannjjm	5180	10	distant	distant	JJ
cord-023095-4dannjjm	5180	11	metastatic	metastatic	JJ
cord-023095-4dannjjm	5180	12	disease	disease	NN
cord-023095-4dannjjm	5180	13	,	,	,
cord-023095-4dannjjm	5180	14	and	and	CC
cord-023095-4dannjjm	5180	15	serum	serum	NN
cord-023095-4dannjjm	5180	16	alkaline	alkaline	JJ
cord-023095-4dannjjm	5180	17	phosphatase	phosphatase	NN
cord-023095-4dannjjm	5180	18	(	(	-LRB-
cord-023095-4dannjjm	5180	19	ALP	ALP	NNP
cord-023095-4dannjjm	5180	20	)	)	-RRB-
cord-023095-4dannjjm	5180	21	concentration	concentration	NN
cord-023095-4dannjjm	5180	22	.	.	.
cord-023095-4dannjjm	5181	1	An	an	DT
cord-023095-4dannjjm	5181	2	increased	increase	VBN
cord-023095-4dannjjm	5181	3	serum	serum	NN
cord-023095-4dannjjm	5181	4	ALP	ALP	NNP
cord-023095-4dannjjm	5181	5	concentration	concentration	NN
cord-023095-4dannjjm	5181	6	is	be	VBZ
cord-023095-4dannjjm	5181	7	associated	associate	VBN
cord-023095-4dannjjm	5181	8	with	with	IN
cord-023095-4dannjjm	5181	9	poor	poor	JJ
cord-023095-4dannjjm	5181	10	prognosis	prognosis	NN
cord-023095-4dannjjm	5181	11	;	;	:
cord-023095-4dannjjm	5181	12	however	however	RB
cord-023095-4dannjjm	5181	13	the	the	DT
cord-023095-4dannjjm	5181	14	mechanisms	mechanism	NNS
cord-023095-4dannjjm	5181	15	underlying	underlie	VBG
cord-023095-4dannjjm	5181	16	this	this	DT
cord-023095-4dannjjm	5181	17	phenomenon	phenomenon	NN
cord-023095-4dannjjm	5181	18	are	be	VBP
cord-023095-4dannjjm	5181	19	currently	currently	RB
cord-023095-4dannjjm	5181	20	unclear	unclear	JJ
cord-023095-4dannjjm	5181	21	.	.	.
cord-023095-4dannjjm	5182	1	During	during	IN
cord-023095-4dannjjm	5182	2	normal	normal	JJ
cord-023095-4dannjjm	5182	3	bone	bone	NN
cord-023095-4dannjjm	5182	4	development	development	NN
cord-023095-4dannjjm	5182	5	ALP	ALP	NNP
cord-023095-4dannjjm	5182	6	may	may	MD
cord-023095-4dannjjm	5182	7	be	be	VB
cord-023095-4dannjjm	5182	8	used	use	VBN
cord-023095-4dannjjm	5182	9	as	as	IN
cord-023095-4dannjjm	5182	10	a	a	DT
cord-023095-4dannjjm	5182	11	marker	marker	NN
cord-023095-4dannjjm	5182	12	for	for	IN
cord-023095-4dannjjm	5182	13	osteoblasts	osteoblast	NNS
cord-023095-4dannjjm	5182	14	.	.	.
cord-023095-4dannjjm	5183	1	Additionally	additionally	RB
cord-023095-4dannjjm	5183	2	,	,	,
cord-023095-4dannjjm	5183	3	ALP	ALP	NNP
cord-023095-4dannjjm	5183	4	is	be	VBZ
cord-023095-4dannjjm	5183	5	a	a	DT
cord-023095-4dannjjm	5183	6	downstream	downstream	JJ
cord-023095-4dannjjm	5183	7	target	target	NN
cord-023095-4dannjjm	5183	8	of	of	IN
cord-023095-4dannjjm	5183	9	activated	activate	VBN
cord-023095-4dannjjm	5183	10	canonical	canonical	JJ
cord-023095-4dannjjm	5183	11	Wnt	Wnt	NNP
cord-023095-4dannjjm	5183	12	/	/	SYM
cord-023095-4dannjjm	5183	13	b	b	NN
cord-023095-4dannjjm	5183	14	-	-	HYPH
cord-023095-4dannjjm	5183	15	catenin	catenin	NN
cord-023095-4dannjjm	5183	16	signaling	signaling	NN
cord-023095-4dannjjm	5183	17	.	.	.
cord-023095-4dannjjm	5184	1	Therefore	therefore	RB
cord-023095-4dannjjm	5184	2	,	,	,
cord-023095-4dannjjm	5184	3	we	-PRON-	PRP
cord-023095-4dannjjm	5184	4	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	5184	5	that	that	IN
cord-023095-4dannjjm	5184	6	increased	increase	VBN
cord-023095-4dannjjm	5184	7	serum	serum	NN
cord-023095-4dannjjm	5184	8	ALP	ALP	NNP
cord-023095-4dannjjm	5184	9	would	would	MD
cord-023095-4dannjjm	5184	10	be	be	VB
cord-023095-4dannjjm	5184	11	associated	associate	VBN
cord-023095-4dannjjm	5184	12	with	with	IN
cord-023095-4dannjjm	5184	13	increased	increase	VBN
cord-023095-4dannjjm	5184	14	expression	expression	NN
cord-023095-4dannjjm	5184	15	of	of	IN
cord-023095-4dannjjm	5184	16	b	b	NN
cord-023095-4dannjjm	5184	17	-	-	HYPH
cord-023095-4dannjjm	5184	18	catenin	catenin	NNS
cord-023095-4dannjjm	5184	19	in	in	IN
cord-023095-4dannjjm	5184	20	canine	canine	JJ
cord-023095-4dannjjm	5184	21	OSA	OSA	NNP
cord-023095-4dannjjm	5184	22	.	.	.
cord-023095-4dannjjm	5185	1	The	the	DT
cord-023095-4dannjjm	5185	2	goals	goal	NNS
cord-023095-4dannjjm	5185	3	of	of	IN
cord-023095-4dannjjm	5185	4	this	this	DT
cord-023095-4dannjjm	5185	5	study	study	NN
cord-023095-4dannjjm	5185	6	were	be	VBD
cord-023095-4dannjjm	5185	7	:	:	:
cord-023095-4dannjjm	5185	8	(	(	-LRB-
cord-023095-4dannjjm	5185	9	1	1	LS
cord-023095-4dannjjm	5185	10	)	)	-RRB-
cord-023095-4dannjjm	5185	11	characterize	characterize	VB
cord-023095-4dannjjm	5185	12	and	and	CC
cord-023095-4dannjjm	5185	13	compare	compare	VB
cord-023095-4dannjjm	5185	14	cellular	cellular	JJ
cord-023095-4dannjjm	5185	15	ALP	ALP	NNP
cord-023095-4dannjjm	5185	16	expression	expression	NN
cord-023095-4dannjjm	5185	17	in	in	IN
cord-023095-4dannjjm	5185	18	OSA	OSA	NNP
cord-023095-4dannjjm	5185	19	tissue	tissue	NN
cord-023095-4dannjjm	5185	20	from	from	IN
cord-023095-4dannjjm	5185	21	patients	patient	NNS
cord-023095-4dannjjm	5185	22	with	with	IN
cord-023095-4dannjjm	5185	23	normal	normal	JJ
cord-023095-4dannjjm	5185	24	and	and	CC
cord-023095-4dannjjm	5185	25	high	high	JJ
cord-023095-4dannjjm	5185	26	serum	serum	NN
cord-023095-4dannjjm	5185	27	ALP	alp	NN
cord-023095-4dannjjm	5185	28	;	;	:
cord-023095-4dannjjm	5185	29	and	and	CC
cord-023095-4dannjjm	5185	30	(	(	-LRB-
cord-023095-4dannjjm	5185	31	2	2	LS
cord-023095-4dannjjm	5185	32	)	)	-RRB-
cord-023095-4dannjjm	5185	33	assess	assess	VB
cord-023095-4dannjjm	5185	34	b	b	NN
cord-023095-4dannjjm	5185	35	-	-	HYPH
cord-023095-4dannjjm	5185	36	catenin	catenin	NN
cord-023095-4dannjjm	5185	37	expression	expression	NN
cord-023095-4dannjjm	5185	38	in	in	IN
cord-023095-4dannjjm	5185	39	those	those	DT
cord-023095-4dannjjm	5185	40	same	same	JJ
cord-023095-4dannjjm	5185	41	patient	patient	JJ
cord-023095-4dannjjm	5185	42	populations	population	NNS
cord-023095-4dannjjm	5185	43	.	.	.
cord-023095-4dannjjm	5186	1	We	-PRON-	PRP
cord-023095-4dannjjm	5186	2	used	use	VBD
cord-023095-4dannjjm	5186	3	frozen	freeze	VBN
cord-023095-4dannjjm	5186	4	OSA	OSA	NNP
cord-023095-4dannjjm	5186	5	samples	sample	NNS
cord-023095-4dannjjm	5186	6	collected	collect	VBN
cord-023095-4dannjjm	5186	7	from	from	IN
cord-023095-4dannjjm	5186	8	patients	patient	NNS
cord-023095-4dannjjm	5186	9	with	with	IN
cord-023095-4dannjjm	5186	10	either	either	CC
cord-023095-4dannjjm	5186	11	high	high	JJ
cord-023095-4dannjjm	5186	12	ALP	ALP	NNP
cord-023095-4dannjjm	5186	13	(	(	-LRB-
cord-023095-4dannjjm	5186	14	n	n	NN
cord-023095-4dannjjm	5186	15	5	5	CD
cord-023095-4dannjjm	5186	16	3	3	CD
cord-023095-4dannjjm	5186	17	)	)	-RRB-
cord-023095-4dannjjm	5186	18	or	or	CC
cord-023095-4dannjjm	5186	19	normal	normal	JJ
cord-023095-4dannjjm	5186	20	ALP	ALP	NNP
cord-023095-4dannjjm	5186	21	(	(	-LRB-
cord-023095-4dannjjm	5186	22	n	n	NN
cord-023095-4dannjjm	5186	23	5	5	CD
cord-023095-4dannjjm	5186	24	3	3	CD
cord-023095-4dannjjm	5186	25	)	)	-RRB-
cord-023095-4dannjjm	5186	26	.	.	.
cord-023095-4dannjjm	5187	1	Total	Total	NNP
cord-023095-4dannjjm	5187	2	RNA	RNA	NNP
cord-023095-4dannjjm	5187	3	was	be	VBD
cord-023095-4dannjjm	5187	4	isolated	isolate	VBN
cord-023095-4dannjjm	5187	5	from	from	IN
cord-023095-4dannjjm	5187	6	the	the	DT
cord-023095-4dannjjm	5187	7	frozen	frozen	JJ
cord-023095-4dannjjm	5187	8	tissue	tissue	NN
cord-023095-4dannjjm	5187	9	,	,	,
cord-023095-4dannjjm	5187	10	converted	convert	VBN
cord-023095-4dannjjm	5187	11	to	to	IN
cord-023095-4dannjjm	5187	12	cDNA	cdna	NN
cord-023095-4dannjjm	5187	13	,	,	,
cord-023095-4dannjjm	5187	14	and	and	CC
cord-023095-4dannjjm	5187	15	analyzed	analyze	VBD
cord-023095-4dannjjm	5187	16	using	use	VBG
cord-023095-4dannjjm	5187	17	quantitative	quantitative	JJ
cord-023095-4dannjjm	5187	18	reverse	reverse	NN
cord-023095-4dannjjm	5187	19	-	-	HYPH
cord-023095-4dannjjm	5187	20	transcriptase	transcriptase	NN
cord-023095-4dannjjm	5187	21	polymerase	polymerase	NN
cord-023095-4dannjjm	5187	22	chain	chain	NN
cord-023095-4dannjjm	5187	23	reaction	reaction	NN
cord-023095-4dannjjm	5187	24	(	(	-LRB-
cord-023095-4dannjjm	5187	25	qRT	qRT	NNP
cord-023095-4dannjjm	5187	26	-	-	HYPH
cord-023095-4dannjjm	5187	27	PCR	PCR	NNP
cord-023095-4dannjjm	5187	28	)	)	-RRB-
cord-023095-4dannjjm	5187	29	with	with	IN
cord-023095-4dannjjm	5187	30	either	either	DT
cord-023095-4dannjjm	5187	31	target	target	NN
cord-023095-4dannjjm	5187	32	gene	gene	NN
cord-023095-4dannjjm	5187	33	ALP	ALP	NNP
cord-023095-4dannjjm	5187	34	(	(	-LRB-
cord-023095-4dannjjm	5187	35	aim	aim	NNP
cord-023095-4dannjjm	5187	36	1	1	CD
cord-023095-4dannjjm	5187	37	)	)	-RRB-
cord-023095-4dannjjm	5187	38	,	,	,
cord-023095-4dannjjm	5187	39	or	or	CC
cord-023095-4dannjjm	5187	40	target	target	NN
cord-023095-4dannjjm	5187	41	gene	gene	NN
cord-023095-4dannjjm	5187	42	b	b	NNP
cord-023095-4dannjjm	5187	43	-	-	:
cord-023095-4dannjjm	5187	44	catenin	catenin	NNP
cord-023095-4dannjjm	5187	45	(	(	-LRB-
cord-023095-4dannjjm	5187	46	aim	aim	VB
cord-023095-4dannjjm	5187	47	2	2	CD
cord-023095-4dannjjm	5187	48	)	)	-RRB-
cord-023095-4dannjjm	5187	49	.	.	.
cord-023095-4dannjjm	5188	1	Additionally	additionally	RB
cord-023095-4dannjjm	5188	2	,	,	,
cord-023095-4dannjjm	5188	3	b	b	NN
cord-023095-4dannjjm	5188	4	-	-	HYPH
cord-023095-4dannjjm	5188	5	catenin	catenin	NN
cord-023095-4dannjjm	5188	6	expression	expression	NN
cord-023095-4dannjjm	5188	7	was	be	VBD
cord-023095-4dannjjm	5188	8	analyzed	analyze	VBN
cord-023095-4dannjjm	5188	9	by	by	IN
cord-023095-4dannjjm	5188	10	Western	western	JJ
cord-023095-4dannjjm	5188	11	blot	blot	NN
cord-023095-4dannjjm	5188	12	.	.	.
cord-023095-4dannjjm	5189	1	QPCR	QPCR	NNP
cord-023095-4dannjjm	5189	2	data	datum	NNS
cord-023095-4dannjjm	5189	3	for	for	IN
cord-023095-4dannjjm	5189	4	bcatenin	bcatenin	NNP
cord-023095-4dannjjm	5189	5	and	and	CC
cord-023095-4dannjjm	5189	6	ALP	ALP	NNP
cord-023095-4dannjjm	5189	7	expression	expression	NN
cord-023095-4dannjjm	5189	8	were	be	VBD
cord-023095-4dannjjm	5189	9	normalized	normalize	VBN
cord-023095-4dannjjm	5189	10	to	to	IN
cord-023095-4dannjjm	5189	11	18S	18S	NNP
cord-023095-4dannjjm	5189	12	,	,	,
cord-023095-4dannjjm	5189	13	and	and	CC
cord-023095-4dannjjm	5189	14	relative	relative	JJ
cord-023095-4dannjjm	5189	15	expression	expression	NN
cord-023095-4dannjjm	5189	16	was	be	VBD
cord-023095-4dannjjm	5189	17	calculated	calculate	VBN
cord-023095-4dannjjm	5189	18	by	by	IN
cord-023095-4dannjjm	5189	19	the	the	DT
cord-023095-4dannjjm	5189	20	DDCt	DDCt	NNS
cord-023095-4dannjjm	5189	21	method	method	NN
cord-023095-4dannjjm	5189	22	.	.	.
cord-023095-4dannjjm	5190	1	The	the	DT
cord-023095-4dannjjm	5190	2	relative	relative	JJ
cord-023095-4dannjjm	5190	3	expression	expression	NN
cord-023095-4dannjjm	5190	4	of	of	IN
cord-023095-4dannjjm	5190	5	cellular	cellular	JJ
cord-023095-4dannjjm	5190	6	ALP	ALP	NNP
cord-023095-4dannjjm	5190	7	was	be	VBD
cord-023095-4dannjjm	5190	8	higher	high	JJR
cord-023095-4dannjjm	5190	9	in	in	IN
cord-023095-4dannjjm	5190	10	high	high	JJ
cord-023095-4dannjjm	5190	11	serum	serum	NN
cord-023095-4dannjjm	5190	12	ALP	alp	NN
cord-023095-4dannjjm	5190	13	samples	sample	NNS
cord-023095-4dannjjm	5190	14	compared	compare	VBN
cord-023095-4dannjjm	5190	15	to	to	IN
cord-023095-4dannjjm	5190	16	normal	normal	JJ
cord-023095-4dannjjm	5190	17	serum	serum	NN
cord-023095-4dannjjm	5190	18	ALP	alp	NN
cord-023095-4dannjjm	5190	19	samples	sample	NNS
cord-023095-4dannjjm	5190	20	:	:	:
cord-023095-4dannjjm	5190	21	44.74	44.74	CD
cord-023095-4dannjjm	5190	22	AE	AE	NNP
cord-023095-4dannjjm	5190	23	22.04	22.04	CD
cord-023095-4dannjjm	5191	1	(	(	-LRB-
cord-023095-4dannjjm	5191	2	mean	mean	VB
cord-023095-4dannjjm	5191	3	relative	relative	JJ
cord-023095-4dannjjm	5191	4	expression	expression	NN
cord-023095-4dannjjm	5191	5	AE	AE	NNP
cord-023095-4dannjjm	5191	6	standard	standard	JJ
cord-023095-4dannjjm	5191	7	deviation	deviation	NN
cord-023095-4dannjjm	5191	8	;	;	:
cord-023095-4dannjjm	5191	9	p	p	NN
cord-023095-4dannjjm	5191	10	o	o	CD
cord-023095-4dannjjm	5191	11	0.001	0.001	CD
cord-023095-4dannjjm	5191	12	)	)	-RRB-
cord-023095-4dannjjm	5191	13	.	.	.
cord-023095-4dannjjm	5192	1	Further	further	RB
cord-023095-4dannjjm	5192	2	,	,	,
cord-023095-4dannjjm	5192	3	the	the	DT
cord-023095-4dannjjm	5192	4	relative	relative	JJ
cord-023095-4dannjjm	5192	5	expression	expression	NN
cord-023095-4dannjjm	5192	6	of	of	IN
cord-023095-4dannjjm	5192	7	b	b	NN
cord-023095-4dannjjm	5192	8	-	-	HYPH
cord-023095-4dannjjm	5192	9	catenin	catenin	NNP
cord-023095-4dannjjm	5192	10	was	be	VBD
cord-023095-4dannjjm	5192	11	also	also	RB
cord-023095-4dannjjm	5192	12	increased	increase	VBN
cord-023095-4dannjjm	5192	13	;	;	:
cord-023095-4dannjjm	5192	14	b	b	LS
cord-023095-4dannjjm	5192	15	-	-	HYPH
cord-023095-4dannjjm	5192	16	catenin	catenin	NN
cord-023095-4dannjjm	5192	17	expression	expression	NN
cord-023095-4dannjjm	5192	18	of	of	IN
cord-023095-4dannjjm	5192	19	high	high	JJ
cord-023095-4dannjjm	5192	20	serum	serum	NN
cord-023095-4dannjjm	5192	21	ALP	alp	NN
cord-023095-4dannjjm	5192	22	samples	sample	NNS
cord-023095-4dannjjm	5192	23	relative	relative	JJ
cord-023095-4dannjjm	5192	24	to	to	IN
cord-023095-4dannjjm	5192	25	low	low	JJ
cord-023095-4dannjjm	5192	26	serum	serum	NN
cord-023095-4dannjjm	5192	27	ALP	alp	NN
cord-023095-4dannjjm	5192	28	samples	sample	NNS
cord-023095-4dannjjm	5192	29	was	be	VBD
cord-023095-4dannjjm	5192	30	24.57	24.57	CD
cord-023095-4dannjjm	5192	31	AE	AE	NNP
cord-023095-4dannjjm	5192	32	11.41	11.41	CD
cord-023095-4dannjjm	5193	1	(	(	-LRB-
cord-023095-4dannjjm	5193	2	p	p	NN
cord-023095-4dannjjm	5193	3	o	o	CD
cord-023095-4dannjjm	5193	4	0.001	0.001	CD
cord-023095-4dannjjm	5193	5	)	)	-RRB-
cord-023095-4dannjjm	5193	6	,	,	,
cord-023095-4dannjjm	5193	7	which	which	WDT
cord-023095-4dannjjm	5193	8	is	be	VBZ
cord-023095-4dannjjm	5193	9	also	also	RB
cord-023095-4dannjjm	5193	10	seen	see	VBN
cord-023095-4dannjjm	5193	11	by	by	IN
cord-023095-4dannjjm	5193	12	Western	western	JJ
cord-023095-4dannjjm	5193	13	blot	blot	NN
cord-023095-4dannjjm	5193	14	.	.	.
cord-023095-4dannjjm	5194	1	This	this	DT
cord-023095-4dannjjm	5194	2	study	study	NN
cord-023095-4dannjjm	5194	3	begins	begin	VBZ
cord-023095-4dannjjm	5194	4	to	to	TO
cord-023095-4dannjjm	5194	5	clarify	clarify	VB
cord-023095-4dannjjm	5194	6	the	the	DT
cord-023095-4dannjjm	5194	7	mechanism	mechanism	NN
cord-023095-4dannjjm	5194	8	behind	behind	IN
cord-023095-4dannjjm	5194	9	high	high	JJ
cord-023095-4dannjjm	5194	10	serum	serum	NN
cord-023095-4dannjjm	5194	11	ALP	ALP	NNP
cord-023095-4dannjjm	5194	12	in	in	IN
cord-023095-4dannjjm	5194	13	canine	canine	JJ
cord-023095-4dannjjm	5194	14	OSA	OSA	NNP
cord-023095-4dannjjm	5194	15	,	,	,
cord-023095-4dannjjm	5194	16	and	and	CC
cord-023095-4dannjjm	5194	17	suggests	suggest	VBZ
cord-023095-4dannjjm	5194	18	the	the	DT
cord-023095-4dannjjm	5194	19	Wnt	Wnt	NNP
cord-023095-4dannjjm	5194	20	signaling	signal	VBG
cord-023095-4dannjjm	5194	21	pathway	pathway	NN
cord-023095-4dannjjm	5194	22	may	may	MD
cord-023095-4dannjjm	5194	23	be	be	VB
cord-023095-4dannjjm	5194	24	active	active	JJ
cord-023095-4dannjjm	5194	25	in	in	IN
cord-023095-4dannjjm	5194	26	this	this	DT
cord-023095-4dannjjm	5194	27	population	population	NN
cord-023095-4dannjjm	5194	28	of	of	IN
cord-023095-4dannjjm	5194	29	patients	patient	NNS
cord-023095-4dannjjm	5194	30	.	.	.
cord-023095-4dannjjm	5195	1	Further	further	JJ
cord-023095-4dannjjm	5195	2	work	work	NN
cord-023095-4dannjjm	5195	3	will	will	MD
cord-023095-4dannjjm	5195	4	focus	focus	VB
cord-023095-4dannjjm	5195	5	on	on	IN
cord-023095-4dannjjm	5195	6	elucidating	elucidate	VBG
cord-023095-4dannjjm	5195	7	the	the	DT
cord-023095-4dannjjm	5195	8	role	role	NN
cord-023095-4dannjjm	5195	9	active	active	JJ
cord-023095-4dannjjm	5195	10	Wnt	Wnt	NNP
cord-023095-4dannjjm	5195	11	signaling	signal	VBG
cord-023095-4dannjjm	5195	12	plays	play	NNS
cord-023095-4dannjjm	5195	13	in	in	IN
cord-023095-4dannjjm	5195	14	the	the	DT
cord-023095-4dannjjm	5195	15	biology	biology	NN
cord-023095-4dannjjm	5195	16	of	of	IN
cord-023095-4dannjjm	5195	17	OSA	OSA	NNP
cord-023095-4dannjjm	5195	18	.	.	.
cord-023095-4dannjjm	5196	1	In	in	IN
cord-023095-4dannjjm	5196	2	the	the	DT
cord-023095-4dannjjm	5196	3	future	future	NN
cord-023095-4dannjjm	5196	4	,	,	,
cord-023095-4dannjjm	5196	5	serum	serum	NN
cord-023095-4dannjjm	5196	6	ALP	alp	NN
cord-023095-4dannjjm	5196	7	status	status	NN
cord-023095-4dannjjm	5196	8	of	of	IN
cord-023095-4dannjjm	5196	9	OSA	OSA	NNP
cord-023095-4dannjjm	5196	10	patients	patient	NNS
cord-023095-4dannjjm	5196	11	may	may	MD
cord-023095-4dannjjm	5196	12	help	help	VB
cord-023095-4dannjjm	5196	13	identify	identify	VB
cord-023095-4dannjjm	5196	14	patients	patient	NNS
cord-023095-4dannjjm	5196	15	that	that	WDT
cord-023095-4dannjjm	5196	16	would	would	MD
cord-023095-4dannjjm	5196	17	benefit	benefit	VB
cord-023095-4dannjjm	5196	18	from	from	IN
cord-023095-4dannjjm	5196	19	therapies	therapy	NNS
cord-023095-4dannjjm	5196	20	targeting	target	VBG
cord-023095-4dannjjm	5196	21	this	this	DT
cord-023095-4dannjjm	5196	22	pathway	pathway	NN
cord-023095-4dannjjm	5196	23	.	.	.
cord-023095-4dannjjm	5197	1	Accurate	accurate	JJ
cord-023095-4dannjjm	5197	2	assessment	assessment	NN
cord-023095-4dannjjm	5197	3	of	of	IN
cord-023095-4dannjjm	5197	4	abdominal	abdominal	JJ
cord-023095-4dannjjm	5197	5	lymph	lymph	NN
cord-023095-4dannjjm	5197	6	node	node	NN
cord-023095-4dannjjm	5197	7	status	status	NN
cord-023095-4dannjjm	5197	8	is	be	VBZ
cord-023095-4dannjjm	5197	9	of	of	IN
cord-023095-4dannjjm	5197	10	vital	vital	JJ
cord-023095-4dannjjm	5197	11	importance	importance	NN
cord-023095-4dannjjm	5197	12	for	for	IN
cord-023095-4dannjjm	5197	13	appropriate	appropriate	JJ
cord-023095-4dannjjm	5197	14	treatment	treatment	NN
cord-023095-4dannjjm	5197	15	planning	planning	NN
cord-023095-4dannjjm	5197	16	and	and	CC
cord-023095-4dannjjm	5197	17	determining	determine	VBG
cord-023095-4dannjjm	5197	18	prognosis	prognosis	NN
cord-023095-4dannjjm	5197	19	in	in	IN
cord-023095-4dannjjm	5197	20	dogs	dog	NNS
cord-023095-4dannjjm	5197	21	with	with	IN
cord-023095-4dannjjm	5197	22	apocrine	apocrine	JJ
cord-023095-4dannjjm	5197	23	gland	gland	NN
cord-023095-4dannjjm	5197	24	adenocarcinoma	adenocarcinoma	NN
cord-023095-4dannjjm	5197	25	of	of	IN
cord-023095-4dannjjm	5197	26	the	the	DT
cord-023095-4dannjjm	5197	27	anal	anal	JJ
cord-023095-4dannjjm	5197	28	sac	sac	NN
cord-023095-4dannjjm	5197	29	(	(	-LRB-
cord-023095-4dannjjm	5197	30	AGAAS	AGAAS	NNP
cord-023095-4dannjjm	5197	31	)	)	-RRB-
cord-023095-4dannjjm	5197	32	.	.	.
cord-023095-4dannjjm	5198	1	Pretreatment	pretreatment	JJ
cord-023095-4dannjjm	5198	2	knowledge	knowledge	NN
cord-023095-4dannjjm	5198	3	of	of	IN
cord-023095-4dannjjm	5198	4	lymph	lymph	NN
cord-023095-4dannjjm	5198	5	node	node	NN
cord-023095-4dannjjm	5198	6	status	status	NN
cord-023095-4dannjjm	5198	7	is	be	VBZ
cord-023095-4dannjjm	5198	8	helpful	helpful	JJ
cord-023095-4dannjjm	5198	9	for	for	IN
cord-023095-4dannjjm	5198	10	determining	determine	VBG
cord-023095-4dannjjm	5198	11	prognosis	prognosis	NN
cord-023095-4dannjjm	5198	12	and	and	CC
cord-023095-4dannjjm	5198	13	planning	plan	VBG
cord-023095-4dannjjm	5198	14	the	the	DT
cord-023095-4dannjjm	5198	15	optimal	optimal	JJ
cord-023095-4dannjjm	5198	16	extent	extent	NN
cord-023095-4dannjjm	5198	17	of	of	IN
cord-023095-4dannjjm	5198	18	lymphadenectomy	lymphadenectomy	NN
cord-023095-4dannjjm	5198	19	.	.	.
cord-023095-4dannjjm	5199	1	In	in	IN
cord-023095-4dannjjm	5199	2	addition	addition	NN
cord-023095-4dannjjm	5199	3	,	,	,
cord-023095-4dannjjm	5199	4	pretreatment	pretreatment	NN
cord-023095-4dannjjm	5199	5	knowledge	knowledge	NN
cord-023095-4dannjjm	5199	6	of	of	IN
cord-023095-4dannjjm	5199	7	lymph	lymph	NN
cord-023095-4dannjjm	5199	8	node	node	NN
cord-023095-4dannjjm	5199	9	status	status	NN
cord-023095-4dannjjm	5199	10	may	may	MD
cord-023095-4dannjjm	5199	11	help	help	VB
cord-023095-4dannjjm	5199	12	in	in	IN
cord-023095-4dannjjm	5199	13	selecting	select	VBG
cord-023095-4dannjjm	5199	14	patients	patient	NNS
cord-023095-4dannjjm	5199	15	who	who	WP
cord-023095-4dannjjm	5199	16	might	may	MD
cord-023095-4dannjjm	5199	17	benefit	benefit	VB
cord-023095-4dannjjm	5199	18	from	from	IN
cord-023095-4dannjjm	5199	19	adjuvant	adjuvant	JJ
cord-023095-4dannjjm	5199	20	chemotherapy	chemotherapy	NN
cord-023095-4dannjjm	5199	21	and	and	CC
cord-023095-4dannjjm	5199	22	radiation	radiation	NN
cord-023095-4dannjjm	5199	23	therapy	therapy	NN
cord-023095-4dannjjm	5199	24	.	.	.
cord-023095-4dannjjm	5200	1	Abdominal	abdominal	JJ
cord-023095-4dannjjm	5200	2	ultrasound	ultrasound	NN
cord-023095-4dannjjm	5200	3	is	be	VBZ
cord-023095-4dannjjm	5200	4	currently	currently	RB
cord-023095-4dannjjm	5200	5	the	the	DT
cord-023095-4dannjjm	5200	6	most	most	RBS
cord-023095-4dannjjm	5200	7	commonly	commonly	RB
cord-023095-4dannjjm	5200	8	employed	employ	VBN
cord-023095-4dannjjm	5200	9	test	test	NN
cord-023095-4dannjjm	5200	10	to	to	TO
cord-023095-4dannjjm	5200	11	screen	screen	VB
cord-023095-4dannjjm	5200	12	for	for	IN
cord-023095-4dannjjm	5200	13	abdominal	abdominal	JJ
cord-023095-4dannjjm	5200	14	lymphadenopathy	lymphadenopathy	NN
cord-023095-4dannjjm	5200	15	in	in	IN
cord-023095-4dannjjm	5200	16	dogs	dog	NNS
cord-023095-4dannjjm	5200	17	with	with	IN
cord-023095-4dannjjm	5200	18	AGAAS	agaa	NNS
cord-023095-4dannjjm	5200	19	.	.	.
cord-023095-4dannjjm	5201	1	Imaging	imaging	NN
cord-023095-4dannjjm	5201	2	studies	study	NNS
cord-023095-4dannjjm	5201	3	in	in	IN
cord-023095-4dannjjm	5201	4	people	people	NNS
cord-023095-4dannjjm	5201	5	indicate	indicate	VBP
cord-023095-4dannjjm	5201	6	that	that	IN
cord-023095-4dannjjm	5201	7	magnetic	magnetic	JJ
cord-023095-4dannjjm	5201	8	resonance	resonance	NN
cord-023095-4dannjjm	5201	9	imaging	imaging	NN
cord-023095-4dannjjm	5201	10	(	(	-LRB-
cord-023095-4dannjjm	5201	11	To	to	TO
cord-023095-4dannjjm	5201	12	determine	determine	VB
cord-023095-4dannjjm	5201	13	and	and	CC
cord-023095-4dannjjm	5201	14	compare	compare	VB
cord-023095-4dannjjm	5201	15	the	the	DT
cord-023095-4dannjjm	5201	16	plasma	plasma	NN
cord-023095-4dannjjm	5201	17	concentration	concentration	NN
cord-023095-4dannjjm	5201	18	of	of	IN
cord-023095-4dannjjm	5201	19	cyclophosphamide	cyclophosphamide	NN
cord-023095-4dannjjm	5201	20	and	and	CC
cord-023095-4dannjjm	5201	21	its	-PRON-	PRP$
cord-023095-4dannjjm	5201	22	metabolite	metabolite	JJ
cord-023095-4dannjjm	5201	23	4-OHCP	4-ohcp	NN
cord-023095-4dannjjm	5201	24	,	,	,
cord-023095-4dannjjm	5201	25	within	within	IN
cord-023095-4dannjjm	5201	26	the	the	DT
cord-023095-4dannjjm	5201	27	plasma	plasma	NN
cord-023095-4dannjjm	5201	28	of	of	IN
cord-023095-4dannjjm	5201	29	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5201	30	bearing	bear	VBG
cord-023095-4dannjjm	5201	31	dogs	dog	NNS
cord-023095-4dannjjm	5201	32	being	be	VBG
cord-023095-4dannjjm	5201	33	treated	treat	VBN
cord-023095-4dannjjm	5201	34	with	with	IN
cord-023095-4dannjjm	5201	35	either	either	CC
cord-023095-4dannjjm	5201	36	oral	oral	JJ
cord-023095-4dannjjm	5201	37	or	or	CC
cord-023095-4dannjjm	5201	38	intravenous	intravenous	JJ
cord-023095-4dannjjm	5201	39	cyclophosphamide	cyclophosphamide	NN
cord-023095-4dannjjm	5201	40	.	.	.
cord-023095-4dannjjm	5202	1	In	in	IN
cord-023095-4dannjjm	5202	2	this	this	DT
cord-023095-4dannjjm	5202	3	prospective	prospective	JJ
cord-023095-4dannjjm	5202	4	study	study	NN
cord-023095-4dannjjm	5202	5	,	,	,
cord-023095-4dannjjm	5202	6	patients	patient	NNS
cord-023095-4dannjjm	5202	7	were	be	VBD
cord-023095-4dannjjm	5202	8	randomly	randomly	RB
cord-023095-4dannjjm	5202	9	assigned	assign	VBN
cord-023095-4dannjjm	5202	10	to	to	IN
cord-023095-4dannjjm	5202	11	either	either	CC
cord-023095-4dannjjm	5202	12	receive	receive	VBP
cord-023095-4dannjjm	5202	13	oral	oral	JJ
cord-023095-4dannjjm	5202	14	or	or	CC
cord-023095-4dannjjm	5202	15	intravenous	intravenous	JJ
cord-023095-4dannjjm	5202	16	cyclophosphamide	cyclophosphamide	NN
cord-023095-4dannjjm	5202	17	,	,	,
cord-023095-4dannjjm	5202	18	at	at	IN
cord-023095-4dannjjm	5202	19	a	a	DT
cord-023095-4dannjjm	5202	20	dose	dose	NN
cord-023095-4dannjjm	5202	21	of	of	IN
cord-023095-4dannjjm	5202	22	250	250	CD
cord-023095-4dannjjm	5202	23	mg	mg	NNP
cord-023095-4dannjjm	5202	24	/	/	SYM
cord-023095-4dannjjm	5202	25	m2	m2	NNP
cord-023095-4dannjjm	5202	26	.	.	.
cord-023095-4dannjjm	5203	1	Based	base	VBN
cord-023095-4dannjjm	5203	2	on	on	IN
cord-023095-4dannjjm	5203	3	a	a	DT
cord-023095-4dannjjm	5203	4	priori	priori	FW
cord-023095-4dannjjm	5203	5	power	power	NN
cord-023095-4dannjjm	5203	6	calculation	calculation	NN
cord-023095-4dannjjm	5203	7	eight	eight	CD
cord-023095-4dannjjm	5203	8	patients	patient	NNS
cord-023095-4dannjjm	5203	9	per	per	IN
cord-023095-4dannjjm	5203	10	treatment	treatment	NN
cord-023095-4dannjjm	5203	11	group	group	NN
cord-023095-4dannjjm	5203	12	were	be	VBD
cord-023095-4dannjjm	5203	13	enrolled	enrol	VBN
cord-023095-4dannjjm	5203	14	.	.	.
cord-023095-4dannjjm	5204	1	Plasma	plasma	NN
cord-023095-4dannjjm	5204	2	was	be	VBD
cord-023095-4dannjjm	5204	3	obtained	obtain	VBN
cord-023095-4dannjjm	5204	4	at	at	IN
cord-023095-4dannjjm	5204	5	times	time	NNS
cord-023095-4dannjjm	5204	6	0	0	CD
cord-023095-4dannjjm	5204	7	,	,	,
cord-023095-4dannjjm	5204	8	15	15	CD
cord-023095-4dannjjm	5204	9	,	,	,
cord-023095-4dannjjm	5204	10	30	30	CD
cord-023095-4dannjjm	5204	11	,	,	,
cord-023095-4dannjjm	5204	12	60	60	CD
cord-023095-4dannjjm	5204	13	minutes	minute	NNS
cord-023095-4dannjjm	5204	14	,	,	,
cord-023095-4dannjjm	5204	15	and	and	CC
cord-023095-4dannjjm	5204	16	then	then	RB
cord-023095-4dannjjm	5204	17	at	at	IN
cord-023095-4dannjjm	5204	18	2	2	CD
cord-023095-4dannjjm	5204	19	,	,	,
cord-023095-4dannjjm	5204	20	4	4	CD
cord-023095-4dannjjm	5204	21	,	,	,
cord-023095-4dannjjm	5204	22	6	6	CD
cord-023095-4dannjjm	5204	23	,	,	,
cord-023095-4dannjjm	5204	24	8	8	CD
cord-023095-4dannjjm	5204	25	,	,	,
cord-023095-4dannjjm	5204	26	24	24	CD
cord-023095-4dannjjm	5204	27	hours	hour	NNS
cord-023095-4dannjjm	5204	28	post	post	NN
cord-023095-4dannjjm	5204	29	administration	administration	NN
cord-023095-4dannjjm	5204	30	for	for	IN
cord-023095-4dannjjm	5204	31	evaluation	evaluation	NN
cord-023095-4dannjjm	5204	32	of	of	IN
cord-023095-4dannjjm	5204	33	4-OHCP	4-ohcp	CD
cord-023095-4dannjjm	5204	34	concentrations	concentration	NNS
cord-023095-4dannjjm	5204	35	by	by	IN
cord-023095-4dannjjm	5204	36	liquid	liquid	JJ
cord-023095-4dannjjm	5204	37	chromatography	chromatography	NN
cord-023095-4dannjjm	5204	38	-	-	HYPH
cord-023095-4dannjjm	5204	39	dual	dual	JJ
cord-023095-4dannjjm	5204	40	mass	mass	NN
cord-023095-4dannjjm	5204	41	spectrometry	spectrometry	NN
cord-023095-4dannjjm	5204	42	(	(	-LRB-
cord-023095-4dannjjm	5204	43	LC	LC	NNP
cord-023095-4dannjjm	5204	44	/	/	SYM
cord-023095-4dannjjm	5204	45	MS	MS	NNP
cord-023095-4dannjjm	5204	46	/	/	SYM
cord-023095-4dannjjm	5204	47	MS	MS	NNP
cord-023095-4dannjjm	5204	48	)	)	-RRB-
cord-023095-4dannjjm	5204	49	.	.	.
cord-023095-4dannjjm	5205	1	Average	average	JJ
cord-023095-4dannjjm	5205	2	values	value	NNS
cord-023095-4dannjjm	5205	3	were	be	VBD
cord-023095-4dannjjm	5205	4	obtained	obtain	VBN
cord-023095-4dannjjm	5205	5	for	for	IN
cord-023095-4dannjjm	5205	6	both	both	CC
cord-023095-4dannjjm	5205	7	cyclophosphamide	cyclophosphamide	IN
cord-023095-4dannjjm	5205	8	and	and	CC
cord-023095-4dannjjm	5205	9	4-OHCP	4-ohcp	CD
cord-023095-4dannjjm	5205	10	concentrations	concentration	NNS
cord-023095-4dannjjm	5205	11	within	within	IN
cord-023095-4dannjjm	5205	12	the	the	DT
cord-023095-4dannjjm	5205	13	plasma	plasma	NN
cord-023095-4dannjjm	5205	14	of	of	IN
cord-023095-4dannjjm	5205	15	both	both	DT
cord-023095-4dannjjm	5205	16	groups	group	NNS
cord-023095-4dannjjm	5205	17	.	.	.
cord-023095-4dannjjm	5206	1	The	the	DT
cord-023095-4dannjjm	5206	2	following	follow	VBG
cord-023095-4dannjjm	5206	3	values	value	NNS
cord-023095-4dannjjm	5206	4	were	be	VBD
cord-023095-4dannjjm	5206	5	obtained	obtain	VBN
cord-023095-4dannjjm	5206	6	,	,	,
cord-023095-4dannjjm	5206	7	half	half	JJ
cord-023095-4dannjjm	5206	8	life	life	NN
cord-023095-4dannjjm	5206	9	(	(	-LRB-
cord-023095-4dannjjm	5206	10	HL	HL	NNP
cord-023095-4dannjjm	5206	11	)	)	-RRB-
cord-023095-4dannjjm	5206	12	,	,	,
cord-023095-4dannjjm	5206	13	time	time	NN
cord-023095-4dannjjm	5206	14	to	to	IN
cord-023095-4dannjjm	5206	15	maximum	maximum	VB
cord-023095-4dannjjm	5206	16	concentration	concentration	NN
cord-023095-4dannjjm	5206	17	(	(	-LRB-
cord-023095-4dannjjm	5206	18	Tmax	Tmax	NNP
cord-023095-4dannjjm	5206	19	)	)	-RRB-
cord-023095-4dannjjm	5206	20	,	,	,
cord-023095-4dannjjm	5206	21	maximum	maximum	JJ
cord-023095-4dannjjm	5206	22	concentration	concentration	NN
cord-023095-4dannjjm	5206	23	(	(	-LRB-
cord-023095-4dannjjm	5206	24	Cmax	Cmax	NNP
cord-023095-4dannjjm	5206	25	)	)	-RRB-
cord-023095-4dannjjm	5206	26	,	,	,
cord-023095-4dannjjm	5206	27	and	and	CC
cord-023095-4dannjjm	5206	28	area	area	NN
cord-023095-4dannjjm	5206	29	under	under	IN
cord-023095-4dannjjm	5206	30	the	the	DT
cord-023095-4dannjjm	5206	31	curve	curve	NN
cord-023095-4dannjjm	5206	32	(	(	-LRB-
cord-023095-4dannjjm	5206	33	AUC	AUC	NNP
cord-023095-4dannjjm	5206	34	)	)	-RRB-
cord-023095-4dannjjm	5206	35	.	.	.
cord-023095-4dannjjm	5207	1	The	the	DT
cord-023095-4dannjjm	5207	2	Mann	Mann	NNP
cord-023095-4dannjjm	5207	3	-	-	HYPH
cord-023095-4dannjjm	5207	4	Whitney	Whitney	NNP
cord-023095-4dannjjm	5207	5	statistical	statistical	JJ
cord-023095-4dannjjm	5207	6	test	test	NN
cord-023095-4dannjjm	5207	7	was	be	VBD
cord-023095-4dannjjm	5207	8	used	use	VBN
cord-023095-4dannjjm	5207	9	to	to	TO
cord-023095-4dannjjm	5207	10	compare	compare	VB
cord-023095-4dannjjm	5207	11	the	the	DT
cord-023095-4dannjjm	5207	12	groups	group	NNS
cord-023095-4dannjjm	5207	13	.	.	.
cord-023095-4dannjjm	5208	1	The	the	DT
cord-023095-4dannjjm	5208	2	AUC	AUC	NNP
cord-023095-4dannjjm	5208	3	for	for	IN
cord-023095-4dannjjm	5208	4	cyclophosphamide	cyclophosphamide	NN
cord-023095-4dannjjm	5208	5	was	be	VBD
cord-023095-4dannjjm	5208	6	statistically	statistically	RB
cord-023095-4dannjjm	5208	7	significant	significant	JJ
cord-023095-4dannjjm	5209	1	(	(	-LRB-
cord-023095-4dannjjm	5209	2	P	p	NN
cord-023095-4dannjjm	5209	3	o	o	NN
cord-023095-4dannjjm	5209	4	0.05	0.05	CD
cord-023095-4dannjjm	5209	5	)	)	-RRB-
cord-023095-4dannjjm	5209	6	when	when	WRB
cord-023095-4dannjjm	5209	7	compared	compare	VBN
cord-023095-4dannjjm	5209	8	between	between	IN
cord-023095-4dannjjm	5209	9	the	the	DT
cord-023095-4dannjjm	5209	10	two	two	CD
cord-023095-4dannjjm	5209	11	groups	group	NNS
cord-023095-4dannjjm	5209	12	.	.	.
cord-023095-4dannjjm	5210	1	The	the	DT
cord-023095-4dannjjm	5210	2	AUC	AUC	NNP
cord-023095-4dannjjm	5210	3	for	for	IN
cord-023095-4dannjjm	5210	4	4-OHCP	4-OHCP	NNP
cord-023095-4dannjjm	5210	5	was	be	VBD
cord-023095-4dannjjm	5210	6	not	not	RB
cord-023095-4dannjjm	5210	7	statistically	statistically	RB
cord-023095-4dannjjm	5210	8	significant	significant	JJ
cord-023095-4dannjjm	5210	9	between	between	IN
cord-023095-4dannjjm	5210	10	the	the	DT
cord-023095-4dannjjm	5210	11	groups	group	NNS
cord-023095-4dannjjm	5210	12	.	.	.
cord-023095-4dannjjm	5211	1	The	the	DT
cord-023095-4dannjjm	5211	2	difference	difference	NN
cord-023095-4dannjjm	5211	3	between	between	IN
cord-023095-4dannjjm	5211	4	Cmax	Cmax	NNP
cord-023095-4dannjjm	5211	5	for	for	IN
cord-023095-4dannjjm	5211	6	cyclophosphamide	cyclophosphamide	NN
cord-023095-4dannjjm	5211	7	and	and	CC
cord-023095-4dannjjm	5211	8	4-OHCP	4-ohcp	NN
cord-023095-4dannjjm	5211	9	was	be	VBD
cord-023095-4dannjjm	5211	10	statistically	statistically	RB
cord-023095-4dannjjm	5211	11	significantly	significantly	RB
cord-023095-4dannjjm	5211	12	(	(	-LRB-
cord-023095-4dannjjm	5211	13	P	p	NN
cord-023095-4dannjjm	5211	14	o	o	NN
cord-023095-4dannjjm	5211	15	0.05	0.05	CD
cord-023095-4dannjjm	5211	16	)	)	-RRB-
cord-023095-4dannjjm	5211	17	between	between	IN
cord-023095-4dannjjm	5211	18	the	the	DT
cord-023095-4dannjjm	5211	19	groups	group	NNS
cord-023095-4dannjjm	5211	20	.	.	.
cord-023095-4dannjjm	5212	1	Although	although	IN
cord-023095-4dannjjm	5212	2	the	the	DT
cord-023095-4dannjjm	5212	3	AUC	AUC	NNP
cord-023095-4dannjjm	5212	4	for	for	IN
cord-023095-4dannjjm	5212	5	cyclophosphamide	cyclophosphamide	NN
cord-023095-4dannjjm	5212	6	was	be	VBD
cord-023095-4dannjjm	5212	7	statistically	statistically	RB
cord-023095-4dannjjm	5212	8	significant	significant	JJ
cord-023095-4dannjjm	5212	9	between	between	IN
cord-023095-4dannjjm	5212	10	the	the	DT
cord-023095-4dannjjm	5212	11	two	two	CD
cord-023095-4dannjjm	5212	12	groups	group	NNS
cord-023095-4dannjjm	5212	13	,	,	,
cord-023095-4dannjjm	5212	14	the	the	DT
cord-023095-4dannjjm	5212	15	AUC	AUC	NNP
cord-023095-4dannjjm	5212	16	for	for	IN
cord-023095-4dannjjm	5212	17	the	the	DT
cord-023095-4dannjjm	5212	18	active	active	JJ
cord-023095-4dannjjm	5212	19	metabolite	metabolite	NN
cord-023095-4dannjjm	5212	20	4-OHCP	4-ohcp	NN
cord-023095-4dannjjm	5212	21	was	be	VBD
cord-023095-4dannjjm	5212	22	not	not	RB
cord-023095-4dannjjm	5212	23	different	different	JJ
cord-023095-4dannjjm	5212	24	when	when	WRB
cord-023095-4dannjjm	5212	25	administered	administer	VBN
cord-023095-4dannjjm	5212	26	intravenously	intravenously	RB
cord-023095-4dannjjm	5212	27	or	or	CC
cord-023095-4dannjjm	5212	28	orally	orally	RB
cord-023095-4dannjjm	5212	29	.	.	.
cord-023095-4dannjjm	5213	1	Thus	thus	RB
cord-023095-4dannjjm	5213	2	drug	drug	NN
cord-023095-4dannjjm	5213	3	exposure	exposure	NN
cord-023095-4dannjjm	5213	4	to	to	IN
cord-023095-4dannjjm	5213	5	the	the	DT
cord-023095-4dannjjm	5213	6	active	active	JJ
cord-023095-4dannjjm	5213	7	metabolite	metabolite	NN
cord-023095-4dannjjm	5213	8	of	of	IN
cord-023095-4dannjjm	5213	9	cyclophosphamide	cyclophosphamide	NN
cord-023095-4dannjjm	5213	10	is	be	VBZ
cord-023095-4dannjjm	5213	11	the	the	DT
cord-023095-4dannjjm	5213	12	same	same	JJ
cord-023095-4dannjjm	5213	13	when	when	WRB
cord-023095-4dannjjm	5213	14	administered	administer	VBN
cord-023095-4dannjjm	5213	15	intravenously	intravenously	RB
cord-023095-4dannjjm	5213	16	or	or	CC
cord-023095-4dannjjm	5213	17	orally	orally	RB
cord-023095-4dannjjm	5213	18	.	.	.
cord-023095-4dannjjm	5214	1	Previously	previously	RB
cord-023095-4dannjjm	5214	2	The	the	DT
cord-023095-4dannjjm	5214	3	percentage	percentage	NN
cord-023095-4dannjjm	5214	4	of	of	IN
cord-023095-4dannjjm	5214	5	successful	successful	JJ
cord-023095-4dannjjm	5214	6	intraosseous	intraosseous	JJ
cord-023095-4dannjjm	5214	7	(	(	-LRB-
cord-023095-4dannjjm	5214	8	IO	IO	NNP
cord-023095-4dannjjm	5214	9	)	)	-RRB-
cord-023095-4dannjjm	5214	10	catheter	catheter	NN
cord-023095-4dannjjm	5214	11	insertions	insertion	NNS
cord-023095-4dannjjm	5214	12	,	,	,
cord-023095-4dannjjm	5214	13	insertion	insertion	NN
cord-023095-4dannjjm	5214	14	times	time	NNS
cord-023095-4dannjjm	5214	15	,	,	,
cord-023095-4dannjjm	5214	16	and	and	CC
cord-023095-4dannjjm	5214	17	'	'	''
cord-023095-4dannjjm	5214	18	'	'	''
cord-023095-4dannjjm	5214	19	ease	ease	NN
cord-023095-4dannjjm	5214	20	of	of	IN
cord-023095-4dannjjm	5214	21	use	use	NN
cord-023095-4dannjjm	5214	22	'	'	''
cord-023095-4dannjjm	5214	23	'	'	''
cord-023095-4dannjjm	5214	24	scores	score	NNS
cord-023095-4dannjjm	5214	25	using	use	VBG
cord-023095-4dannjjm	5214	26	the	the	DT
cord-023095-4dannjjm	5214	27	EZ	EZ	NNP
cord-023095-4dannjjm	5214	28	-	-	HYPH
cord-023095-4dannjjm	5214	29	IO	IO	NNP
cord-023095-4dannjjm	5214	30	G3	G3	NNP
cord-023095-4dannjjm	5214	31	power	power	NN
cord-023095-4dannjjm	5214	32	driver	driver	NN
cord-023095-4dannjjm	5214	33	by	by	IN
cord-023095-4dannjjm	5214	34	a	a	DT
cord-023095-4dannjjm	5214	35	wide	wide	JJ
cord-023095-4dannjjm	5214	36	spectrum	spectrum	NN
cord-023095-4dannjjm	5214	37	of	of	IN
cord-023095-4dannjjm	5214	38	novice	novice	JJ
cord-023095-4dannjjm	5214	39	participants	participant	NNS
cord-023095-4dannjjm	5214	40	in	in	IN
cord-023095-4dannjjm	5214	41	feline	feline	JJ
cord-023095-4dannjjm	5214	42	cadavers	cadaver	NNS
cord-023095-4dannjjm	5214	43	were	be	VBD
cord-023095-4dannjjm	5214	44	evaluated	evaluate	VBN
cord-023095-4dannjjm	5214	45	.	.	.
cord-023095-4dannjjm	5215	1	Novice	novice	JJ
cord-023095-4dannjjm	5215	2	users	user	NNS
cord-023095-4dannjjm	5215	3	'	'	POS
cord-023095-4dannjjm	5215	4	mean	mean	JJ
cord-023095-4dannjjm	5215	5	IO	IO	NNP
cord-023095-4dannjjm	5215	6	catheter	catheter	NN
cord-023095-4dannjjm	5215	7	insertion	insertion	NN
cord-023095-4dannjjm	5215	8	time	time	NN
cord-023095-4dannjjm	5215	9	using	use	VBG
cord-023095-4dannjjm	5215	10	the	the	DT
cord-023095-4dannjjm	5215	11	EZ	EZ	NNP
cord-023095-4dannjjm	5215	12	-	-	HYPH
cord-023095-4dannjjm	5215	13	IO	IO	NNP
cord-023095-4dannjjm	5215	14	G3	G3	NNP
cord-023095-4dannjjm	5215	15	driver	driver	NN
cord-023095-4dannjjm	5215	16	was	be	VBD
cord-023095-4dannjjm	5215	17	also	also	RB
cord-023095-4dannjjm	5215	18	compared	compare	VBN
cord-023095-4dannjjm	5215	19	to	to	IN
cord-023095-4dannjjm	5215	20	the	the	DT
cord-023095-4dannjjm	5215	21	mean	mean	JJ
cord-023095-4dannjjm	5215	22	IV	IV	NNP
cord-023095-4dannjjm	5215	23	catheter	catheter	NN
cord-023095-4dannjjm	5215	24	insertion	insertion	NN
cord-023095-4dannjjm	5215	25	time	time	NN
cord-023095-4dannjjm	5215	26	in	in	IN
cord-023095-4dannjjm	5215	27	normovolemic	normovolemic	JJ
cord-023095-4dannjjm	5215	28	feline	feline	JJ
cord-023095-4dannjjm	5215	29	and	and	CC
cord-023095-4dannjjm	5215	30	canine	canine	JJ
cord-023095-4dannjjm	5215	31	patients	patient	NNS
cord-023095-4dannjjm	5215	32	presented	present	VBN
cord-023095-4dannjjm	5215	33	to	to	IN
cord-023095-4dannjjm	5215	34	the	the	DT
cord-023095-4dannjjm	5215	35	Western	Western	NNP
cord-023095-4dannjjm	5215	36	College	College	NNP
cord-023095-4dannjjm	5215	37	of	of	IN
cord-023095-4dannjjm	5215	38	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	5215	39	Medicine	Medicine	NNP
cord-023095-4dannjjm	5215	40	(	(	-LRB-
cord-023095-4dannjjm	5215	41	WCVM	WCVM	NNP
cord-023095-4dannjjm	5215	42	)	)	-RRB-
cord-023095-4dannjjm	5216	1	Small	Small	NNP
cord-023095-4dannjjm	5216	2	Animal	Animal	NNP
cord-023095-4dannjjm	5216	3	Hospital	Hospital	NNP
cord-023095-4dannjjm	5216	4	.	.	.
cord-023095-4dannjjm	5217	1	Novice	novice	JJ
cord-023095-4dannjjm	5217	2	users	user	NNS
cord-023095-4dannjjm	5217	3	included	include	VBD
cord-023095-4dannjjm	5217	4	40	40	CD
cord-023095-4dannjjm	5217	5	WCVM	wcvm	JJ
cord-023095-4dannjjm	5217	6	personnel	personnel	NNS
cord-023095-4dannjjm	5217	7	(	(	-LRB-
cord-023095-4dannjjm	5217	8	8	8	CD
cord-023095-4dannjjm	5217	9	technicians	technician	NNS
cord-023095-4dannjjm	5217	10	,	,	,
cord-023095-4dannjjm	5217	11	11	11	CD
cord-023095-4dannjjm	5217	12	veterinary	veterinary	JJ
cord-023095-4dannjjm	5217	13	students	student	NNS
cord-023095-4dannjjm	5217	14	,	,	,
cord-023095-4dannjjm	5217	15	5	5	CD
cord-023095-4dannjjm	5217	16	interns	intern	NNS
cord-023095-4dannjjm	5217	17	,	,	,
cord-023095-4dannjjm	5217	18	8	8	CD
cord-023095-4dannjjm	5217	19	residents	resident	NNS
cord-023095-4dannjjm	5217	20	,	,	,
cord-023095-4dannjjm	5217	21	8	8	CD
cord-023095-4dannjjm	5217	22	clinicians	clinician	NNS
cord-023095-4dannjjm	5217	23	)	)	-RRB-
cord-023095-4dannjjm	5217	24	.	.	.
cord-023095-4dannjjm	5218	1	After	after	IN
cord-023095-4dannjjm	5218	2	watching	watch	VBG
cord-023095-4dannjjm	5218	3	a	a	DT
cord-023095-4dannjjm	5218	4	5-minute	5-minute	CD
cord-023095-4dannjjm	5218	5	EZ	EZ	NNP
cord-023095-4dannjjm	5218	6	-	-	HYPH
cord-023095-4dannjjm	5218	7	IO	IO	NNP
cord-023095-4dannjjm	5218	8	G3	G3	NNP
cord-023095-4dannjjm	5218	9	training	training	NN
cord-023095-4dannjjm	5218	10	video	video	NN
cord-023095-4dannjjm	5218	11	,	,	,
cord-023095-4dannjjm	5218	12	each	each	DT
cord-023095-4dannjjm	5218	13	participant	participant	NN
cord-023095-4dannjjm	5218	14	inserted	insert	VBD
cord-023095-4dannjjm	5218	15	3	3	CD
cord-023095-4dannjjm	5218	16	IO	IO	NNP
cord-023095-4dannjjm	5218	17	catheters	catheter	NNS
cord-023095-4dannjjm	5218	18	using	use	VBG
cord-023095-4dannjjm	5218	19	the	the	DT
cord-023095-4dannjjm	5218	20	EZ	EZ	NNP
cord-023095-4dannjjm	5218	21	-	-	HYPH
cord-023095-4dannjjm	5218	22	IO	IO	NNP
cord-023095-4dannjjm	5218	23	G3	G3	NNP
cord-023095-4dannjjm	5218	24	driver	driver	NN
cord-023095-4dannjjm	5218	25	.	.	.
cord-023095-4dannjjm	5219	1	Site	site	NN
cord-023095-4dannjjm	5219	2	(	(	-LRB-
cord-023095-4dannjjm	5219	3	proximal	proximal	JJ
cord-023095-4dannjjm	5219	4	humerus	humerus	NN
cord-023095-4dannjjm	5219	5	or	or	CC
cord-023095-4dannjjm	5219	6	trochanteric	trochanteric	JJ
cord-023095-4dannjjm	5219	7	fossa	fossa	NN
cord-023095-4dannjjm	5219	8	of	of	IN
cord-023095-4dannjjm	5219	9	the	the	DT
cord-023095-4dannjjm	5219	10	femur	femur	NN
cord-023095-4dannjjm	5219	11	)	)	-RRB-
cord-023095-4dannjjm	5219	12	and	and	CC
cord-023095-4dannjjm	5219	13	side	side	NN
cord-023095-4dannjjm	5219	14	of	of	IN
cord-023095-4dannjjm	5219	15	cat	cat	NN
cord-023095-4dannjjm	5219	16	(	(	-LRB-
cord-023095-4dannjjm	5220	1	right	right	UH
cord-023095-4dannjjm	5220	2	or	or	CC
cord-023095-4dannjjm	5220	3	left	left	RB
cord-023095-4dannjjm	5220	4	)	)	-RRB-
cord-023095-4dannjjm	5220	5	were	be	VBD
cord-023095-4dannjjm	5220	6	randomized	randomize	VBN
cord-023095-4dannjjm	5220	7	for	for	IN
cord-023095-4dannjjm	5220	8	each	each	DT
cord-023095-4dannjjm	5220	9	attempt	attempt	NN
cord-023095-4dannjjm	5220	10	for	for	IN
cord-023095-4dannjjm	5220	11	each	each	DT
cord-023095-4dannjjm	5220	12	participant	participant	NN
cord-023095-4dannjjm	5220	13	.	.	.
cord-023095-4dannjjm	5221	1	A	a	DT
cord-023095-4dannjjm	5221	2	15	15	CD
cord-023095-4dannjjm	5221	3	gauge	gauge	NN
cord-023095-4dannjjm	5221	4	x	x	SYM
cord-023095-4dannjjm	5221	5	15	15	CD
cord-023095-4dannjjm	5221	6	mm	mm	NN
cord-023095-4dannjjm	5221	7	long	long	JJ
cord-023095-4dannjjm	5221	8	needle	needle	NN
cord-023095-4dannjjm	5221	9	and	and	CC
cord-023095-4dannjjm	5221	10	a	a	DT
cord-023095-4dannjjm	5221	11	15	15	CD
cord-023095-4dannjjm	5221	12	gauge	gauge	NN
cord-023095-4dannjjm	5221	13	x	x	SYM
cord-023095-4dannjjm	5221	14	25	25	CD
cord-023095-4dannjjm	5221	15	mm	mm	CD
cord-023095-4dannjjm	5221	16	needle	needle	NN
cord-023095-4dannjjm	5221	17	were	be	VBD
cord-023095-4dannjjm	5221	18	used	use	VBN
cord-023095-4dannjjm	5221	19	for	for	IN
cord-023095-4dannjjm	5221	20	IO	IO	NNP
cord-023095-4dannjjm	5221	21	catheter	catheter	NN
cord-023095-4dannjjm	5221	22	insertion	insertion	NN
cord-023095-4dannjjm	5221	23	in	in	IN
cord-023095-4dannjjm	5221	24	the	the	DT
cord-023095-4dannjjm	5221	25	humerus	humerus	NN
cord-023095-4dannjjm	5221	26	and	and	CC
cord-023095-4dannjjm	5221	27	femur	femur	NN
cord-023095-4dannjjm	5221	28	,	,	,
cord-023095-4dannjjm	5221	29	respectively	respectively	RB
cord-023095-4dannjjm	5221	30	.	.	.
cord-023095-4dannjjm	5222	1	Participants	participant	NNS
cord-023095-4dannjjm	5222	2	then	then	RB
cord-023095-4dannjjm	5222	3	graded	grade	VBD
cord-023095-4dannjjm	5222	4	the	the	DT
cord-023095-4dannjjm	5222	5	'	'	''
cord-023095-4dannjjm	5222	6	'	'	''
cord-023095-4dannjjm	5222	7	ease	ease	NN
cord-023095-4dannjjm	5222	8	of	of	IN
cord-023095-4dannjjm	5222	9	use	use	NN
cord-023095-4dannjjm	5222	10	'	'	''
cord-023095-4dannjjm	5222	11	'	'	''
cord-023095-4dannjjm	5222	12	of	of	IN
cord-023095-4dannjjm	5222	13	the	the	DT
cord-023095-4dannjjm	5222	14	EZ	EZ	NNP
cord-023095-4dannjjm	5222	15	-	-	HYPH
cord-023095-4dannjjm	5222	16	IO	IO	NNP
cord-023095-4dannjjm	5222	17	G3	G3	NNP
cord-023095-4dannjjm	5222	18	device	device	NN
cord-023095-4dannjjm	5222	19	on	on	IN
cord-023095-4dannjjm	5222	20	a	a	DT
cord-023095-4dannjjm	5222	21	Visual	visual	JJ
cord-023095-4dannjjm	5222	22	Analog	analog	NN
cord-023095-4dannjjm	5222	23	Scale	scale	NN
cord-023095-4dannjjm	5222	24	(	(	-LRB-
cord-023095-4dannjjm	5222	25	VAS	VAS	NNP
cord-023095-4dannjjm	5222	26	)	)	-RRB-
cord-023095-4dannjjm	5222	27	that	that	WDT
cord-023095-4dannjjm	5222	28	was	be	VBD
cord-023095-4dannjjm	5222	29	converted	convert	VBN
cord-023095-4dannjjm	5222	30	to	to	IN
cord-023095-4dannjjm	5222	31	a	a	DT
cord-023095-4dannjjm	5222	32	5-point	5-point	CD
cord-023095-4dannjjm	5222	33	scale	scale	NN
cord-023095-4dannjjm	5222	34	.	.	.
cord-023095-4dannjjm	5223	1	Twenty	twenty	CD
cord-023095-4dannjjm	5223	2	-	-	HYPH
cord-023095-4dannjjm	5223	3	six	six	CD
cord-023095-4dannjjm	5223	4	IV	IV	NNP
cord-023095-4dannjjm	5223	5	catheter	catheter	NN
cord-023095-4dannjjm	5223	6	insertions	insertion	NNS
cord-023095-4dannjjm	5223	7	in	in	IN
cord-023095-4dannjjm	5223	8	normovolemic	normovolemic	JJ
cord-023095-4dannjjm	5223	9	feline	feline	JJ
cord-023095-4dannjjm	5223	10	and	and	CC
cord-023095-4dannjjm	5223	11	canine	canine	JJ
cord-023095-4dannjjm	5223	12	patients	patient	NNS
cord-023095-4dannjjm	5223	13	performed	perform	VBN
cord-023095-4dannjjm	5223	14	by	by	IN
cord-023095-4dannjjm	5223	15	WCVM	WCVM	NNP
cord-023095-4dannjjm	5223	16	Small	Small	NNP
cord-023095-4dannjjm	5223	17	Animal	Animal	NNP
cord-023095-4dannjjm	5223	18	Hospital	Hospital	NNP
cord-023095-4dannjjm	5223	19	personnel	personnel	NNS
cord-023095-4dannjjm	5223	20	(	(	-LRB-
cord-023095-4dannjjm	5223	21	6	6	CD
cord-023095-4dannjjm	5223	22	technicians	technician	NNS
cord-023095-4dannjjm	5223	23	,	,	,
cord-023095-4dannjjm	5223	24	16	16	CD
cord-023095-4dannjjm	5223	25	veterinary	veterinary	JJ
cord-023095-4dannjjm	5223	26	students	student	NNS
cord-023095-4dannjjm	5223	27	,	,	,
cord-023095-4dannjjm	5223	28	1	1	CD
cord-023095-4dannjjm	5223	29	intern	intern	NN
cord-023095-4dannjjm	5223	30	,	,	,
cord-023095-4dannjjm	5223	31	1	1	CD
cord-023095-4dannjjm	5223	32	resident	resident	NN
cord-023095-4dannjjm	5223	33	,	,	,
cord-023095-4dannjjm	5223	34	2	2	CD
cord-023095-4dannjjm	5223	35	clinicians	clinician	NNS
cord-023095-4dannjjm	5223	36	)	)	-RRB-
cord-023095-4dannjjm	5223	37	were	be	VBD
cord-023095-4dannjjm	5223	38	then	then	RB
cord-023095-4dannjjm	5223	39	timed	time	VBN
cord-023095-4dannjjm	5223	40	and	and	CC
cord-023095-4dannjjm	5223	41	compared	compare	VBN
cord-023095-4dannjjm	5223	42	to	to	IN
cord-023095-4dannjjm	5223	43	the	the	DT
cord-023095-4dannjjm	5223	44	mean	mean	JJ
cord-023095-4dannjjm	5223	45	IO	IO	NNP
cord-023095-4dannjjm	5223	46	catheter	catheter	NN
cord-023095-4dannjjm	5223	47	insertion	insertion	NN
cord-023095-4dannjjm	5223	48	time	time	NN
cord-023095-4dannjjm	5223	49	in	in	IN
cord-023095-4dannjjm	5223	50	feline	feline	JJ
cord-023095-4dannjjm	5223	51	cadavers	cadaver	NNS
cord-023095-4dannjjm	5223	52	by	by	IN
cord-023095-4dannjjm	5223	53	study	study	NN
cord-023095-4dannjjm	5223	54	participants	participant	NNS
cord-023095-4dannjjm	5223	55	using	use	VBG
cord-023095-4dannjjm	5223	56	the	the	DT
cord-023095-4dannjjm	5223	57	EZ	EZ	NNP
cord-023095-4dannjjm	5223	58	-	-	HYPH
cord-023095-4dannjjm	5223	59	IO	IO	NNP
cord-023095-4dannjjm	5223	60	G3	G3	NNP
cord-023095-4dannjjm	5223	61	device	device	NN
cord-023095-4dannjjm	5223	62	.	.	.
cord-023095-4dannjjm	5224	1	The	the	DT
cord-023095-4dannjjm	5224	2	IO	IO	NNP
cord-023095-4dannjjm	5224	3	catheter	catheter	NN
cord-023095-4dannjjm	5224	4	was	be	VBD
cord-023095-4dannjjm	5224	5	inserted	insert	VBN
cord-023095-4dannjjm	5224	6	correctly	correctly	RB
cord-023095-4dannjjm	5224	7	on	on	IN
cord-023095-4dannjjm	5224	8	every	every	DT
cord-023095-4dannjjm	5224	9	attempt	attempt	NN
cord-023095-4dannjjm	5224	10	by	by	IN
cord-023095-4dannjjm	5224	11	70	70	CD
cord-023095-4dannjjm	5224	12	%	%	NN
cord-023095-4dannjjm	5224	13	(	(	-LRB-
cord-023095-4dannjjm	5224	14	28/40	28/40	CD
cord-023095-4dannjjm	5224	15	)	)	-RRB-
cord-023095-4dannjjm	5224	16	of	of	IN
cord-023095-4dannjjm	5224	17	participants	participant	NNS
cord-023095-4dannjjm	5224	18	.	.	.
cord-023095-4dannjjm	5225	1	No	no	DT
cord-023095-4dannjjm	5225	2	difference	difference	NN
cord-023095-4dannjjm	5225	3	was	be	VBD
cord-023095-4dannjjm	5225	4	found	find	VBN
cord-023095-4dannjjm	5225	5	between	between	IN
cord-023095-4dannjjm	5225	6	participant	participant	NN
cord-023095-4dannjjm	5225	7	groups	group	NNS
cord-023095-4dannjjm	5225	8	for	for	IN
cord-023095-4dannjjm	5225	9	mean	mean	JJ
cord-023095-4dannjjm	5225	10	IO	IO	NNP
cord-023095-4dannjjm	5225	11	catheter	catheter	NN
cord-023095-4dannjjm	5225	12	placement	placement	NN
cord-023095-4dannjjm	5225	13	confirmation	confirmation	NN
cord-023095-4dannjjm	5225	14	percentage	percentage	NN
cord-023095-4dannjjm	5226	1	(	(	-LRB-
cord-023095-4dannjjm	5226	2	p	p	NN
cord-023095-4dannjjm	5226	3	5	5	CD
cord-023095-4dannjjm	5226	4	0.72	0.72	CD
cord-023095-4dannjjm	5226	5	)	)	-RRB-
cord-023095-4dannjjm	5226	6	.	.	.
cord-023095-4dannjjm	5227	1	Percentage	percentage	NN
cord-023095-4dannjjm	5227	2	of	of	IN
cord-023095-4dannjjm	5227	3	IO	IO	NNP
cord-023095-4dannjjm	5227	4	catheter	catheter	NN
cord-023095-4dannjjm	5227	5	'	'	''
cord-023095-4dannjjm	5227	6	'	'	''
cord-023095-4dannjjm	5227	7	slippage	slippage	NN
cord-023095-4dannjjm	5227	8	off	off	IN
cord-023095-4dannjjm	5227	9	the	the	DT
cord-023095-4dannjjm	5227	10	bone	bone	NN
cord-023095-4dannjjm	5227	11	'	'	''
cord-023095-4dannjjm	5227	12	'	'	''
cord-023095-4dannjjm	5227	13	at	at	IN
cord-023095-4dannjjm	5227	14	the	the	DT
cord-023095-4dannjjm	5227	15	time	time	NN
cord-023095-4dannjjm	5227	16	of	of	IN
cord-023095-4dannjjm	5227	17	placement	placement	NN
cord-023095-4dannjjm	5227	18	did	do	VBD
cord-023095-4dannjjm	5227	19	not	not	RB
cord-023095-4dannjjm	5227	20	vary	vary	VB
cord-023095-4dannjjm	5227	21	across	across	IN
cord-023095-4dannjjm	5227	22	participant	participant	NN
cord-023095-4dannjjm	5227	23	groups	group	NNS
cord-023095-4dannjjm	5228	1	(	(	-LRB-
cord-023095-4dannjjm	5228	2	p	p	NN
cord-023095-4dannjjm	5228	3	5	5	CD
cord-023095-4dannjjm	5228	4	0.12	0.12	CD
cord-023095-4dannjjm	5228	5	)	)	-RRB-
cord-023095-4dannjjm	5228	6	.	.	.
cord-023095-4dannjjm	5229	1	Mean	mean	JJ
cord-023095-4dannjjm	5229	2	IO	IO	NNP
cord-023095-4dannjjm	5229	3	catheter	catheter	NN
cord-023095-4dannjjm	5229	4	insertion	insertion	NN
cord-023095-4dannjjm	5229	5	times	time	NNS
cord-023095-4dannjjm	5229	6	were	be	VBD
cord-023095-4dannjjm	5229	7	all	all	RB
cord-023095-4dannjjm	5229	8	less	less	JJR
cord-023095-4dannjjm	5229	9	than	than	IN
cord-023095-4dannjjm	5229	10	10	10	CD
cord-023095-4dannjjm	5229	11	seconds	second	NNS
cord-023095-4dannjjm	5229	12	and	and	CC
cord-023095-4dannjjm	5229	13	did	do	VBD
cord-023095-4dannjjm	5229	14	not	not	RB
cord-023095-4dannjjm	5229	15	differ	differ	VB
cord-023095-4dannjjm	5229	16	significantly	significantly	RB
cord-023095-4dannjjm	5229	17	as	as	IN
cord-023095-4dannjjm	5229	18	a	a	DT
cord-023095-4dannjjm	5229	19	function	function	NN
cord-023095-4dannjjm	5229	20	of	of	IN
cord-023095-4dannjjm	5229	21	attempt	attempt	NN
cord-023095-4dannjjm	5229	22	number	number	NN
cord-023095-4dannjjm	5229	23	(	(	-LRB-
cord-023095-4dannjjm	5229	24	p	p	NN
cord-023095-4dannjjm	5229	25	5	5	CD
cord-023095-4dannjjm	5229	26	0.93	0.93	CD
cord-023095-4dannjjm	5229	27	)	)	-RRB-
cord-023095-4dannjjm	5229	28	or	or	CC
cord-023095-4dannjjm	5229	29	as	as	IN
cord-023095-4dannjjm	5229	30	a	a	DT
cord-023095-4dannjjm	5229	31	function	function	NN
cord-023095-4dannjjm	5229	32	of	of	IN
cord-023095-4dannjjm	5229	33	participant	participant	NN
cord-023095-4dannjjm	5229	34	group	group	NN
cord-023095-4dannjjm	5229	35	(	(	-LRB-
cord-023095-4dannjjm	5229	36	p	p	NN
cord-023095-4dannjjm	5229	37	5	5	CD
cord-023095-4dannjjm	5229	38	0.78	0.78	CD
cord-023095-4dannjjm	5229	39	)	)	-RRB-
cord-023095-4dannjjm	5229	40	.	.	.
cord-023095-4dannjjm	5230	1	Participants	participant	NNS
cord-023095-4dannjjm	5230	2	rated	rate	VBD
cord-023095-4dannjjm	5230	3	the	the	DT
cord-023095-4dannjjm	5230	4	EZ	EZ	NNP
cord-023095-4dannjjm	5230	5	-	-	HYPH
cord-023095-4dannjjm	5230	6	IO	IO	NNP
cord-023095-4dannjjm	5230	7	G3	G3	NNP
cord-023095-4dannjjm	5230	8	's	's	POS
cord-023095-4dannjjm	5230	9	'	'	''
cord-023095-4dannjjm	5230	10	'	'	''
cord-023095-4dannjjm	5230	11	ease	ease	NN
cord-023095-4dannjjm	5230	12	of	of	IN
cord-023095-4dannjjm	5230	13	use	use	NN
cord-023095-4dannjjm	5230	14	'	'	''
cord-023095-4dannjjm	5230	15	'	'	''
cord-023095-4dannjjm	5230	16	favorably	favorably	RB
cord-023095-4dannjjm	5230	17	and	and	CC
cord-023095-4dannjjm	5230	18	subjective	subjective	JJ
cord-023095-4dannjjm	5230	19	scores	score	NNS
cord-023095-4dannjjm	5230	20	did	do	VBD
cord-023095-4dannjjm	5230	21	not	not	RB
cord-023095-4dannjjm	5230	22	differ	differ	VB
cord-023095-4dannjjm	5230	23	across	across	IN
cord-023095-4dannjjm	5230	24	participant	participant	NN
cord-023095-4dannjjm	5230	25	groups	group	NNS
cord-023095-4dannjjm	5230	26	with	with	IN
cord-023095-4dannjjm	5230	27	varying	vary	VBG
cord-023095-4dannjjm	5230	28	levels	level	NNS
cord-023095-4dannjjm	5230	29	of	of	IN
cord-023095-4dannjjm	5230	30	clinical	clinical	JJ
cord-023095-4dannjjm	5230	31	experience	experience	NN
cord-023095-4dannjjm	5231	1	(	(	-LRB-
cord-023095-4dannjjm	5231	2	p	p	NN
cord-023095-4dannjjm	5231	3	4	4	CD
cord-023095-4dannjjm	5231	4	0.2	0.2	CD
cord-023095-4dannjjm	5231	5	)	)	-RRB-
cord-023095-4dannjjm	5231	6	.	.	.
cord-023095-4dannjjm	5232	1	Compared	compare	VBN
cord-023095-4dannjjm	5232	2	to	to	IN
cord-023095-4dannjjm	5232	3	the	the	DT
cord-023095-4dannjjm	5232	4	mean	mean	JJ
cord-023095-4dannjjm	5232	5	insertion	insertion	NN
cord-023095-4dannjjm	5232	6	time	time	NN
cord-023095-4dannjjm	5232	7	for	for	IN
cord-023095-4dannjjm	5232	8	IV	IV	NNP
cord-023095-4dannjjm	5232	9	catheterization	catheterization	NN
cord-023095-4dannjjm	5232	10	(	(	-LRB-
cord-023095-4dannjjm	5232	11	188	188	CD
cord-023095-4dannjjm	5232	12	sec	sec	NNP
cord-023095-4dannjjm	5232	13	)	)	-RRB-
cord-023095-4dannjjm	5232	14	,	,	,
cord-023095-4dannjjm	5232	15	mean	mean	JJ
cord-023095-4dannjjm	5232	16	IO	IO	NNP
cord-023095-4dannjjm	5232	17	catheter	catheter	NN
cord-023095-4dannjjm	5232	18	insertion	insertion	NN
cord-023095-4dannjjm	5232	19	by	by	IN
cord-023095-4dannjjm	5232	20	participants	participant	NNS
cord-023095-4dannjjm	5232	21	using	use	VBG
cord-023095-4dannjjm	5232	22	the	the	DT
cord-023095-4dannjjm	5232	23	EZ	EZ	NNP
cord-023095-4dannjjm	5232	24	-	-	HYPH
cord-023095-4dannjjm	5232	25	IO	IO	NNP
cord-023095-4dannjjm	5232	26	G3	G3	NNP
cord-023095-4dannjjm	5232	27	(	(	-LRB-
cord-023095-4dannjjm	5232	28	8	8	CD
cord-023095-4dannjjm	5232	29	sec	sec	NNP
cord-023095-4dannjjm	5232	30	)	)	-RRB-
cord-023095-4dannjjm	5232	31	was	be	VBD
cord-023095-4dannjjm	5232	32	significantly	significantly	RB
cord-023095-4dannjjm	5232	33	faster	fast	JJR
cord-023095-4dannjjm	5233	1	(	(	-LRB-
cord-023095-4dannjjm	5233	2	p	p	NN
cord-023095-4dannjjm	5233	3	5	5	CD
cord-023095-4dannjjm	5233	4	0.001	0.001	CD
cord-023095-4dannjjm	5233	5	)	)	-RRB-
cord-023095-4dannjjm	5233	6	.	.	.
cord-023095-4dannjjm	5234	1	Regardless	regardless	RB
cord-023095-4dannjjm	5234	2	of	of	IN
cord-023095-4dannjjm	5234	3	their	-PRON-	PRP$
cord-023095-4dannjjm	5234	4	level	level	NN
cord-023095-4dannjjm	5234	5	of	of	IN
cord-023095-4dannjjm	5234	6	clinical	clinical	JJ
cord-023095-4dannjjm	5234	7	experience	experience	NN
cord-023095-4dannjjm	5234	8	,	,	,
cord-023095-4dannjjm	5234	9	participants	participant	NNS
cord-023095-4dannjjm	5234	10	rated	rate	VBD
cord-023095-4dannjjm	5234	11	the	the	DT
cord-023095-4dannjjm	5234	12	EZ	EZ	NNP
cord-023095-4dannjjm	5234	13	-	-	HYPH
cord-023095-4dannjjm	5234	14	IO	IO	NNP
cord-023095-4dannjjm	5234	15	G3	G3	NNP
cord-023095-4dannjjm	5234	16	device	device	NN
cord-023095-4dannjjm	5234	17	favorably	favorably	RB
cord-023095-4dannjjm	5234	18	in	in	IN
cord-023095-4dannjjm	5234	19	terms	term	NNS
cord-023095-4dannjjm	5234	20	of	of	IN
cord-023095-4dannjjm	5234	21	its	-PRON-	PRP$
cord-023095-4dannjjm	5234	22	'	'	''
cord-023095-4dannjjm	5234	23	'	'	''
cord-023095-4dannjjm	5234	24	ease	ease	NN
cord-023095-4dannjjm	5234	25	of	of	IN
cord-023095-4dannjjm	5234	26	use	use	NN
cord-023095-4dannjjm	5234	27	'	'	''
cord-023095-4dannjjm	5234	28	'	'	''
cord-023095-4dannjjm	5234	29	and	and	CC
cord-023095-4dannjjm	5234	30	their	-PRON-	PRP$
cord-023095-4dannjjm	5234	31	willingness	willingness	NN
cord-023095-4dannjjm	5234	32	to	to	TO
cord-023095-4dannjjm	5234	33	use	use	VB
cord-023095-4dannjjm	5234	34	the	the	DT
cord-023095-4dannjjm	5234	35	device	device	NN
cord-023095-4dannjjm	5234	36	in	in	IN
cord-023095-4dannjjm	5234	37	the	the	DT
cord-023095-4dannjjm	5234	38	future	future	NN
cord-023095-4dannjjm	5234	39	.	.	.
cord-023095-4dannjjm	5235	1	Regardless	regardless	RB
cord-023095-4dannjjm	5235	2	of	of	IN
cord-023095-4dannjjm	5235	3	their	-PRON-	PRP$
cord-023095-4dannjjm	5235	4	level	level	NN
cord-023095-4dannjjm	5235	5	of	of	IN
cord-023095-4dannjjm	5235	6	clinical	clinical	JJ
cord-023095-4dannjjm	5235	7	experience	experience	NN
cord-023095-4dannjjm	5235	8	,	,	,
cord-023095-4dannjjm	5235	9	study	study	NN
cord-023095-4dannjjm	5235	10	participants	participant	NNS
cord-023095-4dannjjm	5235	11	successfully	successfully	RB
cord-023095-4dannjjm	5235	12	placed	place	VBD
cord-023095-4dannjjm	5235	13	IO	IO	NNP
cord-023095-4dannjjm	5235	14	catheters	catheter	NNS
cord-023095-4dannjjm	5235	15	using	use	VBG
cord-023095-4dannjjm	5235	16	the	the	DT
cord-023095-4dannjjm	5235	17	EZ	EZ	NNP
cord-023095-4dannjjm	5235	18	-	-	HYPH
cord-023095-4dannjjm	5235	19	IO	IO	NNP
cord-023095-4dannjjm	5235	20	G3	G3	NNP
cord-023095-4dannjjm	5235	21	device	device	NN
cord-023095-4dannjjm	5235	22	and	and	CC
cord-023095-4dannjjm	5235	23	did	do	VBD
cord-023095-4dannjjm	5235	24	so	so	RB
cord-023095-4dannjjm	5235	25	significantly	significantly	RB
cord-023095-4dannjjm	5235	26	faster	fast	RBR
cord-023095-4dannjjm	5235	27	than	than	IN
cord-023095-4dannjjm	5235	28	the	the	DT
cord-023095-4dannjjm	5235	29	reported	report	VBN
cord-023095-4dannjjm	5235	30	IV	IV	NNP
cord-023095-4dannjjm	5235	31	catheter	catheter	NN
cord-023095-4dannjjm	5235	32	insertion	insertion	NN
cord-023095-4dannjjm	5235	33	time	time	NN
cord-023095-4dannjjm	5235	34	in	in	IN
cord-023095-4dannjjm	5235	35	normovolemic	normovolemic	JJ
cord-023095-4dannjjm	5235	36	feline	feline	JJ
cord-023095-4dannjjm	5235	37	and	and	CC
cord-023095-4dannjjm	5235	38	canine	canine	JJ
cord-023095-4dannjjm	5235	39	patients	patient	NNS
cord-023095-4dannjjm	5235	40	in	in	IN
cord-023095-4dannjjm	5235	41	the	the	DT
cord-023095-4dannjjm	5235	42	WCVM	WCVM	NNP
cord-023095-4dannjjm	5235	43	Small	Small	NNP
cord-023095-4dannjjm	5235	44	Animal	Animal	NNP
cord-023095-4dannjjm	5235	45	Hospital	Hospital	NNP
cord-023095-4dannjjm	5235	46	.	.	.
cord-023095-4dannjjm	5236	1	Intraosseous	intraosseous	JJ
cord-023095-4dannjjm	5236	2	catheterization	catheterization	NN
cord-023095-4dannjjm	5236	3	using	use	VBG
cord-023095-4dannjjm	5236	4	the	the	DT
cord-023095-4dannjjm	5236	5	EZ	EZ	NNP
cord-023095-4dannjjm	5236	6	-	-	HYPH
cord-023095-4dannjjm	5236	7	IO	IO	NNP
cord-023095-4dannjjm	5236	8	G3	G3	NNP
cord-023095-4dannjjm	5236	9	has	have	VBZ
cord-023095-4dannjjm	5236	10	the	the	DT
cord-023095-4dannjjm	5236	11	potential	potential	NN
cord-023095-4dannjjm	5236	12	to	to	TO
cord-023095-4dannjjm	5236	13	provide	provide	VB
cord-023095-4dannjjm	5236	14	very	very	RB
cord-023095-4dannjjm	5236	15	rapid	rapid	JJ
cord-023095-4dannjjm	5236	16	vascular	vascular	JJ
cord-023095-4dannjjm	5236	17	access	access	NN
cord-023095-4dannjjm	5236	18	and	and	CC
cord-023095-4dannjjm	5236	19	is	be	VBZ
cord-023095-4dannjjm	5236	20	a	a	DT
cord-023095-4dannjjm	5236	21	skill	skill	NN
cord-023095-4dannjjm	5236	22	that	that	WDT
cord-023095-4dannjjm	5236	23	can	can	MD
cord-023095-4dannjjm	5236	24	be	be	VB
cord-023095-4dannjjm	5236	25	easily	easily	RB
cord-023095-4dannjjm	5236	26	learned	learn	VBN
cord-023095-4dannjjm	5236	27	.	.	.
cord-023095-4dannjjm	5237	1	Previously	previously	RB
cord-023095-4dannjjm	5237	2	presented	present	VBN
cord-023095-4dannjjm	5237	3	at	at	IN
cord-023095-4dannjjm	5237	4	the	the	DT
cord-023095-4dannjjm	5237	5	Western	Western	NNP
cord-023095-4dannjjm	5237	6	College	College	NNP
cord-023095-4dannjjm	5237	7	of	of	IN
cord-023095-4dannjjm	5237	8	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	5237	9	Medicine	Medicine	NNP
cord-023095-4dannjjm	5237	10	Undergraduate	Undergraduate	NNP
cord-023095-4dannjjm	5237	11	Poster	Poster	NNP
cord-023095-4dannjjm	5237	12	Competition	Competition	NNP
cord-023095-4dannjjm	5237	13	.	.	.
cord-023095-4dannjjm	5238	1	Multicavitary	multicavitary	JJ
cord-023095-4dannjjm	5238	2	effusion	effusion	NN
cord-023095-4dannjjm	5238	3	is	be	VBZ
cord-023095-4dannjjm	5238	4	a	a	DT
cord-023095-4dannjjm	5238	5	common	common	JJ
cord-023095-4dannjjm	5238	6	cause	cause	NN
cord-023095-4dannjjm	5238	7	of	of	IN
cord-023095-4dannjjm	5238	8	presentation	presentation	NN
cord-023095-4dannjjm	5238	9	for	for	IN
cord-023095-4dannjjm	5238	10	dogs	dog	NNS
cord-023095-4dannjjm	5238	11	to	to	IN
cord-023095-4dannjjm	5238	12	emergency	emergency	NN
cord-023095-4dannjjm	5238	13	medical	medical	JJ
cord-023095-4dannjjm	5238	14	centers	center	NNS
cord-023095-4dannjjm	5238	15	.	.	.
cord-023095-4dannjjm	5239	1	The	the	DT
cord-023095-4dannjjm	5239	2	goal	goal	NN
cord-023095-4dannjjm	5239	3	of	of	IN
cord-023095-4dannjjm	5239	4	this	this	DT
cord-023095-4dannjjm	5239	5	study	study	NN
cord-023095-4dannjjm	5239	6	was	be	VBD
cord-023095-4dannjjm	5239	7	to	to	TO
cord-023095-4dannjjm	5239	8	identify	identify	VB
cord-023095-4dannjjm	5239	9	common	common	JJ
cord-023095-4dannjjm	5239	10	underlying	underlying	JJ
cord-023095-4dannjjm	5239	11	causes	cause	NNS
cord-023095-4dannjjm	5239	12	of	of	IN
cord-023095-4dannjjm	5239	13	multicavitary	multicavitary	JJ
cord-023095-4dannjjm	5239	14	effusion	effusion	NN
cord-023095-4dannjjm	5239	15	as	as	RB
cord-023095-4dannjjm	5239	16	well	well	RB
cord-023095-4dannjjm	5239	17	as	as	IN
cord-023095-4dannjjm	5239	18	determine	determine	VB
cord-023095-4dannjjm	5239	19	their	-PRON-	PRP$
cord-023095-4dannjjm	5239	20	relative	relative	JJ
cord-023095-4dannjjm	5239	21	importance	importance	NN
cord-023095-4dannjjm	5239	22	.	.	.
cord-023095-4dannjjm	5240	1	A	a	DT
cord-023095-4dannjjm	5240	2	retrospective	retrospective	JJ
cord-023095-4dannjjm	5240	3	analysis	analysis	NN
cord-023095-4dannjjm	5240	4	of	of	IN
cord-023095-4dannjjm	5240	5	43	43	CD
cord-023095-4dannjjm	5240	6	cases	case	NNS
cord-023095-4dannjjm	5240	7	of	of	IN
cord-023095-4dannjjm	5240	8	multicavitary	multicavitary	JJ
cord-023095-4dannjjm	5240	9	effusion	effusion	NN
cord-023095-4dannjjm	5240	10	admitted	admit	VBD
cord-023095-4dannjjm	5240	11	to	to	IN
cord-023095-4dannjjm	5240	12	the	the	DT
cord-023095-4dannjjm	5240	13	ICU	ICU	NNP
cord-023095-4dannjjm	5240	14	of	of	IN
cord-023095-4dannjjm	5240	15	a	a	DT
cord-023095-4dannjjm	5240	16	tertiary	tertiary	JJ
cord-023095-4dannjjm	5240	17	referral	referral	JJ
cord-023095-4dannjjm	5240	18	center	center	NN
cord-023095-4dannjjm	5240	19	(	(	-LRB-
cord-023095-4dannjjm	5240	20	Ontario	Ontario	NNP
cord-023095-4dannjjm	5240	21	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	5240	22	College	College	NNP
cord-023095-4dannjjm	5240	23	)	)	-RRB-
cord-023095-4dannjjm	5240	24	from	from	IN
cord-023095-4dannjjm	5240	25	2007	2007	CD
cord-023095-4dannjjm	5240	26	to	to	IN
cord-023095-4dannjjm	5240	27	2010	2010	CD
cord-023095-4dannjjm	5240	28	was	be	VBD
cord-023095-4dannjjm	5240	29	performed	perform	VBN
cord-023095-4dannjjm	5240	30	.	.	.
cord-023095-4dannjjm	5241	1	Twenty	twenty	CD
cord-023095-4dannjjm	5241	2	-	-	HYPH
cord-023095-4dannjjm	5241	3	three	three	CD
cord-023095-4dannjjm	5241	4	different	different	JJ
cord-023095-4dannjjm	5241	5	breeds	breed	NNS
cord-023095-4dannjjm	5241	6	,	,	,
cord-023095-4dannjjm	5241	7	with	with	IN
cord-023095-4dannjjm	5241	8	Golden	Golden	NNP
cord-023095-4dannjjm	5241	9	and	and	CC
cord-023095-4dannjjm	5241	10	Labrador	Labrador	NNP
cord-023095-4dannjjm	5241	11	retrievers	retriever	NNS
cord-023095-4dannjjm	5241	12	(	(	-LRB-
cord-023095-4dannjjm	5241	13	25.6	25.6	CD
cord-023095-4dannjjm	5241	14	%	%	NN
cord-023095-4dannjjm	5241	15	and	and	CC
cord-023095-4dannjjm	5241	16	14	14	CD
cord-023095-4dannjjm	5241	17	%	%	NN
cord-023095-4dannjjm	5241	18	,	,	,
cord-023095-4dannjjm	5241	19	respectively	respectively	RB
cord-023095-4dannjjm	5241	20	)	)	-RRB-
cord-023095-4dannjjm	5241	21	being	be	VBG
cord-023095-4dannjjm	5241	22	most	most	RBS
cord-023095-4dannjjm	5241	23	commonly	commonly	RB
cord-023095-4dannjjm	5241	24	seen	see	VBN
cord-023095-4dannjjm	5241	25	,	,	,
cord-023095-4dannjjm	5241	26	were	be	VBD
cord-023095-4dannjjm	5241	27	included	include	VBN
cord-023095-4dannjjm	5241	28	in	in	IN
cord-023095-4dannjjm	5241	29	the	the	DT
cord-023095-4dannjjm	5241	30	study	study	NN
cord-023095-4dannjjm	5241	31	.	.	.
cord-023095-4dannjjm	5242	1	Ages	age	NNS
cord-023095-4dannjjm	5242	2	ranged	range	VBD
cord-023095-4dannjjm	5242	3	from	from	IN
cord-023095-4dannjjm	5242	4	2	2	CD
cord-023095-4dannjjm	5242	5	to	to	TO
cord-023095-4dannjjm	5242	6	14	14	CD
cord-023095-4dannjjm	5242	7	years	year	NNS
cord-023095-4dannjjm	5242	8	with	with	IN
cord-023095-4dannjjm	5242	9	a	a	DT
cord-023095-4dannjjm	5242	10	median	median	JJ
cord-023095-4dannjjm	5242	11	age	age	NN
cord-023095-4dannjjm	5242	12	of	of	IN
cord-023095-4dannjjm	5242	13	9	9	CD
cord-023095-4dannjjm	5242	14	years	year	NNS
cord-023095-4dannjjm	5242	15	and	and	CC
cord-023095-4dannjjm	5242	16	a	a	DT
cord-023095-4dannjjm	5242	17	mean	mean	NN
cord-023095-4dannjjm	5242	18	of	of	IN
cord-023095-4dannjjm	5242	19	8.1	8.1	CD
cord-023095-4dannjjm	5242	20	years	year	NNS
cord-023095-4dannjjm	5242	21	.	.	.
cord-023095-4dannjjm	5243	1	69.8	69.8	CD
cord-023095-4dannjjm	5243	2	%	%	NN
cord-023095-4dannjjm	5243	3	of	of	IN
cord-023095-4dannjjm	5243	4	cases	case	NNS
cord-023095-4dannjjm	5243	5	were	be	VBD
cord-023095-4dannjjm	5243	6	males	male	NNS
cord-023095-4dannjjm	5243	7	(	(	-LRB-
cord-023095-4dannjjm	5243	8	30/43	30/43	CD
cord-023095-4dannjjm	5243	9	cases	case	NNS
cord-023095-4dannjjm	5243	10	)	)	-RRB-
cord-023095-4dannjjm	5243	11	.	.	.
cord-023095-4dannjjm	5244	1	Most	most	RBS
cord-023095-4dannjjm	5244	2	common	common	JJ
cord-023095-4dannjjm	5244	3	presenting	present	VBG
cord-023095-4dannjjm	5244	4	signs	sign	NNS
cord-023095-4dannjjm	5244	5	included	include	VBD
cord-023095-4dannjjm	5244	6	lethargy	lethargy	NN
cord-023095-4dannjjm	5244	7	(	(	-LRB-
cord-023095-4dannjjm	5244	8	48.8	48.8	CD
cord-023095-4dannjjm	5244	9	%	%	NN
cord-023095-4dannjjm	5244	10	)	)	-RRB-
cord-023095-4dannjjm	5244	11	,	,	,
cord-023095-4dannjjm	5244	12	anorexia	anorexia	NN
cord-023095-4dannjjm	5244	13	(	(	-LRB-
cord-023095-4dannjjm	5244	14	32.6	32.6	CD
cord-023095-4dannjjm	5244	15	%	%	NN
cord-023095-4dannjjm	5244	16	)	)	-RRB-
cord-023095-4dannjjm	5244	17	,	,	,
cord-023095-4dannjjm	5244	18	vomiting	vomit	VBG
cord-023095-4dannjjm	5244	19	(	(	-LRB-
cord-023095-4dannjjm	5244	20	21	21	CD
cord-023095-4dannjjm	5244	21	%	%	NN
cord-023095-4dannjjm	5244	22	)	)	-RRB-
cord-023095-4dannjjm	5244	23	and	and	CC
cord-023095-4dannjjm	5244	24	dyspnea	dyspnea	NN
cord-023095-4dannjjm	5244	25	(	(	-LRB-
cord-023095-4dannjjm	5244	26	21	21	CD
cord-023095-4dannjjm	5244	27	%	%	NN
cord-023095-4dannjjm	5244	28	)	)	-RRB-
cord-023095-4dannjjm	5244	29	.	.	.
cord-023095-4dannjjm	5245	1	Cavitary	cavitary	JJ
cord-023095-4dannjjm	5245	2	effusion	effusion	NN
cord-023095-4dannjjm	5245	3	was	be	VBD
cord-023095-4dannjjm	5245	4	detected	detect	VBN
cord-023095-4dannjjm	5245	5	by	by	IN
cord-023095-4dannjjm	5245	6	either	either	DT
cord-023095-4dannjjm	5245	7	ultrasonography	ultrasonography	NN
cord-023095-4dannjjm	5245	8	(	(	-LRB-
cord-023095-4dannjjm	5245	9	pericardial	pericardial	JJ
cord-023095-4dannjjm	5245	10	,	,	,
cord-023095-4dannjjm	5245	11	pleural	pleural	JJ
cord-023095-4dannjjm	5245	12	or	or	CC
cord-023095-4dannjjm	5245	13	abdominal	abdominal	JJ
cord-023095-4dannjjm	5245	14	)	)	-RRB-
cord-023095-4dannjjm	5245	15	or	or	CC
cord-023095-4dannjjm	5245	16	radiographs	radiograph	NNS
cord-023095-4dannjjm	5245	17	(	(	-LRB-
cord-023095-4dannjjm	5245	18	pleural	pleural	JJ
cord-023095-4dannjjm	5245	19	)	)	-RRB-
cord-023095-4dannjjm	5245	20	.	.	.
cord-023095-4dannjjm	5246	1	Bicavitary	bicavitary	JJ
cord-023095-4dannjjm	5246	2	effusion	effusion	NN
cord-023095-4dannjjm	5246	3	was	be	VBD
cord-023095-4dannjjm	5246	4	present	present	JJ
cord-023095-4dannjjm	5246	5	in	in	IN
cord-023095-4dannjjm	5246	6	28	28	CD
cord-023095-4dannjjm	5246	7	cases	case	NNS
cord-023095-4dannjjm	5246	8	(	(	-LRB-
cord-023095-4dannjjm	5246	9	65.1	65.1	CD
cord-023095-4dannjjm	5246	10	%	%	NN
cord-023095-4dannjjm	5246	11	)	)	-RRB-
cord-023095-4dannjjm	5246	12	whereas	whereas	IN
cord-023095-4dannjjm	5246	13	15	15	CD
cord-023095-4dannjjm	5246	14	cases	case	NNS
cord-023095-4dannjjm	5246	15	(	(	-LRB-
cord-023095-4dannjjm	5246	16	34.9	34.9	CD
cord-023095-4dannjjm	5246	17	%	%	NN
cord-023095-4dannjjm	5246	18	)	)	-RRB-
cord-023095-4dannjjm	5246	19	had	have	VBD
cord-023095-4dannjjm	5246	20	tricavitary	tricavitary	JJ
cord-023095-4dannjjm	5246	21	effusion	effusion	NN
cord-023095-4dannjjm	5246	22	.	.	.
cord-023095-4dannjjm	5247	1	Neoplasia	neoplasia	NN
cord-023095-4dannjjm	5247	2	was	be	VBD
cord-023095-4dannjjm	5247	3	found	find	VBN
cord-023095-4dannjjm	5247	4	to	to	TO
cord-023095-4dannjjm	5247	5	be	be	VB
cord-023095-4dannjjm	5247	6	the	the	DT
cord-023095-4dannjjm	5247	7	most	most	RBS
cord-023095-4dannjjm	5247	8	common	common	JJ
cord-023095-4dannjjm	5247	9	underlying	underlie	VBG
cord-023095-4dannjjm	5247	10	cause	cause	NN
cord-023095-4dannjjm	5247	11	overall	overall	RB
cord-023095-4dannjjm	5247	12	(	(	-LRB-
cord-023095-4dannjjm	5247	13	51.2	51.2	CD
cord-023095-4dannjjm	5247	14	%	%	NN
cord-023095-4dannjjm	5247	15	)	)	-RRB-
cord-023095-4dannjjm	5247	16	,	,	,
cord-023095-4dannjjm	5247	17	with	with	IN
cord-023095-4dannjjm	5247	18	hemangiosarcoma	hemangiosarcoma	NN
cord-023095-4dannjjm	5247	19	being	be	VBG
cord-023095-4dannjjm	5247	20	the	the	DT
cord-023095-4dannjjm	5247	21	leading	leading	JJ
cord-023095-4dannjjm	5247	22	type	type	NN
cord-023095-4dannjjm	5247	23	(	(	-LRB-
cord-023095-4dannjjm	5247	24	40.9	40.9	CD
cord-023095-4dannjjm	5247	25	%	%	NN
cord-023095-4dannjjm	5247	26	of	of	IN
cord-023095-4dannjjm	5247	27	neoplasia	neoplasia	NN
cord-023095-4dannjjm	5247	28	cases	case	NNS
cord-023095-4dannjjm	5247	29	)	)	-RRB-
cord-023095-4dannjjm	5247	30	,	,	,
cord-023095-4dannjjm	5247	31	followed	follow	VBN
cord-023095-4dannjjm	5247	32	by	by	IN
cord-023095-4dannjjm	5247	33	congestive	congestive	JJ
cord-023095-4dannjjm	5247	34	heart	heart	NN
cord-023095-4dannjjm	5247	35	failure	failure	NN
cord-023095-4dannjjm	5247	36	(	(	-LRB-
cord-023095-4dannjjm	5247	37	9.3	9.3	CD
cord-023095-4dannjjm	5247	38	%	%	NN
cord-023095-4dannjjm	5247	39	)	)	-RRB-
cord-023095-4dannjjm	5247	40	,	,	,
cord-023095-4dannjjm	5247	41	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	5247	42	lymphangectasia	lymphangectasia	NNP
cord-023095-4dannjjm	5247	43	(	(	-LRB-
cord-023095-4dannjjm	5247	44	4.7	4.7	CD
cord-023095-4dannjjm	5247	45	%	%	NN
cord-023095-4dannjjm	5247	46	)	)	-RRB-
cord-023095-4dannjjm	5247	47	,	,	,
cord-023095-4dannjjm	5247	48	peritonitis	peritonitis	NN
cord-023095-4dannjjm	5247	49	/	/	SYM
cord-023095-4dannjjm	5247	50	pancreatitis	pancreatitis	NN
cord-023095-4dannjjm	5247	51	(	(	-LRB-
cord-023095-4dannjjm	5247	52	4.7	4.7	CD
cord-023095-4dannjjm	5247	53	%	%	NN
cord-023095-4dannjjm	5247	54	)	)	-RRB-
cord-023095-4dannjjm	5247	55	,	,	,
cord-023095-4dannjjm	5247	56	cirrhotic	cirrhotic	JJ
cord-023095-4dannjjm	5247	57	liver	liver	NN
cord-023095-4dannjjm	5247	58	disease	disease	NN
cord-023095-4dannjjm	5247	59	(	(	-LRB-
cord-023095-4dannjjm	5247	60	2.3	2.3	CD
cord-023095-4dannjjm	5247	61	%	%	NN
cord-023095-4dannjjm	5247	62	)	)	-RRB-
cord-023095-4dannjjm	5247	63	and	and	CC
cord-023095-4dannjjm	5247	64	acute	acute	JJ
cord-023095-4dannjjm	5247	65	renal	renal	JJ
cord-023095-4dannjjm	5247	66	failure	failure	NN
cord-023095-4dannjjm	5247	67	(	(	-LRB-
cord-023095-4dannjjm	5247	68	2.3	2.3	CD
cord-023095-4dannjjm	5247	69	%	%	NN
cord-023095-4dannjjm	5247	70	)	)	-RRB-
cord-023095-4dannjjm	5247	71	.	.	.
cord-023095-4dannjjm	5248	1	In	in	IN
cord-023095-4dannjjm	5248	2	11	11	CD
cord-023095-4dannjjm	5248	3	cases	case	NNS
cord-023095-4dannjjm	5248	4	(	(	-LRB-
cord-023095-4dannjjm	5248	5	25.6	25.6	CD
cord-023095-4dannjjm	5248	6	%	%	NN
cord-023095-4dannjjm	5248	7	)	)	-RRB-
cord-023095-4dannjjm	5248	8	,	,	,
cord-023095-4dannjjm	5248	9	no	no	DT
cord-023095-4dannjjm	5248	10	underlying	underlying	JJ
cord-023095-4dannjjm	5248	11	cause	cause	NN
cord-023095-4dannjjm	5248	12	could	could	MD
cord-023095-4dannjjm	5248	13	be	be	VB
cord-023095-4dannjjm	5248	14	found	find	VBN
cord-023095-4dannjjm	5248	15	.	.	.
cord-023095-4dannjjm	5249	1	Of	of	IN
cord-023095-4dannjjm	5249	2	these	these	DT
cord-023095-4dannjjm	5249	3	,	,	,
cord-023095-4dannjjm	5249	4	4	4	CD
cord-023095-4dannjjm	5249	5	(	(	-LRB-
cord-023095-4dannjjm	5249	6	9.3	9.3	CD
cord-023095-4dannjjm	5249	7	%	%	NN
cord-023095-4dannjjm	5249	8	of	of	IN
cord-023095-4dannjjm	5249	9	all	all	DT
cord-023095-4dannjjm	5249	10	cases	case	NNS
cord-023095-4dannjjm	5249	11	)	)	-RRB-
cord-023095-4dannjjm	5249	12	were	be	VBD
cord-023095-4dannjjm	5249	13	diagnosed	diagnose	VBN
cord-023095-4dannjjm	5249	14	as	as	IN
cord-023095-4dannjjm	5249	15	having	have	VBG
cord-023095-4dannjjm	5249	16	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	5249	17	pericardial	pericardial	JJ
cord-023095-4dannjjm	5249	18	effusion	effusion	NN
cord-023095-4dannjjm	5249	19	.	.	.
cord-023095-4dannjjm	5250	1	Taken	take	VBN
cord-023095-4dannjjm	5250	2	together	together	RB
cord-023095-4dannjjm	5250	3	,	,	,
cord-023095-4dannjjm	5250	4	these	these	DT
cord-023095-4dannjjm	5250	5	findings	finding	NNS
cord-023095-4dannjjm	5250	6	suggest	suggest	VBP
cord-023095-4dannjjm	5250	7	a	a	DT
cord-023095-4dannjjm	5250	8	strong	strong	JJ
cord-023095-4dannjjm	5250	9	association	association	NN
cord-023095-4dannjjm	5250	10	between	between	IN
cord-023095-4dannjjm	5250	11	multicavitary	multicavitary	JJ
cord-023095-4dannjjm	5250	12	effusion	effusion	NN
cord-023095-4dannjjm	5250	13	and	and	CC
cord-023095-4dannjjm	5250	14	diseases	disease	NNS
cord-023095-4dannjjm	5250	15	carrying	carry	VBG
cord-023095-4dannjjm	5250	16	a	a	DT
cord-023095-4dannjjm	5250	17	guarded	guard	VBN
cord-023095-4dannjjm	5250	18	prognosis	prognosis	NN
cord-023095-4dannjjm	5250	19	in	in	IN
cord-023095-4dannjjm	5250	20	dogs	dog	NNS
cord-023095-4dannjjm	5250	21	.	.	.
cord-023095-4dannjjm	5251	1	Infection	infection	NN
cord-023095-4dannjjm	5251	2	control	control	NN
cord-023095-4dannjjm	5251	3	practices	practice	NNS
cord-023095-4dannjjm	5251	4	in	in	IN
cord-023095-4dannjjm	5251	5	veterinary	veterinary	JJ
cord-023095-4dannjjm	5251	6	clinics	clinic	NNS
cord-023095-4dannjjm	5251	7	and	and	CC
cord-023095-4dannjjm	5251	8	hospitals	hospital	NNS
cord-023095-4dannjjm	5251	9	are	be	VBP
cord-023095-4dannjjm	5251	10	becoming	become	VBG
cord-023095-4dannjjm	5251	11	increasingly	increasingly	RB
cord-023095-4dannjjm	5251	12	important	important	JJ
cord-023095-4dannjjm	5251	13	,	,	,
cord-023095-4dannjjm	5251	14	with	with	IN
cord-023095-4dannjjm	5251	15	rising	rise	VBG
cord-023095-4dannjjm	5251	16	client	client	NN
cord-023095-4dannjjm	5251	17	expectations	expectation	NNS
cord-023095-4dannjjm	5251	18	,	,	,
cord-023095-4dannjjm	5251	19	growing	grow	VBG
cord-023095-4dannjjm	5251	20	concern	concern	NN
cord-023095-4dannjjm	5251	21	about	about	IN
cord-023095-4dannjjm	5251	22	the	the	DT
cord-023095-4dannjjm	5251	23	spread	spread	NN
cord-023095-4dannjjm	5251	24	of	of	IN
cord-023095-4dannjjm	5251	25	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	5251	26	-	-	HYPH
cord-023095-4dannjjm	5251	27	resistant	resistant	JJ
cord-023095-4dannjjm	5251	28	pathogens	pathogen	NNS
cord-023095-4dannjjm	5251	29	,	,	,
cord-023095-4dannjjm	5251	30	and	and	CC
cord-023095-4dannjjm	5251	31	the	the	DT
cord-023095-4dannjjm	5251	32	potential	potential	NN
cord-023095-4dannjjm	5251	33	for	for	IN
cord-023095-4dannjjm	5251	34	zoonotic	zoonotic	JJ
cord-023095-4dannjjm	5251	35	transmission	transmission	NN
cord-023095-4dannjjm	5251	36	of	of	IN
cord-023095-4dannjjm	5251	37	disease	disease	NN
cord-023095-4dannjjm	5251	38	.	.	.
cord-023095-4dannjjm	5252	1	Surgical	surgical	JJ
cord-023095-4dannjjm	5252	2	patients	patient	NNS
cord-023095-4dannjjm	5252	3	are	be	VBP
cord-023095-4dannjjm	5252	4	at	at	IN
cord-023095-4dannjjm	5252	5	increased	increase	VBN
cord-023095-4dannjjm	5252	6	risk	risk	NN
cord-023095-4dannjjm	5252	7	of	of	IN
cord-023095-4dannjjm	5252	8	developing	develop	VBG
cord-023095-4dannjjm	5252	9	infections	infection	NNS
cord-023095-4dannjjm	5252	10	,	,	,
cord-023095-4dannjjm	5252	11	and	and	CC
cord-023095-4dannjjm	5252	12	can	can	MD
cord-023095-4dannjjm	5252	13	serve	serve	VB
cord-023095-4dannjjm	5252	14	as	as	IN
cord-023095-4dannjjm	5252	15	sources	source	NNS
cord-023095-4dannjjm	5252	16	of	of	IN
cord-023095-4dannjjm	5252	17	these	these	DT
cord-023095-4dannjjm	5252	18	pathogens	pathogen	NNS
cord-023095-4dannjjm	5252	19	for	for	IN
cord-023095-4dannjjm	5252	20	other	other	JJ
cord-023095-4dannjjm	5252	21	animals	animal	NNS
cord-023095-4dannjjm	5252	22	and	and	CC
cord-023095-4dannjjm	5252	23	people	people	NNS
cord-023095-4dannjjm	5252	24	with	with	IN
cord-023095-4dannjjm	5252	25	whom	whom	WP
cord-023095-4dannjjm	5252	26	they	-PRON-	PRP
cord-023095-4dannjjm	5252	27	have	have	VBP
cord-023095-4dannjjm	5252	28	contact	contact	NN
cord-023095-4dannjjm	5252	29	within	within	IN
cord-023095-4dannjjm	5252	30	and	and	CC
cord-023095-4dannjjm	5252	31	outside	outside	IN
cord-023095-4dannjjm	5252	32	the	the	DT
cord-023095-4dannjjm	5252	33	clinic	clinic	NN
cord-023095-4dannjjm	5252	34	.	.	.
cord-023095-4dannjjm	5253	1	Taking	take	VBG
cord-023095-4dannjjm	5253	2	all	all	DT
cord-023095-4dannjjm	5253	3	reasonable	reasonable	JJ
cord-023095-4dannjjm	5253	4	precautions	precaution	NNS
cord-023095-4dannjjm	5253	5	to	to	TO
cord-023095-4dannjjm	5253	6	reduce	reduce	VB
cord-023095-4dannjjm	5253	7	the	the	DT
cord-023095-4dannjjm	5253	8	risk	risk	NN
cord-023095-4dannjjm	5253	9	of	of	IN
cord-023095-4dannjjm	5253	10	surgical	surgical	JJ
cord-023095-4dannjjm	5253	11	site	site	NN
cord-023095-4dannjjm	5253	12	infections	infection	NNS
cord-023095-4dannjjm	5253	13	,	,	,
cord-023095-4dannjjm	5253	14	beginning	begin	VBG
cord-023095-4dannjjm	5253	15	with	with	IN
cord-023095-4dannjjm	5253	16	preoperative	preoperative	JJ
cord-023095-4dannjjm	5253	17	preparation	preparation	NN
cord-023095-4dannjjm	5253	18	of	of	IN
cord-023095-4dannjjm	5253	19	the	the	DT
cord-023095-4dannjjm	5253	20	surgeon	surgeon	NN
cord-023095-4dannjjm	5253	21	and	and	CC
cord-023095-4dannjjm	5253	22	patient	patient	NN
cord-023095-4dannjjm	5253	23	,	,	,
cord-023095-4dannjjm	5253	24	is	be	VBZ
cord-023095-4dannjjm	5253	25	therefore	therefore	RB
cord-023095-4dannjjm	5253	26	an	an	DT
cord-023095-4dannjjm	5253	27	important	important	JJ
cord-023095-4dannjjm	5253	28	part	part	NN
cord-023095-4dannjjm	5253	29	of	of	IN
cord-023095-4dannjjm	5253	30	any	any	DT
cord-023095-4dannjjm	5253	31	infection	infection	NN
cord-023095-4dannjjm	5253	32	control	control	NN
cord-023095-4dannjjm	5253	33	program	program	NN
cord-023095-4dannjjm	5253	34	.	.	.
cord-023095-4dannjjm	5254	1	While	while	IN
cord-023095-4dannjjm	5254	2	guidelines	guideline	NNS
cord-023095-4dannjjm	5254	3	are	be	VBP
cord-023095-4dannjjm	5254	4	available	available	JJ
cord-023095-4dannjjm	5254	5	for	for	IN
cord-023095-4dannjjm	5254	6	preoperative	preoperative	JJ
cord-023095-4dannjjm	5254	7	preparation	preparation	NN
cord-023095-4dannjjm	5254	8	procedures	procedure	NNS
cord-023095-4dannjjm	5254	9	,	,	,
cord-023095-4dannjjm	5254	10	there	there	EX
cord-023095-4dannjjm	5254	11	has	have	VBZ
cord-023095-4dannjjm	5254	12	been	be	VBN
cord-023095-4dannjjm	5254	13	no	no	DT
cord-023095-4dannjjm	5254	14	objective	objective	JJ
cord-023095-4dannjjm	5254	15	investigation	investigation	NN
cord-023095-4dannjjm	5254	16	of	of	IN
cord-023095-4dannjjm	5254	17	compliance	compliance	NN
cord-023095-4dannjjm	5254	18	with	with	IN
cord-023095-4dannjjm	5254	19	these	these	DT
cord-023095-4dannjjm	5254	20	guidelines	guideline	NNS
cord-023095-4dannjjm	5254	21	in	in	IN
cord-023095-4dannjjm	5254	22	veterinary	veterinary	JJ
cord-023095-4dannjjm	5254	23	practices	practice	NNS
cord-023095-4dannjjm	5254	24	.	.	.
cord-023095-4dannjjm	5255	1	The	the	DT
cord-023095-4dannjjm	5255	2	objectives	objective	NNS
cord-023095-4dannjjm	5255	3	of	of	IN
cord-023095-4dannjjm	5255	4	this	this	DT
cord-023095-4dannjjm	5255	5	pilot	pilot	NN
cord-023095-4dannjjm	5255	6	study	study	NN
cord-023095-4dannjjm	5255	7	were	be	VBD
cord-023095-4dannjjm	5255	8	to	to	TO
cord-023095-4dannjjm	5255	9	describe	describe	VB
cord-023095-4dannjjm	5255	10	a	a	DT
cord-023095-4dannjjm	5255	11	range	range	NN
cord-023095-4dannjjm	5255	12	of	of	IN
cord-023095-4dannjjm	5255	13	preoperative	preoperative	JJ
cord-023095-4dannjjm	5255	14	hand	hand	NN
cord-023095-4dannjjm	5255	15	scrub	scrub	NN
cord-023095-4dannjjm	5255	16	and	and	CC
cord-023095-4dannjjm	5255	17	surgical	surgical	JJ
cord-023095-4dannjjm	5255	18	site	site	NN
cord-023095-4dannjjm	5255	19	preparation	preparation	NN
cord-023095-4dannjjm	5255	20	practices	practice	NNS
cord-023095-4dannjjm	5255	21	in	in	IN
cord-023095-4dannjjm	5255	22	veterinary	veterinary	JJ
cord-023095-4dannjjm	5255	23	clinics	clinic	NNS
cord-023095-4dannjjm	5255	24	,	,	,
cord-023095-4dannjjm	5255	25	and	and	CC
cord-023095-4dannjjm	5255	26	to	to	TO
cord-023095-4dannjjm	5255	27	determine	determine	VB
cord-023095-4dannjjm	5255	28	if	if	IN
cord-023095-4dannjjm	5255	29	there	there	EX
cord-023095-4dannjjm	5255	30	were	be	VBD
cord-023095-4dannjjm	5255	31	any	any	DT
cord-023095-4dannjjm	5255	32	areas	area	NNS
cord-023095-4dannjjm	5255	33	that	that	WDT
cord-023095-4dannjjm	5255	34	consistently	consistently	RB
cord-023095-4dannjjm	5255	35	require	require	VBP
cord-023095-4dannjjm	5255	36	improvement	improvement	NN
cord-023095-4dannjjm	5255	37	.	.	.
cord-023095-4dannjjm	5256	1	Observation	observation	NN
cord-023095-4dannjjm	5256	2	of	of	IN
cord-023095-4dannjjm	5256	3	preparation	preparation	NN
cord-023095-4dannjjm	5256	4	practices	practice	NNS
cord-023095-4dannjjm	5256	5	was	be	VBD
cord-023095-4dannjjm	5256	6	performed	perform	VBN
cord-023095-4dannjjm	5256	7	in	in	IN
cord-023095-4dannjjm	5256	8	each	each	DT
cord-023095-4dannjjm	5256	9	of	of	IN
cord-023095-4dannjjm	5256	10	ten	ten	CD
cord-023095-4dannjjm	5256	11	clinics	clinic	NNS
cord-023095-4dannjjm	5256	12	over	over	IN
cord-023095-4dannjjm	5256	13	9	9	CD
cord-023095-4dannjjm	5256	14	-	-	SYM
cord-023095-4dannjjm	5256	15	14	14	CD
cord-023095-4dannjjm	5256	16	days	day	NNS
cord-023095-4dannjjm	5256	17	using	use	VBG
cord-023095-4dannjjm	5256	18	2	2	CD
cord-023095-4dannjjm	5256	19	-	-	SYM
cord-023095-4dannjjm	5256	20	3	3	CD
cord-023095-4dannjjm	5256	21	small	small	JJ
cord-023095-4dannjjm	5256	22	wireless	wireless	NN
cord-023095-4dannjjm	5256	23	surveillance	surveillance	NN
cord-023095-4dannjjm	5256	24	cameras	camera	NNS
cord-023095-4dannjjm	5256	25	.	.	.
cord-023095-4dannjjm	5257	1	Data	datum	NNS
cord-023095-4dannjjm	5257	2	was	be	VBD
cord-023095-4dannjjm	5257	3	coded	code	VBN
cord-023095-4dannjjm	5257	4	for	for	IN
cord-023095-4dannjjm	5257	5	148	148	CD
cord-023095-4dannjjm	5257	6	surgical	surgical	JJ
cord-023095-4dannjjm	5257	7	patients	patient	NNS
cord-023095-4dannjjm	5257	8	,	,	,
cord-023095-4dannjjm	5257	9	and	and	CC
cord-023095-4dannjjm	5257	10	31	31	CD
cord-023095-4dannjjm	5257	11	surgeons	surgeon	NNS
cord-023095-4dannjjm	5257	12	performing	perform	VBG
cord-023095-4dannjjm	5257	13	a	a	DT
cord-023095-4dannjjm	5257	14	total	total	NN
cord-023095-4dannjjm	5257	15	of	of	IN
cord-023095-4dannjjm	5257	16	190	190	CD
cord-023095-4dannjjm	5257	17	hand	hand	NN
cord-023095-4dannjjm	5257	18	scrubs	scrub	NNS
cord-023095-4dannjjm	5257	19	.	.	.
cord-023095-4dannjjm	5258	1	Patient	patient	JJ
cord-023095-4dannjjm	5258	2	hair	hair	NN
cord-023095-4dannjjm	5258	3	removal	removal	NN
cord-023095-4dannjjm	5258	4	was	be	VBD
cord-023095-4dannjjm	5258	5	most	most	RBS
cord-023095-4dannjjm	5258	6	commonly	commonly	RB
cord-023095-4dannjjm	5258	7	performed	perform	VBN
cord-023095-4dannjjm	5258	8	after	after	IN
cord-023095-4dannjjm	5258	9	induction	induction	NN
cord-023095-4dannjjm	5258	10	of	of	IN
cord-023095-4dannjjm	5258	11	the	the	DT
cord-023095-4dannjjm	5258	12	animal	animal	NN
cord-023095-4dannjjm	5258	13	(	(	-LRB-
cord-023095-4dannjjm	5258	14	129/140	129/140	CD
cord-023095-4dannjjm	5258	15	,	,	,
cord-023095-4dannjjm	5258	16	92	92	CD
cord-023095-4dannjjm	5258	17	%	%	NN
cord-023095-4dannjjm	5258	18	)	)	-RRB-
cord-023095-4dannjjm	5258	19	and	and	CC
cord-023095-4dannjjm	5258	20	using	use	VBG
cord-023095-4dannjjm	5258	21	clippers	clipper	NNS
cord-023095-4dannjjm	5258	22	(	(	-LRB-
cord-023095-4dannjjm	5258	23	114/137	114/137	CD
cord-023095-4dannjjm	5258	24	,	,	,
cord-023095-4dannjjm	5258	25	83	83	CD
cord-023095-4dannjjm	5258	26	%	%	NN
cord-023095-4dannjjm	5258	27	)	)	-RRB-
cord-023095-4dannjjm	5258	28	.	.	.
cord-023095-4dannjjm	5259	1	Steps	step	NNS
cord-023095-4dannjjm	5259	2	in	in	IN
cord-023095-4dannjjm	5259	3	surgical	surgical	JJ
cord-023095-4dannjjm	5259	4	site	site	NN
cord-023095-4dannjjm	5259	5	aseptic	aseptic	JJ
cord-023095-4dannjjm	5259	6	preparation	preparation	NN
cord-023095-4dannjjm	5259	7	ranged	range	VBD
cord-023095-4dannjjm	5259	8	from	from	IN
cord-023095-4dannjjm	5259	9	1	1	CD
cord-023095-4dannjjm	5259	10	-	-	SYM
cord-023095-4dannjjm	5259	11	4	4	CD
cord-023095-4dannjjm	5259	12	.	.	.
cord-023095-4dannjjm	5260	1	Contact	contact	NN
cord-023095-4dannjjm	5260	2	time	time	NN
cord-023095-4dannjjm	5260	3	with	with	IN
cord-023095-4dannjjm	5260	4	soap	soap	NN
cord-023095-4dannjjm	5260	5	ranged	range	VBD
cord-023095-4dannjjm	5260	6	from	from	IN
cord-023095-4dannjjm	5260	7	18	18	CD
cord-023095-4dannjjm	5260	8	-	-	SYM
cord-023095-4dannjjm	5260	9	369s	369s	CD
cord-023095-4dannjjm	5260	10	(	(	-LRB-
cord-023095-4dannjjm	5260	11	mean	mean	UH
cord-023095-4dannjjm	5260	12	82s	82	NNS
cord-023095-4dannjjm	5260	13	,	,	,
cord-023095-4dannjjm	5260	14	median	median	JJ
cord-023095-4dannjjm	5260	15	53s	53s	NNPS
cord-023095-4dannjjm	5260	16	)	)	-RRB-
cord-023095-4dannjjm	5260	17	,	,	,
cord-023095-4dannjjm	5260	18	and	and	CC
cord-023095-4dannjjm	5260	19	with	with	IN
cord-023095-4dannjjm	5260	20	alcohol	alcohol	NN
cord-023095-4dannjjm	5260	21	from	from	IN
cord-023095-4dannjjm	5260	22	3	3	CD
cord-023095-4dannjjm	5260	23	-	-	HYPH
cord-023095-4dannjjm	5260	24	220s	220s	NNPS
cord-023095-4dannjjm	5260	25	(	(	-LRB-
cord-023095-4dannjjm	5260	26	mean	mean	UH
cord-023095-4dannjjm	5260	27	41s	41s	CD
cord-023095-4dannjjm	5260	28	,	,	,
cord-023095-4dannjjm	5260	29	median	median	JJ
cord-023095-4dannjjm	5260	30	30.5s	30.5s	NNP
cord-023095-4dannjjm	5260	31	)	)	-RRB-
cord-023095-4dannjjm	5260	32	.	.	.
cord-023095-4dannjjm	5261	1	Application	application	NN
cord-023095-4dannjjm	5261	2	of	of	IN
cord-023095-4dannjjm	5261	3	alcohol	alcohol	NN
cord-023095-4dannjjm	5261	4	or	or	CC
cord-023095-4dannjjm	5261	5	antiseptic	antiseptic	JJ
cord-023095-4dannjjm	5261	6	using	use	VBG
cord-023095-4dannjjm	5261	7	a	a	DT
cord-023095-4dannjjm	5261	8	'	'	''
cord-023095-4dannjjm	5261	9	'	'	''
cord-023095-4dannjjm	5261	10	cleanest	clean	JJS
cord-023095-4dannjjm	5261	11	to	to	IN
cord-023095-4dannjjm	5261	12	dirtiest	dirty	JJS
cord-023095-4dannjjm	5261	13	'	'	''
cord-023095-4dannjjm	5261	14	'	'	''
cord-023095-4dannjjm	5261	15	pattern	pattern	NN
cord-023095-4dannjjm	5261	16	was	be	VBD
cord-023095-4dannjjm	5261	17	infrequent	infrequent	JJ
cord-023095-4dannjjm	5261	18	(	(	-LRB-
cord-023095-4dannjjm	5261	19	29/66	29/66	CD
cord-023095-4dannjjm	5261	20	(	(	-LRB-
cord-023095-4dannjjm	5261	21	44	44	CD
cord-023095-4dannjjm	5261	22	%	%	NN
cord-023095-4dannjjm	5261	23	)	)	-RRB-
cord-023095-4dannjjm	5261	24	and	and	CC
cord-023095-4dannjjm	5261	25	11/83	11/83	CD
cord-023095-4dannjjm	5261	26	(	(	-LRB-
cord-023095-4dannjjm	5261	27	13	13	CD
cord-023095-4dannjjm	5261	28	%	%	NN
cord-023095-4dannjjm	5261	29	)	)	-RRB-
cord-023095-4dannjjm	5261	30	,	,	,
cord-023095-4dannjjm	5261	31	respectively	respectively	RB
cord-023095-4dannjjm	5261	32	)	)	-RRB-
cord-023095-4dannjjm	5261	33	.	.	.
cord-023095-4dannjjm	5262	1	Potential	potential	JJ
cord-023095-4dannjjm	5262	2	contamination	contamination	NN
cord-023095-4dannjjm	5262	3	of	of	IN
cord-023095-4dannjjm	5262	4	the	the	DT
cord-023095-4dannjjm	5262	5	surgical	surgical	JJ
cord-023095-4dannjjm	5262	6	site	site	NN
cord-023095-4dannjjm	5262	7	occurred	occur	VBD
cord-023095-4dannjjm	5262	8	most	most	RBS
cord-023095-4dannjjm	5262	9	frequently	frequently	RB
cord-023095-4dannjjm	5262	10	when	when	WRB
cord-023095-4dannjjm	5262	11	the	the	DT
cord-023095-4dannjjm	5262	12	animal	animal	NN
cord-023095-4dannjjm	5262	13	was	be	VBD
cord-023095-4dannjjm	5262	14	moved	move	VBN
cord-023095-4dannjjm	5262	15	to	to	IN
cord-023095-4dannjjm	5262	16	the	the	DT
cord-023095-4dannjjm	5262	17	surgery	surgery	NN
cord-023095-4dannjjm	5262	18	table	table	NN
cord-023095-4dannjjm	5262	19	after	after	IN
cord-023095-4dannjjm	5262	20	initial	initial	JJ
cord-023095-4dannjjm	5262	21	preparation	preparation	NN
cord-023095-4dannjjm	5262	22	(	(	-LRB-
cord-023095-4dannjjm	5262	23	40/58	40/58	CD
cord-023095-4dannjjm	5262	24	,	,	,
cord-023095-4dannjjm	5262	25	69	69	CD
cord-023095-4dannjjm	5262	26	%	%	NN
cord-023095-4dannjjm	5262	27	)	)	-RRB-
cord-023095-4dannjjm	5262	28	.	.	.
cord-023095-4dannjjm	5263	1	Preoperative	Preoperative	NNP
cord-023095-4dannjjm	5263	2	alcohol	alcohol	NN
cord-023095-4dannjjm	5263	3	hand	hand	NN
cord-023095-4dannjjm	5263	4	rub	rub	NN
cord-023095-4dannjjm	5263	5	was	be	VBD
cord-023095-4dannjjm	5263	6	used	use	VBN
cord-023095-4dannjjm	5263	7	in	in	IN
cord-023095-4dannjjm	5263	8	2/10	2/10	CD
cord-023095-4dannjjm	5263	9	facilities	facility	NNS
cord-023095-4dannjjm	5263	10	,	,	,
cord-023095-4dannjjm	5263	11	but	but	CC
cord-023095-4dannjjm	5263	12	soap	soap	NN
cord-023095-4dannjjm	5263	13	and	and	CC
cord-023095-4dannjjm	5263	14	water	water	NN
cord-023095-4dannjjm	5263	15	hand	hand	NN
cord-023095-4dannjjm	5263	16	scrub	scrub	NN
cord-023095-4dannjjm	5263	17	was	be	VBD
cord-023095-4dannjjm	5263	18	still	still	RB
cord-023095-4dannjjm	5263	19	more	more	RBR
cord-023095-4dannjjm	5263	20	commonly	commonly	RB
cord-023095-4dannjjm	5263	21	used	use	VBN
cord-023095-4dannjjm	5263	22	even	even	RB
cord-023095-4dannjjm	5263	23	at	at	IN
cord-023095-4dannjjm	5263	24	these	these	DT
cord-023095-4dannjjm	5263	25	clinics	clinic	NNS
cord-023095-4dannjjm	5263	26	.	.	.
cord-023095-4dannjjm	5264	1	Proximal	Proximal	NNP
cord-023095-4dannjjm	5264	2	-	-	HYPH
cord-023095-4dannjjm	5264	3	to	to	IN
cord-023095-4dannjjm	5264	4	-	-	HYPH
cord-023095-4dannjjm	5264	5	distal	distal	JJ
cord-023095-4dannjjm	5264	6	scrubbing	scrubbing	NN
cord-023095-4dannjjm	5264	7	was	be	VBD
cord-023095-4dannjjm	5264	8	noted	note	VBN
cord-023095-4dannjjm	5264	9	in	in	IN
cord-023095-4dannjjm	5264	10	95/142	95/142	CD
cord-023095-4dannjjm	5264	11	(	(	-LRB-
cord-023095-4dannjjm	5264	12	67	67	CD
cord-023095-4dannjjm	5264	13	%	%	NN
cord-023095-4dannjjm	5264	14	)	)	-RRB-
cord-023095-4dannjjm	5264	15	of	of	IN
cord-023095-4dannjjm	5264	16	soap	soap	NN
cord-023095-4dannjjm	5264	17	and	and	CC
cord-023095-4dannjjm	5264	18	water	water	NN
cord-023095-4dannjjm	5264	19	scrubs	scrub	NNS
cord-023095-4dannjjm	5264	20	.	.	.
cord-023095-4dannjjm	5265	1	Contact	contact	NN
cord-023095-4dannjjm	5265	2	time	time	NN
cord-023095-4dannjjm	5265	3	during	during	IN
cord-023095-4dannjjm	5265	4	surgeon	surgeon	NN
cord-023095-4dannjjm	5265	5	hand	hand	NN
cord-023095-4dannjjm	5265	6	preparation	preparation	NN
cord-023095-4dannjjm	5265	7	ranged	range	VBD
cord-023095-4dannjjm	5265	8	from	from	IN
cord-023095-4dannjjm	5265	9	7	7	CD
cord-023095-4dannjjm	5265	10	-	-	HYPH
cord-023095-4dannjjm	5265	11	529s	529	NNS
cord-023095-4dannjjm	5265	12	(	(	-LRB-
cord-023095-4dannjjm	5265	13	mean	mean	VBP
cord-023095-4dannjjm	5265	14	144s	144s	CD
cord-023095-4dannjjm	5265	15	,	,	,
cord-023095-4dannjjm	5265	16	median	median	JJ
cord-023095-4dannjjm	5265	17	124s	124s	CD
cord-023095-4dannjjm	5265	18	)	)	-RRB-
cord-023095-4dannjjm	5265	19	for	for	IN
cord-023095-4dannjjm	5265	20	soap	soap	NN
cord-023095-4dannjjm	5265	21	and	and	CC
cord-023095-4dannjjm	5265	22	water	water	NN
cord-023095-4dannjjm	5265	23	and	and	CC
cord-023095-4dannjjm	5265	24	from	from	IN
cord-023095-4dannjjm	5265	25	4	4	CD
cord-023095-4dannjjm	5265	26	-	-	HYPH
cord-023095-4dannjjm	5265	27	123s	123	NNS
cord-023095-4dannjjm	5265	28	(	(	-LRB-
cord-023095-4dannjjm	5265	29	mean	mean	UH
cord-023095-4dannjjm	5265	30	34s	34	NNS
cord-023095-4dannjjm	5265	31	,	,	,
cord-023095-4dannjjm	5265	32	median	median	JJ
cord-023095-4dannjjm	5265	33	25s	25	NNS
cord-023095-4dannjjm	5265	34	)	)	-RRB-
cord-023095-4dannjjm	5265	35	for	for	IN
cord-023095-4dannjjm	5265	36	alcohol	alcohol	NN
cord-023095-4dannjjm	5265	37	-	-	HYPH
cord-023095-4dannjjm	5265	38	based	base	VBN
cord-023095-4dannjjm	5265	39	hand	hand	NN
cord-023095-4dannjjm	5265	40	rub	rub	NN
cord-023095-4dannjjm	5265	41	.	.	.
cord-023095-4dannjjm	5266	1	Approximately	approximately	RB
cord-023095-4dannjjm	5266	2	75	75	CD
cord-023095-4dannjjm	5266	3	%	%	NN
cord-023095-4dannjjm	5266	4	of	of	IN
cord-023095-4dannjjm	5266	5	the	the	DT
cord-023095-4dannjjm	5266	6	variation	variation	NN
cord-023095-4dannjjm	5266	7	in	in	IN
cord-023095-4dannjjm	5266	8	contact	contact	NN
cord-023095-4dannjjm	5266	9	time	time	NN
cord-023095-4dannjjm	5266	10	was	be	VBD
cord-023095-4dannjjm	5266	11	due	due	JJ
cord-023095-4dannjjm	5266	12	to	to	IN
cord-023095-4dannjjm	5266	13	inter	inter	JJ
cord-023095-4dannjjm	5266	14	-	-	JJ
cord-023095-4dannjjm	5266	15	surgeon	surgeon	NN
cord-023095-4dannjjm	5266	16	variation	variation	NN
cord-023095-4dannjjm	5266	17	.	.	.
cord-023095-4dannjjm	5267	1	No	no	DT
cord-023095-4dannjjm	5267	2	significant	significant	JJ
cord-023095-4dannjjm	5267	3	changes	change	NNS
cord-023095-4dannjjm	5267	4	in	in	IN
cord-023095-4dannjjm	5267	5	practices	practice	NNS
cord-023095-4dannjjm	5267	6	were	be	VBD
cord-023095-4dannjjm	5267	7	identified	identify	VBN
cord-023095-4dannjjm	5267	8	over	over	IN
cord-023095-4dannjjm	5267	9	the	the	DT
cord-023095-4dannjjm	5267	10	course	course	NN
cord-023095-4dannjjm	5267	11	of	of	IN
cord-023095-4dannjjm	5267	12	the	the	DT
cord-023095-4dannjjm	5267	13	observation	observation	NN
cord-023095-4dannjjm	5267	14	period	period	NN
cord-023095-4dannjjm	5267	15	.	.	.
cord-023095-4dannjjm	5268	1	Some	some	DT
cord-023095-4dannjjm	5268	2	preoperative	preoperative	JJ
cord-023095-4dannjjm	5268	3	preparation	preparation	NN
cord-023095-4dannjjm	5268	4	practices	practice	NNS
cord-023095-4dannjjm	5268	5	were	be	VBD
cord-023095-4dannjjm	5268	6	fairly	fairly	RB
cord-023095-4dannjjm	5268	7	consistent	consistent	JJ
cord-023095-4dannjjm	5268	8	between	between	IN
cord-023095-4dannjjm	5268	9	clinics	clinic	NNS
cord-023095-4dannjjm	5268	10	in	in	IN
cord-023095-4dannjjm	5268	11	this	this	DT
cord-023095-4dannjjm	5268	12	study	study	NN
cord-023095-4dannjjm	5268	13	,	,	,
cord-023095-4dannjjm	5268	14	while	while	IN
cord-023095-4dannjjm	5268	15	others	other	NNS
cord-023095-4dannjjm	5268	16	varied	vary	VBD
cord-023095-4dannjjm	5268	17	considerably	considerably	RB
cord-023095-4dannjjm	5268	18	.	.	.
cord-023095-4dannjjm	5269	1	Contact	contact	NN
cord-023095-4dannjjm	5269	2	times	time	NNS
cord-023095-4dannjjm	5269	3	with	with	IN
cord-023095-4dannjjm	5269	4	preparatory	preparatory	JJ
cord-023095-4dannjjm	5269	5	solutions	solution	NNS
cord-023095-4dannjjm	5269	6	were	be	VBD
cord-023095-4dannjjm	5269	7	often	often	RB
cord-023095-4dannjjm	5269	8	far	far	RB
cord-023095-4dannjjm	5269	9	shorter	short	JJR
cord-023095-4dannjjm	5269	10	than	than	IN
cord-023095-4dannjjm	5269	11	recommended	recommend	VBN
cord-023095-4dannjjm	5269	12	,	,	,
cord-023095-4dannjjm	5269	13	and	and	CC
cord-023095-4dannjjm	5269	14	there	there	EX
cord-023095-4dannjjm	5269	15	was	be	VBD
cord-023095-4dannjjm	5269	16	a	a	DT
cord-023095-4dannjjm	5269	17	high	high	JJ
cord-023095-4dannjjm	5269	18	frequency	frequency	NN
cord-023095-4dannjjm	5269	19	of	of	IN
cord-023095-4dannjjm	5269	20	non	non	JJ
cord-023095-4dannjjm	5269	21	-	-	JJ
cord-023095-4dannjjm	5269	22	sterile	sterile	JJ
cord-023095-4dannjjm	5269	23	contact	contact	NN
cord-023095-4dannjjm	5269	24	with	with	IN
cord-023095-4dannjjm	5269	25	the	the	DT
cord-023095-4dannjjm	5269	26	surgical	surgical	JJ
cord-023095-4dannjjm	5269	27	site	site	NN
cord-023095-4dannjjm	5269	28	during	during	IN
cord-023095-4dannjjm	5269	29	movement	movement	NN
cord-023095-4dannjjm	5269	30	of	of	IN
cord-023095-4dannjjm	5269	31	patients	patient	NNS
cord-023095-4dannjjm	5269	32	to	to	IN
cord-023095-4dannjjm	5269	33	the	the	DT
cord-023095-4dannjjm	5269	34	surgical	surgical	JJ
cord-023095-4dannjjm	5269	35	suite	suite	NN
cord-023095-4dannjjm	5269	36	.	.	.
cord-023095-4dannjjm	5270	1	The	the	DT
cord-023095-4dannjjm	5270	2	camera	camera	NN
cord-023095-4dannjjm	5270	3	system	system	NN
cord-023095-4dannjjm	5270	4	used	use	VBD
cord-023095-4dannjjm	5270	5	to	to	TO
cord-023095-4dannjjm	5270	6	perform	perform	VB
cord-023095-4dannjjm	5270	7	this	this	DT
cord-023095-4dannjjm	5270	8	study	study	NN
cord-023095-4dannjjm	5270	9	did	do	VBD
cord-023095-4dannjjm	5270	10	not	not	RB
cord-023095-4dannjjm	5270	11	have	have	VB
cord-023095-4dannjjm	5270	12	a	a	DT
cord-023095-4dannjjm	5270	13	significant	significant	JJ
cord-023095-4dannjjm	5270	14	time	time	NN
cord-023095-4dannjjm	5270	15	-	-	HYPH
cord-023095-4dannjjm	5270	16	dependent	dependent	JJ
cord-023095-4dannjjm	5270	17	effect	effect	NN
cord-023095-4dannjjm	5270	18	on	on	IN
cord-023095-4dannjjm	5270	19	the	the	DT
cord-023095-4dannjjm	5270	20	behavior	behavior	NN
cord-023095-4dannjjm	5270	21	of	of	IN
cord-023095-4dannjjm	5270	22	participants	participant	NNS
cord-023095-4dannjjm	5270	23	,	,	,
cord-023095-4dannjjm	5270	24	and	and	CC
cord-023095-4dannjjm	5270	25	could	could	MD
cord-023095-4dannjjm	5270	26	be	be	VB
cord-023095-4dannjjm	5270	27	useful	useful	JJ
cord-023095-4dannjjm	5270	28	for	for	IN
cord-023095-4dannjjm	5270	29	performing	perform	VBG
cord-023095-4dannjjm	5270	30	similar	similar	JJ
cord-023095-4dannjjm	5270	31	field	field	NN
cord-023095-4dannjjm	5270	32	-	-	HYPH
cord-023095-4dannjjm	5270	33	based	base	VBN
cord-023095-4dannjjm	5270	34	observational	observational	JJ
cord-023095-4dannjjm	5270	35	studies	study	NNS
cord-023095-4dannjjm	5270	36	in	in	IN
cord-023095-4dannjjm	5270	37	the	the	DT
cord-023095-4dannjjm	5270	38	future	future	NN
cord-023095-4dannjjm	5270	39	.	.	.
cord-023095-4dannjjm	5271	1	This	this	DT
cord-023095-4dannjjm	5271	2	prospective	prospective	JJ
cord-023095-4dannjjm	5271	3	randomized	randomized	JJ
cord-023095-4dannjjm	5271	4	study	study	NN
cord-023095-4dannjjm	5271	5	compared	compare	VBD
cord-023095-4dannjjm	5271	6	the	the	DT
cord-023095-4dannjjm	5271	7	percentage	percentage	NN
cord-023095-4dannjjm	5271	8	of	of	IN
cord-023095-4dannjjm	5271	9	successful	successful	JJ
cord-023095-4dannjjm	5271	10	intraosseous	intraosseous	JJ
cord-023095-4dannjjm	5271	11	(	(	-LRB-
cord-023095-4dannjjm	5271	12	IO	IO	NNP
cord-023095-4dannjjm	5271	13	)	)	-RRB-
cord-023095-4dannjjm	5271	14	catheter	catheter	NN
cord-023095-4dannjjm	5271	15	insertions	insertion	NNS
cord-023095-4dannjjm	5271	16	,	,	,
cord-023095-4dannjjm	5271	17	insertion	insertion	NN
cord-023095-4dannjjm	5271	18	times	time	NNS
cord-023095-4dannjjm	5271	19	,	,	,
cord-023095-4dannjjm	5271	20	and	and	CC
cord-023095-4dannjjm	5271	21	'	'	''
cord-023095-4dannjjm	5271	22	'	'	''
cord-023095-4dannjjm	5271	23	ease	ease	NN
cord-023095-4dannjjm	5271	24	of	of	IN
cord-023095-4dannjjm	5271	25	use	use	NN
cord-023095-4dannjjm	5271	26	'	'	''
cord-023095-4dannjjm	5271	27	'	'	''
cord-023095-4dannjjm	5271	28	scores	score	NNS
cord-023095-4dannjjm	5271	29	using	use	VBG
cord-023095-4dannjjm	5271	30	the	the	DT
cord-023095-4dannjjm	5271	31	EZ	EZ	NNP
cord-023095-4dannjjm	5271	32	-	-	HYPH
cord-023095-4dannjjm	5271	33	IO	IO	NNP
cord-023095-4dannjjm	5271	34	G3	G3	NNP
cord-023095-4dannjjm	5271	35	power	power	NN
cord-023095-4dannjjm	5271	36	driver	driver	NN
cord-023095-4dannjjm	5271	37	to	to	IN
cord-023095-4dannjjm	5271	38	manual	manual	JJ
cord-023095-4dannjjm	5271	39	IO	IO	NNP
cord-023095-4dannjjm	5271	40	catheterization	catheterization	NN
cord-023095-4dannjjm	5271	41	in	in	IN
cord-023095-4dannjjm	5271	42	feline	feline	JJ
cord-023095-4dannjjm	5271	43	cadavers	cadaver	NNS
cord-023095-4dannjjm	5271	44	.	.	.
cord-023095-4dannjjm	5272	1	The	the	DT
cord-023095-4dannjjm	5272	2	IO	IO	NNP
cord-023095-4dannjjm	5272	3	catheter	catheter	NN
cord-023095-4dannjjm	5272	4	insertion	insertion	NN
cord-023095-4dannjjm	5272	5	time	time	NN
cord-023095-4dannjjm	5272	6	in	in	IN
cord-023095-4dannjjm	5272	7	cadavers	cadaver	NNS
cord-023095-4dannjjm	5272	8	using	use	VBG
cord-023095-4dannjjm	5272	9	the	the	DT
cord-023095-4dannjjm	5272	10	EZ	EZ	NNP
cord-023095-4dannjjm	5272	11	-	-	HYPH
cord-023095-4dannjjm	5272	12	IO	IO	NNP
cord-023095-4dannjjm	5272	13	G3	G3	NNP
cord-023095-4dannjjm	5272	14	device	device	NN
cord-023095-4dannjjm	5272	15	was	be	VBD
cord-023095-4dannjjm	5272	16	also	also	RB
cord-023095-4dannjjm	5272	17	compared	compare	VBN
cord-023095-4dannjjm	5272	18	to	to	IN
cord-023095-4dannjjm	5272	19	IV	IV	NNP
cord-023095-4dannjjm	5272	20	catheter	catheter	NN
cord-023095-4dannjjm	5272	21	insertion	insertion	NN
cord-023095-4dannjjm	5272	22	time	time	NN
cord-023095-4dannjjm	5272	23	in	in	IN
cord-023095-4dannjjm	5272	24	normovolemic	normovolemic	JJ
cord-023095-4dannjjm	5272	25	feline	feline	JJ
cord-023095-4dannjjm	5272	26	and	and	CC
cord-023095-4dannjjm	5272	27	canine	canine	JJ
cord-023095-4dannjjm	5272	28	patients	patient	NNS
cord-023095-4dannjjm	5272	29	.	.	.
cord-023095-4dannjjm	5273	1	After	after	IN
cord-023095-4dannjjm	5273	2	a	a	DT
cord-023095-4dannjjm	5273	3	purposely	purposely	RB
cord-023095-4dannjjm	5273	4	limited	limit	VBN
cord-023095-4dannjjm	5273	5	training	training	NN
cord-023095-4dannjjm	5273	6	period	period	NN
cord-023095-4dannjjm	5273	7	,	,	,
cord-023095-4dannjjm	5273	8	a	a	DT
cord-023095-4dannjjm	5273	9	preclinical	preclinical	JJ
cord-023095-4dannjjm	5273	10	veterinary	veterinary	JJ
cord-023095-4dannjjm	5273	11	student	student	NN
cord-023095-4dannjjm	5273	12	was	be	VBD
cord-023095-4dannjjm	5273	13	timed	time	VBN
cord-023095-4dannjjm	5273	14	and	and	CC
cord-023095-4dannjjm	5273	15	video	video	NN
cord-023095-4dannjjm	5273	16	-	-	HYPH
cord-023095-4dannjjm	5273	17	recorded	record	VBN
cord-023095-4dannjjm	5273	18	as	as	IN
cord-023095-4dannjjm	5273	19	she	-PRON-	PRP
cord-023095-4dannjjm	5273	20	performed	perform	VBD
cord-023095-4dannjjm	5273	21	20	20	CD
cord-023095-4dannjjm	5273	22	IO	io	NN
cord-023095-4dannjjm	5273	23	catheter	catheter	NN
cord-023095-4dannjjm	5273	24	placements	placement	NNS
cord-023095-4dannjjm	5273	25	in	in	IN
cord-023095-4dannjjm	5273	26	feline	feline	JJ
cord-023095-4dannjjm	5273	27	cadavers	cadaver	NNS
cord-023095-4dannjjm	5273	28	(	(	-LRB-
cord-023095-4dannjjm	5273	29	10	10	CD
cord-023095-4dannjjm	5273	30	IO	IO	NNP
cord-023095-4dannjjm	5273	31	insertions	insertion	NNS
cord-023095-4dannjjm	5273	32	by	by	IN
cord-023095-4dannjjm	5273	33	placing	place	VBG
cord-023095-4dannjjm	5273	34	an	an	DT
cord-023095-4dannjjm	5273	35	Illinois	Illinois	NNP
cord-023095-4dannjjm	5273	36	needle	needle	NN
cord-023095-4dannjjm	5273	37	manually	manually	RB
cord-023095-4dannjjm	5273	38	and	and	CC
cord-023095-4dannjjm	5273	39	10	10	CD
cord-023095-4dannjjm	5273	40	IO	IO	NNP
cord-023095-4dannjjm	5273	41	insertions	insertion	NNS
cord-023095-4dannjjm	5273	42	using	use	VBG
cord-023095-4dannjjm	5273	43	the	the	DT
cord-023095-4dannjjm	5273	44	EZ	EZ	NNP
cord-023095-4dannjjm	5273	45	-	-	HYPH
cord-023095-4dannjjm	5273	46	IO	IO	NNP
cord-023095-4dannjjm	5273	47	G3	G3	NNP
cord-023095-4dannjjm	5273	48	)	)	-RRB-
cord-023095-4dannjjm	5273	49	.	.	.
cord-023095-4dannjjm	5274	1	Order	order	NN
cord-023095-4dannjjm	5274	2	of	of	IN
cord-023095-4dannjjm	5274	3	technique	technique	NN
cord-023095-4dannjjm	5274	4	(	(	-LRB-
cord-023095-4dannjjm	5274	5	manual	manual	JJ
cord-023095-4dannjjm	5274	6	or	or	CC
cord-023095-4dannjjm	5274	7	EZ	EZ	NNP
cord-023095-4dannjjm	5274	8	-	-	HYPH
cord-023095-4dannjjm	5274	9	IO	IO	NNP
cord-023095-4dannjjm	5274	10	G3	G3	NNP
cord-023095-4dannjjm	5274	11	)	)	-RRB-
cord-023095-4dannjjm	5274	12	,	,	,
cord-023095-4dannjjm	5274	13	site	site	NN
cord-023095-4dannjjm	5274	14	of	of	IN
cord-023095-4dannjjm	5274	15	IO	IO	NNP
cord-023095-4dannjjm	5274	16	placement	placement	NN
cord-023095-4dannjjm	5274	17	(	(	-LRB-
cord-023095-4dannjjm	5274	18	proximal	proximal	JJ
cord-023095-4dannjjm	5274	19	humerus	humerus	NNP
cord-023095-4dannjjm	5274	20	or	or	CC
cord-023095-4dannjjm	5274	21	trochanteric	trochanteric	JJ
cord-023095-4dannjjm	5274	22	fossa	fossa	NN
cord-023095-4dannjjm	5274	23	of	of	IN
cord-023095-4dannjjm	5274	24	the	the	DT
cord-023095-4dannjjm	5274	25	femur	femur	NN
cord-023095-4dannjjm	5274	26	)	)	-RRB-
cord-023095-4dannjjm	5274	27	,	,	,
cord-023095-4dannjjm	5274	28	and	and	CC
cord-023095-4dannjjm	5274	29	side	side	NN
cord-023095-4dannjjm	5274	30	of	of	IN
cord-023095-4dannjjm	5274	31	cat	cat	NN
cord-023095-4dannjjm	5274	32	(	(	-LRB-
cord-023095-4dannjjm	5274	33	right	right	UH
cord-023095-4dannjjm	5274	34	or	or	CC
cord-023095-4dannjjm	5274	35	left	left	JJ
cord-023095-4dannjjm	5274	36	)	)	-RRB-
cord-023095-4dannjjm	5274	37	were	be	VBD
cord-023095-4dannjjm	5274	38	randomized	randomize	VBN
cord-023095-4dannjjm	5274	39	for	for	IN
cord-023095-4dannjjm	5274	40	each	each	DT
cord-023095-4dannjjm	5274	41	attempt	attempt	NN
cord-023095-4dannjjm	5274	42	.	.	.
cord-023095-4dannjjm	5275	1	When	when	WRB
cord-023095-4dannjjm	5275	2	using	use	VBG
cord-023095-4dannjjm	5275	3	the	the	DT
cord-023095-4dannjjm	5275	4	EZ	EZ	NNP
cord-023095-4dannjjm	5275	5	-	-	HYPH
cord-023095-4dannjjm	5275	6	IO	IO	NNP
cord-023095-4dannjjm	5275	7	G3	G3	NNP
cord-023095-4dannjjm	5275	8	,	,	,
cord-023095-4dannjjm	5275	9	a	a	DT
cord-023095-4dannjjm	5275	10	15	15	CD
cord-023095-4dannjjm	5275	11	gauge	gauge	NN
cord-023095-4dannjjm	5275	12	x	x	SYM
cord-023095-4dannjjm	5275	13	15	15	CD
cord-023095-4dannjjm	5275	14	mm	mm	NN
cord-023095-4dannjjm	5275	15	long	long	JJ
cord-023095-4dannjjm	5275	16	needle	needle	NN
cord-023095-4dannjjm	5275	17	and	and	CC
cord-023095-4dannjjm	5275	18	a	a	DT
cord-023095-4dannjjm	5275	19	15	15	CD
cord-023095-4dannjjm	5275	20	gauge	gauge	NN
cord-023095-4dannjjm	5275	21	x	x	SYM
cord-023095-4dannjjm	5275	22	25	25	CD
cord-023095-4dannjjm	5275	23	mm	mm	CD
cord-023095-4dannjjm	5275	24	needle	needle	NN
cord-023095-4dannjjm	5275	25	were	be	VBD
cord-023095-4dannjjm	5275	26	used	use	VBN
cord-023095-4dannjjm	5275	27	for	for	IN
cord-023095-4dannjjm	5275	28	IO	IO	NNP
cord-023095-4dannjjm	5275	29	catheter	catheter	NN
cord-023095-4dannjjm	5275	30	insertion	insertion	NN
cord-023095-4dannjjm	5275	31	in	in	IN
cord-023095-4dannjjm	5275	32	the	the	DT
cord-023095-4dannjjm	5275	33	humerus	humerus	NN
cord-023095-4dannjjm	5275	34	and	and	CC
cord-023095-4dannjjm	5275	35	femur	femur	NN
cord-023095-4dannjjm	5275	36	,	,	,
cord-023095-4dannjjm	5275	37	respectively	respectively	RB
cord-023095-4dannjjm	5275	38	.	.	.
cord-023095-4dannjjm	5276	1	After	after	IN
cord-023095-4dannjjm	5276	2	each	each	DT
cord-023095-4dannjjm	5276	3	attempt	attempt	NN
cord-023095-4dannjjm	5276	4	,	,	,
cord-023095-4dannjjm	5276	5	the	the	DT
cord-023095-4dannjjm	5276	6	student	student	NN
cord-023095-4dannjjm	5276	7	graded	grade	VBD
cord-023095-4dannjjm	5276	8	the	the	DT
cord-023095-4dannjjm	5276	9	'	'	''
cord-023095-4dannjjm	5276	10	'	'	''
cord-023095-4dannjjm	5276	11	ease	ease	NN
cord-023095-4dannjjm	5276	12	of	of	IN
cord-023095-4dannjjm	5276	13	use	use	NN
cord-023095-4dannjjm	5276	14	'	'	''
cord-023095-4dannjjm	5276	15	'	'	''
cord-023095-4dannjjm	5276	16	of	of	IN
cord-023095-4dannjjm	5276	17	each	each	DT
cord-023095-4dannjjm	5276	18	technique	technique	NN
cord-023095-4dannjjm	5276	19	on	on	IN
cord-023095-4dannjjm	5276	20	a	a	DT
cord-023095-4dannjjm	5276	21	visual	visual	JJ
cord-023095-4dannjjm	5276	22	analog	analog	NN
cord-023095-4dannjjm	5276	23	scale	scale	NN
cord-023095-4dannjjm	5276	24	(	(	-LRB-
cord-023095-4dannjjm	5276	25	VAS	VAS	NNP
cord-023095-4dannjjm	5276	26	)	)	-RRB-
cord-023095-4dannjjm	5276	27	that	that	WDT
cord-023095-4dannjjm	5276	28	was	be	VBD
cord-023095-4dannjjm	5276	29	converted	convert	VBN
cord-023095-4dannjjm	5276	30	to	to	IN
cord-023095-4dannjjm	5276	31	a	a	DT
cord-023095-4dannjjm	5276	32	5-point	5-point	CD
cord-023095-4dannjjm	5276	33	scale	scale	NN
cord-023095-4dannjjm	5276	34	.	.	.
cord-023095-4dannjjm	5277	1	Twenty	twenty	CD
cord-023095-4dannjjm	5277	2	-	-	HYPH
cord-023095-4dannjjm	5277	3	six	six	CD
cord-023095-4dannjjm	5277	4	IV	IV	NNP
cord-023095-4dannjjm	5277	5	catheter	catheter	NN
cord-023095-4dannjjm	5277	6	insertions	insertion	NNS
cord-023095-4dannjjm	5277	7	in	in	IN
cord-023095-4dannjjm	5277	8	normovolemic	normovolemic	JJ
cord-023095-4dannjjm	5277	9	feline	feline	JJ
cord-023095-4dannjjm	5277	10	and	and	CC
cord-023095-4dannjjm	5277	11	canine	canine	JJ
cord-023095-4dannjjm	5277	12	patients	patient	NNS
cord-023095-4dannjjm	5277	13	performed	perform	VBN
cord-023095-4dannjjm	5277	14	by	by	IN
cord-023095-4dannjjm	5277	15	Western	Western	NNP
cord-023095-4dannjjm	5277	16	College	College	NNP
cord-023095-4dannjjm	5277	17	of	of	IN
cord-023095-4dannjjm	5277	18	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	5277	19	Medicine	Medicine	NNP
cord-023095-4dannjjm	5277	20	(	(	-LRB-
cord-023095-4dannjjm	5277	21	WCVM	WCVM	NNP
cord-023095-4dannjjm	5277	22	)	)	-RRB-
cord-023095-4dannjjm	5277	23	Small	Small	NNP
cord-023095-4dannjjm	5277	24	Animal	Animal	NNP
cord-023095-4dannjjm	5277	25	Hospital	Hospital	NNP
cord-023095-4dannjjm	5277	26	personnel	personnel	NNS
cord-023095-4dannjjm	5277	27	(	(	-LRB-
cord-023095-4dannjjm	5277	28	6	6	CD
cord-023095-4dannjjm	5277	29	technicians	technician	NNS
cord-023095-4dannjjm	5277	30	,	,	,
cord-023095-4dannjjm	5277	31	16	16	CD
cord-023095-4dannjjm	5277	32	veterinary	veterinary	JJ
cord-023095-4dannjjm	5277	33	students	student	NNS
cord-023095-4dannjjm	5277	34	,	,	,
cord-023095-4dannjjm	5277	35	1	1	CD
cord-023095-4dannjjm	5277	36	intern	intern	NN
cord-023095-4dannjjm	5277	37	,	,	,
cord-023095-4dannjjm	5277	38	1	1	CD
cord-023095-4dannjjm	5277	39	resident	resident	NN
cord-023095-4dannjjm	5277	40	,	,	,
cord-023095-4dannjjm	5277	41	2	2	CD
cord-023095-4dannjjm	5277	42	clinicians	clinician	NNS
cord-023095-4dannjjm	5277	43	)	)	-RRB-
cord-023095-4dannjjm	5277	44	were	be	VBD
cord-023095-4dannjjm	5277	45	then	then	RB
cord-023095-4dannjjm	5277	46	timed	time	VBN
cord-023095-4dannjjm	5277	47	and	and	CC
cord-023095-4dannjjm	5277	48	compared	compare	VBN
cord-023095-4dannjjm	5277	49	to	to	IN
cord-023095-4dannjjm	5277	50	the	the	DT
cord-023095-4dannjjm	5277	51	student	student	NN
cord-023095-4dannjjm	5277	52	's	's	POS
cord-023095-4dannjjm	5277	53	mean	mean	JJ
cord-023095-4dannjjm	5277	54	IO	IO	NNP
cord-023095-4dannjjm	5277	55	catheter	catheter	NN
cord-023095-4dannjjm	5277	56	insertion	insertion	NN
cord-023095-4dannjjm	5277	57	time	time	NN
cord-023095-4dannjjm	5277	58	using	use	VBG
cord-023095-4dannjjm	5277	59	the	the	DT
cord-023095-4dannjjm	5277	60	EZ	EZ	NNP
cord-023095-4dannjjm	5277	61	-	-	HYPH
cord-023095-4dannjjm	5277	62	IO	IO	NNP
cord-023095-4dannjjm	5277	63	G3.Median	g3.median	JJ
cord-023095-4dannjjm	5277	64	IO	io	NN
cord-023095-4dannjjm	5277	65	catheter	catheter	NN
cord-023095-4dannjjm	5277	66	insertion	insertion	NN
cord-023095-4dannjjm	5277	67	times	time	NNS
cord-023095-4dannjjm	5277	68	for	for	IN
cord-023095-4dannjjm	5277	69	the	the	DT
cord-023095-4dannjjm	5277	70	2	2	CD
cord-023095-4dannjjm	5277	71	techniques	technique	NNS
cord-023095-4dannjjm	5277	72	were	be	VBD
cord-023095-4dannjjm	5277	73	significantly	significantly	RB
cord-023095-4dannjjm	5277	74	different	different	JJ
cord-023095-4dannjjm	5277	75	(	(	-LRB-
cord-023095-4dannjjm	5277	76	manual	manual	JJ
cord-023095-4dannjjm	5277	77	IO	IO	NNP
cord-023095-4dannjjm	5277	78	technique	technique	NN
cord-023095-4dannjjm	5277	79	24	24	CD
cord-023095-4dannjjm	5277	80	sec	sec	NNP
cord-023095-4dannjjm	5277	81	;	;	:
cord-023095-4dannjjm	5277	82	EZ	EZ	NNP
cord-023095-4dannjjm	5277	83	-	-	HYPH
cord-023095-4dannjjm	5277	84	IO	IO	NNP
cord-023095-4dannjjm	5277	85	G3	G3	NNP
cord-023095-4dannjjm	5277	86	5	5	CD
cord-023095-4dannjjm	5277	87	sec	sec	NNP
cord-023095-4dannjjm	5277	88	)	)	-RRB-
cord-023095-4dannjjm	5278	1	(	(	-LRB-
cord-023095-4dannjjm	5278	2	p	p	NN
cord-023095-4dannjjm	5278	3	o	o	CD
cord-023095-4dannjjm	5278	4	0.001	0.001	CD
cord-023095-4dannjjm	5278	5	)	)	-RRB-
cord-023095-4dannjjm	5278	6	;	;	:
cord-023095-4dannjjm	5278	7	the	the	DT
cord-023095-4dannjjm	5278	8	manual	manual	JJ
cord-023095-4dannjjm	5278	9	method	method	NN
cord-023095-4dannjjm	5278	10	took	take	VBD
cord-023095-4dannjjm	5278	11	48	48	CD
cord-023095-4dannjjm	5278	12	seconds	second	NNS
cord-023095-4dannjjm	5278	13	longer	long	JJR
cord-023095-4dannjjm	5278	14	(	(	-LRB-
cord-023095-4dannjjm	5278	15	95	95	CD
cord-023095-4dannjjm	5278	16	%	%	NN
cord-023095-4dannjjm	5278	17	confidence	confidence	NN
cord-023095-4dannjjm	5278	18	interval	interval	NN
cord-023095-4dannjjm	5278	19	of	of	IN
cord-023095-4dannjjm	5278	20	28	28	CD
cord-023095-4dannjjm	5278	21	to	to	TO
cord-023095-4dannjjm	5278	22	67	67	CD
cord-023095-4dannjjm	5278	23	seconds	second	NNS
cord-023095-4dannjjm	5278	24	)	)	-RRB-
cord-023095-4dannjjm	5278	25	than	than	IN
cord-023095-4dannjjm	5278	26	the	the	DT
cord-023095-4dannjjm	5278	27	EZ	EZ	NNP
cord-023095-4dannjjm	5278	28	-	-	HYPH
cord-023095-4dannjjm	5278	29	IO	IO	NNP
cord-023095-4dannjjm	5278	30	G3	G3	NNP
cord-023095-4dannjjm	5278	31	method	method	NN
cord-023095-4dannjjm	5278	32	.	.	.
cord-023095-4dannjjm	5279	1	Insertion	insertion	NN
cord-023095-4dannjjm	5279	2	time	time	NN
cord-023095-4dannjjm	5279	3	was	be	VBD
cord-023095-4dannjjm	5279	4	more	more	RBR
cord-023095-4dannjjm	5279	5	variable	variable	JJ
cord-023095-4dannjjm	5279	6	for	for	IN
cord-023095-4dannjjm	5279	7	the	the	DT
cord-023095-4dannjjm	5279	8	manual	manual	JJ
cord-023095-4dannjjm	5279	9	technique	technique	NN
cord-023095-4dannjjm	5279	10	than	than	IN
cord-023095-4dannjjm	5279	11	for	for	IN
cord-023095-4dannjjm	5279	12	the	the	DT
cord-023095-4dannjjm	5279	13	EZ	EZ	NNP
cord-023095-4dannjjm	5279	14	-	-	HYPH
cord-023095-4dannjjm	5279	15	IO	IO	NNP
cord-023095-4dannjjm	5279	16	G3	G3	NNP
cord-023095-4dannjjm	5279	17	.	.	.
cord-023095-4dannjjm	5280	1	Percentage	percentage	NN
cord-023095-4dannjjm	5280	2	of	of	IN
cord-023095-4dannjjm	5280	3	catheter	catheter	NN
cord-023095-4dannjjm	5280	4	'	'	''
cord-023095-4dannjjm	5280	5	'	'	''
cord-023095-4dannjjm	5280	6	slippage	slippage	NN
cord-023095-4dannjjm	5280	7	off	off	IN
cord-023095-4dannjjm	5280	8	the	the	DT
cord-023095-4dannjjm	5280	9	bone	bone	NN
cord-023095-4dannjjm	5280	10	'	'	''
cord-023095-4dannjjm	5280	11	'	'	''
cord-023095-4dannjjm	5280	12	and	and	CC
cord-023095-4dannjjm	5280	13	extravasation	extravasation	NN
cord-023095-4dannjjm	5280	14	around	around	IN
cord-023095-4dannjjm	5280	15	the	the	DT
cord-023095-4dannjjm	5280	16	inserted	insert	VBN
cord-023095-4dannjjm	5280	17	catheter	catheter	NN
cord-023095-4dannjjm	5280	18	were	be	VBD
cord-023095-4dannjjm	5280	19	significantly	significantly	RB
cord-023095-4dannjjm	5280	20	higher	high	JJR
cord-023095-4dannjjm	5280	21	for	for	IN
cord-023095-4dannjjm	5280	22	placement	placement	NN
cord-023095-4dannjjm	5280	23	of	of	IN
cord-023095-4dannjjm	5280	24	the	the	DT
cord-023095-4dannjjm	5280	25	manual	manual	JJ
cord-023095-4dannjjm	5280	26	IO	IO	NNP
cord-023095-4dannjjm	5280	27	catheter	catheter	NN
cord-023095-4dannjjm	5280	28	compared	compare	VBN
cord-023095-4dannjjm	5280	29	with	with	IN
cord-023095-4dannjjm	5280	30	placement	placement	NN
cord-023095-4dannjjm	5280	31	of	of	IN
cord-023095-4dannjjm	5280	32	the	the	DT
cord-023095-4dannjjm	5280	33	EZ	EZ	NNP
cord-023095-4dannjjm	5280	34	-	-	HYPH
cord-023095-4dannjjm	5280	35	IO	IO	NNP
cord-023095-4dannjjm	5280	36	G3	G3	NNP
cord-023095-4dannjjm	5280	37	catheter	catheter	NN
cord-023095-4dannjjm	5280	38	(	(	-LRB-
cord-023095-4dannjjm	5281	1	p	p	NN
cord-023095-4dannjjm	5281	2	o	o	NN
cord-023095-4dannjjm	5281	3	0.001	0.001	CD
cord-023095-4dannjjm	5281	4	)	)	-RRB-
cord-023095-4dannjjm	5281	5	.	.	.
cord-023095-4dannjjm	5282	1	Student	student	NN
cord-023095-4dannjjm	5282	2	's	's	POS
cord-023095-4dannjjm	5282	3	subjective	subjective	JJ
cord-023095-4dannjjm	5282	4	ratings	rating	NNS
cord-023095-4dannjjm	5282	5	were	be	VBD
cord-023095-4dannjjm	5282	6	more	more	RBR
cord-023095-4dannjjm	5282	7	favorable	favorable	JJ
cord-023095-4dannjjm	5282	8	and	and	CC
cord-023095-4dannjjm	5282	9	more	more	RBR
cord-023095-4dannjjm	5282	10	consistent	consistent	JJ
cord-023095-4dannjjm	5282	11	for	for	IN
cord-023095-4dannjjm	5282	12	the	the	DT
cord-023095-4dannjjm	5282	13	EZ	EZ	NNP
cord-023095-4dannjjm	5282	14	-	-	HYPH
cord-023095-4dannjjm	5282	15	IO	IO	NNP
cord-023095-4dannjjm	5282	16	G3	G3	NNP
cord-023095-4dannjjm	5282	17	technique	technique	NN
cord-023095-4dannjjm	5282	18	compared	compare	VBN
cord-023095-4dannjjm	5282	19	to	to	IN
cord-023095-4dannjjm	5282	20	the	the	DT
cord-023095-4dannjjm	5282	21	manual	manual	JJ
cord-023095-4dannjjm	5282	22	technique	technique	NN
cord-023095-4dannjjm	5282	23	for	for	IN
cord-023095-4dannjjm	5282	24	IO	IO	NNP
cord-023095-4dannjjm	5282	25	catheter	catheter	NN
cord-023095-4dannjjm	5282	26	insertion	insertion	NN
cord-023095-4dannjjm	5282	27	.	.	.
cord-023095-4dannjjm	5283	1	Compared	compare	VBN
cord-023095-4dannjjm	5283	2	to	to	IN
cord-023095-4dannjjm	5283	3	the	the	DT
cord-023095-4dannjjm	5283	4	mean	mean	JJ
cord-023095-4dannjjm	5283	5	insertion	insertion	NN
cord-023095-4dannjjm	5283	6	time	time	NN
cord-023095-4dannjjm	5283	7	for	for	IN
cord-023095-4dannjjm	5283	8	IV	IV	NNP
cord-023095-4dannjjm	5283	9	catheterization	catheterization	NN
cord-023095-4dannjjm	5283	10	in	in	IN
cord-023095-4dannjjm	5283	11	the	the	DT
cord-023095-4dannjjm	5283	12	WCVM	WCVM	NNP
cord-023095-4dannjjm	5283	13	Small	Small	NNP
cord-023095-4dannjjm	5283	14	Animal	Animal	NNP
cord-023095-4dannjjm	5283	15	Hospital	Hospital	NNP
cord-023095-4dannjjm	5283	16	,	,	,
cord-023095-4dannjjm	5283	17	IO	IO	NNP
cord-023095-4dannjjm	5283	18	catheter	catheter	NN
cord-023095-4dannjjm	5283	19	insertion	insertion	NN
cord-023095-4dannjjm	5283	20	by	by	IN
cord-023095-4dannjjm	5283	21	the	the	DT
cord-023095-4dannjjm	5283	22	student	student	NN
cord-023095-4dannjjm	5283	23	using	use	VBG
cord-023095-4dannjjm	5283	24	the	the	DT
cord-023095-4dannjjm	5283	25	EZ	EZ	NNP
cord-023095-4dannjjm	5283	26	-	-	HYPH
cord-023095-4dannjjm	5283	27	IO	IO	NNP
cord-023095-4dannjjm	5283	28	G3	G3	NNP
cord-023095-4dannjjm	5283	29	was	be	VBD
cord-023095-4dannjjm	5283	30	significantly	significantly	RB
cord-023095-4dannjjm	5283	31	faster	fast	JJR
cord-023095-4dannjjm	5284	1	(	(	-LRB-
cord-023095-4dannjjm	5284	2	IV	IV	NNP
cord-023095-4dannjjm	5284	3	catheter	catheter	NN
cord-023095-4dannjjm	5284	4	188	188	CD
cord-023095-4dannjjm	5284	5	sec	sec	NNP
cord-023095-4dannjjm	5285	1	;	;	:
cord-023095-4dannjjm	5285	2	EZ	EZ	NNP
cord-023095-4dannjjm	5285	3	-	-	HYPH
cord-023095-4dannjjm	5285	4	IO	IO	NNP
cord-023095-4dannjjm	5285	5	G3	G3	NNP
cord-023095-4dannjjm	5285	6	IO	IO	NNP
cord-023095-4dannjjm	5285	7	catheter	catheter	NN
cord-023095-4dannjjm	5285	8	7	7	CD
cord-023095-4dannjjm	5285	9	sec	sec	NNP
cord-023095-4dannjjm	5285	10	)	)	-RRB-
cord-023095-4dannjjm	5286	1	(	(	-LRB-
cord-023095-4dannjjm	5286	2	p	p	NN
cord-023095-4dannjjm	5286	3	o	o	CD
cord-023095-4dannjjm	5286	4	0.001	0.001	CD
cord-023095-4dannjjm	5286	5	)	)	-RRB-
cord-023095-4dannjjm	5286	6	.	.	.
cord-023095-4dannjjm	5287	1	Intraosseous	intraosseous	JJ
cord-023095-4dannjjm	5287	2	catheter	catheter	NN
cord-023095-4dannjjm	5287	3	insertion	insertion	NN
cord-023095-4dannjjm	5287	4	using	use	VBG
cord-023095-4dannjjm	5287	5	the	the	DT
cord-023095-4dannjjm	5287	6	EZ	EZ	NNP
cord-023095-4dannjjm	5287	7	-	-	HYPH
cord-023095-4dannjjm	5287	8	IO	IO	NNP
cord-023095-4dannjjm	5287	9	G3	G3	NNP
cord-023095-4dannjjm	5287	10	can	can	MD
cord-023095-4dannjjm	5287	11	be	be	VB
cord-023095-4dannjjm	5287	12	said	say	VBN
cord-023095-4dannjjm	5287	13	to	to	TO
cord-023095-4dannjjm	5287	14	be	be	VB
cord-023095-4dannjjm	5287	15	significantly	significantly	RB
cord-023095-4dannjjm	5287	16	faster	fast	JJR
cord-023095-4dannjjm	5287	17	,	,	,
cord-023095-4dannjjm	5287	18	less	less	RBR
cord-023095-4dannjjm	5287	19	traumatic	traumatic	JJ
cord-023095-4dannjjm	5287	20	,	,	,
cord-023095-4dannjjm	5287	21	more	more	JJR
cord-023095-4dannjjm	5287	22	user	user	NN
cord-023095-4dannjjm	5287	23	-	-	HYPH
cord-023095-4dannjjm	5287	24	friendly	friendly	JJ
cord-023095-4dannjjm	5287	25	,	,	,
cord-023095-4dannjjm	5287	26	and	and	CC
cord-023095-4dannjjm	5287	27	as	as	RB
cord-023095-4dannjjm	5287	28	effective	effective	JJ
cord-023095-4dannjjm	5287	29	as	as	IN
cord-023095-4dannjjm	5287	30	IO	IO	NNP
cord-023095-4dannjjm	5287	31	catheter	catheter	NN
cord-023095-4dannjjm	5287	32	placement	placement	NN
cord-023095-4dannjjm	5287	33	using	use	VBG
cord-023095-4dannjjm	5287	34	the	the	DT
cord-023095-4dannjjm	5287	35	manual	manual	JJ
cord-023095-4dannjjm	5287	36	technique	technique	NN
cord-023095-4dannjjm	5287	37	.	.	.
cord-023095-4dannjjm	5288	1	Vascular	vascular	JJ
cord-023095-4dannjjm	5288	2	access	access	NN
cord-023095-4dannjjm	5288	3	via	via	IN
cord-023095-4dannjjm	5288	4	IO	IO	NNP
cord-023095-4dannjjm	5288	5	catheter	catheter	NN
cord-023095-4dannjjm	5288	6	insertion	insertion	NN
cord-023095-4dannjjm	5288	7	using	use	VBG
cord-023095-4dannjjm	5288	8	the	the	DT
cord-023095-4dannjjm	5288	9	EZ	EZ	NNP
cord-023095-4dannjjm	5288	10	-	-	HYPH
cord-023095-4dannjjm	5288	11	IO	IO	NNP
cord-023095-4dannjjm	5288	12	G3	G3	NNP
cord-023095-4dannjjm	5288	13	device	device	NN
cord-023095-4dannjjm	5288	14	may	may	MD
cord-023095-4dannjjm	5288	15	be	be	VB
cord-023095-4dannjjm	5288	16	suggested	suggest	VBN
cord-023095-4dannjjm	5288	17	to	to	TO
cord-023095-4dannjjm	5288	18	be	be	VB
cord-023095-4dannjjm	5288	19	faster	fast	JJR
cord-023095-4dannjjm	5288	20	than	than	IN
cord-023095-4dannjjm	5288	21	IV	IV	NNP
cord-023095-4dannjjm	5288	22	catheter	catheter	NN
cord-023095-4dannjjm	5288	23	insertion	insertion	NN
cord-023095-4dannjjm	5288	24	.	.	.
cord-023095-4dannjjm	5289	1	Previously	previously	RB
cord-023095-4dannjjm	5289	2	presented	present	VBN
cord-023095-4dannjjm	5289	3	at	at	IN
cord-023095-4dannjjm	5289	4	the	the	DT
cord-023095-4dannjjm	5289	5	Western	Western	NNP
cord-023095-4dannjjm	5289	6	College	College	NNP
cord-023095-4dannjjm	5289	7	of	of	IN
cord-023095-4dannjjm	5289	8	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	5289	9	Medicine	Medicine	NNP
cord-023095-4dannjjm	5289	10	Undergraduate	Undergraduate	NNP
cord-023095-4dannjjm	5289	11	Poster	Poster	NNP
cord-023095-4dannjjm	5289	12	Competition	Competition	NNP
cord-023095-4dannjjm	5289	13	.	.	.
cord-023095-4dannjjm	5290	1	Computed	compute	VBN
cord-023095-4dannjjm	5290	2	tomography	tomography	NN
cord-023095-4dannjjm	5290	3	(	(	-LRB-
cord-023095-4dannjjm	5290	4	CT	CT	NNP
cord-023095-4dannjjm	5290	5	)	)	-RRB-
cord-023095-4dannjjm	5290	6	has	have	VBZ
cord-023095-4dannjjm	5290	7	been	be	VBN
cord-023095-4dannjjm	5290	8	widely	widely	RB
cord-023095-4dannjjm	5290	9	investigated	investigate	VBN
cord-023095-4dannjjm	5290	10	and	and	CC
cord-023095-4dannjjm	5290	11	applied	apply	VBD
cord-023095-4dannjjm	5290	12	as	as	IN
cord-023095-4dannjjm	5290	13	a	a	DT
cord-023095-4dannjjm	5290	14	means	means	NN
cord-023095-4dannjjm	5290	15	for	for	IN
cord-023095-4dannjjm	5290	16	non	non	JJ
cord-023095-4dannjjm	5290	17	-	-	JJ
cord-023095-4dannjjm	5290	18	invasive	invasive	JJ
cord-023095-4dannjjm	5290	19	quantitative	quantitative	JJ
cord-023095-4dannjjm	5290	20	bone	bone	NN
cord-023095-4dannjjm	5290	21	mineral	mineral	NN
cord-023095-4dannjjm	5290	22	determination	determination	NN
cord-023095-4dannjjm	5290	23	in	in	IN
cord-023095-4dannjjm	5290	24	human	human	JJ
cord-023095-4dannjjm	5290	25	medicine	medicine	NN
cord-023095-4dannjjm	5290	26	.	.	.
cord-023095-4dannjjm	5291	1	The	the	DT
cord-023095-4dannjjm	5291	2	aim	aim	NN
cord-023095-4dannjjm	5291	3	of	of	IN
cord-023095-4dannjjm	5291	4	this	this	DT
cord-023095-4dannjjm	5291	5	study	study	NN
cord-023095-4dannjjm	5291	6	was	be	VBD
cord-023095-4dannjjm	5291	7	to	to	TO
cord-023095-4dannjjm	5291	8	assess	assess	VB
cord-023095-4dannjjm	5291	9	age	age	NN
cord-023095-4dannjjm	5291	10	-	-	HYPH
cord-023095-4dannjjm	5291	11	related	relate	VBN
cord-023095-4dannjjm	5291	12	changes	change	NNS
cord-023095-4dannjjm	5291	13	and	and	CC
cord-023095-4dannjjm	5291	14	anatomic	anatomic	JJ
cord-023095-4dannjjm	5291	15	variation	variation	NN
cord-023095-4dannjjm	5291	16	in	in	IN
cord-023095-4dannjjm	5291	17	bone	bone	NN
cord-023095-4dannjjm	5291	18	mineral	mineral	NN
cord-023095-4dannjjm	5291	19	density	density	NN
cord-023095-4dannjjm	5291	20	(	(	-LRB-
cord-023095-4dannjjm	5291	21	BMD	BMD	NNP
cord-023095-4dannjjm	5291	22	)	)	-RRB-
cord-023095-4dannjjm	5291	23	using	use	VBG
cord-023095-4dannjjm	5291	24	quantitative	quantitative	JJ
cord-023095-4dannjjm	5291	25	CT	CT	NNP
cord-023095-4dannjjm	5291	26	in	in	IN
cord-023095-4dannjjm	5291	27	normal	normal	JJ
cord-023095-4dannjjm	5291	28	cats	cat	NNS
cord-023095-4dannjjm	5291	29	.	.	.
cord-023095-4dannjjm	5292	1	Seventeen	seventeen	CD
cord-023095-4dannjjm	5292	2	normal	normal	JJ
cord-023095-4dannjjm	5292	3	cats	cat	NNS
cord-023095-4dannjjm	5292	4	were	be	VBD
cord-023095-4dannjjm	5292	5	included	include	VBN
cord-023095-4dannjjm	5292	6	in	in	IN
cord-023095-4dannjjm	5292	7	this	this	DT
cord-023095-4dannjjm	5292	8	study	study	NN
cord-023095-4dannjjm	5292	9	and	and	CC
cord-023095-4dannjjm	5292	10	divided	divide	VBD
cord-023095-4dannjjm	5292	11	into	into	IN
cord-023095-4dannjjm	5292	12	the	the	DT
cord-023095-4dannjjm	5292	13	following	following	JJ
cord-023095-4dannjjm	5292	14	3	3	CD
cord-023095-4dannjjm	5292	15	age	age	NN
cord-023095-4dannjjm	5292	16	groups	group	NNS
cord-023095-4dannjjm	5292	17	:	:	:
cord-023095-4dannjjm	5293	1	o	o	NN
cord-023095-4dannjjm	5293	2	1	1	CD
cord-023095-4dannjjm	5293	3	year	year	NN
cord-023095-4dannjjm	5294	1	(	(	-LRB-
cord-023095-4dannjjm	5294	2	n	n	NN
cord-023095-4dannjjm	5294	3	5	5	CD
cord-023095-4dannjjm	5294	4	4	4	CD
cord-023095-4dannjjm	5294	5	)	)	-RRB-
cord-023095-4dannjjm	5294	6	;	;	:
cord-023095-4dannjjm	5294	7	2	2	CD
cord-023095-4dannjjm	5294	8	-	-	SYM
cord-023095-4dannjjm	5294	9	5	5	CD
cord-023095-4dannjjm	5294	10	years	year	NNS
cord-023095-4dannjjm	5294	11	(	(	-LRB-
cord-023095-4dannjjm	5294	12	n	n	NN
cord-023095-4dannjjm	5294	13	5	5	CD
cord-023095-4dannjjm	5294	14	10	10	CD
cord-023095-4dannjjm	5294	15	)	)	-RRB-
cord-023095-4dannjjm	5294	16	;	;	:
cord-023095-4dannjjm	5294	17	and	and	CC
cord-023095-4dannjjm	5294	18	4	4	CD
cord-023095-4dannjjm	5294	19	6	6	CD
cord-023095-4dannjjm	5294	20	years	year	NNS
cord-023095-4dannjjm	5294	21	(	(	-LRB-
cord-023095-4dannjjm	5294	22	n	n	NN
cord-023095-4dannjjm	5294	23	5	5	CD
cord-023095-4dannjjm	5294	24	3	3	CD
cord-023095-4dannjjm	5294	25	)	)	-RRB-
cord-023095-4dannjjm	5294	26	.	.	.
cord-023095-4dannjjm	5295	1	A	a	DT
cord-023095-4dannjjm	5295	2	computed	compute	VBN
cord-023095-4dannjjm	5295	3	tomographic	tomographic	NN
cord-023095-4dannjjm	5295	4	scan	scan	NN
cord-023095-4dannjjm	5295	5	of	of	IN
cord-023095-4dannjjm	5295	6	each	each	DT
cord-023095-4dannjjm	5295	7	vertebra	vertebra	NN
cord-023095-4dannjjm	5295	8	from	from	IN
cord-023095-4dannjjm	5295	9	the	the	DT
cord-023095-4dannjjm	5295	10	12	12	CD
cord-023095-4dannjjm	5295	11	th	th	XX
cord-023095-4dannjjm	5295	12	thoracic	thoracic	NN
cord-023095-4dannjjm	5295	13	to	to	IN
cord-023095-4dannjjm	5295	14	the	the	DT
cord-023095-4dannjjm	5295	15	7	7	CD
cord-023095-4dannjjm	5295	16	th	th	XX
cord-023095-4dannjjm	5295	17	lumbar	lumbar	NN
cord-023095-4dannjjm	5295	18	spine	spine	NN
cord-023095-4dannjjm	5295	19	,	,	,
cord-023095-4dannjjm	5295	20	and	and	CC
cord-023095-4dannjjm	5295	21	the	the	DT
cord-023095-4dannjjm	5295	22	pelvis	pelvi	NNS
cord-023095-4dannjjm	5295	23	,	,	,
cord-023095-4dannjjm	5295	24	was	be	VBD
cord-023095-4dannjjm	5295	25	performed	perform	VBN
cord-023095-4dannjjm	5295	26	with	with	IN
cord-023095-4dannjjm	5295	27	a	a	DT
cord-023095-4dannjjm	5295	28	bone	bone	NN
cord-023095-4dannjjm	5295	29	-	-	HYPH
cord-023095-4dannjjm	5295	30	density	density	NN
cord-023095-4dannjjm	5295	31	phantom	phantom	NN
cord-023095-4dannjjm	5295	32	(	(	-LRB-
cord-023095-4dannjjm	5295	33	50	50	CD
cord-023095-4dannjjm	5295	34	,	,	,
cord-023095-4dannjjm	5295	35	100	100	CD
cord-023095-4dannjjm	5295	36	,	,	,
cord-023095-4dannjjm	5295	37	and	and	CC
cord-023095-4dannjjm	5295	38	150	150	CD
cord-023095-4dannjjm	5295	39	mg	mg	NNP
cord-023095-4dannjjm	5295	40	/	/	SYM
cord-023095-4dannjjm	5295	41	cm	cm	NNP
cord-023095-4dannjjm	5295	42	3	3	CD
cord-023095-4dannjjm	5295	43	,	,	,
cord-023095-4dannjjm	5295	44	calcium	calcium	NN
cord-023095-4dannjjm	5295	45	hydroxyapatite	hydroxyapatite	NN
cord-023095-4dannjjm	5295	46	,	,	,
cord-023095-4dannjjm	5295	47	CIRS	CIRS	NNP
cord-023095-4dannjjm	5295	48	phantom	phantom	NNP
cord-023095-4dannjjm	5295	49	s	s	NNP
cord-023095-4dannjjm	5295	50	)	)	-RRB-
cord-023095-4dannjjm	5295	51	.	.	.
cord-023095-4dannjjm	5296	1	On	on	IN
cord-023095-4dannjjm	5296	2	the	the	DT
cord-023095-4dannjjm	5296	3	central	central	JJ
cord-023095-4dannjjm	5296	4	transverse	transverse	JJ
cord-023095-4dannjjm	5296	5	section	section	NN
cord-023095-4dannjjm	5296	6	,	,	,
cord-023095-4dannjjm	5296	7	the	the	DT
cord-023095-4dannjjm	5296	8	elliptical	elliptical	JJ
cord-023095-4dannjjm	5296	9	region	region	NN
cord-023095-4dannjjm	5296	10	of	of	IN
cord-023095-4dannjjm	5296	11	interest	interest	NN
cord-023095-4dannjjm	5296	12	(	(	-LRB-
cord-023095-4dannjjm	5296	13	ROI	ROI	NNP
cord-023095-4dannjjm	5296	14	)	)	-RRB-
cord-023095-4dannjjm	5296	15	was	be	VBD
cord-023095-4dannjjm	5296	16	drawn	draw	VBN
cord-023095-4dannjjm	5296	17	to	to	TO
cord-023095-4dannjjm	5296	18	measure	measure	VB
cord-023095-4dannjjm	5296	19	the	the	DT
cord-023095-4dannjjm	5296	20	mean	mean	JJ
cord-023095-4dannjjm	5296	21	Hounsfield	Hounsfield	NNP
cord-023095-4dannjjm	5296	22	unit	unit	NN
cord-023095-4dannjjm	5296	23	value	value	NN
cord-023095-4dannjjm	5296	24	.	.	.
cord-023095-4dannjjm	5297	1	Those	those	DT
cord-023095-4dannjjm	5297	2	values	value	NNS
cord-023095-4dannjjm	5297	3	were	be	VBD
cord-023095-4dannjjm	5297	4	converted	convert	VBN
cord-023095-4dannjjm	5297	5	to	to	IN
cord-023095-4dannjjm	5297	6	equivalent	equivalent	JJ
cord-023095-4dannjjm	5297	7	BMD	bmd	NN
cord-023095-4dannjjm	5297	8	by	by	IN
cord-023095-4dannjjm	5297	9	use	use	NN
cord-023095-4dannjjm	5297	10	of	of	IN
cord-023095-4dannjjm	5297	11	the	the	DT
cord-023095-4dannjjm	5297	12	bone	bone	NN
cord-023095-4dannjjm	5297	13	-	-	HYPH
cord-023095-4dannjjm	5297	14	density	density	NN
cord-023095-4dannjjm	5297	15	phantom	phantom	NN
cord-023095-4dannjjm	5297	16	and	and	CC
cord-023095-4dannjjm	5297	17	linear	linear	JJ
cord-023095-4dannjjm	5297	18	regression	regression	NN
cord-023095-4dannjjm	5297	19	analysis	analysis	NN
cord-023095-4dannjjm	5297	20	(	(	-LRB-
cord-023095-4dannjjm	5297	21	r	r	NN
cord-023095-4dannjjm	5297	22	2	2	CD
cord-023095-4dannjjm	5297	23	4	4	CD
cord-023095-4dannjjm	5297	24	0.95	0.95	CD
cord-023095-4dannjjm	5297	25	)	)	-RRB-
cord-023095-4dannjjm	5297	26	.	.	.
cord-023095-4dannjjm	5298	1	The	the	DT
cord-023095-4dannjjm	5298	2	mean	mean	JJ
cord-023095-4dannjjm	5298	3	BMD	bmd	NN
cord-023095-4dannjjm	5298	4	value	value	NN
cord-023095-4dannjjm	5298	5	of	of	IN
cord-023095-4dannjjm	5298	6	the	the	DT
cord-023095-4dannjjm	5298	7	thoracic	thoracic	JJ
cord-023095-4dannjjm	5298	8	vertebrae	vertebrae	NN
cord-023095-4dannjjm	5298	9	(	(	-LRB-
cord-023095-4dannjjm	5298	10	651.3	651.3	CD
cord-023095-4dannjjm	5298	11	AE	AE	NNP
cord-023095-4dannjjm	5298	12	100.4	100.4	CD
cord-023095-4dannjjm	5298	13	mg	mg	NNP
cord-023095-4dannjjm	5298	14	/	/	SYM
cord-023095-4dannjjm	5298	15	cm	cm	NNP
cord-023095-4dannjjm	5298	16	3	3	CD
cord-023095-4dannjjm	5298	17	)	)	-RRB-
cord-023095-4dannjjm	5298	18	was	be	VBD
cord-023095-4dannjjm	5298	19	significantly	significantly	RB
cord-023095-4dannjjm	5298	20	higher	high	JJR
cord-023095-4dannjjm	5298	21	than	than	IN
cord-023095-4dannjjm	5298	22	of	of	IN
cord-023095-4dannjjm	5298	23	the	the	DT
cord-023095-4dannjjm	5298	24	lumbar	lumbar	JJ
cord-023095-4dannjjm	5298	25	vertebrae	vertebrae	NN
cord-023095-4dannjjm	5298	26	(	(	-LRB-
cord-023095-4dannjjm	5298	27	520	520	CD
cord-023095-4dannjjm	5298	28	AE	AE	NNP
cord-023095-4dannjjm	5298	29	119.5	119.5	CD
cord-023095-4dannjjm	5298	30	mg	mg	NNP
cord-023095-4dannjjm	5298	31	/	/	SYM
cord-023095-4dannjjm	5298	32	cm	cm	NNP
cord-023095-4dannjjm	5298	33	3	3	CD
cord-023095-4dannjjm	5298	34	)	)	-RRB-
cord-023095-4dannjjm	5298	35	.	.	.
cord-023095-4dannjjm	5299	1	The	the	DT
cord-023095-4dannjjm	5299	2	maximum	maximum	JJ
cord-023095-4dannjjm	5299	3	BMD	bmd	NN
cord-023095-4dannjjm	5299	4	occurred	occur	VBD
cord-023095-4dannjjm	5299	5	at	at	IN
cord-023095-4dannjjm	5299	6	the	the	DT
cord-023095-4dannjjm	5299	7	T12	T12	NNP
cord-023095-4dannjjm	5299	8	,	,	,
cord-023095-4dannjjm	5299	9	T13	T13	NNP
cord-023095-4dannjjm	5299	10	,	,	,
cord-023095-4dannjjm	5299	11	and	and	CC
cord-023095-4dannjjm	5299	12	L1	L1	NNP
cord-023095-4dannjjm	5299	13	levels	level	NNS
cord-023095-4dannjjm	5299	14	in	in	IN
cord-023095-4dannjjm	5299	15	all	all	DT
cord-023095-4dannjjm	5299	16	age	age	NN
cord-023095-4dannjjm	5299	17	groups	group	NNS
cord-023095-4dannjjm	5299	18	.	.	.
cord-023095-4dannjjm	5300	1	There	there	EX
cord-023095-4dannjjm	5300	2	was	be	VBD
cord-023095-4dannjjm	5300	3	a	a	DT
cord-023095-4dannjjm	5300	4	statistically	statistically	RB
cord-023095-4dannjjm	5300	5	significant	significant	JJ
cord-023095-4dannjjm	5300	6	difference	difference	NN
cord-023095-4dannjjm	5300	7	in	in	IN
cord-023095-4dannjjm	5300	8	the	the	DT
cord-023095-4dannjjm	5300	9	mean	mean	JJ
cord-023095-4dannjjm	5300	10	BMD	bmd	NN
cord-023095-4dannjjm	5300	11	value	value	NN
cord-023095-4dannjjm	5300	12	among	among	IN
cord-023095-4dannjjm	5300	13	the	the	DT
cord-023095-4dannjjm	5300	14	3	3	CD
cord-023095-4dannjjm	5300	15	age	age	NN
cord-023095-4dannjjm	5300	16	groups	group	NNS
cord-023095-4dannjjm	5300	17	at	at	IN
cord-023095-4dannjjm	5300	18	the	the	DT
cord-023095-4dannjjm	5300	19	T12	T12	NNP
cord-023095-4dannjjm	5301	1	(	(	-LRB-
cord-023095-4dannjjm	5301	2	P	p	NN
cord-023095-4dannjjm	5301	3	o	o	NN
cord-023095-4dannjjm	5301	4	0.001	0.001	CD
cord-023095-4dannjjm	5301	5	)	)	-RRB-
cord-023095-4dannjjm	5301	6	,	,	,
cord-023095-4dannjjm	5301	7	T13	T13	NNP
cord-023095-4dannjjm	5301	8	(	(	-LRB-
cord-023095-4dannjjm	5301	9	P	p	NN
cord-023095-4dannjjm	5301	10	o	o	NN
cord-023095-4dannjjm	5301	11	0.001	0.001	CD
cord-023095-4dannjjm	5301	12	)	)	-RRB-
cord-023095-4dannjjm	5301	13	,	,	,
cord-023095-4dannjjm	5301	14	and	and	CC
cord-023095-4dannjjm	5301	15	L4	l4	NN
cord-023095-4dannjjm	5301	16	levels	level	NNS
cord-023095-4dannjjm	5301	17	(	(	-LRB-
cord-023095-4dannjjm	5301	18	P	p	NN
cord-023095-4dannjjm	5301	19	5	5	CD
cord-023095-4dannjjm	5301	20	0.013	0.013	CD
cord-023095-4dannjjm	5301	21	)	)	-RRB-
cord-023095-4dannjjm	5301	22	,	,	,
cord-023095-4dannjjm	5301	23	respectively	respectively	RB
cord-023095-4dannjjm	5301	24	.	.	.
cord-023095-4dannjjm	5302	1	In	in	IN
cord-023095-4dannjjm	5302	2	addition	addition	NN
cord-023095-4dannjjm	5302	3	,	,	,
cord-023095-4dannjjm	5302	4	there	there	EX
cord-023095-4dannjjm	5302	5	was	be	VBD
cord-023095-4dannjjm	5302	6	no	no	DT
cord-023095-4dannjjm	5302	7	significant	significant	JJ
cord-023095-4dannjjm	5302	8	difference	difference	NN
cord-023095-4dannjjm	5302	9	between	between	IN
cord-023095-4dannjjm	5302	10	the	the	DT
cord-023095-4dannjjm	5302	11	mean	mean	JJ
cord-023095-4dannjjm	5302	12	BMD	BMD	NNP
cord-023095-4dannjjm	5302	13	value	value	NN
cord-023095-4dannjjm	5302	14	of	of	IN
cord-023095-4dannjjm	5302	15	the	the	DT
cord-023095-4dannjjm	5302	16	left	left	JJ
cord-023095-4dannjjm	5302	17	and	and	CC
cord-023095-4dannjjm	5302	18	right	right	JJ
cord-023095-4dannjjm	5302	19	iliac	iliac	JJ
cord-023095-4dannjjm	5302	20	bodies	body	NNS
cord-023095-4dannjjm	5302	21	(	(	-LRB-
cord-023095-4dannjjm	5302	22	485.1	485.1	CD
cord-023095-4dannjjm	5302	23	AE	AE	NNP
cord-023095-4dannjjm	5302	24	140.4	140.4	CD
cord-023095-4dannjjm	5302	25	mg	mg	NNP
cord-023095-4dannjjm	5302	26	/	/	SYM
cord-023095-4dannjjm	5302	27	cm	cm	NNP
cord-023095-4dannjjm	5302	28	3	3	CD
cord-023095-4dannjjm	5302	29	and	and	CC
cord-023095-4dannjjm	5302	30	482.1	482.1	CD
cord-023095-4dannjjm	5302	31	AE	AE	NNP
cord-023095-4dannjjm	5303	1	148.2	148.2	CD
cord-023095-4dannjjm	5304	1	mg	mg	NNP
cord-023095-4dannjjm	5304	2	/	/	SYM
cord-023095-4dannjjm	5304	3	cm	cm	NNP
cord-023095-4dannjjm	5304	4	3	3	CD
cord-023095-4dannjjm	5304	5	,	,	,
cord-023095-4dannjjm	5304	6	respectively	respectively	RB
cord-023095-4dannjjm	5304	7	)	)	-RRB-
cord-023095-4dannjjm	5304	8	.	.	.
cord-023095-4dannjjm	5305	1	The	the	DT
cord-023095-4dannjjm	5305	2	present	present	JJ
cord-023095-4dannjjm	5305	3	study	study	NN
cord-023095-4dannjjm	5305	4	suggests	suggest	VBZ
cord-023095-4dannjjm	5305	5	that	that	IN
cord-023095-4dannjjm	5305	6	age	age	NN
cord-023095-4dannjjm	5305	7	-	-	HYPH
cord-023095-4dannjjm	5305	8	related	relate	VBN
cord-023095-4dannjjm	5305	9	changes	change	NNS
cord-023095-4dannjjm	5305	10	and	and	CC
cord-023095-4dannjjm	5305	11	anatomic	anatomic	JJ
cord-023095-4dannjjm	5305	12	variation	variation	NN
cord-023095-4dannjjm	5305	13	in	in	IN
cord-023095-4dannjjm	5305	14	BMD	bmd	NN
cord-023095-4dannjjm	5305	15	values	value	NNS
cord-023095-4dannjjm	5305	16	should	should	MD
cord-023095-4dannjjm	5305	17	be	be	VB
cord-023095-4dannjjm	5305	18	considered	consider	VBN
cord-023095-4dannjjm	5305	19	when	when	WRB
cord-023095-4dannjjm	5305	20	assessing	assess	VBG
cord-023095-4dannjjm	5305	21	BMD	bmd	NN
cord-023095-4dannjjm	5305	22	using	use	VBG
cord-023095-4dannjjm	5305	23	quantitative	quantitative	JJ
cord-023095-4dannjjm	5305	24	CT	CT	NNP
cord-023095-4dannjjm	5305	25	in	in	IN
cord-023095-4dannjjm	5305	26	cats	cat	NNS
cord-023095-4dannjjm	5305	27	with	with	IN
cord-023095-4dannjjm	5305	28	bone	bone	NN
cord-023095-4dannjjm	5305	29	disorders	disorder	NNS
cord-023095-4dannjjm	5305	30	.	.	.
cord-023095-4dannjjm	5306	1	Dynamic	dynamic	JJ
cord-023095-4dannjjm	5306	2	contrast	contrast	NN
cord-023095-4dannjjm	5306	3	-	-	HYPH
cord-023095-4dannjjm	5306	4	enhanced	enhance	VBN
cord-023095-4dannjjm	5306	5	computed	compute	VBN
cord-023095-4dannjjm	5306	6	tomography	tomography	NN
cord-023095-4dannjjm	5306	7	(	(	-LRB-
cord-023095-4dannjjm	5306	8	DCE	DCE	NNP
cord-023095-4dannjjm	5306	9	-	-	HYPH
cord-023095-4dannjjm	5306	10	CT	CT	NNP
cord-023095-4dannjjm	5306	11	)	)	-RRB-
cord-023095-4dannjjm	5306	12	is	be	VBZ
cord-023095-4dannjjm	5306	13	a	a	DT
cord-023095-4dannjjm	5306	14	rapid	rapid	JJ
cord-023095-4dannjjm	5306	15	and	and	CC
cord-023095-4dannjjm	5306	16	widely	widely	RB
cord-023095-4dannjjm	5306	17	available	available	JJ
cord-023095-4dannjjm	5306	18	method	method	NN
cord-023095-4dannjjm	5306	19	of	of	IN
cord-023095-4dannjjm	5306	20	cerebral	cerebral	JJ
cord-023095-4dannjjm	5306	21	perfusion	perfusion	NN
cord-023095-4dannjjm	5306	22	imaging	imaging	NN
cord-023095-4dannjjm	5306	23	.	.	.
cord-023095-4dannjjm	5307	1	However	however	RB
cord-023095-4dannjjm	5307	2	,	,	,
cord-023095-4dannjjm	5307	3	there	there	EX
cord-023095-4dannjjm	5307	4	is	be	VBZ
cord-023095-4dannjjm	5307	5	no	no	DT
cord-023095-4dannjjm	5307	6	established	establish	VBN
cord-023095-4dannjjm	5307	7	reference	reference	NN
cord-023095-4dannjjm	5307	8	value	value	NN
cord-023095-4dannjjm	5307	9	of	of	IN
cord-023095-4dannjjm	5307	10	cerebral	cerebral	JJ
cord-023095-4dannjjm	5307	11	blood	blood	NN
cord-023095-4dannjjm	5307	12	flow	flow	NN
cord-023095-4dannjjm	5307	13	(	(	-LRB-
cord-023095-4dannjjm	5307	14	CBF	CBF	NNP
cord-023095-4dannjjm	5307	15	)	)	-RRB-
cord-023095-4dannjjm	5307	16	measured	measure	VBN
cord-023095-4dannjjm	5307	17	by	by	IN
cord-023095-4dannjjm	5307	18	DCE	DCE	NNP
cord-023095-4dannjjm	5307	19	-	-	HYPH
cord-023095-4dannjjm	5307	20	CT	CT	NNP
cord-023095-4dannjjm	5307	21	according	accord	VBG
cord-023095-4dannjjm	5307	22	to	to	IN
cord-023095-4dannjjm	5307	23	a	a	DT
cord-023095-4dannjjm	5307	24	dog	dog	NN
cord-023095-4dannjjm	5307	25	's	's	POS
cord-023095-4dannjjm	5307	26	age	age	NN
cord-023095-4dannjjm	5307	27	.	.	.
cord-023095-4dannjjm	5308	1	The	the	DT
cord-023095-4dannjjm	5308	2	purpose	purpose	NN
cord-023095-4dannjjm	5308	3	of	of	IN
cord-023095-4dannjjm	5308	4	this	this	DT
cord-023095-4dannjjm	5308	5	study	study	NN
cord-023095-4dannjjm	5308	6	was	be	VBD
cord-023095-4dannjjm	5308	7	to	to	TO
cord-023095-4dannjjm	5308	8	identify	identify	VB
cord-023095-4dannjjm	5308	9	the	the	DT
cord-023095-4dannjjm	5308	10	correlation	correlation	NN
cord-023095-4dannjjm	5308	11	between	between	IN
cord-023095-4dannjjm	5308	12	regional	regional	JJ
cord-023095-4dannjjm	5308	13	CBF	CBF	NNP
cord-023095-4dannjjm	5308	14	and	and	CC
cord-023095-4dannjjm	5308	15	aging	age	VBG
cord-023095-4dannjjm	5308	16	in	in	IN
cord-023095-4dannjjm	5308	17	clinically	clinically	RB
cord-023095-4dannjjm	5308	18	normal	normal	JJ
cord-023095-4dannjjm	5308	19	dogs	dog	NNS
cord-023095-4dannjjm	5308	20	using	use	VBG
cord-023095-4dannjjm	5308	21	DCE	DCE	NNP
cord-023095-4dannjjm	5308	22	-	-	HYPH
cord-023095-4dannjjm	5308	23	CT	CT	NNP
cord-023095-4dannjjm	5308	24	.	.	.
cord-023095-4dannjjm	5309	1	Fourteen	fourteen	CD
cord-023095-4dannjjm	5309	2	dogs	dog	NNS
cord-023095-4dannjjm	5309	3	with	with	IN
cord-023095-4dannjjm	5309	4	no	no	DT
cord-023095-4dannjjm	5309	5	evidence	evidence	NN
cord-023095-4dannjjm	5309	6	of	of	IN
cord-023095-4dannjjm	5309	7	hemodynamic	hemodynamic	JJ
cord-023095-4dannjjm	5309	8	disorders	disorder	NNS
cord-023095-4dannjjm	5309	9	and	and	CC
cord-023095-4dannjjm	5309	10	central	central	JJ
cord-023095-4dannjjm	5309	11	nervous	nervous	JJ
cord-023095-4dannjjm	5309	12	system	system	NN
cord-023095-4dannjjm	5309	13	dysfunction	dysfunction	NN
cord-023095-4dannjjm	5309	14	were	be	VBD
cord-023095-4dannjjm	5309	15	included	include	VBN
cord-023095-4dannjjm	5309	16	in	in	IN
cord-023095-4dannjjm	5309	17	this	this	DT
cord-023095-4dannjjm	5309	18	study	study	NN
cord-023095-4dannjjm	5309	19	.	.	.
cord-023095-4dannjjm	5310	1	Dogs	dog	NNS
cord-023095-4dannjjm	5310	2	were	be	VBD
cord-023095-4dannjjm	5310	3	assigned	assign	VBN
cord-023095-4dannjjm	5310	4	to	to	IN
cord-023095-4dannjjm	5310	5	the	the	DT
cord-023095-4dannjjm	5310	6	following	following	JJ
cord-023095-4dannjjm	5310	7	3	3	CD
cord-023095-4dannjjm	5310	8	age	age	NN
cord-023095-4dannjjm	5310	9	groups	group	NNS
cord-023095-4dannjjm	5310	10	:	:	:
cord-023095-4dannjjm	5311	1	o	o	NN
cord-023095-4dannjjm	5311	2	1	1	CD
cord-023095-4dannjjm	5311	3	year	year	NN
cord-023095-4dannjjm	5311	4	(	(	-LRB-
cord-023095-4dannjjm	5311	5	group	group	NN
cord-023095-4dannjjm	5311	6	1	1	CD
cord-023095-4dannjjm	5311	7	)	)	-RRB-
cord-023095-4dannjjm	5311	8	;	;	:
cord-023095-4dannjjm	5311	9	3	3	CD
cord-023095-4dannjjm	5311	10	-	-	SYM
cord-023095-4dannjjm	5311	11	6	6	CD
cord-023095-4dannjjm	5311	12	years	year	NNS
cord-023095-4dannjjm	5311	13	(	(	-LRB-
cord-023095-4dannjjm	5311	14	group	group	NN
cord-023095-4dannjjm	5311	15	2	2	CD
cord-023095-4dannjjm	5311	16	)	)	-RRB-
cord-023095-4dannjjm	5311	17	;	;	:
cord-023095-4dannjjm	5311	18	and	and	CC
cord-023095-4dannjjm	5311	19	o	o	NN
cord-023095-4dannjjm	5311	20	10	10	CD
cord-023095-4dannjjm	5311	21	years	year	NNS
cord-023095-4dannjjm	5311	22	(	(	-LRB-
cord-023095-4dannjjm	5311	23	group	group	NN
cord-023095-4dannjjm	5311	24	3	3	CD
cord-023095-4dannjjm	5311	25	)	)	-RRB-
cord-023095-4dannjjm	5311	26	.	.	.
cord-023095-4dannjjm	5312	1	DCE	DCE	NNP
cord-023095-4dannjjm	5312	2	-	-	HYPH
cord-023095-4dannjjm	5312	3	CT	CT	NNP
cord-023095-4dannjjm	5312	4	scans	scan	NNS
cord-023095-4dannjjm	5312	5	were	be	VBD
cord-023095-4dannjjm	5312	6	performed	perform	VBN
cord-023095-4dannjjm	5312	7	at	at	IN
cord-023095-4dannjjm	5312	8	the	the	DT
cord-023095-4dannjjm	5312	9	level	level	NN
cord-023095-4dannjjm	5312	10	of	of	IN
cord-023095-4dannjjm	5312	11	the	the	DT
cord-023095-4dannjjm	5312	12	third	third	JJ
cord-023095-4dannjjm	5312	13	ventricle	ventricle	NN
cord-023095-4dannjjm	5312	14	and	and	CC
cord-023095-4dannjjm	5312	15	mesencephalic	mesencephalic	NNP
cord-023095-4dannjjm	5312	16	aqueduct	aqueduct	NNP
cord-023095-4dannjjm	5312	17	.	.	.
cord-023095-4dannjjm	5313	1	CBF	CBF	NNP
cord-023095-4dannjjm	5313	2	in	in	IN
cord-023095-4dannjjm	5313	3	the	the	DT
cord-023095-4dannjjm	5313	4	gray	gray	JJ
cord-023095-4dannjjm	5313	5	and	and	CC
cord-023095-4dannjjm	5313	6	white	white	JJ
cord-023095-4dannjjm	5313	7	matter	matter	NN
cord-023095-4dannjjm	5313	8	was	be	VBD
cord-023095-4dannjjm	5313	9	calculated	calculate	VBN
cord-023095-4dannjjm	5313	10	using	use	VBG
cord-023095-4dannjjm	5313	11	STROKETOOL	STROKETOOL	NNP
cord-023095-4dannjjm	5313	12	-	-	HYPH
cord-023095-4dannjjm	5313	13	CT	CT	NNP
cord-023095-4dannjjm	5313	14	s	s	NNP
cord-023095-4dannjjm	5313	15	software	software	NN
cord-023095-4dannjjm	5313	16	.	.	.
cord-023095-4dannjjm	5314	1	The	the	DT
cord-023095-4dannjjm	5314	2	overall	overall	JJ
cord-023095-4dannjjm	5314	3	mean	mean	JJ
cord-023095-4dannjjm	5314	4	AE	AE	NNP
cord-023095-4dannjjm	5314	5	standard	standard	JJ
cord-023095-4dannjjm	5314	6	deviation	deviation	NN
cord-023095-4dannjjm	5314	7	quantitative	quantitative	JJ
cord-023095-4dannjjm	5314	8	estimate	estimate	NN
cord-023095-4dannjjm	5314	9	for	for	IN
cord-023095-4dannjjm	5314	10	regional	regional	JJ
cord-023095-4dannjjm	5314	11	CBF	cbf	NN
cord-023095-4dannjjm	5314	12	in	in	IN
cord-023095-4dannjjm	5314	13	clinically	clinically	RB
cord-023095-4dannjjm	5314	14	normal	normal	JJ
cord-023095-4dannjjm	5314	15	dogs	dog	NNS
cord-023095-4dannjjm	5314	16	was	be	VBD
cord-023095-4dannjjm	5314	17	67.8	67.8	CD
cord-023095-4dannjjm	5314	18	AE	AE	NNP
cord-023095-4dannjjm	5314	19	12.9	12.9	CD
cord-023095-4dannjjm	5314	20	ml	ml	NNS
cord-023095-4dannjjm	5314	21	/	/	SYM
cord-023095-4dannjjm	5314	22	min/	min/	NNP
cord-023095-4dannjjm	5314	23	100	100	CD
cord-023095-4dannjjm	5314	24	g	g	NN
cord-023095-4dannjjm	5314	25	,	,	,
cord-023095-4dannjjm	5314	26	44.7	44.7	CD
cord-023095-4dannjjm	5314	27	AE	AE	NNP
cord-023095-4dannjjm	5314	28	4.1	4.1	CD
cord-023095-4dannjjm	5314	29	ml	ml	NNS
cord-023095-4dannjjm	5314	30	/	/	SYM
cord-023095-4dannjjm	5314	31	min/100	min/100	NNS
cord-023095-4dannjjm	5314	32	g	g	NN
cord-023095-4dannjjm	5314	33	,	,	,
cord-023095-4dannjjm	5314	34	and	and	CC
cord-023095-4dannjjm	5314	35	31.0	31.0	CD
cord-023095-4dannjjm	5314	36	AE	AE	NNP
cord-023095-4dannjjm	5314	37	3.4	3.4	CD
cord-023095-4dannjjm	5314	38	ml	ml	NNS
cord-023095-4dannjjm	5314	39	/	/	SYM
cord-023095-4dannjjm	5314	40	min/100	min/100	NNS
cord-023095-4dannjjm	5314	41	g	g	NN
cord-023095-4dannjjm	5314	42	in	in	IN
cord-023095-4dannjjm	5314	43	groups	group	NNS
cord-023095-4dannjjm	5314	44	1	1	CD
cord-023095-4dannjjm	5314	45	,	,	,
cord-023095-4dannjjm	5314	46	2	2	CD
cord-023095-4dannjjm	5314	47	,	,	,
cord-023095-4dannjjm	5314	48	and	and	CC
cord-023095-4dannjjm	5314	49	3	3	CD
cord-023095-4dannjjm	5314	50	,	,	,
cord-023095-4dannjjm	5314	51	respectively	respectively	RB
cord-023095-4dannjjm	5314	52	.	.	.
cord-023095-4dannjjm	5315	1	There	there	EX
cord-023095-4dannjjm	5315	2	was	be	VBD
cord-023095-4dannjjm	5315	3	no	no	DT
cord-023095-4dannjjm	5315	4	significant	significant	JJ
cord-023095-4dannjjm	5315	5	regional	regional	JJ
cord-023095-4dannjjm	5315	6	CBF	CBF	NNP
cord-023095-4dannjjm	5315	7	difference	difference	NN
cord-023095-4dannjjm	5315	8	between	between	IN
cord-023095-4dannjjm	5315	9	the	the	DT
cord-023095-4dannjjm	5315	10	right	right	NN
cord-023095-4dannjjm	5315	11	and	and	CC
cord-023095-4dannjjm	5315	12	left	left	JJ
cord-023095-4dannjjm	5315	13	sides	side	NNS
cord-023095-4dannjjm	5315	14	of	of	IN
cord-023095-4dannjjm	5315	15	the	the	DT
cord-023095-4dannjjm	5315	16	brain	brain	NN
cord-023095-4dannjjm	5315	17	in	in	IN
cord-023095-4dannjjm	5315	18	each	each	DT
cord-023095-4dannjjm	5315	19	group	group	NN
cord-023095-4dannjjm	5315	20	.	.	.
cord-023095-4dannjjm	5316	1	Also	also	RB
cord-023095-4dannjjm	5316	2	,	,	,
cord-023095-4dannjjm	5316	3	a	a	DT
cord-023095-4dannjjm	5316	4	statistically	statistically	RB
cord-023095-4dannjjm	5316	5	significant	significant	JJ
cord-023095-4dannjjm	5316	6	difference	difference	NN
cord-023095-4dannjjm	5316	7	in	in	IN
cord-023095-4dannjjm	5316	8	the	the	DT
cord-023095-4dannjjm	5316	9	regional	regional	JJ
cord-023095-4dannjjm	5316	10	CBF	CBF	NNP
cord-023095-4dannjjm	5316	11	was	be	VBD
cord-023095-4dannjjm	5316	12	observed	observe	VBN
cord-023095-4dannjjm	5316	13	between	between	IN
cord-023095-4dannjjm	5316	14	groups	group	NNS
cord-023095-4dannjjm	5316	15	2	2	CD
cord-023095-4dannjjm	5316	16	and	and	CC
cord-023095-4dannjjm	5316	17	3	3	CD
cord-023095-4dannjjm	5316	18	(	(	-LRB-
cord-023095-4dannjjm	5316	19	P	p	NN
cord-023095-4dannjjm	5316	20	o	o	NN
cord-023095-4dannjjm	5316	21	0.001	0.001	CD
cord-023095-4dannjjm	5316	22	)	)	-RRB-
cord-023095-4dannjjm	5316	23	.	.	.
cord-023095-4dannjjm	5317	1	Thus	thus	RB
cord-023095-4dannjjm	5317	2	,	,	,
cord-023095-4dannjjm	5317	3	aging	aging	NN
cord-023095-4dannjjm	5317	4	affects	affect	VBZ
cord-023095-4dannjjm	5317	5	the	the	DT
cord-023095-4dannjjm	5317	6	regional	regional	JJ
cord-023095-4dannjjm	5317	7	CBF	cbf	NN
cord-023095-4dannjjm	5317	8	in	in	IN
cord-023095-4dannjjm	5317	9	normal	normal	JJ
cord-023095-4dannjjm	5317	10	dogs	dog	NNS
cord-023095-4dannjjm	5317	11	and	and	CC
cord-023095-4dannjjm	5317	12	the	the	DT
cord-023095-4dannjjm	5317	13	values	value	NNS
cord-023095-4dannjjm	5317	14	should	should	MD
cord-023095-4dannjjm	5317	15	be	be	VB
cord-023095-4dannjjm	5317	16	considered	consider	VBN
cord-023095-4dannjjm	5317	17	assessing	assess	VBG
cord-023095-4dannjjm	5317	18	the	the	DT
cord-023095-4dannjjm	5317	19	results	result	NNS
cord-023095-4dannjjm	5317	20	of	of	IN
cord-023095-4dannjjm	5317	21	DCE	DCE	NNP
cord-023095-4dannjjm	5317	22	-	-	HYPH
cord-023095-4dannjjm	5317	23	CT	CT	NNP
cord-023095-4dannjjm	5317	24	.	.	.
cord-023095-4dannjjm	5318	1	According	accord	VBG
cord-023095-4dannjjm	5318	2	to	to	IN
cord-023095-4dannjjm	5318	3	several	several	JJ
cord-023095-4dannjjm	5318	4	clinical	clinical	JJ
cord-023095-4dannjjm	5318	5	behavior	behavior	NN
cord-023095-4dannjjm	5318	6	guidelines	guideline	NNS
cord-023095-4dannjjm	5318	7	,	,	,
cord-023095-4dannjjm	5318	8	'	'	''
cord-023095-4dannjjm	5318	9	'	'	``
cord-023095-4dannjjm	5318	10	toileting	toileting	NN
cord-023095-4dannjjm	5318	11	'	'	''
cord-023095-4dannjjm	5318	12	'	'	''
cord-023095-4dannjjm	5318	13	type	type	NN
cord-023095-4dannjjm	5318	14	inappropriate	inappropriate	JJ
cord-023095-4dannjjm	5318	15	urination	urination	NN
cord-023095-4dannjjm	5318	16	(	(	-LRB-
cord-023095-4dannjjm	5318	17	i.e.	i.e.	FW
cord-023095-4dannjjm	5318	18	large	large	JJ
cord-023095-4dannjjm	5318	19	amounts	amount	NNS
cord-023095-4dannjjm	5318	20	of	of	IN
cord-023095-4dannjjm	5318	21	urine	urine	NN
cord-023095-4dannjjm	5318	22	deposited	deposit	VBN
cord-023095-4dannjjm	5318	23	in	in	IN
cord-023095-4dannjjm	5318	24	horizontal	horizontal	JJ
cord-023095-4dannjjm	5318	25	surfaces	surface	NNS
cord-023095-4dannjjm	5318	26	)	)	-RRB-
cord-023095-4dannjjm	5318	27	can	can	MD
cord-023095-4dannjjm	5318	28	arise	arise	VB
cord-023095-4dannjjm	5318	29	in	in	IN
cord-023095-4dannjjm	5318	30	cats	cat	NNS
cord-023095-4dannjjm	5318	31	suffering	suffer	VBG
cord-023095-4dannjjm	5318	32	from	from	IN
cord-023095-4dannjjm	5318	33	a	a	DT
cord-023095-4dannjjm	5318	34	medical	medical	JJ
cord-023095-4dannjjm	5318	35	problem	problem	NN
cord-023095-4dannjjm	5318	36	(	(	-LRB-
cord-023095-4dannjjm	5318	37	typically	typically	RB
cord-023095-4dannjjm	5318	38	lower	low	JJR
cord-023095-4dannjjm	5318	39	urinary	urinary	JJ
cord-023095-4dannjjm	5318	40	tract	tract	NN
cord-023095-4dannjjm	5318	41	disease	disease	NN
cord-023095-4dannjjm	5318	42	)	)	-RRB-
cord-023095-4dannjjm	5318	43	.	.	.
cord-023095-4dannjjm	5319	1	By	by	IN
cord-023095-4dannjjm	5319	2	contrast	contrast	NN
cord-023095-4dannjjm	5319	3	,	,	,
cord-023095-4dannjjm	5319	4	'	'	''
cord-023095-4dannjjm	5319	5	'	'	``
cord-023095-4dannjjm	5319	6	spraying	spray	VBG
cord-023095-4dannjjm	5319	7	'	'	''
cord-023095-4dannjjm	5319	8	'	'	``
cord-023095-4dannjjm	5319	9	type	type	NN
cord-023095-4dannjjm	5319	10	behaviour	behaviour	NN
cord-023095-4dannjjm	5319	11	(	(	-LRB-
cord-023095-4dannjjm	5319	12	i.e.	i.e.	FW
cord-023095-4dannjjm	5319	13	possibly	possibly	RB
cord-023095-4dannjjm	5319	14	smaller	small	JJR
cord-023095-4dannjjm	5319	15	amounts	amount	NNS
cord-023095-4dannjjm	5319	16	of	of	IN
cord-023095-4dannjjm	5319	17	urine	urine	NN
cord-023095-4dannjjm	5319	18	deposited	deposit	VBN
cord-023095-4dannjjm	5319	19	on	on	IN
cord-023095-4dannjjm	5319	20	vertical	vertical	JJ
cord-023095-4dannjjm	5319	21	areas	area	NNS
cord-023095-4dannjjm	5319	22	)	)	-RRB-
cord-023095-4dannjjm	5319	23	is	be	VBZ
cord-023095-4dannjjm	5319	24	more	more	RBR
cord-023095-4dannjjm	5319	25	typically	typically	RB
cord-023095-4dannjjm	5319	26	associated	associate	VBN
cord-023095-4dannjjm	5319	27	with	with	IN
cord-023095-4dannjjm	5319	28	anxiety	anxiety	NN
cord-023095-4dannjjm	5319	29	brought	bring	VBN
cord-023095-4dannjjm	5319	30	about	about	RP
cord-023095-4dannjjm	5319	31	by	by	IN
cord-023095-4dannjjm	5319	32	a	a	DT
cord-023095-4dannjjm	5319	33	threat	threat	NN
cord-023095-4dannjjm	5319	34	to	to	IN
cord-023095-4dannjjm	5319	35	local	local	JJ
cord-023095-4dannjjm	5319	36	resources	resource	NNS
cord-023095-4dannjjm	5319	37	,	,	,
cord-023095-4dannjjm	5319	38	arising	arise	VBG
cord-023095-4dannjjm	5319	39	from	from	IN
cord-023095-4dannjjm	5319	40	either	either	CC
cord-023095-4dannjjm	5319	41	a	a	DT
cord-023095-4dannjjm	5319	42	change	change	NN
cord-023095-4dannjjm	5319	43	in	in	IN
cord-023095-4dannjjm	5319	44	the	the	DT
cord-023095-4dannjjm	5319	45	physical	physical	JJ
cord-023095-4dannjjm	5319	46	environment	environment	NN
cord-023095-4dannjjm	5319	47	or	or	CC
cord-023095-4dannjjm	5319	48	threat	threat	NN
cord-023095-4dannjjm	5319	49	to	to	IN
cord-023095-4dannjjm	5319	50	these	these	DT
cord-023095-4dannjjm	5319	51	resources	resource	NNS
cord-023095-4dannjjm	5319	52	from	from	IN
cord-023095-4dannjjm	5319	53	another	another	DT
cord-023095-4dannjjm	5319	54	cat	cat	NN
cord-023095-4dannjjm	5319	55	.	.	.
cord-023095-4dannjjm	5320	1	However	however	RB
cord-023095-4dannjjm	5320	2	,	,	,
cord-023095-4dannjjm	5320	3	there	there	EX
cord-023095-4dannjjm	5320	4	is	be	VBZ
cord-023095-4dannjjm	5320	5	some	some	DT
cord-023095-4dannjjm	5320	6	evidence	evidence	NN
cord-023095-4dannjjm	5320	7	that	that	IN
cord-023095-4dannjjm	5320	8	'	'	''
cord-023095-4dannjjm	5320	9	'	'	``
cord-023095-4dannjjm	5320	10	sprayers	sprayer	NNS
cord-023095-4dannjjm	5320	11	'	'	''
cord-023095-4dannjjm	5320	12	'	'	''
cord-023095-4dannjjm	5320	13	may	may	MD
cord-023095-4dannjjm	5320	14	also	also	RB
cord-023095-4dannjjm	5320	15	be	be	VB
cord-023095-4dannjjm	5320	16	presented	present	VBN
cord-023095-4dannjjm	5320	17	with	with	IN
cord-023095-4dannjjm	5320	18	a	a	DT
cord-023095-4dannjjm	5320	19	medical	medical	JJ
cord-023095-4dannjjm	5320	20	problem	problem	NN
cord-023095-4dannjjm	5320	21	,	,	,
cord-023095-4dannjjm	5320	22	which	which	WDT
cord-023095-4dannjjm	5320	23	might	may	MD
cord-023095-4dannjjm	5320	24	be	be	VB
cord-023095-4dannjjm	5320	25	linked	link	VBN
cord-023095-4dannjjm	5320	26	to	to	IN
cord-023095-4dannjjm	5320	27	the	the	DT
cord-023095-4dannjjm	5320	28	disease	disease	NN
cord-023095-4dannjjm	5321	1	(	(	-LRB-
cord-023095-4dannjjm	5321	2	e.g.	e.g.	DT
cord-023095-4dannjjm	5321	3	painful	painful	JJ
cord-023095-4dannjjm	5321	4	voiding	voiding	NN
cord-023095-4dannjjm	5321	5	associated	associate	VBN
cord-023095-4dannjjm	5321	6	with	with	IN
cord-023095-4dannjjm	5321	7	crystalluria	crystalluria	NNP
cord-023095-4dannjjm	5321	8	may	may	MD
cord-023095-4dannjjm	5321	9	lead	lead	VB
cord-023095-4dannjjm	5321	10	to	to	IN
cord-023095-4dannjjm	5321	11	a	a	DT
cord-023095-4dannjjm	5321	12	standing	standing	JJ
cord-023095-4dannjjm	5321	13	posture	posture	NN
cord-023095-4dannjjm	5321	14	being	be	VBG
cord-023095-4dannjjm	5321	15	adopted	adopt	VBN
cord-023095-4dannjjm	5321	16	and	and	CC
cord-023095-4dannjjm	5321	17	small	small	JJ
cord-023095-4dannjjm	5321	18	amounts	amount	NNS
cord-023095-4dannjjm	5321	19	eliminated	eliminate	VBN
cord-023095-4dannjjm	5321	20	at	at	IN
cord-023095-4dannjjm	5321	21	a	a	DT
cord-023095-4dannjjm	5321	22	given	give	VBN
cord-023095-4dannjjm	5321	23	time	time	NN
cord-023095-4dannjjm	5321	24	)	)	-RRB-
cord-023095-4dannjjm	5321	25	.	.	.
cord-023095-4dannjjm	5322	1	This	this	DT
cord-023095-4dannjjm	5322	2	might	may	MD
cord-023095-4dannjjm	5322	3	be	be	VB
cord-023095-4dannjjm	5322	4	associated	associate	VBN
cord-023095-4dannjjm	5322	5	with	with	IN
cord-023095-4dannjjm	5322	6	an	an	DT
cord-023095-4dannjjm	5322	7	apprehensive	apprehensive	JJ
cord-023095-4dannjjm	5322	8	state	state	NN
cord-023095-4dannjjm	5322	9	or	or	CC
cord-023095-4dannjjm	5322	10	simply	simply	RB
cord-023095-4dannjjm	5322	11	a	a	DT
cord-023095-4dannjjm	5322	12	co	co	JJ
cord-023095-4dannjjm	5322	13	-	-	JJ
cord-023095-4dannjjm	5322	14	morbid	morbid	JJ
cord-023095-4dannjjm	5322	15	state	state	NN
cord-023095-4dannjjm	5322	16	.	.	.
cord-023095-4dannjjm	5323	1	As	as	IN
cord-023095-4dannjjm	5323	2	part	part	NN
cord-023095-4dannjjm	5323	3	of	of	IN
cord-023095-4dannjjm	5323	4	a	a	DT
cord-023095-4dannjjm	5323	5	larger	large	JJR
cord-023095-4dannjjm	5323	6	research	research	NN
cord-023095-4dannjjm	5323	7	project	project	NN
cord-023095-4dannjjm	5323	8	aimed	aim	VBN
cord-023095-4dannjjm	5323	9	at	at	IN
cord-023095-4dannjjm	5323	10	investigating	investigate	VBG
cord-023095-4dannjjm	5323	11	behavioral	behavioral	JJ
cord-023095-4dannjjm	5323	12	and	and	CC
cord-023095-4dannjjm	5323	13	physical	physical	JJ
cord-023095-4dannjjm	5323	14	aspects	aspect	NNS
cord-023095-4dannjjm	5323	15	of	of	IN
cord-023095-4dannjjm	5323	16	cats	cat	NNS
cord-023095-4dannjjm	5323	17	presented	present	VBN
cord-023095-4dannjjm	5323	18	with	with	IN
cord-023095-4dannjjm	5323	19	inappropriate	inappropriate	JJ
cord-023095-4dannjjm	5323	20	urination	urination	NN
cord-023095-4dannjjm	5323	21	,	,	,
cord-023095-4dannjjm	5323	22	owners	owner	NNS
cord-023095-4dannjjm	5323	23	of	of	IN
cord-023095-4dannjjm	5323	24	14	14	CD
cord-023095-4dannjjm	5323	25	'	'	POS
cord-023095-4dannjjm	5323	26	'	'	``
cord-023095-4dannjjm	5323	27	spraying	spraying	NN
cord-023095-4dannjjm	5323	28	'	'	''
cord-023095-4dannjjm	5323	29	'	'	''
cord-023095-4dannjjm	5323	30	and	and	CC
cord-023095-4dannjjm	5323	31	18	18	CD
cord-023095-4dannjjm	5323	32	'	'	POS
cord-023095-4dannjjm	5323	33	'	'	``
cord-023095-4dannjjm	5323	34	toileting	toileting	NN
cord-023095-4dannjjm	5323	35	'	'	''
cord-023095-4dannjjm	5323	36	'	'	''
cord-023095-4dannjjm	5323	37	cats	cat	NNS
cord-023095-4dannjjm	5323	38	with	with	IN
cord-023095-4dannjjm	5323	39	appropriate	appropriate	JJ
cord-023095-4dannjjm	5323	40	control	control	NN
cord-023095-4dannjjm	5323	41	subjects	subject	NNS
cord-023095-4dannjjm	5323	42	from	from	IN
cord-023095-4dannjjm	5323	43	the	the	DT
cord-023095-4dannjjm	5323	44	same	same	JJ
cord-023095-4dannjjm	5323	45	households	household	NNS
cord-023095-4dannjjm	5323	46	were	be	VBD
cord-023095-4dannjjm	5323	47	recruited	recruit	VBN
cord-023095-4dannjjm	5323	48	throughout	throughout	IN
cord-023095-4dannjjm	5323	49	local	local	JJ
cord-023095-4dannjjm	5323	50	media	medium	NNS
cord-023095-4dannjjm	5323	51	coverage	coverage	NN
cord-023095-4dannjjm	5323	52	and	and	CC
cord-023095-4dannjjm	5323	53	the	the	DT
cord-023095-4dannjjm	5323	54	internet	internet	NN
cord-023095-4dannjjm	5323	55	.	.	.
cord-023095-4dannjjm	5324	1	The	the	DT
cord-023095-4dannjjm	5324	2	case	case	NN
cord-023095-4dannjjm	5324	3	-	-	HYPH
cord-023095-4dannjjm	5324	4	control	control	NN
cord-023095-4dannjjm	5324	5	dyads	dyad	NNS
cord-023095-4dannjjm	5324	6	were	be	VBD
cord-023095-4dannjjm	5324	7	brought	bring	VBN
cord-023095-4dannjjm	5324	8	by	by	IN
cord-023095-4dannjjm	5324	9	the	the	DT
cord-023095-4dannjjm	5324	10	owners	owner	NNS
cord-023095-4dannjjm	5324	11	to	to	IN
cord-023095-4dannjjm	5324	12	the	the	DT
cord-023095-4dannjjm	5324	13	veterinary	veterinary	JJ
cord-023095-4dannjjm	5324	14	hospital	hospital	NN
cord-023095-4dannjjm	5324	15	of	of	IN
cord-023095-4dannjjm	5324	16	the	the	DT
cord-023095-4dannjjm	5324	17	University	University	NNP
cord-023095-4dannjjm	5324	18	of	of	IN
cord-023095-4dannjjm	5324	19	Sa˜o	Sa˜o	NNP
cord-023095-4dannjjm	5324	20	Paulo	Paulo	NNP
cord-023095-4dannjjm	5324	21	,	,	,
cord-023095-4dannjjm	5324	22	at	at	IN
cord-023095-4dannjjm	5324	23	the	the	DT
cord-023095-4dannjjm	5324	24	same	same	JJ
cord-023095-4dannjjm	5324	25	time	time	NN
cord-023095-4dannjjm	5324	26	,	,	,
cord-023095-4dannjjm	5324	27	for	for	IN
cord-023095-4dannjjm	5324	28	a	a	DT
cord-023095-4dannjjm	5324	29	medical	medical	JJ
cord-023095-4dannjjm	5324	30	work	work	NN
cord-023095-4dannjjm	5324	31	-	-	HYPH
cord-023095-4dannjjm	5324	32	up	up	NN
cord-023095-4dannjjm	5324	33	(	(	-LRB-
cord-023095-4dannjjm	5324	34	i.e.	i.e.	FW
cord-023095-4dannjjm	5324	35	physical	physical	JJ
cord-023095-4dannjjm	5324	36	examination	examination	NN
cord-023095-4dannjjm	5324	37	,	,	,
cord-023095-4dannjjm	5324	38	complete	complete	JJ
cord-023095-4dannjjm	5324	39	blood	blood	NN
cord-023095-4dannjjm	5324	40	count	count	NN
cord-023095-4dannjjm	5324	41	,	,	,
cord-023095-4dannjjm	5324	42	biochemical	biochemical	JJ
cord-023095-4dannjjm	5324	43	profile	profile	NN
cord-023095-4dannjjm	5324	44	,	,	,
cord-023095-4dannjjm	5324	45	urinalysis	urinalysis	NN
cord-023095-4dannjjm	5324	46	,	,	,
cord-023095-4dannjjm	5324	47	urine	urine	NN
cord-023095-4dannjjm	5324	48	culture	culture	NN
cord-023095-4dannjjm	5324	49	and	and	CC
cord-023095-4dannjjm	5324	50	abdominal	abdominal	JJ
cord-023095-4dannjjm	5324	51	ultrasound	ultrasound	NN
cord-023095-4dannjjm	5324	52	)	)	-RRB-
cord-023095-4dannjjm	5324	53	.	.	.
cord-023095-4dannjjm	5325	1	No	no	DT
cord-023095-4dannjjm	5325	2	significant	significant	JJ
cord-023095-4dannjjm	5325	3	differences	difference	NNS
cord-023095-4dannjjm	5325	4	between	between	IN
cord-023095-4dannjjm	5325	5	the	the	DT
cord-023095-4dannjjm	5325	6	'	'	``
cord-023095-4dannjjm	5325	7	'	'	``
cord-023095-4dannjjm	5325	8	sprayers	sprayer	NNS
cord-023095-4dannjjm	5325	9	'	'	''
cord-023095-4dannjjm	5325	10	'	'	''
cord-023095-4dannjjm	5325	11	and	and	CC
cord-023095-4dannjjm	5325	12	'	'	``
cord-023095-4dannjjm	5325	13	'	'	``
cord-023095-4dannjjm	5325	14	toileters	toileter	NNS
cord-023095-4dannjjm	5325	15	'	'	''
cord-023095-4dannjjm	5325	16	'	'	''
cord-023095-4dannjjm	5325	17	regarding	regard	VBG
cord-023095-4dannjjm	5325	18	the	the	DT
cord-023095-4dannjjm	5325	19	occurrence	occurrence	NN
cord-023095-4dannjjm	5325	20	of	of	IN
cord-023095-4dannjjm	5325	21	medical	medical	JJ
cord-023095-4dannjjm	5325	22	problems	problem	NNS
cord-023095-4dannjjm	5325	23	were	be	VBD
cord-023095-4dannjjm	5325	24	found	find	VBN
cord-023095-4dannjjm	5325	25	.	.	.
cord-023095-4dannjjm	5326	1	Both	both	DT
cord-023095-4dannjjm	5326	2	groups	group	NNS
cord-023095-4dannjjm	5326	3	had	have	VBD
cord-023095-4dannjjm	5326	4	a	a	DT
cord-023095-4dannjjm	5326	5	similar	similar	JJ
cord-023095-4dannjjm	5326	6	proportion	proportion	NN
cord-023095-4dannjjm	5326	7	of	of	IN
cord-023095-4dannjjm	5326	8	cats	cat	NNS
cord-023095-4dannjjm	5326	9	affected	affect	VBN
cord-023095-4dannjjm	5326	10	by	by	IN
cord-023095-4dannjjm	5326	11	medical	medical	JJ
cord-023095-4dannjjm	5326	12	illnesses	illness	NNS
cord-023095-4dannjjm	5326	13	(	(	-LRB-
cord-023095-4dannjjm	5326	14	sprayers	sprayer	NNS
cord-023095-4dannjjm	5326	15	:	:	:
cord-023095-4dannjjm	5326	16	35.7	35.7	CD
cord-023095-4dannjjm	5326	17	%	%	NN
cord-023095-4dannjjm	5326	18	,	,	,
cord-023095-4dannjjm	5326	19	toileters	toileter	NNS
cord-023095-4dannjjm	5326	20	:	:	:
cord-023095-4dannjjm	5326	21	44.4	44.4	CD
cord-023095-4dannjjm	5326	22	%	%	NN
cord-023095-4dannjjm	5326	23	;	;	:
cord-023095-4dannjjm	5326	24	Chi	Chi	NNP
cord-023095-4dannjjm	5326	25	2	2	CD
cord-023095-4dannjjm	5326	26	,	,	,
cord-023095-4dannjjm	5326	27	p	p	NN
cord-023095-4dannjjm	5326	28	5	5	CD
cord-023095-4dannjjm	5326	29	0.618	0.618	CD
cord-023095-4dannjjm	5326	30	)	)	-RRB-
cord-023095-4dannjjm	5326	31	,	,	,
cord-023095-4dannjjm	5326	32	directly	directly	RB
cord-023095-4dannjjm	5326	33	or	or	CC
cord-023095-4dannjjm	5326	34	indirectly	indirectly	RB
cord-023095-4dannjjm	5326	35	relating	relate	VBG
cord-023095-4dannjjm	5326	36	to	to	IN
cord-023095-4dannjjm	5326	37	the	the	DT
cord-023095-4dannjjm	5326	38	urinary	urinary	JJ
cord-023095-4dannjjm	5326	39	system	system	NN
cord-023095-4dannjjm	5326	40	(	(	-LRB-
cord-023095-4dannjjm	5326	41	e.g.	e.g.	IN
cord-023095-4dannjjm	5326	42	diabetes	diabetes	NN
cord-023095-4dannjjm	5326	43	,	,	,
cord-023095-4dannjjm	5326	44	chronic	chronic	JJ
cord-023095-4dannjjm	5326	45	kidney	kidney	NN
cord-023095-4dannjjm	5326	46	disease	disease	NN
cord-023095-4dannjjm	5326	47	)	)	-RRB-
cord-023095-4dannjjm	5326	48	.	.	.
cord-023095-4dannjjm	5327	1	In	in	IN
cord-023095-4dannjjm	5327	2	both	both	DT
cord-023095-4dannjjm	5327	3	groups	group	NNS
cord-023095-4dannjjm	5327	4	,	,	,
cord-023095-4dannjjm	5327	5	control	control	NN
cord-023095-4dannjjm	5327	6	cats	cat	NNS
cord-023095-4dannjjm	5327	7	also	also	RB
cord-023095-4dannjjm	5327	8	had	have	VBD
cord-023095-4dannjjm	5327	9	a	a	DT
cord-023095-4dannjjm	5327	10	relatively	relatively	RB
cord-023095-4dannjjm	5327	11	high	high	JJ
cord-023095-4dannjjm	5327	12	occurrence	occurrence	NN
cord-023095-4dannjjm	5327	13	of	of	IN
cord-023095-4dannjjm	5327	14	medical	medical	JJ
cord-023095-4dannjjm	5327	15	concerns	concern	NNS
cord-023095-4dannjjm	5327	16	(	(	-LRB-
cord-023095-4dannjjm	5327	17	21.4	21.4	CD
cord-023095-4dannjjm	5327	18	%	%	NN
cord-023095-4dannjjm	5327	19	and	and	CC
cord-023095-4dannjjm	5327	20	27.8	27.8	CD
cord-023095-4dannjjm	5327	21	%	%	NN
cord-023095-4dannjjm	5327	22	,	,	,
cord-023095-4dannjjm	5327	23	respectively	respectively	RB
cord-023095-4dannjjm	5327	24	for	for	IN
cord-023095-4dannjjm	5327	25	each	each	DT
cord-023095-4dannjjm	5327	26	control	control	NN
cord-023095-4dannjjm	5327	27	group	group	NN
cord-023095-4dannjjm	5327	28	)	)	-RRB-
cord-023095-4dannjjm	5327	29	.	.	.
cord-023095-4dannjjm	5328	1	These	these	DT
cord-023095-4dannjjm	5328	2	results	result	NNS
cord-023095-4dannjjm	5328	3	emphasize	emphasize	VBP
cord-023095-4dannjjm	5328	4	the	the	DT
cord-023095-4dannjjm	5328	5	importance	importance	NN
cord-023095-4dannjjm	5328	6	of	of	IN
cord-023095-4dannjjm	5328	7	careful	careful	JJ
cord-023095-4dannjjm	5328	8	medical	medical	JJ
cord-023095-4dannjjm	5328	9	evaluation	evaluation	NN
cord-023095-4dannjjm	5328	10	of	of	IN
cord-023095-4dannjjm	5328	11	cats	cat	NNS
cord-023095-4dannjjm	5328	12	presented	present	VBN
cord-023095-4dannjjm	5328	13	for	for	IN
cord-023095-4dannjjm	5328	14	a	a	DT
cord-023095-4dannjjm	5328	15	urinary	urinary	JJ
cord-023095-4dannjjm	5328	16	housesoiling	housesoiling	NN
cord-023095-4dannjjm	5328	17	problem	problem	NN
cord-023095-4dannjjm	5328	18	.	.	.
cord-023095-4dannjjm	5329	1	The	the	DT
cord-023095-4dannjjm	5329	2	relatively	relatively	RB
cord-023095-4dannjjm	5329	3	high	high	JJ
cord-023095-4dannjjm	5329	4	prevalence	prevalence	NN
cord-023095-4dannjjm	5329	5	of	of	IN
cord-023095-4dannjjm	5329	6	medical	medical	JJ
cord-023095-4dannjjm	5329	7	concerns	concern	NNS
cord-023095-4dannjjm	5329	8	among	among	IN
cord-023095-4dannjjm	5329	9	apparently	apparently	RB
cord-023095-4dannjjm	5329	10	healthy	healthy	JJ
cord-023095-4dannjjm	5329	11	cats	cat	NNS
cord-023095-4dannjjm	5329	12	in	in	IN
cord-023095-4dannjjm	5329	13	multi	multi	JJ
cord-023095-4dannjjm	5329	14	-	-	JJ
cord-023095-4dannjjm	5329	15	cat	cat	JJ
cord-023095-4dannjjm	5329	16	households	household	NNS
cord-023095-4dannjjm	5329	17	may	may	MD
cord-023095-4dannjjm	5329	18	have	have	VB
cord-023095-4dannjjm	5329	19	arisen	arise	VBN
cord-023095-4dannjjm	5329	20	,	,	,
cord-023095-4dannjjm	5329	21	at	at	IN
cord-023095-4dannjjm	5329	22	least	least	JJS
cord-023095-4dannjjm	5329	23	in	in	IN
cord-023095-4dannjjm	5329	24	part	part	NN
cord-023095-4dannjjm	5329	25	,	,	,
cord-023095-4dannjjm	5329	26	as	as	IN
cord-023095-4dannjjm	5329	27	a	a	DT
cord-023095-4dannjjm	5329	28	result	result	NN
cord-023095-4dannjjm	5329	29	of	of	IN
cord-023095-4dannjjm	5329	30	an	an	DT
cord-023095-4dannjjm	5329	31	inability	inability	NN
cord-023095-4dannjjm	5329	32	/	/	SYM
cord-023095-4dannjjm	5329	33	failure	failure	NN
cord-023095-4dannjjm	5329	34	of	of	IN
cord-023095-4dannjjm	5329	35	owners	owner	NNS
cord-023095-4dannjjm	5329	36	to	to	TO
cord-023095-4dannjjm	5329	37	monitor	monitor	VB
cord-023095-4dannjjm	5329	38	individuals	individual	NNS
cord-023095-4dannjjm	5329	39	,	,	,
cord-023095-4dannjjm	5329	40	thus	thus	RB
cord-023095-4dannjjm	5329	41	allowing	allow	VBG
cord-023095-4dannjjm	5329	42	some	some	DT
cord-023095-4dannjjm	5329	43	early	early	JJ
cord-023095-4dannjjm	5329	44	signs	sign	NNS
cord-023095-4dannjjm	5329	45	to	to	TO
cord-023095-4dannjjm	5329	46	pass	pass	VB
cord-023095-4dannjjm	5329	47	unnoticed	unnoticed	JJ
cord-023095-4dannjjm	5329	48	.	.	.
cord-023095-4dannjjm	5330	1	The	the	DT
cord-023095-4dannjjm	5330	2	way	way	NN
cord-023095-4dannjjm	5330	3	in	in	IN
cord-023095-4dannjjm	5330	4	which	which	WDT
cord-023095-4dannjjm	5330	5	medical	medical	JJ
cord-023095-4dannjjm	5330	6	and	and	CC
cord-023095-4dannjjm	5330	7	behavioral	behavioral	JJ
cord-023095-4dannjjm	5330	8	elements	element	NNS
cord-023095-4dannjjm	5330	9	are	be	VBP
cord-023095-4dannjjm	5330	10	linked	link	VBN
cord-023095-4dannjjm	5330	11	(	(	-LRB-
cord-023095-4dannjjm	5330	12	if	if	IN
cord-023095-4dannjjm	5330	13	at	at	RB
cord-023095-4dannjjm	5330	14	all	all	RB
cord-023095-4dannjjm	5330	15	)	)	-RRB-
cord-023095-4dannjjm	5330	16	remain	remain	VBP
cord-023095-4dannjjm	5330	17	unknown	unknown	JJ
cord-023095-4dannjjm	5330	18	but	but	CC
cord-023095-4dannjjm	5330	19	deserve	deserve	VBP
cord-023095-4dannjjm	5330	20	further	further	JJ
cord-023095-4dannjjm	5330	21	investigation	investigation	NN
cord-023095-4dannjjm	5330	22	.	.	.
cord-023095-4dannjjm	5331	1	Considered	consider	VBN
cord-023095-4dannjjm	5331	2	as	as	IN
cord-023095-4dannjjm	5331	3	a	a	DT
cord-023095-4dannjjm	5331	4	semi	semi	JJ
cord-023095-4dannjjm	5331	5	-	-	JJ
cord-023095-4dannjjm	5331	6	social	social	JJ
cord-023095-4dannjjm	5331	7	species	specie	NNS
cord-023095-4dannjjm	5331	8	,	,	,
cord-023095-4dannjjm	5331	9	domestic	domestic	JJ
cord-023095-4dannjjm	5331	10	cats	cat	NNS
cord-023095-4dannjjm	5331	11	appear	appear	VBP
cord-023095-4dannjjm	5331	12	to	to	TO
cord-023095-4dannjjm	5331	13	be	be	VB
cord-023095-4dannjjm	5331	14	highly	highly	RB
cord-023095-4dannjjm	5331	15	sensitive	sensitive	JJ
cord-023095-4dannjjm	5331	16	to	to	IN
cord-023095-4dannjjm	5331	17	the	the	DT
cord-023095-4dannjjm	5331	18	effects	effect	NNS
cord-023095-4dannjjm	5331	19	of	of	IN
cord-023095-4dannjjm	5331	20	social	social	JJ
cord-023095-4dannjjm	5331	21	stress	stress	NN
cord-023095-4dannjjm	5331	22	,	,	,
cord-023095-4dannjjm	5331	23	especially	especially	RB
cord-023095-4dannjjm	5331	24	when	when	WRB
cord-023095-4dannjjm	5331	25	living	live	VBG
cord-023095-4dannjjm	5331	26	in	in	IN
cord-023095-4dannjjm	5331	27	high	high	JJ
cord-023095-4dannjjm	5331	28	density	density	NN
cord-023095-4dannjjm	5331	29	populations	population	NNS
cord-023095-4dannjjm	5331	30	.	.	.
cord-023095-4dannjjm	5332	1	Cats	cat	NNS
cord-023095-4dannjjm	5332	2	are	be	VBP
cord-023095-4dannjjm	5332	3	capable	capable	JJ
cord-023095-4dannjjm	5332	4	of	of	IN
cord-023095-4dannjjm	5332	5	adapting	adapt	VBG
cord-023095-4dannjjm	5332	6	to	to	TO
cord-023095-4dannjjm	5332	7	live	live	VB
cord-023095-4dannjjm	5332	8	ingroup	ingroup	NNP
cord-023095-4dannjjm	5332	9	;	;	:
cord-023095-4dannjjm	5332	10	nonetheless	nonetheless	RB
cord-023095-4dannjjm	5332	11	,	,	,
cord-023095-4dannjjm	5332	12	they	-PRON-	PRP
cord-023095-4dannjjm	5332	13	do	do	VBP
cord-023095-4dannjjm	5332	14	not	not	RB
cord-023095-4dannjjm	5332	15	appreciate	appreciate	VB
cord-023095-4dannjjm	5332	16	living	live	VBG
cord-023095-4dannjjm	5332	17	in	in	IN
cord-023095-4dannjjm	5332	18	close	close	JJ
cord-023095-4dannjjm	5332	19	proximity	proximity	NN
cord-023095-4dannjjm	5332	20	with	with	IN
cord-023095-4dannjjm	5332	21	others	other	NNS
cord-023095-4dannjjm	5332	22	as	as	IN
cord-023095-4dannjjm	5332	23	result	result	NN
cord-023095-4dannjjm	5332	24	of	of	IN
cord-023095-4dannjjm	5332	25	an	an	DT
cord-023095-4dannjjm	5332	26	environment	environment	NN
cord-023095-4dannjjm	5332	27	lacking	lack	VBG
cord-023095-4dannjjm	5332	28	of	of	IN
cord-023095-4dannjjm	5332	29	great	great	JJ
cord-023095-4dannjjm	5332	30	opportunities	opportunity	NNS
cord-023095-4dannjjm	5332	31	of	of	IN
cord-023095-4dannjjm	5332	32	escaping	escape	VBG
cord-023095-4dannjjm	5332	33	and	and	CC
cord-023095-4dannjjm	5332	34	hiding	hide	VBG
cord-023095-4dannjjm	5332	35	.	.	.
cord-023095-4dannjjm	5333	1	This	this	DT
cord-023095-4dannjjm	5333	2	study	study	NN
cord-023095-4dannjjm	5333	3	aimed	aim	VBN
cord-023095-4dannjjm	5333	4	at	at	IN
cord-023095-4dannjjm	5333	5	testing	test	VBG
cord-023095-4dannjjm	5333	6	the	the	DT
cord-023095-4dannjjm	5333	7	following	follow	VBG
cord-023095-4dannjjm	5333	8	hypotheses	hypothesis	NNS
cord-023095-4dannjjm	5333	9	:	:	:
cord-023095-4dannjjm	5333	10	(	(	-LRB-
cord-023095-4dannjjm	5333	11	A	a	NN
cord-023095-4dannjjm	5333	12	)	)	-RRB-
cord-023095-4dannjjm	5333	13	owners	owner	NNS
cord-023095-4dannjjm	5333	14	'	'	POS
cord-023095-4dannjjm	5333	15	perceived	perceive	VBN
cord-023095-4dannjjm	5333	16	quality	quality	NN
cord-023095-4dannjjm	5333	17	of	of	IN
cord-023095-4dannjjm	5333	18	life	life	NN
cord-023095-4dannjjm	5333	19	affects	affect	VBZ
cord-023095-4dannjjm	5333	20	cats	cat	NNS
cord-023095-4dannjjm	5333	21	'	'	POS
cord-023095-4dannjjm	5333	22	global	global	JJ
cord-023095-4dannjjm	5333	23	levels	level	NNS
cord-023095-4dannjjm	5333	24	of	of	IN
cord-023095-4dannjjm	5333	25	stress	stress	NN
cord-023095-4dannjjm	5333	26	;	;	:
cord-023095-4dannjjm	5333	27	(	(	-LRB-
cord-023095-4dannjjm	5333	28	B	b	NN
cord-023095-4dannjjm	5333	29	)	)	-RRB-
cord-023095-4dannjjm	5333	30	cats	cat	NNS
cord-023095-4dannjjm	5333	31	'	'	POS
cord-023095-4dannjjm	5333	32	global	global	JJ
cord-023095-4dannjjm	5333	33	levels	level	NNS
cord-023095-4dannjjm	5333	34	of	of	IN
cord-023095-4dannjjm	5333	35	stress	stress	NN
cord-023095-4dannjjm	5333	36	are	be	VBP
cord-023095-4dannjjm	5333	37	influenced	influence	VBN
cord-023095-4dannjjm	5333	38	by	by	IN
cord-023095-4dannjjm	5333	39	cats	cat	NNS
cord-023095-4dannjjm	5333	40	'	'	POS
cord-023095-4dannjjm	5333	41	personality	personality	NN
cord-023095-4dannjjm	5333	42	;	;	:
cord-023095-4dannjjm	5333	43	(	(	-LRB-
cord-023095-4dannjjm	5333	44	C	C	NNP
cord-023095-4dannjjm	5333	45	)	)	-RRB-
cord-023095-4dannjjm	5333	46	cats	cat	NNS
cord-023095-4dannjjm	5333	47	'	'	POS
cord-023095-4dannjjm	5333	48	living	living	NN
cord-023095-4dannjjm	5333	49	style	style	NN
cord-023095-4dannjjm	5333	50	(	(	-LRB-
cord-023095-4dannjjm	5333	51	single	single	JJ
cord-023095-4dannjjm	5333	52	housing	housing	NN
cord-023095-4dannjjm	5333	53	versus	versus	IN
cord-023095-4dannjjm	5333	54	large	large	JJ
cord-023095-4dannjjm	5333	55	group	group	NN
cord-023095-4dannjjm	5333	56	housing	housing	NN
cord-023095-4dannjjm	5333	57	)	)	-RRB-
cord-023095-4dannjjm	5333	58	does	do	VBZ
cord-023095-4dannjjm	5333	59	affect	affect	VB
cord-023095-4dannjjm	5333	60	stress	stress	NN
cord-023095-4dannjjm	5333	61	levels	level	NNS
cord-023095-4dannjjm	5333	62	in	in	IN
cord-023095-4dannjjm	5333	63	cats	cat	NNS
cord-023095-4dannjjm	5333	64	.	.	.
cord-023095-4dannjjm	5334	1	To	to	IN
cord-023095-4dannjjm	5334	2	our	-PRON-	PRP$
cord-023095-4dannjjm	5334	3	knowledge	knowledge	NN
cord-023095-4dannjjm	5334	4	,	,	,
cord-023095-4dannjjm	5334	5	this	this	DT
cord-023095-4dannjjm	5334	6	is	be	VBZ
cord-023095-4dannjjm	5334	7	the	the	DT
cord-023095-4dannjjm	5334	8	first	first	JJ
cord-023095-4dannjjm	5334	9	study	study	NN
cord-023095-4dannjjm	5334	10	investigating	investigate	VBG
cord-023095-4dannjjm	5334	11	stress	stress	NN
cord-023095-4dannjjm	5334	12	levels	level	NNS
cord-023095-4dannjjm	5334	13	of	of	IN
cord-023095-4dannjjm	5334	14	domestic	domestic	JJ
cord-023095-4dannjjm	5334	15	owned	own	VBN
cord-023095-4dannjjm	5334	16	cats	cat	NNS
cord-023095-4dannjjm	5334	17	,	,	,
cord-023095-4dannjjm	5334	18	under	under	IN
cord-023095-4dannjjm	5334	19	natural	natural	JJ
cord-023095-4dannjjm	5334	20	conditions	condition	NNS
cord-023095-4dannjjm	5334	21	,	,	,
cord-023095-4dannjjm	5334	22	throughout	throughout	IN
cord-023095-4dannjjm	5334	23	measurement	measurement	NN
cord-023095-4dannjjm	5334	24	of	of	IN
cord-023095-4dannjjm	5334	25	faecal	faecal	JJ
cord-023095-4dannjjm	5334	26	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	5334	27	metabolites	metabolite	NNS
cord-023095-4dannjjm	5334	28	concentration	concentration	NN
cord-023095-4dannjjm	5334	29	,	,	,
cord-023095-4dannjjm	5334	30	and	and	CC
cord-023095-4dannjjm	5334	31	taking	take	VBG
cord-023095-4dannjjm	5334	32	into	into	IN
cord-023095-4dannjjm	5334	33	consideration	consideration	NN
cord-023095-4dannjjm	5334	34	cat	cat	NN
cord-023095-4dannjjm	5334	35	personality	personality	NN
cord-023095-4dannjjm	5334	36	,	,	,
cord-023095-4dannjjm	5334	37	cat	cat	NN
cord-023095-4dannjjm	5334	38	living	living	NN
cord-023095-4dannjjm	5334	39	style	style	NN
cord-023095-4dannjjm	5334	40	and	and	CC
cord-023095-4dannjjm	5334	41	owner	owner	NN
cord-023095-4dannjjm	5334	42	's	's	POS
cord-023095-4dannjjm	5334	43	subjective	subjective	JJ
cord-023095-4dannjjm	5334	44	life	life	NN
cord-023095-4dannjjm	5334	45	quality	quality	NN
cord-023095-4dannjjm	5334	46	.	.	.
cord-023095-4dannjjm	5335	1	In	in	IN
cord-023095-4dannjjm	5335	2	this	this	DT
cord-023095-4dannjjm	5335	3	study	study	NN
cord-023095-4dannjjm	5335	4	,	,	,
cord-023095-4dannjjm	5335	5	adrenocortical	adrenocortical	JJ
cord-023095-4dannjjm	5335	6	activity	activity	NN
cord-023095-4dannjjm	5335	7	,	,	,
cord-023095-4dannjjm	5335	8	as	as	IN
cord-023095-4dannjjm	5335	9	a	a	DT
cord-023095-4dannjjm	5335	10	valuable	valuable	JJ
cord-023095-4dannjjm	5335	11	physiological	physiological	JJ
cord-023095-4dannjjm	5335	12	indicator	indicator	NN
cord-023095-4dannjjm	5335	13	of	of	IN
cord-023095-4dannjjm	5335	14	emotional	emotional	JJ
cord-023095-4dannjjm	5335	15	stress	stress	NN
cord-023095-4dannjjm	5335	16	,	,	,
cord-023095-4dannjjm	5335	17	was	be	VBD
cord-023095-4dannjjm	5335	18	evaluated	evaluate	VBN
cord-023095-4dannjjm	5335	19	throughout	throughout	IN
cord-023095-4dannjjm	5335	20	the	the	DT
cord-023095-4dannjjm	5335	21	measurement	measurement	NN
cord-023095-4dannjjm	5335	22	of	of	IN
cord-023095-4dannjjm	5335	23	faecal	faecal	JJ
cord-023095-4dannjjm	5335	24	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	5335	25	metabolites	metabolite	NNS
cord-023095-4dannjjm	5335	26	in	in	IN
cord-023095-4dannjjm	5335	27	fourteen	fourteen	CD
cord-023095-4dannjjm	5335	28	single	single	JJ
cord-023095-4dannjjm	5335	29	and	and	CC
cord-023095-4dannjjm	5335	30	sixteen	sixteen	CD
cord-023095-4dannjjm	5335	31	in	in	IN
cord-023095-4dannjjm	5335	32	-	-	HYPH
cord-023095-4dannjjm	5335	33	group	group	NN
cord-023095-4dannjjm	5335	34	housed	house	VBN
cord-023095-4dannjjm	5335	35	cats	cat	NNS
cord-023095-4dannjjm	5335	36	.	.	.
cord-023095-4dannjjm	5336	1	Cat	cat	NN
cord-023095-4dannjjm	5336	2	personality	personality	NN
cord-023095-4dannjjm	5336	3	as	as	RB
cord-023095-4dannjjm	5336	4	well	well	RB
cord-023095-4dannjjm	5336	5	as	as	IN
cord-023095-4dannjjm	5336	6	owners	owner	NNS
cord-023095-4dannjjm	5336	7	life	life	NN
cord-023095-4dannjjm	5336	8	quality	quality	NN
cord-023095-4dannjjm	5336	9	was	be	VBD
cord-023095-4dannjjm	5336	10	evaluated	evaluate	VBN
cord-023095-4dannjjm	5336	11	by	by	IN
cord-023095-4dannjjm	5336	12	self	self	NN
cord-023095-4dannjjm	5336	13	reported	report	VBD
cord-023095-4dannjjm	5336	14	questionnaires	questionnaire	NNS
cord-023095-4dannjjm	5336	15	given	give	VBN
cord-023095-4dannjjm	5336	16	to	to	IN
cord-023095-4dannjjm	5336	17	the	the	DT
cord-023095-4dannjjm	5336	18	owners	owner	NNS
cord-023095-4dannjjm	5336	19	to	to	TO
cord-023095-4dannjjm	5336	20	answer	answer	VB
cord-023095-4dannjjm	5336	21	.	.	.
cord-023095-4dannjjm	5337	1	Significant	significant	JJ
cord-023095-4dannjjm	5337	2	differences	difference	NNS
cord-023095-4dannjjm	5337	3	in	in	IN
cord-023095-4dannjjm	5337	4	mean	mean	JJ
cord-023095-4dannjjm	5337	5	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	5337	6	metabolites	metabolite	NNS
cord-023095-4dannjjm	5337	7	concentrations	concentration	NNS
cord-023095-4dannjjm	5337	8	(	(	-LRB-
cord-023095-4dannjjm	5337	9	mGCM	mGCM	NNS
cord-023095-4dannjjm	5337	10	)	)	-RRB-
cord-023095-4dannjjm	5337	11	between	between	IN
cord-023095-4dannjjm	5337	12	the	the	DT
cord-023095-4dannjjm	5337	13	two	two	CD
cord-023095-4dannjjm	5337	14	populations	population	NNS
cord-023095-4dannjjm	5337	15	(	(	-LRB-
cord-023095-4dannjjm	5337	16	i.e.	i.e.	FW
cord-023095-4dannjjm	5337	17	single	single	JJ
cord-023095-4dannjjm	5337	18	versus	versus	IN
cord-023095-4dannjjm	5337	19	in	in	IN
cord-023095-4dannjjm	5337	20	-	-	HYPH
cord-023095-4dannjjm	5337	21	group	group	NN
cord-023095-4dannjjm	5337	22	cats	cat	NNS
cord-023095-4dannjjm	5337	23	)	)	-RRB-
cord-023095-4dannjjm	5337	24	were	be	VBD
cord-023095-4dannjjm	5337	25	not	not	RB
cord-023095-4dannjjm	5337	26	detected	detect	VBN
cord-023095-4dannjjm	5337	27	(	(	-LRB-
cord-023095-4dannjjm	5337	28	Random	random	JJ
cord-023095-4dannjjm	5337	29	effect	effect	NN
cord-023095-4dannjjm	5337	30	model	model	NN
cord-023095-4dannjjm	5337	31	,	,	,
cord-023095-4dannjjm	5337	32	p	p	NN
cord-023095-4dannjjm	5337	33	5	5	CD
cord-023095-4dannjjm	5337	34	0.178	0.178	CD
cord-023095-4dannjjm	5337	35	)	)	-RRB-
cord-023095-4dannjjm	5337	36	.	.	.
cord-023095-4dannjjm	5338	1	However	however	RB
cord-023095-4dannjjm	5338	2	,	,	,
cord-023095-4dannjjm	5338	3	when	when	WRB
cord-023095-4dannjjm	5338	4	mGCM	mGCM	NNS
cord-023095-4dannjjm	5338	5	were	be	VBD
cord-023095-4dannjjm	5338	6	taken	take	VBN
cord-023095-4dannjjm	5338	7	as	as	IN
cord-023095-4dannjjm	5338	8	a	a	DT
cord-023095-4dannjjm	5338	9	function	function	NN
cord-023095-4dannjjm	5338	10	of	of	IN
cord-023095-4dannjjm	5338	11	cat	cat	NN
cord-023095-4dannjjm	5338	12	personality	personality	NN
cord-023095-4dannjjm	5338	13	,	,	,
cord-023095-4dannjjm	5338	14	there	there	EX
cord-023095-4dannjjm	5338	15	were	be	VBD
cord-023095-4dannjjm	5338	16	differences	difference	NNS
cord-023095-4dannjjm	5338	17	regarding	regard	VBG
cord-023095-4dannjjm	5338	18	single	single	JJ
cord-023095-4dannjjm	5338	19	catstimid	catstimid	NNP
cord-023095-4dannjjm	5338	20	cats	cat	NNS
cord-023095-4dannjjm	5338	21	showed	show	VBD
cord-023095-4dannjjm	5338	22	higher	high	JJR
cord-023095-4dannjjm	5338	23	levels	level	NNS
cord-023095-4dannjjm	5338	24	in	in	IN
cord-023095-4dannjjm	5338	25	comparison	comparison	NN
cord-023095-4dannjjm	5338	26	to	to	IN
cord-023095-4dannjjm	5338	27	easy	easy	RB
cord-023095-4dannjjm	5338	28	-	-	HYPH
cord-023095-4dannjjm	5338	29	going	going	JJ
cord-023095-4dannjjm	5338	30	(	(	-LRB-
cord-023095-4dannjjm	5338	31	Random	random	JJ
cord-023095-4dannjjm	5338	32	effect	effect	NN
cord-023095-4dannjjm	5338	33	model	model	NN
cord-023095-4dannjjm	5338	34	,	,	,
cord-023095-4dannjjm	5338	35	p	p	NN
cord-023095-4dannjjm	5338	36	5	5	CD
cord-023095-4dannjjm	5338	37	0.018	0.018	CD
cord-023095-4dannjjm	5338	38	)	)	-RRB-
cord-023095-4dannjjm	5338	39	and	and	CC
cord-023095-4dannjjm	5338	40	bossy	bossy	JJ
cord-023095-4dannjjm	5338	41	(	(	-LRB-
cord-023095-4dannjjm	5338	42	Random	random	JJ
cord-023095-4dannjjm	5338	43	effect	effect	NN
cord-023095-4dannjjm	5338	44	model	model	NN
cord-023095-4dannjjm	5338	45	,	,	,
cord-023095-4dannjjm	5338	46	p	p	NN
cord-023095-4dannjjm	5338	47	5	5	CD
cord-023095-4dannjjm	5338	48	0.020	0.020	CD
cord-023095-4dannjjm	5338	49	)	)	-RRB-
cord-023095-4dannjjm	5338	50	cats	cat	NNS
cord-023095-4dannjjm	5338	51	.	.	.
cord-023095-4dannjjm	5339	1	As	as	IN
cord-023095-4dannjjm	5339	2	to	to	IN
cord-023095-4dannjjm	5339	3	owner	owner	NN
cord-023095-4dannjjm	5339	4	subjective	subjective	JJ
cord-023095-4dannjjm	5339	5	life	life	NN
cord-023095-4dannjjm	5339	6	quality	quality	NN
cord-023095-4dannjjm	5339	7	,	,	,
cord-023095-4dannjjm	5339	8	a	a	DT
cord-023095-4dannjjm	5339	9	direct	direct	JJ
cord-023095-4dannjjm	5339	10	association	association	NN
cord-023095-4dannjjm	5339	11	between	between	IN
cord-023095-4dannjjm	5339	12	the	the	DT
cord-023095-4dannjjm	5339	13	scores	score	NNS
cord-023095-4dannjjm	5339	14	given	give	VBN
cord-023095-4dannjjm	5339	15	by	by	IN
cord-023095-4dannjjm	5339	16	the	the	DT
cord-023095-4dannjjm	5339	17	owners	owner	NNS
cord-023095-4dannjjm	5339	18	to	to	IN
cord-023095-4dannjjm	5339	19	the	the	DT
cord-023095-4dannjjm	5339	20	social	social	JJ
cord-023095-4dannjjm	5339	21	dimension	dimension	NN
cord-023095-4dannjjm	5339	22	and	and	CC
cord-023095-4dannjjm	5339	23	mGCM	mGCM	NNS
cord-023095-4dannjjm	5339	24	was	be	VBD
cord-023095-4dannjjm	5339	25	found	find	VBN
cord-023095-4dannjjm	5339	26	for	for	IN
cord-023095-4dannjjm	5339	27	single	single	JJ
cord-023095-4dannjjm	5339	28	cats	cat	NNS
cord-023095-4dannjjm	5339	29	only	only	RB
cord-023095-4dannjjm	5339	30	(	(	-LRB-
cord-023095-4dannjjm	5339	31	i.e.	i.e.	FW
cord-023095-4dannjjm	5339	32	the	the	DT
cord-023095-4dannjjm	5339	33	better	well	JJR
cord-023095-4dannjjm	5339	34	the	the	DT
cord-023095-4dannjjm	5339	35	owner	owner	NN
cord-023095-4dannjjm	5339	36	felt	feel	VBD
cord-023095-4dannjjm	5339	37	itself	-PRON-	PRP
cord-023095-4dannjjm	5339	38	social	social	JJ
cord-023095-4dannjjm	5339	39	wise	wise	RB
cord-023095-4dannjjm	5339	40	the	the	DT
cord-023095-4dannjjm	5339	41	higher	high	JJR
cord-023095-4dannjjm	5339	42	the	the	DT
cord-023095-4dannjjm	5339	43	mGCM	mGCM	NNS
cord-023095-4dannjjm	5339	44	of	of	IN
cord-023095-4dannjjm	5339	45	the	the	DT
cord-023095-4dannjjm	5339	46	cat	cat	NN
cord-023095-4dannjjm	5339	47	;	;	:
cord-023095-4dannjjm	5339	48	Random	random	JJ
cord-023095-4dannjjm	5339	49	effect	effect	NN
cord-023095-4dannjjm	5339	50	model	model	NN
cord-023095-4dannjjm	5339	51	,	,	,
cord-023095-4dannjjm	5339	52	p	p	NN
cord-023095-4dannjjm	5339	53	5	5	CD
cord-023095-4dannjjm	5339	54	0.002	0.002	CD
cord-023095-4dannjjm	5339	55	)	)	-RRB-
cord-023095-4dannjjm	5339	56	.	.	.
cord-023095-4dannjjm	5340	1	Social	social	JJ
cord-023095-4dannjjm	5340	2	stratification	stratification	NN
cord-023095-4dannjjm	5340	3	may	may	MD
cord-023095-4dannjjm	5340	4	compensate	compensate	VB
cord-023095-4dannjjm	5340	5	the	the	DT
cord-023095-4dannjjm	5340	6	stress	stress	NN
cord-023095-4dannjjm	5340	7	resulting	result	VBG
cord-023095-4dannjjm	5340	8	from	from	IN
cord-023095-4dannjjm	5340	9	spatial	spatial	JJ
cord-023095-4dannjjm	5340	10	restriction	restriction	NN
cord-023095-4dannjjm	5340	11	in	in	IN
cord-023095-4dannjjm	5340	12	large	large	JJ
cord-023095-4dannjjm	5340	13	in	in	IN
cord-023095-4dannjjm	5340	14	-	-	HYPH
cord-023095-4dannjjm	5340	15	group	group	NN
cord-023095-4dannjjm	5340	16	living	living	NN
cord-023095-4dannjjm	5340	17	cats	cat	NNS
cord-023095-4dannjjm	5340	18	.	.	.
cord-023095-4dannjjm	5341	1	Other	other	JJ
cord-023095-4dannjjm	5341	2	underexplored	underexplored	JJ
cord-023095-4dannjjm	5341	3	factors	factor	NNS
cord-023095-4dannjjm	5341	4	such	such	JJ
cord-023095-4dannjjm	5341	5	as	as	IN
cord-023095-4dannjjm	5341	6	feline	feline	JJ
cord-023095-4dannjjm	5341	7	personality	personality	NN
cord-023095-4dannjjm	5341	8	and	and	CC
cord-023095-4dannjjm	5341	9	owner	owner	NN
cord-023095-4dannjjm	5341	10	life	life	NN
cord-023095-4dannjjm	5341	11	style	style	NN
cord-023095-4dannjjm	5341	12	seem	seem	VBP
cord-023095-4dannjjm	5341	13	to	to	TO
cord-023095-4dannjjm	5341	14	play	play	VB
cord-023095-4dannjjm	5341	15	an	an	DT
cord-023095-4dannjjm	5341	16	equally	equally	RB
cord-023095-4dannjjm	5341	17	important	important	JJ
cord-023095-4dannjjm	5341	18	role	role	NN
cord-023095-4dannjjm	5341	19	in	in	IN
cord-023095-4dannjjm	5341	20	domestic	domestic	JJ
cord-023095-4dannjjm	5341	21	cats	cat	NNS
cord-023095-4dannjjm	5341	22	'	'	POS
cord-023095-4dannjjm	5341	23	day	day	NN
cord-023095-4dannjjm	5341	24	to	to	IN
cord-023095-4dannjjm	5341	25	day	day	NN
cord-023095-4dannjjm	5341	26	levels	level	NNS
cord-023095-4dannjjm	5341	27	of	of	IN
cord-023095-4dannjjm	5341	28	stress	stress	NN
cord-023095-4dannjjm	5341	29	,	,	,
cord-023095-4dannjjm	5341	30	especially	especially	RB
cord-023095-4dannjjm	5341	31	in	in	IN
cord-023095-4dannjjm	5341	32	the	the	DT
cord-023095-4dannjjm	5341	33	cats	cat	NNS
cord-023095-4dannjjm	5341	34	kept	keep	VBD
cord-023095-4dannjjm	5341	35	as	as	IN
cord-023095-4dannjjm	5341	36	single	single	JJ
cord-023095-4dannjjm	5341	37	pets	pet	NNS
cord-023095-4dannjjm	5341	38	.	.	.
cord-023095-4dannjjm	5342	1	In	in	IN
cord-023095-4dannjjm	5342	2	dogs	dog	NNS
cord-023095-4dannjjm	5342	3	,	,	,
cord-023095-4dannjjm	5342	4	RAAS	RAAS	NNP
cord-023095-4dannjjm	5342	5	activation	activation	NN
cord-023095-4dannjjm	5342	6	is	be	VBZ
cord-023095-4dannjjm	5342	7	a	a	DT
cord-023095-4dannjjm	5342	8	major	major	JJ
cord-023095-4dannjjm	5342	9	feature	feature	NN
cord-023095-4dannjjm	5342	10	of	of	IN
cord-023095-4dannjjm	5342	11	congestive	congestive	JJ
cord-023095-4dannjjm	5342	12	heart	heart	NN
cord-023095-4dannjjm	5342	13	failure	failure	NN
cord-023095-4dannjjm	5342	14	(	(	-LRB-
cord-023095-4dannjjm	5342	15	CHF	CHF	NNP
cord-023095-4dannjjm	5342	16	)	)	-RRB-
cord-023095-4dannjjm	5342	17	.	.	.
cord-023095-4dannjjm	5343	1	Benazepril	Benazepril	NNP
cord-023095-4dannjjm	5343	2	(	(	-LRB-
cord-023095-4dannjjm	5343	3	Fortekor	Fortekor	NNP
cord-023095-4dannjjm	5343	4	s	s	NNP
cord-023095-4dannjjm	5343	5	)	)	-RRB-
cord-023095-4dannjjm	5343	6	is	be	VBZ
cord-023095-4dannjjm	5343	7	a	a	DT
cord-023095-4dannjjm	5343	8	potent	potent	JJ
cord-023095-4dannjjm	5343	9	ACE	ace	NN
cord-023095-4dannjjm	5343	10	inhibitor	inhibitor	NN
cord-023095-4dannjjm	5343	11	with	with	IN
cord-023095-4dannjjm	5343	12	well	well	RB
cord-023095-4dannjjm	5343	13	-	-	HYPH
cord-023095-4dannjjm	5343	14	documented	document	VBN
cord-023095-4dannjjm	5343	15	effectiveness	effectiveness	NN
cord-023095-4dannjjm	5343	16	in	in	IN
cord-023095-4dannjjm	5343	17	canine	canine	JJ
cord-023095-4dannjjm	5343	18	CHF	CHF	NNP
cord-023095-4dannjjm	5343	19	.	.	.
cord-023095-4dannjjm	5344	1	Although	although	IN
cord-023095-4dannjjm	5344	2	ACE	ace	NN
cord-023095-4dannjjm	5344	3	activity	activity	NN
cord-023095-4dannjjm	5344	4	(	(	-LRB-
cord-023095-4dannjjm	5344	5	ACE	ACE	NNP
cord-023095-4dannjjm	5344	6	A	A	NNP
cord-023095-4dannjjm	5344	7	)	)	-RRB-
cord-023095-4dannjjm	5344	8	has	have	VBZ
cord-023095-4dannjjm	5344	9	been	be	VBN
cord-023095-4dannjjm	5344	10	used	use	VBN
cord-023095-4dannjjm	5344	11	in	in	IN
cord-023095-4dannjjm	5344	12	preclinical	preclinical	JJ
cord-023095-4dannjjm	5344	13	studies	study	NNS
cord-023095-4dannjjm	5344	14	as	as	IN
cord-023095-4dannjjm	5344	15	a	a	DT
cord-023095-4dannjjm	5344	16	surrogate	surrogate	JJ
cord-023095-4dannjjm	5344	17	marker	marker	NN
cord-023095-4dannjjm	5344	18	of	of	IN
cord-023095-4dannjjm	5344	19	efficacy	efficacy	NN
cord-023095-4dannjjm	5344	20	,	,	,
cord-023095-4dannjjm	5344	21	some	some	DT
cord-023095-4dannjjm	5344	22	authors	author	NNS
cord-023095-4dannjjm	5344	23	have	have	VBP
cord-023095-4dannjjm	5344	24	reported	report	VBN
cord-023095-4dannjjm	5344	25	a	a	DT
cord-023095-4dannjjm	5344	26	poor	poor	JJ
cord-023095-4dannjjm	5344	27	correlation	correlation	NN
cord-023095-4dannjjm	5344	28	between	between	IN
cord-023095-4dannjjm	5344	29	plasma	plasma	NN
cord-023095-4dannjjm	5344	30	ACE	ACE	NNP
cord-023095-4dannjjm	5344	31	A	A	NNP
cord-023095-4dannjjm	5344	32	and	and	CC
cord-023095-4dannjjm	5344	33	changes	change	VBZ
cord-023095-4dannjjm	5344	34	in	in	IN
cord-023095-4dannjjm	5344	35	angiotensin	angiotensin	NN
cord-023095-4dannjjm	5344	36	II	II	NNP
cord-023095-4dannjjm	5344	37	(	(	-LRB-
cord-023095-4dannjjm	5344	38	AII	AII	NNP
cord-023095-4dannjjm	5344	39	)	)	-RRB-
cord-023095-4dannjjm	5344	40	or	or	CC
cord-023095-4dannjjm	5344	41	aldosterone	aldosterone	NN
cord-023095-4dannjjm	5344	42	(	(	-LRB-
cord-023095-4dannjjm	5344	43	AL	AL	NNP
cord-023095-4dannjjm	5344	44	)	)	-RRB-
cord-023095-4dannjjm	5344	45	.	.	.
cord-023095-4dannjjm	5345	1	The	the	DT
cord-023095-4dannjjm	5345	2	purpose	purpose	NN
cord-023095-4dannjjm	5345	3	of	of	IN
cord-023095-4dannjjm	5345	4	this	this	DT
cord-023095-4dannjjm	5345	5	study	study	NN
cord-023095-4dannjjm	5345	6	was	be	VBD
cord-023095-4dannjjm	5345	7	to	to	TO
cord-023095-4dannjjm	5345	8	investigate	investigate	VB
cord-023095-4dannjjm	5345	9	the	the	DT
cord-023095-4dannjjm	5345	10	effect	effect	NN
cord-023095-4dannjjm	5345	11	of	of	IN
cord-023095-4dannjjm	5345	12	benazepril	benazepril	NNP
cord-023095-4dannjjm	5345	13	on	on	IN
cord-023095-4dannjjm	5345	14	canine	canine	JJ
cord-023095-4dannjjm	5345	15	plasma	plasma	NN
cord-023095-4dannjjm	5345	16	renin	renin	NN
cord-023095-4dannjjm	5345	17	activity	activity	NN
cord-023095-4dannjjm	5345	18	/	/	SYM
cord-023095-4dannjjm	5345	19	concentration	concentration	NN
cord-023095-4dannjjm	5345	20	(	(	-LRB-
cord-023095-4dannjjm	5345	21	PRA	PRA	NNP
cord-023095-4dannjjm	5345	22	/	/	SYM
cord-023095-4dannjjm	5345	23	PRC	PRC	NNP
cord-023095-4dannjjm	5345	24	)	)	-RRB-
cord-023095-4dannjjm	5345	25	,	,	,
cord-023095-4dannjjm	5345	26	angiotensin	angiotensin	NN
cord-023095-4dannjjm	5345	27	I	-PRON-	PRP
cord-023095-4dannjjm	5345	28	(	(	-LRB-
cord-023095-4dannjjm	5345	29	AI	AI	NNP
cord-023095-4dannjjm	5345	30	)	)	-RRB-
cord-023095-4dannjjm	5345	31	,	,	,
cord-023095-4dannjjm	5345	32	AII	AII	NNP
cord-023095-4dannjjm	5345	33	,	,	,
cord-023095-4dannjjm	5345	34	AL	AL	NNP
cord-023095-4dannjjm	5345	35	,	,	,
cord-023095-4dannjjm	5345	36	and	and	CC
cord-023095-4dannjjm	5345	37	fractional	fractional	JJ
cord-023095-4dannjjm	5345	38	excretion	excretion	NN
cord-023095-4dannjjm	5345	39	of	of	IN
cord-023095-4dannjjm	5345	40	potassium	potassium	NN
cord-023095-4dannjjm	5345	41	(	(	-LRB-
cord-023095-4dannjjm	5345	42	UfeK	UfeK	NNP
cord-023095-4dannjjm	5345	43	)	)	-RRB-
cord-023095-4dannjjm	5345	44	,	,	,
cord-023095-4dannjjm	5345	45	sodium	sodium	NN
cord-023095-4dannjjm	5345	46	(	(	-LRB-
cord-023095-4dannjjm	5345	47	UfeNa	UfeNa	NNP
cord-023095-4dannjjm	5345	48	)	)	-RRB-
cord-023095-4dannjjm	5345	49	and	and	CC
cord-023095-4dannjjm	5345	50	aldosterone	aldosterone	NN
cord-023095-4dannjjm	5345	51	(	(	-LRB-
cord-023095-4dannjjm	5345	52	UfeAL	UfeAL	NNP
cord-023095-4dannjjm	5345	53	)	)	-RRB-
cord-023095-4dannjjm	5345	54	.	.	.
cord-023095-4dannjjm	5346	1	Sixteen	sixteen	CD
cord-023095-4dannjjm	5346	2	beagle	beagle	NN
cord-023095-4dannjjm	5346	3	dogs	dog	NNS
cord-023095-4dannjjm	5346	4	were	be	VBD
cord-023095-4dannjjm	5346	5	fed	feed	VBN
cord-023095-4dannjjm	5346	6	a	a	DT
cord-023095-4dannjjm	5346	7	low	low	JJ
cord-023095-4dannjjm	5346	8	-	-	HYPH
cord-023095-4dannjjm	5346	9	sodium	sodium	NN
cord-023095-4dannjjm	5346	10	diet	diet	NN
cord-023095-4dannjjm	5346	11	and	and	CC
cord-023095-4dannjjm	5346	12	dosed	dose	VBN
cord-023095-4dannjjm	5346	13	with	with	IN
cord-023095-4dannjjm	5346	14	placebo	placebo	NN
cord-023095-4dannjjm	5346	15	or	or	CC
cord-023095-4dannjjm	5346	16	benazepril	benazepril	NNP
cord-023095-4dannjjm	5346	17	tablets	tablets	NNP
cord-023095-4dannjjm	5346	18	(	(	-LRB-
cord-023095-4dannjjm	5346	19	10	10	CD
cord-023095-4dannjjm	5346	20	mg	mg	NNP
cord-023095-4dannjjm	5346	21	PO	po	NN
cord-023095-4dannjjm	5346	22	,	,	,
cord-023095-4dannjjm	5346	23	q24h	q24h	CD
cord-023095-4dannjjm	5346	24	)	)	-RRB-
cord-023095-4dannjjm	5346	25	for	for	IN
cord-023095-4dannjjm	5346	26	5	5	CD
cord-023095-4dannjjm	5346	27	days	day	NNS
cord-023095-4dannjjm	5346	28	.	.	.
cord-023095-4dannjjm	5347	1	Blood	blood	NN
cord-023095-4dannjjm	5347	2	and	and	CC
cord-023095-4dannjjm	5347	3	urine	urine	NN
cord-023095-4dannjjm	5347	4	samples	sample	NNS
cord-023095-4dannjjm	5347	5	were	be	VBD
cord-023095-4dannjjm	5347	6	collected	collect	VBN
cord-023095-4dannjjm	5347	7	on	on	IN
cord-023095-4dannjjm	5347	8	day	day	NN
cord-023095-4dannjjm	5347	9	1	1	CD
cord-023095-4dannjjm	5347	10	(	(	-LRB-
cord-023095-4dannjjm	5347	11	D1	D1	NNP
cord-023095-4dannjjm	5347	12	)	)	-RRB-
cord-023095-4dannjjm	5347	13	and	and	CC
cord-023095-4dannjjm	5347	14	day	day	NN
cord-023095-4dannjjm	5347	15	5	5	CD
cord-023095-4dannjjm	5347	16	(	(	-LRB-
cord-023095-4dannjjm	5347	17	D5	D5	NNP
cord-023095-4dannjjm	5347	18	)	)	-RRB-
cord-023095-4dannjjm	5347	19	over	over	IN
cord-023095-4dannjjm	5347	20	24-hour	24-hour	JJ
cord-023095-4dannjjm	5347	21	periods	period	NNS
cord-023095-4dannjjm	5347	22	.	.	.
cord-023095-4dannjjm	5348	1	Data	datum	NNS
cord-023095-4dannjjm	5348	2	were	be	VBD
cord-023095-4dannjjm	5348	3	analyzed	analyze	VBN
cord-023095-4dannjjm	5348	4	by	by	IN
cord-023095-4dannjjm	5348	5	repeated	repeat	VBN
cord-023095-4dannjjm	5348	6	measures	measure	NNS
cord-023095-4dannjjm	5348	7	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	5348	8	of	of	IN
cord-023095-4dannjjm	5348	9	baseline	baseline	JJ
cord-023095-4dannjjm	5348	10	corrected	correct	VBN
cord-023095-4dannjjm	5348	11	values	value	NNS
cord-023095-4dannjjm	5348	12	,	,	,
cord-023095-4dannjjm	5348	13	and	and	CC
cord-023095-4dannjjm	5348	14	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	5348	15	of	of	IN
cord-023095-4dannjjm	5348	16	AUC	AUC	NNP
cord-023095-4dannjjm	5348	17	24hours	24hours	CD
cord-023095-4dannjjm	5348	18	.	.	.
cord-023095-4dannjjm	5349	1	Compared	compare	VBN
cord-023095-4dannjjm	5349	2	with	with	IN
cord-023095-4dannjjm	5349	3	placebo	placebo	NN
cord-023095-4dannjjm	5349	4	,	,	,
cord-023095-4dannjjm	5349	5	benazepril	benazepril	NNP
cord-023095-4dannjjm	5349	6	induced	induce	VBD
cord-023095-4dannjjm	5349	7	a	a	DT
cord-023095-4dannjjm	5349	8	significant	significant	JJ
cord-023095-4dannjjm	5349	9	increase	increase	NN
cord-023095-4dannjjm	5349	10	in	in	IN
cord-023095-4dannjjm	5349	11	PRA	PRA	NNP
cord-023095-4dannjjm	5349	12	and	and	CC
cord-023095-4dannjjm	5349	13	AI	AI	NNP
cord-023095-4dannjjm	5349	14	at	at	IN
cord-023095-4dannjjm	5349	15	D1	d1	NN
cord-023095-4dannjjm	5349	16	(	(	-LRB-
cord-023095-4dannjjm	5349	17	p	p	NN
cord-023095-4dannjjm	5349	18	-	-	HYPH
cord-023095-4dannjjm	5349	19	value	value	NN
cord-023095-4dannjjm	5349	20	[	[	-LRB-
cord-023095-4dannjjm	5349	21	PRA	PRA	NNP
cord-023095-4dannjjm	5349	22	]	]	-RRB-
cord-023095-4dannjjm	5349	23	:	:	:
cord-023095-4dannjjm	5349	24	0.001	0.001	CD
cord-023095-4dannjjm	5349	25	,	,	,
cord-023095-4dannjjm	5349	26	p	p	NN
cord-023095-4dannjjm	5349	27	-	-	HYPH
cord-023095-4dannjjm	5349	28	value	value	NN
cord-023095-4dannjjm	5349	29	[	[	-LRB-
cord-023095-4dannjjm	5349	30	AI	ai	NN
cord-023095-4dannjjm	5349	31	]	]	-RRB-
cord-023095-4dannjjm	5349	32	:	:	:
cord-023095-4dannjjm	5349	33	0.002	0.002	CD
cord-023095-4dannjjm	5349	34	)	)	-RRB-
cord-023095-4dannjjm	5349	35	and	and	CC
cord-023095-4dannjjm	5349	36	D5	D5	NNP
cord-023095-4dannjjm	5349	37	(	(	-LRB-
cord-023095-4dannjjm	5349	38	p	p	NN
cord-023095-4dannjjm	5349	39	-	-	HYPH
cord-023095-4dannjjm	5349	40	value	value	NN
cord-023095-4dannjjm	5349	41	[	[	-LRB-
cord-023095-4dannjjm	5349	42	PRA	PRA	NNP
cord-023095-4dannjjm	5349	43	]	]	-RRB-
cord-023095-4dannjjm	5349	44	:	:	:
cord-023095-4dannjjm	5349	45	0.001	0.001	CD
cord-023095-4dannjjm	5349	46	,	,	,
cord-023095-4dannjjm	5349	47	p	p	NN
cord-023095-4dannjjm	5349	48	-	-	HYPH
cord-023095-4dannjjm	5349	49	value	value	NN
cord-023095-4dannjjm	5349	50	[	[	-LRB-
cord-023095-4dannjjm	5349	51	AI	ai	NN
cord-023095-4dannjjm	5349	52	]	]	-RRB-
cord-023095-4dannjjm	5349	53	o	o	NN
cord-023095-4dannjjm	5349	54	0.001	0.001	CD
cord-023095-4dannjjm	5349	55	)	)	-RRB-
cord-023095-4dannjjm	5349	56	.	.	.
cord-023095-4dannjjm	5350	1	No	no	DT
cord-023095-4dannjjm	5350	2	differences	difference	NNS
cord-023095-4dannjjm	5350	3	in	in	IN
cord-023095-4dannjjm	5350	4	PRC	PRC	NNP
cord-023095-4dannjjm	5350	5	were	be	VBD
cord-023095-4dannjjm	5350	6	noticed	notice	VBN
cord-023095-4dannjjm	5350	7	.	.	.
cord-023095-4dannjjm	5351	1	Based	base	VBN
cord-023095-4dannjjm	5351	2	on	on	IN
cord-023095-4dannjjm	5351	3	AUC	AUC	NNP
cord-023095-4dannjjm	5351	4	24hours	24hours	CD
cord-023095-4dannjjm	5351	5	,	,	,
cord-023095-4dannjjm	5351	6	AII	AII	NNP
cord-023095-4dannjjm	5351	7	levels	level	NNS
cord-023095-4dannjjm	5351	8	were	be	VBD
cord-023095-4dannjjm	5351	9	34	34	CD
cord-023095-4dannjjm	5351	10	%	%	NN
cord-023095-4dannjjm	5351	11	lower	low	JJR
cord-023095-4dannjjm	5351	12	in	in	IN
cord-023095-4dannjjm	5351	13	the	the	DT
cord-023095-4dannjjm	5351	14	benazepril	benazepril	NNP
cord-023095-4dannjjm	5351	15	group	group	NN
cord-023095-4dannjjm	5351	16	at	at	IN
cord-023095-4dannjjm	5351	17	D5	D5	NNP
cord-023095-4dannjjm	5351	18	(	(	-LRB-
cord-023095-4dannjjm	5351	19	p	p	NN
cord-023095-4dannjjm	5351	20	-	-	HYPH
cord-023095-4dannjjm	5351	21	value	value	NN
cord-023095-4dannjjm	5351	22	[	[	-LRB-
cord-023095-4dannjjm	5351	23	AII	AII	NNP
cord-023095-4dannjjm	5351	24	]	]	-RRB-
cord-023095-4dannjjm	5351	25	:	:	:
cord-023095-4dannjjm	5351	26	0.01	0.01	CD
cord-023095-4dannjjm	5351	27	)	)	-RRB-
cord-023095-4dannjjm	5351	28	.	.	.
cord-023095-4dannjjm	5352	1	UfeAL	UfeAL	NNP
cord-023095-4dannjjm	5352	2	and	and	CC
cord-023095-4dannjjm	5352	3	AL	AL	NNP
cord-023095-4dannjjm	5352	4	decreased	decrease	VBD
cord-023095-4dannjjm	5352	5	by	by	IN
cord-023095-4dannjjm	5352	6	up	up	IN
cord-023095-4dannjjm	5352	7	to	to	TO
cord-023095-4dannjjm	5352	8	27	27	CD
cord-023095-4dannjjm	5352	9	%	%	NN
cord-023095-4dannjjm	5352	10	and	and	CC
cord-023095-4dannjjm	5352	11	24	24	CD
cord-023095-4dannjjm	5352	12	%	%	NN
cord-023095-4dannjjm	5352	13	at	at	IN
cord-023095-4dannjjm	5352	14	D1	d1	NN
cord-023095-4dannjjm	5352	15	and	and	CC
cord-023095-4dannjjm	5352	16	D5	D5	NNP
cord-023095-4dannjjm	5352	17	,	,	,
cord-023095-4dannjjm	5352	18	respectively	respectively	RB
cord-023095-4dannjjm	5352	19	,	,	,
cord-023095-4dannjjm	5352	20	though	though	IN
cord-023095-4dannjjm	5352	21	differences	difference	NNS
cord-023095-4dannjjm	5352	22	did	do	VBD
cord-023095-4dannjjm	5352	23	not	not	RB
cord-023095-4dannjjm	5352	24	reach	reach	VB
cord-023095-4dannjjm	5352	25	statistical	statistical	JJ
cord-023095-4dannjjm	5352	26	significance	significance	NN
cord-023095-4dannjjm	5352	27	.	.	.
cord-023095-4dannjjm	5353	1	Benazepril	Benazepril	NNP
cord-023095-4dannjjm	5353	2	markedly	markedly	RB
cord-023095-4dannjjm	5353	3	influences	influence	VBZ
cord-023095-4dannjjm	5353	4	RAAS	RAAS	NNP
cord-023095-4dannjjm	5353	5	dynamics	dynamic	NNS
cord-023095-4dannjjm	5353	6	in	in	IN
cord-023095-4dannjjm	5353	7	dogs	dog	NNS
cord-023095-4dannjjm	5353	8	.	.	.
cord-023095-4dannjjm	5354	1	Decreased	decrease	VBN
cord-023095-4dannjjm	5354	2	exposure	exposure	NN
cord-023095-4dannjjm	5354	3	to	to	IN
cord-023095-4dannjjm	5354	4	AII	AII	NNP
cord-023095-4dannjjm	5354	5	and	and	CC
cord-023095-4dannjjm	5354	6	AL	AL	NNP
cord-023095-4dannjjm	5354	7	are	be	VBP
cord-023095-4dannjjm	5354	8	likely	likely	JJ
cord-023095-4dannjjm	5354	9	to	to	TO
cord-023095-4dannjjm	5354	10	be	be	VB
cord-023095-4dannjjm	5354	11	the	the	DT
cord-023095-4dannjjm	5354	12	key	key	JJ
cord-023095-4dannjjm	5354	13	events	event	NNS
cord-023095-4dannjjm	5354	14	required	require	VBN
cord-023095-4dannjjm	5354	15	to	to	TO
cord-023095-4dannjjm	5354	16	counteract	counteract	VB
cord-023095-4dannjjm	5354	17	pathological	pathological	JJ
cord-023095-4dannjjm	5354	18	remodeling	remodeling	NN
cord-023095-4dannjjm	5354	19	of	of	IN
cord-023095-4dannjjm	5354	20	the	the	DT
cord-023095-4dannjjm	5354	21	heart	heart	NN
cord-023095-4dannjjm	5354	22	in	in	IN
cord-023095-4dannjjm	5354	23	CHF	CHF	NNP
cord-023095-4dannjjm	5354	24	.	.	.
cord-023095-4dannjjm	5355	1	This	this	DT
cord-023095-4dannjjm	5355	2	study	study	NN
cord-023095-4dannjjm	5355	3	compared	compare	VBD
cord-023095-4dannjjm	5355	4	two	two	CD
cord-023095-4dannjjm	5355	5	intravenous	intravenous	JJ
cord-023095-4dannjjm	5355	6	anesthetic	anesthetic	JJ
cord-023095-4dannjjm	5355	7	agents	agent	NNS
cord-023095-4dannjjm	5355	8	,	,	,
cord-023095-4dannjjm	5355	9	alfaxalone	alfaxalone	NN
cord-023095-4dannjjm	5355	10	(	(	-LRB-
cord-023095-4dannjjm	5355	11	ALF	ALF	NNP
cord-023095-4dannjjm	5355	12	)	)	-RRB-
cord-023095-4dannjjm	5355	13	(	(	-LRB-
cord-023095-4dannjjm	5355	14	Alfaxan	Alfaxan	NNP
cord-023095-4dannjjm	5355	15	s	s	NNP
cord-023095-4dannjjm	5355	16	,	,	,
cord-023095-4dannjjm	5355	17	Jurox	Jurox	NNP
cord-023095-4dannjjm	5355	18	Pty	Pty	NNP
cord-023095-4dannjjm	5355	19	.	.	.
cord-023095-4dannjjm	5355	20	Ltd.	Ltd.	NNP
cord-023095-4dannjjm	5355	21	)	)	-RRB-
cord-023095-4dannjjm	5356	1	and	and	CC
cord-023095-4dannjjm	5356	2	propofol	propofol	NN
cord-023095-4dannjjm	5356	3	(	(	-LRB-
cord-023095-4dannjjm	5356	4	PPF	PPF	NNP
cord-023095-4dannjjm	5356	5	)	)	-RRB-
cord-023095-4dannjjm	5356	6	(	(	-LRB-
cord-023095-4dannjjm	5356	7	Rapinovet	Rapinovet	NNP
cord-023095-4dannjjm	5356	8	s	s	POS
cord-023095-4dannjjm	5356	9	,	,	,
cord-023095-4dannjjm	5356	10	Schering	Schering	NNP
cord-023095-4dannjjm	5356	11	Plough	Plough	NNP
cord-023095-4dannjjm	5356	12	Animal	Animal	NNP
cord-023095-4dannjjm	5356	13	Health	Health	NNP
cord-023095-4dannjjm	5356	14	)	)	-RRB-
cord-023095-4dannjjm	5356	15	and	and	CC
cord-023095-4dannjjm	5356	16	their	-PRON-	PRP$
cord-023095-4dannjjm	5356	17	effects	effect	NNS
cord-023095-4dannjjm	5356	18	on	on	IN
cord-023095-4dannjjm	5356	19	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	5356	20	ventilation	ventilation	NN
cord-023095-4dannjjm	5356	21	after	after	IN
cord-023095-4dannjjm	5356	22	induction	induction	NN
cord-023095-4dannjjm	5356	23	of	of	IN
cord-023095-4dannjjm	5356	24	anesthesia	anesthesia	NN
cord-023095-4dannjjm	5356	25	in	in	IN
cord-023095-4dannjjm	5356	26	dogs	dog	NNS
cord-023095-4dannjjm	5356	27	at	at	IN
cord-023095-4dannjjm	5356	28	various	various	JJ
cord-023095-4dannjjm	5356	29	doses	dose	NNS
cord-023095-4dannjjm	5356	30	.	.	.
cord-023095-4dannjjm	5357	1	This	this	DT
cord-023095-4dannjjm	5357	2	randomized	randomized	JJ
cord-023095-4dannjjm	5357	3	,	,	,
cord-023095-4dannjjm	5357	4	crossover	crossover	NN
cord-023095-4dannjjm	5357	5	,	,	,
cord-023095-4dannjjm	5357	6	dose	dose	NN
cord-023095-4dannjjm	5357	7	-	-	HYPH
cord-023095-4dannjjm	5357	8	escalation	escalation	NN
cord-023095-4dannjjm	5357	9	study	study	NN
cord-023095-4dannjjm	5357	10	used	use	VBD
cord-023095-4dannjjm	5357	11	six	six	CD
cord-023095-4dannjjm	5357	12	dogs	dog	NNS
cord-023095-4dannjjm	5357	13	in	in	IN
cord-023095-4dannjjm	5357	14	weight	weight	NN
cord-023095-4dannjjm	5357	15	and	and	CC
cord-023095-4dannjjm	5357	16	gender	gender	NN
cord-023095-4dannjjm	5357	17	-	-	HYPH
cord-023095-4dannjjm	5357	18	matched	match	VBN
cord-023095-4dannjjm	5357	19	pairs	pair	NNS
cord-023095-4dannjjm	5357	20	(	(	-LRB-
cord-023095-4dannjjm	5357	21	3M-3F	3m-3f	CD
cord-023095-4dannjjm	5357	22	)	)	-RRB-
cord-023095-4dannjjm	5357	23	.	.	.
cord-023095-4dannjjm	5358	1	For	for	IN
cord-023095-4dannjjm	5358	2	each	each	DT
cord-023095-4dannjjm	5358	3	drug	drug	NN
cord-023095-4dannjjm	5358	4	,	,	,
cord-023095-4dannjjm	5358	5	each	each	DT
cord-023095-4dannjjm	5358	6	dog	dog	NN
cord-023095-4dannjjm	5358	7	was	be	VBD
cord-023095-4dannjjm	5358	8	dosed	dose	VBN
cord-023095-4dannjjm	5358	9	incrementally	incrementally	RB
cord-023095-4dannjjm	5358	10	at	at	IN
cord-023095-4dannjjm	5358	11	1	1	CD
cord-023095-4dannjjm	5358	12	,	,	,
cord-023095-4dannjjm	5358	13	2	2	CD
cord-023095-4dannjjm	5358	14	,	,	,
cord-023095-4dannjjm	5358	15	5	5	CD
cord-023095-4dannjjm	5358	16	,	,	,
cord-023095-4dannjjm	5358	17	10	10	CD
cord-023095-4dannjjm	5358	18	and	and	CC
cord-023095-4dannjjm	5358	19	20	20	CD
cord-023095-4dannjjm	5358	20	times	time	NNS
cord-023095-4dannjjm	5358	21	the	the	DT
cord-023095-4dannjjm	5358	22	labeled	label	VBN
cord-023095-4dannjjm	5358	23	anesthetic	anesthetic	JJ
cord-023095-4dannjjm	5358	24	induction	induction	NN
cord-023095-4dannjjm	5358	25	dose	dose	NN
cord-023095-4dannjjm	5358	26	rate	rate	NN
cord-023095-4dannjjm	5358	27	(	(	-LRB-
cord-023095-4dannjjm	5358	28	ALF	ALF	NNP
cord-023095-4dannjjm	5358	29	2	2	CD
cord-023095-4dannjjm	5358	30	mg	mg	NNP
cord-023095-4dannjjm	5358	31	/	/	SYM
cord-023095-4dannjjm	5358	32	kg	kg	NNP
cord-023095-4dannjjm	5358	33	,	,	,
cord-023095-4dannjjm	5358	34	PPF	PPF	NNP
cord-023095-4dannjjm	5358	35	6.5	6.5	CD
cord-023095-4dannjjm	5358	36	mg	mg	NNP
cord-023095-4dannjjm	5358	37	/	/	SYM
cord-023095-4dannjjm	5358	38	kg	kg	NNP
cord-023095-4dannjjm	5358	39	)	)	-RRB-
cord-023095-4dannjjm	5358	40	or	or	CC
cord-023095-4dannjjm	5358	41	until	until	IN
cord-023095-4dannjjm	5358	42	a	a	DT
cord-023095-4dannjjm	5358	43	dose	dose	NN
cord-023095-4dannjjm	5358	44	was	be	VBD
cord-023095-4dannjjm	5358	45	reached	reach	VBN
cord-023095-4dannjjm	5358	46	that	that	WDT
cord-023095-4dannjjm	5358	47	rendered	render	VBD
cord-023095-4dannjjm	5358	48	the	the	DT
cord-023095-4dannjjm	5358	49	dog	dog	NN
cord-023095-4dannjjm	5358	50	apneic	apneic	JJ
cord-023095-4dannjjm	5358	51	.	.	.
cord-023095-4dannjjm	5359	1	A	a	DT
cord-023095-4dannjjm	5359	2	minimum	minimum	NN
cord-023095-4dannjjm	5359	3	of	of	IN
cord-023095-4dannjjm	5359	4	three	three	CD
cord-023095-4dannjjm	5359	5	days	day	NNS
cord-023095-4dannjjm	5359	6	was	be	VBD
cord-023095-4dannjjm	5359	7	allowed	allow	VBN
cord-023095-4dannjjm	5359	8	between	between	IN
cord-023095-4dannjjm	5359	9	doses	dose	NNS
cord-023095-4dannjjm	5359	10	.	.	.
cord-023095-4dannjjm	5360	1	For	for	IN
cord-023095-4dannjjm	5360	2	each	each	DT
cord-023095-4dannjjm	5360	3	dose	dose	JJ
cord-023095-4dannjjm	5360	4	administration	administration	NN
cord-023095-4dannjjm	5360	5	,	,	,
cord-023095-4dannjjm	5360	6	the	the	DT
cord-023095-4dannjjm	5360	7	entire	entire	JJ
cord-023095-4dannjjm	5360	8	calculated	calculate	VBN
cord-023095-4dannjjm	5360	9	dose	dose	NN
cord-023095-4dannjjm	5360	10	was	be	VBD
cord-023095-4dannjjm	5360	11	delivered	deliver	VBN
cord-023095-4dannjjm	5360	12	constantly	constantly	RB
cord-023095-4dannjjm	5360	13	over	over	IN
cord-023095-4dannjjm	5360	14	1	1	CD
cord-023095-4dannjjm	5360	15	min	min	NN
cord-023095-4dannjjm	5360	16	.	.	.
cord-023095-4dannjjm	5361	1	The	the	DT
cord-023095-4dannjjm	5361	2	primary	primary	JJ
cord-023095-4dannjjm	5361	3	variable	variable	NN
cord-023095-4dannjjm	5361	4	was	be	VBD
cord-023095-4dannjjm	5361	5	apnea	apnea	NN
cord-023095-4dannjjm	5361	6	,	,	,
cord-023095-4dannjjm	5361	7	defined	define	VBN
cord-023095-4dannjjm	5361	8	as	as	IN
cord-023095-4dannjjm	5361	9	an	an	DT
cord-023095-4dannjjm	5361	10	absence	absence	NN
cord-023095-4dannjjm	5361	11	of	of	IN
cord-023095-4dannjjm	5361	12	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	5361	13	ventilation	ventilation	NN
cord-023095-4dannjjm	5361	14	for	for	IN
cord-023095-4dannjjm	5361	15	1	1	CD
cord-023095-4dannjjm	5361	16	minute	minute	NN
cord-023095-4dannjjm	5361	17	.	.	.
cord-023095-4dannjjm	5362	1	Apneic	Apneic	NNP
cord-023095-4dannjjm	5362	2	dogs	dog	NNS
cord-023095-4dannjjm	5362	3	were	be	VBD
cord-023095-4dannjjm	5362	4	manually	manually	RB
cord-023095-4dannjjm	5362	5	ventilated	ventilate	VBN
cord-023095-4dannjjm	5362	6	with	with	IN
cord-023095-4dannjjm	5362	7	oxygen	oxygen	NN
cord-023095-4dannjjm	5362	8	until	until	IN
cord-023095-4dannjjm	5362	9	they	-PRON-	PRP
cord-023095-4dannjjm	5362	10	resumed	resume	VBD
cord-023095-4dannjjm	5362	11	adequate	adequate	JJ
cord-023095-4dannjjm	5362	12	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	5362	13	ventilation	ventilation	NN
cord-023095-4dannjjm	5362	14	.	.	.
cord-023095-4dannjjm	5363	1	Once	once	IN
cord-023095-4dannjjm	5363	2	the	the	DT
cord-023095-4dannjjm	5363	3	apneic	apneic	JJ
cord-023095-4dannjjm	5363	4	dose	dose	NN
cord-023095-4dannjjm	5363	5	was	be	VBD
cord-023095-4dannjjm	5363	6	determined	determine	VBN
cord-023095-4dannjjm	5363	7	for	for	IN
cord-023095-4dannjjm	5363	8	an	an	DT
cord-023095-4dannjjm	5363	9	individual	individual	JJ
cord-023095-4dannjjm	5363	10	dog	dog	NN
cord-023095-4dannjjm	5363	11	for	for	IN
cord-023095-4dannjjm	5363	12	one	one	CD
cord-023095-4dannjjm	5363	13	drug	drug	NN
cord-023095-4dannjjm	5363	14	,	,	,
cord-023095-4dannjjm	5363	15	the	the	DT
cord-023095-4dannjjm	5363	16	dog	dog	NN
cord-023095-4dannjjm	5363	17	began	begin	VBD
cord-023095-4dannjjm	5363	18	incremental	incremental	JJ
cord-023095-4dannjjm	5363	19	doses	dose	NNS
cord-023095-4dannjjm	5363	20	with	with	IN
cord-023095-4dannjjm	5363	21	the	the	DT
cord-023095-4dannjjm	5363	22	alternate	alternate	JJ
cord-023095-4dannjjm	5363	23	drug	drug	NN
cord-023095-4dannjjm	5363	24	.	.	.
cord-023095-4dannjjm	5364	1	For	for	IN
cord-023095-4dannjjm	5364	2	each	each	DT
cord-023095-4dannjjm	5364	3	anesthetic	anesthetic	JJ
cord-023095-4dannjjm	5364	4	episode	episode	NN
cord-023095-4dannjjm	5364	5	times	time	NNS
cord-023095-4dannjjm	5364	6	were	be	VBD
cord-023095-4dannjjm	5364	7	recorded	record	VBN
cord-023095-4dannjjm	5364	8	from	from	IN
cord-023095-4dannjjm	5364	9	completion	completion	NN
cord-023095-4dannjjm	5364	10	of	of	IN
cord-023095-4dannjjm	5364	11	induction	induction	NN
cord-023095-4dannjjm	5364	12	dose	dose	NN
cord-023095-4dannjjm	5364	13	to	to	IN
cord-023095-4dannjjm	5364	14	;	;	:
cord-023095-4dannjjm	5364	15	removal	removal	NN
cord-023095-4dannjjm	5364	16	of	of	IN
cord-023095-4dannjjm	5364	17	endotracheal	endotracheal	NN
cord-023095-4dannjjm	5364	18	tube	tube	NN
cord-023095-4dannjjm	5364	19	,	,	,
cord-023095-4dannjjm	5364	20	dog	dog	NN
cord-023095-4dannjjm	5364	21	lifting	lifting	NN
cord-023095-4dannjjm	5364	22	head	head	NN
cord-023095-4dannjjm	5364	23	,	,	,
cord-023095-4dannjjm	5364	24	dog	dog	NN
cord-023095-4dannjjm	5364	25	attaining	attain	VBG
cord-023095-4dannjjm	5364	26	sternal	sternal	JJ
cord-023095-4dannjjm	5364	27	recumbency	recumbency	NN
cord-023095-4dannjjm	5364	28	and	and	CC
cord-023095-4dannjjm	5364	29	dog	dog	NN
cord-023095-4dannjjm	5364	30	standing	standing	NN
cord-023095-4dannjjm	5364	31	.	.	.
cord-023095-4dannjjm	5365	1	Pulse	pulse	NN
cord-023095-4dannjjm	5365	2	rate	rate	NN
cord-023095-4dannjjm	5365	3	,	,	,
cord-023095-4dannjjm	5365	4	respiratory	respiratory	JJ
cord-023095-4dannjjm	5365	5	rate	rate	NN
cord-023095-4dannjjm	5365	6	,	,	,
cord-023095-4dannjjm	5365	7	SpO	SpO	NNP
cord-023095-4dannjjm	5365	8	2	2	CD
cord-023095-4dannjjm	5365	9	and	and	CC
cord-023095-4dannjjm	5365	10	ETCO	ETCO	NNP
cord-023095-4dannjjm	5365	11	2	2	CD
cord-023095-4dannjjm	5365	12	were	be	VBD
cord-023095-4dannjjm	5365	13	each	each	DT
cord-023095-4dannjjm	5365	14	measured	measure	VBN
cord-023095-4dannjjm	5365	15	every	every	DT
cord-023095-4dannjjm	5365	16	5	5	CD
cord-023095-4dannjjm	5365	17	min	min	NN
cord-023095-4dannjjm	5365	18	.	.	.
cord-023095-4dannjjm	5366	1	Within	within	IN
cord-023095-4dannjjm	5366	2	-	-	HYPH
cord-023095-4dannjjm	5366	3	dog	dog	NN
cord-023095-4dannjjm	5366	4	comparisons	comparison	NNS
cord-023095-4dannjjm	5366	5	were	be	VBD
cord-023095-4dannjjm	5366	6	made	make	VBN
cord-023095-4dannjjm	5366	7	using	use	VBG
cord-023095-4dannjjm	5366	8	the	the	DT
cord-023095-4dannjjm	5366	9	paired	pair	VBN
cord-023095-4dannjjm	5366	10	Student	Student	NNP
cord-023095-4dannjjm	5366	11	's	's	POS
cord-023095-4dannjjm	5366	12	t	t	NN
cord-023095-4dannjjm	5366	13	-	-	HYPH
cord-023095-4dannjjm	5366	14	test	test	NN
cord-023095-4dannjjm	5366	15	.	.	.
cord-023095-4dannjjm	5367	1	For	for	IN
cord-023095-4dannjjm	5367	2	both	both	DT
cord-023095-4dannjjm	5367	3	ALF	ALF	NNP
cord-023095-4dannjjm	5367	4	and	and	CC
cord-023095-4dannjjm	5367	5	PPF	PPF	NNP
cord-023095-4dannjjm	5367	6	all	all	DT
cord-023095-4dannjjm	5367	7	6	6	CD
cord-023095-4dannjjm	5367	8	dogs	dog	NNS
cord-023095-4dannjjm	5367	9	respired	respire	VBD
cord-023095-4dannjjm	5367	10	voluntarily	voluntarily	RB
cord-023095-4dannjjm	5367	11	at	at	IN
cord-023095-4dannjjm	5367	12	the	the	DT
cord-023095-4dannjjm	5367	13	labeled	label	VBN
cord-023095-4dannjjm	5367	14	(	(	-LRB-
cord-023095-4dannjjm	5367	15	1	1	CD
cord-023095-4dannjjm	5367	16	X	x	NN
cord-023095-4dannjjm	5367	17	)	)	-RRB-
cord-023095-4dannjjm	5367	18	dose	dose	NN
cord-023095-4dannjjm	5367	19	.	.	.
cord-023095-4dannjjm	5368	1	For	for	IN
cord-023095-4dannjjm	5368	2	PPF	PPF	NNP
cord-023095-4dannjjm	5368	3	at	at	IN
cord-023095-4dannjjm	5368	4	2	2	CD
cord-023095-4dannjjm	5368	5	and	and	CC
cord-023095-4dannjjm	5368	6	5	5	CD
cord-023095-4dannjjm	5368	7	X	X	NNS
cord-023095-4dannjjm	5368	8	doses	dose	NNS
cord-023095-4dannjjm	5368	9	,	,	,
cord-023095-4dannjjm	5368	10	4	4	CD
cord-023095-4dannjjm	5368	11	and	and	CC
cord-023095-4dannjjm	5368	12	0	0	CD
cord-023095-4dannjjm	5368	13	dogs	dog	NNS
cord-023095-4dannjjm	5368	14	respired	respire	VBD
cord-023095-4dannjjm	5368	15	voluntarily	voluntarily	RB
cord-023095-4dannjjm	5368	16	respectively	respectively	RB
cord-023095-4dannjjm	5368	17	.	.	.
cord-023095-4dannjjm	5369	1	For	for	IN
cord-023095-4dannjjm	5369	2	ALF	ALF	NNP
cord-023095-4dannjjm	5369	3	at	at	IN
cord-023095-4dannjjm	5369	4	2	2	CD
cord-023095-4dannjjm	5369	5	,	,	,
cord-023095-4dannjjm	5369	6	5	5	CD
cord-023095-4dannjjm	5369	7	and	and	CC
cord-023095-4dannjjm	5369	8	10	10	CD
cord-023095-4dannjjm	5370	1	X	X	NNS
cord-023095-4dannjjm	5370	2	doses	dose	NNS
cord-023095-4dannjjm	5370	3	,	,	,
cord-023095-4dannjjm	5370	4	all	all	DT
cord-023095-4dannjjm	5370	5	6	6	CD
cord-023095-4dannjjm	5370	6	,	,	,
cord-023095-4dannjjm	5370	7	4	4	CD
cord-023095-4dannjjm	5370	8	and	and	CC
cord-023095-4dannjjm	5370	9	1	1	CD
cord-023095-4dannjjm	5370	10	dog	dog	NN
cord-023095-4dannjjm	5370	11	respired	respire	VBD
cord-023095-4dannjjm	5370	12	voluntarily	voluntarily	RB
cord-023095-4dannjjm	5370	13	respectively	respectively	RB
cord-023095-4dannjjm	5370	14	.	.	.
cord-023095-4dannjjm	5371	1	For	for	IN
cord-023095-4dannjjm	5371	2	all	all	DT
cord-023095-4dannjjm	5371	3	six	six	CD
cord-023095-4dannjjm	5371	4	dogs	dog	NNS
cord-023095-4dannjjm	5371	5	to	to	TO
cord-023095-4dannjjm	5371	6	become	become	VB
cord-023095-4dannjjm	5371	7	apneic	apneic	JJ
cord-023095-4dannjjm	5371	8	required	require	VBN
cord-023095-4dannjjm	5371	9	5	5	CD
cord-023095-4dannjjm	5371	10	X	x	NN
cord-023095-4dannjjm	5371	11	dose	dose	NN
cord-023095-4dannjjm	5371	12	of	of	IN
cord-023095-4dannjjm	5371	13	PPF	PPF	NNP
cord-023095-4dannjjm	5371	14	and	and	CC
cord-023095-4dannjjm	5371	15	20	20	CD
cord-023095-4dannjjm	5371	16	X	x	NN
cord-023095-4dannjjm	5371	17	dose	dose	NN
cord-023095-4dannjjm	5371	18	of	of	IN
cord-023095-4dannjjm	5371	19	ALF	ALF	NNP
cord-023095-4dannjjm	5371	20	.	.	.
cord-023095-4dannjjm	5372	1	The	the	DT
cord-023095-4dannjjm	5372	2	mean	mean	JJ
cord-023095-4dannjjm	5372	3	no	no	DT
cord-023095-4dannjjm	5372	4	observable	observable	JJ
cord-023095-4dannjjm	5372	5	adverse	adverse	JJ
cord-023095-4dannjjm	5372	6	effect	effect	NN
cord-023095-4dannjjm	5372	7	dose	dose	NN
cord-023095-4dannjjm	5372	8	(	(	-LRB-
cord-023095-4dannjjm	5372	9	NOAEL	NOAEL	NNP
cord-023095-4dannjjm	5372	10	)	)	-RRB-
cord-023095-4dannjjm	5372	11	expressed	express	VBD
cord-023095-4dannjjm	5372	12	as	as	IN
cord-023095-4dannjjm	5372	13	a	a	DT
cord-023095-4dannjjm	5372	14	multiple	multiple	NN
cord-023095-4dannjjm	5372	15	of	of	IN
cord-023095-4dannjjm	5372	16	the	the	DT
cord-023095-4dannjjm	5372	17	labeled	labeled	JJ
cord-023095-4dannjjm	5372	18	dose	dose	NN
cord-023095-4dannjjm	5372	19	was	be	VBD
cord-023095-4dannjjm	5372	20	higher	high	JJR
cord-023095-4dannjjm	5372	21	for	for	IN
cord-023095-4dannjjm	5372	22	ALF	ALF	NNP
cord-023095-4dannjjm	5372	23	(	(	-LRB-
cord-023095-4dannjjm	5372	24	4.8	4.8	CD
cord-023095-4dannjjm	5372	25	X	X	NNS
cord-023095-4dannjjm	5372	26	)	)	-RRB-
cord-023095-4dannjjm	5372	27	than	than	IN
cord-023095-4dannjjm	5372	28	for	for	IN
cord-023095-4dannjjm	5372	29	PPF	PPF	NNP
cord-023095-4dannjjm	5372	30	(	(	-LRB-
cord-023095-4dannjjm	5372	31	1.7	1.7	CD
cord-023095-4dannjjm	5372	32	X	x	NN
cord-023095-4dannjjm	5372	33	)	)	-RRB-
cord-023095-4dannjjm	5373	1	(	(	-LRB-
cord-023095-4dannjjm	5373	2	p	p	NN
cord-023095-4dannjjm	5373	3	5	5	CD
cord-023095-4dannjjm	5373	4	0.035	0.035	CD
cord-023095-4dannjjm	5373	5	)	)	-RRB-
cord-023095-4dannjjm	5373	6	.	.	.
cord-023095-4dannjjm	5374	1	There	there	EX
cord-023095-4dannjjm	5374	2	were	be	VBD
cord-023095-4dannjjm	5374	3	no	no	DT
cord-023095-4dannjjm	5374	4	significant	significant	JJ
cord-023095-4dannjjm	5374	5	differences	difference	NNS
cord-023095-4dannjjm	5374	6	between	between	IN
cord-023095-4dannjjm	5374	7	times	time	NNS
cord-023095-4dannjjm	5374	8	to	to	IN
cord-023095-4dannjjm	5374	9	extubation	extubation	NN
cord-023095-4dannjjm	5374	10	,	,	,
cord-023095-4dannjjm	5374	11	head	head	NN
cord-023095-4dannjjm	5374	12	lift	lift	NN
cord-023095-4dannjjm	5374	13	or	or	CC
cord-023095-4dannjjm	5374	14	attaining	attain	VBG
cord-023095-4dannjjm	5374	15	sternal	sternal	JJ
cord-023095-4dannjjm	5374	16	recumbency	recumbency	NN
cord-023095-4dannjjm	5374	17	after	after	IN
cord-023095-4dannjjm	5374	18	ALF	ALF	NNP
cord-023095-4dannjjm	5374	19	and	and	CC
cord-023095-4dannjjm	5374	20	PPF	PPF	NNP
cord-023095-4dannjjm	5374	21	at	at	IN
cord-023095-4dannjjm	5374	22	1	1	CD
cord-023095-4dannjjm	5374	23	,	,	,
cord-023095-4dannjjm	5374	24	2	2	CD
cord-023095-4dannjjm	5374	25	and	and	CC
cord-023095-4dannjjm	5374	26	5	5	CD
cord-023095-4dannjjm	5374	27	X	X	NNS
cord-023095-4dannjjm	5374	28	doses	dose	NNS
cord-023095-4dannjjm	5374	29	.	.	.
cord-023095-4dannjjm	5375	1	At	at	IN
cord-023095-4dannjjm	5375	2	the	the	DT
cord-023095-4dannjjm	5375	3	2	2	CD
cord-023095-4dannjjm	5375	4	X	x	NN
cord-023095-4dannjjm	5375	5	dose	dose	NN
cord-023095-4dannjjm	5375	6	,	,	,
cord-023095-4dannjjm	5375	7	dogs	dog	NNS
cord-023095-4dannjjm	5375	8	took	take	VBD
cord-023095-4dannjjm	5375	9	longer	long	RBR
cord-023095-4dannjjm	5375	10	to	to	TO
cord-023095-4dannjjm	5375	11	stand	stand	VB
cord-023095-4dannjjm	5375	12	after	after	IN
cord-023095-4dannjjm	5375	13	ALF	ALF	NNP
cord-023095-4dannjjm	5375	14	(	(	-LRB-
cord-023095-4dannjjm	5375	15	29.0	29.0	CD
cord-023095-4dannjjm	5375	16	AE	AE	NNP
cord-023095-4dannjjm	5375	17	7.0	7.0	CD
cord-023095-4dannjjm	5375	18	min	min	NNP
cord-023095-4dannjjm	5375	19	)	)	-RRB-
cord-023095-4dannjjm	5375	20	than	than	IN
cord-023095-4dannjjm	5375	21	PPF	PPF	NNP
cord-023095-4dannjjm	5375	22	(	(	-LRB-
cord-023095-4dannjjm	5375	23	25.0	25.0	CD
cord-023095-4dannjjm	5375	24	AE	AE	NNP
cord-023095-4dannjjm	5375	25	8.3	8.3	CD
cord-023095-4dannjjm	5375	26	min	min	NN
cord-023095-4dannjjm	5375	27	)	)	-RRB-
cord-023095-4dannjjm	5375	28	.	.	.
cord-023095-4dannjjm	5376	1	We	-PRON-	PRP
cord-023095-4dannjjm	5376	2	concluded	conclude	VBD
cord-023095-4dannjjm	5376	3	that	that	IN
cord-023095-4dannjjm	5376	4	based	base	VBN
cord-023095-4dannjjm	5376	5	on	on	IN
cord-023095-4dannjjm	5376	6	anaesthetic	anaesthetic	JJ
cord-023095-4dannjjm	5376	7	duration	duration	NN
cord-023095-4dannjjm	5376	8	,	,	,
cord-023095-4dannjjm	5376	9	the	the	DT
cord-023095-4dannjjm	5376	10	manufacturer	manufacturer	NN
cord-023095-4dannjjm	5376	11	's	's	POS
cord-023095-4dannjjm	5376	12	labeled	label	VBN
cord-023095-4dannjjm	5376	13	dose	dose	NN
cord-023095-4dannjjm	5376	14	rates	rate	NNS
cord-023095-4dannjjm	5376	15	of	of	IN
cord-023095-4dannjjm	5376	16	2	2	CD
cord-023095-4dannjjm	5376	17	mg	mg	NNP
cord-023095-4dannjjm	5376	18	/	/	SYM
cord-023095-4dannjjm	5376	19	kg	kg	NN
cord-023095-4dannjjm	5376	20	for	for	IN
cord-023095-4dannjjm	5376	21	ALF	ALF	NNP
cord-023095-4dannjjm	5376	22	and	and	CC
cord-023095-4dannjjm	5376	23	6.5	6.5	CD
cord-023095-4dannjjm	5376	24	mg	mg	NNP
cord-023095-4dannjjm	5376	25	/	/	SYM
cord-023095-4dannjjm	5376	26	kg	kg	NNS
cord-023095-4dannjjm	5376	27	for	for	IN
cord-023095-4dannjjm	5376	28	PPF	PPF	NNP
cord-023095-4dannjjm	5376	29	were	be	VBD
cord-023095-4dannjjm	5376	30	equivalent	equivalent	JJ
cord-023095-4dannjjm	5376	31	.	.	.
cord-023095-4dannjjm	5377	1	However	however	RB
cord-023095-4dannjjm	5377	2	,	,	,
cord-023095-4dannjjm	5377	3	based	base	VBN
cord-023095-4dannjjm	5377	4	on	on	IN
cord-023095-4dannjjm	5377	5	the	the	DT
cord-023095-4dannjjm	5377	6	dose	dose	NN
cord-023095-4dannjjm	5377	7	escalation	escalation	NN
cord-023095-4dannjjm	5377	8	,	,	,
cord-023095-4dannjjm	5377	9	the	the	DT
cord-023095-4dannjjm	5377	10	number	number	NN
cord-023095-4dannjjm	5377	11	of	of	IN
cord-023095-4dannjjm	5377	12	dogs	dog	NNS
cord-023095-4dannjjm	5377	13	becoming	become	VBG
cord-023095-4dannjjm	5377	14	apneic	apneic	JJ
cord-023095-4dannjjm	5377	15	at	at	IN
cord-023095-4dannjjm	5377	16	each	each	DT
cord-023095-4dannjjm	5377	17	dose	dose	NN
cord-023095-4dannjjm	5377	18	-	-	HYPH
cord-023095-4dannjjm	5377	19	multiple	multiple	NN
cord-023095-4dannjjm	5377	20	is	be	VBZ
cord-023095-4dannjjm	5377	21	consistent	consistent	JJ
cord-023095-4dannjjm	5377	22	with	with	IN
cord-023095-4dannjjm	5377	23	PPF	PPF	NNP
cord-023095-4dannjjm	5377	24	having	have	VBG
cord-023095-4dannjjm	5377	25	a	a	DT
cord-023095-4dannjjm	5377	26	narrower	narrow	JJR
cord-023095-4dannjjm	5377	27	safety	safety	NN
cord-023095-4dannjjm	5377	28	margin	margin	NN
cord-023095-4dannjjm	5377	29	,	,	,
cord-023095-4dannjjm	5377	30	i.e.	i.e.	FW
cord-023095-4dannjjm	5377	31	,	,	,
cord-023095-4dannjjm	5377	32	PPF	PPF	NNP
cord-023095-4dannjjm	5377	33	caused	cause	VBD
cord-023095-4dannjjm	5377	34	more	more	JJR
cord-023095-4dannjjm	5377	35	respiratory	respiratory	JJ
cord-023095-4dannjjm	5377	36	depression	depression	NN
cord-023095-4dannjjm	5377	37	than	than	IN
cord-023095-4dannjjm	5377	38	ALF	ALF	NNP
cord-023095-4dannjjm	5377	39	.	.	.
cord-023095-4dannjjm	5378	1	Parenteral	parenteral	JJ
cord-023095-4dannjjm	5378	2	levetiracetam	levetiracetam	NNS
cord-023095-4dannjjm	5378	3	(	(	-LRB-
cord-023095-4dannjjm	5378	4	LEV	LEV	NNP
cord-023095-4dannjjm	5378	5	)	)	-RRB-
cord-023095-4dannjjm	5378	6	has	have	VBZ
cord-023095-4dannjjm	5378	7	been	be	VBN
cord-023095-4dannjjm	5378	8	shown	show	VBN
cord-023095-4dannjjm	5378	9	to	to	TO
cord-023095-4dannjjm	5378	10	rapidly	rapidly	RB
cord-023095-4dannjjm	5378	11	attain	attain	VB
cord-023095-4dannjjm	5378	12	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5378	13	levels	level	NNS
cord-023095-4dannjjm	5378	14	in	in	IN
cord-023095-4dannjjm	5378	15	dogs	dog	NNS
cord-023095-4dannjjm	5378	16	when	when	WRB
cord-023095-4dannjjm	5378	17	given	give	VBN
cord-023095-4dannjjm	5378	18	IV	IV	NNP
cord-023095-4dannjjm	5378	19	or	or	CC
cord-023095-4dannjjm	5378	20	IM	IM	NNP
cord-023095-4dannjjm	5378	21	,	,	,
cord-023095-4dannjjm	5378	22	and	and	CC
cord-023095-4dannjjm	5378	23	has	have	VBZ
cord-023095-4dannjjm	5378	24	been	be	VBN
cord-023095-4dannjjm	5378	25	used	use	VBN
cord-023095-4dannjjm	5378	26	offlabel	offlabel	NN
cord-023095-4dannjjm	5378	27	for	for	IN
cord-023095-4dannjjm	5378	28	the	the	DT
cord-023095-4dannjjm	5378	29	treatment	treatment	NN
cord-023095-4dannjjm	5378	30	of	of	IN
cord-023095-4dannjjm	5378	31	seizure	seizure	NN
cord-023095-4dannjjm	5378	32	emergencies	emergency	NNS
cord-023095-4dannjjm	5378	33	.	.	.
cord-023095-4dannjjm	5379	1	The	the	DT
cord-023095-4dannjjm	5379	2	purpose	purpose	NN
cord-023095-4dannjjm	5379	3	of	of	IN
cord-023095-4dannjjm	5379	4	this	this	DT
cord-023095-4dannjjm	5379	5	study	study	NN
cord-023095-4dannjjm	5379	6	was	be	VBD
cord-023095-4dannjjm	5379	7	to	to	TO
cord-023095-4dannjjm	5379	8	determine	determine	VB
cord-023095-4dannjjm	5379	9	the	the	DT
cord-023095-4dannjjm	5379	10	safety	safety	NN
cord-023095-4dannjjm	5379	11	and	and	CC
cord-023095-4dannjjm	5379	12	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	5379	13	of	of	IN
cord-023095-4dannjjm	5379	14	subcutaneously	subcutaneously	RB
cord-023095-4dannjjm	5379	15	administered	administer	VBN
cord-023095-4dannjjm	5379	16	levetiracetam	levetiracetam	NNS
cord-023095-4dannjjm	5379	17	in	in	IN
cord-023095-4dannjjm	5379	18	healthy	healthy	JJ
cord-023095-4dannjjm	5379	19	dogs	dog	NNS
cord-023095-4dannjjm	5379	20	.	.	.
cord-023095-4dannjjm	5380	1	Potential	potential	JJ
cord-023095-4dannjjm	5380	2	application	application	NN
cord-023095-4dannjjm	5380	3	of	of	IN
cord-023095-4dannjjm	5380	4	these	these	DT
cord-023095-4dannjjm	5380	5	results	result	NNS
cord-023095-4dannjjm	5380	6	would	would	MD
cord-023095-4dannjjm	5380	7	be	be	VB
cord-023095-4dannjjm	5380	8	use	use	NN
cord-023095-4dannjjm	5380	9	of	of	IN
cord-023095-4dannjjm	5380	10	SQ	SQ	NNP
cord-023095-4dannjjm	5380	11	LEV	LEV	NNP
cord-023095-4dannjjm	5380	12	instead	instead	RB
cord-023095-4dannjjm	5380	13	of	of	IN
cord-023095-4dannjjm	5380	14	or	or	CC
cord-023095-4dannjjm	5380	15	in	in	IN
cord-023095-4dannjjm	5380	16	addition	addition	NN
cord-023095-4dannjjm	5380	17	to	to	IN
cord-023095-4dannjjm	5380	18	rectal	rectal	JJ
cord-023095-4dannjjm	5380	19	diazepam	diazepam	NN
cord-023095-4dannjjm	5380	20	for	for	IN
cord-023095-4dannjjm	5380	21	the	the	DT
cord-023095-4dannjjm	5380	22	treatment	treatment	NN
cord-023095-4dannjjm	5380	23	of	of	IN
cord-023095-4dannjjm	5380	24	cluster	cluster	NN
cord-023095-4dannjjm	5380	25	seizures	seizure	NNS
cord-023095-4dannjjm	5380	26	at	at	IN
cord-023095-4dannjjm	5380	27	home	home	NN
cord-023095-4dannjjm	5380	28	.	.	.
cord-023095-4dannjjm	5381	1	LEV	LEV	NNP
cord-023095-4dannjjm	5381	2	was	be	VBD
cord-023095-4dannjjm	5381	3	administered	administer	VBN
cord-023095-4dannjjm	5381	4	SQ	SQ	NNP
cord-023095-4dannjjm	5381	5	between	between	IN
cord-023095-4dannjjm	5381	6	the	the	DT
cord-023095-4dannjjm	5381	7	shoulder	shoulder	NN
cord-023095-4dannjjm	5381	8	blades	blade	NNS
cord-023095-4dannjjm	5381	9	to	to	IN
cord-023095-4dannjjm	5381	10	4	4	CD
cord-023095-4dannjjm	5381	11	healthy	healthy	JJ
cord-023095-4dannjjm	5381	12	,	,	,
cord-023095-4dannjjm	5381	13	purpose	purpose	NN
cord-023095-4dannjjm	5381	14	-	-	HYPH
cord-023095-4dannjjm	5381	15	bred	breed	VBN
cord-023095-4dannjjm	5381	16	hound	hound	NN
cord-023095-4dannjjm	5381	17	dogs	dog	NNS
cord-023095-4dannjjm	5381	18	,	,	,
cord-023095-4dannjjm	5381	19	at	at	IN
cord-023095-4dannjjm	5381	20	a	a	DT
cord-023095-4dannjjm	5381	21	dose	dose	NN
cord-023095-4dannjjm	5381	22	of	of	IN
cord-023095-4dannjjm	5381	23	60	60	CD
cord-023095-4dannjjm	5381	24	mg	mg	NN
cord-023095-4dannjjm	5381	25	/	/	SYM
cord-023095-4dannjjm	5381	26	kg	kg	NN
cord-023095-4dannjjm	5381	27	(	(	-LRB-
cord-023095-4dannjjm	5381	28	undiluted	undiluted	JJ
cord-023095-4dannjjm	5381	29	)	)	-RRB-
cord-023095-4dannjjm	5381	30	.	.	.
cord-023095-4dannjjm	5382	1	Blood	blood	NN
cord-023095-4dannjjm	5382	2	samples	sample	NNS
cord-023095-4dannjjm	5382	3	were	be	VBD
cord-023095-4dannjjm	5382	4	collected	collect	VBN
cord-023095-4dannjjm	5382	5	at	at	IN
cord-023095-4dannjjm	5382	6	15	15	CD
cord-023095-4dannjjm	5382	7	,	,	,
cord-023095-4dannjjm	5382	8	120	120	CD
cord-023095-4dannjjm	5382	9	and	and	CC
cord-023095-4dannjjm	5382	10	420	420	CD
cord-023095-4dannjjm	5382	11	minutes	minute	NNS
cord-023095-4dannjjm	5382	12	after	after	IN
cord-023095-4dannjjm	5382	13	LEV	LEV	NNP
cord-023095-4dannjjm	5382	14	administration	administration	NN
cord-023095-4dannjjm	5382	15	via	via	IN
cord-023095-4dannjjm	5382	16	jugular	jugular	NN
cord-023095-4dannjjm	5382	17	venipuncture	venipuncture	NN
cord-023095-4dannjjm	5382	18	.	.	.
cord-023095-4dannjjm	5383	1	Plasma	plasma	NN
cord-023095-4dannjjm	5383	2	LEV	LEV	NNP
cord-023095-4dannjjm	5383	3	concentrations	concentration	NNS
cord-023095-4dannjjm	5383	4	were	be	VBD
cord-023095-4dannjjm	5383	5	measured	measure	VBN
cord-023095-4dannjjm	5383	6	by	by	IN
cord-023095-4dannjjm	5383	7	high	high	JJ
cord-023095-4dannjjm	5383	8	pressure	pressure	NN
cord-023095-4dannjjm	5383	9	liquid	liquid	NN
cord-023095-4dannjjm	5383	10	chromatography	chromatography	NN
cord-023095-4dannjjm	5383	11	.	.	.
cord-023095-4dannjjm	5384	1	None	none	NN
cord-023095-4dannjjm	5384	2	of	of	IN
cord-023095-4dannjjm	5384	3	the	the	DT
cord-023095-4dannjjm	5384	4	dogs	dog	NNS
cord-023095-4dannjjm	5384	5	became	become	VBD
cord-023095-4dannjjm	5384	6	sedated	sedate	VBN
cord-023095-4dannjjm	5384	7	,	,	,
cord-023095-4dannjjm	5384	8	nor	nor	CC
cord-023095-4dannjjm	5384	9	was	be	VBD
cord-023095-4dannjjm	5384	10	there	there	EX
cord-023095-4dannjjm	5384	11	pain	pain	NN
cord-023095-4dannjjm	5384	12	evident	evident	JJ
cord-023095-4dannjjm	5384	13	on	on	IN
cord-023095-4dannjjm	5384	14	palpation	palpation	NN
cord-023095-4dannjjm	5384	15	of	of	IN
cord-023095-4dannjjm	5384	16	the	the	DT
cord-023095-4dannjjm	5384	17	injection	injection	NN
cord-023095-4dannjjm	5384	18	site	site	NN
cord-023095-4dannjjm	5384	19	.	.	.
cord-023095-4dannjjm	5385	1	Mean	mean	JJ
cord-023095-4dannjjm	5385	2	(	(	-LRB-
cord-023095-4dannjjm	5385	3	standard	standard	JJ
cord-023095-4dannjjm	5385	4	deviation	deviation	NN
cord-023095-4dannjjm	5385	5	)	)	-RRB-
cord-023095-4dannjjm	5386	1	LEV	LEV	NNP
cord-023095-4dannjjm	5386	2	concentration	concentration	NN
cord-023095-4dannjjm	5386	3	was	be	VBD
cord-023095-4dannjjm	5386	4	65.2	65.2	CD
cord-023095-4dannjjm	5386	5	(	(	-LRB-
cord-023095-4dannjjm	5386	6	29.5	29.5	CD
cord-023095-4dannjjm	5386	7	)	)	-RRB-
cord-023095-4dannjjm	5386	8	,	,	,
cord-023095-4dannjjm	5386	9	114.5	114.5	CD
cord-023095-4dannjjm	5386	10	(	(	-LRB-
cord-023095-4dannjjm	5386	11	10.5	10.5	CD
cord-023095-4dannjjm	5386	12	)	)	-RRB-
cord-023095-4dannjjm	5386	13	and	and	CC
cord-023095-4dannjjm	5386	14	84.9	84.9	CD
cord-023095-4dannjjm	5386	15	(	(	-LRB-
cord-023095-4dannjjm	5386	16	20.6	20.6	CD
cord-023095-4dannjjm	5386	17	)	)	-RRB-
cord-023095-4dannjjm	5387	1	mg	mg	NNP
cord-023095-4dannjjm	5387	2	/	/	SYM
cord-023095-4dannjjm	5387	3	ml	ml	XX
cord-023095-4dannjjm	5387	4	at	at	IN
cord-023095-4dannjjm	5387	5	15	15	CD
cord-023095-4dannjjm	5387	6	,	,	,
cord-023095-4dannjjm	5387	7	120	120	CD
cord-023095-4dannjjm	5387	8	and	and	CC
cord-023095-4dannjjm	5387	9	420	420	CD
cord-023095-4dannjjm	5387	10	minutes	minute	NNS
cord-023095-4dannjjm	5387	11	,	,	,
cord-023095-4dannjjm	5387	12	respectively	respectively	RB
cord-023095-4dannjjm	5387	13	.	.	.
cord-023095-4dannjjm	5388	1	Administration	Administration	NNP
cord-023095-4dannjjm	5388	2	of	of	IN
cord-023095-4dannjjm	5388	3	SQ	SQ	NNP
cord-023095-4dannjjm	5388	4	LEV	LEV	NNP
cord-023095-4dannjjm	5388	5	was	be	VBD
cord-023095-4dannjjm	5388	6	well	well	RB
cord-023095-4dannjjm	5388	7	tolerated	tolerate	VBN
cord-023095-4dannjjm	5388	8	,	,	,
cord-023095-4dannjjm	5388	9	and	and	CC
cord-023095-4dannjjm	5388	10	exceeded	exceed	VBD
cord-023095-4dannjjm	5388	11	the	the	DT
cord-023095-4dannjjm	5388	12	suggested	suggest	VBN
cord-023095-4dannjjm	5388	13	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5388	14	range	range	NN
cord-023095-4dannjjm	5388	15	(	(	-LRB-
cord-023095-4dannjjm	5388	16	5	5	CD
cord-023095-4dannjjm	5388	17	-	-	SYM
cord-023095-4dannjjm	5388	18	45	45	CD
cord-023095-4dannjjm	5388	19	mg	mg	NNP
cord-023095-4dannjjm	5388	20	/	/	SYM
cord-023095-4dannjjm	5388	21	ml	ml	NNP
cord-023095-4dannjjm	5388	22	)	)	-RRB-
cord-023095-4dannjjm	5388	23	within	within	IN
cord-023095-4dannjjm	5388	24	15	15	CD
cord-023095-4dannjjm	5388	25	minutes	minute	NNS
cord-023095-4dannjjm	5388	26	of	of	IN
cord-023095-4dannjjm	5388	27	administration	administration	NN
cord-023095-4dannjjm	5388	28	,	,	,
cord-023095-4dannjjm	5388	29	and	and	CC
cord-023095-4dannjjm	5388	30	remained	remain	VBD
cord-023095-4dannjjm	5388	31	above	above	IN
cord-023095-4dannjjm	5388	32	the	the	DT
cord-023095-4dannjjm	5388	33	range	range	NN
cord-023095-4dannjjm	5388	34	for	for	IN
cord-023095-4dannjjm	5388	35	at	at	RB
cord-023095-4dannjjm	5388	36	least	least	RBS
cord-023095-4dannjjm	5388	37	7	7	CD
cord-023095-4dannjjm	5388	38	hours	hour	NNS
cord-023095-4dannjjm	5388	39	.	.	.
cord-023095-4dannjjm	5389	1	These	these	DT
cord-023095-4dannjjm	5389	2	data	datum	NNS
cord-023095-4dannjjm	5389	3	indicate	indicate	VBP
cord-023095-4dannjjm	5389	4	that	that	IN
cord-023095-4dannjjm	5389	5	SQ	SQ	NNP
cord-023095-4dannjjm	5389	6	LEV	LEV	NNP
cord-023095-4dannjjm	5389	7	administration	administration	NN
cord-023095-4dannjjm	5389	8	may	may	MD
cord-023095-4dannjjm	5389	9	be	be	VB
cord-023095-4dannjjm	5389	10	an	an	DT
cord-023095-4dannjjm	5389	11	alternative	alternative	NN
cord-023095-4dannjjm	5389	12	for	for	IN
cord-023095-4dannjjm	5389	13	the	the	DT
cord-023095-4dannjjm	5389	14	at	at	IN
cord-023095-4dannjjm	5389	15	-	-	HYPH
cord-023095-4dannjjm	5389	16	home	home	NN
cord-023095-4dannjjm	5389	17	treatment	treatment	NN
cord-023095-4dannjjm	5389	18	of	of	IN
cord-023095-4dannjjm	5389	19	cluster	cluster	NN
cord-023095-4dannjjm	5389	20	seizures	seizure	NNS
cord-023095-4dannjjm	5389	21	in	in	IN
cord-023095-4dannjjm	5389	22	dogs	dog	NNS
cord-023095-4dannjjm	5389	23	,	,	,
cord-023095-4dannjjm	5389	24	and	and	CC
cord-023095-4dannjjm	5389	25	prospective	prospective	JJ
cord-023095-4dannjjm	5389	26	studies	study	NNS
cord-023095-4dannjjm	5389	27	in	in	IN
cord-023095-4dannjjm	5389	28	epileptic	epileptic	JJ
cord-023095-4dannjjm	5389	29	dogs	dog	NNS
cord-023095-4dannjjm	5389	30	are	be	VBP
cord-023095-4dannjjm	5389	31	warranted	warrant	VBN
cord-023095-4dannjjm	5389	32	.	.	.
cord-023095-4dannjjm	5390	1	The	the	DT
cord-023095-4dannjjm	5390	2	purpose	purpose	NN
cord-023095-4dannjjm	5390	3	of	of	IN
cord-023095-4dannjjm	5390	4	this	this	DT
cord-023095-4dannjjm	5390	5	study	study	NN
cord-023095-4dannjjm	5390	6	was	be	VBD
cord-023095-4dannjjm	5390	7	to	to	TO
cord-023095-4dannjjm	5390	8	assess	assess	VB
cord-023095-4dannjjm	5390	9	the	the	DT
cord-023095-4dannjjm	5390	10	effects	effect	NNS
cord-023095-4dannjjm	5390	11	of	of	IN
cord-023095-4dannjjm	5390	12	CYP	CYP	NNP
cord-023095-4dannjjm	5390	13	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	5390	14	(	(	-LRB-
cord-023095-4dannjjm	5390	15	ketoconazole	ketoconazole	NNP
cord-023095-4dannjjm	5390	16	,	,	,
cord-023095-4dannjjm	5390	17	chloramphenicol	chloramphenicol	NN
cord-023095-4dannjjm	5390	18	,	,	,
cord-023095-4dannjjm	5390	19	fluoxetine	fluoxetine	NN
cord-023095-4dannjjm	5390	20	,	,	,
cord-023095-4dannjjm	5390	21	trimethoprim	trimethoprim	NNP
cord-023095-4dannjjm	5390	22	,	,	,
cord-023095-4dannjjm	5390	23	cimetidine	cimetidine	NN
cord-023095-4dannjjm	5390	24	,	,	,
cord-023095-4dannjjm	5390	25	and	and	CC
cord-023095-4dannjjm	5390	26	medetomidine	medetomidine	NNP
cord-023095-4dannjjm	5390	27	)	)	-RRB-
cord-023095-4dannjjm	5390	28	in	in	IN
cord-023095-4dannjjm	5390	29	varying	vary	VBG
cord-023095-4dannjjm	5390	30	combinations	combination	NNS
cord-023095-4dannjjm	5390	31	on	on	IN
cord-023095-4dannjjm	5390	32	the	the	DT
cord-023095-4dannjjm	5390	33	bioavailability	bioavailability	NN
cord-023095-4dannjjm	5390	34	of	of	IN
cord-023095-4dannjjm	5390	35	oral	oral	JJ
cord-023095-4dannjjm	5390	36	methadone	methadone	NN
cord-023095-4dannjjm	5390	37	in	in	IN
cord-023095-4dannjjm	5390	38	healthy	healthy	JJ
cord-023095-4dannjjm	5390	39	Greyhound	Greyhound	NNP
cord-023095-4dannjjm	5390	40	dogs	dog	NNS
cord-023095-4dannjjm	5390	41	.	.	.
cord-023095-4dannjjm	5391	1	The	the	DT
cord-023095-4dannjjm	5391	2	IACUC	IACUC	NNP
cord-023095-4dannjjm	5391	3	approved	approve	VBD
cord-023095-4dannjjm	5391	4	this	this	DT
cord-023095-4dannjjm	5391	5	study	study	NN
cord-023095-4dannjjm	5391	6	.	.	.
cord-023095-4dannjjm	5392	1	CYP	CYP	NNP
cord-023095-4dannjjm	5392	2	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	5392	3	were	be	VBD
cord-023095-4dannjjm	5392	4	administered	administer	VBN
cord-023095-4dannjjm	5392	5	PO	PO	NNP
cord-023095-4dannjjm	5392	6	for	for	IN
cord-023095-4dannjjm	5392	7	48	48	CD
cord-023095-4dannjjm	5392	8	hours	hour	NNS
cord-023095-4dannjjm	5392	9	prior	prior	RB
cord-023095-4dannjjm	5392	10	to	to	IN
cord-023095-4dannjjm	5392	11	methadone	methadone	NNP
cord-023095-4dannjjm	5392	12	administration	administration	NNP
cord-023095-4dannjjm	5392	13	.	.	.
cord-023095-4dannjjm	5393	1	Methadone	Methadone	NNP
cord-023095-4dannjjm	5393	2	hydrochloride	hydrochloride	NN
cord-023095-4dannjjm	5393	3	was	be	VBD
cord-023095-4dannjjm	5393	4	administered	administer	VBN
cord-023095-4dannjjm	5393	5	PO	PO	NNP
cord-023095-4dannjjm	5393	6	at	at	IN
cord-023095-4dannjjm	5393	7	a	a	DT
cord-023095-4dannjjm	5393	8	targeted	targeted	JJ
cord-023095-4dannjjm	5393	9	dose	dose	NN
cord-023095-4dannjjm	5393	10	of	of	IN
cord-023095-4dannjjm	5393	11	1	1	CD
cord-023095-4dannjjm	5393	12	mg	mg	NNP
cord-023095-4dannjjm	5393	13	/	/	SYM
cord-023095-4dannjjm	5393	14	kg	kg	NNP
cord-023095-4dannjjm	5393	15	.	.	.
cord-023095-4dannjjm	5394	1	Blood	blood	NN
cord-023095-4dannjjm	5394	2	was	be	VBD
cord-023095-4dannjjm	5394	3	obtained	obtain	VBN
cord-023095-4dannjjm	5394	4	for	for	IN
cord-023095-4dannjjm	5394	5	the	the	DT
cord-023095-4dannjjm	5394	6	determination	determination	NN
cord-023095-4dannjjm	5394	7	of	of	IN
cord-023095-4dannjjm	5394	8	methadone	methadone	NN
cord-023095-4dannjjm	5394	9	plasma	plasma	NN
cord-023095-4dannjjm	5394	10	concentrations	concentration	NNS
cord-023095-4dannjjm	5394	11	by	by	IN
cord-023095-4dannjjm	5394	12	mass	mass	NN
cord-023095-4dannjjm	5394	13	spectrometry	spectrometry	NN
cord-023095-4dannjjm	5394	14	.	.	.
cord-023095-4dannjjm	5395	1	The	the	DT
cord-023095-4dannjjm	5395	2	area	area	NN
cord-023095-4dannjjm	5395	3	under	under	IN
cord-023095-4dannjjm	5395	4	the	the	DT
cord-023095-4dannjjm	5395	5	curve	curve	NN
cord-023095-4dannjjm	5395	6	(	(	-LRB-
cord-023095-4dannjjm	5395	7	AUC	AUC	NNP
cord-023095-4dannjjm	5395	8	)	)	-RRB-
cord-023095-4dannjjm	5395	9	of	of	IN
cord-023095-4dannjjm	5395	10	methadone	methadone	NN
cord-023095-4dannjjm	5395	11	for	for	IN
cord-023095-4dannjjm	5395	12	each	each	DT
cord-023095-4dannjjm	5395	13	treatment	treatment	NN
cord-023095-4dannjjm	5395	14	group	group	NN
cord-023095-4dannjjm	5395	15	was	be	VBD
cord-023095-4dannjjm	5395	16	compared	compare	VBN
cord-023095-4dannjjm	5395	17	statistically	statistically	RB
cord-023095-4dannjjm	5395	18	to	to	IN
cord-023095-4dannjjm	5395	19	the	the	DT
cord-023095-4dannjjm	5395	20	AUC	AUC	NNP
cord-023095-4dannjjm	5395	21	of	of	IN
cord-023095-4dannjjm	5395	22	methadone	methadone	NN
cord-023095-4dannjjm	5395	23	administered	administer	VBN
cord-023095-4dannjjm	5395	24	without	without	IN
cord-023095-4dannjjm	5395	25	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	5395	26	using	use	VBG
cord-023095-4dannjjm	5395	27	the	the	DT
cord-023095-4dannjjm	5395	28	Mann	Mann	NNP
cord-023095-4dannjjm	5395	29	-	-	HYPH
cord-023095-4dannjjm	5395	30	Whitney	Whitney	NNP
cord-023095-4dannjjm	5395	31	Rank	Rank	NNP
cord-023095-4dannjjm	5395	32	Sum	Sum	NNP
cord-023095-4dannjjm	5395	33	Test	Test	NNP
cord-023095-4dannjjm	5395	34	.	.	.
cord-023095-4dannjjm	5396	1	Significant	significant	JJ
cord-023095-4dannjjm	5396	2	increases	increase	NNS
cord-023095-4dannjjm	5396	3	(	(	-LRB-
cord-023095-4dannjjm	5396	4	P	p	NN
cord-023095-4dannjjm	5396	5	o	o	NN
cord-023095-4dannjjm	5396	6	0.001	0.001	CD
cord-023095-4dannjjm	5396	7	)	)	-RRB-
cord-023095-4dannjjm	5396	8	in	in	IN
cord-023095-4dannjjm	5396	9	the	the	DT
cord-023095-4dannjjm	5396	10	methadone	methadone	NN
cord-023095-4dannjjm	5397	1	AUC	AUC	NNP
cord-023095-4dannjjm	5397	2	occurred	occur	VBD
cord-023095-4dannjjm	5397	3	in	in	IN
cord-023095-4dannjjm	5397	4	all	all	DT
cord-023095-4dannjjm	5397	5	treatment	treatment	NN
cord-023095-4dannjjm	5397	6	groups	group	NNS
cord-023095-4dannjjm	5397	7	which	which	WDT
cord-023095-4dannjjm	5397	8	included	include	VBD
cord-023095-4dannjjm	5397	9	chloramphenicol	chloramphenicol	NN
cord-023095-4dannjjm	5397	10	,	,	,
cord-023095-4dannjjm	5397	11	including	include	VBG
cord-023095-4dannjjm	5397	12	chloramphenicol	chloramphenicol	NNP
cord-023095-4dannjjm	5397	13	as	as	IN
cord-023095-4dannjjm	5397	14	the	the	DT
cord-023095-4dannjjm	5397	15	only	only	JJ
cord-023095-4dannjjm	5397	16	inhibitor	inhibitor	NN
cord-023095-4dannjjm	5397	17	.	.	.
cord-023095-4dannjjm	5398	1	The	the	DT
cord-023095-4dannjjm	5398	2	magnitude	magnitude	NN
cord-023095-4dannjjm	5398	3	of	of	IN
cord-023095-4dannjjm	5398	4	increase	increase	NN
cord-023095-4dannjjm	5398	5	was	be	VBD
cord-023095-4dannjjm	5398	6	at	at	RB
cord-023095-4dannjjm	5398	7	least	least	JJS
cord-023095-4dannjjm	5398	8	50	50	CD
cord-023095-4dannjjm	5398	9	fold	fold	NN
cord-023095-4dannjjm	5398	10	.	.	.
cord-023095-4dannjjm	5399	1	Mean	mean	JJ
cord-023095-4dannjjm	5399	2	concentrations	concentration	NNS
cord-023095-4dannjjm	5399	3	of	of	IN
cord-023095-4dannjjm	5399	4	methadone	methadone	NN
cord-023095-4dannjjm	5399	5	exceeded	exceed	VBD
cord-023095-4dannjjm	5399	6	10	10	CD
cord-023095-4dannjjm	5399	7	ng	ng	NN
cord-023095-4dannjjm	5399	8	/	/	SYM
cord-023095-4dannjjm	5399	9	mL	ml	NN
cord-023095-4dannjjm	5399	10	for	for	IN
cord-023095-4dannjjm	5399	11	at	at	RB
cord-023095-4dannjjm	5399	12	least	least	RBS
cord-023095-4dannjjm	5399	13	10	10	CD
cord-023095-4dannjjm	5399	14	hours	hour	NNS
cord-023095-4dannjjm	5399	15	in	in	IN
cord-023095-4dannjjm	5399	16	all	all	DT
cord-023095-4dannjjm	5399	17	groups	group	NNS
cord-023095-4dannjjm	5399	18	administered	administer	VBD
cord-023095-4dannjjm	5399	19	concurrent	concurrent	JJ
cord-023095-4dannjjm	5399	20	chloramphenicol	chloramphenicol	NN
cord-023095-4dannjjm	5399	21	.	.	.
cord-023095-4dannjjm	5400	1	No	no	DT
cord-023095-4dannjjm	5400	2	significant	significant	JJ
cord-023095-4dannjjm	5400	3	increases	increase	NNS
cord-023095-4dannjjm	5400	4	in	in	IN
cord-023095-4dannjjm	5400	5	the	the	DT
cord-023095-4dannjjm	5400	6	AUC	AUC	NNP
cord-023095-4dannjjm	5400	7	occurred	occur	VBD
cord-023095-4dannjjm	5400	8	in	in	IN
cord-023095-4dannjjm	5400	9	any	any	DT
cord-023095-4dannjjm	5400	10	of	of	IN
cord-023095-4dannjjm	5400	11	the	the	DT
cord-023095-4dannjjm	5400	12	groups	group	NNS
cord-023095-4dannjjm	5400	13	which	which	WDT
cord-023095-4dannjjm	5400	14	did	do	VBD
cord-023095-4dannjjm	5400	15	not	not	RB
cord-023095-4dannjjm	5400	16	include	include	VB
cord-023095-4dannjjm	5400	17	chloramphenicol	chloramphenicol	NN
cord-023095-4dannjjm	5400	18	.	.	.
cord-023095-4dannjjm	5401	1	In	in	IN
cord-023095-4dannjjm	5401	2	conclusion	conclusion	NN
cord-023095-4dannjjm	5401	3	,	,	,
cord-023095-4dannjjm	5401	4	chloramphenicol	chloramphenicol	NN
cord-023095-4dannjjm	5401	5	significantly	significantly	RB
cord-023095-4dannjjm	5401	6	inhibits	inhibit	VBZ
cord-023095-4dannjjm	5401	7	the	the	DT
cord-023095-4dannjjm	5401	8	metabolism	metabolism	NN
cord-023095-4dannjjm	5401	9	of	of	IN
cord-023095-4dannjjm	5401	10	methadone	methadone	NN
cord-023095-4dannjjm	5401	11	in	in	IN
cord-023095-4dannjjm	5401	12	Greyhound	Greyhound	NNP
cord-023095-4dannjjm	5401	13	dogs	dog	NNS
cord-023095-4dannjjm	5401	14	.	.	.
cord-023095-4dannjjm	5402	1	As	as	IN
cord-023095-4dannjjm	5402	2	a	a	DT
cord-023095-4dannjjm	5402	3	result	result	NN
cord-023095-4dannjjm	5402	4	,	,	,
cord-023095-4dannjjm	5402	5	the	the	DT
cord-023095-4dannjjm	5402	6	oral	oral	JJ
cord-023095-4dannjjm	5402	7	bioavailability	bioavailability	NN
cord-023095-4dannjjm	5402	8	of	of	IN
cord-023095-4dannjjm	5402	9	methadone	methadone	NN
cord-023095-4dannjjm	5402	10	is	be	VBZ
cord-023095-4dannjjm	5402	11	significantly	significantly	RB
cord-023095-4dannjjm	5402	12	increased	increase	VBN
cord-023095-4dannjjm	5402	13	and	and	CC
cord-023095-4dannjjm	5402	14	plasma	plasma	NN
cord-023095-4dannjjm	5402	15	concentrations	concentration	NNS
cord-023095-4dannjjm	5402	16	are	be	VBP
cord-023095-4dannjjm	5402	17	achieved	achieve	VBN
cord-023095-4dannjjm	5402	18	that	that	WDT
cord-023095-4dannjjm	5402	19	are	be	VBP
cord-023095-4dannjjm	5402	20	reported	report	VBN
cord-023095-4dannjjm	5402	21	to	to	TO
cord-023095-4dannjjm	5402	22	be	be	VB
cord-023095-4dannjjm	5402	23	effective	effective	JJ
cord-023095-4dannjjm	5402	24	in	in	IN
cord-023095-4dannjjm	5402	25	humans	human	NNS
cord-023095-4dannjjm	5402	26	for	for	IN
cord-023095-4dannjjm	5402	27	10	10	CD
cord-023095-4dannjjm	5402	28	-	-	SYM
cord-023095-4dannjjm	5402	29	36	36	CD
cord-023095-4dannjjm	5402	30	hours	hour	NNS
cord-023095-4dannjjm	5402	31	after	after	IN
cord-023095-4dannjjm	5402	32	a	a	DT
cord-023095-4dannjjm	5402	33	single	single	JJ
cord-023095-4dannjjm	5402	34	oral	oral	JJ
cord-023095-4dannjjm	5402	35	administration	administration	NN
cord-023095-4dannjjm	5402	36	.	.	.
cord-023095-4dannjjm	5403	1	Doxycycline	Doxycycline	NNP
cord-023095-4dannjjm	5403	2	hyclate	hyclate	NNP
cord-023095-4dannjjm	5403	3	is	be	VBZ
cord-023095-4dannjjm	5403	4	used	use	VBN
cord-023095-4dannjjm	5403	5	frequently	frequently	RB
cord-023095-4dannjjm	5403	6	in	in	IN
cord-023095-4dannjjm	5403	7	small	small	JJ
cord-023095-4dannjjm	5403	8	animals	animal	NNS
cord-023095-4dannjjm	5403	9	,	,	,
cord-023095-4dannjjm	5403	10	horses	horse	NNS
cord-023095-4dannjjm	5403	11	and	and	CC
cord-023095-4dannjjm	5403	12	exotic	exotic	JJ
cord-023095-4dannjjm	5403	13	animals	animal	NNS
cord-023095-4dannjjm	5403	14	for	for	IN
cord-023095-4dannjjm	5403	15	treatment	treatment	NN
cord-023095-4dannjjm	5403	16	of	of	IN
cord-023095-4dannjjm	5403	17	a	a	DT
cord-023095-4dannjjm	5403	18	wide	wide	JJ
cord-023095-4dannjjm	5403	19	variety	variety	NN
cord-023095-4dannjjm	5403	20	of	of	IN
cord-023095-4dannjjm	5403	21	infections	infection	NNS
cord-023095-4dannjjm	5403	22	.	.	.
cord-023095-4dannjjm	5404	1	Because	because	IN
cord-023095-4dannjjm	5404	2	doxycycline	doxycycline	NNP
cord-023095-4dannjjm	5404	3	hyclate	hyclate	NNP
cord-023095-4dannjjm	5404	4	tablets	tablet	NNS
cord-023095-4dannjjm	5404	5	may	may	MD
cord-023095-4dannjjm	5404	6	not	not	RB
cord-023095-4dannjjm	5404	7	be	be	VB
cord-023095-4dannjjm	5404	8	suitable	suitable	JJ
cord-023095-4dannjjm	5404	9	for	for	IN
cord-023095-4dannjjm	5404	10	oral	oral	JJ
cord-023095-4dannjjm	5404	11	administration	administration	NN
cord-023095-4dannjjm	5404	12	in	in	IN
cord-023095-4dannjjm	5404	13	some	some	DT
cord-023095-4dannjjm	5404	14	animals	animal	NNS
cord-023095-4dannjjm	5404	15	,	,	,
cord-023095-4dannjjm	5404	16	particularly	particularly	RB
cord-023095-4dannjjm	5404	17	horses	horse	NNS
cord-023095-4dannjjm	5404	18	and	and	CC
cord-023095-4dannjjm	5404	19	cats	cat	NNS
cord-023095-4dannjjm	5404	20	,	,	,
cord-023095-4dannjjm	5404	21	it	-PRON-	PRP
cord-023095-4dannjjm	5404	22	has	have	VBZ
cord-023095-4dannjjm	5404	23	been	be	VBN
cord-023095-4dannjjm	5404	24	compounded	compound	VBN
cord-023095-4dannjjm	5404	25	into	into	IN
cord-023095-4dannjjm	5404	26	liquid	liquid	JJ
cord-023095-4dannjjm	5404	27	suspensions	suspension	NNS
cord-023095-4dannjjm	5404	28	.	.	.
cord-023095-4dannjjm	5405	1	The	the	DT
cord-023095-4dannjjm	5405	2	commercially	commercially	RB
cord-023095-4dannjjm	5405	3	available	available	JJ
cord-023095-4dannjjm	5405	4	doxycycline	doxycycline	NN
cord-023095-4dannjjm	5405	5	calcium	calcium	NN
cord-023095-4dannjjm	5405	6	10	10	CD
cord-023095-4dannjjm	5406	1	mg	mg	NNP
cord-023095-4dannjjm	5406	2	/	/	SYM
cord-023095-4dannjjm	5406	3	ml	ml	CC
cord-023095-4dannjjm	5406	4	oral	oral	JJ
cord-023095-4dannjjm	5406	5	suspension	suspension	NN
cord-023095-4dannjjm	5407	1	,	,	,
cord-023095-4dannjjm	5407	2	Vibramycin	Vibramycin	NNP
cord-023095-4dannjjm	5407	3	s	s	POS
cord-023095-4dannjjm	5407	4	(	(	-LRB-
cord-023095-4dannjjm	5407	5	Pfizer	Pfizer	NNP
cord-023095-4dannjjm	5407	6	)	)	-RRB-
cord-023095-4dannjjm	5407	7	is	be	VBZ
cord-023095-4dannjjm	5407	8	not	not	RB
cord-023095-4dannjjm	5407	9	suitable	suitable	JJ
cord-023095-4dannjjm	5407	10	for	for	IN
cord-023095-4dannjjm	5407	11	use	use	NN
cord-023095-4dannjjm	5407	12	in	in	IN
cord-023095-4dannjjm	5407	13	animals	animal	NNS
cord-023095-4dannjjm	5407	14	due	due	JJ
cord-023095-4dannjjm	5407	15	to	to	IN
cord-023095-4dannjjm	5407	16	its	-PRON-	PRP$
cord-023095-4dannjjm	5407	17	low	low	JJ
cord-023095-4dannjjm	5407	18	concentration	concentration	NN
cord-023095-4dannjjm	5407	19	and	and	CC
cord-023095-4dannjjm	5407	20	flavoring	flavoring	NN
cord-023095-4dannjjm	5407	21	that	that	WDT
cord-023095-4dannjjm	5407	22	animals	animal	NNS
cord-023095-4dannjjm	5407	23	find	find	VBP
cord-023095-4dannjjm	5407	24	unpalatable	unpalatable	JJ
cord-023095-4dannjjm	5407	25	.	.	.
cord-023095-4dannjjm	5408	1	Because	because	IN
cord-023095-4dannjjm	5408	2	of	of	IN
cord-023095-4dannjjm	5408	3	the	the	DT
cord-023095-4dannjjm	5408	4	known	know	VBN
cord-023095-4dannjjm	5408	5	inherent	inherent	JJ
cord-023095-4dannjjm	5408	6	instability	instability	NN
cord-023095-4dannjjm	5408	7	of	of	IN
cord-023095-4dannjjm	5408	8	doxycline	doxycline	NN
cord-023095-4dannjjm	5408	9	in	in	IN
cord-023095-4dannjjm	5408	10	aqueous	aqueous	JJ
cord-023095-4dannjjm	5408	11	vehicles	vehicle	NNS
cord-023095-4dannjjm	5408	12	under	under	IN
cord-023095-4dannjjm	5408	13	storage	storage	NN
cord-023095-4dannjjm	5408	14	,	,	,
cord-023095-4dannjjm	5408	15	this	this	DT
cord-023095-4dannjjm	5408	16	study	study	NN
cord-023095-4dannjjm	5408	17	was	be	VBD
cord-023095-4dannjjm	5408	18	conducted	conduct	VBN
cord-023095-4dannjjm	5408	19	to	to	TO
cord-023095-4dannjjm	5408	20	determine	determine	VB
cord-023095-4dannjjm	5408	21	the	the	DT
cord-023095-4dannjjm	5408	22	potency	potency	NN
cord-023095-4dannjjm	5408	23	of	of	IN
cord-023095-4dannjjm	5408	24	two	two	CD
cord-023095-4dannjjm	5408	25	formulations	formulation	NNS
cord-023095-4dannjjm	5408	26	stored	store	VBN
cord-023095-4dannjjm	5408	27	in	in	IN
cord-023095-4dannjjm	5408	28	dark	dark	JJ
cord-023095-4dannjjm	5408	29	and	and	CC
cord-023095-4dannjjm	5408	30	light	light	JJ
cord-023095-4dannjjm	5408	31	conditions	condition	NNS
cord-023095-4dannjjm	5408	32	.	.	.
cord-023095-4dannjjm	5409	1	A	a	DT
cord-023095-4dannjjm	5409	2	high	high	JJ
cord-023095-4dannjjm	5409	3	pressure	pressure	NN
cord-023095-4dannjjm	5409	4	liquid	liquid	NN
cord-023095-4dannjjm	5409	5	chromatography	chromatography	NN
cord-023095-4dannjjm	5409	6	(	(	-LRB-
cord-023095-4dannjjm	5409	7	HPLC	HPLC	NNP
cord-023095-4dannjjm	5409	8	)	)	-RRB-
cord-023095-4dannjjm	5409	9	assay	assay	NN
cord-023095-4dannjjm	5409	10	with	with	IN
cord-023095-4dannjjm	5409	11	UV	uv	NN
cord-023095-4dannjjm	5409	12	absorption	absorption	NN
cord-023095-4dannjjm	5409	13	at	at	IN
cord-023095-4dannjjm	5409	14	350	350	CD
cord-023095-4dannjjm	5409	15	nm	nm	NN
cord-023095-4dannjjm	5409	16	was	be	VBD
cord-023095-4dannjjm	5409	17	developed	develop	VBN
cord-023095-4dannjjm	5409	18	for	for	IN
cord-023095-4dannjjm	5409	19	analyzing	analyze	VBG
cord-023095-4dannjjm	5409	20	doxycycline	doxycycline	NN
cord-023095-4dannjjm	5409	21	in	in	IN
cord-023095-4dannjjm	5409	22	formulations	formulation	NNS
cord-023095-4dannjjm	5409	23	,	,	,
cord-023095-4dannjjm	5409	24	in	in	IN
cord-023095-4dannjjm	5409	25	comparison	comparison	NN
cord-023095-4dannjjm	5409	26	to	to	IN
cord-023095-4dannjjm	5409	27	a	a	DT
cord-023095-4dannjjm	5409	28	reference	reference	NN
cord-023095-4dannjjm	5409	29	standard	standard	NN
cord-023095-4dannjjm	5409	30	from	from	IN
cord-023095-4dannjjm	5409	31	the	the	DT
cord-023095-4dannjjm	5409	32	United	United	NNP
cord-023095-4dannjjm	5409	33	States	States	NNP
cord-023095-4dannjjm	5409	34	Pharmacopeia	Pharmacopeia	NNP
cord-023095-4dannjjm	5409	35	(	(	-LRB-
cord-023095-4dannjjm	5409	36	USP	USP	NNP
cord-023095-4dannjjm	5409	37	)	)	-RRB-
cord-023095-4dannjjm	5409	38	.	.	.
cord-023095-4dannjjm	5410	1	Doxycycline	Doxycycline	NNP
cord-023095-4dannjjm	5410	2	hyclate	hyclate	NNP
cord-023095-4dannjjm	5411	1	100	100	CD
cord-023095-4dannjjm	5411	2	mg	mg	NN
cord-023095-4dannjjm	5411	3	tablets	tablet	NNS
cord-023095-4dannjjm	5411	4	were	be	VBD
cord-023095-4dannjjm	5411	5	first	first	RB
cord-023095-4dannjjm	5411	6	tested	test	VBN
cord-023095-4dannjjm	5411	7	for	for	IN
cord-023095-4dannjjm	5411	8	potency	potency	NN
cord-023095-4dannjjm	5411	9	.	.	.
cord-023095-4dannjjm	5412	1	The	the	DT
cord-023095-4dannjjm	5412	2	tablets	tablet	NNS
cord-023095-4dannjjm	5412	3	were	be	VBD
cord-023095-4dannjjm	5412	4	then	then	RB
cord-023095-4dannjjm	5412	5	crushed	crush	VBN
cord-023095-4dannjjm	5412	6	and	and	CC
cord-023095-4dannjjm	5412	7	mixed	mix	VBN
cord-023095-4dannjjm	5412	8	with	with	IN
cord-023095-4dannjjm	5412	9	a	a	DT
cord-023095-4dannjjm	5412	10	pharmaceutical	pharmaceutical	JJ
cord-023095-4dannjjm	5412	11	vehicle	vehicle	NN
cord-023095-4dannjjm	5412	12	to	to	TO
cord-023095-4dannjjm	5412	13	make	make	VB
cord-023095-4dannjjm	5412	14	two	two	CD
cord-023095-4dannjjm	5412	15	concentrations	concentration	NNS
cord-023095-4dannjjm	5412	16	:	:	:
cord-023095-4dannjjm	5412	17	33.3	33.3	CD
cord-023095-4dannjjm	5412	18	mg	mg	NNP
cord-023095-4dannjjm	5412	19	/	/	SYM
cord-023095-4dannjjm	5412	20	mL	mL	NNP
cord-023095-4dannjjm	5412	21	and	and	CC
cord-023095-4dannjjm	5412	22	166.7	166.7	CD
cord-023095-4dannjjm	5412	23	mg/	mg/	NN
cord-023095-4dannjjm	5413	1	mL.	mL.	NNP
cord-023095-4dannjjm	5414	1	The	the	DT
cord-023095-4dannjjm	5414	2	vehicle	vehicle	NN
cord-023095-4dannjjm	5414	3	used	use	VBN
cord-023095-4dannjjm	5414	4	was	be	VBD
cord-023095-4dannjjm	5414	5	a	a	DT
cord-023095-4dannjjm	5414	6	50:50	50:50	CD
cord-023095-4dannjjm	5414	7	mixture	mixture	NN
cord-023095-4dannjjm	5414	8	of	of	IN
cord-023095-4dannjjm	5414	9	a	a	DT
cord-023095-4dannjjm	5414	10	Vehicle	vehicle	NN
cord-023095-4dannjjm	5414	11	for	for	IN
cord-023095-4dannjjm	5414	12	Oral	Oral	NNP
cord-023095-4dannjjm	5414	13	Solution	Solution	NNP
cord-023095-4dannjjm	5415	1	(	(	-LRB-
cord-023095-4dannjjm	5415	2	Ora	Ora	NNP
cord-023095-4dannjjm	5415	3	-	-	HYPH
cord-023095-4dannjjm	5415	4	Sweet	Sweet	NNP
cord-023095-4dannjjm	5415	5	,	,	,
cord-023095-4dannjjm	5415	6	USP	USP	NNP
cord-023095-4dannjjm	5415	7	-	-	HYPH
cord-023095-4dannjjm	5415	8	NF	NF	NNP
cord-023095-4dannjjm	5415	9	)	)	-RRB-
cord-023095-4dannjjm	5415	10	and	and	CC
cord-023095-4dannjjm	5415	11	Vehicle	Vehicle	NNP
cord-023095-4dannjjm	5415	12	for	for	IN
cord-023095-4dannjjm	5415	13	Oral	Oral	NNP
cord-023095-4dannjjm	5415	14	Suspension	suspension	NN
cord-023095-4dannjjm	5416	1	(	(	-LRB-
cord-023095-4dannjjm	5416	2	Ora	Ora	NNP
cord-023095-4dannjjm	5416	3	-	-	HYPH
cord-023095-4dannjjm	5416	4	Plus	Plus	NNP
cord-023095-4dannjjm	5416	5	,	,	,
cord-023095-4dannjjm	5416	6	USP	USP	NNP
cord-023095-4dannjjm	5416	7	-	-	HYPH
cord-023095-4dannjjm	5416	8	NF	NF	NNP
cord-023095-4dannjjm	5416	9	)	)	-RRB-
cord-023095-4dannjjm	5416	10	.	.	.
cord-023095-4dannjjm	5417	1	The	the	DT
cord-023095-4dannjjm	5417	2	suspensions	suspension	NNS
cord-023095-4dannjjm	5417	3	were	be	VBD
cord-023095-4dannjjm	5417	4	prepared	prepare	VBN
cord-023095-4dannjjm	5417	5	in	in	IN
cord-023095-4dannjjm	5417	6	replicates	replicate	NNS
cord-023095-4dannjjm	5417	7	of	of	IN
cord-023095-4dannjjm	5417	8	3	3	CD
cord-023095-4dannjjm	5417	9	.	.	.
cord-023095-4dannjjm	5418	1	Each	each	DT
cord-023095-4dannjjm	5418	2	replicate	replicate	NN
cord-023095-4dannjjm	5418	3	was	be	VBD
cord-023095-4dannjjm	5418	4	divided	divide	VBN
cord-023095-4dannjjm	5418	5	,	,	,
cord-023095-4dannjjm	5418	6	with	with	IN
cord-023095-4dannjjm	5418	7	one	one	CD
cord-023095-4dannjjm	5418	8	aliquot	aliquot	NN
cord-023095-4dannjjm	5418	9	stored	store	VBN
cord-023095-4dannjjm	5418	10	at	at	IN
cord-023095-4dannjjm	5418	11	room	room	NN
cord-023095-4dannjjm	5418	12	temperature	temperature	NN
cord-023095-4dannjjm	5418	13	in	in	IN
cord-023095-4dannjjm	5418	14	lighted	light	VBN
cord-023095-4dannjjm	5418	15	conditions	condition	NNS
cord-023095-4dannjjm	5418	16	,	,	,
cord-023095-4dannjjm	5418	17	and	and	CC
cord-023095-4dannjjm	5418	18	the	the	DT
cord-023095-4dannjjm	5418	19	other	other	JJ
cord-023095-4dannjjm	5418	20	aliquot	aliquot	NN
cord-023095-4dannjjm	5418	21	stored	store	VBN
cord-023095-4dannjjm	5418	22	at	at	IN
cord-023095-4dannjjm	5418	23	room	room	NN
cord-023095-4dannjjm	5418	24	temperature	temperature	NN
cord-023095-4dannjjm	5418	25	in	in	IN
cord-023095-4dannjjm	5418	26	the	the	DT
cord-023095-4dannjjm	5418	27	dark	dark	NN
cord-023095-4dannjjm	5418	28	.	.	.
cord-023095-4dannjjm	5419	1	Doxycycline	Doxycycline	NNP
cord-023095-4dannjjm	5419	2	was	be	VBD
cord-023095-4dannjjm	5419	3	extracted	extract	VBN
cord-023095-4dannjjm	5419	4	from	from	IN
cord-023095-4dannjjm	5419	5	the	the	DT
cord-023095-4dannjjm	5419	6	formulations	formulation	NNS
cord-023095-4dannjjm	5419	7	and	and	CC
cord-023095-4dannjjm	5419	8	measured	measure	VBN
cord-023095-4dannjjm	5419	9	by	by	IN
cord-023095-4dannjjm	5419	10	HPLC	HPLC	NNP
cord-023095-4dannjjm	5419	11	at	at	IN
cord-023095-4dannjjm	5419	12	Day	day	NN
cord-023095-4dannjjm	5419	13	0	0	CD
cord-023095-4dannjjm	5419	14	,	,	,
cord-023095-4dannjjm	5419	15	1	1	CD
cord-023095-4dannjjm	5419	16	,	,	,
cord-023095-4dannjjm	5419	17	4	4	CD
cord-023095-4dannjjm	5419	18	,	,	,
cord-023095-4dannjjm	5419	19	7	7	CD
cord-023095-4dannjjm	5419	20	,	,	,
cord-023095-4dannjjm	5419	21	14	14	CD
cord-023095-4dannjjm	5419	22	,	,	,
cord-023095-4dannjjm	5419	23	21	21	CD
cord-023095-4dannjjm	5419	24	,	,	,
cord-023095-4dannjjm	5419	25	and	and	CC
cord-023095-4dannjjm	5419	26	28	28	CD
cord-023095-4dannjjm	5419	27	.	.	.
cord-023095-4dannjjm	5420	1	Each	each	DT
cord-023095-4dannjjm	5420	2	replicate	replicate	NN
cord-023095-4dannjjm	5420	3	was	be	VBD
cord-023095-4dannjjm	5420	4	tested	test	VBN
cord-023095-4dannjjm	5420	5	and	and	CC
cord-023095-4dannjjm	5420	6	the	the	DT
cord-023095-4dannjjm	5420	7	potency	potency	NN
cord-023095-4dannjjm	5420	8	reported	report	VBN
cord-023095-4dannjjm	5420	9	as	as	IN
cord-023095-4dannjjm	5420	10	the	the	DT
cord-023095-4dannjjm	5420	11	percent	percent	NN
cord-023095-4dannjjm	5420	12	doxycycline	doxycycline	NN
cord-023095-4dannjjm	5420	13	relative	relative	JJ
cord-023095-4dannjjm	5420	14	to	to	IN
cord-023095-4dannjjm	5420	15	the	the	DT
cord-023095-4dannjjm	5420	16	USP	USP	NNP
cord-023095-4dannjjm	5420	17	reference	reference	NN
cord-023095-4dannjjm	5420	18	standard	standard	NN
cord-023095-4dannjjm	5420	19	.	.	.
cord-023095-4dannjjm	5421	1	On	on	IN
cord-023095-4dannjjm	5421	2	Day	day	NN
cord-023095-4dannjjm	5421	3	0	0	CD
cord-023095-4dannjjm	5421	4	,	,	,
cord-023095-4dannjjm	5421	5	1	1	CD
cord-023095-4dannjjm	5421	6	,	,	,
cord-023095-4dannjjm	5421	7	4	4	CD
cord-023095-4dannjjm	5421	8	,	,	,
cord-023095-4dannjjm	5421	9	and	and	CC
cord-023095-4dannjjm	5421	10	7	7	CD
cord-023095-4dannjjm	5421	11	,	,	,
cord-023095-4dannjjm	5421	12	the	the	DT
cord-023095-4dannjjm	5421	13	potency	potency	NN
cord-023095-4dannjjm	5421	14	of	of	IN
cord-023095-4dannjjm	5421	15	each	each	DT
cord-023095-4dannjjm	5421	16	formulation	formulation	NN
cord-023095-4dannjjm	5421	17	was	be	VBD
cord-023095-4dannjjm	5421	18	within	within	IN
cord-023095-4dannjjm	5421	19	90	90	CD
cord-023095-4dannjjm	5421	20	-	-	SYM
cord-023095-4dannjjm	5421	21	110	110	CD
cord-023095-4dannjjm	5421	22	%	%	NN
cord-023095-4dannjjm	5421	23	of	of	IN
cord-023095-4dannjjm	5421	24	the	the	DT
cord-023095-4dannjjm	5421	25	reference	reference	NN
cord-023095-4dannjjm	5421	26	standard	standard	NN
cord-023095-4dannjjm	5421	27	(	(	-LRB-
cord-023095-4dannjjm	5421	28	range	range	VB
cord-023095-4dannjjm	5421	29	93.4	93.4	CD
cord-023095-4dannjjm	5421	30	-	-	SYM
cord-023095-4dannjjm	5421	31	109	109	CD
cord-023095-4dannjjm	5421	32	%	%	NN
cord-023095-4dannjjm	5421	33	)	)	-RRB-
cord-023095-4dannjjm	5421	34	.	.	.
cord-023095-4dannjjm	5422	1	This	this	DT
cord-023095-4dannjjm	5422	2	value	value	NN
cord-023095-4dannjjm	5422	3	is	be	VBZ
cord-023095-4dannjjm	5422	4	within	within	IN
cord-023095-4dannjjm	5422	5	the	the	DT
cord-023095-4dannjjm	5422	6	accepted	accept	VBN
cord-023095-4dannjjm	5422	7	range	range	NN
cord-023095-4dannjjm	5422	8	cited	cite	VBN
cord-023095-4dannjjm	5422	9	in	in	IN
cord-023095-4dannjjm	5422	10	USP	USP	NNP
cord-023095-4dannjjm	5422	11	o	o	NNP
cord-023095-4dannjjm	5422	12	795	795	CD
cord-023095-4dannjjm	5422	13	4	4	CD
cord-023095-4dannjjm	5422	14	on	on	IN
cord-023095-4dannjjm	5422	15	Pharmaceutical	Pharmaceutical	NNP
cord-023095-4dannjjm	5422	16	Compounding	Compounding	NNP
cord-023095-4dannjjm	5422	17	-	-	HYPH
cord-023095-4dannjjm	5422	18	Non	Non	NNP
cord-023095-4dannjjm	5422	19	-	-	JJ
cord-023095-4dannjjm	5422	20	Sterile	sterile	JJ
cord-023095-4dannjjm	5422	21	Preparations	preparation	NNS
cord-023095-4dannjjm	5422	22	.	.	.
cord-023095-4dannjjm	5423	1	However	however	RB
cord-023095-4dannjjm	5423	2	,	,	,
cord-023095-4dannjjm	5423	3	starting	start	VBG
cord-023095-4dannjjm	5423	4	at	at	IN
cord-023095-4dannjjm	5423	5	Day	day	NN
cord-023095-4dannjjm	5423	6	14	14	CD
cord-023095-4dannjjm	5423	7	,	,	,
cord-023095-4dannjjm	5423	8	the	the	DT
cord-023095-4dannjjm	5423	9	potency	potency	NN
cord-023095-4dannjjm	5423	10	declined	decline	VBD
cord-023095-4dannjjm	5423	11	dramatically	dramatically	RB
cord-023095-4dannjjm	5423	12	and	and	CC
cord-023095-4dannjjm	5423	13	remained	remain	VBD
cord-023095-4dannjjm	5423	14	low	low	JJ
cord-023095-4dannjjm	5423	15	for	for	IN
cord-023095-4dannjjm	5423	16	the	the	DT
cord-023095-4dannjjm	5423	17	tests	test	NNS
cord-023095-4dannjjm	5423	18	performed	perform	VBN
cord-023095-4dannjjm	5423	19	on	on	IN
cord-023095-4dannjjm	5423	20	Day	Day	NNP
cord-023095-4dannjjm	5423	21	21	21	CD
cord-023095-4dannjjm	5423	22	and	and	CC
cord-023095-4dannjjm	5423	23	28	28	CD
cord-023095-4dannjjm	5423	24	.	.	.
cord-023095-4dannjjm	5424	1	The	the	DT
cord-023095-4dannjjm	5424	2	potency	potency	NN
cord-023095-4dannjjm	5424	3	on	on	IN
cord-023095-4dannjjm	5424	4	Day	Day	NNP
cord-023095-4dannjjm	5424	5	14	14	CD
cord-023095-4dannjjm	5424	6	,	,	,
cord-023095-4dannjjm	5424	7	21	21	CD
cord-023095-4dannjjm	5424	8	,	,	,
cord-023095-4dannjjm	5424	9	and	and	CC
cord-023095-4dannjjm	5424	10	28	28	CD
cord-023095-4dannjjm	5424	11	was	be	VBD
cord-023095-4dannjjm	5424	12	below	below	IN
cord-023095-4dannjjm	5424	13	20	20	CD
cord-023095-4dannjjm	5424	14	%	%	NN
cord-023095-4dannjjm	5424	15	of	of	IN
cord-023095-4dannjjm	5424	16	the	the	DT
cord-023095-4dannjjm	5424	17	reference	reference	NN
cord-023095-4dannjjm	5424	18	standard	standard	NN
cord-023095-4dannjjm	5424	19	(	(	-LRB-
cord-023095-4dannjjm	5424	20	range	range	NNP
cord-023095-4dannjjm	5424	21	14	14	CD
cord-023095-4dannjjm	5424	22	-	-	SYM
cord-023095-4dannjjm	5424	23	18	18	CD
cord-023095-4dannjjm	5424	24	%	%	NN
cord-023095-4dannjjm	5424	25	)	)	-RRB-
cord-023095-4dannjjm	5424	26	.	.	.
cord-023095-4dannjjm	5425	1	There	there	EX
cord-023095-4dannjjm	5425	2	was	be	VBD
cord-023095-4dannjjm	5425	3	also	also	RB
cord-023095-4dannjjm	5425	4	a	a	DT
cord-023095-4dannjjm	5425	5	noticeable	noticeable	JJ
cord-023095-4dannjjm	5425	6	change	change	NN
cord-023095-4dannjjm	5425	7	in	in	IN
cord-023095-4dannjjm	5425	8	the	the	DT
cord-023095-4dannjjm	5425	9	quality	quality	NN
cord-023095-4dannjjm	5425	10	of	of	IN
cord-023095-4dannjjm	5425	11	the	the	DT
cord-023095-4dannjjm	5425	12	formulation	formulation	NN
cord-023095-4dannjjm	5425	13	starting	start	VBG
cord-023095-4dannjjm	5425	14	on	on	IN
cord-023095-4dannjjm	5425	15	Day	Day	NNP
cord-023095-4dannjjm	5425	16	14	14	CD
cord-023095-4dannjjm	5425	17	,	,	,
cord-023095-4dannjjm	5425	18	and	and	CC
cord-023095-4dannjjm	5425	19	a	a	DT
cord-023095-4dannjjm	5425	20	change	change	NN
cord-023095-4dannjjm	5425	21	in	in	IN
cord-023095-4dannjjm	5425	22	the	the	DT
cord-023095-4dannjjm	5425	23	color	color	NN
cord-023095-4dannjjm	5425	24	of	of	IN
cord-023095-4dannjjm	5425	25	the	the	DT
cord-023095-4dannjjm	5425	26	formulation	formulation	NN
cord-023095-4dannjjm	5425	27	to	to	IN
cord-023095-4dannjjm	5425	28	a	a	DT
cord-023095-4dannjjm	5425	29	dark	dark	JJ
cord-023095-4dannjjm	5425	30	brown	brown	NN
cord-023095-4dannjjm	5425	31	.	.	.
cord-023095-4dannjjm	5426	1	These	these	DT
cord-023095-4dannjjm	5426	2	results	result	NNS
cord-023095-4dannjjm	5426	3	indicate	indicate	VBP
cord-023095-4dannjjm	5426	4	that	that	IN
cord-023095-4dannjjm	5426	5	when	when	WRB
cord-023095-4dannjjm	5426	6	doxycycline	doxycycline	NNP
cord-023095-4dannjjm	5426	7	hyclate	hyclate	NNP
cord-023095-4dannjjm	5426	8	tablets	tablet	NNS
cord-023095-4dannjjm	5426	9	are	be	VBP
cord-023095-4dannjjm	5426	10	compounded	compound	VBN
cord-023095-4dannjjm	5426	11	as	as	IN
cord-023095-4dannjjm	5426	12	a	a	DT
cord-023095-4dannjjm	5426	13	suspension	suspension	NN
cord-023095-4dannjjm	5426	14	in	in	IN
cord-023095-4dannjjm	5426	15	an	an	DT
cord-023095-4dannjjm	5426	16	aqueous	aqueous	JJ
cord-023095-4dannjjm	5426	17	vehicle	vehicle	NN
cord-023095-4dannjjm	5426	18	as	as	IN
cord-023095-4dannjjm	5426	19	described	describe	VBN
cord-023095-4dannjjm	5426	20	in	in	IN
cord-023095-4dannjjm	5426	21	this	this	DT
cord-023095-4dannjjm	5426	22	study	study	NN
cord-023095-4dannjjm	5426	23	,	,	,
cord-023095-4dannjjm	5426	24	at	at	IN
cord-023095-4dannjjm	5426	25	33.3	33.3	CD
cord-023095-4dannjjm	5426	26	and	and	CC
cord-023095-4dannjjm	5426	27	166.7	166.7	CD
cord-023095-4dannjjm	5426	28	mg	mg	NNP
cord-023095-4dannjjm	5426	29	/	/	SYM
cord-023095-4dannjjm	5426	30	mL	ml	NN
cord-023095-4dannjjm	5426	31	under	under	IN
cord-023095-4dannjjm	5426	32	the	the	DT
cord-023095-4dannjjm	5426	33	storage	storage	NN
cord-023095-4dannjjm	5426	34	conditions	condition	NNS
cord-023095-4dannjjm	5426	35	used	use	VBN
cord-023095-4dannjjm	5426	36	in	in	IN
cord-023095-4dannjjm	5426	37	this	this	DT
cord-023095-4dannjjm	5426	38	study	study	NN
cord-023095-4dannjjm	5426	39	,	,	,
cord-023095-4dannjjm	5426	40	potency	potency	NN
cord-023095-4dannjjm	5426	41	of	of	IN
cord-023095-4dannjjm	5426	42	the	the	DT
cord-023095-4dannjjm	5426	43	formulation	formulation	NN
cord-023095-4dannjjm	5426	44	can	can	MD
cord-023095-4dannjjm	5426	45	not	not	RB
cord-023095-4dannjjm	5426	46	be	be	VB
cord-023095-4dannjjm	5426	47	assured	assure	VBN
cord-023095-4dannjjm	5426	48	beyond	beyond	IN
cord-023095-4dannjjm	5426	49	7	7	CD
cord-023095-4dannjjm	5426	50	days	day	NNS
cord-023095-4dannjjm	5426	51	.	.	.
cord-023095-4dannjjm	5427	1	We	-PRON-	PRP
cord-023095-4dannjjm	5427	2	recommend	recommend	VBP
cord-023095-4dannjjm	5427	3	a	a	DT
cord-023095-4dannjjm	5427	4	beyond	beyond	IN
cord-023095-4dannjjm	5427	5	-	-	HYPH
cord-023095-4dannjjm	5427	6	use	use	NN
cord-023095-4dannjjm	5427	7	-	-	HYPH
cord-023095-4dannjjm	5427	8	day	day	NN
cord-023095-4dannjjm	5427	9	(	(	-LRB-
cord-023095-4dannjjm	5427	10	BUD	BUD	NNP
cord-023095-4dannjjm	5427	11	)	)	-RRB-
cord-023095-4dannjjm	5427	12	of	of	IN
cord-023095-4dannjjm	5427	13	7	7	CD
cord-023095-4dannjjm	5427	14	days	day	NNS
cord-023095-4dannjjm	5427	15	for	for	IN
cord-023095-4dannjjm	5427	16	formulations	formulation	NNS
cord-023095-4dannjjm	5427	17	prepared	prepare	VBN
cord-023095-4dannjjm	5427	18	and	and	CC
cord-023095-4dannjjm	5427	19	stored	store	VBN
cord-023095-4dannjjm	5427	20	at	at	IN
cord-023095-4dannjjm	5427	21	room	room	NN
cord-023095-4dannjjm	5427	22	temperature	temperature	NN
cord-023095-4dannjjm	5427	23	in	in	IN
cord-023095-4dannjjm	5427	24	light	light	JJ
cord-023095-4dannjjm	5427	25	or	or	CC
cord-023095-4dannjjm	5427	26	dark	dark	JJ
cord-023095-4dannjjm	5427	27	conditions	condition	NNS
cord-023095-4dannjjm	5427	28	.	.	.
cord-023095-4dannjjm	5428	1	Therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5428	2	options	option	NNS
cord-023095-4dannjjm	5428	3	for	for	IN
cord-023095-4dannjjm	5428	4	multidrug	multidrug	NN
cord-023095-4dannjjm	5428	5	resistance	resistance	NN
cord-023095-4dannjjm	5428	6	(	(	-LRB-
cord-023095-4dannjjm	5428	7	MDR	MDR	NNP
cord-023095-4dannjjm	5428	8	)	)	-RRB-
cord-023095-4dannjjm	5428	9	Escherichia	Escherichia	NNP
cord-023095-4dannjjm	5428	10	coli	coli	VBZ
cord-023095-4dannjjm	5428	11	urinary	urinary	JJ
cord-023095-4dannjjm	5428	12	tract	tract	JJ
cord-023095-4dannjjm	5428	13	infections	infection	NNS
cord-023095-4dannjjm	5428	14	(	(	-LRB-
cord-023095-4dannjjm	5428	15	UTI	UTI	NNP
cord-023095-4dannjjm	5428	16	)	)	-RRB-
cord-023095-4dannjjm	5428	17	are	be	VBP
cord-023095-4dannjjm	5428	18	limited	limit	VBN
cord-023095-4dannjjm	5428	19	.	.	.
cord-023095-4dannjjm	5429	1	Fosfomycin	Fosfomycin	NNP
cord-023095-4dannjjm	5429	2	(	(	-LRB-
cord-023095-4dannjjm	5429	3	FOS	FOS	NNP
cord-023095-4dannjjm	5429	4	)	)	-RRB-
cord-023095-4dannjjm	5429	5	tromethamine	tromethamine	NNP
cord-023095-4dannjjm	5429	6	is	be	VBZ
cord-023095-4dannjjm	5429	7	an	an	DT
cord-023095-4dannjjm	5429	8	oral	oral	JJ
cord-023095-4dannjjm	5429	9	,	,	,
cord-023095-4dannjjm	5429	10	broad	broad	JJ
cord-023095-4dannjjm	5429	11	-	-	HYPH
cord-023095-4dannjjm	5429	12	spectrum	spectrum	NN
cord-023095-4dannjjm	5429	13	,	,	,
cord-023095-4dannjjm	5429	14	cell	cell	NN
cord-023095-4dannjjm	5429	15	-	-	HYPH
cord-023095-4dannjjm	5429	16	wall	wall	NN
cord-023095-4dannjjm	5429	17	active	active	JJ
cord-023095-4dannjjm	5429	18	,	,	,
cord-023095-4dannjjm	5429	19	bactericidal	bactericidal	JJ
cord-023095-4dannjjm	5429	20	drug	drug	NN
cord-023095-4dannjjm	5429	21	approved	approve	VBN
cord-023095-4dannjjm	5429	22	for	for	IN
cord-023095-4dannjjm	5429	23	treatment	treatment	NN
cord-023095-4dannjjm	5429	24	of	of	IN
cord-023095-4dannjjm	5429	25	uncomplicated	uncomplicated	JJ
cord-023095-4dannjjm	5429	26	UTI	UTI	NNP
cord-023095-4dannjjm	5429	27	in	in	IN
cord-023095-4dannjjm	5429	28	humans	human	NNS
cord-023095-4dannjjm	5429	29	.	.	.
cord-023095-4dannjjm	5430	1	The	the	DT
cord-023095-4dannjjm	5430	2	purpose	purpose	NN
cord-023095-4dannjjm	5430	3	of	of	IN
cord-023095-4dannjjm	5430	4	this	this	DT
cord-023095-4dannjjm	5430	5	study	study	NN
cord-023095-4dannjjm	5430	6	was	be	VBD
cord-023095-4dannjjm	5430	7	to	to	TO
cord-023095-4dannjjm	5430	8	determine	determine	VB
cord-023095-4dannjjm	5430	9	time	time	NN
cord-023095-4dannjjm	5430	10	dependency	dependency	NN
cord-023095-4dannjjm	5430	11	of	of	IN
cord-023095-4dannjjm	5430	12	FOS	FOS	NNP
cord-023095-4dannjjm	5430	13	and	and	CC
cord-023095-4dannjjm	5430	14	the	the	DT
cord-023095-4dannjjm	5430	15	disposition	disposition	NN
cord-023095-4dannjjm	5430	16	of	of	IN
cord-023095-4dannjjm	5430	17	FOS	FOS	NNP
cord-023095-4dannjjm	5430	18	tromethamine	tromethamine	NN
cord-023095-4dannjjm	5430	19	in	in	IN
cord-023095-4dannjjm	5430	20	dogs	dog	NNS
cord-023095-4dannjjm	5430	21	.	.	.
cord-023095-4dannjjm	5431	1	Using	use	VBG
cord-023095-4dannjjm	5431	2	a	a	DT
cord-023095-4dannjjm	5431	3	randomized	randomized	JJ
cord-023095-4dannjjm	5431	4	,	,	,
cord-023095-4dannjjm	5431	5	double	double	JJ
cord-023095-4dannjjm	5431	6	crossover	crossover	NN
cord-023095-4dannjjm	5431	7	design	design	NN
cord-023095-4dannjjm	5431	8	,	,	,
cord-023095-4dannjjm	5431	9	12	12	CD
cord-023095-4dannjjm	5431	10	client	client	NN
cord-023095-4dannjjm	5431	11	-	-	HYPH
cord-023095-4dannjjm	5431	12	owned	own	VBN
cord-023095-4dannjjm	5431	13	dogs	dog	NNS
cord-023095-4dannjjm	5431	14	received	receive	VBD
cord-023095-4dannjjm	5431	15	FOS	FOS	NNP
cord-023095-4dannjjm	5431	16	sodium	sodium	NN
cord-023095-4dannjjm	5431	17	IV	IV	NNP
cord-023095-4dannjjm	5431	18	(	(	-LRB-
cord-023095-4dannjjm	5431	19	40	40	CD
cord-023095-4dannjjm	5431	20	mg	mg	NNP
cord-023095-4dannjjm	5431	21	/	/	SYM
cord-023095-4dannjjm	5431	22	kg	kg	NNP
cord-023095-4dannjjm	5431	23	)	)	-RRB-
cord-023095-4dannjjm	5431	24	and	and	CC
cord-023095-4dannjjm	5431	25	FOS	FOS	NNP
cord-023095-4dannjjm	5431	26	tromethamine	tromethamine	NNP
cord-023095-4dannjjm	5431	27	(	(	-LRB-
cord-023095-4dannjjm	5431	28	PO	PO	NNP
cord-023095-4dannjjm	5431	29	,	,	,
cord-023095-4dannjjm	5431	30	80	80	CD
cord-023095-4dannjjm	5431	31	mg	mg	NNP
cord-023095-4dannjjm	5431	32	/	/	SYM
cord-023095-4dannjjm	5431	33	kg	kg	NN
cord-023095-4dannjjm	5431	34	)	)	-RRB-
cord-023095-4dannjjm	5432	1	either	either	CC
cord-023095-4dannjjm	5432	2	with	with	IN
cord-023095-4dannjjm	5432	3	(	(	-LRB-
cord-023095-4dannjjm	5432	4	n	n	NN
cord-023095-4dannjjm	5432	5	5	5	CD
cord-023095-4dannjjm	5432	6	6	6	CD
cord-023095-4dannjjm	5432	7	)	)	-RRB-
cord-023095-4dannjjm	5432	8	or	or	CC
cord-023095-4dannjjm	5432	9	without	without	IN
cord-023095-4dannjjm	5432	10	food	food	NN
cord-023095-4dannjjm	5432	11	(	(	-LRB-
cord-023095-4dannjjm	5432	12	n	n	NN
cord-023095-4dannjjm	5432	13	5	5	CD
cord-023095-4dannjjm	5432	14	6	6	CD
cord-023095-4dannjjm	5432	15	)	)	-RRB-
cord-023095-4dannjjm	5432	16	.	.	.
cord-023095-4dannjjm	5433	1	Serum	serum	NN
cord-023095-4dannjjm	5433	2	and	and	CC
cord-023095-4dannjjm	5433	3	urine	urine	NN
cord-023095-4dannjjm	5433	4	were	be	VBD
cord-023095-4dannjjm	5433	5	collected	collect	VBN
cord-023095-4dannjjm	5433	6	for	for	IN
cord-023095-4dannjjm	5433	7	24	24	CD
cord-023095-4dannjjm	5433	8	hr	hr	NN
cord-023095-4dannjjm	5433	9	;	;	:
cord-023095-4dannjjm	5433	10	FOS	FOS	NNP
cord-023095-4dannjjm	5433	11	was	be	VBD
cord-023095-4dannjjm	5433	12	quantitated	quantitate	VBN
cord-023095-4dannjjm	5433	13	with	with	IN
cord-023095-4dannjjm	5433	14	a	a	DT
cord-023095-4dannjjm	5433	15	bioassay	bioassay	NN
cord-023095-4dannjjm	5433	16	(	(	-LRB-
cord-023095-4dannjjm	5433	17	ATCC	ATCC	NNP
cord-023095-4dannjjm	5433	18	E.	E.	NNP
cord-023095-4dannjjm	5433	19	coli	coli	VBZ
cord-023095-4dannjjm	5433	20	25922	25922	CD
cord-023095-4dannjjm	5433	21	,	,	,
cord-023095-4dannjjm	5433	22	serum	serum	NN
cord-023095-4dannjjm	5433	23	or	or	CC
cord-023095-4dannjjm	5433	24	ATCC	atcc	JJ
cord-023095-4dannjjm	5433	25	Proteus	Proteus	NNP
cord-023095-4dannjjm	5433	26	vulgaris	vulgaris	NN
cord-023095-4dannjjm	5433	27	13315	13315	CD
cord-023095-4dannjjm	5433	28	,	,	,
cord-023095-4dannjjm	5433	29	urine	urine	NN
cord-023095-4dannjjm	5433	30	)	)	-RRB-
cord-023095-4dannjjm	5433	31	.	.	.
cord-023095-4dannjjm	5434	1	In	in	IN
cord-023095-4dannjjm	5434	2	-	-	HYPH
cord-023095-4dannjjm	5434	3	vitro	vitro	FW
cord-023095-4dannjjm	5434	4	killing	killing	NN
cord-023095-4dannjjm	5434	5	curves	curve	NNS
cord-023095-4dannjjm	5434	6	(	(	-LRB-
cord-023095-4dannjjm	5434	7	cell	cell	NN
cord-023095-4dannjjm	5434	8	counts	count	VBZ
cord-023095-4dannjjm	5434	9	through	through	IN
cord-023095-4dannjjm	5434	10	24	24	CD
cord-023095-4dannjjm	5434	11	hours	hour	NNS
cord-023095-4dannjjm	5434	12	)	)	-RRB-
cord-023095-4dannjjm	5434	13	were	be	VBD
cord-023095-4dannjjm	5434	14	performed	perform	VBN
cord-023095-4dannjjm	5434	15	at	at	IN
cord-023095-4dannjjm	5434	16	0	0	CD
cord-023095-4dannjjm	5434	17	(	(	-LRB-
cord-023095-4dannjjm	5434	18	control),0.5,1,2,8,16	control),0.5,1,2,8,16	NNS
cord-023095-4dannjjm	5434	19	and	and	CC
cord-023095-4dannjjm	5434	20	32	32	CD
cord-023095-4dannjjm	5434	21	x	x	SYM
cord-023095-4dannjjm	5434	22	MIC	MIC	NNP
cord-023095-4dannjjm	5434	23	for	for	IN
cord-023095-4dannjjm	5434	24	MDR	MDR	NNP
cord-023095-4dannjjm	5434	25	E.	E.	NNP
cord-023095-4dannjjm	5434	26	coli	coli	VBZ
cord-023095-4dannjjm	5434	27	canine	canine	JJ
cord-023095-4dannjjm	5434	28	FOS	FOS	NNP
cord-023095-4dannjjm	5434	29	susceptible	susceptible	JJ
cord-023095-4dannjjm	5434	30	(	(	-LRB-
cord-023095-4dannjjm	5434	31	E	e	NN
cord-023095-4dannjjm	5434	32	-	-	NN
cord-023095-4dannjjm	5434	33	test	test	NN
cord-023095-4dannjjm	5434	34	s	s	NNS
cord-023095-4dannjjm	5434	35	)	)	-RRB-
cord-023095-4dannjjm	5434	36	uropathogens	uropathogen	NNS
cord-023095-4dannjjm	5434	37	.	.	.
cord-023095-4dannjjm	5435	1	Killing	kill	VBG
cord-023095-4dannjjm	5435	2	curves	curve	NNS
cord-023095-4dannjjm	5435	3	indicated	indicate	VBD
cord-023095-4dannjjm	5435	4	FOS	FOS	NNP
cord-023095-4dannjjm	5435	5	to	to	TO
cord-023095-4dannjjm	5435	6	be	be	VB
cord-023095-4dannjjm	5435	7	time	time	NN
cord-023095-4dannjjm	5435	8	dependent	dependent	JJ
cord-023095-4dannjjm	5435	9	.	.	.
cord-023095-4dannjjm	5436	1	After	after	IN
cord-023095-4dannjjm	5436	2	IV	IV	NNP
cord-023095-4dannjjm	5436	3	administration	administration	NN
cord-023095-4dannjjm	5436	4	,	,	,
cord-023095-4dannjjm	5436	5	clearance	clearance	NN
cord-023095-4dannjjm	5436	6	(	(	-LRB-
cord-023095-4dannjjm	5436	7	mlÃkg	mlÃkg	NNP
cord-023095-4dannjjm	5436	8	/	/	SYM
cord-023095-4dannjjm	5436	9	hr	hr	NN
cord-023095-4dannjjm	5436	10	)	)	-RRB-
cord-023095-4dannjjm	5436	11	,	,	,
cord-023095-4dannjjm	5436	12	volume	volume	NN
cord-023095-4dannjjm	5436	13	of	of	IN
cord-023095-4dannjjm	5436	14	distribution	distribution	NN
cord-023095-4dannjjm	5436	15	(	(	-LRB-
cord-023095-4dannjjm	5436	16	L	l	NN
cord-023095-4dannjjm	5436	17	/	/	SYM
cord-023095-4dannjjm	5436	18	kg	kg	NNP
cord-023095-4dannjjm	5436	19	)	)	-RRB-
cord-023095-4dannjjm	5436	20	,	,	,
cord-023095-4dannjjm	5436	21	elimination	elimination	NN
cord-023095-4dannjjm	5436	22	half	half	JJ
cord-023095-4dannjjm	5436	23	-	-	HYPH
cord-023095-4dannjjm	5436	24	life	life	NN
cord-023095-4dannjjm	5436	25	(	(	-LRB-
cord-023095-4dannjjm	5436	26	HL	HL	NNP
cord-023095-4dannjjm	5436	27	;	;	:
cord-023095-4dannjjm	5436	28	hr	hr	NN
cord-023095-4dannjjm	5436	29	)	)	-RRB-
cord-023095-4dannjjm	5436	30	and	and	CC
cord-023095-4dannjjm	5436	31	mean	mean	VB
cord-023095-4dannjjm	5436	32	residence	residence	NN
cord-023095-4dannjjm	5436	33	time	time	NN
cord-023095-4dannjjm	5436	34	(	(	-LRB-
cord-023095-4dannjjm	5436	35	MRT	MRT	NNP
cord-023095-4dannjjm	5436	36	,	,	,
cord-023095-4dannjjm	5436	37	hr	hr	NNP
cord-023095-4dannjjm	5436	38	)	)	-RRB-
cord-023095-4dannjjm	5436	39	were	be	VBD
cord-023095-4dannjjm	5436	40	(	(	-LRB-
cord-023095-4dannjjm	5436	41	mean	mean	VB
cord-023095-4dannjjm	5436	42	AE	AE	NNP
cord-023095-4dannjjm	5436	43	sd	sd	NNP
cord-023095-4dannjjm	5436	44	)	)	-RRB-
cord-023095-4dannjjm	5436	45	:	:	:
cord-023095-4dannjjm	5436	46	210	210	CD
cord-023095-4dannjjm	5436	47	AE	AE	NNP
cord-023095-4dannjjm	5436	48	104	104	CD
cord-023095-4dannjjm	5436	49	,	,	,
cord-023095-4dannjjm	5436	50	0.23	0.23	CD
cord-023095-4dannjjm	5436	51	AE	AE	NNP
cord-023095-4dannjjm	5436	52	0.15	0.15	CD
cord-023095-4dannjjm	5436	53	,	,	,
cord-023095-4dannjjm	5436	54	0.36	0.36	CD
cord-023095-4dannjjm	5436	55	AE	AE	NNP
cord-023095-4dannjjm	5436	56	0.19	0.19	CD
cord-023095-4dannjjm	5436	57	,	,	,
cord-023095-4dannjjm	5436	58	1.14	1.14	CD
cord-023095-4dannjjm	5436	59	AE	AE	NNP
cord-023095-4dannjjm	5436	60	0.35	0.35	CD
cord-023095-4dannjjm	5436	61	and	and	CC
cord-023095-4dannjjm	5436	62	1.7	1.7	CD
cord-023095-4dannjjm	5436	63	AE	AE	NNP
cord-023095-4dannjjm	5436	64	0.4	0.4	CD
cord-023095-4dannjjm	5436	65	,	,	,
cord-023095-4dannjjm	5436	66	respectively	respectively	RB
cord-023095-4dannjjm	5436	67	.	.	.
cord-023095-4dannjjm	5437	1	For	for	IN
cord-023095-4dannjjm	5437	2	PO	PO	NNP
cord-023095-4dannjjm	5437	3	,	,	,
cord-023095-4dannjjm	5437	4	C	C	NNP
cord-023095-4dannjjm	5437	5	max	max	NN
cord-023095-4dannjjm	5437	6	,	,	,
cord-023095-4dannjjm	5437	7	HL	HL	NNP
cord-023095-4dannjjm	5437	8	and	and	CC
cord-023095-4dannjjm	5437	9	MRT	MRT	NNP
cord-023095-4dannjjm	5437	10	were	be	VBD
cord-023095-4dannjjm	5437	11	66	66	CD
cord-023095-4dannjjm	5437	12	AE	AE	NNP
cord-023095-4dannjjm	5437	13	21	21	CD
cord-023095-4dannjjm	5437	14	,	,	,
cord-023095-4dannjjm	5437	15	2.5	2.5	CD
cord-023095-4dannjjm	5437	16	AE	AE	NNP
cord-023095-4dannjjm	5437	17	1.09	1.09	CD
cord-023095-4dannjjm	5437	18	and	and	CC
cord-023095-4dannjjm	5437	19	5.1	5.1	CD
cord-023095-4dannjjm	5437	20	AE	AE	NNP
cord-023095-4dannjjm	5437	21	1.7	1.7	CD
cord-023095-4dannjjm	5437	22	,	,	,
cord-023095-4dannjjm	5437	23	respectively	respectively	RB
cord-023095-4dannjjm	5437	24	.	.	.
cord-023095-4dannjjm	5438	1	Serum	serum	NN
cord-023095-4dannjjm	5438	2	FOS	FOS	NNP
cord-023095-4dannjjm	5438	3	exceeded	exceed	VBD
cord-023095-4dannjjm	5438	4	the	the	DT
cord-023095-4dannjjm	5438	5	MIC	MIC	NNP
cord-023095-4dannjjm	5438	6	90	90	CD
cord-023095-4dannjjm	5438	7	reported	report	VBD
cord-023095-4dannjjm	5438	8	for	for	IN
cord-023095-4dannjjm	5438	9	multidrug	multidrug	NN
cord-023095-4dannjjm	5438	10	resistant	resistant	JJ
cord-023095-4dannjjm	5438	11	(	(	-LRB-
cord-023095-4dannjjm	5438	12	MDR	MDR	NNP
cord-023095-4dannjjm	5438	13	)	)	-RRB-
cord-023095-4dannjjm	5438	14	E.	E.	NNP
cord-023095-4dannjjm	5438	15	coli	coli	NNS
cord-023095-4dannjjm	5438	16	(	(	-LRB-
cord-023095-4dannjjm	5438	17	1.5	1.5	CD
cord-023095-4dannjjm	5438	18	mg	mg	NNP
cord-023095-4dannjjm	5438	19	/	/	SYM
cord-023095-4dannjjm	5438	20	ml	ml	NNP
cord-023095-4dannjjm	5438	21	)	)	-RRB-
cord-023095-4dannjjm	5438	22	for	for	IN
cord-023095-4dannjjm	5438	23	7hr	7hr	NNP
cord-023095-4dannjjm	5438	24	(	(	-LRB-
cord-023095-4dannjjm	5438	25	IV	IV	NNP
cord-023095-4dannjjm	5438	26	;	;	:
cord-023095-4dannjjm	5438	27	2.5	2.5	CD
cord-023095-4dannjjm	5438	28	mg	mg	NNP
cord-023095-4dannjjm	5438	29	/	/	SYM
cord-023095-4dannjjm	5438	30	ml	ml	NNP
cord-023095-4dannjjm	5438	31	)	)	-RRB-
cord-023095-4dannjjm	5438	32	and	and	CC
cord-023095-4dannjjm	5438	33	12hr	12hr	NNP
cord-023095-4dannjjm	5438	34	(	(	-LRB-
cord-023095-4dannjjm	5438	35	PO	po	NN
cord-023095-4dannjjm	5438	36	,	,	,
cord-023095-4dannjjm	5439	1	9	9	CD
cord-023095-4dannjjm	5439	2	mg	mg	NNP
cord-023095-4dannjjm	5439	3	/	/	SYM
cord-023095-4dannjjm	5439	4	ml	ml	NNP
cord-023095-4dannjjm	5439	5	Diminazene	Diminazene	NNP
cord-023095-4dannjjm	5439	6	is	be	VBZ
cord-023095-4dannjjm	5439	7	an	an	DT
cord-023095-4dannjjm	5439	8	aromatic	aromatic	JJ
cord-023095-4dannjjm	5439	9	diamidine	diamidine	NN
cord-023095-4dannjjm	5439	10	,	,	,
cord-023095-4dannjjm	5439	11	anti	anti	JJ
cord-023095-4dannjjm	5439	12	-	-	JJ
cord-023095-4dannjjm	5439	13	protozoal	protozoal	JJ
cord-023095-4dannjjm	5439	14	drug	drug	NN
cord-023095-4dannjjm	5439	15	that	that	WDT
cord-023095-4dannjjm	5439	16	has	have	VBZ
cord-023095-4dannjjm	5439	17	shown	show	VBN
cord-023095-4dannjjm	5439	18	promise	promise	NN
cord-023095-4dannjjm	5439	19	in	in	IN
cord-023095-4dannjjm	5439	20	a	a	DT
cord-023095-4dannjjm	5439	21	small	small	JJ
cord-023095-4dannjjm	5439	22	number	number	NN
cord-023095-4dannjjm	5439	23	of	of	IN
cord-023095-4dannjjm	5439	24	cases	case	NNS
cord-023095-4dannjjm	5439	25	of	of	IN
cord-023095-4dannjjm	5439	26	cytauxzoonosis	cytauxzoonosis	NN
cord-023095-4dannjjm	5439	27	.	.	.
cord-023095-4dannjjm	5440	1	In	in	IN
cord-023095-4dannjjm	5440	2	a	a	DT
cord-023095-4dannjjm	5440	3	noncontrolled	noncontrolled	JJ
cord-023095-4dannjjm	5440	4	case	case	NN
cord-023095-4dannjjm	5440	5	series	series	NN
cord-023095-4dannjjm	5440	6	,	,	,
cord-023095-4dannjjm	5440	7	5	5	CD
cord-023095-4dannjjm	5440	8	of	of	IN
cord-023095-4dannjjm	5440	9	6	6	CD
cord-023095-4dannjjm	5440	10	cats	cat	NNS
cord-023095-4dannjjm	5440	11	with	with	IN
cord-023095-4dannjjm	5440	12	clinical	clinical	JJ
cord-023095-4dannjjm	5440	13	cytauxzoonosis	cytauxzoonosis	NN
cord-023095-4dannjjm	5440	14	given	give	VBN
cord-023095-4dannjjm	5440	15	3	3	CD
cord-023095-4dannjjm	5440	16	mg/	mg/	NN
cord-023095-4dannjjm	5440	17	kg	kg	NNP
cord-023095-4dannjjm	5440	18	of	of	IN
cord-023095-4dannjjm	5440	19	diminazene	diminazene	NNP
cord-023095-4dannjjm	5440	20	aceturate	aceturate	NNP
cord-023095-4dannjjm	5440	21	survived	survive	VBD
cord-023095-4dannjjm	5440	22	infection	infection	NN
cord-023095-4dannjjm	5440	23	.	.	.
cord-023095-4dannjjm	5441	1	Dosage	dosage	JJ
cord-023095-4dannjjm	5441	2	frequency	frequency	NN
cord-023095-4dannjjm	5441	3	was	be	VBD
cord-023095-4dannjjm	5441	4	two	two	CD
cord-023095-4dannjjm	5441	5	intramuscular	intramuscular	JJ
cord-023095-4dannjjm	5441	6	injections	injection	NNS
cord-023095-4dannjjm	5441	7	given	give	VBN
cord-023095-4dannjjm	5441	8	one	one	CD
cord-023095-4dannjjm	5441	9	week	week	NN
cord-023095-4dannjjm	5441	10	apart	apart	RB
cord-023095-4dannjjm	5441	11	.	.	.
cord-023095-4dannjjm	5442	1	Commercial	commercial	JJ
cord-023095-4dannjjm	5442	2	formulations	formulation	NNS
cord-023095-4dannjjm	5442	3	contain	contain	VBP
cord-023095-4dannjjm	5442	4	the	the	DT
cord-023095-4dannjjm	5442	5	diminazene	diminazene	NNP
cord-023095-4dannjjm	5442	6	diaceturate	diaceturate	NN
cord-023095-4dannjjm	5442	7	salt	salt	NN
cord-023095-4dannjjm	5442	8	.	.	.
cord-023095-4dannjjm	5443	1	The	the	DT
cord-023095-4dannjjm	5443	2	active	active	JJ
cord-023095-4dannjjm	5443	3	base	base	NN
cord-023095-4dannjjm	5443	4	is	be	VBZ
cord-023095-4dannjjm	5443	5	diminazene	diminazene	NN
cord-023095-4dannjjm	5443	6	with	with	IN
cord-023095-4dannjjm	5443	7	the	the	DT
cord-023095-4dannjjm	5443	8	salt	salt	NN
cord-023095-4dannjjm	5443	9	consisting	consist	VBG
cord-023095-4dannjjm	5443	10	of	of	IN
cord-023095-4dannjjm	5443	11	two	two	CD
cord-023095-4dannjjm	5443	12	aceturate	aceturate	NN
cord-023095-4dannjjm	5443	13	molecules	molecule	NNS
cord-023095-4dannjjm	5443	14	.	.	.
cord-023095-4dannjjm	5444	1	Currently	currently	RB
cord-023095-4dannjjm	5444	2	there	there	EX
cord-023095-4dannjjm	5444	3	is	be	VBZ
cord-023095-4dannjjm	5444	4	no	no	DT
cord-023095-4dannjjm	5444	5	data	datum	NNS
cord-023095-4dannjjm	5444	6	available	available	JJ
cord-023095-4dannjjm	5444	7	on	on	IN
cord-023095-4dannjjm	5444	8	the	the	DT
cord-023095-4dannjjm	5444	9	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	5444	10	of	of	IN
cord-023095-4dannjjm	5444	11	either	either	DT
cord-023095-4dannjjm	5444	12	diminazene	diminazene	NNP
cord-023095-4dannjjm	5444	13	compound	compound	NN
cord-023095-4dannjjm	5444	14	in	in	IN
cord-023095-4dannjjm	5444	15	cats	cat	NNS
cord-023095-4dannjjm	5444	16	.	.	.
cord-023095-4dannjjm	5445	1	The	the	DT
cord-023095-4dannjjm	5445	2	objective	objective	NN
cord-023095-4dannjjm	5445	3	of	of	IN
cord-023095-4dannjjm	5445	4	this	this	DT
cord-023095-4dannjjm	5445	5	study	study	NN
cord-023095-4dannjjm	5445	6	was	be	VBD
cord-023095-4dannjjm	5445	7	to	to	TO
cord-023095-4dannjjm	5445	8	determine	determine	VB
cord-023095-4dannjjm	5445	9	the	the	DT
cord-023095-4dannjjm	5445	10	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	5445	11	of	of	IN
cord-023095-4dannjjm	5445	12	diminazene	diminazene	NNP
cord-023095-4dannjjm	5445	13	diaceturate	diaceturate	NNP
cord-023095-4dannjjm	5445	14	in	in	IN
cord-023095-4dannjjm	5445	15	healthy	healthy	JJ
cord-023095-4dannjjm	5445	16	cats	cat	NNS
cord-023095-4dannjjm	5445	17	.	.	.
cord-023095-4dannjjm	5446	1	Four	four	CD
cord-023095-4dannjjm	5446	2	purpose	purpose	NN
cord-023095-4dannjjm	5446	3	bred	breed	VBD
cord-023095-4dannjjm	5446	4	cats	cat	NNS
cord-023095-4dannjjm	5446	5	with	with	IN
cord-023095-4dannjjm	5446	6	normal	normal	JJ
cord-023095-4dannjjm	5446	7	physical	physical	JJ
cord-023095-4dannjjm	5446	8	examination	examination	NN
cord-023095-4dannjjm	5446	9	,	,	,
cord-023095-4dannjjm	5446	10	CBC	CBC	NNP
cord-023095-4dannjjm	5446	11	,	,	,
cord-023095-4dannjjm	5446	12	chemistry	chemistry	NN
cord-023095-4dannjjm	5446	13	and	and	CC
cord-023095-4dannjjm	5446	14	urinalysis	urinalysis	NN
cord-023095-4dannjjm	5446	15	were	be	VBD
cord-023095-4dannjjm	5446	16	used	use	VBN
cord-023095-4dannjjm	5446	17	.	.	.
cord-023095-4dannjjm	5447	1	A	a	DT
cord-023095-4dannjjm	5447	2	powdered	powdered	JJ
cord-023095-4dannjjm	5447	3	commercial	commercial	JJ
cord-023095-4dannjjm	5447	4	drug	drug	NN
cord-023095-4dannjjm	5447	5	formulation	formulation	NN
cord-023095-4dannjjm	5447	6	(	(	-LRB-
cord-023095-4dannjjm	5447	7	Veriben	Veriben	NNP
cord-023095-4dannjjm	5447	8	s	s	NNP
cord-023095-4dannjjm	5447	9	,	,	,
cord-023095-4dannjjm	5447	10	Ceva	Ceva	NNP
cord-023095-4dannjjm	5447	11	Sanet	Sanet	NNP
cord-023095-4dannjjm	5447	12	Animale	Animale	NNP
cord-023095-4dannjjm	5447	13	)	)	-RRB-
cord-023095-4dannjjm	5447	14	was	be	VBD
cord-023095-4dannjjm	5447	15	freshly	freshly	RB
cord-023095-4dannjjm	5447	16	reconstituted	reconstitute	VBN
cord-023095-4dannjjm	5447	17	with	with	IN
cord-023095-4dannjjm	5447	18	sterile	sterile	JJ
cord-023095-4dannjjm	5447	19	water	water	NN
cord-023095-4dannjjm	5447	20	to	to	IN
cord-023095-4dannjjm	5447	21	a	a	DT
cord-023095-4dannjjm	5447	22	concentration	concentration	NN
cord-023095-4dannjjm	5447	23	of	of	IN
cord-023095-4dannjjm	5447	24	7	7	CD
cord-023095-4dannjjm	5447	25	mg	mg	NNP
cord-023095-4dannjjm	5447	26	/	/	SYM
cord-023095-4dannjjm	5447	27	mL	mL	NNP
cord-023095-4dannjjm	5447	28	prior	prior	RB
cord-023095-4dannjjm	5447	29	to	to	IN
cord-023095-4dannjjm	5447	30	administration	administration	NN
cord-023095-4dannjjm	5447	31	and	and	CC
cord-023095-4dannjjm	5447	32	sterile	sterile	JJ
cord-023095-4dannjjm	5447	33	filtered	filter	VBN
cord-023095-4dannjjm	5447	34	solution	solution	NN
cord-023095-4dannjjm	5447	35	.	.	.
cord-023095-4dannjjm	5448	1	Heparinized	heparinize	VBN
cord-023095-4dannjjm	5448	2	blood	blood	NN
cord-023095-4dannjjm	5448	3	samples	sample	NNS
cord-023095-4dannjjm	5448	4	were	be	VBD
cord-023095-4dannjjm	5448	5	collected	collect	VBN
cord-023095-4dannjjm	5448	6	just	just	RB
cord-023095-4dannjjm	5448	7	before	before	RB
cord-023095-4dannjjm	5448	8	(	(	-LRB-
cord-023095-4dannjjm	5448	9	hour	hour	NN
cord-023095-4dannjjm	5448	10	0	0	CD
cord-023095-4dannjjm	5448	11	)	)	-RRB-
cord-023095-4dannjjm	5448	12	or	or	CC
cord-023095-4dannjjm	5448	13	0.5	0.5	CD
cord-023095-4dannjjm	5448	14	,	,	,
cord-023095-4dannjjm	5448	15	1	1	CD
cord-023095-4dannjjm	5448	16	,	,	,
cord-023095-4dannjjm	5448	17	2	2	CD
cord-023095-4dannjjm	5448	18	,	,	,
cord-023095-4dannjjm	5448	19	4	4	CD
cord-023095-4dannjjm	5448	20	,	,	,
cord-023095-4dannjjm	5448	21	8	8	CD
cord-023095-4dannjjm	5448	22	,	,	,
cord-023095-4dannjjm	5448	23	12	12	CD
cord-023095-4dannjjm	5448	24	,	,	,
cord-023095-4dannjjm	5448	25	18	18	CD
cord-023095-4dannjjm	5448	26	,	,	,
cord-023095-4dannjjm	5448	27	24	24	CD
cord-023095-4dannjjm	5448	28	,	,	,
cord-023095-4dannjjm	5448	29	36	36	CD
cord-023095-4dannjjm	5448	30	,	,	,
cord-023095-4dannjjm	5448	31	48	48	CD
cord-023095-4dannjjm	5448	32	,	,	,
cord-023095-4dannjjm	5448	33	72	72	CD
cord-023095-4dannjjm	5448	34	,	,	,
cord-023095-4dannjjm	5448	35	120	120	CD
cord-023095-4dannjjm	5448	36	,	,	,
cord-023095-4dannjjm	5448	37	and	and	CC
cord-023095-4dannjjm	5448	38	168	168	CD
cord-023095-4dannjjm	5448	39	hours	hour	NNS
cord-023095-4dannjjm	5448	40	after	after	IN
cord-023095-4dannjjm	5448	41	intramuscular	intramuscular	JJ
cord-023095-4dannjjm	5448	42	administration	administration	NN
cord-023095-4dannjjm	5448	43	of	of	IN
cord-023095-4dannjjm	5448	44	3	3	CD
cord-023095-4dannjjm	5448	45	mg	mg	NNP
cord-023095-4dannjjm	5448	46	/	/	SYM
cord-023095-4dannjjm	5448	47	kg	kg	NNP
cord-023095-4dannjjm	5448	48	(	(	-LRB-
cord-023095-4dannjjm	5448	49	1.68	1.68	CD
cord-023095-4dannjjm	5448	50	mg	mg	NNP
cord-023095-4dannjjm	5448	51	/	/	SYM
cord-023095-4dannjjm	5448	52	kg	kg	NNP
cord-023095-4dannjjm	5448	53	of	of	IN
cord-023095-4dannjjm	5448	54	diminazene	diminazene	NNP
cord-023095-4dannjjm	5448	55	base	base	NN
cord-023095-4dannjjm	5448	56	)	)	-RRB-
cord-023095-4dannjjm	5448	57	diminazene	diminazene	NNP
cord-023095-4dannjjm	5448	58	diaceturate	diaceturate	NNP
cord-023095-4dannjjm	5448	59	.	.	.
cord-023095-4dannjjm	5449	1	The	the	DT
cord-023095-4dannjjm	5449	2	plasma	plasma	NN
cord-023095-4dannjjm	5449	3	was	be	VBD
cord-023095-4dannjjm	5449	4	separated	separate	VBN
cord-023095-4dannjjm	5449	5	by	by	IN
cord-023095-4dannjjm	5449	6	centrifugation	centrifugation	NN
cord-023095-4dannjjm	5449	7	within	within	IN
cord-023095-4dannjjm	5449	8	30	30	CD
cord-023095-4dannjjm	5449	9	minutes	minute	NNS
cord-023095-4dannjjm	5449	10	of	of	IN
cord-023095-4dannjjm	5449	11	collection	collection	NN
cord-023095-4dannjjm	5449	12	and	and	CC
cord-023095-4dannjjm	5449	13	frozen	frozen	JJ
cord-023095-4dannjjm	5449	14	(	(	-LRB-
cord-023095-4dannjjm	5449	15	À801C	À801C	NNP
cord-023095-4dannjjm	5449	16	)	)	-RRB-
cord-023095-4dannjjm	5449	17	until	until	IN
cord-023095-4dannjjm	5449	18	analysis	analysis	NN
cord-023095-4dannjjm	5449	19	.	.	.
cord-023095-4dannjjm	5450	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	5450	2	of	of	IN
cord-023095-4dannjjm	5450	3	diminazene	diminazene	NNP
cord-023095-4dannjjm	5450	4	were	be	VBD
cord-023095-4dannjjm	5450	5	measured	measure	VBN
cord-023095-4dannjjm	5450	6	by	by	IN
cord-023095-4dannjjm	5450	7	HPLC	HPLC	NNP
cord-023095-4dannjjm	5450	8	analysis	analysis	NN
cord-023095-4dannjjm	5450	9	using	use	VBG
cord-023095-4dannjjm	5450	10	UV	uv	NN
cord-023095-4dannjjm	5450	11	absorption	absorption	NN
cord-023095-4dannjjm	5450	12	and	and	CC
cord-023095-4dannjjm	5450	13	ion	ion	NN
cord-023095-4dannjjm	5450	14	-	-	HYPH
cord-023095-4dannjjm	5450	15	pairing	pair	VBG
cord-023095-4dannjjm	5450	16	conditions	condition	NNS
cord-023095-4dannjjm	5450	17	.	.	.
cord-023095-4dannjjm	5451	1	The	the	DT
cord-023095-4dannjjm	5451	2	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	5451	3	profile	profile	NN
cord-023095-4dannjjm	5451	4	was	be	VBD
cord-023095-4dannjjm	5451	5	analyzed	analyze	VBN
cord-023095-4dannjjm	5451	6	using	use	VBG
cord-023095-4dannjjm	5451	7	a	a	DT
cord-023095-4dannjjm	5451	8	simple	simple	JJ
cord-023095-4dannjjm	5451	9	one	one	CD
cord-023095-4dannjjm	5451	10	-	-	HYPH
cord-023095-4dannjjm	5451	11	compartment	compartment	NN
cord-023095-4dannjjm	5451	12	model	model	NN
cord-023095-4dannjjm	5451	13	.	.	.
cord-023095-4dannjjm	5452	1	In	in	IN
cord-023095-4dannjjm	5452	2	these	these	DT
cord-023095-4dannjjm	5452	3	cats	cat	NNS
cord-023095-4dannjjm	5452	4	,	,	,
cord-023095-4dannjjm	5452	5	diminazene	diminazene	NNP
cord-023095-4dannjjm	5452	6	had	have	VBD
cord-023095-4dannjjm	5452	7	a	a	DT
cord-023095-4dannjjm	5452	8	mean	mean	JJ
cord-023095-4dannjjm	5452	9	terminal	terminal	JJ
cord-023095-4dannjjm	5452	10	half	half	JJ
cord-023095-4dannjjm	5452	11	life	life	NN
cord-023095-4dannjjm	5452	12	(	(	-LRB-
cord-023095-4dannjjm	5452	13	T	T	NNP
cord-023095-4dannjjm	5452	14	1/2	1/2	CD
cord-023095-4dannjjm	5452	15	)	)	-RRB-
cord-023095-4dannjjm	5452	16	of	of	IN
cord-023095-4dannjjm	5452	17	1.70	1.70	CD
cord-023095-4dannjjm	5452	18	(	(	-LRB-
cord-023095-4dannjjm	5452	19	1/-0.29	1/-0.29	CD
cord-023095-4dannjjm	5452	20	)	)	-RRB-
cord-023095-4dannjjm	5452	21	hrs	hrs	NN
cord-023095-4dannjjm	5452	22	and	and	CC
cord-023095-4dannjjm	5452	23	mean	mean	VB
cord-023095-4dannjjm	5452	24	peak	peak	NN
cord-023095-4dannjjm	5452	25	plasma	plasma	NN
cord-023095-4dannjjm	5452	26	concentration	concentration	NN
cord-023095-4dannjjm	5452	27	(	(	-LRB-
cord-023095-4dannjjm	5452	28	C	C	NNP
cord-023095-4dannjjm	5452	29	MAX	MAX	NNP
cord-023095-4dannjjm	5452	30	)	)	-RRB-
cord-023095-4dannjjm	5452	31	0.51	0.51	CD
cord-023095-4dannjjm	5452	32	(	(	-LRB-
cord-023095-4dannjjm	5452	33	1	1	CD
cord-023095-4dannjjm	5452	34	/	/	SYM
cord-023095-4dannjjm	5452	35	À	à	NN
cord-023095-4dannjjm	5452	36	0.11	0.11	CD
cord-023095-4dannjjm	5452	37	)	)	-RRB-
cord-023095-4dannjjm	5453	1	mg	mg	NNP
cord-023095-4dannjjm	5453	2	/	/	SYM
cord-023095-4dannjjm	5453	3	mL.	mL.	NNP
cord-023095-4dannjjm	5454	1	The	the	DT
cord-023095-4dannjjm	5454	2	mean	mean	JJ
cord-023095-4dannjjm	5454	3	residence	residence	NN
cord-023095-4dannjjm	5454	4	time	time	NN
cord-023095-4dannjjm	5454	5	(	(	-LRB-
cord-023095-4dannjjm	5454	6	MRT	MRT	NNP
cord-023095-4dannjjm	5454	7	)	)	-RRB-
cord-023095-4dannjjm	5454	8	of	of	IN
cord-023095-4dannjjm	5454	9	diminazene	diminazene	NNP
cord-023095-4dannjjm	5454	10	was	be	VBD
cord-023095-4dannjjm	5454	11	2.45	2.45	CD
cord-023095-4dannjjm	5454	12	hrs	hrs	NN
cord-023095-4dannjjm	5454	13	(	(	-LRB-
cord-023095-4dannjjm	5454	14	1	1	CD
cord-023095-4dannjjm	5454	15	/	/	SYM
cord-023095-4dannjjm	5454	16	À0.42	à0.42	NN
cord-023095-4dannjjm	5454	17	)	)	-RRB-
cord-023095-4dannjjm	5454	18	.	.	.
cord-023095-4dannjjm	5455	1	Systemic	systemic	JJ
cord-023095-4dannjjm	5455	2	clearance	clearance	NN
cord-023095-4dannjjm	5455	3	(	(	-LRB-
cord-023095-4dannjjm	5455	4	CL	CL	NNP
cord-023095-4dannjjm	5455	5	/	/	SYM
cord-023095-4dannjjm	5455	6	F	F	NNP
cord-023095-4dannjjm	5455	7	)	)	-RRB-
cord-023095-4dannjjm	5455	8	was	be	VBD
cord-023095-4dannjjm	5455	9	1.38	1.38	CD
cord-023095-4dannjjm	5455	10	(	(	-LRB-
cord-023095-4dannjjm	5455	11	1	1	CD
cord-023095-4dannjjm	5455	12	/	/	SYM
cord-023095-4dannjjm	5455	13	À	à	NN
cord-023095-4dannjjm	5455	14	0.26	0.26	CD
cord-023095-4dannjjm	5455	15	)	)	-RRB-
cord-023095-4dannjjm	5456	1	L	L	NNP
cord-023095-4dannjjm	5456	2	/	/	SYM
cord-023095-4dannjjm	5456	3	kg	kg	NNP
cord-023095-4dannjjm	5456	4	/	/	SYM
cord-023095-4dannjjm	5456	5	hr	hr	NN
cord-023095-4dannjjm	5456	6	.	.	.
cord-023095-4dannjjm	5457	1	The	the	DT
cord-023095-4dannjjm	5457	2	volume	volume	NN
cord-023095-4dannjjm	5457	3	of	of	IN
cord-023095-4dannjjm	5457	4	distribution	distribution	NN
cord-023095-4dannjjm	5457	5	per	per	IN
cord-023095-4dannjjm	5457	6	fraction	fraction	NN
cord-023095-4dannjjm	5457	7	absorbed	absorb	VBN
cord-023095-4dannjjm	5457	8	(	(	-LRB-
cord-023095-4dannjjm	5457	9	VD	VD	NNP
cord-023095-4dannjjm	5457	10	/	/	SYM
cord-023095-4dannjjm	5457	11	F	F	NNP
cord-023095-4dannjjm	5457	12	)	)	-RRB-
cord-023095-4dannjjm	5457	13	was	be	VBD
cord-023095-4dannjjm	5457	14	3.36	3.36	CD
cord-023095-4dannjjm	5457	15	(	(	-LRB-
cord-023095-4dannjjm	5457	16	1	1	CD
cord-023095-4dannjjm	5457	17	/	/	SYM
cord-023095-4dannjjm	5457	18	À	à	NN
cord-023095-4dannjjm	5457	19	0.72	0.72	CD
cord-023095-4dannjjm	5457	20	)	)	-RRB-
cord-023095-4dannjjm	5458	1	L	L	NNP
cord-023095-4dannjjm	5458	2	/	/	SYM
cord-023095-4dannjjm	5458	3	kg	kg	NN
cord-023095-4dannjjm	5458	4	.	.	.
cord-023095-4dannjjm	5459	1	A	a	DT
cord-023095-4dannjjm	5459	2	single	single	JJ
cord-023095-4dannjjm	5459	3	intramuscular	intramuscular	JJ
cord-023095-4dannjjm	5459	4	dose	dose	NN
cord-023095-4dannjjm	5459	5	of	of	IN
cord-023095-4dannjjm	5459	6	diminazene	diminazene	NNP
cord-023095-4dannjjm	5459	7	diaceturate	diaceturate	NNP
cord-023095-4dannjjm	5459	8	was	be	VBD
cord-023095-4dannjjm	5459	9	well	well	RB
cord-023095-4dannjjm	5459	10	tolerated	tolerate	VBN
cord-023095-4dannjjm	5459	11	by	by	IN
cord-023095-4dannjjm	5459	12	all	all	DT
cord-023095-4dannjjm	5459	13	4	4	CD
cord-023095-4dannjjm	5459	14	cats	cat	NNS
cord-023095-4dannjjm	5459	15	.	.	.
cord-023095-4dannjjm	5460	1	Without	without	IN
cord-023095-4dannjjm	5460	2	knowing	know	VBG
cord-023095-4dannjjm	5460	3	the	the	DT
cord-023095-4dannjjm	5460	4	concentration	concentration	NN
cord-023095-4dannjjm	5460	5	required	require	VBN
cord-023095-4dannjjm	5460	6	to	to	TO
cord-023095-4dannjjm	5460	7	inhibit	inhibit	VB
cord-023095-4dannjjm	5460	8	or	or	CC
cord-023095-4dannjjm	5460	9	kill	kill	VB
cord-023095-4dannjjm	5460	10	Cytauxzoon	Cytauxzoon	NNP
cord-023095-4dannjjm	5460	11	felis	felis	NN
cord-023095-4dannjjm	5460	12	,	,	,
cord-023095-4dannjjm	5460	13	it	-PRON-	PRP
cord-023095-4dannjjm	5460	14	is	be	VBZ
cord-023095-4dannjjm	5460	15	not	not	RB
cord-023095-4dannjjm	5460	16	yet	yet	RB
cord-023095-4dannjjm	5460	17	possible	possible	JJ
cord-023095-4dannjjm	5460	18	to	to	TO
cord-023095-4dannjjm	5460	19	make	make	VB
cord-023095-4dannjjm	5460	20	suggestions	suggestion	NNS
cord-023095-4dannjjm	5460	21	regarding	regard	VBG
cord-023095-4dannjjm	5460	22	optimum	optimum	JJ
cord-023095-4dannjjm	5460	23	dosing	dosing	NN
cord-023095-4dannjjm	5460	24	schedules	schedule	NNS
cord-023095-4dannjjm	5460	25	for	for	IN
cord-023095-4dannjjm	5460	26	this	this	DT
cord-023095-4dannjjm	5460	27	drug	drug	NN
cord-023095-4dannjjm	5460	28	.	.	.
cord-023095-4dannjjm	5461	1	Additional	additional	JJ
cord-023095-4dannjjm	5461	2	toxicology	toxicology	NN
cord-023095-4dannjjm	5461	3	data	datum	NNS
cord-023095-4dannjjm	5461	4	and	and	CC
cord-023095-4dannjjm	5461	5	studies	study	NNS
cord-023095-4dannjjm	5461	6	to	to	TO
cord-023095-4dannjjm	5461	7	assess	assess	VB
cord-023095-4dannjjm	5461	8	clinical	clinical	JJ
cord-023095-4dannjjm	5461	9	efficacy	efficacy	NN
cord-023095-4dannjjm	5461	10	for	for	IN
cord-023095-4dannjjm	5461	11	the	the	DT
cord-023095-4dannjjm	5461	12	treatment	treatment	NN
cord-023095-4dannjjm	5461	13	of	of	IN
cord-023095-4dannjjm	5461	14	cytauxzoonosis	cytauxzoonosis	NN
cord-023095-4dannjjm	5461	15	are	be	VBP
cord-023095-4dannjjm	5461	16	indicated	indicate	VBN
cord-023095-4dannjjm	5461	17	before	before	IN
cord-023095-4dannjjm	5461	18	routine	routine	JJ
cord-023095-4dannjjm	5461	19	clinical	clinical	JJ
cord-023095-4dannjjm	5461	20	use	use	NN
cord-023095-4dannjjm	5461	21	can	can	MD
cord-023095-4dannjjm	5461	22	be	be	VB
cord-023095-4dannjjm	5461	23	considered	consider	VBN
cord-023095-4dannjjm	5461	24	.	.	.
cord-023095-4dannjjm	5462	1	Meloxicam	Meloxicam	NNP
cord-023095-4dannjjm	5462	2	has	have	VBZ
cord-023095-4dannjjm	5462	3	been	be	VBN
cord-023095-4dannjjm	5462	4	shown	show	VBN
cord-023095-4dannjjm	5462	5	to	to	TO
cord-023095-4dannjjm	5462	6	accumulate	accumulate	VB
cord-023095-4dannjjm	5462	7	in	in	IN
cord-023095-4dannjjm	5462	8	areas	area	NNS
cord-023095-4dannjjm	5462	9	of	of	IN
cord-023095-4dannjjm	5462	10	inflammation	inflammation	NN
cord-023095-4dannjjm	5462	11	in	in	IN
cord-023095-4dannjjm	5462	12	both	both	CC
cord-023095-4dannjjm	5462	13	the	the	DT
cord-023095-4dannjjm	5462	14	rat	rat	NN
cord-023095-4dannjjm	5462	15	and	and	CC
cord-023095-4dannjjm	5462	16	human	human	NN
cord-023095-4dannjjm	5462	17	.	.	.
cord-023095-4dannjjm	5463	1	The	the	DT
cord-023095-4dannjjm	5463	2	objective	objective	NN
cord-023095-4dannjjm	5463	3	of	of	IN
cord-023095-4dannjjm	5463	4	this	this	DT
cord-023095-4dannjjm	5463	5	study	study	NN
cord-023095-4dannjjm	5463	6	was	be	VBD
cord-023095-4dannjjm	5463	7	to	to	TO
cord-023095-4dannjjm	5463	8	investigate	investigate	VB
cord-023095-4dannjjm	5463	9	the	the	DT
cord-023095-4dannjjm	5463	10	concentration	concentration	NN
cord-023095-4dannjjm	5463	11	of	of	IN
cord-023095-4dannjjm	5463	12	meloxicam	meloxicam	NN
cord-023095-4dannjjm	5463	13	in	in	IN
cord-023095-4dannjjm	5463	14	synovial	synovial	JJ
cord-023095-4dannjjm	5463	15	fluid	fluid	NN
cord-023095-4dannjjm	5463	16	of	of	IN
cord-023095-4dannjjm	5463	17	inflamed	inflamed	JJ
cord-023095-4dannjjm	5463	18	joints	joint	NNS
cord-023095-4dannjjm	5463	19	versus	versus	IN
cord-023095-4dannjjm	5463	20	that	that	DT
cord-023095-4dannjjm	5463	21	of	of	IN
cord-023095-4dannjjm	5463	22	non	non	JJ
cord-023095-4dannjjm	5463	23	-	-	JJ
cord-023095-4dannjjm	5463	24	inflamed	inflamed	JJ
cord-023095-4dannjjm	5463	25	joints	joint	NNS
cord-023095-4dannjjm	5463	26	in	in	IN
cord-023095-4dannjjm	5463	27	dogs	dog	NNS
cord-023095-4dannjjm	5463	28	.	.	.
cord-023095-4dannjjm	5464	1	Eight	eight	CD
cord-023095-4dannjjm	5464	2	male	male	JJ
cord-023095-4dannjjm	5464	3	dogs	dog	NNS
cord-023095-4dannjjm	5464	4	were	be	VBD
cord-023095-4dannjjm	5464	5	treated	treat	VBN
cord-023095-4dannjjm	5464	6	with	with	IN
cord-023095-4dannjjm	5464	7	0.2	0.2	CD
cord-023095-4dannjjm	5464	8	mg	mg	NN
cord-023095-4dannjjm	5464	9	/	/	SYM
cord-023095-4dannjjm	5464	10	kg	kg	NNS
cord-023095-4dannjjm	5464	11	of	of	IN
cord-023095-4dannjjm	5464	12	meloxicam	meloxicam	NN
cord-023095-4dannjjm	5464	13	on	on	IN
cord-023095-4dannjjm	5464	14	Day	Day	NNP
cord-023095-4dannjjm	5464	15	One	one	CD
cord-023095-4dannjjm	5464	16	and	and	CC
cord-023095-4dannjjm	5464	17	0.1	0.1	CD
cord-023095-4dannjjm	5464	18	mg	mg	NNS
cord-023095-4dannjjm	5464	19	/	/	SYM
cord-023095-4dannjjm	5464	20	kg	kg	NNS
cord-023095-4dannjjm	5464	21	of	of	IN
cord-023095-4dannjjm	5464	22	meloxicam	meloxicam	NN
cord-023095-4dannjjm	5464	23	on	on	IN
cord-023095-4dannjjm	5464	24	Day	Day	NNP
cord-023095-4dannjjm	5464	25	Two	two	CD
cord-023095-4dannjjm	5464	26	.	.	.
cord-023095-4dannjjm	5465	1	All	all	DT
cord-023095-4dannjjm	5465	2	treatments	treatment	NNS
cord-023095-4dannjjm	5465	3	were	be	VBD
cord-023095-4dannjjm	5465	4	administered	administer	VBN
cord-023095-4dannjjm	5465	5	orally	orally	RB
cord-023095-4dannjjm	5465	6	.	.	.
cord-023095-4dannjjm	5466	1	On	on	IN
cord-023095-4dannjjm	5466	2	Day	Day	NNP
cord-023095-4dannjjm	5466	3	Three	three	CD
cord-023095-4dannjjm	5466	4	reversible	reversible	JJ
cord-023095-4dannjjm	5466	5	acute	acute	JJ
cord-023095-4dannjjm	5466	6	synovitis	synovitis	NN
cord-023095-4dannjjm	5466	7	was	be	VBD
cord-023095-4dannjjm	5466	8	induced	induce	VBN
cord-023095-4dannjjm	5466	9	in	in	IN
cord-023095-4dannjjm	5466	10	one	one	CD
cord-023095-4dannjjm	5466	11	stifle	stifle	NN
cord-023095-4dannjjm	5466	12	by	by	IN
cord-023095-4dannjjm	5466	13	aseptic	aseptic	JJ
cord-023095-4dannjjm	5466	14	,	,	,
cord-023095-4dannjjm	5466	15	intra	intra	JJ
cord-023095-4dannjjm	5466	16	-	-	JJ
cord-023095-4dannjjm	5466	17	articular	articular	JJ
cord-023095-4dannjjm	5466	18	administration	administration	NN
cord-023095-4dannjjm	5466	19	of	of	IN
cord-023095-4dannjjm	5466	20	1	1	CD
cord-023095-4dannjjm	5466	21	ml	ml	NN
cord-023095-4dannjjm	5466	22	sodium	sodium	NN
cord-023095-4dannjjm	5466	23	urate	urate	NN
cord-023095-4dannjjm	5466	24	crystal	crystal	NN
cord-023095-4dannjjm	5466	25	suspension	suspension	NN
cord-023095-4dannjjm	5466	26	(	(	-LRB-
cord-023095-4dannjjm	5466	27	10	10	CD
cord-023095-4dannjjm	5466	28	mg	mg	NNP
cord-023095-4dannjjm	5466	29	/	/	SYM
cord-023095-4dannjjm	5466	30	ml	ml	NN
cord-023095-4dannjjm	5466	31	)	)	-RRB-
cord-023095-4dannjjm	5466	32	.	.	.
cord-023095-4dannjjm	5467	1	In	in	IN
cord-023095-4dannjjm	5467	2	four	four	CD
cord-023095-4dannjjm	5467	3	dogs	dog	NNS
cord-023095-4dannjjm	5467	4	synovitis	synovitis	NNP
cord-023095-4dannjjm	5467	5	was	be	VBD
cord-023095-4dannjjm	5467	6	induced	induce	VBN
cord-023095-4dannjjm	5467	7	in	in	IN
cord-023095-4dannjjm	5467	8	the	the	DT
cord-023095-4dannjjm	5467	9	L	L	NNP
cord-023095-4dannjjm	5467	10	stifle	stifle	NN
cord-023095-4dannjjm	5467	11	and	and	CC
cord-023095-4dannjjm	5467	12	in	in	IN
cord-023095-4dannjjm	5467	13	four	four	CD
cord-023095-4dannjjm	5467	14	dogs	dog	NNS
cord-023095-4dannjjm	5467	15	the	the	DT
cord-023095-4dannjjm	5467	16	same	same	JJ
cord-023095-4dannjjm	5467	17	procedure	procedure	NN
cord-023095-4dannjjm	5467	18	was	be	VBD
cord-023095-4dannjjm	5467	19	used	use	VBN
cord-023095-4dannjjm	5467	20	in	in	IN
cord-023095-4dannjjm	5467	21	the	the	DT
cord-023095-4dannjjm	5467	22	R	r	NN
cord-023095-4dannjjm	5467	23	stifle	stifle	VB
cord-023095-4dannjjm	5467	24	.	.	.
cord-023095-4dannjjm	5468	1	In	in	IN
cord-023095-4dannjjm	5468	2	each	each	DT
cord-023095-4dannjjm	5468	3	dog	dog	NN
cord-023095-4dannjjm	5468	4	the	the	DT
cord-023095-4dannjjm	5468	5	stifle	stifle	NN
cord-023095-4dannjjm	5468	6	without	without	IN
cord-023095-4dannjjm	5468	7	induction	induction	NN
cord-023095-4dannjjm	5468	8	of	of	IN
cord-023095-4dannjjm	5468	9	synovitis	synovitis	NNP
cord-023095-4dannjjm	5468	10	served	serve	VBD
cord-023095-4dannjjm	5468	11	as	as	IN
cord-023095-4dannjjm	5468	12	the	the	DT
cord-023095-4dannjjm	5468	13	'	'	``
cord-023095-4dannjjm	5468	14	'	'	``
cord-023095-4dannjjm	5468	15	normal	normal	JJ
cord-023095-4dannjjm	5468	16	'	'	''
cord-023095-4dannjjm	5468	17	'	'	''
cord-023095-4dannjjm	5468	18	joint	joint	JJ
cord-023095-4dannjjm	5468	19	sample	sample	NN
cord-023095-4dannjjm	5468	20	.	.	.
cord-023095-4dannjjm	5469	1	A	a	DT
cord-023095-4dannjjm	5469	2	synovial	synovial	JJ
cord-023095-4dannjjm	5469	3	fluid	fluid	NN
cord-023095-4dannjjm	5469	4	sample	sample	NN
cord-023095-4dannjjm	5469	5	was	be	VBD
cord-023095-4dannjjm	5469	6	collected	collect	VBN
cord-023095-4dannjjm	5469	7	from	from	IN
cord-023095-4dannjjm	5469	8	both	both	CC
cord-023095-4dannjjm	5469	9	the	the	DT
cord-023095-4dannjjm	5469	10	R	r	NN
cord-023095-4dannjjm	5469	11	and	and	CC
cord-023095-4dannjjm	5469	12	L	l	NN
cord-023095-4dannjjm	5469	13	stifle	stifle	VB
cord-023095-4dannjjm	5469	14	of	of	IN
cord-023095-4dannjjm	5469	15	each	each	DT
cord-023095-4dannjjm	5469	16	dog	dog	NN
cord-023095-4dannjjm	5469	17	.	.	.
cord-023095-4dannjjm	5470	1	Sample	sample	NN
cord-023095-4dannjjm	5470	2	collection	collection	NN
cord-023095-4dannjjm	5470	3	occurred	occur	VBD
cord-023095-4dannjjm	5470	4	eight	eight	CD
cord-023095-4dannjjm	5470	5	hours	hour	NNS
cord-023095-4dannjjm	5470	6	after	after	IN
cord-023095-4dannjjm	5470	7	administration	administration	NN
cord-023095-4dannjjm	5470	8	of	of	IN
cord-023095-4dannjjm	5470	9	sodium	sodium	NN
cord-023095-4dannjjm	5470	10	urate	urate	NN
cord-023095-4dannjjm	5470	11	and	and	CC
cord-023095-4dannjjm	5470	12	twenty	twenty	CD
cord-023095-4dannjjm	5470	13	four	four	CD
cord-023095-4dannjjm	5470	14	hours	hour	NNS
cord-023095-4dannjjm	5470	15	after	after	IN
cord-023095-4dannjjm	5470	16	the	the	DT
cord-023095-4dannjjm	5470	17	last	last	JJ
cord-023095-4dannjjm	5470	18	administration	administration	NN
cord-023095-4dannjjm	5470	19	of	of	IN
cord-023095-4dannjjm	5470	20	meloxicam	meloxicam	NNP
cord-023095-4dannjjm	5470	21	.	.	.
cord-023095-4dannjjm	5471	1	Synovial	Synovial	NNP
cord-023095-4dannjjm	5471	2	meloxicam	meloxicam	NN
cord-023095-4dannjjm	5471	3	concentration	concentration	NN
cord-023095-4dannjjm	5471	4	was	be	VBD
cord-023095-4dannjjm	5471	5	analysed	analyse	VBN
cord-023095-4dannjjm	5471	6	using	use	VBG
cord-023095-4dannjjm	5471	7	High	High	NNP
cord-023095-4dannjjm	5471	8	Performance	Performance	NNP
cord-023095-4dannjjm	5471	9	Liquid	Liquid	NNP
cord-023095-4dannjjm	5471	10	Chromatography	Chromatography	NNP
cord-023095-4dannjjm	5471	11	-	-	HYPH
cord-023095-4dannjjm	5471	12	Mass	Mass	NNP
cord-023095-4dannjjm	5471	13	Spectrometry	Spectrometry	NNP
cord-023095-4dannjjm	5471	14	(	(	-LRB-
cord-023095-4dannjjm	5471	15	HPLC/	HPLC/	NNP
cord-023095-4dannjjm	5471	16	MS	MS	NNP
cord-023095-4dannjjm	5471	17	-	-	HYPH
cord-023095-4dannjjm	5471	18	MS	MS	NNP
cord-023095-4dannjjm	5471	19	)	)	-RRB-
cord-023095-4dannjjm	5471	20	.	.	.
cord-023095-4dannjjm	5472	1	The	the	DT
cord-023095-4dannjjm	5472	2	concentration	concentration	NN
cord-023095-4dannjjm	5472	3	of	of	IN
cord-023095-4dannjjm	5472	4	meloxicam	meloxicam	NN
cord-023095-4dannjjm	5472	5	in	in	IN
cord-023095-4dannjjm	5472	6	the	the	DT
cord-023095-4dannjjm	5472	7	inflamed	inflamed	JJ
cord-023095-4dannjjm	5472	8	versus	versus	IN
cord-023095-4dannjjm	5472	9	non	non	JJ
cord-023095-4dannjjm	5472	10	-	-	JJ
cord-023095-4dannjjm	5472	11	inflamed	inflamed	JJ
cord-023095-4dannjjm	5472	12	joint	joint	NN
cord-023095-4dannjjm	5472	13	in	in	IN
cord-023095-4dannjjm	5472	14	each	each	DT
cord-023095-4dannjjm	5472	15	dog	dog	NN
cord-023095-4dannjjm	5472	16	was	be	VBD
cord-023095-4dannjjm	5472	17	compared	compare	VBN
cord-023095-4dannjjm	5472	18	using	use	VBG
cord-023095-4dannjjm	5472	19	the	the	DT
cord-023095-4dannjjm	5472	20	paired	paired	JJ
cord-023095-4dannjjm	5472	21	t	t	NN
cord-023095-4dannjjm	5472	22	-	-	HYPH
cord-023095-4dannjjm	5472	23	test	test	NN
cord-023095-4dannjjm	5472	24	.	.	.
cord-023095-4dannjjm	5473	1	The	the	DT
cord-023095-4dannjjm	5473	2	results	result	NNS
cord-023095-4dannjjm	5473	3	indicate	indicate	VBP
cord-023095-4dannjjm	5473	4	that	that	IN
cord-023095-4dannjjm	5473	5	meloxicam	meloxicam	NNP
cord-023095-4dannjjm	5473	6	preferentially	preferentially	RB
cord-023095-4dannjjm	5473	7	accumulates	accumulate	VBZ
cord-023095-4dannjjm	5473	8	in	in	IN
cord-023095-4dannjjm	5473	9	inflamed	inflamed	JJ
cord-023095-4dannjjm	5473	10	joints	joint	NNS
cord-023095-4dannjjm	5473	11	in	in	IN
cord-023095-4dannjjm	5473	12	the	the	DT
cord-023095-4dannjjm	5473	13	dog	dog	NN
cord-023095-4dannjjm	5473	14	as	as	IN
cord-023095-4dannjjm	5473	15	meloxicam	meloxicam	NNP
cord-023095-4dannjjm	5473	16	concentrations	concentration	NNS
cord-023095-4dannjjm	5473	17	are	be	VBP
cord-023095-4dannjjm	5473	18	statistically	statistically	RB
cord-023095-4dannjjm	5473	19	significantly	significantly	RB
cord-023095-4dannjjm	5473	20	higher	high	JJR
cord-023095-4dannjjm	5473	21	in	in	IN
cord-023095-4dannjjm	5473	22	inflamed	inflamed	JJ
cord-023095-4dannjjm	5473	23	joints	joint	NNS
cord-023095-4dannjjm	5473	24	than	than	IN
cord-023095-4dannjjm	5473	25	in	in	IN
cord-023095-4dannjjm	5473	26	non	non	JJ
cord-023095-4dannjjm	5473	27	-	-	JJ
cord-023095-4dannjjm	5473	28	inflamed	inflamed	JJ
cord-023095-4dannjjm	5473	29	joints	joint	NNS
cord-023095-4dannjjm	5473	30	.	.	.
cord-023095-4dannjjm	5474	1	No	no	DT
cord-023095-4dannjjm	5474	2	national	national	JJ
cord-023095-4dannjjm	5474	3	surveillance	surveillance	NN
cord-023095-4dannjjm	5474	4	system	system	NN
cord-023095-4dannjjm	5474	5	exists	exist	VBZ
cord-023095-4dannjjm	5474	6	for	for	IN
cord-023095-4dannjjm	5474	7	monitoring	monitor	VBG
cord-023095-4dannjjm	5474	8	emergent	emergent	JJ
cord-023095-4dannjjm	5474	9	resistance	resistance	NN
cord-023095-4dannjjm	5474	10	in	in	IN
cord-023095-4dannjjm	5474	11	companion	companion	NN
cord-023095-4dannjjm	5474	12	animals	animal	NNS
cord-023095-4dannjjm	5474	13	.	.	.
cord-023095-4dannjjm	5475	1	However	however	RB
cord-023095-4dannjjm	5475	2	,	,	,
cord-023095-4dannjjm	5475	3	E.	E.	NNP
cord-023095-4dannjjm	5475	4	coli	coli	VBZ
cord-023095-4dannjjm	5475	5	resistance	resistance	NN
cord-023095-4dannjjm	5475	6	is	be	VBZ
cord-023095-4dannjjm	5475	7	an	an	DT
cord-023095-4dannjjm	5475	8	increasing	increase	VBG
cord-023095-4dannjjm	5475	9	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5475	10	and	and	CC
cord-023095-4dannjjm	5475	11	public	public	JJ
cord-023095-4dannjjm	5475	12	health	health	NN
cord-023095-4dannjjm	5475	13	concern	concern	NN
cord-023095-4dannjjm	5475	14	in	in	IN
cord-023095-4dannjjm	5475	15	these	these	DT
cord-023095-4dannjjm	5475	16	in	in	IN
cord-023095-4dannjjm	5475	17	dogs	dog	NNS
cord-023095-4dannjjm	5475	18	and	and	CC
cord-023095-4dannjjm	5475	19	cats	cat	NNS
cord-023095-4dannjjm	5475	20	.	.	.
cord-023095-4dannjjm	5476	1	The	the	DT
cord-023095-4dannjjm	5476	2	purpose	purpose	NN
cord-023095-4dannjjm	5476	3	of	of	IN
cord-023095-4dannjjm	5476	4	this	this	DT
cord-023095-4dannjjm	5476	5	study	study	NN
cord-023095-4dannjjm	5476	6	was	be	VBD
cord-023095-4dannjjm	5476	7	to	to	TO
cord-023095-4dannjjm	5476	8	describe	describe	VB
cord-023095-4dannjjm	5476	9	current	current	JJ
cord-023095-4dannjjm	5476	10	resistance	resistance	NN
cord-023095-4dannjjm	5476	11	patterns	pattern	NNS
cord-023095-4dannjjm	5476	12	of	of	IN
cord-023095-4dannjjm	5476	13	canine	canine	JJ
cord-023095-4dannjjm	5476	14	and	and	CC
cord-023095-4dannjjm	5476	15	feline	feline	JJ
cord-023095-4dannjjm	5476	16	pathogenic	pathogenic	JJ
cord-023095-4dannjjm	5476	17	E.	E.	NNP
cord-023095-4dannjjm	5476	18	coli	coli	NNS
cord-023095-4dannjjm	5476	19	throughout	throughout	IN
cord-023095-4dannjjm	5476	20	the	the	DT
cord-023095-4dannjjm	5476	21	United	United	NNP
cord-023095-4dannjjm	5476	22	States	States	NNP
cord-023095-4dannjjm	5476	23	and	and	CC
cord-023095-4dannjjm	5476	24	identify	identify	VB
cord-023095-4dannjjm	5476	25	risk	risk	NN
cord-023095-4dannjjm	5476	26	factors	factor	NNS
cord-023095-4dannjjm	5476	27	of	of	IN
cord-023095-4dannjjm	5476	28	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	5476	29	resistance	resistance	NN
cord-023095-4dannjjm	5476	30	.	.	.
cord-023095-4dannjjm	5477	1	Isolates	Isolates	NNP
cord-023095-4dannjjm	5477	2	(	(	-LRB-
cord-023095-4dannjjm	5477	3	n	n	NN
cord-023095-4dannjjm	5477	4	5	5	CD
cord-023095-4dannjjm	5477	5	1512	1512	CD
cord-023095-4dannjjm	5477	6	)	)	-RRB-
cord-023095-4dannjjm	5477	7	of	of	IN
cord-023095-4dannjjm	5477	8	clinical	clinical	JJ
cord-023095-4dannjjm	5477	9	E.	E.	NNP
cord-023095-4dannjjm	5477	10	coli	coli	NNS
cord-023095-4dannjjm	5477	11	collected	collect	VBN
cord-023095-4dannjjm	5477	12	from	from	IN
cord-023095-4dannjjm	5477	13	dogs	dog	NNS
cord-023095-4dannjjm	5477	14	or	or	CC
cord-023095-4dannjjm	5477	15	cats	cat	NNS
cord-023095-4dannjjm	5477	16	from	from	IN
cord-023095-4dannjjm	5477	17	May	May	NNP
cord-023095-4dannjjm	5477	18	2008	2008	CD
cord-023095-4dannjjm	5477	19	through	through	IN
cord-023095-4dannjjm	5477	20	May	May	NNP
cord-023095-4dannjjm	5477	21	2010	2010	CD
cord-023095-4dannjjm	5477	22	located	locate	VBN
cord-023095-4dannjjm	5477	23	in	in	IN
cord-023095-4dannjjm	5477	24	6	6	CD
cord-023095-4dannjjm	5477	25	different	different	JJ
cord-023095-4dannjjm	5477	26	regions	region	NNS
cord-023095-4dannjjm	5477	27	.	.	.
cord-023095-4dannjjm	5478	1	Susceptibility	susceptibility	NN
cord-023095-4dannjjm	5478	2	was	be	VBD
cord-023095-4dannjjm	5478	3	determined	determine	VBN
cord-023095-4dannjjm	5478	4	to	to	IN
cord-023095-4dannjjm	5478	5	15	15	CD
cord-023095-4dannjjm	5478	6	drugs	drug	NNS
cord-023095-4dannjjm	5478	7	(	(	-LRB-
cord-023095-4dannjjm	5478	8	6	6	CD
cord-023095-4dannjjm	5478	9	drug	drug	NN
cord-023095-4dannjjm	5478	10	classes	class	NNS
cord-023095-4dannjjm	5478	11	)	)	-RRB-
cord-023095-4dannjjm	5478	12	by	by	IN
cord-023095-4dannjjm	5478	13	broth	broth	NN
cord-023095-4dannjjm	5478	14	microdilution	microdilution	NN
cord-023095-4dannjjm	5478	15	methods	method	NNS
cord-023095-4dannjjm	5478	16	.	.	.
cord-023095-4dannjjm	5479	1	Pharmacodyamaic	Pharmacodyamaic	NNP
cord-023095-4dannjjm	5479	2	statistics	statistic	NNS
cord-023095-4dannjjm	5479	3	were	be	VBD
cord-023095-4dannjjm	5479	4	described	describe	VBN
cord-023095-4dannjjm	5479	5	regionally	regionally	RB
cord-023095-4dannjjm	5479	6	.	.	.
cord-023095-4dannjjm	5480	1	Phenotypes	phenotype	NNS
cord-023095-4dannjjm	5480	2	were	be	VBD
cord-023095-4dannjjm	5480	3	determined	determine	VBN
cord-023095-4dannjjm	5480	4	and	and	CC
cord-023095-4dannjjm	5480	5	type	type	NN
cord-023095-4dannjjm	5480	6	of	of	IN
cord-023095-4dannjjm	5480	7	resistance	resistance	NN
cord-023095-4dannjjm	5480	8	was	be	VBD
cord-023095-4dannjjm	5480	9	based	base	VBN
cord-023095-4dannjjm	5480	10	on	on	IN
cord-023095-4dannjjm	5480	11	the	the	DT
cord-023095-4dannjjm	5480	12	number	number	NN
cord-023095-4dannjjm	5480	13	of	of	IN
cord-023095-4dannjjm	5480	14	drug	drug	NN
cord-023095-4dannjjm	5480	15	classes	class	NNS
cord-023095-4dannjjm	5480	16	to	to	TO
cord-023095-4dannjjm	5480	17	which	which	WDT
cord-023095-4dannjjm	5480	18	resistance	resistance	NN
cord-023095-4dannjjm	5480	19	was	be	VBD
cord-023095-4dannjjm	5480	20	expressed	express	VBN
cord-023095-4dannjjm	5480	21	:	:	:
cord-023095-4dannjjm	5480	22	none	none	NN
cord-023095-4dannjjm	5480	23	(	(	-LRB-
cord-023095-4dannjjm	5480	24	NDR	NDR	NNP
cord-023095-4dannjjm	5480	25	)	)	-RRB-
cord-023095-4dannjjm	5480	26	,	,	,
cord-023095-4dannjjm	5480	27	single	single	JJ
cord-023095-4dannjjm	5480	28	(	(	-LRB-
cord-023095-4dannjjm	5480	29	SDR	SDR	NNP
cord-023095-4dannjjm	5480	30	)	)	-RRB-
cord-023095-4dannjjm	5480	31	and	and	CC
cord-023095-4dannjjm	5480	32	multi	multi	JJ
cord-023095-4dannjjm	5480	33	(	(	-LRB-
cord-023095-4dannjjm	5480	34	MDR	MDR	NNP
cord-023095-4dannjjm	5480	35	)	)	-RRB-
cord-023095-4dannjjm	5480	36	.	.	.
cord-023095-4dannjjm	5481	1	The	the	DT
cord-023095-4dannjjm	5481	2	majority	majority	NN
cord-023095-4dannjjm	5481	3	of	of	IN
cord-023095-4dannjjm	5481	4	isolates	isolate	NNS
cord-023095-4dannjjm	5481	5	were	be	VBD
cord-023095-4dannjjm	5481	6	from	from	IN
cord-023095-4dannjjm	5481	7	urinary	urinary	JJ
cord-023095-4dannjjm	5481	8	tract	tract	NN
cord-023095-4dannjjm	5481	9	(	(	-LRB-
cord-023095-4dannjjm	5481	10	71.5	71.5	CD
cord-023095-4dannjjm	5481	11	%	%	NN
cord-023095-4dannjjm	5481	12	)	)	-RRB-
cord-023095-4dannjjm	5481	13	and	and	CC
cord-023095-4dannjjm	5481	14	dogs	dog	NNS
cord-023095-4dannjjm	5481	15	(	(	-LRB-
cord-023095-4dannjjm	5481	16	75.7	75.7	CD
cord-023095-4dannjjm	5481	17	%	%	NN
cord-023095-4dannjjm	5481	18	)	)	-RRB-
cord-023095-4dannjjm	5481	19	.	.	.
cord-023095-4dannjjm	5482	1	The	the	DT
cord-023095-4dannjjm	5482	2	proportion	proportion	NN
cord-023095-4dannjjm	5482	3	of	of	IN
cord-023095-4dannjjm	5482	4	resistance	resistance	NN
cord-023095-4dannjjm	5482	5	type	type	NN
cord-023095-4dannjjm	5482	6	for	for	IN
cord-023095-4dannjjm	5482	7	each	each	DT
cord-023095-4dannjjm	5482	8	drug	drug	NN
cord-023095-4dannjjm	5482	9	was	be	VBD
cord-023095-4dannjjm	5482	10	:	:	:
cord-023095-4dannjjm	5482	11	NDR	NDR	NNP
cord-023095-4dannjjm	5482	12	(	(	-LRB-
cord-023095-4dannjjm	5482	13	17.5	17.5	CD
cord-023095-4dannjjm	5482	14	%	%	NN
cord-023095-4dannjjm	5482	15	)	)	-RRB-
cord-023095-4dannjjm	5482	16	,	,	,
cord-023095-4dannjjm	5482	17	SDR	SDR	NNP
cord-023095-4dannjjm	5482	18	(	(	-LRB-
cord-023095-4dannjjm	5482	19	56.4	56.4	CD
cord-023095-4dannjjm	5482	20	%	%	NN
cord-023095-4dannjjm	5482	21	)	)	-RRB-
cord-023095-4dannjjm	5482	22	and	and	CC
cord-023095-4dannjjm	5482	23	MDR	MDR	NNP
cord-023095-4dannjjm	5482	24	(	(	-LRB-
cord-023095-4dannjjm	5482	25	26.12	26.12	CD
cord-023095-4dannjjm	5482	26	%	%	NN
cord-023095-4dannjjm	5482	27	)	)	-RRB-
cord-023095-4dannjjm	5482	28	.	.	.
cord-023095-4dannjjm	5483	1	The	the	DT
cord-023095-4dannjjm	5483	2	proportion	proportion	NN
cord-023095-4dannjjm	5483	3	of	of	IN
cord-023095-4dannjjm	5483	4	MDR	MDR	NNP
cord-023095-4dannjjm	5483	5	was	be	VBD
cord-023095-4dannjjm	5483	6	greatest	great	JJS
cord-023095-4dannjjm	5483	7	in	in	IN
cord-023095-4dannjjm	5483	8	the	the	DT
cord-023095-4dannjjm	5483	9	Southwest	Southwest	NNP
cord-023095-4dannjjm	5483	10	(	(	-LRB-
cord-023095-4dannjjm	5483	11	25.29	25.29	CD
cord-023095-4dannjjm	5483	12	%	%	NN
cord-023095-4dannjjm	5483	13	)	)	-RRB-
cord-023095-4dannjjm	5483	14	and	and	CC
cord-023095-4dannjjm	5483	15	least	least	JJS
cord-023095-4dannjjm	5483	16	in	in	IN
cord-023095-4dannjjm	5483	17	the	the	DT
cord-023095-4dannjjm	5483	18	Northwest	Northwest	NNP
cord-023095-4dannjjm	5483	19	(	(	-LRB-
cord-023095-4dannjjm	5483	20	9.19	9.19	CD
cord-023095-4dannjjm	5483	21	%	%	NN
cord-023095-4dannjjm	5483	22	)	)	-RRB-
cord-023095-4dannjjm	5484	1	(	(	-LRB-
cord-023095-4dannjjm	5484	2	P	p	NN
cord-023095-4dannjjm	5484	3	o	o	NN
cord-023095-4dannjjm	5484	4	0.05	0.05	CD
cord-023095-4dannjjm	5484	5	)	)	-RRB-
cord-023095-4dannjjm	5484	6	.	.	.
cord-023095-4dannjjm	5485	1	For	for	IN
cord-023095-4dannjjm	5485	2	all	all	DT
cord-023095-4dannjjm	5485	3	regions	region	NNS
cord-023095-4dannjjm	5485	4	,	,	,
cord-023095-4dannjjm	5485	5	the	the	DT
cord-023095-4dannjjm	5485	6	proportion	proportion	NN
cord-023095-4dannjjm	5485	7	of	of	IN
cord-023095-4dannjjm	5485	8	resistance	resistance	NN
cord-023095-4dannjjm	5485	9	was	be	VBD
cord-023095-4dannjjm	5485	10	:	:	:
cord-023095-4dannjjm	5485	11	cephalothin	cephalothin	NNP
cord-023095-4dannjjm	5485	12	(	(	-LRB-
cord-023095-4dannjjm	5485	13	CPH	CPH	NNP
cord-023095-4dannjjm	5485	14	,	,	,
cord-023095-4dannjjm	5485	15	65.2	65.2	CD
cord-023095-4dannjjm	5485	16	%	%	NN
cord-023095-4dannjjm	5485	17	)	)	-RRB-
cord-023095-4dannjjm	5485	18	4	4	CD
cord-023095-4dannjjm	5485	19	amoxicillin	amoxicillin	NNP
cord-023095-4dannjjm	5485	20	-	-	HYPH
cord-023095-4dannjjm	5485	21	clavulanic	clavulanic	NNP
cord-023095-4dannjjm	5485	22	acid	acid	NN
cord-023095-4dannjjm	5485	23	(	(	-LRB-
cord-023095-4dannjjm	5485	24	AMX	AMX	NNP
cord-023095-4dannjjm	5485	25	,	,	,
cord-023095-4dannjjm	5485	26	59.4	59.4	CD
cord-023095-4dannjjm	5485	27	%	%	NN
cord-023095-4dannjjm	5485	28	)	)	-RRB-
cord-023095-4dannjjm	5485	29	,	,	,
cord-023095-4dannjjm	5485	30	ampicillin	ampicillin	NN
cord-023095-4dannjjm	5485	31	(	(	-LRB-
cord-023095-4dannjjm	5485	32	AMP	amp	NN
cord-023095-4dannjjm	5485	33	,	,	,
cord-023095-4dannjjm	5485	34	52.9	52.9	CD
cord-023095-4dannjjm	5485	35	%	%	NN
cord-023095-4dannjjm	5485	36	)	)	-RRB-
cord-023095-4dannjjm	5485	37	,	,	,
cord-023095-4dannjjm	5485	38	tricarcillin	tricarcillin	NNP
cord-023095-4dannjjm	5485	39	-	-	HYPH
cord-023095-4dannjjm	5485	40	clavulanic	clavulanic	NN
cord-023095-4dannjjm	5485	41	acid	acid	NN
cord-023095-4dannjjm	5486	1	(	(	-LRB-
cord-023095-4dannjjm	5486	2	TCX	TCX	NNP
cord-023095-4dannjjm	5486	3	,	,	,
cord-023095-4dannjjm	5486	4	21.8	21.8	CD
cord-023095-4dannjjm	5486	5	%	%	NN
cord-023095-4dannjjm	5486	6	)	)	-RRB-
cord-023095-4dannjjm	5486	7	,	,	,
cord-023095-4dannjjm	5486	8	doxycyline	doxycyline	JJ
cord-023095-4dannjjm	5486	9	(	(	-LRB-
cord-023095-4dannjjm	5486	10	DXY	DXY	NNP
cord-023095-4dannjjm	5486	11	,	,	,
cord-023095-4dannjjm	5486	12	15.9	15.9	CD
cord-023095-4dannjjm	5486	13	%	%	NN
cord-023095-4dannjjm	5486	14	)	)	-RRB-
cord-023095-4dannjjm	5486	15	4	4	CD
cord-023095-4dannjjm	5486	16	cefoxitin	cefoxitin	NNS
cord-023095-4dannjjm	5486	17	(	(	-LRB-
cord-023095-4dannjjm	5486	18	CFX	CFX	NNP
cord-023095-4dannjjm	5486	19	,	,	,
cord-023095-4dannjjm	5486	20	15.2	15.2	CD
cord-023095-4dannjjm	5486	21	%	%	NN
cord-023095-4dannjjm	5486	22	)	)	-RRB-
cord-023095-4dannjjm	5486	23	,	,	,
cord-023095-4dannjjm	5486	24	cefpodoxime	cefpodoxime	FW
cord-023095-4dannjjm	5486	25	(	(	-LRB-
cord-023095-4dannjjm	5486	26	CPX	CPX	NNP
cord-023095-4dannjjm	5486	27	,	,	,
cord-023095-4dannjjm	5486	28	13.7	13.7	CD
cord-023095-4dannjjm	5486	29	%	%	NN
cord-023095-4dannjjm	5486	30	)	)	-RRB-
cord-023095-4dannjjm	5486	31	,	,	,
cord-023095-4dannjjm	5486	32	chloramphenicol	chloramphenicol	NNP
cord-023095-4dannjjm	5486	33	(	(	-LRB-
cord-023095-4dannjjm	5486	34	CHP	CHP	NNP
cord-023095-4dannjjm	5486	35	,	,	,
cord-023095-4dannjjm	5486	36	13.2	13.2	CD
cord-023095-4dannjjm	5486	37	%	%	NN
cord-023095-4dannjjm	5486	38	)	)	-RRB-
cord-023095-4dannjjm	5486	39	,	,	,
cord-023095-4dannjjm	5486	40	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	5486	41	(	(	-LRB-
cord-023095-4dannjjm	5486	42	ENR	ENR	NNP
cord-023095-4dannjjm	5486	43	,	,	,
cord-023095-4dannjjm	5486	44	13.0	13.0	CD
cord-023095-4dannjjm	5486	45	%	%	NN
cord-023095-4dannjjm	5486	46	)	)	-RRB-
cord-023095-4dannjjm	5486	47	,	,	,
cord-023095-4dannjjm	5486	48	ciprofloxacin	ciprofloxacin	NNP
cord-023095-4dannjjm	5486	49	(	(	-LRB-
cord-023095-4dannjjm	5486	50	CIF,12.3	CIF,12.3	NNP
cord-023095-4dannjjm	5486	51	%	%	NN
cord-023095-4dannjjm	5486	52	)	)	-RRB-
cord-023095-4dannjjm	5486	53	,	,	,
cord-023095-4dannjjm	5486	54	trimethoprim	trimethoprim	NNP
cord-023095-4dannjjm	5486	55	-	-	HYPH
cord-023095-4dannjjm	5486	56	sulfamethoxazole	sulfamethoxazole	NNP
cord-023095-4dannjjm	5486	57	(	(	-LRB-
cord-023095-4dannjjm	5486	58	TMX	TMX	NNP
cord-023095-4dannjjm	5486	59	,	,	,
cord-023095-4dannjjm	5486	60	10.7	10.7	CD
cord-023095-4dannjjm	5486	61	%	%	NN
cord-023095-4dannjjm	5486	62	)	)	-RRB-
cord-023095-4dannjjm	5486	63	,	,	,
cord-023095-4dannjjm	5486	64	ceftazidime(CFZ	ceftazidime(CFZ	''
cord-023095-4dannjjm	5486	65	,	,	,
cord-023095-4dannjjm	5486	66	10.0	10.0	CD
cord-023095-4dannjjm	5486	67	%	%	NN
cord-023095-4dannjjm	5486	68	)	)	-RRB-
cord-023095-4dannjjm	5486	69	,	,	,
cord-023095-4dannjjm	5486	70	gentamicin	gentamicin	FW
cord-023095-4dannjjm	5486	71	(	(	-LRB-
cord-023095-4dannjjm	5486	72	GTM	GTM	NNP
cord-023095-4dannjjm	5486	73	,	,	,
cord-023095-4dannjjm	5486	74	10.0	10.0	CD
cord-023095-4dannjjm	5486	75	%	%	NN
cord-023095-4dannjjm	5486	76	)	)	-RRB-
cord-023095-4dannjjm	5486	77	,	,	,
cord-023095-4dannjjm	5486	78	cefotaxime	cefotaxime	NNP
cord-023095-4dannjjm	5486	79	(	(	-LRB-
cord-023095-4dannjjm	5486	80	CFT	CFT	NNP
cord-023095-4dannjjm	5486	81	,	,	,
cord-023095-4dannjjm	5486	82	9.2	9.2	CD
cord-023095-4dannjjm	5486	83	%	%	NN
cord-023095-4dannjjm	5486	84	)	)	-RRB-
cord-023095-4dannjjm	5486	85	4	4	CD
cord-023095-4dannjjm	5486	86	meropenem	meropenem	NNS
cord-023095-4dannjjm	5486	87	(	(	-LRB-
cord-023095-4dannjjm	5486	88	1.1	1.1	CD
cord-023095-4dannjjm	5486	89	%	%	NN
cord-023095-4dannjjm	5486	90	)	)	-RRB-
cord-023095-4dannjjm	5486	91	(	(	-LRB-
cord-023095-4dannjjm	5486	92	P	p	NN
cord-023095-4dannjjm	5486	93	o	o	NN
cord-023095-4dannjjm	5486	94	0.05	0.05	CD
cord-023095-4dannjjm	5486	95	)	)	-RRB-
cord-023095-4dannjjm	5486	96	.	.	.
cord-023095-4dannjjm	5487	1	The	the	DT
cord-023095-4dannjjm	5487	2	MIC	MIC	NNP
cord-023095-4dannjjm	5487	3	90	90	CD
cord-023095-4dannjjm	5487	4	exceeded	exceed	VBD
cord-023095-4dannjjm	5487	5	the	the	DT
cord-023095-4dannjjm	5487	6	resistant	resistant	JJ
cord-023095-4dannjjm	5487	7	breakpoint	breakpoint	NN
cord-023095-4dannjjm	5487	8	for	for	IN
cord-023095-4dannjjm	5487	9	AMP	AMP	NNP
cord-023095-4dannjjm	5487	10	,	,	,
cord-023095-4dannjjm	5487	11	AMX	AMX	NNP
cord-023095-4dannjjm	5487	12	,	,	,
cord-023095-4dannjjm	5487	13	CPX	CPX	NNP
cord-023095-4dannjjm	5487	14	,	,	,
cord-023095-4dannjjm	5487	15	CPH	CPH	NNP
cord-023095-4dannjjm	5487	16	,	,	,
cord-023095-4dannjjm	5487	17	CIF	CIF	NNP
cord-023095-4dannjjm	5487	18	,	,	,
cord-023095-4dannjjm	5487	19	CFX	CFX	NNP
cord-023095-4dannjjm	5487	20	,	,	,
cord-023095-4dannjjm	5487	21	DXY	DXY	NNP
cord-023095-4dannjjm	5487	22	and	and	CC
cord-023095-4dannjjm	5487	23	ENR	ENR	NNP
cord-023095-4dannjjm	5487	24	whereas	whereas	IN
cord-023095-4dannjjm	5487	25	MIC	MIC	NNP
cord-023095-4dannjjm	5487	26	50	50	CD
cord-023095-4dannjjm	5487	27	did	do	VBD
cord-023095-4dannjjm	5487	28	not	not	RB
cord-023095-4dannjjm	5487	29	surpass	surpass	VB
cord-023095-4dannjjm	5487	30	the	the	DT
cord-023095-4dannjjm	5487	31	susceptible	susceptible	JJ
cord-023095-4dannjjm	5487	32	breakpoint	breakpoint	NN
cord-023095-4dannjjm	5487	33	.	.	.
cord-023095-4dannjjm	5488	1	Beta	beta	NN
cord-023095-4dannjjm	5488	2	-	-	HYPH
cord-023095-4dannjjm	5488	3	lactams	lactam	NNS
cord-023095-4dannjjm	5488	4	(	(	-LRB-
cord-023095-4dannjjm	5488	5	96.37	96.37	CD
cord-023095-4dannjjm	5488	6	%	%	NN
cord-023095-4dannjjm	5488	7	)	)	-RRB-
cord-023095-4dannjjm	5488	8	was	be	VBD
cord-023095-4dannjjm	5488	9	the	the	DT
cord-023095-4dannjjm	5488	10	most	most	JJS
cord-023095-4dannjjm	5488	11	and	and	CC
cord-023095-4dannjjm	5488	12	aminoglycosides	aminoglycoside	NNS
cord-023095-4dannjjm	5488	13	the	the	DT
cord-023095-4dannjjm	5488	14	least	least	JJS
cord-023095-4dannjjm	5488	15	(	(	-LRB-
cord-023095-4dannjjm	5488	16	0.12	0.12	CD
cord-023095-4dannjjm	5488	17	%	%	NN
cord-023095-4dannjjm	5488	18	)	)	-RRB-
cord-023095-4dannjjm	5488	19	SDR	SDR	NNP
cord-023095-4dannjjm	5488	20	.	.	.
cord-023095-4dannjjm	5489	1	The	the	DT
cord-023095-4dannjjm	5489	2	drug	drug	NN
cord-023095-4dannjjm	5489	3	class	class	NN
cord-023095-4dannjjm	5489	4	most	most	RBS
cord-023095-4dannjjm	5489	5	frequently	frequently	RB
cord-023095-4dannjjm	5489	6	involved	involve	VBN
cord-023095-4dannjjm	5489	7	in	in	IN
cord-023095-4dannjjm	5489	8	MDR	MDR	NNP
cord-023095-4dannjjm	5489	9	was	be	VBD
cord-023095-4dannjjm	5489	10	beta	beta	NN
cord-023095-4dannjjm	5489	11	-	-	HYPH
cord-023095-4dannjjm	5489	12	lactams	lactam	NNS
cord-023095-4dannjjm	5489	13	(	(	-LRB-
cord-023095-4dannjjm	5489	14	97.72	97.72	CD
cord-023095-4dannjjm	5489	15	%	%	NN
cord-023095-4dannjjm	5489	16	)	)	-RRB-
cord-023095-4dannjjm	5489	17	and	and	CC
cord-023095-4dannjjm	5489	18	least	least	JJS
cord-023095-4dannjjm	5489	19	,	,	,
cord-023095-4dannjjm	5489	20	GEN	GEN	NNP
cord-023095-4dannjjm	5489	21	(	(	-LRB-
cord-023095-4dannjjm	5489	22	30.13	30.13	CD
cord-023095-4dannjjm	5489	23	%	%	NN
cord-023095-4dannjjm	5489	24	)	)	-RRB-
cord-023095-4dannjjm	5489	25	.	.	.
cord-023095-4dannjjm	5490	1	Resistance	resistance	NN
cord-023095-4dannjjm	5490	2	differs	differ	VBZ
cord-023095-4dannjjm	5490	3	regionally	regionally	RB
cord-023095-4dannjjm	5490	4	,	,	,
cord-023095-4dannjjm	5490	5	being	be	VBG
cord-023095-4dannjjm	5490	6	greatest	great	JJS
cord-023095-4dannjjm	5490	7	in	in	IN
cord-023095-4dannjjm	5490	8	the	the	DT
cord-023095-4dannjjm	5490	9	Southwest	Southwest	NNP
cord-023095-4dannjjm	5490	10	.	.	.
cord-023095-4dannjjm	5491	1	CPH	CPH	NNP
cord-023095-4dannjjm	5491	2	is	be	VBZ
cord-023095-4dannjjm	5491	3	the	the	DT
cord-023095-4dannjjm	5491	4	most	most	JJS
cord-023095-4dannjjm	5491	5	and	and	CC
cord-023095-4dannjjm	5491	6	meropenam	meropenam	NNP
cord-023095-4dannjjm	5491	7	is	be	VBZ
cord-023095-4dannjjm	5491	8	the	the	DT
cord-023095-4dannjjm	5491	9	drug	drug	NN
cord-023095-4dannjjm	5491	10	least	least	JJS
cord-023095-4dannjjm	5491	11	associated	associate	VBN
cord-023095-4dannjjm	5491	12	with	with	IN
cord-023095-4dannjjm	5491	13	resistance	resistance	NN
cord-023095-4dannjjm	5491	14	;	;	:
cord-023095-4dannjjm	5491	15	these	these	DT
cord-023095-4dannjjm	5491	16	patterns	pattern	NNS
cord-023095-4dannjjm	5491	17	are	be	VBP
cord-023095-4dannjjm	5491	18	consistent	consistent	JJ
cord-023095-4dannjjm	5491	19	with	with	IN
cord-023095-4dannjjm	5491	20	current	current	JJ
cord-023095-4dannjjm	5491	21	drugs	drug	NNS
cord-023095-4dannjjm	5491	22	used	use	VBN
cord-023095-4dannjjm	5491	23	by	by	IN
cord-023095-4dannjjm	5491	24	veterinarians	veterinarian	NNS
cord-023095-4dannjjm	5491	25	.	.	.
cord-023095-4dannjjm	5492	1	The	the	DT
cord-023095-4dannjjm	5492	2	fluoroquinolones	fluoroquinolone	NNS
cord-023095-4dannjjm	5492	3	(	(	-LRB-
cord-023095-4dannjjm	5492	4	FQs	fq	NNS
cord-023095-4dannjjm	5492	5	)	)	-RRB-
cord-023095-4dannjjm	5492	6	are	be	VBP
cord-023095-4dannjjm	5492	7	common	common	JJ
cord-023095-4dannjjm	5492	8	choices	choice	NNS
cord-023095-4dannjjm	5492	9	for	for	IN
cord-023095-4dannjjm	5492	10	treatment	treatment	NN
cord-023095-4dannjjm	5492	11	of	of	IN
cord-023095-4dannjjm	5492	12	E.	E.	NNP
cord-023095-4dannjjm	5492	13	coli	coli	VBZ
cord-023095-4dannjjm	5492	14	urinary	urinary	JJ
cord-023095-4dannjjm	5492	15	tract	tract	JJ
cord-023095-4dannjjm	5492	16	infections	infection	NNS
cord-023095-4dannjjm	5492	17	(	(	-LRB-
cord-023095-4dannjjm	5492	18	UTIs	UTIs	NNPS
cord-023095-4dannjjm	5492	19	)	)	-RRB-
cord-023095-4dannjjm	5492	20	in	in	IN
cord-023095-4dannjjm	5492	21	animals	animal	NNS
cord-023095-4dannjjm	5492	22	and	and	CC
cord-023095-4dannjjm	5492	23	humans	human	NNS
cord-023095-4dannjjm	5492	24	.	.	.
cord-023095-4dannjjm	5493	1	2nd	2nd	JJ
cord-023095-4dannjjm	5493	2	generation	generation	NN
cord-023095-4dannjjm	5493	3	drugs	drug	NNS
cord-023095-4dannjjm	5493	4	approved	approve	VBN
cord-023095-4dannjjm	5493	5	in	in	IN
cord-023095-4dannjjm	5493	6	animals	animal	NNS
cord-023095-4dannjjm	5493	7	include	include	VBP
cord-023095-4dannjjm	5493	8	enrofloxacin	enrofloxacin	NNS
cord-023095-4dannjjm	5493	9	(	(	-LRB-
cord-023095-4dannjjm	5493	10	ENR	ENR	NNP
cord-023095-4dannjjm	5493	11	)	)	-RRB-
cord-023095-4dannjjm	5493	12	,	,	,
cord-023095-4dannjjm	5493	13	marbofloxacin	marbofloxacin	NNP
cord-023095-4dannjjm	5493	14	(	(	-LRB-
cord-023095-4dannjjm	5493	15	MAR	MAR	NNP
cord-023095-4dannjjm	5493	16	)	)	-RRB-
cord-023095-4dannjjm	5493	17	,	,	,
cord-023095-4dannjjm	5493	18	orbifloxacin	orbifloxacin	NNP
cord-023095-4dannjjm	5493	19	(	(	-LRB-
cord-023095-4dannjjm	5493	20	ORB	orb	NN
cord-023095-4dannjjm	5493	21	)	)	-RRB-
cord-023095-4dannjjm	5493	22	;	;	:
cord-023095-4dannjjm	5493	23	human	human	JJ
cord-023095-4dannjjm	5493	24	drugs	drug	NNS
cord-023095-4dannjjm	5493	25	include	include	VBP
cord-023095-4dannjjm	5493	26	ciprofloxacin	ciprofloxacin	NNS
cord-023095-4dannjjm	5493	27	(	(	-LRB-
cord-023095-4dannjjm	5493	28	CIP	CIP	NNP
cord-023095-4dannjjm	5493	29	)	)	-RRB-
cord-023095-4dannjjm	5493	30	.	.	.
cord-023095-4dannjjm	5494	1	3rd	3rd	JJ
cord-023095-4dannjjm	5494	2	and	and	CC
cord-023095-4dannjjm	5494	3	4th	4th	JJ
cord-023095-4dannjjm	5494	4	generation	generation	NN
cord-023095-4dannjjm	5494	5	FQ	FQ	NNP
cord-023095-4dannjjm	5494	6	for	for	IN
cord-023095-4dannjjm	5494	7	humans	human	NNS
cord-023095-4dannjjm	5494	8	include	include	VBP
cord-023095-4dannjjm	5494	9	moxifloxacin	moxifloxacin	NNS
cord-023095-4dannjjm	5494	10	(	(	-LRB-
cord-023095-4dannjjm	5494	11	MOX	MOX	NNP
cord-023095-4dannjjm	5494	12	)	)	-RRB-
cord-023095-4dannjjm	5494	13	,	,	,
cord-023095-4dannjjm	5494	14	gatifloxacin	gatifloxacin	NNP
cord-023095-4dannjjm	5494	15	(	(	-LRB-
cord-023095-4dannjjm	5494	16	GAT	GAT	NNP
cord-023095-4dannjjm	5494	17	)	)	-RRB-
cord-023095-4dannjjm	5494	18	and	and	CC
cord-023095-4dannjjm	5494	19	ofloxacin	ofloxacin	NNS
cord-023095-4dannjjm	5494	20	,	,	,
cord-023095-4dannjjm	5494	21	(	(	-LRB-
cord-023095-4dannjjm	5494	22	OFL	OFL	NNP
cord-023095-4dannjjm	5494	23	]	]	-RRB-
cord-023095-4dannjjm	5494	24	)	)	-RRB-
cord-023095-4dannjjm	5494	25	,	,	,
cord-023095-4dannjjm	5494	26	its	-PRON-	PRP$
cord-023095-4dannjjm	5494	27	Lisoform	Lisoform	NNP
cord-023095-4dannjjm	5494	28	levofloxacin	levofloxacin	NNS
cord-023095-4dannjjm	5494	29	(	(	-LRB-
cord-023095-4dannjjm	5494	30	LEV	LEV	NNP
cord-023095-4dannjjm	5494	31	)	)	-RRB-
cord-023095-4dannjjm	5494	32	.	.	.
cord-023095-4dannjjm	5495	1	For	for	IN
cord-023095-4dannjjm	5495	2	animals	animal	NNS
cord-023095-4dannjjm	5495	3	,	,	,
cord-023095-4dannjjm	5495	4	pradofloxacin	pradofloxacin	NNS
cord-023095-4dannjjm	5495	5	(	(	-LRB-
cord-023095-4dannjjm	5495	6	PRA	PRA	NNP
cord-023095-4dannjjm	5495	7	)	)	-RRB-
cord-023095-4dannjjm	5495	8	is	be	VBZ
cord-023095-4dannjjm	5495	9	approved	approve	VBN
cord-023095-4dannjjm	5495	10	for	for	IN
cord-023095-4dannjjm	5495	11	use	use	NN
cord-023095-4dannjjm	5495	12	in	in	IN
cord-023095-4dannjjm	5495	13	Europe	Europe	NNP
cord-023095-4dannjjm	5495	14	.	.	.
cord-023095-4dannjjm	5496	1	The	the	DT
cord-023095-4dannjjm	5496	2	purpose	purpose	NN
cord-023095-4dannjjm	5496	3	of	of	IN
cord-023095-4dannjjm	5496	4	this	this	DT
cord-023095-4dannjjm	5496	5	study	study	NN
cord-023095-4dannjjm	5496	6	was	be	VBD
cord-023095-4dannjjm	5496	7	to	to	TO
cord-023095-4dannjjm	5496	8	assess	assess	VB
cord-023095-4dannjjm	5496	9	the	the	DT
cord-023095-4dannjjm	5496	10	in	in	FW
cord-023095-4dannjjm	5496	11	vitro	vitro	FW
cord-023095-4dannjjm	5496	12	activity	activity	NN
cord-023095-4dannjjm	5496	13	of	of	IN
cord-023095-4dannjjm	5496	14	1st	1st	NN
cord-023095-4dannjjm	5497	1	(	(	-LRB-
cord-023095-4dannjjm	5497	2	Naladixic	Naladixic	NNP
cord-023095-4dannjjm	5497	3	acid	acid	NN
cord-023095-4dannjjm	5497	4	[	[	-LRB-
cord-023095-4dannjjm	5497	5	NAL	NAL	NNP
cord-023095-4dannjjm	5497	6	]	]	-RRB-
cord-023095-4dannjjm	5497	7	through	through	IN
cord-023095-4dannjjm	5497	8	4th	4th	JJ
cord-023095-4dannjjm	5497	9	generation	generation	NN
cord-023095-4dannjjm	5497	10	FQs	FQs	NNP
cord-023095-4dannjjm	5497	11	(	(	-LRB-
cord-023095-4dannjjm	5497	12	n	n	NN
cord-023095-4dannjjm	5497	13	5	5	CD
cord-023095-4dannjjm	5497	14	11	11	CD
cord-023095-4dannjjm	5497	15	)	)	-RRB-
cord-023095-4dannjjm	5498	1	toward	toward	IN
cord-023095-4dannjjm	5498	2	dog	dog	NN
cord-023095-4dannjjm	5498	3	or	or	CC
cord-023095-4dannjjm	5498	4	cat	cat	NN
cord-023095-4dannjjm	5499	1	E.coli	E.coli	NNP
cord-023095-4dannjjm	5499	2	uropathogens	uropathogens	NNP
cord-023095-4dannjjm	5499	3	(	(	-LRB-
cord-023095-4dannjjm	5499	4	n	n	NN
cord-023095-4dannjjm	5499	5	5	5	CD
cord-023095-4dannjjm	5499	6	51	51	CD
cord-023095-4dannjjm	5499	7	)	)	-RRB-
cord-023095-4dannjjm	5499	8	.	.	.
cord-023095-4dannjjm	5500	1	Isolates	isolate	NNS
cord-023095-4dannjjm	5500	2	were	be	VBD
cord-023095-4dannjjm	5500	3	subjected	subject	VBN
cord-023095-4dannjjm	5500	4	to	to	IN
cord-023095-4dannjjm	5500	5	susceptibility	susceptibility	NN
cord-023095-4dannjjm	5500	6	testing	testing	NN
cord-023095-4dannjjm	5500	7	to	to	IN
cord-023095-4dannjjm	5500	8	6	6	CD
cord-023095-4dannjjm	5500	9	drugs	drug	NNS
cord-023095-4dannjjm	5500	10	classes	class	NNS
cord-023095-4dannjjm	5500	11	(	(	-LRB-
cord-023095-4dannjjm	5500	12	15	15	CD
cord-023095-4dannjjm	5500	13	drugs	drug	NNS
cord-023095-4dannjjm	5500	14	)	)	-RRB-
cord-023095-4dannjjm	5500	15	.	.	.
cord-023095-4dannjjm	5501	1	Isolate	isolate	NN
cord-023095-4dannjjm	5501	2	phenotypes	phenotype	NNS
cord-023095-4dannjjm	5501	3	included	include	VBN
cord-023095-4dannjjm	5501	4	no	no	DT
cord-023095-4dannjjm	5501	5	(	(	-LRB-
cord-023095-4dannjjm	5501	6	NDR	NDR	NNP
cord-023095-4dannjjm	5501	7	;	;	:
cord-023095-4dannjjm	5501	8	n	n	NN
cord-023095-4dannjjm	5501	9	5	5	CD
cord-023095-4dannjjm	5501	10	12	12	CD
cord-023095-4dannjjm	5501	11	)	)	-RRB-
cord-023095-4dannjjm	5501	12	,	,	,
cord-023095-4dannjjm	5501	13	single	single	JJ
cord-023095-4dannjjm	5501	14	(	(	-LRB-
cord-023095-4dannjjm	5501	15	SDR	SDR	NNP
cord-023095-4dannjjm	5501	16	;	;	:
cord-023095-4dannjjm	5501	17	n	n	NN
cord-023095-4dannjjm	5501	18	5	5	CD
cord-023095-4dannjjm	5501	19	15	15	CD
cord-023095-4dannjjm	5501	20	)	)	-RRB-
cord-023095-4dannjjm	5501	21	or	or	CC
cord-023095-4dannjjm	5501	22	multidrug	multidrug	NN
cord-023095-4dannjjm	5501	23	(	(	-LRB-
cord-023095-4dannjjm	5501	24	to	to	IN
cord-023095-4dannjjm	5501	25	more	more	JJR
cord-023095-4dannjjm	5501	26	than	than	IN
cord-023095-4dannjjm	5501	27	2	2	CD
cord-023095-4dannjjm	5501	28	drug	drug	NN
cord-023095-4dannjjm	5501	29	classes	class	NNS
cord-023095-4dannjjm	5501	30	;	;	:
cord-023095-4dannjjm	5501	31	MDR	MDR	NNP
cord-023095-4dannjjm	5501	32	;	;	:
cord-023095-4dannjjm	5501	33	n	n	NN
cord-023095-4dannjjm	5501	34	5	5	CD
cord-023095-4dannjjm	5501	35	24	24	CD
cord-023095-4dannjjm	5501	36	)	)	-RRB-
cord-023095-4dannjjm	5501	37	resistance	resistance	NN
cord-023095-4dannjjm	5501	38	(	(	-LRB-
cord-023095-4dannjjm	5501	39	including	include	VBG
cord-023095-4dannjjm	5501	40	ENR	ENR	NNP
cord-023095-4dannjjm	5501	41	resistant	resistant	JJ
cord-023095-4dannjjm	5501	42	[	[	-LRB-
cord-023095-4dannjjm	5501	43	ENR	ENR	NNP
cord-023095-4dannjjm	5501	44	R	R	NNP
cord-023095-4dannjjm	5501	45	-MDR	-MDR	''
cord-023095-4dannjjm	5501	46	;	;	:
cord-023095-4dannjjm	5501	47	n	n	NN
cord-023095-4dannjjm	5501	48	5	5	CD
cord-023095-4dannjjm	5501	49	12	12	CD
cord-023095-4dannjjm	5501	50	]	]	-RRB-
cord-023095-4dannjjm	5501	51	or	or	CC
cord-023095-4dannjjm	5501	52	ENR	ENR	NNP
cord-023095-4dannjjm	5501	53	susceptible	susceptible	JJ
cord-023095-4dannjjm	5501	54	(	(	-LRB-
cord-023095-4dannjjm	5501	55	ENR	ENR	NNP
cord-023095-4dannjjm	5501	56	S	S	NNP
cord-023095-4dannjjm	5501	57	-MDR	-MDR	-RRB-
cord-023095-4dannjjm	5501	58	,	,	,
cord-023095-4dannjjm	5501	59	n	n	NN
cord-023095-4dannjjm	5501	60	5	5	CD
cord-023095-4dannjjm	5501	61	12	12	CD
cord-023095-4dannjjm	5501	62	)	)	-RRB-
cord-023095-4dannjjm	5501	63	.	.	.
cord-023095-4dannjjm	5502	1	The	the	DT
cord-023095-4dannjjm	5502	2	minimum	minimum	JJ
cord-023095-4dannjjm	5502	3	inhibition	inhibition	NN
cord-023095-4dannjjm	5502	4	concentrations	concentration	NNS
cord-023095-4dannjjm	5502	5	(	(	-LRB-
cord-023095-4dannjjm	5502	6	MICs	mic	NNS
cord-023095-4dannjjm	5502	7	)	)	-RRB-
cord-023095-4dannjjm	5502	8	were	be	VBD
cord-023095-4dannjjm	5502	9	determined	determine	VBN
cord-023095-4dannjjm	5502	10	for	for	IN
cord-023095-4dannjjm	5502	11	each	each	DT
cord-023095-4dannjjm	5502	12	isolates	isolate	NNS
cord-023095-4dannjjm	5502	13	using	use	VBG
cord-023095-4dannjjm	5502	14	broth	broth	NN
cord-023095-4dannjjm	5502	15	microdilution	microdilution	NNP
cord-023095-4dannjjm	5502	16	(	(	-LRB-
cord-023095-4dannjjm	5502	17	E.	E.	NNP
cord-023095-4dannjjm	5502	18	coli	coli	VBZ
cord-023095-4dannjjm	5502	19	ATCC	ATCC	NNP
cord-023095-4dannjjm	5502	20	s	s	POS
cord-023095-4dannjjm	5502	21	25922	25922	CD
cord-023095-4dannjjm	5502	22	served	serve	VBD
cord-023095-4dannjjm	5502	23	as	as	IN
cord-023095-4dannjjm	5502	24	a	a	DT
cord-023095-4dannjjm	5502	25	negative	negative	JJ
cord-023095-4dannjjm	5502	26	control	control	NN
cord-023095-4dannjjm	5502	27	)	)	-RRB-
cord-023095-4dannjjm	5502	28	.	.	.
cord-023095-4dannjjm	5503	1	MIC	mic	NN
cord-023095-4dannjjm	5503	2	statistics	statistic	NNS
cord-023095-4dannjjm	5503	3	were	be	VBD
cord-023095-4dannjjm	5503	4	generated	generate	VBN
cord-023095-4dannjjm	5503	5	for	for	IN
cord-023095-4dannjjm	5503	6	each	each	DT
cord-023095-4dannjjm	5503	7	drug	drug	NN
cord-023095-4dannjjm	5503	8	among	among	IN
cord-023095-4dannjjm	5503	9	phenotypes	phenotype	NNS
cord-023095-4dannjjm	5503	10	.	.	.
cord-023095-4dannjjm	5504	1	The	the	DT
cord-023095-4dannjjm	5504	2	overall	overall	JJ
cord-023095-4dannjjm	5504	3	potency	potency	NN
cord-023095-4dannjjm	5504	4	(	(	-LRB-
cord-023095-4dannjjm	5504	5	MIC	MIC	NNP
cord-023095-4dannjjm	5504	6	90	90	CD
cord-023095-4dannjjm	5504	7	)	)	-RRB-
cord-023095-4dannjjm	5504	8	for	for	IN
cord-023095-4dannjjm	5504	9	all	all	DT
cord-023095-4dannjjm	5504	10	ENR	ENR	NNP
cord-023095-4dannjjm	5504	11	susceptible	susceptible	JJ
cord-023095-4dannjjm	5504	12	isolates	isolate	NNS
cord-023095-4dannjjm	5504	13	(	(	-LRB-
cord-023095-4dannjjm	5504	14	NDR	NDR	NNP
cord-023095-4dannjjm	5504	15	,	,	,
cord-023095-4dannjjm	5504	16	SDR	SDR	NNP
cord-023095-4dannjjm	5504	17	and	and	CC
cord-023095-4dannjjm	5504	18	ENR	ENR	NNP
cord-023095-4dannjjm	5504	19	S	S	NNP
cord-023095-4dannjjm	5504	20	-MDR	-MDR	-RRB-
cord-023095-4dannjjm	5504	21	)	)	-RRB-
cord-023095-4dannjjm	5504	22	was	be	VBD
cord-023095-4dannjjm	5504	23	GAT	GAT	NNP
cord-023095-4dannjjm	5504	24	4	4	CD
cord-023095-4dannjjm	5504	25	PRA	PRA	NNP
cord-023095-4dannjjm	5504	26	,	,	,
cord-023095-4dannjjm	5504	27	MOX	MOX	NNP
cord-023095-4dannjjm	5504	28	,	,	,
cord-023095-4dannjjm	5504	29	MAR	MAR	NNP
cord-023095-4dannjjm	5504	30	,	,	,
cord-023095-4dannjjm	5504	31	LEV	LEV	NNP
cord-023095-4dannjjm	5504	32	,	,	,
cord-023095-4dannjjm	5504	33	CIP	CIP	NNP
cord-023095-4dannjjm	5504	34	4	4	CD
cord-023095-4dannjjm	5504	35	SAR	SAR	NNP
cord-023095-4dannjjm	5504	36	,	,	,
cord-023095-4dannjjm	5504	37	ORB	orb	NN
cord-023095-4dannjjm	5504	38	,	,	,
cord-023095-4dannjjm	5504	39	OFL	OFL	NNP
cord-023095-4dannjjm	5504	40	4	4	CD
cord-023095-4dannjjm	5504	41	ENR	ENR	NNP
cord-023095-4dannjjm	5504	42	4	4	CD
cord-023095-4dannjjm	5504	43	NAL	NAL	NNP
cord-023095-4dannjjm	5504	44	.	.	.
cord-023095-4dannjjm	5505	1	Each	each	DT
cord-023095-4dannjjm	5505	2	E.	E.	NNP
cord-023095-4dannjjm	5505	3	coli	coli	NNS
cord-023095-4dannjjm	5505	4	isolate	isolate	VBP
cord-023095-4dannjjm	5505	5	expressing	express	VBG
cord-023095-4dannjjm	5505	6	NDR	NDR	NNP
cord-023095-4dannjjm	5505	7	or	or	CC
cord-023095-4dannjjm	5505	8	SDR	SDR	NNP
cord-023095-4dannjjm	5505	9	was	be	VBD
cord-023095-4dannjjm	5505	10	susceptible	susceptible	JJ
cord-023095-4dannjjm	5505	11	to	to	IN
cord-023095-4dannjjm	5505	12	all	all	DT
cord-023095-4dannjjm	5505	13	FQ	FQ	NNP
cord-023095-4dannjjm	5505	14	.	.	.
cord-023095-4dannjjm	5506	1	However	however	RB
cord-023095-4dannjjm	5506	2	,	,	,
cord-023095-4dannjjm	5506	3	isolates	isolate	NNS
cord-023095-4dannjjm	5506	4	expressing	express	VBG
cord-023095-4dannjjm	5506	5	resistance	resistance	NN
cord-023095-4dannjjm	5506	6	to	to	IN
cord-023095-4dannjjm	5506	7	1st	1st	JJ
cord-023095-4dannjjm	5506	8	or	or	CC
cord-023095-4dannjjm	5506	9	2nd	2nd	JJ
cord-023095-4dannjjm	5506	10	generation	generation	NN
cord-023095-4dannjjm	5506	11	FQ	FQ	NNP
cord-023095-4dannjjm	5506	12	were	be	VBD
cord-023095-4dannjjm	5506	13	also	also	RB
cord-023095-4dannjjm	5506	14	resistance	resistance	NN
cord-023095-4dannjjm	5506	15	to	to	IN
cord-023095-4dannjjm	5506	16	later	later	JJ
cord-023095-4dannjjm	5506	17	generation	generation	NN
cord-023095-4dannjjm	5506	18	drugs	drug	NNS
cord-023095-4dannjjm	5506	19	.	.	.
cord-023095-4dannjjm	5507	1	Glucocorticoids	Glucocorticoids	NNP
cord-023095-4dannjjm	5507	2	(	(	-LRB-
cord-023095-4dannjjm	5507	3	GC	GC	NNP
cord-023095-4dannjjm	5507	4	)	)	-RRB-
cord-023095-4dannjjm	5507	5	are	be	VBP
cord-023095-4dannjjm	5507	6	standard	standard	JJ
cord-023095-4dannjjm	5507	7	therapy	therapy	NN
cord-023095-4dannjjm	5507	8	for	for	IN
cord-023095-4dannjjm	5507	9	allergic	allergic	JJ
cord-023095-4dannjjm	5507	10	asthma	asthma	NN
cord-023095-4dannjjm	5507	11	but	but	CC
cord-023095-4dannjjm	5507	12	do	do	VBP
cord-023095-4dannjjm	5507	13	not	not	RB
cord-023095-4dannjjm	5507	14	reverse	reverse	VB
cord-023095-4dannjjm	5507	15	the	the	DT
cord-023095-4dannjjm	5507	16	underlying	underlying	JJ
cord-023095-4dannjjm	5507	17	type	type	NN
cord-023095-4dannjjm	5507	18	I	-PRON-	PRP
cord-023095-4dannjjm	5507	19	hypersensitivity	hypersensitivity	NN
cord-023095-4dannjjm	5507	20	.	.	.
cord-023095-4dannjjm	5508	1	Allergenspecific	Allergenspecific	NNP
cord-023095-4dannjjm	5508	2	immunotherapy	immunotherapy	NN
cord-023095-4dannjjm	5508	3	(	(	-LRB-
cord-023095-4dannjjm	5508	4	ASIT	ASIT	NNP
cord-023095-4dannjjm	5508	5	)	)	-RRB-
cord-023095-4dannjjm	5508	6	,	,	,
cord-023095-4dannjjm	5508	7	a	a	DT
cord-023095-4dannjjm	5508	8	process	process	NN
cord-023095-4dannjjm	5508	9	of	of	IN
cord-023095-4dannjjm	5508	10	'	'	''
cord-023095-4dannjjm	5508	11	'	'	``
cord-023095-4dannjjm	5508	12	desensitization	desensitization	NN
cord-023095-4dannjjm	5508	13	'	'	''
cord-023095-4dannjjm	5508	14	'	'	''
cord-023095-4dannjjm	5508	15	,	,	,
cord-023095-4dannjjm	5508	16	is	be	VBZ
cord-023095-4dannjjm	5508	17	potentially	potentially	RB
cord-023095-4dannjjm	5508	18	curative	curative	JJ
cord-023095-4dannjjm	5508	19	but	but	CC
cord-023095-4dannjjm	5508	20	requires	require	VBZ
cord-023095-4dannjjm	5508	21	identification	identification	NN
cord-023095-4dannjjm	5508	22	of	of	IN
cord-023095-4dannjjm	5508	23	offending	offend	VBG
cord-023095-4dannjjm	5508	24	allergens	allergen	NNS
cord-023095-4dannjjm	5508	25	.	.	.
cord-023095-4dannjjm	5509	1	The	the	DT
cord-023095-4dannjjm	5509	2	purpose	purpose	NN
cord-023095-4dannjjm	5509	3	of	of	IN
cord-023095-4dannjjm	5509	4	this	this	DT
cord-023095-4dannjjm	5509	5	study	study	NN
cord-023095-4dannjjm	5509	6	was	be	VBD
cord-023095-4dannjjm	5509	7	to	to	TO
cord-023095-4dannjjm	5509	8	determine	determine	VB
cord-023095-4dannjjm	5509	9	if	if	IN
cord-023095-4dannjjm	5509	10	oral	oral	JJ
cord-023095-4dannjjm	5509	11	or	or	CC
cord-023095-4dannjjm	5509	12	inhaled	inhale	VBN
cord-023095-4dannjjm	5509	13	GC	GC	NNP
cord-023095-4dannjjm	5509	14	administered	administer	VBN
cord-023095-4dannjjm	5509	15	at	at	IN
cord-023095-4dannjjm	5509	16	routinely	routinely	RB
cord-023095-4dannjjm	5509	17	used	use	VBN
cord-023095-4dannjjm	5509	18	dosages	dosage	NNS
cord-023095-4dannjjm	5509	19	would	would	MD
cord-023095-4dannjjm	5509	20	interfere	interfere	VB
cord-023095-4dannjjm	5509	21	with	with	IN
cord-023095-4dannjjm	5509	22	allergen	allergen	NN
cord-023095-4dannjjm	5509	23	identification	identification	NN
cord-023095-4dannjjm	5509	24	.	.	.
cord-023095-4dannjjm	5510	1	We	-PRON-	PRP
cord-023095-4dannjjm	5510	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	5510	3	that	that	IN
cord-023095-4dannjjm	5510	4	oral	oral	JJ
cord-023095-4dannjjm	5510	5	but	but	CC
cord-023095-4dannjjm	5510	6	not	not	RB
cord-023095-4dannjjm	5510	7	inhaled	inhale	VBN
cord-023095-4dannjjm	5510	8	GC	GC	NNP
cord-023095-4dannjjm	5510	9	would	would	MD
cord-023095-4dannjjm	5510	10	interfere	interfere	VB
cord-023095-4dannjjm	5510	11	with	with	IN
cord-023095-4dannjjm	5510	12	accurate	accurate	JJ
cord-023095-4dannjjm	5510	13	identification	identification	NN
cord-023095-4dannjjm	5510	14	of	of	IN
cord-023095-4dannjjm	5510	15	allergen	allergen	NN
cord-023095-4dannjjm	5510	16	-	-	HYPH
cord-023095-4dannjjm	5510	17	specific	specific	JJ
cord-023095-4dannjjm	5510	18	IgE	ige	NN
cord-023095-4dannjjm	5510	19	using	use	VBG
cord-023095-4dannjjm	5510	20	skin	skin	NN
cord-023095-4dannjjm	5510	21	and	and	CC
cord-023095-4dannjjm	5510	22	serum	serum	NN
cord-023095-4dannjjm	5510	23	testing	testing	NN
cord-023095-4dannjjm	5510	24	in	in	IN
cord-023095-4dannjjm	5510	25	experimentally	experimentally	RB
cord-023095-4dannjjm	5510	26	asthmatic	asthmatic	JJ
cord-023095-4dannjjm	5510	27	cats	cat	NNS
cord-023095-4dannjjm	5510	28	.	.	.
cord-023095-4dannjjm	5511	1	Asthma	asthma	NN
cord-023095-4dannjjm	5511	2	was	be	VBD
cord-023095-4dannjjm	5511	3	induced	induce	VBN
cord-023095-4dannjjm	5511	4	in	in	IN
cord-023095-4dannjjm	5511	5	eighteen	eighteen	CD
cord-023095-4dannjjm	5511	6	cats	cat	NNS
cord-023095-4dannjjm	5511	7	using	use	VBG
cord-023095-4dannjjm	5511	8	Bermuda	Bermuda	NNP
cord-023095-4dannjjm	5511	9	grass	grass	NN
cord-023095-4dannjjm	5511	10	allergen	allergen	NN
cord-023095-4dannjjm	5511	11	(	(	-LRB-
cord-023095-4dannjjm	5511	12	BGA	BGA	NNP
cord-023095-4dannjjm	5511	13	)	)	-RRB-
cord-023095-4dannjjm	5511	14	.	.	.
cord-023095-4dannjjm	5512	1	Cats	cat	NNS
cord-023095-4dannjjm	5512	2	(	(	-LRB-
cord-023095-4dannjjm	5512	3	n	n	NN
cord-023095-4dannjjm	5512	4	5	5	CD
cord-023095-4dannjjm	5512	5	6	6	CD
cord-023095-4dannjjm	5512	6	/	/	SYM
cord-023095-4dannjjm	5512	7	group	group	NN
cord-023095-4dannjjm	5512	8	)	)	-RRB-
cord-023095-4dannjjm	5512	9	were	be	VBD
cord-023095-4dannjjm	5512	10	randomized	randomize	VBN
cord-023095-4dannjjm	5512	11	to	to	TO
cord-023095-4dannjjm	5512	12	receive	receive	VB
cord-023095-4dannjjm	5512	13	oral	oral	JJ
cord-023095-4dannjjm	5512	14	GC	GC	NNP
cord-023095-4dannjjm	5512	15	(	(	-LRB-
cord-023095-4dannjjm	5512	16	10	10	CD
cord-023095-4dannjjm	5512	17	mg	mg	NNP
cord-023095-4dannjjm	5512	18	prednisolone	prednisolone	NN
cord-023095-4dannjjm	5512	19	q	q	NNP
cord-023095-4dannjjm	5512	20	24	24	CD
cord-023095-4dannjjm	5512	21	hr	hr	NN
cord-023095-4dannjjm	5512	22	PO	PO	NNP
cord-023095-4dannjjm	5512	23	)	)	-RRB-
cord-023095-4dannjjm	5512	24	,	,	,
cord-023095-4dannjjm	5512	25	inhaled	inhale	VBN
cord-023095-4dannjjm	5512	26	GC	GC	NNP
cord-023095-4dannjjm	5512	27	(	(	-LRB-
cord-023095-4dannjjm	5512	28	600	600	CD
cord-023095-4dannjjm	5512	29	ug	ug	NNP
cord-023095-4dannjjm	5512	30	budesonide	budesonide	NNP
cord-023095-4dannjjm	5512	31	q	q	NNP
cord-023095-4dannjjm	5512	32	24hr	24hr	NNP
cord-023095-4dannjjm	5512	33	)	)	-RRB-
cord-023095-4dannjjm	5512	34	or	or	CC
cord-023095-4dannjjm	5512	35	placebo	placebo	NN
cord-023095-4dannjjm	5512	36	(	(	-LRB-
cord-023095-4dannjjm	5512	37	gelatin	gelatin	NN
cord-023095-4dannjjm	5512	38	capsule	capsule	NN
cord-023095-4dannjjm	5512	39	q	q	NNP
cord-023095-4dannjjm	5512	40	24hr	24hr	NNP
cord-023095-4dannjjm	5512	41	PO	PO	NNP
cord-023095-4dannjjm	5512	42	)	)	-RRB-
cord-023095-4dannjjm	5512	43	for	for	IN
cord-023095-4dannjjm	5512	44	one	one	CD
cord-023095-4dannjjm	5512	45	month	month	NN
cord-023095-4dannjjm	5512	46	.	.	.
cord-023095-4dannjjm	5513	1	Intradermal	intradermal	JJ
cord-023095-4dannjjm	5513	2	skin	skin	NN
cord-023095-4dannjjm	5513	3	testing	testing	NN
cord-023095-4dannjjm	5513	4	(	(	-LRB-
cord-023095-4dannjjm	5513	5	IDST	IDST	NNP
cord-023095-4dannjjm	5513	6	)	)	-RRB-
cord-023095-4dannjjm	5513	7	and	and	CC
cord-023095-4dannjjm	5513	8	BGA	BGA	NNP
cord-023095-4dannjjm	5513	9	-	-	HYPH
cord-023095-4dannjjm	5513	10	specific	specific	JJ
cord-023095-4dannjjm	5513	11	IgE	IgE	NNP
cord-023095-4dannjjm	5513	12	amounts	amount	NNS
cord-023095-4dannjjm	5513	13	were	be	VBD
cord-023095-4dannjjm	5513	14	measured	measure	VBN
cord-023095-4dannjjm	5513	15	prior	prior	RB
cord-023095-4dannjjm	5513	16	to	to	IN
cord-023095-4dannjjm	5513	17	,	,	,
cord-023095-4dannjjm	5513	18	during	during	IN
cord-023095-4dannjjm	5513	19	(	(	-LRB-
cord-023095-4dannjjm	5513	20	weeks	week	NNS
cord-023095-4dannjjm	5513	21	one	one	CD
cord-023095-4dannjjm	5513	22	and	and	CC
cord-023095-4dannjjm	5513	23	four	four	CD
cord-023095-4dannjjm	5513	24	)	)	-RRB-
cord-023095-4dannjjm	5513	25	and	and	CC
cord-023095-4dannjjm	5513	26	every	every	DT
cord-023095-4dannjjm	5513	27	two	two	CD
cord-023095-4dannjjm	5513	28	weeks	week	NNS
cord-023095-4dannjjm	5513	29	after	after	IN
cord-023095-4dannjjm	5513	30	treatment	treatment	NN
cord-023095-4dannjjm	5513	31	until	until	IN
cord-023095-4dannjjm	5513	32	both	both	DT
cord-023095-4dannjjm	5513	33	tests	test	NNS
cord-023095-4dannjjm	5513	34	were	be	VBD
cord-023095-4dannjjm	5513	35	positive	positive	JJ
cord-023095-4dannjjm	5513	36	.	.	.
cord-023095-4dannjjm	5514	1	A	a	DT
cord-023095-4dannjjm	5514	2	paired	paired	JJ
cord-023095-4dannjjm	5514	3	T	t	NN
cord-023095-4dannjjm	5514	4	test	test	NN
cord-023095-4dannjjm	5514	5	was	be	VBD
cord-023095-4dannjjm	5514	6	used	use	VBN
cord-023095-4dannjjm	5514	7	to	to	TO
cord-023095-4dannjjm	5514	8	compare	compare	VB
cord-023095-4dannjjm	5514	9	serum	serum	NN
cord-023095-4dannjjm	5514	10	IgE	IgE	NNP
cord-023095-4dannjjm	5514	11	among	among	IN
cord-023095-4dannjjm	5514	12	groups	group	NNS
cord-023095-4dannjjm	5514	13	pre	pre	VBP
cord-023095-4dannjjm	5514	14	-	-	JJ
cord-023095-4dannjjm	5514	15	and	and	CC
cord-023095-4dannjjm	5514	16	post	post	JJ
cord-023095-4dannjjm	5514	17	-	-	NN
cord-023095-4dannjjm	5514	18	treatment	treatment	JJ
cord-023095-4dannjjm	5515	1	(	(	-LRB-
cord-023095-4dannjjm	5515	2	P	p	NN
cord-023095-4dannjjm	5515	3	o	o	NN
cord-023095-4dannjjm	5515	4	0.05	0.05	CD
cord-023095-4dannjjm	5515	5	significant	significant	JJ
cord-023095-4dannjjm	5515	6	)	)	-RRB-
cord-023095-4dannjjm	5515	7	.	.	.
cord-023095-4dannjjm	5516	1	IDST	IDST	NNP
cord-023095-4dannjjm	5516	2	reactivity	reactivity	NN
cord-023095-4dannjjm	5516	3	was	be	VBD
cord-023095-4dannjjm	5516	4	eliminated	eliminate	VBN
cord-023095-4dannjjm	5516	5	in	in	IN
cord-023095-4dannjjm	5516	6	4/6	4/6	CD
cord-023095-4dannjjm	5516	7	cats	cat	NNS
cord-023095-4dannjjm	5516	8	on	on	IN
cord-023095-4dannjjm	5516	9	oral	oral	JJ
cord-023095-4dannjjm	5516	10	GC	GC	NNP
cord-023095-4dannjjm	5516	11	,	,	,
cord-023095-4dannjjm	5516	12	3/6	3/6	CD
cord-023095-4dannjjm	5516	13	on	on	IN
cord-023095-4dannjjm	5516	14	inhaled	inhale	VBN
cord-023095-4dannjjm	5516	15	GC	GC	NNP
cord-023095-4dannjjm	5516	16	,	,	,
cord-023095-4dannjjm	5516	17	and	and	CC
cord-023095-4dannjjm	5516	18	1/6	1/6	DT
cord-023095-4dannjjm	5516	19	placebo	placebo	NN
cord-023095-4dannjjm	5516	20	-	-	HYPH
cord-023095-4dannjjm	5516	21	treated	treat	VBN
cord-023095-4dannjjm	5516	22	cats	cat	NNS
cord-023095-4dannjjm	5516	23	.	.	.
cord-023095-4dannjjm	5517	1	Within	within	IN
cord-023095-4dannjjm	5517	2	two	two	CD
cord-023095-4dannjjm	5517	3	weeks	week	NNS
cord-023095-4dannjjm	5517	4	after	after	IN
cord-023095-4dannjjm	5517	5	stopping	stop	VBG
cord-023095-4dannjjm	5517	6	treatment	treatment	NN
cord-023095-4dannjjm	5517	7	,	,	,
cord-023095-4dannjjm	5517	8	IDST	IDST	NNP
cord-023095-4dannjjm	5517	9	was	be	VBD
cord-023095-4dannjjm	5517	10	again	again	RB
cord-023095-4dannjjm	5517	11	positive	positive	JJ
cord-023095-4dannjjm	5517	12	in	in	IN
cord-023095-4dannjjm	5517	13	all	all	DT
cord-023095-4dannjjm	5517	14	cats	cat	NNS
cord-023095-4dannjjm	5517	15	.	.	.
cord-023095-4dannjjm	5518	1	Contrary	contrary	JJ
cord-023095-4dannjjm	5518	2	to	to	IN
cord-023095-4dannjjm	5518	3	our	-PRON-	PRP$
cord-023095-4dannjjm	5518	4	hypothesis	hypothesis	NN
cord-023095-4dannjjm	5518	5	,	,	,
cord-023095-4dannjjm	5518	6	serum	serum	NNP
cord-023095-4dannjjm	5518	7	IgE	IgE	NNP
cord-023095-4dannjjm	5518	8	reactivity	reactivity	NN
cord-023095-4dannjjm	5518	9	to	to	IN
cord-023095-4dannjjm	5518	10	BGA	BGA	NNP
cord-023095-4dannjjm	5518	11	was	be	VBD
cord-023095-4dannjjm	5518	12	not	not	RB
cord-023095-4dannjjm	5518	13	significantly	significantly	RB
cord-023095-4dannjjm	5518	14	diminished	diminish	VBN
cord-023095-4dannjjm	5518	15	by	by	IN
cord-023095-4dannjjm	5518	16	any	any	DT
cord-023095-4dannjjm	5518	17	treatment	treatment	NN
cord-023095-4dannjjm	5518	18	.	.	.
cord-023095-4dannjjm	5519	1	In	in	IN
cord-023095-4dannjjm	5519	2	conclusion	conclusion	NN
cord-023095-4dannjjm	5519	3	,	,	,
cord-023095-4dannjjm	5519	4	a	a	DT
cord-023095-4dannjjm	5519	5	two	two	CD
cord-023095-4dannjjm	5519	6	week	week	NN
cord-023095-4dannjjm	5519	7	withdrawal	withdrawal	NN
cord-023095-4dannjjm	5519	8	from	from	IN
cord-023095-4dannjjm	5519	9	GCs	GCs	NNP
cord-023095-4dannjjm	5519	10	is	be	VBZ
cord-023095-4dannjjm	5519	11	adequate	adequate	JJ
cord-023095-4dannjjm	5519	12	for	for	IN
cord-023095-4dannjjm	5519	13	IDST	IDST	NNP
cord-023095-4dannjjm	5519	14	identification	identification	NN
cord-023095-4dannjjm	5519	15	of	of	IN
cord-023095-4dannjjm	5519	16	allergen	allergen	NN
cord-023095-4dannjjm	5519	17	but	but	CC
cord-023095-4dannjjm	5519	18	no	no	DT
cord-023095-4dannjjm	5519	19	withdrawal	withdrawal	NN
cord-023095-4dannjjm	5519	20	is	be	VBZ
cord-023095-4dannjjm	5519	21	required	require	VBN
cord-023095-4dannjjm	5519	22	prior	prior	RB
cord-023095-4dannjjm	5519	23	to	to	IN
cord-023095-4dannjjm	5519	24	serum	serum	NN
cord-023095-4dannjjm	5519	25	IgE	IgE	NNP
cord-023095-4dannjjm	5519	26	testing	testing	NN
cord-023095-4dannjjm	5519	27	to	to	TO
cord-023095-4dannjjm	5519	28	identify	identify	VB
cord-023095-4dannjjm	5519	29	the	the	DT
cord-023095-4dannjjm	5519	30	sensitizing	sensitize	VBG
cord-023095-4dannjjm	5519	31	allergens	allergen	NNS
cord-023095-4dannjjm	5519	32	.	.	.
cord-023095-4dannjjm	5520	1	Previously	previously	RB
cord-023095-4dannjjm	5520	2	In	in	IN
cord-023095-4dannjjm	5520	3	people	people	NNS
cord-023095-4dannjjm	5520	4	,	,	,
cord-023095-4dannjjm	5520	5	increasing	increase	VBG
cord-023095-4dannjjm	5520	6	severity	severity	NN
cord-023095-4dannjjm	5520	7	of	of	IN
cord-023095-4dannjjm	5520	8	asthma	asthma	NN
cord-023095-4dannjjm	5520	9	is	be	VBZ
cord-023095-4dannjjm	5520	10	associated	associate	VBN
cord-023095-4dannjjm	5520	11	with	with	IN
cord-023095-4dannjjm	5520	12	low	low	JJ
cord-023095-4dannjjm	5520	13	serum	serum	NN
cord-023095-4dannjjm	5520	14	concentrations	concentration	NNS
cord-023095-4dannjjm	5520	15	of	of	IN
cord-023095-4dannjjm	5520	16	25-hydroxyvitamin	25-hydroxyvitamin	CD
cord-023095-4dannjjm	5520	17	D	d	NN
cord-023095-4dannjjm	5520	18	(	(	-LRB-
cord-023095-4dannjjm	5520	19	25-OH	25-OH	NNP
cord-023095-4dannjjm	5520	20	-	-	HYPH
cord-023095-4dannjjm	5520	21	D	D	NNP
cord-023095-4dannjjm	5520	22	)	)	-RRB-
cord-023095-4dannjjm	5520	23	.	.	.
cord-023095-4dannjjm	5521	1	25-OH	25-OH	NNP
cord-023095-4dannjjm	5521	2	-	-	HYPH
cord-023095-4dannjjm	5521	3	D	D	NNP
cord-023095-4dannjjm	5521	4	is	be	VBZ
cord-023095-4dannjjm	5521	5	thought	think	VBN
cord-023095-4dannjjm	5521	6	to	to	TO
cord-023095-4dannjjm	5521	7	ameliorate	ameliorate	VB
cord-023095-4dannjjm	5521	8	lower	low	JJR
cord-023095-4dannjjm	5521	9	airway	airway	NN
cord-023095-4dannjjm	5521	10	inflammation	inflammation	NN
cord-023095-4dannjjm	5521	11	primarily	primarily	RB
cord-023095-4dannjjm	5521	12	by	by	IN
cord-023095-4dannjjm	5521	13	decreasing	decrease	VBG
cord-023095-4dannjjm	5521	14	the	the	DT
cord-023095-4dannjjm	5521	15	production	production	NN
cord-023095-4dannjjm	5521	16	of	of	IN
cord-023095-4dannjjm	5521	17	pro	pro	JJ
cord-023095-4dannjjm	5521	18	-	-	JJ
cord-023095-4dannjjm	5521	19	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	5521	20	mediators	mediator	NNS
cord-023095-4dannjjm	5521	21	,	,	,
cord-023095-4dannjjm	5521	22	and	and	CC
cord-023095-4dannjjm	5521	23	by	by	IN
cord-023095-4dannjjm	5521	24	increasing	increase	VBG
cord-023095-4dannjjm	5521	25	the	the	DT
cord-023095-4dannjjm	5521	26	production	production	NN
cord-023095-4dannjjm	5521	27	of	of	IN
cord-023095-4dannjjm	5521	28	the	the	DT
cord-023095-4dannjjm	5521	29	anti	anti	JJ
cord-023095-4dannjjm	5521	30	-	-	JJ
cord-023095-4dannjjm	5521	31	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	5521	32	cytokine	cytokine	NN
cord-023095-4dannjjm	5521	33	IL-10	IL-10	NNP
cord-023095-4dannjjm	5521	34	.	.	.
cord-023095-4dannjjm	5522	1	In	in	IN
cord-023095-4dannjjm	5522	2	people	people	NNS
cord-023095-4dannjjm	5522	3	,	,	,
cord-023095-4dannjjm	5522	4	serum	serum	NN
cord-023095-4dannjjm	5522	5	25-OH	25-oh	CD
cord-023095-4dannjjm	5522	6	-	-	HYPH
cord-023095-4dannjjm	5522	7	D	d	NN
cord-023095-4dannjjm	5522	8	concentration	concentration	NN
cord-023095-4dannjjm	5522	9	is	be	VBZ
cord-023095-4dannjjm	5522	10	associated	associate	VBN
cord-023095-4dannjjm	5522	11	with	with	IN
cord-023095-4dannjjm	5522	12	sunlight	sunlight	NN
cord-023095-4dannjjm	5522	13	exposure	exposure	NN
cord-023095-4dannjjm	5522	14	as	as	RB
cord-023095-4dannjjm	5522	15	well	well	RB
cord-023095-4dannjjm	5522	16	as	as	IN
cord-023095-4dannjjm	5522	17	dietary	dietary	JJ
cord-023095-4dannjjm	5522	18	intake	intake	NN
cord-023095-4dannjjm	5522	19	.	.	.
cord-023095-4dannjjm	5523	1	Cats	cat	NNS
cord-023095-4dannjjm	5523	2	do	do	VBP
cord-023095-4dannjjm	5523	3	not	not	RB
cord-023095-4dannjjm	5523	4	rely	rely	VB
cord-023095-4dannjjm	5523	5	on	on	IN
cord-023095-4dannjjm	5523	6	sunlight	sunlight	NN
cord-023095-4dannjjm	5523	7	for	for	IN
cord-023095-4dannjjm	5523	8	vitamin	vitamin	NN
cord-023095-4dannjjm	5523	9	D	d	NN
cord-023095-4dannjjm	5523	10	synthesis	synthesis	NN
cord-023095-4dannjjm	5523	11	;	;	:
cord-023095-4dannjjm	5523	12	all	all	DT
cord-023095-4dannjjm	5523	13	vitamin	vitamin	NN
cord-023095-4dannjjm	5523	14	D	d	NN
cord-023095-4dannjjm	5523	15	comes	come	VBZ
cord-023095-4dannjjm	5523	16	from	from	IN
cord-023095-4dannjjm	5523	17	dietary	dietary	JJ
cord-023095-4dannjjm	5523	18	intake	intake	NN
cord-023095-4dannjjm	5523	19	.	.	.
cord-023095-4dannjjm	5524	1	Cats	cat	NNS
cord-023095-4dannjjm	5524	2	have	have	VBP
cord-023095-4dannjjm	5524	3	a	a	DT
cord-023095-4dannjjm	5524	4	naturally	naturally	RB
cord-023095-4dannjjm	5524	5	occurring	occur	VBG
cord-023095-4dannjjm	5524	6	lower	low	JJR
cord-023095-4dannjjm	5524	7	airway	airway	NN
cord-023095-4dannjjm	5524	8	disease	disease	NN
cord-023095-4dannjjm	5524	9	syndrome	syndrome	NN
cord-023095-4dannjjm	5524	10	(	(	-LRB-
cord-023095-4dannjjm	5524	11	LAD	LAD	NNP
cord-023095-4dannjjm	5524	12	)	)	-RRB-
cord-023095-4dannjjm	5524	13	that	that	WDT
cord-023095-4dannjjm	5524	14	shares	share	VBZ
cord-023095-4dannjjm	5524	15	many	many	JJ
cord-023095-4dannjjm	5524	16	features	feature	NNS
cord-023095-4dannjjm	5524	17	with	with	IN
cord-023095-4dannjjm	5524	18	human	human	JJ
cord-023095-4dannjjm	5524	19	asthma	asthma	NN
cord-023095-4dannjjm	5524	20	.	.	.
cord-023095-4dannjjm	5525	1	The	the	DT
cord-023095-4dannjjm	5525	2	goal	goal	NN
cord-023095-4dannjjm	5525	3	of	of	IN
cord-023095-4dannjjm	5525	4	this	this	DT
cord-023095-4dannjjm	5525	5	study	study	NN
cord-023095-4dannjjm	5525	6	was	be	VBD
cord-023095-4dannjjm	5525	7	to	to	TO
cord-023095-4dannjjm	5525	8	evaluate	evaluate	VB
cord-023095-4dannjjm	5525	9	serum	serum	NN
cord-023095-4dannjjm	5525	10	25-OH	25-oh	CD
cord-023095-4dannjjm	5525	11	-	-	HYPH
cord-023095-4dannjjm	5525	12	D	d	NN
cord-023095-4dannjjm	5525	13	concentrations	concentration	NNS
cord-023095-4dannjjm	5525	14	in	in	IN
cord-023095-4dannjjm	5525	15	cats	cat	NNS
cord-023095-4dannjjm	5525	16	with	with	IN
cord-023095-4dannjjm	5525	17	LAD	lad	NN
cord-023095-4dannjjm	5525	18	.	.	.
cord-023095-4dannjjm	5526	1	Cats	cat	NNS
cord-023095-4dannjjm	5526	2	with	with	IN
cord-023095-4dannjjm	5526	3	naturally	naturally	RB
cord-023095-4dannjjm	5526	4	developing	develop	VBG
cord-023095-4dannjjm	5526	5	LAD	LAD	NNP
cord-023095-4dannjjm	5526	6	were	be	VBD
cord-023095-4dannjjm	5526	7	enrolled	enrol	VBN
cord-023095-4dannjjm	5526	8	.	.	.
cord-023095-4dannjjm	5527	1	Criteria	criterion	NNS
cord-023095-4dannjjm	5527	2	for	for	IN
cord-023095-4dannjjm	5527	3	a	a	DT
cord-023095-4dannjjm	5527	4	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5527	5	of	of	IN
cord-023095-4dannjjm	5527	6	LAD	LAD	NNP
cord-023095-4dannjjm	5527	7	included	include	VBD
cord-023095-4dannjjm	5527	8	a	a	DT
cord-023095-4dannjjm	5527	9	history	history	NN
cord-023095-4dannjjm	5527	10	of	of	IN
cord-023095-4dannjjm	5527	11	cough	cough	NN
cord-023095-4dannjjm	5527	12	,	,	,
cord-023095-4dannjjm	5527	13	wheeze	wheeze	NN
cord-023095-4dannjjm	5527	14	or	or	CC
cord-023095-4dannjjm	5527	15	respiratory	respiratory	JJ
cord-023095-4dannjjm	5527	16	distress	distress	NN
cord-023095-4dannjjm	5527	17	,	,	,
cord-023095-4dannjjm	5527	18	radiographic	radiographic	JJ
cord-023095-4dannjjm	5527	19	evidence	evidence	NN
cord-023095-4dannjjm	5527	20	of	of	IN
cord-023095-4dannjjm	5527	21	a	a	DT
cord-023095-4dannjjm	5527	22	bronchial	bronchial	JJ
cord-023095-4dannjjm	5527	23	pattern	pattern	NN
cord-023095-4dannjjm	5527	24	and	and	CC
cord-023095-4dannjjm	5527	25	hyperinflation	hyperinflation	NN
cord-023095-4dannjjm	5527	26	,	,	,
cord-023095-4dannjjm	5527	27	negative	negative	JJ
cord-023095-4dannjjm	5527	28	heartworm	heartworm	NN
cord-023095-4dannjjm	5527	29	antigen	antigen	NN
cord-023095-4dannjjm	5527	30	and	and	CC
cord-023095-4dannjjm	5527	31	antibody	antibody	NN
cord-023095-4dannjjm	5527	32	test	test	NN
cord-023095-4dannjjm	5527	33	,	,	,
cord-023095-4dannjjm	5527	34	and	and	CC
cord-023095-4dannjjm	5527	35	a	a	DT
cord-023095-4dannjjm	5527	36	resolution	resolution	NN
cord-023095-4dannjjm	5527	37	of	of	IN
cord-023095-4dannjjm	5527	38	clinical	clinical	JJ
cord-023095-4dannjjm	5527	39	signs	sign	NNS
cord-023095-4dannjjm	5527	40	in	in	IN
cord-023095-4dannjjm	5527	41	response	response	NN
cord-023095-4dannjjm	5527	42	to	to	IN
cord-023095-4dannjjm	5527	43	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	5527	44	.	.	.
cord-023095-4dannjjm	5528	1	Dietary	dietary	JJ
cord-023095-4dannjjm	5528	2	history	history	NN
cord-023095-4dannjjm	5528	3	was	be	VBD
cord-023095-4dannjjm	5528	4	obtained	obtain	VBN
cord-023095-4dannjjm	5528	5	.	.	.
cord-023095-4dannjjm	5529	1	25-OH	25-oh	CD
cord-023095-4dannjjm	5529	2	-	-	HYPH
cord-023095-4dannjjm	5529	3	D	d	NN
cord-023095-4dannjjm	5529	4	concentrations	concentration	NNS
cord-023095-4dannjjm	5529	5	were	be	VBD
cord-023095-4dannjjm	5529	6	determined	determine	VBN
cord-023095-4dannjjm	5529	7	on	on	IN
cord-023095-4dannjjm	5529	8	serum	serum	NN
cord-023095-4dannjjm	5529	9	samples	sample	NNS
cord-023095-4dannjjm	5529	10	by	by	IN
cord-023095-4dannjjm	5529	11	a	a	DT
cord-023095-4dannjjm	5529	12	commercial	commercial	JJ
cord-023095-4dannjjm	5529	13	laboratory	laboratory	NN
cord-023095-4dannjjm	5529	14	.	.	.
cord-023095-4dannjjm	5530	1	Twelve	twelve	CD
cord-023095-4dannjjm	5530	2	cats	cat	NNS
cord-023095-4dannjjm	5530	3	with	with	IN
cord-023095-4dannjjm	5530	4	LAD	LAD	NNP
cord-023095-4dannjjm	5530	5	were	be	VBD
cord-023095-4dannjjm	5530	6	enrolled	enrol	VBN
cord-023095-4dannjjm	5530	7	.	.	.
cord-023095-4dannjjm	5531	1	All	all	DT
cord-023095-4dannjjm	5531	2	cats	cat	NNS
cord-023095-4dannjjm	5531	3	ate	eat	VBD
cord-023095-4dannjjm	5531	4	commercial	commercial	JJ
cord-023095-4dannjjm	5531	5	cat	cat	NN
cord-023095-4dannjjm	5531	6	food	food	NN
cord-023095-4dannjjm	5531	7	.	.	.
cord-023095-4dannjjm	5532	1	The	the	DT
cord-023095-4dannjjm	5532	2	median	median	JJ
cord-023095-4dannjjm	5532	3	25-OH	25-oh	CD
cord-023095-4dannjjm	5532	4	-	-	HYPH
cord-023095-4dannjjm	5532	5	D	d	NN
cord-023095-4dannjjm	5532	6	concentration	concentration	NN
cord-023095-4dannjjm	5532	7	was	be	VBD
cord-023095-4dannjjm	5532	8	112	112	CD
cord-023095-4dannjjm	5532	9	nmol	nmol	JJ
cord-023095-4dannjjm	5532	10	/	/	SYM
cord-023095-4dannjjm	5532	11	l	l	NN
cord-023095-4dannjjm	5532	12	with	with	IN
cord-023095-4dannjjm	5532	13	a	a	DT
cord-023095-4dannjjm	5532	14	range	range	NN
cord-023095-4dannjjm	5532	15	of	of	IN
cord-023095-4dannjjm	5532	16	65	65	CD
cord-023095-4dannjjm	5532	17	-	-	SYM
cord-023095-4dannjjm	5532	18	176	176	CD
cord-023095-4dannjjm	5532	19	nmol	nmol	NNP
cord-023095-4dannjjm	5532	20	/	/	SYM
cord-023095-4dannjjm	5532	21	l	l	NN
cord-023095-4dannjjm	5532	22	which	which	WDT
cord-023095-4dannjjm	5532	23	is	be	VBZ
cord-023095-4dannjjm	5532	24	within	within	IN
cord-023095-4dannjjm	5532	25	the	the	DT
cord-023095-4dannjjm	5532	26	reported	report	VBN
cord-023095-4dannjjm	5532	27	reference	reference	NN
cord-023095-4dannjjm	5532	28	range	range	NN
cord-023095-4dannjjm	5532	29	of	of	IN
cord-023095-4dannjjm	5532	30	65	65	CD
cord-023095-4dannjjm	5532	31	-	-	SYM
cord-023095-4dannjjm	5532	32	170	170	CD
cord-023095-4dannjjm	5532	33	nmol	nmol	JJ
cord-023095-4dannjjm	5532	34	/	/	SYM
cord-023095-4dannjjm	5532	35	l	l	NN
cord-023095-4dannjjm	5532	36	.	.	.
cord-023095-4dannjjm	5533	1	In	in	IN
cord-023095-4dannjjm	5533	2	contrast	contrast	NN
cord-023095-4dannjjm	5533	3	to	to	IN
cord-023095-4dannjjm	5533	4	human	human	JJ
cord-023095-4dannjjm	5533	5	asthma	asthma	NN
cord-023095-4dannjjm	5533	6	,	,	,
cord-023095-4dannjjm	5533	7	lower	low	JJR
cord-023095-4dannjjm	5533	8	airway	airway	NN
cord-023095-4dannjjm	5533	9	disease	disease	NN
cord-023095-4dannjjm	5533	10	in	in	IN
cord-023095-4dannjjm	5533	11	cats	cat	NNS
cord-023095-4dannjjm	5533	12	is	be	VBZ
cord-023095-4dannjjm	5533	13	not	not	RB
cord-023095-4dannjjm	5533	14	associated	associate	VBN
cord-023095-4dannjjm	5533	15	with	with	IN
cord-023095-4dannjjm	5533	16	low	low	JJ
cord-023095-4dannjjm	5533	17	serum	serum	NN
cord-023095-4dannjjm	5533	18	concentrations	concentration	NNS
cord-023095-4dannjjm	5533	19	of	of	IN
cord-023095-4dannjjm	5533	20	25-OH	25-oh	CD
cord-023095-4dannjjm	5533	21	-	-	HYPH
cord-023095-4dannjjm	5533	22	D.	D.	NNP
cord-023095-4dannjjm	5533	23	Interstitial	interstitial	JJ
cord-023095-4dannjjm	5533	24	lung	lung	NN
cord-023095-4dannjjm	5533	25	diseases	disease	NNS
cord-023095-4dannjjm	5533	26	(	(	-LRB-
cord-023095-4dannjjm	5533	27	ILD	ILD	NNP
cord-023095-4dannjjm	5533	28	)	)	-RRB-
cord-023095-4dannjjm	5533	29	are	be	VBP
cord-023095-4dannjjm	5533	30	uncommon	uncommon	JJ
cord-023095-4dannjjm	5533	31	in	in	IN
cord-023095-4dannjjm	5533	32	dogs	dog	NNS
cord-023095-4dannjjm	5533	33	,	,	,
cord-023095-4dannjjm	5533	34	with	with	IN
cord-023095-4dannjjm	5533	35	the	the	DT
cord-023095-4dannjjm	5533	36	most	most	RBS
cord-023095-4dannjjm	5533	37	commonly	commonly	RB
cord-023095-4dannjjm	5533	38	recognized	recognize	VBN
cord-023095-4dannjjm	5533	39	ILD	ILD	NNP
cord-023095-4dannjjm	5533	40	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	5533	41	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5533	42	fibrosis	fibrosis	NN
cord-023095-4dannjjm	5533	43	(	(	-LRB-
cord-023095-4dannjjm	5533	44	'	'	''
cord-023095-4dannjjm	5533	45	'	'	''
cord-023095-4dannjjm	5533	46	Westie	Westie	NNP
cord-023095-4dannjjm	5533	47	fibrosis	fibrosis	NN
cord-023095-4dannjjm	5533	48	'	'	''
cord-023095-4dannjjm	5533	49	'	'	''
cord-023095-4dannjjm	5533	50	)	)	-RRB-
cord-023095-4dannjjm	5533	51	.	.	.
cord-023095-4dannjjm	5534	1	In	in	IN
cord-023095-4dannjjm	5534	2	human	human	JJ
cord-023095-4dannjjm	5534	3	medicine	medicine	NN
cord-023095-4dannjjm	5534	4	,	,	,
cord-023095-4dannjjm	5534	5	ILD	ILD	NNP
cord-023095-4dannjjm	5534	6	represent	represent	VBP
cord-023095-4dannjjm	5534	7	a	a	DT
cord-023095-4dannjjm	5534	8	large	large	JJ
cord-023095-4dannjjm	5534	9	umbrella	umbrella	NN
cord-023095-4dannjjm	5534	10	of	of	IN
cord-023095-4dannjjm	5534	11	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5534	12	diseases	disease	NNS
cord-023095-4dannjjm	5534	13	,	,	,
cord-023095-4dannjjm	5534	14	with	with	IN
cord-023095-4dannjjm	5534	15	IPF	IPF	NNP
cord-023095-4dannjjm	5534	16	only	only	RB
cord-023095-4dannjjm	5534	17	a	a	DT
cord-023095-4dannjjm	5534	18	subset	subset	NN
cord-023095-4dannjjm	5534	19	.	.	.
cord-023095-4dannjjm	5535	1	Other	other	JJ
cord-023095-4dannjjm	5535	2	,	,	,
cord-023095-4dannjjm	5535	3	more	more	RBR
cord-023095-4dannjjm	5535	4	treatable	treatable	JJ
cord-023095-4dannjjm	5535	5	,	,	,
cord-023095-4dannjjm	5535	6	ILDs	ild	NNS
cord-023095-4dannjjm	5535	7	are	be	VBP
cord-023095-4dannjjm	5535	8	also	also	RB
cord-023095-4dannjjm	5535	9	identified	identify	VBN
cord-023095-4dannjjm	5535	10	,	,	,
cord-023095-4dannjjm	5535	11	and	and	CC
cord-023095-4dannjjm	5535	12	may	may	MD
cord-023095-4dannjjm	5535	13	respond	respond	VB
cord-023095-4dannjjm	5535	14	to	to	IN
cord-023095-4dannjjm	5535	15	either	either	CC
cord-023095-4dannjjm	5535	16	the	the	DT
cord-023095-4dannjjm	5535	17	removal	removal	NN
cord-023095-4dannjjm	5535	18	of	of	IN
cord-023095-4dannjjm	5535	19	a	a	DT
cord-023095-4dannjjm	5535	20	stimulus	stimulus	NN
cord-023095-4dannjjm	5535	21	(	(	-LRB-
cord-023095-4dannjjm	5535	22	hypersensitivity	hypersensitivity	NN
cord-023095-4dannjjm	5535	23	)	)	-RRB-
cord-023095-4dannjjm	5535	24	or	or	CC
cord-023095-4dannjjm	5535	25	steroid	steroid	NN
cord-023095-4dannjjm	5535	26	therapy	therapy	NN
cord-023095-4dannjjm	5535	27	.	.	.
cord-023095-4dannjjm	5536	1	The	the	DT
cord-023095-4dannjjm	5536	2	goal	goal	NN
cord-023095-4dannjjm	5536	3	of	of	IN
cord-023095-4dannjjm	5536	4	this	this	DT
cord-023095-4dannjjm	5536	5	report	report	NN
cord-023095-4dannjjm	5536	6	is	be	VBZ
cord-023095-4dannjjm	5536	7	to	to	TO
cord-023095-4dannjjm	5536	8	describe	describe	VB
cord-023095-4dannjjm	5536	9	the	the	DT
cord-023095-4dannjjm	5536	10	clinical	clinical	JJ
cord-023095-4dannjjm	5536	11	course	course	NN
cord-023095-4dannjjm	5536	12	,	,	,
cord-023095-4dannjjm	5536	13	including	include	VBG
cord-023095-4dannjjm	5536	14	outcome	outcome	NN
cord-023095-4dannjjm	5536	15	,	,	,
cord-023095-4dannjjm	5536	16	computed	compute	VBN
cord-023095-4dannjjm	5536	17	tomography	tomography	NN
cord-023095-4dannjjm	5536	18	and	and	CC
cord-023095-4dannjjm	5536	19	histopathology	histopathology	NN
cord-023095-4dannjjm	5536	20	of	of	IN
cord-023095-4dannjjm	5536	21	dogs	dog	NNS
cord-023095-4dannjjm	5536	22	affected	affect	VBN
cord-023095-4dannjjm	5536	23	with	with	IN
cord-023095-4dannjjm	5536	24	an	an	DT
cord-023095-4dannjjm	5536	25	ILD	ILD	NNP
cord-023095-4dannjjm	5536	26	.	.	.
cord-023095-4dannjjm	5537	1	The	the	DT
cord-023095-4dannjjm	5537	2	computed	compute	VBN
cord-023095-4dannjjm	5537	3	tomography	tomography	NN
cord-023095-4dannjjm	5537	4	(	(	-LRB-
cord-023095-4dannjjm	5537	5	CT	CT	NNP
cord-023095-4dannjjm	5537	6	)	)	-RRB-
cord-023095-4dannjjm	5537	7	log	log	NN
cord-023095-4dannjjm	5537	8	was	be	VBD
cord-023095-4dannjjm	5537	9	reviewed	review	VBN
cord-023095-4dannjjm	5537	10	for	for	IN
cord-023095-4dannjjm	5537	11	dogs	dog	NNS
cord-023095-4dannjjm	5537	12	that	that	WDT
cord-023095-4dannjjm	5537	13	underwent	undergo	VBD
cord-023095-4dannjjm	5537	14	thoracic	thoracic	JJ
cord-023095-4dannjjm	5537	15	CT	CT	NNP
cord-023095-4dannjjm	5537	16	scanning	scanning	NN
cord-023095-4dannjjm	5537	17	for	for	IN
cord-023095-4dannjjm	5537	18	evaluation	evaluation	NN
cord-023095-4dannjjm	5537	19	of	of	IN
cord-023095-4dannjjm	5537	20	respiratory	respiratory	JJ
cord-023095-4dannjjm	5537	21	signs	sign	NNS
cord-023095-4dannjjm	5537	22	,	,	,
cord-023095-4dannjjm	5537	23	and	and	CC
cord-023095-4dannjjm	5537	24	had	have	VBD
cord-023095-4dannjjm	5537	25	changes	change	NNS
cord-023095-4dannjjm	5537	26	consistent	consistent	JJ
cord-023095-4dannjjm	5537	27	with	with	IN
cord-023095-4dannjjm	5537	28	ILD	ILD	NNP
cord-023095-4dannjjm	5537	29	as	as	IN
cord-023095-4dannjjm	5537	30	the	the	DT
cord-023095-4dannjjm	5537	31	primary	primary	JJ
cord-023095-4dannjjm	5537	32	abnormality	abnormality	NN
cord-023095-4dannjjm	5537	33	,	,	,
cord-023095-4dannjjm	5537	34	including	include	VBG
cord-023095-4dannjjm	5537	35	the	the	DT
cord-023095-4dannjjm	5537	36	presence	presence	NN
cord-023095-4dannjjm	5537	37	of	of	IN
cord-023095-4dannjjm	5537	38	diffuse	diffuse	JJ
cord-023095-4dannjjm	5537	39	disease	disease	NN
cord-023095-4dannjjm	5537	40	in	in	IN
cord-023095-4dannjjm	5537	41	all	all	DT
cord-023095-4dannjjm	5537	42	lobes	lobe	NNS
cord-023095-4dannjjm	5537	43	,	,	,
cord-023095-4dannjjm	5537	44	and	and	CC
cord-023095-4dannjjm	5537	45	at	at	IN
cord-023095-4dannjjm	5537	46	least	least	JJS
cord-023095-4dannjjm	5537	47	2	2	CD
cord-023095-4dannjjm	5537	48	of	of	IN
cord-023095-4dannjjm	5537	49	the	the	DT
cord-023095-4dannjjm	5537	50	following	follow	VBG
cord-023095-4dannjjm	5537	51	:	:	:
cord-023095-4dannjjm	5537	52	reticulation	reticulation	NN
cord-023095-4dannjjm	5537	53	,	,	,
cord-023095-4dannjjm	5537	54	ground	ground	NN
cord-023095-4dannjjm	5537	55	glass	glass	NN
cord-023095-4dannjjm	5537	56	opacity	opacity	NN
cord-023095-4dannjjm	5537	57	,	,	,
cord-023095-4dannjjm	5537	58	consolidation	consolidation	NN
cord-023095-4dannjjm	5537	59	,	,	,
cord-023095-4dannjjm	5537	60	or	or	CC
cord-023095-4dannjjm	5537	61	traction	traction	NN
cord-023095-4dannjjm	5537	62	bronchiectasis	bronchiectasis	NN
cord-023095-4dannjjm	5537	63	.	.	.
cord-023095-4dannjjm	5538	1	Survival	survival	NN
cord-023095-4dannjjm	5538	2	time	time	NN
cord-023095-4dannjjm	5538	3	from	from	IN
cord-023095-4dannjjm	5538	4	CT	CT	NNP
cord-023095-4dannjjm	5538	5	date	date	NN
cord-023095-4dannjjm	5538	6	was	be	VBD
cord-023095-4dannjjm	5538	7	calculated	calculate	VBN
cord-023095-4dannjjm	5538	8	.	.	.
cord-023095-4dannjjm	5539	1	The	the	DT
cord-023095-4dannjjm	5539	2	presence	presence	NN
cord-023095-4dannjjm	5539	3	of	of	IN
cord-023095-4dannjjm	5539	4	moderate	moderate	JJ
cord-023095-4dannjjm	5539	5	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5539	6	hypertension	hypertension	NN
cord-023095-4dannjjm	5539	7	[	[	-LRB-
cord-023095-4dannjjm	5539	8	pHTN	pHTN	NNP
cord-023095-4dannjjm	5539	9	]	]	-RRB-
cord-023095-4dannjjm	5539	10	(	(	-LRB-
cord-023095-4dannjjm	5539	11	4	4	CD
cord-023095-4dannjjm	5539	12	50	50	CD
cord-023095-4dannjjm	5539	13	mmHg	mmHg	NNS
cord-023095-4dannjjm	5539	14	)	)	-RRB-
cord-023095-4dannjjm	5539	15	as	as	IN
cord-023095-4dannjjm	5539	16	estimated	estimate	VBN
cord-023095-4dannjjm	5539	17	by	by	IN
cord-023095-4dannjjm	5539	18	tricuspid	tricuspid	NNP
cord-023095-4dannjjm	5539	19	regurgitant	regurgitant	NNP
cord-023095-4dannjjm	5539	20	jet	jet	NN
cord-023095-4dannjjm	5539	21	,	,	,
cord-023095-4dannjjm	5539	22	was	be	VBD
cord-023095-4dannjjm	5539	23	also	also	RB
cord-023095-4dannjjm	5539	24	reported	report	VBN
cord-023095-4dannjjm	5539	25	and	and	CC
cord-023095-4dannjjm	5539	26	survival	survival	NN
cord-023095-4dannjjm	5539	27	times	time	NNS
cord-023095-4dannjjm	5539	28	were	be	VBD
cord-023095-4dannjjm	5539	29	compared	compare	VBN
cord-023095-4dannjjm	5539	30	with	with	IN
cord-023095-4dannjjm	5539	31	a	a	DT
cord-023095-4dannjjm	5539	32	Mann	Mann	NNP
cord-023095-4dannjjm	5539	33	-	-	HYPH
cord-023095-4dannjjm	5539	34	Whitney	Whitney	NNP
cord-023095-4dannjjm	5539	35	rank	rank	NN
cord-023095-4dannjjm	5539	36	sum	sum	NN
cord-023095-4dannjjm	5539	37	with	with	IN
cord-023095-4dannjjm	5539	38	P	p	NN
cord-023095-4dannjjm	5539	39	o	o	NN
cord-023095-4dannjjm	5539	40	0.05	0.05	CD
cord-023095-4dannjjm	5539	41	considered	consider	VBN
cord-023095-4dannjjm	5539	42	significant	significant	JJ
cord-023095-4dannjjm	5539	43	.	.	.
cord-023095-4dannjjm	5540	1	Thirteen	thirteen	CD
cord-023095-4dannjjm	5540	2	dogs	dog	NNS
cord-023095-4dannjjm	5540	3	were	be	VBD
cord-023095-4dannjjm	5540	4	identified	identify	VBN
cord-023095-4dannjjm	5540	5	.	.	.
cord-023095-4dannjjm	5541	1	Terriers	Terriers	NNPS
cord-023095-4dannjjm	5541	2	and	and	CC
cord-023095-4dannjjm	5541	3	Chihuahuas	Chihuahuas	NNPS
cord-023095-4dannjjm	5541	4	were	be	VBD
cord-023095-4dannjjm	5541	5	the	the	DT
cord-023095-4dannjjm	5541	6	most	most	RBS
cord-023095-4dannjjm	5541	7	commonly	commonly	RB
cord-023095-4dannjjm	5541	8	affected	affect	VBN
cord-023095-4dannjjm	5541	9	breeds	breed	NNS
cord-023095-4dannjjm	5541	10	.	.	.
cord-023095-4dannjjm	5542	1	Two	two	CD
cord-023095-4dannjjm	5542	2	dogs	dog	NNS
cord-023095-4dannjjm	5542	3	were	be	VBD
cord-023095-4dannjjm	5542	4	adolescents	adolescent	NNS
cord-023095-4dannjjm	5542	5	,	,	,
cord-023095-4dannjjm	5542	6	the	the	DT
cord-023095-4dannjjm	5542	7	remaining	remain	VBG
cord-023095-4dannjjm	5542	8	dogs	dog	NNS
cord-023095-4dannjjm	5542	9	ranged	range	VBD
cord-023095-4dannjjm	5542	10	from	from	IN
cord-023095-4dannjjm	5542	11	7	7	CD
cord-023095-4dannjjm	5542	12	-	-	SYM
cord-023095-4dannjjm	5542	13	16	16	CD
cord-023095-4dannjjm	5542	14	years	year	NNS
cord-023095-4dannjjm	5542	15	,	,	,
cord-023095-4dannjjm	5542	16	with	with	IN
cord-023095-4dannjjm	5542	17	a	a	DT
cord-023095-4dannjjm	5542	18	median	median	NN
cord-023095-4dannjjm	5542	19	of	of	IN
cord-023095-4dannjjm	5542	20	11	11	CD
cord-023095-4dannjjm	5542	21	years	year	NNS
cord-023095-4dannjjm	5542	22	.	.	.
cord-023095-4dannjjm	5543	1	Histopathology	Histopathology	NNP
cord-023095-4dannjjm	5543	2	results	result	NNS
cord-023095-4dannjjm	5543	3	(	(	-LRB-
cord-023095-4dannjjm	5543	4	n	n	NN
cord-023095-4dannjjm	5543	5	5	5	CD
cord-023095-4dannjjm	5543	6	5	5	CD
cord-023095-4dannjjm	5543	7	)	)	-RRB-
cord-023095-4dannjjm	5543	8	,	,	,
cord-023095-4dannjjm	5543	9	including	include	VBG
cord-023095-4dannjjm	5543	10	moderate	moderate	JJ
cord-023095-4dannjjm	5543	11	to	to	IN
cord-023095-4dannjjm	5543	12	severe	severe	JJ
cord-023095-4dannjjm	5543	13	interstitial	interstitial	JJ
cord-023095-4dannjjm	5543	14	fibrosis	fibrosis	NN
cord-023095-4dannjjm	5543	15	(	(	-LRB-
cord-023095-4dannjjm	5543	16	3	3	CD
cord-023095-4dannjjm	5543	17	)	)	-RRB-
cord-023095-4dannjjm	5543	18	alveolar	alveolar	JJ
cord-023095-4dannjjm	5543	19	proteinosis	proteinosis	NN
cord-023095-4dannjjm	5543	20	with	with	IN
cord-023095-4dannjjm	5543	21	fibrosis	fibrosis	NN
cord-023095-4dannjjm	5543	22	(	(	-LRB-
cord-023095-4dannjjm	5543	23	1	1	CD
cord-023095-4dannjjm	5543	24	)	)	-RRB-
cord-023095-4dannjjm	5543	25	,	,	,
cord-023095-4dannjjm	5543	26	and	and	CC
cord-023095-4dannjjm	5543	27	interstitial	interstitial	JJ
cord-023095-4dannjjm	5543	28	eosinophilic	eosinophilic	JJ
cord-023095-4dannjjm	5543	29	pneumonia	pneumonia	NN
cord-023095-4dannjjm	5543	30	(	(	-LRB-
cord-023095-4dannjjm	5543	31	1	1	CD
cord-023095-4dannjjm	5543	32	)	)	-RRB-
cord-023095-4dannjjm	5543	33	.	.	.
cord-023095-4dannjjm	5544	1	One	one	PRP
cord-023095-4dannjjm	5544	2	had	have	VBD
cord-023095-4dannjjm	5544	3	suspected	suspect	VBN
cord-023095-4dannjjm	5544	4	cryptogenic	cryptogenic	JJ
cord-023095-4dannjjm	5544	5	organizing	organize	VBG
cord-023095-4dannjjm	5544	6	pneumonia	pneumonia	NN
cord-023095-4dannjjm	5544	7	and	and	CC
cord-023095-4dannjjm	5544	8	had	have	VBD
cord-023095-4dannjjm	5544	9	a	a	DT
cord-023095-4dannjjm	5544	10	good	good	JJ
cord-023095-4dannjjm	5544	11	response	response	NN
cord-023095-4dannjjm	5544	12	to	to	IN
cord-023095-4dannjjm	5544	13	glucocorticoids	glucocorticoid	NNS
cord-023095-4dannjjm	5544	14	.	.	.
cord-023095-4dannjjm	5545	1	Eight	eight	CD
cord-023095-4dannjjm	5545	2	dogs	dog	NNS
cord-023095-4dannjjm	5545	3	died	die	VBD
cord-023095-4dannjjm	5545	4	of	of	IN
cord-023095-4dannjjm	5545	5	respiratory	respiratory	JJ
cord-023095-4dannjjm	5545	6	failure	failure	NN
cord-023095-4dannjjm	5545	7	,	,	,
cord-023095-4dannjjm	5545	8	with	with	IN
cord-023095-4dannjjm	5545	9	a	a	DT
cord-023095-4dannjjm	5545	10	median	median	JJ
cord-023095-4dannjjm	5545	11	post	post	JJ
cord-023095-4dannjjm	5545	12	CT	CT	NNP
cord-023095-4dannjjm	5545	13	survival	survival	NN
cord-023095-4dannjjm	5545	14	time	time	NN
cord-023095-4dannjjm	5545	15	of	of	IN
cord-023095-4dannjjm	5545	16	42	42	CD
cord-023095-4dannjjm	5545	17	days	day	NNS
cord-023095-4dannjjm	5545	18	(	(	-LRB-
cord-023095-4dannjjm	5545	19	range	range	NNP
cord-023095-4dannjjm	5545	20	2	2	CD
cord-023095-4dannjjm	5545	21	-	-	SYM
cord-023095-4dannjjm	5545	22	365	365	CD
cord-023095-4dannjjm	5545	23	)	)	-RRB-
cord-023095-4dannjjm	5545	24	,	,	,
cord-023095-4dannjjm	5545	25	two	two	CD
cord-023095-4dannjjm	5545	26	dogs	dog	NNS
cord-023095-4dannjjm	5545	27	died	die	VBD
cord-023095-4dannjjm	5545	28	of	of	IN
cord-023095-4dannjjm	5545	29	non	non	JJ
cord-023095-4dannjjm	5545	30	-	-	JJ
cord-023095-4dannjjm	5545	31	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5545	32	disease	disease	NN
cord-023095-4dannjjm	5545	33	,	,	,
cord-023095-4dannjjm	5545	34	2	2	CD
cord-023095-4dannjjm	5545	35	dogs	dog	NNS
cord-023095-4dannjjm	5545	36	had	have	VBD
cord-023095-4dannjjm	5545	37	severe	severe	JJ
cord-023095-4dannjjm	5545	38	lower	low	JJR
cord-023095-4dannjjm	5545	39	respiratory	respiratory	JJ
cord-023095-4dannjjm	5545	40	infections	infection	NNS
cord-023095-4dannjjm	5545	41	as	as	IN
cord-023095-4dannjjm	5545	42	puppies	puppy	NNS
cord-023095-4dannjjm	5545	43	with	with	IN
cord-023095-4dannjjm	5545	44	persistent	persistent	JJ
cord-023095-4dannjjm	5545	45	respiratory	respiratory	JJ
cord-023095-4dannjjm	5545	46	signs	sign	NNS
cord-023095-4dannjjm	5545	47	,	,	,
cord-023095-4dannjjm	5545	48	and	and	CC
cord-023095-4dannjjm	5545	49	both	both	DT
cord-023095-4dannjjm	5545	50	are	be	VBP
cord-023095-4dannjjm	5545	51	still	still	RB
cord-023095-4dannjjm	5545	52	alive	alive	JJ
cord-023095-4dannjjm	5545	53	at	at	IN
cord-023095-4dannjjm	5545	54	4	4	CD
cord-023095-4dannjjm	5545	55	2	2	CD
cord-023095-4dannjjm	5545	56	years	year	NNS
cord-023095-4dannjjm	5545	57	since	since	IN
cord-023095-4dannjjm	5545	58	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5545	59	,	,	,
cord-023095-4dannjjm	5545	60	1	1	CD
cord-023095-4dannjjm	5545	61	terrier	terrier	NN
cord-023095-4dannjjm	5545	62	is	be	VBZ
cord-023095-4dannjjm	5545	63	alive	alive	JJ
cord-023095-4dannjjm	5545	64	at	at	IN
cord-023095-4dannjjm	5545	65	19	19	CD
cord-023095-4dannjjm	5545	66	months	month	NNS
cord-023095-4dannjjm	5545	67	and	and	CC
cord-023095-4dannjjm	5545	68	1	1	CD
cord-023095-4dannjjm	5545	69	was	be	VBD
cord-023095-4dannjjm	5545	70	lost	lose	VBN
cord-023095-4dannjjm	5545	71	to	to	TO
cord-023095-4dannjjm	5545	72	follow	follow	VB
cord-023095-4dannjjm	5545	73	up	up	RP
cord-023095-4dannjjm	5545	74	.	.	.
cord-023095-4dannjjm	5546	1	5	5	CD
cord-023095-4dannjjm	5546	2	dogs	dog	NNS
cord-023095-4dannjjm	5546	3	had	have	VBD
cord-023095-4dannjjm	5546	4	PHTN	PHTN	NNP
cord-023095-4dannjjm	5546	5	,	,	,
cord-023095-4dannjjm	5546	6	with	with	IN
cord-023095-4dannjjm	5546	7	a	a	DT
cord-023095-4dannjjm	5546	8	median	median	JJ
cord-023095-4dannjjm	5546	9	survival	survival	NN
cord-023095-4dannjjm	5546	10	of	of	IN
cord-023095-4dannjjm	5546	11	60	60	CD
cord-023095-4dannjjm	5546	12	days	day	NNS
cord-023095-4dannjjm	5546	13	(	(	-LRB-
cord-023095-4dannjjm	5546	14	42	42	CD
cord-023095-4dannjjm	5546	15	-	-	SYM
cord-023095-4dannjjm	5546	16	590	590	CD
cord-023095-4dannjjm	5546	17	)	)	-RRB-
cord-023095-4dannjjm	5546	18	,	,	,
cord-023095-4dannjjm	5546	19	while	while	IN
cord-023095-4dannjjm	5546	20	the	the	DT
cord-023095-4dannjjm	5546	21	5	5	CD
cord-023095-4dannjjm	5546	22	dogs	dog	NNS
cord-023095-4dannjjm	5546	23	without	without	IN
cord-023095-4dannjjm	5546	24	had	have	VBD
cord-023095-4dannjjm	5546	25	a	a	DT
cord-023095-4dannjjm	5546	26	survival	survival	NN
cord-023095-4dannjjm	5546	27	of	of	IN
cord-023095-4dannjjm	5546	28	180	180	CD
cord-023095-4dannjjm	5546	29	days	day	NNS
cord-023095-4dannjjm	5547	1	(	(	-LRB-
cord-023095-4dannjjm	5547	2	range	range	NNP
cord-023095-4dannjjm	5547	3	21	21	CD
cord-023095-4dannjjm	5547	4	-	-	SYM
cord-023095-4dannjjm	5547	5	730	730	CD
cord-023095-4dannjjm	5547	6	)	)	-RRB-
cord-023095-4dannjjm	5547	7	,	,	.
cord-023095-4dannjjm	5548	1	[	[	-LRB-
cord-023095-4dannjjm	5548	2	p	p	NN
cord-023095-4dannjjm	5548	3	5	5	CD
cord-023095-4dannjjm	5548	4	0.3	0.3	CD
cord-023095-4dannjjm	5548	5	]	]	-RRB-
cord-023095-4dannjjm	5548	6	.	.	.
cord-023095-4dannjjm	5549	1	Interstitial	interstitial	JJ
cord-023095-4dannjjm	5549	2	lung	lung	NN
cord-023095-4dannjjm	5549	3	disease	disease	NN
cord-023095-4dannjjm	5549	4	in	in	IN
cord-023095-4dannjjm	5549	5	dogs	dog	NNS
cord-023095-4dannjjm	5549	6	is	be	VBZ
cord-023095-4dannjjm	5549	7	not	not	RB
cord-023095-4dannjjm	5549	8	just	just	RB
cord-023095-4dannjjm	5549	9	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	5549	10	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5549	11	fibrosis	fibrosis	NN
cord-023095-4dannjjm	5549	12	.	.	.
cord-023095-4dannjjm	5550	1	Following	follow	VBG
cord-023095-4dannjjm	5550	2	respiratory	respiratory	JJ
cord-023095-4dannjjm	5550	3	infection	infection	NN
cord-023095-4dannjjm	5550	4	,	,	,
cord-023095-4dannjjm	5550	5	young	young	JJ
cord-023095-4dannjjm	5550	6	dogs	dog	NNS
cord-023095-4dannjjm	5550	7	may	may	MD
cord-023095-4dannjjm	5550	8	develop	develop	VB
cord-023095-4dannjjm	5550	9	an	an	DT
cord-023095-4dannjjm	5550	10	ILD	ILD	NNP
cord-023095-4dannjjm	5550	11	with	with	IN
cord-023095-4dannjjm	5550	12	a	a	DT
cord-023095-4dannjjm	5550	13	relatively	relatively	RB
cord-023095-4dannjjm	5550	14	indolent	indolent	JJ
cord-023095-4dannjjm	5550	15	course	course	NN
cord-023095-4dannjjm	5550	16	and	and	CC
cord-023095-4dannjjm	5550	17	rare	rare	JJ
cord-023095-4dannjjm	5550	18	ILD	ILD	NNP
cord-023095-4dannjjm	5550	19	is	be	VBZ
cord-023095-4dannjjm	5550	20	steroid	steroid	NN
cord-023095-4dannjjm	5550	21	responsive	responsive	JJ
cord-023095-4dannjjm	5550	22	.	.	.
cord-023095-4dannjjm	5551	1	CT	CT	NNP
cord-023095-4dannjjm	5551	2	is	be	VBZ
cord-023095-4dannjjm	5551	3	useful	useful	JJ
cord-023095-4dannjjm	5551	4	to	to	TO
cord-023095-4dannjjm	5551	5	identify	identify	VB
cord-023095-4dannjjm	5551	6	ILD	ILD	NNP
cord-023095-4dannjjm	5551	7	but	but	CC
cord-023095-4dannjjm	5551	8	further	further	JJ
cord-023095-4dannjjm	5551	9	research	research	NN
cord-023095-4dannjjm	5551	10	correlated	correlate	VBN
cord-023095-4dannjjm	5551	11	with	with	IN
cord-023095-4dannjjm	5551	12	echocardiography	echocardiography	NN
cord-023095-4dannjjm	5551	13	and	and	CC
cord-023095-4dannjjm	5551	14	histopathology	histopathology	NN
cord-023095-4dannjjm	5551	15	is	be	VBZ
cord-023095-4dannjjm	5551	16	advised	advise	VBN
cord-023095-4dannjjm	5551	17	to	to	TO
cord-023095-4dannjjm	5551	18	use	use	VB
cord-023095-4dannjjm	5551	19	it	-PRON-	PRP
cord-023095-4dannjjm	5551	20	to	to	TO
cord-023095-4dannjjm	5551	21	prognosticate	prognosticate	VB
cord-023095-4dannjjm	5551	22	.	.	.
cord-023095-4dannjjm	5552	1	Idiopathic	idiopathic	JJ
cord-023095-4dannjjm	5552	2	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5552	3	fibrosis	fibrosis	NN
cord-023095-4dannjjm	5552	4	(	(	-LRB-
cord-023095-4dannjjm	5552	5	IPF	IPF	NNP
cord-023095-4dannjjm	5552	6	)	)	-RRB-
cord-023095-4dannjjm	5552	7	is	be	VBZ
cord-023095-4dannjjm	5552	8	an	an	DT
cord-023095-4dannjjm	5552	9	interstitial	interstitial	JJ
cord-023095-4dannjjm	5552	10	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5552	11	disease	disease	NN
cord-023095-4dannjjm	5552	12	,	,	,
cord-023095-4dannjjm	5552	13	mainly	mainly	RB
cord-023095-4dannjjm	5552	14	described	describe	VBN
cord-023095-4dannjjm	5552	15	in	in	IN
cord-023095-4dannjjm	5552	16	West	West	NNP
cord-023095-4dannjjm	5552	17	Highland	Highland	NNP
cord-023095-4dannjjm	5552	18	white	white	JJ
cord-023095-4dannjjm	5552	19	terriers	terrier	NNS
cord-023095-4dannjjm	5552	20	(	(	-LRB-
cord-023095-4dannjjm	5552	21	WHWT	WHWT	NNP
cord-023095-4dannjjm	5552	22	)	)	-RRB-
cord-023095-4dannjjm	5552	23	.	.	.
cord-023095-4dannjjm	5553	1	Identification	identification	NN
cord-023095-4dannjjm	5553	2	of	of	IN
cord-023095-4dannjjm	5553	3	molecular	molecular	JJ
cord-023095-4dannjjm	5553	4	pathways	pathway	NNS
cord-023095-4dannjjm	5553	5	important	important	JJ
cord-023095-4dannjjm	5553	6	in	in	IN
cord-023095-4dannjjm	5553	7	the	the	DT
cord-023095-4dannjjm	5553	8	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	5553	9	of	of	IN
cord-023095-4dannjjm	5553	10	IPF	IPF	NNP
cord-023095-4dannjjm	5553	11	would	would	MD
cord-023095-4dannjjm	5553	12	improve	improve	VB
cord-023095-4dannjjm	5553	13	our	-PRON-	PRP$
cord-023095-4dannjjm	5553	14	understanding	understanding	NN
cord-023095-4dannjjm	5553	15	of	of	IN
cord-023095-4dannjjm	5553	16	this	this	DT
cord-023095-4dannjjm	5553	17	disease	disease	NN
cord-023095-4dannjjm	5553	18	and	and	CC
cord-023095-4dannjjm	5553	19	may	may	MD
cord-023095-4dannjjm	5553	20	help	help	VB
cord-023095-4dannjjm	5553	21	identify	identify	VB
cord-023095-4dannjjm	5553	22	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5553	23	targets	target	NNS
cord-023095-4dannjjm	5553	24	.	.	.
cord-023095-4dannjjm	5554	1	The	the	DT
cord-023095-4dannjjm	5554	2	aim	aim	NN
cord-023095-4dannjjm	5554	3	of	of	IN
cord-023095-4dannjjm	5554	4	the	the	DT
cord-023095-4dannjjm	5554	5	present	present	JJ
cord-023095-4dannjjm	5554	6	study	study	NN
cord-023095-4dannjjm	5554	7	was	be	VBD
cord-023095-4dannjjm	5554	8	to	to	TO
cord-023095-4dannjjm	5554	9	investigate	investigate	VB
cord-023095-4dannjjm	5554	10	gene	gene	NN
cord-023095-4dannjjm	5554	11	expression	expression	NN
cord-023095-4dannjjm	5554	12	in	in	IN
cord-023095-4dannjjm	5554	13	lungs	lung	NNS
cord-023095-4dannjjm	5554	14	of	of	IN
cord-023095-4dannjjm	5554	15	WHWT	whwt	NN
cord-023095-4dannjjm	5554	16	with	with	IN
cord-023095-4dannjjm	5554	17	IPF	IPF	NNP
cord-023095-4dannjjm	5554	18	using	use	VBG
cord-023095-4dannjjm	5554	19	oligonucleotide	oligonucleotide	JJ
cord-023095-4dannjjm	5554	20	microarray	microarray	NN
cord-023095-4dannjjm	5554	21	.	.	.
cord-023095-4dannjjm	5555	1	Total	Total	NNP
cord-023095-4dannjjm	5555	2	RNA	RNA	NNP
cord-023095-4dannjjm	5555	3	was	be	VBD
cord-023095-4dannjjm	5555	4	extracted	extract	VBN
cord-023095-4dannjjm	5555	5	from	from	IN
cord-023095-4dannjjm	5555	6	post	post	JJ
cord-023095-4dannjjm	5555	7	-	-	JJ
cord-023095-4dannjjm	5555	8	mortem	mortem	JJ
cord-023095-4dannjjm	5555	9	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5555	10	samples	sample	NNS
cord-023095-4dannjjm	5555	11	from	from	IN
cord-023095-4dannjjm	5555	12	five	five	CD
cord-023095-4dannjjm	5555	13	WHWT	WHWT	NNS
cord-023095-4dannjjm	5555	14	with	with	IN
cord-023095-4dannjjm	5555	15	IPF	IPF	NNP
cord-023095-4dannjjm	5555	16	and	and	CC
cord-023095-4dannjjm	5555	17	five	five	CD
cord-023095-4dannjjm	5555	18	control	control	NN
cord-023095-4dannjjm	5555	19	dogs	dog	NNS
cord-023095-4dannjjm	5555	20	(	(	-LRB-
cord-023095-4dannjjm	5555	21	CTRL	CTRL	NNP
cord-023095-4dannjjm	5555	22	)	)	-RRB-
cord-023095-4dannjjm	5555	23	without	without	IN
cord-023095-4dannjjm	5555	24	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5555	25	disease	disease	NN
cord-023095-4dannjjm	5555	26	.	.	.
cord-023095-4dannjjm	5556	1	The	the	DT
cord-023095-4dannjjm	5556	2	RNA	RNA	NNP
cord-023095-4dannjjm	5556	3	was	be	VBD
cord-023095-4dannjjm	5556	4	pooled	pool	VBN
cord-023095-4dannjjm	5556	5	from	from	IN
cord-023095-4dannjjm	5556	6	each	each	DT
cord-023095-4dannjjm	5556	7	group	group	NN
cord-023095-4dannjjm	5556	8	(	(	-LRB-
cord-023095-4dannjjm	5556	9	IPF	IPF	NNP
cord-023095-4dannjjm	5556	10	and	and	CC
cord-023095-4dannjjm	5556	11	CTRL	CTRL	NNP
cord-023095-4dannjjm	5556	12	)	)	-RRB-
cord-023095-4dannjjm	5556	13	and	and	CC
cord-023095-4dannjjm	5556	14	analysed	analyse	VBD
cord-023095-4dannjjm	5556	15	using	use	VBG
cord-023095-4dannjjm	5556	16	the	the	DT
cord-023095-4dannjjm	5556	17	canine	canine	JJ
cord-023095-4dannjjm	5556	18	specific	specific	JJ
cord-023095-4dannjjm	5556	19	Affymetrix	Affymetrix	NNP
cord-023095-4dannjjm	5556	20	microarray	microarray	NN
cord-023095-4dannjjm	5556	21	technology	technology	NN
cord-023095-4dannjjm	5556	22	.	.	.
cord-023095-4dannjjm	5557	1	Genes	gene	NNS
cord-023095-4dannjjm	5557	2	with	with	IN
cord-023095-4dannjjm	5557	3	a	a	DT
cord-023095-4dannjjm	5557	4	minimum	minimum	NN
cord-023095-4dannjjm	5557	5	of	of	IN
cord-023095-4dannjjm	5557	6	a	a	DT
cord-023095-4dannjjm	5557	7	two	two	CD
cord-023095-4dannjjm	5557	8	-	-	HYPH
cord-023095-4dannjjm	5557	9	fold	fold	JJ
cord-023095-4dannjjm	5557	10	difference	difference	NN
cord-023095-4dannjjm	5557	11	in	in	IN
cord-023095-4dannjjm	5557	12	expression	expression	NN
cord-023095-4dannjjm	5557	13	between	between	IN
cord-023095-4dannjjm	5557	14	the	the	DT
cord-023095-4dannjjm	5557	15	two	two	CD
cord-023095-4dannjjm	5557	16	groups	group	NNS
cord-023095-4dannjjm	5557	17	were	be	VBD
cord-023095-4dannjjm	5557	18	selected	select	VBN
cord-023095-4dannjjm	5557	19	for	for	IN
cord-023095-4dannjjm	5557	20	further	further	JJ
cord-023095-4dannjjm	5557	21	analysis	analysis	NN
cord-023095-4dannjjm	5557	22	.	.	.
cord-023095-4dannjjm	5558	1	The	the	DT
cord-023095-4dannjjm	5558	2	most	most	RBS
cord-023095-4dannjjm	5558	3	significant	significant	JJ
cord-023095-4dannjjm	5558	4	biological	biological	JJ
cord-023095-4dannjjm	5558	5	functions	function	NNS
cord-023095-4dannjjm	5558	6	for	for	IN
cord-023095-4dannjjm	5558	7	these	these	DT
cord-023095-4dannjjm	5558	8	genes	gene	NNS
cord-023095-4dannjjm	5558	9	were	be	VBD
cord-023095-4dannjjm	5558	10	identified	identify	VBN
cord-023095-4dannjjm	5558	11	using	use	VBG
cord-023095-4dannjjm	5558	12	Ingenuity	Ingenuity	NNP
cord-023095-4dannjjm	5558	13	Pathways	Pathways	NNP
cord-023095-4dannjjm	5558	14	Analysis	Analysis	NNP
cord-023095-4dannjjm	5558	15	.	.	.
cord-023095-4dannjjm	5559	1	More	More	JJR
cord-023095-4dannjjm	5559	2	than	than	IN
cord-023095-4dannjjm	5559	3	1000	1000	CD
cord-023095-4dannjjm	5559	4	genes	gene	NNS
cord-023095-4dannjjm	5559	5	were	be	VBD
cord-023095-4dannjjm	5559	6	identified	identify	VBN
cord-023095-4dannjjm	5559	7	as	as	IN
cord-023095-4dannjjm	5559	8	having	have	VBG
cord-023095-4dannjjm	5559	9	greater	great	JJR
cord-023095-4dannjjm	5559	10	than	than	IN
cord-023095-4dannjjm	5559	11	twofold	twofold	JJ
cord-023095-4dannjjm	5559	12	difference	difference	NN
cord-023095-4dannjjm	5559	13	in	in	IN
cord-023095-4dannjjm	5559	14	expression	expression	NN
cord-023095-4dannjjm	5559	15	.	.	.
cord-023095-4dannjjm	5560	1	The	the	DT
cord-023095-4dannjjm	5560	2	significant	significant	JJ
cord-023095-4dannjjm	5560	3	biological	biological	JJ
cord-023095-4dannjjm	5560	4	functions	function	NNS
cord-023095-4dannjjm	5560	5	associated	associate	VBN
cord-023095-4dannjjm	5560	6	with	with	IN
cord-023095-4dannjjm	5560	7	these	these	DT
cord-023095-4dannjjm	5560	8	genes	gene	NNS
cord-023095-4dannjjm	5560	9	were	be	VBD
cord-023095-4dannjjm	5560	10	related	relate	VBN
cord-023095-4dannjjm	5560	11	to	to	IN
cord-023095-4dannjjm	5560	12	cellular	cellular	JJ
cord-023095-4dannjjm	5560	13	movement	movement	NN
cord-023095-4dannjjm	5560	14	,	,	,
cord-023095-4dannjjm	5560	15	cellular	cellular	JJ
cord-023095-4dannjjm	5560	16	proliferation	proliferation	NN
cord-023095-4dannjjm	5560	17	and	and	CC
cord-023095-4dannjjm	5560	18	apoptosis	apoptosis	NN
cord-023095-4dannjjm	5560	19	.	.	.
cord-023095-4dannjjm	5561	1	Most	most	RBS
cord-023095-4dannjjm	5561	2	notable	notable	JJ
cord-023095-4dannjjm	5561	3	among	among	IN
cord-023095-4dannjjm	5561	4	these	these	DT
cord-023095-4dannjjm	5561	5	were	be	VBD
cord-023095-4dannjjm	5561	6	genes	gene	NNS
cord-023095-4dannjjm	5561	7	encoding	encode	VBG
cord-023095-4dannjjm	5561	8	the	the	DT
cord-023095-4dannjjm	5561	9	leukocyte	leukocyte	NN
cord-023095-4dannjjm	5561	10	chemotactic	chemotactic	JJ
cord-023095-4dannjjm	5561	11	proteins	protein	NNS
cord-023095-4dannjjm	5561	12	:	:	:
cord-023095-4dannjjm	5561	13	CCL2	CCL2	NNP
cord-023095-4dannjjm	5561	14	(	(	-LRB-
cord-023095-4dannjjm	5561	15	fold	fold	VB
cord-023095-4dannjjm	5561	16	change	change	NN
cord-023095-4dannjjm	5561	17	14.93	14.93	CD
cord-023095-4dannjjm	5561	18	)	)	-RRB-
cord-023095-4dannjjm	5561	19	,	,	,
cord-023095-4dannjjm	5561	20	CCL17	CCL17	NNP
cord-023095-4dannjjm	5561	21	(	(	-LRB-
cord-023095-4dannjjm	5561	22	12.74	12.74	CD
cord-023095-4dannjjm	5561	23	)	)	-RRB-
cord-023095-4dannjjm	5561	24	and	and	CC
cord-023095-4dannjjm	5561	25	IL8	IL8	NNP
cord-023095-4dannjjm	5561	26	(	(	-LRB-
cord-023095-4dannjjm	5561	27	14.32	14.32	CD
cord-023095-4dannjjm	5561	28	)	)	-RRB-
cord-023095-4dannjjm	5561	29	;	;	:
cord-023095-4dannjjm	5561	30	the	the	DT
cord-023095-4dannjjm	5561	31	proteins	protein	NNS
cord-023095-4dannjjm	5561	32	involved	involve	VBN
cord-023095-4dannjjm	5561	33	in	in	IN
cord-023095-4dannjjm	5561	34	fibroblast	fibroblast	NN
cord-023095-4dannjjm	5561	35	migration	migration	NN
cord-023095-4dannjjm	5561	36	;	;	,
cord-023095-4dannjjm	5561	37	and	and	CC
cord-023095-4dannjjm	5561	38	the	the	DT
cord-023095-4dannjjm	5561	39	matrix	matrix	NN
cord-023095-4dannjjm	5561	40	metalloproteinases	metalloproteinase	NNS
cord-023095-4dannjjm	5561	41	(	(	-LRB-
cord-023095-4dannjjm	5561	42	MMPs	MMPs	NNP
cord-023095-4dannjjm	5561	43	)	)	-RRB-
cord-023095-4dannjjm	5561	44	involved	involve	VBN
cord-023095-4dannjjm	5561	45	in	in	IN
cord-023095-4dannjjm	5561	46	matrix	matrix	NN
cord-023095-4dannjjm	5561	47	degradation	degradation	NN
cord-023095-4dannjjm	5561	48	:	:	:
cord-023095-4dannjjm	5561	49	MMP7	MMP7	NNP
cord-023095-4dannjjm	5561	50	(	(	-LRB-
cord-023095-4dannjjm	5561	51	À17.55	à17.55	CD
cord-023095-4dannjjm	5561	52	)	)	-RRB-
cord-023095-4dannjjm	5561	53	,	,	,
cord-023095-4dannjjm	5561	54	MMP9	MMP9	NNP
cord-023095-4dannjjm	5561	55	(	(	-LRB-
cord-023095-4dannjjm	5561	56	-3.42	-3.42	CD
cord-023095-4dannjjm	5561	57	)	)	-RRB-
cord-023095-4dannjjm	5561	58	,	,	,
cord-023095-4dannjjm	5561	59	MMP1	MMP1	NNP
cord-023095-4dannjjm	5561	60	(	(	-LRB-
cord-023095-4dannjjm	5561	61	À2.76	À2.76	NNP
cord-023095-4dannjjm	5561	62	)	)	-RRB-
cord-023095-4dannjjm	5561	63	.	.	.
cord-023095-4dannjjm	5562	1	This	this	DT
cord-023095-4dannjjm	5562	2	study	study	NN
cord-023095-4dannjjm	5562	3	has	have	VBZ
cord-023095-4dannjjm	5562	4	identified	identify	VBN
cord-023095-4dannjjm	5562	5	genes	gene	NNS
cord-023095-4dannjjm	5562	6	which	which	WDT
cord-023095-4dannjjm	5562	7	may	may	MD
cord-023095-4dannjjm	5562	8	be	be	VB
cord-023095-4dannjjm	5562	9	important	important	JJ
cord-023095-4dannjjm	5562	10	in	in	IN
cord-023095-4dannjjm	5562	11	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	5562	12	of	of	IN
cord-023095-4dannjjm	5562	13	IPF	IPF	NNP
cord-023095-4dannjjm	5562	14	,	,	,
cord-023095-4dannjjm	5562	15	e.g.	e.g.	RB
cord-023095-4dannjjm	5562	16	proteins	protein	NNS
cord-023095-4dannjjm	5562	17	involved	involve	VBN
cord-023095-4dannjjm	5562	18	in	in	IN
cord-023095-4dannjjm	5562	19	leukocytes	leukocyte	NNS
cord-023095-4dannjjm	5562	20	chemotaxis	chemotaxis	NN
cord-023095-4dannjjm	5562	21	,	,	,
cord-023095-4dannjjm	5562	22	fibroblast	fibroblast	NN
cord-023095-4dannjjm	5562	23	recruitment	recruitment	NN
cord-023095-4dannjjm	5562	24	and	and	CC
cord-023095-4dannjjm	5562	25	activation	activation	NN
cord-023095-4dannjjm	5562	26	,	,	,
cord-023095-4dannjjm	5562	27	regulation	regulation	NN
cord-023095-4dannjjm	5562	28	of	of	IN
cord-023095-4dannjjm	5562	29	apoptosis	apoptosis	NN
cord-023095-4dannjjm	5562	30	,	,	,
cord-023095-4dannjjm	5562	31	and	and	CC
cord-023095-4dannjjm	5562	32	extracellular	extracellular	JJ
cord-023095-4dannjjm	5562	33	-	-	HYPH
cord-023095-4dannjjm	5562	34	matrix	matrix	NN
cord-023095-4dannjjm	5562	35	turn	turn	NN
cord-023095-4dannjjm	5562	36	-	-	HYPH
cord-023095-4dannjjm	5562	37	over	over	NN
cord-023095-4dannjjm	5562	38	.	.	.
cord-023095-4dannjjm	5563	1	However	however	RB
cord-023095-4dannjjm	5563	2	,	,	,
cord-023095-4dannjjm	5563	3	real	real	JJ
cord-023095-4dannjjm	5563	4	-	-	HYPH
cord-023095-4dannjjm	5563	5	time	time	NN
cord-023095-4dannjjm	5563	6	quantitative	quantitative	JJ
cord-023095-4dannjjm	5563	7	RT	RT	NNP
cord-023095-4dannjjm	5563	8	-	-	HYPH
cord-023095-4dannjjm	5563	9	PCR	PCR	NNP
cord-023095-4dannjjm	5563	10	studies	study	NNS
cord-023095-4dannjjm	5563	11	are	be	VBP
cord-023095-4dannjjm	5563	12	needed	need	VBN
cord-023095-4dannjjm	5563	13	to	to	TO
cord-023095-4dannjjm	5563	14	confirm	confirm	VB
cord-023095-4dannjjm	5563	15	these	these	DT
cord-023095-4dannjjm	5563	16	results	result	NNS
cord-023095-4dannjjm	5563	17	before	before	IN
cord-023095-4dannjjm	5563	18	any	any	DT
cord-023095-4dannjjm	5563	19	definitive	definitive	JJ
cord-023095-4dannjjm	5563	20	conclusions	conclusion	NNS
cord-023095-4dannjjm	5563	21	can	can	MD
cord-023095-4dannjjm	5563	22	be	be	VB
cord-023095-4dannjjm	5563	23	drawn	draw	VBN
cord-023095-4dannjjm	5563	24	.	.	.
cord-023095-4dannjjm	5564	1	Idiopathic	idiopathic	JJ
cord-023095-4dannjjm	5564	2	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5564	3	fibrosis	fibrosis	NN
cord-023095-4dannjjm	5564	4	(	(	-LRB-
cord-023095-4dannjjm	5564	5	IPF	IPF	NNP
cord-023095-4dannjjm	5564	6	)	)	-RRB-
cord-023095-4dannjjm	5564	7	is	be	VBZ
cord-023095-4dannjjm	5564	8	an	an	DT
cord-023095-4dannjjm	5564	9	interstitial	interstitial	JJ
cord-023095-4dannjjm	5564	10	disease	disease	NN
cord-023095-4dannjjm	5564	11	,	,	,
cord-023095-4dannjjm	5564	12	mainly	mainly	RB
cord-023095-4dannjjm	5564	13	described	describe	VBN
cord-023095-4dannjjm	5564	14	in	in	IN
cord-023095-4dannjjm	5564	15	West	West	NNP
cord-023095-4dannjjm	5564	16	Highland	Highland	NNP
cord-023095-4dannjjm	5564	17	white	white	JJ
cord-023095-4dannjjm	5564	18	terriers	terrier	NNS
cord-023095-4dannjjm	5564	19	(	(	-LRB-
cord-023095-4dannjjm	5564	20	WHWT	WHWT	NNP
cord-023095-4dannjjm	5564	21	)	)	-RRB-
cord-023095-4dannjjm	5564	22	.	.	.
cord-023095-4dannjjm	5565	1	Defini	Defini	NNP
cord-023095-4dannjjm	5565	2	-	-	HYPH
cord-023095-4dannjjm	5565	3	tive	tive	JJ
cord-023095-4dannjjm	5565	4	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5565	5	ultimately	ultimately	RB
cord-023095-4dannjjm	5565	6	relies	rely	VBZ
cord-023095-4dannjjm	5565	7	on	on	IN
cord-023095-4dannjjm	5565	8	lung	lung	NN
cord-023095-4dannjjm	5565	9	histopathology	histopathology	NN
cord-023095-4dannjjm	5565	10	.	.	.
cord-023095-4dannjjm	5566	1	Identification	identification	NN
cord-023095-4dannjjm	5566	2	of	of	IN
cord-023095-4dannjjm	5566	3	specific	specific	JJ
cord-023095-4dannjjm	5566	4	biomarkers	biomarker	NNS
cord-023095-4dannjjm	5566	5	would	would	MD
cord-023095-4dannjjm	5566	6	be	be	VB
cord-023095-4dannjjm	5566	7	very	very	RB
cord-023095-4dannjjm	5566	8	helpful	helpful	JJ
cord-023095-4dannjjm	5566	9	.	.	.
cord-023095-4dannjjm	5567	1	Expression	expression	NN
cord-023095-4dannjjm	5567	2	microarray	microarray	NN
cord-023095-4dannjjm	5567	3	is	be	VBZ
cord-023095-4dannjjm	5567	4	a	a	DT
cord-023095-4dannjjm	5567	5	powerful	powerful	JJ
cord-023095-4dannjjm	5567	6	screening	screening	NN
cord-023095-4dannjjm	5567	7	tool	tool	NN
cord-023095-4dannjjm	5567	8	to	to	TO
cord-023095-4dannjjm	5567	9	study	study	VB
cord-023095-4dannjjm	5567	10	local	local	JJ
cord-023095-4dannjjm	5567	11	gene	gene	NN
cord-023095-4dannjjm	5567	12	expression	expression	NN
cord-023095-4dannjjm	5567	13	in	in	IN
cord-023095-4dannjjm	5567	14	a	a	DT
cord-023095-4dannjjm	5567	15	disease	disease	NN
cord-023095-4dannjjm	5567	16	state	state	NN
cord-023095-4dannjjm	5567	17	.	.	.
cord-023095-4dannjjm	5568	1	The	the	DT
cord-023095-4dannjjm	5568	2	aim	aim	NN
cord-023095-4dannjjm	5568	3	of	of	IN
cord-023095-4dannjjm	5568	4	the	the	DT
cord-023095-4dannjjm	5568	5	present	present	JJ
cord-023095-4dannjjm	5568	6	study	study	NN
cord-023095-4dannjjm	5568	7	was	be	VBD
cord-023095-4dannjjm	5568	8	to	to	TO
cord-023095-4dannjjm	5568	9	measure	measure	VB
cord-023095-4dannjjm	5568	10	gene	gene	NN
cord-023095-4dannjjm	5568	11	expression	expression	NN
cord-023095-4dannjjm	5568	12	profiles	profile	NNS
cord-023095-4dannjjm	5568	13	in	in	IN
cord-023095-4dannjjm	5568	14	lungs	lung	NNS
cord-023095-4dannjjm	5568	15	of	of	IN
cord-023095-4dannjjm	5568	16	WHWT	whwt	NN
cord-023095-4dannjjm	5568	17	with	with	IN
cord-023095-4dannjjm	5568	18	IPF	IPF	NNP
cord-023095-4dannjjm	5568	19	to	to	TO
cord-023095-4dannjjm	5568	20	identify	identify	VB
cord-023095-4dannjjm	5568	21	potential	potential	JJ
cord-023095-4dannjjm	5568	22	blood	blood	NN
cord-023095-4dannjjm	5568	23	or	or	CC
cord-023095-4dannjjm	5568	24	bronchoalveolar	bronchoalveolar	NNP
cord-023095-4dannjjm	5568	25	lavage	lavage	NN
cord-023095-4dannjjm	5568	26	fluid	fluid	NN
cord-023095-4dannjjm	5568	27	(	(	-LRB-
cord-023095-4dannjjm	5568	28	BALF	BALF	NNP
cord-023095-4dannjjm	5568	29	)	)	-RRB-
cord-023095-4dannjjm	5568	30	biomarkers	biomarker	NNS
cord-023095-4dannjjm	5568	31	.	.	.
cord-023095-4dannjjm	5569	1	Total	Total	NNP
cord-023095-4dannjjm	5569	2	RNA	RNA	NNP
cord-023095-4dannjjm	5569	3	was	be	VBD
cord-023095-4dannjjm	5569	4	extracted	extract	VBN
cord-023095-4dannjjm	5569	5	from	from	IN
cord-023095-4dannjjm	5569	6	post	post	JJ
cord-023095-4dannjjm	5569	7	-	-	JJ
cord-023095-4dannjjm	5569	8	mortem	mortem	JJ
cord-023095-4dannjjm	5569	9	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5569	10	samples	sample	NNS
cord-023095-4dannjjm	5569	11	from	from	IN
cord-023095-4dannjjm	5569	12	five	five	CD
cord-023095-4dannjjm	5569	13	WHWT	WHWT	NNS
cord-023095-4dannjjm	5569	14	with	with	IN
cord-023095-4dannjjm	5569	15	histopathologically	histopathologically	RB
cord-023095-4dannjjm	5569	16	confirmed	confirm	VBN
cord-023095-4dannjjm	5569	17	IPF	IPF	NNP
cord-023095-4dannjjm	5569	18	and	and	CC
cord-023095-4dannjjm	5569	19	five	five	CD
cord-023095-4dannjjm	5569	20	control	control	NN
cord-023095-4dannjjm	5569	21	dogs	dog	NNS
cord-023095-4dannjjm	5569	22	(	(	-LRB-
cord-023095-4dannjjm	5569	23	CTRL	CTRL	NNP
cord-023095-4dannjjm	5569	24	)	)	-RRB-
cord-023095-4dannjjm	5569	25	without	without	IN
cord-023095-4dannjjm	5569	26	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5569	27	disease	disease	NN
cord-023095-4dannjjm	5569	28	.	.	.
cord-023095-4dannjjm	5570	1	The	the	DT
cord-023095-4dannjjm	5570	2	RNA	RNA	NNP
cord-023095-4dannjjm	5570	3	was	be	VBD
cord-023095-4dannjjm	5570	4	pooled	pool	VBN
cord-023095-4dannjjm	5570	5	from	from	IN
cord-023095-4dannjjm	5570	6	each	each	DT
cord-023095-4dannjjm	5570	7	group	group	NN
cord-023095-4dannjjm	5570	8	(	(	-LRB-
cord-023095-4dannjjm	5570	9	IPF	IPF	NNP
cord-023095-4dannjjm	5570	10	and	and	CC
cord-023095-4dannjjm	5570	11	CTRL	CTRL	NNP
cord-023095-4dannjjm	5570	12	)	)	-RRB-
cord-023095-4dannjjm	5570	13	and	and	CC
cord-023095-4dannjjm	5570	14	analysed	analyse	VBD
cord-023095-4dannjjm	5570	15	using	use	VBG
cord-023095-4dannjjm	5570	16	the	the	DT
cord-023095-4dannjjm	5570	17	canine	canine	JJ
cord-023095-4dannjjm	5570	18	specific	specific	JJ
cord-023095-4dannjjm	5570	19	Affymetrix	Affymetrix	NNP
cord-023095-4dannjjm	5570	20	microarray	microarray	NN
cord-023095-4dannjjm	5570	21	technology	technology	NN
cord-023095-4dannjjm	5570	22	.	.	.
cord-023095-4dannjjm	5571	1	IPA	IPA	NNP
cord-023095-4dannjjm	5571	2	-	-	HYPH
cord-023095-4dannjjm	5571	3	Biomarkers	Biomarkers	NNPS
cord-023095-4dannjjm	5571	4	Analysis	Analysis	NNP
cord-023095-4dannjjm	5571	5	(	(	-LRB-
cord-023095-4dannjjm	5571	6	Ingenuity	Ingenuity	NNP
cord-023095-4dannjjm	5571	7	System	System	NNP
cord-023095-4dannjjm	5571	8	)	)	-RRB-
cord-023095-4dannjjm	5571	9	was	be	VBD
cord-023095-4dannjjm	5571	10	used	use	VBN
cord-023095-4dannjjm	5571	11	to	to	TO
cord-023095-4dannjjm	5571	12	filter	filter	VB
cord-023095-4dannjjm	5571	13	and	and	CC
cord-023095-4dannjjm	5571	14	prioritize	prioritize	VB
cord-023095-4dannjjm	5571	15	biomarkers	biomarker	NNS
cord-023095-4dannjjm	5571	16	candidates	candidate	NNS
cord-023095-4dannjjm	5571	17	using	use	VBG
cord-023095-4dannjjm	5571	18	the	the	DT
cord-023095-4dannjjm	5571	19	three	three	CD
cord-023095-4dannjjm	5571	20	following	follow	VBG
cord-023095-4dannjjm	5571	21	criteria	criterion	NNS
cord-023095-4dannjjm	5571	22	:	:	:
cord-023095-4dannjjm	5571	23	a	a	DT
cord-023095-4dannjjm	5571	24	minimum	minimum	NN
cord-023095-4dannjjm	5571	25	of	of	IN
cord-023095-4dannjjm	5571	26	a	a	DT
cord-023095-4dannjjm	5571	27	two	two	CD
cord-023095-4dannjjm	5571	28	-	-	HYPH
cord-023095-4dannjjm	5571	29	fold	fold	JJ
cord-023095-4dannjjm	5571	30	difference	difference	NN
cord-023095-4dannjjm	5571	31	in	in	IN
cord-023095-4dannjjm	5571	32	expression	expression	NN
cord-023095-4dannjjm	5571	33	between	between	IN
cord-023095-4dannjjm	5571	34	IPF	IPF	NNP
cord-023095-4dannjjm	5571	35	and	and	CC
cord-023095-4dannjjm	5571	36	CTRL	ctrl	NN
cord-023095-4dannjjm	5571	37	;	;	:
cord-023095-4dannjjm	5571	38	expression	expression	NN
cord-023095-4dannjjm	5571	39	of	of	IN
cord-023095-4dannjjm	5571	40	the	the	DT
cord-023095-4dannjjm	5571	41	gene	gene	NN
cord-023095-4dannjjm	5571	42	in	in	IN
cord-023095-4dannjjm	5571	43	lung	lung	NN
cord-023095-4dannjjm	5571	44	tissue	tissue	NN
cord-023095-4dannjjm	5571	45	;	;	:
cord-023095-4dannjjm	5571	46	possible	possible	JJ
cord-023095-4dannjjm	5571	47	detection	detection	NN
cord-023095-4dannjjm	5571	48	of	of	IN
cord-023095-4dannjjm	5571	49	the	the	DT
cord-023095-4dannjjm	5571	50	protein	protein	NN
cord-023095-4dannjjm	5571	51	in	in	IN
cord-023095-4dannjjm	5571	52	blood	blood	NN
cord-023095-4dannjjm	5571	53	or	or	CC
cord-023095-4dannjjm	5571	54	in	in	IN
cord-023095-4dannjjm	5571	55	BALF	BALF	NNP
cord-023095-4dannjjm	5571	56	.	.	.
cord-023095-4dannjjm	5572	1	Fifty	fifty	CD
cord-023095-4dannjjm	5572	2	-	-	HYPH
cord-023095-4dannjjm	5572	3	four	four	CD
cord-023095-4dannjjm	5572	4	molecules	molecule	NNS
cord-023095-4dannjjm	5572	5	met	meet	VBD
cord-023095-4dannjjm	5572	6	all	all	PDT
cord-023095-4dannjjm	5572	7	the	the	DT
cord-023095-4dannjjm	5572	8	criteria	criterion	NNS
cord-023095-4dannjjm	5572	9	.	.	.
cord-023095-4dannjjm	5573	1	Based	base	VBN
cord-023095-4dannjjm	5573	2	on	on	IN
cord-023095-4dannjjm	5573	3	difference	difference	NN
cord-023095-4dannjjm	5573	4	in	in	IN
cord-023095-4dannjjm	5573	5	expression	expression	NN
cord-023095-4dannjjm	5573	6	,	,	,
cord-023095-4dannjjm	5573	7	promising	promise	VBG
cord-023095-4dannjjm	5573	8	proteins	protein	NNS
cord-023095-4dannjjm	5573	9	included	include	VBD
cord-023095-4dannjjm	5573	10	CCL7	CCL7	NNP
cord-023095-4dannjjm	5573	11	(	(	-LRB-
cord-023095-4dannjjm	5573	12	fold	fold	VB
cord-023095-4dannjjm	5573	13	change	change	NN
cord-023095-4dannjjm	5573	14	17.8	17.8	CD
cord-023095-4dannjjm	5573	15	)	)	-RRB-
cord-023095-4dannjjm	5573	16	,	,	,
cord-023095-4dannjjm	5573	17	a3-Actinin	a3-Actinin	NNP
cord-023095-4dannjjm	5573	18	(	(	-LRB-
cord-023095-4dannjjm	5573	19	15.7	15.7	CD
cord-023095-4dannjjm	5573	20	)	)	-RRB-
cord-023095-4dannjjm	5573	21	,	,	,
cord-023095-4dannjjm	5573	22	CCL2	CCL2	NNP
cord-023095-4dannjjm	5573	23	(	(	-LRB-
cord-023095-4dannjjm	5573	24	14.9	14.9	CD
cord-023095-4dannjjm	5573	25	)	)	-RRB-
cord-023095-4dannjjm	5573	26	,	,	,
cord-023095-4dannjjm	5573	27	Serum	Serum	NNP
cord-023095-4dannjjm	5573	28	Amyloid	Amyloid	NNP
cord-023095-4dannjjm	5573	29	A1	A1	NNP
cord-023095-4dannjjm	5573	30	(	(	-LRB-
cord-023095-4dannjjm	5573	31	14.4	14.4	CD
cord-023095-4dannjjm	5573	32	)	)	-RRB-
cord-023095-4dannjjm	5573	33	,	,	,
cord-023095-4dannjjm	5573	34	IL8	IL8	NNP
cord-023095-4dannjjm	5573	35	(	(	-LRB-
cord-023095-4dannjjm	5573	36	14.3	14.3	CD
cord-023095-4dannjjm	5573	37	)	)	-RRB-
cord-023095-4dannjjm	5573	38	,	,	,
cord-023095-4dannjjm	5573	39	PLUNC	PLUNC	NNP
cord-023095-4dannjjm	5573	40	(	(	-LRB-
cord-023095-4dannjjm	5573	41	À25.1	à25.1	CD
cord-023095-4dannjjm	5573	42	)	)	-RRB-
cord-023095-4dannjjm	5573	43	,	,	,
cord-023095-4dannjjm	5573	44	MMP7	MMP7	NNP
cord-023095-4dannjjm	5573	45	(	(	-LRB-
cord-023095-4dannjjm	5573	46	À17.6	à17.6	CD
cord-023095-4dannjjm	5573	47	)	)	-RRB-
cord-023095-4dannjjm	5573	48	.	.	.
cord-023095-4dannjjm	5574	1	Some	some	DT
cord-023095-4dannjjm	5574	2	are	be	VBP
cord-023095-4dannjjm	5574	3	well	well	RB
cord-023095-4dannjjm	5574	4	-	-	HYPH
cord-023095-4dannjjm	5574	5	known	know	VBN
cord-023095-4dannjjm	5574	6	biomarkers	biomarker	NNS
cord-023095-4dannjjm	5574	7	of	of	IN
cord-023095-4dannjjm	5574	8	IPF	IPF	NNP
cord-023095-4dannjjm	5574	9	in	in	IN
cord-023095-4dannjjm	5574	10	humans	human	NNS
cord-023095-4dannjjm	5574	11	either	either	CC
cord-023095-4dannjjm	5574	12	for	for	IN
cord-023095-4dannjjm	5574	13	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5574	14	(	(	-LRB-
cord-023095-4dannjjm	5574	15	MMP7	MMP7	NNP
cord-023095-4dannjjm	5574	16	,	,	,
cord-023095-4dannjjm	5574	17	IL8	il8	NN
cord-023095-4dannjjm	5574	18	)	)	-RRB-
cord-023095-4dannjjm	5574	19	or	or	CC
cord-023095-4dannjjm	5574	20	prognosis	prognosis	NN
cord-023095-4dannjjm	5574	21	(	(	-LRB-
cord-023095-4dannjjm	5574	22	CCL2	CCL2	NNP
cord-023095-4dannjjm	5574	23	)	)	-RRB-
cord-023095-4dannjjm	5574	24	.	.	.
cord-023095-4dannjjm	5575	1	These	these	DT
cord-023095-4dannjjm	5575	2	results	result	NNS
cord-023095-4dannjjm	5575	3	provide	provide	VBP
cord-023095-4dannjjm	5575	4	novel	novel	JJ
cord-023095-4dannjjm	5575	5	potential	potential	JJ
cord-023095-4dannjjm	5575	6	biomarkers	biomarker	NNS
cord-023095-4dannjjm	5575	7	of	of	IN
cord-023095-4dannjjm	5575	8	canine	canine	JJ
cord-023095-4dannjjm	5575	9	IPF	IPF	NNP
cord-023095-4dannjjm	5575	10	.	.	.
cord-023095-4dannjjm	5576	1	Measurement	measurement	NN
cord-023095-4dannjjm	5576	2	of	of	IN
cord-023095-4dannjjm	5576	3	these	these	DT
cord-023095-4dannjjm	5576	4	proteins	protein	NNS
cord-023095-4dannjjm	5576	5	in	in	IN
cord-023095-4dannjjm	5576	6	blood	blood	NN
cord-023095-4dannjjm	5576	7	and	and	CC
cord-023095-4dannjjm	5576	8	BALF	BALF	NNP
cord-023095-4dannjjm	5576	9	of	of	IN
cord-023095-4dannjjm	5576	10	healthy	healthy	JJ
cord-023095-4dannjjm	5576	11	dogs	dog	NNS
cord-023095-4dannjjm	5576	12	,	,	,
cord-023095-4dannjjm	5576	13	dogs	dog	NNS
cord-023095-4dannjjm	5576	14	with	with	IN
cord-023095-4dannjjm	5576	15	IPF	IPF	NNP
cord-023095-4dannjjm	5576	16	and	and	CC
cord-023095-4dannjjm	5576	17	with	with	IN
cord-023095-4dannjjm	5576	18	other	other	JJ
cord-023095-4dannjjm	5576	19	respiratory	respiratory	JJ
cord-023095-4dannjjm	5576	20	diseases	disease	NNS
cord-023095-4dannjjm	5576	21	is	be	VBZ
cord-023095-4dannjjm	5576	22	needed	need	VBN
cord-023095-4dannjjm	5576	23	to	to	TO
cord-023095-4dannjjm	5576	24	assess	assess	VB
cord-023095-4dannjjm	5576	25	their	-PRON-	PRP$
cord-023095-4dannjjm	5576	26	use	use	NN
cord-023095-4dannjjm	5576	27	as	as	IN
cord-023095-4dannjjm	5576	28	biomarkers	biomarker	NNS
cord-023095-4dannjjm	5576	29	of	of	IN
cord-023095-4dannjjm	5576	30	canine	canine	JJ
cord-023095-4dannjjm	5576	31	IPF	IPF	NNP
cord-023095-4dannjjm	5576	32	.	.	.
cord-023095-4dannjjm	5577	1	Heliox	Heliox	NNP
cord-023095-4dannjjm	5577	2	is	be	VBZ
cord-023095-4dannjjm	5577	3	a	a	DT
cord-023095-4dannjjm	5577	4	mixture	mixture	NN
cord-023095-4dannjjm	5577	5	of	of	IN
cord-023095-4dannjjm	5577	6	helium	helium	NN
cord-023095-4dannjjm	5577	7	and	and	CC
cord-023095-4dannjjm	5577	8	oxygen	oxygen	NN
cord-023095-4dannjjm	5577	9	that	that	WDT
cord-023095-4dannjjm	5577	10	has	have	VBZ
cord-023095-4dannjjm	5577	11	been	be	VBN
cord-023095-4dannjjm	5577	12	used	use	VBN
cord-023095-4dannjjm	5577	13	therapeutically	therapeutically	RB
cord-023095-4dannjjm	5577	14	in	in	IN
cord-023095-4dannjjm	5577	15	human	human	JJ
cord-023095-4dannjjm	5577	16	medicine	medicine	NN
cord-023095-4dannjjm	5577	17	for	for	IN
cord-023095-4dannjjm	5577	18	treatment	treatment	NN
cord-023095-4dannjjm	5577	19	of	of	IN
cord-023095-4dannjjm	5577	20	airway	airway	JJ
cord-023095-4dannjjm	5577	21	obstruction	obstruction	NN
cord-023095-4dannjjm	5577	22	.	.	.
cord-023095-4dannjjm	5578	1	Helium	helium	NN
cord-023095-4dannjjm	5578	2	's	's	POS
cord-023095-4dannjjm	5578	3	low	low	JJ
cord-023095-4dannjjm	5578	4	density	density	NN
cord-023095-4dannjjm	5578	5	and	and	CC
cord-023095-4dannjjm	5578	6	other	other	JJ
cord-023095-4dannjjm	5578	7	physical	physical	JJ
cord-023095-4dannjjm	5578	8	properties	property	NNS
cord-023095-4dannjjm	5578	9	have	have	VBP
cord-023095-4dannjjm	5578	10	been	be	VBN
cord-023095-4dannjjm	5578	11	shown	show	VBN
cord-023095-4dannjjm	5578	12	to	to	TO
cord-023095-4dannjjm	5578	13	reduce	reduce	VB
cord-023095-4dannjjm	5578	14	the	the	DT
cord-023095-4dannjjm	5578	15	work	work	NN
cord-023095-4dannjjm	5578	16	of	of	IN
cord-023095-4dannjjm	5578	17	breathing	breathe	VBG
cord-023095-4dannjjm	5578	18	by	by	IN
cord-023095-4dannjjm	5578	19	limiting	limit	VBG
cord-023095-4dannjjm	5578	20	turbulence	turbulence	NN
cord-023095-4dannjjm	5578	21	.	.	.
cord-023095-4dannjjm	5579	1	The	the	DT
cord-023095-4dannjjm	5579	2	purpose	purpose	NN
cord-023095-4dannjjm	5579	3	of	of	IN
cord-023095-4dannjjm	5579	4	this	this	DT
cord-023095-4dannjjm	5579	5	study	study	NN
cord-023095-4dannjjm	5579	6	was	be	VBD
cord-023095-4dannjjm	5579	7	,	,	,
cord-023095-4dannjjm	5579	8	therefore	therefore	RB
cord-023095-4dannjjm	5579	9	,	,	,
cord-023095-4dannjjm	5579	10	to	to	TO
cord-023095-4dannjjm	5579	11	evaluate	evaluate	VB
cord-023095-4dannjjm	5579	12	respiratory	respiratory	JJ
cord-023095-4dannjjm	5579	13	parameters	parameter	NNS
cord-023095-4dannjjm	5579	14	in	in	IN
cord-023095-4dannjjm	5579	15	response	response	NN
cord-023095-4dannjjm	5579	16	to	to	IN
cord-023095-4dannjjm	5579	17	inhaled	inhale	VBN
cord-023095-4dannjjm	5579	18	heliox	heliox	NN
cord-023095-4dannjjm	5579	19	in	in	IN
cord-023095-4dannjjm	5579	20	dogs	dog	NNS
cord-023095-4dannjjm	5579	21	with	with	IN
cord-023095-4dannjjm	5579	22	meso	meso	NNP
cord-023095-4dannjjm	5579	23	-	-	HYPH
cord-023095-4dannjjm	5579	24	and	and	CC
cord-023095-4dannjjm	5579	25	brachycephalic	brachycephalic	JJ
cord-023095-4dannjjm	5579	26	conformation	conformation	NN
cord-023095-4dannjjm	5579	27	.	.	.
cord-023095-4dannjjm	5580	1	Eleven	eleven	CD
cord-023095-4dannjjm	5580	2	healthy	healthy	JJ
cord-023095-4dannjjm	5580	3	dogs	dog	NNS
cord-023095-4dannjjm	5580	4	were	be	VBD
cord-023095-4dannjjm	5580	5	recruited	recruit	VBN
cord-023095-4dannjjm	5580	6	,	,	,
cord-023095-4dannjjm	5580	7	five	five	CD
cord-023095-4dannjjm	5580	8	were	be	VBD
cord-023095-4dannjjm	5580	9	mesocephalic	mesocephalic	JJ
cord-023095-4dannjjm	5580	10	and	and	CC
cord-023095-4dannjjm	5580	11	six	six	CD
cord-023095-4dannjjm	5580	12	were	be	VBD
cord-023095-4dannjjm	5580	13	brachycephalic	brachycephalic	JJ
cord-023095-4dannjjm	5580	14	.	.	.
cord-023095-4dannjjm	5581	1	Flow	flow	NN
cord-023095-4dannjjm	5581	2	-	-	HYPH
cord-023095-4dannjjm	5581	3	volume	volume	NN
cord-023095-4dannjjm	5581	4	loops	loop	NNS
cord-023095-4dannjjm	5581	5	were	be	VBD
cord-023095-4dannjjm	5581	6	collected	collect	VBN
cord-023095-4dannjjm	5581	7	using	use	VBG
cord-023095-4dannjjm	5581	8	commercial	commercial	JJ
cord-023095-4dannjjm	5581	9	software	software	NN
cord-023095-4dannjjm	5581	10	(	(	-LRB-
cord-023095-4dannjjm	5581	11	Buxcor	Buxcor	NNP
cord-023095-4dannjjm	5581	12	)	)	-RRB-
cord-023095-4dannjjm	5581	13	while	while	IN
cord-023095-4dannjjm	5581	14	breathing	breathe	VBG
cord-023095-4dannjjm	5581	15	70:30	70:30	NNP
cord-023095-4dannjjm	5581	16	Helium	Helium	NNP
cord-023095-4dannjjm	5581	17	:	:	:
cord-023095-4dannjjm	5581	18	oxygen	oxygen	NN
cord-023095-4dannjjm	5581	19	(	(	-LRB-
cord-023095-4dannjjm	5581	20	Heliox	Heliox	NNP
cord-023095-4dannjjm	5581	21	)	)	-RRB-
cord-023095-4dannjjm	5581	22	and	and	CC
cord-023095-4dannjjm	5581	23	70:30	70:30	CD
cord-023095-4dannjjm	5581	24	Nitrogen	nitrogen	NN
cord-023095-4dannjjm	5581	25	:	:	:
cord-023095-4dannjjm	5581	26	oxygen	oxygen	NN
cord-023095-4dannjjm	5581	27	(	(	-LRB-
cord-023095-4dannjjm	5581	28	Nitrox	Nitrox	NNP
cord-023095-4dannjjm	5581	29	)	)	-RRB-
cord-023095-4dannjjm	5581	30	in	in	IN
cord-023095-4dannjjm	5581	31	a	a	DT
cord-023095-4dannjjm	5581	32	randomized	randomized	JJ
cord-023095-4dannjjm	5581	33	order	order	NN
cord-023095-4dannjjm	5581	34	via	via	IN
cord-023095-4dannjjm	5581	35	a	a	DT
cord-023095-4dannjjm	5581	36	low	low	JJ
cord-023095-4dannjjm	5581	37	dead	dead	JJ
cord-023095-4dannjjm	5581	38	-	-	HYPH
cord-023095-4dannjjm	5581	39	space	space	NN
cord-023095-4dannjjm	5581	40	face	face	NN
cord-023095-4dannjjm	5581	41	mask	mask	NN
cord-023095-4dannjjm	5581	42	.	.	.
cord-023095-4dannjjm	5582	1	Due	due	IN
cord-023095-4dannjjm	5582	2	to	to	IN
cord-023095-4dannjjm	5582	3	the	the	DT
cord-023095-4dannjjm	5582	4	intrinsic	intrinsic	JJ
cord-023095-4dannjjm	5582	5	gas	gas	NN
cord-023095-4dannjjm	5582	6	properties	property	NNS
cord-023095-4dannjjm	5582	7	,	,	,
cord-023095-4dannjjm	5582	8	gas	gas	NN
cord-023095-4dannjjm	5582	9	flow	flow	NN
cord-023095-4dannjjm	5582	10	rates	rate	NNS
cord-023095-4dannjjm	5582	11	and	and	CC
cord-023095-4dannjjm	5582	12	volumes	volume	NNS
cord-023095-4dannjjm	5582	13	were	be	VBD
cord-023095-4dannjjm	5582	14	corrected	correct	VBN
cord-023095-4dannjjm	5582	15	in	in	IN
cord-023095-4dannjjm	5582	16	-	-	HYPH
cord-023095-4dannjjm	5582	17	vitro	vitro	FW
cord-023095-4dannjjm	5582	18	by	by	IN
cord-023095-4dannjjm	5582	19	a	a	DT
cord-023095-4dannjjm	5582	20	conversion	conversion	NN
cord-023095-4dannjjm	5582	21	factor	factor	NN
cord-023095-4dannjjm	5582	22	for	for	IN
cord-023095-4dannjjm	5582	23	the	the	DT
cord-023095-4dannjjm	5582	24	effect	effect	NN
cord-023095-4dannjjm	5582	25	of	of	IN
cord-023095-4dannjjm	5582	26	helium	helium	NN
cord-023095-4dannjjm	5582	27	on	on	IN
cord-023095-4dannjjm	5582	28	the	the	DT
cord-023095-4dannjjm	5582	29	pneumotachograph	pneumotachograph	NN
cord-023095-4dannjjm	5582	30	.	.	.
cord-023095-4dannjjm	5583	1	Respiratory	respiratory	JJ
cord-023095-4dannjjm	5583	2	rate	rate	NN
cord-023095-4dannjjm	5583	3	,	,	,
cord-023095-4dannjjm	5583	4	tidal	tidal	JJ
cord-023095-4dannjjm	5583	5	volume	volume	NN
cord-023095-4dannjjm	5583	6	(	(	-LRB-
cord-023095-4dannjjm	5583	7	ml	ml	NN
cord-023095-4dannjjm	5583	8	)	)	-RRB-
cord-023095-4dannjjm	5583	9	,	,	,
cord-023095-4dannjjm	5583	10	minute	minute	NN
cord-023095-4dannjjm	5583	11	ventilation	ventilation	NN
cord-023095-4dannjjm	5583	12	(	(	-LRB-
cord-023095-4dannjjm	5583	13	L	L	NNP
cord-023095-4dannjjm	5583	14	)	)	-RRB-
cord-023095-4dannjjm	5583	15	,	,	,
cord-023095-4dannjjm	5583	16	inspiratory	inspiratory	JJ
cord-023095-4dannjjm	5583	17	time	time	NN
cord-023095-4dannjjm	5583	18	(	(	-LRB-
cord-023095-4dannjjm	5583	19	Ti	Ti	NNP
cord-023095-4dannjjm	5583	20	)	)	-RRB-
cord-023095-4dannjjm	5583	21	,	,	,
cord-023095-4dannjjm	5583	22	expiratory	expiratory	JJ
cord-023095-4dannjjm	5583	23	time	time	NN
cord-023095-4dannjjm	5583	24	(	(	-LRB-
cord-023095-4dannjjm	5583	25	Te	Te	NNP
cord-023095-4dannjjm	5583	26	)	)	-RRB-
cord-023095-4dannjjm	5583	27	,	,	,
cord-023095-4dannjjm	5583	28	peak	peak	JJ
cord-023095-4dannjjm	5583	29	inspiratory	inspiratory	JJ
cord-023095-4dannjjm	5583	30	flow	flow	NN
cord-023095-4dannjjm	5583	31	(	(	-LRB-
cord-023095-4dannjjm	5583	32	PIF	PIF	NNP
cord-023095-4dannjjm	5583	33	)	)	-RRB-
cord-023095-4dannjjm	5583	34	and	and	CC
cord-023095-4dannjjm	5583	35	peak	peak	NN
cord-023095-4dannjjm	5583	36	expiratory	expiratory	JJ
cord-023095-4dannjjm	5583	37	flow	flow	NN
cord-023095-4dannjjm	5583	38	(	(	-LRB-
cord-023095-4dannjjm	5583	39	PEF	PEF	NNP
cord-023095-4dannjjm	5583	40	)	)	-RRB-
cord-023095-4dannjjm	5583	41	were	be	VBD
cord-023095-4dannjjm	5583	42	recorded	record	VBN
cord-023095-4dannjjm	5583	43	while	while	IN
cord-023095-4dannjjm	5583	44	breathing	breathe	VBG
cord-023095-4dannjjm	5583	45	heliox	heliox	NNS
cord-023095-4dannjjm	5583	46	or	or	CC
cord-023095-4dannjjm	5583	47	nitrox	nitrox	NN
cord-023095-4dannjjm	5583	48	.	.	.
cord-023095-4dannjjm	5584	1	Values	value	NNS
cord-023095-4dannjjm	5584	2	were	be	VBD
cord-023095-4dannjjm	5584	3	compared	compare	VBN
cord-023095-4dannjjm	5584	4	using	use	VBG
cord-023095-4dannjjm	5584	5	a	a	DT
cord-023095-4dannjjm	5584	6	paired	pair	VBN
cord-023095-4dannjjm	5584	7	sample	sample	NN
cord-023095-4dannjjm	5584	8	t	t	NN
cord-023095-4dannjjm	5584	9	-	-	HYPH
cord-023095-4dannjjm	5584	10	test	test	NN
cord-023095-4dannjjm	5584	11	,	,	,
cord-023095-4dannjjm	5584	12	with	with	IN
cord-023095-4dannjjm	5584	13	P	p	NN
cord-023095-4dannjjm	5584	14	o	o	NN
cord-023095-4dannjjm	5584	15	0.05	0.05	CD
cord-023095-4dannjjm	5584	16	considered	consider	VBN
cord-023095-4dannjjm	5584	17	significant	significant	JJ
cord-023095-4dannjjm	5584	18	.	.	.
cord-023095-4dannjjm	5585	1	All	all	DT
cord-023095-4dannjjm	5585	2	dogs	dog	NNS
cord-023095-4dannjjm	5585	3	cooperated	cooperate	VBD
cord-023095-4dannjjm	5585	4	with	with	IN
cord-023095-4dannjjm	5585	5	testing	testing	NN
cord-023095-4dannjjm	5585	6	.	.	.
cord-023095-4dannjjm	5586	1	There	there	EX
cord-023095-4dannjjm	5586	2	was	be	VBD
cord-023095-4dannjjm	5586	3	no	no	DT
cord-023095-4dannjjm	5586	4	significant	significant	JJ
cord-023095-4dannjjm	5586	5	difference	difference	NN
cord-023095-4dannjjm	5586	6	in	in	IN
cord-023095-4dannjjm	5586	7	respiratory	respiratory	JJ
cord-023095-4dannjjm	5586	8	rate	rate	NN
cord-023095-4dannjjm	5586	9	,	,	,
cord-023095-4dannjjm	5586	10	tidal	tidal	JJ
cord-023095-4dannjjm	5586	11	volume	volume	NN
cord-023095-4dannjjm	5586	12	,	,	,
cord-023095-4dannjjm	5586	13	minute	minute	NN
cord-023095-4dannjjm	5586	14	ventilation	ventilation	NN
cord-023095-4dannjjm	5586	15	,	,	,
cord-023095-4dannjjm	5586	16	inspiratory	inspiratory	JJ
cord-023095-4dannjjm	5586	17	or	or	CC
cord-023095-4dannjjm	5586	18	expiratory	expiratory	JJ
cord-023095-4dannjjm	5586	19	times	time	NNS
cord-023095-4dannjjm	5586	20	,	,	,
cord-023095-4dannjjm	5586	21	or	or	CC
cord-023095-4dannjjm	5586	22	peak	peak	JJ
cord-023095-4dannjjm	5586	23	inspiratory	inspiratory	JJ
cord-023095-4dannjjm	5586	24	flow	flow	NN
cord-023095-4dannjjm	5586	25	.	.	.
cord-023095-4dannjjm	5587	1	Peak	Peak	NNP
cord-023095-4dannjjm	5587	2	expiratory	expiratory	JJ
cord-023095-4dannjjm	5587	3	flow	flow	NN
cord-023095-4dannjjm	5587	4	was	be	VBD
cord-023095-4dannjjm	5587	5	significantly	significantly	RB
cord-023095-4dannjjm	5587	6	higher	high	JJR
cord-023095-4dannjjm	5587	7	(	(	-LRB-
cord-023095-4dannjjm	5587	8	P	p	NN
cord-023095-4dannjjm	5587	9	5	5	CD
cord-023095-4dannjjm	5587	10	0.01	0.01	CD
cord-023095-4dannjjm	5587	11	)	)	-RRB-
cord-023095-4dannjjm	5587	12	while	while	IN
cord-023095-4dannjjm	5587	13	breathing	breathe	VBG
cord-023095-4dannjjm	5587	14	heliox	heliox	NNS
cord-023095-4dannjjm	5587	15	than	than	IN
cord-023095-4dannjjm	5587	16	when	when	WRB
cord-023095-4dannjjm	5587	17	breathing	breathe	VBG
cord-023095-4dannjjm	5587	18	nitrox	nitrox	NN
cord-023095-4dannjjm	5587	19	in	in	IN
cord-023095-4dannjjm	5587	20	brachycephalics	brachycephalic	NNS
cord-023095-4dannjjm	5587	21	but	but	CC
cord-023095-4dannjjm	5587	22	not	not	RB
cord-023095-4dannjjm	5587	23	in	in	IN
cord-023095-4dannjjm	5587	24	mesocephalics	mesocephalic	NNS
cord-023095-4dannjjm	5587	25	(	(	-LRB-
cord-023095-4dannjjm	5587	26	P	p	NN
cord-023095-4dannjjm	5587	27	5	5	CD
cord-023095-4dannjjm	5587	28	0.22	0.22	CD
cord-023095-4dannjjm	5587	29	)	)	-RRB-
cord-023095-4dannjjm	5587	30	.	.	.
cord-023095-4dannjjm	5588	1	Heliox	Heliox	NNP
cord-023095-4dannjjm	5588	2	is	be	VBZ
cord-023095-4dannjjm	5588	3	well	well	RB
cord-023095-4dannjjm	5588	4	-	-	HYPH
cord-023095-4dannjjm	5588	5	tolerated	tolerate	VBN
cord-023095-4dannjjm	5588	6	in	in	IN
cord-023095-4dannjjm	5588	7	healthy	healthy	JJ
cord-023095-4dannjjm	5588	8	dogs	dog	NNS
cord-023095-4dannjjm	5588	9	and	and	CC
cord-023095-4dannjjm	5588	10	results	result	NNS
cord-023095-4dannjjm	5588	11	in	in	IN
cord-023095-4dannjjm	5588	12	an	an	DT
cord-023095-4dannjjm	5588	13	increased	increase	VBN
cord-023095-4dannjjm	5588	14	expiratory	expiratory	JJ
cord-023095-4dannjjm	5588	15	flow	flow	NN
cord-023095-4dannjjm	5588	16	rate	rate	NN
cord-023095-4dannjjm	5588	17	in	in	IN
cord-023095-4dannjjm	5588	18	brachycephalic	brachycephalic	JJ
cord-023095-4dannjjm	5588	19	dogs	dog	NNS
cord-023095-4dannjjm	5588	20	.	.	.
cord-023095-4dannjjm	5589	1	Further	further	JJ
cord-023095-4dannjjm	5589	2	investigation	investigation	NN
cord-023095-4dannjjm	5589	3	of	of	IN
cord-023095-4dannjjm	5589	4	heliox	heliox	NNP
cord-023095-4dannjjm	5589	5	is	be	VBZ
cord-023095-4dannjjm	5589	6	warranted	warrant	VBN
cord-023095-4dannjjm	5589	7	in	in	IN
cord-023095-4dannjjm	5589	8	dogs	dog	NNS
cord-023095-4dannjjm	5589	9	with	with	IN
cord-023095-4dannjjm	5589	10	airway	airway	JJ
cord-023095-4dannjjm	5589	11	obstruction	obstruction	NN
cord-023095-4dannjjm	5589	12	.	.	.
cord-023095-4dannjjm	5590	1	of	of	IN
cord-023095-4dannjjm	5590	2	this	this	DT
cord-023095-4dannjjm	5590	3	prospective	prospective	JJ
cord-023095-4dannjjm	5590	4	multicentric	multicentric	JJ
cord-023095-4dannjjm	5590	5	study	study	NN
cord-023095-4dannjjm	5590	6	is	be	VBZ
cord-023095-4dannjjm	5590	7	to	to	TO
cord-023095-4dannjjm	5590	8	assess	assess	VB
cord-023095-4dannjjm	5590	9	the	the	DT
cord-023095-4dannjjm	5590	10	effects	effect	NNS
cord-023095-4dannjjm	5590	11	that	that	WDT
cord-023095-4dannjjm	5590	12	surgical	surgical	JJ
cord-023095-4dannjjm	5590	13	correction	correction	NN
cord-023095-4dannjjm	5590	14	has	have	VBZ
cord-023095-4dannjjm	5590	15	on	on	IN
cord-023095-4dannjjm	5590	16	the	the	DT
cord-023095-4dannjjm	5590	17	severity	severity	NN
cord-023095-4dannjjm	5590	18	of	of	IN
cord-023095-4dannjjm	5590	19	clinical	clinical	JJ
cord-023095-4dannjjm	5590	20	signs	sign	NNS
cord-023095-4dannjjm	5590	21	and	and	CC
cord-023095-4dannjjm	5590	22	levels	level	NNS
cord-023095-4dannjjm	5590	23	of	of	IN
cord-023095-4dannjjm	5590	24	acute	acute	JJ
cord-023095-4dannjjm	5590	25	phase	phase	NN
cord-023095-4dannjjm	5590	26	proteins	protein	NNS
cord-023095-4dannjjm	5590	27	(	(	-LRB-
cord-023095-4dannjjm	5590	28	C	c	NN
cord-023095-4dannjjm	5590	29	-	-	HYPH
cord-023095-4dannjjm	5590	30	reactive	reactive	JJ
cord-023095-4dannjjm	5590	31	protein	protein	NN
cord-023095-4dannjjm	5590	32	[	[	-LRB-
cord-023095-4dannjjm	5590	33	CRP	CRP	NNP
cord-023095-4dannjjm	5590	34	]	]	-RRB-
cord-023095-4dannjjm	5590	35	,	,	,
cord-023095-4dannjjm	5590	36	Haptoglobin	Haptoglobin	NNP
cord-023095-4dannjjm	5590	37	[	[	-LRB-
cord-023095-4dannjjm	5590	38	Hp	Hp	NNP
cord-023095-4dannjjm	5590	39	]	]	-RRB-
cord-023095-4dannjjm	5590	40	)	)	-RRB-
cord-023095-4dannjjm	5590	41	and	and	CC
cord-023095-4dannjjm	5590	42	cardiac	cardiac	JJ
cord-023095-4dannjjm	5590	43	troponin	troponin	NN
cord-023095-4dannjjm	5591	1	I	-PRON-	PRP
cord-023095-4dannjjm	5591	2	(	(	-LRB-
cord-023095-4dannjjm	5591	3	cTnI	cTnI	NNP
cord-023095-4dannjjm	5591	4	)	)	-RRB-
cord-023095-4dannjjm	5591	5	.	.	.
cord-023095-4dannjjm	5592	1	Thirty	thirty	CD
cord-023095-4dannjjm	5592	2	three	three	CD
cord-023095-4dannjjm	5592	3	brachycephalic	brachycephalic	JJ
cord-023095-4dannjjm	5592	4	dogs	dog	NNS
cord-023095-4dannjjm	5592	5	with	with	IN
cord-023095-4dannjjm	5592	6	BOAS	boa	NNS
cord-023095-4dannjjm	5592	7	were	be	VBD
cord-023095-4dannjjm	5592	8	included	include	VBN
cord-023095-4dannjjm	5592	9	and	and	CC
cord-023095-4dannjjm	5592	10	evaluated	evaluate	VBN
cord-023095-4dannjjm	5592	11	before	before	RB
cord-023095-4dannjjm	5592	12	and	and	CC
cord-023095-4dannjjm	5592	13	,	,	,
cord-023095-4dannjjm	5592	14	approximately	approximately	RB
cord-023095-4dannjjm	5592	15	two	two	CD
cord-023095-4dannjjm	5592	16	months	month	NNS
cord-023095-4dannjjm	5592	17	,	,	,
cord-023095-4dannjjm	5592	18	after	after	IN
cord-023095-4dannjjm	5592	19	surgical	surgical	JJ
cord-023095-4dannjjm	5592	20	correction	correction	NN
cord-023095-4dannjjm	5592	21	.	.	.
cord-023095-4dannjjm	5593	1	The	the	DT
cord-023095-4dannjjm	5593	2	most	most	RBS
cord-023095-4dannjjm	5593	3	common	common	JJ
cord-023095-4dannjjm	5593	4	components	component	NNS
cord-023095-4dannjjm	5593	5	of	of	IN
cord-023095-4dannjjm	5593	6	BOAS	boa	NNS
cord-023095-4dannjjm	5593	7	found	find	VBN
cord-023095-4dannjjm	5593	8	were	be	VBD
cord-023095-4dannjjm	5593	9	elongated	elongated	JJ
cord-023095-4dannjjm	5593	10	soft	soft	JJ
cord-023095-4dannjjm	5593	11	palate	palate	NN
cord-023095-4dannjjm	5593	12	(	(	-LRB-
cord-023095-4dannjjm	5593	13	33/33	33/33	CD
cord-023095-4dannjjm	5593	14	;	;	:
cord-023095-4dannjjm	5593	15	100	100	CD
cord-023095-4dannjjm	5593	16	%	%	NN
cord-023095-4dannjjm	5593	17	)	)	-RRB-
cord-023095-4dannjjm	5593	18	,	,	,
cord-023095-4dannjjm	5593	19	stenotic	stenotic	JJ
cord-023095-4dannjjm	5593	20	nares	nares	NNP
cord-023095-4dannjjm	5593	21	(	(	-LRB-
cord-023095-4dannjjm	5593	22	31/33	31/33	CD
cord-023095-4dannjjm	5593	23	;	;	:
cord-023095-4dannjjm	5593	24	94	94	CD
cord-023095-4dannjjm	5593	25	%	%	NN
cord-023095-4dannjjm	5593	26	)	)	-RRB-
cord-023095-4dannjjm	5593	27	and	and	CC
cord-023095-4dannjjm	5593	28	everted	everted	JJ
cord-023095-4dannjjm	5593	29	laryngeal	laryngeal	NN
cord-023095-4dannjjm	5593	30	saccules	saccule	NNS
cord-023095-4dannjjm	5593	31	(	(	-LRB-
cord-023095-4dannjjm	5593	32	13/33	13/33	CD
cord-023095-4dannjjm	5593	33	;	;	:
cord-023095-4dannjjm	5593	34	39.4	39.4	CD
cord-023095-4dannjjm	5593	35	%	%	NN
cord-023095-4dannjjm	5593	36	)	)	-RRB-
cord-023095-4dannjjm	5593	37	.	.	.
cord-023095-4dannjjm	5594	1	Staphylectomy	Staphylectomy	NNP
cord-023095-4dannjjm	5594	2	was	be	VBD
cord-023095-4dannjjm	5594	3	performed	perform	VBN
cord-023095-4dannjjm	5594	4	by	by	IN
cord-023095-4dannjjm	5594	5	means	mean	NNS
cord-023095-4dannjjm	5594	6	of	of	IN
cord-023095-4dannjjm	5594	7	two	two	CD
cord-023095-4dannjjm	5594	8	different	different	JJ
cord-023095-4dannjjm	5594	9	surgical	surgical	JJ
cord-023095-4dannjjm	5594	10	techniques	technique	NNS
cord-023095-4dannjjm	5594	11	:	:	:
cord-023095-4dannjjm	5594	12	laser	laser	NN
cord-023095-4dannjjm	5594	13	(	(	-LRB-
cord-023095-4dannjjm	5594	14	n	n	NN
cord-023095-4dannjjm	5594	15	5	5	CD
cord-023095-4dannjjm	5594	16	12	12	CD
cord-023095-4dannjjm	5594	17	)	)	-RRB-
cord-023095-4dannjjm	5594	18	or	or	CC
cord-023095-4dannjjm	5594	19	electrical	electrical	JJ
cord-023095-4dannjjm	5594	20	scalpel	scalpel	NN
cord-023095-4dannjjm	5594	21	(	(	-LRB-
cord-023095-4dannjjm	5594	22	n	n	NN
cord-023095-4dannjjm	5594	23	5	5	CD
cord-023095-4dannjjm	5594	24	21	21	CD
cord-023095-4dannjjm	5594	25	)	)	-RRB-
cord-023095-4dannjjm	5594	26	.	.	.
cord-023095-4dannjjm	5595	1	There	there	EX
cord-023095-4dannjjm	5595	2	were	be	VBD
cord-023095-4dannjjm	5595	3	significant	significant	JJ
cord-023095-4dannjjm	5595	4	differences	difference	NNS
cord-023095-4dannjjm	5595	5	between	between	IN
cord-023095-4dannjjm	5595	6	dogs	dog	NNS
cord-023095-4dannjjm	5595	7	depending	depend	VBG
cord-023095-4dannjjm	5595	8	on	on	IN
cord-023095-4dannjjm	5595	9	the	the	DT
cord-023095-4dannjjm	5595	10	surgical	surgical	JJ
cord-023095-4dannjjm	5595	11	technique	technique	NN
cord-023095-4dannjjm	5595	12	used	use	VBN
cord-023095-4dannjjm	5595	13	,	,	,
cord-023095-4dannjjm	5595	14	with	with	IN
cord-023095-4dannjjm	5595	15	a	a	DT
cord-023095-4dannjjm	5595	16	higher	high	JJR
cord-023095-4dannjjm	5595	17	reduction	reduction	NN
cord-023095-4dannjjm	5595	18	of	of	IN
cord-023095-4dannjjm	5595	19	respiratory	respiratory	JJ
cord-023095-4dannjjm	5595	20	signs	sign	NNS
cord-023095-4dannjjm	5595	21	(	(	-LRB-
cord-023095-4dannjjm	5595	22	p	p	NN
cord-023095-4dannjjm	5595	23	o	o	NN
cord-023095-4dannjjm	5595	24	0.002	0.002	CD
cord-023095-4dannjjm	5595	25	)	)	-RRB-
cord-023095-4dannjjm	5595	26	and	and	CC
cord-023095-4dannjjm	5595	27	a	a	DT
cord-023095-4dannjjm	5595	28	better	well	JJR
cord-023095-4dannjjm	5595	29	postsurgical	postsurgical	JJ
cord-023095-4dannjjm	5595	30	improvement	improvement	NN
cord-023095-4dannjjm	5595	31	(	(	-LRB-
cord-023095-4dannjjm	5595	32	p	p	NN
cord-023095-4dannjjm	5595	33	o	o	NN
cord-023095-4dannjjm	5595	34	0.015	0.015	CD
cord-023095-4dannjjm	5595	35	)	)	-RRB-
cord-023095-4dannjjm	5595	36	with	with	IN
cord-023095-4dannjjm	5595	37	the	the	DT
cord-023095-4dannjjm	5595	38	use	use	NN
cord-023095-4dannjjm	5595	39	of	of	IN
cord-023095-4dannjjm	5595	40	laser	laser	NN
cord-023095-4dannjjm	5595	41	.	.	.
cord-023095-4dannjjm	5596	1	The	the	DT
cord-023095-4dannjjm	5596	2	levels	level	NNS
cord-023095-4dannjjm	5596	3	of	of	IN
cord-023095-4dannjjm	5596	4	CRP	crp	NN
cord-023095-4dannjjm	5596	5	,	,	,
cord-023095-4dannjjm	5596	6	Hp	Hp	NNP
cord-023095-4dannjjm	5596	7	and	and	CC
cord-023095-4dannjjm	5596	8	cTnI	cTnI	NNP
cord-023095-4dannjjm	5596	9	were	be	VBD
cord-023095-4dannjjm	5596	10	categorized	categorize	VBN
cord-023095-4dannjjm	5596	11	into	into	IN
cord-023095-4dannjjm	5596	12	normal	normal	JJ
cord-023095-4dannjjm	5596	13	or	or	CC
cord-023095-4dannjjm	5596	14	elevated	elevated	JJ
cord-023095-4dannjjm	5596	15	.	.	.
cord-023095-4dannjjm	5597	1	Before	before	IN
cord-023095-4dannjjm	5597	2	surgical	surgical	JJ
cord-023095-4dannjjm	5597	3	treatment	treatment	NN
cord-023095-4dannjjm	5597	4	three	three	CD
cord-023095-4dannjjm	5597	5	(	(	-LRB-
cord-023095-4dannjjm	5597	6	9.1	9.1	CD
cord-023095-4dannjjm	5597	7	%	%	NN
cord-023095-4dannjjm	5597	8	)	)	-RRB-
cord-023095-4dannjjm	5597	9	,	,	,
cord-023095-4dannjjm	5597	10	six	six	CD
cord-023095-4dannjjm	5597	11	(	(	-LRB-
cord-023095-4dannjjm	5597	12	18.2	18.2	CD
cord-023095-4dannjjm	5597	13	%	%	NN
cord-023095-4dannjjm	5597	14	)	)	-RRB-
cord-023095-4dannjjm	5597	15	and	and	CC
cord-023095-4dannjjm	5597	16	thirteen	thirteen	CD
cord-023095-4dannjjm	5597	17	(	(	-LRB-
cord-023095-4dannjjm	5597	18	39.4	39.4	CD
cord-023095-4dannjjm	5597	19	%	%	NN
cord-023095-4dannjjm	5597	20	)	)	-RRB-
cord-023095-4dannjjm	5597	21	dogs	dog	NNS
cord-023095-4dannjjm	5597	22	had	have	VBD
cord-023095-4dannjjm	5597	23	elevated	elevate	VBN
cord-023095-4dannjjm	5597	24	values	value	NNS
cord-023095-4dannjjm	5597	25	of	of	IN
cord-023095-4dannjjm	5597	26	CRP	crp	NN
cord-023095-4dannjjm	5597	27	,	,	,
cord-023095-4dannjjm	5597	28	Hp	Hp	NNP
cord-023095-4dannjjm	5597	29	and	and	CC
cord-023095-4dannjjm	5597	30	cTnI	cTnI	NNP
cord-023095-4dannjjm	5597	31	,	,	,
cord-023095-4dannjjm	5597	32	respectively	respectively	RB
cord-023095-4dannjjm	5597	33	.	.	.
cord-023095-4dannjjm	5598	1	Two	two	CD
cord-023095-4dannjjm	5598	2	months	month	NNS
cord-023095-4dannjjm	5598	3	after	after	IN
cord-023095-4dannjjm	5598	4	surgical	surgical	JJ
cord-023095-4dannjjm	5598	5	correction	correction	NN
cord-023095-4dannjjm	5598	6	,	,	,
cord-023095-4dannjjm	5598	7	five	five	CD
cord-023095-4dannjjm	5598	8	(	(	-LRB-
cord-023095-4dannjjm	5598	9	15.1	15.1	CD
cord-023095-4dannjjm	5598	10	%	%	NN
cord-023095-4dannjjm	5598	11	)	)	-RRB-
cord-023095-4dannjjm	5598	12	,	,	,
cord-023095-4dannjjm	5598	13	eleven	eleven	CD
cord-023095-4dannjjm	5598	14	(	(	-LRB-
cord-023095-4dannjjm	5598	15	33.3	33.3	CD
cord-023095-4dannjjm	5598	16	%	%	NN
cord-023095-4dannjjm	5598	17	)	)	-RRB-
cord-023095-4dannjjm	5598	18	and	and	CC
cord-023095-4dannjjm	5598	19	fourteen	fourteen	CD
cord-023095-4dannjjm	5598	20	(	(	-LRB-
cord-023095-4dannjjm	5598	21	42.4	42.4	CD
cord-023095-4dannjjm	5598	22	%	%	NN
cord-023095-4dannjjm	5598	23	)	)	-RRB-
cord-023095-4dannjjm	5598	24	dogs	dog	NNS
cord-023095-4dannjjm	5598	25	had	have	VBD
cord-023095-4dannjjm	5598	26	elevated	elevate	VBN
cord-023095-4dannjjm	5598	27	values	value	NNS
cord-023095-4dannjjm	5598	28	of	of	IN
cord-023095-4dannjjm	5598	29	CRP	crp	NN
cord-023095-4dannjjm	5598	30	,	,	,
cord-023095-4dannjjm	5598	31	Hp	Hp	NNP
cord-023095-4dannjjm	5598	32	and	and	CC
cord-023095-4dannjjm	5598	33	cTnI	cTnI	NNP
cord-023095-4dannjjm	5598	34	,	,	,
cord-023095-4dannjjm	5598	35	respectively	respectively	RB
cord-023095-4dannjjm	5598	36	.	.	.
cord-023095-4dannjjm	5599	1	There	there	EX
cord-023095-4dannjjm	5599	2	were	be	VBD
cord-023095-4dannjjm	5599	3	no	no	DT
cord-023095-4dannjjm	5599	4	statistical	statistical	JJ
cord-023095-4dannjjm	5599	5	differences	difference	NNS
cord-023095-4dannjjm	5599	6	between	between	IN
cord-023095-4dannjjm	5599	7	values	value	NNS
cord-023095-4dannjjm	5599	8	of	of	IN
cord-023095-4dannjjm	5599	9	CRP	crp	NN
cord-023095-4dannjjm	5599	10	and	and	CC
cord-023095-4dannjjm	5599	11	cTnI	cTnI	VBN
cord-023095-4dannjjm	5599	12	before	before	IN
cord-023095-4dannjjm	5599	13	and	and	CC
cord-023095-4dannjjm	5599	14	after	after	IN
cord-023095-4dannjjm	5599	15	surgical	surgical	JJ
cord-023095-4dannjjm	5599	16	correction	correction	NN
cord-023095-4dannjjm	5599	17	but	but	CC
cord-023095-4dannjjm	5599	18	the	the	DT
cord-023095-4dannjjm	5599	19	levels	level	NNS
cord-023095-4dannjjm	5599	20	of	of	IN
cord-023095-4dannjjm	5599	21	Hp	Hp	NNP
cord-023095-4dannjjm	5599	22	increased	increase	VBD
cord-023095-4dannjjm	5599	23	significantly	significantly	RB
cord-023095-4dannjjm	5599	24	after	after	IN
cord-023095-4dannjjm	5599	25	surgical	surgical	JJ
cord-023095-4dannjjm	5599	26	treatment	treatment	NN
cord-023095-4dannjjm	5599	27	(	(	-LRB-
cord-023095-4dannjjm	5599	28	p	p	NN
cord-023095-4dannjjm	5599	29	o	o	NN
cord-023095-4dannjjm	5599	30	0.008	0.008	CD
cord-023095-4dannjjm	5599	31	)	)	-RRB-
cord-023095-4dannjjm	5599	32	,	,	,
cord-023095-4dannjjm	5599	33	probably	probably	RB
cord-023095-4dannjjm	5599	34	due	due	JJ
cord-023095-4dannjjm	5599	35	to	to	IN
cord-023095-4dannjjm	5599	36	postsurgical	postsurgical	JJ
cord-023095-4dannjjm	5599	37	treatment	treatment	NN
cord-023095-4dannjjm	5599	38	with	with	IN
cord-023095-4dannjjm	5599	39	corticosteroids	corticosteroid	NNS
cord-023095-4dannjjm	5599	40	.	.	.
cord-023095-4dannjjm	5600	1	As	as	IN
cord-023095-4dannjjm	5600	2	previously	previously	RB
cord-023095-4dannjjm	5600	3	suggested	suggest	VBN
cord-023095-4dannjjm	5600	4	by	by	IN
cord-023095-4dannjjm	5600	5	others	other	NNS
cord-023095-4dannjjm	5600	6	,	,	,
cord-023095-4dannjjm	5600	7	there	there	EX
cord-023095-4dannjjm	5600	8	was	be	VBD
cord-023095-4dannjjm	5600	9	a	a	DT
cord-023095-4dannjjm	5600	10	statistically	statistically	RB
cord-023095-4dannjjm	5600	11	significant	significant	JJ
cord-023095-4dannjjm	5600	12	reduction	reduction	NN
cord-023095-4dannjjm	5600	13	of	of	IN
cord-023095-4dannjjm	5600	14	respiratory	respiratory	JJ
cord-023095-4dannjjm	5600	15	and	and	CC
cord-023095-4dannjjm	5600	16	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	5600	17	signs	sign	NNS
cord-023095-4dannjjm	5600	18	in	in	IN
cord-023095-4dannjjm	5600	19	dogs	dog	NNS
cord-023095-4dannjjm	5600	20	with	with	IN
cord-023095-4dannjjm	5600	21	BOAS	boa	NNS
cord-023095-4dannjjm	5600	22	submitted	submit	VBN
cord-023095-4dannjjm	5600	23	to	to	IN
cord-023095-4dannjjm	5600	24	surgical	surgical	JJ
cord-023095-4dannjjm	5600	25	correction	correction	NN
cord-023095-4dannjjm	5600	26	(	(	-LRB-
cord-023095-4dannjjm	5600	27	p	p	NN
cord-023095-4dannjjm	5600	28	o	o	NN
cord-023095-4dannjjm	5600	29	0,001	0,001	CD
cord-023095-4dannjjm	5600	30	)	)	-RRB-
cord-023095-4dannjjm	5600	31	.	.	.
cord-023095-4dannjjm	5601	1	According	accord	VBG
cord-023095-4dannjjm	5601	2	to	to	IN
cord-023095-4dannjjm	5601	3	the	the	DT
cord-023095-4dannjjm	5601	4	results	result	NNS
cord-023095-4dannjjm	5601	5	obtained	obtain	VBN
cord-023095-4dannjjm	5601	6	in	in	IN
cord-023095-4dannjjm	5601	7	the	the	DT
cord-023095-4dannjjm	5601	8	present	present	JJ
cord-023095-4dannjjm	5601	9	study	study	NN
cord-023095-4dannjjm	5601	10	,	,	,
cord-023095-4dannjjm	5601	11	the	the	DT
cord-023095-4dannjjm	5601	12	determination	determination	NN
cord-023095-4dannjjm	5601	13	of	of	IN
cord-023095-4dannjjm	5601	14	CRP	CRP	NNP
cord-023095-4dannjjm	5601	15	,	,	,
cord-023095-4dannjjm	5601	16	Hp	Hp	NNP
cord-023095-4dannjjm	5601	17	and	and	CC
cord-023095-4dannjjm	5601	18	cTnI	cTnI	VBD
cord-023095-4dannjjm	5601	19	before	before	RB
cord-023095-4dannjjm	5601	20	and	and	CC
cord-023095-4dannjjm	5601	21	two	two	CD
cord-023095-4dannjjm	5601	22	months	month	NNS
cord-023095-4dannjjm	5601	23	after	after	IN
cord-023095-4dannjjm	5601	24	surgical	surgical	JJ
cord-023095-4dannjjm	5601	25	treatment	treatment	NN
cord-023095-4dannjjm	5601	26	do	do	VBP
cord-023095-4dannjjm	5601	27	not	not	RB
cord-023095-4dannjjm	5601	28	have	have	VB
cord-023095-4dannjjm	5601	29	a	a	DT
cord-023095-4dannjjm	5601	30	prognostic	prognostic	JJ
cord-023095-4dannjjm	5601	31	value	value	NN
cord-023095-4dannjjm	5601	32	in	in	IN
cord-023095-4dannjjm	5601	33	dogs	dog	NNS
cord-023095-4dannjjm	5601	34	with	with	IN
cord-023095-4dannjjm	5601	35	BOAS	boa	NNS
cord-023095-4dannjjm	5601	36	.	.	.
cord-023095-4dannjjm	5602	1	Even	even	RB
cord-023095-4dannjjm	5602	2	though	though	RB
cord-023095-4dannjjm	5602	3	,	,	,
cord-023095-4dannjjm	5602	4	near	near	IN
cord-023095-4dannjjm	5602	5	half	half	NN
cord-023095-4dannjjm	5602	6	of	of	IN
cord-023095-4dannjjm	5602	7	the	the	DT
cord-023095-4dannjjm	5602	8	dogs	dog	NNS
cord-023095-4dannjjm	5602	9	studied	study	VBD
cord-023095-4dannjjm	5602	10	had	have	VBD
cord-023095-4dannjjm	5602	11	elevated	elevate	VBN
cord-023095-4dannjjm	5602	12	levels	level	NNS
cord-023095-4dannjjm	5602	13	of	of	IN
cord-023095-4dannjjm	5602	14	cTnI	cTnI	NNP
cord-023095-4dannjjm	5602	15	(	(	-LRB-
cord-023095-4dannjjm	5602	16	39.4	39.4	CD
cord-023095-4dannjjm	5602	17	%	%	NN
cord-023095-4dannjjm	5602	18	)	)	-RRB-
cord-023095-4dannjjm	5602	19	that	that	WDT
cord-023095-4dannjjm	5602	20	persisted	persist	VBD
cord-023095-4dannjjm	5602	21	after	after	IN
cord-023095-4dannjjm	5602	22	surgical	surgical	JJ
cord-023095-4dannjjm	5602	23	treatment	treatment	NN
cord-023095-4dannjjm	5602	24	(	(	-LRB-
cord-023095-4dannjjm	5602	25	42.4	42.4	CD
cord-023095-4dannjjm	5602	26	%	%	NN
cord-023095-4dannjjm	5602	27	)	)	-RRB-
cord-023095-4dannjjm	5602	28	,	,	,
cord-023095-4dannjjm	5602	29	suggesting	suggest	VBG
cord-023095-4dannjjm	5602	30	some	some	DT
cord-023095-4dannjjm	5602	31	degree	degree	NN
cord-023095-4dannjjm	5602	32	of	of	IN
cord-023095-4dannjjm	5602	33	myocardial	myocardial	JJ
cord-023095-4dannjjm	5602	34	damage	damage	NN
cord-023095-4dannjjm	5602	35	is	be	VBZ
cord-023095-4dannjjm	5602	36	present	present	JJ
cord-023095-4dannjjm	5602	37	.	.	.
cord-023095-4dannjjm	5603	1	Further	further	JJ
cord-023095-4dannjjm	5603	2	studies	study	NNS
cord-023095-4dannjjm	5603	3	are	be	VBP
cord-023095-4dannjjm	5603	4	needed	need	VBN
cord-023095-4dannjjm	5603	5	considering	consider	VBG
cord-023095-4dannjjm	5603	6	the	the	DT
cord-023095-4dannjjm	5603	7	influence	influence	NN
cord-023095-4dannjjm	5603	8	of	of	IN
cord-023095-4dannjjm	5603	9	breed	breed	NN
cord-023095-4dannjjm	5603	10	and	and	CC
cord-023095-4dannjjm	5603	11	age	age	NN
cord-023095-4dannjjm	5603	12	.	.	.
cord-023095-4dannjjm	5604	1	To	to	IN
cord-023095-4dannjjm	5604	2	the	the	DT
cord-023095-4dannjjm	5604	3	authors	author	NNS
cord-023095-4dannjjm	5604	4	'	'	POS
cord-023095-4dannjjm	5604	5	knowledge	knowledge	NN
cord-023095-4dannjjm	5604	6	,	,	,
cord-023095-4dannjjm	5604	7	this	this	DT
cord-023095-4dannjjm	5604	8	is	be	VBZ
cord-023095-4dannjjm	5604	9	the	the	DT
cord-023095-4dannjjm	5604	10	first	first	JJ
cord-023095-4dannjjm	5604	11	description	description	NN
cord-023095-4dannjjm	5604	12	of	of	IN
cord-023095-4dannjjm	5604	13	CRP	CRP	NNP
cord-023095-4dannjjm	5604	14	,	,	,
cord-023095-4dannjjm	5604	15	Hp	Hp	NNP
cord-023095-4dannjjm	5604	16	and	and	CC
cord-023095-4dannjjm	5604	17	cTnI	ctni	JJ
cord-023095-4dannjjm	5604	18	determination	determination	NN
cord-023095-4dannjjm	5604	19	in	in	IN
cord-023095-4dannjjm	5604	20	dogs	dog	NNS
cord-023095-4dannjjm	5604	21	with	with	IN
cord-023095-4dannjjm	5604	22	BOAS	boa	NNS
cord-023095-4dannjjm	5604	23	.	.	.
cord-023095-4dannjjm	5605	1	Overweight	overweight	JJ
cord-023095-4dannjjm	5605	2	and	and	CC
cord-023095-4dannjjm	5605	3	obesity	obesity	NN
cord-023095-4dannjjm	5605	4	are	be	VBP
cord-023095-4dannjjm	5605	5	common	common	JJ
cord-023095-4dannjjm	5605	6	conditions	condition	NNS
cord-023095-4dannjjm	5605	7	that	that	WDT
cord-023095-4dannjjm	5605	8	lead	lead	VBP
cord-023095-4dannjjm	5605	9	to	to	IN
cord-023095-4dannjjm	5605	10	alterations	alteration	NNS
cord-023095-4dannjjm	5605	11	in	in	IN
cord-023095-4dannjjm	5605	12	respiratory	respiratory	JJ
cord-023095-4dannjjm	5605	13	mechanics	mechanic	NNS
cord-023095-4dannjjm	5605	14	,	,	,
cord-023095-4dannjjm	5605	15	airway	airway	NN
cord-023095-4dannjjm	5605	16	resistance	resistance	NN
cord-023095-4dannjjm	5605	17	,	,	,
cord-023095-4dannjjm	5605	18	pattern	pattern	NN
cord-023095-4dannjjm	5605	19	of	of	IN
cord-023095-4dannjjm	5605	20	breathing	breathing	NN
cord-023095-4dannjjm	5605	21	and	and	CC
cord-023095-4dannjjm	5605	22	gas	gas	NN
cord-023095-4dannjjm	5605	23	exchange	exchange	NN
cord-023095-4dannjjm	5605	24	in	in	IN
cord-023095-4dannjjm	5605	25	humans	human	NNS
cord-023095-4dannjjm	5605	26	.	.	.
cord-023095-4dannjjm	5606	1	The	the	DT
cord-023095-4dannjjm	5606	2	objective	objective	NN
cord-023095-4dannjjm	5606	3	of	of	IN
cord-023095-4dannjjm	5606	4	the	the	DT
cord-023095-4dannjjm	5606	5	present	present	JJ
cord-023095-4dannjjm	5606	6	study	study	NN
cord-023095-4dannjjm	5606	7	was	be	VBD
cord-023095-4dannjjm	5606	8	to	to	TO
cord-023095-4dannjjm	5606	9	investigate	investigate	VB
cord-023095-4dannjjm	5606	10	if	if	IN
cord-023095-4dannjjm	5606	11	there	there	EX
cord-023095-4dannjjm	5606	12	are	be	VBP
cord-023095-4dannjjm	5606	13	significant	significant	JJ
cord-023095-4dannjjm	5606	14	differences	difference	NNS
cord-023095-4dannjjm	5606	15	on	on	IN
cord-023095-4dannjjm	5606	16	respiratory	respiratory	JJ
cord-023095-4dannjjm	5606	17	parameters	parameter	NNS
cord-023095-4dannjjm	5606	18	and	and	CC
cord-023095-4dannjjm	5606	19	arterial	arterial	JJ
cord-023095-4dannjjm	5606	20	gas	gas	NN
cord-023095-4dannjjm	5606	21	analysis	analysis	NN
cord-023095-4dannjjm	5606	22	of	of	IN
cord-023095-4dannjjm	5606	23	obese	obese	JJ
cord-023095-4dannjjm	5606	24	and	and	CC
cord-023095-4dannjjm	5606	25	overweight	overweight	JJ
cord-023095-4dannjjm	5606	26	cats	cat	NNS
cord-023095-4dannjjm	5606	27	,	,	,
cord-023095-4dannjjm	5606	28	in	in	IN
cord-023095-4dannjjm	5606	29	conscious	conscious	JJ
cord-023095-4dannjjm	5606	30	state	state	NN
cord-023095-4dannjjm	5606	31	and	and	CC
cord-023095-4dannjjm	5606	32	under	under	IN
cord-023095-4dannjjm	5606	33	general	general	JJ
cord-023095-4dannjjm	5606	34	anesthesia	anesthesia	NN
cord-023095-4dannjjm	5606	35	.	.	.
cord-023095-4dannjjm	5607	1	Twenty	twenty	CD
cord-023095-4dannjjm	5607	2	nine	nine	CD
cord-023095-4dannjjm	5607	3	adult	adult	NN
cord-023095-4dannjjm	5607	4	cats	cat	NNS
cord-023095-4dannjjm	5607	5	were	be	VBD
cord-023095-4dannjjm	5607	6	arranged	arrange	VBN
cord-023095-4dannjjm	5607	7	in	in	IN
cord-023095-4dannjjm	5607	8	three	three	CD
cord-023095-4dannjjm	5607	9	groups	group	NNS
cord-023095-4dannjjm	5607	10	:	:	:
cord-023095-4dannjjm	5607	11	obese	obese	JJ
cord-023095-4dannjjm	5607	12	(	(	-LRB-
cord-023095-4dannjjm	5607	13	n	n	NN
cord-023095-4dannjjm	5607	14	5	5	CD
cord-023095-4dannjjm	5607	15	15	15	CD
cord-023095-4dannjjm	5607	16	)	)	-RRB-
cord-023095-4dannjjm	5607	17	,	,	,
cord-023095-4dannjjm	5607	18	overweight	overweight	JJ
cord-023095-4dannjjm	5607	19	(	(	-LRB-
cord-023095-4dannjjm	5607	20	n	n	NN
cord-023095-4dannjjm	5607	21	5	5	CD
cord-023095-4dannjjm	5607	22	7	7	CD
cord-023095-4dannjjm	5607	23	)	)	-RRB-
cord-023095-4dannjjm	5607	24	and	and	CC
cord-023095-4dannjjm	5607	25	with	with	IN
cord-023095-4dannjjm	5607	26	ideal	ideal	JJ
cord-023095-4dannjjm	5607	27	body	body	NN
cord-023095-4dannjjm	5607	28	score	score	NN
cord-023095-4dannjjm	5607	29	index	index	NN
cord-023095-4dannjjm	5607	30	(	(	-LRB-
cord-023095-4dannjjm	5607	31	BSI	BSI	NNP
cord-023095-4dannjjm	5607	32	)	)	-RRB-
cord-023095-4dannjjm	5607	33	(	(	-LRB-
cord-023095-4dannjjm	5607	34	n	n	NN
cord-023095-4dannjjm	5607	35	5	5	CD
cord-023095-4dannjjm	5607	36	7	7	CD
cord-023095-4dannjjm	5607	37	)	)	-RRB-
cord-023095-4dannjjm	5607	38	.	.	.
cord-023095-4dannjjm	5608	1	Mean	mean	JJ
cord-023095-4dannjjm	5608	2	of	of	IN
cord-023095-4dannjjm	5608	3	BSI	BSI	NNP
cord-023095-4dannjjm	5608	4	in	in	IN
cord-023095-4dannjjm	5608	5	the	the	DT
cord-023095-4dannjjm	5608	6	groups	group	NNS
cord-023095-4dannjjm	5608	7	were	be	VBD
cord-023095-4dannjjm	5608	8	:	:	:
cord-023095-4dannjjm	5608	9	8,8	8,8	CD
cord-023095-4dannjjm	5608	10	(	(	-LRB-
cord-023095-4dannjjm	5608	11	obese	obese	JJ
cord-023095-4dannjjm	5608	12	)	)	-RRB-
cord-023095-4dannjjm	5608	13	,	,	.
cord-023095-4dannjjm	5609	1	6,3	6,3	CD
cord-023095-4dannjjm	5609	2	(	(	-LRB-
cord-023095-4dannjjm	5609	3	overweight	overweight	NN
cord-023095-4dannjjm	5609	4	)	)	-RRB-
cord-023095-4dannjjm	5609	5	and	and	CC
cord-023095-4dannjjm	5609	6	4,9	4,9	LS
cord-023095-4dannjjm	5609	7	(	(	-LRB-
cord-023095-4dannjjm	5609	8	ideal	ideal	JJ
cord-023095-4dannjjm	5609	9	BSI	BSI	NNP
cord-023095-4dannjjm	5609	10	)	)	-RRB-
cord-023095-4dannjjm	5609	11	.	.	.
cord-023095-4dannjjm	5610	1	Cats	cat	NNS
cord-023095-4dannjjm	5610	2	did	do	VBD
cord-023095-4dannjjm	5610	3	not	not	RB
cord-023095-4dannjjm	5610	4	had	have	VBD
cord-023095-4dannjjm	5610	5	respiratory	respiratory	JJ
cord-023095-4dannjjm	5610	6	,	,	,
cord-023095-4dannjjm	5610	7	cardiac	cardiac	JJ
cord-023095-4dannjjm	5610	8	or	or	CC
cord-023095-4dannjjm	5610	9	others	other	NNS
cord-023095-4dannjjm	5610	10	systemic	systemic	JJ
cord-023095-4dannjjm	5610	11	diseases	disease	NNS
cord-023095-4dannjjm	5610	12	.	.	.
cord-023095-4dannjjm	5611	1	The	the	DT
cord-023095-4dannjjm	5611	2	respiratory	respiratory	JJ
cord-023095-4dannjjm	5611	3	parameters	parameter	NNS
cord-023095-4dannjjm	5611	4	were	be	VBD
cord-023095-4dannjjm	5611	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	5611	6	with	with	IN
cord-023095-4dannjjm	5611	7	a	a	DT
cord-023095-4dannjjm	5611	8	ventilometer	ventilometer	JJ
cord-023095-4dannjjm	5611	9	equipment	equipment	NN
cord-023095-4dannjjm	5611	10	coupled	couple	VBN
cord-023095-4dannjjm	5611	11	to	to	IN
cord-023095-4dannjjm	5611	12	facemasks	facemask	NNS
cord-023095-4dannjjm	5611	13	in	in	IN
cord-023095-4dannjjm	5611	14	conscious	conscious	JJ
cord-023095-4dannjjm	5611	15	cats	cat	NNS
cord-023095-4dannjjm	5611	16	and	and	CC
cord-023095-4dannjjm	5611	17	directly	directly	RB
cord-023095-4dannjjm	5611	18	to	to	IN
cord-023095-4dannjjm	5611	19	the	the	DT
cord-023095-4dannjjm	5611	20	endotracheal	endotracheal	NN
cord-023095-4dannjjm	5611	21	tube	tube	NN
cord-023095-4dannjjm	5611	22	in	in	IN
cord-023095-4dannjjm	5611	23	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	5611	24	cats	cat	NNS
cord-023095-4dannjjm	5611	25	under	under	IN
cord-023095-4dannjjm	5611	26	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	5611	27	respiration	respiration	NN
cord-023095-4dannjjm	5611	28	.	.	.
cord-023095-4dannjjm	5612	1	The	the	DT
cord-023095-4dannjjm	5612	2	anesthesia	anesthesia	NN
cord-023095-4dannjjm	5612	3	was	be	VBD
cord-023095-4dannjjm	5612	4	performed	perform	VBN
cord-023095-4dannjjm	5612	5	with	with	IN
cord-023095-4dannjjm	5612	6	propofol	propofol	NN
cord-023095-4dannjjm	5612	7	(	(	-LRB-
cord-023095-4dannjjm	5612	8	3	3	CD
cord-023095-4dannjjm	5612	9	AE	AE	NNP
cord-023095-4dannjjm	5612	10	1,2	1,2	CD
cord-023095-4dannjjm	5612	11	ml	ml	NN
cord-023095-4dannjjm	5612	12	/	/	SYM
cord-023095-4dannjjm	5612	13	kg	kg	NNP
cord-023095-4dannjjm	5612	14	)	)	-RRB-
cord-023095-4dannjjm	5612	15	and	and	CC
cord-023095-4dannjjm	5612	16	the	the	DT
cord-023095-4dannjjm	5612	17	cats	cat	NNS
cord-023095-4dannjjm	5612	18	were	be	VBD
cord-023095-4dannjjm	5612	19	maintained	maintain	VBN
cord-023095-4dannjjm	5612	20	in	in	IN
cord-023095-4dannjjm	5612	21	the	the	DT
cord-023095-4dannjjm	5612	22	same	same	JJ
cord-023095-4dannjjm	5612	23	anesthetic	anesthetic	JJ
cord-023095-4dannjjm	5612	24	plan	plan	NN
cord-023095-4dannjjm	5612	25	.	.	.
cord-023095-4dannjjm	5613	1	The	the	DT
cord-023095-4dannjjm	5613	2	three	three	CD
cord-023095-4dannjjm	5613	3	groups	group	NNS
cord-023095-4dannjjm	5613	4	were	be	VBD
cord-023095-4dannjjm	5613	5	compared	compare	VBN
cord-023095-4dannjjm	5613	6	by	by	IN
cord-023095-4dannjjm	5613	7	analysis	analysis	NN
cord-023095-4dannjjm	5613	8	of	of	IN
cord-023095-4dannjjm	5613	9	variance	variance	NN
cord-023095-4dannjjm	5613	10	followed	follow	VBN
cord-023095-4dannjjm	5613	11	by	by	IN
cord-023095-4dannjjm	5613	12	Tukey	Tukey	NNP
cord-023095-4dannjjm	5613	13	's	's	POS
cord-023095-4dannjjm	5613	14	test	test	NN
cord-023095-4dannjjm	5613	15	and	and	CC
cord-023095-4dannjjm	5613	16	conscious	conscious	JJ
cord-023095-4dannjjm	5613	17	and	and	CC
cord-023095-4dannjjm	5613	18	anesthetized	anesthetized	JJ
cord-023095-4dannjjm	5613	19	cats	cat	NNS
cord-023095-4dannjjm	5613	20	were	be	VBD
cord-023095-4dannjjm	5613	21	compared	compare	VBN
cord-023095-4dannjjm	5613	22	by	by	IN
cord-023095-4dannjjm	5613	23	Student	Student	NNP
cord-023095-4dannjjm	5613	24	's	's	POS
cord-023095-4dannjjm	5613	25	T	t	NN
cord-023095-4dannjjm	5613	26	test	test	NN
cord-023095-4dannjjm	5613	27	,	,	,
cord-023095-4dannjjm	5613	28	with	with	IN
cord-023095-4dannjjm	5613	29	a	a	DT
cord-023095-4dannjjm	5613	30	5	5	CD
cord-023095-4dannjjm	5613	31	%	%	NN
cord-023095-4dannjjm	5613	32	significance	significance	NN
cord-023095-4dannjjm	5613	33	level	level	NN
cord-023095-4dannjjm	5613	34	.	.	.
cord-023095-4dannjjm	5614	1	There	there	EX
cord-023095-4dannjjm	5614	2	were	be	VBD
cord-023095-4dannjjm	5614	3	not	not	RB
cord-023095-4dannjjm	5614	4	observed	observe	VBN
cord-023095-4dannjjm	5614	5	differences	difference	NNS
cord-023095-4dannjjm	5614	6	on	on	IN
cord-023095-4dannjjm	5614	7	the	the	DT
cord-023095-4dannjjm	5614	8	respiratory	respiratory	JJ
cord-023095-4dannjjm	5614	9	parameters	parameter	NNS
cord-023095-4dannjjm	5614	10	evaluated	evaluate	VBN
cord-023095-4dannjjm	5614	11	on	on	IN
cord-023095-4dannjjm	5614	12	ventilometry	ventilometry	NN
cord-023095-4dannjjm	5614	13	(	(	-LRB-
cord-023095-4dannjjm	5614	14	tidal	tidal	JJ
cord-023095-4dannjjm	5614	15	volume	volume	NN
cord-023095-4dannjjm	5614	16	,	,	,
cord-023095-4dannjjm	5614	17	expiratory	expiratory	JJ
cord-023095-4dannjjm	5614	18	and	and	CC
cord-023095-4dannjjm	5614	19	inspiratory	inspiratory	JJ
cord-023095-4dannjjm	5614	20	times	time	NNS
cord-023095-4dannjjm	5614	21	and	and	CC
cord-023095-4dannjjm	5614	22	peak	peak	NN
cord-023095-4dannjjm	5614	23	pressures	pressure	NNS
cord-023095-4dannjjm	5614	24	,	,	,
cord-023095-4dannjjm	5614	25	respiratory	respiratory	JJ
cord-023095-4dannjjm	5614	26	rate	rate	NN
cord-023095-4dannjjm	5614	27	and	and	CC
cord-023095-4dannjjm	5614	28	partial	partial	JJ
cord-023095-4dannjjm	5614	29	pressure	pressure	NN
cord-023095-4dannjjm	5614	30	of	of	IN
cord-023095-4dannjjm	5614	31	end	end	NN
cord-023095-4dannjjm	5614	32	tidal	tidal	JJ
cord-023095-4dannjjm	5614	33	CO	co	NN
cord-023095-4dannjjm	5614	34	2	2	CD
cord-023095-4dannjjm	5615	1	(	(	-LRB-
cord-023095-4dannjjm	5615	2	PETCO	PETCO	NNP
cord-023095-4dannjjm	5615	3	2	2	CD
cord-023095-4dannjjm	5615	4	)	)	-RRB-
cord-023095-4dannjjm	5615	5	)	)	-RRB-
cord-023095-4dannjjm	5616	1	and	and	CC
cord-023095-4dannjjm	5616	2	on	on	IN
cord-023095-4dannjjm	5616	3	arterial	arterial	JJ
cord-023095-4dannjjm	5616	4	gas	gas	NN
cord-023095-4dannjjm	5616	5	parameters	parameter	NNS
cord-023095-4dannjjm	5616	6	(	(	-LRB-
cord-023095-4dannjjm	5616	7	PaO	pao	JJ
cord-023095-4dannjjm	5616	8	2	2	CD
cord-023095-4dannjjm	5616	9	e	e	NN
cord-023095-4dannjjm	5616	10	PaCO	paco	NN
cord-023095-4dannjjm	5616	11	2	2	CD
cord-023095-4dannjjm	5616	12	)	)	-RRB-
cord-023095-4dannjjm	5616	13	in	in	IN
cord-023095-4dannjjm	5616	14	the	the	DT
cord-023095-4dannjjm	5616	15	three	three	CD
cord-023095-4dannjjm	5616	16	groups	group	NNS
cord-023095-4dannjjm	5616	17	.	.	.
cord-023095-4dannjjm	5617	1	The	the	DT
cord-023095-4dannjjm	5617	2	PaO	pao	JJ
cord-023095-4dannjjm	5617	3	2	2	CD
cord-023095-4dannjjm	5617	4	of	of	IN
cord-023095-4dannjjm	5617	5	cats	cat	NNS
cord-023095-4dannjjm	5617	6	with	with	IN
cord-023095-4dannjjm	5617	7	ideal	ideal	JJ
cord-023095-4dannjjm	5617	8	BSI	BSI	NNP
cord-023095-4dannjjm	5617	9	was	be	VBD
cord-023095-4dannjjm	5617	10	88,1	88,1	CD
cord-023095-4dannjjm	5617	11	AE	AE	NNP
cord-023095-4dannjjm	5617	12	13,5	13,5	CD
cord-023095-4dannjjm	5617	13	mmHg	mmHg	NNS
cord-023095-4dannjjm	5617	14	,	,	,
cord-023095-4dannjjm	5617	15	although	although	IN
cord-023095-4dannjjm	5617	16	was	be	VBD
cord-023095-4dannjjm	5617	17	not	not	RB
cord-023095-4dannjjm	5617	18	significantly	significantly	RB
cord-023095-4dannjjm	5617	19	different	different	JJ
cord-023095-4dannjjm	5618	1	(	(	-LRB-
cord-023095-4dannjjm	5618	2	p	p	NN
cord-023095-4dannjjm	5618	3	5	5	CD
cord-023095-4dannjjm	5618	4	0,06	0,06	CD
cord-023095-4dannjjm	5618	5	)	)	-RRB-
cord-023095-4dannjjm	5618	6	from	from	IN
cord-023095-4dannjjm	5618	7	overweight	overweight	NN
cord-023095-4dannjjm	5618	8	(	(	-LRB-
cord-023095-4dannjjm	5618	9	72,0	72,0	CD
cord-023095-4dannjjm	5618	10	AE	AE	NNP
cord-023095-4dannjjm	5618	11	11,9	11,9	CD
cord-023095-4dannjjm	5618	12	mmHg	mmHg	NNPS
cord-023095-4dannjjm	5618	13	)	)	-RRB-
cord-023095-4dannjjm	5618	14	and	and	CC
cord-023095-4dannjjm	5618	15	obese	obese	JJ
cord-023095-4dannjjm	5618	16	cats	cat	NNS
cord-023095-4dannjjm	5619	1	(	(	-LRB-
cord-023095-4dannjjm	5619	2	72,6	72,6	DT
cord-023095-4dannjjm	5619	3	AE	AE	NNP
cord-023095-4dannjjm	5619	4	14,6	14,6	CD
cord-023095-4dannjjm	5619	5	mmHg	mmHg	NNS
cord-023095-4dannjjm	5619	6	)	)	-RRB-
cord-023095-4dannjjm	5619	7	.	.	.
cord-023095-4dannjjm	5620	1	Comparison	comparison	NN
cord-023095-4dannjjm	5620	2	of	of	IN
cord-023095-4dannjjm	5620	3	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	5620	4	to	to	IN
cord-023095-4dannjjm	5620	5	conscious	conscious	JJ
cord-023095-4dannjjm	5620	6	cats	cat	NNS
cord-023095-4dannjjm	5620	7	,	,	,
cord-023095-4dannjjm	5620	8	it	-PRON-	PRP
cord-023095-4dannjjm	5620	9	was	be	VBD
cord-023095-4dannjjm	5620	10	detected	detect	VBN
cord-023095-4dannjjm	5620	11	decreases	decrease	NNS
cord-023095-4dannjjm	5620	12	in	in	IN
cord-023095-4dannjjm	5620	13	tidal	tidal	JJ
cord-023095-4dannjjm	5620	14	volume	volume	NN
cord-023095-4dannjjm	5620	15	,	,	,
cord-023095-4dannjjm	5620	16	expiratory	expiratory	JJ
cord-023095-4dannjjm	5620	17	and	and	CC
cord-023095-4dannjjm	5620	18	inspiratory	inspiratory	JJ
cord-023095-4dannjjm	5620	19	times	time	NNS
cord-023095-4dannjjm	5620	20	and	and	CC
cord-023095-4dannjjm	5620	21	peak	peak	NN
cord-023095-4dannjjm	5620	22	pressures	pressure	NNS
cord-023095-4dannjjm	5620	23	and	and	CC
cord-023095-4dannjjm	5620	24	increase	increase	VBP
cord-023095-4dannjjm	5620	25	in	in	IN
cord-023095-4dannjjm	5620	26	PETCO	PETCO	NNP
cord-023095-4dannjjm	5620	27	2	2	CD
cord-023095-4dannjjm	5620	28	in	in	IN
cord-023095-4dannjjm	5620	29	respiratory	respiratory	JJ
cord-023095-4dannjjm	5620	30	rate	rate	NN
cord-023095-4dannjjm	5620	31	in	in	IN
cord-023095-4dannjjm	5620	32	the	the	DT
cord-023095-4dannjjm	5620	33	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	5620	34	cats	cat	NNS
cord-023095-4dannjjm	5620	35	.	.	.
cord-023095-4dannjjm	5621	1	Only	only	RB
cord-023095-4dannjjm	5621	2	PETCO	PETCO	NNP
cord-023095-4dannjjm	5621	3	2	2	CD
cord-023095-4dannjjm	5621	4	,	,	,
cord-023095-4dannjjm	5621	5	inspiratory	inspiratory	JJ
cord-023095-4dannjjm	5621	6	time	time	NN
cord-023095-4dannjjm	5621	7	and	and	CC
cord-023095-4dannjjm	5621	8	respiratory	respiratory	JJ
cord-023095-4dannjjm	5621	9	rate	rate	NN
cord-023095-4dannjjm	5621	10	in	in	IN
cord-023095-4dannjjm	5621	11	overweight	overweight	JJ
cord-023095-4dannjjm	5621	12	cats	cat	NNS
cord-023095-4dannjjm	5621	13	did	do	VBD
cord-023095-4dannjjm	5621	14	not	not	RB
cord-023095-4dannjjm	5621	15	differ	differ	VB
cord-023095-4dannjjm	5621	16	in	in	IN
cord-023095-4dannjjm	5621	17	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	5621	18	cats	cat	NNS
cord-023095-4dannjjm	5621	19	.	.	.
cord-023095-4dannjjm	5622	1	These	these	DT
cord-023095-4dannjjm	5622	2	results	result	NNS
cord-023095-4dannjjm	5622	3	suggest	suggest	VBP
cord-023095-4dannjjm	5622	4	that	that	IN
cord-023095-4dannjjm	5622	5	obesity	obesity	NN
cord-023095-4dannjjm	5622	6	and	and	CC
cord-023095-4dannjjm	5622	7	overweight	overweight	NN
cord-023095-4dannjjm	5622	8	did	do	VBD
cord-023095-4dannjjm	5622	9	not	not	RB
cord-023095-4dannjjm	5622	10	result	result	VB
cord-023095-4dannjjm	5622	11	in	in	IN
cord-023095-4dannjjm	5622	12	impairment	impairment	NN
cord-023095-4dannjjm	5622	13	of	of	IN
cord-023095-4dannjjm	5622	14	respiratory	respiratory	JJ
cord-023095-4dannjjm	5622	15	function	function	NN
cord-023095-4dannjjm	5622	16	in	in	IN
cord-023095-4dannjjm	5622	17	cats	cat	NNS
cord-023095-4dannjjm	5622	18	and	and	CC
cord-023095-4dannjjm	5622	19	propofol	propofol	NN
cord-023095-4dannjjm	5622	20	induced	induce	VBD
cord-023095-4dannjjm	5622	21	respiratory	respiratory	JJ
cord-023095-4dannjjm	5622	22	depression	depression	NN
cord-023095-4dannjjm	5622	23	.	.	.
cord-023095-4dannjjm	5623	1	Osteosarcoma	Osteosarcoma	NNP
cord-023095-4dannjjm	5623	2	(	(	-LRB-
cord-023095-4dannjjm	5623	3	OSA	OSA	NNP
cord-023095-4dannjjm	5623	4	)	)	-RRB-
cord-023095-4dannjjm	5623	5	is	be	VBZ
cord-023095-4dannjjm	5623	6	the	the	DT
cord-023095-4dannjjm	5623	7	most	most	RBS
cord-023095-4dannjjm	5623	8	common	common	JJ
cord-023095-4dannjjm	5623	9	bone	bone	NN
cord-023095-4dannjjm	5623	10	tumor	tumor	NN
cord-023095-4dannjjm	5623	11	in	in	IN
cord-023095-4dannjjm	5623	12	dogs	dog	NNS
cord-023095-4dannjjm	5623	13	,	,	,
cord-023095-4dannjjm	5623	14	however	however	RB
cord-023095-4dannjjm	5623	15	,	,	,
cord-023095-4dannjjm	5623	16	little	little	JJ
cord-023095-4dannjjm	5623	17	is	be	VBZ
cord-023095-4dannjjm	5623	18	known	know	VBN
cord-023095-4dannjjm	5623	19	regarding	regard	VBG
cord-023095-4dannjjm	5623	20	the	the	DT
cord-023095-4dannjjm	5623	21	mechanisms	mechanism	NNS
cord-023095-4dannjjm	5623	22	underlying	underlie	VBG
cord-023095-4dannjjm	5623	23	malignant	malignant	JJ
cord-023095-4dannjjm	5623	24	transformation	transformation	NN
cord-023095-4dannjjm	5623	25	in	in	IN
cord-023095-4dannjjm	5623	26	these	these	DT
cord-023095-4dannjjm	5623	27	tumors	tumor	NNS
cord-023095-4dannjjm	5623	28	.	.	.
cord-023095-4dannjjm	5624	1	Breeds	breed	NNS
cord-023095-4dannjjm	5624	2	such	such	JJ
cord-023095-4dannjjm	5624	3	as	as	IN
cord-023095-4dannjjm	5624	4	Rottweilers	rottweiler	NNS
cord-023095-4dannjjm	5624	5	and	and	CC
cord-023095-4dannjjm	5624	6	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	5624	7	are	be	VBP
cord-023095-4dannjjm	5624	8	at	at	IN
cord-023095-4dannjjm	5624	9	higher	high	JJR
cord-023095-4dannjjm	5624	10	risk	risk	NN
cord-023095-4dannjjm	5624	11	for	for	IN
cord-023095-4dannjjm	5624	12	developing	develop	VBG
cord-023095-4dannjjm	5624	13	OSA	OSA	NNP
cord-023095-4dannjjm	5624	14	,	,	,
cord-023095-4dannjjm	5624	15	suggesting	suggest	VBG
cord-023095-4dannjjm	5624	16	that	that	IN
cord-023095-4dannjjm	5624	17	heritable	heritable	JJ
cord-023095-4dannjjm	5624	18	factors	factor	NNS
cord-023095-4dannjjm	5624	19	play	play	VBP
cord-023095-4dannjjm	5624	20	a	a	DT
cord-023095-4dannjjm	5624	21	role	role	NN
cord-023095-4dannjjm	5624	22	in	in	IN
cord-023095-4dannjjm	5624	23	this	this	DT
cord-023095-4dannjjm	5624	24	disease	disease	NN
cord-023095-4dannjjm	5624	25	.	.	.
cord-023095-4dannjjm	5625	1	MiRNAs	MiRNAs	NNP
cord-023095-4dannjjm	5626	1	have	have	VBP
cord-023095-4dannjjm	5626	2	tumor	tumor	NN
cord-023095-4dannjjm	5626	3	/	/	SYM
cord-023095-4dannjjm	5626	4	tissue	tissue	NN
cord-023095-4dannjjm	5626	5	specific	specific	JJ
cord-023095-4dannjjm	5626	6	roles	role	NNS
cord-023095-4dannjjm	5626	7	in	in	IN
cord-023095-4dannjjm	5626	8	regulating	regulate	VBG
cord-023095-4dannjjm	5626	9	gene	gene	NN
cord-023095-4dannjjm	5626	10	expression	expression	NN
cord-023095-4dannjjm	5626	11	and	and	CC
cord-023095-4dannjjm	5626	12	dysregulated	dysregulate	VBN
cord-023095-4dannjjm	5626	13	miRNA	miRNA	NNP
cord-023095-4dannjjm	5626	14	expression	expression	NN
cord-023095-4dannjjm	5626	15	is	be	VBZ
cord-023095-4dannjjm	5626	16	found	find	VBN
cord-023095-4dannjjm	5626	17	frequently	frequently	RB
cord-023095-4dannjjm	5626	18	in	in	IN
cord-023095-4dannjjm	5626	19	cancer	cancer	NN
cord-023095-4dannjjm	5626	20	.	.	.
cord-023095-4dannjjm	5627	1	We	-PRON-	PRP
cord-023095-4dannjjm	5627	2	hypothesize	hypothesize	VBP
cord-023095-4dannjjm	5627	3	that	that	IN
cord-023095-4dannjjm	5627	4	canine	canine	JJ
cord-023095-4dannjjm	5627	5	OSA	OSA	NNP
cord-023095-4dannjjm	5627	6	is	be	VBZ
cord-023095-4dannjjm	5627	7	characterized	characterize	VBN
cord-023095-4dannjjm	5627	8	by	by	IN
cord-023095-4dannjjm	5627	9	a	a	DT
cord-023095-4dannjjm	5627	10	unique	unique	JJ
cord-023095-4dannjjm	5627	11	miRNA	miRNA	NNP
cord-023095-4dannjjm	5627	12	expression	expression	NN
cord-023095-4dannjjm	5627	13	profile(s	profile(s	RB
cord-023095-4dannjjm	5627	14	)	)	-RRB-
cord-023095-4dannjjm	5627	15	with	with	IN
cord-023095-4dannjjm	5627	16	dysregulation	dysregulation	NN
cord-023095-4dannjjm	5627	17	of	of	IN
cord-023095-4dannjjm	5627	18	some	some	DT
cord-023095-4dannjjm	5627	19	miRNAs	mirna	NNS
cord-023095-4dannjjm	5627	20	being	be	VBG
cord-023095-4dannjjm	5627	21	associated	associate	VBN
cord-023095-4dannjjm	5627	22	with	with	IN
cord-023095-4dannjjm	5627	23	specific	specific	JJ
cord-023095-4dannjjm	5627	24	breeds	breed	NNS
cord-023095-4dannjjm	5627	25	.	.	.
cord-023095-4dannjjm	5628	1	MiRNA	MiRNA	NNP
cord-023095-4dannjjm	5628	2	expression	expression	NN
cord-023095-4dannjjm	5628	3	profiling	profiling	NN
cord-023095-4dannjjm	5628	4	of	of	IN
cord-023095-4dannjjm	5628	5	primary	primary	JJ
cord-023095-4dannjjm	5628	6	OSA	OSA	NNP
cord-023095-4dannjjm	5628	7	tumors	tumor	NNS
cord-023095-4dannjjm	5628	8	from	from	IN
cord-023095-4dannjjm	5628	9	6	6	CD
cord-023095-4dannjjm	5628	10	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	5628	11	and	and	CC
cord-023095-4dannjjm	5628	12	6	6	CD
cord-023095-4dannjjm	5628	13	Rottweilers	Rottweilers	NNPS
cord-023095-4dannjjm	5628	14	was	be	VBD
cord-023095-4dannjjm	5628	15	performed	perform	VBN
cord-023095-4dannjjm	5628	16	using	use	VBG
cord-023095-4dannjjm	5628	17	the	the	DT
cord-023095-4dannjjm	5628	18	Nanostring	Nanostring	NNP
cord-023095-4dannjjm	5628	19	Technologies	Technologies	NNPS
cord-023095-4dannjjm	5628	20	nCounter	nCounter	NNP
cord-023095-4dannjjm	5628	21	miRNA	miRNA	NNP
cord-023095-4dannjjm	5628	22	Expression	Expression	NNP
cord-023095-4dannjjm	5628	23	Assay	Assay	NNP
cord-023095-4dannjjm	5628	24	Kit	Kit	NNP
cord-023095-4dannjjm	5628	25	,	,	,
cord-023095-4dannjjm	5628	26	interrogating	interrogate	VBG
cord-023095-4dannjjm	5628	27	the	the	DT
cord-023095-4dannjjm	5628	28	miRNA	miRNA	NNP
cord-023095-4dannjjm	5628	29	expression	expression	NN
cord-023095-4dannjjm	5628	30	profile	profile	NN
cord-023095-4dannjjm	5628	31	of	of	IN
cord-023095-4dannjjm	5628	32	651	651	CD
cord-023095-4dannjjm	5628	33	human	human	JJ
cord-023095-4dannjjm	5628	34	miRNAs	miRNAs	NNP
cord-023095-4dannjjm	5628	35	,	,	,
cord-023095-4dannjjm	5628	36	168	168	CD
cord-023095-4dannjjm	5628	37	of	of	IN
cord-023095-4dannjjm	5628	38	whose	whose	WP$
cord-023095-4dannjjm	5628	39	mature	mature	JJ
cord-023095-4dannjjm	5628	40	sequences	sequence	NNS
cord-023095-4dannjjm	5628	41	are	be	VBP
cord-023095-4dannjjm	5628	42	100	100	CD
cord-023095-4dannjjm	5628	43	%	%	NN
cord-023095-4dannjjm	5628	44	conserved	conserve	VBN
cord-023095-4dannjjm	5628	45	between	between	IN
cord-023095-4dannjjm	5628	46	human	human	NN
cord-023095-4dannjjm	5628	47	and	and	CC
cord-023095-4dannjjm	5628	48	dog	dog	NN
cord-023095-4dannjjm	5628	49	.	.	.
cord-023095-4dannjjm	5629	1	17	17	CD
cord-023095-4dannjjm	5629	2	miRNAs	mirna	NNS
cord-023095-4dannjjm	5629	3	were	be	VBD
cord-023095-4dannjjm	5629	4	differentially	differentially	RB
cord-023095-4dannjjm	5629	5	expressed	express	VBN
cord-023095-4dannjjm	5629	6	in	in	IN
cord-023095-4dannjjm	5629	7	Greyhound	Greyhound	NNP
cord-023095-4dannjjm	5629	8	versus	versus	IN
cord-023095-4dannjjm	5629	9	Rottweiler	Rottweiler	NNP
cord-023095-4dannjjm	5629	10	tumors	tumor	NNS
cord-023095-4dannjjm	5629	11	(	(	-LRB-
cord-023095-4dannjjm	5629	12	p	p	NN
cord-023095-4dannjjm	5629	13	o	o	NN
cord-023095-4dannjjm	5629	14	0.05	0.05	CD
cord-023095-4dannjjm	5629	15	)	)	-RRB-
cord-023095-4dannjjm	5629	16	,	,	,
cord-023095-4dannjjm	5629	17	suggesting	suggest	VBG
cord-023095-4dannjjm	5629	18	that	that	IN
cord-023095-4dannjjm	5629	19	breed	breed	NN
cord-023095-4dannjjm	5629	20	-	-	HYPH
cord-023095-4dannjjm	5629	21	specific	specific	JJ
cord-023095-4dannjjm	5629	22	dysregulation	dysregulation	NN
cord-023095-4dannjjm	5629	23	of	of	IN
cord-023095-4dannjjm	5629	24	miRNAs	miRNAs	NNP
cord-023095-4dannjjm	5629	25	may	may	MD
cord-023095-4dannjjm	5629	26	contribute	contribute	VB
cord-023095-4dannjjm	5629	27	to	to	IN
cord-023095-4dannjjm	5629	28	the	the	DT
cord-023095-4dannjjm	5629	29	development	development	NN
cord-023095-4dannjjm	5629	30	and	and	CC
cord-023095-4dannjjm	5629	31	progression	progression	NN
cord-023095-4dannjjm	5629	32	of	of	IN
cord-023095-4dannjjm	5629	33	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	5629	34	OSA	OSA	NNP
cord-023095-4dannjjm	5629	35	.	.	.
cord-023095-4dannjjm	5630	1	Hierarchical	hierarchical	JJ
cord-023095-4dannjjm	5630	2	clustering	clustering	NN
cord-023095-4dannjjm	5630	3	revealed	reveal	VBD
cord-023095-4dannjjm	5630	4	distinct	distinct	JJ
cord-023095-4dannjjm	5630	5	miRNA	miRNA	NNP
cord-023095-4dannjjm	5630	6	expression	expression	NN
cord-023095-4dannjjm	5630	7	signatures	signature	NNS
cord-023095-4dannjjm	5630	8	in	in	IN
cord-023095-4dannjjm	5630	9	Greyhound	Greyhound	NNP
cord-023095-4dannjjm	5630	10	OSA	OSA	NNP
cord-023095-4dannjjm	5630	11	tumors	tumor	NNS
cord-023095-4dannjjm	5630	12	as	as	IN
cord-023095-4dannjjm	5630	13	compared	compare	VBN
cord-023095-4dannjjm	5630	14	to	to	IN
cord-023095-4dannjjm	5630	15	Rottweilers	rottweiler	NNS
cord-023095-4dannjjm	5630	16	.	.	.
cord-023095-4dannjjm	5631	1	Based	base	VBN
cord-023095-4dannjjm	5631	2	on	on	IN
cord-023095-4dannjjm	5631	3	these	these	DT
cord-023095-4dannjjm	5631	4	preliminary	preliminary	JJ
cord-023095-4dannjjm	5631	5	results	result	NNS
cord-023095-4dannjjm	5631	6	,	,	,
cord-023095-4dannjjm	5631	7	we	-PRON-	PRP
cord-023095-4dannjjm	5631	8	are	be	VBP
cord-023095-4dannjjm	5631	9	evaluating	evaluate	VBG
cord-023095-4dannjjm	5631	10	a	a	DT
cord-023095-4dannjjm	5631	11	larger	large	JJR
cord-023095-4dannjjm	5631	12	cohort	cohort	NN
cord-023095-4dannjjm	5631	13	of	of	IN
cord-023095-4dannjjm	5631	14	OSA	OSA	NNP
cord-023095-4dannjjm	5631	15	tumor	tumor	NN
cord-023095-4dannjjm	5631	16	samples	sample	NNS
cord-023095-4dannjjm	5631	17	including	include	VBG
cord-023095-4dannjjm	5631	18	Greyhounds	greyhound	NNS
cord-023095-4dannjjm	5631	19	,	,	,
cord-023095-4dannjjm	5631	20	Rottweilers	Rottweilers	NNPS
cord-023095-4dannjjm	5631	21	,	,	,
cord-023095-4dannjjm	5631	22	Golden	Golden	NNP
cord-023095-4dannjjm	5631	23	Retrievers	Retrievers	NNPS
cord-023095-4dannjjm	5631	24	,	,	,
cord-023095-4dannjjm	5631	25	and	and	CC
cord-023095-4dannjjm	5631	26	a	a	DT
cord-023095-4dannjjm	5631	27	mixed	mixed	JJ
cord-023095-4dannjjm	5631	28	population	population	NN
cord-023095-4dannjjm	5631	29	of	of	IN
cord-023095-4dannjjm	5631	30	other	other	JJ
cord-023095-4dannjjm	5631	31	breeds	breed	NNS
cord-023095-4dannjjm	5631	32	.	.	.
cord-023095-4dannjjm	5632	1	Statistical	statistical	JJ
cord-023095-4dannjjm	5632	2	analysis	analysis	NN
cord-023095-4dannjjm	5632	3	will	will	MD
cord-023095-4dannjjm	5632	4	be	be	VB
cord-023095-4dannjjm	5632	5	performed	perform	VBN
cord-023095-4dannjjm	5632	6	to	to	TO
cord-023095-4dannjjm	5632	7	determine	determine	VB
cord-023095-4dannjjm	5632	8	the	the	DT
cord-023095-4dannjjm	5632	9	association	association	NNP
cord-023095-4dannjjm	5632	10	of	of	IN
cord-023095-4dannjjm	5632	11	miRNA	miRNA	NNP
cord-023095-4dannjjm	5632	12	transcript	transcript	NNP
cord-023095-4dannjjm	5632	13	levels	level	NNS
cord-023095-4dannjjm	5632	14	with	with	IN
cord-023095-4dannjjm	5632	15	specific	specific	JJ
cord-023095-4dannjjm	5632	16	breeds	breed	NNS
cord-023095-4dannjjm	5632	17	and	and	CC
cord-023095-4dannjjm	5632	18	overall	overall	JJ
cord-023095-4dannjjm	5632	19	outcome	outcome	NN
cord-023095-4dannjjm	5632	20	.	.	.
cord-023095-4dannjjm	5633	1	Characterization	characterization	NN
cord-023095-4dannjjm	5633	2	of	of	IN
cord-023095-4dannjjm	5633	3	miRNA	miRNA	NNP
cord-023095-4dannjjm	5633	4	expression	expression	NN
cord-023095-4dannjjm	5633	5	in	in	IN
cord-023095-4dannjjm	5633	6	canine	canine	JJ
cord-023095-4dannjjm	5633	7	OSA	OSA	NNP
cord-023095-4dannjjm	5633	8	will	will	MD
cord-023095-4dannjjm	5633	9	facilitate	facilitate	VB
cord-023095-4dannjjm	5633	10	our	-PRON-	PRP$
cord-023095-4dannjjm	5633	11	understanding	understanding	NN
cord-023095-4dannjjm	5633	12	the	the	DT
cord-023095-4dannjjm	5633	13	biology	biology	NN
cord-023095-4dannjjm	5633	14	of	of	IN
cord-023095-4dannjjm	5633	15	this	this	DT
cord-023095-4dannjjm	5633	16	disease	disease	NN
cord-023095-4dannjjm	5633	17	and	and	CC
cord-023095-4dannjjm	5633	18	has	have	VBZ
cord-023095-4dannjjm	5633	19	the	the	DT
cord-023095-4dannjjm	5633	20	potential	potential	NN
cord-023095-4dannjjm	5633	21	to	to	TO
cord-023095-4dannjjm	5633	22	identify	identify	VB
cord-023095-4dannjjm	5633	23	targets	target	NNS
cord-023095-4dannjjm	5633	24	for	for	IN
cord-023095-4dannjjm	5633	25	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5633	26	intervention	intervention	NN
cord-023095-4dannjjm	5633	27	.	.	.
cord-023095-4dannjjm	5634	1	Originally	originally	RB
cord-023095-4dannjjm	5634	2	Combination	combination	NN
cord-023095-4dannjjm	5634	3	therapies	therapy	NNS
cord-023095-4dannjjm	5634	4	using	use	VBG
cord-023095-4dannjjm	5634	5	drugs	drug	NNS
cord-023095-4dannjjm	5634	6	with	with	IN
cord-023095-4dannjjm	5634	7	documented	document	VBN
cord-023095-4dannjjm	5634	8	single	single	JJ
cord-023095-4dannjjm	5634	9	-	-	HYPH
cord-023095-4dannjjm	5634	10	agent	agent	NN
cord-023095-4dannjjm	5634	11	activity	activity	NN
cord-023095-4dannjjm	5634	12	and	and	CC
cord-023095-4dannjjm	5634	13	lack	lack	NN
cord-023095-4dannjjm	5634	14	of	of	IN
cord-023095-4dannjjm	5634	15	overlapping	overlap	VBG
cord-023095-4dannjjm	5634	16	toxicities	toxicity	NNS
cord-023095-4dannjjm	5634	17	could	could	MD
cord-023095-4dannjjm	5634	18	potentially	potentially	RB
cord-023095-4dannjjm	5634	19	improve	improve	VB
cord-023095-4dannjjm	5634	20	outcome	outcome	NN
cord-023095-4dannjjm	5634	21	.	.	.
cord-023095-4dannjjm	5635	1	The	the	DT
cord-023095-4dannjjm	5635	2	hypothesis	hypothesis	NN
cord-023095-4dannjjm	5635	3	intended	intend	VBD
cord-023095-4dannjjm	5635	4	to	to	TO
cord-023095-4dannjjm	5635	5	be	be	VB
cord-023095-4dannjjm	5635	6	tested	test	VBN
cord-023095-4dannjjm	5635	7	is	be	VBZ
cord-023095-4dannjjm	5635	8	that	that	IN
cord-023095-4dannjjm	5635	9	Palladia	Palladia	NNP
cord-023095-4dannjjm	5635	10	s	s	NN
cord-023095-4dannjjm	5635	11	can	can	MD
cord-023095-4dannjjm	5635	12	be	be	VB
cord-023095-4dannjjm	5635	13	safely	safely	RB
cord-023095-4dannjjm	5635	14	administered	administer	VBN
cord-023095-4dannjjm	5635	15	concurrently	concurrently	RB
cord-023095-4dannjjm	5635	16	with	with	IN
cord-023095-4dannjjm	5635	17	a	a	DT
cord-023095-4dannjjm	5635	18	standard	standard	JJ
cord-023095-4dannjjm	5635	19	weekly	weekly	JJ
cord-023095-4dannjjm	5635	20	protocol	protocol	NN
cord-023095-4dannjjm	5635	21	of	of	IN
cord-023095-4dannjjm	5635	22	vinblastine	vinblastine	NN
cord-023095-4dannjjm	5635	23	(	(	-LRB-
cord-023095-4dannjjm	5635	24	VBL	VBL	NNP
cord-023095-4dannjjm	5635	25	)	)	-RRB-
cord-023095-4dannjjm	5635	26	,	,	,
cord-023095-4dannjjm	5635	27	at	at	IN
cord-023095-4dannjjm	5635	28	dosages	dosage	NNS
cord-023095-4dannjjm	5635	29	known	know	VBN
cord-023095-4dannjjm	5635	30	to	to	TO
cord-023095-4dannjjm	5635	31	have	have	VB
cord-023095-4dannjjm	5635	32	activity	activity	NN
cord-023095-4dannjjm	5635	33	against	against	IN
cord-023095-4dannjjm	5635	34	mast	mast	JJ
cord-023095-4dannjjm	5635	35	cell	cell	NN
cord-023095-4dannjjm	5635	36	tumors	tumor	NNS
cord-023095-4dannjjm	5635	37	.	.	.
cord-023095-4dannjjm	5636	1	Dogs	dog	NNS
cord-023095-4dannjjm	5636	2	with	with	IN
cord-023095-4dannjjm	5636	3	histologically	histologically	RB
cord-023095-4dannjjm	5636	4	confirmed	confirm	VBN
cord-023095-4dannjjm	5636	5	measurable	measurable	JJ
cord-023095-4dannjjm	5636	6	mast	mast	JJ
cord-023095-4dannjjm	5636	7	cell	cell	NN
cord-023095-4dannjjm	5636	8	tumors	tumor	NNS
cord-023095-4dannjjm	5636	9	were	be	VBD
cord-023095-4dannjjm	5636	10	evaluated	evaluate	VBN
cord-023095-4dannjjm	5636	11	for	for	IN
cord-023095-4dannjjm	5636	12	eligibility	eligibility	NN
cord-023095-4dannjjm	5636	13	to	to	TO
cord-023095-4dannjjm	5636	14	enter	enter	VB
cord-023095-4dannjjm	5636	15	a	a	DT
cord-023095-4dannjjm	5636	16	standard	standard	JJ
cord-023095-4dannjjm	5636	17	phase	phase	NN
cord-023095-4dannjjm	5636	18	I	-PRON-	PRP
cord-023095-4dannjjm	5636	19	dose	dose	RB
cord-023095-4dannjjm	5636	20	-	-	HYPH
cord-023095-4dannjjm	5636	21	finding	find	VBG
cord-023095-4dannjjm	5636	22	trial	trial	NN
cord-023095-4dannjjm	5636	23	(	(	-LRB-
cord-023095-4dannjjm	5636	24	313	313	CD
cord-023095-4dannjjm	5636	25	cohort	cohort	NN
cord-023095-4dannjjm	5636	26	)	)	-RRB-
cord-023095-4dannjjm	5636	27	,	,	,
cord-023095-4dannjjm	5636	28	at	at	IN
cord-023095-4dannjjm	5636	29	a	a	DT
cord-023095-4dannjjm	5636	30	starting	starting	NN
cord-023095-4dannjjm	5636	31	dose	dose	NN
cord-023095-4dannjjm	5636	32	of	of	IN
cord-023095-4dannjjm	5636	33	2.3	2.3	CD
cord-023095-4dannjjm	5636	34	mg	mg	NNP
cord-023095-4dannjjm	5636	35	/	/	SYM
cord-023095-4dannjjm	5636	36	m2	m2	NNP
cord-023095-4dannjjm	5636	37	IV	IV	NNP
cord-023095-4dannjjm	5636	38	VBL	VBL	NNP
cord-023095-4dannjjm	5636	39	(	(	-LRB-
cord-023095-4dannjjm	5636	40	weekly	weekly	NN
cord-023095-4dannjjm	5636	41	for	for	IN
cord-023095-4dannjjm	5636	42	a	a	DT
cord-023095-4dannjjm	5636	43	total	total	NN
cord-023095-4dannjjm	5636	44	of	of	IN
cord-023095-4dannjjm	5636	45	4	4	CD
cord-023095-4dannjjm	5636	46	treatments	treatment	NNS
cord-023095-4dannjjm	5636	47	)	)	-RRB-
cord-023095-4dannjjm	5636	48	and	and	CC
cord-023095-4dannjjm	5637	1	2.25	2.25	CD
cord-023095-4dannjjm	5637	2	mg	mg	NNP
cord-023095-4dannjjm	5637	3	/	/	SYM
cord-023095-4dannjjm	5637	4	kg	kg	NNP
cord-023095-4dannjjm	5637	5	PO	PO	NNP
cord-023095-4dannjjm	5637	6	Palladia	Palladia	NNP
cord-023095-4dannjjm	5637	7	s	s	NNP
cord-023095-4dannjjm	5637	8	EOD	EOD	NNP
cord-023095-4dannjjm	5637	9	,	,	,
cord-023095-4dannjjm	5637	10	concurrently	concurrently	RB
cord-023095-4dannjjm	5637	11	.	.	.
cord-023095-4dannjjm	5638	1	Dose	dose	JJ
cord-023095-4dannjjm	5638	2	escalation	escalation	NN
cord-023095-4dannjjm	5638	3	of	of	IN
cord-023095-4dannjjm	5638	4	Palladia	Palladia	NNP
cord-023095-4dannjjm	5638	5	s	s	NNP
cord-023095-4dannjjm	5638	6	was	be	VBD
cord-023095-4dannjjm	5638	7	scheduled	schedule	VBN
cord-023095-4dannjjm	5638	8	in	in	IN
cord-023095-4dannjjm	5638	9	0.25	0.25	CD
cord-023095-4dannjjm	5638	10	mg	mg	NNP
cord-023095-4dannjjm	5638	11	/	/	SYM
cord-023095-4dannjjm	5638	12	kg	kg	NN
cord-023095-4dannjjm	5638	13	increments	increment	NNS
cord-023095-4dannjjm	5638	14	until	until	IN
cord-023095-4dannjjm	5638	15	MTD	MTD	NNP
cord-023095-4dannjjm	5638	16	was	be	VBD
cord-023095-4dannjjm	5638	17	established	establish	VBN
cord-023095-4dannjjm	5638	18	or	or	CC
cord-023095-4dannjjm	5638	19	FDA	FDA	NNP
cord-023095-4dannjjm	5638	20	label	label	NN
cord-023095-4dannjjm	5638	21	dose	dose	NN
cord-023095-4dannjjm	5638	22	completed	complete	VBD
cord-023095-4dannjjm	5638	23	(	(	-LRB-
cord-023095-4dannjjm	5638	24	3.25	3.25	CD
cord-023095-4dannjjm	5638	25	mg	mg	NNP
cord-023095-4dannjjm	5638	26	/	/	SYM
cord-023095-4dannjjm	5638	27	kg	kg	NNP
cord-023095-4dannjjm	5638	28	)	)	-RRB-
cord-023095-4dannjjm	5638	29	.	.	.
cord-023095-4dannjjm	5639	1	Safety	safety	NN
cord-023095-4dannjjm	5639	2	evaluation	evaluation	NN
cord-023095-4dannjjm	5639	3	was	be	VBD
cord-023095-4dannjjm	5639	4	performed	perform	VBN
cord-023095-4dannjjm	5639	5	weekly	weekly	RB
cord-023095-4dannjjm	5639	6	throughout	throughout	IN
cord-023095-4dannjjm	5639	7	the	the	DT
cord-023095-4dannjjm	5639	8	4	4	CD
cord-023095-4dannjjm	5639	9	week	week	NN
cord-023095-4dannjjm	5639	10	study	study	NN
cord-023095-4dannjjm	5639	11	period	period	NN
cord-023095-4dannjjm	5639	12	.	.	.
cord-023095-4dannjjm	5640	1	Dose	dose	NN
cord-023095-4dannjjm	5640	2	-	-	HYPH
cord-023095-4dannjjm	5640	3	limiting	limit	VBG
cord-023095-4dannjjm	5640	4	toxicities	toxicity	NNS
cord-023095-4dannjjm	5640	5	were	be	VBD
cord-023095-4dannjjm	5640	6	described	describe	VBN
cord-023095-4dannjjm	5640	7	following	follow	VBG
cord-023095-4dannjjm	5640	8	established	establish	VBN
cord-023095-4dannjjm	5640	9	VCOG	VCOG	NNP
cord-023095-4dannjjm	5640	10	-	-	HYPH
cord-023095-4dannjjm	5640	11	CTCAE(v1.0	CTCAE(v1.0	NNP
cord-023095-4dannjjm	5640	12	)	)	-RRB-
cord-023095-4dannjjm	5640	13	criteria	criterion	NNS
cord-023095-4dannjjm	5640	14	.	.	.
cord-023095-4dannjjm	5641	1	While	while	IN
cord-023095-4dannjjm	5641	2	antitumor	antitumor	JJ
cord-023095-4dannjjm	5641	3	response	response	NN
cord-023095-4dannjjm	5641	4	is	be	VBZ
cord-023095-4dannjjm	5641	5	not	not	RB
cord-023095-4dannjjm	5641	6	a	a	DT
cord-023095-4dannjjm	5641	7	primary	primary	JJ
cord-023095-4dannjjm	5641	8	endpoint	endpoint	NN
cord-023095-4dannjjm	5641	9	of	of	IN
cord-023095-4dannjjm	5641	10	phase	phase	NN
cord-023095-4dannjjm	5642	1	I	-PRON-	PRP
cord-023095-4dannjjm	5642	2	trials	trial	NNS
cord-023095-4dannjjm	5642	3	,	,	,
cord-023095-4dannjjm	5642	4	activity	activity	NN
cord-023095-4dannjjm	5642	5	was	be	VBD
cord-023095-4dannjjm	5642	6	documented	document	VBN
cord-023095-4dannjjm	5642	7	prior	prior	RB
cord-023095-4dannjjm	5642	8	to	to	IN
cord-023095-4dannjjm	5642	9	VBL	VBL	NNP
cord-023095-4dannjjm	5642	10	treatments	treatment	NNS
cord-023095-4dannjjm	5642	11	2	2	CD
cord-023095-4dannjjm	5642	12	-	-	SYM
cord-023095-4dannjjm	5642	13	4	4	CD
cord-023095-4dannjjm	5642	14	,	,	,
cord-023095-4dannjjm	5642	15	and	and	CC
cord-023095-4dannjjm	5643	1	monthly	monthly	RB
cord-023095-4dannjjm	5643	2	thereafter	thereafter	RB
cord-023095-4dannjjm	5643	3	,	,	,
cord-023095-4dannjjm	5643	4	based	base	VBN
cord-023095-4dannjjm	5643	5	on	on	IN
cord-023095-4dannjjm	5643	6	RECIST	RECIST	NNP
cord-023095-4dannjjm	5643	7	criteria	criterion	NNS
cord-023095-4dannjjm	5643	8	.	.	.
cord-023095-4dannjjm	5644	1	Nine	nine	CD
cord-023095-4dannjjm	5644	2	dogs	dog	NNS
cord-023095-4dannjjm	5644	3	have	have	VBP
cord-023095-4dannjjm	5644	4	been	be	VBN
cord-023095-4dannjjm	5644	5	enrolled	enrol	VBN
cord-023095-4dannjjm	5644	6	;	;	:
cord-023095-4dannjjm	5644	7	cohort	cohort	NN
cord-023095-4dannjjm	5644	8	3	3	CD
cord-023095-4dannjjm	5644	9	is	be	VBZ
cord-023095-4dannjjm	5644	10	filled	fill	VBN
cord-023095-4dannjjm	5644	11	and	and	CC
cord-023095-4dannjjm	5644	12	approaching	approach	VBG
cord-023095-4dannjjm	5644	13	completion	completion	NN
cord-023095-4dannjjm	5644	14	of	of	IN
cord-023095-4dannjjm	5644	15	the	the	DT
cord-023095-4dannjjm	5644	16	evaluation	evaluation	NN
cord-023095-4dannjjm	5644	17	period	period	NN
cord-023095-4dannjjm	5644	18	.	.	.
cord-023095-4dannjjm	5645	1	Hematologic	Hematologic	NNP
cord-023095-4dannjjm	5645	2	dose	dose	VBD
cord-023095-4dannjjm	5645	3	limiting	limit	VBG
cord-023095-4dannjjm	5645	4	toxicity	toxicity	NN
cord-023095-4dannjjm	5645	5	led	lead	VBD
cord-023095-4dannjjm	5645	6	to	to	IN
cord-023095-4dannjjm	5645	7	2	2	CD
cord-023095-4dannjjm	5645	8	de	de	NNS
cord-023095-4dannjjm	5645	9	-	-	HYPH
cord-023095-4dannjjm	5645	10	escalations	escalation	NNS
cord-023095-4dannjjm	5645	11	of	of	IN
cord-023095-4dannjjm	5645	12	VBL	VBL	NNP
cord-023095-4dannjjm	5645	13	.	.	.
cord-023095-4dannjjm	5646	1	The	the	DT
cord-023095-4dannjjm	5646	2	current	current	JJ
cord-023095-4dannjjm	5646	3	safe	safe	JJ
cord-023095-4dannjjm	5646	4	combination	combination	NN
cord-023095-4dannjjm	5646	5	appears	appear	VBZ
cord-023095-4dannjjm	5646	6	to	to	TO
cord-023095-4dannjjm	5646	7	include	include	VB
cord-023095-4dannjjm	5646	8	VBL	VBL	NNP
cord-023095-4dannjjm	5646	9	at	at	IN
cord-023095-4dannjjm	5646	10	1.6	1.6	CD
cord-023095-4dannjjm	5646	11	mg	mg	NNP
cord-023095-4dannjjm	5646	12	/	/	SYM
cord-023095-4dannjjm	5646	13	m2	m2	NNP
cord-023095-4dannjjm	5646	14	every	every	DT
cord-023095-4dannjjm	5646	15	other	other	JJ
cord-023095-4dannjjm	5646	16	week	week	NN
cord-023095-4dannjjm	5646	17	and	and	CC
cord-023095-4dannjjm	5646	18	Palladia	Palladia	NNP
cord-023095-4dannjjm	5646	19	s	s	NNP
cord-023095-4dannjjm	5646	20	at	at	IN
cord-023095-4dannjjm	5646	21	2.25	2.25	CD
cord-023095-4dannjjm	5646	22	mg	mg	NNP
cord-023095-4dannjjm	5646	23	/	/	SYM
cord-023095-4dannjjm	5646	24	kg	kg	NNP
cord-023095-4dannjjm	5646	25	EOD	EOD	NNP
cord-023095-4dannjjm	5646	26	.	.	.
cord-023095-4dannjjm	5647	1	Response	response	NN
cord-023095-4dannjjm	5647	2	was	be	VBD
cord-023095-4dannjjm	5647	3	seen	see	VBN
cord-023095-4dannjjm	5647	4	in	in	IN
cord-023095-4dannjjm	5647	5	all	all	DT
cord-023095-4dannjjm	5647	6	but	but	IN
cord-023095-4dannjjm	5647	7	one	one	CD
cord-023095-4dannjjm	5647	8	dog	dog	NN
cord-023095-4dannjjm	5647	9	.	.	.
cord-023095-4dannjjm	5648	1	Without	without	IN
cord-023095-4dannjjm	5648	2	head	head	NN
cord-023095-4dannjjm	5648	3	to	to	IN
cord-023095-4dannjjm	5648	4	head	head	VB
cord-023095-4dannjjm	5648	5	trials	trial	NNS
cord-023095-4dannjjm	5648	6	comparing	compare	VBG
cord-023095-4dannjjm	5648	7	efficacy	efficacy	NN
cord-023095-4dannjjm	5648	8	of	of	IN
cord-023095-4dannjjm	5648	9	bi	bi	JJ
cord-023095-4dannjjm	5648	10	-	-	JJ
cord-023095-4dannjjm	5648	11	weekly	weekly	JJ
cord-023095-4dannjjm	5648	12	VBL	VBL	NNP
cord-023095-4dannjjm	5648	13	combined	combine	VBN
cord-023095-4dannjjm	5648	14	with	with	IN
cord-023095-4dannjjm	5648	15	Palladia	Palladia	NNP
cord-023095-4dannjjm	5648	16	s	s	NNP
cord-023095-4dannjjm	5648	17	and	and	CC
cord-023095-4dannjjm	5648	18	VBL	VBL	NNP
cord-023095-4dannjjm	5648	19	alone	alone	RB
cord-023095-4dannjjm	5648	20	,	,	,
cord-023095-4dannjjm	5648	21	choice	choice	NN
cord-023095-4dannjjm	5648	22	of	of	IN
cord-023095-4dannjjm	5648	23	therapy	therapy	NN
cord-023095-4dannjjm	5648	24	should	should	MD
cord-023095-4dannjjm	5648	25	remain	remain	VB
cord-023095-4dannjjm	5648	26	at	at	IN
cord-023095-4dannjjm	5648	27	the	the	DT
cord-023095-4dannjjm	5648	28	clinician	clinician	NN
cord-023095-4dannjjm	5648	29	's	's	POS
cord-023095-4dannjjm	5648	30	discretion	discretion	NN
cord-023095-4dannjjm	5648	31	.	.	.
cord-023095-4dannjjm	5649	1	Originally	originally	RB
cord-023095-4dannjjm	5649	2	Prostate	prostate	NN
cord-023095-4dannjjm	5649	3	specific	specific	JJ
cord-023095-4dannjjm	5649	4	membrane	membrane	NN
cord-023095-4dannjjm	5649	5	antigen	antigen	NN
cord-023095-4dannjjm	5649	6	(	(	-LRB-
cord-023095-4dannjjm	5649	7	PSMA	PSMA	NNP
cord-023095-4dannjjm	5649	8	)	)	-RRB-
cord-023095-4dannjjm	5649	9	is	be	VBZ
cord-023095-4dannjjm	5649	10	a	a	DT
cord-023095-4dannjjm	5649	11	transmembrane	transmembrane	NN
cord-023095-4dannjjm	5649	12	protein	protein	NN
cord-023095-4dannjjm	5649	13	expressed	express	VBN
cord-023095-4dannjjm	5649	14	by	by	IN
cord-023095-4dannjjm	5649	15	tumor	tumor	NN
cord-023095-4dannjjm	5649	16	-	-	HYPH
cord-023095-4dannjjm	5649	17	associated	associate	VBN
cord-023095-4dannjjm	5649	18	neovasculature	neovasculature	NN
cord-023095-4dannjjm	5649	19	,	,	,
cord-023095-4dannjjm	5649	20	but	but	CC
cord-023095-4dannjjm	5649	21	not	not	RB
cord-023095-4dannjjm	5649	22	normal	normal	JJ
cord-023095-4dannjjm	5649	23	blood	blood	NN
cord-023095-4dannjjm	5649	24	vessels	vessel	NNS
cord-023095-4dannjjm	5649	25	.	.	.
cord-023095-4dannjjm	5650	1	Based	base	VBN
cord-023095-4dannjjm	5650	2	upon	upon	IN
cord-023095-4dannjjm	5650	3	its	-PRON-	PRP$
cord-023095-4dannjjm	5650	4	selective	selective	JJ
cord-023095-4dannjjm	5650	5	expression	expression	NN
cord-023095-4dannjjm	5650	6	in	in	IN
cord-023095-4dannjjm	5650	7	endothelial	endothelial	JJ
cord-023095-4dannjjm	5650	8	cells	cell	NNS
cord-023095-4dannjjm	5650	9	associated	associate	VBN
cord-023095-4dannjjm	5650	10	with	with	IN
cord-023095-4dannjjm	5650	11	cancer	cancer	NN
cord-023095-4dannjjm	5650	12	,	,	,
cord-023095-4dannjjm	5650	13	PSMA	PSMA	NNP
cord-023095-4dannjjm	5650	14	may	may	MD
cord-023095-4dannjjm	5650	15	serve	serve	VB
cord-023095-4dannjjm	5650	16	as	as	IN
cord-023095-4dannjjm	5650	17	a	a	DT
cord-023095-4dannjjm	5650	18	conserved	conserved	JJ
cord-023095-4dannjjm	5650	19	angiogenic	angiogenic	JJ
cord-023095-4dannjjm	5650	20	target	target	NN
cord-023095-4dannjjm	5650	21	shared	share	VBN
cord-023095-4dannjjm	5650	22	by	by	IN
cord-023095-4dannjjm	5650	23	macroscopic	macroscopic	JJ
cord-023095-4dannjjm	5650	24	solid	solid	JJ
cord-023095-4dannjjm	5650	25	tumors	tumor	NNS
cord-023095-4dannjjm	5650	26	of	of	IN
cord-023095-4dannjjm	5650	27	various	various	JJ
cord-023095-4dannjjm	5650	28	histologies	histology	NNS
cord-023095-4dannjjm	5650	29	.	.	.
cord-023095-4dannjjm	5651	1	To	to	TO
cord-023095-4dannjjm	5651	2	investigate	investigate	VB
cord-023095-4dannjjm	5651	3	the	the	DT
cord-023095-4dannjjm	5651	4	feasibility	feasibility	NN
cord-023095-4dannjjm	5651	5	of	of	IN
cord-023095-4dannjjm	5651	6	targeting	target	VBG
cord-023095-4dannjjm	5651	7	a	a	DT
cord-023095-4dannjjm	5651	8	homogenous	homogenous	JJ
cord-023095-4dannjjm	5651	9	population	population	NN
cord-023095-4dannjjm	5651	10	of	of	IN
cord-023095-4dannjjm	5651	11	PSMA	PSMA	NNP
cord-023095-4dannjjm	5651	12	-	-	:
cord-023095-4dannjjm	5651	13	expressing	express	VBG
cord-023095-4dannjjm	5651	14	endothelial	endothelial	JJ
cord-023095-4dannjjm	5651	15	cells	cell	NNS
cord-023095-4dannjjm	5651	16	as	as	IN
cord-023095-4dannjjm	5651	17	a	a	DT
cord-023095-4dannjjm	5651	18	novel	novel	JJ
cord-023095-4dannjjm	5651	19	anticancer	anticancer	JJ
cord-023095-4dannjjm	5651	20	strategy	strategy	NN
cord-023095-4dannjjm	5651	21	,	,	,
cord-023095-4dannjjm	5651	22	we	-PRON-	PRP
cord-023095-4dannjjm	5651	23	have	have	VBP
cord-023095-4dannjjm	5651	24	investigated	investigate	VBN
cord-023095-4dannjjm	5651	25	PSMA	PSMA	NNP
cord-023095-4dannjjm	5651	26	expression	expression	NN
cord-023095-4dannjjm	5651	27	in	in	IN
cord-023095-4dannjjm	5651	28	several	several	JJ
cord-023095-4dannjjm	5651	29	canine	canine	JJ
cord-023095-4dannjjm	5651	30	hemangiosarcoma	hemangiosarcoma	NN
cord-023095-4dannjjm	5651	31	(	(	-LRB-
cord-023095-4dannjjm	5651	32	cHSA	chsa	JJ
cord-023095-4dannjjm	5651	33	)	)	-RRB-
cord-023095-4dannjjm	5651	34	cell	cell	NN
cord-023095-4dannjjm	5651	35	lines	line	NNS
cord-023095-4dannjjm	5651	36	,	,	,
cord-023095-4dannjjm	5651	37	and	and	CC
cord-023095-4dannjjm	5651	38	subsequently	subsequently	RB
cord-023095-4dannjjm	5651	39	developed	develop	VBD
cord-023095-4dannjjm	5651	40	self	self	NN
cord-023095-4dannjjm	5651	41	-	-	HYPH
cord-023095-4dannjjm	5651	42	assembling	assemble	VBG
cord-023095-4dannjjm	5651	43	nanoparticles	nanoparticle	NNS
cord-023095-4dannjjm	5651	44	containing	contain	VBG
cord-023095-4dannjjm	5651	45	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	5651	46	(	(	-LRB-
cord-023095-4dannjjm	5651	47	near	near	IN
cord-023095-4dannjjm	5651	48	infrared	infrared	JJ
cord-023095-4dannjjm	5651	49	dyes	dye	NNS
cord-023095-4dannjjm	5651	50	)	)	-RRB-
cord-023095-4dannjjm	5651	51	and	and	CC
cord-023095-4dannjjm	5651	52	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5651	53	(	(	-LRB-
cord-023095-4dannjjm	5651	54	doxorubicin	doxorubicin	NN
cord-023095-4dannjjm	5651	55	)	)	-RRB-
cord-023095-4dannjjm	5651	56	cargo	cargo	NN
cord-023095-4dannjjm	5651	57	which	which	WDT
cord-023095-4dannjjm	5651	58	selectively	selectively	RB
cord-023095-4dannjjm	5651	59	bind	bind	VBP
cord-023095-4dannjjm	5651	60	to	to	IN
cord-023095-4dannjjm	5651	61	PSMA	PSMA	NNP
cord-023095-4dannjjm	5651	62	by	by	IN
cord-023095-4dannjjm	5651	63	means	mean	NNS
cord-023095-4dannjjm	5651	64	of	of	IN
cord-023095-4dannjjm	5651	65	the	the	DT
cord-023095-4dannjjm	5651	66	A10	A10	NNP
cord-023095-4dannjjm	5651	67	aptamer	aptamer	NN
cord-023095-4dannjjm	5651	68	,	,	,
cord-023095-4dannjjm	5651	69	a	a	DT
cord-023095-4dannjjm	5651	70	commercially	commercially	RB
cord-023095-4dannjjm	5651	71	-	-	HYPH
cord-023095-4dannjjm	5651	72	available	available	JJ
cord-023095-4dannjjm	5651	73	oligonucleotide	oligonucleotide	NN
cord-023095-4dannjjm	5651	74	.	.	.
cord-023095-4dannjjm	5652	1	The	the	DT
cord-023095-4dannjjm	5652	2	expression	expression	NN
cord-023095-4dannjjm	5652	3	of	of	IN
cord-023095-4dannjjm	5652	4	PSMA	PSMA	NNP
cord-023095-4dannjjm	5652	5	by	by	IN
cord-023095-4dannjjm	5652	6	cHSA	chsa	JJ
cord-023095-4dannjjm	5652	7	cells	cell	NNS
cord-023095-4dannjjm	5652	8	was	be	VBD
cord-023095-4dannjjm	5652	9	confirmed	confirm	VBN
cord-023095-4dannjjm	5652	10	transcriptionally	transcriptionally	RB
cord-023095-4dannjjm	5652	11	and	and	CC
cord-023095-4dannjjm	5652	12	translationally	translationally	RB
cord-023095-4dannjjm	5652	13	by	by	IN
cord-023095-4dannjjm	5652	14	real	real	JJ
cord-023095-4dannjjm	5652	15	time	time	NN
cord-023095-4dannjjm	5652	16	PCR	pcr	NN
cord-023095-4dannjjm	5652	17	and	and	CC
cord-023095-4dannjjm	5652	18	immunohistochemistry	immunohistochemistry	NN
cord-023095-4dannjjm	5652	19	,	,	,
cord-023095-4dannjjm	5652	20	respectively	respectively	RB
cord-023095-4dannjjm	5652	21	.	.	.
cord-023095-4dannjjm	5653	1	Selective	selective	JJ
cord-023095-4dannjjm	5653	2	binding	binding	NN
cord-023095-4dannjjm	5653	3	and	and	CC
cord-023095-4dannjjm	5653	4	endocytosis	endocytosis	NN
cord-023095-4dannjjm	5653	5	of	of	IN
cord-023095-4dannjjm	5653	6	A10	A10	NNP
cord-023095-4dannjjm	5653	7	decorated	decorate	VBN
cord-023095-4dannjjm	5653	8	nanoparticles	nanoparticle	NNS
cord-023095-4dannjjm	5653	9	was	be	VBD
cord-023095-4dannjjm	5653	10	studied	study	VBN
cord-023095-4dannjjm	5653	11	by	by	IN
cord-023095-4dannjjm	5653	12	fluorescent	fluorescent	JJ
cord-023095-4dannjjm	5653	13	microscopy	microscopy	NNS
cord-023095-4dannjjm	5653	14	.	.	.
cord-023095-4dannjjm	5654	1	The	the	DT
cord-023095-4dannjjm	5654	2	ability	ability	NN
cord-023095-4dannjjm	5654	3	of	of	IN
cord-023095-4dannjjm	5654	4	A10	A10	NNP
cord-023095-4dannjjm	5654	5	decorated	decorate	VBN
cord-023095-4dannjjm	5654	6	nanoparticles	nanoparticle	NNS
cord-023095-4dannjjm	5654	7	encapsulating	encapsulate	VBG
cord-023095-4dannjjm	5654	8	doxorubicin	doxorubicin	NN
cord-023095-4dannjjm	5654	9	to	to	TO
cord-023095-4dannjjm	5654	10	exert	exert	VB
cord-023095-4dannjjm	5654	11	in	in	IN
cord-023095-4dannjjm	5654	12	vitro	vitro	FW
cord-023095-4dannjjm	5654	13	cytotoxic	cytotoxic	JJ
cord-023095-4dannjjm	5654	14	effects	effect	NNS
cord-023095-4dannjjm	5654	15	in	in	IN
cord-023095-4dannjjm	5654	16	cHSA	chsa	JJ
cord-023095-4dannjjm	5654	17	cells	cell	NNS
cord-023095-4dannjjm	5654	18	was	be	VBD
cord-023095-4dannjjm	5654	19	assessed	assess	VBN
cord-023095-4dannjjm	5654	20	by	by	IN
cord-023095-4dannjjm	5654	21	colony	colony	NN
cord-023095-4dannjjm	5654	22	forming	form	VBG
cord-023095-4dannjjm	5654	23	assays	assay	NNS
cord-023095-4dannjjm	5654	24	.	.	.
cord-023095-4dannjjm	5655	1	Using	use	VBG
cord-023095-4dannjjm	5655	2	a	a	DT
cord-023095-4dannjjm	5655	3	cHSA	chsa	JJ
cord-023095-4dannjjm	5655	4	xenograft	xenograft	NN
cord-023095-4dannjjm	5655	5	murine	murine	JJ
cord-023095-4dannjjm	5655	6	tumor	tumor	NN
cord-023095-4dannjjm	5655	7	model	model	NN
cord-023095-4dannjjm	5655	8	,	,	,
cord-023095-4dannjjm	5655	9	clinically	clinically	RB
cord-023095-4dannjjm	5655	10	-	-	HYPH
cord-023095-4dannjjm	5655	11	relevant	relevant	JJ
cord-023095-4dannjjm	5655	12	anticancer	anticancer	JJ
cord-023095-4dannjjm	5655	13	effects	effect	NNS
cord-023095-4dannjjm	5655	14	of	of	IN
cord-023095-4dannjjm	5655	15	A10	A10	NNP
cord-023095-4dannjjm	5655	16	decorated	decorate	VBN
cord-023095-4dannjjm	5655	17	nanoparticles	nanoparticle	NNS
cord-023095-4dannjjm	5655	18	encapsulating	encapsulate	VBG
cord-023095-4dannjjm	5655	19	doxorubicin	doxorubicin	NN
cord-023095-4dannjjm	5655	20	were	be	VBD
cord-023095-4dannjjm	5655	21	tested	test	VBN
cord-023095-4dannjjm	5655	22	.	.	.
cord-023095-4dannjjm	5656	1	All	all	DT
cord-023095-4dannjjm	5656	2	cHSA	chsa	JJ
cord-023095-4dannjjm	5656	3	cell	cell	NN
cord-023095-4dannjjm	5656	4	lines	line	NNS
cord-023095-4dannjjm	5656	5	expressed	express	VBD
cord-023095-4dannjjm	5656	6	PSMA	PSMA	NNP
cord-023095-4dannjjm	5656	7	mRNA	mRNA	NNP
cord-023095-4dannjjm	5656	8	and	and	CC
cord-023095-4dannjjm	5656	9	protein	protein	NN
cord-023095-4dannjjm	5656	10	.	.	.
cord-023095-4dannjjm	5657	1	A10	A10	NNP
cord-023095-4dannjjm	5657	2	decorated	decorate	VBN
cord-023095-4dannjjm	5657	3	nanoparticles	nanoparticle	NNS
cord-023095-4dannjjm	5657	4	were	be	VBD
cord-023095-4dannjjm	5657	5	selectively	selectively	RB
cord-023095-4dannjjm	5657	6	endocytosed	endocytose	VBN
cord-023095-4dannjjm	5657	7	by	by	IN
cord-023095-4dannjjm	5657	8	PSMA	PSMA	NNP
cord-023095-4dannjjm	5657	9	-	-	HYPH
cord-023095-4dannjjm	5657	10	expressing	express	VBG
cord-023095-4dannjjm	5657	11	cells	cell	NNS
cord-023095-4dannjjm	5657	12	,	,	,
cord-023095-4dannjjm	5657	13	and	and	CC
cord-023095-4dannjjm	5657	14	when	when	WRB
cord-023095-4dannjjm	5657	15	these	these	DT
cord-023095-4dannjjm	5657	16	nanoparticles	nanoparticle	NNS
cord-023095-4dannjjm	5657	17	encapsulated	encapsulate	VBD
cord-023095-4dannjjm	5657	18	doxorubicin	doxorubicin	JJ
cord-023095-4dannjjm	5657	19	,	,	,
cord-023095-4dannjjm	5657	20	significant	significant	JJ
cord-023095-4dannjjm	5657	21	cytotoxic	cytotoxic	JJ
cord-023095-4dannjjm	5657	22	effects	effect	NNS
cord-023095-4dannjjm	5657	23	were	be	VBD
cord-023095-4dannjjm	5657	24	exerted	exert	VBN
cord-023095-4dannjjm	5657	25	in	in	IN
cord-023095-4dannjjm	5657	26	vitro	vitro	FW
cord-023095-4dannjjm	5657	27	.	.	.
cord-023095-4dannjjm	5658	1	Finally	finally	RB
cord-023095-4dannjjm	5658	2	,	,	,
cord-023095-4dannjjm	5658	3	A10	A10	NNP
cord-023095-4dannjjm	5658	4	decorated	decorate	VBD
cord-023095-4dannjjm	5658	5	nanoparticles	nanoparticle	NNS
cord-023095-4dannjjm	5658	6	encapsulating	encapsulate	VBG
cord-023095-4dannjjm	5658	7	doxorubicin	doxorubicin	NN
cord-023095-4dannjjm	5658	8	significantly	significantly	RB
cord-023095-4dannjjm	5658	9	reduced	reduce	VBD
cord-023095-4dannjjm	5658	10	the	the	DT
cord-023095-4dannjjm	5658	11	size	size	NN
cord-023095-4dannjjm	5658	12	of	of	IN
cord-023095-4dannjjm	5658	13	macroscopic	macroscopic	JJ
cord-023095-4dannjjm	5658	14	cHSA	chsa	JJ
cord-023095-4dannjjm	5658	15	tumor	tumor	NN
cord-023095-4dannjjm	5658	16	burdens	burden	NNS
cord-023095-4dannjjm	5658	17	in	in	IN
cord-023095-4dannjjm	5658	18	transplanted	transplanted	JJ
cord-023095-4dannjjm	5658	19	mice	mouse	NNS
cord-023095-4dannjjm	5658	20	.	.	.
cord-023095-4dannjjm	5659	1	Diagnostic	diagnostic	JJ
cord-023095-4dannjjm	5659	2	and	and	CC
cord-023095-4dannjjm	5659	3	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5659	4	nanoparticles	nanoparticle	NNS
cord-023095-4dannjjm	5659	5	can	can	MD
cord-023095-4dannjjm	5659	6	be	be	VB
cord-023095-4dannjjm	5659	7	targeted	target	VBN
cord-023095-4dannjjm	5659	8	to	to	IN
cord-023095-4dannjjm	5659	9	PSMA	PSMA	NNP
cord-023095-4dannjjm	5659	10	-	-	:
cord-023095-4dannjjm	5659	11	expressing	express	VBG
cord-023095-4dannjjm	5659	12	endothelial	endothelial	JJ
cord-023095-4dannjjm	5659	13	cells	cell	NNS
cord-023095-4dannjjm	5659	14	,	,	,
cord-023095-4dannjjm	5659	15	and	and	CC
cord-023095-4dannjjm	5659	16	cHSA	cHSA	NNP
cord-023095-4dannjjm	5659	17	provides	provide	VBZ
cord-023095-4dannjjm	5659	18	a	a	DT
cord-023095-4dannjjm	5659	19	comparative	comparative	JJ
cord-023095-4dannjjm	5659	20	model	model	NN
cord-023095-4dannjjm	5659	21	for	for	IN
cord-023095-4dannjjm	5659	22	the	the	DT
cord-023095-4dannjjm	5659	23	future	future	JJ
cord-023095-4dannjjm	5659	24	study	study	NN
cord-023095-4dannjjm	5659	25	of	of	IN
cord-023095-4dannjjm	5659	26	nanoparticle	nanoparticle	NN
cord-023095-4dannjjm	5659	27	therapeutics	therapeutic	NNS
cord-023095-4dannjjm	5659	28	.	.	.
cord-023095-4dannjjm	5660	1	Canine	canine	JJ
cord-023095-4dannjjm	5660	2	transitional	transitional	JJ
cord-023095-4dannjjm	5660	3	cell	cell	NN
cord-023095-4dannjjm	5660	4	carcinoma	carcinoma	NN
cord-023095-4dannjjm	5660	5	(	(	-LRB-
cord-023095-4dannjjm	5660	6	TCC	TCC	NNP
cord-023095-4dannjjm	5660	7	)	)	-RRB-
cord-023095-4dannjjm	5660	8	is	be	VBZ
cord-023095-4dannjjm	5660	9	the	the	DT
cord-023095-4dannjjm	5660	10	most	most	RBS
cord-023095-4dannjjm	5660	11	common	common	JJ
cord-023095-4dannjjm	5660	12	tumor	tumor	NN
cord-023095-4dannjjm	5660	13	of	of	IN
cord-023095-4dannjjm	5660	14	the	the	DT
cord-023095-4dannjjm	5660	15	urinary	urinary	JJ
cord-023095-4dannjjm	5660	16	tract	tract	NN
cord-023095-4dannjjm	5660	17	,	,	,
cord-023095-4dannjjm	5660	18	and	and	CC
cord-023095-4dannjjm	5660	19	is	be	VBZ
cord-023095-4dannjjm	5660	20	similar	similar	JJ
cord-023095-4dannjjm	5660	21	to	to	IN
cord-023095-4dannjjm	5660	22	human	human	JJ
cord-023095-4dannjjm	5660	23	invasive	invasive	JJ
cord-023095-4dannjjm	5660	24	TCC	tcc	NN
cord-023095-4dannjjm	5660	25	in	in	IN
cord-023095-4dannjjm	5660	26	histopathologic	histopathologic	JJ
cord-023095-4dannjjm	5660	27	characteristics	characteristic	NNS
cord-023095-4dannjjm	5660	28	,	,	,
cord-023095-4dannjjm	5660	29	molecular	molecular	JJ
cord-023095-4dannjjm	5660	30	features	feature	NNS
cord-023095-4dannjjm	5660	31	,	,	,
cord-023095-4dannjjm	5660	32	sites	site	NNS
cord-023095-4dannjjm	5660	33	of	of	IN
cord-023095-4dannjjm	5660	34	metastasis	metastasis	NN
cord-023095-4dannjjm	5660	35	,	,	,
cord-023095-4dannjjm	5660	36	and	and	CC
cord-023095-4dannjjm	5660	37	response	response	NN
cord-023095-4dannjjm	5660	38	to	to	IN
cord-023095-4dannjjm	5660	39	medical	medical	JJ
cord-023095-4dannjjm	5660	40	therapy	therapy	NN
cord-023095-4dannjjm	5660	41	.	.	.
cord-023095-4dannjjm	5661	1	Prevalence	prevalence	NN
cord-023095-4dannjjm	5661	2	is	be	VBZ
cord-023095-4dannjjm	5661	3	increasing	increase	VBG
cord-023095-4dannjjm	5661	4	,	,	,
cord-023095-4dannjjm	5661	5	and	and	CC
cord-023095-4dannjjm	5661	6	novel	novel	JJ
cord-023095-4dannjjm	5661	7	therapies	therapy	NNS
cord-023095-4dannjjm	5661	8	and	and	CC
cord-023095-4dannjjm	5661	9	strategies	strategy	NNS
cord-023095-4dannjjm	5661	10	are	be	VBP
cord-023095-4dannjjm	5661	11	needed	need	VBN
cord-023095-4dannjjm	5661	12	to	to	TO
cord-023095-4dannjjm	5661	13	effectively	effectively	RB
cord-023095-4dannjjm	5661	14	treat	treat	VB
cord-023095-4dannjjm	5661	15	this	this	DT
cord-023095-4dannjjm	5661	16	aggressive	aggressive	JJ
cord-023095-4dannjjm	5661	17	form	form	NN
cord-023095-4dannjjm	5661	18	of	of	IN
cord-023095-4dannjjm	5661	19	cancer	cancer	NN
cord-023095-4dannjjm	5661	20	in	in	IN
cord-023095-4dannjjm	5661	21	both	both	DT
cord-023095-4dannjjm	5661	22	species	specie	NNS
cord-023095-4dannjjm	5661	23	.	.	.
cord-023095-4dannjjm	5662	1	Personalized	personalized	JJ
cord-023095-4dannjjm	5662	2	medicine	medicine	NN
cord-023095-4dannjjm	5662	3	techniques	technique	NNS
cord-023095-4dannjjm	5662	4	intend	intend	VBP
cord-023095-4dannjjm	5662	5	to	to	TO
cord-023095-4dannjjm	5662	6	improve	improve	VB
cord-023095-4dannjjm	5662	7	treatment	treatment	NN
cord-023095-4dannjjm	5662	8	outcome	outcome	NN
cord-023095-4dannjjm	5662	9	by	by	IN
cord-023095-4dannjjm	5662	10	using	use	VBG
cord-023095-4dannjjm	5662	11	patient	patient	JJ
cord-023095-4dannjjm	5662	12	tumor	tumor	NN
cord-023095-4dannjjm	5662	13	profiling	profiling	NN
cord-023095-4dannjjm	5662	14	to	to	TO
cord-023095-4dannjjm	5662	15	identify	identify	VB
cord-023095-4dannjjm	5662	16	potential	potential	JJ
cord-023095-4dannjjm	5662	17	and	and	CC
cord-023095-4dannjjm	5662	18	individualized	individualized	JJ
cord-023095-4dannjjm	5662	19	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5662	20	targets	target	NNS
cord-023095-4dannjjm	5662	21	.	.	.
cord-023095-4dannjjm	5663	1	A	a	DT
cord-023095-4dannjjm	5663	2	genomic	genomic	JJ
cord-023095-4dannjjm	5663	3	algorithm	algorithm	NN
cord-023095-4dannjjm	5663	4	has	have	VBZ
cord-023095-4dannjjm	5663	5	been	be	VBN
cord-023095-4dannjjm	5663	6	developed	develop	VBN
cord-023095-4dannjjm	5663	7	termed	term	VBN
cord-023095-4dannjjm	5663	8	'	'	''
cord-023095-4dannjjm	5663	9	'	'	``
cord-023095-4dannjjm	5663	10	coexpression	coexpression	NN
cord-023095-4dannjjm	5663	11	extrapolation	extrapolation	NN
cord-023095-4dannjjm	5663	12	'	'	''
cord-023095-4dannjjm	5663	13	'	'	''
cord-023095-4dannjjm	5663	14	,	,	,
cord-023095-4dannjjm	5663	15	or	or	CC
cord-023095-4dannjjm	5663	16	COXEN	COXEN	NNP
cord-023095-4dannjjm	5663	17	,	,	,
cord-023095-4dannjjm	5663	18	that	that	WDT
cord-023095-4dannjjm	5663	19	aims	aim	VBZ
cord-023095-4dannjjm	5663	20	to	to	TO
cord-023095-4dannjjm	5663	21	use	use	VB
cord-023095-4dannjjm	5663	22	expression	expression	NN
cord-023095-4dannjjm	5663	23	microarray	microarray	NN
cord-023095-4dannjjm	5663	24	data	datum	NNS
cord-023095-4dannjjm	5663	25	to	to	TO
cord-023095-4dannjjm	5663	26	predict	predict	VB
cord-023095-4dannjjm	5663	27	drug	drug	NN
cord-023095-4dannjjm	5663	28	activity	activity	NN
cord-023095-4dannjjm	5663	29	in	in	IN
cord-023095-4dannjjm	5663	30	patient	patient	JJ
cord-023095-4dannjjm	5663	31	TCC	tcc	NN
cord-023095-4dannjjm	5663	32	samples	sample	NNS
cord-023095-4dannjjm	5663	33	.	.	.
cord-023095-4dannjjm	5664	1	The	the	DT
cord-023095-4dannjjm	5664	2	utility	utility	NN
cord-023095-4dannjjm	5664	3	of	of	IN
cord-023095-4dannjjm	5664	4	this	this	DT
cord-023095-4dannjjm	5664	5	predictive	predictive	JJ
cord-023095-4dannjjm	5664	6	methodology	methodology	NN
cord-023095-4dannjjm	5664	7	has	have	VBZ
cord-023095-4dannjjm	5664	8	been	be	VBN
cord-023095-4dannjjm	5664	9	established	establish	VBN
cord-023095-4dannjjm	5664	10	in	in	IN
cord-023095-4dannjjm	5664	11	other	other	JJ
cord-023095-4dannjjm	5664	12	types	type	NNS
cord-023095-4dannjjm	5664	13	of	of	IN
cord-023095-4dannjjm	5664	14	cancer	cancer	NN
cord-023095-4dannjjm	5664	15	in	in	IN
cord-023095-4dannjjm	5664	16	vitro	vitro	FW
cord-023095-4dannjjm	5664	17	,	,	,
cord-023095-4dannjjm	5664	18	however	however	RB
cord-023095-4dannjjm	5664	19	its	-PRON-	PRP$
cord-023095-4dannjjm	5664	20	clinical	clinical	JJ
cord-023095-4dannjjm	5664	21	utility	utility	NN
cord-023095-4dannjjm	5664	22	has	have	VBZ
cord-023095-4dannjjm	5664	23	not	not	RB
cord-023095-4dannjjm	5664	24	yet	yet	RB
cord-023095-4dannjjm	5664	25	been	be	VBN
cord-023095-4dannjjm	5664	26	determined	determine	VBN
cord-023095-4dannjjm	5664	27	.	.	.
cord-023095-4dannjjm	5665	1	Validation	validation	NN
cord-023095-4dannjjm	5665	2	studies	study	NNS
cord-023095-4dannjjm	5665	3	of	of	IN
cord-023095-4dannjjm	5665	4	COXEN	COXEN	NNP
cord-023095-4dannjjm	5665	5	in	in	IN
cord-023095-4dannjjm	5665	6	10	10	CD
cord-023095-4dannjjm	5665	7	canine	canine	JJ
cord-023095-4dannjjm	5665	8	TCC	tcc	NN
cord-023095-4dannjjm	5665	9	cell	cell	NN
cord-023095-4dannjjm	5665	10	lines	line	NNS
cord-023095-4dannjjm	5665	11	were	be	VBD
cord-023095-4dannjjm	5665	12	conducted	conduct	VBN
cord-023095-4dannjjm	5665	13	.	.	.
cord-023095-4dannjjm	5666	1	The	the	DT
cord-023095-4dannjjm	5666	2	goal	goal	NN
cord-023095-4dannjjm	5666	3	was	be	VBD
cord-023095-4dannjjm	5666	4	to	to	TO
cord-023095-4dannjjm	5666	5	determine	determine	VB
cord-023095-4dannjjm	5666	6	the	the	DT
cord-023095-4dannjjm	5666	7	value	value	NN
cord-023095-4dannjjm	5666	8	of	of	IN
cord-023095-4dannjjm	5666	9	COXEN	COXEN	NNP
cord-023095-4dannjjm	5666	10	in	in	IN
cord-023095-4dannjjm	5666	11	predicting	predict	VBG
cord-023095-4dannjjm	5666	12	baseline	baseline	JJ
cord-023095-4dannjjm	5666	13	sensitivity	sensitivity	NN
cord-023095-4dannjjm	5666	14	of	of	IN
cord-023095-4dannjjm	5666	15	canine	canine	JJ
cord-023095-4dannjjm	5666	16	TCC	tcc	NN
cord-023095-4dannjjm	5666	17	to	to	IN
cord-023095-4dannjjm	5666	18	5	5	CD
cord-023095-4dannjjm	5666	19	chemotherapy	chemotherapy	NN
cord-023095-4dannjjm	5666	20	agents	agent	NNS
cord-023095-4dannjjm	5666	21	(	(	-LRB-
cord-023095-4dannjjm	5666	22	gemcitabine	gemcitabine	NNP
cord-023095-4dannjjm	5666	23	,	,	,
cord-023095-4dannjjm	5666	24	mitoxantrone	mitoxantrone	NNP
cord-023095-4dannjjm	5666	25	,	,	,
cord-023095-4dannjjm	5666	26	carboplatin	carboplatin	NNP
cord-023095-4dannjjm	5666	27	,	,	,
cord-023095-4dannjjm	5666	28	vinblastine	vinblastine	NN
cord-023095-4dannjjm	5666	29	and	and	CC
cord-023095-4dannjjm	5666	30	cisplatin	cisplatin	NN
cord-023095-4dannjjm	5666	31	)	)	-RRB-
cord-023095-4dannjjm	5666	32	that	that	WDT
cord-023095-4dannjjm	5666	33	would	would	MD
cord-023095-4dannjjm	5666	34	then	then	RB
cord-023095-4dannjjm	5666	35	be	be	VB
cord-023095-4dannjjm	5666	36	used	use	VBN
cord-023095-4dannjjm	5666	37	in	in	IN
cord-023095-4dannjjm	5666	38	a	a	DT
cord-023095-4dannjjm	5666	39	proposed	propose	VBN
cord-023095-4dannjjm	5666	40	clinical	clinical	JJ
cord-023095-4dannjjm	5666	41	trial	trial	NN
cord-023095-4dannjjm	5666	42	.	.	.
cord-023095-4dannjjm	5667	1	Additionally	additionally	RB
cord-023095-4dannjjm	5667	2	,	,	,
cord-023095-4dannjjm	5667	3	expression	expression	NN
cord-023095-4dannjjm	5667	4	data	datum	NNS
cord-023095-4dannjjm	5667	5	from	from	IN
cord-023095-4dannjjm	5667	6	25	25	CD
cord-023095-4dannjjm	5667	7	canine	canine	JJ
cord-023095-4dannjjm	5667	8	treatment	treatment	NN
cord-023095-4dannjjm	5667	9	-	-	HYPH
cord-023095-4dannjjm	5667	10	naı¨ve	naı¨ve	NN
cord-023095-4dannjjm	5667	11	primary	primary	JJ
cord-023095-4dannjjm	5667	12	tumor	tumor	NN
cord-023095-4dannjjm	5667	13	samples	sample	NNS
cord-023095-4dannjjm	5667	14	were	be	VBD
cord-023095-4dannjjm	5667	15	generated	generate	VBN
cord-023095-4dannjjm	5667	16	on	on	IN
cord-023095-4dannjjm	5667	17	an	an	DT
cord-023095-4dannjjm	5667	18	Affymetrix	Affymetrix	NNP
cord-023095-4dannjjm	5667	19	array	array	NN
cord-023095-4dannjjm	5667	20	platform	platform	NN
cord-023095-4dannjjm	5667	21	(	(	-LRB-
cord-023095-4dannjjm	5667	22	Canine	Canine	NNP
cord-023095-4dannjjm	5667	23	Genome	Genome	NNP
cord-023095-4dannjjm	5667	24	v	v	NN
cord-023095-4dannjjm	5667	25	2.0	2.0	CD
cord-023095-4dannjjm	5667	26	)	)	-RRB-
cord-023095-4dannjjm	5667	27	.	.	.
cord-023095-4dannjjm	5668	1	Both	both	DT
cord-023095-4dannjjm	5668	2	the	the	DT
cord-023095-4dannjjm	5668	3	expression	expression	NN
cord-023095-4dannjjm	5668	4	data	datum	NNS
cord-023095-4dannjjm	5668	5	and	and	CC
cord-023095-4dannjjm	5668	6	TCC	TCC	NNP
cord-023095-4dannjjm	5668	7	cell	cell	NN
cord-023095-4dannjjm	5668	8	line	line	NN
cord-023095-4dannjjm	5668	9	data	datum	NNS
cord-023095-4dannjjm	5668	10	(	(	-LRB-
cord-023095-4dannjjm	5668	11	antiproliferative	antiproliferative	JJ
cord-023095-4dannjjm	5668	12	effects	effect	NNS
cord-023095-4dannjjm	5668	13	,	,	,
cord-023095-4dannjjm	5668	14	50	50	CD
cord-023095-4dannjjm	5668	15	%	%	NN
cord-023095-4dannjjm	5668	16	growth	growth	NN
cord-023095-4dannjjm	5668	17	inhibition	inhibition	NN
cord-023095-4dannjjm	5668	18	or	or	CC
cord-023095-4dannjjm	5668	19	GC	GC	NNP
cord-023095-4dannjjm	5668	20	50	50	CD
cord-023095-4dannjjm	5668	21	)	)	-RRB-
cord-023095-4dannjjm	5668	22	were	be	VBD
cord-023095-4dannjjm	5668	23	used	use	VBN
cord-023095-4dannjjm	5668	24	to	to	TO
cord-023095-4dannjjm	5668	25	establish	establish	VB
cord-023095-4dannjjm	5668	26	a	a	DT
cord-023095-4dannjjm	5668	27	canine	canine	JJ
cord-023095-4dannjjm	5668	28	specific	specific	JJ
cord-023095-4dannjjm	5668	29	predictive	predictive	JJ
cord-023095-4dannjjm	5668	30	COXEN	coxen	NN
cord-023095-4dannjjm	5668	31	algorithm	algorithm	NN
cord-023095-4dannjjm	5668	32	.	.	.
cord-023095-4dannjjm	5669	1	COXEN	COXEN	NNP
cord-023095-4dannjjm	5669	2	scores	score	NNS
cord-023095-4dannjjm	5669	3	for	for	IN
cord-023095-4dannjjm	5669	4	canine	canine	JJ
cord-023095-4dannjjm	5669	5	TCC	TCC	NNP
cord-023095-4dannjjm	5669	6	cell	cell	NN
cord-023095-4dannjjm	5669	7	-	-	HYPH
cord-023095-4dannjjm	5669	8	line	line	NN
cord-023095-4dannjjm	5669	9	drug	drug	NN
cord-023095-4dannjjm	5669	10	activity	activity	NN
cord-023095-4dannjjm	5669	11	were	be	VBD
cord-023095-4dannjjm	5669	12	then	then	RB
cord-023095-4dannjjm	5669	13	analyzed	analyze	VBN
cord-023095-4dannjjm	5669	14	.	.	.
cord-023095-4dannjjm	5670	1	Scores	score	NNS
cord-023095-4dannjjm	5670	2	predicted	predict	VBD
cord-023095-4dannjjm	5670	3	the	the	DT
cord-023095-4dannjjm	5670	4	activity	activity	NN
cord-023095-4dannjjm	5670	5	of	of	IN
cord-023095-4dannjjm	5670	6	cisplatin	cisplatin	NN
cord-023095-4dannjjm	5670	7	,	,	,
cord-023095-4dannjjm	5670	8	gemcitibine	gemcitibine	NNP
cord-023095-4dannjjm	5670	9	,	,	,
cord-023095-4dannjjm	5670	10	and	and	CC
cord-023095-4dannjjm	5670	11	mitoxantrone	mitoxantrone	VBN
cord-023095-4dannjjm	5670	12	in	in	IN
cord-023095-4dannjjm	5670	13	all	all	DT
cord-023095-4dannjjm	5670	14	10	10	CD
cord-023095-4dannjjm	5670	15	cell	cell	NN
cord-023095-4dannjjm	5670	16	lines	line	NNS
cord-023095-4dannjjm	5670	17	,	,	,
cord-023095-4dannjjm	5670	18	and	and	CC
cord-023095-4dannjjm	5670	19	of	of	IN
cord-023095-4dannjjm	5670	20	carboplatin	carboplatin	NNS
cord-023095-4dannjjm	5670	21	in	in	IN
cord-023095-4dannjjm	5670	22	6	6	CD
cord-023095-4dannjjm	5670	23	cell	cell	NN
cord-023095-4dannjjm	5670	24	lines	line	NNS
cord-023095-4dannjjm	5670	25	.	.	.
cord-023095-4dannjjm	5671	1	Because	because	IN
cord-023095-4dannjjm	5671	2	all	all	DT
cord-023095-4dannjjm	5671	3	of	of	IN
cord-023095-4dannjjm	5671	4	the	the	DT
cord-023095-4dannjjm	5671	5	cell	cell	NN
cord-023095-4dannjjm	5671	6	lines	line	NNS
cord-023095-4dannjjm	5671	7	were	be	VBD
cord-023095-4dannjjm	5671	8	sensitive	sensitive	JJ
cord-023095-4dannjjm	5671	9	to	to	IN
cord-023095-4dannjjm	5671	10	vinblastine	vinblastine	NN
cord-023095-4dannjjm	5671	11	(	(	-LRB-
cord-023095-4dannjjm	5671	12	GI	GI	NNP
cord-023095-4dannjjm	5671	13	50	50	CD
cord-023095-4dannjjm	5671	14	o0.05	o0.05	NN
cord-023095-4dannjjm	5671	15	mM	mm	NN
cord-023095-4dannjjm	5671	16	)	)	-RRB-
cord-023095-4dannjjm	5671	17	,	,	,
cord-023095-4dannjjm	5671	18	the	the	DT
cord-023095-4dannjjm	5671	19	COXEN	COXEN	NNP
cord-023095-4dannjjm	5671	20	score	score	NN
cord-023095-4dannjjm	5671	21	was	be	VBD
cord-023095-4dannjjm	5671	22	not	not	RB
cord-023095-4dannjjm	5671	23	predictive	predictive	JJ
cord-023095-4dannjjm	5671	24	of	of	IN
cord-023095-4dannjjm	5671	25	its	-PRON-	PRP$
cord-023095-4dannjjm	5671	26	potency	potency	NN
cord-023095-4dannjjm	5671	27	.	.	.
cord-023095-4dannjjm	5672	1	Interestingly	interestingly	RB
cord-023095-4dannjjm	5672	2	,	,	,
cord-023095-4dannjjm	5672	3	COXEN	COXEN	NNP
cord-023095-4dannjjm	5672	4	fails	fail	VBZ
cord-023095-4dannjjm	5672	5	to	to	TO
cord-023095-4dannjjm	5672	6	predict	predict	VB
cord-023095-4dannjjm	5672	7	vinblastine	vinblastine	NN
cord-023095-4dannjjm	5672	8	response	response	NN
cord-023095-4dannjjm	5672	9	in	in	IN
cord-023095-4dannjjm	5672	10	human	human	JJ
cord-023095-4dannjjm	5672	11	TCC	TCC	NNP
cord-023095-4dannjjm	5672	12	cell	cell	NN
cord-023095-4dannjjm	5672	13	line	line	NN
cord-023095-4dannjjm	5672	14	data	datum	NNS
cord-023095-4dannjjm	5672	15	as	as	RB
cord-023095-4dannjjm	5672	16	well	well	RB
cord-023095-4dannjjm	5672	17	.	.	.
cord-023095-4dannjjm	5673	1	In	in	IN
cord-023095-4dannjjm	5673	2	concurrent	concurrent	JJ
cord-023095-4dannjjm	5673	3	work	work	NN
cord-023095-4dannjjm	5673	4	,	,	,
cord-023095-4dannjjm	5673	5	comparative	comparative	JJ
cord-023095-4dannjjm	5673	6	genomic	genomic	JJ
cord-023095-4dannjjm	5673	7	studies	study	NNS
cord-023095-4dannjjm	5673	8	to	to	TO
cord-023095-4dannjjm	5673	9	define	define	VB
cord-023095-4dannjjm	5673	10	and	and	CC
cord-023095-4dannjjm	5673	11	compare	compare	VB
cord-023095-4dannjjm	5673	12	the	the	DT
cord-023095-4dannjjm	5673	13	gene	gene	NN
cord-023095-4dannjjm	5673	14	expression	expression	NN
cord-023095-4dannjjm	5673	15	signatures	signature	NNS
cord-023095-4dannjjm	5673	16	of	of	IN
cord-023095-4dannjjm	5673	17	TCC	tcc	NN
cord-023095-4dannjjm	5673	18	in	in	IN
cord-023095-4dannjjm	5673	19	dogs	dog	NNS
cord-023095-4dannjjm	5673	20	and	and	CC
cord-023095-4dannjjm	5673	21	humans	human	NNS
cord-023095-4dannjjm	5673	22	provides	provide	VBZ
cord-023095-4dannjjm	5673	23	further	further	JJ
cord-023095-4dannjjm	5673	24	evidence	evidence	NN
cord-023095-4dannjjm	5673	25	that	that	IN
cord-023095-4dannjjm	5673	26	canine	canine	JJ
cord-023095-4dannjjm	5673	27	TCC	tcc	NN
cord-023095-4dannjjm	5673	28	is	be	VBZ
cord-023095-4dannjjm	5673	29	a	a	DT
cord-023095-4dannjjm	5673	30	valuable	valuable	JJ
cord-023095-4dannjjm	5673	31	genomic	genomic	JJ
cord-023095-4dannjjm	5673	32	model	model	NN
cord-023095-4dannjjm	5673	33	of	of	IN
cord-023095-4dannjjm	5673	34	the	the	DT
cord-023095-4dannjjm	5673	35	human	human	JJ
cord-023095-4dannjjm	5673	36	disease	disease	NN
cord-023095-4dannjjm	5673	37	.	.	.
cord-023095-4dannjjm	5674	1	Current	current	JJ
cord-023095-4dannjjm	5674	2	studies	study	NNS
cord-023095-4dannjjm	5674	3	involve	involve	VBP
cord-023095-4dannjjm	5674	4	testing	test	VBG
cord-023095-4dannjjm	5674	5	the	the	DT
cord-023095-4dannjjm	5674	6	chemo	chemo	NN
cord-023095-4dannjjm	5674	7	-	-	HYPH
cord-023095-4dannjjm	5674	8	predictivity	predictivity	NN
cord-023095-4dannjjm	5674	9	of	of	IN
cord-023095-4dannjjm	5674	10	this	this	DT
cord-023095-4dannjjm	5674	11	derived	derive	VBN
cord-023095-4dannjjm	5674	12	canine	canine	JJ
cord-023095-4dannjjm	5674	13	COXEN	coxen	NN
cord-023095-4dannjjm	5674	14	algorithm	algorithm	NN
cord-023095-4dannjjm	5674	15	in	in	IN
cord-023095-4dannjjm	5674	16	additional	additional	JJ
cord-023095-4dannjjm	5674	17	canine	canine	JJ
cord-023095-4dannjjm	5674	18	TCC	tcc	NN
cord-023095-4dannjjm	5674	19	cell	cell	NN
cord-023095-4dannjjm	5674	20	lines	line	NNS
cord-023095-4dannjjm	5674	21	.	.	.
cord-023095-4dannjjm	5675	1	Canine	canine	JJ
cord-023095-4dannjjm	5675	2	TCC	TCC	NNP
cord-023095-4dannjjm	5675	3	offers	offer	VBZ
cord-023095-4dannjjm	5675	4	an	an	DT
cord-023095-4dannjjm	5675	5	excellent	excellent	JJ
cord-023095-4dannjjm	5675	6	model	model	NN
cord-023095-4dannjjm	5675	7	for	for	IN
cord-023095-4dannjjm	5675	8	in	in	IN
cord-023095-4dannjjm	5675	9	vitro	vitro	FW
cord-023095-4dannjjm	5675	10	and	and	CC
cord-023095-4dannjjm	5675	11	in	in	IN
cord-023095-4dannjjm	5675	12	vivo	vivo	NNP
cord-023095-4dannjjm	5675	13	studies	study	NNS
cord-023095-4dannjjm	5675	14	of	of	IN
cord-023095-4dannjjm	5675	15	the	the	DT
cord-023095-4dannjjm	5675	16	COXEN	COXEN	NNP
cord-023095-4dannjjm	5675	17	approach	approach	NN
cord-023095-4dannjjm	5675	18	.	.	.
cord-023095-4dannjjm	5676	1	This	this	DT
cord-023095-4dannjjm	5676	2	preclinical	preclinical	JJ
cord-023095-4dannjjm	5676	3	work	work	NN
cord-023095-4dannjjm	5676	4	will	will	MD
cord-023095-4dannjjm	5676	5	be	be	VB
cord-023095-4dannjjm	5676	6	used	use	VBN
cord-023095-4dannjjm	5676	7	to	to	TO
cord-023095-4dannjjm	5676	8	guide	guide	VB
cord-023095-4dannjjm	5676	9	the	the	DT
cord-023095-4dannjjm	5676	10	feasibility	feasibility	NN
cord-023095-4dannjjm	5676	11	of	of	IN
cord-023095-4dannjjm	5676	12	future	future	JJ
cord-023095-4dannjjm	5676	13	COXEN	coxen	NN
cord-023095-4dannjjm	5676	14	clinical	clinical	JJ
cord-023095-4dannjjm	5676	15	trials	trial	NNS
cord-023095-4dannjjm	5676	16	in	in	IN
cord-023095-4dannjjm	5676	17	dogs	dog	NNS
cord-023095-4dannjjm	5676	18	and	and	CC
cord-023095-4dannjjm	5676	19	humans	human	NNS
cord-023095-4dannjjm	5676	20	with	with	IN
cord-023095-4dannjjm	5676	21	TCC	TCC	NNP
cord-023095-4dannjjm	5676	22	.	.	.
cord-023095-4dannjjm	5677	1	A	a	DT
cord-023095-4dannjjm	5677	2	small	small	JJ
cord-023095-4dannjjm	5677	3	molecule	molecule	NN
cord-023095-4dannjjm	5677	4	complex	complex	NN
cord-023095-4dannjjm	5677	5	(	(	-LRB-
cord-023095-4dannjjm	5677	6	Aminoact	Aminoact	NNP
cord-023095-4dannjjm	5677	7	)	)	-RRB-
cord-023095-4dannjjm	5677	8	isolated	isolate	VBN
cord-023095-4dannjjm	5677	9	from	from	IN
cord-023095-4dannjjm	5677	10	bovine	bovine	JJ
cord-023095-4dannjjm	5677	11	milk	milk	NN
cord-023095-4dannjjm	5677	12	is	be	VBZ
cord-023095-4dannjjm	5677	13	a	a	DT
cord-023095-4dannjjm	5677	14	natural	natural	JJ
cord-023095-4dannjjm	5677	15	peptide	peptide	NN
cord-023095-4dannjjm	5677	16	mixture	mixture	NN
cord-023095-4dannjjm	5677	17	with	with	IN
cord-023095-4dannjjm	5677	18	multi	multi	JJ
cord-023095-4dannjjm	5677	19	-	-	JJ
cord-023095-4dannjjm	5677	20	kinase	kinase	JJ
cord-023095-4dannjjm	5677	21	inhibitory	inhibitory	JJ
cord-023095-4dannjjm	5677	22	effects	effect	NNS
cord-023095-4dannjjm	5677	23	against	against	IN
cord-023095-4dannjjm	5677	24	epidermal	epidermal	JJ
cord-023095-4dannjjm	5677	25	growth	growth	NN
cord-023095-4dannjjm	5677	26	factor	factor	NN
cord-023095-4dannjjm	5677	27	receptor	receptor	NN
cord-023095-4dannjjm	5677	28	(	(	-LRB-
cord-023095-4dannjjm	5677	29	EGFR	EGFR	NNP
cord-023095-4dannjjm	5677	30	)	)	-RRB-
cord-023095-4dannjjm	5677	31	and	and	CC
cord-023095-4dannjjm	5677	32	insulin	insulin	NN
cord-023095-4dannjjm	5677	33	-	-	HYPH
cord-023095-4dannjjm	5677	34	like	like	JJ
cord-023095-4dannjjm	5677	35	growth	growth	NN
cord-023095-4dannjjm	5677	36	factor	factor	NN
cord-023095-4dannjjm	5678	1	receptor-1	receptor-1	NNP
cord-023095-4dannjjm	5679	1	(	(	-LRB-
cord-023095-4dannjjm	5679	2	IGFR-1	IGFR-1	NNP
cord-023095-4dannjjm	5679	3	)	)	-RRB-
cord-023095-4dannjjm	5679	4	.	.	.
cord-023095-4dannjjm	5680	1	Ingestion	ingestion	NN
cord-023095-4dannjjm	5680	2	of	of	IN
cord-023095-4dannjjm	5680	3	Aminoact	Aminoact	NNP
cord-023095-4dannjjm	5680	4	in	in	IN
cord-023095-4dannjjm	5680	5	people	people	NNS
cord-023095-4dannjjm	5680	6	with	with	IN
cord-023095-4dannjjm	5680	7	cancer	cancer	NN
cord-023095-4dannjjm	5680	8	results	result	NNS
cord-023095-4dannjjm	5680	9	in	in	IN
cord-023095-4dannjjm	5680	10	lower	low	JJR
cord-023095-4dannjjm	5680	11	serum	serum	NN
cord-023095-4dannjjm	5680	12	TNF	tnf	NN
cord-023095-4dannjjm	5680	13	-	-	HYPH
cord-023095-4dannjjm	5680	14	alpha	alpha	NN
cord-023095-4dannjjm	5680	15	,	,	,
cord-023095-4dannjjm	5680	16	an	an	DT
cord-023095-4dannjjm	5680	17	increase	increase	NN
cord-023095-4dannjjm	5680	18	in	in	IN
cord-023095-4dannjjm	5680	19	antioxidant	antioxidant	JJ
cord-023095-4dannjjm	5680	20	superoxide	superoxide	NN
cord-023095-4dannjjm	5680	21	dismutase	dismutase	NN
cord-023095-4dannjjm	5680	22	(	(	-LRB-
cord-023095-4dannjjm	5680	23	SOD	SOD	NNP
cord-023095-4dannjjm	5680	24	)	)	-RRB-
cord-023095-4dannjjm	5680	25	enzyme	enzyme	NN
cord-023095-4dannjjm	5680	26	activity	activity	NN
cord-023095-4dannjjm	5680	27	,	,	,
cord-023095-4dannjjm	5680	28	and	and	CC
cord-023095-4dannjjm	5680	29	subjects	subject	NNS
cord-023095-4dannjjm	5680	30	'	'	POS
cord-023095-4dannjjm	5680	31	blood	blood	NN
cord-023095-4dannjjm	5680	32	serum	serum	NN
cord-023095-4dannjjm	5680	33	causes	cause	VBZ
cord-023095-4dannjjm	5680	34	apopsotis	apopsotis	JJ
cord-023095-4dannjjm	5680	35	in	in	IN
cord-023095-4dannjjm	5680	36	cancer	cancer	NN
cord-023095-4dannjjm	5680	37	cell	cell	NN
cord-023095-4dannjjm	5680	38	lines	line	NNS
cord-023095-4dannjjm	5680	39	.	.	.
cord-023095-4dannjjm	5681	1	This	this	DT
cord-023095-4dannjjm	5681	2	study	study	NN
cord-023095-4dannjjm	5681	3	was	be	VBD
cord-023095-4dannjjm	5681	4	designed	design	VBN
cord-023095-4dannjjm	5681	5	to	to	TO
cord-023095-4dannjjm	5681	6	first	first	RB
cord-023095-4dannjjm	5681	7	assess	assess	VB
cord-023095-4dannjjm	5681	8	safety	safety	NN
cord-023095-4dannjjm	5681	9	and	and	CC
cord-023095-4dannjjm	5681	10	secondly	secondly	RB
cord-023095-4dannjjm	5681	11	the	the	DT
cord-023095-4dannjjm	5681	12	efficacy	efficacy	NN
cord-023095-4dannjjm	5681	13	of	of	IN
cord-023095-4dannjjm	5681	14	three	three	CD
cord-023095-4dannjjm	5681	15	dosage	dosage	NN
cord-023095-4dannjjm	5681	16	levels	level	NNS
cord-023095-4dannjjm	5681	17	of	of	IN
cord-023095-4dannjjm	5681	18	AX-3	AX-3	NNP
cord-023095-4dannjjm	5681	19	in	in	IN
cord-023095-4dannjjm	5681	20	sustaining	sustain	VBG
cord-023095-4dannjjm	5681	21	progression	progression	NN
cord-023095-4dannjjm	5681	22	free	free	JJ
cord-023095-4dannjjm	5681	23	survival	survival	NN
cord-023095-4dannjjm	5681	24	(	(	-LRB-
cord-023095-4dannjjm	5681	25	PFS	PFS	NNP
cord-023095-4dannjjm	5681	26	)	)	-RRB-
cord-023095-4dannjjm	5681	27	for	for	IN
cord-023095-4dannjjm	5681	28	dogs	dog	NNS
cord-023095-4dannjjm	5681	29	with	with	IN
cord-023095-4dannjjm	5681	30	refractory	refractory	JJ
cord-023095-4dannjjm	5681	31	advanced	advanced	JJ
cord-023095-4dannjjm	5681	32	and/or	and/or	CC
cord-023095-4dannjjm	5681	33	metastatic	metastatic	JJ
cord-023095-4dannjjm	5681	34	cancer	cancer	NN
cord-023095-4dannjjm	5681	35	.	.	.
cord-023095-4dannjjm	5682	1	The	the	DT
cord-023095-4dannjjm	5682	2	prospective	prospective	JJ
cord-023095-4dannjjm	5682	3	,	,	,
cord-023095-4dannjjm	5682	4	open	open	JJ
cord-023095-4dannjjm	5682	5	label	label	NN
cord-023095-4dannjjm	5682	6	study	study	NN
cord-023095-4dannjjm	5682	7	included	include	VBD
cord-023095-4dannjjm	5682	8	dogs	dog	NNS
cord-023095-4dannjjm	5682	9	of	of	IN
cord-023095-4dannjjm	5682	10	different	different	JJ
cord-023095-4dannjjm	5682	11	breeds	breed	NNS
cord-023095-4dannjjm	5682	12	with	with	IN
cord-023095-4dannjjm	5682	13	naturally	naturally	RB
cord-023095-4dannjjm	5682	14	occurring	occur	VBG
cord-023095-4dannjjm	5682	15	histologically	histologically	RB
cord-023095-4dannjjm	5682	16	confirmed	confirm	VBD
cord-023095-4dannjjm	5682	17	malignancies	malignancy	NNS
cord-023095-4dannjjm	5682	18	.	.	.
cord-023095-4dannjjm	5683	1	The	the	DT
cord-023095-4dannjjm	5683	2	first	first	JJ
cord-023095-4dannjjm	5683	3	13	13	CD
cord-023095-4dannjjm	5683	4	dogs	dog	NNS
cord-023095-4dannjjm	5683	5	received	receive	VBD
cord-023095-4dannjjm	5683	6	Aminoact	Aminoact	NNP
cord-023095-4dannjjm	5683	7	at	at	IN
cord-023095-4dannjjm	5683	8	1g	1g	CD
cord-023095-4dannjjm	5683	9	/	/	SYM
cord-023095-4dannjjm	5683	10	m	m	NN
cord-023095-4dannjjm	5683	11	2	2	CD
cord-023095-4dannjjm	5683	12	;	;	:
cord-023095-4dannjjm	5683	13	the	the	DT
cord-023095-4dannjjm	5683	14	second	second	JJ
cord-023095-4dannjjm	5683	15	group	group	NN
cord-023095-4dannjjm	5683	16	of	of	IN
cord-023095-4dannjjm	5683	17	7	7	CD
cord-023095-4dannjjm	5683	18	dogs	dog	NNS
cord-023095-4dannjjm	5683	19	subsequently	subsequently	RB
cord-023095-4dannjjm	5683	20	received	receive	VBD
cord-023095-4dannjjm	5683	21	the	the	DT
cord-023095-4dannjjm	5683	22	same	same	JJ
cord-023095-4dannjjm	5683	23	dosage	dosage	NN
cord-023095-4dannjjm	5683	24	1	1	CD
cord-023095-4dannjjm	5683	25	350	350	CD
cord-023095-4dannjjm	5683	26	mg	mg	NN
cord-023095-4dannjjm	5683	27	of	of	IN
cord-023095-4dannjjm	5683	28	Aminoact	Aminoact	NNP
cord-023095-4dannjjm	5683	29	;	;	:
cord-023095-4dannjjm	5683	30	and	and	CC
cord-023095-4dannjjm	5683	31	the	the	DT
cord-023095-4dannjjm	5683	32	third	third	JJ
cord-023095-4dannjjm	5683	33	group	group	NN
cord-023095-4dannjjm	5683	34	of	of	IN
cord-023095-4dannjjm	5683	35	dogs	dog	NNS
cord-023095-4dannjjm	5683	36	subsequently	subsequently	RB
cord-023095-4dannjjm	5683	37	received	receive	VBD
cord-023095-4dannjjm	5683	38	2g/	2g/	CD
cord-023095-4dannjjm	5683	39	m	m	CD
cord-023095-4dannjjm	5683	40	2	2	CD
cord-023095-4dannjjm	5683	41	.	.	.
cord-023095-4dannjjm	5684	1	Each	each	DT
cord-023095-4dannjjm	5684	2	dog	dog	NN
cord-023095-4dannjjm	5684	3	was	be	VBD
cord-023095-4dannjjm	5684	4	treated	treat	VBN
cord-023095-4dannjjm	5684	5	orally	orally	RB
cord-023095-4dannjjm	5684	6	daily	daily	RB
cord-023095-4dannjjm	5684	7	for	for	IN
cord-023095-4dannjjm	5684	8	six	six	CD
cord-023095-4dannjjm	5684	9	weeks	week	NNS
cord-023095-4dannjjm	5684	10	along	along	IN
cord-023095-4dannjjm	5684	11	with	with	IN
cord-023095-4dannjjm	5684	12	550	550	CD
cord-023095-4dannjjm	5684	13	mg	mg	NN
cord-023095-4dannjjm	5684	14	betaine	betaine	NN
cord-023095-4dannjjm	5684	15	HCl	HCl	NNP
cord-023095-4dannjjm	5684	16	,	,	,
cord-023095-4dannjjm	5684	17	that	that	IN
cord-023095-4dannjjm	5684	18	aids	aids	NNP
cord-023095-4dannjjm	5684	19	in	in	IN
cord-023095-4dannjjm	5684	20	peptide	peptide	JJ
cord-023095-4dannjjm	5684	21	absorption	absorption	NN
cord-023095-4dannjjm	5684	22	.	.	.
cord-023095-4dannjjm	5685	1	All	all	DT
cord-023095-4dannjjm	5685	2	patients	patient	NNS
cord-023095-4dannjjm	5685	3	were	be	VBD
cord-023095-4dannjjm	5685	4	evaluated	evaluate	VBN
cord-023095-4dannjjm	5685	5	for	for	IN
cord-023095-4dannjjm	5685	6	toxicity	toxicity	NN
cord-023095-4dannjjm	5685	7	using	use	VBG
cord-023095-4dannjjm	5685	8	the	the	DT
cord-023095-4dannjjm	5685	9	VCOG	VCOG	NNP
cord-023095-4dannjjm	5685	10	-	-	HYPH
cord-023095-4dannjjm	5685	11	CTCAE	CTCAE	NNP
cord-023095-4dannjjm	5685	12	and	and	CC
cord-023095-4dannjjm	5685	13	efficacy	efficacy	NN
cord-023095-4dannjjm	5685	14	using	use	VBG
cord-023095-4dannjjm	5685	15	the	the	DT
cord-023095-4dannjjm	5685	16	RECIST	RECIST	NNP
cord-023095-4dannjjm	5685	17	criteria	criterion	NNS
cord-023095-4dannjjm	5685	18	via	via	IN
cord-023095-4dannjjm	5685	19	assessment	assessment	NN
cord-023095-4dannjjm	5685	20	of	of	IN
cord-023095-4dannjjm	5685	21	clinical	clinical	JJ
cord-023095-4dannjjm	5685	22	parameters	parameter	NNS
cord-023095-4dannjjm	5685	23	,	,	,
cord-023095-4dannjjm	5685	24	blood	blood	NN
cord-023095-4dannjjm	5685	25	work	work	NN
cord-023095-4dannjjm	5685	26	and	and	CC
cord-023095-4dannjjm	5685	27	client	client	NN
cord-023095-4dannjjm	5685	28	questionnaires	questionnaire	NNS
cord-023095-4dannjjm	5685	29	.	.	.
cord-023095-4dannjjm	5686	1	No	no	DT
cord-023095-4dannjjm	5686	2	toxicity	toxicity	NN
cord-023095-4dannjjm	5686	3	other	other	JJ
cord-023095-4dannjjm	5686	4	than	than	IN
cord-023095-4dannjjm	5686	5	mild	mild	JJ
cord-023095-4dannjjm	5686	6	,	,	,
cord-023095-4dannjjm	5686	7	transient	transient	JJ
cord-023095-4dannjjm	5686	8	(	(	-LRB-
cord-023095-4dannjjm	5686	9	grade	grade	NN
cord-023095-4dannjjm	5686	10	I	i	NN
cord-023095-4dannjjm	5686	11	)	)	-RRB-
cord-023095-4dannjjm	5686	12	nausea	nausea	NN
cord-023095-4dannjjm	5686	13	was	be	VBD
cord-023095-4dannjjm	5686	14	noted	note	VBN
cord-023095-4dannjjm	5686	15	,	,	,
cord-023095-4dannjjm	5686	16	nor	nor	CC
cord-023095-4dannjjm	5686	17	were	be	VBD
cord-023095-4dannjjm	5686	18	there	there	EX
cord-023095-4dannjjm	5686	19	any	any	DT
cord-023095-4dannjjm	5686	20	changes	change	NNS
cord-023095-4dannjjm	5686	21	in	in	IN
cord-023095-4dannjjm	5686	22	hemograms	hemogram	NNS
cord-023095-4dannjjm	5686	23	or	or	CC
cord-023095-4dannjjm	5686	24	biochemical	biochemical	JJ
cord-023095-4dannjjm	5686	25	profiles	profile	NNS
cord-023095-4dannjjm	5686	26	in	in	IN
cord-023095-4dannjjm	5686	27	any	any	DT
cord-023095-4dannjjm	5686	28	patient	patient	NN
cord-023095-4dannjjm	5686	29	.	.	.
cord-023095-4dannjjm	5687	1	Dogs	dog	NNS
cord-023095-4dannjjm	5687	2	with	with	IN
cord-023095-4dannjjm	5687	3	tumors	tumor	NNS
cord-023095-4dannjjm	5687	4	that	that	WDT
cord-023095-4dannjjm	5687	5	were	be	VBD
cord-023095-4dannjjm	5687	6	confirmed	confirm	VBN
cord-023095-4dannjjm	5687	7	as	as	IN
cord-023095-4dannjjm	5687	8	responders	responder	NNS
cord-023095-4dannjjm	5687	9	(	(	-LRB-
cord-023095-4dannjjm	5687	10	4	4	CD
cord-023095-4dannjjm	5687	11	50	50	CD
cord-023095-4dannjjm	5687	12	%	%	NN
cord-023095-4dannjjm	5687	13	reduction	reduction	NN
cord-023095-4dannjjm	5687	14	in	in	IN
cord-023095-4dannjjm	5687	15	size	size	NN
cord-023095-4dannjjm	5687	16	)	)	-RRB-
cord-023095-4dannjjm	5687	17	include	include	VBP
cord-023095-4dannjjm	5687	18	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	5687	19	adenocarcinoma	adenocarcinoma	NN
cord-023095-4dannjjm	5687	20	,	,	,
cord-023095-4dannjjm	5687	21	mast	mast	NN
cord-023095-4dannjjm	5687	22	cell	cell	NN
cord-023095-4dannjjm	5687	23	tumor	tumor	NN
cord-023095-4dannjjm	5687	24	,	,	,
cord-023095-4dannjjm	5687	25	trichoepithelioma	trichoepithelioma	NNP
cord-023095-4dannjjm	5687	26	and	and	CC
cord-023095-4dannjjm	5687	27	soft	soft	JJ
cord-023095-4dannjjm	5687	28	tissue	tissue	NN
cord-023095-4dannjjm	5687	29	sarcoma	sarcoma	NN
cord-023095-4dannjjm	5687	30	.	.	.
cord-023095-4dannjjm	5688	1	It	-PRON-	PRP
cord-023095-4dannjjm	5688	2	appears	appear	VBZ
cord-023095-4dannjjm	5688	3	in	in	IN
cord-023095-4dannjjm	5688	4	limited	limited	JJ
cord-023095-4dannjjm	5688	5	studies	study	NNS
cord-023095-4dannjjm	5688	6	that	that	WDT
cord-023095-4dannjjm	5688	7	the	the	DT
cord-023095-4dannjjm	5688	8	response	response	NN
cord-023095-4dannjjm	5688	9	rate	rate	NN
cord-023095-4dannjjm	5688	10	may	may	MD
cord-023095-4dannjjm	5688	11	be	be	VB
cord-023095-4dannjjm	5688	12	more	more	RBR
cord-023095-4dannjjm	5688	13	durable	durable	JJ
cord-023095-4dannjjm	5688	14	at	at	IN
cord-023095-4dannjjm	5688	15	higher	high	JJR
cord-023095-4dannjjm	5688	16	dosages	dosage	NNS
cord-023095-4dannjjm	5688	17	.	.	.
cord-023095-4dannjjm	5689	1	The	the	DT
cord-023095-4dannjjm	5689	2	response	response	NN
cord-023095-4dannjjm	5689	3	to	to	IN
cord-023095-4dannjjm	5689	4	Aminoact	Aminoact	NNP
cord-023095-4dannjjm	5689	5	is	be	VBZ
cord-023095-4dannjjm	5689	6	dose	dose	NN
cord-023095-4dannjjm	5689	7	dependent	dependent	JJ
cord-023095-4dannjjm	5689	8	and	and	CC
cord-023095-4dannjjm	5689	9	only	only	JJ
cord-023095-4dannjjm	5689	10	transient	transient	JJ
cord-023095-4dannjjm	5689	11	mild	mild	JJ
cord-023095-4dannjjm	5689	12	toxicity	toxicity	NN
cord-023095-4dannjjm	5689	13	was	be	VBD
cord-023095-4dannjjm	5689	14	observed	observe	VBN
cord-023095-4dannjjm	5689	15	,	,	,
cord-023095-4dannjjm	5689	16	which	which	WDT
cord-023095-4dannjjm	5689	17	suggest	suggest	VBP
cord-023095-4dannjjm	5689	18	the	the	DT
cord-023095-4dannjjm	5689	19	maximum	maximum	JJ
cord-023095-4dannjjm	5689	20	effective	effective	JJ
cord-023095-4dannjjm	5689	21	dosage	dosage	NN
cord-023095-4dannjjm	5689	22	has	have	VBZ
cord-023095-4dannjjm	5689	23	not	not	RB
cord-023095-4dannjjm	5689	24	been	be	VBN
cord-023095-4dannjjm	5689	25	reached	reach	VBN
cord-023095-4dannjjm	5689	26	.	.	.
cord-023095-4dannjjm	5690	1	Further	further	JJ
cord-023095-4dannjjm	5690	2	clinical	clinical	JJ
cord-023095-4dannjjm	5690	3	studies	study	NNS
cord-023095-4dannjjm	5690	4	will	will	MD
cord-023095-4dannjjm	5690	5	be	be	VB
cord-023095-4dannjjm	5690	6	valuable	valuable	JJ
cord-023095-4dannjjm	5690	7	in	in	IN
cord-023095-4dannjjm	5690	8	determining	determine	VBG
cord-023095-4dannjjm	5690	9	the	the	DT
cord-023095-4dannjjm	5690	10	effective	effective	JJ
cord-023095-4dannjjm	5690	11	dosage	dosage	NN
cord-023095-4dannjjm	5690	12	and	and	CC
cord-023095-4dannjjm	5690	13	response	response	NN
cord-023095-4dannjjm	5690	14	duration	duration	NN
cord-023095-4dannjjm	5690	15	.	.	.
cord-023095-4dannjjm	5691	1	Treating	treat	VBG
cord-023095-4dannjjm	5691	2	cancer	cancer	NN
cord-023095-4dannjjm	5691	3	in	in	IN
cord-023095-4dannjjm	5691	4	dogs	dog	NNS
cord-023095-4dannjjm	5691	5	with	with	IN
cord-023095-4dannjjm	5691	6	Aminoact	Aminoact	NNP
cord-023095-4dannjjm	5691	7	offers	offer	VBZ
cord-023095-4dannjjm	5691	8	a	a	DT
cord-023095-4dannjjm	5691	9	unique	unique	JJ
cord-023095-4dannjjm	5691	10	opportunity	opportunity	NN
cord-023095-4dannjjm	5691	11	as	as	IN
cord-023095-4dannjjm	5691	12	a	a	DT
cord-023095-4dannjjm	5691	13	model	model	NN
cord-023095-4dannjjm	5691	14	for	for	IN
cord-023095-4dannjjm	5691	15	human	human	JJ
cord-023095-4dannjjm	5691	16	cancer	cancer	NN
cord-023095-4dannjjm	5691	17	biology	biology	NN
cord-023095-4dannjjm	5691	18	and	and	CC
cord-023095-4dannjjm	5691	19	translational	translational	JJ
cord-023095-4dannjjm	5691	20	cancer	cancer	NN
cord-023095-4dannjjm	5691	21	therapeutics	therapeutic	NNS
cord-023095-4dannjjm	5691	22	.	.	.
cord-023095-4dannjjm	5692	1	Stereotactic	stereotactic	JJ
cord-023095-4dannjjm	5692	2	radiation	radiation	NN
cord-023095-4dannjjm	5692	3	therapy	therapy	NN
cord-023095-4dannjjm	5692	4	(	(	-LRB-
cord-023095-4dannjjm	5692	5	SRT	SRT	NNP
cord-023095-4dannjjm	5692	6	)	)	-RRB-
cord-023095-4dannjjm	5692	7	combines	combine	VBZ
cord-023095-4dannjjm	5692	8	patient	patient	JJ
cord-023095-4dannjjm	5692	9	immobilization	immobilization	NN
cord-023095-4dannjjm	5692	10	,	,	,
cord-023095-4dannjjm	5692	11	image	image	NN
cord-023095-4dannjjm	5692	12	guidance	guidance	NN
cord-023095-4dannjjm	5692	13	,	,	,
cord-023095-4dannjjm	5692	14	and	and	CC
cord-023095-4dannjjm	5692	15	intensity	intensity	NN
cord-023095-4dannjjm	5692	16	modulated	modulate	VBN
cord-023095-4dannjjm	5692	17	delivery	delivery	NN
cord-023095-4dannjjm	5692	18	to	to	TO
cord-023095-4dannjjm	5692	19	achieve	achieve	VB
cord-023095-4dannjjm	5692	20	ablative	ablative	JJ
cord-023095-4dannjjm	5692	21	radiation	radiation	NN
cord-023095-4dannjjm	5692	22	doses	dose	NNS
cord-023095-4dannjjm	5692	23	within	within	IN
cord-023095-4dannjjm	5692	24	the	the	DT
cord-023095-4dannjjm	5692	25	tumor	tumor	NN
cord-023095-4dannjjm	5692	26	,	,	,
cord-023095-4dannjjm	5692	27	while	while	IN
cord-023095-4dannjjm	5692	28	preferentially	preferentially	RB
cord-023095-4dannjjm	5692	29	sparing	spare	VBG
cord-023095-4dannjjm	5692	30	surrounding	surround	VBG
cord-023095-4dannjjm	5692	31	normal	normal	JJ
cord-023095-4dannjjm	5692	32	tissues	tissue	NNS
cord-023095-4dannjjm	5692	33	.	.	.
cord-023095-4dannjjm	5693	1	The	the	DT
cord-023095-4dannjjm	5693	2	purpose	purpose	NN
cord-023095-4dannjjm	5693	3	of	of	IN
cord-023095-4dannjjm	5693	4	this	this	DT
cord-023095-4dannjjm	5693	5	study	study	NN
cord-023095-4dannjjm	5693	6	was	be	VBD
cord-023095-4dannjjm	5693	7	to	to	TO
cord-023095-4dannjjm	5693	8	evaluate	evaluate	VB
cord-023095-4dannjjm	5693	9	the	the	DT
cord-023095-4dannjjm	5693	10	efficacy	efficacy	NN
cord-023095-4dannjjm	5693	11	of	of	IN
cord-023095-4dannjjm	5693	12	SRT	SRT	NNP
cord-023095-4dannjjm	5693	13	as	as	IN
cord-023095-4dannjjm	5693	14	a	a	DT
cord-023095-4dannjjm	5693	15	means	means	NN
cord-023095-4dannjjm	5693	16	of	of	IN
cord-023095-4dannjjm	5693	17	achieving	achieve	VBG
cord-023095-4dannjjm	5693	18	local	local	JJ
cord-023095-4dannjjm	5693	19	tumor	tumor	NN
cord-023095-4dannjjm	5693	20	control	control	NN
cord-023095-4dannjjm	5693	21	for	for	IN
cord-023095-4dannjjm	5693	22	canine	canine	JJ
cord-023095-4dannjjm	5693	23	nasal	nasal	NN
cord-023095-4dannjjm	5693	24	tumors	tumor	NNS
cord-023095-4dannjjm	5693	25	.	.	.
cord-023095-4dannjjm	5694	1	Retrospective	retrospective	JJ
cord-023095-4dannjjm	5694	2	analysis	analysis	NN
cord-023095-4dannjjm	5694	3	was	be	VBD
cord-023095-4dannjjm	5694	4	performed	perform	VBN
cord-023095-4dannjjm	5694	5	on	on	IN
cord-023095-4dannjjm	5694	6	dogs	dog	NNS
cord-023095-4dannjjm	5694	7	with	with	IN
cord-023095-4dannjjm	5694	8	a	a	DT
cord-023095-4dannjjm	5694	9	nasal	nasal	NN
cord-023095-4dannjjm	5694	10	tumor	tumor	NN
cord-023095-4dannjjm	5694	11	confirmed	confirm	VBN
cord-023095-4dannjjm	5694	12	by	by	IN
cord-023095-4dannjjm	5694	13	histopathology	histopathology	NN
cord-023095-4dannjjm	5694	14	and	and	CC
cord-023095-4dannjjm	5694	15	computed	compute	VBN
cord-023095-4dannjjm	5694	16	tomography	tomography	NN
cord-023095-4dannjjm	5694	17	,	,	,
cord-023095-4dannjjm	5694	18	no	no	DT
cord-023095-4dannjjm	5694	19	previous	previous	JJ
cord-023095-4dannjjm	5694	20	surgical	surgical	NN
cord-023095-4dannjjm	5694	21	or	or	CC
cord-023095-4dannjjm	5694	22	radiation	radiation	NN
cord-023095-4dannjjm	5694	23	therapy	therapy	NN
cord-023095-4dannjjm	5694	24	,	,	,
cord-023095-4dannjjm	5694	25	at	at	IN
cord-023095-4dannjjm	5694	26	least	least	JJS
cord-023095-4dannjjm	5694	27	six	six	CD
cord-023095-4dannjjm	5694	28	months	month	NNS
cord-023095-4dannjjm	5694	29	of	of	IN
cord-023095-4dannjjm	5694	30	follow	follow	NN
cord-023095-4dannjjm	5694	31	-	-	HYPH
cord-023095-4dannjjm	5694	32	up	up	NN
cord-023095-4dannjjm	5694	33	,	,	,
cord-023095-4dannjjm	5694	34	and	and	CC
cord-023095-4dannjjm	5694	35	completion	completion	NN
cord-023095-4dannjjm	5694	36	of	of	IN
cord-023095-4dannjjm	5694	37	three	three	CD
cord-023095-4dannjjm	5694	38	fractions	fraction	NNS
cord-023095-4dannjjm	5694	39	of	of	IN
cord-023095-4dannjjm	5694	40	SRT	SRT	NNP
cord-023095-4dannjjm	5694	41	at	at	IN
cord-023095-4dannjjm	5694	42	CSU.SRT	CSU.SRT	NNP
cord-023095-4dannjjm	5694	43	was	be	VBD
cord-023095-4dannjjm	5694	44	administered	administer	VBN
cord-023095-4dannjjm	5694	45	via	via	IN
cord-023095-4dannjjm	5694	46	the	the	DT
cord-023095-4dannjjm	5694	47	Varian	Varian	NNP
cord-023095-4dannjjm	5694	48	Trilogy	Trilogy	NNP
cord-023095-4dannjjm	5694	49	linear	linear	JJ
cord-023095-4dannjjm	5694	50	accelerator	accelerator	NN
cord-023095-4dannjjm	5694	51	once	once	RB
cord-023095-4dannjjm	5694	52	daily	daily	RB
cord-023095-4dannjjm	5694	53	for	for	IN
cord-023095-4dannjjm	5694	54	three	three	CD
cord-023095-4dannjjm	5694	55	consecutive	consecutive	JJ
cord-023095-4dannjjm	5694	56	days	day	NNS
cord-023095-4dannjjm	5694	57	.	.	.
cord-023095-4dannjjm	5695	1	The	the	DT
cord-023095-4dannjjm	5695	2	Varian	Varian	NNP
cord-023095-4dannjjm	5695	3	Eclipse	Eclipse	NNP
cord-023095-4dannjjm	5695	4	treatment	treatment	NN
cord-023095-4dannjjm	5695	5	planwas	planwas	NN
cord-023095-4dannjjm	5695	6	reviewed	review	VBN
cord-023095-4dannjjm	5695	7	to	to	TO
cord-023095-4dannjjm	5695	8	determine	determine	VB
cord-023095-4dannjjm	5695	9	the	the	DT
cord-023095-4dannjjm	5695	10	planned	plan	VBN
cord-023095-4dannjjm	5695	11	target	target	NN
cord-023095-4dannjjm	5695	12	volume	volume	NN
cord-023095-4dannjjm	5695	13	(	(	-LRB-
cord-023095-4dannjjm	5695	14	PTV	PTV	NNP
cord-023095-4dannjjm	5695	15	)	)	-RRB-
cord-023095-4dannjjm	5695	16	and	and	CC
cord-023095-4dannjjm	5695	17	dose	dose	VBD
cord-023095-4dannjjm	5695	18	to	to	IN
cord-023095-4dannjjm	5695	19	95	95	CD
cord-023095-4dannjjm	5695	20	%	%	NN
cord-023095-4dannjjm	5695	21	of	of	IN
cord-023095-4dannjjm	5695	22	the	the	DT
cord-023095-4dannjjm	5695	23	PTV	PTV	NNP
cord-023095-4dannjjm	5695	24	.	.	.
cord-023095-4dannjjm	5696	1	Kaplan	Kaplan	NNP
cord-023095-4dannjjm	5696	2	-	-	HYPH
cord-023095-4dannjjm	5696	3	Meir	Meir	NNP
cord-023095-4dannjjm	5696	4	survival	survival	NN
cord-023095-4dannjjm	5696	5	analysis	analysis	NN
cord-023095-4dannjjm	5696	6	was	be	VBD
cord-023095-4dannjjm	5696	7	performed	perform	VBN
cord-023095-4dannjjm	5696	8	for	for	IN
cord-023095-4dannjjm	5696	9	disease	disease	NN
cord-023095-4dannjjm	5696	10	free	free	JJ
cord-023095-4dannjjm	5696	11	interval	interval	NN
cord-023095-4dannjjm	5696	12	(	(	-LRB-
cord-023095-4dannjjm	5696	13	DFI	DFI	NNP
cord-023095-4dannjjm	5696	14	)	)	-RRB-
cord-023095-4dannjjm	5696	15	and	and	CC
cord-023095-4dannjjm	5696	16	overall	overall	JJ
cord-023095-4dannjjm	5696	17	survival	survival	NN
cord-023095-4dannjjm	5696	18	(	(	-LRB-
cord-023095-4dannjjm	5696	19	OS	OS	NNP
cord-023095-4dannjjm	5696	20	)	)	-RRB-
cord-023095-4dannjjm	5696	21	.	.	.
cord-023095-4dannjjm	5697	1	Sixteen	sixteen	CD
cord-023095-4dannjjm	5697	2	patients	patient	NNS
cord-023095-4dannjjm	5697	3	with	with	IN
cord-023095-4dannjjm	5697	4	nasal	nasal	NN
cord-023095-4dannjjm	5697	5	tumors	tumor	NNS
cord-023095-4dannjjm	5697	6	(	(	-LRB-
cord-023095-4dannjjm	5697	7	8	8	CD
cord-023095-4dannjjm	5697	8	adenocarcinoma	adenocarcinoma	NN
cord-023095-4dannjjm	5697	9	/	/	SYM
cord-023095-4dannjjm	5697	10	carcinomas	carcinoma	NNS
cord-023095-4dannjjm	5697	11	,	,	,
cord-023095-4dannjjm	5697	12	2	2	CD
cord-023095-4dannjjm	5697	13	squamous	squamous	JJ
cord-023095-4dannjjm	5697	14	cell	cell	NN
cord-023095-4dannjjm	5697	15	carcinomas	carcinoma	NNS
cord-023095-4dannjjm	5697	16	,	,	,
cord-023095-4dannjjm	5697	17	3	3	CD
cord-023095-4dannjjm	5697	18	chondrosarcomas	chondrosarcoma	NNS
cord-023095-4dannjjm	5697	19	,	,	,
cord-023095-4dannjjm	5697	20	2	2	CD
cord-023095-4dannjjm	5697	21	osteosarcomas	osteosarcoma	NNS
cord-023095-4dannjjm	5697	22	,	,	,
cord-023095-4dannjjm	5697	23	and	and	CC
cord-023095-4dannjjm	5697	24	1	1	CD
cord-023095-4dannjjm	5697	25	undifferentiated	undifferentiated	JJ
cord-023095-4dannjjm	5697	26	sarcoma	sarcoma	NN
cord-023095-4dannjjm	5697	27	)	)	-RRB-
cord-023095-4dannjjm	5697	28	were	be	VBD
cord-023095-4dannjjm	5697	29	treated	treat	VBN
cord-023095-4dannjjm	5697	30	with	with	IN
cord-023095-4dannjjm	5697	31	SRT	SRT	NNP
cord-023095-4dannjjm	5697	32	.	.	.
cord-023095-4dannjjm	5698	1	A	a	DT
cord-023095-4dannjjm	5698	2	median	median	JJ
cord-023095-4dannjjm	5698	3	dose	dose	NN
cord-023095-4dannjjm	5698	4	of	of	IN
cord-023095-4dannjjm	5698	5	29.1Gy	29.1gy	CD
cord-023095-4dannjjm	5698	6	was	be	VBD
cord-023095-4dannjjm	5698	7	administered	administer	VBN
cord-023095-4dannjjm	5698	8	to	to	IN
cord-023095-4dannjjm	5698	9	95	95	CD
cord-023095-4dannjjm	5698	10	%	%	NN
cord-023095-4dannjjm	5698	11	PTV	PTV	NNP
cord-023095-4dannjjm	5698	12	with	with	IN
cord-023095-4dannjjm	5698	13	a	a	DT
cord-023095-4dannjjm	5698	14	median	median	JJ
cord-023095-4dannjjm	5698	15	PTV	PTV	NNP
cord-023095-4dannjjm	5698	16	of	of	IN
cord-023095-4dannjjm	5698	17	75.3cc	75.3cc	NN
cord-023095-4dannjjm	5698	18	.	.	.
cord-023095-4dannjjm	5699	1	SRT	SRT	NNP
cord-023095-4dannjjm	5699	2	was	be	VBD
cord-023095-4dannjjm	5699	3	well	well	RB
cord-023095-4dannjjm	5699	4	tolerated	tolerate	VBN
cord-023095-4dannjjm	5699	5	by	by	IN
cord-023095-4dannjjm	5699	6	the	the	DT
cord-023095-4dannjjm	5699	7	normal	normal	JJ
cord-023095-4dannjjm	5699	8	tissues	tissue	NNS
cord-023095-4dannjjm	5699	9	with	with	IN
cord-023095-4dannjjm	5699	10	minimal	minimal	JJ
cord-023095-4dannjjm	5699	11	,	,	,
cord-023095-4dannjjm	5699	12	manageable	manageable	JJ
cord-023095-4dannjjm	5699	13	side	side	NN
cord-023095-4dannjjm	5699	14	effects	effect	NNS
cord-023095-4dannjjm	5699	15	.	.	.
cord-023095-4dannjjm	5700	1	To	to	IN
cord-023095-4dannjjm	5700	2	date	date	NN
cord-023095-4dannjjm	5700	3	,	,	,
cord-023095-4dannjjm	5700	4	the	the	DT
cord-023095-4dannjjm	5700	5	median	median	JJ
cord-023095-4dannjjm	5700	6	DFI	DFI	NNP
cord-023095-4dannjjm	5700	7	is	be	VBZ
cord-023095-4dannjjm	5700	8	270	270	CD
cord-023095-4dannjjm	5700	9	days	day	NNS
cord-023095-4dannjjm	5700	10	,	,	,
cord-023095-4dannjjm	5700	11	while	while	IN
cord-023095-4dannjjm	5700	12	the	the	DT
cord-023095-4dannjjm	5700	13	median	median	JJ
cord-023095-4dannjjm	5700	14	OS	OS	NNP
cord-023095-4dannjjm	5700	15	is	be	VBZ
cord-023095-4dannjjm	5700	16	367	367	CD
cord-023095-4dannjjm	5700	17	days	day	NNS
cord-023095-4dannjjm	5700	18	.	.	.
cord-023095-4dannjjm	5701	1	Based	base	VBN
cord-023095-4dannjjm	5701	2	upon	upon	IN
cord-023095-4dannjjm	5701	3	the	the	DT
cord-023095-4dannjjm	5701	4	initial	initial	JJ
cord-023095-4dannjjm	5701	5	clinical	clinical	JJ
cord-023095-4dannjjm	5701	6	experience	experience	NN
cord-023095-4dannjjm	5701	7	,	,	,
cord-023095-4dannjjm	5701	8	stereotactic	stereotactic	JJ
cord-023095-4dannjjm	5701	9	radiation	radiation	NN
cord-023095-4dannjjm	5701	10	therapy	therapy	NN
cord-023095-4dannjjm	5701	11	is	be	VBZ
cord-023095-4dannjjm	5701	12	an	an	DT
cord-023095-4dannjjm	5701	13	emerging	emerge	VBG
cord-023095-4dannjjm	5701	14	modality	modality	NN
cord-023095-4dannjjm	5701	15	in	in	IN
cord-023095-4dannjjm	5701	16	the	the	DT
cord-023095-4dannjjm	5701	17	management	management	NN
cord-023095-4dannjjm	5701	18	of	of	IN
cord-023095-4dannjjm	5701	19	canine	canine	JJ
cord-023095-4dannjjm	5701	20	nasal	nasal	NN
cord-023095-4dannjjm	5701	21	tumors	tumor	NNS
cord-023095-4dannjjm	5701	22	.	.	.
cord-023095-4dannjjm	5702	1	Canine	canine	JJ
cord-023095-4dannjjm	5702	2	Leptospirosis	leptospirosis	NN
cord-023095-4dannjjm	5702	3	can	can	MD
cord-023095-4dannjjm	5702	4	vary	vary	VB
cord-023095-4dannjjm	5702	5	from	from	IN
cord-023095-4dannjjm	5702	6	subclinical	subclinical	JJ
cord-023095-4dannjjm	5702	7	infection	infection	NN
cord-023095-4dannjjm	5702	8	to	to	IN
cord-023095-4dannjjm	5702	9	illness	illness	NN
cord-023095-4dannjjm	5702	10	that	that	WDT
cord-023095-4dannjjm	5702	11	ranges	range	VBZ
cord-023095-4dannjjm	5702	12	from	from	IN
cord-023095-4dannjjm	5702	13	mild	mild	JJ
cord-023095-4dannjjm	5702	14	to	to	IN
cord-023095-4dannjjm	5702	15	severe	severe	JJ
cord-023095-4dannjjm	5702	16	,	,	,
cord-023095-4dannjjm	5702	17	including	include	VBG
cord-023095-4dannjjm	5702	18	death	death	NN
cord-023095-4dannjjm	5702	19	,	,	,
cord-023095-4dannjjm	5702	20	depending	depend	VBG
cord-023095-4dannjjm	5702	21	on	on	IN
cord-023095-4dannjjm	5702	22	the	the	DT
cord-023095-4dannjjm	5702	23	susceptibility	susceptibility	NN
cord-023095-4dannjjm	5702	24	of	of	IN
cord-023095-4dannjjm	5702	25	the	the	DT
cord-023095-4dannjjm	5702	26	dog	dog	NN
cord-023095-4dannjjm	5702	27	,	,	,
cord-023095-4dannjjm	5702	28	virulence	virulence	NN
cord-023095-4dannjjm	5702	29	of	of	IN
cord-023095-4dannjjm	5702	30	the	the	DT
cord-023095-4dannjjm	5702	31	organism	organism	NN
cord-023095-4dannjjm	5702	32	,	,	,
cord-023095-4dannjjm	5702	33	and	and	CC
cord-023095-4dannjjm	5702	34	route	route	NN
cord-023095-4dannjjm	5702	35	and	and	CC
cord-023095-4dannjjm	5702	36	degree	degree	NN
cord-023095-4dannjjm	5702	37	of	of	IN
cord-023095-4dannjjm	5702	38	infection	infection	NN
cord-023095-4dannjjm	5702	39	.	.	.
cord-023095-4dannjjm	5703	1	The	the	DT
cord-023095-4dannjjm	5703	2	objective	objective	NN
cord-023095-4dannjjm	5703	3	of	of	IN
cord-023095-4dannjjm	5703	4	this	this	DT
cord-023095-4dannjjm	5703	5	study	study	NN
cord-023095-4dannjjm	5703	6	was	be	VBD
cord-023095-4dannjjm	5703	7	to	to	TO
cord-023095-4dannjjm	5703	8	evaluate	evaluate	VB
cord-023095-4dannjjm	5703	9	the	the	DT
cord-023095-4dannjjm	5703	10	ability	ability	NN
cord-023095-4dannjjm	5703	11	of	of	IN
cord-023095-4dannjjm	5703	12	a	a	DT
cord-023095-4dannjjm	5703	13	canine	canine	JJ
cord-023095-4dannjjm	5703	14	Leptospira	Leptospira	NNP
cord-023095-4dannjjm	5703	15	bacterin	bacterin	NN
cord-023095-4dannjjm	5703	16	to	to	TO
cord-023095-4dannjjm	5703	17	prevent	prevent	VB
cord-023095-4dannjjm	5703	18	infection	infection	NN
cord-023095-4dannjjm	5703	19	and	and	CC
cord-023095-4dannjjm	5703	20	disease	disease	NN
cord-023095-4dannjjm	5703	21	following	follow	VBG
cord-023095-4dannjjm	5703	22	challenge	challenge	NN
cord-023095-4dannjjm	5703	23	with	with	IN
cord-023095-4dannjjm	5703	24	virulent	virulent	JJ
cord-023095-4dannjjm	5703	25	Leptospira	Leptospira	NNP
cord-023095-4dannjjm	5703	26	canicola	canicola	NN
cord-023095-4dannjjm	5703	27	,	,	,
cord-023095-4dannjjm	5703	28	L.	L.	NNP
cord-023095-4dannjjm	5703	29	pomona	pomona	NNP
cord-023095-4dannjjm	5703	30	,	,	,
cord-023095-4dannjjm	5703	31	L.	L.	NNP
cord-023095-4dannjjm	5703	32	grippotyphosa	grippotyphosa	NNP
cord-023095-4dannjjm	5703	33	,	,	,
cord-023095-4dannjjm	5703	34	or	or	CC
cord-023095-4dannjjm	5703	35	L.	L.	NNP
cord-023095-4dannjjm	5703	36	icterohaemorrhagiae	icterohaemorrhagiae	NN
cord-023095-4dannjjm	5703	37	.	.	.
cord-023095-4dannjjm	5704	1	Groups	group	NNS
cord-023095-4dannjjm	5704	2	of	of	IN
cord-023095-4dannjjm	5704	3	8week	8week	CD
cord-023095-4dannjjm	5704	4	-	-	HYPH
cord-023095-4dannjjm	5704	5	old	old	JJ
cord-023095-4dannjjm	5704	6	beagles	beagle	NNS
cord-023095-4dannjjm	5704	7	were	be	VBD
cord-023095-4dannjjm	5704	8	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	5704	9	(	(	-LRB-
cord-023095-4dannjjm	5704	10	day	day	NN
cord-023095-4dannjjm	5704	11	0	0	CD
cord-023095-4dannjjm	5704	12	)	)	-RRB-
cord-023095-4dannjjm	5704	13	and	and	CC
cord-023095-4dannjjm	5704	14	boosted	boost	VBN
cord-023095-4dannjjm	5704	15	(	(	-LRB-
cord-023095-4dannjjm	5704	16	day	day	NN
cord-023095-4dannjjm	5704	17	21	21	CD
cord-023095-4dannjjm	5704	18	)	)	-RRB-
cord-023095-4dannjjm	5704	19	with	with	IN
cord-023095-4dannjjm	5704	20	placebo	placebo	NN
cord-023095-4dannjjm	5704	21	(	(	-LRB-
cord-023095-4dannjjm	5704	22	n	n	NN
cord-023095-4dannjjm	5704	23	5	5	CD
cord-023095-4dannjjm	5704	24	10	10	CD
cord-023095-4dannjjm	5704	25	)	)	-RRB-
cord-023095-4dannjjm	5704	26	or	or	CC
cord-023095-4dannjjm	5704	27	the	the	DT
cord-023095-4dannjjm	5704	28	4-way	4-way	JJ
cord-023095-4dannjjm	5704	29	bacterin	bacterin	NNP
cord-023095-4dannjjm	5704	30	(	(	-LRB-
cord-023095-4dannjjm	5704	31	n	n	NN
cord-023095-4dannjjm	5704	32	!	!	NNP
cord-023095-4dannjjm	5704	33	20	20	CD
cord-023095-4dannjjm	5704	34	)	)	-RRB-
cord-023095-4dannjjm	5704	35	and	and	CC
cord-023095-4dannjjm	5704	36	subsequently	subsequently	RB
cord-023095-4dannjjm	5704	37	challenged	challenge	VBD
cord-023095-4dannjjm	5704	38	with	with	IN
cord-023095-4dannjjm	5704	39	each	each	DT
cord-023095-4dannjjm	5704	40	serovar	serovar	NNP
cord-023095-4dannjjm	5704	41	.	.	.
cord-023095-4dannjjm	5705	1	The	the	DT
cord-023095-4dannjjm	5705	2	results	result	NNS
cord-023095-4dannjjm	5705	3	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	5705	4	that	that	IN
cord-023095-4dannjjm	5705	5	blood	blood	NN
cord-023095-4dannjjm	5705	6	and	and	CC
cord-023095-4dannjjm	5705	7	various	various	JJ
cord-023095-4dannjjm	5705	8	tissue	tissue	NN
cord-023095-4dannjjm	5705	9	samples	sample	NNS
cord-023095-4dannjjm	5705	10	from	from	IN
cord-023095-4dannjjm	5705	11	placebo	placebo	NN
cord-023095-4dannjjm	5705	12	-	-	HYPH
cord-023095-4dannjjm	5705	13	recipients	recipient	NNS
cord-023095-4dannjjm	5705	14	became	become	VBD
cord-023095-4dannjjm	5705	15	reliably	reliably	RB
cord-023095-4dannjjm	5705	16	infected	infect	VBN
cord-023095-4dannjjm	5705	17	,	,	,
cord-023095-4dannjjm	5705	18	and	and	CC
cord-023095-4dannjjm	5705	19	the	the	DT
cord-023095-4dannjjm	5705	20	dogs	dog	NNS
cord-023095-4dannjjm	5705	21	developed	develop	VBD
cord-023095-4dannjjm	5705	22	typical	typical	JJ
cord-023095-4dannjjm	5705	23	clinical	clinical	JJ
cord-023095-4dannjjm	5705	24	signs	sign	NNS
cord-023095-4dannjjm	5705	25	of	of	IN
cord-023095-4dannjjm	5705	26	Leptospirosis	leptospirosis	NN
cord-023095-4dannjjm	5705	27	including	include	VBG
cord-023095-4dannjjm	5705	28	loss	loss	NN
cord-023095-4dannjjm	5705	29	of	of	IN
cord-023095-4dannjjm	5705	30	appetite	appetite	NN
cord-023095-4dannjjm	5705	31	,	,	,
cord-023095-4dannjjm	5705	32	ocular	ocular	JJ
cord-023095-4dannjjm	5705	33	congestion	congestion	NN
cord-023095-4dannjjm	5705	34	,	,	,
cord-023095-4dannjjm	5705	35	depression	depression	NN
cord-023095-4dannjjm	5705	36	,	,	,
cord-023095-4dannjjm	5705	37	dehydration	dehydration	NN
cord-023095-4dannjjm	5705	38	,	,	,
cord-023095-4dannjjm	5705	39	jaundice	jaundice	NN
cord-023095-4dannjjm	5705	40	,	,	,
cord-023095-4dannjjm	5705	41	hematuria	hematuria	NN
cord-023095-4dannjjm	5705	42	,	,	,
cord-023095-4dannjjm	5705	43	melena	melena	NN
cord-023095-4dannjjm	5705	44	,	,	,
cord-023095-4dannjjm	5705	45	vomiting	vomiting	NN
cord-023095-4dannjjm	5705	46	,	,	,
cord-023095-4dannjjm	5705	47	petechiae	petechia	NNS
cord-023095-4dannjjm	5705	48	,	,	,
cord-023095-4dannjjm	5705	49	and	and	CC
cord-023095-4dannjjm	5705	50	death	death	NN
cord-023095-4dannjjm	5705	51	.	.	.
cord-023095-4dannjjm	5706	1	In	in	IN
cord-023095-4dannjjm	5706	2	addition	addition	NN
cord-023095-4dannjjm	5706	3	,	,	,
cord-023095-4dannjjm	5706	4	placebo	placebo	NN
cord-023095-4dannjjm	5706	5	-	-	HYPH
cord-023095-4dannjjm	5706	6	recipients	recipient	NNS
cord-023095-4dannjjm	5706	7	developed	develop	VBD
cord-023095-4dannjjm	5706	8	kidney	kidney	NN
cord-023095-4dannjjm	5706	9	and	and	CC
cord-023095-4dannjjm	5706	10	liver	liver	NN
cord-023095-4dannjjm	5706	11	dysfunction	dysfunction	NN
cord-023095-4dannjjm	5706	12	.	.	.
cord-023095-4dannjjm	5707	1	In	in	IN
cord-023095-4dannjjm	5707	2	contrast	contrast	NN
cord-023095-4dannjjm	5707	3	,	,	,
cord-023095-4dannjjm	5707	4	some	some	DT
cord-023095-4dannjjm	5707	5	vaccine	vaccine	NN
cord-023095-4dannjjm	5707	6	-	-	HYPH
cord-023095-4dannjjm	5707	7	recipients	recipient	NNS
cord-023095-4dannjjm	5707	8	became	become	VBD
cord-023095-4dannjjm	5707	9	infected	infected	JJ
cord-023095-4dannjjm	5707	10	,	,	,
cord-023095-4dannjjm	5707	11	but	but	CC
cord-023095-4dannjjm	5707	12	the	the	DT
cord-023095-4dannjjm	5707	13	organisms	organism	NNS
cord-023095-4dannjjm	5707	14	were	be	VBD
cord-023095-4dannjjm	5707	15	cleared	clear	VBN
cord-023095-4dannjjm	5707	16	quickly	quickly	RB
cord-023095-4dannjjm	5707	17	from	from	IN
cord-023095-4dannjjm	5707	18	the	the	DT
cord-023095-4dannjjm	5707	19	blood	blood	NN
cord-023095-4dannjjm	5707	20	.	.	.
cord-023095-4dannjjm	5708	1	Vaccinated	vaccinated	JJ
cord-023095-4dannjjm	5708	2	dogs	dog	NNS
cord-023095-4dannjjm	5708	3	failed	fail	VBD
cord-023095-4dannjjm	5708	4	to	to	TO
cord-023095-4dannjjm	5708	5	develop	develop	VB
cord-023095-4dannjjm	5708	6	severe	severe	JJ
cord-023095-4dannjjm	5708	7	clinical	clinical	JJ
cord-023095-4dannjjm	5708	8	disease	disease	NN
cord-023095-4dannjjm	5708	9	requiring	require	VBG
cord-023095-4dannjjm	5708	10	medical	medical	JJ
cord-023095-4dannjjm	5708	11	intervention	intervention	NN
cord-023095-4dannjjm	5708	12	,	,	,
cord-023095-4dannjjm	5708	13	and	and	CC
cord-023095-4dannjjm	5708	14	no	no	DT
cord-023095-4dannjjm	5708	15	animals	animal	NNS
cord-023095-4dannjjm	5708	16	died	die	VBD
cord-023095-4dannjjm	5708	17	(	(	-LRB-
cord-023095-4dannjjm	5708	18	p	p	NN
cord-023095-4dannjjm	5708	19	!	!	.
cord-023095-4dannjjm	5708	20	0.001	0.001	CD
cord-023095-4dannjjm	5708	21	)	)	-RRB-
cord-023095-4dannjjm	5708	22	.	.	.
cord-023095-4dannjjm	5709	1	A	a	DT
cord-023095-4dannjjm	5709	2	few	few	JJ
cord-023095-4dannjjm	5709	3	of	of	IN
cord-023095-4dannjjm	5709	4	the	the	DT
cord-023095-4dannjjm	5709	5	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	5709	6	dogs	dog	NNS
cord-023095-4dannjjm	5709	7	developed	develop	VBD
cord-023095-4dannjjm	5709	8	clinical	clinical	JJ
cord-023095-4dannjjm	5709	9	abnormalities	abnormality	NNS
cord-023095-4dannjjm	5709	10	,	,	,
cord-023095-4dannjjm	5709	11	but	but	CC
cord-023095-4dannjjm	5709	12	the	the	DT
cord-023095-4dannjjm	5709	13	clinical	clinical	JJ
cord-023095-4dannjjm	5709	14	signs	sign	NNS
cord-023095-4dannjjm	5709	15	remained	remain	VBD
cord-023095-4dannjjm	5709	16	mild	mild	JJ
cord-023095-4dannjjm	5709	17	and	and	CC
cord-023095-4dannjjm	5709	18	were	be	VBD
cord-023095-4dannjjm	5709	19	self	self	NN
cord-023095-4dannjjm	5709	20	-	-	HYPH
cord-023095-4dannjjm	5709	21	limiting	limit	VBG
cord-023095-4dannjjm	5709	22	(	(	-LRB-
cord-023095-4dannjjm	5709	23	p	p	NN
cord-023095-4dannjjm	5709	24	o	o	NN
cord-023095-4dannjjm	5709	25	0.0001	0.0001	CD
cord-023095-4dannjjm	5709	26	for	for	IN
cord-023095-4dannjjm	5709	27	each	each	DT
cord-023095-4dannjjm	5709	28	serovar	serovar	NNP
cord-023095-4dannjjm	5709	29	)	)	-RRB-
cord-023095-4dannjjm	5709	30	.	.	.
cord-023095-4dannjjm	5710	1	Administration	administration	NN
cord-023095-4dannjjm	5710	2	of	of	IN
cord-023095-4dannjjm	5710	3	the	the	DT
cord-023095-4dannjjm	5710	4	bacterin	bacterin	NNP
cord-023095-4dannjjm	5710	5	also	also	RB
cord-023095-4dannjjm	5710	6	prevented	prevent	VBD
cord-023095-4dannjjm	5710	7	thrombocytopenia	thrombocytopenia	NN
cord-023095-4dannjjm	5711	1	(	(	-LRB-
cord-023095-4dannjjm	5711	2	Ciprofloxacin	Ciprofloxacin	NNP
cord-023095-4dannjjm	5711	3	,	,	,
cord-023095-4dannjjm	5711	4	a	a	DT
cord-023095-4dannjjm	5711	5	synthetic	synthetic	JJ
cord-023095-4dannjjm	5711	6	fluoroquinolone	fluoroquinolone	NN
cord-023095-4dannjjm	5711	7	antimicrobic	antimicrobic	NNP
cord-023095-4dannjjm	5711	8	,	,	,
cord-023095-4dannjjm	5711	9	is	be	VBZ
cord-023095-4dannjjm	5711	10	not	not	RB
cord-023095-4dannjjm	5711	11	FDA	FDA	NNP
cord-023095-4dannjjm	5711	12	-	-	HYPH
cord-023095-4dannjjm	5711	13	approved	approve	VBN
cord-023095-4dannjjm	5711	14	for	for	IN
cord-023095-4dannjjm	5711	15	veterinary	veterinary	JJ
cord-023095-4dannjjm	5711	16	use	use	NN
cord-023095-4dannjjm	5711	17	.	.	.
cord-023095-4dannjjm	5712	1	However	however	RB
cord-023095-4dannjjm	5712	2	,	,	,
cord-023095-4dannjjm	5712	3	due	due	IN
cord-023095-4dannjjm	5712	4	to	to	IN
cord-023095-4dannjjm	5712	5	recent	recent	JJ
cord-023095-4dannjjm	5712	6	availability	availability	NN
cord-023095-4dannjjm	5712	7	of	of	IN
cord-023095-4dannjjm	5712	8	less	less	RBR
cord-023095-4dannjjm	5712	9	expensive	expensive	JJ
cord-023095-4dannjjm	5712	10	generic	generic	JJ
cord-023095-4dannjjm	5712	11	formulations	formulation	NNS
cord-023095-4dannjjm	5712	12	,	,	,
cord-023095-4dannjjm	5712	13	extra	extra	JJ
cord-023095-4dannjjm	5712	14	-	-	JJ
cord-023095-4dannjjm	5712	15	label	label	JJ
cord-023095-4dannjjm	5712	16	use	use	NN
cord-023095-4dannjjm	5712	17	of	of	IN
cord-023095-4dannjjm	5712	18	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5712	19	by	by	IN
cord-023095-4dannjjm	5712	20	veterinarians	veterinarian	NNS
cord-023095-4dannjjm	5712	21	appears	appear	VBZ
cord-023095-4dannjjm	5712	22	more	more	RBR
cord-023095-4dannjjm	5712	23	common	common	JJ
cord-023095-4dannjjm	5712	24	.	.	.
cord-023095-4dannjjm	5713	1	Although	although	IN
cord-023095-4dannjjm	5713	2	ciprofloxacin	ciprofloxacin	NNP
cord-023095-4dannjjm	5713	3	crystalluria	crystalluria	NNP
cord-023095-4dannjjm	5713	4	and	and	CC
cord-023095-4dannjjm	5713	5	uroliths	uroliths	NNP
cord-023095-4dannjjm	5713	6	have	have	VBP
cord-023095-4dannjjm	5713	7	been	be	VBN
cord-023095-4dannjjm	5713	8	reported	report	VBN
cord-023095-4dannjjm	5713	9	in	in	IN
cord-023095-4dannjjm	5713	10	humans	human	NNS
cord-023095-4dannjjm	5713	11	,	,	,
cord-023095-4dannjjm	5713	12	we	-PRON-	PRP
cord-023095-4dannjjm	5713	13	are	be	VBP
cord-023095-4dannjjm	5713	14	unaware	unaware	JJ
cord-023095-4dannjjm	5713	15	of	of	IN
cord-023095-4dannjjm	5713	16	any	any	DT
cord-023095-4dannjjm	5713	17	published	publish	VBN
cord-023095-4dannjjm	5713	18	reports	report	NNS
cord-023095-4dannjjm	5713	19	in	in	IN
cord-023095-4dannjjm	5713	20	dogs	dog	NNS
cord-023095-4dannjjm	5713	21	.	.	.
cord-023095-4dannjjm	5714	1	This	this	DT
cord-023095-4dannjjm	5714	2	is	be	VBZ
cord-023095-4dannjjm	5714	3	surprising	surprising	JJ
cord-023095-4dannjjm	5714	4	since	since	IN
cord-023095-4dannjjm	5714	5	mean	mean	JJ
cord-023095-4dannjjm	5714	6	urine	urine	NN
cord-023095-4dannjjm	5714	7	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5714	8	concentration	concentration	NN
cord-023095-4dannjjm	5714	9	(	(	-LRB-
cord-023095-4dannjjm	5714	10	0.36	0.36	CD
cord-023095-4dannjjm	5714	11	mg	mg	NNP
cord-023095-4dannjjm	5714	12	/	/	SYM
cord-023095-4dannjjm	5714	13	ml	ml	NNP
cord-023095-4dannjjm	5714	14	)	)	-RRB-
cord-023095-4dannjjm	5714	15	in	in	IN
cord-023095-4dannjjm	5714	16	dogs	dog	NNS
cord-023095-4dannjjm	5714	17	following	follow	VBG
cord-023095-4dannjjm	5714	18	a	a	DT
cord-023095-4dannjjm	5714	19	modest	modest	JJ
cord-023095-4dannjjm	5714	20	IV	IV	NNP
cord-023095-4dannjjm	5714	21	dose	dose	NN
cord-023095-4dannjjm	5714	22	(	(	-LRB-
cord-023095-4dannjjm	5714	23	13	13	CD
cord-023095-4dannjjm	5714	24	mg	mg	NNP
cord-023095-4dannjjm	5714	25	/	/	SYM
cord-023095-4dannjjm	5714	26	kg	kg	NNP
cord-023095-4dannjjm	5714	27	)	)	-RRB-
cord-023095-4dannjjm	5714	28	was	be	VBD
cord-023095-4dannjjm	5714	29	3	3	CD
cord-023095-4dannjjm	5714	30	times	time	NNS
cord-023095-4dannjjm	5714	31	higher	high	JJR
cord-023095-4dannjjm	5714	32	than	than	IN
cord-023095-4dannjjm	5714	33	the	the	DT
cord-023095-4dannjjm	5714	34	solubility	solubility	NN
cord-023095-4dannjjm	5714	35	of	of	IN
cord-023095-4dannjjm	5714	36	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5714	37	in	in	IN
cord-023095-4dannjjm	5714	38	water	water	NN
cord-023095-4dannjjm	5714	39	(	(	-LRB-
cord-023095-4dannjjm	5714	40	0.12	0.12	CD
cord-023095-4dannjjm	5714	41	mg	mg	NNP
cord-023095-4dannjjm	5714	42	/	/	SYM
cord-023095-4dannjjm	5714	43	ml	ml	NNP
cord-023095-4dannjjm	5714	44	)	)	-RRB-
cord-023095-4dannjjm	5714	45	.	.	.
cord-023095-4dannjjm	5715	1	To	to	TO
cord-023095-4dannjjm	5715	2	identify	identify	VB
cord-023095-4dannjjm	5715	3	the	the	DT
cord-023095-4dannjjm	5715	4	occurrence	occurrence	NN
cord-023095-4dannjjm	5715	5	of	of	IN
cord-023095-4dannjjm	5715	6	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5715	7	uroliths	urolith	NNS
cord-023095-4dannjjm	5715	8	in	in	IN
cord-023095-4dannjjm	5715	9	dogs	dog	NNS
cord-023095-4dannjjm	5715	10	,	,	,
cord-023095-4dannjjm	5715	11	records	record	NNS
cord-023095-4dannjjm	5715	12	from	from	IN
cord-023095-4dannjjm	5715	13	the	the	DT
cord-023095-4dannjjm	5715	14	Minnesota	Minnesota	NNP
cord-023095-4dannjjm	5715	15	Urolith	Urolith	NNP
cord-023095-4dannjjm	5715	16	Center	Center	NNP
cord-023095-4dannjjm	5715	17	were	be	VBD
cord-023095-4dannjjm	5715	18	reviewed	review	VBN
cord-023095-4dannjjm	5715	19	.	.	.
cord-023095-4dannjjm	5716	1	Between	between	IN
cord-023095-4dannjjm	5716	2	January	January	NNP
cord-023095-4dannjjm	5716	3	2001	2001	CD
cord-023095-4dannjjm	5716	4	and	and	CC
cord-023095-4dannjjm	5716	5	December	December	NNP
cord-023095-4dannjjm	5716	6	2009	2009	CD
cord-023095-4dannjjm	5716	7	,	,	,
cord-023095-4dannjjm	5716	8	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5716	9	was	be	VBD
cord-023095-4dannjjm	5716	10	identified	identify	VBN
cord-023095-4dannjjm	5716	11	in	in	IN
cord-023095-4dannjjm	5716	12	uroliths	urolith	NNS
cord-023095-4dannjjm	5716	13	from	from	IN
cord-023095-4dannjjm	5716	14	58	58	CD
cord-023095-4dannjjm	5716	15	dogs	dog	NNS
cord-023095-4dannjjm	5716	16	;	;	:
cord-023095-4dannjjm	5716	17	uroliths	uroliths	NNP
cord-023095-4dannjjm	5716	18	were	be	VBD
cord-023095-4dannjjm	5716	19	composed	compose	VBN
cord-023095-4dannjjm	5716	20	of	of	IN
cord-023095-4dannjjm	5716	21	100	100	CD
cord-023095-4dannjjm	5716	22	%	%	NN
cord-023095-4dannjjm	5716	23	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5716	24	in	in	IN
cord-023095-4dannjjm	5716	25	10	10	CD
cord-023095-4dannjjm	5716	26	,	,	,
cord-023095-4dannjjm	5716	27	mixed	mixed	JJ
cord-023095-4dannjjm	5716	28	uroliths	urolith	NNS
cord-023095-4dannjjm	5716	29	containing	contain	VBG
cord-023095-4dannjjm	5716	30	ciprofloxacin	ciprofloxacin	NNS
cord-023095-4dannjjm	5716	31	were	be	VBD
cord-023095-4dannjjm	5716	32	identified	identify	VBN
cord-023095-4dannjjm	5716	33	in	in	IN
cord-023095-4dannjjm	5716	34	6	6	CD
cord-023095-4dannjjm	5716	35	,	,	,
cord-023095-4dannjjm	5716	36	a	a	DT
cord-023095-4dannjjm	5716	37	shell	shell	NN
cord-023095-4dannjjm	5716	38	of	of	IN
cord-023095-4dannjjm	5716	39	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5716	40	was	be	VBD
cord-023095-4dannjjm	5716	41	observed	observe	VBN
cord-023095-4dannjjm	5716	42	in	in	IN
cord-023095-4dannjjm	5716	43	21	21	CD
cord-023095-4dannjjm	5716	44	,	,	,
cord-023095-4dannjjm	5716	45	and	and	CC
cord-023095-4dannjjm	5716	46	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5716	47	surface	surface	NN
cord-023095-4dannjjm	5716	48	crystals	crystal	NNS
cord-023095-4dannjjm	5716	49	were	be	VBD
cord-023095-4dannjjm	5716	50	identified	identify	VBN
cord-023095-4dannjjm	5716	51	in	in	IN
cord-023095-4dannjjm	5716	52	21	21	CD
cord-023095-4dannjjm	5716	53	.	.	.
cord-023095-4dannjjm	5717	1	Based	base	VBN
cord-023095-4dannjjm	5717	2	on	on	IN
cord-023095-4dannjjm	5717	3	an	an	DT
cord-023095-4dannjjm	5717	4	experimental	experimental	JJ
cord-023095-4dannjjm	5717	5	study	study	NN
cord-023095-4dannjjm	5717	6	in	in	IN
cord-023095-4dannjjm	5717	7	which	which	WDT
cord-023095-4dannjjm	5717	8	83	83	CD
cord-023095-4dannjjm	5717	9	%	%	NN
cord-023095-4dannjjm	5717	10	of	of	IN
cord-023095-4dannjjm	5717	11	human	human	JJ
cord-023095-4dannjjm	5717	12	volunteers	volunteer	NNS
cord-023095-4dannjjm	5717	13	consuming	consume	VBG
cord-023095-4dannjjm	5717	14	1000	1000	CD
cord-023095-4dannjjm	5717	15	mg	mg	NN
cord-023095-4dannjjm	5717	16	of	of	IN
cord-023095-4dannjjm	5717	17	ciprofloxacin	ciprofloxacin	NNP
cord-023095-4dannjjm	5717	18	with	with	IN
cord-023095-4dannjjm	5717	19	NaHCO3	NaHCO3	NNP
cord-023095-4dannjjm	5717	20	exhibited	exhibit	VBD
cord-023095-4dannjjm	5717	21	ciprofloxacin	ciprofloxacin	NNP
cord-023095-4dannjjm	5717	22	crystalluria	crystalluria	NNP
cord-023095-4dannjjm	5717	23	(	(	-LRB-
cord-023095-4dannjjm	5717	24	urine	urine	NN
cord-023095-4dannjjm	5717	25	pH	pH	NNP
cord-023095-4dannjjm	5717	26	47.3	47.3	CD
cord-023095-4dannjjm	5717	27	)	)	-RRB-
cord-023095-4dannjjm	5717	28	,	,	,
cord-023095-4dannjjm	5717	29	while	while	IN
cord-023095-4dannjjm	5717	30	no	no	DT
cord-023095-4dannjjm	5717	31	volunteers	volunteer	NNS
cord-023095-4dannjjm	5717	32	consuming	consume	VBG
cord-023095-4dannjjm	5717	33	1000	1000	CD
cord-023095-4dannjjm	5717	34	mg	mg	NN
cord-023095-4dannjjm	5717	35	of	of	IN
cord-023095-4dannjjm	5717	36	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5717	37	and	and	CC
cord-023095-4dannjjm	5717	38	NH4Cl	NH4Cl	NNP
cord-023095-4dannjjm	5717	39	to	to	TO
cord-023095-4dannjjm	5717	40	acidify	acidify	VB
cord-023095-4dannjjm	5717	41	urine	urine	NN
cord-023095-4dannjjm	5717	42	formed	form	VBN
cord-023095-4dannjjm	5717	43	crystals	crystal	NNS
cord-023095-4dannjjm	5717	44	;	;	:
cord-023095-4dannjjm	5717	45	we	-PRON-	PRP
cord-023095-4dannjjm	5717	46	postulated	postulate	VBD
cord-023095-4dannjjm	5717	47	that	that	IN
cord-023095-4dannjjm	5717	48	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5717	49	uroliths	uroliths	NNP
cord-023095-4dannjjm	5717	50	could	could	MD
cord-023095-4dannjjm	5717	51	be	be	VB
cord-023095-4dannjjm	5717	52	dissolved	dissolve	VBN
cord-023095-4dannjjm	5717	53	in	in	IN
cord-023095-4dannjjm	5717	54	acidic	acidic	JJ
cord-023095-4dannjjm	5717	55	urine	urine	NN
cord-023095-4dannjjm	5717	56	.	.	.
cord-023095-4dannjjm	5718	1	To	to	TO
cord-023095-4dannjjm	5718	2	test	test	VB
cord-023095-4dannjjm	5718	3	this	this	DT
cord-023095-4dannjjm	5718	4	hypothesis	hypothesis	NN
cord-023095-4dannjjm	5718	5	,	,	,
cord-023095-4dannjjm	5718	6	canine	canine	JJ
cord-023095-4dannjjm	5718	7	uroliths	urolith	NNS
cord-023095-4dannjjm	5718	8	composed	compose	VBN
cord-023095-4dannjjm	5718	9	of	of	IN
cord-023095-4dannjjm	5718	10	100	100	CD
cord-023095-4dannjjm	5718	11	%	%	NN
cord-023095-4dannjjm	5718	12	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5718	13	from	from	IN
cord-023095-4dannjjm	5718	14	a	a	DT
cord-023095-4dannjjm	5718	15	single	single	JJ
cord-023095-4dannjjm	5718	16	source	source	NN
cord-023095-4dannjjm	5718	17	(	(	-LRB-
cord-023095-4dannjjm	5718	18	6-yr	6-yr	JJ
cord-023095-4dannjjm	5718	19	-	-	HYPH
cord-023095-4dannjjm	5718	20	old	old	JJ
cord-023095-4dannjjm	5718	21	male	male	NN
cord-023095-4dannjjm	5718	22	,	,	,
cord-023095-4dannjjm	5718	23	English	english	JJ
cord-023095-4dannjjm	5718	24	bulldog	bulldog	NN
cord-023095-4dannjjm	5718	25	receiving	receive	VBG
cord-023095-4dannjjm	5718	26	24	24	CD
cord-023095-4dannjjm	5718	27	mg	mg	NNP
cord-023095-4dannjjm	5718	28	/	/	SYM
cord-023095-4dannjjm	5718	29	kg	kg	NNS
cord-023095-4dannjjm	5718	30	of	of	IN
cord-023095-4dannjjm	5718	31	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5718	32	PO	PO	NNP
cord-023095-4dannjjm	5718	33	,	,	,
cord-023095-4dannjjm	5718	34	q12	q12	NN
cord-023095-4dannjjm	5718	35	hr	hr	NN
cord-023095-4dannjjm	5718	36	to	to	TO
cord-023095-4dannjjm	5718	37	manage	manage	VB
cord-023095-4dannjjm	5718	38	superficial	superficial	JJ
cord-023095-4dannjjm	5718	39	pyoderma	pyoderma	NNS
cord-023095-4dannjjm	5718	40	;	;	,
cord-023095-4dannjjm	5718	41	turbulent	turbulent	JJ
cord-023095-4dannjjm	5718	42	flow	flow	NN
cord-023095-4dannjjm	5718	43	chromatography	chromatography	NN
cord-023095-4dannjjm	5718	44	/	/	SYM
cord-023095-4dannjjm	5718	45	tandem	tandem	NN
cord-023095-4dannjjm	5718	46	mass	mass	NN
cord-023095-4dannjjm	5718	47	spectrometry	spectrometry	NN
cord-023095-4dannjjm	5718	48	detected	detect	VBD
cord-023095-4dannjjm	5718	49	517	517	CD
cord-023095-4dannjjm	5718	50	mg	mg	NN
cord-023095-4dannjjm	5718	51	of	of	IN
cord-023095-4dannjjm	5718	52	ciprofloxacin	ciprofloxacin	NNP
cord-023095-4dannjjm	5718	53	/	/	SYM
cord-023095-4dannjjm	5718	54	g	g	NN
cord-023095-4dannjjm	5718	55	of	of	IN
cord-023095-4dannjjm	5718	56	urolith	urolith	NN
cord-023095-4dannjjm	5718	57	)	)	-RRB-
cord-023095-4dannjjm	5718	58	were	be	VBD
cord-023095-4dannjjm	5718	59	incubated	incubate	VBN
cord-023095-4dannjjm	5718	60	in	in	IN
cord-023095-4dannjjm	5718	61	urine	urine	NN
cord-023095-4dannjjm	5718	62	at	at	IN
cord-023095-4dannjjm	5718	63	selected	select	VBN
cord-023095-4dannjjm	5718	64	pH	pH	NNP
cord-023095-4dannjjm	5718	65	's	's	POS
cord-023095-4dannjjm	5718	66	and	and	CC
cord-023095-4dannjjm	5718	67	monitored	monitor	VBN
cord-023095-4dannjjm	5718	68	for	for	IN
cord-023095-4dannjjm	5718	69	dissolution	dissolution	NN
cord-023095-4dannjjm	5718	70	.	.	.
cord-023095-4dannjjm	5719	1	Urine	urine	NN
cord-023095-4dannjjm	5719	2	obtained	obtain	VBN
cord-023095-4dannjjm	5719	3	from	from	IN
cord-023095-4dannjjm	5719	4	multiple	multiple	JJ
cord-023095-4dannjjm	5719	5	dogs	dog	NNS
cord-023095-4dannjjm	5719	6	not	not	RB
cord-023095-4dannjjm	5719	7	receiving	receive	VBG
cord-023095-4dannjjm	5719	8	fluoroquinolones	fluoroquinolone	NNS
cord-023095-4dannjjm	5719	9	,	,	,
cord-023095-4dannjjm	5719	10	was	be	VBD
cord-023095-4dannjjm	5719	11	pooled	pool	VBN
cord-023095-4dannjjm	5719	12	and	and	CC
cord-023095-4dannjjm	5719	13	divided	divide	VBN
cord-023095-4dannjjm	5719	14	into	into	IN
cord-023095-4dannjjm	5719	15	5	5	CD
cord-023095-4dannjjm	5719	16	aliquots	aliquot	NNS
cord-023095-4dannjjm	5719	17	.	.	.
cord-023095-4dannjjm	5720	1	Aliquots	aliquot	NNS
cord-023095-4dannjjm	5720	2	were	be	VBD
cord-023095-4dannjjm	5720	3	adjusted	adjust	VBN
cord-023095-4dannjjm	5720	4	with	with	IN
cord-023095-4dannjjm	5720	5	HCl	HCl	NNP
cord-023095-4dannjjm	5720	6	or	or	CC
cord-023095-4dannjjm	5720	7	NaOH	NaOH	NNP
cord-023095-4dannjjm	5720	8	to	to	IN
cord-023095-4dannjjm	5720	9	a	a	DT
cord-023095-4dannjjm	5720	10	pH	ph	NN
cord-023095-4dannjjm	5720	11	of	of	IN
cord-023095-4dannjjm	5720	12	3	3	CD
cord-023095-4dannjjm	5720	13	,	,	,
cord-023095-4dannjjm	5720	14	5	5	CD
cord-023095-4dannjjm	5720	15	,	,	,
cord-023095-4dannjjm	5720	16	6	6	CD
cord-023095-4dannjjm	5720	17	,	,	,
cord-023095-4dannjjm	5720	18	7	7	CD
cord-023095-4dannjjm	5720	19	,	,	,
cord-023095-4dannjjm	5720	20	or	or	CC
cord-023095-4dannjjm	5720	21	8	8	CD
cord-023095-4dannjjm	5720	22	.	.	.
cord-023095-4dannjjm	5721	1	Aliquots	Aliquots	NNP
cord-023095-4dannjjm	5721	2	were	be	VBD
cord-023095-4dannjjm	5721	3	capped	cap	VBN
cord-023095-4dannjjm	5721	4	and	and	CC
cord-023095-4dannjjm	5721	5	preserved	preserve	VBN
cord-023095-4dannjjm	5721	6	by	by	IN
cord-023095-4dannjjm	5721	7	refrigeration	refrigeration	NN
cord-023095-4dannjjm	5721	8	;	;	:
cord-023095-4dannjjm	5721	9	pH	pH	NNP
cord-023095-4dannjjm	5721	10	was	be	VBD
cord-023095-4dannjjm	5721	11	monitored	monitor	VBN
cord-023095-4dannjjm	5721	12	and	and	CC
cord-023095-4dannjjm	5721	13	readjusted	readjust	VBN
cord-023095-4dannjjm	5721	14	weekly	weekly	RB
cord-023095-4dannjjm	5721	15	.	.	.
cord-023095-4dannjjm	5722	1	Ten	ten	CD
cord-023095-4dannjjm	5722	2	uroliths	urolith	NNS
cord-023095-4dannjjm	5722	3	of	of	IN
cord-023095-4dannjjm	5722	4	approximately	approximately	RB
cord-023095-4dannjjm	5722	5	equal	equal	JJ
cord-023095-4dannjjm	5722	6	weight	weight	NN
cord-023095-4dannjjm	5722	7	were	be	VBD
cord-023095-4dannjjm	5722	8	randomly	randomly	RB
cord-023095-4dannjjm	5722	9	assigned	assign	VBN
cord-023095-4dannjjm	5722	10	to	to	IN
cord-023095-4dannjjm	5722	11	individual	individual	JJ
cord-023095-4dannjjm	5722	12	flasks	flask	NNS
cord-023095-4dannjjm	5722	13	containing	contain	VBG
cord-023095-4dannjjm	5722	14	10	10	CD
cord-023095-4dannjjm	5722	15	mls	mls	NN
cord-023095-4dannjjm	5722	16	of	of	IN
cord-023095-4dannjjm	5722	17	urine	urine	NN
cord-023095-4dannjjm	5722	18	.	.	.
cord-023095-4dannjjm	5723	1	Flasks	flask	NNS
cord-023095-4dannjjm	5723	2	were	be	VBD
cord-023095-4dannjjm	5723	3	constantly	constantly	RB
cord-023095-4dannjjm	5723	4	agitated	agitate	VBN
cord-023095-4dannjjm	5723	5	and	and	CC
cord-023095-4dannjjm	5723	6	maintained	maintain	VBN
cord-023095-4dannjjm	5723	7	at	at	IN
cord-023095-4dannjjm	5723	8	381C.	381c.	CD
cord-023095-4dannjjm	5723	9	Every	every	DT
cord-023095-4dannjjm	5723	10	24	24	CD
cord-023095-4dannjjm	5723	11	hours	hour	NNS
cord-023095-4dannjjm	5723	12	,	,	,
cord-023095-4dannjjm	5723	13	urine	urine	NN
cord-023095-4dannjjm	5723	14	was	be	VBD
cord-023095-4dannjjm	5723	15	discarded	discard	VBN
cord-023095-4dannjjm	5723	16	and	and	CC
cord-023095-4dannjjm	5723	17	replaced	replace	VBN
cord-023095-4dannjjm	5723	18	with	with	IN
cord-023095-4dannjjm	5723	19	10	10	CD
cord-023095-4dannjjm	5723	20	mls	mls	NN
cord-023095-4dannjjm	5723	21	of	of	IN
cord-023095-4dannjjm	5723	22	urine	urine	NN
cord-023095-4dannjjm	5723	23	of	of	IN
cord-023095-4dannjjm	5723	24	identical	identical	JJ
cord-023095-4dannjjm	5723	25	pH	ph	NN
cord-023095-4dannjjm	5723	26	until	until	IN
cord-023095-4dannjjm	5723	27	stone	stone	NN
cord-023095-4dannjjm	5723	28	dissolution	dissolution	NN
cord-023095-4dannjjm	5723	29	was	be	VBD
cord-023095-4dannjjm	5723	30	complete	complete	JJ
cord-023095-4dannjjm	5723	31	.	.	.
cord-023095-4dannjjm	5724	1	Ciprofloxacin	Ciprofloxacin	NNP
cord-023095-4dannjjm	5724	2	urolith	urolith	NN
cord-023095-4dannjjm	5724	3	dissolution	dissolution	NN
cord-023095-4dannjjm	5724	4	times	time	NNS
cord-023095-4dannjjm	5724	5	at	at	IN
cord-023095-4dannjjm	5724	6	each	each	DT
cord-023095-4dannjjm	5724	7	urine	urine	NN
cord-023095-4dannjjm	5725	1	pH	pH	NNP
cord-023095-4dannjjm	5725	2	are	be	VBP
cord-023095-4dannjjm	5725	3	reported	report	VBN
cord-023095-4dannjjm	5725	4	below	below	RB
cord-023095-4dannjjm	5725	5	.	.	.
cord-023095-4dannjjm	5726	1	Ciprofloxacin	Ciprofloxacin	NNP
cord-023095-4dannjjm	5726	2	uroliths	urolith	NNS
cord-023095-4dannjjm	5726	3	are	be	VBP
cord-023095-4dannjjm	5726	4	a	a	DT
cord-023095-4dannjjm	5726	5	newly	newly	RB
cord-023095-4dannjjm	5726	6	recognized	recognize	VBN
cord-023095-4dannjjm	5726	7	disease	disease	NN
cord-023095-4dannjjm	5726	8	and	and	CC
cord-023095-4dannjjm	5726	9	a	a	DT
cord-023095-4dannjjm	5726	10	potential	potential	JJ
cord-023095-4dannjjm	5726	11	adverse	adverse	JJ
cord-023095-4dannjjm	5726	12	effect	effect	NN
cord-023095-4dannjjm	5726	13	of	of	IN
cord-023095-4dannjjm	5726	14	ciprofloxacin	ciprofloxacin	NNP
cord-023095-4dannjjm	5726	15	administration	administration	NN
cord-023095-4dannjjm	5726	16	in	in	IN
cord-023095-4dannjjm	5726	17	dogs	dog	NNS
cord-023095-4dannjjm	5726	18	.	.	.
cord-023095-4dannjjm	5727	1	In	in	IN
cord-023095-4dannjjm	5727	2	vitro	vitro	FW
cord-023095-4dannjjm	5727	3	dissolution	dissolution	NN
cord-023095-4dannjjm	5727	4	of	of	IN
cord-023095-4dannjjm	5727	5	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	5727	6	uroliths	uroliths	NNP
cord-023095-4dannjjm	5727	7	was	be	VBD
cord-023095-4dannjjm	5727	8	achieved	achieve	VBN
cord-023095-4dannjjm	5727	9	in	in	IN
cord-023095-4dannjjm	5727	10	canine	canine	JJ
cord-023095-4dannjjm	5727	11	urine	urine	NN
cord-023095-4dannjjm	5727	12	,	,	,
cord-023095-4dannjjm	5727	13	supporting	support	VBG
cord-023095-4dannjjm	5727	14	the	the	DT
cord-023095-4dannjjm	5727	15	premise	premise	NN
cord-023095-4dannjjm	5727	16	that	that	IN
cord-023095-4dannjjm	5727	17	in	in	IN
cord-023095-4dannjjm	5727	18	vivo	vivo	NNP
cord-023095-4dannjjm	5727	19	dissolution	dissolution	NN
cord-023095-4dannjjm	5727	20	is	be	VBZ
cord-023095-4dannjjm	5727	21	possible	possible	JJ
cord-023095-4dannjjm	5727	22	.	.	.
cord-023095-4dannjjm	5728	1	Urolith	Urolith	NNP
cord-023095-4dannjjm	5728	2	dissolution	dissolution	NN
cord-023095-4dannjjm	5728	3	times	time	NNS
cord-023095-4dannjjm	5728	4	were	be	VBD
cord-023095-4dannjjm	5728	5	shortest	shortest	RBS
cord-023095-4dannjjm	5728	6	at	at	IN
cord-023095-4dannjjm	5728	7	lower	low	JJR
cord-023095-4dannjjm	5728	8	and	and	CC
cord-023095-4dannjjm	5728	9	higher	high	JJR
cord-023095-4dannjjm	5728	10	pH	pH	NNP
cord-023095-4dannjjm	5728	11	's	's	POS
cord-023095-4dannjjm	5728	12	,	,	,
cord-023095-4dannjjm	5728	13	which	which	WDT
cord-023095-4dannjjm	5728	14	is	be	VBZ
cord-023095-4dannjjm	5728	15	consistent	consistent	JJ
cord-023095-4dannjjm	5728	16	with	with	IN
cord-023095-4dannjjm	5728	17	the	the	DT
cord-023095-4dannjjm	5728	18	pKa	pKa	NNPS
cord-023095-4dannjjm	5728	19	(	(	-LRB-
cord-023095-4dannjjm	5728	20	6.0	6.0	CD
cord-023095-4dannjjm	5728	21	and	and	CC
cord-023095-4dannjjm	5728	22	8.8	8.8	CD
cord-023095-4dannjjm	5728	23	)	)	-RRB-
cord-023095-4dannjjm	5728	24	of	of	IN
cord-023095-4dannjjm	5728	25	this	this	DT
cord-023095-4dannjjm	5728	26	amphiprotic	amphiprotic	JJ
cord-023095-4dannjjm	5728	27	antimicrobic	antimicrobic	NNP
cord-023095-4dannjjm	5728	28	(	(	-LRB-
cord-023095-4dannjjm	5728	29	more	more	RBR
cord-023095-4dannjjm	5728	30	soluble	soluble	JJ
cord-023095-4dannjjm	5728	31	at	at	IN
cord-023095-4dannjjm	5728	32	pH	ph	NN
cord-023095-4dannjjm	5728	33	below	below	IN
cord-023095-4dannjjm	5728	34	the	the	DT
cord-023095-4dannjjm	5728	35	acidic	acidic	JJ
cord-023095-4dannjjm	5728	36	pKa	pKa	NNPS
cord-023095-4dannjjm	5728	37	and	and	CC
cord-023095-4dannjjm	5728	38	above	above	IN
cord-023095-4dannjjm	5728	39	the	the	DT
cord-023095-4dannjjm	5728	40	alkaline	alkaline	JJ
cord-023095-4dannjjm	5728	41	pKa	pKa	NNP
cord-023095-4dannjjm	5728	42	)	)	-RRB-
cord-023095-4dannjjm	5728	43	.	.	.
cord-023095-4dannjjm	5729	1	Foods	food	NNS
cord-023095-4dannjjm	5729	2	designed	design	VBN
cord-023095-4dannjjm	5729	3	to	to	TO
cord-023095-4dannjjm	5729	4	promote	promote	VB
cord-023095-4dannjjm	5729	5	struvite	struvite	NN
cord-023095-4dannjjm	5729	6	urolith	urolith	NN
cord-023095-4dannjjm	5729	7	dissolution	dissolution	NN
cord-023095-4dannjjm	5729	8	may	may	MD
cord-023095-4dannjjm	5729	9	be	be	VB
cord-023095-4dannjjm	5729	10	designed	design	VBN
cord-023095-4dannjjm	5729	11	for	for	IN
cord-023095-4dannjjm	5729	12	short	short	JJ
cord-023095-4dannjjm	5729	13	term	term	NN
cord-023095-4dannjjm	5729	14	feeding	feed	VBG
cord-023095-4dannjjm	5729	15	facilitating	facilitate	VBG
cord-023095-4dannjjm	5729	16	rapid	rapid	JJ
cord-023095-4dannjjm	5729	17	dissolution	dissolution	NN
cord-023095-4dannjjm	5729	18	or	or	CC
cord-023095-4dannjjm	5729	19	may	may	MD
cord-023095-4dannjjm	5729	20	be	be	VB
cord-023095-4dannjjm	5729	21	formulated	formulate	VBN
cord-023095-4dannjjm	5729	22	with	with	IN
cord-023095-4dannjjm	5729	23	a	a	DT
cord-023095-4dannjjm	5729	24	more	more	RBR
cord-023095-4dannjjm	5729	25	moderate	moderate	JJ
cord-023095-4dannjjm	5729	26	target	target	NN
cord-023095-4dannjjm	5729	27	urine	urine	NN
cord-023095-4dannjjm	5729	28	pH	ph	NN
cord-023095-4dannjjm	5729	29	to	to	TO
cord-023095-4dannjjm	5729	30	allow	allow	VB
cord-023095-4dannjjm	5729	31	for	for	IN
cord-023095-4dannjjm	5729	32	dissolution	dissolution	NN
cord-023095-4dannjjm	5729	33	and	and	CC
cord-023095-4dannjjm	5729	34	then	then	RB
cord-023095-4dannjjm	5729	35	life	life	NN
cord-023095-4dannjjm	5729	36	-	-	HYPH
cord-023095-4dannjjm	5729	37	long	long	JJ
cord-023095-4dannjjm	5729	38	maintenance	maintenance	NN
cord-023095-4dannjjm	5729	39	feeding	feeding	NN
cord-023095-4dannjjm	5729	40	minimizing	minimize	VBG
cord-023095-4dannjjm	5729	41	recurrence	recurrence	NN
cord-023095-4dannjjm	5729	42	.	.	.
cord-023095-4dannjjm	5730	1	The	the	DT
cord-023095-4dannjjm	5730	2	purpose	purpose	NN
cord-023095-4dannjjm	5730	3	of	of	IN
cord-023095-4dannjjm	5730	4	this	this	DT
cord-023095-4dannjjm	5730	5	study	study	NN
cord-023095-4dannjjm	5730	6	was	be	VBD
cord-023095-4dannjjm	5730	7	to	to	TO
cord-023095-4dannjjm	5730	8	compare	compare	VB
cord-023095-4dannjjm	5730	9	the	the	DT
cord-023095-4dannjjm	5730	10	efficacy	efficacy	NN
cord-023095-4dannjjm	5730	11	and	and	CC
cord-023095-4dannjjm	5730	12	rate	rate	NN
cord-023095-4dannjjm	5730	13	of	of	IN
cord-023095-4dannjjm	5730	14	dissolution	dissolution	NN
cord-023095-4dannjjm	5730	15	of	of	IN
cord-023095-4dannjjm	5730	16	a	a	DT
cord-023095-4dannjjm	5730	17	maintenance	maintenance	NN
cord-023095-4dannjjm	5730	18	food	food	NN
cord-023095-4dannjjm	5730	19	with	with	IN
cord-023095-4dannjjm	5730	20	a	a	DT
cord-023095-4dannjjm	5730	21	struvite	struvite	NN
cord-023095-4dannjjm	5730	22	dissolution	dissolution	NN
cord-023095-4dannjjm	5730	23	food	food	NN
cord-023095-4dannjjm	5730	24	.	.	.
cord-023095-4dannjjm	5731	1	Sixteen	sixteen	CD
cord-023095-4dannjjm	5731	2	client	client	NN
cord-023095-4dannjjm	5731	3	-	-	HYPH
cord-023095-4dannjjm	5731	4	owned	own	VBN
cord-023095-4dannjjm	5731	5	adult	adult	NN
cord-023095-4dannjjm	5731	6	cats	cat	NNS
cord-023095-4dannjjm	5731	7	(	(	-LRB-
cord-023095-4dannjjm	5731	8	13	13	CD
cord-023095-4dannjjm	5731	9	FS	fs	NN
cord-023095-4dannjjm	5731	10	,	,	,
cord-023095-4dannjjm	5731	11	3	3	CD
cord-023095-4dannjjm	5731	12	MC	MC	NNP
cord-023095-4dannjjm	5731	13	)	)	-RRB-
cord-023095-4dannjjm	5731	14	with	with	IN
cord-023095-4dannjjm	5731	15	naturally	naturally	RB
cord-023095-4dannjjm	5731	16	occurring	occur	VBG
cord-023095-4dannjjm	5731	17	struvite	struvite	NN
cord-023095-4dannjjm	5731	18	urocystoliths	urocystolith	NNS
cord-023095-4dannjjm	5731	19	(	(	-LRB-
cord-023095-4dannjjm	5731	20	mineral	mineral	NN
cord-023095-4dannjjm	5731	21	composition	composition	NN
cord-023095-4dannjjm	5731	22	based	base	VBN
cord-023095-4dannjjm	5731	23	on	on	IN
cord-023095-4dannjjm	5731	24	history	history	NN
cord-023095-4dannjjm	5731	25	,	,	,
cord-023095-4dannjjm	5731	26	radiographs	radiograph	NNS
cord-023095-4dannjjm	5731	27	,	,	,
cord-023095-4dannjjm	5731	28	urinalysis	urinalysis	NN
cord-023095-4dannjjm	5731	29	,	,	,
cord-023095-4dannjjm	5731	30	urine	urine	NN
cord-023095-4dannjjm	5731	31	culture	culture	NN
cord-023095-4dannjjm	5731	32	and	and	CC
cord-023095-4dannjjm	5731	33	physical	physical	JJ
cord-023095-4dannjjm	5731	34	examination	examination	NN
cord-023095-4dannjjm	5731	35	)	)	-RRB-
cord-023095-4dannjjm	5731	36	were	be	VBD
cord-023095-4dannjjm	5731	37	randomized	randomize	VBN
cord-023095-4dannjjm	5731	38	to	to	IN
cord-023095-4dannjjm	5731	39	either	either	CC
cord-023095-4dannjjm	5731	40	a	a	DT
cord-023095-4dannjjm	5731	41	dry	dry	JJ
cord-023095-4dannjjm	5731	42	maintenance	maintenance	NN
cord-023095-4dannjjm	5731	43	food	food	NN
cord-023095-4dannjjm	5731	44	(	(	-LRB-
cord-023095-4dannjjm	5731	45	Test	test	NN
cord-023095-4dannjjm	5731	46	)	)	-RRB-
cord-023095-4dannjjm	5731	47	or	or	CC
cord-023095-4dannjjm	5731	48	a	a	DT
cord-023095-4dannjjm	5731	49	dry	dry	JJ
cord-023095-4dannjjm	5731	50	food	food	NN
cord-023095-4dannjjm	5731	51	known	know	VBN
cord-023095-4dannjjm	5731	52	to	to	TO
cord-023095-4dannjjm	5731	53	dissolve	dissolve	VB
cord-023095-4dannjjm	5731	54	struvite	struvite	NN
cord-023095-4dannjjm	5731	55	uroliths	urolith	NNS
cord-023095-4dannjjm	5731	56	(	(	-LRB-
cord-023095-4dannjjm	5731	57	Control	Control	NNP
cord-023095-4dannjjm	5731	58	)	)	-RRB-
cord-023095-4dannjjm	5731	59	.	.	.
cord-023095-4dannjjm	5732	1	The	the	DT
cord-023095-4dannjjm	5732	2	clinical	clinical	JJ
cord-023095-4dannjjm	5732	3	care	care	NN
cord-023095-4dannjjm	5732	4	team	team	NN
cord-023095-4dannjjm	5732	5	and	and	CC
cord-023095-4dannjjm	5732	6	owner	owner	NN
cord-023095-4dannjjm	5732	7	were	be	VBD
cord-023095-4dannjjm	5732	8	blinded	blind	VBN
cord-023095-4dannjjm	5732	9	to	to	IN
cord-023095-4dannjjm	5732	10	treatment	treatment	NN
cord-023095-4dannjjm	5732	11	assignment	assignment	NN
cord-023095-4dannjjm	5732	12	.	.	.
cord-023095-4dannjjm	5733	1	The	the	DT
cord-023095-4dannjjm	5733	2	Test	test	NN
cord-023095-4dannjjm	5733	3	food	food	NN
cord-023095-4dannjjm	5733	4	was	be	VBD
cord-023095-4dannjjm	5733	5	formulated	formulate	VBN
cord-023095-4dannjjm	5733	6	to	to	TO
cord-023095-4dannjjm	5733	7	provide	provide	VB
cord-023095-4dannjjm	5733	8	0.06	0.06	CD
cord-023095-4dannjjm	5733	9	%	%	NN
cord-023095-4dannjjm	5733	10	Mg	Mg	NNP
cord-023095-4dannjjm	5733	11	(	(	-LRB-
cord-023095-4dannjjm	5733	12	DM	DM	NNP
cord-023095-4dannjjm	5733	13	)	)	-RRB-
cord-023095-4dannjjm	5733	14	,	,	,
cord-023095-4dannjjm	5733	15	0.65	0.65	CD
cord-023095-4dannjjm	5733	16	%	%	NN
cord-023095-4dannjjm	5733	17	P	p	NN
cord-023095-4dannjjm	5733	18	,	,	,
cord-023095-4dannjjm	5733	19	35	35	CD
cord-023095-4dannjjm	5733	20	%	%	NN
cord-023095-4dannjjm	5733	21	protein	protein	NN
cord-023095-4dannjjm	5733	22	,	,	,
cord-023095-4dannjjm	5733	23	and	and	CC
cord-023095-4dannjjm	5733	24	a	a	DT
cord-023095-4dannjjm	5733	25	calculated	calculate	VBN
cord-023095-4dannjjm	5733	26	target	target	NN
cord-023095-4dannjjm	5733	27	urine	urine	NN
cord-023095-4dannjjm	5733	28	pH	pH	NNP
cord-023095-4dannjjm	5733	29	value	value	NN
cord-023095-4dannjjm	5733	30	(	(	-LRB-
cord-023095-4dannjjm	5733	31	UpH	UpH	NNP
cord-023095-4dannjjm	5733	32	)	)	-RRB-
cord-023095-4dannjjm	5733	33	of	of	IN
cord-023095-4dannjjm	5733	34	6.2	6.2	CD
cord-023095-4dannjjm	5733	35	-	-	SYM
cord-023095-4dannjjm	5733	36	6.4	6.4	CD
cord-023095-4dannjjm	5733	37	.	.	.
cord-023095-4dannjjm	5734	1	The	the	DT
cord-023095-4dannjjm	5734	2	Control	Control	NNP
cord-023095-4dannjjm	5734	3	food	food	NN
cord-023095-4dannjjm	5734	4	was	be	VBD
cord-023095-4dannjjm	5734	5	formulated	formulate	VBN
cord-023095-4dannjjm	5734	6	to	to	TO
cord-023095-4dannjjm	5734	7	provide	provide	VB
cord-023095-4dannjjm	5734	8	0.06	0.06	CD
cord-023095-4dannjjm	5734	9	%	%	NN
cord-023095-4dannjjm	5734	10	Mg	Mg	NNP
cord-023095-4dannjjm	5734	11	(	(	-LRB-
cord-023095-4dannjjm	5734	12	DM	DM	NNP
cord-023095-4dannjjm	5734	13	)	)	-RRB-
cord-023095-4dannjjm	5734	14	,	,	,
cord-023095-4dannjjm	5734	15	0.77	0.77	CD
cord-023095-4dannjjm	5734	16	%	%	NN
cord-023095-4dannjjm	5734	17	P	p	NN
cord-023095-4dannjjm	5734	18	,	,	,
cord-023095-4dannjjm	5734	19	35	35	CD
cord-023095-4dannjjm	5734	20	%	%	NN
cord-023095-4dannjjm	5734	21	protein	protein	NN
cord-023095-4dannjjm	5734	22	,	,	,
cord-023095-4dannjjm	5734	23	and	and	CC
cord-023095-4dannjjm	5734	24	a	a	DT
cord-023095-4dannjjm	5734	25	targeted	target	VBN
cord-023095-4dannjjm	5734	26	urine	urine	NN
cord-023095-4dannjjm	5734	27	pH	ph	NN
cord-023095-4dannjjm	5734	28	of	of	IN
cord-023095-4dannjjm	5734	29	5.9	5.9	CD
cord-023095-4dannjjm	5734	30	-	-	SYM
cord-023095-4dannjjm	5734	31	6.1	6.1	CD
cord-023095-4dannjjm	5734	32	.	.	.
cord-023095-4dannjjm	5735	1	Owners	owner	NNS
cord-023095-4dannjjm	5735	2	were	be	VBD
cord-023095-4dannjjm	5735	3	advised	advise	VBN
cord-023095-4dannjjm	5735	4	to	to	TO
cord-023095-4dannjjm	5735	5	feed	feed	VB
cord-023095-4dannjjm	5735	6	the	the	DT
cord-023095-4dannjjm	5735	7	assigned	assign	VBN
cord-023095-4dannjjm	5735	8	diet	diet	NN
cord-023095-4dannjjm	5735	9	exclusively	exclusively	RB
cord-023095-4dannjjm	5735	10	in	in	IN
cord-023095-4dannjjm	5735	11	an	an	DT
cord-023095-4dannjjm	5735	12	amount	amount	NN
cord-023095-4dannjjm	5735	13	to	to	TO
cord-023095-4dannjjm	5735	14	maintain	maintain	VB
cord-023095-4dannjjm	5735	15	body	body	NN
cord-023095-4dannjjm	5735	16	condition	condition	NN
cord-023095-4dannjjm	5735	17	.	.	.
cord-023095-4dannjjm	5736	1	After	after	IN
cord-023095-4dannjjm	5736	2	diet	diet	NN
cord-023095-4dannjjm	5736	3	assignment	assignment	NN
cord-023095-4dannjjm	5736	4	radiographs	radiograph	NNS
cord-023095-4dannjjm	5736	5	were	be	VBD
cord-023095-4dannjjm	5736	6	performed	perform	VBN
cord-023095-4dannjjm	5736	7	at	at	IN
cord-023095-4dannjjm	5736	8	eight	eight	CD
cord-023095-4dannjjm	5736	9	weekly	weekly	JJ
cord-023095-4dannjjm	5736	10	intervals	interval	NNS
cord-023095-4dannjjm	5736	11	until	until	IN
cord-023095-4dannjjm	5736	12	there	there	EX
cord-023095-4dannjjm	5736	13	was	be	VBD
cord-023095-4dannjjm	5736	14	no	no	DT
cord-023095-4dannjjm	5736	15	evidence	evidence	NN
cord-023095-4dannjjm	5736	16	of	of	IN
cord-023095-4dannjjm	5736	17	uroliths	urolith	NNS
cord-023095-4dannjjm	5736	18	or	or	CC
cord-023095-4dannjjm	5736	19	until	until	IN
cord-023095-4dannjjm	5736	20	there	there	EX
cord-023095-4dannjjm	5736	21	was	be	VBD
cord-023095-4dannjjm	5736	22	evidence	evidence	NN
cord-023095-4dannjjm	5736	23	that	that	IN
cord-023095-4dannjjm	5736	24	the	the	DT
cord-023095-4dannjjm	5736	25	uroliths	urolith	NNS
cord-023095-4dannjjm	5736	26	were	be	VBD
cord-023095-4dannjjm	5736	27	the	the	DT
cord-023095-4dannjjm	5736	28	same	same	JJ
cord-023095-4dannjjm	5736	29	size	size	NN
cord-023095-4dannjjm	5736	30	or	or	CC
cord-023095-4dannjjm	5736	31	larger	large	JJR
cord-023095-4dannjjm	5736	32	.	.	.
cord-023095-4dannjjm	5737	1	A	a	DT
cord-023095-4dannjjm	5737	2	physical	physical	JJ
cord-023095-4dannjjm	5737	3	examination	examination	NN
cord-023095-4dannjjm	5737	4	,	,	,
cord-023095-4dannjjm	5737	5	complete	complete	JJ
cord-023095-4dannjjm	5737	6	blood	blood	NN
cord-023095-4dannjjm	5737	7	count	count	NN
cord-023095-4dannjjm	5737	8	,	,	,
cord-023095-4dannjjm	5737	9	serum	serum	NN
cord-023095-4dannjjm	5737	10	chemistry	chemistry	NN
cord-023095-4dannjjm	5737	11	profile	profile	NN
cord-023095-4dannjjm	5737	12	,	,	,
cord-023095-4dannjjm	5737	13	urinalysis	urinalysis	NN
cord-023095-4dannjjm	5737	14	and	and	CC
cord-023095-4dannjjm	5737	15	urine	urine	NN
cord-023095-4dannjjm	5737	16	culture	culture	NN
cord-023095-4dannjjm	5737	17	were	be	VBD
cord-023095-4dannjjm	5737	18	repeated	repeat	VBN
cord-023095-4dannjjm	5737	19	at	at	IN
cord-023095-4dannjjm	5737	20	the	the	DT
cord-023095-4dannjjm	5737	21	conclusion	conclusion	NN
cord-023095-4dannjjm	5737	22	of	of	IN
cord-023095-4dannjjm	5737	23	the	the	DT
cord-023095-4dannjjm	5737	24	study	study	NN
cord-023095-4dannjjm	5737	25	.	.	.
cord-023095-4dannjjm	5738	1	Statistical	statistical	JJ
cord-023095-4dannjjm	5738	2	analysis	analysis	NN
cord-023095-4dannjjm	5738	3	was	be	VBD
cord-023095-4dannjjm	5738	4	by	by	IN
cord-023095-4dannjjm	5738	5	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	5738	6	.	.	.
cord-023095-4dannjjm	5739	1	All	all	DT
cord-023095-4dannjjm	5739	2	uroliths	urolith	NNS
cord-023095-4dannjjm	5739	3	dissolved	dissolve	VBN
cord-023095-4dannjjm	5739	4	in	in	IN
cord-023095-4dannjjm	5739	5	all	all	DT
cord-023095-4dannjjm	5739	6	cats	cat	NNS
cord-023095-4dannjjm	5739	7	and	and	CC
cord-023095-4dannjjm	5739	8	both	both	DT
cord-023095-4dannjjm	5739	9	foods	food	NNS
cord-023095-4dannjjm	5739	10	were	be	VBD
cord-023095-4dannjjm	5739	11	palatable	palatable	JJ
cord-023095-4dannjjm	5739	12	.	.	.
cord-023095-4dannjjm	5740	1	Radiographs	radiograph	NNS
cord-023095-4dannjjm	5740	2	of	of	IN
cord-023095-4dannjjm	5740	3	cats	cat	NNS
cord-023095-4dannjjm	5740	4	fed	feed	VBD
cord-023095-4dannjjm	5740	5	the	the	DT
cord-023095-4dannjjm	5740	6	Control	Control	NNP
cord-023095-4dannjjm	5740	7	food	food	NN
cord-023095-4dannjjm	5740	8	indicated	indicate	VBD
cord-023095-4dannjjm	5740	9	the	the	DT
cord-023095-4dannjjm	5740	10	uroliths	urolith	NNS
cord-023095-4dannjjm	5740	11	dissolved	dissolve	VBN
cord-023095-4dannjjm	5740	12	in	in	IN
cord-023095-4dannjjm	5740	13	a	a	DT
cord-023095-4dannjjm	5740	14	significantly	significantly	RB
cord-023095-4dannjjm	5740	15	shorter	short	JJR
cord-023095-4dannjjm	5740	16	time	time	NN
cord-023095-4dannjjm	5740	17	(	(	-LRB-
cord-023095-4dannjjm	5740	18	mean	mean	VB
cord-023095-4dannjjm	5740	19	AE	AE	NNP
cord-023095-4dannjjm	5740	20	Std	Std	NNP
cord-023095-4dannjjm	5740	21	Dev	Dev	NNP
cord-023095-4dannjjm	5740	22	of	of	IN
cord-023095-4dannjjm	5740	23	1.6	1.6	CD
cord-023095-4dannjjm	5740	24	AE	AE	NNP
cord-023095-4dannjjm	5740	25	0.7	0.7	CD
cord-023095-4dannjjm	5740	26	weeks	week	NNS
cord-023095-4dannjjm	5740	27	)	)	-RRB-
cord-023095-4dannjjm	5740	28	compared	compare	VBN
cord-023095-4dannjjm	5740	29	to	to	IN
cord-023095-4dannjjm	5740	30	cats	cat	NNS
cord-023095-4dannjjm	5740	31	consuming	consume	VBG
cord-023095-4dannjjm	5740	32	the	the	DT
cord-023095-4dannjjm	5740	33	Test	test	NN
cord-023095-4dannjjm	5740	34	food	food	NN
cord-023095-4dannjjm	5740	35	(	(	-LRB-
cord-023095-4dannjjm	5740	36	mean	mean	VB
cord-023095-4dannjjm	5740	37	3.9	3.9	CD
cord-023095-4dannjjm	5740	38	AE	AE	NNP
cord-023095-4dannjjm	5740	39	2	2	CD
cord-023095-4dannjjm	5740	40	weeks	week	NNS
cord-023095-4dannjjm	5740	41	;	;	:
cord-023095-4dannjjm	5740	42	Po0.05	Po0.05	NNP
cord-023095-4dannjjm	5740	43	)	)	-RRB-
cord-023095-4dannjjm	5740	44	.	.	.
cord-023095-4dannjjm	5740	45	)	)	-RRB-
cord-023095-4dannjjm	5740	46	.	.	.
cord-023095-4dannjjm	5741	1	Cats	cat	NNS
cord-023095-4dannjjm	5741	2	in	in	IN
cord-023095-4dannjjm	5741	3	the	the	DT
cord-023095-4dannjjm	5741	4	Control	Control	NNP
cord-023095-4dannjjm	5741	5	group	group	NN
cord-023095-4dannjjm	5741	6	finished	finish	VBD
cord-023095-4dannjjm	5741	7	the	the	DT
cord-023095-4dannjjm	5741	8	study	study	NN
cord-023095-4dannjjm	5741	9	at	at	IN
cord-023095-4dannjjm	5741	10	1	1	CD
cord-023095-4dannjjm	5741	11	(	(	-LRB-
cord-023095-4dannjjm	5741	12	n	n	NN
cord-023095-4dannjjm	5741	13	5	5	CD
cord-023095-4dannjjm	5741	14	4	4	CD
cord-023095-4dannjjm	5741	15	)	)	-RRB-
cord-023095-4dannjjm	5741	16	,	,	,
cord-023095-4dannjjm	5741	17	2	2	CD
cord-023095-4dannjjm	5741	18	(	(	-LRB-
cord-023095-4dannjjm	5741	19	n	n	NN
cord-023095-4dannjjm	5741	20	5	5	CD
cord-023095-4dannjjm	5741	21	3	3	CD
cord-023095-4dannjjm	5741	22	)	)	-RRB-
cord-023095-4dannjjm	5741	23	and	and	CC
cord-023095-4dannjjm	5741	24	3	3	CD
cord-023095-4dannjjm	5741	25	weeks	week	NNS
cord-023095-4dannjjm	5741	26	.	.	.
cord-023095-4dannjjm	5742	1	Cats	cat	NNS
cord-023095-4dannjjm	5742	2	in	in	IN
cord-023095-4dannjjm	5742	3	the	the	DT
cord-023095-4dannjjm	5742	4	Test	test	NN
cord-023095-4dannjjm	5742	5	group	group	NN
cord-023095-4dannjjm	5742	6	finished	finish	VBD
cord-023095-4dannjjm	5742	7	the	the	DT
cord-023095-4dannjjm	5742	8	study	study	NN
cord-023095-4dannjjm	5742	9	1	1	CD
cord-023095-4dannjjm	5742	10	,	,	,
cord-023095-4dannjjm	5742	11	2	2	CD
cord-023095-4dannjjm	5742	12	,	,	,
cord-023095-4dannjjm	5742	13	3	3	CD
cord-023095-4dannjjm	5742	14	(	(	-LRB-
cord-023095-4dannjjm	5742	15	n	n	NN
cord-023095-4dannjjm	5742	16	5	5	CD
cord-023095-4dannjjm	5742	17	2	2	CD
cord-023095-4dannjjm	5742	18	)	)	-RRB-
cord-023095-4dannjjm	5742	19	,	,	,
cord-023095-4dannjjm	5742	20	4	4	CD
cord-023095-4dannjjm	5742	21	,	,	,
cord-023095-4dannjjm	5742	22	5	5	CD
cord-023095-4dannjjm	5742	23	,	,	,
cord-023095-4dannjjm	5742	24	6	6	CD
cord-023095-4dannjjm	5742	25	,	,	,
cord-023095-4dannjjm	5742	26	and	and	CC
cord-023095-4dannjjm	5742	27	7	7	CD
cord-023095-4dannjjm	5742	28	weeks	week	NNS
cord-023095-4dannjjm	5742	29	.	.	.
cord-023095-4dannjjm	5743	1	All	all	PDT
cord-023095-4dannjjm	5743	2	The	the	DT
cord-023095-4dannjjm	5743	3	Minnesota	Minnesota	NNP
cord-023095-4dannjjm	5743	4	Urolith	Urolith	NNP
cord-023095-4dannjjm	5743	5	Center	Center	NNP
cord-023095-4dannjjm	5743	6	occasionally	occasionally	RB
cord-023095-4dannjjm	5743	7	receives	receive	VBZ
cord-023095-4dannjjm	5743	8	uroliths	uroliths	NNP
cord-023095-4dannjjm	5743	9	for	for	IN
cord-023095-4dannjjm	5743	10	analysis	analysis	NN
cord-023095-4dannjjm	5743	11	that	that	WDT
cord-023095-4dannjjm	5743	12	are	be	VBP
cord-023095-4dannjjm	5743	13	immersed	immerse	VBN
cord-023095-4dannjjm	5743	14	in	in	IN
cord-023095-4dannjjm	5743	15	formalin	formalin	NN
cord-023095-4dannjjm	5743	16	.	.	.
cord-023095-4dannjjm	5744	1	Results	result	NNS
cord-023095-4dannjjm	5744	2	of	of	IN
cord-023095-4dannjjm	5744	3	quantitative	quantitative	JJ
cord-023095-4dannjjm	5744	4	analysis	analysis	NN
cord-023095-4dannjjm	5744	5	of	of	IN
cord-023095-4dannjjm	5744	6	these	these	DT
cord-023095-4dannjjm	5744	7	uroliths	urolith	NNS
cord-023095-4dannjjm	5744	8	revealed	reveal	VBD
cord-023095-4dannjjm	5744	9	that	that	IN
cord-023095-4dannjjm	5744	10	some	some	DT
cord-023095-4dannjjm	5744	11	submitted	submit	VBN
cord-023095-4dannjjm	5744	12	in	in	IN
cord-023095-4dannjjm	5744	13	formalin	formalin	NN
cord-023095-4dannjjm	5744	14	consisted	consisted	NNS
cord-023095-4dannjjm	5744	15	of	of	IN
cord-023095-4dannjjm	5744	16	newberyite	newberyite	NNP
cord-023095-4dannjjm	5744	17	(	(	-LRB-
cord-023095-4dannjjm	5744	18	magnesium	magnesium	NN
cord-023095-4dannjjm	5744	19	hydrogen	hydrogen	NN
cord-023095-4dannjjm	5744	20	phosphate	phosphate	NN
cord-023095-4dannjjm	5744	21	trihydrate	trihydrate	NNP
cord-023095-4dannjjm	5744	22	)	)	-RRB-
cord-023095-4dannjjm	5744	23	.	.	.
cord-023095-4dannjjm	5745	1	Because	because	IN
cord-023095-4dannjjm	5745	2	newberyite	newberyite	NNP
cord-023095-4dannjjm	5745	3	is	be	VBZ
cord-023095-4dannjjm	5745	4	uncommonly	uncommonly	RB
cord-023095-4dannjjm	5745	5	found	find	VBN
cord-023095-4dannjjm	5745	6	in	in	IN
cord-023095-4dannjjm	5745	7	uroliths	urolith	NNS
cord-023095-4dannjjm	5745	8	formed	form	VBN
cord-023095-4dannjjm	5745	9	by	by	IN
cord-023095-4dannjjm	5745	10	cats	cat	NNS
cord-023095-4dannjjm	5745	11	and	and	CC
cord-023095-4dannjjm	5745	12	dogs	dog	NNS
cord-023095-4dannjjm	5745	13	,	,	,
cord-023095-4dannjjm	5745	14	we	-PRON-	PRP
cord-023095-4dannjjm	5745	15	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	5745	16	that	that	IN
cord-023095-4dannjjm	5745	17	this	this	DT
cord-023095-4dannjjm	5745	18	mineral	mineral	NN
cord-023095-4dannjjm	5745	19	was	be	VBD
cord-023095-4dannjjm	5745	20	an	an	DT
cord-023095-4dannjjm	5745	21	in	in	IN
cord-023095-4dannjjm	5745	22	vitro	vitro	FW
cord-023095-4dannjjm	5745	23	artifact	artifact	NN
cord-023095-4dannjjm	5745	24	caused	cause	VBN
cord-023095-4dannjjm	5745	25	by	by	IN
cord-023095-4dannjjm	5745	26	exposure	exposure	NN
cord-023095-4dannjjm	5745	27	of	of	IN
cord-023095-4dannjjm	5745	28	struvite	struvite	NN
cord-023095-4dannjjm	5745	29	(	(	-LRB-
cord-023095-4dannjjm	5745	30	magnesium	magnesium	NN
cord-023095-4dannjjm	5745	31	ammonium	ammonium	NN
cord-023095-4dannjjm	5745	32	phosphate	phosphate	NN
cord-023095-4dannjjm	5745	33	hexahydrate	hexahydrate	NNP
cord-023095-4dannjjm	5745	34	)	)	-RRB-
cord-023095-4dannjjm	5745	35	to	to	IN
cord-023095-4dannjjm	5745	36	formalin	formalin	NN
cord-023095-4dannjjm	5745	37	.	.	.
cord-023095-4dannjjm	5746	1	The	the	DT
cord-023095-4dannjjm	5746	2	purpose	purpose	NN
cord-023095-4dannjjm	5746	3	of	of	IN
cord-023095-4dannjjm	5746	4	this	this	DT
cord-023095-4dannjjm	5746	5	study	study	NN
cord-023095-4dannjjm	5746	6	was	be	VBD
cord-023095-4dannjjm	5746	7	to	to	TO
cord-023095-4dannjjm	5746	8	determine	determine	VB
cord-023095-4dannjjm	5746	9	if	if	IN
cord-023095-4dannjjm	5746	10	formalin	formalin	NN
cord-023095-4dannjjm	5746	11	alters	alter	VBZ
cord-023095-4dannjjm	5746	12	the	the	DT
cord-023095-4dannjjm	5746	13	mineral	mineral	NN
cord-023095-4dannjjm	5746	14	composition	composition	NN
cord-023095-4dannjjm	5746	15	of	of	IN
cord-023095-4dannjjm	5746	16	uroliths	uroliths	NNP
cord-023095-4dannjjm	5746	17	.	.	.
cord-023095-4dannjjm	5747	1	Urolith	Urolith	NNP
cord-023095-4dannjjm	5747	2	submissions	submission	NNS
cord-023095-4dannjjm	5747	3	containing	contain	VBG
cord-023095-4dannjjm	5747	4	stones	stone	NNS
cord-023095-4dannjjm	5747	5	of	of	IN
cord-023095-4dannjjm	5747	6	either	either	DT
cord-023095-4dannjjm	5747	7	100	100	CD
cord-023095-4dannjjm	5747	8	%	%	NN
cord-023095-4dannjjm	5747	9	struvite	struvite	NN
cord-023095-4dannjjm	5747	10	(	(	-LRB-
cord-023095-4dannjjm	5747	11	n	n	NN
cord-023095-4dannjjm	5747	12	5	5	CD
cord-023095-4dannjjm	5747	13	5	5	CD
cord-023095-4dannjjm	5747	14	dogs	dog	NNS
cord-023095-4dannjjm	5747	15	and	and	CC
cord-023095-4dannjjm	5747	16	5	5	CD
cord-023095-4dannjjm	5747	17	cats	cat	NNS
cord-023095-4dannjjm	5747	18	)	)	-RRB-
cord-023095-4dannjjm	5747	19	,	,	,
cord-023095-4dannjjm	5747	20	100	100	CD
cord-023095-4dannjjm	5747	21	%	%	NN
cord-023095-4dannjjm	5747	22	calcium	calcium	NN
cord-023095-4dannjjm	5747	23	oxalate	oxalate	NN
cord-023095-4dannjjm	5747	24	(	(	-LRB-
cord-023095-4dannjjm	5747	25	n	n	NN
cord-023095-4dannjjm	5747	26	5	5	CD
cord-023095-4dannjjm	5747	27	5	5	CD
cord-023095-4dannjjm	5747	28	dogs	dog	NNS
cord-023095-4dannjjm	5747	29	and	and	CC
cord-023095-4dannjjm	5747	30	5	5	CD
cord-023095-4dannjjm	5747	31	cats	cat	NNS
cord-023095-4dannjjm	5747	32	)	)	-RRB-
cord-023095-4dannjjm	5747	33	,	,	,
cord-023095-4dannjjm	5747	34	100	100	CD
cord-023095-4dannjjm	5747	35	%	%	NN
cord-023095-4dannjjm	5747	36	calcium	calcium	NN
cord-023095-4dannjjm	5747	37	phosphate	phosphate	NN
cord-023095-4dannjjm	5747	38	apatite	apatite	NN
cord-023095-4dannjjm	5747	39	(	(	-LRB-
cord-023095-4dannjjm	5747	40	n	n	NN
cord-023095-4dannjjm	5747	41	5	5	CD
cord-023095-4dannjjm	5747	42	5	5	CD
cord-023095-4dannjjm	5747	43	dogs	dog	NNS
cord-023095-4dannjjm	5747	44	and	and	CC
cord-023095-4dannjjm	5747	45	5	5	CD
cord-023095-4dannjjm	5747	46	cats	cat	NNS
cord-023095-4dannjjm	5747	47	)	)	-RRB-
cord-023095-4dannjjm	5747	48	,	,	,
cord-023095-4dannjjm	5747	49	100	100	CD
cord-023095-4dannjjm	5747	50	%	%	NN
cord-023095-4dannjjm	5747	51	cystine	cystine	NN
cord-023095-4dannjjm	5747	52	(	(	-LRB-
cord-023095-4dannjjm	5747	53	n	n	NN
cord-023095-4dannjjm	5747	54	5	5	CD
cord-023095-4dannjjm	5747	55	5	5	CD
cord-023095-4dannjjm	5747	56	dogs	dog	NNS
cord-023095-4dannjjm	5747	57	and	and	CC
cord-023095-4dannjjm	5747	58	5	5	CD
cord-023095-4dannjjm	5747	59	cats	cat	NNS
cord-023095-4dannjjm	5747	60	)	)	-RRB-
cord-023095-4dannjjm	5747	61	,	,	,
cord-023095-4dannjjm	5747	62	100	100	CD
cord-023095-4dannjjm	5747	63	%	%	NN
cord-023095-4dannjjm	5747	64	ammonium	ammonium	NN
cord-023095-4dannjjm	5747	65	urate	urate	NN
cord-023095-4dannjjm	5747	66	(	(	-LRB-
cord-023095-4dannjjm	5747	67	n	n	NN
cord-023095-4dannjjm	5747	68	5	5	CD
cord-023095-4dannjjm	5747	69	5	5	CD
cord-023095-4dannjjm	5747	70	dogs	dog	NNS
cord-023095-4dannjjm	5747	71	and	and	CC
cord-023095-4dannjjm	5747	72	5	5	CD
cord-023095-4dannjjm	5747	73	cats	cat	NNS
cord-023095-4dannjjm	5747	74	)	)	-RRB-
cord-023095-4dannjjm	5747	75	,	,	,
cord-023095-4dannjjm	5747	76	and	and	CC
cord-023095-4dannjjm	5747	77	100	100	CD
cord-023095-4dannjjm	5747	78	%	%	NN
cord-023095-4dannjjm	5747	79	silica	silica	NN
cord-023095-4dannjjm	5747	80	(	(	-LRB-
cord-023095-4dannjjm	5747	81	n	n	NN
cord-023095-4dannjjm	5747	82	5	5	CD
cord-023095-4dannjjm	5747	83	5	5	CD
cord-023095-4dannjjm	5747	84	dogs	dog	NNS
cord-023095-4dannjjm	5747	85	)	)	-RRB-
cord-023095-4dannjjm	5747	86	preserved	preserve	VBN
cord-023095-4dannjjm	5747	87	by	by	IN
cord-023095-4dannjjm	5747	88	only	only	JJ
cord-023095-4dannjjm	5747	89	air	air	NN
cord-023095-4dannjjm	5747	90	drying	drying	NN
cord-023095-4dannjjm	5747	91	were	be	VBD
cord-023095-4dannjjm	5747	92	tested	test	VBN
cord-023095-4dannjjm	5747	93	.	.	.
cord-023095-4dannjjm	5748	1	One	one	CD
cord-023095-4dannjjm	5748	2	urolith	urolith	NN
cord-023095-4dannjjm	5748	3	from	from	IN
cord-023095-4dannjjm	5748	4	each	each	DT
cord-023095-4dannjjm	5748	5	submission	submission	NN
cord-023095-4dannjjm	5748	6	was	be	VBD
cord-023095-4dannjjm	5748	7	quantitatively	quantitatively	RB
cord-023095-4dannjjm	5748	8	analyzed	analyze	VBN
cord-023095-4dannjjm	5748	9	by	by	IN
cord-023095-4dannjjm	5748	10	polarized	polarized	JJ
cord-023095-4dannjjm	5748	11	light	light	JJ
cord-023095-4dannjjm	5748	12	microscopy	microscopy	NNS
cord-023095-4dannjjm	5748	13	or	or	CC
cord-023095-4dannjjm	5748	14	infrared	infrared	JJ
cord-023095-4dannjjm	5748	15	spectroscopy	spectroscopy	NN
cord-023095-4dannjjm	5748	16	.	.	.
cord-023095-4dannjjm	5749	1	A	a	DT
cord-023095-4dannjjm	5749	2	subsequent	subsequent	JJ
cord-023095-4dannjjm	5749	3	urolith	urolith	NN
cord-023095-4dannjjm	5749	4	from	from	IN
cord-023095-4dannjjm	5749	5	the	the	DT
cord-023095-4dannjjm	5749	6	same	same	JJ
cord-023095-4dannjjm	5749	7	submission	submission	NN
cord-023095-4dannjjm	5749	8	was	be	VBD
cord-023095-4dannjjm	5749	9	immersed	immerse	VBN
cord-023095-4dannjjm	5749	10	in	in	IN
cord-023095-4dannjjm	5749	11	1	1	CD
cord-023095-4dannjjm	5749	12	ml	ml	NNS
cord-023095-4dannjjm	5749	13	of	of	IN
cord-023095-4dannjjm	5749	14	10	10	CD
cord-023095-4dannjjm	5749	15	%	%	NN
cord-023095-4dannjjm	5749	16	buffered	buffer	VBN
cord-023095-4dannjjm	5749	17	formalin	formalin	NN
cord-023095-4dannjjm	5749	18	for	for	IN
cord-023095-4dannjjm	5749	19	48	48	CD
cord-023095-4dannjjm	5749	20	hours	hour	NNS
cord-023095-4dannjjm	5749	21	at	at	IN
cord-023095-4dannjjm	5749	22	room	room	NN
cord-023095-4dannjjm	5749	23	temperature	temperature	NN
cord-023095-4dannjjm	5749	24	.	.	.
cord-023095-4dannjjm	5750	1	Uroliths	Uroliths	NNP
cord-023095-4dannjjm	5750	2	were	be	VBD
cord-023095-4dannjjm	5750	3	then	then	RB
cord-023095-4dannjjm	5750	4	air	air	NN
cord-023095-4dannjjm	5750	5	dried	dry	VBN
cord-023095-4dannjjm	5750	6	for	for	IN
cord-023095-4dannjjm	5750	7	30	30	CD
cord-023095-4dannjjm	5750	8	minutes	minute	NNS
cord-023095-4dannjjm	5750	9	and	and	CC
cord-023095-4dannjjm	5750	10	the	the	DT
cord-023095-4dannjjm	5750	11	analysis	analysis	NN
cord-023095-4dannjjm	5750	12	was	be	VBD
cord-023095-4dannjjm	5750	13	repeated	repeat	VBN
cord-023095-4dannjjm	5750	14	.	.	.
cord-023095-4dannjjm	5751	1	After	after	IN
cord-023095-4dannjjm	5751	2	exposure	exposure	NN
cord-023095-4dannjjm	5751	3	to	to	IN
cord-023095-4dannjjm	5751	4	formalin	formalin	NN
cord-023095-4dannjjm	5751	5	,	,	,
cord-023095-4dannjjm	5751	6	portions	portion	NNS
cord-023095-4dannjjm	5751	7	of	of	IN
cord-023095-4dannjjm	5751	8	all	all	DT
cord-023095-4dannjjm	5751	9	10	10	CD
cord-023095-4dannjjm	5751	10	struvite	struvite	NN
cord-023095-4dannjjm	5751	11	uroliths	urolith	NNS
cord-023095-4dannjjm	5751	12	were	be	VBD
cord-023095-4dannjjm	5751	13	transformed	transform	VBN
cord-023095-4dannjjm	5751	14	into	into	IN
cord-023095-4dannjjm	5751	15	newberyite	newberyite	NNP
cord-023095-4dannjjm	5751	16	.	.	.
cord-023095-4dannjjm	5752	1	Three	three	CD
cord-023095-4dannjjm	5752	2	(	(	-LRB-
cord-023095-4dannjjm	5752	3	1	1	CD
cord-023095-4dannjjm	5752	4	dog	dog	NN
cord-023095-4dannjjm	5752	5	and	and	CC
cord-023095-4dannjjm	5752	6	2	2	CD
cord-023095-4dannjjm	5752	7	cats	cat	NNS
cord-023095-4dannjjm	5752	8	)	)	-RRB-
cord-023095-4dannjjm	5752	9	of	of	IN
cord-023095-4dannjjm	5752	10	10	10	CD
cord-023095-4dannjjm	5752	11	ammonium	ammonium	NN
cord-023095-4dannjjm	5752	12	urate	urate	NN
cord-023095-4dannjjm	5752	13	uroliths	urolith	NNS
cord-023095-4dannjjm	5752	14	were	be	VBD
cord-023095-4dannjjm	5752	15	completely	completely	RB
cord-023095-4dannjjm	5752	16	dissolved	dissolve	VBN
cord-023095-4dannjjm	5752	17	.	.	.
cord-023095-4dannjjm	5753	1	Newberyite	Newberyite	NNP
cord-023095-4dannjjm	5753	2	was	be	VBD
cord-023095-4dannjjm	5753	3	not	not	RB
cord-023095-4dannjjm	5753	4	detected	detect	VBN
cord-023095-4dannjjm	5753	5	in	in	IN
cord-023095-4dannjjm	5753	6	any	any	DT
cord-023095-4dannjjm	5753	7	of	of	IN
cord-023095-4dannjjm	5753	8	the	the	DT
cord-023095-4dannjjm	5753	9	remaining	remain	VBG
cord-023095-4dannjjm	5753	10	uroliths	urolith	NNS
cord-023095-4dannjjm	5753	11	.	.	.
cord-023095-4dannjjm	5754	1	Likewise	likewise	RB
cord-023095-4dannjjm	5754	2	quantitative	quantitative	JJ
cord-023095-4dannjjm	5754	3	mineral	mineral	NN
cord-023095-4dannjjm	5754	4	analysis	analysis	NN
cord-023095-4dannjjm	5754	5	of	of	IN
cord-023095-4dannjjm	5754	6	non	non	JJ
cord-023095-4dannjjm	5754	7	-	-	JJ
cord-023095-4dannjjm	5754	8	struvite	struvite	JJ
cord-023095-4dannjjm	5754	9	uroliths	urolith	NNS
cord-023095-4dannjjm	5754	10	remained	remain	VBD
cord-023095-4dannjjm	5754	11	unchanged	unchanged	JJ
cord-023095-4dannjjm	5754	12	.	.	.
cord-023095-4dannjjm	5755	1	To	to	TO
cord-023095-4dannjjm	5755	2	avoid	avoid	VB
cord-023095-4dannjjm	5755	3	misdiagnosis	misdiagnosis	NN
cord-023095-4dannjjm	5755	4	of	of	IN
cord-023095-4dannjjm	5755	5	mineral	mineral	NN
cord-023095-4dannjjm	5755	6	composition	composition	NN
cord-023095-4dannjjm	5755	7	,	,	,
cord-023095-4dannjjm	5755	8	uroliths	uroliths	NNP
cord-023095-4dannjjm	5755	9	should	should	MD
cord-023095-4dannjjm	5755	10	not	not	RB
cord-023095-4dannjjm	5755	11	be	be	VB
cord-023095-4dannjjm	5755	12	immersed	immerse	VBN
cord-023095-4dannjjm	5755	13	in	in	IN
cord-023095-4dannjjm	5755	14	formalin	formalin	NN
cord-023095-4dannjjm	5755	15	prior	prior	RB
cord-023095-4dannjjm	5755	16	to	to	IN
cord-023095-4dannjjm	5755	17	analysis	analysis	NN
cord-023095-4dannjjm	5755	18	.	.	.
cord-023095-4dannjjm	5756	1	We	-PRON-	PRP
cord-023095-4dannjjm	5756	2	previously	previously	RB
cord-023095-4dannjjm	5756	3	reported	report	VBD
cord-023095-4dannjjm	5756	4	that	that	IN
cord-023095-4dannjjm	5756	5	transfusion	transfusion	NN
cord-023095-4dannjjm	5756	6	to	to	IN
cord-023095-4dannjjm	5756	7	normal	normal	JJ
cord-023095-4dannjjm	5756	8	dogs	dog	NNS
cord-023095-4dannjjm	5756	9	of	of	IN
cord-023095-4dannjjm	5756	10	autologous	autologous	JJ
cord-023095-4dannjjm	5756	11	erythrocyte	erythrocyte	NN
cord-023095-4dannjjm	5756	12	concentrates	concentrate	VBZ
cord-023095-4dannjjm	5756	13	(	(	-LRB-
cord-023095-4dannjjm	5756	14	pRBCs	prbcs	RB
cord-023095-4dannjjm	5756	15	)	)	-RRB-
cord-023095-4dannjjm	5756	16	that	that	WDT
cord-023095-4dannjjm	5756	17	had	have	VBD
cord-023095-4dannjjm	5756	18	been	be	VBN
cord-023095-4dannjjm	5756	19	stored	store	VBN
cord-023095-4dannjjm	5756	20	for	for	IN
cord-023095-4dannjjm	5756	21	21	21	CD
cord-023095-4dannjjm	5756	22	days	day	NNS
cord-023095-4dannjjm	5756	23	causes	cause	VBZ
cord-023095-4dannjjm	5756	24	a	a	DT
cord-023095-4dannjjm	5756	25	profound	profound	JJ
cord-023095-4dannjjm	5756	26	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	5756	27	response	response	NN
cord-023095-4dannjjm	5756	28	(	(	-LRB-
cord-023095-4dannjjm	5756	29	2X	2x	CD
cord-023095-4dannjjm	5756	30	increase	increase	NN
cord-023095-4dannjjm	5756	31	in	in	IN
cord-023095-4dannjjm	5756	32	leucocyte	leucocyte	NNP
cord-023095-4dannjjm	5756	33	count	count	NN
cord-023095-4dannjjm	5756	34	and	and	CC
cord-023095-4dannjjm	5756	35	fibrinogen	fibrinogen	NN
cord-023095-4dannjjm	5756	36	,	,	,
cord-023095-4dannjjm	5756	37	60X	60x	JJ
cord-023095-4dannjjm	5756	38	increase	increase	NN
cord-023095-4dannjjm	5756	39	in	in	IN
cord-023095-4dannjjm	5756	40	C	C	NNP
cord-023095-4dannjjm	5756	41	-	-	HYPH
cord-023095-4dannjjm	5756	42	Reactive	Reactive	NNP
cord-023095-4dannjjm	5756	43	Protein	Protein	NNP
cord-023095-4dannjjm	5756	44	)	)	-RRB-
cord-023095-4dannjjm	5756	45	.	.	.
cord-023095-4dannjjm	5757	1	We	-PRON-	PRP
cord-023095-4dannjjm	5757	2	speculated	speculate	VBD
cord-023095-4dannjjm	5757	3	that	that	IN
cord-023095-4dannjjm	5757	4	inflammation	inflammation	NN
cord-023095-4dannjjm	5757	5	was	be	VBD
cord-023095-4dannjjm	5757	6	due	due	JJ
cord-023095-4dannjjm	5757	7	to	to	IN
cord-023095-4dannjjm	5757	8	cytokines	cytokine	NNS
cord-023095-4dannjjm	5757	9	produced	produce	VBN
cord-023095-4dannjjm	5757	10	during	during	IN
cord-023095-4dannjjm	5757	11	the	the	DT
cord-023095-4dannjjm	5757	12	storage	storage	NN
cord-023095-4dannjjm	5757	13	period	period	NN
cord-023095-4dannjjm	5757	14	,	,	,
cord-023095-4dannjjm	5757	15	and	and	CC
cord-023095-4dannjjm	5757	16	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	5757	17	that	that	IN
cord-023095-4dannjjm	5757	18	transfusion	transfusion	NN
cord-023095-4dannjjm	5757	19	of	of	IN
cord-023095-4dannjjm	5757	20	fresh	fresh	JJ
cord-023095-4dannjjm	5757	21	(	(	-LRB-
cord-023095-4dannjjm	5757	22	F	f	NN
cord-023095-4dannjjm	5757	23	)	)	-RRB-
cord-023095-4dannjjm	5757	24	pRBCs	prbcs	RB
cord-023095-4dannjjm	5757	25	would	would	MD
cord-023095-4dannjjm	5757	26	elicit	elicit	VB
cord-023095-4dannjjm	5757	27	less	less	JJR
cord-023095-4dannjjm	5757	28	inflammation	inflammation	NN
cord-023095-4dannjjm	5757	29	than	than	IN
cord-023095-4dannjjm	5757	30	would	would	MD
cord-023095-4dannjjm	5757	31	stored	store	VBN
cord-023095-4dannjjm	5757	32	(	(	-LRB-
cord-023095-4dannjjm	5757	33	S	s	NN
cord-023095-4dannjjm	5757	34	)	)	-RRB-
cord-023095-4dannjjm	5757	35	pRBCs	prbcs	RB
cord-023095-4dannjjm	5757	36	.	.	.
cord-023095-4dannjjm	5758	1	A	a	DT
cord-023095-4dannjjm	5758	2	whole	whole	JJ
cord-023095-4dannjjm	5758	3	blood	blood	NN
cord-023095-4dannjjm	5758	4	unit	unit	NN
cord-023095-4dannjjm	5758	5	was	be	VBD
cord-023095-4dannjjm	5758	6	collected	collect	VBN
cord-023095-4dannjjm	5758	7	from	from	IN
cord-023095-4dannjjm	5758	8	healthy	healthy	JJ
cord-023095-4dannjjm	5758	9	dogs	dog	NNS
cord-023095-4dannjjm	5758	10	(	(	-LRB-
cord-023095-4dannjjm	5758	11	n	n	NN
cord-023095-4dannjjm	5758	12	5	5	CD
cord-023095-4dannjjm	5758	13	10	10	CD
cord-023095-4dannjjm	5758	14	)	)	-RRB-
cord-023095-4dannjjm	5758	15	for	for	IN
cord-023095-4dannjjm	5758	16	pRBCs	pRBCs	NNP
cord-023095-4dannjjm	5758	17	on	on	IN
cord-023095-4dannjjm	5758	18	day	day	NN
cord-023095-4dannjjm	5758	19	0	0	CD
cord-023095-4dannjjm	5758	20	,	,	,
cord-023095-4dannjjm	5758	21	then	then	RB
cord-023095-4dannjjm	5758	22	again	again	RB
cord-023095-4dannjjm	5758	23	on	on	IN
cord-023095-4dannjjm	5758	24	day	day	NN
cord-023095-4dannjjm	5758	25	32	32	CD
cord-023095-4dannjjm	5758	26	.	.	.
cord-023095-4dannjjm	5759	1	On	on	IN
cord-023095-4dannjjm	5759	2	day	day	NN
cord-023095-4dannjjm	5759	3	35	35	CD
cord-023095-4dannjjm	5759	4	dogs	dog	NNS
cord-023095-4dannjjm	5759	5	received	receive	VBD
cord-023095-4dannjjm	5759	6	an	an	DT
cord-023095-4dannjjm	5759	7	autologous	autologous	JJ
cord-023095-4dannjjm	5759	8	transfusion	transfusion	NN
cord-023095-4dannjjm	5759	9	of	of	IN
cord-023095-4dannjjm	5759	10	pRBCs	prbcs	RB
cord-023095-4dannjjm	5759	11	stored	store	VBN
cord-023095-4dannjjm	5759	12	for	for	IN
cord-023095-4dannjjm	5759	13	either	either	DT
cord-023095-4dannjjm	5759	14	35	35	CD
cord-023095-4dannjjm	5759	15	days	day	NNS
cord-023095-4dannjjm	5759	16	(	(	-LRB-
cord-023095-4dannjjm	5759	17	S	S	NNP
cord-023095-4dannjjm	5759	18	,	,	,
cord-023095-4dannjjm	5759	19	n	n	NN
cord-023095-4dannjjm	5759	20	5	5	CD
cord-023095-4dannjjm	5759	21	5	5	CD
cord-023095-4dannjjm	5759	22	)	)	-RRB-
cord-023095-4dannjjm	5759	23	or	or	CC
cord-023095-4dannjjm	5759	24	3	3	CD
cord-023095-4dannjjm	5759	25	days	day	NNS
cord-023095-4dannjjm	5759	26	(	(	-LRB-
cord-023095-4dannjjm	5759	27	F	F	NNP
cord-023095-4dannjjm	5759	28	,	,	,
cord-023095-4dannjjm	5759	29	n	n	NN
cord-023095-4dannjjm	5759	30	5	5	CD
cord-023095-4dannjjm	5759	31	5	5	CD
cord-023095-4dannjjm	5759	32	)	)	-RRB-
cord-023095-4dannjjm	5759	33	.	.	.
cord-023095-4dannjjm	5760	1	CBCs	CBCs	NNP
cord-023095-4dannjjm	5760	2	and	and	CC
cord-023095-4dannjjm	5760	3	in	in	IN
cord-023095-4dannjjm	5760	4	-	-	HYPH
cord-023095-4dannjjm	5760	5	tem	tem	NN
cord-023095-4dannjjm	5760	6	thromboelastometry	thromboelastometry	NN
cord-023095-4dannjjm	5760	7	(	(	-LRB-
cord-023095-4dannjjm	5760	8	CT	CT	NNP
cord-023095-4dannjjm	5760	9	:	:	:
cord-023095-4dannjjm	5760	10	coagulation	coagulation	NN
cord-023095-4dannjjm	5760	11	time	time	NN
cord-023095-4dannjjm	5760	12	,	,	,
cord-023095-4dannjjm	5760	13	CFT	CFT	NNP
cord-023095-4dannjjm	5760	14	:	:	:
cord-023095-4dannjjm	5760	15	clot	clot	NN
cord-023095-4dannjjm	5760	16	formation	formation	NN
cord-023095-4dannjjm	5760	17	time	time	NN
cord-023095-4dannjjm	5760	18	,	,	,
cord-023095-4dannjjm	5760	19	a	a	DT
cord-023095-4dannjjm	5760	20	:	:	:
cord-023095-4dannjjm	5760	21	alpha	alpha	NN
cord-023095-4dannjjm	5760	22	,	,	,
cord-023095-4dannjjm	5760	23	MCF	MCF	NNP
cord-023095-4dannjjm	5760	24	:	:	:
cord-023095-4dannjjm	5760	25	maximum	maximum	JJ
cord-023095-4dannjjm	5760	26	clot	clot	NN
cord-023095-4dannjjm	5760	27	firmness	firmness	NN
cord-023095-4dannjjm	5760	28	)	)	-RRB-
cord-023095-4dannjjm	5760	29	were	be	VBD
cord-023095-4dannjjm	5760	30	evaluated	evaluate	VBN
cord-023095-4dannjjm	5760	31	on	on	IN
cord-023095-4dannjjm	5760	32	blood	blood	NN
cord-023095-4dannjjm	5760	33	samples	sample	NNS
cord-023095-4dannjjm	5760	34	collected	collect	VBN
cord-023095-4dannjjm	5760	35	at	at	IN
cord-023095-4dannjjm	5760	36	0	0	CD
cord-023095-4dannjjm	5760	37	(	(	-LRB-
cord-023095-4dannjjm	5760	38	pre	pre	JJ
cord-023095-4dannjjm	5760	39	)	)	-RRB-
cord-023095-4dannjjm	5760	40	and	and	CC
cord-023095-4dannjjm	5760	41	5,9,24,48	5,9,24,48	CD
cord-023095-4dannjjm	5760	42	,	,	,
cord-023095-4dannjjm	5760	43	and	and	CC
cord-023095-4dannjjm	5760	44	72	72	CD
cord-023095-4dannjjm	5760	45	hours	hour	NNS
cord-023095-4dannjjm	5760	46	after	after	IN
cord-023095-4dannjjm	5760	47	transfusion	transfusion	NN
cord-023095-4dannjjm	5760	48	.	.	.
cord-023095-4dannjjm	5761	1	Fresh	fresh	JJ
cord-023095-4dannjjm	5761	2	pRBCs	prbc	NNS
cord-023095-4dannjjm	5761	3	did	do	VBD
cord-023095-4dannjjm	5761	4	not	not	RB
cord-023095-4dannjjm	5761	5	elicit	elicit	VB
cord-023095-4dannjjm	5761	6	any	any	DT
cord-023095-4dannjjm	5761	7	change	change	NN
cord-023095-4dannjjm	5761	8	in	in	IN
cord-023095-4dannjjm	5761	9	leucocytes	leucocyte	NNS
cord-023095-4dannjjm	5761	10	,	,	,
cord-023095-4dannjjm	5761	11	platelets	platelet	NNS
cord-023095-4dannjjm	5761	12	,	,	,
cord-023095-4dannjjm	5761	13	or	or	CC
cord-023095-4dannjjm	5761	14	thromboelastometry	thromboelastometry	NN
cord-023095-4dannjjm	5761	15	.	.	.
cord-023095-4dannjjm	5762	1	Stored	store	VBN
cord-023095-4dannjjm	5762	2	pRBCs	prbcs	RB
cord-023095-4dannjjm	5762	3	elicited	elicit	VBD
cord-023095-4dannjjm	5762	4	a	a	DT
cord-023095-4dannjjm	5762	5	degenerative	degenerative	JJ
cord-023095-4dannjjm	5762	6	left	left	JJ
cord-023095-4dannjjm	5762	7	shift	shift	NN
cord-023095-4dannjjm	5762	8	(	(	-LRB-
cord-023095-4dannjjm	5762	9	5	5	CD
cord-023095-4dannjjm	5762	10	hr	hr	NN
cord-023095-4dannjjm	5762	11	)	)	-RRB-
cord-023095-4dannjjm	5762	12	followed	follow	VBN
cord-023095-4dannjjm	5762	13	by	by	IN
cord-023095-4dannjjm	5762	14	a	a	DT
cord-023095-4dannjjm	5762	15	regenerative	regenerative	JJ
cord-023095-4dannjjm	5762	16	left	left	JJ
cord-023095-4dannjjm	5762	17	shift	shift	NN
cord-023095-4dannjjm	5762	18	(	(	-LRB-
cord-023095-4dannjjm	5762	19	9	9	CD
cord-023095-4dannjjm	5762	20	-	-	SYM
cord-023095-4dannjjm	5762	21	48	48	CD
cord-023095-4dannjjm	5762	22	hr	hr	NN
cord-023095-4dannjjm	5762	23	)	)	-RRB-
cord-023095-4dannjjm	5762	24	,	,	,
cord-023095-4dannjjm	5762	25	thrombocytopenia	thrombocytopenia	NN
cord-023095-4dannjjm	5762	26	(	(	-LRB-
cord-023095-4dannjjm	5762	27	36	36	CD
cord-023095-4dannjjm	5762	28	%	%	NN
cord-023095-4dannjjm	5762	29	decrease	decrease	NN
cord-023095-4dannjjm	5762	30	at	at	IN
cord-023095-4dannjjm	5762	31	5	5	CD
cord-023095-4dannjjm	5762	32	hr	hr	NN
cord-023095-4dannjjm	5762	33	)	)	-RRB-
cord-023095-4dannjjm	5762	34	,	,	,
cord-023095-4dannjjm	5762	35	and	and	CC
cord-023095-4dannjjm	5762	36	marked	mark	VBD
cord-023095-4dannjjm	5762	37	hypocoagulability	hypocoagulability	NN
cord-023095-4dannjjm	5762	38	characterized	characterize	VBN
cord-023095-4dannjjm	5762	39	by	by	IN
cord-023095-4dannjjm	5762	40	prolonged	prolong	VBN
cord-023095-4dannjjm	5762	41	CT	CT	NNP
cord-023095-4dannjjm	5762	42	(	(	-LRB-
cord-023095-4dannjjm	5762	43	5,9,24	5,9,24	CD
cord-023095-4dannjjm	5762	44	hr	hr	NN
cord-023095-4dannjjm	5762	45	)	)	-RRB-
cord-023095-4dannjjm	5762	46	and	and	CC
cord-023095-4dannjjm	5762	47	CFT	CFT	NNP
cord-023095-4dannjjm	5762	48	(	(	-LRB-
cord-023095-4dannjjm	5762	49	5,9	5,9	CD
cord-023095-4dannjjm	5762	50	hr	hr	NN
cord-023095-4dannjjm	5762	51	)	)	-RRB-
cord-023095-4dannjjm	5762	52	,	,	,
cord-023095-4dannjjm	5762	53	and	and	CC
cord-023095-4dannjjm	5762	54	decreased	decrease	VBD
cord-023095-4dannjjm	5762	55	a	a	DT
cord-023095-4dannjjm	5762	56	(	(	-LRB-
cord-023095-4dannjjm	5762	57	5,9	5,9	CD
cord-023095-4dannjjm	5762	58	hr	hr	NN
cord-023095-4dannjjm	5762	59	)	)	-RRB-
cord-023095-4dannjjm	5762	60	and	and	CC
cord-023095-4dannjjm	5762	61	MCF	MCF	NNP
cord-023095-4dannjjm	5762	62	(	(	-LRB-
cord-023095-4dannjjm	5762	63	5,9	5,9	CD
cord-023095-4dannjjm	5762	64	,	,	,
cord-023095-4dannjjm	5762	65	24	24	CD
cord-023095-4dannjjm	5762	66	hr	hr	NN
cord-023095-4dannjjm	5762	67	)	)	-RRB-
cord-023095-4dannjjm	5762	68	.	.	.
cord-023095-4dannjjm	5763	1	Data	datum	NNS
cord-023095-4dannjjm	5763	2	are	be	VBP
cord-023095-4dannjjm	5763	3	mean(SD	mean(sd	NN
cord-023095-4dannjjm	5763	4	)	)	-RRB-
cord-023095-4dannjjm	5763	5	.	.	.
cord-023095-4dannjjm	5764	1	a	a	LS
cord-023095-4dannjjm	5764	2	:	:	:
cord-023095-4dannjjm	5764	3	p	p	NN
cord-023095-4dannjjm	5764	4	o	o	NN
cord-023095-4dannjjm	5764	5	0.05	0.05	CD
cord-023095-4dannjjm	5764	6	between	between	IN
cord-023095-4dannjjm	5764	7	groups	group	NNS
cord-023095-4dannjjm	5764	8	F	F	NNP
cord-023095-4dannjjm	5764	9	and	and	CC
cord-023095-4dannjjm	5764	10	S	S	NNP
cord-023095-4dannjjm	5764	11	by	by	IN
cord-023095-4dannjjm	5764	12	t	t	NNP
cord-023095-4dannjjm	5764	13	test	test	NN
cord-023095-4dannjjm	5764	14	.	.	.
cord-023095-4dannjjm	5765	1	b	b	LS
cord-023095-4dannjjm	5765	2	:	:	:
cord-023095-4dannjjm	5765	3	p	p	NN
cord-023095-4dannjjm	5765	4	o	o	NN
cord-023095-4dannjjm	5765	5	0.05	0.05	CD
cord-023095-4dannjjm	5765	6	compared	compare	VBN
cord-023095-4dannjjm	5765	7	to	to	IN
cord-023095-4dannjjm	5765	8	'	'	''
cord-023095-4dannjjm	5765	9	'	'	``
cord-023095-4dannjjm	5765	10	0	0	CD
cord-023095-4dannjjm	5765	11	'	'	''
cord-023095-4dannjjm	5765	12	'	'	''
cord-023095-4dannjjm	5765	13	by	by	IN
cord-023095-4dannjjm	5765	14	RM	RM	NNP
cord-023095-4dannjjm	5765	15	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	5765	16	.	.	.
cord-023095-4dannjjm	5766	1	Transfusion	transfusion	NN
cord-023095-4dannjjm	5766	2	of	of	IN
cord-023095-4dannjjm	5766	3	autologous	autologous	JJ
cord-023095-4dannjjm	5766	4	stored	store	VBN
cord-023095-4dannjjm	5766	5	pRBCs	pRBCs	NNPS
cord-023095-4dannjjm	5766	6	elicits	elicit	VBZ
cord-023095-4dannjjm	5766	7	a	a	DT
cord-023095-4dannjjm	5766	8	greater	great	JJR
cord-023095-4dannjjm	5766	9	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	5766	10	response	response	NN
cord-023095-4dannjjm	5766	11	than	than	IN
cord-023095-4dannjjm	5766	12	fresh	fresh	JJ
cord-023095-4dannjjm	5766	13	pRBCs	prbc	NNS
cord-023095-4dannjjm	5766	14	,	,	,
cord-023095-4dannjjm	5766	15	and	and	CC
cord-023095-4dannjjm	5766	16	results	result	NNS
cord-023095-4dannjjm	5766	17	in	in	IN
cord-023095-4dannjjm	5766	18	hypocoagulability	hypocoagulability	NN
cord-023095-4dannjjm	5766	19	on	on	IN
cord-023095-4dannjjm	5766	20	thromboelastometry	thromboelastometry	NNP
cord-023095-4dannjjm	5766	21	.	.	.
cord-023095-4dannjjm	5767	1	Clopidogrel	Clopidogrel	NNP
cord-023095-4dannjjm	5767	2	is	be	VBZ
cord-023095-4dannjjm	5767	3	a	a	DT
cord-023095-4dannjjm	5767	4	potent	potent	JJ
cord-023095-4dannjjm	5767	5	antiplatelet	antiplatelet	NN
cord-023095-4dannjjm	5767	6	drug	drug	NN
cord-023095-4dannjjm	5767	7	that	that	WDT
cord-023095-4dannjjm	5767	8	is	be	VBZ
cord-023095-4dannjjm	5767	9	gaining	gain	VBG
cord-023095-4dannjjm	5767	10	popularity	popularity	NN
cord-023095-4dannjjm	5767	11	in	in	IN
cord-023095-4dannjjm	5767	12	veterinary	veterinary	JJ
cord-023095-4dannjjm	5767	13	medicine	medicine	NN
cord-023095-4dannjjm	5767	14	for	for	IN
cord-023095-4dannjjm	5767	15	antithrombotic	antithrombotic	JJ
cord-023095-4dannjjm	5767	16	therapy	therapy	NN
cord-023095-4dannjjm	5767	17	.	.	.
cord-023095-4dannjjm	5768	1	The	the	DT
cord-023095-4dannjjm	5768	2	parent	parent	NN
cord-023095-4dannjjm	5768	3	molecule	molecule	NN
cord-023095-4dannjjm	5768	4	is	be	VBZ
cord-023095-4dannjjm	5768	5	an	an	DT
cord-023095-4dannjjm	5768	6	inactive	inactive	JJ
cord-023095-4dannjjm	5768	7	prodrug	prodrug	NN
cord-023095-4dannjjm	5768	8	that	that	WDT
cord-023095-4dannjjm	5768	9	must	must	MD
cord-023095-4dannjjm	5768	10	be	be	VB
cord-023095-4dannjjm	5768	11	converted	convert	VBN
cord-023095-4dannjjm	5768	12	by	by	IN
cord-023095-4dannjjm	5768	13	hepatic	hepatic	JJ
cord-023095-4dannjjm	5768	14	isozymes	isozyme	NNS
cord-023095-4dannjjm	5768	15	to	to	IN
cord-023095-4dannjjm	5768	16	an	an	DT
cord-023095-4dannjjm	5768	17	active	active	JJ
cord-023095-4dannjjm	5768	18	metabolite	metabolite	NN
cord-023095-4dannjjm	5768	19	.	.	.
cord-023095-4dannjjm	5769	1	The	the	DT
cord-023095-4dannjjm	5769	2	majority	majority	NN
cord-023095-4dannjjm	5769	3	of	of	IN
cord-023095-4dannjjm	5769	4	the	the	DT
cord-023095-4dannjjm	5769	5	parent	parent	NN
cord-023095-4dannjjm	5769	6	molecule	molecule	NN
cord-023095-4dannjjm	5769	7	is	be	VBZ
cord-023095-4dannjjm	5769	8	directed	direct	VBN
cord-023095-4dannjjm	5769	9	to	to	IN
cord-023095-4dannjjm	5769	10	the	the	DT
cord-023095-4dannjjm	5769	11	formation	formation	NN
cord-023095-4dannjjm	5769	12	of	of	IN
cord-023095-4dannjjm	5769	13	inactive	inactive	JJ
cord-023095-4dannjjm	5769	14	metabolites	metabolite	NNS
cord-023095-4dannjjm	5769	15	with	with	IN
cord-023095-4dannjjm	5769	16	only	only	RB
cord-023095-4dannjjm	5769	17	an	an	DT
cord-023095-4dannjjm	5769	18	extremely	extremely	RB
cord-023095-4dannjjm	5769	19	small	small	JJ
cord-023095-4dannjjm	5769	20	proportion	proportion	NN
cord-023095-4dannjjm	5769	21	of	of	IN
cord-023095-4dannjjm	5769	22	parent	parent	NN
cord-023095-4dannjjm	5769	23	molecule	molecule	NN
cord-023095-4dannjjm	5769	24	directed	direct	VBN
cord-023095-4dannjjm	5769	25	to	to	IN
cord-023095-4dannjjm	5769	26	the	the	DT
cord-023095-4dannjjm	5769	27	formation	formation	NN
cord-023095-4dannjjm	5769	28	of	of	IN
cord-023095-4dannjjm	5769	29	the	the	DT
cord-023095-4dannjjm	5769	30	active	active	JJ
cord-023095-4dannjjm	5769	31	metabolite	metabolite	NN
cord-023095-4dannjjm	5769	32	.	.	.
cord-023095-4dannjjm	5770	1	There	there	EX
cord-023095-4dannjjm	5770	2	are	be	VBP
cord-023095-4dannjjm	5770	3	multiple	multiple	JJ
cord-023095-4dannjjm	5770	4	hepatic	hepatic	JJ
cord-023095-4dannjjm	5770	5	isozymes	isozyme	NNS
cord-023095-4dannjjm	5770	6	responsible	responsible	JJ
cord-023095-4dannjjm	5770	7	for	for	IN
cord-023095-4dannjjm	5770	8	the	the	DT
cord-023095-4dannjjm	5770	9	formation	formation	NN
cord-023095-4dannjjm	5770	10	of	of	IN
cord-023095-4dannjjm	5770	11	the	the	DT
cord-023095-4dannjjm	5770	12	active	active	JJ
cord-023095-4dannjjm	5770	13	metabolite	metabolite	NN
cord-023095-4dannjjm	5770	14	.	.	.
cord-023095-4dannjjm	5771	1	A	a	DT
cord-023095-4dannjjm	5771	2	non	non	JJ
cord-023095-4dannjjm	5771	3	-	-	JJ
cord-023095-4dannjjm	5771	4	specific	specific	JJ
cord-023095-4dannjjm	5771	5	hepatic	hepatic	JJ
cord-023095-4dannjjm	5771	6	isozyme	isozyme	NNS
cord-023095-4dannjjm	5771	7	inducer	inducer	NN
cord-023095-4dannjjm	5771	8	such	such	JJ
cord-023095-4dannjjm	5771	9	as	as	IN
cord-023095-4dannjjm	5771	10	rifampin	rifampin	NNP
cord-023095-4dannjjm	5771	11	could	could	MD
cord-023095-4dannjjm	5771	12	increase	increase	VB
cord-023095-4dannjjm	5771	13	the	the	DT
cord-023095-4dannjjm	5771	14	formation	formation	NN
cord-023095-4dannjjm	5771	15	of	of	IN
cord-023095-4dannjjm	5771	16	the	the	DT
cord-023095-4dannjjm	5771	17	active	active	JJ
cord-023095-4dannjjm	5771	18	metabolite	metabolite	NN
cord-023095-4dannjjm	5771	19	of	of	IN
cord-023095-4dannjjm	5771	20	clopidogrel	clopidogrel	NNP
cord-023095-4dannjjm	5771	21	thereby	thereby	RB
cord-023095-4dannjjm	5771	22	increasing	increase	VBG
cord-023095-4dannjjm	5771	23	the	the	DT
cord-023095-4dannjjm	5771	24	pharmacodynamic	pharmacodynamic	JJ
cord-023095-4dannjjm	5771	25	response	response	NN
cord-023095-4dannjjm	5771	26	which	which	WDT
cord-023095-4dannjjm	5771	27	may	may	MD
cord-023095-4dannjjm	5771	28	allow	allow	VB
cord-023095-4dannjjm	5771	29	a	a	DT
cord-023095-4dannjjm	5771	30	reduced	reduce	VBN
cord-023095-4dannjjm	5771	31	drug	drug	NN
cord-023095-4dannjjm	5771	32	dose	dose	NN
cord-023095-4dannjjm	5771	33	to	to	TO
cord-023095-4dannjjm	5771	34	achieve	achieve	VB
cord-023095-4dannjjm	5771	35	a	a	DT
cord-023095-4dannjjm	5771	36	clinical	clinical	JJ
cord-023095-4dannjjm	5771	37	effect	effect	NN
cord-023095-4dannjjm	5771	38	.	.	.
cord-023095-4dannjjm	5772	1	We	-PRON-	PRP
cord-023095-4dannjjm	5772	2	have	have	VBP
cord-023095-4dannjjm	5772	3	previously	previously	RB
cord-023095-4dannjjm	5772	4	presented	present	VBN
cord-023095-4dannjjm	5772	5	data	datum	NNS
cord-023095-4dannjjm	5772	6	supporting	support	VBG
cord-023095-4dannjjm	5772	7	the	the	DT
cord-023095-4dannjjm	5772	8	increased	increase	VBN
cord-023095-4dannjjm	5772	9	pharmacodynamic	pharmacodynamic	JJ
cord-023095-4dannjjm	5772	10	response	response	NN
cord-023095-4dannjjm	5772	11	of	of	IN
cord-023095-4dannjjm	5772	12	clopdiogrel	clopdiogrel	NNP
cord-023095-4dannjjm	5772	13	after	after	IN
cord-023095-4dannjjm	5772	14	rifampin	rifampin	NN
cord-023095-4dannjjm	5772	15	therapy	therapy	NN
cord-023095-4dannjjm	5772	16	.	.	.
cord-023095-4dannjjm	5773	1	The	the	DT
cord-023095-4dannjjm	5773	2	goal	goal	NN
cord-023095-4dannjjm	5773	3	of	of	IN
cord-023095-4dannjjm	5773	4	this	this	DT
cord-023095-4dannjjm	5773	5	study	study	NN
cord-023095-4dannjjm	5773	6	was	be	VBD
cord-023095-4dannjjm	5773	7	to	to	TO
cord-023095-4dannjjm	5773	8	demonstrate	demonstrate	VB
cord-023095-4dannjjm	5773	9	an	an	DT
cord-023095-4dannjjm	5773	10	increased	increase	VBN
cord-023095-4dannjjm	5773	11	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	5773	12	response	response	NN
cord-023095-4dannjjm	5773	13	of	of	IN
cord-023095-4dannjjm	5773	14	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	5773	15	after	after	IN
cord-023095-4dannjjm	5773	16	rifampin	rifampin	NNP
cord-023095-4dannjjm	5773	17	induction	induction	NN
cord-023095-4dannjjm	5773	18	of	of	IN
cord-023095-4dannjjm	5773	19	hepatic	hepatic	JJ
cord-023095-4dannjjm	5773	20	isozymes	isozyme	NNS
cord-023095-4dannjjm	5773	21	.	.	.
cord-023095-4dannjjm	5774	1	Six	six	CD
cord-023095-4dannjjm	5774	2	healthy	healthy	JJ
cord-023095-4dannjjm	5774	3	,	,	,
cord-023095-4dannjjm	5774	4	purpose	purpose	NN
cord-023095-4dannjjm	5774	5	-	-	HYPH
cord-023095-4dannjjm	5774	6	bred	breed	VBN
cord-023095-4dannjjm	5774	7	dogs	dog	NNS
cord-023095-4dannjjm	5774	8	were	be	VBD
cord-023095-4dannjjm	5774	9	used	use	VBN
cord-023095-4dannjjm	5774	10	for	for	IN
cord-023095-4dannjjm	5774	11	this	this	DT
cord-023095-4dannjjm	5774	12	study	study	NN
cord-023095-4dannjjm	5774	13	.	.	.
cord-023095-4dannjjm	5775	1	The	the	DT
cord-023095-4dannjjm	5775	2	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	5775	3	of	of	IN
cord-023095-4dannjjm	5775	4	clopidogrel	clopidogrel	NNP
cord-023095-4dannjjm	5775	5	were	be	VBD
cord-023095-4dannjjm	5775	6	determined	determine	VBN
cord-023095-4dannjjm	5775	7	by	by	IN
cord-023095-4dannjjm	5775	8	measuring	measure	VBG
cord-023095-4dannjjm	5775	9	the	the	DT
cord-023095-4dannjjm	5775	10	parent	parent	NN
cord-023095-4dannjjm	5775	11	molecule	molecule	NN
cord-023095-4dannjjm	5775	12	,	,	,
cord-023095-4dannjjm	5775	13	primary	primary	JJ
cord-023095-4dannjjm	5775	14	inactive	inactive	JJ
cord-023095-4dannjjm	5775	15	metabolite	metabolite	JJ
cord-023095-4dannjjm	5775	16	and	and	CC
cord-023095-4dannjjm	5775	17	active	active	JJ
cord-023095-4dannjjm	5775	18	metabolite	metabolite	NN
cord-023095-4dannjjm	5775	19	through	through	IN
cord-023095-4dannjjm	5775	20	LC	LC	NNP
cord-023095-4dannjjm	5775	21	/	/	SYM
cord-023095-4dannjjm	5775	22	MS	MS	NNP
cord-023095-4dannjjm	5775	23	/	/	SYM
cord-023095-4dannjjm	5775	24	MS	MS	NNP
cord-023095-4dannjjm	5775	25	.	.	.
cord-023095-4dannjjm	5776	1	The	the	DT
cord-023095-4dannjjm	5776	2	pharmacodynamics	pharmacodynamic	NNS
cord-023095-4dannjjm	5776	3	of	of	IN
cord-023095-4dannjjm	5776	4	clopidogrel	clopidogrel	NNS
cord-023095-4dannjjm	5776	5	were	be	VBD
cord-023095-4dannjjm	5776	6	determined	determine	VBN
cord-023095-4dannjjm	5776	7	by	by	IN
cord-023095-4dannjjm	5776	8	measuring	measure	VBG
cord-023095-4dannjjm	5776	9	collagen	collagen	NN
cord-023095-4dannjjm	5776	10	-	-	HYPH
cord-023095-4dannjjm	5776	11	induced	induce	VBN
cord-023095-4dannjjm	5776	12	whole	whole	JJ
cord-023095-4dannjjm	5776	13	blood	blood	NN
cord-023095-4dannjjm	5776	14	aggregation	aggregation	NN
cord-023095-4dannjjm	5776	15	.	.	.
cord-023095-4dannjjm	5777	1	Blood	blood	NN
cord-023095-4dannjjm	5777	2	samples	sample	NNS
cord-023095-4dannjjm	5777	3	were	be	VBD
cord-023095-4dannjjm	5777	4	collected	collect	VBN
cord-023095-4dannjjm	5777	5	prior	prior	RB
cord-023095-4dannjjm	5777	6	to	to	IN
cord-023095-4dannjjm	5777	7	clopidogrel	clopidogrel	NNP
cord-023095-4dannjjm	5777	8	administration	administration	NNP
cord-023095-4dannjjm	5777	9	(	(	-LRB-
cord-023095-4dannjjm	5777	10	baseline	baseline	NNP
cord-023095-4dannjjm	5777	11	)	)	-RRB-
cord-023095-4dannjjm	5777	12	,	,	,
cord-023095-4dannjjm	5777	13	after	after	IN
cord-023095-4dannjjm	5777	14	7	7	CD
cord-023095-4dannjjm	5777	15	days	day	NNS
cord-023095-4dannjjm	5777	16	of	of	IN
cord-023095-4dannjjm	5777	17	2	2	CD
cord-023095-4dannjjm	5777	18	mg	mg	NNP
cord-023095-4dannjjm	5777	19	/	/	SYM
cord-023095-4dannjjm	5777	20	kg	kg	NNP
cord-023095-4dannjjm	5777	21	clopidogrel	clopidogrel	NNP
cord-023095-4dannjjm	5777	22	PO	PO	NNP
cord-023095-4dannjjm	5777	23	q	q	NNP
cord-023095-4dannjjm	5777	24	24	24	CD
cord-023095-4dannjjm	5777	25	hrs	hrs	NN
cord-023095-4dannjjm	5777	26	,	,	,
cord-023095-4dannjjm	5777	27	and	and	CC
cord-023095-4dannjjm	5777	28	after	after	IN
cord-023095-4dannjjm	5777	29	7	7	CD
cord-023095-4dannjjm	5777	30	days	day	NNS
cord-023095-4dannjjm	5777	31	of	of	IN
cord-023095-4dannjjm	5777	32	2	2	CD
cord-023095-4dannjjm	5777	33	mg	mg	NNP
cord-023095-4dannjjm	5777	34	/	/	SYM
cord-023095-4dannjjm	5777	35	kg	kg	NNP
cord-023095-4dannjjm	5777	36	clopidogrel	clopidogrel	NNP
cord-023095-4dannjjm	5777	37	PO	PO	NNP
cord-023095-4dannjjm	5777	38	q	q	NNP
cord-023095-4dannjjm	5777	39	24	24	CD
cord-023095-4dannjjm	5777	40	hrs	hrs	NN
cord-023095-4dannjjm	5777	41	1	1	CD
cord-023095-4dannjjm	5777	42	10	10	CD
cord-023095-4dannjjm	5777	43	mg/	mg/	NN
cord-023095-4dannjjm	5777	44	kg	kg	NNP
cord-023095-4dannjjm	5778	1	PO	PO	NNP
cord-023095-4dannjjm	5779	1	q	q	NNP
cord-023095-4dannjjm	5779	2	12	12	CD
cord-023095-4dannjjm	5779	3	hrs	hrs	NN
cord-023095-4dannjjm	5779	4	rifampin	rifampin	NN
cord-023095-4dannjjm	5779	5	.	.	.
cord-023095-4dannjjm	5780	1	Given	give	VBN
cord-023095-4dannjjm	5780	2	the	the	DT
cord-023095-4dannjjm	5780	3	absence	absence	NN
cord-023095-4dannjjm	5780	4	of	of	IN
cord-023095-4dannjjm	5780	5	a	a	DT
cord-023095-4dannjjm	5780	6	known	know	VBN
cord-023095-4dannjjm	5780	7	standard	standard	NN
cord-023095-4dannjjm	5780	8	for	for	IN
cord-023095-4dannjjm	5780	9	the	the	DT
cord-023095-4dannjjm	5780	10	active	active	JJ
cord-023095-4dannjjm	5780	11	metabolite	metabolite	NN
cord-023095-4dannjjm	5780	12	,	,	,
cord-023095-4dannjjm	5780	13	only	only	RB
cord-023095-4dannjjm	5780	14	a	a	DT
cord-023095-4dannjjm	5780	15	semi	semi	JJ
cord-023095-4dannjjm	5780	16	-	-	JJ
cord-023095-4dannjjm	5780	17	quantitative	quantitative	JJ
cord-023095-4dannjjm	5780	18	assessment	assessment	NN
cord-023095-4dannjjm	5780	19	of	of	IN
cord-023095-4dannjjm	5780	20	active	active	JJ
cord-023095-4dannjjm	5780	21	metabolite	metabolite	JJ
cord-023095-4dannjjm	5780	22	concentration	concentration	NN
cord-023095-4dannjjm	5780	23	can	can	MD
cord-023095-4dannjjm	5780	24	be	be	VB
cord-023095-4dannjjm	5780	25	made	make	VBN
cord-023095-4dannjjm	5780	26	.	.	.
cord-023095-4dannjjm	5781	1	There	there	EX
cord-023095-4dannjjm	5781	2	was	be	VBD
cord-023095-4dannjjm	5781	3	no	no	DT
cord-023095-4dannjjm	5781	4	identifiable	identifiable	JJ
cord-023095-4dannjjm	5781	5	active	active	JJ
cord-023095-4dannjjm	5781	6	metabolite	metabolite	JJ
cord-023095-4dannjjm	5781	7	peak	peak	NN
cord-023095-4dannjjm	5781	8	noted	note	VBN
cord-023095-4dannjjm	5781	9	at	at	IN
cord-023095-4dannjjm	5781	10	baseline	baseline	NN
cord-023095-4dannjjm	5781	11	or	or	CC
cord-023095-4dannjjm	5781	12	after	after	IN
cord-023095-4dannjjm	5781	13	clopidogrel	clopidogrel	JJ
cord-023095-4dannjjm	5781	14	treatment	treatment	NN
cord-023095-4dannjjm	5781	15	.	.	.
cord-023095-4dannjjm	5782	1	However	however	RB
cord-023095-4dannjjm	5782	2	,	,	,
cord-023095-4dannjjm	5782	3	with	with	IN
cord-023095-4dannjjm	5782	4	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	5782	5	and	and	CC
cord-023095-4dannjjm	5782	6	rifampin	rifampin	NN
cord-023095-4dannjjm	5782	7	combined	combine	VBN
cord-023095-4dannjjm	5782	8	administration	administration	NN
cord-023095-4dannjjm	5782	9	there	there	EX
cord-023095-4dannjjm	5782	10	was	be	VBD
cord-023095-4dannjjm	5782	11	an	an	DT
cord-023095-4dannjjm	5782	12	active	active	JJ
cord-023095-4dannjjm	5782	13	metabolite	metabolite	JJ
cord-023095-4dannjjm	5782	14	peak	peak	NN
cord-023095-4dannjjm	5782	15	identified	identify	VBN
cord-023095-4dannjjm	5782	16	in	in	IN
cord-023095-4dannjjm	5782	17	all	all	DT
cord-023095-4dannjjm	5782	18	dogs	dog	NNS
cord-023095-4dannjjm	5782	19	with	with	IN
cord-023095-4dannjjm	5782	20	a	a	DT
cord-023095-4dannjjm	5782	21	mean	mean	JJ
cord-023095-4dannjjm	5782	22	area	area	NN
cord-023095-4dannjjm	5782	23	of	of	IN
cord-023095-4dannjjm	5782	24	41.7	41.7	CD
cord-023095-4dannjjm	5782	25	AE	AE	NNP
cord-023095-4dannjjm	5782	26	23.5	23.5	CD
cord-023095-4dannjjm	5782	27	.	.	.
cord-023095-4dannjjm	5783	1	The	the	DT
cord-023095-4dannjjm	5783	2	development	development	NN
cord-023095-4dannjjm	5783	3	of	of	IN
cord-023095-4dannjjm	5783	4	the	the	DT
cord-023095-4dannjjm	5783	5	active	active	JJ
cord-023095-4dannjjm	5783	6	metabolite	metabolite	JJ
cord-023095-4dannjjm	5783	7	peak	peak	NN
cord-023095-4dannjjm	5783	8	was	be	VBD
cord-023095-4dannjjm	5783	9	associated	associate	VBN
cord-023095-4dannjjm	5783	10	with	with	IN
cord-023095-4dannjjm	5783	11	an	an	DT
cord-023095-4dannjjm	5783	12	increase	increase	NN
cord-023095-4dannjjm	5783	13	in	in	IN
cord-023095-4dannjjm	5783	14	the	the	DT
cord-023095-4dannjjm	5783	15	pharmacodyamic	pharmacodyamic	JJ
cord-023095-4dannjjm	5783	16	response	response	NN
cord-023095-4dannjjm	5783	17	of	of	IN
cord-023095-4dannjjm	5783	18	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	5783	19	in	in	IN
cord-023095-4dannjjm	5783	20	the	the	DT
cord-023095-4dannjjm	5783	21	dogs	dog	NNS
cord-023095-4dannjjm	5783	22	.	.	.
cord-023095-4dannjjm	5784	1	This	this	DT
cord-023095-4dannjjm	5784	2	is	be	VBZ
cord-023095-4dannjjm	5784	3	the	the	DT
cord-023095-4dannjjm	5784	4	first	first	JJ
cord-023095-4dannjjm	5784	5	study	study	NN
cord-023095-4dannjjm	5784	6	in	in	IN
cord-023095-4dannjjm	5784	7	any	any	DT
cord-023095-4dannjjm	5784	8	species	specie	NNS
cord-023095-4dannjjm	5784	9	to	to	TO
cord-023095-4dannjjm	5784	10	document	document	VB
cord-023095-4dannjjm	5784	11	the	the	DT
cord-023095-4dannjjm	5784	12	increased	increase	VBN
cord-023095-4dannjjm	5784	13	formation	formation	NN
cord-023095-4dannjjm	5784	14	of	of	IN
cord-023095-4dannjjm	5784	15	the	the	DT
cord-023095-4dannjjm	5784	16	active	active	JJ
cord-023095-4dannjjm	5784	17	metabolite	metabolite	NN
cord-023095-4dannjjm	5784	18	of	of	IN
cord-023095-4dannjjm	5784	19	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	5784	20	in	in	IN
cord-023095-4dannjjm	5784	21	response	response	NN
cord-023095-4dannjjm	5784	22	to	to	IN
cord-023095-4dannjjm	5784	23	a	a	DT
cord-023095-4dannjjm	5784	24	strong	strong	JJ
cord-023095-4dannjjm	5784	25	,	,	,
cord-023095-4dannjjm	5784	26	non	non	JJ
cord-023095-4dannjjm	5784	27	-	-	JJ
cord-023095-4dannjjm	5784	28	specific	specific	JJ
cord-023095-4dannjjm	5784	29	hepatic	hepatic	JJ
cord-023095-4dannjjm	5784	30	isozyme	isozyme	NNS
cord-023095-4dannjjm	5784	31	inducer	inducer	NN
cord-023095-4dannjjm	5784	32	.	.	.
cord-023095-4dannjjm	5785	1	This	this	DT
cord-023095-4dannjjm	5785	2	increased	increase	VBN
cord-023095-4dannjjm	5785	3	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	5785	4	response	response	NN
cord-023095-4dannjjm	5785	5	was	be	VBD
cord-023095-4dannjjm	5785	6	associated	associate	VBN
cord-023095-4dannjjm	5785	7	with	with	IN
cord-023095-4dannjjm	5785	8	an	an	DT
cord-023095-4dannjjm	5785	9	increased	increase	VBN
cord-023095-4dannjjm	5785	10	pharmacodynamic	pharmacodynamic	JJ
cord-023095-4dannjjm	5785	11	response	response	NN
cord-023095-4dannjjm	5785	12	of	of	IN
cord-023095-4dannjjm	5785	13	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	5785	14	.	.	.
cord-023095-4dannjjm	5786	1	This	this	DT
cord-023095-4dannjjm	5786	2	data	data	NN
cord-023095-4dannjjm	5786	3	provides	provide	VBZ
cord-023095-4dannjjm	5786	4	supportive	supportive	JJ
cord-023095-4dannjjm	5786	5	evidence	evidence	NN
cord-023095-4dannjjm	5786	6	to	to	TO
cord-023095-4dannjjm	5786	7	develop	develop	VB
cord-023095-4dannjjm	5786	8	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5786	9	protocols	protocol	NNS
cord-023095-4dannjjm	5786	10	to	to	TO
cord-023095-4dannjjm	5786	11	improve	improve	VB
cord-023095-4dannjjm	5786	12	the	the	DT
cord-023095-4dannjjm	5786	13	pharmacodynamic	pharmacodynamic	JJ
cord-023095-4dannjjm	5786	14	response	response	NN
cord-023095-4dannjjm	5786	15	to	to	IN
cord-023095-4dannjjm	5786	16	clopidogrel	clopidogrel	NN
cord-023095-4dannjjm	5786	17	in	in	IN
cord-023095-4dannjjm	5786	18	dogs	dog	NNS
cord-023095-4dannjjm	5786	19	that	that	WDT
cord-023095-4dannjjm	5786	20	may	may	MD
cord-023095-4dannjjm	5786	21	reduce	reduce	VB
cord-023095-4dannjjm	5786	22	dosing	dosing	NN
cord-023095-4dannjjm	5786	23	requirements	requirement	NNS
cord-023095-4dannjjm	5786	24	or	or	CC
cord-023095-4dannjjm	5786	25	correct	correct	JJ
cord-023095-4dannjjm	5786	26	subtherapeutic	subtherapeutic	JJ
cord-023095-4dannjjm	5786	27	pharmacodynamic	pharmacodynamic	JJ
cord-023095-4dannjjm	5786	28	response	response	NN
cord-023095-4dannjjm	5786	29	.	.	.
cord-023095-4dannjjm	5787	1	Critical	critical	JJ
cord-023095-4dannjjm	5787	2	illness	illness	NN
cord-023095-4dannjjm	5787	3	-	-	HYPH
cord-023095-4dannjjm	5787	4	related	relate	VBN
cord-023095-4dannjjm	5787	5	corticosteroid	corticosteroid	NN
cord-023095-4dannjjm	5787	6	insufficiency	insufficiency	NN
cord-023095-4dannjjm	5787	7	(	(	-LRB-
cord-023095-4dannjjm	5787	8	CIRCI	CIRCI	NNP
cord-023095-4dannjjm	5787	9	)	)	-RRB-
cord-023095-4dannjjm	5787	10	has	have	VBZ
cord-023095-4dannjjm	5787	11	been	be	VBN
cord-023095-4dannjjm	5787	12	identified	identify	VBN
cord-023095-4dannjjm	5787	13	in	in	IN
cord-023095-4dannjjm	5787	14	humans	human	NNS
cord-023095-4dannjjm	5787	15	,	,	,
cord-023095-4dannjjm	5787	16	foals	foal	NNS
cord-023095-4dannjjm	5787	17	,	,	,
cord-023095-4dannjjm	5787	18	dogs	dog	NNS
cord-023095-4dannjjm	5787	19	and	and	CC
cord-023095-4dannjjm	5787	20	cats	cat	NNS
cord-023095-4dannjjm	5787	21	with	with	IN
cord-023095-4dannjjm	5787	22	lower	lower	RBR
cord-023095-4dannjjm	5787	23	-	-	HYPH
cord-023095-4dannjjm	5787	24	thanexpected	thanexpecte	VBN
cord-023095-4dannjjm	5787	25	circulating	circulate	VBG
cord-023095-4dannjjm	5787	26	cortisol	cortisol	NN
cord-023095-4dannjjm	5787	27	concentrations	concentration	NNS
cord-023095-4dannjjm	5787	28	,	,	,
cord-023095-4dannjjm	5787	29	and/or	and/or	CC
cord-023095-4dannjjm	5787	30	by	by	IN
cord-023095-4dannjjm	5787	31	a	a	DT
cord-023095-4dannjjm	5787	32	blunted	blunt	VBN
cord-023095-4dannjjm	5787	33	cortisol	cortisol	NN
cord-023095-4dannjjm	5787	34	response	response	NN
cord-023095-4dannjjm	5787	35	to	to	IN
cord-023095-4dannjjm	5787	36	ACTH	ACTH	NNP
cord-023095-4dannjjm	5787	37	stimulation	stimulation	NN
cord-023095-4dannjjm	5787	38	.	.	.
cord-023095-4dannjjm	5788	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	5788	2	purpose	purpose	NN
cord-023095-4dannjjm	5788	3	was	be	VBD
cord-023095-4dannjjm	5788	4	to	to	TO
cord-023095-4dannjjm	5788	5	determine	determine	VB
cord-023095-4dannjjm	5788	6	if	if	IN
cord-023095-4dannjjm	5788	7	CIRCI	CIRCI	NNP
cord-023095-4dannjjm	5788	8	exists	exist	VBZ
cord-023095-4dannjjm	5788	9	in	in	IN
cord-023095-4dannjjm	5788	10	critically	critically	RB
cord-023095-4dannjjm	5788	11	ill	ill	JJ
cord-023095-4dannjjm	5788	12	horses	horse	NNS
cord-023095-4dannjjm	5788	13	.	.	.
cord-023095-4dannjjm	5789	1	Endogenous	endogenous	JJ
cord-023095-4dannjjm	5789	2	plasma	plasma	NN
cord-023095-4dannjjm	5789	3	ACTH	ACTH	NNP
cord-023095-4dannjjm	5789	4	and	and	CC
cord-023095-4dannjjm	5789	5	serum	serum	NN
cord-023095-4dannjjm	5789	6	cortisol	cortisol	NN
cord-023095-4dannjjm	5789	7	concentrations	concentration	NNS
cord-023095-4dannjjm	5789	8	,	,	,
cord-023095-4dannjjm	5789	9	and	and	CC
cord-023095-4dannjjm	5789	10	cortisol	cortisol	NN
cord-023095-4dannjjm	5789	11	at	at	IN
cord-023095-4dannjjm	5789	12	T	T	NNP
cord-023095-4dannjjm	5789	13	5	5	CD
cord-023095-4dannjjm	5789	14	0	0	CD
cord-023095-4dannjjm	5789	15	and	and	CC
cord-023095-4dannjjm	5789	16	T	T	NNP
cord-023095-4dannjjm	5789	17	5	5	CD
cord-023095-4dannjjm	5789	18	30	30	CD
cord-023095-4dannjjm	5789	19	min	min	NN
cord-023095-4dannjjm	5789	20	after	after	IN
cord-023095-4dannjjm	5789	21	0.1	0.1	CD
cord-023095-4dannjjm	5789	22	mg	mg	NNP
cord-023095-4dannjjm	5789	23	/	/	SYM
cord-023095-4dannjjm	5789	24	kg	kg	NNP
cord-023095-4dannjjm	5789	25	cosyntropin	cosyntropin	NNP
cord-023095-4dannjjm	5789	26	,	,	,
cord-023095-4dannjjm	5789	27	were	be	VBD
cord-023095-4dannjjm	5789	28	measured	measure	VBN
cord-023095-4dannjjm	5789	29	by	by	IN
cord-023095-4dannjjm	5789	30	radioimmunoassay	radioimmunoassay	JJ
cord-023095-4dannjjm	5789	31	from	from	IN
cord-023095-4dannjjm	5789	32	horses	horse	NNS
cord-023095-4dannjjm	5789	33	with	with	IN
cord-023095-4dannjjm	5789	34	colic	colic	NN
cord-023095-4dannjjm	5789	35	or	or	CC
cord-023095-4dannjjm	5789	36	systemic	systemic	JJ
cord-023095-4dannjjm	5789	37	illness	illness	NN
cord-023095-4dannjjm	5789	38	on	on	IN
cord-023095-4dannjjm	5789	39	admission	admission	NN
cord-023095-4dannjjm	5789	40	,	,	,
cord-023095-4dannjjm	5789	41	and	and	CC
cord-023095-4dannjjm	5789	42	days	day	NNS
cord-023095-4dannjjm	5789	43	2	2	CD
cord-023095-4dannjjm	5789	44	,	,	,
cord-023095-4dannjjm	5789	45	4	4	CD
cord-023095-4dannjjm	5789	46	and	and	CC
cord-023095-4dannjjm	5789	47	6	6	CD
cord-023095-4dannjjm	5789	48	of	of	IN
cord-023095-4dannjjm	5789	49	hospitilization	hospitilization	NN
cord-023095-4dannjjm	5789	50	.	.	.
cord-023095-4dannjjm	5790	1	Horses	horse	NNS
cord-023095-4dannjjm	5790	2	were	be	VBD
cord-023095-4dannjjm	5790	3	divided	divide	VBN
cord-023095-4dannjjm	5790	4	into	into	IN
cord-023095-4dannjjm	5790	5	mild	mild	JJ
cord-023095-4dannjjm	5790	6	,	,	,
cord-023095-4dannjjm	5790	7	moderate	moderate	JJ
cord-023095-4dannjjm	5790	8	,	,	,
cord-023095-4dannjjm	5790	9	or	or	CC
cord-023095-4dannjjm	5790	10	severe	severe	JJ
cord-023095-4dannjjm	5790	11	illness	illness	NN
cord-023095-4dannjjm	5790	12	groups	group	NNS
cord-023095-4dannjjm	5790	13	based	base	VBN
cord-023095-4dannjjm	5790	14	on	on	IN
cord-023095-4dannjjm	5790	15	clinicopathologic	clinicopathologic	NNP
cord-023095-4dannjjm	5790	16	data	datum	NNS
cord-023095-4dannjjm	5790	17	.	.	.
cord-023095-4dannjjm	5791	1	Inappropriately	inappropriately	RB
cord-023095-4dannjjm	5791	2	low	low	JJ
cord-023095-4dannjjm	5791	3	cortisol	cortisol	NN
cord-023095-4dannjjm	5791	4	was	be	VBD
cord-023095-4dannjjm	5791	5	defined	define	VBN
cord-023095-4dannjjm	5791	6	as	as	IN
cord-023095-4dannjjm	5791	7	endogenous	endogenous	JJ
cord-023095-4dannjjm	5791	8	cortisol	cortisol	NN
cord-023095-4dannjjm	5791	9	o	o	NN
cord-023095-4dannjjm	5791	10	mean-1SD	mean-1SD	NNP
cord-023095-4dannjjm	5791	11	achieved	achieve	VBN
cord-023095-4dannjjm	5791	12	after	after	IN
cord-023095-4dannjjm	5791	13	administration	administration	NN
cord-023095-4dannjjm	5791	14	of	of	IN
cord-023095-4dannjjm	5791	15	0.1	0.1	CD
cord-023095-4dannjjm	5791	16	mg	mg	NNP
cord-023095-4dannjjm	5791	17	/	/	SYM
cord-023095-4dannjjm	5791	18	kg	kg	NNP
cord-023095-4dannjjm	5791	19	cosyntropin	cosyntropin	NNP
cord-023095-4dannjjm	5791	20	to	to	IN
cord-023095-4dannjjm	5791	21	normal	normal	JJ
cord-023095-4dannjjm	5791	22	horses	horse	NNS
cord-023095-4dannjjm	5791	23	(	(	-LRB-
cord-023095-4dannjjm	5791	24	o	o	NN
cord-023095-4dannjjm	5791	25	269	269	CD
cord-023095-4dannjjm	5791	26	nmol	nmol	NNP
cord-023095-4dannjjm	5791	27	/	/	SYM
cord-023095-4dannjjm	5791	28	L	L	NNP
cord-023095-4dannjjm	5791	29	)	)	-RRB-
cord-023095-4dannjjm	5791	30	.	.	.
cord-023095-4dannjjm	5792	1	Inadequate	inadequate	JJ
cord-023095-4dannjjm	5792	2	delta	delta	NN
cord-023095-4dannjjm	5792	3	cortisol	cortisol	NN
cord-023095-4dannjjm	5792	4	was	be	VBD
cord-023095-4dannjjm	5792	5	defined	define	VBN
cord-023095-4dannjjm	5792	6	as	as	IN
cord-023095-4dannjjm	5792	7	o	o	UH
cord-023095-4dannjjm	5792	8	mean	mean	NN
cord-023095-4dannjjm	5792	9	delta	delta	NN
cord-023095-4dannjjm	5792	10	cortisol	cortisol	NN
cord-023095-4dannjjm	5792	11	in	in	IN
cord-023095-4dannjjm	5792	12	normal	normal	JJ
cord-023095-4dannjjm	5792	13	horses	horse	NNS
cord-023095-4dannjjm	5792	14	after	after	IN
cord-023095-4dannjjm	5792	15	0.1	0.1	CD
cord-023095-4dannjjm	5792	16	mg	mg	NNP
cord-023095-4dannjjm	5792	17	/	/	SYM
cord-023095-4dannjjm	5792	18	kg	kg	NNP
cord-023095-4dannjjm	5792	19	cosyntropin	cosyntropin	NNP
cord-023095-4dannjjm	5792	20	(	(	-LRB-
cord-023095-4dannjjm	5792	21	o	o	UH
cord-023095-4dannjjm	5792	22	159	159	CD
cord-023095-4dannjjm	5792	23	nmol	nmol	NN
cord-023095-4dannjjm	5792	24	/	/	SYM
cord-023095-4dannjjm	5792	25	L	L	NNP
cord-023095-4dannjjm	5792	26	)	)	-RRB-
cord-023095-4dannjjm	5792	27	.	.	.
cord-023095-4dannjjm	5793	1	Cortisol	cortisol	NN
cord-023095-4dannjjm	5793	2	,	,	,
cord-023095-4dannjjm	5793	3	ACTH	ACTH	NNP
cord-023095-4dannjjm	5793	4	and	and	CC
cord-023095-4dannjjm	5793	5	delta	delta	NN
cord-023095-4dannjjm	5793	6	cortisol	cortisol	NN
cord-023095-4dannjjm	5793	7	were	be	VBD
cord-023095-4dannjjm	5793	8	compared	compare	VBN
cord-023095-4dannjjm	5793	9	using	use	VBG
cord-023095-4dannjjm	5793	10	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	5793	11	between	between	IN
cord-023095-4dannjjm	5793	12	groups	group	NNS
cord-023095-4dannjjm	5793	13	,	,	,
cord-023095-4dannjjm	5793	14	with	with	IN
cord-023095-4dannjjm	5793	15	P	p	NN
cord-023095-4dannjjm	5793	16	o	o	NN
cord-023095-4dannjjm	5793	17	0.05	0.05	CD
cord-023095-4dannjjm	5793	18	considered	consider	VBN
cord-023095-4dannjjm	5793	19	significant	significant	JJ
cord-023095-4dannjjm	5793	20	.	.	.
cord-023095-4dannjjm	5794	1	Fifty	fifty	CD
cord-023095-4dannjjm	5794	2	-	-	HYPH
cord-023095-4dannjjm	5794	3	eight	eight	CD
cord-023095-4dannjjm	5794	4	horses	horse	NNS
cord-023095-4dannjjm	5794	5	classified	classify	VBN
cord-023095-4dannjjm	5794	6	as	as	IN
cord-023095-4dannjjm	5794	7	having	have	VBG
cord-023095-4dannjjm	5794	8	mild	mild	JJ
cord-023095-4dannjjm	5794	9	(	(	-LRB-
cord-023095-4dannjjm	5794	10	11	11	CD
cord-023095-4dannjjm	5794	11	)	)	-RRB-
cord-023095-4dannjjm	5794	12	,	,	,
cord-023095-4dannjjm	5794	13	moderate	moderate	JJ
cord-023095-4dannjjm	5794	14	(	(	-LRB-
cord-023095-4dannjjm	5794	15	30	30	CD
cord-023095-4dannjjm	5794	16	)	)	-RRB-
cord-023095-4dannjjm	5794	17	and	and	CC
cord-023095-4dannjjm	5794	18	severe	severe	JJ
cord-023095-4dannjjm	5794	19	(	(	-LRB-
cord-023095-4dannjjm	5794	20	17	17	CD
cord-023095-4dannjjm	5794	21	)	)	-RRB-
cord-023095-4dannjjm	5794	22	disease	disease	NN
cord-023095-4dannjjm	5794	23	at	at	IN
cord-023095-4dannjjm	5794	24	admission	admission	NN
cord-023095-4dannjjm	5794	25	had	have	VBD
cord-023095-4dannjjm	5794	26	survival	survival	NN
cord-023095-4dannjjm	5794	27	rates	rate	NNS
cord-023095-4dannjjm	5794	28	of	of	IN
cord-023095-4dannjjm	5794	29	100	100	CD
cord-023095-4dannjjm	5794	30	%	%	NN
cord-023095-4dannjjm	5794	31	,	,	,
cord-023095-4dannjjm	5794	32	97	97	CD
cord-023095-4dannjjm	5794	33	%	%	NN
cord-023095-4dannjjm	5794	34	and	and	CC
cord-023095-4dannjjm	5794	35	35	35	CD
cord-023095-4dannjjm	5794	36	%	%	NN
cord-023095-4dannjjm	5794	37	respectively	respectively	RB
cord-023095-4dannjjm	5794	38	.	.	.
cord-023095-4dannjjm	5795	1	Admission	admission	NN
cord-023095-4dannjjm	5795	2	ACTH	ACTH	NNP
cord-023095-4dannjjm	5795	3	and	and	CC
cord-023095-4dannjjm	5795	4	cortisol	cortisol	NN
cord-023095-4dannjjm	5795	5	concentrations	concentration	NNS
cord-023095-4dannjjm	5795	6	were	be	VBD
cord-023095-4dannjjm	5795	7	highest	high	JJS
cord-023095-4dannjjm	5795	8	in	in	IN
cord-023095-4dannjjm	5795	9	severely	severely	RB
cord-023095-4dannjjm	5795	10	ill	ill	JJ
cord-023095-4dannjjm	5795	11	horses	horse	NNS
cord-023095-4dannjjm	5795	12	(	(	-LRB-
cord-023095-4dannjjm	5795	13	93	93	CD
cord-023095-4dannjjm	5795	14	AE	AE	NNP
cord-023095-4dannjjm	5795	15	198pg	198pg	NNP
cord-023095-4dannjjm	5795	16	/	/	SYM
cord-023095-4dannjjm	5795	17	mL	mL	NNP
cord-023095-4dannjjm	5795	18	,	,	,
cord-023095-4dannjjm	5795	19	361	361	CD
cord-023095-4dannjjm	5795	20	AE	AE	NNP
cord-023095-4dannjjm	5795	21	137	137	CD
cord-023095-4dannjjm	5795	22	nmol	nmol	NNP
cord-023095-4dannjjm	5795	23	/	/	SYM
cord-023095-4dannjjm	5795	24	L	l	NN
cord-023095-4dannjjm	5795	25	)	)	-RRB-
cord-023095-4dannjjm	5795	26	compared	compare	VBN
cord-023095-4dannjjm	5795	27	to	to	IN
cord-023095-4dannjjm	5795	28	moderate	moderate	JJ
cord-023095-4dannjjm	5795	29	(	(	-LRB-
cord-023095-4dannjjm	5795	30	31	31	CD
cord-023095-4dannjjm	5795	31	AE	AE	NNP
cord-023095-4dannjjm	5795	32	36	36	CD
cord-023095-4dannjjm	5795	33	,	,	,
cord-023095-4dannjjm	5795	34	279	279	CD
cord-023095-4dannjjm	5795	35	AE	AE	NNP
cord-023095-4dannjjm	5795	36	137	137	CD
cord-023095-4dannjjm	5795	37	)	)	-RRB-
cord-023095-4dannjjm	5795	38	and	and	CC
cord-023095-4dannjjm	5795	39	mildly	mildly	RB
cord-023095-4dannjjm	5795	40	ill	ill	JJ
cord-023095-4dannjjm	5795	41	horses	horse	NNS
cord-023095-4dannjjm	5795	42	(	(	-LRB-
cord-023095-4dannjjm	5795	43	18.0	18.0	CD
cord-023095-4dannjjm	5795	44	AE	AE	NNP
cord-023095-4dannjjm	5795	45	12.0	12.0	CD
cord-023095-4dannjjm	5795	46	,	,	,
cord-023095-4dannjjm	5795	47	237	237	CD
cord-023095-4dannjjm	5795	48	AE	AE	NNP
cord-023095-4dannjjm	5795	49	133	133	CD
cord-023095-4dannjjm	5795	50	)	)	-RRB-
cord-023095-4dannjjm	5795	51	.	.	.
cord-023095-4dannjjm	5796	1	Admission	admission	NN
cord-023095-4dannjjm	5796	2	cortisol	cortisol	NN
cord-023095-4dannjjm	5796	3	concentrations	concentration	NNS
cord-023095-4dannjjm	5796	4	were	be	VBD
cord-023095-4dannjjm	5796	5	higher	high	JJR
cord-023095-4dannjjm	5796	6	overall	overall	RB
cord-023095-4dannjjm	5796	7	in	in	IN
cord-023095-4dannjjm	5796	8	severely	severely	RB
cord-023095-4dannjjm	5796	9	ill	ill	JJ
cord-023095-4dannjjm	5796	10	horses	horse	NNS
cord-023095-4dannjjm	5796	11	(	(	-LRB-
cord-023095-4dannjjm	5796	12	P	p	NN
cord-023095-4dannjjm	5796	13	5	5	CD
cord-023095-4dannjjm	5796	14	0.016	0.016	CD
cord-023095-4dannjjm	5796	15	)	)	-RRB-
cord-023095-4dannjjm	5796	16	,	,	,
cord-023095-4dannjjm	5796	17	but	but	CC
cord-023095-4dannjjm	5796	18	were	be	VBD
cord-023095-4dannjjm	5796	19	low	low	JJ
cord-023095-4dannjjm	5796	20	in	in	IN
cord-023095-4dannjjm	5796	21	24	24	CD
cord-023095-4dannjjm	5796	22	%	%	NN
cord-023095-4dannjjm	5796	23	(	(	-LRB-
cord-023095-4dannjjm	5796	24	4/17	4/17	CD
cord-023095-4dannjjm	5796	25	)	)	-RRB-
cord-023095-4dannjjm	5796	26	.	.	.
cord-023095-4dannjjm	5797	1	Admission	admission	NN
cord-023095-4dannjjm	5797	2	delta	delta	NN
cord-023095-4dannjjm	5797	3	cortisol	cortisol	NN
cord-023095-4dannjjm	5797	4	was	be	VBD
cord-023095-4dannjjm	5797	5	low	low	JJ
cord-023095-4dannjjm	5797	6	in	in	IN
cord-023095-4dannjjm	5797	7	85	85	CD
cord-023095-4dannjjm	5797	8	%	%	NN
cord-023095-4dannjjm	5797	9	(	(	-LRB-
cord-023095-4dannjjm	5797	10	11/13	11/13	CD
cord-023095-4dannjjm	5797	11	)	)	-RRB-
cord-023095-4dannjjm	5797	12	of	of	IN
cord-023095-4dannjjm	5797	13	severely	severely	RB
cord-023095-4dannjjm	5797	14	ill	ill	JJ
cord-023095-4dannjjm	5797	15	horses	horse	NNS
cord-023095-4dannjjm	5797	16	,	,	,
cord-023095-4dannjjm	5797	17	and	and	CC
cord-023095-4dannjjm	5797	18	was	be	VBD
cord-023095-4dannjjm	5797	19	associated	associate	VBN
cord-023095-4dannjjm	5797	20	with	with	IN
cord-023095-4dannjjm	5797	21	marked	marked	JJ
cord-023095-4dannjjm	5797	22	adrenal	adrenal	JJ
cord-023095-4dannjjm	5797	23	hemorrhage	hemorrhage	NN
cord-023095-4dannjjm	5797	24	in	in	IN
cord-023095-4dannjjm	5797	25	non	non	NNS
cord-023095-4dannjjm	5797	26	-	-	NNS
cord-023095-4dannjjm	5797	27	survivors	survivor	NNS
cord-023095-4dannjjm	5797	28	.	.	.
cord-023095-4dannjjm	5798	1	Severely	severely	RB
cord-023095-4dannjjm	5798	2	ill	ill	JJ
cord-023095-4dannjjm	5798	3	horses	horse	NNS
cord-023095-4dannjjm	5798	4	have	have	VBP
cord-023095-4dannjjm	5798	5	high	high	JJ
cord-023095-4dannjjm	5798	6	cortisol	cortisol	NN
cord-023095-4dannjjm	5798	7	and	and	CC
cord-023095-4dannjjm	5798	8	ACTH	ACTH	NNP
cord-023095-4dannjjm	5798	9	,	,	,
cord-023095-4dannjjm	5798	10	but	but	CC
cord-023095-4dannjjm	5798	11	low	low	JJ
cord-023095-4dannjjm	5798	12	cortisol	cortisol	NN
cord-023095-4dannjjm	5798	13	and	and	CC
cord-023095-4dannjjm	5798	14	delta	delta	NN
cord-023095-4dannjjm	5798	15	cortisol	cortisol	NN
cord-023095-4dannjjm	5798	16	may	may	MD
cord-023095-4dannjjm	5798	17	indicate	indicate	VB
cord-023095-4dannjjm	5798	18	CIRCI	CIRCI	NNP
cord-023095-4dannjjm	5798	19	secondary	secondary	JJ
cord-023095-4dannjjm	5798	20	to	to	IN
cord-023095-4dannjjm	5798	21	adrenal	adrenal	JJ
cord-023095-4dannjjm	5798	22	hemorrhage	hemorrhage	NN
cord-023095-4dannjjm	5798	23	.	.	.
cord-023095-4dannjjm	5799	1	Equine	equine	JJ
cord-023095-4dannjjm	5799	2	pituitary	pituitary	NN
cord-023095-4dannjjm	5799	3	pars	pars	FW
cord-023095-4dannjjm	5799	4	intermedia	intermedia	NN
cord-023095-4dannjjm	5799	5	dysfunction	dysfunction	NN
cord-023095-4dannjjm	5799	6	(	(	-LRB-
cord-023095-4dannjjm	5799	7	PPID	PPID	NNP
cord-023095-4dannjjm	5799	8	)	)	-RRB-
cord-023095-4dannjjm	5799	9	is	be	VBZ
cord-023095-4dannjjm	5799	10	a	a	DT
cord-023095-4dannjjm	5799	11	common	common	JJ
cord-023095-4dannjjm	5799	12	endocrinopathy	endocrinopathy	NN
cord-023095-4dannjjm	5799	13	of	of	IN
cord-023095-4dannjjm	5799	14	aged	aged	JJ
cord-023095-4dannjjm	5799	15	horses	horse	NNS
cord-023095-4dannjjm	5799	16	that	that	WDT
cord-023095-4dannjjm	5799	17	results	result	VBZ
cord-023095-4dannjjm	5799	18	from	from	IN
cord-023095-4dannjjm	5799	19	neurodegeneration	neurodegeneration	NN
cord-023095-4dannjjm	5799	20	of	of	IN
cord-023095-4dannjjm	5799	21	the	the	DT
cord-023095-4dannjjm	5799	22	dopaminergic	dopaminergic	JJ
cord-023095-4dannjjm	5799	23	periventricular	periventricular	NNP
cord-023095-4dannjjm	5799	24	neurons	neuron	NNS
cord-023095-4dannjjm	5799	25	that	that	WDT
cord-023095-4dannjjm	5799	26	innervate	innervate	VBP
cord-023095-4dannjjm	5799	27	the	the	DT
cord-023095-4dannjjm	5799	28	intermediate	intermediate	JJ
cord-023095-4dannjjm	5799	29	lobe	lobe	NN
cord-023095-4dannjjm	5799	30	of	of	IN
cord-023095-4dannjjm	5799	31	the	the	DT
cord-023095-4dannjjm	5799	32	pituitary	pituitary	NN
cord-023095-4dannjjm	5799	33	.	.	.
cord-023095-4dannjjm	5800	1	Factors	factor	NNS
cord-023095-4dannjjm	5800	2	that	that	WDT
cord-023095-4dannjjm	5800	3	initiate	initiate	VBP
cord-023095-4dannjjm	5800	4	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	5800	5	dopaminergic	dopaminergic	JJ
cord-023095-4dannjjm	5800	6	neurodegenerative	neurodegenerative	JJ
cord-023095-4dannjjm	5800	7	disease	disease	NN
cord-023095-4dannjjm	5800	8	remain	remain	VBP
cord-023095-4dannjjm	5800	9	elusive	elusive	JJ
cord-023095-4dannjjm	5800	10	,	,	,
cord-023095-4dannjjm	5800	11	however	however	RB
cord-023095-4dannjjm	5800	12	accumulation	accumulation	NN
cord-023095-4dannjjm	5800	13	of	of	IN
cord-023095-4dannjjm	5800	14	misfolded	misfolde	VBN
cord-023095-4dannjjm	5800	15	a	a	DT
cord-023095-4dannjjm	5800	16	-	-	HYPH
cord-023095-4dannjjm	5800	17	synuclein	synuclein	NN
cord-023095-4dannjjm	5800	18	protein	protein	NN
cord-023095-4dannjjm	5800	19	and	and	CC
cord-023095-4dannjjm	5800	20	dysfunctional	dysfunctional	JJ
cord-023095-4dannjjm	5800	21	protein	protein	NN
cord-023095-4dannjjm	5800	22	clearance	clearance	NN
cord-023095-4dannjjm	5800	23	have	have	VBP
cord-023095-4dannjjm	5800	24	been	be	VBN
cord-023095-4dannjjm	5800	25	implicated	implicate	VBN
cord-023095-4dannjjm	5800	26	.	.	.
cord-023095-4dannjjm	5801	1	Misfolded	Misfolded	NNP
cord-023095-4dannjjm	5801	2	protein	protein	NN
cord-023095-4dannjjm	5801	3	accumulation	accumulation	NN
cord-023095-4dannjjm	5801	4	occurs	occur	VBZ
cord-023095-4dannjjm	5801	5	due	due	JJ
cord-023095-4dannjjm	5801	6	to	to	IN
cord-023095-4dannjjm	5801	7	increased	increase	VBN
cord-023095-4dannjjm	5801	8	protein	protein	NN
cord-023095-4dannjjm	5801	9	production	production	NN
cord-023095-4dannjjm	5801	10	or	or	CC
cord-023095-4dannjjm	5801	11	decreased	decrease	VBD
cord-023095-4dannjjm	5801	12	clearance	clearance	NN
cord-023095-4dannjjm	5801	13	of	of	IN
cord-023095-4dannjjm	5801	14	damaged	damaged	JJ
cord-023095-4dannjjm	5801	15	macromolecules	macromolecule	NNS
cord-023095-4dannjjm	5801	16	through	through	IN
cord-023095-4dannjjm	5801	17	the	the	DT
cord-023095-4dannjjm	5801	18	process	process	NN
cord-023095-4dannjjm	5801	19	of	of	IN
cord-023095-4dannjjm	5801	20	autophagy	autophagy	NN
cord-023095-4dannjjm	5801	21	.	.	.
cord-023095-4dannjjm	5802	1	While	while	IN
cord-023095-4dannjjm	5802	2	have	have	VBP
cord-023095-4dannjjm	5802	3	previously	previously	RB
cord-023095-4dannjjm	5802	4	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	5802	5	that	that	IN
cord-023095-4dannjjm	5802	6	horses	horse	NNS
cord-023095-4dannjjm	5802	7	with	with	IN
cord-023095-4dannjjm	5802	8	PPID	PPID	NNP
cord-023095-4dannjjm	5802	9	have	have	VBP
cord-023095-4dannjjm	5802	10	increased	increase	VBN
cord-023095-4dannjjm	5802	11	asynuclein	asynuclein	NNP
cord-023095-4dannjjm	5802	12	in	in	IN
cord-023095-4dannjjm	5802	13	the	the	DT
cord-023095-4dannjjm	5802	14	periventricular	periventricular	NNP
cord-023095-4dannjjm	5802	15	neurons	neuron	NNS
cord-023095-4dannjjm	5802	16	compared	compare	VBN
cord-023095-4dannjjm	5802	17	to	to	IN
cord-023095-4dannjjm	5802	18	controls	control	NNS
cord-023095-4dannjjm	5802	19	,	,	,
cord-023095-4dannjjm	5802	20	it	-PRON-	PRP
cord-023095-4dannjjm	5802	21	remains	remain	VBZ
cord-023095-4dannjjm	5802	22	unknown	unknown	JJ
cord-023095-4dannjjm	5802	23	whether	whether	IN
cord-023095-4dannjjm	5802	24	the	the	DT
cord-023095-4dannjjm	5802	25	protein	protein	NN
cord-023095-4dannjjm	5802	26	accumulates	accumulate	VBZ
cord-023095-4dannjjm	5802	27	due	due	IN
cord-023095-4dannjjm	5802	28	to	to	IN
cord-023095-4dannjjm	5802	29	increased	increase	VBN
cord-023095-4dannjjm	5802	30	production	production	NN
cord-023095-4dannjjm	5802	31	or	or	CC
cord-023095-4dannjjm	5802	32	decreased	decrease	VBD
cord-023095-4dannjjm	5802	33	clearance	clearance	NN
cord-023095-4dannjjm	5802	34	.	.	.
cord-023095-4dannjjm	5803	1	We	-PRON-	PRP
cord-023095-4dannjjm	5803	2	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	5803	3	that	that	IN
cord-023095-4dannjjm	5803	4	autophagy	autophagy	NN
cord-023095-4dannjjm	5803	5	is	be	VBZ
cord-023095-4dannjjm	5803	6	decreased	decrease	VBN
cord-023095-4dannjjm	5803	7	in	in	IN
cord-023095-4dannjjm	5803	8	the	the	DT
cord-023095-4dannjjm	5803	9	pituitary	pituitary	JJ
cord-023095-4dannjjm	5803	10	neurointermediate	neurointermediate	NN
cord-023095-4dannjjm	5803	11	lobe	lobe	NN
cord-023095-4dannjjm	5803	12	from	from	IN
cord-023095-4dannjjm	5803	13	horses	horse	NNS
cord-023095-4dannjjm	5803	14	with	with	IN
cord-023095-4dannjjm	5803	15	PPID	PPID	NNP
cord-023095-4dannjjm	5803	16	compared	compare	VBN
cord-023095-4dannjjm	5803	17	to	to	IN
cord-023095-4dannjjm	5803	18	controls	control	NNS
cord-023095-4dannjjm	5803	19	.	.	.
cord-023095-4dannjjm	5804	1	Neurointermediate	Neurointermediate	NNP
cord-023095-4dannjjm	5804	2	lobe	lobe	NN
cord-023095-4dannjjm	5804	3	pituitary	pituitary	JJ
cord-023095-4dannjjm	5804	4	tissue	tissue	NN
cord-023095-4dannjjm	5804	5	was	be	VBD
cord-023095-4dannjjm	5804	6	from	from	IN
cord-023095-4dannjjm	5804	7	collected	collect	VBN
cord-023095-4dannjjm	5804	8	from	from	IN
cord-023095-4dannjjm	5804	9	horses	horse	NNS
cord-023095-4dannjjm	5804	10	with	with	IN
cord-023095-4dannjjm	5804	11	PPID	PPID	NNP
cord-023095-4dannjjm	5804	12	(	(	-LRB-
cord-023095-4dannjjm	5804	13	n	n	NN
cord-023095-4dannjjm	5804	14	5	5	CD
cord-023095-4dannjjm	5804	15	12	12	CD
cord-023095-4dannjjm	5804	16	)	)	-RRB-
cord-023095-4dannjjm	5804	17	and	and	CC
cord-023095-4dannjjm	5804	18	healthy	healthy	JJ
cord-023095-4dannjjm	5804	19	horses	horse	NNS
cord-023095-4dannjjm	5804	20	(	(	-LRB-
cord-023095-4dannjjm	5804	21	n	n	NN
cord-023095-4dannjjm	5804	22	5	5	CD
cord-023095-4dannjjm	5804	23	37	37	CD
cord-023095-4dannjjm	5804	24	,	,	,
cord-023095-4dannjjm	5804	25	2	2	CD
cord-023095-4dannjjm	5804	26	-	-	SYM
cord-023095-4dannjjm	5804	27	35	35	CD
cord-023095-4dannjjm	5804	28	years	year	NNS
cord-023095-4dannjjm	5804	29	)	)	-RRB-
cord-023095-4dannjjm	5804	30	.	.	.
cord-023095-4dannjjm	5805	1	Realtime	Realtime	NNP
cord-023095-4dannjjm	5805	2	PCR	PCR	NNP
cord-023095-4dannjjm	5805	3	was	be	VBD
cord-023095-4dannjjm	5805	4	used	use	VBN
cord-023095-4dannjjm	5805	5	to	to	TO
cord-023095-4dannjjm	5805	6	determine	determine	VB
cord-023095-4dannjjm	5805	7	the	the	DT
cord-023095-4dannjjm	5805	8	relative	relative	JJ
cord-023095-4dannjjm	5805	9	expression	expression	NN
cord-023095-4dannjjm	5805	10	of	of	IN
cord-023095-4dannjjm	5805	11	autophagy	autophagy	NN
cord-023095-4dannjjm	5805	12	genes	gene	NNS
cord-023095-4dannjjm	5805	13	(	(	-LRB-
cord-023095-4dannjjm	5805	14	mTOR	mTOR	NNP
cord-023095-4dannjjm	5805	15	,	,	,
cord-023095-4dannjjm	5805	16	Beclin1	Beclin1	NNP
cord-023095-4dannjjm	5805	17	,	,	,
cord-023095-4dannjjm	5805	18	ATG12	ATG12	NNP
cord-023095-4dannjjm	5805	19	,	,	,
cord-023095-4dannjjm	5805	20	ATG7	ATG7	NNP
cord-023095-4dannjjm	5805	21	,	,	,
cord-023095-4dannjjm	5805	22	ATG5	ATG5	NNP
cord-023095-4dannjjm	5805	23	,	,	,
cord-023095-4dannjjm	5805	24	PINK	PINK	NNP
cord-023095-4dannjjm	5805	25	,	,	,
cord-023095-4dannjjm	5805	26	LAMP2	lamp2	NN
cord-023095-4dannjjm	5805	27	)	)	-RRB-
cord-023095-4dannjjm	5805	28	and	and	CC
cord-023095-4dannjjm	5805	29	a	a	DT
cord-023095-4dannjjm	5805	30	-	-	HYPH
cord-023095-4dannjjm	5805	31	synuclein	synuclein	NN
cord-023095-4dannjjm	5805	32	Relative	relative	JJ
cord-023095-4dannjjm	5805	33	gene	gene	NN
cord-023095-4dannjjm	5805	34	expression	expression	NN
cord-023095-4dannjjm	5805	35	from	from	IN
cord-023095-4dannjjm	5805	36	horses	horse	NNS
cord-023095-4dannjjm	5805	37	with	with	IN
cord-023095-4dannjjm	5805	38	PPID	PPID	NNP
cord-023095-4dannjjm	5805	39	were	be	VBD
cord-023095-4dannjjm	5805	40	compared	compare	VBN
cord-023095-4dannjjm	5805	41	to	to	IN
cord-023095-4dannjjm	5805	42	healthy	healthy	JJ
cord-023095-4dannjjm	5805	43	horses	horse	NNS
cord-023095-4dannjjm	5805	44	by	by	IN
cord-023095-4dannjjm	5805	45	t	t	NN
cord-023095-4dannjjm	5805	46	-	-	HYPH
cord-023095-4dannjjm	5805	47	test	test	NN
cord-023095-4dannjjm	5805	48	following	follow	VBG
cord-023095-4dannjjm	5805	49	log	log	NN
cord-023095-4dannjjm	5805	50	transformation	transformation	NN
cord-023095-4dannjjm	5805	51	.	.	.
cord-023095-4dannjjm	5806	1	A	a	DT
cord-023095-4dannjjm	5806	2	Pearson	Pearson	NNP
cord-023095-4dannjjm	5806	3	coefficient	coefficient	NN
cord-023095-4dannjjm	5806	4	of	of	IN
cord-023095-4dannjjm	5806	5	correlation	correlation	NN
cord-023095-4dannjjm	5806	6	was	be	VBD
cord-023095-4dannjjm	5806	7	calculated	calculate	VBN
cord-023095-4dannjjm	5806	8	comparing	compare	VBG
cord-023095-4dannjjm	5806	9	a	a	DT
cord-023095-4dannjjm	5806	10	-	-	HYPH
cord-023095-4dannjjm	5806	11	synuclein	synuclein	NN
cord-023095-4dannjjm	5806	12	expression	expression	NN
cord-023095-4dannjjm	5806	13	with	with	IN
cord-023095-4dannjjm	5806	14	autophagy	autophagy	NN
cord-023095-4dannjjm	5806	15	gene	gene	NN
cord-023095-4dannjjm	5806	16	expression	expression	NN
cord-023095-4dannjjm	5806	17	.	.	.
cord-023095-4dannjjm	5807	1	The	the	DT
cord-023095-4dannjjm	5807	2	expression	expression	NN
cord-023095-4dannjjm	5807	3	of	of	IN
cord-023095-4dannjjm	5807	4	a	a	DT
cord-023095-4dannjjm	5807	5	-	-	HYPH
cord-023095-4dannjjm	5807	6	synuclein	synuclein	NN
cord-023095-4dannjjm	5807	7	,	,	,
cord-023095-4dannjjm	5807	8	autophagy	autophagy	NN
cord-023095-4dannjjm	5807	9	-	-	HYPH
cord-023095-4dannjjm	5807	10	related	relate	VBN
cord-023095-4dannjjm	5807	11	genes	gene	NNS
cord-023095-4dannjjm	5807	12	(	(	-LRB-
cord-023095-4dannjjm	5807	13	ATG12	ATG12	NNP
cord-023095-4dannjjm	5807	14	,	,	,
cord-023095-4dannjjm	5807	15	Beclin	Beclin	NNP
cord-023095-4dannjjm	5807	16	,	,	,
cord-023095-4dannjjm	5807	17	Lamp2	Lamp2	NNP
cord-023095-4dannjjm	5807	18	)	)	-RRB-
cord-023095-4dannjjm	5807	19	,	,	,
cord-023095-4dannjjm	5807	20	and	and	CC
cord-023095-4dannjjm	5807	21	mTOR	mTOR	NNP
cord-023095-4dannjjm	5807	22	was	be	VBD
cord-023095-4dannjjm	5807	23	greater	great	JJR
cord-023095-4dannjjm	5807	24	in	in	IN
cord-023095-4dannjjm	5807	25	horses	horse	NNS
cord-023095-4dannjjm	5807	26	with	with	IN
cord-023095-4dannjjm	5807	27	PPID	PPID	NNP
cord-023095-4dannjjm	5807	28	than	than	IN
cord-023095-4dannjjm	5807	29	in	in	IN
cord-023095-4dannjjm	5807	30	healthy	healthy	JJ
cord-023095-4dannjjm	5807	31	horses	horse	NNS
cord-023095-4dannjjm	5807	32	.	.	.
cord-023095-4dannjjm	5808	1	Age	age	NN
cord-023095-4dannjjm	5808	2	was	be	VBD
cord-023095-4dannjjm	5808	3	not	not	RB
cord-023095-4dannjjm	5808	4	correlated	correlate	VBN
cord-023095-4dannjjm	5808	5	to	to	IN
cord-023095-4dannjjm	5808	6	a	a	DT
cord-023095-4dannjjm	5808	7	-	-	HYPH
cord-023095-4dannjjm	5808	8	synuclein	synuclein	NN
cord-023095-4dannjjm	5808	9	or	or	CC
cord-023095-4dannjjm	5808	10	autophagy	autophagy	NN
cord-023095-4dannjjm	5808	11	gene	gene	NN
cord-023095-4dannjjm	5808	12	expression	expression	NN
cord-023095-4dannjjm	5808	13	.	.	.
cord-023095-4dannjjm	5809	1	There	there	EX
cord-023095-4dannjjm	5809	2	was	be	VBD
cord-023095-4dannjjm	5809	3	a	a	DT
cord-023095-4dannjjm	5809	4	significant	significant	JJ
cord-023095-4dannjjm	5809	5	positive	positive	JJ
cord-023095-4dannjjm	5809	6	correlation	correlation	NN
cord-023095-4dannjjm	5809	7	between	between	IN
cord-023095-4dannjjm	5809	8	expression	expression	NN
cord-023095-4dannjjm	5809	9	of	of	IN
cord-023095-4dannjjm	5809	10	a	a	DT
cord-023095-4dannjjm	5809	11	-	-	HYPH
cord-023095-4dannjjm	5809	12	synuclein	synuclein	NN
cord-023095-4dannjjm	5809	13	and	and	CC
cord-023095-4dannjjm	5809	14	Beclin1	Beclin1	NNP
cord-023095-4dannjjm	5809	15	,	,	,
cord-023095-4dannjjm	5809	16	ATG12	ATG12	NNP
cord-023095-4dannjjm	5809	17	,	,	,
cord-023095-4dannjjm	5809	18	ATG7	ATG7	NNP
cord-023095-4dannjjm	5809	19	,	,	,
cord-023095-4dannjjm	5809	20	ATG5	ATG5	NNP
cord-023095-4dannjjm	5809	21	,	,	,
cord-023095-4dannjjm	5809	22	and	and	CC
cord-023095-4dannjjm	5809	23	PINK	PINK	NNP
cord-023095-4dannjjm	5809	24	,	,	,
cord-023095-4dannjjm	5809	25	but	but	CC
cord-023095-4dannjjm	5809	26	not	not	RB
cord-023095-4dannjjm	5809	27	mTOR	mTOR	NNP
cord-023095-4dannjjm	5809	28	expression	expression	NN
cord-023095-4dannjjm	5809	29	.	.	.
cord-023095-4dannjjm	5810	1	Accumulation	accumulation	NN
cord-023095-4dannjjm	5810	2	of	of	IN
cord-023095-4dannjjm	5810	3	a	a	DT
cord-023095-4dannjjm	5810	4	-	-	HYPH
cord-023095-4dannjjm	5810	5	synuclein	synuclein	NN
cord-023095-4dannjjm	5810	6	protein	protein	NN
cord-023095-4dannjjm	5810	7	in	in	IN
cord-023095-4dannjjm	5810	8	horses	horse	NNS
cord-023095-4dannjjm	5810	9	with	with	IN
cord-023095-4dannjjm	5810	10	PPID	PPID	NNP
cord-023095-4dannjjm	5810	11	may	may	MD
cord-023095-4dannjjm	5810	12	result	result	VB
cord-023095-4dannjjm	5810	13	from	from	IN
cord-023095-4dannjjm	5810	14	increased	increase	VBN
cord-023095-4dannjjm	5810	15	a	a	DT
cord-023095-4dannjjm	5810	16	-	-	HYPH
cord-023095-4dannjjm	5810	17	synuclein	synuclein	NN
cord-023095-4dannjjm	5810	18	expression	expression	NN
cord-023095-4dannjjm	5810	19	.	.	.
cord-023095-4dannjjm	5811	1	Autophagy	Autophagy	NNP
cord-023095-4dannjjm	5811	2	genes	gene	NNS
cord-023095-4dannjjm	5811	3	are	be	VBP
cord-023095-4dannjjm	5811	4	upregulated	upregulate	VBN
cord-023095-4dannjjm	5811	5	in	in	IN
cord-023095-4dannjjm	5811	6	horses	horse	NNS
cord-023095-4dannjjm	5811	7	with	with	IN
cord-023095-4dannjjm	5811	8	PPID	PPID	NNP
cord-023095-4dannjjm	5811	9	,	,	,
cord-023095-4dannjjm	5811	10	suggesting	suggest	VBG
cord-023095-4dannjjm	5811	11	a	a	DT
cord-023095-4dannjjm	5811	12	compensatory	compensatory	JJ
cord-023095-4dannjjm	5811	13	response	response	NN
cord-023095-4dannjjm	5811	14	,	,	,
cord-023095-4dannjjm	5811	15	although	although	IN
cord-023095-4dannjjm	5811	16	these	these	DT
cord-023095-4dannjjm	5811	17	findings	finding	NNS
cord-023095-4dannjjm	5811	18	need	need	VBP
cord-023095-4dannjjm	5811	19	to	to	TO
cord-023095-4dannjjm	5811	20	be	be	VB
cord-023095-4dannjjm	5811	21	confirmed	confirm	VBN
cord-023095-4dannjjm	5811	22	by	by	IN
cord-023095-4dannjjm	5811	23	demonstrating	demonstrate	VBG
cord-023095-4dannjjm	5811	24	an	an	DT
cord-023095-4dannjjm	5811	25	increased	increase	VBN
cord-023095-4dannjjm	5811	26	functional	functional	JJ
cord-023095-4dannjjm	5811	27	response	response	NN
cord-023095-4dannjjm	5811	28	.	.	.
cord-023095-4dannjjm	5812	1	asynuclein	asynuclein	NNP
cord-023095-4dannjjm	5812	2	expression	expression	NN
cord-023095-4dannjjm	5812	3	was	be	VBD
cord-023095-4dannjjm	5812	4	positively	positively	RB
cord-023095-4dannjjm	5812	5	correlated	correlate	VBN
cord-023095-4dannjjm	5812	6	to	to	IN
cord-023095-4dannjjm	5812	7	expression	expression	NN
cord-023095-4dannjjm	5812	8	of	of	IN
cord-023095-4dannjjm	5812	9	autophagy	autophagy	NN
cord-023095-4dannjjm	5812	10	genes	gene	NNS
cord-023095-4dannjjm	5812	11	except	except	IN
cord-023095-4dannjjm	5812	12	mTOR	mTOR	NNP
cord-023095-4dannjjm	5812	13	,	,	,
cord-023095-4dannjjm	5812	14	suggesting	suggest	VBG
cord-023095-4dannjjm	5812	15	a	a	DT
cord-023095-4dannjjm	5812	16	-	-	HYPH
cord-023095-4dannjjm	5812	17	synuclein	synuclein	NN
cord-023095-4dannjjm	5812	18	may	may	MD
cord-023095-4dannjjm	5812	19	stimulate	stimulate	VB
cord-023095-4dannjjm	5812	20	autophagy	autophagy	NN
cord-023095-4dannjjm	5812	21	in	in	IN
cord-023095-4dannjjm	5812	22	an	an	DT
cord-023095-4dannjjm	5812	23	mTOR	mTOR	NNP
cord-023095-4dannjjm	5812	24	independent	independent	JJ
cord-023095-4dannjjm	5812	25	manner	manner	NN
cord-023095-4dannjjm	5812	26	.	.	.
cord-023095-4dannjjm	5813	1	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	5813	2	FORUM	forum	NN
cord-023095-4dannjjm	5813	3	SESSION	session	NN
cord-023095-4dannjjm	5814	1	86A	86A	NNS
cord-023095-4dannjjm	5814	2	EFFICACY	efficacy	NN
cord-023095-4dannjjm	5814	3	OF	of	IN
cord-023095-4dannjjm	5814	4	DELAYED	delay	VBN
cord-023095-4dannjjm	5814	5	ANTIVIRAL	antiviral	JJ
cord-023095-4dannjjm	5814	6	THERAPY	therapy	NN
cord-023095-4dannjjm	5814	7	AGAINST	against	IN
cord-023095-4dannjjm	5814	8	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	5814	9	CHALLENGE	CHALLENGE	NNS
cord-023095-4dannjjm	5814	10	.	.	.
cord-023095-4dannjjm	5815	1	LK	LK	NNP
cord-023095-4dannjjm	5815	2	Maxwell	Maxwell	NNP
cord-023095-4dannjjm	5815	3	1	1	CD
cord-023095-4dannjjm	5815	4	,	,	,
cord-023095-4dannjjm	5815	5	LL	LL	NNP
cord-023095-4dannjjm	5815	6	Gilliam	Gilliam	NNP
cord-023095-4dannjjm	5815	7	1	1	CD
cord-023095-4dannjjm	5815	8	,	,	,
cord-023095-4dannjjm	5815	9	N	N	NNP
cord-023095-4dannjjm	5815	10	Pusterla	Pusterla	NNP
cord-023095-4dannjjm	5815	11	2	2	CD
cord-023095-4dannjjm	5815	12	,	,	,
cord-023095-4dannjjm	5815	13	R	R	NNP
cord-023095-4dannjjm	5815	14	Carmichael	Carmichael	NNP
cord-023095-4dannjjm	5815	15	1	1	CD
cord-023095-4dannjjm	5815	16	,	,	,
cord-023095-4dannjjm	5815	17	RW	RW	NNP
cord-023095-4dannjjm	5815	18	Eberle	Eberle	NNP
cord-023095-4dannjjm	5815	19	1	1	CD
cord-023095-4dannjjm	5815	20	,	,	,
cord-023095-4dannjjm	5815	21	JW	JW	NNP
cord-023095-4dannjjm	5815	22	Ritchey	Ritchey	NNP
cord-023095-4dannjjm	5815	23	1	1	CD
cord-023095-4dannjjm	5815	24	,	,	,
cord-023095-4dannjjm	5815	25	TC	TC	NNP
cord-023095-4dannjjm	5815	26	Holbrook	Holbrook	NNP
cord-023095-4dannjjm	5815	27	1	1	CD
cord-023095-4dannjjm	5815	28	,	,	,
cord-023095-4dannjjm	5815	29	T	T	NNP
cord-023095-4dannjjm	5815	30	Gull	Gull	NNP
cord-023095-4dannjjm	5815	31	1	1	CD
cord-023095-4dannjjm	5815	32	,	,	,
cord-023095-4dannjjm	5815	33	GB	GB	NNP
cord-023095-4dannjjm	5815	34	Rezabek	Rezabek	NNP
cord-023095-4dannjjm	5815	35	1	1	CD
cord-023095-4dannjjm	5815	36	,	,	,
cord-023095-4dannjjm	5815	37	D	D	NNP
cord-023095-4dannjjm	5815	38	McFarlane	McFarlane	NNP
cord-023095-4dannjjm	5815	39	1	1	CD
cord-023095-4dannjjm	5815	40	,	,	,
cord-023095-4dannjjm	5815	41	CG	CG	NNP
cord-023095-4dannjjm	5815	42	MacAllister	MacAllister	NNP
cord-023095-4dannjjm	5815	43	1	1	CD
cord-023095-4dannjjm	5815	44	.	.	.
cord-023095-4dannjjm	5816	1	1	1	CD
cord-023095-4dannjjm	5816	2	Oklahoma	Oklahoma	NNP
cord-023095-4dannjjm	5816	3	State	State	NNP
cord-023095-4dannjjm	5816	4	University	University	NNP
cord-023095-4dannjjm	5816	5	,	,	,
cord-023095-4dannjjm	5816	6	Stillwater	Stillwater	NNP
cord-023095-4dannjjm	5816	7	,	,	,
cord-023095-4dannjjm	5816	8	OK	ok	UH
cord-023095-4dannjjm	5816	9	.	.	.
cord-023095-4dannjjm	5817	1	2	2	CD
cord-023095-4dannjjm	5817	2	University	University	NNP
cord-023095-4dannjjm	5817	3	of	of	IN
cord-023095-4dannjjm	5817	4	California	California	NNP
cord-023095-4dannjjm	5817	5	,	,	,
cord-023095-4dannjjm	5817	6	Davis	Davis	NNP
cord-023095-4dannjjm	5817	7	,	,	,
cord-023095-4dannjjm	5817	8	CA	CA	NNP
cord-023095-4dannjjm	5817	9	.	.	.
cord-023095-4dannjjm	5818	1	Equine	equine	JJ
cord-023095-4dannjjm	5818	2	herpes	herpe	NNS
cord-023095-4dannjjm	5818	3	virus	virus	NN
cord-023095-4dannjjm	5818	4	type-1	type-1	NN
cord-023095-4dannjjm	5818	5	(	(	-LRB-
cord-023095-4dannjjm	5818	6	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	5818	7	)	)	-RRB-
cord-023095-4dannjjm	5818	8	outbreaks	outbreak	NNS
cord-023095-4dannjjm	5818	9	are	be	VBP
cord-023095-4dannjjm	5818	10	often	often	RB
cord-023095-4dannjjm	5818	11	not	not	RB
cord-023095-4dannjjm	5818	12	recognized	recognize	VBN
cord-023095-4dannjjm	5818	13	until	until	IN
cord-023095-4dannjjm	5818	14	exposed	expose	VBN
cord-023095-4dannjjm	5818	15	horses	horse	NNS
cord-023095-4dannjjm	5818	16	are	be	VBP
cord-023095-4dannjjm	5818	17	at	at	IN
cord-023095-4dannjjm	5818	18	immediate	immediate	JJ
cord-023095-4dannjjm	5818	19	risk	risk	NN
cord-023095-4dannjjm	5818	20	for	for	IN
cord-023095-4dannjjm	5818	21	developing	develop	VBG
cord-023095-4dannjjm	5818	22	equine	equine	JJ
cord-023095-4dannjjm	5818	23	herpes	herpes	NN
cord-023095-4dannjjm	5818	24	myeloencephalopathy	myeloencephalopathy	NNP
cord-023095-4dannjjm	5818	25	(	(	-LRB-
cord-023095-4dannjjm	5818	26	EHM	ehm	UH
cord-023095-4dannjjm	5818	27	)	)	-RRB-
cord-023095-4dannjjm	5818	28	.	.	.
cord-023095-4dannjjm	5819	1	The	the	DT
cord-023095-4dannjjm	5819	2	objective	objective	NN
cord-023095-4dannjjm	5819	3	of	of	IN
cord-023095-4dannjjm	5819	4	this	this	DT
cord-023095-4dannjjm	5819	5	study	study	NN
cord-023095-4dannjjm	5819	6	was	be	VBD
cord-023095-4dannjjm	5819	7	to	to	TO
cord-023095-4dannjjm	5819	8	determine	determine	VB
cord-023095-4dannjjm	5819	9	whether	whether	IN
cord-023095-4dannjjm	5819	10	delayed	delay	VBN
cord-023095-4dannjjm	5819	11	therapy	therapy	NN
cord-023095-4dannjjm	5819	12	with	with	IN
cord-023095-4dannjjm	5819	13	the	the	DT
cord-023095-4dannjjm	5819	14	antiviral	antiviral	JJ
cord-023095-4dannjjm	5819	15	drugs	drug	NNS
cord-023095-4dannjjm	5819	16	valacyclovir	valacyclovir	NNP
cord-023095-4dannjjm	5819	17	or	or	CC
cord-023095-4dannjjm	5819	18	ganciclovir	ganciclovir	NNP
cord-023095-4dannjjm	5819	19	could	could	MD
cord-023095-4dannjjm	5819	20	protect	protect	VB
cord-023095-4dannjjm	5819	21	those	those	DT
cord-023095-4dannjjm	5819	22	horses	horse	NNS
cord-023095-4dannjjm	5819	23	most	most	RBS
cord-023095-4dannjjm	5819	24	at	at	IN
cord-023095-4dannjjm	5819	25	risk	risk	NN
cord-023095-4dannjjm	5819	26	for	for	IN
cord-023095-4dannjjm	5819	27	EHM	EHM	NNP
cord-023095-4dannjjm	5819	28	.	.	.
cord-023095-4dannjjm	5820	1	Eighteen	eighteen	CD
cord-023095-4dannjjm	5820	2	aged	aged	JJ
cord-023095-4dannjjm	5820	3	(	(	-LRB-
cord-023095-4dannjjm	5820	4	4	4	CD
cord-023095-4dannjjm	5820	5	20	20	CD
cord-023095-4dannjjm	5820	6	years	year	NNS
cord-023095-4dannjjm	5820	7	)	)	-RRB-
cord-023095-4dannjjm	5820	8	mares	mare	NNS
cord-023095-4dannjjm	5820	9	were	be	VBD
cord-023095-4dannjjm	5820	10	randomized	randomize	VBN
cord-023095-4dannjjm	5820	11	to	to	IN
cord-023095-4dannjjm	5820	12	treatment	treatment	NN
cord-023095-4dannjjm	5820	13	:	:	:
cord-023095-4dannjjm	5820	14	no	no	DT
cord-023095-4dannjjm	5820	15	therapy	therapy	NN
cord-023095-4dannjjm	5820	16	(	(	-LRB-
cord-023095-4dannjjm	5820	17	control	control	NN
cord-023095-4dannjjm	5820	18	)	)	-RRB-
cord-023095-4dannjjm	5820	19	,	,	,
cord-023095-4dannjjm	5820	20	oral	oral	JJ
cord-023095-4dannjjm	5820	21	valacyclovir	valacyclovir	NNP
cord-023095-4dannjjm	5820	22	therapy	therapy	NN
cord-023095-4dannjjm	5820	23	,	,	,
cord-023095-4dannjjm	5820	24	or	or	CC
cord-023095-4dannjjm	5820	25	intravenous	intravenous	JJ
cord-023095-4dannjjm	5820	26	ganciclovir	ganciclovir	NN
cord-023095-4dannjjm	5820	27	therapy	therapy	NN
cord-023095-4dannjjm	5820	28	.	.	.
cord-023095-4dannjjm	5821	1	Drug	Drug	NNP
cord-023095-4dannjjm	5821	2	administration	administration	NN
cord-023095-4dannjjm	5821	3	was	be	VBD
cord-023095-4dannjjm	5821	4	initiated	initiate	VBN
cord-023095-4dannjjm	5821	5	at	at	IN
cord-023095-4dannjjm	5821	6	the	the	DT
cord-023095-4dannjjm	5821	7	onset	onset	NN
cord-023095-4dannjjm	5821	8	of	of	IN
cord-023095-4dannjjm	5821	9	the	the	DT
cord-023095-4dannjjm	5821	10	second	second	JJ
cord-023095-4dannjjm	5821	11	febrile	febrile	JJ
cord-023095-4dannjjm	5821	12	phase	phase	NN
cord-023095-4dannjjm	5821	13	,	,	,
cord-023095-4dannjjm	5821	14	between	between	IN
cord-023095-4dannjjm	5821	15	days	day	NNS
cord-023095-4dannjjm	5821	16	4	4	CD
cord-023095-4dannjjm	5821	17	-	-	SYM
cord-023095-4dannjjm	5821	18	6	6	CD
cord-023095-4dannjjm	5821	19	after	after	IN
cord-023095-4dannjjm	5821	20	EHV-1	EHV-1	NNP
cord-023095-4dannjjm	5821	21	inoculation	inoculation	NN
cord-023095-4dannjjm	5821	22	(	(	-LRB-
cord-023095-4dannjjm	5821	23	PI	PI	NNP
cord-023095-4dannjjm	5821	24	)	)	-RRB-
cord-023095-4dannjjm	5821	25	,	,	,
cord-023095-4dannjjm	5821	26	and	and	CC
cord-023095-4dannjjm	5821	27	continued	continue	VBD
cord-023095-4dannjjm	5821	28	for	for	IN
cord-023095-4dannjjm	5821	29	one	one	CD
cord-023095-4dannjjm	5821	30	week	week	NN
cord-023095-4dannjjm	5821	31	.	.	.
cord-023095-4dannjjm	5822	1	Neurological	neurological	JJ
cord-023095-4dannjjm	5822	2	examinations	examination	NNS
cord-023095-4dannjjm	5822	3	were	be	VBD
cord-023095-4dannjjm	5822	4	performed	perform	VBN
cord-023095-4dannjjm	5822	5	prior	prior	RB
cord-023095-4dannjjm	5822	6	to	to	IN
cord-023095-4dannjjm	5822	7	the	the	DT
cord-023095-4dannjjm	5822	8	study	study	NN
cord-023095-4dannjjm	5822	9	and	and	CC
cord-023095-4dannjjm	5822	10	for	for	IN
cord-023095-4dannjjm	5822	11	three	three	CD
cord-023095-4dannjjm	5822	12	weeks	week	NNS
cord-023095-4dannjjm	5822	13	PI	pi	NN
cord-023095-4dannjjm	5822	14	.	.	.
cord-023095-4dannjjm	5823	1	One	one	CD
cord-023095-4dannjjm	5823	2	horse	horse	NN
cord-023095-4dannjjm	5823	3	was	be	VBD
cord-023095-4dannjjm	5823	4	excluded	exclude	VBN
cord-023095-4dannjjm	5823	5	from	from	IN
cord-023095-4dannjjm	5823	6	the	the	DT
cord-023095-4dannjjm	5823	7	study	study	NN
cord-023095-4dannjjm	5823	8	for	for	IN
cord-023095-4dannjjm	5823	9	failure	failure	NN
cord-023095-4dannjjm	5823	10	to	to	TO
cord-023095-4dannjjm	5823	11	become	become	VB
cord-023095-4dannjjm	5823	12	febrile	febrile	JJ
cord-023095-4dannjjm	5823	13	.	.	.
cord-023095-4dannjjm	5824	1	Body	body	NN
cord-023095-4dannjjm	5824	2	temperature	temperature	NN
cord-023095-4dannjjm	5824	3	was	be	VBD
cord-023095-4dannjjm	5824	4	significantly	significantly	RB
cord-023095-4dannjjm	5824	5	lower	low	JJR
cord-023095-4dannjjm	5824	6	in	in	IN
cord-023095-4dannjjm	5824	7	the	the	DT
cord-023095-4dannjjm	5824	8	ganciclovirtherapy	ganciclovirtherapy	NN
cord-023095-4dannjjm	5824	9	horses	horse	NNS
cord-023095-4dannjjm	5824	10	as	as	IN
cord-023095-4dannjjm	5824	11	compared	compare	VBN
cord-023095-4dannjjm	5824	12	to	to	TO
cord-023095-4dannjjm	5824	13	control	control	VB
cord-023095-4dannjjm	5824	14	horses	horse	NNS
cord-023095-4dannjjm	5824	15	on	on	IN
cord-023095-4dannjjm	5824	16	days	day	NNS
cord-023095-4dannjjm	5824	17	6	6	CD
cord-023095-4dannjjm	5824	18	-	-	SYM
cord-023095-4dannjjm	5824	19	8	8	CD
cord-023095-4dannjjm	5824	20	PI	pi	NN
cord-023095-4dannjjm	5824	21	(	(	-LRB-
cord-023095-4dannjjm	5824	22	P	p	NN
cord-023095-4dannjjm	5824	23	o	o	NN
cord-023095-4dannjjm	5824	24	0.05	0.05	CD
cord-023095-4dannjjm	5824	25	)	)	-RRB-
cord-023095-4dannjjm	5824	26	,	,	,
cord-023095-4dannjjm	5824	27	whereas	whereas	IN
cord-023095-4dannjjm	5824	28	valacyclovir	valacyclovir	NNP
cord-023095-4dannjjm	5824	29	-	-	HYPH
cord-023095-4dannjjm	5824	30	therapy	therapy	NN
cord-023095-4dannjjm	5824	31	horses	horse	NNS
cord-023095-4dannjjm	5824	32	did	do	VBD
cord-023095-4dannjjm	5824	33	not	not	RB
cord-023095-4dannjjm	5824	34	differ	differ	VB
cord-023095-4dannjjm	5824	35	from	from	IN
cord-023095-4dannjjm	5824	36	control	control	NN
cord-023095-4dannjjm	5824	37	horses	horse	NNS
cord-023095-4dannjjm	5824	38	.	.	.
cord-023095-4dannjjm	5825	1	Viremia	Viremia	NNP
cord-023095-4dannjjm	5825	2	in	in	IN
cord-023095-4dannjjm	5825	3	whole	whole	JJ
cord-023095-4dannjjm	5825	4	blood	blood	NN
cord-023095-4dannjjm	5825	5	,	,	,
cord-023095-4dannjjm	5825	6	as	as	IN
cord-023095-4dannjjm	5825	7	determined	determine	VBN
cord-023095-4dannjjm	5825	8	by	by	IN
cord-023095-4dannjjm	5825	9	PCR	PCR	NNP
cord-023095-4dannjjm	5825	10	,	,	,
cord-023095-4dannjjm	5825	11	was	be	VBD
cord-023095-4dannjjm	5825	12	also	also	RB
cord-023095-4dannjjm	5825	13	lower	low	JJR
cord-023095-4dannjjm	5825	14	in	in	IN
cord-023095-4dannjjm	5825	15	the	the	DT
cord-023095-4dannjjm	5825	16	ganciclovir	ganciclovir	NN
cord-023095-4dannjjm	5825	17	-	-	HYPH
cord-023095-4dannjjm	5825	18	therapy	therapy	NN
cord-023095-4dannjjm	5825	19	horses	horse	NNS
cord-023095-4dannjjm	5825	20	on	on	IN
cord-023095-4dannjjm	5825	21	days	day	NNS
cord-023095-4dannjjm	5825	22	7	7	CD
cord-023095-4dannjjm	5825	23	-	-	SYM
cord-023095-4dannjjm	5825	24	10	10	CD
cord-023095-4dannjjm	5825	25	PI	pi	NN
cord-023095-4dannjjm	5825	26	and	and	CC
cord-023095-4dannjjm	5825	27	on	on	IN
cord-023095-4dannjjm	5825	28	day	day	NN
cord-023095-4dannjjm	5825	29	7	7	CD
cord-023095-4dannjjm	5825	30	PI	pi	NN
cord-023095-4dannjjm	5825	31	in	in	IN
cord-023095-4dannjjm	5825	32	the	the	DT
cord-023095-4dannjjm	5825	33	valacyclovir	valacyclovir	NNP
cord-023095-4dannjjm	5825	34	-	-	HYPH
cord-023095-4dannjjm	5825	35	therapy	therapy	NN
cord-023095-4dannjjm	5825	36	horses	horse	NNS
cord-023095-4dannjjm	5826	1	(	(	-LRB-
cord-023095-4dannjjm	5826	2	P	p	NN
cord-023095-4dannjjm	5826	3	o	o	NN
cord-023095-4dannjjm	5826	4	0.05	0.05	CD
cord-023095-4dannjjm	5826	5	)	)	-RRB-
cord-023095-4dannjjm	5826	6	.	.	.
cord-023095-4dannjjm	5827	1	Although	although	IN
cord-023095-4dannjjm	5827	2	antiviral	antiviral	JJ
cord-023095-4dannjjm	5827	3	drug	drug	NN
cord-023095-4dannjjm	5827	4	administration	administration	NNP
cord-023095-4dannjjm	5827	5	did	do	VBD
cord-023095-4dannjjm	5827	6	not	not	RB
cord-023095-4dannjjm	5827	7	reduce	reduce	VB
cord-023095-4dannjjm	5827	8	the	the	DT
cord-023095-4dannjjm	5827	9	risk	risk	NN
cord-023095-4dannjjm	5827	10	of	of	IN
cord-023095-4dannjjm	5827	11	ataxia	ataxia	NN
cord-023095-4dannjjm	5827	12	(	(	-LRB-
cord-023095-4dannjjm	5827	13	P	p	NN
cord-023095-4dannjjm	5827	14	5	5	CD
cord-023095-4dannjjm	5827	15	0.06	0.06	CD
cord-023095-4dannjjm	5827	16	)	)	-RRB-
cord-023095-4dannjjm	5827	17	or	or	CC
cord-023095-4dannjjm	5827	18	nasal	nasal	NN
cord-023095-4dannjjm	5827	19	shedding	shedding	NN
cord-023095-4dannjjm	5827	20	,	,	,
cord-023095-4dannjjm	5827	21	ganciclovir	ganciclovir	NNP
cord-023095-4dannjjm	5827	22	therapy	therapy	NN
cord-023095-4dannjjm	5827	23	did	do	VBD
cord-023095-4dannjjm	5827	24	decrease	decrease	VB
cord-023095-4dannjjm	5827	25	the	the	DT
cord-023095-4dannjjm	5827	26	severity	severity	NN
cord-023095-4dannjjm	5827	27	of	of	IN
cord-023095-4dannjjm	5827	28	ataxia	ataxia	NN
cord-023095-4dannjjm	5827	29	(	(	-LRB-
cord-023095-4dannjjm	5827	30	P	p	NN
cord-023095-4dannjjm	5827	31	o	o	NN
cord-023095-4dannjjm	5827	32	0.05	0.05	CD
cord-023095-4dannjjm	5827	33	)	)	-RRB-
cord-023095-4dannjjm	5827	34	as	as	IN
cord-023095-4dannjjm	5827	35	compared	compare	VBN
cord-023095-4dannjjm	5827	36	to	to	IN
cord-023095-4dannjjm	5827	37	valacyclovir	valacyclovir	NNP
cord-023095-4dannjjm	5827	38	-	-	HYPH
cord-023095-4dannjjm	5827	39	therapy	therapy	NN
cord-023095-4dannjjm	5827	40	and	and	CC
cord-023095-4dannjjm	5827	41	control	control	NN
cord-023095-4dannjjm	5827	42	horses	horse	NNS
cord-023095-4dannjjm	5827	43	,	,	,
cord-023095-4dannjjm	5827	44	where	where	WRB
cord-023095-4dannjjm	5827	45	0/6	0/6	CD
cord-023095-4dannjjm	5827	46	,	,	,
cord-023095-4dannjjm	5827	47	2/5	2/5	CD
cord-023095-4dannjjm	5827	48	,	,	,
cord-023095-4dannjjm	5827	49	and	and	CC
cord-023095-4dannjjm	5827	50	4/6	4/6	CD
cord-023095-4dannjjm	5827	51	horses	horse	NNS
cord-023095-4dannjjm	5827	52	,	,	,
cord-023095-4dannjjm	5827	53	respectively	respectively	RB
cord-023095-4dannjjm	5827	54	,	,	,
cord-023095-4dannjjm	5827	55	developed	develop	VBN
cord-023095-4dannjjm	5827	56	at	at	IN
cord-023095-4dannjjm	5827	57	least	least	JJS
cord-023095-4dannjjm	5827	58	a	a	DT
cord-023095-4dannjjm	5827	59	two	two	CD
cord-023095-4dannjjm	5827	60	grade	grade	NN
cord-023095-4dannjjm	5827	61	change	change	NN
cord-023095-4dannjjm	5827	62	in	in	IN
cord-023095-4dannjjm	5827	63	ataxia	ataxia	NN
cord-023095-4dannjjm	5827	64	.	.	.
cord-023095-4dannjjm	5828	1	In	in	IN
cord-023095-4dannjjm	5828	2	summary	summary	NN
cord-023095-4dannjjm	5828	3	,	,	,
cord-023095-4dannjjm	5828	4	ganciclovir	ganciclovir	NNP
cord-023095-4dannjjm	5828	5	administration	administration	NN
cord-023095-4dannjjm	5828	6	provided	provide	VBD
cord-023095-4dannjjm	5828	7	better	well	JJR
cord-023095-4dannjjm	5828	8	protection	protection	NN
cord-023095-4dannjjm	5828	9	against	against	IN
cord-023095-4dannjjm	5828	10	EHM	EHM	NNP
cord-023095-4dannjjm	5828	11	than	than	IN
cord-023095-4dannjjm	5828	12	did	do	VBD
cord-023095-4dannjjm	5828	13	valacyclovir	valacyclovir	NNP
cord-023095-4dannjjm	5828	14	when	when	WRB
cord-023095-4dannjjm	5828	15	therapy	therapy	NN
cord-023095-4dannjjm	5828	16	was	be	VBD
cord-023095-4dannjjm	5828	17	initiated	initiate	VBN
cord-023095-4dannjjm	5828	18	just	just	RB
cord-023095-4dannjjm	5828	19	prior	prior	RB
cord-023095-4dannjjm	5828	20	to	to	IN
cord-023095-4dannjjm	5828	21	the	the	DT
cord-023095-4dannjjm	5828	22	onset	onset	NN
cord-023095-4dannjjm	5828	23	of	of	IN
cord-023095-4dannjjm	5828	24	neurological	neurological	JJ
cord-023095-4dannjjm	5828	25	disease	disease	NN
cord-023095-4dannjjm	5828	26	.	.	.
cord-023095-4dannjjm	5829	1	Equine	equine	JJ
cord-023095-4dannjjm	5829	2	vaccination	vaccination	NN
cord-023095-4dannjjm	5829	3	is	be	VBZ
cord-023095-4dannjjm	5829	4	amongst	amongst	IN
cord-023095-4dannjjm	5829	5	the	the	DT
cord-023095-4dannjjm	5829	6	most	most	RBS
cord-023095-4dannjjm	5829	7	important	important	JJ
cord-023095-4dannjjm	5829	8	method	method	NN
cord-023095-4dannjjm	5829	9	of	of	IN
cord-023095-4dannjjm	5829	10	prophylaxis	prophylaxis	NN
cord-023095-4dannjjm	5829	11	against	against	IN
cord-023095-4dannjjm	5829	12	equine	equine	JJ
cord-023095-4dannjjm	5829	13	influenza	influenza	NN
cord-023095-4dannjjm	5829	14	virus	virus	NN
cord-023095-4dannjjm	5829	15	(	(	-LRB-
cord-023095-4dannjjm	5829	16	EIV	EIV	NNP
cord-023095-4dannjjm	5829	17	)	)	-RRB-
cord-023095-4dannjjm	5829	18	,	,	,
cord-023095-4dannjjm	5829	19	a	a	DT
cord-023095-4dannjjm	5829	20	pathogen	pathogen	NN
cord-023095-4dannjjm	5829	21	in	in	IN
cord-023095-4dannjjm	5829	22	which	which	WDT
cord-023095-4dannjjm	5829	23	continuous	continuous	JJ
cord-023095-4dannjjm	5829	24	antigenic	antigenic	JJ
cord-023095-4dannjjm	5829	25	drift	drift	NN
cord-023095-4dannjjm	5829	26	can	can	MD
cord-023095-4dannjjm	5829	27	lead	lead	VB
cord-023095-4dannjjm	5829	28	to	to	IN
cord-023095-4dannjjm	5829	29	vaccine	vaccine	NN
cord-023095-4dannjjm	5829	30	failure	failure	NN
cord-023095-4dannjjm	5829	31	.	.	.
cord-023095-4dannjjm	5830	1	A	a	DT
cord-023095-4dannjjm	5830	2	6month	6month	JJ
cord-023095-4dannjjm	5830	3	duration	duration	NN
cord-023095-4dannjjm	5830	4	of	of	IN
cord-023095-4dannjjm	5830	5	immunity	immunity	NN
cord-023095-4dannjjm	5830	6	(	(	-LRB-
cord-023095-4dannjjm	5830	7	DOI	DOI	NNP
cord-023095-4dannjjm	5830	8	)	)	-RRB-
cord-023095-4dannjjm	5830	9	challenge	challenge	NN
cord-023095-4dannjjm	5830	10	infection	infection	NN
cord-023095-4dannjjm	5830	11	study	study	NN
cord-023095-4dannjjm	5830	12	was	be	VBD
cord-023095-4dannjjm	5830	13	conducted	conduct	VBN
cord-023095-4dannjjm	5830	14	using	use	VBG
cord-023095-4dannjjm	5830	15	commercial	commercial	JJ
cord-023095-4dannjjm	5830	16	inactivated	inactivate	VBN
cord-023095-4dannjjm	5830	17	vaccines	vaccine	NNS
cord-023095-4dannjjm	5830	18	containing	contain	VBG
cord-023095-4dannjjm	5830	19	different	different	JJ
cord-023095-4dannjjm	5830	20	strains	strain	NNS
cord-023095-4dannjjm	5830	21	of	of	IN
cord-023095-4dannjjm	5830	22	A	a	NN
cord-023095-4dannjjm	5830	23	/	/	SYM
cord-023095-4dannjjm	5830	24	equine/2	equine/2	NN
cord-023095-4dannjjm	5830	25	/	/	SYM
cord-023095-4dannjjm	5830	26	influenza	influenza	NN
cord-023095-4dannjjm	5830	27	virus	virus	NN
cord-023095-4dannjjm	5830	28	's	's	POS
cord-023095-4dannjjm	5830	29	,	,	,
cord-023095-4dannjjm	5830	30	including	include	VBG
cord-023095-4dannjjm	5830	31	Innovator	Innovator	NNP
cord-023095-4dannjjm	5830	32	TM	TM	NNP
cord-023095-4dannjjm	5830	33	,	,	,
cord-023095-4dannjjm	5830	34	containing	contain	VBG
cord-023095-4dannjjm	5830	35	Kentucky/97	Kentucky/97	NNP
cord-023095-4dannjjm	5831	1	(	(	-LRB-
cord-023095-4dannjjm	5831	2	Pfizer	Pfizer	NNP
cord-023095-4dannjjm	5831	3	Animal	Animal	NNP
cord-023095-4dannjjm	5831	4	Health	Health	NNP
cord-023095-4dannjjm	5831	5	,	,	,
cord-023095-4dannjjm	5831	6	New	New	NNP
cord-023095-4dannjjm	5831	7	York	York	NNP
cord-023095-4dannjjm	5831	8	,	,	,
cord-023095-4dannjjm	5831	9	NY	NY	NNP
cord-023095-4dannjjm	5831	10	)	)	-RRB-
cord-023095-4dannjjm	5831	11	,	,	,
cord-023095-4dannjjm	5831	12	and	and	CC
cord-023095-4dannjjm	5831	13	Calvenza	Calvenza	NNP
cord-023095-4dannjjm	5831	14	,	,	,
cord-023095-4dannjjm	5831	15	containing	contain	VBG
cord-023095-4dannjjm	5831	16	a	a	DT
cord-023095-4dannjjm	5831	17	combination	combination	NN
cord-023095-4dannjjm	5831	18	of	of	IN
cord-023095-4dannjjm	5831	19	Ohio/2003	Ohio/2003	NNP
cord-023095-4dannjjm	5831	20	,	,	,
cord-023095-4dannjjm	5831	21	Kentucky/	Kentucky/	NNP
cord-023095-4dannjjm	5831	22	95	95	CD
cord-023095-4dannjjm	5831	23	,	,	,
cord-023095-4dannjjm	5831	24	and	and	CC
cord-023095-4dannjjm	5831	25	Newmarket93	Newmarket93	NNP
cord-023095-4dannjjm	5832	1	(	(	-LRB-
cord-023095-4dannjjm	5832	2	Boehringer	Boehringer	NNP
cord-023095-4dannjjm	5832	3	Ingelheim	Ingelheim	NNP
cord-023095-4dannjjm	5832	4	Vetmedica	Vetmedica	NNP
cord-023095-4dannjjm	5832	5	,	,	,
cord-023095-4dannjjm	5832	6	St.	St.	NNP
cord-023095-4dannjjm	5832	7	Joseph	Joseph	NNP
cord-023095-4dannjjm	5832	8	,	,	,
cord-023095-4dannjjm	5832	9	MS	MS	NNP
cord-023095-4dannjjm	5832	10	)	)	-RRB-
cord-023095-4dannjjm	5832	11	.	.	.
cord-023095-4dannjjm	5833	1	The	the	DT
cord-023095-4dannjjm	5833	2	challenge	challenge	NN
cord-023095-4dannjjm	5833	3	virus	virus	NN
cord-023095-4dannjjm	5833	4	strain	strain	NN
cord-023095-4dannjjm	5833	5	was	be	VBD
cord-023095-4dannjjm	5833	6	Colorado/07	colorado/07	CD
cord-023095-4dannjjm	5833	7	,	,	,
cord-023095-4dannjjm	5833	8	the	the	DT
cord-023095-4dannjjm	5833	9	most	most	RBS
cord-023095-4dannjjm	5833	10	contemporary	contemporary	JJ
cord-023095-4dannjjm	5833	11	challenge	challenge	NN
cord-023095-4dannjjm	5833	12	strain	strain	NN
cord-023095-4dannjjm	5833	13	currently	currently	RB
cord-023095-4dannjjm	5833	14	in	in	IN
cord-023095-4dannjjm	5833	15	use	use	NN
cord-023095-4dannjjm	5833	16	.	.	.
cord-023095-4dannjjm	5834	1	The	the	DT
cord-023095-4dannjjm	5834	2	study	study	NN
cord-023095-4dannjjm	5834	3	design	design	NN
cord-023095-4dannjjm	5834	4	was	be	VBD
cord-023095-4dannjjm	5834	5	a	a	DT
cord-023095-4dannjjm	5834	6	blinded	blinded	JJ
cord-023095-4dannjjm	5834	7	,	,	,
cord-023095-4dannjjm	5834	8	randomized	randomized	JJ
cord-023095-4dannjjm	5834	9	challenge	challenge	NN
cord-023095-4dannjjm	5834	10	trial	trial	NN
cord-023095-4dannjjm	5834	11	.	.	.
cord-023095-4dannjjm	5835	1	Three	three	CD
cord-023095-4dannjjm	5835	2	groups	group	NNS
cord-023095-4dannjjm	5835	3	of	of	IN
cord-023095-4dannjjm	5835	4	10	10	CD
cord-023095-4dannjjm	5835	5	yearling	yearling	NN
cord-023095-4dannjjm	5835	6	ponies	pony	NNS
cord-023095-4dannjjm	5835	7	,	,	,
cord-023095-4dannjjm	5835	8	with	with	IN
cord-023095-4dannjjm	5835	9	no	no	DT
cord-023095-4dannjjm	5835	10	history	history	NN
cord-023095-4dannjjm	5835	11	or	or	CC
cord-023095-4dannjjm	5835	12	serological	serological	JJ
cord-023095-4dannjjm	5835	13	evidence	evidence	NN
cord-023095-4dannjjm	5835	14	of	of	IN
cord-023095-4dannjjm	5835	15	EIV	EIV	NNP
cord-023095-4dannjjm	5835	16	infection	infection	NN
cord-023095-4dannjjm	5835	17	were	be	VBD
cord-023095-4dannjjm	5835	18	established	establish	VBN
cord-023095-4dannjjm	5835	19	.	.	.
cord-023095-4dannjjm	5836	1	Each	each	DT
cord-023095-4dannjjm	5836	2	group	group	NN
cord-023095-4dannjjm	5836	3	received	receive	VBD
cord-023095-4dannjjm	5836	4	one	one	CD
cord-023095-4dannjjm	5836	5	of	of	IN
cord-023095-4dannjjm	5836	6	three	three	CD
cord-023095-4dannjjm	5836	7	treatments	treatment	NNS
cord-023095-4dannjjm	5836	8	:	:	:
cord-023095-4dannjjm	5836	9	vaccination	vaccination	NN
cord-023095-4dannjjm	5836	10	with	with	IN
cord-023095-4dannjjm	5836	11	Innovator	Innovator	NNP
cord-023095-4dannjjm	5836	12	TM	TM	NNP
cord-023095-4dannjjm	5836	13	;	;	:
cord-023095-4dannjjm	5836	14	vaccination	vaccination	NN
cord-023095-4dannjjm	5836	15	with	with	IN
cord-023095-4dannjjm	5836	16	Calvenza	Calvenza	NNP
cord-023095-4dannjjm	5836	17	TM	TM	NNP
cord-023095-4dannjjm	5836	18	;	;	:
cord-023095-4dannjjm	5836	19	or	or	CC
cord-023095-4dannjjm	5836	20	injection	injection	NN
cord-023095-4dannjjm	5836	21	with	with	IN
cord-023095-4dannjjm	5836	22	a	a	DT
cord-023095-4dannjjm	5836	23	saline	saline	NN
cord-023095-4dannjjm	5836	24	placebo	placebo	NN
cord-023095-4dannjjm	5836	25	.	.	.
cord-023095-4dannjjm	5837	1	Each	each	DT
cord-023095-4dannjjm	5837	2	treatment	treatment	NN
cord-023095-4dannjjm	5837	3	was	be	VBD
cord-023095-4dannjjm	5837	4	administered	administer	VBN
cord-023095-4dannjjm	5837	5	3	3	CD
cord-023095-4dannjjm	5837	6	times	time	NNS
cord-023095-4dannjjm	5837	7	,	,	,
cord-023095-4dannjjm	5837	8	at	at	IN
cord-023095-4dannjjm	5837	9	intervals	interval	NNS
cord-023095-4dannjjm	5837	10	of	of	IN
cord-023095-4dannjjm	5837	11	1	1	CD
cord-023095-4dannjjm	5837	12	month	month	NN
cord-023095-4dannjjm	5837	13	between	between	IN
cord-023095-4dannjjm	5837	14	the	the	DT
cord-023095-4dannjjm	5837	15	first	first	JJ
cord-023095-4dannjjm	5837	16	two	two	CD
cord-023095-4dannjjm	5837	17	treatments	treatment	NNS
cord-023095-4dannjjm	5837	18	,	,	,
cord-023095-4dannjjm	5837	19	and	and	CC
cord-023095-4dannjjm	5837	20	3	3	CD
cord-023095-4dannjjm	5837	21	months	month	NNS
cord-023095-4dannjjm	5837	22	between	between	IN
cord-023095-4dannjjm	5837	23	the	the	DT
cord-023095-4dannjjm	5837	24	second	second	JJ
cord-023095-4dannjjm	5837	25	and	and	CC
cord-023095-4dannjjm	5837	26	third	third	JJ
cord-023095-4dannjjm	5837	27	treatments	treatment	NNS
cord-023095-4dannjjm	5837	28	.	.	.
cord-023095-4dannjjm	5838	1	All	all	DT
cord-023095-4dannjjm	5838	2	ponies	pony	NNS
cord-023095-4dannjjm	5838	3	were	be	VBD
cord-023095-4dannjjm	5838	4	challenged	challenge	VBN
cord-023095-4dannjjm	5838	5	by	by	IN
cord-023095-4dannjjm	5838	6	nasal	nasal	NN
cord-023095-4dannjjm	5838	7	nebulization	nebulization	NN
cord-023095-4dannjjm	5838	8	of	of	IN
cord-023095-4dannjjm	5838	9	5X10	5x10	CD
cord-023095-4dannjjm	5838	10	7	7	CD
cord-023095-4dannjjm	5838	11	EID	EID	NNP
cord-023095-4dannjjm	5838	12	50	50	CD
cord-023095-4dannjjm	5838	13	influenza	influenza	NN
cord-023095-4dannjjm	5838	14	virus	virus	NN
cord-023095-4dannjjm	5838	15	A	a	NN
cord-023095-4dannjjm	5838	16	/	/	SYM
cord-023095-4dannjjm	5838	17	eq/2	eq/2	NNP
cord-023095-4dannjjm	5838	18	/	/	SYM
cord-023095-4dannjjm	5838	19	Colorado/07	colorado/07	CD
cord-023095-4dannjjm	5838	20	6	6	CD
cord-023095-4dannjjm	5838	21	months	month	NNS
cord-023095-4dannjjm	5838	22	after	after	IN
cord-023095-4dannjjm	5838	23	the	the	DT
cord-023095-4dannjjm	5838	24	third	third	JJ
cord-023095-4dannjjm	5838	25	treatment	treatment	NN
cord-023095-4dannjjm	5838	26	.	.	.
cord-023095-4dannjjm	5839	1	Clinical	clinical	JJ
cord-023095-4dannjjm	5839	2	signs	sign	NNS
cord-023095-4dannjjm	5839	3	of	of	IN
cord-023095-4dannjjm	5839	4	disease	disease	NN
cord-023095-4dannjjm	5839	5	,	,	,
cord-023095-4dannjjm	5839	6	including	include	VBG
cord-023095-4dannjjm	5839	7	rectal	rectal	JJ
cord-023095-4dannjjm	5839	8	temperature	temperature	NN
cord-023095-4dannjjm	5839	9	,	,	,
cord-023095-4dannjjm	5839	10	nasal	nasal	NN
cord-023095-4dannjjm	5839	11	discharge	discharge	NN
cord-023095-4dannjjm	5839	12	,	,	,
cord-023095-4dannjjm	5839	13	anorexia	anorexia	NN
cord-023095-4dannjjm	5839	14	,	,	,
cord-023095-4dannjjm	5839	15	coughing	coughing	NN
cord-023095-4dannjjm	5839	16	,	,	,
cord-023095-4dannjjm	5839	17	and	and	CC
cord-023095-4dannjjm	5839	18	depression	depression	NN
cord-023095-4dannjjm	5839	19	,	,	,
cord-023095-4dannjjm	5839	20	were	be	VBD
cord-023095-4dannjjm	5839	21	recorded	record	VBN
cord-023095-4dannjjm	5839	22	daily	daily	RB
cord-023095-4dannjjm	5839	23	for	for	IN
cord-023095-4dannjjm	5839	24	2	2	CD
cord-023095-4dannjjm	5839	25	days	day	NNS
cord-023095-4dannjjm	5839	26	prior	prior	RB
cord-023095-4dannjjm	5839	27	to	to	IN
cord-023095-4dannjjm	5839	28	challenge	challenge	NN
cord-023095-4dannjjm	5839	29	infection	infection	NN
cord-023095-4dannjjm	5839	30	,	,	,
cord-023095-4dannjjm	5839	31	and	and	CC
cord-023095-4dannjjm	5839	32	14	14	CD
cord-023095-4dannjjm	5839	33	days	day	NNS
cord-023095-4dannjjm	5839	34	post	post	JJ
cord-023095-4dannjjm	5839	35	-	-	JJ
cord-023095-4dannjjm	5839	36	challenge	challenge	NN
cord-023095-4dannjjm	5839	37	.	.	.
cord-023095-4dannjjm	5840	1	Nasal	nasal	NN
cord-023095-4dannjjm	5840	2	shedding	shedding	NN
cord-023095-4dannjjm	5840	3	of	of	IN
cord-023095-4dannjjm	5840	4	EIV	EIV	NNP
cord-023095-4dannjjm	5840	5	was	be	VBD
cord-023095-4dannjjm	5840	6	measured	measure	VBN
cord-023095-4dannjjm	5840	7	on	on	IN
cord-023095-4dannjjm	5840	8	the	the	DT
cord-023095-4dannjjm	5840	9	same	same	JJ
cord-023095-4dannjjm	5840	10	days	day	NNS
cord-023095-4dannjjm	5840	11	,	,	,
cord-023095-4dannjjm	5840	12	using	use	VBG
cord-023095-4dannjjm	5840	13	a	a	DT
cord-023095-4dannjjm	5840	14	realtime	realtime	JJ
cord-023095-4dannjjm	5840	15	PCR	PCR	NNP
cord-023095-4dannjjm	5840	16	test	test	NN
cord-023095-4dannjjm	5840	17	procedure	procedure	NN
cord-023095-4dannjjm	5840	18	.	.	.
cord-023095-4dannjjm	5841	1	EIV	EIV	NNP
cord-023095-4dannjjm	5841	2	-	-	HYPH
cord-023095-4dannjjm	5841	3	specific	specific	JJ
cord-023095-4dannjjm	5841	4	antibody	antibody	NN
cord-023095-4dannjjm	5841	5	responses	response	NNS
cord-023095-4dannjjm	5841	6	were	be	VBD
cord-023095-4dannjjm	5841	7	measured	measure	VBN
cord-023095-4dannjjm	5841	8	by	by	IN
cord-023095-4dannjjm	5841	9	ELISA	ELISA	NNP
cord-023095-4dannjjm	5841	10	.	.	.
cord-023095-4dannjjm	5842	1	Differences	difference	NNS
cord-023095-4dannjjm	5842	2	between	between	IN
cord-023095-4dannjjm	5842	3	groups	group	NNS
cord-023095-4dannjjm	5842	4	were	be	VBD
cord-023095-4dannjjm	5842	5	analyzed	analyze	VBN
cord-023095-4dannjjm	5842	6	by	by	IN
cord-023095-4dannjjm	5842	7	non	non	JJ
cord-023095-4dannjjm	5842	8	-	-	JJ
cord-023095-4dannjjm	5842	9	parametric	parametric	JJ
cord-023095-4dannjjm	5842	10	repeated	repeat	VBN
cord-023095-4dannjjm	5842	11	measures	measure	NNS
cord-023095-4dannjjm	5842	12	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	5842	13	,	,	,
cord-023095-4dannjjm	5842	14	and	and	CC
cord-023095-4dannjjm	5842	15	differences	difference	NNS
cord-023095-4dannjjm	5842	16	were	be	VBD
cord-023095-4dannjjm	5842	17	declared	declare	VBN
cord-023095-4dannjjm	5842	18	significant	significant	JJ
cord-023095-4dannjjm	5842	19	when	when	WRB
cord-023095-4dannjjm	5842	20	P	p	NN
cord-023095-4dannjjm	5842	21	o	o	NN
cord-023095-4dannjjm	5842	22	0.05	0.05	CD
cord-023095-4dannjjm	5842	23	.	.	.
cord-023095-4dannjjm	5843	1	All	all	DT
cord-023095-4dannjjm	5843	2	control	control	NN
cord-023095-4dannjjm	5843	3	group	group	NN
cord-023095-4dannjjm	5843	4	ponies	pony	NNS
cord-023095-4dannjjm	5843	5	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	5843	6	clinical	clinical	JJ
cord-023095-4dannjjm	5843	7	signs	sign	NNS
cord-023095-4dannjjm	5843	8	of	of	IN
cord-023095-4dannjjm	5843	9	disease	disease	NN
cord-023095-4dannjjm	5843	10	consistent	consistent	JJ
cord-023095-4dannjjm	5843	11	with	with	IN
cord-023095-4dannjjm	5843	12	EIV	EIV	NNP
cord-023095-4dannjjm	5843	13	infection	infection	NN
cord-023095-4dannjjm	5843	14	post	post	JJ
cord-023095-4dannjjm	5843	15	-	-	JJ
cord-023095-4dannjjm	5843	16	challenge	challenge	JJ
cord-023095-4dannjjm	5843	17	infection	infection	NN
cord-023095-4dannjjm	5843	18	,	,	,
cord-023095-4dannjjm	5843	19	including	include	VBG
cord-023095-4dannjjm	5843	20	pyrexia	pyrexia	NN
cord-023095-4dannjjm	5843	21	,	,	,
cord-023095-4dannjjm	5843	22	nasal	nasal	NN
cord-023095-4dannjjm	5843	23	discharge	discharge	NN
cord-023095-4dannjjm	5843	24	,	,	,
cord-023095-4dannjjm	5843	25	inappetance	inappetance	NN
cord-023095-4dannjjm	5843	26	and	and	CC
cord-023095-4dannjjm	5843	27	partial	partial	JJ
cord-023095-4dannjjm	5843	28	anorexia	anorexia	NN
cord-023095-4dannjjm	5843	29	.	.	.
cord-023095-4dannjjm	5844	1	These	these	DT
cord-023095-4dannjjm	5844	2	signs	sign	NNS
cord-023095-4dannjjm	5844	3	were	be	VBD
cord-023095-4dannjjm	5844	4	significantly	significantly	RB
cord-023095-4dannjjm	5844	5	lower	low	JJR
cord-023095-4dannjjm	5844	6	in	in	IN
cord-023095-4dannjjm	5844	7	both	both	DT
cord-023095-4dannjjm	5844	8	vaccine	vaccine	NN
cord-023095-4dannjjm	5844	9	groups	group	NNS
cord-023095-4dannjjm	5844	10	;	;	:
cord-023095-4dannjjm	5844	11	mean	mean	VB
cord-023095-4dannjjm	5844	12	body	body	NN
cord-023095-4dannjjm	5844	13	temperature	temperature	NN
cord-023095-4dannjjm	5844	14	was	be	VBD
cord-023095-4dannjjm	5844	15	elevated	elevate	VBN
cord-023095-4dannjjm	5844	16	(	(	-LRB-
cord-023095-4dannjjm	5844	17	4101.51F	4101.51f	CD
cord-023095-4dannjjm	5844	18	)	)	-RRB-
cord-023095-4dannjjm	5844	19	for	for	IN
cord-023095-4dannjjm	5844	20	8	8	CD
cord-023095-4dannjjm	5844	21	days	day	NNS
cord-023095-4dannjjm	5844	22	in	in	IN
cord-023095-4dannjjm	5844	23	controls	control	NNS
cord-023095-4dannjjm	5844	24	,	,	,
cord-023095-4dannjjm	5844	25	but	but	CC
cord-023095-4dannjjm	5844	26	only	only	RB
cord-023095-4dannjjm	5844	27	2	2	CD
cord-023095-4dannjjm	5844	28	days	day	NNS
cord-023095-4dannjjm	5844	29	in	in	IN
cord-023095-4dannjjm	5844	30	vaccine	vaccine	NN
cord-023095-4dannjjm	5844	31	groups	group	NNS
cord-023095-4dannjjm	5844	32	.	.	.
cord-023095-4dannjjm	5845	1	Nasal	nasal	NN
cord-023095-4dannjjm	5845	2	shedding	shedding	NN
cord-023095-4dannjjm	5845	3	of	of	IN
cord-023095-4dannjjm	5845	4	EIV	EIV	NNP
cord-023095-4dannjjm	5845	5	was	be	VBD
cord-023095-4dannjjm	5845	6	detected	detect	VBN
cord-023095-4dannjjm	5845	7	in	in	IN
cord-023095-4dannjjm	5845	8	all	all	DT
cord-023095-4dannjjm	5845	9	ponies	pony	NNS
cord-023095-4dannjjm	5845	10	in	in	IN
cord-023095-4dannjjm	5845	11	all	all	DT
cord-023095-4dannjjm	5845	12	groups	group	NNS
cord-023095-4dannjjm	5845	13	:	:	:
cord-023095-4dannjjm	5845	14	over	over	IN
cord-023095-4dannjjm	5845	15	the	the	DT
cord-023095-4dannjjm	5845	16	duration	duration	NN
cord-023095-4dannjjm	5845	17	of	of	IN
cord-023095-4dannjjm	5845	18	the	the	DT
cord-023095-4dannjjm	5845	19	study	study	NN
cord-023095-4dannjjm	5845	20	the	the	DT
cord-023095-4dannjjm	5845	21	Calvenza	Calvenza	NNP
cord-023095-4dannjjm	5845	22	group	group	NN
cord-023095-4dannjjm	5845	23	shed	shed	VBD
cord-023095-4dannjjm	5845	24	significantly	significantly	RB
cord-023095-4dannjjm	5845	25	less	less	JJR
cord-023095-4dannjjm	5845	26	virus	virus	NN
cord-023095-4dannjjm	5845	27	than	than	IN
cord-023095-4dannjjm	5845	28	Innovator	Innovator	NNP
cord-023095-4dannjjm	5845	29	and	and	CC
cord-023095-4dannjjm	5845	30	Control	Control	NNP
cord-023095-4dannjjm	5845	31	.	.	.
cord-023095-4dannjjm	5846	1	Over	over	IN
cord-023095-4dannjjm	5846	2	time	time	NN
cord-023095-4dannjjm	5846	3	antibody	antibody	NN
cord-023095-4dannjjm	5846	4	titers	titer	NNS
cord-023095-4dannjjm	5846	5	were	be	VBD
cord-023095-4dannjjm	5846	6	significantly	significantly	RB
cord-023095-4dannjjm	5846	7	higher	high	JJR
cord-023095-4dannjjm	5846	8	in	in	IN
cord-023095-4dannjjm	5846	9	the	the	DT
cord-023095-4dannjjm	5846	10	Calvenza	Calvenza	NNP
cord-023095-4dannjjm	5846	11	than	than	IN
cord-023095-4dannjjm	5846	12	the	the	DT
cord-023095-4dannjjm	5846	13	Innovator	Innovator	NNP
cord-023095-4dannjjm	5846	14	group	group	NN
cord-023095-4dannjjm	5846	15	,	,	,
cord-023095-4dannjjm	5846	16	and	and	CC
cord-023095-4dannjjm	5846	17	both	both	DT
cord-023095-4dannjjm	5846	18	were	be	VBD
cord-023095-4dannjjm	5846	19	significantly	significantly	RB
cord-023095-4dannjjm	5846	20	greater	great	JJR
cord-023095-4dannjjm	5846	21	than	than	IN
cord-023095-4dannjjm	5846	22	controls	control	NNS
cord-023095-4dannjjm	5846	23	.	.	.
cord-023095-4dannjjm	5847	1	This	this	DT
cord-023095-4dannjjm	5847	2	study	study	NN
cord-023095-4dannjjm	5847	3	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	5847	4	that	that	IN
cord-023095-4dannjjm	5847	5	both	both	DT
cord-023095-4dannjjm	5847	6	current	current	JJ
cord-023095-4dannjjm	5847	7	commercial	commercial	NN
cord-023095-4dannjjm	5847	8	inactivated	inactivate	VBD
cord-023095-4dannjjm	5847	9	EIV	EIV	NNP
cord-023095-4dannjjm	5847	10	vaccines	vaccine	NNS
cord-023095-4dannjjm	5847	11	have	have	VBP
cord-023095-4dannjjm	5847	12	a	a	DT
cord-023095-4dannjjm	5847	13	duration	duration	NN
cord-023095-4dannjjm	5847	14	of	of	IN
cord-023095-4dannjjm	5847	15	clinical	clinical	JJ
cord-023095-4dannjjm	5847	16	protection	protection	NN
cord-023095-4dannjjm	5847	17	of	of	IN
cord-023095-4dannjjm	5847	18	at	at	RB
cord-023095-4dannjjm	5847	19	least	least	RBS
cord-023095-4dannjjm	5847	20	6	6	CD
cord-023095-4dannjjm	5847	21	months	month	NNS
cord-023095-4dannjjm	5847	22	after	after	IN
cord-023095-4dannjjm	5847	23	a	a	DT
cord-023095-4dannjjm	5847	24	highly	highly	RB
cord-023095-4dannjjm	5847	25	pathogenic	pathogenic	JJ
cord-023095-4dannjjm	5847	26	challenge	challenge	NN
cord-023095-4dannjjm	5847	27	with	with	IN
cord-023095-4dannjjm	5847	28	a	a	DT
cord-023095-4dannjjm	5847	29	recent	recent	JJ
cord-023095-4dannjjm	5847	30	EIV	EIV	NNP
cord-023095-4dannjjm	5847	31	isolate	isolate	VBP
cord-023095-4dannjjm	5847	32	.	.	.
cord-023095-4dannjjm	5848	1	Both	both	DT
cord-023095-4dannjjm	5848	2	antibody	antibody	NN
cord-023095-4dannjjm	5848	3	responses	response	NNS
cord-023095-4dannjjm	5848	4	and	and	CC
cord-023095-4dannjjm	5848	5	virological	virological	JJ
cord-023095-4dannjjm	5848	6	protection	protection	NN
cord-023095-4dannjjm	5848	7	differed	differ	VBD
cord-023095-4dannjjm	5848	8	between	between	IN
cord-023095-4dannjjm	5848	9	the	the	DT
cord-023095-4dannjjm	5848	10	vaccines	vaccine	NNS
cord-023095-4dannjjm	5848	11	.	.	.
cord-023095-4dannjjm	5849	1	Formulation	formulation	NN
cord-023095-4dannjjm	5849	2	difference	difference	NN
cord-023095-4dannjjm	5849	3	between	between	IN
cord-023095-4dannjjm	5849	4	the	the	DT
cord-023095-4dannjjm	5849	5	vaccines	vaccine	NNS
cord-023095-4dannjjm	5849	6	,	,	,
cord-023095-4dannjjm	5849	7	including	include	VBG
cord-023095-4dannjjm	5849	8	the	the	DT
cord-023095-4dannjjm	5849	9	EIV	EIV	NNP
cord-023095-4dannjjm	5849	10	antigens	antigen	NNS
cord-023095-4dannjjm	5849	11	employed	employ	VBN
cord-023095-4dannjjm	5849	12	,	,	,
cord-023095-4dannjjm	5849	13	may	may	MD
cord-023095-4dannjjm	5849	14	have	have	VB
cord-023095-4dannjjm	5849	15	contributed	contribute	VBN
cord-023095-4dannjjm	5849	16	to	to	IN
cord-023095-4dannjjm	5849	17	this	this	DT
cord-023095-4dannjjm	5849	18	performance	performance	NN
cord-023095-4dannjjm	5849	19	difference	difference	NN
cord-023095-4dannjjm	5849	20	.	.	.
cord-023095-4dannjjm	5850	1	Degenerative	degenerative	JJ
cord-023095-4dannjjm	5850	2	myelopathy	myelopathy	NN
cord-023095-4dannjjm	5850	3	(	(	-LRB-
cord-023095-4dannjjm	5850	4	DM	DM	NNP
cord-023095-4dannjjm	5850	5	)	)	-RRB-
cord-023095-4dannjjm	5850	6	may	may	MD
cord-023095-4dannjjm	5850	7	be	be	VB
cord-023095-4dannjjm	5850	8	homologous	homologous	JJ
cord-023095-4dannjjm	5850	9	to	to	IN
cord-023095-4dannjjm	5850	10	a	a	DT
cord-023095-4dannjjm	5850	11	form	form	NN
cord-023095-4dannjjm	5850	12	of	of	IN
cord-023095-4dannjjm	5850	13	amyotrophic	amyotrophic	JJ
cord-023095-4dannjjm	5850	14	lateral	lateral	JJ
cord-023095-4dannjjm	5850	15	sclerosis	sclerosis	NN
cord-023095-4dannjjm	5850	16	in	in	IN
cord-023095-4dannjjm	5850	17	humans	human	NNS
cord-023095-4dannjjm	5850	18	which	which	WDT
cord-023095-4dannjjm	5850	19	has	have	VBZ
cord-023095-4dannjjm	5850	20	excitotoxic	excitotoxic	JJ
cord-023095-4dannjjm	5850	21	and	and	CC
cord-023095-4dannjjm	5850	22	immunologic	immunologic	JJ
cord-023095-4dannjjm	5850	23	pathogeneses	pathogenese	NNS
cord-023095-4dannjjm	5850	24	described	describe	VBN
cord-023095-4dannjjm	5850	25	.	.	.
cord-023095-4dannjjm	5851	1	The	the	DT
cord-023095-4dannjjm	5851	2	aims	aim	NNS
cord-023095-4dannjjm	5851	3	of	of	IN
cord-023095-4dannjjm	5851	4	this	this	DT
cord-023095-4dannjjm	5851	5	study	study	NN
cord-023095-4dannjjm	5851	6	were	be	VBD
cord-023095-4dannjjm	5851	7	to	to	TO
cord-023095-4dannjjm	5851	8	determine	determine	VB
cord-023095-4dannjjm	5851	9	(	(	-LRB-
cord-023095-4dannjjm	5851	10	i	i	NN
cord-023095-4dannjjm	5851	11	)	)	-RRB-
cord-023095-4dannjjm	5851	12	presence	presence	NN
cord-023095-4dannjjm	5851	13	or	or	CC
cord-023095-4dannjjm	5851	14	absence	absence	NN
cord-023095-4dannjjm	5851	15	of	of	IN
cord-023095-4dannjjm	5851	16	abnormalities	abnormality	NNS
cord-023095-4dannjjm	5851	17	in	in	IN
cord-023095-4dannjjm	5851	18	concentrations	concentration	NNS
cord-023095-4dannjjm	5851	19	of	of	IN
cord-023095-4dannjjm	5851	20	CSF	csf	NN
cord-023095-4dannjjm	5851	21	amino	amino	NN
cord-023095-4dannjjm	5851	22	acid	acid	NN
cord-023095-4dannjjm	5851	23	(	(	-LRB-
cord-023095-4dannjjm	5851	24	AA	AA	NNP
cord-023095-4dannjjm	5851	25	)	)	-RRB-
cord-023095-4dannjjm	5851	26	neurotransmitters	neurotransmitter	NNS
cord-023095-4dannjjm	5851	27	(	(	-LRB-
cord-023095-4dannjjm	5851	28	glutamate	glutamate	NN
cord-023095-4dannjjm	5851	29	,	,	,
cord-023095-4dannjjm	5851	30	glycine	glycine	NN
cord-023095-4dannjjm	5851	31	and	and	CC
cord-023095-4dannjjm	5851	32	gÀaminobutyric	gÀaminobutyric	NNP
cord-023095-4dannjjm	5851	33	acid	acid	NN
cord-023095-4dannjjm	5851	34	(	(	-LRB-
cord-023095-4dannjjm	5851	35	GABA	GABA	NNP
cord-023095-4dannjjm	5851	36	)	)	-RRB-
cord-023095-4dannjjm	5851	37	)	)	-RRB-
cord-023095-4dannjjm	5851	38	and	and	CC
cord-023095-4dannjjm	5851	39	cytokines	cytokine	NNS
cord-023095-4dannjjm	5851	40	in	in	IN
cord-023095-4dannjjm	5851	41	dogs	dog	NNS
cord-023095-4dannjjm	5851	42	with	with	IN
cord-023095-4dannjjm	5851	43	DM	DM	NNP
cord-023095-4dannjjm	5851	44	and	and	CC
cord-023095-4dannjjm	5851	45	if	if	IN
cord-023095-4dannjjm	5851	46	present	present	JJ
cord-023095-4dannjjm	5851	47	(	(	-LRB-
cord-023095-4dannjjm	5851	48	ii	ii	NN
cord-023095-4dannjjm	5851	49	)	)	-RRB-
cord-023095-4dannjjm	5851	50	investigate	investigate	VBP
cord-023095-4dannjjm	5851	51	associations	association	NNS
cord-023095-4dannjjm	5851	52	with	with	IN
cord-023095-4dannjjm	5851	53	disease	disease	NN
cord-023095-4dannjjm	5851	54	severity	severity	NN
cord-023095-4dannjjm	5851	55	.	.	.
cord-023095-4dannjjm	5852	1	Twenty	twenty	CD
cord-023095-4dannjjm	5852	2	-	-	HYPH
cord-023095-4dannjjm	5852	3	two	two	CD
cord-023095-4dannjjm	5852	4	dogs	dog	NNS
cord-023095-4dannjjm	5852	5	histopathologically	histopathologically	RB
cord-023095-4dannjjm	5852	6	confirmed	confirm	VBD
cord-023095-4dannjjm	5852	7	for	for	IN
cord-023095-4dannjjm	5852	8	DM	DM	NNP
cord-023095-4dannjjm	5852	9	and	and	CC
cord-023095-4dannjjm	5852	10	21	21	CD
cord-023095-4dannjjm	5852	11	dogs	dog	NNS
cord-023095-4dannjjm	5852	12	with	with	IN
cord-023095-4dannjjm	5852	13	suspected	suspect	VBN
cord-023095-4dannjjm	5852	14	DM	dm	NN
cord-023095-4dannjjm	5852	15	based	base	VBN
cord-023095-4dannjjm	5852	16	on	on	IN
cord-023095-4dannjjm	5852	17	thorough	thorough	JJ
cord-023095-4dannjjm	5852	18	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	5852	19	investigations	investigation	NNS
cord-023095-4dannjjm	5852	20	and	and	CC
cord-023095-4dannjjm	5852	21	42	42	CD
cord-023095-4dannjjm	5852	22	clinically	clinically	RB
cord-023095-4dannjjm	5852	23	normal	normal	JJ
cord-023095-4dannjjm	5852	24	age	age	NN
cord-023095-4dannjjm	5852	25	-	-	HYPH
cord-023095-4dannjjm	5852	26	matched	match	VBN
cord-023095-4dannjjm	5852	27	control	control	NN
cord-023095-4dannjjm	5852	28	dogs	dog	NNS
cord-023095-4dannjjm	5852	29	were	be	VBD
cord-023095-4dannjjm	5852	30	included	include	VBN
cord-023095-4dannjjm	5852	31	in	in	IN
cord-023095-4dannjjm	5852	32	the	the	DT
cord-023095-4dannjjm	5852	33	study	study	NN
cord-023095-4dannjjm	5852	34	.	.	.
cord-023095-4dannjjm	5853	1	The	the	DT
cord-023095-4dannjjm	5853	2	neurological	neurological	JJ
cord-023095-4dannjjm	5853	3	severity	severity	NN
cord-023095-4dannjjm	5853	4	of	of	IN
cord-023095-4dannjjm	5853	5	the	the	DT
cord-023095-4dannjjm	5853	6	DM	DM	NNP
cord-023095-4dannjjm	5853	7	dogs	dog	NNS
cord-023095-4dannjjm	5853	8	was	be	VBD
cord-023095-4dannjjm	5853	9	graded	grade	VBN
cord-023095-4dannjjm	5853	10	(	(	-LRB-
cord-023095-4dannjjm	5853	11	1	1	CD
cord-023095-4dannjjm	5853	12	-	-	SYM
cord-023095-4dannjjm	5853	13	4	4	CD
cord-023095-4dannjjm	5853	14	)	)	-RRB-
cord-023095-4dannjjm	5853	15	using	use	VBG
cord-023095-4dannjjm	5853	16	an	an	DT
cord-023095-4dannjjm	5853	17	established	establish	VBN
cord-023095-4dannjjm	5853	18	scale	scale	NN
cord-023095-4dannjjm	5853	19	.	.	.
cord-023095-4dannjjm	5854	1	CSF	CSF	NNP
cord-023095-4dannjjm	5854	2	was	be	VBD
cord-023095-4dannjjm	5854	3	evaluated	evaluate	VBN
cord-023095-4dannjjm	5854	4	for	for	IN
cord-023095-4dannjjm	5854	5	presence	presence	NN
cord-023095-4dannjjm	5854	6	of	of	IN
cord-023095-4dannjjm	5854	7	glutamate	glutamate	NN
cord-023095-4dannjjm	5854	8	,	,	,
cord-023095-4dannjjm	5854	9	glycine	glycine	NN
cord-023095-4dannjjm	5854	10	and	and	CC
cord-023095-4dannjjm	5854	11	GABA	GABA	NNP
cord-023095-4dannjjm	5854	12	by	by	IN
cord-023095-4dannjjm	5854	13	high	high	JJ
cord-023095-4dannjjm	5854	14	performance	performance	NN
cord-023095-4dannjjm	5854	15	liquid	liquid	NN
cord-023095-4dannjjm	5854	16	chromatography	chromatography	NN
cord-023095-4dannjjm	5854	17	and	and	CC
cord-023095-4dannjjm	5854	18	for	for	IN
cord-023095-4dannjjm	5854	19	GM	GM	NNP
cord-023095-4dannjjm	5854	20	-	-	HYPH
cord-023095-4dannjjm	5854	21	CSF	CSF	NNP
cord-023095-4dannjjm	5854	22	,	,	,
cord-023095-4dannjjm	5854	23	IFN	IFN	NNP
cord-023095-4dannjjm	5854	24	-	-	HYPH
cord-023095-4dannjjm	5854	25	g	g	NNP
cord-023095-4dannjjm	5854	26	,	,	,
cord-023095-4dannjjm	5854	27	IL-2	IL-2	NNP
cord-023095-4dannjjm	5854	28	,	,	,
cord-023095-4dannjjm	5854	29	IL-4	IL-4	NNP
cord-023095-4dannjjm	5854	30	,	,	,
cord-023095-4dannjjm	5854	31	IL-6	IL-6	NNP
cord-023095-4dannjjm	5854	32	,	,	,
cord-023095-4dannjjm	5854	33	IL-7	IL-7	NNP
cord-023095-4dannjjm	5854	34	,	,	,
cord-023095-4dannjjm	5854	35	IL-8	IL-8	NNP
cord-023095-4dannjjm	5854	36	,	,	,
cord-023095-4dannjjm	5854	37	IL-10	IL-10	NNP
cord-023095-4dannjjm	5854	38	,	,	,
cord-023095-4dannjjm	5854	39	IL-15	IL-15	NNP
cord-023095-4dannjjm	5854	40	,	,	,
cord-023095-4dannjjm	5854	41	IL-18	IL-18	NNP
cord-023095-4dannjjm	5854	42	,	,	,
cord-023095-4dannjjm	5854	43	IP-10	IP-10	NNP
cord-023095-4dannjjm	5854	44	,	,	,
cord-023095-4dannjjm	5854	45	KC	KC	NNP
cord-023095-4dannjjm	5854	46	(	(	-LRB-
cord-023095-4dannjjm	5854	47	keratinocyte	keratinocyte	NNP
cord-023095-4dannjjm	5854	48	chemoattractant	chemoattractant	NNP
cord-023095-4dannjjm	5854	49	)	)	-RRB-
cord-023095-4dannjjm	5854	50	,	,	,
cord-023095-4dannjjm	5854	51	MCP-1	MCP-1	NNP
cord-023095-4dannjjm	5855	1	(	(	-LRB-
cord-023095-4dannjjm	5855	2	monocyte	monocyte	NNP
cord-023095-4dannjjm	5855	3	chemotactic	chemotactic	VBD
cord-023095-4dannjjm	5855	4	protein-1	protein-1	NNP
cord-023095-4dannjjm	5855	5	)	)	-RRB-
cord-023095-4dannjjm	5855	6	and	and	CC
cord-023095-4dannjjm	5855	7	TNF	TNF	NNP
cord-023095-4dannjjm	5855	8	-	-	,
cord-023095-4dannjjm	5855	9	a	a	DT
cord-023095-4dannjjm	5855	10	using	use	VBG
cord-023095-4dannjjm	5855	11	a	a	DT
cord-023095-4dannjjm	5855	12	commercially	commercially	RB
cord-023095-4dannjjm	5855	13	available	available	JJ
cord-023095-4dannjjm	5855	14	,	,	,
cord-023095-4dannjjm	5855	15	canine	canine	JJ
cord-023095-4dannjjm	5855	16	multiplex	multiplex	NN
cord-023095-4dannjjm	5855	17	immunoassay	immunoassay	NN
cord-023095-4dannjjm	5855	18	(	(	-LRB-
cord-023095-4dannjjm	5855	19	Millipore	Millipore	NNP
cord-023095-4dannjjm	5855	20	,	,	,
cord-023095-4dannjjm	5855	21	Billerica	Billerica	NNP
cord-023095-4dannjjm	5855	22	,	,	,
cord-023095-4dannjjm	5855	23	MA	MA	NNP
cord-023095-4dannjjm	5855	24	)	)	-RRB-
cord-023095-4dannjjm	5855	25	.	.	.
cord-023095-4dannjjm	5856	1	All	all	DT
cord-023095-4dannjjm	5856	2	data	data	NN
cord-023095-4dannjjm	5856	3	analyses	analysis	NNS
cord-023095-4dannjjm	5856	4	were	be	VBD
cord-023095-4dannjjm	5856	5	performed	perform	VBN
cord-023095-4dannjjm	5856	6	using	use	VBG
cord-023095-4dannjjm	5856	7	SAS	SAS	NNP
cord-023095-4dannjjm	5856	8	V	V	NNP
cord-023095-4dannjjm	5856	9	9.2	9.2	CD
cord-023095-4dannjjm	5856	10	(	(	-LRB-
cord-023095-4dannjjm	5856	11	Cary	Cary	NNP
cord-023095-4dannjjm	5856	12	,	,	,
cord-023095-4dannjjm	5856	13	NC	NC	NNP
cord-023095-4dannjjm	5856	14	)	)	-RRB-
cord-023095-4dannjjm	5856	15	.	.	.
cord-023095-4dannjjm	5857	1	Analyte	Analyte	NNP
cord-023095-4dannjjm	5857	2	levels	level	NNS
cord-023095-4dannjjm	5857	3	were	be	VBD
cord-023095-4dannjjm	5857	4	compared	compare	VBN
cord-023095-4dannjjm	5857	5	between	between	IN
cord-023095-4dannjjm	5857	6	DM	DM	NNP
cord-023095-4dannjjm	5857	7	confirmed	confirm	VBD
cord-023095-4dannjjm	5857	8	,	,	,
cord-023095-4dannjjm	5857	9	DM	DM	NNP
cord-023095-4dannjjm	5857	10	suspected	suspect	VBD
cord-023095-4dannjjm	5857	11	and	and	CC
cord-023095-4dannjjm	5857	12	control	control	NN
cord-023095-4dannjjm	5857	13	dogs	dog	NNS
cord-023095-4dannjjm	5857	14	by	by	IN
cord-023095-4dannjjm	5857	15	an	an	DT
cord-023095-4dannjjm	5857	16	analysis	analysis	NN
cord-023095-4dannjjm	5857	17	of	of	IN
cord-023095-4dannjjm	5857	18	variance	variance	NN
cord-023095-4dannjjm	5857	19	(	(	-LRB-
cord-023095-4dannjjm	5857	20	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	5857	21	)	)	-RRB-
cord-023095-4dannjjm	5857	22	.	.	.
cord-023095-4dannjjm	5858	1	Spearman	Spearman	NNP
cord-023095-4dannjjm	5858	2	correlation	correlation	NN
cord-023095-4dannjjm	5858	3	was	be	VBD
cord-023095-4dannjjm	5858	4	used	use	VBN
cord-023095-4dannjjm	5858	5	to	to	TO
cord-023095-4dannjjm	5858	6	test	test	VB
cord-023095-4dannjjm	5858	7	for	for	IN
cord-023095-4dannjjm	5858	8	correlations	correlation	NNS
cord-023095-4dannjjm	5858	9	of	of	IN
cord-023095-4dannjjm	5858	10	analyte	analyte	JJ
cord-023095-4dannjjm	5858	11	levels	level	NNS
cord-023095-4dannjjm	5858	12	and	and	CC
cord-023095-4dannjjm	5858	13	neurological	neurological	JJ
cord-023095-4dannjjm	5858	14	grades	grade	NNS
cord-023095-4dannjjm	5858	15	.	.	.
cord-023095-4dannjjm	5859	1	All	all	DT
cord-023095-4dannjjm	5859	2	hypothesis	hypothesis	NN
cord-023095-4dannjjm	5859	3	tests	test	NNS
cord-023095-4dannjjm	5859	4	were	be	VBD
cord-023095-4dannjjm	5859	5	2-sided	2-side	VBN
cord-023095-4dannjjm	5859	6	with	with	IN
cord-023095-4dannjjm	5859	7	a	a	DT
cord-023095-4dannjjm	5859	8	5	5	CD
cord-023095-4dannjjm	5859	9	0.05	0.05	CD
cord-023095-4dannjjm	5859	10	.	.	.
cord-023095-4dannjjm	5860	1	There	there	EX
cord-023095-4dannjjm	5860	2	were	be	VBD
cord-023095-4dannjjm	5860	3	no	no	DT
cord-023095-4dannjjm	5860	4	significant	significant	JJ
cord-023095-4dannjjm	5860	5	differences	difference	NNS
cord-023095-4dannjjm	5860	6	between	between	IN
cord-023095-4dannjjm	5860	7	individual	individual	JJ
cord-023095-4dannjjm	5860	8	CSF	CSF	NNP
cord-023095-4dannjjm	5860	9	analytes	analyte	NNS
cord-023095-4dannjjm	5860	10	in	in	IN
cord-023095-4dannjjm	5860	11	DM	DM	NNP
cord-023095-4dannjjm	5860	12	confirmed	confirm	VBD
cord-023095-4dannjjm	5860	13	and	and	CC
cord-023095-4dannjjm	5860	14	DM	DM	NNP
cord-023095-4dannjjm	5860	15	suspected	suspect	VBD
cord-023095-4dannjjm	5860	16	dogs	dog	NNS
cord-023095-4dannjjm	5860	17	.	.	.
cord-023095-4dannjjm	5861	1	Glutamate	glutamate	NN
cord-023095-4dannjjm	5861	2	levels	level	NNS
cord-023095-4dannjjm	5861	3	were	be	VBD
cord-023095-4dannjjm	5861	4	not	not	RB
cord-023095-4dannjjm	5861	5	significantly	significantly	RB
cord-023095-4dannjjm	5861	6	different	different	JJ
cord-023095-4dannjjm	5861	7	between	between	IN
cord-023095-4dannjjm	5861	8	DM	dm	NN
cord-023095-4dannjjm	5861	9	affected	affect	VBN
cord-023095-4dannjjm	5861	10	(	(	-LRB-
cord-023095-4dannjjm	5861	11	mean	mean	VBP
cord-023095-4dannjjm	5861	12	5	5	CD
cord-023095-4dannjjm	5861	13	0.09	0.09	CD
cord-023095-4dannjjm	5861	14	mg/	mg/	NN
cord-023095-4dannjjm	5861	15	ml	ml	NN
cord-023095-4dannjjm	5861	16	;	;	:
cord-023095-4dannjjm	5862	1	range	range	NN
cord-023095-4dannjjm	5862	2	5	5	CD
cord-023095-4dannjjm	5862	3	0.01	0.01	CD
cord-023095-4dannjjm	5862	4	-	-	HYPH
cord-023095-4dannjjm	5862	5	0.29	0.29	CD
cord-023095-4dannjjm	5862	6	;	;	:
cord-023095-4dannjjm	5862	7	SD	sd	NN
cord-023095-4dannjjm	5862	8	5	5	CD
cord-023095-4dannjjm	5862	9	0.069	0.069	CD
cord-023095-4dannjjm	5862	10	)	)	-RRB-
cord-023095-4dannjjm	5862	11	and	and	CC
cord-023095-4dannjjm	5862	12	control	control	NN
cord-023095-4dannjjm	5862	13	dogs	dog	NNS
cord-023095-4dannjjm	5862	14	(	(	-LRB-
cord-023095-4dannjjm	5862	15	mean	mean	VB
cord-023095-4dannjjm	5862	16	5	5	CD
cord-023095-4dannjjm	5862	17	0.07	0.07	CD
cord-023095-4dannjjm	5862	18	mg/	mg/	NN
cord-023095-4dannjjm	5862	19	ml	ml	NN
cord-023095-4dannjjm	5862	20	;	;	:
cord-023095-4dannjjm	5862	21	range	range	NN
cord-023095-4dannjjm	5862	22	5	5	CD
cord-023095-4dannjjm	5862	23	0.01	0.01	CD
cord-023095-4dannjjm	5862	24	-	-	HYPH
cord-023095-4dannjjm	5862	25	0.29	0.29	CD
cord-023095-4dannjjm	5862	26	;	;	:
cord-023095-4dannjjm	5862	27	SD	sd	NN
cord-023095-4dannjjm	5862	28	5	5	CD
cord-023095-4dannjjm	5862	29	0.056	0.056	CD
cord-023095-4dannjjm	5862	30	)	)	-RRB-
cord-023095-4dannjjm	5862	31	.	.	.
cord-023095-4dannjjm	5863	1	Control	control	NN
cord-023095-4dannjjm	5863	2	dogs	dog	NNS
cord-023095-4dannjjm	5863	3	(	(	-LRB-
cord-023095-4dannjjm	5863	4	mean	mean	VB
cord-023095-4dannjjm	5863	5	5	5	CD
cord-023095-4dannjjm	5863	6	0.86	0.86	CD
cord-023095-4dannjjm	5863	7	mg	mg	NNP
cord-023095-4dannjjm	5863	8	/	/	SYM
cord-023095-4dannjjm	5863	9	ml	ml	NN
cord-023095-4dannjjm	5863	10	;	;	:
cord-023095-4dannjjm	5863	11	range	range	VBP
cord-023095-4dannjjm	5863	12	5	5	CD
cord-023095-4dannjjm	5863	13	0.08	0.08	CD
cord-023095-4dannjjm	5863	14	-	-	HYPH
cord-023095-4dannjjm	5863	15	1.16	1.16	CD
cord-023095-4dannjjm	5863	16	;	;	:
cord-023095-4dannjjm	5863	17	SD	SD	NNP
cord-023095-4dannjjm	5863	18	5	5	CD
cord-023095-4dannjjm	5863	19	0.213	0.213	CD
cord-023095-4dannjjm	5863	20	)	)	-RRB-
cord-023095-4dannjjm	5863	21	had	have	VBD
cord-023095-4dannjjm	5863	22	significantly	significantly	RB
cord-023095-4dannjjm	5863	23	higher	high	JJR
cord-023095-4dannjjm	5863	24	levels	level	NNS
cord-023095-4dannjjm	5863	25	of	of	IN
cord-023095-4dannjjm	5863	26	GABA	GABA	NNP
cord-023095-4dannjjm	5863	27	(	(	-LRB-
cord-023095-4dannjjm	5863	28	p	p	NN
cord-023095-4dannjjm	5863	29	o	o	CD
cord-023095-4dannjjm	5863	30	0.0001	0.0001	CD
cord-023095-4dannjjm	5863	31	)	)	-RRB-
cord-023095-4dannjjm	5863	32	than	than	IN
cord-023095-4dannjjm	5863	33	DM	DM	NNP
cord-023095-4dannjjm	5863	34	dogs	dog	NNS
cord-023095-4dannjjm	5863	35	(	(	-LRB-
cord-023095-4dannjjm	5863	36	mean	mean	VBP
cord-023095-4dannjjm	5863	37	5	5	CD
cord-023095-4dannjjm	5863	38	0.12	0.12	CD
cord-023095-4dannjjm	5863	39	mg	mg	NNP
cord-023095-4dannjjm	5863	40	/	/	SYM
cord-023095-4dannjjm	5863	41	ml	ml	NN
cord-023095-4dannjjm	5863	42	;	;	:
cord-023095-4dannjjm	5863	43	range	range	NN
cord-023095-4dannjjm	5863	44	5	5	CD
cord-023095-4dannjjm	5863	45	0.07	0.07	CD
cord-023095-4dannjjm	5863	46	-	-	HYPH
cord-023095-4dannjjm	5863	47	0.79	0.79	CD
cord-023095-4dannjjm	5863	48	;	;	:
cord-023095-4dannjjm	5863	49	SD	sd	NN
cord-023095-4dannjjm	5863	50	5	5	CD
cord-023095-4dannjjm	5863	51	0.12	0.12	CD
cord-023095-4dannjjm	5863	52	)	)	-RRB-
cord-023095-4dannjjm	5863	53	.	.	.
cord-023095-4dannjjm	5864	1	Control	control	NN
cord-023095-4dannjjm	5864	2	dogs	dog	NNS
cord-023095-4dannjjm	5864	3	(	(	-LRB-
cord-023095-4dannjjm	5864	4	mean	mean	VB
cord-023095-4dannjjm	5864	5	5	5	CD
cord-023095-4dannjjm	5864	6	2.14	2.14	CD
cord-023095-4dannjjm	5864	7	mg	mg	NNP
cord-023095-4dannjjm	5864	8	/	/	SYM
cord-023095-4dannjjm	5864	9	ml	ml	NN
cord-023095-4dannjjm	5864	10	;	;	:
cord-023095-4dannjjm	5864	11	range	range	NN
cord-023095-4dannjjm	5864	12	5	5	CD
cord-023095-4dannjjm	5864	13	0.01	0.01	CD
cord-023095-4dannjjm	5864	14	-	-	HYPH
cord-023095-4dannjjm	5864	15	3.83	3.83	CD
cord-023095-4dannjjm	5864	16	;	;	:
cord-023095-4dannjjm	5864	17	SD	SD	NNP
cord-023095-4dannjjm	5864	18	5	5	CD
cord-023095-4dannjjm	5864	19	0.76	0.76	CD
cord-023095-4dannjjm	5864	20	)	)	-RRB-
cord-023095-4dannjjm	5864	21	also	also	RB
cord-023095-4dannjjm	5864	22	had	have	VBD
cord-023095-4dannjjm	5864	23	significantly	significantly	RB
cord-023095-4dannjjm	5864	24	higher	high	JJR
cord-023095-4dannjjm	5864	25	glycine	glycine	NN
cord-023095-4dannjjm	5864	26	concentrations	concentration	NNS
cord-023095-4dannjjm	5864	27	(	(	-LRB-
cord-023095-4dannjjm	5864	28	p	p	NN
cord-023095-4dannjjm	5864	29	o	o	NN
cord-023095-4dannjjm	5864	30	0.0001	0.0001	CD
cord-023095-4dannjjm	5864	31	)	)	-RRB-
cord-023095-4dannjjm	5864	32	than	than	IN
cord-023095-4dannjjm	5864	33	DM	DM	NNP
cord-023095-4dannjjm	5864	34	dogs	dog	NNS
cord-023095-4dannjjm	5864	35	(	(	-LRB-
cord-023095-4dannjjm	5864	36	mean	mean	VB
cord-023095-4dannjjm	5865	1	5	5	CD
cord-023095-4dannjjm	5865	2	0.45	0.45	CD
cord-023095-4dannjjm	5865	3	mg	mg	NNP
cord-023095-4dannjjm	5865	4	/	/	SYM
cord-023095-4dannjjm	5865	5	ml	ml	NN
cord-023095-4dannjjm	5865	6	;	;	:
cord-023095-4dannjjm	5866	1	range	range	NN
cord-023095-4dannjjm	5866	2	5	5	CD
cord-023095-4dannjjm	5866	3	0.01	0.01	CD
cord-023095-4dannjjm	5866	4	-	-	HYPH
cord-023095-4dannjjm	5866	5	0.98	0.98	CD
cord-023095-4dannjjm	5866	6	;	;	:
cord-023095-4dannjjm	5866	7	SD	sd	NN
cord-023095-4dannjjm	5866	8	5	5	CD
cord-023095-4dannjjm	5866	9	0.24	0.24	CD
cord-023095-4dannjjm	5866	10	)	)	-RRB-
cord-023095-4dannjjm	5866	11	.	.	.
cord-023095-4dannjjm	5867	1	DM	dm	NN
cord-023095-4dannjjm	5867	2	-	-	HYPH
cord-023095-4dannjjm	5867	3	affected	affect	VBN
cord-023095-4dannjjm	5867	4	dogs	dog	NNS
cord-023095-4dannjjm	5867	5	also	also	RB
cord-023095-4dannjjm	5867	6	had	have	VBD
cord-023095-4dannjjm	5867	7	significantly	significantly	RB
cord-023095-4dannjjm	5867	8	higher	high	JJR
cord-023095-4dannjjm	5867	9	levels	level	NNS
cord-023095-4dannjjm	5867	10	of	of	IN
cord-023095-4dannjjm	5867	11	IL-2	il-2	NN
cord-023095-4dannjjm	5867	12	(	(	-LRB-
cord-023095-4dannjjm	5867	13	p	p	NN
cord-023095-4dannjjm	5867	14	5	5	CD
cord-023095-4dannjjm	5867	15	0.03	0.03	CD
cord-023095-4dannjjm	5867	16	)	)	-RRB-
cord-023095-4dannjjm	5867	17	,	,	,
cord-023095-4dannjjm	5867	18	KC	KC	NNP
cord-023095-4dannjjm	5867	19	(	(	-LRB-
cord-023095-4dannjjm	5867	20	p	p	NN
cord-023095-4dannjjm	5867	21	o	o	CD
cord-023095-4dannjjm	5867	22	0.0001	0.0001	CD
cord-023095-4dannjjm	5867	23	)	)	-RRB-
cord-023095-4dannjjm	5867	24	and	and	CC
cord-023095-4dannjjm	5867	25	MCP-1	MCP-1	NNP
cord-023095-4dannjjm	5868	1	(	(	-LRB-
cord-023095-4dannjjm	5868	2	p	p	NN
cord-023095-4dannjjm	5868	3	5	5	CD
cord-023095-4dannjjm	5868	4	0.005	0.005	CD
cord-023095-4dannjjm	5868	5	)	)	-RRB-
cord-023095-4dannjjm	5868	6	than	than	IN
cord-023095-4dannjjm	5868	7	control	control	NN
cord-023095-4dannjjm	5868	8	dogs	dog	NNS
cord-023095-4dannjjm	5868	9	.	.	.
cord-023095-4dannjjm	5869	1	Neurotransmitter	neurotransmitter	NN
cord-023095-4dannjjm	5869	2	levels	level	NNS
cord-023095-4dannjjm	5869	3	were	be	VBD
cord-023095-4dannjjm	5869	4	not	not	RB
cord-023095-4dannjjm	5869	5	significantly	significantly	RB
cord-023095-4dannjjm	5869	6	associated	associate	VBN
cord-023095-4dannjjm	5869	7	with	with	IN
cord-023095-4dannjjm	5869	8	neurological	neurological	JJ
cord-023095-4dannjjm	5869	9	grade	grade	NN
cord-023095-4dannjjm	5869	10	.	.	.
cord-023095-4dannjjm	5870	1	KC	KC	NNP
cord-023095-4dannjjm	5870	2	levels	level	NNS
cord-023095-4dannjjm	5870	3	were	be	VBD
cord-023095-4dannjjm	5870	4	significantly	significantly	RB
cord-023095-4dannjjm	5870	5	higher	high	JJR
cord-023095-4dannjjm	5870	6	in	in	IN
cord-023095-4dannjjm	5870	7	the	the	DT
cord-023095-4dannjjm	5870	8	least	least	JJS
cord-023095-4dannjjm	5870	9	affected	affected	JJ
cord-023095-4dannjjm	5870	10	dogs	dog	NNS
cord-023095-4dannjjm	5870	11	(	(	-LRB-
cord-023095-4dannjjm	5870	12	p	p	NN
cord-023095-4dannjjm	5870	13	5	5	CD
cord-023095-4dannjjm	5870	14	0.0015	0.0015	CD
cord-023095-4dannjjm	5870	15	)	)	-RRB-
cord-023095-4dannjjm	5870	16	.	.	.
cord-023095-4dannjjm	5871	1	There	there	EX
cord-023095-4dannjjm	5871	2	were	be	VBD
cord-023095-4dannjjm	5871	3	no	no	DT
cord-023095-4dannjjm	5871	4	associations	association	NNS
cord-023095-4dannjjm	5871	5	with	with	IN
cord-023095-4dannjjm	5871	6	disease	disease	NN
cord-023095-4dannjjm	5871	7	severity	severity	NN
cord-023095-4dannjjm	5871	8	and	and	CC
cord-023095-4dannjjm	5871	9	analyte	analyte	NN
cord-023095-4dannjjm	5871	10	concentrations	concentration	NNS
cord-023095-4dannjjm	5871	11	.	.	.
cord-023095-4dannjjm	5872	1	DM	DM	NNP
cord-023095-4dannjjm	5872	2	affected	affect	VBD
cord-023095-4dannjjm	5872	3	dogs	dog	NNS
cord-023095-4dannjjm	5872	4	have	have	VBP
cord-023095-4dannjjm	5872	5	an	an	DT
cord-023095-4dannjjm	5872	6	imbalance	imbalance	NN
cord-023095-4dannjjm	5872	7	of	of	IN
cord-023095-4dannjjm	5872	8	CSF	CSF	NNP
cord-023095-4dannjjm	5872	9	AA	AA	NNP
cord-023095-4dannjjm	5872	10	concentrations	concentration	NNS
cord-023095-4dannjjm	5872	11	creating	create	VBG
cord-023095-4dannjjm	5872	12	a	a	DT
cord-023095-4dannjjm	5872	13	relatively	relatively	RB
cord-023095-4dannjjm	5872	14	excitotoxic	excitotoxic	JJ
cord-023095-4dannjjm	5872	15	environment	environment	NN
cord-023095-4dannjjm	5872	16	.	.	.
cord-023095-4dannjjm	5873	1	Reports	report	NNS
cord-023095-4dannjjm	5873	2	in	in	IN
cord-023095-4dannjjm	5873	3	human	human	JJ
cord-023095-4dannjjm	5873	4	ALS	ALS	NNP
cord-023095-4dannjjm	5873	5	confirm	confirm	VBP
cord-023095-4dannjjm	5873	6	an	an	DT
cord-023095-4dannjjm	5873	7	imbalance	imbalance	NN
cord-023095-4dannjjm	5873	8	between	between	IN
cord-023095-4dannjjm	5873	9	CSF	csf	NN
cord-023095-4dannjjm	5873	10	excitatory	excitatory	JJ
cord-023095-4dannjjm	5873	11	and	and	CC
cord-023095-4dannjjm	5873	12	inhibitory	inhibitory	JJ
cord-023095-4dannjjm	5873	13	AAs	aa	NNS
cord-023095-4dannjjm	5873	14	suggesting	suggest	VBG
cord-023095-4dannjjm	5873	15	a	a	DT
cord-023095-4dannjjm	5873	16	pathogenic	pathogenic	JJ
cord-023095-4dannjjm	5873	17	role	role	NN
cord-023095-4dannjjm	5873	18	for	for	IN
cord-023095-4dannjjm	5873	19	excitotoxicity	excitotoxicity	NN
cord-023095-4dannjjm	5873	20	in	in	IN
cord-023095-4dannjjm	5873	21	ALS	ALS	NNP
cord-023095-4dannjjm	5873	22	.	.	.
cord-023095-4dannjjm	5874	1	It	-PRON-	PRP
cord-023095-4dannjjm	5874	2	also	also	RB
cord-023095-4dannjjm	5874	3	appears	appear	VBZ
cord-023095-4dannjjm	5874	4	that	that	IN
cord-023095-4dannjjm	5874	5	DM	DM	NNP
cord-023095-4dannjjm	5874	6	affected	affect	VBN
cord-023095-4dannjjm	5874	7	dogs	dog	NNS
cord-023095-4dannjjm	5874	8	have	have	VBP
cord-023095-4dannjjm	5874	9	increases	increase	NNS
cord-023095-4dannjjm	5874	10	in	in	IN
cord-023095-4dannjjm	5874	11	CSF	CSF	NNP
cord-023095-4dannjjm	5874	12	cytokines	cytokine	NNS
cord-023095-4dannjjm	5874	13	and	and	CC
cord-023095-4dannjjm	5874	14	chemokines	chemokine	NNS
cord-023095-4dannjjm	5874	15	suggestive	suggestive	JJ
cord-023095-4dannjjm	5874	16	of	of	IN
cord-023095-4dannjjm	5874	17	an	an	DT
cord-023095-4dannjjm	5874	18	immunologic	immunologic	JJ
cord-023095-4dannjjm	5874	19	component	component	NN
cord-023095-4dannjjm	5874	20	to	to	IN
cord-023095-4dannjjm	5874	21	the	the	DT
cord-023095-4dannjjm	5874	22	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	5874	23	as	as	IN
cord-023095-4dannjjm	5874	24	is	be	VBZ
cord-023095-4dannjjm	5874	25	similar	similar	JJ
cord-023095-4dannjjm	5874	26	to	to	IN
cord-023095-4dannjjm	5874	27	ALS	ALS	NNP
cord-023095-4dannjjm	5874	28	.	.	.
cord-023095-4dannjjm	5875	1	Further	further	JJ
cord-023095-4dannjjm	5875	2	prospective	prospective	JJ
cord-023095-4dannjjm	5875	3	analysis	analysis	NN
cord-023095-4dannjjm	5875	4	of	of	IN
cord-023095-4dannjjm	5875	5	DM	DM	NNP
cord-023095-4dannjjm	5875	6	is	be	VBZ
cord-023095-4dannjjm	5875	7	warranted	warrant	VBN
cord-023095-4dannjjm	5875	8	to	to	TO
cord-023095-4dannjjm	5875	9	evaluate	evaluate	VB
cord-023095-4dannjjm	5875	10	the	the	DT
cord-023095-4dannjjm	5875	11	role	role	NN
cord-023095-4dannjjm	5875	12	of	of	IN
cord-023095-4dannjjm	5875	13	treatment	treatment	NN
cord-023095-4dannjjm	5875	14	on	on	IN
cord-023095-4dannjjm	5875	15	CSF	csf	NN
cord-023095-4dannjjm	5875	16	variables	variable	NNS
cord-023095-4dannjjm	5875	17	.	.	.
cord-023095-4dannjjm	5876	1	The	the	DT
cord-023095-4dannjjm	5876	2	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	5876	3	of	of	IN
cord-023095-4dannjjm	5876	4	neuropathic	neuropathic	JJ
cord-023095-4dannjjm	5876	5	pain	pain	NN
cord-023095-4dannjjm	5876	6	(	(	-LRB-
cord-023095-4dannjjm	5876	7	NP	NP	NNP
cord-023095-4dannjjm	5876	8	)	)	-RRB-
cord-023095-4dannjjm	5876	9	and	and	CC
cord-023095-4dannjjm	5876	10	syringomyelia	syringomyelia	NNP
cord-023095-4dannjjm	5876	11	(	(	-LRB-
cord-023095-4dannjjm	5876	12	SM	SM	NNP
cord-023095-4dannjjm	5876	13	)	)	-RRB-
cord-023095-4dannjjm	5876	14	in	in	IN
cord-023095-4dannjjm	5876	15	association	association	NN
cord-023095-4dannjjm	5876	16	with	with	IN
cord-023095-4dannjjm	5876	17	Chiari	Chiari	NNP
cord-023095-4dannjjm	5876	18	-	-	HYPH
cord-023095-4dannjjm	5876	19	like	like	JJ
cord-023095-4dannjjm	5876	20	malformation	malformation	NN
cord-023095-4dannjjm	5876	21	(	(	-LRB-
cord-023095-4dannjjm	5876	22	CLM	CLM	NNP
cord-023095-4dannjjm	5876	23	)	)	-RRB-
cord-023095-4dannjjm	5876	24	in	in	IN
cord-023095-4dannjjm	5876	25	dogs	dog	NNS
cord-023095-4dannjjm	5876	26	has	have	VBZ
cord-023095-4dannjjm	5876	27	focused	focus	VBN
cord-023095-4dannjjm	5876	28	on	on	IN
cord-023095-4dannjjm	5876	29	the	the	DT
cord-023095-4dannjjm	5876	30	anatomical	anatomical	JJ
cord-023095-4dannjjm	5876	31	anomalies	anomaly	NNS
cord-023095-4dannjjm	5876	32	and	and	CC
cord-023095-4dannjjm	5876	33	secondary	secondary	JJ
cord-023095-4dannjjm	5876	34	cerebrospinal	cerebrospinal	NN
cord-023095-4dannjjm	5876	35	fluid	fluid	NN
cord-023095-4dannjjm	5876	36	(	(	-LRB-
cord-023095-4dannjjm	5876	37	CSF	CSF	NNP
cord-023095-4dannjjm	5876	38	)	)	-RRB-
cord-023095-4dannjjm	5876	39	flow	flow	NN
cord-023095-4dannjjm	5876	40	abnormalities	abnormality	NNS
cord-023095-4dannjjm	5876	41	.	.	.
cord-023095-4dannjjm	5877	1	Neuropathic	neuropathic	JJ
cord-023095-4dannjjm	5877	2	pain	pain	NN
cord-023095-4dannjjm	5877	3	in	in	IN
cord-023095-4dannjjm	5877	4	humans	human	NNS
cord-023095-4dannjjm	5877	5	has	have	VBZ
cord-023095-4dannjjm	5877	6	been	be	VBN
cord-023095-4dannjjm	5877	7	associated	associate	VBN
cord-023095-4dannjjm	5877	8	with	with	IN
cord-023095-4dannjjm	5877	9	abnormalities	abnormality	NNS
cord-023095-4dannjjm	5877	10	of	of	IN
cord-023095-4dannjjm	5877	11	neurotransmitters	neurotransmitter	NNS
cord-023095-4dannjjm	5877	12	such	such	JJ
cord-023095-4dannjjm	5877	13	as	as	IN
cord-023095-4dannjjm	5877	14	glutamate	glutamate	NN
cord-023095-4dannjjm	5877	15	and	and	CC
cord-023095-4dannjjm	5877	16	serotonin	serotonin	NN
cord-023095-4dannjjm	5877	17	as	as	RB
cord-023095-4dannjjm	5877	18	well	well	RB
cord-023095-4dannjjm	5877	19	as	as	IN
cord-023095-4dannjjm	5877	20	immunologic	immunologic	JJ
cord-023095-4dannjjm	5877	21	mechanisms	mechanism	NNS
cord-023095-4dannjjm	5877	22	.	.	.
cord-023095-4dannjjm	5878	1	The	the	DT
cord-023095-4dannjjm	5878	2	aim	aim	NN
cord-023095-4dannjjm	5878	3	of	of	IN
cord-023095-4dannjjm	5878	4	this	this	DT
cord-023095-4dannjjm	5878	5	study	study	NN
cord-023095-4dannjjm	5878	6	was	be	VBD
cord-023095-4dannjjm	5878	7	to	to	TO
cord-023095-4dannjjm	5878	8	investigate	investigate	VB
cord-023095-4dannjjm	5878	9	the	the	DT
cord-023095-4dannjjm	5878	10	CSF	CSF	NNP
cord-023095-4dannjjm	5878	11	neurotransmitter	neurotransmitter	NN
cord-023095-4dannjjm	5878	12	and	and	CC
cord-023095-4dannjjm	5878	13	cytokine	cytokine	NN
cord-023095-4dannjjm	5878	14	levels	level	NNS
cord-023095-4dannjjm	5878	15	in	in	IN
cord-023095-4dannjjm	5878	16	Brussels	Brussels	NNP
cord-023095-4dannjjm	5878	17	Griffon	Griffon	NNP
cord-023095-4dannjjm	5878	18	dogs	dog	NNS
cord-023095-4dannjjm	5878	19	(	(	-LRB-
cord-023095-4dannjjm	5878	20	BGs	BGs	NNP
cord-023095-4dannjjm	5878	21	)	)	-RRB-
cord-023095-4dannjjm	5878	22	with	with	IN
cord-023095-4dannjjm	5878	23	CLM	CLM	NNP
cord-023095-4dannjjm	5878	24	,	,	,
cord-023095-4dannjjm	5878	25	SM	SM	NNP
cord-023095-4dannjjm	5878	26	and	and	CC
cord-023095-4dannjjm	5878	27	NP	NP	NNP
cord-023095-4dannjjm	5878	28	.	.	.
cord-023095-4dannjjm	5879	1	As	as	IN
cord-023095-4dannjjm	5879	2	part	part	NN
cord-023095-4dannjjm	5879	3	of	of	IN
cord-023095-4dannjjm	5879	4	an	an	DT
cord-023095-4dannjjm	5879	5	MRI	MRI	NNP
cord-023095-4dannjjm	5879	6	study	study	NN
cord-023095-4dannjjm	5879	7	investigating	investigate	VBG
cord-023095-4dannjjm	5879	8	the	the	DT
cord-023095-4dannjjm	5879	9	prevalence	prevalence	NN
cord-023095-4dannjjm	5879	10	of	of	IN
cord-023095-4dannjjm	5879	11	SM	SM	NNP
cord-023095-4dannjjm	5879	12	in	in	IN
cord-023095-4dannjjm	5879	13	BGs	bg	NNS
cord-023095-4dannjjm	5879	14	,	,	,
cord-023095-4dannjjm	5879	15	atlanto	atlanto	NNP
cord-023095-4dannjjm	5879	16	-	-	HYPH
cord-023095-4dannjjm	5879	17	occipital	occipital	NNP
cord-023095-4dannjjm	5879	18	CSF	CSF	NNP
cord-023095-4dannjjm	5879	19	was	be	VBD
cord-023095-4dannjjm	5879	20	acquired	acquire	VBN
cord-023095-4dannjjm	5879	21	from	from	IN
cord-023095-4dannjjm	5879	22	46	46	CD
cord-023095-4dannjjm	5879	23	dogs	dog	NNS
cord-023095-4dannjjm	5879	24	and	and	CC
cord-023095-4dannjjm	5879	25	stored	store	VBN
cord-023095-4dannjjm	5879	26	at	at	IN
cord-023095-4dannjjm	5879	27	-80C	-80C	NNP
cord-023095-4dannjjm	5879	28	until	until	IN
cord-023095-4dannjjm	5879	29	analysis	analysis	NN
cord-023095-4dannjjm	5879	30	.	.	.
cord-023095-4dannjjm	5880	1	All	all	DT
cord-023095-4dannjjm	5880	2	dogs	dog	NNS
cord-023095-4dannjjm	5880	3	underwent	undergo	VBD
cord-023095-4dannjjm	5880	4	a	a	DT
cord-023095-4dannjjm	5880	5	neurologic	neurologic	JJ
cord-023095-4dannjjm	5880	6	exam	exam	NN
cord-023095-4dannjjm	5880	7	prior	prior	RB
cord-023095-4dannjjm	5880	8	to	to	IN
cord-023095-4dannjjm	5880	9	MRI	MRI	NNP
cord-023095-4dannjjm	5880	10	;	;	:
cord-023095-4dannjjm	5880	11	Osirix	Osirix	NNP
cord-023095-4dannjjm	5880	12	s	s	NNP
cord-023095-4dannjjm	5880	13	software	software	NN
cord-023095-4dannjjm	5880	14	was	be	VBD
cord-023095-4dannjjm	5880	15	used	use	VBN
cord-023095-4dannjjm	5880	16	to	to	TO
cord-023095-4dannjjm	5880	17	measure	measure	VB
cord-023095-4dannjjm	5880	18	SM	SM	NNP
cord-023095-4dannjjm	5880	19	and	and	CC
cord-023095-4dannjjm	5880	20	the	the	DT
cord-023095-4dannjjm	5880	21	presence	presence	NN
cord-023095-4dannjjm	5880	22	of	of	IN
cord-023095-4dannjjm	5880	23	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	5880	24	herniation	herniation	NN
cord-023095-4dannjjm	5880	25	and	and	CC
cord-023095-4dannjjm	5880	26	deviation	deviation	NN
cord-023095-4dannjjm	5880	27	were	be	VBD
cord-023095-4dannjjm	5880	28	recorded	record	VBN
cord-023095-4dannjjm	5880	29	.	.	.
cord-023095-4dannjjm	5881	1	Deproteinized	Deproteinized	NNP
cord-023095-4dannjjm	5881	2	CSF	CSF	NNP
cord-023095-4dannjjm	5881	3	samples	sample	NNS
cord-023095-4dannjjm	5881	4	were	be	VBD
cord-023095-4dannjjm	5881	5	analysed	analyse	VBN
cord-023095-4dannjjm	5881	6	for	for	IN
cord-023095-4dannjjm	5881	7	presence	presence	NN
cord-023095-4dannjjm	5881	8	of	of	IN
cord-023095-4dannjjm	5881	9	serotonin	serotonin	NN
cord-023095-4dannjjm	5881	10	(	(	-LRB-
cord-023095-4dannjjm	5881	11	ng	ng	NNP
cord-023095-4dannjjm	5881	12	/	/	SYM
cord-023095-4dannjjm	5881	13	ml	ml	NNP
cord-023095-4dannjjm	5881	14	)	)	-RRB-
cord-023095-4dannjjm	5881	15	,	,	,
cord-023095-4dannjjm	5881	16	glutamate	glutamate	NN
cord-023095-4dannjjm	5881	17	,	,	,
cord-023095-4dannjjm	5881	18	glycine	glycine	NN
cord-023095-4dannjjm	5881	19	and	and	CC
cord-023095-4dannjjm	5881	20	GABA	GABA	NNP
cord-023095-4dannjjm	5882	1	(	(	-LRB-
cord-023095-4dannjjm	5882	2	mg	mg	NNP
cord-023095-4dannjjm	5882	3	/	/	SYM
cord-023095-4dannjjm	5882	4	ml	ml	NNP
cord-023095-4dannjjm	5882	5	)	)	-RRB-
cord-023095-4dannjjm	5882	6	by	by	IN
cord-023095-4dannjjm	5882	7	high	high	JJ
cord-023095-4dannjjm	5882	8	performance	performance	NN
cord-023095-4dannjjm	5882	9	liquid	liquid	NN
cord-023095-4dannjjm	5882	10	chromatography	chromatography	NN
cord-023095-4dannjjm	5882	11	.	.	.
cord-023095-4dannjjm	5883	1	All	all	DT
cord-023095-4dannjjm	5883	2	CSF	CSF	NNP
cord-023095-4dannjjm	5883	3	samples	sample	NNS
cord-023095-4dannjjm	5883	4	were	be	VBD
cord-023095-4dannjjm	5883	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	5883	6	simultaneously	simultaneously	RB
cord-023095-4dannjjm	5883	7	for	for	IN
cord-023095-4dannjjm	5883	8	GM	GM	NNP
cord-023095-4dannjjm	5883	9	-	-	HYPH
cord-023095-4dannjjm	5883	10	CSF	CSF	NNP
cord-023095-4dannjjm	5883	11	,	,	,
cord-023095-4dannjjm	5883	12	IFN	IFN	NNP
cord-023095-4dannjjm	5883	13	-	-	HYPH
cord-023095-4dannjjm	5883	14	g	g	NNP
cord-023095-4dannjjm	5883	15	,	,	,
cord-023095-4dannjjm	5883	16	IL-2	IL-2	NNP
cord-023095-4dannjjm	5883	17	,	,	,
cord-023095-4dannjjm	5883	18	IL-4	IL-4	NNP
cord-023095-4dannjjm	5883	19	,	,	,
cord-023095-4dannjjm	5883	20	IL-6	IL-6	NNP
cord-023095-4dannjjm	5883	21	,	,	,
cord-023095-4dannjjm	5883	22	IL-7	IL-7	NNP
cord-023095-4dannjjm	5883	23	,	,	,
cord-023095-4dannjjm	5883	24	IL-8	IL-8	NNP
cord-023095-4dannjjm	5883	25	,	,	,
cord-023095-4dannjjm	5883	26	IL-10	IL-10	NNP
cord-023095-4dannjjm	5883	27	,	,	,
cord-023095-4dannjjm	5883	28	IL-15	IL-15	NNP
cord-023095-4dannjjm	5883	29	,	,	,
cord-023095-4dannjjm	5883	30	IL-18	IL-18	NNP
cord-023095-4dannjjm	5883	31	,	,	,
cord-023095-4dannjjm	5883	32	IP-10	IP-10	NNP
cord-023095-4dannjjm	5883	33	,	,	,
cord-023095-4dannjjm	5883	34	KC	KC	NNP
cord-023095-4dannjjm	5883	35	,	,	,
cord-023095-4dannjjm	5883	36	MCP-1	MCP-1	NNP
cord-023095-4dannjjm	5883	37	and	and	CC
cord-023095-4dannjjm	5883	38	TNF	TNF	NNP
cord-023095-4dannjjm	5883	39	-	-	HYPH
cord-023095-4dannjjm	5883	40	a	a	NN
cord-023095-4dannjjm	5883	41	.	.	.
cord-023095-4dannjjm	5884	1	A	a	DT
cord-023095-4dannjjm	5884	2	commercially	commercially	RB
cord-023095-4dannjjm	5884	3	available	available	JJ
cord-023095-4dannjjm	5884	4	,	,	,
cord-023095-4dannjjm	5884	5	canine	canine	JJ
cord-023095-4dannjjm	5884	6	multiplex	multiplex	NN
cord-023095-4dannjjm	5884	7	immunoassay	immunoassay	NN
cord-023095-4dannjjm	5884	8	(	(	-LRB-
cord-023095-4dannjjm	5884	9	Millipore	Millipore	NNP
cord-023095-4dannjjm	5884	10	,	,	,
cord-023095-4dannjjm	5884	11	Billerica	Billerica	NNP
cord-023095-4dannjjm	5884	12	,	,	,
cord-023095-4dannjjm	5884	13	MA	MA	NNP
cord-023095-4dannjjm	5884	14	)	)	-RRB-
cord-023095-4dannjjm	5884	15	was	be	VBD
cord-023095-4dannjjm	5884	16	used	use	VBN
cord-023095-4dannjjm	5884	17	for	for	IN
cord-023095-4dannjjm	5884	18	the	the	DT
cord-023095-4dannjjm	5884	19	cytokine	cytokine	NN
cord-023095-4dannjjm	5884	20	analysis	analysis	NN
cord-023095-4dannjjm	5884	21	(	(	-LRB-
cord-023095-4dannjjm	5884	22	pg	pg	NNP
cord-023095-4dannjjm	5884	23	/	/	SYM
cord-023095-4dannjjm	5884	24	ml	ml	NNP
cord-023095-4dannjjm	5884	25	)	)	-RRB-
cord-023095-4dannjjm	5884	26	.	.	.
cord-023095-4dannjjm	5885	1	Student	student	NN
cord-023095-4dannjjm	5885	2	's	's	POS
cord-023095-4dannjjm	5885	3	t	t	NN
cord-023095-4dannjjm	5885	4	-	-	HYPH
cord-023095-4dannjjm	5885	5	tests	test	NNS
cord-023095-4dannjjm	5885	6	were	be	VBD
cord-023095-4dannjjm	5885	7	used	use	VBN
cord-023095-4dannjjm	5885	8	to	to	TO
cord-023095-4dannjjm	5885	9	compare	compare	VB
cord-023095-4dannjjm	5885	10	the	the	DT
cord-023095-4dannjjm	5885	11	means	mean	NNS
cord-023095-4dannjjm	5885	12	of	of	IN
cord-023095-4dannjjm	5885	13	neurotransmitter	neurotransmitter	NN
cord-023095-4dannjjm	5885	14	and	and	CC
cord-023095-4dannjjm	5885	15	cytokine	cytokine	NN
cord-023095-4dannjjm	5885	16	values	value	NNS
cord-023095-4dannjjm	5885	17	between	between	IN
cord-023095-4dannjjm	5885	18	groups	group	NNS
cord-023095-4dannjjm	5885	19	with	with	IN
cord-023095-4dannjjm	5885	20	and	and	CC
cord-023095-4dannjjm	5885	21	without	without	IN
cord-023095-4dannjjm	5885	22	skull	skull	NN
cord-023095-4dannjjm	5885	23	abnormalities	abnormality	NNS
cord-023095-4dannjjm	5885	24	or	or	CC
cord-023095-4dannjjm	5885	25	spinal	spinal	JJ
cord-023095-4dannjjm	5885	26	pain	pain	NN
cord-023095-4dannjjm	5885	27	.	.	.
cord-023095-4dannjjm	5886	1	Simple	Simple	NNP
cord-023095-4dannjjm	5886	2	Pearson	Pearson	NNP
cord-023095-4dannjjm	5886	3	's	's	POS
cord-023095-4dannjjm	5886	4	correlation	correlation	NN
cord-023095-4dannjjm	5886	5	was	be	VBD
cord-023095-4dannjjm	5886	6	used	use	VBN
cord-023095-4dannjjm	5886	7	to	to	TO
cord-023095-4dannjjm	5886	8	test	test	VB
cord-023095-4dannjjm	5886	9	for	for	IN
cord-023095-4dannjjm	5886	10	correlations	correlation	NNS
cord-023095-4dannjjm	5886	11	of	of	IN
cord-023095-4dannjjm	5886	12	neurotransmitter	neurotransmitter	NN
cord-023095-4dannjjm	5886	13	and	and	CC
cord-023095-4dannjjm	5886	14	cytokine	cytokine	NN
cord-023095-4dannjjm	5886	15	values	value	NNS
cord-023095-4dannjjm	5886	16	with	with	IN
cord-023095-4dannjjm	5886	17	syrinx	syrinx	NNP
cord-023095-4dannjjm	5886	18	dimensions	dimension	NNS
cord-023095-4dannjjm	5886	19	and	and	CC
cord-023095-4dannjjm	5886	20	correlations	correlation	NNS
cord-023095-4dannjjm	5886	21	of	of	IN
cord-023095-4dannjjm	5886	22	neurotransmitter	neurotransmitter	NN
cord-023095-4dannjjm	5886	23	with	with	IN
cord-023095-4dannjjm	5886	24	cytokine	cytokine	JJ
cord-023095-4dannjjm	5886	25	values	value	NNS
cord-023095-4dannjjm	5886	26	.	.	.
cord-023095-4dannjjm	5887	1	All	all	DT
cord-023095-4dannjjm	5887	2	hypothesis	hypothesis	NN
cord-023095-4dannjjm	5887	3	tests	test	NNS
cord-023095-4dannjjm	5887	4	were	be	VBD
cord-023095-4dannjjm	5887	5	2-sided	2-sided	JJ
cord-023095-4dannjjm	5887	6	and	and	CC
cord-023095-4dannjjm	5887	7	the	the	DT
cord-023095-4dannjjm	5887	8	significance	significance	NN
cord-023095-4dannjjm	5887	9	level	level	NN
cord-023095-4dannjjm	5887	10	was	be	VBD
cord-023095-4dannjjm	5887	11	a	a	DT
cord-023095-4dannjjm	5887	12	5	5	CD
cord-023095-4dannjjm	5887	13	0.05	0.05	CD
cord-023095-4dannjjm	5887	14	.	.	.
cord-023095-4dannjjm	5888	1	NP	NP	NNP
cord-023095-4dannjjm	5888	2	was	be	VBD
cord-023095-4dannjjm	5888	3	detected	detect	VBN
cord-023095-4dannjjm	5888	4	in	in	IN
cord-023095-4dannjjm	5888	5	8	8	CD
cord-023095-4dannjjm	5888	6	dogs	dog	NNS
cord-023095-4dannjjm	5888	7	(	(	-LRB-
cord-023095-4dannjjm	5888	8	17	17	CD
cord-023095-4dannjjm	5888	9	%	%	NN
cord-023095-4dannjjm	5888	10	)	)	-RRB-
cord-023095-4dannjjm	5888	11	;	;	:
cord-023095-4dannjjm	5888	12	SM	SM	NNP
cord-023095-4dannjjm	5888	13	was	be	VBD
cord-023095-4dannjjm	5888	14	present	present	JJ
cord-023095-4dannjjm	5888	15	24	24	CD
cord-023095-4dannjjm	5888	16	dogs	dog	NNS
cord-023095-4dannjjm	5888	17	(	(	-LRB-
cord-023095-4dannjjm	5888	18	52	52	CD
cord-023095-4dannjjm	5888	19	%	%	NN
cord-023095-4dannjjm	5888	20	)	)	-RRB-
cord-023095-4dannjjm	5888	21	;	;	:
cord-023095-4dannjjm	5888	22	and	and	CC
cord-023095-4dannjjm	5888	23	CM	CM	NNP
cord-023095-4dannjjm	5888	24	was	be	VBD
cord-023095-4dannjjm	5888	25	detected	detect	VBN
cord-023095-4dannjjm	5888	26	in	in	IN
cord-023095-4dannjjm	5888	27	24	24	CD
cord-023095-4dannjjm	5888	28	dogs	dog	NNS
cord-023095-4dannjjm	5888	29	(	(	-LRB-
cord-023095-4dannjjm	5888	30	52	52	CD
cord-023095-4dannjjm	5888	31	%	%	NN
cord-023095-4dannjjm	5888	32	)	)	-RRB-
cord-023095-4dannjjm	5888	33	.	.	.
cord-023095-4dannjjm	5889	1	IFN	IFN	NNP
cord-023095-4dannjjm	5889	2	-	-	HYPH
cord-023095-4dannjjm	5889	3	g	g	NN
cord-023095-4dannjjm	5889	4	levels	level	NNS
cord-023095-4dannjjm	5889	5	were	be	VBD
cord-023095-4dannjjm	5889	6	significantly	significantly	RB
cord-023095-4dannjjm	5889	7	lower	low	JJR
cord-023095-4dannjjm	5889	8	in	in	IN
cord-023095-4dannjjm	5889	9	dogs	dog	NNS
cord-023095-4dannjjm	5889	10	with	with	IN
cord-023095-4dannjjm	5889	11	NP	NP	NNP
cord-023095-4dannjjm	5889	12	than	than	IN
cord-023095-4dannjjm	5889	13	without	without	IN
cord-023095-4dannjjm	5889	14	(	(	-LRB-
cord-023095-4dannjjm	5889	15	p	p	NN
cord-023095-4dannjjm	5889	16	5	5	CD
cord-023095-4dannjjm	5889	17	0.036	0.036	CD
cord-023095-4dannjjm	5889	18	)	)	-RRB-
cord-023095-4dannjjm	5889	19	.	.	.
cord-023095-4dannjjm	5890	1	There	there	EX
cord-023095-4dannjjm	5890	2	were	be	VBD
cord-023095-4dannjjm	5890	3	significant	significant	JJ
cord-023095-4dannjjm	5890	4	positive	positive	JJ
cord-023095-4dannjjm	5890	5	correlations	correlation	NNS
cord-023095-4dannjjm	5890	6	between	between	IN
cord-023095-4dannjjm	5890	7	syrinx	syrinx	NNP
cord-023095-4dannjjm	5890	8	size	size	NN
cord-023095-4dannjjm	5890	9	and	and	CC
cord-023095-4dannjjm	5890	10	IL-8	IL-8	NNP
cord-023095-4dannjjm	5890	11	(	(	-LRB-
cord-023095-4dannjjm	5890	12	p	p	NN
cord-023095-4dannjjm	5890	13	5	5	CD
cord-023095-4dannjjm	5890	14	0.017	0.017	CD
cord-023095-4dannjjm	5890	15	)	)	-RRB-
cord-023095-4dannjjm	5890	16	,	,	,
cord-023095-4dannjjm	5890	17	KC	KC	NNP
cord-023095-4dannjjm	5890	18	(	(	-LRB-
cord-023095-4dannjjm	5890	19	p	p	NN
cord-023095-4dannjjm	5890	20	5	5	CD
cord-023095-4dannjjm	5890	21	0.025	0.025	CD
cord-023095-4dannjjm	5890	22	)	)	-RRB-
cord-023095-4dannjjm	5890	23	and	and	CC
cord-023095-4dannjjm	5890	24	MCP-1	MCP-1	NNP
cord-023095-4dannjjm	5891	1	(	(	-LRB-
cord-023095-4dannjjm	5891	2	p	p	NN
cord-023095-4dannjjm	5891	3	5	5	CD
cord-023095-4dannjjm	5891	4	0.003	0.003	CD
cord-023095-4dannjjm	5891	5	)	)	-RRB-
cord-023095-4dannjjm	5891	6	.	.	.
cord-023095-4dannjjm	5892	1	There	there	EX
cord-023095-4dannjjm	5892	2	were	be	VBD
cord-023095-4dannjjm	5892	3	significant	significant	JJ
cord-023095-4dannjjm	5892	4	negative	negative	JJ
cord-023095-4dannjjm	5892	5	correlations	correlation	NNS
cord-023095-4dannjjm	5892	6	between	between	IN
cord-023095-4dannjjm	5892	7	IFN	IFN	NNP
cord-023095-4dannjjm	5892	8	-	-	HYPH
cord-023095-4dannjjm	5892	9	g	g	NNP
cord-023095-4dannjjm	5892	10	and	and	CC
cord-023095-4dannjjm	5892	11	syrinx	syrinx	NNP
cord-023095-4dannjjm	5892	12	height	height	NNP
cord-023095-4dannjjm	5892	13	(	(	-LRB-
cord-023095-4dannjjm	5892	14	p	p	NN
cord-023095-4dannjjm	5892	15	5	5	CD
cord-023095-4dannjjm	5892	16	0.025	0.025	CD
cord-023095-4dannjjm	5892	17	)	)	-RRB-
cord-023095-4dannjjm	5892	18	and	and	CC
cord-023095-4dannjjm	5892	19	extent	extent	NN
cord-023095-4dannjjm	5892	20	(	(	-LRB-
cord-023095-4dannjjm	5892	21	p	p	NN
cord-023095-4dannjjm	5892	22	5	5	CD
cord-023095-4dannjjm	5892	23	0.042	0.042	CD
cord-023095-4dannjjm	5892	24	)	)	-RRB-
cord-023095-4dannjjm	5892	25	.	.	.
cord-023095-4dannjjm	5893	1	There	there	EX
cord-023095-4dannjjm	5893	2	was	be	VBD
cord-023095-4dannjjm	5893	3	a	a	DT
cord-023095-4dannjjm	5893	4	significant	significant	JJ
cord-023095-4dannjjm	5893	5	negative	negative	JJ
cord-023095-4dannjjm	5893	6	correlation	correlation	NN
cord-023095-4dannjjm	5893	7	between	between	IN
cord-023095-4dannjjm	5893	8	IL-2	IL-2	NNP
cord-023095-4dannjjm	5893	9	and	and	CC
cord-023095-4dannjjm	5893	10	syrinx	syrinx	NNP
cord-023095-4dannjjm	5893	11	height	height	NNP
cord-023095-4dannjjm	5894	1	(	(	-LRB-
cord-023095-4dannjjm	5894	2	p	p	NN
cord-023095-4dannjjm	5894	3	5	5	CD
cord-023095-4dannjjm	5894	4	0.042	0.042	CD
cord-023095-4dannjjm	5894	5	)	)	-RRB-
cord-023095-4dannjjm	5894	6	.	.	.
cord-023095-4dannjjm	5895	1	Neurotransmitter	neurotransmitter	NN
cord-023095-4dannjjm	5895	2	levels	level	NNS
cord-023095-4dannjjm	5895	3	were	be	VBD
cord-023095-4dannjjm	5895	4	not	not	RB
cord-023095-4dannjjm	5895	5	associated	associate	VBN
cord-023095-4dannjjm	5895	6	with	with	IN
cord-023095-4dannjjm	5895	7	skull	skull	NN
cord-023095-4dannjjm	5895	8	abnormalities	abnormality	NNS
cord-023095-4dannjjm	5895	9	or	or	CC
cord-023095-4dannjjm	5895	10	spinal	spinal	JJ
cord-023095-4dannjjm	5895	11	pain	pain	NN
cord-023095-4dannjjm	5895	12	,	,	,
cord-023095-4dannjjm	5895	13	but	but	CC
cord-023095-4dannjjm	5895	14	there	there	EX
cord-023095-4dannjjm	5895	15	was	be	VBD
cord-023095-4dannjjm	5895	16	a	a	DT
cord-023095-4dannjjm	5895	17	positive	positive	JJ
cord-023095-4dannjjm	5895	18	correlation	correlation	NN
cord-023095-4dannjjm	5895	19	of	of	IN
cord-023095-4dannjjm	5895	20	glycine	glycine	NN
cord-023095-4dannjjm	5895	21	with	with	IN
cord-023095-4dannjjm	5895	22	IL-2	IL-2	NNP
cord-023095-4dannjjm	5895	23	(	(	-LRB-
cord-023095-4dannjjm	5895	24	p	p	NN
cord-023095-4dannjjm	5895	25	5	5	CD
cord-023095-4dannjjm	5895	26	0.004	0.004	CD
cord-023095-4dannjjm	5895	27	)	)	-RRB-
cord-023095-4dannjjm	5895	28	and	and	CC
cord-023095-4dannjjm	5895	29	MCP-1	MCP-1	NNP
cord-023095-4dannjjm	5895	30	with	with	IN
cord-023095-4dannjjm	5895	31	glutamate	glutamate	NN
cord-023095-4dannjjm	5895	32	(	(	-LRB-
cord-023095-4dannjjm	5895	33	p	p	NN
cord-023095-4dannjjm	5895	34	5	5	CD
cord-023095-4dannjjm	5895	35	0.0147	0.0147	CD
cord-023095-4dannjjm	5895	36	)	)	-RRB-
cord-023095-4dannjjm	5895	37	and	and	CC
cord-023095-4dannjjm	5895	38	serotonin	serotonin	NN
cord-023095-4dannjjm	5895	39	(	(	-LRB-
cord-023095-4dannjjm	5895	40	p	p	NN
cord-023095-4dannjjm	5895	41	5	5	CD
cord-023095-4dannjjm	5895	42	0.0059	0.0059	CD
cord-023095-4dannjjm	5895	43	)	)	-RRB-
cord-023095-4dannjjm	5895	44	.	.	.
cord-023095-4dannjjm	5896	1	The	the	DT
cord-023095-4dannjjm	5896	2	size	size	NN
cord-023095-4dannjjm	5896	3	of	of	IN
cord-023095-4dannjjm	5896	4	the	the	DT
cord-023095-4dannjjm	5896	5	syrinx	syrinx	NNP
cord-023095-4dannjjm	5896	6	in	in	IN
cord-023095-4dannjjm	5896	7	BGs	bg	NNS
cord-023095-4dannjjm	5896	8	with	with	IN
cord-023095-4dannjjm	5896	9	SM	SM	NNP
cord-023095-4dannjjm	5896	10	is	be	VBZ
cord-023095-4dannjjm	5896	11	associated	associate	VBN
cord-023095-4dannjjm	5896	12	with	with	IN
cord-023095-4dannjjm	5896	13	several	several	JJ
cord-023095-4dannjjm	5896	14	cytokine	cytokine	JJ
cord-023095-4dannjjm	5896	15	elevations	elevation	NNS
cord-023095-4dannjjm	5896	16	but	but	CC
cord-023095-4dannjjm	5896	17	only	only	RB
cord-023095-4dannjjm	5896	18	a	a	DT
cord-023095-4dannjjm	5896	19	decrease	decrease	NN
cord-023095-4dannjjm	5896	20	of	of	IN
cord-023095-4dannjjm	5896	21	IFN	IFN	NNP
cord-023095-4dannjjm	5896	22	-	-	HYPH
cord-023095-4dannjjm	5896	23	g	g	NNP
cord-023095-4dannjjm	5896	24	was	be	VBD
cord-023095-4dannjjm	5896	25	associated	associate	VBN
cord-023095-4dannjjm	5896	26	with	with	IN
cord-023095-4dannjjm	5896	27	NP	NP	NNP
cord-023095-4dannjjm	5896	28	.	.	.
cord-023095-4dannjjm	5897	1	Based	base	VBN
cord-023095-4dannjjm	5897	2	on	on	IN
cord-023095-4dannjjm	5897	3	this	this	DT
cord-023095-4dannjjm	5897	4	study	study	NN
cord-023095-4dannjjm	5897	5	it	-PRON-	PRP
cord-023095-4dannjjm	5897	6	does	do	VBZ
cord-023095-4dannjjm	5897	7	not	not	RB
cord-023095-4dannjjm	5897	8	appear	appear	VB
cord-023095-4dannjjm	5897	9	that	that	IN
cord-023095-4dannjjm	5897	10	excitotoxicity	excitotoxicity	NN
cord-023095-4dannjjm	5897	11	plays	play	VBZ
cord-023095-4dannjjm	5897	12	a	a	DT
cord-023095-4dannjjm	5897	13	role	role	NN
cord-023095-4dannjjm	5897	14	in	in	IN
cord-023095-4dannjjm	5897	15	either	either	CC
cord-023095-4dannjjm	5897	16	SM	SM	NNP
cord-023095-4dannjjm	5897	17	development	development	NN
cord-023095-4dannjjm	5897	18	or	or	CC
cord-023095-4dannjjm	5897	19	NP	NP	NNP
cord-023095-4dannjjm	5897	20	.	.	.
cord-023095-4dannjjm	5898	1	Further	further	JJ
cord-023095-4dannjjm	5898	2	work	work	NN
cord-023095-4dannjjm	5898	3	is	be	VBZ
cord-023095-4dannjjm	5898	4	justified	justify	VBN
cord-023095-4dannjjm	5898	5	on	on	IN
cord-023095-4dannjjm	5898	6	the	the	DT
cord-023095-4dannjjm	5898	7	role	role	NN
cord-023095-4dannjjm	5898	8	of	of	IN
cord-023095-4dannjjm	5898	9	the	the	DT
cord-023095-4dannjjm	5898	10	immune	immune	JJ
cord-023095-4dannjjm	5898	11	system	system	NN
cord-023095-4dannjjm	5898	12	in	in	IN
cord-023095-4dannjjm	5898	13	CM	CM	NNP
cord-023095-4dannjjm	5898	14	,	,	,
cord-023095-4dannjjm	5898	15	SM	SM	NNP
cord-023095-4dannjjm	5898	16	and	and	CC
cord-023095-4dannjjm	5898	17	NP	NP	NNP
cord-023095-4dannjjm	5898	18	.	.	.
cord-023095-4dannjjm	5899	1	Current	current	JJ
cord-023095-4dannjjm	5899	2	knowledge	knowledge	NN
cord-023095-4dannjjm	5899	3	about	about	IN
cord-023095-4dannjjm	5899	4	the	the	DT
cord-023095-4dannjjm	5899	5	conservative	conservative	JJ
cord-023095-4dannjjm	5899	6	management	management	NN
cord-023095-4dannjjm	5899	7	of	of	IN
cord-023095-4dannjjm	5899	8	disk	disk	NN
cord-023095-4dannjjm	5899	9	associated	associate	VBD
cord-023095-4dannjjm	5899	10	cervical	cervical	JJ
cord-023095-4dannjjm	5899	11	spondylomyelopathy	spondylomyelopathy	NN
cord-023095-4dannjjm	5899	12	(	(	-LRB-
cord-023095-4dannjjm	5899	13	DA	DA	NNP
cord-023095-4dannjjm	5899	14	-	-	HYPH
cord-023095-4dannjjm	5899	15	CSM	CSM	NNP
cord-023095-4dannjjm	5899	16	)	)	-RRB-
cord-023095-4dannjjm	5899	17	is	be	VBZ
cord-023095-4dannjjm	5899	18	rather	rather	RB
cord-023095-4dannjjm	5899	19	limited	limited	JJ
cord-023095-4dannjjm	5899	20	and	and	CC
cord-023095-4dannjjm	5899	21	mainly	mainly	RB
cord-023095-4dannjjm	5899	22	based	base	VBN
cord-023095-4dannjjm	5899	23	on	on	IN
cord-023095-4dannjjm	5899	24	retrospectively	retrospectively	RB
cord-023095-4dannjjm	5899	25	retrieved	retrieve	VBN
cord-023095-4dannjjm	5899	26	data	datum	NNS
cord-023095-4dannjjm	5899	27	.	.	.
cord-023095-4dannjjm	5900	1	The	the	DT
cord-023095-4dannjjm	5900	2	goals	goal	NNS
cord-023095-4dannjjm	5900	3	of	of	IN
cord-023095-4dannjjm	5900	4	this	this	DT
cord-023095-4dannjjm	5900	5	study	study	NN
cord-023095-4dannjjm	5900	6	were	be	VBD
cord-023095-4dannjjm	5900	7	to	to	TO
cord-023095-4dannjjm	5900	8	prospectively	prospectively	RB
cord-023095-4dannjjm	5900	9	evaluate	evaluate	VB
cord-023095-4dannjjm	5900	10	the	the	DT
cord-023095-4dannjjm	5900	11	evolution	evolution	NN
cord-023095-4dannjjm	5900	12	of	of	IN
cord-023095-4dannjjm	5900	13	clinical	clinical	JJ
cord-023095-4dannjjm	5900	14	signs	sign	NNS
cord-023095-4dannjjm	5900	15	in	in	IN
cord-023095-4dannjjm	5900	16	dogs	dog	NNS
cord-023095-4dannjjm	5900	17	treated	treat	VBN
cord-023095-4dannjjm	5900	18	conservatively	conservatively	RB
cord-023095-4dannjjm	5900	19	for	for	IN
cord-023095-4dannjjm	5900	20	DA	DA	NNP
cord-023095-4dannjjm	5900	21	-	-	HYPH
cord-023095-4dannjjm	5900	22	CSM	CSM	NNP
cord-023095-4dannjjm	5900	23	.	.	.
cord-023095-4dannjjm	5901	1	Additionally	additionally	RB
cord-023095-4dannjjm	5901	2	,	,	,
cord-023095-4dannjjm	5901	3	several	several	JJ
cord-023095-4dannjjm	5901	4	potential	potential	JJ
cord-023095-4dannjjm	5901	5	prognostic	prognostic	JJ
cord-023095-4dannjjm	5901	6	parameters	parameter	NNS
cord-023095-4dannjjm	5901	7	and	and	CC
cord-023095-4dannjjm	5901	8	the	the	DT
cord-023095-4dannjjm	5901	9	correlation	correlation	NN
cord-023095-4dannjjm	5901	10	of	of	IN
cord-023095-4dannjjm	5901	11	initial	initial	JJ
cord-023095-4dannjjm	5901	12	clinical	clinical	JJ
cord-023095-4dannjjm	5901	13	signs	sign	NNS
cord-023095-4dannjjm	5901	14	with	with	IN
cord-023095-4dannjjm	5901	15	magnetic	magnetic	JJ
cord-023095-4dannjjm	5901	16	resonance	resonance	NN
cord-023095-4dannjjm	5901	17	imaging	imaging	NN
cord-023095-4dannjjm	5901	18	(	(	-LRB-
cord-023095-4dannjjm	5901	19	MRI	MRI	NNP
cord-023095-4dannjjm	5901	20	)	)	-RRB-
cord-023095-4dannjjm	5901	21	and	and	CC
cord-023095-4dannjjm	5901	22	transcranial	transcranial	JJ
cord-023095-4dannjjm	5901	23	magnetic	magnetic	JJ
cord-023095-4dannjjm	5901	24	stimulation	stimulation	NN
cord-023095-4dannjjm	5901	25	(	(	-LRB-
cord-023095-4dannjjm	5901	26	TMS	TMS	NNP
cord-023095-4dannjjm	5901	27	)	)	-RRB-
cord-023095-4dannjjm	5901	28	were	be	VBD
cord-023095-4dannjjm	5901	29	investigated	investigate	VBN
cord-023095-4dannjjm	5901	30	.	.	.
cord-023095-4dannjjm	5902	1	Twenty	twenty	CD
cord-023095-4dannjjm	5902	2	-	-	HYPH
cord-023095-4dannjjm	5902	3	one	one	CD
cord-023095-4dannjjm	5902	4	dogs	dog	NNS
cord-023095-4dannjjm	5902	5	were	be	VBD
cord-023095-4dannjjm	5902	6	included	include	VBN
cord-023095-4dannjjm	5902	7	.	.	.
cord-023095-4dannjjm	5903	1	After	after	IN
cord-023095-4dannjjm	5903	2	neurological	neurological	JJ
cord-023095-4dannjjm	5903	3	evaluation	evaluation	NN
cord-023095-4dannjjm	5903	4	,	,	,
cord-023095-4dannjjm	5903	5	neurological	neurological	JJ
cord-023095-4dannjjm	5903	6	status	status	NN
cord-023095-4dannjjm	5903	7	was	be	VBD
cord-023095-4dannjjm	5903	8	graded	grade	VBN
cord-023095-4dannjjm	5903	9	from	from	IN
cord-023095-4dannjjm	5903	10	0	0	CD
cord-023095-4dannjjm	5903	11	(	(	-LRB-
cord-023095-4dannjjm	5903	12	5	5	CD
cord-023095-4dannjjm	5903	13	normal	normal	JJ
cord-023095-4dannjjm	5903	14	)	)	-RRB-
cord-023095-4dannjjm	5903	15	to	to	IN
cord-023095-4dannjjm	5903	16	6	6	CD
cord-023095-4dannjjm	5903	17	(	(	-LRB-
cord-023095-4dannjjm	5903	18	5	5	CD
cord-023095-4dannjjm	5903	19	tetraplegia	tetraplegia	NNP
cord-023095-4dannjjm	5903	20	)	)	-RRB-
cord-023095-4dannjjm	5903	21	.	.	.
cord-023095-4dannjjm	5904	1	All	all	DT
cord-023095-4dannjjm	5904	2	animals	animal	NNS
cord-023095-4dannjjm	5904	3	underwent	undergo	VBD
cord-023095-4dannjjm	5904	4	low	low	JJ
cord-023095-4dannjjm	5904	5	-	-	HYPH
cord-023095-4dannjjm	5904	6	field	field	NN
cord-023095-4dannjjm	5904	7	MRI	MRI	NNP
cord-023095-4dannjjm	5904	8	and	and	CC
cord-023095-4dannjjm	5904	9	TMS	TMS	NNP
cord-023095-4dannjjm	5904	10	with	with	IN
cord-023095-4dannjjm	5904	11	measurement	measurement	NN
cord-023095-4dannjjm	5904	12	of	of	IN
cord-023095-4dannjjm	5904	13	onset	onset	NN
cord-023095-4dannjjm	5904	14	latencies	latency	NNS
cord-023095-4dannjjm	5904	15	and	and	CC
cord-023095-4dannjjm	5904	16	peak	peak	NN
cord-023095-4dannjjm	5904	17	-	-	HYPH
cord-023095-4dannjjm	5904	18	to	to	IN
cord-023095-4dannjjm	5904	19	-	-	HYPH
cord-023095-4dannjjm	5904	20	peak	peak	NN
cord-023095-4dannjjm	5904	21	amplitudes	amplitude	NNS
cord-023095-4dannjjm	5904	22	from	from	IN
cord-023095-4dannjjm	5904	23	the	the	DT
cord-023095-4dannjjm	5904	24	extensor	extensor	NN
cord-023095-4dannjjm	5904	25	carpi	carpi	NN
cord-023095-4dannjjm	5904	26	radialis	radialis	NN
cord-023095-4dannjjm	5904	27	and	and	CC
cord-023095-4dannjjm	5904	28	cranial	cranial	JJ
cord-023095-4dannjjm	5904	29	tibial	tibial	JJ
cord-023095-4dannjjm	5904	30	muscles	muscle	NNS
cord-023095-4dannjjm	5904	31	.	.	.
cord-023095-4dannjjm	5905	1	From	from	IN
cord-023095-4dannjjm	5905	2	the	the	DT
cord-023095-4dannjjm	5905	3	MR	MR	NNP
cord-023095-4dannjjm	5905	4	images	image	NNS
cord-023095-4dannjjm	5905	5	,	,	,
cord-023095-4dannjjm	5905	6	the	the	DT
cord-023095-4dannjjm	5905	7	following	follow	VBG
cord-023095-4dannjjm	5905	8	dimensions	dimension	NNS
cord-023095-4dannjjm	5905	9	were	be	VBD
cord-023095-4dannjjm	5905	10	calculated	calculate	VBN
cord-023095-4dannjjm	5905	11	:	:	:
cord-023095-4dannjjm	5905	12	remaining	remain	VBG
cord-023095-4dannjjm	5905	13	spinal	spinal	JJ
cord-023095-4dannjjm	5905	14	cord	cord	NN
cord-023095-4dannjjm	5905	15	area	area	NN
cord-023095-4dannjjm	5905	16	;	;	:
cord-023095-4dannjjm	5905	17	compression	compression	NN
cord-023095-4dannjjm	5905	18	ratio	ratio	NN
cord-023095-4dannjjm	5905	19	;	;	:
cord-023095-4dannjjm	5905	20	vertebral	vertebral	JJ
cord-023095-4dannjjm	5905	21	occupying	occupy	VBG
cord-023095-4dannjjm	5905	22	ratio	ratio	NN
cord-023095-4dannjjm	5905	23	of	of	IN
cord-023095-4dannjjm	5905	24	the	the	DT
cord-023095-4dannjjm	5905	25	spinal	spinal	JJ
cord-023095-4dannjjm	5905	26	cord	cord	NN
cord-023095-4dannjjm	5905	27	;	;	:
cord-023095-4dannjjm	5905	28	canal	canal	NN
cord-023095-4dannjjm	5905	29	height	height	NN
cord-023095-4dannjjm	5905	30	to	to	IN
cord-023095-4dannjjm	5905	31	body	body	NN
cord-023095-4dannjjm	5905	32	height	height	NN
cord-023095-4dannjjm	5905	33	ratio	ratio	NN
cord-023095-4dannjjm	5905	34	(	(	-LRB-
cord-023095-4dannjjm	5905	35	CBR	CBR	NNP
cord-023095-4dannjjm	5905	36	)	)	-RRB-
cord-023095-4dannjjm	5905	37	;	;	:
cord-023095-4dannjjm	5905	38	canal	canal	NN
cord-023095-4dannjjm	5905	39	height	height	NN
cord-023095-4dannjjm	5905	40	to	to	IN
cord-023095-4dannjjm	5905	41	body	body	NN
cord-023095-4dannjjm	5905	42	length	length	NN
cord-023095-4dannjjm	5905	43	ratio	ratio	NN
cord-023095-4dannjjm	5905	44	(	(	-LRB-
cord-023095-4dannjjm	5905	45	CBLR	CBLR	NNP
cord-023095-4dannjjm	5905	46	)	)	-RRB-
cord-023095-4dannjjm	5905	47	;	;	:
cord-023095-4dannjjm	5905	48	and	and	CC
cord-023095-4dannjjm	5905	49	the	the	DT
cord-023095-4dannjjm	5905	50	canal	canal	NN
cord-023095-4dannjjm	5905	51	compromise	compromise	NN
cord-023095-4dannjjm	5905	52	ratio	ratio	NN
cord-023095-4dannjjm	5905	53	.	.	.
cord-023095-4dannjjm	5906	1	Intraparenchymal	Intraparenchymal	NNP
cord-023095-4dannjjm	5906	2	intensity	intensity	NN
cord-023095-4dannjjm	5906	3	(	(	-LRB-
cord-023095-4dannjjm	5906	4	ISI	ISI	NNP
cord-023095-4dannjjm	5906	5	)	)	-RRB-
cord-023095-4dannjjm	5906	6	changes	change	NNS
cord-023095-4dannjjm	5906	7	were	be	VBD
cord-023095-4dannjjm	5906	8	graded	grade	VBN
cord-023095-4dannjjm	5906	9	from	from	IN
cord-023095-4dannjjm	5906	10	0	0	CD
cord-023095-4dannjjm	5906	11	to	to	IN
cord-023095-4dannjjm	5906	12	3	3	CD
cord-023095-4dannjjm	5906	13	.	.	.
cord-023095-4dannjjm	5907	1	All	all	DT
cord-023095-4dannjjm	5907	2	dogs	dog	NNS
cord-023095-4dannjjm	5907	3	were	be	VBD
cord-023095-4dannjjm	5907	4	reevaluated	reevaluate	VBN
cord-023095-4dannjjm	5907	5	by	by	IN
cord-023095-4dannjjm	5907	6	the	the	DT
cord-023095-4dannjjm	5907	7	same	same	JJ
cord-023095-4dannjjm	5907	8	person	person	NN
cord-023095-4dannjjm	5907	9	after	after	IN
cord-023095-4dannjjm	5907	10	1	1	CD
cord-023095-4dannjjm	5907	11	,	,	,
cord-023095-4dannjjm	5907	12	3	3	CD
cord-023095-4dannjjm	5907	13	,	,	,
cord-023095-4dannjjm	5907	14	6	6	CD
cord-023095-4dannjjm	5907	15	,	,	,
cord-023095-4dannjjm	5907	16	12	12	CD
cord-023095-4dannjjm	5907	17	,	,	,
cord-023095-4dannjjm	5907	18	and	and	CC
cord-023095-4dannjjm	5907	19	24	24	CD
cord-023095-4dannjjm	5907	20	months	month	NNS
cord-023095-4dannjjm	5907	21	.	.	.
cord-023095-4dannjjm	5908	1	Eight	eight	CD
cord-023095-4dannjjm	5908	2	of	of	IN
cord-023095-4dannjjm	5908	3	21	21	CD
cord-023095-4dannjjm	5908	4	dogs	dog	NNS
cord-023095-4dannjjm	5908	5	(	(	-LRB-
cord-023095-4dannjjm	5908	6	38	38	CD
cord-023095-4dannjjm	5908	7	%	%	NN
cord-023095-4dannjjm	5908	8	)	)	-RRB-
cord-023095-4dannjjm	5908	9	experienced	experience	VBD
cord-023095-4dannjjm	5908	10	a	a	DT
cord-023095-4dannjjm	5908	11	positive	positive	JJ
cord-023095-4dannjjm	5908	12	clinical	clinical	JJ
cord-023095-4dannjjm	5908	13	evolution	evolution	NN
cord-023095-4dannjjm	5908	14	with	with	IN
cord-023095-4dannjjm	5908	15	improvement	improvement	NN
cord-023095-4dannjjm	5908	16	of	of	IN
cord-023095-4dannjjm	5908	17	clinical	clinical	JJ
cord-023095-4dannjjm	5908	18	signs	sign	NNS
cord-023095-4dannjjm	5908	19	or	or	CC
cord-023095-4dannjjm	5908	20	stabilization	stabilization	NN
cord-023095-4dannjjm	5908	21	of	of	IN
cord-023095-4dannjjm	5908	22	mild	mild	JJ
cord-023095-4dannjjm	5908	23	clinical	clinical	JJ
cord-023095-4dannjjm	5908	24	signs	sign	NNS
cord-023095-4dannjjm	5908	25	.	.	.
cord-023095-4dannjjm	5909	1	All	all	DT
cord-023095-4dannjjm	5909	2	dogs	dog	NNS
cord-023095-4dannjjm	5909	3	with	with	IN
cord-023095-4dannjjm	5909	4	a	a	DT
cord-023095-4dannjjm	5909	5	negative	negative	JJ
cord-023095-4dannjjm	5909	6	clinical	clinical	JJ
cord-023095-4dannjjm	5909	7	evolution	evolution	NN
cord-023095-4dannjjm	5909	8	1	1	CD
cord-023095-4dannjjm	5909	9	month	month	NN
cord-023095-4dannjjm	5909	10	after	after	IN
cord-023095-4dannjjm	5909	11	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5909	12	experienced	experience	VBD
cord-023095-4dannjjm	5909	13	a	a	DT
cord-023095-4dannjjm	5909	14	further	further	JJ
cord-023095-4dannjjm	5909	15	progression	progression	NN
cord-023095-4dannjjm	5909	16	of	of	IN
cord-023095-4dannjjm	5909	17	clinical	clinical	JJ
cord-023095-4dannjjm	5909	18	signs	sign	NNS
cord-023095-4dannjjm	5909	19	resulting	result	VBG
cord-023095-4dannjjm	5909	20	in	in	IN
cord-023095-4dannjjm	5909	21	a	a	DT
cord-023095-4dannjjm	5909	22	poor	poor	JJ
cord-023095-4dannjjm	5909	23	outcome	outcome	NN
cord-023095-4dannjjm	5909	24	.	.	.
cord-023095-4dannjjm	5910	1	The	the	DT
cord-023095-4dannjjm	5910	2	opposite	opposite	JJ
cord-023095-4dannjjm	5910	3	was	be	VBD
cord-023095-4dannjjm	5910	4	true	true	JJ
cord-023095-4dannjjm	5910	5	for	for	IN
cord-023095-4dannjjm	5910	6	all	all	DT
cord-023095-4dannjjm	5910	7	dogs	dog	NNS
cord-023095-4dannjjm	5910	8	with	with	IN
cord-023095-4dannjjm	5910	9	a	a	DT
cord-023095-4dannjjm	5910	10	positive	positive	JJ
cord-023095-4dannjjm	5910	11	clinical	clinical	JJ
cord-023095-4dannjjm	5910	12	evolution	evolution	NN
cord-023095-4dannjjm	5910	13	after	after	IN
cord-023095-4dannjjm	5910	14	1	1	CD
cord-023095-4dannjjm	5910	15	month	month	NN
cord-023095-4dannjjm	5910	16	.	.	.
cord-023095-4dannjjm	5911	1	Outcome	outcome	NN
cord-023095-4dannjjm	5911	2	was	be	VBD
cord-023095-4dannjjm	5911	3	further	further	RB
cord-023095-4dannjjm	5911	4	significantly	significantly	RB
cord-023095-4dannjjm	5911	5	associated	associate	VBN
cord-023095-4dannjjm	5911	6	by	by	IN
cord-023095-4dannjjm	5911	7	the	the	DT
cord-023095-4dannjjm	5911	8	remaining	remain	VBG
cord-023095-4dannjjm	5911	9	spinal	spinal	JJ
cord-023095-4dannjjm	5911	10	cord	cord	NN
cord-023095-4dannjjm	5911	11	area	area	NN
cord-023095-4dannjjm	5911	12	and	and	CC
cord-023095-4dannjjm	5911	13	the	the	DT
cord-023095-4dannjjm	5911	14	vertebral	vertebral	JJ
cord-023095-4dannjjm	5911	15	canal	canal	NN
cord-023095-4dannjjm	5911	16	compromise	compromise	NN
cord-023095-4dannjjm	5911	17	ratio	ratio	NN
cord-023095-4dannjjm	5911	18	.	.	.
cord-023095-4dannjjm	5912	1	Prognosis	prognosis	NN
cord-023095-4dannjjm	5912	2	was	be	VBD
cord-023095-4dannjjm	5912	3	not	not	RB
cord-023095-4dannjjm	5912	4	significantly	significantly	RB
cord-023095-4dannjjm	5912	5	affected	affect	VBN
cord-023095-4dannjjm	5912	6	by	by	IN
cord-023095-4dannjjm	5912	7	clinical	clinical	JJ
cord-023095-4dannjjm	5912	8	presentation	presentation	NN
cord-023095-4dannjjm	5912	9	or	or	CC
cord-023095-4dannjjm	5912	10	TMS	tms	NN
cord-023095-4dannjjm	5912	11	.	.	.
cord-023095-4dannjjm	5913	1	Progression	progression	NN
cord-023095-4dannjjm	5913	2	of	of	IN
cord-023095-4dannjjm	5913	3	clinical	clinical	JJ
cord-023095-4dannjjm	5913	4	signs	sign	NNS
cord-023095-4dannjjm	5913	5	,	,	,
cord-023095-4dannjjm	5913	6	in	in	IN
cord-023095-4dannjjm	5913	7	unsuccessfully	unsuccessfully	RB
cord-023095-4dannjjm	5913	8	treated	treat	VBN
cord-023095-4dannjjm	5913	9	dogs	dog	NNS
cord-023095-4dannjjm	5913	10	,	,	,
cord-023095-4dannjjm	5913	11	was	be	VBD
cord-023095-4dannjjm	5913	12	generally	generally	RB
cord-023095-4dannjjm	5913	13	characterized	characterize	VBN
cord-023095-4dannjjm	5913	14	by	by	IN
cord-023095-4dannjjm	5913	15	a	a	DT
cord-023095-4dannjjm	5913	16	rapid	rapid	JJ
cord-023095-4dannjjm	5913	17	and	and	CC
cord-023095-4dannjjm	5913	18	dramatic	dramatic	JJ
cord-023095-4dannjjm	5913	19	deterioration	deterioration	NN
cord-023095-4dannjjm	5913	20	of	of	IN
cord-023095-4dannjjm	5913	21	neurological	neurological	JJ
cord-023095-4dannjjm	5913	22	status	status	NN
cord-023095-4dannjjm	5913	23	.	.	.
cord-023095-4dannjjm	5914	1	There	there	EX
cord-023095-4dannjjm	5914	2	were	be	VBD
cord-023095-4dannjjm	5914	3	no	no	DT
cord-023095-4dannjjm	5914	4	significant	significant	JJ
cord-023095-4dannjjm	5914	5	correlations	correlation	NNS
cord-023095-4dannjjm	5914	6	between	between	IN
cord-023095-4dannjjm	5914	7	clinical	clinical	JJ
cord-023095-4dannjjm	5914	8	presentation	presentation	NN
cord-023095-4dannjjm	5914	9	,	,	,
cord-023095-4dannjjm	5914	10	MRI	MRI	NNP
cord-023095-4dannjjm	5914	11	and	and	CC
cord-023095-4dannjjm	5914	12	TMS	TMS	NNP
cord-023095-4dannjjm	5914	13	.	.	.
cord-023095-4dannjjm	5915	1	Two	two	CD
cord-023095-4dannjjm	5915	2	dogs	dog	NNS
cord-023095-4dannjjm	5915	3	underwent	undergo	VBD
cord-023095-4dannjjm	5915	4	necropsy	necropsy	JJ
cord-023095-4dannjjm	5915	5	and	and	CC
cord-023095-4dannjjm	5915	6	histopathological	histopathological	JJ
cord-023095-4dannjjm	5915	7	examination	examination	NN
cord-023095-4dannjjm	5915	8	.	.	.
cord-023095-4dannjjm	5916	1	This	this	DT
cord-023095-4dannjjm	5916	2	revealed	reveal	VBD
cord-023095-4dannjjm	5916	3	in	in	IN
cord-023095-4dannjjm	5916	4	both	both	DT
cord-023095-4dannjjm	5916	5	cases	case	NNS
cord-023095-4dannjjm	5916	6	chronic	chronic	JJ
cord-023095-4dannjjm	5916	7	Wallerian	wallerian	JJ
cord-023095-4dannjjm	5916	8	degeneration	degeneration	NN
cord-023095-4dannjjm	5916	9	and	and	CC
cord-023095-4dannjjm	5916	10	segmental	segmental	JJ
cord-023095-4dannjjm	5916	11	myelomalacia	myelomalacia	NNS
cord-023095-4dannjjm	5916	12	.	.	.
cord-023095-4dannjjm	5917	1	The	the	DT
cord-023095-4dannjjm	5917	2	results	result	NNS
cord-023095-4dannjjm	5917	3	of	of	IN
cord-023095-4dannjjm	5917	4	this	this	DT
cord-023095-4dannjjm	5917	5	study	study	NN
cord-023095-4dannjjm	5917	6	suggest	suggest	VBP
cord-023095-4dannjjm	5917	7	that	that	IN
cord-023095-4dannjjm	5917	8	conservative	conservative	JJ
cord-023095-4dannjjm	5917	9	treatment	treatment	NN
cord-023095-4dannjjm	5917	10	of	of	IN
cord-023095-4dannjjm	5917	11	DA	DA	NNP
cord-023095-4dannjjm	5917	12	-	-	HYPH
cord-023095-4dannjjm	5917	13	CSM	CSM	NNP
cord-023095-4dannjjm	5917	14	is	be	VBZ
cord-023095-4dannjjm	5917	15	associated	associate	VBN
cord-023095-4dannjjm	5917	16	with	with	IN
cord-023095-4dannjjm	5917	17	a	a	DT
cord-023095-4dannjjm	5917	18	rather	rather	RB
cord-023095-4dannjjm	5917	19	guarded	guard	VBN
cord-023095-4dannjjm	5917	20	prognosis	prognosis	NN
cord-023095-4dannjjm	5917	21	.	.	.
cord-023095-4dannjjm	5918	1	Clinical	clinical	JJ
cord-023095-4dannjjm	5918	2	evolution	evolution	NN
cord-023095-4dannjjm	5918	3	1	1	CD
cord-023095-4dannjjm	5918	4	month	month	NN
cord-023095-4dannjjm	5918	5	after	after	IN
cord-023095-4dannjjm	5918	6	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5918	7	and	and	CC
cord-023095-4dannjjm	5918	8	selected	select	VBN
cord-023095-4dannjjm	5918	9	MRI	mri	NN
cord-023095-4dannjjm	5918	10	parameters	parameter	NNS
cord-023095-4dannjjm	5918	11	can	can	MD
cord-023095-4dannjjm	5918	12	be	be	VB
cord-023095-4dannjjm	5918	13	considered	consider	VBN
cord-023095-4dannjjm	5918	14	as	as	IN
cord-023095-4dannjjm	5918	15	prognostic	prognostic	JJ
cord-023095-4dannjjm	5918	16	indicators	indicator	NNS
cord-023095-4dannjjm	5918	17	.	.	.
cord-023095-4dannjjm	5919	1	The	the	DT
cord-023095-4dannjjm	5919	2	lack	lack	NN
cord-023095-4dannjjm	5919	3	of	of	IN
cord-023095-4dannjjm	5919	4	correlation	correlation	NN
cord-023095-4dannjjm	5919	5	between	between	IN
cord-023095-4dannjjm	5919	6	clinical	clinical	JJ
cord-023095-4dannjjm	5919	7	presentation	presentation	NN
cord-023095-4dannjjm	5919	8	and	and	CC
cord-023095-4dannjjm	5919	9	outcome	outcome	NN
cord-023095-4dannjjm	5919	10	,	,	,
cord-023095-4dannjjm	5919	11	medical	medical	JJ
cord-023095-4dannjjm	5919	12	imaging	imaging	NN
cord-023095-4dannjjm	5919	13	and	and	CC
cord-023095-4dannjjm	5919	14	electrophysiological	electrophysiological	JJ
cord-023095-4dannjjm	5919	15	evaluation	evaluation	NN
cord-023095-4dannjjm	5919	16	is	be	VBZ
cord-023095-4dannjjm	5919	17	disturbing	disturbing	JJ
cord-023095-4dannjjm	5919	18	and	and	CC
cord-023095-4dannjjm	5919	19	warrants	warrant	NNS
cord-023095-4dannjjm	5919	20	further	further	JJ
cord-023095-4dannjjm	5919	21	investigation	investigation	NN
cord-023095-4dannjjm	5919	22	.	.	.
cord-023095-4dannjjm	5920	1	A	a	DT
cord-023095-4dannjjm	5920	2	MRI	MRI	NNP
cord-023095-4dannjjm	5920	3	-	-	HYPH
cord-023095-4dannjjm	5920	4	guided	guide	VBN
cord-023095-4dannjjm	5920	5	stereotactic	stereotactic	NNP
cord-023095-4dannjjm	5920	6	brain	brain	NN
cord-023095-4dannjjm	5920	7	biopsy	biopsy	NNP
cord-023095-4dannjjm	5920	8	system	system	NN
cord-023095-4dannjjm	5920	9	has	have	VBZ
cord-023095-4dannjjm	5920	10	not	not	RB
cord-023095-4dannjjm	5920	11	been	be	VBN
cord-023095-4dannjjm	5920	12	clinically	clinically	RB
cord-023095-4dannjjm	5920	13	evaluated	evaluate	VBN
cord-023095-4dannjjm	5920	14	in	in	IN
cord-023095-4dannjjm	5920	15	dogs	dog	NNS
cord-023095-4dannjjm	5920	16	.	.	.
cord-023095-4dannjjm	5921	1	The	the	DT
cord-023095-4dannjjm	5921	2	purpose	purpose	NN
cord-023095-4dannjjm	5921	3	of	of	IN
cord-023095-4dannjjm	5921	4	this	this	DT
cord-023095-4dannjjm	5921	5	study	study	NN
cord-023095-4dannjjm	5921	6	was	be	VBD
cord-023095-4dannjjm	5921	7	to	to	TO
cord-023095-4dannjjm	5921	8	determine	determine	VB
cord-023095-4dannjjm	5921	9	the	the	DT
cord-023095-4dannjjm	5921	10	ability	ability	NN
cord-023095-4dannjjm	5921	11	of	of	IN
cord-023095-4dannjjm	5921	12	the	the	DT
cord-023095-4dannjjm	5921	13	Brainsight	Brainsight	NNP
cord-023095-4dannjjm	5921	14	TM	TM	NNP
cord-023095-4dannjjm	5921	15	system	system	NN
cord-023095-4dannjjm	5921	16	to	to	TO
cord-023095-4dannjjm	5921	17	obtain	obtain	VB
cord-023095-4dannjjm	5921	18	histologically	histologically	RB
cord-023095-4dannjjm	5921	19	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	5921	20	samples	sample	NNS
cord-023095-4dannjjm	5921	21	and	and	CC
cord-023095-4dannjjm	5921	22	access	access	VB
cord-023095-4dannjjm	5921	23	the	the	DT
cord-023095-4dannjjm	5921	24	impact	impact	NN
cord-023095-4dannjjm	5921	25	of	of	IN
cord-023095-4dannjjm	5921	26	this	this	DT
cord-023095-4dannjjm	5921	27	procedure	procedure	NN
cord-023095-4dannjjm	5921	28	on	on	IN
cord-023095-4dannjjm	5921	29	neurologic	neurologic	JJ
cord-023095-4dannjjm	5921	30	status	status	NN
cord-023095-4dannjjm	5921	31	for	for	IN
cord-023095-4dannjjm	5921	32	72	72	CD
cord-023095-4dannjjm	5921	33	hours	hour	NNS
cord-023095-4dannjjm	5921	34	after	after	IN
cord-023095-4dannjjm	5921	35	the	the	DT
cord-023095-4dannjjm	5921	36	biopsy	biopsy	NN
cord-023095-4dannjjm	5921	37	.	.	.
cord-023095-4dannjjm	5922	1	Five	five	CD
cord-023095-4dannjjm	5922	2	dogs	dog	NNS
cord-023095-4dannjjm	5922	3	with	with	IN
cord-023095-4dannjjm	5922	4	MRI	MRI	NNP
cord-023095-4dannjjm	5922	5	definable	definable	JJ
cord-023095-4dannjjm	5922	6	lesions	lesion	NNS
cord-023095-4dannjjm	5922	7	in	in	IN
cord-023095-4dannjjm	5922	8	the	the	DT
cord-023095-4dannjjm	5922	9	brain	brain	NN
cord-023095-4dannjjm	5922	10	have	have	VBP
cord-023095-4dannjjm	5922	11	been	be	VBN
cord-023095-4dannjjm	5922	12	enrolled	enrol	VBN
cord-023095-4dannjjm	5922	13	.	.	.
cord-023095-4dannjjm	5923	1	Breeds	breed	NNS
cord-023095-4dannjjm	5923	2	included	include	VBD
cord-023095-4dannjjm	5923	3	a	a	DT
cord-023095-4dannjjm	5923	4	Pitbull	Pitbull	NNP
cord-023095-4dannjjm	5923	5	mix	mix	NN
cord-023095-4dannjjm	5923	6	,	,	,
cord-023095-4dannjjm	5923	7	Pembroke	Pembroke	NNP
cord-023095-4dannjjm	5923	8	Welsh	Welsh	NNP
cord-023095-4dannjjm	5923	9	Corgi	Corgi	NNP
cord-023095-4dannjjm	5923	10	,	,	,
cord-023095-4dannjjm	5923	11	French	french	JJ
cord-023095-4dannjjm	5923	12	Bulldog	Bulldog	NNP
cord-023095-4dannjjm	5923	13	,	,	,
cord-023095-4dannjjm	5923	14	Border	Border	NNP
cord-023095-4dannjjm	5923	15	Terrier	Terrier	NNP
cord-023095-4dannjjm	5923	16	and	and	CC
cord-023095-4dannjjm	5923	17	West	West	NNP
cord-023095-4dannjjm	5923	18	Highland	Highland	NNP
cord-023095-4dannjjm	5923	19	White	White	NNP
cord-023095-4dannjjm	5923	20	Terrier	Terrier	NNP
cord-023095-4dannjjm	5923	21	.	.	.
cord-023095-4dannjjm	5924	1	Age	age	NN
cord-023095-4dannjjm	5924	2	ranged	range	VBD
cord-023095-4dannjjm	5924	3	from	from	IN
cord-023095-4dannjjm	5924	4	5	5	CD
cord-023095-4dannjjm	5924	5	-	-	SYM
cord-023095-4dannjjm	5924	6	11	11	CD
cord-023095-4dannjjm	5924	7	years	year	NNS
cord-023095-4dannjjm	5924	8	.	.	.
cord-023095-4dannjjm	5925	1	Weight	weight	NN
cord-023095-4dannjjm	5925	2	ranged	range	VBD
cord-023095-4dannjjm	5925	3	from	from	IN
cord-023095-4dannjjm	5925	4	8.5	8.5	CD
cord-023095-4dannjjm	5925	5	-	-	HYPH
cord-023095-4dannjjm	5925	6	18.8	18.8	CD
cord-023095-4dannjjm	5925	7	kg	kg	NNS
cord-023095-4dannjjm	5925	8	.	.	.
cord-023095-4dannjjm	5926	1	Dogs	dog	NNS
cord-023095-4dannjjm	5926	2	presented	present	VBN
cord-023095-4dannjjm	5926	3	with	with	IN
cord-023095-4dannjjm	5926	4	seizures	seizure	NNS
cord-023095-4dannjjm	5926	5	(	(	-LRB-
cord-023095-4dannjjm	5926	6	n	n	NN
cord-023095-4dannjjm	5926	7	5	5	CD
cord-023095-4dannjjm	5926	8	5	5	CD
cord-023095-4dannjjm	5926	9	)	)	-RRB-
cord-023095-4dannjjm	5926	10	,	,	,
cord-023095-4dannjjm	5926	11	ambulatory	ambulatory	JJ
cord-023095-4dannjjm	5926	12	paresis(n	paresis(n	NNP
cord-023095-4dannjjm	5926	13	5	5	CD
cord-023095-4dannjjm	5926	14	4	4	CD
cord-023095-4dannjjm	5926	15	)	)	-RRB-
cord-023095-4dannjjm	5926	16	,	,	,
cord-023095-4dannjjm	5926	17	unilateral	unilateral	JJ
cord-023095-4dannjjm	5926	18	blindness(n	blindness(n	NNP
cord-023095-4dannjjm	5926	19	5	5	CD
cord-023095-4dannjjm	5926	20	2	2	CD
cord-023095-4dannjjm	5926	21	)	)	-RRB-
cord-023095-4dannjjm	5926	22	and	and	CC
cord-023095-4dannjjm	5926	23	head	head	NN
cord-023095-4dannjjm	5926	24	tilt(n	tilt(n	NNP
cord-023095-4dannjjm	5926	25	5	5	CD
cord-023095-4dannjjm	5926	26	1	1	CD
cord-023095-4dannjjm	5926	27	)	)	-RRB-
cord-023095-4dannjjm	5926	28	.	.	.
cord-023095-4dannjjm	5927	1	One	one	CD
cord-023095-4dannjjm	5927	2	dog	dog	NN
cord-023095-4dannjjm	5927	3	had	have	VBD
cord-023095-4dannjjm	5927	4	a	a	DT
cord-023095-4dannjjm	5927	5	normal	normal	JJ
cord-023095-4dannjjm	5927	6	neurologic	neurologic	JJ
cord-023095-4dannjjm	5927	7	exam	exam	NN
cord-023095-4dannjjm	5927	8	.	.	.
cord-023095-4dannjjm	5928	1	Lesions	lesion	NNS
cord-023095-4dannjjm	5928	2	chosen	choose	VBN
cord-023095-4dannjjm	5928	3	for	for	IN
cord-023095-4dannjjm	5928	4	biopsy	biopsy	NN
cord-023095-4dannjjm	5928	5	were	be	VBD
cord-023095-4dannjjm	5928	6	in	in	IN
cord-023095-4dannjjm	5928	7	the	the	DT
cord-023095-4dannjjm	5928	8	olfactory	olfactory	NN
cord-023095-4dannjjm	5928	9	and/or	and/or	CC
cord-023095-4dannjjm	5928	10	frontal	frontal	JJ
cord-023095-4dannjjm	5928	11	lobes	lobe	NNS
cord-023095-4dannjjm	5928	12	(	(	-LRB-
cord-023095-4dannjjm	5928	13	n	n	NN
cord-023095-4dannjjm	5928	14	5	5	CD
cord-023095-4dannjjm	5928	15	3	3	CD
cord-023095-4dannjjm	5928	16	)	)	-RRB-
cord-023095-4dannjjm	5928	17	,	,	,
cord-023095-4dannjjm	5928	18	parietal	parietal	JJ
cord-023095-4dannjjm	5928	19	lobe(n	lobe(n	NNP
cord-023095-4dannjjm	5928	20	5	5	CD
cord-023095-4dannjjm	5928	21	1	1	CD
cord-023095-4dannjjm	5928	22	)	)	-RRB-
cord-023095-4dannjjm	5928	23	,	,	,
cord-023095-4dannjjm	5928	24	and	and	CC
cord-023095-4dannjjm	5928	25	pyriform	pyriform	NNP
cord-023095-4dannjjm	5928	26	lobe(n	lobe(n	NNP
cord-023095-4dannjjm	5928	27	5	5	CD
cord-023095-4dannjjm	5928	28	1	1	CD
cord-023095-4dannjjm	5928	29	)	)	-RRB-
cord-023095-4dannjjm	5928	30	.	.	.
cord-023095-4dannjjm	5929	1	Lesions	lesion	NNS
cord-023095-4dannjjm	5929	2	were	be	VBD
cord-023095-4dannjjm	5929	3	between	between	IN
cord-023095-4dannjjm	5929	4	14	14	CD
cord-023095-4dannjjm	5929	5	-	-	SYM
cord-023095-4dannjjm	5929	6	22	22	CD
cord-023095-4dannjjm	5929	7	mm	mm	NNS
cord-023095-4dannjjm	5929	8	in	in	IN
cord-023095-4dannjjm	5929	9	diameter	diameter	NN
cord-023095-4dannjjm	5929	10	.	.	.
cord-023095-4dannjjm	5930	1	All	all	DT
cord-023095-4dannjjm	5930	2	lesions	lesion	NNS
cord-023095-4dannjjm	5930	3	were	be	VBD
cord-023095-4dannjjm	5930	4	well	well	RB
cord-023095-4dannjjm	5930	5	-	-	HYPH
cord-023095-4dannjjm	5930	6	circumscribed	circumscribe	VBN
cord-023095-4dannjjm	5930	7	and	and	CC
cord-023095-4dannjjm	5930	8	contrast	contrast	NN
cord-023095-4dannjjm	5930	9	enhancing	enhancing	NN
cord-023095-4dannjjm	5930	10	except	except	IN
cord-023095-4dannjjm	5930	11	for	for	IN
cord-023095-4dannjjm	5930	12	one	one	CD
cord-023095-4dannjjm	5930	13	.	.	.
cord-023095-4dannjjm	5931	1	Histologic	Histologic	NNP
cord-023095-4dannjjm	5931	2	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5931	3	of	of	IN
cord-023095-4dannjjm	5931	4	meningioma(n	meningioma(n	NNP
cord-023095-4dannjjm	5931	5	5	5	CD
cord-023095-4dannjjm	5931	6	3	3	CD
cord-023095-4dannjjm	5931	7	)	)	-RRB-
cord-023095-4dannjjm	5931	8	and	and	CC
cord-023095-4dannjjm	5931	9	granulomatous	granulomatous	JJ
cord-023095-4dannjjm	5931	10	meningoencephalitis(n	meningoencephalitis(n	NNP
cord-023095-4dannjjm	5931	11	5	5	CD
cord-023095-4dannjjm	5931	12	1	1	CD
cord-023095-4dannjjm	5931	13	)	)	-RRB-
cord-023095-4dannjjm	5931	14	were	be	VBD
cord-023095-4dannjjm	5931	15	made	make	VBN
cord-023095-4dannjjm	5931	16	.	.	.
cord-023095-4dannjjm	5932	1	The	the	DT
cord-023095-4dannjjm	5932	2	poorly	poorly	RB
cord-023095-4dannjjm	5932	3	-	-	HYPH
cord-023095-4dannjjm	5932	4	circumscribed	circumscribed	JJ
cord-023095-4dannjjm	5932	5	,	,	,
cord-023095-4dannjjm	5932	6	non	non	JJ
cord-023095-4dannjjm	5932	7	-	-	JJ
cord-023095-4dannjjm	5932	8	contrast	contrast	JJ
cord-023095-4dannjjm	5932	9	enhancing	enhance	VBG
cord-023095-4dannjjm	5932	10	frontal	frontal	JJ
cord-023095-4dannjjm	5932	11	mass	mass	NN
cord-023095-4dannjjm	5932	12	yielded	yield	VBN
cord-023095-4dannjjm	5932	13	non	non	JJ
cord-023095-4dannjjm	5932	14	-	-	JJ
cord-023095-4dannjjm	5932	15	specific	specific	JJ
cord-023095-4dannjjm	5932	16	necrosis	necrosis	NN
cord-023095-4dannjjm	5932	17	.	.	.
cord-023095-4dannjjm	5933	1	Following	follow	VBG
cord-023095-4dannjjm	5933	2	biopsy	biopsy	NN
cord-023095-4dannjjm	5933	3	,	,	,
cord-023095-4dannjjm	5933	4	three	three	CD
cord-023095-4dannjjm	5933	5	dogs	dog	NNS
cord-023095-4dannjjm	5933	6	returned	return	VBD
cord-023095-4dannjjm	5933	7	to	to	IN
cord-023095-4dannjjm	5933	8	pre	pre	JJ
cord-023095-4dannjjm	5933	9	-	-	JJ
cord-023095-4dannjjm	5933	10	biopsy	biopsy	JJ
cord-023095-4dannjjm	5933	11	neurologic	neurologic	JJ
cord-023095-4dannjjm	5933	12	status	status	NN
cord-023095-4dannjjm	5933	13	within	within	IN
cord-023095-4dannjjm	5933	14	12	12	CD
cord-023095-4dannjjm	5933	15	hours	hour	NNS
cord-023095-4dannjjm	5933	16	.	.	.
cord-023095-4dannjjm	5934	1	The	the	DT
cord-023095-4dannjjm	5934	2	French	french	JJ
cord-023095-4dannjjm	5934	3	Bulldog	Bulldog	NNP
cord-023095-4dannjjm	5934	4	took	take	VBD
cord-023095-4dannjjm	5934	5	48	48	CD
cord-023095-4dannjjm	5934	6	hours	hour	NNS
cord-023095-4dannjjm	5934	7	to	to	TO
cord-023095-4dannjjm	5934	8	return	return	VB
cord-023095-4dannjjm	5934	9	to	to	IN
cord-023095-4dannjjm	5934	10	previous	previous	JJ
cord-023095-4dannjjm	5934	11	neurologic	neurologic	JJ
cord-023095-4dannjjm	5934	12	status	status	NN
cord-023095-4dannjjm	5934	13	due	due	IN
cord-023095-4dannjjm	5934	14	to	to	IN
cord-023095-4dannjjm	5934	15	brachycephalic	brachycephalic	JJ
cord-023095-4dannjjm	5934	16	syndrome	syndrome	NN
cord-023095-4dannjjm	5934	17	that	that	WDT
cord-023095-4dannjjm	5934	18	required	require	VBD
cord-023095-4dannjjm	5934	19	oxygen	oxygen	NN
cord-023095-4dannjjm	5934	20	support	support	NN
cord-023095-4dannjjm	5934	21	.	.	.
cord-023095-4dannjjm	5935	1	One	one	CD
cord-023095-4dannjjm	5935	2	dog	dog	NN
cord-023095-4dannjjm	5935	3	had	have	VBD
cord-023095-4dannjjm	5935	4	acute	acute	JJ
cord-023095-4dannjjm	5935	5	respiratory	respiratory	JJ
cord-023095-4dannjjm	5935	6	arrest	arrest	NN
cord-023095-4dannjjm	5935	7	16	16	CD
cord-023095-4dannjjm	5935	8	hours	hour	NNS
cord-023095-4dannjjm	5935	9	post	post	NN
cord-023095-4dannjjm	5935	10	-	-	NN
cord-023095-4dannjjm	5935	11	biopsy	biopsy	JJ
cord-023095-4dannjjm	5935	12	.	.	.
cord-023095-4dannjjm	5936	1	Necropsy	Necropsy	NNP
cord-023095-4dannjjm	5936	2	is	be	VBZ
cord-023095-4dannjjm	5936	3	pending	pende	VBG
cord-023095-4dannjjm	5936	4	.	.	.
cord-023095-4dannjjm	5937	1	These	these	DT
cord-023095-4dannjjm	5937	2	results	result	NNS
cord-023095-4dannjjm	5937	3	suggest	suggest	VBP
cord-023095-4dannjjm	5937	4	that	that	IN
cord-023095-4dannjjm	5937	5	this	this	DT
cord-023095-4dannjjm	5937	6	MRI	MRI	NNP
cord-023095-4dannjjm	5937	7	-	-	HYPH
cord-023095-4dannjjm	5937	8	guided	guide	VBN
cord-023095-4dannjjm	5937	9	biopsy	biopsy	NN
cord-023095-4dannjjm	5937	10	system	system	NN
cord-023095-4dannjjm	5937	11	can	can	MD
cord-023095-4dannjjm	5937	12	provide	provide	VB
cord-023095-4dannjjm	5937	13	an	an	DT
cord-023095-4dannjjm	5937	14	accurate	accurate	JJ
cord-023095-4dannjjm	5937	15	histologic	histologic	JJ
cord-023095-4dannjjm	5937	16	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5937	17	of	of	IN
cord-023095-4dannjjm	5937	18	brain	brain	NN
cord-023095-4dannjjm	5937	19	lesions	lesion	NNS
cord-023095-4dannjjm	5937	20	.	.	.
cord-023095-4dannjjm	5938	1	Biopsies	biopsy	NNS
cord-023095-4dannjjm	5938	2	of	of	IN
cord-023095-4dannjjm	5938	3	poorly	poorly	RB
cord-023095-4dannjjm	5938	4	-	-	HYPH
cord-023095-4dannjjm	5938	5	circumscribed	circumscribed	JJ
cord-023095-4dannjjm	5938	6	and	and	CC
cord-023095-4dannjjm	5938	7	non	non	JJ
cord-023095-4dannjjm	5938	8	-	-	JJ
cord-023095-4dannjjm	5938	9	contrast	contrast	JJ
cord-023095-4dannjjm	5938	10	enhancing	enhance	VBG
cord-023095-4dannjjm	5938	11	brain	brain	NN
cord-023095-4dannjjm	5938	12	lesions	lesion	NNS
cord-023095-4dannjjm	5938	13	may	may	MD
cord-023095-4dannjjm	5938	14	be	be	VB
cord-023095-4dannjjm	5938	15	less	less	RBR
cord-023095-4dannjjm	5938	16	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	5938	17	.	.	.
cord-023095-4dannjjm	5939	1	Further	further	JJ
cord-023095-4dannjjm	5939	2	evaluation	evaluation	NN
cord-023095-4dannjjm	5939	3	is	be	VBZ
cord-023095-4dannjjm	5939	4	on	on	RB
cord-023095-4dannjjm	5939	5	-	-	HYPH
cord-023095-4dannjjm	5939	6	going	go	VBG
cord-023095-4dannjjm	5939	7	to	to	TO
cord-023095-4dannjjm	5939	8	determine	determine	VB
cord-023095-4dannjjm	5939	9	the	the	DT
cord-023095-4dannjjm	5939	10	true	true	JJ
cord-023095-4dannjjm	5939	11	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	5939	12	yield	yield	NN
cord-023095-4dannjjm	5939	13	and	and	CC
cord-023095-4dannjjm	5939	14	complication	complication	NN
cord-023095-4dannjjm	5939	15	rate	rate	NN
cord-023095-4dannjjm	5939	16	of	of	IN
cord-023095-4dannjjm	5939	17	this	this	DT
cord-023095-4dannjjm	5939	18	procedure	procedure	NN
cord-023095-4dannjjm	5939	19	.	.	.
cord-023095-4dannjjm	5940	1	Concurrent	concurrent	JJ
cord-023095-4dannjjm	5940	2	malformations	malformation	NNS
cord-023095-4dannjjm	5940	3	of	of	IN
cord-023095-4dannjjm	5940	4	the	the	DT
cord-023095-4dannjjm	5940	5	craniocervical	craniocervical	NNP
cord-023095-4dannjjm	5940	6	junction	junction	NNP
cord-023095-4dannjjm	5940	7	are	be	VBP
cord-023095-4dannjjm	5940	8	commonly	commonly	RB
cord-023095-4dannjjm	5940	9	identified	identify	VBN
cord-023095-4dannjjm	5940	10	in	in	IN
cord-023095-4dannjjm	5940	11	humans	human	NNS
cord-023095-4dannjjm	5940	12	with	with	IN
cord-023095-4dannjjm	5940	13	Chiari	Chiari	NNP
cord-023095-4dannjjm	5940	14	type	type	NN
cord-023095-4dannjjm	5940	15	I	-PRON-	PRP
cord-023095-4dannjjm	5940	16	malformation	malformation	NN
cord-023095-4dannjjm	5940	17	.	.	.
cord-023095-4dannjjm	5941	1	Recent	recent	JJ
cord-023095-4dannjjm	5941	2	evidence	evidence	NN
cord-023095-4dannjjm	5941	3	suggests	suggest	VBZ
cord-023095-4dannjjm	5941	4	such	such	JJ
cord-023095-4dannjjm	5941	5	craniocervical	craniocervical	JJ
cord-023095-4dannjjm	5941	6	junction	junction	NN
cord-023095-4dannjjm	5941	7	abnormalities	abnormality	NNS
cord-023095-4dannjjm	5941	8	(	(	-LRB-
cord-023095-4dannjjm	5941	9	CJAs	CJAs	NNP
cord-023095-4dannjjm	5941	10	)	)	-RRB-
cord-023095-4dannjjm	5941	11	also	also	RB
cord-023095-4dannjjm	5941	12	occur	occur	VBP
cord-023095-4dannjjm	5941	13	in	in	IN
cord-023095-4dannjjm	5941	14	dogs	dog	NNS
cord-023095-4dannjjm	5941	15	suspected	suspect	VBN
cord-023095-4dannjjm	5941	16	of	of	IN
cord-023095-4dannjjm	5941	17	having	have	VBG
cord-023095-4dannjjm	5941	18	Chiari	Chiari	NNP
cord-023095-4dannjjm	5941	19	-	-	HYPH
cord-023095-4dannjjm	5941	20	like	like	JJ
cord-023095-4dannjjm	5941	21	malformation	malformation	NN
cord-023095-4dannjjm	5941	22	(	(	-LRB-
cord-023095-4dannjjm	5941	23	CLM	CLM	NNP
cord-023095-4dannjjm	5941	24	)	)	-RRB-
cord-023095-4dannjjm	5941	25	.	.	.
cord-023095-4dannjjm	5942	1	The	the	DT
cord-023095-4dannjjm	5942	2	purpose	purpose	NN
cord-023095-4dannjjm	5942	3	of	of	IN
cord-023095-4dannjjm	5942	4	this	this	DT
cord-023095-4dannjjm	5942	5	study	study	NN
cord-023095-4dannjjm	5942	6	was	be	VBD
cord-023095-4dannjjm	5942	7	to	to	TO
cord-023095-4dannjjm	5942	8	objectively	objectively	RB
cord-023095-4dannjjm	5942	9	describe	describe	VB
cord-023095-4dannjjm	5942	10	morphometric	morphometric	JJ
cord-023095-4dannjjm	5942	11	features	feature	NNS
cord-023095-4dannjjm	5942	12	of	of	IN
cord-023095-4dannjjm	5942	13	the	the	DT
cord-023095-4dannjjm	5942	14	craniocervical	craniocervical	NNP
cord-023095-4dannjjm	5942	15	junction	junction	NN
cord-023095-4dannjjm	5942	16	region	region	NN
cord-023095-4dannjjm	5942	17	of	of	IN
cord-023095-4dannjjm	5942	18	dogs	dog	NNS
cord-023095-4dannjjm	5942	19	with	with	IN
cord-023095-4dannjjm	5942	20	suspected	suspect	VBN
cord-023095-4dannjjm	5942	21	CLM	CLM	NNP
cord-023095-4dannjjm	5942	22	and	and	CC
cord-023095-4dannjjm	5942	23	to	to	TO
cord-023095-4dannjjm	5942	24	investigate	investigate	VB
cord-023095-4dannjjm	5942	25	for	for	IN
cord-023095-4dannjjm	5942	26	associations	association	NNS
cord-023095-4dannjjm	5942	27	between	between	IN
cord-023095-4dannjjm	5942	28	these	these	DT
cord-023095-4dannjjm	5942	29	features	feature	NNS
cord-023095-4dannjjm	5942	30	and	and	CC
cord-023095-4dannjjm	5942	31	the	the	DT
cord-023095-4dannjjm	5942	32	occurrence	occurrence	NN
cord-023095-4dannjjm	5942	33	of	of	IN
cord-023095-4dannjjm	5942	34	other	other	JJ
cord-023095-4dannjjm	5942	35	malformations	malformation	NNS
cord-023095-4dannjjm	5942	36	in	in	IN
cord-023095-4dannjjm	5942	37	this	this	DT
cord-023095-4dannjjm	5942	38	region	region	NN
cord-023095-4dannjjm	5942	39	.	.	.
cord-023095-4dannjjm	5943	1	Magnetic	magnetic	JJ
cord-023095-4dannjjm	5943	2	resonance	resonance	NN
cord-023095-4dannjjm	5943	3	(	(	-LRB-
cord-023095-4dannjjm	5943	4	MR	MR	NNP
cord-023095-4dannjjm	5943	5	)	)	-RRB-
cord-023095-4dannjjm	5943	6	and	and	CC
cord-023095-4dannjjm	5943	7	computed	compute	VBN
cord-023095-4dannjjm	5943	8	tomographic	tomographic	NNP
cord-023095-4dannjjm	5943	9	(	(	-LRB-
cord-023095-4dannjjm	5943	10	CT	CT	NNP
cord-023095-4dannjjm	5943	11	)	)	-RRB-
cord-023095-4dannjjm	5943	12	images	image	NNS
cord-023095-4dannjjm	5943	13	from	from	IN
cord-023095-4dannjjm	5943	14	274	274	CD
cord-023095-4dannjjm	5943	15	dogs	dog	NNS
cord-023095-4dannjjm	5943	16	with	with	IN
cord-023095-4dannjjm	5943	17	CLM	CLM	NNP
cord-023095-4dannjjm	5943	18	were	be	VBD
cord-023095-4dannjjm	5943	19	evaluated	evaluate	VBN
cord-023095-4dannjjm	5943	20	.	.	.
cord-023095-4dannjjm	5944	1	Three	three	CD
cord-023095-4dannjjm	5944	2	regions	region	NNS
cord-023095-4dannjjm	5944	3	of	of	IN
cord-023095-4dannjjm	5944	4	neural	neural	JJ
cord-023095-4dannjjm	5944	5	tissue	tissue	NN
cord-023095-4dannjjm	5944	6	compression	compression	NN
cord-023095-4dannjjm	5944	7	were	be	VBD
cord-023095-4dannjjm	5944	8	assessed	assess	VBN
cord-023095-4dannjjm	5944	9	:	:	:
cord-023095-4dannjjm	5944	10	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	5944	11	compression	compression	NN
cord-023095-4dannjjm	5944	12	(	(	-LRB-
cord-023095-4dannjjm	5944	13	CC	cc	NN
cord-023095-4dannjjm	5944	14	)	)	-RRB-
cord-023095-4dannjjm	5944	15	;	;	,
cord-023095-4dannjjm	5944	16	ventral	ventral	JJ
cord-023095-4dannjjm	5944	17	compression	compression	NN
cord-023095-4dannjjm	5944	18	at	at	IN
cord-023095-4dannjjm	5944	19	the	the	DT
cord-023095-4dannjjm	5944	20	C1	C1	NNP
cord-023095-4dannjjm	5944	21	/	/	SYM
cord-023095-4dannjjm	5944	22	C2	C2	NNP
cord-023095-4dannjjm	5944	23	articulation	articulation	NN
cord-023095-4dannjjm	5944	24	,	,	,
cord-023095-4dannjjm	5944	25	termed	term	VBN
cord-023095-4dannjjm	5944	26	'	'	``
cord-023095-4dannjjm	5944	27	'	'	``
cord-023095-4dannjjm	5944	28	medullary	medullary	JJ
cord-023095-4dannjjm	5944	29	kinking	kinking	NN
cord-023095-4dannjjm	5944	30	'	'	''
cord-023095-4dannjjm	5944	31	'	'	''
cord-023095-4dannjjm	5944	32	(	(	-LRB-
cord-023095-4dannjjm	5944	33	MK	MK	NNP
cord-023095-4dannjjm	5944	34	)	)	-RRB-
cord-023095-4dannjjm	5944	35	;	;	:
cord-023095-4dannjjm	5944	36	and	and	CC
cord-023095-4dannjjm	5944	37	dorsal	dorsal	JJ
cord-023095-4dannjjm	5944	38	compression	compression	NN
cord-023095-4dannjjm	5944	39	(	(	-LRB-
cord-023095-4dannjjm	5944	40	DC	DC	NNP
cord-023095-4dannjjm	5944	41	)	)	-RRB-
cord-023095-4dannjjm	5944	42	at	at	IN
cord-023095-4dannjjm	5944	43	the	the	DT
cord-023095-4dannjjm	5944	44	C1	C1	NNP
cord-023095-4dannjjm	5944	45	/	/	SYM
cord-023095-4dannjjm	5944	46	C2	C2	NNP
cord-023095-4dannjjm	5944	47	articulation	articulation	NN
cord-023095-4dannjjm	5944	48	.	.	.
cord-023095-4dannjjm	5945	1	A	a	DT
cord-023095-4dannjjm	5945	2	compression	compression	NN
cord-023095-4dannjjm	5945	3	index	index	NN
cord-023095-4dannjjm	5945	4	(	(	-LRB-
cord-023095-4dannjjm	5945	5	CI	CI	NNP
cord-023095-4dannjjm	5945	6	)	)	-RRB-
cord-023095-4dannjjm	5945	7	was	be	VBD
cord-023095-4dannjjm	5945	8	calculated	calculate	VBN
cord-023095-4dannjjm	5945	9	for	for	IN
cord-023095-4dannjjm	5945	10	all	all	DT
cord-023095-4dannjjm	5945	11	abnormal	abnormal	JJ
cord-023095-4dannjjm	5945	12	regions	region	NNS
cord-023095-4dannjjm	5945	13	for	for	IN
cord-023095-4dannjjm	5945	14	each	each	DT
cord-023095-4dannjjm	5945	15	dog	dog	NN
cord-023095-4dannjjm	5945	16	.	.	.
cord-023095-4dannjjm	5946	1	Multiple	multiple	JJ
cord-023095-4dannjjm	5946	2	logistic	logistic	JJ
cord-023095-4dannjjm	5946	3	regression	regression	NN
cord-023095-4dannjjm	5946	4	analysis	analysis	NN
cord-023095-4dannjjm	5946	5	was	be	VBD
cord-023095-4dannjjm	5946	6	performed	perform	VBN
cord-023095-4dannjjm	5946	7	(	(	-LRB-
cord-023095-4dannjjm	5946	8	p	p	NN
cord-023095-4dannjjm	5946	9	o	o	NN
cord-023095-4dannjjm	5946	10	0.05	0.05	CD
cord-023095-4dannjjm	5946	11	)	)	-RRB-
cord-023095-4dannjjm	5946	12	to	to	TO
cord-023095-4dannjjm	5946	13	ascertain	ascertain	VB
cord-023095-4dannjjm	5946	14	whether	whether	IN
cord-023095-4dannjjm	5946	15	CI	CI	NNP
cord-023095-4dannjjm	5946	16	values	value	NNS
cord-023095-4dannjjm	5946	17	for	for	IN
cord-023095-4dannjjm	5946	18	the	the	DT
cord-023095-4dannjjm	5946	19	different	different	JJ
cord-023095-4dannjjm	5946	20	regions	region	NNS
cord-023095-4dannjjm	5946	21	of	of	IN
cord-023095-4dannjjm	5946	22	compression	compression	NN
cord-023095-4dannjjm	5946	23	were	be	VBD
cord-023095-4dannjjm	5946	24	associated	associate	VBN
cord-023095-4dannjjm	5946	25	with	with	IN
cord-023095-4dannjjm	5946	26	the	the	DT
cord-023095-4dannjjm	5946	27	incidence	incidence	NN
cord-023095-4dannjjm	5946	28	of	of	IN
cord-023095-4dannjjm	5946	29	other	other	JJ
cord-023095-4dannjjm	5946	30	craniocervical	craniocervical	JJ
cord-023095-4dannjjm	5946	31	junction	junction	NN
cord-023095-4dannjjm	5946	32	abnormalities	abnormality	NNS
cord-023095-4dannjjm	5946	33	.	.	.
cord-023095-4dannjjm	5947	1	68	68	CD
cord-023095-4dannjjm	5947	2	%	%	NN
cord-023095-4dannjjm	5947	3	of	of	IN
cord-023095-4dannjjm	5947	4	dogs	dog	NNS
cord-023095-4dannjjm	5947	5	had	have	VBD
cord-023095-4dannjjm	5947	6	MK	MK	NNP
cord-023095-4dannjjm	5947	7	and	and	CC
cord-023095-4dannjjm	5947	8	38	38	CD
cord-023095-4dannjjm	5947	9	%	%	NN
cord-023095-4dannjjm	5947	10	of	of	IN
cord-023095-4dannjjm	5947	11	dogs	dog	NNS
cord-023095-4dannjjm	5947	12	had	have	VBD
cord-023095-4dannjjm	5947	13	DC	DC	NNP
cord-023095-4dannjjm	5947	14	.	.	.
cord-023095-4dannjjm	5948	1	28	28	CD
cord-023095-4dannjjm	5948	2	%	%	NN
cord-023095-4dannjjm	5948	3	of	of	IN
cord-023095-4dannjjm	5948	4	dogs	dog	NNS
cord-023095-4dannjjm	5948	5	also	also	RB
cord-023095-4dannjjm	5948	6	had	have	VBD
cord-023095-4dannjjm	5948	7	evidence	evidence	NN
cord-023095-4dannjjm	5948	8	of	of	IN
cord-023095-4dannjjm	5948	9	atlanto	atlanto	NNS
cord-023095-4dannjjm	5948	10	-	-	HYPH
cord-023095-4dannjjm	5948	11	occipital	occipital	JJ
cord-023095-4dannjjm	5948	12	overlapping	overlap	VBG
cord-023095-4dannjjm	5948	13	(	(	-LRB-
cord-023095-4dannjjm	5948	14	AOO	AOO	NNP
cord-023095-4dannjjm	5948	15	Medical	medical	JJ
cord-023095-4dannjjm	5948	16	infrared	infrared	JJ
cord-023095-4dannjjm	5948	17	imaging	imaging	NN
cord-023095-4dannjjm	5948	18	(	(	-LRB-
cord-023095-4dannjjm	5948	19	MII	MII	NNP
cord-023095-4dannjjm	5948	20	)	)	-RRB-
cord-023095-4dannjjm	5948	21	is	be	VBZ
cord-023095-4dannjjm	5948	22	a	a	DT
cord-023095-4dannjjm	5948	23	non	non	JJ
cord-023095-4dannjjm	5948	24	-	-	JJ
cord-023095-4dannjjm	5948	25	invasive	invasive	JJ
cord-023095-4dannjjm	5948	26	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	5948	27	imaging	imaging	NN
cord-023095-4dannjjm	5948	28	technique	technique	NN
cord-023095-4dannjjm	5948	29	that	that	WDT
cord-023095-4dannjjm	5948	30	measures	measure	VBZ
cord-023095-4dannjjm	5948	31	skin	skin	NN
cord-023095-4dannjjm	5948	32	surface	surface	NN
cord-023095-4dannjjm	5948	33	temperature	temperature	NN
cord-023095-4dannjjm	5948	34	and	and	CC
cord-023095-4dannjjm	5948	35	generates	generate	VBZ
cord-023095-4dannjjm	5948	36	thermal	thermal	JJ
cord-023095-4dannjjm	5948	37	pattern	pattern	NN
cord-023095-4dannjjm	5948	38	maps	map	NNS
cord-023095-4dannjjm	5948	39	based	base	VBN
cord-023095-4dannjjm	5948	40	on	on	IN
cord-023095-4dannjjm	5948	41	predetermined	predetermine	VBN
cord-023095-4dannjjm	5948	42	color	color	NN
cord-023095-4dannjjm	5948	43	scales	scale	NNS
cord-023095-4dannjjm	5948	44	.	.	.
cord-023095-4dannjjm	5949	1	Because	because	IN
cord-023095-4dannjjm	5949	2	skin	skin	NN
cord-023095-4dannjjm	5949	3	temperature	temperature	NN
cord-023095-4dannjjm	5949	4	,	,	,
cord-023095-4dannjjm	5949	5	dependent	dependent	JJ
cord-023095-4dannjjm	5949	6	on	on	IN
cord-023095-4dannjjm	5949	7	regional	regional	JJ
cord-023095-4dannjjm	5949	8	perfusion	perfusion	NN
cord-023095-4dannjjm	5949	9	,	,	,
cord-023095-4dannjjm	5949	10	is	be	VBZ
cord-023095-4dannjjm	5949	11	under	under	IN
cord-023095-4dannjjm	5949	12	direct	direct	JJ
cord-023095-4dannjjm	5949	13	control	control	NN
cord-023095-4dannjjm	5949	14	of	of	IN
cord-023095-4dannjjm	5949	15	the	the	DT
cord-023095-4dannjjm	5949	16	sympathetic	sympathetic	JJ
cord-023095-4dannjjm	5949	17	nervous	nervous	JJ
cord-023095-4dannjjm	5949	18	system	system	NN
cord-023095-4dannjjm	5949	19	,	,	,
cord-023095-4dannjjm	5949	20	MII	MII	NNP
cord-023095-4dannjjm	5949	21	provides	provide	VBZ
cord-023095-4dannjjm	5949	22	information	information	NN
cord-023095-4dannjjm	5949	23	about	about	IN
cord-023095-4dannjjm	5949	24	the	the	DT
cord-023095-4dannjjm	5949	25	function	function	NN
cord-023095-4dannjjm	5949	26	of	of	IN
cord-023095-4dannjjm	5949	27	the	the	DT
cord-023095-4dannjjm	5949	28	autonomic	autonomic	JJ
cord-023095-4dannjjm	5949	29	nervous	nervous	JJ
cord-023095-4dannjjm	5949	30	system	system	NN
cord-023095-4dannjjm	5949	31	.	.	.
cord-023095-4dannjjm	5950	1	Because	because	IN
cord-023095-4dannjjm	5950	2	of	of	IN
cord-023095-4dannjjm	5950	3	recent	recent	JJ
cord-023095-4dannjjm	5950	4	advances	advance	NNS
cord-023095-4dannjjm	5950	5	in	in	IN
cord-023095-4dannjjm	5950	6	technology	technology	NN
cord-023095-4dannjjm	5950	7	and	and	CC
cord-023095-4dannjjm	5950	8	lack	lack	NN
cord-023095-4dannjjm	5950	9	of	of	IN
cord-023095-4dannjjm	5950	10	sedation	sedation	NN
cord-023095-4dannjjm	5950	11	needed	need	VBN
cord-023095-4dannjjm	5950	12	to	to	TO
cord-023095-4dannjjm	5950	13	image	image	VB
cord-023095-4dannjjm	5950	14	patients	patient	NNS
cord-023095-4dannjjm	5950	15	,	,	,
cord-023095-4dannjjm	5950	16	MII	MII	NNP
cord-023095-4dannjjm	5950	17	has	have	VBZ
cord-023095-4dannjjm	5950	18	potential	potential	JJ
cord-023095-4dannjjm	5950	19	use	use	NN
cord-023095-4dannjjm	5950	20	as	as	IN
cord-023095-4dannjjm	5950	21	a	a	DT
cord-023095-4dannjjm	5950	22	screening	screening	NN
cord-023095-4dannjjm	5950	23	test	test	NN
cord-023095-4dannjjm	5950	24	for	for	IN
cord-023095-4dannjjm	5950	25	a	a	DT
cord-023095-4dannjjm	5950	26	variety	variety	NN
cord-023095-4dannjjm	5950	27	of	of	IN
cord-023095-4dannjjm	5950	28	conditions	condition	NNS
cord-023095-4dannjjm	5950	29	that	that	WDT
cord-023095-4dannjjm	5950	30	may	may	MD
cord-023095-4dannjjm	5950	31	result	result	VB
cord-023095-4dannjjm	5950	32	in	in	IN
cord-023095-4dannjjm	5950	33	autonomic	autonomic	JJ
cord-023095-4dannjjm	5950	34	dysregulation	dysregulation	NN
cord-023095-4dannjjm	5950	35	like	like	IN
cord-023095-4dannjjm	5950	36	Chiari	Chiari	NNP
cord-023095-4dannjjm	5950	37	-	-	HYPH
cord-023095-4dannjjm	5950	38	like	like	JJ
cord-023095-4dannjjm	5950	39	malformation	malformation	NN
cord-023095-4dannjjm	5950	40	in	in	IN
cord-023095-4dannjjm	5950	41	dogs	dog	NNS
cord-023095-4dannjjm	5950	42	(	(	-LRB-
cord-023095-4dannjjm	5950	43	CLM	CLM	NNP
cord-023095-4dannjjm	5950	44	)	)	-RRB-
cord-023095-4dannjjm	5950	45	.	.	.
cord-023095-4dannjjm	5951	1	The	the	DT
cord-023095-4dannjjm	5951	2	purposes	purpose	NNS
cord-023095-4dannjjm	5951	3	of	of	IN
cord-023095-4dannjjm	5951	4	this	this	DT
cord-023095-4dannjjm	5951	5	study	study	NN
cord-023095-4dannjjm	5951	6	were	be	VBD
cord-023095-4dannjjm	5951	7	to	to	TO
cord-023095-4dannjjm	5951	8	establish	establish	VB
cord-023095-4dannjjm	5951	9	a	a	DT
cord-023095-4dannjjm	5951	10	MII	MII	NNP
cord-023095-4dannjjm	5951	11	protocol	protocol	NN
cord-023095-4dannjjm	5951	12	for	for	IN
cord-023095-4dannjjm	5951	13	dogs	dog	NNS
cord-023095-4dannjjm	5951	14	suspected	suspect	VBN
cord-023095-4dannjjm	5951	15	of	of	IN
cord-023095-4dannjjm	5951	16	having	have	VBG
cord-023095-4dannjjm	5951	17	CLM	CLM	NNP
cord-023095-4dannjjm	5951	18	,	,	,
cord-023095-4dannjjm	5951	19	to	to	TO
cord-023095-4dannjjm	5951	20	identify	identify	VB
cord-023095-4dannjjm	5951	21	thermal	thermal	JJ
cord-023095-4dannjjm	5951	22	imaging	imaging	NN
cord-023095-4dannjjm	5951	23	patterns	pattern	NNS
cord-023095-4dannjjm	5951	24	for	for	IN
cord-023095-4dannjjm	5951	25	various	various	JJ
cord-023095-4dannjjm	5951	26	regions	region	NNS
cord-023095-4dannjjm	5951	27	of	of	IN
cord-023095-4dannjjm	5951	28	interest	interest	NN
cord-023095-4dannjjm	5951	29	(	(	-LRB-
cord-023095-4dannjjm	5951	30	ROI	ROI	NNP
cord-023095-4dannjjm	5951	31	)	)	-RRB-
cord-023095-4dannjjm	5951	32	,	,	,
cord-023095-4dannjjm	5951	33	to	to	TO
cord-023095-4dannjjm	5951	34	evaluate	evaluate	VB
cord-023095-4dannjjm	5951	35	changes	change	NNS
cord-023095-4dannjjm	5951	36	in	in	IN
cord-023095-4dannjjm	5951	37	thermal	thermal	JJ
cord-023095-4dannjjm	5951	38	patterns	pattern	NNS
cord-023095-4dannjjm	5951	39	and	and	CC
cord-023095-4dannjjm	5951	40	compare	compare	VBP
cord-023095-4dannjjm	5951	41	the	the	DT
cord-023095-4dannjjm	5951	42	results	result	NNS
cord-023095-4dannjjm	5951	43	to	to	IN
cord-023095-4dannjjm	5951	44	those	those	DT
cord-023095-4dannjjm	5951	45	of	of	IN
cord-023095-4dannjjm	5951	46	MRI	MRI	NNP
cord-023095-4dannjjm	5951	47	findings	finding	NNS
cord-023095-4dannjjm	5951	48	,	,	,
cord-023095-4dannjjm	5951	49	considered	consider	VBD
cord-023095-4dannjjm	5951	50	the	the	DT
cord-023095-4dannjjm	5951	51	standard	standard	NN
cord-023095-4dannjjm	5951	52	for	for	IN
cord-023095-4dannjjm	5951	53	diagnosing	diagnose	VBG
cord-023095-4dannjjm	5951	54	CLM	CLM	NNP
cord-023095-4dannjjm	5951	55	in	in	IN
cord-023095-4dannjjm	5951	56	dogs	dog	NNS
cord-023095-4dannjjm	5951	57	.	.	.
cord-023095-4dannjjm	5952	1	One	one	CD
cord-023095-4dannjjm	5952	2	hundred	hundred	CD
cord-023095-4dannjjm	5952	3	and	and	CC
cord-023095-4dannjjm	5952	4	five	five	CD
cord-023095-4dannjjm	5952	5	Cavalier	Cavalier	NNP
cord-023095-4dannjjm	5952	6	King	King	NNP
cord-023095-4dannjjm	5952	7	Charles	Charles	NNP
cord-023095-4dannjjm	5952	8	Spaniel	Spaniel	NNP
cord-023095-4dannjjm	5952	9	dogs	dog	NNS
cord-023095-4dannjjm	5952	10	with	with	IN
cord-023095-4dannjjm	5952	11	clinical	clinical	JJ
cord-023095-4dannjjm	5952	12	signs	sign	NNS
cord-023095-4dannjjm	5952	13	attributable	attributable	JJ
cord-023095-4dannjjm	5952	14	to	to	IN
cord-023095-4dannjjm	5952	15	CLM	CLM	NNP
cord-023095-4dannjjm	5952	16	and	and	CC
cord-023095-4dannjjm	5952	17	confirmed	confirm	VBD
cord-023095-4dannjjm	5952	18	CLM	CLM	NNP
cord-023095-4dannjjm	5952	19	with	with	IN
cord-023095-4dannjjm	5952	20	MRI	MRI	NNP
cord-023095-4dannjjm	5952	21	were	be	VBD
cord-023095-4dannjjm	5952	22	evaluated	evaluate	VBN
cord-023095-4dannjjm	5952	23	with	with	IN
cord-023095-4dannjjm	5952	24	a	a	DT
cord-023095-4dannjjm	5952	25	complete	complete	JJ
cord-023095-4dannjjm	5952	26	blood	blood	NN
cord-023095-4dannjjm	5952	27	count	count	NN
cord-023095-4dannjjm	5952	28	and	and	CC
cord-023095-4dannjjm	5952	29	chemistry	chemistry	NN
cord-023095-4dannjjm	5952	30	profile	profile	NN
cord-023095-4dannjjm	5952	31	,	,	,
cord-023095-4dannjjm	5952	32	examination	examination	NN
cord-023095-4dannjjm	5952	33	by	by	IN
cord-023095-4dannjjm	5952	34	a	a	DT
cord-023095-4dannjjm	5952	35	board	board	NN
cord-023095-4dannjjm	5952	36	certified	certify	VBN
cord-023095-4dannjjm	5952	37	surgeon	surgeon	NN
cord-023095-4dannjjm	5952	38	/	/	SYM
cord-023095-4dannjjm	5952	39	neurologist	neurologist	NN
cord-023095-4dannjjm	5952	40	,	,	,
cord-023095-4dannjjm	5952	41	multidetector	multidetector	NN
cord-023095-4dannjjm	5952	42	CT	CT	NNP
cord-023095-4dannjjm	5952	43	scan	scan	NN
cord-023095-4dannjjm	5952	44	of	of	IN
cord-023095-4dannjjm	5952	45	the	the	DT
cord-023095-4dannjjm	5952	46	craniocervical	craniocervical	NNP
cord-023095-4dannjjm	5952	47	junction	junction	NN
cord-023095-4dannjjm	5952	48	,	,	,
cord-023095-4dannjjm	5952	49	whole	whole	JJ
cord-023095-4dannjjm	5952	50	body	body	NN
cord-023095-4dannjjm	5952	51	MRI	MRI	NNP
cord-023095-4dannjjm	5952	52	and	and	CC
cord-023095-4dannjjm	5952	53	MII	MII	NNP
cord-023095-4dannjjm	5952	54	.	.	.
cord-023095-4dannjjm	5953	1	The	the	DT
cord-023095-4dannjjm	5953	2	protocol	protocol	NN
cord-023095-4dannjjm	5953	3	for	for	IN
cord-023095-4dannjjm	5953	4	thermal	thermal	JJ
cord-023095-4dannjjm	5953	5	imaging	imaging	NN
cord-023095-4dannjjm	5953	6	included	include	VBD
cord-023095-4dannjjm	5953	7	cranial	cranial	JJ
cord-023095-4dannjjm	5953	8	and	and	CC
cord-023095-4dannjjm	5953	9	caudal	caudal	JJ
cord-023095-4dannjjm	5953	10	views	view	NNS
cord-023095-4dannjjm	5953	11	of	of	IN
cord-023095-4dannjjm	5953	12	the	the	DT
cord-023095-4dannjjm	5953	13	body	body	NN
cord-023095-4dannjjm	5953	14	,	,	,
cord-023095-4dannjjm	5953	15	full	full	JJ
cord-023095-4dannjjm	5953	16	lateral	lateral	JJ
cord-023095-4dannjjm	5953	17	right	right	NN
cord-023095-4dannjjm	5953	18	and	and	CC
cord-023095-4dannjjm	5953	19	left	left	JJ
cord-023095-4dannjjm	5953	20	body	body	NN
cord-023095-4dannjjm	5953	21	views	view	NNS
cord-023095-4dannjjm	5953	22	,	,	,
cord-023095-4dannjjm	5953	23	dorsal	dorsal	JJ
cord-023095-4dannjjm	5953	24	views	view	NNS
cord-023095-4dannjjm	5953	25	of	of	IN
cord-023095-4dannjjm	5953	26	the	the	DT
cord-023095-4dannjjm	5953	27	head	head	NN
cord-023095-4dannjjm	5953	28	and	and	CC
cord-023095-4dannjjm	5953	29	body	body	NN
cord-023095-4dannjjm	5953	30	,	,	,
cord-023095-4dannjjm	5953	31	and	and	CC
cord-023095-4dannjjm	5953	32	right	right	UH
cord-023095-4dannjjm	5953	33	and	and	CC
cord-023095-4dannjjm	5953	34	left	leave	VBD
cord-023095-4dannjjm	5953	35	lateral	lateral	JJ
cord-023095-4dannjjm	5953	36	views	view	NNS
cord-023095-4dannjjm	5953	37	of	of	IN
cord-023095-4dannjjm	5953	38	the	the	DT
cord-023095-4dannjjm	5953	39	head	head	NN
cord-023095-4dannjjm	5953	40	.	.	.
cord-023095-4dannjjm	5954	1	Thermal	thermal	JJ
cord-023095-4dannjjm	5954	2	patterns	pattern	NNS
cord-023095-4dannjjm	5954	3	were	be	VBD
cord-023095-4dannjjm	5954	4	assessed	assess	VBN
cord-023095-4dannjjm	5954	5	with	with	IN
cord-023095-4dannjjm	5954	6	custom	custom	NN
cord-023095-4dannjjm	5954	7	image	image	NN
cord-023095-4dannjjm	5954	8	recognition	recognition	NN
cord-023095-4dannjjm	5954	9	software	software	NN
cord-023095-4dannjjm	5954	10	.	.	.
cord-023095-4dannjjm	5955	1	After	after	IN
cord-023095-4dannjjm	5955	2	each	each	DT
cord-023095-4dannjjm	5955	3	dog	dog	NN
cord-023095-4dannjjm	5955	4	was	be	VBD
cord-023095-4dannjjm	5955	5	imaged	image	VBN
cord-023095-4dannjjm	5955	6	awake	awake	JJ
cord-023095-4dannjjm	5955	7	,	,	,
cord-023095-4dannjjm	5955	8	general	general	JJ
cord-023095-4dannjjm	5955	9	anesthesia	anesthesia	NN
cord-023095-4dannjjm	5955	10	was	be	VBD
cord-023095-4dannjjm	5955	11	administered	administer	VBN
cord-023095-4dannjjm	5955	12	and	and	CC
cord-023095-4dannjjm	5955	13	the	the	DT
cord-023095-4dannjjm	5955	14	dogs	dog	NNS
cord-023095-4dannjjm	5955	15	re	re	VBP
cord-023095-4dannjjm	5955	16	-	-	VBD
cord-023095-4dannjjm	5955	17	imaged	image	VBD
cord-023095-4dannjjm	5955	18	using	use	VBG
cord-023095-4dannjjm	5955	19	the	the	DT
cord-023095-4dannjjm	5955	20	same	same	JJ
cord-023095-4dannjjm	5955	21	protocol	protocol	NN
cord-023095-4dannjjm	5955	22	.	.	.
cord-023095-4dannjjm	5956	1	MRI	MRI	NNP
cord-023095-4dannjjm	5956	2	findings	finding	NNS
cord-023095-4dannjjm	5956	3	in	in	IN
cord-023095-4dannjjm	5956	4	dogs	dog	NNS
cord-023095-4dannjjm	5956	5	with	with	IN
cord-023095-4dannjjm	5956	6	severe	severe	JJ
cord-023095-4dannjjm	5956	7	or	or	CC
cord-023095-4dannjjm	5956	8	moderate	moderate	JJ
cord-023095-4dannjjm	5956	9	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	5956	10	compression	compression	NN
cord-023095-4dannjjm	5956	11	and	and	CC
cord-023095-4dannjjm	5956	12	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	5956	13	herniation	herniation	NN
cord-023095-4dannjjm	5956	14	were	be	VBD
cord-023095-4dannjjm	5956	15	compared	compare	VBN
cord-023095-4dannjjm	5956	16	with	with	IN
cord-023095-4dannjjm	5956	17	MII	MII	NNP
cord-023095-4dannjjm	5956	18	results	result	NNS
cord-023095-4dannjjm	5956	19	.	.	.
cord-023095-4dannjjm	5957	1	The	the	DT
cord-023095-4dannjjm	5957	2	top	top	NN
cord-023095-4dannjjm	5957	3	of	of	IN
cord-023095-4dannjjm	5957	4	head	head	NN
cord-023095-4dannjjm	5957	5	and	and	CC
cord-023095-4dannjjm	5957	6	front	front	NN
cord-023095-4dannjjm	5957	7	of	of	IN
cord-023095-4dannjjm	5957	8	head	head	NN
cord-023095-4dannjjm	5957	9	ROI	ROI	NNP
cord-023095-4dannjjm	5957	10	were	be	VBD
cord-023095-4dannjjm	5957	11	89.2	89.2	CD
cord-023095-4dannjjm	5957	12	%	%	NN
cord-023095-4dannjjm	5957	13	and	and	CC
cord-023095-4dannjjm	5957	14	97.3	97.3	CD
cord-023095-4dannjjm	5957	15	%	%	NN
cord-023095-4dannjjm	5957	16	successful	successful	JJ
cord-023095-4dannjjm	5957	17	in	in	IN
cord-023095-4dannjjm	5957	18	identifying	identify	VBG
cord-023095-4dannjjm	5957	19	dogs	dog	NNS
cord-023095-4dannjjm	5957	20	with	with	IN
cord-023095-4dannjjm	5957	21	CLM	CLM	NNP
cord-023095-4dannjjm	5957	22	.	.	.
cord-023095-4dannjjm	5958	1	Based	base	VBN
cord-023095-4dannjjm	5958	2	on	on	IN
cord-023095-4dannjjm	5958	3	these	these	DT
cord-023095-4dannjjm	5958	4	preliminary	preliminary	JJ
cord-023095-4dannjjm	5958	5	findings	finding	NNS
cord-023095-4dannjjm	5958	6	,	,	,
cord-023095-4dannjjm	5958	7	MII	MII	NNP
cord-023095-4dannjjm	5958	8	may	may	MD
cord-023095-4dannjjm	5958	9	be	be	VB
cord-023095-4dannjjm	5958	10	a	a	DT
cord-023095-4dannjjm	5958	11	viable	viable	JJ
cord-023095-4dannjjm	5958	12	screening	screening	NN
cord-023095-4dannjjm	5958	13	tool	tool	NN
cord-023095-4dannjjm	5958	14	to	to	TO
cord-023095-4dannjjm	5958	15	detect	detect	VB
cord-023095-4dannjjm	5958	16	CLM	CLM	NNP
cord-023095-4dannjjm	5958	17	in	in	IN
cord-023095-4dannjjm	5958	18	dogs	dog	NNS
cord-023095-4dannjjm	5958	19	.	.	.
cord-023095-4dannjjm	5959	1	Medical	medical	JJ
cord-023095-4dannjjm	5959	2	infrared	infrared	JJ
cord-023095-4dannjjm	5959	3	imaging	imaging	NN
cord-023095-4dannjjm	5959	4	(	(	-LRB-
cord-023095-4dannjjm	5959	5	MII	MII	NNP
cord-023095-4dannjjm	5959	6	)	)	-RRB-
cord-023095-4dannjjm	5959	7	is	be	VBZ
cord-023095-4dannjjm	5959	8	an	an	DT
cord-023095-4dannjjm	5959	9	imaging	imaging	NN
cord-023095-4dannjjm	5959	10	technique	technique	NN
cord-023095-4dannjjm	5959	11	that	that	WDT
cord-023095-4dannjjm	5959	12	measures	measure	VBZ
cord-023095-4dannjjm	5959	13	skin	skin	NN
cord-023095-4dannjjm	5959	14	surface	surface	NN
cord-023095-4dannjjm	5959	15	temperature	temperature	NN
cord-023095-4dannjjm	5959	16	derived	derive	VBN
cord-023095-4dannjjm	5959	17	from	from	IN
cord-023095-4dannjjm	5959	18	cutaneous	cutaneous	JJ
cord-023095-4dannjjm	5959	19	perfusion	perfusion	NN
cord-023095-4dannjjm	5959	20	and	and	CC
cord-023095-4dannjjm	5959	21	generates	generate	VBZ
cord-023095-4dannjjm	5959	22	thermal	thermal	JJ
cord-023095-4dannjjm	5959	23	pattern	pattern	NN
cord-023095-4dannjjm	5959	24	maps	map	NNS
cord-023095-4dannjjm	5959	25	based	base	VBN
cord-023095-4dannjjm	5959	26	on	on	IN
cord-023095-4dannjjm	5959	27	color	color	NN
cord-023095-4dannjjm	5959	28	scales	scale	NNS
cord-023095-4dannjjm	5959	29	.	.	.
cord-023095-4dannjjm	5960	1	MII	MII	NNP
cord-023095-4dannjjm	5960	2	has	have	VBZ
cord-023095-4dannjjm	5960	3	been	be	VBN
cord-023095-4dannjjm	5960	4	used	use	VBN
cord-023095-4dannjjm	5960	5	as	as	IN
cord-023095-4dannjjm	5960	6	a	a	DT
cord-023095-4dannjjm	5960	7	test	test	NN
cord-023095-4dannjjm	5960	8	for	for	IN
cord-023095-4dannjjm	5960	9	a	a	DT
cord-023095-4dannjjm	5960	10	variety	variety	NN
cord-023095-4dannjjm	5960	11	of	of	IN
cord-023095-4dannjjm	5960	12	conditions	condition	NNS
cord-023095-4dannjjm	5960	13	that	that	WDT
cord-023095-4dannjjm	5960	14	cause	cause	VBP
cord-023095-4dannjjm	5960	15	autonomic	autonomic	JJ
cord-023095-4dannjjm	5960	16	dysregulation	dysregulation	NN
cord-023095-4dannjjm	5960	17	resulting	result	VBG
cord-023095-4dannjjm	5960	18	in	in	IN
cord-023095-4dannjjm	5960	19	altered	alter	VBN
cord-023095-4dannjjm	5960	20	cutaneous	cutaneous	JJ
cord-023095-4dannjjm	5960	21	perfusion	perfusion	NN
cord-023095-4dannjjm	5960	22	.	.	.
cord-023095-4dannjjm	5961	1	Acute	acute	JJ
cord-023095-4dannjjm	5961	2	thoracolumbar	thoracolumbar	RB
cord-023095-4dannjjm	5961	3	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	5961	4	disk	disk	NN
cord-023095-4dannjjm	5961	5	disease	disease	NN
cord-023095-4dannjjm	5961	6	(	(	-LRB-
cord-023095-4dannjjm	5961	7	TLIVDD	TLIVDD	NNP
cord-023095-4dannjjm	5961	8	)	)	-RRB-
cord-023095-4dannjjm	5961	9	is	be	VBZ
cord-023095-4dannjjm	5961	10	common	common	JJ
cord-023095-4dannjjm	5961	11	in	in	IN
cord-023095-4dannjjm	5961	12	dogs	dog	NNS
cord-023095-4dannjjm	5961	13	.	.	.
cord-023095-4dannjjm	5962	1	The	the	DT
cord-023095-4dannjjm	5962	2	purpose	purpose	NN
cord-023095-4dannjjm	5962	3	of	of	IN
cord-023095-4dannjjm	5962	4	this	this	DT
cord-023095-4dannjjm	5962	5	study	study	NN
cord-023095-4dannjjm	5962	6	was	be	VBD
cord-023095-4dannjjm	5962	7	to	to	IN
cord-023095-4dannjjm	5962	8	:	:	:
cord-023095-4dannjjm	5962	9	1	1	LS
cord-023095-4dannjjm	5962	10	)	)	-RRB-
cord-023095-4dannjjm	5962	11	determine	determine	VB
cord-023095-4dannjjm	5962	12	the	the	DT
cord-023095-4dannjjm	5962	13	success	success	NN
cord-023095-4dannjjm	5962	14	of	of	IN
cord-023095-4dannjjm	5962	15	MII	MII	NNP
cord-023095-4dannjjm	5962	16	in	in	IN
cord-023095-4dannjjm	5962	17	identifying	identify	VBG
cord-023095-4dannjjm	5962	18	dogs	dog	NNS
cord-023095-4dannjjm	5962	19	with	with	IN
cord-023095-4dannjjm	5962	20	TLIVDD	TLIVDD	NNP
cord-023095-4dannjjm	5962	21	,	,	,
cord-023095-4dannjjm	5962	22	2	2	CD
cord-023095-4dannjjm	5962	23	)	)	-RRB-
cord-023095-4dannjjm	5962	24	compare	compare	VBP
cord-023095-4dannjjm	5962	25	the	the	DT
cord-023095-4dannjjm	5962	26	MII	MII	NNP
cord-023095-4dannjjm	5962	27	localization	localization	NN
cord-023095-4dannjjm	5962	28	with	with	IN
cord-023095-4dannjjm	5962	29	MRI	MRI	NNP
cord-023095-4dannjjm	5962	30	results	result	NNS
cord-023095-4dannjjm	5962	31	and	and	CC
cord-023095-4dannjjm	5962	32	surgical	surgical	JJ
cord-023095-4dannjjm	5962	33	findings	finding	NNS
cord-023095-4dannjjm	5962	34	3	3	CD
cord-023095-4dannjjm	5962	35	)	)	-RRB-
cord-023095-4dannjjm	5962	36	determine	determine	VB
cord-023095-4dannjjm	5962	37	if	if	IN
cord-023095-4dannjjm	5962	38	the	the	DT
cord-023095-4dannjjm	5962	39	MII	MII	NNP
cord-023095-4dannjjm	5962	40	pattern	pattern	NN
cord-023095-4dannjjm	5962	41	returns	return	VBZ
cord-023095-4dannjjm	5962	42	to	to	IN
cord-023095-4dannjjm	5962	43	that	that	DT
cord-023095-4dannjjm	5962	44	of	of	IN
cord-023095-4dannjjm	5962	45	normal	normal	JJ
cord-023095-4dannjjm	5962	46	dogs	dog	NNS
cord-023095-4dannjjm	5962	47	following	follow	VBG
cord-023095-4dannjjm	5962	48	decompression	decompression	NN
cord-023095-4dannjjm	5962	49	surgery	surgery	NN
cord-023095-4dannjjm	5962	50	.	.	.
cord-023095-4dannjjm	5963	1	72	72	CD
cord-023095-4dannjjm	5963	2	small	small	JJ
cord-023095-4dannjjm	5963	3	breed	breed	NN
cord-023095-4dannjjm	5963	4	chondodystrophic	chondodystrophic	JJ
cord-023095-4dannjjm	5963	5	dogs	dog	NNS
cord-023095-4dannjjm	5963	6	with	with	IN
cord-023095-4dannjjm	5963	7	TLIVDD	TLIVDD	NNP
cord-023095-4dannjjm	5963	8	confirmed	confirm	VBD
cord-023095-4dannjjm	5963	9	with	with	IN
cord-023095-4dannjjm	5963	10	MRI	MRI	NNP
cord-023095-4dannjjm	5963	11	and	and	CC
cord-023095-4dannjjm	5963	12	14	14	CD
cord-023095-4dannjjm	5963	13	dogs	dog	NNS
cord-023095-4dannjjm	5963	14	with	with	IN
cord-023095-4dannjjm	5963	15	no	no	DT
cord-023095-4dannjjm	5963	16	TLIVDD	TLIVDD	NNP
cord-023095-4dannjjm	5963	17	were	be	VBD
cord-023095-4dannjjm	5963	18	evaluated	evaluate	VBN
cord-023095-4dannjjm	5963	19	with	with	IN
cord-023095-4dannjjm	5963	20	MRI	MRI	NNP
cord-023095-4dannjjm	5963	21	and	and	CC
cord-023095-4dannjjm	5963	22	MII	MII	NNP
cord-023095-4dannjjm	5963	23	.	.	.
cord-023095-4dannjjm	5964	1	Regions	region	NNS
cord-023095-4dannjjm	5964	2	correlating	correlate	VBG
cord-023095-4dannjjm	5964	3	with	with	IN
cord-023095-4dannjjm	5964	4	the	the	DT
cord-023095-4dannjjm	5964	5	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	5964	6	disk	disk	NN
cord-023095-4dannjjm	5964	7	spaces	space	NNS
cord-023095-4dannjjm	5964	8	were	be	VBD
cord-023095-4dannjjm	5964	9	analyzed	analyze	VBN
cord-023095-4dannjjm	5964	10	for	for	IN
cord-023095-4dannjjm	5964	11	average	average	JJ
cord-023095-4dannjjm	5964	12	temperatures	temperature	NNS
cord-023095-4dannjjm	5964	13	and	and	CC
cord-023095-4dannjjm	5964	14	thermographic	thermographic	JJ
cord-023095-4dannjjm	5964	15	patterns	pattern	NNS
cord-023095-4dannjjm	5964	16	.	.	.
cord-023095-4dannjjm	5965	1	Thermal	thermal	JJ
cord-023095-4dannjjm	5965	2	patterns	pattern	NNS
cord-023095-4dannjjm	5965	3	were	be	VBD
cord-023095-4dannjjm	5965	4	assessed	assess	VBN
cord-023095-4dannjjm	5965	5	with	with	IN
cord-023095-4dannjjm	5965	6	computer	computer	NN
cord-023095-4dannjjm	5965	7	recognition	recognition	NN
cord-023095-4dannjjm	5965	8	pattern	pattern	NN
cord-023095-4dannjjm	5965	9	analysis	analysis	NN
cord-023095-4dannjjm	5965	10	(	(	-LRB-
cord-023095-4dannjjm	5965	11	CRPA	CRPA	NNP
cord-023095-4dannjjm	5965	12	)	)	-RRB-
cord-023095-4dannjjm	5965	13	software	software	NN
cord-023095-4dannjjm	5965	14	.	.	.
cord-023095-4dannjjm	5966	1	21	21	CD
cord-023095-4dannjjm	5966	2	dogs	dog	NNS
cord-023095-4dannjjm	5966	3	were	be	VBD
cord-023095-4dannjjm	5966	4	re	re	VBN
cord-023095-4dannjjm	5966	5	-	-	VBN
cord-023095-4dannjjm	5966	6	evaluated	evaluate	VBN
cord-023095-4dannjjm	5966	7	8	8	CD
cord-023095-4dannjjm	5966	8	weeks	week	NNS
cord-023095-4dannjjm	5966	9	after	after	IN
cord-023095-4dannjjm	5966	10	surgery	surgery	NN
cord-023095-4dannjjm	5966	11	using	use	VBG
cord-023095-4dannjjm	5966	12	the	the	DT
cord-023095-4dannjjm	5966	13	same	same	JJ
cord-023095-4dannjjm	5966	14	protocol	protocol	NN
cord-023095-4dannjjm	5966	15	.	.	.
cord-023095-4dannjjm	5967	1	When	when	WRB
cord-023095-4dannjjm	5967	2	analyzing	analyze	VBG
cord-023095-4dannjjm	5967	3	temperature	temperature	NN
cord-023095-4dannjjm	5967	4	averages	average	NNS
cord-023095-4dannjjm	5967	5	over	over	IN
cord-023095-4dannjjm	5967	6	a	a	DT
cord-023095-4dannjjm	5967	7	region	region	NN
cord-023095-4dannjjm	5967	8	,	,	,
cord-023095-4dannjjm	5967	9	no	no	DT
cord-023095-4dannjjm	5967	10	significant	significant	JJ
cord-023095-4dannjjm	5967	11	difference	difference	NN
cord-023095-4dannjjm	5967	12	was	be	VBD
cord-023095-4dannjjm	5967	13	found	find	VBN
cord-023095-4dannjjm	5967	14	between	between	IN
cord-023095-4dannjjm	5967	15	control	control	NN
cord-023095-4dannjjm	5967	16	and	and	CC
cord-023095-4dannjjm	5967	17	affected	affect	VBN
cord-023095-4dannjjm	5967	18	dogs	dog	NNS
cord-023095-4dannjjm	5967	19	.	.	.
cord-023095-4dannjjm	5968	1	CRPA	CRPA	NNP
cord-023095-4dannjjm	5968	2	was	be	VBD
cord-023095-4dannjjm	5968	3	90	90	CD
cord-023095-4dannjjm	5968	4	%	%	NN
cord-023095-4dannjjm	5968	5	successful	successful	JJ
cord-023095-4dannjjm	5968	6	in	in	IN
cord-023095-4dannjjm	5968	7	differentiating	differentiate	VBG
cord-023095-4dannjjm	5968	8	normal	normal	JJ
cord-023095-4dannjjm	5968	9	from	from	IN
cord-023095-4dannjjm	5968	10	affected	affected	JJ
cord-023095-4dannjjm	5968	11	dogs	dog	NNS
cord-023095-4dannjjm	5968	12	.	.	.
cord-023095-4dannjjm	5969	1	CRPA	CRPA	NNP
cord-023095-4dannjjm	5969	2	was	be	VBD
cord-023095-4dannjjm	5969	3	97	97	CD
cord-023095-4dannjjm	5969	4	%	%	NN
cord-023095-4dannjjm	5969	5	successful	successful	JJ
cord-023095-4dannjjm	5969	6	in	in	IN
cord-023095-4dannjjm	5969	7	identifying	identify	VBG
cord-023095-4dannjjm	5969	8	the	the	DT
cord-023095-4dannjjm	5969	9	intervertebral	intervertebral	JJ
cord-023095-4dannjjm	5969	10	disk	disk	NN
cord-023095-4dannjjm	5969	11	space	space	NN
cord-023095-4dannjjm	5969	12	when	when	WRB
cord-023095-4dannjjm	5969	13	compared	compare	VBN
cord-023095-4dannjjm	5969	14	with	with	IN
cord-023095-4dannjjm	5969	15	MRI	MRI	NNP
cord-023095-4dannjjm	5969	16	and	and	CC
cord-023095-4dannjjm	5969	17	surgical	surgical	JJ
cord-023095-4dannjjm	5969	18	findings	finding	NNS
cord-023095-4dannjjm	5969	19	.	.	.
cord-023095-4dannjjm	5970	1	Based	base	VBN
cord-023095-4dannjjm	5970	2	on	on	IN
cord-023095-4dannjjm	5970	3	these	these	DT
cord-023095-4dannjjm	5970	4	findings	finding	NNS
cord-023095-4dannjjm	5970	5	,	,	,
cord-023095-4dannjjm	5970	6	MII	MII	NNP
cord-023095-4dannjjm	5970	7	may	may	MD
cord-023095-4dannjjm	5970	8	be	be	VB
cord-023095-4dannjjm	5970	9	a	a	DT
cord-023095-4dannjjm	5970	10	viable	viable	JJ
cord-023095-4dannjjm	5970	11	screening	screening	NN
cord-023095-4dannjjm	5970	12	tool	tool	NN
cord-023095-4dannjjm	5970	13	to	to	TO
cord-023095-4dannjjm	5970	14	detect	detect	VB
cord-023095-4dannjjm	5970	15	TLIVDD	TLIVDD	NNP
cord-023095-4dannjjm	5970	16	in	in	IN
cord-023095-4dannjjm	5970	17	dogs	dog	NNS
cord-023095-4dannjjm	5970	18	.	.	.
cord-023095-4dannjjm	5971	1	Microglia	Microglia	NNP
cord-023095-4dannjjm	5971	2	physiologically	physiologically	RB
cord-023095-4dannjjm	5971	3	shows	show	VBZ
cord-023095-4dannjjm	5971	4	regional	regional	JJ
cord-023095-4dannjjm	5971	5	topographical	topographical	JJ
cord-023095-4dannjjm	5971	6	differences	difference	NNS
cord-023095-4dannjjm	5971	7	in	in	IN
cord-023095-4dannjjm	5971	8	immunophenotype	immunophenotype	NN
cord-023095-4dannjjm	5971	9	and	and	CC
cord-023095-4dannjjm	5971	10	function	function	VB
cord-023095-4dannjjm	5971	11	within	within	IN
cord-023095-4dannjjm	5971	12	the	the	DT
cord-023095-4dannjjm	5971	13	central	central	JJ
cord-023095-4dannjjm	5971	14	nervous	nervous	JJ
cord-023095-4dannjjm	5971	15	system	system	NN
cord-023095-4dannjjm	5971	16	indicating	indicate	VBG
cord-023095-4dannjjm	5971	17	the	the	DT
cord-023095-4dannjjm	5971	18	endowment	endowment	NN
cord-023095-4dannjjm	5971	19	for	for	IN
cord-023095-4dannjjm	5971	20	a	a	DT
cord-023095-4dannjjm	5971	21	prompt	prompt	JJ
cord-023095-4dannjjm	5971	22	response	response	NN
cord-023095-4dannjjm	5971	23	to	to	IN
cord-023095-4dannjjm	5971	24	pathological	pathological	JJ
cord-023095-4dannjjm	5971	25	stimuli	stimulus	NNS
cord-023095-4dannjjm	5971	26	such	such	JJ
cord-023095-4dannjjm	5971	27	as	as	IN
cord-023095-4dannjjm	5971	28	trauma	trauma	NN
cord-023095-4dannjjm	5971	29	.	.	.
cord-023095-4dannjjm	5972	1	Spinal	spinal	JJ
cord-023095-4dannjjm	5972	2	cord	cord	NN
cord-023095-4dannjjm	5972	3	injuries	injury	NNS
cord-023095-4dannjjm	5972	4	(	(	-LRB-
cord-023095-4dannjjm	5972	5	SCI	SCI	NNP
cord-023095-4dannjjm	5972	6	)	)	-RRB-
cord-023095-4dannjjm	5972	7	consist	consist	VBP
cord-023095-4dannjjm	5972	8	of	of	IN
cord-023095-4dannjjm	5972	9	a	a	DT
cord-023095-4dannjjm	5972	10	primary	primary	JJ
cord-023095-4dannjjm	5972	11	injury	injury	NN
cord-023095-4dannjjm	5972	12	encompassing	encompass	VBG
cord-023095-4dannjjm	5972	13	the	the	DT
cord-023095-4dannjjm	5972	14	mechanical	mechanical	JJ
cord-023095-4dannjjm	5972	15	impact	impact	NN
cord-023095-4dannjjm	5972	16	and	and	CC
cord-023095-4dannjjm	5972	17	the	the	DT
cord-023095-4dannjjm	5972	18	'	'	``
cord-023095-4dannjjm	5972	19	'	'	``
cord-023095-4dannjjm	5972	20	secondary	secondary	JJ
cord-023095-4dannjjm	5972	21	wave	wave	NN
cord-023095-4dannjjm	5972	22	'	'	''
cord-023095-4dannjjm	5972	23	'	'	''
cord-023095-4dannjjm	5972	24	of	of	IN
cord-023095-4dannjjm	5972	25	injury	injury	NN
cord-023095-4dannjjm	5972	26	occurring	occur	VBG
cord-023095-4dannjjm	5972	27	minutes	minute	NNS
cord-023095-4dannjjm	5972	28	to	to	IN
cord-023095-4dannjjm	5972	29	weeks	week	NNS
cord-023095-4dannjjm	5972	30	later	later	RB
cord-023095-4dannjjm	5972	31	and	and	CC
cord-023095-4dannjjm	5972	32	comprising	comprise	VBG
cord-023095-4dannjjm	5972	33	various	various	JJ
cord-023095-4dannjjm	5972	34	consecutive	consecutive	JJ
cord-023095-4dannjjm	5972	35	effects	effect	NNS
cord-023095-4dannjjm	5972	36	such	such	JJ
cord-023095-4dannjjm	5972	37	as	as	IN
cord-023095-4dannjjm	5972	38	increased	increase	VBN
cord-023095-4dannjjm	5972	39	production	production	NN
cord-023095-4dannjjm	5972	40	of	of	IN
cord-023095-4dannjjm	5972	41	free	free	JJ
cord-023095-4dannjjm	5972	42	radicals	radical	NNS
cord-023095-4dannjjm	5972	43	,	,	,
cord-023095-4dannjjm	5972	44	excessive	excessive	JJ
cord-023095-4dannjjm	5972	45	release	release	NN
cord-023095-4dannjjm	5972	46	of	of	IN
cord-023095-4dannjjm	5972	47	excitatory	excitatory	JJ
cord-023095-4dannjjm	5972	48	neurotransmitters	neurotransmitter	NNS
cord-023095-4dannjjm	5972	49	and	and	CC
cord-023095-4dannjjm	5972	50	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	5972	51	reactions	reaction	NNS
cord-023095-4dannjjm	5972	52	.	.	.
cord-023095-4dannjjm	5973	1	Activated	activate	VBN
cord-023095-4dannjjm	5973	2	microglia	microglia	NNS
cord-023095-4dannjjm	5973	3	has	have	VBZ
cord-023095-4dannjjm	5973	4	the	the	DT
cord-023095-4dannjjm	5973	5	potential	potential	NN
cord-023095-4dannjjm	5973	6	to	to	TO
cord-023095-4dannjjm	5973	7	perform	perform	VB
cord-023095-4dannjjm	5973	8	some	some	DT
cord-023095-4dannjjm	5973	9	of	of	IN
cord-023095-4dannjjm	5973	10	these	these	DT
cord-023095-4dannjjm	5973	11	reactions	reaction	NNS
cord-023095-4dannjjm	5973	12	,	,	,
cord-023095-4dannjjm	5973	13	their	-PRON-	PRP$
cord-023095-4dannjjm	5973	14	contribution	contribution	NN
cord-023095-4dannjjm	5973	15	to	to	IN
cord-023095-4dannjjm	5973	16	the	the	DT
cord-023095-4dannjjm	5973	17	secondary	secondary	JJ
cord-023095-4dannjjm	5973	18	wave	wave	NN
cord-023095-4dannjjm	5973	19	is	be	VBZ
cord-023095-4dannjjm	5973	20	therefore	therefore	RB
cord-023095-4dannjjm	5973	21	controversially	controversially	RB
cord-023095-4dannjjm	5973	22	discussed	discuss	VBN
cord-023095-4dannjjm	5973	23	.	.	.
cord-023095-4dannjjm	5974	1	It	-PRON-	PRP
cord-023095-4dannjjm	5974	2	has	have	VBZ
cord-023095-4dannjjm	5974	3	to	to	TO
cord-023095-4dannjjm	5974	4	be	be	VB
cord-023095-4dannjjm	5974	5	considered	consider	VBN
cord-023095-4dannjjm	5974	6	a	a	DT
cord-023095-4dannjjm	5974	7	double	double	RB
cord-023095-4dannjjm	5974	8	-	-	HYPH
cord-023095-4dannjjm	5974	9	edged	edged	JJ
cord-023095-4dannjjm	5974	10	sword	sword	NN
cord-023095-4dannjjm	5974	11	as	as	IN
cord-023095-4dannjjm	5974	12	both	both	DT
cord-023095-4dannjjm	5974	13	,	,	,
cord-023095-4dannjjm	5974	14	beneficial	beneficial	JJ
cord-023095-4dannjjm	5974	15	and	and	CC
cord-023095-4dannjjm	5974	16	deleterious	deleterious	JJ
cord-023095-4dannjjm	5974	17	effects	effect	NNS
cord-023095-4dannjjm	5974	18	have	have	VBP
cord-023095-4dannjjm	5974	19	been	be	VBN
cord-023095-4dannjjm	5974	20	attributed	attribute	VBN
cord-023095-4dannjjm	5974	21	to	to	IN
cord-023095-4dannjjm	5974	22	these	these	DT
cord-023095-4dannjjm	5974	23	cells	cell	NNS
cord-023095-4dannjjm	5974	24	.	.	.
cord-023095-4dannjjm	5975	1	The	the	DT
cord-023095-4dannjjm	5975	2	purpose	purpose	NN
cord-023095-4dannjjm	5975	3	of	of	IN
cord-023095-4dannjjm	5975	4	the	the	DT
cord-023095-4dannjjm	5975	5	presented	present	VBN
cord-023095-4dannjjm	5975	6	study	study	NN
cord-023095-4dannjjm	5975	7	was	be	VBD
cord-023095-4dannjjm	5975	8	to	to	TO
cord-023095-4dannjjm	5975	9	assess	assess	VB
cord-023095-4dannjjm	5975	10	microglial	microglial	JJ
cord-023095-4dannjjm	5975	11	involvement	involvement	NN
cord-023095-4dannjjm	5975	12	,	,	,
cord-023095-4dannjjm	5975	13	particularly	particularly	RB
cord-023095-4dannjjm	5975	14	in	in	IN
cord-023095-4dannjjm	5975	15	the	the	DT
cord-023095-4dannjjm	5975	16	'	'	``
cord-023095-4dannjjm	5975	17	'	'	``
cord-023095-4dannjjm	5975	18	secondary	secondary	JJ
cord-023095-4dannjjm	5975	19	wave	wave	NN
cord-023095-4dannjjm	5975	20	'	'	''
cord-023095-4dannjjm	5975	21	'	'	''
cord-023095-4dannjjm	5975	22	following	follow	VBG
cord-023095-4dannjjm	5975	23	SCI	SCI	NNP
cord-023095-4dannjjm	5975	24	.	.	.
cord-023095-4dannjjm	5976	1	Microglia	Microglia	NNP
cord-023095-4dannjjm	5976	2	from	from	IN
cord-023095-4dannjjm	5976	3	15	15	CD
cord-023095-4dannjjm	5976	4	dogs	dog	NNS
cord-023095-4dannjjm	5976	5	with	with	IN
cord-023095-4dannjjm	5976	6	SCI	SCI	NNP
cord-023095-4dannjjm	5976	7	was	be	VBD
cord-023095-4dannjjm	5976	8	isolated	isolate	VBN
cord-023095-4dannjjm	5976	9	and	and	CC
cord-023095-4dannjjm	5976	10	characterized	characterize	VBN
cord-023095-4dannjjm	5976	11	ex	ex	FW
cord-023095-4dannjjm	5976	12	vivo	vivo	NN
cord-023095-4dannjjm	5976	13	in	in	IN
cord-023095-4dannjjm	5976	14	terms	term	NNS
cord-023095-4dannjjm	5976	15	of	of	IN
cord-023095-4dannjjm	5976	16	morphology	morphology	NN
cord-023095-4dannjjm	5976	17	,	,	,
cord-023095-4dannjjm	5976	18	immunophenotype	immunophenotype	NN
cord-023095-4dannjjm	5976	19	,	,	,
cord-023095-4dannjjm	5976	20	and	and	CC
cord-023095-4dannjjm	5976	21	function	function	VB
cord-023095-4dannjjm	5976	22	by	by	IN
cord-023095-4dannjjm	5976	23	flow	flow	NN
cord-023095-4dannjjm	5976	24	cytometry	cytometry	NN
cord-023095-4dannjjm	5976	25	.	.	.
cord-023095-4dannjjm	5977	1	The	the	DT
cord-023095-4dannjjm	5977	2	results	result	NNS
cord-023095-4dannjjm	5977	3	were	be	VBD
cord-023095-4dannjjm	5977	4	compared	compare	VBN
cord-023095-4dannjjm	5977	5	to	to	IN
cord-023095-4dannjjm	5977	6	region	region	NN
cord-023095-4dannjjm	5977	7	-	-	HYPH
cord-023095-4dannjjm	5977	8	specific	specific	JJ
cord-023095-4dannjjm	5977	9	findings	finding	NNS
cord-023095-4dannjjm	5977	10	obtained	obtain	VBN
cord-023095-4dannjjm	5977	11	from	from	IN
cord-023095-4dannjjm	5977	12	healthy	healthy	JJ
cord-023095-4dannjjm	5977	13	control	control	NN
cord-023095-4dannjjm	5977	14	dogs	dog	NNS
cord-023095-4dannjjm	5977	15	(	(	-LRB-
cord-023095-4dannjjm	5977	16	n	n	NN
cord-023095-4dannjjm	5977	17	5	5	CD
cord-023095-4dannjjm	5977	18	30	30	CD
cord-023095-4dannjjm	5977	19	)	)	-RRB-
cord-023095-4dannjjm	5977	20	.	.	.
cord-023095-4dannjjm	5978	1	The	the	DT
cord-023095-4dannjjm	5978	2	histopathological	histopathological	JJ
cord-023095-4dannjjm	5978	3	exam	exam	NN
cord-023095-4dannjjm	5978	4	confirmed	confirm	VBD
cord-023095-4dannjjm	5978	5	the	the	DT
cord-023095-4dannjjm	5978	6	diagnosis	diagnosis	NN
cord-023095-4dannjjm	5978	7	of	of	IN
cord-023095-4dannjjm	5978	8	SCI	SCI	NNP
cord-023095-4dannjjm	5978	9	in	in	IN
cord-023095-4dannjjm	5978	10	the	the	DT
cord-023095-4dannjjm	5978	11	cervical	cervical	NN
cord-023095-4dannjjm	5978	12	(	(	-LRB-
cord-023095-4dannjjm	5978	13	n	n	NN
cord-023095-4dannjjm	5978	14	5	5	CD
cord-023095-4dannjjm	5978	15	5	5	CD
cord-023095-4dannjjm	5978	16	)	)	-RRB-
cord-023095-4dannjjm	5978	17	and	and	CC
cord-023095-4dannjjm	5978	18	thoracolumbar	thoracolumbar	NNP
cord-023095-4dannjjm	5978	19	(	(	-LRB-
cord-023095-4dannjjm	5978	20	n	n	NN
cord-023095-4dannjjm	5978	21	5	5	CD
cord-023095-4dannjjm	5978	22	10	10	CD
cord-023095-4dannjjm	5978	23	)	)	-RRB-
cord-023095-4dannjjm	5978	24	spinal	spinal	JJ
cord-023095-4dannjjm	5978	25	cord	cord	NN
cord-023095-4dannjjm	5978	26	,	,	,
cord-023095-4dannjjm	5978	27	and	and	CC
cord-023095-4dannjjm	5978	28	revealed	reveal	VBD
cord-023095-4dannjjm	5978	29	a	a	DT
cord-023095-4dannjjm	5978	30	significant	significant	JJ
cord-023095-4dannjjm	5978	31	activation	activation	NN
cord-023095-4dannjjm	5978	32	of	of	IN
cord-023095-4dannjjm	5978	33	microglia/	microglia/	CD
cord-023095-4dannjjm	5978	34	macrophages	macrophage	NNS
cord-023095-4dannjjm	5978	35	and	and	CC
cord-023095-4dannjjm	5978	36	upregulation	upregulation	NN
cord-023095-4dannjjm	5978	37	of	of	IN
cord-023095-4dannjjm	5978	38	myelinophagia	myelinophagia	NN
cord-023095-4dannjjm	5978	39	in	in	IN
cord-023095-4dannjjm	5978	40	dogs	dog	NNS
cord-023095-4dannjjm	5978	41	with	with	IN
cord-023095-4dannjjm	5978	42	SCI	SCI	NNP
cord-023095-4dannjjm	5978	43	5	5	CD
cord-023095-4dannjjm	5978	44	days	day	NNS
cord-023095-4dannjjm	5978	45	or	or	CC
cord-023095-4dannjjm	5978	46	longer	long	RBR
cord-023095-4dannjjm	5978	47	prior	prior	RB
cord-023095-4dannjjm	5978	48	to	to	IN
cord-023095-4dannjjm	5978	49	euthanasia	euthanasia	NN
cord-023095-4dannjjm	5978	50	.	.	.
cord-023095-4dannjjm	5979	1	Microglial	Microglial	NNP
cord-023095-4dannjjm	5979	2	ex	ex	NN
cord-023095-4dannjjm	5979	3	vivo	vivo	NN
cord-023095-4dannjjm	5979	4	examination	examination	NN
cord-023095-4dannjjm	5979	5	showed	show	VBD
cord-023095-4dannjjm	5979	6	significantly	significantly	RB
cord-023095-4dannjjm	5979	7	increased	increase	VBN
cord-023095-4dannjjm	5979	8	expressions	expression	NNS
cord-023095-4dannjjm	5979	9	of	of	IN
cord-023095-4dannjjm	5979	10	B7	b7	NN
cord-023095-4dannjjm	5979	11	-	-	HYPH
cord-023095-4dannjjm	5979	12	1	1	CD
cord-023095-4dannjjm	5979	13	,	,	,
cord-023095-4dannjjm	5979	14	B7	b7	NN
cord-023095-4dannjjm	5979	15	-	-	HYPH
cord-023095-4dannjjm	5979	16	2	2	CD
cord-023095-4dannjjm	5979	17	,	,	,
cord-023095-4dannjjm	5979	18	MHC	MHC	NNP
cord-023095-4dannjjm	5979	19	II	II	NNP
cord-023095-4dannjjm	5979	20	,	,	,
cord-023095-4dannjjm	5979	21	CD1c	CD1c	NNP
cord-023095-4dannjjm	5979	22	,	,	,
cord-023095-4dannjjm	5979	23	ICAM-1	ICAM-1	NNP
cord-023095-4dannjjm	5979	24	,	,	,
cord-023095-4dannjjm	5979	25	CD14	CD14	NNP
cord-023095-4dannjjm	5979	26	,	,	,
cord-023095-4dannjjm	5979	27	CD44	CD44	NNP
cord-023095-4dannjjm	5979	28	,	,	,
cord-023095-4dannjjm	5979	29	and	and	CC
cord-023095-4dannjjm	5979	30	CD45	CD45	NNP
cord-023095-4dannjjm	5979	31	,	,	,
cord-023095-4dannjjm	5979	32	and	and	CC
cord-023095-4dannjjm	5979	33	significantly	significantly	RB
cord-023095-4dannjjm	5979	34	enhanced	enhance	VBN
cord-023095-4dannjjm	5979	35	phagocytosis	phagocytosis	NN
cord-023095-4dannjjm	5979	36	and	and	CC
cord-023095-4dannjjm	5979	37	generation	generation	NN
cord-023095-4dannjjm	5979	38	of	of	IN
cord-023095-4dannjjm	5979	39	reactive	reactive	JJ
cord-023095-4dannjjm	5979	40	oxygen	oxygen	NN
cord-023095-4dannjjm	5979	41	species	specie	NNS
cord-023095-4dannjjm	5979	42	(	(	-LRB-
cord-023095-4dannjjm	5979	43	ROS	ROS	NNP
cord-023095-4dannjjm	5979	44	)	)	-RRB-
cord-023095-4dannjjm	5979	45	in	in	IN
cord-023095-4dannjjm	5979	46	SCI	SCI	NNP
cord-023095-4dannjjm	5979	47	compared	compare	VBN
cord-023095-4dannjjm	5979	48	to	to	IN
cord-023095-4dannjjm	5979	49	healthy	healthy	JJ
cord-023095-4dannjjm	5979	50	controls	control	NNS
cord-023095-4dannjjm	5979	51	.	.	.
cord-023095-4dannjjm	5980	1	Microglial	microglial	JJ
cord-023095-4dannjjm	5980	2	cells	cell	NNS
cord-023095-4dannjjm	5980	3	seem	seem	VBP
cord-023095-4dannjjm	5980	4	to	to	TO
cord-023095-4dannjjm	5980	5	be	be	VB
cord-023095-4dannjjm	5980	6	highly	highly	RB
cord-023095-4dannjjm	5980	7	activated	activate	VBN
cord-023095-4dannjjm	5980	8	following	follow	VBG
cord-023095-4dannjjm	5980	9	SCI	SCI	NNP
cord-023095-4dannjjm	5980	10	with	with	IN
cord-023095-4dannjjm	5980	11	an	an	DT
cord-023095-4dannjjm	5980	12	immunophenotype	immunophenotype	NN
cord-023095-4dannjjm	5980	13	indicating	indicate	VBG
cord-023095-4dannjjm	5980	14	their	-PRON-	PRP$
cord-023095-4dannjjm	5980	15	active	active	JJ
cord-023095-4dannjjm	5980	16	role	role	NN
cord-023095-4dannjjm	5980	17	in	in	IN
cord-023095-4dannjjm	5980	18	co	co	NN
cord-023095-4dannjjm	5980	19	-	-	NN
cord-023095-4dannjjm	5980	20	stimulation	stimulation	NN
cord-023095-4dannjjm	5980	21	of	of	IN
cord-023095-4dannjjm	5980	22	T	t	NN
cord-023095-4dannjjm	5980	23	cells	cell	NNS
cord-023095-4dannjjm	5980	24	,	,	,
cord-023095-4dannjjm	5980	25	in	in	IN
cord-023095-4dannjjm	5980	26	leukocyte	leukocyte	NN
cord-023095-4dannjjm	5980	27	adhesion	adhesion	NN
cord-023095-4dannjjm	5980	28	and	and	CC
cord-023095-4dannjjm	5980	29	aggregation	aggregation	NN
cord-023095-4dannjjm	5980	30	,	,	,
cord-023095-4dannjjm	5980	31	and	and	CC
cord-023095-4dannjjm	5980	32	in	in	IN
cord-023095-4dannjjm	5980	33	lipid	lipid	NN
cord-023095-4dannjjm	5980	34	and	and	CC
cord-023095-4dannjjm	5980	35	glycolipid	glycolipid	NNP
cord-023095-4dannjjm	5980	36	presentation	presentation	NN
cord-023095-4dannjjm	5980	37	.	.	.
cord-023095-4dannjjm	5981	1	Microglial	microglial	JJ
cord-023095-4dannjjm	5981	2	phagocytosis	phagocytosis	NN
cord-023095-4dannjjm	5981	3	might	may	MD
cord-023095-4dannjjm	5981	4	play	play	VB
cord-023095-4dannjjm	5981	5	a	a	DT
cord-023095-4dannjjm	5981	6	pivotal	pivotal	JJ
cord-023095-4dannjjm	5981	7	role	role	NN
cord-023095-4dannjjm	5981	8	in	in	IN
cord-023095-4dannjjm	5981	9	removal	removal	NN
cord-023095-4dannjjm	5981	10	of	of	IN
cord-023095-4dannjjm	5981	11	injured	injure	VBN
cord-023095-4dannjjm	5981	12	or	or	CC
cord-023095-4dannjjm	5981	13	damaged	damage	VBN
cord-023095-4dannjjm	5981	14	cells	cell	NNS
cord-023095-4dannjjm	5981	15	and	and	CC
cord-023095-4dannjjm	5981	16	initialize	initialize	VB
cord-023095-4dannjjm	5981	17	subsequent	subsequent	JJ
cord-023095-4dannjjm	5981	18	healing	healing	NN
cord-023095-4dannjjm	5981	19	processes	process	NNS
cord-023095-4dannjjm	5981	20	.	.	.
cord-023095-4dannjjm	5982	1	However	however	RB
cord-023095-4dannjjm	5982	2	,	,	,
cord-023095-4dannjjm	5982	3	as	as	IN
cord-023095-4dannjjm	5982	4	ROS	ROS	NNP
cord-023095-4dannjjm	5982	5	can	can	MD
cord-023095-4dannjjm	5982	6	be	be	VB
cord-023095-4dannjjm	5982	7	directly	directly	RB
cord-023095-4dannjjm	5982	8	neurotoxic	neurotoxic	JJ
cord-023095-4dannjjm	5982	9	an	an	DT
cord-023095-4dannjjm	5982	10	enhanced	enhanced	JJ
cord-023095-4dannjjm	5982	11	microglial	microglial	JJ
cord-023095-4dannjjm	5982	12	generation	generation	NN
cord-023095-4dannjjm	5982	13	might	may	MD
cord-023095-4dannjjm	5982	14	lead	lead	VB
cord-023095-4dannjjm	5982	15	to	to	IN
cord-023095-4dannjjm	5982	16	bystander	bystander	NN
cord-023095-4dannjjm	5982	17	damage	damage	NN
cord-023095-4dannjjm	5982	18	of	of	IN
cord-023095-4dannjjm	5982	19	the	the	DT
cord-023095-4dannjjm	5982	20	traumatized	traumatize	VBN
cord-023095-4dannjjm	5982	21	spinal	spinal	JJ
cord-023095-4dannjjm	5982	22	cord	cord	NN
cord-023095-4dannjjm	5982	23	and	and	CC
cord-023095-4dannjjm	5982	24	might	may	MD
cord-023095-4dannjjm	5982	25	therefore	therefore	RB
cord-023095-4dannjjm	5982	26	add	add	VB
cord-023095-4dannjjm	5982	27	to	to	IN
cord-023095-4dannjjm	5982	28	the	the	DT
cord-023095-4dannjjm	5982	29	deleterious	deleterious	JJ
cord-023095-4dannjjm	5982	30	effects	effect	NNS
cord-023095-4dannjjm	5982	31	of	of	IN
cord-023095-4dannjjm	5982	32	the	the	DT
cord-023095-4dannjjm	5982	33	secondary	secondary	JJ
cord-023095-4dannjjm	5982	34	wave	wave	NN
cord-023095-4dannjjm	5982	35	.	.	.
cord-023095-4dannjjm	5983	1	Modulating	modulate	VBG
cord-023095-4dannjjm	5983	2	the	the	DT
cord-023095-4dannjjm	5983	3	microglial	microglial	JJ
cord-023095-4dannjjm	5983	4	response	response	NN
cord-023095-4dannjjm	5983	5	in	in	IN
cord-023095-4dannjjm	5983	6	SCI	SCI	NNP
cord-023095-4dannjjm	5983	7	might	may	MD
cord-023095-4dannjjm	5983	8	be	be	VB
cord-023095-4dannjjm	5983	9	a	a	DT
cord-023095-4dannjjm	5983	10	valuable	valuable	JJ
cord-023095-4dannjjm	5983	11	novel	novel	JJ
cord-023095-4dannjjm	5983	12	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	5983	13	strategy	strategy	NN
cord-023095-4dannjjm	5983	14	alleviating	alleviate	VBG
cord-023095-4dannjjm	5983	15	further	further	JJ
cord-023095-4dannjjm	5983	16	damage	damage	NN
cord-023095-4dannjjm	5983	17	to	to	IN
cord-023095-4dannjjm	5983	18	the	the	DT
cord-023095-4dannjjm	5983	19	spinal	spinal	JJ
cord-023095-4dannjjm	5983	20	cord	cord	NN
cord-023095-4dannjjm	5983	21	.	.	.
cord-023095-4dannjjm	5984	1	Thymidine	thymidine	NN
cord-023095-4dannjjm	5984	2	kinase	kinase	NN
cord-023095-4dannjjm	5984	3	(	(	-LRB-
cord-023095-4dannjjm	5984	4	TK	TK	NNP
cord-023095-4dannjjm	5984	5	)	)	-RRB-
cord-023095-4dannjjm	5984	6	is	be	VBZ
cord-023095-4dannjjm	5984	7	a	a	DT
cord-023095-4dannjjm	5984	8	soluble	soluble	JJ
cord-023095-4dannjjm	5984	9	biomarker	biomarker	NN
cord-023095-4dannjjm	5984	10	present	present	NN
cord-023095-4dannjjm	5984	11	in	in	IN
cord-023095-4dannjjm	5984	12	S	s	NN
cord-023095-4dannjjm	5984	13	-	-	HYPH
cord-023095-4dannjjm	5984	14	phase	phase	NN
cord-023095-4dannjjm	5984	15	of	of	IN
cord-023095-4dannjjm	5984	16	a	a	DT
cord-023095-4dannjjm	5984	17	salvage	salvage	NN
cord-023095-4dannjjm	5984	18	pathway	pathway	NN
cord-023095-4dannjjm	5984	19	for	for	IN
cord-023095-4dannjjm	5984	20	DNA	dna	NN
cord-023095-4dannjjm	5984	21	synthesis	synthesis	NN
cord-023095-4dannjjm	5984	22	,	,	,
cord-023095-4dannjjm	5984	23	and	and	CC
cord-023095-4dannjjm	5984	24	can	can	MD
cord-023095-4dannjjm	5984	25	be	be	VB
cord-023095-4dannjjm	5984	26	measured	measure	VBN
cord-023095-4dannjjm	5984	27	in	in	IN
cord-023095-4dannjjm	5984	28	serum	serum	NN
cord-023095-4dannjjm	5984	29	.	.	.
cord-023095-4dannjjm	5985	1	TK	TK	NNP
cord-023095-4dannjjm	5985	2	activity	activity	NN
cord-023095-4dannjjm	5985	3	correlates	correlate	VBZ
cord-023095-4dannjjm	5985	4	with	with	IN
cord-023095-4dannjjm	5985	5	stage	stage	NN
cord-023095-4dannjjm	5985	6	,	,	,
cord-023095-4dannjjm	5985	7	prognosis	prognosis	NN
cord-023095-4dannjjm	5985	8	,	,	,
cord-023095-4dannjjm	5985	9	and	and	CC
cord-023095-4dannjjm	5985	10	relapse	relapse	NN
cord-023095-4dannjjm	5985	11	in	in	IN
cord-023095-4dannjjm	5985	12	canine	canine	JJ
cord-023095-4dannjjm	5985	13	and	and	CC
cord-023095-4dannjjm	5985	14	human	human	JJ
cord-023095-4dannjjm	5985	15	lymphoma	lymphoma	NN
cord-023095-4dannjjm	5985	16	.	.	.
cord-023095-4dannjjm	5986	1	We	-PRON-	PRP
cord-023095-4dannjjm	5986	2	previously	previously	RB
cord-023095-4dannjjm	5986	3	reported	report	VBD
cord-023095-4dannjjm	5986	4	the	the	DT
cord-023095-4dannjjm	5986	5	results	result	NNS
cord-023095-4dannjjm	5986	6	of	of	IN
cord-023095-4dannjjm	5986	7	a	a	DT
cord-023095-4dannjjm	5986	8	pilot	pilot	NN
cord-023095-4dannjjm	5986	9	study	study	NN
cord-023095-4dannjjm	5986	10	evaluating	evaluate	VBG
cord-023095-4dannjjm	5986	11	TK	TK	NNP
cord-023095-4dannjjm	5986	12	activity	activity	NN
cord-023095-4dannjjm	5986	13	in	in	IN
cord-023095-4dannjjm	5986	14	archived	archived	JJ
cord-023095-4dannjjm	5986	15	canine	canine	JJ
cord-023095-4dannjjm	5986	16	osteosarcoma	osteosarcoma	NN
cord-023095-4dannjjm	5986	17	,	,	,
cord-023095-4dannjjm	5986	18	transitional	transitional	JJ
cord-023095-4dannjjm	5986	19	cell	cell	NN
cord-023095-4dannjjm	5986	20	carcinoma	carcinoma	NN
cord-023095-4dannjjm	5986	21	,	,	,
cord-023095-4dannjjm	5986	22	and	and	CC
cord-023095-4dannjjm	5986	23	hemangiosarcoma	hemangiosarcoma	NN
cord-023095-4dannjjm	5986	24	(	(	-LRB-
cord-023095-4dannjjm	5986	25	HSA	HSA	NNP
cord-023095-4dannjjm	5986	26	)	)	-RRB-
cord-023095-4dannjjm	5986	27	sera	sera	NNP
cord-023095-4dannjjm	5986	28	,	,	,
cord-023095-4dannjjm	5986	29	and	and	CC
cord-023095-4dannjjm	5986	30	found	find	VBD
cord-023095-4dannjjm	5986	31	elevated	elevate	VBN
cord-023095-4dannjjm	5986	32	TK	TK	NNP
cord-023095-4dannjjm	5986	33	activity	activity	NN
cord-023095-4dannjjm	5986	34	in	in	IN
cord-023095-4dannjjm	5986	35	80	80	CD
cord-023095-4dannjjm	5986	36	%	%	NN
cord-023095-4dannjjm	5986	37	of	of	IN
cord-023095-4dannjjm	5986	38	canine	canine	JJ
cord-023095-4dannjjm	5986	39	HSA	HSA	NNP
cord-023095-4dannjjm	5986	40	sera	sera	NNP
cord-023095-4dannjjm	5986	41	evaluated	evaluate	VBD
cord-023095-4dannjjm	5986	42	.	.	.
cord-023095-4dannjjm	5987	1	The	the	DT
cord-023095-4dannjjm	5987	2	purpose	purpose	NN
cord-023095-4dannjjm	5987	3	of	of	IN
cord-023095-4dannjjm	5987	4	this	this	DT
cord-023095-4dannjjm	5987	5	study	study	NN
cord-023095-4dannjjm	5987	6	was	be	VBD
cord-023095-4dannjjm	5987	7	to	to	TO
cord-023095-4dannjjm	5987	8	prospectively	prospectively	RB
cord-023095-4dannjjm	5987	9	evaluate	evaluate	VB
cord-023095-4dannjjm	5987	10	serum	serum	NN
cord-023095-4dannjjm	5987	11	TK	tk	NN
cord-023095-4dannjjm	5987	12	activity	activity	NN
cord-023095-4dannjjm	5987	13	in	in	IN
cord-023095-4dannjjm	5987	14	a	a	DT
cord-023095-4dannjjm	5987	15	large	large	JJ
cord-023095-4dannjjm	5987	16	number	number	NN
cord-023095-4dannjjm	5987	17	of	of	IN
cord-023095-4dannjjm	5987	18	dogs	dog	NNS
cord-023095-4dannjjm	5987	19	presenting	present	VBG
cord-023095-4dannjjm	5987	20	to	to	IN
cord-023095-4dannjjm	5987	21	emergency	emergency	NN
cord-023095-4dannjjm	5987	22	clinics	clinic	NNS
cord-023095-4dannjjm	5987	23	with	with	IN
cord-023095-4dannjjm	5987	24	hemoabdomen	hemoabdomen	NNP
cord-023095-4dannjjm	5987	25	and	and	CC
cord-023095-4dannjjm	5987	26	a	a	DT
cord-023095-4dannjjm	5987	27	splenic	splenic	JJ
cord-023095-4dannjjm	5987	28	mass	mass	NN
cord-023095-4dannjjm	5987	29	,	,	,
cord-023095-4dannjjm	5987	30	to	to	TO
cord-023095-4dannjjm	5987	31	determine	determine	VB
cord-023095-4dannjjm	5987	32	if	if	IN
cord-023095-4dannjjm	5987	33	TK	TK	NNP
cord-023095-4dannjjm	5987	34	activity	activity	NN
cord-023095-4dannjjm	5987	35	could	could	MD
cord-023095-4dannjjm	5987	36	be	be	VB
cord-023095-4dannjjm	5987	37	used	use	VBN
cord-023095-4dannjjm	5987	38	as	as	IN
cord-023095-4dannjjm	5987	39	a	a	DT
cord-023095-4dannjjm	5987	40	noninvasive	noninvasive	JJ
cord-023095-4dannjjm	5987	41	means	mean	NNS
cord-023095-4dannjjm	5987	42	to	to	TO
cord-023095-4dannjjm	5987	43	distinguish	distinguish	VB
cord-023095-4dannjjm	5987	44	HSA	HSA	NNP
cord-023095-4dannjjm	5987	45	versus	versus	IN
cord-023095-4dannjjm	5987	46	benign	benign	JJ
cord-023095-4dannjjm	5987	47	conditions	condition	NNS
cord-023095-4dannjjm	5987	48	in	in	IN
cord-023095-4dannjjm	5987	49	this	this	DT
cord-023095-4dannjjm	5987	50	population	population	NN
cord-023095-4dannjjm	5987	51	.	.	.
cord-023095-4dannjjm	5988	1	Dogs	dog	NNS
cord-023095-4dannjjm	5988	2	presenting	present	VBG
cord-023095-4dannjjm	5988	3	with	with	IN
cord-023095-4dannjjm	5988	4	hemoabdomen	hemoabdomen	NNP
cord-023095-4dannjjm	5988	5	and	and	CC
cord-023095-4dannjjm	5988	6	a	a	DT
cord-023095-4dannjjm	5988	7	splenic	splenic	JJ
cord-023095-4dannjjm	5988	8	mass	mass	NN
cord-023095-4dannjjm	5988	9	identified	identify	VBN
cord-023095-4dannjjm	5988	10	on	on	IN
cord-023095-4dannjjm	5988	11	ultrasound	ultrasound	NN
cord-023095-4dannjjm	5988	12	examination	examination	NN
cord-023095-4dannjjm	5988	13	were	be	VBD
cord-023095-4dannjjm	5988	14	studied	study	VBN
cord-023095-4dannjjm	5988	15	.	.	.
cord-023095-4dannjjm	5989	1	Serum	serum	NN
cord-023095-4dannjjm	5989	2	was	be	VBD
cord-023095-4dannjjm	5989	3	collected	collect	VBN
cord-023095-4dannjjm	5989	4	prior	prior	RB
cord-023095-4dannjjm	5989	5	to	to	IN
cord-023095-4dannjjm	5989	6	anesthesia	anesthesia	NN
cord-023095-4dannjjm	5989	7	,	,	,
cord-023095-4dannjjm	5989	8	euthanasia	euthanasia	JJ
cord-023095-4dannjjm	5989	9	or	or	CC
cord-023095-4dannjjm	5989	10	surgical	surgical	JJ
cord-023095-4dannjjm	5989	11	intervention	intervention	NN
cord-023095-4dannjjm	5989	12	and	and	CC
cord-023095-4dannjjm	5989	13	frozen	freeze	VBN
cord-023095-4dannjjm	5989	14	until	until	IN
cord-023095-4dannjjm	5989	15	batch	batch	NN
cord-023095-4dannjjm	5989	16	analysis	analysis	NN
cord-023095-4dannjjm	5989	17	.	.	.
cord-023095-4dannjjm	5990	1	Tissue	tissue	NN
cord-023095-4dannjjm	5990	2	from	from	IN
cord-023095-4dannjjm	5990	3	all	all	DT
cord-023095-4dannjjm	5990	4	patients	patient	NNS
cord-023095-4dannjjm	5990	5	was	be	VBD
cord-023095-4dannjjm	5990	6	evaluated	evaluate	VBN
cord-023095-4dannjjm	5990	7	histologically	histologically	RB
cord-023095-4dannjjm	5990	8	by	by	IN
cord-023095-4dannjjm	5990	9	a	a	DT
cord-023095-4dannjjm	5990	10	single	single	JJ
cord-023095-4dannjjm	5990	11	pathologist	pathologist	NN
cord-023095-4dannjjm	5990	12	.	.	.
cord-023095-4dannjjm	5991	1	Sera	Sera	NNP
cord-023095-4dannjjm	5991	2	from	from	IN
cord-023095-4dannjjm	5991	3	age	age	NN
cord-023095-4dannjjm	5991	4	-	-	HYPH
cord-023095-4dannjjm	5991	5	matched	match	VBN
cord-023095-4dannjjm	5991	6	normal	normal	JJ
cord-023095-4dannjjm	5991	7	dogs	dog	NNS
cord-023095-4dannjjm	5991	8	comprised	comprise	VBD
cord-023095-4dannjjm	5991	9	a	a	DT
cord-023095-4dannjjm	5991	10	control	control	NN
cord-023095-4dannjjm	5991	11	population	population	NN
cord-023095-4dannjjm	5991	12	.	.	.
cord-023095-4dannjjm	5992	1	An	an	DT
cord-023095-4dannjjm	5992	2	ELISA	ELISA	NNP
cord-023095-4dannjjm	5992	3	using	use	VBG
cord-023095-4dannjjm	5992	4	azidothymidine	azidothymidine	NNP
cord-023095-4dannjjm	5992	5	as	as	IN
cord-023095-4dannjjm	5992	6	a	a	DT
cord-023095-4dannjjm	5992	7	TK1	tk1	JJ
cord-023095-4dannjjm	5992	8	substrate	substrate	NN
cord-023095-4dannjjm	5992	9	was	be	VBD
cord-023095-4dannjjm	5992	10	used	use	VBN
cord-023095-4dannjjm	5992	11	.	.	.
cord-023095-4dannjjm	5993	1	Comparisons	comparison	NNS
cord-023095-4dannjjm	5993	2	between	between	IN
cord-023095-4dannjjm	5993	3	groups	group	NNS
cord-023095-4dannjjm	5993	4	were	be	VBD
cord-023095-4dannjjm	5993	5	made	make	VBN
cord-023095-4dannjjm	5993	6	using	use	VBG
cord-023095-4dannjjm	5993	7	2-tailed	2-tailed	CD
cord-023095-4dannjjm	5993	8	student	student	NN
cord-023095-4dannjjm	5993	9	T	t	NN
cord-023095-4dannjjm	5993	10	-	-	HYPH
cord-023095-4dannjjm	5993	11	tests	test	NNS
cord-023095-4dannjjm	5993	12	,	,	,
cord-023095-4dannjjm	5993	13	and	and	CC
cord-023095-4dannjjm	5993	14	receiver	receiver	NN
cord-023095-4dannjjm	5993	15	-	-	HYPH
cord-023095-4dannjjm	5993	16	operator	operator	NN
cord-023095-4dannjjm	5993	17	characteristic	characteristic	NN
cord-023095-4dannjjm	5993	18	(	(	-LRB-
cord-023095-4dannjjm	5993	19	ROC	ROC	NNP
cord-023095-4dannjjm	5993	20	)	)	-RRB-
cord-023095-4dannjjm	5993	21	curves	curve	NNS
cord-023095-4dannjjm	5993	22	were	be	VBD
cord-023095-4dannjjm	5993	23	generated	generate	VBN
cord-023095-4dannjjm	5993	24	.	.	.
cord-023095-4dannjjm	5994	1	Sixty	sixty	CD
cord-023095-4dannjjm	5994	2	-	-	HYPH
cord-023095-4dannjjm	5994	3	two	two	CD
cord-023095-4dannjjm	5994	4	patients	patient	NNS
cord-023095-4dannjjm	5994	5	and	and	CC
cord-023095-4dannjjm	5994	6	39	39	CD
cord-023095-4dannjjm	5994	7	normal	normal	JJ
cord-023095-4dannjjm	5994	8	controls	control	NNS
cord-023095-4dannjjm	5994	9	were	be	VBD
cord-023095-4dannjjm	5994	10	studied	study	VBN
cord-023095-4dannjjm	5994	11	.	.	.
cord-023095-4dannjjm	5995	1	There	there	EX
cord-023095-4dannjjm	5995	2	were	be	VBD
cord-023095-4dannjjm	5995	3	35	35	CD
cord-023095-4dannjjm	5995	4	dogs	dog	NNS
cord-023095-4dannjjm	5995	5	with	with	IN
cord-023095-4dannjjm	5995	6	HSA	HSA	NNP
cord-023095-4dannjjm	5995	7	,	,	,
cord-023095-4dannjjm	5995	8	10	10	CD
cord-023095-4dannjjm	5995	9	dogs	dog	NNS
cord-023095-4dannjjm	5995	10	with	with	IN
cord-023095-4dannjjm	5995	11	other	other	JJ
cord-023095-4dannjjm	5995	12	splenic	splenic	JJ
cord-023095-4dannjjm	5995	13	neoplasia	neoplasia	NN
cord-023095-4dannjjm	5995	14	,	,	,
cord-023095-4dannjjm	5995	15	and	and	CC
cord-023095-4dannjjm	5995	16	17	17	CD
cord-023095-4dannjjm	5995	17	dogs	dog	NNS
cord-023095-4dannjjm	5995	18	with	with	IN
cord-023095-4dannjjm	5995	19	benign	benign	JJ
cord-023095-4dannjjm	5995	20	diseases	disease	NNS
cord-023095-4dannjjm	5995	21	.	.	.
cord-023095-4dannjjm	5996	1	Using	use	VBG
cord-023095-4dannjjm	5996	2	a	a	DT
cord-023095-4dannjjm	5996	3	training	training	NN
cord-023095-4dannjjm	5996	4	set	set	NN
cord-023095-4dannjjm	5996	5	of	of	IN
cord-023095-4dannjjm	5996	6	24	24	CD
cord-023095-4dannjjm	5996	7	normal	normal	JJ
cord-023095-4dannjjm	5996	8	dogs	dog	NNS
cord-023095-4dannjjm	5996	9	,	,	,
cord-023095-4dannjjm	5996	10	a	a	DT
cord-023095-4dannjjm	5996	11	cutoff	cutoff	NN
cord-023095-4dannjjm	5996	12	of	of	IN
cord-023095-4dannjjm	5996	13	6.55	6.55	CD
cord-023095-4dannjjm	5996	14	U	U	NNP
cord-023095-4dannjjm	5996	15	/	/	SYM
cord-023095-4dannjjm	5996	16	L	L	NNP
cord-023095-4dannjjm	5996	17	was	be	VBD
cord-023095-4dannjjm	5996	18	established	establish	VBN
cord-023095-4dannjjm	5996	19	from	from	IN
cord-023095-4dannjjm	5996	20	the	the	DT
cord-023095-4dannjjm	5996	21	ROC	ROC	NNP
cord-023095-4dannjjm	5996	22	curve	curve	NN
cord-023095-4dannjjm	5996	23	.	.	.
cord-023095-4dannjjm	5997	1	TK	TK	NNP
cord-023095-4dannjjm	5997	2	activity	activity	NN
cord-023095-4dannjjm	5997	3	was	be	VBD
cord-023095-4dannjjm	5997	4	significantly	significantly	RB
cord-023095-4dannjjm	5997	5	higher	high	JJR
cord-023095-4dannjjm	5997	6	(	(	-LRB-
cord-023095-4dannjjm	5997	7	p	p	NN
cord-023095-4dannjjm	5997	8	o	o	NN
cord-023095-4dannjjm	5997	9	0.0001	0.0001	CD
cord-023095-4dannjjm	5997	10	)	)	-RRB-
cord-023095-4dannjjm	5997	11	in	in	IN
cord-023095-4dannjjm	5997	12	dogs	dog	NNS
cord-023095-4dannjjm	5997	13	with	with	IN
cord-023095-4dannjjm	5997	14	HSA	HSA	NNP
cord-023095-4dannjjm	5997	15	than	than	IN
cord-023095-4dannjjm	5997	16	in	in	IN
cord-023095-4dannjjm	5997	17	the	the	DT
cord-023095-4dannjjm	5997	18	validation	validation	NN
cord-023095-4dannjjm	5997	19	set	set	VBN
cord-023095-4dannjjm	5997	20	of	of	IN
cord-023095-4dannjjm	5997	21	15	15	CD
cord-023095-4dannjjm	5997	22	normal	normal	JJ
cord-023095-4dannjjm	5997	23	dogs	dog	NNS
cord-023095-4dannjjm	5997	24	(	(	-LRB-
cord-023095-4dannjjm	5997	25	mean1	mean1	NN
cord-023095-4dannjjm	5997	26	/	/	SYM
cord-023095-4dannjjm	5997	27	ÀSD	ÀSD	NNP
cord-023095-4dannjjm	5997	28	5	5	CD
cord-023095-4dannjjm	5998	1	17.711	17.711	LS
cord-023095-4dannjjm	5998	2	/	/	SYM
cord-023095-4dannjjm	5998	3	À4.5	à4.5	CD
cord-023095-4dannjjm	5998	4	and	and	CC
cord-023095-4dannjjm	5998	5	2.011	2.011	CD
cord-023095-4dannjjm	5998	6	/	/	SYM
cord-023095-4dannjjm	5998	7	À0.6	à0.6	CD
cord-023095-4dannjjm	5998	8	respectively	respectively	RB
cord-023095-4dannjjm	5998	9	)	)	-RRB-
cord-023095-4dannjjm	5998	10	,	,	,
cord-023095-4dannjjm	5998	11	but	but	CC
cord-023095-4dannjjm	5998	12	not	not	RB
cord-023095-4dannjjm	5998	13	between	between	IN
cord-023095-4dannjjm	5998	14	dogs	dog	NNS
cord-023095-4dannjjm	5998	15	with	with	IN
cord-023095-4dannjjm	5998	16	HSA	HSA	NNP
cord-023095-4dannjjm	5998	17	and	and	CC
cord-023095-4dannjjm	5998	18	benign	benign	JJ
cord-023095-4dannjjm	5998	19	splenic	splenic	JJ
cord-023095-4dannjjm	5998	20	disease	disease	NN
cord-023095-4dannjjm	5999	1	(	(	-LRB-
cord-023095-4dannjjm	5999	2	mean1	mean1	NN
cord-023095-4dannjjm	5999	3	/	/	SYM
cord-023095-4dannjjm	5999	4	ÀSD	ÀSD	NNP
cord-023095-4dannjjm	5999	5	5	5	CD
cord-023095-4dannjjm	5999	6	7.021/	7.021/	CD
cord-023095-4dannjjm	6000	1	À3.7	À3.7	NNP
cord-023095-4dannjjm	6000	2	,	,	,
cord-023095-4dannjjm	6000	3	p	p	NN
cord-023095-4dannjjm	6000	4	5	5	CD
cord-023095-4dannjjm	6000	5	0.13	0.13	CD
cord-023095-4dannjjm	6000	6	)	)	-RRB-
cord-023095-4dannjjm	6000	7	.	.	.
cord-023095-4dannjjm	6001	1	Using	use	VBG
cord-023095-4dannjjm	6001	2	a	a	DT
cord-023095-4dannjjm	6001	3	cutoff	cutoff	NN
cord-023095-4dannjjm	6001	4	of	of	IN
cord-023095-4dannjjm	6001	5	6.55	6.55	CD
cord-023095-4dannjjm	6001	6	U	U	NNP
cord-023095-4dannjjm	6001	7	/	/	SYM
cord-023095-4dannjjm	6001	8	L	L	NNP
cord-023095-4dannjjm	6001	9	,	,	,
cord-023095-4dannjjm	6001	10	TK	TK	NNP
cord-023095-4dannjjm	6001	11	activity	activity	NN
cord-023095-4dannjjm	6001	12	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	6001	13	a	a	DT
cord-023095-4dannjjm	6001	14	sensitivity	sensitivity	NN
cord-023095-4dannjjm	6001	15	of	of	IN
cord-023095-4dannjjm	6001	16	0.54	0.54	CD
cord-023095-4dannjjm	6001	17	,	,	,
cord-023095-4dannjjm	6001	18	specificity	specificity	NN
cord-023095-4dannjjm	6001	19	of	of	IN
cord-023095-4dannjjm	6001	20	0.76	0.76	CD
cord-023095-4dannjjm	6001	21	,	,	,
cord-023095-4dannjjm	6001	22	positive	positive	JJ
cord-023095-4dannjjm	6001	23	predictive	predictive	JJ
cord-023095-4dannjjm	6001	24	value	value	NN
cord-023095-4dannjjm	6001	25	of	of	IN
cord-023095-4dannjjm	6001	26	0.83	0.83	CD
cord-023095-4dannjjm	6001	27	and	and	CC
cord-023095-4dannjjm	6001	28	negative	negative	JJ
cord-023095-4dannjjm	6001	29	predictive	predictive	JJ
cord-023095-4dannjjm	6001	30	value	value	NN
cord-023095-4dannjjm	6001	31	of	of	IN
cord-023095-4dannjjm	6001	32	0.45	0.45	CD
cord-023095-4dannjjm	6001	33	for	for	IN
cord-023095-4dannjjm	6001	34	distinguishing	distinguish	VBG
cord-023095-4dannjjm	6001	35	HSA	HSA	NNP
cord-023095-4dannjjm	6001	36	versus	versus	IN
cord-023095-4dannjjm	6001	37	benign	benign	JJ
cord-023095-4dannjjm	6001	38	splenic	splenic	JJ
cord-023095-4dannjjm	6001	39	disease	disease	NN
cord-023095-4dannjjm	6001	40	.	.	.
cord-023095-4dannjjm	6002	1	When	when	WRB
cord-023095-4dannjjm	6002	2	interval	interval	NN
cord-023095-4dannjjm	6002	3	thresholds	threshold	NNS
cord-023095-4dannjjm	6002	4	of	of	IN
cord-023095-4dannjjm	6002	5	o	o	CD
cord-023095-4dannjjm	6002	6	1.55	1.55	CD
cord-023095-4dannjjm	6002	7	and	and	CC
cord-023095-4dannjjm	6002	8	47.95	47.95	CD
cord-023095-4dannjjm	6002	9	U	U	NNP
cord-023095-4dannjjm	6002	10	/	/	SYM
cord-023095-4dannjjm	6002	11	L	L	NNP
cord-023095-4dannjjm	6002	12	were	be	VBD
cord-023095-4dannjjm	6002	13	used	use	VBN
cord-023095-4dannjjm	6002	14	together	together	RB
cord-023095-4dannjjm	6002	15	,	,	,
cord-023095-4dannjjm	6002	16	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	6002	17	utility	utility	NN
cord-023095-4dannjjm	6002	18	was	be	VBD
cord-023095-4dannjjm	6002	19	markedly	markedly	RB
cord-023095-4dannjjm	6002	20	increased	increase	VBN
cord-023095-4dannjjm	6002	21	for	for	IN
cord-023095-4dannjjm	6002	22	distinguishing	distinguish	VBG
cord-023095-4dannjjm	6002	23	both	both	CC
cord-023095-4dannjjm	6002	24	HSA	HSA	NNP
cord-023095-4dannjjm	6002	25	versus	versus	IN
cord-023095-4dannjjm	6002	26	normal	normal	JJ
cord-023095-4dannjjm	6002	27	and	and	CC
cord-023095-4dannjjm	6002	28	HSA	HSA	NNP
cord-023095-4dannjjm	6002	29	versus	versus	IN
cord-023095-4dannjjm	6002	30	benign	benign	JJ
cord-023095-4dannjjm	6002	31	disease	disease	NN
cord-023095-4dannjjm	6002	32	.	.	.
cord-023095-4dannjjm	6003	1	In	in	IN
cord-023095-4dannjjm	6003	2	conclusion	conclusion	NN
cord-023095-4dannjjm	6003	3	,	,	,
cord-023095-4dannjjm	6003	4	serum	serum	NN
cord-023095-4dannjjm	6003	5	TK	TK	NNP
cord-023095-4dannjjm	6003	6	evaluation	evaluation	NN
cord-023095-4dannjjm	6003	7	may	may	MD
cord-023095-4dannjjm	6003	8	assist	assist	VB
cord-023095-4dannjjm	6003	9	in	in	IN
cord-023095-4dannjjm	6003	10	detection	detection	NN
cord-023095-4dannjjm	6003	11	of	of	IN
cord-023095-4dannjjm	6003	12	canine	canine	JJ
cord-023095-4dannjjm	6003	13	HSA	HSA	NNP
cord-023095-4dannjjm	6003	14	,	,	,
cord-023095-4dannjjm	6003	15	and	and	CC
cord-023095-4dannjjm	6003	16	may	may	MD
cord-023095-4dannjjm	6003	17	also	also	RB
cord-023095-4dannjjm	6003	18	discriminate	discriminate	VB
cord-023095-4dannjjm	6003	19	between	between	IN
cord-023095-4dannjjm	6003	20	benign	benign	JJ
cord-023095-4dannjjm	6003	21	disease	disease	NN
cord-023095-4dannjjm	6003	22	and	and	CC
cord-023095-4dannjjm	6003	23	HSA	HSA	NNP
cord-023095-4dannjjm	6003	24	in	in	IN
cord-023095-4dannjjm	6003	25	dogs	dog	NNS
cord-023095-4dannjjm	6003	26	with	with	IN
cord-023095-4dannjjm	6003	27	hemoabdomen	hemoabdomen	NNP
cord-023095-4dannjjm	6003	28	and	and	CC
cord-023095-4dannjjm	6003	29	a	a	DT
cord-023095-4dannjjm	6003	30	splenic	splenic	JJ
cord-023095-4dannjjm	6003	31	mass	mass	NN
cord-023095-4dannjjm	6003	32	.	.	.
cord-023095-4dannjjm	6004	1	T	T	NNP
cord-023095-4dannjjm	6004	2	cell	cell	NN
cord-023095-4dannjjm	6004	3	chronic	chronic	NN
cord-023095-4dannjjm	6004	4	lymphocytic	lymphocytic	JJ
cord-023095-4dannjjm	6004	5	leukemia	leukemia	NN
cord-023095-4dannjjm	6004	6	(	(	-LRB-
cord-023095-4dannjjm	6004	7	CLL	CLL	NNP
cord-023095-4dannjjm	6004	8	)	)	-RRB-
cord-023095-4dannjjm	6004	9	is	be	VBZ
cord-023095-4dannjjm	6004	10	a	a	DT
cord-023095-4dannjjm	6004	11	heterogeneous	heterogeneous	JJ
cord-023095-4dannjjm	6004	12	disease	disease	NN
cord-023095-4dannjjm	6004	13	that	that	WDT
cord-023095-4dannjjm	6004	14	affects	affect	VBZ
cord-023095-4dannjjm	6004	15	a	a	DT
cord-023095-4dannjjm	6004	16	number	number	NN
cord-023095-4dannjjm	6004	17	of	of	IN
cord-023095-4dannjjm	6004	18	dog	dog	NN
cord-023095-4dannjjm	6004	19	breeds	breed	NNS
cord-023095-4dannjjm	6004	20	.	.	.
cord-023095-4dannjjm	6005	1	CLL	CLL	NNP
cord-023095-4dannjjm	6005	2	patients	patient	NNS
cord-023095-4dannjjm	6005	3	have	have	VBP
cord-023095-4dannjjm	6005	4	variable	variable	JJ
cord-023095-4dannjjm	6005	5	disease	disease	NN
cord-023095-4dannjjm	6005	6	outcomes	outcome	NNS
cord-023095-4dannjjm	6005	7	.	.	.
cord-023095-4dannjjm	6006	1	The	the	DT
cord-023095-4dannjjm	6006	2	objectives	objective	NNS
cord-023095-4dannjjm	6006	3	of	of	IN
cord-023095-4dannjjm	6006	4	this	this	DT
cord-023095-4dannjjm	6006	5	study	study	NN
cord-023095-4dannjjm	6006	6	were	be	VBD
cord-023095-4dannjjm	6006	7	to	to	TO
cord-023095-4dannjjm	6006	8	use	use	VB
cord-023095-4dannjjm	6006	9	gene	gene	NN
cord-023095-4dannjjm	6006	10	expression	expression	NN
cord-023095-4dannjjm	6006	11	profiling	profiling	NN
cord-023095-4dannjjm	6006	12	of	of	IN
cord-023095-4dannjjm	6006	13	CD8	CD8	NNP
cord-023095-4dannjjm	6006	14	T	T	NNP
cord-023095-4dannjjm	6006	15	cell	cell	NN
cord-023095-4dannjjm	6006	16	leukemias	leukemia	NNS
cord-023095-4dannjjm	6006	17	with	with	IN
cord-023095-4dannjjm	6006	18	variable	variable	JJ
cord-023095-4dannjjm	6006	19	outcomes	outcome	NNS
cord-023095-4dannjjm	6006	20	in	in	IN
cord-023095-4dannjjm	6006	21	order	order	NN
cord-023095-4dannjjm	6006	22	to	to	TO
cord-023095-4dannjjm	6006	23	identify	identify	VB
cord-023095-4dannjjm	6006	24	markers	marker	NNS
cord-023095-4dannjjm	6006	25	that	that	WDT
cord-023095-4dannjjm	6006	26	can	can	MD
cord-023095-4dannjjm	6006	27	be	be	VB
cord-023095-4dannjjm	6006	28	used	use	VBN
cord-023095-4dannjjm	6006	29	in	in	IN
cord-023095-4dannjjm	6006	30	routine	routine	JJ
cord-023095-4dannjjm	6006	31	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	6006	32	tests	test	NNS
cord-023095-4dannjjm	6006	33	to	to	TO
cord-023095-4dannjjm	6006	34	distinguish	distinguish	VB
cord-023095-4dannjjm	6006	35	good	good	JJ
cord-023095-4dannjjm	6006	36	from	from	IN
cord-023095-4dannjjm	6006	37	poor	poor	JJ
cord-023095-4dannjjm	6006	38	prognosis	prognosis	NN
cord-023095-4dannjjm	6006	39	disease	disease	NN
cord-023095-4dannjjm	6006	40	,	,	,
cord-023095-4dannjjm	6006	41	and	and	CC
cord-023095-4dannjjm	6006	42	to	to	TO
cord-023095-4dannjjm	6006	43	identify	identify	VB
cord-023095-4dannjjm	6006	44	potential	potential	JJ
cord-023095-4dannjjm	6006	45	targets	target	NNS
cord-023095-4dannjjm	6006	46	for	for	IN
cord-023095-4dannjjm	6006	47	novel	novel	NN
cord-023095-4dannjjm	6006	48	therapy	therapy	NN
cord-023095-4dannjjm	6006	49	.	.	.
cord-023095-4dannjjm	6007	1	Gene	gene	NN
cord-023095-4dannjjm	6007	2	expression	expression	NN
cord-023095-4dannjjm	6007	3	profiling	profiling	NN
cord-023095-4dannjjm	6007	4	of	of	IN
cord-023095-4dannjjm	6007	5	12	12	CD
cord-023095-4dannjjm	6007	6	CD8	CD8	NNP
cord-023095-4dannjjm	6007	7	T	T	NNP
cord-023095-4dannjjm	6007	8	cell	cell	NN
cord-023095-4dannjjm	6007	9	leukemias	leukemia	NNS
cord-023095-4dannjjm	6007	10	(	(	-LRB-
cord-023095-4dannjjm	6007	11	7	7	CD
cord-023095-4dannjjm	6007	12	good	good	JJ
cord-023095-4dannjjm	6007	13	,	,	,
cord-023095-4dannjjm	6007	14	5	5	CD
cord-023095-4dannjjm	6007	15	poor	poor	JJ
cord-023095-4dannjjm	6007	16	prognosis	prognosis	NN
cord-023095-4dannjjm	6007	17	)	)	-RRB-
cord-023095-4dannjjm	6007	18	was	be	VBD
cord-023095-4dannjjm	6007	19	conducted	conduct	VBN
cord-023095-4dannjjm	6007	20	.	.	.
cord-023095-4dannjjm	6008	1	Samples	sample	NNS
cord-023095-4dannjjm	6008	2	from	from	IN
cord-023095-4dannjjm	6008	3	6	6	CD
cord-023095-4dannjjm	6008	4	normal	normal	JJ
cord-023095-4dannjjm	6008	5	dogs	dog	NNS
cord-023095-4dannjjm	6008	6	were	be	VBD
cord-023095-4dannjjm	6008	7	also	also	RB
cord-023095-4dannjjm	6008	8	profiled	profile	VBN
cord-023095-4dannjjm	6008	9	.	.	.
cord-023095-4dannjjm	6009	1	Several	several	JJ
cord-023095-4dannjjm	6009	2	differentially	differentially	RB
cord-023095-4dannjjm	6009	3	expressed	express	VBN
cord-023095-4dannjjm	6009	4	genes	gene	NNS
cord-023095-4dannjjm	6009	5	were	be	VBD
cord-023095-4dannjjm	6009	6	found	find	VBN
cord-023095-4dannjjm	6009	7	including	include	VBG
cord-023095-4dannjjm	6009	8	CD9	CD9	NNP
cord-023095-4dannjjm	6009	9	,	,	,
cord-023095-4dannjjm	6009	10	CD94	CD94	NNP
cord-023095-4dannjjm	6009	11	,	,	,
cord-023095-4dannjjm	6009	12	and	and	CC
cord-023095-4dannjjm	6009	13	CD	CD	NNP
cord-023095-4dannjjm	6009	14	25	25	CD
cord-023095-4dannjjm	6009	15	.	.	.
cord-023095-4dannjjm	6010	1	These	these	DT
cord-023095-4dannjjm	6010	2	were	be	VBD
cord-023095-4dannjjm	6010	3	selected	select	VBN
cord-023095-4dannjjm	6010	4	for	for	IN
cord-023095-4dannjjm	6010	5	further	further	JJ
cord-023095-4dannjjm	6010	6	study	study	NN
cord-023095-4dannjjm	6010	7	using	use	VBG
cord-023095-4dannjjm	6010	8	flow	flow	NN
cord-023095-4dannjjm	6010	9	cytometry	cytometry	NN
cord-023095-4dannjjm	6010	10	to	to	TO
cord-023095-4dannjjm	6010	11	determine	determine	VB
cord-023095-4dannjjm	6010	12	expression	expression	NN
cord-023095-4dannjjm	6010	13	of	of	IN
cord-023095-4dannjjm	6010	14	protein	protein	NN
cord-023095-4dannjjm	6010	15	on	on	IN
cord-023095-4dannjjm	6010	16	the	the	DT
cord-023095-4dannjjm	6010	17	cell	cell	NN
cord-023095-4dannjjm	6010	18	surface	surface	NN
cord-023095-4dannjjm	6010	19	.	.	.
cord-023095-4dannjjm	6011	1	Seventy	seventy	CD
cord-023095-4dannjjm	6011	2	nine	nine	CD
cord-023095-4dannjjm	6011	3	cases	case	NNS
cord-023095-4dannjjm	6011	4	of	of	IN
cord-023095-4dannjjm	6011	5	CD81	CD81	NNP
cord-023095-4dannjjm	6011	6	T	T	NNP
cord-023095-4dannjjm	6011	7	cell	cell	NN
cord-023095-4dannjjm	6011	8	leukemia	leukemia	NN
cord-023095-4dannjjm	6011	9	were	be	VBD
cord-023095-4dannjjm	6011	10	screened	screen	VBN
cord-023095-4dannjjm	6011	11	for	for	IN
cord-023095-4dannjjm	6011	12	CD	CD	NNP
cord-023095-4dannjjm	6011	13	9	9	CD
cord-023095-4dannjjm	6011	14	expression	expression	NN
cord-023095-4dannjjm	6011	15	.	.	.
cord-023095-4dannjjm	6012	1	Forty	forty	CD
cord-023095-4dannjjm	6012	2	seven	seven	CD
cord-023095-4dannjjm	6012	3	had	have	VBD
cord-023095-4dannjjm	6012	4	associated	associate	VBN
cord-023095-4dannjjm	6012	5	outcome	outcome	NN
cord-023095-4dannjjm	6012	6	information	information	NN
cord-023095-4dannjjm	6012	7	.	.	.
cord-023095-4dannjjm	6013	1	Based	base	VBN
cord-023095-4dannjjm	6013	2	on	on	IN
cord-023095-4dannjjm	6013	3	analysis	analysis	NN
cord-023095-4dannjjm	6013	4	to	to	IN
cord-023095-4dannjjm	6013	5	date	date	NN
cord-023095-4dannjjm	6013	6	,	,	,
cord-023095-4dannjjm	6013	7	CD9	CD9	NNP
cord-023095-4dannjjm	6013	8	expression	expression	NN
cord-023095-4dannjjm	6013	9	as	as	IN
cord-023095-4dannjjm	6013	10	assessed	assess	VBN
cord-023095-4dannjjm	6013	11	by	by	IN
cord-023095-4dannjjm	6013	12	flow	flow	NN
cord-023095-4dannjjm	6013	13	cytometry	cytometry	NN
cord-023095-4dannjjm	6013	14	does	do	VBZ
cord-023095-4dannjjm	6013	15	not	not	RB
cord-023095-4dannjjm	6013	16	appear	appear	VB
cord-023095-4dannjjm	6013	17	to	to	TO
cord-023095-4dannjjm	6013	18	provide	provide	VB
cord-023095-4dannjjm	6013	19	prognostic	prognostic	JJ
cord-023095-4dannjjm	6013	20	information	information	NN
cord-023095-4dannjjm	6013	21	.	.	.
cord-023095-4dannjjm	6014	1	A	a	DT
cord-023095-4dannjjm	6014	2	monoclonal	monoclonal	JJ
cord-023095-4dannjjm	6014	3	antibody	antibody	NN
cord-023095-4dannjjm	6014	4	to	to	IN
cord-023095-4dannjjm	6014	5	CD25	CD25	NNP
cord-023095-4dannjjm	6014	6	was	be	VBD
cord-023095-4dannjjm	6014	7	recently	recently	RB
cord-023095-4dannjjm	6014	8	made	make	VBN
cord-023095-4dannjjm	6014	9	available	available	JJ
cord-023095-4dannjjm	6014	10	.	.	.
cord-023095-4dannjjm	6015	1	To	to	IN
cord-023095-4dannjjm	6015	2	date	date	NN
cord-023095-4dannjjm	6015	3	33	33	CD
cord-023095-4dannjjm	6015	4	patients	patient	NNS
cord-023095-4dannjjm	6015	5	with	with	IN
cord-023095-4dannjjm	6015	6	CD8	CD8	NNP
cord-023095-4dannjjm	6015	7	T	T	NNP
cord-023095-4dannjjm	6015	8	cell	cell	NN
cord-023095-4dannjjm	6015	9	leukemia	leukemia	NN
cord-023095-4dannjjm	6015	10	have	have	VBP
cord-023095-4dannjjm	6015	11	been	be	VBN
cord-023095-4dannjjm	6015	12	profiled	profile	VBN
cord-023095-4dannjjm	6015	13	.	.	.
cord-023095-4dannjjm	6016	1	CD25	CD25	NNP
cord-023095-4dannjjm	6016	2	is	be	VBZ
cord-023095-4dannjjm	6016	3	variably	variably	RB
cord-023095-4dannjjm	6016	4	expressed	express	VBN
cord-023095-4dannjjm	6016	5	on	on	IN
cord-023095-4dannjjm	6016	6	T	T	NNP
cord-023095-4dannjjm	6016	7	cell	cell	NN
cord-023095-4dannjjm	6016	8	leukemias	leukemia	NNS
cord-023095-4dannjjm	6016	9	compared	compare	VBN
cord-023095-4dannjjm	6016	10	to	to	IN
cord-023095-4dannjjm	6016	11	normal	normal	JJ
cord-023095-4dannjjm	6016	12	CD8	CD8	NNP
cord-023095-4dannjjm	6016	13	T	T	NNP
cord-023095-4dannjjm	6016	14	cells	cell	NNS
cord-023095-4dannjjm	6016	15	.	.	.
cord-023095-4dannjjm	6017	1	CD25	CD25	NNP
cord-023095-4dannjjm	6017	2	is	be	VBZ
cord-023095-4dannjjm	6017	3	the	the	DT
cord-023095-4dannjjm	6017	4	receptor	receptor	NN
cord-023095-4dannjjm	6017	5	for	for	IN
cord-023095-4dannjjm	6017	6	interleukin	interleukin	NN
cord-023095-4dannjjm	6017	7	2	2	CD
cord-023095-4dannjjm	6017	8	.	.	.
cord-023095-4dannjjm	6018	1	Cyclosporin	Cyclosporin	NNP
cord-023095-4dannjjm	6018	2	,	,	,
cord-023095-4dannjjm	6018	3	a	a	DT
cord-023095-4dannjjm	6018	4	commonly	commonly	RB
cord-023095-4dannjjm	6018	5	used	use	VBN
cord-023095-4dannjjm	6018	6	immunosuppressive	immunosuppressive	JJ
cord-023095-4dannjjm	6018	7	drug	drug	NN
cord-023095-4dannjjm	6018	8	,	,	,
cord-023095-4dannjjm	6018	9	inhibits	inhibit	VBZ
cord-023095-4dannjjm	6018	10	IL-2	il-2	NN
cord-023095-4dannjjm	6018	11	production	production	NN
cord-023095-4dannjjm	6018	12	,	,	,
cord-023095-4dannjjm	6018	13	and	and	CC
cord-023095-4dannjjm	6018	14	has	have	VBZ
cord-023095-4dannjjm	6018	15	been	be	VBN
cord-023095-4dannjjm	6018	16	used	use	VBN
cord-023095-4dannjjm	6018	17	to	to	TO
cord-023095-4dannjjm	6018	18	treat	treat	VB
cord-023095-4dannjjm	6018	19	a	a	DT
cord-023095-4dannjjm	6018	20	subset	subset	NN
cord-023095-4dannjjm	6018	21	of	of	IN
cord-023095-4dannjjm	6018	22	T	T	NNP
cord-023095-4dannjjm	6018	23	cell	cell	NN
cord-023095-4dannjjm	6018	24	leukemias	leukemia	NNS
cord-023095-4dannjjm	6018	25	in	in	IN
cord-023095-4dannjjm	6018	26	people	people	NNS
cord-023095-4dannjjm	6018	27	.	.	.
cord-023095-4dannjjm	6019	1	Thus	thus	RB
cord-023095-4dannjjm	6019	2	,	,	,
cord-023095-4dannjjm	6019	3	the	the	DT
cord-023095-4dannjjm	6019	4	finding	finding	NN
cord-023095-4dannjjm	6019	5	that	that	IN
cord-023095-4dannjjm	6019	6	CD25	CD25	NNP
cord-023095-4dannjjm	6019	7	is	be	VBZ
cord-023095-4dannjjm	6019	8	up	up	RB
cord-023095-4dannjjm	6019	9	regulated	regulate	VBN
cord-023095-4dannjjm	6019	10	on	on	IN
cord-023095-4dannjjm	6019	11	T	T	NNP
cord-023095-4dannjjm	6019	12	cell	cell	NN
cord-023095-4dannjjm	6019	13	leukemias	leukemia	NNS
cord-023095-4dannjjm	6019	14	compared	compare	VBN
cord-023095-4dannjjm	6019	15	with	with	IN
cord-023095-4dannjjm	6019	16	normal	normal	JJ
cord-023095-4dannjjm	6019	17	T	t	NN
cord-023095-4dannjjm	6019	18	cells	cell	NNS
cord-023095-4dannjjm	6019	19	suggests	suggest	VBZ
cord-023095-4dannjjm	6019	20	a	a	DT
cord-023095-4dannjjm	6019	21	possible	possible	JJ
cord-023095-4dannjjm	6019	22	new	new	JJ
cord-023095-4dannjjm	6019	23	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	6019	24	avenue	avenue	NN
cord-023095-4dannjjm	6019	25	.	.	.
cord-023095-4dannjjm	6020	1	Recent	recent	JJ
cord-023095-4dannjjm	6020	2	molecular	molecular	JJ
cord-023095-4dannjjm	6020	3	studies	study	NNS
cord-023095-4dannjjm	6020	4	have	have	VBP
cord-023095-4dannjjm	6020	5	revealed	reveal	VBN
cord-023095-4dannjjm	6020	6	a	a	DT
cord-023095-4dannjjm	6020	7	highly	highly	RB
cord-023095-4dannjjm	6020	8	complex	complex	JJ
cord-023095-4dannjjm	6020	9	bacterial	bacterial	JJ
cord-023095-4dannjjm	6020	10	microbiota	microbiota	NN
cord-023095-4dannjjm	6020	11	in	in	IN
cord-023095-4dannjjm	6020	12	the	the	DT
cord-023095-4dannjjm	6020	13	intestine	intestine	NN
cord-023095-4dannjjm	6020	14	of	of	IN
cord-023095-4dannjjm	6020	15	dogs	dog	NNS
cord-023095-4dannjjm	6020	16	.	.	.
cord-023095-4dannjjm	6021	1	There	there	EX
cord-023095-4dannjjm	6021	2	is	be	VBZ
cord-023095-4dannjjm	6021	3	mounting	mount	VBG
cord-023095-4dannjjm	6021	4	evidence	evidence	NN
cord-023095-4dannjjm	6021	5	that	that	IN
cord-023095-4dannjjm	6021	6	microbes	microbe	NNS
cord-023095-4dannjjm	6021	7	play	play	VBP
cord-023095-4dannjjm	6021	8	an	an	DT
cord-023095-4dannjjm	6021	9	important	important	JJ
cord-023095-4dannjjm	6021	10	role	role	NN
cord-023095-4dannjjm	6021	11	in	in	IN
cord-023095-4dannjjm	6021	12	the	the	DT
cord-023095-4dannjjm	6021	13	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	6021	14	of	of	IN
cord-023095-4dannjjm	6021	15	acute	acute	JJ
cord-023095-4dannjjm	6021	16	and	and	CC
cord-023095-4dannjjm	6021	17	chronic	chronic	JJ
cord-023095-4dannjjm	6021	18	enteropathies	enteropathy	NNS
cord-023095-4dannjjm	6021	19	of	of	IN
cord-023095-4dannjjm	6021	20	dogs	dog	NNS
cord-023095-4dannjjm	6021	21	,	,	,
cord-023095-4dannjjm	6021	22	including	include	VBG
cord-023095-4dannjjm	6021	23	idiopathic	idiopathic	JJ
cord-023095-4dannjjm	6021	24	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6021	25	bowel	bowel	NN
cord-023095-4dannjjm	6021	26	disease	disease	NN
cord-023095-4dannjjm	6021	27	(	(	-LRB-
cord-023095-4dannjjm	6021	28	IBD	IBD	NNP
cord-023095-4dannjjm	6021	29	)	)	-RRB-
cord-023095-4dannjjm	6021	30	.	.	.
cord-023095-4dannjjm	6022	1	Similarly	similarly	RB
cord-023095-4dannjjm	6022	2	,	,	,
cord-023095-4dannjjm	6022	3	compositional	compositional	JJ
cord-023095-4dannjjm	6022	4	changes	change	NNS
cord-023095-4dannjjm	6022	5	of	of	IN
cord-023095-4dannjjm	6022	6	the	the	DT
cord-023095-4dannjjm	6022	7	intestinal	intestinal	JJ
cord-023095-4dannjjm	6022	8	bacterial	bacterial	JJ
cord-023095-4dannjjm	6022	9	ecosystem	ecosystem	NN
cord-023095-4dannjjm	6022	10	have	have	VBP
cord-023095-4dannjjm	6022	11	been	be	VBN
cord-023095-4dannjjm	6022	12	associated	associate	VBN
cord-023095-4dannjjm	6022	13	with	with	IN
cord-023095-4dannjjm	6022	14	IBD	IBD	NNP
cord-023095-4dannjjm	6022	15	in	in	IN
cord-023095-4dannjjm	6022	16	humans	human	NNS
cord-023095-4dannjjm	6022	17	.	.	.
cord-023095-4dannjjm	6023	1	The	the	DT
cord-023095-4dannjjm	6023	2	aim	aim	NN
cord-023095-4dannjjm	6023	3	of	of	IN
cord-023095-4dannjjm	6023	4	this	this	DT
cord-023095-4dannjjm	6023	5	study	study	NN
cord-023095-4dannjjm	6023	6	was	be	VBD
cord-023095-4dannjjm	6023	7	to	to	TO
cord-023095-4dannjjm	6023	8	characterize	characterize	VB
cord-023095-4dannjjm	6023	9	the	the	DT
cord-023095-4dannjjm	6023	10	bacterial	bacterial	JJ
cord-023095-4dannjjm	6023	11	microbiota	microbiota	NN
cord-023095-4dannjjm	6023	12	in	in	IN
cord-023095-4dannjjm	6023	13	dogs	dog	NNS
cord-023095-4dannjjm	6023	14	with	with	IN
cord-023095-4dannjjm	6023	15	various	various	JJ
cord-023095-4dannjjm	6023	16	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	6023	17	disorders	disorder	NNS
cord-023095-4dannjjm	6023	18	using	use	VBG
cord-023095-4dannjjm	6023	19	a	a	DT
cord-023095-4dannjjm	6023	20	next	next	JJ
cord-023095-4dannjjm	6023	21	generation	generation	NN
cord-023095-4dannjjm	6023	22	sequencing	sequencing	NN
cord-023095-4dannjjm	6023	23	technique	technique	NN
cord-023095-4dannjjm	6023	24	.	.	.
cord-023095-4dannjjm	6024	1	Fecal	fecal	JJ
cord-023095-4dannjjm	6024	2	samples	sample	NNS
cord-023095-4dannjjm	6024	3	were	be	VBD
cord-023095-4dannjjm	6024	4	obtained	obtain	VBN
cord-023095-4dannjjm	6024	5	from	from	IN
cord-023095-4dannjjm	6024	6	healthy	healthy	JJ
cord-023095-4dannjjm	6024	7	dogs	dog	NNS
cord-023095-4dannjjm	6024	8	(	(	-LRB-
cord-023095-4dannjjm	6024	9	n	n	NN
cord-023095-4dannjjm	6024	10	5	5	CD
cord-023095-4dannjjm	6024	11	31	31	CD
cord-023095-4dannjjm	6024	12	)	)	-RRB-
cord-023095-4dannjjm	6024	13	,	,	,
cord-023095-4dannjjm	6024	14	dogs	dog	NNS
cord-023095-4dannjjm	6024	15	with	with	IN
cord-023095-4dannjjm	6024	16	acute	acute	JJ
cord-023095-4dannjjm	6024	17	uncomplicated	uncomplicated	JJ
cord-023095-4dannjjm	6024	18	diarrhea	diarrhea	NN
cord-023095-4dannjjm	6024	19	(	(	-LRB-
cord-023095-4dannjjm	6024	20	n	n	NN
cord-023095-4dannjjm	6024	21	5	5	CD
cord-023095-4dannjjm	6024	22	7	7	CD
cord-023095-4dannjjm	6024	23	)	)	-RRB-
cord-023095-4dannjjm	6024	24	,	,	,
cord-023095-4dannjjm	6024	25	dogs	dog	NNS
cord-023095-4dannjjm	6024	26	with	with	IN
cord-023095-4dannjjm	6024	27	acute	acute	JJ
cord-023095-4dannjjm	6024	28	hemorrhagic	hemorrhagic	JJ
cord-023095-4dannjjm	6024	29	diarrhea	diarrhea	NN
cord-023095-4dannjjm	6024	30	(	(	-LRB-
cord-023095-4dannjjm	6024	31	AHD	AHD	NNP
cord-023095-4dannjjm	6024	32	;	;	:
cord-023095-4dannjjm	6024	33	n	n	NN
cord-023095-4dannjjm	6024	34	5	5	CD
cord-023095-4dannjjm	6024	35	13	13	CD
cord-023095-4dannjjm	6024	36	)	)	-RRB-
cord-023095-4dannjjm	6024	37	,	,	,
cord-023095-4dannjjm	6024	38	and	and	CC
cord-023095-4dannjjm	6024	39	dogs	dog	NNS
cord-023095-4dannjjm	6024	40	with	with	IN
cord-023095-4dannjjm	6024	41	active	active	JJ
cord-023095-4dannjjm	6024	42	(	(	-LRB-
cord-023095-4dannjjm	6024	43	n	n	NN
cord-023095-4dannjjm	6024	44	5	5	CD
cord-023095-4dannjjm	6024	45	8)	8)	NN
cord-023095-4dannjjm	6024	46	and	and	CC
cord-023095-4dannjjm	6024	47	therapeutically	therapeutically	RB
cord-023095-4dannjjm	6024	48	controlled	control	VBN
cord-023095-4dannjjm	6024	49	IBD	IBD	NNP
cord-023095-4dannjjm	6024	50	(	(	-LRB-
cord-023095-4dannjjm	6024	51	n	n	NN
cord-023095-4dannjjm	6024	52	5	5	CD
cord-023095-4dannjjm	6024	53	10	10	CD
cord-023095-4dannjjm	6024	54	)	)	-RRB-
cord-023095-4dannjjm	6024	55	.	.	.
cord-023095-4dannjjm	6025	1	The	the	DT
cord-023095-4dannjjm	6025	2	bacterial	bacterial	JJ
cord-023095-4dannjjm	6025	3	composition	composition	NN
cord-023095-4dannjjm	6025	4	was	be	VBD
cord-023095-4dannjjm	6025	5	analyzed	analyze	VBN
cord-023095-4dannjjm	6025	6	by	by	IN
cord-023095-4dannjjm	6025	7	massive	massive	JJ
cord-023095-4dannjjm	6025	8	parallel	parallel	NN
cord-023095-4dannjjm	6025	9	16S	16S	NNP
cord-023095-4dannjjm	6025	10	rRNA	rrna	NN
cord-023095-4dannjjm	6025	11	gene	gene	NN
cord-023095-4dannjjm	6025	12	454-pyrosequencing	454-pyrosequencing	CD
cord-023095-4dannjjm	6025	13	.	.	.
cord-023095-4dannjjm	6026	1	Differences	difference	NNS
cord-023095-4dannjjm	6026	2	between	between	IN
cord-023095-4dannjjm	6026	3	groups	group	NNS
cord-023095-4dannjjm	6026	4	were	be	VBD
cord-023095-4dannjjm	6026	5	analyzed	analyze	VBN
cord-023095-4dannjjm	6026	6	using	use	VBG
cord-023095-4dannjjm	6026	7	Mann	Mann	NNP
cord-023095-4dannjjm	6026	8	-	-	HYPH
cord-023095-4dannjjm	6026	9	Whitney	Whitney	NNP
cord-023095-4dannjjm	6026	10	U	U	NNP
cord-023095-4dannjjm	6026	11	tests	test	VBZ
cord-023095-4dannjjm	6026	12	and	and	CC
cord-023095-4dannjjm	6026	13	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	6026	14	-	-	HYPH
cord-023095-4dannjjm	6026	15	Wallis	Wallis	NNP
cord-023095-4dannjjm	6026	16	tests	test	NNS
cord-023095-4dannjjm	6026	17	followed	follow	VBN
cord-023095-4dannjjm	6026	18	by	by	IN
cord-023095-4dannjjm	6026	19	Dunn	Dunn	NNP
cord-023095-4dannjjm	6026	20	's	's	POS
cord-023095-4dannjjm	6026	21	multiple	multiple	JJ
cord-023095-4dannjjm	6026	22	comparison	comparison	NN
cord-023095-4dannjjm	6026	23	tests	test	NNS
cord-023095-4dannjjm	6026	24	.	.	.
cord-023095-4dannjjm	6027	1	Statistical	statistical	JJ
cord-023095-4dannjjm	6027	2	significance	significance	NN
cord-023095-4dannjjm	6027	3	was	be	VBD
cord-023095-4dannjjm	6027	4	set	set	VBN
cord-023095-4dannjjm	6027	5	at	at	IN
cord-023095-4dannjjm	6027	6	p	p	NN
cord-023095-4dannjjm	6027	7	o	o	NN
cord-023095-4dannjjm	6027	8	0.05	0.05	CD
cord-023095-4dannjjm	6027	9	.	.	.
cord-023095-4dannjjm	6028	1	Significant	significant	JJ
cord-023095-4dannjjm	6028	2	differences	difference	NNS
cord-023095-4dannjjm	6028	3	in	in	IN
cord-023095-4dannjjm	6028	4	the	the	DT
cord-023095-4dannjjm	6028	5	proportions	proportion	NNS
cord-023095-4dannjjm	6028	6	of	of	IN
cord-023095-4dannjjm	6028	7	several	several	JJ
cord-023095-4dannjjm	6028	8	bacterial	bacterial	JJ
cord-023095-4dannjjm	6028	9	groups	group	NNS
cord-023095-4dannjjm	6028	10	were	be	VBD
cord-023095-4dannjjm	6028	11	identified	identify	VBN
cord-023095-4dannjjm	6028	12	between	between	IN
cord-023095-4dannjjm	6028	13	healthy	healthy	JJ
cord-023095-4dannjjm	6028	14	and	and	CC
cord-023095-4dannjjm	6028	15	diseased	diseased	JJ
cord-023095-4dannjjm	6028	16	dogs	dog	NNS
cord-023095-4dannjjm	6028	17	.	.	.
cord-023095-4dannjjm	6029	1	Dogs	dog	NNS
cord-023095-4dannjjm	6029	2	with	with	IN
cord-023095-4dannjjm	6029	3	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	6029	4	disease	disease	NN
cord-023095-4dannjjm	6029	5	had	have	VBD
cord-023095-4dannjjm	6029	6	significantly	significantly	RB
cord-023095-4dannjjm	6029	7	higher	high	JJR
cord-023095-4dannjjm	6029	8	proportions	proportion	NNS
cord-023095-4dannjjm	6029	9	of	of	IN
cord-023095-4dannjjm	6029	10	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	6029	11	(	(	-LRB-
cord-023095-4dannjjm	6029	12	p	p	NN
cord-023095-4dannjjm	6029	13	o	o	NN
cord-023095-4dannjjm	6029	14	0.01	0.01	CD
cord-023095-4dannjjm	6029	15	)	)	-RRB-
cord-023095-4dannjjm	6029	16	.	.	.
cord-023095-4dannjjm	6030	1	Proportions	proportion	NNS
cord-023095-4dannjjm	6030	2	of	of	IN
cord-023095-4dannjjm	6030	3	Firmicutes	Firmicutes	NNPS
cord-023095-4dannjjm	6030	4	were	be	VBD
cord-023095-4dannjjm	6030	5	lower	low	JJR
cord-023095-4dannjjm	6030	6	in	in	IN
cord-023095-4dannjjm	6030	7	diseased	diseased	JJ
cord-023095-4dannjjm	6030	8	dogs	dog	NNS
cord-023095-4dannjjm	6030	9	,	,	,
cord-023095-4dannjjm	6030	10	but	but	CC
cord-023095-4dannjjm	6030	11	this	this	DT
cord-023095-4dannjjm	6030	12	difference	difference	NN
cord-023095-4dannjjm	6030	13	did	do	VBD
cord-023095-4dannjjm	6030	14	not	not	RB
cord-023095-4dannjjm	6030	15	reach	reach	VB
cord-023095-4dannjjm	6030	16	significance	significance	NN
cord-023095-4dannjjm	6030	17	(	(	-LRB-
cord-023095-4dannjjm	6030	18	p	p	NN
cord-023095-4dannjjm	6030	19	5	5	CD
cord-023095-4dannjjm	6030	20	0.06	0.06	CD
cord-023095-4dannjjm	6030	21	)	)	-RRB-
cord-023095-4dannjjm	6030	22	.	.	.
cord-023095-4dannjjm	6031	1	Within	within	IN
cord-023095-4dannjjm	6031	2	the	the	DT
cord-023095-4dannjjm	6031	3	Firmicutes	Firmicutes	NNPS
cord-023095-4dannjjm	6031	4	the	the	DT
cord-023095-4dannjjm	6031	5	most	most	RBS
cord-023095-4dannjjm	6031	6	notable	notable	JJ
cord-023095-4dannjjm	6031	7	findings	finding	NNS
cord-023095-4dannjjm	6031	8	were	be	VBD
cord-023095-4dannjjm	6031	9	decreases	decrease	NNS
cord-023095-4dannjjm	6031	10	in	in	IN
cord-023095-4dannjjm	6031	11	bacterial	bacterial	JJ
cord-023095-4dannjjm	6031	12	groups	group	NNS
cord-023095-4dannjjm	6031	13	belonging	belong	VBG
cord-023095-4dannjjm	6031	14	to	to	IN
cord-023095-4dannjjm	6031	15	Clostridium	clostridium	NN
cord-023095-4dannjjm	6031	16	clusters	cluster	NNS
cord-023095-4dannjjm	6031	17	IV	IV	NNP
cord-023095-4dannjjm	6031	18	and	and	CC
cord-023095-4dannjjm	6031	19	XIVa	XIVa	NNP
cord-023095-4dannjjm	6031	20	(	(	-LRB-
cord-023095-4dannjjm	6031	21	i.e.	i.e.	FW
cord-023095-4dannjjm	6031	22	,	,	,
cord-023095-4dannjjm	6031	23	Ruminococcus	Ruminococcus	NNP
cord-023095-4dannjjm	6031	24	,	,	,
cord-023095-4dannjjm	6031	25	Dorea	Dorea	NNP
cord-023095-4dannjjm	6031	26	,	,	,
cord-023095-4dannjjm	6031	27	and	and	CC
cord-023095-4dannjjm	6031	28	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	6031	29	spp	spp	NNS
cord-023095-4dannjjm	6031	30	.	.	.
cord-023095-4dannjjm	6032	1	;	;	:
cord-023095-4dannjjm	6032	2	p	p	NN
cord-023095-4dannjjm	6032	3	o	o	NN
cord-023095-4dannjjm	6032	4	0.01	0.01	CD
cord-023095-4dannjjm	6032	5	for	for	IN
cord-023095-4dannjjm	6032	6	all	all	DT
cord-023095-4dannjjm	6032	7	)	)	-RRB-
cord-023095-4dannjjm	6032	8	.	.	.
cord-023095-4dannjjm	6033	1	Dogs	dog	NNS
cord-023095-4dannjjm	6033	2	with	with	IN
cord-023095-4dannjjm	6033	3	AHD	AHD	NNP
cord-023095-4dannjjm	6033	4	had	have	VBD
cord-023095-4dannjjm	6033	5	the	the	DT
cord-023095-4dannjjm	6033	6	most	most	RBS
cord-023095-4dannjjm	6033	7	profound	profound	JJ
cord-023095-4dannjjm	6033	8	changes	change	NNS
cord-023095-4dannjjm	6033	9	of	of	IN
cord-023095-4dannjjm	6033	10	the	the	DT
cord-023095-4dannjjm	6033	11	microbiota	microbiota	NN
cord-023095-4dannjjm	6033	12	,	,	,
cord-023095-4dannjjm	6033	13	followed	follow	VBN
cord-023095-4dannjjm	6033	14	by	by	IN
cord-023095-4dannjjm	6033	15	dogs	dog	NNS
cord-023095-4dannjjm	6033	16	with	with	IN
cord-023095-4dannjjm	6033	17	acute	acute	JJ
cord-023095-4dannjjm	6033	18	uncomplicated	uncomplicated	JJ
cord-023095-4dannjjm	6033	19	diarrhea	diarrhea	NN
cord-023095-4dannjjm	6033	20	,	,	,
cord-023095-4dannjjm	6033	21	and	and	CC
cord-023095-4dannjjm	6033	22	dogs	dog	NNS
cord-023095-4dannjjm	6033	23	with	with	IN
cord-023095-4dannjjm	6033	24	active	active	JJ
cord-023095-4dannjjm	6033	25	IBD	IBD	NNP
cord-023095-4dannjjm	6033	26	.	.	.
cord-023095-4dannjjm	6034	1	Faecalibacterium	Faecalibacterium	NNP
cord-023095-4dannjjm	6034	2	spp	spp	NNS
cord-023095-4dannjjm	6034	3	.	.	.
cord-023095-4dannjjm	6035	1	was	be	VBD
cord-023095-4dannjjm	6035	2	the	the	DT
cord-023095-4dannjjm	6035	3	bacterial	bacterial	JJ
cord-023095-4dannjjm	6035	4	group	group	NN
cord-023095-4dannjjm	6035	5	most	most	RBS
cord-023095-4dannjjm	6035	6	prominently	prominently	RB
cord-023095-4dannjjm	6035	7	depleted	deplete	VBN
cord-023095-4dannjjm	6035	8	in	in	IN
cord-023095-4dannjjm	6035	9	dogs	dog	NNS
cord-023095-4dannjjm	6035	10	with	with	IN
cord-023095-4dannjjm	6035	11	active	active	JJ
cord-023095-4dannjjm	6035	12	IBD	IBD	NNP
cord-023095-4dannjjm	6035	13	,	,	,
cord-023095-4dannjjm	6035	14	but	but	CC
cord-023095-4dannjjm	6035	15	was	be	VBD
cord-023095-4dannjjm	6035	16	not	not	RB
cord-023095-4dannjjm	6035	17	significantly	significantly	RB
cord-023095-4dannjjm	6035	18	different	different	JJ
cord-023095-4dannjjm	6035	19	between	between	IN
cord-023095-4dannjjm	6035	20	healthy	healthy	JJ
cord-023095-4dannjjm	6035	21	dogs	dog	NNS
cord-023095-4dannjjm	6035	22	and	and	CC
cord-023095-4dannjjm	6035	23	dogs	dog	NNS
cord-023095-4dannjjm	6035	24	with	with	IN
cord-023095-4dannjjm	6035	25	therapeutically	therapeutically	RB
cord-023095-4dannjjm	6035	26	controlled	control	VBN
cord-023095-4dannjjm	6035	27	IBD	IBD	NNP
cord-023095-4dannjjm	6035	28	(	(	-LRB-
cord-023095-4dannjjm	6035	29	p	p	NN
cord-023095-4dannjjm	6035	30	5	5	CD
cord-023095-4dannjjm	6035	31	0.66	0.66	CD
cord-023095-4dannjjm	6035	32	)	)	-RRB-
cord-023095-4dannjjm	6035	33	.	.	.
cord-023095-4dannjjm	6036	1	Results	result	NNS
cord-023095-4dannjjm	6036	2	of	of	IN
cord-023095-4dannjjm	6036	3	this	this	DT
cord-023095-4dannjjm	6036	4	study	study	NN
cord-023095-4dannjjm	6036	5	revealed	reveal	VBD
cord-023095-4dannjjm	6036	6	bacterial	bacterial	JJ
cord-023095-4dannjjm	6036	7	dysbiosis	dysbiosis	NN
cord-023095-4dannjjm	6036	8	in	in	IN
cord-023095-4dannjjm	6036	9	fecal	fecal	JJ
cord-023095-4dannjjm	6036	10	samples	sample	NNS
cord-023095-4dannjjm	6036	11	of	of	IN
cord-023095-4dannjjm	6036	12	dogs	dog	NNS
cord-023095-4dannjjm	6036	13	with	with	IN
cord-023095-4dannjjm	6036	14	various	various	JJ
cord-023095-4dannjjm	6036	15	GI	GI	NNP
cord-023095-4dannjjm	6036	16	disorders	disorder	NNS
cord-023095-4dannjjm	6036	17	.	.	.
cord-023095-4dannjjm	6037	1	Bacterial	bacterial	JJ
cord-023095-4dannjjm	6037	2	changes	change	NNS
cord-023095-4dannjjm	6037	3	were	be	VBD
cord-023095-4dannjjm	6037	4	more	more	RBR
cord-023095-4dannjjm	6037	5	profound	profound	JJ
cord-023095-4dannjjm	6037	6	in	in	IN
cord-023095-4dannjjm	6037	7	dogs	dog	NNS
cord-023095-4dannjjm	6037	8	with	with	IN
cord-023095-4dannjjm	6037	9	severe	severe	JJ
cord-023095-4dannjjm	6037	10	disease	disease	NN
cord-023095-4dannjjm	6037	11	,	,	,
cord-023095-4dannjjm	6037	12	but	but	CC
cord-023095-4dannjjm	6037	13	were	be	VBD
cord-023095-4dannjjm	6037	14	not	not	RB
cord-023095-4dannjjm	6037	15	identified	identify	VBN
cord-023095-4dannjjm	6037	16	in	in	IN
cord-023095-4dannjjm	6037	17	dogs	dog	NNS
cord-023095-4dannjjm	6037	18	with	with	IN
cord-023095-4dannjjm	6037	19	therapeutically	therapeutically	RB
cord-023095-4dannjjm	6037	20	controlled	control	VBN
cord-023095-4dannjjm	6037	21	IBD	IBD	NNP
cord-023095-4dannjjm	6037	22	,	,	,
cord-023095-4dannjjm	6037	23	suggesting	suggest	VBG
cord-023095-4dannjjm	6037	24	that	that	IN
cord-023095-4dannjjm	6037	25	the	the	DT
cord-023095-4dannjjm	6037	26	microbiota	microbiota	NN
cord-023095-4dannjjm	6037	27	is	be	VBZ
cord-023095-4dannjjm	6037	28	stable	stable	JJ
cord-023095-4dannjjm	6037	29	in	in	IN
cord-023095-4dannjjm	6037	30	non	non	JJ
cord-023095-4dannjjm	6037	31	-	-	JJ
cord-023095-4dannjjm	6037	32	active	active	JJ
cord-023095-4dannjjm	6037	33	disease	disease	NN
cord-023095-4dannjjm	6037	34	.	.	.
cord-023095-4dannjjm	6038	1	The	the	DT
cord-023095-4dannjjm	6038	2	bacterial	bacterial	JJ
cord-023095-4dannjjm	6038	3	groups	group	NNS
cord-023095-4dannjjm	6038	4	identified	identify	VBN
cord-023095-4dannjjm	6038	5	are	be	VBP
cord-023095-4dannjjm	6038	6	considered	consider	VBN
cord-023095-4dannjjm	6038	7	to	to	TO
cord-023095-4dannjjm	6038	8	be	be	VB
cord-023095-4dannjjm	6038	9	important	important	JJ
cord-023095-4dannjjm	6038	10	short	short	JJ
cord-023095-4dannjjm	6038	11	chain	chain	NN
cord-023095-4dannjjm	6038	12	fatty	fatty	JJ
cord-023095-4dannjjm	6038	13	acid	acid	NN
cord-023095-4dannjjm	6038	14	producers	producer	NNS
cord-023095-4dannjjm	6038	15	and	and	CC
cord-023095-4dannjjm	6038	16	may	may	MD
cord-023095-4dannjjm	6038	17	serve	serve	VB
cord-023095-4dannjjm	6038	18	as	as	IN
cord-023095-4dannjjm	6038	19	candidates	candidate	NNS
cord-023095-4dannjjm	6038	20	for	for	IN
cord-023095-4dannjjm	6038	21	the	the	DT
cord-023095-4dannjjm	6038	22	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6038	23	or	or	CC
cord-023095-4dannjjm	6038	24	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	6038	25	monitoring	monitoring	NN
cord-023095-4dannjjm	6038	26	of	of	IN
cord-023095-4dannjjm	6038	27	GI	GI	NNP
cord-023095-4dannjjm	6038	28	disease	disease	NN
cord-023095-4dannjjm	6038	29	.	.	.
cord-023095-4dannjjm	6039	1	Future	future	JJ
cord-023095-4dannjjm	6039	2	studies	study	NNS
cord-023095-4dannjjm	6039	3	are	be	VBP
cord-023095-4dannjjm	6039	4	necessary	necessary	JJ
cord-023095-4dannjjm	6039	5	to	to	TO
cord-023095-4dannjjm	6039	6	determine	determine	VB
cord-023095-4dannjjm	6039	7	if	if	IN
cord-023095-4dannjjm	6039	8	these	these	DT
cord-023095-4dannjjm	6039	9	microbial	microbial	JJ
cord-023095-4dannjjm	6039	10	changes	change	NNS
cord-023095-4dannjjm	6039	11	correlate	correlate	VBP
cord-023095-4dannjjm	6039	12	with	with	IN
cord-023095-4dannjjm	6039	13	functional	functional	JJ
cord-023095-4dannjjm	6039	14	changes	change	NNS
cord-023095-4dannjjm	6039	15	in	in	IN
cord-023095-4dannjjm	6039	16	the	the	DT
cord-023095-4dannjjm	6039	17	intestinal	intestinal	JJ
cord-023095-4dannjjm	6039	18	microbiota	microbiota	NN
cord-023095-4dannjjm	6039	19	.	.	.
cord-023095-4dannjjm	6040	1	Ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	6040	2	oral	oral	JJ
cord-023095-4dannjjm	6040	3	tablets	tablet	NNS
cord-023095-4dannjjm	6040	4	,	,	,
cord-023095-4dannjjm	6040	5	available	available	JJ
cord-023095-4dannjjm	6040	6	in	in	IN
cord-023095-4dannjjm	6040	7	a	a	DT
cord-023095-4dannjjm	6040	8	generic	generic	JJ
cord-023095-4dannjjm	6040	9	formulation	formulation	NN
cord-023095-4dannjjm	6040	10	for	for	IN
cord-023095-4dannjjm	6040	11	people	people	NNS
cord-023095-4dannjjm	6040	12	,	,	,
cord-023095-4dannjjm	6040	13	are	be	VBP
cord-023095-4dannjjm	6040	14	widely	widely	RB
cord-023095-4dannjjm	6040	15	used	use	VBN
cord-023095-4dannjjm	6040	16	for	for	IN
cord-023095-4dannjjm	6040	17	treatment	treatment	NN
cord-023095-4dannjjm	6040	18	in	in	IN
cord-023095-4dannjjm	6040	19	dogs	dog	NNS
cord-023095-4dannjjm	6040	20	.	.	.
cord-023095-4dannjjm	6041	1	Oral	oral	JJ
cord-023095-4dannjjm	6041	2	absorption	absorption	NN
cord-023095-4dannjjm	6041	3	data	datum	NNS
cord-023095-4dannjjm	6041	4	for	for	IN
cord-023095-4dannjjm	6041	5	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	6041	6	in	in	IN
cord-023095-4dannjjm	6041	7	dogs	dog	NNS
cord-023095-4dannjjm	6041	8	has	have	VBZ
cord-023095-4dannjjm	6041	9	been	be	VBN
cord-023095-4dannjjm	6041	10	variable	variable	JJ
cord-023095-4dannjjm	6041	11	,	,	,
cord-023095-4dannjjm	6041	12	and	and	CC
cord-023095-4dannjjm	6041	13	too	too	RB
cord-023095-4dannjjm	6041	14	limited	limited	JJ
cord-023095-4dannjjm	6041	15	to	to	TO
cord-023095-4dannjjm	6041	16	guide	guide	VB
cord-023095-4dannjjm	6041	17	accurate	accurate	JJ
cord-023095-4dannjjm	6041	18	dosing	dosing	NN
cord-023095-4dannjjm	6041	19	.	.	.
cord-023095-4dannjjm	6042	1	Subsequently	subsequently	RB
cord-023095-4dannjjm	6042	2	,	,	,
cord-023095-4dannjjm	6042	3	published	publish	VBN
cord-023095-4dannjjm	6042	4	doses	dose	NNS
cord-023095-4dannjjm	6042	5	for	for	IN
cord-023095-4dannjjm	6042	6	dogs	dog	NNS
cord-023095-4dannjjm	6042	7	in	in	IN
cord-023095-4dannjjm	6042	8	veterinary	veterinary	JJ
cord-023095-4dannjjm	6042	9	formularies	formulary	NNS
cord-023095-4dannjjm	6042	10	have	have	VBP
cord-023095-4dannjjm	6042	11	varied	vary	VBN
cord-023095-4dannjjm	6042	12	from	from	IN
cord-023095-4dannjjm	6042	13	5	5	CD
cord-023095-4dannjjm	6042	14	to	to	IN
cord-023095-4dannjjm	6042	15	25	25	CD
cord-023095-4dannjjm	6042	16	mg	mg	NNP
cord-023095-4dannjjm	6042	17	/	/	SYM
cord-023095-4dannjjm	6042	18	kg	kg	NN
cord-023095-4dannjjm	6042	19	.	.	.
cord-023095-4dannjjm	6043	1	This	this	DT
cord-023095-4dannjjm	6043	2	study	study	NN
cord-023095-4dannjjm	6043	3	was	be	VBD
cord-023095-4dannjjm	6043	4	undertaken	undertake	VBN
cord-023095-4dannjjm	6043	5	to	to	TO
cord-023095-4dannjjm	6043	6	explore	explore	VB
cord-023095-4dannjjm	6043	7	the	the	DT
cord-023095-4dannjjm	6043	8	factors	factor	NNS
cord-023095-4dannjjm	6043	9	that	that	WDT
cord-023095-4dannjjm	6043	10	may	may	MD
cord-023095-4dannjjm	6043	11	affect	affect	VB
cord-023095-4dannjjm	6043	12	oral	oral	JJ
cord-023095-4dannjjm	6043	13	absorption	absorption	NN
cord-023095-4dannjjm	6043	14	of	of	IN
cord-023095-4dannjjm	6043	15	generic	generic	JJ
cord-023095-4dannjjm	6043	16	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	6043	17	in	in	IN
cord-023095-4dannjjm	6043	18	dogs	dog	NNS
cord-023095-4dannjjm	6043	19	,	,	,
cord-023095-4dannjjm	6043	20	and	and	CC
cord-023095-4dannjjm	6043	21	to	to	TO
cord-023095-4dannjjm	6043	22	derive	derive	VB
cord-023095-4dannjjm	6043	23	a	a	DT
cord-023095-4dannjjm	6043	24	pharmacokinetic	pharmacokinetic	NN
cord-023095-4dannjjm	6043	25	-	-	HYPH
cord-023095-4dannjjm	6043	26	based	base	VBN
cord-023095-4dannjjm	6043	27	dose	dose	NN
cord-023095-4dannjjm	6043	28	for	for	IN
cord-023095-4dannjjm	6043	29	treating	treat	VBG
cord-023095-4dannjjm	6043	30	susceptible	susceptible	JJ
cord-023095-4dannjjm	6043	31	bacteria	bacteria	NNS
cord-023095-4dannjjm	6043	32	.	.	.
cord-023095-4dannjjm	6044	1	Six	six	CD
cord-023095-4dannjjm	6044	2	healthy	healthy	JJ
cord-023095-4dannjjm	6044	3	adult	adult	NN
cord-023095-4dannjjm	6044	4	beagle	beagle	NN
cord-023095-4dannjjm	6044	5	dogs	dog	NNS
cord-023095-4dannjjm	6044	6	were	be	VBD
cord-023095-4dannjjm	6044	7	used	use	VBN
cord-023095-4dannjjm	6044	8	for	for	IN
cord-023095-4dannjjm	6044	9	the	the	DT
cord-023095-4dannjjm	6044	10	study	study	NN
cord-023095-4dannjjm	6044	11	(	(	-LRB-
cord-023095-4dannjjm	6044	12	11.2	11.2	CD
cord-023095-4dannjjm	6044	13	kg	kg	NNS
cord-023095-4dannjjm	6044	14	mean	mean	VBP
cord-023095-4dannjjm	6044	15	weight	weight	NN
cord-023095-4dannjjm	6044	16	)	)	-RRB-
cord-023095-4dannjjm	6044	17	.	.	.
cord-023095-4dannjjm	6045	1	After	after	IN
cord-023095-4dannjjm	6045	2	placing	place	VBG
cord-023095-4dannjjm	6045	3	jugular	jugular	NN
cord-023095-4dannjjm	6045	4	vein	vein	NN
cord-023095-4dannjjm	6045	5	catheters	catheter	NNS
cord-023095-4dannjjm	6045	6	for	for	IN
cord-023095-4dannjjm	6045	7	collecting	collect	VBG
cord-023095-4dannjjm	6045	8	blood	blood	NN
cord-023095-4dannjjm	6045	9	samples	sample	NNS
cord-023095-4dannjjm	6045	10	,	,	,
cord-023095-4dannjjm	6045	11	these	these	DT
cord-023095-4dannjjm	6045	12	dogs	dog	NNS
cord-023095-4dannjjm	6045	13	were	be	VBD
cord-023095-4dannjjm	6045	14	administered	administer	VBN
cord-023095-4dannjjm	6045	15	either	either	CC
cord-023095-4dannjjm	6045	16	a	a	DT
cord-023095-4dannjjm	6045	17	single	single	JJ
cord-023095-4dannjjm	6045	18	oral	oral	JJ
cord-023095-4dannjjm	6045	19	dose	dose	NN
cord-023095-4dannjjm	6045	20	of	of	IN
cord-023095-4dannjjm	6045	21	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	6045	22	(	(	-LRB-
cord-023095-4dannjjm	6045	23	250	250	CD
cord-023095-4dannjjm	6045	24	mg	mg	NN
cord-023095-4dannjjm	6045	25	tablet	tablet	NN
cord-023095-4dannjjm	6045	26	;	;	:
cord-023095-4dannjjm	6045	27	mean	mean	VB
cord-023095-4dannjjm	6045	28	dose	dose	NN
cord-023095-4dannjjm	6045	29	23	23	CD
cord-023095-4dannjjm	6045	30	mg	mg	NNP
cord-023095-4dannjjm	6045	31	/	/	SYM
cord-023095-4dannjjm	6045	32	kg	kg	NNP
cord-023095-4dannjjm	6045	33	)	)	-RRB-
cord-023095-4dannjjm	6045	34	,	,	,
cord-023095-4dannjjm	6045	35	or	or	CC
cord-023095-4dannjjm	6045	36	an	an	DT
cord-023095-4dannjjm	6045	37	intravenous	intravenous	JJ
cord-023095-4dannjjm	6045	38	(	(	-LRB-
cord-023095-4dannjjm	6045	39	IV	IV	NNP
cord-023095-4dannjjm	6045	40	)	)	-RRB-
cord-023095-4dannjjm	6045	41	dose	dose	NN
cord-023095-4dannjjm	6045	42	(	(	-LRB-
cord-023095-4dannjjm	6045	43	10	10	CD
cord-023095-4dannjjm	6045	44	mg	mg	NNP
cord-023095-4dannjjm	6045	45	/	/	SYM
cord-023095-4dannjjm	6045	46	kg	kg	NN
cord-023095-4dannjjm	6045	47	;	;	:
cord-023095-4dannjjm	6045	48	2	2	CD
cord-023095-4dannjjm	6045	49	mg	mg	NNP
cord-023095-4dannjjm	6045	50	/	/	SYM
cord-023095-4dannjjm	6045	51	mL	ml	NN
cord-023095-4dannjjm	6045	52	solution	solution	NN
cord-023095-4dannjjm	6045	53	)	)	-RRB-
cord-023095-4dannjjm	6045	54	.	.	.
cord-023095-4dannjjm	6046	1	A	a	DT
cord-023095-4dannjjm	6046	2	randomized	randomized	JJ
cord-023095-4dannjjm	6046	3	crossover	crossover	NN
cord-023095-4dannjjm	6046	4	design	design	NN
cord-023095-4dannjjm	6046	5	was	be	VBD
cord-023095-4dannjjm	6046	6	used	use	VBN
cord-023095-4dannjjm	6046	7	with	with	IN
cord-023095-4dannjjm	6046	8	a	a	DT
cord-023095-4dannjjm	6046	9	washout	washout	NN
cord-023095-4dannjjm	6046	10	time	time	NN
cord-023095-4dannjjm	6046	11	between	between	IN
cord-023095-4dannjjm	6046	12	treatments	treatment	NNS
cord-023095-4dannjjm	6046	13	.	.	.
cord-023095-4dannjjm	6047	1	Blood	blood	NN
cord-023095-4dannjjm	6047	2	was	be	VBD
cord-023095-4dannjjm	6047	3	collected	collect	VBN
cord-023095-4dannjjm	6047	4	for	for	IN
cord-023095-4dannjjm	6047	5	plasma	plasma	NN
cord-023095-4dannjjm	6047	6	drug	drug	NN
cord-023095-4dannjjm	6047	7	analysis	analysis	NN
cord-023095-4dannjjm	6047	8	for	for	IN
cord-023095-4dannjjm	6047	9	24	24	CD
cord-023095-4dannjjm	6047	10	hours	hour	NNS
cord-023095-4dannjjm	6047	11	.	.	.
cord-023095-4dannjjm	6048	1	Ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	6048	2	concentration	concentration	NN
cord-023095-4dannjjm	6048	3	in	in	IN
cord-023095-4dannjjm	6048	4	plasma	plasma	NN
cord-023095-4dannjjm	6048	5	was	be	VBD
cord-023095-4dannjjm	6048	6	analyzed	analyze	VBN
cord-023095-4dannjjm	6048	7	using	use	VBG
cord-023095-4dannjjm	6048	8	high	high	JJ
cord-023095-4dannjjm	6048	9	pressure	pressure	NN
cord-023095-4dannjjm	6048	10	liquid	liquid	NN
cord-023095-4dannjjm	6048	11	chromatography	chromatography	NN
cord-023095-4dannjjm	6048	12	(	(	-LRB-
cord-023095-4dannjjm	6048	13	HPLC	HPLC	NNP
cord-023095-4dannjjm	6048	14	)	)	-RRB-
cord-023095-4dannjjm	6048	15	and	and	CC
cord-023095-4dannjjm	6048	16	pharmacokinetics	pharmacokinetic	NNS
cord-023095-4dannjjm	6048	17	analyzed	analyze	VBD
cord-023095-4dannjjm	6048	18	using	use	VBG
cord-023095-4dannjjm	6048	19	a	a	DT
cord-023095-4dannjjm	6048	20	computer	computer	NN
cord-023095-4dannjjm	6048	21	program	program	NN
cord-023095-4dannjjm	6048	22	.	.	.
cord-023095-4dannjjm	6049	1	Oral	oral	JJ
cord-023095-4dannjjm	6049	2	absorption	absorption	NN
cord-023095-4dannjjm	6049	3	was	be	VBD
cord-023095-4dannjjm	6049	4	also	also	RB
cord-023095-4dannjjm	6049	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	6049	6	via	via	IN
cord-023095-4dannjjm	6049	7	deconvolution	deconvolution	NN
cord-023095-4dannjjm	6049	8	analysis	analysis	NN
cord-023095-4dannjjm	6049	9	.	.	.
cord-023095-4dannjjm	6050	1	The	the	DT
cord-023095-4dannjjm	6050	2	oral	oral	JJ
cord-023095-4dannjjm	6050	3	dose	dose	NN
cord-023095-4dannjjm	6050	4	was	be	VBD
cord-023095-4dannjjm	6050	5	well	well	RB
cord-023095-4dannjjm	6050	6	-	-	HYPH
cord-023095-4dannjjm	6050	7	tolerated	tolerate	VBN
cord-023095-4dannjjm	6050	8	,	,	,
cord-023095-4dannjjm	6050	9	but	but	CC
cord-023095-4dannjjm	6050	10	the	the	DT
cord-023095-4dannjjm	6050	11	IV	IV	NNP
cord-023095-4dannjjm	6050	12	dose	dose	NN
cord-023095-4dannjjm	6050	13	produced	produce	VBN
cord-023095-4dannjjm	6050	14	transient	transient	JJ
cord-023095-4dannjjm	6050	15	vomiting	vomiting	NN
cord-023095-4dannjjm	6050	16	and	and	CC
cord-023095-4dannjjm	6050	17	depression	depression	NN
cord-023095-4dannjjm	6050	18	in	in	IN
cord-023095-4dannjjm	6050	19	some	some	DT
cord-023095-4dannjjm	6050	20	dogs	dog	NNS
cord-023095-4dannjjm	6050	21	.	.	.
cord-023095-4dannjjm	6051	1	After	after	IN
cord-023095-4dannjjm	6051	2	the	the	DT
cord-023095-4dannjjm	6051	3	oral	oral	JJ
cord-023095-4dannjjm	6051	4	dose	dose	NN
cord-023095-4dannjjm	6051	5	,	,	,
cord-023095-4dannjjm	6051	6	the	the	DT
cord-023095-4dannjjm	6051	7	peak	peak	NN
cord-023095-4dannjjm	6051	8	plasma	plasma	NN
cord-023095-4dannjjm	6051	9	concentration	concentration	NN
cord-023095-4dannjjm	6051	10	(	(	-LRB-
cord-023095-4dannjjm	6051	11	C	C	NNP
cord-023095-4dannjjm	6051	12	MAX	MAX	NNP
cord-023095-4dannjjm	6051	13	)	)	-RRB-
cord-023095-4dannjjm	6051	14	was	be	VBD
cord-023095-4dannjjm	6051	15	4.4	4.4	CD
cord-023095-4dannjjm	6051	16	mg/	mg/	NN
cord-023095-4dannjjm	6051	17	mL	ml	NN
cord-023095-4dannjjm	6052	1	(	(	-LRB-
cord-023095-4dannjjm	6052	2	CV	CV	NNP
cord-023095-4dannjjm	6052	3	55.9	55.9	CD
cord-023095-4dannjjm	6052	4	%	%	NN
cord-023095-4dannjjm	6052	5	)	)	-RRB-
cord-023095-4dannjjm	6052	6	,	,	,
cord-023095-4dannjjm	6052	7	terminal	terminal	JJ
cord-023095-4dannjjm	6052	8	half	half	JJ
cord-023095-4dannjjm	6052	9	-	-	HYPH
cord-023095-4dannjjm	6052	10	life	life	NN
cord-023095-4dannjjm	6052	11	(	(	-LRB-
cord-023095-4dannjjm	6052	12	t1/2	t1/2	NNP
cord-023095-4dannjjm	6052	13	)	)	-RRB-
cord-023095-4dannjjm	6052	14	2.6	2.6	CD
cord-023095-4dannjjm	6052	15	hr	hr	NN
cord-023095-4dannjjm	6053	1	(	(	-LRB-
cord-023095-4dannjjm	6053	2	CV	CV	NNP
cord-023095-4dannjjm	6053	3	10.8	10.8	CD
cord-023095-4dannjjm	6053	4	%	%	NN
cord-023095-4dannjjm	6053	5	)	)	-RRB-
cord-023095-4dannjjm	6053	6	,	,	,
cord-023095-4dannjjm	6053	7	AUC	AUC	NNP
cord-023095-4dannjjm	6053	8	22.5	22.5	CD
cord-023095-4dannjjm	6053	9	mg	mg	NNP
cord-023095-4dannjjm	6053	10	Á	Á	NNP
cord-023095-4dannjjm	6053	11	hr	hr	NN
cord-023095-4dannjjm	6053	12	/	/	SYM
cord-023095-4dannjjm	6053	13	mL	ml	NN
cord-023095-4dannjjm	6054	1	(	(	-LRB-
cord-023095-4dannjjm	6054	2	CV	CV	NNP
cord-023095-4dannjjm	6054	3	62.3	62.3	CD
cord-023095-4dannjjm	6054	4	%	%	NN
cord-023095-4dannjjm	6054	5	)	)	-RRB-
cord-023095-4dannjjm	6054	6	,	,	,
cord-023095-4dannjjm	6054	7	and	and	CC
cord-023095-4dannjjm	6054	8	systemic	systemic	JJ
cord-023095-4dannjjm	6054	9	absorption	absorption	NN
cord-023095-4dannjjm	6054	10	(	(	-LRB-
cord-023095-4dannjjm	6054	11	F	F	NNP
cord-023095-4dannjjm	6054	12	)	)	-RRB-
cord-023095-4dannjjm	6054	13	63.7	63.7	CD
cord-023095-4dannjjm	6054	14	%	%	NN
cord-023095-4dannjjm	6054	15	(	(	-LRB-
cord-023095-4dannjjm	6054	16	CV	CV	NNP
cord-023095-4dannjjm	6054	17	41.6	41.6	CD
cord-023095-4dannjjm	6054	18	%	%	NN
cord-023095-4dannjjm	6054	19	)	)	-RRB-
cord-023095-4dannjjm	6054	20	.	.	.
cord-023095-4dannjjm	6055	1	After	after	IN
cord-023095-4dannjjm	6055	2	the	the	DT
cord-023095-4dannjjm	6055	3	IV	IV	NNP
cord-023095-4dannjjm	6055	4	dose	dose	NN
cord-023095-4dannjjm	6055	5	,	,	,
cord-023095-4dannjjm	6055	6	the	the	DT
cord-023095-4dannjjm	6055	7	t1/2	t1/2	NNP
cord-023095-4dannjjm	6055	8	was	be	VBD
cord-023095-4dannjjm	6055	9	3.7	3.7	CD
cord-023095-4dannjjm	6055	10	hr	hr	NN
cord-023095-4dannjjm	6055	11	(	(	-LRB-
cord-023095-4dannjjm	6055	12	CV	CV	NNP
cord-023095-4dannjjm	6055	13	52.3	52.3	CD
cord-023095-4dannjjm	6055	14	%	%	NN
cord-023095-4dannjjm	6055	15	)	)	-RRB-
cord-023095-4dannjjm	6055	16	,	,	,
cord-023095-4dannjjm	6055	17	systemic	systemic	JJ
cord-023095-4dannjjm	6055	18	clearance	clearance	NN
cord-023095-4dannjjm	6055	19	0.587	0.587	CD
cord-023095-4dannjjm	6056	1	L	L	NNP
cord-023095-4dannjjm	6056	2	/	/	SYM
cord-023095-4dannjjm	6056	3	kg	kg	NNP
cord-023095-4dannjjm	6056	4	/	/	SYM
cord-023095-4dannjjm	6056	5	hr	hr	NN
cord-023095-4dannjjm	6057	1	(	(	-LRB-
cord-023095-4dannjjm	6057	2	CV	CV	NNP
cord-023095-4dannjjm	6057	3	33.9	33.9	CD
cord-023095-4dannjjm	6057	4	%	%	NN
cord-023095-4dannjjm	6057	5	)	)	-RRB-
cord-023095-4dannjjm	6057	6	,	,	,
cord-023095-4dannjjm	6057	7	and	and	CC
cord-023095-4dannjjm	6057	8	volume	volume	NN
cord-023095-4dannjjm	6057	9	of	of	IN
cord-023095-4dannjjm	6057	10	distribution	distribution	NN
cord-023095-4dannjjm	6057	11	2.39	2.39	CD
cord-023095-4dannjjm	6057	12	L	l	NN
cord-023095-4dannjjm	6057	13	/	/	SYM
cord-023095-4dannjjm	6057	14	kg	kg	NNP
cord-023095-4dannjjm	6057	15	(	(	-LRB-
cord-023095-4dannjjm	6057	16	CV	CV	NNP
cord-023095-4dannjjm	6057	17	23.7	23.7	CD
cord-023095-4dannjjm	6057	18	%	%	NN
cord-023095-4dannjjm	6057	19	)	)	-RRB-
cord-023095-4dannjjm	6057	20	.	.	.
cord-023095-4dannjjm	6058	1	After	after	IN
cord-023095-4dannjjm	6058	2	examining	examine	VBG
cord-023095-4dannjjm	6058	3	the	the	DT
cord-023095-4dannjjm	6058	4	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	6058	5	results	result	NNS
cord-023095-4dannjjm	6058	6	from	from	IN
cord-023095-4dannjjm	6058	7	the	the	DT
cord-023095-4dannjjm	6058	8	oral	oral	JJ
cord-023095-4dannjjm	6058	9	dose	dose	NN
cord-023095-4dannjjm	6058	10	,	,	,
cord-023095-4dannjjm	6058	11	it	-PRON-	PRP
cord-023095-4dannjjm	6058	12	was	be	VBD
cord-023095-4dannjjm	6058	13	apparent	apparent	JJ
cord-023095-4dannjjm	6058	14	that	that	IN
cord-023095-4dannjjm	6058	15	oral	oral	JJ
cord-023095-4dannjjm	6058	16	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	6058	17	was	be	VBD
cord-023095-4dannjjm	6058	18	absorbed	absorb	VBN
cord-023095-4dannjjm	6058	19	well	well	RB
cord-023095-4dannjjm	6058	20	in	in	IN
cord-023095-4dannjjm	6058	21	some	some	DT
cord-023095-4dannjjm	6058	22	dogs	dog	NNS
cord-023095-4dannjjm	6058	23	(	(	-LRB-
cord-023095-4dannjjm	6058	24	approximately	approximately	RB
cord-023095-4dannjjm	6058	25	80	80	CD
cord-023095-4dannjjm	6058	26	%	%	NN
cord-023095-4dannjjm	6058	27	)	)	-RRB-
cord-023095-4dannjjm	6058	28	,	,	,
cord-023095-4dannjjm	6058	29	but	but	CC
cord-023095-4dannjjm	6058	30	poorly	poorly	RB
cord-023095-4dannjjm	6058	31	in	in	IN
cord-023095-4dannjjm	6058	32	others	other	NNS
cord-023095-4dannjjm	6058	33	(	(	-LRB-
cord-023095-4dannjjm	6058	34	approximately	approximately	RB
cord-023095-4dannjjm	6058	35	30	30	CD
cord-023095-4dannjjm	6058	36	%	%	NN
cord-023095-4dannjjm	6058	37	)	)	-RRB-
cord-023095-4dannjjm	6058	38	.	.	.
cord-023095-4dannjjm	6059	1	To	to	TO
cord-023095-4dannjjm	6059	2	explore	explore	VB
cord-023095-4dannjjm	6059	3	the	the	DT
cord-023095-4dannjjm	6059	4	factors	factor	NNS
cord-023095-4dannjjm	6059	5	that	that	WDT
cord-023095-4dannjjm	6059	6	may	may	MD
cord-023095-4dannjjm	6059	7	have	have	VB
cord-023095-4dannjjm	6059	8	affected	affect	VBN
cord-023095-4dannjjm	6059	9	oral	oral	JJ
cord-023095-4dannjjm	6059	10	absorption	absorption	NN
cord-023095-4dannjjm	6059	11	,	,	,
cord-023095-4dannjjm	6059	12	two	two	CD
cord-023095-4dannjjm	6059	13	high	high	JJ
cord-023095-4dannjjm	6059	14	absorbers	absorber	NNS
cord-023095-4dannjjm	6059	15	and	and	CC
cord-023095-4dannjjm	6059	16	two	two	CD
cord-023095-4dannjjm	6059	17	low	low	JJ
cord-023095-4dannjjm	6059	18	absorbers	absorber	NNS
cord-023095-4dannjjm	6059	19	were	be	VBD
cord-023095-4dannjjm	6059	20	administered	administer	VBN
cord-023095-4dannjjm	6059	21	an	an	DT
cord-023095-4dannjjm	6059	22	additional	additional	JJ
cord-023095-4dannjjm	6059	23	oral	oral	JJ
cord-023095-4dannjjm	6059	24	dose	dose	NN
cord-023095-4dannjjm	6059	25	as	as	IN
cord-023095-4dannjjm	6059	26	a	a	DT
cord-023095-4dannjjm	6059	27	10	10	CD
cord-023095-4dannjjm	6059	28	mg	mg	NNP
cord-023095-4dannjjm	6059	29	/	/	SYM
cord-023095-4dannjjm	6059	30	mL	ml	NN
cord-023095-4dannjjm	6059	31	solution	solution	NN
cord-023095-4dannjjm	6059	32	(	(	-LRB-
cord-023095-4dannjjm	6059	33	250	250	CD
cord-023095-4dannjjm	6059	34	mg	mg	NN
cord-023095-4dannjjm	6059	35	total	total	JJ
cord-023095-4dannjjm	6059	36	dose	dose	NN
cord-023095-4dannjjm	6059	37	)	)	-RRB-
cord-023095-4dannjjm	6059	38	via	via	IN
cord-023095-4dannjjm	6059	39	gastric	gastric	JJ
cord-023095-4dannjjm	6059	40	tube	tube	NN
cord-023095-4dannjjm	6059	41	.	.	.
cord-023095-4dannjjm	6060	1	After	after	IN
cord-023095-4dannjjm	6060	2	administration	administration	NN
cord-023095-4dannjjm	6060	3	of	of	IN
cord-023095-4dannjjm	6060	4	the	the	DT
cord-023095-4dannjjm	6060	5	oral	oral	JJ
cord-023095-4dannjjm	6060	6	solution	solution	NN
cord-023095-4dannjjm	6060	7	,	,	,
cord-023095-4dannjjm	6060	8	the	the	DT
cord-023095-4dannjjm	6060	9	plasma	plasma	NN
cord-023095-4dannjjm	6060	10	concentrations	concentration	NNS
cord-023095-4dannjjm	6060	11	were	be	VBD
cord-023095-4dannjjm	6060	12	more	more	RBR
cord-023095-4dannjjm	6060	13	uniform	uniform	JJ
cord-023095-4dannjjm	6060	14	and	and	CC
cord-023095-4dannjjm	6060	15	consistent	consistent	JJ
cord-023095-4dannjjm	6060	16	among	among	IN
cord-023095-4dannjjm	6060	17	dogs	dog	NNS
cord-023095-4dannjjm	6060	18	.	.	.
cord-023095-4dannjjm	6061	1	Absorption	absorption	NN
cord-023095-4dannjjm	6061	2	of	of	IN
cord-023095-4dannjjm	6061	3	the	the	DT
cord-023095-4dannjjm	6061	4	oral	oral	JJ
cord-023095-4dannjjm	6061	5	solution	solution	NN
cord-023095-4dannjjm	6061	6	of	of	IN
cord-023095-4dannjjm	6061	7	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	6061	8	was	be	VBD
cord-023095-4dannjjm	6061	9	71.0	71.0	CD
cord-023095-4dannjjm	6061	10	%	%	NN
cord-023095-4dannjjm	6061	11	(	(	-LRB-
cord-023095-4dannjjm	6061	12	CV	CV	NNP
cord-023095-4dannjjm	6061	13	7	7	CD
cord-023095-4dannjjm	6061	14	%	%	NN
cord-023095-4dannjjm	6061	15	)	)	-RRB-
cord-023095-4dannjjm	6061	16	with	with	IN
cord-023095-4dannjjm	6061	17	a	a	DT
cord-023095-4dannjjm	6061	18	t1/2	t1/2	NN
cord-023095-4dannjjm	6061	19	of	of	IN
cord-023095-4dannjjm	6061	20	3.1	3.1	CD
cord-023095-4dannjjm	6061	21	(	(	-LRB-
cord-023095-4dannjjm	6061	22	CV	cv	NN
cord-023095-4dannjjm	6061	23	18.6	18.6	CD
cord-023095-4dannjjm	6061	24	%	%	NN
cord-023095-4dannjjm	6061	25	)	)	-RRB-
cord-023095-4dannjjm	6061	26	hr	hr	NN
cord-023095-4dannjjm	6061	27	and	and	CC
cord-023095-4dannjjm	6061	28	C	C	NNP
cord-023095-4dannjjm	6061	29	MAX	MAX	NNP
cord-023095-4dannjjm	6061	30	of	of	IN
cord-023095-4dannjjm	6061	31	4.67	4.67	CD
cord-023095-4dannjjm	6061	32	mg	mg	NNP
cord-023095-4dannjjm	6061	33	/	/	SYM
cord-023095-4dannjjm	6061	34	mL	ml	NN
cord-023095-4dannjjm	6062	1	(	(	-LRB-
cord-023095-4dannjjm	6062	2	CV	cv	NN
cord-023095-4dannjjm	6062	3	17.6	17.6	CD
cord-023095-4dannjjm	6062	4	%	%	NN
cord-023095-4dannjjm	6062	5	)	)	-RRB-
cord-023095-4dannjjm	6062	6	.	.	.
cord-023095-4dannjjm	6063	1	Therefore	therefore	RB
cord-023095-4dannjjm	6063	2	,	,	,
cord-023095-4dannjjm	6063	3	it	-PRON-	PRP
cord-023095-4dannjjm	6063	4	appears	appear	VBZ
cord-023095-4dannjjm	6063	5	that	that	DT
cord-023095-4dannjjm	6063	6	inconsistent	inconsistent	JJ
cord-023095-4dannjjm	6063	7	oral	oral	JJ
cord-023095-4dannjjm	6063	8	absorption	absorption	NN
cord-023095-4dannjjm	6063	9	of	of	IN
cord-023095-4dannjjm	6063	10	ciprofloxacin	ciprofloxacin	NN
cord-023095-4dannjjm	6063	11	in	in	IN
cord-023095-4dannjjm	6063	12	some	some	DT
cord-023095-4dannjjm	6063	13	dogs	dog	NNS
cord-023095-4dannjjm	6063	14	may	may	MD
cord-023095-4dannjjm	6063	15	be	be	VB
cord-023095-4dannjjm	6063	16	formulation	formulation	NN
cord-023095-4dannjjm	6063	17	-	-	HYPH
cord-023095-4dannjjm	6063	18	dependent	dependent	JJ
cord-023095-4dannjjm	6063	19	,	,	,
cord-023095-4dannjjm	6063	20	and	and	CC
cord-023095-4dannjjm	6063	21	affected	affect	VBN
cord-023095-4dannjjm	6063	22	by	by	IN
cord-023095-4dannjjm	6063	23	tablet	tablet	NN
cord-023095-4dannjjm	6063	24	dissolution	dissolution	NN
cord-023095-4dannjjm	6063	25	in	in	IN
cord-023095-4dannjjm	6063	26	the	the	DT
cord-023095-4dannjjm	6063	27	canine	canine	JJ
cord-023095-4dannjjm	6063	28	small	small	JJ
cord-023095-4dannjjm	6063	29	intestine	intestine	NN
cord-023095-4dannjjm	6063	30	.	.	.
cord-023095-4dannjjm	6064	1	Doses	dose	NNS
cord-023095-4dannjjm	6064	2	were	be	VBD
cord-023095-4dannjjm	6064	3	calculated	calculate	VBN
cord-023095-4dannjjm	6064	4	using	use	VBG
cord-023095-4dannjjm	6064	5	the	the	DT
cord-023095-4dannjjm	6064	6	data	datum	NNS
cord-023095-4dannjjm	6064	7	for	for	IN
cord-023095-4dannjjm	6064	8	oral	oral	JJ
cord-023095-4dannjjm	6064	9	tablets	tablet	NNS
cord-023095-4dannjjm	6064	10	in	in	IN
cord-023095-4dannjjm	6064	11	these	these	DT
cord-023095-4dannjjm	6064	12	dogs	dog	NNS
cord-023095-4dannjjm	6064	13	.	.	.
cord-023095-4dannjjm	6065	1	The	the	DT
cord-023095-4dannjjm	6065	2	pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	6065	3	-	-	HYPH
cord-023095-4dannjjm	6065	4	pharmacodynamic	pharmacodynamic	JJ
cord-023095-4dannjjm	6065	5	(	(	-LRB-
cord-023095-4dannjjm	6065	6	PK	PK	NNP
cord-023095-4dannjjm	6065	7	-	-	HYPH
cord-023095-4dannjjm	6065	8	PD	PD	NNP
cord-023095-4dannjjm	6065	9	)	)	-RRB-
cord-023095-4dannjjm	6065	10	target	target	NN
cord-023095-4dannjjm	6065	11	was	be	VBD
cord-023095-4dannjjm	6065	12	an	an	DT
cord-023095-4dannjjm	6065	13	AUC/	auc/	JJ
cord-023095-4dannjjm	6065	14	MIC	MIC	NNP
cord-023095-4dannjjm	6065	15	ratio	ratio	NN
cord-023095-4dannjjm	6065	16	of	of	IN
cord-023095-4dannjjm	6065	17	100	100	CD
cord-023095-4dannjjm	6065	18	.	.	.
cord-023095-4dannjjm	6066	1	Because	because	IN
cord-023095-4dannjjm	6066	2	of	of	IN
cord-023095-4dannjjm	6066	3	the	the	DT
cord-023095-4dannjjm	6066	4	wide	wide	JJ
cord-023095-4dannjjm	6066	5	range	range	NN
cord-023095-4dannjjm	6066	6	in	in	IN
cord-023095-4dannjjm	6066	7	oral	oral	JJ
cord-023095-4dannjjm	6066	8	absorption	absorption	NN
cord-023095-4dannjjm	6066	9	of	of	IN
cord-023095-4dannjjm	6066	10	tablets	tablet	NNS
cord-023095-4dannjjm	6066	11	,	,	,
cord-023095-4dannjjm	6066	12	a	a	DT
cord-023095-4dannjjm	6066	13	dose	dose	NN
cord-023095-4dannjjm	6066	14	to	to	TO
cord-023095-4dannjjm	6066	15	reach	reach	VB
cord-023095-4dannjjm	6066	16	the	the	DT
cord-023095-4dannjjm	6066	17	PK	PK	NNP
cord-023095-4dannjjm	6066	18	-	-	HYPH
cord-023095-4dannjjm	6066	19	PD	PD	NNP
cord-023095-4dannjjm	6066	20	target	target	NN
cord-023095-4dannjjm	6066	21	ranged	range	VBN
cord-023095-4dannjjm	6066	22	from	from	IN
cord-023095-4dannjjm	6066	23	Canine	canine	JJ
cord-023095-4dannjjm	6066	24	distemper	distemper	NN
cord-023095-4dannjjm	6066	25	(	(	-LRB-
cord-023095-4dannjjm	6066	26	CD	CD	NNP
cord-023095-4dannjjm	6066	27	)	)	-RRB-
cord-023095-4dannjjm	6066	28	is	be	VBZ
cord-023095-4dannjjm	6066	29	a	a	DT
cord-023095-4dannjjm	6066	30	highly	highly	RB
cord-023095-4dannjjm	6066	31	contagious	contagious	JJ
cord-023095-4dannjjm	6066	32	,	,	,
cord-023095-4dannjjm	6066	33	acute	acute	JJ
cord-023095-4dannjjm	6066	34	or	or	CC
cord-023095-4dannjjm	6066	35	subacute	subacute	JJ
cord-023095-4dannjjm	6066	36	systemic	systemic	JJ
cord-023095-4dannjjm	6066	37	viral	viral	JJ
cord-023095-4dannjjm	6066	38	disease	disease	NN
cord-023095-4dannjjm	6066	39	of	of	IN
cord-023095-4dannjjm	6066	40	dogs	dog	NNS
cord-023095-4dannjjm	6066	41	and	and	CC
cord-023095-4dannjjm	6066	42	other	other	JJ
cord-023095-4dannjjm	6066	43	carnivores	carnivore	NNS
cord-023095-4dannjjm	6066	44	which	which	WDT
cord-023095-4dannjjm	6066	45	can	can	MD
cord-023095-4dannjjm	6066	46	be	be	VB
cord-023095-4dannjjm	6066	47	controlled	control	VBN
cord-023095-4dannjjm	6066	48	efficiently	efficiently	RB
cord-023095-4dannjjm	6066	49	by	by	IN
cord-023095-4dannjjm	6066	50	the	the	DT
cord-023095-4dannjjm	6066	51	use	use	NN
cord-023095-4dannjjm	6066	52	of	of	IN
cord-023095-4dannjjm	6066	53	modified	modify	VBN
cord-023095-4dannjjm	6066	54	live	live	NN
cord-023095-4dannjjm	6066	55	-	-	HYPH
cord-023095-4dannjjm	6066	56	virus	virus	NN
cord-023095-4dannjjm	6066	57	(	(	-LRB-
cord-023095-4dannjjm	6066	58	MLV	MLV	NNP
cord-023095-4dannjjm	6066	59	)	)	-RRB-
cord-023095-4dannjjm	6066	60	vaccines	vaccine	NNS
cord-023095-4dannjjm	6066	61	.	.	.
cord-023095-4dannjjm	6067	1	However	however	RB
cord-023095-4dannjjm	6067	2	,	,	,
cord-023095-4dannjjm	6067	3	MLV	MLV	NNP
cord-023095-4dannjjm	6067	4	strains	strain	NNS
cord-023095-4dannjjm	6067	5	do	do	VBP
cord-023095-4dannjjm	6067	6	cross	cross	NN
cord-023095-4dannjjm	6067	7	-	-	VB
cord-023095-4dannjjm	6067	8	react	react	VB
cord-023095-4dannjjm	6067	9	with	with	IN
cord-023095-4dannjjm	6067	10	molecular	molecular	JJ
cord-023095-4dannjjm	6067	11	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	6067	12	tests	test	NNS
cord-023095-4dannjjm	6067	13	and	and	CC
cord-023095-4dannjjm	6067	14	cause	cause	VB
cord-023095-4dannjjm	6067	15	significant	significant	JJ
cord-023095-4dannjjm	6067	16	confusion	confusion	NN
cord-023095-4dannjjm	6067	17	for	for	IN
cord-023095-4dannjjm	6067	18	clinicians	clinician	NNS
cord-023095-4dannjjm	6067	19	.	.	.
cord-023095-4dannjjm	6068	1	The	the	DT
cord-023095-4dannjjm	6068	2	purpose	purpose	NN
cord-023095-4dannjjm	6068	3	of	of	IN
cord-023095-4dannjjm	6068	4	this	this	DT
cord-023095-4dannjjm	6068	5	study	study	NN
cord-023095-4dannjjm	6068	6	was	be	VBD
cord-023095-4dannjjm	6068	7	to	to	TO
cord-023095-4dannjjm	6068	8	use	use	VB
cord-023095-4dannjjm	6068	9	quantitative	quantitative	JJ
cord-023095-4dannjjm	6068	10	real	real	JJ
cord-023095-4dannjjm	6068	11	-	-	HYPH
cord-023095-4dannjjm	6068	12	time	time	NN
cord-023095-4dannjjm	6068	13	PCR	PCR	NNP
cord-023095-4dannjjm	6068	14	viral	viral	JJ
cord-023095-4dannjjm	6068	15	load	load	NN
cord-023095-4dannjjm	6068	16	information	information	NN
cord-023095-4dannjjm	6068	17	to	to	TO
cord-023095-4dannjjm	6068	18	differentiate	differentiate	VB
cord-023095-4dannjjm	6068	19	between	between	IN
cord-023095-4dannjjm	6068	20	vaccine	vaccine	NN
cord-023095-4dannjjm	6068	21	virus	virus	NN
cord-023095-4dannjjm	6068	22	used	use	VBN
cord-023095-4dannjjm	6068	23	in	in	IN
cord-023095-4dannjjm	6068	24	MLV	MLV	NNP
cord-023095-4dannjjm	6068	25	vaccines	vaccine	NNS
cord-023095-4dannjjm	6068	26	and	and	CC
cord-023095-4dannjjm	6068	27	wildtype	wildtype	JJ
cord-023095-4dannjjm	6068	28	infections	infection	NNS
cord-023095-4dannjjm	6068	29	in	in	IN
cord-023095-4dannjjm	6068	30	dogs	dog	NNS
cord-023095-4dannjjm	6068	31	.	.	.
cord-023095-4dannjjm	6069	1	A	a	DT
cord-023095-4dannjjm	6069	2	real	real	JJ
cord-023095-4dannjjm	6069	3	-	-	HYPH
cord-023095-4dannjjm	6069	4	time	time	NN
cord-023095-4dannjjm	6069	5	PCR	pcr	NN
cord-023095-4dannjjm	6069	6	test	test	NN
cord-023095-4dannjjm	6069	7	for	for	IN
cord-023095-4dannjjm	6069	8	CD	cd	NN
cord-023095-4dannjjm	6069	9	virus	virus	NN
cord-023095-4dannjjm	6069	10	(	(	-LRB-
cord-023095-4dannjjm	6069	11	CDV	CDV	NNP
cord-023095-4dannjjm	6069	12	)	)	-RRB-
cord-023095-4dannjjm	6069	13	based	base	VBN
cord-023095-4dannjjm	6069	14	on	on	IN
cord-023095-4dannjjm	6069	15	the	the	DT
cord-023095-4dannjjm	6069	16	P	p	NN
cord-023095-4dannjjm	6069	17	gene	gene	NN
cord-023095-4dannjjm	6069	18	for	for	IN
cord-023095-4dannjjm	6069	19	phosphoprotein	phosphoprotein	NN
cord-023095-4dannjjm	6069	20	was	be	VBD
cord-023095-4dannjjm	6069	21	used	use	VBN
cord-023095-4dannjjm	6069	22	to	to	TO
cord-023095-4dannjjm	6069	23	determine	determine	VB
cord-023095-4dannjjm	6069	24	viral	viral	JJ
cord-023095-4dannjjm	6069	25	loads	load	NNS
cord-023095-4dannjjm	6069	26	in	in	IN
cord-023095-4dannjjm	6069	27	vaccinated	vaccinated	JJ
cord-023095-4dannjjm	6069	28	and	and	CC
cord-023095-4dannjjm	6069	29	wildtype	wildtype	JJ
cord-023095-4dannjjm	6069	30	infected	infected	JJ
cord-023095-4dannjjm	6069	31	animals	animal	NNS
cord-023095-4dannjjm	6069	32	.	.	.
cord-023095-4dannjjm	6070	1	A	a	DT
cord-023095-4dannjjm	6070	2	total	total	NN
cord-023095-4dannjjm	6070	3	of	of	IN
cord-023095-4dannjjm	6070	4	158	158	CD
cord-023095-4dannjjm	6070	5	respiratory	respiratory	JJ
cord-023095-4dannjjm	6070	6	mucosal	mucosal	JJ
cord-023095-4dannjjm	6070	7	swab	swab	NN
cord-023095-4dannjjm	6070	8	samples	sample	NNS
cord-023095-4dannjjm	6070	9	from	from	IN
cord-023095-4dannjjm	6070	10	MLV	MLV	NNP
cord-023095-4dannjjm	6070	11	vaccinated	vaccinated	JJ
cord-023095-4dannjjm	6070	12	and	and	CC
cord-023095-4dannjjm	6070	13	asymptomatic	asymptomatic	JJ
cord-023095-4dannjjm	6070	14	dogs	dog	NNS
cord-023095-4dannjjm	6070	15	were	be	VBD
cord-023095-4dannjjm	6070	16	obtained	obtain	VBN
cord-023095-4dannjjm	6070	17	within	within	IN
cord-023095-4dannjjm	6070	18	the	the	DT
cord-023095-4dannjjm	6070	19	first	first	JJ
cord-023095-4dannjjm	6070	20	3	3	CD
cord-023095-4dannjjm	6070	21	weeks	week	NNS
cord-023095-4dannjjm	6070	22	after	after	IN
cord-023095-4dannjjm	6070	23	MLV	MLV	NNP
cord-023095-4dannjjm	6070	24	vaccination	vaccination	NN
cord-023095-4dannjjm	6070	25	.	.	.
cord-023095-4dannjjm	6071	1	Based	base	VBN
cord-023095-4dannjjm	6071	2	on	on	IN
cord-023095-4dannjjm	6071	3	the	the	DT
cord-023095-4dannjjm	6071	4	viral	viral	JJ
cord-023095-4dannjjm	6071	5	load	load	NN
cord-023095-4dannjjm	6071	6	in	in	IN
cord-023095-4dannjjm	6071	7	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	6071	8	animals	animal	NNS
cord-023095-4dannjjm	6071	9	,	,	,
cord-023095-4dannjjm	6071	10	a	a	DT
cord-023095-4dannjjm	6071	11	cutoff	cutoff	NN
cord-023095-4dannjjm	6071	12	value	value	NN
cord-023095-4dannjjm	6071	13	was	be	VBD
cord-023095-4dannjjm	6071	14	established	establish	VBN
cord-023095-4dannjjm	6071	15	for	for	IN
cord-023095-4dannjjm	6071	16	the	the	DT
cord-023095-4dannjjm	6071	17	differentiation	differentiation	NN
cord-023095-4dannjjm	6071	18	of	of	IN
cord-023095-4dannjjm	6071	19	dogs	dog	NNS
cord-023095-4dannjjm	6071	20	with	with	IN
cord-023095-4dannjjm	6071	21	clinical	clinical	JJ
cord-023095-4dannjjm	6071	22	signs	sign	NNS
cord-023095-4dannjjm	6071	23	of	of	IN
cord-023095-4dannjjm	6071	24	respiratory	respiratory	JJ
cord-023095-4dannjjm	6071	25	distress	distress	NN
cord-023095-4dannjjm	6071	26	and	and	CC
cord-023095-4dannjjm	6071	27	presumably	presumably	RB
cord-023095-4dannjjm	6071	28	infected	infect	VBN
cord-023095-4dannjjm	6071	29	with	with	IN
cord-023095-4dannjjm	6071	30	a	a	DT
cord-023095-4dannjjm	6071	31	wildtype	wildtype	JJ
cord-023095-4dannjjm	6071	32	strain	strain	NN
cord-023095-4dannjjm	6071	33	of	of	IN
cord-023095-4dannjjm	6071	34	CDV	CDV	NNP
cord-023095-4dannjjm	6071	35	.	.	.
cord-023095-4dannjjm	6072	1	Two	two	CD
cord-023095-4dannjjm	6072	2	hundred	hundred	CD
cord-023095-4dannjjm	6072	3	clinical	clinical	JJ
cord-023095-4dannjjm	6072	4	cases	case	NNS
cord-023095-4dannjjm	6072	5	with	with	IN
cord-023095-4dannjjm	6072	6	known	know	VBN
cord-023095-4dannjjm	6072	7	clinical	clinical	JJ
cord-023095-4dannjjm	6072	8	and	and	CC
cord-023095-4dannjjm	6072	9	vaccination	vaccination	NN
cord-023095-4dannjjm	6072	10	histories	history	NNS
cord-023095-4dannjjm	6072	11	were	be	VBD
cord-023095-4dannjjm	6072	12	analyzed	analyze	VBN
cord-023095-4dannjjm	6072	13	to	to	TO
cord-023095-4dannjjm	6072	14	validate	validate	VB
cord-023095-4dannjjm	6072	15	the	the	DT
cord-023095-4dannjjm	6072	16	cutoff	cutoff	NN
cord-023095-4dannjjm	6072	17	value	value	NN
cord-023095-4dannjjm	6072	18	.	.	.
cord-023095-4dannjjm	6073	1	The	the	DT
cord-023095-4dannjjm	6073	2	CDV	CDV	NNP
cord-023095-4dannjjm	6073	3	real	real	JJ
cord-023095-4dannjjm	6073	4	-	-	HYPH
cord-023095-4dannjjm	6073	5	time	time	NN
cord-023095-4dannjjm	6073	6	PCR	PCR	NNP
cord-023095-4dannjjm	6073	7	proved	prove	VBD
cord-023095-4dannjjm	6073	8	to	to	TO
cord-023095-4dannjjm	6073	9	be	be	VB
cord-023095-4dannjjm	6073	10	of	of	IN
cord-023095-4dannjjm	6073	11	high	high	JJ
cord-023095-4dannjjm	6073	12	analytical	analytical	JJ
cord-023095-4dannjjm	6073	13	and	and	CC
cord-023095-4dannjjm	6073	14	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	6073	15	sensitivity	sensitivity	NN
cord-023095-4dannjjm	6073	16	:	:	:
cord-023095-4dannjjm	6073	17	A	a	DT
cord-023095-4dannjjm	6073	18	standard	standard	JJ
cord-023095-4dannjjm	6073	19	curve	curve	NN
cord-023095-4dannjjm	6073	20	was	be	VBD
cord-023095-4dannjjm	6073	21	established	establish	VBN
cord-023095-4dannjjm	6073	22	using	use	VBG
cord-023095-4dannjjm	6073	23	known	know	VBN
cord-023095-4dannjjm	6073	24	numbers	number	NNS
cord-023095-4dannjjm	6073	25	of	of	IN
cord-023095-4dannjjm	6073	26	CDV	CDV	NNP
cord-023095-4dannjjm	6073	27	molecules	molecule	NNS
cord-023095-4dannjjm	6073	28	to	to	TO
cord-023095-4dannjjm	6073	29	allow	allow	VB
cord-023095-4dannjjm	6073	30	absolute	absolute	JJ
cord-023095-4dannjjm	6073	31	quantitative	quantitative	JJ
cord-023095-4dannjjm	6073	32	CDV	CDV	NNP
cord-023095-4dannjjm	6073	33	viral	viral	JJ
cord-023095-4dannjjm	6073	34	load	load	NN
cord-023095-4dannjjm	6073	35	data	datum	NNS
cord-023095-4dannjjm	6073	36	.	.	.
cord-023095-4dannjjm	6074	1	The	the	DT
cord-023095-4dannjjm	6074	2	limit	limit	NN
cord-023095-4dannjjm	6074	3	of	of	IN
cord-023095-4dannjjm	6074	4	detection	detection	NN
cord-023095-4dannjjm	6074	5	was	be	VBD
cord-023095-4dannjjm	6074	6	in	in	IN
cord-023095-4dannjjm	6074	7	the	the	DT
cord-023095-4dannjjm	6074	8	single	single	JJ
cord-023095-4dannjjm	6074	9	molecule	molecule	NN
cord-023095-4dannjjm	6074	10	range	range	NN
cord-023095-4dannjjm	6074	11	while	while	IN
cord-023095-4dannjjm	6074	12	the	the	DT
cord-023095-4dannjjm	6074	13	limit	limit	NN
cord-023095-4dannjjm	6074	14	of	of	IN
cord-023095-4dannjjm	6074	15	quantitation	quantitation	NN
cord-023095-4dannjjm	6074	16	was	be	VBD
cord-023095-4dannjjm	6074	17	established	establish	VBN
cord-023095-4dannjjm	6074	18	at	at	IN
cord-023095-4dannjjm	6074	19	around	around	RB
cord-023095-4dannjjm	6074	20	10	10	CD
cord-023095-4dannjjm	6074	21	molecules	molecule	NNS
cord-023095-4dannjjm	6074	22	per	per	IN
cord-023095-4dannjjm	6074	23	PCR	PCR	NNP
cord-023095-4dannjjm	6074	24	reaction	reaction	NN
cord-023095-4dannjjm	6074	25	.	.	.
cord-023095-4dannjjm	6075	1	A	a	DT
cord-023095-4dannjjm	6075	2	comparison	comparison	NN
cord-023095-4dannjjm	6075	3	to	to	IN
cord-023095-4dannjjm	6075	4	IFA	IFA	NNP
cord-023095-4dannjjm	6075	5	showed	show	VBD
cord-023095-4dannjjm	6075	6	real	real	JJ
cord-023095-4dannjjm	6075	7	-	-	HYPH
cord-023095-4dannjjm	6075	8	time	time	NN
cord-023095-4dannjjm	6075	9	PCR	PCR	NNP
cord-023095-4dannjjm	6075	10	to	to	TO
cord-023095-4dannjjm	6075	11	be	be	VB
cord-023095-4dannjjm	6075	12	30	30	CD
cord-023095-4dannjjm	6075	13	%	%	NN
cord-023095-4dannjjm	6075	14	more	more	RBR
cord-023095-4dannjjm	6075	15	sensitive	sensitive	JJ
cord-023095-4dannjjm	6075	16	.	.	.
cord-023095-4dannjjm	6076	1	The	the	DT
cord-023095-4dannjjm	6076	2	CDV	CDV	NNP
cord-023095-4dannjjm	6076	3	viral	viral	JJ
cord-023095-4dannjjm	6076	4	load	load	NN
cord-023095-4dannjjm	6076	5	in	in	IN
cord-023095-4dannjjm	6076	6	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	6076	7	animals	animal	NNS
cord-023095-4dannjjm	6076	8	averaged	average	VBD
cord-023095-4dannjjm	6076	9	26,738	26,738	CD
cord-023095-4dannjjm	6076	10	viral	viral	JJ
cord-023095-4dannjjm	6076	11	particles	particle	NNS
cord-023095-4dannjjm	6076	12	per	per	IN
cord-023095-4dannjjm	6076	13	swab	swab	NN
cord-023095-4dannjjm	6076	14	.	.	.
cord-023095-4dannjjm	6077	1	A	a	DT
cord-023095-4dannjjm	6077	2	cutoff	cutoff	NN
cord-023095-4dannjjm	6077	3	value	value	NN
cord-023095-4dannjjm	6077	4	of	of	IN
cord-023095-4dannjjm	6077	5	107,903	107,903	CD
cord-023095-4dannjjm	6077	6	viral	viral	JJ
cord-023095-4dannjjm	6077	7	particles	particle	NNS
cord-023095-4dannjjm	6077	8	was	be	VBD
cord-023095-4dannjjm	6077	9	calculated	calculate	VBN
cord-023095-4dannjjm	6077	10	by	by	IN
cord-023095-4dannjjm	6077	11	adding	add	VBG
cord-023095-4dannjjm	6077	12	3	3	CD
cord-023095-4dannjjm	6077	13	standard	standard	JJ
cord-023095-4dannjjm	6077	14	deviations	deviation	NNS
cord-023095-4dannjjm	6077	15	to	to	IN
cord-023095-4dannjjm	6077	16	the	the	DT
cord-023095-4dannjjm	6077	17	average	average	JJ
cord-023095-4dannjjm	6077	18	value	value	NN
cord-023095-4dannjjm	6077	19	.	.	.
cord-023095-4dannjjm	6078	1	This	this	DT
cord-023095-4dannjjm	6078	2	cutoff	cutoff	NN
cord-023095-4dannjjm	6078	3	value	value	NN
cord-023095-4dannjjm	6078	4	correctly	correctly	RB
cord-023095-4dannjjm	6078	5	detected	detect	VBD
cord-023095-4dannjjm	6078	6	95.2	95.2	CD
cord-023095-4dannjjm	6078	7	%	%	NN
cord-023095-4dannjjm	6078	8	of	of	IN
cord-023095-4dannjjm	6078	9	the	the	DT
cord-023095-4dannjjm	6078	10	vaccinated	vaccinate	VBN
cord-023095-4dannjjm	6078	11	samples	sample	NNS
cord-023095-4dannjjm	6078	12	.	.	.
cord-023095-4dannjjm	6079	1	Acutely	acutely	RB
cord-023095-4dannjjm	6079	2	infected	infected	JJ
cord-023095-4dannjjm	6079	3	dogs	dog	NNS
cord-023095-4dannjjm	6079	4	with	with	IN
cord-023095-4dannjjm	6079	5	CDV	CDV	NNP
cord-023095-4dannjjm	6079	6	compatible	compatible	JJ
cord-023095-4dannjjm	6079	7	clinical	clinical	JJ
cord-023095-4dannjjm	6079	8	signs	sign	NNS
cord-023095-4dannjjm	6079	9	have	have	VBP
cord-023095-4dannjjm	6079	10	high	high	JJ
cord-023095-4dannjjm	6079	11	viral	viral	JJ
cord-023095-4dannjjm	6079	12	loads	load	NNS
cord-023095-4dannjjm	6079	13	normally	normally	RB
cord-023095-4dannjjm	6079	14	several	several	JJ
cord-023095-4dannjjm	6079	15	logs	log	NNS
cord-023095-4dannjjm	6079	16	higher	high	JJR
cord-023095-4dannjjm	6079	17	than	than	IN
cord-023095-4dannjjm	6079	18	the	the	DT
cord-023095-4dannjjm	6079	19	cutoff	cutoff	NN
cord-023095-4dannjjm	6079	20	value	value	NN
cord-023095-4dannjjm	6079	21	.	.	.
cord-023095-4dannjjm	6080	1	In	in	IN
cord-023095-4dannjjm	6080	2	dogs	dog	NNS
cord-023095-4dannjjm	6080	3	with	with	IN
cord-023095-4dannjjm	6080	4	clinical	clinical	JJ
cord-023095-4dannjjm	6080	5	distress	distress	NN
cord-023095-4dannjjm	6080	6	,	,	,
cord-023095-4dannjjm	6080	7	recent	recent	JJ
cord-023095-4dannjjm	6080	8	CDV	CDV	NNP
cord-023095-4dannjjm	6080	9	MLV	MLV	NNP
cord-023095-4dannjjm	6080	10	vaccination	vaccination	NN
cord-023095-4dannjjm	6080	11	but	but	CC
cord-023095-4dannjjm	6080	12	viral	viral	JJ
cord-023095-4dannjjm	6080	13	loads	load	NNS
cord-023095-4dannjjm	6080	14	below	below	IN
cord-023095-4dannjjm	6080	15	the	the	DT
cord-023095-4dannjjm	6080	16	cutoff	cutoff	NN
cord-023095-4dannjjm	6080	17	value	value	NN
cord-023095-4dannjjm	6080	18	,	,	,
cord-023095-4dannjjm	6080	19	other	other	JJ
cord-023095-4dannjjm	6080	20	infectious	infectious	JJ
cord-023095-4dannjjm	6080	21	agents	agent	NNS
cord-023095-4dannjjm	6080	22	were	be	VBD
cord-023095-4dannjjm	6080	23	detected	detect	VBN
cord-023095-4dannjjm	6080	24	by	by	IN
cord-023095-4dannjjm	6080	25	using	use	VBG
cord-023095-4dannjjm	6080	26	a	a	DT
cord-023095-4dannjjm	6080	27	panel	panel	NN
cord-023095-4dannjjm	6080	28	of	of	IN
cord-023095-4dannjjm	6080	29	real	real	JJ
cord-023095-4dannjjm	6080	30	-	-	HYPH
cord-023095-4dannjjm	6080	31	time	time	NN
cord-023095-4dannjjm	6080	32	PCR	PCR	NNP
cord-023095-4dannjjm	6080	33	tests	test	NNS
cord-023095-4dannjjm	6080	34	.	.	.
cord-023095-4dannjjm	6081	1	Testing	test	VBG
cord-023095-4dannjjm	6081	2	additional	additional	JJ
cord-023095-4dannjjm	6081	3	infectious	infectious	JJ
cord-023095-4dannjjm	6081	4	agents	agent	NNS
cord-023095-4dannjjm	6081	5	in	in	IN
cord-023095-4dannjjm	6081	6	clinical	clinical	JJ
cord-023095-4dannjjm	6081	7	settings	setting	NNS
cord-023095-4dannjjm	6081	8	is	be	VBZ
cord-023095-4dannjjm	6081	9	important	important	JJ
cord-023095-4dannjjm	6081	10	in	in	IN
cord-023095-4dannjjm	6081	11	order	order	NN
cord-023095-4dannjjm	6081	12	to	to	TO
cord-023095-4dannjjm	6081	13	explain	explain	VB
cord-023095-4dannjjm	6081	14	clinical	clinical	JJ
cord-023095-4dannjjm	6081	15	signs	sign	NNS
cord-023095-4dannjjm	6081	16	when	when	WRB
cord-023095-4dannjjm	6081	17	viral	viral	JJ
cord-023095-4dannjjm	6081	18	loads	load	NNS
cord-023095-4dannjjm	6081	19	below	below	IN
cord-023095-4dannjjm	6081	20	cutoff	cutoff	NN
cord-023095-4dannjjm	6081	21	values	value	NNS
cord-023095-4dannjjm	6081	22	indicate	indicate	VBP
cord-023095-4dannjjm	6081	23	that	that	IN
cord-023095-4dannjjm	6081	24	CDV	CDV	NNP
cord-023095-4dannjjm	6081	25	is	be	VBZ
cord-023095-4dannjjm	6081	26	not	not	RB
cord-023095-4dannjjm	6081	27	the	the	DT
cord-023095-4dannjjm	6081	28	cause	cause	NN
cord-023095-4dannjjm	6081	29	of	of	IN
cord-023095-4dannjjm	6081	30	clinical	clinical	JJ
cord-023095-4dannjjm	6081	31	signs	sign	NNS
cord-023095-4dannjjm	6081	32	.	.	.
cord-023095-4dannjjm	6082	1	In	in	IN
cord-023095-4dannjjm	6082	2	conclusion	conclusion	NN
cord-023095-4dannjjm	6082	3	,	,	,
cord-023095-4dannjjm	6082	4	quantitative	quantitative	JJ
cord-023095-4dannjjm	6082	5	real	real	JJ
cord-023095-4dannjjm	6082	6	-	-	HYPH
cord-023095-4dannjjm	6082	7	time	time	NN
cord-023095-4dannjjm	6082	8	PCR	PCR	NNP
cord-023095-4dannjjm	6082	9	is	be	VBZ
cord-023095-4dannjjm	6082	10	a	a	DT
cord-023095-4dannjjm	6082	11	sensitive	sensitive	JJ
cord-023095-4dannjjm	6082	12	,	,	,
cord-023095-4dannjjm	6082	13	rapid	rapid	JJ
cord-023095-4dannjjm	6082	14	and	and	CC
cord-023095-4dannjjm	6082	15	reliable	reliable	JJ
cord-023095-4dannjjm	6082	16	test	test	NN
cord-023095-4dannjjm	6082	17	regardless	regardless	RB
cord-023095-4dannjjm	6082	18	of	of	IN
cord-023095-4dannjjm	6082	19	recent	recent	JJ
cord-023095-4dannjjm	6082	20	vaccination	vaccination	NN
cord-023095-4dannjjm	6082	21	.	.	.
cord-023095-4dannjjm	6083	1	The	the	DT
cord-023095-4dannjjm	6083	2	use	use	NN
cord-023095-4dannjjm	6083	3	of	of	IN
cord-023095-4dannjjm	6083	4	a	a	DT
cord-023095-4dannjjm	6083	5	cutoff	cutoff	NN
cord-023095-4dannjjm	6083	6	value	value	NN
cord-023095-4dannjjm	6083	7	will	will	MD
cord-023095-4dannjjm	6083	8	be	be	VB
cord-023095-4dannjjm	6083	9	of	of	IN
cord-023095-4dannjjm	6083	10	significant	significant	JJ
cord-023095-4dannjjm	6083	11	help	help	NN
cord-023095-4dannjjm	6083	12	to	to	TO
cord-023095-4dannjjm	6083	13	discriminate	discriminate	VB
cord-023095-4dannjjm	6083	14	between	between	IN
cord-023095-4dannjjm	6083	15	vaccine	vaccine	NN
cord-023095-4dannjjm	6083	16	interference	interference	NN
cord-023095-4dannjjm	6083	17	and	and	CC
cord-023095-4dannjjm	6083	18	wildtype	wildtype	JJ
cord-023095-4dannjjm	6083	19	infection	infection	NN
cord-023095-4dannjjm	6083	20	in	in	IN
cord-023095-4dannjjm	6083	21	clinical	clinical	JJ
cord-023095-4dannjjm	6083	22	settings	setting	NNS
cord-023095-4dannjjm	6083	23	.	.	.
cord-023095-4dannjjm	6084	1	Feline	feline	JJ
cord-023095-4dannjjm	6084	2	ureteral	ureteral	JJ
cord-023095-4dannjjm	6084	3	obstructions	obstruction	NNS
cord-023095-4dannjjm	6084	4	are	be	VBP
cord-023095-4dannjjm	6084	5	a	a	DT
cord-023095-4dannjjm	6084	6	common	common	JJ
cord-023095-4dannjjm	6084	7	urinary	urinary	JJ
cord-023095-4dannjjm	6084	8	dilemma	dilemma	NN
cord-023095-4dannjjm	6084	9	and	and	CC
cord-023095-4dannjjm	6084	10	traditional	traditional	JJ
cord-023095-4dannjjm	6084	11	therapy	therapy	NN
cord-023095-4dannjjm	6084	12	is	be	VBZ
cord-023095-4dannjjm	6084	13	associated	associate	VBN
cord-023095-4dannjjm	6084	14	with	with	IN
cord-023095-4dannjjm	6084	15	substantial	substantial	JJ
cord-023095-4dannjjm	6084	16	morbidity	morbidity	NN
cord-023095-4dannjjm	6084	17	/	/	SYM
cord-023095-4dannjjm	6084	18	mortality	mortality	NN
cord-023095-4dannjjm	6084	19	.	.	.
cord-023095-4dannjjm	6085	1	Feline	feline	JJ
cord-023095-4dannjjm	6085	2	nephrostomy	nephrostomy	JJ
cord-023095-4dannjjm	6085	3	tubes	tube	NNS
cord-023095-4dannjjm	6085	4	are	be	VBP
cord-023095-4dannjjm	6085	5	reported	report	VBN
cord-023095-4dannjjm	6085	6	as	as	IN
cord-023095-4dannjjm	6085	7	being	be	VBG
cord-023095-4dannjjm	6085	8	effective	effective	JJ
cord-023095-4dannjjm	6085	9	when	when	WRB
cord-023095-4dannjjm	6085	10	pelvic	pelvic	JJ
cord-023095-4dannjjm	6085	11	drainage	drainage	NN
cord-023095-4dannjjm	6085	12	is	be	VBZ
cord-023095-4dannjjm	6085	13	required	require	VBN
cord-023095-4dannjjm	6085	14	.	.	.
cord-023095-4dannjjm	6086	1	The	the	DT
cord-023095-4dannjjm	6086	2	biggest	big	JJS
cord-023095-4dannjjm	6086	3	limitation	limitation	NN
cord-023095-4dannjjm	6086	4	is	be	VBZ
cord-023095-4dannjjm	6086	5	externalized	externalize	VBN
cord-023095-4dannjjm	6086	6	drainage	drainage	NN
cord-023095-4dannjjm	6086	7	,	,	,
cord-023095-4dannjjm	6086	8	requiring	require	VBG
cord-023095-4dannjjm	6086	9	careful	careful	JJ
cord-023095-4dannjjm	6086	10	management	management	NN
cord-023095-4dannjjm	6086	11	to	to	TO
cord-023095-4dannjjm	6086	12	prevent	prevent	VB
cord-023095-4dannjjm	6086	13	infection	infection	NN
cord-023095-4dannjjm	6086	14	/	/	SYM
cord-023095-4dannjjm	6086	15	dislodgement	dislodgement	NN
cord-023095-4dannjjm	6086	16	.	.	.
cord-023095-4dannjjm	6087	1	The	the	DT
cord-023095-4dannjjm	6087	2	development	development	NN
cord-023095-4dannjjm	6087	3	of	of	IN
cord-023095-4dannjjm	6087	4	an	an	DT
cord-023095-4dannjjm	6087	5	indwelling	indwell	VBG
cord-023095-4dannjjm	6087	6	ureteral	ureteral	JJ
cord-023095-4dannjjm	6087	7	bypass	bypass	NN
cord-023095-4dannjjm	6087	8	using	use	VBG
cord-023095-4dannjjm	6087	9	a	a	DT
cord-023095-4dannjjm	6087	10	combination	combination	NN
cord-023095-4dannjjm	6087	11	locking	locking	NN
cord-023095-4dannjjm	6087	12	-	-	HYPH
cord-023095-4dannjjm	6087	13	loop	loop	NN
cord-023095-4dannjjm	6087	14	nephrostomy	nephrostomy	NNP
cord-023095-4dannjjm	6087	15	/	/	SYM
cord-023095-4dannjjm	6087	16	cystostomy	cystostomy	NN
cord-023095-4dannjjm	6087	17	tube	tube	NN
cord-023095-4dannjjm	6087	18	was	be	VBD
cord-023095-4dannjjm	6087	19	modified	modify	VBN
cord-023095-4dannjjm	6087	20	from	from	IN
cord-023095-4dannjjm	6087	21	humans	human	NNS
cord-023095-4dannjjm	6087	22	,	,	,
cord-023095-4dannjjm	6087	23	resulting	result	VBG
cord-023095-4dannjjm	6087	24	in	in	IN
cord-023095-4dannjjm	6087	25	permanent	permanent	JJ
cord-023095-4dannjjm	6087	26	indwelling	indwell	VBG
cord-023095-4dannjjm	6087	27	drainage	drainage	NN
cord-023095-4dannjjm	6087	28	,	,	,
cord-023095-4dannjjm	6087	29	reduced	reduced	JJ
cord-023095-4dannjjm	6087	30	complications	complication	NNS
cord-023095-4dannjjm	6087	31	,	,	,
cord-023095-4dannjjm	6087	32	and	and	CC
cord-023095-4dannjjm	6087	33	improved	improve	VBD
cord-023095-4dannjjm	6087	34	quality	quality	NN
cord-023095-4dannjjm	6087	35	of	of	IN
cord-023095-4dannjjm	6087	36	life	life	NN
cord-023095-4dannjjm	6087	37	.	.	.
cord-023095-4dannjjm	6088	1	The	the	DT
cord-023095-4dannjjm	6088	2	objective	objective	NN
cord-023095-4dannjjm	6088	3	is	be	VBZ
cord-023095-4dannjjm	6088	4	to	to	TO
cord-023095-4dannjjm	6088	5	describe	describe	VB
cord-023095-4dannjjm	6088	6	the	the	DT
cord-023095-4dannjjm	6088	7	technical	technical	JJ
cord-023095-4dannjjm	6088	8	and	and	CC
cord-023095-4dannjjm	6088	9	clinical	clinical	JJ
cord-023095-4dannjjm	6088	10	outcome	outcome	NN
cord-023095-4dannjjm	6088	11	using	use	VBG
cord-023095-4dannjjm	6088	12	a	a	DT
cord-023095-4dannjjm	6088	13	novel	novel	JJ
cord-023095-4dannjjm	6088	14	device	device	NN
cord-023095-4dannjjm	6088	15	called	call	VBN
cord-023095-4dannjjm	6088	16	a	a	DT
cord-023095-4dannjjm	6088	17	subcutaneous	subcutaneous	JJ
cord-023095-4dannjjm	6088	18	ureteral	ureteral	JJ
cord-023095-4dannjjm	6088	19	bypass	bypass	NN
cord-023095-4dannjjm	6088	20	(	(	-LRB-
cord-023095-4dannjjm	6088	21	SUB	sub	NN
cord-023095-4dannjjm	6088	22	)	)	-RRB-
cord-023095-4dannjjm	6088	23	in	in	IN
cord-023095-4dannjjm	6088	24	cats	cat	NNS
cord-023095-4dannjjm	6088	25	with	with	IN
cord-023095-4dannjjm	6088	26	ureteral	ureteral	JJ
cord-023095-4dannjjm	6088	27	obstructions	obstruction	NNS
cord-023095-4dannjjm	6088	28	.	.	.
cord-023095-4dannjjm	6089	1	Fifteen	fifteen	CD
cord-023095-4dannjjm	6089	2	cats	cat	NNS
cord-023095-4dannjjm	6089	3	(	(	-LRB-
cord-023095-4dannjjm	6089	4	16	16	CD
cord-023095-4dannjjm	6089	5	kidneys	kidney	NNS
cord-023095-4dannjjm	6089	6	)	)	-RRB-
cord-023095-4dannjjm	6089	7	had	have	VBD
cord-023095-4dannjjm	6089	8	a	a	DT
cord-023095-4dannjjm	6089	9	SUB	sub	NN
cord-023095-4dannjjm	6089	10	placed	place	VBN
cord-023095-4dannjjm	6089	11	for	for	IN
cord-023095-4dannjjm	6089	12	:	:	:
cord-023095-4dannjjm	6089	13	ureterolithiasis	ureterolithiasis	NNP
cord-023095-4dannjjm	6089	14	(	(	-LRB-
cord-023095-4dannjjm	6089	15	9	9	CD
cord-023095-4dannjjm	6089	16	)	)	-RRB-
cord-023095-4dannjjm	6089	17	,	,	,
cord-023095-4dannjjm	6089	18	ureteral	ureteral	JJ
cord-023095-4dannjjm	6089	19	stricture	stricture	NN
cord-023095-4dannjjm	6089	20	(	(	-LRB-
cord-023095-4dannjjm	6089	21	1	1	CD
cord-023095-4dannjjm	6089	22	/	/	SYM
cord-023095-4dannjjm	6089	23	À	à	NN
cord-023095-4dannjjm	6089	24	stones	stone	NNS
cord-023095-4dannjjm	6089	25	)	)	-RRB-
cord-023095-4dannjjm	6089	26	(	(	-LRB-
cord-023095-4dannjjm	6089	27	6	6	CD
cord-023095-4dannjjm	6089	28	)	)	-RRB-
cord-023095-4dannjjm	6089	29	,	,	,
cord-023095-4dannjjm	6089	30	and	and	CC
cord-023095-4dannjjm	6089	31	ureteral	ureteral	JJ
cord-023095-4dannjjm	6089	32	stent	stent	NN
cord-023095-4dannjjm	6089	33	rejection	rejection	NN
cord-023095-4dannjjm	6089	34	(	(	-LRB-
cord-023095-4dannjjm	6089	35	2	2	CD
cord-023095-4dannjjm	6089	36	)	)	-RRB-
cord-023095-4dannjjm	6089	37	.	.	.
cord-023095-4dannjjm	6090	1	The	the	DT
cord-023095-4dannjjm	6090	2	median	median	JJ
cord-023095-4dannjjm	6090	3	pre	pre	JJ
cord-023095-4dannjjm	6090	4	-	-	JJ
cord-023095-4dannjjm	6090	5	and	and	CC
cord-023095-4dannjjm	6090	6	post	post	JJ
cord-023095-4dannjjm	6090	7	-	-	JJ
cord-023095-4dannjjm	6090	8	procedure	procedure	JJ
cord-023095-4dannjjm	6090	9	creatinine	creatinine	NN
cord-023095-4dannjjm	6090	10	was	be	VBD
cord-023095-4dannjjm	6090	11	6	6	CD
cord-023095-4dannjjm	6090	12	mg	mg	NNP
cord-023095-4dannjjm	6090	13	/	/	SYM
cord-023095-4dannjjm	6090	14	dL	dl	NN
cord-023095-4dannjjm	6090	15	(	(	-LRB-
cord-023095-4dannjjm	6090	16	range	range	NN
cord-023095-4dannjjm	6090	17	:	:	:
cord-023095-4dannjjm	6090	18	2.8	2.8	CD
cord-023095-4dannjjm	6090	19	-	-	SYM
cord-023095-4dannjjm	6090	20	13	13	CD
cord-023095-4dannjjm	6090	21	)	)	-RRB-
cord-023095-4dannjjm	6090	22	and	and	CC
cord-023095-4dannjjm	6090	23	2.5	2.5	CD
cord-023095-4dannjjm	6090	24	mg	mg	NNP
cord-023095-4dannjjm	6090	25	/	/	SYM
cord-023095-4dannjjm	6090	26	dL	dl	NN
cord-023095-4dannjjm	6090	27	(	(	-LRB-
cord-023095-4dannjjm	6090	28	range	range	NN
cord-023095-4dannjjm	6090	29	:	:	:
cord-023095-4dannjjm	6090	30	2.4	2.4	CD
cord-023095-4dannjjm	6090	31	-	-	SYM
cord-023095-4dannjjm	6090	32	9	9	CD
cord-023095-4dannjjm	6090	33	)	)	-RRB-
cord-023095-4dannjjm	6090	34	,	,	,
cord-023095-4dannjjm	6090	35	respectively	respectively	RB
cord-023095-4dannjjm	6090	36	.	.	.
cord-023095-4dannjjm	6091	1	The	the	DT
cord-023095-4dannjjm	6091	2	median	median	JJ
cord-023095-4dannjjm	6091	3	pelvis	pelvi	NNS
cord-023095-4dannjjm	6091	4	diameter	diameter	VBP
cord-023095-4dannjjm	6091	5	pre	pre	VB
cord-023095-4dannjjm	6091	6	and	and	CC
cord-023095-4dannjjm	6091	7	post	post	JJ
cord-023095-4dannjjm	6091	8	-	-	NN
cord-023095-4dannjjm	6091	9	procedure	procedure	NN
cord-023095-4dannjjm	6091	10	were	be	VBD
cord-023095-4dannjjm	6091	11	15	15	CD
cord-023095-4dannjjm	6092	1	(	(	-LRB-
cord-023095-4dannjjm	6092	2	range	range	NN
cord-023095-4dannjjm	6092	3	:	:	:
cord-023095-4dannjjm	6092	4	7	7	CD
cord-023095-4dannjjm	6092	5	-	-	SYM
cord-023095-4dannjjm	6092	6	28	28	CD
cord-023095-4dannjjm	6092	7	)	)	-RRB-
cord-023095-4dannjjm	6092	8	and	and	CC
cord-023095-4dannjjm	6092	9	5	5	CD
cord-023095-4dannjjm	6092	10	mm	mm	NN
cord-023095-4dannjjm	6092	11	(	(	-LRB-
cord-023095-4dannjjm	6092	12	range	range	NNP
cord-023095-4dannjjm	6092	13	3.4	3.4	CD
cord-023095-4dannjjm	6092	14	-	-	SYM
cord-023095-4dannjjm	6092	15	6	6	CD
cord-023095-4dannjjm	6092	16	)	)	-RRB-
cord-023095-4dannjjm	6092	17	,	,	,
cord-023095-4dannjjm	6092	18	respectively	respectively	RB
cord-023095-4dannjjm	6092	19	.	.	.
cord-023095-4dannjjm	6093	1	Six	six	CD
cord-023095-4dannjjm	6093	2	French	french	JJ
cord-023095-4dannjjm	6093	3	tubes	tube	NNS
cord-023095-4dannjjm	6093	4	were	be	VBD
cord-023095-4dannjjm	6093	5	placed	place	VBN
cord-023095-4dannjjm	6093	6	in	in	IN
cord-023095-4dannjjm	6093	7	14	14	CD
cord-023095-4dannjjm	6093	8	,	,	,
cord-023095-4dannjjm	6093	9	and	and	CC
cord-023095-4dannjjm	6093	10	5	5	CD
cord-023095-4dannjjm	6093	11	Fr	fr	NN
cord-023095-4dannjjm	6093	12	.	.	.
cord-023095-4dannjjm	6094	1	in	in	IN
cord-023095-4dannjjm	6094	2	2	2	CD
cord-023095-4dannjjm	6094	3	.	.	.
cord-023095-4dannjjm	6095	1	The	the	DT
cord-023095-4dannjjm	6095	2	bypass	bypass	NN
cord-023095-4dannjjm	6095	3	remained	remain	VBD
cord-023095-4dannjjm	6095	4	indwelling	indwell	VBG
cord-023095-4dannjjm	6095	5	for	for	IN
cord-023095-4dannjjm	6095	6	a	a	DT
cord-023095-4dannjjm	6095	7	median	median	NN
cord-023095-4dannjjm	6095	8	of	of	IN
cord-023095-4dannjjm	6095	9	4240	4240	CD
cord-023095-4dannjjm	6095	10	days	day	NNS
cord-023095-4dannjjm	6095	11	(	(	-LRB-
cord-023095-4dannjjm	6095	12	range	range	VBP
cord-023095-4dannjjm	6095	13	64	64	CD
cord-023095-4dannjjm	6095	14	-	-	HYPH
cord-023095-4dannjjm	6095	15	4450	4450	CD
cord-023095-4dannjjm	6095	16	)	)	-RRB-
cord-023095-4dannjjm	6095	17	.	.	.
cord-023095-4dannjjm	6096	1	There	there	EX
cord-023095-4dannjjm	6096	2	were	be	VBD
cord-023095-4dannjjm	6096	3	3	3	CD
cord-023095-4dannjjm	6096	4	major	major	JJ
cord-023095-4dannjjm	6096	5	complications	complication	NNS
cord-023095-4dannjjm	6096	6	resulting	result	VBG
cord-023095-4dannjjm	6096	7	in	in	IN
cord-023095-4dannjjm	6096	8	nephrostomy	nephrostomy	JJ
cord-023095-4dannjjm	6096	9	tube	tube	NN
cord-023095-4dannjjm	6096	10	dislodgement	dislodgement	NN
cord-023095-4dannjjm	6096	11	(	(	-LRB-
cord-023095-4dannjjm	6096	12	2	2	CD
cord-023095-4dannjjm	6096	13	)	)	-RRB-
cord-023095-4dannjjm	6096	14	and	and	CC
cord-023095-4dannjjm	6096	15	port	port	NN
cord-023095-4dannjjm	6096	16	leakage	leakage	NN
cord-023095-4dannjjm	6096	17	(	(	-LRB-
cord-023095-4dannjjm	6096	18	1	1	CD
cord-023095-4dannjjm	6096	19	)	)	-RRB-
cord-023095-4dannjjm	6096	20	5	5	CD
cord-023095-4dannjjm	6096	21	days	day	NNS
cord-023095-4dannjjm	6096	22	after	after	IN
cord-023095-4dannjjm	6096	23	surgery	surgery	NN
cord-023095-4dannjjm	6096	24	.	.	.
cord-023095-4dannjjm	6097	1	One	one	CD
cord-023095-4dannjjm	6097	2	patient	patient	NN
cord-023095-4dannjjm	6097	3	with	with	IN
cord-023095-4dannjjm	6097	4	severe	severe	JJ
cord-023095-4dannjjm	6097	5	coagulopathy	coagulopathy	NN
cord-023095-4dannjjm	6097	6	developed	develop	VBD
cord-023095-4dannjjm	6097	7	a	a	DT
cord-023095-4dannjjm	6097	8	clot	clot	NN
cord-023095-4dannjjm	6097	9	which	which	WDT
cord-023095-4dannjjm	6097	10	resolved	resolve	VBD
cord-023095-4dannjjm	6097	11	with	with	IN
cord-023095-4dannjjm	6097	12	tPA	tPA	NNP
cord-023095-4dannjjm	6097	13	infusion	infusion	NN
cord-023095-4dannjjm	6097	14	through	through	IN
cord-023095-4dannjjm	6097	15	the	the	DT
cord-023095-4dannjjm	6097	16	port	port	NN
cord-023095-4dannjjm	6097	17	.	.	.
cord-023095-4dannjjm	6098	1	No	no	DT
cord-023095-4dannjjm	6098	2	SUB	sub	NN
cord-023095-4dannjjm	6098	3	got	get	VBD
cord-023095-4dannjjm	6098	4	occluded	occlude	VBN
cord-023095-4dannjjm	6098	5	/	/	SYM
cord-023095-4dannjjm	6098	6	obstructed	obstruct	VBN
cord-023095-4dannjjm	6098	7	long	long	JJ
cord-023095-4dannjjm	6098	8	-	-	HYPH
cord-023095-4dannjjm	6098	9	term	term	NN
cord-023095-4dannjjm	6098	10	.	.	.
cord-023095-4dannjjm	6099	1	Overall	overall	RB
cord-023095-4dannjjm	6099	2	,	,	,
cord-023095-4dannjjm	6099	3	the	the	DT
cord-023095-4dannjjm	6099	4	use	use	NN
cord-023095-4dannjjm	6099	5	of	of	IN
cord-023095-4dannjjm	6099	6	a	a	DT
cord-023095-4dannjjm	6099	7	SUB	sub	NN
cord-023095-4dannjjm	6099	8	for	for	IN
cord-023095-4dannjjm	6099	9	cats	cat	NNS
cord-023095-4dannjjm	6099	10	with	with	IN
cord-023095-4dannjjm	6099	11	ureteral	ureteral	JJ
cord-023095-4dannjjm	6099	12	obstructions	obstruction	NNS
cord-023095-4dannjjm	6099	13	can	can	MD
cord-023095-4dannjjm	6099	14	be	be	VB
cord-023095-4dannjjm	6099	15	considered	consider	VBN
cord-023095-4dannjjm	6099	16	a	a	DT
cord-023095-4dannjjm	6099	17	functional	functional	JJ
cord-023095-4dannjjm	6099	18	option	option	NN
cord-023095-4dannjjm	6099	19	when	when	WRB
cord-023095-4dannjjm	6099	20	other	other	JJ
cord-023095-4dannjjm	6099	21	therapies	therapy	NNS
cord-023095-4dannjjm	6099	22	have	have	VBP
cord-023095-4dannjjm	6099	23	failed	fail	VBN
cord-023095-4dannjjm	6099	24	or	or	CC
cord-023095-4dannjjm	6099	25	are	be	VBP
cord-023095-4dannjjm	6099	26	contraindicated	contraindicate	VBN
cord-023095-4dannjjm	6099	27	,	,	,
cord-023095-4dannjjm	6099	28	but	but	CC
cord-023095-4dannjjm	6099	29	shtime	shtime	NNP
cord-023095-4dannjjm	6099	30	.	.	.
cord-023095-4dannjjm	6100	1	Oxidative	oxidative	JJ
cord-023095-4dannjjm	6100	2	stress	stress	NN
cord-023095-4dannjjm	6100	3	is	be	VBZ
cord-023095-4dannjjm	6100	4	considered	consider	VBN
cord-023095-4dannjjm	6100	5	central	central	JJ
cord-023095-4dannjjm	6100	6	to	to	IN
cord-023095-4dannjjm	6100	7	the	the	DT
cord-023095-4dannjjm	6100	8	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	6100	9	of	of	IN
cord-023095-4dannjjm	6100	10	many	many	JJ
cord-023095-4dannjjm	6100	11	systemic	systemic	JJ
cord-023095-4dannjjm	6100	12	diseases	disease	NNS
cord-023095-4dannjjm	6100	13	.	.	.
cord-023095-4dannjjm	6101	1	In	in	IN
cord-023095-4dannjjm	6101	2	humans	human	NNS
cord-023095-4dannjjm	6101	3	,	,	,
cord-023095-4dannjjm	6101	4	biomarkers	biomarker	NNS
cord-023095-4dannjjm	6101	5	of	of	IN
cord-023095-4dannjjm	6101	6	oxidative	oxidative	JJ
cord-023095-4dannjjm	6101	7	stress	stress	NN
cord-023095-4dannjjm	6101	8	,	,	,
cord-023095-4dannjjm	6101	9	antioxidant	antioxidant	JJ
cord-023095-4dannjjm	6101	10	depletion	depletion	NN
cord-023095-4dannjjm	6101	11	and	and	CC
cord-023095-4dannjjm	6101	12	lipid	lipid	NN
cord-023095-4dannjjm	6101	13	peroxidation	peroxidation	NN
cord-023095-4dannjjm	6101	14	,	,	,
cord-023095-4dannjjm	6101	15	have	have	VBP
cord-023095-4dannjjm	6101	16	been	be	VBN
cord-023095-4dannjjm	6101	17	correlated	correlate	VBN
cord-023095-4dannjjm	6101	18	with	with	IN
cord-023095-4dannjjm	6101	19	disease	disease	NN
cord-023095-4dannjjm	6101	20	severity	severity	NN
cord-023095-4dannjjm	6101	21	and	and	CC
cord-023095-4dannjjm	6101	22	associated	associate	VBN
cord-023095-4dannjjm	6101	23	with	with	IN
cord-023095-4dannjjm	6101	24	poor	poor	JJ
cord-023095-4dannjjm	6101	25	clinical	clinical	JJ
cord-023095-4dannjjm	6101	26	outcomes	outcome	NNS
cord-023095-4dannjjm	6101	27	.	.	.
cord-023095-4dannjjm	6102	1	Therapeutic	therapeutic	JJ
cord-023095-4dannjjm	6102	2	antioxidant	antioxidant	JJ
cord-023095-4dannjjm	6102	3	supplementation	supplementation	NN
cord-023095-4dannjjm	6102	4	with	with	IN
cord-023095-4dannjjm	6102	5	NAC	NAC	NNP
cord-023095-4dannjjm	6102	6	in	in	IN
cord-023095-4dannjjm	6102	7	glutathione	glutathione	NN
cord-023095-4dannjjm	6102	8	(	(	-LRB-
cord-023095-4dannjjm	6102	9	GSH)-deficient	GSH)-deficient	NNP
cord-023095-4dannjjm	6102	10	patients	patient	NNS
cord-023095-4dannjjm	6102	11	has	have	VBZ
cord-023095-4dannjjm	6102	12	shown	show	VBN
cord-023095-4dannjjm	6102	13	clinical	clinical	JJ
cord-023095-4dannjjm	6102	14	benefits	benefit	NNS
cord-023095-4dannjjm	6102	15	,	,	,
cord-023095-4dannjjm	6102	16	including	include	VBG
cord-023095-4dannjjm	6102	17	repletion	repletion	NN
cord-023095-4dannjjm	6102	18	of	of	IN
cord-023095-4dannjjm	6102	19	intracellular	intracellular	JJ
cord-023095-4dannjjm	6102	20	GSH	GSH	NNP
cord-023095-4dannjjm	6102	21	levels	level	NNS
cord-023095-4dannjjm	6102	22	.	.	.
cord-023095-4dannjjm	6103	1	We	-PRON-	PRP
cord-023095-4dannjjm	6103	2	have	have	VBP
cord-023095-4dannjjm	6103	3	shown	show	VBN
cord-023095-4dannjjm	6103	4	that	that	IN
cord-023095-4dannjjm	6103	5	clinically	clinically	RB
cord-023095-4dannjjm	6103	6	ill	ill	JJ
cord-023095-4dannjjm	6103	7	dogs	dog	NNS
cord-023095-4dannjjm	6103	8	are	be	VBP
cord-023095-4dannjjm	6103	9	GSH	gsh	NN
cord-023095-4dannjjm	6103	10	-	-	HYPH
cord-023095-4dannjjm	6103	11	deficient	deficient	JJ
cord-023095-4dannjjm	6103	12	,	,	,
cord-023095-4dannjjm	6103	13	and	and	CC
cord-023095-4dannjjm	6103	14	that	that	IN
cord-023095-4dannjjm	6103	15	GSH	GSH	NNP
cord-023095-4dannjjm	6103	16	deficiency	deficiency	NN
cord-023095-4dannjjm	6103	17	correlates	correlate	VBZ
cord-023095-4dannjjm	6103	18	with	with	IN
cord-023095-4dannjjm	6103	19	mortality	mortality	NN
cord-023095-4dannjjm	6103	20	,	,	,
cord-023095-4dannjjm	6103	21	but	but	CC
cord-023095-4dannjjm	6103	22	it	-PRON-	PRP
cord-023095-4dannjjm	6103	23	is	be	VBZ
cord-023095-4dannjjm	6103	24	not	not	RB
cord-023095-4dannjjm	6103	25	clear	clear	JJ
cord-023095-4dannjjm	6103	26	whether	whether	IN
cord-023095-4dannjjm	6103	27	there	there	EX
cord-023095-4dannjjm	6103	28	are	be	VBP
cord-023095-4dannjjm	6103	29	direct	direct	JJ
cord-023095-4dannjjm	6103	30	benefits	benefit	NNS
cord-023095-4dannjjm	6103	31	of	of	IN
cord-023095-4dannjjm	6103	32	antioxidant	antioxidant	JJ
cord-023095-4dannjjm	6103	33	intervention	intervention	NN
cord-023095-4dannjjm	6103	34	in	in	IN
cord-023095-4dannjjm	6103	35	these	these	DT
cord-023095-4dannjjm	6103	36	patients	patient	NNS
cord-023095-4dannjjm	6103	37	.	.	.
cord-023095-4dannjjm	6104	1	The	the	DT
cord-023095-4dannjjm	6104	2	purpose	purpose	NN
cord-023095-4dannjjm	6104	3	of	of	IN
cord-023095-4dannjjm	6104	4	this	this	DT
cord-023095-4dannjjm	6104	5	randomized	randomized	JJ
cord-023095-4dannjjm	6104	6	,	,	,
cord-023095-4dannjjm	6104	7	investigator	investigator	NN
cord-023095-4dannjjm	6104	8	-	-	HYPH
cord-023095-4dannjjm	6104	9	blinded	blind	VBN
cord-023095-4dannjjm	6104	10	,	,	,
cord-023095-4dannjjm	6104	11	placebo	placebo	NN
cord-023095-4dannjjm	6104	12	-	-	HYPH
cord-023095-4dannjjm	6104	13	controlled	control	VBN
cord-023095-4dannjjm	6104	14	,	,	,
cord-023095-4dannjjm	6104	15	prospective	prospective	JJ
cord-023095-4dannjjm	6104	16	study	study	NN
cord-023095-4dannjjm	6104	17	was	be	VBD
cord-023095-4dannjjm	6104	18	to	to	TO
cord-023095-4dannjjm	6104	19	evaluate	evaluate	VB
cord-023095-4dannjjm	6104	20	the	the	DT
cord-023095-4dannjjm	6104	21	effect	effect	NN
cord-023095-4dannjjm	6104	22	of	of	IN
cord-023095-4dannjjm	6104	23	NAC	NAC	NNP
cord-023095-4dannjjm	6104	24	to	to	TO
cord-023095-4dannjjm	6104	25	normalize	normalize	VB
cord-023095-4dannjjm	6104	26	blood	blood	NN
cord-023095-4dannjjm	6104	27	antioxidants	antioxidant	NNS
cord-023095-4dannjjm	6105	1	(	(	-LRB-
cord-023095-4dannjjm	6105	2	RBC	RBC	NNP
cord-023095-4dannjjm	6105	3	reduced	reduce	VBN
cord-023095-4dannjjm	6105	4	GSH	GSH	NNP
cord-023095-4dannjjm	6105	5	(	(	-LRB-
cord-023095-4dannjjm	6105	6	RBC	RBC	NNP
cord-023095-4dannjjm	6105	7	GSH	GSH	NNP
cord-023095-4dannjjm	6105	8	)	)	-RRB-
cord-023095-4dannjjm	6105	9	,	,	,
cord-023095-4dannjjm	6105	10	plasma	plasma	NN
cord-023095-4dannjjm	6105	11	cysteine	cysteine	NN
cord-023095-4dannjjm	6105	12	(	(	-LRB-
cord-023095-4dannjjm	6105	13	CYS	CYS	NNP
cord-023095-4dannjjm	6105	14	)	)	-RRB-
cord-023095-4dannjjm	6105	15	,	,	,
cord-023095-4dannjjm	6105	16	serum	serum	NN
cord-023095-4dannjjm	6105	17	vitamin	vitamin	NN
cord-023095-4dannjjm	6105	18	E	e	NN
cord-023095-4dannjjm	6105	19	(	(	-LRB-
cord-023095-4dannjjm	6105	20	vit	vit	NNP
cord-023095-4dannjjm	6105	21	E	E	NNP
cord-023095-4dannjjm	6105	22	)	)	-RRB-
cord-023095-4dannjjm	6105	23	,	,	,
cord-023095-4dannjjm	6105	24	and	and	CC
cord-023095-4dannjjm	6105	25	whole	whole	JJ
cord-023095-4dannjjm	6105	26	blood	blood	NN
cord-023095-4dannjjm	6105	27	selenium	selenium	NN
cord-023095-4dannjjm	6105	28	(	(	-LRB-
cord-023095-4dannjjm	6105	29	Se	Se	NNP
cord-023095-4dannjjm	6105	30	)	)	-RRB-
cord-023095-4dannjjm	6105	31	)	)	-RRB-
cord-023095-4dannjjm	6105	32	,	,	,
cord-023095-4dannjjm	6105	33	reduce	reduce	VB
cord-023095-4dannjjm	6105	34	lipid	lipid	NN
cord-023095-4dannjjm	6105	35	peroxidation	peroxidation	NN
cord-023095-4dannjjm	6105	36	(	(	-LRB-
cord-023095-4dannjjm	6105	37	urine	urine	NNP
cord-023095-4dannjjm	6105	38	isoprostane	isoprostane	NNP
cord-023095-4dannjjm	6105	39	/	/	SYM
cord-023095-4dannjjm	6105	40	creatinine	creatinine	NN
cord-023095-4dannjjm	6105	41	ratio	ratio	NN
cord-023095-4dannjjm	6105	42	(	(	-LRB-
cord-023095-4dannjjm	6105	43	U	U	NNP
cord-023095-4dannjjm	6105	44	I/	I/	NNP
cord-023095-4dannjjm	6105	45	C	C	NNP
cord-023095-4dannjjm	6105	46	)	)	-RRB-
cord-023095-4dannjjm	6105	47	)	)	-RRB-
cord-023095-4dannjjm	6105	48	,	,	,
cord-023095-4dannjjm	6105	49	and	and	CC
cord-023095-4dannjjm	6105	50	improve	improve	VB
cord-023095-4dannjjm	6105	51	illness	illness	NN
cord-023095-4dannjjm	6105	52	scores	score	NNS
cord-023095-4dannjjm	6105	53	(	(	-LRB-
cord-023095-4dannjjm	6105	54	SPI2	SPI2	NNP
cord-023095-4dannjjm	6105	55	)	)	-RRB-
cord-023095-4dannjjm	6105	56	and	and	CC
cord-023095-4dannjjm	6105	57	outcome	outcome	NN
cord-023095-4dannjjm	6105	58	(	(	-LRB-
cord-023095-4dannjjm	6105	59	survival	survival	NN
cord-023095-4dannjjm	6105	60	to	to	TO
cord-023095-4dannjjm	6105	61	discharge	discharge	VB
cord-023095-4dannjjm	6105	62	)	)	-RRB-
cord-023095-4dannjjm	6105	63	in	in	IN
cord-023095-4dannjjm	6105	64	clinically	clinically	RB
cord-023095-4dannjjm	6105	65	ill	ill	JJ
cord-023095-4dannjjm	6105	66	dogs	dog	NNS
cord-023095-4dannjjm	6105	67	.	.	.
cord-023095-4dannjjm	6106	1	Clinically	clinically	RB
cord-023095-4dannjjm	6106	2	ill	ill	JJ
cord-023095-4dannjjm	6106	3	client	client	NN
cord-023095-4dannjjm	6106	4	-	-	HYPH
cord-023095-4dannjjm	6106	5	owned	own	VBN
cord-023095-4dannjjm	6106	6	dogs	dog	NNS
cord-023095-4dannjjm	6106	7	,	,	,
cord-023095-4dannjjm	6106	8	admitted	admit	VBN
cord-023095-4dannjjm	6106	9	to	to	IN
cord-023095-4dannjjm	6106	10	the	the	DT
cord-023095-4dannjjm	6106	11	UW	UW	NNP
cord-023095-4dannjjm	6106	12	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	6106	13	Medical	Medical	NNP
cord-023095-4dannjjm	6106	14	Teaching	Teaching	NNP
cord-023095-4dannjjm	6106	15	Hospital	Hospital	NNP
cord-023095-4dannjjm	6106	16	that	that	WDT
cord-023095-4dannjjm	6106	17	did	do	VBD
cord-023095-4dannjjm	6106	18	not	not	RB
cord-023095-4dannjjm	6106	19	receive	receive	VB
cord-023095-4dannjjm	6106	20	blood	blood	NN
cord-023095-4dannjjm	6106	21	transfusions	transfusion	NNS
cord-023095-4dannjjm	6106	22	,	,	,
cord-023095-4dannjjm	6106	23	TPN	TPN	NNP
cord-023095-4dannjjm	6106	24	,	,	,
cord-023095-4dannjjm	6106	25	vitamins	vitamin	NNS
cord-023095-4dannjjm	6106	26	,	,	,
cord-023095-4dannjjm	6106	27	or	or	CC
cord-023095-4dannjjm	6106	28	antioxidants	antioxidant	NNS
cord-023095-4dannjjm	6106	29	were	be	VBD
cord-023095-4dannjjm	6106	30	eligible	eligible	JJ
cord-023095-4dannjjm	6106	31	for	for	IN
cord-023095-4dannjjm	6106	32	the	the	DT
cord-023095-4dannjjm	6106	33	study	study	NN
cord-023095-4dannjjm	6106	34	.	.	.
cord-023095-4dannjjm	6107	1	Dogs	dog	NNS
cord-023095-4dannjjm	6107	2	enrolled	enrol	VBD
cord-023095-4dannjjm	6107	3	in	in	IN
cord-023095-4dannjjm	6107	4	the	the	DT
cord-023095-4dannjjm	6107	5	study	study	NN
cord-023095-4dannjjm	6107	6	were	be	VBD
cord-023095-4dannjjm	6107	7	randomized	randomize	VBN
cord-023095-4dannjjm	6107	8	to	to	TO
cord-023095-4dannjjm	6107	9	receive	receive	VB
cord-023095-4dannjjm	6107	10	IV	IV	NNP
cord-023095-4dannjjm	6107	11	infusions	infusion	NNS
cord-023095-4dannjjm	6107	12	q.	q.	NNP
cord-023095-4dannjjm	6107	13	6	6	CD
cord-023095-4dannjjm	6107	14	h.	h.	NN
cord-023095-4dannjjm	6107	15	of	of	IN
cord-023095-4dannjjm	6107	16	either	either	CC
cord-023095-4dannjjm	6107	17	NAC	NAC	NNP
cord-023095-4dannjjm	6107	18	(	(	-LRB-
cord-023095-4dannjjm	6107	19	1	1	CD
cord-023095-4dannjjm	6107	20	Â	â	CD
cord-023095-4dannjjm	6107	21	140	140	CD
cord-023095-4dannjjm	6107	22	mg	mg	NN
cord-023095-4dannjjm	6107	23	/	/	SYM
cord-023095-4dannjjm	6107	24	kg	kg	NNP
cord-023095-4dannjjm	6107	25	and	and	CC
cord-023095-4dannjjm	6107	26	6	6	CD
cord-023095-4dannjjm	6107	27	Â	â	CD
cord-023095-4dannjjm	6107	28	70	70	CD
cord-023095-4dannjjm	6107	29	mg	mg	NNP
cord-023095-4dannjjm	6107	30	/	/	SYM
cord-023095-4dannjjm	6107	31	kg	kg	NNP
cord-023095-4dannjjm	6107	32	)	)	-RRB-
cord-023095-4dannjjm	6107	33	or	or	CC
cord-023095-4dannjjm	6107	34	equal	equal	JJ
cord-023095-4dannjjm	6107	35	volumes	volume	NNS
cord-023095-4dannjjm	6107	36	of	of	IN
cord-023095-4dannjjm	6107	37	5	5	CD
cord-023095-4dannjjm	6107	38	%	%	NN
cord-023095-4dannjjm	6107	39	dextrose	dextrose	NN
cord-023095-4dannjjm	6107	40	(	(	-LRB-
cord-023095-4dannjjm	6107	41	placebo	placebo	NN
cord-023095-4dannjjm	6107	42	)	)	-RRB-
cord-023095-4dannjjm	6107	43	over	over	IN
cord-023095-4dannjjm	6107	44	48	48	CD
cord-023095-4dannjjm	6107	45	hours	hour	NNS
cord-023095-4dannjjm	6107	46	.	.	.
cord-023095-4dannjjm	6108	1	At	at	IN
cord-023095-4dannjjm	6108	2	the	the	DT
cord-023095-4dannjjm	6108	3	time	time	NN
cord-023095-4dannjjm	6108	4	of	of	IN
cord-023095-4dannjjm	6108	5	enrollment	enrollment	NN
cord-023095-4dannjjm	6108	6	,	,	,
cord-023095-4dannjjm	6108	7	and	and	CC
cord-023095-4dannjjm	6108	8	2	2	CD
cord-023095-4dannjjm	6108	9	hours	hour	NNS
cord-023095-4dannjjm	6108	10	following	follow	VBG
cord-023095-4dannjjm	6108	11	the	the	DT
cord-023095-4dannjjm	6108	12	final	final	JJ
cord-023095-4dannjjm	6108	13	48	48	CD
cord-023095-4dannjjm	6108	14	hour	hour	NN
cord-023095-4dannjjm	6108	15	infusion	infusion	NN
cord-023095-4dannjjm	6108	16	,	,	,
cord-023095-4dannjjm	6108	17	blood	blood	NN
cord-023095-4dannjjm	6108	18	and	and	CC
cord-023095-4dannjjm	6108	19	urine	urine	NN
cord-023095-4dannjjm	6108	20	were	be	VBD
cord-023095-4dannjjm	6108	21	collected	collect	VBN
cord-023095-4dannjjm	6108	22	to	to	TO
cord-023095-4dannjjm	6108	23	quantify	quantify	VB
cord-023095-4dannjjm	6108	24	RBC	RBC	NNP
cord-023095-4dannjjm	6108	25	GSH	GSH	NNP
cord-023095-4dannjjm	6108	26	,	,	,
cord-023095-4dannjjm	6108	27	CYS	CYS	NNP
cord-023095-4dannjjm	6108	28	,	,	,
cord-023095-4dannjjm	6108	29	vit	vit	NNP
cord-023095-4dannjjm	6108	30	E	E	NNP
cord-023095-4dannjjm	6108	31	,	,	,
cord-023095-4dannjjm	6108	32	and	and	CC
cord-023095-4dannjjm	6108	33	Se	Se	NNP
cord-023095-4dannjjm	6108	34	concentrations	concentration	NNS
cord-023095-4dannjjm	6108	35	;	;	:
cord-023095-4dannjjm	6108	36	U	U	NNP
cord-023095-4dannjjm	6108	37	I	I	NNP
cord-023095-4dannjjm	6108	38	/	/	SYM
cord-023095-4dannjjm	6108	39	C	c	NN
cord-023095-4dannjjm	6108	40	ratios	ratio	NNS
cord-023095-4dannjjm	6108	41	;	;	:
cord-023095-4dannjjm	6108	42	and	and	CC
cord-023095-4dannjjm	6108	43	calculate	calculate	VB
cord-023095-4dannjjm	6108	44	SPI2	SPI2	NNP
cord-023095-4dannjjm	6108	45	scores	score	NNS
cord-023095-4dannjjm	6108	46	.	.	.
cord-023095-4dannjjm	6109	1	RBC	RBC	NNP
cord-023095-4dannjjm	6109	2	GSH	GSH	NNP
cord-023095-4dannjjm	6109	3	and	and	CC
cord-023095-4dannjjm	6109	4	CYS	CYS	NNP
cord-023095-4dannjjm	6109	5	concentrations	concentration	NNS
cord-023095-4dannjjm	6109	6	were	be	VBD
cord-023095-4dannjjm	6109	7	quantified	quantify	VBN
cord-023095-4dannjjm	6109	8	by	by	IN
cord-023095-4dannjjm	6109	9	HPLC	HPLC	NNP
cord-023095-4dannjjm	6109	10	.	.	.
cord-023095-4dannjjm	6110	1	Commercially	commercially	RB
cord-023095-4dannjjm	6110	2	available	available	JJ
cord-023095-4dannjjm	6110	3	HPLC	HPLC	NNP
cord-023095-4dannjjm	6110	4	,	,	,
cord-023095-4dannjjm	6110	5	atomic	atomic	JJ
cord-023095-4dannjjm	6110	6	absorption	absorption	NN
cord-023095-4dannjjm	6110	7	spectroscopy	spectroscopy	NN
cord-023095-4dannjjm	6110	8	,	,	,
cord-023095-4dannjjm	6110	9	and	and	CC
cord-023095-4dannjjm	6110	10	EIA	EIA	NNP
cord-023095-4dannjjm	6110	11	were	be	VBD
cord-023095-4dannjjm	6110	12	used	use	VBN
cord-023095-4dannjjm	6110	13	to	to	TO
cord-023095-4dannjjm	6110	14	quantify	quantify	VB
cord-023095-4dannjjm	6110	15	vit	vit	NNP
cord-023095-4dannjjm	6110	16	E	e	NN
cord-023095-4dannjjm	6110	17	,	,	,
cord-023095-4dannjjm	6110	18	Se	Se	NNP
cord-023095-4dannjjm	6110	19	,	,	,
cord-023095-4dannjjm	6110	20	and	and	CC
cord-023095-4dannjjm	6110	21	U	U	NNP
cord-023095-4dannjjm	6110	22	I	I	NNP
cord-023095-4dannjjm	6110	23	/	/	SYM
cord-023095-4dannjjm	6110	24	C	c	NN
cord-023095-4dannjjm	6110	25	ratios	ratio	NNS
cord-023095-4dannjjm	6110	26	,	,	,
cord-023095-4dannjjm	6110	27	respectively	respectively	RB
cord-023095-4dannjjm	6110	28	.	.	.
cord-023095-4dannjjm	6111	1	Nonparametric	nonparametric	JJ
cord-023095-4dannjjm	6111	2	statistical	statistical	JJ
cord-023095-4dannjjm	6111	3	analyses	analysis	NNS
cord-023095-4dannjjm	6111	4	were	be	VBD
cord-023095-4dannjjm	6111	5	used	use	VBN
cord-023095-4dannjjm	6111	6	,	,	,
cord-023095-4dannjjm	6111	7	with	with	IN
cord-023095-4dannjjm	6111	8	results	result	NNS
cord-023095-4dannjjm	6111	9	reported	report	VBN
cord-023095-4dannjjm	6111	10	as	as	IN
cord-023095-4dannjjm	6111	11	medians	median	NNS
cord-023095-4dannjjm	6111	12	and	and	CC
cord-023095-4dannjjm	6111	13	P	p	NN
cord-023095-4dannjjm	6111	14	o	o	NN
cord-023095-4dannjjm	6111	15	0.05	0.05	CD
cord-023095-4dannjjm	6111	16	considered	consider	VBN
cord-023095-4dannjjm	6111	17	significant	significant	JJ
cord-023095-4dannjjm	6111	18	.	.	.
cord-023095-4dannjjm	6112	1	Sixty	sixty	CD
cord-023095-4dannjjm	6112	2	-	-	HYPH
cord-023095-4dannjjm	6112	3	one	one	CD
cord-023095-4dannjjm	6112	4	ill	ill	JJ
cord-023095-4dannjjm	6112	5	dogs	dog	NNS
cord-023095-4dannjjm	6112	6	were	be	VBD
cord-023095-4dannjjm	6112	7	randomized	randomize	VBN
cord-023095-4dannjjm	6112	8	to	to	IN
cord-023095-4dannjjm	6112	9	either	either	CC
cord-023095-4dannjjm	6112	10	NAC	NAC	NNP
cord-023095-4dannjjm	6112	11	(	(	-LRB-
cord-023095-4dannjjm	6112	12	n	n	NN
cord-023095-4dannjjm	6112	13	5	5	CD
cord-023095-4dannjjm	6112	14	30	30	CD
cord-023095-4dannjjm	6112	15	)	)	-RRB-
cord-023095-4dannjjm	6112	16	or	or	CC
cord-023095-4dannjjm	6112	17	placebo	placebo	NN
cord-023095-4dannjjm	6112	18	(	(	-LRB-
cord-023095-4dannjjm	6112	19	n	n	NNP
cord-023095-4dannjjm	6112	20	5	5	CD
cord-023095-4dannjjm	6112	21	31	31	CD
cord-023095-4dannjjm	6112	22	)	)	-RRB-
cord-023095-4dannjjm	6112	23	.	.	.
cord-023095-4dannjjm	6113	1	Overall	overall	RB
cord-023095-4dannjjm	6113	2	this	this	DT
cord-023095-4dannjjm	6113	3	group	group	NN
cord-023095-4dannjjm	6113	4	of	of	IN
cord-023095-4dannjjm	6113	5	ill	ill	JJ
cord-023095-4dannjjm	6113	6	dogs	dog	NNS
cord-023095-4dannjjm	6113	7	had	have	VBD
cord-023095-4dannjjm	6113	8	significantly	significantly	RB
cord-023095-4dannjjm	6113	9	decreased	decrease	VBN
cord-023095-4dannjjm	6113	10	RBC	RBC	NNP
cord-023095-4dannjjm	6113	11	GSH	GSH	NNP
cord-023095-4dannjjm	6113	12	(	(	-LRB-
cord-023095-4dannjjm	6113	13	1.50	1.50	CD
cord-023095-4dannjjm	6113	14	vs.	vs.	NN
cord-023095-4dannjjm	6113	15	1.91	1.91	CD
cord-023095-4dannjjm	6113	16	mM	mm	NN
cord-023095-4dannjjm	6113	17	;	;	:
cord-023095-4dannjjm	6113	18	P	p	NN
cord-023095-4dannjjm	6113	19	5	5	CD
cord-023095-4dannjjm	6113	20	0.0013	0.0013	CD
cord-023095-4dannjjm	6113	21	)	)	-RRB-
cord-023095-4dannjjm	6113	22	,	,	,
cord-023095-4dannjjm	6113	23	vit	vit	NNP
cord-023095-4dannjjm	6113	24	E	E	NNP
cord-023095-4dannjjm	6113	25	(	(	-LRB-
cord-023095-4dannjjm	6113	26	27	27	CD
cord-023095-4dannjjm	6113	27	vs.	vs.	NN
cord-023095-4dannjjm	6113	28	56	56	CD
cord-023095-4dannjjm	6113	29	mg	mg	NNP
cord-023095-4dannjjm	6113	30	/	/	SYM
cord-023095-4dannjjm	6113	31	mL	ml	NN
cord-023095-4dannjjm	6113	32	;	;	:
cord-023095-4dannjjm	6113	33	P	p	NN
cord-023095-4dannjjm	6113	34	5	5	CD
cord-023095-4dannjjm	6113	35	0.0002	0.0002	CD
cord-023095-4dannjjm	6113	36	)	)	-RRB-
cord-023095-4dannjjm	6113	37	,	,	,
cord-023095-4dannjjm	6113	38	and	and	CC
cord-023095-4dannjjm	6113	39	Se	Se	NNP
cord-023095-4dannjjm	6113	40	(	(	-LRB-
cord-023095-4dannjjm	6113	41	0.37	0.37	CD
cord-023095-4dannjjm	6113	42	vs.	vs.	IN
cord-023095-4dannjjm	6113	43	0.55	0.55	CD
cord-023095-4dannjjm	6113	44	mg	mg	NNP
cord-023095-4dannjjm	6113	45	/	/	SYM
cord-023095-4dannjjm	6113	46	mL	ml	NN
cord-023095-4dannjjm	6113	47	;	;	:
cord-023095-4dannjjm	6113	48	P	p	NN
cord-023095-4dannjjm	6113	49	5	5	CD
cord-023095-4dannjjm	6113	50	0.0308	0.0308	CD
cord-023095-4dannjjm	6113	51	)	)	-RRB-
cord-023095-4dannjjm	6113	52	levels	level	NNS
cord-023095-4dannjjm	6113	53	and	and	CC
cord-023095-4dannjjm	6113	54	elevated	elevated	JJ
cord-023095-4dannjjm	6113	55	U	u	NN
cord-023095-4dannjjm	6113	56	I	I	NNP
cord-023095-4dannjjm	6113	57	/	/	SYM
cord-023095-4dannjjm	6113	58	C	c	NN
cord-023095-4dannjjm	6113	59	ratios	ratio	NNS
cord-023095-4dannjjm	6113	60	(	(	-LRB-
cord-023095-4dannjjm	6113	61	969	969	CD
cord-023095-4dannjjm	6113	62	vs.	vs.	NN
cord-023095-4dannjjm	6113	63	398	398	CD
cord-023095-4dannjjm	6113	64	pg	pg	NNP
cord-023095-4dannjjm	6113	65	/	/	SYM
cord-023095-4dannjjm	6113	66	mg	mg	NN
cord-023095-4dannjjm	6113	67	;	;	:
cord-023095-4dannjjm	6113	68	P	p	NN
cord-023095-4dannjjm	6113	69	5	5	CD
cord-023095-4dannjjm	6113	70	0.0005	0.0005	CD
cord-023095-4dannjjm	6113	71	)	)	-RRB-
cord-023095-4dannjjm	6113	72	in	in	IN
cord-023095-4dannjjm	6113	73	comparison	comparison	NN
cord-023095-4dannjjm	6113	74	to	to	IN
cord-023095-4dannjjm	6113	75	healthy	healthy	JJ
cord-023095-4dannjjm	6113	76	control	control	NN
cord-023095-4dannjjm	6113	77	dogs	dog	NNS
cord-023095-4dannjjm	6113	78	.	.	.
cord-023095-4dannjjm	6114	1	Dogs	dog	NNS
cord-023095-4dannjjm	6114	2	in	in	IN
cord-023095-4dannjjm	6114	3	the	the	DT
cord-023095-4dannjjm	6114	4	placebo	placebo	NN
cord-023095-4dannjjm	6114	5	group	group	NN
cord-023095-4dannjjm	6114	6	showed	show	VBD
cord-023095-4dannjjm	6114	7	a	a	DT
cord-023095-4dannjjm	6114	8	significant	significant	JJ
cord-023095-4dannjjm	6114	9	further	further	JJ
cord-023095-4dannjjm	6114	10	decrease	decrease	NN
cord-023095-4dannjjm	6114	11	in	in	IN
cord-023095-4dannjjm	6114	12	RBC	RBC	NNP
cord-023095-4dannjjm	6114	13	GSH	GSH	NNP
cord-023095-4dannjjm	6114	14	over	over	IN
cord-023095-4dannjjm	6114	15	the	the	DT
cord-023095-4dannjjm	6114	16	next	next	JJ
cord-023095-4dannjjm	6114	17	48	48	CD
cord-023095-4dannjjm	6114	18	hours	hour	NNS
cord-023095-4dannjjm	6114	19	(	(	-LRB-
cord-023095-4dannjjm	6114	20	1.48	1.48	CD
cord-023095-4dannjjm	6114	21	to	to	IN
cord-023095-4dannjjm	6114	22	1.42	1.42	CD
cord-023095-4dannjjm	6114	23	;	;	:
cord-023095-4dannjjm	6114	24	P	p	NN
cord-023095-4dannjjm	6114	25	5	5	CD
cord-023095-4dannjjm	6114	26	0.035	0.035	CD
cord-023095-4dannjjm	6114	27	)	)	-RRB-
cord-023095-4dannjjm	6114	28	.	.	.
cord-023095-4dannjjm	6115	1	NAC	NAC	NNP
cord-023095-4dannjjm	6115	2	supplementation	supplementation	NN
cord-023095-4dannjjm	6115	3	significantly	significantly	RB
cord-023095-4dannjjm	6115	4	increased	increase	VBD
cord-023095-4dannjjm	6115	5	plasma	plasma	NN
cord-023095-4dannjjm	6115	6	CYS	CYS	NNP
cord-023095-4dannjjm	6115	7	levels	level	NNS
cord-023095-4dannjjm	6115	8	(	(	-LRB-
cord-023095-4dannjjm	6115	9	9.1	9.1	CD
cord-023095-4dannjjm	6115	10	to	to	IN
cord-023095-4dannjjm	6115	11	15.1	15.1	CD
cord-023095-4dannjjm	6115	12	mM	mm	CD
cord-023095-4dannjjm	6115	13	;	;	:
cord-023095-4dannjjm	6115	14	P	p	NN
cord-023095-4dannjjm	6115	15	o	o	NN
cord-023095-4dannjjm	6115	16	0.0001	0.0001	CD
cord-023095-4dannjjm	6115	17	)	)	-RRB-
cord-023095-4dannjjm	6115	18	,	,	,
cord-023095-4dannjjm	6115	19	and	and	CC
cord-023095-4dannjjm	6115	20	prevented	prevent	VBD
cord-023095-4dannjjm	6115	21	a	a	DT
cord-023095-4dannjjm	6115	22	further	further	JJ
cord-023095-4dannjjm	6115	23	decline	decline	NN
cord-023095-4dannjjm	6115	24	in	in	IN
cord-023095-4dannjjm	6115	25	RBC	RBC	NNP
cord-023095-4dannjjm	6115	26	GSH	GSH	NNP
cord-023095-4dannjjm	6115	27	(	(	-LRB-
cord-023095-4dannjjm	6115	28	1.55	1.55	CD
cord-023095-4dannjjm	6115	29	to	to	TO
cord-023095-4dannjjm	6115	30	1.58	1.58	CD
cord-023095-4dannjjm	6115	31	mM	mm	CD
cord-023095-4dannjjm	6115	32	;	;	:
cord-023095-4dannjjm	6115	33	P	p	NN
cord-023095-4dannjjm	6115	34	5	5	CD
cord-023095-4dannjjm	6115	35	0.174	0.174	CD
cord-023095-4dannjjm	6115	36	)	)	-RRB-
cord-023095-4dannjjm	6115	37	.	.	.
cord-023095-4dannjjm	6116	1	However	however	RB
cord-023095-4dannjjm	6116	2	,	,	,
cord-023095-4dannjjm	6116	3	serum	serum	NN
cord-023095-4dannjjm	6116	4	vit	vit	NN
cord-023095-4dannjjm	6116	5	E	e	NN
cord-023095-4dannjjm	6116	6	(	(	-LRB-
cord-023095-4dannjjm	6116	7	30	30	CD
cord-023095-4dannjjm	6116	8	vs.	vs.	IN
cord-023095-4dannjjm	6116	9	28	28	CD
cord-023095-4dannjjm	6116	10	mg	mg	NNP
cord-023095-4dannjjm	6116	11	/	/	SYM
cord-023095-4dannjjm	6116	12	mL	mL	NNP
cord-023095-4dannjjm	6116	13	)	)	-RRB-
cord-023095-4dannjjm	6116	14	,	,	,
cord-023095-4dannjjm	6116	15	Se	Se	NNP
cord-023095-4dannjjm	6116	16	(	(	-LRB-
cord-023095-4dannjjm	6116	17	0.40	0.40	CD
cord-023095-4dannjjm	6116	18	vs.	vs.	CC
cord-023095-4dannjjm	6116	19	0.35	0.35	CD
cord-023095-4dannjjm	6116	20	mg/	mg/	NN
cord-023095-4dannjjm	6116	21	mL	mL	NNP
cord-023095-4dannjjm	6116	22	)	)	-RRB-
cord-023095-4dannjjm	6116	23	,	,	,
cord-023095-4dannjjm	6116	24	U	U	NNP
cord-023095-4dannjjm	6116	25	I	I	NNP
cord-023095-4dannjjm	6116	26	/	/	SYM
cord-023095-4dannjjm	6116	27	C	c	NN
cord-023095-4dannjjm	6116	28	ratios	ratio	NNS
cord-023095-4dannjjm	6116	29	(	(	-LRB-
cord-023095-4dannjjm	6116	30	946	946	CD
cord-023095-4dannjjm	6116	31	vs.	vs.	NN
cord-023095-4dannjjm	6116	32	806	806	CD
cord-023095-4dannjjm	6116	33	pg	pg	NNP
cord-023095-4dannjjm	6116	34	/	/	SYM
cord-023095-4dannjjm	6116	35	mg	mg	NNP
cord-023095-4dannjjm	6116	36	)	)	-RRB-
cord-023095-4dannjjm	6116	37	,	,	,
cord-023095-4dannjjm	6116	38	SPI2	SPI2	NNP
cord-023095-4dannjjm	6116	39	scores	score	NNS
cord-023095-4dannjjm	6116	40	(	(	-LRB-
cord-023095-4dannjjm	6116	41	0.74	0.74	CD
cord-023095-4dannjjm	6116	42	vs.	vs.	CC
cord-023095-4dannjjm	6116	43	0.75	0.75	CD
cord-023095-4dannjjm	6116	44	)	)	-RRB-
cord-023095-4dannjjm	6116	45	,	,	,
cord-023095-4dannjjm	6116	46	and	and	CC
cord-023095-4dannjjm	6116	47	outcome	outcome	NN
cord-023095-4dannjjm	6116	48	(	(	-LRB-
cord-023095-4dannjjm	6116	49	81	81	CD
cord-023095-4dannjjm	6116	50	%	%	NN
cord-023095-4dannjjm	6116	51	vs.	vs.	CC
cord-023095-4dannjjm	6116	52	76	76	CD
cord-023095-4dannjjm	6116	53	%	%	NN
cord-023095-4dannjjm	6116	54	)	)	-RRB-
cord-023095-4dannjjm	6116	55	were	be	VBD
cord-023095-4dannjjm	6116	56	not	not	RB
cord-023095-4dannjjm	6116	57	significantly	significantly	RB
cord-023095-4dannjjm	6116	58	different	different	JJ
cord-023095-4dannjjm	6116	59	between	between	IN
cord-023095-4dannjjm	6116	60	the	the	DT
cord-023095-4dannjjm	6116	61	NAC	NAC	NNP
cord-023095-4dannjjm	6116	62	and	and	CC
cord-023095-4dannjjm	6116	63	placebo	placebo	NN
cord-023095-4dannjjm	6116	64	groups	group	NNS
cord-023095-4dannjjm	6116	65	after	after	IN
cord-023095-4dannjjm	6116	66	treatment	treatment	NN
cord-023095-4dannjjm	6116	67	.	.	.
cord-023095-4dannjjm	6117	1	The	the	DT
cord-023095-4dannjjm	6117	2	results	result	NNS
cord-023095-4dannjjm	6117	3	of	of	IN
cord-023095-4dannjjm	6117	4	this	this	DT
cord-023095-4dannjjm	6117	5	study	study	NN
cord-023095-4dannjjm	6117	6	further	far	RBR
cord-023095-4dannjjm	6117	7	support	support	NN
cord-023095-4dannjjm	6117	8	that	that	WDT
cord-023095-4dannjjm	6117	9	clinically	clinically	RB
cord-023095-4dannjjm	6117	10	ill	ill	JJ
cord-023095-4dannjjm	6117	11	dogs	dog	NNS
cord-023095-4dannjjm	6117	12	experience	experience	NN
cord-023095-4dannjjm	6117	13	oxidative	oxidative	JJ
cord-023095-4dannjjm	6117	14	stress	stress	NN
cord-023095-4dannjjm	6117	15	,	,	,
cord-023095-4dannjjm	6117	16	and	and	CC
cord-023095-4dannjjm	6117	17	suggest	suggest	VBP
cord-023095-4dannjjm	6117	18	that	that	IN
cord-023095-4dannjjm	6117	19	antioxidant	antioxidant	JJ
cord-023095-4dannjjm	6117	20	supplementation	supplementation	NN
cord-023095-4dannjjm	6117	21	with	with	IN
cord-023095-4dannjjm	6117	22	NAC	NAC	NNP
cord-023095-4dannjjm	6117	23	within	within	IN
cord-023095-4dannjjm	6117	24	the	the	DT
cord-023095-4dannjjm	6117	25	first	first	JJ
cord-023095-4dannjjm	6117	26	48	48	CD
cord-023095-4dannjjm	6117	27	hours	hour	NNS
cord-023095-4dannjjm	6117	28	of	of	IN
cord-023095-4dannjjm	6117	29	hospitalization	hospitalization	NN
cord-023095-4dannjjm	6117	30	prevents	prevent	VBZ
cord-023095-4dannjjm	6117	31	further	far	RBR
cord-023095-4dannjjm	6117	32	RBC	RBC	NNP
cord-023095-4dannjjm	6117	33	GSH	GSH	NNP
cord-023095-4dannjjm	6117	34	depletion	depletion	NN
cord-023095-4dannjjm	6117	35	.	.	.
cord-023095-4dannjjm	6118	1	Further	further	JJ
cord-023095-4dannjjm	6118	2	studies	study	NNS
cord-023095-4dannjjm	6118	3	are	be	VBP
cord-023095-4dannjjm	6118	4	necessary	necessary	JJ
cord-023095-4dannjjm	6118	5	to	to	TO
cord-023095-4dannjjm	6118	6	investigate	investigate	VB
cord-023095-4dannjjm	6118	7	whether	whether	IN
cord-023095-4dannjjm	6118	8	longer	long	JJR
cord-023095-4dannjjm	6118	9	duration	duration	NN
cord-023095-4dannjjm	6118	10	or	or	CC
cord-023095-4dannjjm	6118	11	combined	combine	VBN
cord-023095-4dannjjm	6118	12	antioxidant	antioxidant	NN
cord-023095-4dannjjm	6118	13	supplementation	supplementation	NN
cord-023095-4dannjjm	6118	14	normalizes	normalize	VBZ
cord-023095-4dannjjm	6118	15	the	the	DT
cord-023095-4dannjjm	6118	16	redox	redox	JJ
cord-023095-4dannjjm	6118	17	state	state	NN
cord-023095-4dannjjm	6118	18	and	and	CC
cord-023095-4dannjjm	6118	19	impacts	impact	NNS
cord-023095-4dannjjm	6118	20	long	long	JJ
cord-023095-4dannjjm	6118	21	-	-	HYPH
cord-023095-4dannjjm	6118	22	term	term	NN
cord-023095-4dannjjm	6118	23	outcome	outcome	NN
cord-023095-4dannjjm	6118	24	.	.	.
cord-023095-4dannjjm	6119	1	Diabetes	diabetes	NN
cord-023095-4dannjjm	6119	2	Mellitus	mellitus	NN
cord-023095-4dannjjm	6119	3	in	in	IN
cord-023095-4dannjjm	6119	4	cats	cat	NNS
cord-023095-4dannjjm	6119	5	is	be	VBZ
cord-023095-4dannjjm	6119	6	very	very	RB
cord-023095-4dannjjm	6119	7	similar	similar	JJ
cord-023095-4dannjjm	6119	8	to	to	IN
cord-023095-4dannjjm	6119	9	Type	Type	NNP
cord-023095-4dannjjm	6119	10	II	II	NNP
cord-023095-4dannjjm	6119	11	Diabetes	diabetes	NN
cord-023095-4dannjjm	6119	12	in	in	IN
cord-023095-4dannjjm	6119	13	Humans	Humans	NNPS
cord-023095-4dannjjm	6119	14	,	,	,
cord-023095-4dannjjm	6119	15	preceded	precede	VBN
cord-023095-4dannjjm	6119	16	by	by	IN
cord-023095-4dannjjm	6119	17	a	a	DT
cord-023095-4dannjjm	6119	18	period	period	NN
cord-023095-4dannjjm	6119	19	of	of	IN
cord-023095-4dannjjm	6119	20	insulin	insulin	NN
cord-023095-4dannjjm	6119	21	resistance	resistance	NN
cord-023095-4dannjjm	6119	22	.	.	.
cord-023095-4dannjjm	6120	1	Evaluating	evaluate	VBG
cord-023095-4dannjjm	6120	2	insulin	insulin	NN
cord-023095-4dannjjm	6120	3	resistance	resistance	NN
cord-023095-4dannjjm	6120	4	in	in	IN
cord-023095-4dannjjm	6120	5	a	a	DT
cord-023095-4dannjjm	6120	6	cat	cat	NN
cord-023095-4dannjjm	6120	7	is	be	VBZ
cord-023095-4dannjjm	6120	8	a	a	DT
cord-023095-4dannjjm	6120	9	time	time	NN
cord-023095-4dannjjm	6120	10	consuming	consume	VBG
cord-023095-4dannjjm	6120	11	,	,	,
cord-023095-4dannjjm	6120	12	expensive	expensive	JJ
cord-023095-4dannjjm	6120	13	,	,	,
cord-023095-4dannjjm	6120	14	and	and	CC
cord-023095-4dannjjm	6120	15	difficult	difficult	JJ
cord-023095-4dannjjm	6120	16	procedure	procedure	NN
cord-023095-4dannjjm	6120	17	.	.	.
cord-023095-4dannjjm	6121	1	There	there	EX
cord-023095-4dannjjm	6121	2	is	be	VBZ
cord-023095-4dannjjm	6121	3	a	a	DT
cord-023095-4dannjjm	6121	4	need	need	NN
cord-023095-4dannjjm	6121	5	for	for	IN
cord-023095-4dannjjm	6121	6	a	a	DT
cord-023095-4dannjjm	6121	7	simple	simple	JJ
cord-023095-4dannjjm	6121	8	biomarker	biomarker	NN
cord-023095-4dannjjm	6121	9	based	base	VBN
cord-023095-4dannjjm	6121	10	test	test	NN
cord-023095-4dannjjm	6121	11	predictive	predictive	NN
cord-023095-4dannjjm	6121	12	of	of	IN
cord-023095-4dannjjm	6121	13	insulin	insulin	NN
cord-023095-4dannjjm	6121	14	resistance	resistance	NN
cord-023095-4dannjjm	6121	15	.	.	.
cord-023095-4dannjjm	6122	1	There	there	EX
cord-023095-4dannjjm	6122	2	is	be	VBZ
cord-023095-4dannjjm	6122	3	a	a	DT
cord-023095-4dannjjm	6122	4	biomarker	biomarker	NN
cord-023095-4dannjjm	6122	5	based	base	VBN
cord-023095-4dannjjm	6122	6	assay	assay	NN
cord-023095-4dannjjm	6122	7	predicative	predicative	JJ
cord-023095-4dannjjm	6122	8	of	of	IN
cord-023095-4dannjjm	6122	9	insulin	insulin	NN
cord-023095-4dannjjm	6122	10	resistance	resistance	NN
cord-023095-4dannjjm	6122	11	in	in	IN
cord-023095-4dannjjm	6122	12	humans	human	NNS
cord-023095-4dannjjm	6122	13	.	.	.
cord-023095-4dannjjm	6123	1	The	the	DT
cord-023095-4dannjjm	6123	2	purpose	purpose	NN
cord-023095-4dannjjm	6123	3	of	of	IN
cord-023095-4dannjjm	6123	4	this	this	DT
cord-023095-4dannjjm	6123	5	study	study	NN
cord-023095-4dannjjm	6123	6	was	be	VBD
cord-023095-4dannjjm	6123	7	to	to	TO
cord-023095-4dannjjm	6123	8	evaluate	evaluate	VB
cord-023095-4dannjjm	6123	9	the	the	DT
cord-023095-4dannjjm	6123	10	utility	utility	NN
cord-023095-4dannjjm	6123	11	of	of	IN
cord-023095-4dannjjm	6123	12	this	this	DT
cord-023095-4dannjjm	6123	13	assay	assay	NN
cord-023095-4dannjjm	6123	14	in	in	IN
cord-023095-4dannjjm	6123	15	overweight	overweight	JJ
cord-023095-4dannjjm	6123	16	cats	cat	NNS
cord-023095-4dannjjm	6123	17	and	and	CC
cord-023095-4dannjjm	6123	18	show	show	VBP
cord-023095-4dannjjm	6123	19	improvement	improvement	NN
cord-023095-4dannjjm	6123	20	in	in	IN
cord-023095-4dannjjm	6123	21	insulin	insulin	NN
cord-023095-4dannjjm	6123	22	sensitivity	sensitivity	NN
cord-023095-4dannjjm	6123	23	following	follow	VBG
cord-023095-4dannjjm	6123	24	weight	weight	NN
cord-023095-4dannjjm	6123	25	loss	loss	NN
cord-023095-4dannjjm	6123	26	and	and	CC
cord-023095-4dannjjm	6123	27	weight	weight	NN
cord-023095-4dannjjm	6123	28	maintenance	maintenance	NN
cord-023095-4dannjjm	6123	29	.	.	.
cord-023095-4dannjjm	6124	1	The	the	DT
cord-023095-4dannjjm	6124	2	insulin	insulin	NN
cord-023095-4dannjjm	6124	3	resistance	resistance	NN
cord-023095-4dannjjm	6124	4	assay	assay	NN
cord-023095-4dannjjm	6124	5	is	be	VBZ
cord-023095-4dannjjm	6124	6	based	base	VBN
cord-023095-4dannjjm	6124	7	on	on	IN
cord-023095-4dannjjm	6124	8	the	the	DT
cord-023095-4dannjjm	6124	9	quantitative	quantitative	JJ
cord-023095-4dannjjm	6124	10	analysis	analysis	NN
cord-023095-4dannjjm	6124	11	of	of	IN
cord-023095-4dannjjm	6124	12	5	5	CD
cord-023095-4dannjjm	6124	13	metabolites	metabolite	NNS
cord-023095-4dannjjm	6124	14	(	(	-LRB-
cord-023095-4dannjjm	6124	15	2-hydroxybuterate	2-hydroxybuterate	CD
cord-023095-4dannjjm	6124	16	,	,	,
cord-023095-4dannjjm	6124	17	creatine	creatine	NN
cord-023095-4dannjjm	6124	18	,	,	,
cord-023095-4dannjjm	6124	19	palmitate	palmitate	NN
cord-023095-4dannjjm	6124	20	,	,	,
cord-023095-4dannjjm	6124	21	decanoylcarnitine	decanoylcarnitine	NNP
cord-023095-4dannjjm	6124	22	,	,	,
cord-023095-4dannjjm	6124	23	and	and	CC
cord-023095-4dannjjm	6124	24	oleoyl	oleoyl	NNP
cord-023095-4dannjjm	6124	25	-	-	HYPH
cord-023095-4dannjjm	6124	26	LPC	LPC	NNP
cord-023095-4dannjjm	6124	27	)	)	-RRB-
cord-023095-4dannjjm	6124	28	.	.	.
cord-023095-4dannjjm	6125	1	A	a	DT
cord-023095-4dannjjm	6125	2	proprietary	proprietary	JJ
cord-023095-4dannjjm	6125	3	algorithm	algorithm	NN
cord-023095-4dannjjm	6125	4	(	(	-LRB-
cord-023095-4dannjjm	6125	5	Metabolon	Metabolon	NNP
cord-023095-4dannjjm	6125	6	,	,	,
cord-023095-4dannjjm	6125	7	Inc	Inc	NNP
cord-023095-4dannjjm	6125	8	,	,	,
cord-023095-4dannjjm	6125	9	Durham	Durham	NNP
cord-023095-4dannjjm	6125	10	NC	NC	NNP
cord-023095-4dannjjm	6125	11	)	)	-RRB-
cord-023095-4dannjjm	6125	12	was	be	VBD
cord-023095-4dannjjm	6125	13	used	use	VBN
cord-023095-4dannjjm	6125	14	to	to	TO
cord-023095-4dannjjm	6125	15	generate	generate	VB
cord-023095-4dannjjm	6125	16	a	a	DT
cord-023095-4dannjjm	6125	17	predictive	predictive	JJ
cord-023095-4dannjjm	6125	18	RD	RD	NNP
cord-023095-4dannjjm	6125	19	(	(	-LRB-
cord-023095-4dannjjm	6125	20	Rate	rate	NN
cord-023095-4dannjjm	6125	21	of	of	IN
cord-023095-4dannjjm	6125	22	Disposal	Disposal	NNP
cord-023095-4dannjjm	6125	23	)	)	-RRB-
cord-023095-4dannjjm	6125	24	value	value	NN
cord-023095-4dannjjm	6125	25	(	(	-LRB-
cord-023095-4dannjjm	6125	26	normal	normal	JJ
cord-023095-4dannjjm	6125	27	range	range	NN
cord-023095-4dannjjm	6125	28	in	in	IN
cord-023095-4dannjjm	6125	29	cats	cat	NNS
cord-023095-4dannjjm	6125	30	6.5	6.5	CD
cord-023095-4dannjjm	6125	31	-	-	HYPH
cord-023095-4dannjjm	6125	32	10.5	10.5	CD
cord-023095-4dannjjm	6125	33	)	)	-RRB-
cord-023095-4dannjjm	6125	34	.	.	.
cord-023095-4dannjjm	6126	1	Individuals	individual	NNS
cord-023095-4dannjjm	6126	2	with	with	IN
cord-023095-4dannjjm	6126	3	an	an	DT
cord-023095-4dannjjm	6126	4	RD	RD	NNP
cord-023095-4dannjjm	6126	5	value	value	NN
cord-023095-4dannjjm	6126	6	less	less	JJR
cord-023095-4dannjjm	6126	7	than	than	IN
cord-023095-4dannjjm	6126	8	6	6	CD
cord-023095-4dannjjm	6126	9	will	will	MD
cord-023095-4dannjjm	6126	10	have	have	VB
cord-023095-4dannjjm	6126	11	a	a	DT
cord-023095-4dannjjm	6126	12	greater	great	JJR
cord-023095-4dannjjm	6126	13	than	than	IN
cord-023095-4dannjjm	6126	14	50	50	CD
cord-023095-4dannjjm	6126	15	%	%	NN
cord-023095-4dannjjm	6126	16	chance	chance	NN
cord-023095-4dannjjm	6126	17	of	of	IN
cord-023095-4dannjjm	6126	18	being	be	VBG
cord-023095-4dannjjm	6126	19	insulin	insulin	NN
cord-023095-4dannjjm	6126	20	resistant	resistant	JJ
cord-023095-4dannjjm	6126	21	and	and	CC
cord-023095-4dannjjm	6126	22	an	an	DT
cord-023095-4dannjjm	6126	23	RD	RD	NNP
cord-023095-4dannjjm	6126	24	value	value	NN
cord-023095-4dannjjm	6126	25	less	less	JJR
cord-023095-4dannjjm	6126	26	than	than	IN
cord-023095-4dannjjm	6126	27	3	3	CD
cord-023095-4dannjjm	6126	28	will	will	MD
cord-023095-4dannjjm	6126	29	have	have	VB
cord-023095-4dannjjm	6126	30	a	a	DT
cord-023095-4dannjjm	6126	31	greater	great	JJR
cord-023095-4dannjjm	6126	32	than	than	IN
cord-023095-4dannjjm	6126	33	90	90	CD
cord-023095-4dannjjm	6126	34	%	%	NN
cord-023095-4dannjjm	6126	35	chance	chance	NN
cord-023095-4dannjjm	6126	36	of	of	IN
cord-023095-4dannjjm	6126	37	being	be	VBG
cord-023095-4dannjjm	6126	38	insulin	insulin	NN
cord-023095-4dannjjm	6126	39	resistant	resistant	JJ
cord-023095-4dannjjm	6126	40	.	.	.
cord-023095-4dannjjm	6127	1	Initial	initial	JJ
cord-023095-4dannjjm	6127	2	studies	study	NNS
cord-023095-4dannjjm	6127	3	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	6127	4	that	that	IN
cord-023095-4dannjjm	6127	5	the	the	DT
cord-023095-4dannjjm	6127	6	RD	RD	NNP
cord-023095-4dannjjm	6127	7	values	value	NNS
cord-023095-4dannjjm	6127	8	indicating	indicate	VBG
cord-023095-4dannjjm	6127	9	insulin	insulin	NN
cord-023095-4dannjjm	6127	10	resistance	resistance	NN
cord-023095-4dannjjm	6127	11	in	in	IN
cord-023095-4dannjjm	6127	12	cats	cat	NNS
cord-023095-4dannjjm	6127	13	correlated	correlate	VBD
cord-023095-4dannjjm	6127	14	with	with	IN
cord-023095-4dannjjm	6127	15	age	age	NN
cord-023095-4dannjjm	6127	16	,	,	,
cord-023095-4dannjjm	6127	17	obesity	obesity	NN
cord-023095-4dannjjm	6127	18	and	and	CC
cord-023095-4dannjjm	6127	19	severity	severity	NN
cord-023095-4dannjjm	6127	20	of	of	IN
cord-023095-4dannjjm	6127	21	diabetes	diabetes	NN
cord-023095-4dannjjm	6127	22	as	as	IN
cord-023095-4dannjjm	6127	23	determined	determine	VBN
cord-023095-4dannjjm	6127	24	by	by	IN
cord-023095-4dannjjm	6127	25	histopathology	histopathology	NN
cord-023095-4dannjjm	6127	26	and	and	CC
cord-023095-4dannjjm	6127	27	blood	blood	NN
cord-023095-4dannjjm	6127	28	glucose	glucose	NN
cord-023095-4dannjjm	6127	29	levels	level	NNS
cord-023095-4dannjjm	6127	30	.	.	.
cord-023095-4dannjjm	6128	1	In	in	IN
cord-023095-4dannjjm	6128	2	a	a	DT
cord-023095-4dannjjm	6128	3	feeding	feeding	NN
cord-023095-4dannjjm	6128	4	study	study	NN
cord-023095-4dannjjm	6128	5	of	of	IN
cord-023095-4dannjjm	6128	6	40	40	CD
cord-023095-4dannjjm	6128	7	cats	cat	NNS
cord-023095-4dannjjm	6128	8	(	(	-LRB-
cord-023095-4dannjjm	6128	9	4	4	CD
cord-023095-4dannjjm	6128	10	39	39	CD
cord-023095-4dannjjm	6128	11	%	%	NN
cord-023095-4dannjjm	6128	12	vs.	vs.	CC
cord-023095-4dannjjm	6128	13	o	o	NN
cord-023095-4dannjjm	6128	14	25	25	CD
cord-023095-4dannjjm	6128	15	%	%	NN
cord-023095-4dannjjm	6128	16	body	body	NN
cord-023095-4dannjjm	6128	17	fat	fat	NN
cord-023095-4dannjjm	6128	18	)	)	-RRB-
cord-023095-4dannjjm	6129	1	RD	RD	NNP
cord-023095-4dannjjm	6129	2	values	value	NNS
cord-023095-4dannjjm	6129	3	improved	improve	VBD
cord-023095-4dannjjm	6129	4	from	from	IN
cord-023095-4dannjjm	6129	5	6.19	6.19	CD
cord-023095-4dannjjm	6129	6	AE	AE	NNP
cord-023095-4dannjjm	6129	7	1.23	1.23	CD
cord-023095-4dannjjm	6129	8	to	to	IN
cord-023095-4dannjjm	6129	9	6.8411.38	6.8411.38	CD
cord-023095-4dannjjm	6130	1	(	(	-LRB-
cord-023095-4dannjjm	6130	2	p	p	NN
cord-023095-4dannjjm	6130	3	5	5	CD
cord-023095-4dannjjm	6130	4	0.029	0.029	CD
cord-023095-4dannjjm	6130	5	)	)	-RRB-
cord-023095-4dannjjm	6130	6	.	.	.
cord-023095-4dannjjm	6131	1	During	during	IN
cord-023095-4dannjjm	6131	2	weight	weight	NN
cord-023095-4dannjjm	6131	3	maintenance	maintenance	NN
cord-023095-4dannjjm	6131	4	,	,	,
cord-023095-4dannjjm	6131	5	19	19	CD
cord-023095-4dannjjm	6131	6	%	%	NN
cord-023095-4dannjjm	6131	7	body	body	NN
cord-023095-4dannjjm	6131	8	fat	fat	NN
cord-023095-4dannjjm	6131	9	for	for	IN
cord-023095-4dannjjm	6131	10	4	4	CD
cord-023095-4dannjjm	6131	11	months	month	NNS
cord-023095-4dannjjm	6131	12	,	,	,
cord-023095-4dannjjm	6131	13	further	further	JJ
cord-023095-4dannjjm	6131	14	improvement	improvement	NN
cord-023095-4dannjjm	6131	15	was	be	VBD
cord-023095-4dannjjm	6131	16	observed	observe	VBN
cord-023095-4dannjjm	6131	17	(	(	-LRB-
cord-023095-4dannjjm	6131	18	RD	RD	NNP
cord-023095-4dannjjm	6131	19	,	,	,
cord-023095-4dannjjm	6131	20	8.30	8.30	CD
cord-023095-4dannjjm	6131	21	1	1	CD
cord-023095-4dannjjm	6131	22	1.08	1.08	CD
cord-023095-4dannjjm	6131	23	(	(	-LRB-
cord-023095-4dannjjm	6131	24	p	p	NN
cord-023095-4dannjjm	6131	25	5	5	CD
cord-023095-4dannjjm	6131	26	9.2E-12	9.2e-12	CD
cord-023095-4dannjjm	6131	27	)	)	-RRB-
cord-023095-4dannjjm	6131	28	)	)	-RRB-
cord-023095-4dannjjm	6131	29	.	.	.
cord-023095-4dannjjm	6132	1	These	these	DT
cord-023095-4dannjjm	6132	2	results	result	NNS
cord-023095-4dannjjm	6132	3	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	6132	4	that	that	IN
cord-023095-4dannjjm	6132	5	long	long	JJ
cord-023095-4dannjjm	6132	6	term	term	NN
cord-023095-4dannjjm	6132	7	weight	weight	NN
cord-023095-4dannjjm	6132	8	maintenance	maintenance	NN
cord-023095-4dannjjm	6132	9	following	follow	VBG
cord-023095-4dannjjm	6132	10	weight	weight	NN
cord-023095-4dannjjm	6132	11	loss	loss	NN
cord-023095-4dannjjm	6132	12	is	be	VBZ
cord-023095-4dannjjm	6132	13	critical	critical	JJ
cord-023095-4dannjjm	6132	14	for	for	IN
cord-023095-4dannjjm	6132	15	increasing	increase	VBG
cord-023095-4dannjjm	6132	16	insulin	insulin	NN
cord-023095-4dannjjm	6132	17	sensitivity	sensitivity	NN
cord-023095-4dannjjm	6132	18	in	in	IN
cord-023095-4dannjjm	6132	19	cats	cat	NNS
cord-023095-4dannjjm	6132	20	.	.	.
cord-023095-4dannjjm	6133	1	The	the	DT
cord-023095-4dannjjm	6133	2	use	use	NN
cord-023095-4dannjjm	6133	3	of	of	IN
cord-023095-4dannjjm	6133	4	monoclonal	monoclonal	JJ
cord-023095-4dannjjm	6133	5	antibodies	antibody	NNS
cord-023095-4dannjjm	6133	6	and	and	CC
cord-023095-4dannjjm	6133	7	antibody	antibody	NN
cord-023095-4dannjjm	6133	8	fragments	fragment	NNS
cord-023095-4dannjjm	6133	9	to	to	TO
cord-023095-4dannjjm	6133	10	directly	directly	RB
cord-023095-4dannjjm	6133	11	target	target	VB
cord-023095-4dannjjm	6133	12	tumor	tumor	NN
cord-023095-4dannjjm	6133	13	antigens	antigen	NNS
cord-023095-4dannjjm	6133	14	and	and	CC
cord-023095-4dannjjm	6133	15	neutralize	neutralize	VB
cord-023095-4dannjjm	6133	16	their	-PRON-	PRP$
cord-023095-4dannjjm	6133	17	growth	growth	NN
cord-023095-4dannjjm	6133	18	factors	factor	NNS
cord-023095-4dannjjm	6133	19	has	have	VBZ
cord-023095-4dannjjm	6133	20	shown	show	VBN
cord-023095-4dannjjm	6133	21	promising	promising	JJ
cord-023095-4dannjjm	6133	22	results	result	NNS
cord-023095-4dannjjm	6133	23	in	in	IN
cord-023095-4dannjjm	6133	24	human	human	JJ
cord-023095-4dannjjm	6133	25	clinical	clinical	JJ
cord-023095-4dannjjm	6133	26	trials	trial	NNS
cord-023095-4dannjjm	6133	27	.	.	.
cord-023095-4dannjjm	6134	1	However	however	RB
cord-023095-4dannjjm	6134	2	,	,	,
cord-023095-4dannjjm	6134	3	these	these	DT
cord-023095-4dannjjm	6134	4	targeted	target	VBN
cord-023095-4dannjjm	6134	5	approaches	approach	NNS
cord-023095-4dannjjm	6134	6	have	have	VBP
cord-023095-4dannjjm	6134	7	not	not	RB
cord-023095-4dannjjm	6134	8	been	be	VBN
cord-023095-4dannjjm	6134	9	possible	possible	JJ
cord-023095-4dannjjm	6134	10	in	in	IN
cord-023095-4dannjjm	6134	11	dogs	dog	NNS
cord-023095-4dannjjm	6134	12	since	since	IN
cord-023095-4dannjjm	6134	13	specific	specific	JJ
cord-023095-4dannjjm	6134	14	tumor	tumor	NN
cord-023095-4dannjjm	6134	15	antigens	antigen	NNS
cord-023095-4dannjjm	6134	16	have	have	VBP
cord-023095-4dannjjm	6134	17	not	not	RB
cord-023095-4dannjjm	6134	18	been	be	VBN
cord-023095-4dannjjm	6134	19	identified	identify	VBN
cord-023095-4dannjjm	6134	20	,	,	,
cord-023095-4dannjjm	6134	21	monoclonal	monoclonal	JJ
cord-023095-4dannjjm	6134	22	antibodies	antibody	NNS
cord-023095-4dannjjm	6134	23	of	of	IN
cord-023095-4dannjjm	6134	24	canine	canine	JJ
cord-023095-4dannjjm	6134	25	origin	origin	NN
cord-023095-4dannjjm	6134	26	are	be	VBP
cord-023095-4dannjjm	6134	27	not	not	RB
cord-023095-4dannjjm	6134	28	available	available	JJ
cord-023095-4dannjjm	6134	29	and	and	CC
cord-023095-4dannjjm	6134	30	the	the	DT
cord-023095-4dannjjm	6134	31	efficacy	efficacy	NN
cord-023095-4dannjjm	6134	32	of	of	IN
cord-023095-4dannjjm	6134	33	xenogeneic	xenogeneic	NNP
cord-023095-4dannjjm	6134	34	antibodies	antibody	NNS
cord-023095-4dannjjm	6134	35	in	in	IN
cord-023095-4dannjjm	6134	36	the	the	DT
cord-023095-4dannjjm	6134	37	dog	dog	NN
cord-023095-4dannjjm	6134	38	is	be	VBZ
cord-023095-4dannjjm	6134	39	limited	limit	VBN
cord-023095-4dannjjm	6134	40	by	by	IN
cord-023095-4dannjjm	6134	41	neutralizing	neutralize	VBG
cord-023095-4dannjjm	6134	42	antibody	antibody	NN
cord-023095-4dannjjm	6134	43	responses	response	NNS
cord-023095-4dannjjm	6134	44	.	.	.
cord-023095-4dannjjm	6135	1	To	to	TO
cord-023095-4dannjjm	6135	2	overcome	overcome	VB
cord-023095-4dannjjm	6135	3	these	these	DT
cord-023095-4dannjjm	6135	4	obstacles	obstacle	NNS
cord-023095-4dannjjm	6135	5	,	,	,
cord-023095-4dannjjm	6135	6	we	-PRON-	PRP
cord-023095-4dannjjm	6135	7	have	have	VBP
cord-023095-4dannjjm	6135	8	generated	generate	VBN
cord-023095-4dannjjm	6135	9	canine	canine	JJ
cord-023095-4dannjjm	6135	10	antibody	antibody	NN
cord-023095-4dannjjm	6135	11	phage	phage	NN
cord-023095-4dannjjm	6135	12	display	display	NN
cord-023095-4dannjjm	6135	13	libraries	library	NNS
cord-023095-4dannjjm	6135	14	from	from	IN
cord-023095-4dannjjm	6135	15	canine	canine	JJ
cord-023095-4dannjjm	6135	16	splenocytes	splenocyte	NNS
cord-023095-4dannjjm	6135	17	.	.	.
cord-023095-4dannjjm	6136	1	These	these	DT
cord-023095-4dannjjm	6136	2	libraries	library	NNS
cord-023095-4dannjjm	6136	3	consist	consist	VBP
cord-023095-4dannjjm	6136	4	of	of	IN
cord-023095-4dannjjm	6136	5	single	single	JJ
cord-023095-4dannjjm	6136	6	chain	chain	NN
cord-023095-4dannjjm	6136	7	variable	variable	NN
cord-023095-4dannjjm	6136	8	fragments	fragment	NNS
cord-023095-4dannjjm	6136	9	(	(	-LRB-
cord-023095-4dannjjm	6136	10	scFv	scFv	NNP
cord-023095-4dannjjm	6136	11	)	)	-RRB-
cord-023095-4dannjjm	6136	12	comprised	comprise	VBN
cord-023095-4dannjjm	6136	13	of	of	IN
cord-023095-4dannjjm	6136	14	canine	canine	JJ
cord-023095-4dannjjm	6136	15	variable	variable	NN
cord-023095-4dannjjm	6136	16	heavy	heavy	JJ
cord-023095-4dannjjm	6136	17	(	(	-LRB-
cord-023095-4dannjjm	6136	18	VH	VH	NNP
cord-023095-4dannjjm	6136	19	)	)	-RRB-
cord-023095-4dannjjm	6136	20	and	and	CC
cord-023095-4dannjjm	6136	21	variable	variable	JJ
cord-023095-4dannjjm	6136	22	light	light	NN
cord-023095-4dannjjm	6136	23	(	(	-LRB-
cord-023095-4dannjjm	6136	24	VL	VL	NNP
cord-023095-4dannjjm	6136	25	)	)	-RRB-
cord-023095-4dannjjm	6137	1	immunoglobulin	immunoglobulin	NN
cord-023095-4dannjjm	6137	2	chains	chain	NNS
cord-023095-4dannjjm	6137	3	displayed	display	VBN
cord-023095-4dannjjm	6137	4	on	on	IN
cord-023095-4dannjjm	6137	5	the	the	DT
cord-023095-4dannjjm	6137	6	surface	surface	NN
cord-023095-4dannjjm	6137	7	of	of	IN
cord-023095-4dannjjm	6137	8	bacteriophage	bacteriophage	NN
cord-023095-4dannjjm	6137	9	(	(	-LRB-
cord-023095-4dannjjm	6137	10	Fig	Fig	NNP
cord-023095-4dannjjm	6137	11	.	.	.
cord-023095-4dannjjm	6137	12	1	1	CD
cord-023095-4dannjjm	6137	13	)	)	-RRB-
cord-023095-4dannjjm	6137	14	.	.	.
cord-023095-4dannjjm	6138	1	The	the	DT
cord-023095-4dannjjm	6138	2	antigen	antigen	NN
cord-023095-4dannjjm	6138	3	specificity	specificity	NN
cord-023095-4dannjjm	6138	4	within	within	IN
cord-023095-4dannjjm	6138	5	these	these	DT
cord-023095-4dannjjm	6138	6	libraries	library	NNS
cord-023095-4dannjjm	6138	7	is	be	VBZ
cord-023095-4dannjjm	6138	8	diverse	diverse	JJ
cord-023095-4dannjjm	6138	9	and	and	CC
cord-023095-4dannjjm	6138	10	recapitulates	recapitulate	VBZ
cord-023095-4dannjjm	6138	11	the	the	DT
cord-023095-4dannjjm	6138	12	antigen	antigen	NN
cord-023095-4dannjjm	6138	13	-	-	HYPH
cord-023095-4dannjjm	6138	14	experienced	experience	VBN
cord-023095-4dannjjm	6138	15	immunoglobulin	immunoglobulin	NN
cord-023095-4dannjjm	6138	16	repertoire	repertoire	NN
cord-023095-4dannjjm	6138	17	of	of	IN
cord-023095-4dannjjm	6138	18	the	the	DT
cord-023095-4dannjjm	6138	19	dog	dog	NN
cord-023095-4dannjjm	6138	20	.	.	.
cord-023095-4dannjjm	6139	1	We	-PRON-	PRP
cord-023095-4dannjjm	6139	2	can	can	MD
cord-023095-4dannjjm	6139	3	now	now	RB
cord-023095-4dannjjm	6139	4	use	use	VB
cord-023095-4dannjjm	6139	5	simple	simple	JJ
cord-023095-4dannjjm	6139	6	panning	panning	NN
cord-023095-4dannjjm	6139	7	techniques	technique	NNS
cord-023095-4dannjjm	6139	8	to	to	TO
cord-023095-4dannjjm	6139	9	isolate	isolate	VB
cord-023095-4dannjjm	6139	10	scFv	scFv	NNS
cord-023095-4dannjjm	6139	11	of	of	IN
cord-023095-4dannjjm	6139	12	canine	canine	JJ
cord-023095-4dannjjm	6139	13	origin	origin	NN
cord-023095-4dannjjm	6139	14	that	that	WDT
cord-023095-4dannjjm	6139	15	bind	bind	VBP
cord-023095-4dannjjm	6139	16	to	to	IN
cord-023095-4dannjjm	6139	17	either	either	CC
cord-023095-4dannjjm	6139	18	known	know	VBN
cord-023095-4dannjjm	6139	19	targets	target	NNS
cord-023095-4dannjjm	6139	20	or	or	CC
cord-023095-4dannjjm	6139	21	unknown	unknown	JJ
cord-023095-4dannjjm	6139	22	targets	target	NNS
cord-023095-4dannjjm	6139	23	which	which	WDT
cord-023095-4dannjjm	6139	24	can	can	MD
cord-023095-4dannjjm	6139	25	then	then	RB
cord-023095-4dannjjm	6139	26	be	be	VB
cord-023095-4dannjjm	6139	27	identified	identify	VBN
cord-023095-4dannjjm	6139	28	using	use	VBG
cord-023095-4dannjjm	6139	29	standard	standard	JJ
cord-023095-4dannjjm	6139	30	molecular	molecular	JJ
cord-023095-4dannjjm	6139	31	techniques	technique	NNS
cord-023095-4dannjjm	6139	32	.	.	.
cord-023095-4dannjjm	6140	1	Canine	canine	JJ
cord-023095-4dannjjm	6140	2	HSA	HSA	NNP
cord-023095-4dannjjm	6140	3	is	be	VBZ
cord-023095-4dannjjm	6140	4	a	a	DT
cord-023095-4dannjjm	6140	5	highly	highly	RB
cord-023095-4dannjjm	6140	6	aggressive	aggressive	JJ
cord-023095-4dannjjm	6140	7	malignancy	malignancy	NN
cord-023095-4dannjjm	6140	8	of	of	IN
cord-023095-4dannjjm	6140	9	vascular	vascular	JJ
cord-023095-4dannjjm	6140	10	endothelial	endothelial	JJ
cord-023095-4dannjjm	6140	11	cells	cell	NNS
cord-023095-4dannjjm	6140	12	that	that	WDT
cord-023095-4dannjjm	6140	13	affects	affect	VBZ
cord-023095-4dannjjm	6140	14	large	large	JJ
cord-023095-4dannjjm	6140	15	breed	breed	NN
cord-023095-4dannjjm	6140	16	dogs	dog	NNS
cord-023095-4dannjjm	6140	17	.	.	.
cord-023095-4dannjjm	6141	1	Although	although	IN
cord-023095-4dannjjm	6141	2	there	there	EX
cord-023095-4dannjjm	6141	3	are	be	VBP
cord-023095-4dannjjm	6141	4	no	no	DT
cord-023095-4dannjjm	6141	5	confirmed	confirm	VBN
cord-023095-4dannjjm	6141	6	immunological	immunological	JJ
cord-023095-4dannjjm	6141	7	targets	target	NNS
cord-023095-4dannjjm	6141	8	for	for	IN
cord-023095-4dannjjm	6141	9	HSA	HSA	NNP
cord-023095-4dannjjm	6141	10	,	,	,
cord-023095-4dannjjm	6141	11	serum	serum	NN
cord-023095-4dannjjm	6141	12	levels	level	NNS
cord-023095-4dannjjm	6141	13	of	of	IN
cord-023095-4dannjjm	6141	14	Vascular	vascular	JJ
cord-023095-4dannjjm	6141	15	Endothelial	Endothelial	NNP
cord-023095-4dannjjm	6141	16	Growth	Growth	NNP
cord-023095-4dannjjm	6141	17	Factor	factor	NN
cord-023095-4dannjjm	6141	18	(	(	-LRB-
cord-023095-4dannjjm	6141	19	VEGF	VEGF	NNP
cord-023095-4dannjjm	6141	20	)	)	-RRB-
cord-023095-4dannjjm	6141	21	are	be	VBP
cord-023095-4dannjjm	6141	22	elevated	elevate	VBN
cord-023095-4dannjjm	6141	23	in	in	IN
cord-023095-4dannjjm	6141	24	these	these	DT
cord-023095-4dannjjm	6141	25	patients	patient	NNS
cord-023095-4dannjjm	6141	26	and	and	CC
cord-023095-4dannjjm	6141	27	,	,	,
cord-023095-4dannjjm	6141	28	as	as	IN
cord-023095-4dannjjm	6141	29	in	in	IN
cord-023095-4dannjjm	6141	30	many	many	JJ
cord-023095-4dannjjm	6141	31	human	human	JJ
cord-023095-4dannjjm	6141	32	cancers	cancer	NNS
cord-023095-4dannjjm	6141	33	,	,	,
cord-023095-4dannjjm	6141	34	VEGF	VEGF	NNP
cord-023095-4dannjjm	6141	35	may	may	MD
cord-023095-4dannjjm	6141	36	represent	represent	VB
cord-023095-4dannjjm	6141	37	an	an	DT
cord-023095-4dannjjm	6141	38	important	important	JJ
cord-023095-4dannjjm	6141	39	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	6141	40	target	target	NN
cord-023095-4dannjjm	6141	41	for	for	IN
cord-023095-4dannjjm	6141	42	neutralization	neutralization	NN
cord-023095-4dannjjm	6141	43	.	.	.
cord-023095-4dannjjm	6142	1	We	-PRON-	PRP
cord-023095-4dannjjm	6142	2	used	use	VBD
cord-023095-4dannjjm	6142	3	simple	simple	JJ
cord-023095-4dannjjm	6142	4	panning	panning	NN
cord-023095-4dannjjm	6142	5	techniques	technique	NNS
cord-023095-4dannjjm	6142	6	to	to	TO
cord-023095-4dannjjm	6142	7	screen	screen	VB
cord-023095-4dannjjm	6142	8	canine	canine	JJ
cord-023095-4dannjjm	6142	9	scFv	scFv	NNP
cord-023095-4dannjjm	6142	10	libraries	library	NNS
cord-023095-4dannjjm	6142	11	generated	generate	VBN
cord-023095-4dannjjm	6142	12	from	from	IN
cord-023095-4dannjjm	6142	13	the	the	DT
cord-023095-4dannjjm	6142	14	spleens	spleen	NNS
cord-023095-4dannjjm	6142	15	of	of	IN
cord-023095-4dannjjm	6142	16	dogs	dog	NNS
cord-023095-4dannjjm	6142	17	with	with	IN
cord-023095-4dannjjm	6142	18	HSA	HSA	NNP
cord-023095-4dannjjm	6142	19	against	against	IN
cord-023095-4dannjjm	6142	20	canine	canine	JJ
cord-023095-4dannjjm	6142	21	VEGF	vegf	NN
cord-023095-4dannjjm	6142	22	and	and	CC
cord-023095-4dannjjm	6142	23	successfully	successfully	RB
cord-023095-4dannjjm	6142	24	isolated	isolate	VBN
cord-023095-4dannjjm	6142	25	3	3	CD
cord-023095-4dannjjm	6142	26	scFv	scfv	JJ
cord-023095-4dannjjm	6142	27	clones	clone	NNS
cord-023095-4dannjjm	6142	28	that	that	WDT
cord-023095-4dannjjm	6142	29	bind	bind	VBP
cord-023095-4dannjjm	6142	30	and	and	CC
cord-023095-4dannjjm	6142	31	neutralize	neutralize	VB
cord-023095-4dannjjm	6142	32	canine	canine	JJ
cord-023095-4dannjjm	6142	33	VEGF	vegf	NN
cord-023095-4dannjjm	6142	34	in	in	IN
cord-023095-4dannjjm	6142	35	vitro	vitro	FW
cord-023095-4dannjjm	6142	36	.	.	.
cord-023095-4dannjjm	6143	1	These	these	DT
cord-023095-4dannjjm	6143	2	scFvs	scfv	NNS
cord-023095-4dannjjm	6143	3	are	be	VBP
cord-023095-4dannjjm	6143	4	now	now	RB
cord-023095-4dannjjm	6143	5	being	be	VBG
cord-023095-4dannjjm	6143	6	taken	take	VBN
cord-023095-4dannjjm	6143	7	into	into	IN
cord-023095-4dannjjm	6143	8	a	a	DT
cord-023095-4dannjjm	6143	9	murine	murine	JJ
cord-023095-4dannjjm	6143	10	model	model	NN
cord-023095-4dannjjm	6143	11	of	of	IN
cord-023095-4dannjjm	6143	12	canine	canine	JJ
cord-023095-4dannjjm	6143	13	HSA	HSA	NNP
cord-023095-4dannjjm	6143	14	to	to	TO
cord-023095-4dannjjm	6143	15	determine	determine	VB
cord-023095-4dannjjm	6143	16	whether	whether	IN
cord-023095-4dannjjm	6143	17	they	-PRON-	PRP
cord-023095-4dannjjm	6143	18	can	can	MD
cord-023095-4dannjjm	6143	19	inhibit	inhibit	VB
cord-023095-4dannjjm	6143	20	tumor	tumor	NN
cord-023095-4dannjjm	6143	21	growth	growth	NN
cord-023095-4dannjjm	6143	22	and	and	CC
cord-023095-4dannjjm	6143	23	metastases	metastasis	NNS
cord-023095-4dannjjm	6143	24	.	.	.
cord-023095-4dannjjm	6144	1	In	in	IN
cord-023095-4dannjjm	6144	2	addition	addition	NN
cord-023095-4dannjjm	6144	3	,	,	,
cord-023095-4dannjjm	6144	4	we	-PRON-	PRP
cord-023095-4dannjjm	6144	5	have	have	VBP
cord-023095-4dannjjm	6144	6	panned	pan	VBN
cord-023095-4dannjjm	6144	7	the	the	DT
cord-023095-4dannjjm	6144	8	same	same	JJ
cord-023095-4dannjjm	6144	9	antigen	antigen	NN
cord-023095-4dannjjm	6144	10	-	-	HYPH
cord-023095-4dannjjm	6144	11	experienced	experience	VBN
cord-023095-4dannjjm	6144	12	scFv	scFv	HYPH
cord-023095-4dannjjm	6144	13	phage	phage	NN
cord-023095-4dannjjm	6144	14	display	display	NN
cord-023095-4dannjjm	6144	15	libraries	library	NNS
cord-023095-4dannjjm	6144	16	against	against	IN
cord-023095-4dannjjm	6144	17	allogeneic	allogeneic	JJ
cord-023095-4dannjjm	6144	18	primary	primary	JJ
cord-023095-4dannjjm	6144	19	canine	canine	JJ
cord-023095-4dannjjm	6144	20	HSA	HSA	NNP
cord-023095-4dannjjm	6144	21	cells	cell	NNS
cord-023095-4dannjjm	6144	22	of	of	IN
cord-023095-4dannjjm	6144	23	low	low	JJ
cord-023095-4dannjjm	6144	24	passage	passage	NN
cord-023095-4dannjjm	6144	25	number	number	NN
cord-023095-4dannjjm	6144	26	to	to	TO
cord-023095-4dannjjm	6144	27	isolate	isolate	VB
cord-023095-4dannjjm	6144	28	canine	canine	NN
cord-023095-4dannjjm	6144	29	-	-	HYPH
cord-023095-4dannjjm	6144	30	derived	derive	VBN
cord-023095-4dannjjm	6144	31	antibody	antibody	NN
cord-023095-4dannjjm	6144	32	fragments	fragment	NNS
cord-023095-4dannjjm	6144	33	that	that	WDT
cord-023095-4dannjjm	6144	34	can	can	MD
cord-023095-4dannjjm	6144	35	target	target	VB
cord-023095-4dannjjm	6144	36	malignant	malignant	JJ
cord-023095-4dannjjm	6144	37	endothelial	endothelial	JJ
cord-023095-4dannjjm	6144	38	cell	cell	NN
cord-023095-4dannjjm	6144	39	surface	surface	NN
cord-023095-4dannjjm	6144	40	molecules	molecule	NNS
cord-023095-4dannjjm	6144	41	.	.	.
cord-023095-4dannjjm	6145	1	Early	early	JJ
cord-023095-4dannjjm	6145	2	results	result	NNS
cord-023095-4dannjjm	6145	3	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	6145	4	enrichment	enrichment	NN
cord-023095-4dannjjm	6145	5	of	of	IN
cord-023095-4dannjjm	6145	6	scFv	scfv	JJ
cord-023095-4dannjjm	6145	7	phage	phage	NN
cord-023095-4dannjjm	6145	8	libraries	library	NNS
cord-023095-4dannjjm	6145	9	for	for	IN
cord-023095-4dannjjm	6145	10	malignant	malignant	JJ
cord-023095-4dannjjm	6145	11	endothelial	endothelial	JJ
cord-023095-4dannjjm	6145	12	cell	cell	NN
cord-023095-4dannjjm	6145	13	binders	binder	NNS
cord-023095-4dannjjm	6145	14	.	.	.
cord-023095-4dannjjm	6146	1	These	these	DT
cord-023095-4dannjjm	6146	2	scFv	scFv	NNS
cord-023095-4dannjjm	6146	3	can	can	MD
cord-023095-4dannjjm	6146	4	be	be	VB
cord-023095-4dannjjm	6146	5	readily	readily	RB
cord-023095-4dannjjm	6146	6	linked	link	VBN
cord-023095-4dannjjm	6146	7	to	to	IN
cord-023095-4dannjjm	6146	8	chemotherapeutic	chemotherapeutic	JJ
cord-023095-4dannjjm	6146	9	agents	agent	NNS
cord-023095-4dannjjm	6146	10	or	or	CC
cord-023095-4dannjjm	6146	11	other	other	JJ
cord-023095-4dannjjm	6146	12	toxins	toxin	NNS
cord-023095-4dannjjm	6146	13	and	and	CC
cord-023095-4dannjjm	6146	14	used	use	VBD
cord-023095-4dannjjm	6146	15	to	to	TO
cord-023095-4dannjjm	6146	16	deliver	deliver	VB
cord-023095-4dannjjm	6146	17	high	high	JJ
cord-023095-4dannjjm	6146	18	doses	dose	NNS
cord-023095-4dannjjm	6146	19	directly	directly	RB
cord-023095-4dannjjm	6146	20	to	to	IN
cord-023095-4dannjjm	6146	21	the	the	DT
cord-023095-4dannjjm	6146	22	malignant	malignant	JJ
cord-023095-4dannjjm	6146	23	cell	cell	NN
cord-023095-4dannjjm	6146	24	.	.	.
cord-023095-4dannjjm	6147	1	This	this	DT
cord-023095-4dannjjm	6147	2	novel	novel	JJ
cord-023095-4dannjjm	6147	3	approach	approach	NN
cord-023095-4dannjjm	6147	4	aims	aim	VBZ
cord-023095-4dannjjm	6147	5	to	to	TO
cord-023095-4dannjjm	6147	6	reduce	reduce	VB
cord-023095-4dannjjm	6147	7	side	side	NN
cord-023095-4dannjjm	6147	8	effects	effect	NNS
cord-023095-4dannjjm	6147	9	of	of	IN
cord-023095-4dannjjm	6147	10	systemic	systemic	JJ
cord-023095-4dannjjm	6147	11	chemotherapy	chemotherapy	NN
cord-023095-4dannjjm	6147	12	and	and	CC
cord-023095-4dannjjm	6147	13	augment	augment	VB
cord-023095-4dannjjm	6147	14	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	6147	15	response	response	NN
cord-023095-4dannjjm	6147	16	.	.	.
cord-023095-4dannjjm	6148	1	Calcitriol	Calcitriol	NNP
cord-023095-4dannjjm	6148	2	,	,	,
cord-023095-4dannjjm	6148	3	(	(	-LRB-
cord-023095-4dannjjm	6148	4	vitamin	vitamin	NN
cord-023095-4dannjjm	6148	5	D	D	NNP
cord-023095-4dannjjm	6148	6	3	3	CD
cord-023095-4dannjjm	6148	7	)	)	-RRB-
cord-023095-4dannjjm	6148	8	,	,	,
cord-023095-4dannjjm	6148	9	has	have	VBZ
cord-023095-4dannjjm	6148	10	antineoplastic	antineoplastic	JJ
cord-023095-4dannjjm	6148	11	activity	activity	NN
cord-023095-4dannjjm	6148	12	and	and	CC
cord-023095-4dannjjm	6148	13	acts	act	VBZ
cord-023095-4dannjjm	6148	14	synergistically	synergistically	RB
cord-023095-4dannjjm	6148	15	to	to	TO
cord-023095-4dannjjm	6148	16	potentiate	potentiate	VB
cord-023095-4dannjjm	6148	17	the	the	DT
cord-023095-4dannjjm	6148	18	antitumor	antitumor	JJ
cord-023095-4dannjjm	6148	19	activity	activity	NN
cord-023095-4dannjjm	6148	20	of	of	IN
cord-023095-4dannjjm	6148	21	a	a	DT
cord-023095-4dannjjm	6148	22	diverse	diverse	JJ
cord-023095-4dannjjm	6148	23	array	array	NN
cord-023095-4dannjjm	6148	24	of	of	IN
cord-023095-4dannjjm	6148	25	chemotherapeutics	chemotherapeutic	NNS
cord-023095-4dannjjm	6148	26	.	.	.
cord-023095-4dannjjm	6149	1	CCNU	CCNU	NNP
cord-023095-4dannjjm	6149	2	,	,	,
cord-023095-4dannjjm	6149	3	vinblastine	vinblastine	NN
cord-023095-4dannjjm	6149	4	,	,	,
cord-023095-4dannjjm	6149	5	corticosteroids	corticosteroid	NNS
cord-023095-4dannjjm	6149	6	,	,	,
cord-023095-4dannjjm	6149	7	and	and	CC
cord-023095-4dannjjm	6149	8	tyrosine	tyrosine	NN
cord-023095-4dannjjm	6149	9	kinase	kinase	NN
cord-023095-4dannjjm	6149	10	inhibitors	inhibitor	NNS
cord-023095-4dannjjm	6149	11	,	,	,
cord-023095-4dannjjm	6149	12	are	be	VBP
cord-023095-4dannjjm	6149	13	used	use	VBN
cord-023095-4dannjjm	6149	14	to	to	TO
cord-023095-4dannjjm	6149	15	treat	treat	VB
cord-023095-4dannjjm	6149	16	canine	canine	JJ
cord-023095-4dannjjm	6149	17	mast	mast	NN
cord-023095-4dannjjm	6149	18	cell	cell	NN
cord-023095-4dannjjm	6149	19	tumors	tumor	NNS
cord-023095-4dannjjm	6149	20	(	(	-LRB-
cord-023095-4dannjjm	6149	21	MCT	MCT	NNP
cord-023095-4dannjjm	6149	22	)	)	-RRB-
cord-023095-4dannjjm	6149	23	.	.	.
cord-023095-4dannjjm	6150	1	Vitamin	vitamin	NN
cord-023095-4dannjjm	6150	2	D	d	NN
cord-023095-4dannjjm	6150	3	receptor	receptor	NN
cord-023095-4dannjjm	6150	4	is	be	VBZ
cord-023095-4dannjjm	6150	5	expressed	express	VBN
cord-023095-4dannjjm	6150	6	in	in	IN
cord-023095-4dannjjm	6150	7	the	the	DT
cord-023095-4dannjjm	6150	8	majority	majority	NN
cord-023095-4dannjjm	6150	9	of	of	IN
cord-023095-4dannjjm	6150	10	canine	canine	JJ
cord-023095-4dannjjm	6150	11	MCTs	mct	NNS
cord-023095-4dannjjm	6150	12	,	,	,
cord-023095-4dannjjm	6150	13	suggesting	suggest	VBG
cord-023095-4dannjjm	6150	14	a	a	DT
cord-023095-4dannjjm	6150	15	role	role	NN
cord-023095-4dannjjm	6150	16	for	for	IN
cord-023095-4dannjjm	6150	17	calcitriol	calcitriol	NN
cord-023095-4dannjjm	6150	18	in	in	IN
cord-023095-4dannjjm	6150	19	the	the	DT
cord-023095-4dannjjm	6150	20	management	management	NN
cord-023095-4dannjjm	6150	21	of	of	IN
cord-023095-4dannjjm	6150	22	dogs	dog	NNS
cord-023095-4dannjjm	6150	23	with	with	IN
cord-023095-4dannjjm	6150	24	these	these	DT
cord-023095-4dannjjm	6150	25	tumors	tumor	NNS
cord-023095-4dannjjm	6150	26	.	.	.
cord-023095-4dannjjm	6151	1	The	the	DT
cord-023095-4dannjjm	6151	2	purpose	purpose	NN
cord-023095-4dannjjm	6151	3	of	of	IN
cord-023095-4dannjjm	6151	4	our	-PRON-	PRP$
cord-023095-4dannjjm	6151	5	study	study	NN
cord-023095-4dannjjm	6151	6	was	be	VBD
cord-023095-4dannjjm	6151	7	to	to	TO
cord-023095-4dannjjm	6151	8	examine	examine	VB
cord-023095-4dannjjm	6151	9	the	the	DT
cord-023095-4dannjjm	6151	10	in	in	FW
cord-023095-4dannjjm	6151	11	vitro	vitro	FW
cord-023095-4dannjjm	6151	12	effects	effect	NNS
cord-023095-4dannjjm	6151	13	of	of	IN
cord-023095-4dannjjm	6151	14	calcitriol	calcitriol	NN
cord-023095-4dannjjm	6151	15	in	in	IN
cord-023095-4dannjjm	6151	16	combination	combination	NN
cord-023095-4dannjjm	6151	17	with	with	IN
cord-023095-4dannjjm	6151	18	CCNU	CCNU	NNP
cord-023095-4dannjjm	6151	19	,	,	,
cord-023095-4dannjjm	6151	20	vinblastine	vinblastine	NN
cord-023095-4dannjjm	6151	21	,	,	,
cord-023095-4dannjjm	6151	22	imatinib	imatinib	RB
cord-023095-4dannjjm	6151	23	,	,	,
cord-023095-4dannjjm	6151	24	or	or	CC
cord-023095-4dannjjm	6151	25	toceranib	toceranib	NN
cord-023095-4dannjjm	6151	26	on	on	IN
cord-023095-4dannjjm	6151	27	canine	canine	JJ
cord-023095-4dannjjm	6151	28	mastocytoma	mastocytoma	NNP
cord-023095-4dannjjm	6151	29	C2	C2	NNP
cord-023095-4dannjjm	6151	30	cells	cell	NNS
cord-023095-4dannjjm	6151	31	.	.	.
cord-023095-4dannjjm	6152	1	Also	also	RB
cord-023095-4dannjjm	6152	2	,	,	,
cord-023095-4dannjjm	6152	3	we	-PRON-	PRP
cord-023095-4dannjjm	6152	4	evaluated	evaluate	VBD
cord-023095-4dannjjm	6152	5	the	the	DT
cord-023095-4dannjjm	6152	6	antitumor	antitumor	JJ
cord-023095-4dannjjm	6152	7	activity	activity	NN
cord-023095-4dannjjm	6152	8	of	of	IN
cord-023095-4dannjjm	6152	9	DN101	DN101	NNP
cord-023095-4dannjjm	6152	10	,	,	,
cord-023095-4dannjjm	6152	11	a	a	DT
cord-023095-4dannjjm	6152	12	highly	highly	RB
cord-023095-4dannjjm	6152	13	concentrated	concentrated	JJ
cord-023095-4dannjjm	6152	14	oral	oral	JJ
cord-023095-4dannjjm	6152	15	formulation	formulation	NN
cord-023095-4dannjjm	6152	16	of	of	IN
cord-023095-4dannjjm	6152	17	calcitriol	calcitriol	NNP
cord-023095-4dannjjm	6152	18	,	,	,
cord-023095-4dannjjm	6152	19	as	as	IN
cord-023095-4dannjjm	6152	20	single	single	JJ
cord-023095-4dannjjm	6152	21	-	-	HYPH
cord-023095-4dannjjm	6152	22	agent	agent	NN
cord-023095-4dannjjm	6152	23	treatment	treatment	NN
cord-023095-4dannjjm	6152	24	in	in	IN
cord-023095-4dannjjm	6152	25	dogs	dog	NNS
cord-023095-4dannjjm	6152	26	with	with	IN
cord-023095-4dannjjm	6152	27	naturally	naturally	RB
cord-023095-4dannjjm	6152	28	occurring	occur	VBG
cord-023095-4dannjjm	6152	29	MCTs	mct	NNS
cord-023095-4dannjjm	6152	30	.	.	.
cord-023095-4dannjjm	6153	1	C2	C2	NNP
cord-023095-4dannjjm	6153	2	cells	cell	NNS
cord-023095-4dannjjm	6153	3	were	be	VBD
cord-023095-4dannjjm	6153	4	incubated	incubate	VBN
cord-023095-4dannjjm	6153	5	with	with	IN
cord-023095-4dannjjm	6153	6	serial	serial	JJ
cord-023095-4dannjjm	6153	7	dilutions	dilution	NNS
cord-023095-4dannjjm	6153	8	of	of	IN
cord-023095-4dannjjm	6153	9	calcitriol	calcitriol	NN
cord-023095-4dannjjm	6153	10	(	(	-LRB-
cord-023095-4dannjjm	6153	11	0.1	0.1	CD
cord-023095-4dannjjm	6153	12	-	-	SYM
cord-023095-4dannjjm	6153	13	25	25	CD
cord-023095-4dannjjm	6153	14	nM	nm	CD
cord-023095-4dannjjm	6153	15	)	)	-RRB-
cord-023095-4dannjjm	6153	16	.	.	.
cord-023095-4dannjjm	6154	1	Twenty	twenty	CD
cord-023095-4dannjjm	6154	2	-	-	HYPH
cord-023095-4dannjjm	6154	3	four	four	CD
cord-023095-4dannjjm	6154	4	hours	hour	NNS
cord-023095-4dannjjm	6154	5	later	later	RB
cord-023095-4dannjjm	6154	6	,	,	,
cord-023095-4dannjjm	6154	7	cells	cell	NNS
cord-023095-4dannjjm	6154	8	were	be	VBD
cord-023095-4dannjjm	6154	9	then	then	RB
cord-023095-4dannjjm	6154	10	treated	treat	VBN
cord-023095-4dannjjm	6154	11	with	with	IN
cord-023095-4dannjjm	6154	12	vehicle	vehicle	NN
cord-023095-4dannjjm	6154	13	control	control	NN
cord-023095-4dannjjm	6154	14	or	or	CC
cord-023095-4dannjjm	6154	15	serial	serial	JJ
cord-023095-4dannjjm	6154	16	dilutions	dilution	NNS
cord-023095-4dannjjm	6154	17	of	of	IN
cord-023095-4dannjjm	6154	18	CCNU	CCNU	NNP
cord-023095-4dannjjm	6154	19	(	(	-LRB-
cord-023095-4dannjjm	6154	20	2.5	2.5	CD
cord-023095-4dannjjm	6154	21	-	-	SYM
cord-023095-4dannjjm	6154	22	20	20	CD
cord-023095-4dannjjm	6154	23	uM	um	UH
cord-023095-4dannjjm	6154	24	)	)	-RRB-
cord-023095-4dannjjm	6154	25	,	,	,
cord-023095-4dannjjm	6154	26	vinblastine	vinblastine	NN
cord-023095-4dannjjm	6154	27	(	(	-LRB-
cord-023095-4dannjjm	6154	28	1.25	1.25	CD
cord-023095-4dannjjm	6154	29	-	-	SYM
cord-023095-4dannjjm	6154	30	10	10	CD
cord-023095-4dannjjm	6154	31	nM	nM	NNP
cord-023095-4dannjjm	6154	32	)	)	-RRB-
cord-023095-4dannjjm	6154	33	,	,	,
cord-023095-4dannjjm	6154	34	imatinib	imatinib	JJ
cord-023095-4dannjjm	6154	35	(	(	-LRB-
cord-023095-4dannjjm	6154	36	1.67	1.67	CD
cord-023095-4dannjjm	6154	37	-	-	SYM
cord-023095-4dannjjm	6154	38	12.5	12.5	CD
cord-023095-4dannjjm	6154	39	nM	nM	NNP
cord-023095-4dannjjm	6154	40	)	)	-RRB-
cord-023095-4dannjjm	6154	41	,	,	,
cord-023095-4dannjjm	6154	42	or	or	CC
cord-023095-4dannjjm	6154	43	toceranib	toceranib	NNP
cord-023095-4dannjjm	6154	44	(	(	-LRB-
cord-023095-4dannjjm	6154	45	3.13	3.13	CD
cord-023095-4dannjjm	6154	46	-	-	SYM
cord-023095-4dannjjm	6154	47	25	25	CD
cord-023095-4dannjjm	6154	48	nM	nM	NNP
cord-023095-4dannjjm	6154	49	)	)	-RRB-
cord-023095-4dannjjm	6154	50	.	.	.
cord-023095-4dannjjm	6155	1	Cell	cell	NN
cord-023095-4dannjjm	6155	2	viability	viability	NN
cord-023095-4dannjjm	6155	3	was	be	VBD
cord-023095-4dannjjm	6155	4	assessed	assess	VBN
cord-023095-4dannjjm	6155	5	with	with	IN
cord-023095-4dannjjm	6155	6	an	an	DT
cord-023095-4dannjjm	6155	7	MTT	MTT	NNP
cord-023095-4dannjjm	6155	8	assay	assay	NN
cord-023095-4dannjjm	6155	9	after	after	IN
cord-023095-4dannjjm	6155	10	48	48	CD
cord-023095-4dannjjm	6155	11	hours	hour	NNS
cord-023095-4dannjjm	6155	12	and	and	CC
cord-023095-4dannjjm	6155	13	data	datum	NNS
cord-023095-4dannjjm	6155	14	was	be	VBD
cord-023095-4dannjjm	6155	15	used	use	VBN
cord-023095-4dannjjm	6155	16	to	to	TO
cord-023095-4dannjjm	6155	17	derive	derive	VB
cord-023095-4dannjjm	6155	18	a	a	DT
cord-023095-4dannjjm	6155	19	combination	combination	NN
cord-023095-4dannjjm	6155	20	index	index	NN
cord-023095-4dannjjm	6155	21	(	(	-LRB-
cord-023095-4dannjjm	6155	22	CI	CI	NNP
cord-023095-4dannjjm	6155	23	:	:	:
cord-023095-4dannjjm	6155	24	values	value	NNS
cord-023095-4dannjjm	6155	25	o	o	NNP
cord-023095-4dannjjm	6155	26	1	1	CD
cord-023095-4dannjjm	6155	27	,	,	,
cord-023095-4dannjjm	6155	28	1	1	CD
cord-023095-4dannjjm	6155	29	,	,	,
cord-023095-4dannjjm	6155	30	41	41	CD
cord-023095-4dannjjm	6155	31	indicate	indicate	VBP
cord-023095-4dannjjm	6155	32	synergism	synergism	NN
cord-023095-4dannjjm	6155	33	,	,	,
cord-023095-4dannjjm	6155	34	additivity	additivity	NN
cord-023095-4dannjjm	6155	35	,	,	,
cord-023095-4dannjjm	6155	36	antagonism	antagonism	NN
cord-023095-4dannjjm	6155	37	,	,	,
cord-023095-4dannjjm	6155	38	respectively	respectively	RB
cord-023095-4dannjjm	6155	39	)	)	-RRB-
cord-023095-4dannjjm	6155	40	.	.	.
cord-023095-4dannjjm	6156	1	In	in	IN
cord-023095-4dannjjm	6156	2	the	the	DT
cord-023095-4dannjjm	6156	3	phase	phase	NN
cord-023095-4dannjjm	6156	4	II	ii	CD
cord-023095-4dannjjm	6156	5	clinical	clinical	JJ
cord-023095-4dannjjm	6156	6	trial	trial	NN
cord-023095-4dannjjm	6156	7	,	,	,
cord-023095-4dannjjm	6156	8	dogs	dog	NNS
cord-023095-4dannjjm	6156	9	were	be	VBD
cord-023095-4dannjjm	6156	10	eligible	eligible	JJ
cord-023095-4dannjjm	6156	11	if	if	IN
cord-023095-4dannjjm	6156	12	they	-PRON-	PRP
cord-023095-4dannjjm	6156	13	had	have	VBD
cord-023095-4dannjjm	6156	14	at	at	RB
cord-023095-4dannjjm	6156	15	least	least	JJS
cord-023095-4dannjjm	6156	16	1	1	CD
cord-023095-4dannjjm	6156	17	measurable	measurable	JJ
cord-023095-4dannjjm	6156	18	,	,	,
cord-023095-4dannjjm	6156	19	histologically	histologically	RB
cord-023095-4dannjjm	6156	20	confirmed	confirm	VBD
cord-023095-4dannjjm	6156	21	,	,	,
cord-023095-4dannjjm	6156	22	MCT	MCT	NNP
cord-023095-4dannjjm	6156	23	.	.	.
cord-023095-4dannjjm	6157	1	Calcitriol	Calcitriol	NNP
cord-023095-4dannjjm	6157	2	was	be	VBD
cord-023095-4dannjjm	6157	3	administered	administer	VBN
cord-023095-4dannjjm	6157	4	orally	orally	RB
cord-023095-4dannjjm	6157	5	.	.	.
cord-023095-4dannjjm	6158	1	RECIST	RECIST	NNP
cord-023095-4dannjjm	6158	2	criteria	criterion	NNS
cord-023095-4dannjjm	6158	3	were	be	VBD
cord-023095-4dannjjm	6158	4	used	use	VBN
cord-023095-4dannjjm	6158	5	to	to	TO
cord-023095-4dannjjm	6158	6	assess	assess	VB
cord-023095-4dannjjm	6158	7	tumor	tumor	NN
cord-023095-4dannjjm	6158	8	response	response	NN
cord-023095-4dannjjm	6158	9	.	.	.
cord-023095-4dannjjm	6159	1	Calcitriol	Calcitriol	NNP
cord-023095-4dannjjm	6159	2	,	,	,
cord-023095-4dannjjm	6159	3	CCNU	CCNU	NNP
cord-023095-4dannjjm	6159	4	,	,	,
cord-023095-4dannjjm	6159	5	vinblastine	vinblastine	NN
cord-023095-4dannjjm	6159	6	,	,	,
cord-023095-4dannjjm	6159	7	imatinib	imatinib	RB
cord-023095-4dannjjm	6159	8	,	,	,
cord-023095-4dannjjm	6159	9	and	and	CC
cord-023095-4dannjjm	6159	10	toceranib	toceranib	NNP
cord-023095-4dannjjm	6159	11	each	each	DT
cord-023095-4dannjjm	6159	12	suppressed	suppress	VBD
cord-023095-4dannjjm	6159	13	C2	C2	NNP
cord-023095-4dannjjm	6159	14	cell	cell	NN
cord-023095-4dannjjm	6159	15	viability	viability	NN
cord-023095-4dannjjm	6159	16	in	in	IN
cord-023095-4dannjjm	6159	17	a	a	DT
cord-023095-4dannjjm	6159	18	dose	dose	NN
cord-023095-4dannjjm	6159	19	-	-	HYPH
cord-023095-4dannjjm	6159	20	dependent	dependent	JJ
cord-023095-4dannjjm	6159	21	manner	manner	NN
cord-023095-4dannjjm	6159	22	.	.	.
cord-023095-4dannjjm	6160	1	CI	CI	NNP
cord-023095-4dannjjm	6160	2	values	value	NNS
cord-023095-4dannjjm	6161	1	o	o	LS
cord-023095-4dannjjm	6161	2	1	1	CD
cord-023095-4dannjjm	6161	3	were	be	VBD
cord-023095-4dannjjm	6161	4	obtained	obtain	VBN
cord-023095-4dannjjm	6161	5	for	for	IN
cord-023095-4dannjjm	6161	6	calcitriol	calcitriol	NN
cord-023095-4dannjjm	6161	7	(	(	-LRB-
cord-023095-4dannjjm	6161	8	0.1	0.1	CD
cord-023095-4dannjjm	6161	9	-	-	SYM
cord-023095-4dannjjm	6161	10	6.25	6.25	CD
cord-023095-4dannjjm	6161	11	nM	nm	NN
cord-023095-4dannjjm	6161	12	)	)	-RRB-
cord-023095-4dannjjm	6161	13	combined	combine	VBN
cord-023095-4dannjjm	6161	14	with	with	IN
cord-023095-4dannjjm	6161	15	CCNU	CCNU	NNP
cord-023095-4dannjjm	6161	16	(	(	-LRB-
cord-023095-4dannjjm	6161	17	5	5	CD
cord-023095-4dannjjm	6161	18	and	and	CC
cord-023095-4dannjjm	6161	19	10uM	10um	CD
cord-023095-4dannjjm	6161	20	)	)	-RRB-
cord-023095-4dannjjm	6161	21	,	,	,
cord-023095-4dannjjm	6161	22	vinblastine	vinblastine	FW
cord-023095-4dannjjm	6161	23	(	(	-LRB-
cord-023095-4dannjjm	6161	24	2.5	2.5	CD
cord-023095-4dannjjm	6161	25	and	and	CC
cord-023095-4dannjjm	6161	26	5	5	CD
cord-023095-4dannjjm	6161	27	nM	nm	CD
cord-023095-4dannjjm	6161	28	)	)	-RRB-
cord-023095-4dannjjm	6161	29	,	,	,
cord-023095-4dannjjm	6161	30	imatinib	imatinib	JJ
cord-023095-4dannjjm	6161	31	(	(	-LRB-
cord-023095-4dannjjm	6161	32	1.67	1.67	CD
cord-023095-4dannjjm	6161	33	-	-	SYM
cord-023095-4dannjjm	6161	34	12.5	12.5	CD
cord-023095-4dannjjm	6161	35	nM	nM	NNP
cord-023095-4dannjjm	6161	36	)	)	-RRB-
cord-023095-4dannjjm	6161	37	and	and	CC
cord-023095-4dannjjm	6161	38	toceranib	toceranib	NNP
cord-023095-4dannjjm	6161	39	(	(	-LRB-
cord-023095-4dannjjm	6161	40	0.1	0.1	CD
cord-023095-4dannjjm	6161	41	-	-	SYM
cord-023095-4dannjjm	6161	42	12.5	12.5	CD
cord-023095-4dannjjm	6161	43	nM	nm	NN
cord-023095-4dannjjm	6161	44	)	)	-RRB-
cord-023095-4dannjjm	6161	45	.	.	.
cord-023095-4dannjjm	6162	1	Due	due	IN
cord-023095-4dannjjm	6162	2	to	to	IN
cord-023095-4dannjjm	6162	3	the	the	DT
cord-023095-4dannjjm	6162	4	occurrence	occurrence	NN
cord-023095-4dannjjm	6162	5	of	of	IN
cord-023095-4dannjjm	6162	6	toxicity	toxicity	NN
cord-023095-4dannjjm	6162	7	(	(	-LRB-
cord-023095-4dannjjm	6162	8	vomiting	vomiting	NN
cord-023095-4dannjjm	6162	9	,	,	,
cord-023095-4dannjjm	6162	10	anorexia	anorexia	NN
cord-023095-4dannjjm	6162	11	,	,	,
cord-023095-4dannjjm	6162	12	hypercalcemia	hypercalcemia	NN
cord-023095-4dannjjm	6162	13	)	)	-RRB-
cord-023095-4dannjjm	6162	14	,	,	,
cord-023095-4dannjjm	6162	15	the	the	DT
cord-023095-4dannjjm	6162	16	phase	phase	NN
cord-023095-4dannjjm	6162	17	II	II	NNP
cord-023095-4dannjjm	6162	18	trial	trial	NN
cord-023095-4dannjjm	6162	19	was	be	VBD
cord-023095-4dannjjm	6162	20	terminated	terminate	VBN
cord-023095-4dannjjm	6162	21	early	early	RB
cord-023095-4dannjjm	6162	22	;	;	:
cord-023095-4dannjjm	6162	23	only	only	RB
cord-023095-4dannjjm	6162	24	10	10	CD
cord-023095-4dannjjm	6162	25	of	of	IN
cord-023095-4dannjjm	6162	26	20	20	CD
cord-023095-4dannjjm	6162	27	planned	plan	VBN
cord-023095-4dannjjm	6162	28	patients	patient	NNS
cord-023095-4dannjjm	6162	29	were	be	VBD
cord-023095-4dannjjm	6162	30	treated	treat	VBN
cord-023095-4dannjjm	6162	31	.	.	.
cord-023095-4dannjjm	6163	1	One	one	CD
cord-023095-4dannjjm	6163	2	dog	dog	NN
cord-023095-4dannjjm	6163	3	with	with	IN
cord-023095-4dannjjm	6163	4	a	a	DT
cord-023095-4dannjjm	6163	5	metastatic	metastatic	JJ
cord-023095-4dannjjm	6163	6	muzzle	muzzle	NN
cord-023095-4dannjjm	6163	7	MCT	MCT	NNP
cord-023095-4dannjjm	6163	8	had	have	VBD
cord-023095-4dannjjm	6163	9	a	a	DT
cord-023095-4dannjjm	6163	10	complete	complete	JJ
cord-023095-4dannjjm	6163	11	response	response	NN
cord-023095-4dannjjm	6163	12	that	that	WDT
cord-023095-4dannjjm	6163	13	lasted	last	VBD
cord-023095-4dannjjm	6163	14	89	89	CD
cord-023095-4dannjjm	6163	15	days	day	NNS
cord-023095-4dannjjm	6163	16	.	.	.
cord-023095-4dannjjm	6164	1	Three	three	CD
cord-023095-4dannjjm	6164	2	dogs	dog	NNS
cord-023095-4dannjjm	6164	3	achieved	achieve	VBD
cord-023095-4dannjjm	6164	4	partial	partial	JJ
cord-023095-4dannjjm	6164	5	response	response	NN
cord-023095-4dannjjm	6164	6	lasting	last	VBG
cord-023095-4dannjjm	6164	7	from	from	IN
cord-023095-4dannjjm	6164	8	74	74	CD
cord-023095-4dannjjm	6164	9	-	-	SYM
cord-023095-4dannjjm	6164	10	90	90	CD
cord-023095-4dannjjm	6164	11	days	day	NNS
cord-023095-4dannjjm	6164	12	.	.	.
cord-023095-4dannjjm	6165	1	In	in	IN
cord-023095-4dannjjm	6165	2	summary	summary	NN
cord-023095-4dannjjm	6165	3	,	,	,
cord-023095-4dannjjm	6165	4	our	-PRON-	PRP$
cord-023095-4dannjjm	6165	5	in	in	FW
cord-023095-4dannjjm	6165	6	vitro	vitro	FW
cord-023095-4dannjjm	6165	7	data	datum	NNS
cord-023095-4dannjjm	6165	8	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	6165	9	that	that	IN
cord-023095-4dannjjm	6165	10	calcitriol	calcitriol	NN
cord-023095-4dannjjm	6165	11	combined	combine	VBN
cord-023095-4dannjjm	6165	12	with	with	IN
cord-023095-4dannjjm	6165	13	CCNU	CCNU	NNP
cord-023095-4dannjjm	6165	14	,	,	,
cord-023095-4dannjjm	6165	15	vinblastine	vinblastine	NN
cord-023095-4dannjjm	6165	16	,	,	,
cord-023095-4dannjjm	6165	17	imatinib	imatinib	NN
cord-023095-4dannjjm	6165	18	or	or	CC
cord-023095-4dannjjm	6165	19	toceranib	toceranib	NN
cord-023095-4dannjjm	6165	20	has	have	VBZ
cord-023095-4dannjjm	6165	21	synergistic	synergistic	JJ
cord-023095-4dannjjm	6165	22	effects	effect	NNS
cord-023095-4dannjjm	6165	23	on	on	IN
cord-023095-4dannjjm	6165	24	C2	C2	NNP
cord-023095-4dannjjm	6165	25	mastocytoma	mastocytoma	NNP
cord-023095-4dannjjm	6165	26	cells	cell	NNS
cord-023095-4dannjjm	6165	27	.	.	.
cord-023095-4dannjjm	6166	1	Antitumor	Antitumor	NNP
cord-023095-4dannjjm	6166	2	responses	response	NNS
cord-023095-4dannjjm	6166	3	were	be	VBD
cord-023095-4dannjjm	6166	4	observed	observe	VBN
cord-023095-4dannjjm	6166	5	in	in	IN
cord-023095-4dannjjm	6166	6	dogs	dog	NNS
cord-023095-4dannjjm	6166	7	with	with	IN
cord-023095-4dannjjm	6166	8	spontaneously	spontaneously	RB
cord-023095-4dannjjm	6166	9	occurring	occur	VBG
cord-023095-4dannjjm	6166	10	MCTs	mct	NNS
cord-023095-4dannjjm	6166	11	treated	treat	VBN
cord-023095-4dannjjm	6166	12	orally	orally	RB
cord-023095-4dannjjm	6166	13	with	with	IN
cord-023095-4dannjjm	6166	14	single	single	JJ
cord-023095-4dannjjm	6166	15	-	-	HYPH
cord-023095-4dannjjm	6166	16	agent	agent	NN
cord-023095-4dannjjm	6166	17	calcitriol	calcitriol	NN
cord-023095-4dannjjm	6166	18	,	,	,
cord-023095-4dannjjm	6166	19	but	but	CC
cord-023095-4dannjjm	6166	20	the	the	DT
cord-023095-4dannjjm	6166	21	frequency	frequency	NN
cord-023095-4dannjjm	6166	22	of	of	IN
cord-023095-4dannjjm	6166	23	adverse	adverse	JJ
cord-023095-4dannjjm	6166	24	effects	effect	NNS
cord-023095-4dannjjm	6166	25	was	be	VBD
cord-023095-4dannjjm	6166	26	high	high	JJ
cord-023095-4dannjjm	6166	27	.	.	.
cord-023095-4dannjjm	6167	1	Together	together	RB
cord-023095-4dannjjm	6167	2	these	these	DT
cord-023095-4dannjjm	6167	3	results	result	NNS
cord-023095-4dannjjm	6167	4	suggest	suggest	VBP
cord-023095-4dannjjm	6167	5	calcitriol	calcitriol	NN
cord-023095-4dannjjm	6167	6	combination	combination	NN
cord-023095-4dannjjm	6167	7	therapies	therapy	NNS
cord-023095-4dannjjm	6167	8	might	may	MD
cord-023095-4dannjjm	6167	9	have	have	VB
cord-023095-4dannjjm	6167	10	significant	significant	JJ
cord-023095-4dannjjm	6167	11	clinical	clinical	JJ
cord-023095-4dannjjm	6167	12	utility	utility	NN
cord-023095-4dannjjm	6167	13	in	in	IN
cord-023095-4dannjjm	6167	14	the	the	DT
cord-023095-4dannjjm	6167	15	treatment	treatment	NN
cord-023095-4dannjjm	6167	16	of	of	IN
cord-023095-4dannjjm	6167	17	canine	canine	JJ
cord-023095-4dannjjm	6167	18	MCTs	mct	NNS
cord-023095-4dannjjm	6167	19	but	but	CC
cord-023095-4dannjjm	6167	20	refinement	refinement	NN
cord-023095-4dannjjm	6167	21	of	of	IN
cord-023095-4dannjjm	6167	22	the	the	DT
cord-023095-4dannjjm	6167	23	calcitriol	calcitriol	NN
cord-023095-4dannjjm	6167	24	-	-	HYPH
cord-023095-4dannjjm	6167	25	dosing	dose	VBG
cord-023095-4dannjjm	6167	26	regimen	regimen	NN
cord-023095-4dannjjm	6167	27	must	must	MD
cord-023095-4dannjjm	6167	28	be	be	VB
cord-023095-4dannjjm	6167	29	done	do	VBN
cord-023095-4dannjjm	6167	30	.	.	.
cord-023095-4dannjjm	6168	1	Cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6168	2	is	be	VBZ
cord-023095-4dannjjm	6168	3	a	a	DT
cord-023095-4dannjjm	6168	4	potent	potent	JJ
cord-023095-4dannjjm	6168	5	immunosuppressive	immunosuppressive	JJ
cord-023095-4dannjjm	6168	6	agent	agent	NN
cord-023095-4dannjjm	6168	7	used	use	VBD
cord-023095-4dannjjm	6168	8	to	to	TO
cord-023095-4dannjjm	6168	9	treat	treat	VB
cord-023095-4dannjjm	6168	10	many	many	JJ
cord-023095-4dannjjm	6168	11	canine	canine	JJ
cord-023095-4dannjjm	6168	12	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6168	13	and	and	CC
cord-023095-4dannjjm	6168	14	immune	immune	JJ
cord-023095-4dannjjm	6168	15	-	-	HYPH
cord-023095-4dannjjm	6168	16	mediated	mediate	VBN
cord-023095-4dannjjm	6168	17	diseases	disease	NNS
cord-023095-4dannjjm	6168	18	.	.	.
cord-023095-4dannjjm	6169	1	Cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6169	2	has	have	VBZ
cord-023095-4dannjjm	6169	3	gained	gain	VBN
cord-023095-4dannjjm	6169	4	popularity	popularity	NN
cord-023095-4dannjjm	6169	5	as	as	IN
cord-023095-4dannjjm	6169	6	an	an	DT
cord-023095-4dannjjm	6169	7	immunosuppressive	immunosuppressive	JJ
cord-023095-4dannjjm	6169	8	agent	agent	NN
cord-023095-4dannjjm	6169	9	because	because	IN
cord-023095-4dannjjm	6169	10	of	of	IN
cord-023095-4dannjjm	6169	11	a	a	DT
cord-023095-4dannjjm	6169	12	favorable	favorable	JJ
cord-023095-4dannjjm	6169	13	toxicity	toxicity	NN
cord-023095-4dannjjm	6169	14	profile	profile	NN
cord-023095-4dannjjm	6169	15	compared	compare	VBN
cord-023095-4dannjjm	6169	16	to	to	IN
cord-023095-4dannjjm	6169	17	many	many	JJ
cord-023095-4dannjjm	6169	18	other	other	JJ
cord-023095-4dannjjm	6169	19	immunosuppressive	immunosuppressive	JJ
cord-023095-4dannjjm	6169	20	agents	agent	NNS
cord-023095-4dannjjm	6169	21	.	.	.
cord-023095-4dannjjm	6170	1	Optimal	optimal	JJ
cord-023095-4dannjjm	6170	2	dosing	dosing	NN
cord-023095-4dannjjm	6170	3	regimens	regimen	NNS
cord-023095-4dannjjm	6170	4	for	for	IN
cord-023095-4dannjjm	6170	5	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6170	6	in	in	IN
cord-023095-4dannjjm	6170	7	the	the	DT
cord-023095-4dannjjm	6170	8	dog	dog	NN
cord-023095-4dannjjm	6170	9	remain	remain	VBP
cord-023095-4dannjjm	6170	10	unclear	unclear	JJ
cord-023095-4dannjjm	6170	11	,	,	,
cord-023095-4dannjjm	6170	12	primarily	primarily	RB
cord-023095-4dannjjm	6170	13	because	because	IN
cord-023095-4dannjjm	6170	14	standard	standard	JJ
cord-023095-4dannjjm	6170	15	methods	method	NNS
cord-023095-4dannjjm	6170	16	that	that	WDT
cord-023095-4dannjjm	6170	17	monitor	monitor	VBP
cord-023095-4dannjjm	6170	18	effectiveness	effectiveness	NN
cord-023095-4dannjjm	6170	19	of	of	IN
cord-023095-4dannjjm	6170	20	immunosuppression	immunosuppression	NN
cord-023095-4dannjjm	6170	21	have	have	VBP
cord-023095-4dannjjm	6170	22	not	not	RB
cord-023095-4dannjjm	6170	23	been	be	VBN
cord-023095-4dannjjm	6170	24	established	establish	VBN
cord-023095-4dannjjm	6170	25	.	.	.
cord-023095-4dannjjm	6171	1	Pharmacokinetic	pharmacokinetic	JJ
cord-023095-4dannjjm	6171	2	testing	testing	NN
cord-023095-4dannjjm	6171	3	is	be	VBZ
cord-023095-4dannjjm	6171	4	currently	currently	RB
cord-023095-4dannjjm	6171	5	used	use	VBN
cord-023095-4dannjjm	6171	6	during	during	IN
cord-023095-4dannjjm	6171	7	treatment	treatment	NN
cord-023095-4dannjjm	6171	8	with	with	IN
cord-023095-4dannjjm	6171	9	oral	oral	JJ
cord-023095-4dannjjm	6171	10	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6171	11	to	to	TO
cord-023095-4dannjjm	6171	12	adjust	adjust	VB
cord-023095-4dannjjm	6171	13	doses	dose	NNS
cord-023095-4dannjjm	6171	14	based	base	VBN
cord-023095-4dannjjm	6171	15	on	on	IN
cord-023095-4dannjjm	6171	16	measurement	measurement	NN
cord-023095-4dannjjm	6171	17	of	of	IN
cord-023095-4dannjjm	6171	18	blood	blood	NN
cord-023095-4dannjjm	6171	19	drug	drug	NN
cord-023095-4dannjjm	6171	20	levels	level	NNS
cord-023095-4dannjjm	6171	21	.	.	.
cord-023095-4dannjjm	6172	1	Individual	individual	JJ
cord-023095-4dannjjm	6172	2	patients	patient	NNS
cord-023095-4dannjjm	6172	3	,	,	,
cord-023095-4dannjjm	6172	4	however	however	RB
cord-023095-4dannjjm	6172	5	,	,	,
cord-023095-4dannjjm	6172	6	often	often	RB
cord-023095-4dannjjm	6172	7	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	6172	8	marked	marked	JJ
cord-023095-4dannjjm	6172	9	variations	variation	NNS
cord-023095-4dannjjm	6172	10	in	in	IN
cord-023095-4dannjjm	6172	11	blood	blood	NN
cord-023095-4dannjjm	6172	12	drug	drug	NN
cord-023095-4dannjjm	6172	13	levels	level	NNS
cord-023095-4dannjjm	6172	14	while	while	IN
cord-023095-4dannjjm	6172	15	on	on	IN
cord-023095-4dannjjm	6172	16	similar	similar	JJ
cord-023095-4dannjjm	6172	17	oral	oral	JJ
cord-023095-4dannjjm	6172	18	doses	dose	NNS
cord-023095-4dannjjm	6172	19	of	of	IN
cord-023095-4dannjjm	6172	20	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6172	21	,	,	,
cord-023095-4dannjjm	6172	22	and	and	CC
cord-023095-4dannjjm	6172	23	can	can	MD
cord-023095-4dannjjm	6172	24	also	also	RB
cord-023095-4dannjjm	6172	25	demonstrate	demonstrate	VB
cord-023095-4dannjjm	6172	26	different	different	JJ
cord-023095-4dannjjm	6172	27	clinical	clinical	JJ
cord-023095-4dannjjm	6172	28	responses	response	NNS
cord-023095-4dannjjm	6172	29	even	even	RB
cord-023095-4dannjjm	6172	30	at	at	IN
cord-023095-4dannjjm	6172	31	comparable	comparable	JJ
cord-023095-4dannjjm	6172	32	drug	drug	NN
cord-023095-4dannjjm	6172	33	levels	level	NNS
cord-023095-4dannjjm	6172	34	,	,	,
cord-023095-4dannjjm	6172	35	making	make	VBG
cord-023095-4dannjjm	6172	36	correlation	correlation	NN
cord-023095-4dannjjm	6172	37	of	of	IN
cord-023095-4dannjjm	6172	38	blood	blood	NN
cord-023095-4dannjjm	6172	39	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6172	40	levels	level	NNS
cord-023095-4dannjjm	6172	41	and	and	CC
cord-023095-4dannjjm	6172	42	degree	degree	NN
cord-023095-4dannjjm	6172	43	of	of	IN
cord-023095-4dannjjm	6172	44	disease	disease	NN
cord-023095-4dannjjm	6172	45	control	control	NN
cord-023095-4dannjjm	6172	46	extremely	extremely	RB
cord-023095-4dannjjm	6172	47	difficult	difficult	JJ
cord-023095-4dannjjm	6172	48	.	.	.
cord-023095-4dannjjm	6173	1	Pharmacodynamic	Pharmacodynamic	NNP
cord-023095-4dannjjm	6173	2	testing	testing	NN
cord-023095-4dannjjm	6173	3	offers	offer	VBZ
cord-023095-4dannjjm	6173	4	an	an	DT
cord-023095-4dannjjm	6173	5	alternative	alternative	JJ
cord-023095-4dannjjm	6173	6	method	method	NN
cord-023095-4dannjjm	6173	7	for	for	IN
cord-023095-4dannjjm	6173	8	regulating	regulate	VBG
cord-023095-4dannjjm	6173	9	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6173	10	dosing	dose	VBG
cord-023095-4dannjjm	6173	11	by	by	IN
cord-023095-4dannjjm	6173	12	objectively	objectively	RB
cord-023095-4dannjjm	6173	13	measuring	measure	VBG
cord-023095-4dannjjm	6173	14	the	the	DT
cord-023095-4dannjjm	6173	15	effects	effect	NNS
cord-023095-4dannjjm	6173	16	of	of	IN
cord-023095-4dannjjm	6173	17	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6173	18	on	on	IN
cord-023095-4dannjjm	6173	19	T	t	NN
cord-023095-4dannjjm	6173	20	-	-	HYPH
cord-023095-4dannjjm	6173	21	cells	cell	NNS
cord-023095-4dannjjm	6173	22	,	,	,
cord-023095-4dannjjm	6173	23	the	the	DT
cord-023095-4dannjjm	6173	24	drug	drug	NN
cord-023095-4dannjjm	6173	25	's	's	POS
cord-023095-4dannjjm	6173	26	main	main	JJ
cord-023095-4dannjjm	6173	27	cellular	cellular	JJ
cord-023095-4dannjjm	6173	28	target	target	NN
cord-023095-4dannjjm	6173	29	in	in	IN
cord-023095-4dannjjm	6173	30	the	the	DT
cord-023095-4dannjjm	6173	31	body	body	NN
cord-023095-4dannjjm	6173	32	.	.	.
cord-023095-4dannjjm	6174	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	6174	2	ACVIM	ACVIM	NNP
cord-023095-4dannjjm	6174	3	Foundation	Foundation	NNP
cord-023095-4dannjjm	6174	4	-	-	HYPH
cord-023095-4dannjjm	6174	5	funded	fund	VBN
cord-023095-4dannjjm	6174	6	research	research	NN
cord-023095-4dannjjm	6174	7	has	have	VBZ
cord-023095-4dannjjm	6174	8	focused	focus	VBN
cord-023095-4dannjjm	6174	9	on	on	IN
cord-023095-4dannjjm	6174	10	developing	develop	VBG
cord-023095-4dannjjm	6174	11	and	and	CC
cord-023095-4dannjjm	6174	12	evaluating	evaluate	VBG
cord-023095-4dannjjm	6174	13	a	a	DT
cord-023095-4dannjjm	6174	14	comprehensive	comprehensive	JJ
cord-023095-4dannjjm	6174	15	panel	panel	NN
cord-023095-4dannjjm	6174	16	of	of	IN
cord-023095-4dannjjm	6174	17	biomarkers	biomarker	NNS
cord-023095-4dannjjm	6174	18	of	of	IN
cord-023095-4dannjjm	6174	19	immunosuppression	immunosuppression	NN
cord-023095-4dannjjm	6174	20	that	that	WDT
cord-023095-4dannjjm	6174	21	can	can	MD
cord-023095-4dannjjm	6174	22	be	be	VB
cord-023095-4dannjjm	6174	23	utilized	utilize	VBN
cord-023095-4dannjjm	6174	24	for	for	IN
cord-023095-4dannjjm	6174	25	pharmacodynamic	pharmacodynamic	JJ
cord-023095-4dannjjm	6174	26	monitoring	monitoring	NN
cord-023095-4dannjjm	6174	27	during	during	IN
cord-023095-4dannjjm	6174	28	treatment	treatment	NN
cord-023095-4dannjjm	6174	29	with	with	IN
cord-023095-4dannjjm	6174	30	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6174	31	and	and	CC
cord-023095-4dannjjm	6174	32	other	other	JJ
cord-023095-4dannjjm	6174	33	immunosuppressive	immunosuppressive	JJ
cord-023095-4dannjjm	6174	34	agents	agent	NNS
cord-023095-4dannjjm	6174	35	that	that	WDT
cord-023095-4dannjjm	6174	36	affect	affect	VBP
cord-023095-4dannjjm	6174	37	T	t	NN
cord-023095-4dannjjm	6174	38	-	-	HYPH
cord-023095-4dannjjm	6174	39	cell	cell	NN
cord-023095-4dannjjm	6174	40	function	function	NN
cord-023095-4dannjjm	6174	41	.	.	.
cord-023095-4dannjjm	6175	1	We	-PRON-	PRP
cord-023095-4dannjjm	6175	2	have	have	VBP
cord-023095-4dannjjm	6175	3	completed	complete	VBN
cord-023095-4dannjjm	6175	4	several	several	JJ
cord-023095-4dannjjm	6175	5	studies	study	NNS
cord-023095-4dannjjm	6175	6	using	use	VBG
cord-023095-4dannjjm	6175	7	flow	flow	NN
cord-023095-4dannjjm	6175	8	cytometry	cytometry	NN
cord-023095-4dannjjm	6175	9	to	to	TO
cord-023095-4dannjjm	6175	10	evaluate	evaluate	VB
cord-023095-4dannjjm	6175	11	activated	activate	VBN
cord-023095-4dannjjm	6175	12	T	t	NN
cord-023095-4dannjjm	6175	13	-	-	HYPH
cord-023095-4dannjjm	6175	14	cell	cell	NN
cord-023095-4dannjjm	6175	15	expression	expression	NN
cord-023095-4dannjjm	6175	16	of	of	IN
cord-023095-4dannjjm	6175	17	surface	surface	NN
cord-023095-4dannjjm	6175	18	molecules	molecule	NNS
cord-023095-4dannjjm	6175	19	(	(	-LRB-
cord-023095-4dannjjm	6175	20	CD25	CD25	NNP
cord-023095-4dannjjm	6175	21	&	&	CC
cord-023095-4dannjjm	6175	22	CD95	CD95	NNP
cord-023095-4dannjjm	6175	23	)	)	-RRB-
cord-023095-4dannjjm	6175	24	and	and	CC
cord-023095-4dannjjm	6175	25	cytokines	cytokine	NNS
cord-023095-4dannjjm	6175	26	(	(	-LRB-
cord-023095-4dannjjm	6175	27	IL-2	IL-2	NNP
cord-023095-4dannjjm	6175	28	,	,	,
cord-023095-4dannjjm	6175	29	IFN	IFN	NNP
cord-023095-4dannjjm	6175	30	-	-	HYPH
cord-023095-4dannjjm	6175	31	g	g	NNP
cord-023095-4dannjjm	6175	32	&	&	CC
cord-023095-4dannjjm	6175	33	IL-4	IL-4	NNP
cord-023095-4dannjjm	6175	34	)	)	-RRB-
cord-023095-4dannjjm	6175	35	as	as	IN
cord-023095-4dannjjm	6175	36	potential	potential	JJ
cord-023095-4dannjjm	6175	37	biomarkers	biomarker	NNS
cord-023095-4dannjjm	6175	38	.	.	.
cord-023095-4dannjjm	6176	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	6176	2	first	first	JJ
cord-023095-4dannjjm	6176	3	study	study	NN
cord-023095-4dannjjm	6176	4	was	be	VBD
cord-023095-4dannjjm	6176	5	an	an	DT
cord-023095-4dannjjm	6176	6	in	in	IN
cord-023095-4dannjjm	6176	7	vitro	vitro	FW
cord-023095-4dannjjm	6176	8	study	study	NN
cord-023095-4dannjjm	6176	9	evaluating	evaluate	VBG
cord-023095-4dannjjm	6176	10	expression	expression	NN
cord-023095-4dannjjm	6176	11	of	of	IN
cord-023095-4dannjjm	6176	12	surface	surface	NN
cord-023095-4dannjjm	6176	13	molecules	molecule	NNS
cord-023095-4dannjjm	6176	14	and	and	CC
cord-023095-4dannjjm	6176	15	cytokines	cytokine	NNS
cord-023095-4dannjjm	6176	16	in	in	IN
cord-023095-4dannjjm	6176	17	canine	canine	JJ
cord-023095-4dannjjm	6176	18	T	t	NN
cord-023095-4dannjjm	6176	19	-	-	HYPH
cord-023095-4dannjjm	6176	20	cells	cell	NNS
cord-023095-4dannjjm	6176	21	exposed	expose	VBN
cord-023095-4dannjjm	6176	22	to	to	IN
cord-023095-4dannjjm	6176	23	varying	vary	VBG
cord-023095-4dannjjm	6176	24	concentrations	concentration	NNS
cord-023095-4dannjjm	6176	25	of	of	IN
cord-023095-4dannjjm	6176	26	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6176	27	.	.	.
cord-023095-4dannjjm	6177	1	This	this	DT
cord-023095-4dannjjm	6177	2	study	study	NN
cord-023095-4dannjjm	6177	3	established	establish	VBD
cord-023095-4dannjjm	6177	4	consistent	consistent	JJ
cord-023095-4dannjjm	6177	5	drug	drug	NN
cord-023095-4dannjjm	6177	6	-	-	HYPH
cord-023095-4dannjjm	6177	7	associated	associate	VBN
cord-023095-4dannjjm	6177	8	suppression	suppression	NN
cord-023095-4dannjjm	6177	9	of	of	IN
cord-023095-4dannjjm	6177	10	the	the	DT
cord-023095-4dannjjm	6177	11	cytokines	cytokine	NNS
cord-023095-4dannjjm	6177	12	IL-2	IL-2	NNP
cord-023095-4dannjjm	6177	13	,	,	,
cord-023095-4dannjjm	6177	14	IFN	IFN	NNP
cord-023095-4dannjjm	6177	15	-	-	HYPH
cord-023095-4dannjjm	6177	16	g	g	NNP
cord-023095-4dannjjm	6177	17	and	and	CC
cord-023095-4dannjjm	6177	18	IL-4	IL-4	NNP
cord-023095-4dannjjm	6177	19	.	.	.
cord-023095-4dannjjm	6178	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	6178	2	second	second	JJ
cord-023095-4dannjjm	6178	3	study	study	NN
cord-023095-4dannjjm	6178	4	was	be	VBD
cord-023095-4dannjjm	6178	5	an	an	DT
cord-023095-4dannjjm	6178	6	in	in	IN
cord-023095-4dannjjm	6178	7	vivo	vivo	NN
cord-023095-4dannjjm	6178	8	study	study	NN
cord-023095-4dannjjm	6178	9	in	in	IN
cord-023095-4dannjjm	6178	10	normal	normal	JJ
cord-023095-4dannjjm	6178	11	dogs	dog	NNS
cord-023095-4dannjjm	6178	12	evaluating	evaluate	VBG
cord-023095-4dannjjm	6178	13	the	the	DT
cord-023095-4dannjjm	6178	14	effects	effect	NNS
cord-023095-4dannjjm	6178	15	of	of	IN
cord-023095-4dannjjm	6178	16	two	two	CD
cord-023095-4dannjjm	6178	17	doses	dose	NNS
cord-023095-4dannjjm	6178	18	of	of	IN
cord-023095-4dannjjm	6178	19	oral	oral	JJ
cord-023095-4dannjjm	6178	20	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6178	21	,	,	,
cord-023095-4dannjjm	6178	22	a	a	DT
cord-023095-4dannjjm	6178	23	high	high	JJ
cord-023095-4dannjjm	6178	24	dose	dose	NN
cord-023095-4dannjjm	6178	25	considered	consider	VBN
cord-023095-4dannjjm	6178	26	to	to	TO
cord-023095-4dannjjm	6178	27	be	be	VB
cord-023095-4dannjjm	6178	28	reliably	reliably	RB
cord-023095-4dannjjm	6178	29	immunosuppressive	immunosuppressive	JJ
cord-023095-4dannjjm	6178	30	(	(	-LRB-
cord-023095-4dannjjm	6178	31	starting	start	VBG
cord-023095-4dannjjm	6178	32	dose	dose	NN
cord-023095-4dannjjm	6178	33	10	10	CD
cord-023095-4dannjjm	6178	34	mg	mg	NNP
cord-023095-4dannjjm	6178	35	/	/	SYM
cord-023095-4dannjjm	6178	36	kg	kg	NN
cord-023095-4dannjjm	6178	37	bid	bid	NN
cord-023095-4dannjjm	6178	38	,	,	,
cord-023095-4dannjjm	6178	39	titrated	titrate	VBN
cord-023095-4dannjjm	6178	40	upwards	upwards	RB
cord-023095-4dannjjm	6178	41	as	as	IN
cord-023095-4dannjjm	6178	42	needed	need	VBN
cord-023095-4dannjjm	6178	43	to	to	TO
cord-023095-4dannjjm	6178	44	attain	attain	VB
cord-023095-4dannjjm	6178	45	trough	trough	JJ
cord-023095-4dannjjm	6178	46	drug	drug	NN
cord-023095-4dannjjm	6178	47	blood	blood	NN
cord-023095-4dannjjm	6178	48	levels	level	NNS
cord-023095-4dannjjm	6178	49	of	of	IN
cord-023095-4dannjjm	6178	50	at	at	RB
cord-023095-4dannjjm	6178	51	least	least	JJS
cord-023095-4dannjjm	6178	52	600	600	CD
cord-023095-4dannjjm	6178	53	ng	ng	NN
cord-023095-4dannjjm	6178	54	/	/	SYM
cord-023095-4dannjjm	6178	55	mL	mL	NNP
cord-023095-4dannjjm	6178	56	)	)	-RRB-
cord-023095-4dannjjm	6178	57	and	and	CC
cord-023095-4dannjjm	6178	58	a	a	DT
cord-023095-4dannjjm	6178	59	lower	low	JJR
cord-023095-4dannjjm	6178	60	dose	dose	NN
cord-023095-4dannjjm	6178	61	used	use	VBN
cord-023095-4dannjjm	6178	62	to	to	TO
cord-023095-4dannjjm	6178	63	treat	treat	VB
cord-023095-4dannjjm	6178	64	atopy	atopy	NN
cord-023095-4dannjjm	6178	65	(	(	-LRB-
cord-023095-4dannjjm	6178	66	5	5	CD
cord-023095-4dannjjm	6178	67	mg	mg	NNP
cord-023095-4dannjjm	6178	68	/	/	SYM
cord-023095-4dannjjm	6178	69	kg	kg	NNP
cord-023095-4dannjjm	6178	70	sid	sid	NNP
cord-023095-4dannjjm	6178	71	)	)	-RRB-
cord-023095-4dannjjm	6178	72	,	,	,
cord-023095-4dannjjm	6178	73	on	on	IN
cord-023095-4dannjjm	6178	74	T	t	NN
cord-023095-4dannjjm	6178	75	-	-	HYPH
cord-023095-4dannjjm	6178	76	cell	cell	NN
cord-023095-4dannjjm	6178	77	expression	expression	NN
cord-023095-4dannjjm	6178	78	of	of	IN
cord-023095-4dannjjm	6178	79	these	these	DT
cord-023095-4dannjjm	6178	80	three	three	CD
cord-023095-4dannjjm	6178	81	cytokines	cytokine	NNS
cord-023095-4dannjjm	6178	82	.	.	.
cord-023095-4dannjjm	6179	1	Significant	significant	JJ
cord-023095-4dannjjm	6179	2	suppression	suppression	NN
cord-023095-4dannjjm	6179	3	of	of	IN
cord-023095-4dannjjm	6179	4	IL-2	IL-2	NNP
cord-023095-4dannjjm	6179	5	and	and	CC
cord-023095-4dannjjm	6179	6	IFN	IFN	NNP
cord-023095-4dannjjm	6179	7	-	-	HYPH
cord-023095-4dannjjm	6179	8	g	g	NN
cord-023095-4dannjjm	6179	9	expression	expression	NN
cord-023095-4dannjjm	6179	10	was	be	VBD
cord-023095-4dannjjm	6179	11	seen	see	VBN
cord-023095-4dannjjm	6179	12	at	at	IN
cord-023095-4dannjjm	6179	13	the	the	DT
cord-023095-4dannjjm	6179	14	high	high	JJ
cord-023095-4dannjjm	6179	15	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6179	16	dose	dose	NN
cord-023095-4dannjjm	6179	17	,	,	,
cord-023095-4dannjjm	6179	18	while	while	IN
cord-023095-4dannjjm	6179	19	at	at	IN
cord-023095-4dannjjm	6179	20	the	the	DT
cord-023095-4dannjjm	6179	21	lower	low	JJR
cord-023095-4dannjjm	6179	22	dose	dose	NN
cord-023095-4dannjjm	6179	23	only	only	JJ
cord-023095-4dannjjm	6179	24	IFN	IFN	NNP
cord-023095-4dannjjm	6179	25	-	-	HYPH
cord-023095-4dannjjm	6179	26	g	g	NN
cord-023095-4dannjjm	6179	27	expression	expression	NN
cord-023095-4dannjjm	6179	28	was	be	VBD
cord-023095-4dannjjm	6179	29	suppressed	suppress	VBN
cord-023095-4dannjjm	6179	30	.	.	.
cord-023095-4dannjjm	6180	1	Because	because	IN
cord-023095-4dannjjm	6180	2	Tcell	Tcell	NNP
cord-023095-4dannjjm	6180	3	expression	expression	NN
cord-023095-4dannjjm	6180	4	of	of	IN
cord-023095-4dannjjm	6180	5	IL-4	IL-4	NNP
cord-023095-4dannjjm	6180	6	was	be	VBD
cord-023095-4dannjjm	6180	7	not	not	RB
cord-023095-4dannjjm	6180	8	significantly	significantly	RB
cord-023095-4dannjjm	6180	9	suppressed	suppress	VBN
cord-023095-4dannjjm	6180	10	at	at	IN
cord-023095-4dannjjm	6180	11	the	the	DT
cord-023095-4dannjjm	6180	12	high	high	JJ
cord-023095-4dannjjm	6180	13	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6180	14	dose	dose	NN
cord-023095-4dannjjm	6180	15	,	,	,
cord-023095-4dannjjm	6180	16	IL-4	IL-4	NNP
cord-023095-4dannjjm	6180	17	was	be	VBD
cord-023095-4dannjjm	6180	18	not	not	RB
cord-023095-4dannjjm	6180	19	evaluated	evaluate	VBN
cord-023095-4dannjjm	6180	20	at	at	IN
cord-023095-4dannjjm	6180	21	the	the	DT
cord-023095-4dannjjm	6180	22	lower	low	JJR
cord-023095-4dannjjm	6180	23	drug	drug	NN
cord-023095-4dannjjm	6180	24	dose	dose	NN
cord-023095-4dannjjm	6180	25	.	.	.
cord-023095-4dannjjm	6181	1	Because	because	IN
cord-023095-4dannjjm	6181	2	of	of	IN
cord-023095-4dannjjm	6181	3	specialized	specialized	JJ
cord-023095-4dannjjm	6181	4	sample	sample	NN
cord-023095-4dannjjm	6181	5	handling	handling	NN
cord-023095-4dannjjm	6181	6	requirements	requirement	NNS
cord-023095-4dannjjm	6181	7	,	,	,
cord-023095-4dannjjm	6181	8	flow	flow	NN
cord-023095-4dannjjm	6181	9	cytometry	cytometry	NN
cord-023095-4dannjjm	6181	10	is	be	VBZ
cord-023095-4dannjjm	6181	11	not	not	RB
cord-023095-4dannjjm	6181	12	as	as	IN
cord-023095-4dannjjm	6181	13	practitioner	practitioner	NN
cord-023095-4dannjjm	6181	14	friendly	friendly	JJ
cord-023095-4dannjjm	6181	15	as	as	IN
cord-023095-4dannjjm	6181	16	other	other	JJ
cord-023095-4dannjjm	6181	17	assays	assay	NNS
cord-023095-4dannjjm	6181	18	(	(	-LRB-
cord-023095-4dannjjm	6181	19	such	such	JJ
cord-023095-4dannjjm	6181	20	as	as	IN
cord-023095-4dannjjm	6181	21	PCR	PCR	NNP
cord-023095-4dannjjm	6181	22	)	)	-RRB-
cord-023095-4dannjjm	6181	23	for	for	IN
cord-023095-4dannjjm	6181	24	routine	routine	JJ
cord-023095-4dannjjm	6181	25	use	use	NN
cord-023095-4dannjjm	6181	26	in	in	IN
cord-023095-4dannjjm	6181	27	pharmacodynamic	pharmacodynamic	JJ
cord-023095-4dannjjm	6181	28	testing	testing	NN
cord-023095-4dannjjm	6181	29	.	.	.
cord-023095-4dannjjm	6182	1	We	-PRON-	PRP
cord-023095-4dannjjm	6182	2	have	have	VBP
cord-023095-4dannjjm	6182	3	therefore	therefore	RB
cord-023095-4dannjjm	6182	4	conducted	conduct	VBN
cord-023095-4dannjjm	6182	5	an	an	DT
cord-023095-4dannjjm	6182	6	in	in	IN
cord-023095-4dannjjm	6182	7	vitro	vitro	FW
cord-023095-4dannjjm	6182	8	study	study	NN
cord-023095-4dannjjm	6182	9	comparing	compare	VBG
cord-023095-4dannjjm	6182	10	the	the	DT
cord-023095-4dannjjm	6182	11	effects	effect	NNS
cord-023095-4dannjjm	6182	12	of	of	IN
cord-023095-4dannjjm	6182	13	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6182	14	on	on	IN
cord-023095-4dannjjm	6182	15	activated	activate	VBN
cord-023095-4dannjjm	6182	16	T	t	NN
cord-023095-4dannjjm	6182	17	-	-	HYPH
cord-023095-4dannjjm	6182	18	cell	cell	NN
cord-023095-4dannjjm	6182	19	expression	expression	NN
cord-023095-4dannjjm	6182	20	of	of	IN
cord-023095-4dannjjm	6182	21	IL-2	IL-2	NNP
cord-023095-4dannjjm	6182	22	and	and	CC
cord-023095-4dannjjm	6182	23	IFN	IFN	NNP
cord-023095-4dannjjm	6182	24	-	-	HYPH
cord-023095-4dannjjm	6182	25	g	g	NNP
cord-023095-4dannjjm	6182	26	using	use	VBG
cord-023095-4dannjjm	6182	27	flow	flow	NN
cord-023095-4dannjjm	6182	28	cytometry	cytometry	NN
cord-023095-4dannjjm	6182	29	and	and	CC
cord-023095-4dannjjm	6182	30	qRT	qRT	NNP
cord-023095-4dannjjm	6182	31	-	-	HYPH
cord-023095-4dannjjm	6182	32	PCR	PCR	NNP
cord-023095-4dannjjm	6182	33	,	,	,
cord-023095-4dannjjm	6182	34	and	and	CC
cord-023095-4dannjjm	6182	35	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	6182	36	dose	dose	NN
cord-023095-4dannjjm	6182	37	dependent	dependent	JJ
cord-023095-4dannjjm	6182	38	and	and	CC
cord-023095-4dannjjm	6182	39	comparable	comparable	JJ
cord-023095-4dannjjm	6182	40	suppression	suppression	NN
cord-023095-4dannjjm	6182	41	of	of	IN
cord-023095-4dannjjm	6182	42	IL-2	IL-2	NNP
cord-023095-4dannjjm	6182	43	and	and	CC
cord-023095-4dannjjm	6182	44	IFN	IFN	NNP
cord-023095-4dannjjm	6182	45	-	-	HYPH
cord-023095-4dannjjm	6182	46	g	g	NNP
cord-023095-4dannjjm	6182	47	using	use	VBG
cord-023095-4dannjjm	6182	48	either	either	CC
cord-023095-4dannjjm	6182	49	methodology	methodology	NN
cord-023095-4dannjjm	6182	50	.	.	.
cord-023095-4dannjjm	6183	1	We	-PRON-	PRP
cord-023095-4dannjjm	6183	2	are	be	VBP
cord-023095-4dannjjm	6183	3	currently	currently	RB
cord-023095-4dannjjm	6183	4	evaluating	evaluate	VBG
cord-023095-4dannjjm	6183	5	,	,	,
cord-023095-4dannjjm	6183	6	using	use	VBG
cord-023095-4dannjjm	6183	7	qRT	qrt	ADD
cord-023095-4dannjjm	6183	8	-	-	HYPH
cord-023095-4dannjjm	6183	9	PCR	PCR	NNP
cord-023095-4dannjjm	6183	10	,	,	,
cord-023095-4dannjjm	6183	11	the	the	DT
cord-023095-4dannjjm	6183	12	effects	effect	NNS
cord-023095-4dannjjm	6183	13	of	of	IN
cord-023095-4dannjjm	6183	14	oral	oral	JJ
cord-023095-4dannjjm	6183	15	cyclosporine	cyclosporine	NN
cord-023095-4dannjjm	6183	16	on	on	IN
cord-023095-4dannjjm	6183	17	T	t	NN
cord-023095-4dannjjm	6183	18	-	-	HYPH
cord-023095-4dannjjm	6183	19	cell	cell	NN
cord-023095-4dannjjm	6183	20	expression	expression	NN
cord-023095-4dannjjm	6183	21	of	of	IN
cord-023095-4dannjjm	6183	22	IL-2	IL-2	NNP
cord-023095-4dannjjm	6183	23	and	and	CC
cord-023095-4dannjjm	6183	24	IFN	IFN	NNP
cord-023095-4dannjjm	6183	25	-	-	HYPH
cord-023095-4dannjjm	6183	26	g	g	NNP
cord-023095-4dannjjm	6183	27	in	in	IN
cord-023095-4dannjjm	6183	28	normal	normal	JJ
cord-023095-4dannjjm	6183	29	dogs	dog	NNS
cord-023095-4dannjjm	6183	30	prior	prior	RB
cord-023095-4dannjjm	6183	31	to	to	IN
cord-023095-4dannjjm	6183	32	moving	move	VBG
cord-023095-4dannjjm	6183	33	on	on	RP
cord-023095-4dannjjm	6183	34	to	to	IN
cord-023095-4dannjjm	6183	35	pharmacodynamic	pharmacodynamic	JJ
cord-023095-4dannjjm	6183	36	trials	trial	NNS
cord-023095-4dannjjm	6183	37	in	in	IN
cord-023095-4dannjjm	6183	38	our	-PRON-	PRP$
cord-023095-4dannjjm	6183	39	clinic	clinic	NN
cord-023095-4dannjjm	6183	40	patients	patient	NNS
cord-023095-4dannjjm	6183	41	.	.	.
cord-023095-4dannjjm	6184	1	EFFECT	effect	NN
cord-023095-4dannjjm	6184	2	OF	of	IN
cord-023095-4dannjjm	6184	3	HYPOTHYROIDISM	hypothyroidism	NN
cord-023095-4dannjjm	6184	4	ON	on	IN
cord-023095-4dannjjm	6184	5	REPRODUCTION	reproduction	NN
cord-023095-4dannjjm	6184	6	IN	in	IN
cord-023095-4dannjjm	6184	7	BITCHES	bitch	NNS
cord-023095-4dannjjm	6184	8	.	.	.
cord-023095-4dannjjm	6185	1	DL	DL	NNP
cord-023095-4dannjjm	6185	2	Panciera	Panciera	NNP
cord-023095-4dannjjm	6185	3	1	1	CD
cord-023095-4dannjjm	6185	4	,	,	,
cord-023095-4dannjjm	6185	5	BJ	BJ	NNP
cord-023095-4dannjjm	6185	6	Purswell	Purswell	NNP
cord-023095-4dannjjm	6185	7	2	2	CD
cord-023095-4dannjjm	6185	8	,	,	,
cord-023095-4dannjjm	6185	9	KA	KA	NNP
cord-023095-4dannjjm	6185	10	Kolster	Kolster	NNP
cord-023095-4dannjjm	6185	11	2	2	CD
cord-023095-4dannjjm	6185	12	,	,	,
cord-023095-4dannjjm	6185	13	SR	SR	NNP
cord-023095-4dannjjm	6185	14	Werre	Werre	NNP
cord-023095-4dannjjm	6185	15	3	3	CD
cord-023095-4dannjjm	6185	16	.	.	.
cord-023095-4dannjjm	6186	1	Departments	department	NNS
cord-023095-4dannjjm	6186	2	of	of	IN
cord-023095-4dannjjm	6186	3	1	1	CD
cord-023095-4dannjjm	6186	4	Small	Small	NNP
cord-023095-4dannjjm	6186	5	Animal	Animal	NNP
cord-023095-4dannjjm	6186	6	Clinical	Clinical	NNP
cord-023095-4dannjjm	6186	7	Sciences	Sciences	NNPS
cord-023095-4dannjjm	6186	8	,	,	,
cord-023095-4dannjjm	6186	9	2	2	CD
cord-023095-4dannjjm	6186	10	Large	Large	NNP
cord-023095-4dannjjm	6186	11	Animal	Animal	NNP
cord-023095-4dannjjm	6186	12	Clinical	Clinical	NNP
cord-023095-4dannjjm	6186	13	Sciences	Sciences	NNPS
cord-023095-4dannjjm	6186	14	,	,	,
cord-023095-4dannjjm	6186	15	and	and	CC
cord-023095-4dannjjm	6186	16	3	3	CD
cord-023095-4dannjjm	6186	17	Laboratory	Laboratory	NNP
cord-023095-4dannjjm	6186	18	for	for	IN
cord-023095-4dannjjm	6186	19	Study	Study	NNP
cord-023095-4dannjjm	6186	20	Design	Design	NNP
cord-023095-4dannjjm	6186	21	and	and	CC
cord-023095-4dannjjm	6186	22	Data	Data	NNP
cord-023095-4dannjjm	6186	23	Analysis	Analysis	NNP
cord-023095-4dannjjm	6186	24	,	,	,
cord-023095-4dannjjm	6186	25	Virginia	Virginia	NNP
cord-023095-4dannjjm	6186	26	-	-	HYPH
cord-023095-4dannjjm	6186	27	Maryland	Maryland	NNP
cord-023095-4dannjjm	6186	28	Regional	Regional	NNP
cord-023095-4dannjjm	6186	29	College	College	NNP
cord-023095-4dannjjm	6186	30	of	of	IN
cord-023095-4dannjjm	6186	31	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	6186	32	Medicine	Medicine	NNP
cord-023095-4dannjjm	6186	33	,	,	,
cord-023095-4dannjjm	6186	34	Virginia	Virginia	NNP
cord-023095-4dannjjm	6186	35	Tech	Tech	NNP
cord-023095-4dannjjm	6186	36	,	,	,
cord-023095-4dannjjm	6186	37	Blacksburg	Blacksburg	NNP
cord-023095-4dannjjm	6186	38	,	,	,
cord-023095-4dannjjm	6186	39	VA	VA	NNP
cord-023095-4dannjjm	6186	40	.	.	.
cord-023095-4dannjjm	6187	1	Numerous	numerous	JJ
cord-023095-4dannjjm	6187	2	reproductive	reproductive	JJ
cord-023095-4dannjjm	6187	3	abnormalities	abnormality	NNS
cord-023095-4dannjjm	6187	4	,	,	,
cord-023095-4dannjjm	6187	5	including	include	VBG
cord-023095-4dannjjm	6187	6	irregular	irregular	JJ
cord-023095-4dannjjm	6187	7	interestrous	interestrous	JJ
cord-023095-4dannjjm	6187	8	period	period	NN
cord-023095-4dannjjm	6187	9	,	,	,
cord-023095-4dannjjm	6187	10	anestrus	anestrus	NNP
cord-023095-4dannjjm	6187	11	,	,	,
cord-023095-4dannjjm	6187	12	and	and	CC
cord-023095-4dannjjm	6187	13	infertility	infertility	NN
cord-023095-4dannjjm	6187	14	have	have	VBP
cord-023095-4dannjjm	6187	15	been	be	VBN
cord-023095-4dannjjm	6187	16	attributed	attribute	VBN
cord-023095-4dannjjm	6187	17	to	to	IN
cord-023095-4dannjjm	6187	18	hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	6187	19	.	.	.
cord-023095-4dannjjm	6188	1	We	-PRON-	PRP
cord-023095-4dannjjm	6188	2	previously	previously	RB
cord-023095-4dannjjm	6188	3	documented	document	VBD
cord-023095-4dannjjm	6188	4	reduced	reduced	JJ
cord-023095-4dannjjm	6188	5	fertility	fertility	NN
cord-023095-4dannjjm	6188	6	and	and	CC
cord-023095-4dannjjm	6188	7	lower	low	JJR
cord-023095-4dannjjm	6188	8	birth	birth	NN
cord-023095-4dannjjm	6188	9	weight	weight	NN
cord-023095-4dannjjm	6188	10	and	and	CC
cord-023095-4dannjjm	6188	11	increased	increase	VBN
cord-023095-4dannjjm	6188	12	periparturient	periparturient	NN
cord-023095-4dannjjm	6188	13	mortality	mortality	NN
cord-023095-4dannjjm	6188	14	in	in	IN
cord-023095-4dannjjm	6188	15	pups	pup	NNS
cord-023095-4dannjjm	6188	16	born	bear	VBN
cord-023095-4dannjjm	6188	17	to	to	IN
cord-023095-4dannjjm	6188	18	bitches	bitch	NNS
cord-023095-4dannjjm	6188	19	with	with	IN
cord-023095-4dannjjm	6188	20	experimentally	experimentally	RB
cord-023095-4dannjjm	6188	21	-	-	HYPH
cord-023095-4dannjjm	6188	22	induced	induce	VBN
cord-023095-4dannjjm	6188	23	hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	6188	24	for	for	IN
cord-023095-4dannjjm	6188	25	a	a	DT
cord-023095-4dannjjm	6188	26	median	median	JJ
cord-023095-4dannjjm	6188	27	duration	duration	NN
cord-023095-4dannjjm	6188	28	of	of	IN
cord-023095-4dannjjm	6188	29	56	56	CD
cord-023095-4dannjjm	6188	30	weeks	week	NNS
cord-023095-4dannjjm	6188	31	.	.	.
cord-023095-4dannjjm	6189	1	The	the	DT
cord-023095-4dannjjm	6189	2	purpose	purpose	NN
cord-023095-4dannjjm	6189	3	of	of	IN
cord-023095-4dannjjm	6189	4	this	this	DT
cord-023095-4dannjjm	6189	5	study	study	NN
cord-023095-4dannjjm	6189	6	was	be	VBD
cord-023095-4dannjjm	6189	7	to	to	TO
cord-023095-4dannjjm	6189	8	evaluate	evaluate	VB
cord-023095-4dannjjm	6189	9	reproductive	reproductive	JJ
cord-023095-4dannjjm	6189	10	function	function	NN
cord-023095-4dannjjm	6189	11	in	in	IN
cord-023095-4dannjjm	6189	12	these	these	DT
cord-023095-4dannjjm	6189	13	same	same	JJ
cord-023095-4dannjjm	6189	14	bitches	bitch	NNS
cord-023095-4dannjjm	6189	15	after	after	IN
cord-023095-4dannjjm	6189	16	hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	6189	17	was	be	VBD
cord-023095-4dannjjm	6189	18	treated	treat	VBN
cord-023095-4dannjjm	6189	19	with	with	IN
cord-023095-4dannjjm	6189	20	a	a	DT
cord-023095-4dannjjm	6189	21	replacement	replacement	NN
cord-023095-4dannjjm	6189	22	dose	dose	NN
cord-023095-4dannjjm	6189	23	of	of	IN
cord-023095-4dannjjm	6189	24	levothyroxine	levothyroxine	NN
cord-023095-4dannjjm	6189	25	.	.	.
cord-023095-4dannjjm	6190	1	Twelve	twelve	CD
cord-023095-4dannjjm	6190	2	multiparous	multiparous	JJ
cord-023095-4dannjjm	6190	3	bitches	bitch	NNS
cord-023095-4dannjjm	6190	4	were	be	VBD
cord-023095-4dannjjm	6190	5	studied	study	VBN
cord-023095-4dannjjm	6190	6	.	.	.
cord-023095-4dannjjm	6191	1	Hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	6191	2	was	be	VBD
cord-023095-4dannjjm	6191	3	induced	induce	VBN
cord-023095-4dannjjm	6191	4	in	in	IN
cord-023095-4dannjjm	6191	5	6	6	CD
cord-023095-4dannjjm	6191	6	dogs	dog	NNS
cord-023095-4dannjjm	6191	7	by	by	IN
cord-023095-4dannjjm	6191	8	administration	administration	NN
cord-023095-4dannjjm	6191	9	of	of	IN
cord-023095-4dannjjm	6191	10	1	1	CD
cord-023095-4dannjjm	6191	11	mCi	mCi	NNPS
cord-023095-4dannjjm	6191	12	/	/	SYM
cord-023095-4dannjjm	6191	13	kg	kg	NN
cord-023095-4dannjjm	6191	14	131	131	CD
cord-023095-4dannjjm	6191	15	I.	i.	NN
cord-023095-4dannjjm	6191	16	Hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	6191	17	was	be	VBD
cord-023095-4dannjjm	6191	18	confirmed	confirm	VBN
cord-023095-4dannjjm	6191	19	by	by	IN
cord-023095-4dannjjm	6191	20	finding	find	VBG
cord-023095-4dannjjm	6191	21	serum	serum	NN
cord-023095-4dannjjm	6191	22	T4	T4	NNP
cord-023095-4dannjjm	6191	23	concentrations	concentration	NNS
cord-023095-4dannjjm	6191	24	before	before	IN
cord-023095-4dannjjm	6191	25	and	and	CC
cord-023095-4dannjjm	6191	26	4	4	CD
cord-023095-4dannjjm	6191	27	hours	hour	NNS
cord-023095-4dannjjm	6191	28	after	after	IN
cord-023095-4dannjjm	6191	29	IV	IV	NNP
cord-023095-4dannjjm	6191	30	administration	administration	NN
cord-023095-4dannjjm	6191	31	of	of	IN
cord-023095-4dannjjm	6191	32	human	human	JJ
cord-023095-4dannjjm	6191	33	recombinant	recombinant	JJ
cord-023095-4dannjjm	6191	34	TSH	TSH	NNP
cord-023095-4dannjjm	6191	35	that	that	WDT
cord-023095-4dannjjm	6191	36	were	be	VBD
cord-023095-4dannjjm	6191	37	o	o	NN
cord-023095-4dannjjm	6191	38	5	5	CD
cord-023095-4dannjjm	6191	39	nmol	nmol	NNP
cord-023095-4dannjjm	6191	40	/	/	SYM
cord-023095-4dannjjm	6191	41	L.	L.	NNP
cord-023095-4dannjjm	6191	42	Levothyroxine	Levothyroxine	NNP
cord-023095-4dannjjm	6191	43	(	(	-LRB-
cord-023095-4dannjjm	6192	1	0.02	0.02	CD
cord-023095-4dannjjm	6192	2	mg	mg	NNP
cord-023095-4dannjjm	6192	3	/	/	SYM
cord-023095-4dannjjm	6192	4	kd	kd	NNP
cord-023095-4dannjjm	6192	5	q	q	NNP
cord-023095-4dannjjm	6192	6	24	24	CD
cord-023095-4dannjjm	6192	7	h	h	NNP
cord-023095-4dannjjm	6192	8	)	)	-RRB-
cord-023095-4dannjjm	6192	9	was	be	VBD
cord-023095-4dannjjm	6192	10	administered	administer	VBN
cord-023095-4dannjjm	6192	11	to	to	IN
cord-023095-4dannjjm	6192	12	all	all	DT
cord-023095-4dannjjm	6192	13	hypothyroid	hypothyroid	JJ
cord-023095-4dannjjm	6192	14	bitches	bitch	NNS
cord-023095-4dannjjm	6192	15	.	.	.
cord-023095-4dannjjm	6193	1	Six	six	CD
cord-023095-4dannjjm	6193	2	bitches	bitch	NNS
cord-023095-4dannjjm	6193	3	served	serve	VBD
cord-023095-4dannjjm	6193	4	as	as	IN
cord-023095-4dannjjm	6193	5	euthyroid	euthyroid	NNP
cord-023095-4dannjjm	6193	6	,	,	,
cord-023095-4dannjjm	6193	7	untreated	untreated	JJ
cord-023095-4dannjjm	6193	8	controls	control	NNS
cord-023095-4dannjjm	6193	9	.	.	.
cord-023095-4dannjjm	6194	1	Dogs	dog	NNS
cord-023095-4dannjjm	6194	2	were	be	VBD
cord-023095-4dannjjm	6194	3	evaluated	evaluate	VBN
cord-023095-4dannjjm	6194	4	daily	daily	RB
cord-023095-4dannjjm	6194	5	for	for	IN
cord-023095-4dannjjm	6194	6	signs	sign	NNS
cord-023095-4dannjjm	6194	7	of	of	IN
cord-023095-4dannjjm	6194	8	estrus	estrus	NN
cord-023095-4dannjjm	6194	9	and	and	CC
cord-023095-4dannjjm	6194	10	were	be	VBD
cord-023095-4dannjjm	6194	11	bred	breed	VBN
cord-023095-4dannjjm	6194	12	by	by	IN
cord-023095-4dannjjm	6194	13	1	1	CD
cord-023095-4dannjjm	6194	14	of	of	IN
cord-023095-4dannjjm	6194	15	2	2	CD
cord-023095-4dannjjm	6194	16	males	male	NNS
cord-023095-4dannjjm	6194	17	when	when	WRB
cord-023095-4dannjjm	6194	18	serum	serum	NN
cord-023095-4dannjjm	6194	19	progesterone	progesterone	NN
cord-023095-4dannjjm	6194	20	was	be	VBD
cord-023095-4dannjjm	6194	21	!	!	.
cord-023095-4dannjjm	6195	1	5	5	LS
cord-023095-4dannjjm	6196	1	ng	ng	NNP
cord-023095-4dannjjm	6196	2	/	/	SYM
cord-023095-4dannjjm	6196	3	ml	ml	NN
cord-023095-4dannjjm	6196	4	.	.	.
cord-023095-4dannjjm	6197	1	Interestrous	interestrous	JJ
cord-023095-4dannjjm	6197	2	interval	interval	NN
cord-023095-4dannjjm	6197	3	,	,	,
cord-023095-4dannjjm	6197	4	gestation	gestation	NN
cord-023095-4dannjjm	6197	5	length	length	NN
cord-023095-4dannjjm	6197	6	,	,	,
cord-023095-4dannjjm	6197	7	strength	strength	NN
cord-023095-4dannjjm	6197	8	and	and	CC
cord-023095-4dannjjm	6197	9	duration	duration	NN
cord-023095-4dannjjm	6197	10	of	of	IN
cord-023095-4dannjjm	6197	11	contractions	contraction	NNS
cord-023095-4dannjjm	6197	12	during	during	IN
cord-023095-4dannjjm	6197	13	whelping	whelping	NN
cord-023095-4dannjjm	6197	14	,	,	,
cord-023095-4dannjjm	6197	15	time	time	NN
cord-023095-4dannjjm	6197	16	between	between	IN
cord-023095-4dannjjm	6197	17	pups	pup	NNS
cord-023095-4dannjjm	6197	18	,	,	,
cord-023095-4dannjjm	6197	19	number	number	NN
cord-023095-4dannjjm	6197	20	of	of	IN
cord-023095-4dannjjm	6197	21	live	live	JJ
cord-023095-4dannjjm	6197	22	pups	pup	NNS
cord-023095-4dannjjm	6197	23	and	and	CC
cord-023095-4dannjjm	6197	24	stillbirths	stillbirth	NNS
cord-023095-4dannjjm	6197	25	,	,	,
cord-023095-4dannjjm	6197	26	viability	viability	NN
cord-023095-4dannjjm	6197	27	of	of	IN
cord-023095-4dannjjm	6197	28	pups	pup	NNS
cord-023095-4dannjjm	6197	29	at	at	IN
cord-023095-4dannjjm	6197	30	birth	birth	NN
cord-023095-4dannjjm	6197	31	,	,	,
cord-023095-4dannjjm	6197	32	weight	weight	NN
cord-023095-4dannjjm	6197	33	of	of	IN
cord-023095-4dannjjm	6197	34	pups	pup	NNS
cord-023095-4dannjjm	6197	35	,	,	,
cord-023095-4dannjjm	6197	36	and	and	CC
cord-023095-4dannjjm	6197	37	periparturient	periparturient	NN
cord-023095-4dannjjm	6197	38	mortality	mortality	NN
cord-023095-4dannjjm	6197	39	were	be	VBD
cord-023095-4dannjjm	6197	40	recorded	record	VBN
cord-023095-4dannjjm	6197	41	.	.	.
cord-023095-4dannjjm	6198	1	The	the	DT
cord-023095-4dannjjm	6198	2	Student	Student	NNP
cord-023095-4dannjjm	6198	3	's	's	POS
cord-023095-4dannjjm	6198	4	t	t	NN
cord-023095-4dannjjm	6198	5	-	-	HYPH
cord-023095-4dannjjm	6198	6	test	test	NN
cord-023095-4dannjjm	6198	7	and	and	CC
cord-023095-4dannjjm	6198	8	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	6198	9	were	be	VBD
cord-023095-4dannjjm	6198	10	used	use	VBN
cord-023095-4dannjjm	6198	11	to	to	TO
cord-023095-4dannjjm	6198	12	compare	compare	VB
cord-023095-4dannjjm	6198	13	differences	difference	NNS
cord-023095-4dannjjm	6198	14	between	between	IN
cord-023095-4dannjjm	6198	15	control	control	NN
cord-023095-4dannjjm	6198	16	and	and	CC
cord-023095-4dannjjm	6198	17	hypothyroid	hypothyroid	JJ
cord-023095-4dannjjm	6198	18	bitches	bitch	NNS
cord-023095-4dannjjm	6198	19	for	for	IN
cord-023095-4dannjjm	6198	20	continuous	continuous	JJ
cord-023095-4dannjjm	6198	21	,	,	,
cord-023095-4dannjjm	6198	22	normally	normally	RB
cord-023095-4dannjjm	6198	23	distributed	distribute	VBN
cord-023095-4dannjjm	6198	24	data	datum	NNS
cord-023095-4dannjjm	6198	25	.	.	.
cord-023095-4dannjjm	6199	1	The	the	DT
cord-023095-4dannjjm	6199	2	Wilcoxon	Wilcoxon	NNP
cord-023095-4dannjjm	6199	3	rank	rank	NN
cord-023095-4dannjjm	6199	4	sum	sum	NN
cord-023095-4dannjjm	6199	5	test	test	NN
cord-023095-4dannjjm	6199	6	was	be	VBD
cord-023095-4dannjjm	6199	7	used	use	VBN
cord-023095-4dannjjm	6199	8	to	to	TO
cord-023095-4dannjjm	6199	9	analyze	analyze	VB
cord-023095-4dannjjm	6199	10	data	datum	NNS
cord-023095-4dannjjm	6199	11	between	between	IN
cord-023095-4dannjjm	6199	12	groups	group	NNS
cord-023095-4dannjjm	6199	13	that	that	WDT
cord-023095-4dannjjm	6199	14	was	be	VBD
cord-023095-4dannjjm	6199	15	not	not	RB
cord-023095-4dannjjm	6199	16	normally	normally	RB
cord-023095-4dannjjm	6199	17	distributed	distribute	VBN
cord-023095-4dannjjm	6199	18	.	.	.
cord-023095-4dannjjm	6200	1	The	the	DT
cord-023095-4dannjjm	6200	2	mean	mean	JJ
cord-023095-4dannjjm	6200	3	duration	duration	NN
cord-023095-4dannjjm	6200	4	of	of	IN
cord-023095-4dannjjm	6200	5	hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	6200	6	prior	prior	RB
cord-023095-4dannjjm	6200	7	to	to	IN
cord-023095-4dannjjm	6200	8	levothyroxine	levothyroxine	NNP
cord-023095-4dannjjm	6200	9	administration	administration	NNP
cord-023095-4dannjjm	6200	10	was	be	VBD
cord-023095-4dannjjm	6200	11	102	102	CD
cord-023095-4dannjjm	6200	12	AE	AE	NNP
cord-023095-4dannjjm	6200	13	8.1	8.1	CD
cord-023095-4dannjjm	6200	14	weeks	week	NNS
cord-023095-4dannjjm	6200	15	.	.	.
cord-023095-4dannjjm	6201	1	Breeding	breeding	NN
cord-023095-4dannjjm	6201	2	took	take	VBD
cord-023095-4dannjjm	6201	3	place	place	NN
cord-023095-4dannjjm	6201	4	after	after	IN
cord-023095-4dannjjm	6201	5	levothyroxine	levothyroxine	NN
cord-023095-4dannjjm	6201	6	treatment	treatment	NN
cord-023095-4dannjjm	6201	7	for	for	IN
cord-023095-4dannjjm	6201	8	46	46	CD
cord-023095-4dannjjm	6201	9	AE	AE	NNP
cord-023095-4dannjjm	6201	10	12.6	12.6	CD
cord-023095-4dannjjm	6201	11	weeks	week	NNS
cord-023095-4dannjjm	6201	12	in	in	IN
cord-023095-4dannjjm	6201	13	the	the	DT
cord-023095-4dannjjm	6201	14	hypothyroid	hypothyroid	JJ
cord-023095-4dannjjm	6201	15	group	group	NN
cord-023095-4dannjjm	6201	16	.	.	.
cord-023095-4dannjjm	6202	1	All	all	DT
cord-023095-4dannjjm	6202	2	6	6	CD
cord-023095-4dannjjm	6202	3	dogs	dog	NNS
cord-023095-4dannjjm	6202	4	in	in	IN
cord-023095-4dannjjm	6202	5	the	the	DT
cord-023095-4dannjjm	6202	6	hypothyroid	hypothyroid	JJ
cord-023095-4dannjjm	6202	7	group	group	NN
cord-023095-4dannjjm	6202	8	and	and	CC
cord-023095-4dannjjm	6202	9	5/6	5/6	CD
cord-023095-4dannjjm	6202	10	control	control	NN
cord-023095-4dannjjm	6202	11	dogs	dog	NNS
cord-023095-4dannjjm	6202	12	were	be	VBD
cord-023095-4dannjjm	6202	13	pregnant	pregnant	JJ
cord-023095-4dannjjm	6202	14	,	,	,
cord-023095-4dannjjm	6202	15	while	while	IN
cord-023095-4dannjjm	6202	16	4/8	4/8	CD
cord-023095-4dannjjm	6202	17	hypothyroid	hypothyroid	NN
cord-023095-4dannjjm	6202	18	and	and	CC
cord-023095-4dannjjm	6202	19	all	all	DT
cord-023095-4dannjjm	6202	20	6	6	CD
cord-023095-4dannjjm	6202	21	control	control	NN
cord-023095-4dannjjm	6202	22	bitches	bitch	NNS
cord-023095-4dannjjm	6202	23	became	become	VBD
cord-023095-4dannjjm	6202	24	pregnant	pregnant	JJ
cord-023095-4dannjjm	6202	25	prior	prior	RB
cord-023095-4dannjjm	6202	26	to	to	IN
cord-023095-4dannjjm	6202	27	levothyroxine	levothyroxine	NNP
cord-023095-4dannjjm	6202	28	administration	administration	NNP
cord-023095-4dannjjm	6202	29	.	.	.
cord-023095-4dannjjm	6203	1	No	no	DT
cord-023095-4dannjjm	6203	2	difference	difference	NN
cord-023095-4dannjjm	6203	3	in	in	IN
cord-023095-4dannjjm	6203	4	interestrus	interestrus	NNP
cord-023095-4dannjjm	6203	5	interval	interval	NN
cord-023095-4dannjjm	6203	6	or	or	CC
cord-023095-4dannjjm	6203	7	gestation	gestation	NN
cord-023095-4dannjjm	6203	8	length	length	NN
cord-023095-4dannjjm	6203	9	was	be	VBD
cord-023095-4dannjjm	6203	10	noted	note	VBN
cord-023095-4dannjjm	6203	11	between	between	IN
cord-023095-4dannjjm	6203	12	groups	group	NNS
cord-023095-4dannjjm	6203	13	.	.	.
cord-023095-4dannjjm	6204	1	During	during	IN
cord-023095-4dannjjm	6204	2	whelping	whelping	NN
cord-023095-4dannjjm	6204	3	,	,	,
cord-023095-4dannjjm	6204	4	no	no	DT
cord-023095-4dannjjm	6204	5	difference	difference	NN
cord-023095-4dannjjm	6204	6	in	in	IN
cord-023095-4dannjjm	6204	7	strength	strength	NN
cord-023095-4dannjjm	6204	8	of	of	IN
cord-023095-4dannjjm	6204	9	contractions	contraction	NNS
cord-023095-4dannjjm	6204	10	,	,	,
cord-023095-4dannjjm	6204	11	contraction	contraction	NN
cord-023095-4dannjjm	6204	12	duration	duration	NN
cord-023095-4dannjjm	6204	13	,	,	,
cord-023095-4dannjjm	6204	14	interval	interval	NN
cord-023095-4dannjjm	6204	15	between	between	IN
cord-023095-4dannjjm	6204	16	pups	pup	NNS
cord-023095-4dannjjm	6204	17	,	,	,
cord-023095-4dannjjm	6204	18	or	or	CC
cord-023095-4dannjjm	6204	19	viability	viability	NN
cord-023095-4dannjjm	6204	20	scores	score	NNS
cord-023095-4dannjjm	6204	21	of	of	IN
cord-023095-4dannjjm	6204	22	pups	pup	NNS
cord-023095-4dannjjm	6204	23	was	be	VBD
cord-023095-4dannjjm	6204	24	found	find	VBN
cord-023095-4dannjjm	6204	25	between	between	IN
cord-023095-4dannjjm	6204	26	groups	group	NNS
cord-023095-4dannjjm	6204	27	.	.	.
cord-023095-4dannjjm	6205	1	Litter	litter	NN
cord-023095-4dannjjm	6205	2	size	size	NN
cord-023095-4dannjjm	6205	3	,	,	,
cord-023095-4dannjjm	6205	4	birth	birth	NN
cord-023095-4dannjjm	6205	5	weight	weight	NN
cord-023095-4dannjjm	6205	6	and	and	CC
cord-023095-4dannjjm	6205	7	peirparturient	peirparturient	JJ
cord-023095-4dannjjm	6205	8	mortality	mortality	NN
cord-023095-4dannjjm	6205	9	were	be	VBD
cord-023095-4dannjjm	6205	10	similar	similar	JJ
cord-023095-4dannjjm	6205	11	between	between	IN
cord-023095-4dannjjm	6205	12	groups	group	NNS
cord-023095-4dannjjm	6205	13	.	.	.
cord-023095-4dannjjm	6206	1	Levothyroxine	Levothyroxine	NNP
cord-023095-4dannjjm	6206	2	administration	administration	NN
cord-023095-4dannjjm	6206	3	reverses	reverse	VBZ
cord-023095-4dannjjm	6206	4	the	the	DT
cord-023095-4dannjjm	6206	5	detrimental	detrimental	JJ
cord-023095-4dannjjm	6206	6	effects	effect	NNS
cord-023095-4dannjjm	6206	7	of	of	IN
cord-023095-4dannjjm	6206	8	hypothyroidism	hypothyroidism	NN
cord-023095-4dannjjm	6206	9	on	on	IN
cord-023095-4dannjjm	6206	10	fertility	fertility	NN
cord-023095-4dannjjm	6206	11	and	and	CC
cord-023095-4dannjjm	6206	12	neonatal	neonatal	JJ
cord-023095-4dannjjm	6206	13	health	health	NN
cord-023095-4dannjjm	6206	14	.	.	.
cord-023095-4dannjjm	6207	1	Racing	race	VBG
cord-023095-4dannjjm	6207	2	sled	sled	JJ
cord-023095-4dannjjm	6207	3	dogs	dog	NNS
cord-023095-4dannjjm	6207	4	have	have	VBP
cord-023095-4dannjjm	6207	5	a	a	DT
cord-023095-4dannjjm	6207	6	high	high	JJ
cord-023095-4dannjjm	6207	7	prevalence	prevalence	NN
cord-023095-4dannjjm	6207	8	of	of	IN
cord-023095-4dannjjm	6207	9	exercise	exercise	NN
cord-023095-4dannjjm	6207	10	-	-	HYPH
cord-023095-4dannjjm	6207	11	induced	induce	VBN
cord-023095-4dannjjm	6207	12	gastric	gastric	JJ
cord-023095-4dannjjm	6207	13	erosions	erosion	NNS
cord-023095-4dannjjm	6207	14	/	/	SYM
cord-023095-4dannjjm	6207	15	ulcers	ulcer	NNS
cord-023095-4dannjjm	6207	16	,	,	,
cord-023095-4dannjjm	6207	17	with	with	IN
cord-023095-4dannjjm	6207	18	reports	report	NNS
cord-023095-4dannjjm	6207	19	ranging	range	VBG
cord-023095-4dannjjm	6207	20	from	from	IN
cord-023095-4dannjjm	6207	21	50	50	CD
cord-023095-4dannjjm	6207	22	-	-	SYM
cord-023095-4dannjjm	6207	23	67	67	CD
cord-023095-4dannjjm	6207	24	%	%	NN
cord-023095-4dannjjm	6207	25	of	of	IN
cord-023095-4dannjjm	6207	26	dogs	dog	NNS
cord-023095-4dannjjm	6207	27	running	run	VBG
cord-023095-4dannjjm	6207	28	at	at	RB
cord-023095-4dannjjm	6207	29	least	least	RBS
cord-023095-4dannjjm	6207	30	100	100	CD
cord-023095-4dannjjm	6207	31	miles	mile	NNS
cord-023095-4dannjjm	6207	32	in	in	IN
cord-023095-4dannjjm	6207	33	a	a	DT
cord-023095-4dannjjm	6207	34	day	day	NN
cord-023095-4dannjjm	6207	35	or	or	CC
cord-023095-4dannjjm	6207	36	less	less	JJR
cord-023095-4dannjjm	6207	37	.	.	.
cord-023095-4dannjjm	6208	1	Omeprazole	omeprazole	NN
cord-023095-4dannjjm	6208	2	reduces	reduce	VBZ
cord-023095-4dannjjm	6208	3	the	the	DT
cord-023095-4dannjjm	6208	4	severity	severity	NN
cord-023095-4dannjjm	6208	5	of	of	IN
cord-023095-4dannjjm	6208	6	,	,	,
cord-023095-4dannjjm	6208	7	but	but	CC
cord-023095-4dannjjm	6208	8	does	do	VBZ
cord-023095-4dannjjm	6208	9	not	not	RB
cord-023095-4dannjjm	6208	10	completely	completely	RB
cord-023095-4dannjjm	6208	11	prevent	prevent	VB
cord-023095-4dannjjm	6208	12	,	,	,
cord-023095-4dannjjm	6208	13	gastritis	gastritis	NN
cord-023095-4dannjjm	6208	14	under	under	IN
cord-023095-4dannjjm	6208	15	racing	racing	NN
cord-023095-4dannjjm	6208	16	conditions	condition	NNS
cord-023095-4dannjjm	6208	17	,	,	,
cord-023095-4dannjjm	6208	18	and	and	CC
cord-023095-4dannjjm	6208	19	can	can	MD
cord-023095-4dannjjm	6208	20	be	be	VB
cord-023095-4dannjjm	6208	21	difficult	difficult	JJ
cord-023095-4dannjjm	6208	22	to	to	TO
cord-023095-4dannjjm	6208	23	administer	administer	VB
cord-023095-4dannjjm	6208	24	under	under	IN
cord-023095-4dannjjm	6208	25	these	these	DT
cord-023095-4dannjjm	6208	26	conditions	condition	NNS
cord-023095-4dannjjm	6208	27	.	.	.
cord-023095-4dannjjm	6209	1	Famotidine	Famotidine	NNP
cord-023095-4dannjjm	6209	2	can	can	MD
cord-023095-4dannjjm	6209	3	be	be	VB
cord-023095-4dannjjm	6209	4	administered	administer	VBN
cord-023095-4dannjjm	6209	5	in	in	IN
cord-023095-4dannjjm	6209	6	food	food	NN
cord-023095-4dannjjm	6209	7	,	,	,
cord-023095-4dannjjm	6209	8	but	but	CC
cord-023095-4dannjjm	6209	9	has	have	VBZ
cord-023095-4dannjjm	6209	10	only	only	RB
cord-023095-4dannjjm	6209	11	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	6209	12	efficacy	efficacy	NN
cord-023095-4dannjjm	6209	13	under	under	IN
cord-023095-4dannjjm	6209	14	less	less	RBR
cord-023095-4dannjjm	6209	15	intense	intense	JJ
cord-023095-4dannjjm	6209	16	training	training	NN
cord-023095-4dannjjm	6209	17	conditions	condition	NNS
cord-023095-4dannjjm	6209	18	.	.	.
cord-023095-4dannjjm	6210	1	The	the	DT
cord-023095-4dannjjm	6210	2	purpose	purpose	NN
cord-023095-4dannjjm	6210	3	of	of	IN
cord-023095-4dannjjm	6210	4	these	these	DT
cord-023095-4dannjjm	6210	5	studies	study	NNS
cord-023095-4dannjjm	6210	6	was	be	VBD
cord-023095-4dannjjm	6210	7	to	to	TO
cord-023095-4dannjjm	6210	8	evaluate	evaluate	VB
cord-023095-4dannjjm	6210	9	different	different	JJ
cord-023095-4dannjjm	6210	10	acid	acid	NN
cord-023095-4dannjjm	6210	11	suppression	suppression	NN
cord-023095-4dannjjm	6210	12	strategies	strategy	NNS
cord-023095-4dannjjm	6210	13	under	under	IN
cord-023095-4dannjjm	6210	14	racing	racing	NN
cord-023095-4dannjjm	6210	15	conditions	condition	NNS
cord-023095-4dannjjm	6210	16	for	for	IN
cord-023095-4dannjjm	6210	17	the	the	DT
cord-023095-4dannjjm	6210	18	prevention	prevention	NN
cord-023095-4dannjjm	6210	19	of	of	IN
cord-023095-4dannjjm	6210	20	exercise	exercise	NN
cord-023095-4dannjjm	6210	21	-	-	HYPH
cord-023095-4dannjjm	6210	22	induced	induce	VBN
cord-023095-4dannjjm	6210	23	gastritis	gastritis	NN
cord-023095-4dannjjm	6210	24	.	.	.
cord-023095-4dannjjm	6211	1	Experiment	experiment	NN
cord-023095-4dannjjm	6211	2	#	#	NN
cord-023095-4dannjjm	6211	3	1	1	CD
cord-023095-4dannjjm	6211	4	was	be	VBD
cord-023095-4dannjjm	6211	5	a	a	DT
cord-023095-4dannjjm	6211	6	randomized	randomized	JJ
cord-023095-4dannjjm	6211	7	placebo	placebo	NN
cord-023095-4dannjjm	6211	8	-	-	HYPH
cord-023095-4dannjjm	6211	9	controlled	control	VBN
cord-023095-4dannjjm	6211	10	study	study	NN
cord-023095-4dannjjm	6211	11	using	use	VBG
cord-023095-4dannjjm	6211	12	36	36	CD
cord-023095-4dannjjm	6211	13	sled	sled	JJ
cord-023095-4dannjjm	6211	14	dogs	dog	NNS
cord-023095-4dannjjm	6211	15	(	(	-LRB-
cord-023095-4dannjjm	6211	16	3	3	CD
cord-023095-4dannjjm	6211	17	-	-	SYM
cord-023095-4dannjjm	6211	18	8	8	CD
cord-023095-4dannjjm	6211	19	years	year	NNS
cord-023095-4dannjjm	6211	20	)	)	-RRB-
cord-023095-4dannjjm	6211	21	competing	compete	VBG
cord-023095-4dannjjm	6211	22	in	in	IN
cord-023095-4dannjjm	6211	23	a	a	DT
cord-023095-4dannjjm	6211	24	330	330	CD
cord-023095-4dannjjm	6211	25	mile	mile	NN
cord-023095-4dannjjm	6211	26	race	race	NN
cord-023095-4dannjjm	6211	27	over	over	IN
cord-023095-4dannjjm	6211	28	50	50	CD
cord-023095-4dannjjm	6211	29	-	-	SYM
cord-023095-4dannjjm	6211	30	60	60	CD
cord-023095-4dannjjm	6211	31	h.	h.	NNP
cord-023095-4dannjjm	6211	32	Treatment	Treatment	NNP
cord-023095-4dannjjm	6211	33	groups	group	NNS
cord-023095-4dannjjm	6212	1	were	be	VBD
cord-023095-4dannjjm	6212	2	famotidine	famotidine	NNP
cord-023095-4dannjjm	6212	3	(	(	-LRB-
cord-023095-4dannjjm	6213	1	approx	approx	NN
cord-023095-4dannjjm	6213	2	1	1	CD
cord-023095-4dannjjm	6213	3	mg	mg	NNP
cord-023095-4dannjjm	6213	4	/	/	SYM
cord-023095-4dannjjm	6213	5	kg	kg	NNP
cord-023095-4dannjjm	6213	6	qd	qd	NNP
cord-023095-4dannjjm	6213	7	)	)	-RRB-
cord-023095-4dannjjm	6213	8	or	or	CC
cord-023095-4dannjjm	6213	9	no	no	DT
cord-023095-4dannjjm	6213	10	treatment	treatment	NN
cord-023095-4dannjjm	6213	11	,	,	,
cord-023095-4dannjjm	6213	12	beginning	begin	VBG
cord-023095-4dannjjm	6213	13	2	2	CD
cord-023095-4dannjjm	6213	14	days	day	NNS
cord-023095-4dannjjm	6213	15	prior	prior	RB
cord-023095-4dannjjm	6213	16	to	to	IN
cord-023095-4dannjjm	6213	17	the	the	DT
cord-023095-4dannjjm	6213	18	start	start	NN
cord-023095-4dannjjm	6213	19	of	of	IN
cord-023095-4dannjjm	6213	20	the	the	DT
cord-023095-4dannjjm	6213	21	race	race	NN
cord-023095-4dannjjm	6213	22	and	and	CC
cord-023095-4dannjjm	6213	23	proceeding	proceeding	NN
cord-023095-4dannjjm	6213	24	until	until	IN
cord-023095-4dannjjm	6213	25	gastroscopy	gastroscopy	NN
cord-023095-4dannjjm	6213	26	was	be	VBD
cord-023095-4dannjjm	6213	27	performed	perform	VBN
cord-023095-4dannjjm	6213	28	24h	24h	NNS
cord-023095-4dannjjm	6213	29	after	after	IN
cord-023095-4dannjjm	6213	30	the	the	DT
cord-023095-4dannjjm	6213	31	race	race	NN
cord-023095-4dannjjm	6213	32	.	.	.
cord-023095-4dannjjm	6214	1	Experiment	experiment	NN
cord-023095-4dannjjm	6214	2	#	#	NN
cord-023095-4dannjjm	6214	3	2	2	CD
cord-023095-4dannjjm	6214	4	was	be	VBD
cord-023095-4dannjjm	6214	5	a	a	DT
cord-023095-4dannjjm	6214	6	randomized	randomized	JJ
cord-023095-4dannjjm	6214	7	positive	positive	JJ
cord-023095-4dannjjm	6214	8	-	-	HYPH
cord-023095-4dannjjm	6214	9	control	control	NN
cord-023095-4dannjjm	6214	10	study	study	NN
cord-023095-4dannjjm	6214	11	using	use	VBG
cord-023095-4dannjjm	6214	12	52	52	CD
cord-023095-4dannjjm	6214	13	sled	sled	JJ
cord-023095-4dannjjm	6214	14	dogs	dog	NNS
cord-023095-4dannjjm	6214	15	(	(	-LRB-
cord-023095-4dannjjm	6214	16	2	2	CD
cord-023095-4dannjjm	6214	17	-	-	SYM
cord-023095-4dannjjm	6214	18	8	8	CD
cord-023095-4dannjjm	6214	19	years	year	NNS
cord-023095-4dannjjm	6214	20	)	)	-RRB-
cord-023095-4dannjjm	6214	21	running	run	VBG
cord-023095-4dannjjm	6214	22	a	a	DT
cord-023095-4dannjjm	6214	23	mock	mock	JJ
cord-023095-4dannjjm	6214	24	race	race	NN
cord-023095-4dannjjm	6214	25	of	of	IN
cord-023095-4dannjjm	6214	26	300	300	CD
cord-023095-4dannjjm	6214	27	miles	mile	NNS
cord-023095-4dannjjm	6214	28	in	in	IN
cord-023095-4dannjjm	6214	29	50h	50h	NNS
cord-023095-4dannjjm	6214	30	.	.	.
cord-023095-4dannjjm	6215	1	Dogs	dog	NNS
cord-023095-4dannjjm	6215	2	were	be	VBD
cord-023095-4dannjjm	6215	3	divided	divide	VBN
cord-023095-4dannjjm	6215	4	into	into	IN
cord-023095-4dannjjm	6215	5	omeprazole	omeprazole	NN
cord-023095-4dannjjm	6215	6	(	(	-LRB-
cord-023095-4dannjjm	6215	7	approx	approx	NN
cord-023095-4dannjjm	6215	8	1	1	CD
cord-023095-4dannjjm	6216	1	mg	mg	NNP
cord-023095-4dannjjm	6216	2	/	/	SYM
cord-023095-4dannjjm	6216	3	kg	kg	NNP
cord-023095-4dannjjm	6216	4	qd	qd	NNP
cord-023095-4dannjjm	6216	5	,	,	,
cord-023095-4dannjjm	6216	6	administered	administer	VBD
cord-023095-4dannjjm	6216	7	30	30	CD
cord-023095-4dannjjm	6216	8	min	min	NN
cord-023095-4dannjjm	6216	9	prior	prior	RB
cord-023095-4dannjjm	6216	10	to	to	IN
cord-023095-4dannjjm	6216	11	a	a	DT
cord-023095-4dannjjm	6216	12	meal	meal	NN
cord-023095-4dannjjm	6216	13	)	)	-RRB-
cord-023095-4dannjjm	6216	14	or	or	CC
cord-023095-4dannjjm	6216	15	famotidine	famotidine	NNP
cord-023095-4dannjjm	6216	16	(	(	-LRB-
cord-023095-4dannjjm	6216	17	approx	approx	NNP
cord-023095-4dannjjm	6216	18	2	2	CD
cord-023095-4dannjjm	6216	19	mg	mg	NNP
cord-023095-4dannjjm	6216	20	/	/	SYM
cord-023095-4dannjjm	6216	21	kg	kg	NN
cord-023095-4dannjjm	6216	22	bid	bid	NN
cord-023095-4dannjjm	6216	23	)	)	-RRB-
cord-023095-4dannjjm	6216	24	groups	group	NNS
cord-023095-4dannjjm	6216	25	beginning	begin	VBG
cord-023095-4dannjjm	6216	26	2	2	CD
cord-023095-4dannjjm	6216	27	days	day	NNS
cord-023095-4dannjjm	6216	28	prior	prior	RB
cord-023095-4dannjjm	6216	29	to	to	IN
cord-023095-4dannjjm	6216	30	the	the	DT
cord-023095-4dannjjm	6216	31	exercise	exercise	NN
cord-023095-4dannjjm	6216	32	challenge	challenge	NN
cord-023095-4dannjjm	6216	33	and	and	CC
cord-023095-4dannjjm	6216	34	continuing	continue	VBG
cord-023095-4dannjjm	6216	35	for	for	IN
cord-023095-4dannjjm	6216	36	24h	24h	NNS
cord-023095-4dannjjm	6216	37	after	after	IN
cord-023095-4dannjjm	6216	38	completion	completion	NN
cord-023095-4dannjjm	6216	39	.	.	.
cord-023095-4dannjjm	6217	1	Gastroscopy	Gastroscopy	NNP
cord-023095-4dannjjm	6217	2	was	be	VBD
cord-023095-4dannjjm	6217	3	performed	perform	VBN
cord-023095-4dannjjm	6217	4	immediately	immediately	RB
cord-023095-4dannjjm	6217	5	prior	prior	RB
cord-023095-4dannjjm	6217	6	to	to	IN
cord-023095-4dannjjm	6217	7	the	the	DT
cord-023095-4dannjjm	6217	8	start	start	NN
cord-023095-4dannjjm	6217	9	of	of	IN
cord-023095-4dannjjm	6217	10	dosing	dosing	NN
cord-023095-4dannjjm	6217	11	and	and	CC
cord-023095-4dannjjm	6217	12	24h	24h	NNS
cord-023095-4dannjjm	6217	13	after	after	IN
cord-023095-4dannjjm	6217	14	completion	completion	NN
cord-023095-4dannjjm	6217	15	of	of	IN
cord-023095-4dannjjm	6217	16	the	the	DT
cord-023095-4dannjjm	6217	17	exercise	exercise	NN
cord-023095-4dannjjm	6217	18	.	.	.
cord-023095-4dannjjm	6218	1	In	in	IN
cord-023095-4dannjjm	6218	2	all	all	DT
cord-023095-4dannjjm	6218	3	cases	case	NNS
cord-023095-4dannjjm	6218	4	,	,	,
cord-023095-4dannjjm	6218	5	mucosal	mucosal	JJ
cord-023095-4dannjjm	6218	6	appearance	appearance	NN
cord-023095-4dannjjm	6218	7	during	during	IN
cord-023095-4dannjjm	6218	8	gastroscopy	gastroscopy	NN
cord-023095-4dannjjm	6218	9	was	be	VBD
cord-023095-4dannjjm	6218	10	blindly	blindly	RB
cord-023095-4dannjjm	6218	11	scored	score	VBN
cord-023095-4dannjjm	6218	12	using	use	VBG
cord-023095-4dannjjm	6218	13	previously	previously	RB
cord-023095-4dannjjm	6218	14	described	describe	VBN
cord-023095-4dannjjm	6218	15	scoring	score	VBG
cord-023095-4dannjjm	6218	16	system	system	NN
cord-023095-4dannjjm	6218	17	.	.	.
cord-023095-4dannjjm	6219	1	Famotidine	Famotidine	NNP
cord-023095-4dannjjm	6220	1	(	(	-LRB-
cord-023095-4dannjjm	6220	2	1	1	CD
cord-023095-4dannjjm	6220	3	mg	mg	NNP
cord-023095-4dannjjm	6220	4	/	/	SYM
cord-023095-4dannjjm	6220	5	kg	kg	NNP
cord-023095-4dannjjm	6220	6	qd	qd	NNP
cord-023095-4dannjjm	6220	7	)	)	-RRB-
cord-023095-4dannjjm	6220	8	reduced	reduce	VBD
cord-023095-4dannjjm	6220	9	the	the	DT
cord-023095-4dannjjm	6220	10	prevalence	prevalence	NN
cord-023095-4dannjjm	6220	11	of	of	IN
cord-023095-4dannjjm	6220	12	clinicallyrelevant	clinicallyrelevant	JJ
cord-023095-4dannjjm	6220	13	,	,	,
cord-023095-4dannjjm	6220	14	exercise	exercise	NN
cord-023095-4dannjjm	6220	15	-	-	HYPH
cord-023095-4dannjjm	6220	16	induced	induce	VBN
cord-023095-4dannjjm	6220	17	gastric	gastric	JJ
cord-023095-4dannjjm	6220	18	lesions	lesion	NNS
cord-023095-4dannjjm	6220	19	compared	compare	VBN
cord-023095-4dannjjm	6220	20	to	to	IN
cord-023095-4dannjjm	6220	21	no	no	DT
cord-023095-4dannjjm	6220	22	treatment	treatment	NN
cord-023095-4dannjjm	6220	23	(	(	-LRB-
cord-023095-4dannjjm	6220	24	7/16	7/16	CD
cord-023095-4dannjjm	6220	25	vs	vs	IN
cord-023095-4dannjjm	6220	26	11/16	11/16	CD
cord-023095-4dannjjm	6220	27	,	,	,
cord-023095-4dannjjm	6220	28	p	p	NN
cord-023095-4dannjjm	6220	29	5	5	CD
cord-023095-4dannjjm	6220	30	0.031	0.031	CD
cord-023095-4dannjjm	6220	31	)	)	-RRB-
cord-023095-4dannjjm	6220	32	.	.	.
cord-023095-4dannjjm	6221	1	Compared	compare	VBN
cord-023095-4dannjjm	6221	2	to	to	IN
cord-023095-4dannjjm	6221	3	famotidine	famotidine	NN
cord-023095-4dannjjm	6221	4	at	at	IN
cord-023095-4dannjjm	6221	5	2	2	CD
cord-023095-4dannjjm	6221	6	mg	mg	NNP
cord-023095-4dannjjm	6221	7	/	/	SYM
cord-023095-4dannjjm	6221	8	kg	kg	NN
cord-023095-4dannjjm	6221	9	bid	bid	NN
cord-023095-4dannjjm	6221	10	,	,	,
cord-023095-4dannjjm	6221	11	omeprazole	omeprazole	NN
cord-023095-4dannjjm	6221	12	significantly	significantly	RB
cord-023095-4dannjjm	6221	13	decreased	decrease	VBD
cord-023095-4dannjjm	6221	14	the	the	DT
cord-023095-4dannjjm	6221	15	severity	severity	NN
cord-023095-4dannjjm	6221	16	(	(	-LRB-
cord-023095-4dannjjm	6221	17	0.4	0.4	CD
cord-023095-4dannjjm	6221	18	vs	vs	IN
cord-023095-4dannjjm	6221	19	1.2	1.2	CD
cord-023095-4dannjjm	6221	20	,	,	,
cord-023095-4dannjjm	6221	21	p	p	NN
cord-023095-4dannjjm	6221	22	5	5	CD
cord-023095-4dannjjm	6221	23	0.0002	0.0002	CD
cord-023095-4dannjjm	6221	24	)	)	-RRB-
cord-023095-4dannjjm	6221	25	and	and	CC
cord-023095-4dannjjm	6221	26	prevalence	prevalence	NN
cord-023095-4dannjjm	6221	27	(	(	-LRB-
cord-023095-4dannjjm	6221	28	2/23	2/23	CD
cord-023095-4dannjjm	6221	29	vs	vs	IN
cord-023095-4dannjjm	6221	30	7/21	7/21	CD
cord-023095-4dannjjm	6221	31	,	,	,
cord-023095-4dannjjm	6221	32	p	p	NN
cord-023095-4dannjjm	6221	33	5	5	CD
cord-023095-4dannjjm	6221	34	0.049	0.049	CD
cord-023095-4dannjjm	6221	35	)	)	-RRB-
cord-023095-4dannjjm	6221	36	of	of	IN
cord-023095-4dannjjm	6221	37	gastric	gastric	JJ
cord-023095-4dannjjm	6221	38	lesions	lesion	NNS
cord-023095-4dannjjm	6221	39	.	.	.
cord-023095-4dannjjm	6222	1	Although	although	IN
cord-023095-4dannjjm	6222	2	famotidine	famotidine	NNP
cord-023095-4dannjjm	6222	3	provides	provide	VBZ
cord-023095-4dannjjm	6222	4	some	some	DT
cord-023095-4dannjjm	6222	5	benefit	benefit	NN
cord-023095-4dannjjm	6222	6	in	in	IN
cord-023095-4dannjjm	6222	7	the	the	DT
cord-023095-4dannjjm	6222	8	prevention	prevention	NN
cord-023095-4dannjjm	6222	9	of	of	IN
cord-023095-4dannjjm	6222	10	exercise	exercise	NN
cord-023095-4dannjjm	6222	11	-	-	HYPH
cord-023095-4dannjjm	6222	12	induced	induce	VBN
cord-023095-4dannjjm	6222	13	gastric	gastric	JJ
cord-023095-4dannjjm	6222	14	lesions	lesion	NNS
cord-023095-4dannjjm	6222	15	,	,	,
cord-023095-4dannjjm	6222	16	neither	neither	CC
cord-023095-4dannjjm	6222	17	the	the	DT
cord-023095-4dannjjm	6222	18	recommended	recommend	VBN
cord-023095-4dannjjm	6222	19	dose	dose	NN
cord-023095-4dannjjm	6222	20	nor	nor	CC
cord-023095-4dannjjm	6222	21	the	the	DT
cord-023095-4dannjjm	6222	22	higher	high	JJR
cord-023095-4dannjjm	6222	23	dose	dose	NN
cord-023095-4dannjjm	6222	24	were	be	VBD
cord-023095-4dannjjm	6222	25	considered	consider	VBN
cord-023095-4dannjjm	6222	26	acceptable	acceptable	JJ
cord-023095-4dannjjm	6222	27	in	in	IN
cord-023095-4dannjjm	6222	28	the	the	DT
cord-023095-4dannjjm	6222	29	prevention	prevention	NN
cord-023095-4dannjjm	6222	30	of	of	IN
cord-023095-4dannjjm	6222	31	exerciseinduced	exerciseinduce	VBN
cord-023095-4dannjjm	6222	32	gastritis	gastritis	NN
cord-023095-4dannjjm	6222	33	as	as	IN
cord-023095-4dannjjm	6222	34	between	between	IN
cord-023095-4dannjjm	6222	35	33	33	CD
cord-023095-4dannjjm	6222	36	-	-	SYM
cord-023095-4dannjjm	6222	37	44	44	CD
cord-023095-4dannjjm	6222	38	%	%	NN
cord-023095-4dannjjm	6222	39	of	of	IN
cord-023095-4dannjjm	6222	40	the	the	DT
cord-023095-4dannjjm	6222	41	dogs	dog	NNS
cord-023095-4dannjjm	6222	42	receiving	receive	VBG
cord-023095-4dannjjm	6222	43	famotidine	famotidine	NN
cord-023095-4dannjjm	6222	44	had	have	VBD
cord-023095-4dannjjm	6222	45	clinically	clinically	RB
cord-023095-4dannjjm	6222	46	significant	significant	JJ
cord-023095-4dannjjm	6222	47	lesions	lesion	NNS
cord-023095-4dannjjm	6222	48	.	.	.
cord-023095-4dannjjm	6223	1	A	a	DT
cord-023095-4dannjjm	6223	2	previous	previous	JJ
cord-023095-4dannjjm	6223	3	study	study	NN
cord-023095-4dannjjm	6223	4	examining	examine	VBG
cord-023095-4dannjjm	6223	5	omeprazole	omeprazole	NN
cord-023095-4dannjjm	6223	6	under	under	IN
cord-023095-4dannjjm	6223	7	racing	racing	NN
cord-023095-4dannjjm	6223	8	conditions	condition	NNS
cord-023095-4dannjjm	6223	9	,	,	,
cord-023095-4dannjjm	6223	10	but	but	CC
cord-023095-4dannjjm	6223	11	without	without	IN
cord-023095-4dannjjm	6223	12	careful	careful	JJ
cord-023095-4dannjjm	6223	13	administration	administration	NN
cord-023095-4dannjjm	6223	14	on	on	IN
cord-023095-4dannjjm	6223	15	an	an	DT
cord-023095-4dannjjm	6223	16	empty	empty	JJ
cord-023095-4dannjjm	6223	17	stomach	stomach	NN
cord-023095-4dannjjm	6223	18	,	,	,
cord-023095-4dannjjm	6223	19	resulted	result	VBD
cord-023095-4dannjjm	6223	20	in	in	IN
cord-023095-4dannjjm	6223	21	a	a	DT
cord-023095-4dannjjm	6223	22	22	22	CD
cord-023095-4dannjjm	6223	23	%	%	NN
cord-023095-4dannjjm	6223	24	prevalence	prevalence	NN
cord-023095-4dannjjm	6223	25	of	of	IN
cord-023095-4dannjjm	6223	26	clinically	clinically	RB
cord-023095-4dannjjm	6223	27	significant	significant	JJ
cord-023095-4dannjjm	6223	28	gastric	gastric	JJ
cord-023095-4dannjjm	6223	29	lesions	lesion	NNS
cord-023095-4dannjjm	6223	30	.	.	.
cord-023095-4dannjjm	6224	1	However	however	RB
cord-023095-4dannjjm	6224	2	,	,	,
cord-023095-4dannjjm	6224	3	the	the	DT
cord-023095-4dannjjm	6224	4	bioavailability	bioavailability	NN
cord-023095-4dannjjm	6224	5	of	of	IN
cord-023095-4dannjjm	6224	6	omeprazole	omeprazole	NN
cord-023095-4dannjjm	6224	7	is	be	VBZ
cord-023095-4dannjjm	6224	8	reduced	reduce	VBN
cord-023095-4dannjjm	6224	9	in	in	IN
cord-023095-4dannjjm	6224	10	the	the	DT
cord-023095-4dannjjm	6224	11	presence	presence	NN
cord-023095-4dannjjm	6224	12	of	of	IN
cord-023095-4dannjjm	6224	13	food	food	NN
cord-023095-4dannjjm	6224	14	,	,	,
cord-023095-4dannjjm	6224	15	and	and	CC
cord-023095-4dannjjm	6224	16	when	when	WRB
cord-023095-4dannjjm	6224	17	the	the	DT
cord-023095-4dannjjm	6224	18	daily	daily	JJ
cord-023095-4dannjjm	6224	19	administration	administration	NN
cord-023095-4dannjjm	6224	20	of	of	IN
cord-023095-4dannjjm	6224	21	the	the	DT
cord-023095-4dannjjm	6224	22	drug	drug	NN
cord-023095-4dannjjm	6224	23	is	be	VBZ
cord-023095-4dannjjm	6224	24	carefully	carefully	RB
cord-023095-4dannjjm	6224	25	scheduled	schedule	VBN
cord-023095-4dannjjm	6224	26	to	to	TO
cord-023095-4dannjjm	6224	27	coincide	coincide	VB
cord-023095-4dannjjm	6224	28	with	with	IN
cord-023095-4dannjjm	6224	29	an	an	DT
cord-023095-4dannjjm	6224	30	empty	empty	JJ
cord-023095-4dannjjm	6224	31	stomach	stomach	NN
cord-023095-4dannjjm	6224	32	,	,	,
cord-023095-4dannjjm	6224	33	the	the	DT
cord-023095-4dannjjm	6224	34	resulting	result	VBG
cord-023095-4dannjjm	6224	35	prevalence	prevalence	NN
cord-023095-4dannjjm	6224	36	of	of	IN
cord-023095-4dannjjm	6224	37	clinically	clinically	RB
cord-023095-4dannjjm	6224	38	significant	significant	JJ
cord-023095-4dannjjm	6224	39	lesions	lesion	NNS
cord-023095-4dannjjm	6224	40	induced	induce	VBN
cord-023095-4dannjjm	6224	41	by	by	IN
cord-023095-4dannjjm	6224	42	racing	racing	NN
cord-023095-4dannjjm	6224	43	-	-	HYPH
cord-023095-4dannjjm	6224	44	intensity	intensity	NN
cord-023095-4dannjjm	6224	45	exercise	exercise	NN
cord-023095-4dannjjm	6224	46	is	be	VBZ
cord-023095-4dannjjm	6224	47	reduced	reduce	VBN
cord-023095-4dannjjm	6224	48	to	to	IN
cord-023095-4dannjjm	6224	49	just	just	RB
cord-023095-4dannjjm	6224	50	over	over	IN
cord-023095-4dannjjm	6224	51	10	10	CD
cord-023095-4dannjjm	6224	52	%	%	NN
cord-023095-4dannjjm	6224	53	.	.	.
cord-023095-4dannjjm	6225	1	The	the	DT
cord-023095-4dannjjm	6225	2	conclusions	conclusion	NNS
cord-023095-4dannjjm	6225	3	of	of	IN
cord-023095-4dannjjm	6225	4	these	these	DT
cord-023095-4dannjjm	6225	5	studies	study	NNS
cord-023095-4dannjjm	6225	6	are	be	VBP
cord-023095-4dannjjm	6225	7	that	that	IN
cord-023095-4dannjjm	6225	8	omeprazole	omeprazole	NN
cord-023095-4dannjjm	6225	9	is	be	VBZ
cord-023095-4dannjjm	6225	10	superior	superior	JJ
cord-023095-4dannjjm	6225	11	to	to	IN
cord-023095-4dannjjm	6225	12	famotidine	famotidine	NN
cord-023095-4dannjjm	6225	13	in	in	IN
cord-023095-4dannjjm	6225	14	preventing	prevent	VBG
cord-023095-4dannjjm	6225	15	gastritis	gastritis	NN
cord-023095-4dannjjm	6225	16	in	in	IN
cord-023095-4dannjjm	6225	17	racing	racing	NN
cord-023095-4dannjjm	6225	18	sled	sled	JJ
cord-023095-4dannjjm	6225	19	dogs	dog	NNS
cord-023095-4dannjjm	6225	20	during	during	IN
cord-023095-4dannjjm	6225	21	competition	competition	NN
cord-023095-4dannjjm	6225	22	.	.	.
cord-023095-4dannjjm	6226	1	Routine	routine	JJ
cord-023095-4dannjjm	6226	2	administration	administration	NN
cord-023095-4dannjjm	6226	3	of	of	IN
cord-023095-4dannjjm	6226	4	omeprazole	omeprazole	NNP
cord-023095-4dannjjm	6226	5	is	be	VBZ
cord-023095-4dannjjm	6226	6	recommended	recommend	VBN
cord-023095-4dannjjm	6226	7	to	to	TO
cord-023095-4dannjjm	6226	8	prevent	prevent	VB
cord-023095-4dannjjm	6226	9	stress	stress	NN
cord-023095-4dannjjm	6226	10	-	-	HYPH
cord-023095-4dannjjm	6226	11	associated	associate	VBN
cord-023095-4dannjjm	6226	12	gastric	gastric	JJ
cord-023095-4dannjjm	6226	13	disease	disease	NN
cord-023095-4dannjjm	6226	14	in	in	IN
cord-023095-4dannjjm	6226	15	exercising	exercise	VBG
cord-023095-4dannjjm	6226	16	and	and	CC
cord-023095-4dannjjm	6226	17	racing	race	VBG
cord-023095-4dannjjm	6226	18	Alaskan	alaskan	JJ
cord-023095-4dannjjm	6226	19	sled	sle	VBN
cord-023095-4dannjjm	6226	20	dogs	dog	NNS
cord-023095-4dannjjm	6226	21	.	.	.
cord-023095-4dannjjm	6227	1	Mares	mare	NNS
cord-023095-4dannjjm	6227	2	may	may	MD
cord-023095-4dannjjm	6227	3	be	be	VB
cord-023095-4dannjjm	6227	4	an	an	DT
cord-023095-4dannjjm	6227	5	important	important	JJ
cord-023095-4dannjjm	6227	6	source	source	NN
cord-023095-4dannjjm	6227	7	of	of	IN
cord-023095-4dannjjm	6227	8	environmental	environmental	JJ
cord-023095-4dannjjm	6227	9	contamination	contamination	NN
cord-023095-4dannjjm	6227	10	with	with	IN
cord-023095-4dannjjm	6227	11	Rhodococcus	Rhodococcus	NNP
cord-023095-4dannjjm	6227	12	equi	equi	NN
cord-023095-4dannjjm	6227	13	on	on	IN
cord-023095-4dannjjm	6227	14	breeding	breed	VBG
cord-023095-4dannjjm	6227	15	farms	farm	NNS
cord-023095-4dannjjm	6227	16	.	.	.
cord-023095-4dannjjm	6228	1	Attempts	attempt	NNS
cord-023095-4dannjjm	6228	2	to	to	TO
cord-023095-4dannjjm	6228	3	reduce	reduce	VB
cord-023095-4dannjjm	6228	4	fecal	fecal	JJ
cord-023095-4dannjjm	6228	5	shedding	shedding	NN
cord-023095-4dannjjm	6228	6	of	of	IN
cord-023095-4dannjjm	6228	7	R	r	NN
cord-023095-4dannjjm	6228	8	equi	equi	NN
cord-023095-4dannjjm	6228	9	by	by	IN
cord-023095-4dannjjm	6228	10	the	the	DT
cord-023095-4dannjjm	6228	11	mare	mare	NN
cord-023095-4dannjjm	6228	12	and	and	CC
cord-023095-4dannjjm	6228	13	the	the	DT
cord-023095-4dannjjm	6228	14	effects	effect	NNS
cord-023095-4dannjjm	6228	15	of	of	IN
cord-023095-4dannjjm	6228	16	the	the	DT
cord-023095-4dannjjm	6228	17	mare	mare	NN
cord-023095-4dannjjm	6228	18	's	's	POS
cord-023095-4dannjjm	6228	19	fecal	fecal	JJ
cord-023095-4dannjjm	6228	20	R	r	NN
cord-023095-4dannjjm	6228	21	equi	equi	NN
cord-023095-4dannjjm	6228	22	concentration	concentration	NN
cord-023095-4dannjjm	6228	23	on	on	IN
cord-023095-4dannjjm	6228	24	airborne	airborne	JJ
cord-023095-4dannjjm	6228	25	concentrations	concentration	NNS
cord-023095-4dannjjm	6228	26	in	in	IN
cord-023095-4dannjjm	6228	27	the	the	DT
cord-023095-4dannjjm	6228	28	foaling	foaling	NN
cord-023095-4dannjjm	6228	29	stall	stall	NN
cord-023095-4dannjjm	6228	30	have	have	VBP
cord-023095-4dannjjm	6228	31	not	not	RB
cord-023095-4dannjjm	6228	32	been	be	VBN
cord-023095-4dannjjm	6228	33	previously	previously	RB
cord-023095-4dannjjm	6228	34	reported	report	VBN
cord-023095-4dannjjm	6228	35	.	.	.
cord-023095-4dannjjm	6229	1	Twenty	twenty	CD
cord-023095-4dannjjm	6229	2	-	-	HYPH
cord-023095-4dannjjm	6229	3	one	one	CD
cord-023095-4dannjjm	6229	4	Arabian	arabian	JJ
cord-023095-4dannjjm	6229	5	mares	mare	NNS
cord-023095-4dannjjm	6229	6	were	be	VBD
cord-023095-4dannjjm	6229	7	treated	treat	VBN
cord-023095-4dannjjm	6229	8	daily	daily	RB
cord-023095-4dannjjm	6229	9	with	with	IN
cord-023095-4dannjjm	6229	10	either	either	DT
cord-023095-4dannjjm	6229	11	oral	oral	JJ
cord-023095-4dannjjm	6229	12	gallium	gallium	NN
cord-023095-4dannjjm	6229	13	nitrate	nitrate	NN
cord-023095-4dannjjm	6229	14	or	or	CC
cord-023095-4dannjjm	6229	15	placebo	placebo	NN
cord-023095-4dannjjm	6229	16	in	in	IN
cord-023095-4dannjjm	6229	17	a	a	DT
cord-023095-4dannjjm	6229	18	randomized	randomized	JJ
cord-023095-4dannjjm	6229	19	double	double	JJ
cord-023095-4dannjjm	6229	20	-	-	HYPH
cord-023095-4dannjjm	6229	21	blind	blind	JJ
cord-023095-4dannjjm	6229	22	study	study	NN
cord-023095-4dannjjm	6229	23	.	.	.
cord-023095-4dannjjm	6230	1	Fecal	fecal	JJ
cord-023095-4dannjjm	6230	2	samples	sample	NNS
cord-023095-4dannjjm	6230	3	were	be	VBD
cord-023095-4dannjjm	6230	4	collected	collect	VBN
cord-023095-4dannjjm	6230	5	at	at	IN
cord-023095-4dannjjm	6230	6	day	day	NN
cord-023095-4dannjjm	6230	7	320	320	CD
cord-023095-4dannjjm	6230	8	of	of	IN
cord-023095-4dannjjm	6230	9	gestation	gestation	NN
cord-023095-4dannjjm	6230	10	(	(	-LRB-
cord-023095-4dannjjm	6230	11	time	time	NN
cord-023095-4dannjjm	6230	12	1	1	CD
cord-023095-4dannjjm	6230	13	)	)	-RRB-
cord-023095-4dannjjm	6230	14	,	,	,
cord-023095-4dannjjm	6230	15	the	the	DT
cord-023095-4dannjjm	6230	16	week	week	NN
cord-023095-4dannjjm	6230	17	before	before	IN
cord-023095-4dannjjm	6230	18	foaling	foal	VBG
cord-023095-4dannjjm	6230	19	(	(	-LRB-
cord-023095-4dannjjm	6230	20	time	time	NN
cord-023095-4dannjjm	6230	21	2	2	CD
cord-023095-4dannjjm	6230	22	)	)	-RRB-
cord-023095-4dannjjm	6230	23	,	,	,
cord-023095-4dannjjm	6230	24	and	and	CC
cord-023095-4dannjjm	6230	25	the	the	DT
cord-023095-4dannjjm	6230	26	week	week	NN
cord-023095-4dannjjm	6230	27	after	after	IN
cord-023095-4dannjjm	6230	28	foaling	foal	VBG
cord-023095-4dannjjm	6230	29	(	(	-LRB-
cord-023095-4dannjjm	6230	30	time	time	NN
cord-023095-4dannjjm	6230	31	3	3	CD
cord-023095-4dannjjm	6230	32	)	)	-RRB-
cord-023095-4dannjjm	6230	33	.	.	.
cord-023095-4dannjjm	6231	1	Airborne	airborne	JJ
cord-023095-4dannjjm	6231	2	concentration	concentration	NN
cord-023095-4dannjjm	6231	3	of	of	IN
cord-023095-4dannjjm	6231	4	R	r	NN
cord-023095-4dannjjm	6231	5	equi	equi	NN
cord-023095-4dannjjm	6231	6	were	be	VBD
cord-023095-4dannjjm	6231	7	measured	measure	VBN
cord-023095-4dannjjm	6231	8	in	in	IN
cord-023095-4dannjjm	6231	9	the	the	DT
cord-023095-4dannjjm	6231	10	stall	stall	NN
cord-023095-4dannjjm	6231	11	within	within	IN
cord-023095-4dannjjm	6231	12	6	6	CD
cord-023095-4dannjjm	6231	13	hours	hour	NNS
cord-023095-4dannjjm	6231	14	post	post	NN
cord-023095-4dannjjm	6231	15	foaling	foaling	NN
cord-023095-4dannjjm	6231	16	using	use	VBG
cord-023095-4dannjjm	6231	17	a	a	DT
cord-023095-4dannjjm	6231	18	microbial	microbial	JJ
cord-023095-4dannjjm	6231	19	air	air	NN
cord-023095-4dannjjm	6231	20	sampling	sampling	NN
cord-023095-4dannjjm	6231	21	system	system	NN
cord-023095-4dannjjm	6231	22	into	into	IN
cord-023095-4dannjjm	6231	23	which	which	WDT
cord-023095-4dannjjm	6231	24	standard	standard	NN
cord-023095-4dannjjm	6231	25	(	(	-LRB-
cord-023095-4dannjjm	6231	26	100-mm	100-mm	CD
cord-023095-4dannjjm	6231	27	)	)	-RRB-
cord-023095-4dannjjm	6231	28	culture	culture	NN
cord-023095-4dannjjm	6231	29	plates	plate	NNS
cord-023095-4dannjjm	6231	30	with	with	IN
cord-023095-4dannjjm	6231	31	a	a	DT
cord-023095-4dannjjm	6231	32	media	medium	NNS
cord-023095-4dannjjm	6231	33	selective	selective	JJ
cord-023095-4dannjjm	6231	34	for	for	IN
cord-023095-4dannjjm	6231	35	R.	R.	NNP
cord-023095-4dannjjm	6231	36	equi	equi	NN
cord-023095-4dannjjm	6231	37	have	have	VBP
cord-023095-4dannjjm	6231	38	been	be	VBN
cord-023095-4dannjjm	6231	39	loaded	load	VBN
cord-023095-4dannjjm	6231	40	.	.	.
cord-023095-4dannjjm	6232	1	Concentration	concentration	NN
cord-023095-4dannjjm	6232	2	of	of	IN
cord-023095-4dannjjm	6232	3	total	total	JJ
cord-023095-4dannjjm	6232	4	R	r	NN
cord-023095-4dannjjm	6232	5	equi	equi	NN
cord-023095-4dannjjm	6232	6	were	be	VBD
cord-023095-4dannjjm	6232	7	determined	determine	VBN
cord-023095-4dannjjm	6232	8	by	by	IN
cord-023095-4dannjjm	6232	9	morphological	morphological	JJ
cord-023095-4dannjjm	6232	10	characteristics	characteristic	NNS
cord-023095-4dannjjm	6232	11	.	.	.
cord-023095-4dannjjm	6233	1	The	the	DT
cord-023095-4dannjjm	6233	2	concentration	concentration	NN
cord-023095-4dannjjm	6233	3	of	of	IN
cord-023095-4dannjjm	6233	4	virulent	virulent	JJ
cord-023095-4dannjjm	6233	5	R	r	NN
cord-023095-4dannjjm	6233	6	equi	equi	NN
cord-023095-4dannjjm	6233	7	was	be	VBD
cord-023095-4dannjjm	6233	8	determined	determine	VBN
cord-023095-4dannjjm	6233	9	using	use	VBG
cord-023095-4dannjjm	6233	10	a	a	DT
cord-023095-4dannjjm	6233	11	modified	modify	VBN
cord-023095-4dannjjm	6233	12	colony	colony	NN
cord-023095-4dannjjm	6233	13	immunoblot	immunoblot	NN
cord-023095-4dannjjm	6233	14	method	method	NN
cord-023095-4dannjjm	6233	15	.	.	.
cord-023095-4dannjjm	6234	1	Concentrations	concentration	NNS
cord-023095-4dannjjm	6234	2	of	of	IN
cord-023095-4dannjjm	6234	3	total	total	JJ
cord-023095-4dannjjm	6234	4	and	and	CC
cord-023095-4dannjjm	6234	5	virulent	virulent	JJ
cord-023095-4dannjjm	6234	6	R	r	NN
cord-023095-4dannjjm	6234	7	equi	equi	NN
cord-023095-4dannjjm	6234	8	were	be	VBD
cord-023095-4dannjjm	6234	9	compared	compare	VBN
cord-023095-4dannjjm	6234	10	among	among	IN
cord-023095-4dannjjm	6234	11	mares	mare	NNS
cord-023095-4dannjjm	6234	12	to	to	TO
cord-023095-4dannjjm	6234	13	examine	examine	VB
cord-023095-4dannjjm	6234	14	effects	effect	NNS
cord-023095-4dannjjm	6234	15	of	of	IN
cord-023095-4dannjjm	6234	16	treatment	treatment	NN
cord-023095-4dannjjm	6234	17	,	,	,
cord-023095-4dannjjm	6234	18	time	time	NN
cord-023095-4dannjjm	6234	19	,	,	,
cord-023095-4dannjjm	6234	20	and	and	CC
cord-023095-4dannjjm	6234	21	treatment	treatment	NN
cord-023095-4dannjjm	6234	22	by	by	IN
cord-023095-4dannjjm	6234	23	time	time	NN
cord-023095-4dannjjm	6234	24	interaction	interaction	NN
cord-023095-4dannjjm	6234	25	.	.	.
cord-023095-4dannjjm	6235	1	There	there	EX
cord-023095-4dannjjm	6235	2	were	be	VBD
cord-023095-4dannjjm	6235	3	significant	significant	JJ
cord-023095-4dannjjm	6235	4	(	(	-LRB-
cord-023095-4dannjjm	6235	5	P	p	NN
cord-023095-4dannjjm	6235	6	o	o	NN
cord-023095-4dannjjm	6235	7	0.05	0.05	CD
cord-023095-4dannjjm	6235	8	)	)	-RRB-
cord-023095-4dannjjm	6235	9	effects	effect	NNS
cord-023095-4dannjjm	6235	10	of	of	IN
cord-023095-4dannjjm	6235	11	treatment	treatment	NN
cord-023095-4dannjjm	6235	12	that	that	WDT
cord-023095-4dannjjm	6235	13	depended	depend	VBD
cord-023095-4dannjjm	6235	14	on	on	IN
cord-023095-4dannjjm	6235	15	time	time	NN
cord-023095-4dannjjm	6235	16	of	of	IN
cord-023095-4dannjjm	6235	17	sample	sample	NN
cord-023095-4dannjjm	6235	18	collection	collection	NN
cord-023095-4dannjjm	6235	19	.	.	.
cord-023095-4dannjjm	6236	1	At	at	IN
cord-023095-4dannjjm	6236	2	sample	sample	NN
cord-023095-4dannjjm	6236	3	times	time	NNS
cord-023095-4dannjjm	6236	4	1	1	CD
cord-023095-4dannjjm	6236	5	and	and	CC
cord-023095-4dannjjm	6236	6	2	2	CD
cord-023095-4dannjjm	6236	7	there	there	EX
cord-023095-4dannjjm	6236	8	were	be	VBD
cord-023095-4dannjjm	6236	9	no	no	DT
cord-023095-4dannjjm	6236	10	significant	significant	JJ
cord-023095-4dannjjm	6236	11	differences	difference	NNS
cord-023095-4dannjjm	6236	12	between	between	IN
cord-023095-4dannjjm	6236	13	groups	group	NNS
cord-023095-4dannjjm	6236	14	in	in	IN
cord-023095-4dannjjm	6236	15	the	the	DT
cord-023095-4dannjjm	6236	16	fecal	fecal	JJ
cord-023095-4dannjjm	6236	17	concentration	concentration	NN
cord-023095-4dannjjm	6236	18	of	of	IN
cord-023095-4dannjjm	6236	19	virulent	virulent	JJ
cord-023095-4dannjjm	6236	20	R	r	NN
cord-023095-4dannjjm	6236	21	equi	equi	NN
cord-023095-4dannjjm	6236	22	.	.	.
cord-023095-4dannjjm	6237	1	At	at	IN
cord-023095-4dannjjm	6237	2	time	time	NN
cord-023095-4dannjjm	6237	3	3	3	CD
cord-023095-4dannjjm	6237	4	concentrations	concentration	NNS
cord-023095-4dannjjm	6237	5	of	of	IN
cord-023095-4dannjjm	6237	6	virulent	virulent	JJ
cord-023095-4dannjjm	6237	7	R	r	NN
cord-023095-4dannjjm	6237	8	equi	equi	NN
cord-023095-4dannjjm	6237	9	were	be	VBD
cord-023095-4dannjjm	6237	10	significantly	significantly	RB
cord-023095-4dannjjm	6237	11	lower	low	JJR
cord-023095-4dannjjm	6237	12	among	among	IN
cord-023095-4dannjjm	6237	13	mares	mare	NNS
cord-023095-4dannjjm	6237	14	in	in	IN
cord-023095-4dannjjm	6237	15	the	the	DT
cord-023095-4dannjjm	6237	16	treatment	treatment	NN
cord-023095-4dannjjm	6237	17	group	group	NN
cord-023095-4dannjjm	6237	18	(	(	-LRB-
cord-023095-4dannjjm	6237	19	P	p	NN
cord-023095-4dannjjm	6237	20	o	o	NN
cord-023095-4dannjjm	6237	21	0.05	0.05	CD
cord-023095-4dannjjm	6237	22	)	)	-RRB-
cord-023095-4dannjjm	6237	23	compared	compare	VBN
cord-023095-4dannjjm	6237	24	to	to	IN
cord-023095-4dannjjm	6237	25	control	control	NN
cord-023095-4dannjjm	6237	26	.	.	.
cord-023095-4dannjjm	6238	1	Effects	effect	NNS
cord-023095-4dannjjm	6238	2	of	of	IN
cord-023095-4dannjjm	6238	3	time	time	NN
cord-023095-4dannjjm	6238	4	depended	depend	VBD
cord-023095-4dannjjm	6238	5	significantly	significantly	RB
cord-023095-4dannjjm	6238	6	on	on	IN
cord-023095-4dannjjm	6238	7	groups	group	NNS
cord-023095-4dannjjm	6238	8	:	:	:
cord-023095-4dannjjm	6238	9	for	for	IN
cord-023095-4dannjjm	6238	10	the	the	DT
cord-023095-4dannjjm	6238	11	control	control	NN
cord-023095-4dannjjm	6238	12	group	group	NN
cord-023095-4dannjjm	6238	13	,	,	,
cord-023095-4dannjjm	6238	14	there	there	EX
cord-023095-4dannjjm	6238	15	were	be	VBD
cord-023095-4dannjjm	6238	16	no	no	DT
cord-023095-4dannjjm	6238	17	significant	significant	JJ
cord-023095-4dannjjm	6238	18	effects	effect	NNS
cord-023095-4dannjjm	6238	19	of	of	IN
cord-023095-4dannjjm	6238	20	time	time	NN
cord-023095-4dannjjm	6238	21	.	.	.
cord-023095-4dannjjm	6239	1	For	for	IN
cord-023095-4dannjjm	6239	2	the	the	DT
cord-023095-4dannjjm	6239	3	treatment	treatment	NN
cord-023095-4dannjjm	6239	4	group	group	NN
cord-023095-4dannjjm	6239	5	,	,	,
cord-023095-4dannjjm	6239	6	concentrations	concentration	NNS
cord-023095-4dannjjm	6239	7	tended	tend	VBD
cord-023095-4dannjjm	6239	8	to	to	TO
cord-023095-4dannjjm	6239	9	decrease	decrease	VB
cord-023095-4dannjjm	6239	10	over	over	IN
cord-023095-4dannjjm	6239	11	time	time	NN
cord-023095-4dannjjm	6239	12	,	,	,
cord-023095-4dannjjm	6239	13	and	and	CC
cord-023095-4dannjjm	6239	14	concentrations	concentration	NNS
cord-023095-4dannjjm	6239	15	at	at	IN
cord-023095-4dannjjm	6239	16	time	time	NN
cord-023095-4dannjjm	6239	17	3	3	CD
cord-023095-4dannjjm	6239	18	were	be	VBD
cord-023095-4dannjjm	6239	19	significantly	significantly	RB
cord-023095-4dannjjm	6239	20	(	(	-LRB-
cord-023095-4dannjjm	6239	21	P	p	NN
cord-023095-4dannjjm	6239	22	o	o	NN
cord-023095-4dannjjm	6239	23	0.05	0.05	CD
cord-023095-4dannjjm	6239	24	)	)	-RRB-
cord-023095-4dannjjm	6239	25	lower	low	JJR
cord-023095-4dannjjm	6239	26	than	than	IN
cord-023095-4dannjjm	6239	27	those	those	DT
cord-023095-4dannjjm	6239	28	at	at	IN
cord-023095-4dannjjm	6239	29	time	time	NN
cord-023095-4dannjjm	6239	30	1	1	CD
cord-023095-4dannjjm	6239	31	.	.	.
cord-023095-4dannjjm	6240	1	No	no	DT
cord-023095-4dannjjm	6240	2	other	other	JJ
cord-023095-4dannjjm	6240	3	differences	difference	NNS
cord-023095-4dannjjm	6240	4	among	among	IN
cord-023095-4dannjjm	6240	5	times	time	NNS
cord-023095-4dannjjm	6240	6	for	for	IN
cord-023095-4dannjjm	6240	7	concentrations	concentration	NNS
cord-023095-4dannjjm	6240	8	in	in	IN
cord-023095-4dannjjm	6240	9	the	the	DT
cord-023095-4dannjjm	6240	10	treatment	treatment	NN
cord-023095-4dannjjm	6240	11	group	group	NN
cord-023095-4dannjjm	6240	12	were	be	VBD
cord-023095-4dannjjm	6240	13	statistically	statistically	RB
cord-023095-4dannjjm	6240	14	significant	significant	JJ
cord-023095-4dannjjm	6240	15	.	.	.
cord-023095-4dannjjm	6241	1	There	there	EX
cord-023095-4dannjjm	6241	2	were	be	VBD
cord-023095-4dannjjm	6241	3	no	no	DT
cord-023095-4dannjjm	6241	4	significant	significant	JJ
cord-023095-4dannjjm	6241	5	effects	effect	NNS
cord-023095-4dannjjm	6241	6	of	of	IN
cord-023095-4dannjjm	6241	7	treatment	treatment	NN
cord-023095-4dannjjm	6241	8	,	,	,
cord-023095-4dannjjm	6241	9	sample	sample	NN
cord-023095-4dannjjm	6241	10	time	time	NN
cord-023095-4dannjjm	6241	11	,	,	,
cord-023095-4dannjjm	6241	12	or	or	CC
cord-023095-4dannjjm	6241	13	their	-PRON-	PRP$
cord-023095-4dannjjm	6241	14	interaction	interaction	NN
cord-023095-4dannjjm	6241	15	on	on	IN
cord-023095-4dannjjm	6241	16	the	the	DT
cord-023095-4dannjjm	6241	17	concentration	concentration	NN
cord-023095-4dannjjm	6241	18	of	of	IN
cord-023095-4dannjjm	6241	19	total	total	JJ
cord-023095-4dannjjm	6241	20	R	r	NN
cord-023095-4dannjjm	6241	21	equi	equi	NN
cord-023095-4dannjjm	6241	22	between	between	IN
cord-023095-4dannjjm	6241	23	groups	group	NNS
cord-023095-4dannjjm	6241	24	;	;	:
cord-023095-4dannjjm	6241	25	however	however	RB
cord-023095-4dannjjm	6241	26	,	,	,
cord-023095-4dannjjm	6241	27	the	the	DT
cord-023095-4dannjjm	6241	28	pattern	pattern	NN
cord-023095-4dannjjm	6241	29	for	for	IN
cord-023095-4dannjjm	6241	30	these	these	DT
cord-023095-4dannjjm	6241	31	data	datum	NNS
cord-023095-4dannjjm	6241	32	was	be	VBD
cord-023095-4dannjjm	6241	33	similar	similar	JJ
cord-023095-4dannjjm	6241	34	to	to	IN
cord-023095-4dannjjm	6242	1	that	that	DT
cord-023095-4dannjjm	6242	2	observed	observe	VBD
cord-023095-4dannjjm	6242	3	for	for	IN
cord-023095-4dannjjm	6242	4	the	the	DT
cord-023095-4dannjjm	6242	5	virulent	virulent	JJ
cord-023095-4dannjjm	6242	6	isolates	isolate	NNS
cord-023095-4dannjjm	6242	7	.	.	.
cord-023095-4dannjjm	6243	1	No	no	DT
cord-023095-4dannjjm	6243	2	significant	significant	JJ
cord-023095-4dannjjm	6243	3	differences	difference	NNS
cord-023095-4dannjjm	6243	4	were	be	VBD
cord-023095-4dannjjm	6243	5	determined	determine	VBN
cord-023095-4dannjjm	6243	6	between	between	IN
cord-023095-4dannjjm	6243	7	treatment	treatment	NN
cord-023095-4dannjjm	6243	8	groups	group	NNS
cord-023095-4dannjjm	6243	9	for	for	IN
cord-023095-4dannjjm	6243	10	airborne	airborne	JJ
cord-023095-4dannjjm	6243	11	concentrations	concentration	NNS
cord-023095-4dannjjm	6243	12	of	of	IN
cord-023095-4dannjjm	6243	13	virulent	virulent	JJ
cord-023095-4dannjjm	6243	14	or	or	CC
cord-023095-4dannjjm	6243	15	total	total	JJ
cord-023095-4dannjjm	6243	16	R	r	NN
cord-023095-4dannjjm	6243	17	equi	equi	NN
cord-023095-4dannjjm	6243	18	.	.	.
cord-023095-4dannjjm	6244	1	Treatment	treatment	NN
cord-023095-4dannjjm	6244	2	of	of	IN
cord-023095-4dannjjm	6244	3	mares	mare	NNS
cord-023095-4dannjjm	6244	4	with	with	IN
cord-023095-4dannjjm	6244	5	oral	oral	JJ
cord-023095-4dannjjm	6244	6	gallium	gallium	NN
cord-023095-4dannjjm	6244	7	nitrate	nitrate	NN
cord-023095-4dannjjm	6244	8	significantly	significantly	RB
cord-023095-4dannjjm	6244	9	reduced	reduce	VBD
cord-023095-4dannjjm	6244	10	the	the	DT
cord-023095-4dannjjm	6244	11	fecal	fecal	JJ
cord-023095-4dannjjm	6244	12	concentrations	concentration	NNS
cord-023095-4dannjjm	6244	13	of	of	IN
cord-023095-4dannjjm	6244	14	virulent	virulent	JJ
cord-023095-4dannjjm	6244	15	R	r	NN
cord-023095-4dannjjm	6244	16	equi	equi	NN
cord-023095-4dannjjm	6244	17	over	over	IN
cord-023095-4dannjjm	6244	18	time	time	NN
cord-023095-4dannjjm	6244	19	,	,	,
cord-023095-4dannjjm	6244	20	but	but	CC
cord-023095-4dannjjm	6244	21	had	have	VBD
cord-023095-4dannjjm	6244	22	no	no	DT
cord-023095-4dannjjm	6244	23	impact	impact	NN
cord-023095-4dannjjm	6244	24	on	on	IN
cord-023095-4dannjjm	6244	25	the	the	DT
cord-023095-4dannjjm	6244	26	airborne	airborne	JJ
cord-023095-4dannjjm	6244	27	concentration	concentration	NN
cord-023095-4dannjjm	6244	28	of	of	IN
cord-023095-4dannjjm	6244	29	R	r	NN
cord-023095-4dannjjm	6244	30	equi	equi	NN
cord-023095-4dannjjm	6244	31	shortly	shortly	RB
cord-023095-4dannjjm	6244	32	after	after	IN
cord-023095-4dannjjm	6244	33	foaling	foal	VBG
cord-023095-4dannjjm	6244	34	.	.	.
cord-023095-4dannjjm	6245	1	The	the	DT
cord-023095-4dannjjm	6245	2	purpose	purpose	NN
cord-023095-4dannjjm	6245	3	of	of	IN
cord-023095-4dannjjm	6245	4	this	this	DT
cord-023095-4dannjjm	6245	5	study	study	NN
cord-023095-4dannjjm	6245	6	was	be	VBD
cord-023095-4dannjjm	6245	7	to	to	TO
cord-023095-4dannjjm	6245	8	evaluate	evaluate	VB
cord-023095-4dannjjm	6245	9	the	the	DT
cord-023095-4dannjjm	6245	10	protein	protein	NN
cord-023095-4dannjjm	6245	11	profile	profile	NN
cord-023095-4dannjjm	6245	12	of	of	IN
cord-023095-4dannjjm	6245	13	bronchoalveolar	bronchoalveolar	NNP
cord-023095-4dannjjm	6245	14	lavage	lavage	NN
cord-023095-4dannjjm	6245	15	fluid	fluid	NN
cord-023095-4dannjjm	6245	16	(	(	-LRB-
cord-023095-4dannjjm	6245	17	BALF	BALF	NNP
cord-023095-4dannjjm	6245	18	)	)	-RRB-
cord-023095-4dannjjm	6245	19	in	in	IN
cord-023095-4dannjjm	6245	20	horses	horse	NNS
cord-023095-4dannjjm	6245	21	affected	affect	VBN
cord-023095-4dannjjm	6245	22	with	with	IN
cord-023095-4dannjjm	6245	23	recurrent	recurrent	JJ
cord-023095-4dannjjm	6245	24	airway	airway	JJ
cord-023095-4dannjjm	6245	25	obstruction	obstruction	NN
cord-023095-4dannjjm	6245	26	(	(	-LRB-
cord-023095-4dannjjm	6245	27	RAO	RAO	NNP
cord-023095-4dannjjm	6245	28	)	)	-RRB-
cord-023095-4dannjjm	6245	29	and	and	CC
cord-023095-4dannjjm	6245	30	in	in	IN
cord-023095-4dannjjm	6245	31	control	control	NN
cord-023095-4dannjjm	6245	32	horses	horse	NNS
cord-023095-4dannjjm	6245	33	using	use	VBG
cord-023095-4dannjjm	6245	34	proteomics	proteomic	NNS
cord-023095-4dannjjm	6245	35	and	and	CC
cord-023095-4dannjjm	6245	36	Western	western	JJ
cord-023095-4dannjjm	6245	37	blot	blot	NN
cord-023095-4dannjjm	6245	38	techniques	technique	NNS
cord-023095-4dannjjm	6245	39	.	.	.
cord-023095-4dannjjm	6246	1	RAO	RAO	NNP
cord-023095-4dannjjm	6246	2	-	-	HYPH
cord-023095-4dannjjm	6246	3	affected	affect	VBN
cord-023095-4dannjjm	6246	4	(	(	-LRB-
cord-023095-4dannjjm	6246	5	n	n	NN
cord-023095-4dannjjm	6246	6	5	5	CD
cord-023095-4dannjjm	6246	7	5	5	CD
cord-023095-4dannjjm	6246	8	)	)	-RRB-
cord-023095-4dannjjm	6246	9	and	and	CC
cord-023095-4dannjjm	6246	10	control	control	NN
cord-023095-4dannjjm	6246	11	horses	horse	NNS
cord-023095-4dannjjm	6246	12	(	(	-LRB-
cord-023095-4dannjjm	6246	13	n	n	NN
cord-023095-4dannjjm	6246	14	5	5	CD
cord-023095-4dannjjm	6246	15	6	6	CD
cord-023095-4dannjjm	6246	16	)	)	-RRB-
cord-023095-4dannjjm	6246	17	were	be	VBD
cord-023095-4dannjjm	6246	18	subjected	subject	VBN
cord-023095-4dannjjm	6246	19	to	to	IN
cord-023095-4dannjjm	6246	20	an	an	DT
cord-023095-4dannjjm	6246	21	experimental	experimental	JJ
cord-023095-4dannjjm	6246	22	exposure	exposure	NN
cord-023095-4dannjjm	6246	23	trial	trial	NN
cord-023095-4dannjjm	6246	24	;	;	:
cord-023095-4dannjjm	6246	25	when	when	WRB
cord-023095-4dannjjm	6246	26	the	the	DT
cord-023095-4dannjjm	6246	27	RAO	RAO	NNP
cord-023095-4dannjjm	6246	28	-	-	HYPH
cord-023095-4dannjjm	6246	29	affected	affect	VBN
cord-023095-4dannjjm	6246	30	horses	horse	NNS
cord-023095-4dannjjm	6246	31	showed	show	VBD
cord-023095-4dannjjm	6246	32	clinical	clinical	JJ
cord-023095-4dannjjm	6246	33	signs	sign	NNS
cord-023095-4dannjjm	6246	34	of	of	IN
cord-023095-4dannjjm	6246	35	disease	disease	NN
cord-023095-4dannjjm	6246	36	,	,	,
cord-023095-4dannjjm	6246	37	BALF	BALF	NNP
cord-023095-4dannjjm	6246	38	was	be	VBD
cord-023095-4dannjjm	6246	39	collected	collect	VBN
cord-023095-4dannjjm	6246	40	from	from	IN
cord-023095-4dannjjm	6246	41	all	all	DT
cord-023095-4dannjjm	6246	42	horses	horse	NNS
cord-023095-4dannjjm	6246	43	.	.	.
cord-023095-4dannjjm	6247	1	BALF	BALF	NNP
cord-023095-4dannjjm	6247	2	was	be	VBD
cord-023095-4dannjjm	6247	3	also	also	RB
cord-023095-4dannjjm	6247	4	collected	collect	VBN
cord-023095-4dannjjm	6247	5	from	from	IN
cord-023095-4dannjjm	6247	6	client	client	NN
cord-023095-4dannjjm	6247	7	-	-	HYPH
cord-023095-4dannjjm	6247	8	owned	own	VBN
cord-023095-4dannjjm	6247	9	RAO	RAO	NNP
cord-023095-4dannjjm	6247	10	-	-	HYPH
cord-023095-4dannjjm	6247	11	affected	affect	VBN
cord-023095-4dannjjm	6247	12	horses	horse	NNS
cord-023095-4dannjjm	6247	13	(	(	-LRB-
cord-023095-4dannjjm	6247	14	n	n	NN
cord-023095-4dannjjm	6247	15	5	5	CD
cord-023095-4dannjjm	6247	16	15	15	CD
cord-023095-4dannjjm	6247	17	)	)	-RRB-
cord-023095-4dannjjm	6247	18	with	with	IN
cord-023095-4dannjjm	6247	19	naturally	naturally	RB
cord-023095-4dannjjm	6247	20	-	-	HYPH
cord-023095-4dannjjm	6247	21	occurring	occur	VBG
cord-023095-4dannjjm	6247	22	clinical	clinical	JJ
cord-023095-4dannjjm	6247	23	signs	sign	NNS
cord-023095-4dannjjm	6247	24	of	of	IN
cord-023095-4dannjjm	6247	25	disease	disease	NN
cord-023095-4dannjjm	6247	26	and	and	CC
cord-023095-4dannjjm	6247	27	client	client	NN
cord-023095-4dannjjm	6247	28	-	-	HYPH
cord-023095-4dannjjm	6247	29	owned	own	VBN
cord-023095-4dannjjm	6247	30	control	control	NN
cord-023095-4dannjjm	6247	31	horses	horse	NNS
cord-023095-4dannjjm	6247	32	(	(	-LRB-
cord-023095-4dannjjm	6247	33	n	n	NN
cord-023095-4dannjjm	6247	34	5	5	CD
cord-023095-4dannjjm	6247	35	12	12	CD
cord-023095-4dannjjm	6247	36	)	)	-RRB-
cord-023095-4dannjjm	6247	37	from	from	IN
cord-023095-4dannjjm	6247	38	the	the	DT
cord-023095-4dannjjm	6247	39	same	same	JJ
cord-023095-4dannjjm	6247	40	environments	environment	NNS
cord-023095-4dannjjm	6247	41	.	.	.
cord-023095-4dannjjm	6248	1	The	the	DT
cord-023095-4dannjjm	6248	2	BALF	BALF	NNP
cord-023095-4dannjjm	6248	3	from	from	IN
cord-023095-4dannjjm	6248	4	the	the	DT
cord-023095-4dannjjm	6248	5	experimental	experimental	JJ
cord-023095-4dannjjm	6248	6	exposure	exposure	NN
cord-023095-4dannjjm	6248	7	trial	trial	NN
cord-023095-4dannjjm	6248	8	horses	horse	NNS
cord-023095-4dannjjm	6248	9	was	be	VBD
cord-023095-4dannjjm	6248	10	subjected	subject	VBN
cord-023095-4dannjjm	6248	11	to	to	IN
cord-023095-4dannjjm	6248	12	trypsin	trypsin	JJ
cord-023095-4dannjjm	6248	13	digestion	digestion	NN
cord-023095-4dannjjm	6248	14	and	and	CC
cord-023095-4dannjjm	6248	15	proteomics	proteomic	NNS
cord-023095-4dannjjm	6248	16	analysis	analysis	NN
cord-023095-4dannjjm	6248	17	with	with	IN
cord-023095-4dannjjm	6248	18	mass	mass	NN
cord-023095-4dannjjm	6248	19	spectrometry	spectrometry	NNP
cord-023095-4dannjjm	6248	20	(	(	-LRB-
cord-023095-4dannjjm	6248	21	MS	MS	NNP
cord-023095-4dannjjm	6248	22	)	)	-RRB-
cord-023095-4dannjjm	6248	23	.	.	.
cord-023095-4dannjjm	6249	1	Peaks	peak	NNS
cord-023095-4dannjjm	6249	2	detected	detect	VBD
cord-023095-4dannjjm	6249	3	with	with	IN
cord-023095-4dannjjm	6249	4	MS	MS	NNP
cord-023095-4dannjjm	6249	5	were	be	VBD
cord-023095-4dannjjm	6249	6	identified	identify	VBN
cord-023095-4dannjjm	6249	7	using	use	VBG
cord-023095-4dannjjm	6249	8	tandem	tandem	JJ
cord-023095-4dannjjm	6249	9	MS	MS	NNP
cord-023095-4dannjjm	6249	10	analysis	analysis	NN
cord-023095-4dannjjm	6249	11	and	and	CC
cord-023095-4dannjjm	6249	12	database	database	NN
cord-023095-4dannjjm	6249	13	searches	search	NNS
cord-023095-4dannjjm	6249	14	.	.	.
cord-023095-4dannjjm	6250	1	Western	western	JJ
cord-023095-4dannjjm	6250	2	blot	blot	NN
cord-023095-4dannjjm	6250	3	was	be	VBD
cord-023095-4dannjjm	6250	4	used	use	VBN
cord-023095-4dannjjm	6250	5	to	to	TO
cord-023095-4dannjjm	6250	6	confirm	confirm	VB
cord-023095-4dannjjm	6250	7	the	the	DT
cord-023095-4dannjjm	6250	8	identity	identity	NN
cord-023095-4dannjjm	6250	9	and	and	CC
cord-023095-4dannjjm	6250	10	expression	expression	NN
cord-023095-4dannjjm	6250	11	levels	level	NNS
cord-023095-4dannjjm	6250	12	of	of	IN
cord-023095-4dannjjm	6250	13	two	two	CD
cord-023095-4dannjjm	6250	14	proteins	protein	NNS
cord-023095-4dannjjm	6250	15	identified	identify	VBN
cord-023095-4dannjjm	6250	16	using	use	VBG
cord-023095-4dannjjm	6250	17	proteomics	proteomic	NNS
cord-023095-4dannjjm	6250	18	techniques	technique	NNS
cord-023095-4dannjjm	6250	19	in	in	IN
cord-023095-4dannjjm	6250	20	the	the	DT
cord-023095-4dannjjm	6250	21	BALF	BALF	NNP
cord-023095-4dannjjm	6250	22	of	of	IN
cord-023095-4dannjjm	6250	23	all	all	DT
cord-023095-4dannjjm	6250	24	horses	horse	NNS
cord-023095-4dannjjm	6250	25	.	.	.
cord-023095-4dannjjm	6251	1	Data	datum	NNS
cord-023095-4dannjjm	6251	2	from	from	IN
cord-023095-4dannjjm	6251	3	MS	MS	NNP
cord-023095-4dannjjm	6251	4	experiments	experiment	NNS
cord-023095-4dannjjm	6251	5	were	be	VBD
cord-023095-4dannjjm	6251	6	analyzed	analyze	VBN
cord-023095-4dannjjm	6251	7	with	with	IN
cord-023095-4dannjjm	6251	8	the	the	DT
cord-023095-4dannjjm	6251	9	Student	Student	NNP
cord-023095-4dannjjm	6251	10	's	's	POS
cord-023095-4dannjjm	6251	11	t	t	NN
cord-023095-4dannjjm	6251	12	-	-	HYPH
cord-023095-4dannjjm	6251	13	test	test	NN
cord-023095-4dannjjm	6251	14	to	to	TO
cord-023095-4dannjjm	6251	15	compare	compare	VB
cord-023095-4dannjjm	6251	16	peak	peak	NN
cord-023095-4dannjjm	6251	17	intensity	intensity	NN
cord-023095-4dannjjm	6251	18	between	between	IN
cord-023095-4dannjjm	6251	19	RAO	RAO	NNP
cord-023095-4dannjjm	6251	20	-	-	HYPH
cord-023095-4dannjjm	6251	21	affected	affect	VBN
cord-023095-4dannjjm	6251	22	and	and	CC
cord-023095-4dannjjm	6251	23	control	control	NN
cord-023095-4dannjjm	6251	24	horses	horse	NNS
cord-023095-4dannjjm	6251	25	.	.	.
cord-023095-4dannjjm	6252	1	Western	western	JJ
cord-023095-4dannjjm	6252	2	blot	blot	NN
cord-023095-4dannjjm	6252	3	band	band	NN
cord-023095-4dannjjm	6252	4	density	density	NN
cord-023095-4dannjjm	6252	5	data	datum	NNS
cord-023095-4dannjjm	6252	6	was	be	VBD
cord-023095-4dannjjm	6252	7	analyzed	analyze	VBN
cord-023095-4dannjjm	6252	8	with	with	IN
cord-023095-4dannjjm	6252	9	the	the	DT
cord-023095-4dannjjm	6252	10	Kruskal	Kruskal	NNP
cord-023095-4dannjjm	6252	11	-	-	HYPH
cord-023095-4dannjjm	6252	12	Wallis	Wallis	NNP
cord-023095-4dannjjm	6252	13	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	6252	14	for	for	IN
cord-023095-4dannjjm	6252	15	comparison	comparison	NN
cord-023095-4dannjjm	6252	16	between	between	IN
cord-023095-4dannjjm	6252	17	groups	group	NNS
cord-023095-4dannjjm	6252	18	of	of	IN
cord-023095-4dannjjm	6252	19	horses	horse	NNS
cord-023095-4dannjjm	6252	20	.	.	.
cord-023095-4dannjjm	6253	1	Significance	significance	NN
cord-023095-4dannjjm	6253	2	level	level	NN
cord-023095-4dannjjm	6253	3	was	be	VBD
cord-023095-4dannjjm	6253	4	set	set	VBN
cord-023095-4dannjjm	6253	5	at	at	IN
cord-023095-4dannjjm	6253	6	P	p	NN
cord-023095-4dannjjm	6253	7	o	o	NN
cord-023095-4dannjjm	6253	8	0.05	0.05	CD
cord-023095-4dannjjm	6253	9	.	.	.
cord-023095-4dannjjm	6254	1	With	with	IN
cord-023095-4dannjjm	6254	2	MS	MS	NNP
cord-023095-4dannjjm	6254	3	proteomic	proteomic	JJ
cord-023095-4dannjjm	6254	4	analysis	analysis	NN
cord-023095-4dannjjm	6254	5	of	of	IN
cord-023095-4dannjjm	6254	6	the	the	DT
cord-023095-4dannjjm	6254	7	BALF	BALF	NNP
cord-023095-4dannjjm	6254	8	from	from	IN
cord-023095-4dannjjm	6254	9	the	the	DT
cord-023095-4dannjjm	6254	10	experimental	experimental	JJ
cord-023095-4dannjjm	6254	11	exposure	exposure	NN
cord-023095-4dannjjm	6254	12	trial	trial	NN
cord-023095-4dannjjm	6254	13	horses	horse	NNS
cord-023095-4dannjjm	6254	14	,	,	,
cord-023095-4dannjjm	6254	15	2049	2049	CD
cord-023095-4dannjjm	6254	16	total	total	JJ
cord-023095-4dannjjm	6254	17	peaks	peak	NNS
cord-023095-4dannjjm	6254	18	(	(	-LRB-
cord-023095-4dannjjm	6254	19	peptides	peptide	NNS
cord-023095-4dannjjm	6254	20	)	)	-RRB-
cord-023095-4dannjjm	6254	21	were	be	VBD
cord-023095-4dannjjm	6254	22	identified	identify	VBN
cord-023095-4dannjjm	6254	23	.	.	.
cord-023095-4dannjjm	6255	1	Of	of	IN
cord-023095-4dannjjm	6255	2	these	these	DT
cord-023095-4dannjjm	6255	3	peaks	peak	NNS
cord-023095-4dannjjm	6255	4	,	,	,
cord-023095-4dannjjm	6255	5	100	100	CD
cord-023095-4dannjjm	6255	6	were	be	VBD
cord-023095-4dannjjm	6255	7	differentially	differentially	RB
cord-023095-4dannjjm	6255	8	expressed	express	VBN
cord-023095-4dannjjm	6255	9	between	between	IN
cord-023095-4dannjjm	6255	10	the	the	DT
cord-023095-4dannjjm	6255	11	RAO	RAO	NNP
cord-023095-4dannjjm	6255	12	-	-	HYPH
cord-023095-4dannjjm	6255	13	affected	affect	VBN
cord-023095-4dannjjm	6255	14	(	(	-LRB-
cord-023095-4dannjjm	6255	15	24	24	CD
cord-023095-4dannjjm	6255	16	over	over	RB
cord-023095-4dannjjm	6255	17	-	-	HYPH
cord-023095-4dannjjm	6255	18	expressed	express	VBN
cord-023095-4dannjjm	6255	19	)	)	-RRB-
cord-023095-4dannjjm	6255	20	and	and	CC
cord-023095-4dannjjm	6255	21	control	control	NN
cord-023095-4dannjjm	6255	22	horses	horse	NNS
cord-023095-4dannjjm	6255	23	(	(	-LRB-
cord-023095-4dannjjm	6255	24	76	76	CD
cord-023095-4dannjjm	6255	25	over	over	RB
cord-023095-4dannjjm	6255	26	-	-	HYPH
cord-023095-4dannjjm	6255	27	expressed	express	VBN
cord-023095-4dannjjm	6255	28	)	)	-RRB-
cord-023095-4dannjjm	6255	29	.	.	.
cord-023095-4dannjjm	6256	1	Identifications	identification	NNS
cord-023095-4dannjjm	6256	2	were	be	VBD
cord-023095-4dannjjm	6256	3	made	make	VBN
cord-023095-4dannjjm	6256	4	for	for	IN
cord-023095-4dannjjm	6256	5	250	250	CD
cord-023095-4dannjjm	6256	6	BALF	BALF	NNP
cord-023095-4dannjjm	6256	7	proteins	protein	NNS
cord-023095-4dannjjm	6256	8	.	.	.
cord-023095-4dannjjm	6257	1	Transferrin	Transferrin	NNP
cord-023095-4dannjjm	6257	2	and	and	CC
cord-023095-4dannjjm	6257	3	secretoglobin	secretoglobin	NNP
cord-023095-4dannjjm	6257	4	were	be	VBD
cord-023095-4dannjjm	6257	5	chosen	choose	VBN
cord-023095-4dannjjm	6257	6	for	for	IN
cord-023095-4dannjjm	6257	7	validation	validation	NN
cord-023095-4dannjjm	6257	8	with	with	IN
cord-023095-4dannjjm	6257	9	Western	western	JJ
cord-023095-4dannjjm	6257	10	blot	blot	NN
cord-023095-4dannjjm	6257	11	.	.	.
cord-023095-4dannjjm	6258	1	Proteomics	Proteomics	NNP
cord-023095-4dannjjm	6258	2	indicated	indicate	VBD
cord-023095-4dannjjm	6258	3	that	that	IN
cord-023095-4dannjjm	6258	4	secretoglobin	secretoglobin	NNP
cord-023095-4dannjjm	6258	5	was	be	VBD
cord-023095-4dannjjm	6258	6	not	not	RB
cord-023095-4dannjjm	6258	7	differentially	differentially	RB
cord-023095-4dannjjm	6258	8	expressed	express	VBN
cord-023095-4dannjjm	6258	9	between	between	IN
cord-023095-4dannjjm	6258	10	the	the	DT
cord-023095-4dannjjm	6258	11	experimental	experimental	JJ
cord-023095-4dannjjm	6258	12	exposure	exposure	NN
cord-023095-4dannjjm	6258	13	trial	trial	NN
cord-023095-4dannjjm	6258	14	group	group	NN
cord-023095-4dannjjm	6258	15	;	;	:
cord-023095-4dannjjm	6258	16	this	this	DT
cord-023095-4dannjjm	6258	17	was	be	VBD
cord-023095-4dannjjm	6258	18	confirmed	confirm	VBN
cord-023095-4dannjjm	6258	19	with	with	IN
cord-023095-4dannjjm	6258	20	Western	western	JJ
cord-023095-4dannjjm	6258	21	blot	blot	NN
cord-023095-4dannjjm	6258	22	analysis	analysis	NN
cord-023095-4dannjjm	6258	23	.	.	.
cord-023095-4dannjjm	6259	1	Western	western	JJ
cord-023095-4dannjjm	6259	2	blot	blot	NN
cord-023095-4dannjjm	6259	3	also	also	RB
cord-023095-4dannjjm	6259	4	showed	show	VBD
cord-023095-4dannjjm	6259	5	that	that	IN
cord-023095-4dannjjm	6259	6	clientowned	clientowne	VBN
cord-023095-4dannjjm	6259	7	RAO	RAO	NNP
cord-023095-4dannjjm	6259	8	-	-	HYPH
cord-023095-4dannjjm	6259	9	affected	affect	VBN
cord-023095-4dannjjm	6259	10	horses	horse	NNS
cord-023095-4dannjjm	6259	11	had	have	VBD
cord-023095-4dannjjm	6259	12	lower	low	JJR
cord-023095-4dannjjm	6259	13	secretoglobin	secretoglobin	NNP
cord-023095-4dannjjm	6259	14	expression	expression	NN
cord-023095-4dannjjm	6259	15	than	than	IN
cord-023095-4dannjjm	6259	16	client	client	NN
cord-023095-4dannjjm	6259	17	-	-	HYPH
cord-023095-4dannjjm	6259	18	owned	own	VBN
cord-023095-4dannjjm	6259	19	control	control	NN
cord-023095-4dannjjm	6259	20	horses	horse	NNS
cord-023095-4dannjjm	6259	21	and	and	CC
cord-023095-4dannjjm	6259	22	control	control	NN
cord-023095-4dannjjm	6259	23	horses	horse	NNS
cord-023095-4dannjjm	6259	24	before	before	IN
cord-023095-4dannjjm	6259	25	experimental	experimental	JJ
cord-023095-4dannjjm	6259	26	exposure	exposure	NN
cord-023095-4dannjjm	6259	27	.	.	.
cord-023095-4dannjjm	6260	1	According	accord	VBG
cord-023095-4dannjjm	6260	2	to	to	IN
cord-023095-4dannjjm	6260	3	the	the	DT
cord-023095-4dannjjm	6260	4	proteomics	proteomic	NNS
cord-023095-4dannjjm	6260	5	data	datum	NNS
cord-023095-4dannjjm	6260	6	,	,	,
cord-023095-4dannjjm	6260	7	transferrin	transferrin	NN
cord-023095-4dannjjm	6260	8	was	be	VBD
cord-023095-4dannjjm	6260	9	over	over	RB
cord-023095-4dannjjm	6260	10	-	-	HYPH
cord-023095-4dannjjm	6260	11	expressed	express	VBN
cord-023095-4dannjjm	6260	12	in	in	IN
cord-023095-4dannjjm	6260	13	control	control	NN
cord-023095-4dannjjm	6260	14	horses	horse	NNS
cord-023095-4dannjjm	6260	15	after	after	IN
cord-023095-4dannjjm	6260	16	experimental	experimental	JJ
cord-023095-4dannjjm	6260	17	exposure	exposure	NN
cord-023095-4dannjjm	6260	18	compared	compare	VBN
cord-023095-4dannjjm	6260	19	to	to	IN
cord-023095-4dannjjm	6260	20	RAO	RAO	NNP
cord-023095-4dannjjm	6260	21	-	-	HYPH
cord-023095-4dannjjm	6260	22	affected	affect	VBN
cord-023095-4dannjjm	6260	23	horses	horse	NNS
cord-023095-4dannjjm	6260	24	.	.	.
cord-023095-4dannjjm	6261	1	While	while	IN
cord-023095-4dannjjm	6261	2	the	the	DT
cord-023095-4dannjjm	6261	3	Western	western	JJ
cord-023095-4dannjjm	6261	4	blot	blot	NN
cord-023095-4dannjjm	6261	5	analysis	analysis	NN
cord-023095-4dannjjm	6261	6	did	do	VBD
cord-023095-4dannjjm	6261	7	not	not	RB
cord-023095-4dannjjm	6261	8	show	show	VB
cord-023095-4dannjjm	6261	9	a	a	DT
cord-023095-4dannjjm	6261	10	statistically	statistically	RB
cord-023095-4dannjjm	6261	11	significant	significant	JJ
cord-023095-4dannjjm	6261	12	difference	difference	NN
cord-023095-4dannjjm	6261	13	in	in	IN
cord-023095-4dannjjm	6261	14	this	this	DT
cord-023095-4dannjjm	6261	15	comparison	comparison	NN
cord-023095-4dannjjm	6261	16	,	,	,
cord-023095-4dannjjm	6261	17	transferrin	transferrin	NN
cord-023095-4dannjjm	6261	18	was	be	VBD
cord-023095-4dannjjm	6261	19	significantly	significantly	RB
cord-023095-4dannjjm	6261	20	over	over	RB
cord-023095-4dannjjm	6261	21	-	-	HYPH
cord-023095-4dannjjm	6261	22	expressed	express	VBN
cord-023095-4dannjjm	6261	23	in	in	IN
cord-023095-4dannjjm	6261	24	control	control	NN
cord-023095-4dannjjm	6261	25	horses	horse	NNS
cord-023095-4dannjjm	6261	26	before	before	IN
cord-023095-4dannjjm	6261	27	experimental	experimental	JJ
cord-023095-4dannjjm	6261	28	exposure	exposure	NN
cord-023095-4dannjjm	6261	29	compared	compare	VBN
cord-023095-4dannjjm	6261	30	to	to	IN
cord-023095-4dannjjm	6261	31	client	client	NN
cord-023095-4dannjjm	6261	32	-	-	HYPH
cord-023095-4dannjjm	6261	33	owned	own	VBN
cord-023095-4dannjjm	6261	34	RAO	RAO	NNP
cord-023095-4dannjjm	6261	35	-	-	HYPH
cord-023095-4dannjjm	6261	36	affected	affect	VBN
cord-023095-4dannjjm	6261	37	horses	horse	NNS
cord-023095-4dannjjm	6261	38	.	.	.
cord-023095-4dannjjm	6262	1	In	in	IN
cord-023095-4dannjjm	6262	2	addition	addition	NN
cord-023095-4dannjjm	6262	3	,	,	,
cord-023095-4dannjjm	6262	4	both	both	CC
cord-023095-4dannjjm	6262	5	secretoglobin	secretoglobin	NNP
cord-023095-4dannjjm	6262	6	and	and	CC
cord-023095-4dannjjm	6262	7	transferrin	transferrin	NN
cord-023095-4dannjjm	6262	8	band	band	NN
cord-023095-4dannjjm	6262	9	densities	density	NNS
cord-023095-4dannjjm	6262	10	on	on	IN
cord-023095-4dannjjm	6262	11	Western	western	JJ
cord-023095-4dannjjm	6262	12	blot	blot	NN
cord-023095-4dannjjm	6262	13	were	be	VBD
cord-023095-4dannjjm	6262	14	negatively	negatively	RB
cord-023095-4dannjjm	6262	15	correlated	correlate	VBN
cord-023095-4dannjjm	6262	16	with	with	IN
cord-023095-4dannjjm	6262	17	airway	airway	JJ
cord-023095-4dannjjm	6262	18	obstruction	obstruction	NN
cord-023095-4dannjjm	6262	19	and	and	CC
cord-023095-4dannjjm	6262	20	neutrophilic	neutrophilic	JJ
cord-023095-4dannjjm	6262	21	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6262	22	inflammation	inflammation	NN
cord-023095-4dannjjm	6262	23	.	.	.
cord-023095-4dannjjm	6263	1	This	this	DT
cord-023095-4dannjjm	6263	2	study	study	NN
cord-023095-4dannjjm	6263	3	demonstrates	demonstrate	VBZ
cord-023095-4dannjjm	6263	4	that	that	IN
cord-023095-4dannjjm	6263	5	proteomics	proteomic	NNS
cord-023095-4dannjjm	6263	6	techniques	technique	NNS
cord-023095-4dannjjm	6263	7	can	can	MD
cord-023095-4dannjjm	6263	8	be	be	VB
cord-023095-4dannjjm	6263	9	used	use	VBN
cord-023095-4dannjjm	6263	10	in	in	IN
cord-023095-4dannjjm	6263	11	the	the	DT
cord-023095-4dannjjm	6263	12	investigation	investigation	NN
cord-023095-4dannjjm	6263	13	of	of	IN
cord-023095-4dannjjm	6263	14	equine	equine	JJ
cord-023095-4dannjjm	6263	15	BALF	BALF	NNP
cord-023095-4dannjjm	6263	16	proteins	protein	NNS
cord-023095-4dannjjm	6263	17	.	.	.
cord-023095-4dannjjm	6264	1	The	the	DT
cord-023095-4dannjjm	6264	2	proteins	protein	NNS
cord-023095-4dannjjm	6264	3	identified	identify	VBN
cord-023095-4dannjjm	6264	4	as	as	IN
cord-023095-4dannjjm	6264	5	differentially	differentially	RB
cord-023095-4dannjjm	6264	6	expressed	express	VBN
cord-023095-4dannjjm	6264	7	between	between	IN
cord-023095-4dannjjm	6264	8	RAO	RAO	NNP
cord-023095-4dannjjm	6264	9	-	-	HYPH
cord-023095-4dannjjm	6264	10	affected	affect	VBN
cord-023095-4dannjjm	6264	11	and	and	CC
cord-023095-4dannjjm	6264	12	control	control	NN
cord-023095-4dannjjm	6264	13	horses	horse	NNS
cord-023095-4dannjjm	6264	14	in	in	IN
cord-023095-4dannjjm	6264	15	this	this	DT
cord-023095-4dannjjm	6264	16	study	study	NN
cord-023095-4dannjjm	6264	17	including	include	VBG
cord-023095-4dannjjm	6264	18	,	,	,
cord-023095-4dannjjm	6264	19	but	but	CC
cord-023095-4dannjjm	6264	20	not	not	RB
cord-023095-4dannjjm	6264	21	limited	limited	JJ
cord-023095-4dannjjm	6264	22	to	to	IN
cord-023095-4dannjjm	6264	23	,	,	,
cord-023095-4dannjjm	6264	24	secretoglobin	secretoglobin	NNP
cord-023095-4dannjjm	6264	25	and	and	CC
cord-023095-4dannjjm	6264	26	transferrin	transferrin	NN
cord-023095-4dannjjm	6264	27	should	should	MD
cord-023095-4dannjjm	6264	28	undergo	undergo	VB
cord-023095-4dannjjm	6264	29	further	further	JJ
cord-023095-4dannjjm	6264	30	evaluation	evaluation	NN
cord-023095-4dannjjm	6264	31	for	for	IN
cord-023095-4dannjjm	6264	32	their	-PRON-	PRP$
cord-023095-4dannjjm	6264	33	use	use	NN
cord-023095-4dannjjm	6264	34	as	as	IN
cord-023095-4dannjjm	6264	35	biomarkers	biomarker	NNS
cord-023095-4dannjjm	6264	36	of	of	IN
cord-023095-4dannjjm	6264	37	RAO	RAO	NNP
cord-023095-4dannjjm	6264	38	,	,	,
cord-023095-4dannjjm	6264	39	and	and	CC
cord-023095-4dannjjm	6264	40	as	as	IN
cord-023095-4dannjjm	6264	41	potential	potential	JJ
cord-023095-4dannjjm	6264	42	targets	target	NNS
cord-023095-4dannjjm	6264	43	of	of	IN
cord-023095-4dannjjm	6264	44	new	new	JJ
cord-023095-4dannjjm	6264	45	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	6264	46	agents	agent	NNS
cord-023095-4dannjjm	6264	47	for	for	IN
cord-023095-4dannjjm	6264	48	RAO	RAO	NNP
cord-023095-4dannjjm	6264	49	.	.	.
cord-023095-4dannjjm	6265	1	Cardiotoxic	cardiotoxic	JJ
cord-023095-4dannjjm	6265	2	effects	effect	NNS
cord-023095-4dannjjm	6265	3	of	of	IN
cord-023095-4dannjjm	6265	4	rattlesnake	rattlesnake	NN
cord-023095-4dannjjm	6265	5	venom	venom	NN
cord-023095-4dannjjm	6265	6	in	in	IN
cord-023095-4dannjjm	6265	7	the	the	DT
cord-023095-4dannjjm	6265	8	horse	horse	NN
cord-023095-4dannjjm	6265	9	are	be	VBP
cord-023095-4dannjjm	6265	10	not	not	RB
cord-023095-4dannjjm	6265	11	well	well	RB
cord-023095-4dannjjm	6265	12	defined	define	VBN
cord-023095-4dannjjm	6265	13	.	.	.
cord-023095-4dannjjm	6266	1	The	the	DT
cord-023095-4dannjjm	6266	2	first	first	JJ
cord-023095-4dannjjm	6266	3	aim	aim	NN
cord-023095-4dannjjm	6266	4	of	of	IN
cord-023095-4dannjjm	6266	5	this	this	DT
cord-023095-4dannjjm	6266	6	study	study	NN
cord-023095-4dannjjm	6266	7	was	be	VBD
cord-023095-4dannjjm	6266	8	to	to	TO
cord-023095-4dannjjm	6266	9	document	document	VB
cord-023095-4dannjjm	6266	10	cardiac	cardiac	JJ
cord-023095-4dannjjm	6266	11	damage	damage	NN
cord-023095-4dannjjm	6266	12	in	in	IN
cord-023095-4dannjjm	6266	13	naturally	naturally	RB
cord-023095-4dannjjm	6266	14	envenomated	envenomate	VBN
cord-023095-4dannjjm	6266	15	horses	horse	NNS
cord-023095-4dannjjm	6266	16	.	.	.
cord-023095-4dannjjm	6267	1	Twenty	twenty	CD
cord-023095-4dannjjm	6267	2	horses	horse	NNS
cord-023095-4dannjjm	6267	3	with	with	IN
cord-023095-4dannjjm	6267	4	clinical	clinical	JJ
cord-023095-4dannjjm	6267	5	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6267	6	of	of	IN
cord-023095-4dannjjm	6267	7	snake	snake	NN
cord-023095-4dannjjm	6267	8	bite	bite	NN
cord-023095-4dannjjm	6267	9	were	be	VBD
cord-023095-4dannjjm	6267	10	included	include	VBN
cord-023095-4dannjjm	6267	11	.	.	.
cord-023095-4dannjjm	6268	1	A	a	DT
cord-023095-4dannjjm	6268	2	snake	snake	NN
cord-023095-4dannjjm	6268	3	venom	venom	NN
cord-023095-4dannjjm	6268	4	ELISA	ELISA	NNP
cord-023095-4dannjjm	6268	5	was	be	VBD
cord-023095-4dannjjm	6268	6	utilized	utilize	VBN
cord-023095-4dannjjm	6268	7	to	to	TO
cord-023095-4dannjjm	6268	8	confirm	confirm	VB
cord-023095-4dannjjm	6268	9	envenomation	envenomation	NN
cord-023095-4dannjjm	6268	10	when	when	WRB
cord-023095-4dannjjm	6268	11	possible	possible	JJ
cord-023095-4dannjjm	6268	12	.	.	.
cord-023095-4dannjjm	6269	1	Serum	serum	NN
cord-023095-4dannjjm	6269	2	and	and	CC
cord-023095-4dannjjm	6269	3	plasma	plasma	NN
cord-023095-4dannjjm	6269	4	were	be	VBD
cord-023095-4dannjjm	6269	5	collected	collect	VBN
cord-023095-4dannjjm	6269	6	at	at	IN
cord-023095-4dannjjm	6269	7	selected	select	VBN
cord-023095-4dannjjm	6269	8	intervals	interval	NNS
cord-023095-4dannjjm	6269	9	.	.	.
cord-023095-4dannjjm	6270	1	Plasma	plasma	NN
cord-023095-4dannjjm	6270	2	was	be	VBD
cord-023095-4dannjjm	6270	3	assayed	assay	VBN
cord-023095-4dannjjm	6270	4	for	for	IN
cord-023095-4dannjjm	6270	5	cardiac	cardiac	NN
cord-023095-4dannjjm	6270	6	troponin	troponin	JJ
cord-023095-4dannjjm	6270	7	I	-PRON-	PRP
cord-023095-4dannjjm	6270	8	(	(	-LRB-
cord-023095-4dannjjm	6270	9	cTnI	cTnI	NNP
cord-023095-4dannjjm	6270	10	)	)	-RRB-
cord-023095-4dannjjm	6270	11	using	use	VBG
cord-023095-4dannjjm	6270	12	a	a	DT
cord-023095-4dannjjm	6270	13	flurometric	flurometric	JJ
cord-023095-4dannjjm	6270	14	assay	assay	NN
cord-023095-4dannjjm	6270	15	(	(	-LRB-
cord-023095-4dannjjm	6270	16	Stratus	Stratus	NNP
cord-023095-4dannjjm	6270	17	CS	CS	NNP
cord-023095-4dannjjm	6270	18	s	s	NNP
cord-023095-4dannjjm	6270	19	,	,	,
cord-023095-4dannjjm	6270	20	Dade	Dade	NNP
cord-023095-4dannjjm	6270	21	Behring	Behring	NNP
cord-023095-4dannjjm	6270	22	)	)	-RRB-
cord-023095-4dannjjm	6270	23	.	.	.
cord-023095-4dannjjm	6271	1	Holter	holter	NN
cord-023095-4dannjjm	6271	2	monitors	monitor	NNS
cord-023095-4dannjjm	6271	3	(	(	-LRB-
cord-023095-4dannjjm	6271	4	Zymed	Zymed	NNP
cord-023095-4dannjjm	6271	5	s	s	NNP
cord-023095-4dannjjm	6271	6	,	,	,
cord-023095-4dannjjm	6271	7	Philips	Philips	NNP
cord-023095-4dannjjm	6271	8	)	)	-RRB-
cord-023095-4dannjjm	6271	9	were	be	VBD
cord-023095-4dannjjm	6271	10	placed	place	VBN
cord-023095-4dannjjm	6271	11	at	at	IN
cord-023095-4dannjjm	6271	12	admission	admission	NN
cord-023095-4dannjjm	6271	13	,	,	,
cord-023095-4dannjjm	6271	14	1	1	CD
cord-023095-4dannjjm	6271	15	week	week	NN
cord-023095-4dannjjm	6271	16	and	and	CC
cord-023095-4dannjjm	6271	17	1	1	CD
cord-023095-4dannjjm	6271	18	month	month	NN
cord-023095-4dannjjm	6271	19	post	post	NN
cord-023095-4dannjjm	6271	20	presentation	presentation	NN
cord-023095-4dannjjm	6271	21	.	.	.
cord-023095-4dannjjm	6272	1	Echocardiography	echocardiography	NN
cord-023095-4dannjjm	6272	2	was	be	VBD
cord-023095-4dannjjm	6272	3	performed	perform	VBN
cord-023095-4dannjjm	6272	4	on	on	IN
cord-023095-4dannjjm	6272	5	available	available	JJ
cord-023095-4dannjjm	6272	6	horses	horse	NNS
cord-023095-4dannjjm	6272	7	5	5	CD
cord-023095-4dannjjm	6272	8	-	-	SYM
cord-023095-4dannjjm	6272	9	7	7	CD
cord-023095-4dannjjm	6272	10	months	month	NNS
cord-023095-4dannjjm	6272	11	after	after	IN
cord-023095-4dannjjm	6272	12	envenomation	envenomation	NN
cord-023095-4dannjjm	6272	13	.	.	.
cord-023095-4dannjjm	6273	1	The	the	DT
cord-023095-4dannjjm	6273	2	second	second	JJ
cord-023095-4dannjjm	6273	3	aim	aim	NN
cord-023095-4dannjjm	6273	4	of	of	IN
cord-023095-4dannjjm	6273	5	this	this	DT
cord-023095-4dannjjm	6273	6	study	study	NN
cord-023095-4dannjjm	6273	7	was	be	VBD
cord-023095-4dannjjm	6273	8	to	to	TO
cord-023095-4dannjjm	6273	9	investigate	investigate	VB
cord-023095-4dannjjm	6273	10	potential	potential	JJ
cord-023095-4dannjjm	6273	11	mechanisms	mechanism	NNS
cord-023095-4dannjjm	6273	12	of	of	IN
cord-023095-4dannjjm	6273	13	the	the	DT
cord-023095-4dannjjm	6273	14	cardiac	cardiac	JJ
cord-023095-4dannjjm	6273	15	damage	damage	NN
cord-023095-4dannjjm	6273	16	.	.	.
cord-023095-4dannjjm	6274	1	Serum	serum	NN
cord-023095-4dannjjm	6274	2	samples	sample	NNS
cord-023095-4dannjjm	6274	3	were	be	VBD
cord-023095-4dannjjm	6274	4	assayed	assay	VBN
cord-023095-4dannjjm	6274	5	for	for	IN
cord-023095-4dannjjm	6274	6	TNFalpha	TNFalpha	NNS
cord-023095-4dannjjm	6274	7	using	use	VBG
cord-023095-4dannjjm	6274	8	a	a	DT
cord-023095-4dannjjm	6274	9	commercial	commercial	JJ
cord-023095-4dannjjm	6274	10	assay	assay	NN
cord-023095-4dannjjm	6274	11	(	(	-LRB-
cord-023095-4dannjjm	6274	12	Endogen	Endogen	NNP
cord-023095-4dannjjm	6274	13	)	)	-RRB-
cord-023095-4dannjjm	6274	14	.	.	.
cord-023095-4dannjjm	6275	1	Antibody	antibody	NN
cord-023095-4dannjjm	6275	2	titers	titer	NNS
cord-023095-4dannjjm	6275	3	to	to	IN
cord-023095-4dannjjm	6275	4	Crotalus	Crotalus	NNP
cord-023095-4dannjjm	6275	5	atrox	atrox	NN
cord-023095-4dannjjm	6275	6	venom	venom	NN
cord-023095-4dannjjm	6275	7	were	be	VBD
cord-023095-4dannjjm	6275	8	measured	measure	VBN
cord-023095-4dannjjm	6275	9	at	at	IN
cord-023095-4dannjjm	6275	10	admission	admission	NN
cord-023095-4dannjjm	6275	11	,	,	,
cord-023095-4dannjjm	6275	12	1	1	CD
cord-023095-4dannjjm	6275	13	week	week	NN
cord-023095-4dannjjm	6275	14	and	and	CC
cord-023095-4dannjjm	6276	1	1	1	CD
cord-023095-4dannjjm	6276	2	month	month	NN
cord-023095-4dannjjm	6276	3	after	after	IN
cord-023095-4dannjjm	6276	4	natural	natural	JJ
cord-023095-4dannjjm	6276	5	envenomation	envenomation	NN
cord-023095-4dannjjm	6276	6	and	and	CC
cord-023095-4dannjjm	6276	7	compared	compare	VBN
cord-023095-4dannjjm	6276	8	to	to	IN
cord-023095-4dannjjm	6276	9	titers	titer	NNS
cord-023095-4dannjjm	6276	10	in	in	IN
cord-023095-4dannjjm	6276	11	vaccinated	vaccinated	JJ
cord-023095-4dannjjm	6276	12	horses	horse	NNS
cord-023095-4dannjjm	6276	13	(	(	-LRB-
cord-023095-4dannjjm	6276	14	Crotalus	Crotalus	NNP
cord-023095-4dannjjm	6276	15	Atrox	Atrox	NNP
cord-023095-4dannjjm	6276	16	Toxoid	Toxoid	NNP
cord-023095-4dannjjm	6276	17	,	,	,
cord-023095-4dannjjm	6276	18	Red	Red	NNP
cord-023095-4dannjjm	6276	19	Rock	Rock	NNP
cord-023095-4dannjjm	6276	20	Biologics	Biologics	NNPS
cord-023095-4dannjjm	6276	21	)	)	-RRB-
cord-023095-4dannjjm	6276	22	.	.	.
cord-023095-4dannjjm	6277	1	A	a	DT
cord-023095-4dannjjm	6277	2	significant	significant	JJ
cord-023095-4dannjjm	6277	3	number	number	NN
cord-023095-4dannjjm	6277	4	of	of	IN
cord-023095-4dannjjm	6277	5	horses	horse	NNS
cord-023095-4dannjjm	6277	6	showed	show	VBD
cord-023095-4dannjjm	6277	7	elevations	elevation	NNS
cord-023095-4dannjjm	6277	8	in	in	IN
cord-023095-4dannjjm	6277	9	cTnI	cTnI	NNP
cord-023095-4dannjjm	6277	10	(	(	-LRB-
cord-023095-4dannjjm	6277	11	p	p	NN
cord-023095-4dannjjm	6277	12	o	o	NN
cord-023095-4dannjjm	6277	13	0.05	0.05	CD
cord-023095-4dannjjm	6277	14	)	)	-RRB-
cord-023095-4dannjjm	6277	15	at	at	IN
cord-023095-4dannjjm	6277	16	one	one	CD
cord-023095-4dannjjm	6277	17	or	or	CC
cord-023095-4dannjjm	6277	18	more	more	JJR
cord-023095-4dannjjm	6277	19	time	time	NN
cord-023095-4dannjjm	6277	20	point	point	NN
cord-023095-4dannjjm	6277	21	indicating	indicate	VBG
cord-023095-4dannjjm	6277	22	myocardial	myocardial	JJ
cord-023095-4dannjjm	6277	23	damage	damage	NN
cord-023095-4dannjjm	6277	24	.	.	.
cord-023095-4dannjjm	6278	1	Holter	Holter	NNP
cord-023095-4dannjjm	6278	2	readings	reading	NNS
cord-023095-4dannjjm	6278	3	revealed	reveal	VBD
cord-023095-4dannjjm	6278	4	the	the	DT
cord-023095-4dannjjm	6278	5	presence	presence	NN
cord-023095-4dannjjm	6278	6	of	of	IN
cord-023095-4dannjjm	6278	7	arrhythmias	arrhythmias	JJ
cord-023095-4dannjjm	6278	8	or	or	CC
cord-023095-4dannjjm	6278	9	persistent	persistent	JJ
cord-023095-4dannjjm	6278	10	tachycardia	tachycardia	NN
cord-023095-4dannjjm	6278	11	in	in	IN
cord-023095-4dannjjm	6278	12	19	19	CD
cord-023095-4dannjjm	6278	13	horses	horse	NNS
cord-023095-4dannjjm	6278	14	.	.	.
cord-023095-4dannjjm	6279	1	Five	five	CD
cord-023095-4dannjjm	6279	2	of	of	IN
cord-023095-4dannjjm	6279	3	twenty	twenty	CD
cord-023095-4dannjjm	6279	4	horses	horse	NNS
cord-023095-4dannjjm	6279	5	were	be	VBD
cord-023095-4dannjjm	6279	6	available	available	JJ
cord-023095-4dannjjm	6279	7	for	for	IN
cord-023095-4dannjjm	6279	8	echocardiography	echocardiography	NN
cord-023095-4dannjjm	6279	9	;	;	:
cord-023095-4dannjjm	6279	10	no	no	DT
cord-023095-4dannjjm	6279	11	abnormalities	abnormality	NNS
cord-023095-4dannjjm	6279	12	were	be	VBD
cord-023095-4dannjjm	6279	13	noted	note	VBN
cord-023095-4dannjjm	6279	14	.	.	.
cord-023095-4dannjjm	6280	1	Horses	horse	NNS
cord-023095-4dannjjm	6280	2	with	with	IN
cord-023095-4dannjjm	6280	3	increased	increase	VBN
cord-023095-4dannjjm	6280	4	cTnI	cTnI	NNP
cord-023095-4dannjjm	6280	5	tended	tend	VBD
cord-023095-4dannjjm	6280	6	to	to	TO
cord-023095-4dannjjm	6280	7	have	have	VB
cord-023095-4dannjjm	6280	8	greater	great	JJR
cord-023095-4dannjjm	6280	9	TNFalpha	TNFalpha	NNS
cord-023095-4dannjjm	6280	10	concentrations	concentration	NNS
cord-023095-4dannjjm	6280	11	compared	compare	VBN
cord-023095-4dannjjm	6280	12	with	with	IN
cord-023095-4dannjjm	6280	13	horses	horse	NNS
cord-023095-4dannjjm	6280	14	without	without	IN
cord-023095-4dannjjm	6280	15	increased	increase	VBN
cord-023095-4dannjjm	6280	16	cTnI.	cTnI.	''
cord-023095-4dannjjm	6280	17	Peak	peak	NN
cord-023095-4dannjjm	6280	18	venom	venom	NN
cord-023095-4dannjjm	6280	19	titers	titer	NNS
cord-023095-4dannjjm	6280	20	in	in	IN
cord-023095-4dannjjm	6280	21	bitten	bite	VBN
cord-023095-4dannjjm	6280	22	horses	horse	NNS
cord-023095-4dannjjm	6280	23	were	be	VBD
cord-023095-4dannjjm	6280	24	significantly	significantly	RB
cord-023095-4dannjjm	6280	25	higher	high	JJR
cord-023095-4dannjjm	6280	26	than	than	IN
cord-023095-4dannjjm	6280	27	peak	peak	NN
cord-023095-4dannjjm	6280	28	titers	titer	NNS
cord-023095-4dannjjm	6280	29	in	in	IN
cord-023095-4dannjjm	6280	30	vaccinated	vaccinated	JJ
cord-023095-4dannjjm	6280	31	horses	horse	NNS
cord-023095-4dannjjm	6280	32	(	(	-LRB-
cord-023095-4dannjjm	6280	33	p	p	NN
cord-023095-4dannjjm	6280	34	o	o	NN
cord-023095-4dannjjm	6280	35	0.05	0.05	CD
cord-023095-4dannjjm	6280	36	)	)	-RRB-
cord-023095-4dannjjm	6280	37	.	.	.
cord-023095-4dannjjm	6281	1	Rattlesnake	rattlesnake	NN
cord-023095-4dannjjm	6281	2	envenomation	envenomation	NN
cord-023095-4dannjjm	6281	3	was	be	VBD
cord-023095-4dannjjm	6281	4	associated	associate	VBN
cord-023095-4dannjjm	6281	5	with	with	IN
cord-023095-4dannjjm	6281	6	evidence	evidence	NN
cord-023095-4dannjjm	6281	7	of	of	IN
cord-023095-4dannjjm	6281	8	cardiac	cardiac	JJ
cord-023095-4dannjjm	6281	9	damage	damage	NN
cord-023095-4dannjjm	6281	10	in	in	IN
cord-023095-4dannjjm	6281	11	a	a	DT
cord-023095-4dannjjm	6281	12	significant	significant	JJ
cord-023095-4dannjjm	6281	13	proportion	proportion	NN
cord-023095-4dannjjm	6281	14	of	of	IN
cord-023095-4dannjjm	6281	15	bitten	bite	VBN
cord-023095-4dannjjm	6281	16	horses	horse	NNS
cord-023095-4dannjjm	6281	17	.	.	.
cord-023095-4dannjjm	6282	1	Further	further	JJ
cord-023095-4dannjjm	6282	2	studies	study	NNS
cord-023095-4dannjjm	6282	3	are	be	VBP
cord-023095-4dannjjm	6282	4	needed	need	VBN
cord-023095-4dannjjm	6282	5	to	to	TO
cord-023095-4dannjjm	6282	6	determine	determine	VB
cord-023095-4dannjjm	6282	7	the	the	DT
cord-023095-4dannjjm	6282	8	cause	cause	NN
cord-023095-4dannjjm	6282	9	as	as	RB
cord-023095-4dannjjm	6282	10	well	well	RB
cord-023095-4dannjjm	6282	11	as	as	IN
cord-023095-4dannjjm	6282	12	mechanisms	mechanism	NNS
cord-023095-4dannjjm	6282	13	to	to	TO
cord-023095-4dannjjm	6282	14	treat	treat	VB
cord-023095-4dannjjm	6282	15	and/or	and/or	CC
cord-023095-4dannjjm	6282	16	prevent	prevent	VB
cord-023095-4dannjjm	6282	17	its	-PRON-	PRP$
cord-023095-4dannjjm	6282	18	occurrence	occurrence	NN
cord-023095-4dannjjm	6282	19	.	.	.
cord-023095-4dannjjm	6283	1	Little	little	JJ
cord-023095-4dannjjm	6283	2	is	be	VBZ
cord-023095-4dannjjm	6283	3	known	know	VBN
cord-023095-4dannjjm	6283	4	about	about	IN
cord-023095-4dannjjm	6283	5	the	the	DT
cord-023095-4dannjjm	6283	6	gastric	gastric	JJ
cord-023095-4dannjjm	6283	7	mucosal	mucosal	JJ
cord-023095-4dannjjm	6283	8	flora	flora	NNS
cord-023095-4dannjjm	6283	9	in	in	IN
cord-023095-4dannjjm	6283	10	healthy	healthy	JJ
cord-023095-4dannjjm	6283	11	horses	horse	NNS
cord-023095-4dannjjm	6283	12	and	and	CC
cord-023095-4dannjjm	6283	13	its	-PRON-	PRP$
cord-023095-4dannjjm	6283	14	role	role	NN
cord-023095-4dannjjm	6283	15	in	in	IN
cord-023095-4dannjjm	6283	16	gastric	gastric	JJ
cord-023095-4dannjjm	6283	17	disease	disease	NN
cord-023095-4dannjjm	6283	18	has	have	VBZ
cord-023095-4dannjjm	6283	19	not	not	RB
cord-023095-4dannjjm	6283	20	been	be	VBN
cord-023095-4dannjjm	6283	21	critically	critically	RB
cord-023095-4dannjjm	6283	22	examined	examine	VBN
cord-023095-4dannjjm	6283	23	.	.	.
cord-023095-4dannjjm	6284	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	6284	2	laboratory	laboratory	NN
cord-023095-4dannjjm	6284	3	previously	previously	RB
cord-023095-4dannjjm	6284	4	reported	report	VBD
cord-023095-4dannjjm	6284	5	that	that	IN
cord-023095-4dannjjm	6284	6	a	a	DT
cord-023095-4dannjjm	6284	7	diverse	diverse	JJ
cord-023095-4dannjjm	6284	8	microbial	microbial	JJ
cord-023095-4dannjjm	6284	9	flora	flora	NNS
cord-023095-4dannjjm	6284	10	with	with	IN
cord-023095-4dannjjm	6284	11	a	a	DT
cord-023095-4dannjjm	6284	12	predominance	predominance	NN
cord-023095-4dannjjm	6284	13	of	of	IN
cord-023095-4dannjjm	6284	14	Streptococcus	streptococcus	NN
cord-023095-4dannjjm	6284	15	spp	spp	NNS
cord-023095-4dannjjm	6284	16	.	.	.
cord-023095-4dannjjm	6285	1	and	and	CC
cord-023095-4dannjjm	6285	2	Lactobacillus	lactobacillus	NN
cord-023095-4dannjjm	6285	3	spp	spp	NNS
cord-023095-4dannjjm	6285	4	.	.	.
cord-023095-4dannjjm	6286	1	exists	exist	VBZ
cord-023095-4dannjjm	6286	2	in	in	IN
cord-023095-4dannjjm	6286	3	healthy	healthy	JJ
cord-023095-4dannjjm	6286	4	horses	horse	NNS
cord-023095-4dannjjm	6286	5	using	use	VBG
cord-023095-4dannjjm	6286	6	Fluorescence	fluorescence	NN
cord-023095-4dannjjm	6286	7	in	in	IN
cord-023095-4dannjjm	6286	8	situ	situ	NN
cord-023095-4dannjjm	6286	9	hybridization	hybridization	NN
cord-023095-4dannjjm	6286	10	(	(	-LRB-
cord-023095-4dannjjm	6286	11	FISH	fish	NN
cord-023095-4dannjjm	6286	12	)	)	-RRB-
cord-023095-4dannjjm	6286	13	.	.	.
cord-023095-4dannjjm	6287	1	The	the	DT
cord-023095-4dannjjm	6287	2	present	present	JJ
cord-023095-4dannjjm	6287	3	study	study	NN
cord-023095-4dannjjm	6287	4	sought	seek	VBD
cord-023095-4dannjjm	6287	5	to	to	TO
cord-023095-4dannjjm	6287	6	further	further	RB
cord-023095-4dannjjm	6287	7	characterize	characterize	VB
cord-023095-4dannjjm	6287	8	the	the	DT
cord-023095-4dannjjm	6287	9	gastric	gastric	JJ
cord-023095-4dannjjm	6287	10	mucosal	mucosal	JJ
cord-023095-4dannjjm	6287	11	flora	flora	NNS
cord-023095-4dannjjm	6287	12	of	of	IN
cord-023095-4dannjjm	6287	13	healthy	healthy	JJ
cord-023095-4dannjjm	6287	14	horses	horse	NNS
cord-023095-4dannjjm	6287	15	using	use	VBG
cord-023095-4dannjjm	6287	16	massive	massive	JJ
cord-023095-4dannjjm	6287	17	parallel	parallel	JJ
cord-023095-4dannjjm	6287	18	16SrRNA	16srrna	CD
cord-023095-4dannjjm	6287	19	bacterial	bacterial	JJ
cord-023095-4dannjjm	6287	20	tag	tag	NN
cord-023095-4dannjjm	6287	21	encoded	encode	VBD
cord-023095-4dannjjm	6287	22	FLX	flx	NN
cord-023095-4dannjjm	6287	23	-	-	HYPH
cord-023095-4dannjjm	6287	24	titanium	titanium	NN
cord-023095-4dannjjm	6287	25	amplicon	amplicon	NN
cord-023095-4dannjjm	6287	26	pyrosequencing	pyrosequencing	NN
cord-023095-4dannjjm	6287	27	(	(	-LRB-
cord-023095-4dannjjm	6287	28	bTEFAP	bTEFAP	NNP
cord-023095-4dannjjm	6287	29	)	)	-RRB-
cord-023095-4dannjjm	6287	30	.	.	.
cord-023095-4dannjjm	6288	1	Biopsies	biopsy	NNS
cord-023095-4dannjjm	6288	2	of	of	IN
cord-023095-4dannjjm	6288	3	the	the	DT
cord-023095-4dannjjm	6288	4	squamous	squamous	JJ
cord-023095-4dannjjm	6288	5	,	,	,
cord-023095-4dannjjm	6288	6	glandular	glandular	JJ
cord-023095-4dannjjm	6288	7	,	,	,
cord-023095-4dannjjm	6288	8	antral	antral	JJ
cord-023095-4dannjjm	6288	9	and	and	CC
cord-023095-4dannjjm	6288	10	any	any	DT
cord-023095-4dannjjm	6288	11	ulcerated	ulcerated	JJ
cord-023095-4dannjjm	6288	12	mucosa	mucosa	NN
cord-023095-4dannjjm	6288	13	were	be	VBD
cord-023095-4dannjjm	6288	14	obtained	obtain	VBN
cord-023095-4dannjjm	6288	15	from	from	IN
cord-023095-4dannjjm	6288	16	4	4	CD
cord-023095-4dannjjm	6288	17	healthy	healthy	JJ
cord-023095-4dannjjm	6288	18	horses	horse	NNS
cord-023095-4dannjjm	6288	19	via	via	IN
cord-023095-4dannjjm	6288	20	gastroscopy	gastroscopy	NN
cord-023095-4dannjjm	6288	21	after	after	IN
cord-023095-4dannjjm	6288	22	a	a	DT
cord-023095-4dannjjm	6288	23	12-hour	12-hour	CD
cord-023095-4dannjjm	6288	24	fast	fast	NN
cord-023095-4dannjjm	6288	25	and	and	CC
cord-023095-4dannjjm	6288	26	2	2	CD
cord-023095-4dannjjm	6288	27	horses	horse	NNS
cord-023095-4dannjjm	6288	28	immediately	immediately	RB
cord-023095-4dannjjm	6288	29	post	post	JJ
cord-023095-4dannjjm	6288	30	-	-	JJ
cord-023095-4dannjjm	6288	31	mortem	mortem	JJ
cord-023095-4dannjjm	6288	32	.	.	.
cord-023095-4dannjjm	6289	1	DNA	DNA	NNP
cord-023095-4dannjjm	6289	2	was	be	VBD
cord-023095-4dannjjm	6289	3	extracted	extract	VBN
cord-023095-4dannjjm	6289	4	from	from	IN
cord-023095-4dannjjm	6289	5	the	the	DT
cord-023095-4dannjjm	6289	6	mucosal	mucosal	JJ
cord-023095-4dannjjm	6289	7	biopsies	biopsy	NNS
cord-023095-4dannjjm	6289	8	and	and	CC
cord-023095-4dannjjm	6289	9	bTEFAP	bTEFAP	NNS
cord-023095-4dannjjm	6289	10	and	and	CC
cord-023095-4dannjjm	6289	11	data	datum	NNS
cord-023095-4dannjjm	6289	12	processing	processing	NN
cord-023095-4dannjjm	6289	13	was	be	VBD
cord-023095-4dannjjm	6289	14	performed	perform	VBN
cord-023095-4dannjjm	6289	15	.	.	.
cord-023095-4dannjjm	6290	1	Hierarchical	hierarchical	JJ
cord-023095-4dannjjm	6290	2	cluster	cluster	NN
cord-023095-4dannjjm	6290	3	analysis	analysis	NN
cord-023095-4dannjjm	6290	4	based	base	VBN
cord-023095-4dannjjm	6290	5	on	on	IN
cord-023095-4dannjjm	6290	6	relative	relative	JJ
cord-023095-4dannjjm	6290	7	abundance	abundance	NN
cord-023095-4dannjjm	6290	8	data	datum	NNS
cord-023095-4dannjjm	6290	9	on	on	IN
cord-023095-4dannjjm	6290	10	the	the	DT
cord-023095-4dannjjm	6290	11	genus	genus	NN
cord-023095-4dannjjm	6290	12	level	level	NN
cord-023095-4dannjjm	6290	13	were	be	VBD
cord-023095-4dannjjm	6290	14	performed	perform	VBN
cord-023095-4dannjjm	6290	15	to	to	TO
cord-023095-4dannjjm	6290	16	look	look	VB
cord-023095-4dannjjm	6290	17	for	for	IN
cord-023095-4dannjjm	6290	18	trends	trend	NNS
cord-023095-4dannjjm	6290	19	in	in	IN
cord-023095-4dannjjm	6290	20	bacterial	bacterial	JJ
cord-023095-4dannjjm	6290	21	diversity	diversity	NN
cord-023095-4dannjjm	6290	22	among	among	IN
cord-023095-4dannjjm	6290	23	the	the	DT
cord-023095-4dannjjm	6290	24	individual	individual	JJ
cord-023095-4dannjjm	6290	25	horses	horse	NNS
cord-023095-4dannjjm	6290	26	.	.	.
cord-023095-4dannjjm	6291	1	Pyrosequencing	pyrosequence	VBG
cord-023095-4dannjjm	6291	2	yielded	yield	VBD
cord-023095-4dannjjm	6291	3	between	between	IN
cord-023095-4dannjjm	6291	4	4,500	4,500	CD
cord-023095-4dannjjm	6291	5	and	and	CC
cord-023095-4dannjjm	6291	6	13,000	13,000	CD
cord-023095-4dannjjm	6291	7	reads	read	NNS
cord-023095-4dannjjm	6291	8	per	per	IN
cord-023095-4dannjjm	6291	9	horse	horse	NN
cord-023095-4dannjjm	6291	10	with	with	IN
cord-023095-4dannjjm	6291	11	9238	9238	CD
cord-023095-4dannjjm	6291	12	,	,	,
cord-023095-4dannjjm	6291	13	16587	16587	CD
cord-023095-4dannjjm	6291	14	,	,	,
cord-023095-4dannjjm	6292	1	16587	16587	CD
cord-023095-4dannjjm	6292	2	reads	read	VBZ
cord-023095-4dannjjm	6292	3	in	in	IN
cord-023095-4dannjjm	6292	4	the	the	DT
cord-023095-4dannjjm	6292	5	antrum	antrum	NN
cord-023095-4dannjjm	6292	6	,	,	,
cord-023095-4dannjjm	6292	7	squamous	squamous	JJ
cord-023095-4dannjjm	6292	8	and	and	CC
cord-023095-4dannjjm	6292	9	glandular	glandular	JJ
cord-023095-4dannjjm	6292	10	regions	region	NNS
cord-023095-4dannjjm	6292	11	,	,	,
cord-023095-4dannjjm	6292	12	respectively	respectively	RB
cord-023095-4dannjjm	6292	13	.	.	.
cord-023095-4dannjjm	6293	1	The	the	DT
cord-023095-4dannjjm	6293	2	microbiome	microbiome	NN
cord-023095-4dannjjm	6293	3	segregated	segregate	VBD
cord-023095-4dannjjm	6293	4	into	into	IN
cord-023095-4dannjjm	6293	5	two	two	CD
cord-023095-4dannjjm	6293	6	distinct	distinct	JJ
cord-023095-4dannjjm	6293	7	clusters	cluster	NNS
cord-023095-4dannjjm	6293	8	:	:	:
cord-023095-4dannjjm	6293	9	Cluster	cluster	NN
cord-023095-4dannjjm	6293	10	1	1	CD
cord-023095-4dannjjm	6293	11	comprised	comprise	VBN
cord-023095-4dannjjm	6293	12	of	of	IN
cord-023095-4dannjjm	6293	13	2	2	CD
cord-023095-4dannjjm	6293	14	horses	horse	NNS
cord-023095-4dannjjm	6293	15	that	that	WDT
cord-023095-4dannjjm	6293	16	were	be	VBD
cord-023095-4dannjjm	6293	17	stabled	stable	VBN
cord-023095-4dannjjm	6293	18	,	,	,
cord-023095-4dannjjm	6293	19	fed	fed	NNP
cord-023095-4dannjjm	6293	20	hay	hay	NN
cord-023095-4dannjjm	6293	21	and	and	CC
cord-023095-4dannjjm	6293	22	sampled	sample	VBN
cord-023095-4dannjjm	6293	23	at	at	IN
cord-023095-4dannjjm	6293	24	post	post	JJ
cord-023095-4dannjjm	6293	25	-	-	JJ
cord-023095-4dannjjm	6293	26	mortem	mortem	JJ
cord-023095-4dannjjm	6293	27	and	and	CC
cord-023095-4dannjjm	6293	28	Cluster	cluster	NN
cord-023095-4dannjjm	6293	29	2	2	CD
cord-023095-4dannjjm	6293	30	consisted	consist	VBD
cord-023095-4dannjjm	6293	31	of	of	IN
cord-023095-4dannjjm	6293	32	4	4	CD
cord-023095-4dannjjm	6293	33	horses	horse	NNS
cord-023095-4dannjjm	6293	34	that	that	WDT
cord-023095-4dannjjm	6293	35	were	be	VBD
cord-023095-4dannjjm	6293	36	pastured	pasture	VBN
cord-023095-4dannjjm	6293	37	on	on	IN
cord-023095-4dannjjm	6293	38	grass	grass	NN
cord-023095-4dannjjm	6293	39	,	,	,
cord-023095-4dannjjm	6293	40	fed	feed	VBD
cord-023095-4dannjjm	6293	41	hay	hay	NN
cord-023095-4dannjjm	6293	42	and	and	CC
cord-023095-4dannjjm	6293	43	biopsied	biopsie	VBD
cord-023095-4dannjjm	6293	44	gastroscopically	gastroscopically	RB
cord-023095-4dannjjm	6293	45	after	after	IN
cord-023095-4dannjjm	6293	46	a	a	DT
cord-023095-4dannjjm	6293	47	12-hour	12-hour	CD
cord-023095-4dannjjm	6293	48	fast	fast	NN
cord-023095-4dannjjm	6293	49	.	.	.
cord-023095-4dannjjm	6294	1	Samples	sample	NNS
cord-023095-4dannjjm	6294	2	from	from	IN
cord-023095-4dannjjm	6294	3	different	different	JJ
cord-023095-4dannjjm	6294	4	antomic	antomic	JJ
cord-023095-4dannjjm	6294	5	regions	region	NNS
cord-023095-4dannjjm	6294	6	clustered	cluster	VBN
cord-023095-4dannjjm	6294	7	by	by	IN
cord-023095-4dannjjm	6294	8	horse	horse	NN
cord-023095-4dannjjm	6294	9	rather	rather	RB
cord-023095-4dannjjm	6294	10	than	than	IN
cord-023095-4dannjjm	6294	11	region	region	NN
cord-023095-4dannjjm	6294	12	.	.	.
cord-023095-4dannjjm	6295	1	Despite	despite	IN
cord-023095-4dannjjm	6295	2	being	be	VBG
cord-023095-4dannjjm	6295	3	very	very	RB
cord-023095-4dannjjm	6295	4	similar	similar	JJ
cord-023095-4dannjjm	6295	5	at	at	IN
cord-023095-4dannjjm	6295	6	the	the	DT
cord-023095-4dannjjm	6295	7	higher	high	JJR
cord-023095-4dannjjm	6295	8	taxonomic	taxonomic	JJ
cord-023095-4dannjjm	6295	9	level	level	NN
cord-023095-4dannjjm	6295	10	(	(	-LRB-
cord-023095-4dannjjm	6295	11	phyla	phylum	NNS
cord-023095-4dannjjm	6295	12	)	)	-RRB-
cord-023095-4dannjjm	6295	13	differences	difference	NNS
cord-023095-4dannjjm	6295	14	in	in	IN
cord-023095-4dannjjm	6295	15	the	the	DT
cord-023095-4dannjjm	6295	16	distribution	distribution	NN
cord-023095-4dannjjm	6295	17	of	of	IN
cord-023095-4dannjjm	6295	18	bacteria	bacteria	NNS
cord-023095-4dannjjm	6295	19	were	be	VBD
cord-023095-4dannjjm	6295	20	seen	see	VBN
cord-023095-4dannjjm	6295	21	at	at	IN
cord-023095-4dannjjm	6295	22	the	the	DT
cord-023095-4dannjjm	6295	23	genus	genus	NN
cord-023095-4dannjjm	6295	24	and	and	CC
cord-023095-4dannjjm	6295	25	species	species	NN
cord-023095-4dannjjm	6295	26	level	level	NN
cord-023095-4dannjjm	6295	27	.	.	.
cord-023095-4dannjjm	6296	1	The	the	DT
cord-023095-4dannjjm	6296	2	dominant	dominant	JJ
cord-023095-4dannjjm	6296	3	bacteria	bacteria	NNS
cord-023095-4dannjjm	6296	4	in	in	IN
cord-023095-4dannjjm	6296	5	Cluster	cluster	NN
cord-023095-4dannjjm	6296	6	1	1	CD
cord-023095-4dannjjm	6296	7	horses	horse	NNS
cord-023095-4dannjjm	6296	8	were	be	VBD
cord-023095-4dannjjm	6296	9	Firmicutes	Firmicutes	NNPS
cord-023095-4dannjjm	6296	10	(	(	-LRB-
cord-023095-4dannjjm	6296	11	483	483	CD
cord-023095-4dannjjm	6296	12	%	%	NN
cord-023095-4dannjjm	6296	13	reads	read	NNS
cord-023095-4dannjjm	6296	14	/	/	SYM
cord-023095-4dannjjm	6296	15	sample	sample	NN
cord-023095-4dannjjm	6296	16	)	)	-RRB-
cord-023095-4dannjjm	6296	17	consisting	consist	VBG
cord-023095-4dannjjm	6296	18	of	of	IN
cord-023095-4dannjjm	6296	19	mainly	mainly	RB
cord-023095-4dannjjm	6296	20	Streptococcus	streptococcus	NN
cord-023095-4dannjjm	6296	21	spp	spp	NNS
cord-023095-4dannjjm	6296	22	.	.	.
cord-023095-4dannjjm	6297	1	,	,	,
cord-023095-4dannjjm	6297	2	Lactobacillus	Lactobacillus	NNP
cord-023095-4dannjjm	6297	3	jensenii	jensenii	NNP
cord-023095-4dannjjm	6297	4	,	,	,
cord-023095-4dannjjm	6297	5	L.	L.	NNP
cord-023095-4dannjjm	6297	6	fornicalis	fornicalis	NNP
cord-023095-4dannjjm	6297	7	and	and	CC
cord-023095-4dannjjm	6297	8	Sarcina	Sarcina	NNP
cord-023095-4dannjjm	6297	9	maxima	maxima	NNP
cord-023095-4dannjjm	6297	10	.	.	.
cord-023095-4dannjjm	6298	1	Cluster	cluster	NN
cord-023095-4dannjjm	6298	2	2	2	CD
cord-023095-4dannjjm	6298	3	had	have	VBD
cord-023095-4dannjjm	6298	4	more	more	JJR
cord-023095-4dannjjm	6298	5	diversity	diversity	NN
cord-023095-4dannjjm	6298	6	with	with	IN
cord-023095-4dannjjm	6298	7	a	a	DT
cord-023095-4dannjjm	6298	8	predominance	predominance	NN
cord-023095-4dannjjm	6298	9	of	of	IN
cord-023095-4dannjjm	6298	10	Proteobacteria	Proteobacteria	NNP
cord-023095-4dannjjm	6298	11	,	,	,
cord-023095-4dannjjm	6298	12	Bacteroidetes	Bacteroidetes	NNPS
cord-023095-4dannjjm	6298	13	and	and	CC
cord-023095-4dannjjm	6298	14	Firmicutes	Firmicutes	NNPS
cord-023095-4dannjjm	6298	15	and	and	CC
cord-023095-4dannjjm	6298	16	51	51	CD
cord-023095-4dannjjm	6298	17	genera	genus	NNS
cord-023095-4dannjjm	6298	18	identified	identify	VBN
cord-023095-4dannjjm	6298	19	such	such	JJ
cord-023095-4dannjjm	6298	20	as	as	IN
cord-023095-4dannjjm	6298	21	Streptococcus	Streptococcus	NNP
cord-023095-4dannjjm	6298	22	spp	spp	NNS
cord-023095-4dannjjm	6298	23	.	.	.
cord-023095-4dannjjm	6299	1	,	,	,
cord-023095-4dannjjm	6299	2	Moraxella	Moraxella	NNP
cord-023095-4dannjjm	6299	3	spp	spp	NNS
cord-023095-4dannjjm	6299	4	.	.	.
cord-023095-4dannjjm	6300	1	,	,	,
cord-023095-4dannjjm	6300	2	Actinobacillus	Actinobacillus	NNP
cord-023095-4dannjjm	6300	3	spp	spp	NNP
cord-023095-4dannjjm	6300	4	.	.	.
cord-023095-4dannjjm	6301	1	,	,	,
cord-023095-4dannjjm	6301	2	and	and	CC
cord-023095-4dannjjm	6301	3	others	other	NNS
cord-023095-4dannjjm	6301	4	.	.	.
cord-023095-4dannjjm	6302	1	Though	though	IN
cord-023095-4dannjjm	6302	2	the	the	DT
cord-023095-4dannjjm	6302	3	relative	relative	JJ
cord-023095-4dannjjm	6302	4	abundance	abundance	NN
cord-023095-4dannjjm	6302	5	of	of	IN
cord-023095-4dannjjm	6302	6	the	the	DT
cord-023095-4dannjjm	6302	7	individual	individual	JJ
cord-023095-4dannjjm	6302	8	taxonomic	taxonomic	JJ
cord-023095-4dannjjm	6302	9	groups	group	NNS
cord-023095-4dannjjm	6302	10	was	be	VBD
cord-023095-4dannjjm	6302	11	significantly	significantly	RB
cord-023095-4dannjjm	6302	12	different	different	JJ
cord-023095-4dannjjm	6302	13	between	between	IN
cord-023095-4dannjjm	6302	14	individual	individual	JJ
cord-023095-4dannjjm	6302	15	horses	horse	NNS
cord-023095-4dannjjm	6302	16	,	,	,
cord-023095-4dannjjm	6302	17	no	no	DT
cord-023095-4dannjjm	6302	18	significant	significant	JJ
cord-023095-4dannjjm	6302	19	differences	difference	NNS
cord-023095-4dannjjm	6302	20	in	in	IN
cord-023095-4dannjjm	6302	21	the	the	DT
cord-023095-4dannjjm	6302	22	overall	overall	JJ
cord-023095-4dannjjm	6302	23	diversity	diversity	NN
cord-023095-4dannjjm	6302	24	could	could	MD
cord-023095-4dannjjm	6302	25	be	be	VB
cord-023095-4dannjjm	6302	26	found	find	VBN
cord-023095-4dannjjm	6302	27	(	(	-LRB-
cord-023095-4dannjjm	6302	28	as	as	IN
cord-023095-4dannjjm	6302	29	assesed	assese	VBN
cord-023095-4dannjjm	6302	30	by	by	IN
cord-023095-4dannjjm	6302	31	Shanon	Shanon	NNP
cord-023095-4dannjjm	6302	32	Weaver	Weaver	NNP
cord-023095-4dannjjm	6302	33	,	,	,
cord-023095-4dannjjm	6302	34	ACE	ACE	NNP
cord-023095-4dannjjm	6302	35	and	and	CC
cord-023095-4dannjjm	6302	36	Choa	Choa	NNP
cord-023095-4dannjjm	6302	37	I	I	NNP
cord-023095-4dannjjm	6302	38	diversity	diversity	NN
cord-023095-4dannjjm	6302	39	indices	index	NNS
cord-023095-4dannjjm	6302	40	)	)	-RRB-
cord-023095-4dannjjm	6302	41	.	.	.
cord-023095-4dannjjm	6303	1	Helicobacter	Helicobacter	NNP
cord-023095-4dannjjm	6303	2	spp	spp	NNS
cord-023095-4dannjjm	6303	3	.	.	.
cord-023095-4dannjjm	6304	1	sequences	sequence	NNS
cord-023095-4dannjjm	6304	2	were	be	VBD
cord-023095-4dannjjm	6304	3	not	not	RB
cord-023095-4dannjjm	6304	4	identified	identify	VBN
cord-023095-4dannjjm	6304	5	in	in	IN
cord-023095-4dannjjm	6304	6	any	any	DT
cord-023095-4dannjjm	6304	7	sample	sample	NN
cord-023095-4dannjjm	6304	8	(	(	-LRB-
cord-023095-4dannjjm	6304	9	out	out	IN
cord-023095-4dannjjm	6304	10	of	of	IN
cord-023095-4dannjjm	6304	11	58,891	58,891	CD
cord-023095-4dannjjm	6304	12	reads	read	NNS
cord-023095-4dannjjm	6304	13	)	)	-RRB-
cord-023095-4dannjjm	6304	14	.	.	.
cord-023095-4dannjjm	6305	1	The	the	DT
cord-023095-4dannjjm	6305	2	ulcerated	ulcerated	JJ
cord-023095-4dannjjm	6305	3	mucosa	mucosa	NN
cord-023095-4dannjjm	6305	4	from	from	IN
cord-023095-4dannjjm	6305	5	Horse	Horse	NNP
cord-023095-4dannjjm	6305	6	3	3	CD
cord-023095-4dannjjm	6305	7	(	(	-LRB-
cord-023095-4dannjjm	6305	8	group	group	NN
cord-023095-4dannjjm	6305	9	1	1	CD
cord-023095-4dannjjm	6305	10	)	)	-RRB-
cord-023095-4dannjjm	6305	11	had	have	VBD
cord-023095-4dannjjm	6305	12	lower	low	JJR
cord-023095-4dannjjm	6305	13	diversity	diversity	NN
cord-023095-4dannjjm	6305	14	and	and	CC
cord-023095-4dannjjm	6305	15	higher	high	JJR
cord-023095-4dannjjm	6305	16	numbers	number	NNS
cord-023095-4dannjjm	6305	17	of	of	IN
cord-023095-4dannjjm	6305	18	bacteria	bacteria	NNS
cord-023095-4dannjjm	6305	19	predominated	predominate	VBN
cord-023095-4dannjjm	6305	20	by	by	IN
cord-023095-4dannjjm	6305	21	Lactobacillus	lactobacillus	NN
cord-023095-4dannjjm	6305	22	equigenerosi	equigenerosi	NN
cord-023095-4dannjjm	6305	23	.	.	.
cord-023095-4dannjjm	6306	1	This	this	DT
cord-023095-4dannjjm	6306	2	data	data	NN
cord-023095-4dannjjm	6306	3	shows	show	VBZ
cord-023095-4dannjjm	6306	4	that	that	IN
cord-023095-4dannjjm	6306	5	the	the	DT
cord-023095-4dannjjm	6306	6	equine	equine	JJ
cord-023095-4dannjjm	6306	7	gastric	gastric	JJ
cord-023095-4dannjjm	6306	8	mucosa	mucosa	JJ
cord-023095-4dannjjm	6306	9	harbors	harbor	VBZ
cord-023095-4dannjjm	6306	10	an	an	DT
cord-023095-4dannjjm	6306	11	abundant	abundant	JJ
cord-023095-4dannjjm	6306	12	and	and	CC
cord-023095-4dannjjm	6306	13	diverse	diverse	JJ
cord-023095-4dannjjm	6306	14	microbiome	microbiome	NN
cord-023095-4dannjjm	6306	15	which	which	WDT
cord-023095-4dannjjm	6306	16	is	be	VBZ
cord-023095-4dannjjm	6306	17	unique	unique	JJ
cord-023095-4dannjjm	6306	18	to	to	IN
cord-023095-4dannjjm	6306	19	each	each	DT
cord-023095-4dannjjm	6306	20	individual	individual	NN
cord-023095-4dannjjm	6306	21	and	and	CC
cord-023095-4dannjjm	6306	22	differs	differ	VBZ
cord-023095-4dannjjm	6306	23	by	by	IN
cord-023095-4dannjjm	6306	24	sampling	sampling	NN
cord-023095-4dannjjm	6306	25	method	method	NN
cord-023095-4dannjjm	6306	26	,	,	,
cord-023095-4dannjjm	6306	27	fasting	fast	VBG
cord-023095-4dannjjm	6306	28	prior	prior	RB
cord-023095-4dannjjm	6306	29	to	to	IN
cord-023095-4dannjjm	6306	30	sampling	sampling	NN
cord-023095-4dannjjm	6306	31	and	and	CC
cord-023095-4dannjjm	6306	32	diet	diet	NN
cord-023095-4dannjjm	6306	33	.	.	.
cord-023095-4dannjjm	6307	1	Seasonal	seasonal	JJ
cord-023095-4dannjjm	6307	2	pasture	pasture	NN
cord-023095-4dannjjm	6307	3	myopathy	myopathy	NN
cord-023095-4dannjjm	6307	4	(	(	-LRB-
cord-023095-4dannjjm	6307	5	SPM	SPM	NNP
cord-023095-4dannjjm	6307	6	;	;	,
cord-023095-4dannjjm	6307	7	atypical	atypical	JJ
cord-023095-4dannjjm	6307	8	myopathy	myopathy	NN
cord-023095-4dannjjm	6307	9	[	[	-LRB-
cord-023095-4dannjjm	6307	10	AM	am	NN
cord-023095-4dannjjm	6307	11	]	]	-RRB-
cord-023095-4dannjjm	6307	12	in	in	IN
cord-023095-4dannjjm	6307	13	Europe	Europe	NNP
cord-023095-4dannjjm	6307	14	)	)	-RRB-
cord-023095-4dannjjm	6307	15	,	,	,
cord-023095-4dannjjm	6307	16	typified	typify	VBN
cord-023095-4dannjjm	6307	17	by	by	IN
cord-023095-4dannjjm	6307	18	nonexertional	nonexertional	JJ
cord-023095-4dannjjm	6307	19	rhabdomyolysis	rhabdomyolysis	NN
cord-023095-4dannjjm	6307	20	,	,	,
cord-023095-4dannjjm	6307	21	occurs	occur	VBZ
cord-023095-4dannjjm	6307	22	in	in	IN
cord-023095-4dannjjm	6307	23	pastured	pastured	JJ
cord-023095-4dannjjm	6307	24	horses	horse	NNS
cord-023095-4dannjjm	6307	25	during	during	IN
cord-023095-4dannjjm	6307	26	autumn	autumn	NN
cord-023095-4dannjjm	6307	27	or	or	CC
cord-023095-4dannjjm	6307	28	spring	spring	NN
cord-023095-4dannjjm	6307	29	.	.	.
cord-023095-4dannjjm	6308	1	Clinical	clinical	JJ
cord-023095-4dannjjm	6308	2	signs	sign	NNS
cord-023095-4dannjjm	6308	3	rapidly	rapidly	RB
cord-023095-4dannjjm	6308	4	progress	progress	VBP
cord-023095-4dannjjm	6308	5	from	from	IN
cord-023095-4dannjjm	6308	6	muscular	muscular	JJ
cord-023095-4dannjjm	6308	7	weakness	weakness	NN
cord-023095-4dannjjm	6308	8	to	to	IN
cord-023095-4dannjjm	6308	9	recumbency	recumbency	NN
cord-023095-4dannjjm	6308	10	and	and	CC
cord-023095-4dannjjm	6308	11	frequently	frequently	RB
cord-023095-4dannjjm	6308	12	death	death	NN
cord-023095-4dannjjm	6308	13	.	.	.
cord-023095-4dannjjm	6309	1	Extensive	extensive	JJ
cord-023095-4dannjjm	6309	2	myonecrosis	myonecrosis	NN
cord-023095-4dannjjm	6309	3	and	and	CC
cord-023095-4dannjjm	6309	4	intramyofiber	intramyofiber	NN
cord-023095-4dannjjm	6309	5	lipid	lipid	NN
cord-023095-4dannjjm	6309	6	storage	storage	NN
cord-023095-4dannjjm	6309	7	occur	occur	VBP
cord-023095-4dannjjm	6309	8	in	in	IN
cord-023095-4dannjjm	6309	9	highly	highly	RB
cord-023095-4dannjjm	6309	10	oxidative	oxidative	JJ
cord-023095-4dannjjm	6309	11	respiratory	respiratory	JJ
cord-023095-4dannjjm	6309	12	and	and	CC
cord-023095-4dannjjm	6309	13	postural	postural	JJ
cord-023095-4dannjjm	6309	14	muscles	muscle	NNS
cord-023095-4dannjjm	6309	15	.	.	.
cord-023095-4dannjjm	6310	1	Recently	recently	RB
cord-023095-4dannjjm	6310	2	,	,	,
cord-023095-4dannjjm	6310	3	a	a	DT
cord-023095-4dannjjm	6310	4	defect	defect	NN
cord-023095-4dannjjm	6310	5	of	of	IN
cord-023095-4dannjjm	6310	6	lipid	lipid	NN
cord-023095-4dannjjm	6310	7	metabolism	metabolism	NN
cord-023095-4dannjjm	6310	8	called	call	VBN
cord-023095-4dannjjm	6310	9	MADD	MADD	NNP
cord-023095-4dannjjm	6310	10	has	have	VBZ
cord-023095-4dannjjm	6310	11	been	be	VBN
cord-023095-4dannjjm	6310	12	identified	identify	VBN
cord-023095-4dannjjm	6310	13	in	in	IN
cord-023095-4dannjjm	6310	14	European	european	JJ
cord-023095-4dannjjm	6310	15	horses	horse	NNS
cord-023095-4dannjjm	6310	16	with	with	IN
cord-023095-4dannjjm	6310	17	AM	AM	NNP
cord-023095-4dannjjm	6310	18	.	.	.
cord-023095-4dannjjm	6311	1	This	this	DT
cord-023095-4dannjjm	6311	2	report	report	NN
cord-023095-4dannjjm	6311	3	documents	document	VBZ
cord-023095-4dannjjm	6311	4	the	the	DT
cord-023095-4dannjjm	6311	5	first	first	JJ
cord-023095-4dannjjm	6311	6	cases	case	NNS
cord-023095-4dannjjm	6311	7	of	of	IN
cord-023095-4dannjjm	6311	8	equine	equine	NN
cord-023095-4dannjjm	6311	9	MADD	MADD	NNP
cord-023095-4dannjjm	6311	10	in	in	IN
cord-023095-4dannjjm	6311	11	the	the	DT
cord-023095-4dannjjm	6311	12	United	United	NNP
cord-023095-4dannjjm	6311	13	States	States	NNP
cord-023095-4dannjjm	6311	14	.	.	.
cord-023095-4dannjjm	6312	1	Six	six	CD
cord-023095-4dannjjm	6312	2	Midwestern	midwestern	JJ
cord-023095-4dannjjm	6312	3	US	US	NNP
cord-023095-4dannjjm	6312	4	horses	horse	NNS
cord-023095-4dannjjm	6312	5	suspected	suspect	VBN
cord-023095-4dannjjm	6312	6	of	of	IN
cord-023095-4dannjjm	6312	7	having	have	VBG
cord-023095-4dannjjm	6312	8	SPM	SPM	NNP
cord-023095-4dannjjm	6312	9	in	in	IN
cord-023095-4dannjjm	6312	10	the	the	DT
cord-023095-4dannjjm	6312	11	spring	spring	NN
cord-023095-4dannjjm	6312	12	or	or	CC
cord-023095-4dannjjm	6312	13	fall	fall	NN
cord-023095-4dannjjm	6312	14	of	of	IN
cord-023095-4dannjjm	6312	15	2009	2009	CD
cord-023095-4dannjjm	6312	16	were	be	VBD
cord-023095-4dannjjm	6312	17	evaluated	evaluate	VBN
cord-023095-4dannjjm	6312	18	for	for	IN
cord-023095-4dannjjm	6312	19	MADD	MADD	NNP
cord-023095-4dannjjm	6312	20	by	by	IN
cord-023095-4dannjjm	6312	21	urine	urine	NN
cord-023095-4dannjjm	6312	22	organic	organic	JJ
cord-023095-4dannjjm	6312	23	acids	acid	NNS
cord-023095-4dannjjm	6312	24	,	,	,
cord-023095-4dannjjm	6312	25	plasma	plasma	NN
cord-023095-4dannjjm	6312	26	acylcarnitines	acylcarnitine	NNS
cord-023095-4dannjjm	6312	27	and/or	and/or	CC
cord-023095-4dannjjm	6312	28	muscle	muscle	NN
cord-023095-4dannjjm	6312	29	carnitine	carnitine	NN
cord-023095-4dannjjm	6312	30	and	and	CC
cord-023095-4dannjjm	6312	31	histopathology	histopathology	NN
cord-023095-4dannjjm	6312	32	.	.	.
cord-023095-4dannjjm	6313	1	Five	five	CD
cord-023095-4dannjjm	6313	2	horses	horse	NNS
cord-023095-4dannjjm	6313	3	had	have	VBD
cord-023095-4dannjjm	6313	4	clinical	clinical	JJ
cord-023095-4dannjjm	6313	5	signs	sign	NNS
cord-023095-4dannjjm	6313	6	and	and	CC
cord-023095-4dannjjm	6313	7	clinicopathologic	clinicopathologic	NNP
cord-023095-4dannjjm	6313	8	data	datum	NNS
cord-023095-4dannjjm	6313	9	consistent	consistent	JJ
cord-023095-4dannjjm	6313	10	with	with	IN
cord-023095-4dannjjm	6313	11	severe	severe	JJ
cord-023095-4dannjjm	6313	12	rhabdomyolysis	rhabdomyolysis	NN
cord-023095-4dannjjm	6313	13	.	.	.
cord-023095-4dannjjm	6314	1	One	one	CD
cord-023095-4dannjjm	6314	2	horse	horse	NN
cord-023095-4dannjjm	6314	3	was	be	VBD
cord-023095-4dannjjm	6314	4	found	find	VBN
cord-023095-4dannjjm	6314	5	dead	dead	JJ
cord-023095-4dannjjm	6314	6	on	on	IN
cord-023095-4dannjjm	6314	7	pasture	pasture	NN
cord-023095-4dannjjm	6314	8	after	after	IN
cord-023095-4dannjjm	6314	9	2	2	CD
cord-023095-4dannjjm	6314	10	days	day	NNS
cord-023095-4dannjjm	6314	11	of	of	IN
cord-023095-4dannjjm	6314	12	rear	rear	JJ
cord-023095-4dannjjm	6314	13	limb	limb	NN
cord-023095-4dannjjm	6314	14	stiffness	stiffness	NN
cord-023095-4dannjjm	6314	15	and	and	CC
cord-023095-4dannjjm	6314	16	inappetance	inappetance	NN
cord-023095-4dannjjm	6314	17	.	.	.
cord-023095-4dannjjm	6315	1	Urinary	urinary	JJ
cord-023095-4dannjjm	6315	2	organic	organic	JJ
cord-023095-4dannjjm	6315	3	acid	acid	NN
cord-023095-4dannjjm	6315	4	profiles	profile	NNS
cord-023095-4dannjjm	6315	5	revealed	reveal	VBD
cord-023095-4dannjjm	6315	6	markedly	markedly	RB
cord-023095-4dannjjm	6315	7	elevated	elevate	VBN
cord-023095-4dannjjm	6315	8	ethylmalonic	ethylmalonic	JJ
cord-023095-4dannjjm	6315	9	and	and	CC
cord-023095-4dannjjm	6315	10	methylsuccinic	methylsuccinic	JJ
cord-023095-4dannjjm	6315	11	acids	acid	NNS
cord-023095-4dannjjm	6315	12	,	,	,
cord-023095-4dannjjm	6315	13	butyrylglycine	butyrylglycine	NNP
cord-023095-4dannjjm	6315	14	,	,	,
cord-023095-4dannjjm	6315	15	isovalerylglycine	isovalerylglycine	NNP
cord-023095-4dannjjm	6315	16	,	,	,
cord-023095-4dannjjm	6315	17	and	and	CC
cord-023095-4dannjjm	6315	18	hexanoylglycine	hexanoylglycine	NN
cord-023095-4dannjjm	6315	19	,	,	,
cord-023095-4dannjjm	6315	20	consistent	consistent	JJ
cord-023095-4dannjjm	6315	21	with	with	IN
cord-023095-4dannjjm	6315	22	equine	equine	JJ
cord-023095-4dannjjm	6315	23	MADD	MADD	NNP
cord-023095-4dannjjm	6315	24	.	.	.
cord-023095-4dannjjm	6316	1	Plasma	plasma	NN
cord-023095-4dannjjm	6316	2	acylcarnitine	acylcarnitine	NN
cord-023095-4dannjjm	6316	3	profiles	profile	NNS
cord-023095-4dannjjm	6316	4	from	from	IN
cord-023095-4dannjjm	6316	5	2	2	CD
cord-023095-4dannjjm	6316	6	horses	horse	NNS
cord-023095-4dannjjm	6316	7	had	have	VBD
cord-023095-4dannjjm	6316	8	marked	mark	VBN
cord-023095-4dannjjm	6316	9	elevations	elevation	NNS
cord-023095-4dannjjm	6316	10	of	of	IN
cord-023095-4dannjjm	6316	11	short	short	JJ
cord-023095-4dannjjm	6316	12	chain	chain	NN
cord-023095-4dannjjm	6316	13	acylcarnitines	acylcarnitine	NNS
cord-023095-4dannjjm	6316	14	,	,	,
cord-023095-4dannjjm	6316	15	while	while	IN
cord-023095-4dannjjm	6316	16	the	the	DT
cord-023095-4dannjjm	6316	17	third	third	JJ
cord-023095-4dannjjm	6316	18	horse	horse	NN
cord-023095-4dannjjm	6316	19	and	and	CC
cord-023095-4dannjjm	6316	20	only	only	JJ
cord-023095-4dannjjm	6316	21	survivor	survivor	NN
cord-023095-4dannjjm	6316	22	had	have	VBD
cord-023095-4dannjjm	6316	23	minor	minor	JJ
cord-023095-4dannjjm	6316	24	elevations	elevation	NNS
cord-023095-4dannjjm	6316	25	of	of	IN
cord-023095-4dannjjm	6316	26	short	short	JJ
cord-023095-4dannjjm	6316	27	chain	chain	NN
cord-023095-4dannjjm	6316	28	acylcarnitines	acylcarnitine	NNS
cord-023095-4dannjjm	6316	29	.	.	.
cord-023095-4dannjjm	6317	1	Affected	affected	JJ
cord-023095-4dannjjm	6317	2	muscle	muscle	NN
cord-023095-4dannjjm	6317	3	showed	show	VBD
cord-023095-4dannjjm	6317	4	extensive	extensive	JJ
cord-023095-4dannjjm	6317	5	degeneration	degeneration	NN
cord-023095-4dannjjm	6317	6	with	with	IN
cord-023095-4dannjjm	6317	7	intramyofiber	intramyofiber	NNP
cord-023095-4dannjjm	6317	8	lipid	lipid	NN
cord-023095-4dannjjm	6317	9	accumulation	accumulation	NN
cord-023095-4dannjjm	6317	10	,	,	,
cord-023095-4dannjjm	6317	11	a	a	DT
cord-023095-4dannjjm	6317	12	marked	marked	JJ
cord-023095-4dannjjm	6317	13	decrease	decrease	NN
cord-023095-4dannjjm	6317	14	in	in	IN
cord-023095-4dannjjm	6317	15	free	free	JJ
cord-023095-4dannjjm	6317	16	carnitine	carnitine	NN
cord-023095-4dannjjm	6317	17	,	,	,
cord-023095-4dannjjm	6317	18	and	and	CC
cord-023095-4dannjjm	6317	19	high	high	JJ
cord-023095-4dannjjm	6317	20	levels	level	NNS
cord-023095-4dannjjm	6317	21	of	of	IN
cord-023095-4dannjjm	6317	22	carnitine	carnitine	NN
cord-023095-4dannjjm	6317	23	esters	ester	NNS
cord-023095-4dannjjm	6317	24	.	.	.
cord-023095-4dannjjm	6318	1	SPM	SPM	NNP
cord-023095-4dannjjm	6318	2	appears	appear	VBZ
cord-023095-4dannjjm	6318	3	to	to	TO
cord-023095-4dannjjm	6318	4	be	be	VB
cord-023095-4dannjjm	6318	5	a	a	DT
cord-023095-4dannjjm	6318	6	highly	highly	RB
cord-023095-4dannjjm	6318	7	fatal	fatal	JJ
cord-023095-4dannjjm	6318	8	emerging	emerge	VBG
cord-023095-4dannjjm	6318	9	disease	disease	NN
cord-023095-4dannjjm	6318	10	of	of	IN
cord-023095-4dannjjm	6318	11	pastured	pastured	JJ
cord-023095-4dannjjm	6318	12	horses	horse	NNS
cord-023095-4dannjjm	6318	13	in	in	IN
cord-023095-4dannjjm	6318	14	the	the	DT
cord-023095-4dannjjm	6318	15	US	US	NNP
cord-023095-4dannjjm	6318	16	characterized	characterize	VBN
cord-023095-4dannjjm	6318	17	by	by	IN
cord-023095-4dannjjm	6318	18	weakness	weakness	NN
cord-023095-4dannjjm	6318	19	,	,	,
cord-023095-4dannjjm	6318	20	colic	colic	NN
cord-023095-4dannjjm	6318	21	-	-	HYPH
cord-023095-4dannjjm	6318	22	like	like	JJ
cord-023095-4dannjjm	6318	23	signs	sign	NNS
cord-023095-4dannjjm	6318	24	and	and	CC
cord-023095-4dannjjm	6318	25	myoglobinuria	myoglobinuria	NNS
cord-023095-4dannjjm	6318	26	.	.	.
cord-023095-4dannjjm	6319	1	The	the	DT
cord-023095-4dannjjm	6319	2	disease	disease	NN
cord-023095-4dannjjm	6319	3	is	be	VBZ
cord-023095-4dannjjm	6319	4	associated	associate	VBN
cord-023095-4dannjjm	6319	5	with	with	IN
cord-023095-4dannjjm	6319	6	a	a	DT
cord-023095-4dannjjm	6319	7	defect	defect	NN
cord-023095-4dannjjm	6319	8	in	in	IN
cord-023095-4dannjjm	6319	9	muscular	muscular	JJ
cord-023095-4dannjjm	6319	10	lipid	lipid	NN
cord-023095-4dannjjm	6319	11	metabolism	metabolism	NN
cord-023095-4dannjjm	6319	12	that	that	WDT
cord-023095-4dannjjm	6319	13	can	can	MD
cord-023095-4dannjjm	6319	14	be	be	VB
cord-023095-4dannjjm	6319	15	diagnosed	diagnose	VBN
cord-023095-4dannjjm	6319	16	by	by	IN
cord-023095-4dannjjm	6319	17	performing	perform	VBG
cord-023095-4dannjjm	6319	18	lipid	lipid	NN
cord-023095-4dannjjm	6319	19	staining	staining	NN
cord-023095-4dannjjm	6319	20	of	of	IN
cord-023095-4dannjjm	6319	21	muscle	muscle	NN
cord-023095-4dannjjm	6319	22	samples	sample	NNS
cord-023095-4dannjjm	6319	23	and	and	CC
cord-023095-4dannjjm	6319	24	urine	urine	VB
cord-023095-4dannjjm	6319	25	organic	organic	JJ
cord-023095-4dannjjm	6319	26	acid	acid	NN
cord-023095-4dannjjm	6319	27	profiles	profile	NNS
cord-023095-4dannjjm	6319	28	.	.	.
cord-023095-4dannjjm	6320	1	Candidatus	Candidatus	NNP
cord-023095-4dannjjm	6320	2	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	6320	3	haemolamae	haemolamae	NN
cord-023095-4dannjjm	6320	4	(	(	-LRB-
cord-023095-4dannjjm	6320	5	CMhl	CMhl	NNP
cord-023095-4dannjjm	6320	6	)	)	-RRB-
cord-023095-4dannjjm	6320	7	is	be	VBZ
cord-023095-4dannjjm	6320	8	a	a	DT
cord-023095-4dannjjm	6320	9	common	common	JJ
cord-023095-4dannjjm	6320	10	red	red	JJ
cord-023095-4dannjjm	6320	11	blood	blood	NN
cord-023095-4dannjjm	6320	12	cell	cell	NN
cord-023095-4dannjjm	6320	13	parasite	parasite	NN
cord-023095-4dannjjm	6320	14	of	of	IN
cord-023095-4dannjjm	6320	15	new	new	JJ
cord-023095-4dannjjm	6320	16	world	world	NN
cord-023095-4dannjjm	6320	17	camelids	camelid	NNS
cord-023095-4dannjjm	6320	18	.	.	.
cord-023095-4dannjjm	6321	1	The	the	DT
cord-023095-4dannjjm	6321	2	high	high	JJ
cord-023095-4dannjjm	6321	3	degree	degree	NN
cord-023095-4dannjjm	6321	4	of	of	IN
cord-023095-4dannjjm	6321	5	parasitemia	parasitemia	NN
cord-023095-4dannjjm	6321	6	that	that	WDT
cord-023095-4dannjjm	6321	7	develops	develop	VBZ
cord-023095-4dannjjm	6321	8	in	in	IN
cord-023095-4dannjjm	6321	9	an	an	DT
cord-023095-4dannjjm	6321	10	infected	infected	JJ
cord-023095-4dannjjm	6321	11	splenectomized	splenectomize	VBN
cord-023095-4dannjjm	6321	12	animal	animal	NN
cord-023095-4dannjjm	6321	13	allows	allow	VBZ
cord-023095-4dannjjm	6321	14	for	for	IN
cord-023095-4dannjjm	6321	15	the	the	DT
cord-023095-4dannjjm	6321	16	efficient	efficient	JJ
cord-023095-4dannjjm	6321	17	collection	collection	NN
cord-023095-4dannjjm	6321	18	of	of	IN
cord-023095-4dannjjm	6321	19	parasitic	parasitic	JJ
cord-023095-4dannjjm	6321	20	DNA	dna	NN
cord-023095-4dannjjm	6321	21	.	.	.
cord-023095-4dannjjm	6322	1	This	this	DT
cord-023095-4dannjjm	6322	2	DNA	dna	NN
cord-023095-4dannjjm	6322	3	can	can	MD
cord-023095-4dannjjm	6322	4	then	then	RB
cord-023095-4dannjjm	6322	5	be	be	VB
cord-023095-4dannjjm	6322	6	used	use	VBN
cord-023095-4dannjjm	6322	7	in	in	IN
cord-023095-4dannjjm	6322	8	the	the	DT
cord-023095-4dannjjm	6322	9	development	development	NN
cord-023095-4dannjjm	6322	10	of	of	IN
cord-023095-4dannjjm	6322	11	genetically	genetically	RB
cord-023095-4dannjjm	6322	12	-	-	HYPH
cord-023095-4dannjjm	6322	13	derived	derive	VBN
cord-023095-4dannjjm	6322	14	tools	tool	NNS
cord-023095-4dannjjm	6322	15	such	such	JJ
cord-023095-4dannjjm	6322	16	as	as	IN
cord-023095-4dannjjm	6322	17	PCR	PCR	NNP
cord-023095-4dannjjm	6322	18	and	and	CC
cord-023095-4dannjjm	6322	19	in	in	IN
cord-023095-4dannjjm	6322	20	-	-	HYPH
cord-023095-4dannjjm	6322	21	situ	situ	NN
cord-023095-4dannjjm	6322	22	hybridization	hybridization	NN
cord-023095-4dannjjm	6322	23	.	.	.
cord-023095-4dannjjm	6323	1	Thus	thus	RB
cord-023095-4dannjjm	6323	2	,	,	,
cord-023095-4dannjjm	6323	3	one	one	CD
cord-023095-4dannjjm	6323	4	splenectomized	splenectomize	VBN
cord-023095-4dannjjm	6323	5	animal	animal	NN
cord-023095-4dannjjm	6323	6	can	can	MD
cord-023095-4dannjjm	6323	7	replace	replace	VB
cord-023095-4dannjjm	6323	8	many	many	JJ
cord-023095-4dannjjm	6323	9	immunologically	immunologically	RB
cord-023095-4dannjjm	6323	10	intact	intact	JJ
cord-023095-4dannjjm	6323	11	animals	animal	NNS
cord-023095-4dannjjm	6323	12	within	within	IN
cord-023095-4dannjjm	6323	13	a	a	DT
cord-023095-4dannjjm	6323	14	research	research	NN
cord-023095-4dannjjm	6323	15	setting	setting	NN
cord-023095-4dannjjm	6323	16	.	.	.
cord-023095-4dannjjm	6324	1	The	the	DT
cord-023095-4dannjjm	6324	2	purpose	purpose	NN
cord-023095-4dannjjm	6324	3	of	of	IN
cord-023095-4dannjjm	6324	4	this	this	DT
cord-023095-4dannjjm	6324	5	study	study	NN
cord-023095-4dannjjm	6324	6	was	be	VBD
cord-023095-4dannjjm	6324	7	to	to	TO
cord-023095-4dannjjm	6324	8	track	track	VB
cord-023095-4dannjjm	6324	9	the	the	DT
cord-023095-4dannjjm	6324	10	natural	natural	JJ
cord-023095-4dannjjm	6324	11	progression	progression	NN
cord-023095-4dannjjm	6324	12	of	of	IN
cord-023095-4dannjjm	6324	13	CMhl	CMhl	NNP
cord-023095-4dannjjm	6324	14	parasitemia	parasitemia	NNP
cord-023095-4dannjjm	6324	15	and	and	CC
cord-023095-4dannjjm	6324	16	associated	associate	VBD
cord-023095-4dannjjm	6324	17	clinical	clinical	JJ
cord-023095-4dannjjm	6324	18	signs	sign	NNS
cord-023095-4dannjjm	6324	19	in	in	IN
cord-023095-4dannjjm	6324	20	a	a	DT
cord-023095-4dannjjm	6324	21	splenectomized	splenectomized	JJ
cord-023095-4dannjjm	6324	22	alpaca	alpaca	NN
cord-023095-4dannjjm	6324	23	.	.	.
cord-023095-4dannjjm	6325	1	An	an	DT
cord-023095-4dannjjm	6325	2	intact	intact	JJ
cord-023095-4dannjjm	6325	3	,	,	,
cord-023095-4dannjjm	6325	4	9-month	9-month	JJ
cord-023095-4dannjjm	6325	5	-	-	HYPH
cord-023095-4dannjjm	6325	6	old	old	JJ
cord-023095-4dannjjm	6325	7	,	,	,
cord-023095-4dannjjm	6325	8	39.1	39.1	CD
cord-023095-4dannjjm	6325	9	kg	kg	NN
cord-023095-4dannjjm	6325	10	male	male	JJ
cord-023095-4dannjjm	6325	11	alpaca	alpaca	NN
cord-023095-4dannjjm	6325	12	was	be	VBD
cord-023095-4dannjjm	6325	13	used	use	VBN
cord-023095-4dannjjm	6325	14	in	in	IN
cord-023095-4dannjjm	6325	15	this	this	DT
cord-023095-4dannjjm	6325	16	study	study	NN
cord-023095-4dannjjm	6325	17	.	.	.
cord-023095-4dannjjm	6326	1	He	-PRON-	PRP
cord-023095-4dannjjm	6326	2	had	have	VBD
cord-023095-4dannjjm	6326	3	tested	test	VBN
cord-023095-4dannjjm	6326	4	positive	positive	JJ
cord-023095-4dannjjm	6326	5	via	via	IN
cord-023095-4dannjjm	6326	6	PCR	PCR	NNP
cord-023095-4dannjjm	6326	7	for	for	IN
cord-023095-4dannjjm	6326	8	CMhl	CMhl	NNP
cord-023095-4dannjjm	6326	9	on	on	IN
cord-023095-4dannjjm	6326	10	three	three	CD
cord-023095-4dannjjm	6326	11	different	different	JJ
cord-023095-4dannjjm	6326	12	occasions	occasion	NNS
cord-023095-4dannjjm	6326	13	,	,	,
cord-023095-4dannjjm	6326	14	although	although	IN
cord-023095-4dannjjm	6326	15	no	no	DT
cord-023095-4dannjjm	6326	16	organisms	organism	NNS
cord-023095-4dannjjm	6326	17	were	be	VBD
cord-023095-4dannjjm	6326	18	seen	see	VBN
cord-023095-4dannjjm	6326	19	on	on	IN
cord-023095-4dannjjm	6326	20	peripheral	peripheral	JJ
cord-023095-4dannjjm	6326	21	blood	blood	NN
cord-023095-4dannjjm	6326	22	smears	smear	NNS
cord-023095-4dannjjm	6326	23	.	.	.
cord-023095-4dannjjm	6327	1	The	the	DT
cord-023095-4dannjjm	6327	2	alpaca	alpaca	NN
cord-023095-4dannjjm	6327	3	was	be	VBD
cord-023095-4dannjjm	6327	4	placed	place	VBN
cord-023095-4dannjjm	6327	5	under	under	IN
cord-023095-4dannjjm	6327	6	general	general	JJ
cord-023095-4dannjjm	6327	7	anesthesia	anesthesia	NN
cord-023095-4dannjjm	6327	8	and	and	CC
cord-023095-4dannjjm	6327	9	a	a	DT
cord-023095-4dannjjm	6327	10	ventral	ventral	JJ
cord-023095-4dannjjm	6327	11	midline	midline	JJ
cord-023095-4dannjjm	6327	12	incision	incision	NN
cord-023095-4dannjjm	6327	13	was	be	VBD
cord-023095-4dannjjm	6327	14	made	make	VBN
cord-023095-4dannjjm	6327	15	.	.	.
cord-023095-4dannjjm	6328	1	The	the	DT
cord-023095-4dannjjm	6328	2	spleen	spleen	NN
cord-023095-4dannjjm	6328	3	was	be	VBD
cord-023095-4dannjjm	6328	4	located	locate	VBN
cord-023095-4dannjjm	6328	5	,	,	,
cord-023095-4dannjjm	6328	6	the	the	DT
cord-023095-4dannjjm	6328	7	vessels	vessel	NNS
cord-023095-4dannjjm	6328	8	ligated	ligate	VBN
cord-023095-4dannjjm	6328	9	,	,	,
cord-023095-4dannjjm	6328	10	and	and	CC
cord-023095-4dannjjm	6328	11	the	the	DT
cord-023095-4dannjjm	6328	12	organ	organ	NN
cord-023095-4dannjjm	6328	13	removed	remove	VBN
cord-023095-4dannjjm	6328	14	.	.	.
cord-023095-4dannjjm	6329	1	Buprenorphine	Buprenorphine	NNP
cord-023095-4dannjjm	6329	2	and	and	CC
cord-023095-4dannjjm	6329	3	flunixin	flunixin	NNP
cord-023095-4dannjjm	6329	4	meglumine	meglumine	NNP
cord-023095-4dannjjm	6329	5	were	be	VBD
cord-023095-4dannjjm	6329	6	given	give	VBN
cord-023095-4dannjjm	6329	7	for	for	IN
cord-023095-4dannjjm	6329	8	2	2	CD
cord-023095-4dannjjm	6329	9	and	and	CC
cord-023095-4dannjjm	6329	10	4	4	CD
cord-023095-4dannjjm	6329	11	days	day	NNS
cord-023095-4dannjjm	6329	12	after	after	IN
cord-023095-4dannjjm	6329	13	surgery	surgery	NN
cord-023095-4dannjjm	6329	14	respectively	respectively	RB
cord-023095-4dannjjm	6329	15	.	.	.
cord-023095-4dannjjm	6330	1	Body	body	NN
cord-023095-4dannjjm	6330	2	weight	weight	NN
cord-023095-4dannjjm	6330	3	,	,	,
cord-023095-4dannjjm	6330	4	attitude	attitude	NN
cord-023095-4dannjjm	6330	5	,	,	,
cord-023095-4dannjjm	6330	6	rectal	rectal	JJ
cord-023095-4dannjjm	6330	7	temperature	temperature	NN
cord-023095-4dannjjm	6330	8	,	,	,
cord-023095-4dannjjm	6330	9	blood	blood	NN
cord-023095-4dannjjm	6330	10	glucose	glucose	NN
cord-023095-4dannjjm	6330	11	,	,	,
cord-023095-4dannjjm	6330	12	and	and	CC
cord-023095-4dannjjm	6330	13	PCV	PCV	NNP
cord-023095-4dannjjm	6330	14	were	be	VBD
cord-023095-4dannjjm	6330	15	recorded	record	VBN
cord-023095-4dannjjm	6330	16	daily	daily	RB
cord-023095-4dannjjm	6330	17	.	.	.
cord-023095-4dannjjm	6331	1	In	in	IN
cord-023095-4dannjjm	6331	2	addition	addition	NN
cord-023095-4dannjjm	6331	3	,	,	,
cord-023095-4dannjjm	6331	4	a	a	DT
cord-023095-4dannjjm	6331	5	peripheral	peripheral	JJ
cord-023095-4dannjjm	6331	6	blood	blood	NN
cord-023095-4dannjjm	6331	7	smear	smear	NN
cord-023095-4dannjjm	6331	8	was	be	VBD
cord-023095-4dannjjm	6331	9	examined	examine	VBN
cord-023095-4dannjjm	6331	10	daily	daily	RB
cord-023095-4dannjjm	6331	11	and	and	CC
cord-023095-4dannjjm	6331	12	the	the	DT
cord-023095-4dannjjm	6331	13	percent	percent	NN
cord-023095-4dannjjm	6331	14	of	of	IN
cord-023095-4dannjjm	6331	15	red	red	JJ
cord-023095-4dannjjm	6331	16	blood	blood	NN
cord-023095-4dannjjm	6331	17	cells	cell	NNS
cord-023095-4dannjjm	6331	18	that	that	WDT
cord-023095-4dannjjm	6331	19	were	be	VBD
cord-023095-4dannjjm	6331	20	infected	infect	VBN
cord-023095-4dannjjm	6331	21	with	with	IN
cord-023095-4dannjjm	6331	22	Mycoplasma	mycoplasma	NN
cord-023095-4dannjjm	6331	23	organisms	organism	NNS
cord-023095-4dannjjm	6331	24	was	be	VBD
cord-023095-4dannjjm	6331	25	determined	determine	VBN
cord-023095-4dannjjm	6331	26	.	.	.
cord-023095-4dannjjm	6332	1	The	the	DT
cord-023095-4dannjjm	6332	2	alpaca	alpaca	NN
cord-023095-4dannjjm	6332	3	was	be	VBD
cord-023095-4dannjjm	6332	4	not	not	RB
cord-023095-4dannjjm	6332	5	parasitemic	parasitemic	NNP
cord-023095-4dannjjm	6332	6	prior	prior	RB
cord-023095-4dannjjm	6332	7	to	to	IN
cord-023095-4dannjjm	6332	8	surgery	surgery	NN
cord-023095-4dannjjm	6332	9	.	.	.
cord-023095-4dannjjm	6333	1	One	one	CD
cord-023095-4dannjjm	6333	2	percent	percent	NN
cord-023095-4dannjjm	6333	3	of	of	IN
cord-023095-4dannjjm	6333	4	the	the	DT
cord-023095-4dannjjm	6333	5	RBC	RBC	NNP
cord-023095-4dannjjm	6333	6	's	's	POS
cord-023095-4dannjjm	6333	7	contained	contain	VBD
cord-023095-4dannjjm	6333	8	mycoplasma	mycoplasma	NN
cord-023095-4dannjjm	6333	9	on	on	IN
cord-023095-4dannjjm	6333	10	days	day	NNS
cord-023095-4dannjjm	6333	11	2	2	CD
cord-023095-4dannjjm	6333	12	and	and	CC
cord-023095-4dannjjm	6333	13	3	3	CD
cord-023095-4dannjjm	6333	14	after	after	IN
cord-023095-4dannjjm	6333	15	splenectomy	splenectomy	NN
cord-023095-4dannjjm	6333	16	.	.	.
cord-023095-4dannjjm	6334	1	Parasitic	parasitic	JJ
cord-023095-4dannjjm	6334	2	bloom	bloom	NN
cord-023095-4dannjjm	6334	3	developed	develop	VBN
cord-023095-4dannjjm	6334	4	on	on	IN
cord-023095-4dannjjm	6334	5	day	day	NN
cord-023095-4dannjjm	6334	6	4	4	CD
cord-023095-4dannjjm	6334	7	with	with	IN
cord-023095-4dannjjm	6334	8	85	85	CD
cord-023095-4dannjjm	6334	9	%	%	NN
cord-023095-4dannjjm	6334	10	of	of	IN
cord-023095-4dannjjm	6334	11	the	the	DT
cord-023095-4dannjjm	6334	12	red	red	JJ
cord-023095-4dannjjm	6334	13	blood	blood	NN
cord-023095-4dannjjm	6334	14	cells	cell	NNS
cord-023095-4dannjjm	6334	15	infected	infect	VBN
cord-023095-4dannjjm	6334	16	,	,	,
cord-023095-4dannjjm	6334	17	and	and	CC
cord-023095-4dannjjm	6334	18	over	over	IN
cord-023095-4dannjjm	6334	19	70	70	CD
cord-023095-4dannjjm	6334	20	%	%	NN
cord-023095-4dannjjm	6334	21	containing	contain	VBG
cord-023095-4dannjjm	6334	22	3	3	CD
cord-023095-4dannjjm	6334	23	or	or	CC
cord-023095-4dannjjm	6334	24	more	more	JJR
cord-023095-4dannjjm	6334	25	organisms	organism	NNS
cord-023095-4dannjjm	6334	26	.	.	.
cord-023095-4dannjjm	6335	1	The	the	DT
cord-023095-4dannjjm	6335	2	alpaca	alpaca	NN
cord-023095-4dannjjm	6335	3	was	be	VBD
cord-023095-4dannjjm	6335	4	treated	treat	VBN
cord-023095-4dannjjm	6335	5	with	with	IN
cord-023095-4dannjjm	6335	6	20	20	CD
cord-023095-4dannjjm	6335	7	mg	mg	NNP
cord-023095-4dannjjm	6335	8	/	/	SYM
cord-023095-4dannjjm	6335	9	kg	kg	NNP
cord-023095-4dannjjm	6335	10	Oxytetracycline	Oxytetracycline	NNP
cord-023095-4dannjjm	6335	11	I.V.	I.V.	NNP
cord-023095-4dannjjm	6335	12	on	on	IN
cord-023095-4dannjjm	6335	13	day	day	NN
cord-023095-4dannjjm	6335	14	4	4	CD
cord-023095-4dannjjm	6335	15	.	.	.
cord-023095-4dannjjm	6336	1	On	on	IN
cord-023095-4dannjjm	6336	2	postoperative	postoperative	JJ
cord-023095-4dannjjm	6336	3	day	day	NN
cord-023095-4dannjjm	6336	4	5	5	CD
cord-023095-4dannjjm	6336	5	no	no	DT
cord-023095-4dannjjm	6336	6	parasites	parasite	NNS
cord-023095-4dannjjm	6336	7	were	be	VBD
cord-023095-4dannjjm	6336	8	seen	see	VBN
cord-023095-4dannjjm	6336	9	in	in	IN
cord-023095-4dannjjm	6336	10	the	the	DT
cord-023095-4dannjjm	6336	11	peripheral	peripheral	JJ
cord-023095-4dannjjm	6336	12	blood	blood	NN
cord-023095-4dannjjm	6336	13	.	.	.
cord-023095-4dannjjm	6337	1	The	the	DT
cord-023095-4dannjjm	6337	2	peripheral	peripheral	JJ
cord-023095-4dannjjm	6337	3	blood	blood	NN
cord-023095-4dannjjm	6337	4	remained	remain	VBD
cord-023095-4dannjjm	6337	5	free	free	JJ
cord-023095-4dannjjm	6337	6	of	of	IN
cord-023095-4dannjjm	6337	7	parasites	parasite	NNS
cord-023095-4dannjjm	6337	8	for	for	IN
cord-023095-4dannjjm	6337	9	11	11	CD
cord-023095-4dannjjm	6337	10	days	day	NNS
cord-023095-4dannjjm	6337	11	.	.	.
cord-023095-4dannjjm	6338	1	On	on	IN
cord-023095-4dannjjm	6338	2	the	the	DT
cord-023095-4dannjjm	6338	3	morning	morning	NN
cord-023095-4dannjjm	6338	4	of	of	IN
cord-023095-4dannjjm	6338	5	the	the	DT
cord-023095-4dannjjm	6338	6	12	12	CD
cord-023095-4dannjjm	6338	7	th	th	CD
cord-023095-4dannjjm	6338	8	day	day	NN
cord-023095-4dannjjm	6338	9	,	,	,
cord-023095-4dannjjm	6338	10	3	3	CD
cord-023095-4dannjjm	6338	11	%	%	NN
cord-023095-4dannjjm	6338	12	of	of	IN
cord-023095-4dannjjm	6338	13	the	the	DT
cord-023095-4dannjjm	6338	14	peripheral	peripheral	JJ
cord-023095-4dannjjm	6338	15	red	red	JJ
cord-023095-4dannjjm	6338	16	blood	blood	NN
cord-023095-4dannjjm	6338	17	cells	cell	NNS
cord-023095-4dannjjm	6338	18	contained	contain	VBD
cord-023095-4dannjjm	6338	19	Mycoplasma	Mycoplasma	NNP
cord-023095-4dannjjm	6338	20	.	.	.
cord-023095-4dannjjm	6339	1	By	by	IN
cord-023095-4dannjjm	6339	2	late	late	RB
cord-023095-4dannjjm	6339	3	that	that	DT
cord-023095-4dannjjm	6339	4	afternoon	afternoon	NN
cord-023095-4dannjjm	6339	5	,	,	,
cord-023095-4dannjjm	6339	6	75	75	CD
cord-023095-4dannjjm	6339	7	%	%	NN
cord-023095-4dannjjm	6339	8	of	of	IN
cord-023095-4dannjjm	6339	9	the	the	DT
cord-023095-4dannjjm	6339	10	observed	observed	JJ
cord-023095-4dannjjm	6339	11	RBC	RBC	NNP
cord-023095-4dannjjm	6339	12	's	's	POS
cord-023095-4dannjjm	6339	13	contained	contain	VBD
cord-023095-4dannjjm	6339	14	3	3	CD
cord-023095-4dannjjm	6339	15	-	-	SYM
cord-023095-4dannjjm	6339	16	4	4	CD
cord-023095-4dannjjm	6339	17	organisms	organism	NNS
cord-023095-4dannjjm	6339	18	.	.	.
cord-023095-4dannjjm	6340	1	The	the	DT
cord-023095-4dannjjm	6340	2	alpaca	alpaca	NN
cord-023095-4dannjjm	6340	3	again	again	RB
cord-023095-4dannjjm	6340	4	received	receive	VBD
cord-023095-4dannjjm	6340	5	oxytetracycline	oxytetracycline	NN
cord-023095-4dannjjm	6340	6	.	.	.
cord-023095-4dannjjm	6341	1	There	there	EX
cord-023095-4dannjjm	6341	2	were	be	VBD
cord-023095-4dannjjm	6341	3	no	no	DT
cord-023095-4dannjjm	6341	4	more	more	JJR
cord-023095-4dannjjm	6341	5	parasites	parasite	NNS
cord-023095-4dannjjm	6341	6	observed	observe	VBN
cord-023095-4dannjjm	6341	7	from	from	IN
cord-023095-4dannjjm	6341	8	that	that	DT
cord-023095-4dannjjm	6341	9	time	time	NN
cord-023095-4dannjjm	6341	10	until	until	IN
cord-023095-4dannjjm	6341	11	the	the	DT
cord-023095-4dannjjm	6341	12	alpaca	alpaca	NN
cord-023095-4dannjjm	6341	13	was	be	VBD
cord-023095-4dannjjm	6341	14	euthanized	euthanize	VBN
cord-023095-4dannjjm	6341	15	5	5	CD
cord-023095-4dannjjm	6341	16	days	day	NNS
cord-023095-4dannjjm	6341	17	later	later	RB
cord-023095-4dannjjm	6341	18	.	.	.
cord-023095-4dannjjm	6342	1	The	the	DT
cord-023095-4dannjjm	6342	2	alpaca	alpaca	NN
cord-023095-4dannjjm	6342	3	lost	lose	VBD
cord-023095-4dannjjm	6342	4	3.7	3.7	CD
cord-023095-4dannjjm	6342	5	kg	kg	NNS
cord-023095-4dannjjm	6342	6	between	between	IN
cord-023095-4dannjjm	6342	7	days	day	NNS
cord-023095-4dannjjm	6342	8	À1	À1	NNP
cord-023095-4dannjjm	6342	9	and	and	CC
cord-023095-4dannjjm	6342	10	12	12	CD
cord-023095-4dannjjm	6342	11	after	after	IN
cord-023095-4dannjjm	6342	12	surgery	surgery	NN
cord-023095-4dannjjm	6342	13	.	.	.
cord-023095-4dannjjm	6343	1	His	-PRON-	PRP$
cord-023095-4dannjjm	6343	2	weight	weight	NN
cord-023095-4dannjjm	6343	3	fluctuated	fluctuate	VBD
cord-023095-4dannjjm	6343	4	between	between	IN
cord-023095-4dannjjm	6343	5	34.9	34.9	CD
cord-023095-4dannjjm	6343	6	and	and	CC
cord-023095-4dannjjm	6343	7	35.4	35.4	CD
cord-023095-4dannjjm	6343	8	kg	kg	NNS
cord-023095-4dannjjm	6343	9	for	for	IN
cord-023095-4dannjjm	6343	10	the	the	DT
cord-023095-4dannjjm	6343	11	remainder	remainder	NN
cord-023095-4dannjjm	6343	12	of	of	IN
cord-023095-4dannjjm	6343	13	the	the	DT
cord-023095-4dannjjm	6343	14	study	study	NN
cord-023095-4dannjjm	6343	15	period	period	NN
cord-023095-4dannjjm	6343	16	.	.	.
cord-023095-4dannjjm	6344	1	Blood	blood	NN
cord-023095-4dannjjm	6344	2	glucose	glucose	NN
cord-023095-4dannjjm	6344	3	ranged	range	VBD
cord-023095-4dannjjm	6344	4	between	between	IN
cord-023095-4dannjjm	6344	5	87	87	CD
cord-023095-4dannjjm	6344	6	and	and	CC
cord-023095-4dannjjm	6344	7	163	163	CD
cord-023095-4dannjjm	6345	1	mg	mg	NNP
cord-023095-4dannjjm	6345	2	/	/	SYM
cord-023095-4dannjjm	6345	3	dL	dl	NN
cord-023095-4dannjjm	6346	1	There	there	EX
cord-023095-4dannjjm	6346	2	was	be	VBD
cord-023095-4dannjjm	6346	3	no	no	DT
cord-023095-4dannjjm	6346	4	major	major	JJ
cord-023095-4dannjjm	6346	5	change	change	NN
cord-023095-4dannjjm	6346	6	in	in	IN
cord-023095-4dannjjm	6346	7	PCV	PCV	NNP
cord-023095-4dannjjm	6346	8	(	(	-LRB-
cord-023095-4dannjjm	6346	9	range	range	NNP
cord-023095-4dannjjm	6346	10	21	21	CD
cord-023095-4dannjjm	6346	11	-	-	SYM
cord-023095-4dannjjm	6346	12	29	29	CD
cord-023095-4dannjjm	6346	13	%	%	NN
cord-023095-4dannjjm	6346	14	)	)	-RRB-
cord-023095-4dannjjm	6346	15	,	,	,
cord-023095-4dannjjm	6346	16	a	a	DT
cord-023095-4dannjjm	6346	17	finding	finding	NN
cord-023095-4dannjjm	6346	18	that	that	WDT
cord-023095-4dannjjm	6346	19	was	be	VBD
cord-023095-4dannjjm	6346	20	expected	expect	VBN
cord-023095-4dannjjm	6346	21	as	as	IN
cord-023095-4dannjjm	6346	22	the	the	DT
cord-023095-4dannjjm	6346	23	spleen	spleen	NN
cord-023095-4dannjjm	6346	24	was	be	VBD
cord-023095-4dannjjm	6346	25	not	not	RB
cord-023095-4dannjjm	6346	26	available	available	JJ
cord-023095-4dannjjm	6346	27	to	to	TO
cord-023095-4dannjjm	6346	28	remove	remove	VB
cord-023095-4dannjjm	6346	29	infected	infected	JJ
cord-023095-4dannjjm	6346	30	red	red	JJ
cord-023095-4dannjjm	6346	31	blood	blood	NN
cord-023095-4dannjjm	6346	32	cells	cell	NNS
cord-023095-4dannjjm	6346	33	.	.	.
cord-023095-4dannjjm	6347	1	Body	body	NN
cord-023095-4dannjjm	6347	2	temperature	temperature	NN
cord-023095-4dannjjm	6347	3	ranged	range	VBD
cord-023095-4dannjjm	6348	1	between	between	IN
cord-023095-4dannjjm	6348	2	38.1	38.1	CD
cord-023095-4dannjjm	6348	3	and	and	CC
cord-023095-4dannjjm	6348	4	39	39	CD
cord-023095-4dannjjm	6348	5	degrees	degree	NNS
cord-023095-4dannjjm	6348	6	Celsius	Celsius	NNP
cord-023095-4dannjjm	6348	7	except	except	IN
cord-023095-4dannjjm	6348	8	for	for	IN
cord-023095-4dannjjm	6348	9	days	day	NNS
cord-023095-4dannjjm	6348	10	4	4	CD
cord-023095-4dannjjm	6348	11	and	and	CC
cord-023095-4dannjjm	6348	12	16	16	CD
cord-023095-4dannjjm	6348	13	when	when	WRB
cord-023095-4dannjjm	6348	14	more	more	JJR
cord-023095-4dannjjm	6348	15	than	than	IN
cord-023095-4dannjjm	6348	16	70	70	CD
cord-023095-4dannjjm	6348	17	%	%	NN
cord-023095-4dannjjm	6348	18	of	of	IN
cord-023095-4dannjjm	6348	19	red	red	JJ
cord-023095-4dannjjm	6348	20	blood	blood	NN
cord-023095-4dannjjm	6348	21	cells	cell	NNS
cord-023095-4dannjjm	6348	22	contained	contain	VBD
cord-023095-4dannjjm	6348	23	parasites	parasite	NNS
cord-023095-4dannjjm	6348	24	.	.	.
cord-023095-4dannjjm	6349	1	On	on	IN
cord-023095-4dannjjm	6349	2	those	those	DT
cord-023095-4dannjjm	6349	3	days	day	NNS
cord-023095-4dannjjm	6349	4	rectal	rectal	JJ
cord-023095-4dannjjm	6349	5	temperature	temperature	NN
cord-023095-4dannjjm	6349	6	reached	reach	VBD
cord-023095-4dannjjm	6349	7	39.4	39.4	CD
cord-023095-4dannjjm	6349	8	and	and	CC
cord-023095-4dannjjm	6349	9	39.1	39.1	CD
cord-023095-4dannjjm	6349	10	degrees	degree	NNS
cord-023095-4dannjjm	6349	11	respectively	respectively	RB
cord-023095-4dannjjm	6349	12	.	.	.
cord-023095-4dannjjm	6350	1	This	this	DT
cord-023095-4dannjjm	6350	2	study	study	NN
cord-023095-4dannjjm	6350	3	confirmed	confirm	VBD
cord-023095-4dannjjm	6350	4	that	that	IN
cord-023095-4dannjjm	6350	5	a	a	DT
cord-023095-4dannjjm	6350	6	non	non	JJ
cord-023095-4dannjjm	6350	7	-	-	JJ
cord-023095-4dannjjm	6350	8	parasitemic	parasitemic	JJ
cord-023095-4dannjjm	6350	9	,	,	,
cord-023095-4dannjjm	6350	10	yet	yet	RB
cord-023095-4dannjjm	6350	11	PCR	PCR	NNP
cord-023095-4dannjjm	6350	12	positive	positive	JJ
cord-023095-4dannjjm	6350	13	alpaca	alpaca	NN
cord-023095-4dannjjm	6350	14	did	do	VBD
cord-023095-4dannjjm	6350	15	indeed	indeed	RB
cord-023095-4dannjjm	6350	16	harbor	harbor	VB
cord-023095-4dannjjm	6350	17	CMhl	CMhl	NNP
cord-023095-4dannjjm	6350	18	.	.	.
cord-023095-4dannjjm	6351	1	The	the	DT
cord-023095-4dannjjm	6351	2	time	time	NN
cord-023095-4dannjjm	6351	3	from	from	IN
cord-023095-4dannjjm	6351	4	splenectomy	splenectomy	NN
cord-023095-4dannjjm	6351	5	to	to	IN
cord-023095-4dannjjm	6351	6	parasitic	parasitic	JJ
cord-023095-4dannjjm	6351	7	bloom	bloom	NN
cord-023095-4dannjjm	6351	8	was	be	VBD
cord-023095-4dannjjm	6351	9	shorter	short	JJR
cord-023095-4dannjjm	6351	10	,	,	,
cord-023095-4dannjjm	6351	11	and	and	CC
cord-023095-4dannjjm	6351	12	the	the	DT
cord-023095-4dannjjm	6351	13	length	length	NN
cord-023095-4dannjjm	6351	14	of	of	IN
cord-023095-4dannjjm	6351	15	oxytetracycline	oxytetracycline	NN
cord-023095-4dannjjm	6351	16	suppression	suppression	NN
cord-023095-4dannjjm	6351	17	longer	long	RBR
cord-023095-4dannjjm	6351	18	than	than	IN
cord-023095-4dannjjm	6351	19	has	have	VBZ
cord-023095-4dannjjm	6351	20	been	be	VBN
cord-023095-4dannjjm	6351	21	observed	observe	VBN
cord-023095-4dannjjm	6351	22	in	in	IN
cord-023095-4dannjjm	6351	23	other	other	JJ
cord-023095-4dannjjm	6351	24	species	specie	NNS
cord-023095-4dannjjm	6351	25	.	.	.
cord-023095-4dannjjm	6352	1	Gastro	gastro	JJ
cord-023095-4dannjjm	6352	2	-	-	HYPH
cord-023095-4dannjjm	6352	3	intestinal	intestinal	JJ
cord-023095-4dannjjm	6352	4	(	(	-LRB-
cord-023095-4dannjjm	6352	5	GI	GI	NNP
cord-023095-4dannjjm	6352	6	)	)	-RRB-
cord-023095-4dannjjm	6352	7	disease	disease	NN
cord-023095-4dannjjm	6352	8	frequently	frequently	RB
cord-023095-4dannjjm	6352	9	results	result	VBZ
cord-023095-4dannjjm	6352	10	in	in	IN
cord-023095-4dannjjm	6352	11	increased	increase	VBN
cord-023095-4dannjjm	6352	12	wall	wall	NN
cord-023095-4dannjjm	6352	13	thickness	thickness	NN
cord-023095-4dannjjm	6352	14	in	in	IN
cord-023095-4dannjjm	6352	15	many	many	JJ
cord-023095-4dannjjm	6352	16	species	specie	NNS
cord-023095-4dannjjm	6352	17	.	.	.
cord-023095-4dannjjm	6353	1	Identification	identification	NN
cord-023095-4dannjjm	6353	2	of	of	IN
cord-023095-4dannjjm	6353	3	changes	change	NNS
cord-023095-4dannjjm	6353	4	in	in	IN
cord-023095-4dannjjm	6353	5	GI	GI	NNP
cord-023095-4dannjjm	6353	6	wall	wall	NN
cord-023095-4dannjjm	6353	7	thickness	thickness	NN
cord-023095-4dannjjm	6353	8	using	use	VBG
cord-023095-4dannjjm	6353	9	ultrasound	ultrasound	NN
cord-023095-4dannjjm	6353	10	has	have	VBZ
cord-023095-4dannjjm	6353	11	proved	prove	VBN
cord-023095-4dannjjm	6353	12	to	to	TO
cord-023095-4dannjjm	6353	13	be	be	VB
cord-023095-4dannjjm	6353	14	a	a	DT
cord-023095-4dannjjm	6353	15	useful	useful	JJ
cord-023095-4dannjjm	6353	16	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	6353	17	tool	tool	NN
cord-023095-4dannjjm	6353	18	and	and	CC
cord-023095-4dannjjm	6353	19	is	be	VBZ
cord-023095-4dannjjm	6353	20	widely	widely	RB
cord-023095-4dannjjm	6353	21	used	use	VBN
cord-023095-4dannjjm	6353	22	in	in	IN
cord-023095-4dannjjm	6353	23	human	human	JJ
cord-023095-4dannjjm	6353	24	patients	patient	NNS
cord-023095-4dannjjm	6353	25	,	,	,
cord-023095-4dannjjm	6353	26	small	small	JJ
cord-023095-4dannjjm	6353	27	animals	animal	NNS
cord-023095-4dannjjm	6353	28	and	and	CC
cord-023095-4dannjjm	6353	29	horses	horse	NNS
cord-023095-4dannjjm	6353	30	.	.	.
cord-023095-4dannjjm	6354	1	Although	although	IN
cord-023095-4dannjjm	6354	2	GI	GI	NNP
cord-023095-4dannjjm	6354	3	motility	motility	NN
cord-023095-4dannjjm	6354	4	has	have	VBZ
cord-023095-4dannjjm	6354	5	been	be	VBN
cord-023095-4dannjjm	6354	6	evaluated	evaluate	VBN
cord-023095-4dannjjm	6354	7	in	in	IN
cord-023095-4dannjjm	6354	8	cattle	cattle	NNS
cord-023095-4dannjjm	6354	9	,	,	,
cord-023095-4dannjjm	6354	10	normal	normal	JJ
cord-023095-4dannjjm	6354	11	reference	reference	NN
cord-023095-4dannjjm	6354	12	ranges	range	VBZ
cord-023095-4dannjjm	6354	13	for	for	IN
cord-023095-4dannjjm	6354	14	wall	wall	NN
cord-023095-4dannjjm	6354	15	thickness	thickness	NN
cord-023095-4dannjjm	6354	16	has	have	VBZ
cord-023095-4dannjjm	6354	17	not	not	RB
cord-023095-4dannjjm	6354	18	been	be	VBN
cord-023095-4dannjjm	6354	19	reported	report	VBN
cord-023095-4dannjjm	6354	20	in	in	IN
cord-023095-4dannjjm	6354	21	ruminants	ruminant	NNS
cord-023095-4dannjjm	6354	22	.	.	.
cord-023095-4dannjjm	6355	1	The	the	DT
cord-023095-4dannjjm	6355	2	aims	aim	NNS
cord-023095-4dannjjm	6355	3	of	of	IN
cord-023095-4dannjjm	6355	4	this	this	DT
cord-023095-4dannjjm	6355	5	study	study	NN
cord-023095-4dannjjm	6355	6	were	be	VBD
cord-023095-4dannjjm	6355	7	to	to	TO
cord-023095-4dannjjm	6355	8	report	report	VB
cord-023095-4dannjjm	6355	9	normal	normal	JJ
cord-023095-4dannjjm	6355	10	values	value	NNS
cord-023095-4dannjjm	6355	11	for	for	IN
cord-023095-4dannjjm	6355	12	wall	wall	NN
cord-023095-4dannjjm	6355	13	thickness	thickness	NN
cord-023095-4dannjjm	6355	14	of	of	IN
cord-023095-4dannjjm	6355	15	various	various	JJ
cord-023095-4dannjjm	6355	16	GI	GI	NNP
cord-023095-4dannjjm	6355	17	structures	structure	NNS
cord-023095-4dannjjm	6355	18	and	and	CC
cord-023095-4dannjjm	6355	19	to	to	TO
cord-023095-4dannjjm	6355	20	assess	assess	VB
cord-023095-4dannjjm	6355	21	the	the	DT
cord-023095-4dannjjm	6355	22	repeatability	repeatability	NN
cord-023095-4dannjjm	6355	23	of	of	IN
cord-023095-4dannjjm	6355	24	this	this	DT
cord-023095-4dannjjm	6355	25	technique	technique	NN
cord-023095-4dannjjm	6355	26	in	in	IN
cord-023095-4dannjjm	6355	27	adult	adult	NN
cord-023095-4dannjjm	6355	28	dairy	dairy	NN
cord-023095-4dannjjm	6355	29	cows	cow	NNS
cord-023095-4dannjjm	6355	30	,	,	,
cord-023095-4dannjjm	6355	31	sheep	sheep	NNS
cord-023095-4dannjjm	6355	32	and	and	CC
cord-023095-4dannjjm	6355	33	goats	goat	NNS
cord-023095-4dannjjm	6355	34	.	.	.
cord-023095-4dannjjm	6356	1	Eight	eight	CD
cord-023095-4dannjjm	6356	2	healthy	healthy	JJ
cord-023095-4dannjjm	6356	3	adult	adult	NN
cord-023095-4dannjjm	6356	4	Holstein	Holstein	NNP
cord-023095-4dannjjm	6356	5	Friesian	Friesian	NNP
cord-023095-4dannjjm	6356	6	(	(	-LRB-
cord-023095-4dannjjm	6356	7	HF	HF	NNP
cord-023095-4dannjjm	6356	8	)	)	-RRB-
cord-023095-4dannjjm	6356	9	cattle	cattle	NNS
cord-023095-4dannjjm	6356	10	(	(	-LRB-
cord-023095-4dannjjm	6356	11	656	656	CD
cord-023095-4dannjjm	6356	12	AE	AE	NNP
cord-023095-4dannjjm	6356	13	11	11	CD
cord-023095-4dannjjm	6356	14	Kg	Kg	NNP
cord-023095-4dannjjm	6356	15	)	)	-RRB-
cord-023095-4dannjjm	6356	16	,	,	,
cord-023095-4dannjjm	6356	17	eight	eight	CD
cord-023095-4dannjjm	6356	18	Jersey	Jersey	NNP
cord-023095-4dannjjm	6356	19	(	(	-LRB-
cord-023095-4dannjjm	6356	20	J	J	NNP
cord-023095-4dannjjm	6356	21	)	)	-RRB-
cord-023095-4dannjjm	6356	22	cattle	cattle	NNS
cord-023095-4dannjjm	6356	23	(	(	-LRB-
cord-023095-4dannjjm	6356	24	458	458	CD
cord-023095-4dannjjm	6356	25	AE	AE	NNP
cord-023095-4dannjjm	6356	26	56	56	CD
cord-023095-4dannjjm	6356	27	kg	kg	NNS
cord-023095-4dannjjm	6356	28	)	)	-RRB-
cord-023095-4dannjjm	6356	29	,	,	,
cord-023095-4dannjjm	6356	30	thirteen	thirteen	CD
cord-023095-4dannjjm	6356	31	adult	adult	NN
cord-023095-4dannjjm	6356	32	sheep	sheep	NNS
cord-023095-4dannjjm	6356	33	(	(	-LRB-
cord-023095-4dannjjm	6356	34	79	79	CD
cord-023095-4dannjjm	6356	35	AE	AE	NNP
cord-023095-4dannjjm	6356	36	11	11	CD
cord-023095-4dannjjm	6356	37	Kg	Kg	NNP
cord-023095-4dannjjm	6356	38	)	)	-RRB-
cord-023095-4dannjjm	6356	39	and	and	CC
cord-023095-4dannjjm	6356	40	eleven	eleven	CD
cord-023095-4dannjjm	6356	41	adult	adult	NN
cord-023095-4dannjjm	6356	42	goats	goat	NNS
cord-023095-4dannjjm	6356	43	(	(	-LRB-
cord-023095-4dannjjm	6356	44	43.5	43.5	CD
cord-023095-4dannjjm	6356	45	AE	AE	NNP
cord-023095-4dannjjm	6356	46	8	8	CD
cord-023095-4dannjjm	6356	47	Kg	Kg	NNP
cord-023095-4dannjjm	6356	48	)	)	-RRB-
cord-023095-4dannjjm	6356	49	were	be	VBD
cord-023095-4dannjjm	6356	50	recruited	recruit	VBN
cord-023095-4dannjjm	6356	51	and	and	CC
cord-023095-4dannjjm	6356	52	examined	examine	VBN
cord-023095-4dannjjm	6356	53	on	on	IN
cord-023095-4dannjjm	6356	54	three	three	CD
cord-023095-4dannjjm	6356	55	consecutive	consecutive	JJ
cord-023095-4dannjjm	6356	56	days	day	NNS
cord-023095-4dannjjm	6356	57	.	.	.
cord-023095-4dannjjm	6357	1	Ultrasonographic	ultrasonographic	JJ
cord-023095-4dannjjm	6357	2	images	image	NNS
cord-023095-4dannjjm	6357	3	were	be	VBD
cord-023095-4dannjjm	6357	4	optimised	optimise	VBN
cord-023095-4dannjjm	6357	5	for	for	IN
cord-023095-4dannjjm	6357	6	the	the	DT
cord-023095-4dannjjm	6357	7	structure	structure	NN
cord-023095-4dannjjm	6357	8	of	of	IN
cord-023095-4dannjjm	6357	9	interest	interest	NN
cord-023095-4dannjjm	6357	10	.	.	.
cord-023095-4dannjjm	6358	1	Structures	structure	NNS
cord-023095-4dannjjm	6358	2	were	be	VBD
cord-023095-4dannjjm	6358	3	identified	identify	VBN
cord-023095-4dannjjm	6358	4	based	base	VBN
cord-023095-4dannjjm	6358	5	upon	upon	IN
cord-023095-4dannjjm	6358	6	appearance	appearance	NN
cord-023095-4dannjjm	6358	7	and	and	CC
cord-023095-4dannjjm	6358	8	anatomical	anatomical	JJ
cord-023095-4dannjjm	6358	9	position	position	NN
cord-023095-4dannjjm	6358	10	.	.	.
cord-023095-4dannjjm	6359	1	A	a	DT
cord-023095-4dannjjm	6359	2	minimum	minimum	NN
cord-023095-4dannjjm	6359	3	of	of	IN
cord-023095-4dannjjm	6359	4	three	three	CD
cord-023095-4dannjjm	6359	5	cineloops	cineloop	NNS
cord-023095-4dannjjm	6359	6	were	be	VBD
cord-023095-4dannjjm	6359	7	obtained	obtain	VBN
cord-023095-4dannjjm	6359	8	of	of	IN
cord-023095-4dannjjm	6359	9	the	the	DT
cord-023095-4dannjjm	6359	10	abdominal	abdominal	JJ
cord-023095-4dannjjm	6359	11	organs	organ	NNS
cord-023095-4dannjjm	6359	12	per	per	IN
cord-023095-4dannjjm	6359	13	intercostal	intercostal	JJ
cord-023095-4dannjjm	6359	14	space	space	NN
cord-023095-4dannjjm	6359	15	(	(	-LRB-
cord-023095-4dannjjm	6359	16	ICS	ICS	NNP
cord-023095-4dannjjm	6359	17	)	)	-RRB-
cord-023095-4dannjjm	6359	18	and	and	CC
cord-023095-4dannjjm	6359	19	three	three	CD
cord-023095-4dannjjm	6359	20	along	along	IN
cord-023095-4dannjjm	6359	21	the	the	DT
cord-023095-4dannjjm	6359	22	ventral	ventral	JJ
cord-023095-4dannjjm	6359	23	midline	midline	NN
cord-023095-4dannjjm	6359	24	in	in	IN
cord-023095-4dannjjm	6359	25	each	each	DT
cord-023095-4dannjjm	6359	26	ICS	ICS	NNP
cord-023095-4dannjjm	6359	27	;	;	:
cord-023095-4dannjjm	6359	28	images	image	NNS
cord-023095-4dannjjm	6359	29	were	be	VBD
cord-023095-4dannjjm	6359	30	analysed	analyse	VBN
cord-023095-4dannjjm	6359	31	offline	offline	JJ
cord-023095-4dannjjm	6359	32	.	.	.
cord-023095-4dannjjm	6360	1	Data	datum	NNS
cord-023095-4dannjjm	6360	2	were	be	VBD
cord-023095-4dannjjm	6360	3	analysed	analyse	VBN
cord-023095-4dannjjm	6360	4	using	use	VBG
cord-023095-4dannjjm	6360	5	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	6360	6	and	and	CC
cord-023095-4dannjjm	6360	7	post	post	VB
cord-023095-4dannjjm	6360	8	-	-	JJ
cord-023095-4dannjjm	6360	9	hoc	hoc	JJ
cord-023095-4dannjjm	6360	10	Bonferoni	Bonferoni	NNP
cord-023095-4dannjjm	6360	11	,	,	,
cord-023095-4dannjjm	6360	12	Student	Student	NNP
cord-023095-4dannjjm	6360	13	's	's	POS
cord-023095-4dannjjm	6360	14	Ttest	Ttest	NNP
cord-023095-4dannjjm	6360	15	and	and	CC
cord-023095-4dannjjm	6360	16	intra	intra	JJ
cord-023095-4dannjjm	6360	17	-	-	JJ
cord-023095-4dannjjm	6360	18	class	class	JJ
cord-023095-4dannjjm	6360	19	correlation	correlation	NN
cord-023095-4dannjjm	6360	20	coefficients	coefficient	NNS
cord-023095-4dannjjm	6360	21	.	.	.
cord-023095-4dannjjm	6361	1	Each	each	DT
cord-023095-4dannjjm	6361	2	structure	structure	NN
cord-023095-4dannjjm	6361	3	was	be	VBD
cord-023095-4dannjjm	6361	4	measured	measure	VBN
cord-023095-4dannjjm	6361	5	per	per	IN
cord-023095-4dannjjm	6361	6	ICS	ics	NN
cord-023095-4dannjjm	6361	7	per	per	IN
cord-023095-4dannjjm	6361	8	species	specie	NNS
cord-023095-4dannjjm	6361	9	;	;	:
cord-023095-4dannjjm	6361	10	if	if	IN
cord-023095-4dannjjm	6361	11	no	no	DT
cord-023095-4dannjjm	6361	12	differences	difference	NNS
cord-023095-4dannjjm	6361	13	were	be	VBD
cord-023095-4dannjjm	6361	14	noted	note	VBN
cord-023095-4dannjjm	6361	15	for	for	IN
cord-023095-4dannjjm	6361	16	structures	structure	NNS
cord-023095-4dannjjm	6361	17	in	in	IN
cord-023095-4dannjjm	6361	18	different	different	JJ
cord-023095-4dannjjm	6361	19	ICS	ICS	NNP
cord-023095-4dannjjm	6361	20	,	,	,
cord-023095-4dannjjm	6361	21	then	then	RB
cord-023095-4dannjjm	6361	22	measurements	measurement	NNS
cord-023095-4dannjjm	6361	23	were	be	VBD
cord-023095-4dannjjm	6361	24	pooled	pool	VBN
cord-023095-4dannjjm	6361	25	.	.	.
cord-023095-4dannjjm	6362	1	No	no	DT
cord-023095-4dannjjm	6362	2	differences	difference	NNS
cord-023095-4dannjjm	6362	3	were	be	VBD
cord-023095-4dannjjm	6362	4	noted	note	VBN
cord-023095-4dannjjm	6362	5	between	between	IN
cord-023095-4dannjjm	6362	6	HF	HF	NNP
cord-023095-4dannjjm	6362	7	and	and	CC
cord-023095-4dannjjm	6362	8	J	J	NNP
cord-023095-4dannjjm	6362	9	cattle	cattle	NNS
cord-023095-4dannjjm	6363	1	so	so	CC
cord-023095-4dannjjm	6363	2	data	datum	NNS
cord-023095-4dannjjm	6363	3	were	be	VBD
cord-023095-4dannjjm	6363	4	pooled	pool	VBN
cord-023095-4dannjjm	6363	5	.	.	.
cord-023095-4dannjjm	6364	1	Data	datum	NNS
cord-023095-4dannjjm	6364	2	are	be	VBP
cord-023095-4dannjjm	6364	3	displayed	display	VBN
cord-023095-4dannjjm	6364	4	in	in	IN
cord-023095-4dannjjm	6364	5	table	table	NN
cord-023095-4dannjjm	6364	6	1	1	CD
cord-023095-4dannjjm	6364	7	.	.	.
cord-023095-4dannjjm	6365	1	Good	good	JJ
cord-023095-4dannjjm	6365	2	repeatability	repeatability	NN
cord-023095-4dannjjm	6365	3	(	(	-LRB-
cord-023095-4dannjjm	6365	4	ICC40.91	ICC40.91	NNP
cord-023095-4dannjjm	6365	5	)	)	-RRB-
cord-023095-4dannjjm	6365	6	was	be	VBD
cord-023095-4dannjjm	6365	7	obtained	obtain	VBN
cord-023095-4dannjjm	6365	8	for	for	IN
cord-023095-4dannjjm	6365	9	all	all	DT
cord-023095-4dannjjm	6365	10	measurements	measurement	NNS
cord-023095-4dannjjm	6365	11	and	and	CC
cord-023095-4dannjjm	6365	12	no	no	DT
cord-023095-4dannjjm	6365	13	differences	difference	NNS
cord-023095-4dannjjm	6365	14	were	be	VBD
cord-023095-4dannjjm	6365	15	noted	note	VBN
cord-023095-4dannjjm	6365	16	between	between	IN
cord-023095-4dannjjm	6365	17	animals	animal	NNS
cord-023095-4dannjjm	6365	18	of	of	IN
cord-023095-4dannjjm	6365	19	the	the	DT
cord-023095-4dannjjm	6365	20	same	same	JJ
cord-023095-4dannjjm	6365	21	species	specie	NNS
cord-023095-4dannjjm	6365	22	or	or	CC
cord-023095-4dannjjm	6365	23	between	between	IN
cord-023095-4dannjjm	6365	24	days	day	NNS
cord-023095-4dannjjm	6365	25	.	.	.
cord-023095-4dannjjm	6366	1	These	these	DT
cord-023095-4dannjjm	6366	2	measurements	measurement	NNS
cord-023095-4dannjjm	6366	3	for	for	IN
cord-023095-4dannjjm	6366	4	assessment	assessment	NN
cord-023095-4dannjjm	6366	5	of	of	IN
cord-023095-4dannjjm	6366	6	normal	normal	JJ
cord-023095-4dannjjm	6366	7	GI	GI	NNP
cord-023095-4dannjjm	6366	8	thickness	thickness	NN
cord-023095-4dannjjm	6366	9	are	be	VBP
cord-023095-4dannjjm	6366	10	repeatable	repeatable	JJ
cord-023095-4dannjjm	6366	11	and	and	CC
cord-023095-4dannjjm	6366	12	may	may	MD
cord-023095-4dannjjm	6366	13	allow	allow	VB
cord-023095-4dannjjm	6366	14	valuable	valuable	JJ
cord-023095-4dannjjm	6366	15	additional	additional	JJ
cord-023095-4dannjjm	6366	16	information	information	NN
cord-023095-4dannjjm	6366	17	to	to	TO
cord-023095-4dannjjm	6366	18	be	be	VB
cord-023095-4dannjjm	6366	19	gained	gain	VBN
cord-023095-4dannjjm	6366	20	from	from	IN
cord-023095-4dannjjm	6366	21	ruminants	ruminant	NNS
cord-023095-4dannjjm	6366	22	with	with	IN
cord-023095-4dannjjm	6366	23	GI	GI	NNP
cord-023095-4dannjjm	6366	24	disease	disease	NN
cord-023095-4dannjjm	6366	25	.	.	.
cord-023095-4dannjjm	6367	1	Ocular	ocular	JJ
cord-023095-4dannjjm	6367	2	infections	infection	NNS
cord-023095-4dannjjm	6367	3	with	with	IN
cord-023095-4dannjjm	6367	4	the	the	DT
cord-023095-4dannjjm	6367	5	infectious	infectious	JJ
cord-023095-4dannjjm	6367	6	bovine	bovine	NN
cord-023095-4dannjjm	6367	7	keratoconjunctivitis	keratoconjunctivitis	NN
cord-023095-4dannjjm	6367	8	(	(	-LRB-
cord-023095-4dannjjm	6367	9	IBK	IBK	NNP
cord-023095-4dannjjm	6367	10	)	)	-RRB-
cord-023095-4dannjjm	6367	11	agent	agent	NN
cord-023095-4dannjjm	6367	12	Moraxella	Moraxella	NNP
cord-023095-4dannjjm	6367	13	bovis	bovi	NNS
cord-023095-4dannjjm	6367	14	(	(	-LRB-
cord-023095-4dannjjm	6367	15	M.	M.	NNP
cord-023095-4dannjjm	6367	16	bovis	bovi	NNS
cord-023095-4dannjjm	6367	17	)	)	-RRB-
cord-023095-4dannjjm	6367	18	are	be	VBP
cord-023095-4dannjjm	6367	19	associated	associate	VBN
cord-023095-4dannjjm	6367	20	with	with	IN
cord-023095-4dannjjm	6367	21	significant	significant	JJ
cord-023095-4dannjjm	6367	22	economic	economic	JJ
cord-023095-4dannjjm	6367	23	loss	loss	NN
cord-023095-4dannjjm	6367	24	in	in	IN
cord-023095-4dannjjm	6367	25	the	the	DT
cord-023095-4dannjjm	6367	26	cattle	cattle	NNS
cord-023095-4dannjjm	6367	27	industry	industry	NN
cord-023095-4dannjjm	6367	28	.	.	.
cord-023095-4dannjjm	6368	1	Although	although	IN
cord-023095-4dannjjm	6368	2	antibiotic	antibiotic	JJ
cord-023095-4dannjjm	6368	3	therapy	therapy	NN
cord-023095-4dannjjm	6368	4	is	be	VBZ
cord-023095-4dannjjm	6368	5	the	the	DT
cord-023095-4dannjjm	6368	6	treatment	treatment	NN
cord-023095-4dannjjm	6368	7	of	of	IN
cord-023095-4dannjjm	6368	8	choice	choice	NN
cord-023095-4dannjjm	6368	9	for	for	IN
cord-023095-4dannjjm	6368	10	IBK	IBK	NNP
cord-023095-4dannjjm	6368	11	,	,	,
cord-023095-4dannjjm	6368	12	treatment	treatment	NN
cord-023095-4dannjjm	6368	13	failures	failure	NNS
cord-023095-4dannjjm	6368	14	are	be	VBP
cord-023095-4dannjjm	6369	1	common	common	JJ
cord-023095-4dannjjm	6369	2	and	and	CC
cord-023095-4dannjjm	6369	3	current	current	JJ
cord-023095-4dannjjm	6369	4	vaccines	vaccine	NNS
cord-023095-4dannjjm	6369	5	are	be	VBP
cord-023095-4dannjjm	6369	6	not	not	RB
cord-023095-4dannjjm	6369	7	optimally	optimally	RB
cord-023095-4dannjjm	6369	8	effective	effective	JJ
cord-023095-4dannjjm	6369	9	mainly	mainly	RB
cord-023095-4dannjjm	6369	10	due	due	JJ
cord-023095-4dannjjm	6369	11	to	to	IN
cord-023095-4dannjjm	6369	12	antigenic	antigenic	JJ
cord-023095-4dannjjm	6369	13	variation	variation	NN
cord-023095-4dannjjm	6369	14	.	.	.
cord-023095-4dannjjm	6370	1	As	as	IN
cord-023095-4dannjjm	6370	2	a	a	DT
cord-023095-4dannjjm	6370	3	result	result	NN
cord-023095-4dannjjm	6370	4	,	,	,
cord-023095-4dannjjm	6370	5	our	-PRON-	PRP$
cord-023095-4dannjjm	6370	6	laboratory	laboratory	NN
cord-023095-4dannjjm	6370	7	has	have	VBZ
cord-023095-4dannjjm	6370	8	been	be	VBN
cord-023095-4dannjjm	6370	9	actively	actively	RB
cord-023095-4dannjjm	6370	10	investigating	investigate	VBG
cord-023095-4dannjjm	6370	11	the	the	DT
cord-023095-4dannjjm	6370	12	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	6370	13	potential	potential	NN
cord-023095-4dannjjm	6370	14	of	of	IN
cord-023095-4dannjjm	6370	15	Bdellovibrio	Bdellovibrio	NNP
cord-023095-4dannjjm	6370	16	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6370	17	109J	109J	NNP
cord-023095-4dannjjm	6370	18	(	(	-LRB-
cord-023095-4dannjjm	6370	19	B.	B.	NNP
cord-023095-4dannjjm	6370	20	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6370	21	)	)	-RRB-
cord-023095-4dannjjm	6370	22	;	;	:
cord-023095-4dannjjm	6370	23	a	a	DT
cord-023095-4dannjjm	6370	24	predatory	predatory	JJ
cord-023095-4dannjjm	6370	25	bacterium	bacterium	NN
cord-023095-4dannjjm	6370	26	capable	capable	JJ
cord-023095-4dannjjm	6370	27	of	of	IN
cord-023095-4dannjjm	6370	28	attacking	attack	VBG
cord-023095-4dannjjm	6370	29	and	and	CC
cord-023095-4dannjjm	6370	30	inducing	induce	VBG
cord-023095-4dannjjm	6370	31	lysis	lysis	NN
cord-023095-4dannjjm	6370	32	of	of	IN
cord-023095-4dannjjm	6370	33	Gram	gram	NN
cord-023095-4dannjjm	6370	34	-	-	HYPH
cord-023095-4dannjjm	6370	35	negative	negative	JJ
cord-023095-4dannjjm	6370	36	bacteria	bacteria	NNS
cord-023095-4dannjjm	6370	37	,	,	,
cord-023095-4dannjjm	6370	38	as	as	IN
cord-023095-4dannjjm	6370	39	a	a	DT
cord-023095-4dannjjm	6370	40	new	new	JJ
cord-023095-4dannjjm	6370	41	treatment	treatment	NN
cord-023095-4dannjjm	6370	42	for	for	IN
cord-023095-4dannjjm	6370	43	IBK	IBK	NNP
cord-023095-4dannjjm	6370	44	.	.	.
cord-023095-4dannjjm	6371	1	We	-PRON-	PRP
cord-023095-4dannjjm	6371	2	have	have	VBP
cord-023095-4dannjjm	6371	3	previously	previously	RB
cord-023095-4dannjjm	6371	4	shown	show	VBN
cord-023095-4dannjjm	6371	5	that	that	IN
cord-023095-4dannjjm	6371	6	B.	B.	NNP
cord-023095-4dannjjm	6371	7	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6371	8	can	can	MD
cord-023095-4dannjjm	6371	9	reduce	reduce	VB
cord-023095-4dannjjm	6371	10	the	the	DT
cord-023095-4dannjjm	6371	11	number	number	NN
cord-023095-4dannjjm	6371	12	of	of	IN
cord-023095-4dannjjm	6371	13	M.	M.	NNP
cord-023095-4dannjjm	6371	14	bovis	bovi	NNS
cord-023095-4dannjjm	6371	15	attached	attach	VBN
cord-023095-4dannjjm	6371	16	to	to	IN
cord-023095-4dannjjm	6371	17	bovine	bovine	JJ
cord-023095-4dannjjm	6371	18	epithelial	epithelial	JJ
cord-023095-4dannjjm	6371	19	cells	cell	NNS
cord-023095-4dannjjm	6371	20	in	in	IN
cord-023095-4dannjjm	6371	21	an	an	DT
cord-023095-4dannjjm	6371	22	in	in	FW
cord-023095-4dannjjm	6371	23	vitro	vitro	FW
cord-023095-4dannjjm	6371	24	model	model	NN
cord-023095-4dannjjm	6371	25	of	of	IN
cord-023095-4dannjjm	6371	26	IBK	IBK	NNP
cord-023095-4dannjjm	6371	27	and	and	CC
cord-023095-4dannjjm	6371	28	that	that	IN
cord-023095-4dannjjm	6371	29	B.	B.	NNP
cord-023095-4dannjjm	6371	30	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6371	31	can	can	MD
cord-023095-4dannjjm	6371	32	be	be	VB
cord-023095-4dannjjm	6371	33	trained	train	VBN
cord-023095-4dannjjm	6371	34	to	to	TO
cord-023095-4dannjjm	6371	35	kill	kill	VB
cord-023095-4dannjjm	6371	36	M.	M.	NNP
cord-023095-4dannjjm	6371	37	bovis	bovi	NNS
cord-023095-4dannjjm	6371	38	as	as	RB
cord-023095-4dannjjm	6371	39	effectively	effectively	RB
cord-023095-4dannjjm	6371	40	as	as	IN
cord-023095-4dannjjm	6371	41	E.	E.	NNP
cord-023095-4dannjjm	6371	42	coli	coli	NNS
cord-023095-4dannjjm	6371	43	using	use	VBG
cord-023095-4dannjjm	6371	44	serial	serial	JJ
cord-023095-4dannjjm	6371	45	passages	passage	NNS
cord-023095-4dannjjm	6371	46	.	.	.
cord-023095-4dannjjm	6372	1	In	in	IN
cord-023095-4dannjjm	6372	2	this	this	DT
cord-023095-4dannjjm	6372	3	study	study	NN
cord-023095-4dannjjm	6372	4	,	,	,
cord-023095-4dannjjm	6372	5	we	-PRON-	PRP
cord-023095-4dannjjm	6372	6	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	6372	7	that	that	IN
cord-023095-4dannjjm	6372	8	B.	B.	NNP
cord-023095-4dannjjm	6372	9	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6372	10	can	can	MD
cord-023095-4dannjjm	6372	11	remain	remain	VB
cord-023095-4dannjjm	6372	12	viable	viable	JJ
cord-023095-4dannjjm	6372	13	in	in	IN
cord-023095-4dannjjm	6372	14	bovine	bovine	JJ
cord-023095-4dannjjm	6372	15	tears	tear	NNS
cord-023095-4dannjjm	6372	16	without	without	IN
cord-023095-4dannjjm	6372	17	its	-PRON-	PRP$
cord-023095-4dannjjm	6372	18	prey	prey	NN
cord-023095-4dannjjm	6372	19	for	for	IN
cord-023095-4dannjjm	6372	20	up	up	IN
cord-023095-4dannjjm	6372	21	to	to	TO
cord-023095-4dannjjm	6372	22	24	24	CD
cord-023095-4dannjjm	6372	23	hours	hour	NNS
cord-023095-4dannjjm	6372	24	.	.	.
cord-023095-4dannjjm	6373	1	This	this	DT
cord-023095-4dannjjm	6373	2	hypothesis	hypothesis	NN
cord-023095-4dannjjm	6373	3	was	be	VBD
cord-023095-4dannjjm	6373	4	addressed	address	VBN
cord-023095-4dannjjm	6373	5	by	by	IN
cord-023095-4dannjjm	6373	6	incubating	incubate	VBG
cord-023095-4dannjjm	6373	7	inocula	inocula	NN
cord-023095-4dannjjm	6373	8	of	of	IN
cord-023095-4dannjjm	6373	9	active	active	JJ
cord-023095-4dannjjm	6373	10	B.	B.	NNP
cord-023095-4dannjjm	6373	11	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6373	12	in	in	IN
cord-023095-4dannjjm	6373	13	its	-PRON-	PRP$
cord-023095-4dannjjm	6373	14	preferred	preferred	JJ
cord-023095-4dannjjm	6373	15	media	medium	NNS
cord-023095-4dannjjm	6373	16	peptone	peptone	NN
cord-023095-4dannjjm	6373	17	yeast	yeast	NN
cord-023095-4dannjjm	6373	18	extract	extract	NN
cord-023095-4dannjjm	6373	19	(	(	-LRB-
cord-023095-4dannjjm	6373	20	PYE	PYE	NNP
cord-023095-4dannjjm	6373	21	)	)	-RRB-
cord-023095-4dannjjm	6373	22	and	and	CC
cord-023095-4dannjjm	6373	23	comparing	compare	VBG
cord-023095-4dannjjm	6373	24	B.	B.	NNP
cord-023095-4dannjjm	6373	25	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6373	26	viability	viability	NN
cord-023095-4dannjjm	6373	27	in	in	IN
cord-023095-4dannjjm	6373	28	bovine	bovine	JJ
cord-023095-4dannjjm	6373	29	tears	tear	NNS
cord-023095-4dannjjm	6373	30	or	or	CC
cord-023095-4dannjjm	6373	31	phosphate	phosphate	NN
cord-023095-4dannjjm	6373	32	buffered	buffer	VBN
cord-023095-4dannjjm	6373	33	saline	saline	NN
cord-023095-4dannjjm	6373	34	(	(	-LRB-
cord-023095-4dannjjm	6373	35	PBS	PBS	NNP
cord-023095-4dannjjm	6373	36	)	)	-RRB-
cord-023095-4dannjjm	6373	37	at	at	IN
cord-023095-4dannjjm	6373	38	time	time	NN
cord-023095-4dannjjm	6373	39	0	0	CD
cord-023095-4dannjjm	6373	40	,	,	,
cord-023095-4dannjjm	6373	41	2	2	CD
cord-023095-4dannjjm	6373	42	,	,	,
cord-023095-4dannjjm	6373	43	4	4	CD
cord-023095-4dannjjm	6373	44	,	,	,
cord-023095-4dannjjm	6373	45	12	12	CD
cord-023095-4dannjjm	6373	46	,	,	,
cord-023095-4dannjjm	6373	47	and	and	CC
cord-023095-4dannjjm	6373	48	24	24	CD
cord-023095-4dannjjm	6373	49	hours	hour	NNS
cord-023095-4dannjjm	6373	50	.	.	.
cord-023095-4dannjjm	6374	1	Using	use	VBG
cord-023095-4dannjjm	6374	2	a	a	DT
cord-023095-4dannjjm	6374	3	plaque	plaque	NN
cord-023095-4dannjjm	6374	4	assay	assay	NN
cord-023095-4dannjjm	6374	5	to	to	TO
cord-023095-4dannjjm	6374	6	quantify	quantify	VB
cord-023095-4dannjjm	6374	7	the	the	DT
cord-023095-4dannjjm	6374	8	mean	mean	JJ
cord-023095-4dannjjm	6374	9	amount	amount	NN
cord-023095-4dannjjm	6374	10	of	of	IN
cord-023095-4dannjjm	6374	11	plaque	plaque	NN
cord-023095-4dannjjm	6374	12	forming	form	VBG
cord-023095-4dannjjm	6374	13	units	unit	NNS
cord-023095-4dannjjm	6374	14	(	(	-LRB-
cord-023095-4dannjjm	6374	15	PFUs	pfus	NN
cord-023095-4dannjjm	6374	16	)	)	-RRB-
cord-023095-4dannjjm	6374	17	of	of	IN
cord-023095-4dannjjm	6374	18	B.	B.	NNP
cord-023095-4dannjjm	6374	19	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6374	20	exposed	expose	VBN
cord-023095-4dannjjm	6374	21	to	to	IN
cord-023095-4dannjjm	6374	22	each	each	DT
cord-023095-4dannjjm	6374	23	treatment	treatment	NN
cord-023095-4dannjjm	6374	24	,	,	,
cord-023095-4dannjjm	6374	25	it	-PRON-	PRP
cord-023095-4dannjjm	6374	26	was	be	VBD
cord-023095-4dannjjm	6374	27	determined	determine	VBN
cord-023095-4dannjjm	6374	28	that	that	IN
cord-023095-4dannjjm	6374	29	viability	viability	NN
cord-023095-4dannjjm	6374	30	of	of	IN
cord-023095-4dannjjm	6374	31	B.	B.	NNP
cord-023095-4dannjjm	6374	32	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6374	33	over	over	IN
cord-023095-4dannjjm	6374	34	time	time	NN
cord-023095-4dannjjm	6374	35	was	be	VBD
cord-023095-4dannjjm	6374	36	comparable	comparable	JJ
cord-023095-4dannjjm	6374	37	between	between	IN
cord-023095-4dannjjm	6374	38	treatment	treatment	NN
cord-023095-4dannjjm	6374	39	groups	group	NNS
cord-023095-4dannjjm	6374	40	.	.	.
cord-023095-4dannjjm	6375	1	Overall	overall	RB
cord-023095-4dannjjm	6375	2	,	,	,
cord-023095-4dannjjm	6375	3	the	the	DT
cord-023095-4dannjjm	6375	4	results	result	NNS
cord-023095-4dannjjm	6375	5	supported	support	VBD
cord-023095-4dannjjm	6375	6	that	that	IN
cord-023095-4dannjjm	6375	7	B.	B.	NNP
cord-023095-4dannjjm	6375	8	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6375	9	can	can	MD
cord-023095-4dannjjm	6375	10	remain	remain	VB
cord-023095-4dannjjm	6375	11	viable	viable	JJ
cord-023095-4dannjjm	6375	12	in	in	IN
cord-023095-4dannjjm	6375	13	tears	tear	NNS
cord-023095-4dannjjm	6375	14	for	for	IN
cord-023095-4dannjjm	6375	15	up	up	IN
cord-023095-4dannjjm	6375	16	to	to	TO
cord-023095-4dannjjm	6375	17	24	24	CD
cord-023095-4dannjjm	6375	18	hours	hour	NNS
cord-023095-4dannjjm	6375	19	in	in	IN
cord-023095-4dannjjm	6375	20	the	the	DT
cord-023095-4dannjjm	6375	21	absence	absence	NN
cord-023095-4dannjjm	6375	22	of	of	IN
cord-023095-4dannjjm	6375	23	prey	prey	NN
cord-023095-4dannjjm	6375	24	bacteria	bacteria	NNS
cord-023095-4dannjjm	6375	25	.	.	.
cord-023095-4dannjjm	6376	1	Further	further	JJ
cord-023095-4dannjjm	6376	2	studies	study	NNS
cord-023095-4dannjjm	6376	3	are	be	VBP
cord-023095-4dannjjm	6376	4	needed	need	VBN
cord-023095-4dannjjm	6376	5	to	to	TO
cord-023095-4dannjjm	6376	6	determine	determine	VB
cord-023095-4dannjjm	6376	7	the	the	DT
cord-023095-4dannjjm	6376	8	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	6376	9	potential	potential	NN
cord-023095-4dannjjm	6376	10	of	of	IN
cord-023095-4dannjjm	6376	11	B.	B.	NNP
cord-023095-4dannjjm	6376	12	bacteriovorus	bacteriovorus	NNP
cord-023095-4dannjjm	6376	13	in	in	IN
cord-023095-4dannjjm	6376	14	an	an	DT
cord-023095-4dannjjm	6376	15	in	in	IN
cord-023095-4dannjjm	6376	16	vivo	vivo	NN
cord-023095-4dannjjm	6376	17	model	model	NN
cord-023095-4dannjjm	6376	18	of	of	IN
cord-023095-4dannjjm	6376	19	IBK	IBK	NNP
cord-023095-4dannjjm	6376	20	.	.	.
cord-023095-4dannjjm	6377	1	Correction	correction	NN
cord-023095-4dannjjm	6377	2	of	of	IN
cord-023095-4dannjjm	6377	3	the	the	DT
cord-023095-4dannjjm	6377	4	measured	measure	VBN
cord-023095-4dannjjm	6377	5	ionized	ionized	JJ
cord-023095-4dannjjm	6377	6	calcium	calcium	NN
cord-023095-4dannjjm	6377	7	concentration	concentration	NN
cord-023095-4dannjjm	6377	8	(	(	-LRB-
cord-023095-4dannjjm	6377	9	cCa	cCa	NNP
cord-023095-4dannjjm	6377	10	21	21	CD
cord-023095-4dannjjm	6377	11	)	)	-RRB-
cord-023095-4dannjjm	6377	12	to	to	IN
cord-023095-4dannjjm	6377	13	a	a	DT
cord-023095-4dannjjm	6377	14	pH	pH	NNP
cord-023095-4dannjjm	6377	15	5	5	CD
cord-023095-4dannjjm	6377	16	7.40	7.40	CD
cord-023095-4dannjjm	6377	17	is	be	VBZ
cord-023095-4dannjjm	6377	18	routinely	routinely	RB
cord-023095-4dannjjm	6377	19	applied	apply	VBN
cord-023095-4dannjjm	6377	20	in	in	IN
cord-023095-4dannjjm	6377	21	experimental	experimental	JJ
cord-023095-4dannjjm	6377	22	studies	study	NNS
cord-023095-4dannjjm	6377	23	in	in	IN
cord-023095-4dannjjm	6377	24	order	order	NN
cord-023095-4dannjjm	6377	25	to	to	TO
cord-023095-4dannjjm	6377	26	assist	assist	VB
cord-023095-4dannjjm	6377	27	in	in	IN
cord-023095-4dannjjm	6377	28	the	the	DT
cord-023095-4dannjjm	6377	29	interpretation	interpretation	NN
cord-023095-4dannjjm	6377	30	of	of	IN
cord-023095-4dannjjm	6377	31	measured	measure	VBN
cord-023095-4dannjjm	6377	32	values	value	NNS
cord-023095-4dannjjm	6377	33	relative	relative	JJ
cord-023095-4dannjjm	6377	34	to	to	IN
cord-023095-4dannjjm	6377	35	a	a	DT
cord-023095-4dannjjm	6377	36	reference	reference	NN
cord-023095-4dannjjm	6377	37	range	range	NN
cord-023095-4dannjjm	6377	38	.	.	.
cord-023095-4dannjjm	6378	1	The	the	DT
cord-023095-4dannjjm	6378	2	equation	equation	NN
cord-023095-4dannjjm	6378	3	most	most	RBS
cord-023095-4dannjjm	6378	4	commonly	commonly	RB
cord-023095-4dannjjm	6378	5	used	use	VBN
cord-023095-4dannjjm	6378	6	for	for	IN
cord-023095-4dannjjm	6378	7	pH	ph	NN
cord-023095-4dannjjm	6378	8	correction	correction	NN
cord-023095-4dannjjm	6378	9	in	in	IN
cord-023095-4dannjjm	6378	10	bovine	bovine	JJ
cord-023095-4dannjjm	6378	11	plasma	plasma	NN
cord-023095-4dannjjm	6378	12	is	be	VBZ
cord-023095-4dannjjm	6378	13	:	:	:
cord-023095-4dannjjm	6378	14	cCa	cCa	NNS
cord-023095-4dannjjm	6378	15	21	21	CD
cord-023095-4dannjjm	6378	16	pH	ph	NN
cord-023095-4dannjjm	6378	17	5	5	CD
cord-023095-4dannjjm	6379	1	7.40	7.40	CD
cord-023095-4dannjjm	6379	2	5	5	CD
cord-023095-4dannjjm	6379	3	cCa	cCa	NNS
cord-023095-4dannjjm	6379	4	21	21	CD
cord-023095-4dannjjm	6379	5	Â10	Â10	NNP
cord-023095-4dannjjm	6379	6	(	(	-LRB-
cord-023095-4dannjjm	6379	7	-0.24Â{7.40	-0.24Â{7.40	:
cord-023095-4dannjjm	6379	8	-pH	-ph	JJ
cord-023095-4dannjjm	6379	9	}	}	-RRB-
cord-023095-4dannjjm	6379	10	)	)	-RRB-
cord-023095-4dannjjm	6379	11	.	.	.
cord-023095-4dannjjm	6380	1	The	the	DT
cord-023095-4dannjjm	6380	2	validity	validity	NN
cord-023095-4dannjjm	6380	3	of	of	IN
cord-023095-4dannjjm	6380	4	this	this	DT
cord-023095-4dannjjm	6380	5	equation	equation	NN
cord-023095-4dannjjm	6380	6	for	for	IN
cord-023095-4dannjjm	6380	7	bovine	bovine	JJ
cord-023095-4dannjjm	6380	8	plasma	plasma	NN
cord-023095-4dannjjm	6380	9	is	be	VBZ
cord-023095-4dannjjm	6380	10	unknown	unknown	JJ
cord-023095-4dannjjm	6380	11	.	.	.
cord-023095-4dannjjm	6381	1	Accordingly	accordingly	RB
cord-023095-4dannjjm	6381	2	,	,	,
cord-023095-4dannjjm	6381	3	our	-PRON-	PRP$
cord-023095-4dannjjm	6381	4	first	first	JJ
cord-023095-4dannjjm	6381	5	objective	objective	NN
cord-023095-4dannjjm	6381	6	was	be	VBD
cord-023095-4dannjjm	6381	7	to	to	TO
cord-023095-4dannjjm	6381	8	characterize	characterize	VB
cord-023095-4dannjjm	6381	9	the	the	DT
cord-023095-4dannjjm	6381	10	in	in	FW
cord-023095-4dannjjm	6381	11	vitro	vitro	FW
cord-023095-4dannjjm	6381	12	relationship	relationship	NN
cord-023095-4dannjjm	6381	13	between	between	IN
cord-023095-4dannjjm	6381	14	cCa	cCa	NNS
cord-023095-4dannjjm	6381	15	21	21	CD
cord-023095-4dannjjm	6381	16	and	and	CC
cord-023095-4dannjjm	6381	17	pH	ph	NN
cord-023095-4dannjjm	6381	18	for	for	IN
cord-023095-4dannjjm	6381	19	bovine	bovine	JJ
cord-023095-4dannjjm	6381	20	plasma	plasma	NN
cord-023095-4dannjjm	6381	21	.	.	.
cord-023095-4dannjjm	6382	1	Feeding	feed	VBG
cord-023095-4dannjjm	6382	2	rations	ration	NNS
cord-023095-4dannjjm	6382	3	with	with	IN
cord-023095-4dannjjm	6382	4	a	a	DT
cord-023095-4dannjjm	6382	5	low	low	JJ
cord-023095-4dannjjm	6382	6	dietary	dietary	JJ
cord-023095-4dannjjm	6382	7	cation	cation	NN
cord-023095-4dannjjm	6382	8	-	-	HYPH
cord-023095-4dannjjm	6382	9	anion	anion	NN
cord-023095-4dannjjm	6382	10	difference	difference	NN
cord-023095-4dannjjm	6382	11	(	(	-LRB-
cord-023095-4dannjjm	6382	12	DCAD	DCAD	NNP
cord-023095-4dannjjm	6382	13	)	)	-RRB-
cord-023095-4dannjjm	6382	14	during	during	IN
cord-023095-4dannjjm	6382	15	late	late	JJ
cord-023095-4dannjjm	6382	16	gestation	gestation	NN
cord-023095-4dannjjm	6382	17	mitigates	mitigate	VBZ
cord-023095-4dannjjm	6382	18	periparturient	periparturient	NN
cord-023095-4dannjjm	6382	19	hypocalcemia	hypocalcemia	NN
cord-023095-4dannjjm	6382	20	in	in	IN
cord-023095-4dannjjm	6382	21	dairy	dairy	NN
cord-023095-4dannjjm	6382	22	cows	cow	NNS
cord-023095-4dannjjm	6382	23	,	,	,
cord-023095-4dannjjm	6382	24	particularly	particularly	RB
cord-023095-4dannjjm	6382	25	when	when	WRB
cord-023095-4dannjjm	6382	26	chloride	chloride	NN
cord-023095-4dannjjm	6382	27	containing	contain	VBG
cord-023095-4dannjjm	6382	28	acidodgenic	acidodgenic	JJ
cord-023095-4dannjjm	6382	29	salts	salt	NNS
cord-023095-4dannjjm	6382	30	are	be	VBP
cord-023095-4dannjjm	6382	31	fed	feed	VBN
cord-023095-4dannjjm	6382	32	.	.	.
cord-023095-4dannjjm	6383	1	The	the	DT
cord-023095-4dannjjm	6383	2	mechanism	mechanism	NN
cord-023095-4dannjjm	6383	3	for	for	IN
cord-023095-4dannjjm	6383	4	this	this	DT
cord-023095-4dannjjm	6383	5	beneficial	beneficial	JJ
cord-023095-4dannjjm	6383	6	effect	effect	NN
cord-023095-4dannjjm	6383	7	remains	remain	VBZ
cord-023095-4dannjjm	6383	8	unclear	unclear	JJ
cord-023095-4dannjjm	6383	9	.	.	.
cord-023095-4dannjjm	6384	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	6384	2	second	second	JJ
cord-023095-4dannjjm	6384	3	objective	objective	NN
cord-023095-4dannjjm	6384	4	was	be	VBD
cord-023095-4dannjjm	6384	5	to	to	TO
cord-023095-4dannjjm	6384	6	determine	determine	VB
cord-023095-4dannjjm	6384	7	whether	whether	IN
cord-023095-4dannjjm	6384	8	hyperchloremia	hyperchloremia	NN
cord-023095-4dannjjm	6384	9	displaces	displace	VBZ
cord-023095-4dannjjm	6384	10	calcium	calcium	NN
cord-023095-4dannjjm	6384	11	from	from	IN
cord-023095-4dannjjm	6384	12	binding	bind	VBG
cord-023095-4dannjjm	6384	13	sites	site	NNS
cord-023095-4dannjjm	6384	14	to	to	IN
cord-023095-4dannjjm	6384	15	albumin	albumin	NN
cord-023095-4dannjjm	6384	16	,	,	,
cord-023095-4dannjjm	6384	17	thereby	thereby	RB
cord-023095-4dannjjm	6384	18	increasing	increase	VBG
cord-023095-4dannjjm	6384	19	cCa	cCa	NNS
cord-023095-4dannjjm	6384	20	21	21	CD
cord-023095-4dannjjm	6384	21	.	.	.
cord-023095-4dannjjm	6385	1	The	the	DT
cord-023095-4dannjjm	6385	2	in	in	FW
cord-023095-4dannjjm	6385	3	vitro	vitro	FW
cord-023095-4dannjjm	6385	4	relationship	relationship	NN
cord-023095-4dannjjm	6385	5	between	between	IN
cord-023095-4dannjjm	6385	6	plasma	plasma	NN
cord-023095-4dannjjm	6385	7	log(cCa	log(cCa	NNP
cord-023095-4dannjjm	6385	8	21	21	CD
cord-023095-4dannjjm	6385	9	)	)	-RRB-
cord-023095-4dannjjm	6385	10	and	and	CC
cord-023095-4dannjjm	6385	11	pH	pH	NNP
cord-023095-4dannjjm	6386	1	in	in	IN
cord-023095-4dannjjm	6386	2	was	be	VBD
cord-023095-4dannjjm	6386	3	investigated	investigate	VBN
cord-023095-4dannjjm	6386	4	using	use	VBG
cord-023095-4dannjjm	6386	5	lithium	lithium	NN
cord-023095-4dannjjm	6386	6	heparin	heparin	NN
cord-023095-4dannjjm	6386	7	anticoagulated	anticoagulate	VBD
cord-023095-4dannjjm	6386	8	blood	blood	NN
cord-023095-4dannjjm	6386	9	from	from	IN
cord-023095-4dannjjm	6386	10	10	10	CD
cord-023095-4dannjjm	6386	11	healthy	healthy	JJ
cord-023095-4dannjjm	6386	12	Holstein	Holstein	NNP
cord-023095-4dannjjm	6386	13	-	-	HYPH
cord-023095-4dannjjm	6386	14	Friesian	friesian	JJ
cord-023095-4dannjjm	6386	15	calves	calf	NNS
cord-023095-4dannjjm	6386	16	.	.	.
cord-023095-4dannjjm	6387	1	Plasma	plasma	NN
cord-023095-4dannjjm	6387	2	was	be	VBD
cord-023095-4dannjjm	6387	3	harvested	harvest	VBN
cord-023095-4dannjjm	6387	4	and	and	CC
cord-023095-4dannjjm	6387	5	tonometered	tonometere	VBN
cord-023095-4dannjjm	6387	6	with	with	IN
cord-023095-4dannjjm	6387	7	CO	CO	NNP
cord-023095-4dannjjm	6387	8	2	2	CD
cord-023095-4dannjjm	6387	9	at	at	IN
cord-023095-4dannjjm	6387	10	371C	371c	CD
cord-023095-4dannjjm	6387	11	over	over	IN
cord-023095-4dannjjm	6387	12	a	a	DT
cord-023095-4dannjjm	6387	13	pH	pH	NNP
cord-023095-4dannjjm	6387	14	range	range	NN
cord-023095-4dannjjm	6387	15	of	of	IN
cord-023095-4dannjjm	6387	16	7.10	7.10	CD
cord-023095-4dannjjm	6387	17	-	-	HYPH
cord-023095-4dannjjm	6387	18	7.70	7.70	CD
cord-023095-4dannjjm	6387	19	.	.	.
cord-023095-4dannjjm	6388	1	Plasma	plasma	NN
cord-023095-4dannjjm	6388	2	chloride	chloride	NN
cord-023095-4dannjjm	6388	3	concentration	concentration	NN
cord-023095-4dannjjm	6388	4	(	(	-LRB-
cord-023095-4dannjjm	6388	5	cCl	cCl	NNS
cord-023095-4dannjjm	6388	6	-	-	,
cord-023095-4dannjjm	6388	7	)	)	-RRB-
cord-023095-4dannjjm	6388	8	was	be	VBD
cord-023095-4dannjjm	6388	9	altered	alter	VBN
cord-023095-4dannjjm	6388	10	by	by	IN
cord-023095-4dannjjm	6388	11	equivolume	equivolume	NNP
cord-023095-4dannjjm	6388	12	dilution	dilution	NN
cord-023095-4dannjjm	6388	13	of	of	IN
cord-023095-4dannjjm	6388	14	plasma	plasma	NN
cord-023095-4dannjjm	6388	15	with	with	IN
cord-023095-4dannjjm	6388	16	3	3	CD
cord-023095-4dannjjm	6388	17	electrolyte	electrolyte	JJ
cord-023095-4dannjjm	6388	18	solutions	solution	NNS
cord-023095-4dannjjm	6388	19	of	of	IN
cord-023095-4dannjjm	6388	20	varying	vary	VBG
cord-023095-4dannjjm	6388	21	cCl	cCl	NNS
cord-023095-4dannjjm	6388	22	-(97	-(97	IN
cord-023095-4dannjjm	6388	23	AE	AE	NNP
cord-023095-4dannjjm	6388	24	1	1	CD
cord-023095-4dannjjm	6388	25	,	,	,
cord-023095-4dannjjm	6388	26	110	110	CD
cord-023095-4dannjjm	6388	27	AE	AE	NNP
cord-023095-4dannjjm	6388	28	1	1	CD
cord-023095-4dannjjm	6388	29	,	,	,
cord-023095-4dannjjm	6388	30	and	and	CC
cord-023095-4dannjjm	6388	31	123	123	CD
cord-023095-4dannjjm	6388	32	AE	ae	NN
cord-023095-4dannjjm	6388	33	1	1	CD
cord-023095-4dannjjm	6388	34	mEq	mEq	NNS
cord-023095-4dannjjm	6388	35	/	/	SYM
cord-023095-4dannjjm	6388	36	L	l	NN
cord-023095-4dannjjm	6388	37	;	;	:
cord-023095-4dannjjm	6388	38	mean	mean	VB
cord-023095-4dannjjm	6388	39	AE	AE	NNP
cord-023095-4dannjjm	6388	40	SD	SD	NNP
cord-023095-4dannjjm	6388	41	)	)	-RRB-
cord-023095-4dannjjm	6388	42	.	.	.
cord-023095-4dannjjm	6389	1	The	the	DT
cord-023095-4dannjjm	6389	2	slope	slope	NN
cord-023095-4dannjjm	6389	3	of	of	IN
cord-023095-4dannjjm	6389	4	the	the	DT
cord-023095-4dannjjm	6389	5	linear	linear	JJ
cord-023095-4dannjjm	6389	6	regression	regression	NN
cord-023095-4dannjjm	6389	7	equation	equation	NN
cord-023095-4dannjjm	6389	8	relating	relate	VBG
cord-023095-4dannjjm	6389	9	log(cCa	log(cCa	NNP
cord-023095-4dannjjm	6389	10	21	21	CD
cord-023095-4dannjjm	6389	11	)	)	-RRB-
cord-023095-4dannjjm	6389	12	to	to	IN
cord-023095-4dannjjm	6389	13	pH	pH	NNP
cord-023095-4dannjjm	6389	14	for	for	IN
cord-023095-4dannjjm	6389	15	112	112	CD
cord-023095-4dannjjm	6389	16	tonometered	tonometere	VBN
cord-023095-4dannjjm	6389	17	plasma	plasma	NN
cord-023095-4dannjjm	6389	18	samples	sample	NNS
cord-023095-4dannjjm	6389	19	from	from	IN
cord-023095-4dannjjm	6389	20	the	the	DT
cord-023095-4dannjjm	6389	21	10	10	CD
cord-023095-4dannjjm	6389	22	calves	calf	NNS
cord-023095-4dannjjm	6389	23	was	be	VBD
cord-023095-4dannjjm	6389	24	-0.24	-0.24	CD
cord-023095-4dannjjm	6389	25	AE	AE	NNP
cord-023095-4dannjjm	6389	26	0.05	0.05	CD
cord-023095-4dannjjm	6389	27	at	at	IN
cord-023095-4dannjjm	6389	28	normal	normal	JJ
cord-023095-4dannjjm	6389	29	values	value	NNS
cord-023095-4dannjjm	6389	30	for	for	IN
cord-023095-4dannjjm	6389	31	cCa	cCa	NNS
cord-023095-4dannjjm	6389	32	21	21	CD
cord-023095-4dannjjm	6389	33	(	(	-LRB-
cord-023095-4dannjjm	6389	34	2.63	2.63	CD
cord-023095-4dannjjm	6389	35	AE	AE	NNP
cord-023095-4dannjjm	6389	36	0.09	0.09	CD
cord-023095-4dannjjm	6389	37	mEq	mEq	NNS
cord-023095-4dannjjm	6389	38	/	/	SYM
cord-023095-4dannjjm	6389	39	L	L	NNP
cord-023095-4dannjjm	6389	40	)	)	-RRB-
cord-023095-4dannjjm	6389	41	,	,	,
cord-023095-4dannjjm	6389	42	albumin	albumin	NN
cord-023095-4dannjjm	6389	43	concentration	concentration	NN
cord-023095-4dannjjm	6389	44	(	(	-LRB-
cord-023095-4dannjjm	6389	45	30.9	30.9	CD
cord-023095-4dannjjm	6389	46	AE	AE	NNP
cord-023095-4dannjjm	6389	47	2.0	2.0	CD
cord-023095-4dannjjm	6389	48	g	g	NN
cord-023095-4dannjjm	6389	49	/	/	SYM
cord-023095-4dannjjm	6389	50	L	L	NNP
cord-023095-4dannjjm	6389	51	)	)	-RRB-
cord-023095-4dannjjm	6389	52	,	,	,
cord-023095-4dannjjm	6389	53	and	and	CC
cord-023095-4dannjjm	6389	54	cCl	cCl	NNS
cord-023095-4dannjjm	6389	55	-(99.1	-(99.1	:
cord-023095-4dannjjm	6389	56	AE	AE	NNP
cord-023095-4dannjjm	6389	57	2.2	2.2	CD
cord-023095-4dannjjm	6389	58	mEq	mEq	NNS
cord-023095-4dannjjm	6389	59	/	/	SYM
cord-023095-4dannjjm	6389	60	L	L	NNP
cord-023095-4dannjjm	6389	61	)	)	-RRB-
cord-023095-4dannjjm	6389	62	.	.	.
cord-023095-4dannjjm	6390	1	The	the	DT
cord-023095-4dannjjm	6390	2	experimentally	experimentally	RB
cord-023095-4dannjjm	6390	3	-	-	HYPH
cord-023095-4dannjjm	6390	4	determined	determine	VBN
cord-023095-4dannjjm	6390	5	value	value	NN
cord-023095-4dannjjm	6390	6	for	for	IN
cord-023095-4dannjjm	6390	7	the	the	DT
cord-023095-4dannjjm	6390	8	slope	slope	NN
cord-023095-4dannjjm	6390	9	for	for	IN
cord-023095-4dannjjm	6390	10	bovine	bovine	JJ
cord-023095-4dannjjm	6390	11	plasma	plasma	NN
cord-023095-4dannjjm	6390	12	was	be	VBD
cord-023095-4dannjjm	6390	13	identical	identical	JJ
cord-023095-4dannjjm	6390	14	to	to	IN
cord-023095-4dannjjm	6390	15	that	that	DT
cord-023095-4dannjjm	6390	16	determined	determine	VBN
cord-023095-4dannjjm	6390	17	previously	previously	RB
cord-023095-4dannjjm	6390	18	for	for	IN
cord-023095-4dannjjm	6390	19	human	human	JJ
cord-023095-4dannjjm	6390	20	plasma	plasma	NN
cord-023095-4dannjjm	6390	21	.	.	.
cord-023095-4dannjjm	6391	1	The	the	DT
cord-023095-4dannjjm	6391	2	formula	formula	NN
cord-023095-4dannjjm	6391	3	for	for	IN
cord-023095-4dannjjm	6391	4	correcting	correct	VBG
cord-023095-4dannjjm	6391	5	cCa	cCa	NNS
cord-023095-4dannjjm	6391	6	21	21	CD
cord-023095-4dannjjm	6391	7	in	in	IN
cord-023095-4dannjjm	6391	8	bovine	bovine	JJ
cord-023095-4dannjjm	6391	9	plasma	plasma	NN
cord-023095-4dannjjm	6391	10	for	for	IN
cord-023095-4dannjjm	6391	11	change	change	NN
cord-023095-4dannjjm	6391	12	in	in	IN
cord-023095-4dannjjm	6391	13	pH	pH	NNP
cord-023095-4dannjjm	6391	14	from	from	IN
cord-023095-4dannjjm	6391	15	7.40	7.40	CD
cord-023095-4dannjjm	6391	16	is	be	VBZ
cord-023095-4dannjjm	6391	17	therefore	therefore	RB
cord-023095-4dannjjm	6391	18	:	:	:
cord-023095-4dannjjm	6391	19	cCa	cCa	NNS
cord-023095-4dannjjm	6391	20	21	21	CD
cord-023095-4dannjjm	6391	21	pH	pH	NNP
cord-023095-4dannjjm	6391	22	5	5	CD
cord-023095-4dannjjm	6391	23	7.40	7.40	CD
cord-023095-4dannjjm	6391	24	5	5	CD
cord-023095-4dannjjm	6392	1	cCa	cCa	NNP
cord-023095-4dannjjm	6392	2	21	21	CD
cord-023095-4dannjjm	6392	3	Â	â	CD
cord-023095-4dannjjm	6392	4	10	10	CD
cord-023095-4dannjjm	6393	1	(	(	-LRB-
cord-023095-4dannjjm	6393	2	À	à	NN
cord-023095-4dannjjm	6393	3	0.24	0.24	CD
cord-023095-4dannjjm	6393	4	Â	â	NN
cord-023095-4dannjjm	6393	5	{	{	-LRB-
cord-023095-4dannjjm	6393	6	7.40-pH	7.40-ph	CD
cord-023095-4dannjjm	6393	7	}	}	-RRB-
cord-023095-4dannjjm	6393	8	)	)	-RRB-
cord-023095-4dannjjm	6393	9	.	.	.
cord-023095-4dannjjm	6394	1	This	this	DT
cord-023095-4dannjjm	6394	2	equation	equation	NN
cord-023095-4dannjjm	6394	3	is	be	VBZ
cord-023095-4dannjjm	6394	4	only	only	RB
cord-023095-4dannjjm	6394	5	valid	valid	JJ
cord-023095-4dannjjm	6394	6	at	at	IN
cord-023095-4dannjjm	6394	7	normal	normal	JJ
cord-023095-4dannjjm	6394	8	concentrations	concentration	NNS
cord-023095-4dannjjm	6394	9	of	of	IN
cord-023095-4dannjjm	6394	10	albumin	albumin	NN
cord-023095-4dannjjm	6394	11	and	and	CC
cord-023095-4dannjjm	6394	12	chloride	chloride	NN
cord-023095-4dannjjm	6394	13	in	in	IN
cord-023095-4dannjjm	6394	14	plasma	plasma	NN
cord-023095-4dannjjm	6394	15	.	.	.
cord-023095-4dannjjm	6395	1	Equivolume	equivolume	NN
cord-023095-4dannjjm	6395	2	dilution	dilution	NN
cord-023095-4dannjjm	6395	3	of	of	IN
cord-023095-4dannjjm	6395	4	plasma	plasma	NN
cord-023095-4dannjjm	6395	5	by	by	IN
cord-023095-4dannjjm	6395	6	electrolyte	electrolyte	JJ
cord-023095-4dannjjm	6395	7	solutions	solution	NNS
cord-023095-4dannjjm	6395	8	of	of	IN
cord-023095-4dannjjm	6395	9	varying	vary	VBG
cord-023095-4dannjjm	6395	10	cClindicated	cClindicated	NNP
cord-023095-4dannjjm	6395	11	that	that	IN
cord-023095-4dannjjm	6395	12	cCa	cCa	VBZ
cord-023095-4dannjjm	6395	13	21	21	CD
cord-023095-4dannjjm	6395	14	pH	pH	NNP
cord-023095-4dannjjm	6395	15	5	5	CD
cord-023095-4dannjjm	6395	16	7.40	7.40	CD
cord-023095-4dannjjm	6395	17	increased	increase	VBN
cord-023095-4dannjjm	6395	18	by	by	IN
cord-023095-4dannjjm	6395	19	0.007	0.007	CD
cord-023095-4dannjjm	6395	20	mEq	mEq	NNS
cord-023095-4dannjjm	6395	21	for	for	IN
cord-023095-4dannjjm	6395	22	every	every	DT
cord-023095-4dannjjm	6395	23	1	1	CD
cord-023095-4dannjjm	6395	24	mEq	mEq	NNS
cord-023095-4dannjjm	6395	25	/	/	SYM
cord-023095-4dannjjm	6395	26	L	L	NNP
cord-023095-4dannjjm	6395	27	increase	increase	NN
cord-023095-4dannjjm	6395	28	in	in	IN
cord-023095-4dannjjm	6395	29	cCl	cCl	NNS
cord-023095-4dannjjm	6395	30	-	-	,
cord-023095-4dannjjm	6395	31	.	.	.
cord-023095-4dannjjm	6396	1	In	in	IN
cord-023095-4dannjjm	6396	2	other	other	JJ
cord-023095-4dannjjm	6396	3	words	word	NNS
cord-023095-4dannjjm	6396	4	,	,	,
cord-023095-4dannjjm	6396	5	plasma	plasma	NN
cord-023095-4dannjjm	6396	6	cCa	cCa	NNS
cord-023095-4dannjjm	6396	7	21	21	CD
cord-023095-4dannjjm	6396	8	at	at	IN
cord-023095-4dannjjm	6396	9	a	a	DT
cord-023095-4dannjjm	6396	10	given	give	VBN
cord-023095-4dannjjm	6396	11	pH	ph	NN
cord-023095-4dannjjm	6396	12	increases	increase	NNS
cord-023095-4dannjjm	6396	13	directly	directly	RB
cord-023095-4dannjjm	6396	14	in	in	IN
cord-023095-4dannjjm	6396	15	response	response	NN
cord-023095-4dannjjm	6396	16	to	to	IN
cord-023095-4dannjjm	6396	17	an	an	DT
cord-023095-4dannjjm	6396	18	increase	increase	NN
cord-023095-4dannjjm	6396	19	in	in	IN
cord-023095-4dannjjm	6396	20	plasma	plasma	NN
cord-023095-4dannjjm	6396	21	cCl	cCl	NNS
cord-023095-4dannjjm	6396	22	-	-	:
cord-023095-4dannjjm	6396	23	,	,	,
cord-023095-4dannjjm	6396	24	presumably	presumably	RB
cord-023095-4dannjjm	6396	25	because	because	IN
cord-023095-4dannjjm	6396	26	the	the	DT
cord-023095-4dannjjm	6396	27	additional	additional	JJ
cord-023095-4dannjjm	6396	28	chloride	chloride	NN
cord-023095-4dannjjm	6396	29	displaces	displace	VBZ
cord-023095-4dannjjm	6396	30	calcium	calcium	NN
cord-023095-4dannjjm	6396	31	that	that	WDT
cord-023095-4dannjjm	6396	32	is	be	VBZ
cord-023095-4dannjjm	6396	33	electrostatically	electrostatically	RB
cord-023095-4dannjjm	6396	34	bound	bind	VBN
cord-023095-4dannjjm	6396	35	to	to	IN
cord-023095-4dannjjm	6396	36	albumin	albumin	NN
cord-023095-4dannjjm	6396	37	.	.	.
cord-023095-4dannjjm	6397	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	6397	2	,	,	,
cord-023095-4dannjjm	6397	3	the	the	DT
cord-023095-4dannjjm	6397	4	increase	increase	NN
cord-023095-4dannjjm	6397	5	in	in	IN
cord-023095-4dannjjm	6397	6	cCa	cCa	NNS
cord-023095-4dannjjm	6397	7	21	21	CD
cord-023095-4dannjjm	6397	8	is	be	VBZ
cord-023095-4dannjjm	6397	9	independent	independent	JJ
cord-023095-4dannjjm	6397	10	to	to	IN
cord-023095-4dannjjm	6397	11	the	the	DT
cord-023095-4dannjjm	6397	12	change	change	NN
cord-023095-4dannjjm	6397	13	in	in	IN
cord-023095-4dannjjm	6397	14	plasma	plasma	NN
cord-023095-4dannjjm	6397	15	pH	ph	NN
cord-023095-4dannjjm	6397	16	induced	induce	VBN
cord-023095-4dannjjm	6397	17	by	by	IN
cord-023095-4dannjjm	6397	18	an	an	DT
cord-023095-4dannjjm	6397	19	increase	increase	NN
cord-023095-4dannjjm	6397	20	in	in	IN
cord-023095-4dannjjm	6397	21	cCland	cCland	NNP
cord-023095-4dannjjm	6397	22	decrease	decrease	NN
cord-023095-4dannjjm	6397	23	in	in	IN
cord-023095-4dannjjm	6397	24	plasma	plasma	NN
cord-023095-4dannjjm	6397	25	strong	strong	JJ
cord-023095-4dannjjm	6397	26	ion	ion	NN
cord-023095-4dannjjm	6397	27	difference	difference	NN
cord-023095-4dannjjm	6397	28	.	.	.
cord-023095-4dannjjm	6398	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	6398	2	finding	finding	NN
cord-023095-4dannjjm	6398	3	that	that	IN
cord-023095-4dannjjm	6398	4	hyperchloremia	hyperchloremia	NN
cord-023095-4dannjjm	6398	5	directly	directly	RB
cord-023095-4dannjjm	6398	6	increases	increase	VBZ
cord-023095-4dannjjm	6398	7	plasma	plasma	NN
cord-023095-4dannjjm	6398	8	cCa	cCa	NNP
cord-023095-4dannjjm	6398	9	21	21	CD
cord-023095-4dannjjm	6398	10	provides	provide	VBZ
cord-023095-4dannjjm	6398	11	an	an	DT
cord-023095-4dannjjm	6398	12	additional	additional	JJ
cord-023095-4dannjjm	6398	13	mechanism	mechanism	NN
cord-023095-4dannjjm	6398	14	by	by	IN
cord-023095-4dannjjm	6398	15	which	which	WDT
cord-023095-4dannjjm	6398	16	ingestion	ingestion	NN
cord-023095-4dannjjm	6398	17	of	of	IN
cord-023095-4dannjjm	6398	18	high	high	JJ
cord-023095-4dannjjm	6398	19	chloride	chloride	NN
cord-023095-4dannjjm	6398	20	(	(	-LRB-
cord-023095-4dannjjm	6398	21	acidogenic	acidogenic	NNP
cord-023095-4dannjjm	6398	22	)	)	-RRB-
cord-023095-4dannjjm	6398	23	rations	ration	NNS
cord-023095-4dannjjm	6398	24	prevents	prevent	VBZ
cord-023095-4dannjjm	6398	25	the	the	DT
cord-023095-4dannjjm	6398	26	clinical	clinical	JJ
cord-023095-4dannjjm	6398	27	signs	sign	NNS
cord-023095-4dannjjm	6398	28	of	of	IN
cord-023095-4dannjjm	6398	29	periparturient	periparturient	NN
cord-023095-4dannjjm	6398	30	paresis	paresis	NNP
cord-023095-4dannjjm	6398	31	.	.	.
cord-023095-4dannjjm	6399	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	6399	2	finding	finding	NN
cord-023095-4dannjjm	6399	3	is	be	VBZ
cord-023095-4dannjjm	6399	4	consistent	consistent	JJ
cord-023095-4dannjjm	6399	5	with	with	IN
cord-023095-4dannjjm	6399	6	the	the	DT
cord-023095-4dannjjm	6399	7	results	result	NNS
cord-023095-4dannjjm	6399	8	of	of	IN
cord-023095-4dannjjm	6399	9	other	other	JJ
cord-023095-4dannjjm	6399	10	studies	study	NNS
cord-023095-4dannjjm	6399	11	that	that	WDT
cord-023095-4dannjjm	6399	12	indicate	indicate	VBP
cord-023095-4dannjjm	6399	13	acidogenic	acidogenic	JJ
cord-023095-4dannjjm	6399	14	salts	salt	NNS
cord-023095-4dannjjm	6399	15	that	that	WDT
cord-023095-4dannjjm	6399	16	contain	contain	VBP
cord-023095-4dannjjm	6399	17	chloride	chloride	NN
cord-023095-4dannjjm	6399	18	as	as	IN
cord-023095-4dannjjm	6399	19	the	the	DT
cord-023095-4dannjjm	6399	20	predominant	predominant	JJ
cord-023095-4dannjjm	6399	21	anion	anion	NN
cord-023095-4dannjjm	6399	22	(	(	-LRB-
cord-023095-4dannjjm	6399	23	ie	ie	NNP
cord-023095-4dannjjm	6399	24	,	,	,
cord-023095-4dannjjm	6399	25	NH	NH	NNP
cord-023095-4dannjjm	6399	26	4	4	CD
cord-023095-4dannjjm	6399	27	Cl	Cl	NNP
cord-023095-4dannjjm	6399	28	,	,	,
cord-023095-4dannjjm	6399	29	CaCl	CaCl	NNP
cord-023095-4dannjjm	6399	30	2	2	CD
cord-023095-4dannjjm	6399	31	)	)	-RRB-
cord-023095-4dannjjm	6399	32	are	be	VBP
cord-023095-4dannjjm	6399	33	more	more	RBR
cord-023095-4dannjjm	6399	34	effective	effective	JJ
cord-023095-4dannjjm	6399	35	in	in	IN
cord-023095-4dannjjm	6399	36	increasing	increase	VBG
cord-023095-4dannjjm	6399	37	cCa	cCa	NNS
cord-023095-4dannjjm	6399	38	21	21	CD
cord-023095-4dannjjm	6399	39	than	than	IN
cord-023095-4dannjjm	6399	40	equimolar	equimolar	JJ
cord-023095-4dannjjm	6399	41	quantities	quantity	NNS
cord-023095-4dannjjm	6399	42	of	of	IN
cord-023095-4dannjjm	6399	43	acidogenic	acidogenic	NNP
cord-023095-4dannjjm	6399	44	salts	salt	NNS
cord-023095-4dannjjm	6399	45	such	such	JJ
cord-023095-4dannjjm	6399	46	as	as	IN
cord-023095-4dannjjm	6399	47	MgSO	MgSO	NNP
cord-023095-4dannjjm	6399	48	4	4	CD
cord-023095-4dannjjm	6399	49	.	.	.
cord-023095-4dannjjm	6400	1	Coagulase	coagulase	JJ
cord-023095-4dannjjm	6400	2	negative	negative	JJ
cord-023095-4dannjjm	6400	3	staphylococci	staphylococcus	NNS
cord-023095-4dannjjm	6400	4	(	(	-LRB-
cord-023095-4dannjjm	6400	5	CNS	CNS	NNP
cord-023095-4dannjjm	6400	6	)	)	-RRB-
cord-023095-4dannjjm	6400	7	are	be	VBP
cord-023095-4dannjjm	6400	8	among	among	IN
cord-023095-4dannjjm	6400	9	the	the	DT
cord-023095-4dannjjm	6400	10	most	most	RBS
cord-023095-4dannjjm	6400	11	common	common	JJ
cord-023095-4dannjjm	6400	12	bacteria	bacteria	NNS
cord-023095-4dannjjm	6400	13	isolated	isolate	VBN
cord-023095-4dannjjm	6400	14	from	from	IN
cord-023095-4dannjjm	6400	15	the	the	DT
cord-023095-4dannjjm	6400	16	bovine	bovine	JJ
cord-023095-4dannjjm	6400	17	mammary	mammary	JJ
cord-023095-4dannjjm	6400	18	gland	gland	NN
cord-023095-4dannjjm	6400	19	.	.	.
cord-023095-4dannjjm	6401	1	Historically	historically	RB
cord-023095-4dannjjm	6401	2	,	,	,
cord-023095-4dannjjm	6401	3	these	these	DT
cord-023095-4dannjjm	6401	4	bacteria	bacteria	NNS
cord-023095-4dannjjm	6401	5	were	be	VBD
cord-023095-4dannjjm	6401	6	lumped	lump	VBN
cord-023095-4dannjjm	6401	7	together	together	RB
cord-023095-4dannjjm	6401	8	as	as	IN
cord-023095-4dannjjm	6401	9	minor	minor	JJ
cord-023095-4dannjjm	6401	10	mastitis	mastitis	NN
cord-023095-4dannjjm	6401	11	pathogens	pathogen	NNS
cord-023095-4dannjjm	6401	12	.	.	.
cord-023095-4dannjjm	6402	1	Modern	modern	JJ
cord-023095-4dannjjm	6402	2	molecular	molecular	JJ
cord-023095-4dannjjm	6402	3	techniques	technique	NNS
cord-023095-4dannjjm	6402	4	have	have	VBP
cord-023095-4dannjjm	6402	5	allowed	allow	VBN
cord-023095-4dannjjm	6402	6	accurate	accurate	JJ
cord-023095-4dannjjm	6402	7	speciation	speciation	NN
cord-023095-4dannjjm	6402	8	and	and	CC
cord-023095-4dannjjm	6402	9	fingerprinting	fingerprinting	NN
cord-023095-4dannjjm	6402	10	of	of	IN
cord-023095-4dannjjm	6402	11	the	the	DT
cord-023095-4dannjjm	6402	12	CNS	CNS	NNP
cord-023095-4dannjjm	6402	13	species	specie	NNS
cord-023095-4dannjjm	6402	14	.	.	.
cord-023095-4dannjjm	6403	1	These	these	DT
cord-023095-4dannjjm	6403	2	methodologies	methodology	NNS
cord-023095-4dannjjm	6403	3	have	have	VBP
cord-023095-4dannjjm	6403	4	recently	recently	RB
cord-023095-4dannjjm	6403	5	been	be	VBN
cord-023095-4dannjjm	6403	6	applied	apply	VBN
cord-023095-4dannjjm	6403	7	to	to	IN
cord-023095-4dannjjm	6403	8	the	the	DT
cord-023095-4dannjjm	6403	9	study	study	NN
cord-023095-4dannjjm	6403	10	of	of	IN
cord-023095-4dannjjm	6403	11	CNS	CNS	NNP
cord-023095-4dannjjm	6403	12	in	in	IN
cord-023095-4dannjjm	6403	13	bovine	bovine	JJ
cord-023095-4dannjjm	6403	14	mastitis	mastitis	NN
cord-023095-4dannjjm	6403	15	.	.	.
cord-023095-4dannjjm	6404	1	The	the	DT
cord-023095-4dannjjm	6404	2	aim	aim	NN
cord-023095-4dannjjm	6404	3	of	of	IN
cord-023095-4dannjjm	6404	4	the	the	DT
cord-023095-4dannjjm	6404	5	studies	study	NNS
cord-023095-4dannjjm	6404	6	presented	present	VBN
cord-023095-4dannjjm	6404	7	here	here	RB
cord-023095-4dannjjm	6404	8	was	be	VBD
cord-023095-4dannjjm	6404	9	to	to	TO
cord-023095-4dannjjm	6404	10	evaluate	evaluate	VB
cord-023095-4dannjjm	6404	11	the	the	DT
cord-023095-4dannjjm	6404	12	role	role	NN
cord-023095-4dannjjm	6404	13	of	of	IN
cord-023095-4dannjjm	6404	14	individual	individual	JJ
cord-023095-4dannjjm	6404	15	CNS	CNS	NNP
cord-023095-4dannjjm	6404	16	species	specie	NNS
cord-023095-4dannjjm	6404	17	on	on	IN
cord-023095-4dannjjm	6404	18	milk	milk	NN
cord-023095-4dannjjm	6404	19	somatic	somatic	JJ
cord-023095-4dannjjm	6404	20	cell	cell	NN
cord-023095-4dannjjm	6404	21	count	count	NN
cord-023095-4dannjjm	6404	22	(	(	-LRB-
cord-023095-4dannjjm	6404	23	SCC	SCC	NNP
cord-023095-4dannjjm	6404	24	)	)	-RRB-
cord-023095-4dannjjm	6404	25	and	and	CC
cord-023095-4dannjjm	6404	26	duration	duration	NN
cord-023095-4dannjjm	6404	27	of	of	IN
cord-023095-4dannjjm	6404	28	intramammary	intramammary	JJ
cord-023095-4dannjjm	6404	29	infection	infection	NN
cord-023095-4dannjjm	6404	30	(	(	-LRB-
cord-023095-4dannjjm	6404	31	IMI	IMI	NNP
cord-023095-4dannjjm	6404	32	)	)	-RRB-
cord-023095-4dannjjm	6404	33	.	.	.
cord-023095-4dannjjm	6405	1	In	in	IN
cord-023095-4dannjjm	6405	2	the	the	DT
cord-023095-4dannjjm	6405	3	first	first	JJ
cord-023095-4dannjjm	6405	4	study	study	NN
cord-023095-4dannjjm	6405	5	,	,	,
cord-023095-4dannjjm	6405	6	mammary	mammary	JJ
cord-023095-4dannjjm	6405	7	quarter	quarter	NN
cord-023095-4dannjjm	6405	8	foremilk	foremilk	NN
cord-023095-4dannjjm	6405	9	samples	sample	NNS
cord-023095-4dannjjm	6405	10	were	be	VBD
cord-023095-4dannjjm	6405	11	aseptically	aseptically	RB
cord-023095-4dannjjm	6405	12	collected	collect	VBN
cord-023095-4dannjjm	6405	13	from	from	IN
cord-023095-4dannjjm	6405	14	all	all	DT
cord-023095-4dannjjm	6405	15	lactating	lactate	VBG
cord-023095-4dannjjm	6405	16	cattle	cattle	NNS
cord-023095-4dannjjm	6405	17	(	(	-LRB-
cord-023095-4dannjjm	6405	18	$	$	$
cord-023095-4dannjjm	6405	19	180	180	CD
cord-023095-4dannjjm	6405	20	head	head	NN
cord-023095-4dannjjm	6405	21	)	)	-RRB-
cord-023095-4dannjjm	6405	22	at	at	IN
cord-023095-4dannjjm	6405	23	the	the	DT
cord-023095-4dannjjm	6405	24	University	University	NNP
cord-023095-4dannjjm	6405	25	of	of	IN
cord-023095-4dannjjm	6405	26	Missouri	Missouri	NNP
cord-023095-4dannjjm	6405	27	dairy	dairy	NN
cord-023095-4dannjjm	6405	28	research	research	NN
cord-023095-4dannjjm	6405	29	center	center	NN
cord-023095-4dannjjm	6405	30	once	once	RB
cord-023095-4dannjjm	6405	31	monthly	monthly	RB
cord-023095-4dannjjm	6405	32	for	for	IN
cord-023095-4dannjjm	6405	33	17	17	CD
cord-023095-4dannjjm	6405	34	months	month	NNS
cord-023095-4dannjjm	6405	35	for	for	IN
cord-023095-4dannjjm	6405	36	bacterial	bacterial	JJ
cord-023095-4dannjjm	6405	37	culture	culture	NN
cord-023095-4dannjjm	6405	38	and	and	CC
cord-023095-4dannjjm	6405	39	milk	milk	NN
cord-023095-4dannjjm	6405	40	SCC	SCC	NNP
cord-023095-4dannjjm	6405	41	.	.	.
cord-023095-4dannjjm	6406	1	Staphylococcal	staphylococcal	JJ
cord-023095-4dannjjm	6406	2	isolates	isolate	NNS
cord-023095-4dannjjm	6406	3	were	be	VBD
cord-023095-4dannjjm	6406	4	speciated	speciate	VBN
cord-023095-4dannjjm	6406	5	by	by	IN
cord-023095-4dannjjm	6406	6	sequencing	sequence	VBG
cord-023095-4dannjjm	6406	7	the	the	DT
cord-023095-4dannjjm	6406	8	rpoB	rpoB	-RRB-
cord-023095-4dannjjm	6406	9	gene	gene	NN
cord-023095-4dannjjm	6406	10	and	and	CC
cord-023095-4dannjjm	6406	11	strain	strain	NN
cord-023095-4dannjjm	6406	12	-	-	HYPH
cord-023095-4dannjjm	6406	13	typed	type	VBN
cord-023095-4dannjjm	6406	14	using	use	VBG
cord-023095-4dannjjm	6406	15	pulsed	pulse	VBN
cord-023095-4dannjjm	6406	16	-	-	HYPH
cord-023095-4dannjjm	6406	17	field	field	NN
cord-023095-4dannjjm	6406	18	gel	gel	NN
cord-023095-4dannjjm	6406	19	electrophoresis	electrophoresis	NN
cord-023095-4dannjjm	6406	20	(	(	-LRB-
cord-023095-4dannjjm	6406	21	PFGE	PFGE	NNP
cord-023095-4dannjjm	6406	22	)	)	-RRB-
cord-023095-4dannjjm	6406	23	.	.	.
cord-023095-4dannjjm	6407	1	Using	use	VBG
cord-023095-4dannjjm	6407	2	species	specie	NNS
cord-023095-4dannjjm	6407	3	and	and	CC
cord-023095-4dannjjm	6407	4	fingerprint	fingerprint	NN
cord-023095-4dannjjm	6407	5	data	datum	NNS
cord-023095-4dannjjm	6407	6	along	along	IN
cord-023095-4dannjjm	6407	7	with	with	IN
cord-023095-4dannjjm	6407	8	published	publish	VBN
cord-023095-4dannjjm	6407	9	definitions	definition	NNS
cord-023095-4dannjjm	6407	10	for	for	IN
cord-023095-4dannjjm	6407	11	staphylococcal	staphylococcal	JJ
cord-023095-4dannjjm	6407	12	IMI	IMI	NNP
cord-023095-4dannjjm	6407	13	,	,	,
cord-023095-4dannjjm	6407	14	91	91	CD
cord-023095-4dannjjm	6407	15	CNS	CNS	NNP
cord-023095-4dannjjm	6407	16	IMIs	imi	NNS
cord-023095-4dannjjm	6407	17	were	be	VBD
cord-023095-4dannjjm	6407	18	identified	identify	VBN
cord-023095-4dannjjm	6407	19	.	.	.
cord-023095-4dannjjm	6408	1	Overall	overall	RB
cord-023095-4dannjjm	6408	2	,	,	,
cord-023095-4dannjjm	6408	3	11	11	CD
cord-023095-4dannjjm	6408	4	species	specie	NNS
cord-023095-4dannjjm	6408	5	of	of	IN
cord-023095-4dannjjm	6408	6	CNS	CNS	NNP
cord-023095-4dannjjm	6408	7	were	be	VBD
cord-023095-4dannjjm	6408	8	identified	identify	VBN
cord-023095-4dannjjm	6408	9	with	with	IN
cord-023095-4dannjjm	6408	10	Staphylococcus	Staphylococcus	NNP
cord-023095-4dannjjm	6408	11	chromogenes	chromogene	NNS
cord-023095-4dannjjm	6408	12	,	,	,
cord-023095-4dannjjm	6408	13	S.	S.	NNP
cord-023095-4dannjjm	6408	14	cohnii	cohnii	NNP
cord-023095-4dannjjm	6408	15	,	,	,
cord-023095-4dannjjm	6408	16	S.	S.	NNP
cord-023095-4dannjjm	6408	17	epidermidis	epidermidis	NN
cord-023095-4dannjjm	6408	18	,	,	,
cord-023095-4dannjjm	6408	19	and	and	CC
cord-023095-4dannjjm	6408	20	S.	S.	NNP
cord-023095-4dannjjm	6408	21	simulans	simulan	NNS
cord-023095-4dannjjm	6408	22	being	be	VBG
cord-023095-4dannjjm	6408	23	most	most	RBS
cord-023095-4dannjjm	6408	24	prevalent	prevalent	JJ
cord-023095-4dannjjm	6408	25	.	.	.
cord-023095-4dannjjm	6409	1	Duration	duration	NN
cord-023095-4dannjjm	6409	2	of	of	IN
cord-023095-4dannjjm	6409	3	IMI	IMI	NNP
cord-023095-4dannjjm	6409	4	and	and	CC
cord-023095-4dannjjm	6409	5	SCC	SCC	NNP
cord-023095-4dannjjm	6409	6	data	datum	NNS
cord-023095-4dannjjm	6409	7	were	be	VBD
cord-023095-4dannjjm	6409	8	analyzed	analyze	VBN
cord-023095-4dannjjm	6409	9	using	use	VBG
cord-023095-4dannjjm	6409	10	regression	regression	NN
cord-023095-4dannjjm	6409	11	models	model	NNS
cord-023095-4dannjjm	6409	12	accounting	account	VBG
cord-023095-4dannjjm	6409	13	for	for	IN
cord-023095-4dannjjm	6409	14	repeated	repeat	VBN
cord-023095-4dannjjm	6409	15	measures	measure	NNS
cord-023095-4dannjjm	6409	16	.	.	.
cord-023095-4dannjjm	6410	1	Mean	mean	JJ
cord-023095-4dannjjm	6410	2	milk	milk	NN
cord-023095-4dannjjm	6410	3	SCC	SCC	NNP
cord-023095-4dannjjm	6410	4	and	and	CC
cord-023095-4dannjjm	6410	5	duration	duration	NN
cord-023095-4dannjjm	6410	6	of	of	IN
cord-023095-4dannjjm	6410	7	IMI	IMI	NNP
cord-023095-4dannjjm	6410	8	were	be	VBD
cord-023095-4dannjjm	6410	9	found	find	VBN
cord-023095-4dannjjm	6410	10	to	to	TO
cord-023095-4dannjjm	6410	11	differ	differ	VB
cord-023095-4dannjjm	6410	12	between	between	IN
cord-023095-4dannjjm	6410	13	CNS	CNS	NNP
cord-023095-4dannjjm	6410	14	species	specie	NNS
cord-023095-4dannjjm	6410	15	(	(	-LRB-
cord-023095-4dannjjm	6410	16	P	p	NN
cord-023095-4dannjjm	6410	17	o	o	NN
cord-023095-4dannjjm	6410	18	0.05	0.05	CD
cord-023095-4dannjjm	6410	19	)	)	-RRB-
cord-023095-4dannjjm	6410	20	.	.	.
cord-023095-4dannjjm	6411	1	Although	although	IN
cord-023095-4dannjjm	6411	2	most	most	JJS
cord-023095-4dannjjm	6411	3	IMIs	imi	NNS
cord-023095-4dannjjm	6411	4	were	be	VBD
cord-023095-4dannjjm	6411	5	of	of	IN
cord-023095-4dannjjm	6411	6	short	short	JJ
cord-023095-4dannjjm	6411	7	duration	duration	NN
cord-023095-4dannjjm	6411	8	(	(	-LRB-
cord-023095-4dannjjm	6411	9	1	1	CD
cord-023095-4dannjjm	6411	10	month	month	NN
cord-023095-4dannjjm	6411	11	)	)	-RRB-
cord-023095-4dannjjm	6411	12	,	,	,
cord-023095-4dannjjm	6411	13	Staphylococcus	Staphylococcus	NNP
cord-023095-4dannjjm	6411	14	capitis	capitis	NN
cord-023095-4dannjjm	6411	15	and	and	CC
cord-023095-4dannjjm	6411	16	S.	S.	NNP
cord-023095-4dannjjm	6411	17	chromogenes	chromogene	NNS
cord-023095-4dannjjm	6411	18	IMIs	imi	NNS
cord-023095-4dannjjm	6411	19	had	have	VBD
cord-023095-4dannjjm	6411	20	longer	long	JJR
cord-023095-4dannjjm	6411	21	mean	mean	VB
cord-023095-4dannjjm	6411	22	durations	duration	NNS
cord-023095-4dannjjm	6411	23	of	of	IN
cord-023095-4dannjjm	6411	24	infection	infection	NN
cord-023095-4dannjjm	6411	25	than	than	IN
cord-023095-4dannjjm	6411	26	3	3	CD
cord-023095-4dannjjm	6411	27	or	or	CC
cord-023095-4dannjjm	6411	28	more	more	JJR
cord-023095-4dannjjm	6411	29	of	of	IN
cord-023095-4dannjjm	6411	30	the	the	DT
cord-023095-4dannjjm	6411	31	other	other	JJ
cord-023095-4dannjjm	6411	32	species	specie	NNS
cord-023095-4dannjjm	6411	33	isolated	isolate	VBN
cord-023095-4dannjjm	6411	34	.	.	.
cord-023095-4dannjjm	6412	1	Mean	mean	JJ
cord-023095-4dannjjm	6412	2	SCCs	scc	NNS
cord-023095-4dannjjm	6412	3	were	be	VBD
cord-023095-4dannjjm	6412	4	under	under	IN
cord-023095-4dannjjm	6412	5	350,000	350,000	CD
cord-023095-4dannjjm	6412	6	cells	cell	NNS
cord-023095-4dannjjm	6412	7	/	/	SYM
cord-023095-4dannjjm	6412	8	ml	ml	NNS
cord-023095-4dannjjm	6412	9	in	in	IN
cord-023095-4dannjjm	6412	10	most	most	JJS
cord-023095-4dannjjm	6412	11	cases	case	NNS
cord-023095-4dannjjm	6412	12	.	.	.
cord-023095-4dannjjm	6413	1	However	however	RB
cord-023095-4dannjjm	6413	2	,	,	,
cord-023095-4dannjjm	6413	3	Staphylococcus	Staphylococcus	NNP
cord-023095-4dannjjm	6413	4	simulans	simulan	NNS
cord-023095-4dannjjm	6413	5	and	and	CC
cord-023095-4dannjjm	6413	6	S.	S.	NNP
cord-023095-4dannjjm	6413	7	xylosus	xylosus	NNP
cord-023095-4dannjjm	6413	8	IMIs	imi	NNS
cord-023095-4dannjjm	6413	9	were	be	VBD
cord-023095-4dannjjm	6413	10	more	more	RBR
cord-023095-4dannjjm	6413	11	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6413	12	(	(	-LRB-
cord-023095-4dannjjm	6413	13	mean	mean	VB
cord-023095-4dannjjm	6413	14	4	4	CD
cord-023095-4dannjjm	6413	15	600,000	600,000	CD
cord-023095-4dannjjm	6413	16	cells	cell	NNS
cord-023095-4dannjjm	6413	17	/	/	SYM
cord-023095-4dannjjm	6413	18	ml	ml	NN
cord-023095-4dannjjm	6413	19	)	)	-RRB-
cord-023095-4dannjjm	6413	20	and	and	CC
cord-023095-4dannjjm	6413	21	had	have	VBD
cord-023095-4dannjjm	6413	22	a	a	DT
cord-023095-4dannjjm	6413	23	higher	high	JJR
cord-023095-4dannjjm	6413	24	mean	mean	JJ
cord-023095-4dannjjm	6413	25	SCC	SCC	NNP
cord-023095-4dannjjm	6413	26	than	than	IN
cord-023095-4dannjjm	6413	27	S.	S.	NNP
cord-023095-4dannjjm	6413	28	cohnii	cohnii	NNP
cord-023095-4dannjjm	6413	29	,	,	,
cord-023095-4dannjjm	6413	30	S.	S.	NNP
cord-023095-4dannjjm	6413	31	epidermidis	epidermidis	NN
cord-023095-4dannjjm	6413	32	,	,	,
cord-023095-4dannjjm	6413	33	and	and	CC
cord-023095-4dannjjm	6413	34	S.	S.	NNP
cord-023095-4dannjjm	6413	35	haemolyticus	haemolyticus	NNP
cord-023095-4dannjjm	6413	36	.	.	.
cord-023095-4dannjjm	6414	1	To	to	TO
cord-023095-4dannjjm	6414	2	examine	examine	VB
cord-023095-4dannjjm	6414	3	the	the	DT
cord-023095-4dannjjm	6414	4	relationship	relationship	NN
cord-023095-4dannjjm	6414	5	between	between	IN
cord-023095-4dannjjm	6414	6	CNS	CNS	NNP
cord-023095-4dannjjm	6414	7	IMI	IMI	NNP
cord-023095-4dannjjm	6414	8	and	and	CC
cord-023095-4dannjjm	6414	9	milk	milk	NN
cord-023095-4dannjjm	6414	10	SCC	SCC	NNP
cord-023095-4dannjjm	6414	11	in	in	IN
cord-023095-4dannjjm	6414	12	a	a	DT
cord-023095-4dannjjm	6414	13	larger	large	JJR
cord-023095-4dannjjm	6414	14	population	population	NN
cord-023095-4dannjjm	6414	15	of	of	IN
cord-023095-4dannjjm	6414	16	cattle	cattle	NNS
cord-023095-4dannjjm	6414	17	,	,	,
cord-023095-4dannjjm	6414	18	CNS	CNS	NNP
cord-023095-4dannjjm	6414	19	isolates	isolate	NNS
cord-023095-4dannjjm	6414	20	from	from	IN
cord-023095-4dannjjm	6414	21	the	the	DT
cord-023095-4dannjjm	6414	22	Canadian	canadian	JJ
cord-023095-4dannjjm	6414	23	Bovine	Bovine	NNP
cord-023095-4dannjjm	6414	24	Mastitis	Mastitis	NNP
cord-023095-4dannjjm	6414	25	Research	Research	NNP
cord-023095-4dannjjm	6414	26	Network	Network	NNP
cord-023095-4dannjjm	6414	27	(	(	-LRB-
cord-023095-4dannjjm	6414	28	CBMRN	CBMRN	NNP
cord-023095-4dannjjm	6414	29	)	)	-RRB-
cord-023095-4dannjjm	6414	30	culture	culture	NN
cord-023095-4dannjjm	6414	31	collection	collection	NN
cord-023095-4dannjjm	6414	32	were	be	VBD
cord-023095-4dannjjm	6414	33	obtained	obtain	VBN
cord-023095-4dannjjm	6414	34	for	for	IN
cord-023095-4dannjjm	6414	35	speciation	speciation	NN
cord-023095-4dannjjm	6414	36	.	.	.
cord-023095-4dannjjm	6415	1	Speciation	speciation	NN
cord-023095-4dannjjm	6415	2	and	and	CC
cord-023095-4dannjjm	6415	3	fingerprinting	fingerprinting	NN
cord-023095-4dannjjm	6415	4	were	be	VBD
cord-023095-4dannjjm	6415	5	performed	perform	VBN
cord-023095-4dannjjm	6415	6	as	as	IN
cord-023095-4dannjjm	6415	7	above	above	RB
cord-023095-4dannjjm	6415	8	.	.	.
cord-023095-4dannjjm	6416	1	Isolates	isolate	NNS
cord-023095-4dannjjm	6416	2	were	be	VBD
cord-023095-4dannjjm	6416	3	from	from	IN
cord-023095-4dannjjm	6416	4	subclinical	subclinical	JJ
cord-023095-4dannjjm	6416	5	IMI	IMI	NNP
cord-023095-4dannjjm	6416	6	from	from	IN
cord-023095-4dannjjm	6416	7	before	before	RB
cord-023095-4dannjjm	6416	8	and	and	CC
cord-023095-4dannjjm	6416	9	after	after	IN
cord-023095-4dannjjm	6416	10	the	the	DT
cord-023095-4dannjjm	6416	11	dry	dry	JJ
cord-023095-4dannjjm	6416	12	period	period	NN
cord-023095-4dannjjm	6416	13	and	and	CC
cord-023095-4dannjjm	6416	14	from	from	IN
cord-023095-4dannjjm	6416	15	subclinical	subclinical	JJ
cord-023095-4dannjjm	6416	16	IMI	IMI	NNP
cord-023095-4dannjjm	6416	17	during	during	IN
cord-023095-4dannjjm	6416	18	lactation	lactation	NN
cord-023095-4dannjjm	6416	19	.	.	.
cord-023095-4dannjjm	6417	1	Data	datum	NNS
cord-023095-4dannjjm	6417	2	associated	associate	VBN
cord-023095-4dannjjm	6417	3	with	with	IN
cord-023095-4dannjjm	6417	4	each	each	DT
cord-023095-4dannjjm	6417	5	isolate	isolate	NN
cord-023095-4dannjjm	6417	6	were	be	VBD
cord-023095-4dannjjm	6417	7	obtained	obtain	VBN
cord-023095-4dannjjm	6417	8	from	from	IN
cord-023095-4dannjjm	6417	9	the	the	DT
cord-023095-4dannjjm	6417	10	CBMRN	CBMRN	NNP
cord-023095-4dannjjm	6417	11	database	database	NN
cord-023095-4dannjjm	6417	12	.	.	.
cord-023095-4dannjjm	6418	1	Nine	nine	CD
cord-023095-4dannjjm	6418	2	-	-	HYPH
cord-023095-4dannjjm	6418	3	hundred	hundred	CD
cord-023095-4dannjjm	6418	4	-	-	HYPH
cord-023095-4dannjjm	6418	5	thirty	thirty	CD
cord-023095-4dannjjm	6418	6	-	-	HYPH
cord-023095-4dannjjm	6418	7	eight	eight	CD
cord-023095-4dannjjm	6418	8	isolates	isolate	NNS
cord-023095-4dannjjm	6418	9	from	from	IN
cord-023095-4dannjjm	6418	10	696	696	CD
cord-023095-4dannjjm	6418	11	mammary	mammary	JJ
cord-023095-4dannjjm	6418	12	quarters	quarter	NNS
cord-023095-4dannjjm	6418	13	in	in	IN
cord-023095-4dannjjm	6418	14	89	89	CD
cord-023095-4dannjjm	6418	15	herds	herd	NNS
cord-023095-4dannjjm	6418	16	were	be	VBD
cord-023095-4dannjjm	6418	17	successfully	successfully	RB
cord-023095-4dannjjm	6418	18	speciated	speciate	VBN
cord-023095-4dannjjm	6418	19	.	.	.
cord-023095-4dannjjm	6419	1	Twenty	twenty	CD
cord-023095-4dannjjm	6419	2	-	-	HYPH
cord-023095-4dannjjm	6419	3	two	two	CD
cord-023095-4dannjjm	6419	4	different	different	JJ
cord-023095-4dannjjm	6419	5	species	specie	NNS
cord-023095-4dannjjm	6419	6	of	of	IN
cord-023095-4dannjjm	6419	7	CNS	CNS	NNP
cord-023095-4dannjjm	6419	8	were	be	VBD
cord-023095-4dannjjm	6419	9	identified	identify	VBN
cord-023095-4dannjjm	6419	10	.	.	.
cord-023095-4dannjjm	6420	1	Staphylococcus	Staphylococcus	NNP
cord-023095-4dannjjm	6420	2	chromogenes	chromogene	NNS
cord-023095-4dannjjm	6420	3	was	be	VBD
cord-023095-4dannjjm	6420	4	the	the	DT
cord-023095-4dannjjm	6420	5	most	most	RBS
cord-023095-4dannjjm	6420	6	frequent	frequent	JJ
cord-023095-4dannjjm	6420	7	species	specie	NNS
cord-023095-4dannjjm	6420	8	identified	identify	VBD
cord-023095-4dannjjm	6420	9	accounting	account	VBG
cord-023095-4dannjjm	6420	10	for	for	IN
cord-023095-4dannjjm	6420	11	40	40	CD
cord-023095-4dannjjm	6420	12	%	%	NN
cord-023095-4dannjjm	6420	13	of	of	IN
cord-023095-4dannjjm	6420	14	the	the	DT
cord-023095-4dannjjm	6420	15	infections	infection	NNS
cord-023095-4dannjjm	6420	16	.	.	.
cord-023095-4dannjjm	6421	1	Three	three	CD
cord-023095-4dannjjm	6421	2	species	specie	NNS
cord-023095-4dannjjm	6421	3	,	,	,
cord-023095-4dannjjm	6421	4	S.	S.	NNP
cord-023095-4dannjjm	6421	5	chromogenes	chromogene	NNS
cord-023095-4dannjjm	6421	6	,	,	,
cord-023095-4dannjjm	6421	7	S.	S.	NNP
cord-023095-4dannjjm	6421	8	xylosus	xylosus	NNP
cord-023095-4dannjjm	6421	9	,	,	,
cord-023095-4dannjjm	6421	10	and	and	CC
cord-023095-4dannjjm	6421	11	S.	S.	NNP
cord-023095-4dannjjm	6421	12	simulans	simulans	NNP
cord-023095-4dannjjm	6421	13	accounted	account	VBD
cord-023095-4dannjjm	6421	14	for	for	IN
cord-023095-4dannjjm	6421	15	475	475	CD
cord-023095-4dannjjm	6421	16	%	%	NN
cord-023095-4dannjjm	6421	17	of	of	IN
cord-023095-4dannjjm	6421	18	all	all	DT
cord-023095-4dannjjm	6421	19	infections	infection	NNS
cord-023095-4dannjjm	6421	20	.	.	.
cord-023095-4dannjjm	6422	1	Data	datum	NNS
cord-023095-4dannjjm	6422	2	were	be	VBD
cord-023095-4dannjjm	6422	3	analyzed	analyze	VBN
cord-023095-4dannjjm	6422	4	using	use	VBG
cord-023095-4dannjjm	6422	5	a	a	DT
cord-023095-4dannjjm	6422	6	linear	linear	JJ
cord-023095-4dannjjm	6422	7	hierarchical	hierarchical	JJ
cord-023095-4dannjjm	6422	8	repeated	repeat	VBN
cord-023095-4dannjjm	6422	9	measures	measure	NNS
cord-023095-4dannjjm	6422	10	mixed	mixed	JJ
cord-023095-4dannjjm	6422	11	model	model	NN
cord-023095-4dannjjm	6422	12	.	.	.
cord-023095-4dannjjm	6423	1	Differences	difference	NNS
cord-023095-4dannjjm	6423	2	in	in	IN
cord-023095-4dannjjm	6423	3	mean	mean	JJ
cord-023095-4dannjjm	6423	4	SCC	SCC	NNP
cord-023095-4dannjjm	6423	5	were	be	VBD
cord-023095-4dannjjm	6423	6	found	find	VBN
cord-023095-4dannjjm	6423	7	between	between	IN
cord-023095-4dannjjm	6423	8	some	some	DT
cord-023095-4dannjjm	6423	9	CNS	CNS	NNP
cord-023095-4dannjjm	6423	10	species	specie	NNS
cord-023095-4dannjjm	6423	11	and	and	CC
cord-023095-4dannjjm	6423	12	culture	culture	NN
cord-023095-4dannjjm	6423	13	negative	negative	JJ
cord-023095-4dannjjm	6423	14	control	control	NN
cord-023095-4dannjjm	6423	15	quarters	quarter	NNS
cord-023095-4dannjjm	6423	16	and	and	CC
cord-023095-4dannjjm	6423	17	also	also	RB
cord-023095-4dannjjm	6423	18	between	between	IN
cord-023095-4dannjjm	6423	19	different	different	JJ
cord-023095-4dannjjm	6423	20	species	specie	NNS
cord-023095-4dannjjm	6423	21	of	of	IN
cord-023095-4dannjjm	6423	22	CNS	CNS	NNP
cord-023095-4dannjjm	6423	23	(	(	-LRB-
cord-023095-4dannjjm	6423	24	P	p	NN
cord-023095-4dannjjm	6423	25	o	o	NN
cord-023095-4dannjjm	6423	26	0.05	0.05	CD
cord-023095-4dannjjm	6423	27	)	)	-RRB-
cord-023095-4dannjjm	6423	28	.	.	.
cord-023095-4dannjjm	6424	1	Overall	overall	RB
cord-023095-4dannjjm	6424	2	,	,	,
cord-023095-4dannjjm	6424	3	our	-PRON-	PRP$
cord-023095-4dannjjm	6424	4	data	datum	NNS
cord-023095-4dannjjm	6424	5	demonstrate	demonstrate	VBP
cord-023095-4dannjjm	6424	6	potential	potential	JJ
cord-023095-4dannjjm	6424	7	differences	difference	NNS
cord-023095-4dannjjm	6424	8	in	in	IN
cord-023095-4dannjjm	6424	9	pathogenicity	pathogenicity	NN
cord-023095-4dannjjm	6424	10	between	between	IN
cord-023095-4dannjjm	6424	11	strains	strain	NNS
cord-023095-4dannjjm	6424	12	of	of	IN
cord-023095-4dannjjm	6424	13	CNS	CNS	NNP
cord-023095-4dannjjm	6424	14	that	that	WDT
cord-023095-4dannjjm	6424	15	cause	cause	VBP
cord-023095-4dannjjm	6424	16	bovine	bovine	JJ
cord-023095-4dannjjm	6424	17	mastitis	mastitis	NN
cord-023095-4dannjjm	6424	18	.	.	.
cord-023095-4dannjjm	6425	1	Passive	passive	JJ
cord-023095-4dannjjm	6425	2	transfer	transfer	NN
cord-023095-4dannjjm	6425	3	of	of	IN
cord-023095-4dannjjm	6425	4	maternally	maternally	RB
cord-023095-4dannjjm	6425	5	derived	derive	VBN
cord-023095-4dannjjm	6425	6	antibodies	antibody	NNS
cord-023095-4dannjjm	6425	7	via	via	IN
cord-023095-4dannjjm	6425	8	ingestion	ingestion	NN
cord-023095-4dannjjm	6425	9	of	of	IN
cord-023095-4dannjjm	6425	10	good	good	JJ
cord-023095-4dannjjm	6425	11	-	-	HYPH
cord-023095-4dannjjm	6425	12	quality	quality	NN
cord-023095-4dannjjm	6425	13	colostrum	colostrum	NN
cord-023095-4dannjjm	6425	14	within	within	IN
cord-023095-4dannjjm	6425	15	the	the	DT
cord-023095-4dannjjm	6425	16	first	first	JJ
cord-023095-4dannjjm	6425	17	24	24	CD
cord-023095-4dannjjm	6425	18	hours	hour	NNS
cord-023095-4dannjjm	6425	19	of	of	IN
cord-023095-4dannjjm	6425	20	life	life	NN
cord-023095-4dannjjm	6425	21	is	be	VBZ
cord-023095-4dannjjm	6425	22	crucial	crucial	JJ
cord-023095-4dannjjm	6425	23	for	for	IN
cord-023095-4dannjjm	6425	24	the	the	DT
cord-023095-4dannjjm	6425	25	health	health	NN
cord-023095-4dannjjm	6425	26	and	and	CC
cord-023095-4dannjjm	6425	27	future	future	JJ
cord-023095-4dannjjm	6425	28	productivity	productivity	NN
cord-023095-4dannjjm	6425	29	of	of	IN
cord-023095-4dannjjm	6425	30	dairy	dairy	NN
cord-023095-4dannjjm	6425	31	calves	calf	NNS
cord-023095-4dannjjm	6425	32	.	.	.
cord-023095-4dannjjm	6426	1	However	however	RB
cord-023095-4dannjjm	6426	2	,	,	,
cord-023095-4dannjjm	6426	3	infectious	infectious	JJ
cord-023095-4dannjjm	6426	4	diseases	disease	NNS
cord-023095-4dannjjm	6426	5	can	can	MD
cord-023095-4dannjjm	6426	6	be	be	VB
cord-023095-4dannjjm	6426	7	transmitted	transmit	VBN
cord-023095-4dannjjm	6426	8	via	via	IN
cord-023095-4dannjjm	6426	9	colostrum	colostrum	NN
cord-023095-4dannjjm	6426	10	feeding	feeding	NN
cord-023095-4dannjjm	6426	11	,	,	,
cord-023095-4dannjjm	6426	12	which	which	WDT
cord-023095-4dannjjm	6426	13	may	may	MD
cord-023095-4dannjjm	6426	14	require	require	VB
cord-023095-4dannjjm	6426	15	use	use	NN
cord-023095-4dannjjm	6426	16	of	of	IN
cord-023095-4dannjjm	6426	17	a	a	DT
cord-023095-4dannjjm	6426	18	colostrum	colostrum	NN
cord-023095-4dannjjm	6426	19	replacement	replacement	NN
cord-023095-4dannjjm	6426	20	product	product	NN
cord-023095-4dannjjm	6426	21	or	or	CC
cord-023095-4dannjjm	6426	22	pasteurization	pasteurization	NN
cord-023095-4dannjjm	6426	23	to	to	TO
cord-023095-4dannjjm	6426	24	decrease	decrease	VB
cord-023095-4dannjjm	6426	25	disease	disease	NN
cord-023095-4dannjjm	6426	26	transmission	transmission	NN
cord-023095-4dannjjm	6426	27	.	.	.
cord-023095-4dannjjm	6427	1	While	while	IN
cord-023095-4dannjjm	6427	2	pasteurization	pasteurization	NN
cord-023095-4dannjjm	6427	3	of	of	IN
cord-023095-4dannjjm	6427	4	colostrum	colostrum	NN
cord-023095-4dannjjm	6427	5	is	be	VBZ
cord-023095-4dannjjm	6427	6	effective	effective	JJ
cord-023095-4dannjjm	6427	7	for	for	IN
cord-023095-4dannjjm	6427	8	sterilization	sterilization	NN
cord-023095-4dannjjm	6427	9	,	,	,
cord-023095-4dannjjm	6427	10	heating	heating	NN
cord-023095-4dannjjm	6427	11	during	during	IN
cord-023095-4dannjjm	6427	12	pasteurization	pasteurization	NN
cord-023095-4dannjjm	6427	13	can	can	MD
cord-023095-4dannjjm	6427	14	alter	alter	VB
cord-023095-4dannjjm	6427	15	the	the	DT
cord-023095-4dannjjm	6427	16	viscosity	viscosity	NN
cord-023095-4dannjjm	6427	17	of	of	IN
cord-023095-4dannjjm	6427	18	colostrum	colostrum	NN
cord-023095-4dannjjm	6427	19	,	,	,
cord-023095-4dannjjm	6427	20	destroys	destroy	VBZ
cord-023095-4dannjjm	6427	21	important	important	JJ
cord-023095-4dannjjm	6427	22	nutritional	nutritional	JJ
cord-023095-4dannjjm	6427	23	biomolecules	biomolecule	NNS
cord-023095-4dannjjm	6427	24	,	,	,
cord-023095-4dannjjm	6427	25	and	and	CC
cord-023095-4dannjjm	6427	26	has	have	VBZ
cord-023095-4dannjjm	6427	27	been	be	VBN
cord-023095-4dannjjm	6427	28	shown	show	VBN
cord-023095-4dannjjm	6427	29	to	to	TO
cord-023095-4dannjjm	6427	30	decrease	decrease	VB
cord-023095-4dannjjm	6427	31	colostral	colostral	NNP
cord-023095-4dannjjm	6427	32	IgG	igg	NN
cord-023095-4dannjjm	6427	33	concentrations	concentration	NNS
cord-023095-4dannjjm	6427	34	.	.	.
cord-023095-4dannjjm	6428	1	The	the	DT
cord-023095-4dannjjm	6428	2	purpose	purpose	NN
cord-023095-4dannjjm	6428	3	of	of	IN
cord-023095-4dannjjm	6428	4	this	this	DT
cord-023095-4dannjjm	6428	5	study	study	NN
cord-023095-4dannjjm	6428	6	was	be	VBD
cord-023095-4dannjjm	6428	7	to	to	TO
cord-023095-4dannjjm	6428	8	investigate	investigate	VB
cord-023095-4dannjjm	6428	9	the	the	DT
cord-023095-4dannjjm	6428	10	effect	effect	NN
cord-023095-4dannjjm	6428	11	of	of	IN
cord-023095-4dannjjm	6428	12	high	high	JJ
cord-023095-4dannjjm	6428	13	pressure	pressure	NN
cord-023095-4dannjjm	6428	14	processing	processing	NN
cord-023095-4dannjjm	6428	15	(	(	-LRB-
cord-023095-4dannjjm	6428	16	HPP	hpp	NN
cord-023095-4dannjjm	6428	17	)	)	-RRB-
cord-023095-4dannjjm	6428	18	on	on	IN
cord-023095-4dannjjm	6428	19	the	the	DT
cord-023095-4dannjjm	6428	20	viscosity	viscosity	NN
cord-023095-4dannjjm	6428	21	,	,	,
cord-023095-4dannjjm	6428	22	IgG	igg	NN
cord-023095-4dannjjm	6428	23	concentration	concentration	NN
cord-023095-4dannjjm	6428	24	,	,	,
cord-023095-4dannjjm	6428	25	and	and	CC
cord-023095-4dannjjm	6428	26	bacterial	bacterial	JJ
cord-023095-4dannjjm	6428	27	contamination	contamination	NN
cord-023095-4dannjjm	6428	28	of	of	IN
cord-023095-4dannjjm	6428	29	bovine	bovine	JJ
cord-023095-4dannjjm	6428	30	colostrum	colostrum	NN
cord-023095-4dannjjm	6428	31	.	.	.
cord-023095-4dannjjm	6429	1	First	first	JJ
cord-023095-4dannjjm	6429	2	milking	milk	VBG
cord-023095-4dannjjm	6429	3	colostrum	colostrum	NN
cord-023095-4dannjjm	6429	4	samples	sample	NNS
cord-023095-4dannjjm	6429	5	were	be	VBD
cord-023095-4dannjjm	6429	6	collected	collect	VBN
cord-023095-4dannjjm	6429	7	from	from	IN
cord-023095-4dannjjm	6429	8	18	18	CD
cord-023095-4dannjjm	6429	9	cows	cow	NNS
cord-023095-4dannjjm	6429	10	from	from	IN
cord-023095-4dannjjm	6429	11	3	3	CD
cord-023095-4dannjjm	6429	12	different	different	JJ
cord-023095-4dannjjm	6429	13	farms	farm	NNS
cord-023095-4dannjjm	6429	14	,	,	,
cord-023095-4dannjjm	6429	15	and	and	CC
cord-023095-4dannjjm	6429	16	50	50	CD
cord-023095-4dannjjm	6429	17	ml	ml	NNS
cord-023095-4dannjjm	6429	18	aliquots	aliquot	NNS
cord-023095-4dannjjm	6429	19	of	of	IN
cord-023095-4dannjjm	6429	20	each	each	DT
cord-023095-4dannjjm	6429	21	sample	sample	NN
cord-023095-4dannjjm	6429	22	were	be	VBD
cord-023095-4dannjjm	6429	23	pooled	pool	VBN
cord-023095-4dannjjm	6429	24	for	for	IN
cord-023095-4dannjjm	6429	25	analysis	analysis	NN
cord-023095-4dannjjm	6429	26	.	.	.
cord-023095-4dannjjm	6430	1	Pooled	pool	VBN
cord-023095-4dannjjm	6430	2	colostrum	colostrum	NN
cord-023095-4dannjjm	6430	3	was	be	VBD
cord-023095-4dannjjm	6430	4	processed	process	VBN
cord-023095-4dannjjm	6430	5	in	in	IN
cord-023095-4dannjjm	6430	6	triplicate	triplicate	NN
cord-023095-4dannjjm	6430	7	using	use	VBG
cord-023095-4dannjjm	6430	8	an	an	DT
cord-023095-4dannjjm	6430	9	isostatic	isostatic	JJ
cord-023095-4dannjjm	6430	10	press	press	NN
cord-023095-4dannjjm	6430	11	at	at	IN
cord-023095-4dannjjm	6430	12	400	400	CD
cord-023095-4dannjjm	6430	13	MPa	MPa	NNS
cord-023095-4dannjjm	6430	14	(	(	-LRB-
cord-023095-4dannjjm	6430	15	60,000	60,000	CD
cord-023095-4dannjjm	6430	16	psig	psig	NNS
cord-023095-4dannjjm	6430	17	)	)	-RRB-
cord-023095-4dannjjm	6430	18	for	for	IN
cord-023095-4dannjjm	6430	19	0	0	CD
cord-023095-4dannjjm	6430	20	,	,	,
cord-023095-4dannjjm	6430	21	5	5	CD
cord-023095-4dannjjm	6430	22	,	,	,
cord-023095-4dannjjm	6430	23	15	15	CD
cord-023095-4dannjjm	6430	24	,	,	,
cord-023095-4dannjjm	6430	25	30	30	CD
cord-023095-4dannjjm	6430	26	,	,	,
cord-023095-4dannjjm	6430	27	and	and	CC
cord-023095-4dannjjm	6430	28	45	45	CD
cord-023095-4dannjjm	6430	29	minutes	minute	NNS
cord-023095-4dannjjm	6430	30	.	.	.
cord-023095-4dannjjm	6431	1	Samples	sample	NNS
cord-023095-4dannjjm	6431	2	were	be	VBD
cord-023095-4dannjjm	6431	3	tested	test	VBN
cord-023095-4dannjjm	6431	4	for	for	IN
cord-023095-4dannjjm	6431	5	the	the	DT
cord-023095-4dannjjm	6431	6	effects	effect	NNS
cord-023095-4dannjjm	6431	7	of	of	IN
cord-023095-4dannjjm	6431	8	HPP	hpp	NN
cord-023095-4dannjjm	6431	9	on	on	IN
cord-023095-4dannjjm	6431	10	the	the	DT
cord-023095-4dannjjm	6431	11	viscosity	viscosity	NN
cord-023095-4dannjjm	6431	12	,	,	,
cord-023095-4dannjjm	6431	13	bacterial	bacterial	JJ
cord-023095-4dannjjm	6431	14	load	load	NN
cord-023095-4dannjjm	6431	15	(	(	-LRB-
cord-023095-4dannjjm	6431	16	CFU	CFU	NNP
cord-023095-4dannjjm	6431	17	/	/	SYM
cord-023095-4dannjjm	6431	18	ml	ml	NNP
cord-023095-4dannjjm	6431	19	)	)	-RRB-
cord-023095-4dannjjm	6431	20	,	,	,
cord-023095-4dannjjm	6431	21	and	and	CC
cord-023095-4dannjjm	6431	22	IgG	igg	NN
cord-023095-4dannjjm	6431	23	concentration	concentration	NN
cord-023095-4dannjjm	6431	24	.	.	.
cord-023095-4dannjjm	6432	1	There	there	EX
cord-023095-4dannjjm	6432	2	was	be	VBD
cord-023095-4dannjjm	6432	3	a	a	DT
cord-023095-4dannjjm	6432	4	significant	significant	JJ
cord-023095-4dannjjm	6432	5	decrease	decrease	NN
cord-023095-4dannjjm	6432	6	(	(	-LRB-
cord-023095-4dannjjm	6432	7	p	p	NN
cord-023095-4dannjjm	6432	8	o	o	NN
cord-023095-4dannjjm	6432	9	0.05	0.05	CD
cord-023095-4dannjjm	6432	10	)	)	-RRB-
cord-023095-4dannjjm	6432	11	in	in	IN
cord-023095-4dannjjm	6432	12	bacterial	bacterial	JJ
cord-023095-4dannjjm	6432	13	load	load	NN
cord-023095-4dannjjm	6432	14	at	at	IN
cord-023095-4dannjjm	6432	15	each	each	DT
cord-023095-4dannjjm	6432	16	time	time	NN
cord-023095-4dannjjm	6432	17	point	point	NN
cord-023095-4dannjjm	6432	18	when	when	WRB
cord-023095-4dannjjm	6432	19	compared	compare	VBN
cord-023095-4dannjjm	6432	20	to	to	IN
cord-023095-4dannjjm	6432	21	time	time	NN
cord-023095-4dannjjm	6432	22	0	0	CD
cord-023095-4dannjjm	6432	23	.	.	.
cord-023095-4dannjjm	6433	1	No	no	DT
cord-023095-4dannjjm	6433	2	significant	significant	JJ
cord-023095-4dannjjm	6433	3	difference	difference	NN
cord-023095-4dannjjm	6433	4	in	in	IN
cord-023095-4dannjjm	6433	5	IgG	igg	NN
cord-023095-4dannjjm	6433	6	concentration	concentration	NN
cord-023095-4dannjjm	6433	7	was	be	VBD
cord-023095-4dannjjm	6433	8	found	find	VBN
cord-023095-4dannjjm	6433	9	between	between	IN
cord-023095-4dannjjm	6433	10	any	any	DT
cord-023095-4dannjjm	6433	11	time	time	NN
cord-023095-4dannjjm	6433	12	points	point	NNS
cord-023095-4dannjjm	6433	13	.	.	.
cord-023095-4dannjjm	6434	1	Subjectively	subjectively	RB
cord-023095-4dannjjm	6434	2	,	,	,
cord-023095-4dannjjm	6434	3	the	the	DT
cord-023095-4dannjjm	6434	4	colostrum	colostrum	NN
cord-023095-4dannjjm	6434	5	viscosity	viscosity	NN
cord-023095-4dannjjm	6434	6	appeared	appear	VBD
cord-023095-4dannjjm	6434	7	to	to	TO
cord-023095-4dannjjm	6434	8	increase	increase	VB
cord-023095-4dannjjm	6434	9	with	with	IN
cord-023095-4dannjjm	6434	10	the	the	DT
cord-023095-4dannjjm	6434	11	processing	processing	NN
cord-023095-4dannjjm	6434	12	time	time	NN
cord-023095-4dannjjm	6434	13	,	,	,
cord-023095-4dannjjm	6434	14	though	though	IN
cord-023095-4dannjjm	6434	15	the	the	DT
cord-023095-4dannjjm	6434	16	rheologic	rheologic	JJ
cord-023095-4dannjjm	6434	17	assessment	assessment	NN
cord-023095-4dannjjm	6434	18	has	have	VBZ
cord-023095-4dannjjm	6434	19	not	not	RB
cord-023095-4dannjjm	6434	20	been	be	VBN
cord-023095-4dannjjm	6434	21	completed	complete	VBN
cord-023095-4dannjjm	6434	22	at	at	IN
cord-023095-4dannjjm	6434	23	this	this	DT
cord-023095-4dannjjm	6434	24	time	time	NN
cord-023095-4dannjjm	6434	25	.	.	.
cord-023095-4dannjjm	6435	1	HPP	HPP	NNP
cord-023095-4dannjjm	6435	2	appears	appear	VBZ
cord-023095-4dannjjm	6435	3	to	to	TO
cord-023095-4dannjjm	6435	4	be	be	VB
cord-023095-4dannjjm	6435	5	an	an	DT
cord-023095-4dannjjm	6435	6	effective	effective	JJ
cord-023095-4dannjjm	6435	7	method	method	NN
cord-023095-4dannjjm	6435	8	to	to	TO
cord-023095-4dannjjm	6435	9	decrease	decrease	VB
cord-023095-4dannjjm	6435	10	bacterial	bacterial	JJ
cord-023095-4dannjjm	6435	11	contamination	contamination	NN
cord-023095-4dannjjm	6435	12	of	of	IN
cord-023095-4dannjjm	6435	13	colostrum	colostrum	NN
cord-023095-4dannjjm	6435	14	while	while	IN
cord-023095-4dannjjm	6435	15	maintaining	maintain	VBG
cord-023095-4dannjjm	6435	16	appropriate	appropriate	JJ
cord-023095-4dannjjm	6435	17	IgG	igg	NN
cord-023095-4dannjjm	6435	18	concentrations	concentration	NNS
cord-023095-4dannjjm	6435	19	.	.	.
cord-023095-4dannjjm	6436	1	Minimizing	minimize	VBG
cord-023095-4dannjjm	6436	2	the	the	DT
cord-023095-4dannjjm	6436	3	processing	processing	NN
cord-023095-4dannjjm	6436	4	time	time	NN
cord-023095-4dannjjm	6436	5	or	or	CC
cord-023095-4dannjjm	6436	6	pressure	pressure	NN
cord-023095-4dannjjm	6436	7	may	may	MD
cord-023095-4dannjjm	6436	8	be	be	VB
cord-023095-4dannjjm	6436	9	necessary	necessary	JJ
cord-023095-4dannjjm	6436	10	to	to	TO
cord-023095-4dannjjm	6436	11	maintain	maintain	VB
cord-023095-4dannjjm	6436	12	an	an	DT
cord-023095-4dannjjm	6436	13	acceptable	acceptable	JJ
cord-023095-4dannjjm	6436	14	viscosity	viscosity	NN
cord-023095-4dannjjm	6436	15	of	of	IN
cord-023095-4dannjjm	6436	16	the	the	DT
cord-023095-4dannjjm	6436	17	colostrum	colostrum	NN
cord-023095-4dannjjm	6436	18	.	.	.
cord-023095-4dannjjm	6437	1	Based	base	VBN
cord-023095-4dannjjm	6437	2	on	on	IN
cord-023095-4dannjjm	6437	3	these	these	DT
cord-023095-4dannjjm	6437	4	results	result	NNS
cord-023095-4dannjjm	6437	5	,	,	,
cord-023095-4dannjjm	6437	6	additional	additional	JJ
cord-023095-4dannjjm	6437	7	studies	study	NNS
cord-023095-4dannjjm	6437	8	are	be	VBP
cord-023095-4dannjjm	6437	9	justified	justify	VBN
cord-023095-4dannjjm	6437	10	in	in	IN
cord-023095-4dannjjm	6437	11	order	order	NN
cord-023095-4dannjjm	6437	12	to	to	TO
cord-023095-4dannjjm	6437	13	determine	determine	VB
cord-023095-4dannjjm	6437	14	the	the	DT
cord-023095-4dannjjm	6437	15	optimum	optimum	JJ
cord-023095-4dannjjm	6437	16	combination	combination	NN
cord-023095-4dannjjm	6437	17	of	of	IN
cord-023095-4dannjjm	6437	18	processing	processing	NN
cord-023095-4dannjjm	6437	19	time	time	NN
cord-023095-4dannjjm	6437	20	and	and	CC
cord-023095-4dannjjm	6437	21	pressure	pressure	NN
cord-023095-4dannjjm	6437	22	and	and	CC
cord-023095-4dannjjm	6437	23	the	the	DT
cord-023095-4dannjjm	6437	24	effect	effect	NN
cord-023095-4dannjjm	6437	25	of	of	IN
cord-023095-4dannjjm	6437	26	HPP	hpp	NN
cord-023095-4dannjjm	6437	27	on	on	IN
cord-023095-4dannjjm	6437	28	specific	specific	JJ
cord-023095-4dannjjm	6437	29	bovine	bovine	JJ
cord-023095-4dannjjm	6437	30	pathogens	pathogen	NNS
cord-023095-4dannjjm	6437	31	.	.	.
cord-023095-4dannjjm	6438	1	The	the	DT
cord-023095-4dannjjm	6438	2	heme	heme	NN
cord-023095-4dannjjm	6438	3	-	-	HYPH
cord-023095-4dannjjm	6438	4	associated	associate	VBN
cord-023095-4dannjjm	6438	5	iron	iron	NN
cord-023095-4dannjjm	6438	6	-	-	HYPH
cord-023095-4dannjjm	6438	7	binding	bind	VBG
cord-023095-4dannjjm	6438	8	apoprotein	apoprotein	NNP
cord-023095-4dannjjm	6438	9	lactoferrin	lactoferrin	NNP
cord-023095-4dannjjm	6438	10	(	(	-LRB-
cord-023095-4dannjjm	6438	11	LF	LF	NNP
cord-023095-4dannjjm	6438	12	)	)	-RRB-
cord-023095-4dannjjm	6438	13	is	be	VBZ
cord-023095-4dannjjm	6438	14	known	know	VBN
cord-023095-4dannjjm	6438	15	for	for	IN
cord-023095-4dannjjm	6438	16	its	-PRON-	PRP$
cord-023095-4dannjjm	6438	17	,	,	,
cord-023095-4dannjjm	6438	18	anti	anti	JJ
cord-023095-4dannjjm	6438	19	-	-	JJ
cord-023095-4dannjjm	6438	20	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6438	21	,	,	,
cord-023095-4dannjjm	6438	22	anti	anti	JJ
cord-023095-4dannjjm	6438	23	-	-	JJ
cord-023095-4dannjjm	6438	24	parasitic	parasitic	JJ
cord-023095-4dannjjm	6438	25	,	,	,
cord-023095-4dannjjm	6438	26	antimicrobial	antimicrobial	JJ
cord-023095-4dannjjm	6438	27	and	and	CC
cord-023095-4dannjjm	6438	28	bactericidal	bactericidal	JJ
cord-023095-4dannjjm	6438	29	effects	effect	NNS
cord-023095-4dannjjm	6438	30	.	.	.
cord-023095-4dannjjm	6439	1	Lactoferrin	Lactoferrin	NNP
cord-023095-4dannjjm	6439	2	demonstrates	demonstrate	VBZ
cord-023095-4dannjjm	6439	3	ubiquity	ubiquity	NN
cord-023095-4dannjjm	6439	4	throughout	throughout	IN
cord-023095-4dannjjm	6439	5	mammalian	mammalian	JJ
cord-023095-4dannjjm	6439	6	host	host	NN
cord-023095-4dannjjm	6439	7	biological	biological	JJ
cord-023095-4dannjjm	6439	8	fluids	fluid	NNS
cord-023095-4dannjjm	6439	9	:	:	:
cord-023095-4dannjjm	6439	10	Saliva	saliva	NN
cord-023095-4dannjjm	6439	11	;	;	:
cord-023095-4dannjjm	6439	12	tears	tear	NNS
cord-023095-4dannjjm	6439	13	;	;	:
cord-023095-4dannjjm	6439	14	mammary	mammary	JJ
cord-023095-4dannjjm	6439	15	secretions	secretion	NNS
cord-023095-4dannjjm	6439	16	,	,	,
cord-023095-4dannjjm	6439	17	as	as	RB
cord-023095-4dannjjm	6439	18	well	well	RB
cord-023095-4dannjjm	6439	19	as	as	IN
cord-023095-4dannjjm	6439	20	at	at	IN
cord-023095-4dannjjm	6439	21	mucosal	mucosal	JJ
cord-023095-4dannjjm	6439	22	surfaces	surface	NNS
cord-023095-4dannjjm	6439	23	.	.	.
cord-023095-4dannjjm	6440	1	It	-PRON-	PRP
cord-023095-4dannjjm	6440	2	is	be	VBZ
cord-023095-4dannjjm	6440	3	also	also	RB
cord-023095-4dannjjm	6440	4	released	release	VBN
cord-023095-4dannjjm	6440	5	from	from	IN
cord-023095-4dannjjm	6440	6	immune	immune	JJ
cord-023095-4dannjjm	6440	7	cells	cell	NNS
cord-023095-4dannjjm	6440	8	under	under	IN
cord-023095-4dannjjm	6440	9	pathogenic	pathogenic	JJ
cord-023095-4dannjjm	6440	10	stimulation	stimulation	NN
cord-023095-4dannjjm	6440	11	.	.	.
cord-023095-4dannjjm	6441	1	The	the	DT
cord-023095-4dannjjm	6441	2	purpose	purpose	NN
cord-023095-4dannjjm	6441	3	of	of	IN
cord-023095-4dannjjm	6441	4	this	this	DT
cord-023095-4dannjjm	6441	5	study	study	NN
cord-023095-4dannjjm	6441	6	which	which	WDT
cord-023095-4dannjjm	6441	7	has	have	VBZ
cord-023095-4dannjjm	6441	8	been	be	VBN
cord-023095-4dannjjm	6441	9	approved	approve	VBN
cord-023095-4dannjjm	6441	10	by	by	IN
cord-023095-4dannjjm	6441	11	Western	Western	NNP
cord-023095-4dannjjm	6441	12	University	University	NNP
cord-023095-4dannjjm	6441	13	's	's	POS
cord-023095-4dannjjm	6441	14	Institutional	Institutional	NNP
cord-023095-4dannjjm	6441	15	Animal	Animal	NNP
cord-023095-4dannjjm	6441	16	Care	Care	NNP
cord-023095-4dannjjm	6441	17	and	and	CC
cord-023095-4dannjjm	6441	18	Use	Use	NNP
cord-023095-4dannjjm	6441	19	Committee	Committee	NNP
cord-023095-4dannjjm	6441	20	is	be	VBZ
cord-023095-4dannjjm	6441	21	to	to	TO
cord-023095-4dannjjm	6441	22	further	further	RB
cord-023095-4dannjjm	6441	23	characterize	characterize	VB
cord-023095-4dannjjm	6441	24	the	the	DT
cord-023095-4dannjjm	6441	25	mechanisms	mechanism	NNS
cord-023095-4dannjjm	6441	26	through	through	IN
cord-023095-4dannjjm	6441	27	which	which	WDT
cord-023095-4dannjjm	6441	28	LF	LF	NNP
cord-023095-4dannjjm	6441	29	modulates	modulate	VBZ
cord-023095-4dannjjm	6441	30	inflammation	inflammation	NN
cord-023095-4dannjjm	6441	31	in	in	IN
cord-023095-4dannjjm	6441	32	the	the	DT
cord-023095-4dannjjm	6441	33	face	face	NN
cord-023095-4dannjjm	6441	34	of	of	IN
cord-023095-4dannjjm	6441	35	bacterial	bacterial	JJ
cord-023095-4dannjjm	6441	36	endotoxin	endotoxin	NN
cord-023095-4dannjjm	6441	37	.	.	.
cord-023095-4dannjjm	6442	1	It	-PRON-	PRP
cord-023095-4dannjjm	6442	2	was	be	VBD
cord-023095-4dannjjm	6442	3	hypothesized	hypothesize	VBN
cord-023095-4dannjjm	6442	4	that	that	IN
cord-023095-4dannjjm	6442	5	LF	LF	NNP
cord-023095-4dannjjm	6442	6	would	would	MD
cord-023095-4dannjjm	6442	7	inhibit	inhibit	VB
cord-023095-4dannjjm	6442	8	p38	p38	JJ
cord-023095-4dannjjm	6442	9	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	6442	10	.	.	.
cord-023095-4dannjjm	6443	1	Numerous	numerous	JJ
cord-023095-4dannjjm	6443	2	studies	study	NNS
cord-023095-4dannjjm	6443	3	speak	speak	VBP
cord-023095-4dannjjm	6443	4	to	to	IN
cord-023095-4dannjjm	6443	5	the	the	DT
cord-023095-4dannjjm	6443	6	ability	ability	NN
cord-023095-4dannjjm	6443	7	of	of	IN
cord-023095-4dannjjm	6443	8	LF	lf	NN
cord-023095-4dannjjm	6443	9	to	to	TO
cord-023095-4dannjjm	6443	10	alter	alter	VB
cord-023095-4dannjjm	6443	11	leukocyte	leukocyte	NN
cord-023095-4dannjjm	6443	12	function	function	NN
cord-023095-4dannjjm	6443	13	,	,	,
cord-023095-4dannjjm	6443	14	inhibit	inhibit	VB
cord-023095-4dannjjm	6443	15	cytokine	cytokine	JJ
cord-023095-4dannjjm	6443	16	production	production	NN
cord-023095-4dannjjm	6443	17	,	,	,
cord-023095-4dannjjm	6443	18	and	and	CC
cord-023095-4dannjjm	6443	19	bind	bind	VB
cord-023095-4dannjjm	6443	20	lipopolysaccharide	lipopolysaccharide	NN
cord-023095-4dannjjm	6443	21	(	(	-LRB-
cord-023095-4dannjjm	6443	22	LPS	LPS	NNP
cord-023095-4dannjjm	6443	23	)	)	-RRB-
cord-023095-4dannjjm	6443	24	;	;	:
cord-023095-4dannjjm	6443	25	mechanisms	mechanism	NNS
cord-023095-4dannjjm	6443	26	through	through	IN
cord-023095-4dannjjm	6443	27	which	which	WDT
cord-023095-4dannjjm	6443	28	it	-PRON-	PRP
cord-023095-4dannjjm	6443	29	is	be	VBZ
cord-023095-4dannjjm	6443	30	believed	believe	VBN
cord-023095-4dannjjm	6443	31	to	to	TO
cord-023095-4dannjjm	6443	32	achieve	achieve	VB
cord-023095-4dannjjm	6443	33	its	-PRON-	PRP$
cord-023095-4dannjjm	6443	34	anti	anti	JJ
cord-023095-4dannjjm	6443	35	-	-	JJ
cord-023095-4dannjjm	6443	36	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6443	37	effects	effect	NNS
cord-023095-4dannjjm	6443	38	.	.	.
cord-023095-4dannjjm	6444	1	Recently	recently	RB
cord-023095-4dannjjm	6444	2	,	,	,
cord-023095-4dannjjm	6444	3	investigators	investigator	NNS
cord-023095-4dannjjm	6444	4	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	6444	5	its	-PRON-	PRP$
cord-023095-4dannjjm	6444	6	ability	ability	NN
cord-023095-4dannjjm	6444	7	to	to	TO
cord-023095-4dannjjm	6444	8	interact	interact	VB
cord-023095-4dannjjm	6444	9	with	with	IN
cord-023095-4dannjjm	6444	10	host	host	NN
cord-023095-4dannjjm	6444	11	DNA	dna	NN
cord-023095-4dannjjm	6444	12	while	while	IN
cord-023095-4dannjjm	6444	13	others	other	NNS
cord-023095-4dannjjm	6444	14	describe	describe	VBP
cord-023095-4dannjjm	6444	15	regulation	regulation	NN
cord-023095-4dannjjm	6444	16	of	of	IN
cord-023095-4dannjjm	6444	17	granulocyte	granulocyte	NN
cord-023095-4dannjjm	6444	18	adhesion	adhesion	NN
cord-023095-4dannjjm	6444	19	and	and	CC
cord-023095-4dannjjm	6444	20	motility	motility	NN
cord-023095-4dannjjm	6444	21	;	;	:
cord-023095-4dannjjm	6444	22	elucidating	elucidate	VBG
cord-023095-4dannjjm	6444	23	its	-PRON-	PRP$
cord-023095-4dannjjm	6444	24	roles	role	NNS
cord-023095-4dannjjm	6444	25	in	in	IN
cord-023095-4dannjjm	6444	26	the	the	DT
cord-023095-4dannjjm	6444	27	apoptotic	apoptotic	JJ
cord-023095-4dannjjm	6444	28	signaling	signaling	NN
cord-023095-4dannjjm	6444	29	.	.	.
cord-023095-4dannjjm	6445	1	In	in	IN
cord-023095-4dannjjm	6445	2	earlier	early	JJR
cord-023095-4dannjjm	6445	3	studies	study	NNS
cord-023095-4dannjjm	6445	4	,	,	,
cord-023095-4dannjjm	6445	5	Dawes	Dawes	NNP
cord-023095-4dannjjm	6445	6	ME	ME	NNP
cord-023095-4dannjjm	6445	7	,	,	,
cord-023095-4dannjjm	6445	8	et	et	NNP
cord-023095-4dannjjm	6445	9	al	al	NNP
cord-023095-4dannjjm	6445	10	.	.	NNP
cord-023095-4dannjjm	6445	11	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	6445	12	lactoferrin	lactoferrin	NNP
cord-023095-4dannjjm	6445	13	's	's	POS
cord-023095-4dannjjm	6445	14	ability	ability	NN
cord-023095-4dannjjm	6445	15	to	to	TO
cord-023095-4dannjjm	6445	16	limit	limit	VB
cord-023095-4dannjjm	6445	17	the	the	DT
cord-023095-4dannjjm	6445	18	expression	expression	NN
cord-023095-4dannjjm	6445	19	of	of	IN
cord-023095-4dannjjm	6445	20	inducible	inducible	JJ
cord-023095-4dannjjm	6445	21	cyclooxygenase-2	cyclooxygenase-2	NNP
cord-023095-4dannjjm	6445	22	and	and	CC
cord-023095-4dannjjm	6445	23	the	the	DT
cord-023095-4dannjjm	6445	24	gelatinase	gelatinase	NN
cord-023095-4dannjjm	6445	25	,	,	,
cord-023095-4dannjjm	6445	26	matrix	matrix	NN
cord-023095-4dannjjm	6445	27	metalloproteinase	metalloproteinase	NN
cord-023095-4dannjjm	6445	28	-9	-9	NN
cord-023095-4dannjjm	6445	29	by	by	IN
cord-023095-4dannjjm	6445	30	LPS	LPS	NNP
cord-023095-4dannjjm	6445	31	-	-	HYPH
cord-023095-4dannjjm	6445	32	induced	induce	VBN
cord-023095-4dannjjm	6445	33	macrophages	macrophage	NNS
cord-023095-4dannjjm	6445	34	.	.	.
cord-023095-4dannjjm	6446	1	The	the	DT
cord-023095-4dannjjm	6446	2	generation	generation	NN
cord-023095-4dannjjm	6446	3	of	of	IN
cord-023095-4dannjjm	6446	4	these	these	DT
cord-023095-4dannjjm	6446	5	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6446	6	mediators	mediator	NNS
cord-023095-4dannjjm	6446	7	is	be	VBZ
cord-023095-4dannjjm	6446	8	modulated	modulate	VBN
cord-023095-4dannjjm	6446	9	by	by	IN
cord-023095-4dannjjm	6446	10	pro	pro	JJ
cord-023095-4dannjjm	6446	11	-	-	JJ
cord-023095-4dannjjm	6446	12	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6446	13	cytokines	cytokine	NNS
cord-023095-4dannjjm	6446	14	such	such	JJ
cord-023095-4dannjjm	6446	15	as	as	IN
cord-023095-4dannjjm	6446	16	interleukin-1	interleukin-1	NNP
cord-023095-4dannjjm	6446	17	b	b	.
cord-023095-4dannjjm	6446	18	(	(	-LRB-
cord-023095-4dannjjm	6446	19	IL-1	IL-1	NNP
cord-023095-4dannjjm	6446	20	b	b	NNP
cord-023095-4dannjjm	6446	21	)	)	-RRB-
cord-023095-4dannjjm	6446	22	and	and	CC
cord-023095-4dannjjm	6446	23	tumor	tumor	NN
cord-023095-4dannjjm	6446	24	necrosis	necrosis	NN
cord-023095-4dannjjm	6446	25	factor	factor	NN
cord-023095-4dannjjm	6446	26	-	-	HYPH
cord-023095-4dannjjm	6446	27	alpha	alpha	NN
cord-023095-4dannjjm	6446	28	(	(	-LRB-
cord-023095-4dannjjm	6446	29	TNF	TNF	NNP
cord-023095-4dannjjm	6446	30	-	-	HYPH
cord-023095-4dannjjm	6446	31	a	a	NNP
cord-023095-4dannjjm	6446	32	)	)	-RRB-
cord-023095-4dannjjm	6446	33	,	,	,
cord-023095-4dannjjm	6446	34	the	the	DT
cord-023095-4dannjjm	6446	35	production	production	NN
cord-023095-4dannjjm	6446	36	of	of	IN
cord-023095-4dannjjm	6446	37	both	both	DT
cord-023095-4dannjjm	6446	38	being	be	VBG
cord-023095-4dannjjm	6446	39	dependent	dependent	JJ
cord-023095-4dannjjm	6446	40	on	on	IN
cord-023095-4dannjjm	6446	41	signaling	signal	VBG
cord-023095-4dannjjm	6446	42	through	through	IN
cord-023095-4dannjjm	6446	43	the	the	DT
cord-023095-4dannjjm	6446	44	p38	p38	CD
cord-023095-4dannjjm	6446	45	mitogenactivated	mitogenactivated	JJ
cord-023095-4dannjjm	6446	46	protein	protein	NN
cord-023095-4dannjjm	6446	47	kinase	kinase	NN
cord-023095-4dannjjm	6446	48	(	(	-LRB-
cord-023095-4dannjjm	6446	49	MAPK	MAPK	NNP
cord-023095-4dannjjm	6446	50	)	)	-RRB-
cord-023095-4dannjjm	6446	51	pathway	pathway	NN
cord-023095-4dannjjm	6446	52	.	.	.
cord-023095-4dannjjm	6447	1	Peripheral	peripheral	JJ
cord-023095-4dannjjm	6447	2	mononuclear	mononuclear	NN
cord-023095-4dannjjm	6447	3	cells	cell	NNS
cord-023095-4dannjjm	6447	4	(	(	-LRB-
cord-023095-4dannjjm	6447	5	5	5	CD
cord-023095-4dannjjm	6447	6	Â	â	CD
cord-023095-4dannjjm	6447	7	10	10	CD
cord-023095-4dannjjm	6447	8	6	6	CD
cord-023095-4dannjjm	6447	9	)	)	-RRB-
cord-023095-4dannjjm	6447	10	isolated	isolate	VBN
cord-023095-4dannjjm	6447	11	from	from	IN
cord-023095-4dannjjm	6447	12	buffy	buffy	NNP
cord-023095-4dannjjm	6447	13	coat	coat	NN
cord-023095-4dannjjm	6447	14	cells	cell	NNS
cord-023095-4dannjjm	6447	15	of	of	IN
cord-023095-4dannjjm	6447	16	healthy	healthy	JJ
cord-023095-4dannjjm	6447	17	neonatal	neonatal	NN
cord-023095-4dannjjm	6447	18	to	to	IN
cord-023095-4dannjjm	6447	19	4-month	4-month	JJ
cord-023095-4dannjjm	6447	20	old	old	JJ
cord-023095-4dannjjm	6447	21	Holstein	Holstein	NNP
cord-023095-4dannjjm	6447	22	calves	calf	NNS
cord-023095-4dannjjm	6447	23	were	be	VBD
cord-023095-4dannjjm	6447	24	cultured	culture	VBN
cord-023095-4dannjjm	6447	25	in	in	IN
cord-023095-4dannjjm	6447	26	the	the	DT
cord-023095-4dannjjm	6447	27	presence	presence	NN
cord-023095-4dannjjm	6447	28	and	and	CC
cord-023095-4dannjjm	6447	29	absence	absence	NN
cord-023095-4dannjjm	6447	30	of	of	IN
cord-023095-4dannjjm	6447	31	LF	lf	NN
cord-023095-4dannjjm	6447	32	(	(	-LRB-
cord-023095-4dannjjm	6447	33	200	200	CD
cord-023095-4dannjjm	6447	34	ng	ng	NN
cord-023095-4dannjjm	6447	35	/	/	SYM
cord-023095-4dannjjm	6447	36	ml	ml	NNP
cord-023095-4dannjjm	6447	37	)	)	-RRB-
cord-023095-4dannjjm	6447	38	,	,	,
cord-023095-4dannjjm	6447	39	LPS	LPS	NNP
cord-023095-4dannjjm	6447	40	(	(	-LRB-
cord-023095-4dannjjm	6447	41	1	1	CD
cord-023095-4dannjjm	6447	42	mg	mg	NNP
cord-023095-4dannjjm	6447	43	/	/	SYM
cord-023095-4dannjjm	6447	44	ml	ml	NNP
cord-023095-4dannjjm	6447	45	)	)	-RRB-
cord-023095-4dannjjm	6447	46	,	,	,
cord-023095-4dannjjm	6447	47	anisomycin	anisomycin	NNP
cord-023095-4dannjjm	6447	48	(	(	-LRB-
cord-023095-4dannjjm	6447	49	25	25	CD
cord-023095-4dannjjm	6447	50	mg	mg	NNP
cord-023095-4dannjjm	6447	51	/	/	SYM
cord-023095-4dannjjm	6447	52	ml	ml	NNP
cord-023095-4dannjjm	6447	53	)	)	-RRB-
cord-023095-4dannjjm	6447	54	,	,	,
cord-023095-4dannjjm	6447	55	a	a	DT
cord-023095-4dannjjm	6447	56	known	know	VBN
cord-023095-4dannjjm	6447	57	p38	p38	CD
cord-023095-4dannjjm	6447	58	activator	activator	NN
cord-023095-4dannjjm	6447	59	-the	-the	NFP
cord-023095-4dannjjm	6447	60	positive	positive	JJ
cord-023095-4dannjjm	6447	61	control	control	NN
cord-023095-4dannjjm	6447	62	,	,	,
cord-023095-4dannjjm	6447	63	and	and	CC
cord-023095-4dannjjm	6447	64	50	50	CD
cord-023095-4dannjjm	6447	65	mM	mm	CD
cord-023095-4dannjjm	6447	66	of	of	IN
cord-023095-4dannjjm	6447	67	SB203580	sb203580	NN
cord-023095-4dannjjm	6447	68	,	,	,
cord-023095-4dannjjm	6447	69	a	a	DT
cord-023095-4dannjjm	6447	70	known	know	VBN
cord-023095-4dannjjm	6447	71	p38	p38	CD
cord-023095-4dannjjm	6447	72	inhibitor	inhibitor	NN
cord-023095-4dannjjm	6447	73	-the	-the	DT
cord-023095-4dannjjm	6447	74	negative	negative	JJ
cord-023095-4dannjjm	6447	75	control	control	NN
cord-023095-4dannjjm	6447	76	.	.	.
cord-023095-4dannjjm	6448	1	Sample	sample	JJ
cord-023095-4dannjjm	6448	2	lysates	lysate	NNS
cord-023095-4dannjjm	6448	3	obtained	obtain	VBD
cord-023095-4dannjjm	6448	4	post	post	NN
cord-023095-4dannjjm	6448	5	culture	culture	NN
cord-023095-4dannjjm	6448	6	was	be	VBD
cord-023095-4dannjjm	6448	7	subjected	subject	VBN
cord-023095-4dannjjm	6448	8	to	to	IN
cord-023095-4dannjjm	6448	9	immunoprecipitation	immunoprecipitation	NN
cord-023095-4dannjjm	6448	10	and	and	CC
cord-023095-4dannjjm	6448	11	kinase	kinase	NN
cord-023095-4dannjjm	6448	12	reactions	reaction	NNS
cord-023095-4dannjjm	6448	13	.	.	.
cord-023095-4dannjjm	6449	1	Reactions	reaction	NNS
cord-023095-4dannjjm	6449	2	were	be	VBD
cord-023095-4dannjjm	6449	3	terminated	terminate	VBN
cord-023095-4dannjjm	6449	4	under	under	IN
cord-023095-4dannjjm	6449	5	reducing	reduce	VBG
cord-023095-4dannjjm	6449	6	conditions	condition	NNS
cord-023095-4dannjjm	6449	7	and	and	CC
cord-023095-4dannjjm	6449	8	evaluated	evaluate	VBN
cord-023095-4dannjjm	6449	9	using	use	VBG
cord-023095-4dannjjm	6449	10	western	western	JJ
cord-023095-4dannjjm	6449	11	immunoblotting	immunoblotting	NN
cord-023095-4dannjjm	6449	12	.	.	.
cord-023095-4dannjjm	6450	1	Phosphorylation	Phosphorylation	NNP
cord-023095-4dannjjm	6450	2	of	of	IN
cord-023095-4dannjjm	6450	3	activated	activate	VBN
cord-023095-4dannjjm	6450	4	transcription	transcription	NN
cord-023095-4dannjjm	6450	5	factor-2	factor-2	NNP
cord-023095-4dannjjm	6450	6	(	(	-LRB-
cord-023095-4dannjjm	6450	7	ATF-2	ATF-2	NNP
cord-023095-4dannjjm	6450	8	)	)	-RRB-
cord-023095-4dannjjm	6450	9	by	by	IN
cord-023095-4dannjjm	6450	10	phosphorylated	phosphorylated	JJ
cord-023095-4dannjjm	6450	11	p38	p38	NN
cord-023095-4dannjjm	6450	12	served	serve	VBD
cord-023095-4dannjjm	6450	13	as	as	IN
cord-023095-4dannjjm	6450	14	the	the	DT
cord-023095-4dannjjm	6450	15	marker	marker	NN
cord-023095-4dannjjm	6450	16	of	of	IN
cord-023095-4dannjjm	6450	17	investigation	investigation	NN
cord-023095-4dannjjm	6450	18	.	.	.
cord-023095-4dannjjm	6451	1	Immunologically	immunologically	RB
cord-023095-4dannjjm	6451	2	reactive	reactive	JJ
cord-023095-4dannjjm	6451	3	ATF-2	ATF-2	NNP
cord-023095-4dannjjm	6451	4	expression	expression	NN
cord-023095-4dannjjm	6451	5	by	by	IN
cord-023095-4dannjjm	6451	6	LPS	LPS	NNP
cord-023095-4dannjjm	6451	7	and	and	CC
cord-023095-4dannjjm	6451	8	anisomycin	anisomycin	NNS
cord-023095-4dannjjm	6451	9	-	-	HYPH
cord-023095-4dannjjm	6451	10	treated	treat	VBN
cord-023095-4dannjjm	6451	11	cells	cell	NNS
cord-023095-4dannjjm	6451	12	was	be	VBD
cord-023095-4dannjjm	6451	13	compatible	compatible	JJ
cord-023095-4dannjjm	6451	14	with	with	IN
cord-023095-4dannjjm	6451	15	a	a	DT
cord-023095-4dannjjm	6451	16	prominent	prominent	JJ
cord-023095-4dannjjm	6451	17	band	band	NN
cord-023095-4dannjjm	6451	18	at	at	IN
cord-023095-4dannjjm	6451	19	40	40	CD
cord-023095-4dannjjm	6451	20	kD.	kd.	JJ
cord-023095-4dannjjm	6451	21	Evidence	evidence	NN
cord-023095-4dannjjm	6451	22	of	of	IN
cord-023095-4dannjjm	6451	23	LF	lf	NN
cord-023095-4dannjjm	6451	24	-	-	HYPH
cord-023095-4dannjjm	6451	25	induced	induce	VBN
cord-023095-4dannjjm	6451	26	inhibition	inhibition	NN
cord-023095-4dannjjm	6451	27	of	of	IN
cord-023095-4dannjjm	6451	28	LPS	LPS	NNP
cord-023095-4dannjjm	6451	29	-	-	HYPH
cord-023095-4dannjjm	6451	30	induced	induce	VBN
cord-023095-4dannjjm	6451	31	p-38	p-38	NNP
cord-023095-4dannjjm	6451	32	activation	activation	NN
cord-023095-4dannjjm	6451	33	was	be	VBD
cord-023095-4dannjjm	6451	34	observed	observe	VBN
cord-023095-4dannjjm	6451	35	in	in	IN
cord-023095-4dannjjm	6451	36	lanes	lane	NNS
cord-023095-4dannjjm	6451	37	representative	representative	NN
cord-023095-4dannjjm	6451	38	of	of	IN
cord-023095-4dannjjm	6451	39	co	co	NNS
cord-023095-4dannjjm	6451	40	-	-	NNS
cord-023095-4dannjjm	6451	41	cultures	culture	NNS
cord-023095-4dannjjm	6451	42	of	of	IN
cord-023095-4dannjjm	6451	43	LF	lf	NN
cord-023095-4dannjjm	6451	44	1	1	CD
cord-023095-4dannjjm	6451	45	LPS	lp	NNS
cord-023095-4dannjjm	6451	46	;	;	:
cord-023095-4dannjjm	6451	47	LF	LF	NNP
cord-023095-4dannjjm	6451	48	1	1	CD
cord-023095-4dannjjm	6451	49	anisomycin	anisomycin	NN
cord-023095-4dannjjm	6451	50	;	;	:
cord-023095-4dannjjm	6451	51	and	and	CC
cord-023095-4dannjjm	6451	52	anisomycin	anisomycin	NN
cord-023095-4dannjjm	6451	53	1	1	CD
cord-023095-4dannjjm	6451	54	SB203580	sb203580	NN
cord-023095-4dannjjm	6451	55	,	,	,
cord-023095-4dannjjm	6451	56	which	which	WDT
cord-023095-4dannjjm	6451	57	was	be	VBD
cord-023095-4dannjjm	6451	58	demonstrated	demonstrate	VBN
cord-023095-4dannjjm	6451	59	by	by	IN
cord-023095-4dannjjm	6451	60	decreased	decrease	VBN
cord-023095-4dannjjm	6451	61	immunological	immunological	JJ
cord-023095-4dannjjm	6451	62	reactivity	reactivity	NN
cord-023095-4dannjjm	6451	63	at	at	IN
cord-023095-4dannjjm	6451	64	40kD.	40kd.	CD
cord-023095-4dannjjm	6452	1	The	the	DT
cord-023095-4dannjjm	6452	2	findings	finding	NNS
cord-023095-4dannjjm	6452	3	here	here	RB
cord-023095-4dannjjm	6452	4	,	,	,
cord-023095-4dannjjm	6452	5	suggest	suggest	VBP
cord-023095-4dannjjm	6452	6	that	that	IN
cord-023095-4dannjjm	6452	7	LF	LF	NNP
cord-023095-4dannjjm	6452	8	interferes	interfere	VBZ
cord-023095-4dannjjm	6452	9	with	with	IN
cord-023095-4dannjjm	6452	10	LPS	LPS	NNP
cord-023095-4dannjjm	6452	11	-	-	HYPH
cord-023095-4dannjjm	6452	12	induced	induce	VBN
cord-023095-4dannjjm	6452	13	p-38	p-38	NNP
cord-023095-4dannjjm	6452	14	activation	activation	NN
cord-023095-4dannjjm	6452	15	of	of	IN
cord-023095-4dannjjm	6452	16	transcription	transcription	NN
cord-023095-4dannjjm	6452	17	factor	factor	NN
cord-023095-4dannjjm	6452	18	ATF-2	ATF-2	NNP
cord-023095-4dannjjm	6452	19	,	,	,
cord-023095-4dannjjm	6452	20	in	in	IN
cord-023095-4dannjjm	6452	21	vitro	vitro	FW
cord-023095-4dannjjm	6452	22	.	.	.
cord-023095-4dannjjm	6453	1	This	this	DT
cord-023095-4dannjjm	6453	2	serves	serve	VBZ
cord-023095-4dannjjm	6453	3	as	as	IN
cord-023095-4dannjjm	6453	4	additional	additional	JJ
cord-023095-4dannjjm	6453	5	proof	proof	NN
cord-023095-4dannjjm	6453	6	of	of	IN
cord-023095-4dannjjm	6453	7	its	-PRON-	PRP$
cord-023095-4dannjjm	6453	8	potential	potential	JJ
cord-023095-4dannjjm	6453	9	use	use	NN
cord-023095-4dannjjm	6453	10	in	in	IN
cord-023095-4dannjjm	6453	11	attenuating	attenuate	VBG
cord-023095-4dannjjm	6453	12	the	the	DT
cord-023095-4dannjjm	6453	13	systemic	systemic	JJ
cord-023095-4dannjjm	6453	14	effects	effect	NNS
cord-023095-4dannjjm	6453	15	of	of	IN
cord-023095-4dannjjm	6453	16	LPS	lp	NNS
cord-023095-4dannjjm	6453	17	.	.	.
cord-023095-4dannjjm	6454	1	Six	six	CD
cord-023095-4dannjjm	6454	2	(	(	-LRB-
cord-023095-4dannjjm	6454	3	6	6	LS
cord-023095-4dannjjm	6454	4	)	)	-RRB-
cord-023095-4dannjjm	6454	5	clinically	clinically	RB
cord-023095-4dannjjm	6454	6	normal	normal	JJ
cord-023095-4dannjjm	6454	7	,	,	,
cord-023095-4dannjjm	6454	8	purpose	purpose	NN
cord-023095-4dannjjm	6454	9	-	-	HYPH
cord-023095-4dannjjm	6454	10	bred	breed	VBN
cord-023095-4dannjjm	6454	11	cats	cat	NNS
cord-023095-4dannjjm	6454	12	of	of	IN
cord-023095-4dannjjm	6454	13	similar	similar	JJ
cord-023095-4dannjjm	6454	14	age	age	NN
cord-023095-4dannjjm	6454	15	and	and	CC
cord-023095-4dannjjm	6454	16	body	body	NN
cord-023095-4dannjjm	6454	17	condition	condition	NN
cord-023095-4dannjjm	6454	18	were	be	VBD
cord-023095-4dannjjm	6454	19	imaged	image	VBN
cord-023095-4dannjjm	6454	20	with	with	IN
cord-023095-4dannjjm	6454	21	[	[	-LRB-
cord-023095-4dannjjm	6454	22	18	18	CD
cord-023095-4dannjjm	6454	23	F	F	NNP
cord-023095-4dannjjm	6454	24	]	]	-RRB-
cord-023095-4dannjjm	6454	25	fluorodeoxyglucose	fluorodeoxyglucose	NNP
cord-023095-4dannjjm	6454	26	(	(	-LRB-
cord-023095-4dannjjm	6454	27	[	[	-LRB-
cord-023095-4dannjjm	6454	28	18	18	CD
cord-023095-4dannjjm	6454	29	F]FDG	f]fdg	NN
cord-023095-4dannjjm	6454	30	)	)	-RRB-
cord-023095-4dannjjm	6454	31	and	and	CC
cord-023095-4dannjjm	6454	32	[	[	-LRB-
cord-023095-4dannjjm	6454	33	18	18	CD
cord-023095-4dannjjm	6455	1	F]FTHA	F]FTHA	NNP
cord-023095-4dannjjm	6455	2	by	by	IN
cord-023095-4dannjjm	6455	3	using	use	VBG
cord-023095-4dannjjm	6455	4	dynamic	dynamic	JJ
cord-023095-4dannjjm	6455	5	cardiac	cardiac	NN
cord-023095-4dannjjm	6455	6	-	-	HYPH
cord-023095-4dannjjm	6455	7	gated	gated	JJ
cord-023095-4dannjjm	6455	8	fused	fuse	VBN
cord-023095-4dannjjm	6455	9	PET	PET	NNP
cord-023095-4dannjjm	6455	10	/	/	SYM
cord-023095-4dannjjm	6455	11	CT	CT	NNP
cord-023095-4dannjjm	6455	12	for	for	IN
cord-023095-4dannjjm	6455	13	kinetic	kinetic	JJ
cord-023095-4dannjjm	6455	14	assessment	assessment	NN
cord-023095-4dannjjm	6455	15	of	of	IN
cord-023095-4dannjjm	6455	16	myocardial	myocardial	JJ
cord-023095-4dannjjm	6455	17	glucose	glucose	NN
cord-023095-4dannjjm	6455	18	and	and	CC
cord-023095-4dannjjm	6455	19	fatty	fatty	JJ
cord-023095-4dannjjm	6455	20	acid	acid	NN
cord-023095-4dannjjm	6455	21	uptake	uptake	NN
cord-023095-4dannjjm	6455	22	and	and	CC
cord-023095-4dannjjm	6455	23	metabolism	metabolism	NN
cord-023095-4dannjjm	6455	24	,	,	,
cord-023095-4dannjjm	6455	25	respectively	respectively	RB
cord-023095-4dannjjm	6455	26	.	.	.
cord-023095-4dannjjm	6456	1	Kinetic	kinetic	JJ
cord-023095-4dannjjm	6456	2	tracer	tracer	NN
cord-023095-4dannjjm	6456	3	uptake	uptake	NN
cord-023095-4dannjjm	6456	4	within	within	IN
cord-023095-4dannjjm	6456	5	the	the	DT
cord-023095-4dannjjm	6456	6	myocardium	myocardium	NN
cord-023095-4dannjjm	6456	7	was	be	VBD
cord-023095-4dannjjm	6456	8	achieved	achieve	VBN
cord-023095-4dannjjm	6456	9	by	by	IN
cord-023095-4dannjjm	6456	10	initiating	initiate	VBG
cord-023095-4dannjjm	6456	11	image	image	NN
cord-023095-4dannjjm	6456	12	data	datum	NNS
cord-023095-4dannjjm	6456	13	acquisition	acquisition	NN
cord-023095-4dannjjm	6456	14	simultaneously	simultaneously	RB
cord-023095-4dannjjm	6456	15	with	with	IN
cord-023095-4dannjjm	6456	16	tracer	tracer	NN
cord-023095-4dannjjm	6456	17	injection	injection	NN
cord-023095-4dannjjm	6456	18	.	.	.
cord-023095-4dannjjm	6457	1	PET	PET	NNP
cord-023095-4dannjjm	6457	2	data	datum	NNS
cord-023095-4dannjjm	6457	3	were	be	VBD
cord-023095-4dannjjm	6457	4	acquired	acquire	VBN
cord-023095-4dannjjm	6457	5	over	over	IN
cord-023095-4dannjjm	6457	6	a	a	DT
cord-023095-4dannjjm	6457	7	1	1	CD
cord-023095-4dannjjm	6457	8	hour	hour	NN
cord-023095-4dannjjm	6457	9	period	period	NN
cord-023095-4dannjjm	6457	10	with	with	IN
cord-023095-4dannjjm	6457	11	the	the	DT
cord-023095-4dannjjm	6457	12	heart	heart	NN
cord-023095-4dannjjm	6457	13	in	in	IN
cord-023095-4dannjjm	6457	14	the	the	DT
cord-023095-4dannjjm	6457	15	center	center	NN
cord-023095-4dannjjm	6457	16	of	of	IN
cord-023095-4dannjjm	6457	17	the	the	DT
cord-023095-4dannjjm	6457	18	scanner	scanner	NN
cord-023095-4dannjjm	6457	19	field	field	NN
cord-023095-4dannjjm	6457	20	of	of	IN
cord-023095-4dannjjm	6457	21	view	view	NN
cord-023095-4dannjjm	6457	22	.	.	.
cord-023095-4dannjjm	6458	1	Regions	region	NNS
cord-023095-4dannjjm	6458	2	of	of	IN
cord-023095-4dannjjm	6458	3	interest	interest	NN
cord-023095-4dannjjm	6458	4	were	be	VBD
cord-023095-4dannjjm	6458	5	drawn	draw	VBN
cord-023095-4dannjjm	6458	6	in	in	IN
cord-023095-4dannjjm	6458	7	the	the	DT
cord-023095-4dannjjm	6458	8	left	left	JJ
cord-023095-4dannjjm	6458	9	ventricular	ventricular	JJ
cord-023095-4dannjjm	6458	10	wall	wall	NN
cord-023095-4dannjjm	6458	11	and	and	CC
cord-023095-4dannjjm	6458	12	thoracic	thoracic	JJ
cord-023095-4dannjjm	6458	13	aorta	aorta	NN
cord-023095-4dannjjm	6458	14	for	for	IN
cord-023095-4dannjjm	6458	15	the	the	DT
cord-023095-4dannjjm	6458	16	purpose	purpose	NN
cord-023095-4dannjjm	6458	17	of	of	IN
cord-023095-4dannjjm	6458	18	measuring	measure	VBG
cord-023095-4dannjjm	6458	19	the	the	DT
cord-023095-4dannjjm	6458	20	kinetics	kinetic	NNS
cord-023095-4dannjjm	6458	21	of	of	IN
cord-023095-4dannjjm	6458	22	tracer	tracer	NN
cord-023095-4dannjjm	6458	23	redistribution	redistribution	NN
cord-023095-4dannjjm	6458	24	.	.	.
cord-023095-4dannjjm	6459	1	Serial	serial	JJ
cord-023095-4dannjjm	6459	2	blood	blood	NN
cord-023095-4dannjjm	6459	3	samples	sample	NNS
cord-023095-4dannjjm	6459	4	were	be	VBD
cord-023095-4dannjjm	6459	5	also	also	RB
cord-023095-4dannjjm	6459	6	taken	take	VBN
cord-023095-4dannjjm	6459	7	during	during	IN
cord-023095-4dannjjm	6459	8	PET	pet	JJ
cord-023095-4dannjjm	6459	9	imaging	imaging	NN
cord-023095-4dannjjm	6459	10	for	for	IN
cord-023095-4dannjjm	6459	11	comparison	comparison	NN
cord-023095-4dannjjm	6459	12	with	with	IN
cord-023095-4dannjjm	6459	13	image	image	NN
cord-023095-4dannjjm	6459	14	data	datum	NNS
cord-023095-4dannjjm	6459	15	.	.	.
cord-023095-4dannjjm	6460	1	The	the	DT
cord-023095-4dannjjm	6460	2	equilibrium	equilibrium	NN
cord-023095-4dannjjm	6460	3	biodistribution	biodistribution	NN
cord-023095-4dannjjm	6460	4	of	of	IN
cord-023095-4dannjjm	6460	5	both	both	DT
cord-023095-4dannjjm	6460	6	tracers	tracer	NNS
cord-023095-4dannjjm	6460	7	was	be	VBD
cord-023095-4dannjjm	6460	8	documented	document	VBN
cord-023095-4dannjjm	6460	9	1	1	CD
cord-023095-4dannjjm	6460	10	hour	hour	NN
cord-023095-4dannjjm	6460	11	post	post	NN
cord-023095-4dannjjm	6460	12	-	-	NN
cord-023095-4dannjjm	6460	13	injection	injection	NN
cord-023095-4dannjjm	6460	14	in	in	IN
cord-023095-4dannjjm	6460	15	a	a	DT
cord-023095-4dannjjm	6460	16	whole	whole	JJ
cord-023095-4dannjjm	6460	17	body	body	NN
cord-023095-4dannjjm	6460	18	PET	PET	NNP
cord-023095-4dannjjm	6460	19	/	/	SYM
cord-023095-4dannjjm	6460	20	CT	CT	NNP
cord-023095-4dannjjm	6460	21	image	image	NN
cord-023095-4dannjjm	6460	22	.	.	.
cord-023095-4dannjjm	6461	1	Standard	standard	JJ
cord-023095-4dannjjm	6461	2	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	6461	3	examination	examination	NN
cord-023095-4dannjjm	6461	4	of	of	IN
cord-023095-4dannjjm	6461	5	cardiac	cardiac	JJ
cord-023095-4dannjjm	6461	6	structures	structure	NNS
cord-023095-4dannjjm	6461	7	was	be	VBD
cord-023095-4dannjjm	6461	8	also	also	RB
cord-023095-4dannjjm	6461	9	performed	perform	VBN
cord-023095-4dannjjm	6461	10	.	.	.
cord-023095-4dannjjm	6462	1	Both	both	DT
cord-023095-4dannjjm	6462	2	radiotracers	radiotracer	NNS
cord-023095-4dannjjm	6462	3	remained	remain	VBD
cord-023095-4dannjjm	6462	4	in	in	IN
cord-023095-4dannjjm	6462	5	the	the	DT
cord-023095-4dannjjm	6462	6	plasma	plasma	NN
cord-023095-4dannjjm	6462	7	fraction	fraction	NN
cord-023095-4dannjjm	6462	8	;	;	:
cord-023095-4dannjjm	6462	9	however	however	RB
cord-023095-4dannjjm	6462	10	,	,	,
cord-023095-4dannjjm	6462	11	[	[	-LRB-
cord-023095-4dannjjm	6462	12	18	18	CD
cord-023095-4dannjjm	6463	1	F]FTHA	F]FTHA	NNP
cord-023095-4dannjjm	6463	2	was	be	VBD
cord-023095-4dannjjm	6463	3	cleared	clear	VBN
cord-023095-4dannjjm	6463	4	from	from	IN
cord-023095-4dannjjm	6463	5	the	the	DT
cord-023095-4dannjjm	6463	6	more	more	RBR
cord-023095-4dannjjm	6463	7	rapidly	rapidly	RB
cord-023095-4dannjjm	6463	8	than	than	IN
cord-023095-4dannjjm	6463	9	[	[	-LRB-
cord-023095-4dannjjm	6463	10	18	18	CD
cord-023095-4dannjjm	6463	11	F]FDG	f]fdg	NN
cord-023095-4dannjjm	6463	12	(	(	-LRB-
cord-023095-4dannjjm	6463	13	t	t	NN
cord-023095-4dannjjm	6463	14	1/2	1/2	CD
cord-023095-4dannjjm	6463	15	$	$	$
cord-023095-4dannjjm	6463	16	2	2	CD
cord-023095-4dannjjm	6463	17	and	and	CC
cord-023095-4dannjjm	6463	18	$	$	$
cord-023095-4dannjjm	6463	19	20	20	CD
cord-023095-4dannjjm	6463	20	min	min	NN
cord-023095-4dannjjm	6463	21	,	,	,
cord-023095-4dannjjm	6463	22	respectively	respectively	RB
cord-023095-4dannjjm	6463	23	)	)	-RRB-
cord-023095-4dannjjm	6463	24	.	.	.
cord-023095-4dannjjm	6464	1	The	the	DT
cord-023095-4dannjjm	6464	2	tracers	tracer	NNS
cord-023095-4dannjjm	6464	3	were	be	VBD
cord-023095-4dannjjm	6464	4	readily	readily	RB
cord-023095-4dannjjm	6464	5	visualized	visualize	VBN
cord-023095-4dannjjm	6464	6	within	within	IN
cord-023095-4dannjjm	6464	7	the	the	DT
cord-023095-4dannjjm	6464	8	feline	feline	JJ
cord-023095-4dannjjm	6464	9	myocardium	myocardium	NN
cord-023095-4dannjjm	6464	10	in	in	IN
cord-023095-4dannjjm	6464	11	dynamic	dynamic	JJ
cord-023095-4dannjjm	6464	12	PET	pet	JJ
cord-023095-4dannjjm	6464	13	images	image	NNS
cord-023095-4dannjjm	6464	14	and	and	CC
cord-023095-4dannjjm	6464	15	analysis	analysis	NN
cord-023095-4dannjjm	6464	16	of	of	IN
cord-023095-4dannjjm	6464	17	the	the	DT
cord-023095-4dannjjm	6464	18	blood	blood	NN
cord-023095-4dannjjm	6464	19	pool	pool	NN
cord-023095-4dannjjm	6464	20	clearance	clearance	NN
cord-023095-4dannjjm	6464	21	from	from	IN
cord-023095-4dannjjm	6464	22	the	the	DT
cord-023095-4dannjjm	6464	23	kinetic	kinetic	JJ
cord-023095-4dannjjm	6464	24	image	image	NN
cord-023095-4dannjjm	6464	25	data	datum	NNS
cord-023095-4dannjjm	6464	26	agreed	agree	VBD
cord-023095-4dannjjm	6464	27	with	with	IN
cord-023095-4dannjjm	6464	28	blood	blood	NN
cord-023095-4dannjjm	6464	29	sampling	sampling	NN
cord-023095-4dannjjm	6464	30	data	datum	NNS
cord-023095-4dannjjm	6464	31	.	.	.
cord-023095-4dannjjm	6465	1	Myocardial	myocardial	JJ
cord-023095-4dannjjm	6465	2	uptake	uptake	NN
cord-023095-4dannjjm	6465	3	of	of	IN
cord-023095-4dannjjm	6465	4	each	each	DT
cord-023095-4dannjjm	6465	5	tracer	tracer	NN
cord-023095-4dannjjm	6465	6	was	be	VBD
cord-023095-4dannjjm	6465	7	best	well	RBS
cord-023095-4dannjjm	6465	8	described	describe	VBN
cord-023095-4dannjjm	6465	9	by	by	IN
cord-023095-4dannjjm	6465	10	a	a	DT
cord-023095-4dannjjm	6465	11	double	double	JJ
cord-023095-4dannjjm	6465	12	exponential	exponential	JJ
cord-023095-4dannjjm	6465	13	analysis	analysis	NN
cord-023095-4dannjjm	6465	14	and	and	CC
cord-023095-4dannjjm	6465	15	was	be	VBD
cord-023095-4dannjjm	6465	16	rapid	rapid	JJ
cord-023095-4dannjjm	6465	17	but	but	CC
cord-023095-4dannjjm	6465	18	variable	variable	JJ
cord-023095-4dannjjm	6465	19	among	among	IN
cord-023095-4dannjjm	6465	20	animals	animal	NNS
cord-023095-4dannjjm	6465	21	(	(	-LRB-
cord-023095-4dannjjm	6465	22	range	range	VBP
cord-023095-4dannjjm	6465	23	1	1	CD
cord-023095-4dannjjm	6465	24	-	-	SYM
cord-023095-4dannjjm	6465	25	30	30	CD
cord-023095-4dannjjm	6465	26	Bq	Bq	NNP
cord-023095-4dannjjm	6465	27	/	/	SYM
cord-023095-4dannjjm	6465	28	cc	cc	NN
cord-023095-4dannjjm	6465	29	/	/	SYM
cord-023095-4dannjjm	6465	30	min	min	NNP
cord-023095-4dannjjm	6465	31	)	)	-RRB-
cord-023095-4dannjjm	6465	32	,	,	,
cord-023095-4dannjjm	6465	33	although	although	IN
cord-023095-4dannjjm	6465	34	blood	blood	NN
cord-023095-4dannjjm	6465	35	glucose	glucose	NN
cord-023095-4dannjjm	6465	36	levels	level	NNS
cord-023095-4dannjjm	6465	37	were	be	VBD
cord-023095-4dannjjm	6465	38	similar	similar	JJ
cord-023095-4dannjjm	6465	39	in	in	IN
cord-023095-4dannjjm	6465	40	all	all	DT
cord-023095-4dannjjm	6465	41	cats	cat	NNS
cord-023095-4dannjjm	6465	42	during	during	IN
cord-023095-4dannjjm	6465	43	image	image	NN
cord-023095-4dannjjm	6465	44	acquisition	acquisition	NN
cord-023095-4dannjjm	6465	45	.	.	.
cord-023095-4dannjjm	6466	1	Physiologic	physiologic	JJ
cord-023095-4dannjjm	6466	2	[	[	-LRB-
cord-023095-4dannjjm	6466	3	18	18	CD
cord-023095-4dannjjm	6466	4	F]FDG	f]fdg	NN
cord-023095-4dannjjm	6466	5	was	be	VBD
cord-023095-4dannjjm	6466	6	observed	observe	VBN
cord-023095-4dannjjm	6466	7	in	in	IN
cord-023095-4dannjjm	6466	8	the	the	DT
cord-023095-4dannjjm	6466	9	brain	brain	NN
cord-023095-4dannjjm	6466	10	,	,	,
cord-023095-4dannjjm	6466	11	salivary	salivary	JJ
cord-023095-4dannjjm	6466	12	tissue	tissue	NN
cord-023095-4dannjjm	6466	13	,	,	,
cord-023095-4dannjjm	6466	14	gastrointestinal	gastrointestinal	JJ
cord-023095-4dannjjm	6466	15	tract	tract	NN
cord-023095-4dannjjm	6466	16	,	,	,
cord-023095-4dannjjm	6466	17	renal	renal	JJ
cord-023095-4dannjjm	6466	18	pelves	pelvis	NNS
cord-023095-4dannjjm	6466	19	and	and	CC
cord-023095-4dannjjm	6466	20	urinary	urinary	JJ
cord-023095-4dannjjm	6466	21	bladder	bladder	NN
cord-023095-4dannjjm	6466	22	,	,	,
cord-023095-4dannjjm	6466	23	with	with	IN
cord-023095-4dannjjm	6467	1	[	[	-LRB-
cord-023095-4dannjjm	6467	2	18	18	CD
cord-023095-4dannjjm	6467	3	F]FTHA	F]FTHA	NNP
cord-023095-4dannjjm	6467	4	seen	see	VBN
cord-023095-4dannjjm	6467	5	in	in	IN
cord-023095-4dannjjm	6467	6	the	the	DT
cord-023095-4dannjjm	6467	7	myocardium	myocardium	NN
cord-023095-4dannjjm	6467	8	,	,	,
cord-023095-4dannjjm	6467	9	liver	liver	NN
cord-023095-4dannjjm	6467	10	and	and	CC
cord-023095-4dannjjm	6467	11	renal	renal	JJ
cord-023095-4dannjjm	6467	12	cortex	cortex	NNS
cord-023095-4dannjjm	6467	13	.	.	.
cord-023095-4dannjjm	6468	1	All	all	DT
cord-023095-4dannjjm	6468	2	cats	cat	NNS
cord-023095-4dannjjm	6468	3	were	be	VBD
cord-023095-4dannjjm	6468	4	normotensive	normotensive	VBN
cord-023095-4dannjjm	6468	5	with	with	IN
cord-023095-4dannjjm	6468	6	normal	normal	JJ
cord-023095-4dannjjm	6468	7	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	6468	8	parameters	parameter	NNS
cord-023095-4dannjjm	6468	9	.	.	.
cord-023095-4dannjjm	6469	1	This	this	DT
cord-023095-4dannjjm	6469	2	study	study	NN
cord-023095-4dannjjm	6469	3	demonstrates	demonstrate	VBZ
cord-023095-4dannjjm	6469	4	the	the	DT
cord-023095-4dannjjm	6469	5	utility	utility	NN
cord-023095-4dannjjm	6469	6	of	of	IN
cord-023095-4dannjjm	6469	7	kinetic	kinetic	JJ
cord-023095-4dannjjm	6469	8	imaging	imaging	NN
cord-023095-4dannjjm	6469	9	using	use	VBG
cord-023095-4dannjjm	6469	10	The	the	DT
cord-023095-4dannjjm	6469	11	left	left	JJ
cord-023095-4dannjjm	6469	12	ventricle	ventricle	NN
cord-023095-4dannjjm	6469	13	(	(	-LRB-
cord-023095-4dannjjm	6469	14	LV	LV	NNP
cord-023095-4dannjjm	6469	15	)	)	-RRB-
cord-023095-4dannjjm	6469	16	shape	shape	NN
cord-023095-4dannjjm	6469	17	has	have	VBZ
cord-023095-4dannjjm	6469	18	been	be	VBN
cord-023095-4dannjjm	6469	19	suggested	suggest	VBN
cord-023095-4dannjjm	6469	20	to	to	TO
cord-023095-4dannjjm	6469	21	change	change	VB
cord-023095-4dannjjm	6469	22	from	from	IN
cord-023095-4dannjjm	6469	23	elliptical	elliptical	JJ
cord-023095-4dannjjm	6469	24	to	to	IN
cord-023095-4dannjjm	6469	25	more	more	RBR
cord-023095-4dannjjm	6469	26	globular	globular	JJ
cord-023095-4dannjjm	6469	27	in	in	IN
cord-023095-4dannjjm	6469	28	response	response	NN
cord-023095-4dannjjm	6469	29	to	to	IN
cord-023095-4dannjjm	6469	30	chronic	chronic	JJ
cord-023095-4dannjjm	6469	31	volume	volume	NN
cord-023095-4dannjjm	6469	32	overload	overload	NN
cord-023095-4dannjjm	6469	33	.	.	.
cord-023095-4dannjjm	6470	1	Real	real	JJ
cord-023095-4dannjjm	6470	2	-	-	HYPH
cord-023095-4dannjjm	6470	3	time	time	NN
cord-023095-4dannjjm	6470	4	three	three	CD
cord-023095-4dannjjm	6470	5	-	-	HYPH
cord-023095-4dannjjm	6470	6	dimensional	dimensional	JJ
cord-023095-4dannjjm	6470	7	echocardiography	echocardiography	NN
cord-023095-4dannjjm	6470	8	(	(	-LRB-
cord-023095-4dannjjm	6470	9	RT3DE	RT3DE	NNP
cord-023095-4dannjjm	6470	10	)	)	-RRB-
cord-023095-4dannjjm	6470	11	offers	offer	VBZ
cord-023095-4dannjjm	6470	12	new	new	JJ
cord-023095-4dannjjm	6470	13	modalities	modality	NNS
cord-023095-4dannjjm	6470	14	for	for	IN
cord-023095-4dannjjm	6470	15	LV	LV	NNP
cord-023095-4dannjjm	6470	16	assessment	assessment	NN
cord-023095-4dannjjm	6470	17	.	.	.
cord-023095-4dannjjm	6471	1	The	the	DT
cord-023095-4dannjjm	6471	2	aim	aim	NN
cord-023095-4dannjjm	6471	3	of	of	IN
cord-023095-4dannjjm	6471	4	the	the	DT
cord-023095-4dannjjm	6471	5	study	study	NN
cord-023095-4dannjjm	6471	6	was	be	VBD
cord-023095-4dannjjm	6471	7	to	to	TO
cord-023095-4dannjjm	6471	8	investigate	investigate	VB
cord-023095-4dannjjm	6471	9	left	leave	VBN
cord-023095-4dannjjm	6471	10	ventricular	ventricular	JJ
cord-023095-4dannjjm	6471	11	changes	change	NNS
cord-023095-4dannjjm	6471	12	in	in	IN
cord-023095-4dannjjm	6471	13	shape	shape	NN
cord-023095-4dannjjm	6471	14	and	and	CC
cord-023095-4dannjjm	6471	15	volume	volume	NN
cord-023095-4dannjjm	6471	16	occurring	occur	VBG
cord-023095-4dannjjm	6471	17	in	in	IN
cord-023095-4dannjjm	6471	18	response	response	NN
cord-023095-4dannjjm	6471	19	to	to	IN
cord-023095-4dannjjm	6471	20	different	different	JJ
cord-023095-4dannjjm	6471	21	severities	severity	NNS
cord-023095-4dannjjm	6471	22	of	of	IN
cord-023095-4dannjjm	6471	23	naturally	naturally	RB
cord-023095-4dannjjm	6471	24	acquired	acquire	VBN
cord-023095-4dannjjm	6471	25	myxomatous	myxomatous	JJ
cord-023095-4dannjjm	6471	26	mitral	mitral	JJ
cord-023095-4dannjjm	6471	27	valve	valve	NN
cord-023095-4dannjjm	6471	28	disease	disease	NN
cord-023095-4dannjjm	6471	29	(	(	-LRB-
cord-023095-4dannjjm	6471	30	MMVD	MMVD	NNP
cord-023095-4dannjjm	6471	31	)	)	-RRB-
cord-023095-4dannjjm	6471	32	in	in	IN
cord-023095-4dannjjm	6471	33	dogs	dog	NNS
cord-023095-4dannjjm	6471	34	using	use	VBG
cord-023095-4dannjjm	6471	35	RT3DE	RT3DE	NNS
cord-023095-4dannjjm	6471	36	.	.	.
cord-023095-4dannjjm	6472	1	Privately	privately	RB
cord-023095-4dannjjm	6472	2	owned	own	VBN
cord-023095-4dannjjm	6472	3	dogs	dog	NNS
cord-023095-4dannjjm	6472	4	were	be	VBD
cord-023095-4dannjjm	6472	5	classified	classify	VBN
cord-023095-4dannjjm	6472	6	by	by	IN
cord-023095-4dannjjm	6472	7	standard	standard	JJ
cord-023095-4dannjjm	6472	8	echocardiography	echocardiography	NN
cord-023095-4dannjjm	6472	9	into	into	IN
cord-023095-4dannjjm	6472	10	:	:	:
cord-023095-4dannjjm	6472	11	Healthy	Healthy	NNP
cord-023095-4dannjjm	6472	12	(	(	-LRB-
cord-023095-4dannjjm	6472	13	20	20	CD
cord-023095-4dannjjm	6472	14	)	)	-RRB-
cord-023095-4dannjjm	6472	15	,	,	,
cord-023095-4dannjjm	6472	16	mild	mild	JJ
cord-023095-4dannjjm	6472	17	(	(	-LRB-
cord-023095-4dannjjm	6472	18	20	20	CD
cord-023095-4dannjjm	6472	19	)	)	-RRB-
cord-023095-4dannjjm	6472	20	,	,	,
cord-023095-4dannjjm	6472	21	moderate	moderate	JJ
cord-023095-4dannjjm	6472	22	(	(	-LRB-
cord-023095-4dannjjm	6472	23	8)	8)	NN
cord-023095-4dannjjm	6472	24	and	and	CC
cord-023095-4dannjjm	6472	25	severe	severe	JJ
cord-023095-4dannjjm	6472	26	MMVD	MMVD	NNP
cord-023095-4dannjjm	6472	27	(	(	-LRB-
cord-023095-4dannjjm	6472	28	17	17	CD
cord-023095-4dannjjm	6472	29	)	)	-RRB-
cord-023095-4dannjjm	6472	30	.	.	.
cord-023095-4dannjjm	6473	1	A	a	DT
cord-023095-4dannjjm	6473	2	LV	LV	NNP
cord-023095-4dannjjm	6473	3	cast	cast	NN
cord-023095-4dannjjm	6473	4	was	be	VBD
cord-023095-4dannjjm	6473	5	obtained	obtain	VBN
cord-023095-4dannjjm	6473	6	using	use	VBG
cord-023095-4dannjjm	6473	7	semi	semi	RB
cord-023095-4dannjjm	6473	8	-	-	JJ
cord-023095-4dannjjm	6473	9	automated	automate	VBN
cord-023095-4dannjjm	6473	10	endocardial	endocardial	JJ
cord-023095-4dannjjm	6473	11	border	border	NN
cord-023095-4dannjjm	6473	12	tracking	tracking	NN
cord-023095-4dannjjm	6473	13	from	from	IN
cord-023095-4dannjjm	6473	14	RT3DE	rt3de	NN
cord-023095-4dannjjm	6473	15	dataset	dataset	NN
cord-023095-4dannjjm	6473	16	,	,	,
cord-023095-4dannjjm	6473	17	from	from	IN
cord-023095-4dannjjm	6473	18	which	which	WDT
cord-023095-4dannjjm	6473	19	global	global	JJ
cord-023095-4dannjjm	6473	20	and	and	CC
cord-023095-4dannjjm	6473	21	regional	regional	JJ
cord-023095-4dannjjm	6473	22	(	(	-LRB-
cord-023095-4dannjjm	6473	23	automatically	automatically	RB
cord-023095-4dannjjm	6473	24	acquired	acquire	VBN
cord-023095-4dannjjm	6473	25	basal	basal	NN
cord-023095-4dannjjm	6473	26	,	,	,
cord-023095-4dannjjm	6473	27	mid	mid	JJ
cord-023095-4dannjjm	6473	28	,	,	,
cord-023095-4dannjjm	6473	29	and	and	CC
cord-023095-4dannjjm	6473	30	apical	apical	JJ
cord-023095-4dannjjm	6473	31	segments	segment	NNS
cord-023095-4dannjjm	6473	32	based	base	VBN
cord-023095-4dannjjm	6473	33	on	on	IN
cord-023095-4dannjjm	6473	34	LV	LV	NNP
cord-023095-4dannjjm	6473	35	long	long	JJ
cord-023095-4dannjjm	6473	36	-	-	HYPH
cord-023095-4dannjjm	6473	37	axis	axis	NN
cord-023095-4dannjjm	6473	38	dimension	dimension	NN
cord-023095-4dannjjm	6473	39	)	)	-RRB-
cord-023095-4dannjjm	6473	40	end	end	NN
cord-023095-4dannjjm	6473	41	-	-	HYPH
cord-023095-4dannjjm	6473	42	diastolic	diastolic	JJ
cord-023095-4dannjjm	6473	43	(	(	-LRB-
cord-023095-4dannjjm	6473	44	EDV	EDV	NNP
cord-023095-4dannjjm	6473	45	)	)	-RRB-
cord-023095-4dannjjm	6473	46	and	and	CC
cord-023095-4dannjjm	6473	47	endsystolic	endsystolic	JJ
cord-023095-4dannjjm	6473	48	volumes	volume	NNS
cord-023095-4dannjjm	6473	49	(	(	-LRB-
cord-023095-4dannjjm	6473	50	ESV	ESV	NNP
cord-023095-4dannjjm	6473	51	)	)	-RRB-
cord-023095-4dannjjm	6473	52	,	,	,
cord-023095-4dannjjm	6473	53	LV	LV	NNP
cord-023095-4dannjjm	6473	54	Long	Long	NNP
cord-023095-4dannjjm	6473	55	-	-	HYPH
cord-023095-4dannjjm	6473	56	axis	axis	NN
cord-023095-4dannjjm	6473	57	dimension	dimension	NN
cord-023095-4dannjjm	6473	58	and	and	CC
cord-023095-4dannjjm	6473	59	RT3DE	RT3DE	NNP
cord-023095-4dannjjm	6473	60	Sphericity	Sphericity	NNP
cord-023095-4dannjjm	6473	61	index	index	NN
cord-023095-4dannjjm	6473	62	,	,	,
cord-023095-4dannjjm	6473	63	were	be	VBD
cord-023095-4dannjjm	6473	64	derived	derive	VBN
cord-023095-4dannjjm	6473	65	.	.	.
cord-023095-4dannjjm	6474	1	Global	global	JJ
cord-023095-4dannjjm	6474	2	and	and	CC
cord-023095-4dannjjm	6474	3	regional	regional	JJ
cord-023095-4dannjjm	6474	4	EDV	EDV	NNP
cord-023095-4dannjjm	6474	5	and	and	CC
cord-023095-4dannjjm	6474	6	ESV	ESV	NNP
cord-023095-4dannjjm	6474	7	increased	increase	VBD
cord-023095-4dannjjm	6474	8	significantly	significantly	RB
cord-023095-4dannjjm	6474	9	with	with	IN
cord-023095-4dannjjm	6474	10	increasing	increase	VBG
cord-023095-4dannjjm	6474	11	MMVD	MMVD	NNP
cord-023095-4dannjjm	6474	12	severity	severity	NN
cord-023095-4dannjjm	6474	13	,	,	,
cord-023095-4dannjjm	6474	14	assessed	assess	VBN
cord-023095-4dannjjm	6474	15	by	by	IN
cord-023095-4dannjjm	6474	16	MMVD	MMVD	NNP
cord-023095-4dannjjm	6474	17	group	group	NN
cord-023095-4dannjjm	6474	18	-	-	HYPH
cord-023095-4dannjjm	6474	19	wise	wise	JJ
cord-023095-4dannjjm	6474	20	comparisons	comparison	NNS
cord-023095-4dannjjm	6474	21	and	and	CC
cord-023095-4dannjjm	6474	22	linear	linear	JJ
cord-023095-4dannjjm	6474	23	regression	regression	NN
cord-023095-4dannjjm	6474	24	analyses	analysis	NNS
cord-023095-4dannjjm	6474	25	using	use	VBG
cord-023095-4dannjjm	6474	26	left	leave	VBN
cord-023095-4dannjjm	6474	27	atrial	atrial	JJ
cord-023095-4dannjjm	6474	28	to	to	IN
cord-023095-4dannjjm	6474	29	aortic	aortic	JJ
cord-023095-4dannjjm	6474	30	root	root	NN
cord-023095-4dannjjm	6474	31	ratio	ratio	NN
cord-023095-4dannjjm	6474	32	,	,	,
cord-023095-4dannjjm	6474	33	and	and	CC
cord-023095-4dannjjm	6474	34	LV	LV	NNP
cord-023095-4dannjjm	6474	35	end	end	NN
cord-023095-4dannjjm	6474	36	-	-	HYPH
cord-023095-4dannjjm	6474	37	diastolic	diastolic	JJ
cord-023095-4dannjjm	6474	38	and	and	CC
cord-023095-4dannjjm	6474	39	end	end	NN
cord-023095-4dannjjm	6474	40	-	-	HYPH
cord-023095-4dannjjm	6474	41	systolic	systolic	JJ
cord-023095-4dannjjm	6474	42	dimensions	dimension	NNS
cord-023095-4dannjjm	6474	43	.	.	.
cord-023095-4dannjjm	6475	1	All	all	DT
cord-023095-4dannjjm	6475	2	three	three	CD
cord-023095-4dannjjm	6475	3	segments	segment	NNS
cord-023095-4dannjjm	6475	4	contributed	contribute	VBD
cord-023095-4dannjjm	6475	5	to	to	IN
cord-023095-4dannjjm	6475	6	the	the	DT
cord-023095-4dannjjm	6475	7	overall	overall	JJ
cord-023095-4dannjjm	6475	8	increased	increase	VBN
cord-023095-4dannjjm	6475	9	global	global	JJ
cord-023095-4dannjjm	6475	10	volumes	volume	NNS
cord-023095-4dannjjm	6475	11	,	,	,
cord-023095-4dannjjm	6475	12	but	but	CC
cord-023095-4dannjjm	6475	13	the	the	DT
cord-023095-4dannjjm	6475	14	mid	mid	JJ
cord-023095-4dannjjm	6475	15	EDV	EDV	NNP
cord-023095-4dannjjm	6475	16	segment	segment	NN
cord-023095-4dannjjm	6475	17	was	be	VBD
cord-023095-4dannjjm	6475	18	strongest	strong	JJS
cord-023095-4dannjjm	6475	19	associated	associate	VBN
cord-023095-4dannjjm	6475	20	with	with	IN
cord-023095-4dannjjm	6475	21	increasing	increase	VBG
cord-023095-4dannjjm	6475	22	LV	LV	NNP
cord-023095-4dannjjm	6475	23	end	end	VB
cord-023095-4dannjjm	6475	24	diastolic	diastolic	JJ
cord-023095-4dannjjm	6475	25	dimension	dimension	NN
cord-023095-4dannjjm	6475	26	(	(	-LRB-
cord-023095-4dannjjm	6475	27	P	p	NN
cord-023095-4dannjjm	6475	28	5	5	CD
cord-023095-4dannjjm	6475	29	0.048	0.048	CD
cord-023095-4dannjjm	6475	30	)	)	-RRB-
cord-023095-4dannjjm	6475	31	.	.	.
cord-023095-4dannjjm	6476	1	Furthermore	furthermore	RB
cord-023095-4dannjjm	6476	2	,	,	,
cord-023095-4dannjjm	6476	3	LV	LV	NNP
cord-023095-4dannjjm	6476	4	Long	Long	NNP
cord-023095-4dannjjm	6476	5	axis	axis	NN
cord-023095-4dannjjm	6476	6	distance	distance	NN
cord-023095-4dannjjm	6476	7	and	and	CC
cord-023095-4dannjjm	6476	8	LV	LV	NNP
cord-023095-4dannjjm	6476	9	Sphericity	Sphericity	NNP
cord-023095-4dannjjm	6476	10	index	index	NN
cord-023095-4dannjjm	6476	11	increased	increase	VBD
cord-023095-4dannjjm	6476	12	with	with	IN
cord-023095-4dannjjm	6476	13	increasing	increase	VBG
cord-023095-4dannjjm	6476	14	MMVD	MMVD	NNP
cord-023095-4dannjjm	6476	15	severity	severity	NN
cord-023095-4dannjjm	6476	16	.	.	.
cord-023095-4dannjjm	6477	1	The	the	DT
cord-023095-4dannjjm	6477	2	basal	basal	NN
cord-023095-4dannjjm	6477	3	and	and	CC
cord-023095-4dannjjm	6477	4	apical	apical	JJ
cord-023095-4dannjjm	6477	5	EDV	EDV	NNP
cord-023095-4dannjjm	6477	6	segments	segment	NNS
cord-023095-4dannjjm	6477	7	were	be	VBD
cord-023095-4dannjjm	6477	8	strongest	strongest	RBS
cord-023095-4dannjjm	6477	9	associated	associate	VBN
cord-023095-4dannjjm	6477	10	with	with	IN
cord-023095-4dannjjm	6477	11	Sphericity	Sphericity	NNP
cord-023095-4dannjjm	6477	12	index	index	NN
cord-023095-4dannjjm	6477	13	(	(	-LRB-
cord-023095-4dannjjm	6477	14	P	p	NN
cord-023095-4dannjjm	6477	15	o	o	NN
cord-023095-4dannjjm	6477	16	0.0001	0.0001	CD
cord-023095-4dannjjm	6477	17	)	)	-RRB-
cord-023095-4dannjjm	6477	18	.	.	.
cord-023095-4dannjjm	6478	1	In	in	IN
cord-023095-4dannjjm	6478	2	conclusion	conclusion	NN
cord-023095-4dannjjm	6478	3	,	,	,
cord-023095-4dannjjm	6478	4	this	this	DT
cord-023095-4dannjjm	6478	5	RT3DE	RT3DE	NNP
cord-023095-4dannjjm	6478	6	study	study	NN
cord-023095-4dannjjm	6478	7	showed	show	VBD
cord-023095-4dannjjm	6478	8	that	that	IN
cord-023095-4dannjjm	6478	9	increased	increase	VBD
cord-023095-4dannjjm	6478	10	LV	LV	NNP
cord-023095-4dannjjm	6478	11	EDV	EDV	NNP
cord-023095-4dannjjm	6478	12	,	,	,
cord-023095-4dannjjm	6478	13	primarily	primarily	RB
cord-023095-4dannjjm	6478	14	in	in	IN
cord-023095-4dannjjm	6478	15	the	the	DT
cord-023095-4dannjjm	6478	16	mid	mid	JJ
cord-023095-4dannjjm	6478	17	segment	segment	NN
cord-023095-4dannjjm	6478	18	,	,	,
cord-023095-4dannjjm	6478	19	leads	lead	VBZ
cord-023095-4dannjjm	6478	20	to	to	IN
cord-023095-4dannjjm	6478	21	rounding	round	VBG
cord-023095-4dannjjm	6478	22	of	of	IN
cord-023095-4dannjjm	6478	23	LV	LV	NNP
cord-023095-4dannjjm	6478	24	apical	apical	JJ
cord-023095-4dannjjm	6478	25	and	and	CC
cord-023095-4dannjjm	6478	26	basal	basal	NN
cord-023095-4dannjjm	6478	27	segments	segment	NNS
cord-023095-4dannjjm	6478	28	in	in	IN
cord-023095-4dannjjm	6478	29	response	response	NN
cord-023095-4dannjjm	6478	30	to	to	IN
cord-023095-4dannjjm	6478	31	increasing	increase	VBG
cord-023095-4dannjjm	6478	32	MMVD	MMVD	NNP
cord-023095-4dannjjm	6478	33	severity	severity	NN
cord-023095-4dannjjm	6478	34	in	in	IN
cord-023095-4dannjjm	6478	35	dogs	dog	NNS
cord-023095-4dannjjm	6478	36	.	.	.
cord-023095-4dannjjm	6479	1	84	84	CD
cord-023095-4dannjjm	6479	2	dogs	dog	NNS
cord-023095-4dannjjm	6479	3	from	from	IN
cord-023095-4dannjjm	6479	4	shelters	shelter	NNS
cord-023095-4dannjjm	6479	5	in	in	IN
cord-023095-4dannjjm	6479	6	Florida	Florida	NNP
cord-023095-4dannjjm	6479	7	with	with	IN
cord-023095-4dannjjm	6479	8	naturally	naturally	RB
cord-023095-4dannjjm	6479	9	acquired	acquire	VBN
cord-023095-4dannjjm	6479	10	DI	DI	NNP
cord-023095-4dannjjm	6479	11	infection	infection	NN
cord-023095-4dannjjm	6479	12	were	be	VBD
cord-023095-4dannjjm	6479	13	euthanized	euthanize	VBN
cord-023095-4dannjjm	6479	14	and	and	CC
cord-023095-4dannjjm	6479	15	necropsied	necropsie	VBN
cord-023095-4dannjjm	6479	16	.	.	.
cord-023095-4dannjjm	6480	1	All	all	DT
cord-023095-4dannjjm	6480	2	adult	adult	NN
cord-023095-4dannjjm	6480	3	DI	DI	NNP
cord-023095-4dannjjm	6480	4	in	in	IN
cord-023095-4dannjjm	6480	5	each	each	DT
cord-023095-4dannjjm	6480	6	dog	dog	NN
cord-023095-4dannjjm	6480	7	were	be	VBD
cord-023095-4dannjjm	6480	8	sexed	sex	VBN
cord-023095-4dannjjm	6480	9	using	use	VBG
cord-023095-4dannjjm	6480	10	morphological	morphological	JJ
cord-023095-4dannjjm	6480	11	features	feature	NNS
cord-023095-4dannjjm	6480	12	.	.	.
cord-023095-4dannjjm	6481	1	Total	total	JJ
cord-023095-4dannjjm	6481	2	worm	worm	NN
cord-023095-4dannjjm	6481	3	burdens	burden	NNS
cord-023095-4dannjjm	6481	4	and	and	CC
cord-023095-4dannjjm	6481	5	numbers	number	NNS
cord-023095-4dannjjm	6481	6	of	of	IN
cord-023095-4dannjjm	6481	7	males	male	NNS
cord-023095-4dannjjm	6481	8	and	and	CC
cord-023095-4dannjjm	6481	9	females	female	NNS
cord-023095-4dannjjm	6481	10	were	be	VBD
cord-023095-4dannjjm	6481	11	recorded	record	VBN
cord-023095-4dannjjm	6481	12	.	.	.
cord-023095-4dannjjm	6482	1	No	no	DT
cord-023095-4dannjjm	6482	2	other	other	JJ
cord-023095-4dannjjm	6482	3	information	information	NN
cord-023095-4dannjjm	6482	4	was	be	VBD
cord-023095-4dannjjm	6482	5	available	available	JJ
cord-023095-4dannjjm	6482	6	for	for	IN
cord-023095-4dannjjm	6482	7	any	any	DT
cord-023095-4dannjjm	6482	8	dog	dog	NN
cord-023095-4dannjjm	6482	9	.	.	.
cord-023095-4dannjjm	6483	1	All	all	DT
cord-023095-4dannjjm	6483	2	data	datum	NNS
cord-023095-4dannjjm	6483	3	,	,	,
cord-023095-4dannjjm	6483	4	raw	raw	JJ
cord-023095-4dannjjm	6483	5	and	and	CC
cord-023095-4dannjjm	6483	6	transformed	transform	VBN
cord-023095-4dannjjm	6483	7	,	,	,
cord-023095-4dannjjm	6483	8	were	be	VBD
cord-023095-4dannjjm	6483	9	examined	examine	VBN
cord-023095-4dannjjm	6483	10	visually	visually	RB
cord-023095-4dannjjm	6483	11	and	and	CC
cord-023095-4dannjjm	6483	12	descriptively	descriptively	RB
cord-023095-4dannjjm	6483	13	.	.	.
cord-023095-4dannjjm	6484	1	Raw	raw	JJ
cord-023095-4dannjjm	6484	2	numerical	numerical	JJ
cord-023095-4dannjjm	6484	3	data	datum	NNS
cord-023095-4dannjjm	6484	4	were	be	VBD
cord-023095-4dannjjm	6484	5	further	further	RB
cord-023095-4dannjjm	6484	6	examined	examine	VBN
cord-023095-4dannjjm	6484	7	by	by	IN
cord-023095-4dannjjm	6484	8	a	a	DT
cord-023095-4dannjjm	6484	9	paired	pair	VBN
cord-023095-4dannjjm	6484	10	T	t	NN
cord-023095-4dannjjm	6484	11	-	-	HYPH
cord-023095-4dannjjm	6484	12	test	test	NN
cord-023095-4dannjjm	6484	13	;	;	:
cord-023095-4dannjjm	6484	14	log	log	NN
cord-023095-4dannjjm	6484	15	-	-	HYPH
cord-023095-4dannjjm	6484	16	odds	odd	NNS
cord-023095-4dannjjm	6484	17	transformed	transform	VBN
cord-023095-4dannjjm	6484	18	data	datum	NNS
cord-023095-4dannjjm	6484	19	were	be	VBD
cord-023095-4dannjjm	6484	20	examined	examine	VBN
cord-023095-4dannjjm	6484	21	by	by	IN
cord-023095-4dannjjm	6484	22	logistic	logistic	JJ
cord-023095-4dannjjm	6484	23	regression	regression	NN
cord-023095-4dannjjm	6484	24	.	.	.
cord-023095-4dannjjm	6485	1	We	-PRON-	PRP
cord-023095-4dannjjm	6485	2	also	also	RB
cord-023095-4dannjjm	6485	3	conducted	conduct	VBD
cord-023095-4dannjjm	6485	4	a	a	DT
cord-023095-4dannjjm	6485	5	binomial	binomial	JJ
cord-023095-4dannjjm	6485	6	distribution	distribution	NN
cord-023095-4dannjjm	6485	7	goodness	goodness	NN
cord-023095-4dannjjm	6485	8	of	of	IN
cord-023095-4dannjjm	6485	9	fit	fit	JJ
cord-023095-4dannjjm	6485	10	analysis	analysis	NN
cord-023095-4dannjjm	6485	11	assuming	assume	VBG
cord-023095-4dannjjm	6485	12	a	a	DT
cord-023095-4dannjjm	6485	13	null	null	JJ
cord-023095-4dannjjm	6485	14	hypothesis	hypothesis	NN
cord-023095-4dannjjm	6485	15	of	of	IN
cord-023095-4dannjjm	6485	16	a	a	DT
cord-023095-4dannjjm	6485	17	M	m	NN
cord-023095-4dannjjm	6485	18	:	:	:
cord-023095-4dannjjm	6485	19	F	F	NNP
cord-023095-4dannjjm	6485	20	5	5	CD
cord-023095-4dannjjm	6485	21	1.0	1.0	CD
cord-023095-4dannjjm	6485	22	.	.	.
cord-023095-4dannjjm	6486	1	Worm	worm	NN
cord-023095-4dannjjm	6486	2	intensities	intensity	NNS
cord-023095-4dannjjm	6486	3	ranged	range	VBD
cord-023095-4dannjjm	6486	4	from	from	IN
cord-023095-4dannjjm	6486	5	1	1	CD
cord-023095-4dannjjm	6486	6	to	to	IN
cord-023095-4dannjjm	6486	7	143	143	CD
cord-023095-4dannjjm	6486	8	DI	di	NN
cord-023095-4dannjjm	6486	9	per	per	IN
cord-023095-4dannjjm	6486	10	dog	dog	NN
cord-023095-4dannjjm	6486	11	.	.	.
cord-023095-4dannjjm	6487	1	Eight	eight	CD
cord-023095-4dannjjm	6487	2	dogs	dog	NNS
cord-023095-4dannjjm	6487	3	had	have	VBD
cord-023095-4dannjjm	6487	4	unisex	unisex	JJ
cord-023095-4dannjjm	6487	5	infections	infection	NNS
cord-023095-4dannjjm	6487	6	:	:	:
cord-023095-4dannjjm	6488	1	7/8	7/8	CD
cord-023095-4dannjjm	6488	2	had	have	VBD
cord-023095-4dannjjm	6488	3	all	all	DT
cord-023095-4dannjjm	6488	4	-	-	HYPH
cord-023095-4dannjjm	6488	5	female	female	JJ
cord-023095-4dannjjm	6488	6	infections	infection	NNS
cord-023095-4dannjjm	6488	7	.	.	.
cord-023095-4dannjjm	6489	1	Dogs	dog	NNS
cord-023095-4dannjjm	6489	2	with	with	IN
cord-023095-4dannjjm	6489	3	lowintensity	lowintensity	NN
cord-023095-4dannjjm	6489	4	dual	dual	JJ
cord-023095-4dannjjm	6489	5	-	-	HYPH
cord-023095-4dannjjm	6489	6	sex	sex	NN
cord-023095-4dannjjm	6489	7	infections	infection	NNS
cord-023095-4dannjjm	6489	8	were	be	VBD
cord-023095-4dannjjm	6489	9	more	more	RBR
cord-023095-4dannjjm	6489	10	likely	likely	JJ
cord-023095-4dannjjm	6489	11	to	to	TO
cord-023095-4dannjjm	6489	12	have	have	VB
cord-023095-4dannjjm	6489	13	greater	great	JJR
cord-023095-4dannjjm	6489	14	numbers	number	NNS
cord-023095-4dannjjm	6489	15	of	of	IN
cord-023095-4dannjjm	6489	16	female	female	JJ
cord-023095-4dannjjm	6489	17	DI	DI	NNP
cord-023095-4dannjjm	6489	18	.	.	.
cord-023095-4dannjjm	6490	1	Overall	overall	RB
cord-023095-4dannjjm	6490	2	,	,	,
cord-023095-4dannjjm	6490	3	sex	sex	NN
cord-023095-4dannjjm	6490	4	ratios	ratio	NNS
cord-023095-4dannjjm	6490	5	were	be	VBD
cord-023095-4dannjjm	6490	6	equal	equal	JJ
cord-023095-4dannjjm	6490	7	(	(	-LRB-
cord-023095-4dannjjm	6490	8	paired	paired	JJ
cord-023095-4dannjjm	6490	9	t	t	NN
cord-023095-4dannjjm	6490	10	-	-	HYPH
cord-023095-4dannjjm	6490	11	test	test	NN
cord-023095-4dannjjm	6490	12	,	,	,
cord-023095-4dannjjm	6490	13	P	p	NN
cord-023095-4dannjjm	6490	14	5	5	CD
cord-023095-4dannjjm	6490	15	0.7	0.7	CD
cord-023095-4dannjjm	6490	16	)	)	-RRB-
cord-023095-4dannjjm	6490	17	.	.	.
cord-023095-4dannjjm	6491	1	However	however	RB
cord-023095-4dannjjm	6491	2	,	,	,
cord-023095-4dannjjm	6491	3	logistic	logistic	JJ
cord-023095-4dannjjm	6491	4	regression	regression	NN
cord-023095-4dannjjm	6491	5	demonstrated	demonstrate	VBD
cord-023095-4dannjjm	6491	6	that	that	IN
cord-023095-4dannjjm	6491	7	the	the	DT
cord-023095-4dannjjm	6491	8	probability	probability	NN
cord-023095-4dannjjm	6491	9	of	of	IN
cord-023095-4dannjjm	6491	10	being	be	VBG
cord-023095-4dannjjm	6491	11	female	female	JJ
cord-023095-4dannjjm	6491	12	is	be	VBZ
cord-023095-4dannjjm	6491	13	strongly	strongly	RB
cord-023095-4dannjjm	6491	14	affected	affect	VBN
cord-023095-4dannjjm	6491	15	by	by	IN
cord-023095-4dannjjm	6491	16	the	the	DT
cord-023095-4dannjjm	6491	17	total	total	JJ
cord-023095-4dannjjm	6491	18	worm	worm	NN
cord-023095-4dannjjm	6491	19	intensity	intensity	NN
cord-023095-4dannjjm	6491	20	,	,	,
cord-023095-4dannjjm	6491	21	with	with	IN
cord-023095-4dannjjm	6491	22	lower	low	JJR
cord-023095-4dannjjm	6491	23	intensities	intensity	NNS
cord-023095-4dannjjm	6491	24	increasing	increase	VBG
cord-023095-4dannjjm	6491	25	the	the	DT
cord-023095-4dannjjm	6491	26	probability	probability	NN
cord-023095-4dannjjm	6491	27	of	of	IN
cord-023095-4dannjjm	6491	28	having	have	VBG
cord-023095-4dannjjm	6491	29	a	a	DT
cord-023095-4dannjjm	6491	30	predominance	predominance	NN
cord-023095-4dannjjm	6491	31	of	of	IN
cord-023095-4dannjjm	6491	32	female	female	JJ
cord-023095-4dannjjm	6491	33	worms	worm	NNS
cord-023095-4dannjjm	6491	34	.	.	.
cord-023095-4dannjjm	6492	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	6492	2	data	datum	NNS
cord-023095-4dannjjm	6492	3	show	show	VBP
cord-023095-4dannjjm	6492	4	that	that	IN
cord-023095-4dannjjm	6492	5	DI	DI	NNP
cord-023095-4dannjjm	6492	6	sex	sex	NN
cord-023095-4dannjjm	6492	7	ratios	ratio	NNS
cord-023095-4dannjjm	6492	8	in	in	IN
cord-023095-4dannjjm	6492	9	naturally	naturally	RB
cord-023095-4dannjjm	6492	10	-	-	HYPH
cord-023095-4dannjjm	6492	11	infected	infect	VBN
cord-023095-4dannjjm	6492	12	dogs	dog	NNS
cord-023095-4dannjjm	6492	13	equal	equal	VBP
cord-023095-4dannjjm	6492	14	1	1	CD
cord-023095-4dannjjm	6492	15	when	when	WRB
cord-023095-4dannjjm	6492	16	examining	examine	VBG
cord-023095-4dannjjm	6492	17	the	the	DT
cord-023095-4dannjjm	6492	18	entire	entire	JJ
cord-023095-4dannjjm	6492	19	dog	dog	NN
cord-023095-4dannjjm	6492	20	population	population	NN
cord-023095-4dannjjm	6492	21	,	,	,
cord-023095-4dannjjm	6492	22	but	but	CC
cord-023095-4dannjjm	6492	23	deviate	deviate	VB
cord-023095-4dannjjm	6492	24	to	to	TO
cord-023095-4dannjjm	6492	25	favor	favor	VB
cord-023095-4dannjjm	6492	26	female	female	JJ
cord-023095-4dannjjm	6492	27	worms	worm	NNS
cord-023095-4dannjjm	6492	28	at	at	IN
cord-023095-4dannjjm	6492	29	low	low	JJ
cord-023095-4dannjjm	6492	30	worm	worm	NN
cord-023095-4dannjjm	6492	31	intensities	intensity	NNS
cord-023095-4dannjjm	6492	32	.	.	.
cord-023095-4dannjjm	6493	1	These	these	DT
cord-023095-4dannjjm	6493	2	data	datum	NNS
cord-023095-4dannjjm	6493	3	could	could	MD
cord-023095-4dannjjm	6493	4	impact	impact	VB
cord-023095-4dannjjm	6493	5	adulticide	adulticide	NN
cord-023095-4dannjjm	6493	6	treatment	treatment	NN
cord-023095-4dannjjm	6493	7	strategies	strategy	NNS
cord-023095-4dannjjm	6493	8	.	.	.
cord-023095-4dannjjm	6494	1	The	the	DT
cord-023095-4dannjjm	6494	2	reasons	reason	NNS
cord-023095-4dannjjm	6494	3	for	for	IN
cord-023095-4dannjjm	6494	4	sex	sex	NN
cord-023095-4dannjjm	6494	5	ratio	ratio	NN
cord-023095-4dannjjm	6494	6	distortion	distortion	NN
cord-023095-4dannjjm	6494	7	in	in	IN
cord-023095-4dannjjm	6494	8	DI	DI	NNP
cord-023095-4dannjjm	6494	9	are	be	VBP
cord-023095-4dannjjm	6494	10	unknown	unknown	JJ
cord-023095-4dannjjm	6494	11	.	.	.
cord-023095-4dannjjm	6495	1	We	-PRON-	PRP
cord-023095-4dannjjm	6495	2	evaluated	evaluate	VBD
cord-023095-4dannjjm	6495	3	cardiac	cardiac	JJ
cord-023095-4dannjjm	6495	4	reverse	reverse	NN
cord-023095-4dannjjm	6495	5	remodeling	remodeling	NN
cord-023095-4dannjjm	6495	6	after	after	IN
cord-023095-4dannjjm	6495	7	mitral	mitral	JJ
cord-023095-4dannjjm	6495	8	valve	valve	NN
cord-023095-4dannjjm	6495	9	repair	repair	NN
cord-023095-4dannjjm	6495	10	under	under	IN
cord-023095-4dannjjm	6495	11	cardiopulmonary	cardiopulmonary	JJ
cord-023095-4dannjjm	6495	12	bypass	bypass	NN
cord-023095-4dannjjm	6495	13	(	(	-LRB-
cord-023095-4dannjjm	6495	14	CPB	CPB	NNP
cord-023095-4dannjjm	6495	15	)	)	-RRB-
cord-023095-4dannjjm	6495	16	for	for	IN
cord-023095-4dannjjm	6495	17	mitral	mitral	JJ
cord-023095-4dannjjm	6495	18	regurgitation	regurgitation	NN
cord-023095-4dannjjm	6495	19	in	in	IN
cord-023095-4dannjjm	6495	20	small	small	JJ
cord-023095-4dannjjm	6495	21	breed	breed	NN
cord-023095-4dannjjm	6495	22	dogs	dog	NNS
cord-023095-4dannjjm	6495	23	.	.	.
cord-023095-4dannjjm	6496	1	Fifty	fifty	CD
cord-023095-4dannjjm	6496	2	dogs	dog	NNS
cord-023095-4dannjjm	6496	3	(	(	-LRB-
cord-023095-4dannjjm	6496	4	body	body	NN
cord-023095-4dannjjm	6496	5	weight	weight	NN
cord-023095-4dannjjm	6496	6	1.8	1.8	CD
cord-023095-4dannjjm	6496	7	-	-	HYPH
cord-023095-4dannjjm	6496	8	9.3	9.3	CD
cord-023095-4dannjjm	6496	9	kg	kg	NN
cord-023095-4dannjjm	6496	10	,	,	,
cord-023095-4dannjjm	6496	11	age	age	NN
cord-023095-4dannjjm	6496	12	5	5	CD
cord-023095-4dannjjm	6496	13	-	-	SYM
cord-023095-4dannjjm	6496	14	14	14	CD
cord-023095-4dannjjm	6496	15	years	year	NNS
cord-023095-4dannjjm	6496	16	)	)	-RRB-
cord-023095-4dannjjm	6496	17	with	with	IN
cord-023095-4dannjjm	6496	18	mitral	mitral	JJ
cord-023095-4dannjjm	6496	19	regurgitation	regurgitation	NN
cord-023095-4dannjjm	6496	20	were	be	VBD
cord-023095-4dannjjm	6496	21	treated	treat	VBN
cord-023095-4dannjjm	6496	22	between	between	IN
cord-023095-4dannjjm	6496	23	August	August	NNP
cord-023095-4dannjjm	6496	24	2006	2006	CD
cord-023095-4dannjjm	6496	25	and	and	CC
cord-023095-4dannjjm	6496	26	November	November	NNP
cord-023095-4dannjjm	6496	27	2009	2009	CD
cord-023095-4dannjjm	6496	28	.	.	.
cord-023095-4dannjjm	6497	1	The	the	DT
cord-023095-4dannjjm	6497	2	cardiac	cardiac	JJ
cord-023095-4dannjjm	6497	3	murmur	murmur	NN
cord-023095-4dannjjm	6497	4	was	be	VBD
cord-023095-4dannjjm	6497	5	grade	grade	NN
cord-023095-4dannjjm	6497	6	4/6	4/6	CD
cord-023095-4dannjjm	6497	7	-	-	HYPH
cord-023095-4dannjjm	6497	8	6/6	6/6	CD
cord-023095-4dannjjm	6497	9	.	.	.
cord-023095-4dannjjm	6498	1	The	the	DT
cord-023095-4dannjjm	6498	2	preoperative	preoperative	JJ
cord-023095-4dannjjm	6498	3	chest	chest	NN
cord-023095-4dannjjm	6498	4	X	X	NNS
cord-023095-4dannjjm	6498	5	-	-	NNS
cord-023095-4dannjjm	6498	6	rays	ray	NNS
cord-023095-4dannjjm	6498	7	showed	show	VBD
cord-023095-4dannjjm	6498	8	cardiac	cardiac	JJ
cord-023095-4dannjjm	6498	9	enlargement	enlargement	NN
cord-023095-4dannjjm	6498	10	(	(	-LRB-
cord-023095-4dannjjm	6498	11	vertebral	vertebral	JJ
cord-023095-4dannjjm	6498	12	heart	heart	NN
cord-023095-4dannjjm	6498	13	scale	scale	NN
cord-023095-4dannjjm	6498	14	(	(	-LRB-
cord-023095-4dannjjm	6498	15	VHS	vhs	NN
cord-023095-4dannjjm	6498	16	)	)	-RRB-
cord-023095-4dannjjm	6499	1	11.0	11.0	CD
cord-023095-4dannjjm	6499	2	-	-	HYPH
cord-023095-4dannjjm	6499	3	13.1	13.1	CD
cord-023095-4dannjjm	6499	4	)	)	-RRB-
cord-023095-4dannjjm	6499	5	.	.	.
cord-023095-4dannjjm	6500	1	Echocardiography	echocardiography	NN
cord-023095-4dannjjm	6500	2	showed	show	VBD
cord-023095-4dannjjm	6500	3	severe	severe	JJ
cord-023095-4dannjjm	6500	4	mitral	mitral	JJ
cord-023095-4dannjjm	6500	5	regurgitation	regurgitation	NN
cord-023095-4dannjjm	6500	6	and	and	CC
cord-023095-4dannjjm	6500	7	left	leave	VBD
cord-023095-4dannjjm	6500	8	atrium	atrium	NN
cord-023095-4dannjjm	6500	9	enlargement	enlargement	NN
cord-023095-4dannjjm	6500	10	(	(	-LRB-
cord-023095-4dannjjm	6500	11	LA	LA	NNP
cord-023095-4dannjjm	6500	12	/	/	SYM
cord-023095-4dannjjm	6500	13	Ao	Ao	NNP
cord-023095-4dannjjm	6500	14	2.0	2.0	NNP
cord-023095-4dannjjm	6500	15	-	-	HYPH
cord-023095-4dannjjm	6500	16	4.2	4.2	CD
cord-023095-4dannjjm	6500	17	)	)	-RRB-
cord-023095-4dannjjm	6500	18	.	.	.
cord-023095-4dannjjm	6501	1	After	after	IN
cord-023095-4dannjjm	6501	2	inducing	induce	VBG
cord-023095-4dannjjm	6501	3	anesthesia	anesthesia	NN
cord-023095-4dannjjm	6501	4	,	,	,
cord-023095-4dannjjm	6501	5	a	a	DT
cord-023095-4dannjjm	6501	6	thoracotomy	thoracotomy	NN
cord-023095-4dannjjm	6501	7	was	be	VBD
cord-023095-4dannjjm	6501	8	performed	perform	VBN
cord-023095-4dannjjm	6501	9	in	in	IN
cord-023095-4dannjjm	6501	10	the	the	DT
cord-023095-4dannjjm	6501	11	fifth	fifth	JJ
cord-023095-4dannjjm	6501	12	intercostal	intercostal	JJ
cord-023095-4dannjjm	6501	13	space	space	NN
cord-023095-4dannjjm	6501	14	.	.	.
cord-023095-4dannjjm	6502	1	CPB	CPB	NNP
cord-023095-4dannjjm	6502	2	was	be	VBD
cord-023095-4dannjjm	6502	3	started	start	VBN
cord-023095-4dannjjm	6502	4	by	by	IN
cord-023095-4dannjjm	6502	5	using	use	VBG
cord-023095-4dannjjm	6502	6	a	a	DT
cord-023095-4dannjjm	6502	7	CPB	CPB	NNP
cord-023095-4dannjjm	6502	8	circuit	circuit	NN
cord-023095-4dannjjm	6502	9	connected	connect	VBN
cord-023095-4dannjjm	6502	10	to	to	IN
cord-023095-4dannjjm	6502	11	carotid	carotid	JJ
cord-023095-4dannjjm	6502	12	artery	artery	NN
cord-023095-4dannjjm	6502	13	and	and	CC
cord-023095-4dannjjm	6502	14	jugular	jugular	NN
cord-023095-4dannjjm	6502	15	vein	vein	NN
cord-023095-4dannjjm	6502	16	catheters	catheter	NNS
cord-023095-4dannjjm	6502	17	.	.	.
cord-023095-4dannjjm	6503	1	After	after	IN
cord-023095-4dannjjm	6503	2	inducing	induce	VBG
cord-023095-4dannjjm	6503	3	cardiac	cardiac	JJ
cord-023095-4dannjjm	6503	4	arrest	arrest	NN
cord-023095-4dannjjm	6503	5	,	,	,
cord-023095-4dannjjm	6503	6	the	the	DT
cord-023095-4dannjjm	6503	7	left	left	JJ
cord-023095-4dannjjm	6503	8	atrium	atrium	NN
cord-023095-4dannjjm	6503	9	was	be	VBD
cord-023095-4dannjjm	6503	10	sectioned	section	VBN
cord-023095-4dannjjm	6503	11	and	and	CC
cord-023095-4dannjjm	6503	12	chordae	chordae	NNP
cord-023095-4dannjjm	6503	13	tendineae	tendineae	NNP
cord-023095-4dannjjm	6503	14	rupture	rupture	NNP
cord-023095-4dannjjm	6503	15	confirmed	confirm	VBD
cord-023095-4dannjjm	6503	16	.	.	.
cord-023095-4dannjjm	6504	1	The	the	DT
cord-023095-4dannjjm	6504	2	chordae	chordae	NN
cord-023095-4dannjjm	6504	3	tendineae	tendineae	NNS
cord-023095-4dannjjm	6504	4	were	be	VBD
cord-023095-4dannjjm	6504	5	replaced	replace	VBN
cord-023095-4dannjjm	6504	6	with	with	IN
cord-023095-4dannjjm	6504	7	expanded	expand	VBN
cord-023095-4dannjjm	6504	8	polytetrafluoroethylene	polytetrafluoroethylene	NN
cord-023095-4dannjjm	6504	9	.	.	.
cord-023095-4dannjjm	6505	1	A	a	DT
cord-023095-4dannjjm	6505	2	mitral	mitral	JJ
cord-023095-4dannjjm	6505	3	annulus	annulus	NN
cord-023095-4dannjjm	6505	4	plasty	plasty	NN
cord-023095-4dannjjm	6505	5	was	be	VBD
cord-023095-4dannjjm	6505	6	also	also	RB
cord-023095-4dannjjm	6505	7	done	do	VBN
cord-023095-4dannjjm	6505	8	,	,	,
cord-023095-4dannjjm	6505	9	and	and	CC
cord-023095-4dannjjm	6505	10	the	the	DT
cord-023095-4dannjjm	6505	11	left	left	JJ
cord-023095-4dannjjm	6505	12	atrium	atrium	NN
cord-023095-4dannjjm	6505	13	was	be	VBD
cord-023095-4dannjjm	6505	14	closed	close	VBN
cord-023095-4dannjjm	6505	15	.	.	.
cord-023095-4dannjjm	6506	1	After	after	IN
cord-023095-4dannjjm	6506	2	de	de	NN
cord-023095-4dannjjm	6506	3	-	-	NN
cord-023095-4dannjjm	6506	4	clamping	clamp	VBG
cord-023095-4dannjjm	6506	5	for	for	IN
cord-023095-4dannjjm	6506	6	restarting	restart	VBG
cord-023095-4dannjjm	6506	7	the	the	DT
cord-023095-4dannjjm	6506	8	heart	heart	NN
cord-023095-4dannjjm	6506	9	,	,	,
cord-023095-4dannjjm	6506	10	the	the	DT
cord-023095-4dannjjm	6506	11	chest	chest	NN
cord-023095-4dannjjm	6506	12	was	be	VBD
cord-023095-4dannjjm	6506	13	closed	close	VBN
cord-023095-4dannjjm	6506	14	.	.	.
cord-023095-4dannjjm	6507	1	Heart	heart	NN
cord-023095-4dannjjm	6507	2	rate	rate	NN
cord-023095-4dannjjm	6507	3	decreased	decrease	VBD
cord-023095-4dannjjm	6507	4	from	from	IN
cord-023095-4dannjjm	6507	5	118	118	CD
cord-023095-4dannjjm	6507	6	-	-	SYM
cord-023095-4dannjjm	6507	7	164	164	CD
cord-023095-4dannjjm	6507	8	bpm	bpm	NN
cord-023095-4dannjjm	6507	9	to	to	IN
cord-023095-4dannjjm	6507	10	75	75	CD
cord-023095-4dannjjm	6507	11	-	-	SYM
cord-023095-4dannjjm	6507	12	138	138	CD
cord-023095-4dannjjm	6507	13	bpm	bpm	NN
cord-023095-4dannjjm	6507	14	.	.	.
cord-023095-4dannjjm	6508	1	The	the	DT
cord-023095-4dannjjm	6508	2	grade	grade	NN
cord-023095-4dannjjm	6508	3	of	of	IN
cord-023095-4dannjjm	6508	4	cardiac	cardiac	JJ
cord-023095-4dannjjm	6508	5	murmur	murmur	NN
cord-023095-4dannjjm	6508	6	was	be	VBD
cord-023095-4dannjjm	6508	7	reduced	reduce	VBN
cord-023095-4dannjjm	6508	8	to	to	IN
cord-023095-4dannjjm	6508	9	0/6	0/6	CD
cord-023095-4dannjjm	6508	10	-	-	CD
cord-023095-4dannjjm	6508	11	3/6	3/6	CD
cord-023095-4dannjjm	6508	12	three	three	CD
cord-023095-4dannjjm	6508	13	months	month	NNS
cord-023095-4dannjjm	6508	14	postoperatively	postoperatively	RB
cord-023095-4dannjjm	6508	15	,	,	,
cord-023095-4dannjjm	6508	16	and	and	CC
cord-023095-4dannjjm	6508	17	the	the	DT
cord-023095-4dannjjm	6508	18	heart	heart	NN
cord-023095-4dannjjm	6508	19	shadow	shadow	NN
cord-023095-4dannjjm	6508	20	was	be	VBD
cord-023095-4dannjjm	6508	21	reduced	reduce	VBN
cord-023095-4dannjjm	6508	22	(	(	-LRB-
cord-023095-4dannjjm	6508	23	VHS	VHS	NNP
cord-023095-4dannjjm	6508	24	9.8	9.8	CD
cord-023095-4dannjjm	6508	25	-	-	HYPH
cord-023095-4dannjjm	6508	26	11.5	11.5	CD
cord-023095-4dannjjm	6508	27	)	)	-RRB-
cord-023095-4dannjjm	6508	28	in	in	IN
cord-023095-4dannjjm	6508	29	the	the	DT
cord-023095-4dannjjm	6508	30	chest	chest	NN
cord-023095-4dannjjm	6508	31	x	x	NNS
cord-023095-4dannjjm	6508	32	-	-	NNS
cord-023095-4dannjjm	6508	33	rays	ray	NNS
cord-023095-4dannjjm	6508	34	.	.	.
cord-023095-4dannjjm	6509	1	Echocardiography	echocardiography	NN
cord-023095-4dannjjm	6509	2	confirmed	confirm	VBD
cord-023095-4dannjjm	6509	3	the	the	DT
cord-023095-4dannjjm	6509	4	marked	marked	JJ
cord-023095-4dannjjm	6509	5	reduction	reduction	NN
cord-023095-4dannjjm	6509	6	in	in	IN
cord-023095-4dannjjm	6509	7	mitral	mitral	JJ
cord-023095-4dannjjm	6509	8	regurgitation	regurgitation	NN
cord-023095-4dannjjm	6509	9	and	and	CC
cord-023095-4dannjjm	6509	10	the	the	DT
cord-023095-4dannjjm	6509	11	left	left	JJ
cord-023095-4dannjjm	6509	12	atrial	atrial	JJ
cord-023095-4dannjjm	6509	13	dimensions	dimension	NNS
cord-023095-4dannjjm	6509	14	(	(	-LRB-
cord-023095-4dannjjm	6509	15	LA	LA	NNP
cord-023095-4dannjjm	6509	16	/	/	SYM
cord-023095-4dannjjm	6509	17	Ao	Ao	NNP
cord-023095-4dannjjm	6509	18	1.2	1.2	CD
cord-023095-4dannjjm	6509	19	-	-	SYM
cord-023095-4dannjjm	6509	20	2.2	2.2	CD
cord-023095-4dannjjm	6509	21	)	)	-RRB-
cord-023095-4dannjjm	6509	22	.	.	.
cord-023095-4dannjjm	6510	1	Mitral	mitral	JJ
cord-023095-4dannjjm	6510	2	valve	valve	NN
cord-023095-4dannjjm	6510	3	repair	repair	NN
cord-023095-4dannjjm	6510	4	reduced	reduce	VBN
cord-023095-4dannjjm	6510	5	enlarged	enlarge	VBD
cord-023095-4dannjjm	6510	6	cardiac	cardiac	JJ
cord-023095-4dannjjm	6510	7	size	size	NN
cord-023095-4dannjjm	6510	8	by	by	IN
cord-023095-4dannjjm	6510	9	reduction	reduction	NN
cord-023095-4dannjjm	6510	10	of	of	IN
cord-023095-4dannjjm	6510	11	regurgitant	regurgitant	JJ
cord-023095-4dannjjm	6510	12	rate	rate	NN
cord-023095-4dannjjm	6510	13	.	.	.
cord-023095-4dannjjm	6511	1	Pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6511	2	arterial	arterial	JJ
cord-023095-4dannjjm	6511	3	hypertension	hypertension	NN
cord-023095-4dannjjm	6511	4	(	(	-LRB-
cord-023095-4dannjjm	6511	5	PAH	PAH	NNP
cord-023095-4dannjjm	6511	6	)	)	-RRB-
cord-023095-4dannjjm	6511	7	is	be	VBZ
cord-023095-4dannjjm	6511	8	a	a	DT
cord-023095-4dannjjm	6511	9	well	well	RB
cord-023095-4dannjjm	6511	10	recognized	recognize	VBN
cord-023095-4dannjjm	6511	11	condition	condition	NN
cord-023095-4dannjjm	6511	12	in	in	IN
cord-023095-4dannjjm	6511	13	dogs	dog	NNS
cord-023095-4dannjjm	6511	14	leading	lead	VBG
cord-023095-4dannjjm	6511	15	to	to	IN
cord-023095-4dannjjm	6511	16	considerable	considerable	JJ
cord-023095-4dannjjm	6511	17	morbidity	morbidity	NN
cord-023095-4dannjjm	6511	18	and	and	CC
cord-023095-4dannjjm	6511	19	mortality	mortality	NN
cord-023095-4dannjjm	6511	20	.	.	.
cord-023095-4dannjjm	6512	1	The	the	DT
cord-023095-4dannjjm	6512	2	majority	majority	NN
cord-023095-4dannjjm	6512	3	of	of	IN
cord-023095-4dannjjm	6512	4	therapeutics	therapeutic	NNS
cord-023095-4dannjjm	6512	5	has	have	VBZ
cord-023095-4dannjjm	6512	6	focused	focus	VBN
cord-023095-4dannjjm	6512	7	on	on	IN
cord-023095-4dannjjm	6512	8	endothelial	endothelial	JJ
cord-023095-4dannjjm	6512	9	dysfunction	dysfunction	NN
cord-023095-4dannjjm	6512	10	causing	cause	VBG
cord-023095-4dannjjm	6512	11	reduced	reduce	VBN
cord-023095-4dannjjm	6512	12	production	production	NN
cord-023095-4dannjjm	6512	13	of	of	IN
cord-023095-4dannjjm	6512	14	vasodilators	vasodilator	NNS
cord-023095-4dannjjm	6512	15	,	,	,
cord-023095-4dannjjm	6512	16	such	such	JJ
cord-023095-4dannjjm	6512	17	as	as	IN
cord-023095-4dannjjm	6512	18	nitric	nitric	JJ
cord-023095-4dannjjm	6512	19	oxide	oxide	NN
cord-023095-4dannjjm	6512	20	and	and	CC
cord-023095-4dannjjm	6512	21	prostacyclin	prostacyclin	NN
cord-023095-4dannjjm	6512	22	,	,	,
cord-023095-4dannjjm	6512	23	coupled	couple	VBN
cord-023095-4dannjjm	6512	24	with	with	IN
cord-023095-4dannjjm	6512	25	overproduction	overproduction	NN
cord-023095-4dannjjm	6512	26	of	of	IN
cord-023095-4dannjjm	6512	27	vasoconstrictors	vasoconstrictor	NNS
cord-023095-4dannjjm	6512	28	,	,	,
cord-023095-4dannjjm	6512	29	such	such	JJ
cord-023095-4dannjjm	6512	30	as	as	IN
cord-023095-4dannjjm	6512	31	endothelin-1	endothelin-1	NNP
cord-023095-4dannjjm	6512	32	.	.	.
cord-023095-4dannjjm	6513	1	More	more	RBR
cord-023095-4dannjjm	6513	2	recently	recently	RB
cord-023095-4dannjjm	6513	3	,	,	,
cord-023095-4dannjjm	6513	4	it	-PRON-	PRP
cord-023095-4dannjjm	6513	5	has	have	VBZ
cord-023095-4dannjjm	6513	6	been	be	VBN
cord-023095-4dannjjm	6513	7	shown	show	VBN
cord-023095-4dannjjm	6513	8	that	that	IN
cord-023095-4dannjjm	6513	9	the	the	DT
cord-023095-4dannjjm	6513	10	mitochondria	mitochondrion	NNS
cord-023095-4dannjjm	6513	11	play	play	VBP
cord-023095-4dannjjm	6513	12	an	an	DT
cord-023095-4dannjjm	6513	13	important	important	JJ
cord-023095-4dannjjm	6513	14	role	role	NN
cord-023095-4dannjjm	6513	15	in	in	IN
cord-023095-4dannjjm	6513	16	the	the	DT
cord-023095-4dannjjm	6513	17	development	development	NN
cord-023095-4dannjjm	6513	18	of	of	IN
cord-023095-4dannjjm	6513	19	PAH	PAH	NNP
cord-023095-4dannjjm	6513	20	as	as	IN
cord-023095-4dannjjm	6513	21	oxygen	oxygen	NN
cord-023095-4dannjjm	6513	22	sensors	sensor	NNS
cord-023095-4dannjjm	6513	23	and	and	CC
cord-023095-4dannjjm	6513	24	regulators	regulator	NNS
cord-023095-4dannjjm	6513	25	of	of	IN
cord-023095-4dannjjm	6513	26	cellular	cellular	JJ
cord-023095-4dannjjm	6513	27	proliferation	proliferation	NN
cord-023095-4dannjjm	6513	28	.	.	.
cord-023095-4dannjjm	6514	1	In	in	IN
cord-023095-4dannjjm	6514	2	PAH	PAH	NNP
cord-023095-4dannjjm	6514	3	,	,	,
cord-023095-4dannjjm	6514	4	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6514	5	artery	artery	NN
cord-023095-4dannjjm	6514	6	smooth	smooth	JJ
cord-023095-4dannjjm	6514	7	muscle	muscle	NN
cord-023095-4dannjjm	6514	8	cells	cell	NNS
cord-023095-4dannjjm	6514	9	undergo	undergo	VBP
cord-023095-4dannjjm	6514	10	a	a	DT
cord-023095-4dannjjm	6514	11	metabolic	metabolic	JJ
cord-023095-4dannjjm	6514	12	shift	shift	NN
cord-023095-4dannjjm	6514	13	from	from	IN
cord-023095-4dannjjm	6514	14	oxidative	oxidative	JJ
cord-023095-4dannjjm	6514	15	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	6514	16	in	in	IN
cord-023095-4dannjjm	6514	17	the	the	DT
cord-023095-4dannjjm	6514	18	mitochondria	mitochondrion	NNS
cord-023095-4dannjjm	6514	19	to	to	IN
cord-023095-4dannjjm	6514	20	glycolysis	glycolysis	NN
cord-023095-4dannjjm	6514	21	in	in	IN
cord-023095-4dannjjm	6514	22	the	the	DT
cord-023095-4dannjjm	6514	23	cytoplasm	cytoplasm	NN
cord-023095-4dannjjm	6514	24	as	as	IN
cord-023095-4dannjjm	6514	25	the	the	DT
cord-023095-4dannjjm	6514	26	major	major	JJ
cord-023095-4dannjjm	6514	27	energy	energy	NN
cord-023095-4dannjjm	6514	28	source	source	NN
cord-023095-4dannjjm	6514	29	and	and	CC
cord-023095-4dannjjm	6514	30	this	this	DT
cord-023095-4dannjjm	6514	31	leads	lead	VBZ
cord-023095-4dannjjm	6514	32	to	to	IN
cord-023095-4dannjjm	6514	33	suppression	suppression	NN
cord-023095-4dannjjm	6514	34	of	of	IN
cord-023095-4dannjjm	6514	35	apoptosis	apoptosis	NN
cord-023095-4dannjjm	6514	36	and	and	CC
cord-023095-4dannjjm	6514	37	increased	increase	VBN
cord-023095-4dannjjm	6514	38	proliferation	proliferation	NN
cord-023095-4dannjjm	6514	39	.	.	.
cord-023095-4dannjjm	6515	1	Dichloroacetate	Dichloroacetate	NNP
cord-023095-4dannjjm	6515	2	(	(	-LRB-
cord-023095-4dannjjm	6515	3	DCA	DCA	NNP
cord-023095-4dannjjm	6515	4	)	)	-RRB-
cord-023095-4dannjjm	6515	5	inhibits	inhibit	VBZ
cord-023095-4dannjjm	6515	6	pyruvate	pyruvate	NN
cord-023095-4dannjjm	6515	7	dehydrogenase	dehydrogenase	NN
cord-023095-4dannjjm	6515	8	kinase	kinase	NN
cord-023095-4dannjjm	6515	9	to	to	TO
cord-023095-4dannjjm	6515	10	activate	activate	VB
cord-023095-4dannjjm	6515	11	pyruvate	pyruvate	NN
cord-023095-4dannjjm	6515	12	dehydrogenase	dehydrogenase	NN
cord-023095-4dannjjm	6515	13	which	which	WDT
cord-023095-4dannjjm	6515	14	catalyzes	catalyze	VBZ
cord-023095-4dannjjm	6515	15	the	the	DT
cord-023095-4dannjjm	6515	16	rate	rate	NN
cord-023095-4dannjjm	6515	17	limiting	limit	VBG
cord-023095-4dannjjm	6515	18	step	step	NN
cord-023095-4dannjjm	6515	19	for	for	IN
cord-023095-4dannjjm	6515	20	entry	entry	NN
cord-023095-4dannjjm	6515	21	of	of	IN
cord-023095-4dannjjm	6515	22	pyruvate	pyruvate	NN
cord-023095-4dannjjm	6515	23	into	into	IN
cord-023095-4dannjjm	6515	24	the	the	DT
cord-023095-4dannjjm	6515	25	Krebs	Krebs	NNP
cord-023095-4dannjjm	6515	26	cycle	cycle	NN
cord-023095-4dannjjm	6515	27	,	,	,
cord-023095-4dannjjm	6515	28	thus	thus	RB
cord-023095-4dannjjm	6515	29	increasing	increase	VBG
cord-023095-4dannjjm	6515	30	mitochondrial	mitochondrial	JJ
cord-023095-4dannjjm	6515	31	respiration	respiration	NN
cord-023095-4dannjjm	6515	32	.	.	.
cord-023095-4dannjjm	6516	1	In	in	IN
cord-023095-4dannjjm	6516	2	three	three	CD
cord-023095-4dannjjm	6516	3	different	different	JJ
cord-023095-4dannjjm	6516	4	rat	rat	NN
cord-023095-4dannjjm	6516	5	models	model	NNS
cord-023095-4dannjjm	6516	6	of	of	IN
cord-023095-4dannjjm	6516	7	PAH	PAH	NNP
cord-023095-4dannjjm	6516	8	,	,	,
cord-023095-4dannjjm	6516	9	DCA	DCA	NNP
cord-023095-4dannjjm	6516	10	has	have	VBZ
cord-023095-4dannjjm	6516	11	been	be	VBN
cord-023095-4dannjjm	6516	12	shown	show	VBN
cord-023095-4dannjjm	6516	13	prevent	prevent	VB
cord-023095-4dannjjm	6516	14	and	and	CC
cord-023095-4dannjjm	6516	15	reverse	reverse	VB
cord-023095-4dannjjm	6516	16	PAH	PAH	NNP
cord-023095-4dannjjm	6516	17	by	by	IN
cord-023095-4dannjjm	6516	18	normalizing	normalize	VBG
cord-023095-4dannjjm	6516	19	molecular	molecular	JJ
cord-023095-4dannjjm	6516	20	pathology	pathology	NN
cord-023095-4dannjjm	6516	21	,	,	,
cord-023095-4dannjjm	6516	22	stimulating	stimulate	VBG
cord-023095-4dannjjm	6516	23	apoptosis	apoptosis	NN
cord-023095-4dannjjm	6516	24	of	of	IN
cord-023095-4dannjjm	6516	25	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6516	26	artery	artery	NN
cord-023095-4dannjjm	6516	27	smooth	smooth	JJ
cord-023095-4dannjjm	6516	28	muscle	muscle	NN
cord-023095-4dannjjm	6516	29	cells	cell	NNS
cord-023095-4dannjjm	6516	30	,	,	,
cord-023095-4dannjjm	6516	31	and	and	CC
cord-023095-4dannjjm	6516	32	reducing	reduce	VBG
cord-023095-4dannjjm	6516	33	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6516	34	artery	artery	NN
cord-023095-4dannjjm	6516	35	hypertrophy	hypertrophy	NN
cord-023095-4dannjjm	6516	36	.	.	.
cord-023095-4dannjjm	6517	1	DCA	DCA	NNP
cord-023095-4dannjjm	6517	2	has	have	VBZ
cord-023095-4dannjjm	6517	3	known	know	VBN
cord-023095-4dannjjm	6517	4	toxic	toxic	JJ
cord-023095-4dannjjm	6517	5	effects	effect	NNS
cord-023095-4dannjjm	6517	6	,	,	,
cord-023095-4dannjjm	6517	7	including	include	VBG
cord-023095-4dannjjm	6517	8	reversible	reversible	JJ
cord-023095-4dannjjm	6517	9	hepatotoxicity	hepatotoxicity	NN
cord-023095-4dannjjm	6517	10	and	and	CC
cord-023095-4dannjjm	6517	11	peripheral	peripheral	JJ
cord-023095-4dannjjm	6517	12	neuropathy	neuropathy	NN
cord-023095-4dannjjm	6517	13	,	,	,
cord-023095-4dannjjm	6517	14	and	and	CC
cord-023095-4dannjjm	6517	15	has	have	VBZ
cord-023095-4dannjjm	6517	16	not	not	RB
cord-023095-4dannjjm	6517	17	been	be	VBN
cord-023095-4dannjjm	6517	18	studied	study	VBN
cord-023095-4dannjjm	6517	19	in	in	IN
cord-023095-4dannjjm	6517	20	any	any	DT
cord-023095-4dannjjm	6517	21	species	specie	NNS
cord-023095-4dannjjm	6517	22	with	with	IN
cord-023095-4dannjjm	6517	23	naturally	naturally	RB
cord-023095-4dannjjm	6517	24	occurring	occur	VBG
cord-023095-4dannjjm	6517	25	PAH	PAH	NNP
cord-023095-4dannjjm	6517	26	.	.	.
cord-023095-4dannjjm	6518	1	The	the	DT
cord-023095-4dannjjm	6518	2	objective	objective	NN
cord-023095-4dannjjm	6518	3	of	of	IN
cord-023095-4dannjjm	6518	4	this	this	DT
cord-023095-4dannjjm	6518	5	open	open	JJ
cord-023095-4dannjjm	6518	6	label	label	NN
cord-023095-4dannjjm	6518	7	pilot	pilot	NN
cord-023095-4dannjjm	6518	8	study	study	NN
cord-023095-4dannjjm	6518	9	is	be	VBZ
cord-023095-4dannjjm	6518	10	to	to	TO
cord-023095-4dannjjm	6518	11	evaluate	evaluate	VB
cord-023095-4dannjjm	6518	12	the	the	DT
cord-023095-4dannjjm	6518	13	therapeutic	therapeutic	JJ
cord-023095-4dannjjm	6518	14	and	and	CC
cord-023095-4dannjjm	6518	15	toxic	toxic	JJ
cord-023095-4dannjjm	6518	16	effects	effect	NNS
cord-023095-4dannjjm	6518	17	of	of	IN
cord-023095-4dannjjm	6518	18	DCA	DCA	NNP
cord-023095-4dannjjm	6518	19	in	in	IN
cord-023095-4dannjjm	6518	20	naturally	naturally	RB
cord-023095-4dannjjm	6518	21	occurring	occur	VBG
cord-023095-4dannjjm	6518	22	canine	canine	JJ
cord-023095-4dannjjm	6518	23	PAH	PAH	NNP
cord-023095-4dannjjm	6518	24	.	.	.
cord-023095-4dannjjm	6519	1	Three	three	CD
cord-023095-4dannjjm	6519	2	dogs	dog	NNS
cord-023095-4dannjjm	6519	3	with	with	IN
cord-023095-4dannjjm	6519	4	PAH	PAH	NNP
cord-023095-4dannjjm	6519	5	diagnosed	diagnose	VBN
cord-023095-4dannjjm	6519	6	by	by	IN
cord-023095-4dannjjm	6519	7	Doppler	Doppler	NNP
cord-023095-4dannjjm	6519	8	echocardiography	echocardiography	NN
cord-023095-4dannjjm	6519	9	and	and	CC
cord-023095-4dannjjm	6519	10	no	no	DT
cord-023095-4dannjjm	6519	11	correctable	correctable	JJ
cord-023095-4dannjjm	6519	12	underlying	underlying	JJ
cord-023095-4dannjjm	6519	13	cause	cause	NN
cord-023095-4dannjjm	6519	14	are	be	VBP
cord-023095-4dannjjm	6519	15	enrolled	enrol	VBN
cord-023095-4dannjjm	6519	16	in	in	IN
cord-023095-4dannjjm	6519	17	the	the	DT
cord-023095-4dannjjm	6519	18	study	study	NN
cord-023095-4dannjjm	6519	19	.	.	.
cord-023095-4dannjjm	6520	1	Dogs	dog	NNS
cord-023095-4dannjjm	6520	2	are	be	VBP
cord-023095-4dannjjm	6520	3	orally	orally	RB
cord-023095-4dannjjm	6520	4	administered	administer	VBN
cord-023095-4dannjjm	6520	5	25	25	CD
cord-023095-4dannjjm	6520	6	mg	mg	NNP
cord-023095-4dannjjm	6520	7	/	/	SYM
cord-023095-4dannjjm	6520	8	kg	kg	NNP
cord-023095-4dannjjm	6520	9	of	of	IN
cord-023095-4dannjjm	6520	10	DCA	DCA	NNP
cord-023095-4dannjjm	6520	11	divided	divide	VBD
cord-023095-4dannjjm	6520	12	daily	daily	RB
cord-023095-4dannjjm	6520	13	for	for	IN
cord-023095-4dannjjm	6520	14	2	2	CD
cord-023095-4dannjjm	6520	15	weeks	week	NNS
cord-023095-4dannjjm	6520	16	,	,	,
cord-023095-4dannjjm	6520	17	and	and	CC
cord-023095-4dannjjm	6520	18	then	then	RB
cord-023095-4dannjjm	6520	19	12.5	12.5	CD
cord-023095-4dannjjm	6520	20	mg	mg	NNP
cord-023095-4dannjjm	6520	21	/	/	SYM
cord-023095-4dannjjm	6520	22	kg	kg	NNP
cord-023095-4dannjjm	6520	23	of	of	IN
cord-023095-4dannjjm	6520	24	DCA	DCA	NNP
cord-023095-4dannjjm	6520	25	divided	divide	VBD
cord-023095-4dannjjm	6520	26	daily	daily	RB
cord-023095-4dannjjm	6520	27	for	for	IN
cord-023095-4dannjjm	6520	28	the	the	DT
cord-023095-4dannjjm	6520	29	remainder	remainder	NN
cord-023095-4dannjjm	6520	30	of	of	IN
cord-023095-4dannjjm	6520	31	the	the	DT
cord-023095-4dannjjm	6520	32	study	study	NN
cord-023095-4dannjjm	6520	33	.	.	.
cord-023095-4dannjjm	6521	1	At	at	IN
cord-023095-4dannjjm	6521	2	baseline	baseline	NN
cord-023095-4dannjjm	6521	3	,	,	,
cord-023095-4dannjjm	6521	4	2	2	CD
cord-023095-4dannjjm	6521	5	,	,	,
cord-023095-4dannjjm	6521	6	4	4	CD
cord-023095-4dannjjm	6521	7	,	,	,
cord-023095-4dannjjm	6521	8	8	8	CD
cord-023095-4dannjjm	6521	9	,	,	,
cord-023095-4dannjjm	6521	10	and	and	CC
cord-023095-4dannjjm	6521	11	12	12	CD
cord-023095-4dannjjm	6521	12	weeks	week	NNS
cord-023095-4dannjjm	6521	13	,	,	,
cord-023095-4dannjjm	6521	14	an	an	DT
cord-023095-4dannjjm	6521	15	echocardiogram	echocardiogram	NN
cord-023095-4dannjjm	6521	16	,	,	,
cord-023095-4dannjjm	6521	17	CBC	CBC	NNP
cord-023095-4dannjjm	6521	18	,	,	,
cord-023095-4dannjjm	6521	19	serum	serum	NN
cord-023095-4dannjjm	6521	20	chemistry	chemistry	NN
cord-023095-4dannjjm	6521	21	profile	profile	NN
cord-023095-4dannjjm	6521	22	,	,	,
cord-023095-4dannjjm	6521	23	urinalysis	urinalysis	NN
cord-023095-4dannjjm	6521	24	,	,	,
cord-023095-4dannjjm	6521	25	NT	NT	NNP
cord-023095-4dannjjm	6521	26	-	-	HYPH
cord-023095-4dannjjm	6521	27	proBNP	probnp	NN
cord-023095-4dannjjm	6521	28	,	,	,
cord-023095-4dannjjm	6521	29	blood	blood	NN
cord-023095-4dannjjm	6521	30	uric	uric	NN
cord-023095-4dannjjm	6521	31	acid	acid	NN
cord-023095-4dannjjm	6521	32	,	,	,
cord-023095-4dannjjm	6521	33	blood	blood	NN
cord-023095-4dannjjm	6521	34	lactate	lactate	NN
cord-023095-4dannjjm	6521	35	,	,	,
cord-023095-4dannjjm	6521	36	noninvasive	noninvasive	JJ
cord-023095-4dannjjm	6521	37	blood	blood	NN
cord-023095-4dannjjm	6521	38	pressure	pressure	NN
cord-023095-4dannjjm	6521	39	,	,	,
cord-023095-4dannjjm	6521	40	nerve	nerve	NN
cord-023095-4dannjjm	6521	41	conduction	conduction	NN
cord-023095-4dannjjm	6521	42	study	study	NN
cord-023095-4dannjjm	6521	43	,	,	,
cord-023095-4dannjjm	6521	44	and	and	CC
cord-023095-4dannjjm	6521	45	trough	trough	NN
cord-023095-4dannjjm	6521	46	DCA	DCA	NNP
cord-023095-4dannjjm	6521	47	level	level	NN
cord-023095-4dannjjm	6521	48	(	(	-LRB-
cord-023095-4dannjjm	6521	49	12	12	CD
cord-023095-4dannjjm	6521	50	hr	hr	NN
cord-023095-4dannjjm	6521	51	post	post	NN
cord-023095-4dannjjm	6521	52	-	-	JJ
cord-023095-4dannjjm	6521	53	dose	dose	JJ
cord-023095-4dannjjm	6521	54	)	)	-RRB-
cord-023095-4dannjjm	6521	55	are	be	VBP
cord-023095-4dannjjm	6521	56	obtained	obtain	VBN
cord-023095-4dannjjm	6521	57	.	.	.
cord-023095-4dannjjm	6522	1	The	the	DT
cord-023095-4dannjjm	6522	2	measured	measure	VBN
cord-023095-4dannjjm	6522	3	echocardiographic	echocardiographic	JJ
cord-023095-4dannjjm	6522	4	parameters	parameter	NNS
cord-023095-4dannjjm	6522	5	include	include	VBP
cord-023095-4dannjjm	6522	6	peak	peak	NN
cord-023095-4dannjjm	6522	7	and	and	CC
cord-023095-4dannjjm	6522	8	mean	mean	JJ
cord-023095-4dannjjm	6522	9	tricuspid	tricuspid	NNP
cord-023095-4dannjjm	6522	10	regurgitant	regurgitant	JJ
cord-023095-4dannjjm	6522	11	flow	flow	NN
cord-023095-4dannjjm	6522	12	velocity	velocity	NN
cord-023095-4dannjjm	6522	13	and	and	CC
cord-023095-4dannjjm	6522	14	pressure	pressure	NN
cord-023095-4dannjjm	6522	15	gradient	gradient	NN
cord-023095-4dannjjm	6522	16	,	,	,
cord-023095-4dannjjm	6522	17	peak	peak	NN
cord-023095-4dannjjm	6522	18	and	and	CC
cord-023095-4dannjjm	6522	19	enddiastolic	enddiastolic	JJ
cord-023095-4dannjjm	6522	20	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6522	21	regurgitant	regurgitant	NN
cord-023095-4dannjjm	6522	22	flow	flow	NN
cord-023095-4dannjjm	6522	23	velocity	velocity	NN
cord-023095-4dannjjm	6522	24	and	and	CC
cord-023095-4dannjjm	6522	25	pressure	pressure	NN
cord-023095-4dannjjm	6522	26	gradient	gradient	NN
cord-023095-4dannjjm	6522	27	,	,	,
cord-023095-4dannjjm	6522	28	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6522	29	valve	valve	NN
cord-023095-4dannjjm	6522	30	flow	flow	NN
cord-023095-4dannjjm	6522	31	velocity	velocity	NN
cord-023095-4dannjjm	6522	32	acceleration	acceleration	NN
cord-023095-4dannjjm	6522	33	time	time	NN
cord-023095-4dannjjm	6522	34	and	and	CC
cord-023095-4dannjjm	6522	35	ejection	ejection	NN
cord-023095-4dannjjm	6522	36	time	time	NN
cord-023095-4dannjjm	6522	37	,	,	,
cord-023095-4dannjjm	6522	38	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6522	39	valve	valve	NN
cord-023095-4dannjjm	6522	40	flow	flow	NN
cord-023095-4dannjjm	6522	41	velocity	velocity	NN
cord-023095-4dannjjm	6522	42	time	time	NN
cord-023095-4dannjjm	6522	43	integral	integral	JJ
cord-023095-4dannjjm	6522	44	,	,	,
cord-023095-4dannjjm	6522	45	right	right	JJ
cord-023095-4dannjjm	6522	46	ventricular	ventricular	JJ
cord-023095-4dannjjm	6522	47	myocardial	myocardial	JJ
cord-023095-4dannjjm	6522	48	performance	performance	NN
cord-023095-4dannjjm	6522	49	index	index	NN
cord-023095-4dannjjm	6522	50	,	,	,
cord-023095-4dannjjm	6522	51	tricuspid	tricuspid	JJ
cord-023095-4dannjjm	6522	52	annular	annular	JJ
cord-023095-4dannjjm	6522	53	plane	plane	NN
cord-023095-4dannjjm	6522	54	systolic	systolic	JJ
cord-023095-4dannjjm	6522	55	excursion	excursion	NN
cord-023095-4dannjjm	6522	56	,	,	,
cord-023095-4dannjjm	6522	57	and	and	CC
cord-023095-4dannjjm	6522	58	systolic	systolic	JJ
cord-023095-4dannjjm	6522	59	tricuspid	tricuspid	JJ
cord-023095-4dannjjm	6522	60	annular	annular	JJ
cord-023095-4dannjjm	6522	61	tissue	tissue	NN
cord-023095-4dannjjm	6522	62	velocity	velocity	NN
cord-023095-4dannjjm	6522	63	.	.	.
cord-023095-4dannjjm	6523	1	Variables	variable	NNS
cord-023095-4dannjjm	6523	2	are	be	VBP
cord-023095-4dannjjm	6523	3	inspected	inspect	VBN
cord-023095-4dannjjm	6523	4	for	for	IN
cord-023095-4dannjjm	6523	5	normalcy	normalcy	NN
cord-023095-4dannjjm	6523	6	and	and	CC
cord-023095-4dannjjm	6523	7	equality	equality	NN
cord-023095-4dannjjm	6523	8	of	of	IN
cord-023095-4dannjjm	6523	9	variances	variance	NNS
cord-023095-4dannjjm	6523	10	and	and	CC
cord-023095-4dannjjm	6523	11	a	a	DT
cord-023095-4dannjjm	6523	12	two	two	CD
cord-023095-4dannjjm	6523	13	-	-	HYPH
cord-023095-4dannjjm	6523	14	sided	sided	JJ
cord-023095-4dannjjm	6523	15	paired	pair	VBN
cord-023095-4dannjjm	6523	16	t	t	NN
cord-023095-4dannjjm	6523	17	-	-	HYPH
cord-023095-4dannjjm	6523	18	test	test	NN
cord-023095-4dannjjm	6523	19	is	be	VBZ
cord-023095-4dannjjm	6523	20	used	use	VBN
cord-023095-4dannjjm	6523	21	to	to	TO
cord-023095-4dannjjm	6523	22	compare	compare	VB
cord-023095-4dannjjm	6523	23	the	the	DT
cord-023095-4dannjjm	6523	24	variables	variable	NNS
cord-023095-4dannjjm	6523	25	before	before	IN
cord-023095-4dannjjm	6523	26	and	and	CC
cord-023095-4dannjjm	6523	27	after	after	IN
cord-023095-4dannjjm	6523	28	treatment	treatment	NN
cord-023095-4dannjjm	6523	29	at	at	IN
cord-023095-4dannjjm	6523	30	each	each	DT
cord-023095-4dannjjm	6523	31	evaluation	evaluation	NN
cord-023095-4dannjjm	6523	32	time	time	NN
cord-023095-4dannjjm	6523	33	.	.	.
cord-023095-4dannjjm	6524	1	The	the	DT
cord-023095-4dannjjm	6524	2	basis	basis	NN
cord-023095-4dannjjm	6524	3	for	for	IN
cord-023095-4dannjjm	6524	4	the	the	DT
cord-023095-4dannjjm	6524	5	role	role	NN
cord-023095-4dannjjm	6524	6	of	of	IN
cord-023095-4dannjjm	6524	7	the	the	DT
cord-023095-4dannjjm	6524	8	mitochondria	mitochondrion	NNS
cord-023095-4dannjjm	6524	9	in	in	IN
cord-023095-4dannjjm	6524	10	PAH	PAH	NNP
cord-023095-4dannjjm	6524	11	and	and	CC
cord-023095-4dannjjm	6524	12	the	the	DT
cord-023095-4dannjjm	6524	13	results	result	NNS
cord-023095-4dannjjm	6524	14	of	of	IN
cord-023095-4dannjjm	6524	15	this	this	DT
cord-023095-4dannjjm	6524	16	pilot	pilot	NN
cord-023095-4dannjjm	6524	17	study	study	NN
cord-023095-4dannjjm	6524	18	will	will	MD
cord-023095-4dannjjm	6524	19	be	be	VB
cord-023095-4dannjjm	6524	20	presented	present	VBN
cord-023095-4dannjjm	6524	21	to	to	TO
cord-023095-4dannjjm	6524	22	determine	determine	VB
cord-023095-4dannjjm	6524	23	if	if	IN
cord-023095-4dannjjm	6524	24	DCA	DCA	NNP
cord-023095-4dannjjm	6524	25	warrants	warrant	NNS
cord-023095-4dannjjm	6524	26	further	further	JJ
cord-023095-4dannjjm	6524	27	study	study	NN
cord-023095-4dannjjm	6524	28	as	as	IN
cord-023095-4dannjjm	6524	29	a	a	DT
cord-023095-4dannjjm	6524	30	therapy	therapy	NN
cord-023095-4dannjjm	6524	31	for	for	IN
cord-023095-4dannjjm	6524	32	dogs	dog	NNS
cord-023095-4dannjjm	6524	33	with	with	IN
cord-023095-4dannjjm	6524	34	PAH	PAH	NNP
cord-023095-4dannjjm	6524	35	.	.	.
cord-023095-4dannjjm	6525	1	study	study	NN
cord-023095-4dannjjm	6525	2	produced	produce	VBD
cord-023095-4dannjjm	6525	3	the	the	DT
cord-023095-4dannjjm	6525	4	strongest	strong	JJS
cord-023095-4dannjjm	6525	5	associations	association	NNS
cord-023095-4dannjjm	6525	6	between	between	IN
cord-023095-4dannjjm	6525	7	the	the	DT
cord-023095-4dannjjm	6525	8	NCL	NCL	NNP
cord-023095-4dannjjm	6525	9	phenotype	phenotype	NN
cord-023095-4dannjjm	6525	10	and	and	CC
cord-023095-4dannjjm	6525	11	CFA2	cfa2	JJ
cord-023095-4dannjjm	6525	12	markers	marker	NNS
cord-023095-4dannjjm	6525	13	.	.	.
cord-023095-4dannjjm	6526	1	All	all	DT
cord-023095-4dannjjm	6526	2	19	19	CD
cord-023095-4dannjjm	6526	3	NCL	NCL	NNP
cord-023095-4dannjjm	6526	4	-	-	HYPH
cord-023095-4dannjjm	6526	5	affected	affect	VBN
cord-023095-4dannjjm	6526	6	Tibetan	Tibetan	NNP
cord-023095-4dannjjm	6526	7	Terriers	Terriers	NNPS
cord-023095-4dannjjm	6526	8	were	be	VBD
cord-023095-4dannjjm	6526	9	homozygous	homozygous	JJ
cord-023095-4dannjjm	6526	10	for	for	IN
cord-023095-4dannjjm	6526	11	the	the	DT
cord-023095-4dannjjm	6526	12	same	same	JJ
cord-023095-4dannjjm	6526	13	haplotype	haplotype	NN
cord-023095-4dannjjm	6526	14	which	which	WDT
cord-023095-4dannjjm	6526	15	extended	extend	VBD
cord-023095-4dannjjm	6526	16	for	for	IN
cord-023095-4dannjjm	6526	17	22	22	CD
cord-023095-4dannjjm	6526	18	consecutive	consecutive	JJ
cord-023095-4dannjjm	6526	19	SNPs	snp	NNS
cord-023095-4dannjjm	6526	20	spanning	span	VBG
cord-023095-4dannjjm	6526	21	0.95	0.95	CD
cord-023095-4dannjjm	6526	22	Mb	Mb	NNS
cord-023095-4dannjjm	6526	23	.	.	.
cord-023095-4dannjjm	6527	1	None	none	NN
cord-023095-4dannjjm	6527	2	of	of	IN
cord-023095-4dannjjm	6527	3	the	the	DT
cord-023095-4dannjjm	6527	4	20	20	CD
cord-023095-4dannjjm	6527	5	annotated	annotate	VBN
cord-023095-4dannjjm	6527	6	genes	gene	NNS
cord-023095-4dannjjm	6527	7	within	within	IN
cord-023095-4dannjjm	6527	8	this	this	DT
cord-023095-4dannjjm	6527	9	target	target	NN
cord-023095-4dannjjm	6527	10	region	region	NN
cord-023095-4dannjjm	6527	11	had	have	VBD
cord-023095-4dannjjm	6527	12	previously	previously	RB
cord-023095-4dannjjm	6527	13	been	be	VBN
cord-023095-4dannjjm	6527	14	associated	associate	VBN
cord-023095-4dannjjm	6527	15	with	with	IN
cord-023095-4dannjjm	6527	16	human	human	JJ
cord-023095-4dannjjm	6527	17	or	or	CC
cord-023095-4dannjjm	6527	18	rodent	rodent	NN
cord-023095-4dannjjm	6527	19	NCL	NCL	NNP
cord-023095-4dannjjm	6527	20	.	.	.
cord-023095-4dannjjm	6528	1	We	-PRON-	PRP
cord-023095-4dannjjm	6528	2	used	use	VBD
cord-023095-4dannjjm	6528	3	DNA	DNA	NNP
cord-023095-4dannjjm	6528	4	from	from	IN
cord-023095-4dannjjm	6528	5	NCL	NCL	NNP
cord-023095-4dannjjm	6528	6	-	-	HYPH
cord-023095-4dannjjm	6528	7	affected	affect	VBN
cord-023095-4dannjjm	6528	8	Tibetan	Tibetan	NNP
cord-023095-4dannjjm	6528	9	Terriers	Terriers	NNPS
cord-023095-4dannjjm	6528	10	to	to	TO
cord-023095-4dannjjm	6528	11	resequence	resequence	VB
cord-023095-4dannjjm	6528	12	the	the	DT
cord-023095-4dannjjm	6528	13	coding	code	VBG
cord-023095-4dannjjm	6528	14	regions	region	NNS
cord-023095-4dannjjm	6528	15	and	and	CC
cord-023095-4dannjjm	6528	16	intron	intron	NN
cord-023095-4dannjjm	6528	17	-	-	HYPH
cord-023095-4dannjjm	6528	18	exon	exon	NN
cord-023095-4dannjjm	6528	19	borders	border	NNS
cord-023095-4dannjjm	6528	20	of	of	IN
cord-023095-4dannjjm	6528	21	several	several	JJ
cord-023095-4dannjjm	6528	22	genes	gene	NNS
cord-023095-4dannjjm	6528	23	harbored	harbor	VBN
cord-023095-4dannjjm	6528	24	within	within	IN
cord-023095-4dannjjm	6528	25	the	the	DT
cord-023095-4dannjjm	6528	26	target	target	NN
cord-023095-4dannjjm	6528	27	region	region	NN
cord-023095-4dannjjm	6528	28	and	and	CC
cord-023095-4dannjjm	6528	29	found	find	VBD
cord-023095-4dannjjm	6528	30	a	a	DT
cord-023095-4dannjjm	6528	31	single	single	JJ
cord-023095-4dannjjm	6528	32	base	base	NN
cord-023095-4dannjjm	6528	33	pair	pair	NN
cord-023095-4dannjjm	6528	34	deletion	deletion	NN
cord-023095-4dannjjm	6528	35	,	,	,
cord-023095-4dannjjm	6528	36	c.1623delG	c.1623delG	NNP
cord-023095-4dannjjm	6528	37	,	,	,
cord-023095-4dannjjm	6528	38	in	in	IN
cord-023095-4dannjjm	6528	39	exon	exon	NN
cord-023095-4dannjjm	6528	40	16	16	CD
cord-023095-4dannjjm	6528	41	of	of	IN
cord-023095-4dannjjm	6528	42	positional	positional	JJ
cord-023095-4dannjjm	6528	43	candidate	candidate	NN
cord-023095-4dannjjm	6528	44	ATP13A2	ATP13A2	NNP
cord-023095-4dannjjm	6528	45	.	.	.
cord-023095-4dannjjm	6529	1	This	this	DT
cord-023095-4dannjjm	6529	2	deletion	deletion	NN
cord-023095-4dannjjm	6529	3	produces	produce	VBZ
cord-023095-4dannjjm	6529	4	a	a	DT
cord-023095-4dannjjm	6529	5	frame	frame	NN
cord-023095-4dannjjm	6529	6	shift	shift	NN
cord-023095-4dannjjm	6529	7	and	and	CC
cord-023095-4dannjjm	6529	8	a	a	DT
cord-023095-4dannjjm	6529	9	predicted	predict	VBN
cord-023095-4dannjjm	6529	10	premature	premature	JJ
cord-023095-4dannjjm	6529	11	termination	termination	NN
cord-023095-4dannjjm	6529	12	codon	codon	NN
cord-023095-4dannjjm	6529	13	.	.	.
cord-023095-4dannjjm	6530	1	We	-PRON-	PRP
cord-023095-4dannjjm	6530	2	genotyped	genotype	VBD
cord-023095-4dannjjm	6530	3	all	all	DT
cord-023095-4dannjjm	6530	4	454	454	CD
cord-023095-4dannjjm	6530	5	Tibetan	Tibetan	NNP
cord-023095-4dannjjm	6530	6	Terrier	Terrier	NNP
cord-023095-4dannjjm	6530	7	DNA	dna	NN
cord-023095-4dannjjm	6530	8	samples	sample	NNS
cord-023095-4dannjjm	6530	9	in	in	IN
cord-023095-4dannjjm	6530	10	our	-PRON-	PRP$
cord-023095-4dannjjm	6530	11	collection	collection	NN
cord-023095-4dannjjm	6530	12	and	and	CC
cord-023095-4dannjjm	6530	13	found	find	VBD
cord-023095-4dannjjm	6530	14	all	all	DT
cord-023095-4dannjjm	6530	15	45	45	CD
cord-023095-4dannjjm	6530	16	NCL	NCL	NNP
cord-023095-4dannjjm	6530	17	-	-	HYPH
cord-023095-4dannjjm	6530	18	affected	affect	VBN
cord-023095-4dannjjm	6530	19	Tibetan	Tibetan	NNP
cord-023095-4dannjjm	6530	20	Terriers	Terriers	NNPS
cord-023095-4dannjjm	6530	21	to	to	TO
cord-023095-4dannjjm	6530	22	be	be	VB
cord-023095-4dannjjm	6530	23	homozygous	homozygous	JJ
cord-023095-4dannjjm	6530	24	for	for	IN
cord-023095-4dannjjm	6530	25	the	the	DT
cord-023095-4dannjjm	6530	26	c.1623delG	c.1623delG	NNP
cord-023095-4dannjjm	6530	27	allele	allele	NN
cord-023095-4dannjjm	6530	28	.	.	.
cord-023095-4dannjjm	6531	1	Eleven	eleven	CD
cord-023095-4dannjjm	6531	2	additional	additional	JJ
cord-023095-4dannjjm	6531	3	c.1623delG	c.1623delG	NNP
cord-023095-4dannjjm	6531	4	homozygotes	homozygote	NNS
cord-023095-4dannjjm	6531	5	were	be	VBD
cord-023095-4dannjjm	6531	6	either	either	CC
cord-023095-4dannjjm	6531	7	less	less	JJR
cord-023095-4dannjjm	6531	8	than	than	IN
cord-023095-4dannjjm	6531	9	5	5	CD
cord-023095-4dannjjm	6531	10	years	year	NNS
cord-023095-4dannjjm	6531	11	old	old	JJ
cord-023095-4dannjjm	6531	12	,	,	,
cord-023095-4dannjjm	6531	13	or	or	CC
cord-023095-4dannjjm	6531	14	lost	lose	VBD
cord-023095-4dannjjm	6531	15	to	to	TO
cord-023095-4dannjjm	6531	16	follow	follow	VB
cord-023095-4dannjjm	6531	17	up	up	RP
cord-023095-4dannjjm	6531	18	.	.	.
cord-023095-4dannjjm	6532	1	There	there	EX
cord-023095-4dannjjm	6532	2	were	be	VBD
cord-023095-4dannjjm	6532	3	no	no	DT
cord-023095-4dannjjm	6532	4	known	know	VBN
cord-023095-4dannjjm	6532	5	cases	case	NNS
cord-023095-4dannjjm	6532	6	of	of	IN
cord-023095-4dannjjm	6532	7	NCL	NCL	NNP
cord-023095-4dannjjm	6532	8	in	in	IN
cord-023095-4dannjjm	6532	9	the	the	DT
cord-023095-4dannjjm	6532	10	remaining	remain	VBG
cord-023095-4dannjjm	6532	11	398	398	CD
cord-023095-4dannjjm	6532	12	Tibetan	Tibetan	NNP
cord-023095-4dannjjm	6532	13	Terriers	Terriers	NNPS
cord-023095-4dannjjm	6532	14	which	which	WDT
cord-023095-4dannjjm	6532	15	were	be	VBD
cord-023095-4dannjjm	6532	16	either	either	DT
cord-023095-4dannjjm	6532	17	heterozygous	heterozygous	JJ
cord-023095-4dannjjm	6532	18	(	(	-LRB-
cord-023095-4dannjjm	6532	19	n	n	NN
cord-023095-4dannjjm	6532	20	5	5	CD
cord-023095-4dannjjm	6532	21	149	149	CD
cord-023095-4dannjjm	6532	22	)	)	-RRB-
cord-023095-4dannjjm	6532	23	or	or	CC
cord-023095-4dannjjm	6532	24	homozygous	homozygous	JJ
cord-023095-4dannjjm	6532	25	for	for	IN
cord-023095-4dannjjm	6532	26	the	the	DT
cord-023095-4dannjjm	6532	27	ancestral	ancestral	JJ
cord-023095-4dannjjm	6532	28	allele	allele	NN
cord-023095-4dannjjm	6532	29	(	(	-LRB-
cord-023095-4dannjjm	6532	30	n	n	NN
cord-023095-4dannjjm	6532	31	5	5	CD
cord-023095-4dannjjm	6532	32	249	249	CD
cord-023095-4dannjjm	6532	33	)	)	-RRB-
cord-023095-4dannjjm	6532	34	.	.	.
cord-023095-4dannjjm	6533	1	ATP13A2	atp13a2	NN
cord-023095-4dannjjm	6533	2	is	be	VBZ
cord-023095-4dannjjm	6533	3	a	a	DT
cord-023095-4dannjjm	6533	4	member	member	NN
cord-023095-4dannjjm	6533	5	of	of	IN
cord-023095-4dannjjm	6533	6	group	group	NN
cord-023095-4dannjjm	6533	7	of	of	IN
cord-023095-4dannjjm	6533	8	ion	ion	NN
cord-023095-4dannjjm	6533	9	transport	transport	NN
cord-023095-4dannjjm	6533	10	genes	gene	NNS
cord-023095-4dannjjm	6533	11	and	and	CC
cord-023095-4dannjjm	6533	12	has	have	VBZ
cord-023095-4dannjjm	6533	13	been	be	VBN
cord-023095-4dannjjm	6533	14	associated	associate	VBN
cord-023095-4dannjjm	6533	15	with	with	IN
cord-023095-4dannjjm	6533	16	lysosomes	lysosome	NNS
cord-023095-4dannjjm	6533	17	.	.	.
cord-023095-4dannjjm	6534	1	Mutations	mutation	NNS
cord-023095-4dannjjm	6534	2	in	in	IN
cord-023095-4dannjjm	6534	3	human	human	JJ
cord-023095-4dannjjm	6534	4	ATP13A2	atp13a2	NN
cord-023095-4dannjjm	6534	5	cause	cause	IN
cord-023095-4dannjjm	6534	6	Kufor	Kufor	NNP
cord-023095-4dannjjm	6534	7	-	-	HYPH
cord-023095-4dannjjm	6534	8	Rakeb	Rakeb	NNP
cord-023095-4dannjjm	6534	9	syndrome	syndrome	NN
cord-023095-4dannjjm	6534	10	(	(	-LRB-
cord-023095-4dannjjm	6534	11	KRS	KRS	NNP
cord-023095-4dannjjm	6534	12	)	)	-RRB-
cord-023095-4dannjjm	6534	13	,	,	,
cord-023095-4dannjjm	6534	14	a	a	DT
cord-023095-4dannjjm	6534	15	rare	rare	JJ
cord-023095-4dannjjm	6534	16	neurodegenerative	neurodegenerative	JJ
cord-023095-4dannjjm	6534	17	disorder	disorder	NN
cord-023095-4dannjjm	6534	18	with	with	IN
cord-023095-4dannjjm	6534	19	clinical	clinical	JJ
cord-023095-4dannjjm	6534	20	features	feature	NNS
cord-023095-4dannjjm	6534	21	that	that	WDT
cord-023095-4dannjjm	6534	22	include	include	VBP
cord-023095-4dannjjm	6534	23	parkinsonism	parkinsonism	NN
cord-023095-4dannjjm	6534	24	plus	plus	CC
cord-023095-4dannjjm	6534	25	spasticity	spasticity	NN
cord-023095-4dannjjm	6534	26	,	,	,
cord-023095-4dannjjm	6534	27	supranuclear	supranuclear	NNP
cord-023095-4dannjjm	6534	28	upgaze	upgaze	NNP
cord-023095-4dannjjm	6534	29	paresis	paresis	NNP
cord-023095-4dannjjm	6534	30	,	,	,
cord-023095-4dannjjm	6534	31	and	and	CC
cord-023095-4dannjjm	6534	32	dementia	dementia	NN
cord-023095-4dannjjm	6534	33	.	.	.
cord-023095-4dannjjm	6535	1	Post	post	JJ
cord-023095-4dannjjm	6535	2	-	-	JJ
cord-023095-4dannjjm	6535	3	mortem	mortem	JJ
cord-023095-4dannjjm	6535	4	findings	finding	NNS
cord-023095-4dannjjm	6535	5	in	in	IN
cord-023095-4dannjjm	6535	6	KRS	KRS	NNP
cord-023095-4dannjjm	6535	7	have	have	VBP
cord-023095-4dannjjm	6535	8	not	not	RB
cord-023095-4dannjjm	6535	9	been	be	VBN
cord-023095-4dannjjm	6535	10	reported	report	VBN
cord-023095-4dannjjm	6535	11	.	.	.
cord-023095-4dannjjm	6536	1	We	-PRON-	PRP
cord-023095-4dannjjm	6536	2	conclude	conclude	VBP
cord-023095-4dannjjm	6536	3	that	that	IN
cord-023095-4dannjjm	6536	4	NCL	NCL	NNP
cord-023095-4dannjjm	6536	5	in	in	IN
cord-023095-4dannjjm	6536	6	Tibetan	tibetan	JJ
cord-023095-4dannjjm	6536	7	terriers	terrier	NNS
cord-023095-4dannjjm	6536	8	is	be	VBZ
cord-023095-4dannjjm	6536	9	caused	cause	VBN
cord-023095-4dannjjm	6536	10	by	by	IN
cord-023095-4dannjjm	6536	11	a	a	DT
cord-023095-4dannjjm	6536	12	mutation	mutation	NN
cord-023095-4dannjjm	6536	13	in	in	IN
cord-023095-4dannjjm	6536	14	ATP13A2	atp13a2	NN
cord-023095-4dannjjm	6536	15	.	.	.
cord-023095-4dannjjm	6537	1	Our	-PRON-	PRP$
cord-023095-4dannjjm	6537	2	results	result	NNS
cord-023095-4dannjjm	6537	3	suggest	suggest	VBP
cord-023095-4dannjjm	6537	4	that	that	IN
cord-023095-4dannjjm	6537	5	KRS	KRS	NNP
cord-023095-4dannjjm	6537	6	may	may	MD
cord-023095-4dannjjm	6537	7	be	be	VB
cord-023095-4dannjjm	6537	8	a	a	DT
cord-023095-4dannjjm	6537	9	form	form	NN
cord-023095-4dannjjm	6537	10	of	of	IN
cord-023095-4dannjjm	6537	11	adult	adult	NN
cord-023095-4dannjjm	6537	12	onset	onset	NN
cord-023095-4dannjjm	6537	13	NCL	NCL	NNP
cord-023095-4dannjjm	6537	14	in	in	IN
cord-023095-4dannjjm	6537	15	humans	human	NNS
cord-023095-4dannjjm	6537	16	.	.	.
cord-023095-4dannjjm	6538	1	Niemann	Niemann	NNP
cord-023095-4dannjjm	6538	2	-	-	HYPH
cord-023095-4dannjjm	6538	3	Pick	Pick	NNP
cord-023095-4dannjjm	6538	4	type	type	NN
cord-023095-4dannjjm	6538	5	C	c	NN
cord-023095-4dannjjm	6538	6	(	(	-LRB-
cord-023095-4dannjjm	6538	7	NPC	NPC	NNP
cord-023095-4dannjjm	6538	8	)	)	-RRB-
cord-023095-4dannjjm	6538	9	disease	disease	NN
cord-023095-4dannjjm	6538	10	is	be	VBZ
cord-023095-4dannjjm	6538	11	a	a	DT
cord-023095-4dannjjm	6538	12	progressive	progressive	JJ
cord-023095-4dannjjm	6538	13	neurological	neurological	JJ
cord-023095-4dannjjm	6538	14	disorder	disorder	NN
cord-023095-4dannjjm	6538	15	characterized	characterize	VBN
cord-023095-4dannjjm	6538	16	by	by	IN
cord-023095-4dannjjm	6538	17	dementia	dementia	NN
cord-023095-4dannjjm	6538	18	and	and	CC
cord-023095-4dannjjm	6538	19	ataxia	ataxia	NN
cord-023095-4dannjjm	6538	20	,	,	,
cord-023095-4dannjjm	6538	21	hepatic	hepatic	JJ
cord-023095-4dannjjm	6538	22	and	and	CC
cord-023095-4dannjjm	6538	23	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6538	24	disease	disease	NN
cord-023095-4dannjjm	6538	25	,	,	,
cord-023095-4dannjjm	6538	26	and	and	CC
cord-023095-4dannjjm	6538	27	death	death	NN
cord-023095-4dannjjm	6538	28	typically	typically	RB
cord-023095-4dannjjm	6538	29	within	within	IN
cord-023095-4dannjjm	6538	30	the	the	DT
cord-023095-4dannjjm	6538	31	first	first	JJ
cord-023095-4dannjjm	6538	32	or	or	CC
cord-023095-4dannjjm	6538	33	second	second	JJ
cord-023095-4dannjjm	6538	34	decade	decade	NN
cord-023095-4dannjjm	6538	35	.	.	.
cord-023095-4dannjjm	6539	1	Despite	despite	IN
cord-023095-4dannjjm	6539	2	the	the	DT
cord-023095-4dannjjm	6539	3	identification	identification	NN
cord-023095-4dannjjm	6539	4	of	of	IN
cord-023095-4dannjjm	6539	5	causative	causative	JJ
cord-023095-4dannjjm	6539	6	mutations	mutation	NNS
cord-023095-4dannjjm	6539	7	,	,	,
cord-023095-4dannjjm	6539	8	the	the	DT
cord-023095-4dannjjm	6539	9	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	6539	10	is	be	VBZ
cord-023095-4dannjjm	6539	11	not	not	RB
cord-023095-4dannjjm	6539	12	clear	clear	JJ
cord-023095-4dannjjm	6539	13	and	and	CC
cord-023095-4dannjjm	6539	14	therapies	therapy	NNS
cord-023095-4dannjjm	6539	15	to	to	TO
cord-023095-4dannjjm	6539	16	successfully	successfully	RB
cord-023095-4dannjjm	6539	17	treat	treat	VB
cord-023095-4dannjjm	6539	18	NPC	NPC	NNP
cord-023095-4dannjjm	6539	19	disease	disease	NN
cord-023095-4dannjjm	6539	20	have	have	VBP
cord-023095-4dannjjm	6539	21	been	be	VBN
cord-023095-4dannjjm	6539	22	ineffective	ineffective	JJ
cord-023095-4dannjjm	6539	23	to	to	IN
cord-023095-4dannjjm	6539	24	date	date	NN
cord-023095-4dannjjm	6539	25	.	.	.
cord-023095-4dannjjm	6540	1	The	the	DT
cord-023095-4dannjjm	6540	2	recent	recent	JJ
cord-023095-4dannjjm	6540	3	use	use	NN
cord-023095-4dannjjm	6540	4	of	of	IN
cord-023095-4dannjjm	6540	5	intravenously	intravenously	RB
cord-023095-4dannjjm	6540	6	administered	administer	VBN
cord-023095-4dannjjm	6540	7	2-hydroxypropylbeta	2-hydroxypropylbeta	CD
cord-023095-4dannjjm	6540	8	-	-	HYPH
cord-023095-4dannjjm	6540	9	cyclodextrin	cyclodextrin	NN
cord-023095-4dannjjm	6540	10	(	(	-LRB-
cord-023095-4dannjjm	6540	11	HPBCD	HPBCD	NNP
cord-023095-4dannjjm	6540	12	)	)	-RRB-
cord-023095-4dannjjm	6540	13	,	,	,
cord-023095-4dannjjm	6540	14	an	an	DT
cord-023095-4dannjjm	6540	15	FDA	FDA	NNP
cord-023095-4dannjjm	6540	16	-	-	HYPH
cord-023095-4dannjjm	6540	17	designated	designate	VBN
cord-023095-4dannjjm	6540	18	orphan	orphan	NN
cord-023095-4dannjjm	6540	19	drug	drug	NN
cord-023095-4dannjjm	6540	20	(	(	-LRB-
cord-023095-4dannjjm	6540	21	May	May	NNP
cord-023095-4dannjjm	6540	22	2010	2010	CD
cord-023095-4dannjjm	6540	23	)	)	-RRB-
cord-023095-4dannjjm	6540	24	,	,	,
cord-023095-4dannjjm	6540	25	in	in	IN
cord-023095-4dannjjm	6540	26	a	a	DT
cord-023095-4dannjjm	6540	27	small	small	JJ
cord-023095-4dannjjm	6540	28	number	number	NN
cord-023095-4dannjjm	6540	29	of	of	IN
cord-023095-4dannjjm	6540	30	children	child	NNS
cord-023095-4dannjjm	6540	31	with	with	IN
cord-023095-4dannjjm	6540	32	NPC	NPC	NNP
cord-023095-4dannjjm	6540	33	disease	disease	NN
cord-023095-4dannjjm	6540	34	is	be	VBZ
cord-023095-4dannjjm	6540	35	based	base	VBN
cord-023095-4dannjjm	6540	36	on	on	IN
cord-023095-4dannjjm	6540	37	favorable	favorable	JJ
cord-023095-4dannjjm	6540	38	treatment	treatment	NN
cord-023095-4dannjjm	6540	39	outcome	outcome	NN
cord-023095-4dannjjm	6540	40	data	datum	NNS
cord-023095-4dannjjm	6540	41	in	in	IN
cord-023095-4dannjjm	6540	42	subcutaneously	subcutaneously	RB
cord-023095-4dannjjm	6540	43	treated	treat	VBN
cord-023095-4dannjjm	6540	44	mouse	mouse	NN
cord-023095-4dannjjm	6540	45	and	and	CC
cord-023095-4dannjjm	6540	46	cat	cat	NN
cord-023095-4dannjjm	6540	47	models	model	NNS
cord-023095-4dannjjm	6540	48	.	.	.
cord-023095-4dannjjm	6541	1	To	to	TO
cord-023095-4dannjjm	6541	2	rigorously	rigorously	RB
cord-023095-4dannjjm	6541	3	evaluate	evaluate	VB
cord-023095-4dannjjm	6541	4	the	the	DT
cord-023095-4dannjjm	6541	5	mechanistic	mechanistic	JJ
cord-023095-4dannjjm	6541	6	,	,	,
cord-023095-4dannjjm	6541	7	pharmacologic	pharmacologic	JJ
cord-023095-4dannjjm	6541	8	,	,	,
cord-023095-4dannjjm	6541	9	and	and	CC
cord-023095-4dannjjm	6541	10	toxicity	toxicity	NN
cord-023095-4dannjjm	6541	11	issues	issue	NNS
cord-023095-4dannjjm	6541	12	associated	associate	VBN
cord-023095-4dannjjm	6541	13	with	with	IN
cord-023095-4dannjjm	6541	14	HPBCD	HPBCD	NNP
cord-023095-4dannjjm	6541	15	therapy	therapy	NN
cord-023095-4dannjjm	6541	16	in	in	IN
cord-023095-4dannjjm	6541	17	NPC	NPC	NNP
cord-023095-4dannjjm	6541	18	disease	disease	NN
cord-023095-4dannjjm	6541	19	,	,	,
cord-023095-4dannjjm	6541	20	we	-PRON-	PRP
cord-023095-4dannjjm	6541	21	have	have	VBP
cord-023095-4dannjjm	6541	22	utilized	utilize	VBN
cord-023095-4dannjjm	6541	23	the	the	DT
cord-023095-4dannjjm	6541	24	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	6541	25	feline	feline	JJ
cord-023095-4dannjjm	6541	26	NPC	NPC	NNP
cord-023095-4dannjjm	6541	27	model	model	NN
cord-023095-4dannjjm	6541	28	harboring	harbor	VBG
cord-023095-4dannjjm	6541	29	a	a	DT
cord-023095-4dannjjm	6541	30	missense	missense	JJ
cord-023095-4dannjjm	6541	31	mutation	mutation	NN
cord-023095-4dannjjm	6541	32	in	in	IN
cord-023095-4dannjjm	6541	33	NPC1	NPC1	NNP
cord-023095-4dannjjm	6541	34	(	(	-LRB-
cord-023095-4dannjjm	6541	35	pC955S	pC955S	NNP
cord-023095-4dannjjm	6541	36	)	)	-RRB-
cord-023095-4dannjjm	6541	37	,	,	,
cord-023095-4dannjjm	6541	38	orthologous	orthologous	NNP
cord-023095-4dannjjm	6541	39	to	to	IN
cord-023095-4dannjjm	6541	40	the	the	DT
cord-023095-4dannjjm	6541	41	most	most	RBS
cord-023095-4dannjjm	6541	42	common	common	JJ
cord-023095-4dannjjm	6541	43	mutation	mutation	NN
cord-023095-4dannjjm	6541	44	in	in	IN
cord-023095-4dannjjm	6541	45	juvenile	juvenile	JJ
cord-023095-4dannjjm	6541	46	-	-	HYPH
cord-023095-4dannjjm	6541	47	onset	onset	NN
cord-023095-4dannjjm	6541	48	patients	patient	NNS
cord-023095-4dannjjm	6541	49	.	.	.
cord-023095-4dannjjm	6542	1	The	the	DT
cord-023095-4dannjjm	6542	2	feline	feline	JJ
cord-023095-4dannjjm	6542	3	NPC	NPC	NNP
cord-023095-4dannjjm	6542	4	model	model	NN
cord-023095-4dannjjm	6542	5	has	have	VBZ
cord-023095-4dannjjm	6542	6	clinical	clinical	JJ
cord-023095-4dannjjm	6542	7	,	,	,
cord-023095-4dannjjm	6542	8	neuropathological	neuropathological	JJ
cord-023095-4dannjjm	6542	9	and	and	CC
cord-023095-4dannjjm	6542	10	biochemical	biochemical	JJ
cord-023095-4dannjjm	6542	11	abnormalities	abnormality	NNS
cord-023095-4dannjjm	6542	12	similar	similar	JJ
cord-023095-4dannjjm	6542	13	to	to	IN
cord-023095-4dannjjm	6542	14	those	those	DT
cord-023095-4dannjjm	6542	15	present	present	JJ
cord-023095-4dannjjm	6542	16	in	in	IN
cord-023095-4dannjjm	6542	17	juvenile	juvenile	JJ
cord-023095-4dannjjm	6542	18	-	-	HYPH
cord-023095-4dannjjm	6542	19	onset	onset	NN
cord-023095-4dannjjm	6542	20	patients	patient	NNS
cord-023095-4dannjjm	6542	21	making	make	VBG
cord-023095-4dannjjm	6542	22	this	this	DT
cord-023095-4dannjjm	6542	23	model	model	NN
cord-023095-4dannjjm	6542	24	homologous	homologous	JJ
cord-023095-4dannjjm	6542	25	to	to	IN
cord-023095-4dannjjm	6542	26	the	the	DT
cord-023095-4dannjjm	6542	27	most	most	RBS
cord-023095-4dannjjm	6542	28	common	common	JJ
cord-023095-4dannjjm	6542	29	disease	disease	NN
cord-023095-4dannjjm	6542	30	form	form	NN
cord-023095-4dannjjm	6542	31	seen	see	VBN
cord-023095-4dannjjm	6542	32	in	in	IN
cord-023095-4dannjjm	6542	33	human	human	JJ
cord-023095-4dannjjm	6542	34	patients	patient	NNS
cord-023095-4dannjjm	6542	35	.	.	.
cord-023095-4dannjjm	6543	1	We	-PRON-	PRP
cord-023095-4dannjjm	6543	2	identified	identify	VBD
cord-023095-4dannjjm	6543	3	that	that	IN
cord-023095-4dannjjm	6543	4	intrathecal	intrathecal	JJ
cord-023095-4dannjjm	6543	5	administration	administration	NN
cord-023095-4dannjjm	6543	6	of	of	IN
cord-023095-4dannjjm	6543	7	HPBCD	HPBCD	NNP
cord-023095-4dannjjm	6543	8	ameliorated	ameliorate	VBD
cord-023095-4dannjjm	6543	9	all	all	DT
cord-023095-4dannjjm	6543	10	clinical	clinical	JJ
cord-023095-4dannjjm	6543	11	aspects	aspect	NNS
cord-023095-4dannjjm	6543	12	of	of	IN
cord-023095-4dannjjm	6543	13	neurological	neurological	JJ
cord-023095-4dannjjm	6543	14	disease	disease	NN
cord-023095-4dannjjm	6543	15	at	at	IN
cord-023095-4dannjjm	6543	16	least	least	JJS
cord-023095-4dannjjm	6543	17	up	up	IN
cord-023095-4dannjjm	6543	18	to	to	TO
cord-023095-4dannjjm	6543	19	24	24	CD
cord-023095-4dannjjm	6543	20	weeks	week	NNS
cord-023095-4dannjjm	6543	21	of	of	IN
cord-023095-4dannjjm	6543	22	age	age	NN
cord-023095-4dannjjm	6543	23	(	(	-LRB-
cord-023095-4dannjjm	6543	24	an	an	DT
cord-023095-4dannjjm	6543	25	age	age	NN
cord-023095-4dannjjm	6543	26	when	when	WRB
cord-023095-4dannjjm	6543	27	untreated	untreated	JJ
cord-023095-4dannjjm	6543	28	cats	cat	NNS
cord-023095-4dannjjm	6543	29	die	die	VBP
cord-023095-4dannjjm	6543	30	)	)	-RRB-
cord-023095-4dannjjm	6543	31	but	but	CC
cord-023095-4dannjjm	6543	32	had	have	VBD
cord-023095-4dannjjm	6543	33	no	no	DT
cord-023095-4dannjjm	6543	34	effect	effect	NN
cord-023095-4dannjjm	6543	35	on	on	IN
cord-023095-4dannjjm	6543	36	hepatic	hepatic	JJ
cord-023095-4dannjjm	6543	37	disease	disease	NN
cord-023095-4dannjjm	6543	38	.	.	.
cord-023095-4dannjjm	6544	1	We	-PRON-	PRP
cord-023095-4dannjjm	6544	2	identified	identify	VBD
cord-023095-4dannjjm	6544	3	that	that	IN
cord-023095-4dannjjm	6544	4	while	while	IN
cord-023095-4dannjjm	6544	5	subcutaneous	subcutaneous	JJ
cord-023095-4dannjjm	6544	6	therapy	therapy	NN
cord-023095-4dannjjm	6544	7	with	with	IN
cord-023095-4dannjjm	6544	8	HPBCD	HPBCD	NNP
cord-023095-4dannjjm	6544	9	at	at	IN
cord-023095-4dannjjm	6544	10	all	all	DT
cord-023095-4dannjjm	6544	11	doses	dose	NNS
cord-023095-4dannjjm	6544	12	ameliorated	ameliorate	VBD
cord-023095-4dannjjm	6544	13	liver	liver	NN
cord-023095-4dannjjm	6544	14	disease	disease	NN
cord-023095-4dannjjm	6544	15	,	,	,
cord-023095-4dannjjm	6544	16	only	only	RB
cord-023095-4dannjjm	6544	17	8000	8000	CD
cord-023095-4dannjjm	6544	18	mg	mg	NNP
cord-023095-4dannjjm	6544	19	/	/	SYM
cord-023095-4dannjjm	6544	20	kg	kg	NNP
cord-023095-4dannjjm	6544	21	substantially	substantially	RB
cord-023095-4dannjjm	6544	22	affected	affect	VBD
cord-023095-4dannjjm	6544	23	neurological	neurological	JJ
cord-023095-4dannjjm	6544	24	disease	disease	NN
cord-023095-4dannjjm	6544	25	but	but	CC
cord-023095-4dannjjm	6544	26	also	also	RB
cord-023095-4dannjjm	6544	27	resulted	result	VBD
cord-023095-4dannjjm	6544	28	in	in	IN
cord-023095-4dannjjm	6544	29	early	early	JJ
cord-023095-4dannjjm	6544	30	death	death	NN
cord-023095-4dannjjm	6544	31	due	due	IN
cord-023095-4dannjjm	6544	32	to	to	IN
cord-023095-4dannjjm	6544	33	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6544	34	toxicity	toxicity	NN
cord-023095-4dannjjm	6544	35	.	.	.
cord-023095-4dannjjm	6545	1	Finally	finally	RB
cord-023095-4dannjjm	6545	2	,	,	,
cord-023095-4dannjjm	6545	3	we	-PRON-	PRP
cord-023095-4dannjjm	6545	4	identified	identify	VBD
cord-023095-4dannjjm	6545	5	a	a	DT
cord-023095-4dannjjm	6545	6	dose	dose	NN
cord-023095-4dannjjm	6545	7	-	-	HYPH
cord-023095-4dannjjm	6545	8	related	relate	VBN
cord-023095-4dannjjm	6545	9	toxic	toxic	JJ
cord-023095-4dannjjm	6545	10	effect	effect	NN
cord-023095-4dannjjm	6545	11	of	of	IN
cord-023095-4dannjjm	6545	12	HPBCD	HPBCD	NNP
cord-023095-4dannjjm	6545	13	on	on	IN
cord-023095-4dannjjm	6545	14	hearing	hearing	NN
cord-023095-4dannjjm	6545	15	function	function	NN
cord-023095-4dannjjm	6545	16	that	that	WDT
cord-023095-4dannjjm	6545	17	had	have	VBD
cord-023095-4dannjjm	6545	18	not	not	RB
cord-023095-4dannjjm	6545	19	been	be	VBN
cord-023095-4dannjjm	6545	20	described	describe	VBN
cord-023095-4dannjjm	6545	21	in	in	IN
cord-023095-4dannjjm	6545	22	any	any	DT
cord-023095-4dannjjm	6545	23	other	other	JJ
cord-023095-4dannjjm	6545	24	species	specie	NNS
cord-023095-4dannjjm	6545	25	.	.	.
cord-023095-4dannjjm	6546	1	Leukodystrophies	Leukodystrophies	NNP
cord-023095-4dannjjm	6546	2	are	be	VBP
cord-023095-4dannjjm	6546	3	disorders	disorder	NNS
cord-023095-4dannjjm	6546	4	of	of	IN
cord-023095-4dannjjm	6546	5	myelin	myelin	NN
cord-023095-4dannjjm	6546	6	synthesis	synthesis	NN
cord-023095-4dannjjm	6546	7	and	and	CC
cord-023095-4dannjjm	6546	8	maintenance	maintenance	NN
cord-023095-4dannjjm	6546	9	that	that	WDT
cord-023095-4dannjjm	6546	10	affect	affect	VBP
cord-023095-4dannjjm	6546	11	CNS	CNS	NNP
cord-023095-4dannjjm	6546	12	myelin	myelin	NN
cord-023095-4dannjjm	6546	13	.	.	.
cord-023095-4dannjjm	6547	1	They	-PRON-	PRP
cord-023095-4dannjjm	6547	2	are	be	VBP
cord-023095-4dannjjm	6547	3	subdivided	subdivide	VBN
cord-023095-4dannjjm	6547	4	as	as	IN
cord-023095-4dannjjm	6547	5	leukodystrophies	leukodystrophies	NNP
cord-023095-4dannjjm	6547	6	,	,	,
cord-023095-4dannjjm	6547	7	hypomyelinating	hypomyelinate	VBG
cord-023095-4dannjjm	6547	8	disorders	disorder	NNS
cord-023095-4dannjjm	6547	9	and	and	CC
cord-023095-4dannjjm	6547	10	spongy	spongy	JJ
cord-023095-4dannjjm	6547	11	degenerations	degeneration	NNS
cord-023095-4dannjjm	6547	12	.	.	.
cord-023095-4dannjjm	6548	1	Although	although	IN
cord-023095-4dannjjm	6548	2	infrequently	infrequently	RB
cord-023095-4dannjjm	6548	3	seen	see	VBN
cord-023095-4dannjjm	6548	4	,	,	,
cord-023095-4dannjjm	6548	5	several	several	JJ
cord-023095-4dannjjm	6548	6	forms	form	NNS
cord-023095-4dannjjm	6548	7	have	have	VBP
cord-023095-4dannjjm	6548	8	been	be	VBN
cord-023095-4dannjjm	6548	9	described	describe	VBN
cord-023095-4dannjjm	6548	10	in	in	IN
cord-023095-4dannjjm	6548	11	various	various	JJ
cord-023095-4dannjjm	6548	12	dog	dog	NN
cord-023095-4dannjjm	6548	13	breeds	breed	NNS
cord-023095-4dannjjm	6548	14	.	.	.
cord-023095-4dannjjm	6549	1	We	-PRON-	PRP
cord-023095-4dannjjm	6549	2	present	present	VBP
cord-023095-4dannjjm	6549	3	a	a	DT
cord-023095-4dannjjm	6549	4	novel	novel	JJ
cord-023095-4dannjjm	6549	5	form	form	NN
cord-023095-4dannjjm	6549	6	of	of	IN
cord-023095-4dannjjm	6549	7	complex	complex	JJ
cord-023095-4dannjjm	6549	8	leukodystrophy	leukodystrophy	NN
cord-023095-4dannjjm	6549	9	consisting	consist	VBG
cord-023095-4dannjjm	6549	10	of	of	IN
cord-023095-4dannjjm	6549	11	hypomyelination	hypomyelination	NN
cord-023095-4dannjjm	6549	12	and	and	CC
cord-023095-4dannjjm	6549	13	spongy	spongy	JJ
cord-023095-4dannjjm	6549	14	degeneration	degeneration	NN
cord-023095-4dannjjm	6549	15	that	that	WDT
cord-023095-4dannjjm	6549	16	presents	present	VBZ
cord-023095-4dannjjm	6549	17	primarily	primarily	RB
cord-023095-4dannjjm	6549	18	with	with	IN
cord-023095-4dannjjm	6549	19	hind	hind	JJ
cord-023095-4dannjjm	6549	20	end	end	NN
cord-023095-4dannjjm	6549	21	tremors	tremor	NNS
cord-023095-4dannjjm	6549	22	in	in	IN
cord-023095-4dannjjm	6549	23	Border	Border	NNP
cord-023095-4dannjjm	6549	24	terrier	terrier	NN
cord-023095-4dannjjm	6549	25	puppies	puppy	NNS
cord-023095-4dannjjm	6549	26	.	.	.
cord-023095-4dannjjm	6550	1	Three	three	CD
cord-023095-4dannjjm	6550	2	Border	Border	NNP
cord-023095-4dannjjm	6550	3	terriers	terrier	NNS
cord-023095-4dannjjm	6550	4	from	from	IN
cord-023095-4dannjjm	6550	5	two	two	CD
cord-023095-4dannjjm	6550	6	different	different	JJ
cord-023095-4dannjjm	6550	7	litters	litter	NNS
cord-023095-4dannjjm	6550	8	(	(	-LRB-
cord-023095-4dannjjm	6550	9	and	and	CC
cord-023095-4dannjjm	6550	10	lineages	lineage	NNS
cord-023095-4dannjjm	6550	11	)	)	-RRB-
cord-023095-4dannjjm	6550	12	are	be	VBP
cord-023095-4dannjjm	6550	13	described	describe	VBN
cord-023095-4dannjjm	6550	14	here	here	RB
cord-023095-4dannjjm	6550	15	that	that	WDT
cord-023095-4dannjjm	6550	16	presented	present	VBD
cord-023095-4dannjjm	6550	17	with	with	IN
cord-023095-4dannjjm	6550	18	a	a	DT
cord-023095-4dannjjm	6550	19	history	history	NN
cord-023095-4dannjjm	6550	20	of	of	IN
cord-023095-4dannjjm	6550	21	shaking	shake	VBG
cord-023095-4dannjjm	6550	22	movements	movement	NNS
cord-023095-4dannjjm	6550	23	.	.	.
cord-023095-4dannjjm	6551	1	The	the	DT
cord-023095-4dannjjm	6551	2	youngest	young	JJS
cord-023095-4dannjjm	6551	3	dog	dog	NN
cord-023095-4dannjjm	6551	4	was	be	VBD
cord-023095-4dannjjm	6551	5	a	a	DT
cord-023095-4dannjjm	6551	6	3-week	3-week	JJ
cord-023095-4dannjjm	6551	7	old	old	JJ
cord-023095-4dannjjm	6551	8	male	male	NN
cord-023095-4dannjjm	6551	9	.	.	.
cord-023095-4dannjjm	6552	1	It	-PRON-	PRP
cord-023095-4dannjjm	6552	2	was	be	VBD
cord-023095-4dannjjm	6552	3	the	the	DT
cord-023095-4dannjjm	6552	4	only	only	JJ
cord-023095-4dannjjm	6552	5	dog	dog	NN
cord-023095-4dannjjm	6552	6	affected	affect	VBN
cord-023095-4dannjjm	6552	7	in	in	IN
cord-023095-4dannjjm	6552	8	the	the	DT
cord-023095-4dannjjm	6552	9	litter	litter	NN
cord-023095-4dannjjm	6552	10	.	.	.
cord-023095-4dannjjm	6553	1	The	the	DT
cord-023095-4dannjjm	6553	2	other	other	JJ
cord-023095-4dannjjm	6553	3	two	two	CD
cord-023095-4dannjjm	6553	4	dogs	dog	NNS
cord-023095-4dannjjm	6553	5	were	be	VBD
cord-023095-4dannjjm	6553	6	6-week	6-week	JJ
cord-023095-4dannjjm	6553	7	old	old	JJ
cord-023095-4dannjjm	6553	8	female	female	JJ
cord-023095-4dannjjm	6553	9	littermates	littermate	NNS
cord-023095-4dannjjm	6553	10	.	.	.
cord-023095-4dannjjm	6554	1	There	there	EX
cord-023095-4dannjjm	6554	2	were	be	VBD
cord-023095-4dannjjm	6554	3	two	two	CD
cord-023095-4dannjjm	6554	4	unaffected	unaffected	JJ
cord-023095-4dannjjm	6554	5	males	male	NNS
cord-023095-4dannjjm	6554	6	in	in	IN
cord-023095-4dannjjm	6554	7	the	the	DT
cord-023095-4dannjjm	6554	8	same	same	JJ
cord-023095-4dannjjm	6554	9	litter	litter	NN
cord-023095-4dannjjm	6554	10	.	.	.
cord-023095-4dannjjm	6555	1	Physical	physical	JJ
cord-023095-4dannjjm	6555	2	examination	examination	NN
cord-023095-4dannjjm	6555	3	revealed	reveal	VBD
cord-023095-4dannjjm	6555	4	no	no	DT
cord-023095-4dannjjm	6555	5	abnormalities	abnormality	NNS
cord-023095-4dannjjm	6555	6	.	.	.
cord-023095-4dannjjm	6556	1	On	on	IN
cord-023095-4dannjjm	6556	2	neurological	neurological	JJ
cord-023095-4dannjjm	6556	3	examination	examination	NN
cord-023095-4dannjjm	6556	4	,	,	,
cord-023095-4dannjjm	6556	5	the	the	DT
cord-023095-4dannjjm	6556	6	affected	affect	VBN
cord-023095-4dannjjm	6556	7	dogs	dog	NNS
cord-023095-4dannjjm	6556	8	displayed	display	VBD
cord-023095-4dannjjm	6556	9	severe	severe	JJ
cord-023095-4dannjjm	6556	10	hind	hind	NN
cord-023095-4dannjjm	6556	11	end	end	NN
cord-023095-4dannjjm	6556	12	tremors	tremor	NNS
cord-023095-4dannjjm	6556	13	,	,	,
cord-023095-4dannjjm	6556	14	with	with	IN
cord-023095-4dannjjm	6556	15	a	a	DT
cord-023095-4dannjjm	6556	16	characteristic	characteristic	JJ
cord-023095-4dannjjm	6556	17	swinging	swinge	VBG
cord-023095-4dannjjm	6556	18	side	side	NN
cord-023095-4dannjjm	6556	19	-	-	HYPH
cord-023095-4dannjjm	6556	20	to	to	IN
cord-023095-4dannjjm	6556	21	-	-	HYPH
cord-023095-4dannjjm	6556	22	side	side	NN
cord-023095-4dannjjm	6556	23	movement	movement	NN
cord-023095-4dannjjm	6556	24	(	(	-LRB-
cord-023095-4dannjjm	6556	25	best	best	RB
cord-023095-4dannjjm	6556	26	described	describe	VBN
cord-023095-4dannjjm	6556	27	as	as	IN
cord-023095-4dannjjm	6556	28	'	'	``
cord-023095-4dannjjm	6556	29	'	'	``
cord-023095-4dannjjm	6556	30	rumpshaker	rumpshaker	NNP
cord-023095-4dannjjm	6556	31	'	'	''
cord-023095-4dannjjm	6556	32	'	'	''
cord-023095-4dannjjm	6556	33	)	)	-RRB-
cord-023095-4dannjjm	6556	34	.	.	.
cord-023095-4dannjjm	6557	1	The	the	DT
cord-023095-4dannjjm	6557	2	tremors	tremor	NNS
cord-023095-4dannjjm	6557	3	also	also	RB
cord-023095-4dannjjm	6557	4	involved	involve	VBD
cord-023095-4dannjjm	6557	5	the	the	DT
cord-023095-4dannjjm	6557	6	head	head	NN
cord-023095-4dannjjm	6557	7	and	and	CC
cord-023095-4dannjjm	6557	8	thoracic	thoracic	JJ
cord-023095-4dannjjm	6557	9	limbs	limb	NNS
cord-023095-4dannjjm	6557	10	but	but	CC
cord-023095-4dannjjm	6557	11	to	to	IN
cord-023095-4dannjjm	6557	12	a	a	DT
cord-023095-4dannjjm	6557	13	lesser	less	JJR
cord-023095-4dannjjm	6557	14	degree	degree	NN
cord-023095-4dannjjm	6557	15	,	,	,
cord-023095-4dannjjm	6557	16	and	and	CC
cord-023095-4dannjjm	6557	17	disappeared	disappear	VBD
cord-023095-4dannjjm	6557	18	when	when	WRB
cord-023095-4dannjjm	6557	19	the	the	DT
cord-023095-4dannjjm	6557	20	dogs	dog	NNS
cord-023095-4dannjjm	6557	21	were	be	VBD
cord-023095-4dannjjm	6557	22	asleep	asleep	JJ
cord-023095-4dannjjm	6557	23	or	or	CC
cord-023095-4dannjjm	6557	24	at	at	IN
cord-023095-4dannjjm	6557	25	rest	rest	NN
cord-023095-4dannjjm	6557	26	.	.	.
cord-023095-4dannjjm	6558	1	Severe	severe	JJ
cord-023095-4dannjjm	6558	2	cerebellar	cerebellar	JJ
cord-023095-4dannjjm	6558	3	ataxia	ataxia	NN
cord-023095-4dannjjm	6558	4	was	be	VBD
cord-023095-4dannjjm	6558	5	observed	observe	VBN
cord-023095-4dannjjm	6558	6	when	when	WRB
cord-023095-4dannjjm	6558	7	the	the	DT
cord-023095-4dannjjm	6558	8	dogs	dog	NNS
cord-023095-4dannjjm	6558	9	ambulated	ambulate	VBD
cord-023095-4dannjjm	6558	10	.	.	.
cord-023095-4dannjjm	6559	1	Proprioceptive	proprioceptive	JJ
cord-023095-4dannjjm	6559	2	positioning	positioning	NN
cord-023095-4dannjjm	6559	3	was	be	VBD
cord-023095-4dannjjm	6559	4	delayed	delay	VBN
cord-023095-4dannjjm	6559	5	in	in	IN
cord-023095-4dannjjm	6559	6	the	the	DT
cord-023095-4dannjjm	6559	7	pelvic	pelvic	JJ
cord-023095-4dannjjm	6559	8	limbs	limb	NNS
cord-023095-4dannjjm	6559	9	of	of	IN
cord-023095-4dannjjm	6559	10	all	all	DT
cord-023095-4dannjjm	6559	11	3	3	CD
cord-023095-4dannjjm	6559	12	dogs	dog	NNS
cord-023095-4dannjjm	6559	13	.	.	.
cord-023095-4dannjjm	6560	1	Spinal	spinal	JJ
cord-023095-4dannjjm	6560	2	reflexes	reflex	NNS
cord-023095-4dannjjm	6560	3	and	and	CC
cord-023095-4dannjjm	6560	4	nociception	nociception	NN
cord-023095-4dannjjm	6560	5	appeared	appear	VBD
cord-023095-4dannjjm	6560	6	normal	normal	JJ
cord-023095-4dannjjm	6560	7	.	.	.
cord-023095-4dannjjm	6561	1	Necropsy	Necropsy	NNP
cord-023095-4dannjjm	6561	2	was	be	VBD
cord-023095-4dannjjm	6561	3	performed	perform	VBN
cord-023095-4dannjjm	6561	4	in	in	IN
cord-023095-4dannjjm	6561	5	all	all	DT
cord-023095-4dannjjm	6561	6	3	3	CD
cord-023095-4dannjjm	6561	7	puppies	puppy	NNS
cord-023095-4dannjjm	6561	8	.	.	.
cord-023095-4dannjjm	6562	1	No	no	DT
cord-023095-4dannjjm	6562	2	macroscopic	macroscopic	JJ
cord-023095-4dannjjm	6562	3	changes	change	NNS
cord-023095-4dannjjm	6562	4	were	be	VBD
cord-023095-4dannjjm	6562	5	observed	observe	VBN
cord-023095-4dannjjm	6562	6	.	.	.
cord-023095-4dannjjm	6563	1	Histologic	Histologic	NNP
cord-023095-4dannjjm	6563	2	evaluation	evaluation	NN
cord-023095-4dannjjm	6563	3	of	of	IN
cord-023095-4dannjjm	6563	4	the	the	DT
cord-023095-4dannjjm	6563	5	CNS	CNS	NNP
cord-023095-4dannjjm	6563	6	revealed	reveal	VBD
cord-023095-4dannjjm	6563	7	spongy	spongy	JJ
cord-023095-4dannjjm	6563	8	degeneration	degeneration	NN
cord-023095-4dannjjm	6563	9	and	and	CC
cord-023095-4dannjjm	6563	10	hypomyelination	hypomyelination	NN
cord-023095-4dannjjm	6563	11	in	in	IN
cord-023095-4dannjjm	6563	12	all	all	DT
cord-023095-4dannjjm	6563	13	funiculi	funiculus	NNS
cord-023095-4dannjjm	6563	14	of	of	IN
cord-023095-4dannjjm	6563	15	the	the	DT
cord-023095-4dannjjm	6563	16	cervical	cervical	JJ
cord-023095-4dannjjm	6563	17	and	and	CC
cord-023095-4dannjjm	6563	18	thoracic	thoracic	JJ
cord-023095-4dannjjm	6563	19	spinal	spinal	JJ
cord-023095-4dannjjm	6563	20	cord	cord	NN
cord-023095-4dannjjm	6563	21	.	.	.
cord-023095-4dannjjm	6564	1	White	white	JJ
cord-023095-4dannjjm	6564	2	matter	matter	NN
cord-023095-4dannjjm	6564	3	of	of	IN
cord-023095-4dannjjm	6564	4	the	the	DT
cord-023095-4dannjjm	6564	5	frontal	frontal	JJ
cord-023095-4dannjjm	6564	6	,	,	,
cord-023095-4dannjjm	6564	7	temporal	temporal	JJ
cord-023095-4dannjjm	6564	8	and	and	CC
cord-023095-4dannjjm	6564	9	parietal	parietal	JJ
cord-023095-4dannjjm	6564	10	cortices	cortex	NNS
cord-023095-4dannjjm	6564	11	had	have	VBD
cord-023095-4dannjjm	6564	12	mild	mild	JJ
cord-023095-4dannjjm	6564	13	multifocal	multifocal	JJ
cord-023095-4dannjjm	6564	14	spongy	spongy	JJ
cord-023095-4dannjjm	6564	15	degeneration	degeneration	NN
cord-023095-4dannjjm	6564	16	and	and	CC
cord-023095-4dannjjm	6564	17	hypomyelination	hypomyelination	NN
cord-023095-4dannjjm	6564	18	,	,	,
cord-023095-4dannjjm	6564	19	whereas	whereas	IN
cord-023095-4dannjjm	6564	20	white	white	JJ
cord-023095-4dannjjm	6564	21	matter	matter	NN
cord-023095-4dannjjm	6564	22	of	of	IN
cord-023095-4dannjjm	6564	23	the	the	DT
cord-023095-4dannjjm	6564	24	cerebellum	cerebellum	NN
cord-023095-4dannjjm	6564	25	,	,	,
cord-023095-4dannjjm	6564	26	medulla	medulla	NN
cord-023095-4dannjjm	6564	27	and	and	CC
cord-023095-4dannjjm	6564	28	pons	pons	NNP
cord-023095-4dannjjm	6564	29	showed	show	VBD
cord-023095-4dannjjm	6564	30	severe	severe	JJ
cord-023095-4dannjjm	6564	31	diffuse	diffuse	JJ
cord-023095-4dannjjm	6564	32	spongy	spongy	JJ
cord-023095-4dannjjm	6564	33	degeneration	degeneration	NN
cord-023095-4dannjjm	6564	34	and	and	CC
cord-023095-4dannjjm	6564	35	hypomyelination	hypomyelination	NN
cord-023095-4dannjjm	6564	36	with	with	IN
cord-023095-4dannjjm	6564	37	gliosis	gliosis	NNP
cord-023095-4dannjjm	6564	38	.	.	.
cord-023095-4dannjjm	6565	1	The	the	DT
cord-023095-4dannjjm	6565	2	combination	combination	NN
cord-023095-4dannjjm	6565	3	of	of	IN
cord-023095-4dannjjm	6565	4	reduced	reduce	VBN
cord-023095-4dannjjm	6565	5	myelin	myelin	NN
cord-023095-4dannjjm	6565	6	formation	formation	NN
cord-023095-4dannjjm	6565	7	combined	combine	VBN
cord-023095-4dannjjm	6565	8	with	with	IN
cord-023095-4dannjjm	6565	9	spongiform	spongiform	JJ
cord-023095-4dannjjm	6565	10	white	white	JJ
cord-023095-4dannjjm	6565	11	matter	matter	NN
cord-023095-4dannjjm	6565	12	changes	change	NNS
cord-023095-4dannjjm	6565	13	in	in	IN
cord-023095-4dannjjm	6565	14	the	the	DT
cord-023095-4dannjjm	6565	15	absence	absence	NN
cord-023095-4dannjjm	6565	16	of	of	IN
cord-023095-4dannjjm	6565	17	microglial	microglial	JJ
cord-023095-4dannjjm	6565	18	responses	response	NNS
cord-023095-4dannjjm	6565	19	suggest	suggest	VBP
cord-023095-4dannjjm	6565	20	a	a	DT
cord-023095-4dannjjm	6565	21	complex	complex	JJ
cord-023095-4dannjjm	6565	22	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	6565	23	affecting	affect	VBG
cord-023095-4dannjjm	6565	24	both	both	CC
cord-023095-4dannjjm	6565	25	oligodendrocytes	oligodendrocyte	NNS
cord-023095-4dannjjm	6565	26	'	'	POS
cord-023095-4dannjjm	6565	27	capacity	capacity	NN
cord-023095-4dannjjm	6565	28	to	to	TO
cord-023095-4dannjjm	6565	29	synthesize	synthesize	VB
cord-023095-4dannjjm	6565	30	myelin	myelin	NN
cord-023095-4dannjjm	6565	31	and	and	CC
cord-023095-4dannjjm	6565	32	the	the	DT
cord-023095-4dannjjm	6565	33	stability	stability	NN
cord-023095-4dannjjm	6565	34	of	of	IN
cord-023095-4dannjjm	6565	35	the	the	DT
cord-023095-4dannjjm	6565	36	myelin	myelin	NN
cord-023095-4dannjjm	6565	37	that	that	WDT
cord-023095-4dannjjm	6565	38	was	be	VBD
cord-023095-4dannjjm	6565	39	formed	form	VBN
cord-023095-4dannjjm	6565	40	.	.	.
cord-023095-4dannjjm	6566	1	The	the	DT
cord-023095-4dannjjm	6566	2	number	number	NN
cord-023095-4dannjjm	6566	3	of	of	IN
cord-023095-4dannjjm	6566	4	oligodendrocytes	oligodendrocyte	NNS
cord-023095-4dannjjm	6566	5	and	and	CC
cord-023095-4dannjjm	6566	6	axons	axon	NNS
cord-023095-4dannjjm	6566	7	appeared	appear	VBD
cord-023095-4dannjjm	6566	8	subjectively	subjectively	RB
cord-023095-4dannjjm	6566	9	normal	normal	JJ
cord-023095-4dannjjm	6566	10	indicating	indicate	VBG
cord-023095-4dannjjm	6566	11	a	a	DT
cord-023095-4dannjjm	6566	12	primarily	primarily	RB
cord-023095-4dannjjm	6566	13	hypomyelinating	hypomyelinating	JJ
cord-023095-4dannjjm	6566	14	process	process	NN
cord-023095-4dannjjm	6566	15	.	.	.
cord-023095-4dannjjm	6567	1	The	the	DT
cord-023095-4dannjjm	6567	2	clinical	clinical	JJ
cord-023095-4dannjjm	6567	3	and	and	CC
cord-023095-4dannjjm	6567	4	pathological	pathological	JJ
cord-023095-4dannjjm	6567	5	features	feature	NNS
cord-023095-4dannjjm	6567	6	of	of	IN
cord-023095-4dannjjm	6567	7	this	this	DT
cord-023095-4dannjjm	6567	8	disease	disease	NN
cord-023095-4dannjjm	6567	9	have	have	VBP
cord-023095-4dannjjm	6567	10	not	not	RB
cord-023095-4dannjjm	6567	11	been	be	VBN
cord-023095-4dannjjm	6567	12	described	describe	VBN
cord-023095-4dannjjm	6567	13	in	in	IN
cord-023095-4dannjjm	6567	14	any	any	DT
cord-023095-4dannjjm	6567	15	other	other	JJ
cord-023095-4dannjjm	6567	16	canine	canine	JJ
cord-023095-4dannjjm	6567	17	leukodystrophy	leukodystrophy	NN
cord-023095-4dannjjm	6567	18	.	.	.
cord-023095-4dannjjm	6568	1	The	the	DT
cord-023095-4dannjjm	6568	2	primary	primary	JJ
cord-023095-4dannjjm	6568	3	and	and	CC
cord-023095-4dannjjm	6568	4	most	most	RBS
cord-023095-4dannjjm	6568	5	striking	striking	JJ
cord-023095-4dannjjm	6568	6	clinical	clinical	JJ
cord-023095-4dannjjm	6568	7	feature	feature	NN
cord-023095-4dannjjm	6568	8	is	be	VBZ
cord-023095-4dannjjm	6568	9	the	the	DT
cord-023095-4dannjjm	6568	10	presence	presence	NN
cord-023095-4dannjjm	6568	11	of	of	IN
cord-023095-4dannjjm	6568	12	severe	severe	JJ
cord-023095-4dannjjm	6568	13	tremors	tremor	NNS
cord-023095-4dannjjm	6568	14	in	in	IN
cord-023095-4dannjjm	6568	15	the	the	DT
cord-023095-4dannjjm	6568	16	hind	hind	NN
cord-023095-4dannjjm	6568	17	end	end	NN
cord-023095-4dannjjm	6568	18	,	,	,
cord-023095-4dannjjm	6568	19	causing	cause	VBG
cord-023095-4dannjjm	6568	20	the	the	DT
cord-023095-4dannjjm	6568	21	'	'	``
cord-023095-4dannjjm	6568	22	'	'	``
cord-023095-4dannjjm	6568	23	rumpshaker	rumpshaker	NN
cord-023095-4dannjjm	6568	24	'	'	''
cord-023095-4dannjjm	6568	25	'	'	''
cord-023095-4dannjjm	6568	26	pheynotype	pheynotype	NN
cord-023095-4dannjjm	6568	27	.	.	.
cord-023095-4dannjjm	6569	1	Genetic	genetic	JJ
cord-023095-4dannjjm	6569	2	studies	study	NNS
cord-023095-4dannjjm	6569	3	are	be	VBP
cord-023095-4dannjjm	6569	4	underway	underway	JJ
cord-023095-4dannjjm	6569	5	to	to	TO
cord-023095-4dannjjm	6569	6	determine	determine	VB
cord-023095-4dannjjm	6569	7	if	if	IN
cord-023095-4dannjjm	6569	8	the	the	DT
cord-023095-4dannjjm	6569	9	disease	disease	NN
cord-023095-4dannjjm	6569	10	is	be	VBZ
cord-023095-4dannjjm	6569	11	inherited	inherit	VBN
cord-023095-4dannjjm	6569	12	and	and	CC
cord-023095-4dannjjm	6569	13	the	the	DT
cord-023095-4dannjjm	6569	14	inheritance	inheritance	NN
cord-023095-4dannjjm	6569	15	mode	mode	NN
cord-023095-4dannjjm	6569	16	.	.	.
cord-023095-4dannjjm	6570	1	A	a	DT
cord-023095-4dannjjm	6570	2	syndrome	syndrome	NN
cord-023095-4dannjjm	6570	3	of	of	IN
cord-023095-4dannjjm	6570	4	Border	border	NN
cord-023095-4dannjjm	6570	5	collie	collie	NN
cord-023095-4dannjjm	6570	6	collapse	collapse	NN
cord-023095-4dannjjm	6570	7	(	(	-LRB-
cord-023095-4dannjjm	6570	8	BCC	BCC	NNP
cord-023095-4dannjjm	6570	9	)	)	-RRB-
cord-023095-4dannjjm	6570	10	appears	appear	VBZ
cord-023095-4dannjjm	6570	11	to	to	TO
cord-023095-4dannjjm	6570	12	be	be	VB
cord-023095-4dannjjm	6570	13	common	common	JJ
cord-023095-4dannjjm	6570	14	in	in	IN
cord-023095-4dannjjm	6570	15	dogs	dog	NNS
cord-023095-4dannjjm	6570	16	used	use	VBN
cord-023095-4dannjjm	6570	17	for	for	IN
cord-023095-4dannjjm	6570	18	working	work	VBG
cord-023095-4dannjjm	6570	19	stock	stock	NN
cord-023095-4dannjjm	6570	20	.	.	.
cord-023095-4dannjjm	6571	1	This	this	DT
cord-023095-4dannjjm	6571	2	syndrome	syndrome	NN
cord-023095-4dannjjm	6571	3	has	have	VBZ
cord-023095-4dannjjm	6571	4	also	also	RB
cord-023095-4dannjjm	6571	5	been	be	VBN
cord-023095-4dannjjm	6571	6	called	call	VBN
cord-023095-4dannjjm	6571	7	malignant	malignant	JJ
cord-023095-4dannjjm	6571	8	hyperthermia	hyperthermia	NN
cord-023095-4dannjjm	6571	9	,	,	,
cord-023095-4dannjjm	6571	10	heat	heat	NN
cord-023095-4dannjjm	6571	11	intolerance	intolerance	NN
cord-023095-4dannjjm	6571	12	,	,	,
cord-023095-4dannjjm	6571	13	exerciseinduced	exerciseinduced	JJ
cord-023095-4dannjjm	6571	14	collapse	collapse	NN
cord-023095-4dannjjm	6571	15	and	and	CC
cord-023095-4dannjjm	6571	16	'	'	''
cord-023095-4dannjjm	6571	17	'	'	``
cord-023095-4dannjjm	6571	18	wobbles	wobble	NNS
cord-023095-4dannjjm	6571	19	'	'	''
cord-023095-4dannjjm	6571	20	'	'	''
cord-023095-4dannjjm	6571	21	.	.	.
cord-023095-4dannjjm	6572	1	A	a	DT
cord-023095-4dannjjm	6572	2	presumptive	presumptive	JJ
cord-023095-4dannjjm	6572	3	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6572	4	of	of	IN
cord-023095-4dannjjm	6572	5	BCC	BCC	NNP
cord-023095-4dannjjm	6572	6	can	can	MD
cord-023095-4dannjjm	6572	7	only	only	RB
cord-023095-4dannjjm	6572	8	be	be	VB
cord-023095-4dannjjm	6572	9	made	make	VBN
cord-023095-4dannjjm	6572	10	by	by	IN
cord-023095-4dannjjm	6572	11	eliminating	eliminate	VBG
cord-023095-4dannjjm	6572	12	other	other	JJ
cord-023095-4dannjjm	6572	13	causes	cause	NNS
cord-023095-4dannjjm	6572	14	of	of	IN
cord-023095-4dannjjm	6572	15	exercise	exercise	NN
cord-023095-4dannjjm	6572	16	intolerance	intolerance	NN
cord-023095-4dannjjm	6572	17	and	and	CC
cord-023095-4dannjjm	6572	18	weakness	weakness	NN
cord-023095-4dannjjm	6572	19	.	.	.
cord-023095-4dannjjm	6573	1	The	the	DT
cord-023095-4dannjjm	6573	2	purpose	purpose	NN
cord-023095-4dannjjm	6573	3	of	of	IN
cord-023095-4dannjjm	6573	4	this	this	DT
cord-023095-4dannjjm	6573	5	study	study	NN
cord-023095-4dannjjm	6573	6	was	be	VBD
cord-023095-4dannjjm	6573	7	to	to	TO
cord-023095-4dannjjm	6573	8	describe	describe	VB
cord-023095-4dannjjm	6573	9	the	the	DT
cord-023095-4dannjjm	6573	10	clinical	clinical	JJ
cord-023095-4dannjjm	6573	11	features	feature	NNS
cord-023095-4dannjjm	6573	12	of	of	IN
cord-023095-4dannjjm	6573	13	collapse	collapse	NN
cord-023095-4dannjjm	6573	14	in	in	IN
cord-023095-4dannjjm	6573	15	affected	affected	JJ
cord-023095-4dannjjm	6573	16	dogs	dog	NNS
cord-023095-4dannjjm	6573	17	and	and	CC
cord-023095-4dannjjm	6573	18	determine	determine	VBP
cord-023095-4dannjjm	6573	19	if	if	IN
cord-023095-4dannjjm	6573	20	there	there	EX
cord-023095-4dannjjm	6573	21	were	be	VBD
cord-023095-4dannjjm	6573	22	characteristic	characteristic	JJ
cord-023095-4dannjjm	6573	23	clinical	clinical	JJ
cord-023095-4dannjjm	6573	24	or	or	CC
cord-023095-4dannjjm	6573	25	laboratory	laboratory	NN
cord-023095-4dannjjm	6573	26	features	feature	NNS
cord-023095-4dannjjm	6573	27	at	at	IN
cord-023095-4dannjjm	6573	28	rest	rest	NN
cord-023095-4dannjjm	6573	29	or	or	CC
cord-023095-4dannjjm	6573	30	after	after	IN
cord-023095-4dannjjm	6573	31	exercise	exercise	NN
cord-023095-4dannjjm	6573	32	that	that	WDT
cord-023095-4dannjjm	6573	33	could	could	MD
cord-023095-4dannjjm	6573	34	aid	aid	VB
cord-023095-4dannjjm	6573	35	in	in	IN
cord-023095-4dannjjm	6573	36	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6573	37	.	.	.
cord-023095-4dannjjm	6574	1	Seven	seven	CD
cord-023095-4dannjjm	6574	2	adult	adult	NN
cord-023095-4dannjjm	6574	3	Border	Border	NNP
cord-023095-4dannjjm	6574	4	collies	collie	NNS
cord-023095-4dannjjm	6574	5	with	with	IN
cord-023095-4dannjjm	6574	6	a	a	DT
cord-023095-4dannjjm	6574	7	history	history	NN
cord-023095-4dannjjm	6574	8	of	of	IN
cord-023095-4dannjjm	6574	9	collapse	collapse	NN
cord-023095-4dannjjm	6574	10	during	during	IN
cord-023095-4dannjjm	6574	11	sheep	sheep	NN
cord-023095-4dannjjm	6574	12	herding	herding	NN
cord-023095-4dannjjm	6574	13	(	(	-LRB-
cord-023095-4dannjjm	6574	14	affected	affect	VBN
cord-023095-4dannjjm	6574	15	)	)	-RRB-
cord-023095-4dannjjm	6574	16	and	and	CC
cord-023095-4dannjjm	6574	17	5	5	CD
cord-023095-4dannjjm	6574	18	adult	adult	NN
cord-023095-4dannjjm	6574	19	Border	Border	NNP
cord-023095-4dannjjm	6574	20	collies	collie	NNS
cord-023095-4dannjjm	6574	21	regularly	regularly	RB
cord-023095-4dannjjm	6574	22	used	use	VBD
cord-023095-4dannjjm	6574	23	for	for	IN
cord-023095-4dannjjm	6574	24	sheep	sheep	NN
cord-023095-4dannjjm	6574	25	herding	herding	NN
cord-023095-4dannjjm	6574	26	but	but	CC
cord-023095-4dannjjm	6574	27	showing	show	VBG
cord-023095-4dannjjm	6574	28	no	no	DT
cord-023095-4dannjjm	6574	29	signs	sign	NNS
cord-023095-4dannjjm	6574	30	of	of	IN
cord-023095-4dannjjm	6574	31	exercise	exercise	NN
cord-023095-4dannjjm	6574	32	intolerance	intolerance	NN
cord-023095-4dannjjm	6574	33	(	(	-LRB-
cord-023095-4dannjjm	6574	34	normal	normal	JJ
cord-023095-4dannjjm	6574	35	)	)	-RRB-
cord-023095-4dannjjm	6574	36	were	be	VBD
cord-023095-4dannjjm	6574	37	evaluated	evaluate	VBN
cord-023095-4dannjjm	6574	38	before	before	IN
cord-023095-4dannjjm	6574	39	and	and	CC
cord-023095-4dannjjm	6574	40	after	after	IN
cord-023095-4dannjjm	6574	41	participating	participate	VBG
cord-023095-4dannjjm	6574	42	in	in	IN
cord-023095-4dannjjm	6574	43	a	a	DT
cord-023095-4dannjjm	6574	44	videotaped	videotape	VBN
cord-023095-4dannjjm	6574	45	10	10	CD
cord-023095-4dannjjm	6574	46	minute	minute	NN
cord-023095-4dannjjm	6574	47	exercise	exercise	NN
cord-023095-4dannjjm	6574	48	protocol	protocol	NN
cord-023095-4dannjjm	6574	49	consisting	consist	VBG
cord-023095-4dannjjm	6574	50	ofa	ofa	NNP
cord-023095-4dannjjm	6574	51	series	series	NN
cord-023095-4dannjjm	6574	52	of	of	IN
cord-023095-4dannjjm	6574	53	continuous	continuous	JJ
cord-023095-4dannjjm	6574	54	short	short	JJ
cord-023095-4dannjjm	6574	55	outruns	outrun	NNS
cord-023095-4dannjjm	6574	56	and	and	CC
cord-023095-4dannjjm	6574	57	fetches	fetch	VBZ
cord-023095-4dannjjm	6574	58	of	of	IN
cord-023095-4dannjjm	6574	59	three	three	CD
cord-023095-4dannjjm	6574	60	sheep	sheep	NNS
cord-023095-4dannjjm	6574	61	in	in	IN
cord-023095-4dannjjm	6574	62	an	an	DT
cord-023095-4dannjjm	6574	63	outdoor	outdoor	JJ
cord-023095-4dannjjm	6574	64	pen	pen	NN
cord-023095-4dannjjm	6574	65	.	.	.
cord-023095-4dannjjm	6575	1	Exercise	exercise	NN
cord-023095-4dannjjm	6575	2	was	be	VBD
cord-023095-4dannjjm	6575	3	halted	halt	VBN
cord-023095-4dannjjm	6575	4	at	at	IN
cord-023095-4dannjjm	6575	5	10	10	CD
cord-023095-4dannjjm	6575	6	minutes	minute	NNS
cord-023095-4dannjjm	6575	7	or	or	CC
cord-023095-4dannjjm	6575	8	earlier	early	RBR
cord-023095-4dannjjm	6575	9	if	if	IN
cord-023095-4dannjjm	6575	10	there	there	EX
cord-023095-4dannjjm	6575	11	were	be	VBD
cord-023095-4dannjjm	6575	12	signs	sign	NNS
cord-023095-4dannjjm	6575	13	of	of	IN
cord-023095-4dannjjm	6575	14	gait	gait	NN
cord-023095-4dannjjm	6575	15	or	or	CC
cord-023095-4dannjjm	6575	16	mentation	mentation	NN
cord-023095-4dannjjm	6575	17	abnormalities	abnormality	NNS
cord-023095-4dannjjm	6575	18	.	.	.
cord-023095-4dannjjm	6576	1	Pre	pre	JJ
cord-023095-4dannjjm	6576	2	-	-	JJ
cord-023095-4dannjjm	6576	3	exercise	exercise	JJ
cord-023095-4dannjjm	6576	4	evaluation	evaluation	NN
cord-023095-4dannjjm	6576	5	included	include	VBD
cord-023095-4dannjjm	6576	6	physical	physical	JJ
cord-023095-4dannjjm	6576	7	examination	examination	NN
cord-023095-4dannjjm	6576	8	,	,	,
cord-023095-4dannjjm	6576	9	orthopedic	orthopedic	NN
cord-023095-4dannjjm	6576	10	and	and	CC
cord-023095-4dannjjm	6576	11	neurological	neurological	JJ
cord-023095-4dannjjm	6576	12	exam	exam	NN
cord-023095-4dannjjm	6576	13	.	.	.
cord-023095-4dannjjm	6577	1	Pre	pre	JJ
cord-023095-4dannjjm	6577	2	and	and	CC
cord-023095-4dannjjm	6577	3	immediate	immediate	JJ
cord-023095-4dannjjm	6577	4	post	post	JJ
cord-023095-4dannjjm	6577	5	exercise	exercise	NN
cord-023095-4dannjjm	6577	6	rectal	rectal	JJ
cord-023095-4dannjjm	6577	7	temperature	temperature	NN
cord-023095-4dannjjm	6577	8	,	,	,
cord-023095-4dannjjm	6577	9	pulse	pulse	NN
cord-023095-4dannjjm	6577	10	and	and	CC
cord-023095-4dannjjm	6577	11	respiration	respiration	NN
cord-023095-4dannjjm	6577	12	,	,	,
cord-023095-4dannjjm	6577	13	patellar	patellar	JJ
cord-023095-4dannjjm	6577	14	reflexes	reflex	NNS
cord-023095-4dannjjm	6577	15	,	,	,
cord-023095-4dannjjm	6577	16	ECG	ECG	NNP
cord-023095-4dannjjm	6577	17	,	,	,
cord-023095-4dannjjm	6577	18	CBC	CBC	NNP
cord-023095-4dannjjm	6577	19	,	,	,
cord-023095-4dannjjm	6577	20	serum	serum	NN
cord-023095-4dannjjm	6577	21	biochemistry	biochemistry	NN
cord-023095-4dannjjm	6577	22	profile	profile	NN
cord-023095-4dannjjm	6577	23	,	,	,
cord-023095-4dannjjm	6577	24	cortisol	cortisol	NN
cord-023095-4dannjjm	6577	25	,	,	,
cord-023095-4dannjjm	6577	26	arterial	arterial	JJ
cord-023095-4dannjjm	6577	27	blood	blood	NN
cord-023095-4dannjjm	6577	28	gas	gas	NN
cord-023095-4dannjjm	6577	29	and	and	CC
cord-023095-4dannjjm	6577	30	plasma	plasma	NN
cord-023095-4dannjjm	6577	31	lactate	lactate	NN
cord-023095-4dannjjm	6577	32	and	and	CC
cord-023095-4dannjjm	6577	33	pyruvate	pyruvate	NN
cord-023095-4dannjjm	6577	34	concentrations	concentration	NNS
cord-023095-4dannjjm	6577	35	were	be	VBD
cord-023095-4dannjjm	6577	36	measured	measure	VBN
cord-023095-4dannjjm	6577	37	.	.	.
cord-023095-4dannjjm	6578	1	Clinical	clinical	JJ
cord-023095-4dannjjm	6578	2	parameters	parameter	NNS
cord-023095-4dannjjm	6578	3	(	(	-LRB-
cord-023095-4dannjjm	6578	4	gait	gait	NN
cord-023095-4dannjjm	6578	5	,	,	,
cord-023095-4dannjjm	6578	6	temperature	temperature	NN
cord-023095-4dannjjm	6578	7	,	,	,
cord-023095-4dannjjm	6578	8	reflexes	reflex	NNS
cord-023095-4dannjjm	6578	9	)	)	-RRB-
cord-023095-4dannjjm	6578	10	and	and	CC
cord-023095-4dannjjm	6578	11	lactate	lactate	NN
cord-023095-4dannjjm	6578	12	and	and	CC
cord-023095-4dannjjm	6578	13	pyruvate	pyruvate	NN
cord-023095-4dannjjm	6578	14	concentrations	concentration	NNS
cord-023095-4dannjjm	6578	15	were	be	VBD
cord-023095-4dannjjm	6578	16	evaluated	evaluate	VBN
cord-023095-4dannjjm	6578	17	at	at	IN
cord-023095-4dannjjm	6578	18	intervals	interval	NNS
cord-023095-4dannjjm	6578	19	up	up	IN
cord-023095-4dannjjm	6578	20	to	to	TO
cord-023095-4dannjjm	6578	21	120	120	CD
cord-023095-4dannjjm	6578	22	minutes	minute	NNS
cord-023095-4dannjjm	6578	23	after	after	IN
cord-023095-4dannjjm	6578	24	exercise	exercise	NN
cord-023095-4dannjjm	6578	25	.	.	.
cord-023095-4dannjjm	6579	1	Additional	additional	JJ
cord-023095-4dannjjm	6579	2	testing	testing	NN
cord-023095-4dannjjm	6579	3	in	in	IN
cord-023095-4dannjjm	6579	4	affected	affect	VBN
cord-023095-4dannjjm	6579	5	dogs	dog	NNS
cord-023095-4dannjjm	6579	6	included	include	VBD
cord-023095-4dannjjm	6579	7	measurement	measurement	NN
cord-023095-4dannjjm	6579	8	of	of	IN
cord-023095-4dannjjm	6579	9	acetylcholine	acetylcholine	NN
cord-023095-4dannjjm	6579	10	receptor	receptor	NN
cord-023095-4dannjjm	6579	11	antibodies	antibody	NNS
cord-023095-4dannjjm	6579	12	(	(	-LRB-
cord-023095-4dannjjm	6579	13	AChRab	achrab	JJ
cord-023095-4dannjjm	6579	14	)	)	-RRB-
cord-023095-4dannjjm	6579	15	and	and	CC
cord-023095-4dannjjm	6579	16	DNA	dna	NN
cord-023095-4dannjjm	6579	17	testing	testing	NN
cord-023095-4dannjjm	6579	18	for	for	IN
cord-023095-4dannjjm	6579	19	dynamin	dynamin	NN
cord-023095-4dannjjm	6579	20	-	-	HYPH
cord-023095-4dannjjm	6579	21	associated	associate	VBN
cord-023095-4dannjjm	6579	22	exercise	exercise	NN
cord-023095-4dannjjm	6580	1	induced	induce	VBN
cord-023095-4dannjjm	6580	2	collapse	collapse	NN
cord-023095-4dannjjm	6580	3	(	(	-LRB-
cord-023095-4dannjjm	6580	4	dEIC	deic	NN
cord-023095-4dannjjm	6580	5	)	)	-RRB-
cord-023095-4dannjjm	6580	6	and	and	CC
cord-023095-4dannjjm	6580	7	the	the	DT
cord-023095-4dannjjm	6580	8	ryanodine	ryanodine	JJ
cord-023095-4dannjjm	6580	9	receptor	receptor	NN
cord-023095-4dannjjm	6580	10	mutation	mutation	NN
cord-023095-4dannjjm	6580	11	associated	associate	VBN
cord-023095-4dannjjm	6580	12	with	with	IN
cord-023095-4dannjjm	6580	13	canine	canine	JJ
cord-023095-4dannjjm	6580	14	malignant	malignant	JJ
cord-023095-4dannjjm	6580	15	hyperthermia(MH	hyperthermia(MH	NNS
cord-023095-4dannjjm	6580	16	)	)	-RRB-
cord-023095-4dannjjm	6580	17	.	.	.
cord-023095-4dannjjm	6581	1	One	one	CD
cord-023095-4dannjjm	6581	2	week	week	NN
cord-023095-4dannjjm	6581	3	after	after	IN
cord-023095-4dannjjm	6581	4	exercise	exercise	NN
cord-023095-4dannjjm	6581	5	affected	affect	VBN
cord-023095-4dannjjm	6581	6	dogs	dog	NNS
cord-023095-4dannjjm	6581	7	had	have	VBD
cord-023095-4dannjjm	6581	8	thoracic	thoracic	JJ
cord-023095-4dannjjm	6581	9	radiographs	radiograph	NNS
cord-023095-4dannjjm	6581	10	and	and	CC
cord-023095-4dannjjm	6581	11	echocardiography	echocardiography	NN
cord-023095-4dannjjm	6581	12	performed	perform	VBN
cord-023095-4dannjjm	6581	13	and	and	CC
cord-023095-4dannjjm	6581	14	were	be	VBD
cord-023095-4dannjjm	6581	15	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	6581	16	for	for	IN
cord-023095-4dannjjm	6581	17	EMG	EMG	NNP
cord-023095-4dannjjm	6581	18	and	and	CC
cord-023095-4dannjjm	6581	19	muscle	muscle	NN
cord-023095-4dannjjm	6581	20	biopsies	biopsy	NNS
cord-023095-4dannjjm	6581	21	.	.	.
cord-023095-4dannjjm	6582	1	There	there	EX
cord-023095-4dannjjm	6582	2	were	be	VBD
cord-023095-4dannjjm	6582	3	no	no	DT
cord-023095-4dannjjm	6582	4	significant	significant	JJ
cord-023095-4dannjjm	6582	5	differences	difference	NNS
cord-023095-4dannjjm	6582	6	in	in	IN
cord-023095-4dannjjm	6582	7	temperature	temperature	NN
cord-023095-4dannjjm	6582	8	,	,	,
cord-023095-4dannjjm	6582	9	pulse	pulse	NN
cord-023095-4dannjjm	6582	10	,	,	,
cord-023095-4dannjjm	6582	11	respiration	respiration	NN
cord-023095-4dannjjm	6582	12	,	,	,
cord-023095-4dannjjm	6582	13	or	or	CC
cord-023095-4dannjjm	6582	14	any	any	DT
cord-023095-4dannjjm	6582	15	laboratory	laboratory	NN
cord-023095-4dannjjm	6582	16	parameter	parameter	NN
cord-023095-4dannjjm	6582	17	at	at	IN
cord-023095-4dannjjm	6582	18	any	any	DT
cord-023095-4dannjjm	6582	19	time	time	NN
cord-023095-4dannjjm	6582	20	point	point	NN
cord-023095-4dannjjm	6582	21	between	between	IN
cord-023095-4dannjjm	6582	22	normal	normal	JJ
cord-023095-4dannjjm	6582	23	and	and	CC
cord-023095-4dannjjm	6582	24	affected	affected	JJ
cord-023095-4dannjjm	6582	25	dogs	dog	NNS
cord-023095-4dannjjm	6582	26	.	.	.
cord-023095-4dannjjm	6583	1	No	no	DT
cord-023095-4dannjjm	6583	2	arrhythmias	arrhythmia	NNS
cord-023095-4dannjjm	6583	3	were	be	VBD
cord-023095-4dannjjm	6583	4	detected	detect	VBN
cord-023095-4dannjjm	6583	5	.	.	.
cord-023095-4dannjjm	6584	1	Affected	affected	JJ
cord-023095-4dannjjm	6584	2	dogs	dog	NNS
cord-023095-4dannjjm	6584	3	were	be	VBD
cord-023095-4dannjjm	6584	4	negative	negative	JJ
cord-023095-4dannjjm	6584	5	for	for	IN
cord-023095-4dannjjm	6584	6	the	the	DT
cord-023095-4dannjjm	6584	7	DNA	dna	NN
cord-023095-4dannjjm	6584	8	mutations	mutation	NNS
cord-023095-4dannjjm	6584	9	tested	test	VBN
cord-023095-4dannjjm	6584	10	and	and	CC
cord-023095-4dannjjm	6584	11	for	for	IN
cord-023095-4dannjjm	6584	12	AChR	AChR	NNP
cord-023095-4dannjjm	6584	13	ab	ab	NNP
cord-023095-4dannjjm	6584	14	.	.	.
cord-023095-4dannjjm	6585	1	Thoracic	thoracic	JJ
cord-023095-4dannjjm	6585	2	radiographs	radiograph	NNS
cord-023095-4dannjjm	6585	3	,	,	,
cord-023095-4dannjjm	6585	4	echocardiograms	echocardiogram	NNS
cord-023095-4dannjjm	6585	5	,	,	,
cord-023095-4dannjjm	6585	6	EMGs	EMGs	NNP
cord-023095-4dannjjm	6585	7	and	and	CC
cord-023095-4dannjjm	6585	8	muscle	muscle	NN
cord-023095-4dannjjm	6585	9	biopsies	biopsy	NNS
cord-023095-4dannjjm	6585	10	were	be	VBD
cord-023095-4dannjjm	6585	11	normal	normal	JJ
cord-023095-4dannjjm	6585	12	.	.	.
cord-023095-4dannjjm	6586	1	The	the	DT
cord-023095-4dannjjm	6586	2	5	5	CD
cord-023095-4dannjjm	6586	3	normal	normal	JJ
cord-023095-4dannjjm	6586	4	dogs	dog	NNS
cord-023095-4dannjjm	6586	5	had	have	VBD
cord-023095-4dannjjm	6586	6	no	no	DT
cord-023095-4dannjjm	6586	7	alterations	alteration	NNS
cord-023095-4dannjjm	6586	8	in	in	IN
cord-023095-4dannjjm	6586	9	mentation	mentation	NN
cord-023095-4dannjjm	6586	10	or	or	CC
cord-023095-4dannjjm	6586	11	gait	gait	NN
cord-023095-4dannjjm	6586	12	during	during	IN
cord-023095-4dannjjm	6586	13	or	or	CC
cord-023095-4dannjjm	6586	14	after	after	IN
cord-023095-4dannjjm	6586	15	exercise	exercise	NN
cord-023095-4dannjjm	6586	16	.	.	.
cord-023095-4dannjjm	6587	1	Three	three	CD
cord-023095-4dannjjm	6587	2	of	of	IN
cord-023095-4dannjjm	6587	3	the	the	DT
cord-023095-4dannjjm	6587	4	affected	affect	VBN
cord-023095-4dannjjm	6587	5	dogs	dog	NNS
cord-023095-4dannjjm	6587	6	had	have	VBD
cord-023095-4dannjjm	6587	7	exercise	exercise	NN
cord-023095-4dannjjm	6587	8	halted	halt	VBN
cord-023095-4dannjjm	6587	9	early	early	RB
cord-023095-4dannjjm	6587	10	(	(	-LRB-
cord-023095-4dannjjm	6587	11	6	6	CD
cord-023095-4dannjjm	6587	12	min-9	min-9	NN
cord-023095-4dannjjm	6587	13	min	min	NN
cord-023095-4dannjjm	6587	14	)	)	-RRB-
cord-023095-4dannjjm	6587	15	because	because	IN
cord-023095-4dannjjm	6587	16	of	of	IN
cord-023095-4dannjjm	6587	17	altered	alter	VBN
cord-023095-4dannjjm	6587	18	gait	gait	NN
cord-023095-4dannjjm	6587	19	or	or	CC
cord-023095-4dannjjm	6587	20	mentation	mentation	NN
cord-023095-4dannjjm	6587	21	.	.	.
cord-023095-4dannjjm	6588	1	All	all	DT
cord-023095-4dannjjm	6588	2	7	7	CD
cord-023095-4dannjjm	6588	3	of	of	IN
cord-023095-4dannjjm	6588	4	the	the	DT
cord-023095-4dannjjm	6588	5	affected	affect	VBN
cord-023095-4dannjjm	6588	6	dogs	dog	NNS
cord-023095-4dannjjm	6588	7	were	be	VBD
cord-023095-4dannjjm	6588	8	abnormal	abnormal	JJ
cord-023095-4dannjjm	6588	9	in	in	IN
cord-023095-4dannjjm	6588	10	the	the	DT
cord-023095-4dannjjm	6588	11	15	15	CD
cord-023095-4dannjjm	6588	12	minutes	minute	NNS
cord-023095-4dannjjm	6588	13	following	follow	VBG
cord-023095-4dannjjm	6588	14	exercise	exercise	NN
cord-023095-4dannjjm	6588	15	.	.	.
cord-023095-4dannjjm	6589	1	Abnormalities	abnormality	NNS
cord-023095-4dannjjm	6589	2	seen	see	VBN
cord-023095-4dannjjm	6589	3	in	in	IN
cord-023095-4dannjjm	6589	4	all	all	DT
cord-023095-4dannjjm	6589	5	dogs	dog	NNS
cord-023095-4dannjjm	6589	6	included	include	VBD
cord-023095-4dannjjm	6589	7	disorientation	disorientation	NN
cord-023095-4dannjjm	6589	8	,	,	,
cord-023095-4dannjjm	6589	9	dull	dull	JJ
cord-023095-4dannjjm	6589	10	mentation	mentation	NN
cord-023095-4dannjjm	6589	11	,	,	,
cord-023095-4dannjjm	6589	12	swaying	sway	VBG
cord-023095-4dannjjm	6589	13	,	,	,
cord-023095-4dannjjm	6589	14	falling	fall	VBG
cord-023095-4dannjjm	6589	15	to	to	IN
cord-023095-4dannjjm	6589	16	the	the	DT
cord-023095-4dannjjm	6589	17	side	side	NN
cord-023095-4dannjjm	6589	18	,	,	,
cord-023095-4dannjjm	6589	19	exaggerated	exaggerated	JJ
cord-023095-4dannjjm	6589	20	lifting	lifting	NN
cord-023095-4dannjjm	6589	21	of	of	IN
cord-023095-4dannjjm	6589	22	limbs	limb	NNS
cord-023095-4dannjjm	6589	23	each	each	DT
cord-023095-4dannjjm	6589	24	step	step	NN
cord-023095-4dannjjm	6589	25	,	,	,
cord-023095-4dannjjm	6589	26	choppy	choppy	JJ
cord-023095-4dannjjm	6589	27	gait	gait	NN
cord-023095-4dannjjm	6589	28	,	,	,
cord-023095-4dannjjm	6589	29	delayed	delay	VBN
cord-023095-4dannjjm	6589	30	limb	limb	NN
cord-023095-4dannjjm	6589	31	protraction	protraction	NN
cord-023095-4dannjjm	6589	32	,	,	,
cord-023095-4dannjjm	6589	33	scuffing	scuffing	NN
cord-023095-4dannjjm	6589	34	of	of	IN
cord-023095-4dannjjm	6589	35	rear	rear	NN
cord-023095-4dannjjm	6589	36	and/or	and/or	CC
cord-023095-4dannjjm	6589	37	forelegs	foreleg	NNS
cord-023095-4dannjjm	6589	38	,	,	,
cord-023095-4dannjjm	6589	39	and	and	CC
cord-023095-4dannjjm	6589	40	crossing	crossing	NN
cord-023095-4dannjjm	6589	41	legs	leg	NNS
cord-023095-4dannjjm	6589	42	when	when	WRB
cord-023095-4dannjjm	6589	43	turning	turn	VBG
cord-023095-4dannjjm	6589	44	.	.	.
cord-023095-4dannjjm	6590	1	All	all	DT
cord-023095-4dannjjm	6590	2	dogs	dog	NNS
cord-023095-4dannjjm	6590	3	returned	return	VBD
cord-023095-4dannjjm	6590	4	to	to	IN
cord-023095-4dannjjm	6590	5	normal	normal	JJ
cord-023095-4dannjjm	6590	6	by	by	IN
cord-023095-4dannjjm	6590	7	30	30	CD
cord-023095-4dannjjm	6590	8	minutes	minute	NNS
cord-023095-4dannjjm	6590	9	.	.	.
cord-023095-4dannjjm	6591	1	BCC	BCC	NNP
cord-023095-4dannjjm	6591	2	appears	appear	VBZ
cord-023095-4dannjjm	6591	3	to	to	TO
cord-023095-4dannjjm	6591	4	be	be	VB
cord-023095-4dannjjm	6591	5	an	an	DT
cord-023095-4dannjjm	6591	6	episodic	episodic	JJ
cord-023095-4dannjjm	6591	7	nervous	nervous	JJ
cord-023095-4dannjjm	6591	8	system	system	NN
cord-023095-4dannjjm	6591	9	disorder	disorder	NN
cord-023095-4dannjjm	6591	10	that	that	WDT
cord-023095-4dannjjm	6591	11	can	can	MD
cord-023095-4dannjjm	6591	12	be	be	VB
cord-023095-4dannjjm	6591	13	triggered	trigger	VBN
cord-023095-4dannjjm	6591	14	by	by	IN
cord-023095-4dannjjm	6591	15	exercise	exercise	NN
cord-023095-4dannjjm	6591	16	.	.	.
cord-023095-4dannjjm	6592	1	Genetic	genetic	JJ
cord-023095-4dannjjm	6592	2	testing	testing	NN
cord-023095-4dannjjm	6592	3	excluded	exclude	VBD
cord-023095-4dannjjm	6592	4	dEIC	deic	NN
cord-023095-4dannjjm	6592	5	and	and	CC
cord-023095-4dannjjm	6592	6	the	the	DT
cord-023095-4dannjjm	6592	7	described	describe	VBN
cord-023095-4dannjjm	6592	8	canine	canine	NN
cord-023095-4dannjjm	6592	9	MH	MH	NNP
cord-023095-4dannjjm	6592	10	mutation	mutation	NN
cord-023095-4dannjjm	6592	11	.	.	.
cord-023095-4dannjjm	6593	1	Common	common	JJ
cord-023095-4dannjjm	6593	2	causes	cause	NNS
cord-023095-4dannjjm	6593	3	of	of	IN
cord-023095-4dannjjm	6593	4	exercise	exercise	NN
cord-023095-4dannjjm	6593	5	intolerance	intolerance	NN
cord-023095-4dannjjm	6593	6	were	be	VBD
cord-023095-4dannjjm	6593	7	eliminated	eliminate	VBN
cord-023095-4dannjjm	6593	8	,	,	,
cord-023095-4dannjjm	6593	9	but	but	CC
cord-023095-4dannjjm	6593	10	the	the	DT
cord-023095-4dannjjm	6593	11	cause	cause	NN
cord-023095-4dannjjm	6593	12	of	of	IN
cord-023095-4dannjjm	6593	13	collapse	collapse	NN
cord-023095-4dannjjm	6593	14	in	in	IN
cord-023095-4dannjjm	6593	15	BCC	BCC	NNP
cord-023095-4dannjjm	6593	16	was	be	VBD
cord-023095-4dannjjm	6593	17	not	not	RB
cord-023095-4dannjjm	6593	18	determined	determine	VBN
cord-023095-4dannjjm	6593	19	and	and	CC
cord-023095-4dannjjm	6593	20	no	no	DT
cord-023095-4dannjjm	6593	21	clinical	clinical	JJ
cord-023095-4dannjjm	6593	22	or	or	CC
cord-023095-4dannjjm	6593	23	biochemical	biochemical	JJ
cord-023095-4dannjjm	6593	24	marker	marker	NN
cord-023095-4dannjjm	6593	25	to	to	TO
cord-023095-4dannjjm	6593	26	aid	aid	VB
cord-023095-4dannjjm	6593	27	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6593	28	was	be	VBD
cord-023095-4dannjjm	6593	29	established	establish	VBN
cord-023095-4dannjjm	6593	30	.	.	.
cord-023095-4dannjjm	6594	1	Equine	Equine	NNP
cord-023095-4dannjjm	6594	2	Cushing	Cushing	NNP
cord-023095-4dannjjm	6594	3	's	's	POS
cord-023095-4dannjjm	6594	4	disease	disease	NN
cord-023095-4dannjjm	6594	5	(	(	-LRB-
cord-023095-4dannjjm	6594	6	ECD	ECD	NNP
cord-023095-4dannjjm	6594	7	)	)	-RRB-
cord-023095-4dannjjm	6594	8	is	be	VBZ
cord-023095-4dannjjm	6594	9	common	common	JJ
cord-023095-4dannjjm	6594	10	in	in	IN
cord-023095-4dannjjm	6594	11	older	old	JJR
cord-023095-4dannjjm	6594	12	horses	horse	NNS
cord-023095-4dannjjm	6594	13	.	.	.
cord-023095-4dannjjm	6595	1	The	the	DT
cord-023095-4dannjjm	6595	2	purpose	purpose	NN
cord-023095-4dannjjm	6595	3	of	of	IN
cord-023095-4dannjjm	6595	4	this	this	DT
cord-023095-4dannjjm	6595	5	study	study	NN
cord-023095-4dannjjm	6595	6	was	be	VBD
cord-023095-4dannjjm	6595	7	to	to	TO
cord-023095-4dannjjm	6595	8	determine	determine	VB
cord-023095-4dannjjm	6595	9	the	the	DT
cord-023095-4dannjjm	6595	10	frequency	frequency	NN
cord-023095-4dannjjm	6595	11	of	of	IN
cord-023095-4dannjjm	6595	12	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6595	13	,	,	,
cord-023095-4dannjjm	6595	14	identify	identify	VB
cord-023095-4dannjjm	6595	15	prognostic	prognostic	JJ
cord-023095-4dannjjm	6595	16	factors	factor	NNS
cord-023095-4dannjjm	6595	17	and	and	CC
cord-023095-4dannjjm	6595	18	assess	assess	VB
cord-023095-4dannjjm	6595	19	owner	owner	NN
cord-023095-4dannjjm	6595	20	satisfaction	satisfaction	NN
cord-023095-4dannjjm	6595	21	with	with	IN
cord-023095-4dannjjm	6595	22	treatment	treatment	NN
cord-023095-4dannjjm	6595	23	.	.	.
cord-023095-4dannjjm	6596	1	The	the	DT
cord-023095-4dannjjm	6596	2	study	study	NN
cord-023095-4dannjjm	6596	3	was	be	VBD
cord-023095-4dannjjm	6596	4	a	a	DT
cord-023095-4dannjjm	6596	5	retrospective	retrospective	JJ
cord-023095-4dannjjm	6596	6	cohort	cohort	NN
cord-023095-4dannjjm	6596	7	design	design	NN
cord-023095-4dannjjm	6596	8	evaluating	evaluate	VBG
cord-023095-4dannjjm	6596	9	equine	equine	JJ
cord-023095-4dannjjm	6596	10	accessions	accession	NNS
cord-023095-4dannjjm	6596	11	reported	report	VBN
cord-023095-4dannjjm	6596	12	to	to	IN
cord-023095-4dannjjm	6596	13	the	the	DT
cord-023095-4dannjjm	6596	14	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	6596	15	Medical	Medical	NNP
cord-023095-4dannjjm	6596	16	Data	Data	NNP
cord-023095-4dannjjm	6596	17	Base	Base	NNP
cord-023095-4dannjjm	6596	18	(	(	-LRB-
cord-023095-4dannjjm	6596	19	VMDB	VMDB	NNP
cord-023095-4dannjjm	6596	20	)	)	-RRB-
cord-023095-4dannjjm	6596	21	and	and	CC
cord-023095-4dannjjm	6596	22	the	the	DT
cord-023095-4dannjjm	6596	23	Ohio	Ohio	NNP
cord-023095-4dannjjm	6596	24	State	State	NNP
cord-023095-4dannjjm	6596	25	University	University	NNP
cord-023095-4dannjjm	6596	26	from	from	IN
cord-023095-4dannjjm	6596	27	1993	1993	CD
cord-023095-4dannjjm	6596	28	-	-	SYM
cord-023095-4dannjjm	6596	29	2004	2004	CD
cord-023095-4dannjjm	6596	30	.	.	.
cord-023095-4dannjjm	6597	1	Proportional	proportional	JJ
cord-023095-4dannjjm	6597	2	accessions	accession	NNS
cord-023095-4dannjjm	6597	3	,	,	,
cord-023095-4dannjjm	6597	4	annual	annual	JJ
cord-023095-4dannjjm	6597	5	incidence	incidence	NN
cord-023095-4dannjjm	6597	6	and	and	CC
cord-023095-4dannjjm	6597	7	demographic	demographic	JJ
cord-023095-4dannjjm	6597	8	characteristics	characteristic	NNS
cord-023095-4dannjjm	6597	9	of	of	IN
cord-023095-4dannjjm	6597	10	horses	horse	NNS
cord-023095-4dannjjm	6597	11	with	with	IN
cord-023095-4dannjjm	6597	12	ECD	ECD	NNP
cord-023095-4dannjjm	6597	13	were	be	VBD
cord-023095-4dannjjm	6597	14	compared	compare	VBN
cord-023095-4dannjjm	6597	15	with	with	IN
cord-023095-4dannjjm	6597	16	all	all	DT
cord-023095-4dannjjm	6597	17	accessions	accession	NNS
cord-023095-4dannjjm	6597	18	in	in	IN
cord-023095-4dannjjm	6597	19	the	the	DT
cord-023095-4dannjjm	6597	20	VMDB	VMDB	NNP
cord-023095-4dannjjm	6597	21	.	.	.
cord-023095-4dannjjm	6598	1	Medical	medical	JJ
cord-023095-4dannjjm	6598	2	records	record	NNS
cord-023095-4dannjjm	6598	3	for	for	IN
cord-023095-4dannjjm	6598	4	a	a	DT
cord-023095-4dannjjm	6598	5	subset	subset	NN
cord-023095-4dannjjm	6598	6	of	of	IN
cord-023095-4dannjjm	6598	7	horses	horse	NNS
cord-023095-4dannjjm	6598	8	were	be	VBD
cord-023095-4dannjjm	6598	9	extracted	extract	VBN
cord-023095-4dannjjm	6598	10	and	and	CC
cord-023095-4dannjjm	6598	11	owners	owner	NNS
cord-023095-4dannjjm	6598	12	contacted	contact	VBD
cord-023095-4dannjjm	6598	13	to	to	TO
cord-023095-4dannjjm	6598	14	obtain	obtain	VB
cord-023095-4dannjjm	6598	15	long	long	JJ
cord-023095-4dannjjm	6598	16	-	-	HYPH
cord-023095-4dannjjm	6598	17	term	term	NN
cord-023095-4dannjjm	6598	18	follow	follow	VB
cord-023095-4dannjjm	6598	19	up	up	RP
cord-023095-4dannjjm	6598	20	information	information	NN
cord-023095-4dannjjm	6598	21	.	.	.
cord-023095-4dannjjm	6599	1	Two	two	CD
cord-023095-4dannjjm	6599	2	hundred	hundred	CD
cord-023095-4dannjjm	6599	3	seventeen	seventeen	CD
cord-023095-4dannjjm	6599	4	new	new	JJ
cord-023095-4dannjjm	6599	5	cases	case	NNS
cord-023095-4dannjjm	6599	6	of	of	IN
cord-023095-4dannjjm	6599	7	ECD	ECD	NNP
cord-023095-4dannjjm	6599	8	were	be	VBD
cord-023095-4dannjjm	6599	9	reported	report	VBN
cord-023095-4dannjjm	6599	10	to	to	IN
cord-023095-4dannjjm	6599	11	the	the	DT
cord-023095-4dannjjm	6599	12	VMDB	VMDB	NNP
cord-023095-4dannjjm	6599	13	.	.	.
cord-023095-4dannjjm	6600	1	Incidence	incidence	NN
cord-023095-4dannjjm	6600	2	increased	increase	VBD
cord-023095-4dannjjm	6600	3	from	from	IN
cord-023095-4dannjjm	6600	4	0.25/1,000	0.25/1,000	CD
cord-023095-4dannjjm	6600	5	in	in	IN
cord-023095-4dannjjm	6600	6	1993	1993	CD
cord-023095-4dannjjm	6600	7	to	to	IN
cord-023095-4dannjjm	6600	8	3.72/1,000	3.72/1,000	CD
cord-023095-4dannjjm	6600	9	in	in	IN
cord-023095-4dannjjm	6600	10	2002	2002	CD
cord-023095-4dannjjm	6600	11	.	.	.
cord-023095-4dannjjm	6601	1	Eighty	eighty	CD
cord-023095-4dannjjm	6601	2	-	-	HYPH
cord-023095-4dannjjm	6601	3	one	one	CD
cord-023095-4dannjjm	6601	4	percent	percent	NN
cord-023095-4dannjjm	6601	5	of	of	IN
cord-023095-4dannjjm	6601	6	horses	horse	NNS
cord-023095-4dannjjm	6601	7	were	be	VBD
cord-023095-4dannjjm	6601	8	!	!	.
cord-023095-4dannjjm	6602	1	15	15	CD
cord-023095-4dannjjm	6602	2	years	year	NNS
cord-023095-4dannjjm	6602	3	of	of	IN
cord-023095-4dannjjm	6602	4	age	age	NN
cord-023095-4dannjjm	6602	5	.	.	.
cord-023095-4dannjjm	6603	1	Average	average	JJ
cord-023095-4dannjjm	6603	2	delay	delay	NN
cord-023095-4dannjjm	6603	3	from	from	IN
cord-023095-4dannjjm	6603	4	onset	onset	NN
cord-023095-4dannjjm	6603	5	of	of	IN
cord-023095-4dannjjm	6603	6	signs	sign	NNS
cord-023095-4dannjjm	6603	7	to	to	IN
cord-023095-4dannjjm	6603	8	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6603	9	was	be	VBD
cord-023095-4dannjjm	6603	10	180	180	CD
cord-023095-4dannjjm	6603	11	days	day	NNS
cord-023095-4dannjjm	6603	12	(	(	-LRB-
cord-023095-4dannjjm	6603	13	range	range	VB
cord-023095-4dannjjm	6603	14	1	1	CD
cord-023095-4dannjjm	6603	15	to	to	IN
cord-023095-4dannjjm	6603	16	1,824	1,824	CD
cord-023095-4dannjjm	6603	17	days	day	NNS
cord-023095-4dannjjm	6603	18	)	)	-RRB-
cord-023095-4dannjjm	6603	19	.	.	.
cord-023095-4dannjjm	6604	1	Hirsutism	hirsutism	NN
cord-023095-4dannjjm	6604	2	(	(	-LRB-
cord-023095-4dannjjm	6604	3	84	84	CD
cord-023095-4dannjjm	6604	4	%	%	NN
cord-023095-4dannjjm	6604	5	)	)	-RRB-
cord-023095-4dannjjm	6604	6	and	and	CC
cord-023095-4dannjjm	6604	7	laminitis	laminitis	NN
cord-023095-4dannjjm	6604	8	(	(	-LRB-
cord-023095-4dannjjm	6604	9	50	50	CD
cord-023095-4dannjjm	6604	10	%	%	NN
cord-023095-4dannjjm	6604	11	)	)	-RRB-
cord-023095-4dannjjm	6604	12	were	be	VBD
cord-023095-4dannjjm	6604	13	the	the	DT
cord-023095-4dannjjm	6604	14	most	most	RBS
cord-023095-4dannjjm	6604	15	common	common	JJ
cord-023095-4dannjjm	6604	16	clinical	clinical	JJ
cord-023095-4dannjjm	6604	17	signs	sign	NNS
cord-023095-4dannjjm	6604	18	.	.	.
cord-023095-4dannjjm	6605	1	Improvement	improvement	NN
cord-023095-4dannjjm	6605	2	in	in	IN
cord-023095-4dannjjm	6605	3	one	one	CD
cord-023095-4dannjjm	6605	4	or	or	CC
cord-023095-4dannjjm	6605	5	more	more	JJR
cord-023095-4dannjjm	6605	6	signs	sign	NNS
cord-023095-4dannjjm	6605	7	2	2	CD
cord-023095-4dannjjm	6605	8	months	month	NNS
cord-023095-4dannjjm	6605	9	after	after	IN
cord-023095-4dannjjm	6605	10	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6605	11	was	be	VBD
cord-023095-4dannjjm	6605	12	reported	report	VBN
cord-023095-4dannjjm	6605	13	by	by	IN
cord-023095-4dannjjm	6605	14	9/22	9/22	CD
cord-023095-4dannjjm	6605	15	(	(	-LRB-
cord-023095-4dannjjm	6605	16	41	41	CD
cord-023095-4dannjjm	6605	17	%	%	NN
cord-023095-4dannjjm	6605	18	)	)	-RRB-
cord-023095-4dannjjm	6605	19	of	of	IN
cord-023095-4dannjjm	6605	20	horse	horse	NN
cord-023095-4dannjjm	6605	21	owners	owner	NNS
cord-023095-4dannjjm	6605	22	.	.	.
cord-023095-4dannjjm	6606	1	None	none	NN
cord-023095-4dannjjm	6606	2	of	of	IN
cord-023095-4dannjjm	6606	3	the	the	DT
cord-023095-4dannjjm	6606	4	clinical	clinical	JJ
cord-023095-4dannjjm	6606	5	or	or	CC
cord-023095-4dannjjm	6606	6	laboratory	laboratory	NN
cord-023095-4dannjjm	6606	7	data	datum	NNS
cord-023095-4dannjjm	6606	8	were	be	VBD
cord-023095-4dannjjm	6606	9	associated	associate	VBN
cord-023095-4dannjjm	6606	10	with	with	IN
cord-023095-4dannjjm	6606	11	survival	survival	NN
cord-023095-4dannjjm	6606	12	and	and	CC
cord-023095-4dannjjm	6606	13	,	,	,
cord-023095-4dannjjm	6606	14	50	50	CD
cord-023095-4dannjjm	6606	15	%	%	NN
cord-023095-4dannjjm	6606	16	of	of	IN
cord-023095-4dannjjm	6606	17	horses	horse	NNS
cord-023095-4dannjjm	6606	18	were	be	VBD
cord-023095-4dannjjm	6606	19	alive	alive	JJ
cord-023095-4dannjjm	6606	20	,	,	,
cord-023095-4dannjjm	6606	21	4.6	4.6	CD
cord-023095-4dannjjm	6606	22	years	year	NNS
cord-023095-4dannjjm	6606	23	after	after	IN
cord-023095-4dannjjm	6606	24	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6606	25	.	.	.
cord-023095-4dannjjm	6607	1	17/20	17/20	CD
cord-023095-4dannjjm	6607	2	(	(	-LRB-
cord-023095-4dannjjm	6607	3	85	85	CD
cord-023095-4dannjjm	6607	4	%	%	NN
cord-023095-4dannjjm	6607	5	)	)	-RRB-
cord-023095-4dannjjm	6607	6	of	of	IN
cord-023095-4dannjjm	6607	7	horses	horse	NNS
cord-023095-4dannjjm	6607	8	were	be	VBD
cord-023095-4dannjjm	6607	9	euthanatized	euthanatize	VBN
cord-023095-4dannjjm	6607	10	and	and	CC
cord-023095-4dannjjm	6607	11	13/17	13/17	CD
cord-023095-4dannjjm	6607	12	(	(	-LRB-
cord-023095-4dannjjm	6607	13	76	76	CD
cord-023095-4dannjjm	6607	14	%	%	NN
cord-023095-4dannjjm	6607	15	)	)	-RRB-
cord-023095-4dannjjm	6607	16	were	be	VBD
cord-023095-4dannjjm	6607	17	euthanatized	euthanatize	VBN
cord-023095-4dannjjm	6607	18	due	due	IN
cord-023095-4dannjjm	6607	19	to	to	IN
cord-023095-4dannjjm	6607	20	conditions	condition	NNS
cord-023095-4dannjjm	6607	21	associated	associate	VBN
cord-023095-4dannjjm	6607	22	with	with	IN
cord-023095-4dannjjm	6607	23	ECD	ECD	NNP
cord-023095-4dannjjm	6607	24	.	.	.
cord-023095-4dannjjm	6608	1	Twenty	twenty	CD
cord-023095-4dannjjm	6608	2	-	-	HYPH
cord-023095-4dannjjm	6608	3	eight	eight	CD
cord-023095-4dannjjm	6608	4	of	of	IN
cord-023095-4dannjjm	6608	5	29	29	CD
cord-023095-4dannjjm	6608	6	(	(	-LRB-
cord-023095-4dannjjm	6608	7	97	97	CD
cord-023095-4dannjjm	6608	8	%	%	NN
cord-023095-4dannjjm	6608	9	)	)	-RRB-
cord-023095-4dannjjm	6608	10	of	of	IN
cord-023095-4dannjjm	6608	11	horse	horse	NN
cord-023095-4dannjjm	6608	12	owners	owner	NNS
cord-023095-4dannjjm	6608	13	said	say	VBD
cord-023095-4dannjjm	6608	14	they	-PRON-	PRP
cord-023095-4dannjjm	6608	15	would	would	MD
cord-023095-4dannjjm	6608	16	treat	treat	VB
cord-023095-4dannjjm	6608	17	a	a	DT
cord-023095-4dannjjm	6608	18	second	second	JJ
cord-023095-4dannjjm	6608	19	horse	horse	NN
cord-023095-4dannjjm	6608	20	for	for	IN
cord-023095-4dannjjm	6608	21	ECD	ECD	NNP
cord-023095-4dannjjm	6608	22	.	.	.
cord-023095-4dannjjm	6609	1	ECD	ECD	NNP
cord-023095-4dannjjm	6609	2	is	be	VBZ
cord-023095-4dannjjm	6609	3	becoming	become	VBG
cord-023095-4dannjjm	6609	4	a	a	DT
cord-023095-4dannjjm	6609	5	more	more	RBR
cord-023095-4dannjjm	6609	6	frequent	frequent	JJ
cord-023095-4dannjjm	6609	7	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6609	8	.	.	.
cord-023095-4dannjjm	6610	1	Fifty	fifty	CD
cord-023095-4dannjjm	6610	2	percent	percent	NN
cord-023095-4dannjjm	6610	3	of	of	IN
cord-023095-4dannjjm	6610	4	horses	horse	NNS
cord-023095-4dannjjm	6610	5	survived	survive	VBD
cord-023095-4dannjjm	6610	6	4.5	4.5	CD
cord-023095-4dannjjm	6610	7	years	year	NNS
cord-023095-4dannjjm	6610	8	after	after	IN
cord-023095-4dannjjm	6610	9	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6610	10	and	and	CC
cord-023095-4dannjjm	6610	11	owners	owner	NNS
cord-023095-4dannjjm	6610	12	were	be	VBD
cord-023095-4dannjjm	6610	13	satisfied	satisfied	JJ
cord-023095-4dannjjm	6610	14	with	with	IN
cord-023095-4dannjjm	6610	15	the	the	DT
cord-023095-4dannjjm	6610	16	horse	horse	NN
cord-023095-4dannjjm	6610	17	's	's	POS
cord-023095-4dannjjm	6610	18	quality	quality	NN
cord-023095-4dannjjm	6610	19	of	of	IN
cord-023095-4dannjjm	6610	20	life	life	NN
cord-023095-4dannjjm	6610	21	.	.	.
cord-023095-4dannjjm	6611	1	Supported	support	VBN
cord-023095-4dannjjm	6611	2	by	by	IN
cord-023095-4dannjjm	6611	3	Centers	Centers	NNPS
cord-023095-4dannjjm	6611	4	of	of	IN
cord-023095-4dannjjm	6611	5	Excellence	Excellence	NNP
cord-023095-4dannjjm	6611	6	in	in	IN
cord-023095-4dannjjm	6611	7	Livestock	Livestock	NNP
cord-023095-4dannjjm	6611	8	Diseases	Diseases	NNPS
cord-023095-4dannjjm	6611	9	and	and	CC
cord-023095-4dannjjm	6611	10	Human	Human	NNP
cord-023095-4dannjjm	6611	11	Health	Health	NNP
cord-023095-4dannjjm	6611	12	,	,	,
cord-023095-4dannjjm	6611	13	College	College	NNP
cord-023095-4dannjjm	6611	14	of	of	IN
cord-023095-4dannjjm	6611	15	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	6611	16	Medicine	Medicine	NNP
cord-023095-4dannjjm	6611	17	,	,	,
cord-023095-4dannjjm	6611	18	University	University	NNP
cord-023095-4dannjjm	6611	19	of	of	IN
cord-023095-4dannjjm	6611	20	Tennessee	Tennessee	NNP
cord-023095-4dannjjm	6611	21	.	.	.
cord-023095-4dannjjm	6612	1	The	the	DT
cord-023095-4dannjjm	6612	2	role	role	NN
cord-023095-4dannjjm	6612	3	of	of	IN
cord-023095-4dannjjm	6612	4	the	the	DT
cord-023095-4dannjjm	6612	5	hypothalamic	hypothalamic	JJ
cord-023095-4dannjjm	6612	6	-	-	HYPH
cord-023095-4dannjjm	6612	7	pituitary	pituitary	NN
cord-023095-4dannjjm	6612	8	-	-	HYPH
cord-023095-4dannjjm	6612	9	adrenal	adrenal	NN
cord-023095-4dannjjm	6612	10	(	(	-LRB-
cord-023095-4dannjjm	6612	11	HPA	HPA	NNP
cord-023095-4dannjjm	6612	12	)	)	-RRB-
cord-023095-4dannjjm	6612	13	axis	axis	NN
cord-023095-4dannjjm	6612	14	in	in	IN
cord-023095-4dannjjm	6612	15	sepsis	sepsis	NN
cord-023095-4dannjjm	6612	16	has	have	VBZ
cord-023095-4dannjjm	6612	17	been	be	VBN
cord-023095-4dannjjm	6612	18	a	a	DT
cord-023095-4dannjjm	6612	19	subject	subject	NN
cord-023095-4dannjjm	6612	20	of	of	IN
cord-023095-4dannjjm	6612	21	a	a	DT
cord-023095-4dannjjm	6612	22	great	great	JJ
cord-023095-4dannjjm	6612	23	deal	deal	NN
cord-023095-4dannjjm	6612	24	of	of	IN
cord-023095-4dannjjm	6612	25	research	research	NN
cord-023095-4dannjjm	6612	26	.	.	.
cord-023095-4dannjjm	6613	1	The	the	DT
cord-023095-4dannjjm	6613	2	role	role	NN
cord-023095-4dannjjm	6613	3	that	that	WDT
cord-023095-4dannjjm	6613	4	the	the	DT
cord-023095-4dannjjm	6613	5	somatogenic	somatogenic	NNP
cord-023095-4dannjjm	6613	6	axis	axis	NN
cord-023095-4dannjjm	6613	7	plays	play	VBZ
cord-023095-4dannjjm	6613	8	in	in	IN
cord-023095-4dannjjm	6613	9	sepsis	sepsis	NN
cord-023095-4dannjjm	6613	10	is	be	VBZ
cord-023095-4dannjjm	6613	11	less	less	RBR
cord-023095-4dannjjm	6613	12	well	well	RB
cord-023095-4dannjjm	6613	13	understood	understand	VBN
cord-023095-4dannjjm	6613	14	and	and	CC
cord-023095-4dannjjm	6613	15	how	how	WRB
cord-023095-4dannjjm	6613	16	these	these	DT
cord-023095-4dannjjm	6613	17	two	two	CD
cord-023095-4dannjjm	6613	18	axes	axis	NNS
cord-023095-4dannjjm	6613	19	interact	interact	VBP
cord-023095-4dannjjm	6613	20	during	during	IN
cord-023095-4dannjjm	6613	21	critical	critical	JJ
cord-023095-4dannjjm	6613	22	illness	illness	NN
cord-023095-4dannjjm	6613	23	is	be	VBZ
cord-023095-4dannjjm	6613	24	not	not	RB
cord-023095-4dannjjm	6613	25	clear	clear	JJ
cord-023095-4dannjjm	6613	26	.	.	.
cord-023095-4dannjjm	6614	1	The	the	DT
cord-023095-4dannjjm	6614	2	purpose	purpose	NN
cord-023095-4dannjjm	6614	3	of	of	IN
cord-023095-4dannjjm	6614	4	this	this	DT
cord-023095-4dannjjm	6614	5	study	study	NN
cord-023095-4dannjjm	6614	6	was	be	VBD
cord-023095-4dannjjm	6614	7	to	to	TO
cord-023095-4dannjjm	6614	8	assess	assess	VB
cord-023095-4dannjjm	6614	9	inter	inter	JJ
cord-023095-4dannjjm	6614	10	-	-	NNS
cord-023095-4dannjjm	6614	11	relationships	relationship	NNS
cord-023095-4dannjjm	6614	12	of	of	IN
cord-023095-4dannjjm	6614	13	adrenocorticotropin	adrenocorticotropin	NNP
cord-023095-4dannjjm	6614	14	(	(	-LRB-
cord-023095-4dannjjm	6614	15	ACTH	ACTH	NNP
cord-023095-4dannjjm	6614	16	)	)	-RRB-
cord-023095-4dannjjm	6614	17	,	,	,
cord-023095-4dannjjm	6614	18	cortisol	cortisol	NN
cord-023095-4dannjjm	6614	19	,	,	,
cord-023095-4dannjjm	6614	20	and	and	CC
cord-023095-4dannjjm	6614	21	insulin	insulin	NN
cord-023095-4dannjjm	6614	22	-	-	HYPH
cord-023095-4dannjjm	6614	23	like	like	JJ
cord-023095-4dannjjm	6614	24	growth	growth	NN
cord-023095-4dannjjm	6614	25	factor	factor	NN
cord-023095-4dannjjm	6614	26	-	-	:
cord-023095-4dannjjm	6614	27	I	i	NN
cord-023095-4dannjjm	6614	28	(	(	-LRB-
cord-023095-4dannjjm	6614	29	IGF	IGF	NNP
cord-023095-4dannjjm	6614	30	-	-	HYPH
cord-023095-4dannjjm	6614	31	I	I	NNP
cord-023095-4dannjjm	6614	32	)	)	-RRB-
cord-023095-4dannjjm	6614	33	,	,	,
cord-023095-4dannjjm	6614	34	in	in	IN
cord-023095-4dannjjm	6614	35	septic	septic	JJ
cord-023095-4dannjjm	6614	36	and	and	CC
cord-023095-4dannjjm	6614	37	non	non	JJ
cord-023095-4dannjjm	6614	38	-	-	JJ
cord-023095-4dannjjm	6614	39	septic	septic	JJ
cord-023095-4dannjjm	6614	40	term	term	NN
cord-023095-4dannjjm	6614	41	foals	foal	NNS
cord-023095-4dannjjm	6614	42	.	.	.
cord-023095-4dannjjm	6615	1	Blood	blood	NN
cord-023095-4dannjjm	6615	2	samples	sample	NNS
cord-023095-4dannjjm	6615	3	were	be	VBD
cord-023095-4dannjjm	6615	4	obtained	obtain	VBN
cord-023095-4dannjjm	6615	5	from	from	IN
cord-023095-4dannjjm	6615	6	term	term	NN
cord-023095-4dannjjm	6615	7	septic	septic	JJ
cord-023095-4dannjjm	6615	8	foals	foal	NNS
cord-023095-4dannjjm	6615	9	less	less	JJR
cord-023095-4dannjjm	6615	10	than	than	IN
cord-023095-4dannjjm	6615	11	7	7	CD
cord-023095-4dannjjm	6615	12	days	day	NNS
cord-023095-4dannjjm	6615	13	of	of	IN
cord-023095-4dannjjm	6615	14	age	age	NN
cord-023095-4dannjjm	6615	15	(	(	-LRB-
cord-023095-4dannjjm	6615	16	n	n	NN
cord-023095-4dannjjm	6615	17	5	5	CD
cord-023095-4dannjjm	6615	18	20	20	CD
cord-023095-4dannjjm	6615	19	)	)	-RRB-
cord-023095-4dannjjm	6615	20	admitted	admit	VBD
cord-023095-4dannjjm	6615	21	to	to	IN
cord-023095-4dannjjm	6615	22	Texas	Texas	NNP
cord-023095-4dannjjm	6615	23	A&M	A&M	NNP
cord-023095-4dannjjm	6615	24	University	University	NNP
cord-023095-4dannjjm	6615	25	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	6615	26	Medical	Medical	NNP
cord-023095-4dannjjm	6615	27	Teaching	Teaching	NNP
cord-023095-4dannjjm	6615	28	Hospital	Hospital	NNP
cord-023095-4dannjjm	6615	29	or	or	CC
cord-023095-4dannjjm	6615	30	Mid	Mid	NNP
cord-023095-4dannjjm	6615	31	-	-	NNP
cord-023095-4dannjjm	6615	32	Atlantic	Atlantic	NNP
cord-023095-4dannjjm	6615	33	Equine	Equine	NNP
cord-023095-4dannjjm	6615	34	Hospital	Hospital	NNP
cord-023095-4dannjjm	6615	35	.	.	.
cord-023095-4dannjjm	6616	1	The	the	DT
cord-023095-4dannjjm	6616	2	foals	foal	NNS
cord-023095-4dannjjm	6616	3	were	be	VBD
cord-023095-4dannjjm	6616	4	classified	classify	VBN
cord-023095-4dannjjm	6616	5	as	as	IN
cord-023095-4dannjjm	6616	6	septic	septic	JJ
cord-023095-4dannjjm	6616	7	by	by	IN
cord-023095-4dannjjm	6616	8	a	a	DT
cord-023095-4dannjjm	6616	9	sepsis	sepsis	NN
cord-023095-4dannjjm	6616	10	score	score	NN
cord-023095-4dannjjm	6616	11	!	!	.
cord-023095-4dannjjm	6617	1	11	11	CD
cord-023095-4dannjjm	6618	1	and/	and/	NNP
cord-023095-4dannjjm	6618	2	or	or	CC
cord-023095-4dannjjm	6618	3	a	a	DT
cord-023095-4dannjjm	6618	4	positive	positive	JJ
cord-023095-4dannjjm	6618	5	blood	blood	NN
cord-023095-4dannjjm	6618	6	culture	culture	NN
cord-023095-4dannjjm	6618	7	.	.	.
cord-023095-4dannjjm	6619	1	Non	non	JJ
cord-023095-4dannjjm	6619	2	-	-	JJ
cord-023095-4dannjjm	6619	3	septic	septic	JJ
cord-023095-4dannjjm	6619	4	term	term	NN
cord-023095-4dannjjm	6619	5	foals	foal	NNS
cord-023095-4dannjjm	6619	6	less	less	JJR
cord-023095-4dannjjm	6619	7	than	than	IN
cord-023095-4dannjjm	6619	8	7	7	CD
cord-023095-4dannjjm	6619	9	days	day	NNS
cord-023095-4dannjjm	6619	10	of	of	IN
cord-023095-4dannjjm	6619	11	age	age	NN
cord-023095-4dannjjm	6619	12	(	(	-LRB-
cord-023095-4dannjjm	6619	13	n	n	NN
cord-023095-4dannjjm	6619	14	5	5	CD
cord-023095-4dannjjm	6619	15	8)	8)	NNP
cord-023095-4dannjjm	6619	16	and	and	CC
cord-023095-4dannjjm	6619	17	having	have	VBG
cord-023095-4dannjjm	6619	18	a	a	DT
cord-023095-4dannjjm	6619	19	sepsis	sepsis	NN
cord-023095-4dannjjm	6619	20	score	score	NN
cord-023095-4dannjjm	6619	21	o	o	NN
cord-023095-4dannjjm	6619	22	11	11	CD
cord-023095-4dannjjm	6619	23	and	and	CC
cord-023095-4dannjjm	6619	24	a	a	DT
cord-023095-4dannjjm	6619	25	negative	negative	JJ
cord-023095-4dannjjm	6619	26	blood	blood	NN
cord-023095-4dannjjm	6619	27	culture	culture	NN
cord-023095-4dannjjm	6619	28	,	,	,
cord-023095-4dannjjm	6619	29	were	be	VBD
cord-023095-4dannjjm	6619	30	obtained	obtain	VBN
cord-023095-4dannjjm	6619	31	from	from	IN
cord-023095-4dannjjm	6619	32	Texas	Texas	NNP
cord-023095-4dannjjm	6619	33	A&M	A&M	NNP
cord-023095-4dannjjm	6619	34	University	University	NNP
cord-023095-4dannjjm	6619	35	Veterinary	Veterinary	NNP
cord-023095-4dannjjm	6619	36	Medical	Medical	NNP
cord-023095-4dannjjm	6619	37	Teaching	Teaching	NNP
cord-023095-4dannjjm	6619	38	Hospital	Hospital	NNP
cord-023095-4dannjjm	6619	39	and	and	CC
cord-023095-4dannjjm	6619	40	Mid	Mid	NNP
cord-023095-4dannjjm	6619	41	-	-	NNP
cord-023095-4dannjjm	6619	42	Atlantic	Atlantic	NNP
cord-023095-4dannjjm	6619	43	Equine	Equine	NNP
cord-023095-4dannjjm	6619	44	Hospital	Hospital	NNP
cord-023095-4dannjjm	6619	45	.	.	.
cord-023095-4dannjjm	6620	1	Plasma	plasma	NN
cord-023095-4dannjjm	6620	2	and	and	CC
cord-023095-4dannjjm	6620	3	serum	serum	NN
cord-023095-4dannjjm	6620	4	were	be	VBD
cord-023095-4dannjjm	6620	5	processed	process	VBN
cord-023095-4dannjjm	6620	6	from	from	IN
cord-023095-4dannjjm	6620	7	whole	whole	JJ
cord-023095-4dannjjm	6620	8	blood	blood	NN
cord-023095-4dannjjm	6620	9	collected	collect	VBN
cord-023095-4dannjjm	6620	10	by	by	IN
cord-023095-4dannjjm	6620	11	jugular	jugular	NN
cord-023095-4dannjjm	6620	12	venipuncture	venipuncture	NN
cord-023095-4dannjjm	6620	13	upon	upon	IN
cord-023095-4dannjjm	6620	14	admission	admission	NN
cord-023095-4dannjjm	6620	15	,	,	,
cord-023095-4dannjjm	6620	16	at	at	IN
cord-023095-4dannjjm	6620	17	24	24	CD
cord-023095-4dannjjm	6620	18	hours	hour	NNS
cord-023095-4dannjjm	6620	19	post	post	NN
cord-023095-4dannjjm	6620	20	admission	admission	NN
cord-023095-4dannjjm	6620	21	and	and	CC
cord-023095-4dannjjm	6620	22	at	at	IN
cord-023095-4dannjjm	6620	23	5	5	CD
cord-023095-4dannjjm	6620	24	days	day	NNS
cord-023095-4dannjjm	6620	25	post	post	NN
cord-023095-4dannjjm	6620	26	admission	admission	NN
cord-023095-4dannjjm	6620	27	or	or	CC
cord-023095-4dannjjm	6620	28	at	at	IN
cord-023095-4dannjjm	6620	29	the	the	DT
cord-023095-4dannjjm	6620	30	time	time	NN
cord-023095-4dannjjm	6620	31	of	of	IN
cord-023095-4dannjjm	6620	32	discharge	discharge	NN
cord-023095-4dannjjm	6620	33	.	.	.
cord-023095-4dannjjm	6621	1	Plasma	plasma	NN
cord-023095-4dannjjm	6621	2	concentrations	concentration	NNS
cord-023095-4dannjjm	6621	3	of	of	IN
cord-023095-4dannjjm	6621	4	ACTH	ACTH	NNP
cord-023095-4dannjjm	6621	5	,	,	,
cord-023095-4dannjjm	6621	6	and	and	CC
cord-023095-4dannjjm	6621	7	serum	serum	NN
cord-023095-4dannjjm	6621	8	concentrations	concentration	NNS
cord-023095-4dannjjm	6621	9	of	of	IN
cord-023095-4dannjjm	6621	10	cortisol	cortisol	NN
cord-023095-4dannjjm	6621	11	and	and	CC
cord-023095-4dannjjm	6621	12	IGF	IGF	NNP
cord-023095-4dannjjm	6621	13	-	-	:
cord-023095-4dannjjm	6621	14	I	-PRON-	PRP
cord-023095-4dannjjm	6621	15	were	be	VBD
cord-023095-4dannjjm	6621	16	determined	determine	VBN
cord-023095-4dannjjm	6621	17	by	by	IN
cord-023095-4dannjjm	6621	18	specific	specific	JJ
cord-023095-4dannjjm	6621	19	RIAs	ria	NNS
cord-023095-4dannjjm	6621	20	.	.	.
cord-023095-4dannjjm	6622	1	Data	datum	NNS
cord-023095-4dannjjm	6622	2	were	be	VBD
cord-023095-4dannjjm	6622	3	analyzed	analyze	VBN
cord-023095-4dannjjm	6622	4	using	use	VBG
cord-023095-4dannjjm	6622	5	linear	linear	JJ
cord-023095-4dannjjm	6622	6	mixed	mix	VBN
cord-023095-4dannjjm	6622	7	-	-	HYPH
cord-023095-4dannjjm	6622	8	effects	effect	NNS
cord-023095-4dannjjm	6622	9	modeling	modeling	NN
cord-023095-4dannjjm	6622	10	with	with	IN
cord-023095-4dannjjm	6622	11	foal	foal	NN
cord-023095-4dannjjm	6622	12	modeled	model	VBN
cord-023095-4dannjjm	6622	13	as	as	IN
cord-023095-4dannjjm	6622	14	a	a	DT
cord-023095-4dannjjm	6622	15	random	random	JJ
cord-023095-4dannjjm	6622	16	effect	effect	NN
cord-023095-4dannjjm	6622	17	and	and	CC
cord-023095-4dannjjm	6622	18	day	day	NN
cord-023095-4dannjjm	6622	19	of	of	IN
cord-023095-4dannjjm	6622	20	admission	admission	NN
cord-023095-4dannjjm	6622	21	modeled	model	VBN
cord-023095-4dannjjm	6622	22	as	as	IN
cord-023095-4dannjjm	6622	23	an	an	DT
cord-023095-4dannjjm	6622	24	ordered	order	VBN
cord-023095-4dannjjm	6622	25	categorical	categorical	JJ
cord-023095-4dannjjm	6622	26	variable	variable	NN
cord-023095-4dannjjm	6622	27	;	;	:
cord-023095-4dannjjm	6622	28	post	post	JJ
cord-023095-4dannjjm	6622	29	-	-	JJ
cord-023095-4dannjjm	6622	30	hoc	hoc	JJ
cord-023095-4dannjjm	6622	31	testing	testing	NN
cord-023095-4dannjjm	6622	32	of	of	IN
cord-023095-4dannjjm	6622	33	pair	pair	NN
cord-023095-4dannjjm	6622	34	-	-	HYPH
cord-023095-4dannjjm	6622	35	wise	wise	JJ
cord-023095-4dannjjm	6622	36	comparisons	comparison	NNS
cord-023095-4dannjjm	6622	37	was	be	VBD
cord-023095-4dannjjm	6622	38	made	make	VBN
cord-023095-4dannjjm	6622	39	using	use	VBG
cord-023095-4dannjjm	6622	40	the	the	DT
cord-023095-4dannjjm	6622	41	method	method	NN
cord-023095-4dannjjm	6622	42	of	of	IN
cord-023095-4dannjjm	6622	43	Sidak	Sidak	NNP
cord-023095-4dannjjm	6622	44	.	.	.
cord-023095-4dannjjm	6623	1	Significance	significance	NN
cord-023095-4dannjjm	6623	2	was	be	VBD
cord-023095-4dannjjm	6623	3	set	set	VBN
cord-023095-4dannjjm	6623	4	at	at	IN
cord-023095-4dannjjm	6623	5	P	p	NN
cord-023095-4dannjjm	6623	6	o	o	NN
cord-023095-4dannjjm	6623	7	0.05	0.05	CD
cord-023095-4dannjjm	6623	8	,	,	,
cord-023095-4dannjjm	6623	9	and	and	CC
cord-023095-4dannjjm	6623	10	analyses	analysis	NNS
cord-023095-4dannjjm	6623	11	were	be	VBD
cord-023095-4dannjjm	6623	12	performed	perform	VBN
cord-023095-4dannjjm	6623	13	using	use	VBG
cord-023095-4dannjjm	6623	14	S	S	NNP
cord-023095-4dannjjm	6623	15	-	-	HYPH
cord-023095-4dannjjm	6623	16	PLUS	PLUS	NNP
cord-023095-4dannjjm	6623	17	software	software	NN
cord-023095-4dannjjm	6623	18	(	(	-LRB-
cord-023095-4dannjjm	6623	19	TIBCO	TIBCO	NNP
cord-023095-4dannjjm	6623	20	,	,	,
cord-023095-4dannjjm	6623	21	Inc.	Inc.	NNP
cord-023095-4dannjjm	6623	22	,	,	,
cord-023095-4dannjjm	6623	23	Seattle	Seattle	NNP
cord-023095-4dannjjm	6623	24	,	,	,
cord-023095-4dannjjm	6623	25	WA	WA	NNP
cord-023095-4dannjjm	6623	26	)	)	-RRB-
cord-023095-4dannjjm	6623	27	.	.	.
cord-023095-4dannjjm	6624	1	Plasma	plasma	NN
cord-023095-4dannjjm	6624	2	concentrations	concentration	NNS
cord-023095-4dannjjm	6624	3	of	of	IN
cord-023095-4dannjjm	6624	4	ACTH	ACTH	NNP
cord-023095-4dannjjm	6624	5	were	be	VBD
cord-023095-4dannjjm	6624	6	not	not	RB
cord-023095-4dannjjm	6624	7	significantly	significantly	RB
cord-023095-4dannjjm	6624	8	different	different	JJ
cord-023095-4dannjjm	6624	9	between	between	IN
cord-023095-4dannjjm	6624	10	septic	septic	JJ
cord-023095-4dannjjm	6624	11	and	and	CC
cord-023095-4dannjjm	6624	12	non	non	JJ
cord-023095-4dannjjm	6624	13	-	-	JJ
cord-023095-4dannjjm	6624	14	septic	septic	JJ
cord-023095-4dannjjm	6624	15	foals	foal	NNS
cord-023095-4dannjjm	6624	16	whereas	whereas	IN
cord-023095-4dannjjm	6624	17	septic	septic	JJ
cord-023095-4dannjjm	6624	18	foals	foal	NNS
cord-023095-4dannjjm	6624	19	had	have	VBD
cord-023095-4dannjjm	6624	20	greater	great	JJR
cord-023095-4dannjjm	6624	21	serum	serum	NN
cord-023095-4dannjjm	6624	22	cortisol	cortisol	NN
cord-023095-4dannjjm	6624	23	(	(	-LRB-
cord-023095-4dannjjm	6624	24	37	37	CD
cord-023095-4dannjjm	6624	25	AE	AE	NNP
cord-023095-4dannjjm	6624	26	8	8	CD
cord-023095-4dannjjm	6624	27	ng	ng	NN
cord-023095-4dannjjm	6624	28	/	/	SYM
cord-023095-4dannjjm	6624	29	mL	ml	NN
cord-023095-4dannjjm	6624	30	vs	vs	IN
cord-023095-4dannjjm	6624	31	25	25	CD
cord-023095-4dannjjm	6624	32	AE	AE	NNP
cord-023095-4dannjjm	6624	33	7	7	CD
cord-023095-4dannjjm	6624	34	ng	ng	NN
cord-023095-4dannjjm	6624	35	/	/	SYM
cord-023095-4dannjjm	6624	36	mL	ml	NN
cord-023095-4dannjjm	6624	37	)	)	-RRB-
cord-023095-4dannjjm	6624	38	but	but	CC
cord-023095-4dannjjm	6624	39	lower	low	JJR
cord-023095-4dannjjm	6624	40	serum	serum	NN
cord-023095-4dannjjm	6624	41	IGF	IGF	NNP
cord-023095-4dannjjm	6624	42	-	-	:
cord-023095-4dannjjm	6624	43	I	I	NNP
cord-023095-4dannjjm	6625	1	(	(	-LRB-
cord-023095-4dannjjm	6625	2	116	116	CD
cord-023095-4dannjjm	6625	3	AE	AE	NNP
cord-023095-4dannjjm	6625	4	14	14	CD
cord-023095-4dannjjm	6625	5	ng	ng	NN
cord-023095-4dannjjm	6625	6	/	/	SYM
cord-023095-4dannjjm	6625	7	mL	ml	NN
cord-023095-4dannjjm	6625	8	vs	vs	IN
cord-023095-4dannjjm	6625	9	152	152	CD
cord-023095-4dannjjm	6625	10	AE	AE	NNP
cord-023095-4dannjjm	6625	11	15	15	CD
cord-023095-4dannjjm	6625	12	ng	ng	NN
cord-023095-4dannjjm	6625	13	/	/	SYM
cord-023095-4dannjjm	6625	14	mL	ml	NN
cord-023095-4dannjjm	6626	1	)	)	-RRB-
cord-023095-4dannjjm	6626	2	relative	relative	JJ
cord-023095-4dannjjm	6626	3	to	to	IN
cord-023095-4dannjjm	6626	4	non	non	JJ
cord-023095-4dannjjm	6626	5	-	-	JJ
cord-023095-4dannjjm	6626	6	septic	septic	JJ
cord-023095-4dannjjm	6626	7	foals	foal	NNS
cord-023095-4dannjjm	6626	8	pooled	pool	VBD
cord-023095-4dannjjm	6626	9	overall	overall	JJ
cord-023095-4dannjjm	6626	10	sampling	sampling	NN
cord-023095-4dannjjm	6626	11	times	time	NNS
cord-023095-4dannjjm	6626	12	.	.	.
cord-023095-4dannjjm	6627	1	The	the	DT
cord-023095-4dannjjm	6627	2	positive	positive	JJ
cord-023095-4dannjjm	6627	3	association	association	NN
cord-023095-4dannjjm	6627	4	of	of	IN
cord-023095-4dannjjm	6627	5	the	the	DT
cord-023095-4dannjjm	6627	6	peripheral	peripheral	JJ
cord-023095-4dannjjm	6627	7	blood	blood	NN
cord-023095-4dannjjm	6627	8	concentrations	concentration	NNS
cord-023095-4dannjjm	6627	9	of	of	IN
cord-023095-4dannjjm	6627	10	ACTH	ACTH	NNP
cord-023095-4dannjjm	6627	11	and	and	CC
cord-023095-4dannjjm	6627	12	cortisol	cortisol	NN
cord-023095-4dannjjm	6627	13	depended	depend	VBD
cord-023095-4dannjjm	6627	14	on	on	IN
cord-023095-4dannjjm	6627	15	disease	disease	NN
cord-023095-4dannjjm	6627	16	status	status	NN
cord-023095-4dannjjm	6627	17	of	of	IN
cord-023095-4dannjjm	6627	18	the	the	DT
cord-023095-4dannjjm	6627	19	foals	foal	NNS
cord-023095-4dannjjm	6627	20	.	.	.
cord-023095-4dannjjm	6628	1	Specifically	specifically	RB
cord-023095-4dannjjm	6628	2	,	,	,
cord-023095-4dannjjm	6628	3	cortisol	cortisol	NN
cord-023095-4dannjjm	6628	4	and	and	CC
cord-023095-4dannjjm	6628	5	ACTH	ACTH	NNP
cord-023095-4dannjjm	6628	6	were	be	VBD
cord-023095-4dannjjm	6628	7	positively	positively	RB
cord-023095-4dannjjm	6628	8	correlated	correlate	VBN
cord-023095-4dannjjm	6628	9	for	for	IN
cord-023095-4dannjjm	6628	10	the	the	DT
cord-023095-4dannjjm	6628	11	septic	septic	JJ
cord-023095-4dannjjm	6628	12	foals	foal	NNS
cord-023095-4dannjjm	6628	13	(	(	-LRB-
cord-023095-4dannjjm	6628	14	P	p	NN
cord-023095-4dannjjm	6628	15	5	5	CD
cord-023095-4dannjjm	6628	16	0.027	0.027	CD
cord-023095-4dannjjm	6628	17	)	)	-RRB-
cord-023095-4dannjjm	6628	18	but	but	CC
cord-023095-4dannjjm	6628	19	not	not	RB
cord-023095-4dannjjm	6628	20	significantly	significantly	RB
cord-023095-4dannjjm	6628	21	correlated	correlate	VBN
cord-023095-4dannjjm	6628	22	in	in	IN
cord-023095-4dannjjm	6628	23	the	the	DT
cord-023095-4dannjjm	6628	24	non	non	JJ
cord-023095-4dannjjm	6628	25	-	-	JJ
cord-023095-4dannjjm	6628	26	septic	septic	JJ
cord-023095-4dannjjm	6628	27	foals	foal	NNS
cord-023095-4dannjjm	6628	28	.	.	.
cord-023095-4dannjjm	6629	1	Peripheral	peripheral	JJ
cord-023095-4dannjjm	6629	2	concentrations	concentration	NNS
cord-023095-4dannjjm	6629	3	of	of	IN
cord-023095-4dannjjm	6629	4	ACTH	ACTH	NNP
cord-023095-4dannjjm	6629	5	and	and	CC
cord-023095-4dannjjm	6629	6	IGF	IGF	NNP
cord-023095-4dannjjm	6629	7	-	-	:
cord-023095-4dannjjm	6629	8	I	-PRON-	PRP
cord-023095-4dannjjm	6629	9	were	be	VBD
cord-023095-4dannjjm	6629	10	not	not	RB
cord-023095-4dannjjm	6629	11	significantly	significantly	RB
cord-023095-4dannjjm	6629	12	correlated	correlate	VBN
cord-023095-4dannjjm	6629	13	whether	whether	IN
cord-023095-4dannjjm	6629	14	data	datum	NNS
cord-023095-4dannjjm	6629	15	were	be	VBD
cord-023095-4dannjjm	6629	16	pooled	pool	VBN
cord-023095-4dannjjm	6629	17	overall	overall	RB
cord-023095-4dannjjm	6629	18	or	or	CC
cord-023095-4dannjjm	6629	19	stratified	stratify	VBN
cord-023095-4dannjjm	6629	20	by	by	IN
cord-023095-4dannjjm	6629	21	sepsis	sepsis	NN
cord-023095-4dannjjm	6629	22	status	status	NN
cord-023095-4dannjjm	6629	23	.	.	.
cord-023095-4dannjjm	6630	1	However	however	RB
cord-023095-4dannjjm	6630	2	,	,	,
cord-023095-4dannjjm	6630	3	peripheral	peripheral	JJ
cord-023095-4dannjjm	6630	4	concentrations	concentration	NNS
cord-023095-4dannjjm	6630	5	of	of	IN
cord-023095-4dannjjm	6630	6	cortisol	cortisol	NN
cord-023095-4dannjjm	6630	7	and	and	CC
cord-023095-4dannjjm	6630	8	IGF	IGF	NNP
cord-023095-4dannjjm	6630	9	-	-	:
cord-023095-4dannjjm	6630	10	I	-PRON-	PRP
cord-023095-4dannjjm	6630	11	were	be	VBD
cord-023095-4dannjjm	6630	12	negatively	negatively	RB
cord-023095-4dannjjm	6630	13	associated	associate	VBN
cord-023095-4dannjjm	6630	14	(	(	-LRB-
cord-023095-4dannjjm	6630	15	P	p	NN
cord-023095-4dannjjm	6630	16	5	5	CD
cord-023095-4dannjjm	6630	17	0.019	0.019	CD
cord-023095-4dannjjm	6630	18	)	)	-RRB-
cord-023095-4dannjjm	6630	19	;	;	:
cord-023095-4dannjjm	6630	20	disease	disease	NN
cord-023095-4dannjjm	6630	21	status	status	NN
cord-023095-4dannjjm	6630	22	did	do	VBD
cord-023095-4dannjjm	6630	23	not	not	RB
cord-023095-4dannjjm	6630	24	influence	influence	VB
cord-023095-4dannjjm	6630	25	this	this	DT
cord-023095-4dannjjm	6630	26	association	association	NN
cord-023095-4dannjjm	6630	27	,	,	,
cord-023095-4dannjjm	6630	28	although	although	IN
cord-023095-4dannjjm	6630	29	it	-PRON-	PRP
cord-023095-4dannjjm	6630	30	appeared	appear	VBD
cord-023095-4dannjjm	6630	31	to	to	TO
cord-023095-4dannjjm	6630	32	be	be	VB
cord-023095-4dannjjm	6630	33	a	a	DT
cord-023095-4dannjjm	6630	34	stronger	strong	JJR
cord-023095-4dannjjm	6630	35	association	association	NN
cord-023095-4dannjjm	6630	36	for	for	IN
cord-023095-4dannjjm	6630	37	the	the	DT
cord-023095-4dannjjm	6630	38	septic	septic	NN
cord-023095-4dannjjm	6630	39	than	than	IN
cord-023095-4dannjjm	6630	40	the	the	DT
cord-023095-4dannjjm	6630	41	non	non	JJ
cord-023095-4dannjjm	6630	42	-	-	JJ
cord-023095-4dannjjm	6630	43	septic	septic	JJ
cord-023095-4dannjjm	6630	44	foals	foal	NNS
cord-023095-4dannjjm	6630	45	.	.	.
cord-023095-4dannjjm	6631	1	The	the	DT
cord-023095-4dannjjm	6631	2	negative	negative	JJ
cord-023095-4dannjjm	6631	3	correlation	correlation	NN
cord-023095-4dannjjm	6631	4	between	between	IN
cord-023095-4dannjjm	6631	5	serum	serum	NN
cord-023095-4dannjjm	6631	6	concentrations	concentration	NNS
cord-023095-4dannjjm	6631	7	of	of	IN
cord-023095-4dannjjm	6631	8	the	the	DT
cord-023095-4dannjjm	6631	9	adrenal	adrenal	JJ
cord-023095-4dannjjm	6631	10	axis	axis	NN
cord-023095-4dannjjm	6631	11	steroid	steroid	NN
cord-023095-4dannjjm	6631	12	cortisol	cortisol	NN
cord-023095-4dannjjm	6631	13	and	and	CC
cord-023095-4dannjjm	6631	14	the	the	DT
cord-023095-4dannjjm	6631	15	somatogenic	somatogenic	NNP
cord-023095-4dannjjm	6631	16	axis	axis	NN
cord-023095-4dannjjm	6631	17	peptide	peptide	NN
cord-023095-4dannjjm	6631	18	IGF	IGF	NNP
cord-023095-4dannjjm	6631	19	-	-	:
cord-023095-4dannjjm	6631	20	I	-PRON-	PRP
cord-023095-4dannjjm	6631	21	may	may	MD
cord-023095-4dannjjm	6631	22	reflect	reflect	VB
cord-023095-4dannjjm	6631	23	interactions	interaction	NNS
cord-023095-4dannjjm	6631	24	of	of	IN
cord-023095-4dannjjm	6631	25	these	these	DT
cord-023095-4dannjjm	6631	26	homeorhetic	homeorhetic	JJ
cord-023095-4dannjjm	6631	27	hormones	hormone	NNS
cord-023095-4dannjjm	6631	28	.	.	.
cord-023095-4dannjjm	6632	1	Further	further	JJ
cord-023095-4dannjjm	6632	2	studies	study	NNS
cord-023095-4dannjjm	6632	3	of	of	IN
cord-023095-4dannjjm	6632	4	these	these	DT
cord-023095-4dannjjm	6632	5	and	and	CC
cord-023095-4dannjjm	6632	6	other	other	JJ
cord-023095-4dannjjm	6632	7	metabolic	metabolic	JJ
cord-023095-4dannjjm	6632	8	hormones	hormone	NNS
cord-023095-4dannjjm	6632	9	in	in	IN
cord-023095-4dannjjm	6632	10	a	a	DT
cord-023095-4dannjjm	6632	11	greater	great	JJR
cord-023095-4dannjjm	6632	12	number	number	NN
cord-023095-4dannjjm	6632	13	of	of	IN
cord-023095-4dannjjm	6632	14	foals	foal	NNS
cord-023095-4dannjjm	6632	15	are	be	VBP
cord-023095-4dannjjm	6632	16	warranted	warrant	VBN
cord-023095-4dannjjm	6632	17	to	to	TO
cord-023095-4dannjjm	6632	18	better	well	RBR
cord-023095-4dannjjm	6632	19	understand	understand	VB
cord-023095-4dannjjm	6632	20	how	how	WRB
cord-023095-4dannjjm	6632	21	these	these	DT
cord-023095-4dannjjm	6632	22	factors	factor	NNS
cord-023095-4dannjjm	6632	23	contribute	contribute	VBP
cord-023095-4dannjjm	6632	24	to	to	IN
cord-023095-4dannjjm	6632	25	survival	survival	NN
cord-023095-4dannjjm	6632	26	or	or	CC
cord-023095-4dannjjm	6632	27	non	non	JJ
cord-023095-4dannjjm	6632	28	-	-	JJ
cord-023095-4dannjjm	6632	29	survival	survival	NN
cord-023095-4dannjjm	6632	30	of	of	IN
cord-023095-4dannjjm	6632	31	critically	critically	RB
cord-023095-4dannjjm	6632	32	ill	ill	JJ
cord-023095-4dannjjm	6632	33	foals	foal	NNS
cord-023095-4dannjjm	6632	34	.	.	.
cord-023095-4dannjjm	6633	1	Botulism	botulism	NN
cord-023095-4dannjjm	6633	2	is	be	VBZ
cord-023095-4dannjjm	6633	3	a	a	DT
cord-023095-4dannjjm	6633	4	potentially	potentially	RB
cord-023095-4dannjjm	6633	5	fatal	fatal	JJ
cord-023095-4dannjjm	6633	6	paralytic	paralytic	JJ
cord-023095-4dannjjm	6633	7	disorder	disorder	NN
cord-023095-4dannjjm	6633	8	which	which	WDT
cord-023095-4dannjjm	6633	9	definitive	definitive	JJ
cord-023095-4dannjjm	6633	10	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6633	11	is	be	VBZ
cord-023095-4dannjjm	6633	12	difficult	difficult	JJ
cord-023095-4dannjjm	6633	13	.	.	.
cord-023095-4dannjjm	6634	1	The	the	DT
cord-023095-4dannjjm	6634	2	purpose	purpose	NN
cord-023095-4dannjjm	6634	3	of	of	IN
cord-023095-4dannjjm	6634	4	this	this	DT
cord-023095-4dannjjm	6634	5	study	study	NN
cord-023095-4dannjjm	6634	6	was	be	VBD
cord-023095-4dannjjm	6634	7	to	to	TO
cord-023095-4dannjjm	6634	8	investigate	investigate	VB
cord-023095-4dannjjm	6634	9	if	if	IN
cord-023095-4dannjjm	6634	10	repetitive	repetitive	JJ
cord-023095-4dannjjm	6634	11	stimulation	stimulation	NN
cord-023095-4dannjjm	6634	12	of	of	IN
cord-023095-4dannjjm	6634	13	the	the	DT
cord-023095-4dannjjm	6634	14	common	common	JJ
cord-023095-4dannjjm	6634	15	peroneal	peroneal	NN
cord-023095-4dannjjm	6634	16	nerve	nerve	NN
cord-023095-4dannjjm	6634	17	will	will	MD
cord-023095-4dannjjm	6634	18	aid	aid	VB
cord-023095-4dannjjm	6634	19	in	in	IN
cord-023095-4dannjjm	6634	20	the	the	DT
cord-023095-4dannjjm	6634	21	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6634	22	of	of	IN
cord-023095-4dannjjm	6634	23	suspected	suspect	VBN
cord-023095-4dannjjm	6634	24	botulism	botulism	NN
cord-023095-4dannjjm	6634	25	in	in	IN
cord-023095-4dannjjm	6634	26	foals	foal	NNS
cord-023095-4dannjjm	6634	27	.	.	.
cord-023095-4dannjjm	6635	1	Four	four	CD
cord-023095-4dannjjm	6635	2	healthy	healthy	JJ
cord-023095-4dannjjm	6635	3	foals	foal	NNS
cord-023095-4dannjjm	6635	4	were	be	VBD
cord-023095-4dannjjm	6635	5	used	use	VBN
cord-023095-4dannjjm	6635	6	for	for	IN
cord-023095-4dannjjm	6635	7	its	-PRON-	PRP$
cord-023095-4dannjjm	6635	8	comparison	comparison	NN
cord-023095-4dannjjm	6635	9	with	with	IN
cord-023095-4dannjjm	6635	10	3	3	CD
cord-023095-4dannjjm	6635	11	foals	foal	NNS
cord-023095-4dannjjm	6635	12	with	with	IN
cord-023095-4dannjjm	6635	13	suspected	suspect	VBN
cord-023095-4dannjjm	6635	14	botulism	botulism	NN
cord-023095-4dannjjm	6635	15	.	.	.
cord-023095-4dannjjm	6636	1	Controls	control	NNS
cord-023095-4dannjjm	6636	2	were	be	VBD
cord-023095-4dannjjm	6636	3	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	6636	4	and	and	CC
cord-023095-4dannjjm	6636	5	affected	affect	VBN
cord-023095-4dannjjm	6636	6	foals	foal	NNS
cord-023095-4dannjjm	6636	7	were	be	VBD
cord-023095-4dannjjm	6636	8	sedated	sedate	VBN
cord-023095-4dannjjm	6636	9	to	to	TO
cord-023095-4dannjjm	6636	10	avoid	avoid	VB
cord-023095-4dannjjm	6636	11	risks	risk	NNS
cord-023095-4dannjjm	6636	12	of	of	IN
cord-023095-4dannjjm	6636	13	anesthesia	anesthesia	NN
cord-023095-4dannjjm	6636	14	.	.	.
cord-023095-4dannjjm	6637	1	The	the	DT
cord-023095-4dannjjm	6637	2	common	common	JJ
cord-023095-4dannjjm	6637	3	peroneal	peroneal	NN
cord-023095-4dannjjm	6637	4	nerve	nerve	NN
cord-023095-4dannjjm	6637	5	was	be	VBD
cord-023095-4dannjjm	6637	6	chosen	choose	VBN
cord-023095-4dannjjm	6637	7	for	for	IN
cord-023095-4dannjjm	6637	8	its	-PRON-	PRP$
cord-023095-4dannjjm	6637	9	superficial	superficial	JJ
cord-023095-4dannjjm	6637	10	location	location	NN
cord-023095-4dannjjm	6637	11	and	and	CC
cord-023095-4dannjjm	6637	12	easy	easy	JJ
cord-023095-4dannjjm	6637	13	access	access	NN
cord-023095-4dannjjm	6637	14	.	.	.
cord-023095-4dannjjm	6638	1	Stimulating	stimulating	JJ
cord-023095-4dannjjm	6638	2	electrodes	electrode	NNS
cord-023095-4dannjjm	6638	3	were	be	VBD
cord-023095-4dannjjm	6638	4	placed	place	VBN
cord-023095-4dannjjm	6638	5	along	along	IN
cord-023095-4dannjjm	6638	6	the	the	DT
cord-023095-4dannjjm	6638	7	common	common	JJ
cord-023095-4dannjjm	6638	8	peroneal	peroneal	NN
cord-023095-4dannjjm	6638	9	nerve	nerve	NN
cord-023095-4dannjjm	6638	10	.	.	.
cord-023095-4dannjjm	6639	1	For	for	IN
cord-023095-4dannjjm	6639	2	recording	record	VBG
cord-023095-4dannjjm	6639	3	,	,	,
cord-023095-4dannjjm	6639	4	the	the	DT
cord-023095-4dannjjm	6639	5	active	active	JJ
cord-023095-4dannjjm	6639	6	and	and	CC
cord-023095-4dannjjm	6639	7	reference	reference	NN
cord-023095-4dannjjm	6639	8	electrodes	electrode	NNS
cord-023095-4dannjjm	6639	9	were	be	VBD
cord-023095-4dannjjm	6639	10	positioned	position	VBN
cord-023095-4dannjjm	6639	11	over	over	IN
cord-023095-4dannjjm	6639	12	the	the	DT
cord-023095-4dannjjm	6639	13	midpoint	midpoint	NN
cord-023095-4dannjjm	6639	14	and	and	CC
cord-023095-4dannjjm	6639	15	distal	distal	JJ
cord-023095-4dannjjm	6639	16	end	end	NN
cord-023095-4dannjjm	6639	17	of	of	IN
cord-023095-4dannjjm	6639	18	the	the	DT
cord-023095-4dannjjm	6639	19	extensor	extensor	NN
cord-023095-4dannjjm	6639	20	digitorum	digitorum	FW
cord-023095-4dannjjm	6639	21	longus	longus	NN
cord-023095-4dannjjm	6639	22	muscle	muscle	NN
cord-023095-4dannjjm	6639	23	,	,	,
cord-023095-4dannjjm	6639	24	respectively	respectively	RB
cord-023095-4dannjjm	6639	25	.	.	.
cord-023095-4dannjjm	6640	1	Repeated	repeat	VBN
cord-023095-4dannjjm	6640	2	supramaximal	supramaximal	JJ
cord-023095-4dannjjm	6640	3	stimulation	stimulation	NN
cord-023095-4dannjjm	6640	4	of	of	IN
cord-023095-4dannjjm	6640	5	the	the	DT
cord-023095-4dannjjm	6640	6	nerve	nerve	NN
cord-023095-4dannjjm	6640	7	was	be	VBD
cord-023095-4dannjjm	6640	8	performed	perform	VBN
cord-023095-4dannjjm	6640	9	utilizing	utilize	VBG
cord-023095-4dannjjm	6640	10	a	a	DT
cord-023095-4dannjjm	6640	11	range	range	NN
cord-023095-4dannjjm	6640	12	of	of	IN
cord-023095-4dannjjm	6640	13	frequencies	frequency	NNS
cord-023095-4dannjjm	6640	14	(	(	-LRB-
cord-023095-4dannjjm	6640	15	1	1	CD
cord-023095-4dannjjm	6640	16	to	to	IN
cord-023095-4dannjjm	6640	17	50	50	CD
cord-023095-4dannjjm	6640	18	Hz	Hz	NNS
cord-023095-4dannjjm	6640	19	)	)	-RRB-
cord-023095-4dannjjm	6640	20	.	.	.
cord-023095-4dannjjm	6641	1	Amplitude	amplitude	NN
cord-023095-4dannjjm	6641	2	,	,	,
cord-023095-4dannjjm	6641	3	area	area	NN
cord-023095-4dannjjm	6641	4	under	under	IN
cord-023095-4dannjjm	6641	5	the	the	DT
cord-023095-4dannjjm	6641	6	curve	curve	NN
cord-023095-4dannjjm	6641	7	and	and	CC
cord-023095-4dannjjm	6641	8	percentages	percentage	NNS
cord-023095-4dannjjm	6641	9	of	of	IN
cord-023095-4dannjjm	6641	10	decrement	decrement	NN
cord-023095-4dannjjm	6641	11	or	or	CC
cord-023095-4dannjjm	6641	12	increment	increment	NN
cord-023095-4dannjjm	6641	13	for	for	IN
cord-023095-4dannjjm	6641	14	each	each	DT
cord-023095-4dannjjm	6641	15	M	m	CD
cord-023095-4dannjjm	6641	16	wave	wave	NN
cord-023095-4dannjjm	6641	17	over	over	IN
cord-023095-4dannjjm	6641	18	subsequent	subsequent	JJ
cord-023095-4dannjjm	6641	19	potentials	potential	NNS
cord-023095-4dannjjm	6641	20	for	for	IN
cord-023095-4dannjjm	6641	21	each	each	DT
cord-023095-4dannjjm	6641	22	set	set	NN
cord-023095-4dannjjm	6641	23	of	of	IN
cord-023095-4dannjjm	6641	24	stimuli	stimulus	NNS
cord-023095-4dannjjm	6641	25	were	be	VBD
cord-023095-4dannjjm	6641	26	analyzed	analyze	VBN
cord-023095-4dannjjm	6641	27	.	.	.
cord-023095-4dannjjm	6642	1	Baseline	Baseline	NNP
cord-023095-4dannjjm	6642	2	M	M	NNP
cord-023095-4dannjjm	6642	3	waves	wave	NNS
cord-023095-4dannjjm	6642	4	were	be	VBD
cord-023095-4dannjjm	6642	5	decreased	decrease	VBN
cord-023095-4dannjjm	6642	6	in	in	IN
cord-023095-4dannjjm	6642	7	affected	affect	VBN
cord-023095-4dannjjm	6642	8	foals	foal	NNS
cord-023095-4dannjjm	6642	9	compared	compare	VBN
cord-023095-4dannjjm	6642	10	to	to	IN
cord-023095-4dannjjm	6642	11	controls	control	NNS
cord-023095-4dannjjm	6642	12	.	.	.
cord-023095-4dannjjm	6643	1	A	a	DT
cord-023095-4dannjjm	6643	2	decremental	decremental	JJ
cord-023095-4dannjjm	6643	3	response	response	NN
cord-023095-4dannjjm	6643	4	was	be	VBD
cord-023095-4dannjjm	6643	5	seen	see	VBN
cord-023095-4dannjjm	6643	6	at	at	IN
cord-023095-4dannjjm	6643	7	all	all	DT
cord-023095-4dannjjm	6643	8	frequencies	frequency	NNS
cord-023095-4dannjjm	6643	9	in	in	IN
cord-023095-4dannjjm	6643	10	control	control	NN
cord-023095-4dannjjm	6643	11	foals	foal	NNS
cord-023095-4dannjjm	6643	12	.	.	.
cord-023095-4dannjjm	6644	1	Decremental	Decremental	NNP
cord-023095-4dannjjm	6644	2	responses	response	NNS
cord-023095-4dannjjm	6644	3	were	be	VBD
cord-023095-4dannjjm	6644	4	also	also	RB
cord-023095-4dannjjm	6644	5	observed	observe	VBN
cord-023095-4dannjjm	6644	6	in	in	IN
cord-023095-4dannjjm	6644	7	affected	affected	JJ
cord-023095-4dannjjm	6644	8	foals	foal	NNS
cord-023095-4dannjjm	6644	9	at	at	IN
cord-023095-4dannjjm	6644	10	low	low	JJ
cord-023095-4dannjjm	6644	11	frequencies	frequency	NNS
cord-023095-4dannjjm	6644	12	.	.	.
cord-023095-4dannjjm	6645	1	However	however	RB
cord-023095-4dannjjm	6645	2	,	,	,
cord-023095-4dannjjm	6645	3	an	an	DT
cord-023095-4dannjjm	6645	4	incremental	incremental	JJ
cord-023095-4dannjjm	6645	5	response	response	NN
cord-023095-4dannjjm	6645	6	in	in	IN
cord-023095-4dannjjm	6645	7	amplitude	amplitude	NN
cord-023095-4dannjjm	6645	8	and	and	CC
cord-023095-4dannjjm	6645	9	area	area	NN
cord-023095-4dannjjm	6645	10	under	under	IN
cord-023095-4dannjjm	6645	11	the	the	DT
cord-023095-4dannjjm	6645	12	curve	curve	NN
cord-023095-4dannjjm	6645	13	was	be	VBD
cord-023095-4dannjjm	6645	14	seen	see	VBN
cord-023095-4dannjjm	6645	15	in	in	IN
cord-023095-4dannjjm	6645	16	all	all	DT
cord-023095-4dannjjm	6645	17	affected	affect	VBN
cord-023095-4dannjjm	6645	18	foals	foal	NNS
cord-023095-4dannjjm	6645	19	at	at	IN
cord-023095-4dannjjm	6645	20	50	50	CD
cord-023095-4dannjjm	6645	21	Hz	Hz	NNS
cord-023095-4dannjjm	6645	22	.	.	.
cord-023095-4dannjjm	6646	1	Reduced	reduce	VBN
cord-023095-4dannjjm	6646	2	baseline	baseline	JJ
cord-023095-4dannjjm	6646	3	M	m	CD
cord-023095-4dannjjm	6646	4	waves	wave	NNS
cord-023095-4dannjjm	6646	5	with	with	IN
cord-023095-4dannjjm	6646	6	incremental	incremental	JJ
cord-023095-4dannjjm	6646	7	responses	response	NNS
cord-023095-4dannjjm	6646	8	at	at	IN
cord-023095-4dannjjm	6646	9	high	high	JJ
cord-023095-4dannjjm	6646	10	rates	rate	NNS
cord-023095-4dannjjm	6646	11	are	be	VBP
cord-023095-4dannjjm	6646	12	supportive	supportive	JJ
cord-023095-4dannjjm	6646	13	of	of	IN
cord-023095-4dannjjm	6646	14	a	a	DT
cord-023095-4dannjjm	6646	15	presynaptic	presynaptic	JJ
cord-023095-4dannjjm	6646	16	neuromuscular	neuromuscular	JJ
cord-023095-4dannjjm	6646	17	disorder	disorder	NN
cord-023095-4dannjjm	6646	18	which	which	WDT
cord-023095-4dannjjm	6646	19	botulism	botulism	NN
cord-023095-4dannjjm	6646	20	was	be	VBD
cord-023095-4dannjjm	6646	21	the	the	DT
cord-023095-4dannjjm	6646	22	most	most	RBS
cord-023095-4dannjjm	6646	23	likely	likely	JJ
cord-023095-4dannjjm	6646	24	cause	cause	NN
cord-023095-4dannjjm	6646	25	in	in	IN
cord-023095-4dannjjm	6646	26	these	these	DT
cord-023095-4dannjjm	6646	27	foals	foal	NNS
cord-023095-4dannjjm	6646	28	.	.	.
cord-023095-4dannjjm	6647	1	Repetitive	repetitive	JJ
cord-023095-4dannjjm	6647	2	nerve	nerve	NN
cord-023095-4dannjjm	6647	3	stimulation	stimulation	NN
cord-023095-4dannjjm	6647	4	is	be	VBZ
cord-023095-4dannjjm	6647	5	a	a	DT
cord-023095-4dannjjm	6647	6	safe	safe	JJ
cord-023095-4dannjjm	6647	7	,	,	,
cord-023095-4dannjjm	6647	8	simple	simple	JJ
cord-023095-4dannjjm	6647	9	,	,	,
cord-023095-4dannjjm	6647	10	fast	fast	JJ
cord-023095-4dannjjm	6647	11	,	,	,
cord-023095-4dannjjm	6647	12	and	and	CC
cord-023095-4dannjjm	6647	13	non	non	JJ
cord-023095-4dannjjm	6647	14	-	-	JJ
cord-023095-4dannjjm	6647	15	invasive	invasive	JJ
cord-023095-4dannjjm	6647	16	technique	technique	NN
cord-023095-4dannjjm	6647	17	that	that	WDT
cord-023095-4dannjjm	6647	18	can	can	MD
cord-023095-4dannjjm	6647	19	aid	aid	VB
cord-023095-4dannjjm	6647	20	in	in	IN
cord-023095-4dannjjm	6647	21	the	the	DT
cord-023095-4dannjjm	6647	22	diagnosis	diagnosis	NN
cord-023095-4dannjjm	6647	23	of	of	IN
cord-023095-4dannjjm	6647	24	suspected	suspect	VBN
cord-023095-4dannjjm	6647	25	botulism	botulism	NN
cord-023095-4dannjjm	6647	26	in	in	IN
cord-023095-4dannjjm	6647	27	foals	foal	NNS
cord-023095-4dannjjm	6647	28	.	.	.
cord-023095-4dannjjm	6648	1	This	this	DT
cord-023095-4dannjjm	6648	2	study	study	NN
cord-023095-4dannjjm	6648	3	examined	examine	VBD
cord-023095-4dannjjm	6648	4	the	the	DT
cord-023095-4dannjjm	6648	5	frequency	frequency	NN
cord-023095-4dannjjm	6648	6	with	with	IN
cord-023095-4dannjjm	6648	7	which	which	WDT
cord-023095-4dannjjm	6648	8	dogs	dog	NNS
cord-023095-4dannjjm	6648	9	are	be	VBP
cord-023095-4dannjjm	6648	10	exposed	expose	VBN
cord-023095-4dannjjm	6648	11	to	to	IN
cord-023095-4dannjjm	6648	12	E.	E.	NNP
cord-023095-4dannjjm	6648	13	chaffeensis	chaffeensis	NNP
cord-023095-4dannjjm	6648	14	and	and	CC
cord-023095-4dannjjm	6648	15	E.	E.	NNP
cord-023095-4dannjjm	6648	16	ewingii	ewingii	NNP
cord-023095-4dannjjm	6648	17	relative	relative	NN
cord-023095-4dannjjm	6648	18	to	to	IN
cord-023095-4dannjjm	6648	19	E.	E.	NNP
cord-023095-4dannjjm	6648	20	canis	canis	NNP
cord-023095-4dannjjm	6648	21	,	,	,
cord-023095-4dannjjm	6648	22	which	which	WDT
cord-023095-4dannjjm	6648	23	is	be	VBZ
cord-023095-4dannjjm	6648	24	transmitted	transmit	VBN
cord-023095-4dannjjm	6648	25	by	by	IN
cord-023095-4dannjjm	6648	26	the	the	DT
cord-023095-4dannjjm	6648	27	more	more	RBR
cord-023095-4dannjjm	6648	28	ubiquitously	ubiquitously	RB
cord-023095-4dannjjm	6648	29	distributed	distribute	VBN
cord-023095-4dannjjm	6648	30	brown	brown	JJ
cord-023095-4dannjjm	6648	31	dog	dog	NN
cord-023095-4dannjjm	6648	32	tick	tick	NN
cord-023095-4dannjjm	6648	33	(	(	-LRB-
cord-023095-4dannjjm	6648	34	Rhipicephalus	Rhipicephalus	NNP
cord-023095-4dannjjm	6648	35	sanguineus	sanguineus	NNP
cord-023095-4dannjjm	6648	36	)	)	-RRB-
cord-023095-4dannjjm	6648	37	.	.	.
cord-023095-4dannjjm	6649	1	A	a	DT
cord-023095-4dannjjm	6649	2	total	total	NN
cord-023095-4dannjjm	6649	3	of	of	IN
cord-023095-4dannjjm	6649	4	6,512	6,512	CD
cord-023095-4dannjjm	6649	5	canine	canine	JJ
cord-023095-4dannjjm	6649	6	serum	serum	NN
cord-023095-4dannjjm	6649	7	samples	sample	NNS
cord-023095-4dannjjm	6649	8	,	,	,
cord-023095-4dannjjm	6649	9	ranging	range	VBG
cord-023095-4dannjjm	6649	10	from	from	IN
cord-023095-4dannjjm	6649	11	182	182	CD
cord-023095-4dannjjm	6649	12	to	to	IN
cord-023095-4dannjjm	6649	13	614	614	CD
cord-023095-4dannjjm	6649	14	from	from	IN
cord-023095-4dannjjm	6649	15	each	each	DT
cord-023095-4dannjjm	6649	16	of	of	IN
cord-023095-4dannjjm	6649	17	the	the	DT
cord-023095-4dannjjm	6649	18	14	14	CD
cord-023095-4dannjjm	6649	19	participating	participate	VBG
cord-023095-4dannjjm	6649	20	institutions	institution	NNS
cord-023095-4dannjjm	6649	21	,	,	,
cord-023095-4dannjjm	6649	22	collected	collect	VBN
cord-023095-4dannjjm	6649	23	at	at	IN
cord-023095-4dannjjm	6649	24	random	random	JJ
cord-023095-4dannjjm	6649	25	from	from	IN
cord-023095-4dannjjm	6649	26	clinical	clinical	JJ
cord-023095-4dannjjm	6649	27	accessions	accession	NNS
cord-023095-4dannjjm	6649	28	,	,	,
cord-023095-4dannjjm	6649	29	diagnostic	diagnostic	JJ
cord-023095-4dannjjm	6649	30	laboratories	laboratory	NNS
cord-023095-4dannjjm	6649	31	and/or	and/or	CC
cord-023095-4dannjjm	6649	32	shelters	shelter	NNS
cord-023095-4dannjjm	6649	33	were	be	VBD
cord-023095-4dannjjm	6649	34	evaluated	evaluate	VBN
cord-023095-4dannjjm	6649	35	.	.	.
cord-023095-4dannjjm	6650	1	All	all	DT
cord-023095-4dannjjm	6650	2	serum	serum	NN
cord-023095-4dannjjm	6650	3	samples	sample	NNS
cord-023095-4dannjjm	6650	4	were	be	VBD
cord-023095-4dannjjm	6650	5	tested	test	VBN
cord-023095-4dannjjm	6650	6	by	by	IN
cord-023095-4dannjjm	6650	7	three	three	CD
cord-023095-4dannjjm	6650	8	microtiter	microtiter	NN
cord-023095-4dannjjm	6650	9	plate	plate	NN
cord-023095-4dannjjm	6650	10	ELISAs	elisa	NNS
cord-023095-4dannjjm	6650	11	using	use	VBG
cord-023095-4dannjjm	6650	12	species	species	NN
cord-023095-4dannjjm	6650	13	-	-	HYPH
cord-023095-4dannjjm	6650	14	specific	specific	JJ
cord-023095-4dannjjm	6650	15	peptides	peptide	NNS
cord-023095-4dannjjm	6650	16	for	for	IN
cord-023095-4dannjjm	6650	17	antibodies	antibody	NNS
cord-023095-4dannjjm	6650	18	to	to	IN
cord-023095-4dannjjm	6650	19	E.	E.	NNP
cord-023095-4dannjjm	6650	20	canis	canis	NNP
cord-023095-4dannjjm	6650	21	,	,	,
cord-023095-4dannjjm	6650	22	E.	E.	NNP
cord-023095-4dannjjm	6650	23	chaffeensis	chaffeensis	NNP
cord-023095-4dannjjm	6650	24	and	and	CC
cord-023095-4dannjjm	6650	25	E.	E.	NNP
cord-023095-4dannjjm	6650	26	ewingii	ewingii	NNP
cord-023095-4dannjjm	6650	27	.	.	.
cord-023095-4dannjjm	6651	1	Zip	zip	NN
cord-023095-4dannjjm	6651	2	code	code	NN
cord-023095-4dannjjm	6651	3	information	information	NN
cord-023095-4dannjjm	6651	4	for	for	IN
cord-023095-4dannjjm	6651	5	sample	sample	NN
cord-023095-4dannjjm	6651	6	origin	origin	NN
cord-023095-4dannjjm	6651	7	was	be	VBD
cord-023095-4dannjjm	6651	8	provided	provide	VBN
cord-023095-4dannjjm	6651	9	by	by	IN
cord-023095-4dannjjm	6651	10	the	the	DT
cord-023095-4dannjjm	6651	11	collaborator	collaborator	NN
cord-023095-4dannjjm	6651	12	and	and	CC
cord-023095-4dannjjm	6651	13	was	be	VBD
cord-023095-4dannjjm	6651	14	used	use	VBN
cord-023095-4dannjjm	6651	15	to	to	TO
cord-023095-4dannjjm	6651	16	assess	assess	VB
cord-023095-4dannjjm	6651	17	seroprevalence	seroprevalence	NN
cord-023095-4dannjjm	6651	18	by	by	IN
cord-023095-4dannjjm	6651	19	region	region	NN
cord-023095-4dannjjm	6651	20	.	.	.
cord-023095-4dannjjm	6652	1	Comparisons	comparison	NNS
cord-023095-4dannjjm	6652	2	were	be	VBD
cord-023095-4dannjjm	6652	3	evaluated	evaluate	VBN
cord-023095-4dannjjm	6652	4	using	use	VBG
cord-023095-4dannjjm	6652	5	the	the	DT
cord-023095-4dannjjm	6652	6	Chi	Chi	NNP
cord-023095-4dannjjm	6652	7	-	-	HYPH
cord-023095-4dannjjm	6652	8	square	square	JJ
cord-023095-4dannjjm	6652	9	test	test	NN
cord-023095-4dannjjm	6652	10	.	.	.
cord-023095-4dannjjm	6653	1	Seroreactivity	Seroreactivity	NNP
cord-023095-4dannjjm	6653	2	for	for	IN
cord-023095-4dannjjm	6653	3	at	at	RB
cord-023095-4dannjjm	6653	4	least	least	JJS
cord-023095-4dannjjm	6653	5	2	2	CD
cord-023095-4dannjjm	6653	6	of	of	IN
cord-023095-4dannjjm	6653	7	3	3	CD
cord-023095-4dannjjm	6653	8	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	6653	9	spp	spp	NNS
cord-023095-4dannjjm	6653	10	was	be	VBD
cord-023095-4dannjjm	6653	11	found	find	VBN
cord-023095-4dannjjm	6653	12	in	in	IN
cord-023095-4dannjjm	6653	13	samples	sample	NNS
cord-023095-4dannjjm	6653	14	from	from	IN
cord-023095-4dannjjm	6653	15	every	every	DT
cord-023095-4dannjjm	6653	16	institution	institution	NN
cord-023095-4dannjjm	6654	1	Both	both	DT
cord-023095-4dannjjm	6654	2	Mississippi	Mississippi	NNP
cord-023095-4dannjjm	6654	3	and	and	CC
cord-023095-4dannjjm	6654	4	Oklahoma	Oklahoma	NNP
cord-023095-4dannjjm	6654	5	had	have	VBD
cord-023095-4dannjjm	6654	6	greater	great	JJR
cord-023095-4dannjjm	6654	7	than	than	IN
cord-023095-4dannjjm	6654	8	a	a	DT
cord-023095-4dannjjm	6654	9	7	7	CD
cord-023095-4dannjjm	6654	10	%	%	NN
cord-023095-4dannjjm	6654	11	Samples	sample	NNS
cord-023095-4dannjjm	6654	12	from	from	IN
cord-023095-4dannjjm	6654	13	Ohio	Ohio	NNP
cord-023095-4dannjjm	6654	14	had	have	VBD
cord-023095-4dannjjm	6654	15	the	the	DT
cord-023095-4dannjjm	6654	16	lowest	low	JJS
cord-023095-4dannjjm	6654	17	aggregate	aggregate	JJ
cord-023095-4dannjjm	6654	18	seroprevalence	seroprevalence	NN
cord-023095-4dannjjm	6654	19	(	(	-LRB-
cord-023095-4dannjjm	6654	20	1.0	1.0	CD
cord-023095-4dannjjm	6654	21	%	%	NN
cord-023095-4dannjjm	6654	22	)	)	-RRB-
cord-023095-4dannjjm	6654	23	with	with	IN
cord-023095-4dannjjm	6654	24	only	only	RB
cord-023095-4dannjjm	6654	25	4	4	CD
cord-023095-4dannjjm	6654	26	dogs	dog	NNS
cord-023095-4dannjjm	6654	27	E.	E.	NNP
cord-023095-4dannjjm	6654	28	canis	canis	NN
cord-023095-4dannjjm	6654	29	seropositive	seropositive	NN
cord-023095-4dannjjm	6654	30	,	,	,
cord-023095-4dannjjm	6654	31	one	one	CD
cord-023095-4dannjjm	6654	32	E.	E.	NNP
cord-023095-4dannjjm	6654	33	ewingii	ewingii	NN
cord-023095-4dannjjm	6654	34	seropositive	seropositive	JJ
cord-023095-4dannjjm	6654	35	and	and	CC
cord-023095-4dannjjm	6654	36	no	no	DT
cord-023095-4dannjjm	6654	37	E.	E.	NNP
cord-023095-4dannjjm	6654	38	chaffeensis	chaffeensis	FW
cord-023095-4dannjjm	6654	39	seroreactors	seroreactors	NNP
cord-023095-4dannjjm	6654	40	.	.	.
cord-023095-4dannjjm	6655	1	The	the	DT
cord-023095-4dannjjm	6655	2	geospatial	geospatial	JJ
cord-023095-4dannjjm	6655	3	pattern	pattern	NN
cord-023095-4dannjjm	6655	4	of	of	IN
cord-023095-4dannjjm	6655	5	E.	E.	NNP
cord-023095-4dannjjm	6655	6	chaffeensis	chaffeensis	NNP
cord-023095-4dannjjm	6655	7	and	and	CC
cord-023095-4dannjjm	6655	8	E.	E.	NNP
cord-023095-4dannjjm	6655	9	ewingii	ewingii	NNP
cord-023095-4dannjjm	6656	1	seropositive	seropositive	JJ
cord-023095-4dannjjm	6656	2	samples	sample	NNS
cord-023095-4dannjjm	6656	3	was	be	VBD
cord-023095-4dannjjm	6656	4	similar	similar	JJ
cord-023095-4dannjjm	6656	5	to	to	IN
cord-023095-4dannjjm	6656	6	that	that	DT
cord-023095-4dannjjm	6656	7	previously	previously	RB
cord-023095-4dannjjm	6656	8	reported	report	VBN
cord-023095-4dannjjm	6656	9	based	base	VBN
cord-023095-4dannjjm	6656	10	on	on	IN
cord-023095-4dannjjm	6656	11	modeling	model	VBG
cord-023095-4dannjjm	6656	12	seroreactivity	seroreactivity	NN
cord-023095-4dannjjm	6656	13	to	to	IN
cord-023095-4dannjjm	6656	14	E.	E.	NNP
cord-023095-4dannjjm	6656	15	chaffeensis	chaffeensis	NN
cord-023095-4dannjjm	6656	16	in	in	IN
cord-023095-4dannjjm	6656	17	white	white	JJ
cord-023095-4dannjjm	6656	18	-	-	HYPH
cord-023095-4dannjjm	6656	19	tailed	tailed	JJ
cord-023095-4dannjjm	6656	20	deer	deer	NN
cord-023095-4dannjjm	6656	21	as	as	RB
cord-023095-4dannjjm	6656	22	well	well	RB
cord-023095-4dannjjm	6656	23	as	as	IN
cord-023095-4dannjjm	6656	24	the	the	DT
cord-023095-4dannjjm	6656	25	distribution	distribution	NN
cord-023095-4dannjjm	6656	26	of	of	IN
cord-023095-4dannjjm	6656	27	human	human	JJ
cord-023095-4dannjjm	6656	28	monocytic	monocytic	JJ
cord-023095-4dannjjm	6656	29	ehrlichiosis	ehrlichiosis	NNP
cord-023095-4dannjjm	6656	30	(	(	-LRB-
cord-023095-4dannjjm	6656	31	HME	HME	NNP
cord-023095-4dannjjm	6656	32	)	)	-RRB-
cord-023095-4dannjjm	6656	33	cases	case	NNS
cord-023095-4dannjjm	6656	34	reported	report	VBN
cord-023095-4dannjjm	6656	35	by	by	IN
cord-023095-4dannjjm	6656	36	the	the	DT
cord-023095-4dannjjm	6656	37	CDC	CDC	NNP
cord-023095-4dannjjm	6656	38	.	.	.
cord-023095-4dannjjm	6657	1	This	this	DT
cord-023095-4dannjjm	6657	2	study	study	NN
cord-023095-4dannjjm	6657	3	provides	provide	VBZ
cord-023095-4dannjjm	6657	4	the	the	DT
cord-023095-4dannjjm	6657	5	first	first	JJ
cord-023095-4dannjjm	6657	6	large	large	JJ
cord-023095-4dannjjm	6657	7	scale	scale	NN
cord-023095-4dannjjm	6657	8	regional	regional	JJ
cord-023095-4dannjjm	6657	9	documentation	documentation	NN
cord-023095-4dannjjm	6657	10	of	of	IN
cord-023095-4dannjjm	6657	11	canine	canine	JJ
cord-023095-4dannjjm	6657	12	exposure	exposure	NN
cord-023095-4dannjjm	6657	13	to	to	IN
cord-023095-4dannjjm	6657	14	these	these	DT
cord-023095-4dannjjm	6657	15	three	three	CD
cord-023095-4dannjjm	6657	16	Ehrlichia	Ehrlichia	NNP
cord-023095-4dannjjm	6657	17	spp	spp	NNS
cord-023095-4dannjjm	6657	18	.	.	.
cord-023095-4dannjjm	6658	1	,	,	,
cord-023095-4dannjjm	6658	2	highlighting	highlight	VBG
cord-023095-4dannjjm	6658	3	where	where	WRB
cord-023095-4dannjjm	6658	4	infections	infection	NNS
cord-023095-4dannjjm	6658	5	most	most	RBS
cord-023095-4dannjjm	6658	6	commonly	commonly	RB
cord-023095-4dannjjm	6658	7	occur	occur	VBP
cord-023095-4dannjjm	6658	8	and	and	CC
cord-023095-4dannjjm	6658	9	thus	thus	RB
cord-023095-4dannjjm	6658	10	identifying	identify	VBG
cord-023095-4dannjjm	6658	11	areas	area	NNS
cord-023095-4dannjjm	6658	12	where	where	WRB
cord-023095-4dannjjm	6658	13	heightened	heightened	JJ
cord-023095-4dannjjm	6658	14	awareness	awareness	NN
cord-023095-4dannjjm	6658	15	about	about	IN
cord-023095-4dannjjm	6658	16	these	these	DT
cord-023095-4dannjjm	6658	17	emerging	emerge	VBG
cord-023095-4dannjjm	6658	18	vector	vector	NN
cord-023095-4dannjjm	6658	19	Urinary	urinary	JJ
cord-023095-4dannjjm	6658	20	incontinence	incontinence	NN
cord-023095-4dannjjm	6658	21	(	(	-LRB-
cord-023095-4dannjjm	6658	22	UI	UI	NNP
cord-023095-4dannjjm	6658	23	)	)	-RRB-
cord-023095-4dannjjm	6658	24	occurs	occur	VBZ
cord-023095-4dannjjm	6658	25	in	in	IN
cord-023095-4dannjjm	6658	26	approximately	approximately	RB
cord-023095-4dannjjm	6658	27	20	20	CD
cord-023095-4dannjjm	6658	28	%	%	NN
cord-023095-4dannjjm	6658	29	of	of	IN
cord-023095-4dannjjm	6658	30	spayed	spayed	JJ
cord-023095-4dannjjm	6658	31	female	female	JJ
cord-023095-4dannjjm	6658	32	dogs	dog	NNS
cord-023095-4dannjjm	6658	33	.	.	.
cord-023095-4dannjjm	6659	1	The	the	DT
cord-023095-4dannjjm	6659	2	most	most	RBS
cord-023095-4dannjjm	6659	3	common	common	JJ
cord-023095-4dannjjm	6659	4	cause	cause	NN
cord-023095-4dannjjm	6659	5	is	be	VBZ
cord-023095-4dannjjm	6659	6	urethral	urethral	JJ
cord-023095-4dannjjm	6659	7	sphincter	sphincter	NN
cord-023095-4dannjjm	6659	8	mechanism	mechanism	NN
cord-023095-4dannjjm	6659	9	incompetency	incompetency	NN
cord-023095-4dannjjm	6659	10	(	(	-LRB-
cord-023095-4dannjjm	6659	11	USMI	USMI	NNP
cord-023095-4dannjjm	6659	12	)	)	-RRB-
cord-023095-4dannjjm	6659	13	.	.	.
cord-023095-4dannjjm	6660	1	Pharmacological	pharmacological	JJ
cord-023095-4dannjjm	6660	2	agents	agent	NNS
cord-023095-4dannjjm	6660	3	are	be	VBP
cord-023095-4dannjjm	6660	4	effective	effective	JJ
cord-023095-4dannjjm	6660	5	,	,	,
cord-023095-4dannjjm	6660	6	however	however	RB
cord-023095-4dannjjm	6660	7	,	,	,
cord-023095-4dannjjm	6660	8	not	not	RB
cord-023095-4dannjjm	6660	9	all	all	DT
cord-023095-4dannjjm	6660	10	dogs	dog	NNS
cord-023095-4dannjjm	6660	11	respond	respond	VBP
cord-023095-4dannjjm	6660	12	,	,	,
cord-023095-4dannjjm	6660	13	and	and	CC
cord-023095-4dannjjm	6660	14	dogs	dog	NNS
cord-023095-4dannjjm	6660	15	may	may	MD
cord-023095-4dannjjm	6660	16	become	become	VB
cord-023095-4dannjjm	6660	17	refractory	refractory	JJ
cord-023095-4dannjjm	6660	18	to	to	IN
cord-023095-4dannjjm	6660	19	treatment	treatment	NN
cord-023095-4dannjjm	6660	20	over	over	IN
cord-023095-4dannjjm	6660	21	time	time	NN
cord-023095-4dannjjm	6660	22	.	.	.
cord-023095-4dannjjm	6661	1	Urethral	urethral	JJ
cord-023095-4dannjjm	6661	2	bulking	bulking	NN
cord-023095-4dannjjm	6661	3	,	,	,
cord-023095-4dannjjm	6661	4	where	where	WRB
cord-023095-4dannjjm	6661	5	a	a	DT
cord-023095-4dannjjm	6661	6	compound	compound	NN
cord-023095-4dannjjm	6661	7	is	be	VBZ
cord-023095-4dannjjm	6661	8	injected	inject	VBN
cord-023095-4dannjjm	6661	9	submucosally	submucosally	RB
cord-023095-4dannjjm	6661	10	in	in	IN
cord-023095-4dannjjm	6661	11	the	the	DT
cord-023095-4dannjjm	6661	12	urethra	urethra	NN
cord-023095-4dannjjm	6661	13	,	,	,
cord-023095-4dannjjm	6661	14	has	have	VBZ
cord-023095-4dannjjm	6661	15	been	be	VBN
cord-023095-4dannjjm	6661	16	used	use	VBN
cord-023095-4dannjjm	6661	17	in	in	IN
cord-023095-4dannjjm	6661	18	women	woman	NNS
cord-023095-4dannjjm	6661	19	and	and	CC
cord-023095-4dannjjm	6661	20	in	in	IN
cord-023095-4dannjjm	6661	21	female	female	JJ
cord-023095-4dannjjm	6661	22	dogs	dog	NNS
cord-023095-4dannjjm	6661	23	with	with	IN
cord-023095-4dannjjm	6661	24	urinary	urinary	JJ
cord-023095-4dannjjm	6661	25	incontinence	incontinence	NN
cord-023095-4dannjjm	6661	26	.	.	.
cord-023095-4dannjjm	6662	1	New	new	JJ
cord-023095-4dannjjm	6662	2	synthetic	synthetic	JJ
cord-023095-4dannjjm	6662	3	compounds	compound	NNS
cord-023095-4dannjjm	6662	4	have	have	VBP
cord-023095-4dannjjm	6662	5	been	be	VBN
cord-023095-4dannjjm	6662	6	used	use	VBN
cord-023095-4dannjjm	6662	7	in	in	IN
cord-023095-4dannjjm	6662	8	human	human	JJ
cord-023095-4dannjjm	6662	9	medicine	medicine	NN
cord-023095-4dannjjm	6662	10	;	;	:
cord-023095-4dannjjm	6662	11	the	the	DT
cord-023095-4dannjjm	6662	12	most	most	RBS
cord-023095-4dannjjm	6662	13	promising	promising	JJ
cord-023095-4dannjjm	6662	14	is	be	VBZ
cord-023095-4dannjjm	6662	15	Polydimethylsiloxane	Polydimethylsiloxane	NNP
cord-023095-4dannjjm	6662	16	(	(	-LRB-
cord-023095-4dannjjm	6662	17	PDMS	PDMS	NNP
cord-023095-4dannjjm	6662	18	)	)	-RRB-
cord-023095-4dannjjm	6662	19	,	,	,
cord-023095-4dannjjm	6662	20	which	which	WDT
cord-023095-4dannjjm	6662	21	has	have	VBZ
cord-023095-4dannjjm	6662	22	been	be	VBN
cord-023095-4dannjjm	6662	23	shown	show	VBN
cord-023095-4dannjjm	6662	24	to	to	TO
cord-023095-4dannjjm	6662	25	be	be	VB
cord-023095-4dannjjm	6662	26	more	more	RBR
cord-023095-4dannjjm	6662	27	effective	effective	JJ
cord-023095-4dannjjm	6662	28	than	than	IN
cord-023095-4dannjjm	6662	29	glutaraldehyde	glutaraldehyde	JJ
cord-023095-4dannjjm	6662	30	cross	cross	JJ
cord-023095-4dannjjm	6662	31	-	-	JJ
cord-023095-4dannjjm	6662	32	linked	link	VBN
cord-023095-4dannjjm	6662	33	collagen	collagen	NN
cord-023095-4dannjjm	6662	34	.	.	.
cord-023095-4dannjjm	6663	1	The	the	DT
cord-023095-4dannjjm	6663	2	purpose	purpose	NN
cord-023095-4dannjjm	6663	3	of	of	IN
cord-023095-4dannjjm	6663	4	this	this	DT
cord-023095-4dannjjm	6663	5	descriptive	descriptive	JJ
cord-023095-4dannjjm	6663	6	clinical	clinical	JJ
cord-023095-4dannjjm	6663	7	trial	trial	NN
cord-023095-4dannjjm	6663	8	is	be	VBZ
cord-023095-4dannjjm	6663	9	to	to	TO
cord-023095-4dannjjm	6663	10	evaluate	evaluate	VB
cord-023095-4dannjjm	6663	11	the	the	DT
cord-023095-4dannjjm	6663	12	safety	safety	NN
cord-023095-4dannjjm	6663	13	and	and	CC
cord-023095-4dannjjm	6663	14	effectiveness	effectiveness	NN
cord-023095-4dannjjm	6663	15	of	of	IN
cord-023095-4dannjjm	6663	16	PDMS	PDMS	NNP
cord-023095-4dannjjm	6663	17	urethral	urethral	JJ
cord-023095-4dannjjm	6663	18	bulking	bulk	VBG
cord-023095-4dannjjm	6663	19	agent	agent	NN
cord-023095-4dannjjm	6663	20	(	(	-LRB-
cord-023095-4dannjjm	6663	21	PDMS	PDMS	NNP
cord-023095-4dannjjm	6663	22	UBA	UBA	NNP
cord-023095-4dannjjm	6663	23	)	)	-RRB-
cord-023095-4dannjjm	6663	24	in	in	IN
cord-023095-4dannjjm	6663	25	client	client	NN
cord-023095-4dannjjm	6663	26	-	-	HYPH
cord-023095-4dannjjm	6663	27	owned	own	VBN
cord-023095-4dannjjm	6663	28	,	,	,
cord-023095-4dannjjm	6663	29	spayed	spay	VBN
cord-023095-4dannjjm	6663	30	female	female	JJ
cord-023095-4dannjjm	6663	31	dogs	dog	NNS
cord-023095-4dannjjm	6663	32	with	with	IN
cord-023095-4dannjjm	6663	33	naturally	naturally	RB
cord-023095-4dannjjm	6663	34	-	-	HYPH
cord-023095-4dannjjm	6663	35	occurring	occur	VBG
cord-023095-4dannjjm	6663	36	UI	UI	NNP
cord-023095-4dannjjm	6663	37	due	due	IN
cord-023095-4dannjjm	6663	38	to	to	IN
cord-023095-4dannjjm	6663	39	USMI.Twenty	usmi.twenty	CD
cord-023095-4dannjjm	6663	40	-	-	HYPH
cord-023095-4dannjjm	6663	41	two	two	CD
cord-023095-4dannjjm	6663	42	,	,	,
cord-023095-4dannjjm	6663	43	spayed	spay	VBN
cord-023095-4dannjjm	6663	44	female	female	JJ
cord-023095-4dannjjm	6663	45	dogs	dog	NNS
cord-023095-4dannjjm	6663	46	were	be	VBD
cord-023095-4dannjjm	6663	47	included	include	VBN
cord-023095-4dannjjm	6663	48	.	.	.
cord-023095-4dannjjm	6664	1	Dogs	dog	NNS
cord-023095-4dannjjm	6664	2	had	have	VBD
cord-023095-4dannjjm	6664	3	a	a	DT
cord-023095-4dannjjm	6664	4	median	median	JJ
cord-023095-4dannjjm	6664	5	age	age	NN
cord-023095-4dannjjm	6664	6	of	of	IN
cord-023095-4dannjjm	6664	7	6	6	CD
cord-023095-4dannjjm	6664	8	years	year	NNS
cord-023095-4dannjjm	6664	9	(	(	-LRB-
cord-023095-4dannjjm	6664	10	2	2	CD
cord-023095-4dannjjm	6664	11	to	to	TO
cord-023095-4dannjjm	6664	12	11	11	CD
cord-023095-4dannjjm	6664	13	years	year	NNS
cord-023095-4dannjjm	6664	14	)	)	-RRB-
cord-023095-4dannjjm	6664	15	.	.	.
cord-023095-4dannjjm	6665	1	Eighteen	eighteen	CD
cord-023095-4dannjjm	6665	2	dog	dog	NN
cord-023095-4dannjjm	6665	3	breeds	breed	NNS
cord-023095-4dannjjm	6665	4	were	be	VBD
cord-023095-4dannjjm	6665	5	represented	represent	VBN
cord-023095-4dannjjm	6665	6	,	,	,
cord-023095-4dannjjm	6665	7	and	and	CC
cord-023095-4dannjjm	6665	8	dogs	dog	NNS
cord-023095-4dannjjm	6665	9	weighed	weigh	VBD
cord-023095-4dannjjm	6665	10	a	a	DT
cord-023095-4dannjjm	6665	11	median	median	NN
cord-023095-4dannjjm	6665	12	of	of	IN
cord-023095-4dannjjm	6665	13	29.9	29.9	CD
cord-023095-4dannjjm	6665	14	kg	kg	NNS
cord-023095-4dannjjm	6665	15	(	(	-LRB-
cord-023095-4dannjjm	6665	16	7.3	7.3	CD
cord-023095-4dannjjm	6665	17	to	to	IN
cord-023095-4dannjjm	6665	18	62.7	62.7	CD
cord-023095-4dannjjm	6665	19	kg	kg	NNS
cord-023095-4dannjjm	6665	20	)	)	-RRB-
cord-023095-4dannjjm	6665	21	.	.	.
cord-023095-4dannjjm	6666	1	Average	average	JJ
cord-023095-4dannjjm	6666	2	length	length	NN
cord-023095-4dannjjm	6666	3	of	of	IN
cord-023095-4dannjjm	6666	4	time	time	NN
cord-023095-4dannjjm	6666	5	of	of	IN
cord-023095-4dannjjm	6666	6	UI	UI	NNP
cord-023095-4dannjjm	6666	7	was	be	VBD
cord-023095-4dannjjm	6666	8	2.5	2.5	CD
cord-023095-4dannjjm	6666	9	AE	AE	NNP
cord-023095-4dannjjm	6666	10	2.3	2.3	CD
cord-023095-4dannjjm	6666	11	years	year	NNS
cord-023095-4dannjjm	6666	12	;	;	:
cord-023095-4dannjjm	6666	13	18/22	18/22	CD
cord-023095-4dannjjm	6666	14	dogs	dog	NNS
cord-023095-4dannjjm	6666	15	had	have	VBD
cord-023095-4dannjjm	6666	16	been	be	VBN
cord-023095-4dannjjm	6666	17	treated	treat	VBN
cord-023095-4dannjjm	6666	18	medically	medically	RB
cord-023095-4dannjjm	6666	19	,	,	,
cord-023095-4dannjjm	6666	20	of	of	IN
cord-023095-4dannjjm	6666	21	which	which	WDT
cord-023095-4dannjjm	6666	22	2/18	2/18	CD
cord-023095-4dannjjm	6666	23	were	be	VBD
cord-023095-4dannjjm	6666	24	continent	continent	VBN
cord-023095-4dannjjm	6666	25	,	,	,
cord-023095-4dannjjm	6666	26	14/18	14/18	CD
cord-023095-4dannjjm	6666	27	were	be	VBD
cord-023095-4dannjjm	6666	28	improved	improve	VBN
cord-023095-4dannjjm	6666	29	,	,	,
cord-023095-4dannjjm	6666	30	and	and	CC
cord-023095-4dannjjm	6666	31	2/18	2/18	CD
cord-023095-4dannjjm	6666	32	had	have	VBD
cord-023095-4dannjjm	6666	33	no	no	DT
cord-023095-4dannjjm	6666	34	improvement	improvement	NN
cord-023095-4dannjjm	6666	35	.	.	.
cord-023095-4dannjjm	6667	1	Dogs	dog	NNS
cord-023095-4dannjjm	6667	2	were	be	VBD
cord-023095-4dannjjm	6667	3	deemed	deem	VBN
cord-023095-4dannjjm	6667	4	healthy	healthy	JJ
cord-023095-4dannjjm	6667	5	based	base	VBN
cord-023095-4dannjjm	6667	6	on	on	IN
cord-023095-4dannjjm	6667	7	results	result	NNS
cord-023095-4dannjjm	6667	8	of	of	IN
cord-023095-4dannjjm	6667	9	physical	physical	JJ
cord-023095-4dannjjm	6667	10	examination	examination	NN
cord-023095-4dannjjm	6667	11	,	,	,
cord-023095-4dannjjm	6667	12	complete	complete	JJ
cord-023095-4dannjjm	6667	13	blood	blood	NN
cord-023095-4dannjjm	6667	14	cell	cell	NN
cord-023095-4dannjjm	6667	15	counts	count	NNS
cord-023095-4dannjjm	6667	16	,	,	,
cord-023095-4dannjjm	6667	17	plasma	plasma	NN
cord-023095-4dannjjm	6667	18	biochemical	biochemical	JJ
cord-023095-4dannjjm	6667	19	analysis	analysis	NN
cord-023095-4dannjjm	6667	20	,	,	,
cord-023095-4dannjjm	6667	21	and	and	CC
cord-023095-4dannjjm	6667	22	urinalysis	urinalysis	NN
cord-023095-4dannjjm	6667	23	;	;	:
cord-023095-4dannjjm	6667	24	urine	urine	NN
cord-023095-4dannjjm	6667	25	cultures	culture	NNS
cord-023095-4dannjjm	6667	26	were	be	VBD
cord-023095-4dannjjm	6667	27	negative	negative	JJ
cord-023095-4dannjjm	6667	28	.	.	.
cord-023095-4dannjjm	6668	1	Dogs	dog	NNS
cord-023095-4dannjjm	6668	2	were	be	VBD
cord-023095-4dannjjm	6668	3	anesthetized	anesthetize	VBN
cord-023095-4dannjjm	6668	4	,	,	,
cord-023095-4dannjjm	6668	5	positioned	position	VBN
cord-023095-4dannjjm	6668	6	in	in	IN
cord-023095-4dannjjm	6668	7	dorsal	dorsal	JJ
cord-023095-4dannjjm	6668	8	recumbency	recumbency	NN
cord-023095-4dannjjm	6668	9	,	,	,
cord-023095-4dannjjm	6668	10	and	and	CC
cord-023095-4dannjjm	6668	11	cystoscopy	cystoscopy	NN
cord-023095-4dannjjm	6668	12	performed	perform	VBN
cord-023095-4dannjjm	6668	13	using	use	VBG
cord-023095-4dannjjm	6668	14	a	a	DT
cord-023095-4dannjjm	6668	15	2.7	2.7	CD
cord-023095-4dannjjm	6668	16	mm	mm	NN
cord-023095-4dannjjm	6668	17	,	,	,
cord-023095-4dannjjm	6668	18	0-or	0-or	CD
cord-023095-4dannjjm	6668	19	30-degree	30-degree	CD
cord-023095-4dannjjm	6668	20	,	,	,
cord-023095-4dannjjm	6668	21	18	18	CD
cord-023095-4dannjjm	6668	22	cm	cm	NN
cord-023095-4dannjjm	6668	23	rigid	rigid	JJ
cord-023095-4dannjjm	6668	24	cystoscope	cystoscope	NN
cord-023095-4dannjjm	6668	25	.	.	.
cord-023095-4dannjjm	6669	1	Urethral	urethral	JJ
cord-023095-4dannjjm	6669	2	bulking	bulking	NN
cord-023095-4dannjjm	6669	3	was	be	VBD
cord-023095-4dannjjm	6669	4	performed	perform	VBN
cord-023095-4dannjjm	6669	5	with	with	IN
cord-023095-4dannjjm	6669	6	PDMS	PDMS	NNP
cord-023095-4dannjjm	6669	7	UBA	UBA	NNP
cord-023095-4dannjjm	6669	8	.	.	.
cord-023095-4dannjjm	6670	1	On	on	IN
cord-023095-4dannjjm	6670	2	average	average	JJ
cord-023095-4dannjjm	6670	3	,	,	,
cord-023095-4dannjjm	6670	4	2.5	2.5	CD
cord-023095-4dannjjm	6670	5	AE	AE	NNP
cord-023095-4dannjjm	6670	6	0.9	0.9	CD
cord-023095-4dannjjm	6670	7	ml	ml	NNS
cord-023095-4dannjjm	6670	8	were	be	VBD
cord-023095-4dannjjm	6670	9	injected	inject	VBN
cord-023095-4dannjjm	6670	10	in	in	IN
cord-023095-4dannjjm	6670	11	3	3	CD
cord-023095-4dannjjm	6670	12	to	to	TO
cord-023095-4dannjjm	6670	13	5	5	CD
cord-023095-4dannjjm	6670	14	locations	location	NNS
cord-023095-4dannjjm	6670	15	approximately	approximately	RB
cord-023095-4dannjjm	6670	16	1	1	CD
cord-023095-4dannjjm	6670	17	to	to	IN
cord-023095-4dannjjm	6670	18	1.5	1.5	CD
cord-023095-4dannjjm	6670	19	cm	cm	NNS
cord-023095-4dannjjm	6670	20	distal	distal	JJ
cord-023095-4dannjjm	6670	21	to	to	IN
cord-023095-4dannjjm	6670	22	the	the	DT
cord-023095-4dannjjm	6670	23	trigone	trigone	NN
cord-023095-4dannjjm	6670	24	submucosally	submucosally	RB
cord-023095-4dannjjm	6670	25	in	in	IN
cord-023095-4dannjjm	6670	26	the	the	DT
cord-023095-4dannjjm	6670	27	proximal	proximal	JJ
cord-023095-4dannjjm	6670	28	urethra	urethra	NN
cord-023095-4dannjjm	6670	29	.	.	.
cord-023095-4dannjjm	6671	1	Good	good	JJ
cord-023095-4dannjjm	6671	2	coaptation	coaptation	NN
cord-023095-4dannjjm	6671	3	was	be	VBD
cord-023095-4dannjjm	6671	4	achieved	achieve	VBN
cord-023095-4dannjjm	6671	5	in	in	IN
cord-023095-4dannjjm	6671	6	all	all	DT
cord-023095-4dannjjm	6671	7	dogs	dog	NNS
cord-023095-4dannjjm	6671	8	.	.	.
cord-023095-4dannjjm	6672	1	The	the	DT
cord-023095-4dannjjm	6672	2	procedure	procedure	NN
cord-023095-4dannjjm	6672	3	took	take	VBD
cord-023095-4dannjjm	6672	4	on	on	IN
cord-023095-4dannjjm	6672	5	average	average	JJ
cord-023095-4dannjjm	6672	6	15.9	15.9	CD
cord-023095-4dannjjm	6672	7	AE	AE	NNP
cord-023095-4dannjjm	6672	8	4.3	4.3	CD
cord-023095-4dannjjm	6672	9	minutes	minute	NNS
cord-023095-4dannjjm	6672	10	.	.	.
cord-023095-4dannjjm	6673	1	One	one	CD
cord-023095-4dannjjm	6673	2	dog	dog	NN
cord-023095-4dannjjm	6673	3	experienced	experience	VBD
cord-023095-4dannjjm	6673	4	urethral	urethral	JJ
cord-023095-4dannjjm	6673	5	obstruction	obstruction	NN
cord-023095-4dannjjm	6673	6	after	after	IN
cord-023095-4dannjjm	6673	7	the	the	DT
cord-023095-4dannjjm	6673	8	procedure	procedure	NN
cord-023095-4dannjjm	6673	9	;	;	:
cord-023095-4dannjjm	6673	10	a	a	DT
cord-023095-4dannjjm	6673	11	Foley	Foley	NNP
cord-023095-4dannjjm	6673	12	catheter	catheter	NN
cord-023095-4dannjjm	6673	13	was	be	VBD
cord-023095-4dannjjm	6673	14	inserted	insert	VBN
cord-023095-4dannjjm	6673	15	for	for	IN
cord-023095-4dannjjm	6673	16	approximately	approximately	RB
cord-023095-4dannjjm	6673	17	12	12	CD
cord-023095-4dannjjm	6673	18	hours	hour	NNS
cord-023095-4dannjjm	6673	19	and	and	CC
cord-023095-4dannjjm	6673	20	removed	remove	VBN
cord-023095-4dannjjm	6673	21	at	at	IN
cord-023095-4dannjjm	6673	22	which	which	WDT
cord-023095-4dannjjm	6673	23	time	time	NN
cord-023095-4dannjjm	6673	24	she	-PRON-	PRP
cord-023095-4dannjjm	6673	25	urinated	urinate	VBD
cord-023095-4dannjjm	6673	26	normally	normally	RB
cord-023095-4dannjjm	6673	27	and	and	CC
cord-023095-4dannjjm	6673	28	was	be	VBD
cord-023095-4dannjjm	6673	29	continent	continent	NN
cord-023095-4dannjjm	6673	30	.	.	.
cord-023095-4dannjjm	6674	1	Three	three	CD
cord-023095-4dannjjm	6674	2	dogs	dog	NNS
cord-023095-4dannjjm	6674	3	experienced	experience	VBD
cord-023095-4dannjjm	6674	4	an	an	DT
cord-023095-4dannjjm	6674	5	acute	acute	JJ
cord-023095-4dannjjm	6674	6	allergic	allergic	JJ
cord-023095-4dannjjm	6674	7	reaction	reaction	NN
cord-023095-4dannjjm	6674	8	characterized	characterize	VBN
cord-023095-4dannjjm	6674	9	by	by	IN
cord-023095-4dannjjm	6674	10	blepharedema	blepharedema	NNP
cord-023095-4dannjjm	6674	11	and	and	CC
cord-023095-4dannjjm	6674	12	urticaria	urticaria	NN
cord-023095-4dannjjm	6674	13	treated	treat	VBN
cord-023095-4dannjjm	6674	14	successfully	successfully	RB
cord-023095-4dannjjm	6674	15	with	with	IN
cord-023095-4dannjjm	6674	16	diphenhydramine	diphenhydramine	NN
cord-023095-4dannjjm	6674	17	.	.	.
cord-023095-4dannjjm	6675	1	Dogs	dog	NNS
cord-023095-4dannjjm	6675	2	were	be	VBD
cord-023095-4dannjjm	6675	3	discharged	discharge	VBN
cord-023095-4dannjjm	6675	4	on	on	IN
cord-023095-4dannjjm	6675	5	day	day	NN
cord-023095-4dannjjm	6675	6	of	of	IN
cord-023095-4dannjjm	6675	7	procedure	procedure	NN
cord-023095-4dannjjm	6675	8	except	except	IN
cord-023095-4dannjjm	6675	9	for	for	IN
cord-023095-4dannjjm	6675	10	the	the	DT
cord-023095-4dannjjm	6675	11	one	one	CD
cord-023095-4dannjjm	6675	12	dog	dog	NN
cord-023095-4dannjjm	6675	13	that	that	WDT
cord-023095-4dannjjm	6675	14	experienced	experience	VBD
cord-023095-4dannjjm	6675	15	urethral	urethral	JJ
cord-023095-4dannjjm	6675	16	obstruction	obstruction	NN
cord-023095-4dannjjm	6675	17	.	.	.
cord-023095-4dannjjm	6676	1	All	all	DT
cord-023095-4dannjjm	6676	2	dogs	dog	NNS
cord-023095-4dannjjm	6676	3	were	be	VBD
cord-023095-4dannjjm	6676	4	treated	treat	VBN
cord-023095-4dannjjm	6676	5	with	with	IN
cord-023095-4dannjjm	6676	6	Meloxicam	Meloxicam	NNP
cord-023095-4dannjjm	6676	7	(	(	-LRB-
cord-023095-4dannjjm	6676	8	0.1	0.1	CD
cord-023095-4dannjjm	6676	9	mg	mg	NNP
cord-023095-4dannjjm	6676	10	/	/	SYM
cord-023095-4dannjjm	6676	11	kg	kg	NN
cord-023095-4dannjjm	6676	12	PO	po	NN
cord-023095-4dannjjm	6677	1	q24h	q24h	NNS
cord-023095-4dannjjm	6677	2	for	for	IN
cord-023095-4dannjjm	6677	3	3	3	CD
cord-023095-4dannjjm	6677	4	days).Owners	days).owner	NNS
cord-023095-4dannjjm	6677	5	were	be	VBD
cord-023095-4dannjjm	6677	6	contacted	contact	VBN
cord-023095-4dannjjm	6677	7	on	on	IN
cord-023095-4dannjjm	6677	8	day	day	NN
cord-023095-4dannjjm	6677	9	after	after	IN
cord-023095-4dannjjm	6677	10	discharge	discharge	NN
cord-023095-4dannjjm	6677	11	and	and	CC
cord-023095-4dannjjm	6677	12	21/22	21/22	CD
cord-023095-4dannjjm	6677	13	dogs	dog	NNS
cord-023095-4dannjjm	6677	14	were	be	VBD
cord-023095-4dannjjm	6677	15	continent	continent	NN
cord-023095-4dannjjm	6677	16	;	;	:
cord-023095-4dannjjm	6677	17	1/22	1/22	CD
cord-023095-4dannjjm	6677	18	dogs	dog	NNS
cord-023095-4dannjjm	6677	19	was	be	VBD
cord-023095-4dannjjm	6677	20	improved	improve	VBN
cord-023095-4dannjjm	6677	21	.	.	.
cord-023095-4dannjjm	6678	1	Dogs	dog	NNS
cord-023095-4dannjjm	6678	2	were	be	VBD
cord-023095-4dannjjm	6678	3	re	re	VBN
cord-023095-4dannjjm	6678	4	-	-	VBN
cord-023095-4dannjjm	6678	5	evaluated	evaluate	VBN
cord-023095-4dannjjm	6678	6	1	1	CD
cord-023095-4dannjjm	6678	7	week	week	NN
cord-023095-4dannjjm	6678	8	after	after	IN
cord-023095-4dannjjm	6678	9	discharge	discharge	NN
cord-023095-4dannjjm	6678	10	and	and	CC
cord-023095-4dannjjm	6678	11	21/22	21/22	CD
cord-023095-4dannjjm	6678	12	dogs	dog	NNS
cord-023095-4dannjjm	6678	13	were	be	VBD
cord-023095-4dannjjm	6678	14	continent	continent	NN
cord-023095-4dannjjm	6678	15	and	and	CC
cord-023095-4dannjjm	6678	16	1/22	1/22	CD
cord-023095-4dannjjm	6678	17	dogs	dog	NNS
cord-023095-4dannjjm	6679	1	Polyneuropathy	Polyneuropathy	NNP
cord-023095-4dannjjm	6679	2	in	in	IN
cord-023095-4dannjjm	6679	3	large	large	JJ
cord-023095-4dannjjm	6679	4	breed	breed	NN
cord-023095-4dannjjm	6679	5	dogs	dog	NNS
cord-023095-4dannjjm	6679	6	is	be	VBZ
cord-023095-4dannjjm	6679	7	a	a	DT
cord-023095-4dannjjm	6679	8	relatively	relatively	RB
cord-023095-4dannjjm	6679	9	common	common	JJ
cord-023095-4dannjjm	6679	10	clinical	clinical	JJ
cord-023095-4dannjjm	6679	11	problem	problem	NN
cord-023095-4dannjjm	6679	12	for	for	IN
cord-023095-4dannjjm	6679	13	which	which	WDT
cord-023095-4dannjjm	6679	14	the	the	DT
cord-023095-4dannjjm	6679	15	genetic	genetic	JJ
cord-023095-4dannjjm	6679	16	basis	basis	NN
cord-023095-4dannjjm	6679	17	is	be	VBZ
cord-023095-4dannjjm	6679	18	generally	generally	RB
cord-023095-4dannjjm	6679	19	unknown	unknown	JJ
cord-023095-4dannjjm	6679	20	.	.	.
cord-023095-4dannjjm	6680	1	The	the	DT
cord-023095-4dannjjm	6680	2	first	first	JJ
cord-023095-4dannjjm	6680	3	cases	case	NNS
cord-023095-4dannjjm	6680	4	of	of	IN
cord-023095-4dannjjm	6680	5	polyneuropathy	polyneuropathy	NNS
cord-023095-4dannjjm	6680	6	in	in	IN
cord-023095-4dannjjm	6680	7	the	the	DT
cord-023095-4dannjjm	6680	8	Leonberger	Leonberger	NNP
cord-023095-4dannjjm	6680	9	breed	breed	NN
cord-023095-4dannjjm	6680	10	(	(	-LRB-
cord-023095-4dannjjm	6680	11	Leonberger	Leonberger	NNP
cord-023095-4dannjjm	6680	12	polyneuropathy	polyneuropathy	NNS
cord-023095-4dannjjm	6680	13	or	or	CC
cord-023095-4dannjjm	6680	14	LPN	LPN	NNP
cord-023095-4dannjjm	6680	15	)	)	-RRB-
cord-023095-4dannjjm	6680	16	were	be	VBD
cord-023095-4dannjjm	6680	17	identified	identify	VBN
cord-023095-4dannjjm	6680	18	in	in	IN
cord-023095-4dannjjm	6680	19	1999	1999	CD
cord-023095-4dannjjm	6680	20	by	by	IN
cord-023095-4dannjjm	6680	21	one	one	CD
cord-023095-4dannjjm	6680	22	of	of	IN
cord-023095-4dannjjm	6680	23	the	the	DT
cord-023095-4dannjjm	6680	24	authors	author	NNS
cord-023095-4dannjjm	6680	25	(	(	-LRB-
cord-023095-4dannjjm	6680	26	GDS	GDS	NNP
cord-023095-4dannjjm	6680	27	)	)	-RRB-
cord-023095-4dannjjm	6680	28	and	and	CC
cord-023095-4dannjjm	6680	29	a	a	DT
cord-023095-4dannjjm	6680	30	report	report	NN
cord-023095-4dannjjm	6680	31	published	publish	VBN
cord-023095-4dannjjm	6680	32	in	in	IN
cord-023095-4dannjjm	6680	33	2003	2003	CD
cord-023095-4dannjjm	6680	34	(	(	-LRB-
cord-023095-4dannjjm	6680	35	MuscleNerve	MuscleNerve	NNP
cord-023095-4dannjjm	6680	36	27:471	27:471	CD
cord-023095-4dannjjm	6680	37	-	-	SYM
cord-023095-4dannjjm	6680	38	477	477	CD
cord-023095-4dannjjm	6680	39	)	)	-RRB-
cord-023095-4dannjjm	6680	40	.	.	.
cord-023095-4dannjjm	6681	1	In	in	IN
cord-023095-4dannjjm	6681	2	this	this	DT
cord-023095-4dannjjm	6681	3	report	report	NN
cord-023095-4dannjjm	6681	4	a	a	DT
cord-023095-4dannjjm	6681	5	spontaneous	spontaneous	JJ
cord-023095-4dannjjm	6681	6	,	,	,
cord-023095-4dannjjm	6681	7	distal	distal	JJ
cord-023095-4dannjjm	6681	8	and	and	CC
cord-023095-4dannjjm	6681	9	symmetrical	symmetrical	JJ
cord-023095-4dannjjm	6681	10	polyneuropathy	polyneuropathy	NNS
cord-023095-4dannjjm	6681	11	with	with	IN
cord-023095-4dannjjm	6681	12	onset	onset	NN
cord-023095-4dannjjm	6681	13	between	between	IN
cord-023095-4dannjjm	6681	14	1	1	CD
cord-023095-4dannjjm	6681	15	to	to	TO
cord-023095-4dannjjm	6681	16	9	9	CD
cord-023095-4dannjjm	6681	17	years	year	NNS
cord-023095-4dannjjm	6681	18	of	of	IN
cord-023095-4dannjjm	6681	19	age	age	NN
cord-023095-4dannjjm	6681	20	was	be	VBD
cord-023095-4dannjjm	6681	21	described	describe	VBN
cord-023095-4dannjjm	6681	22	and	and	CC
cord-023095-4dannjjm	6681	23	characterized	characterize	VBN
cord-023095-4dannjjm	6681	24	clinically	clinically	RB
cord-023095-4dannjjm	6681	25	,	,	,
cord-023095-4dannjjm	6681	26	electrophysiologically	electrophysiologically	RB
cord-023095-4dannjjm	6681	27	,	,	,
cord-023095-4dannjjm	6681	28	histologically	histologically	RB
cord-023095-4dannjjm	6681	29	and	and	CC
cord-023095-4dannjjm	6681	30	morphometrically	morphometrically	RB
cord-023095-4dannjjm	6681	31	.	.	.
cord-023095-4dannjjm	6682	1	There	there	EX
cord-023095-4dannjjm	6682	2	were	be	VBD
cord-023095-4dannjjm	6682	3	striking	strike	VBG
cord-023095-4dannjjm	6682	4	similarities	similarity	NNS
cord-023095-4dannjjm	6682	5	between	between	IN
cord-023095-4dannjjm	6682	6	LPN	LPN	NNP
cord-023095-4dannjjm	6682	7	and	and	CC
cord-023095-4dannjjm	6682	8	the	the	DT
cord-023095-4dannjjm	6682	9	Charcot	Charcot	NNP
cord-023095-4dannjjm	6682	10	-	-	HYPH
cord-023095-4dannjjm	6682	11	Marie	Marie	NNP
cord-023095-4dannjjm	6682	12	-	-	HYPH
cord-023095-4dannjjm	6682	13	Tooth	Tooth	NNP
cord-023095-4dannjjm	6682	14	group	group	NN
cord-023095-4dannjjm	6682	15	of	of	IN
cord-023095-4dannjjm	6682	16	human	human	JJ
cord-023095-4dannjjm	6682	17	inherited	inherit	VBN
cord-023095-4dannjjm	6682	18	sensory	sensory	JJ
cord-023095-4dannjjm	6682	19	and	and	CC
cord-023095-4dannjjm	6682	20	motor	motor	NN
cord-023095-4dannjjm	6682	21	polyneuropathies	polyneuropathie	NNS
cord-023095-4dannjjm	6682	22	,	,	,
cord-023095-4dannjjm	6682	23	which	which	WDT
cord-023095-4dannjjm	6682	24	have	have	VBP
cord-023095-4dannjjm	6682	25	many	many	JJ
cord-023095-4dannjjm	6682	26	known	know	VBN
cord-023095-4dannjjm	6682	27	genetic	genetic	JJ
cord-023095-4dannjjm	6682	28	mutations	mutation	NNS
cord-023095-4dannjjm	6682	29	.	.	.
cord-023095-4dannjjm	6683	1	A	a	DT
cord-023095-4dannjjm	6683	2	genome	genome	NN
cord-023095-4dannjjm	6683	3	-	-	HYPH
cord-023095-4dannjjm	6683	4	wide	wide	JJ
cord-023095-4dannjjm	6683	5	case	case	NN
cord-023095-4dannjjm	6683	6	-	-	HYPH
cord-023095-4dannjjm	6683	7	control	control	NN
cord-023095-4dannjjm	6683	8	association	association	NNP
cord-023095-4dannjjm	6683	9	study	study	NN
cord-023095-4dannjjm	6683	10	for	for	IN
cord-023095-4dannjjm	6683	11	LPN	LPN	NNP
cord-023095-4dannjjm	6683	12	was	be	VBD
cord-023095-4dannjjm	6683	13	performed	perform	VBN
cord-023095-4dannjjm	6683	14	with	with	IN
cord-023095-4dannjjm	6683	15	53	53	CD
cord-023095-4dannjjm	6683	16	cases	case	NNS
cord-023095-4dannjjm	6683	17	and	and	CC
cord-023095-4dannjjm	6683	18	42	42	CD
cord-023095-4dannjjm	6683	19	controls	control	NNS
cord-023095-4dannjjm	6683	20	on	on	IN
cord-023095-4dannjjm	6683	21	high	high	JJ
cord-023095-4dannjjm	6683	22	-	-	HYPH
cord-023095-4dannjjm	6683	23	density	density	NN
cord-023095-4dannjjm	6683	24	170	170	CD
cord-023095-4dannjjm	6683	25	K	K	NNP
cord-023095-4dannjjm	6683	26	canine	canine	JJ
cord-023095-4dannjjm	6683	27	SNP	SNP	NNP
cord-023095-4dannjjm	6683	28	arrays	array	NNS
cord-023095-4dannjjm	6683	29	and	and	CC
cord-023095-4dannjjm	6683	30	revealed	reveal	VBD
cord-023095-4dannjjm	6683	31	a	a	DT
cord-023095-4dannjjm	6683	32	significantly	significantly	RB
cord-023095-4dannjjm	6683	33	associated	associate	VBN
cord-023095-4dannjjm	6683	34	region	region	NN
cord-023095-4dannjjm	6683	35	on	on	IN
cord-023095-4dannjjm	6683	36	CFA	CFA	NNP
cord-023095-4dannjjm	6683	37	16	16	CD
cord-023095-4dannjjm	6683	38	(	(	-LRB-
cord-023095-4dannjjm	6683	39	P	p	NN
cord-023095-4dannjjm	6683	40	raw	raw	JJ
cord-023095-4dannjjm	6683	41	5	5	CD
cord-023095-4dannjjm	6683	42	2.36	2.36	CD
cord-023095-4dannjjm	6683	43	Â	â	CD
cord-023095-4dannjjm	6683	44	10	10	CD
cord-023095-4dannjjm	6683	45	À10	À10	NNP
cord-023095-4dannjjm	6683	46	P	p	NN
cord-023095-4dannjjm	6683	47	genome	genome	NN
cord-023095-4dannjjm	6683	48	5	5	CD
cord-023095-4dannjjm	6683	49	9.99	9.99	CD
cord-023095-4dannjjm	6683	50	Â	â	CD
cord-023095-4dannjjm	6683	51	10	10	CD
cord-023095-4dannjjm	6683	52	À5	À5	NNP
cord-023095-4dannjjm	6683	53	)	)	-RRB-
cord-023095-4dannjjm	6683	54	.	.	.
cord-023095-4dannjjm	6684	1	A	a	DT
cord-023095-4dannjjm	6684	2	clear	clear	JJ
cord-023095-4dannjjm	6684	3	association	association	NN
cord-023095-4dannjjm	6684	4	of	of	IN
cord-023095-4dannjjm	6684	5	an	an	DT
cord-023095-4dannjjm	6684	6	approximately	approximately	RB
cord-023095-4dannjjm	6684	7	1	1	CD
cord-023095-4dannjjm	6684	8	Mb	Mb	NNP
cord-023095-4dannjjm	6684	9	CFA16	CFA16	NNP
cord-023095-4dannjjm	6684	10	haplotype	haplotype	NN
cord-023095-4dannjjm	6684	11	with	with	IN
cord-023095-4dannjjm	6684	12	cases	case	NNS
cord-023095-4dannjjm	6684	13	(	(	-LRB-
cord-023095-4dannjjm	6684	14	P	p	NN
cord-023095-4dannjjm	6684	15	5	5	CD
cord-023095-4dannjjm	6684	16	1.71	1.71	CD
cord-023095-4dannjjm	6684	17	Â	â	CD
cord-023095-4dannjjm	6684	18	10	10	CD
cord-023095-4dannjjm	6684	19	À8	à8	CD
cord-023095-4dannjjm	6684	20	)	)	-RRB-
cord-023095-4dannjjm	6684	21	was	be	VBD
cord-023095-4dannjjm	6684	22	observed	observe	VBN
cord-023095-4dannjjm	6684	23	,	,	,
cord-023095-4dannjjm	6684	24	particularly	particularly	RB
cord-023095-4dannjjm	6684	25	with	with	IN
cord-023095-4dannjjm	6684	26	those	those	DT
cord-023095-4dannjjm	6684	27	cases	case	NNS
cord-023095-4dannjjm	6684	28	that	that	WDT
cord-023095-4dannjjm	6684	29	were	be	VBD
cord-023095-4dannjjm	6684	30	affected	affect	VBN
cord-023095-4dannjjm	6684	31	more	more	RBR
cord-023095-4dannjjm	6684	32	severely	severely	RB
cord-023095-4dannjjm	6684	33	and	and	CC
cord-023095-4dannjjm	6684	34	at	at	IN
cord-023095-4dannjjm	6684	35	a	a	DT
cord-023095-4dannjjm	6684	36	younger	young	JJR
cord-023095-4dannjjm	6684	37	age	age	NN
cord-023095-4dannjjm	6684	38	(	(	-LRB-
cord-023095-4dannjjm	6684	39	P	p	NN
cord-023095-4dannjjm	6684	40	5	5	CD
cord-023095-4dannjjm	6684	41	2.55	2.55	CD
cord-023095-4dannjjm	6684	42	Â	â	CD
cord-023095-4dannjjm	6684	43	10	10	CD
cord-023095-4dannjjm	6684	44	À11	À11	NNPS
cord-023095-4dannjjm	6684	45	)	)	-RRB-
cord-023095-4dannjjm	6684	46	.	.	.
cord-023095-4dannjjm	6685	1	A	a	DT
cord-023095-4dannjjm	6685	2	positional	positional	JJ
cord-023095-4dannjjm	6685	3	candidate	candidate	NN
cord-023095-4dannjjm	6685	4	gene	gene	NN
cord-023095-4dannjjm	6685	5	,	,	,
cord-023095-4dannjjm	6685	6	ARHGEF10	ARHGEF10	NNP
cord-023095-4dannjjm	6685	7	,	,	,
cord-023095-4dannjjm	6685	8	which	which	WDT
cord-023095-4dannjjm	6685	9	has	have	VBZ
cord-023095-4dannjjm	6685	10	previously	previously	RB
cord-023095-4dannjjm	6685	11	been	be	VBN
cord-023095-4dannjjm	6685	12	associated	associate	VBN
cord-023095-4dannjjm	6685	13	with	with	IN
cord-023095-4dannjjm	6685	14	peripheral	peripheral	JJ
cord-023095-4dannjjm	6685	15	nerve	nerve	NN
cord-023095-4dannjjm	6685	16	abnormalities	abnormality	NNS
cord-023095-4dannjjm	6685	17	in	in	IN
cord-023095-4dannjjm	6685	18	humans	human	NNS
cord-023095-4dannjjm	6685	19	,	,	,
cord-023095-4dannjjm	6685	20	was	be	VBD
cord-023095-4dannjjm	6685	21	sequenced	sequence	VBN
cord-023095-4dannjjm	6685	22	,	,	,
cord-023095-4dannjjm	6685	23	revealing	reveal	VBG
cord-023095-4dannjjm	6685	24	a	a	DT
cord-023095-4dannjjm	6685	25	deletion	deletion	NN
cord-023095-4dannjjm	6685	26	that	that	WDT
cord-023095-4dannjjm	6685	27	results	result	VBZ
cord-023095-4dannjjm	6685	28	in	in	IN
cord-023095-4dannjjm	6685	29	a	a	DT
cord-023095-4dannjjm	6685	30	frame	frame	NN
cord-023095-4dannjjm	6685	31	shift	shift	NN
cord-023095-4dannjjm	6685	32	and	and	CC
cord-023095-4dannjjm	6685	33	premature	premature	JJ
cord-023095-4dannjjm	6685	34	stop	stop	NN
cord-023095-4dannjjm	6685	35	codon	codon	NN
cord-023095-4dannjjm	6685	36	.	.	.
cord-023095-4dannjjm	6686	1	Of	of	IN
cord-023095-4dannjjm	6686	2	all	all	DT
cord-023095-4dannjjm	6686	3	Leonbergers	Leonbergers	NNPS
cord-023095-4dannjjm	6686	4	with	with	IN
cord-023095-4dannjjm	6686	5	young	young	JJ
cord-023095-4dannjjm	6686	6	onset	onset	NN
cord-023095-4dannjjm	6686	7	LPN	LPN	NNP
cord-023095-4dannjjm	6686	8	(	(	-LRB-
cord-023095-4dannjjm	6686	9	before	before	IN
cord-023095-4dannjjm	6686	10	4	4	CD
cord-023095-4dannjjm	6686	11	years	year	NNS
cord-023095-4dannjjm	6686	12	)	)	-RRB-
cord-023095-4dannjjm	6686	13	,	,	,
cord-023095-4dannjjm	6686	14	48.5	48.5	CD
cord-023095-4dannjjm	6686	15	%	%	NN
cord-023095-4dannjjm	6686	16	(	(	-LRB-
cord-023095-4dannjjm	6686	17	32	32	CD
cord-023095-4dannjjm	6686	18	of	of	IN
cord-023095-4dannjjm	6686	19	66	66	CD
cord-023095-4dannjjm	6686	20	)	)	-RRB-
cord-023095-4dannjjm	6686	21	have	have	VBP
cord-023095-4dannjjm	6686	22	two	two	CD
cord-023095-4dannjjm	6686	23	copies	copy	NNS
cord-023095-4dannjjm	6686	24	of	of	IN
cord-023095-4dannjjm	6686	25	this	this	DT
cord-023095-4dannjjm	6686	26	deletion	deletion	NN
cord-023095-4dannjjm	6686	27	,	,	,
cord-023095-4dannjjm	6686	28	and	and	CC
cord-023095-4dannjjm	6686	29	,	,	,
cord-023095-4dannjjm	6686	30	of	of	IN
cord-023095-4dannjjm	6686	31	all	all	DT
cord-023095-4dannjjm	6686	32	young	young	JJ
cord-023095-4dannjjm	6686	33	onset	onset	NN
cord-023095-4dannjjm	6686	34	Leonbergers	Leonbergers	NNPS
cord-023095-4dannjjm	6686	35	that	that	WDT
cord-023095-4dannjjm	6686	36	are	be	VBP
cord-023095-4dannjjm	6686	37	nerve	nerve	JJ
cord-023095-4dannjjm	6686	38	biopsy	biopsy	NN
cord-023095-4dannjjm	6686	39	positive	positive	JJ
cord-023095-4dannjjm	6686	40	for	for	IN
cord-023095-4dannjjm	6686	41	LPN	LPN	NNP
cord-023095-4dannjjm	6686	42	,	,	,
cord-023095-4dannjjm	6686	43	59.4	59.4	CD
cord-023095-4dannjjm	6686	44	%	%	NN
cord-023095-4dannjjm	6686	45	(	(	-LRB-
cord-023095-4dannjjm	6686	46	19	19	CD
cord-023095-4dannjjm	6686	47	of	of	IN
cord-023095-4dannjjm	6686	48	32	32	CD
cord-023095-4dannjjm	6686	49	)	)	-RRB-
cord-023095-4dannjjm	6686	50	have	have	VBP
cord-023095-4dannjjm	6686	51	two	two	CD
cord-023095-4dannjjm	6686	52	copies	copy	NNS
cord-023095-4dannjjm	6686	53	of	of	IN
cord-023095-4dannjjm	6686	54	this	this	DT
cord-023095-4dannjjm	6686	55	deletion	deletion	NN
cord-023095-4dannjjm	6686	56	.	.	.
cord-023095-4dannjjm	6687	1	Importantly	importantly	RB
cord-023095-4dannjjm	6687	2	,	,	,
cord-023095-4dannjjm	6687	3	nearly	nearly	RB
cord-023095-4dannjjm	6687	4	all	all	DT
cord-023095-4dannjjm	6687	5	dogs	dog	NNS
cord-023095-4dannjjm	6687	6	carrying	carry	VBG
cord-023095-4dannjjm	6687	7	two	two	CD
cord-023095-4dannjjm	6687	8	copies	copy	NNS
cord-023095-4dannjjm	6687	9	of	of	IN
cord-023095-4dannjjm	6687	10	the	the	DT
cord-023095-4dannjjm	6687	11	deletion	deletion	NN
cord-023095-4dannjjm	6687	12	(	(	-LRB-
cord-023095-4dannjjm	6687	13	32	32	CD
cord-023095-4dannjjm	6687	14	of	of	IN
cord-023095-4dannjjm	6687	15	34	34	CD
cord-023095-4dannjjm	6687	16	or	or	CC
cord-023095-4dannjjm	6687	17	94.1	94.1	CD
cord-023095-4dannjjm	6687	18	%	%	NN
cord-023095-4dannjjm	6687	19	)	)	-RRB-
cord-023095-4dannjjm	6687	20	are	be	VBP
cord-023095-4dannjjm	6687	21	affected	affect	VBN
cord-023095-4dannjjm	6687	22	with	with	IN
cord-023095-4dannjjm	6687	23	LPN	LPN	NNP
cord-023095-4dannjjm	6687	24	by	by	IN
cord-023095-4dannjjm	6687	25	the	the	DT
cord-023095-4dannjjm	6687	26	age	age	NN
cord-023095-4dannjjm	6687	27	of	of	IN
cord-023095-4dannjjm	6687	28	4	4	CD
cord-023095-4dannjjm	6687	29	years	year	NNS
cord-023095-4dannjjm	6687	30	.	.	.
cord-023095-4dannjjm	6688	1	The	the	DT
cord-023095-4dannjjm	6688	2	Leonberger	Leonberger	NNP
cord-023095-4dannjjm	6688	3	breed	breed	NN
cord-023095-4dannjjm	6688	4	was	be	VBD
cord-023095-4dannjjm	6688	5	generated	generate	VBN
cord-023095-4dannjjm	6688	6	from	from	IN
cord-023095-4dannjjm	6688	7	crossing	cross	VBG
cord-023095-4dannjjm	6688	8	several	several	JJ
cord-023095-4dannjjm	6688	9	breeds	breed	NNS
cord-023095-4dannjjm	6688	10	,	,	,
cord-023095-4dannjjm	6688	11	including	include	VBG
cord-023095-4dannjjm	6688	12	the	the	DT
cord-023095-4dannjjm	6688	13	St.	St.	NNP
cord-023095-4dannjjm	6688	14	Bernard	Bernard	NNP
cord-023095-4dannjjm	6688	15	,	,	,
cord-023095-4dannjjm	6688	16	and	and	CC
cord-023095-4dannjjm	6688	17	a	a	DT
cord-023095-4dannjjm	6688	18	polyneuropathy	polyneuropathy	NN
cord-023095-4dannjjm	6688	19	clinically	clinically	RB
cord-023095-4dannjjm	6688	20	and	and	CC
cord-023095-4dannjjm	6688	21	histologically	histologically	RB
cord-023095-4dannjjm	6688	22	similar	similar	JJ
cord-023095-4dannjjm	6688	23	to	to	IN
cord-023095-4dannjjm	6688	24	LPN	LPN	NNP
cord-023095-4dannjjm	6688	25	occurs	occur	VBZ
cord-023095-4dannjjm	6688	26	in	in	IN
cord-023095-4dannjjm	6688	27	this	this	DT
cord-023095-4dannjjm	6688	28	breed	breed	NN
cord-023095-4dannjjm	6688	29	.	.	.
cord-023095-4dannjjm	6689	1	To	to	TO
cord-023095-4dannjjm	6689	2	determine	determine	VB
cord-023095-4dannjjm	6689	3	if	if	IN
cord-023095-4dannjjm	6689	4	the	the	DT
cord-023095-4dannjjm	6689	5	ARHGEF10	ARHGEF10	NNP
cord-023095-4dannjjm	6689	6	mutation	mutation	NN
cord-023095-4dannjjm	6689	7	was	be	VBD
cord-023095-4dannjjm	6689	8	associated	associate	VBN
cord-023095-4dannjjm	6689	9	with	with	IN
cord-023095-4dannjjm	6689	10	polyneuropathy	polyneuropathy	NNS
cord-023095-4dannjjm	6689	11	in	in	IN
cord-023095-4dannjjm	6689	12	the	the	DT
cord-023095-4dannjjm	6689	13	St.	St.	NNP
cord-023095-4dannjjm	6689	14	Bernard	Bernard	NNP
cord-023095-4dannjjm	6689	15	,	,	,
cord-023095-4dannjjm	6689	16	DNA	DNA	NNP
cord-023095-4dannjjm	6689	17	was	be	VBD
cord-023095-4dannjjm	6689	18	extracted	extract	VBN
cord-023095-4dannjjm	6689	19	from	from	IN
cord-023095-4dannjjm	6689	20	archived	archived	JJ
cord-023095-4dannjjm	6689	21	frozen	frozen	JJ
cord-023095-4dannjjm	6689	22	muscle	muscle	NN
cord-023095-4dannjjm	6689	23	biopsy	biopsy	NN
cord-023095-4dannjjm	6689	24	specimens	specimen	NNS
cord-023095-4dannjjm	6689	25	from	from	IN
cord-023095-4dannjjm	6689	26	clinical	clinical	JJ
cord-023095-4dannjjm	6689	27	cases	case	NNS
cord-023095-4dannjjm	6689	28	(	(	-LRB-
cord-023095-4dannjjm	6689	29	n	n	NN
cord-023095-4dannjjm	6689	30	5	5	CD
cord-023095-4dannjjm	6689	31	3	3	CD
cord-023095-4dannjjm	6689	32	)	)	-RRB-
cord-023095-4dannjjm	6689	33	.	.	.
cord-023095-4dannjjm	6690	1	The	the	DT
cord-023095-4dannjjm	6690	2	identical	identical	JJ
cord-023095-4dannjjm	6690	3	ARHGEF10	arhgef10	NN
cord-023095-4dannjjm	6690	4	Startle	startle	VB
cord-023095-4dannjjm	6690	5	disease	disease	NN
cord-023095-4dannjjm	6690	6	or	or	CC
cord-023095-4dannjjm	6690	7	hyperekplexia	hyperekplexia	NN
cord-023095-4dannjjm	6690	8	is	be	VBZ
cord-023095-4dannjjm	6690	9	caused	cause	VBN
cord-023095-4dannjjm	6690	10	by	by	IN
cord-023095-4dannjjm	6690	11	defects	defect	NNS
cord-023095-4dannjjm	6690	12	in	in	IN
cord-023095-4dannjjm	6690	13	mammalian	mammalian	JJ
cord-023095-4dannjjm	6690	14	glycinergic	glycinergic	JJ
cord-023095-4dannjjm	6690	15	neurotransmission	neurotransmission	NN
cord-023095-4dannjjm	6690	16	resulting	result	VBG
cord-023095-4dannjjm	6690	17	in	in	IN
cord-023095-4dannjjm	6690	18	an	an	DT
cord-023095-4dannjjm	6690	19	exaggerated	exaggerated	JJ
cord-023095-4dannjjm	6690	20	startle	startle	VB
cord-023095-4dannjjm	6690	21	reflex	reflex	NN
cord-023095-4dannjjm	6690	22	and	and	CC
cord-023095-4dannjjm	6690	23	extensor	extensor	JJ
cord-023095-4dannjjm	6690	24	hypertonia	hypertonia	NNP
cord-023095-4dannjjm	6690	25	triggered	trigger	VBN
cord-023095-4dannjjm	6690	26	by	by	IN
cord-023095-4dannjjm	6690	27	noise	noise	NN
cord-023095-4dannjjm	6690	28	or	or	CC
cord-023095-4dannjjm	6690	29	touch	touch	NN
cord-023095-4dannjjm	6690	30	.	.	.
cord-023095-4dannjjm	6691	1	In	in	IN
cord-023095-4dannjjm	6691	2	humans	human	NNS
cord-023095-4dannjjm	6691	3	and	and	CC
cord-023095-4dannjjm	6691	4	animals	animal	NNS
cord-023095-4dannjjm	6691	5	,	,	,
cord-023095-4dannjjm	6691	6	startle	startle	VB
cord-023095-4dannjjm	6691	7	disease	disease	NN
cord-023095-4dannjjm	6691	8	is	be	VBZ
cord-023095-4dannjjm	6691	9	typically	typically	RB
cord-023095-4dannjjm	6691	10	caused	cause	VBN
cord-023095-4dannjjm	6691	11	by	by	IN
cord-023095-4dannjjm	6691	12	mutations	mutation	NNS
cord-023095-4dannjjm	6691	13	in	in	IN
cord-023095-4dannjjm	6691	14	one	one	CD
cord-023095-4dannjjm	6691	15	of	of	IN
cord-023095-4dannjjm	6691	16	three	three	CD
cord-023095-4dannjjm	6691	17	genes	gene	NNS
cord-023095-4dannjjm	6691	18	(	(	-LRB-
cord-023095-4dannjjm	6691	19	GLRA1	GLRA1	NNP
cord-023095-4dannjjm	6691	20	,	,	,
cord-023095-4dannjjm	6691	21	GLRB	GLRB	NNP
cord-023095-4dannjjm	6691	22	,	,	,
cord-023095-4dannjjm	6691	23	and	and	CC
cord-023095-4dannjjm	6691	24	SLC6A5	slc6a5	NN
cord-023095-4dannjjm	6691	25	)	)	-RRB-
cord-023095-4dannjjm	6691	26	encoding	encode	VBG
cord-023095-4dannjjm	6691	27	postsynaptic	postsynaptic	JJ
cord-023095-4dannjjm	6691	28	glycine	glycine	NN
cord-023095-4dannjjm	6691	29	receptor	receptor	NN
cord-023095-4dannjjm	6691	30	subunits	subunit	NNS
cord-023095-4dannjjm	6691	31	(	(	-LRB-
cord-023095-4dannjjm	6691	32	a1	a1	NNP
cord-023095-4dannjjm	6691	33	and	and	CC
cord-023095-4dannjjm	6691	34	b	b	NNP
cord-023095-4dannjjm	6691	35	)	)	-RRB-
cord-023095-4dannjjm	6691	36	or	or	CC
cord-023095-4dannjjm	6691	37	a	a	DT
cord-023095-4dannjjm	6691	38	presynaptic	presynaptic	JJ
cord-023095-4dannjjm	6691	39	glycine	glycine	NN
cord-023095-4dannjjm	6691	40	transporter	transporter	NN
cord-023095-4dannjjm	6691	41	(	(	-LRB-
cord-023095-4dannjjm	6691	42	GlyT2	GlyT2	NNP
cord-023095-4dannjjm	6691	43	)	)	-RRB-
cord-023095-4dannjjm	6691	44	.	.	.
cord-023095-4dannjjm	6692	1	A	a	DT
cord-023095-4dannjjm	6692	2	litter	litter	NN
cord-023095-4dannjjm	6692	3	of	of	IN
cord-023095-4dannjjm	6692	4	seven	seven	CD
cord-023095-4dannjjm	6692	5	Irish	irish	JJ
cord-023095-4dannjjm	6692	6	Wolfhounds	Wolfhounds	NNPS
cord-023095-4dannjjm	6692	7	was	be	VBD
cord-023095-4dannjjm	6692	8	recently	recently	RB
cord-023095-4dannjjm	6692	9	identified	identify	VBN
cord-023095-4dannjjm	6692	10	in	in	IN
cord-023095-4dannjjm	6692	11	which	which	WDT
cord-023095-4dannjjm	6692	12	two	two	CD
cord-023095-4dannjjm	6692	13	puppies	puppy	NNS
cord-023095-4dannjjm	6692	14	developed	develop	VBD
cord-023095-4dannjjm	6692	15	muscle	muscle	NN
cord-023095-4dannjjm	6692	16	stiffness	stiffness	NN
cord-023095-4dannjjm	6692	17	and	and	CC
cord-023095-4dannjjm	6692	18	tremor	tremor	NN
cord-023095-4dannjjm	6692	19	beginning	begin	VBG
cord-023095-4dannjjm	6692	20	at	at	IN
cord-023095-4dannjjm	6692	21	5	5	CD
cord-023095-4dannjjm	6692	22	-	-	SYM
cord-023095-4dannjjm	6692	23	7	7	CD
cord-023095-4dannjjm	6692	24	days	day	NNS
cord-023095-4dannjjm	6692	25	of	of	IN
cord-023095-4dannjjm	6692	26	age	age	NN
cord-023095-4dannjjm	6692	27	post	post	NN
cord-023095-4dannjjm	6692	28	-	-	NN
cord-023095-4dannjjm	6692	29	partum	partum	JJ
cord-023095-4dannjjm	6692	30	.	.	.
cord-023095-4dannjjm	6693	1	Signs	sign	NNS
cord-023095-4dannjjm	6693	2	were	be	VBD
cord-023095-4dannjjm	6693	3	dramatic	dramatic	JJ
cord-023095-4dannjjm	6693	4	when	when	WRB
cord-023095-4dannjjm	6693	5	the	the	DT
cord-023095-4dannjjm	6693	6	puppies	puppy	NNS
cord-023095-4dannjjm	6693	7	were	be	VBD
cord-023095-4dannjjm	6693	8	handled	handle	VBN
cord-023095-4dannjjm	6693	9	and	and	CC
cord-023095-4dannjjm	6693	10	resolved	resolve	VBN
cord-023095-4dannjjm	6693	11	when	when	WRB
cord-023095-4dannjjm	6693	12	the	the	DT
cord-023095-4dannjjm	6693	13	puppies	puppy	NNS
cord-023095-4dannjjm	6693	14	were	be	VBD
cord-023095-4dannjjm	6693	15	relaxed	relaxed	JJ
cord-023095-4dannjjm	6693	16	or	or	CC
cord-023095-4dannjjm	6693	17	sleeping	sleep	VBG
cord-023095-4dannjjm	6693	18	.	.	.
cord-023095-4dannjjm	6694	1	Both	both	DT
cord-023095-4dannjjm	6694	2	puppies	puppy	NNS
cord-023095-4dannjjm	6694	3	were	be	VBD
cord-023095-4dannjjm	6694	4	euthanized	euthanize	VBN
cord-023095-4dannjjm	6694	5	due	due	IN
cord-023095-4dannjjm	6694	6	to	to	IN
cord-023095-4dannjjm	6694	7	ongoing	ongoing	JJ
cord-023095-4dannjjm	6694	8	stiffness	stiffness	NN
cord-023095-4dannjjm	6694	9	,	,	,
cord-023095-4dannjjm	6694	10	tremor	tremor	NN
cord-023095-4dannjjm	6694	11	and	and	CC
cord-023095-4dannjjm	6694	12	breathing	breathing	NN
cord-023095-4dannjjm	6694	13	difficulties	difficulty	NNS
cord-023095-4dannjjm	6694	14	.	.	.
cord-023095-4dannjjm	6695	1	Necropsies	Necropsies	NNP
cord-023095-4dannjjm	6695	2	were	be	VBD
cord-023095-4dannjjm	6695	3	performed	perform	VBN
cord-023095-4dannjjm	6695	4	,	,	,
cord-023095-4dannjjm	6695	5	but	but	CC
cord-023095-4dannjjm	6695	6	no	no	DT
cord-023095-4dannjjm	6695	7	microscopic	microscopic	JJ
cord-023095-4dannjjm	6695	8	pathological	pathological	JJ
cord-023095-4dannjjm	6695	9	abnormalities	abnormality	NNS
cord-023095-4dannjjm	6695	10	were	be	VBD
cord-023095-4dannjjm	6695	11	identified	identify	VBN
cord-023095-4dannjjm	6695	12	in	in	IN
cord-023095-4dannjjm	6695	13	the	the	DT
cord-023095-4dannjjm	6695	14	peripheral	peripheral	JJ
cord-023095-4dannjjm	6695	15	or	or	CC
cord-023095-4dannjjm	6695	16	central	central	JJ
cord-023095-4dannjjm	6695	17	nervous	nervous	JJ
cord-023095-4dannjjm	6695	18	system	system	NN
cord-023095-4dannjjm	6695	19	.	.	.
cord-023095-4dannjjm	6696	1	Based	base	VBN
cord-023095-4dannjjm	6696	2	on	on	IN
cord-023095-4dannjjm	6696	3	the	the	DT
cord-023095-4dannjjm	6696	4	clinical	clinical	JJ
cord-023095-4dannjjm	6696	5	signs	sign	NNS
cord-023095-4dannjjm	6696	6	,	,	,
cord-023095-4dannjjm	6696	7	exons	exon	NNS
cord-023095-4dannjjm	6696	8	from	from	IN
cord-023095-4dannjjm	6696	9	the	the	DT
cord-023095-4dannjjm	6696	10	three	three	CD
cord-023095-4dannjjm	6696	11	candidate	candidate	NN
cord-023095-4dannjjm	6696	12	genes	gene	NNS
cord-023095-4dannjjm	6696	13	were	be	VBD
cord-023095-4dannjjm	6696	14	amplified	amplify	VBN
cord-023095-4dannjjm	6696	15	from	from	IN
cord-023095-4dannjjm	6696	16	genomic	genomic	JJ
cord-023095-4dannjjm	6696	17	DNA	dna	NN
cord-023095-4dannjjm	6696	18	isolated	isolate	VBN
cord-023095-4dannjjm	6696	19	using	use	VBG
cord-023095-4dannjjm	6696	20	PCR	PCR	NNP
cord-023095-4dannjjm	6696	21	and	and	CC
cord-023095-4dannjjm	6696	22	directly	directly	RB
cord-023095-4dannjjm	6696	23	sequenced	sequence	VBN
cord-023095-4dannjjm	6696	24	.	.	.
cord-023095-4dannjjm	6697	1	No	no	DT
cord-023095-4dannjjm	6697	2	deleterious	deleterious	JJ
cord-023095-4dannjjm	6697	3	polymorphisms	polymorphism	NNS
cord-023095-4dannjjm	6697	4	were	be	VBD
cord-023095-4dannjjm	6697	5	identified	identify	VBN
cord-023095-4dannjjm	6697	6	in	in	IN
cord-023095-4dannjjm	6697	7	either	either	CC
cord-023095-4dannjjm	6697	8	GLRA1	GLRA1	NNP
cord-023095-4dannjjm	6697	9	or	or	CC
cord-023095-4dannjjm	6697	10	GLRB	GLRB	NNP
cord-023095-4dannjjm	6697	11	.	.	.
cord-023095-4dannjjm	6698	1	However	however	RB
cord-023095-4dannjjm	6698	2	,	,	,
cord-023095-4dannjjm	6698	3	difficulties	difficulty	NNS
cord-023095-4dannjjm	6698	4	were	be	VBD
cord-023095-4dannjjm	6698	5	experienced	experience	VBN
cord-023095-4dannjjm	6698	6	in	in	IN
cord-023095-4dannjjm	6698	7	amplifying	amplify	VBG
cord-023095-4dannjjm	6698	8	SLC6A5	SLC6A5	NNP
cord-023095-4dannjjm	6698	9	exons	exon	NNS
cord-023095-4dannjjm	6698	10	2	2	CD
cord-023095-4dannjjm	6698	11	and	and	CC
cord-023095-4dannjjm	6698	12	3	3	CD
cord-023095-4dannjjm	6698	13	from	from	IN
cord-023095-4dannjjm	6698	14	affected	affected	JJ
cord-023095-4dannjjm	6698	15	animals	animal	NNS
cord-023095-4dannjjm	6698	16	,	,	,
cord-023095-4dannjjm	6698	17	although	although	IN
cord-023095-4dannjjm	6698	18	control	control	NN
cord-023095-4dannjjm	6698	19	samples	sample	NNS
cord-023095-4dannjjm	6698	20	were	be	VBD
cord-023095-4dannjjm	6698	21	positive	positive	JJ
cord-023095-4dannjjm	6698	22	,	,	,
cord-023095-4dannjjm	6698	23	suggesting	suggest	VBG
cord-023095-4dannjjm	6698	24	that	that	IN
cord-023095-4dannjjm	6698	25	the	the	DT
cord-023095-4dannjjm	6698	26	PCR	PCR	NNP
cord-023095-4dannjjm	6698	27	primer	primer	NN
cord-023095-4dannjjm	6698	28	designs	design	NNS
cord-023095-4dannjjm	6698	29	and	and	CC
cord-023095-4dannjjm	6698	30	conditions	condition	NNS
cord-023095-4dannjjm	6698	31	were	be	VBD
cord-023095-4dannjjm	6698	32	not	not	RB
cord-023095-4dannjjm	6698	33	at	at	IN
cord-023095-4dannjjm	6698	34	fault	fault	NN
cord-023095-4dannjjm	6698	35	.	.	.
cord-023095-4dannjjm	6699	1	Further	further	JJ
cord-023095-4dannjjm	6699	2	PCRs	pcr	NNS
cord-023095-4dannjjm	6699	3	revealed	reveal	VBD
cord-023095-4dannjjm	6699	4	that	that	IN
cord-023095-4dannjjm	6699	5	the	the	DT
cord-023095-4dannjjm	6699	6	reason	reason	NN
cord-023095-4dannjjm	6699	7	for	for	IN
cord-023095-4dannjjm	6699	8	this	this	DT
cord-023095-4dannjjm	6699	9	anomaly	anomaly	NN
cord-023095-4dannjjm	6699	10	was	be	VBD
cord-023095-4dannjjm	6699	11	the	the	DT
cord-023095-4dannjjm	6699	12	presence	presence	NN
cord-023095-4dannjjm	6699	13	of	of	IN
cord-023095-4dannjjm	6699	14	a	a	DT
cord-023095-4dannjjm	6699	15	homozygous	homozygous	JJ
cord-023095-4dannjjm	6699	16	4.2	4.2	CD
cord-023095-4dannjjm	6699	17	kb	kb	NNP
cord-023095-4dannjjm	6699	18	deletion	deletion	NN
cord-023095-4dannjjm	6699	19	encompassing	encompass	VBG
cord-023095-4dannjjm	6699	20	exons	exon	NNS
cord-023095-4dannjjm	6699	21	2	2	CD
cord-023095-4dannjjm	6699	22	and	and	CC
cord-023095-4dannjjm	6699	23	3	3	CD
cord-023095-4dannjjm	6699	24	of	of	IN
cord-023095-4dannjjm	6699	25	the	the	DT
cord-023095-4dannjjm	6699	26	GlyT2	GlyT2	NNP
cord-023095-4dannjjm	6699	27	gene	gene	NN
cord-023095-4dannjjm	6699	28	in	in	IN
cord-023095-4dannjjm	6699	29	both	both	CC
cord-023095-4dannjjm	6699	30	affected	affect	VBN
cord-023095-4dannjjm	6699	31	animals	animal	NNS
cord-023095-4dannjjm	6699	32	.	.	.
cord-023095-4dannjjm	6700	1	This	this	DT
cord-023095-4dannjjm	6700	2	deletion	deletion	NN
cord-023095-4dannjjm	6700	3	is	be	VBZ
cord-023095-4dannjjm	6700	4	predicted	predict	VBN
cord-023095-4dannjjm	6700	5	to	to	TO
cord-023095-4dannjjm	6700	6	result	result	VB
cord-023095-4dannjjm	6700	7	in	in	IN
cord-023095-4dannjjm	6700	8	the	the	DT
cord-023095-4dannjjm	6700	9	loss	loss	NN
cord-023095-4dannjjm	6700	10	of	of	IN
cord-023095-4dannjjm	6700	11	part	part	NN
cord-023095-4dannjjm	6700	12	of	of	IN
cord-023095-4dannjjm	6700	13	the	the	DT
cord-023095-4dannjjm	6700	14	large	large	JJ
cord-023095-4dannjjm	6700	15	cytoplasmic	cytoplasmic	JJ
cord-023095-4dannjjm	6700	16	N	n	NN
cord-023095-4dannjjm	6700	17	-	-	HYPH
cord-023095-4dannjjm	6700	18	terminus	terminus	NN
cord-023095-4dannjjm	6700	19	that	that	WDT
cord-023095-4dannjjm	6700	20	is	be	VBZ
cord-023095-4dannjjm	6700	21	vital	vital	JJ
cord-023095-4dannjjm	6700	22	for	for	IN
cord-023095-4dannjjm	6700	23	trafficking	trafficking	NN
cord-023095-4dannjjm	6700	24	of	of	IN
cord-023095-4dannjjm	6700	25	GlyT2	GlyT2	NNP
cord-023095-4dannjjm	6700	26	to	to	IN
cord-023095-4dannjjm	6700	27	synaptic	synaptic	JJ
cord-023095-4dannjjm	6700	28	sites	site	NNS
cord-023095-4dannjjm	6700	29	,	,	,
cord-023095-4dannjjm	6700	30	and	and	CC
cord-023095-4dannjjm	6700	31	a	a	DT
cord-023095-4dannjjm	6700	32	loss	loss	NN
cord-023095-4dannjjm	6700	33	of	of	IN
cord-023095-4dannjjm	6700	34	all	all	DT
cord-023095-4dannjjm	6700	35	subsequent	subsequent	JJ
cord-023095-4dannjjm	6700	36	transmembrane	transmembrane	NN
cord-023095-4dannjjm	6700	37	domains	domain	NNS
cord-023095-4dannjjm	6700	38	via	via	IN
cord-023095-4dannjjm	6700	39	a	a	DT
cord-023095-4dannjjm	6700	40	frameshift	frameshift	NN
cord-023095-4dannjjm	6700	41	.	.	.
cord-023095-4dannjjm	6701	1	This	this	DT
cord-023095-4dannjjm	6701	2	genetic	genetic	JJ
cord-023095-4dannjjm	6701	3	lesion	lesion	NN
cord-023095-4dannjjm	6701	4	was	be	VBD
cord-023095-4dannjjm	6701	5	confirmed	confirm	VBN
cord-023095-4dannjjm	6701	6	by	by	IN
cord-023095-4dannjjm	6701	7	defining	define	VBG
cord-023095-4dannjjm	6701	8	the	the	DT
cord-023095-4dannjjm	6701	9	deletion	deletion	NN
cord-023095-4dannjjm	6701	10	breakpoint	breakpoint	NN
cord-023095-4dannjjm	6701	11	,	,	,
cord-023095-4dannjjm	6701	12	Southern	southern	JJ
cord-023095-4dannjjm	6701	13	blotting	blotting	NN
cord-023095-4dannjjm	6701	14	and	and	CC
cord-023095-4dannjjm	6701	15	Multiplex	Multiplex	NNP
cord-023095-4dannjjm	6701	16	Ligationdependent	Ligationdependent	NNP
cord-023095-4dannjjm	6701	17	Probe	Probe	NNP
cord-023095-4dannjjm	6701	18	Amplification	Amplification	NNP
cord-023095-4dannjjm	6701	19	(	(	-LRB-
cord-023095-4dannjjm	6701	20	MLPA	MLPA	NNP
cord-023095-4dannjjm	6701	21	)	)	-RRB-
cord-023095-4dannjjm	6701	22	.	.	.
cord-023095-4dannjjm	6702	1	This	this	DT
cord-023095-4dannjjm	6702	2	analysis	analysis	NN
cord-023095-4dannjjm	6702	3	enabled	enable	VBD
cord-023095-4dannjjm	6702	4	the	the	DT
cord-023095-4dannjjm	6702	5	development	development	NN
cord-023095-4dannjjm	6702	6	of	of	IN
cord-023095-4dannjjm	6702	7	a	a	DT
cord-023095-4dannjjm	6702	8	rapid	rapid	JJ
cord-023095-4dannjjm	6702	9	genotyping	genotyping	NN
cord-023095-4dannjjm	6702	10	test	test	NN
cord-023095-4dannjjm	6702	11	that	that	WDT
cord-023095-4dannjjm	6702	12	revealed	reveal	VBD
cord-023095-4dannjjm	6702	13	heterozygosity	heterozygosity	NN
cord-023095-4dannjjm	6702	14	for	for	IN
cord-023095-4dannjjm	6702	15	the	the	DT
cord-023095-4dannjjm	6702	16	deletion	deletion	NN
cord-023095-4dannjjm	6702	17	in	in	IN
cord-023095-4dannjjm	6702	18	the	the	DT
cord-023095-4dannjjm	6702	19	dam	dam	NN
cord-023095-4dannjjm	6702	20	and	and	CC
cord-023095-4dannjjm	6702	21	sire	sire	JJ
cord-023095-4dannjjm	6702	22	and	and	CC
cord-023095-4dannjjm	6702	23	three	three	CD
cord-023095-4dannjjm	6702	24	other	other	JJ
cord-023095-4dannjjm	6702	25	siblings	sibling	NNS
cord-023095-4dannjjm	6702	26	,	,	,
cord-023095-4dannjjm	6702	27	suggesting	suggest	VBG
cord-023095-4dannjjm	6702	28	recessive	recessive	JJ
cord-023095-4dannjjm	6702	29	inheritance	inheritance	NN
cord-023095-4dannjjm	6702	30	of	of	IN
cord-023095-4dannjjm	6702	31	this	this	DT
cord-023095-4dannjjm	6702	32	disorder	disorder	NN
cord-023095-4dannjjm	6702	33	.	.	.
cord-023095-4dannjjm	6703	1	Wider	wide	JJR
cord-023095-4dannjjm	6703	2	testing	testing	NN
cord-023095-4dannjjm	6703	3	of	of	IN
cord-023095-4dannjjm	6703	4	related	related	JJ
cord-023095-4dannjjm	6703	5	animals	animal	NNS
cord-023095-4dannjjm	6703	6	has	have	VBZ
cord-023095-4dannjjm	6703	7	identified	identify	VBN
cord-023095-4dannjjm	6703	8	a	a	DT
cord-023095-4dannjjm	6703	9	total	total	NN
cord-023095-4dannjjm	6703	10	of	of	IN
cord-023095-4dannjjm	6703	11	18	18	CD
cord-023095-4dannjjm	6703	12	carriers	carrier	NNS
cord-023095-4dannjjm	6703	13	of	of	IN
cord-023095-4dannjjm	6703	14	the	the	DT
cord-023095-4dannjjm	6703	15	SLC6A5	SLC6A5	NNP
cord-023095-4dannjjm	6703	16	deletion	deletion	NN
cord-023095-4dannjjm	6703	17	and	and	CC
cord-023095-4dannjjm	6703	18	enabled	enable	VBD
cord-023095-4dannjjm	6703	19	the	the	DT
cord-023095-4dannjjm	6703	20	identification	identification	NN
cord-023095-4dannjjm	6703	21	of	of	IN
cord-023095-4dannjjm	6703	22	non	non	JJ
cord-023095-4dannjjm	6703	23	-	-	JJ
cord-023095-4dannjjm	6703	24	carrier	carrier	JJ
cord-023095-4dannjjm	6703	25	animals	animal	NNS
cord-023095-4dannjjm	6703	26	to	to	TO
cord-023095-4dannjjm	6703	27	guide	guide	VB
cord-023095-4dannjjm	6703	28	future	future	JJ
cord-023095-4dannjjm	6703	29	breeding	breeding	NN
cord-023095-4dannjjm	6703	30	strategies	strategy	NNS
cord-023095-4dannjjm	6703	31	.	.	.
cord-023095-4dannjjm	6704	1	Insulin	insulin	NN
cord-023095-4dannjjm	6704	2	resistance	resistance	NN
cord-023095-4dannjjm	6704	3	(	(	-LRB-
cord-023095-4dannjjm	6704	4	IR	IR	NNP
cord-023095-4dannjjm	6704	5	)	)	-RRB-
cord-023095-4dannjjm	6704	6	,	,	,
cord-023095-4dannjjm	6704	7	obesity	obesity	NN
cord-023095-4dannjjm	6704	8	,	,	,
cord-023095-4dannjjm	6704	9	and	and	CC
cord-023095-4dannjjm	6704	10	type	type	NN
cord-023095-4dannjjm	6704	11	2	2	CD
cord-023095-4dannjjm	6704	12	diabetes	diabetes	NN
cord-023095-4dannjjm	6704	13	affect	affect	VBP
cord-023095-4dannjjm	6704	14	glucagon	glucagon	NN
cord-023095-4dannjjm	6704	15	-	-	HYPH
cord-023095-4dannjjm	6704	16	like	like	JJ
cord-023095-4dannjjm	6704	17	peptide	peptide	NN
cord-023095-4dannjjm	6704	18	1	1	CD
cord-023095-4dannjjm	6704	19	(	(	-LRB-
cord-023095-4dannjjm	6704	20	GLP-1	GLP-1	NNP
cord-023095-4dannjjm	6704	21	)	)	-RRB-
cord-023095-4dannjjm	6704	22	concentrations	concentration	NNS
cord-023095-4dannjjm	6704	23	in	in	IN
cord-023095-4dannjjm	6704	24	humans	human	NNS
cord-023095-4dannjjm	6704	25	and	and	CC
cord-023095-4dannjjm	6704	26	rodents	rodent	NNS
cord-023095-4dannjjm	6704	27	,	,	,
cord-023095-4dannjjm	6704	28	but	but	CC
cord-023095-4dannjjm	6704	29	this	this	DT
cord-023095-4dannjjm	6704	30	incretin	incretin	NNP
cord-023095-4dannjjm	6704	31	hormone	hormone	NN
cord-023095-4dannjjm	6704	32	has	have	VBZ
cord-023095-4dannjjm	6704	33	not	not	RB
cord-023095-4dannjjm	6704	34	been	be	VBN
cord-023095-4dannjjm	6704	35	examined	examine	VBN
cord-023095-4dannjjm	6704	36	in	in	IN
cord-023095-4dannjjm	6704	37	horses	horse	NNS
cord-023095-4dannjjm	6704	38	.	.	.
cord-023095-4dannjjm	6705	1	We	-PRON-	PRP
cord-023095-4dannjjm	6705	2	therefore	therefore	RB
cord-023095-4dannjjm	6705	3	hypothesized	hypothesize	VBD
cord-023095-4dannjjm	6705	4	that	that	IN
cord-023095-4dannjjm	6705	5	GLP-1	glp-1	JJ
cord-023095-4dannjjm	6705	6	concentrations	concentration	NNS
cord-023095-4dannjjm	6705	7	would	would	MD
cord-023095-4dannjjm	6705	8	change	change	VB
cord-023095-4dannjjm	6705	9	in	in	IN
cord-023095-4dannjjm	6705	10	horses	horse	NNS
cord-023095-4dannjjm	6705	11	as	as	IN
cord-023095-4dannjjm	6705	12	obesity	obesity	NN
cord-023095-4dannjjm	6705	13	and	and	CC
cord-023095-4dannjjm	6705	14	IR	IR	NNP
cord-023095-4dannjjm	6705	15	were	be	VBD
cord-023095-4dannjjm	6705	16	induced	induce	VBN
cord-023095-4dannjjm	6705	17	or	or	CC
cord-023095-4dannjjm	6705	18	exacerbated	exacerbate	VBN
cord-023095-4dannjjm	6705	19	by	by	IN
cord-023095-4dannjjm	6705	20	overfeeding	overfeed	VBG
cord-023095-4dannjjm	6705	21	.	.	.
cord-023095-4dannjjm	6706	1	Six	six	CD
cord-023095-4dannjjm	6706	2	horses	horse	NNS
cord-023095-4dannjjm	6706	3	previously	previously	RB
cord-023095-4dannjjm	6706	4	diagnosed	diagnose	VBN
cord-023095-4dannjjm	6706	5	with	with	IN
cord-023095-4dannjjm	6706	6	Equine	Equine	NNP
cord-023095-4dannjjm	6706	7	Metabolic	Metabolic	NNP
cord-023095-4dannjjm	6706	8	Syndrome	Syndrome	NNP
cord-023095-4dannjjm	6706	9	were	be	VBD
cord-023095-4dannjjm	6706	10	provided	provide	VBN
cord-023095-4dannjjm	6706	11	with	with	IN
cord-023095-4dannjjm	6706	12	twice	twice	PDT
cord-023095-4dannjjm	6706	13	the	the	DT
cord-023095-4dannjjm	6706	14	amount	amount	NN
cord-023095-4dannjjm	6706	15	of	of	IN
cord-023095-4dannjjm	6706	16	digestible	digestible	JJ
cord-023095-4dannjjm	6706	17	energy	energy	NN
cord-023095-4dannjjm	6706	18	required	require	VBN
cord-023095-4dannjjm	6706	19	for	for	IN
cord-023095-4dannjjm	6706	20	maintenance	maintenance	NN
cord-023095-4dannjjm	6706	21	as	as	IN
cord-023095-4dannjjm	6706	22	sweet	sweet	JJ
cord-023095-4dannjjm	6706	23	feed	feed	NN
cord-023095-4dannjjm	6706	24	and	and	CC
cord-023095-4dannjjm	6706	25	hay	hay	NN
cord-023095-4dannjjm	6706	26	for	for	IN
cord-023095-4dannjjm	6706	27	8	8	CD
cord-023095-4dannjjm	6706	28	weeks	week	NNS
cord-023095-4dannjjm	6706	29	.	.	.
cord-023095-4dannjjm	6707	1	Intravenous	intravenous	JJ
cord-023095-4dannjjm	6707	2	and	and	CC
cord-023095-4dannjjm	6707	3	oral	oral	JJ
cord-023095-4dannjjm	6707	4	glucose	glucose	NN
cord-023095-4dannjjm	6707	5	tolerance	tolerance	NN
cord-023095-4dannjjm	6707	6	tests	test	NNS
cord-023095-4dannjjm	6707	7	(	(	-LRB-
cord-023095-4dannjjm	6707	8	OGTTs	OGTTs	NNP
cord-023095-4dannjjm	6707	9	)	)	-RRB-
cord-023095-4dannjjm	6707	10	were	be	VBD
cord-023095-4dannjjm	6707	11	performed	perform	VBN
cord-023095-4dannjjm	6707	12	at	at	IN
cord-023095-4dannjjm	6707	13	0	0	CD
cord-023095-4dannjjm	6707	14	and	and	CC
cord-023095-4dannjjm	6707	15	8	8	CD
cord-023095-4dannjjm	6707	16	weeks	week	NNS
cord-023095-4dannjjm	6707	17	.	.	.
cord-023095-4dannjjm	6708	1	Effects	effect	NNS
cord-023095-4dannjjm	6708	2	of	of	IN
cord-023095-4dannjjm	6708	3	time	time	NN
cord-023095-4dannjjm	6708	4	and	and	CC
cord-023095-4dannjjm	6708	5	period	period	NN
cord-023095-4dannjjm	6708	6	(	(	-LRB-
cord-023095-4dannjjm	6708	7	0	0	CD
cord-023095-4dannjjm	6708	8	and	and	CC
cord-023095-4dannjjm	6708	9	8	8	CD
cord-023095-4dannjjm	6708	10	weeks	week	NNS
cord-023095-4dannjjm	6708	11	)	)	-RRB-
cord-023095-4dannjjm	6708	12	were	be	VBD
cord-023095-4dannjjm	6708	13	assessed	assess	VBN
cord-023095-4dannjjm	6708	14	by	by	IN
cord-023095-4dannjjm	6708	15	repeated	repeat	VBN
cord-023095-4dannjjm	6708	16	measures	measure	NNS
cord-023095-4dannjjm	6708	17	ANOVA.Mean	ANOVA.Mean	NNP
cord-023095-4dannjjm	6708	18	body	body	NN
cord-023095-4dannjjm	6708	19	weight	weight	NN
cord-023095-4dannjjm	6708	20	increased	increase	VBD
cord-023095-4dannjjm	6708	21	from	from	IN
cord-023095-4dannjjm	6708	22	438	438	CD
cord-023095-4dannjjm	6708	23	AE	AE	NNP
cord-023095-4dannjjm	6708	24	61	61	CD
cord-023095-4dannjjm	6708	25	kg	kg	NN
cord-023095-4dannjjm	6708	26	(	(	-LRB-
cord-023095-4dannjjm	6708	27	range	range	NN
cord-023095-4dannjjm	6708	28	,	,	,
cord-023095-4dannjjm	6708	29	381	381	CD
cord-023095-4dannjjm	6708	30	to	to	TO
cord-023095-4dannjjm	6708	31	533	533	CD
cord-023095-4dannjjm	6708	32	kg	kg	NNS
cord-023095-4dannjjm	6708	33	)	)	-RRB-
cord-023095-4dannjjm	6708	34	to	to	IN
cord-023095-4dannjjm	6708	35	464	464	CD
cord-023095-4dannjjm	6708	36	AE	AE	NNP
cord-023095-4dannjjm	6708	37	61	61	CD
cord-023095-4dannjjm	6708	38	kg	kg	NN
cord-023095-4dannjjm	6708	39	(	(	-LRB-
cord-023095-4dannjjm	6708	40	range	range	NN
cord-023095-4dannjjm	6708	41	,	,	,
cord-023095-4dannjjm	6708	42	394	394	CD
cord-023095-4dannjjm	6708	43	to	to	TO
cord-023095-4dannjjm	6708	44	550	550	CD
cord-023095-4dannjjm	6708	45	kg	kg	NNS
cord-023095-4dannjjm	6708	46	)	)	-RRB-
cord-023095-4dannjjm	6708	47	over	over	IN
cord-023095-4dannjjm	6708	48	8	8	CD
cord-023095-4dannjjm	6708	49	weeks	week	NNS
cord-023095-4dannjjm	6708	50	,	,	,
cord-023095-4dannjjm	6708	51	with	with	IN
cord-023095-4dannjjm	6708	52	individual	individual	JJ
cord-023095-4dannjjm	6708	53	horse	horse	NN
cord-023095-4dannjjm	6708	54	weight	weight	NN
cord-023095-4dannjjm	6708	55	gain	gain	NN
cord-023095-4dannjjm	6708	56	varying	vary	VBG
cord-023095-4dannjjm	6708	57	from	from	IN
cord-023095-4dannjjm	6708	58	2	2	CD
cord-023095-4dannjjm	6708	59	to	to	TO
cord-023095-4dannjjm	6708	60	10	10	CD
cord-023095-4dannjjm	6708	61	%	%	NN
cord-023095-4dannjjm	6708	62	.	.	.
cord-023095-4dannjjm	6709	1	Mean	mean	JJ
cord-023095-4dannjjm	6709	2	body	body	NN
cord-023095-4dannjjm	6709	3	condition	condition	NN
cord-023095-4dannjjm	6709	4	score	score	NN
cord-023095-4dannjjm	6709	5	increased	increase	VBD
cord-023095-4dannjjm	6709	6	(	(	-LRB-
cord-023095-4dannjjm	6709	7	P	p	NN
cord-023095-4dannjjm	6709	8	5	5	CD
cord-023095-4dannjjm	6709	9	0.006	0.006	CD
cord-023095-4dannjjm	6709	10	)	)	-RRB-
cord-023095-4dannjjm	6709	11	from	from	IN
cord-023095-4dannjjm	6709	12	6	6	CD
cord-023095-4dannjjm	6709	13	AE	AE	NNP
cord-023095-4dannjjm	6709	14	2	2	CD
cord-023095-4dannjjm	6709	15	(	(	-LRB-
cord-023095-4dannjjm	6709	16	range	range	NN
cord-023095-4dannjjm	6709	17	,	,	,
cord-023095-4dannjjm	6709	18	4	4	CD
cord-023095-4dannjjm	6709	19	to	to	IN
cord-023095-4dannjjm	6709	20	8.5	8.5	CD
cord-023095-4dannjjm	6709	21	)	)	-RRB-
cord-023095-4dannjjm	6709	22	to	to	IN
cord-023095-4dannjjm	6709	23	8	8	CD
cord-023095-4dannjjm	6709	24	AE	AE	NNP
cord-023095-4dannjjm	6709	25	1	1	CD
cord-023095-4dannjjm	6709	26	(	(	-LRB-
cord-023095-4dannjjm	6709	27	range	range	NN
cord-023095-4dannjjm	6709	28	,	,	,
cord-023095-4dannjjm	6709	29	7	7	CD
cord-023095-4dannjjm	6709	30	to	to	TO
cord-023095-4dannjjm	6709	31	9	9	CD
cord-023095-4dannjjm	6709	32	)	)	-RRB-
cord-023095-4dannjjm	6709	33	.	.	.
cord-023095-4dannjjm	6710	1	Three	three	CD
cord-023095-4dannjjm	6710	2	horses	horse	NNS
cord-023095-4dannjjm	6710	3	developed	develop	VBD
cord-023095-4dannjjm	6710	4	mild	mild	JJ
cord-023095-4dannjjm	6710	5	laminitis	laminitis	NN
cord-023095-4dannjjm	6710	6	.	.	.
cord-023095-4dannjjm	6711	1	Glucagon	Glucagon	NNP
cord-023095-4dannjjm	6711	2	-	-	HYPH
cord-023095-4dannjjm	6711	3	like	like	JJ
cord-023095-4dannjjm	6711	4	peptide	peptide	NN
cord-023095-4dannjjm	6711	5	1	1	CD
cord-023095-4dannjjm	6711	6	concentrations	concentration	NNS
cord-023095-4dannjjm	6711	7	increased	increase	VBD
cord-023095-4dannjjm	6711	8	over	over	IN
cord-023095-4dannjjm	6711	9	time	time	NN
cord-023095-4dannjjm	6711	10	during	during	IN
cord-023095-4dannjjm	6711	11	OGTTs	ogtt	NNS
cord-023095-4dannjjm	6711	12	(	(	-LRB-
cord-023095-4dannjjm	6711	13	P	p	NN
cord-023095-4dannjjm	6711	14	5	5	CD
cord-023095-4dannjjm	6711	15	0.023	0.023	CD
cord-023095-4dannjjm	6711	16	)	)	-RRB-
cord-023095-4dannjjm	6711	17	,	,	,
cord-023095-4dannjjm	6711	18	but	but	CC
cord-023095-4dannjjm	6711	19	the	the	DT
cord-023095-4dannjjm	6711	20	period	period	NN
cord-023095-4dannjjm	6711	21	Â	â	CD
cord-023095-4dannjjm	6711	22	time	time	NN
cord-023095-4dannjjm	6711	23	effect	effect	NN
cord-023095-4dannjjm	6711	24	was	be	VBD
cord-023095-4dannjjm	6711	25	not	not	RB
cord-023095-4dannjjm	6711	26	significant	significant	JJ
cord-023095-4dannjjm	6712	1	(	(	-LRB-
cord-023095-4dannjjm	6712	2	P	p	NN
cord-023095-4dannjjm	6712	3	5	5	CD
cord-023095-4dannjjm	6712	4	0.141	0.141	CD
cord-023095-4dannjjm	6712	5	)	)	-RRB-
cord-023095-4dannjjm	6712	6	.	.	.
cord-023095-4dannjjm	6713	1	Area	area	NN
cord-023095-4dannjjm	6713	2	under	under	IN
cord-023095-4dannjjm	6713	3	the	the	DT
cord-023095-4dannjjm	6713	4	GLP-1	glp-1	JJ
cord-023095-4dannjjm	6713	5	curve	curve	NN
cord-023095-4dannjjm	6713	6	remained	remain	VBD
cord-023095-4dannjjm	6713	7	unaffected	unaffected	JJ
cord-023095-4dannjjm	6713	8	by	by	IN
cord-023095-4dannjjm	6713	9	weight	weight	NN
cord-023095-4dannjjm	6713	10	gain	gain	NN
cord-023095-4dannjjm	6713	11	,	,	,
cord-023095-4dannjjm	6713	12	whereas	whereas	IN
cord-023095-4dannjjm	6713	13	area	area	NN
cord-023095-4dannjjm	6713	14	under	under	IN
cord-023095-4dannjjm	6713	15	the	the	DT
cord-023095-4dannjjm	6713	16	insulin	insulin	NN
cord-023095-4dannjjm	6713	17	curve	curve	NN
cord-023095-4dannjjm	6713	18	increased	increase	VBD
cord-023095-4dannjjm	6713	19	(	(	-LRB-
cord-023095-4dannjjm	6713	20	P	p	NN
cord-023095-4dannjjm	6713	21	5	5	CD
cord-023095-4dannjjm	6713	22	0.003	0.003	CD
cord-023095-4dannjjm	6713	23	)	)	-RRB-
cord-023095-4dannjjm	6713	24	over	over	IN
cord-023095-4dannjjm	6713	25	time	time	NN
cord-023095-4dannjjm	6713	26	,	,	,
cord-023095-4dannjjm	6713	27	indicating	indicate	VBG
cord-023095-4dannjjm	6713	28	a	a	DT
cord-023095-4dannjjm	6713	29	reduction	reduction	NN
cord-023095-4dannjjm	6713	30	in	in	IN
cord-023095-4dannjjm	6713	31	insulin	insulin	NN
cord-023095-4dannjjm	6713	32	sensitivity	sensitivity	NN
cord-023095-4dannjjm	6713	33	.	.	.
cord-023095-4dannjjm	6714	1	Obesity	obesity	NN
cord-023095-4dannjjm	6714	2	and	and	CC
cord-023095-4dannjjm	6714	3	IR	IR	NNP
cord-023095-4dannjjm	6714	4	were	be	VBD
cord-023095-4dannjjm	6714	5	induced	induce	VBN
cord-023095-4dannjjm	6714	6	or	or	CC
cord-023095-4dannjjm	6714	7	exacerbated	exacerbate	VBN
cord-023095-4dannjjm	6714	8	when	when	WRB
cord-023095-4dannjjm	6714	9	horses	horse	NNS
cord-023095-4dannjjm	6714	10	previously	previously	RB
cord-023095-4dannjjm	6714	11	diagnosed	diagnose	VBN
cord-023095-4dannjjm	6714	12	with	with	IN
cord-023095-4dannjjm	6714	13	EMS	EMS	NNP
cord-023095-4dannjjm	6714	14	were	be	VBD
cord-023095-4dannjjm	6714	15	overfed	overfed	JJ
cord-023095-4dannjjm	6714	16	,	,	,
cord-023095-4dannjjm	6714	17	but	but	CC
cord-023095-4dannjjm	6714	18	GLP-1	glp-1	JJ
cord-023095-4dannjjm	6714	19	concentrations	concentration	NNS
cord-023095-4dannjjm	6714	20	did	do	VBD
cord-023095-4dannjjm	6714	21	not	not	RB
cord-023095-4dannjjm	6714	22	change	change	VB
cord-023095-4dannjjm	6714	23	as	as	IN
cord-023095-4dannjjm	6714	24	a	a	DT
cord-023095-4dannjjm	6714	25	result	result	NN
cord-023095-4dannjjm	6714	26	.	.	.
cord-023095-4dannjjm	6715	1	Hypertonic	Hypertonic	NNP
cord-023095-4dannjjm	6715	2	saline	saline	NN
cord-023095-4dannjjm	6715	3	solution	solution	NN
cord-023095-4dannjjm	6715	4	(	(	-LRB-
cord-023095-4dannjjm	6715	5	7.2	7.2	CD
cord-023095-4dannjjm	6715	6	%	%	NN
cord-023095-4dannjjm	6715	7	)	)	-RRB-
cord-023095-4dannjjm	6715	8	(	(	-LRB-
cord-023095-4dannjjm	6715	9	HSS	HSS	NNP
cord-023095-4dannjjm	6715	10	)	)	-RRB-
cord-023095-4dannjjm	6715	11	is	be	VBZ
cord-023095-4dannjjm	6715	12	an	an	DT
cord-023095-4dannjjm	6715	13	intravenous	intravenous	JJ
cord-023095-4dannjjm	6715	14	fluid	fluid	NN
cord-023095-4dannjjm	6715	15	used	use	VBN
cord-023095-4dannjjm	6715	16	for	for	IN
cord-023095-4dannjjm	6715	17	the	the	DT
cord-023095-4dannjjm	6715	18	emergency	emergency	NN
cord-023095-4dannjjm	6715	19	treatment	treatment	NN
cord-023095-4dannjjm	6715	20	of	of	IN
cord-023095-4dannjjm	6715	21	intravascular	intravascular	JJ
cord-023095-4dannjjm	6715	22	volume	volume	NN
cord-023095-4dannjjm	6715	23	deficits	deficit	NNS
cord-023095-4dannjjm	6715	24	.	.	.
cord-023095-4dannjjm	6716	1	The	the	DT
cord-023095-4dannjjm	6716	2	use	use	NN
cord-023095-4dannjjm	6716	3	of	of	IN
cord-023095-4dannjjm	6716	4	this	this	DT
cord-023095-4dannjjm	6716	5	fluid	fluid	NN
cord-023095-4dannjjm	6716	6	in	in	IN
cord-023095-4dannjjm	6716	7	horses	horse	NNS
cord-023095-4dannjjm	6716	8	with	with	IN
cord-023095-4dannjjm	6716	9	severe	severe	JJ
cord-023095-4dannjjm	6716	10	dehydration	dehydration	NN
cord-023095-4dannjjm	6716	11	is	be	VBZ
cord-023095-4dannjjm	6716	12	controversial	controversial	JJ
cord-023095-4dannjjm	6716	13	.	.	.
cord-023095-4dannjjm	6717	1	The	the	DT
cord-023095-4dannjjm	6717	2	purpose	purpose	NN
cord-023095-4dannjjm	6717	3	of	of	IN
cord-023095-4dannjjm	6717	4	this	this	DT
cord-023095-4dannjjm	6717	5	study	study	NN
cord-023095-4dannjjm	6717	6	was	be	VBD
cord-023095-4dannjjm	6717	7	to	to	TO
cord-023095-4dannjjm	6717	8	compare	compare	VB
cord-023095-4dannjjm	6717	9	the	the	DT
cord-023095-4dannjjm	6717	10	use	use	NN
cord-023095-4dannjjm	6717	11	of	of	IN
cord-023095-4dannjjm	6717	12	HSS	hss	NN
cord-023095-4dannjjm	6717	13	and	and	CC
cord-023095-4dannjjm	6717	14	isotonic	isotonic	JJ
cord-023095-4dannjjm	6717	15	saline	saline	NN
cord-023095-4dannjjm	6717	16	solution	solution	NN
cord-023095-4dannjjm	6717	17	(	(	-LRB-
cord-023095-4dannjjm	6717	18	0.9	0.9	CD
cord-023095-4dannjjm	6717	19	%	%	NN
cord-023095-4dannjjm	6717	20	)	)	-RRB-
cord-023095-4dannjjm	6718	1	(	(	-LRB-
cord-023095-4dannjjm	6718	2	ISS	ISS	NNP
cord-023095-4dannjjm	6718	3	)	)	-RRB-
cord-023095-4dannjjm	6718	4	for	for	IN
cord-023095-4dannjjm	6718	5	the	the	DT
cord-023095-4dannjjm	6718	6	emergency	emergency	NN
cord-023095-4dannjjm	6718	7	treatment	treatment	NN
cord-023095-4dannjjm	6718	8	of	of	IN
cord-023095-4dannjjm	6718	9	endurance	endurance	NN
cord-023095-4dannjjm	6718	10	horses	horse	NNS
cord-023095-4dannjjm	6718	11	.	.	.
cord-023095-4dannjjm	6719	1	Endurance	endurance	NN
cord-023095-4dannjjm	6719	2	horses	horse	NNS
cord-023095-4dannjjm	6719	3	eliminated	eliminate	VBN
cord-023095-4dannjjm	6719	4	from	from	IN
cord-023095-4dannjjm	6719	5	competition	competition	NN
cord-023095-4dannjjm	6719	6	and	and	CC
cord-023095-4dannjjm	6719	7	requiring	require	VBG
cord-023095-4dannjjm	6719	8	intravenous	intravenous	JJ
cord-023095-4dannjjm	6719	9	fluid	fluid	NN
cord-023095-4dannjjm	6719	10	therapy	therapy	NN
cord-023095-4dannjjm	6719	11	were	be	VBD
cord-023095-4dannjjm	6719	12	eligible	eligible	JJ
cord-023095-4dannjjm	6719	13	for	for	IN
cord-023095-4dannjjm	6719	14	enrollment	enrollment	NN
cord-023095-4dannjjm	6719	15	in	in	IN
cord-023095-4dannjjm	6719	16	the	the	DT
cord-023095-4dannjjm	6719	17	study	study	NN
cord-023095-4dannjjm	6719	18	.	.	.
cord-023095-4dannjjm	6720	1	Twenty	twenty	CD
cord-023095-4dannjjm	6720	2	-	-	HYPH
cord-023095-4dannjjm	6720	3	two	two	CD
cord-023095-4dannjjm	6720	4	horses	horse	NNS
cord-023095-4dannjjm	6720	5	were	be	VBD
cord-023095-4dannjjm	6720	6	randomly	randomly	RB
cord-023095-4dannjjm	6720	7	assigned	assign	VBN
cord-023095-4dannjjm	6720	8	to	to	TO
cord-023095-4dannjjm	6720	9	receive	receive	VB
cord-023095-4dannjjm	6720	10	4	4	CD
cord-023095-4dannjjm	6720	11	ml	ml	NNS
cord-023095-4dannjjm	6720	12	/	/	SYM
cord-023095-4dannjjm	6720	13	kg	kg	NNS
cord-023095-4dannjjm	6720	14	of	of	IN
cord-023095-4dannjjm	6720	15	either	either	DT
cord-023095-4dannjjm	6720	16	HSS	HSS	NNP
cord-023095-4dannjjm	6720	17	or	or	CC
cord-023095-4dannjjm	6720	18	ISS	ISS	NNP
cord-023095-4dannjjm	6720	19	along	along	IN
cord-023095-4dannjjm	6720	20	with	with	IN
cord-023095-4dannjjm	6720	21	5	5	CD
cord-023095-4dannjjm	6720	22	L	l	NN
cord-023095-4dannjjm	6720	23	lactate	lactate	NN
cord-023095-4dannjjm	6720	24	Ringer	Ringer	NNP
cord-023095-4dannjjm	6720	25	's	's	POS
cord-023095-4dannjjm	6720	26	solution	solution	NN
cord-023095-4dannjjm	6720	27	(	(	-LRB-
cord-023095-4dannjjm	6720	28	LRS	LRS	NNP
cord-023095-4dannjjm	6720	29	)	)	-RRB-
cord-023095-4dannjjm	6720	30	.	.	.
cord-023095-4dannjjm	6721	1	Following	follow	VBG
cord-023095-4dannjjm	6721	2	this	this	DT
cord-023095-4dannjjm	6721	3	bolus	bolus	NN
cord-023095-4dannjjm	6721	4	,	,	,
cord-023095-4dannjjm	6721	5	all	all	DT
cord-023095-4dannjjm	6721	6	horses	horse	NNS
cord-023095-4dannjjm	6721	7	were	be	VBD
cord-023095-4dannjjm	6721	8	treated	treat	VBN
cord-023095-4dannjjm	6721	9	with	with	IN
cord-023095-4dannjjm	6721	10	an	an	DT
cord-023095-4dannjjm	6721	11	additional	additional	JJ
cord-023095-4dannjjm	6721	12	10L	10l	NN
cord-023095-4dannjjm	6721	13	of	of	IN
cord-023095-4dannjjm	6721	14	LRS	LRS	NNP
cord-023095-4dannjjm	6721	15	.	.	.
cord-023095-4dannjjm	6722	1	Blood	blood	NN
cord-023095-4dannjjm	6722	2	and	and	CC
cord-023095-4dannjjm	6722	3	urine	urine	NN
cord-023095-4dannjjm	6722	4	samples	sample	NNS
cord-023095-4dannjjm	6722	5	were	be	VBD
cord-023095-4dannjjm	6722	6	collected	collect	VBN
cord-023095-4dannjjm	6722	7	before	before	RB
cord-023095-4dannjjm	6722	8	,	,	,
cord-023095-4dannjjm	6722	9	during	during	IN
cord-023095-4dannjjm	6722	10	and	and	CC
cord-023095-4dannjjm	6722	11	after	after	IN
cord-023095-4dannjjm	6722	12	treatment	treatment	NN
cord-023095-4dannjjm	6722	13	.	.	.
cord-023095-4dannjjm	6723	1	Data	datum	NNS
cord-023095-4dannjjm	6723	2	was	be	VBD
cord-023095-4dannjjm	6723	3	compared	compare	VBN
cord-023095-4dannjjm	6723	4	using	use	VBG
cord-023095-4dannjjm	6723	5	two	two	CD
cord-023095-4dannjjm	6723	6	-	-	HYPH
cord-023095-4dannjjm	6723	7	way	way	NN
cord-023095-4dannjjm	6723	8	ANOVA	anova	NN
cord-023095-4dannjjm	6723	9	with	with	IN
cord-023095-4dannjjm	6723	10	repeated	repeat	VBN
cord-023095-4dannjjm	6723	11	measures	measure	NNS
cord-023095-4dannjjm	6723	12	.	.	.
cord-023095-4dannjjm	6724	1	As	as	IN
cord-023095-4dannjjm	6724	2	compared	compare	VBN
cord-023095-4dannjjm	6724	3	to	to	IN
cord-023095-4dannjjm	6724	4	ISS	ISS	NNP
cord-023095-4dannjjm	6724	5	,	,	,
cord-023095-4dannjjm	6724	6	HSS	HSS	NNP
cord-023095-4dannjjm	6724	7	horses	horse	NNS
cord-023095-4dannjjm	6724	8	showed	show	VBD
cord-023095-4dannjjm	6724	9	a	a	DT
cord-023095-4dannjjm	6724	10	greater	great	JJR
cord-023095-4dannjjm	6724	11	decrease	decrease	NN
cord-023095-4dannjjm	6724	12	in	in	IN
cord-023095-4dannjjm	6724	13	PCV	pcv	NN
cord-023095-4dannjjm	6724	14	(	(	-LRB-
cord-023095-4dannjjm	6724	15	p	p	NN
cord-023095-4dannjjm	6724	16	5	5	CD
cord-023095-4dannjjm	6724	17	0.04	0.04	CD
cord-023095-4dannjjm	6724	18	)	)	-RRB-
cord-023095-4dannjjm	6724	19	,	,	,
cord-023095-4dannjjm	6724	20	total	total	JJ
cord-023095-4dannjjm	6724	21	protein	protein	NN
cord-023095-4dannjjm	6724	22	(	(	-LRB-
cord-023095-4dannjjm	6724	23	p	p	NN
cord-023095-4dannjjm	6724	24	5	5	CD
cord-023095-4dannjjm	6724	25	0.01	0.01	CD
cord-023095-4dannjjm	6724	26	)	)	-RRB-
cord-023095-4dannjjm	6724	27	,	,	,
cord-023095-4dannjjm	6724	28	albumin	albumin	NN
cord-023095-4dannjjm	6724	29	(	(	-LRB-
cord-023095-4dannjjm	6724	30	p	p	NN
cord-023095-4dannjjm	6724	31	5	5	CD
cord-023095-4dannjjm	6724	32	0.01	0.01	CD
cord-023095-4dannjjm	6724	33	)	)	-RRB-
cord-023095-4dannjjm	6724	34	,	,	,
cord-023095-4dannjjm	6724	35	and	and	CC
cord-023095-4dannjjm	6724	36	globulin	globulin	NN
cord-023095-4dannjjm	6724	37	(	(	-LRB-
cord-023095-4dannjjm	6724	38	p	p	NN
cord-023095-4dannjjm	6724	39	5	5	CD
cord-023095-4dannjjm	6724	40	0.02	0.02	CD
cord-023095-4dannjjm	6724	41	)	)	-RRB-
cord-023095-4dannjjm	6724	42	.	.	.
cord-023095-4dannjjm	6725	1	HSS	HSS	NNP
cord-023095-4dannjjm	6725	2	horses	horse	NNS
cord-023095-4dannjjm	6725	3	showed	show	VBD
cord-023095-4dannjjm	6725	4	a	a	DT
cord-023095-4dannjjm	6725	5	greater	great	JJR
cord-023095-4dannjjm	6725	6	increase	increase	NN
cord-023095-4dannjjm	6725	7	in	in	IN
cord-023095-4dannjjm	6725	8	sodium	sodium	NN
cord-023095-4dannjjm	6725	9	and	and	CC
cord-023095-4dannjjm	6725	10	chloride	chloride	NN
cord-023095-4dannjjm	6725	11	(	(	-LRB-
cord-023095-4dannjjm	6725	12	p	p	NN
cord-023095-4dannjjm	6725	13	o	o	NN
cord-023095-4dannjjm	6725	14	0.001	0.001	CD
cord-023095-4dannjjm	6725	15	)	)	-RRB-
cord-023095-4dannjjm	6725	16	as	as	IN
cord-023095-4dannjjm	6725	17	compared	compare	VBN
cord-023095-4dannjjm	6725	18	to	to	IN
cord-023095-4dannjjm	6725	19	ISS	ISS	NNP
cord-023095-4dannjjm	6725	20	horses	horse	NNS
cord-023095-4dannjjm	6725	21	.	.	.
cord-023095-4dannjjm	6726	1	Horses	horse	NNS
cord-023095-4dannjjm	6726	2	receiving	receive	VBG
cord-023095-4dannjjm	6726	3	HSS	HSS	NNP
cord-023095-4dannjjm	6726	4	had	have	VBD
cord-023095-4dannjjm	6726	5	a	a	DT
cord-023095-4dannjjm	6726	6	shorter	short	JJR
cord-023095-4dannjjm	6726	7	time	time	NN
cord-023095-4dannjjm	6726	8	to	to	IN
cord-023095-4dannjjm	6726	9	urination	urination	NN
cord-023095-4dannjjm	6726	10	(	(	-LRB-
cord-023095-4dannjjm	6726	11	p	p	NN
cord-023095-4dannjjm	6726	12	5	5	CD
cord-023095-4dannjjm	6726	13	0.03	0.03	CD
cord-023095-4dannjjm	6726	14	)	)	-RRB-
cord-023095-4dannjjm	6726	15	and	and	CC
cord-023095-4dannjjm	6726	16	lower	lower	VB
cord-023095-4dannjjm	6726	17	specific	specific	JJ
cord-023095-4dannjjm	6726	18	gravity	gravity	NN
cord-023095-4dannjjm	6726	19	(	(	-LRB-
cord-023095-4dannjjm	6726	20	p	p	NN
cord-023095-4dannjjm	6726	21	o	o	NN
cord-023095-4dannjjm	6726	22	0.001	0.001	CD
cord-023095-4dannjjm	6726	23	)	)	-RRB-
cord-023095-4dannjjm	6726	24	than	than	IN
cord-023095-4dannjjm	6726	25	those	those	DT
cord-023095-4dannjjm	6726	26	receiving	receive	VBG
cord-023095-4dannjjm	6726	27	ISS.Results	iss.results	XX
cord-023095-4dannjjm	6726	28	of	of	IN
cord-023095-4dannjjm	6726	29	this	this	DT
cord-023095-4dannjjm	6726	30	study	study	NN
cord-023095-4dannjjm	6726	31	indicate	indicate	VBP
cord-023095-4dannjjm	6726	32	that	that	IN
cord-023095-4dannjjm	6726	33	HSS	HSS	NNP
cord-023095-4dannjjm	6726	34	may	may	MD
cord-023095-4dannjjm	6726	35	provide	provide	VB
cord-023095-4dannjjm	6726	36	faster	fast	JJR
cord-023095-4dannjjm	6726	37	restoration	restoration	NN
cord-023095-4dannjjm	6726	38	of	of	IN
cord-023095-4dannjjm	6726	39	intravascular	intravascular	JJ
cord-023095-4dannjjm	6726	40	volume	volume	NN
cord-023095-4dannjjm	6726	41	deficits	deficit	NNS
cord-023095-4dannjjm	6726	42	than	than	IN
cord-023095-4dannjjm	6726	43	ISS	ISS	NNP
cord-023095-4dannjjm	6726	44	in	in	IN
cord-023095-4dannjjm	6726	45	endurance	endurance	NN
cord-023095-4dannjjm	6726	46	horses	horse	NNS
cord-023095-4dannjjm	6726	47	receiving	receive	VBG
cord-023095-4dannjjm	6726	48	emergency	emergency	NN
cord-023095-4dannjjm	6726	49	medical	medical	JJ
cord-023095-4dannjjm	6726	50	treatment	treatment	NN
cord-023095-4dannjjm	6726	51	.	.	.
cord-023095-4dannjjm	6727	1	More	more	RBR
cord-023095-4dannjjm	6727	2	profound	profound	JJ
cord-023095-4dannjjm	6727	3	electrolyte	electrolyte	JJ
cord-023095-4dannjjm	6727	4	changes	change	NNS
cord-023095-4dannjjm	6727	5	should	should	MD
cord-023095-4dannjjm	6727	6	be	be	VB
cord-023095-4dannjjm	6727	7	expected	expect	VBN
cord-023095-4dannjjm	6727	8	with	with	IN
cord-023095-4dannjjm	6727	9	HSS	HSS	NNP
cord-023095-4dannjjm	6727	10	however	however	RB
cord-023095-4dannjjm	6727	11	.	.	.
cord-023095-4dannjjm	6728	1	b	b	LS
cord-023095-4dannjjm	6728	2	2	2	CD
cord-023095-4dannjjm	6729	1	-adrenergic	-adrenergic	JJ
cord-023095-4dannjjm	6729	2	receptor	receptor	NN
cord-023095-4dannjjm	6729	3	agonists	agonist	NNS
cord-023095-4dannjjm	6729	4	have	have	VBP
cord-023095-4dannjjm	6729	5	been	be	VBN
cord-023095-4dannjjm	6729	6	shown	show	VBN
cord-023095-4dannjjm	6729	7	to	to	TO
cord-023095-4dannjjm	6729	8	increase	increase	VB
cord-023095-4dannjjm	6729	9	erythrocyte	erythrocyte	NN
cord-023095-4dannjjm	6729	10	carbonic	carbonic	JJ
cord-023095-4dannjjm	6729	11	anhydrase	anhydrase	NN
cord-023095-4dannjjm	6729	12	activity	activity	NN
cord-023095-4dannjjm	6729	13	,	,	,
cord-023095-4dannjjm	6729	14	which	which	WDT
cord-023095-4dannjjm	6729	15	may	may	MD
cord-023095-4dannjjm	6729	16	stimulate	stimulate	VB
cord-023095-4dannjjm	6729	17	the	the	DT
cord-023095-4dannjjm	6729	18	Jacobs	Jacobs	NNP
cord-023095-4dannjjm	6729	19	-	-	HYPH
cord-023095-4dannjjm	6729	20	Stewart	Stewart	NNP
cord-023095-4dannjjm	6729	21	cycle	cycle	NN
cord-023095-4dannjjm	6729	22	and	and	CC
cord-023095-4dannjjm	6729	23	increase	increase	VB
cord-023095-4dannjjm	6729	24	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6729	25	circulation	circulation	NN
cord-023095-4dannjjm	6729	26	transvascular	transvascular	NNP
cord-023095-4dannjjm	6729	27	fluid	fluid	JJ
cord-023095-4dannjjm	6729	28	fluxes	flux	NNS
cord-023095-4dannjjm	6729	29	during	during	IN
cord-023095-4dannjjm	6729	30	exercise	exercise	NN
cord-023095-4dannjjm	6729	31	.	.	.
cord-023095-4dannjjm	6730	1	Increase	increase	VB
cord-023095-4dannjjm	6730	2	in	in	IN
cord-023095-4dannjjm	6730	3	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6730	4	transvascular	transvascular	JJ
cord-023095-4dannjjm	6730	5	fluid	fluid	JJ
cord-023095-4dannjjm	6730	6	fluxes	flux	NNS
cord-023095-4dannjjm	6730	7	(	(	-LRB-
cord-023095-4dannjjm	6730	8	J	J	NNP
cord-023095-4dannjjm	6730	9	V	V	NNP
cord-023095-4dannjjm	6730	10	-	-	HYPH
cord-023095-4dannjjm	6730	11	A	A	NNP
cord-023095-4dannjjm	6730	12	)	)	-RRB-
cord-023095-4dannjjm	6730	13	and	and	CC
cord-023095-4dannjjm	6730	14	consequent	consequent	JJ
cord-023095-4dannjjm	6730	15	increase	increase	NN
cord-023095-4dannjjm	6730	16	in	in	IN
cord-023095-4dannjjm	6730	17	the	the	DT
cord-023095-4dannjjm	6730	18	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6730	19	interstitial	interstitial	JJ
cord-023095-4dannjjm	6730	20	fluid	fluid	NN
cord-023095-4dannjjm	6730	21	would	would	MD
cord-023095-4dannjjm	6730	22	be	be	VB
cord-023095-4dannjjm	6730	23	detrimental	detrimental	JJ
cord-023095-4dannjjm	6730	24	for	for	IN
cord-023095-4dannjjm	6730	25	alveolar	alveolar	NN
cord-023095-4dannjjm	6730	26	O	o	NN
cord-023095-4dannjjm	6730	27	2	2	CD
cord-023095-4dannjjm	6730	28	exchange	exchange	NN
cord-023095-4dannjjm	6730	29	during	during	IN
cord-023095-4dannjjm	6730	30	the	the	DT
cord-023095-4dannjjm	6730	31	fast	fast	JJ
cord-023095-4dannjjm	6730	32	erythrocyte	erythrocyte	NN
cord-023095-4dannjjm	6730	33	transition	transition	NN
cord-023095-4dannjjm	6730	34	time	time	NN
cord-023095-4dannjjm	6730	35	across	across	IN
cord-023095-4dannjjm	6730	36	the	the	DT
cord-023095-4dannjjm	6730	37	pulmonary	pulmonary	JJ
cord-023095-4dannjjm	6730	38	capillaries	capillary	NNS
cord-023095-4dannjjm	6730	39	.	.	.
cord-023095-4dannjjm	6731	1	Therefore	therefore	RB
cord-023095-4dannjjm	6731	2	,	,	,
cord-023095-4dannjjm	6731	3	we	-PRON-	PRP
cord-023095-4dannjjm	6731	4	hypothesised	hypothesise	VBD
cord-023095-4dannjjm	6731	5	that	that	DT
cord-023095-4dannjjm	6731	6	treatment	treatment	NN
cord-023095-4dannjjm	6731	7	with	with	IN
cord-023095-4dannjjm	6731	8	inhaled	inhale	VBN
cord-023095-4dannjjm	6731	9	b	b	NN
cord-023095-4dannjjm	6731	10	2	2	CD
cord-023095-4dannjjm	6731	11	-adrenergic	-adrenergic	JJ
cord-023095-4dannjjm	6731	12	receptor	receptor	NN
cord-023095-4dannjjm	6731	13	agonist	agonist	NN
cord-023095-4dannjjm	6731	14	will	will	MD
cord-023095-4dannjjm	6731	15	increase	increase	VB
cord-023095-4dannjjm	6731	16	J	J	NNP
cord-023095-4dannjjm	6731	17	V	V	NNP
cord-023095-4dannjjm	6731	18	-	-	HYPH
cord-023095-4dannjjm	6731	19	A	A	NNP
cord-023095-4dannjjm	6731	20	and	and	CC
cord-023095-4dannjjm	6731	21	the	the	DT
cord-023095-4dannjjm	6731	22	alveolar	alveolar	NN
cord-023095-4dannjjm	6731	23	-	-	HYPH
cord-023095-4dannjjm	6731	24	arterial	arterial	JJ
cord-023095-4dannjjm	6731	25	PO	po	NN
cord-023095-4dannjjm	6731	26	2	2	CD
cord-023095-4dannjjm	6731	27	difference	difference	NN
cord-023095-4dannjjm	6731	28	(	(	-LRB-
cord-023095-4dannjjm	6731	29	AaDO	AaDO	NNP
cord-023095-4dannjjm	6731	30	2	2	CD
cord-023095-4dannjjm	6731	31	)	)	-RRB-
cord-023095-4dannjjm	6731	32	during	during	IN
cord-023095-4dannjjm	6731	33	exercise	exercise	NN
cord-023095-4dannjjm	6731	34	.	.	.
cord-023095-4dannjjm	6732	1	Six	six	CD
cord-023095-4dannjjm	6732	2	STB	STB	NNP
cord-023095-4dannjjm	6732	3	horses	horse	NNS
cord-023095-4dannjjm	6732	4	were	be	VBD
cord-023095-4dannjjm	6732	5	exercised	exercise	VBN
cord-023095-4dannjjm	6732	6	on	on	IN
cord-023095-4dannjjm	6732	7	a	a	DT
cord-023095-4dannjjm	6732	8	high	high	JJ
cord-023095-4dannjjm	6732	9	-	-	HYPH
cord-023095-4dannjjm	6732	10	speed	speed	NN
cord-023095-4dannjjm	6732	11	treadmill	treadmill	NN
cord-023095-4dannjjm	6732	12	at	at	IN
cord-023095-4dannjjm	6732	13	80	80	CD
cord-023095-4dannjjm	6732	14	%	%	NN
cord-023095-4dannjjm	6732	15	VO	VO	NNP
cord-023095-4dannjjm	6732	16	2	2	CD
cord-023095-4dannjjm	6732	17	peak	peak	NN
cord-023095-4dannjjm	6732	18	until	until	IN
cord-023095-4dannjjm	6732	19	fatigue	fatigue	NN
cord-023095-4dannjjm	6732	20	.	.	.
cord-023095-4dannjjm	6733	1	Horses	horse	NNS
cord-023095-4dannjjm	6733	2	were	be	VBD
cord-023095-4dannjjm	6733	3	randomly	randomly	RB
cord-023095-4dannjjm	6733	4	assigned	assign	VBN
cord-023095-4dannjjm	6733	5	to	to	IN
cord-023095-4dannjjm	6733	6	treatment	treatment	NN
cord-023095-4dannjjm	6733	7	with	with	IN
cord-023095-4dannjjm	6733	8	salbutamol	salbutamol	NN
cord-023095-4dannjjm	6733	9	(	(	-LRB-
cord-023095-4dannjjm	6733	10	Sal	Sal	NNP
cord-023095-4dannjjm	6733	11	:	:	:
cord-023095-4dannjjm	6733	12	500mcg	500mcg	CD
cord-023095-4dannjjm	6733	13	)	)	-RRB-
cord-023095-4dannjjm	6733	14	or	or	CC
cord-023095-4dannjjm	6733	15	placebo	placebo	NN
cord-023095-4dannjjm	6733	16	(	(	-LRB-
cord-023095-4dannjjm	6733	17	Control	control	NN
cord-023095-4dannjjm	6733	18	:	:	:
cord-023095-4dannjjm	6734	1	Con	con	NN
cord-023095-4dannjjm	6734	2	)	)	-RRB-
cord-023095-4dannjjm	6734	3	inhalation	inhalation	NN
cord-023095-4dannjjm	6734	4	via	via	IN
cord-023095-4dannjjm	6734	5	Aeromask	Aeromask	NNP
cord-023095-4dannjjm	6734	6	Ã	Ã	NNP
cord-023095-4dannjjm	6734	7	60	60	CD
cord-023095-4dannjjm	6734	8	min	min	NN
cord-023095-4dannjjm	6734	9	prior	prior	RB
cord-023095-4dannjjm	6734	10	to	to	IN
cord-023095-4dannjjm	6734	11	exercise	exercise	VB
cord-023095-4dannjjm	6734	12	,	,	,
cord-023095-4dannjjm	6734	13	with	with	IN
cord-023095-4dannjjm	6734	14	cross	cross	NN
cord-023095-4dannjjm	6734	15	over	over	IN
cord-023095-4dannjjm	6734	16	treatment	treatment	NN
cord-023095-4dannjjm	6734	17	used	use	VBN
cord-023095-4dannjjm	6734	18	at	at	IN
cord-023095-4dannjjm	6734	19	the	the	DT
cord-023095-4dannjjm	6734	20	repeated	repeat	VBN
cord-023095-4dannjjm	6734	21	exercise	exercise	NN
cord-023095-4dannjjm	6734	22	test	test	NN
cord-023095-4dannjjm	6734	23	(	(	-LRB-
cord-023095-4dannjjm	6734	24	8	8	CD
cord-023095-4dannjjm	6734	25	days	day	NNS
cord-023095-4dannjjm	6734	26	later	later	RB
cord-023095-4dannjjm	6734	27	)	)	-RRB-
cord-023095-4dannjjm	6734	28	.	.	.
cord-023095-4dannjjm	6735	1	Arterial	arterial	JJ
cord-023095-4dannjjm	6735	2	and	and	CC
cord-023095-4dannjjm	6735	3	mixedvenous	mixedvenous	JJ
cord-023095-4dannjjm	6735	4	blood	blood	NN
cord-023095-4dannjjm	6735	5	,	,	,
cord-023095-4dannjjm	6735	6	as	as	RB
cord-023095-4dannjjm	6735	7	well	well	RB
cord-023095-4dannjjm	6735	8	as	as	IN
cord-023095-4dannjjm	6735	9	CO	co	NN
cord-023095-4dannjjm	6735	10	2	2	CD
cord-023095-4dannjjm	6735	11	elimination	elimination	NN
cord-023095-4dannjjm	6735	12	and	and	CC
cord-023095-4dannjjm	6735	13	O	o	NN
cord-023095-4dannjjm	6735	14	2	2	CD
cord-023095-4dannjjm	6735	15	uptake	uptake	NN
cord-023095-4dannjjm	6735	16	,	,	,
cord-023095-4dannjjm	6735	17	were	be	VBD
cord-023095-4dannjjm	6735	18	sampled	sample	VBN
cord-023095-4dannjjm	6735	19	simultaneously	simultaneously	RB
cord-023095-4dannjjm	6735	20	at	at	IN
cord-023095-4dannjjm	6735	21	rest	rest	NN
cord-023095-4dannjjm	6735	22	,	,	,
cord-023095-4dannjjm	6735	23	during	during	IN
cord-023095-4dannjjm	6735	24	exercise	exercise	NN
cord-023095-4dannjjm	6735	25	at	at	IN
cord-023095-4dannjjm	6735	26	60	60	CD
cord-023095-4dannjjm	6735	27	sec	sec	NNP
cord-023095-4dannjjm	6735	28	intervals	interval	NNS
cord-023095-4dannjjm	6735	29	until	until	IN
cord-023095-4dannjjm	6735	30	fatigue	fatigue	NN
cord-023095-4dannjjm	6735	31	,	,	,
cord-023095-4dannjjm	6735	32	and	and	CC
cord-023095-4dannjjm	6735	33	into	into	IN
cord-023095-4dannjjm	6735	34	recovery	recovery	NN
cord-023095-4dannjjm	6735	35	.	.	.
cord-023095-4dannjjm	6736	1	Blood	blood	NN
cord-023095-4dannjjm	6736	2	gases	gas	NNS
cord-023095-4dannjjm	6736	3	were	be	VBD
cord-023095-4dannjjm	6736	4	analyzed	analyze	VBN
cord-023095-4dannjjm	6736	5	.	.	.
cord-023095-4dannjjm	6737	1	AaDO	AaDO	NNP
cord-023095-4dannjjm	6737	2	2	2	CD
cord-023095-4dannjjm	6737	3	was	be	VBD
cord-023095-4dannjjm	6737	4	calculated	calculate	VBN
cord-023095-4dannjjm	6737	5	using	use	VBG
cord-023095-4dannjjm	6737	6	the	the	DT
cord-023095-4dannjjm	6737	7	inspired	inspire	VBN
cord-023095-4dannjjm	6737	8	PO	PO	NNP
cord-023095-4dannjjm	6737	9	2	2	CD
cord-023095-4dannjjm	6737	10	(	(	-LRB-
cord-023095-4dannjjm	6737	11	149	149	CD
cord-023095-4dannjjm	6737	12	mmHg	mmHg	NNS
cord-023095-4dannjjm	6737	13	)	)	-RRB-
cord-023095-4dannjjm	6737	14	,	,	,
cord-023095-4dannjjm	6737	15	and	and	CC
cord-023095-4dannjjm	6737	16	blood	blood	NN
cord-023095-4dannjjm	6737	17	partial	partial	JJ
cord-023095-4dannjjm	6737	18	pressure	pressure	NN
cord-023095-4dannjjm	6737	19	of	of	IN
cord-023095-4dannjjm	6737	20	O	o	NN
cord-023095-4dannjjm	6737	21	2	2	CD
cord-023095-4dannjjm	6737	22	and	and	CC
cord-023095-4dannjjm	6737	23	CO	CO	NNP
cord-023095-4dannjjm	6737	24	2	2	CD
cord-023095-4dannjjm	6737	25	.	.	.
cord-023095-4dannjjm	6738	1	Blood	blood	NN
cord-023095-4dannjjm	6738	2	volume	volume	NN
cord-023095-4dannjjm	6738	3	(	(	-LRB-
cord-023095-4dannjjm	6738	4	%	%	NN
cord-023095-4dannjjm	6738	5	)	)	-RRB-
cord-023095-4dannjjm	6738	6	changes	change	NNS
cord-023095-4dannjjm	6738	7	across	across	IN
cord-023095-4dannjjm	6738	8	the	the	DT
cord-023095-4dannjjm	6738	9	lung	lung	NN
cord-023095-4dannjjm	6738	10	were	be	VBD
cord-023095-4dannjjm	6738	11	calculated	calculate	VBN
cord-023095-4dannjjm	6738	12	from	from	IN
cord-023095-4dannjjm	6738	13	changes	change	NNS
cord-023095-4dannjjm	6738	14	in	in	IN
cord-023095-4dannjjm	6738	15	hemoglobin	hemoglobin	NN
cord-023095-4dannjjm	6738	16	and	and	CC
cord-023095-4dannjjm	6738	17	hematocrit	hematocrit	NN
cord-023095-4dannjjm	6738	18	values	value	NNS
cord-023095-4dannjjm	6738	19	in	in	IN
cord-023095-4dannjjm	6738	20	venous	venous	JJ
cord-023095-4dannjjm	6738	21	and	and	CC
cord-023095-4dannjjm	6738	22	arterial	arterial	JJ
cord-023095-4dannjjm	6738	23	blood	blood	NN
cord-023095-4dannjjm	6738	24	.	.	.
cord-023095-4dannjjm	6739	1	Cardiac	cardiac	JJ
cord-023095-4dannjjm	6739	2	output	output	NN
cord-023095-4dannjjm	6739	3	(	(	-LRB-
cord-023095-4dannjjm	6739	4	Q	Q	NNP
cord-023095-4dannjjm	6739	5	)	)	-RRB-
cord-023095-4dannjjm	6739	6	was	be	VBD
cord-023095-4dannjjm	6739	7	calculated	calculate	VBN
cord-023095-4dannjjm	6739	8	using	use	VBG
cord-023095-4dannjjm	6739	9	the	the	DT
cord-023095-4dannjjm	6739	10	Fick	Fick	NNP
cord-023095-4dannjjm	6739	11	equation	equation	NN
cord-023095-4dannjjm	6739	12	.	.	.
cord-023095-4dannjjm	6740	1	J	J	NNP
cord-023095-4dannjjm	6740	2	V	V	NNP
cord-023095-4dannjjm	6740	3	-	-	:
cord-023095-4dannjjm	6740	4	A	A	NNP
cord-023095-4dannjjm	6740	5	was	be	VBD
cord-023095-4dannjjm	6740	6	calculated	calculate	VBN
cord-023095-4dannjjm	6740	7	using	use	VBG
cord-023095-4dannjjm	6740	8	Q	q	NN
cord-023095-4dannjjm	6740	9	and	and	CC
cord-023095-4dannjjm	6740	10	blood	blood	NN
cord-023095-4dannjjm	6740	11	volume	volume	NN
cord-023095-4dannjjm	6740	12	changes	change	NNS
cord-023095-4dannjjm	6740	13	across	across	IN
cord-023095-4dannjjm	6740	14	the	the	DT
cord-023095-4dannjjm	6740	15	lung	lung	NN
cord-023095-4dannjjm	6740	16	.	.	.
cord-023095-4dannjjm	6741	1	Variables	variable	NNS
cord-023095-4dannjjm	6741	2	were	be	VBD
cord-023095-4dannjjm	6741	3	analyzed	analyze	VBN
cord-023095-4dannjjm	6741	4	using	use	VBG
cord-023095-4dannjjm	6741	5	two	two	CD
cord-023095-4dannjjm	6741	6	-	-	HYPH
cord-023095-4dannjjm	6741	7	way	way	NN
cord-023095-4dannjjm	6741	8	repeated	repeat	VBN
cord-023095-4dannjjm	6741	9	-	-	HYPH
cord-023095-4dannjjm	6741	10	measures	measure	NNS
cord-023095-4dannjjm	6741	11	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	6741	12	(	(	-LRB-
cord-023095-4dannjjm	6741	13	P	p	NN
cord-023095-4dannjjm	6741	14	o	o	NN
cord-023095-4dannjjm	6741	15	0.05).The	0.05).the	CD
cord-023095-4dannjjm	6741	16	duration	duration	NN
cord-023095-4dannjjm	6741	17	of	of	IN
cord-023095-4dannjjm	6741	18	exercise	exercise	NN
cord-023095-4dannjjm	6741	19	to	to	IN
cord-023095-4dannjjm	6741	20	fatigue	fatigue	NN
cord-023095-4dannjjm	6741	21	was	be	VBD
cord-023095-4dannjjm	6741	22	4.3	4.3	CD
cord-023095-4dannjjm	6741	23	AE	AE	NNP
cord-023095-4dannjjm	6741	24	0.3	0.3	CD
cord-023095-4dannjjm	6741	25	min	min	NN
cord-023095-4dannjjm	6741	26	and	and	CC
cord-023095-4dannjjm	6741	27	4.4	4.4	CD
cord-023095-4dannjjm	6741	28	AE	AE	NNP
cord-023095-4dannjjm	6741	29	0.4	0.4	CD
cord-023095-4dannjjm	6741	30	min	min	NN
cord-023095-4dannjjm	6741	31	in	in	IN
cord-023095-4dannjjm	6741	32	both	both	CC
cord-023095-4dannjjm	6741	33	Con	Con	NNP
cord-023095-4dannjjm	6741	34	and	and	CC
cord-023095-4dannjjm	6741	35	Sal	Sal	NNP
cord-023095-4dannjjm	6741	36	,	,	,
cord-023095-4dannjjm	6741	37	respectively	respectively	RB
cord-023095-4dannjjm	6741	38	.	.	.
cord-023095-4dannjjm	6742	1	At	at	IN
cord-023095-4dannjjm	6742	2	rest	rest	NN
cord-023095-4dannjjm	6742	3	Sal	Sal	NNP
cord-023095-4dannjjm	6742	4	had	have	VBD
cord-023095-4dannjjm	6742	5	no	no	DT
cord-023095-4dannjjm	6742	6	effect	effect	NN
cord-023095-4dannjjm	6742	7	on	on	IN
cord-023095-4dannjjm	6742	8	J	J	NNP
cord-023095-4dannjjm	6742	9	V	V	NNP
cord-023095-4dannjjm	6742	10	-	-	HYPH
cord-023095-4dannjjm	6742	11	A	A	NNP
cord-023095-4dannjjm	6742	12	,	,	,
cord-023095-4dannjjm	6742	13	oxygen	oxygen	NN
cord-023095-4dannjjm	6742	14	consumption	consumption	NN
cord-023095-4dannjjm	6742	15	(	(	-LRB-
cord-023095-4dannjjm	6742	16	VO	VO	NNP
cord-023095-4dannjjm	6742	17	2	2	CD
cord-023095-4dannjjm	6742	18	)	)	-RRB-
cord-023095-4dannjjm	6742	19	,	,	,
cord-023095-4dannjjm	6742	20	blood	blood	NN
cord-023095-4dannjjm	6742	21	oxygen	oxygen	NN
cord-023095-4dannjjm	6742	22	saturation	saturation	NN
cord-023095-4dannjjm	6742	23	(	(	-LRB-
cord-023095-4dannjjm	6742	24	SO	so	RB
cord-023095-4dannjjm	6742	25	2	2	CD
cord-023095-4dannjjm	6742	26	)	)	-RRB-
cord-023095-4dannjjm	6742	27	or	or	CC
cord-023095-4dannjjm	6742	28	AaDO	AaDO	NNP
cord-023095-4dannjjm	6742	29	2	2	CD
cord-023095-4dannjjm	6742	30	(	(	-LRB-
cord-023095-4dannjjm	6742	31	P40.05	p40.05	NN
cord-023095-4dannjjm	6742	32	)	)	-RRB-
cord-023095-4dannjjm	6742	33	.	.	.
cord-023095-4dannjjm	6743	1	At	at	IN
cord-023095-4dannjjm	6743	2	the	the	DT
cord-023095-4dannjjm	6743	3	onset	onset	NN
cord-023095-4dannjjm	6743	4	of	of	IN
cord-023095-4dannjjm	6743	5	exercise	exercise	NN
cord-023095-4dannjjm	6743	6	J	J	NNP
cord-023095-4dannjjm	6743	7	V	V	NNP
cord-023095-4dannjjm	6743	8	-	-	:
cord-023095-4dannjjm	6743	9	A	A	NNP
cord-023095-4dannjjm	6743	10	increased	increase	VBN
cord-023095-4dannjjm	6743	11	in	in	IN
cord-023095-4dannjjm	6743	12	Con	Con	NNP
cord-023095-4dannjjm	6743	13	and	and	CC
cord-023095-4dannjjm	6743	14	Sal	Sal	NNP
cord-023095-4dannjjm	6743	15	(	(	-LRB-
cord-023095-4dannjjm	6743	16	P	p	NN
cord-023095-4dannjjm	6743	17	o	o	CD
cord-023095-4dannjjm	6743	18	0.0001	0.0001	CD
cord-023095-4dannjjm	6743	19	)	)	-RRB-
cord-023095-4dannjjm	6743	20	and	and	CC
cord-023095-4dannjjm	6743	21	at	at	IN
cord-023095-4dannjjm	6743	22	fatigue	fatigue	NN
cord-023095-4dannjjm	6743	23	reached	reach	VBD
cord-023095-4dannjjm	6743	24	10.0	10.0	CD
cord-023095-4dannjjm	6743	25	AE	AE	NNP
cord-023095-4dannjjm	6743	26	2.4	2.4	CD
cord-023095-4dannjjm	6743	27	L	l	NN
cord-023095-4dannjjm	6743	28	/	/	SYM
cord-023095-4dannjjm	6743	29	min	min	NN
cord-023095-4dannjjm	6743	30	and	and	CC
cord-023095-4dannjjm	6743	31	10.0	10.0	CD
cord-023095-4dannjjm	6743	32	AE	AE	NNP
cord-023095-4dannjjm	6743	33	1.6	1.6	CD
cord-023095-4dannjjm	6743	34	L	l	NN
cord-023095-4dannjjm	6743	35	/	/	SYM
cord-023095-4dannjjm	6743	36	min	min	NN
cord-023095-4dannjjm	6743	37	,	,	,
cord-023095-4dannjjm	6743	38	respectively	respectively	RB
cord-023095-4dannjjm	6743	39	.	.	.
cord-023095-4dannjjm	6744	1	Treatment	treatment	NN
cord-023095-4dannjjm	6744	2	with	with	IN
cord-023095-4dannjjm	6744	3	Sal	Sal	NNP
cord-023095-4dannjjm	6744	4	had	have	VBD
cord-023095-4dannjjm	6744	5	no	no	DT
cord-023095-4dannjjm	6744	6	effect	effect	NN
cord-023095-4dannjjm	6744	7	on	on	IN
cord-023095-4dannjjm	6744	8	J	J	NNP
cord-023095-4dannjjm	6744	9	V	V	NNP
cord-023095-4dannjjm	6744	10	-	-	:
cord-023095-4dannjjm	6744	11	A	a	NN
cord-023095-4dannjjm	6744	12	during	during	IN
cord-023095-4dannjjm	6744	13	exercise	exercise	NN
cord-023095-4dannjjm	6744	14	(	(	-LRB-
cord-023095-4dannjjm	6744	15	P	p	NN
cord-023095-4dannjjm	6744	16	5	5	CD
cord-023095-4dannjjm	6744	17	0.9	0.9	CD
cord-023095-4dannjjm	6744	18	)	)	-RRB-
cord-023095-4dannjjm	6744	19	.	.	.
cord-023095-4dannjjm	6745	1	At	at	IN
cord-023095-4dannjjm	6745	2	the	the	DT
cord-023095-4dannjjm	6745	3	onset	onset	NN
cord-023095-4dannjjm	6745	4	of	of	IN
cord-023095-4dannjjm	6745	5	exercise	exercise	NN
cord-023095-4dannjjm	6745	6	SO	so	RB
cord-023095-4dannjjm	6745	7	2	2	CD
cord-023095-4dannjjm	6745	8	and	and	CC
cord-023095-4dannjjm	6745	9	VO	VO	NNP
cord-023095-4dannjjm	6745	10	2	2	CD
cord-023095-4dannjjm	6745	11	increased	increase	VBD
cord-023095-4dannjjm	6745	12	in	in	IN
cord-023095-4dannjjm	6745	13	Con	Con	NNP
cord-023095-4dannjjm	6745	14	and	and	CC
cord-023095-4dannjjm	6745	15	Sal	Sal	NNP
cord-023095-4dannjjm	6745	16	(	(	-LRB-
cord-023095-4dannjjm	6745	17	P	p	NN
cord-023095-4dannjjm	6745	18	o	o	NN
cord-023095-4dannjjm	6745	19	0.0001	0.0001	CD
cord-023095-4dannjjm	6745	20	)	)	-RRB-
cord-023095-4dannjjm	6745	21	.	.	.
cord-023095-4dannjjm	6746	1	Treatment	treatment	NN
cord-023095-4dannjjm	6746	2	with	with	IN
cord-023095-4dannjjm	6746	3	Sal	Sal	NNP
cord-023095-4dannjjm	6746	4	had	have	VBD
cord-023095-4dannjjm	6746	5	no	no	DT
cord-023095-4dannjjm	6746	6	effect	effect	NN
cord-023095-4dannjjm	6746	7	on	on	IN
cord-023095-4dannjjm	6746	8	SO	so	RB
cord-023095-4dannjjm	6746	9	2	2	CD
cord-023095-4dannjjm	6746	10	or	or	CC
cord-023095-4dannjjm	6746	11	VO	VO	NNP
cord-023095-4dannjjm	6746	12	2	2	CD
cord-023095-4dannjjm	6746	13	during	during	IN
cord-023095-4dannjjm	6746	14	exercise	exercise	NN
cord-023095-4dannjjm	6746	15	(	(	-LRB-
cord-023095-4dannjjm	6746	16	P40.05	p40.05	NN
cord-023095-4dannjjm	6746	17	)	)	-RRB-
cord-023095-4dannjjm	6746	18	.	.	.
cord-023095-4dannjjm	6747	1	AaDO	AaDO	NNP
cord-023095-4dannjjm	6747	2	2	2	CD
cord-023095-4dannjjm	6747	3	increased	increase	VBD
cord-023095-4dannjjm	6747	4	during	during	IN
cord-023095-4dannjjm	6747	5	exercise	exercise	NN
cord-023095-4dannjjm	6747	6	in	in	IN
cord-023095-4dannjjm	6747	7	Con	Con	NNP
cord-023095-4dannjjm	6747	8	and	and	CC
cord-023095-4dannjjm	6747	9	Sal	Sal	NNP
cord-023095-4dannjjm	6747	10	(	(	-LRB-
cord-023095-4dannjjm	6747	11	P	p	NN
cord-023095-4dannjjm	6747	12	o	o	CD
cord-023095-4dannjjm	6747	13	0.0001	0.0001	CD
cord-023095-4dannjjm	6747	14	)	)	-RRB-
cord-023095-4dannjjm	6747	15	and	and	CC
cord-023095-4dannjjm	6747	16	at	at	IN
cord-023095-4dannjjm	6747	17	fatigue	fatigue	NN
cord-023095-4dannjjm	6747	18	reached	reach	VBD
cord-023095-4dannjjm	6747	19	19.4	19.4	CD
cord-023095-4dannjjm	6747	20	AE	AE	NNP
cord-023095-4dannjjm	6747	21	2.3	2.3	CD
cord-023095-4dannjjm	6747	22	mmHg	mmHg	NNS
cord-023095-4dannjjm	6747	23	and	and	CC
cord-023095-4dannjjm	6747	24	18.1	18.1	CD
cord-023095-4dannjjm	6747	25	AE	AE	NNP
cord-023095-4dannjjm	6747	26	2.4	2.4	CD
cord-023095-4dannjjm	6747	27	mmHg	mmHg	NNS
cord-023095-4dannjjm	6747	28	,	,	,
cord-023095-4dannjjm	6747	29	respectively	respectively	RB
cord-023095-4dannjjm	6747	30	.	.	.
cord-023095-4dannjjm	6748	1	Treatment	treatment	NN
cord-023095-4dannjjm	6748	2	with	with	IN
cord-023095-4dannjjm	6748	3	Sal	Sal	NNP
cord-023095-4dannjjm	6748	4	had	have	VBD
cord-023095-4dannjjm	6748	5	no	no	DT
cord-023095-4dannjjm	6748	6	effect	effect	NN
cord-023095-4dannjjm	6748	7	on	on	IN
cord-023095-4dannjjm	6748	8	AaDO	AaDO	NNP
cord-023095-4dannjjm	6748	9	2	2	CD
cord-023095-4dannjjm	6748	10	during	during	IN
cord-023095-4dannjjm	6748	11	exercise	exercise	NN
cord-023095-4dannjjm	6749	1	(	(	-LRB-
cord-023095-4dannjjm	6749	2	P	p	NN
cord-023095-4dannjjm	6749	3	5	5	CD
cord-023095-4dannjjm	6749	4	0.3).Inhaled	0.3).inhaled	CD
cord-023095-4dannjjm	6749	5	b	b	NN
cord-023095-4dannjjm	6749	6	2	2	CD
cord-023095-4dannjjm	6749	7	-adrenergic	-adrenergic	JJ
cord-023095-4dannjjm	6749	8	receptor	receptor	NN
cord-023095-4dannjjm	6749	9	agonist	agonist	NN
cord-023095-4dannjjm	6749	10	salbutamol	salbutamol	NN
cord-023095-4dannjjm	6749	11	at	at	IN
cord-023095-4dannjjm	6749	12	the	the	DT
cord-023095-4dannjjm	6749	13	dose	dose	NN
cord-023095-4dannjjm	6749	14	of	of	IN
cord-023095-4dannjjm	6749	15	500mcg	500mcg	NNP
cord-023095-4dannjjm	6749	16	given	give	VBN
cord-023095-4dannjjm	6749	17	60	60	CD
cord-023095-4dannjjm	6749	18	min	min	NN
cord-023095-4dannjjm	6749	19	before	before	IN
cord-023095-4dannjjm	6749	20	exercise	exercise	NN
cord-023095-4dannjjm	6749	21	did	do	VBD
cord-023095-4dannjjm	6749	22	not	not	RB
cord-023095-4dannjjm	6749	23	affect	affect	VB
cord-023095-4dannjjm	6749	24	the	the	DT
cord-023095-4dannjjm	6749	25	duration	duration	NN
cord-023095-4dannjjm	6749	26	of	of	IN
cord-023095-4dannjjm	6749	27	exercise	exercise	NN
cord-023095-4dannjjm	6749	28	to	to	IN
cord-023095-4dannjjm	6749	29	fatigue	fatigue	NN
cord-023095-4dannjjm	6749	30	,	,	,
cord-023095-4dannjjm	6749	31	J	J	NNP
cord-023095-4dannjjm	6749	32	V	V	NNP
cord-023095-4dannjjm	6749	33	-	-	HYPH
cord-023095-4dannjjm	6749	34	A	A	NNP
cord-023095-4dannjjm	6749	35	,	,	,
cord-023095-4dannjjm	6749	36	VO	VO	NNP
cord-023095-4dannjjm	6749	37	2	2	CD
cord-023095-4dannjjm	6749	38	,	,	,
cord-023095-4dannjjm	6749	39	SO	so	RB
cord-023095-4dannjjm	6749	40	2	2	CD
cord-023095-4dannjjm	6749	41	or	or	CC
cord-023095-4dannjjm	6749	42	AaDO	AaDO	NNP
cord-023095-4dannjjm	6749	43	2	2	CD
cord-023095-4dannjjm	6749	44	.	.	.
cord-023095-4dannjjm	6750	1	Therefore	therefore	RB
cord-023095-4dannjjm	6750	2	,	,	,
cord-023095-4dannjjm	6750	3	it	-PRON-	PRP
cord-023095-4dannjjm	6750	4	had	have	VBD
cord-023095-4dannjjm	6750	5	no	no	DT
cord-023095-4dannjjm	6750	6	detrimental	detrimental	JJ
cord-023095-4dannjjm	6750	7	effect	effect	NN
cord-023095-4dannjjm	6750	8	on	on	IN
cord-023095-4dannjjm	6750	9	alveolar	alveolar	NN
cord-023095-4dannjjm	6750	10	-	-	HYPH
cord-023095-4dannjjm	6750	11	capillary	capillary	JJ
cord-023095-4dannjjm	6750	12	diffusion	diffusion	NN
cord-023095-4dannjjm	6750	13	distance	distance	NN
cord-023095-4dannjjm	6750	14	and	and	CC
cord-023095-4dannjjm	6750	15	the	the	DT
cord-023095-4dannjjm	6750	16	ventilation	ventilation	NN
cord-023095-4dannjjm	6750	17	/	/	SYM
cord-023095-4dannjjm	6750	18	perfusion	perfusion	NN
cord-023095-4dannjjm	6750	19	mismatch	mismatch	NN
cord-023095-4dannjjm	6750	20	in	in	IN
cord-023095-4dannjjm	6750	21	exercising	exercise	VBG
cord-023095-4dannjjm	6750	22	horses	horse	NNS
cord-023095-4dannjjm	6750	23	.	.	.
cord-023095-4dannjjm	6751	1	Inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6751	2	Airway	Airway	NNP
cord-023095-4dannjjm	6751	3	Disease	Disease	NNP
cord-023095-4dannjjm	6751	4	(	(	-LRB-
cord-023095-4dannjjm	6751	5	IAD	IAD	NNP
cord-023095-4dannjjm	6751	6	)	)	-RRB-
cord-023095-4dannjjm	6751	7	and	and	CC
cord-023095-4dannjjm	6751	8	recurrent	recurrent	JJ
cord-023095-4dannjjm	6751	9	airway	airway	JJ
cord-023095-4dannjjm	6751	10	obstruction	obstruction	NN
cord-023095-4dannjjm	6751	11	(	(	-LRB-
cord-023095-4dannjjm	6751	12	RAO	RAO	NNP
cord-023095-4dannjjm	6751	13	)	)	-RRB-
cord-023095-4dannjjm	6751	14	represent	represent	VBP
cord-023095-4dannjjm	6751	15	two	two	CD
cord-023095-4dannjjm	6751	16	classes	class	NNS
cord-023095-4dannjjm	6751	17	of	of	IN
cord-023095-4dannjjm	6751	18	equine	equine	JJ
cord-023095-4dannjjm	6751	19	lung	lung	NN
cord-023095-4dannjjm	6751	20	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6751	21	diseases	disease	NNS
cord-023095-4dannjjm	6751	22	that	that	WDT
cord-023095-4dannjjm	6751	23	may	may	MD
cord-023095-4dannjjm	6751	24	share	share	VB
cord-023095-4dannjjm	6751	25	some	some	DT
cord-023095-4dannjjm	6751	26	similar	similar	JJ
cord-023095-4dannjjm	6751	27	immunologic	immunologic	JJ
cord-023095-4dannjjm	6751	28	mechanisms	mechanism	NNS
cord-023095-4dannjjm	6751	29	.	.	.
cord-023095-4dannjjm	6752	1	There	there	EX
cord-023095-4dannjjm	6752	2	is	be	VBZ
cord-023095-4dannjjm	6752	3	evidence	evidence	NN
cord-023095-4dannjjm	6752	4	that	that	IN
cord-023095-4dannjjm	6752	5	Th2	Th2	NNP
cord-023095-4dannjjm	6752	6	cytokines	cytokine	NNS
cord-023095-4dannjjm	6752	7	and	and	CC
cord-023095-4dannjjm	6752	8	IL-17	IL-17	NNP
cord-023095-4dannjjm	6752	9	play	play	VB
cord-023095-4dannjjm	6752	10	some	some	DT
cord-023095-4dannjjm	6752	11	role	role	NN
cord-023095-4dannjjm	6752	12	in	in	IN
cord-023095-4dannjjm	6752	13	RAO	RAO	NNP
cord-023095-4dannjjm	6752	14	.	.	.
cord-023095-4dannjjm	6753	1	IAD	IAD	NNP
cord-023095-4dannjjm	6753	2	is	be	VBZ
cord-023095-4dannjjm	6753	3	a	a	DT
cord-023095-4dannjjm	6753	4	common	common	JJ
cord-023095-4dannjjm	6753	5	condition	condition	NN
cord-023095-4dannjjm	6753	6	in	in	IN
cord-023095-4dannjjm	6753	7	horses	horse	NNS
cord-023095-4dannjjm	6753	8	,	,	,
cord-023095-4dannjjm	6753	9	but	but	CC
cord-023095-4dannjjm	6753	10	its	-PRON-	PRP$
cord-023095-4dannjjm	6753	11	pathophysiology	pathophysiology	NN
cord-023095-4dannjjm	6753	12	is	be	VBZ
cord-023095-4dannjjm	6753	13	still	still	RB
cord-023095-4dannjjm	6753	14	not	not	RB
cord-023095-4dannjjm	6753	15	understood	understand	VBN
cord-023095-4dannjjm	6753	16	.	.	.
cord-023095-4dannjjm	6754	1	The	the	DT
cord-023095-4dannjjm	6754	2	aim	aim	NN
cord-023095-4dannjjm	6754	3	of	of	IN
cord-023095-4dannjjm	6754	4	the	the	DT
cord-023095-4dannjjm	6754	5	present	present	JJ
cord-023095-4dannjjm	6754	6	study	study	NN
cord-023095-4dannjjm	6754	7	was	be	VBD
cord-023095-4dannjjm	6754	8	therefore	therefore	RB
cord-023095-4dannjjm	6754	9	to	to	TO
cord-023095-4dannjjm	6754	10	determine	determine	VB
cord-023095-4dannjjm	6754	11	the	the	DT
cord-023095-4dannjjm	6754	12	mRNA	mRNA	NNP
cord-023095-4dannjjm	6754	13	expression	expression	NN
cord-023095-4dannjjm	6754	14	of	of	IN
cord-023095-4dannjjm	6754	15	Th1	th1	NN
cord-023095-4dannjjm	6754	16	,	,	,
cord-023095-4dannjjm	6754	17	Th2	Th2	NNP
cord-023095-4dannjjm	6754	18	and	and	CC
cord-023095-4dannjjm	6754	19	Th17	th17	CD
cord-023095-4dannjjm	6754	20	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6754	21	cytokines	cytokine	NNS
cord-023095-4dannjjm	6754	22	,	,	,
cord-023095-4dannjjm	6754	23	to	to	TO
cord-023095-4dannjjm	6754	24	understand	understand	VB
cord-023095-4dannjjm	6754	25	the	the	DT
cord-023095-4dannjjm	6754	26	immunological	immunological	JJ
cord-023095-4dannjjm	6754	27	mechanisms	mechanism	NNS
cord-023095-4dannjjm	6754	28	of	of	IN
cord-023095-4dannjjm	6754	29	IAD.The	IAD.The	NNP
cord-023095-4dannjjm	6754	30	mRNA	mRNA	NNP
cord-023095-4dannjjm	6754	31	expression	expression	NN
cord-023095-4dannjjm	6754	32	of	of	IN
cord-023095-4dannjjm	6754	33	ten	ten	CD
cord-023095-4dannjjm	6754	34	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6754	35	cytokines	cytokine	NNS
cord-023095-4dannjjm	6754	36	and	and	CC
cord-023095-4dannjjm	6754	37	chemokines	chemokine	NNS
cord-023095-4dannjjm	6754	38	was	be	VBD
cord-023095-4dannjjm	6754	39	measured	measure	VBN
cord-023095-4dannjjm	6754	40	in	in	IN
cord-023095-4dannjjm	6754	41	the	the	DT
cord-023095-4dannjjm	6754	42	bronchoalveolar	bronchoalveolar	JJ
cord-023095-4dannjjm	6754	43	fluid	fluid	NN
cord-023095-4dannjjm	6754	44	(	(	-LRB-
cord-023095-4dannjjm	6754	45	BALF	BALF	NNP
cord-023095-4dannjjm	6754	46	)	)	-RRB-
cord-023095-4dannjjm	6754	47	of	of	IN
cord-023095-4dannjjm	6754	48	seventeen	seventeen	CD
cord-023095-4dannjjm	6754	49	horses	horse	NNS
cord-023095-4dannjjm	6754	50	with	with	IN
cord-023095-4dannjjm	6754	51	IAD	IAD	NNP
cord-023095-4dannjjm	6754	52	and	and	CC
cord-023095-4dannjjm	6754	53	compared	compare	VBN
cord-023095-4dannjjm	6754	54	with	with	IN
cord-023095-4dannjjm	6754	55	ten	ten	CD
cord-023095-4dannjjm	6754	56	control	control	NN
cord-023095-4dannjjm	6754	57	horses	horse	NNS
cord-023095-4dannjjm	6754	58	.	.	.
cord-023095-4dannjjm	6755	1	The	the	DT
cord-023095-4dannjjm	6755	2	horses	horse	NNS
cord-023095-4dannjjm	6755	3	were	be	VBD
cord-023095-4dannjjm	6755	4	selected	select	VBN
cord-023095-4dannjjm	6755	5	based	base	VBN
cord-023095-4dannjjm	6755	6	on	on	IN
cord-023095-4dannjjm	6755	7	1-their	1-their	CD
cord-023095-4dannjjm	6755	8	clinical	clinical	JJ
cord-023095-4dannjjm	6755	9	signs	sign	NNS
cord-023095-4dannjjm	6755	10	,	,	,
cord-023095-4dannjjm	6755	11	2-the	2-the	NNP
cord-023095-4dannjjm	6755	12	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6755	13	cells	cell	NNS
cord-023095-4dannjjm	6755	14	count	count	VBP
cord-023095-4dannjjm	6755	15	in	in	IN
cord-023095-4dannjjm	6755	16	the	the	DT
cord-023095-4dannjjm	6755	17	BALF	BALF	NNP
cord-023095-4dannjjm	6755	18	,	,	,
cord-023095-4dannjjm	6755	19	3-their	3-their	CD
cord-023095-4dannjjm	6755	20	physical	physical	JJ
cord-023095-4dannjjm	6755	21	examination	examination	NN
cord-023095-4dannjjm	6755	22	and	and	CC
cord-023095-4dannjjm	6755	23	4-their	4-their	CD
cord-023095-4dannjjm	6755	24	medical	medical	JJ
cord-023095-4dannjjm	6755	25	history	history	NN
cord-023095-4dannjjm	6755	26	.	.	.
cord-023095-4dannjjm	6756	1	The	the	DT
cord-023095-4dannjjm	6756	2	mRNA	mrna	NN
cord-023095-4dannjjm	6756	3	expression	expression	NN
cord-023095-4dannjjm	6756	4	of	of	IN
cord-023095-4dannjjm	6756	5	IL-5	IL-5	NNP
cord-023095-4dannjjm	6756	6	,	,	,
cord-023095-4dannjjm	6756	7	IL-1b	IL-1b	NNP
cord-023095-4dannjjm	6756	8	,	,	,
cord-023095-4dannjjm	6756	9	IL-6	IL-6	NNP
cord-023095-4dannjjm	6756	10	,	,	,
cord-023095-4dannjjm	6756	11	IL-8	IL-8	NNP
cord-023095-4dannjjm	6756	12	and	and	CC
cord-023095-4dannjjm	6756	13	IL-10	IL-10	NNP
cord-023095-4dannjjm	6756	14	was	be	VBD
cord-023095-4dannjjm	6756	15	significantly	significantly	RB
cord-023095-4dannjjm	6756	16	up	up	RB
cord-023095-4dannjjm	6756	17	-	-	HYPH
cord-023095-4dannjjm	6756	18	regulated	regulate	VBN
cord-023095-4dannjjm	6756	19	in	in	IN
cord-023095-4dannjjm	6756	20	BALF	BALF	NNP
cord-023095-4dannjjm	6756	21	from	from	IN
cord-023095-4dannjjm	6756	22	horses	horse	NNS
cord-023095-4dannjjm	6756	23	with	with	IN
cord-023095-4dannjjm	6756	24	IAD.Furthermore	IAD.Furthermore	NNP
cord-023095-4dannjjm	6756	25	,	,	,
cord-023095-4dannjjm	6756	26	the	the	DT
cord-023095-4dannjjm	6756	27	BALF	BALF	NNP
cord-023095-4dannjjm	6756	28	samples	sample	NNS
cord-023095-4dannjjm	6756	29	were	be	VBD
cord-023095-4dannjjm	6756	30	subdivided	subdivide	VBN
cord-023095-4dannjjm	6756	31	in	in	IN
cord-023095-4dannjjm	6756	32	two	two	CD
cord-023095-4dannjjm	6756	33	groups	group	NNS
cord-023095-4dannjjm	6756	34	based	base	VBN
cord-023095-4dannjjm	6756	35	on	on	IN
cord-023095-4dannjjm	6756	36	the	the	DT
cord-023095-4dannjjm	6756	37	differential	differential	JJ
cord-023095-4dannjjm	6756	38	cells	cell	NNS
cord-023095-4dannjjm	6756	39	count	count	VBP
cord-023095-4dannjjm	6756	40	1-BALF	1-balf	CD
cord-023095-4dannjjm	6756	41	with	with	IN
cord-023095-4dannjjm	6756	42	increased	increase	VBN
cord-023095-4dannjjm	6756	43	mast	mast	NN
cord-023095-4dannjjm	6756	44	cells	cell	NNS
cord-023095-4dannjjm	6756	45	(	(	-LRB-
cord-023095-4dannjjm	6756	46	IAD	IAD	NNP
cord-023095-4dannjjm	6756	47	-	-	HYPH
cord-023095-4dannjjm	6756	48	Mast	Mast	NNP
cord-023095-4dannjjm	6756	49	)	)	-RRB-
cord-023095-4dannjjm	6756	50	and	and	CC
cord-023095-4dannjjm	6756	51	2-BALF	2-balf	CD
cord-023095-4dannjjm	6756	52	with	with	IN
cord-023095-4dannjjm	6756	53	increased	increase	VBN
cord-023095-4dannjjm	6756	54	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	6756	55	(	(	-LRB-
cord-023095-4dannjjm	6756	56	IAD	IAD	NNP
cord-023095-4dannjjm	6756	57	-	-	HYPH
cord-023095-4dannjjm	6756	58	Neutro	Neutro	NNP
cord-023095-4dannjjm	6756	59	)	)	-RRB-
cord-023095-4dannjjm	6756	60	.	.	.
cord-023095-4dannjjm	6757	1	IL-4	IL-4	NNP
cord-023095-4dannjjm	6757	2	was	be	VBD
cord-023095-4dannjjm	6757	3	significantly	significantly	RB
cord-023095-4dannjjm	6757	4	down	down	RB
cord-023095-4dannjjm	6757	5	-	-	HYPH
cord-023095-4dannjjm	6757	6	regulated	regulate	VBN
cord-023095-4dannjjm	6757	7	in	in	IN
cord-023095-4dannjjm	6757	8	the	the	DT
cord-023095-4dannjjm	6757	9	IAD	IAD	NNP
cord-023095-4dannjjm	6757	10	-	-	HYPH
cord-023095-4dannjjm	6757	11	Neutro	Neutro	NNP
cord-023095-4dannjjm	6757	12	group	group	NN
cord-023095-4dannjjm	6757	13	compared	compare	VBN
cord-023095-4dannjjm	6757	14	to	to	IN
cord-023095-4dannjjm	6757	15	the	the	DT
cord-023095-4dannjjm	6757	16	IAD	IAD	NNP
cord-023095-4dannjjm	6757	17	-	-	HYPH
cord-023095-4dannjjm	6757	18	Mast	Mast	NNP
cord-023095-4dannjjm	6757	19	group	group	NN
cord-023095-4dannjjm	6757	20	.	.	.
cord-023095-4dannjjm	6758	1	IL-17	IL-17	NNP
cord-023095-4dannjjm	6758	2	,	,	,
cord-023095-4dannjjm	6759	1	IL-5	IL-5	NNP
cord-023095-4dannjjm	6759	2	and	and	CC
cord-023095-4dannjjm	6759	3	IL-8	IL-8	NNP
cord-023095-4dannjjm	6759	4	were	be	VBD
cord-023095-4dannjjm	6759	5	significantly	significantly	RB
cord-023095-4dannjjm	6759	6	up	up	RB
cord-023095-4dannjjm	6759	7	-	-	HYPH
cord-023095-4dannjjm	6759	8	regulated	regulate	VBN
cord-023095-4dannjjm	6759	9	in	in	IN
cord-023095-4dannjjm	6759	10	the	the	DT
cord-023095-4dannjjm	6759	11	IAD	IAD	NNP
cord-023095-4dannjjm	6759	12	-	-	HYPH
cord-023095-4dannjjm	6759	13	Neutro	Neutro	NNP
cord-023095-4dannjjm	6759	14	group	group	NN
cord-023095-4dannjjm	6759	15	compared	compare	VBN
cord-023095-4dannjjm	6759	16	to	to	IN
cord-023095-4dannjjm	6759	17	the	the	DT
cord-023095-4dannjjm	6759	18	IAD	IAD	NNP
cord-023095-4dannjjm	6759	19	-	-	HYPH
cord-023095-4dannjjm	6759	20	Mast	Mast	NNP
cord-023095-4dannjjm	6759	21	group	group	NN
cord-023095-4dannjjm	6759	22	.	.	.
cord-023095-4dannjjm	6760	1	The	the	DT
cord-023095-4dannjjm	6760	2	present	present	JJ
cord-023095-4dannjjm	6760	3	study	study	NN
cord-023095-4dannjjm	6760	4	shows	show	VBZ
cord-023095-4dannjjm	6760	5	that	that	IN
cord-023095-4dannjjm	6760	6	IAD	IAD	NNP
cord-023095-4dannjjm	6760	7	in	in	IN
cord-023095-4dannjjm	6760	8	horses	horse	NNS
cord-023095-4dannjjm	6760	9	is	be	VBZ
cord-023095-4dannjjm	6760	10	characterized	characterize	VBN
cord-023095-4dannjjm	6760	11	by	by	IN
cord-023095-4dannjjm	6760	12	a	a	DT
cord-023095-4dannjjm	6760	13	Th2	Th2	NNP
cord-023095-4dannjjm	6760	14	and	and	CC
cord-023095-4dannjjm	6760	15	a	a	DT
cord-023095-4dannjjm	6760	16	Th17	Th17	NNP
cord-023095-4dannjjm	6760	17	mRNA	mrna	NN
cord-023095-4dannjjm	6760	18	inflammatory	inflammatory	JJ
cord-023095-4dannjjm	6760	19	expression	expression	NN
cord-023095-4dannjjm	6760	20	profile	profile	NN
cord-023095-4dannjjm	6760	21	and	and	CC
cord-023095-4dannjjm	6760	22	that	that	IN
cord-023095-4dannjjm	6760	23	different	different	JJ
cord-023095-4dannjjm	6760	24	immunological	immunological	JJ
cord-023095-4dannjjm	6760	25	mechanisms	mechanism	NNS
cord-023095-4dannjjm	6760	26	are	be	VBP
cord-023095-4dannjjm	6760	27	involved	involve	VBN
cord-023095-4dannjjm	6760	28	in	in	IN
cord-023095-4dannjjm	6760	29	mast	mast	NN
cord-023095-4dannjjm	6760	30	cells	cell	NNS
cord-023095-4dannjjm	6760	31	or	or	CC
cord-023095-4dannjjm	6760	32	neutrophils	neutrophil	NNS
cord-023095-4dannjjm	6760	33	accumulation	accumulation	NN
cord-023095-4dannjjm	6760	34	in	in	IN
cord-023095-4dannjjm	6760	35	the	the	DT
cord-023095-4dannjjm	6760	36	BALF	BALF	NNP
cord-023095-4dannjjm	6760	37	of	of	IN
cord-023095-4dannjjm	6760	38	horses	horse	NNS
cord-023095-4dannjjm	6760	39	with	with	IN
cord-023095-4dannjjm	6760	40	IAD	IAD	NNP
cord-023095-4dannjjm	6760	41	.	.	.
cord-023095-4dannjjm	6761	1	b	b	LS
cord-023095-4dannjjm	6761	2	2	2	CD
cord-023095-4dannjjm	6761	3	-adrenoreceptor	-adrenoreceptor	NNP
cord-023095-4dannjjm	6761	4	(	(	-LRB-
cord-023095-4dannjjm	6761	5	b	b	NN
cord-023095-4dannjjm	6761	6	2	2	CD
cord-023095-4dannjjm	6761	7	-AR	-AR	NNS
cord-023095-4dannjjm	6761	8	)	)	-RRB-
cord-023095-4dannjjm	6761	9	agonists	agonist	NNS
cord-023095-4dannjjm	6761	10	are	be	VBP
cord-023095-4dannjjm	6761	11	a	a	DT
cord-023095-4dannjjm	6761	12	class	class	NN
cord-023095-4dannjjm	6761	13	of	of	IN
cord-023095-4dannjjm	6761	14	medications	medication	NNS
cord-023095-4dannjjm	6761	15	that	that	WDT
cord-023095-4dannjjm	6761	16	promote	promote	VBP
cord-023095-4dannjjm	6761	17	smooth	smooth	JJ
cord-023095-4dannjjm	6761	18	muscle	muscle	NN
cord-023095-4dannjjm	6761	19	relaxation	relaxation	NN
cord-023095-4dannjjm	6761	20	and	and	CC
cord-023095-4dannjjm	6761	21	bronchodilation	bronchodilation	NN
cord-023095-4dannjjm	6761	22	in	in	IN
cord-023095-4dannjjm	6761	23	horses	horse	NNS
cord-023095-4dannjjm	6761	24	and	and	CC
cord-023095-4dannjjm	6761	25	humans	human	NNS
cord-023095-4dannjjm	6761	26	with	with	IN
cord-023095-4dannjjm	6761	27	airway	airway	NN
cord-023095-4dannjjm	6761	28	disease	disease	NN
cord-023095-4dannjjm	6761	29	.	.	.
cord-023095-4dannjjm	6762	1	Activated	activate	VBN
cord-023095-4dannjjm	6762	2	human	human	JJ
cord-023095-4dannjjm	6762	3	peripheral	peripheral	JJ
cord-023095-4dannjjm	6762	4	blood	blood	NN
cord-023095-4dannjjm	6762	5	lymphocytes	lymphocyte	NNS
cord-023095-4dannjjm	6762	6	(	(	-LRB-
cord-023095-4dannjjm	6762	7	PBLs	pbl	NNS
cord-023095-4dannjjm	6762	8	)	)	-RRB-
cord-023095-4dannjjm	6762	9	also	also	RB
cord-023095-4dannjjm	6762	10	respond	respond	VBP
cord-023095-4dannjjm	6762	11	to	to	IN
cord-023095-4dannjjm	6762	12	b	b	NN
cord-023095-4dannjjm	6762	13	2	2	CD
cord-023095-4dannjjm	6762	14	-AR	-ar	NN
cord-023095-4dannjjm	6762	15	agonist	agonist	JJ
cord-023095-4dannjjm	6762	16	stimulation	stimulation	NN
cord-023095-4dannjjm	6762	17	by	by	IN
cord-023095-4dannjjm	6762	18	attenuating	attenuate	VBG
cord-023095-4dannjjm	6762	19	the	the	DT
cord-023095-4dannjjm	6762	20	production	production	NN
cord-023095-4dannjjm	6762	21	of	of	IN
cord-023095-4dannjjm	6762	22	cytokines	cytokine	NNS
cord-023095-4dannjjm	6762	23	associated	associate	VBN
cord-023095-4dannjjm	6762	24	with	with	IN
cord-023095-4dannjjm	6762	25	the	the	DT
cord-023095-4dannjjm	6762	26	pathogenesis	pathogenesis	NN
cord-023095-4dannjjm	6762	27	of	of	IN
cord-023095-4dannjjm	6762	28	asthma	asthma	NN
cord-023095-4dannjjm	6762	29	and	and	CC
cord-023095-4dannjjm	6762	30	Recurrent	Recurrent	NNP
cord-023095-4dannjjm	6762	31	Airway	Airway	NNP
cord-023095-4dannjjm	6762	32	Obstruction	obstruction	NN
cord-023095-4dannjjm	6762	33	(	(	-LRB-
cord-023095-4dannjjm	6762	34	RAO	RAO	NNP
cord-023095-4dannjjm	6762	35	)	)	-RRB-
cord-023095-4dannjjm	6762	36	.	.	.
cord-023095-4dannjjm	6763	1	The	the	DT
cord-023095-4dannjjm	6763	2	aim	aim	NN
cord-023095-4dannjjm	6763	3	of	of	IN
cord-023095-4dannjjm	6763	4	this	this	DT
cord-023095-4dannjjm	6763	5	study	study	NN
cord-023095-4dannjjm	6763	6	was	be	VBD
cord-023095-4dannjjm	6763	7	to	to	TO
cord-023095-4dannjjm	6763	8	develop	develop	VB
cord-023095-4dannjjm	6763	9	an	an	DT
cord-023095-4dannjjm	6763	10	in	in	IN
cord-023095-4dannjjm	6763	11	vitro	vitro	FW
cord-023095-4dannjjm	6763	12	technique	technique	NN
cord-023095-4dannjjm	6763	13	for	for	IN
cord-023095-4dannjjm	6763	14	measuring	measure	VBG
cord-023095-4dannjjm	6763	15	the	the	DT
cord-023095-4dannjjm	6763	16	response	response	NN
cord-023095-4dannjjm	6763	17	of	of	IN
cord-023095-4dannjjm	6763	18	equine	equine	JJ
cord-023095-4dannjjm	6763	19	PBLs	pbl	NNS
cord-023095-4dannjjm	6763	20	to	to	IN
cord-023095-4dannjjm	6763	21	stimulation	stimulation	NN
cord-023095-4dannjjm	6763	22	with	with	IN
cord-023095-4dannjjm	6763	23	Salbutamol	Salbutamol	NNP
cord-023095-4dannjjm	6763	24	,	,	,
cord-023095-4dannjjm	6763	25	a	a	DT
cord-023095-4dannjjm	6763	26	b	b	NN
cord-023095-4dannjjm	6763	27	2	2	CD
cord-023095-4dannjjm	6763	28	-AR	-ar	NN
cord-023095-4dannjjm	6763	29	agonist	agonist	NN
cord-023095-4dannjjm	6763	30	.	.	.
cord-023095-4dannjjm	6764	1	This	this	DT
cord-023095-4dannjjm	6764	2	method	method	NN
cord-023095-4dannjjm	6764	3	was	be	VBD
cord-023095-4dannjjm	6764	4	then	then	RB
cord-023095-4dannjjm	6764	5	used	use	VBN
cord-023095-4dannjjm	6764	6	to	to	TO
cord-023095-4dannjjm	6764	7	compare	compare	VB
cord-023095-4dannjjm	6764	8	the	the	DT
cord-023095-4dannjjm	6764	9	response	response	NN
cord-023095-4dannjjm	6764	10	of	of	IN
cord-023095-4dannjjm	6764	11	PBLs	pbl	NNS
cord-023095-4dannjjm	6764	12	from	from	IN
cord-023095-4dannjjm	6764	13	RAO	RAO	NNP
cord-023095-4dannjjm	6764	14	-	-	HYPH
cord-023095-4dannjjm	6764	15	affected	affect	VBN
cord-023095-4dannjjm	6764	16	and	and	CC
cord-023095-4dannjjm	6764	17	non	non	JJ
cord-023095-4dannjjm	6764	18	-	-	JJ
cord-023095-4dannjjm	6764	19	affected	affected	JJ
cord-023095-4dannjjm	6764	20	horses	horse	NNS
cord-023095-4dannjjm	6764	21	to	to	IN
cord-023095-4dannjjm	6764	22	b	b	NN
cord-023095-4dannjjm	6764	23	2	2	CD
cord-023095-4dannjjm	6764	24	-AR	-ar	NN
cord-023095-4dannjjm	6764	25	agonist	agonist	JJ
cord-023095-4dannjjm	6764	26	stimulation	stimulation	NN
cord-023095-4dannjjm	6764	27	.	.	.
cord-023095-4dannjjm	6765	1	PBLs	pbl	NNS
cord-023095-4dannjjm	6765	2	from	from	IN
cord-023095-4dannjjm	6765	3	4	4	CD
cord-023095-4dannjjm	6765	4	RAO	RAO	NNP
cord-023095-4dannjjm	6765	5	and	and	CC
cord-023095-4dannjjm	6765	6	4	4	CD
cord-023095-4dannjjm	6765	7	nonaffected	nonaffecte	VBN
cord-023095-4dannjjm	6765	8	horses	horse	NNS
cord-023095-4dannjjm	6765	9	were	be	VBD
cord-023095-4dannjjm	6765	10	cultured	cultured	JJ
cord-023095-4dannjjm	6765	11	(	(	-LRB-
cord-023095-4dannjjm	6765	12	4x10	4x10	CD
cord-023095-4dannjjm	6765	13	6	6	CD
cord-023095-4dannjjm	6765	14	/ml	/ml	.
cord-023095-4dannjjm	6765	15	)	)	-RRB-
cord-023095-4dannjjm	6765	16	in	in	IN
cord-023095-4dannjjm	6765	17	RPMI	RPMI	NNP
cord-023095-4dannjjm	6765	18	complete	complete	JJ
cord-023095-4dannjjm	6765	19	media	medium	NNS
cord-023095-4dannjjm	6765	20	with	with	IN
cord-023095-4dannjjm	6765	21	Concanavalin	Concanavalin	NNP
cord-023095-4dannjjm	6765	22	A	A	NNP
cord-023095-4dannjjm	6765	23	(	(	-LRB-
cord-023095-4dannjjm	6765	24	ConA	ConA	NNP
cord-023095-4dannjjm	6765	25	,	,	,
cord-023095-4dannjjm	6765	26	2ug/10	2ug/10	NNP
cord-023095-4dannjjm	6765	27	6	6	CD
cord-023095-4dannjjm	6765	28	cells	cell	NNS
cord-023095-4dannjjm	6765	29	)	)	-RRB-
cord-023095-4dannjjm	6765	30	for	for	IN
cord-023095-4dannjjm	6765	31	0	0	CD
cord-023095-4dannjjm	6765	32	,	,	,
cord-023095-4dannjjm	6765	33	1	1	CD
cord-023095-4dannjjm	6765	34	,	,	,
cord-023095-4dannjjm	6765	35	or	or	CC
cord-023095-4dannjjm	6765	36	2	2	CD
cord-023095-4dannjjm	6765	37	days	day	NNS
cord-023095-4dannjjm	6765	38	then	then	RB
cord-023095-4dannjjm	6765	39	stimulated	stimulate	VBD
cord-023095-4dannjjm	6765	40	with	with	IN
cord-023095-4dannjjm	6765	41	Salbutamol	Salbutamol	NNP
cord-023095-4dannjjm	6765	42	(	(	-LRB-
cord-023095-4dannjjm	6765	43	30	30	CD
cord-023095-4dannjjm	6765	44	minutes	minute	NNS
cord-023095-4dannjjm	6765	45	)	)	-RRB-
cord-023095-4dannjjm	6765	46	.	.	.
cord-023095-4dannjjm	6766	1	Using	use	VBG
cord-023095-4dannjjm	6766	2	flow	flow	NN
cord-023095-4dannjjm	6766	3	cytometric	cytometric	NN
cord-023095-4dannjjm	6766	4	techniques	technique	NNS
cord-023095-4dannjjm	6766	5	,	,	,
cord-023095-4dannjjm	6766	6	response	response	NN
cord-023095-4dannjjm	6766	7	was	be	VBD
cord-023095-4dannjjm	6766	8	measured	measure	VBN
cord-023095-4dannjjm	6766	9	by	by	IN
cord-023095-4dannjjm	6766	10	detecting	detect	VBG
cord-023095-4dannjjm	6766	11	protein	protein	NN
cord-023095-4dannjjm	6766	12	kinase	kinase	VBZ
cord-023095-4dannjjm	6766	13	A	a	DT
cord-023095-4dannjjm	6766	14	phosphorylation	phosphorylation	NN
cord-023095-4dannjjm	6766	15	of	of	IN
cord-023095-4dannjjm	6766	16	vasodilator	vasodilator	NN
cord-023095-4dannjjm	6766	17	stimulated	stimulate	VBD
cord-023095-4dannjjm	6766	18	phosphoprotein	phosphoprotein	NN
cord-023095-4dannjjm	6766	19	(	(	-LRB-
cord-023095-4dannjjm	6766	20	VASP	VASP	NNP
cord-023095-4dannjjm	6766	21	)	)	-RRB-
cord-023095-4dannjjm	6766	22	.	.	.
cord-023095-4dannjjm	6767	1	Results	result	NNS
cord-023095-4dannjjm	6767	2	were	be	VBD
cord-023095-4dannjjm	6767	3	verified	verify	VBN
cord-023095-4dannjjm	6767	4	by	by	IN
cord-023095-4dannjjm	6767	5	western	western	JJ
cord-023095-4dannjjm	6767	6	blot	blot	NN
cord-023095-4dannjjm	6767	7	analysis	analysis	NN
cord-023095-4dannjjm	6767	8	.	.	.
cord-023095-4dannjjm	6768	1	Activated	activated	JJ
cord-023095-4dannjjm	6768	2	PBLs	pbl	NNS
cord-023095-4dannjjm	6768	3	were	be	VBD
cord-023095-4dannjjm	6768	4	then	then	RB
cord-023095-4dannjjm	6768	5	incubated	incubate	VBN
cord-023095-4dannjjm	6768	6	with	with	IN
cord-023095-4dannjjm	6768	7	ConA	ConA	NNP
cord-023095-4dannjjm	6768	8	for	for	IN
cord-023095-4dannjjm	6768	9	one	one	CD
cord-023095-4dannjjm	6768	10	day	day	NN
cord-023095-4dannjjm	6768	11	were	be	VBD
cord-023095-4dannjjm	6768	12	pre	pre	VBN
cord-023095-4dannjjm	6768	13	-	-	JJ
cord-023095-4dannjjm	6768	14	incubated	incubate	VBN
cord-023095-4dannjjm	6769	1	with	with	IN
cord-023095-4dannjjm	6769	2	b	b	NN
cord-023095-4dannjjm	6769	3	2	2	CD
cord-023095-4dannjjm	6769	4	or	or	CC
cord-023095-4dannjjm	6769	5	b	b	NN
cord-023095-4dannjjm	6769	6	-	-	HYPH
cord-023095-4dannjjm	6769	7	adrenoreceptor	adrenoreceptor	NN
cord-023095-4dannjjm	6769	8	antagonist	antagonist	NN
cord-023095-4dannjjm	6769	9	(	(	-LRB-
cord-023095-4dannjjm	6769	10	ICI	ICI	NNP
cord-023095-4dannjjm	6769	11	118,551	118,551	CD
cord-023095-4dannjjm	6769	12	,	,	,
cord-023095-4dannjjm	6769	13	Sigma	Sigma	NNP
cord-023095-4dannjjm	6769	14	s	s	POS
cord-023095-4dannjjm	6769	15	;	;	:
cord-023095-4dannjjm	6769	16	Atenolol	Atenolol	NNP
cord-023095-4dannjjm	6769	17	,	,	,
cord-023095-4dannjjm	6769	18	Sigma	Sigma	NNP
cord-023095-4dannjjm	6769	19	s	s	POS
cord-023095-4dannjjm	6769	20	)	)	-RRB-
cord-023095-4dannjjm	6769	21	for	for	IN
cord-023095-4dannjjm	6769	22	15	15	CD
cord-023095-4dannjjm	6769	23	minutes	minute	NNS
cord-023095-4dannjjm	6769	24	,	,	,
cord-023095-4dannjjm	6769	25	followed	follow	VBN
cord-023095-4dannjjm	6769	26	by	by	IN
cord-023095-4dannjjm	6769	27	30	30	CD
cord-023095-4dannjjm	6769	28	minutes	minute	NNS
cord-023095-4dannjjm	6769	29	Salbutamol	Salbutamol	NNP
cord-023095-4dannjjm	6769	30	(	(	-LRB-
cord-023095-4dannjjm	6769	31	500	500	CD
cord-023095-4dannjjm	6769	32	nM	nm	NN
cord-023095-4dannjjm	6769	33	)	)	-RRB-
cord-023095-4dannjjm	6769	34	stimulation	stimulation	NN
cord-023095-4dannjjm	6769	35	.	.	.
cord-023095-4dannjjm	6770	1	Results	result	NNS
cord-023095-4dannjjm	6770	2	were	be	VBD
cord-023095-4dannjjm	6770	3	analyzed	analyze	VBN
cord-023095-4dannjjm	6770	4	by	by	IN
cord-023095-4dannjjm	6770	5	ANOVA	ANOVA	NNP
cord-023095-4dannjjm	6770	6	or	or	CC
cord-023095-4dannjjm	6770	7	ANCOVA	ANCOVA	NNP
cord-023095-4dannjjm	6770	8	and	and	CC
cord-023095-4dannjjm	6770	9	differences	difference	NNS
cord-023095-4dannjjm	6770	10	were	be	VBD
cord-023095-4dannjjm	6770	11	considered	consider	VBN
cord-023095-4dannjjm	6770	12	significant	significant	JJ
cord-023095-4dannjjm	6770	13	when	when	WRB
cord-023095-4dannjjm	6770	14	p	p	NN
cord-023095-4dannjjm	6770	15	o	o	NN
cord-023095-4dannjjm	6770	16	0.05.Response	0.05.response	NN
cord-023095-4dannjjm	6770	17	to	to	IN
cord-023095-4dannjjm	6770	18	b	b	NN
cord-023095-4dannjjm	6770	19	-	-	HYPH
cord-023095-4dannjjm	6770	20	antagonist	antagonist	NN
cord-023095-4dannjjm	6770	21	was	be	VBD
cord-023095-4dannjjm	6770	22	only	only	RB
cord-023095-4dannjjm	6770	23	observed	observe	VBN
cord-023095-4dannjjm	6770	24	in	in	IN
cord-023095-4dannjjm	6770	25	activated	activate	VBN
cord-023095-4dannjjm	6770	26	PBLs	pbl	NNS
cord-023095-4dannjjm	6770	27	(	(	-LRB-
cord-023095-4dannjjm	6770	28	pre	pre	JJ
cord-023095-4dannjjm	6770	29	-	-	JJ
cord-023095-4dannjjm	6770	30	cultured	cultured	JJ
cord-023095-4dannjjm	6770	31	with	with	IN
cord-023095-4dannjjm	6770	32	Con	Con	NNP
cord-023095-4dannjjm	6770	33	A	A	NNP
cord-023095-4dannjjm	6770	34	)	)	-RRB-
cord-023095-4dannjjm	6770	35	and	and	CC
cord-023095-4dannjjm	6770	36	was	be	VBD
cord-023095-4dannjjm	6770	37	greater	great	JJR
cord-023095-4dannjjm	6770	38	in	in	IN
cord-023095-4dannjjm	6770	39	cells	cell	NNS
cord-023095-4dannjjm	6770	40	from	from	IN
cord-023095-4dannjjm	6770	41	RAO	RAO	NNP
cord-023095-4dannjjm	6770	42	horses	horse	NNS
cord-023095-4dannjjm	6770	43	as	as	IN
cord-023095-4dannjjm	6770	44	compared	compare	VBN
cord-023095-4dannjjm	6770	45	to	to	IN
cord-023095-4dannjjm	6770	46	cells	cell	NNS
cord-023095-4dannjjm	6770	47	from	from	IN
cord-023095-4dannjjm	6770	48	non	non	JJ
cord-023095-4dannjjm	6770	49	-	-	JJ
cord-023095-4dannjjm	6770	50	affected	affected	JJ
cord-023095-4dannjjm	6770	51	horses	horse	NNS
cord-023095-4dannjjm	6770	52	.	.	.
cord-023095-4dannjjm	6771	1	The	the	DT
cord-023095-4dannjjm	6771	2	addition	addition	NN
cord-023095-4dannjjm	6771	3	of	of	IN
cord-023095-4dannjjm	6771	4	b	b	NN
cord-023095-4dannjjm	6771	5	-	-	HYPH
cord-023095-4dannjjm	6771	6	antagonist	antagonist	NN
cord-023095-4dannjjm	6771	7	attenuated	attenuate	VBD
cord-023095-4dannjjm	6771	8	the	the	DT
cord-023095-4dannjjm	6771	9	response	response	NN
cord-023095-4dannjjm	6771	10	of	of	IN
cord-023095-4dannjjm	6771	11	PBLs	pbl	NNS
cord-023095-4dannjjm	6771	12	to	to	IN
cord-023095-4dannjjm	6771	13	Salbutamol	Salbutamol	NNP
cord-023095-4dannjjm	6771	14	while	while	IN
cord-023095-4dannjjm	6771	15	the	the	DT
cord-023095-4dannjjm	6771	16	addition	addition	NN
cord-023095-4dannjjm	6771	17	of	of	IN
cord-023095-4dannjjm	6771	18	a	a	DT
cord-023095-4dannjjm	6771	19	b	b	NN
cord-023095-4dannjjm	6771	20	1	1	CD
cord-023095-4dannjjm	6771	21	-antagonist	-antagonist	SYM
cord-023095-4dannjjm	6771	22	had	have	VBD
cord-023095-4dannjjm	6771	23	no	no	DT
cord-023095-4dannjjm	6771	24	effect	effect	NN
cord-023095-4dannjjm	6771	25	.	.	.
cord-023095-4dannjjm	6772	1	These	these	DT
cord-023095-4dannjjm	6772	2	findings	finding	NNS
cord-023095-4dannjjm	6772	3	indicate	indicate	VBP
cord-023095-4dannjjm	6772	4	that	that	IN
cord-023095-4dannjjm	6772	5	activated	activate	VBN
cord-023095-4dannjjm	6772	6	PBLs	pbl	NNS
cord-023095-4dannjjm	6772	7	from	from	IN
cord-023095-4dannjjm	6772	8	RAO	RAO	NNP
cord-023095-4dannjjm	6772	9	-	-	HYPH
cord-023095-4dannjjm	6772	10	affected	affect	VBN
cord-023095-4dannjjm	6772	11	horses	horse	NNS
cord-023095-4dannjjm	6772	12	have	have	VBP
cord-023095-4dannjjm	6772	13	a	a	DT
cord-023095-4dannjjm	6772	14	greater	great	JJR
cord-023095-4dannjjm	6772	15	response	response	NN
cord-023095-4dannjjm	6772	16	to	to	IN
cord-023095-4dannjjm	6772	17	Salbutamol	Salbutamol	NNP
cord-023095-4dannjjm	6772	18	as	as	IN
cord-023095-4dannjjm	6772	19	compared	compare	VBN
cord-023095-4dannjjm	6772	20	to	to	IN
cord-023095-4dannjjm	6772	21	PBLs	pbl	NNS
cord-023095-4dannjjm	6772	22	from	from	IN
cord-023095-4dannjjm	6772	23	non	non	JJ
cord-023095-4dannjjm	6772	24	-	-	JJ
cord-023095-4dannjjm	6772	25	affected	affected	JJ
cord-023095-4dannjjm	6772	26	horses	horse	NNS
cord-023095-4dannjjm	6772	27	,	,	,
cord-023095-4dannjjm	6772	28	and	and	CC
cord-023095-4dannjjm	6772	29	this	this	DT
cord-023095-4dannjjm	6772	30	response	response	NN
cord-023095-4dannjjm	6772	31	is	be	VBZ
cord-023095-4dannjjm	6772	32	mediated	mediate	VBN
cord-023095-4dannjjm	6772	33	mainly	mainly	RB
cord-023095-4dannjjm	6772	34	through	through	IN
cord-023095-4dannjjm	6772	35	the	the	DT
cord-023095-4dannjjm	6772	36	b	b	NN
cord-023095-4dannjjm	6772	37	2	2	CD
cord-023095-4dannjjm	6772	38	-AR.Human	-ar.human	NN
cord-023095-4dannjjm	6772	39	b	b	NN
cord-023095-4dannjjm	6772	40	2	2	CD
cord-023095-4dannjjm	6772	41	-AR	-AR	NNS
cord-023095-4dannjjm	6772	42	are	be	VBP
cord-023095-4dannjjm	6772	43	known	know	VBN
cord-023095-4dannjjm	6772	44	be	be	VB
cord-023095-4dannjjm	6772	45	polymorphic	polymorphic	JJ
cord-023095-4dannjjm	6772	46	and	and	CC
cord-023095-4dannjjm	6772	47	this	this	DT
cord-023095-4dannjjm	6772	48	polymorphism	polymorphism	NN
cord-023095-4dannjjm	6772	49	results	result	VBZ
cord-023095-4dannjjm	6772	50	in	in	IN
cord-023095-4dannjjm	6772	51	a	a	DT
cord-023095-4dannjjm	6772	52	variable	variable	JJ
cord-023095-4dannjjm	6772	53	response	response	NN
cord-023095-4dannjjm	6772	54	to	to	IN
cord-023095-4dannjjm	6772	55	b	b	NN
cord-023095-4dannjjm	6772	56	2	2	CD
cord-023095-4dannjjm	6772	57	-agonist	-agonist	NN
cord-023095-4dannjjm	6772	58	binding	binding	NN
cord-023095-4dannjjm	6772	59	that	that	WDT
cord-023095-4dannjjm	6772	60	affects	affect	VBZ
cord-023095-4dannjjm	6772	61	long	long	JJ
cord-023095-4dannjjm	6772	62	term	term	NN
cord-023095-4dannjjm	6772	63	outcome	outcome	NN
cord-023095-4dannjjm	6772	64	in	in	IN
cord-023095-4dannjjm	6772	65	human	human	JJ
cord-023095-4dannjjm	6772	66	asthmatics	asthmatic	NNS
cord-023095-4dannjjm	6772	67	.	.	.
cord-023095-4dannjjm	6773	1	Further	further	JJ
cord-023095-4dannjjm	6773	2	studies	study	NNS
cord-023095-4dannjjm	6773	3	are	be	VBP
cord-023095-4dannjjm	6773	4	required	require	VBN
cord-023095-4dannjjm	6773	5	to	to	TO
cord-023095-4dannjjm	6773	6	determine	determine	VB
cord-023095-4dannjjm	6773	7	if	if	IN
cord-023095-4dannjjm	6773	8	the	the	DT
cord-023095-4dannjjm	6773	9	difference	difference	NN
cord-023095-4dannjjm	6773	10	in	in	IN
cord-023095-4dannjjm	6773	11	response	response	NN
cord-023095-4dannjjm	6773	12	of	of	IN
cord-023095-4dannjjm	6773	13	PBLs	pbl	NNS
cord-023095-4dannjjm	6773	14	from	from	IN
cord-023095-4dannjjm	6773	15	RAO	RAO	NNP
cord-023095-4dannjjm	6773	16	affected	affect	VBD
cord-023095-4dannjjm	6773	17	as	as	IN
cord-023095-4dannjjm	6773	18	compared	compare	VBN
cord-023095-4dannjjm	6773	19	to	to	IN
cord-023095-4dannjjm	6773	20	non	non	JJ
cord-023095-4dannjjm	6773	21	-	-	JJ
cord-023095-4dannjjm	6773	22	affected	affected	JJ
cord-023095-4dannjjm	6773	23	horses	horse	NNS
cord-023095-4dannjjm	6773	24	is	be	VBZ
cord-023095-4dannjjm	6773	25	due	due	JJ
cord-023095-4dannjjm	6773	26	to	to	IN
cord-023095-4dannjjm	6773	27	genetic	genetic	JJ
cord-023095-4dannjjm	6773	28	polymorphism	polymorphism	NN
cord-023095-4dannjjm	6773	29	in	in	IN
cord-023095-4dannjjm	6773	30	the	the	DT
cord-023095-4dannjjm	6773	31	equine	equine	NN
cord-023095-4dannjjm	6773	32	b	b	NN
cord-023095-4dannjjm	6773	33	2	2	CD
cord-023095-4dannjjm	6773	34	-AR	-AR	NNS
cord-023095-4dannjjm	6773	35	,	,	,
cord-023095-4dannjjm	6773	36	and	and	CC
cord-023095-4dannjjm	6773	37	whether	whether	IN
cord-023095-4dannjjm	6773	38	this	this	DT
cord-023095-4dannjjm	6773	39	difference	difference	NN
cord-023095-4dannjjm	6773	40	is	be	VBZ
cord-023095-4dannjjm	6773	41	associated	associate	VBN
cord-023095-4dannjjm	6773	42	with	with	IN
cord-023095-4dannjjm	6773	43	a	a	DT
cord-023095-4dannjjm	6773	44	propensity	propensity	NN
cord-023095-4dannjjm	6773	45	for	for	IN
cord-023095-4dannjjm	6773	46	horses	horse	NNS
cord-023095-4dannjjm	6773	47	to	to	TO
cord-023095-4dannjjm	6773	48	develop	develop	VB
cord-023095-4dannjjm	6773	49	equine	equine	JJ
cord-023095-4dannjjm	6773	50	RAO	RAO	NNP
cord-023095-4dannjjm	6773	51	.	.	.